id,Uniprot,Gene names,Protein names,Sequence Window,Modified sequence,Aa Position,Known site,EOC 1,EOC 2,EOC 3,EOC 4,FTE 13,FTE 14,FTE 15,FTE 16,FTE 17,OSE 26,OSE 27,OSE 28,OSE 29,AvgExp,EOC 1 mean normalized,EOC 2  mean normalized,EOC 3  mean normalized,EOC 4  mean normalized,FTE 13  mean normalized,FTE 14  mean normalized,FTE 15  mean normalized,FTE 16  mean normalized,FTE 17  mean normalized,OSE 26  mean normalized,OSE 27  mean normalized,OSE 28  mean normalized,OSE 29  mean normalized,GOBP,GOCC ,Tf domains,Kinases,Phosphatases,Adaptors,p value,adj p value,EOC vs FTE p value,EOC vs OSE_ p value,FTE vs OSE p value,PCA component 1,"Significant in Lawrence et al , 2014", Cluster,Protein identified,phopsphorylated site/protein significance
78,O00161,SNAP23,Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23),HQITDESLESTRR,_AHQITDES(ph)LESTRR_,S20,+,20.76,23.42,,23.73,26.09,26.20,25.85,25.82,25.52,23.61,24.80,,,24.58,-3.82,-1.16, ,-0.85,1.51,1.62,1.27,1.24,0.94,-0.97,0.22, , ,post-Golgi vesicle-mediated transport;protein transport;exocytosis;cellular membrane fusion;vesicle targeting,Golgi apparatus;specific granule;neuron projection;synapse;cell junction;azurophil granule;nucleus;plasma membrane,,,,,1.52E-03,1.28E-02,2.77E-04,6.68E-02,5.06E-02,,,A, YES,
96,O00264,PGRMC1,Membrane-associated progesterone receptor component 1 (mPR),PAASGDSDDDEPP,_GDQPAASGDS(ph)DDDEPPPLPR_,S57,+,28.07,27.17,27.77,25.72,31.31,30.18,30.49,30.28,30.50,31.53,30.74,30.50,30.37,29.59,-1.51,-2.41,-1.82,-3.87,1.73,0.60,0.90,0.69,0.91,1.95,1.15,0.91,0.78,,integral to membrane;nucleolus;endoplasmic reticulum;endoplasmic reticulum membrane;cell surface,,,,,8.2E-06,4.38E-04,9.6E-06,8.68E-06,6.9E-01,,,A, YES,+
158,O00767,SCD,Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase),AVKEKGSTLDLSD,_EKGS(ph)TLDLSDLEAEK_,S198,+,19.39,,,,25.75,24.82,25.66,26.15,25.32,25.19,23.78,24.73,24.47,24.53,-5.13, , , ,1.22,0.30,1.14,1.62,0.79,0.66,-0.75,0.20,-0.05,fatty acid biosynthetic process,integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,1.3E-05,6.08E-04,6.66E-06,4.78E-05,7.35E-02,,,A, YES,
182,O14578,CIT,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),RLHRRVSEVEAVL,_RVS(ph)EVEAVLSQK_,S108,+,,,,20.94,25.16,25.20,25.21,25.70,23.40,23.83,,24.33,23.36,24.13, , , ,-3.18,1.04,1.07,1.08,1.58,-0.72,-0.30, ,0.20,-0.76,generation of neurons;cell cycle cytokinesis;spermatogenesis;dendrite development;mitosis;mitotic metaphase/anaphase transition;negative regulation of dendrite morphogenesis;intracellular signal transduction;mitotic sister chromatid segregation,vacuole;actin cytoskeleton;ruffle,,+,,,3.56E-03,2.18E-02,1.42E-03,1.46E-02,1.14E-01,,,A, YES,
199,O14647,CHD2,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),AVSDPRSPPSQKS,_(gl)QPLPPLHPAVSDPRS(ph)PPSQK_,S1789,,21.77,22.94,22.05,22.20,,,24.25,,25.47,25.53,24.39,25.16,,23.75,-1.98,-0.81,-1.70,-1.55, , ,0.50, ,1.72,1.78,0.64,1.41, ,regulation of transcription from RNA polymerase II promoter,nucleus,,,,,2.91E-03,1.94E-02,4.14E-03,1.14E-03,8.34E-01,,,A, YES,
219,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),EIQKENSREALAE,_ENS(ph)REALAEAALESPRPALVR_,S269,+,,22.99,23.54,22.05,,,24.96,,24.38,25.57,26.59,27.30,,24.67, ,-1.68,-1.13,-2.62, , ,0.29, ,-0.29,0.89,1.92,2.62, ,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,1.37E-03,1.22E-02,2.43E-02,2.47E-04,5.02E-02,,,A, YES,
237,O14924,RGS12,Regulator of G-protein signaling 12 (RGS12),SQQVPSSPASKHS,_ALPDSQQVPSS(ph)PASK_,S49,+,21.81,23.59,23.59,23.87,24.39,25.27,25.14,25.62,24.48,23.53,24.52,23.38,23.88,24.08,-2.28,-0.49,-0.49,-0.21,0.31,1.19,1.06,1.53,0.40,-0.55,0.44,-0.70,-0.21,regulation of G-protein coupled receptor protein signaling pathway;termination of G-protein coupled receptor signaling pathway,condensed nuclear chromosome;plasma membrane;cytoplasm,,,,,5.96E-03,3.09E-02,1.76E-03,1.48E-01,4.63E-02,,,A,,
328,O15320,CTAGE5,cTAGE family member 5 (Protein cTAGE-5) (Meningioma-expressed antigen 6/11),ETRAFLSPPTLLE,_AFLS(ph)PPTLLEGPLR_,S456,+,25.09,23.91,22.84,25.07,27.19,26.54,26.41,26.69,27.51,26.18,26.60,26.04,27.78,25.99,-0.89,-2.07,-3.15,-0.92,1.20,0.55,0.42,0.70,1.52,0.19,0.62,0.05,1.79,,,,,,,1.06E-03,1.02E-02,5.24E-04,1.75E-03,7.1E-01,,,A, YES,
374,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),KFHALSSPQSPFP,_FHALSS(ph)PQSPFPSTPTSR_,S1544,+,22.83,21.62,22.12,22.85,26.31,24.69,24.12,25.98,27.14,26.23,23.97,,,24.35,-1.52,-2.73,-2.23,-1.50,1.96,0.34,-0.23,1.63,2.79,1.88,-0.38, , ,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,1.71E-03,1.39E-02,3.61E-04,8.48E-03,5.6E-01,,,A, YES,
379,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),KLIDLESPTPESQ,_LIDLES(ph)PTPESQK_,S1528,+,25.58,26.07,26.23,27.74,29.54,30.44,29.45,29.25,30.20,28.86,28.91,28.08,30.17,28.50,-2.92,-2.43,-2.27,-0.76,1.04,1.94,0.95,0.75,1.70,0.36,0.41,-0.42,1.67,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,6.54E-05,1.61E-03,2.1E-05,4.61E-04,1.99E-01,,,A, YES,
380,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),DPVVHLSPNKQGH,_QDPVVHLS(ph)PNK_,S1249,+,23.44,22.18,21.07,25.07,23.77,26.57,25.97,26.28,26.45,25.67,24.63,24.32,27.08,24.81,-1.36,-2.63,-3.74,0.26,-1.04,1.77,1.16,1.47,1.65,0.86,-0.18,-0.49,2.27,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,1.11E-02,4.86E-02,4.59E-03,1.62E-02,6.48E-01,,,A, YES,
391,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),LPAFRESPSGRLM,_VLPAFRES(ph)PSGR_,S1234,+,23.50,22.98,,24.90,26.67,27.28,25.98,25.77,25.91,25.10,24.62,25.35,24.19,25.19,-1.69,-2.21, ,-0.29,1.49,2.09,0.79,0.59,0.72,-0.09,-0.57,0.16,-0.99,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,2.16E-03,1.64E-02,7.96E-04,1.38E-01,1.37E-02,,,A, YES,
424,O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),KGLLSDSMTDVPV,_GLLSDS(ph)M(ox)TDVPVDTGVAAR_,S21,+,25.83,20.14,20.38,,26.16,,26.10,25.46,24.82,25.41,25.27,25.36,26.03,24.63,1.19,-4.50,-4.26, ,1.53, ,1.47,0.82,0.19,0.78,0.64,0.73,1.39,regulation of cell proliferation,perinuclear region of cytoplasm,,,,,9.28E-03,4.25E-02,5.95E-03,7.32E-03,9.11E-01,,,A, YES,
486,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),KVFDDESDEKEDE,_VFDDES(ph)DEKEDEEYADEK_,S642,+,28.24,27.10,27.58,27.62,28.24,29.89,29.57,29.15,29.84,29.71,28.58,28.47,28.65,28.66,-0.43,-1.56,-1.09,-1.04,-0.42,1.22,0.91,0.49,1.17,1.05,-0.08,-0.20,-0.02,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,8.63E-03,4.05E-02,2.91E-03,2.16E-02,4.17E-01,,,A, YES,
488,O43731,KDELR3,ER lumen protein retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3) (KDEL receptor 3),LKGKKLSLPMPI_,_KLS(ph)LPM(ox)PI_,S209,,19.77,23.21,20.52,18.90,24.22,25.82,23.71,21.61,23.55,,24.78,,26.69,22.98,-3.21,0.23,-2.46,-4.08,1.24,2.84,0.73,-1.37,0.57, ,1.80, ,3.71,protein retention in ER lumen;vesicle-mediated transport;protein transport;activation of signaling protein activity involved in unfolded protein response,integral to membrane;endoplasmic reticulum membrane,,,,,5.61E-03,2.96E-02,1.26E-02,2.53E-03,1.52E-01,,,A, YES,
597,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),GSDNYGSLSRVTR,_HYEDGYPGGSDNYGS(ph)LSR_,S230,+,25.74,24.72,22.35,25.38,27.38,27.66,27.04,27.21,27.64,26.11,25.53,27.31,27.65,26.29,-0.55,-1.57,-3.93,-0.90,1.10,1.37,0.75,0.92,1.35,-0.17,-0.76,1.02,1.36,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,5.54E-03,2.95E-02,1.7E-03,2.08E-02,3E-01,,,A, YES,
696,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),TGQRLVSPGSANE,_LVS(ph)PGSANETSSILVESVTR_,S2509,+,25.39,25.29,24.11,26.42,28.28,27.09,26.70,26.70,27.59,28.79,28.69,27.06,29.39,27.04,-1.65,-1.75,-2.93,-0.62,1.25,0.05,-0.34,-0.34,0.55,1.75,1.65,0.02,2.35,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,1E-03,1E-02,9.35E-03,2.69E-04,6.69E-02,+,,A, YES,
697,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),DEEIPRSPFKVKV,_YADEEIPRS(ph)PFK_,S1536,+,,23.72,22.47,25.47,25.44,25.75,26.28,25.96,26.69,26.22,26.49,28.01,27.71,25.85, ,-2.13,-3.38,-0.38,-0.41,-0.10,0.43,0.11,0.84,0.36,0.64,2.16,1.86,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,3.2E-03,2.06E-02,1.57E-02,9.99E-04,1.11E-01,+,,A, YES,
698,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),DSQSWRSPLKALS,_ADDTDSQSWRS(ph)PLK_,S1474,,23.52,24.05,24.55,23.33,27.02,25.84,26.66,26.56,25.71,27.03,25.29,25.00,25.88,25.42,-1.90,-1.37,-0.87,-2.09,1.60,0.42,1.24,1.14,0.29,1.61,-0.13,-0.42,0.46,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,7.05E-04,8.1E-03,2.33E-04,2.98E-03,3.11E-01,+,,A, YES,
699,O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),APKAQLSPGIYDD,_AQLS(ph)PGIYDDTSAR_,S1472,+,25.25,23.53,23.27,24.88,25.98,26.76,25.60,25.89,26.17,25.45,24.17,25.01,25.17,25.16,0.08,-1.64,-1.90,-0.29,0.82,1.60,0.43,0.73,1.01,0.28,-0.99,-0.15,0.01,"cerebellum development;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;spindle assembly;definitive erythrocyte differentiation;transforming growth factor beta receptor signaling pathway;cholesterol homeostasis;negative regulation of phosphatidylinositol 3-kinase cascade;transcription initiation from RNA polymerase II promoter;regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;positive regulation of histone deacetylation;negative regulation of JNK cascade;Notch signaling pathway;regulation of fatty acid transport;circadian regulation of gene expression;thalamus development;chromatin modification;regulation of multicellular organism growth",spindle microtubule;nuclear chromatin;transcription factor complex;transcriptional repressor complex;perinuclear region of cytoplasm,Other TF domain,,,,1.13E-02,4.9E-02,3.73E-03,2.55E-01,4.67E-02,,,A, YES,
737,O75427,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),TTSVPGSPGLPGR,_(ac)AAAVAAPLAAGGEEAAATTSVPGS(ph)PGLPGRR_,S25,+,28.24,27.81,28.35,27.17,28.22,27.09,27.92,28.06,27.87,29.10,28.96,29.50,30.32,28.36,-0.12,-0.55,0.00,-1.19,-0.13,-1.26,-0.43,-0.29,-0.49,0.75,0.61,1.15,1.96,nervous system development,PML body,,,,,6.02E-03,3.11E-02,6.98E-01,3.62E-03,5.6E-03,,,A, YES,
743,O75448,MED24,Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component) (ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4) (CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component) (Trap100) (hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component) (DRIP100),DANILSSPTDRSM,_LLSSNEDDANILSS(ph)PTDR_,S783,+,25.15,22.94,22.94,24.05,27.13,26.91,26.62,26.28,26.38,26.84,25.16,25.61,,25.50,-0.35,-2.56,-2.56,-1.45,1.63,1.41,1.12,0.78,0.88,1.34,-0.34,0.11, ,"transcription initiation from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;protein heterooligomerization;androgen receptor signaling pathway",mediator complex,,,,,3.4E-03,2.13E-02,8.93E-04,1.99E-02,2.21E-01,,,A, YES,
801,O75925,PIAS1,E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein),SLPHQASPVSRTP,_GILSLPHQAS(ph)PVSR_,S494,+,21.49,23.09,23.28,21.67,24.90,24.20,24.44,24.88,24.70,24.37,23.97,23.20,24.01,23.71,-2.21,-0.62,-0.42,-2.04,1.19,0.50,0.73,1.17,1.00,0.66,0.26,-0.50,0.30,"regulation of interferon-gamma-mediated signaling pathway;JAK-STAT cascade;interferon-gamma-mediated signaling pathway;positive regulation of transcription, DNA-dependent;protein sumoylation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;androgen receptor signaling pathway;positive regulation of protein sumoylation",nucleoplasm;nuclear speck,SAP-domain,,,,9.81E-04,1E-02,2.7E-04,8.04E-03,1.6E-01,,,A, YES,
806,O75970,MPDZ,Multiple PDZ domain protein (Multi-PDZ domain protein 1),TKDADLSPVNASI,_DADLS(ph)PVNASIIK_,S483,+,,21.82,21.82,22.68,,23.21,25.71,24.17,25.43,26.76,26.05,24.73,25.59,24.36, ,-2.55,-2.55,-1.68, ,-1.15,1.34,-0.19,1.07,2.40,1.69,0.37,1.23,cell adhesion;virus-host interaction,apical plasma membrane;Schmidt-Lanterman incisure;postsynaptic density;cytoplasm;cytoplasmic vesicle;tight junction;postsynaptic membrane;apicolateral plasma membrane,,,,,3.46E-03,2.15E-02,1.45E-02,1.1E-03,1.17E-01,,,A, YES,
813,O76021,RSL1D1,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),VKATNESEDEIPQ,_ATNES(ph)EDEIPQLVPIGKK_,S361,+,29.61,25.54,25.81,26.93,31.49,29.44,29.15,29.91,29.91,31.03,29.50,30.34,30.58,29.17,0.43,-3.63,-3.37,-2.25,2.31,0.27,-0.02,0.74,0.74,1.86,0.33,1.17,1.41,regulation of protein localization;translation,nucleolus;large ribosomal subunit,,,,,1.14E-03,1.07E-02,1.23E-03,7.51E-04,6.48E-01,,,A, YES,
887,O94979,SEC31A,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),SDQVAQSDGEESP,_DSDQVAQS(ph)DGEESPAAEEQLLGEHIK_,S527,+,,23.05,23.05,24.09,24.11,24.44,26.80,24.74,27.09,26.55,27.42,27.87,26.74,25.50, ,-2.44,-2.44,-1.41,-1.39,-1.06,1.31,-0.75,1.60,1.05,1.93,2.37,1.24,COPII vesicle coating;response to calcium ion;antigen processing and presentation of peptide antigen via MHC class I;post-translational protein modification;activation of signaling protein activity involved in unfolded protein response;protein transport;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,endosome;cytosol;COPII vesicle coat;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,4.24E-03,2.45E-02,5.12E-02,1.52E-03,2.91E-02,,,A, YES,
959,O95365,ZBTB7A,Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A),EDEDVASPDGLGR,_HFKDEDEDEDVAS(ph)PDGLGR_,S549,+,24.36,21.09,21.09,22.58,26.62,25.99,25.28,25.86,25.91,24.47,23.17,23.48,23.65,24.12,0.24,-3.03,-3.03,-1.54,2.50,1.87,1.16,1.74,1.79,0.35,-0.95,-0.64,-0.47,"regulation of osteoclast differentiation;multicellular organismal development;cell differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,5.46E-04,6.8E-03,2.47E-04,1.72E-01,2.72E-03,,,A, YES,
1016,O95674,CDS2,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),VDGETASDSESRA,_VDGETAS(ph)DSESR_,S33,+,26.10,23.38,23.48,22.92,23.43,24.67,27.69,25.82,19.85,30.62,29.17,28.69,28.30,25.70,0.40,-2.32,-2.22,-2.79,-2.27,-1.03,1.99,0.12,-5.85,4.92,3.47,2.99,2.60,small molecule metabolic process;CDP-diacylglycerol biosynthetic process;phosphatidylglycerol biosynthetic process,integral to membrane;mitochondrial inner membrane;endoplasmic reticulum,,,,,9.21E-04,9.65E-03,7.11E-01,6.73E-04,9.14E-04,,,A, YES,+
1033,O95772,STARD3NL,MLN64 N-terminal domain homolog (STARD3 N-terminal-like protein),LIVQDASERAALI,_LLIVQDAS(ph)ER_,S193,+,22.41,24.44,24.71,23.19,25.38,25.51,24.88,24.86,24.52,26.26,26.06,24.93,25.11,24.79,-2.38,-0.35,-0.08,-1.60,0.59,0.73,0.09,0.07,-0.27,1.47,1.27,0.14,0.33,,integral to membrane;late endosome membrane,,,,,9.4E-03,4.28E-02,1.92E-02,3.39E-03,3.21E-01,,,A, YES,
1053,O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",GTPRSLSAIDRAG,_SLS(ph)AIDR_,S264,+,24.56,24.19,24.83,21.66,25.87,25.94,25.82,25.12,25.89,26.56,25.75,25.36,26.33,25.22,-0.66,-1.04,-0.39,-3.57,0.65,0.71,0.60,-0.10,0.67,1.34,0.53,0.14,1.11,activation of cysteine-type endopeptidase activity involved in apoptotic process;neuron differentiation;neuron apoptotic process;apoptotic DNA fragmentation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cell redox homeostasis;mitochondrial respiratory chain complex I assembly,cytosol;mitochondrial inner membrane;nucleus;mitochondrial membrane part;perinuclear region of cytoplasm;mitochondrial intermembrane space,,,,,3.55E-03,2.18E-02,3.6E-03,2.13E-03,6.58E-01,,,A, YES,
1060,O96013,PAK4,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),RDKRPLSGPDVGT,_RPLS(ph)GPDVGTPQPAGLASGAK_,S181,+,23.65,23.72,24.26,23.99,24.85,,26.38,25.70,25.39,25.43,26.66,26.85,25.46,25.20,-1.55,-1.48,-0.93,-1.20,-0.35, ,1.19,0.50,0.20,0.24,1.46,1.65,0.27,cell proliferation;signal transduction;cell migration;apoptotic process;cytoskeleton organization;cell growth;cell cycle,Golgi apparatus,,+,,,2.26E-03,1.67E-02,5.24E-03,7.88E-04,3.62E-01,,,A, YES,
1124,P02686,MBP,Myelin basic protein (MBP) (Myelin A1 protein) (Myelin membrane encephalitogenic protein),HLIRLFSRDAPGR,_LFS(ph)RDAPGREDNTFK_,S96,+,22.25,23.11,23.94,21.94,22.84,23.90,26.23,23.42,26.40,26.86,24.96,27.29,24.70,24.45,-2.20,-1.34,-0.51,-2.51,-1.61,-0.55,1.78,-1.03,1.95,2.41,0.51,2.84,0.25,myelination;immune response;central nervous system development;response to toxin;synaptic transmission;negative regulation of axonogenesis;axon ensheathment,neuronal cell body;compact myelin;plasma membrane;internode region of axon,,,,,4.03E-03,2.36E-02,2.25E-02,1.15E-03,1.18E-01,,,A,,
1170,P05386,RPLP1,60S acidic ribosomal protein P1,EAKKEESEESDDD,_KEES(ph)EES(ph)DDDMGFGLFD_,S102,+,31.02,,,,,,25.64,23.35,26.21,21.30,25.25,24.23,25.86,25.36,5.66, , , , , ,0.28,-2.01,0.85,-4.05,-0.10,-1.13,0.50,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,3.43E-03,2.14E-02,4.71E-03,1.51E-03,4.31E-01,,,A, YES,
1179,P05412,JUN,Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),GETPPLSPIDMES,_EEPQTVPEM(ox)PGETPPLS(ph)PIDM(ox)ESQER_,S243,+,23.55,22.83,,23.98,,,,,26.80,26.30,25.24,24.70,25.29,24.84,-1.28,-2.00, ,-0.86, , , , ,1.97,1.46,0.40,-0.14,0.45,"negative regulation of cell proliferation;toll-like receptor 4 signaling pathway;negative regulation of transcription, DNA-dependent;liver development;SMAD protein import into nucleus;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;negative regulation by host of viral transcription;transforming growth factor beta receptor signaling pathway;negative regulation of protein autophosphorylation;SMAD protein signal transduction;response to mechanical stimulus;positive regulation of neuron apoptotic process;positive regulation of fibroblast proliferation;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;leading edge cell differentiation;response to cAMP;TRIF-dependent toll-like receptor signaling pathway;response to radiation;cellular response to potassium ion starvation;response to hydrogen peroxide;monocyte differentiation;negative regulation of neuron apoptotic process;membrane depolarization;response to cytokine stimulus;learning;toll-like receptor 1 signaling pathway;positive regulation of DNA replication;aging;response to drug;microglial cell activation;axon regeneration;circadian rhythm;negative regulation of DNA binding;release of cytochrome c from mitochondria;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 3 signaling pathway;angiogenesis;regulation of cell cycle;cellular response to calcium ion;innate immune response;positive regulation by host of viral transcription;positive regulation of monocyte differentiation;positive regulation of endothelial cell proliferation;positive regulation of smooth muscle cell proliferation",nucleoplasm;cytosol;nuclear euchromatin;transcription factor complex;transcriptional repressor complex,bZIP,,,,8.33E-03,3.96E-02,5.34E-03,1.18E-02,1.55E-01,,,A,,
1181,P05412,JUN,Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),NSDLLTSPDVGLL,_NSDLLTS(ph)PDVGLLK_,S63,+,24.22,21.66,22.40,23.27,24.62,23.17,23.70,24.20,25.38,27.36,25.15,24.40,25.73,24.25,-0.03,-2.59,-1.85,-0.98,0.37,-1.08,-0.55,-0.05,1.13,3.11,0.90,0.15,1.48,"negative regulation of cell proliferation;toll-like receptor 4 signaling pathway;negative regulation of transcription, DNA-dependent;liver development;SMAD protein import into nucleus;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;negative regulation by host of viral transcription;transforming growth factor beta receptor signaling pathway;negative regulation of protein autophosphorylation;SMAD protein signal transduction;response to mechanical stimulus;positive regulation of neuron apoptotic process;positive regulation of fibroblast proliferation;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;leading edge cell differentiation;response to cAMP;TRIF-dependent toll-like receptor signaling pathway;response to radiation;cellular response to potassium ion starvation;response to hydrogen peroxide;monocyte differentiation;negative regulation of neuron apoptotic process;membrane depolarization;response to cytokine stimulus;learning;toll-like receptor 1 signaling pathway;positive regulation of DNA replication;aging;response to drug;microglial cell activation;axon regeneration;circadian rhythm;negative regulation of DNA binding;release of cytochrome c from mitochondria;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 3 signaling pathway;angiogenesis;regulation of cell cycle;cellular response to calcium ion;innate immune response;positive regulation by host of viral transcription;positive regulation of monocyte differentiation;positive regulation of endothelial cell proliferation;positive regulation of smooth muscle cell proliferation",nucleoplasm;cytosol;nuclear euchromatin;transcription factor complex;transcriptional repressor complex,bZIP,,,,6.8E-03,3.37E-02,4.84E-02,1.88E-03,9.2E-02,,,A,,
1184,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",KASLENSLREVEA,_ASLENS(ph)LREVEAR_,S323,,20.58,,,20.21,24.49,24.20,22.66,24.44,22.97,,,23.42,,22.87,-2.29, , ,-2.66,1.62,1.33,-0.21,1.57,0.10, , ,0.55, ,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,6.65E-03,3.34E-02,1.08E-03,3.31E-02,7.44E-01,,,A,,
1185,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",PQVRDWSHYFKII,_DWS(ph)HYFK_,S127,+,19.47,21.35,21.35,18.70,22.68,21.80,22.32,22.40,,22.50,23.12,23.01,21.95,21.72,-2.25,-0.37,-0.37,-3.02,0.96,0.07,0.60,0.68, ,0.78,1.40,1.29,0.22,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,1.04E-03,1.02E-02,1.57E-03,5.03E-04,5.76E-01,,,A,,
1205,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",LRRTVQSLEIDLD,_TVQS(ph)LEIDLDSM(ox)R_,S305,+,23.60,22.16,22.01,22.49,25.73,24.38,25.58,25.10,25.36,24.14,26.03,25.58,25.01,24.40,-0.79,-2.24,-2.39,-1.91,1.33,-0.01,1.18,0.70,0.96,-0.26,1.63,1.18,0.62,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,3.34E-04,4.92E-03,2.25E-04,4.25E-04,9.42E-01,,,A,,
1257,P07199,CENPB,Major centromere autoantigen B (Centromere protein B) (CENP-B),TPAAPASPAAVPS,_TPAAPAS(ph)PAAVPSEGSGGSTTGWR_,S156,+,24.08,,,23.83,25.83,25.25,24.71,25.24,25.12,23.82,23.78,23.35,23.56,24.42,-0.34, , ,-0.58,1.42,0.83,0.29,0.82,0.71,-0.60,-0.64,-1.06,-0.85,"regulation of transcription, DNA-dependent","chromosome, centromeric region;nucleus",,,,,5.29E-03,2.85E-02,1.04E-02,6.87E-01,2.4E-03,,,A, YES,
1290,P08238,HSP90AB1,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),TNRRRLSELLRYH,_RLS(ph)ELLR_,S452,+,21.09,18.74,18.51,19.95,23.25,,22.55,23.63,,20.96,22.54,21.98,21.69,21.35,-0.26,-2.61,-2.84,-1.41,1.90, ,1.20,2.28, ,-0.39,1.18,0.62,0.34,"axon guidance;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;placenta development;innate immune response;cellular response to organic cyclic compound;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;protein folding;response to salt stress;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;response to unfolded protein;positive regulation of nitric oxide biosynthetic process",cytosol;mitochondrion;basolateral plasma membrane;apical plasma membrane;brush border membrane;melanosome,,,,,5.28E-04,6.64E-03,1.81E-04,4.61E-03,7.12E-02,,,A, YES,
1318,P08670,VIM,Vimentin,RETNLDSLPLVDT,_ETNLDS(ph)LPLVDTHSK_,S430,+,21.66,23.76,24.25,23.20,27.15,28.17,25.78,26.89,27.74,26.12,27.80,25.82,27.78,25.86,-4.19,-2.09,-1.61,-2.65,1.30,2.32,-0.08,1.03,1.88,0.26,1.94,-0.04,1.93,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,1.87E-05,7.68E-04,1.12E-05,4.11E-05,6.97E-01,,,A,,
1340,P08670,VIM,Vimentin,TSTRTYSLGSALR,_TYS(ph)LGSALRPSTSR_,S39,+,20.25,26.20,27.01,24.43,27.21,27.01,26.57,27.34,27.23,26.46,28.16,28.41,27.14,26.42,-6.16,-0.21,0.59,-1.99,0.79,0.59,0.15,0.92,0.81,0.04,1.74,2.00,0.72,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,4.96E-03,2.72E-02,5.21E-03,2.77E-03,6.28E-01,,,A,,
1353,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",DHYNNLSASKVL_,_SLLEGQEDHYNNLS(ph)ASK_,S395,+,25.21,23.44,23.24,,25.94,24.57,26.17,26.67,24.11,25.90,26.83,26.99,26.21,25.44,-0.23,-2.00,-2.20, ,0.50,-0.87,0.73,1.23,-1.33,0.46,1.39,1.55,0.77,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,9.31E-03,4.25E-02,3.51E-02,2.97E-03,1.49E-01,,,A,,
1363,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",MSIHFSSPVFTSR,_(ac)SIHFSS(ph)PVFTSR_,S7,+,28.40,26.10,26.48,25.18,29.28,28.15,29.00,29.32,27.35,28.00,28.28,28.51,29.48,27.96,0.43,-1.87,-1.49,-2.78,1.32,0.18,1.04,1.36,-0.61,0.04,0.31,0.55,1.52,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,8.92E-03,4.14E-02,5.06E-03,8.33E-03,9.39E-01,,,A, YES,
1415,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),SPEAPASPEREEV,_DGSPEAPAS(ph)PEREEVALSEYK_,S1349,+,,22.44,22.24,24.87,24.21,,24.59,25.03,,,26.20,,26.91,24.56, ,-2.12,-2.32,0.31,-0.35, ,0.03,0.47, , ,1.64, ,2.35,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,1.09E-02,4.81E-02,1.01E-01,3.29E-03,5.38E-02,,,A, YES,
1458,P12931,SRC,Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src),ASQRRRSLEPAEN,_S(ph)LEPAENVHGAGGGAFPASQTPSK_,S17,+,22.80,23.06,23.12,22.39,,,,,25.70,26.52,25.21,26.47,,24.41,-1.61,-1.35,-1.29,-2.02, , , , ,1.29,2.11,0.80,2.06, ,fibroblast growth factor receptor signaling pathway;Ras protein signal transduction;signal complex assembly;peptidyl-tyrosine phosphorylation;forebrain development;negative regulation of intrinsic apoptotic signaling pathway;negative regulation of focal adhesion assembly;platelet activation;uterus development;epidermal growth factor receptor signaling pathway;cellular membrane organization;nerve growth factor receptor signaling pathway;positive regulation of canonical Wnt receptor signaling pathway;cell cycle;oogenesis;intracellular protein kinase cascade;T cell costimulation;response to interleukin-1;bone resorption;regulation of vascular permeability;negative regulation of anoikis;virus-host interaction;positive regulation of protein kinase B signaling cascade;regulation of intracellular estrogen receptor signaling pathway;branching involved in mammary gland duct morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to progesterone stimulus;axon guidance;negative regulation of protein homooligomerization;cell adhesion;negative regulation of extrinsic apoptotic signaling pathway;regulation of bone resorption;positive regulation of integrin activation;leukocyte migration;progesterone receptor signaling pathway,cytosol;caveola;late endosome;mitochondrial inner membrane;nucleus;cytoskeleton;lysosome,,+,,+,1.79E-03,1.43E-02,8.42E-03,2.78E-04,7E-01,,,A, YES,
1459,P12956,XRCC6,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),MNKRLGSLVDEFK,_RLGS(ph)LVDEFK_,S520,+,21.87,21.49,22.16,,,,24.28,24.68,24.03,23.17,,,23.35,23.13,-1.26,-1.64,-0.97, , , ,1.15,1.55,0.90,0.04, , ,0.22,"negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of neurogenesis;double-strand break repair via nonhomologous end joining;viral reproduction;V(D)J recombination;DNA ligation;telomere maintenance;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;nonhomologous end joining complex;Ku70:Ku80 complex;nuclear telomere cap complex;DNA-dependent protein kinase-DNA ligase 4 complex;membrane;cytoplasm,SAP-domain,,,,6.54E-03,3.3E-02,1.67E-03,3.8E-02,1.99E-01,,,A, YES,
1529,P14923,JUP,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),RRALMGSPQLVAA,_ALM(ox)GS(ph)PQLVAAVVR_,S182,+,26.34,24.83,25.32,23.08,27.18,28.07,26.65,26.35,28.02,27.94,26.21,25.30,27.23,26.35,0.00,-1.52,-1.02,-3.27,0.83,1.72,0.30,0.01,1.67,1.60,-0.14,-1.04,0.88,cellular response to indole-3-methanol;negative regulation of Wnt receptor signaling pathway involved in heart development;endothelial cell-cell adhesion;negative regulation of heart induction by canonical Wnt receptor signaling pathway;adherens junction organization;oocyte development;cytoskeletal anchoring at plasma membrane;bundle of His cell to Purkinje myocyte communication;skin development;regulation of heart rate by cardiac conduction;cell morphogenesis;cell migration;gastrulation;positive regulation of protein import into nucleus;regulation of cell proliferation;positive regulation of sequence-specific DNA binding transcription factor activity;regulation of ventricular cardiac muscle cell action potential;detection of mechanical stimulus;desmosome assembly;regulation of apoptotic process;positive regulation of canonical Wnt receptor signaling pathway;morphogenesis of embryonic epithelium;atrioventricular valve morphogenesis;ectoderm development;nervous system development,Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;internal side of plasma membrane;gamma-catenin-TCF7L2 complex;actin cytoskeleton;cytosol;zonula adherens;fascia adherens;catenin complex;apicolateral plasma membrane;desmosome,,,,,8.52E-03,4.01E-02,2.9E-03,2.07E-02,4.27E-01,,,A, YES,
1530,P14923,JUP,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),DYRKRVSVELTNS,_RVS(ph)VELTNSLFK_,S665,+,22.07,23.78,23.78,,24.27,24.19,24.68,24.75,25.89,27.80,26.43,25.74,26.38,24.98,-2.91,-1.20,-1.20, ,-0.71,-0.79,-0.30,-0.23,0.91,2.82,1.45,0.76,1.40,cellular response to indole-3-methanol;negative regulation of Wnt receptor signaling pathway involved in heart development;endothelial cell-cell adhesion;negative regulation of heart induction by canonical Wnt receptor signaling pathway;adherens junction organization;oocyte development;cytoskeletal anchoring at plasma membrane;bundle of His cell to Purkinje myocyte communication;skin development;regulation of heart rate by cardiac conduction;cell morphogenesis;cell migration;gastrulation;positive regulation of protein import into nucleus;regulation of cell proliferation;positive regulation of sequence-specific DNA binding transcription factor activity;regulation of ventricular cardiac muscle cell action potential;detection of mechanical stimulus;desmosome assembly;regulation of apoptotic process;positive regulation of canonical Wnt receptor signaling pathway;morphogenesis of embryonic epithelium;atrioventricular valve morphogenesis;ectoderm development;nervous system development,Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;internal side of plasma membrane;gamma-catenin-TCF7L2 complex;actin cytoskeleton;cytosol;zonula adherens;fascia adherens;catenin complex;apicolateral plasma membrane;desmosome,,,,,2.13E-04,3.66E-03,2.75E-03,6.11E-05,2.96E-02,,,A, YES,
1540,P15336,ATF2,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1),KMPLDLSPLATPI,_KM(ox)PLDLS(ph)PLATPIIR_,S112,+,22.13,23.38,,23.44,24.90,25.16,24.79,24.90,26.02,25.39,24.20,23.58,25.29,24.43,-2.30,-1.05, ,-0.99,0.47,0.73,0.36,0.46,1.59,0.96,-0.23,-0.86,0.86,toll-like receptor 3 signaling pathway;fat cell differentiation;toll-like receptor 4 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;innate immune response;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;adipose tissue development;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transforming growth factor beta2 production;response to osmotic stress;toll-like receptor 1 signaling pathway,nucleoplasm,bZIP,,,,5.28E-03,2.85E-02,1.84E-03,1.5E-02,3.37E-01,,,A,,
1644,P17181,IFNAR1,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1),NLLLSTSEEQIEK,_NLLLSTS(ph)EEQIEK_,S426,+,22.38,22.38,22.38,23.17,24.22,24.20,23.68,23.60,24.94,24.81,23.72,24.65,24.82,23.77,-1.38,-1.39,-1.39,-0.60,0.45,0.44,-0.09,-0.17,1.17,1.05,-0.05,0.89,1.06,defense response to virus;T cell activation;response to virus;type I interferon biosynthetic process;type I interferon-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;JAK-STAT cascade;positive regulation of interferon-gamma production,integral to plasma membrane,,,,,1.03E-02,4.61E-02,1.38E-02,4.52E-03,4.53E-01,,,A,,
1682,P17980,PSMC3,26S protease regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1),LLPNIESPVTRQE,_(ac)M(ox)NLLPNIES(ph)PVTRQEK_,S9,+,22.55,22.58,22.58,,25.48,24.90,24.81,25.00,24.73,25.89,25.25,,25.48,24.48,-1.93,-1.90,-1.90, ,1.00,0.42,0.34,0.52,0.25,1.41,0.77, ,1.00,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;blastocyst development;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome accessory complex,,,,,7.04E-04,8.1E-03,1.03E-03,3.91E-04,2.85E-01,,,A, YES,
1716,P18669,PGAM1,Phosphoglycerate mutase 1 (EC 3.1.3.13) (EC 5.4.2.1) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),VKIWRRSYDVPPP,_S(ph)YDVPPPPM(ox)EPDHPFYSNISK_,S118,+,,22.82,22.90,25.38,26.79,,26.87,27.75,,24.55,28.31,28.15,,25.95, ,-3.13,-3.04,-0.56,0.84, ,0.93,1.80, ,-1.40,2.36,2.20, ,small molecule metabolic process;regulation of glycolysis;gluconeogenesis;glycolysis;respiratory burst;regulation of pentose-phosphate shunt,cytosol,,,,,1.14E-02,4.95E-02,7.03E-03,8.91E-03,8.99E-01,,,A, YES,
1745,P19338,NCL,Nucleolin (Protein C23),LQGPRGSPNARSQ,_LELQGPRGS(ph)PNAR_,S563,+,27.95,28.73,29.05,28.55,31.76,30.90,30.91,31.23,29.52,29.75,28.97,29.21,30.02,29.73,-1.79,-1.00,-0.69,-1.19,2.03,1.17,1.18,1.49,-0.22,0.01,-0.76,-0.53,0.29,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,1.09E-03,1.04E-02,3E-04,7.9E-02,1.79E-02,,,A, YES,+
1760,P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",TPAPSDSPSSQRI,_SKETSSPGTDDVFTPAPSDS(ph)PSSQR_,S785,+,26.03,26.27,25.02,26.81,29.41,29.54,28.58,28.68,29.59,27.40,28.91,28.37,28.73,27.95,-1.92,-1.68,-2.93,-1.14,1.46,1.59,0.63,0.73,1.64,-0.55,0.96,0.42,0.78,intracellular protein kinase cascade;cell differentiation;small molecule metabolic process;protein oligomerization;hyaluronan catabolic process;cellular response to acidity;response to drug;cell growth;carbohydrate metabolic process;sodium ion export;response to organic cyclic compound;response to acid;regulation of intracellular pH,membrane raft;integral to membrane;basolateral plasma membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,9.67E-05,2.1E-03,2.8E-05,9.3E-04,1.42E-01,+,,A, YES,
1761,P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",PAHKLDSPTMSRA,_LDS(ph)PTM(ox)SR_,S693,+,20.51,24.36,23.91,22.48,27.00,27.37,26.20,26.46,26.99,25.85,26.93,26.60,27.24,25.53,-5.02,-1.17,-1.62,-3.06,1.47,1.84,0.67,0.93,1.46,0.32,1.40,1.07,1.71,intracellular protein kinase cascade;cell differentiation;small molecule metabolic process;protein oligomerization;hyaluronan catabolic process;cellular response to acidity;response to drug;cell growth;carbohydrate metabolic process;sodium ion export;response to organic cyclic compound;response to acid;regulation of intracellular pH,membrane raft;integral to membrane;basolateral plasma membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,4.24E-05,1.28E-03,2.8E-05,7.3E-05,8.34E-01,+,,A, YES,+
1770,P20042,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta),_____MSGDEMIF,_(ac)S(ph)GDEM(ox)IFDPTM(ox)SKK_,S2,+,29.94,28.37,28.68,29.41,31.61,30.53,30.94,31.45,30.44,30.73,30.87,29.91,30.40,30.25,-0.31,-1.88,-1.57,-0.84,1.36,0.28,0.69,1.20,0.19,0.48,0.61,-0.34,0.15,,cytosol;eukaryotic translation initiation factor 2 complex,,,,,4.33E-03,2.48E-02,1.38E-03,1.48E-02,3.35E-01,,+,A, YES,+
1803,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),FVVPVASPSGDAR,_FNEEHIPDSPFVVPVAS(ph)PSGDAR_,S2319,+,22.15,,,,25.28,,24.17,,24.79,25.27,,25.65,26.00,24.76,-2.60, , , ,0.52, ,-0.59, ,0.03,0.51, ,0.89,1.24,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,1.77E-03,1.42E-02,4.84E-03,5.93E-04,1.82E-01,+,,A,,
1810,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),GDEIPFSPYRVRA,_YGGDEIPFS(ph)PYRVR_,S1630,+,,,,21.66,24.16,24.67,24.63,23.81,24.11,24.76,24.09,24.81,24.97,24.17, , , ,-2.50,-0.01,0.50,0.46,-0.36,-0.06,0.60,-0.08,0.65,0.80,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,4.49E-03,2.52E-02,5.2E-03,2.37E-03,4.34E-01,+,,A,,
1822,P21796,VDAC1,Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM),TFDSSFSPNTGKK,_LTFDSSFS(ph)PNTGKK_,S104,+,25.90,26.83,26.98,26.45,27.60,27.89,28.33,28.52,28.71,28.30,27.89,27.69,28.52,27.66,-1.76,-0.84,-0.69,-1.21,-0.06,0.22,0.67,0.86,1.04,0.64,0.22,0.02,0.86,neuron-neuron synaptic transmission;behavioral fear response;apoptotic process;learning;virus-host interaction,pore complex;mitochondrial outer membrane;mitochondrial nucleoid;mitochondrial inner membrane;plasma membrane,,,,,3.01E-03,1.98E-02,1.57E-03,3.81E-03,8.12E-01,,,A, YES,
1840,P22626,HNRNPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),GGNFGGSPGYGGG,_GFGDGYNGYGGGPGGGNFGGS(ph)PGYGGGR_,S259,+,24.39,24.10,22.55,26.56,28.82,28.24,27.76,27.78,27.30,25.89,25.46,25.57,26.45,26.22,-1.83,-2.12,-3.67,0.34,2.60,2.02,1.54,1.56,1.08,-0.33,-0.76,-0.65,0.23,"RNA transport;mRNA splicing, via spliceosome",nucleoplasm;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,3.68E-04,5.24E-03,1.09E-04,8.87E-02,5.53E-03,,,A, YES,
1942,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),LAKDMESPTKLDV,_DM(ox)ES(ph)PTKLDVTLAK_,S297,+,25.70,25.46,25.30,26.98,30.80,31.17,29.22,32.71,28.34,27.11,29.77,27.58,31.27,28.57,-2.87,-3.11,-3.27,-1.59,2.23,2.60,0.65,4.14,-0.23,-1.46,1.20,-0.99,2.70,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,1.01E-03,1E-02,2.66E-04,1.07E-02,1.23E-01,,,A, YES,+
2042,P30622,CLIP1,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),RYARKISGTTALQ,_KIS(ph)GTTALQEALK_,S348,+,23.78,24.69,24.80,23.87,25.70,25.59,25.94,26.57,25.46,25.92,27.13,26.95,26.15,25.58,-1.80,-0.89,-0.78,-1.71,0.12,0.01,0.36,0.99,-0.12,0.34,1.55,1.37,0.57,transport;mitotic prometaphase;microtubule bundle formation;positive regulation of microtubule polymerization,endosome;cytoplasmic vesicle membrane;centrosome;cytosol;intermediate filament;cytoplasmic microtubule;microtubule;kinetochore;ruffle,,,,,1.28E-03,1.16E-02,4.99E-03,4.2E-04,1.71E-01,,,A, YES,+
2066,P31943,HNRNPH1,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]",KHTGPNSPDTAND,_HTGPNS(ph)PDTANDGFVR_,S104,+,28.14,29.10,28.94,28.51,31.11,31.08,30.26,31.15,31.26,30.16,30.23,29.22,29.93,29.93,-1.79,-0.83,-0.99,-1.42,1.18,1.15,0.33,1.22,1.33,0.23,0.30,-0.71,0.00,"mRNA splicing, via spliceosome;regulation of RNA splicing",nucleoplasm;catalytic step 2 spliceosome;actin cytoskeleton;cytoplasm,,,,,9.24E-04,9.65E-03,2.33E-04,3.64E-02,3.31E-02,,,A, YES,+
2108,P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),SDASDASGEEGGR,_IHDLEDDLEM(ox)SSDAS(ph)DAS(ph)GEEGGRVPK_,S224,+,25.38,23.81,23.97,,28.68,28.55,27.21,28.33,26.87,28.53,26.39,,27.19,26.81,-1.43,-3.00,-2.84, ,1.87,1.74,0.40,1.52,0.06,1.72,-0.42, ,0.38,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;mRNA splicing, via spliceosome;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription",transcription factor TFIIF complex;cell junction,Other TF domain,,,,4.32E-04,5.86E-03,1.41E-04,1.53E-03,4.3E-01,,,A, YES,+
2123,P35579,MYH9,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)",KGAGDGSDEEVDG,_KGAGDGS(ph)DEEVDGKADGAEAK_,S1943,+,30.17,30.86,29.84,32.39,32.95,33.93,32.96,34.01,33.21,31.23,33.41,32.10,32.95,32.31,-2.14,-1.45,-2.47,0.08,0.64,1.63,0.66,1.70,0.91,-1.08,1.10,-0.21,0.64,cell-cell adhesion;platelet formation;establishment of T cell polarity;blood vessel endothelial cell migration;protein transport;integrin-mediated signaling pathway;cytokinesis;establishment of meiotic spindle localization;regulation of cell shape;angiogenesis;meiotic metaphase I;meiotic spindle organization;membrane protein ectodomain proteolysis;in utero embryonic development;actin filament-based movement;axon guidance;termination of G-protein coupled receptor signaling pathway;actin cytoskeleton reorganization;monocyte differentiation;uropod organization;myoblast fusion;leukocyte migration,cleavage furrow;stress fiber;plasma membrane;nucleus;spindle;cortical cytoskeleton;actomyosin contractile ring;cell-cell adherens junction;protein complex;immunological synapse;cytosol;neuromuscular junction;uropod;extracellular vesicular exosome;myosin II complex;ruffle,,,,,8.44E-03,3.99E-02,2.34E-03,6.76E-02,1.39E-01,,,A,,
2138,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),EGQNGSSPKSKTK,_WLNSGRGDEASEEGQNGSS(ph)PK_,S465,+,,23.58,22.81,24.91,25.89,26.53,26.91,27.04,26.26,23.94,26.65,24.64,25.43,25.38, ,-1.80,-2.58,-0.47,0.51,1.15,1.53,1.66,0.88,-1.44,1.26,-0.74,0.05,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,4.48E-03,2.52E-02,1.43E-03,8.94E-02,4.45E-02,,,A, YES,
2140,P35613,BSG,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),DDDDAGSAPLKSS,_RKPEDVLDDDDAGS(ph)APLK_,S246,+,21.06,24.66,,23.20,27.10,27.13,25.11,26.59,25.76,,23.68,,25.38,24.97,-3.91,-0.30, ,-1.77,2.13,2.16,0.14,1.62,0.80, ,-1.29, ,0.41,decidualization;response to cAMP;embryo implantation;blood coagulation;response to peptide hormone stimulus;pyruvate metabolic process;odontogenesis of dentin-containing tooth;response to mercury ion;cell surface receptor signaling pathway;leukocyte migration,mitochondrion;membrane raft;sarcolemma;Golgi membrane;integral to membrane;plasma membrane;melanosome;acrosomal membrane,,,,,4.38E-03,2.5E-02,8.73E-04,1.2E-01,7.19E-02,,,A, YES,
2163,P36578,RPL4,60S ribosomal protein L4 (60S ribosomal protein L1),LSRILKSPEIQRA,_ILKS(ph)PEIQR_,S295,+,,23.05,23.73,24.42,27.41,26.35,25.69,26.67,24.33,23.50,23.23,23.63,24.09,24.67, ,-1.63,-0.95,-0.26,2.73,1.68,1.02,2.00,-0.34,-1.17,-1.44,-1.04,-0.59,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit;nucleolus,,,,,1.86E-03,1.48E-02,4.32E-03,6.72E-01,8.81E-04,,,A, YES,
2265,P43243,MATR3,Matrin-3,RHFRRDSFDDRGP,_RDS(ph)FDDR_,S188,+,26.65,25.14,24.25,25.21,28.55,26.67,27.16,27.65,28.07,27.36,26.95,28.17,27.60,26.88,-0.23,-1.74,-2.63,-1.67,1.67,-0.21,0.28,0.77,1.19,0.48,0.07,1.29,0.72,,nuclear inner membrane;nuclear matrix,,,,,1.85E-03,1.47E-02,1.05E-03,2.26E-03,8.65E-01,,,A, YES,
2280,P45880,VDAC2,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),TFDTTFSPNTGKK,_LTFDTTFS(ph)PNTGK_,S115,+,24.56,25.15,24.90,25.03,26.96,27.44,26.98,27.03,27.47,27.18,27.14,27.12,27.64,26.51,-1.95,-1.36,-1.60,-1.48,0.46,0.93,0.47,0.52,0.96,0.67,0.63,0.61,1.13,negative regulation of protein polymerization;negative regulation of intrinsic apoptotic signaling pathway,pore complex;mitochondrial outer membrane;mitochondrial nucleoid;mitochondrial inner membrane,,,,,1.04E-04,2.19E-03,9.59E-05,1.07E-04,8.26E-01,,,A, YES,
2327,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],NERASVSPMDEPV,_ASVS(ph)PM(ox)DEPVPDSESPIEK_,S1378,+,24.17,23.65,21.44,26.32,26.05,26.52,28.46,26.46,27.43,27.59,28.62,28.43,26.49,26.28,-2.11,-2.63,-4.84,0.04,-0.23,0.24,2.18,0.18,1.15,1.31,2.34,2.15,0.21,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,1.72E-03,1.39E-02,3.35E-03,7.34E-04,3.53E-01,,,A, YES,
2329,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],PVPDSESPIEKVL,_ASVSPM(ox)DEPVPDSES(ph)PIEK_,S1389,+,26.03,25.73,24.30,27.66,28.65,28.65,29.53,29.04,28.69,27.68,30.41,28.87,28.96,28.02,-1.98,-2.28,-3.72,-0.36,0.64,0.63,1.51,1.02,0.67,-0.34,2.40,0.86,0.94,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,9.93E-04,1E-02,7.45E-04,9.47E-04,9.19E-01,,,A, YES,
2336,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],NNEETESPSQEFV,_DVM(ox)SDETNNEETES(ph)PSQEFVNITK_,S1154,+,23.04,,,24.15,27.24,25.45,26.74,26.65,26.70,26.95,27.55,,27.11,26.16,-3.11, , ,-2.01,1.08,-0.71,0.58,0.49,0.54,0.80,1.39, ,0.95,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,4.58E-04,6.1E-03,6.66E-04,2.63E-04,2.8E-01,,,A, YES,
2343,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],LTPRESSPLYSPT,_ESS(ph)PLYSPTFSDSTSAVK_,S1793,+,,24.50,23.98,27.07,28.63,27.89,28.40,28.95,27.03,26.15,28.87,28.00,28.41,27.32, ,-2.83,-3.35,-0.26,1.30,0.57,1.08,1.63,-0.29,-1.17,1.54,0.68,1.09,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,5.22E-03,2.82E-02,2.4E-03,7.33E-03,6.62E-01,,,A, YES,
2344,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ESSPLYSPTFSDS,_ESSPLYS(ph)PTFSDSTSAVK_,S1797,+,23.41,24.14,23.03,25.77,27.93,26.36,27.48,27.85,26.87,25.87,28.45,27.21,27.90,26.33,-2.92,-2.19,-3.30,-0.56,1.60,0.03,1.15,1.52,0.54,-0.46,2.12,0.88,1.57,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,3.91E-04,5.46E-03,3.02E-04,4.12E-04,9.3E-01,,,A, YES,
2346,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KRESVASGDDRAE,_RES(ph)VAS(ph)GDDRAEEDM(ox)DEAIEK_,S995,+,23.67,25.38,25.30,26.86,25.48,28.73,28.15,29.63,28.08,27.60,29.26,28.36,29.09,27.35,-3.68,-1.97,-2.05,-0.50,-1.88,1.38,0.79,2.28,0.73,0.25,1.91,1.01,1.74,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,3.15E-03,2.06E-02,4.41E-03,1.53E-03,4.85E-01,,,A, YES,
2349,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],AGFEESSETGDYE,_FEDEGAGFEESS(ph)ETGDYEEK_,S937,+,23.23,23.50,21.83,26.24,23.32,24.69,27.83,25.74,27.28,26.54,28.68,27.99,26.52,25.65,-2.41,-2.15,-3.82,0.59,-2.32,-0.95,2.19,0.10,1.63,0.90,3.03,2.34,0.88,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,1.12E-02,4.88E-02,6.74E-02,3.18E-03,1.08E-01,,,A, YES,
2354,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],RKLGDVSPTQIDV,_LGDVS(ph)PTQIDVSQFGSFK_,S1501,+,25.22,25.98,25.34,27.68,27.37,24.95,29.23,28.26,29.66,29.43,30.94,29.71,28.98,27.90,-2.68,-1.92,-2.56,-0.22,-0.54,-2.95,1.33,0.35,1.76,1.52,3.04,1.81,1.07,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,3.35E-03,2.12E-02,4.96E-02,8.83E-04,4.4E-02,,,A, YES,
2364,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],LSPSPPSPLEKTP,_SPSLSPSPPS(ph)PLEK_,S1265,+,24.96,26.15,25.31,28.04,28.55,28.59,29.28,29.50,28.22,27.48,30.84,29.15,30.11,28.17,-3.21,-2.02,-2.86,-0.13,0.38,0.42,1.11,1.33,0.05,-0.69,2.67,0.98,1.95,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,2.34E-03,1.69E-02,3.55E-03,1.12E-03,4.52E-01,,,A, YES,
2371,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],LEGEKLSPKSDIS,_VQSLEGEKLS(ph)PK_,S1779,+,24.14,27.32,26.90,26.23,29.18,28.69,30.17,29.65,28.35,28.41,29.39,29.05,28.54,28.15,-4.01,-0.84,-1.26,-1.92,1.02,0.54,2.02,1.49,0.19,0.25,1.23,0.90,0.39,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,1.43E-03,1.23E-02,6.21E-04,2.79E-03,6.03E-01,,,A, YES,
2465,P49736,MCM2,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),RGLLYDSDEEDEE,_RGLLYDS(ph)DEEDEERPAR_,S139,+,26.07,23.73,23.73,21.63,31.35,29.23,28.09,29.14,27.80,27.94,25.77,27.80,27.78,26.93,-0.86,-3.20,-3.20,-5.30,4.42,2.30,1.16,2.22,0.87,1.01,-1.15,0.87,0.85,S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;nucleosome assembly,nucleoplasm;chromatin;nuclear origin of replication recognition complex;MCM complex,,,,,2.71E-04,4.25E-03,7.77E-05,3.86E-03,6.43E-02,,,A, YES,
2482,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),GHRRTPSEADRWL,_RTPS(ph)EADRWLEEVSK_,S379,+,20.17,21.85,21.88,,26.29,25.56,25.27,25.91,25.26,,26.76,27.01,26.12,24.73,-4.56,-2.89,-2.86, ,1.55,0.83,0.54,1.18,0.52, ,2.03,2.27,1.38,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,5.23E-06,3.43E-04,1.04E-05,3.52E-06,1.34E-01,,,A, YES,+
2500,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],QNPRKQSLPATSI,_KQS(ph)LPATSIPTPASFK_,S1509,+,24.05,23.77,24.09,22.66,24.80,26.04,24.20,25.45,25.69,25.67,25.34,24.68,26.10,24.81,-0.76,-1.04,-0.73,-2.15,-0.01,1.23,-0.61,0.64,0.88,0.86,0.53,-0.13,1.29,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,5.89E-03,3.07E-02,5.48E-03,3.54E-03,6.98E-01,,,A, YES,
2745,P56181,NDUFV3,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)",KGRKVASPSPSGS,_VAS(ph)PSPSGSVLFTDEGVPK_,S81,,24.43,23.42,23.32,23.09,24.60,25.43,25.27,25.30,25.55,25.46,25.09,24.87,25.82,24.74,-0.32,-1.33,-1.42,-1.65,-0.14,0.68,0.53,0.56,0.81,0.72,0.35,0.13,1.07,"mitochondrial electron transport, NADH to ubiquinone;small molecule metabolic process",nucleus;mitochondrial respiratory chain complex I,,,,,3.01E-03,1.98E-02,2.29E-03,2.4E-03,8.65E-01,,,A,,
2785,P61247,RPS3A,40S ribosomal protein S3a (v-fos transformation effector protein) (Fte-1),EPPVQESV_____,_VERADGYEPPVQES(ph)V_,S263,+,25.89,25.46,25.90,26.06,27.20,26.79,27.78,27.42,27.15,27.21,26.57,26.57,26.25,26.63,-0.74,-1.18,-0.73,-0.57,0.56,0.16,1.14,0.78,0.52,0.57,-0.06,-0.06,-0.39,"translational termination;translational elongation;cell differentiation;viral transcription;induction of apoptosis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,1.05E-02,4.69E-02,3.03E-03,5.48E-02,2.06E-01,,,A, YES,
2790,P61313,RPL15,60S ribosomal protein L15,WQYRQLSALHRAP,_(gl)QLS(ph)ALHR_,S34,+,23.08,23.21,21.54,24.26,25.50,26.00,25.46,25.71,25.27,25.55,25.09,24.50,25.46,24.66,-1.58,-1.46,-3.13,-0.41,0.83,1.34,0.80,1.05,0.61,0.89,0.43,-0.16,0.80,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,2.6E-03,1.8E-02,9.46E-04,6.66E-03,4.54E-01,,,A, YES,
2860,P78332,RBM6,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),DFQNSQSPVQDQD,_EGETQGVAFEHESPADFQNSQS(ph)PVQDQDK_,S230,+,23.91,23.82,23.82,22.78,24.90,26.63,25.77,26.20,26.42,24.86,25.62,24.60,25.67,25.00,-1.09,-1.18,-1.18,-2.22,-0.10,1.63,0.77,1.20,1.42,-0.14,0.62,-0.40,0.67,RNA processing,nucleus,,,,,1.91E-03,1.5E-02,5.82E-04,1.28E-02,1.47E-01,,,A, YES,
2878,P78527,PRKDC,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460),DREKRLSFAVPFR,_RLS(ph)FAVPFR_,S893,+,19.46,,,,23.31,23.50,22.49,22.92,,23.16,21.99,23.15,23.11,22.56,-3.11, , , ,0.75,0.94,-0.08,0.35, ,0.59,-0.57,0.58,0.54,germ cell programmed cell death;T cell receptor V(D)J recombination;peptidyl-serine phosphorylation;T cell differentiation in thymus;cellular response to insulin stimulus;response to gamma radiation;apoptotic process;telomere maintenance;immunoglobulin V(D)J recombination;B cell lineage commitment;positive regulation of transcription from RNA polymerase II promoter;somitogenesis;brain development;pro-B cell differentiation;double-strand break repair via nonhomologous end joining;protein destabilization;T cell lineage commitment;heart development;positive regulation of apoptotic process,transcription factor complex;nucleolus;DNA-dependent protein kinase-DNA ligase 4 complex,,+,,,2.2E-03,1.65E-02,1.39E-03,2.11E-03,7.16E-01,,,A, YES,
2913,P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),GEKGPSSEGPEEE,_QEEEQDLDGEKGPSS(ph)EGPEEEDGEGFSFK_,S128,,22.05,22.10,,22.88,25.84,,24.40,25.09,26.24,24.60,25.99,24.93,25.62,24.52,-2.48,-2.43, ,-1.65,1.32, ,-0.12,0.56,1.72,0.08,1.47,0.41,1.10,,integral to membrane,,,,,3.18E-04,4.77E-03,2.4E-04,3.29E-04,8.56E-01,,,A, YES,
2915,P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),GFSFKYSPGKLRG,_GPSSEGPEEEDGEGFSFKYS(ph)PGK_,S144,+,22.52,26.06,26.27,25.78,25.83,27.63,28.00,27.89,28.73,26.75,28.69,27.87,29.37,27.03,-4.51,-0.97,-0.76,-1.25,-1.20,0.59,0.97,0.86,1.70,-0.28,1.66,0.84,2.34,,integral to membrane,,,,,5.16E-03,2.8E-02,6.86E-03,2.44E-03,5E-01,,,A, YES,
2937,P98175,RBM10,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),HRRAHLSENELEA,_AHLS(ph)ENELEALEK_,S862,,22.58,22.79,23.09,23.12,24.04,25.27,24.99,24.93,25.26,25.32,24.90,25.61,23.15,24.24,-1.66,-1.44,-1.15,-1.11,-0.19,1.04,0.75,0.69,1.03,1.09,0.66,1.38,-1.09,mRNA processing;RNA splicing,chromatin remodeling complex,C2H2-type,,,,4.48E-03,2.52E-02,2.21E-03,5.74E-03,7.8E-01,,+,A,,
2963,Q00839,HNRNPU,Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold attachment factor A) (SAF-A) (p120) (pp120),MEPGNGSLDLGGD,_LQAALDDEEAGGRPAM(ox)EPGNGS(ph)LDLGGDSAGR_,S59,+,25.81,23.83,24.40,23.71,27.91,27.58,27.03,27.27,27.46,27.67,26.02,26.38,27.00,26.31,-0.50,-2.48,-1.91,-2.60,1.60,1.26,0.72,0.96,1.15,1.35,-0.29,0.07,0.68,"CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;CRD-mediated mRNA stability complex;cell surface;catalytic step 2 spliceosome,SAP-domain,,,,1.57E-04,2.92E-03,5.31E-05,8.21E-04,2.69E-01,,,A, YES,
2969,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",TITSESSPGKREK,_AQTLPTSVVTITSESS(ph)PGK_,S2341,+,22.78,23.17,23.17,21.45,,,27.60,,27.81,26.71,25.91,25.94,26.07,25.06,-2.28,-1.89,-1.89,-3.62, , ,2.54, ,2.75,1.65,0.85,0.88,1.01,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,7.62E-06,4.2E-04,5.42E-06,1.79E-05,6.12E-02,,,A, YES,
3044,Q02241,KIF23,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),THQELASDGEIET,_YM(ox)LTHQELAS(ph)DGEIETK_,S580,+,20.35,22.19,23.04,22.90,26.52,25.86,25.85,25.46,24.26,23.61,,23.28,23.49,23.90,-3.55,-1.72,-0.86,-1.00,2.61,1.96,1.94,1.56,0.36,-0.29, ,-0.62,-0.41,blood coagulation;microtubule-based movement;cell cycle cytokinesis;spindle midzone assembly involved in mitosis;mitotic spindle elongation;positive regulation of cell cycle cytokinesis;antigen processing and presentation of exogenous peptide antigen via MHC class II,nucleoplasm;kinesin complex;centrosome;centralspindlin complex;cytosol;intercellular bridge;midbody;microtubule,,,,,2.41E-04,3.95E-03,4.69E-05,3.29E-02,1.45E-02,,,A, YES,
3076,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),EKVELPSEEQVSG,_VELPS(ph)EEQVSGSQGPSEEK_,S381,+,24.46,25.06,25.63,24.85,26.78,27.33,30.66,28.54,30.84,31.07,31.03,25.99,29.66,27.84,-3.38,-2.78,-2.21,-2.99,-1.06,-0.51,2.82,0.70,3.00,3.24,3.19,-1.85,1.82,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,9.76E-04,1E-02,1.21E-03,5.91E-04,5.71E-01,,,A, YES,
3085,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),KSATLSSTESTAS,_SATLS(ph)S(ph)TESTASEM(ox)QEEM(ox)K_,S645,+,23.65,24.17,24.17,22.54,25.02,25.14,25.82,,25.58,27.76,26.63,,,25.05,-1.40,-0.88,-0.88,-2.51,-0.03,0.09,0.77, ,0.53,2.72,1.58, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,2.8E-04,4.29E-03,2.85E-03,9.18E-05,2.16E-02,,,A, YES,
3119,Q03135,CAV1,Caveolin-1,_MADELSEKQVYD,_(ac)ADELS(ph)EKQVYDAHTK_,S6,,22.49,26.05,25.58,26.95,29.20,28.35,26.93,28.44,27.17,25.70,26.35,25.58,25.78,26.50,-4.02,-0.46,-0.93,0.44,2.69,1.84,0.43,1.93,0.66,-0.80,-0.15,-0.93,-0.72,vesicle organization;apoptotic signaling pathway;response to estrogen stimulus;negative regulation of endothelial cell proliferation;caveolin-mediated endocytosis;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;positive regulation of metalloenzyme activity;nitric oxide homeostasis;positive regulation of endocytosis;vasoconstriction;negative regulation of protein binding;positive regulation of canonical Wnt receptor signaling pathway;negative regulation of JAK-STAT cascade;membrane depolarization;mammary gland involution;response to drug;cytosolic calcium ion homeostasis;lipid storage;negative regulation of tyrosine phosphorylation of Stat5 protein;skeletal muscle tissue development;negative regulation of anoikis;negative regulation of epithelial cell differentiation;small molecule metabolic process;caveola assembly;negative regulation of transcription from RNA polymerase II promoter;protein homooligomerization;maintenance of protein location in cell;leukocyte migration;MAPK cascade;negative regulation of cytokine-mediated signaling pathway;negative regulation of peptidyl-serine phosphorylation;nitric oxide metabolic process;negative regulation of protein ubiquitination;response to mechanical stimulus;positive regulation of vasoconstriction;cellular response to hyperoxia;negative regulation of nitric oxide biosynthetic process;cholesterol efflux;response to calcium ion;vasculogenesis;positive regulation of microtubule polymerization;inactivation of MAPK activity;positive regulation of intrinsic apoptotic signaling pathway;triglyceride metabolic process;positive regulation of calcium ion transport into cytosol;negative regulation of BMP signaling pathway;positive regulation of peptidyl-serine phosphorylation;regulation of nitric-oxide synthase activity;negative regulation of canonical Wnt receptor signaling pathway;calcium ion transport;T cell costimulation;cholesterol homeostasis;blood coagulation;regulation of blood coagulation;cholesterol transport;response to nutrient;virus-host interaction;cellular response to starvation;response to progesterone stimulus;microtubule polymerization;response to hypoxia;regulation of fatty acid metabolic process;response to glucocorticoid stimulus;receptor internalization involved in canonical Wnt receptor signaling pathway;regulation of smooth muscle contraction;lactation,mitochondrion;basolateral plasma membrane;flagellum;Golgi membrane;caveola;cell cortex;focal adhesion;endocytic vesicle membrane;integral to plasma membrane;acrosomal membrane;endosome;apical plasma membrane;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;lipid particle;cell surface;basal plasma membrane,,,,,9.8E-03,4.43E-02,5.11E-03,6.21E-01,1.53E-02,,,A, YES,
3148,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),REAEEESDHN___,_WLREAEEES(ph)DHN_,S1556,+,28.19,29.34,29.94,29.54,30.70,30.70,31.63,31.50,30.23,30.06,30.61,30.48,30.01,30.23,-2.03,-0.89,-0.29,-0.69,0.47,0.48,1.41,1.28,0.01,-0.16,0.39,0.26,-0.22,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,6.19E-03,3.16E-02,1.77E-03,3.25E-02,2.16E-01,,,A, YES,+
3171,Q05397,PTK2,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),KPDVRLSRGSIDR,_FLKPDVRLS(ph)R_,S794,+,,19.88,,20.02,23.03,22.55,23.09,23.25,21.73,22.03,22.73,22.98,23.07,22.21, ,-2.34, ,-2.20,0.82,0.33,0.88,1.04,-0.49,-0.18,0.51,0.77,0.86,neuron migration;signal complex assembly;regulation of endothelial cell migration;negative regulation of synapse assembly;placenta development;regulation of focal adhesion assembly;peptidyl-tyrosine phosphorylation;integrin-mediated signaling pathway;regulation of Rho GTPase activity;netrin-activated signaling pathway;negative regulation of axonogenesis;regulation of cell shape;vasculogenesis;platelet activation;regulation of osteoblast differentiation;regulation of cytoskeleton organization;establishment of nucleus localization;ephrin receptor signaling pathway;central nervous system neuron axonogenesis;heart morphogenesis;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;negative regulation of cell-cell adhesion;protein autophosphorylation;cellular component disassembly involved in execution phase of apoptosis;embryo development;endothelial cell migration;growth hormone receptor signaling pathway;positive regulation of cell migration;cell motility;establishment of cell polarity;positive regulation of cell proliferation;positive regulation of phosphatidylinositol 3-kinase activity;microtubule cytoskeleton organization;negative regulation of anoikis;negative regulation of organ growth;angiogenesis;positive regulation of protein kinase B signaling cascade;regulation of cell adhesion mediated by integrin;extracellular matrix organization;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of protein kinase activity,apical plasma membrane;microtubule organizing center;cell cortex;cytosol;cytoskeleton;focal adhesion;nucleus;lamellipodium,,+,,,3.88E-03,2.31E-02,2.49E-03,3.46E-03,9.56E-01,+,,A, YES,
3181,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],KARLSYSDKNLID,_ARLSYS(ph)DK_,S647,+,29.66,29.22,,,,,,26.36,25.90,25.24,25.94,25.91,24.48,26.59,3.07,2.63, , , , , ,-0.23,-0.69,-1.35,-0.65,-0.68,-2.11,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,4.2E-04,5.82E-03,1.46E-03,1.08E-04,3.14E-01,+,,A, YES,
3212,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),PKAIPVSPSAVEE,_AIPVS(ph)PSAVEEDEDEDGHTVVATAR_,S1617,+,25.13,25.98,26.37,25.66,28.58,28.11,28.72,28.90,28.00,29.93,28.35,27.75,28.78,27.71,-2.58,-1.74,-1.34,-2.05,0.87,0.39,1.00,1.19,0.29,2.21,0.64,0.04,1.06,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,4.16E-05,1.27E-03,4.95E-05,3.71E-05,6.52E-01,,,A, YES,+
3277,Q08945,SSRP1,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),YDEYADSDEDQHD,_NRGLKEGM(ox)NPSYDEYADS(ph)DEDQHDAYLER_,S444,+,28.89,24.94,24.94,24.18,30.62,29.31,29.35,28.16,29.68,29.61,27.02,29.02,28.13,27.99,0.90,-3.05,-3.05,-3.81,2.63,1.32,1.36,0.17,1.69,1.63,-0.97,1.03,0.14,"DNA repair;viral reproduction;regulation of transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;DNA replication;positive regulation of viral transcription",nucleoplasm;nucleolus;chromosome;cytoplasm,HMG-box,,,,8.68E-03,4.06E-02,2.88E-03,2.79E-02,2.84E-01,,,A, YES,+
3312,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AKDIDISSPEFKI,_EGAKDIDIS(ph)SPEFK_,S176,+,,22.39,22.39,19.82,27.46,26.15,,24.99,24.27,21.94,,,23.19,23.62, ,-1.23,-1.23,-3.80,3.84,2.53, ,1.37,0.65,-1.68, , ,-0.43,nervous system development,nucleus,,,,,3.1E-03,2.03E-02,1.09E-03,2.49E-01,1.18E-02,,,A,,
3313,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KDIDISSPEFKIK,_DIDISS(ph)PEFK_,S177,+,30.90,27.43,27.89,27.67,30.86,30.26,31.09,30.79,31.11,31.95,30.52,29.24,30.48,30.02,0.89,-2.59,-2.12,-2.34,0.84,0.25,1.08,0.78,1.09,1.93,0.50,-0.77,0.47,nervous system development,nucleus,,,,,8.29E-03,3.96E-02,3.77E-03,1.08E-02,7.31E-01,,,A,,
3340,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LKGPRISAPNVDF,_IS(ph)APNVDFNLEGPKVK_,S5448,+,26.00,26.51,26.14,27.12,27.47,28.77,28.32,29.09,29.80,27.97,29.63,29.17,29.87,28.14,-2.14,-1.63,-2.00,-1.02,-0.67,0.63,0.18,0.95,1.66,-0.17,1.49,1.02,1.73,nervous system development,nucleus,,,,,9.27E-04,9.66E-03,1.54E-03,4.62E-04,4.23E-01,,,A,,
3373,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VELNLKSPKVKGD,_VSM(ox)PDVELNLKS(ph)PK_,S3426,+,23.66,23.22,23.22,19.59,27.22,25.09,,27.30,,,25.14,,25.30,24.42,-0.76,-1.20,-1.20,-4.82,2.80,0.68, ,2.88, , ,0.73, ,0.89,nervous system development,nucleus,,,,,7.34E-03,3.59E-02,2.02E-03,2.79E-02,2.99E-01,,,A,,
3391,Q12769,NUP160,Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160),YDRPGASPKRNHD,_LIRPEYAWIVQPVSGAVYDRPGAS(ph)PK_,S1157,+,23.00,21.94,21.94,,24.62,,23.76,23.69,25.69,25.68,,25.77,,24.01,-1.01,-2.07,-2.07, ,0.61, ,-0.25,-0.32,1.68,1.67, ,1.76, ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA export from nucleus;regulation of glucose transport;mitotic prometaphase;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;nuclear pore outer ring,,,,,1.06E-02,4.71E-02,2.82E-02,4.17E-03,1.27E-01,,,A, YES,+
3425,Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),DDVSIRSPETKCP,_VLDDVSIRS(ph)PETK_,S1237,+,,23.16,23.52,21.24,25.75,26.22,24.88,24.90,24.78,,24.12,24.07,25.60,24.38, ,-1.22,-0.87,-3.15,1.36,1.84,0.49,0.51,0.40, ,-0.27,-0.32,1.21,"brain development;positive regulation of transcription, DNA-dependent;anterior/posterior pattern specification;embryonic placenta development;negative regulation of transcription from RNA polymerase II promoter;endoderm development;transcription, DNA-dependent;chromatin remodeling",NURF complex;cytoplasm,,,,,2.59E-03,1.8E-02,7.24E-04,1.15E-02,2.99E-01,,,A, YES,+
3607,Q13286,CLN3,Battenin (Batten disease protein) (Protein CLN3),GSRRRFSDSEGEE,_RFS(ph)DS(ph)EGEETVPEPR_,S12,+,25.38,25.73,25.92,23.54,27.33,27.39,27.08,26.92,26.70,27.90,27.91,28.60,28.31,26.82,-1.45,-1.09,-0.90,-3.29,0.51,0.57,0.26,0.10,-0.12,1.07,1.09,1.78,1.48,vacuolar transport;protein processing;neuromuscular process controlling balance;galactosylceramide metabolic process;protein folding;lysosomal lumen pH elevation;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;cell death;receptor-mediated endocytosis;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;arginine transport;neurotransmitter metabolic process;negative regulation of proteolysis;sphingomyelin metabolic process;associative learning;vesicle transport along microtubule;protein catabolic process;amyloid precursor protein catabolic process;autophagic vacuole fusion;regulation of action potential;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;cellular amino acid metabolic process;globoside metabolic process,mitochondrion;late endosome;synaptic vesicle;lysosomal membrane;Golgi membrane;early endosome;autophagic vacuole;trans-Golgi network;neuron projection;caveola;integral to endoplasmic reticulum membrane;Golgi stack;nucleus,,,,,1.17E-04,2.38E-03,1.22E-03,3.31E-05,5.02E-02,,,A, YES,+
3630,Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),SGSGCRSPSLGSD,_S(ph)PSLGSDLTFATR_,S393,+,24.13,21.70,21.90,21.18,23.98,24.34,24.98,23.86,24.46,24.29,23.68,23.05,22.92,23.42,0.71,-1.72,-1.52,-2.24,0.55,0.92,1.56,0.44,1.04,0.87,0.25,-0.37,-0.50,,dystrophin-associated glycoprotein complex;synapse;transport vesicle membrane;cell junction;microtubule;cytoplasm,,,,,9.46E-03,4.31E-02,2.68E-03,5.61E-02,1.84E-01,,,A, YES,
3676,Q13443,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),SVPRHVSPVTPPR,_HVS(ph)PVT(ph)PPREVPIYANR_,S758,+,21.80,23.39,23.39,,25.25,24.38,25.19,25.46,25.40,25.33,24.73,24.42,24.95,24.47,-2.67,-1.08,-1.08, ,0.78,-0.09,0.72,0.99,0.93,0.85,0.25,-0.06,0.47,transforming growth factor beta receptor signaling pathway;positive regulation of macrophage fusion;monocyte activation;positive regulation of cell adhesion mediated by integrin;activation of MAPKK activity;integrin-mediated signaling pathway;positive regulation of membrane protein ectodomain proteolysis;positive regulation of keratinocyte migration;cell-cell adhesion mediated by integrin;keratinocyte differentiation;PMA-inducible membrane protein ectodomain proteolysis;response to calcium ion;cell-matrix adhesion;cellular response to lipopolysaccharide;response to glucocorticoid stimulus;response to hydrogen peroxide;response to tumor necrosis factor;positive regulation of protein secretion;response to manganese ion,intrinsic to external side of plasma membrane;extracellular space;integral to membrane;cytoplasm,,,,,2.75E-03,1.87E-02,1.33E-03,4.04E-03,5.83E-01,,,A, YES,
3679,Q13451,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5) (FKBP-5) (FKBP54) (p54) (HSP90-binding immunophilin) (Rotamase),AKNNEESPTATVA,_NNEES(ph)PTATVAEQGEDITSK_,S13,+,22.48,25.59,25.21,25.56,25.97,27.57,27.58,27.94,27.45,25.21,26.38,25.74,26.63,26.10,-3.62,-0.51,-0.89,-0.54,-0.13,1.47,1.48,1.84,1.35,-0.89,0.28,-0.36,0.53,protein folding,nucleus;membrane;cytoplasm,,,,,6.95E-03,3.44E-02,1.95E-03,1.09E-01,7.3E-02,,,A, YES,
3772,Q13796,SHROOM2,Protein Shroom2 (Apical-like protein) (Protein APXL),KKKAPSSPPPPPP,_APSS(ph)PPPPPPPLRSDSFAATK_,S313,+,,21.24,21.24,21.00,24.36,22.59,24.05,22.96,24.11,22.77,,24.39,23.73,22.95, ,-1.71,-1.71,-1.95,1.41,-0.36,1.10,0.02,1.16,-0.18, ,1.44,0.78,establishment of melanosome localization;cell migration;negative regulation of actin filament depolymerization;lens morphogenesis in camera-type eye;cell-cell junction maintenance;brain development;cellular pigment accumulation;apical protein localization;melanosome organization;eye pigment granule organization;ear development,neuronal cell body;filamentous actin;apical plasma membrane;cell-cell adherens junction;cell cortex;tight junction;cytoskeleton;microtubule,,,,,7.25E-03,3.56E-02,4.01E-03,6.75E-03,9.82E-01,,,A, YES,
3789,Q13946,PDE7A,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.17) (HCP1) (TM22)",NIRRLLSFQRYLR,_LLS(ph)FQR_,S80,+,21.03,20.90,20.90,,23.86,24.59,23.75,24.56,23.23,23.06,23.99,23.28,23.91,23.09,-2.05,-2.19,-2.19, ,0.77,1.50,0.66,1.47,0.14,-0.03,0.91,0.19,0.83,signal transduction;cAMP-mediated signaling;cAMP catabolic process,cytosol,,,,,5.11E-04,6.49E-03,2.33E-04,1.15E-03,3.92E-01,,,A,,
3801,Q14008,CKAP5,Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG),EYKKKYSDADIEP,_KYS(ph)DADIEPFLK_,S1801,+,20.45,,,,23.05,22.27,22.93,23.07,23.07,,23.52,23.50,23.15,22.78,-2.33, , , ,0.27,-0.51,0.15,0.29,0.29, ,0.74,0.73,0.37,G2/M transition of mitotic cell cycle;centrosome organization;mitotic prometaphase;spindle organization;RNA transport;cell division;establishment or maintenance of microtubule cytoskeleton polarity,cytosol;centrosome;spindle pole;protein complex,,,,,7.67E-03,3.71E-02,9.11E-03,3.93E-03,3.44E-01,,,A, YES,
3827,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),EPVKEESSELEQP,_SEPVKEES(ph)SELEQPFAQDTSSVGPDRK_,S234,+,23.85,22.91,,22.64,,25.42,25.22,,26.11,24.89,24.13,23.27,,24.27,-0.42,-1.36, ,-1.63, ,1.15,0.95, ,1.84,0.62,-0.14,-1.00, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,1.04E-02,4.65E-02,3.51E-03,1.77E-01,4.76E-02,,,A, YES,
3847,Q14156,EFR3A,Protein EFR3 homolog A (Protein EFR3-like),TDEDRLSRRKSIV,_LSVPYVPQVTDEDRLS(ph)R_,S650,+,25.16,22.40,22.27,22.93,26.71,24.44,24.24,25.63,26.39,25.18,25.97,26.19,26.43,24.92,0.24,-2.52,-2.65,-1.99,1.79,-0.48,-0.68,0.71,1.47,0.26,1.05,1.27,1.51,,plasma membrane;intracellular,,,,,3.68E-03,2.22E-02,4.81E-03,1.83E-03,5.15E-01,,,A, YES,
3867,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),RPEDDYSPRERRG,_M(ox)VEPENAVTITPLRPEDDYS(ph)PRER_,S835,+,26.50,23.11,23.11,23.05,28.21,27.41,27.12,27.27,27.52,27.06,26.52,26.39,27.69,26.23,0.27,-3.12,-3.12,-3.17,1.98,1.18,0.89,1.04,1.29,0.83,0.30,0.16,1.47,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,1.28E-03,1.16E-02,4.96E-04,3.37E-03,3.99E-01,,,A, YES,+
3902,Q14289,PTK2B,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),DGEKRNSLPQIPM,_RNS(ph)LPQIPM(ox)LNLEAR_,S375,+,20.42,22.63,22.63,22.33,23.98,23.97,23.54,25.12,24.04,,25.23,25.07,24.05,23.58,-3.16,-0.95,-0.95,-1.25,0.39,0.38,-0.04,1.54,0.45, ,1.65,1.48,0.47,negative regulation of apoptotic process;neuron projection development;negative regulation of cell proliferation;MAPK cascade;chemokine-mediated signaling pathway;positive regulation of ERK1 and ERK2 cascade;signal complex assembly;focal adhesion assembly;blood vessel endothelial cell migration;stress fiber assembly;negative regulation of bone mineralization;positive regulation of translation;response to mechanical stimulus;regulation of inositol trisphosphate biosynthetic process;positive regulation of cell growth;activation of Rac GTPase activity;regulation of release of sequestered calcium ion into cytosol;integrin-mediated signaling pathway;sprouting angiogenesis;regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;regulation of cell shape;positive regulation of reactive oxygen species metabolic process;response to calcium ion;vascular endothelial growth factor receptor signaling pathway;response to lithium ion;response to cAMP;positive regulation of JUN kinase activity;response to glucose stimulus;regulation of actin cytoskeleton reorganization;epidermal growth factor receptor signaling pathway;tumor necrosis factor-mediated signaling pathway;response to hydrogen peroxide;elevation of cytosolic calcium ion concentration;response to cocaine;protein autophosphorylation;response to drug;regulation of macrophage chemotaxis;bone resorption;positive regulation of actin filament polymerization;positive regulation of JNK cascade;activation of Janus kinase activity;glial cell proliferation;response to hormone stimulus;positive regulation of phosphatidylinositol 3-kinase activity;apoptotic process;positive regulation of cell proliferation;response to osmotic stress;response to ethanol;oocyte maturation;negative regulation of myeloid cell differentiation;cellular response to retinoic acid;positive regulation of B cell chemotaxis;positive regulation of peptidyl-tyrosine phosphorylation;regulation of establishment of cell polarity;marginal zone B cell differentiation;response to hypoxia;negative regulation of potassium ion transport;response to stress;positive regulation of neuron projection development;positive regulation of cell-matrix adhesion;positive regulation of endothelial cell migration,axon;membrane raft;postsynaptic density;perinuclear region of cytoplasm;cell cortex;cytosol;growth cone;plasma membrane;focal adhesion;nucleus;lamellipodium,,+,,,6.15E-03,3.15E-02,8.89E-03,2.91E-03,3.52E-01,,,A, YES,
3934,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",VLSRKQSVFSAPS,_KQS(ph)VFSAPSLSAGASAAEPLDR_,S934,+,27.84,24.82,25.51,24.28,28.54,27.96,28.26,26.12,29.26,29.02,30.02,28.28,29.91,27.68,0.16,-2.86,-2.17,-3.40,0.86,0.28,0.58,-1.56,1.59,1.34,2.34,0.60,2.23,fibroblast growth factor receptor signaling pathway;sensory perception of umami taste;energy reserve metabolic process;sensory perception of sweet taste;protein heterooligomerization;sensory perception of bitter taste;platelet activation;response to calcium ion;small molecule metabolic process;activation of phospholipase C activity;G-protein coupled receptor signaling pathway;calcium ion transport into cytosol;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway;protein homooligomerization,nucleoplasm;neuronal cell body;myelin sheath;apical part of cell;brush border;nucleolus;endoplasmic reticulum membrane;integral to plasma membrane;platelet dense tubular network membrane;nuclear outer membrane,,,,,1.02E-03,1.01E-02,5.58E-03,3.06E-04,1.18E-01,+,,A, YES,+
3937,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",GKNVRRSIQGVGH,_S(ph)IQGVGHM(ox)M(ox)STM(ox)VLSR_,S916,+,24.66,23.78,24.19,22.75,26.83,25.44,25.34,26.70,24.79,27.25,26.90,24.84,27.29,25.44,-0.78,-1.66,-1.26,-2.69,1.38,0.00,-0.11,1.26,-0.65,1.81,1.45,-0.60,1.85,fibroblast growth factor receptor signaling pathway;sensory perception of umami taste;energy reserve metabolic process;sensory perception of sweet taste;protein heterooligomerization;sensory perception of bitter taste;platelet activation;response to calcium ion;small molecule metabolic process;activation of phospholipase C activity;G-protein coupled receptor signaling pathway;calcium ion transport into cytosol;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway;protein homooligomerization,nucleoplasm;neuronal cell body;myelin sheath;apical part of cell;brush border;nucleolus;endoplasmic reticulum membrane;integral to plasma membrane;platelet dense tubular network membrane;nuclear outer membrane,,,,,3.35E-03,2.12E-02,8.53E-03,1.2E-03,2.64E-01,+,,A, YES,
3967,Q14684,RRP1B,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),VGDGDLSAEEIPE,_VGDGDLS(ph)AEEIPENEVSLRR_,S227,+,24.41,,,21.30,27.15,25.66,26.34,25.94,26.39,26.56,25.00,26.38,25.62,25.52,-1.12, , ,-4.22,1.63,0.14,0.82,0.42,0.87,1.04,-0.52,0.86,0.09,rRNA processing;negative regulation of phosphatase activity,"cytosol;preribosome, small subunit precursor;nucleolus",,,,,1.92E-03,1.5E-02,9.18E-04,3.09E-03,5.43E-01,,,A, YES,
3981,Q14694,USP10,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),EEQGEGSEDEWEQ,_NHSVNEEEQEEQGEGS(ph)EDEWEQVGPR_,S576,+,23.06,23.77,23.77,23.79,27.16,25.40,26.33,27.13,26.66,25.58,25.20,25.39,23.65,25.15,-2.09,-1.38,-1.38,-1.35,2.01,0.25,1.18,1.99,1.51,0.43,0.05,0.25,-1.49,"regulation of autophagy;protein deubiquitination;DNA repair;autophagy;DNA damage response, signal transduction by p53 class mediator;ubiquitin-dependent protein catabolic process",intermediate filament cytoskeleton;nucleus;early endosome,,,,,6.31E-04,7.49E-03,1.96E-04,4.19E-02,1.29E-02,,,A, YES,
3989,Q14764,MVP,Major vault protein (MVP) (Lung resistance-related protein),SPGEGISPQSAQA,_RVASGPSPGEGIS(ph)PQSAQAPQAPGDNHVVPVLR_,S873,+,25.49,24.15,24.36,23.49,26.92,26.39,26.78,26.66,26.54,28.11,28.67,26.71,27.52,26.29,-0.80,-2.14,-1.93,-2.80,0.63,0.10,0.48,0.37,0.25,1.82,2.38,0.42,1.23,protein transport;response to drug;mRNA transport,ribonucleoprotein complex;extracellular vesicular exosome;nucleus;nuclear pore;cytoplasm,,,,,4.85E-05,1.35E-03,4.1E-04,1.5E-05,5.86E-02,,,A, YES,
4012,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),GKAAKNSEEEEEE,_AAKNS(ph)EEEEEEK_,S563,+,17.50,16.80,16.80,18.14,,21.13,20.19,21.74,21.28,19.20,20.19,22.28,21.32,19.71,-2.22,-2.92,-2.92,-1.57, ,1.41,0.48,2.03,1.56,-0.51,0.48,2.57,1.60,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,4.63E-04,6.12E-03,2.77E-04,6.42E-04,6.33E-01,,,A, YES,
4037,Q15019,SEP2,Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5),HLPDAESDEDEDF,_IYHLPDAES(ph)DEDEDFKEQTR_,S218,+,30.89,27.55,27.99,27.59,30.31,32.14,32.12,32.31,32.40,32.62,31.95,32.38,32.53,30.98,-0.09,-3.43,-2.99,-3.40,-0.67,1.16,1.13,1.33,1.41,1.63,0.97,1.39,1.55,neuron projection development;mitosis;smoothened signaling pathway;regulation of protein localization;cilium assembly;regulation of L-glutamate transport;cell division,septin complex;condensed chromosome kinetochore;cleavage furrow;actin cytoskeleton;perinuclear region of cytoplasm;cytoplasm;midbody;nucleolus;cell surface;spindle;cilium membrane;exocyst,,,,,1.3E-04,2.54E-03,1.91E-04,8.64E-05,5.02E-01,,,A, YES,+
4079,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),NAGGFRSRSSSVG,_AGTLSITEFADM(ox)LSGNAGGFRS(ph)R_,S4245,+,25.43,26.63,26.52,27.75,29.93,30.36,29.64,30.18,30.96,27.90,29.87,30.76,31.95,29.07,-3.64,-2.44,-2.55,-1.32,0.86,1.29,0.57,1.12,1.89,-1.16,0.80,1.69,2.88,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,1.81E-04,3.2E-03,1.19E-04,2.57E-04,8.97E-01,,,A,,
4098,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),AQQQKRSIQEELQ,_S(ph)IQEELQQLR_,S1417,,21.27,,,20.25,23.73,23.52,,23.01,22.44,,23.50,,23.88,22.70,-1.43, , ,-2.45,1.03,0.82, ,0.31,-0.26, ,0.81, ,1.18,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,6.7E-03,3.35E-02,5.69E-03,4.18E-03,4.74E-01,,,A,,
4102,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),FRSRSSSVGSSSS,_SSS(ph)VGSSSSYPISPAVSR_,S4249,+,31.04,30.58,29.99,31.34,32.75,32.78,31.97,32.59,32.52,31.83,32.30,31.48,31.88,31.77,-0.73,-1.19,-1.78,-0.44,0.97,1.01,0.19,0.82,0.75,0.06,0.53,-0.29,0.10,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,9.02E-03,4.17E-02,2.54E-03,5.71E-02,1.73E-01,,,A,,
4109,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),GRKRTSSEDNLYL,_TSS(ph)EDNLYLAVLR_,S21,,27.18,23.69,23.46,26.09,29.56,28.26,27.75,27.69,28.66,28.51,29.60,29.40,29.83,27.67,-0.49,-3.98,-4.21,-1.58,1.90,0.60,0.08,0.03,0.99,0.85,1.93,1.73,2.17,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,1.31E-04,2.54E-03,4.17E-04,5.47E-05,2.06E-01,,,A,,
4166,Q15459,SF3A1,Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114),VEMEVESDEEDDK,_FGESEEVEM(ox)EVES(ph)DEEDDKQEK_,S329,+,30.12,24.85,24.85,26.21,30.32,30.56,28.61,29.30,29.97,30.45,28.60,28.85,29.89,28.66,1.46,-3.81,-3.81,-2.45,1.66,1.90,-0.05,0.64,1.31,1.79,-0.06,0.19,1.23,mRNA 3'-splice site recognition,nucleoplasm;U2-type spliceosomal complex;catalytic step 2 spliceosome,,,,,5.59E-03,2.96E-02,2.71E-03,7.07E-03,7.74E-01,+,,A, YES,
4167,Q15477,SKIV2L,Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP),PLARASSLEDLVL,_ASS(ph)LEDLVLK_,S255,+,27.73,25.08,25.38,25.83,28.67,27.68,28.24,28.61,27.63,28.52,28.82,28.76,28.45,27.65,0.08,-2.57,-2.26,-1.82,1.03,0.03,0.60,0.97,-0.02,0.88,1.17,1.11,0.80,,Ski complex;nucleus,,,,,8.16E-04,8.83E-03,1.29E-03,4.25E-04,4.47E-01,,,A,,
4198,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),KYVSGSSPDLVTR,_YVSGS(ph)S(ph)PDLVTRK_,S594,+,23.09,24.62,25.36,25.19,27.16,26.51,27.28,27.16,25.92,26.03,26.55,26.38,25.98,25.94,-2.85,-1.32,-0.58,-0.75,1.22,0.57,1.34,1.22,-0.02,0.09,0.60,0.44,0.04,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,1.25E-03,1.14E-02,4.08E-04,4.94E-03,3.21E-01,,,A, YES,
4316,Q24JP5,TMEM132A,Transmembrane protein 132A (HSPA5-binding protein 1),EPAAEASDEAERR,_VPGPAEGPAEPAAEAS(ph)DEAERRAR_,S529,,,23.48,23.89,26.64,28.19,28.87,26.53,27.93,27.91,27.01,28.51,27.76,27.77,27.04, ,-3.56,-3.15,-0.40,1.15,1.83,-0.51,0.89,0.87,-0.03,1.47,0.72,0.73,brain development;negative regulation of programmed cell death,integral to membrane;endoplasmic reticulum membrane;Golgi membrane,,,,,1.3E-03,1.18E-02,7.74E-04,1.55E-03,8.57E-01,,,A, YES,+
4320,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),DTSLDKSFSEDAV,_S(ph)FSEDAVTDSSGSGTLPR_,S1192,+,21.80,22.43,21.75,24.54,,24.22,26.44,25.27,25.87,24.07,,27.28,25.79,24.50,-2.69,-2.07,-2.75,0.04, ,-0.28,1.94,0.77,1.38,-0.43, ,2.78,1.29,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,7.64E-03,3.71E-02,5.78E-03,5.2E-03,7.71E-01,,,A, YES,
4377,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),KAVEARSPGLQKE,_AVEARS(ph)PGLQK_,S720,+,,27.47,27.47,,23.80,21.99,23.92,23.81,23.28,23.43,23.55,23.49,22.66,24.08, ,3.39,3.39, ,-0.28,-2.09,-0.16,-0.27,-0.80,-0.65,-0.53,-0.59,-1.42,,spindle;cytoplasm,,,,,6.77E-04,7.93E-03,5.49E-04,5.58E-04,8.92E-01,,,A, YES,+
4471,Q53GS9,USP39,U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K),REVDEDSEPEREV,_EVDEDS(ph)EPEREVRAK_,S82,+,27.77,27.99,27.59,26.94,29.98,29.71,28.17,29.87,28.17,26.83,27.20,26.75,28.01,28.08,-0.31,-0.08,-0.49,-1.13,1.91,1.64,0.09,1.79,0.09,-1.25,-0.88,-1.32,-0.06,spliceosomal complex assembly;ubiquitin-dependent protein catabolic process,nucleus,,,,,6.47E-03,3.27E-02,1.6E-02,4.33E-01,2.76E-03,+,,A, YES,
4509,Q5HYI7,MTX3,Metaxin-3,NSFQRLSP_____,_LTPAEEENNSFQRLS(ph)P_,S250,+,24.79,24.12,24.47,24.32,26.24,26.37,25.70,26.39,26.53,27.42,26.59,25.98,26.80,25.83,-1.03,-1.71,-1.36,-1.50,0.42,0.55,-0.12,0.56,0.71,1.59,0.76,0.16,0.98,protein targeting to mitochondrion,mitochondrial outer membrane,,,,,3.62E-04,5.2E-03,7.38E-04,1.76E-04,3.46E-01,,,A, YES,
4516,Q5JRA6,MIA3,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),SSSRGSSPTRVLD,_GSS(ph)PTRVLDEGK_,S1745,+,20.42,23.88,23.88,21.81,22.28,23.90,28.31,23.61,28.56,27.13,,28.12,27.85,24.98,-4.56,-1.10,-1.10,-3.17,-2.70,-1.07,3.33,-1.37,3.58,2.15, ,3.14,2.87,negative regulation of cell adhesion;negative regulation of cell migration;protein transport;exocytosis;wound healing;positive regulation of leukocyte migration,integral to membrane;endoplasmic reticulum membrane,,,,,6.15E-03,3.15E-02,2.76E-02,2.09E-03,9.89E-02,,,A, YES,
4533,Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),ATSLSTSPTELGS,_HIISATSLSTS(ph)PTELGSR_,S226,,23.55,,,23.13,26.74,25.77,26.00,26.53,25.56,25.60,27.37,26.35,27.09,25.79,-2.24, , ,-2.66,0.95,-0.02,0.21,0.74,-0.23,-0.19,1.58,0.56,1.30,,,,,,,5.57E-04,6.85E-03,8.66E-04,2.96E-04,3.7E-01,,,A, YES,
4536,Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),SEKLKFSDDEEEE,_LKFS(ph)DDEEEEEVVK_,S388,,20.73,23.31,23.31,21.95,,25.06,26.25,24.85,25.75,25.55,26.84,25.86,26.10,24.63,-3.90,-1.32,-1.32,-2.68, ,0.43,1.62,0.22,1.12,0.92,2.21,1.23,1.47,,,,,,,7.79E-05,1.81E-03,1.72E-04,3.61E-05,3.5E-01,,,A, YES,
4548,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),QQKVNFSEEGETE,_VNFS(ph)EEGETEEDDQDSSHSSVTTVK_,S215,+,,24.25,24.25,23.90,26.56,26.30,25.37,26.26,25.93,26.42,26.62,25.68,26.66,25.68, ,-1.43,-1.43,-1.78,0.87,0.61,-0.31,0.58,0.25,0.74,0.94,-0.01,0.98,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,4.47E-03,2.52E-02,4.61E-03,2.51E-03,5.92E-01,,,A, YES,+
4550,Q5JVS0,HABP4,Intracellular hyaluronan-binding protein 4 (IHABP-4) (IHABP4) (Ki-1/57 intracellular antigen),VAQRPDSPGGGLQ,_SLPAPVAQRPDS(ph)PGGGLQAPGQK_,S108,+,,23.78,24.25,24.65,25.31,26.17,26.99,26.78,25.97,25.82,26.63,26.03,25.88,25.69, ,-1.90,-1.44,-1.04,-0.37,0.48,1.30,1.09,0.29,0.13,0.94,0.34,0.19,"platelet degranulation;cellular response to mechanical stimulus;platelet activation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of DNA binding",cytosol;extracellular region;sarcomere;nucleus,,,,,3.01E-03,1.98E-02,1.56E-03,3.8E-03,7.63E-01,,,A, YES,
4579,Q5SNT6,FAM21B,WASH complex subunit FAM21B,APPLLFSDEEEKE,_ETVSEAPPLLFS(ph)DEEEK_,S640,+,23.81,20.76,20.76,23.65,22.09,23.61,25.33,25.50,25.05,26.00,26.50,26.80,24.94,24.21,-0.40,-3.46,-3.46,-0.56,-2.13,-0.60,1.12,1.28,0.83,1.78,2.29,2.59,0.72,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,9.34E-03,4.26E-02,9.78E-02,2.94E-03,5.04E-02,,,A,,
4615,Q5SYE7,NHSL1,NHS-like protein 1,ALRAVPSPTTGEE,_AVPS(ph)PTTGEEGSVHSR_,S1229,+,24.16,23.09,23.35,24.15,27.32,26.55,27.21,26.78,25.60,23.78,25.78,24.66,26.03,25.27,-1.11,-2.18,-1.91,-1.11,2.06,1.28,1.94,1.51,0.33,-1.49,0.52,-0.61,0.76,,,,,,,3.53E-04,5.12E-03,9.13E-05,3.99E-02,1.16E-02,,,A,,
4679,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),QQVRTGSTSSKED,_TGS(ph)TSSKEDDYESDAATIVQK_,S362,,24.43,22.79,,23.53,26.20,25.57,26.99,26.96,25.81,23.39,25.99,25.75,25.76,25.26,-0.83,-2.47, ,-1.73,0.94,0.30,1.72,1.70,0.55,-1.87,0.72,0.48,0.49,virus-host interaction,integral to membrane;nucleus;cytoskeleton;cytoplasm,,,,,4.65E-03,2.59E-02,1.4E-03,4.19E-02,1.03E-01,,,A, YES,+
4680,Q5T5C0,STXBP5,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),KMSRKLSLPTDLK,_KLS(ph)LPTDLKPDLDVK_,S394,+,21.11,22.85,22.36,23.97,24.36,25.81,26.11,26.50,25.51,24.27,26.67,27.15,26.51,24.86,-3.75,-2.01,-2.50,-0.89,-0.50,0.95,1.25,1.64,0.65,-0.59,1.81,2.29,1.65,protein transport;exocytosis;positive regulation of exocytosis,cytoplasmic vesicle membrane;acetylcholine-gated channel complex;synaptic vesicle;cell junction,,,,,3.85E-04,5.42E-03,5.63E-04,2.3E-04,4.95E-01,,,A,,
4708,Q5TAQ9,DCAF8,DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A),NRVHDRSEEEEEE,_VHDRS(ph)EEEEEEEEEEEEEQPR_,S80,+,24.01,24.63,25.04,,26.94,27.41,27.27,27.41,26.98,26.25,27.87,27.24,27.08,26.51,-2.50,-1.88,-1.47, ,0.43,0.90,0.76,0.90,0.47,-0.26,1.36,0.73,0.57,protein ubiquitination,Cul4-RING ubiquitin ligase complex,,,,,1.18E-04,2.38E-03,7.84E-05,1.68E-04,8.51E-01,,,A, YES,+
4710,Q5TCQ9,MAGI3,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",SIIRSGSPKLDPS,_SGS(ph)PKLDPSEVYLK_,S699,,21.76,20.95,21.18,,24.89,24.73,24.92,24.71,23.27,24.51,,24.22,23.43,23.51,-1.75,-2.56,-2.33, ,1.38,1.23,1.41,1.21,-0.24,1.01, ,0.71,-0.08,positive regulation of JUN kinase activity;apoptotic process;virus-host interaction;intracellular signal transduction,tight junction;plasma membrane;nucleus;membrane,,,,,1.7E-04,3.1E-03,5.82E-05,6.16E-04,4.46E-01,+,,A, YES,
4797,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),RQEKRSSGFISEL,_RSS(ph)GFISELPSEEGK_,S968,+,24.91,24.88,25.53,24.69,24.77,25.89,26.56,26.95,26.23,28.47,27.69,28.17,26.83,26.28,-1.36,-1.39,-0.74,-1.58,-1.50,-0.39,0.28,0.68,-0.04,2.20,1.41,1.89,0.55,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,4.64E-04,6.12E-03,2.9E-02,1.15E-04,9.12E-03,,,A, YES,+
4811,Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),RVTQHESDNENEI,_VTQHES(ph)DNENEIQIQNK_,S122,+,24.75,25.99,26.42,26.18,27.99,28.47,27.09,27.49,28.17,26.94,25.09,26.09,27.04,26.75,-1.99,-0.76,-0.33,-0.57,1.24,1.72,0.34,0.75,1.42,0.20,-1.65,-0.65,0.29,regulation of cell morphogenesis;multicellular organismal development;cytoskeleton organization,,,,,,2.88E-03,1.92E-02,9.65E-04,2.15E-01,1.63E-02,,,A, YES,
4851,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],GPGRAESKESVGS,_FLREPVVTPQDLEGPGRAES(ph)K_,S472,+,22.78,24.46,24.73,23.63,24.27,25.76,27.23,26.43,26.43,26.98,27.27,26.95,26.29,25.63,-2.85,-1.17,-0.90,-2.01,-1.36,0.13,1.59,0.80,0.80,1.34,1.64,1.32,0.65,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,7.54E-04,8.45E-03,2.74E-03,2.62E-04,1.84E-01,,,A, YES,+
4936,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),PDILLDSPERKQK,_DVPPDILLDS(ph)PERK_,S318,+,23.43,22.27,22.80,21.98,25.51,25.16,24.09,24.07,24.08,23.49,23.63,24.18,24.14,23.76,-0.32,-1.49,-0.96,-1.78,1.76,1.40,0.33,0.31,0.32,-0.26,-0.12,0.42,0.39,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,3.36E-03,2.12E-02,9.64E-04,1.84E-02,2.19E-01,,,A, YES,
4937,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),ETEDDESDGEDRG,_NNTAAETEDDES(ph)DGEDRGGGTSGSLRR_,S2672,+,24.19,25.33,26.04,22.76,26.12,27.14,26.12,26.05,26.23,25.67,24.09,24.29,24.37,25.26,-1.07,0.07,0.78,-2.50,0.85,1.88,0.85,0.79,0.97,0.41,-1.18,-0.97,-0.89,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,7.41E-03,3.61E-02,3.67E-03,5.6E-01,1.34E-02,,,A, YES,
4941,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),ETEDDESDGEDRG,_NNTAAETEDDES(ph)DGEDRGGGTSGVR_,S2672,+,24.21,25.63,25.93,24.62,27.36,27.52,27.19,27.23,26.86,26.63,25.17,24.72,25.33,26.03,-1.82,-0.40,-0.10,-1.41,1.33,1.49,1.16,1.19,0.83,0.60,-0.86,-1.31,-0.70,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,1.39E-03,1.23E-02,6.94E-04,4.53E-01,3.75E-03,,,A, YES,
4967,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),AWKWRLSPGETPE,_WRLS(ph)PGETPER_,S195,+,22.71,23.44,23.44,22.24,25.53,24.61,24.36,25.18,24.74,25.51,24.77,25.26,24.60,24.34,-1.63,-0.90,-0.90,-2.10,1.19,0.27,0.03,0.84,0.40,1.17,0.43,0.92,0.27,,cytoskeleton;cytoplasm,,,,,1.34E-03,1.2E-02,1.21E-03,9.85E-04,7.56E-01,,,A, YES,
5002,Q6P4E1,CASC4,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),FFDENESPVDPQH,_FFDENES(ph)PVDPQHGSK_,S345,+,20.36,22.53,22.05,21.48,26.08,26.78,24.93,25.49,26.30,25.26,24.69,24.58,26.33,24.37,-4.01,-1.84,-2.32,-2.89,1.70,2.40,0.56,1.11,1.92,0.88,0.32,0.21,1.95,,integral to membrane,,,,,4.09E-06,2.96E-04,1.63E-06,2.38E-05,2.47E-01,,,A, YES,+
5053,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),TTVNGQSPPEHSA,_NALPPVLTTVNGQS(ph)PPEHSAPAK_,S143,+,23.10,22.61,,24.18,25.96,24.95,26.19,26.40,25.18,25.47,25.93,26.16,26.09,25.18,-2.09,-2.58, ,-1.01,0.78,-0.24,1.01,1.22,-0.01,0.28,0.75,0.98,0.90,positive regulation of macroautophagy,,,,,,6.1E-04,7.35E-03,5.85E-04,4.7E-04,7.35E-01,,,A, YES,+
5193,Q71RC2,LARP4,La-related protein 4 (La ribonucleoprotein domain family member 4),QTTIPVSPPSTTK,_DGLNQTTIPVS(ph)PPSTTKPSR_,S512,+,24.21,23.40,23.53,25.19,26.50,26.96,27.41,28.37,26.65,26.94,27.16,26.99,27.94,26.25,-2.04,-2.85,-2.72,-1.06,0.25,0.71,1.16,2.12,0.40,0.69,0.91,0.74,1.69,regulation of cell morphogenesis;cytoskeleton organization,,,,,,4.02E-05,1.25E-03,3.58E-05,4.82E-05,8.86E-01,,,A, YES,
5214,Q7KZF4,SND1,Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator),DYIRPASPATETV,_VNVTVDYIRPAS(ph)PATETVPAFSER_,S426,+,,22.78,22.29,,24.91,23.80,24.40,24.90,25.16,25.22,24.94,25.97,24.60,24.45, ,-1.68,-2.16, ,0.46,-0.65,-0.05,0.44,0.71,0.77,0.48,1.52,0.15,"nucleic acid phosphodiester bond hydrolysis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;gene silencing by RNA",RNA-induced silencing complex;mitochondrion;nucleus;melanosome;cytoplasm,,,,,2.86E-03,1.92E-02,5.16E-03,1.24E-03,2.95E-01,,,A, YES,
5227,Q7L1V2,MON1B,Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein),DQPPSPSPPPQSE,_DKDQPPSPS(ph)PPPQSEALSSTSR_,S61,+,,23.02,23.77,22.83,,25.72,26.08,24.69,24.16,24.60,25.29,25.46,26.02,24.70, ,-1.67,-0.93,-1.86, ,1.03,1.39,0.00,-0.54,-0.09,0.60,0.76,1.33,,,,,,,4.16E-03,2.43E-02,4.05E-03,2.38E-03,7.74E-01,,,A, YES,
5236,Q7L4E1,FAM73B,Protein FAM73B,LPLTEGSLRLRAD,_TLM(ox)LPLTEGS(ph)LR_,S276,+,24.18,19.94,18.91,23.30,25.35,25.02,24.42,24.54,24.59,24.04,25.35,25.09,24.97,23.82,0.36,-3.88,-4.91,-0.52,1.52,1.20,0.59,0.72,0.76,0.22,1.52,1.27,1.14,,integral to membrane,,,,,3.5E-03,2.16E-02,2.44E-03,2.98E-03,9.26E-01,,,A, YES,
5307,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),ELEKRTSPQVLGS,_RTS(ph)PQVLGSILK_,S572,+,22.88,21.23,21.65,18.77,24.30,,24.61,22.76,23.50,24.12,24.41,23.83,24.37,23.04,-0.16,-1.81,-1.39,-4.26,1.27, ,1.57,-0.28,0.47,1.08,1.37,0.79,1.34,,polysomal ribosome;nucleus,,,,,1.89E-03,1.5E-02,2.6E-03,9.19E-04,6.13E-01,,,A, YES,+
5329,Q7Z478,DHX29,ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) (Nucleic acid helicase DDXx),QIQATISPPLQPK,_FQSPQIQATIS(ph)PPLQPK_,S200,+,21.54,23.25,23.98,,24.79,,25.54,25.60,24.25,24.36,25.47,23.35,,24.21,-2.67,-0.96,-0.24, ,0.58, ,1.33,1.38,0.03,0.15,1.26,-0.86, ,,mitochondrion,,,,,1.11E-02,4.86E-02,3.76E-03,2.52E-02,4.21E-01,,,A, YES,
5391,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",MDVDQPSPSAQDT,_REESPM(ox)DVDQPS(ph)PSAQDTQSIASDGTPQGEK_,S3800,+,25.37,25.66,24.89,24.37,25.91,27.50,27.20,27.99,26.78,25.46,26.69,26.42,26.24,26.19,-0.82,-0.53,-1.30,-1.82,-0.28,1.31,1.01,1.80,0.59,-0.73,0.50,0.23,0.05,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,8.77E-03,4.08E-02,2.44E-03,7.92E-02,1.23E-01,,,A, YES,
5431,Q86UP2,KTN1,Kinectin (CG-1 antigen) (Kinesin receptor),NGNLHESDSESVP,_EIQNGNLHES(ph)DSESVPR_,S75,+,26.17,27.04,26.19,27.26,28.35,28.63,28.47,28.80,27.97,28.46,28.80,28.09,27.95,27.86,-1.69,-0.82,-1.67,-0.60,0.49,0.77,0.61,0.94,0.11,0.60,0.94,0.23,0.09,microtubule-based movement,integral to plasma membrane;endoplasmic reticulum membrane,,,,,1.01E-02,4.55E-02,4.95E-03,1.13E-02,8.12E-01,,,A, YES,
5494,Q86VR2,FAM134C,Protein FAM134C,EDLDGHSDPEESF,_GQTPLTEGSEDLDGHS(ph)DPEESFAR_,S320,+,27.05,25.11,25.67,25.28,28.77,28.73,28.41,28.35,29.40,28.20,28.53,28.32,28.74,27.73,-0.68,-2.63,-2.06,-2.46,1.04,0.99,0.67,0.61,1.67,0.47,0.80,0.59,1.00,,integral to membrane,,,,,6.41E-05,1.59E-03,3.35E-05,1.49E-04,6.23E-01,,,A, YES,
5501,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),CLRRRPSDENTIA,_RRPS(ph)DENTIAPSEVQK_,S788,+,22.09,24.65,25.22,24.56,27.03,27.64,26.40,27.69,27.08,27.24,27.23,26.50,26.84,26.17,-4.08,-1.51,-0.95,-1.61,0.86,1.47,0.24,1.52,0.92,1.07,1.06,0.34,0.67,cell adhesion,plasma membrane,,,,,8.04E-05,1.86E-03,4.6E-05,1.57E-04,7.22E-01,,,A, YES,+
5648,Q8IWS0,PHF6,PHD finger protein 6 (PHD-like zinc finger protein),HELEPSSPKSKKK,_TAHNSEADLEESFNEHELEPSS(ph)PK_,S121,+,23.02,23.28,23.28,22.46,26.51,27.24,26.83,27.32,27.19,26.81,26.81,26.49,26.91,25.70,-2.69,-2.42,-2.42,-3.25,0.81,1.54,1.12,1.61,1.49,1.11,1.11,0.78,1.21,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,,,,,6.63E-07,1.34E-04,4.29E-07,1.64E-06,5.59E-01,,+,A, YES,+
5670,Q8IX90,SKA3,Spindle and kinetochore-associated protein 3,SEKSPRSPQLSDF,_S(ph)PQLSDFGLER_,S155,+,21.71,21.40,21.40,21.37,25.59,23.85,23.91,26.39,23.76,21.35,22.17,25.05,23.16,23.16,-1.46,-1.76,-1.76,-1.79,2.43,0.69,0.75,3.23,0.60,-1.81,-0.99,1.89,0.00,mitosis;chromosome segregation;regulation of microtubule polymerization or depolymerization;cell division,spindle microtubule;cytoplasm;condensed chromosome outer kinetochore,,,,,4.82E-03,2.66E-02,1.62E-03,1.19E-01,3.56E-02,,,A,,
5681,Q8IXQ4,KIAA1704,Uncharacterized protein KIAA1704 (Lipopolysaccharide-specific response protein 7),FKKQDDSPPRPII,_(gl)QDDS(ph)PPRPIIGPALPPGFIK_,S105,+,,24.65,24.72,24.90,27.76,26.83,26.71,27.37,27.23,26.22,25.93,25.37,28.00,26.31, ,-1.66,-1.59,-1.41,1.45,0.52,0.41,1.06,0.92,-0.09,-0.37,-0.93,1.69,,,,,,,2.86E-03,1.92E-02,8.85E-04,1.62E-02,1.72E-01,,,A,,
5712,Q8IYI6,EXOC8,Exocyst complex component 8 (Exocyst complex 84 kDa subunit),LRRQLESGGFEAR,_(gl)QLES(ph)GGFEAR_,S19,+,,23.17,22.66,24.32,24.65,24.69,25.32,25.55,24.98,25.37,25.78,25.58,24.99,24.76, ,-1.58,-2.09,-0.43,-0.10,-0.06,0.56,0.79,0.22,0.61,1.03,0.82,0.24,protein transport;exocytosis,growth cone;plasma membrane;nucleus;exocyst;cytoplasm,,,,,8.32E-03,3.96E-02,1.18E-02,3.62E-03,4.3E-01,,,A, YES,
5813,Q8N3V7,SYNPO,Synaptopodin,VSPRAASPAKPSS,_AAS(ph)PAKPSSLDLVPNLPK_,S589,+,22.18,23.08,23.17,22.66,27.72,26.76,27.09,25.35,27.59,22.48,26.81,24.47,28.35,25.21,-3.03,-2.13,-2.04,-2.55,2.51,1.56,1.88,0.14,2.38,-2.73,1.61,-0.74,3.14,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,2.23E-03,1.67E-02,6.1E-04,1.73E-02,1.61E-01,,,A, YES,
5814,Q8N3V7,SYNPO,Synaptopodin,APRDRASPAAAEE,_DRAS(ph)PAAAEEVVPEWASCLK_,S441,+,21.80,21.95,21.95,21.20,25.58,,25.70,23.79,26.78,21.54,24.61,,,23.49,-1.69,-1.54,-1.54,-2.29,2.09, ,2.21,0.30,3.29,-1.95,1.12, , ,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,1.22E-03,1.13E-02,2.18E-04,1.16E-01,2.75E-02,,,A, YES,
5819,Q8N3V7,SYNPO,Synaptopodin,SCTSPRSPLPAPP,_S(ph)PLPAPPRPFLYR_,S840,,,20.38,19.35,19.79,24.89,23.84,25.05,24.44,25.34,,25.78,23.49,23.90,23.29, ,-2.92,-3.95,-3.50,1.59,0.54,1.75,1.15,2.05, ,2.48,0.20,0.60,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,1.48E-05,6.63E-04,6.41E-06,4.36E-05,6.31E-01,,,A, YES,
5832,Q8N4C8,MINK1,Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6),HLPQAGSLERNRV,_SDSVLPASHGHLPQAGS(ph)LER_,S743,+,,22.48,22.48,21.74,24.35,24.58,23.96,24.27,24.65,22.93,25.27,24.11,24.08,23.74, ,-1.26,-1.26,-2.00,0.61,0.83,0.22,0.53,0.91,-0.81,1.53,0.37,0.34,regulation of cell migration;protein autophosphorylation;JNK cascade;regulation of cell-matrix adhesion;regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity;dendrite morphogenesis;regulation of cell-cell adhesion;actin cytoskeleton reorganization;negative thymic T cell selection;positive regulation of JNK cascade;synaptic transmission,axon;Golgi apparatus;cell junction;plasma membrane;postsynaptic density;postsynaptic membrane,,+,,,8.49E-03,4E-02,3.69E-03,1.21E-02,6.25E-01,,,A,,
5841,Q8N554,ZNF276,Zinc finger protein 276 (Zfp-276) (Zinc finger protein 477),PPPGPPSPSVTTE,_ALPLEAEPPPGPPS(ph)PSVTTEGQAVKPEPT_,S383,,22.51,23.14,23.49,23.44,24.41,25.01,24.34,24.70,25.68,24.97,,,25.22,24.26,-1.76,-1.13,-0.77,-0.82,0.15,0.75,0.07,0.44,1.41,0.70, , ,0.96,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,5.35E-03,2.87E-02,2.67E-03,5.88E-03,6.68E-01,,,A,,
5879,Q8N720,ZNF655,Zinc finger protein 655 (Vav-interacting Krueppel-like protein),AQEAAGSPRVQFQ,_(ac)M(ox)EEIPAQEAAGS(ph)PR_,S12,,23.20,23.39,23.60,,25.40,25.73,25.08,24.76,25.26,24.40,23.69,,24.13,24.42,-1.22,-1.03,-0.82, ,0.98,1.31,0.65,0.34,0.84,-0.03,-0.74, ,-0.29,"regulation of mitotic cell cycle;G1 phase;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus;cytoplasm,C2H2-type,,,,6.21E-03,3.16E-02,1.94E-03,2.2E-01,3.18E-02,,,A,,
5906,Q8NB78,KDM1B,Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2),KASFDHSPDSLPL,_ASFDHS(ph)PDSLPLR_,S17,+,21.19,,,22.20,23.72,24.43,24.42,24.19,24.33,24.00,22.62,22.25,23.53,23.35,-2.16, , ,-1.15,0.37,1.08,1.06,0.83,0.98,0.65,-0.73,-1.11,0.18,"multicellular organismal development;regulation of DNA methylation;DNA methylation involved in gamete generation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of gene expression by genetic imprinting",nucleus,,,,,4.58E-03,2.57E-02,1.7E-03,5.53E-02,4.95E-02,,,A, YES,+
5991,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),VNGRKTSLDVSNS,_KTS(ph)LDVSNSAEPGFLAPGAR_,S648,+,,22.74,,23.49,25.13,24.78,25.43,25.64,24.69,,25.96,26.27,25.39,24.95, ,-2.21, ,-1.46,0.17,-0.17,0.48,0.69,-0.26, ,1.01,1.32,0.44,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,2.74E-03,1.87E-02,5.74E-03,1.19E-03,1.86E-01,,,A, YES,
6077,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),LTDEVNSPDSDRR,_TLTDEVNS(ph)PDSDRR_,S283,+,26.17,27.05,27.04,25.95,28.47,28.96,28.00,28.14,27.85,27.30,26.39,27.22,26.55,27.31,-1.14,-0.26,-0.27,-1.37,1.16,1.65,0.69,0.82,0.54,-0.02,-0.93,-0.10,-0.76,"positive regulation of transcription, DNA-dependent;nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;chromatin remodeling;nervous system development",SWI/SNF complex;npBAF complex;nBAF complex,,,,,2.37E-03,1.7E-02,1.03E-03,3.82E-01,7.4E-03,,,A, YES,+
6087,Q8TBE7,SLC35G2,Solute carrier family 35 member G2 (Transmembrane protein 22),YQEILDSPIK___,_QDYQEILDS(ph)PIK_,S409,+,,21.32,21.32,21.52,25.72,24.25,24.82,25.63,25.05,25.22,24.99,24.30,25.53,24.14, ,-2.82,-2.82,-2.62,1.58,0.11,0.68,1.49,0.91,1.08,0.85,0.16,1.39,,integral to membrane;Golgi apparatus,,,,,6.3E-05,1.58E-03,4.59E-05,8.06E-05,8.71E-01,,,A,,
6119,Q8TDY2,RB1CC1,RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200),MENIMHSQNCEIK,_LLEM(ox)ENIMHS(ph)QNCEIK_,S943,,20.06,,,,23.32,25.61,24.46,25.53,25.12,,24.99,26.62,25.56,24.59,-4.53, , , ,-1.26,1.03,-0.12,0.94,0.54, ,0.40,2.03,0.97,"regulation of autophagy;negative regulation of apoptotic process;JNK cascade;regulation of transcription, DNA-dependent;liver development;autophagic vacuole assembly;positive regulation of protein phosphorylation;positive regulation of cell size;transcription, DNA-dependent;cell cycle;heart development",pre-autophagosomal structure membrane;cytosol;ULK1-ATG13-FIP200 complex;nucleus,,,,,2.27E-03,1.67E-02,3.55E-03,1.12E-03,2.7E-01,,,A,,
6203,Q8WUB8,PHF10,PHD finger protein 10 (BRG1-associated factor 45a) (BAF45a) (XAP135),EYYKRYSPDELRY,_RYS(ph)PDELR_,S88,+,23.03,24.13,24.07,23.05,25.70,25.07,24.77,24.46,24.83,23.46,22.57,,22.94,24.01,-0.97,0.12,0.06,-0.96,1.69,1.07,0.76,0.46,0.82,-0.55,-1.44, ,-1.07,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;nervous system development",npBAF complex,,,,,3.98E-03,2.34E-02,9.93E-03,3.31E-01,1.93E-03,,,A, YES,
6218,Q8WUM9,SLC20A1,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),ERERLPSVDLKEE,_LPS(ph)VDLK_,S335,+,20.02,20.56,20.56,23.64,22.97,23.06,26.71,24.90,27.06,26.37,27.25,28.06,26.84,24.46,-4.45,-3.90,-3.90,-0.82,-1.49,-1.40,2.25,0.44,2.60,1.90,2.79,3.60,2.38,positive regulation of I-kappaB kinase/NF-kappaB cascade;phosphate-containing compound metabolic process,integral to plasma membrane,,,,,3.63E-04,5.2E-03,4.09E-03,1.05E-04,3.74E-02,,,A, YES,
6242,Q8WVM0,TFB1M,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (h-mtTFB) (h-mtTFB1) (hTFB1M) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",LRPRQLSISHFKS,_(gl)QLS(ph)ISHFK_,S296,,20.15,,,18.98,21.04,22.35,20.95,22.31,21.92,21.89,21.43,,23.09,21.41,-1.26, , ,-2.43,-0.37,0.94,-0.46,0.90,0.51,0.48,0.02, ,1.68,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;rRNA methylation",mitochondrial nucleoid,Other TF domain,,,,1.13E-02,4.92E-02,1.08E-02,6.24E-03,5.11E-01,,,A, YES,
6310,Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),TPAVLLSPTKEPP,_SLPTPAVLLS(ph)PTK_,S259,+,22.96,21.87,21.87,21.51,,,25.44,22.86,25.37,26.31,26.39,,23.82,23.84,-0.88,-1.97,-1.97,-2.33, , ,1.60,-0.98,1.53,2.47,2.55, ,-0.02,cytoskeleton organization,Z disc;actin filament;nucleus;focal adhesion;lamellipodium;ruffle,,,,,1.08E-02,4.77E-02,2.26E-02,3.52E-03,3.28E-01,,,A, YES,
6369,Q8WZ74,CTTNBP2,Cortactin-binding protein 2 (CortBP2),QRLSLGSDDEADL,_LSLGS(ph)DDEADLVK_,S376,+,20.26,,,,24.25,23.15,24.06,24.62,23.49,22.76,24.97,22.65,25.25,23.55,-3.28, , , ,0.71,-0.40,0.51,1.07,-0.06,-0.78,1.42,-0.90,1.70,brain development,synaptic vesicle,,,,,8.41E-03,3.98E-02,5.54E-03,6.37E-03,9.92E-01,,,A,,
6373,Q92466,DDB2,DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2),RNKRSRSPLELEP,_S(ph)PLELEPEAKK_,S26,+,23.62,25.41,25.58,24.73,29.06,28.31,27.15,27.66,28.40,26.32,27.58,26.62,26.91,26.72,-3.10,-1.31,-1.14,-1.99,2.34,1.59,0.43,0.94,1.68,-0.40,0.86,-0.10,0.19,"response to UV;nucleotide-excision repair, DNA damage removal;protein autoubiquitination;protein polyubiquitination;pyrimidine dimer repair",nucleoplasm;protein complex,,,,,5.28E-05,1.42E-03,1.26E-05,1.8E-03,3.49E-02,+,,A, YES,
6382,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),GLMRTASELLLDR,_TAS(ph)ELLLDRR_,S1646,+,22.66,26.64,26.16,27.10,28.82,28.99,28.69,28.13,28.36,28.42,29.20,28.58,28.94,27.75,-5.09,-1.11,-1.58,-0.64,1.08,1.24,0.94,0.39,0.62,0.67,1.45,0.84,1.19,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,2.4E-03,1.71E-02,1.98E-03,1.82E-03,8.1E-01,,,A, YES,
6386,Q92538,GBF1,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1),PDAGAQSDSELPS,_ADAPDAGAQS(ph)DSELPSYHQNDVSLDR_,S1298,+,25.25,23.80,23.80,25.69,27.98,,26.91,28.22,27.06,24.71,28.85,27.16,27.46,26.41,-1.15,-2.61,-2.61,-0.72,1.57, ,0.50,1.81,0.66,-1.70,2.44,0.75,1.05,"retrograde vesicle-mediated transport, Golgi to ER;post-Golgi vesicle-mediated transport;COPI coating of Golgi vesicle;regulation of ARF protein signal transduction",trans-Golgi network;Golgi membrane,,,,,6.4E-03,3.25E-02,2.8E-03,1.02E-02,5.33E-01,,,A, YES,
6392,Q92543,SNX19,Sorting nexin-19,PRSEPQSPTEELS,_SEPQS(ph)PTEELSEAETESKPQTEGK_,S699,+,,22.99,22.14,23.64,24.71,25.42,24.50,25.02,24.82,23.75,25.64,25.12,25.32,24.42, ,-1.44,-2.29,-0.78,0.28,1.00,0.08,0.60,0.40,-0.67,1.22,0.70,0.90,protein transport;cell communication,cytoplasmic vesicle membrane,,,,,1.12E-02,4.88E-02,7.59E-03,8.1E-03,9.07E-01,,,A, YES,
6394,Q92545,TMEM131,Transmembrane protein 131 (Protein RW1),FTEQPPSPLPKSK,_DFDHHDSPALEVFTEQPPS(ph)PLPK_,S1375,+,24.18,21.93,,,,25.20,25.32,25.68,26.02,26.13,,25.45,25.82,25.08,-0.91,-3.15, , , ,0.12,0.24,0.60,0.94,1.05, ,0.36,0.74,,integral to membrane,,,,,7.09E-03,3.5E-02,5.69E-03,4.45E-03,7.18E-01,,,A, YES,
6402,Q92585,MAML1,Mastermind-like protein 1 (Mam-1),ARYEAVSPERLEL,_YEAVS(ph)PERLELER_,S45,+,22.43,21.12,21.02,21.16,24.92,23.46,24.44,25.46,23.48,21.97,,22.71,23.27,22.95,-0.52,-1.83,-1.94,-1.79,1.97,0.50,1.49,2.51,0.53,-0.98, ,-0.25,0.31,transcription initiation from RNA polymerase II promoter;positive regulation of myotube differentiation;Notch signaling pathway;myoblast differentiation;protein phosphorylation;atrioventricular node cell development;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;nuclear speck;MAML1-RBP-Jkappa- ICN1 complex,,,,,7.67E-04,8.53E-03,1.71E-04,9.8E-02,1.52E-02,,,A, YES,
6414,Q92599,SEP8,Septin-8,TDLERFSNAEPEP,_(ac)AATDLERFS(ph)NAEPEPR_,S10,,25.85,25.55,26.19,24.90,26.98,26.67,26.76,27.15,26.14,26.74,27.55,26.76,27.28,26.50,-0.65,-0.95,-0.31,-1.60,0.47,0.17,0.26,0.65,-0.37,0.24,1.04,0.26,0.78,cell cycle,septin complex;cytoplasm,,,,,8.82E-03,4.09E-02,1.13E-02,4.01E-03,5.04E-01,,,A, YES,
6512,Q92945,KHSRP,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),LFIIRGSPQQIDH,_LFIIRGS(ph)PQQIDHAK_,S480,+,,20.87,20.87,,24.14,24.46,23.77,23.98,23.97,23.98,,22.53,23.31,23.19, ,-2.31,-2.31, ,0.95,1.27,0.58,0.79,0.78,0.79, ,-0.65,0.12,"RNA splicing, via transesterification reactions;mRNA processing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA transport",nucleoplasm;cytosol,Other TF domain,,,,1.21E-03,1.12E-02,3.69E-04,6.8E-03,1.64E-01,,,A, YES,
6517,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),DSGGNTSPGVTAN,_EPALPLEPDSGGNTS(ph)PGVTANGEAR_,S668,+,26.02,22.19,22.19,24.17,26.08,,25.06,27.97,28.60,27.77,27.22,,27.51,25.89,0.13,-3.70,-3.70,-1.72,0.19, ,-0.82,2.08,2.71,1.88,1.33, ,1.62,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,4.21E-03,2.45E-02,4.52E-03,2.32E-03,5.63E-01,,,A, YES,+
6644,Q96E09,FAM122A,Protein FAM122A,GLLLPASPVRMHS,_HGLLLPAS(ph)PVR_,S76,+,22.93,22.73,22.19,22.77,25.01,24.91,24.51,24.46,24.55,23.79,23.78,24.00,23.87,23.81,-0.88,-1.08,-1.62,-1.04,1.20,1.10,0.70,0.65,0.74,-0.02,-0.03,0.20,0.06,,,,,,,3.9E-03,2.31E-02,1.04E-03,5.83E-02,8.07E-02,,,A,,
6648,Q96E09,FAM122A,Protein FAM122A,GLRRSNSAPLIHG,_SNS(ph)APLIHGLSDTSPVFQAEAPSAR_,S37,+,25.22,23.90,23.90,,26.09,26.56,25.94,26.17,26.73,26.36,26.34,26.93,,25.83,-0.61,-1.93,-1.93, ,0.26,0.73,0.11,0.34,0.90,0.53,0.51,1.10, ,,,,,,,6.78E-03,3.37E-02,5.37E-03,4.58E-03,6.38E-01,,,A,,
6653,Q96EB6,SIRT1,NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],ALQPGGSPSAAGA,_(ac)ADEAALALQPGGS(ph)PSAAGADREAASSPAGEPLR_,S14,+,24.82,23.62,22.99,23.82,26.52,25.67,25.83,25.98,25.98,26.03,,25.04,25.56,25.15,-0.33,-1.54,-2.16,-1.34,1.37,0.52,0.67,0.82,0.83,0.87, ,-0.12,0.41,"regulation of mitotic cell cycle;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of helicase activity;negative regulation of fat cell differentiation;fatty acid homeostasis;regulation of glucose metabolic process;regulation of smooth muscle cell apoptotic process;negative regulation of DNA damage response, signal transduction by p53 class mediator;muscle organ development;regulation of peroxisome proliferator activated receptor signaling pathway;proteasomal ubiquitin-dependent protein catabolic process;peptidyl-lysine acetylation;negative regulation of TOR signaling cascade;white fat cell differentiation;regulation of protein import into nucleus, translocation;DNA synthesis involved in DNA repair;cell aging;cellular response to hypoxia;transcription, DNA-dependent;positive regulation of macrophage apoptotic process;cellular response to ionizing radiation;negative regulation of protein kinase B signaling cascade;cellular response to tumor necrosis factor;negative regulation of I-kappaB kinase/NF-kappaB cascade;methylation-dependent chromatin silencing;spermatogenesis;ovulation from ovarian follicle;negative regulation of cell growth;positive regulation of transcription from RNA polymerase II promoter;positive regulation of cellular senescence;positive regulation of cAMP-dependent protein kinase activity;negative regulation of cAMP-dependent protein kinase activity;positive regulation of MHC class II biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;maintenance of chromatin silencing;negative regulation of apoptotic process;cellular response to hydrogen peroxide;negative regulation of prostaglandin biosynthetic process;triglyceride mobilization;negative regulation of NF-kappaB transcription factor activity;negative regulation of androgen receptor signaling pathway;negative regulation of peptidyl-lysine acetylation;rRNA processing;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;response to insulin stimulus;positive regulation of cholesterol efflux;positive regulation of insulin receptor signaling pathway;DNA replication;single strand break repair;positive regulation of adaptive immune response;establishment of chromatin silencing;peptidyl-lysine deacetylation;regulation of endodeoxyribonuclease activity;negative regulation of cellular response to testosterone stimulus;cholesterol homeostasis;cellular glucose homeostasis;positive regulation of cell proliferation;virus-host interaction;cellular triglyceride homeostasis;cellular response to starvation;negative regulation of cellular senescence;angiogenesis;pyrimidine dimer repair by nucleotide-excision repair;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;chromatin silencing at rDNA;protein destabilization;positive regulation of macroautophagy;regulation of bile acid biosynthetic process;positive regulation of chromatin silencing;positive regulation of DNA repair;protein ubiquitination",nuclear heterochromatin;nuclear inner membrane;cytoplasm;nuclear euchromatin;nucleolus;PML body;rDNA heterochromatin;chromatin silencing complex,,,,,2.18E-03,1.64E-02,5.93E-04,8.78E-03,4.11E-01,,,A,,
6722,Q96I25,RBM17,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),RRPDPDSDEDEDY,_RPDPDS(ph)DEDEDYERER_,S155,+,26.34,26.41,26.74,26.00,30.01,28.75,28.95,28.91,29.28,27.70,27.49,28.44,26.87,27.84,-1.49,-1.43,-1.10,-1.84,2.17,0.91,1.11,1.08,1.44,-0.14,-0.35,0.60,-0.96,mRNA processing;RNA splicing,nucleus;spliceosomal complex,,,,,6.68E-05,1.63E-03,1.62E-05,1.45E-02,5.32E-03,+,,A, YES,+
6786,Q96L91,EP400,E1A-binding protein p400 (EC 3.6.4.-) (CAG repeat protein 32) (Domino homolog) (hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein),TASKPASPIGGPT,_VAVNALAVGEPGTASKPAS(ph)PIGGPTQEEK_,S1615,+,22.72,22.21,22.21,,24.36,25.34,24.22,24.36,24.85,24.60,23.20,23.66,25.09,23.90,-1.18,-1.69,-1.69, ,0.46,1.43,0.31,0.46,0.95,0.70,-0.70,-0.24,1.19,histone H2A acetylation;histone H4 acetylation,nuclear speck;NuA4 histone acetyltransferase complex,,,,,4.23E-03,2.45E-02,1.5E-03,1.16E-02,3.55E-01,,,A,,
6952,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),LLLERPSPIRDRR,_LLLERPS(ph)PIRDR_,S700,+,24.84,24.69,24.99,24.52,27.22,26.35,26.50,26.57,25.83,24.88,26.19,26.34,26.63,25.81,-0.97,-1.12,-0.82,-1.29,1.41,0.54,0.69,0.76,0.01,-0.93,0.38,0.53,0.82,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,6.57E-03,3.31E-02,2.08E-03,2.11E-02,3.41E-01,,,A, YES,
6973,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),QGLRPESPPPAGP,_GLLAQGLRPES(ph)PPPAGPLLNGAPAGES(ph)PQPK_,S652,+,27.55,25.19,25.74,26.71,29.02,27.98,29.65,29.95,28.08,28.44,30.64,28.91,28.20,28.16,-0.61,-2.97,-2.42,-1.45,0.87,-0.18,1.50,1.79,-0.08,0.28,2.48,0.75,0.04,negative regulation of apoptotic process,cytosol;adherens junction,,,,,1.52E-03,1.28E-02,1.17E-03,1.33E-03,8.84E-01,,,A, YES,+
6997,Q99567,NUP88,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),EGLKNQSPTEAEK,_NQS(ph)PTEAEKPASSSLPSSPPPQLLTR_,S35,+,,24.72,25.12,23.00,25.82,27.14,25.55,26.27,26.28,26.03,,,27.33,25.73, ,-1.00,-0.60,-2.73,0.09,1.42,-0.18,0.55,0.55,0.30, , ,1.61,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,9.49E-03,4.31E-02,6.36E-03,7.29E-03,5.37E-01,,,A, YES,
7135,Q9BRJ6,C7orf50,Uncharacterized protein C7orf50,ELDEEGSDPPLPG,_ELDEEGS(ph)DPPLPGRAQR_,S175,+,25.64,24.84,24.93,26.56,27.71,27.51,27.22,27.07,26.94,26.62,25.30,25.02,25.34,26.21,-0.57,-1.36,-1.28,0.35,1.50,1.30,1.01,0.86,0.74,0.41,-0.91,-1.18,-0.87,,,,,,,3.81E-03,2.27E-02,2.74E-03,8.06E-01,4.75E-03,,,A, YES,
7147,Q9BSQ5,CCM2,Malcavernin (Cerebral cavernous malformations 2 protein),RGIITDSFGRHRR,_GIITDS(ph)FGR_,S287,+,23.90,23.44,23.06,23.99,25.76,25.94,25.76,25.88,26.11,25.48,25.76,25.66,25.71,25.11,-1.21,-1.67,-2.06,-1.12,0.65,0.83,0.65,0.77,0.99,0.37,0.65,0.55,0.59,vasculogenesis;stress-activated MAPK cascade;integrin-mediated signaling pathway;endothelial tube morphogenesis,cytoplasm,,,,,1.17E-04,2.38E-03,5.65E-05,2.87E-04,5.76E-01,,,A, YES,
7183,Q9BTX1,NDC1,Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48),EPKKLNSPEETAF,_KLNS(ph)PEETAFQTPK_,S291,+,20.16,22.04,22.04,23.40,24.58,24.36,23.88,23.90,24.32,23.31,,22.65,23.44,23.17,-3.02,-1.13,-1.13,0.23,1.40,1.19,0.70,0.73,1.14,0.14, ,-0.53,0.27,protein transport;nuclear pore distribution;nuclear pore complex assembly;mRNA transport,nuclear membrane;nuclear pore,,,,,5.75E-03,3.02E-02,1.29E-03,7.82E-02,1.17E-01,,,A,,
7249,Q9BX95,SGPP1,Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1),GALRRNSLTGEEG,_RNS(ph)LTGEEGQLAR_,S112,+,21.16,26.80,25.76,27.92,28.87,29.36,28.45,28.82,28.97,29.99,28.64,28.63,29.54,27.92,-6.75,-1.12,-2.16,0.01,0.95,1.44,0.54,0.91,1.05,2.08,0.72,0.71,1.62,phospholipid metabolic process;small molecule metabolic process;sphinganine-1-phosphate metabolic process;apoptotic process;sphingosine metabolic process;sphingolipid biosynthetic process,integral to membrane;endoplasmic reticulum membrane,,,,,5.92E-03,3.08E-02,4.98E-03,3.88E-03,7.67E-01,,,A, YES,
7257,Q9BXF6,RAB11FIP5,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),RGSRSNSSSEAVL,_SNS(ph)SSEAVLGQEELSAQAK_,S395,,22.99,22.76,,20.88,24.25,24.42,23.66,24.60,,,25.87,24.55,25.43,23.94,-0.95,-1.18, ,-3.06,0.31,0.48,-0.27,0.66, , ,1.93,0.61,1.49,protein transport,mitochondrial outer membrane;centrosome;recycling endosome membrane,,,,,3.45E-03,2.15E-02,1.24E-02,1.12E-03,1.41E-01,,,A, YES,
7266,Q9BXK5,BCL2L13,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),SLVEELSPASEKK,_EINAREESLVEELS(ph)PASEK_,S426,+,24.87,24.74,25.33,23.70,23.48,25.95,26.29,24.97,26.58,28.05,28.02,26.63,28.27,25.91,-1.05,-1.17,-0.58,-2.22,-2.43,0.04,0.38,-0.94,0.66,2.14,2.11,0.72,2.35,induction of apoptosis,mitochondrion;integral to membrane;nucleus;mitochondrial membrane,,,,,8.6E-04,9.21E-03,1.87E-01,2.98E-04,3.07E-03,,,A, YES,
7315,Q9BZ71,PITPNM3,"Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1)",SKRLSKSNIDISS,_S(ph)NIDISSGLEDEEPKRPLPR_,S285,,,21.55,21.68,,,23.54,25.84,23.94,,26.09,25.88,26.05,25.12,24.41, ,-2.86,-2.73, , ,-0.87,1.43,-0.47, ,1.68,1.47,1.64,0.71,phosphatidylinositol metabolic process,endomembrane system;integral to membrane;intracellular,,,,,8.71E-04,9.28E-03,6.4E-03,2.24E-04,6.88E-02,,,A,,
7378,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,RHNGSLSPGLEAR,_HNGS(ph)LS(ph)PGLEARDPLEAR_,S1385,+,26.21,22.50,21.65,23.63,27.50,27.36,27.33,28.21,26.56,26.05,28.40,27.41,27.47,26.18,0.04,-3.68,-4.52,-2.55,1.33,1.18,1.16,2.03,0.39,-0.12,2.23,1.23,1.29,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,2.54E-04,4.08E-03,1.73E-04,3.32E-04,9.4E-01,,,A, YES,+
7389,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,FGTRPLSSGFSPE,_SFGTRPLS(ph)SGFSPEEAQQQDEEFEK_,S983,+,25.36,24.55,24.29,26.23,28.92,29.34,29.27,30.17,29.34,27.37,30.44,28.95,29.58,27.99,-2.62,-3.43,-3.70,-1.75,0.93,1.35,1.28,2.19,1.35,-0.61,2.46,0.96,1.59,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,8.02E-06,4.35E-04,4.59E-06,2.09E-05,6.11E-01,,,A, YES,+
7439,Q9H0C8,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) (EC 3.1.3.16),LPEPERSPRPAAG,_(ac)M(ox)DLFGDLPEPERS(ph)PRPAAGK_,S13,+,,25.51,25.96,24.94,27.23,27.29,26.99,27.32,27.09,26.27,26.20,26.18,26.70,26.47, ,-0.96,-0.51,-1.54,0.75,0.82,0.51,0.85,0.62,-0.20,-0.27,-0.29,0.23,negative regulation of cell cycle;regulation of S phase of mitotic cell cycle;protein dephosphorylation,cytoplasm,,,,,3.39E-03,2.13E-02,1.01E-03,4.05E-02,7.76E-02,,,A, YES,
7502,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),YSQFQESDDADED,_VVDYSQFQES(ph)DDADEDYGRDSGPPTK_,S19,+,29.59,26.64,27.36,26.23,30.16,29.85,30.88,30.30,30.87,29.50,29.85,30.65,29.22,29.32,0.28,-2.68,-1.96,-3.08,0.84,0.54,1.57,0.98,1.55,0.19,0.54,1.33,-0.10,,nucleus,,,,,8.6E-04,9.21E-03,3.15E-04,2.66E-03,4.13E-01,,,A,,
7616,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),PVRLHSSNPNLST,_LHSS(ph)NPNLSTLDFGEEK_,S304,+,24.83,,,24.17,25.45,25.69,27.43,26.24,27.93,26.81,27.94,27.43,26.56,26.41,-1.58, , ,-2.24,-0.96,-0.72,1.02,-0.17,1.52,0.41,1.53,1.02,0.16,lipid transport,,,,,,1.16E-03,1.08E-02,2.22E-03,5.18E-04,3.27E-01,,,A, YES,
7657,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),ETREPGSPPSVQR,_ALVEFESNPEETREPGS(ph)PPSVQR_,S47,+,26.14,25.80,25.75,26.78,29.76,29.60,29.28,29.67,28.99,29.31,28.80,28.94,29.71,28.35,-2.21,-2.55,-2.60,-1.57,1.41,1.25,0.94,1.33,0.65,0.96,0.45,0.59,1.37,virus-host interaction,nucleolus,,,,,2.68E-06,2.42E-04,1.52E-06,8E-06,5.47E-01,,,A, YES,
7659,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),GGLRPESPESLTS,_LGGLRPES(ph)PESLTSVSR_,S18,+,27.95,27.05,27.75,27.85,29.83,29.06,30.06,29.88,29.10,29.54,28.96,29.36,28.43,28.83,-0.88,-1.78,-1.09,-0.98,1.00,0.23,1.23,1.05,0.26,0.71,0.12,0.53,-0.40,virus-host interaction,nucleolus,,,,,2.36E-03,1.7E-02,7.84E-04,7.83E-03,3.61E-01,,,A, YES,
7697,Q9H7F0,ATP13A3,Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1),VKLVHDSLEDLQM,_LVHDS(ph)LEDLQM(ox)TR_,S817,+,26.67,26.21,26.51,25.05,25.73,27.44,28.58,27.23,27.24,28.17,28.23,28.00,28.82,27.22,-0.55,-1.01,-0.71,-2.17,-1.49,0.22,1.36,0.01,0.02,0.95,1.01,0.78,1.60,cation transport;ATP catabolic process,integral to membrane,,,,,5.94E-03,3.09E-02,4.65E-02,1.63E-03,8.38E-02,,,A, YES,
7733,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),DANASESP_____,_APTTVEDRVGDSTPVSEKPVSAAVDANASES(ph)P_,S404,+,25.36,24.99,24.99,24.57,26.53,25.58,25.83,27.63,27.09,28.63,26.28,,27.90,26.28,-0.92,-1.29,-1.29,-1.71,0.24,-0.71,-0.45,1.35,0.81,2.34,0.00, ,1.62,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,2.59E-03,1.8E-02,7.8E-03,9.75E-04,1.63E-01,,,A, YES,
7741,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),VPPRAKSPTPESS,_AKS(ph)PTPESSTIASYVTLR_,S855,+,24.19,23.98,23.98,22.18,26.27,26.53,26.76,25.81,26.93,26.46,26.27,25.94,25.94,25.48,-1.29,-1.50,-1.50,-3.30,0.79,1.05,1.28,0.33,1.45,0.98,0.79,0.46,0.46,,cytoplasm,,,,,5.23E-05,1.42E-03,2.78E-05,1.22E-04,6.28E-01,,,A, YES,
7752,Q9HB09,BCL2L12,Bcl-2-like protein 12 (Bcl2-L-12) (Bcl-2-related proline-rich protein),SKLVRLSSDSFAR,_LVRLS(ph)SDSFAR_,S241,+,21.28,23.87,24.36,24.20,27.53,27.78,27.27,27.21,26.70,26.15,26.41,26.45,27.95,25.93,-4.66,-2.07,-1.58,-1.74,1.60,1.84,1.34,1.27,0.77,0.21,0.48,0.51,2.01,apoptotic process,,,,,,2.51E-05,9.03E-04,1.08E-05,9.63E-05,3.92E-01,,,A,,
7795,Q9HCD5,NCOA5,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),MYRREGSYDRYLR,_EGS(ph)YDRYLR_,S126,+,23.07,27.74,27.74,24.32,29.42,29.20,28.24,27.81,27.81,27.71,26.31,24.59,27.19,27.01,-3.94,0.73,0.73,-2.69,2.40,2.19,1.23,0.80,0.80,0.69,-0.70,-2.42,0.18,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,1.78E-03,1.43E-02,4.65E-04,5.37E-02,4.24E-02,,,A, YES,
7823,Q9HCM4,EPB41L5,Band 4.1-like protein 5,QLEMENSPLLSPR,_QLEM(ox)ENS(ph)PLLSPR_,S517,,,20.42,20.33,24.82,26.54,27.59,25.87,24.49,27.78,24.44,24.43,22.61,25.19,24.54, ,-4.12,-4.21,0.28,2.00,3.05,1.33,-0.06,3.23,-0.10,-0.11,-1.93,0.65,"paraxial mesoderm development;neural plate morphogenesis;mesoderm migration involved in gastrulation;left/right axis specification;actomyosin structure organization;somite rostral/caudal axis specification;positive regulation of focal adhesion assembly;positive regulation of epithelial to mesenchymal transition;apical constriction;unidimensional cell growth;positive regulation of epithelial cell migration;substrate-dependent cell migration, cell attachment to substrate;posttranscriptional regulation of gene expression;cellular response to transforming growth factor beta stimulus;epithelial to mesenchymal transition;axial mesoderm morphogenesis;regulation of establishment of protein localization;embryonic foregut morphogenesis;in utero embryonic development;positive regulation of protein binding;negative regulation of protein binding;endoderm development;ectoderm development;negative regulation of cell-cell adhesion",ruffle membrane;focal adhesion;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,1.72E-03,1.39E-02,5.25E-04,5.21E-02,2.96E-02,,,A, YES,
7852,Q9NQC3,RTN4,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),MEDLDQSPLVSSS,_(ac)M(ox)EDLDQS(ph)PLVSSSDS(ph)PPRPQPAFK_,S7,+,28.96,27.75,28.26,29.87,31.53,31.03,31.85,31.41,31.18,30.90,31.32,29.58,32.69,30.49,-1.53,-2.74,-2.23,-0.62,1.05,0.55,1.36,0.92,0.69,0.41,0.83,-0.90,2.21,regulation of branching morphogenesis of a nerve;aging;cerebral cortex radial glia guided migration;regulation of axon regeneration;olfactory nerve development;positive regulation of glial cell differentiation;negative regulation of neuron differentiation;response to activity;apoptotic process;regulation of cell migration;angiogenesis;endoplasmic reticulum tubular network organization;regulation of sensory perception of pain;negative regulation of neuron projection regeneration;positive regulation of dopamine secretion;negative regulation of axon extension;cardiac epithelial to mesenchymal transition;axonal fasciculation;nerve growth factor receptor signaling pathway;oligodendrocyte differentiation;regulation of apoptotic process,neuronal cell body;neuron projection;nuclear envelope;integral to endoplasmic reticulum membrane;plasma membrane;myelin sheath;protein complex,,,,,1.1E-03,1.05E-02,5.31E-04,1.88E-03,6.89E-01,,,A, YES,
7899,Q9NRA0,SPHK2,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),ATVEPASPTPAHS,_LSYLPATVEPAS(ph)PTPAHSLPR_,S328,+,20.24,22.51,22.51,,24.38,24.48,24.25,24.60,23.90,24.67,25.74,24.13,24.58,23.83,-3.59,-1.32,-1.32, ,0.55,0.65,0.41,0.77,0.06,0.84,1.91,0.29,0.75,negative regulation of apoptotic process;small molecule metabolic process;protein kinase C-activating G-protein coupled receptor signaling pathway;cell proliferation;brain development;positive regulation of cell proliferation;blood vessel development;sphingosine metabolic process;sphingolipid biosynthetic process;sphinganine-1-phosphate biosynthetic process,cytosol;lysosomal membrane;membrane,,,,,6.91E-04,8.06E-03,9.62E-04,3.84E-04,4.31E-01,,,A,,
7973,Q9NVM6,DNAJC17,DnaJ homolog subfamily C member 17,QAQAQESEEEEES,_(gl)QAQAQES(ph)EEEEESRSTR_,S112,+,25.00,23.50,24.30,26.07,26.50,26.14,26.96,27.03,27.21,26.09,25.04,25.89,25.51,25.79,-0.79,-2.29,-1.49,0.28,0.71,0.35,1.18,1.24,1.42,0.31,-0.75,0.10,-0.27,protein folding,,,,,,6.7E-03,3.35E-02,1.87E-03,1.05E-01,7.31E-02,,,A,,
7987,Q9NWB6,ARGLU1,Arginine and glutamate-rich protein 1,DRERASSPPDRID,_ASS(ph)PPDRIDIFGR_,S77,+,29.22,28.24,28.52,28.10,30.99,30.74,30.69,30.91,30.75,30.43,29.99,30.29,30.43,29.95,-0.72,-1.71,-1.43,-1.85,1.05,0.79,0.74,0.96,0.81,0.49,0.05,0.34,0.49,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,1.71E-04,3.1E-03,5.51E-05,1.01E-03,2.37E-01,,,A, YES,
8005,Q9NWV8,BABAM1,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),EVAEPSSPTEEEE,_(ac)M(ox)EVAEPSS(ph)PTEEEEEEEEHSAEPRPR_,S8,+,27.25,27.89,28.07,27.16,29.99,30.11,29.54,30.05,29.37,29.22,28.59,29.17,29.19,28.89,-1.64,-1.00,-0.82,-1.74,1.10,1.22,0.65,1.15,0.48,0.33,-0.30,0.28,0.30,protein K63-linked deubiquitination;double-strand break repair;G2/M transition DNA damage checkpoint;chromatin modification;response to ionizing radiation;positive regulation of DNA repair,BRISC complex;BRCA1-A complex;cytoplasm,,,,,2.65E-04,4.19E-03,6.89E-05,3.73E-03,9.5E-02,,,A, YES,
8010,Q9NX40,OCIAD1,OCIA domain-containing protein 1 (Ovarian carcinoma immunoreactive antigen),FKKLENSPLGEAL,_LENS(ph)PLGEALR_,S108,+,,22.34,22.34,22.88,25.22,25.68,26.08,25.75,,23.35,,24.13,25.32,24.31, ,-1.97,-1.97,-1.42,0.91,1.37,1.77,1.44, ,-0.96, ,-0.18,1.01,,endosome;mitochondrion,,,,,5.49E-04,6.8E-03,1.38E-04,1.32E-02,3.86E-02,,,A, YES,
8014,Q9NX94,WBP1L,WW domain binding protein 1-like (Outcome predictor in acute leukemia 1),SSTRPPSIADPDP,_SSTRPPS(ph)IADPDPSDLPVDR_,S173,,,23.79,,22.98,25.89,26.43,24.75,25.21,26.05,,26.26,24.71,26.19,25.23, ,-1.44, ,-2.24,0.66,1.20,-0.48,-0.02,0.82, ,1.03,-0.51,0.97,,integral to membrane,,,,,1.1E-02,4.83E-02,6.34E-03,9.25E-03,9.28E-01,,,A,,
8016,Q9NXD2,MTMR10,Myotubularin-related protein 10,GNLCRRSILGTPL,_S(ph)ILGTPLSK_,S751,+,19.76,21.21,21.76,21.84,23.59,22.91,24.18,24.53,22.57,24.87,24.08,22.97,23.59,22.91,-3.15,-1.70,-1.15,-1.07,0.68,0.00,1.27,1.62,-0.34,1.96,1.17,0.05,0.68,,,,,,,5.26E-04,6.63E-03,6.2E-04,3.57E-04,6.13E-01,,,A,,
8024,Q9NY27,PPP4R2,Serine/threonine-protein phosphatase 4 regulatory subunit 2,VMFPGNSPSYTER,_M(ox)NGVM(ox)FPGNS(ph)PSYTER_,S159,+,23.10,22.82,23.27,24.30,25.45,24.91,25.26,25.28,25.14,24.73,24.02,24.11,25.11,24.42,-1.32,-1.61,-1.15,-0.12,1.02,0.49,0.84,0.86,0.72,0.31,-0.40,-0.31,0.68,cellular protein modification process;regulation of double-strand break repair via homologous recombination;mRNA processing;RNA splicing,protein phosphatase 4 complex;nucleus;centrosome,,,,,3.75E-03,2.25E-02,1.03E-03,2.65E-02,1.7E-01,,,A, YES,
8026,Q9NY61,AATF,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),RAGDRNSEDDGVV,_AGDRNS(ph)EDDGVVM(ox)TFSSVK_,S203,+,25.72,25.84,26.51,23.53,27.42,27.70,27.26,27.13,26.53,26.89,27.00,27.32,26.71,26.58,-0.86,-0.74,-0.07,-3.06,0.84,1.12,0.68,0.55,-0.05,0.30,0.42,0.73,0.13,"regulation of mitotic cell cycle;negative regulation of apoptotic process;embryonic cleavage;response to DNA damage stimulus;ribosome biogenesis;cell adhesion;negative regulation of superoxide anion generation;apoptotic process;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;negative regulation of amyloid precursor protein biosynthetic process;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Golgi apparatus;focal adhesion;centrosome,,,,,3.26E-03,2.09E-02,1.51E-03,4.88E-03,7.05E-01,,,A, YES,+
8041,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),KQKFNDSEGDDTE,_(gl)QKFNDS(ph)EGDDTEETEDYR_,S395,+,29.11,27.26,27.87,27.34,30.26,29.49,29.85,28.81,30.05,30.53,29.35,29.55,28.86,29.10,0.00,-1.84,-1.23,-1.77,1.16,0.39,0.75,-0.29,0.95,1.43,0.25,0.45,-0.25,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,6.63E-03,3.34E-02,3.45E-03,7.32E-03,8.48E-01,,+,A, YES,+
8062,Q9NYM9,BET1L,BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15),DWARAQSPGAVEE,_AQS(ph)PGAVEEILDRENKR_,S9,+,23.94,25.15,24.78,24.30,25.98,27.46,26.67,26.63,28.21,26.93,26.67,26.56,28.40,26.28,-2.34,-1.13,-1.50,-1.99,-0.30,1.17,0.39,0.35,1.92,0.65,0.39,0.27,2.12,"protein transport;retrograde transport, endosome to Golgi",SNARE complex;endosome;Golgi stack;Golgi apparatus;nucleus;integral to Golgi membrane,,,,,1.12E-03,1.06E-02,9.72E-04,8.99E-04,7.99E-01,,,A, YES,
8084,Q9NZJ7,MTCH1,Mitochondrial carrier homolog 1 (Presenilin-associated protein),LLFRRVSSGSCFA,_RVS(ph)SGSCFALE_,S346,,21.47,21.73,21.73,22.58,22.37,24.52,23.32,,24.19,24.64,23.79,23.88,24.42,23.22,-1.75,-1.49,-1.49,-0.64,-0.85,1.30,0.10, ,0.97,1.42,0.57,0.66,1.20,regulation of signal transduction;activation of cysteine-type endopeptidase activity involved in apoptotic process;transport;positive regulation of apoptotic process;neuronal ion channel clustering,mitochondrion;integral to membrane;mitochondrial inner membrane,,,,,3.19E-03,2.06E-02,8.25E-03,1.03E-03,3.19E-01,,,A, YES,
8110,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),APPPPISPTQLSD,_KAPPPPIS(ph)PTQLSDVSSPR_,S273,+,21.97,22.64,22.64,23.41,24.63,24.99,23.86,24.81,24.02,24.21,25.05,25.21,24.40,23.99,-2.01,-1.35,-1.35,-0.58,0.64,1.01,-0.13,0.82,0.03,0.22,1.06,1.23,0.41,,cell cortex;mitochondrion;cytoskeleton,,,,,8.13E-04,8.83E-03,9.13E-04,5.44E-04,6.34E-01,,,A, YES,
8117,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),PSVLIHSLGKSTT,_SSPSVLIHS(ph)LGK_,S390,+,,23.02,23.02,22.21,24.66,24.79,24.21,23.90,23.68,23.64,24.11,24.42,23.55,23.77, ,-0.75,-0.75,-1.55,0.89,1.03,0.44,0.13,-0.09,-0.13,0.34,0.66,-0.22,,cell cortex;mitochondrion;cytoskeleton,,,,,9.52E-03,4.32E-02,3.75E-03,1.67E-02,5.12E-01,,,A, YES,
8148,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,VAAEGASDTEREE,_LRGAVAAEGAS(ph)DTEREEPTESQGLAAR_,S915,+,25.04,24.89,24.63,24.97,28.16,27.96,27.44,27.22,26.93,27.39,27.44,27.56,27.89,26.73,-1.70,-1.84,-2.11,-1.76,1.43,1.23,0.71,0.49,0.20,0.66,0.71,0.83,1.15,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,2.09E-05,8.22E-04,1.77E-05,2.85E-05,9.52E-01,,,A,,
8163,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,QLERPVSPETQAD,_LQLERPVS(ph)PETQADLQR_,S988,+,25.35,24.35,24.77,22.49,25.92,25.27,26.79,26.03,26.58,27.58,26.80,27.24,25.60,25.75,-0.40,-1.40,-0.98,-3.27,0.17,-0.48,1.04,0.28,0.82,1.82,1.05,1.49,-0.15,,,,,,,2.23E-03,1.67E-02,5.24E-03,8.54E-04,2.91E-01,,,A,,
8166,Q9P227,ARHGAP23,Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23),GPGALVSPRFERC,_SAEALGPGALVS(ph)PR_,S372,+,20.92,21.54,22.09,21.85,23.50,22.96,23.66,23.78,22.87,,23.71,22.87,24.10,22.82,-1.90,-1.28,-0.74,-0.97,0.68,0.14,0.84,0.96,0.05, ,0.89,0.05,1.28,signal transduction;positive regulation of GTPase activity,intracellular,,,,,1.99E-03,1.54E-02,1.4E-03,1.8E-03,7.19E-01,,,A,,
8219,Q9P2N5,RBM27,RNA-binding protein 27 (RNA-binding motif protein 27),RKKKYPSPQKTRS,_KYPS(ph)PQK_,S120,+,,,,23.21,19.50,19.62,19.89,,20.15,20.21,,20.03,,20.37, , , ,2.84,-0.87,-0.76,-0.48, ,-0.22,-0.16, ,-0.34, ,mRNA processing,nuclear speck;nucleus;cytoplasm,,,,,5.48E-04,6.8E-03,1.96E-04,1.24E-03,6.09E-01,,,A, YES,
8243,Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),NSTGSLSPKHSLK,_STPSHGSVSSLNSTGSLS(ph)PK_,S255,+,24.85,24.74,25.16,23.96,26.06,25.76,26.28,26.28,26.48,25.76,25.91,26.41,25.56,25.63,-0.78,-0.89,-0.47,-1.67,0.43,0.13,0.65,0.65,0.85,0.13,0.28,0.78,-0.07,negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis,coated pit;plasma membrane;nucleus,,,,,5.67E-03,2.98E-02,2.23E-03,1.05E-02,5.63E-01,,,A, YES,+
8302,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),SRNGETSPRTKIT,_VNVPEESRNGETS(ph)PR_,S461,+,23.60,24.34,24.34,,27.56,26.50,27.37,26.02,26.38,25.88,25.41,24.58,24.42,25.53,-1.93,-1.20,-1.20, ,2.03,0.96,1.84,0.49,0.85,0.35,-0.12,-0.96,-1.12,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,2.01E-03,1.54E-02,1.02E-03,1.36E-01,7.41E-03,,,A, YES,+
8323,Q9UH62,ARMCX3,Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3) (Protein ALEX3),AVQKRASPNSDDT,_RAS(ph)PNSDDTVLSPQELQK_,S110,+,,22.85,23.23,21.24,23.72,25.70,25.36,24.30,,25.55,25.20,24.60,25.03,24.25, ,-1.41,-1.02,-3.01,-0.54,1.44,1.11,0.05, ,1.29,0.95,0.35,0.78,cellular protein localization;positive regulation of transcription from RNA polymerase II promoter,integral to mitochondrial outer membrane,,,,,1.41E-03,1.23E-02,1.85E-03,7.23E-04,6.05E-01,,,A, YES,
8356,Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),SKISRKSVQPTSE,_S(ph)VQPTSEERIPK_,S327,+,22.08,24.39,24.84,23.97,24.67,24.68,25.13,22.82,24.71,25.92,26.45,25.97,26.30,24.76,-2.68,-0.37,0.08,-0.79,-0.09,-0.08,0.36,-1.94,-0.06,1.15,1.68,1.21,1.53,protein heterooligomerization;cell cycle;cell division,stress fiber;microtubule;perinuclear region of cytoplasm,,,,,3.4E-03,2.13E-02,2.12E-01,1.12E-03,1.08E-02,,,A, YES,
8374,Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),VTVPTPSPTPVRS,_LLEENETEAVTVPTPS(ph)PTPVR_,S414,+,26.30,22.93,23.36,24.46,26.43,25.72,26.32,26.43,27.03,26.40,27.46,27.35,27.48,25.97,0.32,-3.04,-2.61,-1.51,0.46,-0.26,0.34,0.45,1.05,0.43,1.49,1.37,1.50,positive regulation of actin filament polymerization;filopodium assembly;signal transduction;positive regulation of actin cytoskeleton reorganization;response to bacterium,cytosol;cell junction;plasma membrane;nucleus;cytoskeleton,,,,,1.48E-03,1.26E-02,4.87E-03,5.08E-04,2.04E-01,,,A, YES,+
8379,Q9UHW9,SLC12A6,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),RLTSIGSDEDEET,_LTSIGS(ph)DEDEETETYQEK_,S1017,+,22.46,23.01,23.78,23.24,25.53,25.37,25.35,24.77,25.22,25.96,24.57,,24.16,24.45,-2.00,-1.44,-0.67,-1.21,1.08,0.92,0.90,0.32,0.77,1.51,0.12, ,-0.30,angiogenesis;potassium ion transport;cellular hypotonic salinity response,integral to membrane;basolateral plasma membrane,,,,,1.7E-03,1.39E-02,5.49E-04,4.67E-03,5.88E-01,,,A,,
8436,Q9UK61,FAM208A,Protein FAM208A (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140),TGGNARSPEDQLG,_LIPITGGNARS(ph)PEDQLGK_,S927,+,24.80,25.15,25.72,24.63,25.90,27.37,27.86,26.87,28.20,28.17,26.13,26.43,27.26,26.50,-1.70,-1.35,-0.78,-1.87,-0.60,0.88,1.36,0.37,1.70,1.67,-0.37,-0.07,0.76,,,,,,,2.38E-03,1.71E-02,1.1E-03,3.81E-03,6.86E-01,,,A, YES,
8491,Q9ULH0,KIDINS220,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),PSDEDESGTEESD,_LPSDEDES(ph)GTEESDNTPLLK_,S1427,+,23.58,22.81,22.81,22.41,,,25.50,,26.83,26.19,24.82,24.82,25.72,24.55,-0.97,-1.74,-1.74,-2.14, , ,0.95, ,2.28,1.65,0.27,0.28,1.17,nerve growth factor receptor signaling pathway;dendrite morphogenesis;activation of MAPKK activity;in utero embryonic development,cytosol;integral to membrane,,,,,2.15E-03,1.64E-02,1.35E-03,2.65E-03,3.11E-01,,,A, YES,
8532,Q9ULT0,TTC7A,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),GGNRRGSPSAAFT,_RGS(ph)PSAAFTFPDTDDFGK_,S51,+,23.75,19.58,19.58,,25.87,26.24,23.32,25.38,26.04,25.01,24.78,24.16,26.05,24.15,-0.39,-4.57,-4.57, ,1.72,2.10,-0.82,1.23,1.89,0.87,0.63,0.02,1.90,cellular iron ion homeostasis;hemopoiesis,,,,,,7.24E-03,3.56E-02,3.56E-03,8.73E-03,6.7E-01,,,A,,
8590,Q9UNF1,MAGED2,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),ALLSLRSPKARRG,_ALLSLRS(ph)PK_,S229,+,,21.38,21.38,21.68,24.62,22.74,23.84,23.65,22.56,,,22.79,22.68,22.73, ,-1.35,-1.35,-1.06,1.89,0.01,1.11,0.92,-0.17, , ,0.06,-0.05,,,,,,,9.75E-03,4.41E-02,2.13E-03,4.99E-02,3.39E-01,,,A, YES,
8599,Q9UP95,SLC12A4,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),RLESLYSDEEDES,_LESLYS(ph)DEEDESAVGADK_,S967,+,24.33,22.32,22.00,24.29,23.42,26.89,27.55,26.75,27.40,26.25,28.12,27.13,28.03,25.73,-1.40,-3.41,-3.73,-1.44,-2.31,1.16,1.82,1.02,1.67,0.52,2.39,1.40,2.31,cell volume homeostasis;potassium ion transport,integral to plasma membrane,,,,,6.47E-04,7.63E-03,1.77E-03,2.56E-04,2.49E-01,,,A, YES,
8604,Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",EDVDVPSPDEKSV,_LLDAEDVDVPS(ph)PDEK_,S275,,25.58,22.76,22.87,21.78,25.65,25.31,25.41,25.17,25.79,27.53,26.25,24.51,26.20,24.99,0.60,-2.23,-2.11,-3.21,0.67,0.33,0.43,0.19,0.80,2.55,1.26,-0.47,1.21,regulation of microtubule-based process;wound healing;positive regulation of Wnt receptor signaling pathway;regulation of epithelial cell migration;regulation of focal adhesion assembly;Golgi to plasma membrane protein transport;cell cycle arrest;Wnt receptor signaling pathway,ruffle membrane;Golgi apparatus;microtubule,,,,,4E-03,2.36E-02,7.07E-03,1.66E-03,3.82E-01,,,A, YES,
8606,Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",LLKRQGSFSEDVI,_(gl)QGS(ph)FSEDVISHKGDLR_,S3922,+,23.64,24.58,25.18,23.06,27.63,26.19,26.55,26.42,26.34,26.65,25.61,25.92,25.53,25.64,-2.00,-1.06,-0.46,-2.58,1.99,0.55,0.91,0.78,0.70,1.01,-0.03,0.28,-0.10,regulation of microtubule-based process;wound healing;positive regulation of Wnt receptor signaling pathway;regulation of epithelial cell migration;regulation of focal adhesion assembly;Golgi to plasma membrane protein transport;cell cycle arrest;Wnt receptor signaling pathway,ruffle membrane;Golgi apparatus;microtubule,,,,,2.72E-04,4.25E-03,8.41E-05,1.7E-03,2.2E-01,,,A, YES,
8642,Q9UPU7,TBC1D2B,TBC1 domain family member 2B,DKGELVSDEEEDT,_ERDTSPDKGELVS(ph)DEEEDT_,S831,+,23.35,24.71,25.00,25.96,27.30,27.07,26.83,27.62,26.14,23.13,26.08,24.49,25.09,25.60,-2.25,-0.89,-0.60,0.36,1.70,1.47,1.23,2.02,0.54,-2.46,0.49,-1.11,-0.50,positive regulation of Rab GTPase activity,intracellular,,,,,2.63E-03,1.82E-02,1.93E-03,7.92E-01,3.49E-03,,,A, YES,
8851,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),KVKPPPSPTTEGP,_VKPPPS(ph)PTTEGPSLQPDLAPEEAAGTQRPK_,S778,,,25.01,23.58,24.71,24.86,26.25,25.10,26.92,26.56,27.20,29.00,27.53,28.61,26.28, ,-1.26,-2.70,-1.57,-1.42,-0.02,-1.18,0.64,0.28,0.92,2.73,1.25,2.33,,,,,,,7.18E-04,8.12E-03,7.6E-02,2.44E-04,4.04E-03,,,A, YES,+
8872,Q9Y2K6,USP20,Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2),VADEGESESEDDD,_AVPIAVADEGES(ph)ES(ph)EDDDLKPR_,S132,+,24.89,23.07,23.38,23.35,26.20,26.84,25.61,25.77,26.89,26.63,26.65,25.95,26.67,25.53,-0.64,-2.46,-2.15,-2.18,0.67,1.31,0.08,0.24,1.36,1.10,1.12,0.42,1.14,protein K63-linked deubiquitination;regulation of G-protein coupled receptor protein signaling pathway;protein K48-linked deubiquitination;endocytosis;ubiquitin-dependent protein catabolic process,perinuclear region of cytoplasm,,,,,1.09E-04,2.28E-03,1.21E-04,9.43E-05,6.9E-01,,,A,,
8904,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),HRRIDISPSTFRK,_IDIS(ph)PSTFR_,S682,+,28.82,29.78,29.73,29.25,31.83,31.53,30.71,30.82,30.90,31.18,30.01,30.21,30.84,30.43,-1.61,-0.65,-0.70,-1.18,1.40,1.10,0.28,0.39,0.46,0.75,-0.42,-0.23,0.41,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,7.99E-03,3.85E-02,2.31E-03,3.89E-02,2.26E-01,,,A, YES,+
8917,Q9Y2W2,WBP11,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),DEDMLYSPELAQR,_DEDM(ox)LYS(ph)PELAQR_,S237,+,24.69,22.82,23.40,22.74,26.60,26.93,25.91,26.04,26.52,26.04,25.22,25.04,26.32,25.25,-0.56,-2.43,-1.85,-2.51,1.35,1.68,0.66,0.79,1.27,0.79,-0.03,-0.22,1.07,mRNA processing;RNA splicing;rRNA processing,nuclear speck;nucleus;cytoplasm,,,,,1.36E-04,2.61E-03,4.3E-05,8.92E-04,2.13E-01,,,A, YES,+
8935,Q9Y320,TMX2,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),STPTTVSDGENKK,_AGDNIPEEQPVASTPTTVS(ph)DGENKK_,S250,+,23.32,24.84,24.84,24.81,25.32,26.90,26.49,26.29,25.60,26.80,26.23,26.43,27.06,25.77,-2.44,-0.92,-0.92,-0.95,-0.44,1.13,0.72,0.53,-0.17,1.04,0.47,0.67,1.29,cell redox homeostasis,integral to membrane,,,,,3.82E-03,2.28E-02,6.85E-03,1.59E-03,3.44E-01,,,A, YES,+
8941,Q9Y385,UBE2J1,Ubiquitin-conjugating enzyme E2 J1 (EC 6.3.2.19) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),QSQRRLSTSPDVI,_RLS(ph)TSPDVIQGHQPR_,S266,+,25.28,24.39,22.69,24.91,26.22,27.75,27.25,27.02,27.02,27.38,27.65,27.65,27.93,26.39,-1.12,-2.01,-3.71,-1.49,-0.17,1.35,0.86,0.62,0.62,0.99,1.26,1.25,1.54,ER-associated protein catabolic process;protein N-linked glycosylation via asparagine,integral to membrane;endoplasmic reticulum membrane,,,,,1.28E-04,2.52E-03,2.97E-04,6.34E-05,3E-01,+,,A, YES,+
9057,Q9Y4J8,DTNA,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin) (Dystrophin-related protein 3),FEDLVPSPTSEKA,_TQFEDLVPS(ph)PTSEK_,S310,+,21.43,23.71,23.15,24.21,24.82,24.98,24.92,25.44,24.82,24.87,26.28,25.37,25.15,24.55,-3.12,-0.84,-1.40,-0.34,0.27,0.43,0.37,0.89,0.27,0.32,1.73,0.82,0.60,signal transduction;striated muscle contraction;neuromuscular synaptic transmission,synapse;cell junction;plasma membrane;protein complex;cytoplasm,,,,,4.38E-03,2.5E-02,6.21E-03,2.04E-03,4.73E-01,,,A, YES,
9121,Q9Y5Q9,GTF3C3,General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma),QEKGKLSAEENPD,_GKLS(ph)AEENPDDSEVPSSSGINSTK_,S43,+,25.22,25.08,25.49,24.83,27.21,27.21,26.66,26.94,26.57,26.10,25.29,25.52,25.55,25.97,-0.75,-0.90,-0.48,-1.15,1.23,1.23,0.69,0.97,0.59,0.12,-0.68,-0.45,-0.42,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex,,,,,1.39E-03,1.23E-02,4.7E-04,1.93E-01,9.22E-03,,,A, YES,
9150,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",DKNRLLSPRPSLL,_NRLLS(ph)PRPSLLTPTGDPR_,S921,+,23.19,23.34,,22.80,26.63,25.97,24.80,25.42,24.85,23.42,25.39,25.68,25.55,24.75,-1.57,-1.42, ,-1.95,1.88,1.21,0.05,0.67,0.10,-1.34,0.64,0.93,0.79,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,4.22E-03,2.45E-02,1.54E-03,1.06E-02,3.87E-01,,,A, YES,
9154,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",EPEKPVSPPPIES,_(gl)QQQLEEEAAKPPEPEKPVS(ph)PPPIESK_,S215,+,22.84,23.42,23.42,22.63,24.50,25.07,24.74,24.10,25.35,25.19,,24.65,25.33,24.27,-1.43,-0.85,-0.85,-1.64,0.23,0.80,0.47,-0.17,1.08,0.92, ,0.38,1.06,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,1.47E-03,1.26E-02,1.35E-03,1.1E-03,5.52E-01,,,A, YES,
9162,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",DGIEPVSPPEGMT,_TSVLGGGEDGIEPVS(ph)PPEGM(ox)TEPGHSR_,S2213,+,24.04,24.10,24.51,23.77,25.50,27.06,26.69,26.30,26.75,26.11,,26.66,26.38,25.66,-1.62,-1.56,-1.15,-1.89,-0.15,1.40,1.03,0.65,1.10,0.46, ,1.00,0.72,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,2.45E-04,3.99E-03,1.11E-04,4.99E-04,8.82E-01,,,A, YES,
9195,Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",GEDFPASPQRRNT,_LIRDFQEYVEPGEDFPAS(ph)PQRR_,S207,+,24.98,24.81,24.81,24.91,28.75,25.69,27.68,28.75,27.16,26.67,27.32,27.78,27.29,26.66,-1.69,-1.85,-1.85,-1.75,2.09,-0.97,1.02,2.09,0.50,0.01,0.65,1.12,0.63,transport;mitosis;regulation of centrosome cycle;cell division;virus-host interaction;positive regulation of mitotic cell cycle spindle assembly checkpoint,cytoplasmic dynein complex;plasma membrane;microtubule;centrosome;condensed chromosome kinetochore;spindle pole;kinetochore,,,,,6.28E-04,7.48E-03,2.77E-04,1.38E-03,5.75E-01,,,A, YES,+
9226,Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),RPQRPRSPPLPAV,_S(ph)PPLPAVIR_,S553,+,26.92,25.85,26.11,26.20,27.84,28.27,27.67,27.84,27.78,28.15,27.33,26.90,28.66,27.35,-0.43,-1.50,-1.24,-1.15,0.49,0.92,0.33,0.50,0.44,0.80,-0.02,-0.45,1.32,,cytosol;nucleus,,,,,6.12E-03,3.15E-02,3.08E-03,7.21E-03,8.12E-01,,,A, YES,
9235,Q9P2E9,RRBP1,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),AGAPASSPEAPPA,_SHVEDGDIAGAPASS(ph)PEAPPAEQDPVQLK_,S1407,,26.00,26.15,26.85,24.60,28.60,28.53,,28.40,29.24,29.49,28.17,26.59,28.83,27.62,-1.62,-1.47,-0.77,-3.02,0.98,0.91, ,0.78,1.62,1.87,0.55,-1.03,1.21,signal transduction;protein transport;translation,integral to endoplasmic reticulum membrane;ribosome,,,,,7.91E-04,8.72E-03,4.02E-04,1.38E-03,5.44E-01,,,A, YES,
9284,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PKKETESEAEDNL,_KET(ph)ES(ph)EAEDNLDDLEK_,S886,+,29.88,29.80,29.93,29.46,31.40,31.88,31.17,30.99,31.72,31.11,29.97,30.07,30.79,30.63,-0.75,-0.83,-0.70,-1.17,0.77,1.25,0.54,0.36,1.09,0.48,-0.66,-0.55,0.16,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,5.8E-03,3.04E-02,1.68E-03,1.32E-01,5.08E-02,,,A, YES,+
9322,B1AJR3,LL22NC03-75H12.2-001,Novel protein (Uncharacterized protein),__MFPASPWAQPA,_MFPAS(ph)PWAQPAQAK_,S5,,26.80,27.69,27.45,28.24,30.22,30.21,29.91,30.41,29.32,29.57,30.49,30.36,31.05,29.36,-2.56,-1.67,-1.92,-1.13,0.85,0.84,0.55,1.05,-0.04,0.21,1.13,1.00,1.69,,,,,,,1.04E-04,2.19E-03,1.61E-04,6.82E-05,4.78E-01,,,A,,
9416,B4DY08,HNRNPC,"Heterogeneous nuclear ribonucleoproteins C1/C2 (cDNA FLJ53542, highly similar to Heterogeneous nuclear ribonucleoproteins C)",EGGADDSAEEGDL,_MESEGGADDS(ph)AEEGDLLDDDDNEDRGDDQVK_,S247,,27.34,25.16,25.16,23.59,30.11,29.24,28.96,26.92,29.28,28.81,25.52,28.07,27.37,27.35,-0.01,-2.18,-2.18,-3.76,2.76,1.89,1.61,-0.43,1.93,1.46,-1.83,0.72,0.02,,ribonucleoprotein complex,,,,,6.3E-03,3.21E-02,1.92E-03,5.18E-02,1.11E-01,+,,A,,
9443,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),EALGEKSPDSATV,_S(ph)PDSATVSGYDIM(ox)K_,S976,+,24.66,25.09,24.89,25.55,28.24,28.40,27.04,27.55,27.77,28.15,27.35,25.96,27.84,26.81,-2.15,-1.72,-1.92,-1.26,1.44,1.59,0.23,0.75,0.96,1.34,0.54,-0.85,1.03,,cytoskeleton;cytoplasm,,,,,2.4E-04,3.95E-03,9.04E-05,8.76E-04,3.8E-01,,,A, YES,
9462,P48681,NES,Nestin,NQEPLRSPEVGDE,_ENQEPLRS(ph)PEVGDEEALRPLTK_,S680,+,,23.70,23.70,,26.27,26.18,25.01,25.53,27.05,27.21,24.53,27.15,26.92,25.75, ,-2.05,-2.05, ,0.52,0.43,-0.74,-0.22,1.30,1.46,-1.22,1.40,1.17,negative regulation of apoptotic process;response to nutrient levels;response to drug;response to ionizing radiation;cell projection morphogenesis;embryonic camera-type eye development;G2/M transition of mitotic cell cycle;negative regulation of protein binding;brain development;stem cell proliferation;positive regulation of neural precursor cell proliferation;negative regulation of catalytic activity;positive regulation of intermediate filament depolymerization,intermediate filament;cytoplasm,,,,,2.36E-03,1.7E-02,2.75E-03,1.31E-03,5.25E-01,,,A, YES,
9472,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),YVDAETSL_____,_KYVDAETS(ph)L_,S1134,+,24.06,23.02,23.11,23.90,26.93,25.99,26.27,26.34,26.18,26.73,24.75,24.05,25.34,25.13,-1.07,-2.11,-2.02,-1.23,1.80,0.86,1.14,1.21,1.05,1.60,-0.38,-1.08,0.21,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,5.33E-04,6.68E-03,1.31E-04,1.25E-02,5.61E-02,,,A, YES,
9526,O95249,GOSR1,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28),RDGRRDSSDTTPL,_DGRRDS(ph)SDTTPLLNGSSQDR_,S49,,20.61,23.90,23.28,23.90,26.39,27.20,26.36,26.58,27.23,24.35,26.59,24.68,26.69,25.21,-4.60,-1.31,-1.93,-1.31,1.18,1.99,1.15,1.36,2.01,-0.86,1.38,-0.53,1.47,"protein transport;ER to Golgi vesicle-mediated transport;retrograde transport, endosome to Golgi;intra-Golgi vesicle-mediated transport",SNARE complex;integral to membrane;Golgi apparatus;Golgi membrane;cis-Golgi network,,,,,6.01E-04,7.28E-03,1.63E-04,5.85E-03,1.37E-01,,,A, YES,
9536,O14607,UTY,Histone demethylase UTY (EC 1.14.11.-) (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein),IKVDLLSICFFRD,_VDLLS(ph)ICFFRDMK_,S468,,20.71,21.95,22.09,21.82,,,23.80,21.67,23.19,23.96,24.36,25.04,23.91,22.95,-2.25,-1.00,-0.86,-1.13, , ,0.85,-1.29,0.23,1.00,1.40,2.09,0.96,chromatin modification,nucleus,,,,,2.41E-03,1.71E-02,6.21E-02,4.42E-04,4.31E-02,,,A,,
9597,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),PPQQQASPPQLPK,_DAQGQPGLERAQQELVPPQQQAS(ph)PPQLPK_,S1069,,22.21,23.13,22.91,24.32,25.38,24.86,25.40,26.13,25.12,25.57,25.13,24.58,,24.56,-2.35,-1.43,-1.66,-0.24,0.82,0.30,0.84,1.57,0.56,1.01,0.57,0.01, ,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,3.73E-03,2.24E-02,1.24E-03,8.52E-03,6.31E-01,,,A, YES,+
9598,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),DPRFTGSFDDDPD,_FTGS(ph)FDDDPDPHRDPYGEEVDRR_,S1327,+,21.67,,,,26.36,25.91,26.74,27.16,24.45,,26.11,27.23,24.85,25.61,-3.94, , , ,0.75,0.30,1.13,1.55,-1.16, ,0.50,1.62,-0.76,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,3.68E-03,2.22E-02,2.18E-03,3.42E-03,9.35E-01,,,A, YES,
9796,O00192,ARVCF,Armadillo repeat protein deleted in velo-cardio-facial syndrome,MDRNFDTLDLPKR,_NFDT(ph)LDLPK_,T573,+,24.62,22.63,22.29,21.75,25.99,27.39,26.84,26.30,27.49,28.70,26.79,25.91,27.34,25.69,-1.07,-3.07,-3.41,-3.94,0.29,1.70,1.14,0.60,1.79,3.01,1.09,0.21,1.65,multicellular organismal development;cell adhesion,plasma membrane;nucleus;intracellular;cytoplasm,,,,,2.32E-05,8.72E-04,3.11E-05,1.97E-05,5.77E-01,,,A, YES,
9824,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),QPADPSTPEQQNS,_GGQGDPAVPTQQPADPST(ph)PEQQNS(ph)PSGSEQFVR_,T514,,24.31,,,,27.71,,27.39,28.15,26.71,26.43,26.05,,26.76,26.69,-2.38, , , ,1.02, ,0.70,1.46,0.02,-0.26,-0.64, ,0.08,,focal adhesion;cytoskeleton;cytoplasm,,,,,1.06E-02,4.71E-02,4.46E-03,4.25E-02,1.04E-01,,,A, YES,
9834,O15439,ABCC4,Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B),QPPVPGTPTLRNR,_KDNEESEQPPVPGT(ph)PTLR_,T646,+,26.34,25.45,25.63,25.46,25.35,28.94,27.94,27.62,29.31,28.21,27.62,27.76,29.11,27.29,-0.94,-1.84,-1.66,-1.82,-1.94,1.65,0.65,0.33,2.02,0.92,0.33,0.48,1.82,platelet degranulation;platelet activation;ATP catabolic process;transmembrane transport,integral to membrane;platelet dense granule membrane;plasma membrane,,,,,6.19E-03,3.16E-02,6.39E-03,3.41E-03,6.33E-01,,,A, YES,
9912,O95248,SBF1,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),QRLGLGTLSSSLS,_LGLGT(ph)LSSSLSR_,T1137,+,19.96,20.96,21.73,,25.94,25.50,25.08,25.47,24.19,24.53,25.68,25.37,25.79,24.18,-4.23,-3.23,-2.45, ,1.75,1.32,0.90,1.29,0.00,0.35,1.49,1.18,1.61,spermatogenesis;protein dephosphorylation,integral to membrane;nucleus,,,+,,1.65E-06,2.07E-04,1.64E-06,2.15E-06,8.55E-01,,,A, YES,
9924,P00533,EGFR,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),ELVEPLTPSGEAP,_ELVEPLT(ph)PSGEAPNQALLR_,T693,+,27.24,24.56,24.91,24.90,28.78,27.55,28.08,27.66,27.58,27.80,28.29,26.83,28.24,27.11,0.14,-2.55,-2.20,-2.21,1.67,0.45,0.97,0.55,0.47,0.69,1.18,-0.28,1.14,regulation of nitric-oxide synthase activity;positive regulation of MAP kinase activity;negative regulation of apoptotic process;positive regulation of catenin import into nucleus;cell-cell adhesion;protein autophosphorylation;cerebral cortex cell migration;activation of phospholipase A2 activity by calcium-mediated signaling;regulation of peptidyl-tyrosine phosphorylation;positive regulation of cell migration;hair follicle development;protein insertion into membrane;digestive tract morphogenesis;embryonic placenta development;positive regulation of fibroblast proliferation;ossification;positive regulation of protein kinase B signaling cascade;activation of phospholipase C activity;positive regulation of epithelial cell proliferation;axon guidance;response to stress;negative regulation of protein catabolic process;cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;response to UV-A;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;salivary gland morphogenesis;morphogenesis of an epithelial fold;positive regulation of nitric oxide biosynthetic process;positive regulation of DNA replication;positive regulation of DNA repair,endosome;endocytic vesicle;membrane raft;basolateral plasma membrane;Golgi membrane;perinuclear region of cytoplasm;nuclear membrane;Shc-EGFR complex;endosome membrane;extracellular space;integral to membrane;nucleus;endoplasmic reticulum membrane,,+,,,1.13E-03,1.06E-02,6.27E-04,1.53E-03,8.26E-01,,+,A, YES,+
10008,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),EPSEVPTPKRPRG,_KQPPKEPSEVPT(ph)PK_,T42,+,,26.99,26.99,,24.37,23.35,24.62,23.68,23.48,22.52,,21.36,21.68,23.90, ,3.08,3.08, ,0.47,-0.55,0.72,-0.23,-0.42,-1.39, ,-2.54,-2.22,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,2.75E-04,4.25E-03,4.15E-03,1.3E-04,4.31E-03,,,A, YES,
10057,P25445,FAS,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),KKEAYDTLIKDLK,_EAYDT(ph)LIK_,T272,,19.38,20.48,20.72,,20.34,,22.12,,22.30,24.08,,,22.78,21.53,-2.15,-1.04,-0.80, ,-1.18, ,0.60, ,0.77,2.55, , ,1.26,negative regulation of apoptotic process;negative regulation of B cell activation;renal system process;response to toxin;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of necrotic cell death;negative thymic T cell selection;activation-induced cell death of T cells;cellular response to lithium ion;cellular response to mechanical stimulus;response to peptide hormone stimulus;response to growth factor stimulus;response to estrogen stimulus;neuron apoptotic process;spleen development;gene expression;response to lipopolysaccharide;B cell mediated immunity;cellular response to hyperoxia;inflammatory cell apoptotic process;transformed cell apoptotic process;regulation of cell proliferation;immunoglobulin production;aging;positive regulation of protein homooligomerization;response to drug;extrinsic apoptotic signaling pathway via death domain receptors;spermatogenesis;ovulation cycle;regulation of lymphocyte differentiation;regulation of myeloid cell differentiation;dendrite regeneration;protein complex assembly;response to hypoxia;response to glucocorticoid stimulus;protein homooligomerization,membrane raft;external side of plasma membrane;perinuclear region of cytoplasm;CD95 death-inducing signaling complex;cytosol;extracellular region;integral to membrane;nucleus,,,,,1.12E-02,4.88E-02,9.71E-02,3.37E-03,5.73E-02,,,A, YES,
10195,P68363,TUBA1B,Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain),VNAAIATIKTKRS,_DVNAAIAT(ph)IK_,T334,+,19.69,21.74,21.74,21.67,24.93,24.36,23.35,24.04,23.13,,23.23,24.42,22.82,22.93,-3.24,-1.18,-1.18,-1.26,2.00,1.43,0.42,1.12,0.21, ,0.31,1.50,-0.11,protein polymerization;microtubule-based process;microtubule-based movement;'de novo' posttranslational protein folding;microtubule cytoskeleton organization;cytoskeleton-dependent intracellular transport;cell division,cytoplasmic microtubule;microtubule,,,,,2.16E-03,1.64E-02,7.14E-04,5.87E-03,4.95E-01,,,A, YES,
10217,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",PAQSAATLPARTQ,_TALPAQSAAT(ph)LPAR_,T2187,+,23.34,21.46,20.06,20.62,22.91,,24.40,24.73,,,26.26,24.54,,23.15,0.19,-1.69,-3.09,-2.53,-0.23, ,1.26,1.58, , ,3.12,1.39, ,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,7.4E-03,3.61E-02,1.77E-02,2.6E-03,2.14E-01,,,A, YES,
10290,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],EAPAVVTEEEDDD,_GTEAPAVVT(ph)EEEDDDEETAPPVIAPRPDHTK_,T169,+,21.39,22.82,22.82,21.24,25.68,25.35,26.40,26.75,24.42,25.50,26.58,27.03,24.39,24.64,-3.26,-1.83,-1.83,-3.41,1.04,0.71,1.76,2.11,-0.23,0.86,1.93,2.39,-0.25,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,8.85E-05,1.95E-03,8.23E-05,8.74E-05,8.2E-01,,,A, YES,
10322,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),MRILELTPEPDRP,_ILELT(ph)PEPDRPR_,T1186,+,24.14,23.78,23.53,24.39,27.52,27.96,26.65,26.21,26.53,26.45,26.19,26.48,26.90,25.90,-1.76,-2.12,-2.37,-1.51,1.61,2.06,0.74,0.31,0.63,0.54,0.29,0.58,0.99,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,4.33E-05,1.28E-03,1.72E-05,1.84E-04,3.47E-01,,,A,,
10368,Q15233,NONO,"Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (55 kDa nuclear protein) (DNA-binding p52/p100 complex, 52 kDa subunit) (NMT55) (p54(nrb)) (p54nrb)",IGAIGGTPPAFNR,_FGQAATM(ox)EGIGAIGGT(ph)PPAFNR_,T450,+,25.60,22.59,21.29,24.16,27.63,26.48,26.47,26.66,26.70,25.05,26.30,25.46,27.13,25.50,0.10,-2.91,-4.21,-1.34,2.12,0.98,0.97,1.16,1.20,-0.45,0.80,-0.04,1.63,"DNA repair;mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination",nucleolus;nuclear speck;paraspeckles;nuclear matrix,Other TF domain,,,,1.36E-03,1.21E-02,4.3E-04,5.9E-03,2.92E-01,,,A, YES,
10383,Q16630,CPSF6,Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit) (CFIm68) (CPSF 68 kDa subunit) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7),PGREMDTARTPLS,_EM(ox)DT(ph)ARTPLSEAEFEEIM(ox)NR_,T331,+,24.02,21.63,21.74,21.63,25.54,25.61,,24.63,25.55,22.84,25.14,24.44,25.96,24.06,-0.04,-2.43,-2.32,-2.43,1.48,1.55, ,0.57,1.49,-1.22,1.08,0.38,1.90,protein tetramerization;mRNA polyadenylation,mRNA cleavage factor complex;ribonucleoprotein complex;paraspeckles,,,,,2.32E-03,1.69E-02,8.6E-04,6.73E-03,3.24E-01,,,A, YES,
10395,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),LETIPITPVERNY,_ALETIPIT(ph)PVER_,T3996,,23.02,23.00,22.26,23.18,,25.12,24.42,24.37,25.08,24.99,24.50,23.98,25.34,24.11,-1.09,-1.11,-1.84,-0.93, ,1.02,0.32,0.27,0.98,0.89,0.40,-0.13,1.24,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,6.18E-03,3.16E-02,4.17E-03,4.97E-03,9.32E-01,,,A,,
10425,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),FSEEGETEEDDQD,_VNFSEEGET(ph)EEDDQDSSHSSVTTVK_,T220,+,25.29,25.29,26.02,24.63,27.97,27.83,27.36,26.49,27.52,27.32,27.55,27.39,27.40,26.77,-1.49,-1.49,-0.76,-2.14,1.20,1.06,0.58,-0.29,0.74,0.55,0.78,0.62,0.63,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,3.52E-04,5.12E-03,2.46E-04,4.25E-04,9.77E-01,,,A, YES,+
10440,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,IDNIDGTPVRDER,_GPTSTSIDNIDGT(ph)PVRDER_,T686,+,24.69,24.61,23.13,24.41,27.83,28.14,25.80,25.53,26.63,25.75,25.71,25.51,26.50,25.71,-1.02,-1.10,-2.58,-1.30,2.12,2.43,0.09,-0.18,0.92,0.04,-0.01,-0.20,0.79,,"DNA-directed RNA polymerase II, holoenzyme",,,,,4.63E-03,2.59E-02,1.27E-03,3.38E-02,1.61E-01,,,A, YES,
10453,Q69YN4,KIAA1429,Protein virilizer homolog,QPRGPRTPPGPPP,_T(ph)PPGPPPPDDDEDDPVPLPVSGDK_,T184,+,25.74,24.54,24.75,24.48,,25.98,27.45,25.56,28.14,28.47,26.01,26.71,27.18,26.25,-0.51,-1.71,-1.50,-1.77, ,-0.27,1.20,-0.69,1.89,2.22,-0.24,0.46,0.93,mRNA processing;RNA splicing,nucleus,,,,,1.02E-02,4.57E-02,1.15E-02,4.7E-03,6.65E-01,,,A, YES,
10586,Q8N684,CPSF7,Cleavage and polyadenylation specificity factor subunit 7 (Cleavage and polyadenylation specificity factor 59 kDa subunit) (CFIm59) (CPSF 59 kDa subunit) (Pre-mRNA cleavage factor Im 59 kDa subunit),SADGRATPSENLV,_DSSDSADGRAT(ph)PSENLVPSSAR_,T194,+,23.90,23.59,23.60,22.94,25.87,26.33,24.77,24.77,25.69,23.69,24.21,24.74,25.73,24.60,-0.70,-1.01,-1.00,-1.66,1.27,1.73,0.17,0.17,1.08,-0.92,-0.39,0.14,1.13,"protein tetramerization;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",mRNA cleavage factor complex,,,,,7.35E-03,3.59E-02,2.02E-03,7.18E-02,1.16E-01,,,A, YES,+
10672,Q96GX8,C16orf74,Uncharacterized protein C16orf74,IIITPPTPTGMML,_HLDVPDIIITPPT(ph)PTGM(ox)M(ox)LPR_,T44,+,,22.09,22.09,,26.43,26.05,25.72,25.60,25.59,25.77,25.59,24.18,27.72,25.16, ,-3.08,-3.08, ,1.26,0.88,0.56,0.43,0.42,0.61,0.42,-0.98,2.56,,,,,,,6.15E-03,3.15E-02,3.95E-03,5.03E-03,9.27E-01,,,A,,
10729,Q9BQQ3,GORASP1,Golgi reassembly-stacking protein 1 (Golgi peripheral membrane protein p65) (Golgi phosphoprotein 5) (GOLPH5) (Golgi reassembly-stacking protein of 65 kDa) (GRASP65),HKKPPGTPPPSAL,_KPPGT(ph)PPPSALPLGAPPPDALPPGPTPEDSPSLETGSR_,T143,+,22.06,22.58,22.61,,25.23,26.79,25.86,,26.47,24.59,26.69,25.61,27.42,25.08,-3.03,-2.51,-2.47, ,0.15,1.71,0.78, ,1.38,-0.49,1.60,0.53,2.34,protein transport;Golgi organization;mitotic prophase,cytosol;Golgi membrane,,,,,2.4E-04,3.95E-03,2.1E-04,2.16E-04,9.86E-01,,,A,,
10829,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",EESRPYTNKVITL,_LYNSEESRPYT(ph)NK_,T893,+,24.00,26.56,27.34,23.46,27.16,28.58,27.98,27.69,28.25,28.09,25.55,27.63,27.20,26.88,-2.88,-0.32,0.46,-3.42,0.28,1.70,1.09,0.80,1.37,1.20,-1.34,0.74,0.32,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,3.56E-03,2.18E-02,1.09E-03,1.46E-02,2.87E-01,,+,A, YES,
10871,Q9UKK3,PARP4,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),YKPLDITPPPDQK,_NYDPYKPLDIT(ph)PPPDQK_,T101,+,23.82,22.33,21.85,20.75,24.88,24.57,25.05,25.54,25.24,25.45,25.67,26.05,24.82,24.31,-0.49,-1.98,-2.46,-3.56,0.57,0.26,0.74,1.23,0.93,1.14,1.36,1.74,0.52,DNA repair;transport;protein ADP-ribosylation;inflammatory response;cell death;response to drug,spindle microtubule;ribonucleoprotein complex;nucleus;cytoplasm,,,,,7.59E-05,1.81E-03,1.23E-04,4.97E-05,4.55E-01,,,A, YES,
10883,Q9UN86,G3BP2,Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2),LEEKSTTPPPAEP,_STT(ph)PPPAEPVSLPQEPPKPR_,T227,+,26.58,27.15,27.27,27.57,28.95,29.18,29.26,29.38,28.49,28.57,29.43,28.73,29.29,28.45,-1.87,-1.30,-1.18,-0.88,0.50,0.73,0.81,0.93,0.04,0.12,0.98,0.28,0.84,regulation of small GTPase mediated signal transduction;Ras protein signal transduction;mRNA transport;cytoplasmic sequestering of NF-kappaB,cytosol,,,,,7.94E-04,8.73E-03,4.99E-04,9.68E-04,9.2E-01,,,A, YES,+
11020,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),ALGKDVTPPPETE,_DVT(ph)PPPETEVVLIK_,T538,+,29.24,26.77,27.09,27.14,29.01,28.03,29.03,29.39,29.02,29.46,29.95,29.88,29.97,28.77,0.47,-2.00,-1.68,-1.63,0.24,-0.74,0.26,0.62,0.25,0.69,1.19,1.11,1.20,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,4.19E-03,2.44E-02,1.96E-02,1.23E-03,1.41E-01,,,A, YES,+
11059,O14979,HNRNPDL,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),MEDMNEYSNIEEF,_M(ox)EDMNEY(ph)SNIEEFAEGSK_,Y7,+,23.63,25.38,25.38,25.50,25.64,27.24,26.03,26.65,26.79,26.69,26.76,26.69,28.32,26.21,-2.58,-0.83,-0.83,-0.71,-0.56,1.04,-0.18,0.44,0.58,0.48,0.56,0.48,2.11,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleus;cytoplasm,Other TF domain,,,,2.97E-03,1.96E-02,7.29E-03,1.09E-03,2.75E-01,,,A, YES,
11076,Q13838,DDX39B,Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein),DNELLDYEDDEVE,_AENDVDNELLDY(ph)EDDEVETAAGGDGAEAPAKK_,Y13,+,25.06,25.31,25.74,24.99,27.99,28.98,27.64,28.03,28.10,27.46,27.18,27.32,29.04,27.14,-2.09,-1.83,-1.40,-2.16,0.85,1.84,0.50,0.89,0.96,0.32,0.04,0.18,1.90,spliceosomal complex assembly;RNA secondary structure unwinding;intronless viral mRNA export from host nucleus,nuclear speck;transcription export complex;spliceosomal complex;cytoplasm,,,,,5.96E-05,1.54E-03,2.61E-05,1.94E-04,4.5E-01,,,A, YES,
1064,O96019,ACTL6A,Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K),EAVREGSPANWKR,_EAVREGS(ph)PANWK_,S233,+,24.28,25.36,25.95,24.68,26.00,25.91,25.70,25.79,25.14,24.70,22.97,23.86,23.28,24.89,-0.62,0.46,1.05,-0.22,1.11,1.02,0.81,0.90,0.25,-0.19,-1.92,-1.04,-1.61,"neural retina development;histone H4 acetylation;regulation of transcription from RNA polymerase II promoter;DNA repair;histone H2A acetylation;signal transduction;transcription, DNA-dependent;chromatin remodeling;DNA recombination;regulation of growth;nervous system development",SWI/SNF complex;plasma membrane;npBAF complex;NuA4 histone acetyltransferase complex;Ino80 complex,,,,,4.77E-03,2.64E-02,1.25E-01,4.51E-02,1.28E-03,,,B, YES,
1276,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),EMKNDKSEEEQSS,_S(ph)EEEQSSSSVKK_,S220,+,27.06,27.20,26.40,27.80,27.49,28.10,26.06,26.75,26.10,24.47,24.11,24.34,25.58,26.27,0.80,0.93,0.14,1.54,1.22,1.84,-0.21,0.49,-0.16,-1.80,-2.16,-1.92,-0.69,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,7.6E-04,8.49E-03,5.36E-01,4.5E-04,1.01E-03,+,,B, YES,
1437,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",___MEVSPLQPVN,_(ac)M(ox)EVS(ph)PLQPVNENM(ox)QVNK_,S4,+,22.65,23.47,23.47,22.63,26.03,25.57,24.75,24.80,23.52,23.66,,,24.19,24.07,-1.41,-0.60,-0.60,-1.44,1.96,1.50,0.69,0.74,-0.55,-0.40, , ,0.13,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,9.25E-03,4.24E-02,1.66E-03,1.07E-01,1.99E-01,,,B, YES,
1778,P20700,LMNB1,Lamin-B1,EERLKLSPSPSSR,_LKLS(ph)PS(ph)PSSR_,S391,+,26.61,26.81,27.08,26.92,27.79,26.60,26.70,27.17,25.50,24.02,24.58,24.64,24.72,26.09,0.52,0.72,0.99,0.83,1.70,0.52,0.61,1.08,-0.59,-2.07,-1.51,-1.45,-1.37,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,4.4E-04,5.92E-03,9E-01,4.4E-04,3.51E-04,,,B, YES,
1851,P23246,SFPQ,"Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)",RSEEKISDSEGFK,_SEEKIS(ph)DSEGFK_,S273,+,25.76,24.77,24.98,,23.65,24.07,22.09,24.51,21.86,22.21,20.31,,22.61,23.35,2.41,1.42,1.64, ,0.31,0.72,-1.26,1.16,-1.49,-1.14,-3.04, ,-0.74,"DNA repair;negative regulation of transcription from RNA polymerase II promoter;alternative mRNA splicing, via spliceosome;transcription, DNA-dependent;DNA recombination",paraspeckles;nuclear matrix;cytoplasm,Other TF domain,,,,4.75E-03,2.64E-02,3.09E-02,1.56E-03,6.6E-02,,,B, YES,
1903,P25205,MCM3,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),KRSEDESETEDEE,_KRSEDES(ph)ET(ph)EDEEEK_,S672,+,26.53,27.49,28.35,26.25,28.31,26.17,25.96,28.09,25.76,22.54,22.83,24.50,24.16,25.92,0.61,1.57,2.43,0.33,2.39,0.25,0.04,2.17,-0.15,-3.38,-3.09,-1.41,-1.76,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;alpha DNA polymerase:primase complex;centrosome;perinuclear region of cytoplasm;MCM complex,,,,,1.1E-03,1.05E-02,6.46E-01,2.02E-03,5.05E-04,,,B,,
2412,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),PRERSDSGGSSSE,_SDS(ph)GGSSSEPFDR_,S761,+,26.78,25.76,23.30,26.48,25.68,23.47,23.31,25.25,23.70,,22.40,,22.24,24.40,2.39,1.36,-1.10,2.08,1.28,-0.93,-1.09,0.85,-0.70, ,-1.99, ,-2.16,,nucleus;cytoplasm,,,,,1.14E-02,4.95E-02,7.03E-02,4.09E-03,6.67E-02,,,B, YES,
2467,P49736,MCM2,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),NDPLTSSPGRSSR,_GNDPLTSS(ph)PGR_,S27,+,27.00,26.66,27.29,28.11,28.51,26.84,26.67,28.25,26.15,25.97,23.89,24.30,25.47,26.55,0.46,0.11,0.74,1.56,1.96,0.29,0.13,1.70,-0.40,-0.57,-2.66,-2.24,-1.08,S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;nucleosome assembly,nucleoplasm;chromatin;nuclear origin of replication recognition complex;MCM complex,,,,,5.38E-03,2.88E-02,7.37E-01,7.25E-03,2.51E-03,,,B, YES,
2998,Q01167,FOXK2,Forkhead box protein K2 (Cellular transcription factor ILF-1) (FOXK1) (Interleukin enhancer-binding factor 1),SLSREGSPAPLEP,_EGS(ph)PAPLEPEPGAAQPK_,S398,+,26.01,26.19,25.42,26.43,26.53,26.11,25.46,26.05,24.68,23.65,24.80,23.65,,25.41,0.59,0.77,0.01,1.01,1.11,0.70,0.04,0.64,-0.73,-1.76,-0.61,-1.76, ,tissue development;embryo development;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process,transcription factor complex,Forkhead,,,,7.86E-03,3.8E-02,5.56E-01,3.95E-03,8.81E-03,,,B,,
3310,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AEAEASSPKGKFS,_ASLGSLEGEAEAEASS(ph)PKGK_,S5763,+,28.40,24.72,25.22,25.00,28.85,28.66,29.49,29.78,29.56,25.84,28.63,24.81,27.71,27.44,0.96,-2.72,-2.21,-2.43,1.42,1.22,2.05,2.34,2.13,-1.60,1.20,-2.62,0.27,nervous system development,nucleus,,,,,2.19E-03,1.65E-02,7.85E-04,2.46E-01,1.1E-02,,,B,,
3469,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),PVKDPVSPASQKM,_QSQQPM(ox)KPIS(ph)PVKDPVS(ph)PASQK_,S1101,+,26.14,25.45,24.39,26.31,26.90,25.66,25.16,26.11,26.55,23.43,23.43,23.92,23.96,25.19,0.96,0.27,-0.80,1.13,1.71,0.47,-0.03,0.93,1.37,-1.76,-1.76,-1.26,-1.23,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,9.99E-04,1E-02,5.67E-01,2.15E-03,4.27E-04,,+,B, YES,
3515,Q12996,CSTF3,Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77),KRPNEDSDEDEEK,_RPNEDS(ph)DEDEEKGAVVPPVHDIYR_,S691,+,23.50,25.81,26.43,24.94,25.21,24.94,21.74,25.29,22.49,20.13,20.79,20.83,23.15,23.48,0.02,2.33,2.95,1.46,1.73,1.46,-1.74,1.81,-0.99,-3.35,-2.69,-2.65,-0.33,"termination of RNA polymerase II transcription;mRNA cleavage;mRNA splicing, via spliceosome;mRNA polyadenylation",nucleoplasm,,,,,4.31E-03,2.47E-02,3.89E-01,1.8E-03,7.44E-03,,,B, YES,
3538,Q13112,CHAF1B,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),RTQDPSSPGTTPP,_TQDPSS(ph)PGTTPPQAR_,S429,+,24.90,25.31,25.31,25.09,25.90,24.58,24.93,25.15,23.86,24.12,21.58,23.08,21.98,24.29,0.61,1.02,1.02,0.80,1.61,0.28,0.64,0.86,-0.43,-0.17,-2.71,-1.21,-2.31,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;protein complex assembly;cell cycle;DNA replication;DNA replication-dependent nucleosome assembly",cytoplasm;CAF-1 complex,,,,,3.47E-03,2.15E-02,7.39E-01,3.02E-03,2.35E-03,,,B, YES,
3624,Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),RGLGPPSPPAPPR,_GLGPPS(ph)PPAPPRGPAGEAGAS(ph)PPVRR_,S95,+,26.45,26.60,26.18,27.14,28.34,27.05,26.69,28.34,28.33,25.81,25.22,24.07,25.51,26.59,-0.15,0.01,-0.42,0.54,1.74,0.46,0.09,1.74,1.74,-0.78,-1.37,-2.52,-1.08,,dystrophin-associated glycoprotein complex;synapse;transport vesicle membrane;cell junction;microtubule;cytoplasm,,,,,8.9E-04,9.37E-03,6.39E-02,1.83E-02,2.23E-04,,,B, YES,
3625,Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),AGEAGASPPVRRV,_GPAGEAGAS(ph)PPVRR_,S110,+,26.51,26.85,26.25,27.29,28.42,27.16,26.63,28.37,28.26,25.81,25.45,25.15,25.72,26.76,-0.25,0.09,-0.51,0.53,1.66,0.40,-0.13,1.61,1.50,-0.95,-1.31,-1.61,-1.04,,dystrophin-associated glycoprotein complex;synapse;transport vesicle membrane;cell junction;microtubule;cytoplasm,,,,,1.98E-03,1.53E-02,8.71E-02,2.87E-02,5.1E-04,,,B, YES,
4009,Q14966,ZNF638,Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein),RNPFRGSPKCFRS,_NPFRGS(ph)PK_,S552,+,25.54,24.24,24.62,,23.32,23.02,21.57,22.07,21.91,,21.85,,21.90,23.00,2.54,1.24,1.61, ,0.32,0.01,-1.44,-0.93,-1.10, ,-1.15, ,-1.11,"RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear speck;cytoplasm,Other TF domain,,,,3.26E-03,2.09E-02,2.28E-03,2.77E-03,4.86E-01,,,B, YES,
4021,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),EAERKNSLISSLE,_KNS(ph)LISSLEEEVSILNR_,S1225,+,25.59,23.80,,24.67,27.07,27.56,25.46,27.40,27.93,22.16,24.03,,25.68,25.58,0.01,-1.78, ,-0.91,1.50,1.99,-0.12,1.82,2.35,-3.42,-1.55, ,0.10,G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;nucleus organization;mitotic anaphase;cell division;lung epithelial cell differentiation,spindle microtubule;nucleoplasm;cytosol;chromosome;apical part of cell;spindle pole;nuclear matrix,,,,,4.31E-03,2.47E-02,1.08E-02,4.34E-01,1.85E-03,,,B, YES,
4065,Q15059,BRD3,Bromodomain-containing protein 3 (RING3-like protein),TASRSESPPPLSD,_SES(ph)PPPLSDPK_,S263,+,26.90,27.51,27.18,27.65,26.37,26.84,26.45,26.62,26.25,25.24,24.78,,25.37,26.43,0.47,1.08,0.75,1.22,-0.06,0.41,0.02,0.19,-0.18,-1.19,-1.64, ,-1.06,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",nucleus,,+,,,1.46E-03,1.25E-02,6.28E-02,4.33E-04,1.17E-02,,,B, YES,
4291,Q16666,IFI16,Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator),EQTQPPSPAGAGM,_VSEEQTQPPS(ph)PAGAGM(ox)STAM(ox)GR_,S157,+,29.87,29.48,29.57,29.94,29.07,30.09,28.60,29.17,29.06,26.17,26.36,27.51,29.40,28.79,1.08,0.69,0.78,1.14,0.28,1.30,-0.19,0.37,0.27,-2.62,-2.43,-1.28,0.61,"regulation of autophagy;negative regulation of innate immune response;defense response to virus;autophagy;inflammatory response;cellular response to ionizing radiation;negative regulation of DNA binding;negative regulation of cysteine-type endopeptidase activity;activation of cysteine-type endopeptidase activity;positive regulation of transcription from RNA polymerase II promoter;cellular response to glucose starvation;negative regulation of viral genome replication;innate immune response;intrinsic apoptotic signaling pathway by p53 class mediator;cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;monocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of interleukin-1 beta production;activation of innate immune response",nucleolus;nuclear speck;cytoplasm,Other TF domain,,,,5.15E-03,2.8E-02,3.76E-01,2.08E-03,9.13E-03,,,B,,
4611,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),TVRSTGSATSLAS,_STGS(ph)ATSLASQGER_,S593,+,24.66,23.85,23.66,24.10,24.54,24.62,25.89,25.46,23.95,21.80,,20.40,21.92,23.74,0.92,0.11,-0.07,0.36,0.80,0.88,2.15,1.72,0.21,-1.93, ,-3.34,-1.81,,centriole;microtubule;centrosome;spindle,,,,,1.21E-04,2.44E-03,4.6E-01,3.14E-04,5.64E-05,,,B, YES,
5339,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),DLDRPGSDRQERE,_EGPDLDRPGS(ph)DRQER_,S651,+,24.66,26.68,26.36,24.65,26.17,26.31,25.71,25.77,25.45,22.73,24.56,23.99,23.42,25.11,-0.45,1.57,1.25,-0.46,1.06,1.20,0.60,0.66,0.34,-2.38,-0.55,-1.12,-1.70,"transcription, DNA-dependent",nucleus,,,,,3.06E-03,2.01E-02,5.71E-01,5.93E-03,1.24E-03,,,B, YES,
5883,Q8N8A6,DDX51,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),NDAEPGSPEAPQG,_VNDAEPGS(ph)PEAPQGK_,S83,+,26.30,27.04,27.46,27.44,28.08,26.41,26.78,26.51,26.49,26.16,23.92,25.11,24.66,26.34,-0.04,0.70,1.12,1.10,1.75,0.08,0.44,0.17,0.16,-0.17,-2.41,-1.23,-1.67,rRNA processing,nucleolus,,,,,5.4E-03,2.88E-02,8.55E-01,4.01E-03,4.03E-03,,,B, YES,
6746,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KSSRGGSPDLWKS,_GGS(ph)PDLWK_,S476,+,26.05,26.60,26.48,26.84,25.57,25.92,26.04,25.91,26.29,22.42,22.71,22.58,22.96,25.11,0.94,1.50,1.38,1.73,0.46,0.81,0.93,0.81,1.19,-2.68,-2.40,-2.53,-2.14,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,3.21E-07,1.1E-04,1.81E-01,2.12E-07,8.96E-07,,,B, YES,
6922,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KKQKMDSDEDEKE,_(gl)QKM(ox)DS(ph)DEDEKEGEEEK_,S377,+,23.59,23.76,23.54,24.62,26.63,23.61,22.75,23.66,24.09,,21.19,18.04,22.23,23.14,0.44,0.62,0.40,1.47,3.49,0.47,-0.39,0.52,0.95, ,-1.95,-5.11,-0.92,"transcription, DNA-dependent",nucleus,,,,,2.56E-03,1.78E-02,9.78E-01,2.44E-03,1.65E-03,,,B, YES,
7644,Q9H5H4,ZNF768,Zinc finger protein 768,PRFEPESPGFESR,_FEPES(ph)PGFESR_,S52,+,25.97,25.20,25.24,25.67,26.41,26.53,25.64,25.81,26.95,24.36,24.00,24.59,25.27,25.51,0.45,-0.31,-0.27,0.16,0.90,1.02,0.13,0.30,1.44,-1.15,-1.51,-0.92,-0.24,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter","DNA-directed RNA polymerase II, core complex",C2H2-type,,,,8.35E-03,3.96E-02,1.33E-01,7E-02,2.31E-03,,,B,,
7646,Q9H5H4,ZNF768,Zinc finger protein 768,PRYEPQSPGYEPR,_YEPQS(ph)PGYEPR_,S94,+,25.42,25.15,24.46,25.47,24.57,25.30,24.14,25.37,24.76,22.31,22.80,23.25,23.32,24.33,1.08,0.82,0.13,1.13,0.24,0.97,-0.19,1.04,0.43,-2.02,-1.54,-1.08,-1.01,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter","DNA-directed RNA polymerase II, core complex",C2H2-type,,,,5.85E-04,7.15E-03,3.8E-01,2.86E-04,1.09E-03,,,B,,
7837,Q9NPH3,IL1RAP,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),KSPRRSSSDEQGL,_RSS(ph)S(ph)DEQGLSYSSLK_,S556,+,23.71,24.98,24.98,24.19,27.06,27.18,25.41,26.62,23.63,22.73,,,22.03,24.78,-1.06,0.21,0.21,-0.58,2.28,2.40,0.63,1.84,-1.14,-2.05, , ,-2.74,inflammatory response;immune response;protein complex assembly;interleukin-2 biosynthetic process;innate immune response,extracellular region;intracellular;integral to plasma membrane,,,,,5.88E-03,3.07E-02,5.7E-02,7.93E-02,1.89E-03,,,B, YES,
7869,Q9NQG6,SMCR7L,Mitochondrial dynamic protein MID51 (Mitochondrial dynamic protein of 51 kDa) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like),AISAPTSPTRLSH,_AISAPTS(ph)PTR_,S59,+,25.98,26.08,25.65,26.13,25.05,25.10,24.78,24.95,,24.45,23.39,,23.84,25.04,0.94,1.04,0.61,1.09,0.01,0.07,-0.25,-0.09, ,-0.59,-1.64, ,-1.20,mitochondrial fusion,mitochondrial outer membrane;integral to membrane,,,,,3.62E-03,2.2E-02,3.7E-02,9.5E-04,5.92E-02,,,B,,
7941,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),AQQRAESPESSAI,_AES(ph)PESSAIESTQSTPQK_,S1358,,28.93,28.61,28.69,28.89,28.91,29.27,28.65,29.23,29.01,28.08,26.94,26.71,27.73,28.43,0.50,0.18,0.26,0.46,0.48,0.83,0.21,0.79,0.57,-0.36,-1.49,-1.72,-0.71,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,5.12E-03,2.8E-02,5.77E-01,9.34E-03,2.04E-03,,,B, YES,
8040,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),VKKETQSPEQVKS,_ETQS(ph)PEQVK_,S494,+,26.01,26.06,26.03,27.36,26.84,26.89,24.70,26.54,25.43,22.77,24.80,23.75,23.31,25.42,0.59,0.63,0.61,1.94,1.42,1.46,-0.72,1.11,0.01,-2.66,-0.62,-1.67,-2.11,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,8.82E-04,9.33E-03,6.1E-01,5.67E-04,1.03E-03,,+,B, YES,
8896,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),SAVSELSPRERSP,_ASAVSELS(ph)PRER_,S243,+,31.59,31.53,30.96,32.10,31.15,32.30,30.37,30.74,31.38,30.14,29.24,28.99,29.68,30.78,0.81,0.75,0.18,1.32,0.37,1.52,-0.41,-0.05,0.60,-0.65,-1.55,-1.79,-1.10,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,2.46E-03,1.74E-02,3.44E-01,1.01E-03,4.88E-03,,,B, YES,
9392,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),SEEKGDSDDEKPR,_SSSISEEKGDS(ph)DDEKPR_,S118,+,24.68,24.12,24.72,25.73,27.59,25.71,23.62,25.58,25.18,19.23,23.98,22.66,22.83,24.28,0.40,-0.16,0.44,1.45,3.31,1.43,-0.66,1.30,0.90,-5.05,-0.30,-1.62,-1.45,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,3.48E-03,2.15E-02,6.87E-01,5.35E-03,1.58E-03,+,,B, YES,
10159,P50613,CDK7,Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit),SPNRAYTHQVVTR,_SFGS(ph)PNRAYT(ph)HQVVTR_,S164/T170,+,24.15,24.52,24.43,26.76,26.32,24.1,25.27,25.72,24.93,23.12,22.1,21.88,22.84,24.32,-0.17,0.20,0.11,2.44,2.00,-0.22,0.95,1.40,0.61,-1.20,-2.22,-2.44,-1.48,"termination of RNA polymerase I transcription;S phase of mitotic cell cycle;G1 phase of mitotic cell cycle;nucleotide-excision repair, DNA damage removal;G1/S transition of mitotic cell cycle;cell cycle arrest;viral reproduction;androgen receptor signaling pathway;cell division;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase II promoter;transcription initiation from RNA polymerase I promoter;7-methylguanosine mRNA capping;transcription elongation from RNA polymerase I promoter;G2/M transition of mitotic cell cycle;cell proliferation;regulation of cyclin-dependent protein kinase activity;transcription-coupled nucleotide-excision repair;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription",cytosol;mitochondrion;holo TFIIH complex;cytoskeleton;perinuclear region of cytoplasm,,+,,,1.42E-03,1.23E-02,4.88E-01,3.53E-03,5.51E-04,,,B, YES,+
10398,Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),QPKVQTTPPPAVQ,_VQTT(ph)PPPAVQGQK_,T605,+,24.20,24.04,24.07,23.96,23.90,23.27,24.13,24.51,22.84,21.66,22.41,21.87,22.46,23.33,0.87,0.71,0.74,0.63,0.56,-0.06,0.80,1.18,-0.49,-1.67,-0.93,-1.47,-0.87,protein stabilization;protein autophosphorylation;endocytosis;regulation of protein localization;positive regulation of Notch signaling pathway;regulation of clathrin-mediated endocytosis,coated pit;cell leading edge;extrinsic to plasma membrane;clathrin complex;terminal button;clathrin-coated vesicle,,+,,,2.27E-03,1.67E-02,4.93E-01,1.15E-03,3.17E-03,,,B, YES,
38,A6ND36,FAM83G,Protein FAM83G,ALVKAKSVDEIAK,_AKS(ph)VDEIAK_,S356,+,24.64,25.77,26.52,25.70,22.38,19.86,22.95,22.94,21.49,21.22,23.48,23.30,,23.35,1.29,2.42,3.17,2.34,-0.97,-3.49,-0.41,-0.42,-1.86,-2.13,0.13,-0.06, ,,,,,,,1.45E-03,1.25E-02,3.85E-04,6.79E-03,3.75E-01,,,C,,
51,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,PTKYSLSPSKSYK,_YSLS(ph)PSK_,SNaN,+,26.20,25.58,25.21,26.45,23.25,22.24,,22.38,22.25,22.00,,,21.70,23.73,2.48,1.86,1.48,2.72,-0.47,-1.49, ,-1.35,-1.47,-1.72, , ,-2.02,protein targeting to Golgi,intracellular,,,,,2.3E-05,8.72E-04,2E-05,2.53E-05,3.11E-01,,,C, YES,+
121,O00499,BIN1,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),KGNKSPSPPDGSP,_SPS(ph)PPDGSPAATPEIR_,S267,+,26.94,27.30,,26.35,22.87,24.03,23.55,25.09,23.22,23.31,,,,24.74,2.20,2.56, ,1.61,-1.87,-0.71,-1.19,0.35,-1.52,-1.43, , , ,multicellular organismal development;cell proliferation;positive regulation of endocytosis;endocytosis;positive regulation of GTPase activity;muscle cell differentiation;virus-host interaction,synaptic vesicle;nucleus;axon terminus;actin cytoskeleton;varicosity;cytoplasm;cerebellar mossy fiber,,,,,1.55E-03,1.29E-02,3.87E-04,4.14E-03,6.5E-01,,,C, YES,+
203,O14681,EI24,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),SAEKFPSPHPSPA,_FPS(ph)PHPS(ph)PAK_,S326,+,26.72,26.17,26.16,,22.54,,23.00,22.92,23.90,25.21,,,,24.58,2.14,1.59,1.58, ,-2.04, ,-1.58,-1.66,-0.67,0.64, , , ,autophagy;negative regulation of cell growth;response to drug;apoptotic process;induction of apoptosis,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,,,,,2.85E-03,1.92E-02,4.27E-04,3.19E-01,3.85E-02,,,C, YES,+
206,O14683,TP53I11,Tumor protein p53-inducible protein 11 (p53-induced gene 11 protein),PLMKKHSQTDLVS,_KHS(ph)QTDLVSR_,S14,+,27.51,26.97,27.06,26.39,23.44,19.78,23.04,21.43,,19.86,22.61,25.05,21.80,23.74,3.77,3.23,3.32,2.64,-0.30,-3.97,-0.70,-2.32, ,-3.89,-1.14,1.31,-1.94,negative regulation of cell proliferation;response to stress,integral to membrane,,,,,2.19E-04,3.75E-03,1.42E-04,3.13E-04,6.85E-01,,,C,,
232,O14828,SCAMP3,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),QPSRKLSPTEPKN,_KLS(ph)PTEPK_,S76,+,27.22,27.84,27.60,28.12,25.06,24.80,24.70,25.36,24.77,25.46,26.38,25.97,24.72,26.00,1.22,1.84,1.60,2.12,-0.94,-1.20,-1.30,-0.64,-1.23,-0.54,0.38,-0.03,-1.28,post-Golgi vesicle-mediated transport;protein transport;response to retinoic acid,integral to membrane;Golgi membrane,,,,,6.29E-05,1.58E-03,1.94E-05,5.17E-04,1.69E-01,,,C, YES,+
246,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),IPRRLASTSDIEE,_LAS(ph)TSDIEEK_,S507,+,28.65,25.15,24.26,25.44,,23.93,22.88,21.81,24.09,22.44,,,23.07,24.17,4.47,0.97,0.09,1.27, ,-0.24,-1.29,-2.36,-0.08,-1.73, , ,-1.10,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,1.13E-02,4.91E-02,6.51E-03,9.55E-03,6.99E-01,+,,C, YES,
264,O15014,ZNF609,Zinc finger protein 609,RLVEPHSPSPSSK,_LVEPHS(ph)PS(ph)PSSK_,S576,+,25.04,24.29,24.04,24.18,22.37,,,,23.31,22.51,22.28,21.36,,23.26,1.77,1.03,0.78,0.91,-0.90, , , ,0.05,-0.75,-0.99,-1.91, ,,nucleus,C2H2-type,,,,8.76E-03,4.08E-02,3.6E-02,1.85E-03,2.91E-01,,,C, YES,
265,O15014,ZNF609,Zinc finger protein 609,VEPHSPSPSSKFS,_LVEPHS(ph)PS(ph)PSSK_,S578,+,25.04,24.29,24.04,24.18,22.37,,,,23.31,22.51,22.28,21.36,,23.26,1.77,1.03,0.78,0.91,-0.90, , , ,0.05,-0.75,-0.99,-1.91, ,,nucleus,C2H2-type,,,,8.76E-03,4.08E-02,3.6E-02,1.85E-03,2.91E-01,,,C, YES,
298,O15164,TRIM24,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (Tripartite motif-containing protein 24),LDPSQKSPLHVGE,_S(ph)PLHVGETR_,S722,+,25.96,25.56,25.45,25.59,,,21.95,,21.50,21.39,21.56,21.71,,23.41,2.56,2.15,2.04,2.19, , ,-1.46, ,-1.91,-2.02,-1.85,-1.70, ,"negative regulation of cell proliferation;protein autophosphorylation;regulation of protein stability;negative regulation of transcription, DNA-dependent;regulation of vitamin D receptor signaling pathway;protein catabolic process;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;cellular response to estrogen stimulus;calcium ion homeostasis;regulation of apoptotic process",cytosol;nuclear euchromatin;nucleus;perichromatin fibrils,Other TF domain,+,,,1.62E-05,6.85E-04,3.37E-05,6.78E-06,7.94E-01,,,C,,
398,O43290,SART1,U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1),RGRRRVSEVEEEK,_RVS(ph)EVEEEKEPVPQPLPSDDTR_,S448,+,27.87,29.20,29.79,27.04,25.64,24.59,25.55,24.37,25.95,26.51,25.68,26.52,24.80,26.42,1.45,2.77,3.37,0.62,-0.79,-1.84,-0.88,-2.05,-0.47,0.08,-0.74,0.10,-1.62,intrinsic apoptotic signaling pathway;positive regulation of cytotoxic T cell differentiation;cell cycle arrest;spliceosomal snRNP assembly,cytosol;Golgi apparatus;Cajal body;catalytic step 2 spliceosome,,,,,8.02E-04,8.79E-03,2.62E-04,3.46E-03,3.03E-01,+,,C, YES,
421,O43395,PRPF3,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3) (hPrp3) (U4/U6 snRNP 90 kDa protein),GDDDEESDEEAVK,_WDEQTSNTKGDDDEES(ph)DEEAVKK_,S619,+,27.65,29.09,29.53,28.04,22.05,20.63,26.15,,26.73,26.75,22.47,25.18,22.74,25.58,2.07,3.51,3.95,2.46,-3.54,-4.96,0.56, ,1.14,1.17,-3.11,-0.40,-2.84,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;spliceosomal complex;cytoplasm,,,,,5.84E-03,3.05E-02,3.25E-03,6.15E-03,7.57E-01,+,,C, YES,
438,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),GSKFRYSGRTQAQ,_FRYS(ph)GR_,S518,,27.73,26.32,26.75,24.47,22.73,,,22.00,,21.71,22.03,22.89,,24.07,3.66,2.25,2.68,0.40,-1.34, , ,-2.08, ,-2.36,-2.04,-1.18, ,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,6.21E-04,7.42E-03,9.54E-04,2.61E-04,8.76E-01,,,C, YES,
477,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),RGSEEDSPKKESK,_ESEEGNPVRGSEEDS(ph)PKK_,S498,+,25.89,27.98,28.65,25.67,23.59,24.25,25.03,24.79,24.88,25.43,21.56,24.36,23.61,25.05,0.83,2.92,3.60,0.62,-1.47,-0.80,-0.02,-0.26,-0.18,0.38,-3.49,-0.69,-1.44,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,5.71E-03,3E-02,1.15E-02,2.16E-03,3.31E-01,,,C, YES,+
487,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),VLDEEGSEREFDE,_VLDEEGS(ph)EREFDEDS(ph)DEKEEEEDTYEK_,S616,+,28.39,27.14,27.03,26.71,22.85,22.80,22.82,23.19,22.34,25.01,22.75,22.53,21.18,24.21,4.18,2.93,2.82,2.50,-1.36,-1.41,-1.39,-1.02,-1.87,0.80,-1.46,-1.68,-3.03,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,7.25E-06,4.11E-04,5.59E-06,1.24E-05,9.18E-01,,,C, YES,+
579,O60551,NMT2,Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase),TEHAKGSPGGYLG,_GS(ph)PGGYLGAK_,S38,+,24.65,24.72,24.36,24.99,,,23.88,,22.39,22.11,,22.07,,23.65,1.01,1.07,0.71,1.34, , ,0.23, ,-1.26,-1.53, ,-1.58, ,egress of virus within host cell;N-terminal protein myristoylation;protein lipoylation,cytosol;Golgi apparatus;plasma membrane,,,,,1.11E-02,4.87E-02,4E-02,2.87E-03,2.17E-01,,,C, YES,
621,O60784,TOM1,Target of Myb protein 1,RLPNLSSPSAEGP,_AADRLPNLSS(ph)PSAEGPPGPPSGPAPR_,S462,+,24.85,23.31,,23.53,26.26,26.00,26.30,27.08,26.06,27.52,28.58,,,25.95,-1.10,-2.64, ,-2.42,0.31,0.05,0.35,1.13,0.11,1.57,2.63, , ,intracellular protein transport;endocytosis;protein transport;endosomal transport,cytosol;membrane;early endosome,,,,,1.91E-04,3.34E-03,1.1E-03,8.14E-05,2.43E-02,,,C, YES,+
640,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),NKKWDGSEEDEDN,_SNKKWDGS(ph)EEDEDNSK_,S164,+,28.02,29.87,30.14,29.16,27.08,24.71,26.04,26.46,25.58,25.24,24.40,25.26,,26.83,1.19,3.04,3.31,2.33,0.25,-2.12,-0.79,-0.37,-1.25,-1.59,-2.43,-1.57, ,regulation of translational initiation;GTP catabolic process,cytosol,,,,,2.83E-05,9.68E-04,7.02E-05,1.62E-05,1.4E-01,,,C, YES,+
644,O60885,BRD4,Bromodomain-containing protein 4 (Protein HUNK1),KEEKIHSPIIRSE,_IHS(ph)PIIR_,S1117,+,23.35,24.06,23.89,24.01,22.71,23.34,21.44,22.43,,21.68,,21.04,,22.80,0.56,1.27,1.09,1.22,-0.08,0.54,-1.35,-0.37, ,-1.12, ,-1.76, ,histone H4-K12 acetylation;chromosome segregation;protein phosphorylation;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of DNA binding;histone H3-K14 acetylation;positive regulation of G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;regulation of transcription involved in G1 phase of mitotic cell cycle;virus-host interaction,nuclear chromatin;condensed nuclear chromosome;cytoplasm,,+,,,7.19E-03,3.54E-02,2.29E-02,2.62E-03,1.29E-01,,,C, YES,
647,O60885,BRD4,Bromodomain-containing protein 4 (Protein HUNK1),PPPTYESEEEDKC,_SKPPPTYES(ph)EEEDK_,S601,+,25.37,26.07,26.80,25.66,22.74,24.40,25.20,24.68,24.21,24.30,22.05,23.36,22.58,24.42,0.95,1.65,2.38,1.25,-1.68,-0.01,0.78,0.26,-0.21,-0.11,-2.37,-1.05,-1.84,histone H4-K12 acetylation;chromosome segregation;protein phosphorylation;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of DNA binding;histone H3-K14 acetylation;positive regulation of G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;regulation of transcription involved in G1 phase of mitotic cell cycle;virus-host interaction,nuclear chromatin;condensed nuclear chromosome;cytoplasm,,+,,,2.84E-03,1.92E-02,2.46E-02,7.65E-04,7.53E-02,,,C, YES,
659,O75113,N4BP1,NEDD4-binding protein 1 (N4BP1),CQKRRFSDSEERH,_RFS(ph)DSEER_,S288,+,22.81,26.16,26.19,25.35,20.57,20.45,21.02,21.55,19.81,18.79,20.97,20.93,18.89,21.81,1.00,4.35,4.39,3.54,-1.23,-1.36,-0.79,-0.25,-1.99,-3.02,-0.84,-0.88,-2.92,negative regulation of protein ubiquitination;negative regulation of proteasomal ubiquitin-dependent protein catabolic process,PML body;nucleolus,,,,,9.65E-06,5E-04,2.14E-05,6.03E-06,3.04E-01,,,C,,
681,O75179,ANKRD17,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),GKLTVASPKRGQK,_LTVAS(ph)PK_,S1458,+,23.37,23.74,24.31,25.12,21.20,,,21.85,20.55,21.32,,21.75,21.45,22.47,0.90,1.28,1.84,2.65,-1.26, , ,-0.62,-1.91,-1.15, ,-0.71,-1.02,virus-host interaction,nucleus;cytoplasm,,,,,2.3E-03,1.68E-02,1.21E-03,2.88E-03,6.71E-01,,,C,,
686,O75351,VPS4B,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),DEKGNDSDGEGES,_GNDS(ph)DGEGESDDPEKK_,S102,+,24.03,25.10,25.29,25.40,22.29,23.72,22.33,24.98,21.56,,20.48,21.60,,23.34,0.68,1.75,1.94,2.06,-1.05,0.38,-1.01,1.64,-1.78, ,-2.87,-1.75, ,endosome to lysosome transport via multivesicular body sorting pathway;potassium ion transport;endosome organization;intracellular cholesterol transport;response to lipid;cellular membrane organization;protein transport;cell cycle;cell division,late endosome;vacuolar membrane;late endosome membrane;early endosome;cytosol;endosome membrane;nucleus;lysosome,,,,,2.79E-03,1.89E-02,2.11E-02,1E-03,4.33E-02,,,C, YES,
727,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),RRHKSDSPESDAE,_HKS(ph)DS(ph)PES(ph)DAEREK_,S867,+,26.09,25.27,25.49,26.32,20.29,,21.43,,21.36,21.65,,,,23.49,2.60,1.78,2.00,2.83,-3.20, ,-2.06, ,-2.12,-1.84, , , ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,1.74E-04,3.12E-03,2.66E-05,1.73E-03,5.42E-01,+,,C, YES,
728,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),KSDSPESDAEREK,_SDS(ph)PES(ph)DAEREK_,S870,+,26.82,28.07,28.55,28.10,23.94,24.51,25.31,23.92,25.88,26.00,24.66,25.40,22.73,25.68,1.13,2.38,2.87,2.42,-1.74,-1.17,-0.38,-1.76,0.20,0.32,-1.02,-0.29,-2.95,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,7.09E-04,8.1E-03,5E-04,7.63E-04,9.84E-01,+,,C, YES,+
761,O75569,PRKRA,"Interferon-inducible double stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double stranded RNA-dependent activator)",PLEREDSGTFSLG,_EDS(ph)GTFSLGK_,S18,+,28.15,26.93,26.52,25.30,24.98,24.04,25.63,24.50,24.85,24.78,23.07,23.98,,25.23,2.92,1.70,1.29,0.07,-0.25,-1.19,0.40,-0.73,-0.38,-0.45,-2.16,-1.25, ,skeletal system morphogenesis;negative regulation of cell proliferation;response to virus;immune response;protein phosphorylation;middle ear morphogenesis;response to stress;production of siRNA involved in RNA interference;induction of apoptosis;outer ear morphogenesis,perinuclear region of cytoplasm;cytoplasm,,,,,3.26E-03,2.09E-02,7.4E-03,1.33E-03,2.2E-01,,,C, YES,
772,O75643,SNRNP200,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),EVREEASDDDMEG,_EEAS(ph)DDDMEGDEAVVR_,S225,+,30.26,29.36,29.07,28.88,29.51,29.40,29.42,29.01,29.21,28.52,27.87,27.75,27.46,28.90,1.36,0.46,0.17,-0.02,0.61,0.50,0.51,0.11,0.31,-0.39,-1.03,-1.16,-1.44,cis assembly of pre-catalytic spliceosome,nucleoplasm;catalytic step 2 spliceosome;U5 snRNP,,,,,1.05E-02,4.68E-02,9.14E-01,7.88E-03,7.04E-03,+,,C, YES,
796,O75909,CCNK,Cyclin-K,KRAVVVSPKEENK,_RAVVVS(ph)PKEENK_,S340,+,26.39,27.75,28.22,26.64,25.69,25.89,25.00,25.54,25.40,24.62,23.43,25.14,24.17,25.68,0.70,2.07,2.54,0.96,0.01,0.20,-0.69,-0.14,-0.28,-1.07,-2.25,-0.54,-1.51,"mitosis;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;cell division;transcription from RNA polymerase II promoter",,,,,,4.89E-04,6.33E-03,7.15E-03,1.25E-04,3.98E-02,,,C, YES,+
812,O76021,RSL1D1,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),SETPGKSPEKKPK,_AAESETPGKS(ph)PEK_,S427,+,24.96,26.61,27.52,26.41,19.45,21.71,23.72,21.85,22.99,22.46,21.97,23.88,23.55,23.62,1.34,2.99,3.90,2.79,-4.17,-1.92,0.10,-1.77,-0.63,-1.17,-1.65,0.26,-0.07,regulation of protein localization;translation,nucleolus;large ribosomal subunit,,,,,2.45E-03,1.73E-02,7.39E-04,1.13E-02,2.64E-01,,,C, YES,
896,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),QADESQSPRDRGR,_SSEPVQADESQS(ph)PR_,S856,+,24.52,25.41,25.19,,20.35,,20.55,,20.21,23.95,18.92,21.28,,22.26,2.25,3.14,2.93, ,-1.91, ,-1.71, ,-2.06,1.68,-3.34,-0.98, ,,tight junction;apical plasma membrane;nucleus,,,,,1.79E-03,1.43E-02,7.21E-04,4.01E-03,3.47E-01,+,,C,,
900,O95071,UBR5,"E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",PQQRRISQSQPVR,_RIS(ph)QSQPVR_,S1549,+,24.92,25.14,23.59,24.71,22.81,22.07,21.85,21.98,22.32,22.05,21.69,22.98,21.16,22.87,2.05,2.27,0.72,1.85,-0.06,-0.80,-1.01,-0.88,-0.55,-0.81,-1.17,0.11,-1.70,"positive regulation of catenin import into nucleus;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;response to DNA damage stimulus;cell proliferation;DNA repair;positive regulation of protein import into nucleus, translocation;positive regulation of canonical Wnt receptor signaling pathway;protein polyubiquitination;negative regulation of double-strand break repair;progesterone receptor signaling pathway",nucleus;cytoplasm,,,,,2.29E-04,3.85E-03,2.52E-04,1.82E-04,6.75E-01,+,,C, YES,
907,O95171,SCEL,Sciellin,NITRGQSLDNLIK,_GQS(ph)LDNLIK_,S369,+,24.39,23.49,23.04,22.88,,,22.54,21.83,,27.78,24.38,,,23.79,0.60,-0.30,-0.75,-0.91, , ,-1.25,-1.96, ,3.99,0.59, , ,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,1.08E-02,4.76E-02,1.81E-01,2.35E-02,4.99E-03,,,C, YES,
921,O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",KKRRTRSRSPESQ,_S(ph)RS(ph)PESQVIGENTK_,S305,,27.98,26.01,24.49,27.26,24.17,22.35,23.21,22.93,22.62,,23.11,,24.08,24.38,3.59,1.63,0.10,2.87,-0.21,-2.03,-1.17,-1.45,-1.76, ,-1.28, ,-0.31,mRNA processing;RNA splicing,nucleus,,,,,1.13E-03,1.06E-02,2.34E-04,6.15E-03,5.49E-01,,,C, YES,
922,O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",RRTRSRSPESQVI,_S(ph)RS(ph)PESQVIGENTK_,S307,,28.00,26.01,24.49,27.28,24.36,22.35,24.14,23.82,24.36,22.57,24.25,22.96,24.08,24.51,3.49,1.50,-0.03,2.76,-0.15,-2.16,-0.37,-0.69,-0.16,-1.95,-0.26,-1.55,-0.44,mRNA processing;RNA splicing,nucleus,,,,,1.33E-03,1.19E-02,1.47E-03,8.5E-04,6.34E-01,,,C, YES,
958,O95365,ZBTB7A,Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A),GAAAGDSDEESRA,_AGAAAGDS(ph)DEESRADDK_,S337,+,26.21,26.26,26.79,27.69,27.65,22.99,24.90,24.71,25.50,23.07,23.64,23.93,23.42,25.14,1.07,1.12,1.65,2.56,2.52,-2.14,-0.24,-0.43,0.36,-2.07,-1.49,-1.20,-1.72,"regulation of osteoclast differentiation;multicellular organismal development;cell differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,6.02E-03,3.11E-02,8.58E-02,1.65E-03,4.6E-02,,,C, YES,
963,O95391,SLU7,Pre-mRNA-splicing factor SLU7 (hSlu7),LVEQANSPKHQWG,_LVEQANS(ph)PK_,S215,+,24.66,25.06,25.22,26.54,22.08,22.45,23.60,22.12,24.66,22.66,22.61,23.66,21.86,23.63,1.03,1.43,1.59,2.91,-1.55,-1.18,-0.03,-1.51,1.03,-0.97,-1.02,0.04,-1.77,"intracellular protein transport;cellular response to stress;alternative mRNA splicing, via spliceosome;mRNA 3'-splice site recognition",small nuclear ribonucleoprotein complex;nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,2.03E-03,1.56E-02,2.11E-03,1.29E-03,6.61E-01,+,,C,,
966,O95400,CD2BP2,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),GKHSLDSDEEEDD,_HSLDS(ph)DEEEDDDDGGSSK_,S49,+,27.59,29.33,29.06,27.23,23.40,21.04,25.87,22.21,26.14,26.40,23.25,25.33,,25.57,2.02,3.76,3.49,1.66,-2.17,-4.54,0.30,-3.37,0.57,0.83,-2.32,-0.24, ,assembly of spliceosomal tri-snRNP;negative regulation of phosphatase activity,nucleoplasm;U5 snRNP;cytoplasm,,,,,2.32E-03,1.69E-02,5.54E-04,1.48E-02,2.69E-01,,,C, YES,+
968,O95400,CD2BP2,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),GPGQPSSPQRLDR,_GPGQPSS(ph)PQRLDR_,S195,+,27.34,27.64,28.00,27.42,26.85,26.40,27.32,26.54,27.15,24.21,25.88,26.58,24.42,26.60,0.74,1.04,1.41,0.82,0.25,-0.20,0.72,-0.06,0.56,-2.39,-0.72,-0.02,-2.17,assembly of spliceosomal tri-snRNP;negative regulation of phosphatase activity,nucleoplasm;U5 snRNP;cytoplasm,,,,,4.49E-03,2.52E-02,2.82E-01,1.62E-03,1.07E-02,,,C, YES,
993,O95453,PARN,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease),RMKKELSPAGSIS,_ELS(ph)PAGSISK_,S558,+,28.36,27.94,27.75,27.77,27.29,27.25,28.28,27.24,28.38,26.99,25.66,25.89,26.49,27.33,1.03,0.61,0.42,0.44,-0.04,-0.08,0.95,-0.09,1.05,-0.34,-1.67,-1.44,-0.84,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nuclear-transcribed mRNA poly(A) tail shortening;RNA modification;female gamete generation",cytosol;nucleolus;nucleus,,,,,7.04E-03,3.48E-02,5.06E-01,3.27E-03,9.12E-03,,,C, YES,
1035,O95785,WIZ,Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803),SPQLSLSPRPASP,_SPQLSLS(ph)PRPAS(ph)PK_,S193,+,26.16,25.00,25.57,25.32,,23.76,23.55,23.83,24.90,23.38,21.35,,,24.28,1.88,0.72,1.29,1.04, ,-0.52,-0.73,-0.45,0.61,-0.90,-2.93, , ,,nucleus,C2H2-type,,,,1.02E-02,4.58E-02,7.66E-02,3.27E-03,6.24E-02,,,C,,
1063,O96017,CHEK2,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),KILGETSLMRTLC,_ILGETS(ph)LM(ox)R_,S158,+,25.85,24.75,25.11,23.47,22.59,23.08,21.53,21.72,22.04,22.24,,21.33,22.89,23.05,2.80,1.70,2.06,0.42,-0.46,0.03,-1.52,-1.33,-1.01,-0.81, ,-1.72,-0.16,"regulation of protein catabolic process;double-strand break repair;cellular protein catabolic process;protein autophosphorylation;G2/M transition of mitotic cell cycle;spindle assembly involved in mitosis;positive regulation of transcription, DNA-dependent;intrinsic apoptotic signaling pathway in response to DNA damage;response to gamma radiation;transcription, DNA-dependent;replicative senescence;cell division;signal transduction involved in intra-S DNA damage checkpoint;DNA damage induced protein phosphorylation",PML body,,+,,,1.87E-03,1.49E-02,9.7E-04,2.38E-03,9.56E-01,,,C,,
1085,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SSRRGFSANSARL,_RGFS(ph)ANS(ph)AR_,S19,+,26.99,25.81,26.08,22.16,21.58,,21.80,22.32,,21.60,,19.96,,23.14,3.85,2.67,2.93,-0.99,-1.57, ,-1.34,-0.82, ,-1.55, ,-3.18, ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,5.12E-03,2.8E-02,6.88E-03,2.38E-03,3.73E-01,,,C, YES,
1087,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",ERGRLDSELRGMQ,_LDS(ph)ELR_,S208,+,27.71,27.40,27.94,,25.77,24.34,26.21,26.32,,23.82,24.68,,22.97,25.72,1.99,1.69,2.22, ,0.05,-1.38,0.50,0.61, ,-1.90,-1.03, ,-2.75,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,1.36E-03,1.21E-02,2.75E-02,3.76E-04,2.06E-02,,,C, YES,
1101,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],SRGRASSHSSQTQ,_ASS(ph)HSSQTQGGGSVTK_,S404,+,26.35,25.81,26.63,25.53,20.10,20.83,20.83,20.86,21.98,18.30,,21.96,19.64,22.40,3.95,3.41,4.23,3.13,-2.31,-1.57,-1.57,-1.54,-0.42,-4.10, ,-0.44,-2.76,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,4.58E-05,1.32E-03,6.63E-05,3.48E-05,3.01E-01,,,C, YES,
1110,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],RLRLSPSPTSQRS,_LRLS(ph)PS(ph)PTSQR_,S392,+,32.65,30.98,31.57,30.56,30.84,29.07,29.63,30.85,28.50,28.89,27.51,29.57,27.02,29.82,2.83,1.16,1.75,0.74,1.02,-0.75,-0.19,1.04,-1.32,-0.93,-2.31,-0.25,-2.80,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,5.99E-03,3.1E-02,7.55E-02,1.63E-03,5.2E-02,,,C, YES,+
1126,P02765,AHSG,Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A;Alpha-2-HS-glycoprotein chain B],CDSSPDSAEDVRK,_CDSSPDS(ph)AEDVRK_,S138,+,24.66,27.54,26.43,25.00,21.42,23.44,22.04,20.74,22.58,21.19,21.87,22.35,21.09,23.10,1.55,4.43,3.33,1.90,-1.68,0.34,-1.07,-2.36,-0.53,-1.91,-1.23,-0.75,-2.01,negative regulation of insulin receptor signaling pathway;male gonad development;pinocytosis;regulation of inflammatory response;cerebral cortex development;negative regulation of bone mineralization;positive regulation of bone resorption;negative regulation of cell growth;cellular response to insulin stimulus;organ regeneration;positive regulation of phagocytosis;acute-phase response;skeletal system development;ossification,extracellular space;extracellular matrix;protein complex,,,,,3.75E-05,1.21E-03,5.02E-05,3.05E-05,5.73E-01,,,C, YES,
1159,P04920,SLC4A2,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),RALTQPSPVSTPS,_ALTQPS(ph)PVSTPSSVQFFLQEDDSADRK_,S130,+,23.28,,,23.04,,,24.71,23.47,,26.89,26.89,26.53,25.96,25.09,-1.82, , ,-2.05, , ,-0.39,-1.63, ,1.79,1.79,1.43,0.87,bicarbonate transport,integral to membrane;basolateral plasma membrane;plasma membrane,,,,,1.6E-03,1.33E-02,2.67E-01,4.82E-04,4.37E-03,,,C, YES,
1250,P06748,NPM1,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),TPKGPSSVEDIKA,_GPSS(ph)VEDIK_,S243,+,27.20,26.36,,26.46,23.05,23.76,24.17,22.74,24.34,23.59,22.69,22.73,22.83,24.16,3.04,2.20, ,2.30,-1.11,-0.40,0.01,-1.42,0.18,-0.57,-1.47,-1.43,-1.33,negative regulation of apoptotic process;negative regulation of centrosome duplication;negative regulation of cell proliferation;protein oligomerization;regulation of endodeoxyribonuclease activity;positive regulation of NF-kappaB transcription factor activity;DNA repair;intracellular protein transport;CENP-A containing nucleosome assembly at centromere;virus-host interaction;regulation of centriole replication;cell aging;centrosome cycle;ribosome assembly;signal transduction;nucleocytoplasmic transport;regulation of endoribonuclease activity,nucleoplasm;ribonucleoprotein complex;nucleolus;spindle pole centrosome,,,,,2.16E-05,8.37E-04,5.49E-05,1.13E-05,2.12E-01,,+,C, YES,
1280,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),EEQSSSSVKKDET,_SEEEQSSSS(ph)VKKDETNVK_,S228,+,26.29,25.79,23.63,26.24,22.51,21.89,24.22,22.48,24.84,23.13,,22.97,21.67,23.81,2.49,1.98,-0.17,2.44,-1.29,-1.92,0.42,-1.33,1.04,-0.68, ,-0.84,-2.14,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,4.3E-03,2.47E-02,4.39E-03,2.6E-03,4.96E-01,+,,C, YES,
1296,P08559,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",MSDPGVSYRTREE,_YHGHS(ph)M(ox)SDPGVS(ph)YR_,S300,+,25.04,27.24,,28.18,24.64,,22.35,24.62,20.30,,21.03,20.71,,23.79,1.25,3.45, ,4.40,0.85, ,-1.44,0.83,-3.49, ,-2.76,-3.08, ,regulation of acetyl-CoA biosynthetic process from pyruvate;pyruvate metabolic process;glycolysis,mitochondrial matrix,,,,,1.79E-03,1.43E-02,4.73E-03,7.45E-04,1.14E-01,,,C, YES,
1337,P08670,VIM,Vimentin,RSVSSSSYRRMFG,_SVSSSS(ph)YRR_,S10,+,19.73,24.12,24.09,26.76,18.13,20.12,19.68,20.64,19.59,,20.40,25.53,23.48,21.86,-2.13,2.27,2.23,4.91,-3.72,-1.73,-2.18,-1.22,-2.27, ,-1.46,3.68,1.62,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,1.04E-02,4.63E-02,4.55E-03,6.91E-01,1.85E-02,,,C,,
1374,P09601,HMOX1,Heme oxygenase 1 (HO-1) (EC 1.14.99.3),HDTKDQSPSRAPG,_DQS(ph)PSRAPGLR_,S229,+,25.78,28.54,28.84,29.29,23.68,22.38,21.45,,23.24,22.10,22.43,26.10,23.87,24.81,0.97,3.73,4.04,4.48,-1.13,-2.43,-3.36, ,-1.57,-2.71,-2.38,1.29,-0.94,negative regulation of apoptotic process;transmembrane transport;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of smooth muscle cell proliferation;response to estrogen stimulus;cell death;negative regulation of leukocyte migration;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;positive regulation of vasodilation;low-density lipoprotein particle clearance;regulation of angiogenesis;negative regulation of mast cell cytokine production;cellular iron ion homeostasis;cellular response to cadmium ion;heme catabolic process;response to nicotine;negative regulation of mast cell degranulation;cellular response to hypoxia;response to hydrogen peroxide;negative regulation of neuron apoptotic process;positive regulation of chemokine biosynthetic process;intracellular protein kinase cascade;negative regulation of DNA binding;positive regulation of I-kappaB kinase/NF-kappaB cascade;wound healing involved in inflammatory response;cellular response to nutrient;heme oxidation;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of sequence-specific DNA binding transcription factor activity;excretion;endothelial cell proliferation;angiogenesis;small molecule metabolic process;small GTPase mediated signal transduction;positive regulation of angiogenesis;erythrocyte homeostasis;protein homooligomerization;regulation of blood pressure;smooth muscle hyperplasia;positive regulation of smooth muscle cell proliferation,cytosol;caveola;extracellular space;nucleolus;nucleus;endoplasmic reticulum membrane,,,,,1.48E-04,2.78E-03,6.61E-05,4.43E-04,3.33E-01,,,C, YES,+
1378,P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1),___MSKSESPKEP,_S(ph)ES(ph)PKEPEQLRK_,S4,+,27.01,28.21,28.41,26.98,24.50,,21.42,,23.49,24.47,20.06,,,24.95,2.06,3.26,3.46,2.03,-0.45, ,-3.53, ,-1.46,-0.48,-4.89, , ,"RNA export from nucleus;nuclear import;mRNA splicing, via spliceosome;alternative mRNA splicing, via spliceosome;virus-host interaction;mRNA transport",nucleoplasm;intermediate filament cytoskeleton;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,1.47E-03,1.26E-02,1.45E-03,9.37E-04,4.94E-01,+,,C, YES,
1431,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",EEENEESDNEKET,_VPDEEENEES(ph)DNEKETEK_,S1106,+,28.25,28.30,29.14,26.67,25.71,27.42,28.17,27.19,26.86,26.43,22.92,25.03,25.57,26.74,1.51,1.55,2.40,-0.07,-1.04,0.68,1.43,0.45,0.12,-0.31,-3.82,-1.72,-1.17,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,9.14E-03,4.2E-02,4.21E-01,3.74E-03,1.42E-02,,,C, YES,
1455,P12694,BCKDHA,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)",YRIGHHSTSDDSS,_IGHHS(ph)TSDDSSAYR_,S337,+,25.84,26.82,25.59,25.70,24.03,23.66,,22.90,23.18,21.83,23.89,23.27,22.41,24.09,1.75,2.73,1.49,1.60,-0.07,-0.43, ,-1.19,-0.91,-2.27,-0.21,-0.83,-1.68,response to glucocorticoid stimulus;branched-chain amino acid catabolic process;response to cAMP;response to nutrient;cellular nitrogen compound metabolic process,mitochondrial alpha-ketoglutarate dehydrogenase complex,,,,,1.87E-04,3.3E-03,5E-04,7.41E-05,3.33E-01,,,C, YES,
1483,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",ERGRLDSELRNMQ,_LDS(ph)ELR_,SNaN,+,27.71,27.40,27.94,,25.77,24.34,26.21,26.32,,21.04,24.68,,22.97,25.44,2.27,1.96,2.50, ,0.33,-1.10,0.78,0.89, ,-4.40,-0.76, ,-2.47,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,9.86E-04,1E-02,6.32E-02,2.94E-04,6.55E-03,,,C, YES,+
1531,P15056,BRAF,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),KIHRSASEPSLNR,_SAS(ph)EPSLNR_,S942,+,24.81,25.22,,26.54,22.57,21.44,22.12,22.90,21.13,,22.42,22.23,,23.14,1.68,2.09, ,3.40,-0.57,-1.70,-1.02,-0.24,-2.01, ,-0.72,-0.91, ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;fibroblast growth factor receptor signaling pathway;positive regulation of gene expression;small GTPase mediated signal transduction;response to cAMP;positive regulation of ERK1 and ERK2 cascade;cellular response to calcium ion;response to peptide hormone stimulus;activation of MAPKK activity;nerve growth factor receptor signaling pathway;synaptic transmission;negative regulation of neuron apoptotic process;organ morphogenesis;response to epidermal growth factor stimulus,cytosol;plasma membrane;nucleus,,+,,,3.24E-04,4.82E-03,8.83E-05,1.22E-03,6.87E-01,,+,C,,
1543,P15408,FOSL2,Fos-related antigen 2 (FRA-2),RRDEQLSPEEEEK,_RRDEQLS(ph)PEEEEK_,S81,+,25.21,26.17,26.63,26.40,24.07,24.59,24.69,25.42,25.38,23.65,22.30,23.31,21.98,24.60,0.61,1.57,2.03,1.80,-0.53,-0.01,0.09,0.82,0.78,-0.95,-2.30,-1.29,-2.62,"cell death;positive regulation of fibroblast proliferation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,bZIP,,,,1.58E-04,2.92E-03,5.03E-02,4.39E-05,1.69E-03,,,C, YES,
1545,P15408,FOSL2,Fos-related antigen 2 (FRA-2),SPEERRSPPAPGL,_S(ph)PPAPGLQPMR_,S161,+,29.57,29.14,28.91,29.70,28.76,28.54,27.94,27.99,28.77,28.13,26.74,28.05,27.68,28.46,1.12,0.68,0.45,1.24,0.31,0.09,-0.51,-0.47,0.31,-0.32,-1.72,-0.41,-0.78,"cell death;positive regulation of fibroblast proliferation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,bZIP,,,,7.93E-03,3.83E-02,4.05E-02,2.27E-03,1.28E-01,,,C, YES,
1561,P15923,TCF3,Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1),GAPGALSPSYDGG,_AGAPGALS(ph)PSYDGGLHGLQSK_,S379,+,22.32,22.26,22.26,,25.54,24.98,24.44,24.56,25.47,24.86,,23.82,,24.05,-1.73,-1.79,-1.79, ,1.49,0.93,0.39,0.51,1.42,0.81, ,-0.23, ,"G1 phase of mitotic cell cycle;histone H4 acetylation;response to drug;positive regulation of cell cycle;T cell differentiation in thymus;Peyer's patch development;immunoglobulin V(D)J recombination;response to lipopolysaccharide;B cell lineage commitment;positive regulation of transcription from RNA polymerase II promoter;positive regulation of muscle cell differentiation;protein stabilization;natural killer cell differentiation;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of neuron differentiation;positive regulation of B cell proliferation;cell development;histone H3 acetylation;transcription, DNA-dependent;muscle cell differentiation",transcription factor complex;nucleus;nuclear nucleosome;protein complex;cytoplasm,bHLH,,,,9.61E-04,9.93E-03,1.94E-04,7.49E-03,3.09E-01,,,C,,
1597,P16104,H2AFX,Histone H2AX (H2a/x) (Histone H2A.X),KKATQASQEY___,_KATQAS(ph)QEY_,S140,+,23.77,24.29,23.46,25.42,20.43,19.85,,20.92,21.06,,,,20.03,22.14,1.63,2.16,1.32,3.28,-1.71,-2.29, ,-1.21,-1.07, , , ,-2.11,meiosis;spermatogenesis;nucleosome assembly;response to ionizing radiation;double-strand break repair via homologous recombination;DNA damage checkpoint;positive regulation of DNA repair,nucleoplasm;nuclear chromatin;condensed nuclear chromosome;XY body;male germ cell nucleus;replication fork;nucleosome,,,,,2.3E-04,3.86E-03,5.43E-05,8.33E-04,5.9E-01,,,C, YES,
1619,P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),ELEKRASGQAFEL,_RAS(ph)GQAFELILSPR_,S16,+,22.16,,,20.58,25.50,,24.99,24.14,23.30,24.53,24.98,26.59,25.02,24.18,-2.02, , ,-3.60,1.32, ,0.81,-0.04,-0.88,0.36,0.80,2.41,0.84,mitotic spindle organization;axonogenesis;response to virus;negative regulation of microtubule polymerization;microtubule depolymerization;positive regulation of cellular component movement;intracellular signal transduction,cytosol;microtubule;intracellular,,,,,1.24E-03,1.14E-02,2.76E-03,4.83E-04,2.65E-01,,,C, YES,+
1623,P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),AEERRKSHEAEVL,_S(ph)HEAEVLK_,S63,+,25.91,28.50,29.15,28.32,21.64,21.92,25.79,23.76,24.18,23.49,23.40,26.00,,25.17,0.74,3.33,3.98,3.14,-3.53,-3.25,0.62,-1.41,-0.99,-1.68,-1.77,0.83, ,mitotic spindle organization;axonogenesis;response to virus;negative regulation of microtubule polymerization;microtubule depolymerization;positive regulation of cellular component movement;intracellular signal transduction,cytosol;microtubule;intracellular,,,,,1.53E-03,1.28E-02,4.19E-04,6.35E-03,4.14E-01,,,C, YES,
1658,P17480,UBTF,Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1) (UBF-1),RGKLPESPKRAEE,_GKLPES(ph)PK_,S447,+,24.96,25.11,25.38,24.98,,,21.62,,,21.13,18.82,20.10,,22.76,2.20,2.35,2.62,2.22, , ,-1.14, , ,-1.63,-3.94,-2.67, ,transcription initiation from RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter;termination of RNA polymerase I transcription;positive regulation of transcription from RNA polymerase I promoter,nucleoplasm;nucleolus,HMG-box,,,,1.63E-04,3E-03,5.19E-03,1.44E-05,1.42E-01,,,C, YES,
1677,P17844,DDX5,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),_MSGYSSDRDRGR,_(ac)SGYSS(ph)DRDR_,S6,+,24.75,24.93,24.66,27.02,21.96,20.91,21.42,21.65,21.31,,21.39,22.32,,22.94,1.81,1.99,1.73,4.09,-0.97,-2.03,-1.52,-1.29,-1.63, ,-1.55,-0.62, ,"regulation of viral genome replication;positive regulation of DNA damage response, signal transduction by p53 class mediator;in utero embryonic development;cell growth;regulation of osteoblast differentiation;intrinsic apoptotic signaling pathway by p53 class mediator;negative regulation of transcription from RNA polymerase II promoter;positive regulation of intracellular estrogen receptor signaling pathway;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of androgen receptor signaling pathway;regulation of skeletal muscle cell differentiation;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter",nucleolus;catalytic step 2 spliceosome,,,,,4.67E-05,1.33E-03,9.98E-06,3.47E-04,5.85E-01,+,+,C, YES,
1708,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),KSVESTSPEPSKI,_SVESTS(ph)PEPSK_,S283,+,25.50,25.37,24.84,25.62,26.14,,23.98,23.88,25.08,23.23,22.95,23.23,22.81,24.38,1.12,0.98,0.45,1.23,1.75, ,-0.41,-0.51,0.70,-1.16,-1.43,-1.16,-1.58,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,2.83E-03,1.92E-02,2.77E-01,8.68E-04,8.46E-03,,,C, YES,
1713,P18615,NELFE,Negative elongation factor E (NELF-E) (RNA-binding protein RD),PFQRSISADDDLQ,_SIS(ph)ADDDLQESSR_,S115,+,27.92,26.26,,26.57,23.62,24.44,,23.96,,,24.07,23.68,,25.07,2.86,1.20, ,1.50,-1.44,-0.62, ,-1.11, , ,-1.00,-1.39, ,negative regulation of transcription elongation from RNA polymerase II promoter;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,mitochondrion;NELF complex,,,,,2.24E-03,1.67E-02,1.33E-03,2.1E-03,8.62E-01,,,C, YES,
1727,P18887,XRCC1,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),TSKPQESPKGKRK,_AIGSTSKPQES(ph)PK_,S210,+,24.66,25.16,26.10,23.49,20.94,,22.29,20.29,21.56,22.77,18.62,21.14,20.55,22.30,2.37,2.87,3.80,1.20,-1.36, ,-0.01,-2.01,-0.73,0.47,-3.67,-1.16,-1.75,single strand break repair;base-excision repair;response to drug;response to hypoxia;response to organic substance,nucleoplasm,,,,,8.14E-03,3.91E-02,1.04E-02,3.54E-03,6.02E-01,,,C, YES,
1741,P19174,PLCG1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)",GRAREGSFESRYQ,_AREGS(ph)FESR_,S1248,+,24.84,23.94,22.43,25.62,21.85,20.31,,21.88,20.77,,21.73,23.10,,22.65,2.19,1.29,-0.21,2.97,-0.80,-2.34, ,-0.76,-1.88, ,-0.92,0.45, ,protein secretion;fibroblast growth factor receptor signaling pathway;calcium ion transport;positive regulation of epithelial cell migration;blood coagulation;positive regulation of blood vessel endothelial cell migration;inositol trisphosphate biosynthetic process;activation of MAPKK activity;phospholipid catabolic process;cytokine-mediated signaling pathway;virus-host interaction;intracellular signal transduction;response to morphine;response to gravity;activation of phospholipase C activity;in utero embryonic development;axon guidance;cellular response to epidermal growth factor stimulus;positive regulation of angiogenesis;T cell receptor signaling pathway;epidermal growth factor receptor signaling pathway;response to hydrogen peroxide;nerve growth factor receptor signaling pathway;leukocyte migration,neuron projection;cytosol;signalosome;plasma membrane;lamellipodium;ruffle,,,,,4.45E-03,2.52E-02,8.48E-04,4.56E-02,2.06E-01,+,,C, YES,
1754,P19338,NCL,Nucleolin (Protein C23),AKKVVVSPTKKVA,_KVVVS(ph)PTK_,S67,+,30.07,31.23,32.18,29.03,26.81,23.77,26.11,26.15,25.18,26.57,24.38,26.55,24.26,27.10,2.97,4.13,5.08,1.93,-0.29,-3.33,-0.99,-0.95,-1.92,-0.53,-2.72,-0.55,-2.84,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,4.78E-04,6.26E-03,3.99E-04,4.51E-04,8.6E-01,,,C, YES,
1777,P20700,LMNB1,Lamin-B1,GPTTPLSPTRLSR,_AGGPTTPLS(ph)PTR_,S23,+,28.30,26.03,26.00,26.08,26.42,25.50,25.91,25.81,,23.73,24.18,23.92,25.17,25.59,2.71,0.44,0.41,0.49,0.83,-0.08,0.33,0.22, ,-1.86,-1.41,-1.66,-0.42,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,4.25E-03,2.46E-02,2.33E-01,1.21E-03,1.49E-02,,,C, YES,
1779,P20700,LMNB1,Lamin-B1,RLKLSPSPSSRVT,_LSPS(ph)PSSR_,S393,+,26.02,26.17,26.48,26.45,27.85,24.06,24.13,25.42,25.06,23.91,22.40,23.73,22.85,24.96,1.06,1.20,1.52,1.49,2.89,-0.90,-0.84,0.45,0.09,-1.05,-2.57,-1.23,-2.11,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,2.84E-03,1.92E-02,2.19E-01,9.58E-04,8.73E-03,,,C, YES,
1781,P20700,LMNB1,Lamin-B1,VTVSRASSSRSVR,_VTVSRAS(ph)SSR_,S404,+,24.53,25.79,26.54,26.16,22.64,22.63,22.95,23.46,23.27,21.41,21.23,23.02,22.09,23.52,1.01,2.27,3.03,2.64,-0.87,-0.88,-0.57,-0.06,-0.25,-2.11,-2.29,-0.49,-1.43,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,2.21E-04,3.76E-03,1.36E-03,6.96E-05,9.77E-02,,,C, YES,
1787,P20810,CAST,Calpastatin (Calpain inhibitor) (Sperm BS-17 component),GQKPAASPRPRRA,_(ac)SQPGQKPAAS(ph)PRPR_,S11,,25.98,27.59,28.04,26.58,25.73,23.28,24.39,25.55,22.85,24.56,24.55,25.08,21.95,25.09,0.90,2.50,2.95,1.50,0.64,-1.81,-0.70,0.46,-2.24,-0.52,-0.54,-0.01,-3.13,,,,,,,4.28E-03,2.47E-02,4.17E-03,2.59E-03,6.78E-01,,,C, YES,
1794,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),RDSKRDSLEEGEL,_RDS(ph)LEEGELR_,S47,+,,25.14,25.52,23.96,22.32,22.83,,,,21.93,22.20,22.84,22.33,23.23, ,1.91,2.29,0.73,-0.91,-0.39, , , ,-1.30,-1.03,-0.39,-0.90,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,6.71E-03,3.35E-02,1.21E-02,2E-03,7.19E-01,,,C,,
1795,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),ASHWSRSPPRPPR,_S(ph)PPRPPR_,S222,+,25.15,26.01,26.65,25.23,,20.77,21.69,21.92,21.73,,,,19.85,23.22,1.93,2.79,3.42,2.01, ,-2.45,-1.53,-1.30,-1.49, , , ,-3.37,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,4.37E-05,1.28E-03,2.63E-05,6.83E-05,9.77E-02,,,C,,
1832,P22087,FBL,rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen),YGEKRVSISEGDD,_RVS(ph)ISEGDDKIEYR_,S63,+,28.03,28.66,29.45,26.81,25.79,26.14,25.02,26.31,25.37,25.74,25.20,26.26,26.59,26.57,1.47,2.09,2.89,0.24,-0.78,-0.43,-1.55,-0.26,-1.20,-0.83,-1.37,-0.31,0.02,tRNA processing;snoRNA metabolic process;rRNA processing,granular component;box C/D snoRNP complex;Cajal body,,,,,8.21E-03,3.93E-02,3.68E-03,1.1E-02,7.14E-01,,,C, YES,+
1849,P23193,TCEA1,Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o),AITSQNSPEAREE,_KKEPAITSQNS(ph)PEAR_,S100,+,25.42,26.98,27.25,25.88,22.91,22.52,23.97,23.44,23.80,22.40,21.69,22.08,19.99,23.72,1.70,3.26,3.53,2.16,-0.81,-1.20,0.25,-0.28,0.08,-1.31,-2.03,-1.64,-3.73,"regulation of DNA-dependent transcription, elongation;transcription-coupled nucleotide-excision repair;erythrocyte differentiation;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;nucleolus,Other TF domain,,,,5.02E-06,3.37E-04,1.44E-04,1.28E-06,8.38E-03,,,C, YES,+
1866,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),PRERHPSWRSEET,_ERHPS(ph)WR_,S406,+,25.40,26.11,26.41,25.76,23.64,21.92,22.86,23.64,20.74,21.80,21.98,23.38,18.38,23.23,2.17,2.88,3.18,2.53,0.41,-1.31,-0.38,0.41,-2.49,-1.43,-1.26,0.14,-4.85,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,4.45E-04,5.96E-03,1.56E-03,1.63E-04,1.9E-01,,,C, YES,
1869,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),RRESEKSLENETL,_S(ph)LENETLNK_,S445,+,31.59,30.86,31.03,31.83,25.41,25.73,31.41,26.36,29.22,29.32,28.73,28.93,25.79,28.94,2.65,1.92,2.09,2.89,-3.53,-3.21,2.47,-2.58,0.28,0.38,-0.21,-0.01,-3.15,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,1.04E-02,4.65E-02,4.17E-03,1.65E-02,6.1E-01,,,C, YES,
1872,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),ERSRTGSESSQTG,_TGS(ph)ESSQTGTSTTSSR_,S422,+,24.95,23.49,24.33,23.85,19.56,21.23,20.97,20.55,,18.49,21.81,20.54,,21.80,3.15,1.70,2.53,2.05,-2.23,-0.57,-0.83,-1.24, ,-3.30,0.01,-1.26, ,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,8.52E-03,4.01E-02,6.47E-03,5.68E-03,7.65E-01,,,C, YES,
1888,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PTYSPTSPKYSPT,_YSPTS(ph)PTYSPTS(ph)PK_,S1920,+,26.37,25.35,25.42,24.84,23.99,,,,23.32,23.02,,22.51,,24.35,2.02,1.00,1.06,0.48,-0.36, , , ,-1.03,-1.33, ,-1.84, ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,9.67E-03,4.39E-02,2.52E-02,2.76E-03,2.93E-01,,,C, YES,+
1918,P26368,U2AF2,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),HGGLIRSPRHEKK,_GAKEEHGGLIRS(ph)PR_,S79,+,26.99,28.27,28.24,27.60,27.68,26.66,27.02,26.56,27.34,26.18,26.14,26.39,24.43,26.88,0.10,1.39,1.36,0.71,0.80,-0.22,0.14,-0.32,0.46,-0.71,-0.75,-0.49,-2.45,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;spliceosomal complex,,,,,8.73E-03,4.08E-02,1.91E-01,2.69E-03,3E-02,+,,C, YES,
1922,P26373,RPL13,60S ribosomal protein L13 (Breast basic conserved protein 1),PKKGDSSAEELKL,_KGDSS(ph)AEELK_,S140,+,22.93,24.68,24.56,24.22,,19.44,19.60,20.25,,,,20.75,,22.05,0.88,2.62,2.50,2.17, ,-2.62,-2.46,-1.80, , , ,-1.31, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,3.04E-04,4.6E-03,4.04E-05,4.91E-03,3.34E-01,,,C, YES,
1953,P27824,CANX,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),LEEKQKSDAEEDG,_S(ph)DAEEDGGTVS(ph)QEEEDRKPK_,S554,+,29.82,31.97,32.47,29.52,26.65,27.06,28.51,25.97,28.88,30.10,28.08,28.31,26.69,28.77,1.05,3.20,3.70,0.75,-2.13,-1.71,-0.27,-2.80,0.11,1.33,-0.69,-0.46,-2.08,protein secretion;antigen processing and presentation of peptide antigen via MHC class I;aging;synaptic vesicle endocytosis;post-translational protein modification;protein folding;clathrin-mediated endocytosis;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuronal cell body;axon;ribosome;integral to lumenal side of endoplasmic reticulum membrane;endoplasmic reticulum lumen;rough endoplasmic reticulum;dendrite cytoplasm;dendritic spine;melanosome,,,,,3.5E-03,2.16E-02,1.08E-03,1.41E-02,2.93E-01,,,C, YES,
1998,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),STSKAVSPPHLDG,_AVS(ph)PPHLDGPPS(ph)PRS(ph)PVIGSEVFLPNSNHVASGAGEAEER_,S518,+,28.32,28.81,27.93,28.28,27.30,25.29,25.87,26.69,27.71,25.63,22.56,,24.42,26.57,1.75,2.24,1.37,1.72,0.73,-1.28,-0.70,0.12,1.14,-0.94,-4.01, ,-2.15,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,2.57E-04,4.11E-03,1.54E-02,7.07E-05,6.04E-03,+,,C, YES,+
1999,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),HLDGPPSPRSPVI,_AVS(ph)PPHLDGPPS(ph)PRS(ph)PVIGSEVFLPNSNHVASGAGEAEER_,S527,+,28.42,28.94,28.08,28.43,28.53,27.18,26.85,27.54,28.09,26.79,25.84,24.34,26.28,27.33,1.09,1.61,0.75,1.10,1.20,-0.15,-0.48,0.21,0.76,-0.54,-1.49,-2.99,-1.05,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,1.12E-03,1.06E-02,1.21E-01,3.36E-04,6.01E-03,+,,C, YES,
2011,P29692,EEF1D,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),PQTQHVSPMRQVE,_ATAPQTQHVS(ph)PM(ox)R_,S133,+,27.88,28.78,26.55,28.12,27.59,25.77,25.79,27.37,24.54,24.81,24.62,25.21,24.41,26.27,1.61,2.52,0.28,1.86,1.32,-0.50,-0.48,1.11,-1.72,-1.45,-1.65,-1.06,-1.85,translational elongation;positive regulation of I-kappaB kinase/NF-kappaB cascade,cytosol;eukaryotic translation elongation factor 1 complex,Other TF domain,,,,1.68E-03,1.38E-02,1.76E-02,4.42E-04,6.08E-02,,,C, YES,
2034,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],RAYRPPSGEKWSK,_AYRPPS(ph)GEK_,S79,+,24.82,25.88,26.00,25.50,21.87,21.88,22.26,21.11,21.60,21.61,20.70,21.48,21.85,22.81,2.01,3.07,3.19,2.69,-0.94,-0.93,-0.56,-1.70,-1.21,-1.20,-2.12,-1.34,-0.96,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,3.65E-07,1.13E-04,5.64E-07,3.76E-07,4.86E-01,,,C,,
2064,P31930,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",TKNRPGSALEKEV,_NRPGS(ph)ALEK_,S107,+,23.07,25.27,24.83,24.38,21.08,21.52,21.07,21.59,21.43,21.67,,21.42,20.89,22.35,0.71,2.92,2.48,2.03,-1.28,-0.83,-1.28,-0.76,-0.92,-0.68, ,-0.93,-1.46,"small molecule metabolic process;mitochondrial electron transport, ubiquinol to cytochrome c;respiratory electron transport chain;aerobic respiration;proteolysis;oxidative phosphorylation;response to activity;response to alkaloid",mitochondrial respiratory chain;mitochondrial respiratory chain complex III,,,,,7.24E-05,1.74E-03,3.85E-05,1.37E-04,9.86E-01,,,C, YES,
2069,P31949,S100A11,Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11),_MAKISSPTETER,_ISS(ph)PTETER_,S6,+,25.33,23.91,23.81,25.10,22.15,,21.12,23.28,20.90,20.02,22.82,20.54,20.88,22.49,2.84,1.43,1.32,2.61,-0.33, ,-1.37,0.79,-1.59,-2.47,0.33,-1.95,-1.61,signal transduction;negative regulation of cell proliferation;negative regulation of DNA replication,nucleus;ruffle;cytoplasm,,,,,6.09E-04,7.35E-03,1.86E-03,2.06E-04,2.82E-01,,,C, YES,
2196,P40123,CAP2,Adenylyl cyclase-associated protein 2 (CAP 2),HTPSPTSPKSYPS,_SHTPSPTS(ph)PK_,S312,+,22.30,24.75,25.59,24.74,21.00,19.73,21.21,21.91,,19.62,,22.57,,22.34,-0.04,2.41,3.25,2.40,-1.34,-2.61,-1.14,-0.43, ,-2.73, ,0.23, ,signal transduction;establishment or maintenance of cell polarity;activation of adenylate cyclase activity;cytoskeleton organization;axon guidance,plasma membrane,,,,,8.19E-03,3.93E-02,2.87E-03,1.31E-02,9.02E-01,,+,C, YES,
2215,P41212,ETV6,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),NMIRRLSPAERAQ,_RLS(ph)PAER_,S213,+,26.38,27.45,27.64,26.09,23.42,23.72,22.11,22.35,,22.19,,,22.05,24.34,2.04,3.11,3.30,1.75,-0.92,-0.62,-2.23,-1.99, ,-2.15, , ,-2.29,"cell differentiation;transcription, DNA-dependent",nucleus,Other TF domain,,,,2.06E-05,8.19E-04,1.82E-05,2.24E-05,2.98E-01,,,C, YES,
2223,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",REQGTESRSSTPL,_LREQGTES(ph)R_,S156,,23.90,23.52,23.52,25.51,19.18,19.81,20.82,20.70,20.06,,,22.27,,21.93,1.97,1.59,1.59,3.58,-2.75,-2.11,-1.11,-1.23,-1.87, , ,0.34, ,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,9.16E-03,4.21E-02,1.11E-03,3.84E-01,1.23E-01,,,C, YES,
2259,P42696,RBM34,RNA-binding protein 34 (RNA-binding motif protein 34),KRKRKRSVQEGEN,_S(ph)VQEGENPDDGVR_,S12,+,26.07,24.89,23.40,27.20,22.86,,,,21.97,,22.27,22.31,,23.87,2.20,1.02,-0.47,3.33,-1.01, , , ,-1.90, ,-1.60,-1.56, ,,nucleolus,,,,,1.08E-02,4.76E-02,8.2E-03,6.53E-03,9.12E-01,,,C,,
2270,P43243,MATR3,Matrin-3,SRKRSYSPDGKES,_SYS(ph)PDGKESPSDKK_,S598,+,25.22,27.18,27.67,27.64,26.75,23.90,23.09,25.44,23.25,20.92,,24.19,23.06,24.86,0.36,2.32,2.81,2.78,1.89,-0.97,-1.77,0.58,-1.61,-3.94, ,-0.67,-1.80,,nuclear inner membrane;nuclear matrix,,,,,4.68E-03,2.6E-02,2.75E-02,1.47E-03,8.65E-02,,,C, YES,
2408,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),RLRRDYSYERVGP,_DYS(ph)YER_,S1014,,22.71,24.33,23.53,25.33,,21.36,19.93,,21.04,,20.95,,20.22,22.15,0.55,2.18,1.37,3.18, ,-0.80,-2.23, ,-1.12, ,-1.20, ,-1.94,,nucleus;cytoplasm,,,,,1.42E-03,1.23E-02,8.43E-04,1.44E-03,8.4E-01,,,C, YES,
2414,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),TASETRSEGSEYE,_S(ph)EGS(ph)EYEEIPK_,S1089,+,26.61,26.83,26.62,26.10,23.61,,25.58,,23.78,24.46,24.83,23.59,22.38,24.94,1.66,1.88,1.67,1.16,-1.33, ,0.63, ,-1.16,-0.49,-0.11,-1.36,-2.56,,nucleus;cytoplasm,,,,,3.69E-03,2.23E-02,8.36E-03,1.12E-03,4.8E-01,,,C, YES,
2422,P48960,CD97,CD97 antigen (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: CD97 antigen subunit alpha;CD97 antigen subunit beta],TRALRASESGI__,_ALRAS(ph)ESGI_,S703,+,28.52,27.48,27.78,27.24,24.59,24.08,24.13,24.32,25.74,26.15,24.60,25.73,25.09,25.80,2.72,1.67,1.97,1.43,-1.21,-1.73,-1.67,-1.49,-0.06,0.34,-1.20,-0.08,-0.71,neuropeptide signaling pathway;inflammatory response;immune response;cell adhesion;cellular component movement;cell-cell signaling,extracellular space;integral to plasma membrane,,,,,8.84E-05,1.95E-03,2.57E-05,8.56E-04,1.41E-01,,,C, YES,
2442,P49207,RPL34,60S ribosomal protein L34,TYRRRLSYNTASN,_RLS(ph)YNTASNK_,S12,+,26.77,27.55,27.84,29.16,24.44,22.65,24.32,24.73,,22.32,24.86,26.37,21.10,25.18,1.59,2.38,2.67,3.98,-0.74,-2.52,-0.85,-0.44, ,-2.86,-0.31,1.20,-4.08,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,1.4E-03,1.23E-02,1.67E-03,7.84E-04,7.1E-01,,,C, YES,+
2447,P49321,NASP,Nuclear autoantigenic sperm protein (NASP),QGATEKSPEDKVQ,_VAQGATEKS(ph)PEDK_,S451,+,23.33,22.89,23.07,22.68,,19.75,20.52,19.57,21.20,,,20.06,19.84,21.29,2.04,1.60,1.78,1.39, ,-1.54,-0.77,-1.72,-0.09, , ,-1.23,-1.45,cell proliferation;blastocyst development;protein transport;cell cycle;DNA replication;histone exchange,nucleus;cytoplasm,,,,,4.23E-04,5.84E-03,2.42E-04,5.34E-04,6.42E-01,,,C, YES,
2458,P49585,PCYT1A,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),TRERSPSPSFRWP,_SPS(ph)PSFR_,S331,+,27.88,25.37,23.28,26.52,23.25,23.79,22.87,23.28,21.78,,22.67,23.03,22.54,23.86,4.02,1.52,-0.57,2.66,-0.61,-0.07,-0.98,-0.57,-2.08, ,-1.18,-0.82,-1.32,response to abiotic stimulus,cytosol;glycogen granule;endoplasmic reticulum membrane,,,,,2.07E-03,1.58E-02,1.35E-03,2E-03,7.71E-01,,,C, YES,+
2468,P49736,MCM2,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),TDALTSSPGRDLP,_RTDALTSS(ph)PGR_,S41,+,25.64,26.21,26.27,26.69,23.88,,,23.65,21.53,20.63,,,,24.31,1.33,1.90,1.96,2.38,-0.43, , ,-0.66,-2.78,-3.68, , , ,S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;nucleosome assembly,nucleoplasm;chromatin;nuclear origin of replication recognition complex;MCM complex,,,,,5.92E-04,7.2E-03,1.34E-03,3.21E-04,5.03E-02,,,C, YES,
2473,P49756,RBM25,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),KLGASNSPGQPNS,_LGASNS(ph)PGQPNSVK_,S677,+,28.98,28.44,29.01,29.47,26.65,25.73,26.92,26.50,26.86,26.81,25.50,26.37,24.77,27.08,1.90,1.36,1.93,2.39,-0.43,-1.34,-0.16,-0.58,-0.22,-0.26,-1.58,-0.71,-2.30,"mRNA processing;RNA splicing;apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nuclear speck;cytoplasm,,,,,3.6E-04,5.19E-03,9.95E-04,1.49E-04,2.46E-01,+,,C, YES,+
2499,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],PTRYSLSPSKSYK,_YSLS(ph)PSK_,S788,+,26.78,26.23,26.27,26.90,23.25,22.24,,23.42,22.25,22.00,,,21.70,24.10,2.68,2.12,2.17,2.79,-0.85,-1.87, ,-0.69,-1.85,-2.10, , ,-2.40,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,5.71E-06,3.68E-04,6.51E-06,5.48E-06,1.64E-01,,,C, YES,
2574,P51608,MECP2,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),VPEASASPKQRRS,_AETSEGSGSAPAVPEASAS(ph)PK_,S92,+,28.47,29.26,28.73,27.54,25.18,25.68,27.66,24.65,25.73,27.67,27.73,26.44,25.80,26.96,1.50,2.30,1.76,0.58,-1.79,-1.29,0.70,-2.32,-1.23,0.71,0.76,-0.52,-1.16,"negative regulation of histone methylation;cerebellum development;startle response;long-term memory;regulation of respiratory gaseous exchange by neurological system process;glutamine metabolic process;positive regulation of synapse assembly;sensory perception of pain;neurological system process involved in regulation of systemic arterial blood pressure;mitochondrial electron transport, ubiquinol to cytochrome c;negative regulation of histone acetylation;respiratory gaseous exchange;glucocorticoid metabolic process;post-embryonic development;behavioral fear response;histone acetylation;proprioception;synapse assembly;pathogenesis;positive regulation of transcription, DNA-dependent;dendrite development;protein localization;catecholamine secretion;histone methylation;transcription, DNA-dependent;negative regulation of neuron apoptotic process;adult locomotory behavior;long-term synaptic potentiation;embryo development;cardiolipin metabolic process;phosphatidylcholine metabolic process;positive regulation of cell proliferation;visual learning;neuron maturation;ventricular system development;inositol metabolic process;regulation of excitatory postsynaptic membrane potential;response to hypoxia;social behavior;chromatin silencing;negative regulation of transcription from RNA polymerase II promoter;regulation of gene expression by genetic imprinting",nuclear chromatin;cytosol;nucleus;heterochromatin;protein complex,Other TF domain,,,,2.67E-03,1.83E-02,7.01E-04,3.08E-02,1.08E-01,,,C, YES,
2616,P52594,AGFG1,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),KGTPSQSPVVGRS,_GTPSQS(ph)PVVGR_,S112,+,27.37,26.56,25.62,27.71,24.61,24.13,25.05,25.30,25.43,24.73,24.25,25.57,22.57,25.30,2.07,1.26,0.32,2.41,-0.69,-1.17,-0.25,0.00,0.13,-0.57,-1.05,0.27,-2.73,multicellular organismal development;cell differentiation;spermatogenesis;mRNA export from nucleus;regulation of ARF GTPase activity,Golgi apparatus;cytoplasmic membrane-bounded vesicle;nuclear pore,,,,,2.46E-03,1.74E-02,4.96E-03,1E-03,3.39E-01,,,C, YES,
2728,P55287,CDH11,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),LADLYGSKDTFDD,_LADLYGS(ph)K_,S771,+,,25.16,24.71,27.52,26.15,26.76,24.96,25.32,25.63,,22.80,23.76,23.11,25.08, ,0.08,-0.37,2.44,1.07,1.68,-0.12,0.24,0.55, ,-2.28,-1.32,-1.97,adherens junction organization;homophilic cell adhesion;cell junction assembly;skeletal system development;ossification,integral to membrane;plasma membrane,,,,,3.59E-03,2.19E-02,7.71E-01,3.07E-03,2.39E-03,,,C,,
2737,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),ASGPSESPSPPAA,_TEPAAEAEAASGPSES(ph)PSPPAAEELPGSHAEPPVPAQGEAPGEQARDER_,S83,+,25.63,25.63,25.63,25.20,25.70,,26.09,26.17,26.32,,27.96,27.33,27.02,26.25,-0.62,-0.61,-0.61,-1.04,-0.54, ,-0.15,-0.07,0.07, ,1.71,1.09,0.77,regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,5.19E-03,2.81E-02,1.83E-01,1.52E-03,1.92E-02,,,C, YES,+
2761,P58107,EPPK1,Epiplakin (450 kDa epidermal antigen),AEAEAGSPRPDPR,_AEAEAGS(ph)PRPDPR_,S2508,+,27.09,26.26,26.94,23.97,20.04,,,19.97,,,21.13,20.55,,23.25,3.85,3.01,3.70,0.73,-3.20, , ,-3.27, , ,-2.11,-2.70, ,,cytoskeleton;cytoplasm,,,,,1.38E-04,2.61E-03,6.73E-05,2.4E-04,4.52E-01,,,C, YES,
2787,P61247,RPS3A,40S ribosomal protein S3a (v-fos transformation effector protein) (Fte-1),LHGEGSSSGKATG,_LM(ox)ELHGEGSS(ph)SGK_,S237,+,,25.38,25.55,25.45,,21.93,22.99,22.43,23.35,22.85,22.50,,20.95,23.34, ,2.04,2.21,2.11, ,-1.41,-0.35,-0.91,0.01,-0.49,-0.83, ,-2.39,"translational termination;translational elongation;cell differentiation;viral transcription;induction of apoptosis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,4.93E-04,6.34E-03,7.2E-04,2.65E-04,3.78E-01,,,C, YES,
2806,P62328,TMSB4X,Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)],_____MSDKPDMA,_(ac)S(ph)DKPDMAEIEKFDK_,S2,+,28.59,28.83,28.84,28.96,25.82,21.90,26.98,25.86,22.88,25.13,,23.77,,26.14,2.45,2.69,2.70,2.82,-0.32,-4.25,0.84,-0.28,-3.26,-1.01, ,-2.37, ,platelet degranulation;regulation of cell migration;platelet activation;osteoblast differentiation;sequestering of actin monomers;actin cytoskeleton organization,cytosol;extracellular region;platelet alpha granule lumen;nucleus;cytoskeleton,,,,,1.41E-03,1.23E-02,5.33E-04,2.54E-03,8.38E-01,+,,C, YES,
2811,P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),KRRRLSSLRASTS,_RRLS(ph)S(ph)LR_,S236,+,32.08,28.42,28.98,30.85,27.44,23.66,26.03,26.01,25.78,25.71,23.74,23.93,,26.89,5.19,1.54,2.09,3.97,0.55,-3.22,-0.85,-0.88,-1.10,-1.18,-3.15,-2.95, ,"translational termination;translational elongation;viral transcription;ribosomal small subunit biogenesis;glucose homeostasis;TOR signaling cascade;translational initiation;insulin receptor signaling pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,1.5E-04,2.8E-03,3.29E-04,8.07E-05,1.92E-01,,,C, YES,
2812,P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),LSSLRASTSKSES,_LSS(ph)LRAS(ph)TSK_,S240,+,30.36,29.45,30.16,30.58,23.97,24.19,25.96,26.78,25.90,27.37,23.07,27.04,23.35,26.78,3.57,2.66,3.38,3.80,-2.82,-2.59,-0.83,-0.01,-0.89,0.59,-3.71,0.26,-3.43,"translational termination;translational elongation;viral transcription;ribosomal small subunit biogenesis;glucose homeostasis;TOR signaling cascade;translational initiation;insulin receptor signaling pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,2.85E-04,4.35E-03,2.39E-04,2.88E-04,8.76E-01,,,C, YES,+
2822,P62979,RPS27A,Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin;40S ribosomal protein S27a],YNIQKESTLHLVL,_ES(ph)TLHLVLR_,S65,,23.97,25.51,25.76,21.94,21.73,,,,20.54,24.93,26.03,25.20,,23.96,0.01,1.55,1.81,-2.02,-2.23, , , ,-3.42,0.98,2.07,1.24, ,"S phase of mitotic cell cycle;G1 phase of mitotic cell cycle;fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;DNA repair;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;toll-like receptor 2 signaling pathway;nucleotide-binding oligomerization domain containing signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral transcription;activation of MAPK activity;endosomal transport;TRIF-dependent toll-like receptor signaling pathway;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;I-kappaB kinase/NF-kappaB cascade;Notch receptor processing;negative regulation of epidermal growth factor receptor signaling pathway;cellular membrane organization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;regulation of apoptotic process;toll-like receptor 1 signaling pathway;translational termination;egress of virus within host cell;JNK cascade;G1/S transition of mitotic cell cycle;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of transcription from RNA polymerase II promoter in response to hypoxia;apoptotic process;cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;translational elongation;transcription initiation from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;negative regulation of type I interferon production;innate immune response;M/G1 transition of mitotic cell cycle;T cell receptor signaling pathway;Notch signaling pathway;translational initiation;negative regulation of transcription from RNA polymerase II promoter;SRP-dependent cotranslational protein targeting to membrane;protein polyubiquitination",nucleoplasm;endosome membrane;cytosolic small ribosomal subunit;plasma membrane;endocytic vesicle membrane,,,,,3.18E-03,2.06E-02,9.88E-03,1.74E-01,1.49E-03,,,C, YES,
2824,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",QIYRRRSPSPYYS,_RS(ph)PS(ph)PYYSR_,S228,+,30.02,32.31,31.41,31.51,29.78,26.38,24.38,27.38,28.63,26.71,24.40,23.91,23.44,27.71,2.30,4.60,3.70,3.80,2.07,-1.34,-3.33,-0.33,0.92,-1.00,-3.31,-3.80,-4.27,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,2.62E-05,9.13E-04,7.22E-04,6.48E-06,1.29E-02,,,C,,
2825,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",YRRRSPSPYYSRY,_RS(ph)PS(ph)PYYSR_,S230,,29.78,31.94,30.36,31.17,29.77,26.10,24.38,27.47,28.00,26.58,23.98,24.42,22.95,27.45,2.32,4.49,2.91,3.72,2.32,-1.36,-3.08,0.02,0.54,-0.88,-3.48,-3.03,-4.50,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,4.89E-05,1.35E-03,1.38E-03,1.2E-05,1.43E-02,,,C,,
2831,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",RRSRSRSYSRDYR,_S(ph)RS(ph)YSRDYR_,S49,+,26.73,28.40,29.31,25.44,25.68,23.68,23.44,24.03,23.69,22.65,,22.86,21.80,24.81,1.92,3.59,4.50,0.63,0.87,-1.13,-1.37,-0.78,-1.12,-2.16, ,-1.95,-3.01,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,1.16E-03,1.08E-02,6.98E-03,3.8E-04,7.48E-02,,,C,,
2910,P84103,SRSF3,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",DRRRERSLSRERN,_ERS(ph)LS(ph)RER_,S138,+,32.15,30.79,29.85,30.84,24.48,23.03,22.08,22.59,24.34,19.88,21.02,20.16,19.96,24.71,7.45,6.08,5.15,6.13,-0.23,-1.67,-2.62,-2.12,-0.37,-4.82,-3.68,-4.55,-4.75,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,9.09E-11,1.98E-07,1.84E-09,3.09E-11,1.68E-04,,,C, YES,
2911,P84103,SRSF3,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",RRERSLSRERNHK,_ERS(ph)LS(ph)RER_,S140,+,32.13,30.71,29.82,30.81,24.25,22.44,21.81,22.59,24.27,19.88,21.02,19.86,19.96,24.58,7.55,6.13,5.24,6.23,-0.33,-2.14,-2.77,-1.99,-0.31,-4.70,-3.56,-4.72,-4.62,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,1.16E-10,1.98E-07,1.83E-09,4.23E-11,3.54E-04,,,C, YES,
2921,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),SRSAPASPTHPGL,_S(ph)APAS(ph)PTHPGLM(ox)S(ph)PR_,S420,+,28.06,27.27,26.91,27.32,26.12,25.68,26.13,25.31,26.95,25.62,24.93,25.53,25.05,26.22,1.83,1.05,0.69,1.10,-0.10,-0.54,-0.09,-0.91,0.73,-0.60,-1.29,-0.69,-1.17,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,1.91E-03,1.5E-02,9.58E-03,5.69E-04,1.31E-01,,,C, YES,+
2944,Q00536,CDK16,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),HPPRKISTEDINK,_KIS(ph)TEDINK_,S110,+,26.41,26.31,25.35,26.46,,22.37,22.33,,22.44,22.30,22.58,23.48,20.39,23.67,2.74,2.64,1.68,2.78, ,-1.31,-1.34, ,-1.23,-1.37,-1.10,-0.19,-3.29,regulation of insulin secretion involved in cellular response to glucose stimulus;spermatogenesis;neuron projection development;exocytosis;cell cycle;growth hormone secretion,neuron projection;synapse;transport vesicle;extrinsic to internal side of plasma membrane;cell junction;cytoplasm,,+,,,4.79E-05,1.35E-03,8.59E-05,2.46E-05,7.89E-01,,,C,,
2966,Q00839,HNRNPU,Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold attachment factor A) (SAF-A) (p120) (pp120),___MSSSPVNVKK,_(ac)SSS(ph)PVNVKK_,S4,+,30.00,30.31,30.42,31.31,30.56,29.42,29.01,29.60,29.44,28.64,27.04,28.65,27.39,29.37,0.63,0.95,1.05,1.95,1.19,0.05,-0.35,0.24,0.07,-0.73,-2.33,-0.72,-1.98,"CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;CRD-mediated mRNA stability complex;cell surface;catalytic step 2 spliceosome,SAP-domain,,,,1.06E-03,1.02E-02,1.13E-01,3.14E-04,6.08E-03,,,C, YES,+
2971,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",TSSKESSPIPSPT,_ESS(ph)PIPSPTSDRK_,S2165,+,29.37,30.26,30.28,30.65,24.43,,28.30,25.40,28.72,28.28,26.67,26.39,24.22,27.75,1.62,2.51,2.53,2.90,-3.32, ,0.55,-2.35,0.97,0.53,-1.07,-1.35,-3.52,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,2.98E-03,1.97E-02,3.22E-03,1.66E-03,7.48E-01,,,C, YES,
2972,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",ESSPIPSPTSDRK,_ESS(ph)PIPS(ph)PTSDRK_,S2169,+,29.34,30.20,30.22,30.68,24.92,25.12,28.23,26.25,28.93,28.19,26.62,26.20,26.37,27.79,1.55,2.41,2.43,2.89,-2.87,-2.67,0.44,-1.54,1.14,0.40,-1.17,-1.59,-1.42,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,1E-03,1E-02,5.75E-04,1.33E-03,8.49E-01,,,C, YES,
2980,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",RKRRPPSPEPSTK,_RRPPS(ph)PEPSTK_,S2102,+,26.72,29.28,29.24,28.71,25.63,26.24,26.39,25.75,26.58,26.75,27.78,27.23,27.02,27.18,-0.46,2.10,2.06,1.53,-1.54,-0.94,-0.79,-1.42,-0.60,-0.43,0.60,0.05,-0.16,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,2.51E-03,1.76E-02,6.53E-04,4.1E-02,7.66E-02,,,C, YES,
2988,Q01105,SET,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),MAPKRQSPLPPQK,_RQS(ph)PLPPQK_,S7,+,25.44,25.81,26.11,23.11,20.03,20.17,20.00,20.06,20.63,21.62,20.60,20.92,18.99,21.81,3.64,4.00,4.31,1.31,-1.78,-1.64,-1.81,-1.75,-1.18,-0.19,-1.21,-0.88,-2.82,"nucleosome disassembly;negative regulation of transcription, DNA-dependent;mRNA metabolic process;nucleocytoplasmic transport;negative regulation of histone acetylation;gene expression;negative regulation of neuron apoptotic process;nucleosome assembly;DNA replication",nucleoplasm;cytosol;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm,,,,,2.47E-06,2.34E-04,1.46E-06,6.87E-06,5.91E-01,,,C, YES,
2989,Q01105,SET,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),DGADETSEKEQQE,_ELNSNHDGADETS(ph)EK_,S24,,27.13,28.10,28.43,27.93,,20.99,25.61,22.78,26.20,21.94,22.83,24.79,21.59,24.86,2.27,3.24,3.57,3.06, ,-3.87,0.75,-2.08,1.34,-2.92,-2.03,-0.07,-3.27,"nucleosome disassembly;negative regulation of transcription, DNA-dependent;mRNA metabolic process;nucleocytoplasmic transport;negative regulation of histone acetylation;gene expression;negative regulation of neuron apoptotic process;nucleosome assembly;DNA replication",nucleoplasm;cytosol;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm,,,,,6.18E-04,7.42E-03,1.81E-03,2.13E-04,2.95E-01,,,C, YES,
2991,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",SRLRSKSPPKSPE,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_,S208,,29.87,29.94,29.70,28.80,25.33,22.62,,24.13,28.24,28.54,24.87,26.44,23.23,26.81,3.06,3.13,2.89,1.99,-1.48,-4.19, ,-2.68,1.44,1.73,-1.94,-0.37,-3.58,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,3.57E-03,2.18E-02,1.66E-03,5.6E-03,5.57E-01,,,C, YES,
3036,Q02078,MEF2A,Myocyte-specific enhancer factor 2A (Serum response factor-like protein 1),IKSEPISPPRDRM,_SEPIS(ph)PPRDR_,S398,+,24.90,23.98,23.61,24.20,23.36,23.85,24.19,22.90,24.50,23.25,21.10,22.10,20.82,23.29,1.61,0.69,0.32,0.91,0.07,0.56,0.90,-0.39,1.21,-0.04,-2.19,-1.19,-2.47,toll-like receptor 4 signaling pathway;dendrite morphogenesis;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;apoptotic process;mitochondrion distribution;MyD88-dependent toll-like receptor signaling pathway;muscle organ development;cardiac conduction;toll-like receptor 3 signaling pathway;positive regulation of muscle cell differentiation;TRIF-dependent toll-like receptor signaling pathway;cellular response to calcium ion;mitochondrial genome maintenance;innate immune response;negative regulation of transcription from RNA polymerase II promoter;ventricular cardiac myofibril development;nerve growth factor receptor signaling pathway;ERK5 cascade;toll-like receptor 1 signaling pathway,nucleoplasm;nuclear chromatin,MADS-box domain,,,,2.27E-03,1.67E-02,3.99E-01,1.01E-03,3.9E-03,,,C,,
3046,Q02543,RPL18A,60S ribosomal protein L18a,GQVFEKSPLRVKN,_S(ph)PLRVK_,S71,+,21.67,24.54,24.54,24.23,,,20.49,,19.64,,19.99,20.91,,22.00,-0.33,2.54,2.54,2.23, , ,-1.51, ,-2.36, ,-2.01,-1.09, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,5.57E-03,2.95E-02,2.85E-03,6.01E-03,7.13E-01,,,C, YES,
3047,Q02818,NUCB1,Nucleobindin-1 (CALNUC),AKAQRLSQETEAL,_AQRLS(ph)QETEALGR_,S369,+,29.05,29.45,29.17,26.24,25.57,27.42,23.99,27.06,25.27,26.51,26.11,25.26,25.30,26.65,2.40,2.81,2.53,-0.40,-1.08,0.77,-2.65,0.41,-1.38,-0.14,-0.54,-1.38,-1.35,,microtubule cytoskeleton;extracellular space;endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;membrane,,,,,5.34E-03,2.87E-02,3.6E-03,4.41E-03,9.35E-01,,,C, YES,
3053,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",KKRNPWSDDESKS,_RNPWS(ph)DDES(ph)K_,S1308,+,26.21,27.56,27.83,25.49,22.09,21.68,22.85,,24.65,25.08,,21.01,,24.44,1.77,3.11,3.39,1.05,-2.36,-2.77,-1.60, ,0.20,0.64, ,-3.44, ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,4.91E-03,2.7E-02,1.61E-03,9.36E-03,8.42E-01,,,C, YES,
3139,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),GLRKAASLTEDRD,_AAS(ph)LTEDRDR_,S1169,+,30.62,29.69,26.21,29.08,25.84,25.13,25.01,25.80,24.04,22.39,25.42,24.01,23.24,25.88,4.74,3.80,0.33,3.19,-0.05,-0.75,-0.87,-0.09,-1.84,-3.50,-0.47,-1.87,-2.64,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,6.39E-05,1.59E-03,2.93E-04,2.4E-05,1.28E-01,,,C, YES,
3145,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),RVVQRSSLSRERG,_VVQRSS(ph)LS(ph)RER_,S1105,+,29.73,28.33,28.79,29.21,26.40,24.15,25.44,25.74,24.53,24.29,21.96,26.24,,26.23,3.49,2.10,2.56,2.98,0.17,-2.09,-0.80,-0.50,-1.70,-1.95,-4.27,0.01, ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,2.73E-04,4.25E-03,5.29E-04,1.49E-04,2.31E-01,,,C, YES,
3146,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),VQRSSLSRERGEK,_VVQRSS(ph)LS(ph)RER_,S1107,+,29.43,27.93,28.16,28.85,25.41,20.02,23.64,24.24,23.22,22.13,21.96,21.72,,24.73,4.71,3.20,3.43,4.13,0.68,-4.71,-1.08,-0.49,-1.50,-2.59,-2.77,-3.01, ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,1.29E-05,6.08E-04,2.7E-05,8.55E-06,1.65E-01,,,C, YES,
3176,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",KPIETGSPKTKEC,_KPIETGS(ph)PK_,S448,+,26.84,27.34,28.13,26.28,21.28,23.72,24.31,23.07,23.31,,,24.44,23.74,24.77,2.07,2.57,3.36,1.51,-3.49,-1.05,-0.46,-1.70,-1.46, , ,-0.33,-1.03,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,1.03E-03,1.01E-02,1.72E-04,1.19E-02,2.9E-01,,,C, YES,
3178,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",EEDMDMSD_____,_VNGDDHHEEDMDM(ox)S(ph)D_,S482,+,26.46,25.59,25.57,26.13,23.38,22.76,22.67,23.96,24.46,22.87,20.66,21.89,20.84,23.63,2.82,1.96,1.93,2.50,-0.26,-0.88,-0.96,0.33,0.82,-0.76,-2.97,-1.75,-2.79,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,1.6E-05,6.85E-04,8.6E-04,3.72E-06,5.42E-03,,,C, YES,+
3180,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],NEKARLSYSDKNL,_ARLS(ph)YSDK_,S645,+,27.46,30.44,31.08,27.78,26.14,25.40,25.68,21.65,20.76,20.38,,,,25.68,1.78,4.76,5.40,2.10,0.46,-0.27,0.00,-4.02,-4.91,-5.30, , , ,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,1.3E-03,1.17E-02,1.59E-03,1.09E-03,8.86E-02,+,,C, YES,
3190,Q05682,CALD1,Caldesmon (CDM),EKPKRGSIGENQG,_RGS(ph)IGENQGEEK_,S202,,23.66,26.70,26.83,27.55,,21.81,22.56,21.65,24.22,21.13,22.90,23.53,22.47,23.75,-0.09,2.95,3.08,3.80, ,-1.94,-1.19,-2.10,0.47,-2.62,-0.85,-0.22,-1.28,actin filament bundle assembly;muscle contraction;positive regulation of protein binding;cellular component movement,neuronal cell body;postsynaptic density;actin cytoskeleton;cytosol;actin filament;myofibril;actin cap;plasma membrane,,,,,1.03E-03,1.01E-02,9.09E-04,7.98E-04,9.48E-01,,,C, YES,
3241,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",KVDGPRSPSYGRS,_VDGPRS(ph)PS(ph)YGR_,S199,+,31.38,31.68,31.73,31.41,30.45,29.52,28.52,29.43,27.90,27.83,28.09,29.28,26.14,29.49,1.89,2.20,2.24,1.92,0.97,0.03,-0.97,-0.05,-1.59,-1.66,-1.40,-0.21,-3.35,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,1.73E-04,3.12E-03,1.7E-03,4.87E-05,5.59E-02,,,C, YES,+
3242,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",DGPRSPSYGRSRS,_VDGPRS(ph)PS(ph)YGR_,S201,+,30.62,29.87,28.10,29.67,27.96,20.54,22.69,24.66,24.49,23.54,21.38,,,25.77,4.84,4.10,2.33,3.90,2.19,-5.24,-3.08,-1.12,-1.28,-2.23,-4.40, , ,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,3.22E-04,4.81E-03,2.87E-04,3.07E-04,2.95E-01,,,C, YES,
3370,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LKVDVKSPKTKKT,_VDVKS(ph)PK_,S5077,+,25.56,26.48,27.23,27.23,20.75,23.01,23.77,23.80,23.58,,23.95,22.90,24.47,24.39,1.16,2.09,2.83,2.83,-3.65,-1.38,-0.62,-0.59,-0.82, ,-0.44,-1.49,0.08,nervous system development,nucleus,,,,,1.32E-03,1.19E-02,3.33E-04,7.26E-03,3.25E-01,,,C,,
3444,Q12872,SFSWAP,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",VKLDDDSDDDEES,_VKLDDDS(ph)DDDEESK_,S397,+,25.90,25.75,,25.74,21.61,21.57,23.70,21.76,24.98,22.36,21.39,20.95,,23.25,2.65,2.50, ,2.50,-1.63,-1.68,0.45,-1.49,1.74,-0.89,-1.85,-2.30, ,"negative regulation of mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleus,,,,,7.08E-04,8.1E-03,1.74E-03,3.15E-04,1.65E-01,,,C, YES,
3456,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),GGPGKLSPRKGVS,_GGPGKLS(ph)PR_,S1362,+,25.59,27.06,25.36,26.42,24.50,23.58,23.20,23.34,23.98,23.06,22.37,23.11,21.99,24.12,1.47,2.94,1.25,2.30,0.38,-0.54,-0.92,-0.78,-0.14,-1.06,-1.75,-1.00,-2.13,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,4.51E-05,1.31E-03,3.24E-04,1.47E-05,7.12E-02,,+,C, YES,+
3468,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),QPMKPISPVKDPV,_(gl)QSQQPM(ox)KPIS(ph)PVKDPVS(ph)PASQK_,S1094,+,26.42,25.65,24.39,26.56,26.73,23.99,24.66,25.91,26.36,23.71,22.07,22.97,,24.95,1.47,0.70,-0.56,1.61,1.78,-0.96,-0.29,0.96,1.41,-1.24,-2.88,-1.98, ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,2.88E-03,1.92E-02,5.68E-01,1.59E-03,3.29E-03,,+,C, YES,
3491,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),EDGEEKSPSKKKK,_RPM(ox)EEDGEEKS(ph)PSK_,S382,+,26.41,25.23,25.98,25.07,21.59,21.58,22.00,21.89,22.07,20.29,20.90,20.57,22.55,22.78,3.63,2.45,3.20,2.29,-1.19,-1.20,-0.78,-0.89,-0.71,-2.49,-1.88,-2.20,-0.23,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,8.85E-07,1.51E-04,2.59E-06,5.39E-07,1.8E-01,,,C, YES,
3556,Q13153,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),NSQKYMSFTDKSA,_YMS(ph)FTDK_,S144,+,25.48,26.04,26.39,26.37,21.57,21.06,24.52,23.22,23.03,22.42,22.80,24.27,,23.93,1.55,2.11,2.46,2.44,-2.36,-2.87,0.59,-0.71,-0.90,-1.51,-1.13,0.35, ,positive regulation of peptidyl-serine phosphorylation;neuromuscular junction development;cellular response to stress;protein autophosphorylation;T cell costimulation;wound healing;negative regulation of cell proliferation involved in contact inhibition;cellular response to insulin stimulus;apoptotic process;branching morphogenesis of a tube;exocytosis;positive regulation of JUN kinase activity;response to hypoxia;positive regulation of stress fiber assembly;axon guidance;T cell receptor signaling pathway;dendrite development;actin cytoskeleton reorganization;positive regulation of intracellular estrogen receptor signaling pathway;receptor clustering,Z disc;axon;intercalated disc;Golgi apparatus;protein complex;cytosol;growth cone;nuclear membrane;plasma membrane;focal adhesion;dendrite;ruffle,,+,,,8.76E-04,9.3E-03,2.72E-04,2.92E-03,5.3E-01,+,,C, YES,
3565,Q13185,CBX3,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),TKRKSLSDSESDD,_SLS(ph)DSESDDSK_,S95,+,27.25,25.22,25.11,26.46,22.79,23.59,23.50,24.06,24.45,22.23,22.48,25.26,23.02,24.26,2.99,0.95,0.84,2.20,-1.47,-0.68,-0.76,-0.20,0.19,-2.03,-1.78,1.00,-1.25,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;chromatin remodeling","nuclear euchromatin;condensed chromosome, centromeric region;nuclear inner membrane;nuclear centromeric heterochromatin;spindle",,,,,3.52E-03,2.16E-02,4.42E-03,1.81E-03,5.38E-01,,,C, YES,
3576,Q13242,SRSF9,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GSRGRDSPYQSRG,_GRDS(ph)PYQSR_,S204,+,21.64,27.05,23.99,25.73,19.09,17.63,,19.08,18.82,,,19.36,,21.38,0.26,5.67,2.62,4.35,-2.29,-3.75, ,-2.30,-2.55, , ,-2.02, ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm;nucleolus,,,,,7.15E-04,8.12E-03,9.44E-05,7.23E-03,6.74E-01,,,C, YES,
3579,Q13242,SRSF9,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",YPERSTSYGYSRS,_STS(ph)YGYSR_,S189,+,25.16,26.55,24.53,27.16,23.38,22.88,23.06,23.07,23.60,20.95,22.02,22.05,21.00,23.49,1.67,3.06,1.04,3.67,-0.11,-0.61,-0.43,-0.43,0.11,-2.54,-1.47,-1.45,-2.50,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm;nucleolus,,,,,1.07E-05,5.32E-04,2.57E-04,2.76E-06,1.26E-02,,,C, YES,
3580,Q13243,SRSF5,"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)",SSSRSKSPASVDR,_S(ph)PAS(ph)VDRQR_,S250,+,24.98,24.49,24.85,25.14,,,19.31,,19.82,,17.22,20.18,,22.00,2.98,2.49,2.85,3.14, , ,-2.69, ,-2.18, ,-4.78,-1.82, ,regulation of cell cycle;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;response to wounding;mRNA splice site selection,nucleolus;nuclear speck;cytoplasm,,,,,1.1E-04,2.28E-03,1.85E-04,4.93E-05,4.25E-01,,,C, YES,
3582,Q13247,SRSF6,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",PPSKARSVSPPPK,_ARS(ph)VS(ph)PPPKR_,S314,+,28.06,27.16,27.51,28.91,23.34,21.87,22.20,22.31,23.98,23.84,19.89,22.57,20.46,24.01,4.06,3.15,3.50,4.90,-0.67,-2.13,-1.80,-1.70,-0.03,-0.17,-4.12,-1.44,-3.55,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm,,,,,3.91E-06,2.96E-04,1.13E-05,2.2E-06,2.02E-01,,,C, YES,+
3583,Q13247,SRSF6,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",SKARSVSPPPKRA,_ARS(ph)VS(ph)PPPKR_,S316,+,28.06,27.16,27.51,28.91,23.34,21.87,22.20,22.31,23.98,23.84,19.89,22.57,20.46,24.01,4.06,3.15,3.50,4.90,-0.67,-2.13,-1.80,-1.70,-0.03,-0.17,-4.12,-1.44,-3.55,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm,,,,,3.91E-06,2.96E-04,1.13E-05,2.2E-06,2.02E-01,,,C, YES,+
3602,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),GVKRSRSGEGEVS,_S(ph)GEGEVSGLM(ox)RK_,S473,+,31.96,28.32,28.06,28.61,28.02,26.60,25.81,26.35,27.11,24.66,22.87,23.87,,26.85,5.11,1.46,1.20,1.75,1.17,-0.25,-1.05,-0.51,0.26,-2.19,-3.98,-2.99, ,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,7.69E-05,1.81E-03,6.27E-03,2.06E-05,3.24E-03,,,C, YES,
3632,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),KADRDQSPFSKIK,_KADRDQS(ph)PFSK_,S687,+,28.43,29.49,30.20,27.64,27.08,25.82,25.53,25.86,25.95,24.00,24.59,25.61,24.02,26.48,1.95,3.01,3.72,1.16,0.60,-0.65,-0.95,-0.62,-0.53,-2.47,-1.89,-0.87,-2.46,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,4.31E-05,1.28E-03,7.53E-04,1.13E-05,2.41E-02,,,C, YES,
3633,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),IKENQRSPVRVKE,_ENQRS(ph)PVRVK_,S397,+,25.42,27.08,27.90,24.45,20.38,22.04,21.94,21.83,22.82,21.18,21.60,20.73,20.28,22.89,2.52,4.18,5.00,1.56,-2.52,-0.86,-0.96,-1.07,-0.08,-1.71,-1.30,-2.16,-2.62,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,1.54E-05,6.67E-04,4.19E-05,8.22E-06,2.35E-01,,,C, YES,+
3639,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),KKFDHESSPGTDE,_KFDHES(ph)S(ph)PGT(ph)DEDK_,S744,+,27.29,26.45,26.79,23.83,,20.34,21.85,20.15,23.58,,20.72,20.34,19.10,22.77,4.52,3.68,4.02,1.06, ,-2.42,-0.92,-2.62,0.81, ,-2.04,-2.42,-3.67,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,8.66E-05,1.93E-03,2.59E-04,3.66E-05,1.62E-01,,,C, YES,+
3653,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SRKRKLSGDQPAA,_RKLS(ph)GDQPAAR_,S1350,+,27.27,28.00,27.95,26.83,25.80,24.64,22.83,24.04,24.07,20.16,21.91,22.69,22.59,24.52,2.75,3.48,3.43,2.30,1.28,0.11,-1.69,-0.48,-0.45,-4.36,-2.61,-1.83,-1.93,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,2.18E-06,2.13E-04,1.45E-04,5.05E-07,2.33E-03,,,C, YES,+
3661,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SAPAKESPRKGAA,_TSQVGAASAPAKES(ph)PRK_,S381,+,22.87,25.66,25.66,22.51,20.83,,19.33,19.48,19.88,20.36,,,,21.84,1.02,3.82,3.82,0.67,-1.01, ,-2.51,-2.36,-1.96,-1.48, , , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,5.15E-03,2.8E-02,9.15E-04,2.42E-02,7.01E-01,,,C, YES,
3680,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),LIERIQSIKEEKE,_IQS(ph)IKEEK_,S1972,+,24.93,24.74,22.59,23.74,22.13,,20.70,19.85,,,19.47,21.51,20.44,22.01,2.93,2.73,0.58,1.73,0.12, ,-1.31,-2.16, , ,-2.54,-0.50,-1.57,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,1.59E-03,1.32E-02,1.94E-03,8.13E-04,6.65E-01,,,C, YES,
3705,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),ERSKDASPINRWS,_DAS(ph)PINRWS(ph)PTR_,S431,+,28.92,27.25,26.37,28.37,23.60,,24.27,24.16,25.89,23.88,,22.48,,25.52,3.40,1.73,0.85,2.85,-1.92, ,-1.24,-1.36,0.37,-1.64, ,-3.04, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,2.75E-04,4.25E-03,4.74E-04,1.59E-04,1.61E-01,,,C, YES,+
3706,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),SPINRWSPTRRRS,_DAS(ph)PINRWS(ph)PTR_,S437,+,28.94,27.25,26.37,28.37,24.30,24.36,24.97,24.77,25.98,24.65,,22.48,,25.68,3.27,1.57,0.69,2.70,-1.38,-1.32,-0.71,-0.90,0.31,-1.02, ,-3.20, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,3.33E-04,4.92E-03,5.69E-04,2.15E-04,1.35E-01,,,C, YES,+
3709,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),SKDRKKSPIINES,_S(ph)PIINESR_,S277,+,28.96,28.71,28.40,28.93,25.67,23.81,25.82,24.51,26.41,26.36,24.60,25.78,22.87,26.22,2.75,2.49,2.18,2.71,-0.55,-2.41,-0.39,-1.71,0.19,0.14,-1.61,-0.44,-3.35,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,1.23E-04,2.45E-03,1.47E-04,9.8E-05,6.33E-01,,,C, YES,+
3715,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),KSRRSRSPLLNDR,_S(ph)RS(ph)PLLNDRR_,S368,+,29.84,29.31,29.88,28.47,26.73,24.08,25.22,24.49,25.75,25.27,21.74,23.64,,26.20,3.64,3.10,3.67,2.27,0.52,-2.12,-0.98,-1.72,-0.45,-0.93,-4.46,-2.56, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,2.8E-05,9.68E-04,1.38E-04,1.19E-05,5.56E-02,,,C, YES,+
3718,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),RDKSRRSRSPLLN,_S(ph)RS(ph)PLLNDRR_,S366,+,29.81,29.21,29.75,28.46,26.67,24.08,25.08,24.27,25.65,25.06,21.74,23.40,,26.10,3.71,3.11,3.65,2.36,0.57,-2.02,-1.02,-1.83,-0.45,-1.04,-4.36,-2.69, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,1.77E-05,7.36E-04,9.46E-05,7.42E-06,4.55E-02,,,C, YES,+
3719,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),RDRGKKSRSPVDL,_S(ph)RS(ph)PVDLRGK_,S292,+,31.04,29.41,30.01,28.44,25.33,22.51,23.95,22.88,25.08,24.88,,22.01,,25.96,5.08,3.45,4.05,2.48,-0.62,-3.45,-2.01,-3.08,-0.88,-1.08, ,-3.95, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,3.47E-05,1.14E-03,1.51E-05,8.15E-05,6.35E-01,,,C, YES,+
3720,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),RGKKSRSPVDLRG,_S(ph)RS(ph)PVDLRGK_,S294,+,31.15,29.50,30.06,28.51,25.33,22.51,23.95,22.88,25.13,24.88,21.47,22.01,,25.62,5.54,3.89,4.44,2.89,-0.28,-3.11,-1.67,-2.73,-0.48,-0.74,-4.14,-3.60, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,6.18E-06,3.91E-04,9.99E-06,5.05E-06,2.25E-01,,,C, YES,+
3887,Q14207,NPAT,Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus) (Nuclear protein of the ATM locus) (p220),PSSRRFSEDSSTS,_RFS(ph)EDSSTSK_,S352,+,24.02,23.32,23.62,23.44,19.48,19.93,20.24,19.95,20.39,,,,19.18,21.36,2.66,1.97,2.27,2.09,-1.88,-1.43,-1.11,-1.41,-0.97, , , ,-2.18,"positive regulation of transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;transcription, DNA-dependent",Cajal body,,,,,2.48E-05,9.02E-04,5.91E-06,1.14E-04,3.1E-01,,,C,,
3918,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),FRGRYRSPYSGPK,_YRS(ph)PYSGPK_,S97,+,25.31,26.57,27.23,25.86,25.25,24.04,,24.19,24.72,24.71,23.94,21.86,22.39,24.67,0.64,1.90,2.55,1.19,0.57,-0.63, ,-0.48,0.05,0.04,-0.73,-2.82,-2.28,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,3.92E-03,2.32E-02,4.45E-02,9.08E-04,7.07E-02,,,C, YES,
3947,Q14669,TRIP12,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),GVKRSASPDYNRT,_RSAS(ph)PDYNR_,S77,+,25.01,25.69,25.65,25.93,19.89,21.37,20.53,21.13,20.94,21.30,20.39,20.50,21.69,22.31,2.71,3.38,3.35,3.62,-2.42,-0.94,-1.78,-1.18,-1.37,-1.01,-1.92,-1.81,-0.62,DNA repair;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;embryo development;response to DNA damage stimulus;negative regulation of double-strand break repair,nucleoplasm;cytoplasm,,,,,6.97E-08,5.96E-05,5.16E-08,1.83E-07,6.92E-01,+,,C, YES,
3948,Q14669,TRIP12,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),PRRPKYSPPRDDD,_YS(ph)PPRDDDK_,S1016,+,25.12,26.76,26.66,26.62,,,23.44,20.02,23.98,24.26,22.83,23.65,20.25,23.96,1.16,2.79,2.70,2.66, , ,-0.52,-3.95,0.02,0.30,-1.13,-0.31,-3.71,DNA repair;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;embryo development;response to DNA damage stimulus;negative regulation of double-strand break repair,nucleoplasm;cytoplasm,,,,,3.93E-03,2.32E-02,3E-03,2.93E-03,8.02E-01,+,,C, YES,
3987,Q14739,LBR,Lamin-B receptor (Integral nuclear envelope inner membrane protein) (LMN2R),SARRSASASHQAD,_SAS(ph)ASHQADIK_,S99,+,23.81,25.93,25.94,25.70,24.74,22.68,22.67,22.97,25.30,21.58,21.76,22.93,22.12,23.70,0.11,2.23,2.24,1.99,1.04,-1.02,-1.03,-0.74,1.60,-2.12,-1.94,-0.77,-1.58,cholesterol biosynthetic process,integral to nuclear inner membrane;mitochondrion;nuclear pore,,,,,1.6E-03,1.33E-02,3.16E-02,4.08E-04,3.2E-02,,,C, YES,
3996,Q14814,MEF2D,Myocyte-specific enhancer factor 2D,IKSEPVSPSRERS,_SEPVS(ph)PSRER_,S377,+,25.41,25.57,24.77,24.76,23.03,19.88,21.83,21.75,23.11,21.02,21.92,22.55,21.58,22.86,2.55,2.71,1.91,1.90,0.17,-2.98,-1.03,-1.11,0.25,-1.84,-0.94,-0.31,-1.28,endochondral ossification;osteoblast differentiation;adult heart development;apoptotic process;chondrocyte differentiation;muscle organ development;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleus,MADS-box domain,,,,1.12E-04,2.32E-03,1.03E-04,1.14E-04,8.24E-01,,,C, YES,
4002,Q14865,ARID5B,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2),KKARAVSPLDPSK,_AVS(ph)PLDPSK_,S789,+,24.60,26.32,25.64,26.68,25.11,26.22,24.98,24.70,25.34,22.97,23.30,24.51,23.80,24.94,-0.34,1.38,0.71,1.74,0.17,1.29,0.04,-0.23,0.40,-1.96,-1.64,-0.43,-1.14,"male gonad development;fat pad development;muscle organ morphogenesis;fat cell differentiation;adrenal gland development;kidney development;negative regulation of transcription, DNA-dependent;liver development;palate development;adipose tissue development;skeletal system morphogenesis;post-embryonic development;platelet-derived growth factor receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;face morphogenesis;fibroblast migration;female gonad development;multicellular organism growth;cell development;transcription, DNA-dependent",nucleus,ARID domain,,,,4.6E-03,2.57E-02,2.86E-01,1.66E-03,1.07E-02,,,C,,
4008,Q14966,ZNF638,Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein),KAVIVSSPKAKAT,_AVIVSS(ph)PK_,S1401,+,25.71,25.76,26.37,26.36,23.69,22.85,22.39,22.75,22.45,23.04,20.45,21.34,22.35,23.50,2.21,2.26,2.87,2.86,0.19,-0.65,-1.11,-0.75,-1.05,-0.46,-3.05,-2.16,-1.15,"RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear speck;cytoplasm,Other TF domain,,,,2.43E-05,9E-04,1.28E-04,9.12E-06,9.96E-02,,,C, YES,+
4023,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),NEKQAASPLEPKE,_(gl)QAAS(ph)PLEPK_,S271,+,25.13,25.09,25.86,24.55,,23.09,22.31,21.45,23.82,22.62,21.25,,18.83,23.09,2.03,2.00,2.77,1.46, ,-0.01,-0.78,-1.64,0.73,-0.47,-1.84, ,-4.26,G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;nucleus organization;mitotic anaphase;cell division;lung epithelial cell differentiation,spindle microtubule;nucleoplasm;cytosol;chromosome;apical part of cell;spindle pole;nuclear matrix,,,,,2.64E-03,1.82E-02,2.27E-02,7.03E-04,6.82E-02,,,C, YES,
4067,Q15061,WDR43,WD repeat-containing protein 43,RLQAKESPQRKKR,_LQAKES(ph)PQRK_,S77,+,23.72,23.97,23.23,24.99,23.53,21.94,21.41,22.06,21.82,19.90,20.88,21.56,22.00,22.39,1.33,1.59,0.85,2.60,1.14,-0.45,-0.97,-0.33,-0.57,-2.49,-1.51,-0.83,-0.38,,nucleolus,,,,,7.69E-04,8.53E-03,5.32E-03,2.21E-04,9.11E-02,,,C, YES,
4091,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),AQLRKASDSELER,_KAS(ph)DSELER_,S1902,,23.91,23.05,23.71,24.79,20.68,21.28,20.61,21.94,21.32,,21.78,20.29,22.02,22.12,1.80,0.94,1.59,2.67,-1.44,-0.83,-1.51,-0.18,-0.80, ,-0.33,-1.83,-0.10,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,1.28E-04,2.52E-03,5.1E-05,3.48E-04,7.33E-01,,,C,,
4094,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),LQSKRASFAEKTA,_RAS(ph)FAEK_,S1584,+,,27.70,28.33,28.51,25.03,24.98,24.04,25.31,24.16,,25.43,26.42,25.91,25.98, ,1.72,2.35,2.53,-0.95,-1.00,-1.94,-0.68,-1.83, ,-0.55,0.44,-0.08,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,9.79E-04,1E-02,2.29E-04,1.86E-02,6.92E-02,,,C,,
4111,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),FKTRKASAQASLA,_KAS(ph)AQASLASK_,S1283,+,23.06,21.90,,22.82,22.07,20.65,21.29,21.58,,20.23,19.91,,,21.50,1.56,0.40, ,1.32,0.57,-0.85,-0.21,0.08, ,-1.27,-1.59, , ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,9.18E-03,4.21E-02,5.05E-02,3.14E-03,7.07E-02,,,C, YES,
4155,Q15390,MTFR1,Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region),YRYRSDSQDEVEK,_YRSDS(ph)QDEVEK_,S247,+,24.02,24.12,23.46,25.38,,21.28,21.56,20.66,,,,22.33,,22.85,1.17,1.27,0.60,2.53, ,-1.57,-1.29,-2.19, , , ,-0.52, ,mitochondrial fission;aerobic respiration,mitochondrion;plasma membrane,,,,,3.91E-03,2.32E-02,5.4E-04,5.9E-02,2.62E-01,,,C,,
4242,Q16181,SEP7,Septin-7 (CDC10 protein homolog),KGQLTKSPLAQME,_S(ph)PLAQM(ox)EEERR_,S307,+,24.60,26.63,27.23,26.14,23.20,22.83,25.12,23.21,23.23,21.42,,,22.56,24.20,0.40,2.43,3.03,1.94,-1.00,-1.37,0.93,-0.98,-0.97,-2.77, , ,-1.63,mitosis;regulation of embryonic cell shape;protein heterooligomerization;cilium morphogenesis;cytokinesis,septin complex;condensed chromosome kinetochore;cleavage furrow;cytoplasm;microtubule cytoskeleton;midbody;stress fiber;nucleolus;plasma membrane;spindle;cilium axoneme,,,,,9.3E-04,9.67E-03,2.89E-03,4.33E-04,8.28E-02,,,C, YES,
4245,Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),PVSAPPSPRDISM,_LDQPVS(ph)APPS(ph)PR_,S244,+,29.85,27.71,27.91,27.76,25.51,25.93,26.11,26.74,24.04,23.23,26.09,,24.22,26.26,3.59,1.45,1.66,1.51,-0.75,-0.33,-0.15,0.48,-2.22,-3.03,-0.17, ,-2.03,,cytoskeleton;cytoplasm,,,,,1.14E-03,1.07E-02,3.17E-03,4.67E-04,1.68E-01,,+,C, YES,+
4284,Q16647,PTGIS,Prostacyclin synthase (EC 5.3.99.4) (Prostaglandin I2 synthase),PKLARGSLSVGDK,_LARGS(ph)LSVGDK_,S221,,,27.13,27.84,23.60,22.10,25.04,26.53,25.03,23.80,,28.95,29.70,28.36,26.19, ,0.94,1.66,-2.58,-4.09,-1.15,0.34,-1.16,-2.39, ,2.76,3.51,2.17,cellular response to interleukin-6;negative regulation of nitric oxide biosynthetic process;negative regulation of NF-kappaB transcription factor activity;negative regulation of inflammatory response;xenobiotic metabolic process;cellular response to interleukin-1;positive regulation of angiogenesis;cellular response to hypoxia;positive regulation of peroxisome proliferator activated receptor signaling pathway;prostaglandin biosynthetic process;positive regulation of apoptotic process,caveola;extracellular space;integral to membrane;nucleus;endoplasmic reticulum membrane,,,,,2.28E-03,1.67E-02,2.22E-01,1.37E-02,5.99E-04,,,C, YES,
4343,Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),GSLTPPSSPKTQR,_VGSLT(ph)PPS(ph)SPK_,S622,+,27.74,26.69,26.73,27.02,23.34,24.13,24.87,25.54,,25.83,24.73,,,25.66,2.07,1.03,1.06,1.36,-2.32,-1.53,-0.79,-0.12, ,0.17,-0.93, , ,protein stabilization;protein autophosphorylation;endocytosis;regulation of protein localization;positive regulation of Notch signaling pathway;regulation of clathrin-mediated endocytosis,coated pit;cell leading edge;extrinsic to plasma membrane;clathrin complex;terminal button;clathrin-coated vesicle,,+,,,5.34E-03,2.87E-02,1.09E-03,3.57E-02,2.97E-01,,,C, YES,
4381,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),APSPAPSPTPAPP,_ESAAPAS(ph)PAPS(ph)PAPS(ph)PTPAPPQK_,S520,+,26.57,24.87,25.24,24.77,,,23.03,23.32,24.18,21.36,,,,24.17,2.40,0.70,1.07,0.60, , ,-1.14,-0.84,0.01,-2.81, , , ,,spindle;cytoplasm,,,,,6.74E-03,3.36E-02,2.73E-02,2.71E-03,6.34E-02,,,C, YES,
4458,Q53EL6,PDCD4,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),GRKRFVSEGDGGR,_RFVS(ph)EGDGGR_,S443,+,27.95,28.27,27.16,27.94,23.11,25.45,24.22,23.43,25.49,22.16,24.52,24.56,22.20,25.11,2.83,3.16,2.05,2.83,-2.00,0.33,-0.89,-1.68,0.37,-2.95,-0.59,-0.55,-2.91,"apoptotic process;negative regulation of transcription, DNA-dependent;negative regulation of JUN kinase activity;negative regulation of cell cycle;cell aging",cytosol;nucleus,,,,,3.13E-05,1.05E-03,1.05E-04,1.42E-05,1.84E-01,,,C, YES,+
4466,Q53F19,C17orf85,Uncharacterized protein C17orf85 (Protein ELG),PALGLPSPEAESG,_AEAPAGPALGLPS(ph)PEAESGVDRGEPEPM(ox)EVEEGELEIVPVRR_,S25,+,24.16,24.75,,22.85,25.45,,25.91,25.50,26.95,26.57,,26.47,28.23,25.68,-1.52,-0.93, ,-2.83,-0.24, ,0.23,-0.19,1.27,0.88, ,0.79,2.54,,,,,,,3.35E-03,2.12E-02,1.3E-02,1.08E-03,1.3E-01,,,C,,
4470,Q53GS9,USP39,U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K),AASSRGSPVRVKR,_EPEAASSRGS(ph)PVR_,S46,+,24.01,23.65,23.48,25.08,23.64,22.75,21.59,21.81,22.48,21.47,,,19.82,22.71,1.30,0.95,0.77,2.37,0.94,0.04,-1.12,-0.90,-0.22,-1.24, , ,-2.89,spliceosomal complex assembly;ubiquitin-dependent protein catabolic process,nucleus,,,,,1.42E-03,1.23E-02,1.42E-02,5.03E-04,2.91E-02,+,,C, YES,
4528,Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),YKVGNESPVQELK,_VGNES(ph)PVQELK_,S50,+,26.68,27.11,27.13,27.84,23.68,23.74,,23.11,25.82,25.93,27.45,26.67,24.02,25.76,0.91,1.34,1.37,2.08,-2.09,-2.03, ,-2.65,0.06,0.16,1.68,0.91,-1.75,regulation of cell migration,cytosol;endosome membrane;Golgi apparatus;microtubule;perinuclear region of cytoplasm,,,,,3.08E-03,2.01E-02,9.91E-04,1.41E-01,2.26E-02,,,C, YES,
4603,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),PRIRANSISRLSD,_IRANS(ph)ISR_,S1168,+,25.25,23.92,23.98,25.78,,20.50,20.57,20.48,,,,23.43,19.50,22.60,2.65,1.32,1.38,3.18, ,-2.10,-2.03,-2.12, , , ,0.83,-3.10,,centriole;microtubule;centrosome;spindle,,,,,1.5E-03,1.27E-02,4.06E-04,5.89E-03,3.82E-01,,,C, YES,
4641,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,DQARDSSFERRHG,_DSS(ph)FERR_,S621,+,23.79,24.59,23.09,25.24,19.62,20.21,19.90,20.38,,,17.63,20.35,19.43,21.29,2.50,3.30,1.80,3.94,-1.68,-1.09,-1.39,-0.92, , ,-3.66,-0.94,-1.86,,,,,,,1.22E-05,5.89E-04,2.42E-05,7.32E-06,2.45E-01,,,C, YES,
4642,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,IIKKEVSPEVVRS,_KEVS(ph)PEVVR_,S198,+,28.84,28.69,27.87,28.67,27.02,26.98,26.74,26.13,27.11,25.65,25.19,25.91,25.84,26.97,1.86,1.72,0.90,1.70,0.05,0.00,-0.23,-0.84,0.14,-1.32,-1.79,-1.06,-1.13,,,,,,,5.03E-05,1.38E-03,9.17E-04,1.31E-05,2.35E-02,,,C, YES,+
4648,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,TSGRLRSPSNDSA,_LRS(ph)PS(ph)NDSAHR_,S1208,+,23.26,24.33,23.21,23.60,19.81,19.68,19.82,20.57,19.42,,19.21,19.06,18.52,20.87,2.39,3.46,2.34,2.72,-1.07,-1.19,-1.06,-0.30,-1.46, ,-1.66,-1.82,-2.36,,,,,,,7.16E-07,1.34E-04,1.54E-06,5.49E-07,1.09E-01,,,C, YES,
4651,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,NTEESSSPVRKES,_RNTEESSS(ph)PVRK_,S110,+,22.16,24.03,24.93,22.88,22.14,,,18.52,,,16.80,19.17,,21.33,0.83,2.71,3.60,1.55,0.81, , ,-2.81, , ,-4.53,-2.16, ,,,,,,,1.01E-02,4.56E-02,6.42E-02,2.35E-03,1.27E-01,,,C, YES,
4666,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,SSNYRRSPERPTG,_S(ph)PERPTGDLRER_,S77,+,27.52,28.05,27.89,27.94,27.53,23.02,26.14,26.22,26.06,25.58,25.26,25.86,22.90,26.15,1.37,1.90,1.74,1.79,1.38,-3.13,-0.01,0.07,-0.09,-0.57,-0.89,-0.30,-3.25,,,,,,,8.11E-03,3.9E-02,1.92E-02,2.8E-03,2.77E-01,,,C, YES,+
4714,Q5TCZ1,SH3PXD2A,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),ASESQDSPRKLKY,_EAEEGPTGASESQDS(ph)PRK_,S474,+,24.26,24.39,24.10,24.65,,21.63,,,,,20.11,22.02,20.99,22.77,1.49,1.62,1.33,1.88, ,-1.14, , , , ,-2.66,-0.75,-1.78,superoxide metabolic process;cell communication,podosome;cell junction;cell projection;cytoplasm,,,,,2.06E-03,1.58E-02,1.26E-02,2.83E-04,5.55E-01,,,C,,
4749,Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),KHDRRRSQSIEQE,_S(ph)QS(ph)IEQESQEK_,S527,+,28.27,27.76,26.24,27.19,23.70,21.12,21.72,21.92,23.56,22.53,21.76,22.84,22.01,23.89,4.37,3.87,2.34,3.30,-0.20,-2.77,-2.18,-1.97,-0.33,-1.36,-2.14,-1.05,-1.88,mRNA processing;RNA splicing,spliceosomal complex,,,,,7.47E-07,1.34E-04,7.63E-07,1.11E-06,8.55E-01,+,,C, YES,+
4752,Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),ERRRSRSIDRGLE,_S(ph)RS(ph)IDRGLER_,S320,+,29.91,30.60,30.64,28.78,27.34,26.58,26.92,26.67,28.24,27.04,24.97,26.32,23.53,27.50,2.41,3.10,3.13,1.28,-0.16,-0.93,-0.58,-0.83,0.74,-0.46,-2.54,-1.18,-3.97,mRNA processing;RNA splicing,spliceosomal complex,,,,,6.12E-05,1.57E-03,1.05E-03,1.6E-05,2.62E-02,+,,C, YES,
4753,Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),EKERRRSRSIDRG,_S(ph)RS(ph)IDRGLER_,S318,+,27.37,25.88,26.39,25.31,23.90,21.55,22.70,22.20,23.25,22.17,,20.90,,23.78,3.59,2.10,2.61,1.52,0.12,-2.23,-1.08,-1.59,-0.54,-1.61, ,-2.88, ,mRNA processing;RNA splicing,spliceosomal complex,,,,,1.13E-04,2.33E-03,1.45E-04,9.37E-05,1.64E-01,+,,C, YES,+
4757,Q5VUA4,ZNF318,Zinc finger protein 318 (Endocrine regulatory protein),GIPKDNSPLREKF,_DNS(ph)PLREK_,S464,+,,25.25,24.95,25.91,19.80,21.98,21.61,22.14,22.38,,20.96,21.64,21.26,22.53, ,2.71,2.41,3.37,-2.74,-0.55,-0.92,-0.39,-0.15, ,-1.57,-0.90,-1.27,"meiosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,5.81E-05,1.53E-03,4.66E-05,6.61E-05,6.5E-01,,,C,,
4793,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),ERDGQSSPQPSPR,_ERDGQSS(ph)PQPSPR_,S1270,+,25.08,24.06,24.36,23.10,20.54,,20.10,,20.90,19.75,20.63,21.68,,22.02,3.06,2.04,2.34,1.08,-1.48, ,-1.92, ,-1.12,-2.27,-1.39,-0.34, ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,2.36E-04,3.94E-03,1.66E-04,2.61E-04,8.09E-01,,,C, YES,
4837,Q658Y4,FAM91A1,Protein FAM91A1,LADRKLSDASDER,_KLS(ph)DASDER_,S671,+,24.63,26.02,24.39,26.05,,19.14,,20.49,18.54,,20.21,19.50,19.37,21.83,2.79,4.19,2.56,4.22, ,-2.70, ,-1.35,-3.29, ,-1.63,-2.33,-2.47,,,,,,,1.77E-06,2.07E-04,1.41E-06,2.47E-06,6.91E-01,,,C, YES,+
4853,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],VANGPRSPPSLRC,_S(ph)PPSLR_,S582,+,24.43,24.43,24.25,25.90,22.31,21.46,22.15,22.79,21.52,21.38,22.09,22.15,21.28,22.78,1.65,1.65,1.47,3.12,-0.47,-1.32,-0.63,0.01,-1.26,-1.40,-0.69,-0.63,-1.50,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,5.58E-05,1.48E-03,7.85E-05,4.19E-05,5.37E-01,,,C, YES,
4888,Q6DD88,ATL3,Atlastin-3 (EC 3.6.5.-),AVVGRPSMDKKAQ,_DAVVGRPS(ph)M(ox)DK_,S535,+,24.56,25.93,25.99,25.72,,23.47,23.46,,24.23,24.49,24.04,23.96,23.27,24.46,0.09,1.47,1.53,1.25, ,-1.00,-1.01, ,-0.23,0.02,-0.42,-0.51,-1.20,endoplasmic reticulum organization;protein homooligomerization;Golgi organization,integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,1.1E-02,4.82E-02,6.81E-03,9.24E-03,7.09E-01,,,C, YES,
4961,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),SREERLSPRETRE,_EERLS(ph)PR_,S145,+,26.50,28.27,28.48,26.73,25.68,24.09,24.19,24.58,24.47,,24.30,,22.03,25.39,1.10,2.87,3.09,1.34,0.29,-1.31,-1.21,-0.81,-0.92, ,-1.10, ,-3.36,,cytoskeleton;cytoplasm,,,,,4.09E-04,5.68E-03,1.05E-03,2.17E-04,8.74E-02,,,C, YES,+
5031,Q6PD62,CTR9,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),PKGEEGSDDDETE,_GEEGS(ph)DDDETENGPKPK_,S970,+,25.16,26.71,27.41,27.26,21.86,20.71,23.52,22.24,24.17,23.07,20.62,22.52,,23.77,1.39,2.93,3.64,3.49,-1.91,-3.06,-0.25,-1.53,0.40,-0.70,-3.15,-1.25, ,"stem cell maintenance;histone H2B ubiquitination;JAK-STAT cascade;positive regulation of histone H3-K79 methylation;Wnt receptor signaling pathway;interleukin-6-mediated signaling pathway;positive regulation of histone H3-K4 methylation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of myeloid cell differentiation;cellular response to lipopolysaccharide;histone monoubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone H3-K4 trimethylation;endodermal cell fate commitment;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nuclear speck;transcriptionally active chromatin;Cdc73/Paf1 complex,,,,,3.91E-04,5.46E-03,3.16E-04,3.82E-04,6.28E-01,,,C, YES,+
5111,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),EMHRSQSWEERGD,_SQS(ph)WEER_,S160,+,25.81,26.01,23.06,27.91,21.06,,,23.15,22.70,21.19,22.36,23.50,19.54,23.30,2.51,2.71,-0.24,4.61,-2.24, , ,-0.15,-0.60,-2.10,-0.94,0.21,-3.76,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,3.29E-03,2.09E-02,6.22E-03,1.12E-03,5.73E-01,,,C, YES,
5135,Q6ZRV2,FAM83H,Protein FAM83H,HNESKGSPTSAYP,_GS(ph)PTSAYPERKGS(ph)PTPGFSTR_,S870,+,27.24,25.84,25.77,27.48,,,23.02,22.16,21.88,23.93,22.77,21.94,,24.20,3.03,1.64,1.57,3.28, , ,-1.18,-2.04,-2.33,-0.27,-1.43,-2.27, ,biomineral tissue development,,,,,,8.46E-05,1.9E-03,4.57E-05,1.57E-04,4.93E-01,,,C, YES,+
5203,Q76M96,CCDC80,Coiled-coil domain-containing protein 80 (Down-regulated by oncogenes protein 1) (Up-regulated in BRS-3 deficient mouse homolog),AQDKILSNEYEEK,_ILS(ph)NEYEEK_,S503,,,26.81,25.51,26.03,22.86,,23.00,21.72,24.15,,24.36,24.25,23.28,24.20, ,2.62,1.31,1.84,-1.34, ,-1.19,-2.48,-0.05, ,0.16,0.05,-0.92,positive regulation of cell-substrate adhesion;extracellular matrix organization,interstitial matrix;basement membrane,,,,,1.43E-03,1.23E-02,4.03E-04,8.91E-03,1.68E-01,,,C, YES,
5205,Q7KYR7,BTN2A1,Butyrophilin subfamily 2 member A1,RVGTHQSL_____,_VGTHQS(ph)L_,S374,+,24.02,25.36,,26.21,,22.11,,22.23,22.70,22.12,22.69,,21.87,23.26,0.76,2.10, ,2.95, ,-1.15, ,-1.03,-0.55,-1.13,-0.56, ,-1.39,lipid metabolic process,integral to plasma membrane,,,,,1.67E-03,1.38E-02,1.48E-03,1.1E-03,8.65E-01,,,C, YES,
5209,Q7KZ85,SUPT6H,Transcription elongation factor SPT6 (hSPT6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),RRVKKMSDDEDDD,_KM(ox)S(ph)DDEDDDEEEYGKEEHEK_,S125,+,27.05,27.86,28.36,26.55,24.72,24.63,24.32,24.90,25.49,24.95,22.51,23.53,,25.41,1.64,2.45,2.96,1.14,-0.68,-0.78,-1.09,-0.50,0.09,-0.45,-2.90,-1.88, ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling;virus-host interaction",nucleus,,,,,1.78E-04,3.17E-03,7.52E-04,7.14E-05,8.86E-02,,,C, YES,
5238,Q7L4I2,RSRC2,Arginine/serine-rich coiled-coil protein 2,LAPEKTSPDRDKK,_DGLAPEKTS(ph)PDRDK_,S17,+,24.99,26.08,25.29,23.85,20.87,21.03,20.90,21.43,,,20.33,,,22.75,2.24,3.33,2.53,1.10,-1.89,-1.72,-1.86,-1.32, , ,-2.42, , ,,,,,,,1.39E-04,2.63E-03,3.59E-05,4.67E-04,4.87E-01,,,C, YES,
5240,Q7L4I2,RSRC2,Arginine/serine-rich coiled-coil protein 2,QSEVSVSPRASKH,_KKEQSEVS(ph)VS(ph)PR_,S32,+,29.25,29.02,28.67,29.01,26.18,24.05,27.24,26.90,27.50,26.83,25.78,26.52,24.89,27.06,2.18,1.95,1.60,1.94,-0.89,-3.01,0.18,-0.17,0.44,-0.24,-1.28,-0.54,-2.17,,,,,,,8.09E-04,8.83E-03,9.77E-04,5.12E-04,5.9E-01,,,C, YES,
5248,Q7L8J4,SH3BP5L,SH3 domain-binding protein 5-like (SH3BP-5-like),SLRTVASDLQKCD,_TVAS(ph)DLQK_,S343,+,24.56,26.33,26.08,27.26,22.98,22.73,24.30,24.58,22.08,22.89,24.53,23.78,,24.34,0.22,1.99,1.74,2.92,-1.36,-1.61,-0.04,0.23,-2.26,-1.45,0.19,-0.56, ,,,,,,,3.21E-03,2.06E-02,1.03E-03,8E-03,5.97E-01,,,C,,
5289,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),KLSGEHSESSTPR,_LSGEHS(ph)ES(ph)STPRPR_,S1269,+,26.04,27.23,27.62,26.07,23.08,22.08,21.64,21.66,23.73,21.40,20.78,21.44,20.87,23.36,2.69,3.87,4.26,2.72,-0.27,-1.28,-1.72,-1.69,0.37,-1.96,-2.58,-1.92,-2.48,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,2.02E-07,1.1E-04,1.44E-06,8.42E-08,3.18E-02,,,C, YES,+
5309,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),GADNDGSGSESGY,_GADNDGS(ph)GSESGYTTPK_,S212,+,25.54,25.37,25.23,26.25,23.43,23.24,23.61,23.46,23.63,23.34,22.22,22.63,,24.00,1.54,1.37,1.23,2.26,-0.57,-0.75,-0.39,-0.54,-0.36,-0.66,-1.77,-1.37, ,,polysomal ribosome;nucleus,,,,,9.96E-05,2.13E-03,2.58E-04,5.08E-05,1.51E-01,,,C, YES,
5322,Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),IRTRRQSSGSATN,_RQS(ph)SGSATNVASTPDNR_,S646,+,25.93,23.79,23.05,25.51,22.23,,21.31,21.41,,,21.62,22.27,,23.01,2.92,0.78,0.04,2.49,-0.78, ,-1.70,-1.61, , ,-1.39,-0.74, ,establishment of spindle orientation;microtubule anchoring;microtubule organizing center organization;axon guidance;G2/M transition of mitotic cell cycle;microtubule nucleation;mitotic prometaphase;microtubule bundle formation;negative regulation of microtubule depolymerization;exit from mitosis;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;centrosomal corona;cortical microtubule cytoskeleton;cytosol;cytoplasmic microtubule;kinetochore,,,,,2.4E-03,1.71E-02,9.12E-04,4.24E-03,7.45E-01,,,C, YES,
5338,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),ERARGDSEALDEE,_ERARGDS(ph)EALDEES_,S663,+,28.23,28.44,28.78,27.72,27.91,26.90,26.93,27.03,27.06,26.15,25.54,26.37,24.01,27.01,1.23,1.43,1.78,0.71,0.91,-0.11,-0.07,0.02,0.06,-0.85,-1.47,-0.64,-3.00,"transcription, DNA-dependent",nucleus,,,,,8.62E-04,9.21E-03,7.2E-02,2.36E-04,7.48E-03,,,C, YES,
5340,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),HEEGRDSEEGPRC,_EHEEGRDS(ph)EEGPR_,S625,+,26.88,26.98,26.10,25.58,21.31,20.41,20.96,20.99,21.89,,21.04,19.76,,22.90,3.98,4.08,3.20,2.68,-1.59,-2.49,-1.94,-1.91,-1.01, ,-1.86,-3.14, ,"transcription, DNA-dependent",nucleus,,,,,3.16E-07,1.1E-04,1.71E-07,8.02E-07,3.2E-01,,,C, YES,
5345,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),ERTRKRSEGFSMD,_S(ph)EGFSM(ox)DRK_,S454,+,24.38,25.51,26.20,23.76,,,21.22,20.41,21.13,20.28,19.78,22.15,,22.48,1.90,3.03,3.72,1.28, , ,-1.26,-2.07,-1.35,-2.20,-2.70,-0.34, ,"transcription, DNA-dependent",nucleus,,,,,3E-04,4.55E-03,3.14E-04,2.07E-04,8.25E-01,,,C, YES,
5364,Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),AHKRPASVSSSAA,_RPAS(ph)VSSSAAVEHEQR_,S240,+,23.98,24.10,24.10,22.83,,21.64,21.64,,22.42,,20.42,,20.40,22.39,1.59,1.71,1.71,0.44, ,-0.75,-0.75, ,0.03, ,-1.98, ,-2.00,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,1.98E-03,1.53E-02,1.64E-02,5.42E-04,5.45E-02,,,C, YES,
5427,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),SETSWESPKQIKK,_SETSWES(ph)PK_,S568,+,28.17,28.28,28.14,27.81,26.89,,25.10,24.03,,,,26.46,24.47,26.59,1.58,1.68,1.55,1.21,0.29, ,-1.49,-2.56, , , ,-0.13,-2.12,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,1E-02,4.51E-02,4.31E-03,1.2E-02,8.92E-01,,,C, YES,
5478,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),EEEDNHSDEEDRA,_GPSQEEEDNHS(ph)DEEDRAS(ph)EPK_,S67,+,24.38,26.87,26.98,25.56,24.44,23.28,23.54,23.88,22.33,22.19,22.56,,,24.18,0.20,2.69,2.79,1.37,0.26,-0.90,-0.64,-0.31,-1.85,-1.99,-1.62, , ,,nucleus,,,,,1.33E-03,1.19E-02,2.19E-03,7.71E-04,1.72E-01,,,C, YES,+
5482,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),SGGRLGSPKPERQ,_LGS(ph)PKPER_,S868,+,26.55,27.47,27.21,28.79,24.89,24.41,24.50,24.86,25.11,22.92,24.44,25.24,23.66,25.39,1.17,2.09,1.82,3.40,-0.50,-0.98,-0.89,-0.53,-0.27,-2.47,-0.95,-0.15,-1.72,,nucleus,,,,,7.15E-05,1.73E-03,1.96E-04,3.38E-05,2.44E-01,,,C, YES,+
5504,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),SLQKSSSLGNLKK,_SSS(ph)LGNLK_,S449,+,25.45,26.60,,27.16,23.05,24.65,22.00,25.07,24.27,23.93,23.06,22.24,,24.32,1.14,2.29, ,2.84,-1.27,0.33,-2.31,0.76,-0.05,-0.39,-1.26,-2.07, ,cell adhesion,plasma membrane,,,,,2.66E-03,1.83E-02,3.61E-03,1.4E-03,3.53E-01,,,C, YES,+
5567,Q8IU81,IRF2BP1,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 6.3.2.-),PRRRKASPEPEGE,_KAS(ph)PEPEGEAAGK_,S384,+,24.82,25.29,25.58,25.26,20.67,21.67,21.15,21.37,21.41,20.07,21.97,22.54,21.81,22.58,2.24,2.70,3.00,2.67,-1.91,-0.92,-1.44,-1.21,-1.18,-2.51,-0.61,-0.05,-0.78,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,3.86E-06,2.96E-04,2.1E-06,1.19E-05,5.24E-01,,,C, YES,
5569,Q8IU81,IRF2BP1,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 6.3.2.-),VLPEGRSPGPPAL,_S(ph)PGPPALK_,S66,+,25.07,24.10,24.18,24.43,,22.50,,,22.79,22.37,,,20.90,23.29,1.78,0.81,0.89,1.14, ,-0.80, , ,-0.50,-0.92, , ,-2.40,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,8E-03,3.85E-02,2.58E-02,2.14E-03,2.39E-01,,,C, YES,
5597,Q8IVF2,AHNAK2,Protein AHNAK2,GPQRSHSSSEAYE,_SHS(ph)SSEAYEPR_,S180,+,25.17,26.62,26.04,22.55,24.32,21.71,23.65,24.09,23.66,21.40,22.26,,19.30,23.40,1.77,3.22,2.64,-0.85,0.93,-1.69,0.26,0.70,0.27,-2.00,-1.14, ,-4.10,,nucleus,,,,,2.91E-03,1.94E-02,6.94E-02,8.65E-04,2.19E-02,,,C, YES,
5608,Q8IVF2,AHNAK2,Protein AHNAK2,PKVQRPSLKMPKV,_VQRPS(ph)LK_,S665,+,24.99,23.87,24.37,23.08,21.88,,22.44,22.02,20.77,,21.69,22.00,,22.71,2.28,1.16,1.66,0.37,-0.83, ,-0.27,-0.69,-1.94, ,-1.02,-0.71, ,,nucleus,,,,,9.07E-03,4.19E-02,3.28E-03,1.36E-02,9.3E-01,,,C, YES,
5774,Q8N201,INTS1,Integrator complex subunit 1 (Int1),EAPKPKSSPEQPI,_S(ph)SPEQPIGQGR_,S1326,+,25.36,24.80,24.30,26.37,23.07,23.27,23.46,,24.22,23.27,,22.56,,24.07,1.29,0.73,0.24,2.31,-0.99,-0.80,-0.61, ,0.15,-0.80, ,-1.51, ,negative regulation of apoptotic process;inner cell mass cell proliferation;snRNA processing;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;U2 snRNA 3'-end processing,nuclear membrane;integrator complex;integral to membrane,,,,,7.46E-03,3.63E-02,7.11E-03,4.49E-03,4.21E-01,,,C, YES,
5884,Q8N8S7,ENAH,Protein enabled homolog,TMNGSKSPVISRP,_S(ph)PVISRPK_,S471,,23.38,26.74,26.58,25.64,,,22.27,,21.66,21.96,22.20,24.04,,23.83,-0.44,2.91,2.75,1.81, , ,-1.56, ,-2.17,-1.87,-1.63,0.21, ,T cell receptor signaling pathway;actin polymerization or depolymerization;intracellular transport;neural tube closure;axon guidance,filopodium;cytosol;synapse;stress fiber;plasma membrane;focal adhesion;lamellipodium,,,,,6.42E-03,3.25E-02,3.56E-03,7.2E-03,4.77E-01,+,,C, YES,
5888,Q8N9T8,KRI1,Protein KRI1 homolog,YVDEENSDGETSN,_YVDEENS(ph)DGETSNHR_,S138,+,28.37,27.94,,26.68,24.90,22.87,22.27,22.82,,19.30,23.62,20.95,22.47,23.83,4.54,4.10, ,2.84,1.07,-0.96,-1.57,-1.02, ,-4.54,-0.21,-2.88,-1.37,,,,,,,6.15E-05,1.57E-03,3.57E-04,1.88E-05,8.98E-02,,,C, YES,
5916,Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),KDELTESPKYIQK,_DELTES(ph)PK_,S234,+,26.11,24.66,24.90,26.03,21.89,22.90,24.36,23.53,23.52,22.73,22.67,23.08,23.06,23.80,2.31,0.86,1.10,2.23,-1.91,-0.91,0.55,-0.27,-0.29,-1.07,-1.14,-0.72,-0.74,regulation of mRNA stability,plasma membrane;nucleus;perinuclear region of cytoplasm;cytoplasm,,,,,2.27E-03,1.67E-02,2.82E-03,1.24E-03,5.51E-01,,,C, YES,
5917,Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),REFDRHSGSDRSS,_EFDRHS(ph)GSDR_,S197,+,24.44,23.74,23.63,24.77,20.02,,20.03,19.79,,,18.43,20.07,,21.66,2.78,2.08,1.97,3.12,-1.64, ,-1.63,-1.86, , ,-3.22,-1.59, ,regulation of mRNA stability,plasma membrane;nucleus;perinuclear region of cytoplasm;cytoplasm,,,,,2.56E-05,9.12E-04,2.71E-05,2.07E-05,3.7E-01,,,C, YES,
5941,Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),LSQGRSSPQLDPL,_TQLS(ph)QGRSS(ph)PQLDPLRK_,S183,+,27.81,27.18,26.56,27.10,23.68,,26.38,21.76,25.54,24.16,25.25,24.93,,25.49,2.32,1.70,1.07,1.62,-1.81, ,0.89,-3.73,0.05,-1.32,-0.24,-0.55, ,multicellular organismal development;regulation of translation;cytoplasmic mRNA processing body assembly,intracellular membrane-bounded organelle;cytoplasmic stress granule;cytoplasmic mRNA processing body,,,,,1.08E-02,4.76E-02,4.08E-03,1.74E-02,6.35E-01,,,C, YES,+
5943,Q8ND76,CCNY,Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X),AHSRLESYRPDTD,_LES(ph)YRPDTDLSR_,S25,+,24.63,24.67,23.75,25.17,21.96,,21.82,22.37,21.30,,24.18,,23.44,23.33,1.30,1.34,0.42,1.84,-1.37, ,-1.51,-0.96,-2.03, ,0.85, ,0.11,G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein kinase activity;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,,,,1E-03,1E-02,2.02E-04,2.13E-01,1.26E-02,,,C, YES,+
5964,Q8NDX5,PHC3,Polyhomeotic-like protein 3 (Early development regulatory protein 3) (Homolog of polyhomeotic 3) (hPH3),ISQRDPSPESNKK,_ISQRDPS(ph)PESNK_,S222,+,24.36,27.07,27.84,25.79,,,22.16,,22.24,23.10,22.46,,21.49,24.06,0.31,3.02,3.78,1.73, , ,-1.89, ,-1.82,-0.95,-1.60, ,-2.57,multicellular organismal development,actin cytoskeleton;PRC1 complex,,,,,1.51E-03,1.28E-02,1.58E-03,8.42E-04,8.79E-01,,,C,,
6038,Q8NHG8,ZNRF2,E3 ubiquitin-protein ligase ZNRF2 (EC 6.3.2.-) (Protein Ells2) (RING finger protein 202) (Zinc/RING finger protein 2),DRPVGGSPGGPRL,_DRPVGGS(ph)PGGPR_,S73,+,23.59,24.69,23.20,24.05,20.83,,,20.65,,20.19,20.57,,,22.22,1.36,2.47,0.98,1.83,-1.39, , ,-1.58, ,-2.03,-1.65, , ,protein ubiquitination,endosome membrane;cell junction;plasma membrane;lysosomal membrane;presynaptic membrane,,,,,1.06E-03,1.02E-02,1.19E-03,5.61E-04,6.9E-01,,,C,,
6107,Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L (EC 6.3.2.-) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (Rhysin-2) (Rhysin2),TPMDIDSDDSKAA,_EGHETPM(ox)DIDS(ph)DDSK_,S532,+,26.68,28.65,29.44,27.87,23.87,21.19,25.32,25.54,22.38,24.94,23.54,24.13,21.13,24.98,1.70,3.67,4.47,2.90,-1.11,-3.79,0.35,0.57,-2.60,-0.04,-1.44,-0.85,-3.84,histone monoubiquitination;response to DNA damage stimulus,nucleus;cytoplasm,,,,,9.9E-04,1E-02,8.43E-04,8.28E-04,8.2E-01,,,C, YES,
6108,Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L (EC 6.3.2.-) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (Rhysin-2) (Rhysin2),EQKQQFSPSMTER,_QQFS(ph)PSM(ox)TER_,S202,+,27.83,26.55,26.52,27.69,23.39,23.63,25.53,26.34,22.90,23.27,25.50,24.32,24.52,25.23,2.60,1.32,1.29,2.46,-1.84,-1.60,0.30,1.11,-2.33,-1.96,0.27,-0.91,-0.71,histone monoubiquitination;response to DNA damage stimulus,nucleus;cytoplasm,,,,,2.21E-03,1.65E-02,1.37E-03,2.32E-03,9.56E-01,,,C, YES,
6115,Q8TDM6,DLG5,Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG),EFSRRLSMSEVKD,_RLS(ph)M(ox)SEVK_,S1326,+,23.95,24.40,24.40,24.52,23.82,22.94,22.25,23.11,23.06,20.53,21.50,22.31,22.54,23.02,0.92,1.37,1.37,1.49,0.79,-0.09,-0.77,0.08,0.04,-2.50,-1.53,-0.71,-0.48,negative regulation of cell proliferation;cell-cell adhesion;regulation of apoptotic process;intracellular signal transduction,plasma membrane;cell-cell adherens junction;cytoplasm,,,,,2.58E-03,1.79E-02,4.79E-02,7.65E-04,2.63E-02,,,C, YES,
6139,Q8TEB9,RHBDD1,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),RLHRFDSQ_____,_(gl)QRLHRFDS(ph)Q_,S105,+,25.89,27.45,27.83,25.29,23.89,23.42,24.52,23.22,25.30,25.15,23.42,23.03,23.46,24.76,1.13,2.69,3.07,0.53,-0.87,-1.34,-0.24,-1.54,0.54,0.39,-1.34,-1.73,-1.30,negative regulation of apoptotic process;cellular response to UV;positive regulation of protein processing;ER-associated protein catabolic process;positive regulation of secretion;post-translational protein modification;cellular response to unfolded protein;membrane protein intracellular domain proteolysis;membrane protein proteolysis;positive regulation of protein catabolic process;apoptotic process;spermatid differentiation,mitochondrion;integral to endoplasmic reticulum membrane;endoplasmic reticulum quality control compartment,,,,,1.53E-03,1.28E-02,1.63E-03,9.85E-04,6.5E-01,,,C,,
6149,Q8TEU7,RAPGEF6,Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2) (PDZ-GEF2) (RA-GEF-2),KRARRSSLLNAKK,_RSS(ph)LLNAK_,S1144,+,22.64,24.49,24.60,23.58,21.52,,,,,20.62,21.20,21.33,,22.50,0.15,1.99,2.11,1.08,-0.98, , , , ,-1.88,-1.30,-1.17, ,regulation of GTPase activity;regulation of small GTPase mediated signal transduction;Ras protein signal transduction,plasma membrane;cytoplasm,,,,,1.05E-02,4.67E-02,3.85E-02,1.71E-03,6.49E-01,,,C, YES,
6196,Q8WU90,ZC3H15,Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4),AENGERSDLEEDN,_AENGERS(ph)DLEEDNER_,S381,+,26.92,27.87,28.28,26.06,24.83,22.69,24.09,24.60,,,24.19,24.42,22.24,25.11,1.81,2.76,3.17,0.95,-0.27,-2.42,-1.02,-0.50, , ,-0.91,-0.69,-2.86,cytokine-mediated signaling pathway,nucleolus;cytoplasm,,,,,7E-04,8.1E-03,7.51E-04,4.69E-04,5.77E-01,,,C, YES,
6214,Q8WUI4,HDAC7,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),PLRKTVSEPNLKL,_TVS(ph)EPNLK_,S155,+,27.16,26.46,26.54,27.10,24.16,22.16,24.44,24.37,22.48,,23.24,23.49,,24.69,2.47,1.76,1.85,2.41,-0.53,-2.53,-0.26,-0.32,-2.21, ,-1.45,-1.20, ,"vasculogenesis;cell-cell junction assembly;negative regulation of interleukin-2 production;Notch signaling pathway;histone H3 deacetylation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell migration involved in sprouting angiogenesis;transcription, DNA-dependent;histone H4 deacetylation;negative regulation of osteoblast differentiation",histone deacetylase complex;nucleus;cytoplasm,,,,,1.88E-04,3.3E-03,6.82E-05,4.65E-04,8.34E-01,,,C, YES,
6232,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),KAKKLTSDEEGEP,_KLT(ph)S(ph)DEEGEPSGK_,S570,+,27.00,28.46,29.02,28.48,24.82,25.71,25.75,25.65,,26.02,24.72,25.38,23.93,26.25,0.75,2.21,2.77,2.24,-1.42,-0.53,-0.50,-0.60, ,-0.22,-1.52,-0.86,-2.31,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,4.28E-04,5.84E-03,8.5E-04,1.88E-04,4.52E-01,,,C, YES,+
6271,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),IMRRGESLDNLDS,_RGES(ph)LDNLDSPR_,S1102,+,28.10,28.12,27.28,28.03,25.49,25.91,27.95,26.14,27.36,25.41,22.05,26.84,25.33,26.46,1.64,1.66,0.82,1.57,-0.97,-0.55,1.49,-0.32,0.90,-1.06,-4.42,0.38,-1.13,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,7.62E-03,3.7E-02,8.23E-02,2.1E-03,6.06E-02,,,C, YES,
6279,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),PTPRSHSPSASQS,_SHS(ph)PSASQSGSQLR_,S1185,+,25.93,26.55,26.76,25.17,23.36,22.15,22.35,21.89,23.22,23.81,21.38,,21.30,23.66,2.27,2.90,3.11,1.51,-0.29,-1.51,-1.31,-1.77,-0.43,0.15,-2.28, ,-2.35,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,5.89E-05,1.54E-03,5.43E-05,6.26E-05,5.36E-01,,,C, YES,+
6295,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),RMYPPRSPKSAAP,_M(ox)YPPRS(ph)PK_,S449,+,23.27,24.57,25.09,23.91,22.17,20.85,20.80,21.00,20.74,21.92,21.66,21.81,21.04,22.22,1.05,2.35,2.87,1.70,-0.05,-1.37,-1.41,-1.22,-1.48,-0.30,-0.55,-0.41,-1.18,,membrane,,,,,8.22E-05,1.88E-03,3.15E-05,3.44E-04,3.45E-01,,,C, YES,
6297,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),QGSGRESPSLASR,_QGSGRES(ph)PSLASR_,S339,+,28.76,28.47,28.24,28.68,28.38,27.87,24.78,27.25,27.76,25.75,23.69,24.55,23.59,26.75,2.01,1.72,1.48,1.93,1.63,1.12,-1.97,0.50,1.01,-1.00,-3.06,-2.20,-3.16,,membrane,,,,,9.86E-05,2.12E-03,5.62E-02,2.88E-05,9.22E-04,,,C, YES,
6300,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),STSTPTSPGPRTH,_STSTPTS(ph)PGPR_,S684,+,24.01,,,23.85,23.01,22.43,21.59,22.06,21.49,21.59,22.08,21.97,21.36,22.31,1.70, , ,1.54,0.69,0.12,-0.72,-0.25,-0.82,-0.73,-0.23,-0.35,-0.95,,membrane,,,,,8.33E-03,3.96E-02,1.02E-02,3.96E-03,4.64E-01,,,C, YES,
6304,Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),EKDGPISPKKKKP,_DGPIS(ph)PKK_,S911,+,26.44,26.07,26.84,25.15,21.41,21.38,22.57,21.94,22.00,20.76,20.15,,21.44,23.01,3.43,3.05,3.83,2.14,-1.60,-1.63,-0.44,-1.07,-1.02,-2.25,-2.87, ,-1.57,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of mitosis;positive regulation of insulin-like growth factor receptor signaling pathway;positive regulation of peptidyl-threonine phosphorylation;regulation of cell morphogenesis;positive regulation of transcription, DNA-dependent;regulation of protein phosphorylation;insulin receptor signaling pathway;positive regulation of cell proliferation;protein import into nucleus;cytoskeleton organization;regulation of growth;positive regulation of transcription from RNA polymerase II promoter",nucleus,,,,,4.61E-06,3.15E-04,1.14E-05,2.95E-06,1.13E-01,,,C, YES,
6346,Q8WY36,BBX,HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2),SSRDLPSPKKAKT,_DLPS(ph)PKK_,S183,+,24.60,24.60,24.32,25.22,22.08,21.45,20.80,21.38,21.90,20.51,,,21.15,22.55,2.06,2.05,1.77,2.67,-0.47,-1.10,-1.75,-1.16,-0.64,-2.04, , ,-1.39,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,1.46E-05,6.63E-04,1.1E-05,2.1E-05,2.68E-01,,,C,,
6351,Q8WYL5,SSH1,Protein phosphatase Slingshot homolog 1 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 1) (SSH-1L) (hSSH-1L),NLTRSSSSDSIHS,_SSS(ph)SDSIHSVR_,S625,+,22.21,26.40,,26.02,23.53,21.03,22.19,22.13,22.51,,22.54,21.06,21.22,22.80,-0.60,3.59, ,3.21,0.73,-1.77,-0.61,-0.68,-0.29, ,-0.26,-1.74,-1.58,regulation of actin polymerization or depolymerization;cell morphogenesis;regulation of axonogenesis;regulation of cellular protein metabolic process;actin cytoskeleton organization;cellular response to ATP;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation,midbody;plasma membrane;cytoskeleton;lamellipodium;cleavage furrow;cytoplasm,,,+,,1.12E-02,4.87E-02,1.17E-02,5.86E-03,4.72E-01,,,C,,
6384,Q92522,H1FX,Histone H1x,GGSAALSPSKKRK,_AGGSAALS(ph)PSK_,S31,+,25.98,26.11,27.02,25.48,22.04,21.16,20.43,24.61,19.21,,,21.57,20.57,23.11,2.88,3.00,3.91,2.37,-1.07,-1.94,-2.68,1.50,-3.90, , ,-1.54,-2.54,nucleosome assembly,nucleus;nucleosome,,,,,4.39E-03,2.5E-02,1.94E-03,5.63E-03,7.47E-01,,,C, YES,
6432,Q92610,ZNF592,Zinc finger protein 592,SIKPSDSPRSICS,_SIKPSDS(ph)PR_,S348,,24.21,25.04,23.52,25.50,22.35,21.76,,21.31,20.73,20.44,20.53,20.49,,22.35,1.85,2.69,1.16,3.14,0.00,-0.59, ,-1.04,-1.62,-1.91,-1.83,-1.86, ,"cell death;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,4.12E-05,1.27E-03,1.36E-04,1.74E-05,1.33E-01,,,C,,
6506,Q92922,SMARCC1,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),NEEPVRSPERRDR,_NEEPVRS(ph)PERR_,S310,+,25.79,27.87,28.55,26.69,23.50,23.98,24.47,22.91,24.71,25.30,23.60,25.43,23.55,25.11,0.69,2.76,3.45,1.59,-1.60,-1.13,-0.63,-2.19,-0.39,0.20,-1.51,0.32,-1.55,"nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;insulin receptor signaling pathway;transcription, DNA-dependent;organ morphogenesis;chromatin remodeling;nervous system development;positive regulation of transcription from RNA polymerase II promoter",XY body;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,9.6E-04,9.93E-03,3.48E-04,2.99E-03,4.08E-01,,,C, YES,+
6518,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),ERQELGSPEERLQ,_(gl)QELGS(ph)PEER_,S904,+,26.81,27.11,27.66,28.30,24.55,24.26,25.33,25.95,24.99,23.10,25.66,25.23,24.73,25.67,1.14,1.44,1.99,2.63,-1.12,-1.41,-0.34,0.29,-0.68,-2.56,-0.01,-0.44,-0.94,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,2.49E-03,1.75E-02,2.84E-03,1.43E-03,5.98E-01,,,C, YES,
6528,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),GLFRSESLESPRG,_SES(ph)LESPRGER_,S617,+,27.42,26.76,26.98,27.21,25.12,23.78,23.79,23.93,24.77,22.04,24.25,23.77,22.31,24.78,2.64,1.98,2.20,2.43,0.34,-1.00,-0.99,-0.85,0.00,-2.74,-0.53,-1.01,-2.47,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,8.49E-06,4.46E-04,7.17E-05,2.84E-06,4.7E-02,,,C, YES,+
6541,Q969E4,TCEAL3,Transcription elongation factor A protein-like 3 (TCEA-like protein 3) (Transcription elongation factor S-II protein-like 3),PDDEGKSDEEEKP,_S(ph)DEEEKPDVEGK_,S30,+,26.71,30.75,31.20,28.81,,,23.01,,23.62,22.05,,19.64,,25.72,0.98,5.03,5.47,3.08, , ,-2.71, ,-2.10,-3.67, ,-6.08, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,9.09E-05,1.99E-03,4.65E-04,2.4E-05,9.23E-02,,,C, YES,
6569,Q96AQ6,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein),ALQAPHSPSKTDG,_ALQAPHS(ph)PSK_,S14,+,27.01,28.42,29.16,24.74,,20.35,22.01,,23.25,25.42,23.87,22.80,22.16,24.47,2.53,3.95,4.69,0.27, ,-4.12,-2.46, ,-1.22,0.95,-0.61,-1.67,-2.31,"multicellular organismal development;cell differentiation;negative regulation of transcription, DNA-dependent",cytosol;nucleus;microtubule,,,,,6.66E-04,7.83E-03,2.52E-04,3.31E-03,1.29E-01,,,C, YES,
6652,Q96E39,RBMXL1,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)",EQATKPSFERGRH,_VEQATKPS(ph)FER_,S88,+,26.75,25.71,25.09,25.23,22.75,23.36,24.19,,25.04,23.52,23.43,22.66,,24.34,2.41,1.37,0.75,0.89,-1.59,-0.97,-0.15, ,0.71,-0.82,-0.91,-1.68, ,mRNA processing;RNA splicing,ribonucleoprotein complex;nucleus,,,,,3.28E-03,2.09E-02,5.06E-03,1.47E-03,3.93E-01,,,C, YES,+
6654,Q96EB6,SIRT1,NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],GPGLERSPGEPGG,_S(ph)PGEPGGAAPEREVPAAAR_,S47,+,22.87,23.85,22.49,24.85,22.48,23.35,22.91,22.97,,19.71,21.08,21.00,,22.50,0.37,1.34,-0.01,2.34,-0.02,0.85,0.41,0.46, ,-2.79,-1.43,-1.50, ,"regulation of mitotic cell cycle;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of helicase activity;negative regulation of fat cell differentiation;fatty acid homeostasis;regulation of glucose metabolic process;regulation of smooth muscle cell apoptotic process;negative regulation of DNA damage response, signal transduction by p53 class mediator;muscle organ development;regulation of peroxisome proliferator activated receptor signaling pathway;proteasomal ubiquitin-dependent protein catabolic process;peptidyl-lysine acetylation;negative regulation of TOR signaling cascade;white fat cell differentiation;regulation of protein import into nucleus, translocation;DNA synthesis involved in DNA repair;cell aging;cellular response to hypoxia;transcription, DNA-dependent;positive regulation of macrophage apoptotic process;cellular response to ionizing radiation;negative regulation of protein kinase B signaling cascade;cellular response to tumor necrosis factor;negative regulation of I-kappaB kinase/NF-kappaB cascade;methylation-dependent chromatin silencing;spermatogenesis;ovulation from ovarian follicle;negative regulation of cell growth;positive regulation of transcription from RNA polymerase II promoter;positive regulation of cellular senescence;positive regulation of cAMP-dependent protein kinase activity;negative regulation of cAMP-dependent protein kinase activity;positive regulation of MHC class II biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;maintenance of chromatin silencing;negative regulation of apoptotic process;cellular response to hydrogen peroxide;negative regulation of prostaglandin biosynthetic process;triglyceride mobilization;negative regulation of NF-kappaB transcription factor activity;negative regulation of androgen receptor signaling pathway;negative regulation of peptidyl-lysine acetylation;rRNA processing;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;response to insulin stimulus;positive regulation of cholesterol efflux;positive regulation of insulin receptor signaling pathway;DNA replication;single strand break repair;positive regulation of adaptive immune response;establishment of chromatin silencing;peptidyl-lysine deacetylation;regulation of endodeoxyribonuclease activity;negative regulation of cellular response to testosterone stimulus;cholesterol homeostasis;cellular glucose homeostasis;positive regulation of cell proliferation;virus-host interaction;cellular triglyceride homeostasis;cellular response to starvation;negative regulation of cellular senescence;angiogenesis;pyrimidine dimer repair by nucleotide-excision repair;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;chromatin silencing at rDNA;protein destabilization;positive regulation of macroautophagy;regulation of bile acid biosynthetic process;positive regulation of chromatin silencing;positive regulation of DNA repair;protein ubiquitination",nuclear heterochromatin;nuclear inner membrane;cytoplasm;nuclear euchromatin;nucleolus;PML body;rDNA heterochromatin;chromatin silencing complex,,,,,1.7E-03,1.39E-02,2.28E-01,5.51E-04,5.26E-03,,,C,,
6662,Q96EV2,RBM33,RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33),VKVKPASPVAQPK,_VKPAS(ph)PVAQPK_,S765,+,24.59,25.77,25.90,24.41,20.44,21.42,22.00,21.00,23.09,22.50,21.93,22.31,20.83,22.78,1.80,2.99,3.11,1.63,-2.35,-1.37,-0.78,-1.79,0.31,-0.28,-0.85,-0.48,-1.95,,,,,,,4.88E-05,1.35E-03,2.6E-05,1.14E-04,6.28E-01,,,C, YES,+
6667,Q96F86,EDC3,Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1),SQDVAVSPQQQQC,_SQDVAVS(ph)PQQQQCSK_,S131,+,,24.06,24.06,24.60,22.75,,22.40,22.00,21.15,21.12,20.61,,,22.53, ,1.53,1.53,2.07,0.22, ,-0.12,-0.53,-1.38,-1.41,-1.92, , ,gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,cytosol;cytoplasmic mRNA processing body,,,,,1.93E-03,1.51E-02,5.64E-03,7.78E-04,1.03E-01,,,C, YES,
6676,Q96FV9,THOC1,THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) (p84N5) (hTREX84),LLKENESPDVRRD,_ENES(ph)PDVRR_,S560,+,23.30,25.16,,24.15,,20.90,20.75,20.32,21.61,,20.34,20.02,,21.84,1.46,3.32, ,2.31, ,-0.94,-1.09,-1.52,-0.22, ,-1.50,-1.82, ,"intronless viral mRNA export from host nucleus;regulation of DNA-dependent transcription, elongation;signal transduction;mRNA processing;apoptotic process;RNA splicing;transcription, DNA-dependent;RNA processing",THO complex part of transcription export complex;nuclear speck;nuclear matrix;cytoplasm,Other TF domain,,,,2.48E-04,4.01E-03,2.34E-04,1.98E-04,3.32E-01,+,,C, YES,
6680,Q96G23,CERS2,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),LVEDERSDREETE,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,S341,+,26.65,28.46,27.92,27.12,21.34,24.46,22.75,,23.98,22.85,23.80,24.13,22.94,24.70,1.95,3.76,3.22,2.42,-3.36,-0.24,-1.95, ,-0.72,-1.85,-0.90,-0.58,-1.76,phospholipid metabolic process;small molecule metabolic process;ceramide biosynthetic process;sphingolipid biosynthetic process,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,Homeobox,,,,2.25E-05,8.62E-04,1.65E-05,3.5E-05,6.76E-01,,,C, YES,+
6729,Q96J92,WNK4,Serine/threonine-protein kinase WNK4 (EC 2.7.11.1) (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4),GIMRRNSLSGSST,_RNS(ph)LSGSSTGSQEQR_,S1217,+,,23.72,,25.15,21.36,,19.91,21.52,21.10,,20.56,22.95,21.28,21.95, ,1.77, ,3.20,-0.59, ,-2.04,-0.43,-0.85, ,-1.39,1.01,-0.67,intracellular protein kinase cascade;chloride transport;protein localization;ion transport;negative regulation of pancreatic juice secretion,tight junction;cytoplasm,,+,,,5.45E-03,2.91E-02,2.11E-03,1.07E-02,4.19E-01,,,C, YES,
6759,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KTAPPASPEARKR,_TAPPAS(ph)PEARK_,S542,+,22.92,25.21,25.40,24.77,23.81,22.43,21.85,22.46,22.52,21.97,21.02,22.26,20.35,22.84,0.08,2.36,2.56,1.93,0.97,-0.42,-0.99,-0.39,-0.32,-0.88,-1.83,-0.58,-2.49,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,8.13E-04,8.83E-03,7.43E-03,2.21E-04,6.79E-02,,,C, YES,
6832,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),FFGRDRSPLRRSP,_S(ph)PLRRS(ph)PPR_,S215,+,26.22,26.29,26.46,26.14,23.27,21.55,21.96,22.19,21.84,19.02,20.75,21.29,21.02,22.92,3.29,3.37,3.54,3.22,0.34,-1.38,-0.96,-0.73,-1.08,-3.90,-2.18,-1.64,-1.90,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,1.36E-07,9.31E-05,1.92E-06,4.5E-08,8.62E-03,,,C, YES,
6839,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),YERTRLSPPRASY,_TRLS(ph)PPR_,S582,+,24.79,26.85,,25.12,23.88,23.20,22.06,22.38,22.14,21.77,22.31,22.26,,23.34,1.45,3.51, ,1.78,0.54,-0.14,-1.28,-0.96,-1.20,-1.57,-1.03,-1.08, ,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,4.29E-04,5.84E-03,5.67E-04,2.71E-04,3.49E-01,,,C, YES,
6850,Q96PY5,FMNL2,Formin-like protein 2 (Formin homology 2 domain-containing protein 2),SKPWSRSIEDLHR,_S(ph)IEDLHR_,S171,+,26.79,27.23,25.18,26.34,26.69,26.09,26.28,26.40,26.17,25.46,23.88,24.13,22.58,25.63,1.16,1.60,-0.46,0.71,1.05,0.46,0.65,0.77,0.54,-0.17,-1.76,-1.50,-3.05,regulation of cell morphogenesis;cortical actin cytoskeleton organization,cytoplasm,,,,,2.47E-03,1.74E-02,6.38E-01,1.49E-03,2.63E-03,,,C, YES,
6874,Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),SGGGEESEGEEVD,_RGGGS(ph)GGGEES(ph)EGEEVDED_,S304,+,28.03,28.82,28.72,28.98,27.80,27.07,27.82,28.05,28.07,27.24,26.84,27.42,25.17,27.69,0.34,1.13,1.03,1.28,0.11,-0.62,0.13,0.35,0.38,-0.46,-0.86,-0.28,-2.52,"regulation of myeloid cell differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",DNA replication factor A complex,Other TF domain,,,,9.12E-03,4.2E-02,1.09E-01,2.58E-03,5.47E-02,,,C, YES,
6893,Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),AAAGSASPRSWDE,_RPAAAAAAGSAS(ph)PR_,S153,+,28.81,28.02,27.93,26.69,24.78,23.89,24.08,23.04,24.60,22.66,23.15,24.13,21.97,24.90,3.91,3.11,3.03,1.78,-0.12,-1.02,-0.83,-1.86,-0.30,-2.24,-1.76,-0.78,-2.93,regulation of DNA-dependent DNA replication initiation;DNA synthesis involved in DNA repair;DNA replication,mitochondrion;nucleus;perinuclear region of cytoplasm,,,,,1.86E-06,2.07E-04,9.46E-06,8.13E-07,8.01E-02,,,C, YES,
6899,Q96S94,CCNL2,Cyclin-L2 (Paneth cell-enhanced expression protein),GKGSKPSPLSVKN,_GSKPS(ph)PLSVK_,S126,+,23.13,24.54,25.23,23.89,20.87,21.53,22.04,21.44,21.54,22.72,21.32,21.54,,22.48,0.65,2.06,2.75,1.40,-1.61,-0.95,-0.44,-1.04,-0.94,0.24,-1.16,-0.95, ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck;nucleus,,,,,1.68E-03,1.38E-02,5.18E-04,5.13E-03,5.38E-01,,,C,,
6931,Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),MNSDTTSPELREH,_YM(ox)NSDTTS(ph)PELR_,S1112,+,26.14,26.44,25.93,25.77,24.53,24.27,23.53,23.75,24.21,23.39,,,,24.80,1.35,1.64,1.13,0.97,-0.27,-0.52,-1.27,-1.05,-0.59,-1.40, , , ,negative regulation of apoptotic process;aging;response to organic nitrogen;blood coagulation;interphase of mitotic cell cycle;cellular response to glucose stimulus;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;negative regulation of transcription regulatory region DNA binding;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;cellular protein localization;in utero embryonic development;response to methylglyoxal;negative regulation of transcription from RNA polymerase II promoter;positive regulation of defense response to virus by host;DNA replication;activation of innate immune response;positive regulation of chromatin silencing,transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex;kinetochore,,,,,2.56E-03,1.79E-02,8.67E-04,4.7E-03,4.16E-01,,,C, YES,
6937,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),SYLSKNSEDDELA,_NS(ph)EDDELAK_,S1227,+,23.87,24.19,24.55,24.42,,,21.21,,21.61,,20.44,22.01,,22.79,1.08,1.40,1.76,1.63, , ,-1.58, ,-1.17, ,-2.35,-0.78, ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,7.57E-03,3.68E-02,6.5E-03,4.24E-03,8.34E-01,,,C, YES,
6951,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),RLHSYSSPSTKNS,_LHSYSS(ph)PSTK_,S128,+,23.36,24.23,,24.56,22.23,,20.22,21.15,22.25,,20.71,21.39,,22.23,1.13,2.00, ,2.32,0.00, ,-2.01,-1.09,0.02, ,-1.53,-0.85, ,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,3.37E-03,2.12E-02,2.24E-03,2.81E-03,6.02E-01,,,C, YES,
6961,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),NVDAAVSPRGAAA,_NVDAAVS(ph)PR_,S2101,+,24.92,24.62,24.25,26.04,23.35,23.32,22.33,22.91,22.96,22.27,,21.75,,23.52,1.40,1.10,0.73,2.52,-0.17,-0.20,-1.19,-0.61,-0.56,-1.25, ,-1.77, ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,6.35E-04,7.51E-03,1.09E-03,3.86E-04,1.49E-01,,+,C, YES,+
6981,Q99442,SEC62,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),NHGTEGSGGERHS,_VGPGNHGTEGS(ph)GGER_,S335,,22.87,23.95,,24.53,,19.11,,,19.52,,20.77,18.77,20.79,21.29,1.58,2.66, ,3.24, ,-2.18, , ,-1.76, ,-0.52,-2.52,-0.50,cotranslational protein targeting to membrane,rough endoplasmic reticulum;intermediate filament cytoskeleton;integral to membrane;aggresome;endoplasmic reticulum membrane,,,,,5.66E-04,6.93E-03,3.55E-04,6.76E-04,3.79E-01,,,C, YES,
7011,Q99569,PKP4,Plakophilin-4 (p0071),GQVGSSSPKRSGM,_VASPSQGQVGSSS(ph)PK_,S293,+,25.36,23.81,,24.81,22.27,22.48,22.66,22.23,23.09,,21.80,21.34,20.61,22.77,2.59,1.04, ,2.04,-0.49,-0.29,-0.11,-0.54,0.32, ,-0.97,-1.43,-2.16,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,1.22E-04,2.44E-03,9.82E-04,4.25E-05,2.92E-02,,,C, YES,
7017,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",RRSRFHSPSTTWS,_FHS(ph)PSTTWSPNK_,S481,+,25.66,25.44,25.44,25.28,,21.70,,,22.20,,24.20,24.18,,24.26,1.40,1.17,1.17,1.02, ,-2.56, , ,-2.06, ,-0.06,-0.08, ,spliceosomal complex assembly,nucleus,,,,,1.01E-03,1E-02,2.62E-04,9.7E-02,1.11E-02,,,C, YES,+
7055,Q99700,ATXN2,Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein),IKPNETSPSFSKA,_ENIKPNETS(ph)PSFSK_,S693,+,23.16,25.57,26.04,26.00,25.75,,27.77,28.18,27.04,26.89,27.17,27.64,27.43,26.55,-3.39,-0.98,-0.51,-0.55,-0.81, ,1.22,1.63,0.49,0.33,0.62,1.09,0.88,neuromuscular process;cerebellar Purkinje cell differentiation;RNA metabolic process;homeostasis of number of cells;negative regulation of multicellular organism growth;cell death;negative regulation of receptor internalization;RNA transport;neuron projection morphogenesis;stress granule assembly;regulation of translation;cytoplasmic mRNA processing body assembly,trans-Golgi network;Golgi apparatus;nucleus;polysome;cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,9.06E-03,4.18E-02,7.38E-03,5.59E-03,8.92E-01,,,C, YES,
7077,Q99959,PKP2,Plakophilin-2,TAKAYHSLKD___,_AYHS(ph)LKD_,S834,,28.56,24.11,23.49,25.07,20.45,18.22,21.19,21.35,,,19.82,23.98,,22.62,5.94,1.48,0.87,2.44,-2.18,-4.40,-1.44,-1.27, , ,-2.81,1.36, ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,3.84E-03,2.29E-02,7.7E-04,2.8E-02,2.86E-01,,,C, YES,
7082,Q99959,PKP2,Plakophilin-2,LEISPDSSPERAH,_RLEIS(ph)PDS(ph)S(ph)PER_,S154,+,28.25,26.74,27.64,26.51,26.57,25.05,25.47,,24.75,23.98,24.38,21.72,25.53,25.55,2.70,1.19,2.09,0.96,1.02,-0.50,-0.08, ,-0.80,-1.57,-1.17,-3.83,-0.02,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,3.7E-03,2.23E-02,4.61E-02,8.53E-04,6.44E-02,,,C, YES,+
7088,Q99959,PKP2,Plakophilin-2,RPGTSRSMGNLLE,_S(ph)MGNLLEK_,S251,+,27.79,24.36,24.79,26.05,,,23.27,21.78,21.54,21.21,22.33,23.64,22.19,23.54,4.25,0.82,1.25,2.51, , ,-0.27,-1.76,-2.01,-2.33,-1.21,0.10,-1.35,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,1.08E-03,1.04E-02,1.01E-03,7.63E-04,8.66E-01,,,C, YES,
7122,Q9BRD0,BUD13,BUD13 homolog,HDTPDPSPRRARH,_DRHDT(ph)PDPS(ph)PRR_,S151,+,25.67,26.37,26.41,25.73,21.43,18.31,21.51,24.16,23.09,21.44,,,,23.41,2.26,2.96,3.00,2.32,-1.98,-5.10,-1.90,0.75,-0.33,-1.97, , , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,3.51E-03,2.16E-02,6.34E-04,1.34E-02,8.69E-01,,,C, YES,
7124,Q9BRD0,BUD13,BUD13 homolog,HDTPDPSPLRGAR,_HDT(ph)PDPS(ph)PLRGAR_,S163,+,26.04,25.96,,25.44,23.58,22.50,21.96,22.68,,,21.65,,,23.73,2.31,2.23, ,1.71,-0.15,-1.22,-1.76,-1.05, , ,-2.08, , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,6.94E-04,8.07E-03,3.4E-04,9.42E-04,2.81E-01,,,C, YES,
7153,Q9BST9,RTKN,Rhotekin,KTSRRPSDSGPPA,_RPS(ph)DSGPPAER_,S56,+,25.62,24.62,24.36,24.06,20.60,20.47,20.88,21.68,,20.82,22.05,,,22.52,3.11,2.10,1.85,1.55,-1.91,-2.05,-1.64,-0.84, ,-1.70,-0.47, , ,apoptotic process;Rho protein signal transduction,intracellular,,,,,7.68E-05,1.81E-03,1.85E-05,4.63E-04,4.67E-01,,,C, YES,
7157,Q9BTA9,WAC,WW domain-containing adapter protein with coiled-coil,QGHEPVSPRSLQR,_(gl)QQGHEPVS(ph)PR_,S408,+,25.12,26.54,27.03,27.10,25.79,23.59,24.74,25.25,25.25,20.77,21.33,22.22,20.21,24.23,0.89,2.31,2.80,2.88,1.56,-0.64,0.52,1.03,1.02,-3.45,-2.89,-2.01,-4.02,"histone H2B conserved C-terminal lysine ubiquitination;histone monoubiquitination;response to DNA damage stimulus;positive regulation of transcription, DNA-dependent;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;cell cycle checkpoint;positive regulation of macroautophagy;transcription, DNA-dependent",nuclear speck;nucleus;spliceosomal complex,,,,,4.16E-06,2.96E-04,8.2E-02,1.71E-06,2.22E-05,,,C, YES,
7186,Q9BU76,MMTAG2,Multiple myeloma tumor-associated protein 2 (hMMTAG2),ATSSPTSPERPRH,_RPAEATSSPTS(ph)PERPR_,S220,+,26.30,24.13,23.36,25.85,24.04,21.33,22.73,,22.69,,22.73,21.49,22.07,23.34,2.96,0.79,0.02,2.51,0.70,-2.01,-0.61, ,-0.65, ,-0.61,-1.85,-1.27,,,,,,,4.2E-03,2.45E-02,5.48E-03,2.03E-03,4.65E-01,,,C,,
7232,Q9BW71,HIRIP3,HIRA-interacting protein 3,KESEQESEEEILA,_ESEQES(ph)EEEILAQK_,S227,+,25.00,24.39,24.27,23.35,,,25.35,24.44,25.31,,21.51,,22.19,23.98,1.02,0.41,0.29,-0.63, , ,1.37,0.46,1.34, ,-2.47, ,-1.79,chromatin assembly or disassembly,nucleus,,,,,2.28E-03,1.67E-02,2.65E-01,4.43E-03,1.08E-03,,,C,,
7235,Q9BW71,HIRIP3,HIRA-interacting protein 3,GVAAEVSPAKEEN,_NGVAAEVS(ph)PAK_,S125,+,25.98,24.97,25.45,25.20,24.09,,23.22,22.78,22.64,,22.62,21.53,,23.85,2.13,1.12,1.60,1.35,0.24, ,-0.63,-1.07,-1.21, ,-1.23,-2.32, ,chromatin assembly or disassembly,nucleus,,,,,2.16E-03,1.64E-02,5.01E-03,9.38E-04,1.52E-01,,,C,,
7236,Q9BWF3,RBM4,RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a),YYGRDRSPLRRAT,_DRS(ph)PLRR_,S309,+,25.80,25.90,26.28,25.82,23.19,21.55,21.96,22.19,21.84,19.02,20.75,21.29,21.02,22.82,2.99,3.08,3.46,3.00,0.37,-1.27,-0.86,-0.63,-0.97,-3.79,-2.07,-1.53,-1.79,"negative regulation of translation involved in gene silencing by miRNA;cell differentiation;regulation of nucleocytoplasmic transport;positive regulation of muscle cell differentiation;negative regulation of translation in response to stress;negative regulation of translational initiation;entrainment of circadian clock by photoperiod;stress-activated MAPK cascade;mRNA processing;RNA splicing;circadian regulation of translation;IRES-dependent translational initiation;RNA processing;regulation of alternative mRNA splicing, via spliceosome",nucleolus;nuclear speck;cytoplasmic stress granule,,,,,4.77E-07,1.34E-04,7.69E-06,1.46E-07,9.92E-03,,,C, YES,
7255,Q9BXF6,RAB11FIP5,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),THKRTYSDEANQM,_RTYS(ph)DEANQM(ox)R_,S307,+,25.73,27.49,27.65,26.75,25.40,24.41,24.49,24.25,25.11,24.34,25.69,26.09,23.68,25.47,0.26,2.03,2.18,1.28,-0.07,-1.06,-0.98,-1.21,-0.36,-1.12,0.22,0.62,-1.79,protein transport,mitochondrial outer membrane;centrosome;recycling endosome membrane,,,,,5.55E-03,2.95E-02,2.55E-03,7.7E-03,7.19E-01,,,C, YES,+
7274,Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),NRRERFSPPRHEL,_ERFS(ph)PPRHELS(ph)PPQK_,S67,+,25.48,26.99,27.49,25.91,25.27,23.74,24.16,25.16,26.08,24.20,22.15,20.99,22.52,24.63,0.85,2.37,2.87,1.28,0.65,-0.89,-0.46,0.53,1.45,-0.43,-2.48,-3.64,-2.10,"cell proliferation;neuronal stem cell maintenance;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to arsenic-containing substance;primary miRNA processing",nucleoplasm;cytoplasm,,,,,3.39E-04,4.96E-03,6.72E-02,9.55E-05,2.98E-03,,,C, YES,
7275,Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),PPRHELSPPQKRM,_HELS(ph)PPQK_,S74,+,25.80,26.97,27.46,26.04,25.27,23.74,24.16,25.16,26.08,24.20,22.15,20.99,22.52,24.66,1.14,2.31,2.80,1.38,0.62,-0.92,-0.49,0.50,1.42,-0.46,-2.51,-3.67,-2.13,"cell proliferation;neuronal stem cell maintenance;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to arsenic-containing substance;primary miRNA processing",nucleoplasm;cytoplasm,,,,,2.01E-04,3.48E-03,4.24E-02,5.34E-05,2.56E-03,,,C, YES,
7276,Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),___MGDSDDEYDR,_(ac)GDS(ph)DDEYDRRR_,S4,+,28.64,27.65,26.30,29.02,26.38,26.08,24.96,25.17,25.88,23.66,24.32,24.68,23.78,25.89,2.75,1.77,0.41,3.13,0.50,0.20,-0.93,-0.72,0.00,-2.22,-1.57,-1.21,-2.11,"cell proliferation;neuronal stem cell maintenance;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to arsenic-containing substance;primary miRNA processing",nucleoplasm;cytoplasm,,,,,3.65E-05,1.19E-03,8.8E-04,9.14E-06,1.61E-02,,,C, YES,
7300,Q9BYW2,SETD2,Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (SET domain-containing protein 2) (hSET2) (p231HBP),SNRLNDSPTLKKL,_LNDS(ph)PTLK_,S624,+,25.58,25.67,25.07,27.65,24.90,23.91,23.43,23.68,24.07,23.54,,22.23,,24.52,1.06,1.15,0.55,3.13,0.38,-0.61,-1.09,-0.85,-0.45,-0.98, ,-2.29, ,"angiogenesis;stem cell development;histone H3-K36 methylation;regulation of transcription, DNA-dependent;pericardium development;neural tube closure;embryonic cranial skeleton morphogenesis;peptidyl-lysine trimethylation;mesoderm morphogenesis;cell migration involved in vasculogenesis;forebrain development;coronary vasculature morphogenesis;transcription, DNA-dependent;morphogenesis of a branching structure;embryonic placenta morphogenesis",chromosome;nucleus,Other TF domain,,,,1.99E-03,1.54E-02,3.57E-03,1.07E-03,1.65E-01,,+,C, YES,
7340,Q9BZZ5,API5,Apoptosis inhibitor 5 (API-5) (Antiapoptosis clone 11 protein) (AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor) (FIF) (Protein XAGL),EDTTSGSPPKKSS,_RASEDTTSGS(ph)PPKK_,S464,+,24.24,25.89,26.52,23.59,21.07,21.48,21.40,,21.07,,18.75,20.51,19.04,22.14,2.10,3.75,4.38,1.45,-1.07,-0.66,-0.75, ,-1.07, ,-3.39,-1.63,-3.10,negative regulation of apoptotic process;apoptotic process,spliceosomal complex;cytoplasm,,,,,1.4E-05,6.47E-04,1.41E-04,4.17E-06,2.42E-02,,,C, YES,
7382,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,LRPRNRSAEEGEL,_S(ph)AEEGELAESK_,S1666,+,29.85,29.72,29.81,29.02,28.20,27.32,27.99,29.02,27.90,27.55,28.07,28.08,25.64,28.32,1.53,1.40,1.49,0.70,-0.12,-1.00,-0.33,0.70,-0.42,-0.77,-0.25,-0.24,-2.68,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,5.61E-03,2.96E-02,1.79E-02,1.8E-03,2.08E-01,,,C, YES,+
7388,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,QTSRRPSQGPPAR,_RPS(ph)QGPPAR_,S1545,+,24.60,24.63,,24.68,20.08,20.33,19.65,20.65,19.15,,21.65,20.32,19.47,21.38,3.21,3.25, ,3.30,-1.30,-1.05,-1.73,-0.73,-2.23, ,0.26,-1.06,-1.91,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,6.85E-06,3.97E-04,2.55E-06,2.92E-05,4.13E-01,,,C, YES,
7426,Q9GZY8,MFF,Mitochondrial fission factor,QLVRNDSLPVLRG,_NDS(ph)LPVLR_,S146,,26.53,25.71,,26.00,23.50,23.80,22.95,23.39,23.78,20.83,23.25,23.20,23.81,23.90,2.63,1.81, ,2.11,-0.39,-0.10,-0.95,-0.51,-0.12,-3.06,-0.64,-0.70,-0.09,positive regulation of release of cytochrome c from mitochondria;peroxisome fission;mitochondrion morphogenesis;release of cytochrome c from mitochondria;mitochondrial fragmentation involved in apoptotic process;regulation of peroxisome organization;protein homooligomerization;protein targeting to mitochondrion,mitochondrial outer membrane;integral to mitochondrial membrane;peroxisome,,,,,5.17E-04,6.54E-03,1.24E-03,2.22E-04,2.5E-01,,,C, YES,+
7441,Q9H0D6,XRN2,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),KRKAEDSDSEPEP,_RKAEDS(ph)DS(ph)EPEPEDNVR_,S499,+,29.53,26.05,25.54,26.31,27.57,24.21,24.23,23.98,25.25,23.08,,,21.30,25.19,4.34,0.87,0.35,1.12,2.38,-0.98,-0.95,-1.20,0.06,-2.11, , ,-3.89,"regulation of transcription, DNA-dependent;cell growth;DNA-dependent transcription, termination;spermatogenesis;DNA catabolic process, exonucleolytic;mRNA processing;RNA catabolic process;RNA processing",nucleolus;aggresome,,,,,4.02E-03,2.36E-02,6.1E-02,1.38E-03,2.55E-02,,,C, YES,
7490,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),KATVTPSPVKGKG,_ATVTPS(ph)PVK_,S181,+,30.26,29.20,30.11,28.73,24.79,21.56,26.51,27.05,23.08,23.98,24.34,25.84,,26.29,3.98,2.92,3.82,2.44,-1.50,-4.72,0.22,0.76,-3.21,-2.30,-1.95,-0.45, ,,nucleus,,,,,3.16E-03,2.06E-02,1.41E-03,4.52E-03,9.19E-01,,,C,,
7524,Q9H2H9,SLC38A1,Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),DRESRRSLTNSHL,_S(ph)LT(ph)NSHLEK_,S52,+,30.05,28.54,28.86,30.76,27.35,26.12,26.06,26.12,24.61,25.62,25.12,24.15,23.96,26.72,3.33,1.82,2.14,4.04,0.63,-0.60,-0.65,-0.60,-2.11,-1.09,-1.59,-2.57,-2.76,neurotransmitter uptake,axon;integral to membrane;plasma membrane,,,,,1.18E-05,5.78E-04,8.87E-05,4.07E-06,5.8E-02,,,C,,
7540,Q9H2U2,PPA2,"Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2)",VESVSSSPNKESN,_SLVESVSSS(ph)PNK_,S317,+,29.43,28.28,28.09,26.96,22.94,24.84,26.84,24.08,26.59,26.99,25.92,25.43,24.10,26.19,3.24,2.09,1.90,0.77,-3.25,-1.35,0.65,-2.12,0.40,0.79,-0.27,-0.76,-2.09,phosphate-containing compound metabolic process;tRNA aminoacylation for protein translation;diphosphate metabolic process,mitochondrial matrix,,,,,4.07E-03,2.38E-02,1.54E-03,8.69E-03,5.13E-01,,,C, YES,+
7543,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),EIAIVHSDAEKEQ,_EIAIVHS(ph)DAEKEQEEEEQK_,S347,+,30.75,31.60,31.46,30.08,26.22,26.16,29.99,26.20,30.32,29.94,28.54,28.86,27.06,29.02,1.74,2.59,2.45,1.07,-2.80,-2.85,0.98,-2.81,1.30,0.92,-0.48,-0.15,-1.95,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,1.15E-02,4.98E-02,3.78E-03,3.02E-02,3.89E-01,,,C, YES,
7545,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),RRTRRESRQESDP,_RES(ph)RQES(ph)DPEDDDVK_,S96,+,27.31,26.15,26.79,25.16,,,,,19.06,,23.44,23.96,22.36,24.28,3.03,1.87,2.51,0.88, , , , ,-5.22, ,-0.84,-0.32,-1.92,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,1.78E-04,3.17E-03,8.01E-05,4.21E-03,4.44E-03,,,C, YES,
7546,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),RESRQESDPEDDD,_RES(ph)RQES(ph)DPEDDDVK_,S100,+,27.86,27.86,28.58,27.86,27.93,26.75,26.89,26.13,27.67,26.29,25.04,25.73,24.02,26.82,1.04,1.05,1.76,1.04,1.11,-0.06,0.07,-0.69,0.85,-0.52,-1.77,-1.08,-2.80,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,2.33E-03,1.69E-02,2.23E-01,8.01E-04,7.03E-03,,,C, YES,+
7547,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),LLRRGFSDSGGGP,_GFS(ph)DSGGGPPAK_,S66,+,27.30,26.53,26.84,25.64,22.28,20.92,,,20.40,,,20.38,,23.78,3.51,2.74,3.05,1.86,-1.50,-2.87, , ,-3.39, , ,-3.41, ,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,3.92E-05,1.24E-03,1.28E-05,1.01E-04,4.5E-01,,,C, YES,
7571,Q9H3R2,MUC13,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),KISVTVSETFDPE,_ISVT(ph)VS(ph)ETFDPEEK_,S224,,26.19,25.24,,27.00,21.38,22.14,25.31,24.57,25.22,23.22,,24.46,22.60,24.30,1.89,0.94, ,2.70,-2.93,-2.16,1.01,0.27,0.92,-1.09, ,0.15,-1.70,O-glycan processing;post-translational protein modification,integral to membrane;extracellular region;apical plasma membrane;Golgi lumen,,,,,4.47E-03,2.52E-02,3.04E-03,3.64E-03,7.53E-01,,,C, YES,
7810,Q9HCG8,CWC22,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb),RGERRNSFSENEK,_RNS(ph)FSENEK_,S829,+,26.71,27.61,27.81,26.90,21.97,22.50,22.78,23.86,23.75,20.83,21.84,23.44,22.43,24.03,2.68,3.57,3.78,2.87,-2.06,-1.53,-1.25,-0.18,-0.29,-3.20,-2.20,-0.59,-1.60,"mRNA splicing, via spliceosome;regulation of mRNA splicing, via spliceosome",catalytic step 2 spliceosome;cytoplasm,,,,,1.05E-06,1.64E-04,3.13E-06,6.3E-07,1.78E-01,,,C, YES,+
7865,Q9NQG5,RPRD1B,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),SMEDSKSPPPKAT,_LSM(ox)EDSKS(ph)PPPK_,S134,+,24.03,26.10,26.57,25.03,23.17,23.06,22.64,23.07,22.94,22.90,22.52,24.06,22.09,23.71,0.32,2.39,2.86,1.33,-0.54,-0.64,-1.06,-0.63,-0.76,-0.80,-1.19,0.35,-1.62,"dephosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;transcription, DNA-dependent;regulation of cell cycle process;positive regulation of transcription from RNA polymerase II promoter","DNA-directed RNA polymerase II, holoenzyme",,,,,1E-03,1E-02,7.87E-04,9.09E-04,8.82E-01,,,C, YES,
7906,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),PSQRSSSPVGLAK,_SSS(ph)PVGLAK_,S776,+,25.37,24.65,25.30,25.91,22.76,21.66,,21.87,,21.91,,21.85,,23.47,1.89,1.17,1.82,2.43,-0.71,-1.82, ,-1.61, ,-1.57, ,-1.62, ,,cytosol;PML body;nuclear speck;nucleus;cytoplasm,,,,,1.03E-03,1.01E-02,6.52E-04,1E-03,7.87E-01,,,C,,
7912,Q9NRG0,CHRAC1,Chromatin accessibility complex protein 1 (CHRAC-1) (Chromatin accessibility complex 15 kDa protein) (CHRAC-15) (HuCHRAC15) (DNA polymerase epsilon subunit p15),NDNDNESDHDEAD,_REEDEENDNDNES(ph)DHDEADS_,S124,+,24.92,24.71,25.51,25.26,21.79,21.10,22.71,22.76,23.58,20.98,20.26,19.57,,22.76,2.16,1.95,2.75,2.49,-0.97,-1.67,-0.06,0.00,0.81,-1.78,-2.50,-3.19, ,chromatin remodeling,chromatin accessibility complex;epsilon DNA polymerase complex,,,,,4.85E-04,6.31E-03,1.11E-02,1.36E-04,1.7E-02,,,C, YES,
8004,Q9NWV8,BABAM1,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),MEVAEPSSPTEEE,_M(ox)EVAEPS(ph)S(ph)PTEEEEEEEEHSAEPRPR_,S7,+,23.13,23.76,23.96,23.52,25.60,25.86,,25.56,,24.46,24.63,24.66,25.20,24.58,-1.44,-0.81,-0.62,-1.06,1.02,1.28, ,0.99, ,-0.12,0.05,0.09,0.62,protein K63-linked deubiquitination;double-strand break repair;G2/M transition DNA damage checkpoint;chromatin modification;response to ionizing radiation;positive regulation of DNA repair,BRISC complex;BRCA1-A complex;cytoplasm,,,,,2.27E-03,1.67E-02,7.56E-04,1.8E-02,8.91E-02,,,C, YES,
8008,Q9NWW5,CLN6,Ceroid-lipofuscinosis neuronal protein 6 (Protein CLN6),LQARHGSVSADEA,_HGS(ph)VSADEAAR_,S31,+,27.02,28.83,28.13,28.30,24.40,25.37,24.72,25.22,25.74,23.28,18.88,26.04,24.57,25.42,1.60,3.41,2.70,2.87,-1.02,-0.05,-0.71,-0.20,0.31,-2.14,-6.55,0.62,-0.85,positive regulation of proteolysis;cellular macromolecule catabolic process;protein catabolic process;glycosaminoglycan metabolic process;locomotion involved in locomotory behavior;cell death;visual perception;cholesterol metabolic process;lysosomal lumen acidification;ganglioside metabolic process,integral to membrane;endoplasmic reticulum membrane;endoplasmic reticulum lumen,,,,,1.28E-03,1.16E-02,9.29E-03,3.56E-04,8.8E-02,,,C, YES,
8034,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),GEPQEESPLKSKS,_KAEGEPQEES(ph)PLK_,S175,+,29.32,30.77,30.55,30.35,30.14,29.63,29.71,29.72,29.89,28.37,26.74,25.54,27.97,29.13,0.19,1.64,1.42,1.22,1.01,0.50,0.58,0.59,0.76,-0.76,-2.39,-3.59,-1.16,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,2.11E-04,3.65E-03,3.97E-01,1.16E-04,3.82E-04,,+,C, YES,+
8045,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),SHSIQHSPERSGS,_NT(ph)PSQHSHSIQHS(ph)PER_,S266,+,25.75,27.68,27.99,26.74,24.30,21.84,22.53,22.66,22.58,23.53,22.01,20.62,21.81,23.85,1.90,3.83,4.14,2.89,0.45,-2.01,-1.32,-1.18,-1.27,-0.32,-1.84,-3.23,-2.04,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,6.76E-06,3.97E-04,1.7E-05,4E-06,2.53E-01,,+,C, YES,
8046,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),HSTRQKSPEIHRR,_S(ph)PEIHRR_,S646,+,27.57,29.55,27.88,29.23,26.83,27.09,24.53,26.41,29.41,22.97,24.06,23.56,24.23,26.41,1.16,3.14,1.47,2.82,0.42,0.68,-1.87,0.00,3.00,-3.44,-2.35,-2.85,-2.18,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,9.85E-05,2.12E-03,3.91E-02,2.68E-05,1.25E-03,,+,C, YES,+
8076,Q9NZ32,ACTR10,Actin-related protein 10 (Actin-related protein 11) (hARP11),LMKRAFSTEK___,_RAFS(ph)TEK_,S414,+,23.53,26.28,27.07,26.74,21.43,20.83,,22.21,20.66,19.40,23.10,23.86,21.55,23.06,0.47,3.23,4.01,3.69,-1.63,-2.22, ,-0.85,-2.39,-3.66,0.05,0.80,-1.50,microtubule-based movement,dynactin complex;cytoplasm,,,,,1.63E-03,1.35E-02,7.41E-04,3.12E-03,4.85E-01,,,C, YES,+
8102,Q9NZT2,OGFR,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),KVEEEGSPGDPDH,_KVEEEGS(ph)PGDPDHEASTQGR_,S315,+,23.74,25.93,26.22,24.73,25.24,23.85,24.75,25.67,24.70,23.10,23.14,23.59,22.10,24.37,-0.63,1.57,1.86,0.36,0.87,-0.52,0.39,1.31,0.33,-1.26,-1.23,-0.78,-2.26,regulation of cell growth,nucleus;membrane;cytoplasm,,,,,6.4E-03,3.25E-02,6.8E-01,3.74E-03,6.1E-03,,,C, YES,
8108,Q9P0B6,CCDC167,Coiled-coil domain-containing protein 167,LHSRELSPEARRS,_ELS(ph)PEARR_,S42,,23.83,25.59,25.90,26.06,23.81,23.10,22.65,22.69,23.85,19.42,20.59,22.76,21.84,23.24,0.59,2.35,2.66,2.82,0.57,-0.13,-0.59,-0.55,0.61,-3.82,-2.65,-0.48,-1.40,,integral to membrane,,,,,1.37E-04,2.61E-03,7.8E-03,3.22E-05,8.22E-03,,,C,,
8151,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,RTISINSPKAQTV,_TISINS(ph)PK_,S867,+,25.05,25.93,26.30,26.25,23.48,24.27,23.99,23.54,24.16,23.30,,23.79,22.28,24.36,0.69,1.56,1.94,1.89,-0.88,-0.09,-0.37,-0.82,-0.20,-1.07, ,-0.57,-2.08,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,7.3E-04,8.23E-03,1.87E-03,3.21E-04,1.79E-01,,,C,,
8162,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,LAGPPASPGKAQP,_GLAGPPAS(ph)PGK_,S604,+,27.04,26.99,27.63,26.16,22.99,23.89,25.04,23.62,25.19,23.77,22.90,24.26,22.51,24.77,2.27,2.23,2.86,1.39,-1.78,-0.88,0.27,-1.15,0.42,-1.00,-1.87,-0.51,-2.26,,,,,,,2.42E-04,3.95E-03,7.55E-04,9.73E-05,2.13E-01,,,C,,
8233,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),QREKVASDTEEAD,_VAS(ph)DTEEADRTSSK_,S102,+,26.30,27.35,27.76,25.77,22.03,22.40,23.25,22.12,24.19,22.96,22.74,23.28,22.25,24.03,2.27,3.32,3.73,1.74,-2.00,-1.63,-0.78,-1.91,0.16,-1.07,-1.29,-0.75,-1.78,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,6.44E-06,3.93E-04,5.33E-06,1.02E-05,9.86E-01,,,C,,
8235,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),VKEEASSPLKSNK,_VKEEASS(ph)PLK_,S88,+,25.80,26.77,27.31,24.78,,,,22.26,,22.35,21.65,22.08,21.49,23.83,1.97,2.94,3.47,0.95, , , ,-1.57, ,-1.49,-2.18,-1.76,-2.34,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,3.06E-04,4.61E-03,2.93E-03,3.34E-05,7.11E-01,,,C,,
8256,Q9UBI6,GNG12,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,MSSKTASTNNIAQ,_TAS(ph)TNNIAQAR_,S7,,23.95,23.96,,24.47,22.36,,,22.28,22.46,22.15,22.28,,20.68,22.73,1.22,1.23, ,1.74,-0.37, , ,-0.45,-0.27,-0.58,-0.45, ,-2.05,small molecule metabolic process;G-protein coupled receptor signaling pathway;energy reserve metabolic process;cerebral cortex development;signal transduction;synaptic transmission;response to lipopolysaccharide;cellular response to glucagon stimulus,actin filament;plasma membrane;heterotrimeric G-protein complex,,,,,8.93E-03,4.14E-02,1.92E-02,2.91E-03,3.21E-01,,,C, YES,
8267,Q9UBV2,SEL1L,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),SKTTLTSDESVKD,_TTLTS(ph)DESVK_,S41,,29.58,27.32,28.00,25.22,23.09,23.96,24.94,24.88,23.62,21.14,,,,25.17,4.41,2.14,2.82,0.05,-2.08,-1.22,-0.24,-0.30,-1.55,-4.03, , , ,Notch signaling pathway;response to endoplasmic reticulum stress,integral to membrane;endoplasmic reticulum membrane,,,,,1.03E-03,1.01E-02,2.21E-03,7.1E-04,4.76E-02,,,C, YES,
8279,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),SRERDLSRDRSRG,_ERDLS(ph)RDR_,S169,+,24.07,24.99,25.77,21.71,22.75,21.51,21.90,21.51,20.96,,19.75,20.02,,22.27,1.80,2.73,3.50,-0.55,0.48,-0.76,-0.37,-0.76,-1.31, ,-2.51,-2.25, ,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,3.73E-03,2.24E-02,2.01E-02,1.39E-03,6.23E-02,+,,C, YES,
8282,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),DRSRGRSIDQDYE,_S(ph)IDQDYER_,S221,+,28.33,26.93,,27.66,26.48,24.07,26.79,26.65,25.92,24.39,24.92,26.13,23.04,25.94,2.39,0.99, ,1.71,0.54,-1.87,0.85,0.70,-0.02,-1.55,-1.02,0.18,-2.90,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,5.57E-03,2.95E-02,4.14E-02,1.67E-03,7.17E-02,+,,C, YES,+
8285,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),ESNRSFSPEERRH,_SFS(ph)PEER_,S392,+,26.92,25.36,23.81,26.01,24.50,22.78,23.38,24.24,22.01,,22.93,22.39,21.41,23.81,3.11,1.55,0.00,2.20,0.69,-1.03,-0.43,0.43,-1.81, ,-0.88,-1.43,-2.40,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,1.65E-03,1.36E-02,4.96E-03,6.42E-04,1.59E-01,+,,C, YES,
8290,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),SRSWEDSPERGRP,_SWEDS(ph)PER_,S151,+,27.12,25.48,23.81,26.12,25.48,24.51,25.15,25.22,24.79,23.90,23.35,22.76,22.20,24.61,2.51,0.87,-0.80,1.51,0.87,-0.10,0.54,0.62,0.19,-0.70,-1.26,-1.85,-2.40,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,1.94E-03,1.51E-02,2.04E-01,6.55E-04,6.39E-03,+,,C, YES,
8312,Q9UGU0,TCF20,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),NDTVTISPKQEGF,_ENDTVTIS(ph)PK_,S1522,+,26.58,26.04,26.38,26.03,22.21,22.64,24.60,23.24,,26.46,,23.23,,24.74,1.84,1.30,1.64,1.29,-2.53,-2.10,-0.14,-1.50, ,1.72, ,-1.51, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,8.41E-03,3.98E-02,1.7E-03,1.76E-01,9.4E-02,,,C,,
8327,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),PDSRASSLSESSP,_ASS(ph)LSESSPPK_,S369,+,26.33,25.52,25.73,27.52,24.25,22.11,24.08,22.67,22.36,26.07,23.43,25.73,22.47,24.48,1.85,1.03,1.25,3.04,-0.23,-2.37,-0.40,-1.81,-2.12,1.59,-1.05,1.25,-2.01,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,4.4E-03,2.5E-02,1.18E-03,4.76E-02,1.1E-01,,,C, YES,
8350,Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),FRQRMFSPMEEKE,_M(ox)FS(ph)PMEEK_,S694,+,25.66,26.98,26.78,27.01,23.95,25.32,24.53,25.09,24.47,24.86,23.43,23.72,23.92,25.06,0.61,1.92,1.72,1.96,-1.11,0.26,-0.53,0.03,-0.58,-0.19,-1.63,-1.34,-1.13,spermatid development;transcription from RNA polymerase II promoter,mitochondrion;nucleolus,,,,,4.69E-04,6.16E-03,1.64E-03,1.71E-04,1.9E-01,,,C, YES,
8387,Q9UID3,VPS51,Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog),GSGPGDSPEGPEG,_(ac)AAAAAAGPSPGSGPGDS(ph)PEGPEGEAPER_,S18,+,25.05,23.66,23.66,24.53,26.39,25.60,27.18,26.91,24.87,25.06,23.70,22.22,,24.90,0.15,-1.24,-1.24,-0.38,1.49,0.70,2.28,2.00,-0.03,0.16,-1.21,-2.68, ,"autophagy;protein transport;retrograde transport, endosome to Golgi;lipid transport",integral to membrane;GARP complex,,,,,7.28E-03,3.57E-02,6.76E-03,7.68E-01,6.02E-03,,,C, YES,
8400,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),RSSRRQSLELQKC,_RQS(ph)LELQK_,S1338,+,25.23,25.49,25.85,25.71,,23.98,,23.69,24.46,23.58,22.28,23.38,,24.36,0.86,1.12,1.49,1.34, ,-0.38, ,-0.68,0.10,-0.79,-2.08,-0.99, ,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,3.63E-03,2.2E-02,2.16E-02,8.71E-04,1.33E-01,,,C, YES,+
8444,Q9UKA4,AKAP11,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),KASVRKSFSEDVF,_S(ph)FSEDVFQSVK_,S18,+,22.76,20.91,20.91,22.08,22.61,21.78,,21.68,,23.65,26.41,24.55,24.35,22.88,-0.12,-1.97,-1.97,-0.80,-0.28,-1.10, ,-1.20, ,0.77,3.53,1.67,1.47,intracellular protein kinase cascade;regulation of protein kinase A signaling cascade,nucleolus;plasma membrane;protein complex;microtubule organizing center;cytoplasm,,,,,3.36E-03,2.12E-02,8.96E-01,2.19E-03,2.85E-03,,,C,,
8465,Q9UKK3,PARP4,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),HRVLHYSQG____,_VLHYS(ph)QG_,S1722,+,26.78,24.15,22.64,24.19,21.37,,21.70,22.21,21.08,21.88,22.10,21.41,,22.68,4.09,1.47,-0.04,1.51,-1.31, ,-0.99,-0.47,-1.61,-0.81,-0.59,-1.27, ,DNA repair;transport;protein ADP-ribosylation;inflammatory response;cell death;response to drug,spindle microtubule;ribonucleoprotein complex;nucleus;cytoplasm,,,,,2.36E-03,1.7E-02,1.12E-03,3.31E-03,8.03E-01,,,C, YES,
8568,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),SHKRSLSLGDKEI,_SLS(ph)LGDKEISR_,S869,+,26.44,27.18,27.42,27.18,26.96,24.19,23.60,25.83,23.40,24.15,23.60,24.61,21.96,25.12,1.32,2.06,2.31,2.07,1.85,-0.93,-1.52,0.71,-1.71,-0.97,-1.52,-0.51,-3.16,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,1.92E-03,1.5E-02,1.02E-02,5.64E-04,1.23E-01,,,C, YES,
8591,Q9UNL2,SSR3,Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma),EVTRKLSEADNRK,_KLS(ph)EADNRK_,S105,+,23.45,23.51,21.78,24.29,21.30,21.77,20.17,22.18,21.17,,20.24,20.76,21.68,21.86,1.60,1.65,-0.08,2.43,-0.55,-0.09,-1.69,0.32,-0.69, ,-1.62,-1.10,-0.17,translation;SRP-dependent cotranslational protein targeting to membrane,integral to endoplasmic reticulum membrane;Sec61 translocon complex,,,,,4.69E-03,2.61E-02,4.37E-03,2.99E-03,5.42E-01,,,C,,
8641,Q9UPU5,USP24,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),RVSDQNSPVLPKK,_VSDQNS(ph)PVLPKK_,S1887,+,27.60,27.79,27.69,28.01,26.71,26.07,26.89,27.18,25.72,26.29,24.77,26.75,24.45,26.61,0.99,1.18,1.08,1.40,0.10,-0.54,0.28,0.57,-0.89,-0.32,-1.83,0.14,-2.16,ubiquitin-dependent protein catabolic process,,,,,,4.79E-03,2.65E-02,2.92E-02,1.34E-03,1.08E-01,,,C, YES,
8663,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),LLDRARSRTPPSA,_S(ph)RT(ph)PPSAPSQSR_,S2407,+,27.65,24.25,24.84,28.37,25.67,,24.04,24.01,24.95,23.34,24.31,24.34,22.87,24.89,2.76,-0.63,-0.04,3.48,0.78, ,-0.85,-0.88,0.07,-1.55,-0.58,-0.54,-2.01,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,6.71E-03,3.35E-02,2.29E-02,1.89E-03,2.34E-01,,,C, YES,
8691,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KGQSQTSPDHRSD,_GQSQTS(ph)PDHRSDTSSPEVR_,S1064,+,26.42,26.31,25.60,26.05,24.60,22.93,23.47,23.97,24.13,22.99,23.40,23.27,22.71,24.30,2.13,2.02,1.30,1.75,0.31,-1.37,-0.83,-0.33,-0.16,-1.31,-0.89,-1.03,-1.59,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,3.8E-05,1.21E-03,1.53E-04,1.55E-05,1.46E-01,,,C, YES,
8714,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TSERAPSPSSRMG,_M(ox)TSERAPS(ph)PSSR_,S2426,+,27.32,27.96,28.61,28.29,25.26,26.34,25.52,25.76,26.19,25.27,25.30,26.42,26.86,26.55,0.78,1.41,2.07,1.75,-1.29,-0.21,-1.02,-0.79,-0.36,-1.28,-1.25,-0.13,0.32,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.92E-03,2.7E-02,2.44E-03,6.16E-03,7.88E-01,,,C, YES,
8724,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RQSHSESPSLQSK,_QSHSES(ph)PSLQSK_,S1083,+,29.12,29.17,27.15,29.57,26.94,26.32,25.78,26.26,26.24,23.99,25.55,25.49,24.46,26.62,2.50,2.55,0.53,2.95,0.32,-0.30,-0.83,-0.36,-0.38,-2.62,-1.07,-1.13,-2.16,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,3.33E-05,1.11E-03,4.62E-04,9.24E-06,3.05E-02,,,C, YES,+
8729,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),VERRRPSPQPSPR,_RRPS(ph)PQPS(ph)PR_,S2702,+,28.48,28.61,28.15,28.08,23.19,21.43,20.63,21.26,22.02,20.75,21.37,21.02,21.13,23.55,4.93,5.06,4.60,4.54,-0.36,-2.11,-2.92,-2.29,-1.52,-2.80,-2.18,-2.52,-2.42,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,6.56E-10,7.48E-07,1.27E-09,7.24E-10,2.41E-01,,,C, YES,
8737,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSSRSSPELTRK,_S(ph)SRSS(ph)PELTRK_,S1694,+,28.81,28.78,28.95,28.55,24.56,,20.65,21.77,21.74,,19.29,21.16,,24.43,4.39,4.35,4.53,4.12,0.14, ,-3.77,-2.66,-2.69, ,-5.14,-3.26, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.17E-06,1.74E-04,1.84E-06,9.72E-07,6.39E-02,,,C, YES,
8738,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ALKRVPSPTPAPK,_RVPS(ph)PTPAPK_,S2581,+,26.81,27.61,27.90,26.71,25.50,25.09,24.28,24.89,24.75,,24.95,25.19,23.62,25.61,1.20,2.00,2.29,1.11,-0.11,-0.52,-1.33,-0.72,-0.85, ,-0.66,-0.42,-1.99,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.98E-04,6.37E-03,4.36E-04,4.4E-04,5.77E-01,,,C, YES,+
8762,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TARGKRSLTRSPP,_S(ph)LT(ph)RS(ph)PPAIR_,S2067,+,29.63,27.24,26.98,27.19,26.17,23.56,24.24,25.19,25.21,24.42,,,,25.98,3.64,1.25,0.99,1.21,0.19,-2.42,-1.74,-0.79,-0.78,-1.56, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,5.14E-03,2.8E-02,1.19E-03,1.3E-02,6.97E-01,,,C, YES,+
8763,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KRSLTRSPPAIRR,_S(ph)LT(ph)RS(ph)PPAIR_,S2071,+,29.63,27.24,26.98,27.19,26.17,23.56,24.24,25.19,25.21,24.42,,,,25.98,3.64,1.25,0.99,1.21,0.19,-2.42,-1.74,-0.79,-0.78,-1.56, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,5.14E-03,2.8E-02,1.19E-03,1.3E-02,6.97E-01,,,C, YES,+
8765,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KRSRSRSPLAIRR,_S(ph)RS(ph)RS(ph)PLAIR_,S2046,+,32.25,29.23,29.02,30.19,27.69,25.02,26.08,21.14,26.55,25.97,23.73,24.70,,26.80,5.45,2.44,2.23,3.39,0.90,-1.78,-0.72,-5.66,-0.25,-0.83,-3.07,-2.10, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,7.38E-04,8.29E-03,5.46E-04,7.24E-04,6.86E-01,,,C, YES,+
8771,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PRKRSRSRSPLAI,_S(ph)RS(ph)RS(ph)PLAIR_,S2044,+,32.13,29.23,29.00,30.17,27.69,25.02,26.08,,26.55,25.97,23.73,24.70,,27.30,4.83,1.93,1.71,2.87,0.40,-2.28,-1.22, ,-0.75,-1.33,-3.57,-2.59, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,8.35E-05,1.89E-03,3.64E-04,3.01E-05,1E-01,,,C, YES,+
8773,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KRGHSRSRSPQWR,_S(ph)RS(ph)PQWRR_,S508,+,27.20,27.12,27.36,27.23,20.26,,20.98,19.22,21.40,20.90,,,,23.52,3.68,3.60,3.84,3.71,-3.25, ,-2.54,-4.30,-2.12,-2.62, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.04E-06,2.12E-04,2.39E-07,4.49E-05,6.66E-01,,,C, YES,
8774,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GHSRSRSPQWRRS,_S(ph)RS(ph)PQWRR_,S510,+,27.20,27.12,27.36,27.23,20.26,,20.98,19.22,21.40,20.90,,,,23.52,3.68,3.60,3.84,3.71,-3.25, ,-2.54,-4.30,-2.12,-2.62, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.04E-06,2.12E-04,2.39E-07,4.49E-05,6.66E-01,,,C, YES,
8779,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),THRRSRSRTPLIS,_S(ph)RT(ph)PLISR_,S1878,+,29.81,29.34,29.76,28.97,27.87,24.30,25.31,25.25,26.06,25.33,23.19,23.36,21.54,26.16,3.65,3.18,3.60,2.81,1.71,-1.86,-0.85,-0.91,-0.10,-0.83,-2.97,-2.80,-4.63,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.07E-05,5.32E-04,4.08E-04,2.59E-06,7.25E-03,,,C, YES,+
8781,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),IRRRSRSRTPLLP,_S(ph)RT(ph)PLLPR_,S2032,+,30.12,28.55,28.49,29.27,27.52,26.01,26.78,26.53,26.74,26.43,24.70,22.86,24.84,26.83,3.28,1.72,1.66,2.43,0.69,-0.82,-0.06,-0.30,-0.09,-0.41,-2.14,-3.97,-1.99,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,3.97E-05,1.24E-03,2.04E-03,9.22E-06,7.08E-03,,,C, YES,+
8782,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PVTRRRSRSRTSP,_S(ph)RS(ph)RTS(ph)PITR_,S1970,+,25.47,25.40,25.75,25.71,21.89,,20.35,,,20.76,20.17,,20.50,22.89,2.58,2.51,2.86,2.82,-1.00, ,-2.53, , ,-2.13,-2.72, ,-2.39,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1E-05,5.1E-04,3.71E-05,2.89E-06,3.81E-01,,,C, YES,
8783,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TRRRSRSRTSPIT,_S(ph)RTS(ph)PITR_,S1972,+,27.42,26.00,25.34,27.88,21.85,,20.87,,20.53,20.76,20.17,,20.50,23.13,4.29,2.87,2.21,4.75,-1.28, ,-2.26, ,-2.61,-2.38,-2.96, ,-2.64,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.57E-06,2.07E-04,2.88E-06,9.41E-07,4.31E-01,,,C, YES,
8784,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSRSRTSPITRRR,_S(ph)RTS(ph)PITR_,S1975,+,27.84,25.94,26.53,28.08,24.86,24.38,20.87,22.07,23.46,22.29,23.66,23.85,23.04,24.37,3.47,1.56,2.15,3.71,0.49,0.00,-3.50,-2.30,-0.92,-2.09,-0.71,-0.53,-1.34,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.25E-04,3.81E-03,1.5E-04,3.06E-04,9.19E-01,,,C, YES,
8786,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSRSRTSPVTRRR,_S(ph)RSRTS(ph)PVTR_,S1987,+,25.53,25.97,25.88,26.81,19.13,,19.79,20.43,20.52,18.56,,,,22.51,3.02,3.46,3.37,4.30,-3.39, ,-2.72,-2.09,-2.00,-3.95, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1E-06,1.63E-04,3.02E-07,3.84E-06,1.48E-01,,,C, YES,
8787,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TRRRSRSRTPPAI,_S(ph)RT(ph)PPAIRR_,S2020,+,29.87,29.28,28.45,30.19,24.49,,22.42,23.20,23.83,22.95,,,,26.08,3.79,3.21,2.38,4.11,-1.59, ,-3.65,-2.87,-2.25,-3.13, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.16E-06,2.96E-04,7.68E-07,3.08E-05,6.03E-01,,,C, YES,
8788,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRRRGRSRTPPTS,_S(ph)RT(ph)PPTSR_,S1842,+,24.13,23.42,23.25,24.31,18.66,18.78,19.52,19.74,20.71,18.18,,,,21.07,3.06,2.34,2.18,3.24,-2.41,-2.29,-1.55,-1.33,-0.36,-2.89, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.95E-05,7.86E-04,6.04E-06,6.76E-05,1.87E-01,,,C, YES,
8789,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SRRRSRSRTPPVT,_S(ph)RT(ph)PPVTR_,S1925,+,29.24,28.70,28.17,31.32,25.27,22.71,22.79,23.49,24.73,23.68,19.84,,20.77,25.06,4.18,3.64,3.11,6.26,0.21,-2.35,-2.27,-1.57,-0.33,-1.38,-5.22, ,-4.29,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.88E-06,2.07E-04,1.11E-05,8.44E-07,2.36E-02,,,C, YES,
8790,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SRKRSRSRTSPAP,_S(ph)RT(ph)SPAPWKR_,S1854,+,28.57,27.31,27.79,27.34,24.84,23.22,22.96,,24.72,23.36,,,,25.57,3.00,1.74,2.22,1.77,-0.72,-2.35,-2.61, ,-0.85,-2.20, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,7.9E-04,8.72E-03,2.02E-04,2.23E-03,6.04E-01,,,C, YES,
8800,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSVSPCSNVE,_S(ph)VS(ph)PCSNVESR_,S954,+,27.35,26.33,25.86,26.25,23.69,24.09,23.49,23.11,25.75,,22.09,22.30,22.14,24.37,2.98,1.96,1.49,1.88,-0.69,-0.28,-0.88,-1.26,1.38, ,-2.28,-2.07,-2.23,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,3.1E-05,1.05E-03,6.24E-04,9.23E-06,1.01E-02,,,C, YES,
8801,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TALAGRSPSPASG,_THTTALAGRS(ph)PS(ph)PASGR_,S295,+,29.22,28.75,28.19,29.20,29.35,22.91,23.30,24.98,26.50,20.64,21.12,20.48,19.77,24.95,4.27,3.80,3.23,4.25,4.40,-2.05,-1.66,0.03,1.54,-4.32,-3.83,-4.48,-5.19,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.73E-06,2.42E-04,2.66E-03,6.34E-07,1.73E-04,,,C, YES,
8802,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),LAGRSPSPASGRR,_THTTALAGRS(ph)PS(ph)PASGR_,S297,+,29.22,28.75,28.19,29.20,29.35,22.91,23.30,24.98,26.50,20.64,21.12,20.48,19.77,24.95,4.27,3.80,3.23,4.25,4.40,-2.05,-1.66,0.03,1.54,-4.32,-3.83,-4.48,-5.19,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.76E-06,2.42E-04,2.72E-03,6.42E-07,1.72E-04,,,C, YES,
8817,Q9UQE7,SMC3,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide) (hCAP),DVEGSQSQDEGEG,_KGDVEGSQS(ph)QDEGEGSGESER_,S1067,+,25.85,25.98,24.42,25.23,24.89,23.18,22.37,23.97,23.39,21.20,21.64,,20.15,23.52,2.33,2.46,0.90,1.71,1.37,-0.34,-1.16,0.44,-0.13,-2.32,-1.88, ,-3.38,DNA mediated transformation;DNA repair;meiosis;mitotic spindle organization;negative regulation of DNA endoreduplication;sister chromatid cohesion;signal transduction;mitotic metaphase/anaphase transition;mitotic prometaphase;cell division,"nucleoplasm;nuclear matrix;meiotic cohesin complex;cytoplasm;chromatin;chromosome, centromeric region;basement membrane;lateral element;spindle pole",,,,,5.37E-05,1.43E-03,6.55E-03,1.44E-05,2.01E-03,,+,C, YES,
8865,Q9Y2J2,EPB41L3,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",ATTKGISQTNLIT,_GIS(ph)QTNLITTVTPEK_,S478,+,,25.15,25.26,24.90,22.19,23.13,,23.23,,21.79,22.40,,,23.51, ,1.64,1.76,1.39,-1.32,-0.37, ,-0.27, ,-1.72,-1.11, , ,cortical actin cytoskeleton organization,cell-cell junction;juxtaparanode region of axon;plasma membrane;paranode region of axon;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,3.65E-03,2.21E-02,5.42E-03,1.63E-03,3.04E-01,,,C, YES,
8889,Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),PRSRERSPSPLRG,_ERS(ph)PS(ph)PLRGNVVPS(ph)PLPTR_,S30,+,27.89,27.86,23.99,27.91,24.70,24.17,23.31,24.14,21.97,,23.82,23.95,26.90,25.05,2.83,2.81,-1.06,2.86,-0.35,-0.88,-1.74,-0.91,-3.08, ,-1.23,-1.10,1.85,"regulation of transcription, DNA-dependent;regulation of mRNA stability;intracellular signal transduction",cytosol;P granule;cytoplasmic mRNA processing body,,,,,9.94E-03,4.49E-02,2.44E-03,5.27E-02,2.67E-01,,,C, YES,
8891,Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),RGNVVPSPLPTRR,_GNVVPS(ph)PLPTR_,S41,+,26.86,26.24,,25.63,23.27,24.06,23.88,24.58,22.00,,24.46,21.58,,24.25,2.61,1.98, ,1.37,-0.99,-0.19,-0.38,0.32,-2.25, ,0.21,-2.68, ,"regulation of transcription, DNA-dependent;regulation of mRNA stability;intracellular signal transduction",cytosol;P granule;cytoplasmic mRNA processing body,,,,,6.79E-03,3.37E-02,4.34E-03,5.64E-03,5.55E-01,,,C, YES,
8894,Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),RRTRTFSATVRAS,_TFS(ph)ATVR_,S52,+,29.61,30.10,29.35,31.00,28.50,25.42,29.07,28.81,24.66,24.04,26.38,29.44,22.49,27.61,2.00,2.49,1.74,3.39,0.89,-2.18,1.47,1.20,-2.94,-3.56,-1.22,1.84,-5.11,"regulation of transcription, DNA-dependent;regulation of mRNA stability;intracellular signal transduction",cytosol;P granule;cytoplasmic mRNA processing body,,,,,8.43E-03,3.99E-02,2.97E-02,2.59E-03,1.86E-01,,,C, YES,
8903,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),AHDEMKSPREPGY,_S(ph)PREPGYK_,S698,+,25.64,28.18,28.24,27.72,,18.62,23.13,,24.38,23.03,22.76,24.07,,24.58,1.06,3.60,3.67,3.14, ,-5.95,-1.45, ,-0.20,-1.55,-1.82,-0.51, ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,1.4E-03,1.23E-02,5.27E-04,3.8E-03,3.33E-01,,,C, YES,
8907,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),AAKNKKSPEIHRR,_S(ph)PEIHRR_,S672,+,25.34,25.75,25.33,27.13,,19.41,21.69,19.38,22.48,20.15,20.65,23.35,20.70,22.61,2.73,3.14,2.72,4.52, ,-3.20,-0.92,-3.23,-0.14,-2.47,-1.97,0.74,-1.92,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,4.38E-05,1.28E-03,2.84E-05,7.67E-05,5.91E-01,,,C, YES,
8909,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),PFRGSQSPKRYKL,_TDSEKPFRGS(ph)QS(ph)PK_,S408,+,27.91,29.30,30.05,29.01,26.51,21.94,24.85,26.12,25.44,22.45,24.30,25.39,23.56,25.91,2.00,3.39,4.14,3.10,0.60,-3.97,-1.06,0.21,-0.47,-3.46,-1.61,-0.52,-2.35,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,2.76E-04,4.25E-03,7.46E-04,1.18E-04,2.52E-01,,,C, YES,+
8916,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),SRSRSYSPAHNRE,_S(ph)YS(ph)PAHNRER_,S55,+,24.73,27.19,28.08,24.69,21.82,21.10,20.15,20.95,21.00,19.12,20.08,18.37,,22.27,2.45,4.92,5.81,2.41,-0.45,-1.17,-2.13,-1.33,-1.27,-3.16,-2.19,-3.90, ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,7.34E-06,4.11E-04,3.64E-05,3.32E-06,4.25E-02,,,C, YES,
8968,Q9Y3T9,NOC2L,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),AREAARSPDKPGG,_EAARS(ph)PDKPGGSPSASR_,S49,+,24.25,26.04,,25.65,23.47,22.51,22.31,22.39,22.67,,22.89,22.67,22.73,23.42,0.83,2.62, ,2.23,0.05,-0.90,-1.10,-1.03,-0.75, ,-0.53,-0.74,-0.69,"cellular response to UV;nucleolus to nucleoplasm transport;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone acetylation;apoptotic process;transcription, DNA-dependent;negative regulation of B cell apoptotic process",nucleoplasm;chromatin assembly complex;nucleolus,,,,,8.85E-04,9.34E-03,4.16E-04,1.4E-03,8.68E-01,,,C, YES,+
8992,Q9Y490,TLN1,Talin-1,VLDKASSLIEEAK,_ASS(ph)LIEEAK_,S1164,,,25.08,,25.11,,21.11,22.61,21.45,23.30,,22.26,21.59,,22.81, ,2.26, ,2.30, ,-1.70,-0.21,-1.37,0.48, ,-0.55,-1.23, ,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,5.6E-03,2.96E-02,3.09E-03,5.12E-03,8.09E-01,+,,C, YES,
8996,Q9Y490,TLN1,Talin-1,GHSRTVSDSIKKL,_TVS(ph)DSIKK_,S1641,,,24.97,22.71,25.24,22.11,19.32,20.46,21.30,20.90,,21.16,22.28,21.49,21.99, ,2.98,0.72,3.24,0.12,-2.68,-1.54,-0.70,-1.10, ,-0.83,0.28,-0.51,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,1.05E-03,1.02E-02,3.02E-04,4.72E-03,3.17E-01,+,,C, YES,
9077,Q9Y519,TMEM184B,Transmembrane protein 184B (Putative MAPK-activating protein FM08),GLSRSHSLSGARD,_SHS(ph)LSGARDNEK_,S61,+,23.33,23.15,24.00,23.25,20.13,,20.11,19.89,,,,20.81,,21.83,1.50,1.31,2.17,1.42,-1.70, ,-1.73,-1.94, , , ,-1.02, ,,integral to membrane,,,,,5.95E-03,3.09E-02,9.53E-04,4.22E-02,4.65E-01,,,C,,
9106,Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),VQEHEDSGDSEVE,_VQEHEDS(ph)GDS(ph)EVENEAK_,S97,+,28.37,26.55,26.20,26.35,27.83,26.63,26.24,25.91,26.83,26.43,23.55,21.99,23.88,25.90,2.47,0.64,0.30,0.45,1.92,0.73,0.34,0.00,0.92,0.53,-2.35,-3.91,-2.03,rRNA processing,nucleolus;nucleus,,,,,3.18E-03,2.06E-02,7.47E-01,2.16E-03,2.83E-03,,,C, YES,
9123,Q9Y5S9,RBM8A,RNA-binding protein 8A (Binder of OVCA1-1) (BOV-1) (RNA-binding motif protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein RBM8A),KGRGFGSEEGSRA,_GFGS(ph)EEGSR_,S42,+,26.40,27.21,26.05,26.53,22.93,22.89,,23.03,23.53,,22.25,,,24.53,1.87,2.67,1.52,1.99,-1.61,-1.64, ,-1.51,-1.01, ,-2.29, , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;regulation of translation",nucleoplasm;cytosol;exon-exon junction complex;nuclear speck;catalytic step 2 spliceosome,,,,,1.35E-04,2.6E-03,4.18E-05,3.61E-04,3.66E-01,+,,C, YES,+
9161,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",PRGKSRSPAPPAD,_SRS(ph)PAPPADK_,S1007,+,22.92,23.50,23.71,24.04,,20.62,20.86,19.46,21.63,19.53,,21.76,,21.80,1.11,1.70,1.90,2.24, ,-1.18,-0.95,-2.34,-0.17,-2.27, ,-0.04, ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,2.85E-03,1.92E-02,1.09E-03,4.63E-03,9.96E-01,,,C, YES,
9187,Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),VRGREGSLTGTKD,_GREGS(ph)LTGTK_,S1079,+,25.25,26.06,26.60,24.68,,20.40,21.41,20.33,20.89,19.83,22.17,22.51,21.84,22.66,2.59,3.40,3.94,2.02, ,-2.27,-1.26,-2.33,-1.78,-2.83,-0.49,-0.15,-0.83,positive regulation of protein glycosylation in Golgi;regulation of establishment of cell polarity;exocytosis;negative regulation of Rho GTPase activity;endomembrane system organization;protein transport;Golgi organization;regulation of ARF protein signal transduction;positive regulation of wound healing;negative regulation of actin filament polymerization,trans-Golgi network;cytosol;small nuclear ribonucleoprotein complex;nucleolus;nuclear matrix;Golgi membrane;perinuclear region of cytoplasm,,,,,6.62E-06,3.97E-04,3.12E-06,2.68E-05,2.2E-01,,,C, YES,+
9202,Q9Y6I3,EPN1,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),__MSTSSLRRQMK,_(ac)STSS(ph)LRR_,S5,,25.06,24.25,24.09,27.58,21.66,21.09,23.15,22.83,20.91,,,26.14,,23.68,1.39,0.58,0.42,3.90,-2.01,-2.59,-0.52,-0.85,-2.77, , ,2.46, ,Notch signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;embryonic organ development;female pregnancy;endocytosis;in utero embryonic development,coated pit;plasma membrane;nucleus;cytoplasm,,,,,2.42E-03,1.71E-02,8.91E-04,5.24E-01,5.8E-03,,,C, YES,+
9203,Q9Y6K1,DNMT3A,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA),PQPEEGSPAGGQK,_RSEPQPEEGS(ph)PAGGQK_,S105,+,24.46,24.57,25.00,23.35,,20.86,,19.88,20.92,20.65,,,,22.46,2.00,2.11,2.54,0.89, ,-1.61, ,-2.59,-1.54,-1.81, , , ,DNA methylation involved in embryo development;DNA methylation on cytosine within a CG sequence;cellular response to amino acid stimulus;S-adenosylmethioninamine metabolic process;methylation-dependent chromatin silencing;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;hypermethylation of CpG island;DNA methylation involved in gamete generation;regulation of gene expression by genetic imprinting;S-adenosylhomocysteine metabolic process,"nuclear heterochromatin;chromosome, centromeric region;euchromatin;nuclear matrix;cytoplasm",,,,,1.11E-03,1.05E-02,2.32E-04,4.33E-03,9.2E-01,,+,C,,
9231,Q9Y6Y8,SEC23IP,SEC23-interacting protein (p125),AEKVVESPDFSKD,_VVES(ph)PDFSKDEDYLGK_,S926,+,25.25,25.10,25.37,24.02,,23.63,23.94,23.90,,,,22.54,21.80,23.95,1.30,1.15,1.42,0.07, ,-0.32,-0.01,-0.05, , , ,-1.41,-2.15,intracellular protein transport;Golgi organization,endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle membrane;endoplasmic reticulum,,,,,7.1E-03,3.5E-02,1.2E-01,1.95E-03,3.59E-02,,,C, YES,
9248,Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),ADQKMSSPEDDSD,_ESSTSEGADQKM(ox)S(ph)S(ph)PEDDSDTK_,S384,+,23.59,,,23.02,,22.11,21.54,21.99,22.68,20.52,,20.97,20.92,21.93,1.66, , ,1.10, ,0.19,-0.39,0.07,0.75,-1.41, ,-0.95,-1.01,"hormone metabolic process;intracellular estrogen receptor signaling pathway;growth;chromatin organization;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,SAP-domain,,,,8.66E-03,4.06E-02,7.83E-02,3E-03,4.24E-02,,,C, YES,
9252,Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),ASREKRSVVSFDK,_S(ph)VVS(ph)FDK_,S601,+,27.62,26.05,24.95,25.37,,21.77,22.06,22.55,,,,,22.62,24.12,3.49,1.92,0.83,1.25, ,-2.35,-2.06,-1.57, , , , ,-1.51,"hormone metabolic process;intracellular estrogen receptor signaling pathway;growth;chromatin organization;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,SAP-domain,,,,1.42E-03,1.23E-02,2.47E-04,8.26E-03,6.71E-01,,,C, YES,
9277,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KIKKAASPSPQSV,_KAAS(ph)PS(ph)PQSVR_,S750,+,27.13,27.35,27.06,29.31,26.42,25.93,25.59,25.74,25.97,26.04,25.46,26.17,24.82,26.38,0.74,0.97,0.68,2.92,0.04,-0.46,-0.79,-0.65,-0.41,-0.35,-0.93,-0.21,-1.56,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,4.43E-03,2.51E-02,5.1E-03,2.35E-03,5.79E-01,,,C, YES,
9281,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),APQTSSSPPPVRR,_APQTSSS(ph)PPPVR_,S708,+,27.44,26.87,26.69,27.46,26.50,26.48,25.33,25.70,25.55,24.19,25.16,25.76,24.30,25.95,1.49,0.92,0.73,1.50,0.55,0.52,-0.63,-0.25,-0.41,-1.77,-0.80,-0.20,-1.66,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,1.74E-03,1.41E-02,2.27E-02,4.5E-04,4.87E-02,,,C, YES,
9286,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRRHRPSPPATPP,_HRPS(ph)PPAT(ph)PPPK_,S402,+,27.69,29.41,29.38,28.61,26.53,24.33,24.52,25.37,26.50,24.94,22.42,21.61,21.52,25.60,2.09,3.81,3.78,3.01,0.93,-1.27,-1.08,-0.23,0.90,-0.66,-3.19,-4.00,-4.09,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,4.07E-06,2.96E-04,4.34E-04,9.08E-07,1.69E-03,,,C, YES,+
9291,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PRKVELSESEEDK,_KVELS(ph)ES(ph)EEDKGGK_,S461,+,31.04,28.01,28.14,28.09,29.50,28.70,26.28,27.83,25.93,25.62,23.92,24.54,26.18,27.21,3.83,0.79,0.92,0.88,2.29,1.48,-0.94,0.61,-1.28,-1.60,-3.29,-2.67,-1.03,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,2.39E-03,1.71E-02,2.05E-01,7.96E-04,7.82E-03,,,C, YES,
9299,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),SPQRRQSPSPSTR,_RQS(ph)PS(ph)PSTRPIR_,S725,+,29.13,28.39,25.54,29.25,26.35,21.98,24.40,21.73,24.19,23.90,21.30,23.90,24.07,24.93,4.20,3.46,0.60,4.32,1.42,-2.96,-0.53,-3.20,-0.75,-1.03,-3.63,-1.04,-0.86,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,3.7E-04,5.24E-03,4.04E-04,2.79E-04,6.69E-01,,,C, YES,+
9302,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),GTEKRESPSPAPK,_RES(ph)PS(ph)PAPKPR_,S448,+,28.20,28.63,28.72,27.99,23.14,21.87,19.39,21.79,22.63,21.55,21.32,23.04,,24.02,4.18,4.61,4.69,3.97,-0.88,-2.15,-4.63,-2.23,-1.40,-2.47,-2.71,-0.99, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,2.73E-07,1.1E-04,1.32E-07,9.79E-07,7.88E-01,,,C, YES,+
9306,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PTRRRRSPSPAPP,_S(ph)PS(ph)PAPPPRR_,S572,+,27.55,28.82,28.59,28.68,25.62,22.17,22.74,23.08,23.72,22.74,,21.18,21.40,24.69,2.86,4.13,3.90,3.99,0.93,-2.52,-1.95,-1.61,-0.97,-1.95, ,-3.51,-3.29,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,7.45E-07,1.34E-04,2.93E-06,4.12E-07,3.7E-02,,,C, YES,+
9307,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRRRSPSPAPPPR,_S(ph)PS(ph)PAPPPRR_,S574,+,27.55,28.82,28.59,28.68,25.62,22.17,22.74,23.08,23.72,22.74,,21.18,21.40,24.69,2.86,4.13,3.90,3.99,0.93,-2.52,-1.95,-1.61,-0.97,-1.95, ,-3.51,-3.29,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,7.45E-07,1.34E-04,2.93E-06,4.12E-07,3.7E-02,,,C, YES,+
9308,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PKRRTASPPPPPK,_RRT(ph)AS(ph)PPPPPK_,S628,+,27.95,29.40,29.26,28.27,24.40,23.32,23.56,23.11,25.69,24.41,22.64,20.64,21.08,24.90,3.04,4.50,4.36,3.37,-0.50,-1.58,-1.34,-1.79,0.78,-0.49,-2.26,-4.27,-3.83,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,1.56E-06,2.07E-04,1.47E-05,5.4E-07,3E-02,,,C, YES,+
9309,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PRRRTPSPPPRRR,_RRT(ph)PS(ph)PPPR_,S595,+,26.81,28.54,26.38,28.22,24.29,22.74,20.81,21.97,22.40,21.20,,19.92,,23.94,2.88,4.60,2.45,4.28,0.35,-1.20,-3.12,-1.96,-1.54,-2.74, ,-4.01, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,6.3E-06,3.92E-04,9.9E-06,5.67E-06,7.04E-02,,,C, YES,
9313,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PIQRRYSPSPPPK,_RYS(ph)PS(ph)PPPK_,S617,+,28.24,29.28,28.90,29.89,24.65,22.66,23.36,23.75,25.31,23.77,,21.68,20.49,25.16,3.07,4.11,3.73,4.73,-0.51,-2.50,-1.80,-1.42,0.14,-1.40, ,-3.49,-4.68,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,7.09E-07,1.34E-04,3.51E-06,3.55E-07,2.43E-02,,,C, YES,+
9314,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),QRRYSPSPPPKRR,_RYS(ph)PS(ph)PPPK_,S619,+,28.24,29.28,28.90,29.89,24.65,22.66,23.36,23.75,25.31,23.77,,21.68,20.49,25.16,3.07,4.11,3.73,4.73,-0.51,-2.50,-1.80,-1.42,0.14,-1.40, ,-3.49,-4.68,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,7.09E-07,1.34E-04,3.51E-06,3.55E-07,2.43E-02,,,C, YES,+
9315,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TRKSRVSVSPGRT,_SRVS(ph)VS(ph)PGRTSGK_,S424,+,29.89,30.36,30.75,30.36,26.38,22.32,22.77,23.05,26.32,24.46,22.01,20.69,21.00,25.41,4.48,4.95,5.33,4.95,0.97,-3.09,-2.65,-2.36,0.90,-0.96,-3.40,-4.72,-4.41,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,1.31E-06,1.86E-04,1.02E-05,4.88E-07,3.88E-02,,,C, YES,+
9316,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KSRVSVSPGRTSG,_VSVS(ph)PGR_,S426,+,30.01,30.52,30.90,30.59,27.25,25.36,25.59,25.85,26.74,25.93,24.67,25.08,23.56,27.08,2.93,3.43,3.82,3.51,0.17,-1.72,-1.49,-1.23,-0.34,-1.15,-2.41,-2.00,-3.52,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,2.52E-07,1.1E-04,1.82E-06,1.03E-07,3.21E-02,,,C, YES,+
9376,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),AKLSEGSQPAEEE,_AAKLS(ph)EGS(ph)QPAEEEEDQETPSR_,S145,+,26.24,26.08,26.71,25.86,25.14,25.04,25.24,24.20,25.46,23.70,23.31,22.71,,24.97,1.27,1.10,1.74,0.89,0.17,0.06,0.26,-0.77,0.49,-1.28,-1.66,-2.26, ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,1.16E-03,1.08E-02,9.59E-02,3.64E-04,6.29E-03,+,,C, YES,
9383,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),GVPAGNSDTEGGQ,_GVPAGNS(ph)DTEGGQPGRK_,S742,+,25.14,25.04,25.61,25.77,21.33,19.89,21.51,21.09,21.44,21.29,,21.96,,22.73,2.40,2.31,2.88,3.03,-1.40,-2.84,-1.22,-1.64,-1.29,-1.45, ,-0.78, ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,8.35E-05,1.89E-03,1.6E-05,7.67E-04,4.62E-01,+,,C, YES,+
9384,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),LQPERGSPKKCEA,_LQPERGS(ph)PK_,S633,+,26.53,27.70,27.76,27.26,24.64,23.74,,,,,22.70,23.18,,25.44,1.09,2.27,2.32,1.82,-0.80,-1.70, , , , ,-2.73,-2.26, ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,2.5E-04,4.03E-03,1.01E-03,6.95E-05,1.45E-01,+,,C, YES,+
9385,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),VQARRLSQPESAE,_RLS(ph)QPESAEK_,S614,+,30.15,30.67,30.84,29.14,27.45,,26.16,26.60,27.69,27.01,25.72,26.41,24.61,27.71,2.45,2.97,3.13,1.44,-0.26, ,-1.54,-1.10,-0.01,-0.70,-1.99,-1.29,-3.10,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,2.59E-05,9.13E-04,1.5E-04,8.07E-06,1.23E-01,+,,C, YES,+
9389,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),EKSKSPSPPRLTE,_SKS(ph)PS(ph)PPRLTEDR_,S290,+,26.21,26.30,25.22,26.25,23.90,22.40,,22.39,25.15,22.23,23.42,,,24.35,1.87,1.95,0.87,1.91,-0.44,-1.95, ,-1.95,0.81,-2.12,-0.93, , ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,3.16E-03,2.06E-02,2.57E-03,2.34E-03,4.74E-01,+,,C, YES,
9418,O43172,PRPF4,U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4),SDKEGMSPAKRTK,_EVIDAS(ph)DKEGMS(ph)PAKR_,S79,,29.63,25.69,25.69,27.81,28.58,27.27,,,24.76,24.48,20.99,23.10,25.38,25.76,3.87,-0.07,-0.07,2.04,2.82,1.51, , ,-1.00,-1.28,-4.77,-2.66,-0.38,"mRNA splicing, via spliceosome",U4/U6 snRNP;nuclear speck;Cajal body;spliceosomal complex,,,,,1.09E-02,4.8E-02,5.28E-01,4.18E-03,1.56E-02,,,C, YES,
9421,B4E106,cDNA FLJ53399,"cDNA FLJ53399, highly similar to Monocarboxylate transporter 1",GPKEEESPV____,_DTEGGPKEEES(ph)PV_,S478,,23.71,24.90,,26.49,27.29,28.10,25.14,26.06,25.35,,,21.83,23.60,25.25,-1.54,-0.35, ,1.24,2.04,2.85,-0.10,0.82,0.10, , ,-3.41,-1.65,transmembrane transport,integral to membrane,,,,,8.3E-03,3.96E-02,2.04E-01,3.53E-02,2.6E-03,,,C, YES,
9436,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TRKSRVSVSPGRT,_SRVS(ph)VS(ph)PGRTSVTK_,S429,+,29.69,29.16,28.70,29.96,27.19,24.68,25.64,25.68,27.36,24.68,,,,27.27,2.42,1.89,1.43,2.69,-0.09,-2.60,-1.64,-1.59,0.08,-2.59, , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,4.35E-04,5.87E-03,2.09E-04,7.35E-04,1.95E-01,,,C, YES,+
9437,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KSRVSVSPGRTSV,_VSVS(ph)PGR_,S431,,29.82,29.38,28.87,30.24,27.81,25.88,25.68,26.60,27.58,25.27,24.51,24.91,23.25,26.91,2.92,2.48,1.96,3.33,0.91,-1.03,-1.23,-0.30,0.67,-1.63,-2.40,-2.00,-3.66,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,2.15E-06,2.13E-04,1.67E-04,4.92E-07,1.94E-03,,,C, YES,+
9489,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),VGDESPSPERLKN,_NLSLTDFVGDESPS(ph)PERLK_,S597,+,22.19,,,23.37,23.88,,22.45,22.86,,26.03,27.75,25.52,24.90,24.33,-2.14, , ,-0.95,-0.45, ,-1.88,-1.47, ,1.70,3.42,1.20,0.57,apoptotic process,Golgi apparatus;nucleus,,,,,3.39E-03,2.13E-02,7.65E-01,2.83E-03,2.21E-03,,,C, YES,
9515,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),KETERASPIKMDL,_ETERAS(ph)PIK_,S375,+,27.24,29.28,29.97,29.44,25.20,25.77,26.53,26.21,23.71,22.87,24.93,27.06,25.41,26.43,0.81,2.85,3.54,3.01,-1.23,-0.66,0.09,-0.22,-2.72,-3.56,-1.50,0.63,-1.02,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,1.24E-03,1.14E-02,1.39E-03,7.82E-04,6.22E-01,,,C, YES,+
9927,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],____METPSQRRA,_(ac)M(ox)ET(ph)PSQRR_,T3,+,23.60,22.93,,22.59,19.38,20.44,,20.18,19.02,,,21.39,,21.19,2.41,1.74, ,1.40,-1.82,-0.75, ,-1.01,-2.17, , ,0.20, ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,2.48E-03,1.74E-02,3.16E-04,1.11E-01,1.03E-01,,,C, YES,
9979,P13639,EEF2,Elongation factor 2 (EF-2),AGETRFTDTRKDE,_AGETRFT(ph)DTR_,T57,+,29.43,27.99,27.50,32.26,24.64,23.50,26.44,23.60,22.40,22.41,22.78,29.56,23.28,25.83,3.60,2.16,1.67,6.43,-1.19,-2.33,0.61,-2.23,-3.43,-3.42,-3.05,3.73,-2.55,translational elongation,cytosol;ribonucleoprotein complex;polysome,,,,,2.12E-03,1.62E-02,1.08E-03,2.97E-03,7.71E-01,,,C, YES,
10098,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),PGSTPTTPTSSQA,_SPGS(ph)TPTT(ph)PTSSQAPQK_,T437,+,26.04,25.63,25.84,25.86,22.49,,24.61,,25.04,23.00,,,21.17,24.41,1.63,1.22,1.43,1.45,-1.92, ,0.20, ,0.63,-1.41, , ,-3.24,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,2.93E-03,1.94E-02,3.11E-02,7.8E-04,4.65E-02,,,C, YES,+
10205,P80723,BASP1,Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22),ATEEEGTPKESEP,_KAEGAATEEEGT(ph)PK_,T36,+,23.33,25.68,25.37,25.05,,22.87,21.55,21.02,23.84,22.28,23.15,22.58,23.59,23.36,-0.03,2.32,2.01,1.70, ,-0.48,-1.81,-2.34,0.48,-1.08,-0.21,-0.78,0.23,"thorax and anterior abdomen determination;metanephric mesenchyme development;positive regulation of heart growth;negative regulation of transcription, DNA-dependent;gonad development;mesenchymal to epithelial transition;positive regulation of metanephric ureteric bud development;diaphragm development;glomerular visceral epithelial cell differentiation",growth cone;nuclear speck;plasma membrane;cytoskeleton;cytoplasm,,,,,6.7E-03,3.35E-02,2.63E-03,1.36E-02,4.29E-01,,,C, YES,
10235,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],RKDKEGTPPLTKE,_DKEGT(ph)PPLTK_,T337,+,24.09,25.56,25.96,24.42,,,21.01,,21.64,22.07,22.07,22.14,,23.22,0.87,2.34,2.74,1.20, , ,-2.21, ,-1.58,-1.15,-1.15,-1.07, ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,4.59E-04,6.1E-03,2.74E-04,6.71E-04,3.23E-01,,,C, YES,
10430,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),VNSTRETPPKSKL,_TVNSTRET(ph)PPK_,T51,+,24.85,25.83,26.67,24.40,,,21.67,,21.03,21.34,20.80,21.19,,23.09,1.76,2.74,3.59,1.31, , ,-1.42, ,-2.06,-1.74,-2.28,-1.89, ,nucleosome assembly,nucleus;nucleosome,,,,,4.86E-04,6.31E-03,8.55E-04,1.87E-04,7.88E-01,,,C, YES,
10476,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),GSPRAVTPVPTKT,_AVT(ph)PVPTK_,T526,+,26.87,26.71,27.40,26.49,26.54,25.85,24.73,26.90,25.25,25.38,21.08,21.08,22.94,25.17,1.70,1.54,2.23,1.32,1.37,0.68,-0.44,1.73,0.08,0.21,-4.09,-4.09,-2.24,positive regulation of macroautophagy,,,,,,7.11E-04,8.1E-03,4.2E-01,3.61E-04,1.2E-03,,,C, YES,
10620,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),LKAKKLTSDEEGE,_KLT(ph)S(ph)DEEGEPSGK_,T569,+,24.05,24.95,25.67,25.07,,21.65,22.05,22.17,22.95,22.02,20.98,,20.96,22.96,1.10,2.00,2.71,2.11, ,-1.31,-0.91,-0.78,-0.01,-0.94,-1.98, ,-2.00,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,4.28E-04,5.84E-03,1.25E-03,1.65E-04,1.88E-01,,,C, YES,+
10636,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),TRSRSHTSEGAHL,_SHT(ph)SEGAHLDITPNSGAAGNSAGPK_,T328,+,25.93,25.76,25.46,24.27,22.77,22.94,22.10,23.03,,,24.53,23.32,,24.01,1.92,1.75,1.44,0.26,-1.24,-1.07,-1.91,-0.98, , ,0.52,-0.69, ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,2.67E-03,1.83E-02,4.73E-04,5.42E-02,1.15E-01,,,C, YES,
10663,Q96B36,AKT1S1,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),PRPRLNTSDFQKL,_LNT(ph)SDFQK_,T266,+,26.83,26.39,25.82,29.09,24.19,23.38,24.34,24.40,25.07,22.96,23.66,,,25.10,1.72,1.29,0.72,3.98,-0.92,-1.73,-0.76,-0.71,-0.03,-2.14,-1.44, , ,negative regulation of TOR signaling cascade;fibroblast growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of cell size;negative regulation of protein kinase activity;nerve growth factor receptor signaling pathway;regulation of neuron apoptotic process;phosphatidylinositol-mediated signaling,nucleus;cytosolic part;protein complex,,,,,5.55E-04,6.85E-03,5.86E-04,4.47E-04,2.55E-01,,,C,,
10709,Q99442,SEC62,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),KEETPGTPKKKET,_EETPGT(ph)PK_,T158,+,26.02,26.29,26.25,27.01,18.30,20.81,22.94,19.90,22.92,21.80,23.58,25.27,22.35,23.34,2.68,2.95,2.91,3.67,-5.04,-2.53,-0.40,-3.44,-0.42,-1.54,0.23,1.93,-0.99,cotranslational protein targeting to membrane,rough endoplasmic reticulum;intermediate filament cytoskeleton;integral to membrane;aggresome;endoplasmic reticulum membrane,,,,,7.72E-05,1.81E-03,1.81E-05,3.71E-03,2.49E-02,,,C, YES,
10768,Q9H3R2,MUC13,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),PGKISVTVSETFD,_ISVT(ph)VS(ph)ETFDPEEK_,T222,,25.55,25.24,,27.00,21.38,22.14,25.31,24.57,25.22,23.22,,24.46,22.60,24.24,1.30,1.00, ,2.76,-2.87,-2.10,1.07,0.33,0.97,-1.03, ,0.21,-1.65,O-glycan processing;post-translational protein modification,integral to membrane;extracellular region;apical plasma membrane;Golgi lumen,,,,,8.72E-03,4.08E-02,5.8E-03,6.62E-03,7.61E-01,,,C, YES,
10889,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PKALPQTPRPRSR,_ALPQT(ph)PRPR_,T1492,+,24.50,25.10,24.93,24.85,24.82,23.55,22.80,22.88,23.50,22.50,22.94,22.99,21.75,23.62,0.87,1.47,1.30,1.22,1.20,-0.07,-0.83,-0.75,-0.12,-1.12,-0.68,-0.63,-1.87,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.93E-03,1.51E-02,1.51E-02,5.28E-04,8.29E-02,,,C, YES,
10891,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),DRARSRTPPSAPS,_S(ph)RT(ph)PPSAPSQSR_,T2409,+,28.12,27.81,28.42,28.33,25.14,24.98,22.07,20.81,25.00,22.94,,23.43,,25.19,2.93,2.62,3.23,3.14,-0.05,-0.21,-3.12,-4.37,-0.19,-2.24, ,-1.76, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,3.76E-04,5.32E-03,1.61E-04,6.96E-04,7.08E-01,,,C, YES,
10892,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KDGLPRTPSRRSR,_DGLPRT(ph)PS(ph)RR_,T1434,+,26.97,27.70,27.78,27.21,24.73,25.55,25.40,25.04,26.18,25.70,25.33,25.71,24.77,26.00,0.96,1.69,1.77,1.21,-1.28,-0.46,-0.60,-0.96,0.17,-0.30,-0.67,-0.30,-1.23,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,8.48E-04,9.14E-03,5.84E-04,9.13E-04,9.97E-01,,,C, YES,+
10894,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),MKDIPRTPSRGRS,_DIPRT(ph)PSRGR_,T1472,+,28.78,29.16,26.80,29.55,23.97,25.10,25.13,21.39,26.91,24.02,25.40,25.43,24.25,25.84,2.95,3.32,0.96,3.71,-1.87,-0.74,-0.70,-4.45,1.07,-1.82,-0.44,-0.41,-1.59,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,5.09E-04,6.49E-03,2.79E-04,8.03E-04,7.74E-01,,,C, YES,+
10903,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ANEQSVTPQRRSC,_SGT(ph)PPRQGSITSPQANEQSVT(ph)PQRR_,T866,+,26.93,27.28,27.39,26.96,24.16,23.80,23.77,,25.81,24.55,,,,25.63,1.30,1.66,1.76,1.34,-1.47,-1.83,-1.86, ,0.18,-1.08, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.8E-03,2.65E-02,8.21E-04,2.14E-02,8.63E-01,,,C, YES,
10909,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTPLISRR,_S(ph)RT(ph)PLISR_,T1880,+,29.74,29.17,29.54,28.89,26.27,23.54,24.80,24.74,25.60,24.91,22.19,22.64,,26.00,3.74,3.16,3.54,2.88,0.27,-2.46,-1.20,-1.26,-0.41,-1.09,-3.81,-3.36, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.51E-06,3.14E-04,2.45E-05,2.01E-06,3.33E-02,,,C, YES,+
10910,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTPLLPRK,_S(ph)RT(ph)PLLPR_,T2034,+,30.07,28.43,28.37,29.22,26.81,24.35,25.30,25.47,26.22,25.75,23.91,22.86,21.73,26.04,4.03,2.39,2.33,3.18,0.78,-1.69,-0.73,-0.57,0.18,-0.29,-2.12,-3.18,-4.31,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.53E-05,6.67E-04,3.56E-04,3.95E-06,1.42E-02,,,C, YES,+
10913,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTPPAIRR,_S(ph)RT(ph)PPAIRR_,T2022,+,29.87,29.28,28.45,30.19,24.49,,22.42,23.20,23.83,22.95,,,,26.08,3.79,3.21,2.38,4.11,-1.59, ,-3.65,-2.87,-2.25,-3.13, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,4.16E-06,2.96E-04,7.68E-07,3.08E-05,6.03E-01,,,C, YES,
10914,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRGRSRTPPTSRK,_S(ph)RT(ph)PPTSR_,T1844,+,24.13,23.42,23.25,24.31,18.66,18.78,19.52,19.74,20.71,18.18,,,,21.07,3.06,2.34,2.18,3.24,-2.41,-2.29,-1.55,-1.33,-0.36,-2.89, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.95E-05,7.86E-04,6.04E-06,6.76E-05,1.87E-01,,,C, YES,
10915,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTPPVTRR,_S(ph)RT(ph)PPVTR_,T1927,+,29.24,28.70,28.17,31.32,25.27,22.71,22.79,23.49,24.73,23.68,19.84,,20.77,25.06,4.18,3.64,3.11,6.26,0.21,-2.35,-2.27,-1.57,-0.33,-1.38,-5.22, ,-4.29,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,1.88E-06,2.07E-04,1.11E-05,8.44E-07,2.36E-02,,,C, YES,
10920,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QKTVARTPLGQRS,_TVART(ph)PLGQR_,T1531,+,27.08,27.80,27.93,27.50,25.21,25.46,24.50,24.41,24.94,24.56,24.53,24.60,22.58,25.47,1.61,2.33,2.46,2.03,-0.26,-0.01,-0.97,-1.06,-0.53,-0.91,-0.94,-0.87,-2.89,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.45E-05,9E-04,1.04E-04,1.01E-05,1.34E-01,,,C, YES,+
10921,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TKVKPETPPRQSH,_VKPET(ph)PPR_,T983,+,26.30,27.34,27.56,25.76,24.55,24.33,23.69,24.55,25.18,24.41,20.76,,19.13,24.46,1.84,2.88,3.10,1.30,0.08,-0.13,-0.78,0.09,0.72,-0.05,-3.70, ,-5.33,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,2.6E-04,4.14E-03,1.91E-02,7.2E-05,5.05E-03,,,C, YES,
10928,Q9Y222,DMTF1,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),MKDTCNTGKWTEE,_DTCNT(ph)GKWT(ph)EEEEK_,T232,,22.90,23.61,23.60,23.45,21.68,,25.04,,24.52,25.16,26.78,27.01,25.72,24.50,-1.60,-0.89,-0.90,-1.05,-2.82, ,0.54, ,0.03,0.67,2.28,2.51,1.23,"transcription, DNA-dependent;cell cycle",nucleus;cytoplasm,DNA binding region,,,,5.19E-03,2.81E-02,6.31E-01,1.85E-03,8.47E-03,,,C, YES,
10929,Q9Y222,DMTF1,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),CNTGKWTEEEEKR,_DT(ph)CNTGKWT(ph)EEEEK_,T236,,22.90,23.61,23.60,23.45,21.68,,25.04,,24.52,25.16,26.78,27.01,26.30,24.55,-1.65,-0.94,-0.95,-1.10,-2.87, ,0.49, ,-0.03,0.61,2.23,2.46,1.75,"transcription, DNA-dependent;cell cycle",nucleus;cytoplasm,DNA binding region,,,,3.25E-03,2.09E-02,6.28E-01,1.17E-03,5.56E-03,,,C, YES,
10957,Q9Y4G6,TLN2,Talin-2,SKLDEGTPPEPKG,_LDEGT(ph)PPEPK_,T1843,+,26.99,26.24,25.68,25.77,21.80,22.21,23.59,22.46,24.66,23.97,23.96,24.16,,24.29,2.70,1.95,1.39,1.48,-2.49,-2.08,-0.70,-1.84,0.37,-0.32,-0.33,-0.13, ,cell-cell junction assembly;cell adhesion;cytoskeletal anchoring at plasma membrane,actin cytoskeleton;cytoplasm;cell-cell junction;fascia adherens;synapse;focal adhesion;plasma membrane;ruffle,,,,,3.37E-04,4.94E-03,6.96E-05,5.51E-03,1.23E-01,,,C, YES,
10997,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RPSPPATPPPKTR,_HRPS(ph)PPAT(ph)PPPK_,T406,+,27.69,29.41,29.38,28.61,26.53,24.33,24.52,25.37,26.50,24.94,22.42,21.61,21.52,25.60,2.09,3.81,3.78,3.01,0.93,-1.27,-1.08,-0.23,0.90,-0.66,-3.19,-4.00,-4.09,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,4.07E-06,2.96E-04,4.34E-04,9.08E-07,1.69E-03,,,C, YES,+
10999,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PPPKRRTASPPPP,_RRT(ph)AS(ph)PPPPPK_,T626,+,27.87,29.32,29.23,28.10,22.96,22.00,22.99,,25.56,24.14,21.31,20.64,,24.92,2.95,4.40,4.31,3.18,-1.96,-2.92,-1.93, ,0.64,-0.78,-3.61,-4.28, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,1.49E-05,6.63E-04,3.71E-05,7.7E-06,1.78E-01,,,C, YES,+
0,A0AVK6,E2F8,Transcription factor E2F8 (E2F-8),MLISAVSPEIRNR,_M(ox)LISAVS(ph)PEIR_,S71,,22.08,,,,,,,,,,,,22.48,22.28,-0.20, , , , , , , , , , , ,0.20,"negative regulation of cytokinesis;cell proliferation;chorionic trophoblast cell differentiation;cell cycle comprising mitosis without cytokinesis;negative regulation of transcription from RNA polymerase II promoter;trophoblast giant cell differentiation;hepatocyte differentiation;transcription, DNA-dependent;positive regulation of DNA endoreduplication;sprouting angiogenesis;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex,DNA binding region,,,,,,,,,,,,,
2,A0JNW5,UHRF1BP1L,UHRF1-binding protein 1-like,LVYKSGSGEIGSE,_SGS(ph)GEIGSETSDKK_,S639,,20.47,25.38,24.44,23.97,,,21.38,,20.87,,,,,22.75,-2.28,2.63,1.69,1.22, , ,-1.37, ,-1.88, , , , ,,,,,,,,,,,,,,,,
3,A0MZ66,KIAA1598,Shootin-1,ATSESKSMPVLGS,_S(ph)M(ox)PVLGSVSSVTK_,S446,+,25.66,24.59,25.17,23.89,,,,,23.44,23.16,24.82,,23.25,24.25,1.41,0.34,0.92,-0.36, , , , ,-0.80,-1.09,0.57, ,-0.99,axon guidance,cytosol;axon,,,,,,,,,,,,,,
4,A0MZ66,KIAA1598,Shootin-1,AEADSSSPTGILA,_VTAEADSSS(ph)PTGILATSESK_,S434,+,26.98,23.88,24.58,22.18,,,25.34,25.33,,24.29,25.03,,,24.70,2.28,-0.82,-0.12,-2.52, , ,0.64,0.63, ,-0.41,0.33, , ,axon guidance,cytosol;axon,,,,,,,,,,,,,,
10,A1A5D9,CCDC64B,Bicaudal D-related protein 2 (BICD-related protein 2) (BICDR-2) (Coiled-coil domain-containing protein 64B),RLQRRVSELEEES,_RVS(ph)ELEEESR_,S277,,23.99,23.20,23.20,,,21.61,,,,,,,,23.00,0.99,0.20,0.20, , ,-1.39, , , , , , , ,,,,,,,,,,,,,,,,
11,A1KXE4,FAM168B,Myelin-associated neurite-outgrowth inhibitor (Mani) (p20),_MNPVYSPGSSGV,_(ac)M(ox)NPVYS(ph)PGSSGVPYANAK_,S6,,23.79,20.92,20.92,21.52,23.30,,,23.56,23.03,,,,,22.44,1.35,-1.51,-1.51,-0.91,0.86, , ,1.13,0.59, , , , ,,axon;integral to membrane;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
12,A1L170,C1orf226,Uncharacterized protein C1orf226,TECRRASSPSLIE,_RAS(ph)S(ph)PSLIER_,S222,,25.38,,,,,,,,,,,,,25.38,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
13,A1L170,C1orf226,Uncharacterized protein C1orf226,ECRRASSPSLIER,_ASS(ph)PSLIER_,S223,+,26.26,23.88,,22.55,22.66,22.56,,23.17,22.70,21.67,,,,23.18,3.08,0.70, ,-0.63,-0.52,-0.62, ,-0.01,-0.48,-1.51, , , ,,,,,,,,,,,,,,,,
14,A1L170,C1orf226,Uncharacterized protein C1orf226,PQARTSSLDNEGP,_TSS(ph)LDNEGPHPDLLSFE_,S258,,23.51,,,,,,,,,,,,,23.51,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
15,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),RFVSSFSRRSSVA,_FVSSFS(ph)R_,S558,,24.57,,,23.34,,,,,,,,23.12,,23.68,0.90, , ,-0.34, , , , , , , ,-0.55, ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
16,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),NVKGPLSPFNSRA,_GPLS(ph)PFNSR_,S76,+,25.38,24.75,25.43,24.27,25.36,24.69,26.31,25.69,27.20,26.13,25.86,25.53,25.44,25.54,-0.16,-0.80,-0.11,-1.27,-0.18,-0.86,0.77,0.15,1.66,0.59,0.32,-0.02,-0.10,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
17,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),MESSGGSPGKGPG,_IWEGM(ox)ESSGGS(ph)PGK_,S771,,22.89,23.50,23.50,,,,23.15,,,24.49,,,,23.51,-0.62,0.00,0.00, , , ,-0.36, , ,0.99, , , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
18,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),QLARQYSLRIKSN,_(gl)QYS(ph)LRIK_,S878,+,,24.16,24.16,,22.95,21.02,22.91,22.07,22.71,25.19,,22.99,23.35,23.15, ,1.01,1.01, ,-0.20,-2.13,-0.24,-1.08,-0.44,2.04, ,-0.16,0.20,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
19,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),SVRRRESLSYIPK,_RRES(ph)LSYIPK_,S685,+,,21.30,21.30,,22.53,,22.23,21.61,22.50,23.63,,22.95,21.94,22.22, ,-0.92,-0.92, ,0.31, ,0.01,-0.61,0.28,1.41, ,0.73,-0.28,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
20,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),PVNRSHSVPENMV,_SHS(ph)VPENM(ox)VEPPLSGR_,S1025,+,23.86,21.00,21.00,22.55,22.88,,23.19,22.87,23.23,23.27,,,,22.65,1.21,-1.65,-1.65,-0.10,0.23, ,0.55,0.22,0.58,0.62, , , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
22,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),SARSPLSPTETFS,_SPLS(ph)PTETFSWPDVR_,S984,,21.73,,,,,,,,,,,,,21.73,0.00, , , , , , , , , , , , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
23,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),LVSRSSSVLSLEG,_SSS(ph)VLS(ph)LEGS(ph)EK_,S584,,21.29,,,,,,,,,,,,,21.29,0.00, , , , , , , , , , , , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
24,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),RSSSVLSLEGSEK,_SSS(ph)VLS(ph)LEGS(ph)EK_,S587,+,23.35,,,,23.92,,23.98,23.78,22.91,24.12,24.66,23.49,,23.78,-0.43, , , ,0.15, ,0.21,0.00,-0.87,0.34,0.88,-0.28, ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
25,A1L390,PLEKHG3,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),VLSLEGSEKGLAR,_SSS(ph)VLS(ph)LEGS(ph)EK_,S591,+,22.62,22.53,23.25,,22.62,,23.20,23.52,,23.48,23.01,,,23.03,-0.41,-0.50,0.22, ,-0.41, ,0.17,0.49, ,0.45,-0.02, , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
26,A2A2V5,SERTM1,Serine-rich and transmembrane domain-containing protein 1,STFSNLSS_____,_STFSNLS(ph)S_,S106,,,,,,24.49,,,,,,21.71,25.58,,23.93, , , , ,0.56, , , , , ,-2.21,1.66, ,,integral to membrane,,,,,,,,,,,,,,
31,A2A2Y4,FRMD3,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),EYEDPPSEEEDKI,_EYEDPPS(ph)EEEDK_,S86,,24.03,,,,,,23.88,,23.54,,,,,23.82,0.22, , , , , ,0.06, ,-0.28, , , , ,,integral to membrane;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
32,A2RRP1,NBAS,Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein),DEGEEDSDSDYEI,_AGEEDEGEEDS(ph)DS(ph)DYEISAK_,S473,+,26.68,23.66,23.66,23.98,27.05,26.55,25.55,24.95,26.27,25.96,24.52,25.14,24.93,25.30,1.37,-1.64,-1.64,-1.32,1.75,1.25,0.25,-0.35,0.97,0.66,-0.78,-0.16,-0.37,,cytoplasm,,,,,,,,,,,,,,
33,A2RRP1,NBAS,Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein),GEEDSDSDYEISA,_AGEEDEGEEDS(ph)DS(ph)DYEISAK_,S475,,24.32,,,,,,,,,,,,,24.32,0.00, , , , , , , , , , , , ,,cytoplasm,,,,,,,,,,,,,,
35,A5YM69,ARHGEF35,Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein),SRAEELSPAALSP,_AEELS(ph)PAALS(ph)PLLEPIR_,S445,,25.00,,,,,,,,,,,,,25.00,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
36,A5YM69,ARHGEF35,Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein),LSPAALSPLLEPI,_AEELS(ph)PAALS(ph)PLLEPIR_,S450,,26.20,,,,,,,,,,,,,26.20,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
37,A6ND36,FAM83G,Protein FAM83G,___MAFSQVQCLD,_(ac)AFS(ph)QVQCLDDNHVNWR_,S4,,21.39,,,,,,,,,,,,,21.39,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
39,A6ND36,FAM83G,Protein FAM83G,PPRRQLSAPHITR,_(gl)QLS(ph)APHITR_,S650,+,24.48,23.41,24.10,22.98,23.85,22.95,24.10,24.13,22.77,24.62,25.46,24.98,25.02,24.06,0.41,-0.65,0.04,-1.08,-0.22,-1.12,0.04,0.06,-1.29,0.55,1.40,0.92,0.95,,,,,,,,,,,,,,,,
43,A6NEL2,SOWAHB,Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B),AATSRASPPALLP,_AS(ph)PPALLPGPAPR_,S271,,21.85,,,,,,,,,,,,,21.85,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
44,A6NFI3,ZNF316,Zinc finger protein 316,LHTTPDSPAAQLE,_(ac)AALHTTPDS(ph)PAAQLER_,S10,+,27.69,27.76,28.10,27.07,28.68,28.96,27.79,28.12,28.46,28.00,27.32,27.71,27.94,27.97,-0.28,-0.21,0.13,-0.90,0.71,0.99,-0.18,0.15,0.49,0.03,-0.64,-0.26,-0.03,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
45,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,TPKAVVSPPKFVF,_AVVS(ph)PPK_,S2510,,21.79,23.53,23.53,22.48,23.19,22.29,,22.94,,,,,,22.82,-1.03,0.71,0.71,-0.34,0.37,-0.53, ,0.12, , , , , ,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
46,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,LITPHVSRSSTPR,_DSLIT(ph)PHVS(ph)R_,S2454,+,26.69,26.08,26.30,25.29,,25.92,26.75,25.51,24.84,,,,,25.92,0.76,0.16,0.37,-0.63, ,-0.01,0.83,-0.41,-1.08, , , , ,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
47,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,GFSIPVSADGFKF,_EGFSIPVS(ph)ADGFK_,S1894,,22.84,,,,,,,,,,,,,22.84,0.00, , , , , , , , , , , , ,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
52,A7E2V4,ZSWIM8,Zinc finger SWIM domain-containing protein 8,RGPRRLSAEGGDK,_RLS(ph)AEGGDK_,S64,,,,,22.61,,,,,17.50,,,19.97,,20.03, , , ,2.58, , , , ,-2.53, , ,-0.05, ,,,,,,,,,,,,,,,,
53,A7KAX9,ARHGAP32,Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP),FFTLDLSPTEDKS,_LSPFFTLDLS(ph)PTEDK_,S797,,25.58,,,,,,,,,,,,,25.58,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,postsynaptic density;Golgi membrane;actin cytoskeleton;cell cortex;cytosol;endosome membrane;cell junction;plasma membrane;endoplasmic reticulum membrane;postsynaptic membrane,,,,,,,,,,,,,,
54,A7KAX9,ARHGAP32,Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP),TLRSAKSEESLTS,_S(ph)EESLTSLHAVDGDSK_,S632,,23.49,24.03,24.03,,,,23.52,,,,,,,23.77,-0.27,0.26,0.26, , , ,-0.25, , , , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,postsynaptic density;Golgi membrane;actin cytoskeleton;cell cortex;cytosol;endosome membrane;cell junction;plasma membrane;endoplasmic reticulum membrane;postsynaptic membrane,,,,,,,,,,,,,,
56,A7KAX9,ARHGAP32,Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP),KVVYAFSPKIGRK,_VVYAFS(ph)PK_,S818,,24.72,23.17,23.64,23.32,23.97,23.90,23.15,23.11,23.61,23.39,,23.61,23.35,23.58,1.14,-0.41,0.07,-0.26,0.39,0.32,-0.43,-0.47,0.03,-0.19, ,0.03,-0.23,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,postsynaptic density;Golgi membrane;actin cytoskeleton;cell cortex;cytosol;endosome membrane;cell junction;plasma membrane;endoplasmic reticulum membrane;postsynaptic membrane,,,,,,,,,,,,,,
57,A8CG34,POM121C,Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C),RNGPSSSPFSSPA,_NGPSSS(ph)PFSSPASSR_,S170,,,22.85,,,,24.44,,,23.49,23.53,,,24.01,23.66, ,-0.82, , , ,0.78, , ,-0.17,-0.14, , ,0.35,protein transport;mRNA transport,nuclear membrane;endoplasmic reticulum membrane;nuclear pore,,,,,,,,,,,,,,
58,A8CG34,POM121C,Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C),FGSSAKSPLPSYP,_S(ph)PLPSYPGANPQPAFGAAEGQPPGAAK_,S693,,22.64,,,,,,,,,,,,,22.64,0.00, , , , , , , , , , , , ,protein transport;mRNA transport,nuclear membrane;endoplasmic reticulum membrane;nuclear pore,,,,,,,,,,,,,,
64,B4DJY2,TMEM233,Transmembrane protein 233 (Dispanin subfamily B member 2) (DSPB2) (Interferon-induced transmembrane domain-containing protein D2),MSQYAPSPDFKRA,_(ac)SQYAPS(ph)PDFK_,S7,,,,,,26.78,25.33,21.49,24.97,25.66,22.40,24.85,22.30,25.31,24.34, , , , ,2.43,0.99,-2.85,0.62,1.32,-1.94,0.51,-2.04,0.97,response to biotic stimulus,integral to membrane,,,,,,,,,,,,,,
65,B7ZBB8,PPP1R3G,Protein phosphatase 1 regulatory subunit 3G,PIGARLSLEAPGP,_LS(ph)LEAPGPAPFR_,S9,,23.00,,,,,,,,,,,,,23.00,0.00, , , , , , , , , , , , ,glucose homeostasis;positive regulation of glycogen (starch) synthase activity;positive regulation of glycogen biosynthetic process,cytoplasm,,,,,,,,,,,,,,
66,B7ZBB8,PPP1R3G,Protein phosphatase 1 regulatory subunit 3G,CRARSFSLPADPI,_SFS(ph)LPADPILQAAK_,S86,,27.17,,,,,,,,,,,,,27.17,0.00, , , , , , , , , , , , ,glucose homeostasis;positive regulation of glycogen (starch) synthase activity;positive regulation of glycogen biosynthetic process,cytoplasm,,,,,,,,,,,,,,
68,C9JLW8,FAM195B,Protein FAM195B,RTSSPRSPPSSSE,_S(ph)PPSSSEIFTPAHEENVR_,S16,+,22.42,24.07,21.13,23.73,25.35,23.34,,24.96,23.25,,24.99,23.35,24.49,23.74,-1.32,0.34,-2.61,0.00,1.62,-0.40, ,1.22,-0.48, ,1.26,-0.38,0.76,,,,,,,,,,,,,,,,
69,O00116,AGPS,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",KARRAASAATAAP,_AAS(ph)AATAAPTATPAAQESGTIPK_,S65,+,24.15,24.22,24.17,24.41,24.06,25.92,24.82,24.17,25.43,25.73,24.55,25.30,26.21,24.86,-0.71,-0.64,-0.69,-0.44,-0.80,1.07,-0.03,-0.69,0.57,0.87,-0.31,0.44,1.36,response to chemical stimulus;ether lipid biosynthetic process,mitochondrion;peroxisomal matrix;peroxisomal membrane,,,,,,,,,,,,,,
71,O00151,PDLIM1,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),AMPFTASPASSTT,_SAM(ox)PFTAS(ph)PASSTTAR_,S130,,,23.31,23.31,22.08,23.21,,,,21.74,,,22.29,,22.66, ,0.65,0.65,-0.58,0.55, , , ,-0.91, , ,-0.37, ,"response to oxidative stress;response to hypoxia;regulation of transcription, DNA-dependent",transcription factor complex;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
72,O00151,PDLIM1,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),SEHKVWSPLVTEE,_VWS(ph)PLVTEEGK_,S90,+,24.72,24.06,24.66,23.56,,22.50,23.32,23.42,23.60,23.13,,22.45,,23.54,1.18,0.51,1.12,0.02, ,-1.04,-0.22,-0.12,0.06,-0.41, ,-1.09, ,"response to oxidative stress;response to hypoxia;regulation of transcription, DNA-dependent",transcription factor complex;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
73,O00159,MYO1C,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),ASKDVESPSWRST,_DVES(ph)PSWR_,S384,+,26.05,26.31,26.34,26.22,27.87,27.06,27.28,27.57,27.54,27.08,26.66,24.96,26.57,26.73,-0.68,-0.42,-0.39,-0.51,1.14,0.33,0.55,0.84,0.81,0.35,-0.07,-1.77,-0.16,protein transport;mRNA transport,stereocilium membrane;nucleoplasm;filamentous actin;lateral plasma membrane;unconventional myosin complex;cytoplasm;brush border;extracellular vesicular exosome;nucleolus;nuclear pore;basal plasma membrane;microvillus;myosin I complex,,,,,,,,,,,,,,
74,O00159,MYO1C,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),KDVESPSWRSTTV,_DVESPS(ph)WR_,S386,,22.15,23.00,22.36,22.60,,,23.77,,,,,,24.18,23.01,-0.86,-0.01,-0.65,-0.41, , ,0.76, , , , , ,1.17,protein transport;mRNA transport,stereocilium membrane;nucleoplasm;filamentous actin;lateral plasma membrane;unconventional myosin complex;cytoplasm;brush border;extracellular vesicular exosome;nucleolus;nuclear pore;basal plasma membrane;microvillus;myosin I complex,,,,,,,,,,,,,,
75,O00159,MYO1C,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),LRNDNSSRFGKYM,_NDNSS(ph)RFGK_,S233,,21.91,21.85,20.84,22.40,,,,,19.38,,,19.30,,20.95,0.96,0.90,-0.10,1.45, , , , ,-1.57, , ,-1.64, ,protein transport;mRNA transport,stereocilium membrane;nucleoplasm;filamentous actin;lateral plasma membrane;unconventional myosin complex;cytoplasm;brush border;extracellular vesicular exosome;nucleolus;nuclear pore;basal plasma membrane;microvillus;myosin I complex,,,,,,,,,,,,,,
76,O00159,MYO1C,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),KYCRSISPEWKQQ,_SIS(ph)PEWK_,S840,,22.69,24.31,22.60,24.89,24.83,24.04,24.85,24.75,24.77,24.09,23.88,23.27,24.27,24.10,-1.40,0.22,-1.50,0.80,0.74,-0.06,0.75,0.65,0.68,-0.01,-0.22,-0.83,0.18,protein transport;mRNA transport,stereocilium membrane;nucleoplasm;filamentous actin;lateral plasma membrane;unconventional myosin complex;cytoplasm;brush border;extracellular vesicular exosome;nucleolus;nuclear pore;basal plasma membrane;microvillus;myosin I complex,,,,,,,,,,,,,,
80,O00161,SNAP23,Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23),__MDNLSSEEIQQ,_(ac)M(ox)DNLS(ph)SEEIQQR_,S5,+,,22.74,22.74,,25.32,25.12,,24.38,25.33,24.13,,24.47,23.90,24.24, ,-1.50,-1.50, ,1.08,0.88, ,0.14,1.09,-0.10, ,0.23,-0.33,post-Golgi vesicle-mediated transport;protein transport;exocytosis;cellular membrane fusion;vesicle targeting,Golgi apparatus;specific granule;neuron projection;synapse;cell junction;azurophil granule;nucleus;plasma membrane,,,,,,,,,,,,,,
86,O00186,STXBP3,Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C),KPKDKVSLIKDE_,_DKVS(ph)LIKDE_,S587,,21.61,,,,,,,23.39,23.52,23.70,,,23.23,23.09,-1.48, , , , , , ,0.30,0.43,0.61, , ,0.14,neutrophil degranulation;negative regulation of calcium ion-dependent exocytosis;protein transport;platelet aggregation;vesicle docking involved in exocytosis,basolateral plasma membrane;platelet alpha granule;apical plasma membrane;specific granule;cytosol;nucleus;plasma membrane;tertiary granule,,,,,,,,,,,,,,
88,O00193,SMAP,Small acidic protein,ESEKEESAEELQA,_EES(ph)AEELQAAEHPDEVEDPK_,S147,+,30.34,30.92,31.33,28.79,28.15,27.23,30.47,26.48,29.47,30.24,27.94,29.75,26.16,29.02,1.32,1.90,2.31,-0.23,-0.87,-1.80,1.45,-2.54,0.45,1.22,-1.08,0.73,-2.86,,,,,,,,,,,,,,,,
90,O00193,SMAP,Small acidic protein,GVKRSASPDDDLG,_SAS(ph)PDDDLGSSNWEAADLGNEERK_,S17,+,28.78,25.89,25.89,22.77,30.29,28.22,28.29,27.42,28.48,28.45,27.19,29.03,26.47,27.47,1.30,-1.58,-1.58,-4.70,2.81,0.74,0.81,-0.05,1.00,0.98,-0.29,1.56,-1.00,,,,,,,,,,,,,,,,
91,O00203,AP3B1,AP-3 complex subunit beta-1 (Adapter-related protein complex 3 subunit beta-1) (Adaptor protein complex AP-3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain),GKNFYESDDDQKE,_NFYES(ph)DDDQKEK_,S227,+,27.71,28.76,28.63,29.24,26.59,27.50,28.89,27.29,27.96,27.57,27.56,28.86,26.27,27.91,-0.20,0.85,0.72,1.33,-1.32,-0.41,0.98,-0.62,0.06,-0.34,-0.35,0.95,-1.64,"endocytosis;anterograde synaptic vesicle transport;positive regulation of NK T cell differentiation;anterograde axon cargo transport;intracellular protein transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;blood coagulation;protein targeting to lysosome;melanosome organization",Golgi apparatus;AP-3 adaptor complex;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
92,O00203,AP3B1,AP-3 complex subunit beta-1 (Adapter-related protein complex 3 subunit beta-1) (Adaptor protein complex AP-3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain),PAPLLESPFKDRD,_PAPLLES(ph)PFK_,S560,,,,,,,,,,21.83,23.35,,23.22,,22.80, , , , , , , , ,-0.97,0.55, ,0.42, ,"endocytosis;anterograde synaptic vesicle transport;positive regulation of NK T cell differentiation;anterograde axon cargo transport;intracellular protein transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;blood coagulation;protein targeting to lysosome;melanosome organization",Golgi apparatus;AP-3 adaptor complex;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
93,O00231,PSMD11,26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5),EFQRAQSLLSTDR,_AQS(ph)LLSTDR_,S14,,23.46,24.44,,24.03,,,,,,,,,,23.98,-0.52,0.46, ,0.06, , , , , , , , , ,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;stem cell differentiation;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;proteasome assembly;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome accessory complex,,,,,,,,,,,,,,
94,O00264,PGRMC1,Membrane-associated progesterone receptor component 1 (mPR),EEPTVYSDEEEPK,_LLKEGEEPTVYS(ph)DEEEPKDESAR_,S181,+,32.41,32.69,32.92,32.43,33.19,32.47,32.63,32.17,32.77,32.95,32.47,31.86,31.78,32.52,-0.10,0.17,0.40,-0.09,0.67,-0.05,0.11,-0.35,0.25,0.43,-0.05,-0.65,-0.73,,integral to membrane;nucleolus;endoplasmic reticulum;endoplasmic reticulum membrane;cell surface,,,,,,,,,,,,,,
97,O00267,SUPT5H,Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein),GGFAPMSPRISSP,_DVTNFTVGGFAPM(ox)S(ph)PR_,S662,,25.41,,,,22.79,,,23.13,,22.36,,24.39,23.61,23.62,1.80, , , ,-0.83, , ,-0.48, ,-1.25, ,0.77,-0.01,"7-methylguanosine mRNA capping;negative regulation of DNA-dependent transcription, elongation;retroviral genome replication;positive regulation of transcription elongation from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;positive regulation of DNA-dependent transcription, elongation;cell cycle;positive regulation of macroautophagy;transcription elongation from RNA polymerase II promoter;chromatin remodeling;response to organic substance;positive regulation of viral transcription;positive regulation of transcription from RNA polymerase II promoter",DSIF complex,,,,,,,,,,,,,,
98,O00273,DFFA,DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD),ISASKASPPGDLQ,_AS(ph)PPGDLQNPK_,S315,+,24.65,24.59,24.70,25.30,,21.19,24.42,,23.92,23.19,21.83,22.74,,23.65,1.00,0.94,1.05,1.64, ,-2.46,0.77, ,0.27,-0.47,-1.82,-0.91, ,negative regulation of apoptotic process;apoptotic DNA fragmentation;intracellular signal transduction;induction of apoptosis,nucleoplasm;nuclear chromatin;cytosol,,,,,,,,,,,,,,
101,O00299,CLIC1,Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC),EEVDETSAEDEGV,_VLDNYLTSPLPEEVDETS(ph)AEDEGVSQRK_,S156,,25.40,,,,,,,,,25.39,,24.92,,25.24,0.17, , , , , , , , ,0.16, ,-0.32, ,signal transduction,nuclear membrane;brush border;nuclear envelope;plasma membrane;chloride channel complex;cytoplasm,,,,,,,,,,,,,,
103,O00329,PIK3CD,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)",ILERRGSGELYEH,_RGS(ph)GELYEHEK_,S187,,21.67,,,,,,20.41,22.47,,19.50,21.36,,,21.08,0.59, , , , , ,-0.67,1.39, ,-1.58,0.28, , ,inflammatory response;B cell activation;T cell chemotaxis;natural killer cell chemotaxis;respiratory burst involved in defense response;adaptive immune response;B cell homeostasis;phosphatidylinositol 3-kinase cascade;mast cell differentiation;small molecule metabolic process;cytokine production;natural killer cell differentiation;protein phosphorylation;neutrophil chemotaxis;T cell differentiation;innate immune response;neutrophil extravasation;T cell receptor signaling pathway;mast cell chemotaxis;mast cell degranulation;B cell receptor signaling pathway;B cell chemotaxis,phosphatidylinositol 3-kinase complex;plasma membrane,,,,,,,,,,,,,,
106,O00409,FOXN3,Forkhead box protein N3 (Checkpoint suppressor 1),SVLRSVSPVQDLD,_SVS(ph)PVQDLDDDTPPSPAHSDM(ox)PYDAR_,S85,,,,,,24.17,24.34,,,24.76,,,,,24.43, , , , ,-0.26,-0.08, , ,0.34, , , , ,"tissue development;negative regulation of transcription, DNA-dependent;embryo development;G2 phase of mitotic cell cycle;DNA damage checkpoint;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process",transcription factor complex,Forkhead,,,,,,,,,,,,,
107,O00418,EEF2K,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),SNRKYESDEDSLG,_KYES(ph)DEDSLGSSGR_,S470,,21.65,,,,23.28,22.65,22.09,23.46,,,,,,22.62,-0.97, , , ,0.66,0.02,-0.54,0.83, , , , , ,translational elongation;regulation of protein autophosphorylation;protein autophosphorylation;insulin receptor signaling pathway,cytosol,,+,,,,,,,,,,,,
108,O00418,EEF2K,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),GVDGGQSPRAGHD,_LEGVDGGQS(ph)PR_,S18,,25.14,24.66,,25.70,20.80,,,22.02,,,,,,23.66,1.48,1.00, ,2.03,-2.87, , ,-1.64, , , , , ,translational elongation;regulation of protein autophosphorylation;protein autophosphorylation;insulin receptor signaling pathway,cytosol,,+,,,,,,,,,,,,
109,O00425,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3),ARFAGASIKIAPA,_FAGAS(ph)IK_,S417,,23.00,,,,,,,19.91,,,,,,21.46,1.54, , , , , , ,-1.54, , , , , ,anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process;translation,cytosol;nucleus,,,,,,,,,,,,,,
110,O00429,DNM1L,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),ELPSAVSRDKSSK,_ELPSAVS(ph)RDK_,S529,,25.11,24.24,24.24,,,,,,,,,,,24.53,0.58,-0.29,-0.29, , , , , , , , , , ,protein homotetramerization;positive regulation of release of cytochrome c from mitochondria;peroxisome fission;positive regulation of mitochondrial fission;mitochondrion morphogenesis;cellular component disassembly involved in execution phase of apoptosis;GTP catabolic process;mitochondrial fragmentation involved in apoptotic process;regulation of peroxisome organization;membrane fission involved in mitochondrial fission;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of protein secretion;dynamin polymerization involved in mitochondrial fission,endomembrane system;Golgi apparatus;peroxisome;protein complex;perinuclear region of cytoplasm;cytosol;mitochondrial outer membrane;microtubule,,,,,,,,,,,,,,
111,O00429,DNM1L,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),IPIMPASPQKGHA,_SKPIPIM(ox)PAS(ph)PQK_,S605,+,25.68,24.66,25.02,24.07,23.18,23.68,26.01,26.16,22.99,24.78,25.28,24.89,,24.70,0.98,-0.04,0.32,-0.63,-1.52,-1.02,1.31,1.46,-1.71,0.08,0.58,0.19, ,protein homotetramerization;positive regulation of release of cytochrome c from mitochondria;peroxisome fission;positive regulation of mitochondrial fission;mitochondrion morphogenesis;cellular component disassembly involved in execution phase of apoptosis;GTP catabolic process;mitochondrial fragmentation involved in apoptotic process;regulation of peroxisome organization;membrane fission involved in mitochondrial fission;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of protein secretion;dynamin polymerization involved in mitochondrial fission,endomembrane system;Golgi apparatus;peroxisome;protein complex;perinuclear region of cytoplasm;cytosol;mitochondrial outer membrane;microtubule,,,,,,,,,,,,,,
112,O00443,PIK3C2A,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),ADAGSFSPTPGQI,_SADAGSFS(ph)PTPGQIGGAVK_,S1553,+,21.94,21.19,21.19,,,,,24.08,24.13,25.05,25.14,23.07,,23.22,-1.28,-2.03,-2.03, , , , ,0.85,0.90,1.82,1.92,-0.15, ,vascular smooth muscle contraction;platelet-derived growth factor receptor signaling pathway;small molecule metabolic process;endocytosis;exocytosis;clathrin coat assembly;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;phosphatidylinositol-mediated signaling,cytosol;vesicle;Golgi apparatus;plasma membrane;nucleus;clathrin-coated vesicle,,,,,,,,,,+,,,,
113,O00443,PIK3C2A,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),TVTRSQSLNIRTT,_SQS(ph)LNIR_,S338,+,25.82,24.43,23.77,27.24,23.90,22.18,24.30,23.95,22.15,23.05,22.81,23.88,,23.96,1.86,0.47,-0.19,3.28,-0.05,-1.78,0.35,-0.01,-1.80,-0.91,-1.15,-0.08, ,vascular smooth muscle contraction;platelet-derived growth factor receptor signaling pathway;small molecule metabolic process;endocytosis;exocytosis;clathrin coat assembly;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;phosphatidylinositol-mediated signaling,cytosol;vesicle;Golgi apparatus;plasma membrane;nucleus;clathrin-coated vesicle,,,,,,,,,,+,,,,
114,O00443,PIK3C2A,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),VSNLQVSPKSEDI,_VSNLQVS(ph)PK_,S259,+,25.72,26.38,26.43,26.45,24.46,23.70,25.40,25.04,25.21,25.88,25.90,23.44,24.65,25.28,0.44,1.10,1.15,1.17,-0.83,-1.58,0.12,-0.25,-0.07,0.60,0.62,-1.84,-0.63,vascular smooth muscle contraction;platelet-derived growth factor receptor signaling pathway;small molecule metabolic process;endocytosis;exocytosis;clathrin coat assembly;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;phosphatidylinositol-mediated signaling,cytosol;vesicle;Golgi apparatus;plasma membrane;nucleus;clathrin-coated vesicle,,,,,,,,,,+,,,,
117,O00461,GOLIM4,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",NEEQKQSNQKQEN,_EENLPDENEEQKQS(ph)NQK_,S583,,23.30,25.48,25.25,25.94,22.43,22.64,23.18,22.78,24.18,,,,,23.91,-0.61,1.57,1.34,2.03,-1.48,-1.27,-0.72,-1.13,0.27, , , , ,transport,Golgi cisterna membrane;endosome membrane;endocytic vesicle;integral to membrane;nucleus;Golgi lumen;cis-Golgi network,,,,,,,,,,,,,,
118,O00470,MEIS1,Homeobox protein Meis1,REGGSKSDSEDIT,_EGGSKS(ph)DSEDITR_,S196,+,23.57,25.27,,25.58,21.00,23.28,23.24,20.07,23.34,,,25.16,20.52,23.10,0.47,2.17, ,2.47,-2.11,0.18,0.14,-3.03,0.24, , ,2.06,-2.59,negative regulation of myeloid cell differentiation;angiogenesis;negative regulation of neuron differentiation;lens morphogenesis in camera-type eye;definitive hemopoiesis,transcription factor complex,Homeobox,,,,,,,,,,,,,
120,O00499,BIN1,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),PAKGNKSPSPPDG,_S(ph)PSPPDGSPAATPEIR_,S265,+,24.74,25.32,,25.90,22.87,24.03,25.74,25.21,24.37,,25.66,24.93,,24.88,-0.14,0.44, ,1.03,-2.00,-0.85,0.86,0.33,-0.51, ,0.79,0.05, ,multicellular organismal development;cell proliferation;positive regulation of endocytosis;endocytosis;positive regulation of GTPase activity;muscle cell differentiation;virus-host interaction,synaptic vesicle;nucleus;axon terminus;actin cytoskeleton;varicosity;cytoplasm;cerebellar mossy fiber,,,,,,,,,,,,,,
122,O00499,BIN1,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),PSPPDGSPAATPE,_SPS(ph)PPDGS(ph)PAATPEIR_,S272,+,25.83,25.79,,25.33,24.38,24.97,25.15,25.04,24.05,23.31,24.95,23.13,23.83,24.65,1.18,1.14, ,0.69,-0.26,0.32,0.50,0.39,-0.60,-1.34,0.30,-1.51,-0.82,multicellular organismal development;cell proliferation;positive regulation of endocytosis;endocytosis;positive regulation of GTPase activity;muscle cell differentiation;virus-host interaction,synaptic vesicle;nucleus;axon terminus;actin cytoskeleton;varicosity;cytoplasm;cerebellar mossy fiber,,,,,,,,,,,,,,
123,O00499,BIN1,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),GATLPKSPSQLRK,_VNHEPEPAGGATPGATLPKS(ph)PSQLR_,S300,,,,,,24.74,,,24.19,,,,,,24.47, , , , ,0.27, , ,-0.27, , , , , ,multicellular organismal development;cell proliferation;positive regulation of endocytosis;endocytosis;positive regulation of GTPase activity;muscle cell differentiation;virus-host interaction,synaptic vesicle;nucleus;axon terminus;actin cytoskeleton;varicosity;cytoplasm;cerebellar mossy fiber,,,,,,,,,,,,,,
124,O00505,KPNA3,Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma),EESLEDSDVDADF,_RNVPQEESLEDS(ph)DVDADFK_,S60,+,26.39,,,,26.70,25.75,27.90,25.44,27.66,28.61,27.07,28.40,26.01,26.99,-0.61, , , ,-0.29,-1.24,0.90,-1.55,0.67,1.61,0.08,1.41,-0.98,NLS-bearing substrate import into nucleus;viral entry into host cell;protein complex assembly;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
125,O00512,BCL9,B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog),PVEGPLSPSRGDF,_IPVEGPLS(ph)PSRGDFPK_,S687,+,25.69,22.93,23.47,21.00,24.30,24.59,24.36,23.15,24.70,24.22,23.61,,24.05,23.84,1.85,-0.91,-0.37,-2.84,0.46,0.75,0.52,-0.69,0.86,0.38,-0.23, ,0.21,somatic stem cell maintenance;myotube differentiation involved in skeletal muscle regeneration;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway,nucleus;cytoplasm,,,,,,,,,,,,,,
127,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),KDWSALSSLARQR,_DWSALS(ph)SLAR_,S12,,20.26,,,,,,,,,,,,,20.26,0.00, , , , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
128,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),EEADMSSPTQRTY,_EEEADM(ox)SS(ph)PTQR_,S356,+,25.27,26.65,27.64,21.15,22.48,,,21.53,,26.98,,,,24.53,0.75,2.12,3.11,-3.38,-2.05, , ,-3.00, ,2.45, , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
129,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),KGVPEKSPVLEKS,_GVPEKS(ph)PVLEK_,S177,,22.70,23.91,24.70,,,,,,,,,,,23.77,-1.07,0.14,0.93, , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
130,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),RRHRNLSSTTDDE,_NLS(ph)S(ph)TTDDEAPR_,S38,,28.69,24.40,24.40,,,,,,,,,,,25.83,2.86,-1.43,-1.43, , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
131,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),RHRNLSSTTDDEA,_NLS(ph)S(ph)TTDDEAPR_,S39,,26.32,,,,,,,,,,,,,26.32,0.00, , , , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
132,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),ASERLPSVEEAEV,_LPS(ph)VEEAEVPKPLPPASK_,S64,,22.81,,,,,,,,,,,,,22.81,0.00, , , , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
133,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),EGRNSLSPVQATQ,_NSLS(ph)PVQATQK_,S123,,25.84,22.15,22.15,,,,,,,,,,,23.38,2.46,-1.23,-1.23, , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
134,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),TLTRSASMKLPDN,_SAS(ph)M(ox)KLPDNTVK_,S394,,28.01,26.45,26.26,23.18,,,,,,21.55,,,,25.09,2.92,1.36,1.17,-1.91, , , , , ,-3.54, , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
136,O00533,CHL1,Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein],PDPEIQSVKDETF,_EDLHPDPEIQS(ph)VK_,S1127,,,24.39,24.39,21.74,,,22.17,,,,,21.70,,22.88, ,1.51,1.51,-1.13, , ,-0.71, , , , ,-1.18, ,signal transduction;cell adhesion;neuron migration;cognition;axon guidance;adult locomotory behavior,integral to membrane;proteinaceous extracellular matrix;plasma membrane;apical part of cell;dendrite,,,,,,,,,,,,,,
137,O00559,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein),GRGRKLSGDQITL,_KLS(ph)GDQITLPTTVDYSSVPK_,S36,+,27.71,26.84,26.93,26.01,28.35,28.28,27.63,28.29,28.40,29.27,28.10,28.17,28.32,27.87,-0.16,-1.03,-0.94,-1.86,0.48,0.41,-0.24,0.42,0.53,1.40,0.23,0.30,0.45,regulation of cell growth;apoptotic process,integral to membrane;Golgi apparatus;plasma membrane;focal adhesion;Golgi membrane,,,,,,,,,,,,,,
138,O00560,SDCBP,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),_MSLYPSLEDLKV,_(ac)SLYPS(ph)LEDLK_,S6,,22.66,,,,23.55,,,,,20.87,,22.76,,22.46,0.20, , , ,1.09, , , , ,-1.59, ,0.30, ,"protein targeting to membrane;substrate-dependent cell migration, cell extension;Ras protein signal transduction;axon guidance;actin cytoskeleton organization;positive regulation of JNK cascade;positive regulation of phosphorylation;synaptic transmission;intracellular signal transduction",cytosol;adherens junction;extracellular vesicular exosome;interleukin-5 receptor complex;nucleus;cytoskeleton;focal adhesion;endoplasmic reticulum membrane;melanosome,,,,,,,,,,,,,,
139,O00562,PITPNM1,"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)",PPGPDASPDASFG,_SAASNTGTPDGPEAPPGPDAS(ph)PDASFGK_,S300,,,,,,23.85,,,25.33,22.89,23.74,,,,23.95, , , , ,-0.10, , ,1.38,-1.07,-0.21, , , ,phototransduction;brain development;protein transport;lipid metabolic process,Golgi cisterna membrane;midbody;lipid particle;endoplasmic reticulum membrane;membrane;cleavage furrow,,,,,,,,,,,,,,
141,O00566,MPHOSPH10,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),LEEEEVSDMGNDD,_EDLEDLEEEEVS(ph)DM(ox)GNDDPEM(ox)GER_,S139,,24.43,,,,,,,,,26.19,,,,25.31,-0.88, , , , , , , , ,0.88, , , ,"RNA splicing, via transesterification reactions;rRNA processing;negative regulation of phosphatase activity",nucleolus;chromosome;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
142,O00566,MPHOSPH10,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),EREEDGSEIEADD,_EEDGS(ph)EIEADDK_,S120,,24.23,25.63,26.03,25.27,,,22.24,,,22.65,,,,24.34,-0.11,1.29,1.69,0.93, , ,-2.10, , ,-1.69, , , ,"RNA splicing, via transesterification reactions;rRNA processing;negative regulation of phosphatase activity",nucleolus;chromosome;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
144,O00566,MPHOSPH10,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),VFSDEDSDLDFDI,_SPVFSDEDS(ph)DLDFDISK_,S171,,22.36,,,,,,,,,,,,,22.36,0.00, , , , , , , , , , , , ,"RNA splicing, via transesterification reactions;rRNA processing;negative regulation of phosphatase activity",nucleolus;chromosome;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
145,O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),SKEELMSSDLEET,_EELM(ox)S(ph)SDLEETAGSTSIPK_,S519,+,28.77,24.82,24.82,24.68,26.22,22.44,26.84,26.05,27.36,30.29,25.93,26.92,25.18,26.18,2.59,-1.36,-1.36,-1.49,0.04,-3.74,0.66,-0.12,1.18,4.11,-0.25,0.74,-1.00,cell death;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;cytoplasm,,,,,,,,,,,,,,
146,O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),KEELMSSDLEETA,_SFSKEELMSS(ph)DLEETAGSTSIPK_,S520,+,29.86,24.50,25.41,24.97,28.61,26.43,28.64,24.63,29.03,28.93,27.83,28.59,27.96,27.34,2.52,-2.84,-1.92,-2.37,1.27,-0.91,1.30,-2.71,1.69,1.59,0.49,1.25,0.63,cell death;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;cytoplasm,,,,,,,,,,,,,,
147,O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),SKEEPVSSGPEEA,_EEPVS(ph)S(ph)GPEEAVGK_,S569,+,27.02,23.21,23.79,25.51,26.78,26.15,,25.58,24.99,22.28,23.12,,25.96,24.94,2.08,-1.74,-1.15,0.57,1.83,1.20, ,0.63,0.05,-2.66,-1.83, ,1.02,cell death;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;cytoplasm,,,,,,,,,,,,,,
148,O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),KEEPVSSGPEEAV,_EEPVS(ph)S(ph)GPEEAVGK_,S570,+,28.81,27.70,28.46,29.35,27.55,26.63,29.08,27.23,28.18,27.09,26.15,26.84,26.71,27.68,1.13,0.02,0.78,1.67,-0.12,-1.04,1.41,-0.45,0.51,-0.58,-1.53,-0.84,-0.96,cell death;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;cytoplasm,,,,,,,,,,,,,,
149,O00567,NOP56,Nucleolar protein 56 (Nucleolar protein 5A),LIAHAGSLTNLAK,_LIAHAGS(ph)LTNLAK_,S314,+,23.79,21.55,21.55,26.08,24.73,,25.47,24.16,,22.01,,27.25,,24.07,-0.27,-2.52,-2.52,2.01,0.66, ,1.41,0.10, ,-2.06, ,3.19, ,cell death;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;cytoplasm,,,,,,,,,,,,,,
150,O00571,DDX3X,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)",DKDAYSSFGSRSD,_DAYSS(ph)FGSR_,S71,,23.27,,,,,,,,,,,21.73,21.62,22.21,1.06, , , , , , , , , , ,-0.48,-0.58,"negative regulation of apoptotic process;intracellular protein kinase cascade;intrinsic apoptotic signaling pathway;chromosome segregation;cellular response to arsenic-containing substance;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of cell growth;positive regulation of cell growth;negative regulation of intrinsic apoptotic signaling pathway;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;positive regulation of translational initiation;positive regulation of G1/S transition of mitotic cell cycle;RNA secondary structure unwinding;response to virus;negative regulation of translation;cellular response to osmotic stress;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;innate immune response;mature ribosome assembly;transcription, DNA-dependent;stress granule assembly;positive regulation of chemokine (C-C motif) ligand 5 production;negative regulation of protein complex assembly;positive regulation of apoptotic process",mitochondrial outer membrane;nuclear speck;nucleus;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
151,O00571,DDX3X,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)",FFSDRGSGSRGRF,_SSFFSDRGS(ph)GSR_,S90,,25.34,,,24.72,,,,,,,,22.70,,24.26,1.09, , ,0.47, , , , , , , ,-1.55, ,"negative regulation of apoptotic process;intracellular protein kinase cascade;intrinsic apoptotic signaling pathway;chromosome segregation;cellular response to arsenic-containing substance;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of cell growth;positive regulation of cell growth;negative regulation of intrinsic apoptotic signaling pathway;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;positive regulation of translational initiation;positive regulation of G1/S transition of mitotic cell cycle;RNA secondary structure unwinding;response to virus;negative regulation of translation;cellular response to osmotic stress;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;innate immune response;mature ribosome assembly;transcription, DNA-dependent;stress granule assembly;positive regulation of chemokine (C-C motif) ligand 5 production;negative regulation of protein complex assembly;positive regulation of apoptotic process",mitochondrial outer membrane;nuclear speck;nucleus;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
153,O00712,NFIB,Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein),PLFSSASPQDSSP,_PLFSSAS(ph)PQDSSPR_,S328,+,25.79,23.89,,25.48,,24.92,26.83,23.49,26.63,25.59,24.56,25.53,,25.27,0.52,-1.38, ,0.21, ,-0.35,1.56,-1.78,1.36,0.32,-0.71,0.26, ,anterior commissure morphogenesis;negative regulation of DNA binding;principal sensory nucleus of trigeminal nerve development;lung ciliated cell differentiation;Type II pneumocyte differentiation;negative regulation of mesenchymal cell proliferation involved in lung development;Type I pneumocyte differentiation;commissural neuron axon guidance;glial cell differentiation;Clara cell differentiation;DNA replication;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell proliferation involved in lung morphogenesis;chondrocyte differentiation,nucleolus;nucleus;cerebellar mossy fiber,CTF/NF-I family,,,,,,,,,,,,,
157,O00712,NFIB,Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein),FYPSPSSPAAGSR,_TISIDENM(ox)EPSPTGDFYPSPSS(ph)PAAGSR_,S295,+,25.34,,,,24.00,26.65,,25.27,24.81,24.63,24.60,,,25.04,0.30, , , ,-1.04,1.60, ,0.22,-0.23,-0.41,-0.44, , ,anterior commissure morphogenesis;negative regulation of DNA binding;principal sensory nucleus of trigeminal nerve development;lung ciliated cell differentiation;Type II pneumocyte differentiation;negative regulation of mesenchymal cell proliferation involved in lung development;Type I pneumocyte differentiation;commissural neuron axon guidance;glial cell differentiation;Clara cell differentiation;DNA replication;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell proliferation involved in lung morphogenesis;chondrocyte differentiation,nucleolus;nucleus;cerebellar mossy fiber,CTF/NF-I family,,,,,,,,,,,,,
159,O14490,DLGAP1,Disks large-associated protein 1 (DAP-1) (Guanylate kinase-associated protein) (hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1) (SAPAP1),PLIRERSLESSQR,_ERS(ph)LESSQR_,S616,,24.23,23.50,,19.40,,,,21.21,,,,20.26,,21.72,2.51,1.78, ,-2.32, , , ,-0.51, , , ,-1.46, ,synaptic transmission,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane,,,,,,,,,,,,,,
160,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",PGIRGPSPSPVGS,_GPS(ph)PSPVGSPASVAQSR_,S696,+,25.33,,,26.04,26.37,25.41,23.90,24.25,24.04,,,,24.02,24.92,0.41, , ,1.12,1.45,0.49,-1.02,-0.67,-0.88, , , ,-0.90,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
162,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",QPGSALSPRQPSG,_NPQM(ox)PQYSSPQPGSALS(ph)PR_,S772,+,23.46,,,23.71,25.49,24.98,24.15,24.16,25.02,23.36,23.76,23.82,23.53,24.13,-0.67, , ,-0.42,1.36,0.85,0.02,0.03,0.89,-0.77,-0.37,-0.31,-0.60,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
163,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",SHHAPMSPGSSGG,_SHHAPM(ox)S(ph)PGSSGGGGQPLAR_,S363,+,,,,,23.92,22.65,22.53,22.54,23.30,22.58,,,21.12,22.66, , , , ,1.26,-0.02,-0.13,-0.12,0.63,-0.08, , ,-1.54,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
165,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",GMSRSNSVGIQDA,_SNS(ph)VGIQDAFNDGSDSTFQK_,S1184,+,24.69,19.81,19.81,,23.17,23.78,22.67,,24.04,24.06,,23.90,,22.88,1.81,-3.07,-3.07, ,0.29,0.90,-0.21, ,1.16,1.18, ,1.01, ,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
166,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",LDPGRFSKVSSPA,_TLLDPGRFS(ph)K_,S1534,,24.38,23.65,23.15,23.49,24.83,25.69,24.59,23.73,25.02,23.66,23.72,24.25,23.81,24.15,0.23,-0.50,-1.00,-0.66,0.68,1.54,0.44,-0.42,0.87,-0.49,-0.43,0.09,-0.34,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
168,O14497,ARID1A,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",RFSKVSSPAPMEG,_VSS(ph)PAPM(ox)EGGEEEEELLGPK_,S1538,+,27.92,27.09,27.42,26.23,26.15,25.98,26.34,25.53,26.19,28.01,23.04,25.86,24.65,26.19,1.73,0.91,1.23,0.04,-0.04,-0.20,0.15,-0.66,0.00,1.82,-3.14,-0.32,-1.53,"intracellular estrogen receptor signaling pathway;chromatin-mediated maintenance of transcription;nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;nucleosome mobilization;glucocorticoid receptor signaling pathway;transcription, DNA-dependent;androgen receptor signaling pathway;nervous system development",nuclear chromatin;SWI/SNF complex;npBAF complex;nBAF complex,ARID domain,,,,,,,,,,,,,
169,O14523,C2CD2L,C2 domain-containing protein 2-like (Transmembrane protein 24),QKEAGLSQSHDDL,_EAGLS(ph)QSHDDLSNATATPSVRK_,S660,,,23.49,,,,22.38,,21.83,24.05,22.80,22.40,,25.22,23.17, ,0.32, , , ,-0.79, ,-1.34,0.89,-0.37,-0.76, ,2.06,,integral to membrane,,,,,,,,,,,,,,
170,O14523,C2CD2L,C2 domain-containing protein 2-like (Transmembrane protein 24),EAGLSQSHDDLSN,_EAGLSQS(ph)HDDLSNATATPSVR_,S662,+,22.10,22.38,22.38,22.30,23.87,,,,25.25,24.24,,22.33,,23.11,-1.00,-0.72,-0.72,-0.81,0.76, , , ,2.14,1.13, ,-0.78, ,,integral to membrane,,,,,,,,,,,,,,
175,O14545,TRAFD1,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),LNTGSSSPRGVEE,_ALPSLNTGSSS(ph)PR_,S327,+,27.52,26.42,26.42,28.44,,,26.50,,,22.64,26.39,27.32,,26.46,1.06,-0.04,-0.04,1.99, , ,0.04, , ,-3.81,-0.06,0.86, ,negative regulation of innate immune response;response to cytokine stimulus,intracellular,,,,,,,,,,,,,,
176,O14545,TRAFD1,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),SQPQETSPELPRR,_LDSQPQETS(ph)PELPR_,S415,+,27.30,26.93,25.52,28.71,27.67,27.35,27.24,27.88,25.29,23.07,27.36,28.72,26.54,26.89,0.41,0.04,-1.37,1.82,0.78,0.46,0.35,0.99,-1.60,-3.82,0.47,1.83,-0.35,negative regulation of innate immune response;response to cytokine stimulus,intracellular,,,,,,,,,,,,,,
177,O14558,HSPB6,Heat shock protein beta-6 (HspB6) (Heat shock 20 kDa-like protein p20),SWLRRASAPLPGL,_RAS(ph)APLPGLSAPGR_,S16,,21.64,22.58,,24.51,,,,,,,,24.97,,23.43,-1.78,-0.85, ,1.09, , , , , , , ,1.55, ,response to stress,nucleus;cytoplasm,,,,,,,,,,,,,,
178,O14576,DYNC1I1,"Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)",RANRADSEEEGTV,_ANRADS(ph)EEEGTVELSA_,S598,,,,,,,,,23.50,,,24.19,,23.42,23.71, , , , , , , ,-0.20, , ,0.49, ,-0.29,vesicle transport along microtubule;antigen processing and presentation of exogenous peptide antigen via MHC class II,condensed chromosome kinetochore;perinuclear region of cytoplasm;cytoplasmic dynein complex;cytosol;vesicle;microtubule;kinetochore;spindle pole,,,,,,,,,,,,,,
180,O14578,CIT,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),ELRRDKSPGRPLE,_DKS(ph)PGRPLER_,S1584,,,,,,,20.88,,22.83,,,,20.19,,21.30, , , , , ,-0.42, ,1.53, , , ,-1.11, ,generation of neurons;cell cycle cytokinesis;spermatogenesis;dendrite development;mitosis;mitotic metaphase/anaphase transition;negative regulation of dendrite morphogenesis;intracellular signal transduction;mitotic sister chromatid segregation,vacuole;actin cytoskeleton;ruffle,,+,,,,,,,,,,,,
181,O14578,CIT,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),STRRERSPGRLFE,_ERS(ph)PGRLFEDSSR_,S1606,+,,,,,25.01,22.79,24.98,25.22,22.26,22.46,,23.34,22.80,23.61, , , , ,1.40,-0.82,1.38,1.61,-1.35,-1.15, ,-0.27,-0.80,generation of neurons;cell cycle cytokinesis;spermatogenesis;dendrite development;mitosis;mitotic metaphase/anaphase transition;negative regulation of dendrite morphogenesis;intracellular signal transduction;mitotic sister chromatid segregation,vacuole;actin cytoskeleton;ruffle,,+,,,,,,,,,,,,
183,O14578,CIT,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),VVSGLDSPAKTSS,_SESVVSGLDS(ph)PAK_,S68,+,21.67,22.36,22.36,21.88,,,,23.39,22.64,22.81,,,23.10,22.53,-0.85,-0.17,-0.17,-0.64, , , ,0.86,0.11,0.28, , ,0.57,generation of neurons;cell cycle cytokinesis;spermatogenesis;dendrite development;mitosis;mitotic metaphase/anaphase transition;negative regulation of dendrite morphogenesis;intracellular signal transduction;mitotic sister chromatid segregation,vacuole;actin cytoskeleton;ruffle,,+,,,,,,,,,,,,
184,O14579,COPE,Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP),HESRRDSIVAELD,_RDS(ph)IVAELDR_,S99,+,24.46,26.66,,24.72,25.46,24.03,23.90,25.99,,,26.34,,25.42,25.22,-0.76,1.44, ,-0.50,0.24,-1.19,-1.32,0.77, , ,1.12, ,0.20,"retrograde vesicle-mediated transport, Golgi to ER;COPI coating of Golgi vesicle;protein transport;intra-Golgi vesicle-mediated transport",cytosol;COPI vesicle coat,,,,,,,,,,,,,,
185,O14617,AP3D1,AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adapter-related protein complex 3 subunit delta-1) (Delta-adaptin),RPKHRPSEADEEE,_HRPS(ph)EADEEELAR_,S658,+,22.83,23.68,23.97,22.47,24.24,23.21,24.82,25.00,24.01,21.05,24.74,24.10,,23.68,-0.85,0.00,0.29,-1.21,0.56,-0.47,1.14,1.32,0.34,-2.63,1.06,0.43, ,"anterograde synaptic vesicle transport;eye pigment biosynthetic process;positive regulation of NK T cell differentiation;anterograde axon cargo transport;intracellular protein transport;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;synaptic vesicle membrane organization;protein localization to organelle;regulation of sequestering of zinc ion",membrane coat;endosome membrane;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
186,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),RMDRGVSMPNMLE,_GVS(ph)M(ox)PNM(ox)LEPK_,S459,+,26.46,24.16,23.76,,22.17,,23.01,23.75,,22.92,23.90,,,23.77,2.70,0.40,-0.01, ,-1.59, ,-0.76,-0.02, ,-0.84,0.13, , ,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
187,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),DKQERQSLGESPR,_(gl)QERQS(ph)LGESPR_,S210,,24.69,,,,,,,,,,,,,24.69,0.00, , , , , , , , , , , , ,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
188,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),ESPRTLSPTPSAE,_TLS(ph)PTPSAEGYQDVRDR_,S219,+,29.05,26.14,26.59,23.77,27.27,26.37,27.46,27.44,26.13,27.07,27.06,23.94,25.49,26.44,2.60,-0.30,0.15,-2.67,0.83,-0.07,1.01,0.99,-0.31,0.63,0.62,-2.50,-0.96,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
189,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),TLSPTPSAEGYQD,_TLS(ph)PTPS(ph)AEGYQDVRDR_,S223,,25.01,,,,,,,,,,,,,25.01,0.00, , , , , , , , , , , , ,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
191,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),DMKRRSSGREEDD,_RSS(ph)GREEDDEELLR_,S340,+,25.17,22.25,22.45,,25.71,24.16,21.90,25.18,21.76,,23.04,22.50,22.85,23.36,1.81,-1.11,-0.91, ,2.35,0.80,-1.46,1.82,-1.60, ,-0.32,-0.86,-0.51,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
193,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),MIHRSTSQGSINS,_STS(ph)QGSINSPVYSR_,S240,+,28.07,23.72,23.47,23.09,22.97,22.63,24.74,23.78,23.90,23.64,23.22,,22.21,23.79,4.28,-0.06,-0.32,-0.70,-0.81,-1.15,0.95,-0.01,0.12,-0.14,-0.57, ,-1.58,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
194,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),RSTSQGSINSPVY,_STS(ph)QGS(ph)INSPVYSR_,S243,,26.03,21.11,,,,,,,,,,,,23.57,2.46,-2.46, , , , , , , , , , , ,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
195,O14639,ABLIM1,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),PSSKTASLPGYGR,_TAS(ph)LPGYGR_,S408,+,27.76,25.05,24.76,23.05,25.05,23.70,24.86,24.93,22.91,24.22,24.84,,21.82,24.41,3.35,0.64,0.35,-1.37,0.64,-0.72,0.44,0.52,-1.51,-0.19,0.43, ,-2.59,visual perception;organ morphogenesis;cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
196,O14646,CHD1,Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1),SSSGPRSPLDQRS,_ASSSGPRS(ph)PLDQR_,S1677,+,23.52,25.06,25.48,24.66,24.22,23.34,23.12,23.44,23.88,24.21,22.83,,21.91,23.81,-0.28,1.25,1.67,0.85,0.41,-0.47,-0.69,-0.36,0.07,0.40,-0.98, ,-1.89,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling",nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
200,O14647,CHD2,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),SPHDSKSPLDHRS,_S(ph)PLDHRSPLER_,S1801,+,,23.02,23.02,,20.21,,23.93,,24.64,25.69,21.48,25.16,,23.39, ,-0.38,-0.38, ,-3.19, ,0.54, ,1.25,2.29,-1.91,1.77, ,regulation of transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
201,O14647,CHD2,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),SPLDHRSPLERSL,_SPLDHRS(ph)PLER_,S1807,+,20.74,,,22.28,21.28,24.30,23.68,23.12,24.08,21.90,23.72,,22.55,22.76,-2.02, , ,-0.48,-1.49,1.53,0.91,0.35,1.31,-0.87,0.95, ,-0.21,regulation of transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
204,O14681,EI24,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),FPSPHPSPAKLKA,_FPS(ph)PHPS(ph)PAK_,S330,+,26.91,26.31,26.40,21.48,22.54,,23.00,22.92,23.90,25.42,21.83,21.31,,23.82,3.09,2.49,2.58,-2.34,-1.28, ,-0.82,-0.90,0.08,1.60,-1.99,-2.51, ,autophagy;negative regulation of cell growth;response to drug;apoptotic process;induction of apoptosis,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
205,O14681,EI24,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),AQRRAQSIERKQE,_RAQS(ph)IER_,S56,,,19.03,19.03,22.28,17.14,,,18.88,,,,19.10,,19.24, ,-0.21,-0.21,3.04,-2.11, , ,-0.37, , , ,-0.14, ,autophagy;negative regulation of cell growth;response to drug;apoptotic process;induction of apoptosis,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
207,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),QEDRALSPVIPLI,_ALS(ph)PVIPLIPR_,S4738,+,25.38,25.49,25.53,25.44,26.01,26.02,25.75,25.76,25.64,25.47,25.26,24.90,26.20,25.60,-0.23,-0.12,-0.07,-0.16,0.41,0.42,0.14,0.16,0.04,-0.13,-0.34,-0.71,0.60,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
208,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),ASEPLLSPPPFGE,_ASEPLLS(ph)PPPFGESR_,S2274,+,22.98,,,22.65,24.37,23.54,24.02,24.74,23.70,24.72,23.95,22.64,24.90,23.84,-0.86, , ,-1.18,0.53,-0.30,0.18,0.91,-0.14,0.88,0.11,-1.20,1.07,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
210,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),EVLFPESPARAGT,_IPNSYEVLFPES(ph)PAR_,S4822,,22.86,,,,,,,,,,,,,22.86,0.00, , , , , , , , , , , , ,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
211,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),KLEGPVSPDVEPG,_LEGPVS(ph)PDVEPGKEETEESK_,S1671,+,26.24,23.71,,20.73,24.42,26.13,25.53,25.34,26.20,26.95,24.28,24.62,23.16,24.78,1.47,-1.07, ,-4.05,-0.36,1.35,0.76,0.56,1.43,2.18,-0.49,-0.16,-1.61,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
212,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),QRSGITSPVEKRE,_SGITS(ph)PVEK_,S2640,,25.39,,,25.33,,,,22.39,23.21,,,,,24.08,1.31, , ,1.25, , , ,-1.69,-0.87, , , , ,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
213,O14686,KMT2D,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),KGLEGKSPDTGPD,_S(ph)PDTGPDWLK_,S4849,,22.77,,,,,,,,,22.12,,,,22.45,0.33, , , , , , , , ,-0.33, , , ,"oocyte growth;histone H3-K4 methylation;chromatin silencing;positive regulation of intracellular estrogen receptor signaling pathway;response to estrogen stimulus;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",histone methyltransferase complex,,,,,,,,,,,,,,
214,Q99666,RGPD5,RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63),TTKAVVSPPKFVF,_AVVS(ph)PPK_,S1534,,21.79,23.35,23.35,22.48,,,,,,,,,,22.74,-0.96,0.61,0.61,-0.26, , , , , , , , , ,protein targeting to Golgi,cytoplasm,,,,,,,,,,,,,,
215,Q99666,RGPD5,RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63),VLGLTPSPRQKSM,_YVASVLGLTPS(ph)PR_,S21,,,,,,24.79,23.39,,,,,,,22.80,23.66, , , , ,1.13,-0.27, , , , , , ,-0.86,protein targeting to Golgi,cytoplasm,,,,,,,,,,,,,,
216,O14730,RIOK3,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog),DLVGVASPEPGTA,_(ac)M(ox)DLVGVAS(ph)PEPGTAAAWGPSK_,S8,,23.61,,,,,,,,,,,,,23.61,0.00, , , , , , , , , , , , ,chromosome segregation,,,+,,,,,,,,,,,,
217,O14737,PDCD5,Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19),RRKVMDSDEDDDY,_VM(ox)DS(ph)DEDDDY_,S119,+,24.36,23.42,23.42,22.88,26.26,21.92,24.60,25.18,22.99,,22.85,23.69,,23.78,0.58,-0.36,-0.36,-0.90,2.48,-1.86,0.82,1.40,-0.79, ,-0.92,-0.09, ,apoptotic process;induction of apoptosis,nucleus;cytoplasm,,,,,,,,,,,,,,
218,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),AEAALESPRPALV,_ENSREALAEAALES(ph)PRPALVR_,S280,+,27.65,25.86,26.34,24.57,27.11,26.10,28.06,28.17,25.91,26.66,28.00,28.81,27.19,26.96,0.70,-1.10,-0.61,-2.39,0.16,-0.85,1.10,1.21,-1.05,-0.30,1.04,1.86,0.23,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,,,,,,,,,,
220,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),_____MSADAAAG,_(ac)S(ph)ADAAAGAPLPR_,S2,+,23.87,23.53,23.77,23.23,23.36,,24.30,24.04,,22.86,,23.96,,23.66,0.21,-0.13,0.11,-0.42,-0.29, ,0.64,0.39, ,-0.80, ,0.30, ,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,,,,,,,,,,
222,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),ALVRSASSDTSEE,_SAS(ph)SDTSEELNSQDSPPK_,S290,+,28.82,29.51,29.50,29.14,24.74,25.65,29.48,25.78,27.63,28.44,29.08,30.43,26.67,28.07,0.76,1.44,1.43,1.07,-3.33,-2.41,1.41,-2.29,-0.44,0.38,1.01,2.37,-1.39,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,,,,,,,,,,
223,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),LVRSASSDTSEEL,_SAS(ph)S(ph)DTS(ph)EELNSQDSPPK_,S291,+,26.04,26.76,27.31,25.99,,22.37,25.50,23.95,,24.49,22.34,26.65,,25.14,0.90,1.62,2.17,0.85, ,-2.77,0.36,-1.19, ,-0.65,-2.80,1.51, ,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,,,,,,,,,,
224,O14745,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),SASSDTSEELNSQ,_SAS(ph)SDTS(ph)EELNSQDSPPK_,S294,,25.62,25.79,26.49,,,,,,,,,,,25.97,-0.34,-0.18,0.52, , , , , , , , , , ,adenylate cyclase-activating dopamine receptor signaling pathway;renal sodium ion transport;negative regulation of cell proliferation;glutathione transport;regulation of sodium:hydrogen antiporter activity;cellular phosphate ion homeostasis;negative regulation of protein kinase B signaling cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of sodium:hydrogen antiporter activity;apoptotic process;Wnt receptor signaling pathway;regulation of protein kinase activity;negative regulation of phosphatidylinositol 3-kinase cascade;renal phosphate ion absorption;protein complex assembly;cellular protein localization;bile acid secretion;regulation of excretion;microvillus assembly;negative regulation of sodium ion transport;negative regulation of platelet-derived growth factor receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;phospholipase C-activating dopamine receptor signaling pathway,microvillus membrane;intracellular membrane-bounded organelle;endomembrane system;apical plasma membrane;centrosome;actin cytoskeleton;filopodium;brush border membrane;ruffle,,,,,,,,,,,,,,
225,O14757,CHEK1,Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1),KRPRVTSGGVSES,_VTS(ph)GGVSESPSGFSK_,S186,,24.70,22.78,22.78,,,,22.56,23.02,,,,22.32,,23.03,1.68,-0.25,-0.25, , , ,-0.46,-0.01, , , ,-0.70, ,chromatin-mediated maintenance of transcription;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;regulation of S phase;G2/M transition DNA damage checkpoint;regulation of mitotic centrosome separation;DNA repair;G2/M transition of mitotic cell cycle;cellular response to caffeine;cellular response to mechanical stimulus;regulation of double-strand break repair via homologous recombination;negative regulation of mitosis;replicative senescence;DNA replication;regulation of histone H3-K9 acetylation;DNA damage induced protein phosphorylation,nucleoplasm;cytosol;condensed nuclear chromosome;chromatin;replication fork;centrosome,,+,,,,,,,,,,,,
229,O14791,APOL1,Apolipoprotein L1 (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I),RVTEPISAESGEQ,_VTEPIS(ph)AES(ph)GEQVER_,S190,,24.77,,,,,,,,,,,,,24.77,0.00, , , , , , , , , , , , ,cytolysis;cholesterol metabolic process;lipid transport;killing of cells of other organism;lipoprotein metabolic process;innate immune response,intrinsic to membrane;high-density lipoprotein particle;very-low-density lipoprotein particle,,,,,,,,,,,,,,
230,O14791,APOL1,Apolipoprotein L1 (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I),EPISAESGEQVER,_VTEPIS(ph)AES(ph)GEQVER_,S193,,25.72,23.44,23.44,,,,,,,,,,,24.20,1.52,-0.76,-0.76, , , , , , , , , , ,cytolysis;cholesterol metabolic process;lipid transport;killing of cells of other organism;lipoprotein metabolic process;innate immune response,intrinsic to membrane;high-density lipoprotein particle;very-low-density lipoprotein particle,,,,,,,,,,,,,,
231,O14828,SCAMP3,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),VIQHRPSRQYATL,_DGGNPFAEPSELDNPFQDPAVIQHRPS(ph)R_,S32,,25.17,,,,22.51,,,,,,,22.75,,23.48,1.69, , , ,-0.96, , , , , , ,-0.73, ,post-Golgi vesicle-mediated transport;protein transport;response to retinoic acid,integral to membrane;Golgi membrane,,,,,,,,,,,,,,
233,O14874,BCKDK,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)",LALRARSTSATDT,_S(ph)TSATDTHHVEM(ox)AR_,S31,+,21.57,24.26,24.26,21.89,22.03,20.84,20.31,,,,21.21,,,22.05,-0.48,2.22,2.22,-0.16,-0.02,-1.20,-1.74, , , ,-0.84, , ,branched-chain amino acid catabolic process,mitochondrial alpha-ketoglutarate dehydrogenase complex,,+,,,,,,,,,,,,
234,O14879,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3 (IFIT-3) (CIG49) (ISG-60) (Interferon-induced 60 kDa protein) (IFI-60K) (Interferon-induced protein with tetratricopeptide repeats 4) (IFIT-4) (Retinoic acid-induced gene G protein) (P60) (RIG-G),KQAIELSPDNQYV,_QAIELS(ph)PDNQYVK_,S203,,,24.32,24.32,22.61,22.83,,21.08,23.04,,,,,,23.03, ,1.28,1.28,-0.42,-0.20, ,-1.96,0.01, , , , , ,negative regulation of apoptotic process;defense response to virus;negative regulation of cell proliferation;response to virus;type I interferon-mediated signaling pathway;cellular response to interferon-alpha,cytosol;mitochondrion,,,,,,,,,,,,,,
235,O14896,IRF6,Interferon regulatory factor 6 (IRF-6),SVRLQISTPDIKD,_LQIS(ph)TPDIK_,S329,,25.59,22.82,23.17,21.28,,,,,,23.88,,,,23.35,2.24,-0.53,-0.18,-2.07, , , , , ,0.53, , , ,"skin development;negative regulation of cell proliferation;keratinocyte proliferation;type I interferon-mediated signaling pathway;interferon-gamma-mediated signaling pathway;positive regulation of transcription, DNA-dependent;cell cycle arrest;cell development;transcription, DNA-dependent;keratinocyte differentiation;mammary gland epithelial cell differentiation",cytosol;nucleus,Other TF domain,,,,,,,,,,,,,
236,O14908,GIPC1,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Tax interaction protein 2) (TIP-2),KAFDMISQRSAGG,_AFDM(ox)IS(ph)QR_,S222,,23.35,,,21.90,,,,,,,,,,22.62,0.73, , ,-0.73, , , , , , , , , ,positive regulation of transforming growth factor beta receptor signaling pathway;regulation of protein stability;G-protein coupled receptor signaling pathway;glutamate secretion;endothelial cell migration;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;protein targeting;regulation of synaptic plasticity;synaptic transmission,endocytic vesicle;synaptic vesicle;vesicle membrane;brush border;cell cortex;cytosol;dendritic spine;cytosolic part;dendritic shaft,,,,,,,,,,,,,,
238,O14936,CASK,Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog),YRTQSSSCEDLPS,_TQSSS(ph)CEDLPSTTQPK_,S571,,23.59,25.31,,24.59,22.23,24.11,22.82,,26.06,23.80,,,23.34,23.98,-0.40,1.33, ,0.60,-1.76,0.13,-1.16, ,2.08,-0.18, , ,-0.65,negative regulation of keratinocyte proliferation;negative regulation of cell-matrix adhesion;positive regulation of calcium ion import;negative regulation of cellular response to growth factor stimulus;calcium ion import;negative regulation of wound healing;cell adhesion;positive regulation of transcription from RNA polymerase II promoter,basolateral plasma membrane;nuclear lamina;nuclear matrix;actin cytoskeleton;cytoplasm;cell-cell junction;cytosol;nucleolus;basement membrane;presynaptic membrane;cilium membrane,,+,,,,,,,,,,,,
239,O14950,MYL12B,"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)",RPQRATSNVFAMF,_ATS(ph)NVFAM(ox)FDQSQIQEFK_,S19,+,27.23,24.35,24.21,29.56,25.30,24.24,27.31,25.87,25.94,24.55,25.22,30.62,28.67,26.39,0.84,-2.04,-2.18,3.17,-1.09,-2.15,0.92,-0.52,-0.45,-1.84,-1.17,4.23,2.28,regulation of cell shape;muscle contraction;axon guidance,Z disc;cytosol;stress fiber;apical part of cell;myosin II complex,,,,,,,,,,,,,,
240,O14967,CLGN,Calmegin,MKEADESTGSGDG,_EADES(ph)TGSGDGPIK_,S591,,,,,,,22.55,,,23.90,23.25,,23.04,,23.18, , , , , ,-0.63, , ,0.71,0.06, ,-0.14, ,protein folding;binding of sperm to zona pellucida;single fertilization;protein complex assembly,nuclear envelope;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
244,O14967,CLGN,Calmegin,QSNKSGSEDEMKE,_SGS(ph)EDEM(ox)KEADESTGSGDGPIK_,S581,,,,,,25.43,25.17,,25.26,,,,,23.03,24.72, , , , ,0.70,0.45, ,0.54, , , , ,-1.69,protein folding;binding of sperm to zona pellucida;single fertilization;protein complex assembly,nuclear envelope;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
245,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),EKRDKKSPLIEST,_S(ph)PLIESTANM(ox)DNNQSQK_,S299,+,22.10,24.65,,24.94,25.16,,24.75,24.09,25.90,26.38,23.44,25.07,,24.65,-2.55,0.00, ,0.29,0.51, ,0.10,-0.56,1.25,1.73,-1.21,0.42, ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
247,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),RRLASTSDIEEKE,_RLAS(ph)TS(ph)DIEEK_,S509,,24.97,,,,,,,,,,,,,24.97,0.00, , , , , , , , , , , , ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
248,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),RLWAEDSTEKEKD,_LWAEDS(ph)TEK_,S562,,24.38,,,,22.47,23.69,,22.49,23.72,,22.66,,,23.24,1.15, , , ,-0.76,0.45, ,-0.74,0.48, ,-0.58, , ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
249,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),ALERRISEMEEEL,_RIS(ph)EM(ox)EEELK_,S939,+,24.58,25.14,25.14,24.56,24.23,24.58,23.84,24.42,23.82,23.25,23.98,23.68,23.50,24.21,0.37,0.93,0.93,0.35,0.02,0.37,-0.37,0.21,-0.39,-0.96,-0.23,-0.53,-0.71,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
251,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),GVTRSASSPRLSS,_SAS(ph)SPRLSSSLDNK_,S472,,,,,,,,25.72,,24.53,,,25.86,,25.37, , , , , , ,0.35, ,-0.84, , ,0.49, ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
252,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),LLGRSGSYSYLEE,_SGS(ph)YSYLEER_,S854,+,27.45,24.30,,26.18,23.27,,23.28,23.04,,,,26.46,,24.85,2.59,-0.55, ,1.32,-1.59, ,-1.57,-1.81, , , ,1.61, ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
253,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),GLRKTGSYGALAE,_TGS(ph)YGALAEITASK_,S445,+,27.08,24.84,,24.74,23.52,24.82,25.18,24.55,24.52,23.95,25.01,25.99,,24.93,2.15,-0.09, ,-0.19,-1.41,-0.11,0.25,-0.38,-0.41,-0.98,0.09,1.06, ,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
256,O14976,GAK,Cyclin-G-associated kinase (EC 2.7.11.1),RDESEVSDEGGSP,_ESES(ph)ALM(ox)EDRDESEVS(ph)DEGGSPISSEGQEPR_,S750,,23.92,,,,,,,,,,,,,23.92,0.00, , , , , , , , , , , , ,cell cycle,Golgi apparatus;focal adhesion;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
258,O14979,HNRNPDL,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),VFVGGLSPDTSEE,_VFVGGLS(ph)PDTSEEQIK_,S122,+,26.14,25.65,25.66,26.14,25.44,27.55,27.89,26.98,27.81,27.51,26.75,26.56,27.27,26.72,-0.58,-1.07,-1.06,-0.58,-1.28,0.83,1.17,0.26,1.09,0.79,0.03,-0.16,0.55,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
261,O15014,ZNF609,Zinc finger protein 609,TLTKAPSLTDLVK,_APS(ph)LTDLVK_,S1055,+,23.37,20.87,21.10,23.32,22.11,23.19,,,24.13,21.72,22.10,23.58,23.35,22.62,0.75,-1.76,-1.52,0.70,-0.51,0.56, , ,1.51,-0.90,-0.52,0.95,0.73,,nucleus,C2H2-type,,,,,,,,,,,,,
262,O15014,ZNF609,Zinc finger protein 609,PPRFCDSPTSDLE,_FCDS(ph)PTSDLEM(ox)R_,S358,,21.67,23.16,,21.20,22.66,23.01,,,23.27,,,,,22.49,-0.83,0.66, ,-1.29,0.17,0.51, , ,0.77, , , , ,,nucleus,C2H2-type,,,,,,,,,,,,,
263,O15014,ZNF609,Zinc finger protein 609,FTDNAPSPSIGGS,_IYSFTDNAPS(ph)PSIGGSSR_,S804,,,,,,21.65,24.09,,,23.81,,,,23.59,23.28, , , , ,-1.64,0.81, , ,0.52, , , ,0.30,,nucleus,C2H2-type,,,,,,,,,,,,,
266,O15014,ZNF609,Zinc finger protein 609,SHYKSKSPTISDK,_SKS(ph)PTISDK_,S1313,,,20.55,20.55,22.06,,16.80,,,,,,19.53,,19.90, ,0.65,0.65,2.16, ,-3.10, , , , , ,-0.37, ,,nucleus,C2H2-type,,,,,,,,,,,,,
267,O15014,ZNF609,Zinc finger protein 609,KRVRTNSMGSATG,_TNS(ph)M(ox)GSATGPLPGTK_,S467,+,24.85,23.16,23.16,24.49,24.96,24.67,,24.44,24.87,,23.54,,,24.24,0.61,-1.08,-1.08,0.25,0.72,0.43, ,0.20,0.63, ,-0.70, , ,,nucleus,C2H2-type,,,,,,,,,,,,,
268,O15020,SPTBN2,"Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)",MTMPPVSPVGAEG,_AM(ox)TM(ox)PPVS(ph)PVGAEGPVVLR_,S2359,,25.72,22.93,22.93,,,,,,,,,,,23.86,1.86,-0.93,-0.93, , , , , , , , , , ,vesicle-mediated transport;synaptic vesicle exocytosis;cell death;actin filament capping;axon guidance;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuronal cell body;cytosol;spectrin,,,,,,,,,,,,,,
269,O15021,MAST4,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),RSGRRKSAGNIPL,_S(ph)AGNIPLSPLAR_,S1370,,22.34,22.02,21.67,,22.95,,23.52,,22.64,,,,,22.52,-0.18,-0.50,-0.85, ,0.42, ,0.99, ,0.12, , , , ,,cytoplasm,,+,,,,,,,,,,,,
270,O15021,MAST4,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),HMTKSDSLPSFRV,_SDS(ph)LPSFR_,S2520,,22.57,,,,,,21.26,,,,,24.03,,22.62,-0.05, , , , , ,-1.36, , , , ,1.41, ,,cytoplasm,,+,,,,,,,,,,,,
271,O15021,MAST4,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),SKTELPSPESAQS,_TELPS(ph)PESAQSPSPSGDVR_,S1822,,,22.37,,22.48,,,23.46,,23.63,,24.87,23.78,,23.43, ,-1.06, ,-0.95, , ,0.02, ,0.20, ,1.44,0.35, ,,cytoplasm,,+,,,,,,,,,,,,
272,O15021,MAST4,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),KVGRQESVDDLDR,_VGRQES(ph)VDDLDRDK_,S1523,,21.25,,,22.76,,,25.12,,22.85,21.58,22.53,26.31,21.71,23.02,-1.76, , ,-0.25, , ,2.11, ,-0.17,-1.43,-0.49,3.29,-1.30,,cytoplasm,,+,,,,,,,,,,,,
273,O15031,PLXNB2,Plexin-B2 (MM1),LEGLEESVRDRCK,_SQLEGLEES(ph)VRDR_,S1244,,25.10,,,22.38,22.12,,,,,,,24.45,,23.51,1.59, , ,-1.13,-1.39, , , , , , ,0.94, ,regulation of cell shape;positive regulation of GTPase activity;neural tube closure;regulation of neuron migration;brain development;regulation of protein phosphorylation;regulation of Rho GTPase activity;neuroblast proliferation;positive regulation of axonogenesis,intracellular;integral to plasma membrane,,,,,,,,,,,,,,
274,O15031,PLXNB2,Plexin-B2 (MM1),SQQPEDSQQDLPG,_VGVSQQPEDS(ph)QQDLPGER_,S1570,+,,,,23.79,25.11,25.40,24.32,23.64,24.20,22.83,23.44,23.64,23.46,23.98, , , ,-0.19,1.13,1.42,0.33,-0.34,0.22,-1.15,-0.54,-0.34,-0.53,regulation of cell shape;positive regulation of GTPase activity;neural tube closure;regulation of neuron migration;brain development;regulation of protein phosphorylation;regulation of Rho GTPase activity;neuroblast proliferation;positive regulation of axonogenesis,intracellular;integral to plasma membrane,,,,,,,,,,,,,,
275,O15042,U2SURP,U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140),SILQGDSPTKWRT,_LYSILQGDS(ph)PTK_,S484,+,21.67,22.95,23.42,24.36,24.29,25.72,25.19,25.01,25.42,25.10,22.08,23.47,24.92,24.12,-2.45,-1.18,-0.71,0.24,0.17,1.60,1.07,0.89,1.30,0.98,-2.04,-0.66,0.79,RNA processing,nucleus,,,,,,,,,,,,,,
276,O15042,U2SURP,U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140),DTQSSKSEEHHLY,_S(ph)EEHHLYSNPIK_,S810,+,24.80,27.13,28.03,25.15,,,26.87,,27.00,27.27,23.96,26.33,,26.28,-1.48,0.85,1.75,-1.13, , ,0.59, ,0.71,0.99,-2.33,0.05, ,RNA processing,nucleus,,,,,,,,,,,,,,
277,O15042,U2SURP,U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140),DGVPIKSLDDDLD,_S(ph)LDDDLDGVPLDATEDSK_,S730,,22.73,,,,23.70,25.47,22.80,22.80,23.97,25.71,25.95,23.79,25.40,24.23,-1.50, , , ,-0.53,1.24,-1.43,-1.43,-0.26,1.48,1.72,-0.44,1.17,RNA processing,nucleus,,,,,,,,,,,,,,
279,O15047,SETD1A,Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1),PASPARSGSPAPE,_S(ph)GS(ph)PAPETTNESVPFAQHSSLDSR_,S468,,22.37,,,23.68,,,,,,,,24.00,,23.35,-0.98, , ,0.33, , , , , , , ,0.65, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nuclear speck;chromosome;Set1C/COMPASS complex,,,,,,,,,,,,,,
280,O15047,SETD1A,Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1),SPARSGSPAPETT,_S(ph)GS(ph)PAPETTNESVPFAQHSSLDSR_,S470,+,24.28,24.40,,,25.60,26.17,24.70,25.29,24.91,,,,25.66,25.13,-0.85,-0.73, , ,0.48,1.05,-0.43,0.16,-0.22, , , ,0.54,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nuclear speck;chromosome;Set1C/COMPASS complex,,,,,,,,,,,,,,
281,O15062,ZBTB5,Zinc finger and BTB domain-containing protein 5,AEKIDLSPESSDR,_IDLS(ph)PESSDR_,S371,,22.96,23.01,,23.22,22.12,,,,,,,,21.75,22.61,0.35,0.40, ,0.61,-0.49, , , , , , , ,-0.86,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
282,O15075,DCLK1,Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1),PSPSPTSPGSLRK,_SPSPSPTS(ph)PGSLRK_,S337,+,,,,,23.01,22.22,25.93,25.40,,,26.25,24.53,22.85,24.32, , , , ,-1.30,-2.09,1.61,1.09, , ,1.94,0.22,-1.46,response to virus;central nervous system projection neuron axonogenesis;neuron migration;endosomal transport;dendrite morphogenesis;axon extension;central nervous system development;forebrain development;intracellular signal transduction,intracellular;integral to plasma membrane,,+,,,,,,,,,,,,
283,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),SDPGLDSPRTSPV,_NSVLSDPGLDS(ph)PRT(ph)SPVIM(ox)AR_,S251,,25.88,,,22.33,23.59,,26.10,,23.86,,,,,24.35,1.53, , ,-2.02,-0.76, ,1.75, ,-0.49, , , , ,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
286,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),SLGGESSGGTTPV,_SLGGESS(ph)GGTTPVGSFHTEAAR_,S1458,+,25.34,22.93,21.98,,25.82,23.66,24.58,22.84,24.48,21.95,23.23,25.47,23.05,23.78,1.56,-0.85,-1.80, ,2.04,-0.11,0.80,-0.93,0.70,-1.83,-0.55,1.69,-0.73,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
288,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),NVPRSRSDVDMDA,_SRS(ph)DVDM(ox)DAAAEATR_,S635,+,23.34,23.88,23.47,,24.64,24.42,24.36,23.61,23.54,22.06,22.51,23.64,,23.59,-0.25,0.29,-0.12, ,1.06,0.84,0.77,0.02,-0.05,-1.53,-1.08,0.06, ,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
289,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),_____MSVRLPQS,_(ac)S(ph)VRLPQSIDR_,S2,,26.00,,,22.53,21.06,,,21.28,,,,,,22.72,3.28, , ,-0.19,-1.66, , ,-1.44, , , , , ,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
290,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),WTDGSLSPPAKEP,_WTDGSLS(ph)PPAK_,S1480,+,23.37,23.47,23.34,,25.17,,23.97,24.88,23.55,22.77,24.52,25.48,,24.05,-0.69,-0.58,-0.71, ,1.12, ,-0.08,0.83,-0.50,-1.28,0.47,1.43, ,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
291,O15119,TBX3,T-box transcription factor TBX3 (T-box protein 3),SSSMSLSPKLCAE,_SSTLSSSSM(ox)SLS(ph)PK_,S687,,,,,22.87,23.63,,22.72,24.00,23.24,,,,23.24,23.28, , , ,-0.41,0.35, ,-0.56,0.72,-0.04, , , ,-0.05,"negative regulation of apoptotic process;embryonic digit morphogenesis;cardiac muscle cell fate commitment;stem cell maintenance;positive regulation of cell cycle;negative regulation of transcription, DNA-dependent;embryonic forelimb morphogenesis;atrioventricular bundle cell differentiation;outflow tract morphogenesis;mesoderm morphogenesis;palate development;limbic system development;blood vessel development;positive regulation of stem cell proliferation;sinoatrial node cell development;male genitalia development;in utero embryonic development;cell aging;specification of organ position;positive regulation of transcription, DNA-dependent;ventricular septum morphogenesis;transcription, DNA-dependent;skeletal system development;mammary placode formation;mammary gland development;positive regulation of cell proliferation;organ morphogenesis;negative regulation of epithelial cell differentiation;follicle-stimulating hormone secretion;negative regulation of myoblast differentiation;branching involved in mammary gland duct morphogenesis;regulation of transcription from RNA polymerase II promoter;luteinizing hormone secretion;female genitalia development;heart looping;anterior/posterior axis specification, embryo",nucleus,Other TF domain,,,,,,,,,,,,,
292,O15119,TBX3,T-box transcription factor TBX3 (T-box protein 3),VAALAASPASVAV,_VAALAAS(ph)PASVAVDSGSELNSR_,S660,,,,,,22.96,23.40,,22.69,22.71,,,,24.89,23.33, , , , ,-0.37,0.07, ,-0.64,-0.62, , , ,1.56,"negative regulation of apoptotic process;embryonic digit morphogenesis;cardiac muscle cell fate commitment;stem cell maintenance;positive regulation of cell cycle;negative regulation of transcription, DNA-dependent;embryonic forelimb morphogenesis;atrioventricular bundle cell differentiation;outflow tract morphogenesis;mesoderm morphogenesis;palate development;limbic system development;blood vessel development;positive regulation of stem cell proliferation;sinoatrial node cell development;male genitalia development;in utero embryonic development;cell aging;specification of organ position;positive regulation of transcription, DNA-dependent;ventricular septum morphogenesis;transcription, DNA-dependent;skeletal system development;mammary placode formation;mammary gland development;positive regulation of cell proliferation;organ morphogenesis;negative regulation of epithelial cell differentiation;follicle-stimulating hormone secretion;negative regulation of myoblast differentiation;branching involved in mammary gland duct morphogenesis;regulation of transcription from RNA polymerase II promoter;luteinizing hormone secretion;female genitalia development;heart looping;anterior/posterior axis specification, embryo",nucleus,Other TF domain,,,,,,,,,,,,,
295,O15155,BET1,BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18),TAIKSLSIEIGHE,_SLS(ph)IEIGHEVK_,S50,+,25.22,25.47,25.83,19.81,25.43,25.53,25.90,24.84,26.67,27.06,27.06,21.35,26.00,25.09,0.13,0.38,0.74,-5.28,0.34,0.44,0.81,-0.25,1.58,1.97,1.97,-3.74,0.91,protein transport;ER to Golgi vesicle-mediated transport;vesicle fusion with Golgi apparatus,integral to membrane;Golgi cisterna;endoplasmic reticulum membrane;Golgi membrane;cis-Golgi network,,,,,,,,,,,,,,
296,O15164,TRIM24,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (Tripartite motif-containing protein 24),SEDNKFSDDSDDD,_NESEDNKFS(ph)DDS(ph)DDDFVQPR_,S936,,25.13,,,,,,,,,,,,,25.13,0.00, , , , , , , , , , , , ,"negative regulation of cell proliferation;protein autophosphorylation;regulation of protein stability;negative regulation of transcription, DNA-dependent;regulation of vitamin D receptor signaling pathway;protein catabolic process;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;cellular response to estrogen stimulus;calcium ion homeostasis;regulation of apoptotic process",cytosol;nuclear euchromatin;nucleus;perichromatin fibrils,Other TF domain,+,,,,,,,,,,,,
297,O15164,TRIM24,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (Tripartite motif-containing protein 24),NKFSDDSDDDFVQ,_NESEDNKFS(ph)DDS(ph)DDDFVQPR_,S939,,25.13,,,,,,,,,22.89,,,,24.01,1.12, , , , , , , , ,-1.12, , , ,"negative regulation of cell proliferation;protein autophosphorylation;regulation of protein stability;negative regulation of transcription, DNA-dependent;regulation of vitamin D receptor signaling pathway;protein catabolic process;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;cellular response to estrogen stimulus;calcium ion homeostasis;regulation of apoptotic process",cytosol;nuclear euchromatin;nucleus;perichromatin fibrils,Other TF domain,+,,,,,,,,,,,,
299,O15173,PGRMC2,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),MKKRDFSLEQLRQ,_KRDFS(ph)LEQLR_,S104,,21.14,,,,23.24,21.91,,,24.69,,,,,22.74,-1.60, , , ,0.49,-0.84, , ,1.94, , , , ,,integral to membrane,,,,,,,,,,,,,,
300,O15173,PGRMC2,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),KPGEEPSEYTDEE,_LLKPGEEPS(ph)EYT(ph)DEEDTK_,S208,,26.36,,,23.80,,,23.14,,24.28,24.16,,,23.00,24.12,2.23, , ,-0.32, , ,-0.99, ,0.16,0.04, , ,-1.12,,integral to membrane,,,,,,,,,,,,,,
301,O15213,WDR46,WD repeat-containing protein 46 (WD repeat-containing protein BING4),PTTAGASPGPPRN,_RYWEEETVPTTAGAS(ph)PGPPR_,S41,+,,,,21.70,23.80,22.88,22.34,23.38,,23.12,22.97,22.85,,22.88, , , ,-1.18,0.92,0.00,-0.54,0.50, ,0.24,0.09,-0.03, ,,,,,,,,,,,,,,,,
302,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),GRSRATSFSSAGE,_ATS(ph)FSSAGEVPK_,S64,,25.09,24.29,22.62,22.58,22.71,,24.24,22.12,27.16,26.80,24.42,25.78,23.36,24.26,0.82,0.03,-1.64,-1.69,-1.55, ,-0.03,-2.14,2.90,2.54,0.15,1.52,-0.90,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
305,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),TPERQSSPSGSEQ,_QSS(ph)PSGSEQLVR_,S454,,26.35,27.75,25.50,25.81,24.65,24.84,24.83,27.17,26.78,24.89,26.54,22.99,25.09,25.63,0.72,2.12,-0.13,0.18,-0.98,-0.79,-0.80,1.54,1.15,-0.74,0.91,-2.64,-0.54,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
306,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),QQPADPSTPEQQN,_GGQGDPAVPTQQPADPS(ph)TPEQQNSPSGSEQFVR_,S513,,,,,,,,,26.62,26.94,,26.06,,,26.54, , , , , , , ,0.08,0.40, ,-0.48, , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
307,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),TPEQQNSPSGSEQ,_GGQGDPAVPTQQPADPST(ph)PEQQNS(ph)PSGSEQFVR_,S520,,24.31,,,,26.47,,26.22,27.43,,24.64,,,,25.81,-1.51, , , ,0.66, ,0.41,1.62, ,-1.18, , , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
312,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),QLVRRESCGSSVL,_RES(ph)CGSSVLTDFEGK_,S466,,25.48,26.50,26.19,23.94,25.99,27.03,28.73,27.70,28.67,27.75,27.90,26.24,27.74,26.91,-1.43,-0.42,-0.73,-2.98,-0.92,0.12,1.82,0.79,1.76,0.84,0.99,-0.67,0.83,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
313,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),_____MSISALGG,_(ac)S(ph)ISALGGR_,S2,,22.57,,,,,,21.06,,,24.65,,21.17,,22.36,0.21, , , , , ,-1.30, , ,2.29, ,-1.19, ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
315,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),RYSNVSSIEDSFA,_YSNVSS(ph)IEDSFAM(ox)EK_,S603,,,19.90,19.90,,22.07,22.25,,,23.40,24.36,,,,21.98, ,-2.09,-2.09, ,0.09,0.27, , ,1.42,2.38, , , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
317,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),AKKSTGSPTQETQ,_STGS(ph)PTQETQAPFIAK_,S206,,27.93,27.30,27.18,25.14,28.56,28.17,28.53,28.70,29.15,30.07,27.90,26.33,27.99,27.92,0.01,-0.62,-0.74,-2.78,0.64,0.25,0.61,0.78,1.23,2.15,-0.02,-1.59,0.07,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
322,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),DEQKRSSPTQETQ,_RSS(ph)PTQETQAPFIAK_,S43,,20.88,24.06,24.06,,,,,,,23.62,,,,23.16,-2.28,0.91,0.91, , , , , , ,0.47, , , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
323,O15234,CASC3,Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz),TSVRDPSPEADAP,_LEQTSVRDPS(ph)PEADAPVLGSPEK_,S363,+,24.69,23.82,24.31,23.56,,,26.19,23.98,25.19,24.18,27.01,26.69,24.60,24.93,-0.24,-1.11,-0.62,-1.37, , ,1.26,-0.95,0.26,-0.75,2.08,1.76,-0.33,"intracellular mRNA localization;response to stress;mRNA transport;mRNA processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;RNA splicing;gene expression;regulation of translation",cytosol;exon-exon junction complex;ribonucleoprotein complex;nuclear speck;perinuclear region of cytoplasm,,,,,,,,,,,,,,
324,O15234,CASC3,Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz),DAPVLGSPEKEEA,_RLEQTSVRDPS(ph)PEADAPVLGS(ph)PEK_,S373,,23.04,,,,,,,,,,,,,23.04,0.00, , , , , , , , , , , , ,"intracellular mRNA localization;response to stress;mRNA transport;mRNA processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;RNA splicing;gene expression;regulation of translation",cytosol;exon-exon junction complex;ribonucleoprotein complex;nuclear speck;perinuclear region of cytoplasm,,,,,,,,,,,,,,
325,O15234,CASC3,Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz),VTGERQSGDGQES,_STVTGERQS(ph)GDGQESTEPVENK_,S148,+,25.60,25.78,26.16,26.04,26.09,25.59,27.14,26.16,26.62,26.01,25.13,25.55,23.79,25.82,-0.22,-0.04,0.34,0.22,0.27,-0.23,1.32,0.34,0.80,0.19,-0.69,-0.27,-2.03,"intracellular mRNA localization;response to stress;mRNA transport;mRNA processing;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;RNA splicing;gene expression;regulation of translation",cytosol;exon-exon junction complex;ribonucleoprotein complex;nuclear speck;perinuclear region of cytoplasm,,,,,,,,,,,,,,
326,O15258,RER1,Protein RER1,_____MSEGDSVG,_(ac)S(ph)EGDSVGESVHGKPSVVYR_,S2,,23.53,,,22.83,24.01,24.37,24.44,23.96,25.08,24.17,25.40,,24.47,24.23,-0.70, , ,-1.39,-0.22,0.14,0.22,-0.27,0.85,-0.06,1.18, ,0.25,"retrograde vesicle-mediated transport, Golgi to ER",integral to Golgi membrane,,,,,,,,,,,,,,
327,O15258,RER1,Protein RER1,PSLMEDSDDGPSL,_VDPSLM(ox)EDS(ph)DDGPSLPTK_,S95,+,26.56,,,,26.75,25.95,25.90,24.75,26.69,27.22,25.69,25.95,25.96,26.14,0.42, , , ,0.61,-0.19,-0.24,-1.39,0.55,1.08,-0.45,-0.20,-0.18,"retrograde vesicle-mediated transport, Golgi to ER",integral to Golgi membrane,,,,,,,,,,,,,,
329,O15320,CTAGE5,cTAGE family member 5 (Protein cTAGE-5) (Meningioma-expressed antigen 6/11),RSFNMPSLDKMDG,_SFNMPS(ph)LDK_,S567,+,26.97,24.11,24.11,24.00,,,24.16,,24.51,23.39,,25.71,,24.62,2.35,-0.51,-0.51,-0.62, , ,-0.46, ,-0.11,-1.23, ,1.09, ,,,,,,,,,,,,,,,,
331,O15372,EIF3H,Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit),CKEKDFSPEALKK,_DFS(ph)PEALKK_,S183,+,24.04,24.00,24.76,24.80,25.69,24.68,25.95,23.83,23.04,24.80,24.27,24.15,23.36,24.41,-0.37,-0.41,0.35,0.39,1.28,0.27,1.54,-0.59,-1.37,0.39,-0.15,-0.27,-1.05,translational initiation;regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
332,O15400,STX7,Syntaxin-7,ARVRASSRVSGSF,_ASS(ph)RVS(ph)GSFPEDSSK_,S126,,23.51,24.35,23.82,25.23,,,,,,,,,,24.23,-0.72,0.13,-0.41,1.00, , , , , , , , , ,post-Golgi vesicle-mediated transport;intracellular protein transport;endosome to lysosome transport;vesicle fusion,SNARE complex;integral to membrane;late endosome membrane;lysosomal membrane;early endosome membrane,,,,,,,,,,,,,,
333,O15400,STX7,Syntaxin-7,RASSRVSGSFPED,_ASS(ph)RVS(ph)GSFPEDSSK_,S129,+,25.12,26.95,26.69,27.13,26.67,26.74,26.75,26.99,26.65,26.62,26.41,27.63,26.56,26.68,-1.57,0.27,0.00,0.45,-0.01,0.05,0.07,0.30,-0.04,-0.07,-0.28,0.95,-0.13,post-Golgi vesicle-mediated transport;intracellular protein transport;endosome to lysosome transport;vesicle fusion,SNARE complex;integral to membrane;late endosome membrane;lysosomal membrane;early endosome membrane,,,,,,,,,,,,,,
334,O15400,STX7,Syntaxin-7,SSRVSGSFPEDSS,_VSGS(ph)FPEDSSK_,S131,,,,,25.24,,,23.05,,,,25.30,,,24.53, , , ,0.71, , ,-1.48, , , ,0.77, , ,post-Golgi vesicle-mediated transport;intracellular protein transport;endosome to lysosome transport;vesicle fusion,SNARE complex;integral to membrane;late endosome membrane;lysosomal membrane;early endosome membrane,,,,,,,,,,,,,,
335,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),ARERALSPGLEES,_ALS(ph)PGLEESGLGLLAR_,S1857,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
336,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),DSGNPKSPDKAQA,_ATDGDLAQEPGPGLTFEDSGNPKS(ph)PDK_,S2543,,22.78,22.85,22.85,22.99,,,25.00,23.71,24.40,24.66,24.34,,,23.73,-0.95,-0.88,-0.88,-0.74, , ,1.27,-0.02,0.67,0.93,0.61, , ,,,,,,,,,,,,,,,,
337,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),TYGKAVSPPPSPR,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_,S991,,22.95,,,22.25,,,,,,,,,,22.60,0.35, , ,-0.35, , , , , , , , , ,,,,,,,,,,,,,,,,
338,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),AVSPPPSPRASPV,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_,S995,,22.95,,,22.25,,,,,,,,,,22.60,0.35, , ,-0.35, , , , , , , , , ,,,,,,,,,,,,,,,,
339,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),PPSPRASPVAALK,_AVS(ph)PPPS(ph)PRAS(ph)PVAALK_,S999,,22.95,,,22.25,,,,,,,,,,22.60,0.35, , ,-0.35, , , , , , , , , ,,,,,,,,,,,,,,,,
340,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),RLAERLSPFLAES,_LAERLS(ph)PFLAESK_,S263,+,,,,,24.34,24.77,23.81,22.47,24.09,,22.32,23.36,23.97,23.64, , , , ,0.70,1.13,0.17,-1.17,0.45, ,-1.32,-0.28,0.33,,,,,,,,,,,,,,,,
341,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),PERLALSPEDKPI,_LALS(ph)PEDKPIRLS(ph)PSK_,S1127,,23.74,21.26,20.80,22.06,,,,,22.52,,,,,22.08,1.67,-0.82,-1.27,-0.01, , , , ,0.44, , , , ,,,,,,,,,,,,,,,,
342,O15417,TNRC18,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),DKPIRLSPSKITE,_LALS(ph)PEDKPIRLS(ph)PSK_,S1136,,23.74,21.26,20.80,22.06,,,,,22.52,,,,,22.08,1.67,-0.82,-1.27,-0.01, , , , ,0.44, , , , ,,,,,,,,,,,,,,,,
343,O15427,SLC16A3,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),VHTPETSV_____,_NGEVVHTPETS(ph)V_,S464,+,,26.36,26.54,27.59,26.85,27.78,27.42,27.39,,27.32,27.68,26.79,28.56,27.30, ,-0.94,-0.76,0.29,-0.45,0.48,0.12,0.09, ,0.02,0.38,-0.51,1.27,blood coagulation;pyruvate metabolic process;leukocyte migration,nuclear membrane;integral to plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
344,O15427,SLC16A3,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),HKPPADSGVDLRE,_LHKPPADS(ph)GVDLR_,S436,+,,23.91,23.28,23.48,24.62,24.47,22.33,24.04,23.11,21.04,23.83,,24.85,23.54, ,0.37,-0.26,-0.06,1.07,0.93,-1.21,0.49,-0.43,-2.51,0.29, ,1.31,blood coagulation;pyruvate metabolic process;leukocyte migration,nuclear membrane;integral to plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
345,O15438,ABCC3,Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3),APGKNASGEDEVL,_NAS(ph)GEDEVLLGAR_,S332,,,20.82,,,,22.97,,,23.58,21.00,,,22.46,22.16, ,-1.34, , , ,0.81, , ,1.41,-1.17, , ,0.30,bile acid and bile salt transport;bile acid metabolic process,integral to plasma membrane,,,,,,,,,,,,,,
347,O15440,ABCC5,Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11),KEYIIPSPGYRSV,_EYIIPS(ph)PGYR_,S14,,22.57,,,,,,,,,,,,,22.57,0.00, , , , , , , , , , , , ,hyaluronan biosynthetic process;response to insulin stimulus;carbohydrate metabolic process;response to lipopolysaccharide;ATP catabolic process,integral to plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
349,O15440,ABCC5,Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11),WDSSHSSIQNSPK,_NATLAWDSSHSS(ph)IQNS(ph)PK_,S505,,25.31,,,,,,,,,,,,,25.31,0.00, , , , , , , , , , , , ,hyaluronan biosynthetic process;response to insulin stimulus;carbohydrate metabolic process;response to lipopolysaccharide;ATP catabolic process,integral to plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
350,O15440,ABCC5,Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11),HSSIQNSPKLTPK,_NATLAWDSSHSS(ph)IQNS(ph)PK_,S509,,25.51,22.24,22.24,,,,,,,,,,,23.33,2.18,-1.09,-1.09, , , , , , , , , , ,hyaluronan biosynthetic process;response to insulin stimulus;carbohydrate metabolic process;response to lipopolysaccharide;ATP catabolic process,integral to plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
353,O15446,CD3EAP,DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein) (ASE-1) (CD3-epsilon-associated protein) (CAST) (CD3E-associated protein) (RNA polymerase I-associated factor PAF49),LEDTVLSPTKKRK,_QEQINTEPLEDTVLS(ph)PTK_,S285,,24.09,22.97,22.97,,23.15,,,,,26.00,,23.73,24.51,23.92,0.17,-0.95,-0.95, ,-0.76, , , , ,2.09, ,-0.19,0.59,transmembrane receptor protein tyrosine kinase signaling pathway;rRNA transcription,mitochondrion;DNA-directed RNA polymerase I complex;chromosome;RNA polymerase I transcription factor complex,,,,,,,,,,,,,,
354,O15511,ARPC5,Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC),VKDRAGSIVLKVL,_DRAGS(ph)IVLK_,S77,+,22.77,23.93,24.14,23.13,22.37,23.05,23.55,24.09,22.56,22.40,23.34,24.22,23.02,23.27,-0.50,0.66,0.87,-0.15,-0.91,-0.23,0.28,0.81,-0.71,-0.88,0.06,0.95,-0.26,regulation of actin filament polymerization;cellular component movement;actin cytoskeleton organization,Arp2/3 protein complex;cell projection;cytoplasm,,,,,,,,,,,,,,
355,O15530,PDPK1,3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1),KQARANSFVGTAQ,_ANS(ph)FVGTAQYVSPELLTEK_,S191,+,27.17,26.67,26.33,27.74,28.17,26.62,28.39,28.59,27.29,27.13,28.38,28.10,27.63,27.55,-0.38,-0.89,-1.23,0.18,0.62,-0.94,0.84,1.04,-0.27,-0.42,0.83,0.55,0.07,"regulation of I-kappaB kinase/NF-kappaB cascade;protein autophosphorylation;fibroblast growth factor receptor signaling pathway;T cell costimulation;negative regulation of transforming growth factor beta receptor signaling pathway;regulation of endothelial cell migration;negative regulation of toll-like receptor signaling pathway;focal adhesion assembly;actin cytoskeleton organization;negative regulation of protein kinase activity;insulin receptor signaling pathway;phosphatidylinositol-mediated signaling;negative regulation of cardiac muscle cell apoptotic process;platelet activation;positive regulation of establishment of protein localization to plasma membrane;regulation of transcription, DNA-dependent;regulation of mast cell degranulation;activation of protein kinase B activity;T cell receptor signaling pathway;epidermal growth factor receptor signaling pathway;hyperosmotic response;nerve growth factor receptor signaling pathway;type B pancreatic cell development;transcription, DNA-dependent;synaptic transmission;regulation of apoptotic process;peptidyl-threonine phosphorylation",nucleoplasm;cytosol;plasma membrane;focal adhesion;cytoplasmic membrane-bounded vesicle,,+,,,,,,,,,,,,
356,O15534,PER1,Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui),SSSTAPSALGERG,_GLDSSSTAPS(ph)ALGER_,S815,+,22.01,,,24.22,,23.75,23.54,22.94,21.70,,24.67,24.57,,23.43,-1.41, , ,0.80, ,0.32,0.11,-0.48,-1.73, ,1.24,1.14, ,"response to light stimulus;negative regulation of transcription from RNA polymerase II promoter;entrainment of circadian clock;circadian regulation of gene expression;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
357,O15541,RNF113A,RING finger protein 113A (Zinc finger protein 183),_MAEQLSPGKAVD,_(ac)AEQLS(ph)PGK_,S6,,22.30,,,22.31,,,,22.42,23.84,,22.30,,,22.63,-0.34, , ,-0.32, , , ,-0.22,1.20, ,-0.33, , ,,,,,,,,,,,,,,,,
358,O15541,RNF113A,RING finger protein 113A (Zinc finger protein 183),ENYEVGSDDEEIP,_YGVYEDENYEVGS(ph)DDEEIPFK_,S253,,22.80,,,,,,,,,,,,,22.80,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
360,O15551,CLDN3,Claudin-3 (Clostridium perfringens enterotoxin receptor 2) (CPE-R 2) (CPE-receptor 2) (Rat ventral prostate.1 protein homolog) (hRVP1),STGPGASLGTGYD,_STGPGAS(ph)LGTGYDR_,S209,,24.48,24.31,23.59,22.06,,,,,,21.31,,,23.34,23.18,1.30,1.13,0.41,-1.12, , , , , ,-1.87, , ,0.16,response to hypoxia;calcium-independent cell-cell adhesion,tight junction;integral to plasma membrane,,,,,,,,,,,,,,
361,O15551,CLDN3,Claudin-3 (Clostridium perfringens enterotoxin receptor 2) (CPE-R 2) (CPE-receptor 2) (Rat ventral prostate.1 protein homolog) (hRVP1),ATKVVYSAPRSTG,_VVYS(ph)APR_,S199,,24.67,26.59,24.44,22.89,,,,,,21.43,,,,24.00,0.67,2.59,0.43,-1.11, , , , , ,-2.58, , , ,response to hypoxia;calcium-independent cell-cell adhesion,tight junction;integral to plasma membrane,,,,,,,,,,,,,,
363,O43150,ASAP2,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP)",HEDLDESDDDMDE,_LLHEDLDES(ph)DDDM(ox)DEK_,S701,+,26.06,25.79,25.79,25.62,25.32,25.55,27.32,25.69,26.51,26.56,26.01,26.47,24.48,25.94,0.12,-0.15,-0.15,-0.32,-0.62,-0.39,1.39,-0.24,0.58,0.62,0.08,0.53,-1.46,positive regulation of GTPase activity;regulation of ARF GTPase activity,Golgi cisterna membrane;plasma membrane,,,,,,,,,,,,,,
364,O43159,RRP8,Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1) (Nucleomethylin),TEKTEVSPVPRTD,_TEVS(ph)PVPR_,S223,,23.63,,,24.43,21.95,,,,,,,,,23.34,0.29, , ,1.10,-1.39, , , , , , , , ,"cellular response to glucose starvation;regulation of transcription by glucose;intrinsic apoptotic signaling pathway by p53 class mediator;chromatin silencing at rDNA;chromatin modification;transcription, DNA-dependent;positive regulation of cell cycle arrest;rRNA processing",rDNA heterochromatin;nucleolus;plasma membrane;chromatin silencing complex;cytoplasm,,,,,,,,,,,,,,
367,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),RPLSAASNSDQLE,_ASFFAASDENHRPLSAAS(ph)NSDQLEDQALAQM(ox)K_,S1690,,,,,,,,23.48,,24.53,23.48,,,,23.83, , , , , , ,-0.35, ,0.70,-0.35, , , ,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
368,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),TRDLRASPKPTSK,_DLRAS(ph)PKPTSK_,S1507,+,21.79,23.46,23.62,24.65,23.48,22.85,,22.48,23.39,22.05,22.76,22.19,22.62,22.94,-1.15,0.51,0.68,1.71,0.54,-0.09, ,-0.47,0.45,-0.90,-0.18,-0.76,-0.32,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
369,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),YSSKDSSPTLASK,_DSS(ph)PTLASK_,S1712,,21.53,22.57,,25.48,,22.84,24.39,24.66,25.99,21.60,23.44,22.41,27.04,23.81,-2.29,-1.25, ,1.67, ,-0.98,0.58,0.85,2.18,-2.21,-0.37,-1.40,3.23,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
370,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),LHREYGSTSSIDK,_EYGS(ph)TSSIDK_,S208,+,24.05,24.73,23.50,28.44,22.25,24.01,26.65,25.64,24.97,24.40,25.20,26.50,25.16,25.04,-0.99,-0.31,-1.53,3.40,-2.79,-1.03,1.61,0.60,-0.07,-0.63,0.16,1.46,0.13,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
375,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),ALSSPQSPFPSTP,_FHALSS(ph)PQS(ph)PFPSTPTSR_,S1547,,22.83,,,,21.85,,,,,,,,,22.34,0.49, , , ,-0.49, , , , , , , , ,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
378,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),SSRHSASPVVFTS,_HSAS(ph)PVVFTSAR_,S1412,+,21.57,23.40,23.40,22.63,24.43,25.60,,23.59,24.40,,24.34,,24.35,23.77,-2.20,-0.37,-0.37,-1.14,0.66,1.83, ,-0.18,0.63, ,0.57, ,0.58,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
381,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),QCRNSPSNLSSSS,_NSPS(ph)NLSSSSDTGSVGGTYR_,S1151,,,,,,21.80,23.89,,,21.73,,,,,22.47, , , , ,-0.67,1.42, , ,-0.74, , , , ,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
382,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),FGVSRRSPASIDR,_S(ph)PASIDRQNTQSDIGGSGK_,S1181,+,23.50,25.78,,26.96,26.15,26.44,25.80,25.84,26.28,24.39,24.85,24.03,25.06,25.42,-1.92,0.36, ,1.54,0.73,1.01,0.37,0.42,0.86,-1.03,-0.57,-1.40,-0.36,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
384,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),NIPRSISSDGRPL,_SIS(ph)SDGRPLER_,S1116,,,,,,23.78,,,,24.46,,,,,24.12, , , , ,-0.34, , , ,0.34, , , , ,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
385,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),FSASDSSLTDIQE,_SLHGEFSASDSS(ph)LTDIQETR_,S1629,,,,,,21.65,22.84,,,23.55,,,,22.99,22.76, , , , ,-1.10,0.08, , ,0.79, , , ,0.23,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
388,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),ALHRTLSDESIYN,_TLS(ph)DESIYNSQR_,S1564,+,26.06,25.77,25.50,27.81,28.57,27.93,27.24,27.36,27.41,25.97,27.79,26.96,26.04,26.95,-0.89,-1.18,-1.46,0.85,1.62,0.98,0.29,0.40,0.45,-0.98,0.83,0.01,-0.91,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
390,O43166,SIPA1L1,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),PLWHSSSEVISMA,_VAPLWHSSS(ph)EVISM(ox)ADR_,S1346,,,,,23.72,,25.32,23.59,,24.78,21.47,24.01,23.11,25.47,23.93, , , ,-0.22, ,1.38,-0.35, ,0.85,-2.46,0.08,-0.82,1.54,actin cytoskeleton reorganization;regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;regulation of synaptic plasticity;regulation of axonogenesis;activation of Rap GTPase activity,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
392,O43194,GPR39,G-protein coupled receptor 39,RPLLFASRRQSSA,_FVQRPLLFAS(ph)R_,S110,,24.18,,,,,,,,,,,,,24.18,0.00, , , , , , , , , , , , ,,integral to plasma membrane,,,,,,,,,,,,,,
393,O43194,GPR39,G-protein coupled receptor 39,TEKIFLSTFQSEA,_IFLS(ph)TFQSEAEPQSK_,S125,,20.67,,,,,,,,,,,,,20.67,0.00, , , , , , , , , , , , ,,integral to plasma membrane,,,,,,,,,,,,,,
395,O43194,GPR39,G-protein coupled receptor 39,QSLSLESLEPNSG,_SQSLSLES(ph)LEPNSGAK_,S144,,20.64,,,,,,,,24.25,23.38,,,23.98,23.06,-2.43, , , , , , , ,1.19,0.31, , ,0.92,,integral to plasma membrane,,,,,,,,,,,,,,
396,O43237,DYNC1LI2,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",EEGCQGSPQRRGP,_DFQDYM(ox)EPEEGCQGS(ph)PQR_,S194,+,23.28,23.77,,25.60,23.11,24.50,25.65,26.12,24.30,23.99,23.85,24.21,23.30,24.31,-1.02,-0.54, ,1.30,-1.20,0.19,1.34,1.82,0.00,-0.31,-0.46,-0.10,-1.01,transport;microtubule cytoskeleton organization;centrosome localization;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;cytoplasmic dynein complex;microtubule;centrosome,,,,,,,,,,,,,,
397,O43281,EFS,Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3),HRPRLPSAESLSR,_LPS(ph)AESLSR_,S129,,25.53,22.64,,22.81,,,,,,,,,,23.66,1.87,-1.02, ,-0.85, , , , , , , , , ,cell adhesion;intracellular signal transduction,cytoplasm,,,,,,,,,,,,,,
400,O43291,SPINT2,Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2) (HAI-2) (Placental bikunin),ALRTVWSSGDDKE,_TVWS(ph)SGDDK_,S237,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,cellular component movement,integral to membrane;extracellular region;cytoplasm,,,,,,,,,,,,,,
401,O43294,TGFB1I1,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),EDKKRPSLPSSPS,_KRPS(ph)LPS(ph)SPSPGLPK_,S137,,,22.75,22.75,23.92,,,,22.33,22.41,,21.98,23.50,,22.81, ,-0.06,-0.06,1.11, , , ,-0.48,-0.40, ,-0.82,0.70, ,"negative regulation of cell proliferation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of epithelial to mesenchymal transition;transcription from RNA polymerase II promoter;negative regulation of fat cell differentiation;positive regulation of transcription, DNA-dependent;cell adhesion;Wnt receptor signaling pathway;ubiquitin-dependent SMAD protein catabolic process;androgen receptor signaling pathway;cell fate commitment;morphogenesis of embryonic epithelium;epithelial cell differentiation",intracellular;focal adhesion;cytoskeleton;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
403,O43294,TGFB1I1,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),TNEGSPSPPEPTG,_VQNHLPASGPTQPPVVSSTNEGSPS(ph)PPEPTGK_,S194,,,,,23.83,,24.83,,,,,25.51,,,24.72, , , ,-0.89, ,0.11, , , , ,0.79, , ,"negative regulation of cell proliferation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of epithelial to mesenchymal transition;transcription from RNA polymerase II promoter;negative regulation of fat cell differentiation;positive regulation of transcription, DNA-dependent;cell adhesion;Wnt receptor signaling pathway;ubiquitin-dependent SMAD protein catabolic process;androgen receptor signaling pathway;cell fate commitment;morphogenesis of embryonic epithelium;epithelial cell differentiation",intracellular;focal adhesion;cytoskeleton;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
404,O43295,SRGAP3,SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP),SKNDLQSPTEHIS,_NDLQS(ph)PTEHISDYGFGGVM(ox)GR_,S813,,23.05,,,,,,,,,,,,,23.05,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
406,O43306,ADCY6,Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase),RDAEPPSPTPAGP,_DAEPPS(ph)PTPAGPPR_,S54,+,25.91,24.98,,25.24,23.81,25.00,,24.15,25.26,24.20,24.64,,25.14,24.83,1.08,0.15, ,0.41,-1.02,0.17, ,-0.69,0.42,-0.63,-0.20, ,0.31,adenylate cyclase-activating G-protein coupled receptor signaling pathway;fibroblast growth factor receptor signaling pathway;energy reserve metabolic process;transmembrane transport;dopamine receptor signaling pathway;activation of protein kinase A activity;water transport;intracellular signal transduction;cellular response to prostaglandin E stimulus;activation of phospholipase C activity;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;cellular response to catecholamine stimulus;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;cellular response to glucagon stimulus,microvillus membrane;endosome;membrane raft;integral to membrane;sarcolemma;plasma membrane;cilium,,,,,,,,,,,,,,
407,O43310,CTIF,CBP80/20-dependent translation initiation factor,SLEAPRSPDTLAP,_LEDTAGDTGHSSLEAPRS(ph)PDTLAPVASER_,S299,,,,,,,,,,,,25.86,24.38,,25.12, , , , , , , , , , ,0.74,-0.74, ,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation",perinuclear region of cytoplasm,,,,,,,,,,,,,,
410,O43310,CTIF,CBP80/20-dependent translation initiation factor,EAGSSRSQEIEEL,_S(ph)QEIEELER_,S18,+,,25.82,22.78,26.68,24.99,24.22,23.83,24.49,23.81,,25.49,,,24.68, ,1.14,-1.90,2.00,0.31,-0.45,-0.85,-0.19,-0.87, ,0.81, , ,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation",perinuclear region of cytoplasm,,,,,,,,,,,,,,
411,O43314,PPIP5K2,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2),GRRRRRSGEQITS,_S(ph)GEQITSSPVSPK_,S1006,+,21.96,23.03,22.46,23.14,,21.99,23.03,24.18,,21.83,,22.44,,22.67,-0.71,0.36,-0.21,0.47, ,-0.68,0.36,1.50, ,-0.85, ,-0.23, ,inositol metabolic process,cytosol,,,,,,,,,,,,,,
414,O43318,MAP3K7,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),SEGKRMSADMSEI,_M(ox)S(ph)ADM(ox)SEIEAR_,S389,+,23.61,24.66,24.66,24.30,24.19,22.28,23.90,24.26,22.80,,23.20,26.17,22.30,23.86,-0.25,0.80,0.80,0.43,0.33,-1.58,0.04,0.40,-1.06, ,-0.66,2.31,-1.56,"negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;JNK cascade;positive regulation of NF-kappaB transcription factor activity;transforming growth factor beta receptor signaling pathway;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of JNK cascade;I-kappaB phosphorylation;toll-like receptor 2 signaling pathway;positive regulation of interleukin-2 production;neural tube formation;apoptotic process;nucleotide-binding oligomerization domain containing signaling pathway;MyD88-dependent toll-like receptor signaling pathway;toll-like receptor 3 signaling pathway;angiogenesis;positive regulation of T cell activation;activation of MAPK activity;positive regulation of JUN kinase activity;TRIF-dependent toll-like receptor signaling pathway;innate immune response;T cell receptor signaling pathway;histone H3 acetylation;transcription, DNA-dependent;activation of NF-kappaB-inducing kinase activity;toll-like receptor 1 signaling pathway;positive regulation of T cell cytokine production",cytosol;endosome membrane;Ada2/Gcn5/Ada3 transcription activator complex;plasma membrane,,+,,,,,,,,,,,,
415,O43318,MAP3K7,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),GQPRRRSIQDLTV,_S(ph)IQDLTVTGTEPGQVSSR_,S412,+,26.27,22.34,22.06,23.70,26.90,25.56,25.28,27.65,23.79,22.97,25.56,27.97,24.55,24.97,1.30,-2.63,-2.91,-1.27,1.93,0.59,0.31,2.68,-1.18,-2.00,0.59,3.00,-0.42,"negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;JNK cascade;positive regulation of NF-kappaB transcription factor activity;transforming growth factor beta receptor signaling pathway;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of JNK cascade;I-kappaB phosphorylation;toll-like receptor 2 signaling pathway;positive regulation of interleukin-2 production;neural tube formation;apoptotic process;nucleotide-binding oligomerization domain containing signaling pathway;MyD88-dependent toll-like receptor signaling pathway;toll-like receptor 3 signaling pathway;angiogenesis;positive regulation of T cell activation;activation of MAPK activity;positive regulation of JUN kinase activity;TRIF-dependent toll-like receptor signaling pathway;innate immune response;T cell receptor signaling pathway;histone H3 acetylation;transcription, DNA-dependent;activation of NF-kappaB-inducing kinase activity;toll-like receptor 1 signaling pathway;positive regulation of T cell cytokine production",cytosol;endosome membrane;Ada2/Gcn5/Ada3 transcription activator complex;plasma membrane,,+,,,,,,,,,,,,
417,O43353,RIPK2,Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2),VVSRSPSLNLLQN,_SPS(ph)LNLLQNK_,S531,,23.36,,,,,,20.25,,,,,,,21.81,1.55, , , , , ,-1.55, , , , , , ,inflammatory response;toll-like receptor 4 signaling pathway;positive regulation of tumor necrosis factor production;positive regulation of ERK1 and ERK2 cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of interleukin-12 production;positive regulation of chemokine production;T cell proliferation;positive regulation of protein ubiquitination;toll-like receptor 2 signaling pathway;nucleotide-binding oligomerization domain containing signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of interferon-beta production;nucleotide-binding oligomerization domain containing 2 signaling pathway;activation of MAPK activity;TRIF-dependent toll-like receptor signaling pathway;cellular response to peptidoglycan;I-kappaB kinase/NF-kappaB cascade;nerve growth factor receptor signaling pathway;response to interleukin-18;toll-like receptor 1 signaling pathway;response to exogenous dsRNA;positive regulation of interferon-gamma production;positive regulation of T-helper 1 type immune response;JNK cascade;positive regulation of T-helper 1 cell differentiation;response to interleukin-1;Toll signaling pathway;defense response to Gram-positive bacterium;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of JNK cascade;apoptotic process;adaptive immune response;positive regulation of interleukin-2 production;positive regulation of cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;positive regulation of interleukin-6 production;positive regulation of interferon-alpha production;response to interleukin-12;positive regulation of immature T cell proliferation;innate immune response;T cell receptor signaling pathway;lipopolysaccharide-mediated signaling pathway;nucleotide-binding oligomerization domain containing 1 signaling pathway;positive regulation of alpha-beta T cell proliferation;cellular response to lipoteichoic acid;positive regulation of apoptotic process,cytosol,,+,,,,,,,,,,,,
419,O43390,HNRNPR,Heterogeneous nuclear ribonucleoprotein R (hnRNP R),NRLFVGSIPKSKT,_LFVGS(ph)IPK_,S249,,20.74,20.32,,20.50,22.26,21.61,,21.97,,21.35,,20.96,21.48,21.24,-0.50,-0.92, ,-0.75,1.02,0.37, ,0.73, ,0.10, ,-0.28,0.24,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
425,O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),____MDSAGQDIN,_(ac)M(ox)DS(ph)AGQDINLNSPNK_,S3,,22.61,22.60,22.60,,,,,22.21,,,22.63,,,22.53,0.08,0.07,0.07, , , , ,-0.32, , ,0.10, , ,regulation of cell proliferation,perinuclear region of cytoplasm,,,,,,,,,,,,,,
426,O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),QDINLNSPNKGLL,_(ac)MDSAGQDINLNS(ph)PNK_,S12,+,26.26,25.31,26.26,22.86,27.28,25.68,26.95,27.12,,26.40,26.40,,26.75,26.12,0.15,-0.81,0.15,-3.26,1.16,-0.43,0.84,1.00, ,0.29,0.28, ,0.63,regulation of cell proliferation,perinuclear region of cytoplasm,,,,,,,,,,,,,,
427,O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),NSATFKSFEDRVG,_S(ph)FEDRVGT(ph)IK_,S166,+,30.18,29.00,29.61,29.81,28.10,26.73,30.41,29.01,27.55,27.76,28.23,30.83,27.45,28.82,1.36,0.18,0.79,0.99,-0.72,-2.09,1.59,0.19,-1.27,-1.06,-0.59,2.01,-1.37,regulation of cell proliferation,perinuclear region of cytoplasm,,,,,,,,,,,,,,
429,O43432,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),VLRLVLSGEKKEQ,_LVLS(ph)GEK_,S240,,23.08,,,,,,,,,,,,,23.08,0.00, , , , , , , , , , , , ,RNA metabolic process;regulation of translational initiation;meiotic prophase I;positive regulation of protein phosphorylation;spermatogenesis;positive regulation of translation;cytokine-mediated signaling pathway;virus-host interaction,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
430,O43432,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),PVLKSPSPVLRLV,_SPS(ph)PVLR_,S232,+,24.57,24.76,24.65,26.26,,,,22.29,,23.66,22.63,24.27,22.17,23.92,0.65,0.84,0.73,2.34, , , ,-1.63, ,-0.26,-1.29,0.35,-1.75,RNA metabolic process;regulation of translational initiation;meiotic prophase I;positive regulation of protein phosphorylation;spermatogenesis;positive regulation of translation;cytokine-mediated signaling pathway;virus-host interaction,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
431,O43432,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),NLNSRRSPVPAQI,_S(ph)PVPAQIAITVPK_,S495,+,25.43,25.03,22.30,25.78,24.53,24.46,23.82,24.95,22.98,,25.44,23.44,24.18,24.36,1.07,0.67,-2.06,1.42,0.17,0.09,-0.54,0.59,-1.38, ,1.08,-0.92,-0.18,RNA metabolic process;regulation of translational initiation;meiotic prophase I;positive regulation of protein phosphorylation;spermatogenesis;positive regulation of translation;cytokine-mediated signaling pathway;virus-host interaction,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
432,O43439,CBFA2T2,Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85),LVSRQHSPGSADS,_(gl)QHS(ph)PGSADSLSNDSQR_,S183,,24.47,,,,21.84,22.01,,,,,,,,22.77,1.69, , , ,-0.93,-0.76, , , , , , , ,"positive regulation of neuron projection development;negative regulation of transcription, DNA-dependent;negative regulation of neuron projection development;positive regulation of transcription from RNA polymerase II promoter;epithelial cell differentiation",nucleus,,,,,,,,,,,,,,
434,O43474,KLF4,Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor),VLKASLSAPGSEY,_ASLS(ph)APGSEYGSPSVISVSK_,S186,,22.93,,,,,,,,,,,,,22.93,0.00, , , , , , , , , , , , ,negative regulation of cell proliferation;fat cell differentiation;epidermis morphogenesis;stem cell maintenance;positive regulation of hemoglobin biosynthetic process;negative regulation of NF-kappaB transcription factor activity;negative regulation of cell migration involved in sprouting angiogenesis;negative regulation of protein kinase B signaling cascade;negative regulation of smooth muscle cell proliferation;negative regulation of chemokine (C-X-C motif) ligand 2 production;post-embryonic hemopoiesis;epidermal cell differentiation;negative regulation of interleukin-8 biosynthetic process;mesodermal cell fate determination;cellular response to growth factor stimulus;post-embryonic camera-type eye development;negative regulation of phosphatidylinositol 3-kinase cascade;negative regulation of inflammatory response;response to retinoic acid;regulation of phosphatidylinositol 3-kinase activity;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of heterotypic cell-cell adhesion;negative regulation of muscle hyperplasia;negative regulation of transcription from RNA polymerase II promoter;negative regulation of response to cytokine stimulus;negative regulation of ERK1 and ERK2 cascade,nuclear chromatin;transcription factor complex,C2H2-type,,,,,,,,,,,,,
435,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),MNGKEISPGSGPG,_EIS(ph)PGSGPGEIRK_,S715,+,24.13,24.97,25.04,25.78,25.82,25.34,26.52,25.46,26.49,27.10,24.56,23.84,22.71,25.21,-1.08,-0.25,-0.17,0.57,0.61,0.13,1.31,0.25,1.27,1.89,-0.65,-1.37,-2.50,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
436,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),KEISPGSGPGEIR,_EISPGS(ph)GPGEIR_,S718,+,22.83,24.26,,23.54,,,22.93,23.11,,,,22.14,22.97,23.11,-0.28,1.15, ,0.43, , ,-0.18,-0.01, , , ,-0.97,-0.14,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
437,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),NQQNQSSDPEEEK,_EVAENQQNQSS(ph)DPEEEK_,S39,+,23.49,24.46,24.32,23.23,,21.87,22.49,21.85,23.00,25.17,21.68,21.77,21.37,22.89,0.60,1.57,1.43,0.34, ,-1.03,-0.40,-1.04,0.11,2.28,-1.21,-1.12,-1.52,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
440,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),LQTQGSSHETLNI,_ITPLSLQTQGSS(ph)HETLNIVEEK_,S683,,,23.19,,24.45,,25.80,,,,,24.53,24.52,26.66,24.86, ,-1.67, ,-0.41, ,0.94, , , , ,-0.32,-0.34,1.80,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
441,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),TFYRLVSPEQPPK,_LVS(ph)PEQPPK_,S499,+,22.68,23.78,22.65,21.39,22.26,22.90,23.24,,23.38,23.42,,,,22.86,-0.18,0.93,-0.21,-1.46,-0.59,0.04,0.39, ,0.52,0.56, , , ,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
442,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),WLKKQKSYTLVVA,_(gl)QKS(ph)YTLVVAK_,S87,,26.42,,,,22.95,,,23.36,,,,,,24.25,2.17, , , ,-1.29, , ,-0.88, , , , , ,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
443,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),SKRVSRSLDGAPI,_S(ph)LDGAPIGVM(ox)DQSLM(ox)K_,S550,,22.12,,,22.08,,,,,,,,,,22.10,0.02, , ,-0.02, , , , , , , , , ,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
447,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),DSPSKSSAEAQTP,_DSPSKSS(ph)AEAQTPEDTPNK_,S71,+,24.83,28.10,28.17,28.36,26.31,26.98,28.16,28.02,27.18,27.51,27.89,26.42,24.62,27.12,-2.29,0.98,1.06,1.24,-0.81,-0.14,1.04,0.91,0.06,0.39,0.77,-0.70,-2.50,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
448,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),HAFKTESGEETDL,_TES(ph)GEETDLISPPQEEVK_,S298,+,23.75,26.08,26.38,27.60,26.45,26.45,28.52,26.42,28.46,28.16,28.01,27.66,26.18,26.93,-3.18,-0.86,-0.55,0.67,-0.48,-0.49,1.59,-0.51,1.53,1.23,1.08,0.73,-0.75,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
449,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),KMSGSASSENREG,_M(ox)SGSAS(ph)SENREGTLSDSTGSEK_,S351,,24.06,26.68,27.44,25.72,24.09,25.45,28.27,24.39,28.33,27.69,26.10,26.15,24.30,26.05,-1.99,0.62,1.39,-0.33,-1.97,-0.60,2.22,-1.66,2.28,1.64,0.05,0.10,-1.76,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
450,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),KDGSNKSGAEEQG,_S(ph)GAEEQGPIDGPSK_,S224,,25.97,28.32,29.08,25.51,,,,,25.63,25.80,,,,26.72,-0.75,1.60,2.36,-1.21, , , , ,-1.09,-0.92, , , ,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
451,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),GPIDGPSKSGAEE,_SGAEEQGPIDGPS(ph)K_,S236,,22.11,23.68,24.38,,22.12,,,,,,,,,23.07,-0.96,0.60,1.31, ,-0.95, , , , , , , , ,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
452,O43493,TGOLN2,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),PQEEVKSSEPTED,_S(ph)SEPTEDVEPK_,S314,,24.59,25.95,,26.03,22.39,,21.82,,23.77,24.75,22.65,23.24,,23.91,0.68,2.04, ,2.12,-1.52, ,-2.09, ,-0.14,0.84,-1.26,-0.67, ,,trans-Golgi network;integral to membrane;transport vesicle;Golgi apparatus;plasma membrane;nucleus,,,,,,,,,,,,,,
454,O43516,WIPF1,WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein),LPQRNLSLSSSTP,_NLS(ph)LSSSTPPLPSPGR_,S340,,,22.67,22.93,21.67,,,,,,,,,,22.42, ,0.25,0.51,-0.76, , , , , , , , , ,actin polymerization or depolymerization;protein complex assembly;actin filament-based movement;positive regulation of protein export from nucleus,actin filament;cytoplasmic membrane-bounded vesicle;actin cytoskeleton,,,,,,,,,,,,,,
455,O43524,FOXO3,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),PESADDSPSQLSK,_AALQTAPESADDS(ph)PSQLSK_,S284,,23.45,,,,,,,,,,,,,23.45,0.00, , , , , , , , , , , , ,"initiation of primordial ovarian follicle growth;fibroblast growth factor receptor signaling pathway;positive regulation of erythrocyte differentiation;embryo development;regulation of sequence-specific DNA binding transcription factor activity;induction of apoptosis;ovulation from ovarian follicle;glucose homeostasis;insulin receptor signaling pathway;apoptotic process;oocyte maturation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;tissue development;response to DNA damage stimulus;regulation of cell proliferation;DNA damage response, signal transduction by p53 class mediator;epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;antral ovarian follicle growth;nerve growth factor receptor signaling pathway;regulation of translation;pattern specification process",cytosol;transcription factor complex,Forkhead,,,,,,,,,,,,,
456,O43524,FOXO3,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),MAEAPASPAPLSP,_(ac)AEAPAS(ph)PAPLS(ph)PLEVELDPEFEPQSRPR_,S7,,26.38,,,,,,,,,,,,,26.38,0.00, , , , , , , , , , , , ,"initiation of primordial ovarian follicle growth;fibroblast growth factor receptor signaling pathway;positive regulation of erythrocyte differentiation;embryo development;regulation of sequence-specific DNA binding transcription factor activity;induction of apoptosis;ovulation from ovarian follicle;glucose homeostasis;insulin receptor signaling pathway;apoptotic process;oocyte maturation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;tissue development;response to DNA damage stimulus;regulation of cell proliferation;DNA damage response, signal transduction by p53 class mediator;epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;antral ovarian follicle growth;nerve growth factor receptor signaling pathway;regulation of translation;pattern specification process",cytosol;transcription factor complex,Forkhead,,,,,,,,,,,,,
457,O43524,FOXO3,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),ASPAPLSPLEVEL,_(ac)AEAPAS(ph)PAPLS(ph)PLEVELDPEFEPQSRPR_,S12,,26.38,,,,,,,,,,,,,26.38,0.00, , , , , , , , , , , , ,"initiation of primordial ovarian follicle growth;fibroblast growth factor receptor signaling pathway;positive regulation of erythrocyte differentiation;embryo development;regulation of sequence-specific DNA binding transcription factor activity;induction of apoptosis;ovulation from ovarian follicle;glucose homeostasis;insulin receptor signaling pathway;apoptotic process;oocyte maturation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;tissue development;response to DNA damage stimulus;regulation of cell proliferation;DNA damage response, signal transduction by p53 class mediator;epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;antral ovarian follicle growth;nerve growth factor receptor signaling pathway;regulation of translation;pattern specification process",cytosol;transcription factor complex,Forkhead,,,,,,,,,,,,,
459,O43524,FOXO3,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),LSKWPGSPTSRSS,_WPGS(ph)PTSR_,S294,+,26.29,23.75,24.49,23.52,23.42,23.80,23.87,23.32,22.14,,22.11,23.22,21.78,23.48,2.81,0.28,1.02,0.05,-0.06,0.32,0.39,-0.15,-1.34, ,-1.37,-0.26,-1.69,"initiation of primordial ovarian follicle growth;fibroblast growth factor receptor signaling pathway;positive regulation of erythrocyte differentiation;embryo development;regulation of sequence-specific DNA binding transcription factor activity;induction of apoptosis;ovulation from ovarian follicle;glucose homeostasis;insulin receptor signaling pathway;apoptotic process;oocyte maturation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;tissue development;response to DNA damage stimulus;regulation of cell proliferation;DNA damage response, signal transduction by p53 class mediator;epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;antral ovarian follicle growth;nerve growth factor receptor signaling pathway;regulation of translation;pattern specification process",cytosol;transcription factor complex,Forkhead,,,,,,,,,,,,,
461,O43572,AKAP10,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",SLAEPVSPSKKHE,_(gl)QSSLAEPVS(ph)PSK_,S187,+,26.00,25.27,25.27,25.00,24.33,24.73,25.11,24.95,24.55,26.01,24.92,25.66,24.96,25.13,0.86,0.14,0.14,-0.13,-0.80,-0.41,-0.03,-0.19,-0.59,0.88,-0.21,0.53,-0.18,signal transduction;blood coagulation;protein localization;termination of G-protein coupled receptor signaling pathway,cytosol;mitochondrion;plasma membrane,,,,,,,,,,,,,,
462,O43583,DENR,Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3),KLTVENSPKQEAG,_LTVENS(ph)PK_,S73,+,23.24,24.94,25.21,26.64,23.63,25.54,23.91,26.84,21.59,,23.83,23.66,24.21,24.44,-1.20,0.50,0.78,2.21,-0.81,1.10,-0.52,2.40,-2.85, ,-0.61,-0.77,-0.23,,,,,,,,,,,,,,,,
463,O43598,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL),VPGRSESWERGEP,_(ac)AAAM(ox)VPGRSES(ph)WER_,S12,+,24.07,25.56,25.56,24.01,23.61,,,23.69,22.42,,23.19,23.72,,23.98,0.09,1.58,1.58,0.03,-0.37, , ,-0.29,-1.56, ,-0.79,-0.26, ,cell proliferation;positive regulation of cell growth;deoxyribonucleoside monophosphate catabolic process;nucleotide metabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
465,O43639,NCK2,Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta),TSARDASPTPSTD,_DAS(ph)PTPSTDAEYPANGSGADR_,S90,,22.89,23.71,,23.47,,,,,,,,,,23.35,-0.47,0.35, ,0.11, , , , , , , , , ,lamellipodium assembly;T cell activation;negative regulation of cell proliferation;cell migration;signal complex assembly;axon guidance;regulation of epidermal growth factor-activated receptor activity;positive regulation of actin filament polymerization;epidermal growth factor receptor signaling pathway;actin filament organization;positive regulation of T cell proliferation;regulation of translation;positive regulation of transcription from RNA polymerase II promoter,cytosol;endoplasmic reticulum;vesicle membrane,,,,,,,,,,,,,,
466,O43665,RGS10,Regulator of G-protein signaling 10 (RGS10),RAVSRLSRKRPPS,_AVSRLS(ph)R_,S10,,26.09,,,25.57,,,,,,,,22.83,,24.83,1.26, , ,0.74, , , , , , , ,-2.00, ,termination of G-protein coupled receptor signaling pathway,neuronal cell body;dendritic spine;plasma membrane;nucleus;axon terminus;cytoplasm,,,,,,,,,,,,,,
467,O43684,BUB3,Mitotic checkpoint protein BUB3,VEYLDPSPEVQKK,_VAVEYLDPS(ph)PEVQK_,S211,,22.48,,,,20.58,23.11,,,23.64,22.93,,,,22.55,-0.07, , , ,-1.97,0.56, , ,1.09,0.38, , , ,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;regulation of chromosome segregation;meiosis;attachment of spindle microtubules to kinetochore;mitotic prometaphase;cell division;mitotic sister chromatid segregation,cytosol;nucleus;condensed chromosome kinetochore;kinetochore,,,,,,,,,,,,,,
468,O43707,ACTN4,Alpha-actinin-4 (F-actin cross-linking protein) (Non-muscle alpha-actinin 4),KFRQKASIHEAWT,_AS(ph)IHEAWTDGK_,S423,+,,22.94,22.94,23.64,,23.59,24.30,,24.41,23.59,24.16,24.27,23.89,23.77, ,-0.83,-0.83,-0.13, ,-0.19,0.53, ,0.64,-0.19,0.38,0.50,0.11,platelet degranulation;positive regulation of pinocytosis;platelet activation;actin crosslink formation;response to hypoxia;positive regulation of sodium:hydrogen antiporter activity;protein transport;positive regulation of cellular component movement;actin filament bundle assembly;negative regulation of cellular component movement;regulation of apoptotic process,cortical cytoskeleton;ribonucleoprotein complex;platelet alpha granule lumen;pseudopodium;protein complex;perinuclear region of cytoplasm;stress fiber;extracellular vesicular exosome;nucleus,,,,,,,,,,,,,,
469,O43707,ACTN4,Alpha-actinin-4 (F-actin cross-linking protein) (Non-muscle alpha-actinin 4),FAIQDISVEETSA,_FAIQDIS(ph)VEETSAK_,S159,+,,,,23.81,26.18,26.65,26.08,26.86,28.13,25.61,26.26,26.44,27.28,26.33, , , ,-2.52,-0.15,0.32,-0.25,0.53,1.80,-0.72,-0.07,0.11,0.95,platelet degranulation;positive regulation of pinocytosis;platelet activation;actin crosslink formation;response to hypoxia;positive regulation of sodium:hydrogen antiporter activity;protein transport;positive regulation of cellular component movement;actin filament bundle assembly;negative regulation of cellular component movement;regulation of apoptotic process,cortical cytoskeleton;ribonucleoprotein complex;platelet alpha granule lumen;pseudopodium;protein complex;perinuclear region of cytoplasm;stress fiber;extracellular vesicular exosome;nucleus,,,,,,,,,,,,,,
470,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),EKLFEESDDKEDE,_LFEES(ph)DDKEDEDADGKEVEDADEK_,S676,+,28.93,28.62,29.20,27.24,25.58,27.15,29.07,26.29,28.91,29.95,27.46,28.56,27.32,28.02,0.91,0.60,1.17,-0.78,-2.44,-0.87,1.04,-1.73,0.89,1.93,-0.57,0.54,-0.70,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
471,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),DLDEEGSEKELHE,_EFEENGLEKDLDEEGS(ph)EK_,S579,+,23.73,24.27,24.04,25.63,27.10,27.04,22.63,27.31,23.46,21.91,21.64,24.67,22.38,24.29,-0.56,-0.02,-0.26,1.33,2.81,2.75,-1.66,3.02,-0.84,-2.38,-2.65,0.38,-1.92,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
472,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),REFDEDSDEKEEE,_VLDEEGS(ph)EREFDEDS(ph)DEKEEEEDTYEK_,S624,+,28.33,23.39,23.39,,25.64,26.05,24.59,25.03,22.92,26.74,22.38,,,24.85,3.48,-1.46,-1.46, ,0.80,1.20,-0.26,0.19,-1.93,1.89,-2.46, , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
473,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),ELEENDSENSEFE,_ELEENDS(ph)ENS(ph)EFEDDGS(ph)EK_,S597,,25.22,,,,,,,,,,,,,25.22,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
474,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),ENDSENSEFEDDG,_ELEENDS(ph)ENS(ph)EFEDDGS(ph)EK_,S600,,25.89,,,,,,,,,23.53,,,,24.71,1.18, , , , , , , , ,-1.18, , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
475,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),EFEDDGSEKVLDE,_ELEENDS(ph)ENS(ph)EFEDDGS(ph)EK_,S607,,25.21,,,,,,,,,,,,,25.21,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
476,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),DDLNKESEEEVGP,_ESEDDLNKES(ph)EEEVGPTK_,S529,+,26.81,26.76,26.95,24.82,,24.30,26.24,,26.46,27.80,25.83,25.92,,26.19,0.62,0.57,0.76,-1.37, ,-1.89,0.05, ,0.27,1.61,-0.36,-0.27, ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
478,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),EKLFDDSDERGTL,_LFDDS(ph)DER_,S721,+,26.75,21.20,21.20,20.21,22.92,22.72,24.48,22.27,23.34,23.35,24.46,23.90,,23.07,3.69,-1.87,-1.87,-2.86,-0.14,-0.35,1.41,-0.80,0.27,0.29,1.39,0.83, ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
479,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),FDEEEDSSEKLFD,_LFDEEEDS(ph)S(ph)EK_,S713,+,28.71,28.35,28.52,26.88,,,27.45,,27.24,29.34,26.27,27.82,24.43,27.50,1.21,0.84,1.02,-0.62, , ,-0.05, ,-0.26,1.84,-1.23,0.32,-3.07,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
480,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),DEEEDSSEKLFDD,_LFDEEEDS(ph)S(ph)EK_,S714,+,28.00,,,27.60,22.74,24.16,28.56,,27.65,22.68,26.85,,25.55,25.98,2.02, , ,1.62,-3.23,-1.81,2.59, ,1.67,-3.29,0.87, ,-0.43,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
481,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),LFEDDDSNEKLFD,_LFEDDDS(ph)NEK_,S702,+,29.55,29.13,29.18,28.77,24.21,26.19,28.91,26.71,28.62,28.84,22.86,28.44,27.15,27.58,1.97,1.55,1.60,1.19,-3.37,-1.39,1.33,-0.87,1.04,1.26,-4.72,0.85,-0.43,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
482,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),KQSEDGSEREFEE,_QSEDGS(ph)EREFEENGLEK_,S561,,23.17,22.25,,,,23.05,24.00,,23.86,26.03,,,,23.73,-0.56,-1.48, , , ,-0.67,0.27, ,0.13,2.30, , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
483,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),GLRRSDSVSASER,_SDS(ph)VSASER_,S387,+,25.01,23.39,23.39,26.22,,,20.58,20.46,,,18.95,23.78,18.69,22.28,2.73,1.12,1.12,3.94, , ,-1.69,-1.82, , ,-3.32,1.50,-3.58,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
484,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),ENNAKESSPEKEA,_TEDGGEFEEGASENNAKES(ph)S(ph)PEK_,S452,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
485,O43719,HTATSF1,HIV Tat-specific factor 1 (Tat-SF1),NNAKESSPEKEAE,_TEDGGEFEEGASENNAKES(ph)S(ph)PEK_,S453,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;viral genome replication",nucleus,,,,,,,,,,,,,,
491,O43741,PRKAB2,5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2),CRDLSSSPPGPYG,_DLSSS(ph)PPGPYGQEM(ox)YAFR_,S184,+,25.49,25.82,,25.72,22.65,25.00,24.47,25.50,24.02,,25.80,23.73,24.79,24.82,0.67,1.01, ,0.90,-2.17,0.18,-0.35,0.68,-0.80, ,0.99,-1.09,-0.03,regulation of fatty acid biosynthetic process;small molecule metabolic process;energy reserve metabolic process;cellular lipid metabolic process;carnitine shuttle;insulin receptor signaling pathway;cell cycle arrest;regulation of fatty acid oxidation;fatty acid biosynthetic process,nucleoplasm;cytosol;AMP-activated protein kinase complex;apical plasma membrane;cAMP-dependent protein kinase complex,,,,,,,,,,,,,,
492,O43752,STX6,Syntaxin-6,_____MSMEDPFF,_(ac)S(ph)M(ox)EDPFFVVK_,S2,,24.09,,,,,,,,,,,,,24.09,0.00, , , , , , , , , , , , ,"intracellular protein transport;Golgi vesicle transport;retrograde transport, endosome to Golgi;endosome organization;vesicle fusion",Golgi apparatus;Golgi membrane;clathrin-coated vesicle;perinuclear region of cytoplasm;early endosome;SNARE complex;integral to membrane;plasma membrane;trans-Golgi network membrane,,,,,,,,,,,,,,
493,O43765,SGTA,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),IRSRTPSASNDDQ,_SRTPS(ph)ASNDDQQE_,S305,+,22.94,24.38,24.42,25.34,22.18,22.10,23.64,24.38,23.17,,24.12,24.21,22.13,23.58,-0.64,0.79,0.83,1.75,-1.40,-1.48,0.06,0.79,-0.41, ,0.53,0.62,-1.45,virus-host interaction,cytoplasm,,,,,,,,,,,,,,
494,O43768,ENSA,Alpha-endosulfine (ARPP-19e),_____MSQKQEEE,_(ac)S(ph)QKQEEENPAEETGEEK_,S2,,25.01,25.03,,23.93,,,,,,,,,,24.66,0.36,0.37, ,-0.73, , , , , , , , , ,G2/M transition of mitotic cell cycle;transport;mitosis;response to nutrient;cell division,cytoplasm,,,,,,,,,,,,,,
495,O43768,ENSA,Alpha-endosulfine (ARPP-19e),GQKYFDSGDYNMA,_YFDS(ph)GDYNM(ox)AK_,S67,+,22.28,22.95,23.36,25.57,,,23.23,22.99,,21.29,22.53,25.17,,23.27,-0.98,-0.31,0.10,2.31, , ,-0.03,-0.27, ,-1.97,-0.74,1.90, ,G2/M transition of mitotic cell cycle;transport;mitosis;response to nutrient;cell division,cytoplasm,,,,,,,,,,,,,,
496,O43815,STRN,Striatin,SAAADFSDEDEDD,_FLESAAADFS(ph)DEDEDDDVDGREK_,S245,,22.58,,,,24.24,,,,23.66,24.10,,23.04,,23.52,-0.95, , , ,0.71, , , ,0.14,0.58, ,-0.48, ,negative regulation of cell proliferation;dendrite development;locomotory behavior;Wnt receptor signaling pathway;tight junction assembly,tight junction;neuronal cell body;postsynaptic density;protein complex;postsynaptic membrane;cytoplasm,,,,,,,,,,,,,,
497,O43818,RRP9,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),KMNEEISSDSESE,_M(ox)NEEIS(ph)S(ph)DS(ph)ESESLAPR_,S50,,24.22,,,,,,,,,,,,,24.22,0.00, , , , , , , , , , , , ,rRNA processing,small nuclear ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
498,O43818,RRP9,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),MNEEISSDSESES,_M(ox)NEEIS(ph)S(ph)DS(ph)ESESLAPR_,S51,,25.11,,,,22.99,24.61,,,,22.40,,,,23.78,1.33, , , ,-0.78,0.83, , , ,-1.38, , , ,rRNA processing,small nuclear ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
499,O43818,RRP9,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),EEISSDSESESLA,_M(ox)NEEIS(ph)S(ph)DS(ph)ESESLAPR_,S53,,24.78,,,,,,,,,,,,,24.78,0.00, , , , , , , , , , , , ,rRNA processing,small nuclear ribonucleoprotein complex;small nucleolar ribonucleoprotein complex,,,,,,,,,,,,,,
500,O43823,AKAP8,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),KLARVDSEGDFSE,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_,S323,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,signal transduction;mitosis;mitotic chromosome condensation,condensed chromosome;mitochondrion;Golgi apparatus;female pronucleus;nuclear matrix,,,,,,,,,,,,,,
501,O43823,AKAP8,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),DSEGDFSENDDAA,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_,S328,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,signal transduction;mitosis;mitotic chromosome condensation,condensed chromosome;mitochondrion;Golgi apparatus;female pronucleus;nuclear matrix,,,,,,,,,,,,,,
502,O43823,AKAP8,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),EQTDAESKDAVPT,_VAPAPAAADAEVEQTDAES(ph)K_,S685,,22.59,21.80,,,,,22.35,,,,,,,22.25,0.35,-0.45, , , , ,0.11, , , , , , ,signal transduction;mitosis;mitotic chromosome condensation,condensed chromosome;mitochondrion;Golgi apparatus;female pronucleus;nuclear matrix,,,,,,,,,,,,,,
503,O43823,AKAP8,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),AAGDFRSGDEEFK,_VDS(ph)EGDFS(ph)ENDDAAGDFRS(ph)GDEEFK_,S339,,23.05,,,,,,,,,,,,,23.05,0.00, , , , , , , , , , , , ,signal transduction;mitosis;mitotic chromosome condensation,condensed chromosome;mitochondrion;Golgi apparatus;female pronucleus;nuclear matrix,,,,,,,,,,,,,,
505,O43847,NRD1,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C),EEGRRGSLSNAGD,_RGS(ph)LSNAGDPEIVK_,S94,+,24.86,24.75,24.46,26.70,25.74,23.54,27.93,26.96,22.26,25.57,25.18,28.64,26.56,25.63,-0.77,-0.88,-1.17,1.07,0.12,-2.09,2.30,1.34,-3.37,-0.06,-0.44,3.01,0.93,neuromuscular junction development;cell proliferation;proteolysis;cell migration;regulation of endopeptidase activity;positive regulation of membrane protein ectodomain proteolysis,cytosol;cell surface,,,,,,,,,,,,,,
506,O43852,CALU,Calumenin (Crocalbin) (IEF SSP 9302),QLTPEESKERLGK,_TFDQLTPEES(ph)K_,S69,+,26.80,25.54,25.61,23.20,,23.84,,,23.14,21.44,24.25,,,24.23,2.57,1.31,1.39,-1.03, ,-0.39, , ,-1.09,-2.78,0.02, , ,platelet degranulation;platelet activation,extracellular region;Golgi apparatus;endoplasmic reticulum;sarcoplasmic reticulum lumen;melanosome,,,,,,,,,,,,,,
507,O43852,CALU,Calumenin (Crocalbin) (IEF SSP 9302),VHNDAQSFDYDHD,_VHNDAQS(ph)FDY(ph)DHDAFLGAEEAK_,S44,+,26.26,26.04,25.76,25.78,26.00,28.74,28.14,27.26,27.99,27.24,28.21,29.11,25.80,27.10,-0.84,-1.06,-1.34,-1.32,-1.10,1.64,1.03,0.16,0.88,0.13,1.10,2.01,-1.30,platelet degranulation;platelet activation,extracellular region;Golgi apparatus;endoplasmic reticulum;sarcoplasmic reticulum lumen;melanosome,,,,,,,,,,,,,,
508,O43896,KIF1C,Kinesin-like protein KIF1C,PSARPPSPPLSSW,_M(ox)PSARPPS(ph)PPLSSWER_,S915,,,24.13,,,23.09,23.04,22.65,24.48,,,25.35,,,23.79, ,0.34, , ,-0.70,-0.75,-1.14,0.69, , ,1.57, , ,"retrograde vesicle-mediated transport, Golgi to ER;microtubule-based movement",Golgi apparatus;endoplasmic reticulum;microtubule associated complex;microtubule,,,,,,,,,,,,,,
509,O43896,KIF1C,Kinesin-like protein KIF1C,RMRRQRSAPDLKE,_QRS(ph)APDLK_,S1092,+,20.43,23.90,23.90,23.66,,,20.84,20.68,20.26,20.80,21.48,21.03,,21.70,-1.27,2.20,2.20,1.96, , ,-0.86,-1.02,-1.43,-0.89,-0.22,-0.67, ,"retrograde vesicle-mediated transport, Golgi to ER;microtubule-based movement",Golgi apparatus;endoplasmic reticulum;microtubule associated complex;microtubule,,,,,,,,,,,,,,
510,O43933,PEX1,Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1),GRYRSQSGEDESM,_SQS(ph)GEDESM(ox)NQPGPIK_,S889,+,25.17,24.51,23.85,24.90,24.71,24.32,24.86,24.71,24.34,24.98,24.10,24.09,23.43,24.46,0.71,0.05,-0.61,0.44,0.25,-0.14,0.40,0.25,-0.12,0.52,-0.36,-0.37,-1.03,protein import into peroxisome matrix;microtubule-based peroxisome localization,cytosol;peroxisomal membrane;nucleus,,,,,,,,,,,,,,
511,O60220,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein),KPVFSESLSD___,_SKPVFSES(ph)LSD_,S94,+,21.95,22.43,21.92,21.43,23.70,,,,23.76,23.48,,,,22.67,-0.72,-0.24,-0.74,-1.24,1.03, , , ,1.09,0.81, , , ,cellular protein metabolic process;chaperone-mediated protein transport;protein targeting to mitochondrion;protein import into mitochondrial inner membrane;nervous system development,mitochondrial inner membrane;mitochondrial intermembrane space protein transporter complex;mitochondrial intermembrane space,,,,,,,,,,,,,,
513,O60231,DHX16,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),YRLLEDSEESSEE,_LLEDS(ph)EES(ph)SEETVSR_,S43,+,28.15,24.37,23.24,24.36,26.80,,25.87,26.25,25.49,24.54,25.24,24.11,25.88,25.36,2.79,-0.99,-2.12,-1.00,1.44, ,0.51,0.89,0.13,-0.82,-0.12,-1.25,0.52,mRNA processing;RNA splicing,nucleus,,,,,,,,,,+,,,,
514,O60231,DHX16,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),LEDSEESSEETVS,_LLEDSEES(ph)S(ph)EETVSR_,S46,+,27.91,,,23.44,25.38,24.60,22.59,23.52,23.72,24.14,22.13,,23.53,24.09,3.81, , ,-0.65,1.28,0.50,-1.51,-0.58,-0.38,0.05,-1.96, ,-0.57,mRNA processing;RNA splicing,nucleus,,,,,,,,,,+,,,,
515,O60231,DHX16,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),EDSEESSEETVSR,_LLEDSEES(ph)S(ph)EETVSR_,S47,,24.63,,,,,,,,,,,,,24.63,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing,nucleus,,,,,,,,,,+,,,,
516,O60231,DHX16,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),QTEKPESEDEWER,_(gl)QQTEKPES(ph)EDEWER_,S100,+,26.34,25.85,25.72,26.61,26.19,26.76,25.45,26.42,24.98,24.47,25.08,24.52,24.45,25.60,0.73,0.25,0.11,1.01,0.59,1.16,-0.15,0.82,-0.62,-1.13,-0.53,-1.09,-1.15,mRNA processing;RNA splicing,nucleus,,,,,,,,,,+,,,,
517,O60238,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L),TSRDHSSQSEEEV,_DHSS(ph)QSEEEVVEGEK_,S78,,,,,26.31,,,,,,,,,,26.31, , , ,0.00, , , , , , , , , ,negative regulation of apoptotic process;defense response to virus;mitochondrial protein catabolic process;apoptotic process;virus-host interaction;induction of apoptosis,mitochondrial outer membrane;intrinsic to membrane;nuclear envelope;integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
518,O60238,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L),RDHSSQSEEEVVE,_DHSSQS(ph)EEEVVEGEK_,S80,+,25.86,26.95,25.82,26.53,23.79,27.76,25.75,26.79,26.53,26.02,26.98,26.81,26.31,26.30,-0.45,0.65,-0.48,0.23,-2.51,1.46,-0.55,0.49,0.23,-0.28,0.68,0.51,0.01,negative regulation of apoptotic process;defense response to virus;mitochondrial protein catabolic process;apoptotic process;virus-host interaction;induction of apoptosis,mitochondrial outer membrane;intrinsic to membrane;nuclear envelope;integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
519,O60238,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L),HPKRSVSLSMRKS,_SVS(ph)LSM(ox)R_,S126,,,22.34,,23.88,,,,,,,,,,23.11, ,-0.77, ,0.77, , , , , , , , , ,negative regulation of apoptotic process;defense response to virus;mitochondrial protein catabolic process;apoptotic process;virus-host interaction;induction of apoptosis,mitochondrial outer membrane;intrinsic to membrane;nuclear envelope;integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
520,O60245,PCDH7,Protocadherin-7 (Brain-heart protocadherin) (BH-Pcdh),VNGGPGSPDLARH,_SVNGGPGS(ph)PDLAR_,S989,,,,,27.88,25.18,,,24.43,,,,23.84,26.76,25.62, , , ,2.26,-0.44, , ,-1.19, , , ,-1.78,1.15,homophilic cell adhesion,integral to plasma membrane,,,,,,,,,,,,,,
521,O60256,PRPSAP2,Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41),LVDGRHSPPMVRS,_LGIAVIHGEAQDAESDLVDGRHS(ph)PPM(ox)VR_,S227,,,23.11,,22.89,,23.31,24.27,,23.44,,24.49,,,23.58, ,-0.48, ,-0.69, ,-0.27,0.68, ,-0.14, ,0.90, , ,nucleotide biosynthetic process;nucleobase-containing compound metabolic process,protein complex,,,,,,,,,,,,,,
522,O60264,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),EIFDDASPGKQKE,_GGPEGVAAQAVASAASAGPADAEMEEIFDDAS(ph)PGK_,S66,,28.66,,,25.21,,,,,28.01,29.03,26.43,26.06,,27.24,1.43, , ,-2.03, , , , ,0.78,1.80,-0.81,-1.17, ,"nucleosome positioning;double-strand break repair;DNA-dependent transcription, initiation;CENP-A containing nucleosome assembly at centromere;chromatin silencing at rDNA;regulation of transcription from RNA polymerase II promoter;embryo development",nucleoplasm;condensed chromosome;nucleolus;RSF complex;NURF complex;chromatin silencing complex,,,,,,,,,,,,,,
524,O60264,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),EKQNLLSVGDYRH,_(gl)QNLLS(ph)VGDYR_,S137,,23.70,19.32,19.32,,,,,,,,,22.61,22.04,21.40,2.30,-2.08,-2.08, , , , , , , , ,1.22,0.64,"nucleosome positioning;double-strand break repair;DNA-dependent transcription, initiation;CENP-A containing nucleosome assembly at centromere;chromatin silencing at rDNA;regulation of transcription from RNA polymerase II promoter;embryo development",nucleoplasm;condensed chromosome;nucleolus;RSF complex;NURF complex;chromatin silencing complex,,,,,,,,,,,,,,
525,O60264,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),AQKTPTSPLKMKP,_(gl)QTELFAHFIQPAAQKTPTS(ph)PLK_,S116,,,,,,27.86,,,27.06,,,,,,27.46, , , , ,0.40, , ,-0.40, , , , , ,"nucleosome positioning;double-strand break repair;DNA-dependent transcription, initiation;CENP-A containing nucleosome assembly at centromere;chromatin silencing at rDNA;regulation of transcription from RNA polymerase II promoter;embryo development",nucleoplasm;condensed chromosome;nucleolus;RSF complex;NURF complex;chromatin silencing complex,,,,,,,,,,,,,,
526,O60269,GPRIN2,G protein-regulated inducer of neurite outgrowth 2 (GRIN2),APASEDSLSVEGR,_APASEDS(ph)LS(ph)VEGR_,S427,,23.53,,,,,,,,,,,,,23.53,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
527,O60269,GPRIN2,G protein-regulated inducer of neurite outgrowth 2 (GRIN2),ASEDSLSVEGRRG,_APASEDS(ph)LS(ph)VEGR_,S429,,23.92,,,,,,,,,,,,,23.92,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
528,O60271,SPAG9,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),RNVSTGSAENEEK,_NVSTGS(ph)AENEEK_,S332,+,20.88,,,24.62,,,20.39,22.05,,,20.87,22.59,19.40,21.54,-0.66, , ,3.07, , ,-1.16,0.51, , ,-0.67,1.05,-2.14,"positive regulation of muscle cell differentiation;activation of JUN kinase activity;negative regulation of protein homodimerization activity;striated muscle cell differentiation;spermatogenesis;positive regulation of cell migration;positive regulation of neuron differentiation;protein homooligomerization;retrograde transport, endosome to Golgi;muscle cell differentiation",cytosol;acrosomal vesicle;integral to membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
530,O60271,SPAG9,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),SKQRSASQSSLDK,_SAS(ph)QSS(ph)LDKLDQELKEQQK_,S730,,21.00,,,,24.53,,,23.60,,,,,,23.04,-2.05, , , ,1.49, , ,0.56, , , , , ,"positive regulation of muscle cell differentiation;activation of JUN kinase activity;negative regulation of protein homodimerization activity;striated muscle cell differentiation;spermatogenesis;positive regulation of cell migration;positive regulation of neuron differentiation;protein homooligomerization;retrograde transport, endosome to Golgi;muscle cell differentiation",cytosol;acrosomal vesicle;integral to membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
532,O60271,SPAG9,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),RSASQSSLDKLDQ,_SASQSS(ph)LDKLDQELK_,S733,+,,22.95,22.95,20.76,25.66,25.80,23.76,24.78,,17.77,25.04,22.96,24.50,23.36, ,-0.41,-0.41,-2.59,2.30,2.44,0.40,1.42, ,-5.59,1.68,-0.40,1.14,"positive regulation of muscle cell differentiation;activation of JUN kinase activity;negative regulation of protein homodimerization activity;striated muscle cell differentiation;spermatogenesis;positive regulation of cell migration;positive regulation of neuron differentiation;protein homooligomerization;retrograde transport, endosome to Golgi;muscle cell differentiation",cytosol;acrosomal vesicle;integral to membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
536,O60292,SIPA1L3,Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3),QDGWPRSPGRAFL,_DVEFQDGWPRS(ph)PGR_,S158,+,21.07,,,,,,23.13,22.51,23.27,22.50,,,21.76,22.37,-1.31, , , , , ,0.76,0.13,0.90,0.12, , ,-0.61,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
537,O60292,SIPA1L3,Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3),DRRREVSPAPAVA,_EVS(ph)PAPAVAGQSK_,S1364,+,24.17,24.48,24.63,24.43,23.87,22.53,23.35,23.52,24.09,23.74,,,23.02,23.80,0.37,0.68,0.83,0.63,0.07,-1.27,-0.45,-0.28,0.28,-0.06, , ,-0.78,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
539,O60292,SIPA1L3,Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3),GLQRTLSDESLCS,_TLS(ph)DESLCSGR_,S1544,,22.53,,,,23.50,23.44,,,,,,,23.48,23.24,-0.71, , , ,0.26,0.20, , , , , , ,0.24,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
541,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),PASSGLSPKEEGE,_(ac)ATADTPAPASSGLS(ph)PK_,S15,+,24.86,24.94,,24.83,22.98,,23.89,22.89,24.21,24.82,,,,24.18,0.68,0.76, ,0.65,-1.20, ,-0.29,-1.28,0.03,0.64, , , ,RNA processing,intracellular,,,,,,,,,,,,,,
542,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),LEDGEISDDDNNS,_EEGELEDGEIS(ph)DDDNNSQIR_,S28,,23.60,,,,,,,,,22.93,,,,23.27,0.34, , , , , , , , ,-0.34, , , ,RNA processing,intracellular,,,,,,,,,,,,,,
543,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),ISDNSFSSDEEQS,_KPISDNSFS(ph)S(ph)DEEQSTGPIK_,S1303,,25.31,,,,,,,,23.89,23.47,,,,24.22,1.09, , , , , , , ,-0.34,-0.75, , , ,RNA processing,intracellular,,,,,,,,,,,,,,
544,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),SDNSFSSDEEQST,_KPISDNSFS(ph)S(ph)DEEQSTGPIK_,S1304,,25.31,,,,,,,,23.89,,,,,24.60,0.71, , , , , , , ,-0.71, , , , ,RNA processing,intracellular,,,,,,,,,,,,,,
545,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),MMRLDSSPVSSPR,_LDSS(ph)PVSSPR_,S949,,22.72,23.70,,24.16,23.63,,,21.55,,,,,,23.15,-0.43,0.54, ,1.01,0.48, , ,-1.60, , , , , ,RNA processing,intracellular,,,,,,,,,,,,,,
546,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),NLTRRISTSDILS,_RIS(ph)TSDILSEK_,S352,+,24.41,24.47,24.48,22.95,25.25,25.43,25.68,24.84,25.59,23.78,,24.19,24.88,24.66,-0.25,-0.19,-0.18,-1.72,0.59,0.77,1.02,0.18,0.93,-0.88, ,-0.47,0.21,RNA processing,intracellular,,,,,,,,,,,,,,
547,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),RRSRSKSSDPDLR,_S(ph)SDPDLRR_,S502,,23.06,23.06,18.81,,,,,,,,,22.66,,21.90,1.16,1.16,-3.08, , , , , , , , ,0.76, ,RNA processing,intracellular,,,,,,,,,,,,,,
548,O60318,MCM3AP,80 kDa MCM3-associated protein (Protein GANP),PGDGEVSPSTEDA,_KPGDGEVS(ph)PSTEDAPFQHSPLGK_,S153,,,,,,23.21,23.79,24.18,,,24.76,,,,23.99, , , , ,-0.77,-0.20,0.19, , ,0.77, , , ,protein import into nucleus;DNA replication,cytosol;nucleus,,,,,,,,,,,,,,
549,O60333,KIF1B,Kinesin-like protein KIF1B (Klp),WRPRGDSLILEHQ,_GDS(ph)LILEHQWELEK_,S1441,,21.01,,,,,,,,,,,,,21.01,0.00, , , , , , , , , , , , ,neuron-neuron synaptic transmission;mitochondrion transport along microtubule;apoptotic process;neuromuscular synaptic transmission;anterograde axon cargo transport,neuron projection;cytoplasmic vesicle membrane;mitochondrion;microtubule associated complex;microtubule,,,,,,,,,,,,,,
550,O60333,KIF1B,Kinesin-like protein KIF1B (Klp),MTRSGLSLEELRI,_SGLS(ph)LEELR_,S1011,+,23.54,23.53,23.24,24.07,,23.24,23.59,24.42,22.54,22.19,24.50,23.46,,23.48,0.06,0.05,-0.25,0.59, ,-0.24,0.10,0.93,-0.94,-1.29,1.02,-0.03, ,neuron-neuron synaptic transmission;mitochondrion transport along microtubule;apoptotic process;neuromuscular synaptic transmission;anterograde axon cargo transport,neuron projection;cytoplasmic vesicle membrane;mitochondrion;microtubule associated complex;microtubule,,,,,,,,,,,,,,
551,O60333,KIF1B,Kinesin-like protein KIF1B (Klp),RMRRQFSAPNLKA,_QFS(ph)APNLK_,S1141,,21.06,21.36,21.80,23.81,,,22.21,21.92,,,,23.80,22.51,22.31,-1.25,-0.95,-0.51,1.50, , ,-0.10,-0.38, , , ,1.49,0.20,neuron-neuron synaptic transmission;mitochondrion transport along microtubule;apoptotic process;neuromuscular synaptic transmission;anterograde axon cargo transport,neuron projection;cytoplasmic vesicle membrane;mitochondrion;microtubule associated complex;microtubule,,,,,,,,,,,,,,
552,O60341,KDM1A,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),ESLANLSEDEYYS,_EM(ox)DESLANLS(ph)EDEYYS(ph)EEER_,S131,,25.66,,,,24.52,24.29,22.66,23.39,24.28,,,,,24.14,1.53, , , ,0.39,0.15,-1.47,-0.74,0.15, , , , ,"negative regulation of apoptotic process;positive regulation of erythrocyte differentiation;granulocyte differentiation;negative regulation of DNA binding;regulation of primitive erythrocyte differentiation;negative regulation of histone H3-K4 methylation;blood coagulation;positive regulation of megakaryocyte differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of stem cell proliferation;pituitary gland development;muscle cell development;in utero embryonic development;positive regulation of sequence-specific DNA binding transcription factor activity;cell proliferation;negative regulation of protein binding;positive regulation of hormone biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;positive regulation of neural precursor cell proliferation",nuclear chromatin;transcription factor complex,,,,,,,,,,,,,,
553,O60341,KDM1A,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),SEDEYYSEEERNA,_EM(ox)DESLANLS(ph)EDEYYS(ph)EEER_,S137,,25.50,,,,,,,,,24.08,,,,24.79,0.71, , , , , , , , ,-0.71, , , ,"negative regulation of apoptotic process;positive regulation of erythrocyte differentiation;granulocyte differentiation;negative regulation of DNA binding;regulation of primitive erythrocyte differentiation;negative regulation of histone H3-K4 methylation;blood coagulation;positive regulation of megakaryocyte differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of stem cell proliferation;pituitary gland development;muscle cell development;in utero embryonic development;positive regulation of sequence-specific DNA binding transcription factor activity;cell proliferation;negative regulation of protein binding;positive regulation of hormone biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;positive regulation of neural precursor cell proliferation",nuclear chromatin;transcription factor complex,,,,,,,,,,,,,,
554,O60341,KDM1A,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),PEEENESEPEEPS,_KLPPPPPQAPPEEENES(ph)EPEEPSGVEGAAFQSR_,S166,+,24.86,,,,26.39,25.95,,26.28,26.29,26.73,,24.48,25.16,25.77,-0.91, , , ,0.62,0.18, ,0.52,0.52,0.96, ,-1.29,-0.60,"negative regulation of apoptotic process;positive regulation of erythrocyte differentiation;granulocyte differentiation;negative regulation of DNA binding;regulation of primitive erythrocyte differentiation;negative regulation of histone H3-K4 methylation;blood coagulation;positive regulation of megakaryocyte differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of stem cell proliferation;pituitary gland development;muscle cell development;in utero embryonic development;positive regulation of sequence-specific DNA binding transcription factor activity;cell proliferation;negative regulation of protein binding;positive regulation of hormone biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;positive regulation of neural precursor cell proliferation",nuclear chromatin;transcription factor complex,,,,,,,,,,,,,,
555,O60341,KDM1A,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),GVPAQQSPSM___,_QATPGVPAQQS(ph)PSM(ox)_,S849,+,,,,23.41,24.04,24.59,,24.16,24.06,24.32,,,24.27,24.12, , , ,-0.71,-0.09,0.47, ,0.03,-0.06,0.20, , ,0.15,"negative regulation of apoptotic process;positive regulation of erythrocyte differentiation;granulocyte differentiation;negative regulation of DNA binding;regulation of primitive erythrocyte differentiation;negative regulation of histone H3-K4 methylation;blood coagulation;positive regulation of megakaryocyte differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter;negative regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of stem cell proliferation;pituitary gland development;muscle cell development;in utero embryonic development;positive regulation of sequence-specific DNA binding transcription factor activity;cell proliferation;negative regulation of protein binding;positive regulation of hormone biosynthetic process;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;positive regulation of neural precursor cell proliferation",nuclear chromatin;transcription factor complex,,,,,,,,,,,,,,
556,O60343,TBC1D4,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),MRGRLGSVDSFER,_LGS(ph)VDS(ph)FER_,S588,+,23.42,,,24.18,21.80,22.79,,22.18,23.05,21.11,22.26,25.84,23.16,22.98,0.44, , ,1.20,-1.18,-0.19, ,-0.80,0.07,-1.87,-0.72,2.86,0.18,positive regulation of Rab GTPase activity;vesicle-mediated transport;cellular response to insulin stimulus,cytoplasm,,,,,,,,,,,,,,
557,O60343,TBC1D4,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),RLGSVDSFERSNS,_LGS(ph)VDS(ph)FER_,S591,,21.91,21.11,,24.44,,,,,,,21.91,24.75,22.01,22.69,-0.78,-1.58, ,1.75, , , , , , ,-0.78,2.07,-0.68,positive regulation of Rab GTPase activity;vesicle-mediated transport;cellular response to insulin stimulus,cytoplasm,,,,,,,,,,,,,,
558,O60344,ECE2,Endothelin-converting enzyme 2 (ECE-2) [Includes: Methyltransferase-like region (EC 2.1.1.-);Endothelin-converting enzyme 2 region (EC 3.4.24.71)],____MASPGAGRA,_(ac)AS(ph)PGAGRAPPELPER_,S3,,23.72,,,22.30,24.11,23.25,23.50,24.24,,,22.87,23.15,,23.39,0.33, , ,-1.10,0.72,-0.14,0.11,0.85, , ,-0.52,-0.24, ,proteolysis;brain development;cardioblast differentiation;peptide hormone processing;cell-cell signaling,cytoplasmic vesicle membrane;integral to membrane;Golgi membrane,,,,,,,,,,,,,,
559,O60353,FZD6,Frizzled-6 (Fz-6) (hFz6),RSEGRISPKSDIT,_SEGRIS(ph)PK_,S598,,19.05,20.39,21.11,22.20,,,,,,,,,,20.69,-1.64,-0.30,0.42,1.51, , , , , , , , , ,"non-canonical Wnt receptor signaling pathway;G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger;angiogenesis;platelet activation;negative regulation of canonical Wnt receptor signaling pathway;gonad development;neural tube closure;cell proliferation in midbrain;axonogenesis;hair follicle development;establishment of planar polarity;negative regulation of sequence-specific DNA binding transcription factor activity;inner ear morphogenesis;Wnt receptor signaling pathway, planar cell polarity pathway",apical part of cell;neuron projection membrane;integral to plasma membrane;cytoplasm;apicolateral plasma membrane,,,,,,,,,,,,,,
560,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),TKEEVASLRAKLS,_EEVAS(ph)LR_,S1308,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
561,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),RNKGKYSPTVQTR,_GKYS(ph)PTVQTR_,S14,,25.53,23.82,22.59,,,,19.25,,19.45,22.24,,,,22.15,3.38,1.67,0.44, , , ,-2.89, ,-2.70,0.09, , , ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
562,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),LFYRLWSLERTAH,_LWS(ph)LER_,S1612,,23.07,,,,,,,,,,,,,23.07,0.00, , , , , , , , , , , , ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
563,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),____MNSLFRKRN,_(ac)MNS(ph)LFRK_,S3,,26.57,22.68,20.15,20.70,,,21.47,,,,,22.43,,22.33,4.24,0.35,-2.19,-1.63, , ,-0.87, , , , ,0.10, ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
564,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),NQGPQESVVRKEV,_NQGPQES(ph)VVRK_,S929,,25.91,,,,,,,,,,,,,25.91,0.00, , , , , , , , , , , , ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
565,O60437,PPL,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),QRNRPDSGVEEAW,_NRPDS(ph)GVEEAWK_,S885,+,24.84,24.95,25.61,,22.54,23.12,23.70,23.47,22.10,25.23,,24.27,,23.98,0.85,0.97,1.63, ,-1.44,-0.86,-0.28,-0.51,-1.89,1.25, ,0.29, ,keratinization,mitochondrion;plasma membrane;nucleus;cytoskeleton;desmosome,,,,,,,,,,,,,,
566,O60447,EVI5,Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein),QLNKSDSNQYIGE,_SDS(ph)NQYIGELK_,S689,,19.82,21.36,21.51,23.02,,,24.10,,21.73,,22.48,23.08,,22.14,-2.32,-0.78,-0.63,0.88, , ,1.96, ,-0.41, ,0.34,0.94, ,positive regulation of Rab GTPase activity;multicellular organismal development;cell proliferation;cell cycle;cell division,nucleus;spindle;microtubule organizing center,,,,,,,,,,,,,,
569,O60499,STX10,Syntaxin-10 (Syn10),AAQKSPSDLLDAS,_SPS(ph)DLLDASAVSATSR_,S103,,23.46,19.45,19.45,,,,,22.67,21.81,23.77,,,,21.77,1.69,-2.32,-2.32, , , , ,0.90,0.04,2.00, , , ,"intracellular protein transport;Golgi vesicle transport;retrograde transport, endosome to Golgi",integral to membrane;Golgi membrane,,,,,,,,,,,,,,
570,O60502,MGEA5,Bifunctional protein NCOAT (Meningioma-expressed antigen 5) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) [Includes: Protein O-GlcNAcase (EC 3.2.1.169) (Glycoside hydrolase O-GlcNAcase) (Hexosaminidase C) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (O-GlcNAcase) (OGA);Histone acetyltransferase (HAT) (EC 2.3.1.48)],KLENEGSDEDIET,_LENEGS(ph)DEDIETDVLYSPQM(ox)ALK_,S364,,25.98,,,,23.30,,,,,,,,,24.64,1.34, , , ,-1.34, , , , , , , , ,aging;positive regulation of mitochondrial depolarization;positive regulation of DNA metabolic process;positive regulation of growth hormone secretion;glycoprotein catabolic process;positive regulation of glucose import;protein targeting to membrane;positive regulation of proteolysis;necrotic cell death;negative regulation of cardiac muscle adaptation;positive regulation of insulin secretion;negative regulation of protein glycosylation;N-acetylglucosamine metabolic process;dATP metabolic process;response to steroid hormone stimulus;positive regulation of protein complex disassembly;positive regulation of calcium ion transport into cytosol;positive regulation of cell killing,nucleus;cytoplasm,,,,,,,,,,,,,,
571,O60504,SORBS3,Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3),_MADGGSPFLGRR,_(ac)ADGGS(ph)PFLGRR_,S6,,26.87,25.09,25.09,26.53,27.28,27.04,26.71,26.45,27.60,25.79,25.25,27.05,26.57,26.41,0.47,-1.32,-1.32,0.12,0.87,0.63,0.30,0.04,1.20,-0.62,-1.16,0.64,0.16,cell-substrate adhesion;negative regulation of transcription from RNA polymerase II promoter;cell adhesion;positive regulation of stress fiber assembly;positive regulation of MAPK cascade;muscle contraction,cytosol;nucleus;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
572,O60504,SORBS3,Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3),GPQLPTSPRLTAA,_LRLCDDGPQLPTS(ph)PR_,S127,+,26.15,25.19,,27.52,25.39,25.19,27.60,26.59,27.21,24.86,26.42,26.89,24.44,26.12,0.03,-0.93, ,1.40,-0.73,-0.93,1.48,0.47,1.09,-1.26,0.30,0.77,-1.68,cell-substrate adhesion;negative regulation of transcription from RNA polymerase II promoter;cell adhesion;positive regulation of stress fiber assembly;positive regulation of MAPK cascade;muscle contraction,cytosol;nucleus;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
573,O60508,CDC40,Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17),LMHLTKSPSSKPS,_S(ph)PSSKPSLAVAVDSAPEVAVK_,S43,,,22.47,22.47,,,,,,22.97,23.15,,21.83,,22.58, ,-0.11,-0.11, , , , , ,0.39,0.58, ,-0.75, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,,,,,,,,,,
574,O60524,NEMF,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),ELIQEESSEDEGE,_DELNEELIQEES(ph)S(ph)EDEGEYEEVRK_,S705,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,nuclear export,nucleus;cytoplasm,,,,,,,,,,,,,,
575,O60524,NEMF,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),LIQEESSEDEGEY,_DELNEELIQEES(ph)S(ph)EDEGEYEEVRK_,S706,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,nuclear export,nucleus;cytoplasm,,,,,,,,,,,,,,
576,O60524,NEMF,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),KKKKLPSDSGDLE,_KLPS(ph)DSGDLEALEGK_,S789,+,24.52,23.70,24.38,22.30,,22.42,25.75,24.64,23.11,25.21,25.41,25.12,24.72,24.27,0.24,-0.57,0.11,-1.98, ,-1.85,1.47,0.37,-1.16,0.94,1.13,0.85,0.45,nuclear export,nucleus;cytoplasm,,,,,,,,,,,,,,
578,O60524,NEMF,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),RNPYLLSEEEDDD,_NPYLLS(ph)EEEDDDVDGDVNVEK_,S375,+,23.53,,,,25.29,22.61,24.86,24.66,23.93,24.56,25.13,,24.56,24.35,-0.81, , , ,0.94,-1.74,0.51,0.32,-0.42,0.21,0.78, ,0.21,nuclear export,nucleus;cytoplasm,,,,,,,,,,,,,,
580,O60551,NMT2,Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase),CRYWHRSLNPRKL,_YWHRS(ph)LNPR_,S220,,,26.22,25.71,25.79,25.63,27.23,26.80,26.51,26.84,26.10,26.65,26.23,27.03,26.39, ,-0.18,-0.68,-0.60,-0.77,0.83,0.41,0.11,0.45,-0.30,0.25,-0.17,0.64,egress of virus within host cell;N-terminal protein myristoylation;protein lipoylation,cytosol;Golgi apparatus;plasma membrane,,,,,,,,,,,,,,
581,O60563,CCNT1,Cyclin-T1 (CycT1) (Cyclin-T),AADKHNSVEDSVT,_HNS(ph)VEDSVTK_,S495,+,24.58,,,,,21.74,21.35,21.33,22.24,21.18,,,20.64,21.86,2.71, , , , ,-0.13,-0.52,-0.54,0.38,-0.68, , ,-1.23,transcription initiation from RNA polymerase II promoter;protein phosphorylation;transforming growth factor beta receptor signaling pathway;regulation of cyclin-dependent protein kinase activity;viral reproduction;cell cycle;cell division;transcription elongation from RNA polymerase II promoter;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription,positive transcription elongation factor complex b,,,,,,,,,,,,,,
584,O60583,CCNT2,Cyclin-T2 (CycT2),SSSSVTSPIKMKI,_QGQSQAASSSSVTS(ph)PIK_,S305,+,24.38,24.50,24.79,24.48,23.91,24.88,24.47,23.99,25.33,25.86,22.61,23.23,23.99,24.34,0.04,0.15,0.45,0.14,-0.43,0.54,0.13,-0.35,0.99,1.51,-1.73,-1.11,-0.35,transcription initiation from RNA polymerase II promoter;transforming growth factor beta receptor signaling pathway;regulation of cyclin-dependent protein kinase activity;viral reproduction;cell cycle;cell division;transcription elongation from RNA polymerase II promoter;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm,,,,,,,,,,,,,,
585,O60613,SEL,15 kDa selenoprotein,LKWNTDSVEEFLS,_WNTDS(ph)VEEFLSEK_,S150,,22.25,,,,,,,,,,,,,22.25,0.00, , , , , , , , , , , , ,'de novo' posttranslational protein folding,endoplasmic reticulum lumen,,,,,,,,,,,,,,
586,O60658,PDE8A,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.17)",DGLRRLSGNEYVL,_RLS(ph)GNEYVLSTK_,S411,+,,22.02,,21.78,23.83,24.74,23.25,23.27,23.88,21.83,22.84,22.65,23.18,23.02, ,-1.00, ,-1.24,0.80,1.71,0.23,0.24,0.85,-1.19,-0.19,-0.38,0.16,"regulation of transcription, DNA-dependent;cAMP catabolic process;intracellular signal transduction;cyclic nucleotide metabolic process",cytosol,,,,,,,,,,,,,,
588,O60664,PLIN3,Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17),LVSSKVSGAQEMV,_ELVSSKVS(ph)GAQEM(ox)VSSAK_,S130,,24.85,24.53,25.14,,,,22.66,,,,24.84,,,24.41,0.44,0.13,0.74, , , ,-1.74, , , ,0.43, , ,vesicle-mediated transport,endosome;endosome membrane;lipid particle;Golgi apparatus,,,,,,,,,,,,,,
589,O60664,PLIN3,Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17),YFVRLGSLSERLR,_LGS(ph)LSER_,S241,,26.46,,,23.20,,,,,,,,,,24.83,1.63, , ,-1.63, , , , , , , , , ,vesicle-mediated transport,endosome;endosome membrane;lipid particle;Golgi apparatus,,,,,,,,,,,,,,
590,O60673,REV3L,DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3),SKLGFLSERSTSP,_LGFLS(ph)ER_,S1036,,22.64,20.00,20.00,,20.92,21.11,,20.35,,,,,,20.84,1.80,-0.84,-0.84, ,0.09,0.27, ,-0.48, , , , , ,translesion synthesis;DNA-dependent DNA replication,zeta DNA polymerase complex;chromosome;nucleus,,,,,,,,,,,,,,
593,O60684,KPNA6,Importin subunit alpha-7 (Karyopherin subunit alpha-6),_METMASPGKDNY,_(ac)M(ox)ETM(ox)AS(ph)PGKDNYR_,S6,,,,,,25.92,24.71,,26.08,,,,,22.64,24.84, , , , ,1.08,-0.13, ,1.25, , , , ,-2.20,NLS-bearing substrate import into nucleus,nucleus;cytoplasm,,,,,,,,,,,,,,
594,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),AQHERGSLASLDS,_GS(ph)LAS(ph)LDSLRK_,S346,,24.03,,,,,,,,,22.49,,,,23.26,0.77, , , , , , , , ,-0.77, , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
595,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),ERGSLASLDSLRK,_GSLAS(ph)LDS(ph)LRK_,S349,+,29.25,25.79,23.96,26.68,27.45,28.37,27.04,27.10,27.84,27.69,26.54,26.69,27.79,27.09,2.16,-1.30,-3.13,-0.41,0.36,1.28,-0.05,0.01,0.75,0.59,-0.55,-0.41,0.70,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
596,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),SLASLDSLRKGGP,_GSLAS(ph)LDS(ph)LRK_,S352,+,29.54,25.76,25.34,25.02,27.12,27.24,26.27,25.89,25.46,27.64,23.62,27.34,27.04,26.41,3.14,-0.65,-1.07,-1.39,0.72,0.83,-0.14,-0.51,-0.95,1.23,-2.78,0.94,0.63,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
599,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),KEGWKKSDFQVNL,_S(ph)DFQVNLNNASR_,S841,,,22.66,,22.88,,22.54,,,24.82,25.40,,,,23.66, ,-1.00, ,-0.78, ,-1.12, , ,1.16,1.74, , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
600,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),VNLNNASRSQSSH,_SDFQVNLNNAS(ph)R_,S851,,25.02,21.86,21.86,22.60,20.96,,,,,,,,,22.46,2.56,-0.60,-0.60,0.14,-1.50, , , , , , , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
601,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),NRTLDRSGDLGDM,_S(ph)GDLGDM(ox)EPLK_,S914,+,26.27,25.73,25.43,26.18,25.76,27.22,26.94,25.88,27.26,27.03,26.31,25.25,25.98,26.25,0.02,-0.52,-0.82,-0.07,-0.49,0.97,0.69,-0.37,1.01,0.78,0.06,-1.00,-0.27,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
602,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),MGSNTKSLDNNYS,_S(ph)LDNNYSTPNER_,S893,,24.81,24.52,,24.42,,,,,,,,,,24.58,0.23,-0.06, ,-0.17, , , , , , , , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
603,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),LEDDQRSMGYDDL,_S(ph)M(ox)GYDDLDYGM(ox)M(ox)SDYGTAR_,S288,+,25.87,21.26,,22.87,22.32,23.07,,23.47,,,,,22.79,23.09,2.78,-1.83, ,-0.22,-0.77,-0.03, ,0.38, , , , ,-0.30,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
605,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),NASRSQSSHSYDD,_SQS(ph)SHS(ph)YDDSTLPLIDR_,S855,,26.40,,,,,,,,,,,,,26.40,0.00, , , , , , , , , , , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
607,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),RSQSSHSYDDSTL,_SQS(ph)SHS(ph)YDDSTLPLIDR_,S858,+,25.66,23.35,,22.76,26.10,25.81,,24.56,,26.14,25.95,,25.15,25.05,0.60,-1.70, ,-2.29,1.04,0.76, ,-0.49, ,1.09,0.90, ,0.10,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
608,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),QVRVGGSSVDLHR,_VGGS(ph)S(ph)VDLHR_,S268,+,28.03,25.92,23.21,26.90,25.75,25.63,24.71,25.15,25.48,,24.41,26.18,24.74,25.51,2.52,0.41,-2.30,1.39,0.24,0.12,-0.80,-0.36,-0.02, ,-1.10,0.67,-0.77,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
609,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),VRVGGSSVDLHRF,_VGGS(ph)S(ph)VDLHR_,S269,+,26.71,25.47,22.51,25.14,22.95,,,21.75,,,,,20.81,23.62,3.09,1.85,-1.11,1.52,-0.66, , ,-1.87, , , , ,-2.81,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
610,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),LERVRVSPQDANP,_VRVS(ph)PQDANPLM(ox)ANGTLTR_,S47,,,,,,22.94,23.31,23.43,23.60,22.63,,,,,23.18, , , , ,-0.24,0.13,0.25,0.42,-0.55, , , , ,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
611,O60749,SNX2,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),ALSRALSQLAEVE,_ALS(ph)QLAEVEEK_,S365,,21.15,19.86,,,,,,,,,,,,20.50,0.64,-0.64, , , , , , , , , , , ,intracellular protein transport;endocytosis;cell communication,endosome membrane;early endosome membrane,,,,,,,,,,,,,,
612,O60749,SNX2,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),IESKSMSAPVIFD,_SM(ox)S(ph)APVIFDR_,S119,+,24.39,23.42,23.83,21.61,,21.54,,,,,22.83,23.81,,23.06,1.33,0.36,0.77,-1.45, ,-1.53, , , , ,-0.23,0.75, ,intracellular protein transport;endocytosis;cell communication,endosome membrane;early endosome membrane,,,,,,,,,,,,,,
613,O60749,SNX2,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),KVGKEDSSSTEFV,_VGKEDS(ph)SSTEFVEK_,S226,,25.26,,,,,,,,,,,,,25.26,0.00, , , , , , , , , , , , ,intracellular protein transport;endocytosis;cell communication,endosome membrane;early endosome membrane,,,,,,,,,,,,,,
615,O60762,DPM1,Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) (Dolichol-phosphate mannose synthase) (DPM synthase) (Dolichyl-phosphate beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase),MASLEVSRSPRRS,_(ac)ASLEVS(ph)RSPRR_,S7,+,,28.01,28.01,27.46,28.64,,,28.71,28.78,28.65,28.72,28.69,29.56,28.52, ,-0.51,-0.51,-1.06,0.11, , ,0.19,0.26,0.13,0.20,0.16,1.04,dolichol-linked oligosaccharide biosynthetic process;C-terminal protein lipidation;GPI anchor biosynthetic process;GDP-mannose metabolic process;protein N-linked glycosylation via asparagine;dolichol metabolic process;protein O-linked mannosylation,dolichol-phosphate-mannose synthase complex;endoplasmic reticulum membrane,,,,,,,,,,,,,,
616,O60762,DPM1,Dolichol-phosphate mannosyltransferase (EC 2.4.1.83) (Dolichol-phosphate mannose synthase) (DPM synthase) (Dolichyl-phosphate beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase),SLEVSRSPRRSRR,_(ac)ASLEVSRS(ph)PR_,S9,+,29.93,31.66,31.80,30.58,31.27,32.05,31.37,31.27,30.93,31.40,31.21,30.93,31.01,31.19,-1.26,0.47,0.62,-0.61,0.09,0.87,0.18,0.09,-0.26,0.21,0.03,-0.25,-0.18,dolichol-linked oligosaccharide biosynthetic process;C-terminal protein lipidation;GPI anchor biosynthetic process;GDP-mannose metabolic process;protein N-linked glycosylation via asparagine;dolichol metabolic process;protein O-linked mannosylation,dolichol-phosphate-mannose synthase complex;endoplasmic reticulum membrane,,,,,,,,,,,,,,
617,O60763,USO1,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),AVRALKSLSKKYR,_ALKS(ph)LSK_,S48,,,24.85,24.85,,,,,,,,,,,24.85, ,0.00,0.00, , , , , , , , , , ,intracellular protein transport;vesicle fusion with Golgi apparatus,cytosol;Golgi membrane,,,,,,,,,,,,,,
618,O60763,USO1,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),EEDELESGDQEDE,_LKDLGHPVEEEDELES(ph)GDQEDEDDESEDPGKDLDHI_,S942,+,28.36,23.98,23.98,23.72,30.07,27.72,28.94,26.01,30.14,29.78,27.27,28.45,27.21,27.36,1.00,-3.37,-3.37,-3.63,2.72,0.36,1.58,-1.35,2.78,2.43,-0.08,1.09,-0.15,intracellular protein transport;vesicle fusion with Golgi apparatus,cytosol;Golgi membrane,,,,,,,,,,,,,,
619,O60763,USO1,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),EDEDDESEDPGKD,_DLGHPVEEEDELES(ph)GDQEDEDDES(ph)EDPGK_,S952,,23.42,,,,,,,,,,,,,23.42,0.00, , , , , , , , , , , , ,intracellular protein transport;vesicle fusion with Golgi apparatus,cytosol;Golgi membrane,,,,,,,,,,,,,,
622,O60784,TOM1,Target of Myb protein 1,VRAGLQSLEASGR,_AGLQS(ph)LEASGR_,S355,+,24.89,23.62,23.12,25.10,,22.12,,21.70,,,22.14,22.40,,23.14,1.76,0.48,-0.02,1.97, ,-1.02, ,-1.44, , ,-1.00,-0.73, ,intracellular protein transport;endocytosis;protein transport;endosomal transport,cytosol;membrane;early endosome,,,,,,,,,,,,,,
623,O60784,TOM1,Target of Myb protein 1,LQSLEASGRLEDE,_AGLQSLEAS(ph)GR_,S359,,21.54,,,22.79,,,,,,,,,,22.16,-0.62, , ,0.62, , , , , , , , , ,intracellular protein transport;endocytosis;protein transport;endosomal transport,cytosol;membrane;early endosome,,,,,,,,,,,,,,
624,O60784,TOM1,Target of Myb protein 1,TDLDMLSPIHTPQ,_GLEFPM(ox)TDLDM(ox)LS(ph)PIHT(ph)PQR_,S160,+,23.78,21.66,,,,,22.63,23.35,22.48,24.69,25.06,22.98,,23.33,0.45,-1.67, , , , ,-0.70,0.02,-0.84,1.36,1.73,-0.34, ,intracellular protein transport;endocytosis;protein transport;endosomal transport,cytosol;membrane;early endosome,,,,,,,,,,,,,,
625,O60825,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105);Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",VRMRRNSFTPLSS,_NS(ph)FTPLSSSNTIR_,S433,+,23.19,23.71,24.15,,,,,22.90,23.74,20.10,,24.16,22.08,23.00,0.19,0.71,1.15, , , , ,-0.11,0.74,-2.91, ,1.16,-0.92,"positive regulation of glucokinase activity;small molecule metabolic process;fructose 2,6-bisphosphate metabolic process;positive regulation of insulin secretion;response to glucose stimulus;lactate metabolic process;pyruvate metabolic process;glycolysis;fructose metabolic process",cytosol,,,,,,,,,,,,,,
626,O60825,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105);Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",RRPRNYSVGSRPL,_NYS(ph)VGSRPLKPLS(ph)PLR_,S450,,22.83,21.16,,,,,,,,,,,,22.00,0.83,-0.83, , , , , , , , , , , ,"positive regulation of glucokinase activity;small molecule metabolic process;fructose 2,6-bisphosphate metabolic process;positive regulation of insulin secretion;response to glucose stimulus;lactate metabolic process;pyruvate metabolic process;glycolysis;fructose metabolic process",cytosol,,,,,,,,,,,,,,
627,O60825,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105);Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",RPLKPLSPLRAQD,_NYS(ph)VGSRPLKPLS(ph)PLR_,S460,,22.83,21.16,,,,,,,,,,,,22.00,0.83,-0.83, , , , , , , , , , , ,"positive regulation of glucokinase activity;small molecule metabolic process;fructose 2,6-bisphosphate metabolic process;positive regulation of insulin secretion;response to glucose stimulus;lactate metabolic process;pyruvate metabolic process;glycolysis;fructose metabolic process",cytosol,,,,,,,,,,,,,,
628,O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),AKAGLESGAEPGD,_AGLES(ph)GAEPGDGDSDTTK_,S485,+,24.90,24.68,24.68,26.29,23.05,24.23,24.88,24.46,,24.60,,,24.14,24.59,0.30,0.09,0.09,1.70,-1.54,-0.36,0.29,-0.13, ,0.01, , ,-0.45,cell proliferation;telomere maintenance via telomerase;pseudouridine synthesis;rRNA processing,nucleoplasm;nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
629,O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),EPGDGDSDTTKKK,_AKAGLESGAEPGDGDS(ph)DTTK_,S494,+,29.18,28.78,29.71,29.52,29.57,29.93,27.59,29.52,30.46,30.31,28.44,28.51,26.56,29.08,0.09,-0.30,0.63,0.44,0.49,0.84,-1.49,0.44,1.38,1.23,-0.64,-0.58,-2.53,cell proliferation;telomere maintenance via telomerase;pseudouridine synthesis;rRNA processing,nucleoplasm;nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
630,O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),KEVELVSE_____,_EVELVS(ph)E_,S513,+,29.46,28.38,28.81,29.32,31.18,30.14,29.95,29.99,29.36,29.90,27.69,28.23,29.00,29.34,0.12,-0.96,-0.53,-0.02,1.84,0.80,0.61,0.65,0.02,0.56,-1.65,-1.11,-0.34,cell proliferation;telomere maintenance via telomerase;pseudouridine synthesis;rRNA processing,nucleoplasm;nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
631,O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),AKRKRESESESDE,_RES(ph)ES(ph)ESDETPPAAPQLIK_,S451,,23.03,,,,,23.75,,,,,,,,23.39,-0.36, , , , ,0.36, , , , , , , ,cell proliferation;telomere maintenance via telomerase;pseudouridine synthesis;rRNA processing,nucleoplasm;nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
632,O60832,DKC1,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),RKRESESESDETP,_RES(ph)ES(ph)ESDETPPAAPQLIK_,S453,,24.41,,,,24.63,25.51,,22.10,22.44,24.62,,,,23.95,0.46, , , ,0.68,1.56, ,-1.85,-1.52,0.67, , , ,cell proliferation;telomere maintenance via telomerase;pseudouridine synthesis;rRNA processing,nucleoplasm;nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
633,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),DWEAMASDEETEK,_EETPPPVEPEEEEDTEDAGLDDWEAM(ox)AS(ph)DEETEK_,S511,,25.97,,,,,,,,,,,,,25.97,0.00, , , , , , , , , , , , ,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
635,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),EPIPGESPKMFGR,_IEPIPGES(ph)PK_,S1168,+,24.11,24.68,24.64,24.69,22.85,23.30,24.95,23.32,23.32,23.61,23.79,24.46,23.42,23.93,0.17,0.74,0.70,0.76,-1.08,-0.64,1.02,-0.61,-0.61,-0.32,-0.14,0.53,-0.52,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
637,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),GESGDESDEFLQS,_INSSGESGDES(ph)DEFLQSRK_,S190,,24.44,,,,,,,,,25.61,23.53,,,24.52,-0.09, , , , , , , , ,1.08,-1.00, , ,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
638,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),QKGKKQSFDDNDS,_KQS(ph)FDDNDS(ph)EELEDK_,S107,,27.57,25.66,25.66,24.41,,,24.84,,24.86,25.06,,,,25.44,2.13,0.23,0.23,-1.03, , ,-0.60, ,-0.58,-0.38, , , ,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
639,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),SFDDNDSEELEDK,_QSFDDNDS(ph)EELEDKDSK_,S113,+,29.16,28.06,28.31,28.13,29.58,29.25,29.52,29.84,28.84,29.23,28.30,27.67,27.91,28.75,0.40,-0.69,-0.45,-0.62,0.83,0.50,0.77,1.08,0.09,0.47,-0.45,-1.09,-0.85,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
641,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),PGPNIESGNEDDD,_PGPNIES(ph)GNEDDDASFK_,S214,+,29.56,30.09,30.24,30.17,30.06,30.16,31.70,31.11,30.07,29.58,29.73,28.88,29.50,30.07,-0.51,0.02,0.18,0.10,0.00,0.10,1.64,1.04,0.01,-0.48,-0.33,-1.18,-0.57,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
642,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),PKVEMYSGSDDDD,_VEM(ox)YS(ph)GS(ph)DDDDDFNK_,S135,+,28.63,25.62,25.62,24.29,27.04,27.19,26.35,25.19,26.66,27.56,26.27,,25.83,26.35,2.28,-0.74,-0.74,-2.06,0.69,0.83,0.00,-1.16,0.31,1.21,-0.09, ,-0.52,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
643,O60841,EIF5B,Eukaryotic translation initiation factor 5B (eIF-5B) (Translation initiation factor IF-2),VEMYSGSDDDDDF,_VEM(ox)YS(ph)GS(ph)DDDDDFNK_,S137,+,29.12,25.61,26.11,,28.15,26.18,26.31,27.20,22.45,28.25,24.29,24.80,26.41,26.24,2.88,-0.63,-0.13, ,1.91,-0.06,0.07,0.96,-3.79,2.01,-1.95,-1.44,0.17,regulation of translational initiation;GTP catabolic process,cytosol,,,,,,,,,,,,,,
645,O60885,BRD4,Bromodomain-containing protein 4 (Protein HUNK1),EPVVAVSSPAVPP,_M(ox)PDEPEEPVVAVS(ph)SPAVPPPTK_,S469,+,,24.81,25.45,24.54,24.66,25.63,26.62,,25.52,26.67,24.27,24.92,24.98,25.28, ,-0.47,0.17,-0.74,-0.62,0.35,1.34, ,0.24,1.39,-1.01,-0.36,-0.30,histone H4-K12 acetylation;chromosome segregation;protein phosphorylation;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of DNA binding;histone H3-K14 acetylation;positive regulation of G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;regulation of transcription involved in G1 phase of mitotic cell cycle;virus-host interaction,nuclear chromatin;condensed nuclear chromosome;cytoplasm,,+,,,,,,,,,,,,
646,O60885,BRD4,Bromodomain-containing protein 4 (Protein HUNK1),PVVAVSSPAVPPP,_M(ox)PDEPEEPVVAVSS(ph)PAVPPPTK_,S470,+,24.97,24.68,,24.81,25.53,26.71,25.04,,26.80,,22.25,24.92,24.98,25.07,-0.10,-0.39, ,-0.26,0.46,1.64,-0.03, ,1.73, ,-2.82,-0.15,-0.08,histone H4-K12 acetylation;chromosome segregation;protein phosphorylation;positive regulation of transcription elongation from RNA polymerase II promoter;positive regulation of DNA binding;histone H3-K14 acetylation;positive regulation of G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;regulation of transcription involved in G1 phase of mitotic cell cycle;virus-host interaction,nuclear chromatin;condensed nuclear chromosome;cytoplasm,,+,,,,,,,,,,,,
648,O60930,RNASEH1,Ribonuclease H1 (RNase H1) (EC 3.1.26.4) (Ribonuclease H type II),FVRKSASPEVSEG,_SAS(ph)PEVSEGHENQHGQESEAK_,S76,,21.62,23.28,23.92,22.95,,,21.46,22.24,21.46,20.18,,,,22.14,-0.52,1.14,1.78,0.81, , ,-0.68,0.11,-0.68,-1.96, , , ,mitochondrial DNA replication;RNA catabolic process,mitochondrion;nucleus,,,,,,,,,,,,,,
649,O60934,NBN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1),IPNYQLSPTKLPS,_IPNYQLS(ph)PTK_,S432,+,24.91,23.03,,23.15,25.02,25.02,24.38,24.13,24.30,23.24,21.88,,23.74,23.89,1.02,-0.86, ,-0.74,1.13,1.13,0.49,0.24,0.41,-0.65,-2.01, ,-0.15,"positive regulation of protein autophosphorylation;positive regulation of kinase activity;mitotic cell cycle G1/S transition checkpoint;response to drug;neuromuscular process controlling balance;isotype switching;regulation of DNA-dependent DNA replication initiation;negative regulation of neuron differentiation;cell cycle arrest;positive regulation of cell proliferation;apoptotic process;telomere maintenance;mitotic cell cycle G2/M transition DNA damage checkpoint;double-strand break repair via homologous recombination;regulation of fibroblast proliferation;blastocyst growth;DNA damage response, signal transduction by p53 class mediator;DNA duplex unwinding;cell proliferation;meiosis","nucleoplasm;nucleolus;replication fork;nuclear chromosome, telomeric region;nuclear inclusion body;Mre11 complex",,,,,,,,,,,,,,
650,O60934,NBN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1),TPGPSLSQGVSVD,_TTTPGPSLS(ph)QGVSVDEK_,S343,,23.27,,,,,,,,,,,,,23.27,0.00, , , , , , , , , , , , ,"positive regulation of protein autophosphorylation;positive regulation of kinase activity;mitotic cell cycle G1/S transition checkpoint;response to drug;neuromuscular process controlling balance;isotype switching;regulation of DNA-dependent DNA replication initiation;negative regulation of neuron differentiation;cell cycle arrest;positive regulation of cell proliferation;apoptotic process;telomere maintenance;mitotic cell cycle G2/M transition DNA damage checkpoint;double-strand break repair via homologous recombination;regulation of fibroblast proliferation;blastocyst growth;DNA damage response, signal transduction by p53 class mediator;DNA duplex unwinding;cell proliferation;meiosis","nucleoplasm;nucleolus;replication fork;nuclear chromosome, telomeric region;nuclear inclusion body;Mre11 complex",,,,,,,,,,,,,,
651,O60934,NBN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1),SLSQGVSVDEKLM,_TTTPGPSLSQGVS(ph)VDEK_,S347,,23.07,,,,,,,,,,,,,23.07,0.00, , , , , , , , , , , , ,"positive regulation of protein autophosphorylation;positive regulation of kinase activity;mitotic cell cycle G1/S transition checkpoint;response to drug;neuromuscular process controlling balance;isotype switching;regulation of DNA-dependent DNA replication initiation;negative regulation of neuron differentiation;cell cycle arrest;positive regulation of cell proliferation;apoptotic process;telomere maintenance;mitotic cell cycle G2/M transition DNA damage checkpoint;double-strand break repair via homologous recombination;regulation of fibroblast proliferation;blastocyst growth;DNA damage response, signal transduction by p53 class mediator;DNA duplex unwinding;cell proliferation;meiosis","nucleoplasm;nucleolus;replication fork;nuclear chromosome, telomeric region;nuclear inclusion body;Mre11 complex",,,,,,,,,,,,,,
652,O60941,DTNB,Dystrobrevin beta (DTN-B) (Beta-dystrobrevin),LVKELHSAEEGAE,_ELHS(ph)AEEGAEEEEEK_,S571,,,,,,,23.14,22.49,21.78,23.38,23.71,,,21.61,22.68, , , , , ,0.45,-0.19,-0.91,0.70,1.02, , ,-1.07,,synapse;cytoplasm,,,,,,,,,,,,,,
654,O75022,LILRB3,Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a),GLLRRSSPAADVQ,_RSS(ph)PAADVQEENLYAAVK_,S503,,,23.90,23.90,,,,,,,,,,,23.90, ,0.00,0.00, , , , , , , , , , ,negative regulation of osteoclast differentiation;defense response;cell surface receptor signaling pathway,integral to plasma membrane,,,,,,,,,,,,,,
655,O75044,SRGAP2,SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34),SVKSTVSETFMSK,_STVS(ph)ETFM(ox)SKPSIAK_,S426,,,23.72,24.02,23.45,23.52,,,23.06,,,,,,23.55, ,0.17,0.46,-0.10,-0.04, , ,-0.49, , , , , ,small GTPase mediated signal transduction;lamellipodium assembly involved in ameboidal cell migration;dendritic spine development;axon guidance;negative regulation of neuron migration;actin filament severing;filopodium assembly;substrate adhesion-dependent cell spreading;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,postsynaptic density;phagocytic vesicle;cytosol;cell junction;nucleus;plasma membrane;lamellipodium;postsynaptic membrane,,,,,,,,,,,,,,
656,O75044,SRGAP2,SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34),PVVAPTSEPSSPL,_TSPVVAPTS(ph)EPS(ph)SPLHTQLLK_,S989,,22.86,,,,,,,,,,,,,22.86,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;lamellipodium assembly involved in ameboidal cell migration;dendritic spine development;axon guidance;negative regulation of neuron migration;actin filament severing;filopodium assembly;substrate adhesion-dependent cell spreading;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,postsynaptic density;phagocytic vesicle;cytosol;cell junction;nucleus;plasma membrane;lamellipodium;postsynaptic membrane,,,,,,,,,,,,,,
658,O75051,PLXNA2,Plexin-A2 (Semaphorin receptor OCT),SFRYTGSPDSLRS,_YTGS(ph)PDSLR_,S1630,+,,21.13,,23.67,23.75,23.73,22.83,23.00,23.93,,20.52,,23.34,22.88, ,-1.75, ,0.79,0.87,0.85,-0.04,0.12,1.05, ,-2.36, ,0.46,regulation of cell migration;somitogenesis;cerebellar granule cell precursor tangential migration;pharyngeal system development;centrosome localization;axon guidance;neural tube development;limb bud formation,intracellular;semaphorin receptor complex;integral to plasma membrane,,,,,,,,,,,,,,
660,O75128,COBL,Protein cordon-bleu,ETFRKSSLGNDET,_KSS(ph)LGNDETDK_,S102,,19.89,25.19,26.10,,,19.28,,,20.93,20.45,,,,21.97,-2.08,3.22,4.12, , ,-2.69, , ,-1.04,-1.53, , , ,notochord development;embryonic axis specification;digestive tract development;actin filament polymerization;liver development;neural tube closure;positive regulation of dendrite development;floor plate development;actin filament network formation;somite specification;collateral sprouting in absence of injury,neuronal cell body;cell cortex;plasma membrane;dendritic growth cone;axonal growth cone;ruffle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
661,O75128,COBL,Protein cordon-bleu,ADPKPISPQQKSA,_LQADPKPIS(ph)PQQK_,S707,,19.93,25.27,25.27,,,,,,,24.52,,,,23.75,-3.82,1.53,1.53, , , , , , ,0.77, , , ,notochord development;embryonic axis specification;digestive tract development;actin filament polymerization;liver development;neural tube closure;positive regulation of dendrite development;floor plate development;actin filament network formation;somite specification;collateral sprouting in absence of injury,neuronal cell body;cell cortex;plasma membrane;dendritic growth cone;axonal growth cone;ruffle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
662,O75151,PHF2,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),APKRDLSFLLDKK,_DLS(ph)FLLDK_,S705,,20.68,,,,,,,,,,,,,20.68,0.00, , , , , , , , , , , , ,"negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;liver development",nucleolus,,,,,,,,,,,,,,
663,O75151,PHF2,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),VYPSLESDEDNPI,_DSDYVYPSLES(ph)DEDNPIFK_,S882,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,"negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;liver development",nucleolus,,,,,,,,,,,,,,
664,O75151,PHF2,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),EKEEPPSPIEATP,_EEPPS(ph)PIEATPPQSLLEK_,S474,+,24.31,24.45,24.45,24.86,,,27.06,,26.52,26.24,,24.22,,25.26,-0.95,-0.82,-0.82,-0.40, , ,1.80, ,1.25,0.98, ,-1.05, ,"negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;liver development",nucleolus,,,,,,,,,,,,,,
665,O75151,PHF2,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),KSRESASPTIPNL,_ESAS(ph)PTIPNLDLLEAHTK_,S539,,20.92,,,,24.61,,24.21,23.95,22.54,,,,,23.24,-2.33, , , ,1.36, ,0.96,0.70,-0.71, , , , ,"negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;liver development",nucleolus,,,,,,,,,,,,,,
666,O75151,PHF2,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),SDDAPYSPTARVG,_GSDDAPYS(ph)PTAR_,S905,+,21.40,,,24.25,22.90,24.00,23.16,,23.82,23.35,,,,23.27,-1.87, , ,0.98,-0.37,0.73,-0.11, ,0.55,0.08, , , ,"negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;liver development",nucleolus,,,,,,,,,,,,,,
668,O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A,SVQSNPSPQLRSV,_LSVQSNPS(ph)PQLR_,S78,+,22.86,,,22.73,23.28,22.71,23.12,22.35,23.03,22.97,,,22.45,22.83,0.02, , ,-0.10,0.45,-0.12,0.29,-0.49,0.20,0.14, , ,-0.38,,,,,,,,,,,,,,,,
669,O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A,MKTRRLSSASTGK,_RLS(ph)SAS(ph)TGKPPLSVEDDFEK_,S704,,24.06,,,,21.74,,,,,,,,,22.90,1.16, , , ,-1.16, , , , , , , , ,,,,,,,,,,,,,,,,
670,O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A,RRLSSASTGKPPL,_RLS(ph)SAS(ph)TGKPPLSVEDDFEK_,S707,,24.06,,,,21.74,,,,,,,,,22.90,1.16, , , ,-1.16, , , , , , , , ,,,,,,,,,,,,,,,,
673,O75152,ZC3H11A,Zinc finger CCCH domain-containing protein 11A,DDDDQFSEEGDET,_VESSENVPSPTHPPVVINAADDDEDDDDQFS(ph)EEGDETK_,S117,,25.51,,,,,,,,,26.42,,,,25.97,-0.45, , , , , , , , ,0.45, , , ,,,,,,,,,,,,,,,,
674,O75153,CLUH,Clustered mitochondria protein homolog,PGQEAGSEEEGSS,_SEDPPGQEAGS(ph)EEEGSSASGLAK_,S596,+,23.14,23.02,23.02,23.49,24.32,,,,,23.97,23.64,,,23.52,-0.37,-0.50,-0.50,-0.02,0.81, , , , ,0.45,0.13, , ,,cytoplasm,,,,,,,,,,,,,,
675,O75161,NPHP4,Nephrocystin-4 (Nephroretinin),FSNQPDSPISASQ,_IFSNQPDS(ph)PISASQDK_,S142,+,22.94,22.17,,22.64,,24.78,24.80,,,23.22,,23.56,,23.45,-0.50,-1.27, ,-0.81, ,1.34,1.35, , ,-0.23, ,0.12, ,cell-cell adhesion;retina development in camera-type eye;hippo signaling cascade;visual behavior;actin cytoskeleton organization,tight junction;cytosol;cell-cell junction;centrosome;microtubule basal body;cilium;membrane,,,,,,,,,,,,,,
677,O75167,PHACTR2,Phosphatase and actin regulator 2,KLVRRLSQRPTTE,_RLS(ph)QRPTTEELEQR_,S442,+,,,,,23.99,22.57,24.03,24.05,21.28,22.68,24.42,22.78,22.66,23.16, , , , ,0.83,-0.59,0.86,0.89,-1.88,-0.48,1.25,-0.38,-0.51,,,,,,,,,,,,,,,,
678,O75175,CNOT3,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),DSEVSQSPAKNGS,_RGRSTDSEVSQS(ph)PAK_,S299,+,19.41,23.90,23.90,,,19.56,20.04,21.84,19.61,19.65,20.22,,,20.90,-1.50,3.00,3.00, , ,-1.35,-0.86,0.94,-1.29,-1.26,-0.68, , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;nuclear-transcribed mRNA poly(A) tail shortening",cytosol;nucleus;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
680,O75179,ANKRD17,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),SSPSSPSPPAQPG,_EHYPVSSPSS(ph)PS(ph)PPAQPGGVSR_,S1796,,22.71,,,22.10,,,,,,,,,,22.40,0.31, , ,-0.31, , , , , , , , , ,virus-host interaction,nucleus;cytoplasm,,,,,,,,,,,,,,
682,O75179,ANKRD17,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),LDCGSASPNKVAS,_NSPLDCGSAS(ph)PNK_,S1816,,23.14,23.57,23.92,24.54,,,,,,,,,,23.79,-0.65,-0.22,0.13,0.75, , , , , , , , , ,virus-host interaction,nucleus;cytoplasm,,,,,,,,,,,,,,
683,O75179,ANKRD17,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),SNSSRKSDNHSPA,_S(ph)DNHSPAVVTTTVSSK_,S1384,+,22.77,24.51,24.51,23.30,,,23.38,,,23.12,23.09,23.88,,23.57,-0.80,0.94,0.94,-0.27, , ,-0.19, , ,-0.45,-0.48,0.31, ,virus-host interaction,nucleus;cytoplasm,,,,,,,,,,,,,,
687,O75362,ZNF217,Zinc finger protein 217,RRAGAESPTMSVD,_AGAES(ph)PTM(ox)SVDGR_,S407,,25.62,24.93,,22.59,,22.92,,21.01,,20.71,,,,22.96,2.65,1.97, ,-0.37, ,-0.05, ,-1.95, ,-2.25, , , ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",histone deacetylase complex,C2H2-type,,,,,,,,,,,,,
688,O75367,H2AFY,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),EVSKAASADSTTE,_AAS(ph)ADS(ph)TTEGTPADGFTVLSTK_,S169,,25.95,,,,,,,,,,,,,25.95,0.00, , , , , , , , , , , , ,dosage compensation;nucleosome assembly;chromatin modification,condensed chromosome;Barr body;nucleosome,,,,,,,,,,,,,,
689,O75367,H2AFY,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),KAASADSTTEGTP,_AASADS(ph)TTEGTPADGFTVLSTK_,S172,,26.38,23.65,23.65,,,,,,24.01,24.73,,,,24.49,1.89,-0.83,-0.83, , , , , ,-0.47,0.24, , , ,dosage compensation;nucleosome assembly;chromatin modification,condensed chromosome;Barr body;nucleosome,,,,,,,,,,,,,,
690,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),RTSRAPSVATVGS,_APS(ph)VATVGSICDLNLK_,S2138,+,23.27,24.50,,24.54,22.86,24.09,24.79,22.24,25.36,24.96,24.91,25.40,23.75,24.22,-0.95,0.27, ,0.32,-1.37,-0.14,0.57,-1.98,1.14,0.74,0.69,1.18,-0.47,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,,,,,,+,,,,
691,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),VYGRGLSEGRTFE,_GLS(ph)EGRTFEM(ox)SDFIVDTR_,S2044,+,,,,,24.15,22.99,,23.46,24.92,21.62,22.32,25.82,25.90,23.90, , , , ,0.25,-0.91, ,-0.44,1.02,-2.27,-1.58,1.92,2.01,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,,,,,,+,,,,
695,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),LDVTILSPSRKVV,_LDVTILS(ph)PSRK_,S983,,,21.13,21.13,,,,,,21.75,22.95,,22.60,,21.91, ,-0.78,-0.78, , , , , ,-0.16,1.04, ,0.68, ,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,,,,,,+,,,,
703,O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),EPEKPVSPPPVEQ,_(gl)QQQLEEEAAKPPEPEKPVS(ph)PPPVEQK_,S224,+,21.88,22.92,22.92,,23.78,24.30,24.02,23.66,24.53,24.52,22.99,23.92,,23.59,-1.71,-0.67,-0.67, ,0.19,0.71,0.43,0.08,0.95,0.94,-0.60,0.34, ,"cerebellum development;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;spindle assembly;definitive erythrocyte differentiation;transforming growth factor beta receptor signaling pathway;cholesterol homeostasis;negative regulation of phosphatidylinositol 3-kinase cascade;transcription initiation from RNA polymerase II promoter;regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;positive regulation of histone deacetylation;negative regulation of JNK cascade;Notch signaling pathway;regulation of fatty acid transport;circadian regulation of gene expression;thalamus development;chromatin modification;regulation of multicellular organism growth",spindle microtubule;nuclear chromatin;transcription factor complex;transcriptional repressor complex;perinuclear region of cytoplasm,Other TF domain,,,,,,,,,,,,,
704,O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),KQIKRESPPIRAF,_RES(ph)PPIRAFEGAITK_,S1322,,,21.31,21.31,,,22.45,,,23.48,23.48,,23.61,,22.61, ,-1.30,-1.30, , ,-0.16, , ,0.87,0.87, ,1.00, ,"cerebellum development;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;spindle assembly;definitive erythrocyte differentiation;transforming growth factor beta receptor signaling pathway;cholesterol homeostasis;negative regulation of phosphatidylinositol 3-kinase cascade;transcription initiation from RNA polymerase II promoter;regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;positive regulation of histone deacetylation;negative regulation of JNK cascade;Notch signaling pathway;regulation of fatty acid transport;circadian regulation of gene expression;thalamus development;chromatin modification;regulation of multicellular organism growth",spindle microtubule;nuclear chromatin;transcription factor complex;transcriptional repressor complex;perinuclear region of cytoplasm,Other TF domain,,,,,,,,,,,,,
705,O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),QRNDARSPGSISY,_S(ph)PGSISYLPSFFTK_,S2184,,,,,24.23,,,,,,,,,,24.23, , , ,0.00, , , , , , , , , ,"cerebellum development;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;spindle assembly;definitive erythrocyte differentiation;transforming growth factor beta receptor signaling pathway;cholesterol homeostasis;negative regulation of phosphatidylinositol 3-kinase cascade;transcription initiation from RNA polymerase II promoter;regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;positive regulation of histone deacetylation;negative regulation of JNK cascade;Notch signaling pathway;regulation of fatty acid transport;circadian regulation of gene expression;thalamus development;chromatin modification;regulation of multicellular organism growth",spindle microtubule;nuclear chromatin;transcription factor complex;transcriptional repressor complex;perinuclear region of cytoplasm,Other TF domain,,,,,,,,,,,,,
706,O75376,NCOR1,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),RPGSRVSPENLVD,_VS(ph)PENLVDK_,S2120,+,24.18,24.20,22.93,24.62,,23.14,23.40,23.16,22.76,,,,,23.55,0.63,0.65,-0.62,1.07, ,-0.41,-0.15,-0.39,-0.79, , , , ,"cerebellum development;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation;spindle assembly;definitive erythrocyte differentiation;transforming growth factor beta receptor signaling pathway;cholesterol homeostasis;negative regulation of phosphatidylinositol 3-kinase cascade;transcription initiation from RNA polymerase II promoter;regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;positive regulation of histone deacetylation;negative regulation of JNK cascade;Notch signaling pathway;regulation of fatty acid transport;circadian regulation of gene expression;thalamus development;chromatin modification;regulation of multicellular organism growth",spindle microtubule;nuclear chromatin;transcription factor complex;transcriptional repressor complex;perinuclear region of cytoplasm,Other TF domain,,,,,,,,,,,,,
707,O75379,VAMP4,Vesicle-associated membrane protein 4 (VAMP-4),NLLEDDSDEEEDF,_NLLEDDS(ph)DEEEDFFLR_,S30,,24.22,,,,23.54,,,,,24.17,,25.37,,24.33,-0.11, , , ,-0.78, , , , ,-0.15, ,1.05, ,vesicle-mediated transport,trans-Golgi network;endosome;integral to membrane;Golgi membrane;lysosome,,,,,,,,,,,,,,
708,O75381,PEX14,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),PGKEGHSPEGSTV,_EGHS(ph)PEGSTVTYHLLGPQEEGEGVVDVK_,S239,,,,,,,,,,25.01,25.78,25.22,,,25.34, , , , , , , , ,-0.33,0.45,-0.12, , ,"microtubule anchoring;negative regulation of protein homotetramerization;negative regulation of transcription, DNA-dependent;protein import into peroxisome matrix, substrate release;negative regulation of protein binding;peroxisome transport along microtubule;protein import into peroxisome matrix, translocation;negative regulation of sequence-specific DNA binding transcription factor activity;protein homooligomerization",integral to membrane;peroxisomal membrane;nucleus;protein complex,,,,,,,,,,,,,,
711,O75382,TRIM3,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),MAKREDSPGPEVQ,_REDS(ph)PGPEVQPM(ox)DK_,S7,+,,24.71,24.98,23.78,24.69,24.89,22.87,25.30,22.81,22.33,23.14,22.83,23.70,23.83, ,0.87,1.15,-0.05,0.85,1.05,-0.97,1.47,-1.03,-1.50,-0.70,-1.00,-0.14,protein transport;nervous system development,early endosome;cytoplasm,,,,,,,,,,,,,,
712,O75382,TRIM3,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),VKRRVKSPGGPGS,_S(ph)PGGPGSHVR_,S437,,19.28,21.76,22.30,22.05,,,,,,,19.41,18.20,,20.50,-1.22,1.26,1.80,1.55, , , , , , ,-1.09,-2.30, ,protein transport;nervous system development,early endosome;cytoplasm,,,,,,,,,,,,,,
713,O75385,ULK1,Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1),IERNLQSPTQFQT,_NLQS(ph)PTQFQTPR_,S450,,22.66,,,22.95,23.15,,22.65,,,,23.56,,23.62,23.10,-0.44, , ,-0.15,0.05, ,-0.45, , , ,0.47, ,0.52,neuron projection development;protein autophosphorylation;receptor internalization;Ras protein signal transduction;response to starvation;autophagic vacuole assembly;negative regulation of collateral sprouting;neuron projection regeneration;radial glia guided migration of cerebellar granule cell;axon extension;cerebellar granule cell differentiation;protein localization;positive regulation of macroautophagy;regulation of nerve growth factor receptor signaling pathway;cellular response to nutrient levels,pre-autophagosomal structure membrane;neuronal cell body;neuron projection;cytosol;cytoplasmic vesicle membrane;ULK1-ATG13-FIP200 complex;autophagic vacuole,,+,,,,,,,,,,,,
714,O75385,ULK1,Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1),LPPILGSPTKAVP,_NPLPPILGS(ph)PTK_,S623,+,24.40,21.66,20.34,23.66,24.11,24.37,24.09,24.52,24.28,22.63,25.35,23.89,25.46,23.75,0.65,-2.09,-3.41,-0.09,0.36,0.62,0.34,0.77,0.53,-1.12,1.60,0.13,1.71,neuron projection development;protein autophosphorylation;receptor internalization;Ras protein signal transduction;response to starvation;autophagic vacuole assembly;negative regulation of collateral sprouting;neuron projection regeneration;radial glia guided migration of cerebellar granule cell;axon extension;cerebellar granule cell differentiation;protein localization;positive regulation of macroautophagy;regulation of nerve growth factor receptor signaling pathway;cellular response to nutrient levels,pre-autophagosomal structure membrane;neuronal cell body;neuron projection;cytosol;cytoplasmic vesicle membrane;ULK1-ATG13-FIP200 complex;autophagic vacuole,,+,,,,,,,,,,,,
715,O75385,ULK1,Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1),DFPKTPSSQNLLA,_TPS(ph)SQNLLALLAR_,S638,+,24.19,22.66,22.66,24.09,,,23.46,,22.44,,,25.22,23.47,23.52,0.67,-0.86,-0.86,0.57, , ,-0.07, ,-1.08, , ,1.70,-0.06,neuron projection development;protein autophosphorylation;receptor internalization;Ras protein signal transduction;response to starvation;autophagic vacuole assembly;negative regulation of collateral sprouting;neuron projection regeneration;radial glia guided migration of cerebellar granule cell;axon extension;cerebellar granule cell differentiation;protein localization;positive regulation of macroautophagy;regulation of nerve growth factor receptor signaling pathway;cellular response to nutrient levels,pre-autophagosomal structure membrane;neuronal cell body;neuron projection;cytosol;cytoplasmic vesicle membrane;ULK1-ATG13-FIP200 complex;autophagic vacuole,,+,,,,,,,,,,,,
718,O75396,SEC22B,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),NNLSSLSKKYRQD,_ANNLSSLS(ph)K_,S177,,25.11,24.26,24.27,27.72,,,,,,,,23.84,,25.04,0.07,-0.78,-0.77,2.68, , , , , , , ,-1.20, ,protein transport;ER to Golgi vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;melanosome;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
719,O75396,SEC22B,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),QRGEALSALDSKA,_GEALS(ph)ALDSK_,S164,,20.03,22.34,,22.51,,,,,,,,,,21.63,-1.60,0.71, ,0.89, , , , , , , , , ,protein transport;ER to Golgi vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;melanosome;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
720,O75396,SEC22B,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),ALSALDSKANNLS,_GEALSALDS(ph)K_,S168,,23.15,24.03,,,,,,,,,,,,23.59,-0.44,0.44, , , , , , , , , , , ,protein transport;ER to Golgi vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;melanosome;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
721,O75396,SEC22B,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),ARRNLGSINTELQ,_NLGS(ph)INTELQDVQR_,S137,+,29.64,29.94,28.21,30.02,29.59,30.80,29.29,29.49,31.07,29.55,30.56,30.23,31.11,29.96,-0.33,-0.02,-1.75,0.06,-0.37,0.84,-0.67,-0.48,1.11,-0.41,0.60,0.27,1.15,protein transport;ER to Golgi vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;melanosome;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
722,O75398,DEAF1,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),LTPGPQSPPTPLA,_GPAAPLTPGPQS(ph)PPTPLAPGQEK_,S176,+,21.91,22.05,22.41,21.84,21.30,24.36,22.82,23.03,23.55,23.06,22.06,,,22.58,-0.67,-0.53,-0.17,-0.74,-1.28,1.78,0.24,0.45,0.97,0.48,-0.52, , ,embryonic skeletal system development;germ cell development;regulation of transcription from RNA polymerase II promoter;neural tube closure;transcription from RNA polymerase II promoter;regulation of mammary gland epithelial cell proliferation,transcription factor complex;extracellular region;nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
723,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),SGNWDTSGSELSE,_DSGNWDTS(ph)GSELS(ph)EGELEK_,S915,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,,,,,,+,,,,
724,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),NWDTSGSELSEGE,_DSGNWDTSGS(ph)ELS(ph)EGELEK_,S917,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,,,,,,+,,,,
725,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),TSGSELSEGELEK,_DSGNWDTSGS(ph)ELS(ph)EGELEK_,S920,,26.47,23.72,,,23.88,24.50,,,,,,,,24.64,1.83,-0.92, , ,-0.76,-0.14, , , , , , , ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,,,,,,+,,,,
726,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),KKRRHKSDSPESD,_HKS(ph)DS(ph)PES(ph)DAEREK_,S865,,25.21,23.45,23.98,22.61,,,20.89,19.17,,,,,,22.55,2.66,0.90,1.43,0.06, , ,-1.66,-3.38, , , , , ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,,,,,,+,,,,
729,O75410,TACC1,Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1),ELDENTSPLLGDA,_ASYHFSPEELDENTS(ph)PLLGDAR_,S292,,24.96,,,24.77,25.44,,,,24.73,,23.90,24.15,,24.66,0.30, , ,0.11,0.79, , , ,0.07, ,-0.76,-0.51, ,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;microtubule cytoskeleton organization;cell cycle;cell division;cerebral cortex development,microtubule cytoskeleton;intermediate filament cytoskeleton;nucleus;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
732,O75410,TACC1,Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1),DPEEEDSQAETKS,_GGAAGEDEAGGPEGDPEEEDS(ph)QAETK_,S60,,,,,,,,23.19,24.50,,22.92,,,,23.54, , , , , , ,-0.35,0.97, ,-0.61, , , ,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;microtubule cytoskeleton organization;cell cycle;cell division;cerebral cortex development,microtubule cytoskeleton;intermediate filament cytoskeleton;nucleus;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
733,O75420,GIGYF1,PERQ amino acid-rich with GYF domain-containing protein 1 (GRB10-interacting GYF protein 1),SCFYQRSIEEGDG,_S(ph)IEEGDGAFGR_,S137,,23.46,,,,,,,,,,,,,23.46,0.00, , , , , , , , , , , , ,insulin-like growth factor receptor signaling pathway,,,,,,,,,,,,,,,
734,O75420,GIGYF1,PERQ amino acid-rich with GYF domain-containing protein 1 (GRB10-interacting GYF protein 1),TMSRSLSVPDSGR,_SLS(ph)VPDSGR_,S638,+,21.10,24.82,,24.51,20.36,23.97,,23.43,,,21.65,,,22.84,-1.73,1.98, ,1.68,-2.47,1.13, ,0.59, , ,-1.18, , ,insulin-like growth factor receptor signaling pathway,,,,,,,,,,,,,,,
735,O75420,GIGYF1,PERQ amino acid-rich with GYF domain-containing protein 1 (GRB10-interacting GYF protein 1),PFAPGPSPPPLLG,_VPFAPGPS(ph)PPPLLGNM(ox)DQER_,S538,+,23.69,22.28,,21.69,21.48,,,23.10,,,23.43,,23.95,22.80,0.89,-0.52, ,-1.11,-1.32, , ,0.30, , ,0.63, ,1.15,insulin-like growth factor receptor signaling pathway,,,,,,,,,,,,,,,
738,O75427,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),FLFRSSSQSGSGP,_SSS(ph)QSGSGPS(ph)SPDSVLRPR_,S513,,23.38,,,,,,,,,,,,,23.38,0.00, , , , , , , , , , , , ,nervous system development,PML body,,,,,,,,,,,,,,
740,O75436,VPS26A,Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26),FHQRFESPESQAS,_FES(ph)PESQASAEQPEM(ox)_,S315,,,,,22.25,22.92,,,23.89,21.83,,22.58,,,22.69, , , ,-0.44,0.22, , ,1.19,-0.86, ,-0.12, , ,"vacuolar transport;retrograde transport, endosome to Golgi",endosome;cytosol;vesicle;endosome membrane;retromer complex,,,,,,,,,,,,,,
741,O75448,MED24,Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component) (ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4) (CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component) (Trap100) (hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component) (DRIP100),KLMRLLSSNEDDA,_LLS(ph)SNEDDANILSS(ph)PTDR_,S772,+,26.69,,,,24.81,25.89,,23.69,25.00,24.09,23.59,,,24.82,1.87, , , ,-0.01,1.07, ,-1.14,0.18,-0.74,-1.23, , ,"transcription initiation from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;protein heterooligomerization;androgen receptor signaling pathway",mediator complex,,,,,,,,,,,,,,
744,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),DHEEKASNEDVTK,_EDTDHEEKAS(ph)NEDVTK_,S129,,23.96,24.53,,23.73,,19.99,21.13,,22.82,,,,,22.69,1.27,1.84, ,1.03, ,-2.71,-1.56, ,0.12, , , , ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
745,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),VEEKETSVSKEDT,_ETS(ph)VSKEDTDHEEK_,S116,,,21.81,,,,,,,,,,,,21.81, ,0.00, , , , , , , , , , , ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
746,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),TKQSNASSDVEVE,_QSNAS(ph)SDVEVEEK_,S105,,28.15,28.47,28.47,29.28,,26.10,,,26.93,,,,,27.90,0.25,0.57,0.57,1.38, ,-1.80, , ,-0.97, , , , ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
747,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),KQSNASSDVEVEE,_(gl)QSNASS(ph)DVEVEEK_,S106,,28.82,27.94,27.09,29.24,24.58,27.81,28.98,27.72,28.29,27.23,26.29,27.31,26.94,27.56,1.27,0.38,-0.47,1.68,-2.98,0.26,1.43,0.16,0.73,-0.33,-1.27,-0.25,-0.61,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
748,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),TGVTSTSDSEEEG,_TGVTSTS(ph)DS(ph)EEEGDDQEGEK_,S273,,26.14,24.26,23.72,23.63,24.67,,24.03,24.02,25.31,23.81,,,21.34,24.09,2.05,0.17,-0.38,-0.46,0.58, ,-0.07,-0.07,1.22,-0.28, , ,-2.75,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
749,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),VTSTSDSEEEGDD,_TGVTSTS(ph)DS(ph)EEEGDDQEGEK_,S275,,26.25,23.80,,,24.00,25.62,23.05,22.51,24.60,,,,,24.26,1.99,-0.46, , ,-0.26,1.35,-1.22,-1.75,0.34, , , , ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
750,O75494,SRSF10,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",EGRNVYSSSRYDD,_NVYS(ph)SSR_,S106,+,24.16,23.69,22.01,25.07,24.31,25.29,24.11,25.28,25.21,22.80,23.85,23.50,,24.11,0.05,-0.41,-2.10,0.96,0.20,1.18,0.00,1.17,1.11,-1.31,-0.26,-0.60, ,"assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;cytoplasmic transport;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleoplasm;nuclear speck;cytoplasm,,,,,,,,,,,,,,
751,O75494,SRSF10,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",RRSRSRSFDYNYR,_S(ph)RS(ph)FDYNYRR_,S133,+,28.55,29.05,28.95,27.98,28.80,28.60,26.76,28.86,27.95,27.62,27.08,27.84,25.69,27.98,0.57,1.07,0.97,0.00,0.82,0.62,-1.22,0.88,-0.03,-0.36,-0.90,-0.14,-2.29,"assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;cytoplasmic transport;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleoplasm;nuclear speck;cytoplasm,,,,,,,,,,,,,,
752,O75494,SRSF10,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",ERRRSRSRSFDYN,_S(ph)RS(ph)FDYNYRR_,S131,+,27.87,26.74,27.20,26.79,27.41,24.73,26.12,25.64,26.25,25.46,23.11,,,26.12,1.75,0.62,1.08,0.67,1.29,-1.39,0.00,-0.48,0.13,-0.66,-3.01, , ,"assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;cytoplasmic transport;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleoplasm;nuclear speck;cytoplasm,,,,,,,,,,,,,,
753,O75494,SRSF10,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",RSRSWTSPKSSGH,_SWTS(ph)PK_,S255,+,22.76,24.94,22.84,26.20,21.36,21.48,,21.21,,21.18,,,,22.75,0.01,2.19,0.09,3.46,-1.38,-1.26, ,-1.54, ,-1.57, , , ,"assembly of spliceosomal tri-snRNP;negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;cytoplasmic transport;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleoplasm;nuclear speck;cytoplasm,,,,,,,,,,,,,,
755,O75509,TNFRSF21,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),LLTVEPSPQDKNK,_LENSALLTVEPS(ph)PQDK_,S231,+,24.68,22.67,22.67,23.42,,23.39,23.19,,24.04,25.22,,25.38,,23.85,0.83,-1.18,-1.18,-0.43, ,-0.46,-0.66, ,0.19,1.37, ,1.53, ,signal transduction;small molecule metabolic process;neuron apoptotic process;cellular lipid metabolic process,axon;integral to membrane;plasma membrane;cytoplasm,,,,,,,,,,,,,,
756,O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),VDESTLSPEEQKE,_LLVDVDESTLS(ph)PEEQK_,S488,,23.14,,,,,,24.29,23.31,23.90,24.15,,,,23.76,-0.62, , , , , ,0.53,-0.45,0.14,0.39, , , ,"anterior/posterior pattern specification;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,,+,,,
758,O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),RRTMIISPERLDP,_TM(ox)IIS(ph)PERLDPFADGGK_,S129,+,23.69,23.69,23.31,22.61,21.45,23.04,23.98,,26.09,24.85,24.82,25.66,24.93,24.01,-0.32,-0.32,-0.70,-1.40,-2.56,-0.97,-0.03, ,2.08,0.84,0.81,1.65,0.92,"anterior/posterior pattern specification;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,,+,,,
759,O75554,WBP4,WW domain-binding protein 4 (WBP-4) (Formin-binding protein 21) (WW domain-containing-binding protein 4),LGTLDESKSSDSH,_VNENSLGTLDES(ph)K_,S199,,,24.38,24.38,,,,23.07,,,23.03,,22.57,,23.49, ,0.90,0.90, , , ,-0.41, , ,-0.46, ,-0.92, ,"mRNA cis splicing, via spliceosome",nuclear speck;plasma membrane;spliceosomal complex,,,,,,,,,,,,,,
762,O75569,PRKRA,"Interferon-inducible double stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double stranded RNA-dependent activator)",TICRLESFMETGK,_LES(ph)FM(ox)ETGK_,S167,,24.96,23.27,23.27,,,,,,,,,,,23.83,1.13,-0.56,-0.56, , , , , , , , , , ,skeletal system morphogenesis;negative regulation of cell proliferation;response to virus;immune response;protein phosphorylation;middle ear morphogenesis;response to stress;production of siRNA involved in RNA interference;induction of apoptosis;outer ear morphogenesis,perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
764,O75592,MYCBP2,Probable E3 ubiquitin-protein ligase MYCBP2 (EC 6.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc),EKALLSSPEGEEK,_ALLS(ph)S(ph)PEGEEK_,S3894,,23.25,23.27,23.27,22.03,,,22.18,,,,,,,22.80,0.45,0.47,0.47,-0.77, , ,-0.62, , , , , , ,"branchiomotor neuron axon guidance;central nervous system projection neuron axonogenesis;regulation of protein localization;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of cytoskeleton organization;protein ubiquitination",microtubule cytoskeleton;axon;nucleus,,,,,,,,,,,,,,
765,O75592,MYCBP2,Probable E3 ubiquitin-protein ligase MYCBP2 (EC 6.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc),PRERSKSDSYTLD,_S(ph)DSYTLDPDTLRK_,S2833,,21.74,23.65,23.65,,23.68,,,,,23.25,,,,23.20,-1.46,0.46,0.46, ,0.48, , , , ,0.06, , , ,"branchiomotor neuron axon guidance;central nervous system projection neuron axonogenesis;regulation of protein localization;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of cytoskeleton organization;protein ubiquitination",microtubule cytoskeleton;axon;nucleus,,,,,,,,,,,,,,
767,O75592,MYCBP2,Probable E3 ubiquitin-protein ligase MYCBP2 (EC 6.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc),SHSRSLSPNHNTL,_S(ph)LS(ph)PNHNTLQTLK_,S2751,+,23.15,22.85,22.85,21.63,21.71,,22.98,22.65,,21.43,,22.31,,22.40,0.75,0.46,0.46,-0.77,-0.69, ,0.59,0.25, ,-0.97, ,-0.08, ,"branchiomotor neuron axon guidance;central nervous system projection neuron axonogenesis;regulation of protein localization;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of cytoskeleton organization;protein ubiquitination",microtubule cytoskeleton;axon;nucleus,,,,,,,,,,,,,,
770,O75592,MYCBP2,Probable E3 ubiquitin-protein ligase MYCBP2 (EC 6.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc),VFQRSYSVVASEY,_SYS(ph)VVASEYDK_,S3440,,24.63,,,20.72,,,,,,,,20.58,,21.98,2.65, , ,-1.25, , , , , , , ,-1.40, ,"branchiomotor neuron axon guidance;central nervous system projection neuron axonogenesis;regulation of protein localization;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of cytoskeleton organization;protein ubiquitination",microtubule cytoskeleton;axon;nucleus,,,,,,,,,,,,,,
771,O75592,MYCBP2,Probable E3 ubiquitin-protein ligase MYCBP2 (EC 6.3.2.-) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc),PRRRVNSGDTEVG,_VNS(ph)GDTEVGSSLLR_,S3467,,24.34,,,21.65,,,,,,,,,,23.00,1.34, , ,-1.34, , , , , , , , , ,"branchiomotor neuron axon guidance;central nervous system projection neuron axonogenesis;regulation of protein localization;transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of cytoskeleton organization;protein ubiquitination",microtubule cytoskeleton;axon;nucleus,,,,,,,,,,,,,,
773,O75643,SNRNP200,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),KPKPFGSEEQLLP,_PFGS(ph)EEQLLPVEK_,S457,,21.35,,,,,,,,22.20,,,,,21.78,-0.42, , , , , , , ,0.42, , , , ,cis assembly of pre-catalytic spliceosome,nucleoplasm;catalytic step 2 spliceosome;U5 snRNP,,,,,,,,,,+,,,,
774,O75665,OFD1,Oral-facial-digital syndrome 1 protein (Protein 71-7A),KNITSSSPERHIF,_NITSSS(ph)PERHIFGEDR_,S354,,,,,,23.56,22.77,22.48,23.18,,,,,23.46,23.09, , , , ,0.47,-0.32,-0.61,0.09, , , , ,0.37,G2/M transition of mitotic cell cycle;cilium axoneme assembly;cilium morphogenesis;epithelial cilium movement involved in determination of left/right asymmetry,cytosol;centriole;nucleus;microtubule basal body;cilium,,,,,,,,,,,,,,
776,O75674,TOM1L1,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),LLDLSPSPRMPRA,_EATNTTSEPSAPSQDLLDLSPS(ph)PR_,S246,+,24.06,,,23.89,24.80,,25.46,25.93,24.10,23.59,25.65,26.00,24.09,24.76,-0.70, , ,-0.87,0.04, ,0.70,1.17,-0.65,-1.17,0.90,1.25,-0.67,intracellular protein transport;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,endosome;cytosol;endosome membrane;Golgi stack;lysosome,,,,,,,,,,,,,,
777,O75676,RPS6KA4,Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB),RLEPVYSPPGSPP,_LEPVYS(ph)PPGS(ph)PPPGDPR_,S343,,24.09,,,,,,,,,,,,,24.09,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;inflammatory response;histone H3-S28 phosphorylation;negative regulation of cytokine production;positive regulation of NF-kappaB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of CREB transcription factor activity;axon guidance;interleukin-1-mediated signaling pathway;histone H3-S10 phosphorylation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of histone acetylation,nucleus;cytoplasm,,+,,,,,,,,,,,,
778,O75676,RPS6KA4,Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB),VYSPPGSPPPGDP,_LEPVYS(ph)PPGS(ph)PPPGDPR_,S347,+,24.90,22.55,,23.38,23.46,23.34,23.58,24.00,22.25,,,,,23.43,1.47,-0.88, ,-0.05,0.02,-0.09,0.14,0.57,-1.18, , , , ,intracellular protein kinase cascade;inflammatory response;histone H3-S28 phosphorylation;negative regulation of cytokine production;positive regulation of NF-kappaB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of CREB transcription factor activity;axon guidance;interleukin-1-mediated signaling pathway;histone H3-S10 phosphorylation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of histone acetylation,nucleus;cytoplasm,,+,,,,,,,,,,,,
781,O75683,SURF6,Surfeit locus protein 6,GSAKELSPAALEK,_ELS(ph)PAALEKR_,S138,+,26.02,26.84,26.70,27.67,27.80,28.05,28.86,27.14,27.07,26.67,,27.20,,27.27,-1.26,-0.43,-0.58,0.40,0.53,0.77,1.58,-0.13,-0.20,-0.60, ,-0.08, ,ribosome biogenesis,granular component;nucleoplasm part,,,,,,,,,,,,,,
782,O75691,UTP20,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),ADEKAESDGEEKE,_AES(ph)DGEEKEEVK_,S2601,,20.19,,,23.34,,,20.04,,20.64,,,,21.72,21.19,-0.99, , ,2.15, , ,-1.14, ,-0.55, , , ,0.54,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);negative regulation of cell proliferation;endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)","small-subunit processome;nucleoplasm;preribosome, small subunit precursor;nucleolus;cytoplasm;90S preribosome",,,,,,,,,,,,,,
784,O75694,NUP155,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),___MPSSLLGAAM,_PSS(ph)LLGAAM(ox)PASTSAAALQEALENAGR_,S4,,27.44,,,26.28,,,,26.06,27.27,25.77,,23.55,,26.06,1.38, , ,0.22, , , ,0.00,1.21,-0.29, ,-2.51, ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;nucleocytoplasmic transport;protein transport;viral reproduction;nuclear envelope organization;cytokine-mediated signaling pathway,nuclear membrane;nuclear envelope;nuclear pore,,,,,,,,,,,,,,
785,O75695,RP2,Protein XRP2,ERPKQYSWDQREK,_(gl)QYS(ph)WDQREK_,S28,,,23.21,23.21,22.32,,,22.59,,22.99,23.55,,,,22.98, ,0.23,0.23,-0.66, , ,-0.39, ,0.01,0.58, , , ,protein folding;UTP biosynthetic process;cell morphogenesis;visual perception;protein transport;GTP biosynthetic process;CTP biosynthetic process,plasma membrane;cilium;cytoplasm,,,,,,,,,,,,,,
786,O75717,WDHD1,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),GRPRQRSHILEDD,_(gl)QRS(ph)HILEDDENSVDISM(ox)LK_,S374,,20.21,,,,23.20,,23.83,21.58,,,,21.75,,22.11,-1.91, , , ,1.09, ,1.72,-0.53, , , ,-0.37, ,,nucleoplasm;cytoplasm,HMG-box,,,,,,,,,,,,,
787,O75717,WDHD1,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),LEDDENSVDISML,_SHILEDDENS(ph)VDISM(ox)LK_,S383,+,22.59,21.81,21.38,,24.44,22.91,24.77,23.77,24.87,25.08,22.06,23.78,,23.40,-0.81,-1.60,-2.03, ,1.03,-0.50,1.37,0.37,1.47,1.67,-1.35,0.38, ,,nucleoplasm;cytoplasm,HMG-box,,,,,,,,,,,,,
788,O75781,PALM,Paralemmin-1 (Paralemmin),ENAAAPSPVRAPA,_ENAAAPS(ph)PVRAPAPS(ph)PAK_,S116,,22.46,23.86,23.86,,,,,,,,,,,23.39,-0.93,0.47,0.47, , , , , , , , , , ,regulation of cell shape;protein targeting to plasma membrane;negative regulation of dopamine receptor signaling pathway;negative regulation of adenylate cyclase activity;cellular response to electrical stimulus;positive regulation of dendritic spine development;synapse maturation;positive regulation of filopodium assembly;cytoskeleton organization;cellular component movement,axon;dendritic spine;basolateral plasma membrane;cytoplasmic membrane-bounded vesicle;integral to plasma membrane;filopodium membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
789,O75781,PALM,Paralemmin-1 (Paralemmin),VRAPAPSPAKEER,_ENAAAPS(ph)PVRAPAPS(ph)PAK_,S124,+,23.86,25.44,26.24,22.42,,,23.77,,22.65,,25.47,24.78,24.03,24.30,-0.44,1.14,1.94,-1.88, , ,-0.53, ,-1.64, ,1.17,0.49,-0.27,regulation of cell shape;protein targeting to plasma membrane;negative regulation of dopamine receptor signaling pathway;negative regulation of adenylate cyclase activity;cellular response to electrical stimulus;positive regulation of dendritic spine development;synapse maturation;positive regulation of filopodium assembly;cytoskeleton organization;cellular component movement,axon;dendritic spine;basolateral plasma membrane;cytoplasmic membrane-bounded vesicle;integral to plasma membrane;filopodium membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
790,O75807,PPP1R15A,Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34) (Myeloid differentiation primary response protein MyD116 homolog),GQRAPLSPSLLIR,_APLS(ph)PSLLIR_,S101,,20.72,,,,,,,,,,,,,20.72,0.00, , , , , , , , , , , , ,transforming growth factor beta receptor signaling pathway;endoplasmic reticulum unfolded protein response;negative regulation of transforming growth factor beta receptor signaling pathway;cell cycle arrest;apoptotic process;response to DNA damage stimulus;regulation of translation,cytosol;endoplasmic reticulum,,,,,,,,,,,,,,
791,O75815,BCAR3,Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B),KSPRQNSPVTQDG,_QNS(ph)PVTQDGIQESPWQDR_,S83,,23.68,,,21.63,23.55,,22.05,23.97,,,,,,22.98,0.70, , ,-1.34,0.58, ,-0.93,0.99, , , , , ,signal transduction;small GTPase mediated signal transduction;response to drug,intracellular,,,,,,,,,,,,,,
792,O75815,BCAR3,Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B),PVFRTGSEPALSP,_TGS(ph)EPALSPAVVR_,S370,,22.87,,,20.92,,,,,,,22.65,,,22.15,0.72, , ,-1.22, , , , , , ,0.50, , ,signal transduction;small GTPase mediated signal transduction;response to drug,intracellular,,,,,,,,,,,,,,
793,O75821,EIF3G,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44),LATGDTSPEPELL,_GIPLATGDTS(ph)PEPELLPGAPLPPPK_,S42,+,30.78,27.20,27.46,28.20,29.61,27.94,29.98,30.43,28.72,30.47,30.39,29.06,30.29,29.27,1.51,-2.07,-1.81,-1.07,0.34,-1.33,0.71,1.16,-0.56,1.20,1.12,-0.21,1.02,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
794,O75822,EIF3J,Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35),AAAAGDSDSWDAD,_(ac)AAAAAAAGDS(ph)DSWDADAFSVEDPVRK_,S11,,26.38,,,,24.83,,,,,,,,,25.60,0.78, , , ,-0.78, , , , , , , , ,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
797,O75909,CCNK,Cyclin-K,ENKENSSPSVTSA,_ENSS(ph)PSVTSANLDHTK_,S9,,,,,,,,23.22,,24.11,23.81,22.19,,,23.33, , , , , , ,-0.11, ,0.78,0.48,-1.14, , ,"mitosis;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;cell division;transcription from RNA polymerase II promoter",,,,,,,,,,,,,,,
798,O75909,CCNK,Cyclin-K,QQPKKPSPQPSSP,_KPS(ph)PQPS(ph)SPR_,S324,,21.98,21.74,,23.34,,,,,,,,,,22.35,-0.37,-0.61, ,0.99, , , , , , , , , ,"mitosis;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;cell division;transcription from RNA polymerase II promoter",,,,,,,,,,,,,,,
802,O75955,FLOT1,Flotillin-1,TLVSSGSGTMGAA,_ITLVSSGS(ph)GTM(ox)GAAK_,S385,+,26.30,24.53,24.38,23.69,23.75,24.59,23.61,23.84,22.75,,,23.19,,24.06,2.23,0.47,0.31,-0.37,-0.31,0.53,-0.45,-0.22,-1.31, , ,-0.87, ,protein localization to plasma membrane;axonogenesis;regulation of Rho protein signal transduction,endosome;caveola;integral to membrane;sarcolemma;melanosome;flotillin complex;centriolar satellite,,,,,,,,,,,,,,
803,O75962,TRIO,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),PRAGAASPLNSPL,_AGAAS(ph)PLNS(ph)PLSSAVPSLGK_,S2142,+,25.11,20.37,20.71,23.14,,,23.98,,23.66,22.93,25.51,24.17,,23.29,1.83,-2.92,-2.57,-0.15, , ,0.69, ,0.38,-0.36,2.22,0.88, ,transmembrane receptor protein tyrosine phosphatase signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;axon guidance,cytosol,,+,,,,,,,,,,,,
804,O75962,TRIO,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),AASPLNSPLSSAV,_AGAAS(ph)PLNS(ph)PLSSAVPSLGK_,S2146,,24.90,,,,,,,,,,,,,24.90,0.00, , , , , , , , , , , , ,transmembrane receptor protein tyrosine phosphatase signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;axon guidance,cytosol,,+,,,,,,,,,,,,
807,O75970,MPDZ,Multiple PDZ domain protein (Multi-PDZ domain protein 1),SLPQLVSPIVSRS,_GSLPQLVS(ph)PIVSR_,S230,+,22.46,22.32,22.03,23.75,23.76,24.49,24.75,24.79,23.64,23.20,25.06,24.03,24.63,23.76,-1.30,-1.45,-1.73,-0.01,0.00,0.72,0.99,1.03,-0.12,-0.57,1.30,0.27,0.87,cell adhesion;virus-host interaction,apical plasma membrane;Schmidt-Lanterman incisure;postsynaptic density;cytoplasm;cytoplasmic vesicle;tight junction;postsynaptic membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
809,O75970,MPDZ,Multiple PDZ domain protein (Multi-PDZ domain protein 1),AKPLPLSPEEGYV,_PLPLS(ph)PEEGYVSAK_,S790,,,,,,,,,,22.66,24.59,24.54,,,23.93, , , , , , , , ,-1.27,0.66,0.61, , ,cell adhesion;virus-host interaction,apical plasma membrane;Schmidt-Lanterman incisure;postsynaptic density;cytoplasm;cytoplasmic vesicle;tight junction;postsynaptic membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
814,O76024,WFS1,Wolframin,RLNATASLEQERS,_LNATAS(ph)LEQER_,S32,,25.23,24.16,,23.18,,,,,,,22.04,,,23.65,1.58,0.51, ,-0.47, , , , , , ,-1.62, , ,ER-associated protein catabolic process;kidney development;renal water homeostasis;positive regulation of calcium ion transport;positive regulation of protein ubiquitination;glucose homeostasis;polyubiquitinated misfolded protein transport;negative regulation of sequence-specific DNA binding transcription factor activity;protein maturation by protein folding;positive regulation of proteolysis;protein stabilization;endoplasmic reticulum calcium ion homeostasis;sensory perception of sound;ER overload response;visual perception;activation of signaling protein activity involved in unfolded protein response;negative regulation of neuron apoptotic process;negative regulation of type B pancreatic cell apoptotic process;positive regulation of growth,integral to endoplasmic reticulum membrane;dendrite,,,,,,,,,,,,,,
815,O76024,WFS1,Wolframin,MLERLVSSESKNY,_M(ox)LERLVS(ph)SESK_,S235,,,25.32,25.32,,,,,,,24.78,,24.16,,24.90, ,0.43,0.43, , , , , , ,-0.11, ,-0.74, ,ER-associated protein catabolic process;kidney development;renal water homeostasis;positive regulation of calcium ion transport;positive regulation of protein ubiquitination;glucose homeostasis;polyubiquitinated misfolded protein transport;negative regulation of sequence-specific DNA binding transcription factor activity;protein maturation by protein folding;positive regulation of proteolysis;protein stabilization;endoplasmic reticulum calcium ion homeostasis;sensory perception of sound;ER overload response;visual perception;activation of signaling protein activity involved in unfolded protein response;negative regulation of neuron apoptotic process;negative regulation of type B pancreatic cell apoptotic process;positive regulation of growth,integral to endoplasmic reticulum membrane;dendrite,,,,,,,,,,,,,,
816,O76031,CLPX,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",SEEEYDSGVEEEG,_ESSEEEYDS(ph)GVEEEGWPR_,S617,,21.68,,,22.05,,,,,,,,,,21.86,-0.18, , ,0.18, , , , , , , , , ,protein folding;proteolysis involved in cellular protein catabolic process,mitochondrial nucleoid;mitochondrial inner membrane;mitochondrial endopeptidase Clp complex;nucleus,,,,,,,,,,,,,,
821,O76070,SNCG,Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR),VFKKGFSIAKEGV,_GFS(ph)IAK_,S9,,22.56,,,,,,,,,,,,,22.56,0.00, , , , , , , , , , , , ,synapse organization;regulation of neurotransmitter secretion;regulation of dopamine secretion;synaptic transmission;adult locomotory behavior,neuronal cell body;axon terminus;spindle;perinuclear region of cytoplasm;microtubule organizing center,,,,,,,,,,,,,,
824,O76094,SRP72,Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein),VSSPPTSPRPGSA,_TVSS(ph)PPTS(ph)PRPGSAATVSASTSNIIPPR_,S625,+,25.78,23.31,,25.67,25.12,,24.26,,,23.31,,25.05,,24.64,1.14,-1.33, ,1.03,0.48, ,-0.38, , ,-1.33, ,0.41, ,response to drug;translation;SRP-dependent cotranslational protein targeting to membrane,"cytosol;nucleolus;endoplasmic reticulum;plasma membrane;signal recognition particle, endoplasmic reticulum targeting",,,,,,,,,,,,,,
826,O94776,MTA2,Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex),PEAQSLSPYTTSA,_GHLSRPEAQSLS(ph)PYTTSANR_,S435,,,,,,23.71,23.70,,23.19,,,,,22.67,23.32, , , , ,0.39,0.38, ,-0.12, , , , ,-0.65,chromatin assembly or disassembly;negative regulation of transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,NuRD complex;transcription factor complex,,,,,,,,,,,,,,
827,O94782,USP1,Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1),EESSEISPEPKTE,_VEESSEIS(ph)PEPK_,S475,,25.65,26.17,26.17,23.30,,,24.99,,,24.67,,22.75,,24.81,0.84,1.36,1.36,-1.52, , ,0.18, , ,-0.14, ,-2.06, ,response to UV;DNA repair;regulation of DNA repair;monoubiquitinated protein deubiquitination;ubiquitin-dependent protein catabolic process,nucleoplasm,,,,,,,,,,,,,,
829,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),SQKASQSRPNSSA,_ASQS(ph)RPNS(ph)SALETLGGEK_,S450,,21.08,24.21,24.71,25.64,,,21.56,,,,,25.56,,23.79,-2.72,0.42,0.92,1.85, , ,-2.23, , , , ,1.77, ,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
830,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),SQSRPNSSALETL,_ASQSRPNS(ph)SALETLGGEK_,S454,+,21.08,25.18,25.40,25.93,24.36,25.01,25.97,26.26,24.12,24.80,26.69,24.81,24.42,24.93,-3.85,0.26,0.48,1.00,-0.57,0.08,1.05,1.34,-0.81,-0.12,1.76,-0.11,-0.50,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
831,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),QSRPNSSALETLG,_ASQSRPNS(ph)S(ph)ALETLGGEK_,S455,+,21.08,23.01,22.42,24.71,24.41,21.69,,23.24,24.90,,,,24.64,23.34,-2.27,-0.33,-0.93,1.37,1.07,-1.65, ,-0.11,1.56, , , ,1.29,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
832,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),LNKEMGSLSIKDP,_EM(ox)GS(ph)LSIKDPK_,S514,+,,26.08,26.08,23.86,,,23.74,,22.73,22.83,23.59,26.01,,24.36, ,1.71,1.71,-0.50, , ,-0.62, ,-1.64,-1.53,-0.78,1.64, ,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
833,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),RRILRLSTFEKRK,_ILRLS(ph)TFEK_,S13,+,20.83,22.17,23.03,,22.24,21.00,22.95,,22.30,21.65,23.85,25.12,22.41,22.51,-1.67,-0.34,0.53, ,-0.26,-1.51,0.45, ,-0.20,-0.85,1.34,2.61,-0.09,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
834,O94804,STK10,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),EQGGDLSPAANRS,_(gl)QVAEQGGDLS(ph)PAANRSQK_,S438,+,25.45,28.19,28.22,28.54,28.09,27.46,28.76,29.34,27.67,26.26,28.37,28.71,26.53,27.81,-2.36,0.38,0.40,0.72,0.27,-0.35,0.94,1.53,-0.14,-1.55,0.55,0.89,-1.28,protein autophosphorylation;cell cycle;lymphocyte aggregation;regulation of lymphocyte migration,plasma membrane,,+,,,,,,,,,,,,
836,O94806,PRKD3,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),KMRKRYSVDKSLS,_RYS(ph)VDK_,S829,,22.15,23.89,23.89,22.93,,,,19.66,18.11,,,20.17,,21.54,0.61,2.35,2.35,1.39, , , ,-1.88,-3.44, , ,-1.37, ,protein kinase C-activating G-protein coupled receptor signaling pathway;intracellular signal transduction,nucleus;membrane;cytoplasm,,+,,,,,,,,,,,,
837,O94806,PRKD3,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),EKSFRRSVVGTPA,_S(ph)VVGTPAYLAPEVLR_,S742,,25.35,,,24.95,,,,,,25.40,24.74,,,25.11,0.24, , ,-0.16, , , , , ,0.29,-0.37, , ,protein kinase C-activating G-protein coupled receptor signaling pathway;intracellular signal transduction,nucleus;membrane;cytoplasm,,+,,,,,,,,,,,,
838,O94806,PRKD3,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),DANRTISPSTSNN,_TIS(ph)PSTSNNIPLM(ox)R_,S397,,25.31,23.03,23.58,24.60,24.66,24.13,25.19,25.19,21.71,24.95,25.52,24.41,23.42,24.28,1.03,-1.25,-0.71,0.31,0.38,-0.16,0.90,0.91,-2.57,0.67,1.23,0.13,-0.87,protein kinase C-activating G-protein coupled receptor signaling pathway;intracellular signal transduction,nucleus;membrane;cytoplasm,,+,,,,,,,,,,,,
840,O94808,GFPT2,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2),RMKRLDSSACLHA,_RLDS(ph)SACLHAVGDK_,S244,+,,23.49,23.49,24.41,,,24.66,,23.04,,24.70,27.55,,24.48, ,-0.99,-0.99,-0.07, , ,0.19, ,-1.44, ,0.22,3.07, ,glutamine metabolic process;energy reserve metabolic process;post-translational protein modification;dolichol-linked oligosaccharide biosynthetic process;fructose 6-phosphate metabolic process;carbohydrate biosynthetic process;UDP-N-acetylglucosamine biosynthetic process;protein N-linked glycosylation via asparagine,cytosol,,,,,,,,,,,,,,
841,O94826,TOMM70A,Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit),TPEGRASPAPGSG,_AS(ph)PAPGSGHPEGPGAHLDMNSLDR_,S91,+,25.49,26.74,23.24,24.82,25.84,26.33,24.09,26.09,23.97,,25.70,22.22,25.27,24.98,0.51,1.75,-1.74,-0.16,0.86,1.35,-0.90,1.11,-1.02, ,0.72,-2.77,0.29,cellular protein metabolic process;protein targeting to mitochondrion,integral to membrane;mitochondrial outer membrane translocase complex,,,,,,,,,,,,,,
844,O94827,PLEKHG5,Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720),VPSPPPSPRLRRR,_APES(ph)PRVPSPPPS(ph)PR_,S911,+,,,,22.21,23.65,21.68,22.50,23.30,22.51,,,20.87,,22.39, , , ,-0.18,1.26,-0.70,0.11,0.91,0.12, , ,-1.52, ,positive regulation of I-kappaB kinase/NF-kappaB cascade;endothelial cell migration;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
845,O94842,TOX4,TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1),RLSTTPSPTSSLH,_LSTT(ph)PS(ph)PTSS(ph)LHEDGVEDFRR_,S106,,25.22,22.60,,,,,,23.13,,,24.51,,,23.86,1.36,-1.27, , , , , ,-0.74, , ,0.65, , ,,PTW/PP1 phosphatase complex;chromatin;nucleus,HMG-box,,,,,,,,,,,,,
846,O94842,TOX4,TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1),TPSPTSSLHEDGV,_LSTT(ph)PS(ph)PTSS(ph)LHEDGVEDFRR_,S110,,25.76,23.25,23.03,23.53,25.19,,,24.82,,,,,,24.26,1.49,-1.01,-1.23,-0.73,0.92, , ,0.56, , , , , ,,PTW/PP1 phosphatase complex;chromatin;nucleus,HMG-box,,,,,,,,,,,,,
848,O94854,KIAA0754,Uncharacterized protein KIAA0754,CEKVPFSPRTAEF,_VPFS(ph)PR_,S442,,22.46,22.84,22.84,,,,23.56,,22.69,,22.90,,22.77,22.87,-0.40,-0.02,-0.02, , , ,0.70, ,-0.18, ,0.03, ,-0.10,,,,,,,,,,,,,,,,
849,O94868,FCHSD2,FCH and double SH3 domains protein 2 (Carom) (SH3 multiple domains protein 3),MREIQISPSPKPH,_EIQIS(ph)PSPK_,S508,,22.87,,,23.37,,,,,,,22.15,,,22.80,0.07, , ,0.57, , , , , , ,-0.65, , ,,,,,,,,,,,,,,,,
850,O94874,UFL1,E3 UFM1-protein ligase 1 (EC 6.3.2.-) (LZAP-binding protein),GRKDDDSDDESQS,_GRKDDDS(ph)DDESQSSHTGK_,S458,,23.93,,,,,,,20.39,20.25,,,,,21.52,2.41, , , , , , ,-1.14,-1.27, , , , ,negative regulation of protein ubiquitination;protein ufmylation;negative regulation of NF-kappaB transcription factor activity,endoplasmic reticulum;nucleus,,,,,,,,,,,,,,
851,O94876,TMCC1,Transmembrane and coiled-coil domains protein 1,VISNFQSSPKYGS,_ALGVISNFQS(ph)SPK_,S89,,,23.61,19.07,23.36,,,,,25.87,25.98,25.11,,24.58,23.94, ,-0.33,-4.87,-0.58, , , , ,1.93,2.04,1.17, ,0.64,,integral to membrane,,,,,,,,,,,,,,
852,O94876,TMCC1,Transmembrane and coiled-coil domains protein 1,ISNFQSSPKYGSE,_ALGVISNFQSS(ph)PK_,S90,,25.75,24.90,24.90,,23.75,24.34,25.27,,,,,,,24.82,0.93,0.08,0.08, ,-1.07,-0.48,0.46, , , , , , ,,integral to membrane,,,,,,,,,,,,,,
853,O94876,TMCC1,Transmembrane and coiled-coil domains protein 1,IRNKFGSADNIPN,_NKFGS(ph)ADNIPNLKDSLEEGQVDDAGK_,S58,+,26.83,25.68,25.93,24.56,25.80,25.57,27.72,24.43,27.56,27.68,21.78,26.59,26.37,25.88,0.95,-0.21,0.05,-1.33,-0.08,-0.32,1.84,-1.45,1.68,1.80,-4.11,0.71,0.48,,integral to membrane,,,,,,,,,,,,,,
854,O94880,PHF14,PHD finger protein 14,EREKQLSPEAQAR,_(gl)QLS(ph)PEAQAR_,S530,+,21.28,20.18,20.18,,21.56,21.61,22.19,22.34,22.12,,,,,21.43,-0.15,-1.25,-1.25, ,0.13,0.17,0.76,0.91,0.68, , , , ,,,,,,,,,,,,,,,,
855,O94880,PHF14,PHD finger protein 14,TRGRKRSFVPEEE,_S(ph)FVPEEEK_,S835,+,26.61,25.58,26.34,25.37,,22.47,25.13,22.26,25.61,25.74,23.68,23.83,23.00,24.64,1.98,0.95,1.71,0.74, ,-2.17,0.49,-2.38,0.97,1.11,-0.96,-0.81,-1.64,,,,,,,,,,,,,,,,
856,O94880,PHF14,PHD finger protein 14,TLSQSKSNEDSLI,_S(ph)NEDS(ph)LILEK_,S298,,25.29,24.04,,23.61,,,,,25.74,25.14,,,,24.76,0.53,-0.73, ,-1.15, , , , ,0.97,0.38, , , ,,,,,,,,,,,,,,,,
857,O94880,PHF14,PHD finger protein 14,SKSNEDSLILEKS,_S(ph)NEDS(ph)LILEK_,S302,+,25.35,23.24,23.63,22.95,23.70,24.28,21.02,23.55,24.30,23.38,,,,23.54,1.81,-0.30,0.09,-0.59,0.16,0.74,-2.52,0.01,0.76,-0.16, , , ,,,,,,,,,,,,,,,,
860,O94885,SASH1,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),KLKAGGSVESLRS,_AGGS(ph)VESLR_,S488,,25.87,24.87,22.66,25.14,,,21.96,,,,,,,24.10,1.77,0.77,-1.44,1.04, , ,-2.14, , , , , , ,,,,,,,,,,,,,,,,
861,O94885,SASH1,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),YKEVIKSPTASRI,_EVIKS(ph)PTASR_,S423,,23.96,23.95,23.95,,,,,,,,,,,23.95,0.01,0.00,0.00, , , , , , , , , , ,,,,,,,,,,,,,,,,
862,O94885,SASH1,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),IYVDVLSEDEEKP,_FIYVDVLS(ph)EDEEK_,S595,,26.27,,,,21.03,,,,,,,,,23.65,2.62, , , ,-2.62, , , , , , , , ,,,,,,,,,,,,,,,,
863,O94885,SASH1,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),LNKNRRSLPVSIC,_S(ph)LPVSICR_,S794,,22.88,22.49,,21.70,,22.07,23.00,,22.57,,,,,22.45,0.43,0.04, ,-0.76, ,-0.38,0.55, ,0.12, , , , ,,,,,,,,,,,,,,,,
864,O94885,SASH1,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),SHGRTCSFGGFDL,_TCS(ph)FGGFDLTNR_,S388,,24.95,,,,,,,,,20.56,,,,22.75,2.19, , , , , , , , ,-2.19, , , ,,,,,,,,,,,,,,,,
866,O94888,UBXN7,UBX domain-containing protein 7,KCARSESLIDASE,_SES(ph)LIDASEDS(ph)QLEAAIR_,S280,,24.00,,,,,,,,,,,,,24.00,0.00, , , , , , , , , , , , ,,Cdc48p-Npl4p-Ufd1p AAA ATPase complex,,,,,,,,,,,,,,
867,O94888,UBXN7,UBX domain-containing protein 7,IDASEDSQLEAAI,_SES(ph)LIDASEDS(ph)QLEAAIR_,S288,,25.35,,,,,,,,,,,,,25.35,0.00, , , , , , , , , , , , ,,Cdc48p-Npl4p-Ufd1p AAA ATPase complex,,,,,,,,,,,,,,
868,O94889,KLHL18,Kelch-like protein 18,TWTRVGSMNSKRR,_VGS(ph)M(ox)NSKR_,S219,,,,,27.03,,,,,,,,,,27.03, , , ,0.00, , , , , , , , , ,,,,,,,,,,,,,,,,
869,O94913,PCF11,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),RSPKSRSPIIHSP,_SRS(ph)PIIHS(ph)PK_,S489,,25.28,25.18,25.96,24.26,,,,,,,,,,25.17,0.11,0.01,0.79,-0.91, , , , , , , , , ,"mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA cleavage;mRNA splicing, via spliceosome",mRNA cleavage factor complex,,,,,,,,,,,,,,
870,O94913,PCF11,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),RSPIIHSPKRRDR,_SRS(ph)PIIHS(ph)PK_,S494,,25.28,25.18,25.96,24.26,,,,,,,,,,25.17,0.11,0.01,0.79,-0.91, , , , , , , , , ,"mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA cleavage;mRNA splicing, via spliceosome",mRNA cleavage factor complex,,,,,,,,,,,,,,
873,O94915,FRYL,Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein),SNARSNSLRLSLI,_SNS(ph)LRLSLIGDR_,S1941,+,,21.22,21.22,,23.79,23.27,24.50,24.92,22.42,23.54,24.72,25.43,24.09,23.56, ,-2.33,-2.33, ,0.23,-0.29,0.94,1.36,-1.13,-0.02,1.16,1.88,0.54,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",,,,,,,,,,,,,,,
874,O94915,FRYL,Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein),YGGDTGSPEISFT,_TYGGDTGS(ph)PEISFTK_,S2272,+,21.50,21.95,21.95,22.68,24.08,23.79,24.05,23.81,22.30,,,22.70,22.94,22.89,-1.38,-0.94,-0.94,-0.21,1.19,0.90,1.17,0.92,-0.58, , ,-0.19,0.06,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",,,,,,,,,,,,,,,
875,O94921,CDK14,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),KFGKADSYEKLEK,_FGKADS(ph)YEK_,S134,,20.51,25.26,,25.11,,,22.14,22.08,21.27,,,,,22.73,-2.22,2.53, ,2.38, , ,-0.59,-0.65,-1.46, , , , ,G2/M transition of mitotic cell cycle;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,cytosol;plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,+,,,,,,,,,,,,
876,O94921,CDK14,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),KLRRTLSESFSRI,_TLS(ph)ESFSR_,S24,+,24.62,22.88,21.10,25.24,20.63,22.67,23.32,21.95,,,20.90,24.80,,22.81,1.80,0.07,-1.72,2.43,-2.18,-0.14,0.51,-0.86, , ,-1.91,1.99, ,G2/M transition of mitotic cell cycle;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,cytosol;plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,+,,,,,,,,,,,,
877,O94921,CDK14,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),RVQRTQSTFDPFE,_TQS(ph)TFDPFEK_,S78,,24.06,21.53,21.53,23.62,,,23.58,,21.09,,,23.60,,22.71,1.35,-1.19,-1.19,0.91, , ,0.86, ,-1.63, , ,0.88, ,G2/M transition of mitotic cell cycle;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,cytosol;plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,+,,,,,,,,,,,,
878,O94923,GLCE,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),HVAKQQSEEAFPQ,_(gl)QQS(ph)EEAFPQEQQK_,S9,,24.55,25.31,,26.11,,26.09,23.97,26.34,24.92,26.53,,24.13,25.10,25.31,-0.75,0.01, ,0.80, ,0.79,-1.34,1.03,-0.39,1.23, ,-1.17,-0.20,heparan sulfate proteoglycan biosynthetic process;heparin biosynthetic process;carbohydrate metabolic process,integral to membrane;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
880,O94929,ABLIM3,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),RQRRASSPGYIDS,_ASS(ph)PGYIDSPTYSR_,S311,+,,22.75,22.75,25.48,25.70,26.25,25.18,26.02,25.50,24.47,25.17,23.25,25.55,24.84, ,-2.09,-2.09,0.64,0.86,1.41,0.34,1.18,0.66,-0.37,0.33,-1.59,0.71,cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
881,O94929,ABLIM3,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),PRARRFSSGGEED,_RFS(ph)SGGEEDDFDR_,S392,,21.60,24.27,,24.68,22.30,23.20,,22.97,,,,,,23.17,-1.57,1.10, ,1.51,-0.87,0.03, ,-0.20, , , , , ,cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
883,O94929,ABLIM3,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),YSRQGMSPTFSRS,_(gl)QGM(ox)S(ph)PTFSR_,S326,+,21.11,20.31,20.31,25.38,22.88,23.88,22.78,24.01,24.27,22.82,22.21,21.79,,22.65,-1.53,-2.34,-2.34,2.74,0.24,1.23,0.14,1.36,1.62,0.17,-0.44,-0.86, ,cytoskeleton organization;axon guidance;positive regulation of transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
884,O94964,SOGA1,"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form;C-terminal 80 kDa form (80-kDa SOGA fragment)]",KAAKLGSSEEVRL,_LGS(ph)SEEVR_,S1184,,27.89,24.52,23.47,,,,,24.93,25.09,,22.93,22.49,,24.47,3.41,0.04,-1.01, , , , ,0.46,0.62, ,-1.55,-1.98, ,regulation of autophagy,extracellular space,,,,,,,,,,,,,,
885,O94964,SOGA1,"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form;C-terminal 80 kDa form (80-kDa SOGA fragment)]",GIRVYYSPPVARR,_VYYS(ph)PPVAR_,S858,+,22.04,21.97,,23.39,24.53,24.11,24.21,24.25,20.80,,,,,23.16,-1.12,-1.19, ,0.23,1.37,0.95,1.05,1.08,-2.36, , , , ,regulation of autophagy,extracellular space,,,,,,,,,,,,,,
886,O94979,SEC31A,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),PVAGHESPKIPYE,_AQGEPVAGHES(ph)PKIPYEK_,S799,+,25.20,27.86,27.34,27.37,27.67,27.16,28.24,29.24,26.27,25.45,27.28,26.70,26.62,27.11,-1.90,0.76,0.23,0.26,0.56,0.05,1.13,2.13,-0.84,-1.66,0.17,-0.41,-0.49,COPII vesicle coating;response to calcium ion;antigen processing and presentation of peptide antigen via MHC class I;post-translational protein modification;activation of signaling protein activity involved in unfolded protein response;protein transport;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,endosome;cytosol;COPII vesicle coat;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
888,O94979,SEC31A,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),QSDGEESPAAEEQ,_DSDQVAQSDGEES(ph)PAAEEQLLGEHIK_,S532,,23.11,,,,,,23.16,,24.39,23.18,,,,23.46,-0.35, , , , , ,-0.30, ,0.93,-0.28, , , ,COPII vesicle coating;response to calcium ion;antigen processing and presentation of peptide antigen via MHC class I;post-translational protein modification;activation of signaling protein activity involved in unfolded protein response;protein transport;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,endosome;cytosol;COPII vesicle coat;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
889,O94979,SEC31A,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),LREQTLSPTITSG,_EQTLS(ph)PTITSGLHNIAR_,S1163,+,22.42,24.60,,22.27,25.62,24.93,25.59,25.17,23.69,23.31,25.00,24.55,22.18,24.11,-1.69,0.49, ,-1.84,1.51,0.82,1.48,1.06,-0.42,-0.80,0.89,0.44,-1.93,COPII vesicle coating;response to calcium ion;antigen processing and presentation of peptide antigen via MHC class I;post-translational protein modification;activation of signaling protein activity involved in unfolded protein response;protein transport;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,endosome;cytosol;COPII vesicle coat;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
892,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),LVKRRDSEEFGVK,_RRDS(ph)EEFGVK_,S203,,24.66,25.05,25.44,,,,,,,25.91,,,,25.27,-0.60,-0.22,0.18, , , , , , ,0.64, , , ,,tight junction;apical plasma membrane;nucleus,,,,,,,,,,+,,,,
893,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),PRHAQRSPEASQT,_S(ph)PEASQTDSPVESPR_,S319,,24.25,23.92,,,,,,,,,,,22.84,23.67,0.58,0.25, , , , , , , , , , ,-0.83,,tight junction;apical plasma membrane;nucleus,,,,,,,,,,+,,,,
894,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),GSHGRRSPGGGSE,_S(ph)PGGGSEANGLALVSGFK_,S164,,26.67,20.79,20.79,,,,,,,25.98,,,,23.56,3.11,-2.77,-2.77, , , , , , ,2.42, , , ,,tight junction;apical plasma membrane;nucleus,,,,,,,,,,+,,,,
895,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),KKTTQRSREDLSA,_S(ph)REDLSALTR_,S591,,23.65,24.88,22.65,,21.54,,,,,23.42,,,,23.23,0.42,1.65,-0.57, ,-1.69, , , , ,0.19, , , ,,tight junction;apical plasma membrane;nucleus,,,,,,,,,,+,,,,
897,O95049,TJP3,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),VDSRTISEPDEQR,_TIS(ph)EPDEQR_,S346,+,26.95,26.25,25.71,22.90,21.61,,,22.02,21.28,25.06,20.71,,,23.61,3.34,2.64,2.09,-0.72,-2.00, , ,-1.59,-2.33,1.45,-2.90, , ,,tight junction;apical plasma membrane;nucleus,,,,,,,,,,+,,,,
898,O95070,YIF1A,Protein YIF1A (54TMp) (YIP1-interacting factor homolog A),GYGAHGSKHRARA,_(ac)AYHSGYGAHGS(ph)K_,S12,,23.27,22.99,22.99,24.93,,,,,,,,23.07,,23.45,-0.18,-0.46,-0.46,1.48, , , , , , , ,-0.38, ,vesicle-mediated transport;protein transport;activation of signaling protein activity involved in unfolded protein response,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;Golgi apparatus;centrosome;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
901,O95071,UBR5,"E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",RWLDGASFDNERG,_WLDGAS(ph)FDNER_,S327,,23.98,,,,,,,,,,,,,23.98,0.00, , , , , , , , , , , , ,"positive regulation of catenin import into nucleus;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;response to DNA damage stimulus;cell proliferation;DNA repair;positive regulation of protein import into nucleus, translocation;positive regulation of canonical Wnt receptor signaling pathway;protein polyubiquitination;negative regulation of double-strand break repair;progesterone receptor signaling pathway",nucleus;cytoplasm,,,,,,,,,,+,,,,
902,O95104,SCAF4,"Splicing factor, arginine/serine-rich 15 (CTD-binding SR-like protein RA4) (SR-related and CTD-associated factor 4)",VTNNEGSPPPPVK,_IEIIQPLLDM(ox)AAGTSNAAPVAENVTNNEGS(ph)PPPPVK_,S154,+,28.02,28.17,28.33,28.83,26.34,26.87,28.80,26.07,29.70,29.15,27.66,26.35,27.91,27.86,0.16,0.31,0.47,0.97,-1.52,-0.99,0.94,-1.79,1.84,1.29,-0.20,-1.51,0.05,mRNA processing,nucleus,,,,,,,,,,,,,,
906,O95171,SCEL,Sciellin,GIQSLGSPIKVNQ,_GIQSLGS(ph)PIK_,S292,,,24.36,25.13,22.34,,,21.93,22.08,,25.30,,,,23.52, ,0.84,1.61,-1.18, , ,-1.59,-1.44, ,1.77, , , ,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,,,,,,,,,,
908,O95171,SCEL,Sciellin,REKRAKSLESLIY,_S(ph)LESLIYM(ox)STR_,S269,,22.83,,,,22.70,,,,,25.42,,,,23.65,-0.82, , , ,-0.95, , , , ,1.77, , , ,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,,,,,,,,,,
910,O95171,SCEL,Sciellin,DEHINVSPKAVKN,_SSEQGLDEHINVS(ph)PK_,S455,,22.64,26.22,27.11,,25.73,22.96,25.90,24.59,24.42,28.37,24.66,,24.04,25.15,-2.51,1.07,1.96, ,0.58,-2.19,0.75,-0.56,-0.73,3.22,-0.49, ,-1.11,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,,,,,,,,,,
913,O95171,SCEL,Sciellin,VLNRHNSHDALDR,_VVLNRHNS(ph)HDALDR_,S68,+,,,,,23.98,,,22.77,22.22,22.49,21.55,21.56,20.54,22.16, , , , ,1.83, , ,0.61,0.06,0.33,-0.61,-0.59,-1.62,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,,,,,,,,,,
914,O95171,SCEL,Sciellin,TISRYSSDDTLDR,_YSS(ph)DDTLDR_,S91,+,23.07,25.03,24.64,24.39,24.02,23.17,26.65,22.00,24.68,,25.75,23.55,26.05,24.42,-1.35,0.61,0.22,-0.02,-0.40,-1.25,2.23,-2.41,0.27, ,1.34,-0.86,1.63,embryo development;keratinocyte differentiation,plasma membrane;cornified envelope;cytoplasm,,,,,,,,,,,,,,
915,O95183,VAMP5,Vesicle-associated membrane protein 5 (VAMP-5) (Myobrevin),DQLLDMSSTFNKT,_SDQLLDM(ox)S(ph)STFNK_,S48,,,,,21.56,22.95,24.87,22.30,,23.90,,,,,23.12, , , ,-1.55,-0.16,1.76,-0.82, ,0.78, , , , ,cell differentiation;vesicle-mediated transport;skeletal muscle tissue development;muscle organ development,trans-Golgi network;endomembrane system;Golgi apparatus;plasma membrane;integral to plasma membrane,,,,,,,,,,,,,,
916,O95197,RTN3,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),APGGGGSPGACPA,_(ac)AEPSAATQSHSISSSSFGAEPSAPGGGGS(ph)PGACPALGTK_,S30,+,26.07,25.57,25.57,23.50,,,25.13,,25.71,27.39,,,25.54,25.56,0.51,0.01,0.01,-2.05, , ,-0.43, ,0.15,1.83, , ,-0.02,endoplasmic reticulum tubular network organization;vesicle-mediated transport;apoptotic process;virus-host interaction;response to stress,extracellular space;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
917,O95197,RTN3,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),EKDSPESPFEVII,_DSPES(ph)PFEVIIDK_,S134,,22.08,,,,,,,,,,,,,22.08,0.00, , , , , , , , , , , , ,endoplasmic reticulum tubular network organization;vesicle-mediated transport;apoptotic process;virus-host interaction;response to stress,extracellular space;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
919,O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",YIEREESDGEYDE,_ENVEYIEREES(ph)DGEYDEFGRK_,S120,+,27.74,28.91,29.29,26.27,26.28,27.24,27.08,27.11,27.12,25.52,28.06,27.22,26.78,27.28,0.46,1.64,2.01,-1.01,-1.00,-0.04,-0.20,-0.17,-0.16,-1.76,0.78,-0.06,-0.50,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
920,O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",EVEDKESEGEEED,_EVEDKES(ph)EGEEEDEDEDLSK_,S153,+,28.68,29.03,29.13,28.90,27.00,29.19,29.34,29.29,29.60,27.89,27.39,27.65,28.28,28.57,0.11,0.47,0.56,0.33,-1.57,0.62,0.77,0.72,1.04,-0.68,-1.18,-0.91,-0.28,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
923,O95218,ZRANB2,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",KYNLDASEEEDSN,_YNLDAS(ph)EEEDSNKK_,S188,+,29.90,29.89,29.86,30.07,27.32,29.50,29.97,29.10,30.57,28.95,28.84,28.92,29.17,29.39,0.51,0.50,0.48,0.68,-2.07,0.12,0.58,-0.28,1.18,-0.44,-0.55,-0.46,-0.22,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
925,O95235,KIF20A,Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6),EHSLQVSPSLEKG,_EHSLQVS(ph)PSLEK_,S514,+,21.68,23.48,23.65,19.36,25.03,23.56,24.09,23.32,23.01,22.24,,,,22.94,-1.26,0.54,0.71,-3.58,2.09,0.62,1.14,0.38,0.06,-0.70, , , ,vesicle-mediated transport;microtubule-based movement;microtubule bundle formation;protein transport;M phase of mitotic cell cycle;cytokinesis,nucleoplasm;Golgi apparatus;microtubule associated complex;microtubule;spindle,,,,,,,,,,,,,,
926,O95239,KIF4A,Chromosome-associated kinesin KIF4A (Chromokinesin-A),LRRRTFSLTEVRG,_TFS(ph)LTEVR_,S801,,23.24,,,,21.26,,,21.32,,,,20.82,,21.66,1.58, , , ,-0.40, , ,-0.34, , , ,-0.84, ,blood coagulation;axon guidance;anterograde axon cargo transport;organelle organization;antigen processing and presentation of exogenous peptide antigen via MHC class II,spindle microtubule;cytosol;midbody;chromosome;nucleus;microtubule associated complex;nuclear matrix,,,,,,,,,,,,,,
927,O95248,SBF1,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),GLGTLSSSLSRAK,_LGLGTLSS(ph)SLSR_,S1140,,21.59,23.05,,23.11,,,,,,,,,,22.58,-0.99,0.47, ,0.52, , , , , , , , , ,spermatogenesis;protein dephosphorylation,integral to membrane;nucleus,,,+,,,,,,,,,,,
928,O95248,SBF1,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),LGTLSSSLSRAKS,_LGLGTLSSS(ph)LSR_,S1141,+,22.11,23.11,23.11,,23.91,24.30,24.22,24.19,24.16,24.73,24.99,23.99,24.34,23.93,-1.82,-0.82,-0.82, ,-0.02,0.36,0.29,0.26,0.23,0.80,1.06,0.06,0.41,spermatogenesis;protein dephosphorylation,integral to membrane;nucleus,,,+,,,,,,,,,,,
930,O95251,KAT7,"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)",QSSQDSSPVRNLQ,_LSQSSQDSS(ph)PVRNLQSFGTEEPAYSTR_,S50,+,,,,25.04,25.46,20.26,25.20,25.33,24.31,,,24.20,,24.26, , , ,0.78,1.20,-3.99,0.94,1.08,0.05, , ,-0.06, ,"histone H4-K12 acetylation;histone H4-K8 acetylation;histone H4-K5 acetylation;histone H3 acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA replication",histone acetyltransferase complex,,,,,,,,,,,,,,
931,O95251,KAT7,"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)",QTRSSGSETEQVV,_SSGS(ph)ETEQVVDFSDRETK_,S95,+,,,,,24.48,24.77,23.71,22.72,24.13,24.36,22.38,,,23.79, , , , ,0.69,0.98,-0.08,-1.07,0.34,0.57,-1.42, , ,"histone H4-K12 acetylation;histone H4-K8 acetylation;histone H4-K5 acetylation;histone H3 acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA replication",histone acetyltransferase complex,,,,,,,,,,,,,,
933,O95279,KCNK5,Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2),RAPEDSSPAPEVF,_APEDSS(ph)PAPEVFM(ox)NQLDR_,S385,,21.77,,,,,,,,,,22.53,,,22.15,-0.38, , , , , , , , , ,0.38, , ,excretion,integral to plasma membrane,,,,,,,,,,,,,,
936,O95292,VAPB,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),TPIVSKSLSSSLD,_S(ph)LSSS(ph)LDDTEVK_,S156,,22.78,22.90,22.90,22.78,,,,,,23.75,23.30,,,23.07,-0.28,-0.17,-0.17,-0.29, , , , , ,0.68,0.23, , ,phospholipid metabolic process;cellular calcium ion homeostasis;small molecule metabolic process;positive regulation of viral genome replication;cell death;activation of signaling protein activity involved in unfolded protein response;sphingolipid biosynthetic process;virus-host interaction,integral to membrane;Golgi apparatus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
937,O95292,VAPB,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),IVSKSLSSSLDDT,_SLS(ph)SSLDDTEVK_,S158,+,26.26,24.62,24.71,24.16,23.93,24.98,24.20,24.78,25.18,25.83,25.65,24.78,25.21,24.95,1.31,-0.32,-0.23,-0.78,-1.01,0.04,-0.74,-0.17,0.23,0.88,0.71,-0.17,0.26,phospholipid metabolic process;cellular calcium ion homeostasis;small molecule metabolic process;positive regulation of viral genome replication;cell death;activation of signaling protein activity involved in unfolded protein response;sphingolipid biosynthetic process;virus-host interaction,integral to membrane;Golgi apparatus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
939,O95292,VAPB,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),SKSLSSSLDDTEV,_S(ph)LSSS(ph)LDDTEVK_,S160,+,22.78,24.18,24.66,22.19,,26.56,25.41,25.00,25.69,,25.93,,,24.71,-1.93,-0.53,-0.05,-2.52, ,1.84,0.70,0.29,0.98, ,1.22, , ,phospholipid metabolic process;cellular calcium ion homeostasis;small molecule metabolic process;positive regulation of viral genome replication;cell death;activation of signaling protein activity involved in unfolded protein response;sphingolipid biosynthetic process;virus-host interaction,integral to membrane;Golgi apparatus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
940,O95295,SNAPIN,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),GIYPPGSPGK___,_AM(ox)LDSGIYPPGS(ph)PGK_,S133,+,23.24,,,,24.76,24.53,26.25,25.43,24.04,23.90,24.31,,24.23,24.52,-1.28, , , ,0.24,0.01,1.73,0.91,-0.49,-0.62,-0.21, ,-0.29,neuron projection development;synaptic vesicle exocytosis;anterograde synaptic vesicle transport;anterograde axon cargo transport;intracellular protein transport;terminal button organization;synaptic vesicle maturation;melanosome organization;virus-host interaction;synaptic vesicle fusion to presynaptic membrane,synaptic vesicle;Golgi apparatus;Golgi membrane;perinuclear region of cytoplasm;neuron projection;synaptic vesicle membrane;cell junction;nucleolus;BLOC-1 complex,,,,,,,,,,,,,,
941,O95297,MPZL1,Myelin protein zero-like protein 1 (Protein zero-related),GCSTSESLSPVKQ,_DYTGCSTSES(ph)LSPVK_,S182,,,,,22.98,,,,,,,,,,22.98, , , ,0.00, , , , , , , , , ,transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling,integral to plasma membrane,,,,,,,,,,,,,,
942,O95297,MPZL1,Myelin protein zero-like protein 1 (Protein zero-related),KINKSESVVYADI,_SES(ph)VVYADIRKN_,S234,,23.30,20.90,,23.94,,,21.48,,,,,25.70,,23.06,0.24,-2.17, ,0.87, , ,-1.58, , , , ,2.64, ,transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling,integral to plasma membrane,,,,,,,,,,,,,,
943,O95297,MPZL1,Myelin protein zero-like protein 1 (Protein zero-related),KQAPRKSPSDTEG,_S(ph)PSDTEGLVK_,S193,,21.02,22.73,22.73,24.45,,,,,24.19,23.18,,23.47,,23.11,-2.09,-0.38,-0.38,1.34, , , , ,1.08,0.07, ,0.36, ,transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling,integral to plasma membrane,,,,,,,,,,,,,,
944,O95297,MPZL1,Myelin protein zero-like protein 1 (Protein zero-related),APRKSPSDTEGLV,_SPS(ph)DTEGLVK_,S195,,,,,23.62,,,22.98,,22.72,24.23,21.84,22.12,,22.92, , , ,0.70, , ,0.06, ,-0.20,1.31,-1.08,-0.79, ,transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling,integral to plasma membrane,,,,,,,,,,,,,,
949,O95359,TACC2,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),NETKFSSPTEELD,_FSS(ph)PTEELDYR_,S2512,+,25.26,21.76,,23.57,25.27,23.05,24.84,25.11,23.23,22.80,26.06,21.88,23.34,23.85,1.41,-2.09, ,-0.28,1.42,-0.79,0.99,1.26,-0.62,-1.04,2.22,-1.96,-0.51,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;astral microtubule organization;cerebral cortex development,nucleolus;Golgi apparatus;microtubule organizing center,,,,,,,,,,,,,,
950,O95359,TACC2,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),LDNTPASPPRSPA,_LDNTPAS(ph)PPRSPAEPNDIPIAK_,S2317,+,28.20,25.81,26.36,25.96,26.44,25.06,28.96,28.09,28.10,26.91,28.44,25.53,26.70,26.97,1.23,-1.15,-0.60,-1.00,-0.53,-1.91,2.00,1.12,1.13,-0.06,1.47,-1.43,-0.27,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;astral microtubule organization;cerebral cortex development,nucleolus;Golgi apparatus;microtubule organizing center,,,,,,,,,,,,,,
951,O95359,TACC2,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),PASPPRSPAEPND,_LDNTPAS(ph)PPRS(ph)PAEPNDIPIAK_,S2321,+,28.26,25.53,26.16,25.86,26.25,26.76,27.71,27.52,27.64,26.29,25.82,,23.93,26.48,1.78,-0.95,-0.32,-0.61,-0.23,0.29,1.23,1.04,1.16,-0.19,-0.66, ,-2.55,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;astral microtubule organization;cerebral cortex development,nucleolus;Golgi apparatus;microtubule organizing center,,,,,,,,,,,,,,
953,O95359,TACC2,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),SGGQEDSPAKGLS,_TLPLTTAPEAGEVTPSDSGGQEDS(ph)PAK_,S2256,,25.22,,,,,,24.62,24.09,23.70,23.28,,,,24.18,1.04, , , , , ,0.44,-0.09,-0.48,-0.90, , , ,regulation of microtubule-based process;interkinetic nuclear migration;neurogenesis;astral microtubule organization;cerebral cortex development,nucleolus;Golgi apparatus;microtubule organizing center,,,,,,,,,,,,,,
954,O95361,TRIM16,Tripartite motif-containing protein 16 (Estrogen-responsive B box protein),QPPAPLSPDSGSP,_ATAQPPAPLS(ph)PDSGSPSPDSGSASPVEEEDVGSSEK_,S24,,23.65,22.85,22.85,,,,,25.26,,25.97,23.77,24.19,,24.08,-0.43,-1.23,-1.23, , , , ,1.18, ,1.89,-0.31,0.12, ,"histone H4 acetylation;response to growth hormone stimulus;response to retinoic acid;positive regulation of keratinocyte differentiation;response to organophosphorus;positive regulation of transcription, DNA-dependent;positive regulation of retinoic acid receptor signaling pathway;histone H3 acetylation;positive regulation of interleukin-1 beta secretion",PML body;cytoplasm,,,,,,,,,,,,,,
961,O95365,ZBTB7A,Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A),APAQPSSPDARRN,_GGAPDPSPGATATPGAPAQPSS(ph)PDAR_,S526,+,25.07,24.53,,23.42,24.36,23.43,25.43,23.03,25.57,23.50,24.13,23.79,24.35,24.22,0.86,0.31, ,-0.80,0.15,-0.79,1.22,-1.19,1.35,-0.71,-0.09,-0.43,0.13,"regulation of osteoclast differentiation;multicellular organismal development;cell differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
962,O95382,MAP3K6,Mitogen-activated protein kinase kinase kinase 6 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 2),VEKEAVSPRSEEL,_AALGVLGPEVEKEAVS(ph)PR_,S1121,,,,,,22.83,,,21.89,,,,,,22.36, , , , ,0.47, , ,-0.47, , , , , ,activation of JUN kinase activity,,,+,,,,,,,,,,,,
964,O95394,PGM3,Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),GVMVTASHNPEED,_STIGVM(ox)VTAS(ph)HNPEEDNGVK_,S64,+,24.36,25.72,25.68,25.84,23.55,26.67,26.43,26.84,26.06,24.55,26.18,27.50,26.35,25.83,-1.46,-0.10,-0.14,0.01,-2.27,0.85,0.60,1.01,0.23,-1.28,0.36,1.68,0.53,dolichol-linked oligosaccharide biosynthetic process;glucosamine metabolic process;UDP-N-acetylglucosamine biosynthetic process;protein N-linked glycosylation via asparagine;hemopoiesis;post-translational protein modification,cytosol,,,,,,,,,,,,,,
965,O95398,RAPGEF3,Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI),HNPVPLSPLRSRV,_SHNPVPLS(ph)PLR_,S157,,20.61,22.40,21.83,,,,,,,21.82,23.40,,,22.01,-1.40,0.39,-0.18, , , , , , ,-0.20,1.39, , ,angiogenesis;small molecule metabolic process;platelet activation;small GTPase mediated signal transduction;energy reserve metabolic process;cell proliferation;positive regulation of angiogenesis;regulation of insulin secretion;signal transduction;regulation of small GTPase mediated signal transduction,endomembrane system;plasma membrane;cAMP-dependent protein kinase complex,,,,,,,,,,,,,,
969,O95402,MED26,Mediator of RNA polymerase II transcription subunit 26 (Activator-recruited cofactor 70 kDa component) (ARC70) (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26) (Transcriptional coactivator CRSP70),GCKAGLSPAEPLL,_AGLS(ph)PAEPLLSR_,S361,+,20.65,,,19.97,22.15,21.95,21.89,22.28,20.95,21.56,22.16,,22.78,21.63,-0.99, , ,-1.67,0.52,0.32,0.26,0.64,-0.69,-0.07,0.53, ,1.15,transcription initiation from RNA polymerase II promoter,mediator complex,,,,,,,,,,,,,,
970,O95402,MED26,Mediator of RNA polymerase II transcription subunit 26 (Activator-recruited cofactor 70 kDa component) (ARC70) (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26) (Transcriptional coactivator CRSP70),MTAAPASPQQIRD,_(ac)TAAPAS(ph)PQQIRDR_,S7,+,23.25,,,23.09,24.09,24.34,23.68,24.22,23.69,22.60,,,23.78,23.64,-0.38, , ,-0.55,0.46,0.71,0.04,0.58,0.05,-1.04, , ,0.14,transcription initiation from RNA polymerase II promoter,mediator complex,,,,,,,,,,,,,,
971,O95425,SVIL,Supervillin (Archvillin) (p205/p250),RASDPASPHIGRS,_ASDPAS(ph)PHIGR_,S50,,23.75,,,,,,,,,,,,,23.75,0.00, , , , , , , , , , , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
972,O95425,SVIL,Supervillin (Archvillin) (p205/p250),GMEKYGSFEEAEA,_YGS(ph)FEEAEASYPILNR_,S542,+,27.43,21.56,21.56,19.19,24.95,,23.21,22.99,22.93,27.84,23.75,24.44,,23.62,3.80,-2.06,-2.06,-4.44,1.32, ,-0.42,-0.63,-0.69,4.22,0.13,0.82, ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
973,O95425,SVIL,Supervillin (Archvillin) (p205/p250),FSGRDSSFTEVPR,_DSS(ph)FTEVPR_,S238,,26.12,,,22.79,,,,,21.66,,,,,23.53,2.60, , ,-0.73, , , , ,-1.87, , , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
974,O95425,SVIL,Supervillin (Archvillin) (p205/p250),FTEVPRSPKHAHS,_DSSFTEVPRS(ph)PK_,S245,+,28.77,27.74,27.69,26.46,28.62,29.01,28.63,28.53,28.92,30.26,28.14,27.12,28.60,28.35,0.43,-0.60,-0.66,-1.88,0.27,0.66,0.28,0.19,0.58,1.92,-0.20,-1.22,0.25,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
975,O95425,SVIL,Supervillin (Archvillin) (p205/p250),FREMEKSFDEQNV,_S(ph)FDEQNVPK_,S313,+,28.96,27.06,27.71,27.34,25.46,24.82,27.20,25.60,26.18,29.83,25.28,25.99,24.00,26.57,2.39,0.49,1.13,0.77,-1.11,-1.75,0.63,-0.97,-0.39,3.26,-1.29,-0.58,-2.57,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
976,O95425,SVIL,Supervillin (Archvillin) (p205/p250),ENFSNVSLRSVNL,_ENFSNVS(ph)LR_,S996,,23.07,,,,,,,,,,,21.84,,22.45,0.62, , , , , , , , , , ,-0.62, ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
977,O95425,SVIL,Supervillin (Archvillin) (p205/p250),VTESRESQMTIEE,_ES(ph)QM(ox)T(ph)IEER_,S754,,,24.26,,25.44,,22.05,,22.85,,,,,,23.65, ,0.61, ,1.79, ,-1.60, ,-0.80, , , , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
978,O95425,SVIL,Supervillin (Archvillin) (p205/p250),DYKFSSSIENSDS,_FSSS(ph)IENSDSPVR_,S488,+,26.05,23.17,23.15,23.69,,23.04,23.92,21.97,22.73,26.13,22.52,24.27,,23.69,2.36,-0.53,-0.54,0.00, ,-0.66,0.23,-1.73,-0.96,2.43,-1.18,0.57, ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
979,O95425,SVIL,Supervillin (Archvillin) (p205/p250),SIENSDSPVRSIL,_FSSS(ph)IENSDS(ph)PVR_,S494,+,25.19,21.00,21.00,21.94,20.95,21.24,22.40,21.21,22.20,26.06,,,22.80,22.36,2.83,-1.36,-1.36,-0.43,-1.42,-1.12,0.03,-1.15,-0.16,3.70, , ,0.43,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
980,O95425,SVIL,Supervillin (Archvillin) (p205/p250),VKKGLASPTAITP,_GLAS(ph)PTAITPVASPICGK_,S799,,23.57,,,,,,,,22.83,25.61,,,,24.00,-0.43, , , , , , , ,-1.17,1.61, , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
981,O95425,SVIL,Supervillin (Archvillin) (p205/p250),RQAHDLSPAAESS,_(gl)QAHDLS(ph)PAAESSSTFSFSGR_,S221,+,25.90,,,19.83,27.27,25.24,25.46,25.83,26.93,26.85,25.58,24.30,26.39,25.42,0.48, , ,-5.59,1.85,-0.17,0.04,0.41,1.51,1.43,0.17,-1.11,0.97,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
986,O95425,SVIL,Supervillin (Archvillin) (p205/p250),DYNMPRSPVEMDE,_SVDYNM(ox)PRS(ph)PVEM(ox)DEDFDVIFDPYAPK_,S896,,25.98,,,,24.86,,,,24.68,27.55,,,,25.77,0.21, , , ,-0.90, , , ,-1.09,1.78, , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
988,O95425,SVIL,Supervillin (Archvillin) (p205/p250),GEGLLDSPSKTMS,_TPTGEGLLDS(ph)PSK_,S694,,23.81,24.53,24.53,22.10,,,22.82,21.03,,24.46,,,,23.32,0.49,1.20,1.20,-1.22, , ,-0.51,-2.30, ,1.13, , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
989,O95425,SVIL,Supervillin (Archvillin) (p205/p250),QQAASRSPSFGDP,_S(ph)PSFGDPQLS(ph)PEARPR_,S261,,26.69,22.03,22.03,22.54,,,22.22,,,23.12,23.46,,,23.16,3.53,-1.12,-1.12,-0.62, , ,-0.93, , ,-0.04,0.30, , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
990,O95425,SVIL,Supervillin (Archvillin) (p205/p250),AASRSPSFGDPQL,_SPS(ph)FGDPQLS(ph)PEARPR_,S263,,25.64,22.26,22.26,,,,,,,,,,,23.38,2.25,-1.13,-1.13, , , , , , , , , , ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
991,O95425,SVIL,Supervillin (Archvillin) (p205/p250),FGDPQLSPEARPR,_SPS(ph)FGDPQLS(ph)PEARPR_,S270,,28.00,25.80,26.71,21.94,28.52,27.97,27.77,27.41,27.60,27.87,27.24,25.34,27.31,26.88,1.12,-1.08,-0.17,-4.95,1.64,1.09,0.89,0.53,0.71,0.99,0.35,-1.54,0.42,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
992,O95429,BAG4,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),YRSSGNSPTPVSR,_SSGNS(ph)PTPVSR_,S143,,21.53,,,23.39,20.32,,,,21.78,,,20.86,,21.58,-0.04, , ,1.81,-1.26, , , ,0.21, , ,-0.72, ,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of fibroblast migration;ruffle assembly;positive regulation of stress fiber assembly;cellular response to tumor necrosis factor;positive regulation of cell adhesion;protein folding;cellular response to epidermal growth factor stimulus;positive regulation of actin filament polymerization;protein localization to plasma membrane;negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",cytosol;plasma membrane;nucleus,,,,,,,,,,,,,,
996,O95453,PARN,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease),HYYRNNSFTAPST,_NNS(ph)FTAPSTVGK_,S496,,27.45,,,25.39,,,,,,,,,,26.42,1.03, , ,-1.03, , , , , , , , , ,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nuclear-transcribed mRNA poly(A) tail shortening;RNA modification;female gamete generation",cytosol;nucleolus;nucleus,,,,,,,,,,,,,,
997,O95466,FMNL1,Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin),NKPLEQSVEDLSK,_NKPLEQS(ph)VEDLSK_,S184,+,21.79,25.98,25.84,23.10,22.11,23.61,,22.23,26.01,22.66,,,,23.70,-1.91,2.28,2.14,-0.60,-1.60,-0.09, ,-1.47,2.30,-1.05, , , ,actin filament severing;regulation of cell shape;cortical actin cytoskeleton organization;substrate-dependent cell migration,cytosol;cell cortex;plasma membrane;bleb;phagocytic vesicle,,,,,,,,,,,,,,
998,O95466,FMNL1,Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin),ALGRRDSELGPGV,_RDS(ph)ELGPGVK_,S624,,,26.60,25.60,23.78,,,,,,,,,,25.33, ,1.27,0.27,-1.55, , , , , , , , , ,actin filament severing;regulation of cell shape;cortical actin cytoskeleton organization;substrate-dependent cell migration,cytosol;cell cortex;plasma membrane;bleb;phagocytic vesicle,,,,,,,,,,,,,,
999,O95477,ABCA1,ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein),DHLKDLSLHKNQT,_DLS(ph)LHK_,S2234,,,25.75,25.75,25.42,,,,,,,,,,25.64, ,0.11,0.11,-0.22, , , , , , , , , ,"phospholipid efflux;phagocytosis, engulfment;intracellular cholesterol transport;lipoprotein metabolic process;negative regulation of cholesterol storage;cholesterol homeostasis;response to low-density lipoprotein particle stimulus;platelet dense granule organization;cholesterol metabolic process;reverse cholesterol transport;positive regulation of cAMP biosynthetic process;ATP catabolic process;negative regulation of macrophage derived foam cell differentiation;regulation of Cdc42 protein signal transduction;cellular response to retinoic acid;cholesterol efflux;cellular response to lipopolysaccharide;endosomal transport;lysosome organization;cellular lipid metabolic process;G-protein coupled receptor signaling pathway;phospholipid homeostasis;protein lipidation;phospholipid translocation;interleukin-1 beta secretion;peptide secretion;response to laminar fluid shear stress;positive regulation of cholesterol efflux;high-density lipoprotein particle assembly",membrane raft;Golgi apparatus;integral to plasma membrane;phagocytic vesicle,,,,,,,,,,,,,,
1000,O95490,LPHN2,Latrophilin-2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Lectomedin-1),QISRGNSDGYIIP,_GNS(ph)DGYIIPINK_,S1355,+,24.08,,,22.79,23.35,24.56,23.75,23.27,24.46,24.52,22.60,23.30,23.28,23.63,0.45, , ,-0.84,-0.28,0.93,0.12,-0.36,0.82,0.89,-1.03,-0.34,-0.35,neuropeptide signaling pathway;brain development,integral to membrane;plasma membrane,,,,,,,,,,,,,,
1002,O95544,NADK,NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase),AKSRSLSASPALG,_SLS(ph)ASPALGSTK_,S48,,20.11,23.21,20.99,23.45,,,,,,,,,,21.94,-1.83,1.27,-0.95,1.51, , , , , , , , , ,NADP biosynthetic process;water-soluble vitamin metabolic process;NAD metabolic process;ATP metabolic process,cytosol,,,,,,,,,,,,,,
1003,O95562,SFT2D2,Vesicle transport protein SFT2B (SFT2 domain-containing protein 2),KLKKVLSGQDTED,_VLS(ph)GQDTEDR_,S9,,24.66,,,,,,,,,,,,,24.66,0.00, , , , , , , , , , , , ,vesicle-mediated transport;protein transport,integral to membrane,,,,,,,,,,,,,,
1004,O95571,ETHE1,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",VARRQLSQRGGSG,_(gl)QLS(ph)QRGGSGAPILLR_,S14,,,,,,21.09,,,,,24.17,,23.72,,22.99, , , , ,-1.90, , , , ,1.18, ,0.73, ,"sulfide oxidation, using sulfide:quinone oxidoreductase;sulfur amino acid catabolic process;cellular nitrogen compound metabolic process",nucleus;mitochondrial matrix,,,,,,,,,,,,,,
1005,O95602,POLR1A,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),EEVDYESEEEEER,_QEEEVDYES(ph)EEEEER_,S1429,,21.55,24.23,24.23,,,,,,,,,,,23.34,-1.79,0.89,0.89, , , , , , , , , , ,transcription initiation from RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter;termination of RNA polymerase I transcription;rRNA transcription,nucleoplasm;DNA-directed RNA polymerase I complex,,,,,,,,,,,,,,
1006,O95613,PCNT,Pericentrin (Kendrin) (Pericentrin-B),ALLRRESEVLDLK,_RES(ph)EVLDLK_,S1535,+,21.94,20.68,20.68,23.81,,,23.70,,22.85,24.01,23.11,24.72,24.58,23.01,-1.07,-2.33,-2.33,0.80, , ,0.69, ,-0.16,1.00,0.10,1.71,1.57,spindle organization;neuron migration;in utero embryonic development;limb morphogenesis;G2/M transition of mitotic cell cycle;multicellular organism growth;brain morphogenesis;olfactory bulb development;apoptotic process;neural precursor cell proliferation;cerebellar cortex morphogenesis;cilium assembly;microtubule cytoskeleton organization,intercellular bridge;cytosol;centriole;microtubule;centrosome,,,,,,,,,,,,,,
1007,O95613,PCNT,Pericentrin (Kendrin) (Pericentrin-B),ARLSPGSGGPEAQ,_LSPGS(ph)GGPEAQTAGPVTPASISGR_,S2237,,22.00,21.44,,21.42,,,,,,,,,22.86,21.93,0.07,-0.49, ,-0.51, , , , , , , , ,0.93,spindle organization;neuron migration;in utero embryonic development;limb morphogenesis;G2/M transition of mitotic cell cycle;multicellular organism growth;brain morphogenesis;olfactory bulb development;apoptotic process;neural precursor cell proliferation;cerebellar cortex morphogenesis;cilium assembly;microtubule cytoskeleton organization,intercellular bridge;cytosol;centriole;microtubule;centrosome,,,,,,,,,,,,,,
1008,O95613,PCNT,Pericentrin (Kendrin) (Pericentrin-B),PDEMPDSPIQEKS,_NWDSLIPDEM(ox)PDS(ph)PIQEK_,S2059,,24.43,,,,22.35,,,,,22.66,,,,23.15,1.28, , , ,-0.80, , , , ,-0.49, , , ,spindle organization;neuron migration;in utero embryonic development;limb morphogenesis;G2/M transition of mitotic cell cycle;multicellular organism growth;brain morphogenesis;olfactory bulb development;apoptotic process;neural precursor cell proliferation;cerebellar cortex morphogenesis;cilium assembly;microtubule cytoskeleton organization,intercellular bridge;cytosol;centriole;microtubule;centrosome,,,,,,,,,,,,,,
1009,O95625,ZBTB11,Zinc finger and BTB domain-containing protein 11,VEVAHISGGE___,_VEVAHIS(ph)GGE_,S266,+,24.04,23.07,23.50,23.89,,22.66,22.84,,23.53,23.50,,,,23.38,0.66,-0.31,0.12,0.51, ,-0.72,-0.54, ,0.15,0.12, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
1010,O95628,CNOT4,CCR4-NOT transcription complex subunit 4 (EC 6.3.2.-) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp),QDQPSLSPTSLQN,_ELSVQDQPSLS(ph)PTSLQNSSSHTTTAK_,S415,+,23.53,23.49,23.49,21.45,23.60,,24.76,25.34,23.89,,25.42,24.09,24.56,23.96,-0.44,-0.47,-0.47,-2.51,-0.37, ,0.80,1.37,-0.08, ,1.46,0.12,0.59,"protein autoubiquitination;transcription, DNA-dependent;regulation of transcription, DNA-dependent;nuclear-transcribed mRNA poly(A) tail shortening",cytosol;nucleus,,,,,,,,,,,,,,
1014,O95674,CDS2,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),PPEDKESESEAKV,_VAHEPVAPPEDKES(ph)ESEAK_,S21,+,23.31,26.80,26.80,24.16,,23.70,26.89,,26.59,28.08,26.99,26.57,,25.99,-2.68,0.81,0.81,-1.83, ,-2.29,0.90, ,0.60,2.09,1.00,0.58, ,small molecule metabolic process;CDP-diacylglycerol biosynthetic process;phosphatidylglycerol biosynthetic process,integral to membrane;mitochondrial inner membrane;endoplasmic reticulum,,,,,,,,,,,,,,
1020,O95677,EYA4,Eyes absent homolog 4 (EC 3.1.3.48),GRKNNPSPPPDSD,_NNPS(ph)PPPDSDLER_,S132,+,23.23,21.94,,23.05,24.47,25.06,24.86,25.13,24.07,,24.42,23.52,,23.97,-0.75,-2.04, ,-0.92,0.50,1.08,0.89,1.16,0.10, ,0.44,-0.46, ,"anatomical structure morphogenesis;sensory perception of sound;regulation of transcription, DNA-dependent;middle ear morphogenesis;DNA repair;visual perception;chromatin modification;transcription, DNA-dependent;peptidyl-tyrosine dephosphorylation",nucleus;cytoplasm,,,,,,,,,,,,,,
1021,O95678,KRT75,"Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)",EDIANRSRAEAES,_AQYEDIANRS(ph)R_,SNaN,+,25.66,26.55,26.53,26.91,26.86,26.85,26.18,26.83,25.21,24.01,26.71,25.50,25.18,26.08,-0.41,0.47,0.46,0.83,0.79,0.77,0.10,0.75,-0.87,-2.07,0.64,-0.57,-0.90,,keratin filament,,,,,,,,,,,,,,
1022,O95678,KRT75,"Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)",LNNKFASFIDKVR,_FAS(ph)FIDK_,S104,+,26.29,24.83,24.16,23.70,23.55,24.45,25.02,25.22,23.84,24.88,24.88,26.03,26.19,24.85,1.44,-0.02,-0.68,-1.14,-1.30,-0.40,0.17,0.37,-1.01,0.03,0.03,1.18,1.34,,keratin filament,,,,,,,,,,,,,,
1023,O95684,FGFR1OP,FGFR1 oncogene partner,DLSDVHSPPKSPE,_GPTTGEGALDLSDVHS(ph)PPKS(ph)PEGK_,S156,,,23.86,23.86,22.99,,,,,,,,,,23.57, ,0.29,0.29,-0.58, , , , , , , , , ,G2/M transition of mitotic cell cycle;positive regulation of cell migration;microtubule anchoring;positive regulation of cell growth;positive regulation of cell proliferation,cytosol;nucleus;centrosome;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1024,O95684,FGFR1OP,FGFR1 oncogene partner,VHSPPKSPEGKTS,_GPTTGEGALDLSDVHS(ph)PPKS(ph)PEGK_,S160,,,23.86,23.86,22.99,,,,,,,,,,23.57, ,0.29,0.29,-0.58, , , , , , , , , ,G2/M transition of mitotic cell cycle;positive regulation of cell migration;microtubule anchoring;positive regulation of cell growth;positive regulation of cell proliferation,cytosol;nucleus;centrosome;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1025,O95685,PPP1R3D,Protein phosphatase 1 regulatory subunit 3D (Protein phosphatase 1 regulatory subunit 6) (PP1 subunit R6) (Protein phosphatase 1-binding subunit R6),ILRRARSLPSSPE,_ARS(ph)LPSS(ph)PER_,S74,,26.32,25.65,24.68,26.11,21.90,,,20.93,,,,,,24.27,2.06,1.38,0.41,1.85,-2.36, , ,-3.33, , , , , ,regulation of glycogen catabolic process;glycogen metabolic process;regulation of glycogen biosynthetic process,glycogen granule,,,+,,,,,,,,,,,
1026,O95685,PPP1R3D,Protein phosphatase 1 regulatory subunit 3D (Protein phosphatase 1 regulatory subunit 6) (PP1 subunit R6) (Protein phosphatase 1-binding subunit R6),ARSLPSSPERRQK,_S(ph)LPSS(ph)PERR_,S78,,26.32,25.65,24.68,25.85,21.90,,,20.93,,,,,,24.22,2.10,1.43,0.45,1.63,-2.32, , ,-3.29, , , , , ,regulation of glycogen catabolic process;glycogen metabolic process;regulation of glycogen biosynthetic process,glycogen granule,,,+,,,,,,,,,,,
1028,O95696,BRD1,Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2),VHGEPTSDLSDID,_VHGEPTS(ph)DLSDID_,S1052,+,22.52,22.20,,22.02,25.04,25.14,23.12,23.56,24.13,24.84,,,23.27,23.58,-1.06,-1.39, ,-1.57,1.46,1.56,-0.47,-0.02,0.54,1.25, , ,-0.32,histone H3 acetylation,MOZ/MORF histone acetyltransferase complex,,,,,,,,,,,,,,
1029,O95696,BRD1,Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2),EPTSDLSDID___,_VHGEPTSDLS(ph)DID_,S1055,+,23.62,,,,24.04,22.95,22.91,22.31,22.89,23.58,,,,23.19,0.44, , , ,0.86,-0.24,-0.27,-0.88,-0.30,0.39, , , ,histone H3 acetylation,MOZ/MORF histone acetyltransferase complex,,,,,,,,,,,,,,
1030,O95714,HERC2,E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2),AVPFLASDNEEEE,_IRAEEEDLAAVPFLAS(ph)DNEEEEDEK_,S2928,,23.55,,,,,,,,,24.32,,,,23.94,-0.39, , , , , , , , ,0.39, , , ,intracellular protein transport;DNA repair;spermatogenesis;protein ubiquitination involved in ubiquitin-dependent protein catabolic process,centriole;mitochondrial inner membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
1031,O95747,OXSR1,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),DGGWEWSDDEFDE,_TEDGGWEWS(ph)DDEFDEESEEGK_,S339,,25.07,,,,,,,,,,,,,25.07,0.00, , , , , , , , , , , , ,response to oxidative stress;intracellular protein kinase cascade,cytoplasm,,+,,,,,,,,,,,,
1032,O95772,STARD3NL,MLN64 N-terminal domain homolog (STARD3 N-terminal-like protein),LMARIESYEGREK,_IES(ph)YEGREK_,S39,+,22.30,26.08,26.90,25.72,24.15,23.86,22.24,21.64,22.82,23.61,23.35,,22.45,23.76,-1.46,2.32,3.14,1.96,0.39,0.10,-1.52,-2.12,-0.93,-0.15,-0.41, ,-1.31,,integral to membrane;late endosome membrane,,,,,,,,,,,,,,
1034,O95785,WIZ,Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803),PLALAGSPTPKNP,_TPLALAGS(ph)PTPK_,S177,+,23.93,24.38,24.38,23.14,,23.00,24.15,,24.34,24.91,22.92,21.10,23.97,23.66,0.27,0.73,0.73,-0.51, ,-0.65,0.49, ,0.68,1.25,-0.74,-2.56,0.31,,nucleus,C2H2-type,,,,,,,,,,,,,
1036,O95785,WIZ,Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803),LSPRPASPKAQWP,_SPQLSLS(ph)PRPAS(ph)PK_,S198,+,26.88,25.85,26.49,26.00,24.38,24.11,25.88,23.81,26.16,24.90,24.22,25.21,24.55,25.26,1.62,0.59,1.22,0.74,-0.88,-1.16,0.62,-1.46,0.90,-0.37,-1.04,-0.06,-0.72,,nucleus,C2H2-type,,,,,,,,,,,,,
1038,O95793,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,TFFEPGSGDENGT,_VTFFEPGS(ph)GDENGTSNK_,S309,,23.28,,,22.00,,,,,,,,,,22.64,0.64, , ,-0.64, , , , , , , , , ,intracellular mRNA localization,rough endoplasmic reticulum;microtubule associated complex;cytoplasmic stress granule,,,,,,,,,,,,,,
1039,O95801,TTC4,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),FMSRAPSEIDPRE,_APS(ph)EIDPR_,S51,,23.64,19.55,19.55,,,,,,,,,,,20.91,2.73,-1.36,-1.36, , , , , , , , , , ,,,,,,,,,,,,,,,,
1041,O95810,SDPR,Serum deprivation-response protein (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein),SSPFKVSPLTFGR,_VS(ph)PLTFGR_,S293,+,19.23,24.72,24.09,24.74,24.69,23.68,25.19,24.26,23.64,,23.98,23.98,,23.84,-4.61,0.89,0.25,0.90,0.85,-0.16,1.35,0.42,-0.19, ,0.15,0.15, ,,cytosol;caveola;Golgi apparatus;plasma membrane,,,,,,,,,,,,,,
1042,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),RPLRAASPFRSSV,_AAS(ph)PFR_,S264,,23.84,,,25.29,,,,,,,,,,24.56,-0.72, , ,0.72, , , , , , , , , ,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
1044,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),APQRSQSPLRGMP,_SQS(ph)PLRGM(ox)PETTQPDK_,S136,+,24.43,24.33,24.33,,23.73,26.35,27.82,28.00,26.87,24.60,25.82,27.33,25.65,25.77,-1.34,-1.44,-1.44, ,-2.04,0.58,2.05,2.23,1.10,-1.17,0.05,1.56,-0.12,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
1045,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),SSTPLHSPSPIRV,_SSTPLHS(ph)PSPIR_,S289,,26.31,26.41,26.41,,22.36,,23.74,23.42,,,,23.02,,24.52,1.78,1.89,1.89, ,-2.16, ,-0.78,-1.11, , , ,-1.50, ,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
1046,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),VPCPPPSPGPSAV,_VPPAPVPCPPPS(ph)PGPSAVPS(ph)SPK_,S377,+,27.05,24.60,25.19,25.53,,22.75,26.04,23.34,24.81,23.72,25.08,24.55,,24.79,2.26,-0.19,0.41,0.74, ,-2.04,1.25,-1.45,0.03,-1.07,0.29,-0.24, ,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
1049,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),PSAVPSSPKSVAT,_VPPAPVPCPPPS(ph)PGPSAVPSS(ph)PK_,S386,,24.53,22.98,22.98,24.52,,,,,,,,,,23.75,0.78,-0.77,-0.77,0.76, , , , , , , , , ,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
1050,O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",QKKAALSASEGEE,_AALS(ph)ASEGEEVPQDK_,S112,,,25.69,,,,,,,,,,,,25.69, ,0.00, , , , , , , , , , , ,activation of cysteine-type endopeptidase activity involved in apoptotic process;neuron differentiation;neuron apoptotic process;apoptotic DNA fragmentation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cell redox homeostasis;mitochondrial respiratory chain complex I assembly,cytosol;mitochondrial inner membrane;nucleus;mitochondrial membrane part;perinuclear region of cytoplasm;mitochondrial intermembrane space,,,,,,,,,,,,,,
1051,O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",KAALSASEGEEVP,_AALSAS(ph)EGEEVPQDK_,S114,,23.54,25.01,23.78,22.39,21.53,25.04,22.72,,,24.63,,,23.31,23.55,-0.01,1.46,0.23,-1.16,-2.02,1.49,-0.83, , ,1.08, , ,-0.24,activation of cysteine-type endopeptidase activity involved in apoptotic process;neuron differentiation;neuron apoptotic process;apoptotic DNA fragmentation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cell redox homeostasis;mitochondrial respiratory chain complex I assembly,cytosol;mitochondrial inner membrane;nucleus;mitochondrial membrane part;perinuclear region of cytoplasm;mitochondrial intermembrane space,,,,,,,,,,,,,,
1052,O95831,AIFM1,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",KIGDFRSLEKISR,_IGDFRS(ph)LEK_,S288,,,21.70,21.40,,,,,,22.01,23.18,,,,22.07, ,-0.37,-0.67, , , , , ,-0.06,1.10, , , ,activation of cysteine-type endopeptidase activity involved in apoptotic process;neuron differentiation;neuron apoptotic process;apoptotic DNA fragmentation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;cell redox homeostasis;mitochondrial respiratory chain complex I assembly,cytosol;mitochondrial inner membrane;nucleus;mitochondrial membrane part;perinuclear region of cytoplasm;mitochondrial intermembrane space,,,,,,,,,,,,,,
1057,O95983,MBD3,Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3),QRVRYDSSNQVKG,_VRYDS(ph)SNQVK_,S53,,23.27,25.60,25.60,,20.83,,,20.77,20.86,,,,,22.82,0.45,2.78,2.78, ,-1.99, , ,-2.05,-1.96, , , , ,"methylation-dependent chromatin silencing;histone acetylation;tissue development;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;in utero embryonic development",NuRD complex;heterochromatin;cytoplasm,,,,,,,,,,,,,,
1058,O95983,MBD3,Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3),ARYLGGSMDLSTF,_YLGGS(ph)M(ox)DLSTFDFR_,S24,,24.26,,,,,,,,,,,,,24.26,0.00, , , , , , , , , , , , ,"methylation-dependent chromatin silencing;histone acetylation;tissue development;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;in utero embryonic development",NuRD complex;heterochromatin;cytoplasm,,,,,,,,,,,,,,
1059,Q9NZH5,PTTG2,Securin-2 (Pituitary tumor-transforming gene 2 protein),FQLGPPSPVKMPS,_LFQLGPPS(ph)PVK_,S165,+,24.32,23.88,23.88,22.78,21.33,22.22,25.06,23.35,23.08,22.79,22.30,23.87,,23.24,1.08,0.64,0.64,-0.45,-1.91,-1.02,1.82,0.11,-0.16,-0.45,-0.94,0.63, ,chromosome organization;DNA metabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
1061,O96013,PAK4,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),EVPRRKSLVGTPY,_S(ph)LVGTPYWM(ox)APELISR_,S474,+,27.28,24.88,23.94,26.78,27.40,22.41,26.92,27.58,24.18,26.13,26.76,27.46,26.73,26.03,1.24,-1.16,-2.09,0.75,1.37,-3.62,0.89,1.54,-1.85,0.10,0.73,1.43,0.69,cell proliferation;signal transduction;cell migration;apoptotic process;cytoskeleton organization;cell growth;cell cycle,Golgi apparatus,,+,,,,,,,,,,,,
1062,O96017,CHEK2,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),RKFAIGSAREADP,_FAIGS(ph)AR_,S39,,24.23,23.21,23.21,21.84,,,,,,,,,,23.12,1.11,0.09,0.09,-1.28, , , , , , , , , ,"regulation of protein catabolic process;double-strand break repair;cellular protein catabolic process;protein autophosphorylation;G2/M transition of mitotic cell cycle;spindle assembly involved in mitosis;positive regulation of transcription, DNA-dependent;intrinsic apoptotic signaling pathway in response to DNA damage;response to gamma radiation;transcription, DNA-dependent;replicative senescence;cell division;signal transduction involved in intra-S DNA damage checkpoint;DNA damage induced protein phosphorylation",PML body,,+,,,,,,,,,,,,
1065,O96028,WHSC1,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1),TPIKNGSPEIKLK,_GIGTPPNTTPIKNGS(ph)PEIK_,S121,,,,,,23.28,,,22.25,,,,,,22.76, , , , ,0.52, , ,-0.52, , , , , ,"membranous septum morphogenesis;atrial septum secundum morphogenesis;atrial septum primum morphogenesis;anatomical structure morphogenesis;negative regulation of transcription from RNA polymerase II promoter;bone development;transcription, DNA-dependent",nuclear membrane;nucleolus;chromosome;cytoplasm,HMG-box,,,,,,,,,,,,,
1066,P00338,LDHA,L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59),VKVTLTSEEEARL,_VTLTS(ph)EEEAR_,S310,,24.17,23.97,,23.59,,,,,,,,,,23.91,0.26,0.06, ,-0.32, , , , , , , , , ,cellular response to extracellular stimulus;cellular carbohydrate metabolic process;pyruvate metabolic process;glycolysis,cytosol;mitochondrion;flagellum,,,,,,,,,,,,,,
1067,P00450,CP,Ceruloplasmin (EC 1.16.3.1) (Ferroxidase),NQCRRQSEDSTFY,_RQS(ph)EDSTFYLGER_,S651,,24.62,,,,,,,,,,,,,24.62,0.00, , , , , , , , , , , , ,copper ion transport;cellular iron ion homeostasis;transmembrane transport,extracellular space,,,,,,,,,,,,,,
1068,P00533,EGFR,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),KGSHQISLDNPDY,_GSHQIS(ph)LDNPDYQQDFFPK_,S1166,,,,,,23.35,,23.30,,,,,22.74,,23.13, , , , ,0.22, ,0.17, , , , ,-0.39, ,regulation of nitric-oxide synthase activity;positive regulation of MAP kinase activity;negative regulation of apoptotic process;positive regulation of catenin import into nucleus;cell-cell adhesion;protein autophosphorylation;cerebral cortex cell migration;activation of phospholipase A2 activity by calcium-mediated signaling;regulation of peptidyl-tyrosine phosphorylation;positive regulation of cell migration;hair follicle development;protein insertion into membrane;digestive tract morphogenesis;embryonic placenta development;positive regulation of fibroblast proliferation;ossification;positive regulation of protein kinase B signaling cascade;activation of phospholipase C activity;positive regulation of epithelial cell proliferation;axon guidance;response to stress;negative regulation of protein catabolic process;cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;response to UV-A;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;salivary gland morphogenesis;morphogenesis of an epithelial fold;positive regulation of nitric oxide biosynthetic process;positive regulation of DNA replication;positive regulation of DNA repair,endosome;endocytic vesicle;membrane raft;basolateral plasma membrane;Golgi membrane;perinuclear region of cytoplasm;nuclear membrane;Shc-EGFR complex;endosome membrane;extracellular space;integral to membrane;nucleus;endoplasmic reticulum membrane,,+,,,,,,,,,+,,,
1070,P00533,EGFR,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),KIKVLGSGAFGTV,_VLGS(ph)GAFGTVYK_,S720,,22.26,,,,,,,,,,,,,22.26,0.00, , , , , , , , , , , , ,regulation of nitric-oxide synthase activity;positive regulation of MAP kinase activity;negative regulation of apoptotic process;positive regulation of catenin import into nucleus;cell-cell adhesion;protein autophosphorylation;cerebral cortex cell migration;activation of phospholipase A2 activity by calcium-mediated signaling;regulation of peptidyl-tyrosine phosphorylation;positive regulation of cell migration;hair follicle development;protein insertion into membrane;digestive tract morphogenesis;embryonic placenta development;positive regulation of fibroblast proliferation;ossification;positive regulation of protein kinase B signaling cascade;activation of phospholipase C activity;positive regulation of epithelial cell proliferation;axon guidance;response to stress;negative regulation of protein catabolic process;cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;response to UV-A;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;salivary gland morphogenesis;morphogenesis of an epithelial fold;positive regulation of nitric oxide biosynthetic process;positive regulation of DNA replication;positive regulation of DNA repair,endosome;endocytic vesicle;membrane raft;basolateral plasma membrane;Golgi membrane;perinuclear region of cytoplasm;nuclear membrane;Shc-EGFR complex;endosome membrane;extracellular space;integral to membrane;nucleus;endoplasmic reticulum membrane,,+,,,,,,,,,+,,,
1071,P00558,PGK 1.00,Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2),FAKALESPERPFL,_ALES(ph)PERPFLAILGGAK_,S203,+,26.21,27.54,26.63,27.01,26.32,26.91,26.14,27.98,27.22,26.52,28.34,27.91,27.27,27.08,-0.87,0.46,-0.45,-0.06,-0.75,-0.17,-0.94,0.90,0.14,-0.56,1.26,0.84,0.19,small molecule metabolic process;gluconeogenesis;glycolysis,cytosol,,,,,,,,,,,,,,
1072,P01024,C3,Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain;Complement C3 alpha chain;C3a anaphylatoxin;Acylation stimulating protein (ASP) (C3adesArg);Complement C3b alpha' chain;Complement C3c alpha' chain fragment 1;Complement C3dg fragment;Complement C3g fragment;Complement C3d fragment;Complement C3f fragment;Complement C3c alpha' chain fragment 2],AARRRRSVQLTEK,_S(ph)VQLTEK_,S672,,25.17,,,24.69,,,,,,,,21.54,,23.80,1.37, , ,0.89, , , , , , , ,-2.26, ,"inflammatory response;complement activation, classical pathway;complement activation, alternative pathway;positive regulation of lipid storage;regulation of triglyceride biosynthetic process;fatty acid metabolic process;positive regulation of phagocytosis;positive regulation of G-protein coupled receptor protein signaling pathway;positive regulation of type IIa hypersensitivity;positive regulation vascular endothelial growth factor production;G-protein coupled receptor signaling pathway;positive regulation of angiogenesis;positive regulation of activation of membrane attack complex;negative regulation of endopeptidase activity;positive regulation of protein phosphorylation;positive regulation of glucose transport;regulation of complement activation",extracellular space;extracellular vesicular exosome;plasma membrane,,,,,,,,,,,,,,
1073,P01034,CST3,Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin),GGPMDASVEEEGV,_LVGGPM(ox)DAS(ph)VEEEGVRR_,S43,,23.62,24.52,,22.18,,,,23.21,,,22.72,,22.35,23.10,0.52,1.42, ,-0.92, , , ,0.11, , ,-0.38, ,-0.75,"cellular response to hydrogen peroxide;response to toxin;response to drug;embryo implantation;response to axon injury;negative regulation of blood vessel remodeling;negative regulation of extracellular matrix disassembly;extracellular fibril organization;regulation of programmed cell death;positive regulation of cell proliferation;apoptotic process;salivary gland development;defense response;negative regulation of collagen catabolic process;negative regulation of cell death;Sertoli cell development;response to nutrient levels;response to hypoxia;eye development;response to estradiol stimulus;circadian sleep/wake cycle, REM sleep;cell activation;brain development;negative regulation of elastin catabolic process;response to carbohydrate stimulus;negative regulation of histolysis;positive regulation of DNA replication",neuronal cell body;axon part;endoplasmic reticulum;perinuclear region of cytoplasm;nuclear membrane;vesicle;extracellular space;contractile fiber;basement membrane;lysosome;multivesicular body,,,,,,,,,,,,,,
1077,P01583,IL1A,Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1),EAIANDSEEEIIK,_RLS(ph)LSQSITDDDLEAIANDS(ph)EEEIIKPR_,S104,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;negative regulation of cell proliferation;inflammatory response;immune response;positive regulation of mitosis;positive regulation of ERK1 and ERK2 cascade;response to gamma radiation;response to lipopolysaccharide;response to L-ascorbic acid;regulation of sensory perception of pain;positive regulation of cytokine secretion;response to organic cyclic compound;keratinization;positive regulation of cell division;fever generation;wound healing;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of JNK cascade;response to organic nitrogen;apoptotic process;positive regulation of steroid biosynthetic process;cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interleukin-6 production;positive regulation vascular endothelial growth factor production;response to hypoxia;response to ozone;positive regulation of interleukin-2 biosynthetic process;cellular response to heat;positive regulation of angiogenesis;cell proliferation;response to copper ion,cytosol;extracellular space;cell surface,,,,,,,,,,,,,,
1079,P02511,CRYAB,Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component),SFLRAPSWFDTGL,_APS(ph)WFDTGLSEM(ox)R_,S59,,26.90,22.08,22.08,,,,,,,,,,,23.68,3.21,-1.61,-1.61, , , , , , , , , , ,negative regulation of apoptotic process;negative regulation of intracellular transport;negative regulation of gene expression;aging;protein folding;negative regulation of cell growth;negative regulation of reactive oxygen species metabolic process;apoptotic process involved in morphogenesis;stress-activated MAPK cascade;glucose metabolic process;lens development in camera-type eye;muscle organ development;response to hypoxia;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;response to estradiol stimulus;microtubule polymerization or depolymerization;response to hydrogen peroxide;tubulin complex assembly;protein homooligomerization;muscle contraction,Z disc;mitochondrion;Golgi apparatus;actin filament bundle;cytoplasm;cytosol;microtubule cytoskeleton;plasma membrane;nucleus;cell surface,,,,,,,,,,,,,,
1080,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",IGGGLSSVGGGSS,_AIGGGLSS(ph)VGGGSSTIK_,S512,,24.91,22.41,22.91,,23.02,,23.22,22.79,,,,,,23.21,1.70,-0.80,-0.30, ,-0.19, ,0.01,-0.42, , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1083,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",TTIRSHSSSRRGF,_(ac)ASTSTTIRSHS(ph)SSR_,S12,,23.87,27.53,27.53,,,,,,,,,,,26.31,-2.44,1.22,1.22, , , , , , , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1086,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",RGFSANSARLPGV,_RGFS(ph)ANS(ph)AR_,S22,+,29.08,28.72,29.60,22.39,25.39,23.69,26.05,24.97,19.57,23.05,21.68,22.19,24.21,24.66,4.42,4.06,4.94,-2.27,0.73,-0.97,1.39,0.31,-5.09,-1.62,-2.99,-2.47,-0.45,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1088,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",GGSKRISIGGGSC,_IS(ph)IGGGSCAISGGYGSR_,S71,,22.41,,,,,,,,,,,,,22.41,0.00, , , , , , , , , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1089,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",LRRQLDSIVGERG,_(gl)QLDS(ph)IVGER_,S198,,21.05,,,,,,,,,,,,,21.05,0.00, , , , , , , , , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1090,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SRSGFSSVSVSRS,_SGFSS(ph)VSVSR_,S35,,23.51,23.38,23.38,,21.51,,22.47,,,,,,,22.85,0.66,0.53,0.53, ,-1.34, ,-0.38, , , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1091,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",SGFSSVSVSRSRG,_SGFSSVS(ph)VSR_,S37,+,31.18,28.83,29.63,25.59,27.40,26.08,27.91,27.49,,26.23,25.55,24.63,24.54,27.09,4.09,1.74,2.54,-1.50,0.31,-1.01,0.83,0.41, ,-0.86,-1.54,-2.46,-2.55,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1092,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",AGFGSRSLYGLGG,_S(ph)LYGLGGSK_,S60,+,30.73,30.09,31.00,24.19,28.04,26.84,28.84,28.43,22.75,28.10,25.81,22.83,25.32,27.15,3.58,2.94,3.85,-2.96,0.89,-0.31,1.69,1.28,-4.40,0.95,-1.35,-4.32,-1.83,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1093,P02538,KRT6A,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",LYGLGGSKRISIG,_SLYGLGGS(ph)K_,S67,,25.18,21.94,21.94,,,,,,,,,,,23.02,2.16,-1.08,-1.08, , , , , , , , , , ,cell differentiation;positive regulation of cell proliferation;ectoderm development,intermediate filament;keratin filament,,,,,,,,,,,,,,
1096,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],GPISSGSSASSVT,_ASASGSGAQVGGPISSGS(ph)SASSVTVTR_,S615,,26.33,22.49,22.80,22.54,22.88,23.17,23.00,22.47,23.71,,,23.10,23.50,23.27,3.05,-0.78,-0.47,-0.73,-0.39,-0.10,-0.28,-0.80,0.44, , ,-0.17,0.23,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1097,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],PISSGSSASSVTV,_ASASGSGAQVGGPISSGSS(ph)ASSVTVTR_,S616,+,25.70,23.60,23.75,23.58,22.94,23.93,23.66,23.30,24.15,24.39,22.66,23.32,,23.75,1.95,-0.15,0.00,-0.17,-0.81,0.18,-0.08,-0.45,0.40,0.64,-1.08,-0.43, ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1099,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],SGSSASSVTVTRS,_ASASGSGAQVGGPISSGSS(ph)ASS(ph)VTVTR_,S619,,25.03,,,,,,,,21.52,,,23.21,,23.25,1.78, , , , , , , ,-1.73, , ,-0.05, ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1102,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],GRASSHSSQTQGG,_GRASSHS(ph)S(ph)QTQGGGSVTK_,S406,,25.89,23.47,21.56,24.45,,,,,,,,,,23.84,2.05,-0.37,-2.28,0.60, , , , , , , , , ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1103,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],RASSHSSQTQGGG,_GRASS(ph)HSS(ph)QTQGGGSVTK_,S407,,27.00,25.50,25.94,25.60,,,,,21.25,,,,,25.06,1.95,0.44,0.88,0.54, , , , ,-3.81, , , , ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1104,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],SRIRIDSLSAQLS,_IRIDS(ph)LSAQLSQLQK_,S301,+,23.51,,,,25.37,23.38,,23.25,24.74,25.31,22.21,,24.89,24.08,-0.57, , , ,1.29,-0.71, ,-0.84,0.66,1.23,-1.87, ,0.81,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1105,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LDNARQSAERNSN,_LDNARQS(ph)AER_,S277,+,24.76,22.81,18.87,23.26,17.52,,,,,,19.32,19.89,24.78,21.40,3.35,1.41,-2.53,1.86,-3.88, , , , , ,-2.08,-1.51,3.38,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1106,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],KKRKLESTESRSS,_RKLES(ph)TESR_,S423,+,24.86,24.69,25.38,22.84,,,20.21,,20.29,,,20.43,,22.67,2.19,2.02,2.71,0.17, , ,-2.46, ,-2.38, , ,-2.24, ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1108,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],STESRSSFSQHAR,_LESTESRSS(ph)FSQHAR_,S429,+,25.37,25.26,25.62,23.66,23.18,22.76,22.86,22.62,25.07,24.79,22.53,24.20,17.28,23.48,1.89,1.79,2.14,0.19,-0.30,-0.72,-0.62,-0.86,1.60,1.31,-0.94,0.72,-6.20,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1109,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],EERLRLSPSPTSQ,_LRLS(ph)PS(ph)PTSQR_,S390,+,32.26,31.05,31.51,29.92,31.23,30.23,30.02,29.08,29.86,29.86,29.25,29.80,30.06,30.32,1.94,0.74,1.19,-0.39,0.91,-0.09,-0.30,-1.24,-0.45,-0.46,-1.07,-0.52,-0.26,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1112,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],FQKNIYSEELRET,_NIYS(ph)EELR_,S212,+,24.46,24.79,24.70,24.34,22.14,25.36,,24.33,24.23,23.76,23.94,25.30,24.77,24.34,0.12,0.44,0.36,0.00,-2.21,1.02, ,-0.01,-0.11,-0.58,-0.40,0.96,0.43,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1113,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],VRLRNKSNEDQSM,_S(ph)NEDQSMGNWQIK_,S458,+,27.44,26.15,26.35,26.19,21.13,23.18,25.18,24.46,26.25,26.70,25.02,25.98,23.58,25.20,2.24,0.95,1.15,0.99,-4.07,-2.02,-0.02,-0.74,1.05,1.50,-0.18,0.78,-1.62,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1114,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],KSNEDQSMGNWQI,_SNEDQS(ph)M(ox)GNWQIK_,S463,+,23.83,23.43,23.43,22.13,22.30,23.31,23.11,22.99,23.42,23.23,22.84,,22.20,23.02,0.82,0.41,0.41,-0.88,-0.72,0.29,0.09,-0.03,0.40,0.21,-0.18, ,-0.82,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1115,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],QRRATRSGAQASS,_S(ph)GAQASSTPLSPTR_,S12,+,26.02,24.44,,24.01,25.14,25.09,23.46,,23.73,23.28,,,22.49,24.18,1.84,0.25, ,-0.17,0.96,0.90,-0.73, ,-0.46,-0.90, , ,-1.70,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1117,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],ASSTPLSPTRITR,_SGAQASSTPLS(ph)PTRITR_,S22,+,30.65,28.85,28.85,29.47,29.44,28.78,29.12,29.44,27.37,27.63,28.10,28.24,28.69,28.82,1.83,0.03,0.04,0.65,0.62,-0.04,0.30,0.63,-1.44,-1.19,-0.72,-0.58,-0.12,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1118,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],YIDRVRSLETENA,_S(ph)LETENAGLR_,S51,,24.29,22.90,,,23.80,,,,,,23.59,,,23.64,0.65,-0.74, , ,0.16, , , , , ,-0.06, , ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1119,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],YRSVGGSGGGSFG,_SVGGS(ph)GGGSFGDNLVTR_,S632,+,26.35,25.92,26.05,,24.55,25.27,26.91,,27.08,27.95,26.73,26.99,25.28,26.28,0.07,-0.36,-0.23, ,-1.73,-1.01,0.63, ,0.80,1.67,0.45,0.71,-1.00,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1120,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],GGSGGGSFGDNLV,_SVGGSGGGS(ph)FGDNLVTR_,S636,,24.52,,,,,,,,,,,,,24.52,0.00, , , , , , , , , , , , ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1123,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],RTALINSTGEEVA,_TALINS(ph)TGEEVAM(ox)RK_,S533,,23.58,21.65,21.65,,,,21.87,,,22.08,,,22.13,22.16,1.42,-0.51,-0.51, , , ,-0.29, , ,-0.08, , ,-0.03,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1125,P02751,FN1,Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin;Ugl-Y1;Ugl-Y2;Ugl-Y3],QADREDSRE____,_TNTNVNCPIECFM(ox)PLDVQADREDS(ph)RE_,S2353,,,,,,,,,23.24,25.11,,,,,24.18, , , , , , , ,-0.93,0.93, , , , ,platelet degranulation;regulation of cell shape;angiogenesis;platelet activation;peptide cross-linking;extracellular matrix organization;calcium-independent cell-matrix adhesion;substrate adhesion-dependent cell spreading;cell-substrate junction assembly;acute-phase response;leukocyte migration,endoplasmic reticulum-Golgi intermediate compartment;proteinaceous extracellular matrix;basement membrane;apical plasma membrane;platelet alpha granule lumen;fibrinogen complex,,,,,,,,,,,,,,
1127,P02771,AFP,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),ATCCQLSEDKLLA,_M(ox)AATAATCCQLS(ph)EDK_,S307,,24.38,24.44,,,,,,,,21.70,,20.67,,22.80,1.59,1.64, , , , , , , ,-1.10, ,-2.13, ,pancreas development;transport;liver development;ovulation from ovarian follicle;progesterone metabolic process;SMAD protein signal transduction;organ regeneration;response to organic substance,extracellular space;cytoplasm,,,,,,,,,,,,,,
1128,P02794,FTH1,Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein),KHTLGDSDNES__,_HTLGDS(ph)DNES_,S179,+,25.65,25.93,25.71,28.20,26.29,25.22,24.55,24.79,25.04,23.91,24.21,27.08,24.38,25.46,0.19,0.47,0.25,2.74,0.83,-0.24,-0.91,-0.67,-0.42,-1.55,-1.25,1.62,-1.08,post-Golgi vesicle-mediated transport;cellular membrane organization;immune response;iron ion transport;intracellular sequestering of iron ion;transmembrane transport;negative regulation of fibroblast proliferation,cytosol;mitochondrion;intracellular ferritin complex,,,,,,,,,,,,,,
1130,P04049,RAF1,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),GYQRRASDDGKLT,_RAS(ph)DDGKLTDPSK_,S43,,,20.60,20.60,,,20.43,,22.80,,,,,,21.11, ,-0.51,-0.51, , ,-0.68, ,1.69, , , , , ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;negative regulation of cell proliferation;MAPK cascade;regulation of cell differentiation;fibroblast growth factor receptor signaling pathway;activation of adenylate cyclase activity;Ras protein signal transduction;insulin receptor signaling pathway;regulation of cell motility;activation of MAPKK activity;cytoskeleton organization;platelet activation;regulation of Rho protein signal transduction;response to hypoxia;axon guidance;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cell proliferation;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;heart development;negative regulation of protein complex assembly,mitochondrial outer membrane;cytosol;plasma membrane;nucleus;pseudopodium,,+,,,,,,,,,,,,
1131,P04049,RAF1,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),KINRSASEPSLHR,_SAS(ph)EPSLHR_,S1034,,26.11,,,28.01,,,,,,,,,,27.06,-0.95, , ,0.95, , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;negative regulation of cell proliferation;MAPK cascade;regulation of cell differentiation;fibroblast growth factor receptor signaling pathway;activation of adenylate cyclase activity;Ras protein signal transduction;insulin receptor signaling pathway;regulation of cell motility;activation of MAPKK activity;cytoskeleton organization;platelet activation;regulation of Rho protein signal transduction;response to hypoxia;axon guidance;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cell proliferation;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;heart development;negative regulation of protein complex assembly,mitochondrial outer membrane;cytosol;plasma membrane;nucleus;pseudopodium,,+,,,,,,,,,,,,
1134,P04049,RAF1,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),QRQRSTSTPNVHM,_STS(ph)TPNVHM(ox)VSTTLPVDSR_,S672,+,22.75,24.01,24.01,24.73,25.95,24.62,26.56,27.61,23.95,24.22,26.86,26.78,24.53,25.12,-2.38,-1.11,-1.11,-0.39,0.83,-0.51,1.44,2.49,-1.17,-0.90,1.74,1.66,-0.59,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;negative regulation of cell proliferation;MAPK cascade;regulation of cell differentiation;fibroblast growth factor receptor signaling pathway;activation of adenylate cyclase activity;Ras protein signal transduction;insulin receptor signaling pathway;regulation of cell motility;activation of MAPKK activity;cytoskeleton organization;platelet activation;regulation of Rho protein signal transduction;response to hypoxia;axon guidance;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cell proliferation;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;heart development;negative regulation of protein complex assembly,mitochondrial outer membrane;cytosol;plasma membrane;nucleus;pseudopodium,,+,,,,,,,,,,,,
1135,P04075,ALDOA,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),ILAADESTGSIAK,_GILAADES(ph)TGSIAK_,S36,+,26.52,25.53,25.50,25.16,24.13,24.11,24.30,25.19,23.39,22.88,25.42,25.52,24.25,24.76,1.76,0.76,0.74,0.40,-0.64,-0.65,-0.46,0.43,-1.37,-1.88,0.66,0.76,-0.51,"platelet degranulation;muscle cell homeostasis;regulation of cell shape;protein homotetramerization;platelet activation;striated muscle contraction;fructose 1,6-bisphosphate metabolic process;actin filament organization;gluconeogenesis;glycolysis;ATP biosynthetic process;fructose metabolic process",cytosol;extracellular vesicular exosome;platelet alpha granule lumen;I band;actin cytoskeleton,,,,,,,,,,,,,,
1136,P04075,ALDOA,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),ADESTGSIAKRLQ,_GILAADESTGS(ph)IAK_,S39,+,26.49,26.56,26.36,25.29,,24.81,25.64,25.73,24.58,24.44,26.23,26.33,24.94,25.61,0.87,0.95,0.74,-0.33, ,-0.80,0.03,0.11,-1.04,-1.18,0.61,0.71,-0.67,"platelet degranulation;muscle cell homeostasis;regulation of cell shape;protein homotetramerization;platelet activation;striated muscle contraction;fructose 1,6-bisphosphate metabolic process;actin filament organization;gluconeogenesis;glycolysis;ATP biosynthetic process;fructose metabolic process",cytosol;extracellular vesicular exosome;platelet alpha granule lumen;I band;actin cytoskeleton,,,,,,,,,,,,,,
1137,P04075,ALDOA,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),IAKRLQSIGTENT,_LQS(ph)IGTENTEENR_,S46,+,25.04,25.20,24.19,23.80,23.46,23.28,24.42,25.12,23.17,22.87,25.04,24.88,23.85,24.18,0.86,1.03,0.01,-0.38,-0.72,-0.90,0.25,0.94,-1.01,-1.30,0.86,0.70,-0.33,"platelet degranulation;muscle cell homeostasis;regulation of cell shape;protein homotetramerization;platelet activation;striated muscle contraction;fructose 1,6-bisphosphate metabolic process;actin filament organization;gluconeogenesis;glycolysis;ATP biosynthetic process;fructose metabolic process",cytosol;extracellular vesicular exosome;platelet alpha granule lumen;I band;actin cytoskeleton,,,,,,,,,,,,,,
1138,P04083,ANXA1,Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35),SKGGPGSAVSPYP,_GGPGS(ph)AVSPYPTFNPSSDVAALHK_,S34,,23.42,,,,,,,,,,,,,23.42,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;insulin secretion;inflammatory response;cellular response to hydrogen peroxide;cellular response to glucocorticoid stimulus;neutrophil clearance;response to drug;negative regulation of acute inflammatory response;response to interleukin-1;positive regulation of vesicle fusion;response to peptide hormone stimulus;negative regulation of protein secretion;keratinocyte differentiation;alpha-beta T cell differentiation;cell surface receptor signaling pathway;cellular component movement;positive regulation of prostaglandin biosynthetic process;endocrine pancreas development;peptide cross-linking;regulation of cell proliferation;arachidonic acid secretion;gliogenesis;response to estradiol stimulus;estrous cycle phase;response to X-ray;hepatocyte differentiation;cell cycle;positive regulation of apoptotic process,basolateral plasma membrane;sarcolemma;cornified envelope;cilium;protein complex;cytoplasm;extracellular space;extracellular vesicular exosome;plasma membrane;mitochondrial membrane;nucleus,,,,,,,,,,,,,,
1140,P04233,CD74,HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74),DQRDLISNNEQLP,_DLIS(ph)NNEQLPM(ox)LGR_,S25,,24.53,,,,,,,,,,,,,24.53,0.00, , , , , , , , , , , , ,"positive regulation of dendritic cell antigen processing and presentation;negative regulation of apoptotic process;immunoglobulin mediated immune response;positive regulation of ERK1 and ERK2 cascade;negative regulation of T cell differentiation;antigen processing and presentation of endogenous antigen;intracellular protein transport;negative thymic T cell selection;macrophage migration inhibitory factor signaling pathway;positive thymic T cell selection;positive regulation of fibroblast proliferation;regulation of macrophage activation;prostaglandin biosynthetic process;positive regulation of cytokine-mediated signaling pathway;chaperone mediated protein folding requiring cofactor;defense response;negative regulation of mature B cell apoptotic process;negative regulation of DNA damage response, signal transduction by p53 class mediator;antigen processing and presentation of exogenous peptide antigen via MHC class II;positive regulation of neutrophil chemotaxis;positive regulation of peptidyl-tyrosine phosphorylation;T cell selection;activation of MAPK activity;positive regulation of T cell differentiation;protein complex assembly;positive regulation of macrophage cytokine production;negative regulation of peptide secretion;positive regulation of type 2 immune response;cell proliferation;positive regulation of B cell proliferation;positive regulation of chemokine (C-X-C motif) ligand 2 production",integral to lumenal side of endoplasmic reticulum membrane;ER to Golgi transport vesicle membrane;clathrin-coated endocytic vesicle membrane;lysosomal membrane;external side of plasma membrane;Golgi membrane;MHC class II protein complex;macrophage migration inhibitory factor receptor complex;NOS2-CD74 complex;lysosomal lumen;plasma membrane;cell surface;trans-Golgi network membrane;multivesicular body,,,,,,,,,,,,,,
1141,P04406,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),QNIIPASTGAAKA,_GALQNIIPAS(ph)TGAAK_,S210,,,,,,23.72,23.76,23.83,22.96,,,,23.60,23.18,23.51, , , , ,0.21,0.25,0.32,-0.55, , , ,0.09,-0.33,small molecule metabolic process;protein stabilization;negative regulation of translation;peptidyl-cysteine S-trans-nitrosylation;gluconeogenesis;neuron apoptotic process;glycolysis;microtubule cytoskeleton organization;cellular response to interferon-gamma,ribonucleoprotein complex;perinuclear region of cytoplasm;cytosol;microtubule cytoskeleton;extracellular vesicular exosome;lipid particle;nucleus;plasma membrane,,,,,,,,,,,,,,
1142,P04406,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),FQERDPSKIKWGD,_LVINGNPITIFQERDPS(ph)K_,S83,+,27.80,25.46,25.46,26.36,,,26.43,26.16,26.42,26.44,28.88,28.18,27.42,26.82,0.98,-1.36,-1.36,-0.46, , ,-0.39,-0.66,-0.40,-0.38,2.06,1.37,0.60,small molecule metabolic process;protein stabilization;negative regulation of translation;peptidyl-cysteine S-trans-nitrosylation;gluconeogenesis;neuron apoptotic process;glycolysis;microtubule cytoskeleton organization;cellular response to interferon-gamma,ribonucleoprotein complex;perinuclear region of cytoplasm;cytosol;microtubule cytoskeleton;extracellular vesicular exosome;lipid particle;nucleus;plasma membrane,,,,,,,,,,,,,,
1143,P04626,ERBB2,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),EDLGPASPLDSTF,_FVVIQNEDLGPAS(ph)PLDSTFYR_,S983,,28.24,,,,,,,,,,,,,28.24,0.00, , , , , , , , , , , , ,"positive regulation of MAP kinase activity;neuromuscular junction development;negative regulation of apoptotic process;regulation of microtubule-based process;regulation of ERK1 and ERK2 cascade;liver development;positive regulation of Rho GTPase activity;positive regulation of translation;positive regulation of transcription from RNA polymerase I promoter;positive regulation of cell growth;phosphatidylinositol 3-kinase cascade;regulation of angiogenesis;positive regulation of epithelial cell proliferation;peripheral nervous system development;transcription, DNA-dependent;heart development;mammary gland involution;protein autophosphorylation;wound healing;response to drug;response to axon injury;estrus;positive regulation of transcription from RNA polymerase III promoter;myelination;mammary gland development;sympathetic nervous system development;negative regulation of immature T cell proliferation in thymus;response to progesterone stimulus;positive regulation of Ras protein signal transduction;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of cell adhesion;cell proliferation;tongue development;glial cell differentiation;motor neuron axon guidance",membrane raft;basolateral plasma membrane;apical plasma membrane;receptor complex;perinuclear region of cytoplasm;lateral loop;endosome membrane;integral to membrane;nucleus;postsynaptic membrane;basal plasma membrane;microvillus,,+,,,,,,,,,,,,
1144,P04626,ERBB2,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),RSSSTRSGGGDLT,_S(ph)GGGDLTLGLEPSEEEAPR_,S1039,,26.44,,,22.35,,,,,,,,,,24.39,2.04, , ,-2.04, , , , , , , , , ,"positive regulation of MAP kinase activity;neuromuscular junction development;negative regulation of apoptotic process;regulation of microtubule-based process;regulation of ERK1 and ERK2 cascade;liver development;positive regulation of Rho GTPase activity;positive regulation of translation;positive regulation of transcription from RNA polymerase I promoter;positive regulation of cell growth;phosphatidylinositol 3-kinase cascade;regulation of angiogenesis;positive regulation of epithelial cell proliferation;peripheral nervous system development;transcription, DNA-dependent;heart development;mammary gland involution;protein autophosphorylation;wound healing;response to drug;response to axon injury;estrus;positive regulation of transcription from RNA polymerase III promoter;myelination;mammary gland development;sympathetic nervous system development;negative regulation of immature T cell proliferation in thymus;response to progesterone stimulus;positive regulation of Ras protein signal transduction;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of cell adhesion;cell proliferation;tongue development;glial cell differentiation;motor neuron axon guidance",membrane raft;basolateral plasma membrane;apical plasma membrane;receptor complex;perinuclear region of cytoplasm;lateral loop;endosome membrane;integral to membrane;nucleus;postsynaptic membrane;basal plasma membrane;microvillus,,+,,,,,,,,,,,,
1146,P04626,ERBB2,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),EEEAPRSPLAPSE,_SGGGDLTLGLEPSEEEAPRS(ph)PLAPSEGAGSDVFDGDLGM(ox)GAAK_,S1058,,24.95,,,,,,,,,,,,,24.95,0.00, , , , , , , , , , , , ,"positive regulation of MAP kinase activity;neuromuscular junction development;negative regulation of apoptotic process;regulation of microtubule-based process;regulation of ERK1 and ERK2 cascade;liver development;positive regulation of Rho GTPase activity;positive regulation of translation;positive regulation of transcription from RNA polymerase I promoter;positive regulation of cell growth;phosphatidylinositol 3-kinase cascade;regulation of angiogenesis;positive regulation of epithelial cell proliferation;peripheral nervous system development;transcription, DNA-dependent;heart development;mammary gland involution;protein autophosphorylation;wound healing;response to drug;response to axon injury;estrus;positive regulation of transcription from RNA polymerase III promoter;myelination;mammary gland development;sympathetic nervous system development;negative regulation of immature T cell proliferation in thymus;response to progesterone stimulus;positive regulation of Ras protein signal transduction;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of cell adhesion;cell proliferation;tongue development;glial cell differentiation;motor neuron axon guidance",membrane raft;basolateral plasma membrane;apical plasma membrane;receptor complex;perinuclear region of cytoplasm;lateral loop;endosome membrane;integral to membrane;nucleus;postsynaptic membrane;basal plasma membrane;microvillus,,+,,,,,,,,,,,,
1149,P04632,CAPNS1,Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit),_MFLVNSFLKGGG,_(ac)M(ox)FLVNS(ph)FLK_,S6,,22.29,,,,,,,,,,,,,22.29,0.00, , , , , , , , , , , , ,proteolysis;positive regulation of cell proliferation,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1150,P04637,TP53,Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53),PNNTSSSPQPKKK,_RALPNNTSSS(ph)PQPK_,S315,,26.72,22.63,23.27,,21.22,,20.71,21.64,,,,,,22.70,4.02,-0.07,0.57, ,-1.48, ,-1.98,-1.06, , , , , ,"cellular response to UV;cell differentiation;positive regulation of release of cytochrome c from mitochondria;negative regulation of transforming growth factor beta receptor signaling pathway;Ras protein signal transduction;T cell differentiation in thymus;negative regulation of helicase activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;neuron apoptotic process;response to gamma radiation;DNA strand renaturation;cellular response to drug;somitogenesis;in utero embryonic development;intrinsic apoptotic signaling pathway by p53 class mediator;multicellular organism growth;cellular response to hypoxia;protein localization;T cell lineage commitment;rRNA transcription;positive regulation of cell aging;double-strand break repair;negative regulation of neuroblast proliferation;cellular response to ionizing radiation;negative regulation of cell growth;cell cycle arrest;regulation of mitochondrial membrane permeability;B cell lineage commitment;positive regulation of transcription from RNA polymerase II promoter;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of protein oligomerization;oxidative stress-induced premature senescence;cell proliferation;negative regulation of transcription from RNA polymerase II promoter;replicative senescence;negative regulation of apoptotic process;response to antibiotic;induction of apoptosis;negative regulation of fibroblast proliferation;protein tetramerization;T cell proliferation involved in immune response;positive regulation of neuron apoptotic process;cellular response to glucose starvation;positive regulation of reactive oxygen species metabolic process;base-excision repair;cellular protein localization;nucleotide-excision repair;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;response to salt stress;chromosome organization;central nervous system development;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;determination of adult lifespan;positive regulation of intrinsic apoptotic signaling pathway;negative regulation of DNA replication;positive regulation of thymocyte apoptotic process;release of cytochrome c from mitochondria;blood coagulation;mitotic cell cycle arrest;virus-host interaction;gastrulation;protein import into nucleus, translocation;ER overload response;response to X-ray",nuclear chromatin;mitochondrion;chromatin assembly complex;endoplasmic reticulum;replication fork;nuclear matrix;cytoplasm;cytosol;PML body;nucleolus;nucleus,DNA binding region,,,,,,,,,,,,,
1152,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),ALSRQLSSGVSEI,_QLS(ph)SGVSEIR_,S82,+,34.69,32.07,31.37,32.89,32.04,30.84,30.85,32.00,29.77,29.45,31.62,31.78,29.76,31.47,3.22,0.60,-0.10,1.42,0.57,-0.63,-0.62,0.53,-1.70,-2.02,0.15,0.31,-1.71,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1153,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),LSRQLSSGVSEIR,_(gl)QLS(ph)S(ph)GVSEIR_,S83,,25.91,,,,,,27.91,,,,24.40,21.68,28.37,25.65,0.26, , , , , ,2.26, , , ,-1.26,-3.97,2.71,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1154,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),QLSSGVSEIRHTA,_(gl)QLS(ph)SGVS(ph)EIRHTADR_,S86,,26.51,,,,,,,,,,,,,26.51,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1155,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),GPEAAKSDETAAK,_AQLGGPEAAKS(ph)DETAAK_,S199,+,24.66,23.99,,22.89,24.04,22.90,21.87,23.75,,,23.88,23.92,20.07,23.20,1.46,0.80, ,-0.30,0.84,-0.30,-1.33,0.55, , ,0.68,0.73,-3.13,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1156,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),SLLRGPSWDPFRD,_GPS(ph)WDPFRDWYPHSR_,S15,,25.79,18.24,18.24,22.09,22.25,,,,,,,,,21.32,4.47,-3.08,-3.08,0.77,0.93, , , , , , , , ,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1158,P04792,HSPB1,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),PPAAIESPAVAAP,_LPEEWSQWLGGSSWPGYVRPLPPAAIES(ph)PAVAAPAYSR_,S65,,26.19,,,,,,,,,,,,,26.19,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;intracellular protein kinase cascade;response to virus;regulation of I-kappaB kinase/NF-kappaB cascade;regulation of translational initiation;positive regulation of angiogenesis;mRNA metabolic process;positive regulation of tumor necrosis factor biosynthetic process;cell death;response to unfolded protein;positive regulation of blood vessel endothelial cell migration;positive regulation of interleukin-1 beta production;gene expression;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;cellular component movement,Z disc;proteasome complex;cytosol;cytoskeleton;nucleus;plasma membrane;cell surface;spindle,,,,,,,,,,,,,,
1160,P04920,SLC4A2,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),RRRPGASPTGETP,_RRPGAS(ph)PTGETPTIEEGEEDEDEASEAEGAR_,S99,+,,23.18,23.18,,25.25,24.71,24.65,25.20,,25.69,25.14,25.82,25.40,24.82, ,-1.65,-1.65, ,0.43,-0.11,-0.17,0.38, ,0.87,0.31,1.00,0.58,bicarbonate transport,integral to membrane;basolateral plasma membrane;plasma membrane,,,,,,,,,,,,,,
1161,P04920,SLC4A2,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),EDEDEASEAEGAR,_RRPGASPTGETPTIEEGEEDEDEAS(ph)EAEGAR_,S118,+,,,,,,25.17,25.51,25.65,,24.66,24.99,26.24,23.34,25.08, , , , , ,0.09,0.43,0.57, ,-0.42,-0.09,1.16,-1.74,bicarbonate transport,integral to membrane;basolateral plasma membrane;plasma membrane,,,,,,,,,,,,,,
1162,P05023,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1),RLNIPVSQVNPRD,_LNIPVS(ph)QVNPR_,S653,,22.65,,,21.04,,,,,,,22.74,,22.95,22.34,0.30, , ,-1.30, , , , , , ,0.39, ,0.60,response to drug;positive regulation of striated muscle contraction;negative regulation of heart contraction;positive regulation of heart contraction;regulation of sodium ion transport;regulation of blood pressure;regulation of the force of heart contraction;negative regulation of glucocorticoid biosynthetic process;ATP biosynthetic process,sodium:potassium-exchanging ATPase complex;basolateral plasma membrane;Golgi apparatus;endoplasmic reticulum;sarcolemma;melanosome,,,,,,,,,,,,,,
1163,P05023,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1),YEPAAVSEQGDKK,_YEPAAVS(ph)EQGDKK_,S16,+,26.54,26.14,26.65,24.52,,,22.39,,,24.05,,23.92,,24.89,1.65,1.26,1.76,-0.37, , ,-2.50, , ,-0.83, ,-0.97, ,response to drug;positive regulation of striated muscle contraction;negative regulation of heart contraction;positive regulation of heart contraction;regulation of sodium ion transport;regulation of blood pressure;regulation of the force of heart contraction;negative regulation of glucocorticoid biosynthetic process;ATP biosynthetic process,sodium:potassium-exchanging ATPase complex;basolateral plasma membrane;Golgi apparatus;endoplasmic reticulum;sarcolemma;melanosome,,,,,,,,,,,,,,
1164,P05067,APP,Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP;Soluble APP-alpha (S-APP-alpha);Soluble APP-beta (S-APP-beta);C99;Beta-amyloid protein 42 (Beta-APP42);Beta-amyloid protein 40 (Beta-APP40);C83;P3(42);P3(40);C80;Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59));Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57));Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50));C31],FQEKVESLEQEAA,_VES(ph)LEQEAANER_,S441,+,28.15,25.04,24.93,23.70,,23.04,,23.82,22.58,23.55,,,,24.35,3.80,0.68,0.58,-0.65, ,-1.31, ,-0.53,-1.77,-0.80, , , ,"response to oxidative stress;platelet degranulation;regulation of protein binding;neuromuscular process controlling balance;regulation of synapse structure and activity;induction of apoptosis;neuron remodeling;neuron apoptotic process;forebrain development;axon midline choice point recognition;platelet activation;cellular copper ion homeostasis;dendrite development;positive regulation of mitotic cell cycle;adult locomotory behavior;synaptic growth at neuromuscular junction;mating behavior;smooth endoplasmic reticulum calcium ion homeostasis;suckling behavior;ionotropic glutamate receptor signaling pathway;regulation of epidermal growth factor-activated receptor activity;negative regulation of neuron differentiation;cholesterol metabolic process;visual learning;positive regulation of transcription from RNA polymerase II promoter;endocytosis;protein phosphorylation;extracellular matrix organization;innate immune response;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;Notch signaling pathway;axon cargo transport;cell adhesion;collateral sprouting in absence of injury;mRNA polyadenylation;regulation of multicellular organism growth;G2 phase of mitotic cell cycle;regulation of translation",spindle midzone;apical part of cell;dendritic spine;integral to plasma membrane;dendritic shaft;axon;Golgi apparatus;platelet alpha granule lumen;perinuclear region of cytoplasm;cytosol;coated pit;neuromuscular junction;extracellular region;synapse;ciliary rootlet;cell surface,,,,,,,,,,,,,,
1165,P05114,HMGN1,Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1),ETKTEESPASDEA,_TEES(ph)PAS(ph)DEAGEK_,S86,+,26.19,25.37,,23.98,24.09,26.56,22.28,25.82,26.76,,25.34,23.90,24.50,24.98,1.21,0.39, ,-1.00,-0.89,1.58,-2.70,0.84,1.78, ,0.36,-1.09,-0.48,"response to UV-C;response to UV-B;chromatin organization;regulation of epithelial cell proliferation;regulation of development, heterochronic;pyrimidine dimer repair by nucleotide-excision repair;post-embryonic camera-type eye morphogenesis;transcription-coupled nucleotide-excision repair;positive regulation of DNA-dependent transcription, elongation",chromatin;nucleus;cytoplasm,,,,,,,,,,,,,,
1166,P05114,HMGN1,Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1),TEESPASDEAGEK,_TEES(ph)PAS(ph)DEAGEK_,S89,+,26.93,25.95,25.31,25.81,24.40,27.29,25.92,25.71,26.93,24.63,26.08,24.62,26.80,25.88,1.06,0.07,-0.57,-0.06,-1.47,1.41,0.05,-0.17,1.06,-1.25,0.20,-1.25,0.93,"response to UV-C;response to UV-B;chromatin organization;regulation of epithelial cell proliferation;regulation of development, heterochronic;pyrimidine dimer repair by nucleotide-excision repair;post-embryonic camera-type eye morphogenesis;transcription-coupled nucleotide-excision repair;positive regulation of DNA-dependent transcription, elongation",chromatin;nucleus;cytoplasm,,,,,,,,,,,,,,
1167,P05187,ALPP,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",YPLRGSSIFGLAP,_GSS(ph)IFGLAPGK_,S395,,24.10,,,,,,,,,,,,,24.10,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane;cell surface;anchored to membrane,,,+,,,,,,,,,,,
1168,P05187,ALPP,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",DKHVPDSGATATA,_HVPDS(ph)GATATAYLCGVK_,S114,,24.78,21.54,21.53,,,,,,,,,,,22.62,2.17,-1.08,-1.09, , , , , , , , , , ,,integral to membrane;plasma membrane;cell surface;anchored to membrane,,,+,,,,,,,,,,,
1169,P05187,ALPP,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",AALRLLSRNPRGF,_LLS(ph)RNPR_,S322,,22.79,24.11,23.86,23.01,21.04,24.55,21.52,21.11,,,24.70,24.07,25.43,23.29,-0.50,0.82,0.57,-0.28,-2.25,1.26,-1.77,-2.18, , ,1.41,0.78,2.14,,integral to membrane;plasma membrane;cell surface;anchored to membrane,,,+,,,,,,,,,,,
1171,P05386,RPLP1,60S acidic ribosomal protein P1,KEESEESDDDMGF,_KEES(ph)EES(ph)DDDMGFGLFD_,S105,+,31.56,,,,30.24,,23.30,,,29.66,24.47,27.43,23.58,27.18,4.38, , , ,3.07, ,-3.88, , ,2.48,-2.71,0.26,-3.60,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1172,P05387,RPLP2,60S acidic ribosomal protein P2 (Renal carcinoma antigen NY-REN-44),VSAAPGSAAPAAG,_LASVPAGGAVAVSAAPGS(ph)AAPAAGSAPAAAEEK_,S79,+,26.21,24.74,23.66,24.62,23.66,24.52,26.74,24.95,27.08,27.32,26.67,,27.75,25.66,0.55,-0.92,-2.00,-1.04,-2.00,-1.14,1.08,-0.71,1.42,1.65,1.01, ,2.09,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1173,P05387,RPLP2,60S acidic ribosomal protein P2 (Renal carcinoma antigen NY-REN-44),AAPAAGSAPAAAE,_LASVPAGGAVAVSAAPGSAAPAAGS(ph)APAAAEEK_,S86,,25.62,,,22.88,,,,,,24.84,,23.59,24.57,24.30,1.32, , ,-1.42, , , , , ,0.54, ,-0.71,0.27,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1174,P05387,RPLP2,60S acidic ribosomal protein P2 (Renal carcinoma antigen NY-REN-44),AALGGNSSPSAKD,_YVASYLLAALGGNS(ph)SPSAK_,S16,+,,23.12,23.12,25.57,25.64,,,,,25.39,24.33,24.76,25.60,24.69, ,-1.57,-1.57,0.88,0.95, , , , ,0.70,-0.36,0.07,0.91,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1177,P05388,RPLP0,60S acidic ribosomal protein P0 (60S ribosomal protein L10E),VEAKEESEESDED,_VEAKEES(ph)EES(ph)DEDM(ox)GFGLFD_,S304,,26.93,,,,23.90,,,,24.04,24.70,,23.69,,24.65,2.27, , , ,-0.75, , , ,-0.61,0.05, ,-0.97, ,"translational termination;translational elongation;viral transcription;ribosome biogenesis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;virus-host interaction",cytosolic large ribosomal subunit;nucleus,,,,,,,,,,,,,,
1178,P05388,RPLP0,60S acidic ribosomal protein P0 (60S ribosomal protein L10E),KEESEESDEDMGF,_VEAKEES(ph)EES(ph)DEDM(ox)GFGLFD_,S307,,27.47,,,,,,,,,,,,,27.47,0.00, , , , , , , , , , , , ,"translational termination;translational elongation;viral transcription;ribosome biogenesis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;virus-host interaction",cytosolic large ribosomal subunit;nucleus,,,,,,,,,,,,,,
1180,P05412,JUN,Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),GLLKLASPELERL,_LAS(ph)PELER_,S100,+,27.35,27.82,26.90,29.05,27.02,28.00,27.19,27.76,28.03,27.37,27.49,27.06,27.80,27.60,-0.26,0.22,-0.70,1.45,-0.58,0.40,-0.41,0.16,0.43,-0.24,-0.12,-0.54,0.19,"negative regulation of cell proliferation;toll-like receptor 4 signaling pathway;negative regulation of transcription, DNA-dependent;liver development;SMAD protein import into nucleus;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;negative regulation by host of viral transcription;transforming growth factor beta receptor signaling pathway;negative regulation of protein autophosphorylation;SMAD protein signal transduction;response to mechanical stimulus;positive regulation of neuron apoptotic process;positive regulation of fibroblast proliferation;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;leading edge cell differentiation;response to cAMP;TRIF-dependent toll-like receptor signaling pathway;response to radiation;cellular response to potassium ion starvation;response to hydrogen peroxide;monocyte differentiation;negative regulation of neuron apoptotic process;membrane depolarization;response to cytokine stimulus;learning;toll-like receptor 1 signaling pathway;positive regulation of DNA replication;aging;response to drug;microglial cell activation;axon regeneration;circadian rhythm;negative regulation of DNA binding;release of cytochrome c from mitochondria;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 3 signaling pathway;angiogenesis;regulation of cell cycle;cellular response to calcium ion;innate immune response;positive regulation by host of viral transcription;positive regulation of monocyte differentiation;positive regulation of endothelial cell proliferation;positive regulation of smooth muscle cell proliferation",nucleoplasm;cytosol;nuclear euchromatin;transcription factor complex;transcriptional repressor complex,bZIP,,,,,,,,,,,,,
1182,P05455,SSB,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),KKTKFASDDEHDE,_TKFAS(ph)DDEHDEHDENGATGPVK_,S366,+,28.89,30.20,30.46,29.22,29.88,31.22,30.79,29.79,31.03,30.86,30.46,31.05,29.70,30.27,-1.38,-0.08,0.19,-1.06,-0.39,0.95,0.52,-0.48,0.75,0.59,0.19,0.78,-0.58,histone mRNA metabolic process;tRNA modification,ribonucleoprotein complex;nucleus,,,,,,,,,,,,,,
1183,P05556,ITGB1,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),ENPIYKSAVTTVV,_S(ph)AVTTVVNPK_,S785,,24.13,21.15,,25.14,,,22.29,,21.06,,,25.35,,23.19,0.95,-2.03, ,1.95, , ,-0.90, ,-2.13, , ,2.16, ,regulation of immune response;negative regulation of cell proliferation;cell fate specification;response to transforming growth factor beta stimulus;cellular response to mechanical stimulus;leukocyte cell-cell adhesion;B cell differentiation;homophilic cell adhesion;integrin-mediated signaling pathway;cell-cell adhesion mediated by integrin;cardiac muscle cell differentiation;positive regulation of endocytosis;in utero embryonic development;cellular response to vitamin D;cell junction assembly;tight junction assembly;cellular calcium ion homeostasis;maternal process involved in female pregnancy;cell migration involved in sprouting angiogenesis;response to drug;cellular response to ionizing radiation;positive regulation of MAPK cascade;G1/S transition of mitotic cell cycle;calcium-independent cell-matrix adhesion;positive regulation of cell-substrate adhesion;tissue homeostasis;blood coagulation;germ cell migration;positive regulation of cell migration;negative regulation of neuron differentiation;response to activity;response to gonadotropin stimulus;positive regulation of cell proliferation;negative regulation of anoikis;virus-host interaction;regulation of cell cycle;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of cell projection organization;axon guidance;regulation of G-protein coupled receptor protein signaling pathway;positive regulation of neuron differentiation;cellular defense response;positive regulation of neuron projection development;sarcomere organization;protein transport within lipid bilayer;positive regulation of apoptotic process;leukocyte migration,membrane raft;alpha3-beta1 integrin complex;cleavage furrow;hemidesmosome;myelin sheath abaxonal region;alpha8-beta1 integrin complex;basement membrane;focal adhesion;melanosome;acrosomal vesicle;intercalated disc;alpha9-beta1 integrin complex;sarcolemma;external side of plasma membrane;neuromuscular junction;cell surface;ruffle,,,,,,,,,,,,,,
1186,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",VDGKVVSETNDTK,_IVDGKVVS(ph)ETNDTK_,S420,,,,,,25.69,24.86,,25.93,,,,,24.68,25.29, , , , ,0.40,-0.43, ,0.64, , , , ,-0.61,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1187,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",YLDRVRSLETENR,_VRS(ph)LETENR_,S100,+,25.43,26.17,21.34,25.98,25.30,24.82,24.62,24.75,24.02,22.63,26.32,25.45,25.76,24.81,0.61,1.35,-3.48,1.17,0.48,0.01,-0.20,-0.06,-0.80,-2.18,1.50,0.64,0.95,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1188,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",LGDALDSSNSMQT,_LLEDGEDFNLGDALDS(ph)SNSM(ox)QTIQK_,S398,,25.56,,,,23.94,,,,,,,24.89,,24.80,0.76, , , ,-0.86, , , , , , ,0.09, ,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1193,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",PVSSAASVYAGAG,_PVSSAAS(ph)VYAGAGGSGSR_,S34,+,26.68,26.32,27.31,,26.59,,26.44,,25.86,24.85,,25.83,27.09,26.33,0.35,-0.01,0.98, ,0.26, ,0.11, ,-0.47,-1.48, ,-0.50,0.76,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1194,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",YAGAGGSGSRISV,_SLGSVQAPSYGARPVSSAASVYAGAGGS(ph)GSR_,S42,,25.05,23.25,23.25,,,,,26.42,,,25.98,,,24.79,0.26,-1.54,-1.54, , , , ,1.63, , ,1.19, , ,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1198,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",MSFTTRSTFSTNY,_S(ph)TFSTNYR_,S7,+,27.23,24.11,24.58,,25.61,25.60,25.48,26.18,24.42,25.11,25.16,27.11,27.06,25.64,1.59,-1.53,-1.06, ,-0.03,-0.04,-0.16,0.54,-1.22,-0.53,-0.48,1.47,1.42,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1199,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",TTRSTFSTNYRSL,_STFS(ph)TNYR_,S10,,28.20,,,26.01,25.69,,25.62,20.59,,,,27.65,,25.63,2.57, , ,0.38,0.06, ,0.00,-5.04, , , ,2.02, ,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1200,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",FSTNYRSLGSVQA,_S(ph)LGSVQAPSYGARPVSSAASVYAGAGGSGSR_,S15,,,,,,,,,,,,,26.22,25.03,25.62, , , , , , , , , , , ,0.59,-0.59,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1201,P05783,KRT18,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",NYRSLGSVQAPSY,_SLGS(ph)VQAPSYGAR_,S18,+,27.50,23.66,,24.98,25.10,22.14,24.05,24.56,23.87,,25.32,24.84,24.00,24.55,2.95,-0.88, ,0.43,0.55,-2.41,-0.49,0.01,-0.68, ,0.77,0.29,-0.55,negative regulation of apoptotic process;anatomical structure morphogenesis;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process;cell cycle;virus-host interaction,nucleolus;keratin filament;perinuclear region of cytoplasm;centriolar satellite,,,,,,,,,,,,,,
1206,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SRAEAESMYQIKY,_AEAES(ph)M(ox)YQIK_,S280,,24.97,24.30,24.52,,,,22.11,,,22.83,23.54,,,23.71,1.26,0.59,0.81, , , ,-1.60, , ,-0.88,-0.17, , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1207,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SGPRAFSSRSYTS,_AFS(ph)SRS(ph)YTSGPGSR_,S21,+,25.47,26.11,26.87,24.03,24.25,21.40,,21.15,,,,,22.60,23.98,1.49,2.12,2.89,0.04,0.26,-2.59, ,-2.83, , , , ,-1.39,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1209,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",RAFSSRSYTSGPG,_AFSSRS(ph)YTSGPGSR_,S24,+,26.54,28.64,29.59,24.52,28.27,26.75,27.54,27.74,26.71,27.98,25.01,30.26,28.12,27.51,-0.97,1.13,2.08,-2.99,0.75,-0.76,0.03,0.23,-0.80,0.47,-2.50,2.75,0.60,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1211,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",EDIANRSRAEAES,_AQYEDIANRS(ph)R_,S274,+,25.89,26.67,26.53,27.06,26.86,26.89,26.46,26.83,25.21,24.69,27.03,26.71,25.60,26.34,-0.45,0.33,0.19,0.72,0.52,0.55,0.12,0.49,-1.13,-1.65,0.69,0.37,-0.74,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1212,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",RDGKLVSESSDVL,_LVS(ph)ESSDVLPK_,S475,+,28.29,26.31,26.69,26.22,27.14,26.71,27.01,25.27,26.90,27.88,27.82,27.70,28.55,27.11,1.18,-0.80,-0.43,-0.89,0.03,-0.40,-0.11,-1.84,-0.22,0.77,0.71,0.59,1.43,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1213,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",GKLVSESSDVLPK,_LVSES(ph)SDVLPK_,S477,,25.49,,,23.63,22.53,26.23,26.12,24.50,25.76,26.41,25.21,25.47,26.11,25.22,0.26, , ,-1.59,-2.69,1.01,0.89,-0.72,0.54,1.19,-0.01,0.24,0.88,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1214,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",KLVSESSDVLPK_,_LVSESS(ph)DVLPK_,S478,+,24.80,24.20,23.70,,25.11,,25.01,,,,,25.41,25.73,24.85,-0.05,-0.65,-1.15, ,0.26, ,0.16, , , , ,0.56,0.88,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1216,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",VNQSLLSPLVLEV,_GGLGGGYGGASGM(ox)GGITAVTVNQSLLS(ph)PLVLEVDPNIQAVR_,S74,,24.98,,,,,,,,,,,,,24.98,0.00, , , , , , , , , , , , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1217,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",GPGSRISSSSFSR,_SYTSGPGSRIS(ph)SSSFSR_,S34,+,26.02,24.17,24.77,23.38,,,23.71,,23.36,23.25,25.11,28.47,,24.69,1.33,-0.52,0.08,-1.32, , ,-0.99, ,-1.33,-1.44,0.42,3.78, ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1220,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SRISSSSFSRVGS,_ISSSS(ph)FSR_,S37,,23.96,22.27,22.27,,,,,,,,,31.92,,25.11,-1.15,-2.83,-2.83, , , , , , , , ,6.82, ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1221,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",ISSSSFSRVGSSN,_ISSSSFS(ph)R_,S39,+,28.96,,,26.04,20.15,22.66,23.42,,22.95,,,24.80,,24.14,4.82, , ,1.90,-3.99,-1.48,-0.72, ,-1.19, , ,0.66, ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1222,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SFSRVGSSNFRGG,_VGS(ph)SNFR_,S43,+,30.50,27.34,24.50,32.32,24.47,23.13,25.15,24.28,22.50,21.42,23.17,30.25,24.23,25.64,4.86,1.70,-1.13,6.68,-1.16,-2.50,-0.48,-1.35,-3.14,-4.21,-2.47,4.62,-1.41,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1223,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SGMQNMSIHTKTT,_LESGM(ox)QNM(ox)S(ph)IHTK_,S410,+,26.42,24.51,24.51,24.29,,,21.37,22.44,,21.22,,26.24,21.68,23.63,2.79,0.88,0.88,0.66, , ,-2.26,-1.19, ,-2.41, ,2.61,-1.96,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1224,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",LLEGEESRLESGM,_LLEGEES(ph)R_,S400,,21.99,24.08,,22.98,,,,,,,,,,23.02,-1.02,1.06, ,-0.04, , , , , , , , , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1225,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",EMNRNISRLQAEI,_NIS(ph)RLQAEIEGLK_,S315,,,,,,22.10,21.80,,22.89,,,24.45,22.78,,22.80, , , , ,-0.70,-1.00, ,0.08, , ,1.65,-0.03, ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1226,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",_____MSIRVTQK,_(ac)S(ph)IRVTQK_,S2,+,20.94,29.75,30.48,32.06,28.26,26.63,28.82,,26.27,27.85,26.70,32.84,28.48,28.26,-7.32,1.50,2.23,3.80,0.00,-1.62,0.56, ,-1.99,-0.41,-1.56,4.58,0.22,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1227,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SMDNSRSLDMDSI,_S(ph)LDMDSIIAEVK_,S253,+,27.18,23.58,23.74,23.13,25.17,24.02,23.88,23.79,23.75,24.97,25.41,25.38,25.24,24.56,2.63,-0.98,-0.82,-1.43,0.62,-0.54,-0.68,-0.77,-0.81,0.42,0.85,0.83,0.68,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1228,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",RSLDMDSIIAEVK,_SLDM(ox)DS(ph)IIAEVK_,S258,+,27.72,19.62,19.62,19.85,26.36,25.96,25.92,25.44,25.55,27.26,25.76,26.21,26.13,24.72,3.00,-5.10,-5.10,-4.87,1.64,1.24,1.19,0.71,0.82,2.54,1.04,1.49,1.40,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1229,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",MDNMFESYINNLR,_SNM(ox)DNM(ox)FES(ph)YINNLRR_,S142,,,,,,23.27,,23.91,,22.45,23.30,,,,23.23, , , , ,0.04, ,0.68, ,-0.78,0.06, , , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1230,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",QKSYKVSTSGPRA,_SYKVS(ph)TSGPR_,S13,,24.29,,,23.80,,,,20.90,19.33,,,24.63,,22.59,1.70, , ,1.21, , , ,-1.69,-3.26, , ,2.04, ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1231,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SFSRTSSSRAVVV,_TSS(ph)SRAVVVK_,S457,+,24.24,24.49,24.49,27.39,19.40,21.57,19.62,21.20,,20.35,20.49,29.27,22.38,22.91,1.33,1.58,1.58,4.48,-3.51,-1.34,-3.29,-1.71, ,-2.56,-2.42,6.36,-0.53,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1232,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",AYGGLTSPGLSYS,_TTSGYAGGLSSAYGGLTS(ph)PGLSYSLGSSFGSGAGSSSFSR_,S432,,27.33,20.76,20.76,,21.24,,,,,22.04,20.92,,,22.17,5.16,-1.42,-1.42, ,-0.94, , , , ,-0.13,-1.26, , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1233,P06241,FYN,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn),TEERDGSLNQSSG,_DGS(ph)LNQSSGYR_,S21,,,,,24.18,21.76,,,21.96,21.79,,,,,22.42, , , ,1.76,-0.66, , ,-0.46,-0.63, , , , ,intracellular protein kinase cascade;negative regulation of gene expression;protein autophosphorylation;T cell costimulation;calcium ion transport;response to drug;neuron migration;dendrite morphogenesis;activated T cell proliferation;detection of mechanical stimulus involved in sensory perception of pain;peptidyl-tyrosine phosphorylation;forebrain development;viral reproduction;cellular response to growth factor stimulus;response to ethanol;virus-host interaction;regulation of defense response to virus by virus;regulation of cell shape;platelet activation;axon guidance;negative regulation of protein catabolic process;T cell receptor signaling pathway;cellular response to peptide hormone stimulus;feeding behavior;learning;leukocyte migration,endosome;cytosol;mitochondrion;plasma membrane;nucleus,,+,,,,,,,,,,,,
1234,P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),GGNIYISPLKSPY,_IPGGNIYIS(ph)PLK_,S807,+,23.93,22.34,22.34,21.49,,,24.34,23.01,22.83,22.44,22.33,23.90,24.78,23.07,0.86,-0.73,-0.73,-1.58, , ,1.27,-0.05,-0.24,-0.63,-0.74,0.84,1.72,"S phase of mitotic cell cycle;regulation of centromere complex assembly;neuron projection development;G1 phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;Ras protein signal transduction;positive regulation of mitotic metaphase/anaphase transition;negative regulation of transcription, DNA-dependent;striated muscle cell differentiation;neuron apoptotic process;enucleate erythrocyte differentiation;negative regulation of epithelial cell proliferation;cell division;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;regulation of cohesin localization to chromatin;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;protein localization to chromosome, centromeric region;transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;negative regulation of cell growth;myoblast differentiation;negative regulation of protein kinase activity;cell cycle arrest;negative regulation of sequence-specific DNA binding transcription factor activity;androgen receptor signaling pathway;chromatin remodeling;virus-host interaction;negative regulation of S phase of mitotic cell cycle;neuron maturation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of macrophage differentiation;sister chromatid biorientation;regulation of lipid kinase activity;maintenance of mitotic sister chromatid cohesion",chromatin;SWI/SNF complex;PML body;spindle;Rb-E2F complex,Other TF domain,,,,,,,,,,,,,
1235,P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),EDPEQDSGPEDLP,_TAATAAAAAAEPPAPPPPPPPEEDPEQDS(ph)GPEDLPLVR_,S37,,27.83,,,,24.48,,,,24.49,25.34,22.90,23.71,,24.79,3.04, , , ,-0.31, , , ,-0.31,0.55,-1.89,-1.08, ,"S phase of mitotic cell cycle;regulation of centromere complex assembly;neuron projection development;G1 phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;Ras protein signal transduction;positive regulation of mitotic metaphase/anaphase transition;negative regulation of transcription, DNA-dependent;striated muscle cell differentiation;neuron apoptotic process;enucleate erythrocyte differentiation;negative regulation of epithelial cell proliferation;cell division;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;regulation of cohesin localization to chromatin;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;protein localization to chromosome, centromeric region;transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;negative regulation of cell growth;myoblast differentiation;negative regulation of protein kinase activity;cell cycle arrest;negative regulation of sequence-specific DNA binding transcription factor activity;androgen receptor signaling pathway;chromatin remodeling;virus-host interaction;negative regulation of S phase of mitotic cell cycle;neuron maturation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of macrophage differentiation;sister chromatid biorientation;regulation of lipid kinase activity;maintenance of mitotic sister chromatid cohesion",chromatin;SWI/SNF complex;PML body;spindle;Rb-E2F complex,Other TF domain,,,,,,,,,,,,,
1236,P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),IPHIPRSPYKFPS,_S(ph)PYKFPS(ph)SPLR_,S788,,21.38,,,,,,,,,,,,,21.38,0.00, , , , , , , , , , , , ,"S phase of mitotic cell cycle;regulation of centromere complex assembly;neuron projection development;G1 phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;Ras protein signal transduction;positive regulation of mitotic metaphase/anaphase transition;negative regulation of transcription, DNA-dependent;striated muscle cell differentiation;neuron apoptotic process;enucleate erythrocyte differentiation;negative regulation of epithelial cell proliferation;cell division;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;regulation of cohesin localization to chromatin;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;protein localization to chromosome, centromeric region;transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;negative regulation of cell growth;myoblast differentiation;negative regulation of protein kinase activity;cell cycle arrest;negative regulation of sequence-specific DNA binding transcription factor activity;androgen receptor signaling pathway;chromatin remodeling;virus-host interaction;negative regulation of S phase of mitotic cell cycle;neuron maturation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of macrophage differentiation;sister chromatid biorientation;regulation of lipid kinase activity;maintenance of mitotic sister chromatid cohesion",chromatin;SWI/SNF complex;PML body;spindle;Rb-E2F complex,Other TF domain,,,,,,,,,,,,,
1238,P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),VIPINGSPRTPRR,_TAVIPINGS(ph)PR_,S249,+,25.36,23.25,24.15,21.26,25.72,25.25,25.57,25.76,25.24,25.27,23.53,24.59,23.63,24.51,0.86,-1.25,-0.36,-3.25,1.21,0.75,1.07,1.25,0.73,0.76,-0.98,0.09,-0.87,"S phase of mitotic cell cycle;regulation of centromere complex assembly;neuron projection development;G1 phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;Ras protein signal transduction;positive regulation of mitotic metaphase/anaphase transition;negative regulation of transcription, DNA-dependent;striated muscle cell differentiation;neuron apoptotic process;enucleate erythrocyte differentiation;negative regulation of epithelial cell proliferation;cell division;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;regulation of cohesin localization to chromatin;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;protein localization to chromosome, centromeric region;transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;negative regulation of cell growth;myoblast differentiation;negative regulation of protein kinase activity;cell cycle arrest;negative regulation of sequence-specific DNA binding transcription factor activity;androgen receptor signaling pathway;chromatin remodeling;virus-host interaction;negative regulation of S phase of mitotic cell cycle;neuron maturation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of macrophage differentiation;sister chromatid biorientation;regulation of lipid kinase activity;maintenance of mitotic sister chromatid cohesion",chromatin;SWI/SNF complex;PML body;spindle;Rb-E2F complex,Other TF domain,,,,,,,,,,,,,
1240,P06454,PTMA,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed;Thymosin alpha-1]",_____MSDAAVDT,_(ac)S(ph)DAAVDTSSEITTK_,S2,+,28.49,25.13,25.58,24.94,26.65,26.32,26.39,25.99,25.96,25.70,24.36,25.29,25.71,25.89,2.61,-0.76,-0.31,-0.94,0.76,0.44,0.51,0.10,0.08,-0.19,-1.52,-0.60,-0.18,"transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
1241,P06454,PTMA,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed;Thymosin alpha-1]",DAAVDTSSEITTK,_(ac)SDAAVDTS(ph)SEITTK_,S9,,,,,,,,25.38,,24.24,,,,23.92,24.51, , , , , , ,0.87, ,-0.28, , , ,-0.59,"transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
1242,P06454,PTMA,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed;Thymosin alpha-1]",AAVDTSSEITTKD,_(ac)SDAAVDTSS(ph)EITTK_,S10,+,27.07,25.58,25.97,24.60,25.75,25.29,,25.28,,23.56,,24.09,,25.24,1.82,0.34,0.73,-0.65,0.51,0.05, ,0.04, ,-1.68, ,-1.16, ,"transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
1245,P06703,S100A6,Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6),KELTIGSKLQDAE,_ELTIGS(ph)KLQDAEIAR_,S46,,,23.18,23.05,23.09,24.32,21.66,,25.21,,,,,,23.42, ,-0.24,-0.37,-0.32,0.90,-1.76, ,1.80, , , , , ,signal transduction;axonogenesis;positive regulation of fibroblast proliferation,cytosol;nuclear envelope;extrinsic to internal side of plasma membrane;ruffle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1246,P06733,ENO1,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),IEEELGSKAKFAG,_IEEELGS(ph)K_,S419,,25.44,24.97,24.81,25.29,,,,,,,,,,25.13,0.31,-0.15,-0.31,0.16, , , , , , , , , ,"negative regulation of cell growth;small molecule metabolic process;response to virus;negative regulation of transcription from RNA polymerase II promoter;gluconeogenesis;glycolysis;transcription, DNA-dependent",cytosol;M band;extracellular vesicular exosome;phosphopyruvate hydratase complex;plasma membrane;nucleus,Other TF domain,,,,,,,,,,,,,
1247,P06733,ENO1,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),IAPALVSKKLNVT,_TIAPALVS(ph)K_,S79,,22.59,22.78,,22.16,,,,21.86,,,,,,22.35,0.24,0.44, ,-0.19, , , ,-0.49, , , , , ,"negative regulation of cell growth;small molecule metabolic process;response to virus;negative regulation of transcription from RNA polymerase II promoter;gluconeogenesis;glycolysis;transcription, DNA-dependent",cytosol;M band;extracellular vesicular exosome;phosphopyruvate hydratase complex;plasma membrane;nucleus,Other TF domain,,,,,,,,,,,,,
1249,P06748,NPM1,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),AMNYEGSPIKVTL,_DELHIVEAEAM(ox)NYEGS(ph)PIK_,S70,+,27.92,27.28,27.17,27.90,25.65,27.74,29.05,27.89,29.99,29.59,27.98,28.97,28.95,28.16,-0.24,-0.88,-0.99,-0.26,-2.51,-0.42,0.89,-0.27,1.84,1.43,-0.18,0.81,0.79,negative regulation of apoptotic process;negative regulation of centrosome duplication;negative regulation of cell proliferation;protein oligomerization;regulation of endodeoxyribonuclease activity;positive regulation of NF-kappaB transcription factor activity;DNA repair;intracellular protein transport;CENP-A containing nucleosome assembly at centromere;virus-host interaction;regulation of centriole replication;cell aging;centrosome cycle;ribosome assembly;signal transduction;nucleocytoplasmic transport;regulation of endoribonuclease activity,nucleoplasm;ribonucleoprotein complex;nucleolus;spindle pole centrosome,,,,,,,,,,,+,,,
1252,P06748,NPM1,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),___MEDSMDMDMS,_(ac)M(ox)EDS(ph)M(ox)DM(ox)DM(ox)SPLRPQNYLFGCELK_,S4,+,27.68,24.10,24.32,24.33,,,,25.52,24.39,,,24.96,,25.04,2.63,-0.94,-0.72,-0.71, , , ,0.47,-0.65, , ,-0.08, ,negative regulation of apoptotic process;negative regulation of centrosome duplication;negative regulation of cell proliferation;protein oligomerization;regulation of endodeoxyribonuclease activity;positive regulation of NF-kappaB transcription factor activity;DNA repair;intracellular protein transport;CENP-A containing nucleosome assembly at centromere;virus-host interaction;regulation of centriole replication;cell aging;centrosome cycle;ribosome assembly;signal transduction;nucleocytoplasmic transport;regulation of endoribonuclease activity,nucleoplasm;ribonucleoprotein complex;nucleolus;spindle pole centrosome,,,,,,,,,,,+,,,
1253,P06748,NPM1,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),SMDMDMSPLRPQN,_(ac)M(ox)EDSM(ox)DM(ox)DMS(ph)PLRPQNYLFGCELK_,S10,+,28.92,25.65,25.93,26.91,25.58,,26.36,,28.68,28.80,,,26.83,27.07,1.85,-1.42,-1.14,-0.16,-1.49, ,-0.72, ,1.60,1.72, , ,-0.25,negative regulation of apoptotic process;negative regulation of centrosome duplication;negative regulation of cell proliferation;protein oligomerization;regulation of endodeoxyribonuclease activity;positive regulation of NF-kappaB transcription factor activity;DNA repair;intracellular protein transport;CENP-A containing nucleosome assembly at centromere;virus-host interaction;regulation of centriole replication;cell aging;centrosome cycle;ribosome assembly;signal transduction;nucleocytoplasmic transport;regulation of endoribonuclease activity,nucleoplasm;ribonucleoprotein complex;nucleolus;spindle pole centrosome,,,,,,,,,,,+,,,
1256,P07197,NEFM,Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein),VTETRSSFSRVSG,_VTETRSS(ph)FSR_,S23,,,,,22.70,,,,21.38,21.65,21.72,21.50,23.11,,22.01, , , ,0.69, , , ,-0.63,-0.36,-0.29,-0.51,1.10, ,regulation of axon diameter;axon cargo transport;neurofilament cytoskeleton organization;microtubule cytoskeleton organization;intermediate filament bundle assembly,neuromuscular junction;neurofilament;cytoplasm,,,,,,,,,,,,,,
1258,P07237,P4HB,Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55),TKYKPESEELTAE,_YKPES(ph)EELTAER_,S331,,26.44,,,,22.13,22.10,,,,,,,,23.56,2.88, , , ,-1.43,-1.46, , , , , , , ,glycerol ether metabolic process;extracellular matrix organization;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;cell redox homeostasis;lipoprotein metabolic process;lipid metabolic process,endoplasmic reticulum-Golgi intermediate compartment;extracellular region;plasma membrane;melanosome;endoplasmic reticulum lumen;cell surface,,,,,,,,,,,,,,
1259,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),RRAEDGSVIDYEL,_AEDGS(ph)VIDYELIDQDAR_,S184,,23.08,,,21.37,,,,,,,,,,22.23,0.86, , ,-0.86, , , , , , , , , ,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
1260,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),DIISDTSGDFRKL,_DIISDTS(ph)GDFRK_,S164,,,22.73,23.13,,,24.18,24.26,,,,,23.36,,23.53, ,-0.80,-0.40, , ,0.65,0.73, , , , ,-0.17, ,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
1261,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),EILCKLSLEGDHS,_LS(ph)LEGDHSTPPSAYGSVK_,S12,+,,24.96,24.14,25.00,,,25.73,22.49,23.88,25.91,25.74,26.62,,24.94, ,0.02,-0.80,0.06, , ,0.79,-2.45,-1.06,0.97,0.80,1.68, ,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
1262,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),PPSAYGSVKAYTN,_LSLEGDHSTPPSAYGS(ph)VK_,S26,+,28.22,26.54,26.91,27.28,25.45,25.56,27.56,27.29,24.55,23.18,25.57,31.15,26.50,26.60,1.62,-0.06,0.31,0.69,-1.15,-1.04,0.96,0.69,-2.05,-3.41,-1.02,4.55,-0.10,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
1263,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),_____MSTVHEIL,_(ac)S(ph)TVHEILCK_,S2,,23.74,22.82,22.82,,,,,,23.69,,,25.72,,23.76,-0.02,-0.94,-0.94, , , , , ,-0.07, , ,1.96, ,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
1267,P07814,EPRS,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS);Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],SQSSDSSPTRNSE,_EYIPGQPPLSQSSDSS(ph)PTR_,S886,,25.74,26.63,,26.18,,,29.36,,,,,,,26.98,-1.24,-0.34, ,-0.80, , ,2.38, , , , , , ,prolyl-tRNA aminoacylation;negative regulation of translation;glutamyl-tRNA aminoacylation;protein complex assembly;tRNA aminoacylation for protein translation;cellular response to interferon-gamma,cytosol;ribonucleoprotein complex,,,,,,,,,,,,,,
1269,P07900,HSP90AA1,Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Renal carcinoma antigen NY-REN-38),ERDKEVSDDEAEE,_EVS(ph)DDEAEEKEDKEEEK_,S231,+,30.19,30.46,29.47,31.35,24.92,26.83,29.44,28.31,29.05,25.50,29.58,29.94,26.48,28.58,1.62,1.88,0.89,2.77,-3.66,-1.75,0.86,-0.27,0.47,-3.08,1.00,1.36,-2.10,regulation of nitric-oxide synthase activity;chaperone-mediated protein complex assembly;protein import into mitochondrial outer membrane;axon guidance;nitric oxide metabolic process;G2/M transition of mitotic cell cycle;signal transduction;protein refolding;response to unfolded protein;positive regulation of nitric oxide biosynthetic process,cytosol;plasma membrane;melanosome,,,,,,,,,,,,,,
1271,P07900,HSP90AA1,Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Renal carcinoma antigen NY-REN-38),EIEDVGSDEEEEK,_PEIEDVGS(ph)DEEEEKK_,S263,+,33.48,33.35,33.56,33.07,30.41,31.42,34.03,32.46,34.04,34.03,33.93,33.97,31.68,33.03,0.45,0.31,0.53,0.04,-2.62,-1.61,1.00,-0.57,1.01,0.99,0.90,0.93,-1.36,regulation of nitric-oxide synthase activity;chaperone-mediated protein complex assembly;protein import into mitochondrial outer membrane;axon guidance;nitric oxide metabolic process;G2/M transition of mitotic cell cycle;signal transduction;protein refolding;response to unfolded protein;positive regulation of nitric oxide biosynthetic process,cytosol;plasma membrane;melanosome,,,,,,,,,,,,,,
1273,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),GEDDRDSANGEDD,_EAEEGEDDRDS(ph)ANGEDDS_,S286,+,29.57,28.17,27.85,29.68,27.49,27.31,,28.51,30.30,27.27,27.23,29.13,25.97,28.21,1.36,-0.03,-0.36,1.48,-0.72,-0.90, ,0.30,2.09,-0.93,-0.98,0.93,-2.24,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
1274,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),TNVKMESEGGADD,_M(ox)ES(ph)EGGADDS(ph)AEEGDLLDDDDNEDRGDDQLELIKDDEK_,S240,,29.24,,,,,,,,24.92,,,,,27.08,2.16, , , , , , , ,-2.16, , , , ,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
1275,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),EGGADDSAEEGDL,_M(ox)ES(ph)EGGADDS(ph)AEEGDLLDDDDNEDRGDDQLELIKDDEK_,S247,+,32.77,,,,31.89,24.80,22.76,,28.84,32.50,25.26,30.55,27.13,28.50,4.27, , , ,3.39,-3.70,-5.74, ,0.34,4.00,-3.24,2.05,-1.37,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
1277,P07910,HNRNPC,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),KSEEEQSSSSVKK,_SEEEQS(ph)SSS(ph)VKKDETNVK_,S225,,25.74,25.77,,25.56,,,,,22.59,,,,,24.91,0.82,0.85, ,0.65, , , , ,-2.32, , , , ,"mRNA splicing, via spliceosome",nucleoplasm;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
1282,P07948,LYN,Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn),KGKDSLSDDGVDL,_DSLS(ph)DDGVDLK_,S13,+,24.92,26.42,26.94,24.59,25.29,25.67,25.67,25.29,24.96,27.03,25.05,25.03,25.08,25.53,-0.62,0.88,1.41,-0.95,-0.24,0.13,0.14,-0.25,-0.57,1.50,-0.48,-0.50,-0.46,platelet degranulation;neuron projection development;dendritic cell differentiation;response to toxin;regulation of inflammatory response;regulation of erythrocyte differentiation;positive regulation of oligodendrocyte progenitor proliferation;positive regulation of Fc receptor mediated stimulatory signaling pathway;tolerance induction to self antigen;response to amino acid stimulus;peptidyl-tyrosine phosphorylation;regulation of B cell apoptotic process;oligodendrocyte development;negative regulation of B cell proliferation;regulation of release of sequestered calcium ion into cytosol;positive regulation of mast cell proliferation;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;regulation of mast cell degranulation;positive regulation of tyrosine phosphorylation of STAT protein;response to insulin stimulus;B cell receptor signaling pathway;regulation of cytokine production;response to organic cyclic compound;negative regulation of ERK1 and ERK2 cascade;negative regulation of toll-like receptor 4 signaling pathway;Fc receptor mediated inhibitory signaling pathway;protein autophosphorylation;negative regulation of immune response;T cell costimulation;regulation of platelet aggregation;positive regulation of stress-activated protein kinase signaling cascade;histamine secretion by mast cell;negative regulation of myeloid leukocyte differentiation;response to axon injury;negative regulation of MAP kinase activity;positive regulation of cell migration;regulation of cytokine secretion;erythrocyte differentiation;positive regulation of phosphatidylinositol 3-kinase activity;B cell homeostasis;negative regulation of toll-like receptor 2 signaling pathway;virus-host interaction;cellular response to retinoic acid;negative regulation of mast cell proliferation;regulation of cell adhesion mediated by integrin;regulation of B cell receptor signaling pathway;positive regulation of glial cell proliferation;response to DNA damage stimulus;innate immune response;cellular response to heat;positive regulation of dendritic cell apoptotic process;regulation of monocyte chemotaxis;lipopolysaccharide-mediated signaling pathway;Fc receptor mediated stimulatory signaling pathway;cellular response to extracellular stimulus;response to carbohydrate stimulus;cytokine secretion;positive regulation of neuron projection development;positive regulation of cellular component movement;response to sterol depletion;leukocyte migration,membrane raft;Golgi apparatus;mitochondrial crista;postsynaptic density;alpha2-beta1 integrin complex;perinuclear region of cytoplasm;mitochondrial intermembrane space;cytosol;plasma membrane;nucleus,,+,,,,,,,,,,,,
1283,P08047,SP1,Transcription factor Sp1,_____MSDQDHSM,_(ac)S(ph)DQDHSM(ox)DEM(ox)TAVVK_,S2,,,,,25.58,23.89,,,24.52,,,,24.53,24.68,24.64, , , ,0.94,-0.75, , ,-0.12, , , ,-0.11,0.04,embryonic skeletal system development;liver development;lung development;transforming growth factor beta receptor signaling pathway;embryonic placenta development;enucleate erythrocyte differentiation;embryonic camera-type eye morphogenesis;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;ossification;transcription initiation from RNA polymerase II promoter;trophectodermal cell differentiation;embryonic process involved in female pregnancy;definitive hemopoiesis;megakaryocyte differentiation;positive regulation by host of viral transcription,nucleoplasm;protein-DNA complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
1284,P08047,SP1,Transcription factor Sp1,MSDQDHSMDEMTA,_(ac)SDQDHS(ph)M(ox)DEM(ox)TAVVK_,S7,+,25.52,25.77,26.23,25.55,24.16,25.57,25.66,23.54,25.20,25.94,24.15,,,25.21,0.31,0.56,1.02,0.34,-1.05,0.36,0.45,-1.67,-0.01,0.73,-1.06, , ,embryonic skeletal system development;liver development;lung development;transforming growth factor beta receptor signaling pathway;embryonic placenta development;enucleate erythrocyte differentiation;embryonic camera-type eye morphogenesis;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;ossification;transcription initiation from RNA polymerase II promoter;trophectodermal cell differentiation;embryonic process involved in female pregnancy;definitive hemopoiesis;megakaryocyte differentiation;positive regulation by host of viral transcription,nucleoplasm;protein-DNA complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
1288,P08238,HSP90AB1,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),KIEDVGSDEEDDS,_PKIEDVGS(ph)DEEDDSGKDK_,S255,+,34.23,34.38,34.69,34.69,32.36,31.80,33.60,32.92,32.97,33.59,31.88,33.47,29.51,33.08,1.14,1.29,1.61,1.61,-0.72,-1.28,0.51,-0.17,-0.11,0.50,-1.20,0.39,-3.57,"axon guidance;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;placenta development;innate immune response;cellular response to organic cyclic compound;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;protein folding;response to salt stress;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;response to unfolded protein;positive regulation of nitric oxide biosynthetic process",cytosol;mitochondrion;basolateral plasma membrane;apical plasma membrane;brush border membrane;melanosome,,,,,,,,,,,,,,
1289,P08238,HSP90AB1,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),EREKEISDDEAEE,_EREKEIS(ph)DDEAEEEK_,S226,+,33.05,33.34,33.16,34.03,29.04,29.16,32.51,30.95,31.98,31.27,31.42,32.22,27.81,31.53,1.52,1.80,1.63,2.49,-2.49,-2.37,0.98,-0.59,0.45,-0.26,-0.11,0.68,-3.73,"axon guidance;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;placenta development;innate immune response;cellular response to organic cyclic compound;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;protein folding;response to salt stress;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;response to unfolded protein;positive regulation of nitric oxide biosynthetic process",cytosol;mitochondrion;basolateral plasma membrane;apical plasma membrane;brush border membrane;melanosome,,,,,,,,,,,,,,
1291,Q16772,GSTA3,Glutathione S-transferase A3 (EC 2.5.1.18) (GST class-alpha member 3) (Glutathione S-transferase A3-3),KFLQPGSPRKPPA,_FLQPGS(ph)PR_,S152,,25.35,21.00,21.00,,,,,,22.11,,,,,22.36,2.98,-1.37,-1.37, , , , , ,-0.25, , , , ,xenobiotic metabolic process;glutathione metabolic process,cytosol,,,,,,,,,,,,,,
1292,P08473,MME,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10),_MGKSESQMDITD,_SES(ph)QM(ox)DITDINTPKPK_,S6,+,21.65,25.76,,26.86,23.18,,22.44,21.59,26.69,,,24.36,23.79,24.04,-2.39,1.73, ,2.83,-0.85, ,-1.59,-2.44,2.65, , ,0.32,-0.25,cellular response to UV-B;sensory perception of pain;kidney development;cellular response to cytokine stimulus;cellular response to UV-A;beta-amyloid metabolic process;proteolysis;creatinine metabolic process;replicative senescence,brush border;axon;neuron projection terminus;synaptic vesicle;integral to plasma membrane;dendrite,,,,,,,,,,,,,,
1293,P08559,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",RYGMGTSVERAAA,_YGMGTS(ph)VER_,S232,+,25.14,27.00,,30.10,24.28,21.80,26.10,26.23,,,24.88,26.69,21.54,25.38,-0.24,1.62, ,4.73,-1.09,-3.58,0.73,0.86, , ,-0.50,1.31,-3.83,regulation of acetyl-CoA biosynthetic process from pyruvate;pyruvate metabolic process;glycolysis,mitochondrial matrix,,,,,,,,,,,,,,
1294,P08559,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",YRYHGHSMSDPGV,_YHGHS(ph)M(ox)SDPGVSYR_,S293,+,24.80,25.54,25.47,28.49,28.80,28.17,28.11,28.39,27.05,25.01,27.46,27.84,24.80,26.92,-2.12,-1.37,-1.45,1.57,1.88,1.25,1.19,1.47,0.13,-1.91,0.55,0.93,-2.12,regulation of acetyl-CoA biosynthetic process from pyruvate;pyruvate metabolic process;glycolysis,mitochondrial matrix,,,,,,,,,,,,,,
1295,P08559,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",YHGHSMSDPGVSY,_YHGHSM(ox)S(ph)DPGVS(ph)YR_,S295,,24.95,26.57,,24.19,,,,,,,,,,25.24,-0.29,1.33, ,-1.05, , , , , , , , , ,regulation of acetyl-CoA biosynthetic process from pyruvate;pyruvate metabolic process;glycolysis,mitochondrial matrix,,,,,,,,,,,,,,
1298,P08575,PTPRC,Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45),KSKNRNSNVIPYD,_NRNS(ph)NVIPYDYNR_,S812,,,26.84,25.58,,24.27,,,,,,,,,25.56, ,1.28,0.01, ,-1.29, , , , , , , , ,defense response to virus;stem cell development;positive regulation of isotype switching to IgG isotypes;negative regulation of cytokine-mediated signaling pathway;T cell proliferation;heterotypic cell-cell adhesion;bone marrow development;negative thymic T cell selection;negative regulation of protein autophosphorylation;positive thymic T cell selection;leukocyte cell-cell adhesion;B cell differentiation;response to gamma radiation;immunoglobulin biosynthetic process;positive regulation of stem cell proliferation;B cell proliferation;activation of MAPK activity;negative regulation of T cell mediated cytotoxicity;positive regulation of B cell proliferation;positive regulation of antigen receptor-mediated signaling pathway;B cell receptor signaling pathway;negative regulation of cell adhesion involved in substrate-bound cell migration;regulation of S phase;release of sequestered calcium ion into cytosol;negative regulation of protein kinase activity;hematopoietic progenitor cell differentiation;positive regulation of gamma-delta T cell differentiation;regulation of B cell receptor signaling pathway;positive regulation of T cell mediated cytotoxicity;axon guidance;positive regulation of protein kinase activity;T cell differentiation;T cell receptor signaling pathway;positive regulation of alpha-beta T cell proliferation;positive regulation of humoral immune response mediated by circulating immunoglobulin;negative regulation of peptidyl-tyrosine phosphorylation;positive regulation of T cell proliferation;regulation of B cell differentiation;positive regulation of apoptotic process;positive regulation of hematopoietic stem cell migration,membrane raft;focal adhesion;integral to plasma membrane;external side of plasma membrane,,,+,,,,,,,,,,,
1299,P08581,MET,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),QIKDLGSELVRYD,_DLGS(ph)ELVR_,S966,+,24.53,,,,22.27,21.13,22.66,21.94,21.85,23.07,,,,22.49,2.04, , , ,-0.22,-1.36,0.17,-0.55,-0.65,0.57, , , ,pancreas development;myotube differentiation;muscle cell migration;positive regulation of mitosis;neuron migration;positive regulation of peptidyl-threonine phosphorylation;liver development;placenta development;oligodendrocyte development;central nervous system neuron differentiation;cellular response to glucose stimulus;sperm motility;activation of MAPK activity;cell aging;myoblast proliferation;adult behavior;positive regulation of glucose transport;response to organic cyclic compound;response to acid;positive regulation of DNA replication;male gonad development;positive regulation of peptidyl-serine phosphorylation;protein autophosphorylation;response to drug;cellular response to arsenic-containing substance;response to wounding;branching morphogenesis of a tube;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;positive regulation of dendrite morphogenesis;cellular response to interleukin-6;regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling;negative regulation of peptidyl-threonine phosphorylation;axon guidance;cell proliferation;brain development;negative regulation of hydrogen peroxide-mediated programmed cell death;positive regulation of neuron projection development;cellular response to peptide hormone stimulus;lactation,neuronal cell body;flagellum;postsynaptic density;cytoplasm;extracellular space;integral to plasma membrane;postsynaptic membrane;basal plasma membrane;excitatory synapse,,+,,,,,,,,,,,,
1300,P08581,MET,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),VSARSVSPTTEMV,_SVS(ph)PTTEM(ox)VSNESVDYR_,S990,+,24.79,23.38,23.38,,25.92,24.31,25.30,25.27,22.52,23.90,25.01,23.21,24.85,24.32,0.47,-0.94,-0.94, ,1.60,-0.01,0.98,0.95,-1.80,-0.43,0.69,-1.11,0.53,pancreas development;myotube differentiation;muscle cell migration;positive regulation of mitosis;neuron migration;positive regulation of peptidyl-threonine phosphorylation;liver development;placenta development;oligodendrocyte development;central nervous system neuron differentiation;cellular response to glucose stimulus;sperm motility;activation of MAPK activity;cell aging;myoblast proliferation;adult behavior;positive regulation of glucose transport;response to organic cyclic compound;response to acid;positive regulation of DNA replication;male gonad development;positive regulation of peptidyl-serine phosphorylation;protein autophosphorylation;response to drug;cellular response to arsenic-containing substance;response to wounding;branching morphogenesis of a tube;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;positive regulation of dendrite morphogenesis;cellular response to interleukin-6;regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling;negative regulation of peptidyl-threonine phosphorylation;axon guidance;cell proliferation;brain development;negative regulation of hydrogen peroxide-mediated programmed cell death;positive regulation of neuron projection development;cellular response to peptide hormone stimulus;lactation,neuronal cell body;flagellum;postsynaptic density;cytoplasm;extracellular space;integral to plasma membrane;postsynaptic membrane;basal plasma membrane;excitatory synapse,,+,,,,,,,,,,,,
1301,P08581,MET,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),PTTEMVSNESVDY,_SVSPTTEM(ox)VS(ph)NESVDYR_,S997,,21.57,,,,23.73,23.87,,22.52,,,,,22.63,22.86,-1.30, , , ,0.87,1.00, ,-0.34, , , , ,-0.24,pancreas development;myotube differentiation;muscle cell migration;positive regulation of mitosis;neuron migration;positive regulation of peptidyl-threonine phosphorylation;liver development;placenta development;oligodendrocyte development;central nervous system neuron differentiation;cellular response to glucose stimulus;sperm motility;activation of MAPK activity;cell aging;myoblast proliferation;adult behavior;positive regulation of glucose transport;response to organic cyclic compound;response to acid;positive regulation of DNA replication;male gonad development;positive regulation of peptidyl-serine phosphorylation;protein autophosphorylation;response to drug;cellular response to arsenic-containing substance;response to wounding;branching morphogenesis of a tube;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;positive regulation of dendrite morphogenesis;cellular response to interleukin-6;regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling;negative regulation of peptidyl-threonine phosphorylation;axon guidance;cell proliferation;brain development;negative regulation of hydrogen peroxide-mediated programmed cell death;positive regulation of neuron projection development;cellular response to peptide hormone stimulus;lactation,neuronal cell body;flagellum;postsynaptic density;cytoplasm;extracellular space;integral to plasma membrane;postsynaptic membrane;basal plasma membrane;excitatory synapse,,+,,,,,,,,,,,,
1302,P08621,SNRNP70,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),GDMAEPSEAGDAP,_GGGGDM(ox)AEPS(ph)EAGDAPPDDGPPGELGPDGPDGPEEK_,S320,+,25.63,23.61,23.61,24.74,23.99,24.26,26.17,24.62,27.34,25.86,,26.23,,25.10,0.53,-1.49,-1.49,-0.35,-1.10,-0.84,1.07,-0.48,2.24,0.77, ,1.14, ,"mRNA splicing, via spliceosome;regulation of RNA splicing",nucleoplasm;nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
1303,P08621,SNRNP70,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),EGLGNDSRDMYME,_GGGGGQDNGLEGLGNDS(ph)R_,S410,+,24.64,,,23.91,,,22.94,,22.93,22.02,,,22.55,23.17,1.47, , ,0.75, , ,-0.22, ,-0.23,-1.15, , ,-0.62,"mRNA splicing, via spliceosome;regulation of RNA splicing",nucleoplasm;nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
1304,P08621,SNRNP70,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),DERPGPSPLPHRD,_YDERPGPS(ph)PLPHR_,S226,,22.98,24.58,,22.85,,23.69,,,,,,,,23.52,-0.55,1.05, ,-0.67, ,0.16, , , , , , , ,"mRNA splicing, via spliceosome;regulation of RNA splicing",nucleoplasm;nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
1306,P08648,ITGA5,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain;Integrin alpha-5 light chain],LESSLSSSEGEEP,_LLESSLSS(ph)SEGEEPVEYK_,S127,+,25.58,28.17,28.18,30.35,29.25,30.31,28.45,30.68,29.56,29.88,30.14,31.38,29.52,29.34,-3.76,-1.17,-1.16,1.01,-0.09,0.97,-0.89,1.34,0.21,0.54,0.79,2.04,0.18,"positive regulation of vascular endothelial growth factor receptor signaling pathway;blood coagulation;leukocyte cell-cell adhesion;integrin-mediated signaling pathway;negative regulation of anoikis;cell-cell adhesion mediated by integrin;virus-host interaction;wound healing, spreading of epidermal cells;angiogenesis;positive regulation of peptidyl-tyrosine phosphorylation;axon guidance;heterophilic cell-cell adhesion;memory;cell adhesion;cell-substrate junction assembly;leukocyte migration",integrin complex;alphav-beta3 integrin-vitronectin complex;external side of plasma membrane;ruffle,,,,,,,,,,,,,,
1309,P08651,NFIC,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),MEGGISSPVKKTE,_NWTEDM(ox)EGGISS(ph)PVKK_,S290,+,27.31,26.45,25.43,27.52,27.17,28.34,27.79,27.25,27.60,26.04,25.98,27.27,26.84,27.00,0.31,-0.55,-1.57,0.52,0.17,1.34,0.79,0.25,0.60,-0.96,-1.02,0.27,-0.16,negative regulation of transcription from RNA polymerase II promoter;DNA replication;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
1312,P08651,NFIC,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),KTEMDKSPFNSPS,_S(ph)PFNSPSPQDSPR_,S300,,25.30,25.62,22.55,24.17,,,,,,,,,,24.41,0.89,1.21,-1.86,-0.24, , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
1313,P08651,NFIC,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),SPFNSPSPQDSPR,_SPFNSPS(ph)PQDSPR_,S306,+,27.10,26.28,26.46,27.64,25.68,28.30,27.35,26.47,26.67,23.25,25.53,26.84,26.26,26.45,0.65,-0.16,0.01,1.19,-0.77,1.85,0.90,0.02,0.22,-3.20,-0.91,0.39,-0.19,negative regulation of transcription from RNA polymerase II promoter;DNA replication;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
1314,P08651,NFIC,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),SPSPQDSPRLSSF,_SPFNSPS(ph)PQDS(ph)PR_,S310,,22.61,,,,,,,,,,,,,22.61,0.00, , , , , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
1315,P08670,VIM,Vimentin,QVINETSQHHDDL,_DGQVINETS(ph)QHHDDLE_,S459,+,21.26,26.98,27.06,27.32,29.64,28.76,28.74,29.33,29.04,24.25,27.81,27.44,28.70,27.41,-6.15,-0.43,-0.35,-0.09,2.23,1.35,1.32,1.92,1.63,-3.16,0.40,0.03,1.29,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1316,P08670,VIM,Vimentin,AENTLQSFRQDVD,_EEAENTLQS(ph)FRQDVDNASLAR_,S205,,,22.95,,,23.03,23.08,,,,,,,24.66,23.43, ,-0.48, , ,-0.40,-0.35, , , , , , ,1.24,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1317,P08670,VIM,Vimentin,QDVDNASLARLDL,_QDVDNAS(ph)LARLDLER_,S214,+,22.79,26.98,24.13,27.15,27.22,26.81,24.36,26.63,26.52,,27.44,25.69,27.40,26.09,-3.30,0.88,-1.97,1.06,1.12,0.72,-1.73,0.54,0.43, ,1.35,-0.40,1.31,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1319,P08670,VIM,Vimentin,PLVDTHSKRTLLI,_ETNLDSLPLVDTHS(ph)K_,S438,+,22.12,24.09,24.09,22.13,21.00,24.85,24.07,23.66,24.41,,26.01,23.05,24.87,23.69,-1.57,0.39,0.39,-1.57,-2.70,1.15,0.37,-0.03,0.72, ,2.31,-0.64,1.18,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1320,P08670,VIM,Vimentin,SKFADLSEAANRN,_FADLS(ph)EAANRNNDALR_,S299,,,,,,,22.95,22.32,,24.04,,23.30,,,23.15, , , , , ,-0.20,-0.83, ,0.89, ,0.15, , ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1321,P08670,VIM,Vimentin,LKGTNESLERQMR,_GTNES(ph)LER_,S339,+,,24.30,,24.89,22.76,,20.96,22.50,22.97,,21.56,21.96,22.66,22.73, ,1.57, ,2.16,0.03, ,-1.77,-0.23,0.24, ,-1.17,-0.77,-0.07,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1323,P08670,VIM,Vimentin,PLPNFSSLNLRET,_ISLPLPNFSS(ph)LNLR_,S420,,,,,20.17,25.67,25.14,,24.92,25.80,,26.59,,,24.71, , , ,-4.54,0.96,0.42, ,0.20,1.08, ,1.88, , ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1324,P08670,VIM,Vimentin,LLEGEESRILCLF,_LLEGEES(ph)R_,S409,,21.99,24.08,,22.98,,,,,,,,,,23.02,-1.02,1.06, ,-0.04, , , , , , , , , ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1327,P08670,VIM,Vimentin,GGPGTASRPSSSR,_M(ox)FGGPGTAS(ph)RPSSSR_,S22,,,,,25.25,24.99,,,,24.61,21.57,,,23.10,23.90, , , ,1.35,1.09, , , ,0.71,-2.33, , ,-0.81,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1328,P08670,VIM,Vimentin,GTASRPSSSRSYV,_M(ox)FGGPGTASRPS(ph)SSR_,S25,+,,25.00,25.00,25.69,,,24.50,,24.69,23.09,24.57,27.26,24.02,24.87, ,0.13,0.13,0.82, , ,-0.37, ,-0.18,-1.78,-0.30,2.39,-0.85,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1329,P08670,VIM,Vimentin,TASRPSSSRSYVT,_M(ox)FGGPGTASRPSS(ph)SR_,S26,,,25.41,26.17,25.40,,,,,,,22.51,25.32,,24.96, ,0.45,1.21,0.44, , , , , , ,-2.45,0.36, ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1331,P08670,VIM,Vimentin,YRRQVQSLTCEVD,_QVQS(ph)LTCEVDALK_,S325,+,,22.92,21.97,23.23,,23.73,23.17,,24.97,23.09,,,23.75,23.35, ,-0.43,-1.38,-0.12, ,0.37,-0.18, ,1.62,-0.27, , ,0.40,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1332,P08670,VIM,Vimentin,RPSTSRSLYASSP,_S(ph)LYASSPGGVYATR_,S51,,,,,,,,,,,,,29.33,29.23,29.28, , , , , , , , , , , ,0.05,-0.05,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1333,P08670,VIM,Vimentin,SRSLYASSPGGVY,_SLYAS(ph)SPGGVYATR_,S55,+,24.89,28.64,29.40,28.66,23.23,29.78,,30.76,29.49,27.91,29.06,,22.82,27.70,-2.80,0.95,1.70,0.96,-4.46,2.09, ,3.07,1.79,0.21,1.37, ,-4.87,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1334,P08670,VIM,Vimentin,RSLYASSPGGVYA,_SLYASS(ph)PGGVYATR_,S56,,,22.07,21.84,19.62,31.03,,30.35,,23.60,,,,,24.75, ,-2.68,-2.91,-5.13,6.28, ,5.60, ,-1.15, , , , ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1336,P08670,VIM,Vimentin,__MSTRSVSSSSY,_(ac)STRS(ph)VSSSSYR_,S5,+,,25.12,25.12,23.58,25.46,23.87,,24.20,24.87,23.49,,,,24.46, ,0.66,0.66,-0.89,1.00,-0.60, ,-0.26,0.40,-0.97, , , ,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1338,P08670,VIM,Vimentin,RPSSSRSYVTTST,_S(ph)YVTTSTR_,S29,+,,21.55,22.21,25.21,22.04,21.50,21.50,21.10,22.38,,21.57,,20.94,22.00, ,-0.45,0.21,3.21,0.04,-0.50,-0.50,-0.90,0.38, ,-0.43, ,-1.06,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1339,P08670,VIM,Vimentin,RSYVTTSTRTYSL,_SYVTTS(ph)TR_,S34,+,,22.70,23.38,25.51,23.22,21.85,21.65,22.11,22.57,20.89,22.38,22.75,21.38,22.53, ,0.17,0.85,2.98,0.68,-0.68,-0.88,-0.42,0.04,-1.64,-0.15,0.22,-1.15,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1342,P08670,VIM,Vimentin,GSALRPSTSRSLY,_TYSLGSALRPS(ph)TSR_,S47,+,,24.47,24.47,21.87,25.19,24.88,24.69,24.40,25.75,23.40,25.40,25.52,24.76,24.57, ,-0.09,-0.09,-2.69,0.63,0.31,0.12,-0.17,1.18,-1.16,0.83,0.95,0.19,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
1344,P0CW22,RPS17L,40S ribosomal protein S17-like,KLLDFGSLSNLQV,_LLDFGS(ph)LSNLQVTQPTVGM(ox)NFK_,S113,+,26.09,24.63,24.63,26.85,,,19.58,,26.05,,25.84,25.94,,24.95,1.14,-0.32,-0.32,1.90, , ,-5.37, ,1.10, ,0.89,0.98, ,translation,ribosome,,,,,,,,,,,,,,
1345,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",VAFRAPSIHGGSG,_APS(ph)IHGGSGGR_,S35,+,31.16,28.54,28.81,27.98,26.93,25.35,26.23,26.85,25.02,25.86,21.94,29.99,27.31,27.08,4.09,1.46,1.73,0.91,-0.14,-1.72,-0.85,-0.22,-2.05,-1.21,-5.13,2.92,0.23,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1346,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",PSIHGGSGGRGVS,_APSIHGGS(ph)GGR_,S40,+,25.85,22.32,,19.85,21.02,,20.91,21.48,18.65,23.82,25.02,19.40,21.02,21.76,4.09,0.56, ,-1.91,-0.74, ,-0.85,-0.28,-3.11,2.06,3.26,-2.36,-0.74,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1347,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",SGGRGVSVSSARF,_GVS(ph)VSSAR_,S46,,25.62,,,23.97,,,,,,,,21.08,,23.55,2.06, , ,0.41, , , , , , , ,-2.48, ,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1349,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",YSYRQSSATSSFG,_QSS(ph)ATSSFGGLGGGSVR_,S10,+,27.72,23.97,24.58,22.32,25.97,24.61,23.99,26.21,22.65,25.80,25.21,26.78,25.69,25.04,2.68,-1.07,-0.46,-2.72,0.93,-0.43,-1.04,1.17,-2.39,0.76,0.17,1.74,0.65,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1350,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",RQSSATSSFGGLG,_(gl)QSSATS(ph)SFGGLGGGSVR_,S13,,28.70,23.49,24.09,22.78,26.16,23.28,25.60,25.32,23.25,23.77,25.75,25.53,26.84,24.97,3.74,-1.48,-0.87,-2.19,1.19,-1.68,0.63,0.35,-1.72,-1.20,0.78,0.56,1.87,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1351,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",QSSATSSFGGLGG,_QSSATSS(ph)FGGLGGGSVR_,S14,,25.48,,,,,,25.36,24.06,,,25.33,27.96,24.59,25.46,0.02, , , , , ,-0.10,-1.40, , ,-0.14,2.50,-0.88,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1352,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",GGLGGGSVRFGPG,_QSSATSSFGGLGGGS(ph)VR_,S22,+,29.11,24.37,24.23,25.33,25.49,25.29,25.61,28.17,23.76,25.05,25.86,30.59,27.15,26.15,2.95,-1.78,-1.92,-0.83,-0.67,-0.87,-0.54,2.01,-2.39,-1.11,-0.29,4.44,1.00,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
1356,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",AQVRLSSARPGGL,_LSS(ph)ARPGGLGSS(ph)SLYGLGASRPR_,S28,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1359,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",GGLGSSSLYGLGA,_PGGLGSSS(ph)LYGLGASRPR_,S38,+,25.09,21.24,21.24,,22.48,,21.88,,,,22.29,24.45,23.44,22.76,2.32,-1.52,-1.52, ,-0.28, ,-0.88, , , ,-0.47,1.68,0.68,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1360,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",PRVAVRSAYGGPV,_S(ph)AYGGPVGAGIR_,S53,,26.22,21.99,,23.60,22.38,,21.78,22.02,,,,24.94,22.27,23.15,3.07,-1.16, ,0.45,-0.77, ,-1.37,-1.13, , , ,1.78,-0.88,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1361,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",_____MSIHFSSP,_(ac)S(ph)IHFSSPVFTSR_,S2,,31.93,22.99,22.71,25.17,27.46,26.43,26.76,26.79,25.19,25.76,26.93,32.52,30.95,27.05,4.89,-4.06,-4.34,-1.87,0.42,-0.62,-0.28,-0.26,-1.86,-1.29,-0.11,5.48,3.91,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1362,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",_MSIHFSSPVFTS,_(ac)SIHFS(ph)SPVFTSR_,S6,,20.26,,,22.09,22.69,,,23.72,,,25.14,,,22.78,-2.52, , ,-0.70,-0.09, , ,0.94, , ,2.36, , ,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1364,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",SMDNSRSLDLDGI,_S(ph)LDLDGIIAEVK_,S254,,26.03,,,,,,,,,,,,,26.03,0.00, , , , , , , , , , , , ,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1365,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",LEAELRSMQDVVE,_S(ph)M(ox)QDVVEDFK_,S168,,25.77,22.05,19.60,,,,21.98,21.53,,,22.95,,23.98,22.55,3.22,-0.50,-2.95, , , ,-0.57,-1.03, , ,0.40, ,1.43,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1366,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",RVRQEESEQIKTL,_VRQEES(ph)EQIK_,S92,,,,,,,20.06,,21.49,,20.54,22.07,21.82,21.85,21.30, , , , , ,-1.25, ,0.19, ,-0.77,0.77,0.52,0.54,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
1367,P08779,KRT16,"Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)",GSCRAPSTYGGGL,_APS(ph)TYGGGLSVSSR_,S44,,23.96,,,,,,,,,,,,,23.96,0.00, , , , , , , , , , , , ,cell proliferation;intermediate filament cytoskeleton organization;cytoskeleton organization;epidermis development,intermediate filament,,,,,,,,,,,,,,
1368,P08913,ADRA2A,Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR),QVKPGDSLPRRGP,_ASQVKPGDS(ph)LPR_,S331,,,,,,22.19,,21.80,23.79,,,21.82,,21.06,22.13, , , , ,0.06, ,-0.33,1.66, , ,-0.32, ,-1.08,negative regulation of adenylate cyclase activity;energy reserve metabolic process;adenylate cyclase-inhibiting adrenergic receptor signaling pathway;actin cytoskeleton organization;negative regulation of epinephrine secretion;positive regulation of cell migration;glucose homeostasis;negative regulation of norepinephrine secretion;positive regulation of cell proliferation;negative regulation of lipid catabolic process;positive regulation of membrane protein ectodomain proteolysis;positive regulation of cytokine production;negative regulation of insulin secretion involved in cellular response to glucose stimulus;cellular component movement;negative regulation of calcium ion transport;small molecule metabolic process;platelet activation;negative regulation of calcium ion-dependent exocytosis;intestinal absorption;Rho protein signal transduction;activation of MAPK activity by adrenergic receptor signaling pathway;cellular response to hormone stimulus;activation of protein kinase B activity;fear response;positive regulation of potassium ion transport;negative regulation of calcium ion transmembrane transporter activity;phospholipase C-activating adrenergic receptor signaling pathway;positive regulation of wound healing;epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway;negative regulation of adrenergic receptor signaling pathway,basolateral plasma membrane;receptor complex;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
1369,P09382,LGALS1,Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1),VAPDAKSFVLNLG,_S(ph)FVLNLGK_,S30,,,21.12,19.26,22.61,,21.60,,22.13,23.27,,,,,21.66, ,-0.55,-2.40,0.94, ,-0.06, ,0.47,1.60, , , , ,positive regulation of erythrocyte aggregation;response to drug;response to axon injury;multicellular organismal response to stress;positive regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to organic cyclic compound;myoblast differentiation;negative regulation of cell-substrate adhesion;apoptotic process;cellular response to glucose stimulus;regulation of apoptotic process;negative regulation of neuron projection development,extracellular space;proteinaceous extracellular matrix;nucleus;cell surface;cytoplasm,,,,,,,,,,,,,,
1370,P09493,TPM1,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),VTKLEKSIDDLEE,_S(ph)IDDLEEK_,S252,,,,,25.90,23.49,24.76,23.80,24.57,24.95,22.22,,,,24.24, , , ,1.66,-0.75,0.52,-0.44,0.33,0.71,-2.02, , , ,muscle filament sliding;ventricular cardiac muscle tissue morphogenesis;wound healing;cardiac muscle contraction;positive regulation of stress fiber assembly;regulation of muscle contraction;positive regulation of cell adhesion;ruffle organization;negative regulation of cell migration;positive regulation of heart rate by epinephrine;positive regulation of ATPase activity;sarcomere organization;cellular response to reactive oxygen species,ruffle membrane;cytosol;stress fiber;muscle thin filament tropomyosin;bleb,,,,,,,,,,,,,,
1373,P09496,CLTA,Clathrin light chain A (Lca),QVDRLQSEPESIR,_LQS(ph)EPESIRK_,S105,,24.41,24.90,24.22,23.21,,,,,20.88,,22.19,,,23.30,1.11,1.60,0.91,-0.10, , , , ,-2.42, ,-1.11, , ,post-Golgi vesicle-mediated transport;endocytosis;axon guidance;intracellular protein transport;cellular membrane organization;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;clathrin coat;clathrin-coated endocytic vesicle membrane;plasma membrane;clathrin coat of trans-Golgi network vesicle;clathrin coat of coated pit;trans-Golgi network membrane,,,,,,,,,,,,,,
1375,P09603,CSF1,Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1],EPQRADSPLEQPE,_ADS(ph)PLEQPEGSPLTQDDR_,S222,,22.16,,,,24.25,26.50,,,25.48,23.88,,23.84,,24.35,-2.19, , , ,-0.10,2.15, , ,1.13,-0.47, ,-0.51, ,inflammatory response;positive regulation of odontogenesis of dentin-containing tooth;macrophage differentiation;odontogenesis;osteoclast differentiation;positive regulation of cell migration;monocyte activation;regulation of ossification;positive regulation of multicellular organism growth;ossification;positive regulation of osteoclast differentiation;positive regulation of macrophage differentiation;positive regulation of gene expression;positive regulation of Ras protein signal transduction;branching involved in mammary gland duct morphogenesis;positive regulation of protein kinase activity;innate immune response;mammary duct terminal end bud growth;positive regulation of monocyte differentiation;cell proliferation;positive regulation of macrophage derived foam cell differentiation;homeostasis of number of cells within a tissue;developmental process involved in reproduction;positive regulation of mononuclear cell proliferation;positive regulation of cell-matrix adhesion;mammary gland fat development,extracellular space;integral to membrane;receptor complex;plasma membrane;membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1376,P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1),AVSREDSQRPGAH,_EDS(ph)QRPGAHLTVK_,S95,,23.98,23.06,,,,21.42,20.33,,,,,22.45,,22.25,1.73,0.81, , , ,-0.83,-1.92, , , , ,0.20, ,"RNA export from nucleus;nuclear import;mRNA splicing, via spliceosome;alternative mRNA splicing, via spliceosome;virus-host interaction;mRNA transport",nucleoplasm;intermediate filament cytoskeleton;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,+,,,,
1377,P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1),SSSSYGSGRRF__,_NQGGYGGSSSSSSYGS(ph)GR_,S368,,24.86,,,24.81,,,,,,,,22.23,,23.97,0.90, , ,0.85, , , , , , , ,-1.74, ,"RNA export from nucleus;nuclear import;mRNA splicing, via spliceosome;alternative mRNA splicing, via spliceosome;virus-host interaction;mRNA transport",nucleoplasm;intermediate filament cytoskeleton;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,+,,,,
1379,P09651,HNRNPA1,Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1),_MSKSESPKEPEQ,_S(ph)ES(ph)PKEPEQLRK_,S6,+,30.89,32.13,32.01,30.91,30.96,30.39,30.15,29.85,30.99,30.65,29.81,29.68,28.59,30.54,0.35,1.59,1.47,0.37,0.42,-0.15,-0.39,-0.69,0.45,0.11,-0.73,-0.86,-1.95,"RNA export from nucleus;nuclear import;mRNA splicing, via spliceosome;alternative mRNA splicing, via spliceosome;virus-host interaction;mRNA transport",nucleoplasm;intermediate filament cytoskeleton;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,+,,,,
1383,P09758,TACSTD2,Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1),ELRKEPSL_____,_ELGELRKEPS(ph)L_,S322,+,27.92,28.63,29.56,23.66,25.55,23.98,23.25,22.02,,,,22.42,,25.22,2.70,3.41,4.34,-1.57,0.33,-1.24,-1.97,-3.21, , , ,-2.80, ,negative regulation of stress fiber assembly;regulation of epithelial cell proliferation;negative regulation of ruffle assembly;cell proliferation;negative regulation of epithelial cell migration;negative regulation of substrate adhesion-dependent cell spreading;visual perception;ureteric bud morphogenesis;negative regulation of branching involved in ureteric bud morphogenesis;cell surface receptor signaling pathway,cytosol;lateral plasma membrane;integral to plasma membrane;basal plasma membrane,,,,,,,,,,,,,,
1385,P0C1Z6,TFPT,TCF3 fusion partner (INO80 complex subunit F) (Protein FB1),PEKETLSPPRRTP,_ETLS(ph)PPR_,S158,,23.24,,,23.96,,,,,,,,,,23.60,-0.36, , ,0.36, , , , , , , , , ,"DNA repair;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination;induction of apoptosis",Ino80 complex;cytoplasm,,,,,,,,,,,,,,
1386,P0C1Z6,TFPT,TCF3 fusion partner (INO80 complex subunit F) (Protein FB1),PYPTLASPASD__,_LLPYPTLAS(ph)PASD_,S240,,22.48,,,,23.97,,,,21.79,24.16,,,,23.10,-0.62, , , ,0.87, , , ,-1.31,1.06, , , ,"DNA repair;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination;induction of apoptosis",Ino80 complex;cytoplasm,,,,,,,,,,,,,,
1387,P0C1Z6,TFPT,TCF3 fusion partner (INO80 complex subunit F) (Protein FB1),TLASPASD_____,_LLPYPTLASPAS(ph)D_,S243,,25.11,,,,,,,,21.68,,,,,23.40,1.72, , , , , , , ,-1.72, , , , ,"DNA repair;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination;induction of apoptosis",Ino80 complex;cytoplasm,,,,,,,,,,,,,,
1389,P0C7T5,ATXN1L,Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1),NLVRRESEALDSP,_RES(ph)EALDSPNSK_,S284,,24.34,23.40,,23.83,,,,,,,,,,23.86,0.49,-0.46, ,-0.03, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;dendrite,Other TF domain,,,,,,,,,,,,,
1390,P0CG38,POTEI,POTE ankyrin domain family member I,KQEYDESGPSIVH,_(gl)QEYDES(ph)GPSIVHRK_,S365,,20.27,23.64,24.51,,,23.43,23.74,,,,22.83,,22.05,22.93,-2.65,0.72,1.59, , ,0.50,0.81, , , ,-0.09, ,-0.88,,,,,,,,,,,,,,,,
1391,P0DJ93,SMIM13,Small integral membrane protein 13,EGDHEPSGSETEE,_ELVGDTGSQEGDHEPS(ph)GS(ph)ETEEDTSSSPHR_,S58,,25.36,,,,,,,,23.47,,,,,24.42,0.95, , , , , , , ,-0.95, , , , ,,integral to membrane,,,,,,,,,,,,,,
1392,P0DJ93,SMIM13,Small integral membrane protein 13,DHEPSGSETEEDT,_ELVGDTGSQEGDHEPS(ph)GS(ph)ETEEDTSSSPHR_,S60,,25.36,,,,,,,,23.47,,,,,24.42,0.95, , , , , , , ,-0.95, , , , ,,integral to membrane,,,,,,,,,,,,,,
1393,P10155,TROVE2,60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2),EKQIANSQDGYVW,_QIANS(ph)QDGYVWQVTDM(ox)NR_,S19,,24.38,,,,,,,,,,,,,24.38,0.00, , , , , , , , , , , , ,cell projection organization;transcription from RNA polymerase III promoter,ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
1395,P10301,RRAS,Ras-related protein R-Ras (p23),EQELPPSPPSAPR,_YQEQELPPS(ph)PPSAPR_,S201,+,22.66,,,21.17,22.27,,,23.32,24.66,24.78,24.75,23.61,24.95,23.58,-0.92, , ,-2.40,-1.30, , ,-0.25,1.09,1.20,1.17,0.03,1.37,positive regulation of angiogenesis;negative regulation of cell migration;synaptic transmission;Ras protein signal transduction;axon guidance,plasma membrane,,,,,,,,,,,,,,
1396,P10398,ARAF,Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks),RQQFYHSVQDLSG,_(gl)QQFYHS(ph)VQDLSGGSR_,S157,,22.50,,,23.06,,,,,,,,23.93,22.88,23.09,-0.59, , ,-0.03, , , , , , , ,0.84,-0.22,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;intracellular signal transduction,cytosol;mitochondrion,,+,,,,,,,,,,,,
1397,P10412,HIST1H1E,Histone H1.4 (Histone H1b) (Histone H1s-4),AGKRKASGPPVSE,_KAS(ph)GPPVSELITK_,S36,,21.91,25.22,25.51,21.87,25.55,23.42,22.04,21.60,24.38,22.65,,22.94,,23.37,-1.46,1.85,2.14,-1.51,2.18,0.05,-1.33,-1.77,1.01,-0.73, ,-0.43, ,nucleosome positioning;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
1398,P10412,HIST1H1E,Histone H1.4 (Histone H1b) (Histone H1s-4),_____MSETAPAA,_(ac)S(ph)ETAPAAPAAPAPAEKTPVKK_,S2,,,23.42,23.49,,29.70,23.76,,26.22,,,,,,25.32, ,-1.90,-1.83, ,4.38,-1.56, ,0.90, , , , , ,nucleosome positioning;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
1399,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),APSDWDSRGKDSY,_AIPVAQDLNAPSDWDS(ph)RGK_,S205,,23.55,,,22.40,24.73,,22.57,,,27.87,,,,24.23,-0.67, , ,-1.82,0.50, ,-1.66, , ,3.65, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1400,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),RKANDESNEHSDV,_ANDES(ph)NEHSDVIDSQELSK_,S240,,24.80,26.58,24.34,,,,,,,25.84,23.91,,,25.10,-0.30,1.49,-0.75, , , , , , ,0.75,-1.18, , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1401,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),HSDVIDSQELSKV,_ANDESNEHSDVIDS(ph)QELSK_,S249,,24.70,26.80,24.70,,,,,,,24.14,21.36,,,24.34,0.36,2.46,0.36, , , , , , ,-0.20,-2.98, , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1402,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),DSRGKDSYETSQL,_GKDS(ph)YETSQLDDQS(ph)AETHSHK_,S210,,,26.79,,,,,,,,,,,,26.79, ,0.00, , , , , , , , , , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1403,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),SQLDDQSAETHSH,_DSYETSQLDDQS(ph)AETHSHK_,S220,,,26.75,22.73,,,,,,,27.86,,,,25.78, ,0.97,-3.05, , , , , , ,2.08, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1404,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),HLKFRISHELDSA,_FRIS(ph)HELDS(ph)ASSEVN_,S289,,23.88,23.61,21.79,,,,22.79,,,28.36,,,,24.09,-0.20,-0.48,-2.30, , , ,-1.29, , ,4.28, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1405,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),ISHELDSASSEVN,_ISHELDS(ph)AS(ph)SEVN_,S294,,24.38,28.70,,,,,22.79,,,25.82,,,25.57,25.45,-1.07,3.25, , , , ,-2.66, , ,0.37, , ,0.12,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1406,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),HELDSASSEVN__,_ISHELDS(ph)AS(ph)SEVN_,S296,+,22.59,28.23,,,22.47,,,,25.74,27.42,25.74,,24.47,25.24,-2.64,2.99, , ,-2.77, , , ,0.50,2.19,0.51, ,-0.77,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1407,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),APQNAVSSEETND,_QNLLAPQNAVS(ph)SEETNDFK_,S62,,,23.42,,,,,,,,24.95,,,,24.18, ,-0.77, , , , , , , ,0.77, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1408,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),PQNAVSSEETNDF,_QNLLAPQNAVSS(ph)EETNDFK_,S63,,,22.73,21.45,,,,,,,24.98,,,,23.05, ,-0.33,-1.60, , , , , , ,1.93, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1409,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),APQTLPSKSNESH,_(gl)QNLLAPQTLPS(ph)K_,S62,,23.20,23.44,,21.55,,,21.95,,,25.72,,23.60,,23.24,-0.04,0.20, ,-1.70, , ,-1.29, , ,2.48, ,0.36, ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
1410,P10644,PRKAR1A,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1) [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed]",SREDEISPPPPNP,_EDEIS(ph)PPPPNPVVK_,S83,+,25.25,28.49,27.28,28.56,29.19,29.12,28.46,28.78,27.04,25.73,29.13,29.16,28.01,28.02,-2.76,0.48,-0.73,0.55,1.17,1.11,0.44,0.76,-0.98,-2.28,1.12,1.14,-0.01,small molecule metabolic process;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;regulation of transcription from RNA polymerase II promoter;energy reserve metabolic process;transmembrane transport;regulation of insulin secretion;blood coagulation;epidermal growth factor receptor signaling pathway;activation of protein kinase A activity;nerve growth factor receptor signaling pathway;water transport;mesoderm formation;cellular response to glucagon stimulus;intracellular signal transduction,neuromuscular junction;cytosol;cAMP-dependent protein kinase complex;protein complex,,,,,,,,,,,,,,
1412,P10809,HSPD1,"60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",IEQSWGSPKVTKD,_TVIIEQSWGS(ph)PK_,S70,,23.47,,,,,,,,,,22.34,,,22.90,0.57, , , , , , , , , ,-0.57, , ,negative regulation of apoptotic process;T cell activation;positive regulation of interleukin-12 production;positive regulation of interleukin-10 production;positive regulation of macrophage activation;activation of cysteine-type endopeptidase activity involved in apoptotic process;B cell cytokine production;response to unfolded protein;MyD88-dependent toll-like receptor signaling pathway;protein maturation;virus-host interaction;isotype switching to IgG isotypes;positive regulation of interleukin-6 production;protein stabilization;B cell proliferation;chaperone-mediated protein complex assembly;positive regulation of interferon-alpha production;positive regulation of T cell mediated immune response to tumor cell;positive regulation of T cell activation;protein refolding;'de novo' protein folding;positive regulation of apoptotic process;positive regulation of interferon-gamma production,mitochondrial inner membrane;plasma membrane part;early endosome;secretory granule;coated pit;cytosol;extracellular space;coated vesicle;lipopolysaccharide receptor complex;mitochondrial matrix;cell surface,,,,,,,,,,,,,,
1413,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),EGKKETSPESSLI,_KETS(ph)PESSLIQDEIAVK_,S1151,,,,,22.38,23.52,,24.45,,,,25.10,,23.82,23.85, , , ,-1.47,-0.34, ,0.60, , , ,1.25, ,-0.03,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,,,,,,,,,,
1414,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),AEIITQSPGRSSV,_ARVDHGAEIITQS(ph)PGR_,S1778,+,20.63,24.63,23.02,27.39,26.66,26.71,26.24,27.09,,,28.18,,27.00,25.75,-5.13,-1.12,-2.74,1.64,0.90,0.96,0.48,1.34, , ,2.42, ,1.24,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,,,,,,,,,,
1417,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),EVARRKSVPSETV,_S(ph)VPSETVVEDSR_,S829,+,,22.57,22.57,28.56,24.90,24.77,24.09,24.14,21.90,,27.82,25.73,27.24,24.94, ,-2.37,-2.37,3.63,-0.04,-0.16,-0.84,-0.79,-3.04, ,2.89,0.80,2.31,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,,,,,,,,,,
1421,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),IPALQGSTKSPRY,_IPALQGS(ph)TK_,S185,,,,,24.20,,,,,,,,21.71,,22.96, , , ,1.25, , , , , , , ,-1.25, ,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,,,,,,,,,,
1422,P11166,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",FRQGGASQSDKTP,_(gl)QGGAS(ph)QSDKTPEELFHPLGADSQV_,S397,,28.41,23.63,,,,,,26.39,,,,,,26.14,2.27,-2.51, , , , , ,0.25, , , , , ,cellular response to glucose starvation;regulation of insulin secretion;energy reserve metabolic process;response to osmotic stress;L-ascorbic acid metabolic process,basolateral plasma membrane;female pronucleus;caveola;cell-cell junction;midbody;integral to membrane;plasma membrane;melanosome,,,,,,,,,,,,,,
1423,P11166,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",HPLGADSQV____,_TPEELFHPLGADS(ph)QV_,S414,,24.92,,,,,,,,,,,,,24.92,0.00, , , , , , , , , , , , ,cellular response to glucose starvation;regulation of insulin secretion;energy reserve metabolic process;response to osmotic stress;L-ascorbic acid metabolic process,basolateral plasma membrane;female pronucleus;caveola;cell-cell junction;midbody;integral to membrane;plasma membrane;melanosome,,,,,,,,,,,,,,
1424,P11166,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",TFDEIASGFRQGG,_TFDEIAS(ph)GFR_,S389,,24.35,,,,,,,,,,,,,24.35,0.00, , , , , , , , , , , , ,cellular response to glucose starvation;regulation of insulin secretion;energy reserve metabolic process;response to osmotic stress;L-ascorbic acid metabolic process,basolateral plasma membrane;female pronucleus;caveola;cell-cell junction;midbody;integral to membrane;plasma membrane;melanosome,,,,,,,,,,,,,,
1425,P11169,SLC2A3,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",GVMEMNSIEPAKE,_DGVMEMNS(ph)IEPAK_,S278,,,23.93,24.42,25.47,,,,24.43,28.61,,,,,25.37, ,-1.44,-0.95,0.09, , , ,-0.94,3.24, , , , ,L-ascorbic acid metabolic process,integral to membrane;plasma membrane,,,,,,,,,,,,,,
1426,P11274,BCR,Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26),LSVKFNSREFSLK,_LSVKFNS(ph)R_,S624,+,23.33,20.75,20.88,23.69,23.11,21.20,23.62,22.80,,,21.99,24.97,,22.63,0.70,-1.88,-1.75,1.05,0.47,-1.43,0.99,0.17, , ,-0.65,2.33, ,regulation of cell cycle;small GTPase mediated signal transduction;negative regulation of inflammatory response;neuromuscular process controlling balance;actin cytoskeleton organization;brain development;negative regulation of cell migration;inner ear morphogenesis;regulation of small GTPase mediated signal transduction;positive regulation of phagocytosis;response to lipopolysaccharide;negative regulation of neutrophil degranulation,cytosol;plasma membrane,,+,,,,,,,,,,,,
1427,P11274,BCR,Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26),FNSREFSLKRMPS,_FNSREFS(ph)LK_,S628,,,20.38,19.17,,,,,,,22.43,,23.91,,21.47, ,-1.09,-2.31, , , , , , ,0.96, ,2.44, ,regulation of cell cycle;small GTPase mediated signal transduction;negative regulation of inflammatory response;neuromuscular process controlling balance;actin cytoskeleton organization;brain development;negative regulation of cell migration;inner ear morphogenesis;regulation of small GTPase mediated signal transduction;positive regulation of phagocytosis;response to lipopolysaccharide;negative regulation of neutrophil degranulation,cytosol;plasma membrane,,+,,,,,,,,,,,,
1429,P11387,TOP 1.00,DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I),KENGFSSPPQIKD,_ENGFSS(ph)PPQIK_,S112,+,23.83,25.59,25.85,26.05,,24.70,26.65,,26.75,27.24,26.71,26.69,23.20,25.75,-1.92,-0.16,0.10,0.30, ,-1.05,0.90, ,1.00,1.49,0.96,0.94,-2.55,embryonic cleavage;chromosome segregation;response to drug;programmed cell death;phosphorylation;DNA topological change;chromatin remodeling;DNA replication;virus-host interaction,nucleoplasm;replication fork protection complex;nucleolus;perikaryon;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
1430,P11387,TOP 1.00,DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I),DHLHNDSQIEADF,_(ac)SGDHLHNDS(ph)QIEADFR_,S10,,23.05,22.39,,23.09,25.08,,,23.94,,,,,,23.51,-0.46,-1.12, ,-0.42,1.57, , ,0.43, , , , , ,embryonic cleavage;chromosome segregation;response to drug;programmed cell death;phosphorylation;DNA topological change;chromatin remodeling;DNA replication;virus-host interaction,nucleoplasm;replication fork protection complex;nucleolus;perikaryon;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
1432,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",FTMDLDSDEDFSD,_FTM(ox)DLDS(ph)DEDFS(ph)DFDEK_,S1332,,23.86,,,,,,,,,,,,,23.86,0.00, , , , , , , , , , , , ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1434,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",SVPLSSSPPATHF,_SVVSDLEADDVKGSVPLSSS(ph)PPATHFPDETEITNPVPK_,S1393,+,27.25,23.76,23.76,,29.17,27.91,25.68,27.45,23.58,27.41,,26.47,,26.24,1.01,-2.48,-2.48, ,2.93,1.67,-0.57,1.20,-2.67,1.16, ,0.23, ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1435,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",NENTEGSPQEDGV,_NENTEGS(ph)PQEDGVELEGLK_,S1247,+,27.33,25.22,25.77,24.10,27.07,26.63,27.31,26.43,26.62,26.16,,24.89,25.76,26.11,1.22,-0.89,-0.34,-2.01,0.96,0.53,1.20,0.32,0.51,0.06, ,-1.22,-0.34,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1436,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",IKYLEESDEDDLF,_YLEES(ph)DEDDLF_,S1525,,28.04,,,,24.84,,,,,,,,,26.44,1.60, , , ,-1.60, , , , , , , , ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1438,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",ELKPQKSVVSDLE,_S(ph)VVS(ph)DLEADDVK_,S1374,,25.19,,,,,,21.89,,,21.51,,22.55,,22.79,2.41, , , , , ,-0.90, , ,-1.28, ,-0.23, ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1439,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",PQKSVVSDLEADD,_S(ph)VVS(ph)DLEADDVK_,S1377,+,27.51,25.06,25.06,24.45,,,27.24,,25.98,26.25,24.47,25.64,26.33,25.80,1.71,-0.74,-0.74,-1.35, , ,1.44, ,0.18,0.45,-1.33,-0.16,0.53,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1440,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",DEDFVPSDASPPK,_TDDEDFVPS(ph)DAS(ph)PPK_,S1351,,24.77,,,,,,,,,,,,,24.77,0.00, , , , , , , , , , , , ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1441,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",FVPSDASPPKTKT,_TDDEDFVPS(ph)DAS(ph)PPK_,S1354,,24.77,23.15,,22.10,,,23.21,,23.35,24.15,,,,23.45,1.32,-0.31, ,-1.36, , ,-0.25, ,-0.10,0.69, , , ,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1442,P11388,TOP2A,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",MAEVLPSPRGQRV,_TQM(ox)AEVLPS(ph)PR_,S1213,+,24.55,24.31,24.88,24.72,26.30,25.78,25.74,25.74,23.98,24.25,,,24.47,24.98,-0.43,-0.66,-0.10,-0.26,1.33,0.81,0.77,0.77,-1.00,-0.72, , ,-0.50,sister chromatid segregation;aging;response to drug;positive regulation of retroviral genome replication;DNA repair;DNA topological change;DNA ligation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;DNA-dependent DNA replication;embryonic cleavage;mitotic cell cycle G2/M transition decatenation checkpoint;apoptotic chromosome condensation;mitotic recombination;resolution of meiotic recombination intermediates;positive regulation of apoptotic process;response to parathyroid hormone stimulus,nucleoplasm;DNA topoisomerase complex (ATP-hydrolyzing);synaptonemal complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
1445,P11532,DMD,Dystrophin,SLQRSDSSQPMLL,_SDS(ph)SQPM(ox)LLR_,S3615,,24.56,,,22.30,23.34,,,,,,,,,23.40,1.16, , ,-1.10,-0.06, , , , , , , , ,"muscle filament sliding;muscle cell homeostasis;regulation of transcription, DNA-dependent;neurotransmitter receptor metabolic process;peptide biosynthetic process;neuron projection morphogenesis;olfactory nerve structural organization;skeletal muscle tissue development;muscle organ development",Z disc;neuron projection terminus;membrane raft;sarcolemma;cell-substrate junction;cytosol;dystrophin-associated glycoprotein complex;nucleus;cytoskeleton;costamere;postsynaptic membrane;cell surface,,,,,,,,,,,,,,
1446,P11717,IGF2R,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),HGDDQDSEDEVLT,_ALSSLHGDDQDS(ph)EDEVLTIPEVK_,S2332,+,25.62,,,,29.24,,24.56,24.74,27.49,29.60,27.09,27.98,24.47,26.76,-1.14, , , ,2.48, ,-2.20,-2.02,0.74,2.85,0.34,1.23,-2.28,receptor-mediated endocytosis,endosome;trans-Golgi network transport vesicle;endocytic vesicle;nuclear envelope lumen;lysosomal membrane;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
1447,P11717,IGF2R,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),VSFHDDSDEDLLH,_LVSFHDDS(ph)DEDLLHI_,S2407,+,24.32,20.08,20.08,,27.05,20.42,24.57,23.99,25.52,26.48,26.52,27.61,26.41,24.42,-0.10,-4.34,-4.34, ,2.63,-4.00,0.15,-0.43,1.10,2.06,2.10,3.19,1.99,receptor-mediated endocytosis,endosome;trans-Golgi network transport vesicle;endocytic vesicle;nuclear envelope lumen;lysosomal membrane;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
1451,P12270,TPR,Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein),EELAAMSPTAAAV,_GAILSEEELAAM(ox)S(ph)PTAAAVAK_,S379,+,26.16,23.91,23.47,24.78,24.91,26.86,25.80,24.23,26.60,27.18,25.29,24.83,27.03,25.47,0.69,-1.55,-2.00,-0.69,-0.55,1.40,0.33,-1.23,1.14,1.71,-0.18,-0.63,1.56,glucose transport;small molecule metabolic process;seryl-tRNA aminoacylation;carbohydrate metabolic process;mRNA transport;mitotic cell cycle spindle assembly checkpoint;regulation of glucose transport;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;condensed chromosome kinetochore;nuclear pore;cytoplasm,,,,,,,,,,,,,,
1452,P12270,TPR,Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein),APRAPQSPRRPPH,_(gl)QAPRAPQS(ph)PR_,S2073,+,26.04,27.96,28.93,26.11,22.63,21.72,22.61,22.70,23.38,26.55,21.06,22.82,21.56,24.16,1.88,3.80,4.77,1.95,-1.53,-2.44,-1.54,-1.46,-0.78,2.39,-3.10,-1.34,-2.60,glucose transport;small molecule metabolic process;seryl-tRNA aminoacylation;carbohydrate metabolic process;mRNA transport;mitotic cell cycle spindle assembly checkpoint;regulation of glucose transport;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;condensed chromosome kinetochore;nuclear pore;cytoplasm,,,,,,,,,,,,,,
1456,P12694,BCKDHA,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)",DSSAYRSVDEVNY,_S(ph)VDEVNYWDK_,S347,+,25.43,24.32,22.83,23.54,,23.84,,23.40,23.05,22.17,23.59,22.81,,23.50,1.93,0.82,-0.67,0.05, ,0.34, ,-0.09,-0.45,-1.33,0.09,-0.69, ,response to glucocorticoid stimulus;branched-chain amino acid catabolic process;response to cAMP;response to nutrient;cellular nitrogen compound metabolic process,mitochondrial alpha-ketoglutarate dehydrogenase complex,,,,,,,,,,,,,,
1457,P12830,CDH1,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1;E-Cad/CTF2;E-Cad/CTF3],VAPTLMSVPRYLP,_NDVAPTLM(ox)S(ph)VPR_,S793,,23.52,,,23.42,,,,,,,24.96,24.86,25.39,24.43,-0.91, , ,-1.01, , , , , , ,0.53,0.43,0.96,"regulation of immune response;neuron projection development;cellular response to indole-3-methanol;response to toxin;response to drug;cellular component disassembly involved in execution phase of apoptosis;cellular response to amino acid stimulus;regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to lithium ion;adherens junction organization;homophilic cell adhesion;regulation of water loss via skin;trophectodermal cell differentiation;regulation of branching involved in salivary gland morphogenesis;cochlea development;pituitary gland development;protein metabolic process;salivary gland cavitation;sensory perception of sound;positive regulation of transcription factor import into nucleus;synapse assembly;regulation of protein localization to cell surface;positive regulation of transcription, DNA-dependent;protein localization to plasma membrane;protein homooligomerization;cell junction assembly;tight junction assembly;negative regulation of cell-cell adhesion",basolateral plasma membrane;aggresome;lateral plasma membrane;apical part of cell;node of Ranvier;apical junction complex;integral to membrane;focal adhesion;endosome;Golgi apparatus;internal side of plasma membrane;Schmidt-Lanterman incisure;cell-cell adherens junction;actin cytoskeleton;perinuclear region of cytoplasm;trans-Golgi network;lateral loop;catenin complex;cell surface,,,,,,,,,,,,,,
1460,P12956,XRCC6,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),RPKVEYSEEELKT,_VEYS(ph)EEELK_,S560,,,24.12,,20.56,,,,,,,,,,22.34, ,1.78, ,-1.78, , , , , , , , , ,"negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of neurogenesis;double-strand break repair via nonhomologous end joining;viral reproduction;V(D)J recombination;DNA ligation;telomere maintenance;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;nonhomologous end joining complex;Ku70:Ku80 complex;nuclear telomere cap complex;DNA-dependent protein kinase-DNA ligase 4 complex;membrane;cytoplasm,SAP-domain,,,,,,,,,,,,,
1464,P13521,SCG2,Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN)],QEEVRDSKENIEK,_IESQTQEEVRDS(ph)K_,S128,,,23.94,24.02,,,,22.30,,22.10,20.48,22.22,22.11,,22.45, ,1.49,1.57, , , ,-0.15, ,-0.35,-1.98,-0.23,-0.34, ,negative regulation of apoptotic process;MAPK cascade;inflammatory response;angiogenesis;protein secretion;endothelial cell migration;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;eosinophil chemotaxis;induction of positive chemotaxis,secretory granule;extracellular space,,,,,,,,,,,,,,
1466,P13611,VCAN,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M),IGHPIDSESKEDE,_M(ox)SDLSVIGHPIDS(ph)ESK_,S362,,,24.29,,23.16,20.65,22.40,24.87,,29.44,25.50,23.27,,23.76,24.15, ,0.14, ,-0.99,-3.50,-1.74,0.72, ,5.29,1.36,-0.88, ,-0.39,multicellular organismal development;chondroitin sulfate biosynthetic process;carbohydrate metabolic process;axon regeneration;glial cell migration;chondroitin sulfate catabolic process;cell adhesion;dermatan sulfate biosynthetic process;heart development;cell recognition,lysosomal lumen;extracellular space;proteinaceous extracellular matrix;Golgi lumen,,,,,,,,,,,,,,
1467,P13611,VCAN,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M),HPIDSESKEDEPC,_RM(ox)SDLSVIGHPIDSES(ph)K_,S364,,,24.89,,23.16,,,22.95,,29.12,24.71,,,,24.97, ,-0.08, ,-1.80, , ,-2.02, ,4.15,-0.25, , , ,multicellular organismal development;chondroitin sulfate biosynthetic process;carbohydrate metabolic process;axon regeneration;glial cell migration;chondroitin sulfate catabolic process;cell adhesion;dermatan sulfate biosynthetic process;heart development;cell recognition,lysosomal lumen;extracellular space;proteinaceous extracellular matrix;Golgi lumen,,,,,,,,,,,,,,
1468,P13611,VCAN,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M),IESETTSEEQIQE,_(gl)QEVNPVRQEIESETTS(ph)EEQIQEEK_,S1129,+,,23.32,,23.58,,26.00,22.42,,28.28,26.67,,,25.58,25.12, ,-1.80, ,-1.55, ,0.88,-2.70, ,3.16,1.55, , ,0.46,multicellular organismal development;chondroitin sulfate biosynthetic process;carbohydrate metabolic process;axon regeneration;glial cell migration;chondroitin sulfate catabolic process;cell adhesion;dermatan sulfate biosynthetic process;heart development;cell recognition,lysosomal lumen;extracellular space;proteinaceous extracellular matrix;Golgi lumen,,,,,,,,,,,,,,
1469,P13639,EEF2,Elongation factor 2 (EF-2),VMKFSVSPVVRVA,_FSVS(ph)PVVR_,S502,+,22.14,22.19,,19.82,21.98,,22.23,21.82,21.24,,22.55,21.98,,21.77,0.37,0.42, ,-1.96,0.21, ,0.46,0.05,-0.53, ,0.77,0.21, ,translational elongation,cytosol;ribonucleoprotein complex;polysome,,,,,,,,,,,,,,
1472,P13646,KRT13,"Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",MIGFPSSAGSVSP,_M(ox)IGFPSS(ph)AGSVSPR_,S422,,23.84,24.92,24.92,,,,,,,,,,,24.56,-0.72,0.36,0.36, , , , , , , , , , ,cellular response to retinoic acid;tongue morphogenesis;response to radiation;epidermis development,extracellular vesicular exosome;keratin filament,,,,,,,,,,,,,,
1474,P13646,KRT13,"Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",SSAGSVSPRSTSV,_M(ox)IGFPSSAGSVS(ph)PR_,S427,+,32.16,26.51,24.92,22.54,23.38,,,24.45,22.92,,,,,25.27,6.89,1.25,-0.35,-2.73,-1.89, , ,-0.82,-2.35, , , , ,cellular response to retinoic acid;tongue morphogenesis;response to radiation;epidermis development,extracellular vesicular exosome;keratin filament,,,,,,,,,,,,,,
1475,P13646,KRT13,"Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",LKQSPASPERDYS,_(gl)QSPAS(ph)PERDYSPYYK_,S147,,25.63,22.62,,,,,,,,,,,,24.12,1.50,-1.50, , , , , , , , , , , ,cellular response to retinoic acid;tongue morphogenesis;response to radiation;epidermis development,extracellular vesicular exosome;keratin filament,,,,,,,,,,,,,,
1484,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGSKRISISTSGG,_RIS(ph)ISTSGGSFR_,S75,,22.80,26.60,26.60,,,,,,,,,,,25.34,-2.54,1.27,1.27, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1485,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SKRISISTSGGSF,_ISIS(ph)TSGGSFR_,S77,,25.97,25.74,26.66,,,,,,,22.07,,,,25.11,0.86,0.63,1.55, , , , , , ,-3.04, , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1486,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",ISTSGGSFRNRFG,_ISISTSGGS(ph)FR_,S82,,28.04,25.99,26.58,,,,,,,,,,,26.87,1.17,-0.88,-0.29, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1487,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",__MSRQSSVSFRS,_QS(ph)SVSFR_,S5,,28.08,24.77,25.24,,,,,,,,,,,26.03,2.05,-1.26,-0.79, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1488,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",_MSRQSSVSFRSG,_(gl)QSS(ph)VSFR_,S6,,26.11,19.91,20.17,,,,,,,,,,,22.06,4.05,-2.15,-1.89, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1489,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SRQSSVSFRSGGS,_(gl)QSSVS(ph)FR_,S8,,27.19,28.25,28.25,,,,,,,,,,,27.90,-0.71,0.35,0.35, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1490,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",RSGGSRSFSTASA,_S(ph)FSTASAITPSVSR_,S16,,29.31,26.22,26.83,,,,,,23.39,,,22.28,,25.61,3.70,0.62,1.22, , , , , ,-2.21, , ,-3.33, ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1491,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGSRSFSTASAIT,_SFS(ph)TASAITPSVSR_,S18,,27.80,25.49,26.43,,,,,,,21.87,,,23.23,24.96,2.84,0.53,1.47, , , , , , ,-3.10, , ,-1.73,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1492,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",RSFSTASAITPSV,_S(ph)FSTAS(ph)AITPSVSR_,S21,,25.33,25.61,25.61,,,,,,22.07,22.06,,,,24.14,1.20,1.47,1.47, , , , , ,-2.06,-2.08, , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1495,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",PSVSRTSFTSVSR,_TS(ph)FTSVSR_,S31,,27.80,25.34,25.18,,,,,,,,,,,26.10,1.70,-0.77,-0.93, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1496,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",SRTSFTSVSRSGG,_TSFTS(ph)VSR_,S34,,23.67,24.04,24.04,,,,,,,,,,,23.92,-0.25,0.12,0.12, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1497,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",TSFTSVSRSGGGG,_TSFTSVS(ph)R_,S36,,29.97,29.85,30.80,,,,,,,,,,,30.21,-0.23,-0.36,0.59, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1500,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGYGSRSLYNLGG,_S(ph)LYNLGGSK_,S64,+,29.91,29.08,29.95,22.44,21.96,,21.92,21.87,,24.13,,,,25.16,4.76,3.92,4.80,-2.72,-3.20, ,-3.24,-3.28, ,-1.03, , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1501,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",LYNLGGSKRISIS,_SLYNLGGS(ph)K_,S71,,24.59,24.19,24.19,,,,,,,,,,,24.33,0.27,-0.13,-0.13, , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1502,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",_____MSRQSSVS,_(ac)S(ph)RQSS(ph)VSFR_,S2,,25.14,,,,,,,,,,,,,25.14,0.00, , , , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
1503,P13667,PDIA4,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72),DLGLSESGEDVNA,_DLGLSES(ph)GEDVNAAILDESGK_,S470,,22.17,,,,,,,,,,,,,22.17,0.00, , , , , , , , , , , , ,protein folding;protein secretion;glycerol ether metabolic process;cell redox homeostasis,melanosome;endoplasmic reticulum lumen;cell surface,,,,,,,,,,,,,,
1504,P13796,LCP1,Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1),__MARGSVSDEEM,_(ac)ARGS(ph)VSDEEM(ox)M(ox)ELR_,S5,+,29.68,28.70,28.65,24.91,23.44,,,22.11,,21.68,,,,25.60,4.08,3.11,3.05,-0.69,-2.15, , ,-3.48, ,-3.91, , , ,T cell activation involved in immune response;organ regeneration;actin filament bundle assembly;regulation of intracellular protein transport,ruffle membrane;cytosol;actin filament;cell junction;plasma membrane;phagocytic cup;actin cytoskeleton,,,,,,,,,,,,,,
1505,P13796,LCP1,Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1),LLREGESLEDLMK,_EGES(ph)LEDLM(ox)K_,S257,,27.51,26.82,26.39,24.53,22.58,,,,,,,,,25.57,1.95,1.25,0.82,-1.04,-2.99, , , , , , , , ,T cell activation involved in immune response;organ regeneration;actin filament bundle assembly;regulation of intracellular protein transport,ruffle membrane;cytosol;actin filament;cell junction;plasma membrane;phagocytic cup;actin cytoskeleton,,,,,,,,,,,,,,
1506,P13797,PLS3,Plastin-3 (T-plastin),QKINNFSADIKDS,_INNFS(ph)ADIK_,S266,+,19.93,23.22,23.34,22.78,,21.89,23.14,22.15,21.78,22.80,,22.07,,22.31,-2.38,0.91,1.03,0.47, ,-0.42,0.83,-0.16,-0.53,0.49, ,-0.24, ,,cytoplasm,,,,,,,,,,,,,,
1507,P13797,PLS3,Plastin-3 (T-plastin),DLKRAESMLQQAD,_RAES(ph)M(ox)LQQADK_,S312,+,22.68,26.23,26.05,23.87,,,22.35,,23.14,22.94,,23.05,20.12,23.38,-0.70,2.85,2.67,0.49, , ,-1.04, ,-0.24,-0.44, ,-0.33,-3.26,,cytoplasm,,,,,,,,,,,,,,
1508,P13798,APEH,Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH),ALDVSASDDEIAR,_ALDVSAS(ph)DDEIAR_,S187,+,23.12,22.04,22.04,23.48,23.77,24.98,23.86,24.17,,,24.22,23.28,24.33,23.57,-0.46,-1.54,-1.54,-0.09,0.20,1.41,0.29,0.60, , ,0.65,-0.29,0.76,proteolysis,nuclear membrane;cytoplasm,,,,,,,,,,,,,,
1509,P13807,GYS1,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",SLSRHSSPHQSED,_HSS(ph)PHQS(ph)EDEEDPR_,S589,,26.18,24.51,24.60,25.43,,,,,,,,,,25.18,1.00,-0.67,-0.58,0.25, , , , , , , , , ,small molecule metabolic process;heart development;glucose metabolic process;glycogen biosynthetic process,cytosol;inclusion body,,,,,,,,,,,,,,
1510,P13807,GYS1,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",HSSPHQSEDEEDP,_HSS(ph)PHQS(ph)EDEEDPR_,S593,,25.89,24.07,24.22,25.33,,,,,,,,,,24.88,1.01,-0.81,-0.65,0.45, , , , , , , , , ,small molecule metabolic process;heart development;glucose metabolic process;glycogen biosynthetic process,cytosol;inclusion body,,,,,,,,,,,,,,
1511,P13807,GYS1,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",ESLLVGSLPDMNK,_LYESLLVGS(ph)LPDM(ox)NK_,S348,,20.98,,,,,,,,,,,,,20.98,0.00, , , , , , , , , , , , ,small molecule metabolic process;heart development;glucose metabolic process;glycogen biosynthetic process,cytosol;inclusion body,,,,,,,,,,,,,,
1512,P13807,GYS1,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",SGSKRNSVDTATS,_RNS(ph)VDTATSSSLSTPSEPLS(ph)PTSSLGEERN_,S646,,23.35,24.13,,,,25.65,25.50,25.73,,,,27.52,,25.31,-1.96,-1.19, , , ,0.34,0.19,0.42, , , ,2.20, ,small molecule metabolic process;heart development;glucose metabolic process;glycogen biosynthetic process,cytosol;inclusion body,,,,,,,,,,,,,,
1514,P13861,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,ADAKGDSESEEDE,_VADAKGDS(ph)ES(ph)EEDEDLEVPVPSRFNR_,S78,,29.60,,,,26.74,26.29,,24.01,,24.65,,,26.92,26.37,3.23, , , ,0.37,-0.07, ,-2.36, ,-1.72, , ,0.55,small molecule metabolic process;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;energy reserve metabolic process;transmembrane transport;regulation of insulin secretion;blood coagulation;epidermal growth factor receptor signaling pathway;protein heterooligomerization;activation of protein kinase A activity;nerve growth factor receptor signaling pathway;water transport;cellular response to glucagon stimulus;intracellular signal transduction,T-tubule;cytosol;plasma membrane;centrosome;cAMP-dependent protein kinase complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1515,P13861,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,AKGDSESEEDEDL,_VADAKGDS(ph)ES(ph)EEDEDLEVPVPSRFNR_,S80,,29.61,,,,26.37,,,,22.39,25.08,,,,25.86,3.75, , , ,0.51, , , ,-3.48,-0.78, , , ,small molecule metabolic process;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;energy reserve metabolic process;transmembrane transport;regulation of insulin secretion;blood coagulation;epidermal growth factor receptor signaling pathway;protein heterooligomerization;activation of protein kinase A activity;nerve growth factor receptor signaling pathway;water transport;cellular response to glucagon stimulus;intracellular signal transduction,T-tubule;cytosol;plasma membrane;centrosome;cAMP-dependent protein kinase complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1516,P13861,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,RFNRRVSVCAETY,_RVS(ph)VCAETYNPDEEEEDTDPR_,S99,+,23.73,24.36,,23.56,24.34,,23.87,24.00,23.05,,24.38,,,23.91,-0.18,0.45, ,-0.35,0.42, ,-0.05,0.09,-0.86, ,0.47, , ,small molecule metabolic process;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;energy reserve metabolic process;transmembrane transport;regulation of insulin secretion;blood coagulation;epidermal growth factor receptor signaling pathway;protein heterooligomerization;activation of protein kinase A activity;nerve growth factor receptor signaling pathway;water transport;cellular response to glucagon stimulus;intracellular signal transduction,T-tubule;cytosol;plasma membrane;centrosome;cAMP-dependent protein kinase complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1517,P14314,PRKCSH,Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH),LQAGKKSLEDQVE,_S(ph)LEDQVEM(ox)LR_,S168,,24.21,,,,,,,,,,21.27,,,22.74,1.47, , , , , , , , , ,-1.47, , ,protein folding;intracellular protein kinase cascade;N-glycan processing;protein N-linked glycosylation via asparagine;post-translational protein modification;innate immune response,endoplasmic reticulum lumen,,,,,,,,,,,,,,
1518,P14317,HCLS1,Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75),KAVTKRSPEAPQP,_S(ph)PEAPQPVIAM(ox)EEPAVPAPLPK_,S238,,25.62,23.30,,,,,,,,,,,,24.46,1.16,-1.16, , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;positive regulation of protein kinase B signaling cascade;positive regulation of granulocyte differentiation;positive regulation of actin cytoskeleton reorganization;negative regulation of leukocyte apoptotic process;positive regulation of tyrosine phosphorylation of STAT protein;positive regulation of phosphatidylinositol 3-kinase cascade;cellular response to cytokine stimulus;positive regulation of transcription factor import into nucleus;regulation of actin filament polymerization;response to hormone stimulus;erythrocyte differentiation;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;intracellular signal transduction,mitochondrion;transcription factor complex;plasma membrane;cytoplasm,,,,,,,,,,,,,,
1519,P14618,PKM,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),SFIRKASDVHEVR,_KAS(ph)DVHEVR_,S249,,18.90,21.20,19.11,19.41,18.85,,,,,,,,,19.49,-0.60,1.70,-0.38,-0.08,-0.64, , , , , , , , ,skeletal muscle tissue regeneration;response to muscle inactivity;small molecule metabolic process;response to gravity;response to hypoxia;liver development;programmed cell death;pyruvate biosynthetic process;response to insulin stimulus;glycolysis;organ regeneration;response to nutrient;ATP biosynthetic process,cytosol;mitochondrion;extracellular vesicular exosome;flagellum;plasma membrane;nucleus,,,,,,,,,,,,,,
1520,P14618,PKM,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),CRLDIDSPPITAR,_LDIDS(ph)PPITAR_,S37,,25.17,,,,25.75,,,,,,,,,25.46,-0.29, , , ,0.29, , , , , , , , ,skeletal muscle tissue regeneration;response to muscle inactivity;small molecule metabolic process;response to gravity;response to hypoxia;liver development;programmed cell death;pyruvate biosynthetic process;response to insulin stimulus;glycolysis;organ regeneration;response to nutrient;ATP biosynthetic process,cytosol;mitochondrion;extracellular vesicular exosome;flagellum;plasma membrane;nucleus,,,,,,,,,,,,,,
1521,P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),KEEKEESDDEAAV,_TETVEEPM(ox)EEEEAAKEEKEES(ph)DDEAAVEEEEEEK_,S306,+,29.45,29.24,27.75,28.54,23.81,,28.57,,25.29,27.23,26.84,27.42,,27.41,2.03,1.83,0.33,1.13,-3.60, ,1.16, ,-2.13,-0.18,-0.57,0.00, ,negative regulation of apoptotic process;ER-associated protein catabolic process;response to hypoxia;actin rod assembly;innate immune response;protein folding;sequestering of calcium ion;activation of signaling protein activity involved in unfolded protein response;protein transport;regulation of phosphoprotein phosphatase activity;cellular response to ATP,cytosol;midbody;plasma membrane part;melanosome;endoplasmic reticulum membrane;endoplasmic reticulum lumen;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1522,P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),DLPLNVSRETLQQ,_GVVDSDDLPLNVS(ph)R_,S447,,21.90,,,,,,,,,,,,,21.90,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;ER-associated protein catabolic process;response to hypoxia;actin rod assembly;innate immune response;protein folding;sequestering of calcium ion;activation of signaling protein activity involved in unfolded protein response;protein transport;regulation of phosphoprotein phosphatase activity;cellular response to ATP,cytosol;midbody;plasma membrane part;melanosome;endoplasmic reticulum membrane;endoplasmic reticulum lumen;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1523,P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),IAKSGTSEFLNKM,_SGTS(ph)EFLNK_,S172,,23.03,22.70,22.22,,,,,,,,21.30,,,22.31,0.72,0.39,-0.10, , , , , , , ,-1.01, , ,negative regulation of apoptotic process;ER-associated protein catabolic process;response to hypoxia;actin rod assembly;innate immune response;protein folding;sequestering of calcium ion;activation of signaling protein activity involved in unfolded protein response;protein transport;regulation of phosphoprotein phosphatase activity;cellular response to ATP,cytosol;midbody;plasma membrane part;melanosome;endoplasmic reticulum membrane;endoplasmic reticulum lumen;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1524,P14672,SLC2A4,"Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)",AFHRTPSLLEQEV,_TPS(ph)LLEQEVKPSTELEYLGPDEND_,S488,,24.97,,,,,,,,,,,,,24.97,0.00, , , , , , , , , , , , ,glucose homeostasis;small molecule metabolic process;glucose import;cellular response to insulin stimulus;brown fat cell differentiation;carbohydrate metabolic process;response to ethanol,trans-Golgi network transport vesicle;sarcolemma;vesicle membrane;external side of plasma membrane;clathrin-coated vesicle;perinuclear region of cytoplasm;coated pit;extracellular vesicular exosome;integral to plasma membrane;insulin-responsive compartment;multivesicular body,,,,,,,,,,,,,,
1525,P14859,POU2F1,"POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)",ADGGAASQDESSA,_(ac)ADGGAAS(ph)QDESSAAAAAAADSR_,S8,,22.71,,,,,,,,,,,,,22.71,0.00, , , , , , , , , , , , ,"lens induction in camera-type eye;olfactory placode formation;negative regulation of transcription, DNA-dependent;transcription from RNA polymerase III promoter;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;transcription factor complex,Homeobox,,,,,,,,,,,,,
1526,P14859,POU2F1,"POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)",SGGTSSSPIKAIF,_RINPPSSGGTSSS(ph)PIK_,S471,+,22.78,23.72,24.46,,22.90,23.49,,23.39,23.09,24.40,21.72,21.64,22.81,23.13,-0.35,0.59,1.33, ,-0.23,0.37, ,0.26,-0.04,1.28,-1.40,-1.49,-0.32,"lens induction in camera-type eye;olfactory placode formation;negative regulation of transcription, DNA-dependent;transcription from RNA polymerase III promoter;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;transcription factor complex,Homeobox,,,,,,,,,,,,,
1528,P14868,DARS,"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)",NAYLAQSPQLYKQ,_NNAYLAQS(ph)PQLYK_,S249,+,21.12,22.45,22.82,23.23,23.84,23.60,23.77,24.29,,23.82,23.83,22.34,23.08,23.18,-2.06,-0.73,-0.36,0.05,0.66,0.42,0.59,1.11, ,0.64,0.65,-0.84,-0.11,aspartyl-tRNA aminoacylation;protein complex assembly,cytosol,,,,,,,,,,,,,,
1532,P15056,BRAF,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),ARSNPKSPQKPIV,_S(ph)PQKPIVR_,S151,,23.95,24.13,24.65,23.62,,,,,,,,20.45,,23.36,0.59,0.77,1.29,0.26, , , , , , , ,-2.91, ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;fibroblast growth factor receptor signaling pathway;positive regulation of gene expression;small GTPase mediated signal transduction;response to cAMP;positive regulation of ERK1 and ERK2 cascade;cellular response to calcium ion;response to peptide hormone stimulus;activation of MAPKK activity;nerve growth factor receptor signaling pathway;synaptic transmission;negative regulation of neuron apoptotic process;organ morphogenesis;response to epidermal growth factor stimulus,cytosol;plasma membrane;nucleus,,+,,,,,,,,,+,,,
1533,P15056,BRAF,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),QRDRSSSAPNVHI,_SSS(ph)APNVHINTIEPVNIDDLIR_,S196,,24.36,,,,,,,,,,,,,24.36,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;fibroblast growth factor receptor signaling pathway;positive regulation of gene expression;small GTPase mediated signal transduction;response to cAMP;positive regulation of ERK1 and ERK2 cascade;cellular response to calcium ion;response to peptide hormone stimulus;activation of MAPKK activity;nerve growth factor receptor signaling pathway;synaptic transmission;negative regulation of neuron apoptotic process;organ morphogenesis;response to epidermal growth factor stimulus,cytosol;plasma membrane;nucleus,,+,,,,,,,,,+,,,
1534,P15086,CPB1,Carboxypeptidase B (EC 3.4.17.2) (Pancreas-specific protein) (PASP),FIRNKLSSIKAYL,_NKLS(ph)SIK_,S295,,,22.92,,22.41,,,,,,,,,,22.66, ,0.25, ,-0.25, , , , , , , , , ,proteolysis,extracellular region,,,,,,,,,,,,,,
1536,P15291,B4GALT1,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22);N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase);Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38);Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)]",AAIGQSSGELRTG,_LPQLVGVSTPLQGGSNSAAAIGQSS(ph)GELR_,S61,,,,,25.82,,,24.26,26.98,26.71,,,,,25.94, , , ,-0.12, , ,-1.68,1.03,0.77, , , , ,negative regulation of cell proliferation;galactose metabolic process;regulation of cellular component movement;post-translational protein modification;lactose biosynthetic process;development of secondary sexual characteristics;positive regulation of apoptotic process involved in mammary gland involution;angiogenesis involved in wound healing;protein N-linked glycosylation via asparagine;mammary gland development;keratan sulfate biosynthetic process;branching morphogenesis of a tube;oligosaccharide biosynthetic process;epithelial cell development;positive regulation of epithelial cell proliferation involved in wound healing;penetration of zona pellucida;extracellular matrix organization;binding of sperm to zona pellucida;Notch signaling pathway;cell adhesion;regulation of acrosome reaction;acute inflammatory response;leukocyte migration,glycocalyx;basolateral plasma membrane;external side of plasma membrane;Golgi membrane;Golgi cisterna membrane;integral to membrane;extracellular region;brush border membrane;Golgi trans cisterna;desmosome,,,,,,,,,,,,,,
1538,P15311,EZR,Ezrin (Cytovillin) (Villin-2) (p81),RQLLTLSSELSQA,_QLLTLS(ph)SELSQAR_,S535,,23.68,,,,,,,,,,,,,23.68,0.00, , , , , , , , , , , , ,regulation of cell shape;axon guidance;establishment or maintenance of apical/basal cell polarity;leukocyte cell-cell adhesion;membrane to membrane docking;actin filament bundle assembly;cytoskeletal anchoring at plasma membrane;epithelial cell differentiation,microvillus membrane;cortical cytoskeleton;basolateral plasma membrane;apical plasma membrane;apical part of cell;microtubule basal body;extrinsic to membrane;uropod;ruffle membrane;cytosol;filopodium;actin filament;nucleolus;microvillus;ruffle,,,,,,,,,,,,,,
1539,P15311,EZR,Ezrin (Cytovillin) (Villin-2) (p81),TLSSELSQARDEN,_QLLTLSSELS(ph)QARDENK_,S539,,21.65,20.88,20.88,,,,22.77,,,22.45,,,,21.72,-0.08,-0.84,-0.84, , , ,1.04, , ,0.72, , , ,regulation of cell shape;axon guidance;establishment or maintenance of apical/basal cell polarity;leukocyte cell-cell adhesion;membrane to membrane docking;actin filament bundle assembly;cytoskeletal anchoring at plasma membrane;epithelial cell differentiation,microvillus membrane;cortical cytoskeleton;basolateral plasma membrane;apical plasma membrane;apical part of cell;microtubule basal body;extrinsic to membrane;uropod;ruffle membrane;cytosol;filopodium;actin filament;nucleolus;microvillus;ruffle,,,,,,,,,,,,,,
1542,P15374,UCHL3,Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3),EESVSMSPEERAR,_FLEESVSM(ox)S(ph)PEER_,S130,+,23.88,24.25,24.57,24.14,24.25,24.02,25.03,,,22.33,25.36,25.45,23.25,24.23,-0.35,0.02,0.34,-0.09,0.02,-0.21,0.80, , ,-1.90,1.13,1.22,-0.98,ubiquitin-dependent protein catabolic process,mitochondrion;nucleus,,,,,,,,,,,,,,
1544,P15408,FOSL2,Fos-related antigen 2 (FRA-2),GPVCKISPEERRS,_IS(ph)PEERR_,S155,,,24.55,,24.38,,,,,,,,,,24.46, ,0.08, ,-0.08, , , , , , , , , ,"cell death;positive regulation of fibroblast proliferation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,bZIP,,,,,,,,,,,,,
1546,P15408,FOSL2,Fos-related antigen 2 (FRA-2),EPLEEDSPSSSSA,_QEPLEEDS(ph)PSSSSAGLDK_,S191,+,26.06,26.02,26.34,25.95,26.81,26.70,26.67,26.26,28.21,26.35,24.18,26.43,26.35,26.33,-0.27,-0.31,0.00,-0.38,0.48,0.37,0.34,-0.08,1.88,0.02,-2.15,0.09,0.02,"cell death;positive regulation of fibroblast proliferation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,bZIP,,,,,,,,,,,,,
1551,P15408,FOSL2,Fos-related antigen 2 (FRA-2),SSDSLNSPTLLAL,_RSS(ph)SSGDQSSDSLNS(ph)PTLLAL_,S281,,24.75,,,,,,,,,,,,,24.75,0.00, , , , , , , , , , , , ,"cell death;positive regulation of fibroblast proliferation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,bZIP,,,,,,,,,,,,,
1554,P15822,HIVEP1,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),LFLSHESPKALSI,_LGLVLQPDAGGLFLSHES(ph)PK_,S479,,20.73,,,,,,,,,,,,,20.73,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
1555,P15822,HIVEP1,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),MLSPANSLDIAME,_M(ox)LSPANS(ph)LDIAM(ox)EK_,S1753,,23.00,,,22.55,,,,,,,,,,22.77,0.22, , ,-0.22, , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
1558,P15822,HIVEP1,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),ALGNQKSTVVEFS,_S(ph)TVVEFSNK_,S2033,,22.81,21.67,,,,,,,,,,,,22.24,0.57,-0.57, , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
1559,P15880,RPS2,40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3),KTHTRVSVQRTQA,_THTRVS(ph)VQR_,S281,+,21.64,22.58,22.98,22.65,21.19,18.95,20.78,21.54,20.03,19.77,21.00,21.97,,21.26,0.38,1.33,1.72,1.39,-0.07,-2.30,-0.48,0.28,-1.23,-1.48,-0.26,0.72, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",nucleoplasm;cytosolic small ribosomal subunit,,,,,,,,,,,+,,,
1560,P15884,TCF4,Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2),GSHDNLSPPFVNS,_DLGSHDNLS(ph)PPFVNSR_,S13,,,,,,22.43,23.30,,,23.82,,,,,23.18, , , , ,-0.75,0.11, , ,0.64, , , , ,transcription initiation from RNA polymerase II promoter;positive regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;protein-DNA complex assembly,transcription factor complex,bHLH,,,,,,,,,,,,,
1563,P15923,TCF3,Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1),PRARTSSTDEVLS,_TSS(ph)TDEVLSLEEK_,S530,,22.44,,,,22.97,22.49,,,23.42,,,,,22.83,-0.39, , , ,0.14,-0.34, , ,0.59, , , , ,"G1 phase of mitotic cell cycle;histone H4 acetylation;response to drug;positive regulation of cell cycle;T cell differentiation in thymus;Peyer's patch development;immunoglobulin V(D)J recombination;response to lipopolysaccharide;B cell lineage commitment;positive regulation of transcription from RNA polymerase II promoter;positive regulation of muscle cell differentiation;protein stabilization;natural killer cell differentiation;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of neuron differentiation;positive regulation of B cell proliferation;cell development;histone H3 acetylation;transcription, DNA-dependent;muscle cell differentiation",transcription factor complex;nucleus;nuclear nucleosome;protein complex;cytoplasm,bHLH,,,,,,,,,,,,,
1564,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),RMIRAESGPDLRY,_M(ox)IRAES(ph)GPDLR_,S22,+,30.18,26.24,26.46,24.96,26.02,26.33,25.21,26.78,25.42,25.14,25.19,25.06,25.41,26.03,4.15,0.21,0.43,-1.07,-0.01,0.30,-0.82,0.75,-0.61,-0.89,-0.84,-0.97,-0.62,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1565,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),GGYTCQSGSGWDE,_GGGGYTCQS(ph)GSGWDEFTK_,S176,,25.83,22.54,22.54,,,,,,,23.11,,,,23.50,2.32,-0.97,-0.97, , , , , , ,-0.39, , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1566,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),SSKGLPSPYNMSS,_GLPS(ph)PYNM(ox)SSAPGSR_,S2815,+,28.16,25.60,25.55,24.27,24.77,22.82,,25.11,,24.38,,,,25.08,3.08,0.51,0.47,-0.81,-0.31,-2.26, ,0.03, ,-0.71, , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1567,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),PSPYNMSSAPGSR,_GLPSPYNM(ox)S(ph)SAPGS(ph)R_,S2820,+,29.40,25.38,25.46,24.47,25.03,,25.40,,,,25.11,23.07,24.43,25.31,4.09,0.08,0.15,-0.83,-0.27, ,0.10, , , ,-0.20,-2.24,-0.88,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1568,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),SPYNMSSAPGSRS,_GLPS(ph)PYNMSS(ph)APGS(ph)R_,S2821,,28.62,22.28,,23.74,,,,25.84,,24.81,,,,25.06,3.57,-2.78, ,-1.32, , , ,0.78, ,-0.25, , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1569,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),MSSAPGSRSGSRS,_GLPSPYNM(ox)SS(ph)APGS(ph)R_,S2825,+,30.11,23.32,,24.04,,,,,23.16,24.81,24.44,,24.00,24.84,5.27,-1.52, ,-0.80, , , , ,-1.68,-0.03,-0.41, ,-0.84,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1573,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),EIERLQSLTENLT,_LQS(ph)LTENLTK_,S1708,,22.44,,,,,,,,,,,,,22.44,0.00, , , , , , , , , , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1574,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),VQKRSMSFQGIRQ,_SM(ox)S(ph)FQGIR_,S2209,,28.55,22.35,,22.45,,,,,,,,,,24.45,4.10,-2.10, ,-2.00, , , , , , , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1575,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),DQYRSGSLSLTQF,_SGS(ph)LSLTQFADM(ox)ISLK_,S2551,,26.08,,,,,,,,,,,,,26.08,0.00, , , , , , , , , , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1578,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),LTIRSSSFSDTLE,_SSS(ph)FSDTLEESSPIAAIFDTENLEK_,S2608,,30.07,,,,,,,,20.24,,,,,25.16,4.91, , , , , , , ,-4.91, , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1579,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),EKRRRKSVEDRFD,_S(ph)VEDRFDQQKNDYDQLQK_,S1127,+,29.89,28.81,29.67,25.43,25.36,25.52,26.43,26.92,25.20,27.25,25.92,25.27,23.74,26.57,3.31,2.24,3.10,-1.14,-1.21,-1.05,-0.14,0.35,-1.37,0.68,-0.65,-1.30,-2.83,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1580,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),LLKGKKSVEEVAS,_S(ph)VEEVASEIQPFLR_,S2000,,24.02,,,,,,,,,,,,,24.02,0.00, , , , , , , , , , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1581,P15924,DSP,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),VDRKTGSQYDIQD,_TGS(ph)QYDIQDAIDK_,S2526,,22.71,,,,,,,,,,,,,22.71,0.00, , , , , , , , , , , , ,skin development;regulation of heart rate by cardiac conduction;cell-cell adhesion;intermediate filament organization;wound healing;cellular component disassembly involved in execution phase of apoptosis;peptide cross-linking;desmosome organization;regulation of ventricular cardiac muscle cell action potential;protein localization to adherens junction;adherens junction organization;bundle of His cell to Purkinje myocyte communication;ventricular compact myocardium morphogenesis;keratinocyte differentiation,mitochondrion;intercalated disc;fascia adherens;basolateral plasma membrane;plasma membrane;cornified envelope;desmosome,,,,,,,,,,,,,,
1586,P15941,MUC1,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha);Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],RYVPPSSTDRSPY,_YVPPSS(ph)TDRSPYEK_,S1232,,25.20,24.98,25.04,,,,,,,26.85,,,,25.52,-0.32,-0.54,-0.48, , , , , , ,1.33, , , ,"negative regulation of apoptotic process;negative regulation of transcription by competitive promoter binding;post-translational protein modification;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;O-glycan processing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4 acetylation;positive regulation of transcription from RNA polymerase II promoter in response to stress",nuclear chromatin;extracellular region;apical plasma membrane;Golgi lumen;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
1587,P15941,MUC1,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha);Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],PSSTDRSPYEKVS,_YVPPSSTDRS(ph)PYEK_,S1236,+,23.51,26.50,26.50,22.23,23.66,,,23.85,,26.98,22.81,,,24.50,-1.00,1.99,1.99,-2.27,-0.84, , ,-0.66, ,2.47,-1.70, , ,"negative regulation of apoptotic process;negative regulation of transcription by competitive promoter binding;post-translational protein modification;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;O-glycan processing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4 acetylation;positive regulation of transcription from RNA polymerase II promoter in response to stress",nuclear chromatin;extracellular region;apical plasma membrane;Golgi lumen;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
1588,P16070,CD44,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),LVNKESSETPDQF,_ESS(ph)ETPDQFM(ox)TADETR_,S305,+,,23.76,23.76,25.29,,,23.72,,24.02,,24.00,25.16,22.65,24.05, ,-0.29,-0.29,1.24, , ,-0.33, ,-0.03, ,-0.04,1.12,-1.39,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;monocyte aggregation;positive regulation of ERK1 and ERK2 cascade;branching involved in prostate gland morphogenesis;interferon-gamma-mediated signaling pathway;cellular response to fibroblast growth factor stimulus;wound healing involved in inflammatory response;positive regulation of heterotypic cell-cell adhesion;Wnt receptor signaling pathway;negative regulation of DNA damage response, signal transduction by p53 class mediator;small molecule metabolic process;positive regulation of peptidyl-tyrosine phosphorylation;hyaluronan catabolic process;positive regulation of gene expression;cell-matrix adhesion;carbohydrate metabolic process;branching involved in ureteric bud morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of monocyte aggregation;cartilage development",basolateral plasma membrane;integral to plasma membrane;external side of plasma membrane;cell surface,,,,,,,,,,,,,,
1593,P16070,CD44,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),KKLVINSGNGAVE,_LVINS(ph)GNGAVEDR_,S273,+,20.62,22.19,23.00,23.72,24.76,24.91,23.48,24.30,23.70,23.30,23.47,25.14,23.77,23.56,-2.95,-1.38,-0.57,0.15,1.20,1.34,-0.08,0.73,0.13,-0.27,-0.10,1.57,0.21,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;monocyte aggregation;positive regulation of ERK1 and ERK2 cascade;branching involved in prostate gland morphogenesis;interferon-gamma-mediated signaling pathway;cellular response to fibroblast growth factor stimulus;wound healing involved in inflammatory response;positive regulation of heterotypic cell-cell adhesion;Wnt receptor signaling pathway;negative regulation of DNA damage response, signal transduction by p53 class mediator;small molecule metabolic process;positive regulation of peptidyl-tyrosine phosphorylation;hyaluronan catabolic process;positive regulation of gene expression;cell-matrix adhesion;carbohydrate metabolic process;branching involved in ureteric bud morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of monocyte aggregation;cartilage development",basolateral plasma membrane;integral to plasma membrane;external side of plasma membrane;cell surface,,,,,,,,,,,,,,
1594,P16070,CD44,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),VEDRKPSGLNGEA,_LVINSGNGAVEDRKPS(ph)GLNGEASK_,S284,+,,24.53,25.07,24.82,27.21,27.60,22.85,26.70,26.75,25.83,27.05,27.06,26.69,26.01, ,-1.49,-0.94,-1.19,1.19,1.59,-3.16,0.69,0.74,-0.18,1.04,1.05,0.67,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;monocyte aggregation;positive regulation of ERK1 and ERK2 cascade;branching involved in prostate gland morphogenesis;interferon-gamma-mediated signaling pathway;cellular response to fibroblast growth factor stimulus;wound healing involved in inflammatory response;positive regulation of heterotypic cell-cell adhesion;Wnt receptor signaling pathway;negative regulation of DNA damage response, signal transduction by p53 class mediator;small molecule metabolic process;positive regulation of peptidyl-tyrosine phosphorylation;hyaluronan catabolic process;positive regulation of gene expression;cell-matrix adhesion;carbohydrate metabolic process;branching involved in ureteric bud morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of monocyte aggregation;cartilage development",basolateral plasma membrane;integral to plasma membrane;external side of plasma membrane;cell surface,,,,,,,,,,,,,,
1596,P16070,CD44,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),NGEASKSQEMVHL,_S(ph)QEMVHLVNK_,S293,+,24.34,30.65,30.93,32.04,27.35,26.92,29.01,26.84,30.42,30.70,27.17,29.09,24.85,28.49,-4.15,2.17,2.44,3.56,-1.14,-1.57,0.52,-1.65,1.94,2.21,-1.32,0.61,-3.63,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;monocyte aggregation;positive regulation of ERK1 and ERK2 cascade;branching involved in prostate gland morphogenesis;interferon-gamma-mediated signaling pathway;cellular response to fibroblast growth factor stimulus;wound healing involved in inflammatory response;positive regulation of heterotypic cell-cell adhesion;Wnt receptor signaling pathway;negative regulation of DNA damage response, signal transduction by p53 class mediator;small molecule metabolic process;positive regulation of peptidyl-tyrosine phosphorylation;hyaluronan catabolic process;positive regulation of gene expression;cell-matrix adhesion;carbohydrate metabolic process;branching involved in ureteric bud morphogenesis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of monocyte aggregation;cartilage development",basolateral plasma membrane;integral to plasma membrane;external side of plasma membrane;cell surface,,,,,,,,,,,,,,
1598,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),LTRDYNSLTRSEH,_DYNS(ph)LTR_,S1424,+,24.35,23.72,23.13,,,,23.71,22.93,,24.36,,22.10,,23.47,0.88,0.25,-0.34, , , ,0.24,-0.54, ,0.89, ,-1.37, ,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
1599,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),TLTSVSSHDSRLT,_DYSTLTSVSS(ph)HDSR_,S1448,,,,,,,,22.29,,,23.49,22.46,22.11,,22.59, , , , , , ,-0.30, , ,0.90,-0.13,-0.47, ,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
1600,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),ELQEVDSLLRGRQ,_LLELQEVDS(ph)LLRGR_,S1069,+,,,,,24.13,,24.17,24.75,24.04,27.71,25.15,24.75,24.77,24.94, , , , ,-0.80, ,-0.76,-0.18,-0.89,2.78,0.21,-0.18,-0.16,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
1602,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),FPGSTNSLHRMTT,_M(ox)DFAFPGSTNS(ph)LHR_,S1387,,23.07,21.10,20.62,,23.15,,24.26,24.05,21.35,24.80,23.21,23.75,24.40,23.07,0.00,-1.97,-2.45, ,0.08, ,1.19,0.98,-1.72,1.73,0.14,0.68,1.34,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
1603,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),VPHRVLSTSSTLT,_VLS(ph)TSSTLTR_,S1413,,23.62,,,,,,,,,,,22.68,,23.15,0.47, , , , , , , , , , ,-0.47, ,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
1604,P16150,SPN,Leukosialin (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43),RKSRQGSLAMEEL,_SRQGS(ph)LAM(ox)EELK_,S355,,,23.82,23.82,,22.78,,,22.62,,,,,,23.26, ,0.56,0.56, ,-0.48, , ,-0.64, , , , , ,response to protozoan;immune response;T cell costimulation;chemotaxis;negative thymic T cell selection;blood coagulation;establishment or maintenance of cell polarity;cell surface receptor signaling pathway;regulation of defense response to virus;negative regulation of cell adhesion;defense response to bacterium;cellular defense response;positive regulation of tumor necrosis factor biosynthetic process;negative regulation of type IV hypersensitivity;positive regulation of T cell proliferation;negative regulation of T cell proliferation;leukocyte migration,uropod;extracellular space;basement membrane;integral to plasma membrane;external side of plasma membrane;cell surface,,,,,,,,,,,,,,
1605,P16157,ANK1,Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin),LDQVVESPAIPRI,_LDQVVES(ph)PAIPR_,S178,,,,,,,,23.56,,23.07,21.80,22.23,,,22.67, , , , , , ,0.90, ,0.41,-0.87,-0.43, , ,protein targeting to plasma membrane;porphyrin-containing compound biosynthetic process;exocytosis;monovalent inorganic cation transport;erythrocyte development;axon guidance;signal transduction;ER to Golgi vesicle-mediated transport;cytoskeleton organization;maintenance of epithelial cell apical/basal polarity,cytosol;M band;cortical cytoskeleton;spectrin-associated cytoskeleton;sarcoplasmic reticulum;basolateral plasma membrane,,,,,,,,,,,,,,
1606,P16220,CREB1,Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1),KILNDLSSDAPGV,_ILNDLS(ph)SDAPGVPRIEEEK_,S128,,25.40,23.80,23.80,22.69,,,,,22.68,24.83,,,,23.87,1.54,-0.07,-0.07,-1.18, , , , ,-1.18,0.97, , , ,fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;transforming growth factor beta receptor signaling pathway;positive regulation of transforming growth factor beta3 production;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of multicellular organism growth;positive regulation of hormone secretion;protein stabilization;negative regulation of transcription by competitive promoter binding;activation of phospholipase C activity;TRIF-dependent toll-like receptor signaling pathway;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;regulation of apoptotic process;toll-like receptor 1 signaling pathway;response to drug;positive regulation of fat cell differentiation;Toll signaling pathway;stress-activated MAPK cascade;phosphatidylinositol-mediated signaling;virus-host interaction;regulation of circadian rhythm;toll-like receptor 3 signaling pathway;pituitary gland development;protein phosphorylation;axon guidance;innate immune response;positive regulation of lipid biosynthetic process;lactation;regulation of cell size,nucleoplasm;nuclear euchromatin;mitochondrion;transcription factor complex,bZIP,,,,,,,,,,,,,
1609,P16234,PDGFRA,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a),LYDRPASYKKKSM,_SLYDRPAS(ph)YK_,S767,,,24.22,24.22,25.55,,,,,,,,,,24.66, ,-0.44,-0.44,0.89, , , , , , , , , ,inner ear development;platelet aggregation;positive regulation of ERK1 and ERK2 cascade;regulation of mesenchymal stem cell differentiation;peptidyl-tyrosine phosphorylation;response to inorganic substance;positive regulation of fibroblast proliferation;palate development;cardiac myofibril assembly;estrogen metabolic process;vascular endothelial growth factor receptor signaling pathway;male genitalia development;in utero embryonic development;response to hyperoxia;regulation of chemotaxis;metanephric glomerular capillary formation;gliogenesis;response to estradiol stimulus;regulation of actin cytoskeleton reorganization;embryonic cranial skeleton morphogenesis;odontogenesis of dentin-containing tooth;elevation of cytosolic calcium ion concentration;response to cytokine stimulus;positive regulation of DNA replication;luteinization;protein autophosphorylation;adrenal gland development;cellular response to amino acid stimulus;Leydig cell differentiation;signal transduction involved in regulation of gene expression;cell chemotaxis;lung development;positive regulation of cell migration;positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase activity;virus-host interaction;retina vasculature development in camera-type eye;phosphatidylinositol-mediated signaling;positive regulation of phospholipase C activity;extracellular matrix organization;face morphogenesis;positive regulation of phosphatidylinositol 3-kinase cascade;negative regulation of platelet activation;embryonic digestive tract morphogenesis,nucleus;integral to plasma membrane;cytoplasm,,+,,,,,,,,,,,,
1610,P16284,PECAM1,Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31),YSRTEGSLDGT__,_YSRTEGS(ph)LDGT_,S713,,,26.05,26.05,,,,,,22.28,,,,,24.80, ,1.26,1.26, , , , , ,-2.51, , , , ,platelet degranulation;platelet activation;phagocytosis;glomerular endothelium development;diapedesis;signal transduction;cell adhesion;cell recognition,extracellular space;integral to membrane;cell junction;plasma membrane;platelet alpha granule membrane,,,,,,,,,,,,,,
1612,P16333,NCK1,Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha),KVKRKPSVPDSAS,_RKPS(ph)VPDSASPADDSFVDPGER_,S85,+,24.58,23.94,23.42,23.83,25.22,25.25,25.51,25.42,24.54,22.75,26.70,25.77,25.99,24.84,-0.26,-0.90,-1.42,-1.01,0.38,0.41,0.67,0.58,-0.30,-2.09,1.86,0.93,1.15,lamellipodium assembly;T cell activation;cell migration;signal complex assembly;axon guidance;positive regulation of actin filament polymerization;T cell receptor signaling pathway;actin filament organization;positive regulation of T cell proliferation;positive regulation of transcription from RNA polymerase II promoter;regulation of translation,cytosol;endoplasmic reticulum;plasma membrane;nucleus;vesicle membrane,,,,,,,,,,,,,,
1613,P16383,GCFC2,GC-rich sequence DNA-binding factor 2 (GC-rich sequence DNA-binding factor) (Transcription factor 9) (TCF-9),SRTLDVSTDEEDK,_TLDVS(ph)T(ph)DEEDK_,S96,,24.34,,,22.67,20.62,,,,,21.49,,,,22.28,2.06, , ,0.39,-1.66, , , , ,-0.79, , , ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
1614,P16401,HIST1H1B,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),_____MSETAPAE,_(ac)S(ph)ETAPAETATPAPVEK_,S2,+,30.61,30.33,30.07,30.15,30.17,30.94,24.33,29.93,31.57,30.11,27.34,28.90,29.14,29.51,1.10,0.82,0.57,0.64,0.67,1.43,-5.18,0.42,2.06,0.60,-2.17,-0.61,-0.37,nucleosome assembly,nuclear chromatin;nucleosome,,,,,,,,,,,,,,
1615,P16401,HIST1H1B,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),PAPVEKSPAKKKA,_SETAPAETATPAPVEKS(ph)PAK_,S18,+,27.65,28.00,28.76,26.99,34.03,33.03,27.93,33.15,27.70,25.79,25.34,24.04,33.30,28.90,-1.26,-0.90,-0.14,-1.91,5.12,4.13,-0.97,4.25,-1.20,-3.11,-3.56,-4.86,4.40,nucleosome assembly,nuclear chromatin;nucleosome,,,,,,,,,,,,,,
1616,P16402,HIST1H1D,Histone H1.3 (Histone H1c) (Histone H1s-2),_____MSETAPLA,_(ac)S(ph)ETAPLAPTIPAPAEKTPVK_,S2,+,27.46,25.89,26.19,24.92,28.32,,26.60,24.43,26.60,27.11,,25.47,24.27,26.12,1.34,-0.23,0.08,-1.20,2.20, ,0.49,-1.69,0.49,1.00, ,-0.64,-1.84,nucleosome positioning;nucleosome assembly,nuclear chromatin;nucleosome,,,,,,,,,,,,,,
1617,P16403,HIST1H1C,Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1),_____MSETAPAA,_(ac)S(ph)ETAPAAPAAAPPAEKAPVK_,S2,,,22.95,22.95,,29.29,,,26.34,,,,,,25.38, ,-2.43,-2.43, ,3.91, , ,0.96, , , , , ,nucleosome positioning;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
1618,P16615,ATP2A2,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",FDELNPSAQRDAC,_EFDELNPS(ph)AQR_,S663,+,26.24,26.45,24.55,25.83,26.21,26.65,24.34,25.89,25.68,23.01,26.96,25.13,26.89,25.68,0.56,0.77,-1.13,0.15,0.53,0.97,-1.33,0.21,0.00,-2.67,1.29,-0.55,1.21,cellular calcium ion homeostasis;negative regulation of heart contraction;blood coagulation;ER-nucleus signaling pathway;response to peptide hormone stimulus;cell adhesion;regulation of the force of heart contraction;sarcoplasmic reticulum calcium ion transport;ATP biosynthetic process;epidermis development,integral to plasma membrane;protein complex;platelet dense tubular network membrane;sarcoplasmic reticulum membrane,,,,,,,,,,,,,,
1620,P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),AFELILSPRSKES,_RASGQAFELILS(ph)PR_,S25,+,24.61,24.64,24.64,,25.81,24.43,25.24,26.24,25.03,24.22,24.83,24.84,24.34,24.91,-0.30,-0.27,-0.27, ,0.90,-0.48,0.33,1.34,0.13,-0.68,-0.08,-0.06,-0.57,mitotic spindle organization;axonogenesis;response to virus;negative regulation of microtubule polymerization;microtubule depolymerization;positive regulation of cellular component movement;intracellular signal transduction,cytosol;microtubule;intracellular,,,,,,,,,,,,,,
1621,P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),PKKKDLSLEEIQK,_DLS(ph)LEEIQK_,S46,+,21.99,21.46,21.46,22.29,23.14,23.13,23.38,23.70,22.15,23.21,22.87,23.11,,22.66,-0.66,-1.20,-1.20,-0.36,0.48,0.47,0.72,1.04,-0.50,0.55,0.21,0.45, ,mitotic spindle organization;axonogenesis;response to virus;negative regulation of microtubule polymerization;microtubule depolymerization;positive regulation of cellular component movement;intracellular signal transduction,cytosol;microtubule;intracellular,,,,,,,,,,,,,,
1622,P16949,STMN1,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),VPEFPLSPPKKKD,_ESVPEFPLS(ph)PPKKK_,S38,+,26.44,27.31,28.15,28.01,26.10,27.07,29.56,28.26,27.32,28.70,28.42,28.96,27.75,27.85,-1.41,-0.54,0.30,0.16,-1.75,-0.78,1.71,0.41,-0.53,0.85,0.56,1.11,-0.11,mitotic spindle organization;axonogenesis;response to virus;negative regulation of microtubule polymerization;microtubule depolymerization;positive regulation of cellular component movement;intracellular signal transduction,cytosol;microtubule;intracellular,,,,,,,,,,,,,,
1625,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),PPTQQSSAE____,_AGEAPTENPAPPTQQSS(ph)AE_,S370,,24.59,22.92,,,22.42,,,,24.14,,,,22.48,23.31,1.28,-0.39, , ,-0.89, , , ,0.83, , , ,-0.83,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1626,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),SGPNQPSVRRGYR,_ENQQATSGPNQPS(ph)VR_,S324,,25.63,,,24.69,,,,,,,,,,25.16,0.47, , ,-0.47, , , , , , , , , ,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1627,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),EEEEEGSGSSEGF,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_,S201,,23.51,,,,,,,,,,,,,23.51,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1628,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),EEEGSGSSEGFDP,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_,S203,+,23.51,,,22.73,24.69,23.65,24.50,23.49,,24.19,22.95,,,23.71,-0.20, , ,-0.99,0.97,-0.06,0.79,-0.22, ,0.47,-0.77, , ,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1629,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),EEGSGSSEGFDPP,_NYAGEEEEEGS(ph)GS(ph)S(ph)EGFDPPATDR_,S204,,23.51,,,,,,,,,,,,,23.51,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1630,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),_____MSEAGEAT,_(ac)S(ph)EAGEATTTTTTTLPQAPTEAAAAAPQDPAPK_,S2,,26.06,,,,23.27,,,,,24.06,,,,24.46,1.60, , , ,-1.19, , , , ,-0.40, , , ,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1631,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),QDPAPKSPVGSGA,_S(ph)PVGSGAPQAAAPAPAAHVAGNPGGDAAPAATGTAAAASLATAAGSEDAEKK_,S34,+,27.72,27.32,27.32,25.67,24.52,,29.61,25.77,29.85,30.37,28.86,28.34,26.06,27.62,0.10,-0.30,-0.30,-1.95,-3.09, ,1.99,-1.84,2.24,2.76,1.24,0.72,-1.56,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1632,P16989,YBX3,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),PKSPVGSGAPQAA,_SPVGS(ph)GAPQAAAPAPAAHVAGNPGGDAAPAATGTAAAASLATAAGSEDAEK_,S38,,26.63,,,26.67,,,,,,,,,26.65,26.65,-0.02, , ,0.02, , , , , , , , ,0.00,"negative regulation of apoptotic process;male gonad development;fertilization;positive regulation of organ growth;negative regulation of skeletal muscle tissue development;response to cold;in utero embryonic development;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;organ regeneration;transcription, DNA-dependent",nucleus;polysome;gap junction;cytoplasm,Other TF domain,,,,,,,,,,,,,
1633,P17026,ZNF22,Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26),FSRLRRSLDDKPY,_S(ph)LDDKPYK_,S49,,25.72,25.82,25.84,24.66,,,,,22.74,,,,,24.96,0.76,0.87,0.88,-0.30, , , , ,-2.21, , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;odontogenesis",nucleolus;plasma membrane,C2H2-type,,,,,,,,,,,,,
1634,P17029,ZKSCAN1,Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18),REATGLSPQAAQE,_EATGLS(ph)PQAAQEK_,S13,,25.29,27.05,,26.55,,,,,,,,,24.92,25.95,-0.66,1.10, ,0.60, , , , , , , , ,-1.03,"viral reproduction;transcription, DNA-dependent",mitochondrion;nucleus,C2H2-type,,,,,,,,,,,,,
1636,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),EEEEGISQESSEE,_KLEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_,S99,+,26.41,24.86,24.05,,28.73,27.79,25.28,27.20,26.42,27.14,25.98,22.78,25.92,26.05,0.37,-1.18,-1.99, ,2.68,1.74,-0.76,1.15,0.37,1.09,-0.06,-3.27,-0.13,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
1637,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),EGISQESSEEEQ_,_KLEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_,S102,+,28.18,25.69,26.39,23.95,31.68,30.06,24.84,29.45,28.42,27.98,26.78,23.27,27.10,27.21,0.97,-1.52,-0.83,-3.26,4.47,2.85,-2.38,2.24,1.20,0.77,-0.44,-3.95,-0.11,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
1638,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),GISQESSEEEQ__,_KLEKEEEEGIS(ph)QES(ph)S(ph)EEEQ_,S103,+,28.28,26.40,24.42,24.06,31.07,26.67,27.73,27.89,27.24,26.06,27.26,25.34,27.60,26.93,1.36,-0.52,-2.50,-2.87,4.15,-0.25,0.80,0.96,0.31,-0.86,0.34,-1.59,0.68,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
1640,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),GTALVGSQKEPSE,_KQPPVSPGTALVGS(ph)QK_,S44,+,23.23,22.75,22.75,22.46,22.56,,24.27,23.80,24.00,25.19,,24.33,,23.53,-0.30,-0.79,-0.79,-1.08,-0.97, ,0.74,0.27,0.47,1.66, ,0.80, ,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
1641,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),ESSSKSSQPLASK,_(ac)SESSSKSS(ph)QPLASK_,S9,+,23.59,24.33,24.91,25.34,,,,,22.55,,20.03,20.84,,23.09,0.50,1.25,1.83,2.26, , , , ,-0.54, ,-3.06,-2.24, ,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
1645,P17252,PRKCA,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),VFPGNDSTASQDV,_(ac)ADVFPGNDS(ph)TASQDVANR_,S10,,23.70,,,,,,,,,,,25.19,,24.45,-0.74, , , , , , , , , , ,0.74, ,response to reactive oxygen species;response to antibiotic;negative regulation of cell proliferation;fibroblast growth factor receptor signaling pathway;positive regulation of synapse assembly;peptidyl-serine phosphorylation;apoptotic signaling pathway;positive regulation of ERK1 and ERK2 cascade;energy reserve metabolic process;mRNA metabolic process;response to peptide hormone stimulus;response to mechanical stimulus;regulation of the force of heart contraction;gene expression;negative regulation of glucose import;positive regulation of exocytosis;intracellular signal transduction;positive regulation of inflammatory response;platelet activation;negative regulation of translation;activation of phospholipase C activity;positive regulation of cardiac muscle hypertrophy;response to estradiol stimulus;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;inactivation of MAPK activity;central nervous system neuron axonogenesis;positive regulation of mitotic cell cycle;nerve growth factor receptor signaling pathway;synaptic transmission;induction of positive chemotaxis;cellular response to carbohydrate stimulus;chondrocyte differentiation;cellular calcium ion homeostasis;aging;activation of adenylate cyclase activity;regulation of platelet aggregation;negative regulation of adenylate cyclase activity;response to interleukin-1;negative regulation of heart contraction;regulation of peptidyl-tyrosine phosphorylation;regulation of receptor-mediated endocytosis;positive regulation of blood vessel endothelial cell migration;response to ethanol;negative regulation of insulin receptor signaling pathway;angiogenesis;negative regulation of glial cell apoptotic process;small molecule metabolic process;positive regulation of macrophage differentiation;neutrophil chemotaxis;regulation of muscle contraction;learning or memory;response to corticosterone stimulus;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of protein phosphorylation;desmosome assembly;cell adhesion;positive regulation of dense core granule biogenesis;positive regulation of endothelial cell proliferation;positive regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of smooth muscle cell proliferation,nucleoplasm;neuronal cell body;membrane raft;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;plasma membrane;mitochondrial membrane;dendrite;photoreceptor outer segment,,+,,,,,,,,,,,,
1646,P17252,PRKCA,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),GNDSTASQDVANR,_(ac)ADVFPGNDS(ph)TAS(ph)QDVANR_,S13,,25.12,,,,,,,,,,,24.63,,24.87,0.25, , , , , , , , , , ,-0.25, ,response to reactive oxygen species;response to antibiotic;negative regulation of cell proliferation;fibroblast growth factor receptor signaling pathway;positive regulation of synapse assembly;peptidyl-serine phosphorylation;apoptotic signaling pathway;positive regulation of ERK1 and ERK2 cascade;energy reserve metabolic process;mRNA metabolic process;response to peptide hormone stimulus;response to mechanical stimulus;regulation of the force of heart contraction;gene expression;negative regulation of glucose import;positive regulation of exocytosis;intracellular signal transduction;positive regulation of inflammatory response;platelet activation;negative regulation of translation;activation of phospholipase C activity;positive regulation of cardiac muscle hypertrophy;response to estradiol stimulus;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;inactivation of MAPK activity;central nervous system neuron axonogenesis;positive regulation of mitotic cell cycle;nerve growth factor receptor signaling pathway;synaptic transmission;induction of positive chemotaxis;cellular response to carbohydrate stimulus;chondrocyte differentiation;cellular calcium ion homeostasis;aging;activation of adenylate cyclase activity;regulation of platelet aggregation;negative regulation of adenylate cyclase activity;response to interleukin-1;negative regulation of heart contraction;regulation of peptidyl-tyrosine phosphorylation;regulation of receptor-mediated endocytosis;positive regulation of blood vessel endothelial cell migration;response to ethanol;negative regulation of insulin receptor signaling pathway;angiogenesis;negative regulation of glial cell apoptotic process;small molecule metabolic process;positive regulation of macrophage differentiation;neutrophil chemotaxis;regulation of muscle contraction;learning or memory;response to corticosterone stimulus;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of protein phosphorylation;desmosome assembly;cell adhesion;positive regulation of dense core granule biogenesis;positive regulation of endothelial cell proliferation;positive regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of smooth muscle cell proliferation,nucleoplasm;neuronal cell body;membrane raft;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;plasma membrane;mitochondrial membrane;dendrite;photoreceptor outer segment,,+,,,,,,,,,,,,
1647,P17252,PRKCA,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),NPQWNESFTFKLK,_STLNPQWNES(ph)FTFK_,S226,,24.46,22.10,,,,,,,,,,,,23.28,1.18,-1.18, , , , , , , , , , , ,response to reactive oxygen species;response to antibiotic;negative regulation of cell proliferation;fibroblast growth factor receptor signaling pathway;positive regulation of synapse assembly;peptidyl-serine phosphorylation;apoptotic signaling pathway;positive regulation of ERK1 and ERK2 cascade;energy reserve metabolic process;mRNA metabolic process;response to peptide hormone stimulus;response to mechanical stimulus;regulation of the force of heart contraction;gene expression;negative regulation of glucose import;positive regulation of exocytosis;intracellular signal transduction;positive regulation of inflammatory response;platelet activation;negative regulation of translation;activation of phospholipase C activity;positive regulation of cardiac muscle hypertrophy;response to estradiol stimulus;regulation of insulin secretion;epidermal growth factor receptor signaling pathway;inactivation of MAPK activity;central nervous system neuron axonogenesis;positive regulation of mitotic cell cycle;nerve growth factor receptor signaling pathway;synaptic transmission;induction of positive chemotaxis;cellular response to carbohydrate stimulus;chondrocyte differentiation;cellular calcium ion homeostasis;aging;activation of adenylate cyclase activity;regulation of platelet aggregation;negative regulation of adenylate cyclase activity;response to interleukin-1;negative regulation of heart contraction;regulation of peptidyl-tyrosine phosphorylation;regulation of receptor-mediated endocytosis;positive regulation of blood vessel endothelial cell migration;response to ethanol;negative regulation of insulin receptor signaling pathway;angiogenesis;negative regulation of glial cell apoptotic process;small molecule metabolic process;positive regulation of macrophage differentiation;neutrophil chemotaxis;regulation of muscle contraction;learning or memory;response to corticosterone stimulus;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of protein phosphorylation;desmosome assembly;cell adhesion;positive regulation of dense core granule biogenesis;positive regulation of endothelial cell proliferation;positive regulation of lipopolysaccharide-mediated signaling pathway;positive regulation of smooth muscle cell proliferation,nucleoplasm;neuronal cell body;membrane raft;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;plasma membrane;mitochondrial membrane;dendrite;photoreceptor outer segment,,+,,,,,,,,,,,,
1648,P17275,JUNB,Transcription factor jun-B,DATPPVSPINMED,_S(ph)RDAT(ph)PPVS(ph)PINMEDQER_,S259,,28.07,25.77,25.77,24.88,24.75,,,22.45,,,,,,25.28,2.79,0.49,0.49,-0.41,-0.53, , ,-2.83, , , , , ,response to light stimulus;response to drug;osteoclast differentiation;transforming growth factor beta receptor signaling pathway;response to peptide hormone stimulus;positive regulation of cell differentiation;response to mechanical stimulus;positive regulation of transcription from RNA polymerase II promoter;trophectodermal cell differentiation;transcription initiation from RNA polymerase II promoter;response to progesterone stimulus;labyrinthine layer blood vessel development;decidualization;regulation of cell cycle;vasculogenesis;osteoblast differentiation;response to cAMP;cellular response to calcium ion;embryonic process involved in female pregnancy;positive regulation of transcription from RNA polymerase II promoter during mitosis;response to corticosterone stimulus;cellular response to hormone stimulus;osteoblast proliferation;response to cytokine stimulus,nucleoplasm;chromatin,bZIP,,,,,,,,,,,,,
1649,P17275,JUNB,Transcription factor jun-B,TVPEARSRDATPP,_S(ph)RDAT(ph)PPVS(ph)PINMEDQER_,S251,,26.90,,,21.75,,,,,,,,,,24.32,2.57, , ,-2.57, , , , , , , , , ,response to light stimulus;response to drug;osteoclast differentiation;transforming growth factor beta receptor signaling pathway;response to peptide hormone stimulus;positive regulation of cell differentiation;response to mechanical stimulus;positive regulation of transcription from RNA polymerase II promoter;trophectodermal cell differentiation;transcription initiation from RNA polymerase II promoter;response to progesterone stimulus;labyrinthine layer blood vessel development;decidualization;regulation of cell cycle;vasculogenesis;osteoblast differentiation;response to cAMP;cellular response to calcium ion;embryonic process involved in female pregnancy;positive regulation of transcription from RNA polymerase II promoter during mitosis;response to corticosterone stimulus;cellular response to hormone stimulus;osteoblast proliferation;response to cytokine stimulus,nucleoplasm;chromatin,bZIP,,,,,,,,,,,,,
1650,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),ASSRASSRPRPDD,_ASS(ph)RPRPDDLEI_,S274,,21.41,27.74,25.55,26.73,27.90,27.61,26.35,27.06,25.86,25.50,26.05,27.51,26.48,26.29,-4.88,1.45,-0.73,0.44,1.61,1.32,0.06,0.77,-0.43,-0.79,-0.24,1.22,0.19,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1651,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),TGDRNNSSCRNYN,_LVTGDRNNS(ph)SCR_,S197,,19.26,26.40,,,19.95,,19.76,,20.11,,,20.80,,21.05,-1.79,5.36, , ,-1.10, ,-1.29, ,-0.94, , ,-0.24, ,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1652,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),GDRNNSSCRNYNK,_LVTGDRNNSS(ph)CR_,S198,,,25.77,,25.95,19.95,,,,19.30,,,20.80,,22.35, ,3.42, ,3.59,-2.41, , , ,-3.05, , ,-1.55, ,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1653,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),QAGSTISNSHAQP,_M(ox)GQAGSTIS(ph)NSHAQPFDFPDDNQNSK_,S229,,,,,,,25.84,24.56,,,,,,,25.20, , , , , ,0.64,-0.64, , , , , , ,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1655,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),NYNKQASEQNWAN,_(gl)QAS(ph)EQNWANYSAEQNR_,S207,+,,23.66,21.99,24.17,22.53,24.13,23.16,23.50,23.63,,,,,23.35, ,0.32,-1.36,0.83,-0.82,0.78,-0.19,0.16,0.29, , , , ,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1657,P17302,GJA1,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),ATSGALSPAKDCG,_SDPYHATSGALS(ph)PAK_,S156,,23.35,25.31,24.96,,,22.88,,,,26.30,24.52,,,24.55,-1.20,0.75,0.40, , ,-1.67, , , ,1.75,-0.03, , ,regulation of calcium ion transport;skeletal muscle tissue regeneration;negative regulation of gene expression;negative regulation of cell proliferation;protein oligomerization;neuron migration;positive regulation of I-kappaB kinase/NF-kappaB cascade;response to peptide hormone stimulus;positive regulation of protein catabolic process;limb bud formation;apoptotic process;epithelial cell maturation;blood vessel morphogenesis;positive regulation of gene expression;regulation of heart contraction;in utero embryonic development;adult heart development;cell-cell signaling;gap junction assembly;cellular membrane organization;positive regulation of striated muscle tissue development;ATP transport;response to pH;heart looping;neuron projection morphogenesis;vascular transport;heart development;muscle contraction,Golgi-associated vesicle membrane;intercalated disc;membrane raft;connexon complex;early endosome;mitochondrial outer membrane;cytosol;contractile fiber;fascia adherens;endoplasmic reticulum membrane;integral to plasma membrane;multivesicular body;lysosome,,,,,,,,,,,,,,
1659,P17509,HOXB6,Homeobox protein Hox-B6 (Homeobox protein Hox-2.2) (Homeobox protein Hox-2B) (Homeobox protein Hu-2),LSASQLSAEEEEE,_LLSASQLS(ph)AEEEEEK_,S214,+,25.69,24.10,24.10,23.49,24.49,,22.70,,,25.52,23.55,,,24.20,1.49,-0.10,-0.10,-0.72,0.28, ,-1.50, , ,1.31,-0.65, , ,"embryonic skeletal system morphogenesis;erythrocyte homeostasis;anterior/posterior axis specification, embryo;transcription, DNA-dependent",nucleus,Homeobox,,,,,,,,,,,,,
1662,P17544,ATF7,Cyclic AMP-dependent transcription factor ATF-7 (cAMP-dependent transcription factor ATF-7) (Activating transcription factor 7) (Transcription factor ATF-A),AGPLDMSLPSTPD,_AAAGPLDM(ox)S(ph)LPST(ph)PDIK_,S97,,22.59,22.62,22.62,,,,,,,,,,,22.61,-0.02,0.01,0.01, , , , , , , , , , ,"transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear periphery;cytoplasm,bZIP,,,,,,,,,,,,,
1664,P17661,DES,Desmin,LNFRETSPEQRGS,_ETS(ph)PEQRGSEVHTK_,S432,,,26.21,27.20,,,,,23.43,,,23.74,,,25.14, ,1.06,2.06, , , , ,-1.71, , ,-1.40, , ,muscle filament sliding;regulation of heart contraction;cytoskeleton organization,Z disc;neuromuscular junction;cytosol;type III intermediate filament;intermediate filament;fascia adherens;sarcolemma,,,,,,,,,,,,,,
1668,P17706,PTPN2,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),SPAFDHSPNKIMT,_EDLSPAFDHS(ph)PNK_,S304,+,25.79,25.76,26.60,23.97,24.20,25.60,25.98,25.48,25.29,25.65,23.86,24.63,24.74,25.20,0.60,0.56,1.41,-1.23,-1.00,0.40,0.78,0.29,0.09,0.45,-1.34,-0.57,-0.45,interferon-gamma-mediated signaling pathway;insulin receptor signaling pathway;regulation of interferon-gamma-mediated signaling pathway,nucleoplasm;endoplasmic reticulum,,,+,,,,,,,,,,,
1672,P17812,CTPS1,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),SDRSGSSSPDSEI,_SGSS(ph)S(ph)PDSEITELK_,S574,,24.55,,,28.80,,,27.88,,,,,26.86,25.12,26.64,-2.09, , ,2.15, , ,1.24, , , , ,0.22,-1.52,glutamine metabolic process;response to drug;nucleobase-containing small molecule interconversion;CTP biosynthetic process;'de novo' CTP biosynthetic process,cytosol,,,,,,,,,,,,,,
1673,P17812,CTPS1,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),DRSGSSSPDSEIT,_SGSSS(ph)PDSEITELKFPSINHD_,S575,+,27.26,27.72,27.22,28.35,27.81,25.55,28.80,28.07,27.46,27.90,28.76,27.93,,27.74,-0.47,-0.02,-0.52,0.61,0.07,-2.18,1.06,0.33,-0.27,0.17,1.03,0.20, ,glutamine metabolic process;response to drug;nucleobase-containing small molecule interconversion;CTP biosynthetic process;'de novo' CTP biosynthetic process,cytosol,,,,,,,,,,,,,,
1674,P17812,CTPS1,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),QKGCRLSPRDTYS,_GCRLS(ph)PR_,S562,+,21.49,25.14,24.13,25.49,20.30,,20.54,20.82,,,,,,22.56,-1.07,2.58,1.58,2.93,-2.26, ,-2.02,-1.74, , , , , ,glutamine metabolic process;response to drug;nucleobase-containing small molecule interconversion;CTP biosynthetic process;'de novo' CTP biosynthetic process,cytosol,,,,,,,,,,,,,,
1675,P17844,DDX5,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),LVEDRGSGRSRGR,_LLQLVEDRGS(ph)GR_,S480,,23.46,22.17,22.17,22.85,22.24,,,,,,,24.38,,22.88,0.58,-0.71,-0.71,-0.03,-0.63, , , , , , ,1.50, ,"regulation of viral genome replication;positive regulation of DNA damage response, signal transduction by p53 class mediator;in utero embryonic development;cell growth;regulation of osteoblast differentiation;intrinsic apoptotic signaling pathway by p53 class mediator;negative regulation of transcription from RNA polymerase II promoter;positive regulation of intracellular estrogen receptor signaling pathway;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of androgen receptor signaling pathway;regulation of skeletal muscle cell differentiation;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter",nucleolus;catalytic step 2 spliceosome,,,,,,,,,,+,+,,,
1678,P17858,PFKL,"6-phosphofructokinase, liver type (EC 2.7.1.11) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphofructokinase 1) (Phosphohexokinase)",VTRRTLSMDKGF_,_RTLS(ph)MDK_,S775,,25.12,22.62,21.85,22.87,,,,19.11,,,,20.68,,22.04,3.08,0.58,-0.19,0.82, , , ,-2.93, , , ,-1.36, ,"protein homotetramerization;small molecule metabolic process;protein oligomerization;fructose 1,6-bisphosphate metabolic process;response to glucose stimulus;fructose 6-phosphate metabolic process;negative regulation of insulin secretion;glycolysis",6-phosphofructokinase complex,,,,,,,,,,,,,,
1679,P17861,XBP1,X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5),PAQRGASPEAASG,_GAS(ph)PEAASGGLPQAR_,S47,,22.83,24.18,,,,,,,,,,,,23.50,-0.68,0.68, , , , , , , , , , , ,"immune response;serotonin secretion, neurotransmission;response to drug;exocrine pancreas development;positive regulation of endoplasmic reticulum unfolded protein response;transcription from RNA polymerase II promoter;epithelial cell maturation involved in salivary gland development;activation of signaling protein activity involved in unfolded protein response;response to electrical stimulus",nucleoplasm,bZIP,,,,,,,,,,,,,
1680,P17936,IGFBP3,Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3),TDTQNFSSESKRE,_VDYESQSTDTQNFS(ph)SESK_,S53,,,23.13,23.13,,,,,,,24.28,,,,23.52, ,-0.38,-0.38, , , , , , ,0.77, , , ,type B pancreatic cell proliferation;negative regulation of signal transduction;regulation of cell growth;protein phosphorylation;positive regulation of insulin-like growth factor receptor signaling pathway;negative regulation of protein phosphorylation;positive regulation of myoblast differentiation;positive regulation of MAPK cascade;negative regulation of smooth muscle cell proliferation;negative regulation of smooth muscle cell migration;apoptotic process;regulation of glucose metabolic process;positive regulation of apoptotic process,insulin-like growth factor binding protein complex;insulin-like growth factor binary complex;insulin-like growth factor ternary complex;nucleus,,,,,,,,,,,,,,
1683,P17987,TCP1,T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha),KDDKHGSYEDAVH,_HGS(ph)YEDAVHSGALND_,S544,+,23.53,24.77,24.62,24.25,22.31,22.73,24.81,,24.93,25.15,24.66,24.44,,24.20,-0.67,0.57,0.42,0.05,-1.89,-1.47,0.61, ,0.73,0.95,0.46,0.24, ,'de novo' posttranslational protein folding;tubulin complex assembly,nuclear heterochromatin;Golgi apparatus;centrosome;chaperonin-containing T-complex;cytosol;cell junction;plasma membrane;microtubule;nucleus;pericentriolar material,,,,,,,,,,,,,,
1684,P17987,TCP1,T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha),YEDAVHSGALND_,_HGSYEDAVHS(ph)GALND_,S551,+,,23.39,23.39,23.22,,,23.84,22.78,22.95,24.02,23.21,23.25,,23.34, ,0.05,0.05,-0.12, , ,0.50,-0.56,-0.39,0.68,-0.13,-0.09, ,'de novo' posttranslational protein folding;tubulin complex assembly,nuclear heterochromatin;Golgi apparatus;centrosome;chaperonin-containing T-complex;cytosol;cell junction;plasma membrane;microtubule;nucleus;pericentriolar material,,,,,,,,,,,,,,
1685,P18031,PTPN1,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),NRYRDVSPFDHSR,_YRDVS(ph)PFDHSR_,S50,+,,24.08,22.02,23.32,24.95,24.19,23.72,22.55,26.05,22.43,23.55,22.41,24.93,23.68, ,0.40,-1.66,-0.36,1.27,0.51,0.03,-1.13,2.36,-1.26,-0.13,-1.28,1.25,negative regulation of insulin receptor signaling pathway;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;type I interferon-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;endoplasmic reticulum unfolded protein response;regulation of endocytosis;actin cytoskeleton reorganization;interferon-gamma-mediated signaling pathway;insulin receptor signaling pathway,cytosol;cytoplasmic vesicle;endoplasmic reticulum;endoplasmic reticulum membrane;early endosome,,,+,,,,,,,,,,,
1686,P18031,PTPN1,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),IKEEKGSPLNAAP,_GS(ph)PLNAAPYGIESM(ox)SQDTEVR_,S352,+,25.53,23.96,24.13,24.53,,,25.60,,26.60,27.39,27.61,22.95,26.96,25.53,0.00,-1.56,-1.40,-1.00, , ,0.08, ,1.08,1.86,2.08,-2.57,1.44,negative regulation of insulin receptor signaling pathway;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;type I interferon-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;endoplasmic reticulum unfolded protein response;regulation of endocytosis;actin cytoskeleton reorganization;interferon-gamma-mediated signaling pathway;insulin receptor signaling pathway,cytosol;cytoplasmic vesicle;endoplasmic reticulum;endoplasmic reticulum membrane;early endosome,,,+,,,,,,,,,,,
1687,P18031,PTPN1,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),SRVVGGSLRGAQA,_VVGGS(ph)LR_,S378,,24.40,24.80,,26.61,,,,,,,23.38,24.56,22.19,24.32,0.07,0.48, ,2.28, , , , , , ,-0.95,0.24,-2.13,negative regulation of insulin receptor signaling pathway;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;type I interferon-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;endoplasmic reticulum unfolded protein response;regulation of endocytosis;actin cytoskeleton reorganization;interferon-gamma-mediated signaling pathway;insulin receptor signaling pathway,cytosol;cytoplasmic vesicle;endoplasmic reticulum;endoplasmic reticulum membrane;early endosome,,,+,,,,,,,,,,,
1688,P18085,ARF4,ADP-ribosylation factor 4,DKLGLQSLRNRTW,_LGLQS(ph)LR_,S147,+,23.14,23.26,23.01,22.71,,23.05,23.94,23.31,23.90,23.70,,24.52,23.81,23.49,-0.34,-0.23,-0.48,-0.78, ,-0.44,0.46,-0.18,0.41,0.21, ,1.04,0.32,epidermal growth factor receptor signaling pathway;brain development;vesicle-mediated transport;protein transport;small GTPase mediated signal transduction;response to axon injury,Golgi apparatus;plasma membrane,,,,,,,,,,,,,,
1689,P18206,VCL,Vinculin (Metavinculin) (MV),ASQLQDSLKDLKA,_ALASQLQDS(ph)LK_,S579,+,21.97,22.98,,24.54,,24.13,,24.40,23.03,,23.38,23.23,,23.46,-1.49,-0.47, ,1.08, ,0.68, ,0.95,-0.43, ,-0.08,-0.23, ,platelet degranulation;lamellipodium assembly;platelet activation;epithelial cell-cell adhesion;cell-matrix adhesion;negative regulation of cell migration;apical junction assembly;protein localization to cell surface;adherens junction assembly;muscle contraction;cellular component movement;morphogenesis of an epithelium,cell-cell adherens junction;protein complex;cytosol;actin filament;stress fiber;extracellular region;fascia adherens;plasma membrane;cytoskeleton;focal adhesion;costamere,,,,,,,,,,+,,,,
1690,P18206,VCL,Vinculin (Metavinculin) (MV),LRDPSASPGDAGE,_DPSAS(ph)PGDAGEQAIR_,S290,+,26.03,24.72,,24.76,26.15,,24.95,26.35,25.14,22.42,25.40,25.79,23.65,25.03,0.99,-0.31, ,-0.28,1.12, ,-0.09,1.32,0.10,-2.61,0.37,0.76,-1.38,platelet degranulation;lamellipodium assembly;platelet activation;epithelial cell-cell adhesion;cell-matrix adhesion;negative regulation of cell migration;apical junction assembly;protein localization to cell surface;adherens junction assembly;muscle contraction;cellular component movement;morphogenesis of an epithelium,cell-cell adherens junction;protein complex;cytosol;actin filament;stress fiber;extracellular region;fascia adherens;plasma membrane;cytoskeleton;focal adhesion;costamere,,,,,,,,,,+,,,,
1691,P18206,VCL,Vinculin (Metavinculin) (MV),EAIDTKSLLDASE,_S(ph)LLDASEEAIKK_,S721,+,26.07,26.58,26.58,27.25,26.07,27.19,28.75,27.71,27.94,27.49,28.36,28.89,26.40,27.33,-1.26,-0.75,-0.75,-0.08,-1.26,-0.14,1.42,0.38,0.61,0.17,1.03,1.57,-0.93,platelet degranulation;lamellipodium assembly;platelet activation;epithelial cell-cell adhesion;cell-matrix adhesion;negative regulation of cell migration;apical junction assembly;protein localization to cell surface;adherens junction assembly;muscle contraction;cellular component movement;morphogenesis of an epithelium,cell-cell adherens junction;protein complex;cytosol;actin filament;stress fiber;extracellular region;fascia adherens;plasma membrane;cytoskeleton;focal adhesion;costamere,,,,,,,,,,+,,,,
1695,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),VCAAGTSPVGEIG,_EM(ox)EHNTVCAAGTS(ph)PVGEIGEEK_,S1556,+,26.11,24.74,24.74,24.43,25.97,26.65,26.20,25.40,26.86,26.53,24.61,25.55,25.11,25.61,0.50,-0.86,-0.86,-1.18,0.36,1.04,0.60,-0.21,1.25,0.92,-1.00,-0.06,-0.49,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1696,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),TLAALLSPKESSG,_ESDQTLAALLS(ph)PK_,S1697,+,28.14,27.03,27.21,26.80,26.34,28.48,27.84,27.70,28.74,29.05,27.58,27.32,28.89,27.78,0.36,-0.74,-0.57,-0.98,-1.44,0.70,0.07,-0.08,0.96,1.27,-0.20,-0.45,1.11,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1697,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),SFLKFDSEPSAVA,_FDS(ph)EPSAVALELPTR_,S160,,22.89,,,,,,,,,,,,,22.89,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1699,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),PLRRRFSRSPIRR,_RFS(ph)RS(ph)PIR_,S2029,+,22.98,25.82,25.56,26.20,24.71,21.08,21.78,22.01,23.27,21.71,,,,23.51,-0.53,2.31,2.05,2.69,1.20,-2.43,-1.73,-1.50,-0.24,-1.80, , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1700,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),RRRFSRSPIRRKR,_RFS(ph)RS(ph)PIR_,S2031,+,22.98,25.82,25.56,26.20,24.71,21.08,21.78,22.01,23.27,21.71,,,,23.51,-0.53,2.31,2.05,2.69,1.20,-2.43,-1.73,-1.50,-0.24,-1.80, , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1701,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),SVVRRRSFSISPV,_RRS(ph)FS(ph)IS(ph)PVR_,S2009,,24.58,,,,,,,,,,,,,24.58,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1702,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),VRRRSFSISPVRL,_RRS(ph)FS(ph)IS(ph)PVR_,S2011,+,24.52,20.33,,,,21.81,,21.66,21.36,22.19,,,21.96,21.98,2.54,-1.64, , , ,-0.17, ,-0.32,-0.61,0.22, , ,-0.02,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1703,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),RRSFSISPVRLRR,_RRS(ph)FS(ph)IS(ph)PVR_,S2013,,24.85,,,,,23.77,,,,,,,,24.31,0.54, , , , ,-0.54, , , , , , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1704,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),RDRSAASPVVSSM,_SAAS(ph)PVVSSM(ox)PER_,S1769,+,25.93,27.88,25.63,24.89,26.34,27.90,25.06,25.38,26.40,23.86,26.10,27.28,26.14,26.06,-0.13,1.82,-0.43,-1.17,0.28,1.84,-1.00,-0.68,0.34,-2.20,0.04,1.22,0.08,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1705,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),GNIDLESDSFLKF,_SHDDGNIDLES(ph)DSFLK_,S152,,23.82,20.40,20.40,,,,,,24.32,24.88,,,,22.76,1.06,-2.37,-2.37, , , , , ,1.56,2.11, , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1706,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),AMLGSKSPDPYRL,_S(ph)PDPYRLAQDPYR_,S910,+,20.16,22.89,22.89,,24.04,,25.49,24.30,26.76,26.43,,23.52,23.89,24.04,-3.88,-1.15,-1.15, ,0.00, ,1.46,0.27,2.73,2.39, ,-0.52,-0.15,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1707,P18583,SON,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),PVRLRRSRTPLRR,_S(ph)RT(ph)PLRR_,S2020,+,25.42,24.72,24.72,24.90,20.56,,18.68,,19.93,,,,,22.70,2.71,2.01,2.01,2.20,-2.14, ,-4.02, ,-2.78, , , , ,negative regulation of apoptotic process;regulation of cell cycle;regulation of RNA splicing;mRNA processing;RNA splicing;cell cycle;microtubule cytoskeleton organization;cytokinesis,nuclear speck,,,,,,,,,,,,,,
1710,P18615,NELFE,Negative elongation factor E (NELF-E) (RNA-binding protein RD),GVKRSLSEQPVMD,_SLS(ph)EQPVM(ox)DTATATEQAK_,S51,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,negative regulation of transcription elongation from RNA polymerase II promoter;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,mitochondrion;NELF complex,,,,,,,,,,,,,,
1711,P18615,NELFE,Negative elongation factor E (NELF-E) (RNA-binding protein RD),PFRRSDSFPERRA,_SDS(ph)FPER_,S251,,25.03,25.48,,25.75,,,,,,,,21.92,18.27,23.29,1.74,2.19, ,2.46, , , , , , , ,-1.37,-5.02,negative regulation of transcription elongation from RNA polymerase II promoter;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,mitochondrion;NELF complex,,,,,,,,,,,,,,
1715,P18669,PGAM1,Phosphoglycerate mutase 1 (EC 3.1.3.13) (EC 5.4.2.1) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),LIRHGESAWNLEN,_HGES(ph)AWNLENR_,S14,+,22.54,24.79,,23.47,25.08,24.11,25.07,25.77,,,24.77,24.95,,24.50,-1.97,0.28, ,-1.04,0.57,-0.40,0.56,1.26, , ,0.26,0.45, ,small molecule metabolic process;regulation of glycolysis;gluconeogenesis;glycolysis;respiratory burst;regulation of pentose-phosphate shunt,cytosol,,,,,,,,,,,,,,
1717,P18754,RCC1,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),RIAKRRSPPADAI,_S(ph)PPADAIPK_,S11,+,25.31,26.42,25.85,25.34,26.16,25.76,24.29,24.89,24.96,25.00,23.94,22.52,23.68,24.93,0.38,1.49,0.92,0.41,1.23,0.83,-0.64,-0.04,0.03,0.07,-0.99,-2.41,-1.26,chromosome segregation;spindle assembly;regulation of S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;mitotic spindle organization;mitosis;viral reproduction;cell division;regulation of mitosis,nucleoplasm;nuclear membrane;nuclear chromatin;condensed nuclear chromosome;cytoplasm,,,,,,,,,,,,,,
1718,P18850,ATF6,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],AEPQPLSPASSSY,_AEPQPLS(ph)PASSSYSVSSPR_,S95,,22.47,22.54,22.54,,,,,,,23.76,,,,22.82,-0.36,-0.29,-0.29, , , , , , ,0.94, , , ,"protein folding;positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response;activation of signaling protein activity involved in unfolded protein response;transcription, DNA-dependent",nucleoplasm;nuclear envelope;integral to membrane;endoplasmic reticulum membrane;Golgi membrane,bZIP,,,,,,,,,,,,,
1721,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),VVSESDSPVKRPG,_EWNGVVSESDS(ph)PVK_,S21,,25.23,,,21.46,,,23.13,22.93,22.54,23.48,,,,23.13,2.10, , ,-1.67, , ,0.00,-0.20,-0.58,0.35, , , ,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1722,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),NQQGEDSGSDPED,_QSQIQNQQGEDS(ph)GS(ph)DPEDTY_,S880,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1723,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),QGEDSGSDPEDTY,_QSQIQNQQGEDS(ph)GS(ph)DPEDTY_,S882,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1724,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),EVLEEQSEDEDRE,_TIQEVLEEQS(ph)EDEDREAK_,S111,+,24.92,,,,25.83,26.58,23.11,25.17,,25.66,24.50,,25.77,25.19,-0.27, , , ,0.63,1.38,-2.08,-0.02, ,0.47,-0.69, ,0.58,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1725,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),AARVLGSEGEEED,_VLGS(ph)EGEEEDEALS(ph)PAK_,S36,+,27.61,22.86,22.86,24.28,26.15,25.14,25.79,25.38,25.09,25.90,23.35,25.36,24.50,24.95,2.67,-2.08,-2.08,-0.66,1.21,0.19,0.85,0.44,0.14,0.96,-1.59,0.42,-0.44,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1726,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),EEDEALSPAKGQK,_VLGS(ph)EGEEEDEALS(ph)PAK_,S46,+,28.07,25.16,26.03,24.74,25.52,25.98,26.71,26.50,25.44,25.81,23.22,25.67,25.72,25.74,2.33,-0.58,0.29,-1.00,-0.21,0.25,0.98,0.76,-0.29,0.08,-2.52,-0.07,-0.02,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
1729,P18887,XRCC1,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),QAAGPSSPQKPPT,_TKPTQAAGPSS(ph)PQKPPT(ph)PEETK_,S416,,24.95,25.01,,24.90,23.31,,,24.09,,22.99,,,,24.21,0.74,0.80, ,0.69,-0.90, , ,-0.12, ,-1.22, , , ,single strand break repair;base-excision repair;response to drug;response to hypoxia;response to organic substance,nucleoplasm,,,,,,,,,,,,,,
1730,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",RFVSSGSGGGYGG,_FVSSGS(ph)GGGYGGGM(ox)R_,S56,,26.60,,,,,,,,,,,,,26.60,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
1731,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",GSTRGGSLLAGGG,_GGS(ph)LLAGGGGFGGGSLSGGGGSR_,S22,,25.57,,,,,,,,,,,,,25.57,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
1732,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",GGFGGGSLSGGGG,_GGSLLAGGGGFGGGS(ph)LSGGGGSR_,S34,,27.22,,,,,,,,,,,,,27.22,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
1733,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",QKQTPTSPECDYS,_(gl)QTPTS(ph)PECDYSQYFK_,S148,,23.98,,,,,,,,,,,,,23.98,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
1734,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",STFGGGSTRGGSL,_(ac)TTTFLQTSSSTFGGGS(ph)TR_,S17,,23.50,,,,,,,,,,,,,23.50,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
1735,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",LNNKFASFIDKVR,_FAS(ph)FIDK_,SNaN,,26.29,24.83,24.16,23.70,,24.45,25.02,24.37,23.84,24.88,24.88,26.03,26.19,24.89,1.40,-0.06,-0.72,-1.18, ,-0.44,0.13,-0.51,-1.05,-0.01,-0.01,1.14,1.30,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
1736,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",GAFSSVSMSGGAG,_RGAFSSVS(ph)M(ox)SGGAGR_,S34,,25.21,,,,,,,,,,,,,25.21,0.00, , , , , , , , , , , , ,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
1737,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",RGFSCGSAIVGGG,_GFSCGS(ph)AIVGGGK_,S19,,24.83,,,,,,,,,,,,,24.83,0.00, , , , , , , , , , , , ,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
1738,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",RGNKSISMSVAGS,_SIS(ph)M(ox)SVAGSR_,S62,,23.58,,,,,,,,,,,,,23.58,0.00, , , , , , , , , , , , ,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
1739,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",GGFGSRSLYNLRG,_S(ph)LYNLR_,S51,,27.08,,,,,,,,,,,,,27.08,0.00, , , , , , , , , , , , ,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
1740,P19021,PAM,Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3);Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)],RLSTEGSDQEKED,_GFDRLSTEGS(ph)DQEK_,S223,,,24.95,24.95,,,,23.10,,25.76,26.31,,,,25.01, ,-0.07,-0.07, , , ,-1.91, ,0.75,1.29, , , ,response to drug;response to hypoxia;response to estradiol stimulus;response to glucocorticoid stimulus;cellular protein modification process;limb development;central nervous system development;response to pH;heart development;response to copper ion;peptide metabolic process,secretory granule;integral to membrane;extracellular region;perikaryon,,,,,,,,,,,,,,
1743,P19338,NCL,Nucleolin (Protein C23),AAAAPASEDEDDE,_AAAAAPAS(ph)EDEDDEDDEDDEDDDDDEEDDS(ph)EEEAM(ox)ETTPAK_,S184,,29.73,,,,,,,,,24.23,,,,26.98,2.75, , , , , , , , ,-2.75, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1744,P19338,NCL,Nucleolin (Protein C23),DDEEDDSEEEAME,_AAAAAPASEDEDDEDDEDDEDDDDDEEDDS(ph)EEEAM(ox)ETTPAK_,S206,,30.43,,,,26.06,,23.04,,25.95,26.95,,,,26.49,3.94, , , ,-0.42, ,-3.45, ,-0.53,0.47, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1746,P19338,NCL,Nucleolin (Protein C23),NAKKEDSDEEEDD,_KEDS(ph)DEEEDDDS(ph)EEDEEDDEDEDEDEDEIEPAAMK_,S145,,31.23,,,,27.83,24.53,23.98,,27.19,28.65,,,,27.23,3.99, , , ,0.59,-2.71,-3.25, ,-0.04,1.41, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1747,P19338,NCL,Nucleolin (Protein C23),EEEDDDSEEDEED,_KEDS(ph)DEEEDDDS(ph)EEDEEDDEDEDEDEDEIEPAAMK_,S153,,30.96,,,,24.38,,,,24.97,26.06,,,,26.59,4.37, , , ,-2.21, , , ,-1.62,-0.54, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1748,P19338,NCL,Nucleolin (Protein C23),KEVEEDSEDEEMS,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,S28,,28.27,,,,,,,,,,,,,28.27,0.00, , , , , , , , , , , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1749,P19338,NCL,Nucleolin (Protein C23),SEDEEMSEDEEDD,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,S34,,27.53,,,,,,,,,,,,,27.53,0.00, , , , , , , , , , , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1750,P19338,NCL,Nucleolin (Protein C23),EDEEDDSSGEEVV,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,S41,,28.10,,,,,,,,,25.85,,,,26.98,1.12, , , , , , , , ,-1.12, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1751,P19338,NCL,Nucleolin (Protein C23),DEEDDSSGEEVVI,_EVEEDS(ph)EDEEM(ox)S(ph)EDEEDDS(ph)S(ph)GEEVVIPQKK_,S42,,28.00,,,,26.07,26.11,,24.54,,,,,25.21,25.98,2.01, , , ,0.08,0.12, ,-1.44, , , , ,-0.77,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1752,P19338,NCL,Nucleolin (Protein C23),GFVDFNSEEDAKA,_GFGFVDFNS(ph)EEDAK_,S619,,23.12,,,,22.60,,,,,22.34,,,,22.69,0.43, , , ,-0.08, , , , ,-0.35, , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1753,P19338,NCL,Nucleolin (Protein C23),LFVKGLSEDTTEE,_GLS(ph)EDTTEETLK_,S580,,25.21,23.40,23.54,22.23,,,,,21.65,,,,,23.21,2.00,0.19,0.33,-0.98, , , , ,-1.55, , , , ,angiogenesis,nucleoplasm;cell cortex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
1755,P19474,TRIM21,E3 ubiquitin-protein ligase TRIM21 (EC 6.3.2.-) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21),KDLDITSPELRSV,_DLDITS(ph)PELR_,S266,,22.31,,,20.16,,,21.99,,,21.60,22.16,22.92,,21.85,0.45, , ,-1.70, , ,0.14, , ,-0.25,0.30,1.06, ,negative regulation of protein deubiquitination;protein autoubiquitination;positive regulation of cell cycle;negative regulation of NF-kappaB transcription factor activity;protein trimerization;protein monoubiquitination;protein destabilization;cell cycle;protein polyubiquitination,ribonucleoprotein complex;nucleus;cytoplasmic mRNA processing body;cytoplasm,,,,,,,,,,,,,,
1756,P19532,TFE3,Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33),PLLSSVSPAVSKA,_AASDPLLSSVS(ph)PAVSK_,S451,,,25.24,,25.26,,,,,,23.13,26.24,,24.72,24.92, ,0.32, ,0.34, , , , , ,-1.78,1.32, ,-0.20,"regulation of osteoclast differentiation;humoral immune response;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus;cytoplasm,bHLH,,,,,,,,,,,,,
1757,P19532,TFE3,Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33),ASSRRSSFSMEEE,_RSS(ph)FSM(ox)EEES_,S463,,21.02,24.08,,24.98,22.19,,22.75,22.64,,,,,,22.94,-1.93,1.13, ,2.04,-0.75, ,-0.20,-0.30, , , , , ,"regulation of osteoclast differentiation;humoral immune response;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus;cytoplasm,bHLH,,,,,,,,,,,,,
1758,P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",SRARIGSDPLAYE,_IGS(ph)DPLAYEPK_,S703,+,27.41,27.63,27.80,27.49,25.38,26.66,29.40,26.08,29.42,29.67,30.20,29.14,28.76,28.08,-0.67,-0.45,-0.28,-0.59,-2.70,-1.42,1.32,-2.00,1.34,1.59,2.12,1.06,0.69,intracellular protein kinase cascade;cell differentiation;small molecule metabolic process;protein oligomerization;hyaluronan catabolic process;cellular response to acidity;response to drug;cell growth;carbohydrate metabolic process;sodium ion export;response to organic cyclic compound;response to acid;regulation of intracellular pH,membrane raft;integral to membrane;basolateral plasma membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,+,,,,
1762,P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",KIPSAVSTVSMQN,_IPSAVS(ph)TVS(ph)M(ox)QNIHPK_,S602,,24.00,21.31,,,,,,,,,,,,22.65,1.34,-1.34, , , , , , , , , , , ,intracellular protein kinase cascade;cell differentiation;small molecule metabolic process;protein oligomerization;hyaluronan catabolic process;cellular response to acidity;response to drug;cell growth;carbohydrate metabolic process;sodium ion export;response to organic cyclic compound;response to acid;regulation of intracellular pH,membrane raft;integral to membrane;basolateral plasma membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,+,,,,
1763,P19634,SLC9A1,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",SAVSTVSMQNIHP,_IPSAVS(ph)TVS(ph)M(ox)QNIHPK_,S605,,24.00,21.31,,,,,,,,,,,,22.65,1.34,-1.34, , , , , , , , , , , ,intracellular protein kinase cascade;cell differentiation;small molecule metabolic process;protein oligomerization;hyaluronan catabolic process;cellular response to acidity;response to drug;cell growth;carbohydrate metabolic process;sodium ion export;response to organic cyclic compound;response to acid;regulation of intracellular pH,membrane raft;integral to membrane;basolateral plasma membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,+,,,,
1764,P19784,CSNK2A2,Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1),YNVRVASRYFKGP,_VAS(ph)RYFK_,S194,+,21.50,24.20,24.20,,23.68,22.81,23.94,23.49,22.89,23.32,24.58,24.43,22.88,23.49,-2.00,0.71,0.71, ,0.18,-0.69,0.45,0.00,-0.61,-0.17,1.09,0.94,-0.61,"mitotic cell cycle spindle checkpoint;apoptotic process;Wnt receptor signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;axon guidance",cytosol;nucleus,,+,,,,,,,,,,,,
1765,P19971,TYMP,Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase),DFSGEGSQGLPDP,_(ac)AALM(ox)TPGTGAPPAPGDFSGEGS(ph)QGLPDPSPEPK_,S23,,25.08,25.51,26.28,22.89,,,,,,,,,,24.94,0.14,0.57,1.34,-2.05, , , , , , , , , ,cell differentiation;angiogenesis;pyrimidine nucleotide metabolic process;pyrimidine nucleoside catabolic process;mitochondrial genome maintenance;chemotaxis;pyrimidine nucleobase metabolic process;DNA replication;pyrimidine nucleoside salvage,cytosol,,,,,,,,,,,,,,
1766,P20020,ATP2B1,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),GDMANNSVAYSGV,_(ac)GDM(ox)ANNS(ph)VAYSGVK_,S8,,23.17,,,,,,,,,,,22.55,,22.86,0.31, , , , , , , , , , ,-0.31, ,blood coagulation;ATP biosynthetic process,integral to plasma membrane,,,,,,,,,,,,,,
1767,P20020,ATP2B1,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),YSGVKNSLKEANH,_(ac)GDM(ox)ANNSVAYSGVKNS(ph)LK_,S17,+,24.70,23.25,23.25,23.43,,24.74,23.93,23.84,,,23.24,23.98,23.84,23.82,0.88,-0.57,-0.57,-0.39, ,0.92,0.11,0.02, , ,-0.58,0.16,0.02,blood coagulation;ATP biosynthetic process,integral to plasma membrane,,,,,,,,,,,,,,
1768,P20020,ATP2B1,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),EFRIEDSEPHIPL,_IEDS(ph)EPHIPLIDDTDAEDDAPTKR_,S1119,+,27.52,,,,26.22,,24.66,23.11,27.03,26.35,24.72,26.81,23.88,25.59,1.93, , , ,0.63, ,-0.93,-2.48,1.44,0.76,-0.87,1.23,-1.71,blood coagulation;ATP biosynthetic process,integral to plasma membrane,,,,,,,,,,,,,,
1769,P20042,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta),KDLKIESDVQEPT,_IES(ph)DVQEPTEPEDDLDIM(ox)LGNKK_,S105,+,24.63,23.07,23.49,,26.57,,24.37,24.21,24.95,25.96,25.10,25.14,,24.75,-0.12,-1.68,-1.26, ,1.82, ,-0.38,-0.54,0.20,1.21,0.35,0.40, ,,cytosol;eukaryotic translation initiation factor 2 complex,,,,,,,,,,,+,,,
1771,P20138,CD33,Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33),PTTGSASPKHQKK,_NDTHPTTGSAS(ph)PK_,S180,,,22.44,20.04,,,,,,,,,,,21.24, ,1.20,-1.20, , , , , , , , , , ,signal transduction;negative regulation of cell proliferation;cell adhesion;cell-cell signaling,integral to plasma membrane;external side of plasma membrane,,,,,,,,,,,,,,
1773,P20337,RAB3B,Ras-related protein Rab-3B,CDKMSDSLDTDPS,_M(ox)SDS(ph)LDTDPSM(ox)LGSSK_,S190,+,,,,22.46,,24.15,24.68,,24.59,,22.84,22.81,23.24,23.54, , , ,-1.08, ,0.61,1.14, ,1.05, ,-0.70,-0.73,-0.30,protein transport;small GTPase mediated signal transduction;regulation of exocytosis;peptidyl-cysteine methylation,secretory granule;cytosol;synaptic vesicle;plasma membrane,,,,,,,,,,,,,,
1774,P20340,RAB6A,Ras-related protein Rab-6A (Rab-6),_____MSTGGDFG,_(ac)S(ph)TGGDFGNPLRK_,S2,,25.86,,,25.86,26.26,,,,,26.47,,,25.75,26.04,-0.18, , ,-0.18,0.22, , , , ,0.43, , ,-0.29,"retrograde vesicle-mediated transport, Golgi to ER;small GTPase mediated signal transduction;protein targeting to Golgi;peptidyl-cysteine methylation;minus-end-directed organelle transport along microtubule",trans-Golgi network;cytosol;cytoplasmic vesicle;Golgi apparatus;membrane;Golgi membrane,,,,,,,,,,,,,,
1775,P20591,MX1,"Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed]",___MVVSEVDIAK,_VVS(ph)EVDIAK_,S4,,,22.81,22.81,22.33,,,,,,,,,,22.65, ,0.16,0.16,-0.32, , , , , , , , , ,defense response to virus;negative regulation of viral genome replication;response to virus;type I interferon-mediated signaling pathway;GTP catabolic process;induction of apoptosis,cytosol;nucleus;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
1776,P20645,M6PR,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),DQLGEESEERDDH,_GVGDDQLGEES(ph)EERDDHLLPM(ox)_,S158,+,,24.43,24.43,,24.12,24.32,24.00,,24.17,24.19,23.83,,24.42,24.21, ,0.22,0.22, ,-0.10,0.11,-0.21, ,-0.04,-0.02,-0.38, ,0.20,endosome to lysosome transport;receptor-mediated endocytosis,endosome;late endosome;lysosomal membrane;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
1780,P20700,LMNB1,Lamin-B1,ALGDKKSLEGDLE,_S(ph)LEGDLEDLK_,S158,,21.74,,,,,,,,,22.61,,,,22.17,-0.44, , , , , , , , ,0.44, , , ,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
1784,P20719,HOXA5,Homeobox protein Hox-A5 (Homeobox protein Hox-1C),SVGRSGSGHFGSG,_SGS(ph)GHFGSGER_,S61,,,,,22.75,,,,,,,,,,22.75, , , ,0.00, , , , , , , , , ,"respiratory system process;mammary gland alveolus development;cell-cell signaling involved in mammary gland development;embryonic skeletal system morphogenesis;negative regulation of angiogenesis;intestinal epithelial cell maturation;negative regulation of erythrocyte differentiation;thyroid gland development;anterior/posterior pattern specification;lung-associated mesenchyme development;regulation of mammary gland epithelial cell proliferation;positive regulation of transcription from RNA polymerase II promoter;trachea cartilage morphogenesis;cell migration;lung alveolus development;positive regulation of receptor biosynthetic process;positive regulation of myeloid cell differentiation;multicellular organism growth;bronchiole development;mesenchymal-epithelial cell signaling;transcription, DNA-dependent;epithelial tube branching involved in lung morphogenesis;positive regulation of apoptotic process;lung goblet cell differentiation;mammary gland epithelial cell differentiation",nucleus,Homeobox,,,,,,,,,,,,,
1785,P20749,BCL3,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),RPLRAPSPEPAAP,_APS(ph)PEPAAPR_,S41,,22.78,,,,,,20.02,,,,,,,21.40,1.38, , , , , ,-1.38, , , , , , ,"T-helper 1 type immune response;negative regulation of apoptotic process;regulation of NF-kappaB import into nucleus;negative regulation of transcription, DNA-dependent;positive regulation of interleukin-10 biosynthetic process;maintenance of protein location in nucleus;positive regulation of translation;negative regulation of interleukin-8 biosynthetic process;spleen development;regulation of DNA binding;T-helper 2 cell differentiation;positive regulation of transcription from RNA polymerase II promoter;germinal center formation;humoral immune response mediated by circulating immunoglobulin;response to UV-C;response to virus;marginal zone B cell differentiation;extracellular matrix organization;protein import into nucleus, translocation;DNA damage response, signal transduction by p53 class mediator;I-kappaB kinase/NF-kappaB cascade;negative regulation of tumor necrosis factor biosynthetic process;positive regulation of transcription, DNA-dependent;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;defense response to bacterium;antimicrobial humoral response;transcription, DNA-dependent;defense response to protozoan;positive regulation of interferon-gamma production;follicular dendritic cell differentiation",Bcl3-Bcl10 complex;nucleus;Bcl3/NF-kappaB2 complex;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
1786,P20810,CAST,Calpastatin (Calpain inhibitor) (Sperm BS-17 component),SDFTCGSPTAAGK,_PIGPDDAIDALSSDFTCGS(ph)PTAAGK_,S285,,25.28,24.79,24.79,,,,,,,26.66,,,,25.38,-0.10,-0.59,-0.59, , , , , , ,1.28, , , ,,,,,,,,,,,,,,,,
1788,P20930,FLG,Filaggrin,GSHHEQSVDRSGH,_(gl)QGSHHEQS(ph)VDR_,S860,,18.70,21.80,,,,,20.50,,20.10,,,,,20.27,-1.57,1.53, , , , ,0.22, ,-0.18, , , , ,nucleoside triphosphate catabolic process;keratinocyte differentiation,intermediate filament;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
1789,P20962,PTMS,Parathymosin,_____MSEKSVEA,_(ac)S(ph)EKSVEAAAELSAK_,S2,,22.66,24.80,24.80,,23.22,22.24,,,,,,,,23.54,-0.88,1.25,1.25, ,-0.32,-1.30, , , , , , , ,DNA replication,cytosol;nucleus,,,,,,,,,,,,,,
1791,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),SDLQDISDSERKT,_DLLSDLQDIS(ph)DSER_,S258,,26.19,,,,25.24,23.85,,22.27,,24.95,,,,24.50,1.69, , , ,0.74,-0.65, ,-2.23, ,0.44, , , ,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,,,,,,,,,,
1792,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),LAREYGSPLKAYT,_VGDFGLAREYGS(ph)PLK_,S564,+,26.90,27.19,26.00,27.34,24.88,25.54,26.81,25.90,27.72,29.30,23.94,25.16,,26.39,0.51,0.80,-0.39,0.95,-1.51,-0.85,0.42,-0.49,1.33,2.91,-2.45,-1.23, ,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,,,,,,,,,,
1793,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),RVKRGTSPRPPEG,_RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK_,S727,+,24.92,24.44,25.15,22.79,22.07,25.62,25.72,24.75,27.04,27.26,,26.12,26.70,25.22,-0.30,-0.77,-0.07,-2.43,-3.15,0.41,0.50,-0.46,1.82,2.05, ,0.91,1.48,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,,,,,,,,,,
1796,P21291,CSRP1,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1),AGALVHSE_____,_GFGFGQGAGALVHS(ph)E_,S186,+,24.50,,,22.54,22.87,,22.22,23.75,,,23.13,23.97,,23.28,1.22, , ,-0.74,-0.42, ,-1.06,0.47, , ,-0.15,0.69, ,,nucleus,,,,,,,,,,,,,,
1798,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),QGGSAGSPARFTI,_AFGPGLQGGSAGS(ph)PAR_,S1084,+,23.20,23.05,23.05,25.69,26.31,24.39,24.01,26.19,,,23.18,24.86,22.16,24.19,-0.99,-1.14,-1.14,1.50,2.12,0.20,-0.18,2.00, , ,-1.01,0.67,-2.03,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1799,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),RRRRAPSVANVGS,_APS(ph)VANVGSHCDLSLK_,S2144,+,23.10,25.53,25.14,23.96,23.76,26.56,27.12,25.40,27.42,27.05,26.63,28.75,26.66,25.93,-2.83,-0.40,-0.79,-1.97,-2.17,0.63,1.19,-0.53,1.49,1.12,0.70,2.82,0.73,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1800,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),CSGPGLSPGMVRA,_CSGPGLS(ph)PGM(ox)VR_,S1459,+,21.55,23.28,22.15,23.81,22.53,,22.90,22.90,23.18,22.26,22.03,,21.46,22.55,-1.00,0.73,-0.40,1.26,-0.02, ,0.34,0.35,0.63,-0.29,-0.52, ,-1.09,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1801,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),DQHVPGSPFSVKV,_FADQHVPGS(ph)PFSVK_,S2120,+,19.75,20.15,,22.55,22.88,22.83,,22.68,23.02,,23.18,23.89,,22.32,-2.58,-2.18, ,0.22,0.56,0.50, ,0.36,0.69, ,0.86,1.56, ,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1802,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),GEHVPNSPFQVTA,_FGGEHVPNS(ph)PFQVTALAGDQPSVQPPLR_,S1726,,,,,23.71,24.64,,24.15,,25.54,24.92,,24.90,,24.64, , , ,-0.93,-0.01, ,-0.49, ,0.90,0.27, ,0.26, ,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1804,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),MTAQVTSPSGKTH,_IPEISIQDM(ox)TAQVTS(ph)PSGK_,S2172,+,23.38,24.27,,25.95,23.00,24.78,25.94,23.44,27.67,27.28,26.48,26.25,27.01,25.46,-2.07,-1.18, ,0.50,-2.45,-0.68,0.48,-2.01,2.22,1.82,1.02,0.80,1.55,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1807,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),PFSVAVSPSLDLS,_SPFSVAVS(ph)PSLDLSK_,S966,,,,,22.93,,22.82,,,24.83,,24.78,25.00,25.50,24.31, , , ,-1.38, ,-1.49, , ,0.52, ,0.48,0.69,1.19,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1808,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),SVAVSPSLDLSKI,_SPFSVAVSPS(ph)LDLSK_,S968,+,24.46,,,22.27,25.37,22.82,24.30,24.23,,24.60,26.14,,23.27,24.16,0.29, , ,-1.89,1.21,-1.34,0.13,0.07, ,0.44,1.98, ,-0.89,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1809,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),TVRYAPSEAGLHE,_YAPS(ph)EAGLHEM(ox)DIR_,S1827,,,,,23.51,,23.58,22.48,23.16,25.27,,22.92,23.85,23.84,23.57, , , ,-0.07, ,0.00,-1.10,-0.41,1.70, ,-0.66,0.27,0.26,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
1812,P21359,NF1,Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated],LLGTRKSFDHLIS,_S(ph)FDHLISDTK_,S2188,+,24.92,18.47,,23.05,,,25.86,24.34,,,24.06,24.77,,23.64,1.28,-5.17, ,-0.59, , ,2.22,0.70, , ,0.42,1.13, ,"MAPK cascade;negative regulation of cell-matrix adhesion;Ras protein signal transduction;metanephros development;liver development;negative regulation of fibroblast proliferation;negative regulation of cell migration;negative regulation of endothelial cell proliferation;myelination in peripheral nervous system;positive regulation of neuron apoptotic process;phosphatidylinositol 3-kinase cascade;regulation of angiogenesis;spinal cord development;camera-type eye morphogenesis;negative regulation of osteoclast differentiation;regulation of long-term neuronal synaptic plasticity;negative regulation of oligodendrocyte differentiation;heart development;regulation of blood vessel endothelial cell migration;negative regulation of astrocyte differentiation;negative regulation of neuroblast proliferation;adrenal gland development;negative regulation of angiogenesis;wound healing;negative regulation of neurotransmitter secretion;collagen fibril organization;forebrain morphogenesis;actin cytoskeleton organization;cerebral cortex development;negative regulation of MAP kinase activity;pigmentation;smooth muscle tissue development;negative regulation of Rac protein signal transduction;skeletal muscle tissue development;visual learning;sympathetic nervous system development;negative regulation of transcription factor import into nucleus;artery morphogenesis;regulation of synaptic transmission, GABAergic;forebrain astrocyte development;osteoblast differentiation;regulation of cell-matrix adhesion;response to hypoxia;neural tube development;regulation of bone resorption;positive regulation of endothelial cell proliferation;negative regulation of Ras protein signal transduction;positive regulation of adenylate cyclase activity",intrinsic to internal side of plasma membrane;axon;nucleus;dendrite;cytoplasm,,,,,,,,,,,,,,
1813,P21580,TNFAIP3,Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 3.4.19.12) (EC 6.3.2.-) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50;A20p37],AASGKVSPTASRF,_HFAAASGKVS(ph)PTASR_,S645,+,,23.68,23.68,,22.90,20.56,23.61,24.17,21.18,22.69,23.24,21.61,,22.73, ,0.94,0.94, ,0.17,-2.17,0.88,1.44,-1.55,-0.04,0.51,-1.12, ,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;negative regulation of B cell activation;inflammatory response;protein oligomerization;response to muramyl dipeptide;regulation of vascular wound healing;negative regulation of NF-kappaB transcription factor activity;positive regulation of hepatocyte proliferation;negative regulation of toll-like receptor 3 signaling pathway;negative regulation of smooth muscle cell proliferation;protein K48-linked ubiquitination;negative regulation of protein ubiquitination;proteolysis;negative regulation of interleukin-1 beta production;nucleotide-binding oligomerization domain containing signaling pathway;negative regulation of osteoclast proliferation;negative regulation of CD40 signaling pathway;negative regulation of bone resorption;tolerance induction to lipopolysaccharide;negative regulation of tumor necrosis factor production;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;protein K63-linked deubiquitination;negative regulation of chronic inflammatory response;regulation of germinal center formation;negative regulation of interleukin-6 production;negative regulation of endothelial cell apoptotic process;negative regulation of interleukin-2 production;negative regulation of I-kappaB kinase/NF-kappaB cascade;negative regulation of toll-like receptor 5 signaling pathway;positive regulation of protein catabolic process;regulation of defense response to virus by host;negative regulation of toll-like receptor 2 signaling pathway;negative regulation of type I interferon production;negative regulation of inflammatory response;innate immune response;B-1 B cell homeostasis;negative regulation of cyclin-dependent protein kinase activity,cytosol;nucleus;centrosome;lysosome,,,,,,,,,,,,,,
1814,P21580,TNFAIP3,Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 3.4.19.12) (EC 6.3.2.-) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50;A20p37],MLRSLESGSNFAP,_SLES(ph)GSNFAPLK_,S220,,23.80,,,,,,22.31,22.15,,23.68,24.08,,,23.20,0.60, , , , , ,-0.89,-1.05, ,0.47,0.87, , ,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway;negative regulation of B cell activation;inflammatory response;protein oligomerization;response to muramyl dipeptide;regulation of vascular wound healing;negative regulation of NF-kappaB transcription factor activity;positive regulation of hepatocyte proliferation;negative regulation of toll-like receptor 3 signaling pathway;negative regulation of smooth muscle cell proliferation;protein K48-linked ubiquitination;negative regulation of protein ubiquitination;proteolysis;negative regulation of interleukin-1 beta production;nucleotide-binding oligomerization domain containing signaling pathway;negative regulation of osteoclast proliferation;negative regulation of CD40 signaling pathway;negative regulation of bone resorption;tolerance induction to lipopolysaccharide;negative regulation of tumor necrosis factor production;negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway;protein K63-linked deubiquitination;negative regulation of chronic inflammatory response;regulation of germinal center formation;negative regulation of interleukin-6 production;negative regulation of endothelial cell apoptotic process;negative regulation of interleukin-2 production;negative regulation of I-kappaB kinase/NF-kappaB cascade;negative regulation of toll-like receptor 5 signaling pathway;positive regulation of protein catabolic process;regulation of defense response to virus by host;negative regulation of toll-like receptor 2 signaling pathway;negative regulation of type I interferon production;negative regulation of inflammatory response;innate immune response;B-1 B cell homeostasis;negative regulation of cyclin-dependent protein kinase activity,cytosol;nucleus;centrosome;lysosome,,,,,,,,,,,,,,
1815,P21709,EPHA1,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),VTLRLPSLSGSDG,_LPS(ph)LSGSDGIPYR_,S906,,21.72,,,,,,,,,,,,,21.72,0.00, , , , , , , , , , , , ,angiogenesis;protein autophosphorylation;positive regulation of stress fiber assembly;activation of Rho GTPase activity;regulation of Rac GTPase activity;positive regulation of angiogenesis;negative regulation of cell migration;peptidyl-tyrosine phosphorylation;positive regulation of cell migration;negative regulation of protein kinase activity;substrate adhesion-dependent cell spreading;positive regulation of cell proliferation;positive regulation of cell-matrix adhesion,integral to plasma membrane,,+,,,,,,,,,,,,
1816,P21709,EPHA1,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),LPSLSGSDGIPYR,_LPSLSGS(ph)DGIPYR_,S910,,22.10,,,,,,,,,,,,,22.10,0.00, , , , , , , , , , , , ,angiogenesis;protein autophosphorylation;positive regulation of stress fiber assembly;activation of Rho GTPase activity;regulation of Rac GTPase activity;positive regulation of angiogenesis;negative regulation of cell migration;peptidyl-tyrosine phosphorylation;positive regulation of cell migration;negative regulation of protein kinase activity;substrate adhesion-dependent cell spreading;positive regulation of cell proliferation;positive regulation of cell-matrix adhesion,integral to plasma membrane,,+,,,,,,,,,,,,
1817,P21730,C5AR1,C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88),NVLTEESVVRESK,_NVLTEES(ph)VVR_,S327,,,27.02,26.01,22.97,22.50,,,,,,,,,24.62, ,2.39,1.39,-1.66,-2.13, , , , , , , , ,sensory perception of chemical stimulus;immune response;activation of phospholipase C activity;activation of MAPK activity;neutrophil chemotaxis;chemotaxis;defense response to Gram-positive bacterium;cellular defense response;response to peptidoglycan;elevation of cytosolic calcium ion concentration,integral to plasma membrane,,,,,,,,,,,,,,
1820,P21731,TBXA2R,Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor),TRPRSLSLQPQLT,_SLS(ph)LQPQLTQR_,S331,+,,18.02,,22.50,,22.23,22.21,21.91,22.78,,,22.82,22.63,21.89, ,-3.87, ,0.61, ,0.34,0.32,0.02,0.89, , ,0.94,0.74,inflammatory response;platelet activation;response to drug;second-messenger-mediated signaling;positive regulation of blood pressure;positive regulation of angiogenesis;positive regulation of smooth muscle contraction;elevation of cytosolic calcium ion concentration;response to nutrient;response to lipopolysaccharide;positive regulation of vasoconstriction,acrosomal vesicle;integral to plasma membrane,,,,,,,,,,,,,,
1823,P21860,ERBB3,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),YLERGESIEPLDP,_GES(ph)IEPLDPSEK_,S43,,25.63,24.29,24.58,,,,,,,25.54,,22.51,,24.51,1.12,-0.22,0.07, , , , , , ,1.03, ,-2.00, ,negative regulation of signal transduction;mammary gland involution;wound healing;response to drug;Schwann cell differentiation;odontogenesis;circadian rhythm;cranial nerve development;axonogenesis;neuron apoptotic process;cellular response to insulin stimulus;skeletal muscle tissue development;positive regulation of glucose import;phosphatidylinositol 3-kinase cascade;negative regulation of secretion;endocardial cushion development;regulation of cell proliferation;positive regulation of phosphatidylinositol 3-kinase cascade;negative regulation of cell adhesion;transmembrane receptor protein tyrosine kinase signaling pathway;tongue development;heart development;negative regulation of neuron apoptotic process,basolateral plasma membrane;apical plasma membrane;receptor complex;lateral plasma membrane;extracellular space;nucleus;integral to plasma membrane;postsynaptic membrane,,+,,,,,,,,,,,,
1824,P21964,COMT,Catechol O-methyltransferase (EC 2.1.1.6),IYKGPGSEAGP__,_AIYKGPGS(ph)EAGP_,S217,,22.90,24.38,,25.26,25.43,26.46,23.84,25.07,24.73,23.24,,,,24.59,-1.69,-0.21, ,0.67,0.84,1.87,-0.75,0.48,0.14,-1.35, , , ,negative regulation of dopamine metabolic process;response to drug;dopamine catabolic process;positive regulation of homocysteine metabolic process;negative regulation of smooth muscle cell proliferation;response to pain;multicellular organismal reproductive process;response to lipopolysaccharide;estrogen metabolic process;small molecule metabolic process;neurotransmitter biosynthetic process;xenobiotic metabolic process;female pregnancy;neurotransmitter catabolic process;response to organic cyclic compound;learning,cytosol;mitochondrion;intracellular membrane-bounded organelle;integral to membrane;plasma membrane,,,,,,,,,,,,,,
1825,P21980,TGM2,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2),DCSRRSSPVYVGR,_RSS(ph)PVYVGR_,S216,+,,23.94,24.01,,23.65,22.90,22.94,24.40,,,25.66,21.44,21.69,23.40, ,0.53,0.61, ,0.25,-0.51,-0.47,1.00, , ,2.26,-1.96,-1.71,positive regulation of inflammatory response;salivary gland cavitation;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;apoptotic cell clearance;positive regulation of cell adhesion;induction of apoptosis;branching involved in salivary gland morphogenesis;blood vessel remodeling;positive regulation of I-kappaB kinase/NF-kappaB cascade;protein homooligomerization;elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway;positive regulation of smooth muscle cell proliferation,mitochondrion;plasma membrane,,,,,,,,,,,,,,
1826,P22059,OSBP,Oxysterol-binding protein 1,SGKGDMSDEDDEN,_GDM(ox)S(ph)DEDDENEFFDAPEIITM(ox)PENLGHK_,S351,,25.18,,,,,,,,,,,,,25.18,0.00, , , , , , , , , , , , ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1827,P22059,OSBP,Oxysterol-binding protein 1,VKMLAESDESGDE,_MLAES(ph)DES(ph)GDEESVSQTDK_,S190,,27.65,24.94,25.40,24.63,,,,,23.43,22.80,,,,24.81,2.84,0.13,0.59,-0.18, , , , ,-1.38,-2.01, , , ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1828,P22059,OSBP,Oxysterol-binding protein 1,LAESDESGDEESV,_MLAES(ph)DES(ph)GDEESVSQTDK_,S193,+,27.84,25.73,25.88,25.49,24.16,,24.71,24.03,23.43,24.50,23.59,,,24.93,2.90,0.79,0.94,0.56,-0.78, ,-0.23,-0.91,-1.50,-0.44,-1.35, , ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1829,P22059,OSBP,Oxysterol-binding protein 1,GHKRTGSNISGAS,_RTGS(ph)NIS(ph)GASSDISLDEQYK_,S379,,24.67,,,,,,,,,,,25.60,,25.14,-0.47, , , , , , , , , , ,0.47, ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1830,P22059,OSBP,Oxysterol-binding protein 1,RTGSNISGASSDI,_RTGS(ph)NIS(ph)GASSDISLDEQYK_,S382,,24.67,,,,,,,,,,,,,24.67,0.00, , , , , , , , , , , , ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1831,P22059,OSBP,Oxysterol-binding protein 1,ALQRSLSELESLK,_SLS(ph)ELESLK_,S240,+,23.81,22.88,22.77,22.49,25.73,,22.89,24.13,24.81,24.00,22.78,23.55,,23.62,0.19,-0.74,-0.85,-1.13,2.11, ,-0.74,0.51,1.19,0.38,-0.84,-0.07, ,lipid transport,Golgi membrane,,,,,,,,,,,,,,
1833,P22223,CDH3,Cadherin-3 (Placental cadherin) (P-cadherin),TYDVHLSLSDHGN,_(gl)QDTYDVHLS(ph)LSDHGNK_,S565,,25.65,25.53,26.33,24.27,24.59,23.90,26.31,25.15,26.73,26.48,24.98,25.21,,25.43,0.23,0.10,0.90,-1.15,-0.84,-1.53,0.88,-0.28,1.30,1.05,-0.44,-0.22, ,response to stimulus;adherens junction organization;visual perception;homophilic cell adhesion;cell adhesion;cell junction assembly,integral to membrane;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
1834,P22234,PAICS,Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase);Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)],VYELLDSPGKVLL,_TKEVYELLDS(ph)PGK_,S27,+,22.41,22.21,23.02,22.85,22.73,,25.00,23.10,23.55,23.46,,24.13,23.81,23.30,-0.89,-1.09,-0.28,-0.45,-0.56, ,1.70,-0.19,0.25,0.16, ,0.84,0.51,purine ribonucleoside monophosphate biosynthetic process;purine nucleobase biosynthetic process;'de novo' IMP biosynthetic process,cytosol,,,,,,,,,,,,,,
1835,P22234,PAICS,Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase);Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)],RRIATGSFLKRNP,_IATGS(ph)FLK_,S107,+,20.45,21.26,21.02,21.85,21.82,21.30,22.08,22.89,20.82,,21.61,,,21.51,-1.06,-0.25,-0.49,0.34,0.31,-0.21,0.57,1.38,-0.69, ,0.09, , ,purine ribonucleoside monophosphate biosynthetic process;purine nucleobase biosynthetic process;'de novo' IMP biosynthetic process,cytosol,,,,,,,,,,,,,,
1836,P22314,UBA1,Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1),GMAKNGSEADIDE,_NGS(ph)EADIDEGLYSR_,S46,+,24.78,24.06,23.28,25.45,24.47,25.19,25.89,25.21,25.17,23.76,25.50,25.49,25.77,24.93,-0.14,-0.87,-1.64,0.52,-0.45,0.26,0.96,0.28,0.25,-1.17,0.58,0.57,0.85,cell death;protein ubiquitination,,,,,,,,,,,,,,,
1837,P22314,UBA1,Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1),___MSSSPLSKKR,_(ac)SSS(ph)PLSKK_,S4,+,22.78,24.66,24.46,24.50,23.74,,,24.16,,,,22.05,23.22,23.70,-0.91,0.97,0.76,0.81,0.04, , ,0.46, , , ,-1.65,-0.48,cell death;protein ubiquitination,,,,,,,,,,,,,,,
1839,P22466,GAL,Galanin peptides [Cleaved into: Galanin;Galanin message-associated peptide (GMAP)],DLPAAASSEDIER,_LLDLPAAAS(ph)SEDIERS_,S116,,23.46,,,,,,,,,,,,,23.46,0.00, , , , , , , , , , , , ,neuropeptide signaling pathway;insulin secretion;inflammatory response;smooth muscle contraction;response to drug;regulation of glucocorticoid metabolic process;growth hormone secretion;response to insulin stimulus;response to estrogen stimulus;negative regulation of lymphocyte proliferation;feeding behavior;positive regulation of apoptotic process;nervous system development,secretory granule;extracellular region;Golgi apparatus,,,,,,,,,,,,,,
1841,P22626,HNRNPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),SNFRGGSDGYGSG,_GGGGNFGPGPGSNFRGGS(ph)DGYGSGR_,S231,+,,,,,24.62,24.01,23.18,23.05,23.90,,22.14,22.19,23.06,23.27, , , , ,1.35,0.74,-0.09,-0.22,0.63, ,-1.13,-1.08,-0.21,"RNA transport;mRNA splicing, via spliceosome",nucleoplasm;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
1842,P22626,HNRNPA2B1,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),PGGSGGSGGYGGR,_NM(ox)GGPYGGGNYGPGGSGGS(ph)GGYGGR_,S344,+,22.93,23.02,22.97,24.21,24.71,24.93,24.38,24.52,25.45,24.84,,,,24.20,-1.26,-1.17,-1.23,0.01,0.52,0.73,0.18,0.33,1.25,0.65, , , ,"RNA transport;mRNA splicing, via spliceosome",nucleoplasm;nucleolus;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
1844,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),RPVSRGSGVNAAG,_RPVS(ph)RGS(ph)GVNAAGDGTIR_,S95,,28.19,26.96,24.53,22.27,24.02,,24.00,26.52,,,24.48,22.83,,24.87,3.33,2.09,-0.34,-2.59,-0.85, ,-0.86,1.65, , ,-0.39,-2.04, ,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
1845,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),DSRRPVSRGSGVN,_RPVS(ph)RGS(ph)GVNAAGDGTIR_,S92,+,25.60,25.56,23.49,22.27,23.05,22.32,23.56,26.40,,,21.08,22.29,20.63,23.29,2.30,2.26,0.20,-1.02,-0.25,-0.98,0.27,3.11, , ,-2.22,-1.00,-2.67,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
1846,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),QPPTTPSPEPEPE,_WGGNPLQPPTT(ph)PS(ph)PEPEPEPDGR_,S24,+,29.60,22.23,22.23,,27.58,24.00,27.65,27.50,,,27.60,,28.10,26.28,3.32,-4.04,-4.04, ,1.30,-2.28,1.38,1.22, , ,1.33, ,1.82,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
1847,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),PEPDGRSRRGGGR,_WGGNPLQPPTTPS(ph)PEPEPEPDGRS(ph)R_,S35,,27.14,,,,,,25.81,,,,25.74,25.66,26.11,26.09,1.04, , , , , ,-0.28, , , ,-0.36,-0.43,0.02,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
1848,Q92570,NR4A3,Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1),EVVRTDSLKGRRG,_EVVRTDS(ph)LK_,S119,,24.91,,,,,,,,,,,20.78,,22.85,2.07, , , , , , , , , , ,-2.07, ,transcription initiation from RNA polymerase II promoter;semicircular canal morphogenesis;cellular response to stress;positive regulation of cell cycle;neuromuscular process controlling balance;axon guidance;vestibular reflex;positive regulation of leukocyte apoptotic process;adult behavior;response to peptide hormone stimulus;hippocampus development;organ regeneration;negative regulation of neuron apoptotic process;mesoderm formation,nucleoplasm;transcription factor complex,NR C4-type,,,,,,,,,,,,,
1850,P23229,ITGA6,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain;Integrin alpha-6 light chain],EIHAQPSDKERLT,_AEIHAQPS(ph)DK_,S1059,,25.14,22.55,22.69,22.20,,,21.73,,,20.44,,18.92,,21.95,3.19,0.60,0.74,0.25, , ,-0.23, , ,-1.52, ,-3.03, ,negative regulation of apoptotic process;hemidesmosome assembly;blood coagulation;cell adhesion;positive regulation of phosphorylation;integrin-mediated signaling pathway;positive regulation of apoptotic process;positive regulation of transcription from RNA polymerase II promoter;leukocyte migration,integrin complex;plasma membrane,,,,,,,,,,+,,,,
1852,P23381,WARS,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS;T2-TrpRS]",MTPRKLSFDFQ__,_KLS(ph)FDFQ_,S467,+,27.46,24.38,25.03,24.46,26.67,25.49,26.54,28.15,25.94,26.33,25.23,26.86,24.88,25.96,1.50,-1.57,-0.93,-1.49,0.72,-0.47,0.59,2.20,-0.02,0.37,-0.73,0.91,-1.07,regulation of angiogenesis;negative regulation of cell proliferation;angiogenesis;tryptophanyl-tRNA aminoacylation,cytosol,,,,,,,,,,,,,,
1854,P23443,RPS6KB1,Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),PRRFIGSPRTPVS,_FIGS(ph)PRT(ph)PVS(ph)PVK_,S388,,22.97,22.71,,23.62,,,,20.50,,,,,,22.45,0.52,0.26, ,1.17, , , ,-1.95, , , , , ,negative regulation of apoptotic process;long-term memory;germ cell development;response to toxin;TOR signaling cascade;response to electrical stimulus involved in regulation of muscle adaptation;insulin receptor signaling pathway;response to mechanical stimulus;response to lipopolysaccharide;positive regulation of translational initiation;response to leucine;cell migration;response to glucagon stimulus;response to glucose stimulus;regulation of glucose import;protein kinase B signaling cascade;positive regulation of smooth muscle cell migration;response to tumor necrosis factor;positive regulation of mitotic cell cycle;aging;response to drug;response to wounding;G1/S transition of mitotic cell cycle;response to testosterone stimulus;positive regulation of skeletal muscle tissue growth;apoptotic process;cellular response to growth factor stimulus;response to ethanol;response to nutrient;phosphatidylinositol-mediated signaling;negative regulation of insulin receptor signaling pathway;skeletal muscle contraction;skeletal muscle atrophy;response to glucocorticoid stimulus;response to heat;positive regulation of smooth muscle cell proliferation,mitochondrion;perinuclear region of cytoplasm;cytoplasm;cytosol;mitochondrial outer membrane;neuron projection;synapse;cell junction;nucleus;cell surface,,+,,,,,,,,,,,,
1855,P23443,RPS6KB1,Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),SPRTPVSPVKFSP,_FIGS(ph)PRT(ph)PVS(ph)PVK_,S394,,22.32,,,,,,,,,,,,,22.32,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;long-term memory;germ cell development;response to toxin;TOR signaling cascade;response to electrical stimulus involved in regulation of muscle adaptation;insulin receptor signaling pathway;response to mechanical stimulus;response to lipopolysaccharide;positive regulation of translational initiation;response to leucine;cell migration;response to glucagon stimulus;response to glucose stimulus;regulation of glucose import;protein kinase B signaling cascade;positive regulation of smooth muscle cell migration;response to tumor necrosis factor;positive regulation of mitotic cell cycle;aging;response to drug;response to wounding;G1/S transition of mitotic cell cycle;response to testosterone stimulus;positive regulation of skeletal muscle tissue growth;apoptotic process;cellular response to growth factor stimulus;response to ethanol;response to nutrient;phosphatidylinositol-mediated signaling;negative regulation of insulin receptor signaling pathway;skeletal muscle contraction;skeletal muscle atrophy;response to glucocorticoid stimulus;response to heat;positive regulation of smooth muscle cell proliferation,mitochondrion;perinuclear region of cytoplasm;cytoplasm;cytosol;mitochondrial outer membrane;neuron projection;synapse;cell junction;nucleus;cell surface,,+,,,,,,,,,,,,
1856,P23470,PTPRG,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),KEKNRNSSVVPSE,_NRNS(ph)SVVPSER_,S1153,,,,,23.96,22.25,,,,22.32,21.98,20.86,20.79,,22.03, , , ,1.94,0.22, , , ,0.30,-0.05,-1.17,-1.24, ,transmembrane receptor protein tyrosine kinase signaling pathway,integral to plasma membrane,,,+,,,,,,,,,,,
1857,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),KLPLQESEEEERE,_LPLQES(ph)EEEEREER_,S121,+,,27.90,27.60,,25.60,,25.76,,27.01,,27.07,27.46,24.69,26.64, ,1.26,0.97, ,-1.04, ,-0.87, ,0.37, ,0.43,0.83,-1.95,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1858,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),LSTFRESFKKRVI,_LSTFRES(ph)FKK_,S358,,,,,23.21,,,,,,,,25.66,,24.44, , , ,-1.22, , , , , , , ,1.22, ,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1859,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),GQDHDFSESSEEE,_RVIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_,S371,,24.53,,,,24.99,26.06,,,25.50,24.10,,,,25.04,-0.50, , , ,-0.05,1.02, , ,0.46,-0.93, , , ,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1860,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),DHDFSESSEEEAP,_RVIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_,S373,,25.26,,,,,,,26.23,,24.98,,,24.65,25.28,-0.02, , , , , , ,0.95, ,-0.30, , ,-0.63,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1861,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),HDFSESSEEEAPA,_RVIGQDHDFS(ph)ES(ph)S(ph)EEEAPAEASSGALR_,S374,+,25.03,,,,27.37,27.29,25.91,,27.29,24.98,,,25.99,26.27,-1.23, , , ,1.11,1.02,-0.36, ,1.02,-1.29, , ,-0.28,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1862,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),FISAPRSEPVINN,_S(ph)EPVINNDNPLESNDEK_,S314,,,,,23.40,,,,,,,,,22.70,23.05, , , ,0.35, , , , , , , , ,-0.35,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1863,P23497,SP100,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),NDNPLESNDEKEG,_SEPVINNDNPLES(ph)NDEK_,S326,+,26.08,27.44,28.09,27.81,25.09,26.67,27.80,25.18,29.19,27.99,27.15,27.60,24.06,26.93,-0.85,0.50,1.15,0.87,-1.84,-0.26,0.87,-1.75,2.26,1.05,0.22,0.67,-2.87,"retinoic acid receptor signaling pathway;negative regulation of viral transcription;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;virus-host interaction;type I interferon-mediated signaling pathway;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cellular component movement;response to type I interferon;response to cytokine stimulus",nuclear periphery;PML body;nucleolus;cytoplasm,HMG-box,,,,,,,,,,,,,
1864,P23528,CFL1,"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)",____MASGVAVSD,_(ac)AS(ph)GVAVSDGVIK_,S3,+,28.50,29.18,29.14,29.93,28.73,30.61,29.50,29.69,29.78,28.14,29.80,30.79,29.62,29.49,-1.00,-0.31,-0.36,0.44,-0.76,1.12,0.01,0.20,0.28,-1.35,0.31,1.30,0.13,platelet degranulation;negative regulation of apoptotic process;response to amino acid stimulus;actin cytoskeleton organization;actin filament organization;establishment of cell polarity;cytokinesis;platelet activation;positive regulation of actin filament depolymerization;response to virus;neural fold formation;protein phosphorylation;neural crest cell migration;axon guidance;Rho protein signal transduction;regulation of cell morphogenesis,ruffle membrane;lamellipodium membrane;cortical actin cytoskeleton;nucleus;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
1865,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),GRRAFGSGYRRDD,_AFGS(ph)GYR_,S283,,25.48,,,23.77,,,,,,,,,,24.63,0.85, , ,-0.85, , , , , , , , , ,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
1870,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),RSRLPKSPPYTAF,_S(ph)PPYTAFLGNLPYDVTEESIK_,S93,+,27.51,24.29,24.29,23.88,,,25.09,,24.09,26.70,24.94,25.95,,25.19,2.31,-0.90,-0.90,-1.32, , ,-0.11, ,-1.11,1.51,-0.25,0.76, ,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
1873,P23588,EIF4B,Eukaryotic translation initiation factor 4B (eIF-4B),RTGSESSQTGTST,_SRTGS(ph)ESS(ph)QTGTSTTSSR_,S425,,22.72,23.69,23.69,,,,,,,,,,,23.37,-0.64,0.32,0.32, , , , , , , , , , ,insulin receptor signaling pathway;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
1874,P24385,CCND1,G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene),EETCAPSVSYFKC,_AEETCAPS(ph)VSYFKCVQK_,S41,,22.56,26.33,26.33,24.71,24.40,,24.68,,,25.10,,23.70,22.53,24.48,-1.92,1.85,1.85,0.23,-0.08, ,0.19, , ,0.62, ,-0.79,-1.95,S phase of mitotic cell cycle;positive regulation of cyclin-dependent protein kinase activity;mammary gland alveolus development;G1 phase of mitotic cell cycle;fat cell differentiation;response to drug;liver development;Leydig cell differentiation;G1/S transition of mitotic cell cycle;mitotic cell cycle G1/S transition DNA damage checkpoint;response to organic nitrogen;response to estrogen stimulus;response to magnesium ion;response to ethanol;cell division;negative regulation of epithelial cell differentiation;positive regulation of mammary gland epithelial cell proliferation;response to calcium ion;re-entry into mitotic cell cycle;response to corticosterone stimulus;canonical Wnt receptor signaling pathway;endoplasmic reticulum unfolded protein response;response to UV-A;response to X-ray;organ regeneration;negative regulation of Wnt receptor signaling pathway;response to iron ion;lactation;response to vitamin E;mammary gland epithelial cell proliferation,nucleoplasm;cytosol;cyclin-dependent protein kinase holoenzyme complex;membrane,,,,,,,,,,,,,,
1876,P33947,KDELR2,ER lumen protein retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2),LKGKKLSLPA___,_KLS(ph)LPA_,S147,,22.50,23.60,23.68,23.16,23.10,24.90,23.03,23.12,24.74,23.38,23.12,22.94,24.38,23.51,-1.01,0.09,0.17,-0.35,-0.41,1.38,-0.48,-0.39,1.23,-0.13,-0.39,-0.58,0.87,protein retention in ER lumen;intracellular protein transport;vesicle-mediated transport,integral to membrane;Golgi apparatus;endoplasmic reticulum;endoplasmic reticulum membrane;cis-Golgi network,,,,,,,,,,,,,,
1877,P24534,EEF1B2,Elongation factor 1-beta (EF-1-beta),DIDLFGSDDEEES,_DDDDIDLFGS(ph)DDEEESEEAK_,S106,,29.61,,,,29.73,,,,,26.84,,25.69,,27.97,1.64, , , ,1.76, , , , ,-1.13, ,-2.28, ,,cytosol;eukaryotic translation elongation factor 1 complex,,,,,,,,,,,,,,
1878,P24534,EEF1B2,Elongation factor 1-beta (EF-1-beta),GFGDLKSPAGLQV,_S(ph)PAGLQVLNDYLADK_,S8,,21.72,,,,,,,,,,,,,21.72,0.00, , , , , , , , , , , , ,,cytosol;eukaryotic translation elongation factor 1 complex,,,,,,,,,,,,,,
1882,P24534,EEF1B2,Elongation factor 1-beta (EF-1-beta),GSGATDSKDDDDI,_YGPADVEDTTGSGATDS(ph)K_,S95,+,27.36,23.10,23.76,23.70,,24.92,22.55,,,22.70,,21.50,,23.70,3.66,-0.59,0.06,0.00, ,1.22,-1.15, , ,-1.00, ,-2.20, ,,cytosol;eukaryotic translation elongation factor 1 complex,,,,,,,,,,,,,,
1883,P24723,PRKCH,Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta),DEFRNFSYVSPEL,_NFS(ph)YVSPELQP_,S243,+,22.70,,,,24.25,22.33,,20.76,22.84,22.82,22.94,,23.24,22.73,-0.04, , , ,1.51,-0.40, ,-1.98,0.11,0.08,0.20, ,0.51,negative regulation of glial cell apoptotic process;platelet activation;positive regulation of glial cell proliferation;positive regulation of B cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;positive regulation of keratinocyte differentiation;regulation of tight junction assembly;signal transduction;positive regulation of macrophage derived foam cell differentiation;intracellular signal transduction,cytosol;plasma membrane,,+,,,,,,,,,,,,
1886,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PKYSPTSPTYSPT,_YSPTS(ph)PTYSPTSPK_,S1913,+,26.34,25.55,25.36,25.85,24.46,24.12,24.03,23.76,24.95,25.02,23.44,25.96,,24.90,1.43,0.65,0.46,0.94,-0.45,-0.79,-0.88,-1.14,0.05,0.12,-1.46,1.06, ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
1887,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PTSPTYSPTSPKY,_YSPTSPTYS(ph)PTSPK_,S1917,,24.66,23.53,23.80,23.37,,,,,23.12,22.38,,,,23.48,1.18,0.05,0.32,-0.11, , , , ,-0.35,-1.09, , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
1889,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PKYSPTSPTYSPT,_YSPTS(ph)PTYSPTSPVYTPT(ph)SPK_,S1892,,24.58,,,,,,22.71,,,,,,,23.64,0.93, , , , , ,-0.93, , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
1891,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PKYSPTSPTYSPT,_YSPTS(ph)PTYSPTTPK_,S1878,+,25.44,23.20,23.46,24.17,24.95,25.22,24.58,23.30,24.87,24.97,,,,24.42,1.03,-1.21,-0.96,-0.25,0.53,0.81,0.17,-1.12,0.45,0.55, , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
1892,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),PTSPTYSPTTPKY,_YSPTS(ph)PTYS(ph)PTTPK_,S1882,,23.28,22.94,22.97,22.74,,,,,,,,,,22.98,0.30,-0.05,-0.01,-0.24, , , , , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
1895,P25054,APC,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),PSIESYSEDDESK,_PSIESYS(ph)EDDESK_,S886,,21.34,22.76,22.76,24.01,,,22.66,,,23.42,,21.99,,22.71,-1.36,0.06,0.06,1.31, , ,-0.05, , ,0.71, ,-0.72, ,pancreas development;negative regulation of apoptotic process;negative regulation of cell proliferation;retina development in camera-type eye;negative regulation of MAPK cascade;kidney development;T cell differentiation in thymus;regulation of attachment of spindle microtubules to kinetochore;mitotic metaphase/anaphase transition;axonogenesis;skin development;cytokinesis after mitosis;regulation of nitrogen compound metabolic process;cell migration;dorsal/ventral pattern formation;negative regulation of epithelial cell proliferation involved in prostate gland development;positive regulation of microtubule polymerization;regulation of osteoblast differentiation;canonical Wnt receptor signaling pathway;chromosome organization;negative regulation of microtubule depolymerization;proximal/distal pattern formation;tight junction assembly;muscle cell homeostasis;positive regulation of cell division;somatic stem cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;response to drug;cellular component disassembly involved in execution phase of apoptosis;mitotic cell cycle spindle assembly checkpoint;regulation of osteoclast differentiation;hair follicle development;positive regulation of cell migration;anterior/posterior pattern specification;positive regulation of protein catabolic process;cell cycle arrest;establishment or maintenance of cell polarity;positive regulation of epithelial cell differentiation;negative regulation of odontogenesis;axis specification;protein complex assembly;response to DNA damage stimulus;thymus development;positive regulation of cell adhesion;negative regulation of cyclin-dependent protein kinase activity;positive regulation of pseudopodium assembly;cell adhesion;cytoplasmic microtubule organization;positive regulation of apoptotic process,neuronal cell body;microtubule plus end;lateral plasma membrane;centrosome;axonal growth cone;tight junction;ruffle membrane;cytosol;adherens junction;synapse;cytoplasmic microtubule;nucleus;lamellipodium;beta-catenin destruction complex;kinetochore,,,,,,,,,,+,,,,
1896,P25054,APC,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),SVKSELSPVARQT,_SELS(ph)PVAR_,S2182,+,23.13,22.52,22.15,24.12,22.79,,22.15,22.14,,,,,,22.71,0.42,-0.19,-0.56,1.41,0.07, ,-0.57,-0.58, , , , , ,pancreas development;negative regulation of apoptotic process;negative regulation of cell proliferation;retina development in camera-type eye;negative regulation of MAPK cascade;kidney development;T cell differentiation in thymus;regulation of attachment of spindle microtubules to kinetochore;mitotic metaphase/anaphase transition;axonogenesis;skin development;cytokinesis after mitosis;regulation of nitrogen compound metabolic process;cell migration;dorsal/ventral pattern formation;negative regulation of epithelial cell proliferation involved in prostate gland development;positive regulation of microtubule polymerization;regulation of osteoblast differentiation;canonical Wnt receptor signaling pathway;chromosome organization;negative regulation of microtubule depolymerization;proximal/distal pattern formation;tight junction assembly;muscle cell homeostasis;positive regulation of cell division;somatic stem cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;response to drug;cellular component disassembly involved in execution phase of apoptosis;mitotic cell cycle spindle assembly checkpoint;regulation of osteoclast differentiation;hair follicle development;positive regulation of cell migration;anterior/posterior pattern specification;positive regulation of protein catabolic process;cell cycle arrest;establishment or maintenance of cell polarity;positive regulation of epithelial cell differentiation;negative regulation of odontogenesis;axis specification;protein complex assembly;response to DNA damage stimulus;thymus development;positive regulation of cell adhesion;negative regulation of cyclin-dependent protein kinase activity;positive regulation of pseudopodium assembly;cell adhesion;cytoplasmic microtubule organization;positive regulation of apoptotic process,neuronal cell body;microtubule plus end;lateral plasma membrane;centrosome;axonal growth cone;tight junction;ruffle membrane;cytosol;adherens junction;synapse;cytoplasmic microtubule;nucleus;lamellipodium;beta-catenin destruction complex;kinetochore,,,,,,,,,,+,,,,
1897,P25054,APC,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),LNSGRQSPSQNER,_YSDEQLNSGRQS(ph)PSQNER_,S941,,,,,,24.11,,,24.38,24.21,23.68,23.64,,,24.00, , , , ,0.11, , ,0.38,0.21,-0.33,-0.36, , ,pancreas development;negative regulation of apoptotic process;negative regulation of cell proliferation;retina development in camera-type eye;negative regulation of MAPK cascade;kidney development;T cell differentiation in thymus;regulation of attachment of spindle microtubules to kinetochore;mitotic metaphase/anaphase transition;axonogenesis;skin development;cytokinesis after mitosis;regulation of nitrogen compound metabolic process;cell migration;dorsal/ventral pattern formation;negative regulation of epithelial cell proliferation involved in prostate gland development;positive regulation of microtubule polymerization;regulation of osteoblast differentiation;canonical Wnt receptor signaling pathway;chromosome organization;negative regulation of microtubule depolymerization;proximal/distal pattern formation;tight junction assembly;muscle cell homeostasis;positive regulation of cell division;somatic stem cell maintenance;negative regulation of canonical Wnt receptor signaling pathway;response to drug;cellular component disassembly involved in execution phase of apoptosis;mitotic cell cycle spindle assembly checkpoint;regulation of osteoclast differentiation;hair follicle development;positive regulation of cell migration;anterior/posterior pattern specification;positive regulation of protein catabolic process;cell cycle arrest;establishment or maintenance of cell polarity;positive regulation of epithelial cell differentiation;negative regulation of odontogenesis;axis specification;protein complex assembly;response to DNA damage stimulus;thymus development;positive regulation of cell adhesion;negative regulation of cyclin-dependent protein kinase activity;positive regulation of pseudopodium assembly;cell adhesion;cytoplasmic microtubule organization;positive regulation of apoptotic process,neuronal cell body;microtubule plus end;lateral plasma membrane;centrosome;axonal growth cone;tight junction;ruffle membrane;cytosol;adherens junction;synapse;cytoplasmic microtubule;nucleus;lamellipodium;beta-catenin destruction complex;kinetochore,,,,,,,,,,+,,,,
1898,P25098,ADRBK1,Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2),PLVQRGSANGL__,_VPLVQRGS(ph)ANGL_,S356,,22.60,21.29,21.29,,,,,,,,,,,21.73,0.87,-0.44,-0.44, , , , , , , , , , ,fibroblast growth factor receptor signaling pathway;aging;peptidyl-serine phosphorylation;cardiac muscle contraction;G-protein coupled acetylcholine receptor signaling pathway;negative regulation of the force of heart contraction by chemical signal;negative regulation of striated muscle contraction;activation of phospholipase C activity;positive regulation of catecholamine secretion;receptor internalization;tachykinin receptor signaling pathway;termination of G-protein coupled receptor signaling pathway;follicle-stimulating hormone signaling pathway;epidermal growth factor receptor signaling pathway;response to hydrogen peroxide;desensitization of G-protein coupled receptor protein signaling pathway;nerve growth factor receptor signaling pathway;response to organic cyclic compound;heart development;peptidyl-threonine phosphorylation,axon;basolateral plasma membrane;apical plasma membrane;caveola;cytosol;dendritic spine;synapse;plasma membrane;dendritic shaft,,+,,,,,,,,,,,,
1901,P25205,MCM3,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),YDPYDFSDTEEEM,_DGDSYDPYDFS(ph)DTEEEM(ox)PQVHTPK_,S711,+,27.08,,,,27.41,,25.37,24.65,26.34,27.52,23.71,26.65,25.19,25.99,1.09, , , ,1.42, ,-0.62,-1.34,0.35,1.53,-2.28,0.66,-0.80,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;alpha DNA polymerase:primase complex;centrosome;perinuclear region of cytoplasm;MCM complex,,,,,,,,,,,,,,
1905,P25440,BRD2,Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein),LPTGYDSEEEEES,_TAPPALPTGYDS(ph)EEEEESRPM(ox)SYDEK_,S513,+,25.33,,,,25.47,24.71,25.18,23.86,25.48,25.92,23.74,,24.44,24.90,0.43, , , ,0.56,-0.20,0.27,-1.05,0.58,1.02,-1.16, ,-0.46,"spermatogenesis;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;nucleosome assembly;chromatin modification",nucleus;cytoplasm,,+,,,,,,,,,,,,
1907,P25445,FAS,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),NQGSHESPTLNPE,_ENQGSHES(ph)PTLNPETVAINLSDVDLSK_,S191,,,,,,,,25.39,25.21,25.82,28.71,26.24,,,26.27, , , , , , ,-0.88,-1.06,-0.45,2.43,-0.04, , ,negative regulation of apoptotic process;negative regulation of B cell activation;renal system process;response to toxin;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of necrotic cell death;negative thymic T cell selection;activation-induced cell death of T cells;cellular response to lithium ion;cellular response to mechanical stimulus;response to peptide hormone stimulus;response to growth factor stimulus;response to estrogen stimulus;neuron apoptotic process;spleen development;gene expression;response to lipopolysaccharide;B cell mediated immunity;cellular response to hyperoxia;inflammatory cell apoptotic process;transformed cell apoptotic process;regulation of cell proliferation;immunoglobulin production;aging;positive regulation of protein homooligomerization;response to drug;extrinsic apoptotic signaling pathway via death domain receptors;spermatogenesis;ovulation cycle;regulation of lymphocyte differentiation;regulation of myeloid cell differentiation;dendrite regeneration;protein complex assembly;response to hypoxia;response to glucocorticoid stimulus;protein homooligomerization,membrane raft;external side of plasma membrane;perinuclear region of cytoplasm;CD95 death-inducing signaling complex;cytosol;extracellular region;integral to membrane;nucleus,,,,,,,,,,,,,,
1908,P25490,YY1,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),VVGGDDSDGLRAE,_EEVVGGDDS(ph)DGLR_,S118,,23.91,23.14,23.40,,,,,,,,,,,23.48,0.42,-0.34,-0.08, , , , , , , , , , ,cellular response to UV;cell differentiation;response to UV-C;camera-type eye morphogenesis;spermatogenesis;RNA localization;anterior/posterior pattern specification;chromosome organization;double-strand break repair via homologous recombination,transcription factor complex;plasma membrane;PcG protein complex;nuclear matrix;Ino80 complex,C2H2-type,,,,,,,,,,,,,
1910,P25788,PSMA3,Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),LKEEDESDDDNM_,_YAKESLKEEDES(ph)DDDNM(ox)_,S243,+,28.79,27.75,25.81,30.45,30.78,29.00,29.21,29.94,29.52,28.06,27.52,28.42,26.59,28.60,0.19,-0.86,-2.80,1.84,2.17,0.40,0.61,1.34,0.92,-0.54,-1.08,-0.18,-2.01,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination","proteasome core complex;nucleoplasm;cytosol;proteasome core complex, alpha-subunit complex",,,,,,,,,,,,,,
1911,P25929,NPY1R,Neuropeptide Y receptor type 1 (NPY1-R),TSLKQASPVAFKK,_(gl)QAS(ph)PVAFK_,S125,,,,,,,22.21,,,22.50,,,22.35,,22.36, , , , , ,-0.14, , ,0.15, , ,0.00, ,locomotory behavior;sensory perception of pain;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;negative regulation of hormone secretion;response to estradiol stimulus;outflow tract morphogenesis;regulation of multicellular organism growth;regulation of blood pressure;glucose metabolic process;feeding behavior;positive regulation of vasoconstriction;reduction of cytosolic calcium ion concentration,cytosol;axon;synaptic vesicle;integral to plasma membrane,,,,,,,,,,,,,,
1912,P25942,CD40,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40),GKESRISVQERQ_,_ESRIS(ph)VQERQ_,S272,,23.32,25.12,25.12,23.46,,23.12,22.73,22.28,26.80,27.99,24.67,24.38,22.72,24.31,-0.99,0.81,0.81,-0.85, ,-1.19,-1.58,-2.03,2.49,3.68,0.36,0.07,-1.59,positive regulation of MAP kinase activity;defense response to virus;regulation of immune response;positive regulation of Cdc42 GTPase activity;inflammatory response;cellular calcium ion homeostasis;positive regulation of isotype switching to IgG isotypes;positive regulation of NF-kappaB transcription factor activity;positive regulation of interleukin-12 production;positive regulation of protein kinase C signaling cascade;immune response-regulating cell surface receptor signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to mechanical stimulus;positive regulation of Rac GTPase activity;positive regulation of transcription from RNA polymerase II promoter;B cell proliferation;platelet activation;protein complex assembly;positive regulation of B cell proliferation;positive regulation of tyrosine phosphorylation of Stat1 protein;positive regulation of endothelial cell apoptotic process;regulation of immunoglobulin secretion,intracellular membrane-bounded organelle;CD40 receptor complex;extracellular region;external side of plasma membrane,,,,,,,,,,,,,,
1913,P26006,ITGA3,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain;Integrin alpha-3 light chain],EMKSQPSETERLT,_SQPS(ph)ETERLTDDY_,S1028,+,25.27,23.32,,26.00,26.35,25.81,26.30,26.36,25.96,26.19,25.73,26.81,25.50,25.80,-0.53,-2.48, ,0.20,0.55,0.01,0.50,0.56,0.16,0.39,-0.07,1.01,-0.30,memory;blood coagulation;neuron migration;integrin-mediated signaling pathway;cell-matrix adhesion;leukocyte migration,integrin complex;basolateral plasma membrane;cell surface,,,,,,,,,,,,,,
1914,P26038,MSN,Moesin (Membrane-organizing extension spike protein),RIDEFESM_____,_(gl)QRIDEFES(ph)M(ox)_,S576,+,22.13,24.57,22.25,24.44,25.21,22.78,24.63,24.91,23.98,24.13,23.01,24.90,,23.91,-1.78,0.66,-1.67,0.52,1.30,-1.13,0.72,1.00,0.06,0.22,-0.90,0.99, ,leukocyte cell-cell adhesion;membrane to membrane docking;regulation of lymphocyte migration;leukocyte migration,basolateral plasma membrane;apical part of cell;plasma membrane;filopodium membrane;microvillus membrane;apical plasma membrane;internal side of plasma membrane;cytoplasm;extrinsic to membrane;uropod;filopodium;secretory granule membrane;extracellular vesicular exosome;nucleolus;cytoskeleton;cell surface;microvillus,,,,,,,,,,,,,,
1915,P26232,CTNNA2,Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein),EDYDVRSRTSVQT,_S(ph)RTS(ph)VQTEDDQLIAGQSAR_,S651,,27.62,23.72,,22.81,,,,,,,27.34,,,25.37,2.25,-1.65, ,-2.56, , , , , , ,1.97, , ,cell-cell adhesion;positive regulation of muscle cell differentiation;dendrite morphogenesis;prepulse inhibition;axonogenesis;regulation of synapse structural plasticity;brain morphogenesis;radial glia guided migration of Purkinje cell;muscle cell differentiation,cytosol;axon;adherens junction;basolateral plasma membrane;lamellipodium;cell-cell adherens junction;actin cytoskeleton,,,,,,,,,,,,,,
1916,P26232,CTNNA2,Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein),DVRSRTSVQTEDD,_S(ph)RTS(ph)VQTEDDQLIAGQSAR_,S655,+,28.13,26.10,25.70,25.41,26.07,,24.94,,26.31,27.58,27.38,26.65,26.65,26.45,1.69,-0.35,-0.74,-1.04,-0.38, ,-1.51, ,-0.13,1.13,0.94,0.20,0.20,cell-cell adhesion;positive regulation of muscle cell differentiation;dendrite morphogenesis;prepulse inhibition;axonogenesis;regulation of synapse structural plasticity;brain morphogenesis;radial glia guided migration of Purkinje cell;muscle cell differentiation,cytosol;axon;adherens junction;basolateral plasma membrane;lamellipodium;cell-cell adherens junction;actin cytoskeleton,,,,,,,,,,,,,,
1917,P26358,DNMT1,DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT),NIPEMPSPKKMHQ,_EADDDEEVDDNIPEMPS(ph)PKK_,S714,+,26.83,25.77,26.71,25.13,27.06,25.48,27.52,27.38,26.26,26.48,,24.76,24.95,26.19,0.64,-0.43,0.52,-1.06,0.87,-0.71,1.32,1.19,0.07,0.29, ,-1.44,-1.25,"maintenance of DNA methylation;positive regulation of gene expression;gene silencing;cellular response to amino acid stimulus;regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;chromatin modification;positive regulation of histone H3-K4 methylation",replication fork;nucleus;centromeric heterochromatin,Other TF domain,,,,,,,,,,,,,
1919,P26368,U2AF2,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),_____MSDFDEFE,_(ac)S(ph)DFDEFERQLNENKQER_,S2,+,29.23,20.34,21.21,22.33,30.37,25.72,26.53,26.31,27.46,28.58,26.62,27.93,26.90,26.12,3.11,-5.78,-4.91,-3.78,4.26,-0.40,0.41,0.19,1.35,2.46,0.50,1.81,0.78,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;spliceosomal complex,,,,,,,,,,+,,,,
1920,P26373,RPL13,60S ribosomal protein L13 (Breast basic conserved protein 1),RAGRGFSLEELRV,_GFS(ph)LEELR_,S77,,21.06,,,22.72,,,,,,,,,,21.89,-0.83, , ,0.83, , , , , , , , , ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1923,P26373,RPL13,60S ribosomal protein L13 (Breast basic conserved protein 1),PRRRNKSTESLQA,_NKS(ph)TESLQANVQR_,S106,,25.43,,,,,,,21.98,,,,,,23.71,1.73, , , , , , ,-1.73, , , , , ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
1924,P26599,PTBP1,Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I),TKDYGNSPLHRFK,_DYGNS(ph)PLHR_,S433,,23.52,,,,,,,,,22.72,,,,23.12,0.40, , , , , , , , ,-0.40, , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;negative regulation of muscle cell differentiation;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nucleolus,,,,,,,,,,,,,,
1926,P26599,PTBP1,Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I),ELKTDSSPNQARA,_ELKTDSS(ph)PNQAR_,S141,+,22.34,24.46,25.15,23.96,25.27,25.80,,25.46,21.47,20.17,,,23.85,23.79,-1.45,0.66,1.36,0.17,1.47,2.01, ,1.67,-2.32,-3.62, , ,0.05,"negative regulation of mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;negative regulation of muscle cell differentiation;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nucleolus,,,,,,,,,,,,,,
1928,P26651,ZFP36,Tristetraprolin (TTP) (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Protein TIS11A) (TIS11) (Zinc finger protein 36 homolog) (Zfp-36),RLGPELSPSPTSP,_LGPELS(ph)PSPTS(ph)PTATSTTPSR_,S88,,23.61,,,,,,,,,,,,,23.61,0.00, , , , , , , , , , , , ,negative regulation of myeloid cell differentiation;intracellular protein kinase cascade;mRNA catabolic process;negative regulation of inflammatory response;regulation of tumor necrosis factor production;response to stress;3'-UTR-mediated mRNA stabilization;negative regulation of transcription from RNA polymerase II promoter;RNA destabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;gene expression;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;nucleus;cytoplasmic stress granule,,,,,,,,,,,,,,
1929,P26651,ZFP36,Tristetraprolin (TTP) (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Protein TIS11A) (TIS11) (Zinc finger protein 36 homolog) (Zfp-36),GPELSPSPTSPTA,_LGPELSPS(ph)PTS(ph)PTATSTTPSR_,S90,,23.02,,,,,,23.10,,,,,23.09,22.93,23.04,-0.02, , , , , ,0.06, , , , ,0.05,-0.10,negative regulation of myeloid cell differentiation;intracellular protein kinase cascade;mRNA catabolic process;negative regulation of inflammatory response;regulation of tumor necrosis factor production;response to stress;3'-UTR-mediated mRNA stabilization;negative regulation of transcription from RNA polymerase II promoter;RNA destabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;gene expression;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;nucleus;cytoplasmic stress granule,,,,,,,,,,,,,,
1930,P26651,ZFP36,Tristetraprolin (TTP) (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Protein TIS11A) (TIS11) (Zinc finger protein 36 homolog) (Zfp-36),LSPSPTSPTATST,_LGPELS(ph)PSPTS(ph)PTATSTTPSR_,S93,+,25.44,,,,22.52,,23.10,23.39,,,22.55,23.09,22.93,23.29,2.15, , , ,-0.77, ,-0.19,0.10, , ,-0.74,-0.20,-0.36,negative regulation of myeloid cell differentiation;intracellular protein kinase cascade;mRNA catabolic process;negative regulation of inflammatory response;regulation of tumor necrosis factor production;response to stress;3'-UTR-mediated mRNA stabilization;negative regulation of transcription from RNA polymerase II promoter;RNA destabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;gene expression;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;nucleus;cytoplasmic stress granule,,,,,,,,,,,,,,
1931,P26651,ZFP36,Tristetraprolin (TTP) (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Protein TIS11A) (TIS11) (Zinc finger protein 36 homolog) (Zfp-36),VLRQSISFSGLPS,_(gl)QSIS(ph)FSGLPSGR_,S186,,25.42,,,,,,,,,,,,,25.42,0.00, , , , , , , , , , , , ,negative regulation of myeloid cell differentiation;intracellular protein kinase cascade;mRNA catabolic process;negative regulation of inflammatory response;regulation of tumor necrosis factor production;response to stress;3'-UTR-mediated mRNA stabilization;negative regulation of transcription from RNA polymerase II promoter;RNA destabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;gene expression;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;nucleus;cytoplasmic stress granule,,,,,,,,,,,,,,
1932,P26651,ZFP36,Tristetraprolin (TTP) (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Protein TIS11A) (TIS11) (Zinc finger protein 36 homolog) (Zfp-36),LPGRSTSLVEGRS,_STS(ph)LVEGR_,S60,,24.49,,,,,,,,,,,,,24.49,0.00, , , , , , , , , , , , ,negative regulation of myeloid cell differentiation;intracellular protein kinase cascade;mRNA catabolic process;negative regulation of inflammatory response;regulation of tumor necrosis factor production;response to stress;3'-UTR-mediated mRNA stabilization;negative regulation of transcription from RNA polymerase II promoter;RNA destabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;gene expression;nuclear-transcribed mRNA poly(A) tail shortening,cytosol;nucleus;cytoplasmic stress granule,,,,,,,,,,,,,,
1933,P27348,YWHAQ,14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1),EERNLLSVAYKNV,_NLLS(ph)VAYK_,S45,,22.48,21.08,,19.88,,,,,,,,,,21.15,1.33,-0.06, ,-1.26, , , , , , , , , ,"protein targeting;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent",cytoplasm,,,,,,,,,,,,,,
1934,P27448,MARK3,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),KGIAPASPMLGNA,_GIAPAS(ph)PM(ox)LGNASNPNK_,S469,+,24.80,23.73,24.00,24.50,,23.34,25.16,22.09,25.88,24.06,23.90,25.05,22.95,24.12,0.68,-0.39,-0.12,0.38, ,-0.79,1.04,-2.03,1.75,-0.06,-0.22,0.93,-1.17,,plasma membrane,,+,,,,,,,,,,,,
1937,P27540,ARNT,"Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta)",KERFARSDDEQSS,_FARS(ph)DDEQSSADKER_,S77,+,19.04,24.96,24.96,23.25,22.68,20.10,,20.54,22.60,,20.74,,,22.09,-3.05,2.86,2.86,1.16,0.58,-2.00, ,-1.56,0.50, ,-1.36, , ,"cell differentiation;mRNA transcription from RNA polymerase II promoter;positive regulation vascular endothelial growth factor production;positive regulation of erythrocyte differentiation;positive regulation of hormone biosynthetic process;regulation of transcription from RNA polymerase II promoter in response to hypoxia;positive regulation of vascular endothelial growth factor receptor signaling pathway;positive regulation of transcription, DNA-dependent;embryonic placenta development;positive regulation of glycolysis;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;positive regulation of endothelial cell proliferation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of protein sumoylation",nucleoplasm;transcription factor complex;cytoplasm,bHLH,,,,,,,,,,,,,
1938,P27708,CAD,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],PRIHRASDPGLPA,_IHRAS(ph)DPGLPAEEPKEK_,S1796,+,23.35,25.32,25.21,26.03,25.21,25.86,27.57,27.43,25.84,26.24,27.11,28.21,23.43,25.91,-2.56,-0.59,-0.70,0.12,-0.70,-0.05,1.66,1.52,-0.07,0.33,1.20,2.30,-2.48,drug metabolic process;response to caffeine;protein autophosphorylation;glutamine metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;embryo development;response to testosterone stimulus;female pregnancy;organ regeneration;peptidyl-threonine phosphorylation;carbamoyl phosphate biosynthetic process;glutamine catabolic process;pyrimidine nucleoside biosynthetic process;'de novo' UMP biosynthetic process;response to amine stimulus,neuronal cell body;cytosol;terminal button;protein complex;nuclear matrix,,,,,,,,,,,,,,
1939,P27708,CAD,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],AGGRRLSSFVTKG,_RLS(ph)SFVTK_,S1343,+,23.24,,,21.78,22.28,,,22.68,,,,24.13,22.44,22.76,0.48, , ,-0.98,-0.48, , ,-0.08, , , ,1.38,-0.31,drug metabolic process;response to caffeine;protein autophosphorylation;glutamine metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;embryo development;response to testosterone stimulus;female pregnancy;organ regeneration;peptidyl-threonine phosphorylation;carbamoyl phosphate biosynthetic process;glutamine catabolic process;pyrimidine nucleoside biosynthetic process;'de novo' UMP biosynthetic process;response to amine stimulus,neuronal cell body;cytosol;terminal button;protein complex;nuclear matrix,,,,,,,,,,,,,,
1940,P27708,CAD,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5);Aspartate carbamoyltransferase (EC 2.1.3.2);Dihydroorotase (EC 3.5.2.3)],CRVLGTSPEAIDS,_VLGTS(ph)PEAIDSAENR_,S975,,21.20,,,22.42,,,,,,,,,,21.81,-0.61, , ,0.61, , , , , , , , , ,drug metabolic process;response to caffeine;protein autophosphorylation;glutamine metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;embryo development;response to testosterone stimulus;female pregnancy;organ regeneration;peptidyl-threonine phosphorylation;carbamoyl phosphate biosynthetic process;glutamine catabolic process;pyrimidine nucleoside biosynthetic process;'de novo' UMP biosynthetic process;response to amine stimulus,neuronal cell body;cytosol;terminal button;protein complex;nuclear matrix,,,,,,,,,,,,,,
1941,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),DALTEPSPDIEGE,_(ac)ADLSLADALTEPS(ph)PDIEGEIK_,S14,,25.83,,,,,,,,,24.60,,,,25.22,0.61, , , , , , , , ,-0.61, , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1943,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),NKELPPSPEKKTK,_ELPPS(ph)PEKK_,S1841,+,21.37,26.76,26.76,24.02,,23.95,21.53,21.08,,21.49,22.84,,21.41,23.12,-1.75,3.64,3.64,0.90, ,0.83,-1.59,-2.04, ,-1.63,-0.28, ,-1.71,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1944,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),RLATNTSAPDLKN,_LATNTS(ph)APDLK_,S2073,+,19.93,24.13,24.19,24.94,23.75,22.91,23.88,,23.53,22.91,23.46,26.78,24.63,23.75,-3.82,0.37,0.44,1.19,0.00,-0.84,0.13, ,-0.22,-0.84,-0.30,3.03,0.88,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1945,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),VRSKVGSTENIKH,_VGS(ph)TENIK_,S2086,+,24.27,26.59,26.17,28.15,24.12,24.20,24.88,25.24,24.46,22.88,24.44,25.22,23.64,24.94,-0.67,1.64,1.23,3.21,-0.83,-0.74,-0.07,0.29,-0.48,-2.06,-0.50,0.27,-1.30,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1946,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),TGPSSRSPSTLLP,_S(ph)PSTLLPK_,S1970,,24.32,22.99,,23.49,,23.13,22.74,,22.04,,,,,23.12,1.20,-0.13, ,0.37, ,0.01,-0.38, ,-1.08, , , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1947,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),PSSRSPSTLLPKK,_SPS(ph)TLLPK_,S1972,,24.60,,,,24.34,,,24.20,,21.49,21.34,,,23.20,1.41, , , ,1.15, , ,1.01, ,-1.71,-1.86, , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1951,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),AQAKVGSLDNVGH,_VGS(ph)LDNVGHLPAGGAVK_,S2218,+,25.78,26.91,27.08,26.86,27.32,27.49,27.96,27.73,26.91,27.54,28.15,28.16,27.93,27.37,-1.59,-0.46,-0.29,-0.51,-0.05,0.12,0.59,0.36,-0.46,0.17,0.78,0.79,0.56,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
1952,P27824,CANX,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),DEILNRSPRNRKP,_AEEDEILNRS(ph)PRNR_,S583,+,33.90,34.39,34.01,33.59,34.69,34.69,34.69,34.69,34.69,34.69,34.69,34.69,34.69,34.47,-0.57,-0.08,-0.46,-0.88,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,0.22,protein secretion;antigen processing and presentation of peptide antigen via MHC class I;aging;synaptic vesicle endocytosis;post-translational protein modification;protein folding;clathrin-mediated endocytosis;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuronal cell body;axon;ribosome;integral to lumenal side of endoplasmic reticulum membrane;endoplasmic reticulum lumen;rough endoplasmic reticulum;dendrite cytoplasm;dendritic spine;melanosome,,,,,,,,,,,,,,
1954,P27824,CANX,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),EDGGTVSQEEEDR,_(gl)QKS(ph)DAEEDGGTVS(ph)QEEEDR_,S564,+,29.61,32.34,32.72,30.14,28.75,28.51,31.29,28.85,31.42,29.91,31.07,30.97,27.60,30.24,-0.63,2.09,2.48,-0.10,-1.50,-1.74,1.04,-1.40,1.18,-0.33,0.83,0.73,-2.65,protein secretion;antigen processing and presentation of peptide antigen via MHC class I;aging;synaptic vesicle endocytosis;post-translational protein modification;protein folding;clathrin-mediated endocytosis;protein N-linked glycosylation via asparagine;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuronal cell body;axon;ribosome;integral to lumenal side of endoplasmic reticulum membrane;endoplasmic reticulum lumen;rough endoplasmic reticulum;dendrite cytoplasm;dendritic spine;melanosome,,,,,,,,,,,,,,
1955,P28066,PSMA5,Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain),RGVNTFSPEGRLF,_GVNTFS(ph)PEGR_,S16,,25.21,24.42,,24.14,,21.65,,,,,23.10,,,23.70,1.51,0.71, ,0.44, ,-2.06, , , , ,-0.60, , ,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination","proteasome core complex;nucleoplasm;cytosol;proteasome core complex, alpha-subunit complex",,,,,,,,,,,,,,
1956,P28066,PSMA5,Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain),VEKRITSPLMEPS,_ITS(ph)PLM(ox)EPSSIEK_,S56,+,25.21,24.36,23.91,23.33,25.77,25.26,25.40,25.35,24.14,23.69,26.17,26.39,24.80,24.91,0.30,-0.55,-0.99,-1.57,0.87,0.35,0.50,0.44,-0.77,-1.22,1.26,1.48,-0.10,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination","proteasome core complex;nucleoplasm;cytosol;proteasome core complex, alpha-subunit complex",,,,,,,,,,,,,,
1958,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),RTPLGASLDEQSS,_TPLGAS(ph)LDEQSSSTLK_,S92,+,25.52,23.11,23.23,24.29,25.08,24.86,25.44,25.37,26.13,25.92,26.26,24.14,23.32,24.82,0.70,-1.71,-1.59,-0.53,0.26,0.04,0.62,0.55,1.30,1.10,1.43,-0.68,-1.50,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1959,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),MTQQKDSFEMEEV,_DS(ph)FEM(ox)EEVQSTEGEAPHVPATYQLGLTK_,S466,,23.88,,,,,,23.49,,,24.99,,24.38,,24.19,-0.31, , , , , ,-0.70, , ,0.81, ,0.20, ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1960,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),GKILNVSVIEESG,_ILNVS(ph)VIEESGNK_,S330,,22.56,,,,,,,,,,,,,22.56,0.00, , , , , , , , , , , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1961,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),RAVRMPSPFRSSA,_M(ox)PS(ph)PFR_,S1040,,23.46,21.67,22.30,,21.15,21.25,20.67,,,,,,,21.75,1.71,-0.08,0.55, ,-0.60,-0.50,-1.08, , , , , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1962,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),ILKSLASIEAKCS,_SLAS(ph)IEAK_,S668,+,28.50,27.12,27.72,27.66,27.52,26.39,27.08,27.28,26.98,27.60,26.81,27.36,25.25,27.17,1.32,-0.05,0.55,0.48,0.34,-0.78,-0.09,0.11,-0.20,0.42,-0.36,0.18,-1.92,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1963,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),GYPLRRSQSLPTT,_S(ph)QS(ph)LPTTLLSPVR_,S737,+,26.04,20.23,,21.61,24.58,24.02,24.13,24.02,23.97,24.16,24.66,,23.98,23.76,2.28,-3.53, ,-2.16,0.82,0.26,0.36,0.26,0.21,0.39,0.90, ,0.21,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1964,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),PLRRSQSLPTTLL,_S(ph)QS(ph)LPTTLLSPVR_,S739,+,27.57,24.44,23.27,25.43,28.15,27.21,27.07,27.42,27.87,26.76,27.99,25.95,26.94,26.62,0.95,-2.18,-3.35,-1.19,1.52,0.59,0.45,0.79,1.25,0.14,1.37,-0.67,0.32,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1965,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),LPTTLLSPVRVVS,_SQS(ph)LPTTLLS(ph)PVR_,S746,,22.74,,,,,,,,,,,,,22.74,0.00, , , , , , , , , , , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
1971,P28347,TEAD1,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),SWSGSESPAENME,_(ac)M(ox)EPSSWSGSES(ph)PAENM(ox)ER_,S11,+,21.57,21.71,21.64,23.50,24.32,24.95,24.19,24.25,23.56,23.68,,,,23.34,-1.77,-1.63,-1.70,0.17,0.99,1.61,0.86,0.91,0.23,0.34, , , ,transcription initiation from RNA polymerase II promoter;hippo signaling cascade,nucleoplasm,Other TF domain,,,,,,,,,,,,,
1972,P28370,SMARCA1,Probable global transcription activator SNF2L1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1),QPSAQKSPTSPLN,_S(ph)PTSPLNM(ox)K_,S116,,,,,24.71,,,22.10,,22.96,22.38,,,,23.04, , , ,1.67, , ,-0.94, ,-0.08,-0.66, , , ,"ATP-dependent chromatin remodeling;positive regulation of transcription, DNA-dependent;brain development;neuron differentiation;transcription, DNA-dependent;chromatin remodeling",NURF complex,,,,,,,,,,,,,,
1973,P28370,SMARCA1,Probable global transcription activator SNF2L1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1),AQKSPTSPLNMKL,_SPTS(ph)PLNM(ox)K_,S119,,22.71,23.47,24.25,,22.59,,,,,,,20.71,,22.75,-0.04,0.72,1.51, ,-0.15, , , , , , ,-2.03, ,"ATP-dependent chromatin remodeling;positive regulation of transcription, DNA-dependent;brain development;neuron differentiation;transcription, DNA-dependent;chromatin remodeling",NURF complex,,,,,,,,,,,,,,
1974,P28715,ERCC5,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),RELTPASPTCTNS,_ELTPAS(ph)PTCTNSVSK_,S358,+,21.94,22.51,20.83,23.98,,22.68,,,23.80,,,22.09,22.33,22.52,-0.58,-0.01,-1.69,1.46, ,0.16, , ,1.28, , ,-0.44,-0.19,"negative regulation of apoptotic process;UV protection;response to UV-C;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA damage removal;multicellular organism growth;determination of adult lifespan;transcription-coupled nucleotide-excision repair",nucleoplasm,,,,,,,,,,,,,,
1975,P28715,ERCC5,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),PDATPPSPRTLLA,_EPDATPPS(ph)PR_,S173,+,24.42,25.52,25.61,25.74,25.29,26.01,24.37,25.05,24.80,23.42,23.47,24.31,24.53,24.81,-0.39,0.71,0.80,0.92,0.48,1.20,-0.44,0.24,-0.01,-1.39,-1.34,-0.50,-0.28,"negative regulation of apoptotic process;UV protection;response to UV-C;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA damage removal;multicellular organism growth;determination of adult lifespan;transcription-coupled nucleotide-excision repair",nucleoplasm,,,,,,,,,,,,,,
1976,P28715,ERCC5,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),FDSSLLSSDDETK,_FDSSLLS(ph)S(ph)DDETK_,S394,,23.35,,,22.54,,,,,,,,,,22.95,0.41, , ,-0.41, , , , , , , , , ,"negative regulation of apoptotic process;UV protection;response to UV-C;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA damage removal;multicellular organism growth;determination of adult lifespan;transcription-coupled nucleotide-excision repair",nucleoplasm,,,,,,,,,,,,,,
1977,P28715,ERCC5,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),DSSLLSSDDETKC,_FDSSLLS(ph)S(ph)DDETK_,S395,+,25.06,23.69,23.69,23.69,23.54,24.54,,23.42,25.73,25.43,23.88,24.64,23.92,24.27,0.79,-0.58,-0.58,-0.58,-0.73,0.27, ,-0.85,1.46,1.17,-0.39,0.37,-0.35,"negative regulation of apoptotic process;UV protection;response to UV-C;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA damage removal;multicellular organism growth;determination of adult lifespan;transcription-coupled nucleotide-excision repair",nucleoplasm,,,,,,,,,,,,,,
1978,P28715,ERCC5,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),VDEGSISPRTLSA,_NAPAAVDEGSIS(ph)PR_,S216,+,26.25,27.80,27.48,27.90,26.89,28.19,27.45,27.55,28.06,27.15,27.01,27.46,27.69,27.45,-1.20,0.35,0.03,0.45,-0.56,0.74,0.00,0.10,0.61,-0.30,-0.44,0.00,0.24,"negative regulation of apoptotic process;UV protection;response to UV-C;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA damage removal;multicellular organism growth;determination of adult lifespan;transcription-coupled nucleotide-excision repair",nucleoplasm,,,,,,,,,,,,,,
1980,P29317,EPHA2,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),NQRARQSPEDVYF,_ARQS(ph)PEDVYFSK_,S570,,,,,,23.03,,,23.93,22.66,,,,23.28,23.23, , , , ,-0.20, , ,0.71,-0.57, , , ,0.06,regulation of ERK1 and ERK2 cascade;negative regulation of protein kinase B signaling cascade;osteoclast differentiation;cell chemotaxis;bone remodeling;response to growth factor stimulus;neuron differentiation;activation of Rac GTPase activity;apoptotic process;regulation of lamellipodium assembly;keratinocyte differentiation;regulation of angiogenesis;angiogenesis;vasculogenesis;positive regulation of establishment of protein localization to plasma membrane;lens fiber cell morphogenesis;regulation of cell adhesion mediated by integrin;osteoblast differentiation;branching involved in mammary gland duct morphogenesis;notochord cell development;axial mesoderm formation;protein kinase B signaling cascade;ephrin receptor signaling pathway;cell adhesion;neural tube development;notochord formation;skeletal system development;regulation of blood vessel endothelial cell migration;mammary gland epithelial cell proliferation,ruffle membrane;lamellipodium membrane;leading edge membrane;focal adhesion;integral to plasma membrane,,+,,,,,,,,,,,,
1981,P29317,EPHA2,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),VSIRLPSTSGSEG,_LPS(ph)TSGSEGVPFR_,S897,+,25.91,20.59,,23.88,26.12,,25.70,25.33,,25.09,24.44,23.56,27.12,24.77,1.13,-4.18, ,-0.89,1.35, ,0.93,0.55, ,0.32,-0.34,-1.21,2.35,regulation of ERK1 and ERK2 cascade;negative regulation of protein kinase B signaling cascade;osteoclast differentiation;cell chemotaxis;bone remodeling;response to growth factor stimulus;neuron differentiation;activation of Rac GTPase activity;apoptotic process;regulation of lamellipodium assembly;keratinocyte differentiation;regulation of angiogenesis;angiogenesis;vasculogenesis;positive regulation of establishment of protein localization to plasma membrane;lens fiber cell morphogenesis;regulation of cell adhesion mediated by integrin;osteoblast differentiation;branching involved in mammary gland duct morphogenesis;notochord cell development;axial mesoderm formation;protein kinase B signaling cascade;ephrin receptor signaling pathway;cell adhesion;neural tube development;notochord formation;skeletal system development;regulation of blood vessel endothelial cell migration;mammary gland epithelial cell proliferation,ruffle membrane;lamellipodium membrane;leading edge membrane;focal adhesion;integral to plasma membrane,,+,,,,,,,,,,,,
1983,P29317,EPHA2,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),LPSTSGSEGVPFR,_VSIRLPSTSGS(ph)EGVPFR_,S901,+,24.56,,,,28.00,25.71,25.94,27.08,26.11,24.87,26.13,24.83,27.30,26.05,-1.50, , , ,1.95,-0.34,-0.11,1.03,0.06,-1.19,0.08,-1.22,1.24,regulation of ERK1 and ERK2 cascade;negative regulation of protein kinase B signaling cascade;osteoclast differentiation;cell chemotaxis;bone remodeling;response to growth factor stimulus;neuron differentiation;activation of Rac GTPase activity;apoptotic process;regulation of lamellipodium assembly;keratinocyte differentiation;regulation of angiogenesis;angiogenesis;vasculogenesis;positive regulation of establishment of protein localization to plasma membrane;lens fiber cell morphogenesis;regulation of cell adhesion mediated by integrin;osteoblast differentiation;branching involved in mammary gland duct morphogenesis;notochord cell development;axial mesoderm formation;protein kinase B signaling cascade;ephrin receptor signaling pathway;cell adhesion;neural tube development;notochord formation;skeletal system development;regulation of blood vessel endothelial cell migration;mammary gland epithelial cell proliferation,ruffle membrane;lamellipodium membrane;leading edge membrane;focal adhesion;integral to plasma membrane,,+,,,,,,,,,,,,
1984,P29323,EPHB2,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3),FLEDDTSDPTYTS,_FLEDDTS(ph)DPTYTSALGGK_,S776,+,25.44,,,23.01,27.77,25.79,25.89,24.76,26.70,26.87,25.77,25.46,26.94,25.85,-0.42, , ,-2.85,1.92,-0.06,0.04,-1.10,0.84,1.02,-0.08,-0.40,1.09,positive regulation of synapse assembly;corpus callosum development;central nervous system projection neuron axonogenesis;urogenital system development;peptidyl-tyrosine phosphorylation;palate development;commissural neuron axon guidance;inner ear morphogenesis;retinal ganglion cell axon guidance;negative regulation of axonogenesis;angiogenesis;positive regulation of long-term neuronal synaptic plasticity;camera-type eye morphogenesis;dendritic spine morphogenesis;axonal fasciculation;optic nerve morphogenesis;learning;regulation of body fluid levels,neuronal cell body;axon;integral to plasma membrane;dendrite,,+,,,,,,,,,,,,
1986,P29374,ARID4A,AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1),KILGQSSPEKKIR,_ILGQSS(ph)PEK_,S864,,26.36,24.50,25.41,,,22.15,23.01,22.40,,,,,,23.97,2.39,0.53,1.44, , ,-1.82,-0.96,-1.57, , , , , ,"negative regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",transcriptional repressor complex,,,,,,,,,,,,,,
1989,P29374,ARID4A,AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1),NRGRRSSLPVTED,_RSS(ph)LPVTEDEK_,S147,,25.07,24.83,25.24,23.23,,,,,,22.69,,,,24.21,0.86,0.62,1.02,-0.98, , , , , ,-1.52, , , ,"negative regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",transcriptional repressor complex,,,,,,,,,,,,,,
1990,P29375,KDM5A,Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2),STDTQTSPEPGTR,_VEPEVLSTDTQTS(ph)PEPGTR_,S204,,22.59,,,,,,,,22.71,,,,,22.65,-0.06, , , , , , , ,0.06, , , , ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;chromatin modification;transcription from RNA polymerase II promoter",nucleolus;nucleus;cytoplasm,,,,,,,,,,,,,,
1992,P29375,KDM5A,Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2),VVSSVSSSPRQTM,_VVSSVSS(ph)SPR_,S1330,,24.20,23.27,,21.80,,,,,,,,,,23.09,1.11,0.18, ,-1.29, , , , , , , , , ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;chromatin modification;transcription from RNA polymerase II promoter",nucleolus;nucleus;cytoplasm,,,,,,,,,,,,,,
1994,P29401,TKT,Transketolase (TK) (EC 2.2.1.1),PQEDAPSVDIANI,_ILATPPQEDAPS(ph)VDIANIR_,S295,,24.46,,,,,,,21.24,22.58,,,,,22.76,1.70, , , , , , ,-1.52,-0.18, , , , ,"xylulose biosynthetic process;energy reserve metabolic process;regulation of growth;glyceraldehyde-3-phosphate biosynthetic process;ribose phosphate biosynthetic process;pentose-phosphate shunt, non-oxidative branch",cytosol;peroxisome;nucleus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
1995,P29401,TKT,Transketolase (TK) (EC 2.2.1.1),LNLRKISSDLDGH,_KIS(ph)SDLDGHPVPK_,S104,,,,,,23.08,23.59,,23.52,,21.11,,,23.60,22.98, , , , ,0.10,0.61, ,0.54, ,-1.86, , ,0.62,"xylulose biosynthetic process;energy reserve metabolic process;regulation of growth;glyceraldehyde-3-phosphate biosynthetic process;ribose phosphate biosynthetic process;pentose-phosphate shunt, non-oxidative branch",cytosol;peroxisome;nucleus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
1996,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),AVSKKASPEAAST,_KAS(ph)PEAASTPRDPIDVDLPEEAER_,S403,+,24.17,26.97,26.04,25.02,28.17,27.95,26.42,28.00,27.90,26.38,29.31,25.62,28.20,26.93,-2.77,0.04,-0.90,-1.92,1.23,1.02,-0.51,1.06,0.97,-0.56,2.38,-1.32,1.27,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2000,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),GPPSPRSPVIGSE,_S(ph)PVIGSEVFLPNSNHVASGAGEAEER_,S530,+,26.71,25.94,25.33,24.39,27.25,,25.26,26.06,27.06,25.27,27.42,,25.74,26.04,0.67,-0.10,-0.71,-1.65,1.22, ,-0.78,0.02,1.02,-0.77,1.38, ,-0.29,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2001,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),EARLARSSPEQPR,_LARS(ph)S(ph)PEQPRPSTSK_,S504,+,25.50,27.91,27.91,27.54,22.65,23.69,25.99,22.51,24.59,21.09,26.94,25.20,26.00,25.19,0.31,2.72,2.72,2.35,-2.54,-1.51,0.80,-2.68,-0.61,-4.11,1.75,0.01,0.81,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2002,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),ARLARSSPEQPRP,_LARS(ph)S(ph)PEQPRPSTSK_,S505,+,26.27,30.06,30.51,27.83,28.12,27.66,24.68,27.26,27.73,26.52,25.76,24.92,26.27,27.20,-0.93,2.86,3.31,0.63,0.92,0.46,-2.52,0.06,0.53,-0.68,-1.44,-2.28,-0.93,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2004,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),EPAPARSPRPQQD,_(ac)M(ox)EPAPARS(ph)PR_,S8,,22.70,26.56,,24.11,,,,,,,,,,24.46,-1.76,2.10, ,-0.35, , , , , , , , , ,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2007,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),SLQRRLSVYRQIV,_RLS(ph)VYR_,S117,,22.52,25.55,,24.60,25.95,25.40,23.66,24.91,24.69,24.89,24.74,23.85,23.13,24.49,-1.97,1.06, ,0.11,1.45,0.91,-0.83,0.42,0.20,0.40,0.25,-0.64,-1.36,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2008,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),ISSSEDSDAENSS,_VVVISSSEDS(ph)DAENSSSR_,S565,+,,,,,25.32,24.64,23.48,24.22,24.86,,23.64,,23.74,24.27, , , , ,1.05,0.37,-0.79,-0.05,0.59, ,-0.63, ,-0.53,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2009,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),AVSKKASPEAAST,_KAS(ph)PEAASTPR_,S403,+,18.63,25.45,22.31,23.76,24.49,24.26,22.70,25.62,26.83,26.09,25.96,24.50,26.08,24.36,-5.73,1.09,-2.05,-0.60,0.13,-0.10,-1.66,1.25,2.47,1.73,1.60,0.14,1.72,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
2012,P29692,EEF1D,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),DIDLFGSDNEEED,_QVEPPAKKPATPAEDDEDDDIDLFGS(ph)DNEEEDK_,S162,+,31.51,,,,28.96,,25.81,,28.39,32.22,25.56,30.06,,28.93,2.58, , , ,0.03, ,-3.12, ,-0.54,3.29,-3.37,1.13, ,translational elongation;positive regulation of I-kappaB kinase/NF-kappaB cascade,cytosol;eukaryotic translation elongation factor 1 complex,Other TF domain,,,,,,,,,,,,,
2014,P29692,EEF1D,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),GASRQSSGPGASS,_(gl)QSS(ph)GPGASSGTSGDHGELVVR_,S41,,23.04,,,,,,,,,,,,,23.04,0.00, , , , , , , , , , , , ,translational elongation;positive regulation of I-kappaB kinase/NF-kappaB cascade,cytosol;eukaryotic translation elongation factor 1 complex,Other TF domain,,,,,,,,,,,,,
2015,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",EDGATPSPSNETP,_AEDGATPS(ph)PSNETPKK_,S145,+,25.85,27.45,27.63,27.83,25.91,25.58,27.49,25.73,26.63,25.35,26.03,25.27,24.84,26.28,-0.43,1.18,1.35,1.55,-0.36,-0.69,1.21,-0.55,0.36,-0.93,-0.25,-1.00,-1.43,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2017,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",EAAEPGSPTAAEG,_EAPAEGEAAEPGS(ph)PTAAEGEAASAASSTSSPK_,S118,+,28.85,27.70,28.28,28.30,27.65,28.49,28.77,28.63,29.51,30.01,29.01,28.01,29.07,28.64,0.21,-0.94,-0.35,-0.34,-0.99,-0.15,0.14,0.00,0.87,1.37,0.37,-0.62,0.43,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2022,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",ELQANGSAPAADK,_EELQANGS(ph)APAADK_,S63,,21.67,23.48,23.48,24.65,,,22.24,,,,,,,23.10,-1.43,0.38,0.38,1.54, , ,-0.86, , , , , , ,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2024,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",AGSGAASPSAAEK,_EEPAAAGSGAAS(ph)PSAAEK_,S81,,25.01,26.08,26.66,26.74,,,,,,25.20,,23.76,,25.57,-0.57,0.51,1.08,1.16, , , , , ,-0.37, ,-1.82, ,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2025,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",EAAVASSPSKANG,_GEAAAERPGEAAVASS(ph)PSK_,S27,+,25.28,28.50,29.33,27.89,27.88,27.80,29.43,27.95,28.24,27.93,26.24,27.64,26.62,27.75,-2.47,0.75,1.58,0.14,0.13,0.05,1.68,0.21,0.49,0.18,-1.51,-0.11,-1.13,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2027,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",APEAGASPVEKEA,_GEPAAAAAPEAGAS(ph)PVEK_,S101,+,28.31,29.76,30.38,29.40,25.93,28.56,29.55,29.17,30.03,30.67,29.44,28.54,29.64,29.18,-0.87,0.57,1.20,0.22,-3.25,-0.63,0.37,-0.01,0.85,1.49,0.26,-0.64,0.46,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2028,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",FKLSGFSFKKNKK,_LSGFS(ph)FKK_,S170,+,26.46,26.63,26.56,28.85,28.93,26.51,27.55,27.05,25.20,24.74,25.27,29.85,25.77,26.88,-0.41,-0.24,-0.31,1.97,2.06,-0.37,0.68,0.18,-1.67,-2.14,-1.61,2.97,-1.10,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2029,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",KVNGDASPAAAES,_VNGDAS(ph)PAAAESGAK_,S46,+,23.40,24.34,24.78,26.49,,22.00,24.27,,24.42,23.84,22.59,23.92,,24.01,-0.61,0.34,0.78,2.48, ,-2.00,0.26, ,0.42,-0.17,-1.42,-0.08, ,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
2030,P30050,RPL12,60S ribosomal protein L12,SLARELSGTIKEI,_ELS(ph)GTIK_,S126,,23.57,23.76,23.79,23.05,,,,,,,,,,23.54,0.03,0.22,0.25,-0.50, , , , , , , , , ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2031,P30050,RPL12,60S ribosomal protein L12,IGPLGLSPKKVGD,_IGPLGLS(ph)PK_,S38,+,22.90,23.84,24.54,22.94,24.85,22.39,22.98,24.32,21.89,23.44,21.89,,23.87,23.32,-0.42,0.52,1.22,-0.38,1.53,-0.93,-0.34,1.00,-1.43,0.12,-1.43, ,0.55,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2032,P30086,PEBP1,Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)],VKNRPTSISWDGL,_NRPTS(ph)ISWDGLDSGK_,S52,+,23.13,24.60,24.54,23.29,25.61,24.96,26.06,27.24,24.49,25.17,27.14,26.92,21.67,24.99,-1.86,-0.39,-0.45,-1.70,0.62,-0.02,1.07,2.26,-0.49,0.18,2.15,1.93,-3.31,spermatid development;response to oxidative stress;MAPK cascade;aging;response to toxin;response to drug;positive regulation of mitosis;positive regulation of cAMP-mediated signaling;negative regulation of MAPK cascade;response to wounding;positive regulation of acetylcholine metabolic process;regulation of neurotransmitter levels;response to activity;response to electrical stimulus;regulation of the force of heart contraction;response to ethanol;eating behavior;response to calcium ion;negative regulation of protein phosphorylation;response to cAMP;response to corticosterone stimulus;brain development;response to heat,neuronal cell body;synaptic vesicle;Golgi apparatus;apical part of cell;mitochondrial outer membrane;extracellular space;rough endoplasmic reticulum;axon terminus;cell surface,,,,,,,,,,,,,,
2033,P30273,FCER1G,High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma),GVYTGLSTRNQET,_SDGVYTGLS(ph)TR_,S69,,22.48,25.44,25.69,23.93,21.75,,,,,,,,,23.86,-1.38,1.59,1.83,0.07,-2.11, , , , , , , , ,"phagocytosis, engulfment;neutrophil activation involved in immune response;mast cell activation;positive regulation of tumor necrosis factor production;positive regulation of mast cell cytokine production;immunoglobulin mediated immune response;negative regulation of mast cell apoptotic process;regulation of platelet activation;positive regulation of interleukin-10 production;positive regulation of type III hypersensitivity;positive regulation of mast cell degranulation;integrin-mediated signaling pathway;positive regulation of phagocytosis;antigen processing and presentation of exogenous peptide antigen via MHC class II;positive regulation of interleukin-6 production;positive regulation of type IIa hypersensitivity;platelet activation;neutrophil chemotaxis;serotonin secretion by platelet;Fc receptor mediated stimulatory signaling pathway;defense response to bacterium;antigen processing and presentation of exogenous peptide antigen via MHC class I;positive regulation of type I hypersensitivity;leukocyte migration",Fc-epsilon receptor I complex;integral to plasma membrane;external side of plasma membrane,,,,,,,,,,,,,,
2035,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],RRILIPSDIESSK,_ILIPS(ph)DIESSK_,S163,+,25.95,22.22,22.17,23.72,26.59,25.84,25.16,25.27,25.43,25.15,24.58,24.96,25.84,24.84,1.11,-2.62,-2.66,-1.12,1.75,1.01,0.32,0.43,0.60,0.32,-0.26,0.12,1.00,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,,,,,,,,,,
2036,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],AKVEETSPLGNAR,_VEETS(ph)PLGNAR_,S846,+,26.65,26.50,24.64,26.87,24.26,,25.68,,,23.47,24.13,24.66,23.10,25.00,1.66,1.50,-0.36,1.88,-0.74, ,0.68, , ,-1.53,-0.86,-0.33,-1.90,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,,,,,,,,,,
2037,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],YHTPPRSRSCSES,_YHT(ph)PPRS(ph)R_,S47,,21.73,23.16,23.08,23.23,17.86,,,,,,,,,21.81,-0.08,1.35,1.26,1.42,-3.95, , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,,,,,,,,,,
2038,P30533,LRPAP1,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),KLRHAESVGDGER,_LRHAES(ph)VGDGER_,S310,,24.17,,,,,21.33,,,,,,,,22.75,1.42, , , , ,-1.42, , , , , , , ,protein folding;negative regulation of protein binding;negative regulation of very-low-density lipoprotein particle clearance;negative regulation of beta-amyloid clearance,vesicle;rough endoplasmic reticulum lumen;integral to membrane;extracellular region;endoplasmic reticulum;plasma membrane;cell surface,,,,,,,,,,,,,,
2039,P30533,LRPAP1,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),PSPKRESGEEFRM,_RES(ph)GEEFR_,S50,,22.89,25.27,24.97,21.50,,,,,,,,,,23.66,-0.77,1.61,1.31,-2.16, , , , , , , , , ,protein folding;negative regulation of protein binding;negative regulation of very-low-density lipoprotein particle clearance;negative regulation of beta-amyloid clearance,vesicle;rough endoplasmic reticulum lumen;integral to membrane;extracellular region;endoplasmic reticulum;plasma membrane;cell surface,,,,,,,,,,,,,,
2040,P30533,LRPAP1,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),VSHQGYSTEAEFE,_VSHQGYS(ph)TEAEFEEPR_,S247,,24.04,23.09,22.50,,,,,,,,,,,23.21,0.83,-0.12,-0.71, , , , , , , , , , ,protein folding;negative regulation of protein binding;negative regulation of very-low-density lipoprotein particle clearance;negative regulation of beta-amyloid clearance,vesicle;rough endoplasmic reticulum lumen;integral to membrane;extracellular region;endoplasmic reticulum;plasma membrane;cell surface,,,,,,,,,,,,,,
2041,P30566,ADSL,Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase),AGGDHGSPDSYRS,_(ac)AAGGDHGS(ph)PDSYRSPLASR_,S9,+,21.71,22.58,22.58,,26.42,,26.79,24.30,21.41,,,23.90,,23.71,-2.00,-1.13,-1.13, ,2.71, ,3.08,0.59,-2.30, , ,0.19, ,purine nucleobase metabolic process;'de novo' IMP biosynthetic process;response to hypoxia;aerobic respiration;'de novo' AMP biosynthetic process;protein tetramerization;AMP biosynthetic process;response to nutrient,cytosol;mitochondrion,,,,,,,,,,,,,,
2043,P30622,CLIP1,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),TKTASESISNLSE,_TASES(ph)ISNLSEAGSIK_,S195,+,24.48,22.43,22.43,23.60,,,22.07,,21.06,22.79,,24.27,,22.89,1.59,-0.46,-0.46,0.71, , ,-0.82, ,-1.84,-0.10, ,1.38, ,transport;mitotic prometaphase;microtubule bundle formation;positive regulation of microtubule polymerization,endosome;cytoplasmic vesicle membrane;centrosome;cytosol;intermediate filament;cytoplasmic microtubule;microtubule;kinetochore;ruffle,,,,,,,,,,,,,,
2044,P30622,CLIP1,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),ESISNLSEAGSIK,_TASESISNLS(ph)EAGS(ph)IK_,S200,,26.02,,,,,,,,,,,,,26.02,0.00, , , , , , , , , , , , ,transport;mitotic prometaphase;microtubule bundle formation;positive regulation of microtubule polymerization,endosome;cytoplasmic vesicle membrane;centrosome;cytosol;intermediate filament;cytoplasmic microtubule;microtubule;kinetochore;ruffle,,,,,,,,,,,,,,
2045,P30622,CLIP1,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),NLSEAGSIKKGER,_TASES(ph)ISNLS(ph)EAGS(ph)IK_,S204,+,25.14,24.30,24.43,24.32,23.40,22.30,25.55,22.75,25.02,25.20,25.01,25.57,,24.42,0.73,-0.12,0.01,-0.09,-1.01,-2.11,1.13,-1.66,0.60,0.79,0.59,1.15, ,transport;mitotic prometaphase;microtubule bundle formation;positive regulation of microtubule polymerization,endosome;cytoplasmic vesicle membrane;centrosome;cytosol;intermediate filament;cytoplasmic microtubule;microtubule;kinetochore;ruffle,,,,,,,,,,,,,,
2049,P31321,PRKAR1B,cAMP-dependent protein kinase type I-beta regulatory subunit,SHDEEVSPTPPNP,_SNSQSDSHDEEVS(ph)PTPPNPVVK_,S83,+,,23.30,,23.00,23.35,23.23,23.27,23.20,,,23.07,23.69,,23.26, ,0.03, ,-0.26,0.09,-0.03,0.00,-0.06, , ,-0.20,0.42, ,small molecule metabolic process;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;protein phosphorylation;energy reserve metabolic process;learning or memory;transmembrane transport;regulation of insulin secretion;blood coagulation;epidermal growth factor receptor signaling pathway;activation of protein kinase A activity;nerve growth factor receptor signaling pathway;water transport;cellular response to glucagon stimulus,cytosol;cAMP-dependent protein kinase complex,,,,,,,,,,,,,,
2050,P31350,RRM2,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),PQQLQLSPLKGLS,_VPLAPITDPQQLQLS(ph)PLK_,S20,,26.45,,,26.34,,,25.77,26.41,,,24.27,24.25,,25.58,0.87, , ,0.75, , ,0.19,0.83, , ,-1.31,-1.33, ,deoxyribonucleoside diphosphate metabolic process;deoxyribonucleotide biosynthetic process;regulation of transcription involved in G1/S phase of mitotic cell cycle;protein heterotetramerization;nucleobase-containing small molecule interconversion;DNA replication,nucleoplasm;cytosol;ribonucleoside-diphosphate reductase complex,,,,,,,,,,,,,,
2051,P31629,HIVEP2,Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2),PPSLRGSHSFDER,_GS(ph)HSFDER_,S563,,24.04,23.87,,25.93,20.31,19.01,,21.84,,,,,,22.50,1.54,1.37, ,3.43,-2.19,-3.49, ,-0.66, , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
2055,P31629,HIVEP2,Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2),EASDKMSPGPPIP,_M(ox)S(ph)PGPPIPLDIASR_,S296,,23.38,22.56,22.56,21.82,,,23.39,21.78,23.25,24.08,23.30,23.35,,22.95,0.44,-0.39,-0.39,-1.12, , ,0.44,-1.16,0.31,1.13,0.35,0.40, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
2059,P31689,DNAJA1,DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2),PENGFLSPDKLSL,_VNFPENGFLS(ph)PDK_,S335,+,23.75,25.05,25.05,24.48,,,25.06,,23.01,24.42,24.27,24.36,23.21,24.27,-0.52,0.78,0.78,0.21, , ,0.79, ,-1.25,0.16,0.01,0.10,-1.06,sperm motility;protein folding;spermatogenesis;response to heat;response to unfolded protein;androgen receptor signaling pathway,membrane,,,,,,,,,,,,,,
2061,P31749,AKT1,RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha),MDFRSGSPSDNSG,_SGS(ph)PSDNSGAEEM(ox)EVSLAK_,S124,+,24.69,25.44,22.88,26.14,25.72,24.75,,26.74,23.87,,,,,25.03,-0.34,0.41,-2.15,1.11,0.69,-0.28, ,1.71,-1.16, , , , ,"negative regulation of fatty acid beta-oxidation;inflammatory response;regulation of neuron projection development;peptidyl-serine phosphorylation;negative regulation of cell size;positive regulation of cell growth;glucose metabolic process;positive regulation of glucose import;glucose transport;positive regulation of establishment of protein localization to plasma membrane;platelet activation;peripheral nervous system myelin maintenance;response to fluid shear stress;protein catabolic process;positive regulation of sequence-specific DNA binding transcription factor activity;negative regulation of JNK cascade;cellular response to epidermal growth factor stimulus;protein kinase B signaling cascade;glycogen cell differentiation involved in embryonic placenta development;nerve growth factor receptor signaling pathway;response to food;mammary gland epithelial cell differentiation;protein autophosphorylation;negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of fat cell differentiation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;negative regulation of release of cytochrome c from mitochondria;positive regulation of sodium ion transport;small molecule metabolic process;G-protein coupled receptor signaling pathway;positive regulation of nitric-oxide synthase activity;cell proliferation;response to UV-A;positive regulation of nitric oxide biosynthetic process;positive regulation of lipid biosynthetic process;regulation of translation;negative regulation of apoptotic process;fibroblast growth factor receptor signaling pathway;germ cell development;maternal placenta development;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;striated muscle cell differentiation;activation-induced cell death of T cells;mRNA metabolic process;insulin receptor signaling pathway;translation;gene expression;glycogen biosynthetic process;labyrinthine layer blood vessel development;epidermal growth factor receptor signaling pathway;anagen;regulation of G1/S transition checkpoint;positive regulation of peptidyl-serine phosphorylation;T cell costimulation;positive regulation of glycogen biosynthetic process;glucose homeostasis;negative regulation of protein kinase activity;positive regulation of blood vessel endothelial cell migration;apoptotic mitochondrial changes;osteoblast differentiation;endocrine pancreas development;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;protein import into nucleus, translocation;nitric oxide biosynthetic process;insulin-like growth factor receptor signaling pathway;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;response to heat;cell projection organization;protein ubiquitination",nucleoplasm;microtubule cytoskeleton;cytosol;plasma membrane;lamellipodium;spindle,,+,,,,,,,,+,,,,
2062,P31749,AKT1,RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha),GSPSDNSGAEEME,_SGS(ph)PSDNS(ph)GAEEM(ox)EVSLAK_,S129,,24.13,22.81,22.57,23.74,,,23.50,,,,,,,23.35,0.77,-0.54,-0.78,0.39, , ,0.15, , , , , , ,"negative regulation of fatty acid beta-oxidation;inflammatory response;regulation of neuron projection development;peptidyl-serine phosphorylation;negative regulation of cell size;positive regulation of cell growth;glucose metabolic process;positive regulation of glucose import;glucose transport;positive regulation of establishment of protein localization to plasma membrane;platelet activation;peripheral nervous system myelin maintenance;response to fluid shear stress;protein catabolic process;positive regulation of sequence-specific DNA binding transcription factor activity;negative regulation of JNK cascade;cellular response to epidermal growth factor stimulus;protein kinase B signaling cascade;glycogen cell differentiation involved in embryonic placenta development;nerve growth factor receptor signaling pathway;response to food;mammary gland epithelial cell differentiation;protein autophosphorylation;negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of fat cell differentiation;positive regulation of transcription from RNA polymerase II promoter;phosphatidylinositol-mediated signaling;negative regulation of release of cytochrome c from mitochondria;positive regulation of sodium ion transport;small molecule metabolic process;G-protein coupled receptor signaling pathway;positive regulation of nitric-oxide synthase activity;cell proliferation;response to UV-A;positive regulation of nitric oxide biosynthetic process;positive regulation of lipid biosynthetic process;regulation of translation;negative regulation of apoptotic process;fibroblast growth factor receptor signaling pathway;germ cell development;maternal placenta development;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;striated muscle cell differentiation;activation-induced cell death of T cells;mRNA metabolic process;insulin receptor signaling pathway;translation;gene expression;glycogen biosynthetic process;labyrinthine layer blood vessel development;epidermal growth factor receptor signaling pathway;anagen;regulation of G1/S transition checkpoint;positive regulation of peptidyl-serine phosphorylation;T cell costimulation;positive regulation of glycogen biosynthetic process;glucose homeostasis;negative regulation of protein kinase activity;positive regulation of blood vessel endothelial cell migration;apoptotic mitochondrial changes;osteoblast differentiation;endocrine pancreas development;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;protein import into nucleus, translocation;nitric oxide biosynthetic process;insulin-like growth factor receptor signaling pathway;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;response to heat;cell projection organization;protein ubiquitination",nucleoplasm;microtubule cytoskeleton;cytosol;plasma membrane;lamellipodium;spindle,,+,,,,,,,,+,,,,
2063,P31751,AKT2,RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta),LLKSDGSFIGYKE,_SDGS(ph)FIGYK_,S34,,23.19,20.55,,,,,,,20.63,,,21.02,,21.35,1.85,-0.80, , , , , , ,-0.72, , ,-0.33, ,positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;fat cell differentiation;negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;regulation of JNK cascade;positive regulation of cell migration;positive regulation of glucose import in response to insulin stimulus;insulin receptor signaling pathway;glucose metabolic process;response to osmotic stress;positive regulation of glucose import;positive regulation of transcription from RNA polymerase II promoter;positive regulation of cell motility;glycogen biosynthetic process;regulation of cell migration;positive regulation of sodium ion transport;peripheral nervous system myelin maintenance;positive regulation of fatty acid beta-oxidation;regulation of cell cycle arrest;positive regulation of signal transduction;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;protein localization to plasma membrane;protein kinase B signaling cascade;carbohydrate transport;positive regulation of positive chemotaxis;positive regulation of nitric oxide biosynthetic process;response to muscle activity;negative regulation of RNA splicing;regulation of translation;mammary gland epithelial cell differentiation,nucleoplasm;cytosol;mitochondrion;plasma membrane;nucleus;lamellipodium;insulin-responsive compartment,,+,,,,,,,,,,,,
2065,P31943,HNRNPH1,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]",AFVELESEDEVKL,_EGRPSGEAFVELES(ph)EDEVK_,S63,+,22.61,,,,23.19,25.26,24.93,24.77,25.58,24.98,24.06,23.52,25.53,24.44,-1.83, , , ,-1.25,0.82,0.48,0.33,1.14,0.53,-0.38,-0.93,1.09,"mRNA splicing, via spliceosome;regulation of RNA splicing",nucleoplasm;catalytic step 2 spliceosome;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2067,P31948,STIP1,Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521),QYNRHDSPEDVKR,_HDS(ph)PEDVK_,S481,,18.35,21.30,,22.30,,,,,,,,,,20.65,-2.30,0.65, ,1.65, , , , , , , , , ,axon guidance;response to stress,Golgi apparatus;nucleus;protein complex,,,,,,,,,,,,,,
2068,P31949,S100A11,Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11),__MAKISSPTETE,_(ac)AKIS(ph)SPTETER_,S5,+,25.33,23.51,24.04,23.11,24.01,,22.56,24.76,21.95,,,,,23.66,1.67,-0.15,0.38,-0.55,0.35, ,-1.10,1.10,-1.70, , , , ,signal transduction;negative regulation of cell proliferation;negative regulation of DNA replication,nucleus;ruffle;cytoplasm,,,,,,,,,,,,,,
2070,P32004,L1CAM,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),ETFGEYSDNEEKA,_DETFGEYS(ph)DNEEK_,S1172,,24.05,26.22,26.22,,,,23.20,22.76,,25.27,22.78,23.23,,24.22,-0.17,2.01,2.01, , , ,-1.02,-1.46, ,1.05,-1.44,-0.99, ,homotypic cell-cell adhesion;positive regulation of cell-cell adhesion;positive regulation of calcium-mediated signaling;axon guidance;heterophilic cell-cell adhesion;blood coagulation;leukocyte cell-cell adhesion;cell death;cell adhesion;homophilic cell adhesion;cell-cell adhesion mediated by integrin;leukocyte migration;cell surface receptor signaling pathway,integral to membrane;plasma membrane;terminal button;external side of plasma membrane;presynaptic membrane,,,,,,,,,,,,,,
2071,P32246,CCR1,C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191),TGEHELSAGF___,_VSSTSPSTGEHELS(ph)AGF_,S352,,,26.44,26.25,,,,,,,,,,,26.34, ,0.09,-0.09, , , , , , , , , , ,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;negative regulation of gene expression;inflammatory response;positive regulation of osteoclast differentiation;immune response;exocytosis;calcium ion transport;positive regulation of ERK1 and ERK2 cascade;cell-cell signaling;positive regulation of calcium ion transport;negative regulation of bone mineralization;dendritic cell chemotaxis;cell adhesion;elevation of cytosolic calcium ion concentration;positive regulation of monocyte chemotaxis",integral to plasma membrane;external side of plasma membrane,,,,,,,,,,,,,,
2072,P32418,SLC8A1,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),DKQPLTSKEEEER,_QPLT(ph)S(ph)KEEEER_,S52,,22.91,25.27,,24.58,28.00,28.20,23.48,27.49,,25.35,23.06,,25.89,25.42,-2.52,-0.15, ,-0.84,2.58,2.78,-1.94,2.06, ,-0.07,-2.36, ,0.47,response to drug;cardiac muscle cell development;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;telencephalon development;regulation of heart rate;relaxation of smooth muscle;blood coagulation;sodium ion export;regulation of the force of heart contraction;cellular response to reactive oxygen species;response to nutrient;vascular smooth muscle contraction;response to ATP;cell communication by electrical coupling involved in cardiac conduction;cellular response to cAMP;response to hypoxia;calcium ion transport into cytosol;response to glucose stimulus;calcium ion import;cellular response to caffeine;response to hydrogen peroxide;regulation of sodium ion transport;reduction of cytosolic calcium ion concentration;relaxation of cardiac muscle,Z disc;T-tubule;mitochondrion;intercalated disc;dendritic spine;microtubule;integral to plasma membrane,,,,,,,,,,,,,,
2073,P32519,ELF1,ETS-related transcription factor Elf-1 (E74-like factor 1),QEKYADSPGASSP,_YADS(ph)PGASSPEQPK_,S139,,23.66,,,23.83,22.56,,22.72,,23.71,21.65,,,,23.02,0.64, , ,0.81,-0.46, ,-0.31, ,0.69,-1.37, , , ,"regulation of cytokine production;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;negative regulation of T cell receptor signaling pathway",nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
2075,P32519,ELF1,ETS-related transcription factor Elf-1 (E74-like factor 1),DSPGASSPEQPKR,_YADSPGASS(ph)PEQPK_,S144,+,25.69,26.04,26.60,22.49,,25.27,,23.83,23.98,23.62,,,,24.69,1.00,1.35,1.91,-2.20, ,0.58, ,-0.86,-0.71,-1.07, , , ,"regulation of cytokine production;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;negative regulation of T cell receptor signaling pathway",nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
2076,P33240,CSTF2,Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64),SQPGGFSPGQNQV,_QVPVM(ox)QGTGM(ox)QGASIQGGSQPGGFS(ph)PGQNQVTPQDHEK_,S500,,,,,,24.63,,,,24.45,,,,,24.54, , , , ,0.09, , , ,-0.09, , , , ,"termination of RNA polymerase II transcription;mRNA cleavage;mRNA splicing, via spliceosome;mRNA polyadenylation",mRNA cleavage and polyadenylation specificity factor complex;cleavage body,,,,,,,,,,,,,,
2077,P33241,LSP1,Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein) (pp52) (Lymphocyte-specific antigen WP34),KLARQASIELPSM,_QAS(ph)IELPSM(ox)AVASTK_,S252,,23.53,29.08,29.58,22.49,,,22.40,,,,,,,25.42,-1.89,3.67,4.16,-2.93, , ,-3.02, , , , , , ,chemotaxis;cellular defense response;cellular component movement,plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2078,P33241,LSP1,Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein) (pp52) (Lymphocyte-specific antigen WP34),LIDRTESLNRSIE,_LIDRTES(ph)LNR_,S204,,,27.34,27.30,22.63,22.05,,,,,,,,,24.83, ,2.51,2.47,-2.20,-2.78, , , , , , , , ,chemotaxis;cellular defense response;cellular component movement,plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2079,P33241,LSP1,Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein) (pp52) (Lymphocyte-specific antigen WP34),EPPQCRSPEGEQE,_S(ph)PEGEQEDRPGLHAYEK_,S111,,,25.60,24.50,,22.24,21.02,,,,,22.32,,23.36,23.17, ,2.43,1.33, ,-0.93,-2.16, , , , ,-0.85, ,0.19,chemotaxis;cellular defense response;cellular component movement,plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2082,P33316,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)",EETPAISPSKRAR,_PCSEETPAIS(ph)PSK_,S11,,26.75,27.10,27.10,27.64,26.87,25.51,26.52,28.41,25.13,,,,,26.78,-0.04,0.32,0.32,0.86,0.09,-1.27,-0.26,1.63,-1.66, , , , ,pyrimidine nucleobase metabolic process;dUMP biosynthetic process;pyrimidine nucleoside biosynthetic process;dUTP metabolic process;DNA replication,nucleoplasm;mitochondrion,,,,,,,,,,,,,,
2083,P33527,ABCC1,Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter),ISRHHNSTAELQK,_HHNS(ph)TAELQK_,S839,,,20.13,,,20.82,,,,,,,,,20.48, ,-0.34, , ,0.34, , , , , , , , ,response to oxidative stress;drug export;phospholipid efflux;response to drug;cell chemotaxis;positive regulation of cell migration;plasma membrane long-chain fatty acid transport;glutathione transmembrane transport,basolateral plasma membrane;Golgi apparatus;nucleus;integral to plasma membrane,,,,,,,,,,,,,,
2084,P33527,ABCC1,Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter),QLQRQLSSSSSYS,_(gl)QLS(ph)SSSSYSGDISR_,S824,,22.34,,,22.58,,23.01,,,22.25,,,,,22.54,-0.20, , ,0.03, ,0.47, , ,-0.30, , , , ,response to oxidative stress;drug export;phospholipid efflux;response to drug;cell chemotaxis;positive regulation of cell migration;plasma membrane long-chain fatty acid transport;glutathione transmembrane transport,basolateral plasma membrane;Golgi apparatus;nucleus;integral to plasma membrane,,,,,,,,,,,,,,
2088,P34910,EVI2B,Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361),EIKLFESSENIED,_LFES(ph)SENIEDSNNPK_,S294,,,24.90,24.03,23.70,,,,,25.10,,,,,24.43, ,0.47,-0.40,-0.73, , , , ,0.67, , , , ,,integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2089,P34932,HSPA4,Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2),FHGRAFSDPFVEA,_AFS(ph)DPFVEAEK_,S76,+,25.78,23.72,23.74,24.34,25.26,24.88,24.92,25.92,24.32,25.22,25.39,26.07,26.06,25.05,0.74,-1.32,-1.31,-0.70,0.21,-0.17,-0.13,0.87,-0.73,0.18,0.34,1.02,1.01,chaperone-mediated protein complex assembly;response to heat;response to unfolded protein;protein import into mitochondrial outer membrane;positive regulation of protein binding,cytosol;lipid particle;nucleus;cytoplasm,,,,,,,,,,,,,,
2090,P34932,HSPA4,Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2),SEDDRNSFTLKLE,_FVSEDDRNS(ph)FTLK_,S647,,,,,,,,,,22.51,,23.25,23.65,,23.14, , , , , , , , ,-0.63, ,0.12,0.52, ,chaperone-mediated protein complex assembly;response to heat;response to unfolded protein;protein import into mitochondrial outer membrane;positive regulation of protein binding,cytosol;lipid particle;nucleus;cytoplasm,,,,,,,,,,,,,,
2091,P43250,GRK6,G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6),LDIEQFSTVKGVN,_DVLDIEQFS(ph)TVK_,S227,,23.63,,,,,,,,23.01,,,22.36,,23.00,0.63, , , , , , , ,0.01, , ,-0.64, ,regulation of G-protein coupled receptor protein signaling pathway;Wnt receptor signaling pathway;termination of G-protein coupled receptor signaling pathway,membrane,,+,,,,,,,,,,,,
2092,P35221,CTNNA1,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),PEELDDSDFETED,_TPEELDDS(ph)DFETEDFDVRSR_,S641,+,30.47,,,,29.49,23.34,23.19,22.83,27.04,29.29,24.11,27.49,23.66,26.09,4.38, , , ,3.40,-2.75,-2.90,-3.26,0.95,3.20,-1.98,1.39,-2.43,negative regulation of apoptotic process;male gonad development;negative regulation of neuroblast proliferation;cellular response to indole-3-methanol;aging;ovarian follicle development;axon regeneration;apical junction assembly;response to estrogen stimulus;adherens junction organization;establishment or maintenance of cell polarity;positive regulation of muscle cell differentiation;gap junction assembly;positive regulation of smoothened signaling pathway;cell adhesion;odontogenesis of dentin-containing tooth;muscle cell differentiation,cytosol;cell-cell junction;acrosomal vesicle;zonula adherens;lamellipodium;catenin complex;actin cytoskeleton,,,,,,,,,,,,,,
2093,P35221,CTNNA1,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),EDFDVRSRTSVQT,_TPEELDDS(ph)DFETEDFDVRS(ph)R_,S652,,27.85,23.72,,22.81,,,,,,,27.34,,,25.43,2.42,-1.71, ,-2.62, , , , , , ,1.91, , ,negative regulation of apoptotic process;male gonad development;negative regulation of neuroblast proliferation;cellular response to indole-3-methanol;aging;ovarian follicle development;axon regeneration;apical junction assembly;response to estrogen stimulus;adherens junction organization;establishment or maintenance of cell polarity;positive regulation of muscle cell differentiation;gap junction assembly;positive regulation of smoothened signaling pathway;cell adhesion;odontogenesis of dentin-containing tooth;muscle cell differentiation,cytosol;cell-cell junction;acrosomal vesicle;zonula adherens;lamellipodium;catenin complex;actin cytoskeleton,,,,,,,,,,,,,,
2094,P35222,CTNNB1,Catenin beta-1 (Beta-catenin),DYKKRLSVELTSS,_RLS(ph)VELTSSLFR_,S675,,,,,,23.17,,22.61,21.90,24.48,,,,,23.04, , , , ,0.14, ,-0.43,-1.14,1.44, , , , ,"renal vesicle formation;pancreas development;negative regulation of cell proliferation;cell-cell adhesion;synaptic vesicle transport;neuron migration;T cell differentiation in thymus;mesenchymal to epithelial transition involved in metanephros morphogenesis;osteoclast differentiation;glial cell fate determination;regulation of T cell proliferation;lung-associated mesenchyme development;cytoskeletal anchoring at plasma membrane;adherens junction assembly;regulation of calcium ion import;regulation of fibroblast proliferation;positive regulation of neuroblast proliferation;smooth muscle cell differentiation;regulation of angiogenesis;central nervous system vasculogenesis;anterior/posterior axis specification;canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition;in utero embryonic development;branching involved in ureteric bud morphogenesis;response to estradiol stimulus;endodermal cell fate commitment;positive regulation of epithelial cell proliferation involved in prostate gland development;negative regulation of osteoclast differentiation;odontogenesis of dentin-containing tooth;positive regulation of determination of dorsal identity;embryonic skeletal limb joint morphogenesis;transcription, DNA-dependent;regulation of centriole-centriole cohesion;genitalia morphogenesis;response to cytokine stimulus;regulation of nephron tubule epithelial cell differentiation;lung induction;cellular response to indole-3-methanol;regulation of smooth muscle cell proliferation;embryonic heart tube development;response to drug;oviduct development;cellular component disassembly involved in execution phase of apoptosis;regulation of centromeric sister chromatid cohesion;patterning of blood vessels;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of heart induction by canonical Wnt receptor signaling pathway;renal outer medulla development;oocyte development;midgut development;androgen receptor signaling pathway;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;renal inner medulla development;positive regulation of branching involved in lung morphogenesis;positive regulation of muscle cell differentiation;embryonic axis specification;cell-matrix adhesion;hair follicle placode formation;thymus development;regulation of protein localization to cell surface;regulation of myelination;negative regulation of chondrocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of endothelial cell differentiation;tongue morphogenesis;protein localization to cell surface;positive regulation of apoptotic process;ectoderm development;response to cadmium ion;embryonic digit morphogenesis;cell fate specification;fungiform papilla formation;cell maturation;liver development;embryonic hindlimb morphogenesis;synapse organization;forebrain development;positive regulation of mesenchymal cell proliferation;endothelial tube morphogenesis;mesenchymal cell proliferation involved in lung development;hair follicle morphogenesis;skin development;trachea formation;determination of dorsal/ventral asymmetry;male genitalia development;gastrulation with mouth forming second;positive regulation of fibroblast growth factor receptor signaling pathway;negative regulation of oligodendrocyte differentiation;proximal/distal pattern formation;hair cell differentiation;regulation of secondary heart field cardioblast proliferation;positive regulation of MAPK cascade;lens morphogenesis in camera-type eye;epithelial cell differentiation involved in prostate gland development;bone resorption;myoblast differentiation;nephron tubule formation;lung cell differentiation;hindbrain development;embryonic foregut morphogenesis;canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process;dorsal/ventral axis specification;positive regulation of osteoblast differentiation;positive regulation of heparan sulfate proteoglycan biosynthetic process;epithelial tube branching involved in lung morphogenesis;Schwann cell proliferation;canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation",Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;apical part of cell;beta-catenin-TCF7L2 complex;Scrib-APC-beta-catenin complex;cell cortex;zonula adherens;transcription factor complex;fascia adherens;dendritic shaft;cell-substrate adherens junction;microvillus membrane;centrosome;internal side of plasma membrane;perinuclear region of cytoplasm;cytosol;synapse;catenin complex;lamellipodium;spindle pole;beta-catenin destruction complex;desmosome,,,,,,,,,,+,,,,
2095,P35222,CTNNB1,Catenin beta-1 (Beta-catenin),DTQRRTSMGGTQQ,_RTS(ph)M(ox)GGTQQQFVEGVR_,S552,+,28.37,27.59,26.70,28.41,28.59,29.53,27.18,28.61,28.36,28.17,27.95,27.66,28.14,28.10,0.27,-0.51,-1.40,0.31,0.50,1.43,-0.92,0.51,0.26,0.07,-0.14,-0.44,0.04,"renal vesicle formation;pancreas development;negative regulation of cell proliferation;cell-cell adhesion;synaptic vesicle transport;neuron migration;T cell differentiation in thymus;mesenchymal to epithelial transition involved in metanephros morphogenesis;osteoclast differentiation;glial cell fate determination;regulation of T cell proliferation;lung-associated mesenchyme development;cytoskeletal anchoring at plasma membrane;adherens junction assembly;regulation of calcium ion import;regulation of fibroblast proliferation;positive regulation of neuroblast proliferation;smooth muscle cell differentiation;regulation of angiogenesis;central nervous system vasculogenesis;anterior/posterior axis specification;canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition;in utero embryonic development;branching involved in ureteric bud morphogenesis;response to estradiol stimulus;endodermal cell fate commitment;positive regulation of epithelial cell proliferation involved in prostate gland development;negative regulation of osteoclast differentiation;odontogenesis of dentin-containing tooth;positive regulation of determination of dorsal identity;embryonic skeletal limb joint morphogenesis;transcription, DNA-dependent;regulation of centriole-centriole cohesion;genitalia morphogenesis;response to cytokine stimulus;regulation of nephron tubule epithelial cell differentiation;lung induction;cellular response to indole-3-methanol;regulation of smooth muscle cell proliferation;embryonic heart tube development;response to drug;oviduct development;cellular component disassembly involved in execution phase of apoptosis;regulation of centromeric sister chromatid cohesion;patterning of blood vessels;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of heart induction by canonical Wnt receptor signaling pathway;renal outer medulla development;oocyte development;midgut development;androgen receptor signaling pathway;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;renal inner medulla development;positive regulation of branching involved in lung morphogenesis;positive regulation of muscle cell differentiation;embryonic axis specification;cell-matrix adhesion;hair follicle placode formation;thymus development;regulation of protein localization to cell surface;regulation of myelination;negative regulation of chondrocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of endothelial cell differentiation;tongue morphogenesis;protein localization to cell surface;positive regulation of apoptotic process;ectoderm development;response to cadmium ion;embryonic digit morphogenesis;cell fate specification;fungiform papilla formation;cell maturation;liver development;embryonic hindlimb morphogenesis;synapse organization;forebrain development;positive regulation of mesenchymal cell proliferation;endothelial tube morphogenesis;mesenchymal cell proliferation involved in lung development;hair follicle morphogenesis;skin development;trachea formation;determination of dorsal/ventral asymmetry;male genitalia development;gastrulation with mouth forming second;positive regulation of fibroblast growth factor receptor signaling pathway;negative regulation of oligodendrocyte differentiation;proximal/distal pattern formation;hair cell differentiation;regulation of secondary heart field cardioblast proliferation;positive regulation of MAPK cascade;lens morphogenesis in camera-type eye;epithelial cell differentiation involved in prostate gland development;bone resorption;myoblast differentiation;nephron tubule formation;lung cell differentiation;hindbrain development;embryonic foregut morphogenesis;canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process;dorsal/ventral axis specification;positive regulation of osteoblast differentiation;positive regulation of heparan sulfate proteoglycan biosynthetic process;epithelial tube branching involved in lung morphogenesis;Schwann cell proliferation;canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation",Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;apical part of cell;beta-catenin-TCF7L2 complex;Scrib-APC-beta-catenin complex;cell cortex;zonula adherens;transcription factor complex;fascia adherens;dendritic shaft;cell-substrate adherens junction;microvillus membrane;centrosome;internal side of plasma membrane;perinuclear region of cytoplasm;cytosol;synapse;catenin complex;lamellipodium;spindle pole;beta-catenin destruction complex;desmosome,,,,,,,,,,+,,,,
2096,P35222,CTNNB1,Catenin beta-1 (Beta-catenin),RHAIMRSPQMVSA,_S(ph)PQM(ox)VSAIVR_,S191,+,26.17,24.99,23.16,26.50,25.24,25.46,25.52,24.13,25.56,24.68,21.82,23.06,,24.69,1.48,0.30,-1.53,1.81,0.55,0.77,0.82,-0.56,0.87,-0.01,-2.87,-1.63, ,"renal vesicle formation;pancreas development;negative regulation of cell proliferation;cell-cell adhesion;synaptic vesicle transport;neuron migration;T cell differentiation in thymus;mesenchymal to epithelial transition involved in metanephros morphogenesis;osteoclast differentiation;glial cell fate determination;regulation of T cell proliferation;lung-associated mesenchyme development;cytoskeletal anchoring at plasma membrane;adherens junction assembly;regulation of calcium ion import;regulation of fibroblast proliferation;positive regulation of neuroblast proliferation;smooth muscle cell differentiation;regulation of angiogenesis;central nervous system vasculogenesis;anterior/posterior axis specification;canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition;in utero embryonic development;branching involved in ureteric bud morphogenesis;response to estradiol stimulus;endodermal cell fate commitment;positive regulation of epithelial cell proliferation involved in prostate gland development;negative regulation of osteoclast differentiation;odontogenesis of dentin-containing tooth;positive regulation of determination of dorsal identity;embryonic skeletal limb joint morphogenesis;transcription, DNA-dependent;regulation of centriole-centriole cohesion;genitalia morphogenesis;response to cytokine stimulus;regulation of nephron tubule epithelial cell differentiation;lung induction;cellular response to indole-3-methanol;regulation of smooth muscle cell proliferation;embryonic heart tube development;response to drug;oviduct development;cellular component disassembly involved in execution phase of apoptosis;regulation of centromeric sister chromatid cohesion;patterning of blood vessels;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of heart induction by canonical Wnt receptor signaling pathway;renal outer medulla development;oocyte development;midgut development;androgen receptor signaling pathway;cellular response to growth factor stimulus;positive regulation of transcription from RNA polymerase II promoter;renal inner medulla development;positive regulation of branching involved in lung morphogenesis;positive regulation of muscle cell differentiation;embryonic axis specification;cell-matrix adhesion;hair follicle placode formation;thymus development;regulation of protein localization to cell surface;regulation of myelination;negative regulation of chondrocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of endothelial cell differentiation;tongue morphogenesis;protein localization to cell surface;positive regulation of apoptotic process;ectoderm development;response to cadmium ion;embryonic digit morphogenesis;cell fate specification;fungiform papilla formation;cell maturation;liver development;embryonic hindlimb morphogenesis;synapse organization;forebrain development;positive regulation of mesenchymal cell proliferation;endothelial tube morphogenesis;mesenchymal cell proliferation involved in lung development;hair follicle morphogenesis;skin development;trachea formation;determination of dorsal/ventral asymmetry;male genitalia development;gastrulation with mouth forming second;positive regulation of fibroblast growth factor receptor signaling pathway;negative regulation of oligodendrocyte differentiation;proximal/distal pattern formation;hair cell differentiation;regulation of secondary heart field cardioblast proliferation;positive regulation of MAPK cascade;lens morphogenesis in camera-type eye;epithelial cell differentiation involved in prostate gland development;bone resorption;myoblast differentiation;nephron tubule formation;lung cell differentiation;hindbrain development;embryonic foregut morphogenesis;canonical Wnt receptor signaling pathway involved in negative regulation of apoptotic process;dorsal/ventral axis specification;positive regulation of osteoblast differentiation;positive regulation of heparan sulfate proteoglycan biosynthetic process;epithelial tube branching involved in lung morphogenesis;Schwann cell proliferation;canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation",Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;apical part of cell;beta-catenin-TCF7L2 complex;Scrib-APC-beta-catenin complex;cell cortex;zonula adherens;transcription factor complex;fascia adherens;dendritic shaft;cell-substrate adherens junction;microvillus membrane;centrosome;internal side of plasma membrane;perinuclear region of cytoplasm;cytosol;synapse;catenin complex;lamellipodium;spindle pole;beta-catenin destruction complex;desmosome,,,,,,,,,,+,,,,
2097,P35226,BMI1,Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51),NAGELESDSGSDK,_DGLTNAGELES(ph)DSGSDK_,S156,,21.61,,,22.95,,,,,,,,,,22.28,-0.67, , ,0.67, , , , , , , , , ,"negative regulation of apoptotic process;embryonic skeletal system morphogenesis;positive regulation of ubiquitin-protein ligase activity;segment specification;positive regulation of immature T cell proliferation in thymus;positive regulation of fibroblast proliferation;histone ubiquitination;histone acetylation;somatic stem cell division;in utero embryonic development;brain development;humoral immune response;negative regulation of transcription from RNA polymerase II promoter;positive regulation of B cell proliferation;transcription, DNA-dependent;hemopoiesis;rostrocaudal neural tube patterning",ubiquitin ligase complex;nuclear body;nucleolus;PRC1 complex;cytoplasm,,,,,,,,,,,,,,
2100,P35240,NF2,Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin),TDMKRLSMEIEKE,_RLS(ph)MEIEK_,S476,+,23.54,29.17,23.16,27.42,25.01,27.21,26.94,26.81,27.21,27.29,26.85,26.67,25.87,26.40,-2.86,2.78,-3.24,1.03,-1.39,0.81,0.55,0.42,0.81,0.89,0.45,0.28,-0.53,negative regulation of cell proliferation;negative regulation of tyrosine phosphorylation of Stat3 protein;negative regulation of DNA replication;negative regulation of cell-matrix adhesion;regulation of hippo signaling cascade;cell-cell junction organization;negative regulation of MAPK cascade;actin cytoskeleton organization;negative regulation of cell migration;negative regulation of protein kinase activity;negative regulation of tyrosine phosphorylation of Stat5 protein;positive regulation of stress fiber assembly;lens fiber cell differentiation;odontogenesis of dentin-containing tooth;Schwann cell proliferation;mesoderm formation;negative regulation of cell-cell adhesion;ectoderm development,cortical actin cytoskeleton;cleavage furrow;perinuclear region of cytoplasm;extrinsic to membrane;early endosome;ruffle membrane;adherens junction;nucleolus;plasma membrane;cytoskeleton;lamellipodium;filopodium membrane,,,,,,,,,,,,,,
2103,P35251,RFC1,Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),IIYDSDSESEETL,_IIYDSDS(ph)ESEETLQVK_,S71,,21.07,,,,25.60,,,,22.61,24.49,,,,23.44,-2.37, , , ,2.16, , , ,-0.84,1.05, , , ,"telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;telomere maintenance via telomerase;telomere maintenance via recombination;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;DNA strand elongation involved in DNA replication;transcription, DNA-dependent;nucleotide-excision repair, DNA gap filling",nucleoplasm;DNA replication factor C complex,Other TF domain,,,,,,,,,,,,,
2106,P35251,RFC1,Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),AKKESVSPEDSEK,_KESVS(ph)PEDSEK_,S368,+,22.56,,,24.72,,20.90,21.30,21.29,21.64,,,22.68,,22.16,0.41, , ,2.56, ,-1.25,-0.86,-0.86,-0.52, , ,0.52, ,"telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;telomere maintenance via telomerase;telomere maintenance via recombination;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;DNA strand elongation involved in DNA replication;transcription, DNA-dependent;nucleotide-excision repair, DNA gap filling",nucleoplasm;DNA replication factor C complex,Other TF domain,,,,,,,,,,,,,
2107,P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),EMSSDASDASGEE,_IHDLEDDLEM(ox)SSDAS(ph)DAS(ph)GEEGGRVPK_,S221,,24.67,,,,24.48,,,,,,,,,24.58,0.10, , , ,-0.10, , , , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;mRNA splicing, via spliceosome;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription",transcription factor TFIIF complex;cell junction,Other TF domain,,,,,,,,,,,,,
2109,P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),GSSRGNSRPGTPS,_GNS(ph)RPGT(ph)PSAEGGSTSSTLR_,S385,,24.88,23.54,,23.83,,,,,,,,,,24.08,0.79,-0.54, ,-0.25, , , , , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;mRNA splicing, via spliceosome;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription",transcription factor TFIIF complex;cell junction,Other TF domain,,,,,,,,,,,,,
2112,P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),TGPQSLSGKSTPQ,_LDTGPQSLS(ph)GK_,S433,+,25.23,24.21,23.42,23.88,22.03,,,,23.95,,,23.79,,23.79,1.44,0.42,-0.37,0.09,-1.75, , , ,0.16, , ,0.00, ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;mRNA splicing, via spliceosome;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription",transcription factor TFIIF complex;cell junction,Other TF domain,,,,,,,,,,,,,
2113,P35270,SPR,Sepiapterin reductase (SPR) (EC 1.1.1.153),LINNAGSLGDVSK,_LLLINNAGS(ph)LGDVSK_,S103,,21.31,,,,,,,,,,,,,21.31,0.00, , , , , , , , , , , , ,regulation of nitric-oxide synthase activity;nitric oxide biosynthetic process;small molecule metabolic process;tetrahydrobiopterin biosynthetic process,cytosol;nucleus,,,,,,,,,,,,,,
2114,P35318,ADM,ADM [Cleaved into: Adrenomedullin (AM);Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)],GRRRRRSLPEAGP,_S(ph)LPEAGPGR_,S85,,24.56,21.94,,21.76,,,,,,,,,,22.75,1.80,-0.81, ,-0.99, , , , , , , , , ,negative regulation of cell proliferation;response to cold;spongiotrophoblast layer development;cAMP biosynthetic process;regulation of the force of heart contraction;cAMP-mediated signaling;response to lipopolysaccharide;positive regulation of vasodilation;positive regulation of heart rate;progesterone biosynthetic process;positive regulation of vasculogenesis;vasculogenesis;response to starvation;neural tube closure;androgen metabolic process;cell-cell signaling;response to insulin stimulus;odontogenesis of dentin-containing tooth;organ regeneration;elevation of cytosolic calcium ion concentration;heart development;blood circulation;aging;response to wounding;branching involved in labyrinthine layer morphogenesis;G-protein coupled receptor internalization;hormone secretion;positive regulation of cell proliferation;positive regulation of cAMP biosynthetic process;negative regulation of vasoconstriction;response to hypoxia;developmental growth;positive regulation of angiogenesis;signal transduction;neuron projection regeneration;response to glucocorticoid stimulus;female pregnancy;vascular smooth muscle cell development;negative regulation of vascular permeability,extracellular space;cytoplasm,,,,,,,,,,,,,,
2116,P35367,HRH1,Histamine H1 receptor (H1R) (HH1R),GKLRSGSNTGLDY,_SGS(ph)NTGLDYIK_,S380,+,22.99,21.74,20.32,22.82,23.83,23.61,22.41,23.90,23.01,,22.07,,22.89,22.69,0.30,-0.95,-2.37,0.13,1.14,0.92,-0.28,1.22,0.32, ,-0.62, ,0.20,inflammatory response;phospholipase C-activating G-protein coupled receptor signaling pathway;response to gravity;inositol phosphate-mediated signaling;cellular response to histamine;negative regulation of steroid biosynthetic process;positive regulation of inositol trisphosphate biosynthetic process;synaptic transmission;positive regulation of nitric oxide biosynthetic process;positive regulation of vasoconstriction,nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2117,P35367,HRH1,Histamine H1 receptor (H1R) (HH1R),RELINRSLPSFSE,_S(ph)LPS(ph)FSEIK_,S230,,21.89,,,,,,,,,,,,,21.89,0.00, , , , , , , , , , , , ,inflammatory response;phospholipase C-activating G-protein coupled receptor signaling pathway;response to gravity;inositol phosphate-mediated signaling;cellular response to histamine;negative regulation of steroid biosynthetic process;positive regulation of inositol trisphosphate biosynthetic process;synaptic transmission;positive regulation of nitric oxide biosynthetic process;positive regulation of vasoconstriction,nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2118,P35367,HRH1,Histamine H1 receptor (H1R) (HH1R),INRSLPSFSEIKL,_S(ph)LPS(ph)FSEIK_,S233,,23.65,21.85,22.69,22.56,23.18,23.36,24.96,24.87,,,24.39,,,23.50,0.15,-1.65,-0.81,-0.95,-0.32,-0.14,1.46,1.37, , ,0.89, , ,inflammatory response;phospholipase C-activating G-protein coupled receptor signaling pathway;response to gravity;inositol phosphate-mediated signaling;cellular response to histamine;negative regulation of steroid biosynthetic process;positive regulation of inositol trisphosphate biosynthetic process;synaptic transmission;positive regulation of nitric oxide biosynthetic process;positive regulation of vasoconstriction,nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2119,P35568,IRS1,Insulin receptor substrate 1 (IRS-1),____MASPPESDG,_(ac)AS(ph)PPESDGFSDVRK_,S3,,23.10,24.38,24.06,26.83,25.86,25.53,26.32,26.06,25.24,25.04,24.82,25.45,25.31,25.23,-2.13,-0.85,-1.17,1.60,0.62,0.30,1.09,0.83,0.00,-0.19,-0.41,0.22,0.08,protein localization to nucleus;negative regulation of somatostatin secretion;positive regulation of glycogen biosynthetic process;positive regulation of glucagon secretion;positive regulation of cell migration;glucose homeostasis;protein heterooligomerization;positive regulation of glucose import in response to insulin stimulus;insulin receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase activity;positive regulation of mesenchymal cell proliferation;positive regulation of cell proliferation;mammary gland development;phosphatidylinositol 3-kinase cascade;regulation of gene expression;negative regulation of insulin receptor signaling pathway;JAK-STAT cascade involved in growth hormone signaling pathway;positive regulation of fatty acid beta-oxidation;protein kinase B signaling cascade;negative regulation of insulin secretion;insulin-like growth factor receptor signaling pathway;positive regulation of phosphorylation;lipid catabolic process;nerve growth factor receptor signaling pathway;positive regulation of insulin receptor signaling pathway,cytosol;caveola;nucleus;insulin receptor complex,,,,+,,,,,,,,,,
2120,P35568,IRS1,Insulin receptor substrate 1 (IRS-1),FTRVNLSPNRNQS,_VNLS(ph)PNR_,S1078,,21.40,,,24.43,,,,,,,,,,22.92,-1.51, , ,1.51, , , , , , , , , ,protein localization to nucleus;negative regulation of somatostatin secretion;positive regulation of glycogen biosynthetic process;positive regulation of glucagon secretion;positive regulation of cell migration;glucose homeostasis;protein heterooligomerization;positive regulation of glucose import in response to insulin stimulus;insulin receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase activity;positive regulation of mesenchymal cell proliferation;positive regulation of cell proliferation;mammary gland development;phosphatidylinositol 3-kinase cascade;regulation of gene expression;negative regulation of insulin receptor signaling pathway;JAK-STAT cascade involved in growth hormone signaling pathway;positive regulation of fatty acid beta-oxidation;protein kinase B signaling cascade;negative regulation of insulin secretion;insulin-like growth factor receptor signaling pathway;positive regulation of phosphorylation;lipid catabolic process;nerve growth factor receptor signaling pathway;positive regulation of insulin receptor signaling pathway,cytosol;caveola;nucleus;insulin receptor complex,,,,+,,,,,,,,,,
2121,P35579,MYH9,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)",ADEIANSSGKGAL,_DELADEIANS(ph)SGK_,S1713,,24.33,23.57,22.94,24.04,22.71,,,24.61,,,,,,23.70,0.63,-0.13,-0.76,0.34,-0.99, , ,0.91, , , , , ,cell-cell adhesion;platelet formation;establishment of T cell polarity;blood vessel endothelial cell migration;protein transport;integrin-mediated signaling pathway;cytokinesis;establishment of meiotic spindle localization;regulation of cell shape;angiogenesis;meiotic metaphase I;meiotic spindle organization;membrane protein ectodomain proteolysis;in utero embryonic development;actin filament-based movement;axon guidance;termination of G-protein coupled receptor signaling pathway;actin cytoskeleton reorganization;monocyte differentiation;uropod organization;myoblast fusion;leukocyte migration,cleavage furrow;stress fiber;plasma membrane;nucleus;spindle;cortical cytoskeleton;actomyosin contractile ring;cell-cell adherens junction;protein complex;immunological synapse;cytosol;neuromuscular junction;uropod;extracellular vesicular exosome;myosin II complex;ruffle,,,,,,,,,,,,,,
2124,P35580,MYH10,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",HNIPQESPKPVKH,_DHNIPQES(ph)PKPVK_,S214,,,24.89,24.89,,,,22.60,22.55,,21.56,,,,23.30, ,1.59,1.59, , , ,-0.70,-0.75, ,-1.74, , , ,"nuclear migration;fourth ventricle development;retina development in camera-type eye;lateral ventricle development;cerebellar Purkinje cell layer development;third ventricle development;substrate-dependent cell migration, cell extension;neuron migration;neuromuscular process controlling balance;ventricular cardiac muscle cell development;cardiac myofibril assembly;cytokinesis after mitosis;plasma membrane repair;regulation of cell shape;exocytosis;in utero embryonic development;actin filament-based movement;axon guidance;adult heart development;cell proliferation",neuronal cell body;axon;myosin complex;cleavage furrow;neuromuscular junction;cell cortex;growth cone;dendritic spine;midbody;stress fiber;plasma membrane;spindle;myosin II complex,,,,,,,,,,,,,,
2127,P35580,MYH10,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",LHLEGASLELSDD,_(gl)QLHLEGAS(ph)LELS(ph)DDDTESK_,S1968,,24.97,,,,,,,,,,,,,24.97,0.00, , , , , , , , , , , , ,"nuclear migration;fourth ventricle development;retina development in camera-type eye;lateral ventricle development;cerebellar Purkinje cell layer development;third ventricle development;substrate-dependent cell migration, cell extension;neuron migration;neuromuscular process controlling balance;ventricular cardiac muscle cell development;cardiac myofibril assembly;cytokinesis after mitosis;plasma membrane repair;regulation of cell shape;exocytosis;in utero embryonic development;actin filament-based movement;axon guidance;adult heart development;cell proliferation",neuronal cell body;axon;myosin complex;cleavage furrow;neuromuscular junction;cell cortex;growth cone;dendritic spine;midbody;stress fiber;plasma membrane;spindle;myosin II complex,,,,,,,,,,,,,,
2128,P35580,MYH10,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",GASLELSDDDTES,_(gl)QLHLEGASLELS(ph)DDDTESK_,S1972,+,26.58,,,,23.54,,24.03,,25.25,26.48,23.77,25.71,23.91,24.91,1.67, , , ,-1.37, ,-0.88, ,0.34,1.57,-1.14,0.80,-0.99,"nuclear migration;fourth ventricle development;retina development in camera-type eye;lateral ventricle development;cerebellar Purkinje cell layer development;third ventricle development;substrate-dependent cell migration, cell extension;neuron migration;neuromuscular process controlling balance;ventricular cardiac muscle cell development;cardiac myofibril assembly;cytokinesis after mitosis;plasma membrane repair;regulation of cell shape;exocytosis;in utero embryonic development;actin filament-based movement;axon guidance;adult heart development;cell proliferation",neuronal cell body;axon;myosin complex;cleavage furrow;neuromuscular junction;cell cortex;growth cone;dendritic spine;midbody;stress fiber;plasma membrane;spindle;myosin II complex,,,,,,,,,,,,,,
2129,P35606,COPB2,Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102),LDGKPASPTPVIV,_STAQQELDGKPAS(ph)PTPVIVASHTANK_,S859,+,26.53,27.76,27.38,26.68,28.41,27.55,30.16,28.44,28.76,28.29,30.33,29.52,27.54,28.26,-1.73,-0.50,-0.88,-1.57,0.15,-0.71,1.90,0.18,0.50,0.03,2.07,1.27,-0.72,"retrograde vesicle-mediated transport, Golgi to ER;intracellular protein transport;COPI coating of Golgi vesicle;intra-Golgi vesicle-mediated transport",cytosol;COPI vesicle coat;actin cytoskeleton,,,,,,,,,,,,,,
2130,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),RAAVVTSPPPTTA,_AAVVTS(ph)PPPTTAPHK_,S12,+,25.15,24.13,24.63,22.89,24.77,25.89,26.01,25.42,24.79,25.17,26.42,24.87,25.62,25.06,0.09,-0.93,-0.43,-2.17,-0.28,0.83,0.95,0.36,-0.26,0.11,1.36,-0.19,0.56,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2131,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),EAHRPPSPTEAPT,_EEEAHRPPS(ph)PTEAPTEASPEPAPDPAPVAEEAAPSAVEEGAAADPGSDGSPGK_,S669,,,,,,,,,,,,27.80,26.17,,26.99, , , , , , , , , , ,0.82,-0.82, ,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2132,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),AAADPGSDGSPGK,_EEEAHRPPS(ph)PTEAPTEASPEPAPDPAPVAEEAAPSAVEEGAAADPGS(ph)DGSPGK_,S707,,24.12,,,,,,,,,24.90,,,,24.51,-0.39, , , , , , , , ,0.39, , , ,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2133,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),KKFRTPSFLKKSK,_TPS(ph)FLKK_,S726,+,25.01,22.28,22.63,24.40,24.64,23.55,25.54,24.46,23.52,,23.12,26.53,22.42,24.01,1.00,-1.73,-1.38,0.39,0.64,-0.46,1.53,0.45,-0.49, ,-0.89,2.53,-1.59,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2134,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),ERKQKGSEENLDE,_QKGS(ph)EENLDEAREQK_,S586,+,,26.21,25.95,25.81,24.44,26.03,26.83,25.79,26.38,26.17,23.48,,22.67,25.43, ,0.78,0.52,0.38,-0.99,0.59,1.39,0.35,0.95,0.74,-1.95, ,-2.76,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2136,P35611,ADD1,Alpha-adducin (Erythrocyte adducin subunit alpha),KSRSPGSPVGEGT,_SPGS(ph)PVGEGTGSPPK_,S358,+,27.84,28.06,27.42,27.87,26.19,26.75,28.20,26.93,26.76,26.14,27.31,25.86,25.41,26.98,0.86,1.08,0.44,0.89,-0.79,-0.23,1.22,-0.05,-0.22,-0.84,0.33,-1.12,-1.57,cell volume homeostasis;barbed-end actin filament capping;cell morphogenesis;cellular component disassembly involved in execution phase of apoptosis;in utero embryonic development;hemoglobin metabolic process;positive regulation of protein binding;multicellular organism growth;activation of signaling protein activity involved in unfolded protein response;erythrocyte differentiation;homeostasis of number of cells within a tissue;actin filament bundle assembly,cytosol;dendritic spine;synapse;plasma membrane;nucleus;F-actin capping protein complex,,,,,,,,,,,,,,
2139,P35612,ADD2,Beta-adducin (Erythrocyte adducin subunit beta),APEEPGSPAKSAP,_KLELDGEKETAPEEPGS(ph)PAK_,S344,,,,,,24.22,24.65,24.84,25.17,,,,,23.27,24.43, , , , ,-0.21,0.22,0.41,0.74, , , , ,-1.16,barbed-end actin filament capping;actin filament bundle assembly;ion transport;hemopoiesis;positive regulation of protein binding,plasma membrane;F-actin capping protein complex;cytoplasm,,,,,,,,,,,,,,
2141,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),PAAKPGSPQAKSL,_ITPPAAKPGS(ph)PQAK_,S667,+,25.38,26.70,27.37,25.41,26.00,24.81,25.21,25.09,24.66,25.52,24.02,22.61,23.65,25.11,0.27,1.59,2.26,0.30,0.89,-0.30,0.10,-0.02,-0.45,0.41,-1.09,-2.50,-1.46,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2144,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),SRSAFLSQRYYED,_SAFLS(ph)QR_,S963,,24.28,21.54,21.54,,,,,,,,,,,22.45,1.83,-0.91,-0.91, , , , , , , , , , ,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2145,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),SAQGSSSPVPSMV,_SAQGSSS(ph)PVPSM(ox)VQK_,S646,,24.68,,,,,,,,,21.11,,,,22.90,1.79, , , , , , , , ,-1.79, , , ,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2146,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),GERQPKSPGSTPT,_S(ph)PGSTPTTPTSSQAPQK_,S430,,,25.45,,24.89,,,,,,,,,,25.17, ,0.28, ,-0.28, , , , , , , , , ,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2147,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),QPKSPGSTPTTPT,_SPGS(ph)TPTTPTSSQAPQK_,S433,+,26.34,26.00,26.56,26.39,21.68,24.19,25.81,23.35,25.98,23.00,,,,24.93,1.41,1.07,1.63,1.46,-3.25,-0.74,0.88,-1.58,1.06,-1.93, , , ,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2148,P35658,NUP214,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),PVVRTPSIQPSLL,_TPS(ph)IQPSLLPHAAPFAK_,S1012,,24.90,,,23.00,21.17,,22.91,,,,,24.16,,23.23,1.67, , ,-0.23,-2.06, ,-0.32, , , , ,0.94, ,glucose transport;regulation of cell cycle;small molecule metabolic process;protein export from nucleus;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mRNA metabolic process;viral reproduction;gene expression;protein import into nucleus;cytokine-mediated signaling pathway,nucleoplasm;cytosol;nuclear pore,,,,,,,,,,,,,,
2149,P35659,DEK,Protein DEK,PGPREESEEEEDE,_EPEMPGPREES(ph)EEEEDEDDEEEEEEEK_,S32,+,30.46,28.91,28.88,28.08,29.40,28.82,28.75,29.56,29.45,29.07,26.37,27.68,26.53,28.61,1.85,0.30,0.26,-0.53,0.78,0.21,0.14,0.95,0.84,0.46,-2.24,-0.93,-2.09,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2150,P35659,DEK,Protein DEK,DDEDKESEEEPPK,_ES(ph)EEEPPKK_,S251,,,23.98,24.09,,,,,,20.17,21.65,,,,22.47, ,1.51,1.62, , , , , ,-2.30,-0.82, , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2151,P35659,DEK,Protein DEK,NSSKKESESEDSS,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_,S301,,23.32,,,,,,,,,,,,,23.32,0.00, , , , , , , , , , , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2152,P35659,DEK,Protein DEK,SKKESESEDSSDD,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_,S303,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2153,P35659,DEK,Protein DEK,ESESEDSSDDEPL,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_,S306,,25.73,,,,,,,,22.96,,,,,24.34,1.39, , , , , , , ,-1.39, , , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2154,P35659,DEK,Protein DEK,SESEDSSDDEPLI,_KES(ph)ES(ph)EDS(ph)S(ph)DDEPLIK_,S307,,25.73,,,,,,,,,22.84,,,,24.29,1.44, , , , , , , , ,-1.44, , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2155,P35659,DEK,Protein DEK,TPTQPASEKEPEM,_(ac)SASAPAAEGEGTPTQPAS(ph)EKEPEM(ox)PGPR_,S19,,,,,,,24.45,25.97,,,,,,,25.21, , , , , ,-0.76,0.76, , , , , , ,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
2157,P35680,HNF1B,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1),HAKGRLSGDEGSE,_GRLS(ph)GDEGS(ph)EDGDDYDTPPILK_,S75,,24.31,,,21.55,,,,,,24.57,,,,23.48,0.83, , ,-1.93, , , , , ,1.09, , , ,"regulation of branch elongation involved in ureteric bud branching;negative regulation of apoptotic process;insulin secretion;hepatoblast differentiation;kidney development;regulation of pronephros size;pronephric nephron tubule development;mesonephric duct formation;inner cell mass cell differentiation;anterior/posterior pattern specification;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;hindbrain development;positive regulation of transcription initiation from RNA polymerase II promoter;endocrine pancreas development;ureteric bud elongation;response to glucose stimulus;regulation of endodermal cell fate specification;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;epithelial cell proliferation;endodermal cell fate specification;embryonic digestive tract morphogenesis;regulation of Wnt receptor signaling pathway",transcription factor complex;nucleus,Homeobox,,,,,,,,,,,,,
2158,P35680,HNF1B,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1),LSGDEGSEDGDDY,_GRLS(ph)GDEGS(ph)EDGDDYDTPPILK_,S80,,24.31,,,21.55,,,,,,25.12,,,,23.66,0.65, , ,-2.11, , , , , ,1.46, , , ,"regulation of branch elongation involved in ureteric bud branching;negative regulation of apoptotic process;insulin secretion;hepatoblast differentiation;kidney development;regulation of pronephros size;pronephric nephron tubule development;mesonephric duct formation;inner cell mass cell differentiation;anterior/posterior pattern specification;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;hindbrain development;positive regulation of transcription initiation from RNA polymerase II promoter;endocrine pancreas development;ureteric bud elongation;response to glucose stimulus;regulation of endodermal cell fate specification;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;epithelial cell proliferation;endodermal cell fate specification;embryonic digestive tract morphogenesis;regulation of Wnt receptor signaling pathway",transcription factor complex;nucleus,Homeobox,,,,,,,,,,,,,
2159,P35680,HNF1B,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1),LETLPLSPGSGAE,_LETLPLS(ph)PGSGAEPDTK_,S49,,,,,,,,,,,25.33,,24.25,,24.79, , , , , , , , , ,0.54, ,-0.54, ,"regulation of branch elongation involved in ureteric bud branching;negative regulation of apoptotic process;insulin secretion;hepatoblast differentiation;kidney development;regulation of pronephros size;pronephric nephron tubule development;mesonephric duct formation;inner cell mass cell differentiation;anterior/posterior pattern specification;branching morphogenesis of a tube;genitalia development;positive regulation of transcription from RNA polymerase II promoter;hindbrain development;positive regulation of transcription initiation from RNA polymerase II promoter;endocrine pancreas development;ureteric bud elongation;response to glucose stimulus;regulation of endodermal cell fate specification;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;epithelial cell proliferation;endodermal cell fate specification;embryonic digestive tract morphogenesis;regulation of Wnt receptor signaling pathway",transcription factor complex;nucleus,Homeobox,,,,,,,,,,,,,
2160,P35712,SOX6,Transcription factor SOX-6,PVKSPTSPTQNLF,_SPTS(ph)PTQNLFPASK_,S401,,,,,,,23.65,22.60,,,,,,,23.13, , , , , ,0.53,-0.53, , , , , , ,"gene silencing;erythrocyte development;cellular response to transforming growth factor beta stimulus;cardiac cell differentiation;positive regulation of transcription from RNA polymerase II promoter;muscle organ development;post-embryonic development;cell morphogenesis;positive regulation of mesenchymal stem cell differentiation;in utero embryonic development;oligodendrocyte cell fate specification;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cartilage development;transcription, DNA-dependent;muscle cell differentiation;cartilage development;positive regulation of chondrocyte differentiation",nucleus,HMG-box,,,,,,,,,,,,,
2162,P36021,SLC16A2,Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter),ALQSQASEEAKGP,_(ac)ALQSQAS(ph)EEAK_,S8,,,26.05,,25.02,,,,,,,23.74,,,24.94, ,1.12, ,0.08, , , , , , ,-1.20, , ,,integral to plasma membrane,,,,,,,,,,,,,,
2164,P36871,PGM1,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),GIILTASHNPGGP,_AIGGIILTAS(ph)HNPGGPNGDFGIK_,S117,+,26.96,26.58,26.49,26.51,26.52,25.08,26.29,28.02,26.11,25.72,26.48,27.29,26.87,26.53,0.43,0.05,-0.04,-0.02,-0.01,-1.46,-0.24,1.49,-0.42,-0.81,-0.06,0.76,0.34,galactose catabolic process;small molecule metabolic process;glucose metabolic process;glycogen catabolic process;glycogen biosynthetic process,cytosol;actin cytoskeleton,,,,,,,,,,,,,,
2165,P36915,GNL1,Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1),ATWGNGSGEEEEE,_DVAGATWGNGS(ph)GEEEEEEDGPAVLVEQQTDSAM(ox)EPTGPTQER_,S322,,25.20,,,,,,,,,,,,,25.20,0.00, , , , , , , , , , , , ,signal transduction;T cell mediated immunity;response to DNA damage stimulus;ribosome biogenesis,cytosol;extracellular space,,,,,,,,,,,,,,
2166,P36915,GNL1,Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1),EEQTDTSDGESVT,_EEQTDTS(ph)DGESVTHHIR_,S49,,24.94,27.01,26.70,24.19,25.30,24.64,23.28,26.45,21.84,23.83,25.38,25.53,,24.92,0.02,2.09,1.77,-0.73,0.38,-0.29,-1.64,1.53,-3.09,-1.10,0.46,0.60, ,signal transduction;T cell mediated immunity;response to DNA damage stimulus;ribosome biogenesis,cytosol;extracellular space,,,,,,,,,,,,,,
2167,P37173,TGFBR2,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),EHLDRLSGRSCSE,_FSELEHLDRLS(ph)GR_,S548,,,,,,24.75,24.38,23.60,23.70,22.48,,,,24.81,23.95, , , , ,0.80,0.43,-0.35,-0.26,-1.48, , , ,0.86,positive regulation of T cell tolerance induction;peptidyl-serine phosphorylation;negative regulation of transforming growth factor beta receptor signaling pathway;bronchus morphogenesis;positive regulation of NK T cell differentiation;positive regulation of epithelial cell migration;transforming growth factor beta receptor signaling pathway;positive regulation of mesenchymal cell proliferation;palate development;regulation of growth;trachea formation;positive regulation of reactive oxygen species metabolic process;vasculogenesis;in utero embryonic development;positive regulation of B cell tolerance induction;embryonic cranial skeleton morphogenesis;lung lobe morphogenesis;pathway-restricted SMAD protein phosphorylation;activation of protein kinase activity;heart development;myeloid dendritic cell differentiation;response to drug;smoothened signaling pathway;patterning of blood vessels;embryonic hemopoiesis;apoptotic process;lens development in camera-type eye;mammary gland morphogenesis;positive regulation of tolerance induction to self antigen;gastrulation;response to cholesterol;brain development;signal transduction by phosphorylation;peptidyl-threonine phosphorylation;cartilage development,transforming growth factor beta receptor homodimeric complex;caveola;external side of plasma membrane,,+,,,,,,,,,,,,
2168,P37198,NUP62,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),ELEDLLSPLEELV,_ELEDLLS(ph)PLEELVK_,S408,,22.27,,,,,,,,,,,,,22.27,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;negative regulation of cell proliferation;transmembrane transport;negative regulation of MAP kinase activity;mRNA transport;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of Ras protein signal transduction;cell death;protein transport;viral reproduction;cytokine-mediated signaling pathway;glucose transport;small molecule metabolic process;carbohydrate metabolic process;cell aging;regulation of glucose transport;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of transcription, DNA-dependent;nucleocytoplasmic transport;transcription, DNA-dependent;negative regulation of Ras protein signal transduction;hormone-mediated signaling pathway;positive regulation of epidermal growth factor receptor signaling pathway",nuclear membrane;ribonucleoprotein complex;nucleocytoplasmic shuttling complex;spindle pole;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2170,P37275,ZEB1,Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8) (TCF-8),STVNLQSPLKMTN,_NNDQPQSANANEPQDSTVNLQS(ph)PLK_,S538,,,,,22.47,,,,23.77,24.60,,,,,23.61, , , ,-1.14, , , ,0.16,0.98, , , , ,"cell proliferation;positive regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;immune response;transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
2171,P37802,TAGLN2,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),ENPRNFSDNQLQE,_NFS(ph)DNQLQEGK_,S163,,27.71,25.66,25.49,25.08,23.05,,,,,,,21.09,,24.68,3.03,0.98,0.81,0.40,-1.63, , , , , , ,-3.59, ,muscle organ development,,,,,,,,,,,,,,,
2172,P37802,TAGLN2,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),GTNRGASQAGMTG,_GAS(ph)QAGM(ox)TGYGM(ox)PR_,S185,,23.84,,,,,,,,,,,,,23.84,0.00, , , , , , , , , , , , ,muscle organ development,,,,,,,,,,,,,,,
2173,P37837,TALDO1,Transaldolase (EC 2.2.1.2),TIVMGASFRNTGE,_TIVM(ox)GAS(ph)FR_,S237,+,25.93,25.01,23.74,24.71,24.37,24.44,23.44,24.44,23.23,21.73,24.22,22.61,23.23,23.93,2.00,1.08,-0.19,0.78,0.44,0.51,-0.49,0.51,-0.70,-2.20,0.29,-1.33,-0.70,"fructose 6-phosphate metabolic process;pentose-phosphate shunt;glyceraldehyde-3-phosphate metabolic process;xylulose biosynthetic process;energy reserve metabolic process;pentose-phosphate shunt, non-oxidative branch",cytosol,,,,,,,,,,,,,,
2174,P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",EQATKPSFESGRR,_VEQATKPS(ph)FESGR_,S88,+,26.26,26.48,24.73,26.27,25.50,27.20,25.70,24.51,27.37,26.30,25.09,25.70,24.88,25.85,0.42,0.64,-1.12,0.43,-0.34,1.35,-0.15,-1.33,1.52,0.45,-0.76,-0.15,-0.97,"negative regulation of mRNA splicing, via spliceosome;membrane protein ectodomain proteolysis;transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;mRNA splicing, via spliceosome;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nuclear euchromatin;extracellular vesicular exosome;supraspliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2175,P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",YGGSRDSYSSSRS,_DGYGGSRDS(ph)YSSSR_,S326,+,24.67,24.97,23.22,25.38,23.96,22.78,21.00,22.66,23.42,,22.49,,,23.45,1.22,1.52,-0.24,1.93,0.50,-0.67,-2.46,-0.79,-0.04, ,-0.97, , ,"negative regulation of mRNA splicing, via spliceosome;membrane protein ectodomain proteolysis;transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;mRNA splicing, via spliceosome;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nuclear euchromatin;extracellular vesicular exosome;supraspliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2176,P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",GSRDSYSSSRSDL,_DSYS(ph)SSRSDLYSSGR_,S328,+,23.61,22.48,,24.18,,,22.97,23.89,23.09,,23.58,,,23.40,0.21,-0.92, ,0.79, , ,-0.43,0.49,-0.31, ,0.18, , ,"negative regulation of mRNA splicing, via spliceosome;membrane protein ectodomain proteolysis;transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;mRNA splicing, via spliceosome;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nuclear euchromatin;extracellular vesicular exosome;supraspliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2177,P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",RRDVYLSPRDDGY,_DVYLS(ph)PRDDGYSTK_,S208,+,29.85,31.23,31.15,30.65,32.62,32.62,30.55,31.92,32.13,32.11,31.12,31.18,31.33,31.42,-1.57,-0.19,-0.27,-0.77,1.20,1.20,-0.87,0.50,0.71,0.68,-0.30,-0.24,-0.09,"negative regulation of mRNA splicing, via spliceosome;membrane protein ectodomain proteolysis;transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;mRNA splicing, via spliceosome;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nuclear euchromatin;extracellular vesicular exosome;supraspliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2180,P38159,RBMX,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",ERGLPPSMERGYP,_GLPPS(ph)MER_,S352,+,24.68,26.46,27.35,27.16,26.30,26.43,26.05,26.18,26.65,26.86,24.43,24.74,24.86,26.01,-1.34,0.45,1.34,1.15,0.28,0.42,0.04,0.17,0.63,0.85,-1.58,-1.27,-1.15,"negative regulation of mRNA splicing, via spliceosome;membrane protein ectodomain proteolysis;transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome;cellular response to interleukin-1;mRNA splicing, via spliceosome;protein homooligomerization;positive regulation of transcription from RNA polymerase II promoter;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;nuclear euchromatin;extracellular vesicular exosome;supraspliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2182,P38398,BRCA1,Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53),SDKELVSDDEERG,_ELVS(ph)DDEER_,S812,,23.73,26.53,26.53,,,,,,,,,,,25.60,-1.87,0.93,0.93, , , , , , , , , , ,"G2/M transition DNA damage checkpoint;chromosome segregation;cellular response to indole-3-methanol;protein autoubiquitination;regulation of transcription from RNA polymerase III promoter;negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of protein ubiquitination;response to estrogen stimulus;substrate adhesion-dependent cell spreading;regulation of cell motility;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of fatty acid biosynthetic process;androgen receptor signaling pathway;positive regulation of histone H3-K4 methylation;positive regulation of cell cycle arrest;double-strand break repair via homologous recombination;fatty acid biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;postreplication repair;positive regulation of histone H4-K20 methylation;regulation of cell proliferation;positive regulation of histone H3-K9 acetylation;protein K6-linked ubiquitination;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K16 acetylation;negative regulation of histone H3-K9 methylation;cell cycle;positive regulation of DNA repair",nucleoplasm;ribonucleoprotein complex;BRCA1-BARD1 complex;BRCA1-A complex;chromosome;gamma-tubulin ring complex;plasma membrane;ruffle,,,,,,,,,,,,,,
2187,P38432,COIL,Coilin (p80),PRLIIESPSNTSS,_LIIES(ph)PSNTSSTEPA_,S566,+,25.84,24.56,24.24,25.05,26.13,26.26,25.76,25.98,26.34,25.60,24.95,24.27,25.91,25.45,0.39,-0.90,-1.21,-0.40,0.68,0.81,0.31,0.53,0.89,0.15,-0.50,-1.19,0.46,,female germ cell nucleus;nucleolus;Cajal body,,,,,,,,,,,,,,
2188,P38432,COIL,Coilin (p80),TLEARNSSEKLPT,_VTLEARNS(ph)SEK_,S271,+,24.72,24.62,25.27,23.69,,,23.32,,23.58,25.07,23.07,23.07,,24.05,0.68,0.57,1.22,-0.35, , ,-0.72, ,-0.47,1.03,-0.97,-0.97, ,,female germ cell nucleus;nucleolus;Cajal body,,,,,,,,,,,,,,
2189,P38646,HSPA9,"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)",LLARKDSETGENI,_KDS(ph)ETGENIR_,S613,,23.70,,,23.22,,,,,,,,,,23.46,0.24, , ,-0.24, , , , , , , , , ,protein folding;negative regulation of apoptotic process;protein export from nucleus;cellular protein metabolic process;protein targeting to mitochondrion,mitochondrial nucleoid;nucleolus;cell surface,,,,,,,,,,,,,,
2190,P38919,EIF4A3,"Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265) (NMP 265) (hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]",TMATSGSARKRLL,_(ac)ATTATM(ox)ATSGS(ph)ARK_,S12,+,25.74,25.51,26.19,25.83,24.98,23.61,24.59,24.68,23.48,23.63,,24.02,,24.75,0.99,0.76,1.44,1.08,0.23,-1.14,-0.16,-0.07,-1.27,-1.12, ,-0.73, ,"negative regulation of translation;mRNA transport;positive regulation of translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;rRNA processing",cytosol;exon-exon junction complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
2191,P39023,RPL3,60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B),SAPRHGSLGFLPR,_HGS(ph)LGFLPR_,S13,+,,,,19.69,22.58,,22.71,23.82,,20.35,22.48,23.15,,22.11, , , ,-2.42,0.47, ,0.59,1.71, ,-1.76,0.37,1.03, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2192,P39687,ANP32A,Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32) (Leucine-rich acidic nuclear protein) (LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I) (PHAPI),LRNRTPSDVKELV,_NRTPS(ph)DVK_,S17,,19.95,,,,,,,,,,,,,19.95,0.00, , , , , , , , , , , , ,"mRNA metabolic process;nucleocytoplasmic transport;transcription, DNA-dependent;regulation of transcription, DNA-dependent;gene expression;intracellular signal transduction",nucleoplasm;endoplasmic reticulum;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2193,P39880,CUX1,Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (Homeobox protein cux-1),RLEKAASREEPIE,_AAS(ph)REEPIEWEF_,S1507,,23.71,19.74,19.74,,,,,,,,,23.03,,21.55,2.15,-1.81,-1.81, , , , , , , , ,1.47, ,"multicellular organismal development;negative regulation of transcription from RNA polymerase II promoter;retrograde transport, vesicle recycling within Golgi;auditory receptor cell differentiation;transcription, DNA-dependent;lung development",cytosol;nucleus;Golgi membrane,Homeobox,,,,,,,,,,,,,
2198,P40189,IL6ST,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130),RSKQVSSVNEEDF,_QVSS(ph)VNEEDFVR_,S778,,,23.61,,23.91,21.91,,,,,,23.13,,23.38,23.19, ,0.42, ,0.73,-1.28, , , , , ,-0.06, ,0.19,positive regulation of adaptive immune response;negative regulation of apoptotic process;glycogen metabolic process;triglyceride mobilization;oncostatin-M-mediated signaling pathway;JAK-STAT cascade;leukemia inhibitory factor signaling pathway;positive regulation of tyrosine phosphorylation of Stat3 protein;interleukin-6-mediated signaling pathway;response to nutrient;positive regulation vascular endothelial growth factor production;negative regulation of interleukin-6-mediated signaling pathway;regulation of Notch signaling pathway;positive regulation of acute inflammatory response;positive regulation of cardiac muscle hypertrophy;positive regulation of smooth muscle cell migration;positive regulation of osteoblast differentiation;positive regulation of T cell proliferation;positive regulation of tyrosine phosphorylation of Stat1 protein;interleukin-11-mediated signaling pathway;positive regulation of astrocyte differentiation;reduction of cytosolic calcium ion concentration,neuronal cell body;interleukin-6 receptor complex;ciliary neurotrophic factor receptor complex;external side of plasma membrane;extracellular space;extracellular region;dendrite;oncostatin-M receptor complex,,,,,,,,,,,,,,
2200,P40222,TXLNA,Alpha-taxilin,GAQAPSSPRVTEA,_RPEGPGAQAPSS(ph)PR_,S515,+,24.35,26.18,,25.73,21.22,21.27,21.19,,,,22.97,,,23.27,1.07,2.91, ,2.46,-2.05,-2.00,-2.09, , , ,-0.30, , ,cell proliferation;exocytosis,extracellular region;cytoplasm,,,,,,,,,,,,,,
2201,P40227,CCT6A,T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20),KSETDTSLIRGLV,_SETDTS(ph)LIR_,S203,,22.73,23.94,,24.35,,23.46,,,,,,,,23.62,-0.89,0.32, ,0.73, ,-0.16, , , , , , , ,'de novo' posttranslational protein folding,cytosol;microtubule;chaperonin-containing T-complex,,,,,,,,,,,,,,
2202,P40306,PSMB10,Proteasome subunit beta type-10 (EC 3.4.25.1) (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i),LLRTLSSPTEPVK,_TLSS(ph)PTEPVK_,S230,+,24.96,25.82,25.72,24.36,22.52,22.85,24.32,23.64,23.81,24.90,,,,24.29,0.67,1.53,1.43,0.07,-1.77,-1.44,0.03,-0.65,-0.48,0.61, , , ,"S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;T cell proliferation;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;cell morphogenesis;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;humoral immune response;regulation of apoptotic process;protein polyubiquitination",proteasome core complex;nucleoplasm;cytosol,,,,,,,,,,,,,,
2203,P40425,PBX2,Pre-B-cell leukemia transcription factor 2 (Homeobox protein PBX2) (Protein G17),VTQGGHSRTSSPT,_TAVSVTQGGHS(ph)R_,S330,,24.34,,,23.36,,,,,,,,,,23.85,0.49, , ,-0.49, , , , , , , , , ,"transcription, DNA-dependent;proximal/distal pattern formation;embryonic limb morphogenesis;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;nucleus,Homeobox,,,,,,,,,,,,,
2204,P40818,USP8,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),PSKLKRSYSSPDI,_RS(ph)YSSPDITQAIQEEEK_,S610,+,22.58,25.91,26.26,25.22,24.58,26.95,27.06,27.18,26.30,26.37,26.92,,26.39,25.98,-3.40,-0.06,0.28,-0.76,-1.40,0.98,1.08,1.20,0.32,0.39,0.94, ,0.41,protein K63-linked deubiquitination;cell proliferation;cytokinesis after mitosis;protein K48-linked deubiquitination;endosome organization;Ras protein signal transduction;ubiquitin-dependent protein catabolic process,cytosol;midbody;endosome membrane;extrinsic to plasma membrane;nucleus;early endosome,,,,,,,,,,,,,,
2205,P40818,USP8,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),KLKRSYSSPDITQ,_SYS(ph)SPDITQAIQEEEK_,S612,+,,23.63,,24.42,27.06,25.30,27.01,27.98,25.73,26.08,27.09,27.95,23.04,25.94, ,-2.30, ,-1.52,1.12,-0.64,1.07,2.04,-0.20,0.15,1.16,2.02,-2.89,protein K63-linked deubiquitination;cell proliferation;cytokinesis after mitosis;protein K48-linked deubiquitination;endosome organization;Ras protein signal transduction;ubiquitin-dependent protein catabolic process,cytosol;midbody;endosome membrane;extrinsic to plasma membrane;nucleus;early endosome,,,,,,,,,,,,,,
2207,P40855,PEX19,Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein),TDLQNSSMSEEEL,_NATDLQNSS(ph)M(ox)SEEELTK_,S127,+,21.96,23.87,,24.86,22.22,23.17,23.35,25.71,,,,25.23,,23.80,-1.84,0.07, ,1.06,-1.58,-0.62,-0.45,1.92, , , ,1.44, ,peroxisome membrane biogenesis;protein stabilization;protein import into peroxisome membrane;peroxisome fission;chaperone-mediated protein transport;negative regulation of lipid binding;peroxisome organization;chaperone-mediated protein folding,cytosol;integral to membrane;peroxisomal membrane;nucleus;brush border membrane;protein complex,,,,,,,,,,,,,,
2209,P41162,ETV3,ETS translocation variant 3 (ETS domain transcriptional repressor PE1) (PE-1) (Mitogenic Ets transcriptional suppressor),MYPDPHSPFAVSP,_PGM(ox)YPDPHS(ph)PFAVS(ph)PIPGR_,S245,,24.01,,,,,,,,,,,,,24.01,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
2210,P41162,ETV3,ETS translocation variant 3 (ETS domain transcriptional repressor PE1) (PE-1) (Mitogenic Ets transcriptional suppressor),HSPFAVSPIPGRG,_PGM(ox)YPDPHS(ph)PFAVS(ph)PIPGR_,S250,,24.01,,,,,,,,,,,,,24.01,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
2211,P41162,ETV3,ETS translocation variant 3 (ETS domain transcriptional repressor PE1) (PE-1) (Mitogenic Ets transcriptional suppressor),SGVVPQSAPPVPT,_SSGVVPQS(ph)APPVPTASSR_,S139,,24.31,,,,,,,,,,,,,24.31,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
2212,P41182,BCL6,B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51),GLVSPQSPQKSDC,_GLVSPQS(ph)PQK_,S333,+,25.33,27.20,28.06,23.63,23.11,21.44,,,,,24.13,22.04,,24.37,0.96,2.83,3.69,-0.74,-1.26,-2.93, , , , ,-0.24,-2.33, ,"negative regulation of cell proliferation;type 2 immune response;negative regulation of cell-matrix adhesion;regulation of inflammatory response;negative regulation of isotype switching to IgE isotypes;erythrocyte development;actin cytoskeleton organization;spermatogenesis;negative regulation of cell growth;B cell differentiation;regulation of memory T cell differentiation;regulation of Rho GTPase activity;negative regulation of S phase of mitotic cell cycle;germinal center formation;negative regulation of mast cell cytokine production;negative regulation of type 2 immune response;cell morphogenesis;Rho protein signal transduction;response to DNA damage stimulus;protein import into nucleus, translocation;negative regulation of Rho protein signal transduction;positive regulation of B cell proliferation;negative regulation of transcription from RNA polymerase II promoter;regulation of germinal center formation;positive regulation of cellular component movement;transcription, DNA-dependent;positive regulation of apoptotic process;negative regulation of B cell apoptotic process;negative regulation of T-helper 2 cell differentiation",nucleus,C2H2-type,,,,,,,,,,,,,
2213,P41208,CETN2,Centrin-2 (Caltractin isoform 1),SQRKRMSPKPELT,_RM(ox)S(ph)PKPELTEEQK_,S20,+,23.24,25.47,25.67,24.07,,20.99,23.84,,24.42,23.59,23.21,23.03,20.36,23.44,-0.20,2.02,2.23,0.62, ,-2.46,0.39, ,0.98,0.14,-0.24,-0.42,-3.08,G2/M transition of mitotic cell cycle;spermatogenesis;mitosis;centriole replication;regulation of cytokinesis;nucleotide-excision repair;cell division,cytosol;centriole;XPC complex;microtubule basal body;photoreceptor connecting cilium,,,,,,,,,,,,,,
2214,P41212,ETV6,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),SYTPPESPVPSYA,_ISYT(ph)PPES(ph)PVPSYASSTPLHVPVPR_,S22,,26.80,,,,26.41,,,,,27.28,,,,26.83,-0.03, , , ,-0.42, , , , ,0.45, , , ,"cell differentiation;transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
2216,P41227,NAA10,N-alpha-acetyltransferase 10 (EC 2.3.1.-) (EC 2.3.1.88) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit),GLAAEDSGGDSKD,_GLAAEDS(ph)GGDSK_,S205,,22.09,,,23.17,,,20.54,,,,,21.52,,21.83,0.26, , ,1.34, , ,-1.29, , , , ,-0.31, ,internal protein amino acid acetylation;N-terminal protein amino acid acetylation;DNA packaging,nucleus;cytoplasm,,,,,,,,,,,,,,
2217,P41229,KDM5C,Lysine-specific demethylase 5C (EC 1.14.11.-) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169),NGDSVTSPEKVAP,_VQGLLENGDSVTS(ph)PEK_,S1292,+,23.41,22.63,22.63,22.16,,,24.45,23.35,24.04,24.36,,,24.09,23.46,-0.05,-0.83,-0.83,-1.30, , ,0.99,-0.11,0.58,0.91, , ,0.63,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
2218,P41236,PPP1R2,Protein phosphatase inhibitor 2 (IPP-2),RIQEQESSGEEDS,_IQEQES(ph)S(ph)GEEDSDLSPEEREK_,S121,,28.13,,,,23.16,,,,,23.40,,,,24.90,3.23, , , ,-1.74, , , , ,-1.49, , , ,regulation of signal transduction;glycogen metabolic process;generation of precursor metabolites and energy;regulation of phosphoprotein phosphatase activity,,,,,,,,,,,,,,,
2219,P41236,PPP1R2,Protein phosphatase inhibitor 2 (IPP-2),IQEQESSGEEDSD,_IQEQES(ph)S(ph)GEEDSDLSPEEREK_,S122,+,28.37,26.09,26.09,23.79,23.16,,25.30,25.48,22.60,25.11,,26.02,,25.20,3.17,0.89,0.89,-1.41,-2.04, ,0.09,0.28,-2.60,-0.09, ,0.82, ,regulation of signal transduction;glycogen metabolic process;generation of precursor metabolites and energy;regulation of phosphoprotein phosphatase activity,,,,,,,,,,,,,,,
2220,P41252,IARS,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",LKPYPVSPSDKVL,_APLKPYPVS(ph)PSDK_,S1047,+,23.67,25.69,25.73,25.63,24.71,26.40,26.60,26.67,25.45,25.81,25.69,24.71,25.93,25.59,-1.92,0.10,0.13,0.04,-0.88,0.81,1.01,1.08,-0.14,0.22,0.09,-0.88,0.34,isoleucyl-tRNA aminoacylation;tRNA aminoacylation for protein translation;regulation of translational fidelity,cytosol;nucleus,,,,,,,,,,,,,,
2221,P41440,SLC19A1,Folate transporter 1 (FOLT) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (Solute carrier family 19 member 1),__MVPSSPAVEKQ,_(ac)M(ox)VPSS(ph)PAVEK_,S5,,23.96,22.95,22.95,,23.48,22.77,22.57,23.18,22.66,24.30,,21.52,,23.03,0.93,-0.08,-0.08, ,0.45,-0.26,-0.46,0.14,-0.38,1.26, ,-1.52, ,folic acid metabolic process,integral to plasma membrane,,,,,,,,,,,,,,
2222,P41970,ELK3,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),SLDRAASPVLLSS,_AAS(ph)PVLLSSNSQK_,S131,,23.66,22.67,,,,,22.25,,21.91,,,,,22.62,1.04,0.05, , , , ,-0.38, ,-0.71, , , , ,"signal transduction;angiogenesis;wound healing;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",mitochondrion;nucleus,Other TF domain,,,,,,,,,,,,,
2227,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",LPTISSSAENTRQ,_SSTPLPTISSS(ph)AENTR_,S168,,22.44,,,23.11,,23.90,,,,,,,,23.15,-0.71, , ,-0.04, ,0.75, , , , , , , ,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
2228,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",KGPPDFSSDEERE,_GPPDFS(ph)S(ph)DEEREPT(ph)PVLGSGAAAAGR_,S66,,29.01,24.00,24.68,25.22,24.02,27.06,,,,25.13,,,26.95,25.76,3.25,-1.76,-1.08,-0.54,-1.74,1.30, , , ,-0.63, , ,1.19,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
2229,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",GPPDFSSDEEREP,_GPPDFS(ph)S(ph)DEEREPT(ph)PVLGSGAAAAGR_,S67,,29.21,24.36,,,27.27,,27.83,27.21,27.57,27.96,26.29,27.26,,27.22,1.99,-2.85, , ,0.05, ,0.61,-0.01,0.35,0.75,-0.93,0.04, ,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
2230,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",NDSDRYSDNEEGK,_QNGSNDSDRYS(ph)DNEEGK_,S184,+,22.67,22.79,,23.65,,,19.81,20.34,19.56,,,18.65,,21.07,1.60,1.72, ,2.58, , ,-1.26,-0.73,-1.51, , ,-2.42, ,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
2231,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",SHISDQSPLSSKR,_SHISDQS(ph)PLSSK_,S351,+,24.26,23.43,23.14,24.53,24.91,,23.17,23.62,21.96,,,23.42,,23.60,0.66,-0.18,-0.46,0.92,1.31, ,-0.43,0.02,-1.64, , ,-0.19, ,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
2237,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",LPTISSSAENTRQ,_SSTPLPTISSS(ph)AENTR_,S168,,22.44,,,23.11,,23.90,,,,,,,,23.15,-0.71, , ,-0.04, ,0.75, , , , , , , ,,nuclear envelope;integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
2238,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",GNFKHASPILPIT,_HAS(ph)PILPITEFSDIPR_,S306,,20.57,,,,,,,,,,,,,20.57,0.00, , , , , , , , , , , , ,,nuclear envelope;integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
2239,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",DFRMEESFSSKYV,_M(ox)EES(ph)FSSKYVPK_,S385,+,20.78,26.35,26.67,24.90,24.12,,,,25.21,,24.81,26.53,,24.92,-4.14,1.42,1.75,-0.02,-0.80, , , ,0.29, ,-0.11,1.61, ,,nuclear envelope;integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
2241,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",NDSDRYSDNEEDS,_QNGSNDSDRYS(ph)DNEEDSK_,S184,+,25.01,25.42,23.75,26.36,26.65,27.65,25.33,26.73,26.38,25.01,,25.19,24.34,25.65,-0.64,-0.23,-1.90,0.70,1.00,2.00,-0.32,1.08,0.73,-0.64, ,-0.46,-1.31,,nuclear envelope;integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
2242,P42224,STAT1,Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84),DNLLPMSPEEFDE,_LQTTDNLLPM(ox)S(ph)PEEFDEVSR_,S727,+,27.44,,,23.97,24.95,,,23.87,23.17,,23.52,23.66,,24.37,3.07, , ,-0.40,0.58, , ,-0.50,-1.20, ,-0.85,-0.70, ,defense response to virus;blood circulation;renal tubule development;negative regulation of angiogenesis;negative regulation of I-kappaB kinase/NF-kappaB cascade;induction of apoptosis;negative regulation of metanephric nephron tubule epithelial cell differentiation;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;interferon-gamma-mediated signaling pathway;negative regulation of endothelial cell proliferation;positive regulation of mesenchymal cell proliferation;metanephric mesenchymal cell differentiation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;JAK-STAT cascade involved in growth hormone signaling pathway;metanephric mesenchymal cell proliferation involved in metanephros development;type I interferon-mediated signaling pathway;response to cAMP;cellular response to interferon-beta;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;lipopolysaccharide-mediated signaling pathway;tumor necrosis factor-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;response to exogenous dsRNA;positive regulation of smooth muscle cell proliferation,nucleoplasm;nuclear chromatin;cytosol;axon;nucleolus;dendrite,transcription factor STAT family,,,,,,,,,,,,,
2243,P42331,ARHGAP25,Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25),SKDIPLSPPAQKN,_DIPLS(ph)PPAQK_,S356,,18.84,23.11,23.11,,,,,,22.13,,,,,21.80,-2.96,1.31,1.31, , , , , ,0.33, , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
2244,P42356,PI4KA,Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67),EGVRRRSFNDFRS,_S(ph)FNDFR_,S172,+,23.30,22.80,,23.64,22.69,24.25,,23.34,,,,,22.82,23.26,0.04,-0.47, ,0.37,-0.57,0.99, ,0.07, , , , ,-0.44,phosphatidylinositol biosynthetic process;signal transduction;small molecule metabolic process;synaptic transmission;phosphatidylinositol-mediated signaling,cytosol;Golgi-associated vesicle,,,,,,,,,,,,,,
2245,P42566,EPS15,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),SINKLDSPDPFKL,_S(ph)INKLDS(ph)PDPFK_,S796,+,27.24,26.73,26.86,26.71,23.13,,26.47,,20.02,26.41,26.12,25.82,23.81,25.39,1.85,1.33,1.47,1.32,-2.26, ,1.07, ,-5.38,1.02,0.73,0.43,-1.58,cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis;protein transport;clathrin coat assembly;endocytic recycling,cytosol;coated pit;intracellular membrane-bounded organelle;plasma membrane;AP-2 adaptor complex;early endosome membrane;cilium membrane,,,,,,,,,,,,,,
2246,P42566,EPS15,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),PFPGNDSPKEKDP,_LNDPFQPFPGNDS(ph)PK_,S814,+,27.63,24.59,24.99,25.53,23.59,,27.24,24.32,27.03,28.02,27.67,27.04,26.28,26.16,1.46,-1.57,-1.17,-0.63,-2.57, ,1.08,-1.84,0.87,1.86,1.51,0.88,0.12,cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis;protein transport;clathrin coat assembly;endocytic recycling,cytosol;coated pit;intracellular membrane-bounded organelle;plasma membrane;AP-2 adaptor complex;early endosome membrane;cilium membrane,,,,,,,,,,,,,,
2247,P42566,EPS15,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),KNIIGSSPVADFS,_NIIGSS(ph)PVADFSAIK_,S324,+,24.55,24.29,24.78,23.13,24.11,23.36,24.20,24.36,24.11,25.52,24.44,23.32,24.38,24.20,0.35,0.09,0.58,-1.07,-0.09,-0.83,0.00,0.17,-0.09,1.32,0.24,-0.87,0.19,cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis;protein transport;clathrin coat assembly;endocytic recycling,cytosol;coated pit;intracellular membrane-bounded organelle;plasma membrane;AP-2 adaptor complex;early endosome membrane;cilium membrane,,,,,,,,,,,,,,
2248,P42566,EPS15,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),LPPGKRSINKLDS,_S(ph)INKLDS(ph)PDPFK_,S790,,24.12,,,,,,,,,,,,,24.12,0.00, , , , , , , , , , , , ,cell proliferation;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis;protein transport;clathrin coat assembly;endocytic recycling,cytosol;coated pit;intracellular membrane-bounded organelle;plasma membrane;AP-2 adaptor complex;early endosome membrane;cilium membrane,,,,,,,,,,,,,,
2251,P42677,RPS27,40S ribosomal protein S27 (Metallopan-stimulin 1) (MPS-1),RLTEGCSFRRKQH,_LTEGCS(ph)FR_,S78,+,24.66,23.63,,27.54,22.78,23.19,25.37,22.58,,,,25.06,,24.35,0.31,-0.72, ,3.18,-1.57,-1.16,1.02,-1.77, , , ,0.71, ,"translational termination;translational elongation;viral transcription;cell proliferation;mitotic prometaphase;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleus,,,,,,,,,,,,,,
2252,P42677,RPS27,40S ribosomal protein S27 (Metallopan-stimulin 1) (MPS-1),KDLLHPSPEEEKR,_DLLHPS(ph)PEEEK_,S11,+,25.87,25.83,26.03,26.57,26.20,27.63,27.81,27.96,26.67,26.59,24.86,26.48,26.22,26.52,-0.65,-0.68,-0.48,0.06,-0.32,1.11,1.29,1.44,0.16,0.07,-1.66,-0.03,-0.29,"translational termination;translational elongation;viral transcription;cell proliferation;mitotic prometaphase;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleus,,,,,,,,,,,,,,
2253,P42684,ABL2,Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),RKQRDKSPSSLLE,_S(ph)PSSLLEDAK_,S595,+,26.26,26.31,24.15,27.14,22.87,22.80,25.06,,23.49,24.44,,24.24,,24.68,1.59,1.64,-0.53,2.46,-1.81,-1.87,0.38, ,-1.18,-0.24, ,-0.44, ,regulation of autophagy;cellular response to retinoic acid;positive regulation of oxidoreductase activity;regulation of cell adhesion;axon guidance;regulation of endocytosis;regulation of actin cytoskeleton reorganization;signal transduction;peptidyl-tyrosine phosphorylation;regulation of cell motility;cell adhesion;positive regulation of neuron projection development;actin filament bundle assembly,cytosol;actin cytoskeleton,,+,,,,,,,,+,,,,
2254,P42684,ABL2,Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),KGGFFSSFMKKRN,_GGFFSS(ph)FM(ox)K_,S619,,21.15,,,,,,,,,,,,,21.15,0.00, , , , , , , , , , , , ,regulation of autophagy;cellular response to retinoic acid;positive regulation of oxidoreductase activity;regulation of cell adhesion;axon guidance;regulation of endocytosis;regulation of actin cytoskeleton reorganization;signal transduction;peptidyl-tyrosine phosphorylation;regulation of cell motility;cell adhesion;positive regulation of neuron projection development;actin filament bundle assembly,cytosol;actin cytoskeleton,,+,,,,,,,,+,,,,
2255,P42684,ABL2,Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),KVPVLISPTLKHT,_VPVLIS(ph)PTLK_,S797,,23.39,22.94,22.94,,,,23.90,21.62,,,,23.28,23.11,23.03,0.36,-0.09,-0.09, , , ,0.87,-1.40, , , ,0.26,0.08,regulation of autophagy;cellular response to retinoic acid;positive regulation of oxidoreductase activity;regulation of cell adhesion;axon guidance;regulation of endocytosis;regulation of actin cytoskeleton reorganization;signal transduction;peptidyl-tyrosine phosphorylation;regulation of cell motility;cell adhesion;positive regulation of neuron projection development;actin filament bundle assembly,cytosol;actin cytoskeleton,,+,,,,,,,,+,,,,
2256,P42694,HELZ,Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein),SNPQNRSPESRPS,_(gl)QVDLESNPQNRS(ph)PESRPSVVYPSTK_,S1317,,,,,,,,24.74,,,24.95,24.50,,23.49,24.42, , , , , , ,0.32, , ,0.53,0.08, ,-0.93,,nucleus,,,,,,,,,,,,,,
2257,P42695,NCAPD3,Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3),SRHRSRSLGVLPF,_S(ph)LGVLPFTLNSGSPEK_,S432,,21.56,,,,,,,,,,,,,21.56,0.00, , , , , , , , , , , , ,mitotic chromosome condensation;cell division,nuclear centromeric heterochromatin;nuclear condensin complex,,,,,,,,,,,,,,
2260,P42696,RBM34,RNA-binding protein 34 (RNA-binding motif protein 34),DDGVRGSPPEDYR,_SVQEGENPDDGVRGS(ph)PPEDYR_,S26,,21.06,,,23.23,23.24,22.84,,,23.07,,22.96,,,22.73,-1.68, , ,0.49,0.51,0.11, , ,0.34, ,0.23, , ,,nucleolus,,,,,,,,,,,,,,
2261,P42858,HTT,Huntingtin (Huntington disease protein) (HD protein),LLSPQMSGEEEDS,_LLSPQM(ox)S(ph)GEEEDSDLAAK_,S1329,+,24.31,24.68,24.62,24.43,25.23,25.12,25.06,25.10,25.08,24.83,25.38,25.13,24.83,24.91,-0.60,-0.23,-0.29,-0.47,0.32,0.21,0.15,0.19,0.17,-0.08,0.47,0.23,-0.08,"neuron development;endoplasmic reticulum organization;olfactory lobe development;hormone metabolic process;striatum development;neuron apoptotic process;regulation of synaptic plasticity;lactate biosynthetic process from pyruvate;L-glutamate import;regulation of protein phosphatase type 2A activity;response to calcium ion;establishment of mitotic spindle orientation;endosomal transport;vesicle transport along microtubule;quinolinate biosynthetic process;cell aging;citrulline metabolic process;iron ion homeostasis;neural plate formation;determination of adult lifespan;ER to Golgi vesicle-mediated transport;Golgi organization;protein import into nucleus;negative regulation of neuron apoptotic process;insulin secretion;urea cycle;locomotory behavior;dopamine receptor signaling pathway;spermatogenesis;anterior/posterior pattern specification;visual learning;regulation of mitochondrial membrane permeability;organ development;social behavior;retrograde vesicle-mediated transport, Golgi to ER;axon cargo transport;negative regulation of extrinsic apoptotic signaling pathway;regulation of mitochondrial membrane potential;paraxial mesoderm formation",cytoplasmic vesicle membrane;axon;late endosome;Golgi apparatus;endoplasmic reticulum;inclusion body;protein complex;autophagic vacuole;cytosol;nucleus;dendrite,,,,,,,,,,,,,,
2263,P43007,SLC1A4,Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (SATT) (Solute carrier family 1 member 4),KSEEETSPLVTHQ,_SEEETS(ph)PLVTHQNPAGPVASAPELESK_,S209,,,,,,,,24.34,,24.66,22.70,,,,23.90, , , , , , ,0.44, ,0.76,-1.20, , , ,"synaptic transmission, glutamatergic;cognition",intermediate filament;melanosome;integral to plasma membrane,,,,,,,,,,,,,,
2264,P43121,MCAM,Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146),LPPSRKSELVVEV,_S(ph)ELVVEVK_,S606,,21.08,,,,,,,,,,,22.49,22.23,21.93,-0.85, , , , , , , , , , ,0.56,0.30,vascular wound healing;cell adhesion;glomerular filtration,integral to membrane;external side of plasma membrane,,,,,,,,,,,,,,
2267,P43243,MATR3,Matrin-3,ENADGQSDENKDD,_DTSENADGQS(ph)DENKDDYTIPDEYR_,S766,+,25.63,25.83,,24.79,,,26.81,,28.32,27.22,25.31,25.75,23.39,25.90,-0.27,-0.07, ,-1.10, , ,0.92, ,2.43,1.32,-0.58,-0.14,-2.51,,nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
2268,P43243,MATR3,Matrin-3,TEPGAESSENADD,_NEENTEPGAES(ph)SENADDPNK_,S747,,22.95,23.75,23.84,23.19,,,21.38,,,22.92,,,,23.00,-0.05,0.75,0.83,0.18, , ,-1.63, , ,-0.08, , , ,,nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
2271,P43243,MATR3,Matrin-3,KSFQQSSLSRDSQ,_SFQQSS(ph)LSR_,S9,,26.40,,,27.48,,,,,,,,,,26.94,-0.54, , ,0.54, , , , , , , , , ,,nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
2272,P43243,MATR3,Matrin-3,SPDGKESPSDKKS,_SYS(ph)PDGKES(ph)PSDK_,S604,,,22.95,,24.34,,,21.62,,,,,,,22.97, ,-0.02, ,1.37, , ,-1.35, , , , , , ,,nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
2275,P43307,SSR1,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),NQINKASPRRLPR,_VEM(ox)GTSSQNDVDM(ox)SWIPQETLNQINKAS(ph)PR_,S268,+,26.91,25.37,25.65,26.21,30.25,29.75,27.25,29.90,28.79,25.65,28.65,26.78,30.65,27.83,-0.92,-2.47,-2.18,-1.62,2.42,1.92,-0.58,2.07,0.95,-2.19,0.82,-1.05,2.82,activation of signaling protein activity involved in unfolded protein response;positive regulation of cell proliferation;translation;SRP-dependent cotranslational protein targeting to membrane,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
2276,P43487,RANBP1,Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1),KLFRFASENDLPE,_FAS(ph)ENDLPEWK_,S60,,23.68,,,,,,,,,,,,,23.68,0.00, , , , , , , , , , , , ,signal transduction;spindle organization;viral reproduction;positive regulation of GTPase activity;intracellular transport;positive regulation of mitotic centrosome separation,nuclear envelope;centrosome;cytoplasm,,,,,,,,,,,,,,
2277,P43487,RANBP1,Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1),EKLEALSVKEETK,_LEALS(ph)VK_,S188,,21.79,22.20,22.65,,,,,,,,,,,22.21,-0.43,-0.01,0.44, , , , , , , , , , ,signal transduction;spindle organization;viral reproduction;positive regulation of GTPase activity;intracellular transport;positive regulation of mitotic centrosome separation,nuclear envelope;centrosome;cytoplasm,,,,,,,,,,,,,,
2278,P43490,NAMPT,Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin),KVTKSYSFDEIRK,_SYS(ph)FDEIRK_,S472,,22.90,24.10,,,,,22.29,,,,,,,23.10,-0.20,1.01, , , , ,-0.81, , , , , , ,positive regulation of nitric-oxide synthase biosynthetic process;NAD metabolic process;NAD biosynthetic process;cell-cell signaling;signal transduction;water-soluble vitamin metabolic process;positive regulation of cell proliferation;nicotinamide metabolic process;positive regulation of transcription from RNA polymerase II promoter,cytosol,,,,,,,,,,,,,,
2283,P45973,CBX5,Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha),TADSSSSEDEEEY,_RTADSSSS(ph)EDEEEYVVEK_,S14,,21.33,,,,22.33,23.83,24.14,,24.57,,,,22.80,23.17,-1.84, , , ,-0.84,0.66,0.98, ,1.40, , , ,-0.37,"blood coagulation;negative regulation of transcription, DNA-dependent;virus-host interaction",histone deacetylase complex;nuclear envelope;nuclear centromeric heterochromatin;chromocenter;cytoplasm;nucleolus;transcriptional repressor complex;kinetochore;histone methyltransferase complex,,,,,,,,,,,,,,
2284,P45974,USP5,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),GRSAADSISESVP,_SAADS(ph)ISESVPVGPK_,S760,+,24.56,22.41,22.76,21.93,24.03,22.49,22.91,,22.01,,22.47,22.59,22.32,22.77,1.79,-0.36,-0.01,-0.84,1.26,-0.28,0.14, ,-0.76, ,-0.30,-0.18,-0.45,positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein K48-linked deubiquitination;ubiquitin-dependent protein catabolic process,lysosome,,,,,,,,,,,,,,
2286,P46013,MKI67,Antigen KI-67,IKAFKESPKQILD,_AFKES(ph)PKQILDPAASVTGSR_,S2528,,,23.84,23.84,23.42,24.42,22.62,,23.49,18.47,,,,,22.87, ,0.97,0.97,0.55,1.55,-0.25, ,0.62,-4.40, , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2287,P46013,MKI67,Antigen KI-67,AQSLVISPPAPSP,_AQSLVIS(ph)PPAPSPR_,S579,,,,,,23.59,,,23.50,,,,,,23.55, , , , ,0.04, , ,-0.04, , , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2288,P46013,MKI67,Antigen KI-67,ISPPAPSPRKTPV,_AQSLVISPPAPS(ph)PR_,S584,+,24.25,21.82,21.82,22.63,26.08,24.36,24.04,25.51,22.06,22.64,,,24.36,23.60,0.65,-1.78,-1.78,-0.97,2.48,0.77,0.45,1.92,-1.54,-0.96, , ,0.76,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2290,P46013,MKI67,Antigen KI-67,TTGRRESVNLGKS,_RES(ph)VNLGK_,S374,,25.35,22.65,22.65,24.05,,,,,,,,,,23.67,1.68,-1.03,-1.03,0.38, , , , , , , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2291,P46013,MKI67,Antigen KI-67,AVAEPASPEQELD,_SGGSGHAVAEPAS(ph)PEQELDQNK_,S308,+,24.08,25.50,25.50,23.85,26.24,26.31,26.58,26.32,25.50,25.42,,24.16,,25.40,-1.32,0.09,0.09,-1.56,0.83,0.91,1.17,0.91,0.10,0.02, ,-1.24, ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2292,P46013,MKI67,Antigen KI-67,TRSHRDSEDI___,_SHRDS(ph)EDI_,S3253,,22.93,23.22,23.22,21.51,,,,17.96,,,,,,21.77,1.16,1.45,1.45,-0.26, , , ,-3.81, , , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2293,P46013,MKI67,Antigen KI-67,TKIACKSPQPDPV,_S(ph)PQPDPVDTPASTK_,S2344,+,23.86,23.52,24.34,24.06,,,25.38,,24.04,24.69,,,,24.27,-0.41,-0.75,0.07,-0.21, , ,1.11, ,-0.23,0.42, , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2294,P46013,MKI67,Antigen KI-67,TEVSCKSPQPESF,_S(ph)PQPESFK_,S2466,,23.25,23.42,23.42,24.09,,,,,,,,,,23.54,-0.30,-0.13,-0.13,0.55, , , , , , , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2298,P46013,MKI67,Antigen KI-67,YSQQQNSPQKHKN,_TPVQYSQQQNS(ph)PQK_,S357,+,25.57,24.41,25.26,24.09,22.63,,23.32,22.58,22.34,22.88,,,,23.68,1.89,0.73,1.58,0.41,-1.05, ,-0.35,-1.10,-1.33,-0.80, , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2301,P46013,MKI67,Antigen KI-67,SRSSFSSDPDESE,_SSFSS(ph)DPDESEGIPLK_,S131,,,21.50,21.50,22.08,23.78,,22.52,,21.71,,,,,22.18, ,-0.68,-0.68,-0.10,1.60, ,0.34, ,-0.47, , , , ,meiosis;cell proliferation;organ regeneration;DNA metabolic process;cellular response to heat,"condensed chromosome;chromosome, centromeric region;nucleolus;cytoplasm",,,,,,,,,,,,,,
2302,P46019,PHKA2,"Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit)",LSAHRKSLNLVDS,_S(ph)LNLVDSPQPLLEK_,S729,+,25.05,20.97,21.70,21.85,,,21.50,,21.34,,,23.90,,22.33,2.72,-1.36,-0.63,-0.48, , ,-0.83, ,-0.99, , ,1.57, ,small molecule metabolic process;glucose metabolic process;glycogen catabolic process,cytosol;plasma membrane;phosphorylase kinase complex,,,,,,,,,,,,,,
2303,P46019,PHKA2,"Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit)",MRSRSNSGVRLDG,_SNS(ph)GVRLDGYAR_,S7,+,21.46,24.22,24.22,21.82,25.72,23.32,25.99,26.25,23.54,23.66,24.90,24.86,23.64,24.12,-2.66,0.10,0.10,-2.30,1.60,-0.80,1.86,2.12,-0.58,-0.46,0.77,0.74,-0.48,small molecule metabolic process;glucose metabolic process;glycogen catabolic process,cytosol;plasma membrane;phosphorylase kinase complex,,,,,,,,,,,,,,
2305,P46060,RANGAP1,Ran GTPase-activating protein 1 (RanGAP1),PAPVLSSPPPADV,_ILDPNTGEPAPVLSS(ph)PPPADVSTFLAFPSPEK_,S428,+,27.99,26.86,26.86,26.05,26.86,24.92,,28.24,28.51,28.76,26.40,,25.61,27.01,0.99,-0.15,-0.15,-0.95,-0.15,-2.09, ,1.23,1.51,1.76,-0.61, ,-1.40,signal transduction;mitotic prometaphase;negative regulation of protein export from nucleus,nuclear membrane;cytosol;condensed chromosome kinetochore;spindle pole;nuclear pore;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2307,P46087,NOP2,Putative ribosomal RNA methyltransferase NOP2 (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),PQPPTVSPIRSSR,_GPQPPTVS(ph)PIR_,S782,+,25.32,23.42,23.42,25.05,26.58,25.86,26.63,26.14,24.47,,25.46,26.56,25.45,25.36,-0.05,-1.95,-1.95,-0.31,1.21,0.50,1.27,0.78,-0.90, ,0.10,1.20,0.09,positive regulation of cell proliferation;rRNA processing,nucleolus,,,,,,,,,,,,,,
2308,P46087,NOP2,Putative ribosomal RNA methyltransferase NOP2 (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),QTPAVLSPSKTQA,_GTDTQTPAVLS(ph)PSK_,S728,+,27.60,27.45,28.30,26.89,25.43,26.49,27.61,26.53,26.70,28.40,25.82,26.33,27.37,26.99,0.60,0.46,1.31,-0.10,-1.56,-0.51,0.62,-0.47,-0.29,1.41,-1.18,-0.66,0.38,positive regulation of cell proliferation;rRNA processing,nucleolus,,,,,,,,,,,,,,
2309,P46087,NOP2,Putative ribosomal RNA methyltransferase NOP2 (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),AKRRLGSVEAPKT,_LGS(ph)VEAPK_,S58,,23.01,,,,,,,,,,,,,23.01,0.00, , , , , , , , , , , , ,positive regulation of cell proliferation;rRNA processing,nucleolus,,,,,,,,,,,,,,
2310,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),KKKDELSDYAEKS,_KKDELS(ph)DYAEK_,S1023,+,19.77,24.05,24.85,23.30,25.27,24.18,23.58,23.56,24.53,24.13,22.71,22.83,,23.56,-3.79,0.49,1.29,-0.27,1.71,0.62,0.01,0.00,0.97,0.56,-0.85,-0.73, ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2311,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),QERETFSSAEGTV,_(gl)QERETFS(ph)SAEGTVDK_,S851,,,22.84,22.84,26.19,,,24.97,,23.11,22.44,,22.76,,23.59, ,-0.76,-0.76,2.60, , ,1.38, ,-0.48,-1.15, ,-0.83, ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2312,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),VKLTPVSLSNSPI,_LTPVS(ph)LSNS(ph)PIK_,S556,,23.46,20.94,20.94,,,,,,,,,,,21.78,1.68,-0.84,-0.84, , , , , , , , , , ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2314,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),PVSLSNSPIKGAD,_LTPVSLSNS(ph)PIK_,S560,+,24.78,25.55,26.36,25.66,24.45,26.03,26.66,,25.96,26.90,25.11,25.29,26.79,25.80,-1.01,-0.25,0.56,-0.13,-1.35,0.23,0.86, ,0.17,1.10,-0.69,-0.50,0.99,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2315,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),RHKLTVSDGESGE,_LTVS(ph)DGESGEEK_,S1310,+,20.87,23.87,24.13,23.61,,24.23,23.02,22.37,22.46,23.16,21.94,,,22.97,-2.09,0.90,1.17,0.64, ,1.26,0.06,-0.60,-0.50,0.19,-1.02, , ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2316,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),ETVDQNSDSDEML,_QSETVDQNS(ph)DSDEM(ox)LAILK_,S691,,,,,,23.91,,,23.31,23.40,23.91,,,22.87,23.48, , , , ,0.43, , ,-0.17,-0.08,0.43, , ,-0.61,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2317,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),ESSNYDSELEKEI,_RQTQSESSNYDS(ph)ELEK_,S781,,,,,,,22.69,,,23.02,22.75,,,,22.82, , , , , ,-0.13, , ,0.20,-0.07, , , ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2318,P46100,ATRX,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),VTKYVESDDEKPL,_YVES(ph)DDEKPLDDETVNEDASNENSENDITM(ox)QSLPK_,S92,,,,,,26.35,,24.04,24.31,25.41,26.05,,24.75,,25.15, , , , ,1.20, ,-1.11,-0.84,0.26,0.90, ,-0.40, ,"DNA repair;forebrain development;regulation of transcription, DNA-dependent;DNA methylation;DNA recombination",nuclear heterochromatin,,,,,,,,,,,,,,
2322,P46379,BAG6,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (BAG6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),QGAERASPEPQRE,_VGDPPQPLPEEPM(ox)EVQGAERAS(ph)PEPQR_,S958,+,21.81,25.00,25.30,23.34,23.35,,22.89,,,,24.28,,,23.71,-1.90,1.29,1.59,-0.37,-0.36, ,-0.82, , , ,0.57, , ,cell differentiation;transport;kidney development;embryo development;lung development;synaptonemal complex assembly;spermatogenesis;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;protein stabilization;tail-anchored membrane protein insertion into ER membrane;internal peptidyl-lysine acetylation;regulation of cell proliferation;ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;brain development;chromatin modification,BAT3 complex;nucleus,,,,,,,,,,,,,,
2323,P46379,BAG6,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (BAG6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),PQRENASPAPGTT,_ENAS(ph)PAPGTTAEEAM(ox)SR_,S967,+,24.30,25.50,25.37,24.28,25.50,26.04,24.89,25.99,23.73,,25.88,24.58,,25.10,-0.80,0.40,0.28,-0.81,0.40,0.94,-0.21,0.90,-1.37, ,0.78,-0.52, ,cell differentiation;transport;kidney development;embryo development;lung development;synaptonemal complex assembly;spermatogenesis;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;protein stabilization;tail-anchored membrane protein insertion into ER membrane;internal peptidyl-lysine acetylation;regulation of cell proliferation;ubiquitin-dependent protein catabolic process;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;brain development;chromatin modification,BAT3 complex;nucleus,,,,,,,,,,,,,,
2324,P46783,RPS10,40S ribosomal protein S10,AEAGAGSATEFQF,_KAEAGAGS(ph)ATEFQFR_,S146,,,,,21.46,23.38,24.52,,,,,23.34,,22.74,23.09, , , ,-1.63,0.29,1.44, , , , ,0.25, ,-0.35,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2325,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SGRGAESPFEEKS,_GAES(ph)PFEEKSGK_,S1427,+,25.35,26.62,27.24,24.80,28.19,,27.36,28.19,24.89,25.59,27.24,26.76,26.09,26.53,-1.17,0.09,0.72,-1.73,1.67, ,0.83,1.67,-1.64,-0.94,0.71,0.24,-0.44,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2328,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],DEPVPDSESPIEK,_ASVSPM(ox)DEPVPDS(ph)ESPIEK_,S1387,+,22.76,23.58,22.07,24.95,25.59,24.95,25.61,,,,,,25.95,24.43,-1.67,-0.85,-2.37,0.51,1.16,0.52,1.17, , , , , ,1.52,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2331,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],NPAASTSPSLSHR,_(ac)ATVVVEATEPEPSGSIANPAASTS(ph)PSLSHR_,S25,,,,,26.05,28.85,,28.10,28.70,27.58,,,25.24,29.20,27.67, , , ,-1.63,1.17, ,0.42,1.03,-0.09, , ,-2.44,1.53,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2333,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ALNRDLSTPGLEK,_DLS(ph)TPGLEK_,S1852,,24.93,,,24.40,,,,,,,,22.38,,23.91,1.03, , ,0.50, , , , , , , ,-1.53, ,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2335,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],VSSEKVSPSKSPS,_DSISAVSSEKVS(ph)PSK_,S1252,+,,,,23.93,,,27.51,24.20,26.19,23.98,26.53,,25.42,25.39, , , ,-1.46, , ,2.11,-1.19,0.80,-1.42,1.13, ,0.03,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2338,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ASASTISPPSSME,_DYNASASTIS(ph)PPSSM(ox)EEDK_,S1208,+,,22.83,,25.21,,,26.15,25.91,25.62,25.53,27.10,26.03,24.76,25.46, ,-2.63, ,-0.26, , ,0.69,0.45,0.16,0.07,1.64,0.57,-0.70,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2339,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ECPRPMSISPPDF,_EECPRPM(ox)S(ph)ISPPDFSPK_,S1618,,,,,21.66,,,24.31,,23.76,,23.92,,,23.41, , , ,-1.75, , ,0.90, ,0.35, ,0.51, , ,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2340,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],AERSLMSSPEDLT,_SLM(ox)S(ph)S(ph)PEDLTK_,S831,+,25.75,22.00,,22.51,21.47,23.24,21.22,,22.22,24.93,23.27,,22.95,22.96,2.79,-0.95, ,-0.44,-1.48,0.28,-1.73, ,-0.74,1.97,0.31, ,0.00,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2341,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ERSLMSSPEDLTK,_SLM(ox)S(ph)S(ph)PEDLTK_,S832,+,25.92,24.58,22.45,26.00,23.72,26.30,26.14,26.10,24.62,25.87,27.85,26.13,26.43,25.55,0.38,-0.97,-3.09,0.45,-1.83,0.75,0.59,0.56,-0.93,0.33,2.30,0.58,0.89,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2345,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],IREKRESVASGDD,_RES(ph)VAS(ph)GDDRAEEDM(ox)DEAIEK_,S992,+,23.67,24.47,24.47,25.78,,23.82,28.40,24.52,26.23,25.76,26.90,26.45,25.62,25.51,-1.84,-1.04,-1.04,0.28, ,-1.69,2.90,-0.99,0.72,0.26,1.39,0.95,0.12,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2347,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],PSKEEPSPVKAEV,_EVPSKEEPS(ph)PVKAEVAEK_,S614,,,,,,26.54,,,27.33,,,,,25.41,26.43, , , , ,0.11, , ,0.91, , , , ,-1.02,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2351,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KGEAEQSEEEADE,_GEAEQS(ph)EEEADEEDKAEDAREEEYEPEK_,S1016,+,23.17,25.39,24.47,27.99,26.03,28.36,28.42,29.55,28.16,24.77,30.03,28.37,28.69,27.18,-4.01,-1.80,-2.71,0.80,-1.16,1.17,1.23,2.37,0.98,-2.41,2.85,1.19,1.50,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2352,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],IERTTKSPSDSGY,_S(ph)PSDSGYSYETIGK_,S1915,+,22.23,23.31,23.31,26.10,26.69,25.62,27.75,26.80,26.19,26.08,27.08,23.88,25.94,25.46,-3.23,-2.15,-2.15,0.64,1.23,0.16,2.29,1.34,0.73,0.62,1.62,-1.58,0.48,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2353,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KSVRKESKEETPE,_KES(ph)KEETPEVTK_,S561,,,,,,21.94,21.30,,22.47,,,,,20.95,21.66, , , , ,0.28,-0.36, ,0.80, , , , ,-0.72,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2355,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],PEETTRSPDEEDY,_PEETTRS(ph)PDEEDYDYESYEK_,S1881,,,,,,,,23.93,,,24.79,27.28,23.93,,24.98, , , , , , ,-1.05, , ,-0.19,2.30,-1.05, ,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2356,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KSGKQGSPDQVSP,_QGS(ph)PDQVSPVSEM(ox)TSTSLYQDK_,S1438,,,,,,25.84,,24.39,,22.94,,24.78,23.53,22.89,24.06, , , , ,1.78, ,0.33, ,-1.12, ,0.72,-0.53,-1.17,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2357,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],GSPDQVSPVSEMT,_QGSPDQVS(ph)PVSEM(ox)TSTSLYQDK_,S1443,+,,,,22.19,26.65,23.92,24.04,25.16,24.95,24.67,26.00,24.96,25.76,24.83, , , ,-2.64,1.82,-0.91,-0.79,0.33,0.12,-0.16,1.17,0.13,0.93,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2358,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],EKLSPKSDISPLT,_S(ph)DISPLTPR_,S1782,,,,,,24.75,,22.61,,,,,,,23.68, , , , ,1.07, ,-1.07, , , , , , ,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2359,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SPKSDISPLTPRE,_SDIS(ph)PLTPR_,S1785,+,23.50,23.88,21.77,26.13,26.69,26.27,26.19,26.27,24.91,23.90,27.20,26.46,26.07,25.33,-1.83,-1.44,-3.55,0.80,1.36,0.95,0.87,0.94,-0.41,-1.43,1.87,1.13,0.75,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2361,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KVSPSKSPSLSPS,_S(ph)PSLS(ph)PSPPS(ph)PLEK_,S1256,+,23.44,21.62,21.62,23.65,21.32,,23.56,23.46,22.19,,24.60,23.64,23.75,22.99,0.45,-1.37,-1.37,0.66,-1.67, ,0.58,0.47,-0.80, ,1.61,0.66,0.76,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2363,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SKSPSLSPSPPSP,_S(ph)PSLS(ph)PSPPS(ph)PLEK_,S1260,,22.71,,,23.29,24.85,,,,,,,,,23.62,-0.90, , ,-0.33,1.23, , , , , , , , ,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2366,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],TCHSSSSPPIDAA,_TATCHSSSS(ph)PPIDAASAEPYGFR_,S1819,+,,,,22.42,25.25,,21.06,,,23.22,23.80,25.22,24.73,23.67, , , ,-1.25,1.58, ,-2.61, , ,-0.45,0.13,1.55,1.06,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2367,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],KTLEVVSPSQSVT,_TLEVVS(ph)PSQSVTGSAGHTPYYQSPTDEK_,S1322,+,,,,,24.95,,26.43,26.58,25.97,24.75,27.71,25.31,26.40,26.01, , , , ,-1.06, ,0.41,0.56,-0.04,-1.26,1.70,-0.70,0.38,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2368,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],ISEKTTSPPEVSG,_TTS(ph)PPEVSGYSYEK_,S1965,+,,23.81,,,25.85,26.52,27.17,27.07,,24.66,,26.87,26.07,26.00, ,-2.19, , ,-0.16,0.52,1.17,1.07, ,-1.34, ,0.87,0.06,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2370,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],VLSPLRSPPLIGS,_VLSPLRS(ph)PPLIGSESAYESFLSADDK_,S1400,+,,,,27.27,26.12,28.08,29.91,30.60,29.14,27.89,30.99,29.93,27.63,28.76, , , ,-1.48,-2.64,-0.68,1.16,1.85,0.39,-0.87,2.23,1.17,-1.12,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2372,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],AEVAPVSPEVTQE,_VSAEAEVAPVS(ph)PEVTQEVVEEHCASPEDK_,S1298,+,,,,,23.05,,24.90,24.38,25.00,24.25,,24.56,25.33,24.50, , , , ,-1.45, ,0.40,-0.11,0.50,-0.24, ,0.06,0.83,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
2376,P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),LQLGAVSPGTLTP,_AHSS(ph)PASLQLGAVS(ph)PGTLTPTGVVSGPAATPTAQHLR_,S138,,24.07,,,,,,,,,,,,,24.07,0.00, , , , , , , , , , , , ,paraxial mesoderm development;negative regulation of apoptotic process;notochord development;somatic stem cell maintenance;hippo signaling cascade;contact inhibition;positive regulation of cell proliferation;regulation of keratinocyte proliferation;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell differentiation;transcription initiation from RNA polymerase II promoter;positive regulation of organ growth;vasculogenesis;embryonic heart tube morphogenesis;response to DNA damage stimulus;cell proliferation;cellular response to gamma radiation;regulation of stem cell proliferation;positive regulation of canonical Wnt receptor signaling pathway;lateral mesoderm development,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
2377,P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),VHVRGDSETDLEA,_GDS(ph)ETDLEALFNAVM(ox)NPK_,S61,,25.35,,,,,,,,,,,,,25.35,0.00, , , , , , , , , , , , ,paraxial mesoderm development;negative regulation of apoptotic process;notochord development;somatic stem cell maintenance;hippo signaling cascade;contact inhibition;positive regulation of cell proliferation;regulation of keratinocyte proliferation;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell differentiation;transcription initiation from RNA polymerase II promoter;positive regulation of organ growth;vasculogenesis;embryonic heart tube morphogenesis;response to DNA damage stimulus;cell proliferation;cellular response to gamma radiation;regulation of stem cell proliferation;positive regulation of canonical Wnt receptor signaling pathway;lateral mesoderm development,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
2378,P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),SHSRQASTDAGTA,_QAS(ph)TDAGTAGALTPQHVR_,S109,+,28.63,28.29,26.85,29.29,29.22,28.40,29.77,29.99,27.31,26.63,28.81,29.81,27.62,28.51,0.12,-0.22,-1.66,0.78,0.71,-0.11,1.26,1.49,-1.20,-1.88,0.30,1.30,-0.89,paraxial mesoderm development;negative regulation of apoptotic process;notochord development;somatic stem cell maintenance;hippo signaling cascade;contact inhibition;positive regulation of cell proliferation;regulation of keratinocyte proliferation;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell differentiation;transcription initiation from RNA polymerase II promoter;positive regulation of organ growth;vasculogenesis;embryonic heart tube morphogenesis;response to DNA damage stimulus;cell proliferation;cellular response to gamma radiation;regulation of stem cell proliferation;positive regulation of canonical Wnt receptor signaling pathway;lateral mesoderm development,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
2380,P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),QHLRQSSFEIPDD,_QSS(ph)FEIPDDVPLPAGWEM(ox)AK_,S164,,29.17,,,,,,,,,,,,,29.17,0.00, , , , , , , , , , , , ,paraxial mesoderm development;negative regulation of apoptotic process;notochord development;somatic stem cell maintenance;hippo signaling cascade;contact inhibition;positive regulation of cell proliferation;regulation of keratinocyte proliferation;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell differentiation;transcription initiation from RNA polymerase II promoter;positive regulation of organ growth;vasculogenesis;embryonic heart tube morphogenesis;response to DNA damage stimulus;cell proliferation;cellular response to gamma radiation;regulation of stem cell proliferation;positive regulation of canonical Wnt receptor signaling pathway;lateral mesoderm development,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
2382,P46937,YAP1,Yorkie homolog (65 kDa Yes-associated protein) (YAP65),TQNPVSSPGMSQE,_SQLPTLEQDGGTQNPVSS(ph)PGM(ox)SQELR_,S313,+,25.58,22.73,22.73,25.03,,24.60,25.43,25.53,,23.94,25.49,,,24.56,1.01,-1.83,-1.83,0.47, ,0.04,0.87,0.97, ,-0.62,0.93, , ,paraxial mesoderm development;negative regulation of apoptotic process;notochord development;somatic stem cell maintenance;hippo signaling cascade;contact inhibition;positive regulation of cell proliferation;regulation of keratinocyte proliferation;keratinocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial cell differentiation;transcription initiation from RNA polymerase II promoter;positive regulation of organ growth;vasculogenesis;embryonic heart tube morphogenesis;response to DNA damage stimulus;cell proliferation;cellular response to gamma radiation;regulation of stem cell proliferation;positive regulation of canonical Wnt receptor signaling pathway;lateral mesoderm development,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
2384,P46939,UTRN,Utrophin (Dystrophin-related protein 1) (DRP-1),EKHLESSDEDEKM,_HLESS(ph)DEDEK_,S1796,,17.39,17.89,18.15,19.17,,,,,,,,,,18.15,-0.76,-0.26,0.00,1.02, , , , , , , , , ,positive regulation of cell-matrix adhesion;muscle contraction;muscle organ development,protein complex;cytoplasm;neuromuscular junction;dystrophin-associated glycoprotein complex;cell junction;cytoskeleton;nucleus;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
2385,P46940,IQGAP1,Ras GTPase-activating-like protein IQGAP1 (p195),LFRALQSPALGLR,_ALQS(ph)PALGLR_,S330,+,23.44,,,24.16,24.11,25.24,24.90,24.84,24.37,,24.34,23.70,24.62,24.37,-0.93, , ,-0.21,-0.26,0.86,0.53,0.47,0.00, ,-0.03,-0.67,0.24,glomerular visceral epithelial cell development;small molecule metabolic process;negative regulation of dephosphorylation;small GTPase mediated signal transduction;energy reserve metabolic process;cellular response to calcium ion;positive regulation of protein kinase activity;signal transduction;regulation of insulin secretion;regulation of cytokine production;positive regulation of Ras GTPase activity,ribonucleoprotein complex;cell leading edge;lateral plasma membrane;cytoplasm;neuron projection;actin filament;midbody;slit diaphragm;plasma membrane;microtubule;nucleus,,,,,,,,,,,,,,
2386,P46940,IQGAP1,Ras GTPase-activating-like protein IQGAP1 (p195),_____MSAADEVD,_(ac)S(ph)AADEVDGLGVARPHYGSVLDNER_,S2,,24.36,,,,25.06,,,,,23.50,,,,24.31,0.06, , , ,0.75, , , , ,-0.80, , , ,glomerular visceral epithelial cell development;small molecule metabolic process;negative regulation of dephosphorylation;small GTPase mediated signal transduction;energy reserve metabolic process;cellular response to calcium ion;positive regulation of protein kinase activity;signal transduction;regulation of insulin secretion;regulation of cytokine production;positive regulation of Ras GTPase activity,ribonucleoprotein complex;cell leading edge;lateral plasma membrane;cytoplasm;neuron projection;actin filament;midbody;slit diaphragm;plasma membrane;microtubule;nucleus,,,,,,,,,,,,,,
2387,P46940,IQGAP1,Ras GTPase-activating-like protein IQGAP1 (p195),ARPHYGSVLDNER,_(ac)SAADEVDGLGVARPHYGS(ph)VLDNER_,S19,,24.09,,,,,,,,,,24.24,,,24.16,-0.08, , , , , , , , , ,0.08, , ,glomerular visceral epithelial cell development;small molecule metabolic process;negative regulation of dephosphorylation;small GTPase mediated signal transduction;energy reserve metabolic process;cellular response to calcium ion;positive regulation of protein kinase activity;signal transduction;regulation of insulin secretion;regulation of cytokine production;positive regulation of Ras GTPase activity,ribonucleoprotein complex;cell leading edge;lateral plasma membrane;cytoplasm;neuron projection;actin filament;midbody;slit diaphragm;plasma membrane;microtubule;nucleus,,,,,,,,,,,,,,
2388,P47712,PLA2G4A,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase);Lysophospholipase (EC 3.1.1.5)],SNDSSDSDDESHE,_HIVSNDSSDS(ph)DDESHEPK_,S437,+,22.95,25.69,26.18,26.49,,,23.87,,,23.88,22.48,24.95,,24.56,-1.61,1.13,1.62,1.93, , ,-0.70, , ,-0.69,-2.08,0.39, ,surfactant homeostasis;phosphatidylcholine acyl-chain remodeling;positive regulation of fever generation;icosanoid biosynthetic process;positive regulation of vesicle fusion;icosanoid metabolic process;response to vitamin D;phosphatidylethanolamine acyl-chain remodeling;phospholipid catabolic process;response to lipopolysaccharide;positive regulation of prostaglandin biosynthetic process;response to calcium ion;platelet activation;response to methylmercury;arachidonic acid secretion;phosphatidylglycerol acyl-chain remodeling;response to hydrogen peroxide;phosphatidylinositol acyl-chain remodeling;luteolysis;positive regulation of bone mineralization;aging;arachidonic acid metabolic process;cellular response to antibiotic;ovulation from ovarian follicle;response to organic nitrogen;cardiolipin acyl-chain remodeling;positive regulation of cell proliferation;decidualization;platelet activating factor biosynthetic process;phosphatidylserine acyl-chain remodeling;phosphatidic acid biosynthetic process;response to glucocorticoid stimulus;response to heat;positive regulation of apoptotic process,cytosol;mitochondrial inner membrane;Golgi apparatus;nucleus;zymogen granule;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2391,P47755,CAPZA2,F-actin-capping protein subunit alpha-2 (CapZ alpha-2),DLEEQLSDEEKVR,_(ac)ADLEEQLS(ph)DEEKVR_,S9,,23.95,,,,25.62,,,,,25.50,,23.32,,24.60,-0.65, , , ,1.02, , , , ,0.90, ,-1.27, ,blood coagulation;actin filament capping;protein complex assembly;innate immune response;cellular component movement;actin cytoskeleton organization,cytosol;cortical cytoskeleton;extracellular region;F-actin capping protein complex;membrane,,,,,,,,,,,,,,
2393,P47914,RPL29,60S ribosomal protein L29 (Cell surface heparin-binding protein HIP),QAPTKASE_____,_RTQAPTKAS(ph)E_,S158,+,18.49,21.73,22.65,22.66,18.95,,19.28,20.52,19.12,,,,19.91,20.37,-1.88,1.36,2.28,2.29,-1.41, ,-1.09,0.15,-1.25, , , ,-0.46,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;embryo implantation;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2394,P47974,ZFP36L2,"Zinc finger protein 36, C3H1 type-like 2 (ZFP36-like 2) (Butyrate response factor 2) (EGF-response factor 2) (ERF-2) (Protein TIS11D)",PIFSRLSISDD__,_RLPIFSRLS(ph)ISDD_,S317,+,24.13,,,19.38,25.27,,23.82,23.98,26.04,23.08,25.61,26.67,25.96,24.39,-0.26, , ,-5.01,0.87, ,-0.57,-0.42,1.64,-1.31,1.22,2.28,1.56,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;cell proliferation;regulation of mRNA stability",nucleus;cytoplasm,,,,,,,,,,,,,,
2395,P47974,ZFP36L2,"Zinc finger protein 36, C3H1 type-like 2 (ZFP36-like 2) (Butyrate response factor 2) (EGF-response factor 2) (ERF-2) (Protein TIS11D)",FRDRSFSENGDRS,_SFS(ph)ENGDR_,S125,,19.18,,,22.78,,,,,,,,,,20.98,-1.80, , ,1.80, , , , , , , , , ,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;cell proliferation;regulation of mRNA stability",nucleus;cytoplasm,,,,,,,,,,,,,,
2400,P48382,RFX5,DNA-binding protein RFX5 (Regulatory factor X 5),DLKGSESPEMGPE,_GSES(ph)PEM(ox)GPEVTPAPR_,S145,,23.46,24.02,,22.74,,,,,,,,,,23.40,0.05,0.62, ,-0.67, , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
2401,P48506,GCLC,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),KVRLVLSGEKVLE,_LVLS(ph)GEK_,S70,,23.08,,,,,,,,,,,,,23.08,0.00, , , , , , , , , , , , ,"response to oxidative stress;negative regulation of apoptotic process;negative regulation of transcription, DNA-dependent;cell redox homeostasis;glutathione biosynthetic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of protein ubiquitination;response to hormone stimulus;response to arsenic-containing substance;regulation of mitochondrial depolarization;glutamate metabolic process;response to nitrosative stress;L-ascorbic acid metabolic process;xenobiotic metabolic process;regulation of blood vessel size;response to heat;negative regulation of neuron apoptotic process;cysteine metabolic process",glutamate-cysteine ligase complex;cytosol,,,,,,,,,,,,,,
2402,P48552,NRIP1,Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140),FKSEPVSPQDFSF,_SEPVS(ph)PQDFSFSK_,S807,,24.17,22.06,21.98,20.66,,,22.59,,23.55,23.49,,22.39,,22.61,1.56,-0.56,-0.63,-1.95, , ,-0.02, ,0.94,0.88, ,-0.23, ,"ovarian follicle rupture;lipid storage;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;androgen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",histone deacetylase complex;nucleus,,,,,,,,,,,,,,
2405,P48594,SERPINB4,Serpin B4 (Leupin) (Peptidase inhibitor 11) (PI-11) (Squamous cell carcinoma antigen 2) (SCCA-2),____MNSLSEANT,_MNS(ph)LS(ph)EANTK_,S3,,22.56,29.36,29.36,20.02,,,,20.71,,,,21.61,20.17,23.40,-0.84,5.96,5.96,-3.38, , , ,-2.68, , , ,-1.79,-3.23,immune response;regulation of proteolysis,extracellular region;cytoplasm,,,,,,,,,,,,,,
2406,P48594,SERPINB4,Serpin B4 (Leupin) (Peptidase inhibitor 11) (PI-11) (Squamous cell carcinoma antigen 2) (SCCA-2),__MNSLSEANTKF,_MNS(ph)LS(ph)EANTK_,S5,,22.56,29.36,29.36,20.02,,,,20.71,,,,21.61,20.17,23.40,-0.84,5.96,5.96,-3.38, , , ,-2.68, , , ,-1.79,-3.23,immune response;regulation of proteolysis,extracellular region;cytoplasm,,,,,,,,,,,,,,
2407,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),DGGRASSLLSRFS,_ASS(ph)LLSR_,S160,,23.25,,,21.39,,,,,,,,,,22.32,0.93, , ,-0.93, , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
2409,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),PPGAPPSPAPARF,_EGTLTQVPLAPPPPGAPPS(ph)PAPAR_,S1147,+,24.35,,,22.97,23.39,,23.73,,,,23.88,25.32,23.96,23.94,0.41, , ,-0.97,-0.55, ,-0.21, , , ,-0.07,1.38,0.02,,nucleus;cytoplasm,,,,,,,,,,,,,,
2410,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),LIPGPLSPVARGG,_LIPGPLS(ph)PVAR_,S1219,,27.81,26.79,27.10,26.60,27.75,26.94,27.60,27.56,27.26,27.80,27.67,27.31,28.16,27.41,0.40,-0.62,-0.31,-0.81,0.33,-0.47,0.19,0.15,-0.15,0.39,0.26,-0.11,0.75,,nucleus;cytoplasm,,,,,,,,,,,,,,
2413,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),PRGRTASETRSEG,_TAS(ph)ETRS(ph)EGSEYEEIPK_,S1085,,25.14,23.99,24.44,24.40,,,,,22.11,,,,,24.02,1.13,-0.03,0.42,0.38, , , , ,-1.91, , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
2415,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),ETRSEGSEYEEIP,_S(ph)EGS(ph)EYEEIPK_,S1092,,25.50,,,,,23.90,,,,,,,,24.70,0.80, , , , ,-0.80, , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
2416,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),RRRQRGSETGSET,_(gl)QRGS(ph)ET(ph)GSETHESDLAPSDK_,S1106,+,26.21,24.79,25.32,25.65,21.65,24.83,24.83,24.46,25.17,25.46,24.95,,24.67,24.83,1.38,-0.04,0.49,0.82,-3.19,0.00,0.00,-0.37,0.34,0.63,0.12, ,-0.16,,nucleus;cytoplasm,,,,,,,,,,,,,,
2417,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),RGSETGSETHESD,_GSETGS(ph)ETHESDLAPSDK_,S1110,+,24.50,25.13,25.13,24.78,,22.88,23.15,23.24,,,,,,24.12,0.38,1.02,1.02,0.67, ,-1.24,-0.97,-0.88, , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
2418,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),EPRPLTSPLRQAA,_PLTS(ph)PLRQAADEDDK_,S808,,,21.96,,21.69,,22.80,,,,,,,,22.15, ,-0.19, ,-0.46, ,0.65, , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
2419,P48730,CSNK1D,Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26),GAPVNISSSDLTG,_GAPVNIS(ph)SSDLTGR_,S325,,23.55,,,22.32,,22.64,,21.49,23.38,,,,,22.68,0.88, , ,-0.35, ,-0.04, ,-1.19,0.70, , , , ,regulation of circadian rhythm;spindle assembly;DNA repair;G2/M transition of mitotic cell cycle;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein phosphorylation;signal transduction;circadian regulation of gene expression;Wnt receptor signaling pathway;positive regulation of canonical Wnt receptor signaling pathway,spindle microtubule;cytosol;Golgi apparatus;plasma membrane;nucleus;centrosome;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
2421,P48739,PITPNB,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),TMRKRGSVRGTSA,_RGS(ph)VRGTSAADV_,S262,+,26.84,29.02,29.98,26.45,27.39,26.46,29.10,27.91,26.79,27.81,28.22,28.81,25.28,27.70,-0.85,1.32,2.28,-1.25,-0.31,-1.23,1.40,0.21,-0.91,0.12,0.52,1.11,-2.41,small molecule metabolic process;glycerophospholipid biosynthetic process;in utero embryonic development;phospholipid transport,endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
2423,P49006,MARCKSL1,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),EEAAGASPAKANG,_GDVTAEEAAGAS(ph)PAK_,S22,+,25.32,26.47,27.21,26.43,27.90,27.71,28.39,28.33,26.81,27.79,26.04,25.91,26.96,27.02,-1.70,-0.55,0.19,-0.60,0.88,0.69,1.37,1.31,-0.21,0.77,-0.98,-1.11,-0.06,vesicle-mediated transport;positive regulation of cell proliferation,plasma membrane;cytoplasm,,,,,,,,,,,,,,
2426,P49006,MARCKSL1,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),KKPFKLSGLSFKR,_PFKLS(ph)GLS(ph)FKR_,S101,,24.45,,,,,,,,,,,,,24.45,0.00, , , , , , , , , , , , ,vesicle-mediated transport;positive regulation of cell proliferation,plasma membrane;cytoplasm,,,,,,,,,,,,,,
2427,P49006,MARCKSL1,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),FKLSGLSFKRNRK,_PFKLS(ph)GLS(ph)FKR_,S104,+,26.58,23.46,23.55,25.59,26.79,24.66,25.60,25.83,,,,26.29,,25.37,1.21,-1.92,-1.82,0.22,1.42,-0.71,0.23,0.46, , , ,0.91, ,vesicle-mediated transport;positive regulation of cell proliferation,plasma membrane;cytoplasm,,,,,,,,,,,,,,
2429,P49023,PXN,Paxillin,RDGGRSSPGGQDE,_DGGRSS(ph)PGGQDEGGFM(ox)AQGK_,S303,+,25.37,25.71,25.62,25.74,26.54,24.88,22.74,26.44,23.32,23.08,,,,24.94,0.42,0.76,0.68,0.80,1.60,-0.07,-2.20,1.50,-1.62,-1.87, , , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2431,P49023,PXN,Paxillin,QQPQSSSPVYGSS,_FIHQQPQSSS(ph)PVYGSSAK_,S85,+,25.15,23.95,23.68,24.40,25.58,24.83,26.52,26.92,24.26,23.34,26.43,23.31,25.20,24.89,0.26,-0.94,-1.21,-0.49,0.69,-0.06,1.63,2.03,-0.63,-1.55,1.54,-1.58,0.31,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2432,P49023,PXN,Paxillin,QQQTRISASSATR,_IS(ph)ASSATR_,S258,+,20.69,24.52,,26.74,20.35,20.89,20.63,,20.57,,,,,22.06,-1.37,2.47, ,4.68,-1.70,-1.17,-1.43, ,-1.48, , , , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2433,P49023,PXN,Paxillin,FPNKQKSAEPSPT,_(gl)QKS(ph)AEPS(ph)PTVM(ox)STSLGSNLSELDR_,S126,,25.20,,,,,,,,,,,,,25.20,0.00, , , , , , , , , , , , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2434,P49023,PXN,Paxillin,QKSAEPSPTVMST,_(gl)QKS(ph)AEPS(ph)PTVM(ox)STSLGSNLSELDR_,S130,,25.20,,,,,,,,,,,,,25.20,0.00, , , , , , , , , , , , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2435,P49023,PXN,Paxillin,PTVMSTSLGSNLS,_SAEPSPTVM(ox)STS(ph)LGSNLSELDR_,S137,,23.97,,,22.94,,,,21.64,,,,,,22.85,1.12, , ,0.09, , , ,-1.21, , , , , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2438,P49023,PXN,Paxillin,GKTGSSSPPGGPP,_TGSSS(ph)PPGGPPKPGSQLDSM(ox)LGSLQSDLNK_,S322,,26.52,26.87,26.87,25.33,28.42,27.84,28.05,28.97,26.19,26.92,29.47,27.19,27.16,27.37,-0.85,-0.50,-0.50,-2.04,1.05,0.47,0.68,1.60,-1.18,-0.45,2.10,-0.18,-0.21,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2439,P49023,PXN,Paxillin,PQDSVGSPCSRVG,_TSSVSNPQDSVGS(ph)PCSR_,S106,,23.84,,,,,,21.81,,,,24.63,,,23.43,0.41, , , , , ,-1.62, , , ,1.20, , ,lamellipodium assembly;activation of MAPK activity;signal complex assembly;focal adhesion assembly;peptidyl-tyrosine phosphorylation;growth hormone receptor signaling pathway;epidermal growth factor receptor signaling pathway;cell adhesion;integrin-mediated signaling pathway;branching morphogenesis of a tube;cellular response to reactive oxygen species;cytoskeleton organization;muscle contraction;cell junction assembly;cellular component movement,cell cortex;plasma membrane;microtubule associated complex;focal adhesion;lamellipodium,,,,,,,,,,+,,,,
2440,P49116,NR2C2,Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4),IRKDLRSPLIATP,_DLRS(ph)PLIATPTFVADK_,S238,+,23.57,20.92,,,,21.22,23.25,,24.41,23.59,21.86,21.51,,22.54,1.03,-1.62, , , ,-1.32,0.71, ,1.87,1.05,-0.68,-1.03, ,transcription initiation from RNA polymerase II promoter;cerebellum development;cell differentiation;positive regulation of behavior;positive regulation of embryonic development;spermatogenesis;meiotic cell cycle;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm,NR C4-type,,,,,,,,,,,,,
2441,P49116,NR2C2,Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4),GKVILASPETSSA,_VILAS(ph)PETSSAK_,S87,+,21.48,23.43,23.43,,23.02,23.25,23.02,,22.33,,,,22.43,22.80,-1.32,0.63,0.63, ,0.22,0.45,0.22, ,-0.47, , , ,-0.36,transcription initiation from RNA polymerase II promoter;cerebellum development;cell differentiation;positive regulation of behavior;positive regulation of embryonic development;spermatogenesis;meiotic cell cycle;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm,NR C4-type,,,,,,,,,,,,,
2443,P49321,NASP,Nuclear autoantigenic sperm protein (NASP),RAKLVPSQEETKL,_LVPS(ph)QEETK_,S421,,25.63,24.36,25.06,25.24,,,22.36,,,23.28,,,,24.32,1.31,0.04,0.73,0.92, , ,-1.96, , ,-1.04, , , ,cell proliferation;blastocyst development;protein transport;cell cycle;DNA replication;histone exchange,nucleus;cytoplasm,,,,,,,,,,,,,,
2445,P49321,NASP,Nuclear autoantigenic sperm protein (NASP),EKTEDESLVENND,_TEDES(ph)LVENNDNIDEEAR_,S127,,21.52,22.99,22.99,,,,,,,,,,,22.50,-0.98,0.49,0.49, , , , , , , , , , ,cell proliferation;blastocyst development;protein transport;cell cycle;DNA replication;histone exchange,nucleus;cytoplasm,,,,,,,,,,,,,,
2448,P49321,NASP,Nuclear autoantigenic sperm protein (NASP),IDETEGSEEDDKE,_TEDESLVENNDNIDET(ph)EGS(ph)EEDDK_,S141,,27.62,25.75,25.75,23.30,,,26.35,,25.61,26.49,,25.00,,25.73,1.89,0.02,0.02,-2.44, , ,0.61, ,-0.13,0.76, ,-0.73, ,cell proliferation;blastocyst development;protein transport;cell cycle;DNA replication;histone exchange,nucleus;cytoplasm,,,,,,,,,,,,,,
2449,P49327,FASN,Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38);[Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39);3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41);3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59);Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39);Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],LRLGMLSPEGTCK,_LGM(ox)LS(ph)PEGTCK_,S207,,,,,23.98,,,,,,,,,,23.98, , , ,0.00, , , , , , , , , ,triglyceride biosynthetic process;pantothenate metabolic process;long-chain fatty-acyl-CoA biosynthetic process;fatty acid metabolic process;energy reserve metabolic process;fatty acid biosynthetic process;positive regulation of cellular metabolic process,cytosol;mitochondrion;glycogen granule;Golgi apparatus;plasma membrane;melanosome,,,,,,,,,,,,,,
2450,P49327,FASN,Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38);[Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39);3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41);3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59);Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39);Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],RPTPQDSPIFLPV,_RPTPQDS(ph)PIFLPVDDTSFR_,S1411,+,,,,,24.27,,23.01,23.60,22.80,21.79,22.79,23.25,22.99,23.06, , , , ,1.21, ,-0.05,0.54,-0.26,-1.27,-0.27,0.19,-0.07,triglyceride biosynthetic process;pantothenate metabolic process;long-chain fatty-acyl-CoA biosynthetic process;fatty acid metabolic process;energy reserve metabolic process;fatty acid biosynthetic process;positive regulation of cellular metabolic process,cytosol;mitochondrion;glycogen granule;Golgi apparatus;plasma membrane;melanosome,,,,,,,,,,,,,,
2451,P49407,ARRB1,Beta-arrestin-1 (Arrestin beta-1),EEDGTGSPQLNNR,_EEEEDGTGS(ph)PQLNNR_,S404,+,23.58,26.92,27.06,25.02,,,23.49,,24.03,22.53,,21.15,,24.22,-0.64,2.70,2.84,0.80, , ,-0.73, ,-0.20,-1.69, ,-3.07, ,post-Golgi vesicle-mediated transport;positive regulation of peptidyl-serine phosphorylation;phototransduction;positive regulation of Rho protein signal transduction;positive regulation of ERK1 and ERK2 cascade;negative regulation of NF-kappaB transcription factor activity;stress fiber assembly;G-protein coupled receptor internalization;negative regulation of protein ubiquitination;protein transport;positive regulation of histone H4 acetylation;positive regulation of transcription from RNA polymerase II promoter;proteasomal ubiquitin-dependent protein catabolic process;platelet activation;transcription from RNA polymerase II promoter;negative regulation of interleukin-8 production;positive regulation of protein binding;Notch signaling pathway;cellular membrane organization;positive regulation of insulin secretion involved in cellular response to glucose stimulus;negative regulation of interleukin-6 production;protein ubiquitination,cytoplasmic vesicle membrane;lysosomal membrane;pseudopodium;Golgi membrane;chromatin;coated pit;cytosol;nucleus;plasma membrane,,,,,,,,,,,,,,
2452,P49450,CENPA,Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A),EAPRRRSPSPTPT,_RRS(ph)PS(ph)PTPTPGPSR_,S17,+,26.47,27.02,26.46,26.38,24.81,20.75,21.28,22.29,21.19,,,,,24.07,2.39,2.95,2.38,2.31,0.74,-3.33,-2.79,-1.78,-2.88, , , , ,"mitotic prometaphase;kinetochore assembly;CENP-A containing nucleosome assembly at centromere;establishment of mitotic spindle orientation;protein localization to chromosome, centromeric region;virus-host interaction",nucleoplasm;cytosol;condensed chromosome inner kinetochore;condensed nuclear chromosome kinetochore;nucleosome,,,,,,,,,,,,,,
2453,P49450,CENPA,Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A),PRRRSPSPTPTPG,_RRS(ph)PS(ph)PTPTPGPSR_,S19,+,26.47,27.02,26.46,26.38,24.81,20.75,21.28,22.29,21.19,,,,,24.07,2.39,2.95,2.38,2.31,0.74,-3.33,-2.79,-1.78,-2.88, , , , ,"mitotic prometaphase;kinetochore assembly;CENP-A containing nucleosome assembly at centromere;establishment of mitotic spindle orientation;protein localization to chromosome, centromeric region;virus-host interaction",nucleoplasm;cytosol;condensed chromosome inner kinetochore;condensed nuclear chromosome kinetochore;nucleosome,,,,,,,,,,,,,,
2454,P49454,CENPF,Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin),AQKLALSPLSLGK,_LALS(ph)PLSLGK_,S3119,+,,22.02,22.02,20.10,22.52,22.48,22.98,22.60,21.68,21.80,,,22.32,22.05, ,-0.03,-0.03,-1.95,0.47,0.43,0.93,0.54,-0.37,-0.25, , ,0.27,"regulation of striated muscle tissue development;cell differentiation;kinetochore assembly;metaphase plate congression;response to drug;negative regulation of transcription, DNA-dependent;mitotic cell cycle spindle assembly checkpoint;cell proliferation;mitotic prometaphase;protein transport;regulation of G2/M transition of mitotic cell cycle;cell division;DNA replication;G2 phase of mitotic cell cycle;muscle organ development",nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytosol;midbody;pronucleus;spindle pole;condensed chromosome outer kinetochore,,,,,,,,,,,,,,
2455,P49585,PCYT1A,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),AAAYDISEDEED_,_AAAYDIS(ph)EDEED_,S362,+,27.73,25.33,25.33,25.85,25.49,,26.60,25.62,27.01,24.26,25.25,26.11,26.42,25.92,1.81,-0.59,-0.59,-0.07,-0.43, ,0.69,-0.30,1.09,-1.66,-0.66,0.19,0.50,response to abiotic stimulus,cytosol;glycogen granule;endoplasmic reticulum membrane,,,,,,,,,,,,,,
2456,P49585,PCYT1A,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),AKELNVSFINEKK,_ELNVS(ph)FINEK_,S233,,23.01,,,,,,21.04,,,,,,,22.02,0.98, , , , , ,-0.98, , , , , , ,response to abiotic stimulus,cytosol;glycogen granule;endoplasmic reticulum membrane,,,,,,,,,,,,,,
2457,P49585,PCYT1A,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),SPTRERSPSPSFR,_ERS(ph)PS(ph)PSFR_,S329,,27.09,25.35,23.10,25.63,,,,,,,,,,25.29,1.80,0.06,-2.19,0.34, , , , , , , , , ,response to abiotic stimulus,cytosol;glycogen granule;endoplasmic reticulum membrane,,,,,,,,,,,,,,
2459,P49590,HARS2,"Probable histidine--tRNA ligase, mitochondrial (EC 6.1.1.21) (Histidine--tRNA ligase-like) (Histidyl-tRNA synthetase) (HisRS)",QGTRDLSPQHMVV,_DLS(ph)PQHM(ox)VVR_,S42,,23.95,26.03,,,,,,24.59,,22.40,,,,24.24,-0.29,1.79, , , , , ,0.35, ,-1.84, , , ,histidyl-tRNA aminoacylation;tRNA aminoacylation for protein translation,mitochondrial matrix,,,,,,,,,,,,,,
2460,P49662,CASP4,Caspase-4 (CASP-4) (EC 3.4.22.57) (ICE(rel)-II) (Protease ICH-2) (Protease TX) [Cleaved into: Caspase-4 subunit 1;Caspase-4 subunit 2],PLKVLESLGKDFL,_VLES(ph)LGK_,S16,,22.46,,,,,,,,,,,,,22.46,0.00, , , , , , , , , , , , ,proteolysis;apoptotic process;induction of apoptosis,intracellular,,,,,,,,,,,,,,
2464,P49736,MCM2,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),SFTMASSPAQRRR,_(ac)AESSESFTM(ox)ASS(ph)PAQR_,S13,+,24.65,25.05,25.05,25.53,27.55,26.42,26.67,26.96,25.84,24.49,21.72,24.81,26.81,25.50,-0.86,-0.45,-0.45,0.02,2.05,0.91,1.17,1.46,0.34,-1.02,-3.79,-0.70,1.31,S phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;nucleosome assembly,nucleoplasm;chromatin;nuclear origin of replication recognition complex;MCM complex,,,,,,,,,,,,,,
2472,P49756,RBM25,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),KFEDEDSDDVPRK,_FEDEDS(ph)DDVPRK_,S703,+,25.61,26.42,27.17,25.50,21.13,21.22,26.00,,25.85,26.62,24.13,25.48,22.09,24.77,0.84,1.65,2.40,0.73,-3.64,-3.54,1.24, ,1.08,1.85,-0.64,0.71,-2.68,"mRNA processing;RNA splicing;apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nuclear speck;cytoplasm,,,,,,,,,,+,,,,
2474,P49756,RBM25,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),SPGQPNSVKRKKL,_LGASNSPGQPNS(ph)VK_,S683,,24.99,,,25.55,,,,,,,,23.66,,24.73,0.26, , ,0.81, , , , , , , ,-1.07, ,"mRNA processing;RNA splicing;apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nuclear speck;cytoplasm,,,,,,,,,,+,,,,
2475,P49756,RBM25,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),IKQEPESEEEEEE,_RQPQIKQEPES(ph)EEEEEEK_,S583,+,25.56,26.70,26.57,26.65,27.04,27.34,27.69,26.43,27.69,27.46,26.13,26.49,26.19,26.76,-1.20,-0.07,-0.20,-0.12,0.28,0.58,0.93,-0.33,0.92,0.69,-0.63,-0.27,-0.57,"mRNA processing;RNA splicing;apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nuclear speck;cytoplasm,,,,,,,,,,+,,,,
2478,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),TAPSPSSPTSPTS,_IVVGSSVAPGNTAPSPSS(ph)PTS(ph)PTSDATTSLEM(ox)NNPHAIPR_,S230,,25.27,,,,,,,,,,,,,25.27,0.00, , , , , , , , , , , , ,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,,,,,,,,,,
2480,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),QLARQGSFRGFPA,_QGS(ph)FRGFPALSQK_,S265,+,26.78,23.93,24.52,26.70,25.06,24.16,26.43,26.10,24.68,24.02,25.39,27.79,24.88,25.42,1.36,-1.49,-0.90,1.28,-0.35,-1.26,1.02,0.68,-0.74,-1.40,-0.03,2.37,-0.54,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,,,,,,,,,,
2481,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),KQRTNPSPTNPFS,_TNPS(ph)PTNPFSSDLQK_,S575,+,23.23,22.45,20.95,24.54,23.78,,23.05,23.61,,23.73,,,,23.17,0.06,-0.72,-2.22,1.37,0.61, ,-0.12,0.44, ,0.56, , , ,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,,,,,,,,,,
2484,P49760,CLK2,Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2),RRRREDSYHVRSR,_EDS(ph)YHVR_,S50,,22.15,24.14,24.68,,19.26,,,,,,,,,22.56,-0.41,1.58,2.12, ,-3.29, , , , , , , , ,peptidyl-tyrosine phosphorylation;negative regulation of gluconeogenesis;protein autophosphorylation;response to retinoic acid;regulation of RNA splicing;response to ionizing radiation,nuclear speck;nucleus,,+,,,,,,,,,,,,
2485,P49761,CLK3,Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3),HCKRYRSPEPDPY,_YRS(ph)PEPDPYLSYR_,S9,,,21.18,,20.17,25.24,,23.55,,23.08,22.90,,,,22.69, ,-1.51, ,-2.52,2.55, ,0.87, ,0.40,0.22, , , ,peptidyl-tyrosine phosphorylation;protein autophosphorylation;regulation of RNA splicing,acrosomal vesicle;intermediate filament cytoskeleton;nuclear speck;nucleus,,+,,,,,,,,,,,,
2486,P49768,PSEN1,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit;Presenilin-1 CTF subunit;Presenilin-1 CTF12 (PS1-CTF12)],AVQELSSSILAGE,_AAVQELSS(ph)SILAGEDPEER_,S274,+,25.05,23.22,22.03,25.12,25.68,,23.08,26.38,27.00,26.84,24.06,26.91,26.40,25.15,-0.10,-1.92,-3.12,-0.03,0.53, ,-2.07,1.23,1.85,1.69,-1.09,1.76,1.26,"response to oxidative stress;positive regulation of MAP kinase activity;negative regulation of apoptotic process;regulation of resting membrane potential;cell-cell adhesion;cell fate specification;neuron development;regulation of protein binding;cerebral cortex cell migration;neuron migration;regulation of phosphorylation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein glycosylation;neuron apoptotic process;regulation of synaptic plasticity;protein transport;membrane protein intracellular domain proteolysis;mitochondrial transport;blood vessel development;negative regulation of axonogenesis;intracellular signal transduction;post-embryonic development;somitogenesis;positive regulation of catalytic activity;Cajal-Retzius cell differentiation;positive regulation of receptor recycling;myeloid leukocyte differentiation;beta-amyloid metabolic process;Notch receptor processing;memory;choline transport;brain morphogenesis;T cell activation involved in immune response;epithelial cell proliferation;nerve growth factor receptor signaling pathway;anagen;negative regulation of neuron apoptotic process;embryonic limb morphogenesis;skin morphogenesis;synaptic vesicle targeting;protein processing;smooth endoplasmic reticulum calcium ion homeostasis;regulation of synaptic transmission, glutamatergic;apoptotic process;activation of MAPKK activity;positive regulation of coagulation;hematopoietic progenitor cell differentiation;skeletal system morphogenesis;membrane protein ectodomain proteolysis;response to DNA damage stimulus;amyloid precursor protein catabolic process;negative regulation of ubiquitin-protein ligase activity;thymus development;autophagic vacuole assembly;dorsal/ventral neural tube patterning;L-glutamate transport;T cell receptor signaling pathway;Notch signaling pathway;negative regulation of transcription from RNA polymerase II promoter;heart looping;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;positive regulation of apoptotic process;negative regulation of epidermal growth factor-activated receptor activity",Z disc;neuronal cell body;membrane raft;mitochondrial inner membrane;Golgi membrane;cell cortex;integral to plasma membrane;endoplasmic reticulum membrane;smooth endoplasmic reticulum;kinetochore;dendritic shaft;axon;gamma-secretase complex;apical plasma membrane;Golgi apparatus;centrosome;lysosomal membrane;perinuclear region of cytoplasm;neuromuscular junction;cytoplasmic vesicle;growth cone;rough endoplasmic reticulum;ciliary rootlet;cell surface;nuclear outer membrane,,,,,,,,,,,,,,
2487,P49768,PSEN1,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit;Presenilin-1 CTF subunit;Presenilin-1 CTF12 (PS1-CTF12)],VQELSSSILAGED,_AAVQELSSS(ph)ILAGEDPEERGVK_,S275,+,25.45,24.41,24.41,24.13,26.39,26.65,26.03,23.77,25.19,26.96,26.21,25.31,27.05,25.54,-0.09,-1.13,-1.13,-1.40,0.85,1.11,0.49,-1.77,-0.34,1.43,0.68,-0.23,1.51,"response to oxidative stress;positive regulation of MAP kinase activity;negative regulation of apoptotic process;regulation of resting membrane potential;cell-cell adhesion;cell fate specification;neuron development;regulation of protein binding;cerebral cortex cell migration;neuron migration;regulation of phosphorylation;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;protein glycosylation;neuron apoptotic process;regulation of synaptic plasticity;protein transport;membrane protein intracellular domain proteolysis;mitochondrial transport;blood vessel development;negative regulation of axonogenesis;intracellular signal transduction;post-embryonic development;somitogenesis;positive regulation of catalytic activity;Cajal-Retzius cell differentiation;positive regulation of receptor recycling;myeloid leukocyte differentiation;beta-amyloid metabolic process;Notch receptor processing;memory;choline transport;brain morphogenesis;T cell activation involved in immune response;epithelial cell proliferation;nerve growth factor receptor signaling pathway;anagen;negative regulation of neuron apoptotic process;embryonic limb morphogenesis;skin morphogenesis;synaptic vesicle targeting;protein processing;smooth endoplasmic reticulum calcium ion homeostasis;regulation of synaptic transmission, glutamatergic;apoptotic process;activation of MAPKK activity;positive regulation of coagulation;hematopoietic progenitor cell differentiation;skeletal system morphogenesis;membrane protein ectodomain proteolysis;response to DNA damage stimulus;amyloid precursor protein catabolic process;negative regulation of ubiquitin-protein ligase activity;thymus development;autophagic vacuole assembly;dorsal/ventral neural tube patterning;L-glutamate transport;T cell receptor signaling pathway;Notch signaling pathway;negative regulation of transcription from RNA polymerase II promoter;heart looping;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;positive regulation of apoptotic process;negative regulation of epidermal growth factor-activated receptor activity",Z disc;neuronal cell body;membrane raft;mitochondrial inner membrane;Golgi membrane;cell cortex;integral to plasma membrane;endoplasmic reticulum membrane;smooth endoplasmic reticulum;kinetochore;dendritic shaft;axon;gamma-secretase complex;apical plasma membrane;Golgi apparatus;centrosome;lysosomal membrane;perinuclear region of cytoplasm;neuromuscular junction;cytoplasmic vesicle;growth cone;rough endoplasmic reticulum;ciliary rootlet;cell surface;nuclear outer membrane,,,,,,,,,,,,,,
2488,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),GFSSRASDKDITV,_AS(ph)DKDITVSK_,S192,+,22.35,23.44,23.44,23.52,22.87,21.84,,22.33,,,,,19.89,22.46,-0.11,0.98,0.98,1.06,0.41,-0.62, ,-0.13, , , , ,-2.57,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2490,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),IPSIVSSPLNSPL,_RIPSIVSS(ph)PLNS(ph)PLDR_,S334,+,25.76,20.96,20.96,21.51,25.95,25.21,23.56,23.90,25.57,23.98,24.62,22.55,26.30,23.91,1.85,-2.95,-2.95,-2.40,2.04,1.30,-0.35,-0.01,1.66,0.07,0.71,-1.36,2.39,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2491,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),VSSPLNSPLDRSG,_RIPSIVS(ph)SPLNS(ph)PLDR_,S338,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2492,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),SLPPLWSPEAERS,_NTSLPPLWS(ph)PEAER_,S209,,23.43,,,23.06,24.65,,,,,,,,,23.71,-0.28, , ,-0.65,0.94, , , , , , , , ,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2493,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),VLDILKSPGFASP,_S(ph)PGFASPK_,S614,,25.36,23.23,23.82,23.12,,,,,,,,,,23.88,1.48,-0.65,-0.06,-0.77, , , , , , , , , ,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2494,P49790,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),NKVQMTSPSSTGS,_VQM(ox)TS(ph)PSSTGSPM(ox)FK_,S516,+,27.28,25.71,26.53,24.54,24.24,24.75,24.44,24.11,25.46,25.50,24.13,,24.96,25.14,2.14,0.57,1.39,-0.59,-0.90,-0.39,-0.69,-1.03,0.32,0.36,-1.00, ,-0.17,glucose transport;small molecule metabolic process;viral entry into host cell;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;viral penetration into host nucleus;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nucleolus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
2496,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],PATGILSPRGDDY,_FESPATGILS(ph)PR_,S955,+,23.90,23.77,23.46,23.31,23.50,,23.46,,22.58,,,,,23.43,0.47,0.35,0.03,-0.11,0.08, ,0.03, ,-0.85, , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2497,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],IKHSTPSPTRYSL,_HSTPS(ph)PTRYSLS(ph)PSK_,S781,+,25.11,25.96,26.78,24.93,24.12,20.04,,22.56,23.63,,,,,24.14,0.97,1.82,2.64,0.79,-0.02,-4.10, ,-1.58,-0.51, , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2501,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],HETDGGSAHGDDD,_NHETDGGS(ph)AHGDDDDDGPHFEPVVPLPDK_,S1160,,23.34,,,,,,23.97,,25.26,24.96,23.34,23.58,,24.07,-0.73, , , , , ,-0.11, ,1.19,0.88,-0.74,-0.50, ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2502,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],NRPDYVSEEEEDD,_NRPDYVS(ph)EEEEDDEDFETAVK_,S2668,,21.71,,,,24.98,,,,,24.28,,,24.84,23.95,-2.25, , , ,1.03, , , , ,0.33, , ,0.89,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2503,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],SFVHQASFKFGQG,_SGSSFVHQAS(ph)FK_,S1456,,26.16,,,,,22.12,,,,,,25.87,,24.72,1.44, , , , ,-2.59, , , , , ,1.15, ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2504,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],GEDEDGSDEEVVH,_VGEDEDGS(ph)DEEVVHNEDIHFEPIVSLPEVEVK_,S2900,,25.52,,,,,,,,,,,,,25.52,0.00, , , , , , , , , , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2505,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],VQGSTPSPRQKSM,_YIASVQGSTPS(ph)PR_,S21,,22.38,,,,24.32,,23.21,22.57,,,,,,23.12,-0.74, , , ,1.20, ,0.09,-0.55, , , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
2506,P49815,TSC2,Tuberin (Tuberous sclerosis 2 protein),ADVGRLSPEVKAR,_ADVGRLS(ph)PEVK_,S1296,+,24.49,26.67,27.32,25.12,,24.99,28.13,,24.54,25.46,26.87,26.87,24.27,25.89,-1.39,0.78,1.44,-0.77, ,-0.89,2.25, ,-1.35,-0.43,0.99,0.99,-1.62,negative regulation of cell proliferation;fibroblast growth factor receptor signaling pathway;regulation of insulin receptor signaling pathway;negative regulation of protein kinase B signaling cascade;negative regulation of MAP kinase activity;regulation of endocytosis;negative regulation of cell size;protein heterooligomerization;negative regulation of protein kinase activity;insulin receptor signaling pathway;cell cycle arrest;regulation of small GTPase mediated signal transduction;phosphatidylinositol 3-kinase cascade;negative regulation of epithelial cell proliferation;phosphatidylinositol-mediated signaling;negative regulation of phosphatidylinositol 3-kinase cascade;negative regulation of TOR signaling cascade;endocytosis;response to hypoxia;neural tube closure;protein kinase B signaling cascade;epidermal growth factor receptor signaling pathway;positive chemotaxis;insulin-like growth factor receptor signaling pathway;protein homooligomerization;nerve growth factor receptor signaling pathway;protein import into nucleus;negative regulation of Wnt receptor signaling pathway;heart development;cell projection organization;acute-phase response,TSC1-TSC2 complex;neuronal cell body;cytoskeletal part;Golgi apparatus;perinuclear region of cytoplasm;caveola;growth cone;nucleus;dendrite;membrane,,,,,,,,,,,,,,
2511,P49840,GSK3A,Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1),RGEPNVSYICSRY,_QLVRGEPNVS(ph)YICSR_,S215,,,,,,,,,23.10,,23.19,,23.86,,23.38, , , , , , , ,-0.28, ,-0.19, ,0.47, ,fibroblast growth factor receptor signaling pathway;regulation of systemic arterial blood pressure;positive regulation of peptidyl-threonine phosphorylation;cellular response to organic cyclic compound;cellular response to lithium ion;insulin receptor signaling pathway;Wnt receptor signaling pathway;negative regulation of glucose import;positive regulation of glycogen (starch) synthase activity;negative regulation of TOR signaling cascade;negative regulation of type B pancreatic cell development;cell migration;negative regulation of glycogen (starch) synthase activity;negative regulation of UDP-glucose catabolic process;epidermal growth factor receptor signaling pathway;activation of signaling protein activity involved in unfolded protein response;nerve growth factor receptor signaling pathway;nervous system development;positive regulation of peptidyl-serine phosphorylation;glycogen metabolic process;negative regulation of canonical Wnt receptor signaling pathway;positive regulation of heart contraction;negative regulation of glycogen biosynthetic process;cardiac left ventricle morphogenesis;hypermethylation of CpG island;positive regulation of protein catabolic process;positive regulation of cAMP biosynthetic process;phosphatidylinositol-mediated signaling;positive regulation of transcription from RNA polymerase II promoter;negative regulation of insulin receptor signaling pathway;negative regulation of cell growth involved in cardiac muscle cell development;positive regulation of adrenergic receptor signaling pathway;regulation of gene expression by genetic imprinting,cytosol;beta-catenin destruction complex,,+,,,,,,,,,,,,
2514,P49848,TAF6,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),KQEAGDSPPPAPG,_QEAGDS(ph)PPPAPGTPK_,S643,+,23.48,25.21,25.21,22.47,23.54,,24.64,23.69,22.64,23.32,,23.91,,23.81,-0.33,1.40,1.40,-1.35,-0.27, ,0.83,-0.13,-1.18,-0.49, ,0.10, ,transcription initiation from RNA polymerase II promoter;negative regulation of cell proliferation;viral reproduction;negative regulation of cell cycle;transcription elongation from RNA polymerase II promoter;regulation of sequence-specific DNA binding transcription factor activity,transcription factor TFTC complex;MLL1 complex;transcription factor TFIID complex;cytoplasm,,,,,,,,,,,,,,
2515,P49902,NT5C2,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II),ATRNRTSVDFKDT,_NRTS(ph)VDFK_,S482,,24.88,24.56,24.90,23.44,,,,,,21.03,,21.55,,23.39,1.49,1.16,1.51,0.04, , , , , ,-2.36, ,-1.84, ,drug metabolic process;purine nucleobase metabolic process;purine nucleotide catabolic process,cytosol,,,+,,,,,,,,,,,
2517,P49916,LIG3,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),TTGQVTSPVKGAS,_LTTTGQVTS(ph)PVK_,S210,+,26.50,27.27,27.27,24.71,24.97,,25.90,25.77,23.68,25.64,,24.27,24.49,25.50,1.00,1.77,1.77,-0.78,-0.53, ,0.40,0.27,-1.82,0.14, ,-1.22,-1.01,spermatogenesis;lagging strand elongation;base-excision repair;reciprocal meiotic recombination;nucleotide-excision repair;DNA ligation involved in DNA repair;cell division,nucleoplasm;chromosome,,,,,,,,,,,,,,
2519,P49959,MRE11A,Double-strand break repair protein MRE11A (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),KGVDFESSEDDDD,_GVDFES(ph)S(ph)EDDDDDPFM(ox)NTSSLR_,S687,+,26.70,,,,25.20,,23.24,23.44,24.83,24.80,,23.50,,24.53,2.17, , , ,0.67, ,-1.29,-1.09,0.30,0.27, ,-1.03, ,positive regulation of protein autophosphorylation;telomere maintenance via telomerase;synapsis;positive regulation of kinase activity;DNA duplex unwinding;cell proliferation;negative regulation of DNA endoreduplication;sister chromatid cohesion;double-strand break repair via nonhomologous end joining;regulation of mitotic recombination;reciprocal meiotic recombination;cell cycle checkpoint;heart development;double-strand break repair via homologous recombination,nucleoplasm;nuclear chromatin;condensed nuclear chromosome;Mre11 complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2520,P49959,MRE11A,Double-strand break repair protein MRE11A (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),GVDFESSEDDDDD,_GVDFES(ph)S(ph)EDDDDDPFM(ox)NTSSLR_,S688,,26.48,,,,,,,,,,,,,26.48,0.00, , , , , , , , , , , , ,positive regulation of protein autophosphorylation;telomere maintenance via telomerase;synapsis;positive regulation of kinase activity;DNA duplex unwinding;cell proliferation;negative regulation of DNA endoreduplication;sister chromatid cohesion;double-strand break repair via nonhomologous end joining;regulation of mitotic recombination;reciprocal meiotic recombination;cell cycle checkpoint;heart development;double-strand break repair via homologous recombination,nucleoplasm;nuclear chromatin;condensed nuclear chromosome;Mre11 complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2521,P50395,GDI2,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),RFKIPGSPPESMG,_IPGS(ph)PPESM(ox)GR_,S61,+,24.35,22.47,22.47,,22.83,22.56,24.84,23.87,22.90,,22.90,23.59,,23.28,1.07,-0.81,-0.81, ,-0.45,-0.71,1.56,0.59,-0.38, ,-0.37,0.31, ,protein transport;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction,cytosol;Golgi apparatus;membrane;cell surface,,,,,,,,,,,,,,
2522,P50402,EMD,Emerin,THYRPVSASRSSL,_DSAYQSITHYRPVS(ph)ASR_,S171,,,,,23.96,25.74,25.58,,,26.84,,,,25.50,25.53, , , ,-1.57,0.22,0.06, , ,1.31, , , ,-0.02,skeletal muscle cell differentiation;regulation of canonical Wnt receptor signaling pathway;negative regulation of catenin import into nucleus;positive regulation of protein export from nucleus;negative regulation of fibroblast proliferation;nuclear envelope reassembly;cellular response to growth factor stimulus;muscle contraction;muscle organ development,integral to membrane;nuclear inner membrane;endoplasmic reticulum;microtubule;spindle;nuclear outer membrane,,,,,,,,,,,,,,
2526,P50479,PDLIM4,PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein),PEIQDGSPTTSRR,_IHIDPEIQDGS(ph)PTTSR_,S112,+,25.00,27.71,24.79,28.02,28.86,29.03,26.93,28.40,28.44,25.47,28.47,26.95,28.09,27.40,-2.40,0.31,-2.60,0.63,1.46,1.64,-0.47,1.00,1.04,-1.93,1.08,-0.44,0.69,,,,,,,,,,,,,,,,
2527,P50502,ST13,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),LKADEPSSEESDL,_ADEPS(ph)S(ph)EES(ph)DLEIDK_,S65,,28.40,,,23.23,,,,,21.81,,,,,24.48,3.92, , ,-1.25, , , , ,-2.67, , , , ,protein folding;negative regulation of protein refolding;protein homooligomerization;chaperone cofactor-dependent protein refolding,cytosol;protein complex;cytoplasm,,,,,,,,,,,,,,
2528,P50502,ST13,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),KADEPSSEESDLE,_ADEPS(ph)S(ph)EES(ph)DLEIDK_,S66,+,28.46,23.87,23.90,24.63,22.54,23.22,24.17,22.25,23.12,24.17,23.17,24.80,,24.03,4.44,-0.15,-0.12,0.61,-1.49,-0.80,0.15,-1.78,-0.91,0.15,-0.86,0.77, ,protein folding;negative regulation of protein refolding;protein homooligomerization;chaperone cofactor-dependent protein refolding,cytosol;protein complex;cytoplasm,,,,,,,,,,,,,,
2529,P50502,ST13,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),EPSSEESDLEIDK,_ADEPS(ph)S(ph)EES(ph)DLEIDK_,S69,+,28.85,24.74,25.27,26.09,,,26.58,22.39,24.92,25.90,24.59,26.74,21.94,25.27,3.58,-0.54,0.00,0.82, , ,1.30,-2.88,-0.35,0.62,-0.69,1.47,-3.33,protein folding;negative regulation of protein refolding;protein homooligomerization;chaperone cofactor-dependent protein refolding,cytosol;protein complex;cytoplasm,,,,,,,,,,,,,,
2537,P50851,LRBA,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),GKSAAKSPVDIVT,_S(ph)PVDIVTGGISPVR_,S1488,,22.17,,,,,,,,,,,,,22.17,0.00, , , , , , , , , , , , ,,integral to membrane;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
2538,P50851,LRBA,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),GDDDTLSSVDEKD,_SQALGNQNSENEILLEGDDDTLS(ph)SVDEK_,S2053,,22.62,,,,,,,,,,,,,22.62,0.00, , , , , , , , , , , , ,,integral to membrane;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
2539,P50851,LRBA,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),ELKVEGSPTEEAN,_VEGS(ph)PTEEANLPTELQDNSLSPAASEAGEK_,S1118,,26.32,,,,,,24.59,,24.79,26.53,25.31,,,25.51,0.82, , , , , ,-0.92, ,-0.72,1.02,-0.20, , ,,integral to membrane;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
2540,P50851,LRBA,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),LQDNSLSPAASEA,_VEGS(ph)PTEEANLPTELQDNSLS(ph)PAASEAGEK_,S1135,+,24.24,21.68,,22.00,,,25.23,,25.10,26.23,25.50,24.49,,24.31,-0.07,-2.62, ,-2.31, , ,0.92, ,0.79,1.93,1.19,0.18, ,,integral to membrane;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
2544,P50914,RPL14,60S ribosomal protein L14 (CAG-ISL 7),AALLKASPKKAPG,_AALLKAS(ph)PK_,S139,+,23.06,26.70,26.70,23.75,27.37,24.52,,26.22,,,,,23.05,25.17,-2.11,1.53,1.53,-1.42,2.20,-0.65, ,1.05, , , , ,-2.12,"translational termination;translational elongation;viral transcription;ribosomal large subunit biogenesis;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2545,P51003,PAPOLA,Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha),KHYGITSPISLAA,_HYGITS(ph)PISLAAPK_,S24,,,,,,,23.28,22.86,,,22.33,,,23.19,22.91, , , , , ,0.37,-0.06, , ,-0.59, , ,0.28,"termination of RNA polymerase II transcription;mRNA splicing, via spliceosome;mRNA polyadenylation",nucleoplasm;cytoplasm,,,,,,,,,,,,,,
2546,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),NGPTSASGDDISK,_AINGPTSAS(ph)GDDISK_,S574,+,23.06,22.78,22.58,23.40,21.76,,23.70,23.47,23.60,,21.97,22.48,,22.88,0.18,-0.10,-0.30,0.52,-1.12, ,0.82,0.59,0.72, ,-0.91,-0.40, ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
2547,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),ERKDELSDWSLAG,_DELS(ph)DWS(ph)LAGEDDRDSR_,S407,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
2548,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),DELSDWSLAGEDD,_DELS(ph)DWS(ph)LAGEDDRDSR_,S410,,25.25,,,,,,,,,,,21.57,,23.41,1.84, , , , , , , , , , ,-1.84, ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
2549,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),GTNSELSNPSETE,_RGPNYTSGYGTNSELS(ph)NPS(ph)ETESERK_,S393,,23.25,,,,,,,,,,,,,23.25,0.00, , , , , , , , , , , , ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
2550,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),SELSNPSETESER,_RGPNYTSGYGTNSELS(ph)NPS(ph)ETESERK_,S396,,23.25,,,,,,24.44,,,,,24.21,,23.96,-0.72, , , , , ,0.47, , , , ,0.24, ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
2551,P51116,FXR2,Fragile X mental retardation syndrome-related protein 2,GNRTDGSISGDRQ,_TDGS(ph)IS(ph)GDRQPVTVADYISR_,S601,+,25.47,22.33,22.33,23.48,24.08,24.80,24.19,24.22,24.43,24.57,25.45,23.62,24.30,24.10,1.37,-1.77,-1.77,-0.62,-0.02,0.71,0.09,0.12,0.33,0.47,1.35,-0.48,0.21,,cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2552,P51116,FXR2,Fragile X mental retardation syndrome-related protein 2,RTDGSISGDRQPV,_TDGS(ph)IS(ph)GDRQPVTVADYISR_,S603,,25.47,,,,,,,,22.74,23.91,,,,24.04,1.43, , , , , , , ,-1.30,-0.13, , , ,,cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2553,P51116,FXR2,Fragile X mental retardation syndrome-related protein 2,SDVSTASETESEK,_TGGPAYGPSSDVSTAS(ph)ETESEK_,S453,,22.78,,,24.01,,,23.53,,22.99,,23.73,,,23.41,-0.63, , ,0.60, , ,0.12, ,-0.42, ,0.32, , ,,cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2554,P51149,RAB7A,Ras-related protein Rab-7a,GQERFQSLGVAFY,_FQS(ph)LGVAFYR_,S72,,27.42,22.04,,,23.56,,,22.47,22.83,21.84,,,,23.36,4.06,-1.32, , ,0.20, , ,-0.89,-0.53,-1.52, , , ,endosome to lysosome transport;early endosome to late endosome transport;endocytosis;small GTPase mediated signal transduction;epidermal growth factor catabolic process;phagosome maturation;protein targeting to lysosome;antigen processing and presentation of exogenous peptide antigen via MHC class II,late endosome;Golgi apparatus;melanosome;lysosomal membrane;phagocytic vesicle,,,,,,,,,,,,,,
2556,P51159,RAB27A,Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram),RSNGHASTDQLSE,_SNGHAS(ph)TDQLSEEK_,S198,,,23.86,23.63,23.89,,,21.12,,22.63,22.31,,,,22.91, ,0.95,0.73,0.98, , ,-1.79, ,-0.27,-0.60, , , ,multivesicular body sorting pathway;melanosome transport;exocytosis;small GTPase mediated signal transduction;natural killer cell degranulation;blood coagulation;protein targeting;melanocyte differentiation;cytotoxic T cell degranulation;positive regulation of exocytosis,exocytic vesicle;Golgi apparatus;apical plasma membrane;secretory granule membrane;melanosome;multivesicular body membrane;dendrite;lysosome;photoreceptor outer segment,,,,,,,,,,,,,,
2558,P51397,DAP,Death-associated protein 1 (DAP-1),____MSSPPEGKL,_(ac)SS(ph)PPEGKLETK_,S3,+,24.46,,,29.13,29.31,28.37,29.11,30.71,27.18,25.92,28.14,27.42,27.32,27.92,-3.46, , ,1.22,1.39,0.45,1.19,2.80,-0.74,-1.99,0.22,-0.49,-0.59,"autophagy;activation of cysteine-type endopeptidase activity involved in apoptotic process;apoptotic signaling pathway;negative regulation of NF-kappaB transcription factor activity;cellular response to amino acid starvation;negative regulation of transcription, DNA-dependent;negative regulation of autophagy",,,,,,,,,,,,,,,
2559,P51511,MMP15,Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2),AEPGADSAEGDVG,_WPDVARPPFNPHGGAEPGADS(ph)AEGDVGDGDGDFGAGVNK_,S589,,,,,,,,,,,24.23,,25.16,,24.70, , , , , , , , , ,-0.47, ,0.47, ,proteolysis;cellular protein modification process;response to estradiol stimulus,extracellular matrix;integral to plasma membrane,,,,,,,,,,,,,,
2561,P51531,SMARCA2,Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2),KAKPVVSDFDSDE,_AKPVVS(ph)DFDS(ph)DEEQDER_,S1550,,22.56,,,,,,,,22.65,,,,,22.60,-0.04, , , , , , , ,0.04, , , , ,negative regulation of cell proliferation;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;aortic smooth muscle cell differentiation;chromatin remodeling;nervous system development,nucleoplasm;nuclear chromatin;intermediate filament cytoskeleton;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,Other TF domain,,,,,,,,,,,,,
2562,P51531,SMARCA2,Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2),VVSDFDSDEEQDE,_AKPVVS(ph)DFDS(ph)DEEQDER_,S1554,,23.33,24.00,24.00,,,,,,22.65,,,,,23.50,-0.16,0.51,0.51, , , , , ,-0.85, , , , ,negative regulation of cell proliferation;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;aortic smooth muscle cell differentiation;chromatin remodeling;nervous system development,nucleoplasm;nuclear chromatin;intermediate filament cytoskeleton;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,Other TF domain,,,,,,,,,,,,,
2563,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),EPLDETSQMSDLP,_KAENAEGQTPAIGPDGEPLDETS(ph)QM(ox)S(ph)DLPVK_,S610,,25.91,23.38,23.38,,,,,,,,,,,24.22,1.69,-0.85,-0.85, , , , , , , , , , ,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2564,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),DETSQMSDLPVKV,_KAENAEGQTPAIGPDGEPLDETS(ph)QM(ox)S(ph)DLPVK_,S613,,26.20,,,,,24.17,24.55,,25.77,25.45,,,,25.23,0.97, , , , ,-1.06,-0.67, ,0.54,0.22, , , ,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2565,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),RAKPVVSDDDSEE,_AKPVVS(ph)DDDS(ph)EEEQEEDR_,S1593,,23.78,23.83,23.83,,,,,,,,,,,23.81,-0.03,0.01,0.01, , , , , , , , , , ,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2566,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),VVSDDDSEEEQEE,_AKPVVS(ph)DDDS(ph)EEEQEEDR_,S1597,+,23.78,23.83,23.83,,24.53,24.97,,23.00,23.59,24.21,,,22.99,23.86,-0.07,-0.03,-0.03, ,0.68,1.11, ,-0.86,-0.27,0.35, , ,-0.87,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2567,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),EQEEDRSGSGSEE,_AKPVVSDDDSEEEQEEDRS(ph)GSGSEED_,S1606,,,,,,24.62,25.24,,23.59,24.46,23.69,,,,24.32, , , , ,0.30,0.93, ,-0.73,0.14,-0.63, , , ,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2568,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),EVDYSDSLTEKQW,_EVDYSDS(ph)LTEK_,S1349,+,26.03,23.74,23.74,23.36,22.22,22.20,23.10,22.73,21.66,22.92,,23.50,,23.20,2.83,0.54,0.54,0.16,-0.98,-1.00,-0.10,-0.47,-1.54,-0.28, ,0.30, ,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2569,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),KIPDPDSDDVSEV,_KIPDPDS(ph)DDVS(ph)EVDAR_,S695,+,26.32,,,,25.38,23.12,23.64,23.72,23.98,24.16,22.40,23.34,23.48,23.95,2.36, , , ,1.43,-0.83,-0.31,-0.24,0.03,0.20,-1.55,-0.62,-0.47,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2570,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),PDSDDVSEVDARH,_KIPDPDS(ph)DDVS(ph)EVDAR_,S699,+,24.15,,,,,24.56,24.66,,24.20,22.95,22.58,,24.56,23.95,0.19, , , , ,0.61,0.71, ,0.25,-1.00,-1.37, ,0.61,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2571,P51532,SMARCA4,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),PPAEKLSPNPPNL,_LS(ph)PNPPNLTK_,S1419,+,25.48,24.58,24.55,25.34,23.78,25.10,26.07,23.90,25.66,26.22,23.56,25.44,24.15,24.91,0.57,-0.33,-0.36,0.43,-1.13,0.19,1.16,-1.02,0.75,1.31,-1.35,0.53,-0.76,neural retina development;nucleosome disassembly;negative regulation of androgen receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation by host of viral transcription;negative regulation of cell growth;negative regulation of transcription from RNA polymerase II promoter;chromatin remodeling;negative regulation of S phase of mitotic cell cycle;nervous system development,nuclear chromatin;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
2572,P51580,TPMT,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),LDIEEYSDTEVQK,_TSLDIEEYS(ph)DTEVQK_,S14,,24.35,,,,,23.10,,,22.48,,23.77,24.06,,23.55,0.80, , , , ,-0.45, , ,-1.07, ,0.22,0.51, ,xenobiotic metabolic process;small molecule metabolic process;nucleobase-containing compound metabolic process,cytosol,,,,,,,,,,,,,,
2575,P51608,MECP2,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),KMPFQTSPGGKAE,_M(ox)PFQTS(ph)PGGK_,S241,,24.05,25.16,25.16,,,,22.49,22.27,21.08,,,,,23.37,0.68,1.79,1.79, , , ,-0.87,-1.10,-2.29, , , , ,"negative regulation of histone methylation;cerebellum development;startle response;long-term memory;regulation of respiratory gaseous exchange by neurological system process;glutamine metabolic process;positive regulation of synapse assembly;sensory perception of pain;neurological system process involved in regulation of systemic arterial blood pressure;mitochondrial electron transport, ubiquinol to cytochrome c;negative regulation of histone acetylation;respiratory gaseous exchange;glucocorticoid metabolic process;post-embryonic development;behavioral fear response;histone acetylation;proprioception;synapse assembly;pathogenesis;positive regulation of transcription, DNA-dependent;dendrite development;protein localization;catecholamine secretion;histone methylation;transcription, DNA-dependent;negative regulation of neuron apoptotic process;adult locomotory behavior;long-term synaptic potentiation;embryo development;cardiolipin metabolic process;phosphatidylcholine metabolic process;positive regulation of cell proliferation;visual learning;neuron maturation;ventricular system development;inositol metabolic process;regulation of excitatory postsynaptic membrane potential;response to hypoxia;social behavior;chromatin silencing;negative regulation of transcription from RNA polymerase II promoter;regulation of gene expression by genetic imprinting",nuclear chromatin;cytosol;nucleus;heterochromatin;protein complex,Other TF domain,,,,,,,,,,,,,
2576,P51608,MECP2,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),ERLEEKSEDQDLQ,_S(ph)EDQDLQGLK_,S25,,22.74,24.54,23.28,,,,,,21.77,,,,,23.08,-0.35,1.46,0.20, , , , , ,-1.31, , , , ,"negative regulation of histone methylation;cerebellum development;startle response;long-term memory;regulation of respiratory gaseous exchange by neurological system process;glutamine metabolic process;positive regulation of synapse assembly;sensory perception of pain;neurological system process involved in regulation of systemic arterial blood pressure;mitochondrial electron transport, ubiquinol to cytochrome c;negative regulation of histone acetylation;respiratory gaseous exchange;glucocorticoid metabolic process;post-embryonic development;behavioral fear response;histone acetylation;proprioception;synapse assembly;pathogenesis;positive regulation of transcription, DNA-dependent;dendrite development;protein localization;catecholamine secretion;histone methylation;transcription, DNA-dependent;negative regulation of neuron apoptotic process;adult locomotory behavior;long-term synaptic potentiation;embryo development;cardiolipin metabolic process;phosphatidylcholine metabolic process;positive regulation of cell proliferation;visual learning;neuron maturation;ventricular system development;inositol metabolic process;regulation of excitatory postsynaptic membrane potential;response to hypoxia;social behavior;chromatin silencing;negative regulation of transcription from RNA polymerase II promoter;regulation of gene expression by genetic imprinting",nuclear chromatin;cytosol;nucleus;heterochromatin;protein complex,Other TF domain,,,,,,,,,,,,,
2579,P51610,HCFC1,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6],_MASAVSPANLPA,_(ac)ASAVS(ph)PANLPAVLLQPR_,S6,+,26.80,24.78,25.05,24.71,27.18,27.11,26.29,26.45,27.50,27.55,24.95,,27.32,26.31,0.49,-1.53,-1.26,-1.60,0.87,0.80,-0.01,0.14,1.19,1.25,-1.35, ,1.01,protein stabilization;positive regulation of gene expression;positive regulation of cell cycle;histone H4-K5 acetylation;histone H4-K16 acetylation;regulation of protein complex assembly;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;histone H4-K8 acetylation;cell cycle;release from viral latency,neuronal cell body;mitochondrion;MLL5-L complex;histone acetyltransferase complex;MLL1 complex;Set1C/COMPASS complex,,,,,,,,,,,,,,
2580,P51610,HCFC1,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6],PEELQVSPGPRQQ,_AVTTVTQSTPVPGPSVPPPEELQVS(ph)PGPR_,S1507,+,27.18,23.24,23.24,,27.42,23.31,26.00,26.26,26.81,24.64,25.23,25.55,26.21,25.42,1.76,-2.18,-2.18, ,1.99,-2.11,0.58,0.84,1.39,-0.78,-0.20,0.12,0.79,protein stabilization;positive regulation of gene expression;positive regulation of cell cycle;histone H4-K5 acetylation;histone H4-K16 acetylation;regulation of protein complex assembly;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;histone H4-K8 acetylation;cell cycle;release from viral latency,neuronal cell body;mitochondrion;MLL5-L complex;histone acetyltransferase complex;MLL1 complex;Set1C/COMPASS complex,,,,,,,,,,,,,,
2581,P51610,HCFC1,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6],TITLVKSPISVPG,_S(ph)PISVPGGSALISNLGK_,S666,+,25.80,24.47,24.75,24.92,,,25.48,23.09,26.29,26.27,24.14,,,25.02,0.77,-0.55,-0.27,-0.11, , ,0.46,-1.93,1.27,1.24,-0.88, , ,protein stabilization;positive regulation of gene expression;positive regulation of cell cycle;histone H4-K5 acetylation;histone H4-K16 acetylation;regulation of protein complex assembly;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;histone H4-K8 acetylation;cell cycle;release from viral latency,neuronal cell body;mitochondrion;MLL5-L complex;histone acetyltransferase complex;MLL1 complex;Set1C/COMPASS complex,,,,,,,,,,,,,,
2582,P51610,HCFC1,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1;HCF N-terminal chain 2;HCF N-terminal chain 3;HCF N-terminal chain 4;HCF N-terminal chain 5;HCF N-terminal chain 6;HCF C-terminal chain 1;HCF C-terminal chain 2;HCF C-terminal chain 3;HCF C-terminal chain 4;HCF C-terminal chain 5;HCF C-terminal chain 6],TVKVASSPVMVSN,_VASS(ph)PVM(ox)VSNPATR_,S598,,24.15,23.89,23.89,,23.66,,,,,23.47,,,,23.81,0.34,0.08,0.08, ,-0.15, , , , ,-0.34, , , ,protein stabilization;positive regulation of gene expression;positive regulation of cell cycle;histone H4-K5 acetylation;histone H4-K16 acetylation;regulation of protein complex assembly;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;histone H4-K8 acetylation;cell cycle;release from viral latency,neuronal cell body;mitochondrion;MLL5-L complex;histone acetyltransferase complex;MLL1 complex;Set1C/COMPASS complex,,,,,,,,,,,,,,
2584,P51636,CAV2,Caveolin-2,LFMDDDSYSHHSG,_ADVQLFM(ox)DDDS(ph)YSHHSGLEYADPEK_,S18,,,,,,24.42,,,,24.15,24.63,,24.12,24.34,24.33, , , , ,0.09, , , ,-0.18,0.30, ,-0.21,0.01,protein oligomerization;endoplasmic reticulum organization;mitochondrion organization;positive regulation of dopamine receptor signaling pathway;caveola assembly;negative regulation of endothelial cell proliferation;skeletal muscle fiber development;vesicle docking;synaptic transmission;vesicle fusion;regulation of mitosis,transport vesicle;Golgi apparatus;protein complex;Golgi membrane;perinuclear region of cytoplasm;caveola;cytosol;lipid particle;extrinsic to internal side of plasma membrane;nucleus;integral to plasma membrane;membrane;acrosomal membrane;cell surface,,,,,,,,,,,,,,
2586,P51636,CAV2,Caveolin-2,DSYSHHSGLEYAD,_ADVQLFM(ox)DDDSYSHHS(ph)GLEYADPEK_,S23,,,,,,24.42,,24.83,,,25.60,26.11,24.66,26.43,25.34, , , , ,-0.92, ,-0.51, , ,0.26,0.76,-0.68,1.09,protein oligomerization;endoplasmic reticulum organization;mitochondrion organization;positive regulation of dopamine receptor signaling pathway;caveola assembly;negative regulation of endothelial cell proliferation;skeletal muscle fiber development;vesicle docking;synaptic transmission;vesicle fusion;regulation of mitosis,transport vesicle;Golgi apparatus;protein complex;Golgi membrane;perinuclear region of cytoplasm;caveola;cytosol;lipid particle;extrinsic to internal side of plasma membrane;nucleus;integral to plasma membrane;membrane;acrosomal membrane;cell surface,,,,,,,,,,,,,,
2587,P51636,CAV2,Caveolin-2,MDDDSYSHHSGLE,_(ac)M(ox)DDDSYS(ph)HHS(ph)GLEYADPEK_,S7,,,,,23.29,,,,,,22.22,,,,22.76, , , ,0.53, , , , , ,-0.53, , , ,protein oligomerization;endoplasmic reticulum organization;mitochondrion organization;positive regulation of dopamine receptor signaling pathway;caveola assembly;negative regulation of endothelial cell proliferation;skeletal muscle fiber development;vesicle docking;synaptic transmission;vesicle fusion;regulation of mitosis,transport vesicle;Golgi apparatus;protein complex;Golgi membrane;perinuclear region of cytoplasm;caveola;cytosol;lipid particle;extrinsic to internal side of plasma membrane;nucleus;integral to plasma membrane;membrane;acrosomal membrane;cell surface,,,,,,,,,,,,,,
2588,P51636,CAV2,Caveolin-2,DSYSHHSGLEYAD,_(ac)M(ox)DDDSYSHHS(ph)GLEYADPEK_,S10,+,,23.40,21.96,24.16,23.64,24.06,23.71,23.86,23.31,23.85,23.22,,,23.52, ,-0.11,-1.56,0.64,0.13,0.54,0.19,0.34,-0.21,0.33,-0.30, , ,protein oligomerization;endoplasmic reticulum organization;mitochondrion organization;positive regulation of dopamine receptor signaling pathway;caveola assembly;negative regulation of endothelial cell proliferation;skeletal muscle fiber development;vesicle docking;synaptic transmission;vesicle fusion;regulation of mitosis,transport vesicle;Golgi apparatus;protein complex;Golgi membrane;perinuclear region of cytoplasm;caveola;cytosol;lipid particle;extrinsic to internal side of plasma membrane;nucleus;integral to plasma membrane;membrane;acrosomal membrane;cell surface,,,,,,,,,,,,,,
2589,P51659,HSD17B4,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12);Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",HTSRATSTATSGF,_ATS(ph)TATSGFAGAIGQK_,S318,,21.00,24.12,19.84,,,24.38,,,22.28,,24.27,,,22.65,-1.65,1.47,-2.81, , ,1.73, , ,-0.37, ,1.63, , ,medium-chain fatty-acyl-CoA metabolic process;fatty acid beta-oxidation using acyl-CoA oxidase;very long-chain fatty-acyl-CoA metabolic process;bile acid biosynthetic process;estrogen metabolic process;androgen metabolic process;alpha-linolenic acid metabolic process,peroxisomal matrix;peroxisomal membrane,,,,,,,,,,,,,,
2590,P51659,HSD17B4,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12);Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",____MGSPLRFDG,_(ac)GS(ph)PLRFDGR_,S3,+,19.78,26.70,26.21,27.07,28.40,28.44,27.99,28.48,28.45,27.93,28.08,28.39,29.03,27.30,-7.52,-0.61,-1.10,-0.23,1.10,1.14,0.69,1.18,1.15,0.63,0.78,1.09,1.73,medium-chain fatty-acyl-CoA metabolic process;fatty acid beta-oxidation using acyl-CoA oxidase;very long-chain fatty-acyl-CoA metabolic process;bile acid biosynthetic process;estrogen metabolic process;androgen metabolic process;alpha-linolenic acid metabolic process,peroxisomal matrix;peroxisomal membrane,,,,,,,,,,,,,,
2591,P51784,USP11,Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11),YVTKPNSDDEDDG,_YVTKPNS(ph)DDEDDGDEK_,S605,+,23.71,25.96,26.62,25.08,,,24.34,,24.44,25.45,,23.27,,24.86,-1.14,1.10,1.76,0.22, , ,-0.52, ,-0.42,0.59, ,-1.59, ,protein deubiquitination;ubiquitin-dependent protein catabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
2593,P51798,CLCN7,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),RVGHMSSVELDDE,_VGHM(ox)SS(ph)VELDDELLDPDM(ox)DPPHPFPK_,S14,,,,,,25.62,,26.10,,,23.00,26.62,27.39,26.60,25.89, , , , ,-0.27, ,0.21, , ,-2.89,0.73,1.50,0.72,response to pH,cytoplasmic vesicle;integral to membrane;lysosomal membrane,,,,,,,,,,,,,,
2594,P51812,RPS6KA3,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),AKTPKDSPGIPPS,_DS(ph)PGIPPSANAHQLFR_,S369,+,19.49,22.77,,20.21,,,23.38,,,21.33,22.84,24.98,,22.14,-2.66,0.63, ,-1.93, , ,1.24, , ,-0.81,0.70,2.83, ,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;central nervous system development;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway;skeletal system development,nucleoplasm;cytosol,,+,,,,,,,,+,,,,
2595,P51812,RPS6KA3,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),ALNRNQSPVLEPV,_NQS(ph)PVLEPVGR_,S715,+,24.38,,,,24.91,24.16,25.52,24.96,23.63,,23.62,,22.95,24.27,0.11, , , ,0.65,-0.11,1.25,0.69,-0.63, ,-0.65, ,-1.31,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to lipopolysaccharide;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;central nervous system development;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway;skeletal system development,nucleoplasm;cytosol,,+,,,,,,,,+,,,,
2596,P51858,HDGF,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),GDLLEDSPKRPKE,_RRAGDLLEDS(ph)PK_,S165,+,31.57,31.65,31.12,30.00,29.84,29.99,31.05,29.59,31.51,31.44,30.10,30.70,28.65,30.56,1.01,1.09,0.56,-0.55,-0.71,-0.56,0.50,-0.96,0.95,0.88,-0.46,0.15,-1.90,cell proliferation;activation of signaling protein activity involved in unfolded protein response,extracellular space;transcriptional repressor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
2597,P51858,HDGF,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),GIRDHESL_____,_EDAEAPGIRDHES(ph)L_,S239,+,25.73,26.78,27.73,22.92,,,25.17,,25.82,26.59,22.66,24.62,,25.34,0.40,1.45,2.39,-2.41, , ,-0.16, ,0.48,1.25,-2.67,-0.72, ,cell proliferation;activation of signaling protein activity involved in unfolded protein response,extracellular space;transcriptional repressor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
2598,P51858,HDGF,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),KGNAEGSSDEEGK,_KGNAEGS(ph)S(ph)DEEGKLVIDEPAK_,S132,,28.29,,,22.57,,25.69,,,,,,,24.13,25.17,3.12, , ,-2.60, ,0.52, , , , , , ,-1.04,cell proliferation;activation of signaling protein activity involved in unfolded protein response,extracellular space;transcriptional repressor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
2599,P51858,HDGF,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),GNAEGSSDEEGKL,_KGNAEGS(ph)S(ph)DEEGKLVIDEPAK_,S133,,28.29,,,22.57,,25.69,,,,,,,24.13,25.17,3.12, , ,-2.60, ,0.52, , , , , , ,-1.04,cell proliferation;activation of signaling protein activity involved in unfolded protein response,extracellular space;transcriptional repressor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
2603,P51965,UBE2E1,Ubiquitin-conjugating enzyme E2 E1 (EC 6.3.2.19) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1),_____MSDDDSRA,_(ac)S(ph)DDDSRASTSSSSSSSSNQQTEKETNTPK_,S2,,,,,,25.44,,,22.96,,,,,,24.20, , , , ,1.24, , ,-1.24, , , , , ,histone H2B ubiquitination;histone monoubiquitination;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;protein K48-linked ubiquitination;ISG15-protein conjugation;cytokine-mediated signaling pathway;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,nucleoplasm;cytosol;ubiquitin ligase complex,,,,,,,,,,,,,,
2604,P51991,HNRNPA3,Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3),GGRSSGSPYGGGY,_SSGS(ph)PYGGGYGSGGGSGGYGSR_,S358,+,25.73,25.91,26.26,25.70,25.93,26.78,25.76,25.61,26.08,25.49,25.62,25.14,,25.83,-0.10,0.08,0.43,-0.13,0.10,0.94,-0.07,-0.23,0.25,-0.35,-0.22,-0.70, ,"mRNA splicing, via spliceosome",nucleoplasm;nucleolus;catalytic step 2 spliceosome,,,,,,,,,,,,,,
2605,P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),GVVKFESPEVAER,_FES(ph)PEVAER_,S701,+,23.35,24.01,23.35,24.46,,21.80,24.19,,24.48,23.08,22.18,,,23.43,-0.08,0.57,-0.08,1.03, ,-1.63,0.76, ,1.05,-0.36,-1.26, , ,"alternative mRNA splicing, via spliceosome",paraspeckles;integral to plasma membrane;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
2606,P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),GGGGGASFDRAIE,_M(ox)GLAM(ox)GGGGGAS(ph)FDR_,S618,,24.79,,,24.66,,,,,,,,,,24.72,0.07, , ,-0.07, , , , , , , , , ,"alternative mRNA splicing, via spliceosome",paraspeckles;integral to plasma membrane;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
2607,P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),IERMGLSMERMVP,_M(ox)GLS(ph)MER_,S528,,22.17,,,24.53,,,,,21.55,,,,,22.75,-0.58, , ,1.78, , , , ,-1.20, , , , ,"alternative mRNA splicing, via spliceosome",paraspeckles;integral to plasma membrane;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
2608,P52272,HNRNPM,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),GMDRVGSEIERMG,_VGS(ph)EIER_,S432,,25.81,23.98,,21.47,,,,,,,,,,23.75,2.06,0.23, ,-2.28, , , , , , , , , ,"alternative mRNA splicing, via spliceosome",paraspeckles;integral to plasma membrane;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
2609,P52292,KPNA2,Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha),FPDDATSPLQENR,_NVSSFPDDATS(ph)PLQENR_,S62,,23.42,23.30,23.30,23.83,24.55,23.95,,23.99,,,,,,23.76,-0.35,-0.47,-0.47,0.07,0.79,0.19, ,0.23, , , , , ,NLS-bearing substrate import into nucleus;M phase specific microtubule process;regulation of DNA recombination;G2 phase of mitotic cell cycle;cytokine-mediated signaling pathway;virus-host interaction;DNA metabolic process,nucleoplasm;cytosol,,,,,,,,,,,,,,
2611,P52569,SLC7A2,Low affinity cationic amino acid transporter 2 (CAT-2) (CAT2) (Solute carrier family 7 member 2),KDGLGSSPRVTSK,_DGLGSS(ph)PRVTSK_,S455,,21.02,26.25,27.19,,,,21.82,,,,,,,24.07,-3.05,2.18,3.12, , , ,-2.25, , , , , , ,nitric oxide biosynthetic process;nitric oxide production involved in inflammatory response;regulation of inflammatory response;macrophage activation;cellular amino acid metabolic process,integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2612,P52569,SLC7A2,Low affinity cationic amino acid transporter 2 (CAT-2) (CAT2) (Solute carrier family 7 member 2),HHPRNLSSPFIFH,_NLS(ph)S(ph)PFIFHEK_,S646,+,25.93,24.52,24.09,29.33,24.50,25.20,,25.37,25.29,,25.19,26.27,24.45,25.47,0.46,-0.95,-1.38,3.86,-0.97,-0.27, ,-0.09,-0.18, ,-0.27,0.81,-1.02,nitric oxide biosynthetic process;nitric oxide production involved in inflammatory response;regulation of inflammatory response;macrophage activation;cellular amino acid metabolic process,integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2613,P52569,SLC7A2,Low affinity cationic amino acid transporter 2 (CAT-2) (CAT2) (Solute carrier family 7 member 2),HPRNLSSPFIFHE,_NLS(ph)S(ph)PFIFHEK_,S647,+,24.95,24.09,23.90,20.75,,,,22.84,21.48,22.59,24.51,21.24,,22.93,2.02,1.16,0.97,-2.18, , , ,-0.09,-1.44,-0.33,1.58,-1.69, ,nitric oxide biosynthetic process;nitric oxide production involved in inflammatory response;regulation of inflammatory response;macrophage activation;cellular amino acid metabolic process,integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2614,P52594,AGFG1,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),PVGSVVSVPSQSS,_APVGSVVS(ph)VPSQSSASSDK_,S253,+,26.01,24.51,25.13,22.06,,,,,21.92,24.10,24.27,,,24.00,2.01,0.51,1.13,-1.94, , , , ,-2.08,0.10,0.27, , ,multicellular organismal development;cell differentiation;spermatogenesis;mRNA export from nucleus;regulation of ARF GTPase activity,Golgi apparatus;cytoplasmic membrane-bounded vesicle;nuclear pore,,,,,,,,,,,,,,
2617,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),AAAPGASPSPGGD,_AAAAPGAS(ph)PSPGGDAAWSEAGPGPRPLAR_,S41,,23.16,,,20.24,22.72,,,,23.48,,,,,22.40,0.76, , ,-2.16,0.32, , , ,1.08, , , , ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2618,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),MVTGNGSLKRKSS,_M(ox)VTGNGS(ph)LKR_,S309,,22.55,20.52,20.52,,,,,,,,,19.70,,20.82,1.73,-0.30,-0.30, , , , , , , , ,-1.12, ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2619,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),TYVTDKSEEDNEI,_S(ph)EEDNEIES(ph)EEEVQPK_,S219,,27.27,24.24,24.24,,,,,,,,,,,25.25,2.02,-1.01,-1.01, , , , , , , , , , ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2620,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),EDNEIESEEEVQP,_S(ph)EEDNEIES(ph)EEEVQPK_,S227,+,29.41,27.05,27.00,26.24,24.53,25.27,27.66,25.02,27.79,26.01,24.88,26.25,24.89,26.31,3.10,0.74,0.69,-0.06,-1.78,-1.04,1.35,-1.29,1.48,-0.29,-1.43,-0.06,-1.42,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2621,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),KKRRVISDSESDI,_VIS(ph)DS(ph)ESDIGGS(ph)DVEFKPDTK_,S252,,24.82,,,,,,,,,,,,,24.82,0.00, , , , , , , , , , , , ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2622,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),RRVISDSESDIGG,_VIS(ph)DS(ph)ESDIGGS(ph)DVEFKPDTK_,S254,,25.74,,,,,,,,23.34,,,,,24.54,1.20, , , , , , , ,-1.20, , , , ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2623,P52701,MSH6,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS-alpha 160 kDa subunit) (p160),ESDIGGSDVEFKP,_VISDS(ph)ESDIGGS(ph)DVEFKPDTK_,S261,,25.20,,,,,,,,23.34,,,,,24.27,0.93, , , , , , , ,-0.93, , , , ,response to UV;negative regulation of DNA recombination;positive regulation of helicase activity;isotype switching;somatic hypermutation of immunoglobulin genes;determination of adult lifespan;intrinsic apoptotic signaling pathway in response to DNA damage;meiotic mismatch repair;reciprocal meiotic recombination,nuclear chromatin;nuclear chromosome;MutSalpha complex,,,,,,,,,,,,,,
2624,P52732,KIF11,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),FGKNLNSLFNNME,_NLNS(ph)LFNNM(ox)EELIK_,S540,,,23.42,23.61,23.12,,,24.25,,24.02,,,24.26,,23.78, ,-0.36,-0.17,-0.66, , ,0.47, ,0.24, , ,0.48, ,spindle assembly involved in mitosis;blood coagulation;microtubule-based movement;mitotic centrosome separation;cell division;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule;chromatin remodeling complex;spindle pole;spindle,,,,,,,,,,,,,,
2625,P52732,KIF11,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),DMVFGASTKQIDV,_TYTFDM(ox)VFGAS(ph)TK_,S75,,21.24,22.51,23.32,,,,,,20.44,,,,,21.88,-0.64,0.63,1.45, , , , , ,-1.44, , , , ,spindle assembly involved in mitosis;blood coagulation;microtubule-based movement;mitotic centrosome separation;cell division;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule;chromatin remodeling complex;spindle pole;spindle,,,,,,,,,,,,,,
2626,P52735,VAV2,Guanine nucleotide exchange factor VAV2 (VAV-2),SASRASSRSPVFT,_ASS(ph)RS(ph)PVFTPR_,S769,,26.27,24.92,22.35,25.88,24.18,21.52,21.40,24.04,,,,,,23.82,2.45,1.10,-1.47,2.06,0.36,-2.30,-2.42,0.22, , , , , ,lamellipodium assembly;angiogenesis;platelet activation;cell migration;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;axon guidance;apoptotic process;nerve growth factor receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase activity;regulation of small GTPase mediated signal transduction,cytosol;plasma membrane,,,,,,,,,,+,,,,
2627,P52735,VAV2,Guanine nucleotide exchange factor VAV2 (VAV-2),SRASSRSPVFTPR,_ASS(ph)RS(ph)PVFTPR_,S771,,26.36,25.18,24.09,26.00,24.90,22.95,24.15,24.98,,,,23.39,,24.67,1.69,0.52,-0.57,1.33,0.24,-1.72,-0.52,0.31, , , ,-1.28, ,lamellipodium assembly;angiogenesis;platelet activation;cell migration;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;axon guidance;apoptotic process;nerve growth factor receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase activity;regulation of small GTPase mediated signal transduction,cytosol;plasma membrane,,,,,,,,,,+,,,,
2628,P52756,RBM5,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),DYRDYDSPERERE,_DYDS(ph)PERER_,S59,,23.40,25.17,24.68,24.75,,,,,,,,,,24.50,-1.10,0.67,0.18,0.25, , , , , , , , , ,"negative regulation of cell proliferation;spliceosomal complex assembly;apoptotic process;positive regulation of apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;spliceosomal complex,C2H2-type,,,,,,,,,,,,,
2629,P52756,RBM5,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),AAYSGDSDNEEEL,_RGLVAAYSGDS(ph)DNEEELVER_,S624,,24.66,,,,23.52,,,,,,,,23.46,23.88,0.78, , , ,-0.36, , , , , , , ,-0.42,"negative regulation of cell proliferation;spliceosomal complex assembly;apoptotic process;positive regulation of apoptotic process;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm;spliceosomal complex,C2H2-type,,,,,,,,,,,,,
2630,P52907,CAPZA1,F-actin-capping protein subunit alpha-1 (CapZ alpha-1),DFDDRVSDEEKVR,_(ac)ADFDDRVS(ph)DEEKVR_,S9,+,24.16,24.30,24.30,24.15,26.31,25.09,25.62,25.06,24.32,24.31,24.32,24.47,24.31,24.67,-0.51,-0.37,-0.37,-0.52,1.64,0.42,0.95,0.39,-0.35,-0.36,-0.35,-0.20,-0.36,blood coagulation;actin filament capping;protein complex assembly;innate immune response;cellular component movement;actin cytoskeleton organization,cytosol;extracellular region;F-actin capping protein complex;WASH complex,,,,,,,,,,,,,,
2631,P52926,HMGA2,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),EETEETSSQESAE,_KPAQEETEETS(ph)SQES(ph)AEED_,S101,+,26.41,23.30,,,23.03,20.51,22.61,,,,23.32,,21.16,22.91,3.51,0.39, , ,0.12,-2.40,-0.29, , , ,0.42, ,-1.75,"negative regulation of apoptotic process;fat pad development;fat cell differentiation;regulation of stem cell maintenance;DNA damage response, detection of DNA damage;negative regulation of double-strand break repair via nonhomologous end joining;mesodermal cell differentiation;negative regulation by host of viral transcription;positive regulation of cell cycle arrest;cell division;positive regulation of transcription regulatory region DNA binding;positive regulation of multicellular organism growth;response to virus;positive regulation of stem cell proliferation;base-excision repair;mesodermal-endodermal cell signaling;endodermal cell differentiation;histone H2A-S139 phosphorylation;negative regulation of retroviral genome replication;chondrocyte proliferation;senescence-associated heterochromatin focus assembly;chondrocyte differentiation;male gonad development;negative regulation of astrocyte differentiation;regulation of growth hormone secretion;adrenal gland development;somatic stem cell maintenance;chromosome condensation;negative regulation of DNA binding;positive regulation of cellular response to X-ray;epithelial to mesenchymal transition;stem cell differentiation;spermatogenesis;regulation of cellular response to drug;mitotic cell cycle G2/M transition DNA damage checkpoint;pituitary gland development;positive regulation of cellular senescence;mitosis;positive regulation of response to DNA damage stimulus;cell proliferation in forebrain;oncogene-induced senescence;chromosome breakage;positive regulation of apoptotic process",senescence-associated heterochromatin focus;protein-DNA complex;nuclear chromosome;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
2632,P52926,HMGA2,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),ETEETSSQESAEE,_KPAQEETEETS(ph)S(ph)QES(ph)AEED_,S102,,24.05,,,,,,,,,,,,,24.05,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;fat pad development;fat cell differentiation;regulation of stem cell maintenance;DNA damage response, detection of DNA damage;negative regulation of double-strand break repair via nonhomologous end joining;mesodermal cell differentiation;negative regulation by host of viral transcription;positive regulation of cell cycle arrest;cell division;positive regulation of transcription regulatory region DNA binding;positive regulation of multicellular organism growth;response to virus;positive regulation of stem cell proliferation;base-excision repair;mesodermal-endodermal cell signaling;endodermal cell differentiation;histone H2A-S139 phosphorylation;negative regulation of retroviral genome replication;chondrocyte proliferation;senescence-associated heterochromatin focus assembly;chondrocyte differentiation;male gonad development;negative regulation of astrocyte differentiation;regulation of growth hormone secretion;adrenal gland development;somatic stem cell maintenance;chromosome condensation;negative regulation of DNA binding;positive regulation of cellular response to X-ray;epithelial to mesenchymal transition;stem cell differentiation;spermatogenesis;regulation of cellular response to drug;mitotic cell cycle G2/M transition DNA damage checkpoint;pituitary gland development;positive regulation of cellular senescence;mitosis;positive regulation of response to DNA damage stimulus;cell proliferation in forebrain;oncogene-induced senescence;chromosome breakage;positive regulation of apoptotic process",senescence-associated heterochromatin focus;protein-DNA complex;nuclear chromosome;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
2633,P52926,HMGA2,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),ETSSQESAEED__,_KPAQEETEETS(ph)SQES(ph)AEED_,S105,,26.17,,,,,,,,25.83,25.74,,,,25.91,0.25, , , , , , , ,-0.08,-0.17, , , ,"negative regulation of apoptotic process;fat pad development;fat cell differentiation;regulation of stem cell maintenance;DNA damage response, detection of DNA damage;negative regulation of double-strand break repair via nonhomologous end joining;mesodermal cell differentiation;negative regulation by host of viral transcription;positive regulation of cell cycle arrest;cell division;positive regulation of transcription regulatory region DNA binding;positive regulation of multicellular organism growth;response to virus;positive regulation of stem cell proliferation;base-excision repair;mesodermal-endodermal cell signaling;endodermal cell differentiation;histone H2A-S139 phosphorylation;negative regulation of retroviral genome replication;chondrocyte proliferation;senescence-associated heterochromatin focus assembly;chondrocyte differentiation;male gonad development;negative regulation of astrocyte differentiation;regulation of growth hormone secretion;adrenal gland development;somatic stem cell maintenance;chromosome condensation;negative regulation of DNA binding;positive regulation of cellular response to X-ray;epithelial to mesenchymal transition;stem cell differentiation;spermatogenesis;regulation of cellular response to drug;mitotic cell cycle G2/M transition DNA damage checkpoint;pituitary gland development;positive regulation of cellular senescence;mitosis;positive regulation of response to DNA damage stimulus;cell proliferation in forebrain;oncogene-induced senescence;chromosome breakage;positive regulation of apoptotic process",senescence-associated heterochromatin focus;protein-DNA complex;nuclear chromosome;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
2634,P52926,HMGA2,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),EPTGEPSPKRPRG,_KQQQEPTGEPS(ph)PK_,S44,+,25.57,24.55,25.47,23.66,21.83,22.85,22.41,21.62,23.92,25.59,22.70,21.80,,23.50,2.08,1.05,1.97,0.16,-1.66,-0.65,-1.08,-1.88,0.43,2.10,-0.80,-1.70, ,"negative regulation of apoptotic process;fat pad development;fat cell differentiation;regulation of stem cell maintenance;DNA damage response, detection of DNA damage;negative regulation of double-strand break repair via nonhomologous end joining;mesodermal cell differentiation;negative regulation by host of viral transcription;positive regulation of cell cycle arrest;cell division;positive regulation of transcription regulatory region DNA binding;positive regulation of multicellular organism growth;response to virus;positive regulation of stem cell proliferation;base-excision repair;mesodermal-endodermal cell signaling;endodermal cell differentiation;histone H2A-S139 phosphorylation;negative regulation of retroviral genome replication;chondrocyte proliferation;senescence-associated heterochromatin focus assembly;chondrocyte differentiation;male gonad development;negative regulation of astrocyte differentiation;regulation of growth hormone secretion;adrenal gland development;somatic stem cell maintenance;chromosome condensation;negative regulation of DNA binding;positive regulation of cellular response to X-ray;epithelial to mesenchymal transition;stem cell differentiation;spermatogenesis;regulation of cellular response to drug;mitotic cell cycle G2/M transition DNA damage checkpoint;pituitary gland development;positive regulation of cellular senescence;mitosis;positive regulation of response to DNA damage stimulus;cell proliferation in forebrain;oncogene-induced senescence;chromosome breakage;positive regulation of apoptotic process",senescence-associated heterochromatin focus;protein-DNA complex;nuclear chromosome;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
2635,P52943,CRIP2,Cysteine-rich protein 2 (CRP-2) (Protein ESP1),GPSRASSVTTFTG,_ASS(ph)VTTFTGEPNTCPR_,S115,,27.28,,,22.52,,,,,,,,23.28,,24.36,2.92, , ,-1.84, , , , , , , ,-1.08, ,positive regulation of cell proliferation;hemopoiesis,cell cortex,,,,,,,,,,,,,,
2636,P52943,CRIP2,Cysteine-rich protein 2 (CRP-2) (Protein ESP1),NIGGAGSYIYEKP,_GVNIGGAGS(ph)YIYEK_,S74,,23.35,,,,,,,,,,,,,23.35,0.00, , , , , , , , , , , , ,positive regulation of cell proliferation;hemopoiesis,cell cortex,,,,,,,,,,,,,,
2637,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],DSENLASPSEYPE,_DSENLAS(ph)PSEYPENGER_,S623,+,26.99,26.49,24.95,26.98,27.34,26.80,26.86,27.07,27.18,26.41,26.66,25.72,26.95,26.65,0.35,-0.16,-1.69,0.33,0.69,0.16,0.22,0.42,0.53,-0.24,0.01,-0.93,0.31,"glucose transport;small molecule metabolic process;protein import into nucleus, docking;nuclear pore organization;carbohydrate metabolic process;mRNA transport;regulation of glucose transport;mitotic prometaphase;viral reproduction;cytokine-mediated signaling pathway;DNA replication;virus-host interaction",nucleoplasm;nuclear membrane;cytosol;nuclear pore outer ring,,,,,,,,,,,,,,
2638,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],NNSNLFSPVNRDS,_NLNNSNLFS(ph)PVNR_,S612,+,26.27,24.11,23.27,24.18,23.28,,22.89,24.19,,,24.30,,,24.06,2.21,0.05,-0.80,0.12,-0.78, ,-1.17,0.12, , ,0.24, , ,"glucose transport;small molecule metabolic process;protein import into nucleus, docking;nuclear pore organization;carbohydrate metabolic process;mRNA transport;regulation of glucose transport;mitotic prometaphase;viral reproduction;cytokine-mediated signaling pathway;DNA replication;virus-host interaction",nucleoplasm;nuclear membrane;cytosol;nuclear pore outer ring,,,,,,,,,,,,,,
2640,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],PPPQSQSPEVEQL,_PAPPPQSQS(ph)PEVEQLGR_,S934,+,23.95,21.71,21.71,24.73,21.64,,25.28,,25.17,24.78,23.70,25.17,,23.78,0.16,-2.07,-2.07,0.94,-2.14, ,1.49, ,1.39,1.00,-0.09,1.39, ,"glucose transport;small molecule metabolic process;protein import into nucleus, docking;nuclear pore organization;carbohydrate metabolic process;mRNA transport;regulation of glucose transport;mitotic prometaphase;viral reproduction;cytokine-mediated signaling pathway;DNA replication;virus-host interaction",nucleoplasm;nuclear membrane;cytosol;nuclear pore outer ring,,,,,,,,,,,,,,
2641,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],KYGLQDSDEEEEE,_YGLQDS(ph)DEEEEEHPSK_,S888,+,28.62,28.72,29.28,28.64,27.03,27.46,29.13,28.57,27.77,28.67,27.49,29.18,26.98,28.27,0.34,0.45,1.01,0.37,-1.24,-0.82,0.86,0.30,-0.50,0.39,-0.78,0.91,-1.30,"glucose transport;small molecule metabolic process;protein import into nucleus, docking;nuclear pore organization;carbohydrate metabolic process;mRNA transport;regulation of glucose transport;mitotic prometaphase;viral reproduction;cytokine-mediated signaling pathway;DNA replication;virus-host interaction",nucleoplasm;nuclear membrane;cytosol;nuclear pore outer ring,,,,,,,,,,,,,,
2643,P53396,ACLY,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme),PQDSVPSPRSLQG,_PAM(ox)PQDSVPS(ph)PR_,S481,+,26.99,27.04,27.42,27.47,24.46,27.99,27.63,26.56,27.54,28.15,26.56,26.80,26.84,27.03,-0.05,0.01,0.38,0.44,-2.57,0.95,0.59,-0.48,0.51,1.12,-0.48,-0.23,-0.19,triglyceride biosynthetic process;coenzyme A metabolic process;energy reserve metabolic process;positive regulation of cellular metabolic process;cellular carbohydrate metabolic process;long-chain fatty-acyl-CoA biosynthetic process;ATP catabolic process;citrate metabolic process,cytosol;mitochondrion;citrate lyase complex;plasma membrane;nucleus,,,,,,,,,,,,,,
2644,P53396,ACLY,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme),APSRTASFSESRA,_TAS(ph)FSESRADEVAPAKK_,S455,+,27.78,28.05,27.60,29.38,28.64,29.39,29.19,29.54,29.02,28.64,29.58,29.74,28.24,28.83,-1.05,-0.78,-1.23,0.55,-0.19,0.56,0.36,0.71,0.19,-0.19,0.75,0.90,-0.59,triglyceride biosynthetic process;coenzyme A metabolic process;energy reserve metabolic process;positive regulation of cellular metabolic process;cellular carbohydrate metabolic process;long-chain fatty-acyl-CoA biosynthetic process;ATP catabolic process;citrate metabolic process,cytosol;mitochondrion;citrate lyase complex;plasma membrane;nucleus,,,,,,,,,,,,,,
2645,P53621,COPA,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide);Proxenin],IPKDADSQNPDAP,_DADS(ph)QNPDAPEGKR_,S402,,24.28,21.99,21.99,23.29,,,,,,,,,,22.89,1.39,-0.90,-0.90,0.40, , , , , , , , , ,"retrograde vesicle-mediated transport, Golgi to ER;intracellular protein transport;COPI coating of Golgi vesicle;pancreatic juice secretion",cytosol;extracellular space;COPI vesicle coat,,,,,,,,,,,,,,
2646,P53621,COPA,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide);Proxenin],LRKKNLSPGAVES,_NLS(ph)PGAVESDVR_,S173,+,25.10,23.48,22.51,25.57,24.88,24.22,24.32,,23.78,22.74,26.23,,,24.28,0.81,-0.80,-1.77,1.29,0.59,-0.07,0.04, ,-0.50,-1.54,1.95, , ,"retrograde vesicle-mediated transport, Golgi to ER;intracellular protein transport;COPI coating of Golgi vesicle;pancreatic juice secretion",cytosol;extracellular space;COPI vesicle coat,,,,,,,,,,,,,,
2647,P53805,RCAN1,Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1),DKQFLISPPASPP,_(gl)QFLIS(ph)PPAS(ph)PPVGWK_,S82,,21.14,,,,,,,,,,,,,21.14,0.00, , , , , , , , , , , , ,blood circulation;calcium-mediated signaling;negative regulation of smooth muscle cell differentiation;signal transduction;skeletal muscle fiber development;central nervous system development;response to estrogen stimulus;response to mechanical stimulus;regulation of phosphoprotein phosphatase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
2648,P53805,RCAN1,Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1),LISPPASPPVGWK,_(gl)QFLIS(ph)PPAS(ph)PPVGWK_,S86,,21.14,,,,,,,,,,,,,21.14,0.00, , , , , , , , , , , , ,blood circulation;calcium-mediated signaling;negative regulation of smooth muscle cell differentiation;signal transduction;skeletal muscle fiber development;central nervous system development;response to estrogen stimulus;response to mechanical stimulus;regulation of phosphoprotein phosphatase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
2649,P53814,SMTN,Smoothelin,PCQRSLSVLSPRQ,_SLS(ph)VLSPR_,S257,,,,,21.67,,,,,,,,,,21.67, , , ,0.00, , , , , , , , , ,smooth muscle contraction;muscle organ development,actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2651,P53985,SLC16A1,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),GPKEEESPV____,_DTDGGPKEEES(ph)PV_,S478,,,,,,,,,,24.60,24.56,21.61,,22.63,23.35, , , , , , , , ,1.25,1.21,-1.74, ,-0.72,blood coagulation;pyruvate metabolic process;leukocyte migration,mitochondrion;integral to membrane;plasma membrane,,,,,,,,,,,,,,
2652,P53985,SLC16A1,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),SKEEETSIDVAGK,_EEETS(ph)IDVAGKPNEVTK_,S447,+,23.26,27.46,26.76,26.74,27.44,27.03,27.71,27.01,28.11,27.53,26.80,27.83,27.23,26.99,-3.73,0.47,-0.23,-0.26,0.45,0.04,0.72,0.02,1.12,0.54,-0.19,0.83,0.23,blood coagulation;pyruvate metabolic process;leukocyte migration,mitochondrion;integral to membrane;plasma membrane,,,,,,,,,,,,,,
2655,P53999,SUB1,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14),SSSGSDSDSEVDK,_ELVSSSSSGSDS(ph)DSEVDKK_,S17,,23.95,,,,21.35,21.95,,,,,,23.34,,22.65,1.31, , , ,-1.29,-0.70, , , , , ,0.69, ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",transcription factor complex;nucleolus,Other TF domain,,,,,,,,,,,,,
2656,P53999,SUB1,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14),SGSDSDSEVDKKL,_ELVSSSSSGSDSDS(ph)EVDK_,S19,,25.74,,,,21.41,,22.51,23.69,22.47,22.66,,,,23.08,2.66, , , ,-1.67, ,-0.57,0.61,-0.61,-0.42, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",transcription factor complex;nucleolus,Other TF domain,,,,,,,,,,,,,
2661,P54105,CLNS1A,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",DEEEEDSDDDVEP,_FEEESKEPVADEEEEDS(ph)DDDVEPITEFR_,S102,,28.84,,,,28.74,,,,,26.36,,26.70,,27.66,1.18, , , ,1.08, , , , ,-1.30, ,-0.96, ,cell volume homeostasis;blood circulation;transport;ncRNA metabolic process;chloride transport;spliceosomal snRNP assembly,cytosol;plasma membrane;nucleus;cytoskeleton,,,,,,,,,,,,,,
2665,P54253,ATXN1,Ataxin-1 (Spinocerebellar ataxia type 1 protein),GLHKALSTGLDYS,_ALS(ph)TGLDYSPPSAPR_,S82,,22.63,,,22.16,,,,,,,,,,22.39,0.23, , ,-0.23, , , , , , , , , ,"nuclear export;cell death;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear inclusion body;nuclear matrix;cytoplasm,Other TF domain,,,,,,,,,,,,,
2667,P54253,ATXN1,Ataxin-1 (Spinocerebellar ataxia type 1 protein),GLITPGSPPPAQQ,_APGLITPGS(ph)PPPAQQNQYVHISSSPQNTGR_,S238,,24.44,22.10,22.10,,,,,,23.15,,,23.77,23.98,23.26,1.18,-1.15,-1.15, , , , , ,-0.11, , ,0.51,0.72,"nuclear export;cell death;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear inclusion body;nuclear matrix;cytoplasm,Other TF domain,,,,,,,,,,,,,
2669,P54259,ATN1,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),GRSEEISESESEE,_SEEIS(ph)ESESEETNAPKK_,S77,+,22.33,24.13,,22.43,24.79,26.43,24.04,25.97,24.06,22.20,24.87,22.60,23.95,23.99,-1.65,0.15, ,-1.55,0.81,2.45,0.06,1.98,0.08,-1.78,0.89,-1.38,-0.04,"regulation of neuron differentiation;cell migration;toxin metabolic process;central nervous system development;maintenance of cell polarity;negative regulation of transcription from RNA polymerase II promoter;neuron apoptotic process;transcription, DNA-dependent",cell leading edge;cell junction;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
2671,P54259,ATN1,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),PGYKPGSPPSFRT,_TAT(ph)PPGYKPGS(ph)PPSFR_,S661,,22.58,,,,,,,,,,,,,22.58,0.00, , , , , , , , , , , , ,"regulation of neuron differentiation;cell migration;toxin metabolic process;central nervous system development;maintenance of cell polarity;negative regulation of transcription from RNA polymerase II promoter;neuron apoptotic process;transcription, DNA-dependent",cell leading edge;cell junction;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
2672,P54259,ATN1,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),ELPRPQSPSDLDS,_TEQELPRPQS(ph)PSDLDSLDGR_,S101,+,24.14,22.34,22.73,,25.96,,24.91,25.13,,24.00,22.76,,,24.00,0.15,-1.66,-1.27, ,1.96, ,0.91,1.13, ,0.00,-1.23, , ,"regulation of neuron differentiation;cell migration;toxin metabolic process;central nervous system development;maintenance of cell polarity;negative regulation of transcription from RNA polymerase II promoter;neuron apoptotic process;transcription, DNA-dependent",cell leading edge;cell junction;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
2673,P54259,ATN1,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),SPSDLDSLDGRSL,_TEQELPRPQS(ph)PSDLDS(ph)LDGR_,S107,,22.80,,,,,,,,,,,,,22.80,0.00, , , , , , , , , , , , ,"regulation of neuron differentiation;cell migration;toxin metabolic process;central nervous system development;maintenance of cell polarity;negative regulation of transcription from RNA polymerase II promoter;neuron apoptotic process;transcription, DNA-dependent",cell leading edge;cell junction;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
2674,P54274,TERF1,Telomeric repeat-binding factor 1 (NIMA-interacting protein 2) (TTAGGG repeat-binding factor 1) (Telomeric protein Pin2/TRF1),VSSAAPSPRGCAD,_(ac)AEDVSSAAPS(ph)PR_,S11,+,26.20,26.45,26.45,25.84,27.23,27.23,26.31,26.37,26.45,26.46,24.69,25.31,25.90,26.22,-0.03,0.23,0.23,-0.38,1.01,1.01,0.09,0.15,0.22,0.24,-1.53,-0.91,-0.32,age-dependent telomere shortening;telomere maintenance via telomerase;response to drug;positive regulation of mitosis;negative regulation of telomere maintenance via telomerase;positive regulation of microtubule polymerization;negative regulation of telomere maintenance via semi-conservative replication;mitotic cell cycle spindle assembly checkpoint;induction of apoptosis;G2/M transition of mitotic cell cycle;mitosis;telomere maintenance via telomere shortening;protein homooligomerization;positive regulation of mitotic cell cycle;cell division,"nucleoplasm;chromosome, telomeric region;nucleus;nuclear telomere cap complex;spindle;cytoplasm",,,,,,,,,,,,,,
2675,P54646,PRKAA2,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),PPLIADSPKARCP,_M(ox)PPLIADS(ph)PK_,S377,+,24.38,24.14,,21.94,,22.20,23.62,21.80,21.90,22.55,,,,22.82,1.56,1.33, ,-0.88, ,-0.62,0.81,-1.02,-0.92,-0.26, , , ,"negative regulation of apoptotic process;autophagy;regulation of fatty acid biosynthetic process;response to caffeine;cholesterol biosynthetic process;energy reserve metabolic process;carnitine shuttle;fatty acid homeostasis;glucose homeostasis;protein heterooligomerization;positive regulation of autophagy;insulin receptor signaling pathway;response to activity;cell cycle arrest;Wnt receptor signaling pathway;fatty acid biosynthetic process;cellular response to glucose starvation;regulation of circadian rhythm;small molecule metabolic process;regulation of energy homeostasis;negative regulation of TOR signaling cascade;regulation of transcription, DNA-dependent;cellular lipid metabolic process;rhythmic process;lipid biosynthetic process;positive regulation of glycolysis;regulation of fatty acid oxidation;transcription, DNA-dependent",nucleoplasm;cytosol;AMP-activated protein kinase complex;apical plasma membrane,,+,,,,,,,,,,,,
2676,P54725,RAD23A,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),AAREDKSPSEESA,_S(ph)PSEESAPTTSPESVSGSVPSSGSSGR_,S123,+,24.46,24.98,24.13,23.32,23.35,,,,,,24.26,22.82,,23.90,0.56,1.08,0.22,-0.58,-0.55, , , , , ,0.36,-1.08, ,proteasomal ubiquitin-dependent protein catabolic process;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of viral genome replication;nucleotide-excision repair;virus-host interaction,proteasome complex;nucleus,,,,,,,,,,,,,,
2677,P54725,RAD23A,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),REDKSPSEESAPT,_SPS(ph)EESAPTTSPESVSGSVPSSGSSGR_,S125,,24.38,24.84,25.76,22.80,,,,,,22.71,,23.17,,23.95,0.44,0.89,1.82,-1.14, , , , , ,-1.24, ,-0.77, ,proteasomal ubiquitin-dependent protein catabolic process;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of viral genome replication;nucleotide-excision repair;virus-host interaction,proteasome complex;nucleus,,,,,,,,,,,,,,
2679,P54727,RAD23B,UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58),ETPVATSPTATDS,_PAETPVATS(ph)PTATDSTSGDSSR_,S160,+,27.82,28.35,27.30,28.48,26.96,28.03,29.89,28.58,29.81,28.19,30.58,29.35,29.34,28.67,-0.85,-0.32,-1.37,-0.19,-1.70,-0.63,1.22,-0.09,1.14,-0.47,1.92,0.68,0.67,"spermatogenesis;proteasomal ubiquitin-dependent protein catabolic process;regulation of proteasomal ubiquitin-dependent protein catabolic process;nucleotide-excision repair, DNA damage recognition;nucleotide-excision repair, DNA damage removal",nucleoplasm;proteasome complex;XPC complex;cytoplasm,,,,,,,,,,,,,,
2680,P54760,EPHB4,Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11),RFLEENSSDPTYT,_FLEENS(ph)SDPTYTSSLGGK_,S769,+,22.88,,,,23.46,23.93,25.11,,24.58,24.63,,21.76,24.39,23.84,-0.96, , , ,-0.39,0.09,1.27, ,0.73,0.78, ,-2.08,0.55,protein autophosphorylation;heart morphogenesis;cell migration involved in sprouting angiogenesis;cell adhesion,integral to plasma membrane;cell surface,,+,,,,,,,,,,,,
2683,P54762,EPHB1,Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2),YLQDDTSDPTYTS,_YLQDDTS(ph)DPTYTSSLGGKIPVR_,S335,,,,,,23.91,,,23.02,,,,,,23.47, , , , ,0.45, , ,-0.45, , , , , ,cell-substrate adhesion;angiogenesis;regulation of ERK1 and ERK2 cascade;protein autophosphorylation;positive regulation of synapse assembly;central nervous system projection neuron axonogenesis;camera-type eye morphogenesis;cell chemotaxis;regulation of JNK cascade;dendritic spine morphogenesis;detection of temperature stimulus involved in sensory perception of pain;establishment of cell polarity;optic nerve morphogenesis;neural precursor cell proliferation;retinal ganglion cell axon guidance,axon;membrane raft;integral to plasma membrane;dendrite;early endosome membrane,,+,,,,,,,,,,,,
2684,P55008,AIF1,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),DDPKYSSDEDLPS,_YSS(ph)DEDLPSK_,S39,,,28.09,28.74,23.49,,,,,20.69,,,,,25.25, ,2.83,3.49,-1.76, , , , ,-4.56, , , , ,"negative regulation of apoptotic process;negative regulation of gene expression;inflammatory response;phagocytosis, engulfment;ruffle assembly;actin filament polymerization;microglial cell activation;response to axon injury;negative regulation of smooth muscle cell proliferation;negative regulation of smooth muscle cell chemotaxis;positive regulation of muscle hyperplasia;positive regulation of T cell migration;actin filament bundle assembly;response to electrical stimulus;positive regulation of G1/S transition of mitotic cell cycle;cellular response to hormone stimulus;positive regulation of protein phosphorylation;cellular response to extracellular stimulus;positive regulation of T cell proliferation;positive regulation of nitric oxide biosynthetic process;positive regulation of smooth muscle cell chemotaxis;cellular response to interferon-gamma;Rac protein signal transduction;positive regulation of smooth muscle cell proliferation;positive regulation of monocyte chemotaxis",perinuclear region of cytoplasm;cytosol;ruffle membrane;actin filament;nucleus;perikaryon;lamellipodium;phagocytic cup,,,,,,,,,,,,,,
2686,P55011,SLC12A2,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1),QEELLSSQEKSPG,_EGLDISHLQGQEELLSS(ph)QEK_,S940,,,,,,,,22.17,,22.70,24.51,23.31,22.00,24.63,23.22, , , , , , ,-1.05, ,-0.52,1.29,0.09,-1.22,1.41,detection of mechanical stimulus involved in sensory perception of sound;potassium ion transport;branching involved in mammary gland duct morphogenesis;mammary duct terminal end bud growth;multicellular organism growth;sodium ion transport;transepithelial ammonium transport;transepithelial chloride transport,basolateral plasma membrane;apical plasma membrane;integral to plasma membrane,,,,,,,,,,,,,,
2688,P55042,RRAD,GTP-binding protein RAD (RAD1) (Ras associated with diabetes),FRAKSKSCHDLSV,_S(ph)CHDLSVL_,S301,,23.75,,,17.53,,,23.44,,,,,,,21.57,2.18, , ,-4.05, , ,1.87, , , , , , ,negative regulation of cell growth;small GTPase mediated signal transduction,plasma membrane,,,,,,,,,,,,,,
2689,P55042,RRAD,GTP-binding protein RAD (RAD1) (Ras associated with diabetes),PPLHRRSMPVDER,_S(ph)M(ox)PVDERDLQAALTPGALTAAAAGTGTQGPR_,S39,+,22.61,,,,25.78,,26.73,26.03,,24.40,24.25,,25.81,25.09,-2.48, , , ,0.69, ,1.64,0.94, ,-0.69,-0.83, ,0.72,negative regulation of cell growth;small GTPase mediated signal transduction,plasma membrane,,,,,,,,,,,,,,
2690,P55072,VCP,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),____MASGADSKG,_(ac)AS(ph)GADSKGDDLSTAILK_,S3,+,22.17,,,22.21,24.04,,23.00,23.95,23.04,23.34,,,,23.11,-0.93, , ,-0.89,0.93, ,-0.11,0.84,-0.07,0.23, , , ,"double-strand break repair;translesion synthesis;ER-associated protein catabolic process;aggresome assembly;activation of cysteine-type endopeptidase activity involved in apoptotic process;endoplasmic reticulum unfolded protein response;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein complex assembly;retrograde protein transport, ER to cytosol;ER to Golgi vesicle-mediated transport;protein N-linked glycosylation via asparagine;protein homooligomerization;protein ubiquitination",cytosol;proteasome complex;site of double-strand break;endoplasmic reticulum;nucleus,,,,,,,,,,,,,,
2692,P55081,MFAP1,Microfibrillar-associated protein 1,RMEREDSSEEEEE,_M(ox)EREDS(ph)S(ph)EEEEEEIDDEEIERR_,S132,,27.42,,,22.75,25.18,25.11,,,,,,,23.47,24.78,2.64, , ,-2.04,0.39,0.32, , , , , , ,-1.32,,microfibril,,,,,,,,,,,,,,
2693,P55081,MFAP1,Microfibrillar-associated protein 1,MEREDSSEEEEEE,_M(ox)EREDS(ph)S(ph)EEEEEEIDDEEIERR_,S133,,27.42,,,22.75,22.89,26.10,,22.71,24.03,,,,,24.32,3.11, , ,-1.57,-1.43,1.79, ,-1.60,-0.29, , , , ,,microfibril,,,,,,,,,,,,,,
2694,P55081,MFAP1,Microfibrillar-associated protein 1,PEVVGESDSEVEG,_IVEPEVVGES(ph)DS(ph)EVEGDAWR_,S116,,27.99,,,,27.46,,,,24.62,26.65,,,,26.68,1.32, , , ,0.78, , , ,-2.06,-0.03, , , ,,microfibril,,,,,,,,,,,,,,
2695,P55081,MFAP1,Microfibrillar-associated protein 1,VVGESDSEVEGDA,_IVEPEVVGES(ph)DS(ph)EVEGDAWR_,S118,,27.56,,,,25.47,,,,24.49,26.22,,,,25.94,1.63, , , ,-0.47, , , ,-1.45,0.29, , , ,,microfibril,,,,,,,,,,,,,,
2696,P55081,MFAP1,Microfibrillar-associated protein 1,DYAPMESSDEEDE,_RPDYAPM(ox)ES(ph)S(ph)DEEDEEFQFIK_,S52,,24.55,,,,,,,,,25.33,,,,24.94,-0.39, , , , , , , , ,0.39, , , ,,microfibril,,,,,,,,,,,,,,
2697,P55081,MFAP1,Microfibrillar-associated protein 1,YAPMESSDEEDEE,_RPDYAPM(ox)ES(ph)S(ph)DEEDEEFQFIK_,S53,,24.35,,,,23.58,,,,24.13,,,,,24.02,0.33, , , ,-0.44, , , ,0.11, , , , ,,microfibril,,,,,,,,,,,,,,
2698,P55085,F2RL1,"Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1;Proteinase-activated receptor 2, alternate cleaved 2]",VKQMQVSLTSKKH,_QM(ox)QVS(ph)LTSK_,S373,,,20.22,20.22,24.67,21.42,,,22.12,,22.09,,,,21.79, ,-1.57,-1.57,2.88,-0.37, , ,0.33, ,0.30, , , ,"interferon-gamma secretion;defense response to virus;inflammatory response;positive regulation of Rho protein signal transduction;positive regulation of ERK1 and ERK2 cascade;negative regulation of toll-like receptor 3 signaling pathway;positive regulation of interleukin-8 secretion;leukocyte proliferation;positive regulation of superoxide anion generation;positive regulation of toll-like receptor 3 signaling pathway;positive regulation of vasodilation;positive regulation of leukocyte chemotaxis;positive regulation of actin filament depolymerization;interleukin-10 secretion;positive regulation of renin secretion into blood stream;negative regulation of JNK cascade;interleukin-1 beta secretion;T cell activation involved in immune response;positive regulation of eosinophil degranulation;positive regulation of positive chemotaxis;elevation of cytosolic calcium ion concentration;positive regulation of cytokine secretion involved in immune response;mature dendritic cell differentiation;negative regulation of tumor necrosis factor-mediated signaling pathway;chemokine (C-C motif) ligand 2 secretion;positive regulation of I-kappaB kinase/NF-kappaB cascade;blood coagulation;positive regulation of JNK cascade;regulation of blood coagulation;positive regulation of interleukin-6 secretion;establishment of endothelial barrier;positive regulation of transcription from RNA polymerase II promoter;neutrophil activation;negative regulation of chemokine secretion;positive regulation of phagocytosis, engulfment;positive regulation of phosphatidylinositol 3-kinase cascade;innate immune response;positive regulation of glomerular filtration;positive regulation of neutrophil mediated killing of gram-negative bacterium;positive regulation of toll-like receptor 2 signaling pathway;positive regulation of toll-like receptor 4 signaling pathway;positive regulation of pseudopodium assembly;leukocyte migration",Golgi apparatus;integral to plasma membrane;pseudopodium,,,,,,,,,,,,,,
2700,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),VANQPPSPGGKSA,_SSPNVANQPPS(ph)PGGK_,S1182,+,26.90,25.78,26.63,25.44,25.94,26.12,26.46,26.30,25.78,26.28,25.62,23.98,24.32,25.81,1.09,-0.03,0.82,-0.37,0.13,0.30,0.65,0.49,-0.03,0.47,-0.19,-1.83,-1.49,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2701,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),LQYITVSKEELSS,_DLQYITVS(ph)K_,S1501,,22.96,21.64,,23.67,,,,,25.46,,22.41,,23.59,23.29,-0.33,-1.65, ,0.38, , , , ,2.18, ,-0.88, ,0.30,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2702,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),RDYEPPSPSPAPG,_DYEPPS(ph)PSPAPGAPPPPPQR_,S1696,,27.22,24.40,24.40,,,,,,,22.64,,,,24.66,2.56,-0.27,-0.27, , , , , , ,-2.03, , , ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2703,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),SSGDSLSPDPWKR,_EELSSGDSLS(ph)PDPWKR_,S1512,,22.59,,,21.32,,,,,23.46,,,,,22.45,0.13, , ,-1.13, , , , ,1.00, , , , ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2704,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),ERQRLFSQGQDVS,_LFS(ph)QGQDVSNK_,S1799,+,26.96,22.43,22.85,22.29,,,,,23.96,22.32,22.35,23.16,22.79,23.24,3.73,-0.80,-0.38,-0.95, , , , ,0.72,-0.91,-0.88,-0.08,-0.44,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2705,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),LYRLQLSVTEVGT,_LQLS(ph)VTEVGTEK_,S424,+,22.89,,,,,,22.49,,23.52,22.18,22.99,21.98,22.42,22.64,0.25, , , , , ,-0.15, ,0.88,-0.46,0.35,-0.66,-0.22,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2706,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),TLLNQPSPMMQRI,_(gl)QGAIYHGLATLLNQPS(ph)PM(ox)M(ox)QR_,S1107,+,25.42,27.02,27.02,25.14,26.70,26.25,26.56,27.27,27.89,27.04,27.32,25.24,23.73,26.35,-0.93,0.67,0.67,-1.22,0.35,-0.10,0.20,0.92,1.54,0.69,0.96,-1.11,-2.62,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2707,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),KEKRSKSQDADSP,_S(ph)QDADSPGSSGAPENLTFK_,S1774,,24.01,22.88,22.88,,,,24.22,,23.96,24.92,24.19,,,23.87,0.14,-0.98,-0.98, , , ,0.35, ,0.09,1.06,0.32, , ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2708,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),KSQDADSPGSSGA,_SQDADS(ph)PGS(ph)SGAPENLTFK_,S1779,+,26.28,23.43,23.43,,26.49,24.59,25.50,25.15,24.96,26.59,23.95,23.59,24.04,24.83,1.45,-1.40,-1.40, ,1.65,-0.25,0.66,0.32,0.13,1.76,-0.88,-1.25,-0.79,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2709,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),DADSPGSSGAPEN,_SQDADS(ph)PGS(ph)SGAPENLTFK_,S1782,,23.15,,,,,,,,,,,,,23.15,0.00, , , , , , , , , , , , ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2710,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),IQRVTRSQEELRE,_S(ph)QEELREDK_,S1275,+,25.23,27.00,26.92,26.61,25.54,25.24,24.79,25.56,26.04,25.55,25.61,25.18,23.80,25.62,-0.39,1.38,1.30,0.99,-0.08,-0.38,-0.83,-0.06,0.42,-0.07,-0.01,-0.44,-1.82,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2713,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),SFTRTISNPEVVM,_TIS(ph)NPEVVM(ox)K_,S216,+,27.81,23.86,,25.69,23.28,,26.34,24.47,,,,25.90,,25.34,2.48,-1.48, ,0.36,-2.05, ,1.00,-0.86, , , ,0.57, ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2714,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),LKTQVLSPDSLFT,_TQVLS(ph)PDSLFTAK_,S1721,+,26.70,23.94,23.94,,23.34,,21.93,22.18,,25.89,22.57,,,23.81,2.89,0.13,0.13, ,-0.47, ,-1.88,-1.63, ,2.08,-1.24, , ,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2715,P55196,MLLT4,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6),LMTRTSSVVTLEV,_TSS(ph)VVTLEVAK_,S1083,+,26.25,25.23,25.46,24.45,26.11,26.05,25.63,26.04,26.29,26.07,25.87,25.39,24.73,25.66,0.59,-0.43,-0.19,-1.21,0.45,0.39,-0.03,0.38,0.63,0.41,0.22,-0.27,-0.93,signal transduction;adherens junction organization;cell adhesion;cell junction assembly;cell-cell signaling,cytosol;cell-cell junction;plasma membrane;nucleus;apical part of cell;cell-cell adherens junction,,,,,,,,,,,,,,
2716,P55197,MLLT10,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),GSLSPRSPVSSLQ,_S(ph)PVSSLQIR_,S348,,23.08,22.30,,21.25,,,,,,,,,22.57,22.30,0.78,0.00, ,-1.05, , , , , , , , ,0.27,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus;cytoplasm,DNA binding region,,,,,,,,,,,,,
2717,P55198,MLLT6,Protein AF-17 (ALL1-fused gene from chromosome 17 protein),HKKRPESPPSILT,_KRPES(ph)PPSILTPPVVPTADK_,S258,,,20.66,20.66,,,23.34,,,23.00,24.09,23.71,,23.05,22.64, ,-1.98,-1.98, , ,0.69, , ,0.35,1.44,1.06, ,0.41,"regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
2719,P55201,BRPF1,Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140),RRLPALSHSEGEE,_RLPALS(ph)HS(ph)EGEEDEDEEEDEGK_,S460,,23.13,,,,,,,,,,,,,23.13,0.00, , , , , , , , , , , , ,"positive regulation of transcription, DNA-dependent;histone H3 acetylation;transcription, DNA-dependent",plasma membrane;MOZ/MORF histone acetyltransferase complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
2720,P55201,BRPF1,Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140),LPALSHSEGEEDE,_RLPALS(ph)HS(ph)EGEEDEDEEEDEGK_,S462,,23.13,,,,,,,,,,,,,23.13,0.00, , , , , , , , , , , , ,"positive regulation of transcription, DNA-dependent;histone H3 acetylation;transcription, DNA-dependent",plasma membrane;MOZ/MORF histone acetyltransferase complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
2721,P55209,NAP1L1,Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNRP),PTGYIESLPRVVK,_LDGLVETPTGYIES(ph)LPR_,S69,,22.22,,,,,,,,,,,,,22.22,0.00, , , , , , , , , , , , ,positive regulation of cell proliferation;nucleosome assembly;DNA replication,chromatin assembly complex;melanosome,,,,,,,,,,,,,,
2722,P55210,CASP7,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20;Caspase-7 subunit p11],FVPSLFSKKKKNV,_SSFVPSLFS(ph)K_,S37,,22.77,,,,,,,,,,,,,22.77,0.00, , , , , , , , , , , , ,response to UV;aging;cellular component disassembly involved in execution phase of apoptosis;protein processing;release of cytochrome c from mitochondria;induction of apoptosis;proteolysis;positive regulation of neuron apoptotic process;heart development;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,nucleoplasm;cytosol,,,,,,,,,,,,,,
2723,P55265,ADAR,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),SEKTAESQTPTPS,_TAES(ph)QTPT(ph)PSATSFFSGK_,S617,,21.66,,,,,,,,,,,,,21.66,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;defense response to virus;response to interferon-alpha;response to virus;protein export from nucleus;positive regulation of viral genome replication;type I interferon-mediated signaling pathway;adenosine to inosine editing;negative regulation of protein kinase activity by regulation of protein phosphorylation;mRNA modification;mRNA processing;protein import into nucleus;gene expression;gene silencing by RNA,nucleoplasm;nucleolus;nucleus;supraspliceosomal complex;cytoplasm,,,,,,,,,,,,,,
2725,P55265,ADAR,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),MLLLSRSPEAQPK,_TM(ox)LLLSRS(ph)PEAQPK_,S843,+,24.51,21.08,,24.28,25.60,,24.47,24.28,22.90,23.35,25.38,24.50,21.92,23.84,0.67,-2.77, ,0.44,1.76, ,0.63,0.44,-0.95,-0.49,1.54,0.66,-1.92,negative regulation of apoptotic process;defense response to virus;response to interferon-alpha;response to virus;protein export from nucleus;positive regulation of viral genome replication;type I interferon-mediated signaling pathway;adenosine to inosine editing;negative regulation of protein kinase activity by regulation of protein phosphorylation;mRNA modification;mRNA processing;protein import into nucleus;gene expression;gene silencing by RNA,nucleoplasm;nucleolus;nucleus;supraspliceosomal complex;cytoplasm,,,,,,,,,,,,,,
2726,P55285,CDH6,Cadherin-6 (Kidney cadherin) (K-cadherin),MYGGVDSDKDS__,_KLADM(ox)YGGVDS(ph)DK_,S786,,27.10,25.80,25.91,21.29,27.93,28.71,26.86,27.32,28.99,29.21,26.44,23.09,27.07,26.59,0.50,-0.79,-0.68,-5.30,1.34,2.12,0.27,0.72,2.39,2.61,-0.16,-3.51,0.48,adherens junction organization;homophilic cell adhesion;cell adhesion;cell junction assembly,integral to membrane;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
2729,P55287,CDH11,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),LRPAPNSVDVDDF,_PGLRPAPNS(ph)VDVDDFINTR_,S697,,,,,,28.70,25.46,25.11,27.04,26.36,23.63,27.25,27.34,27.89,26.53, , , , ,2.17,-1.07,-1.42,0.51,-0.17,-2.90,0.72,0.81,1.36,adherens junction organization;homophilic cell adhesion;cell junction assembly;skeletal system development;ossification,integral to membrane;plasma membrane,,,,,,,,,,,,,,
2731,P55327,TPD52,Tumor protein D52 (Protein N8),NSPTFKSFEEKVE,_NSPTFKS(ph)FEEKVENLK_,S136,,,,,,23.39,,,25.69,,,,,,24.54, , , , ,-1.15, , ,1.15, , , , , ,anatomical structure morphogenesis;secretion;B cell differentiation,endoplasmic reticulum;perinuclear region of cytoplasm,,,,,,,,,,,,,,
2732,P55854,SUMO3,Small ubiquitin-related modifier 3 (SUMO-3) (SMT3 homolog 1) (SUMO-2) (Ubiquitin-like protein SMT3B) (Smt3B),VAGQDGSVVQFKI,_VAGQDGS(ph)VVQFK_,S28,,23.06,22.46,22.48,,,,,,,,,,,22.67,0.39,-0.21,-0.19, , , , , , , , , , ,protein sumoylation,kinetochore;cytoplasm,,,,,,,,,,,,,,
2733,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),ADEPSFSDPEDFV,_ALENGDADEPSFS(ph)DPEDFVDDVSEEELLGDVLK_,S154,,27.07,,,,,,,,,,,,,27.07,0.00, , , , , , , , , , , , ,regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
2734,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),QARDERSDSRAQA,_S(ph)DSRAQAVSEDAGGNEGR_,S117,+,25.78,24.28,24.65,25.10,25.66,26.03,25.62,26.02,24.98,,25.63,25.83,23.19,25.23,0.55,-0.95,-0.58,-0.13,0.43,0.80,0.38,0.79,-0.25, ,0.40,0.60,-2.04,regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
2735,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),RDERSDSRAQAVS,_DERSDS(ph)RAQAVSEDAGGNEGR_,S119,+,24.89,24.78,25.25,25.11,26.24,26.57,25.58,26.33,24.86,25.14,,,,25.47,-0.59,-0.70,-0.22,-0.37,0.77,1.09,0.10,0.86,-0.61,-0.33, , , ,regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
2738,P55884,EIF3B,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),GPSESPSPPAAEE,_TEPAAEAEAASGPSESPS(ph)PPAAEELPGSHAEPPVPAQGEAPGEQAR_,S85,+,24.38,,,23.38,25.88,25.76,24.90,26.91,,,27.12,,24.98,25.41,-1.04, , ,-2.04,0.47,0.35,-0.51,1.50, , ,1.71, ,-0.44,regulation of translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
2744,P56181,NDUFV3,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)",SSSDSESDDEADV,_VTSPSSSSSSSSSDSES(ph)DDEADVSEVTPR_,S147,,24.00,,,22.52,24.97,25.05,24.22,24.66,24.34,25.71,23.11,23.04,,24.16,-0.16, , ,-1.64,0.80,0.89,0.06,0.50,0.18,1.55,-1.05,-1.12, ,"mitochondrial electron transport, NADH to ubiquinone;small molecule metabolic process",nucleus;mitochondrial respiratory chain complex I,,,,,,,,,,,,,,
2746,P56524,HDAC4,Histone deacetylase 4 (HD4) (EC 3.5.1.98),PLSRAQSSPASAT,_AQS(ph)SPASATFPVSVQEPPTKPR_,S515,,,,,22.17,,,23.35,24.19,,,,,,23.24, , , ,-1.07, , ,0.11,0.96, , , , , ,"negative regulation of cell proliferation;inflammatory response;regulation of protein binding;regulation of cardiac muscle contraction by calcium ion signaling;peptidyl-lysine deacetylation;response to interleukin-1;B cell differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of cell proliferation;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;histone H4 deacetylation;negative regulation of glycolysis;cardiac muscle hypertrophy in response to stress;positive regulation of sequence-specific DNA binding transcription factor activity;osteoblast development;histone H3 deacetylation;negative regulation of transcription from RNA polymerase II promoter;response to denervation involved in regulation of muscle adaptation;transcription, DNA-dependent;negative regulation of myotube differentiation;skeletal system development;positive regulation of protein sumoylation;nervous system development",neuromuscular junction;histone deacetylase complex;cytosol;transcriptional repressor complex;cytoplasm;actomyosin,,,,,,,,,,,,,,
2748,P56524,HDAC4,Histone deacetylase 4 (HD4) (EC 3.5.1.98),KQEPIESDEEEAE,_(gl)QEPIES(ph)DEEEAEPPREVEPGQR_,S448,+,24.96,,,23.28,25.76,24.55,25.00,24.25,24.13,23.40,23.31,25.09,23.31,24.28,0.69, , ,-0.99,1.49,0.28,0.72,-0.03,-0.15,-0.87,-0.97,0.81,-0.97,"negative regulation of cell proliferation;inflammatory response;regulation of protein binding;regulation of cardiac muscle contraction by calcium ion signaling;peptidyl-lysine deacetylation;response to interleukin-1;B cell differentiation;negative regulation of sequence-specific DNA binding transcription factor activity;positive regulation of cell proliferation;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;histone H4 deacetylation;negative regulation of glycolysis;cardiac muscle hypertrophy in response to stress;positive regulation of sequence-specific DNA binding transcription factor activity;osteoblast development;histone H3 deacetylation;negative regulation of transcription from RNA polymerase II promoter;response to denervation involved in regulation of muscle adaptation;transcription, DNA-dependent;negative regulation of myotube differentiation;skeletal system development;positive regulation of protein sumoylation;nervous system development",neuromuscular junction;histone deacetylase complex;cytosol;transcriptional repressor complex;cytoplasm;actomyosin,,,,,,,,,,,,,,
2752,P56747,CLDN6,Claudin-6 (Skullin),HYMARYSTSAPAI,_YS(ph)TSAPAISR_,S140,,26.57,22.53,22.53,27.52,,,,,,,,,,24.79,1.78,-2.26,-2.26,2.73, , , , , , , , , ,calcium-independent cell-cell adhesion,tight junction;integral to membrane;plasma membrane,,,,,,,,,,,,,,
2754,P56945,BCAR1,Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas),QSRPLPSPPKFTS,_PLPS(ph)PPK_,S491,,,,,22.51,,,,,,,,,,22.51, , , ,0.00, , , , , , , , , ,regulation of cell growth;cell chemotaxis;cellular response to hepatocyte growth factor stimulus;insulin receptor signaling pathway;actin filament organization;integrin-mediated signaling pathway;cell division;platelet-derived growth factor receptor signaling pathway;platelet activation;vascular endothelial growth factor receptor signaling pathway;G-protein coupled receptor signaling pathway;cell proliferation;T cell receptor signaling pathway;epidermal growth factor receptor signaling pathway;hepatocyte growth factor receptor signaling pathway;B cell receptor signaling pathway;cell adhesion;nerve growth factor receptor signaling pathway;regulation of apoptotic process;positive regulation of endothelial cell migration,cytosol;focal adhesion;ruffle,,,,,,,,,,,,,,
2755,P56945,BCAR1,Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas),AEGKRLSASSTGS,_RLS(ph)ASSTGSTR_,S280,+,20.48,,,24.58,,18.10,20.32,21.56,,,21.66,23.05,17.69,20.93,-0.45, , ,3.65, ,-2.83,-0.61,0.63, , ,0.73,2.12,-3.24,regulation of cell growth;cell chemotaxis;cellular response to hepatocyte growth factor stimulus;insulin receptor signaling pathway;actin filament organization;integrin-mediated signaling pathway;cell division;platelet-derived growth factor receptor signaling pathway;platelet activation;vascular endothelial growth factor receptor signaling pathway;G-protein coupled receptor signaling pathway;cell proliferation;T cell receptor signaling pathway;epidermal growth factor receptor signaling pathway;hepatocyte growth factor receptor signaling pathway;B cell receptor signaling pathway;cell adhesion;nerve growth factor receptor signaling pathway;regulation of apoptotic process;positive regulation of endothelial cell migration,cytosol;focal adhesion;ruffle,,,,,,,,,,,,,,
2756,P57060,RWDD2B,RWD domain-containing protein 2B,ERQRKFSIFEEKV,_KFS(ph)IFEEK_,S275,,,,,,23.30,22.98,23.52,24.53,22.34,22.21,23.68,,,23.22, , , , ,0.07,-0.24,0.30,1.31,-0.88,-1.01,0.45, , ,,,,,,,,,,,,,,,,
2757,P57682,KLF3,Krueppel-like factor 3 (Basic krueppel-like factor) (CACCC-box-binding protein BKLF) (TEF-2),RPLPVESPDTQRK,_RPLPVES(ph)PDTQRK_,S250,+,20.66,23.30,23.30,,,22.33,24.10,,24.13,,22.33,22.40,,22.82,-2.16,0.48,0.48, , ,-0.49,1.28, ,1.31, ,-0.48,-0.42, ,"multicellular organismal development;transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
2758,P57735,RAB25,Ras-related protein Rab-25 (CATX-8),RYRAITSAYYRGA,_AITS(ph)AYYR_,S78,+,22.92,22.68,20.89,22.77,24.21,,22.22,22.64,22.84,22.68,23.19,22.26,23.44,22.73,0.19,-0.05,-1.84,0.04,1.48, ,-0.51,-0.09,0.11,-0.05,0.46,-0.47,0.72,protein transport;small GTPase mediated signal transduction;positive regulation of cell proliferation;pseudopodium organization,cytoplasmic vesicle;cytoplasmic membrane-bounded vesicle;pseudopodium;pseudopodium membrane,,,,,,,,,,,,,,
2759,P57740,NUP107,Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107),SGFGEISSPVIRE,_SGFGEIS(ph)SPVIR_,S10,,22.98,,,,,,,,,,,,,22.98,0.00, , , , , , , , , , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA export from nucleus;regulation of glucose transport;mitotic prometaphase;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;condensed chromosome kinetochore;nuclear pore outer ring,,,,,,,,,,,,,,
2760,P57740,NUP107,Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107),GFGEISSPVIREA,_SGFGEISS(ph)PVIR_,S11,+,23.60,20.79,,20.76,22.61,22.51,,,21.90,,,,22.93,22.16,1.45,-1.37, ,-1.40,0.45,0.35, , ,-0.25, , , ,0.77,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA export from nucleus;regulation of glucose transport;mitotic prometaphase;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;condensed chromosome kinetochore;nuclear pore outer ring,,,,,,,,,,,,,,
2762,P58107,EPPK1,Epiplakin (450 kDa epidermal antigen),GLRKQVSARDLFR,_(gl)QVS(ph)ARDLFR_,S1529,,21.34,,,,,,,,,,,26.06,22.04,23.15,-1.80, , , , , , , , , , ,2.91,-1.11,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2763,P58107,EPPK1,Epiplakin (450 kDa epidermal antigen),GLRRQVSASELHT,_QVS(ph)ASELHTSGILGPETLR_,S2716,+,32.07,28.83,29.64,25.71,27.36,23.65,24.84,25.05,,27.69,28.71,30.31,25.77,27.47,4.60,1.36,2.17,-1.76,-0.11,-3.82,-2.63,-2.42, ,0.22,1.24,2.84,-1.70,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2765,P58335,ANTXR2,Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2),WPTVDASYYGGRG,_KWPTVDAS(ph)YYGGR_,S381,,,,,,,,23.23,,,,23.02,24.76,,23.67, , , , , , ,-0.44, , , ,-0.65,1.09, ,reproductive process,integral to membrane;extracellular region;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
2766,P58340,MLF 1.00,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),QMIRSFSEPFGRD,_SFS(ph)EPFGR_,S9,,24.29,20.59,20.59,,,,,,,,,,,21.82,2.47,-1.23,-1.23, , , , , , , , , , ,"myeloid progenitor cell differentiation;cell cycle arrest;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
2767,P60174,TPI1,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),MNGRKQSLGELIG,_(gl)QS(ph)LGELIGTLNAAK_,S21,+,31.41,30.44,29.05,30.62,30.90,30.87,31.50,31.79,31.30,30.93,31.37,31.69,31.16,31.00,0.41,-0.57,-1.95,-0.38,-0.10,-0.13,0.50,0.79,0.30,-0.08,0.37,0.69,0.16,small molecule metabolic process;pentose-phosphate shunt;gluconeogenesis;glycolysis;glyceraldehyde-3-phosphate metabolic process;embryo development,cytosol;nucleus,,,,,,,,,,,,,,
2768,P60174,TPI1,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),AFTGEISPGMIKD,_VTNGAFTGEIS(ph)PGM(ox)IK_,S80,,23.44,,,,,,22.43,22.48,,,,,,22.78,0.66, , , , , ,-0.35,-0.31, , , , , ,small molecule metabolic process;pentose-phosphate shunt;gluconeogenesis;glycolysis;glyceraldehyde-3-phosphate metabolic process;embryo development,cytosol;nucleus,,,,,,,,,,,,,,
2771,P60468,SEC61B,Protein transport protein Sec61 subunit beta,VGSSGRSPSKAVA,_PGPTPSGTNVGSSGRS(ph)PSK_,S17,+,30.73,31.71,32.60,31.34,30.93,21.18,30.64,29.00,28.73,29.70,29.94,30.45,28.44,29.65,1.08,2.06,2.95,1.70,1.28,-8.46,0.99,-0.65,-0.91,0.06,0.29,0.81,-1.20,"retrograde protein transport, ER to cytosol;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;ER-associated protein catabolic process;translation;SRP-dependent cotranslational protein targeting to membrane;protein import into nucleus, translocation",integral to membrane;endoplasmic reticulum Sec complex,,,,,,,,,,,,,,
2772,P60709,ACTB,"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]",ITALAPSTMKIKI,_EITALAPS(ph)TM(ox)K_,S323,+,24.02,25.04,24.84,25.92,24.44,25.54,25.02,24.96,25.45,24.57,24.45,24.72,25.81,24.98,-0.96,0.06,-0.14,0.93,-0.55,0.56,0.04,-0.02,0.46,-0.41,-0.53,-0.26,0.83,blood coagulation;response to calcium ion;adherens junction organization;'de novo' posttranslational protein folding;cell junction assembly;axon guidance;cellular component movement,axon;cortical cytoskeleton;ribonucleoprotein complex;MLL5-L complex;cytosol;extracellular vesicular exosome;cytoskeleton;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
2774,P60981,DSTN,Destrin (Actin-depolymerizing factor) (ADF),____MASGVQVAD,_(ac)AS(ph)GVQVADEVCR_,S3,+,23.80,22.14,20.29,24.48,22.11,23.35,22.99,22.93,24.09,,,24.39,,23.06,0.74,-0.91,-2.77,1.42,-0.95,0.29,-0.07,-0.13,1.04, , ,1.33, ,actin filament severing;actin polymerization or depolymerization;positive regulation of actin filament depolymerization;cytokinesis;cellular component movement,cortical actin cytoskeleton;actin cytoskeleton,,,,,,,,,,,,,,
2775,P61018,RAB4B,Ras-related protein Rab-4B,IQYGDASLRQLRQ,_M(ox)GSGIQYGDAS(ph)LR_,S193,,22.91,,,,,,,,21.11,,,,,22.01,0.90, , , , , , , ,-0.90, , , , ,vesicle-mediated transport;protein transport;small GTPase mediated signal transduction,mitochondrion;plasma membrane;intracellular,,,,,,,,,,,,,,
2779,P61224,RAP1B,Ras-related protein Rap-1b (GTP-binding protein smg p21B),DPTIEDSYRKEQF,_YDPTIEDS(ph)YRK_,S39,,,23.95,,,,22.80,,,,,23.59,23.58,,23.48, ,0.47, , , ,-0.68, , , , ,0.11,0.10, ,cell proliferation;regulation of insulin secretion;platelet activation;regulation of establishment of cell polarity;small GTPase mediated signal transduction;energy reserve metabolic process,cytosol;cell-cell junction;lipid particle;plasma membrane,,,,,,,,,,,,,,
2780,P61244,MAX,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),SDSSSESEPEEPQ,_GSTISAFDGGSDSSSES(ph)EPEEPQSR_,S135,,,,,,23.06,24.12,,,,,,,,23.59, , , , ,-0.53,0.53, , , , , , , ,negative regulation of gene expression;retina development in camera-type eye;protein complex assembly;response to axon injury;transcription from RNA polymerase II promoter;neuron apoptotic process;response to insulin stimulus;cellular response to peptide hormone stimulus;cellular response to starvation,PML body;MLL1 complex;dendrite;cytoplasm,bHLH,,,,,,,,,,,,,
2781,P61244,MAX,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),_____MSDNDDIE,_(ac)S(ph)DNDDIEVES(ph)DEEQPR_,S2,,25.19,,,,,,,,,,,,,25.19,0.00, , , , , , , , , , , , ,negative regulation of gene expression;retina development in camera-type eye;protein complex assembly;response to axon injury;transcription from RNA polymerase II promoter;neuron apoptotic process;response to insulin stimulus;cellular response to peptide hormone stimulus;cellular response to starvation,PML body;MLL1 complex;dendrite;cytoplasm,bHLH,,,,,,,,,,,,,
2782,P61244,MAX,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),DDIEVESDEEQPR,_(ac)S(ph)DNDDIEVES(ph)DEEQPR_,S11,,25.91,,,,,,,,,,,,,25.91,0.00, , , , , , , , , , , , ,negative regulation of gene expression;retina development in camera-type eye;protein complex assembly;response to axon injury;transcription from RNA polymerase II promoter;neuron apoptotic process;response to insulin stimulus;cellular response to peptide hormone stimulus;cellular response to starvation,PML body;MLL1 complex;dendrite;cytoplasm,bHLH,,,,,,,,,,,,,
2783,P61244,MAX,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),_____MSDNDDIE,_(ac)S(ph)DNDDIEVESDADKRAHHNALER_,S2,+,24.34,23.19,23.19,22.94,26.78,24.81,24.11,24.05,25.45,25.37,22.52,,23.92,24.22,0.12,-1.04,-1.04,-1.28,2.55,0.59,-0.11,-0.17,1.23,1.15,-1.70, ,-0.30,negative regulation of gene expression;retina development in camera-type eye;protein complex assembly;response to axon injury;transcription from RNA polymerase II promoter;neuron apoptotic process;response to insulin stimulus;cellular response to peptide hormone stimulus;cellular response to starvation,PML body;MLL1 complex;dendrite;cytoplasm,bHLH,,,,,,,,,,,,,
2791,P61313,RPL15,60S ribosomal protein L15,QLKFARSLQSVAE,_S(ph)LQSVAEER_,S97,+,19.72,22.00,,23.98,22.89,22.28,24.01,23.66,22.15,,,,21.88,22.51,-2.79,-0.51, ,1.47,0.38,-0.23,1.50,1.16,-0.36, , , ,-0.63,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2792,P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),RDYDDMSPRRGPP,_RDYDDM(ox)S(ph)PR_,S260,+,28.15,27.46,26.50,30.07,27.68,28.33,27.95,28.01,29.20,27.04,25.42,27.18,26.58,27.66,0.49,-0.20,-1.16,2.41,0.02,0.67,0.29,0.35,1.54,-0.62,-2.24,-0.48,-1.08,"positive regulation of low-density lipoprotein particle receptor biosynthetic process;signal transduction;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;regulation of low-density lipoprotein particle clearance;positive regulation of receptor-mediated endocytosis;virus-host interaction",nucleoplasm;nuclear chromatin;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
2793,P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),YAGGRGSYGDLGG,_GS(ph)YGDLGGPIITTQVTIPK_,S355,,23.53,,,,,,,,,,,,,23.53,0.00, , , , , , , , , , , , ,"positive regulation of low-density lipoprotein particle receptor biosynthetic process;signal transduction;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;regulation of low-density lipoprotein particle clearance;positive regulation of receptor-mediated endocytosis;virus-host interaction",nucleoplasm;nuclear chromatin;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
2794,P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),LDLISESPIKGRA,_IILDLISES(ph)PIKGR_,S192,+,24.63,23.30,23.71,24.31,26.63,23.94,24.88,25.35,25.84,24.79,23.63,24.98,25.80,24.75,-0.12,-1.45,-1.05,-0.44,1.88,-0.81,0.12,0.60,1.09,0.04,-1.12,0.23,1.04,"positive regulation of low-density lipoprotein particle receptor biosynthetic process;signal transduction;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;regulation of low-density lipoprotein particle clearance;positive regulation of receptor-mediated endocytosis;virus-host interaction",nucleoplasm;nuclear chromatin;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
2795,P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),EGLQLPSPTATSQ,_IIPTLEEGLQLPS(ph)PTATSQLPLESDAVECLNYQHYK_,S116,+,27.91,27.08,27.08,25.96,28.07,,27.71,28.46,28.51,29.73,24.86,27.90,27.11,27.53,0.38,-0.45,-0.45,-1.57,0.54, ,0.17,0.92,0.97,2.20,-2.67,0.37,-0.42,"positive regulation of low-density lipoprotein particle receptor biosynthetic process;signal transduction;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;regulation of low-density lipoprotein particle clearance;positive regulation of receptor-mediated endocytosis;virus-host interaction",nucleoplasm;nuclear chromatin;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
2797,P62070,RRAS2,Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene),AGWRDGSGQEKYR,_(ac)AAAGWRDGS(ph)GQEK_,S10,+,,23.09,23.39,,24.30,24.40,24.16,24.35,24.79,24.42,,24.03,,24.10, ,-1.01,-0.71, ,0.20,0.29,0.05,0.25,0.69,0.32, ,-0.08, ,positive regulation of cell migration;Ras protein signal transduction,endoplasmic reticulum;plasma membrane,,,,,,,,,,+,,,,
2798,P62070,RRAS2,Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene),EQECPPSPEPTRK,_FQEQECPPS(ph)PEPTRK_,S186,+,,24.32,24.46,23.98,,25.06,25.85,25.43,26.60,27.10,26.21,,25.58,25.46, ,-1.14,-1.00,-1.47, ,-0.40,0.39,-0.03,1.14,1.64,0.75, ,0.12,positive regulation of cell migration;Ras protein signal transduction,endoplasmic reticulum;plasma membrane,,,,,,,,,,+,,,,
2800,P62258,YWHAE,14-3-3 protein epsilon (14-3-3E),AELDTLSEESYKD,_AAFDDAIAELDTLS(ph)EESYK_,S210,,26.71,,,,,,,,,25.53,25.92,26.43,,26.15,0.56, , , , , , , , ,-0.62,-0.23,0.28, ,neuron migration;hippo signaling cascade;negative regulation of protein dephosphorylation;cerebral cortex development;G2/M transition of mitotic cell cycle;hippocampus development;protein targeting;apoptotic process;nerve growth factor receptor signaling pathway;virus-host interaction,cytosol;axon part;mitochondrion;kinesin complex;melanosome,,,,,,,,,,,,,,
2801,P62263,RPS14,40S ribosomal protein S14,TPIPSDSTRRKGG,_IEDVTPIPSDS(ph)TR_,S139,,25.26,,,26.02,21.84,,21.76,22.17,,,,22.58,,23.27,1.98, , ,2.75,-1.43, ,-1.51,-1.11, , , ,-0.69, ,"translational termination;translational elongation;viral transcription;negative regulation of transcription from RNA polymerase II promoter;translational initiation;erythrocyte differentiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;ribosomal small subunit assembly;maturation of SSU-rRNA;SRP-dependent cotranslational protein targeting to membrane",mitochondrion;cytosolic small ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2803,P62280,RPS11,40S ribosomal protein S11,PFTGNVSIRGRIL,_KCPFTGNVS(ph)IR_,S67,,21.55,,,23.59,,,24.17,23.16,,,,24.34,,23.36,-1.81, , ,0.22, , ,0.81,-0.20, , , ,0.98, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit,,,,,,,,,,,,,,
2807,P62333,PSMC6,26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),IGGRRFSEGTSAD,_RFS(ph)EGTSADREIQR_,S244,,,,,,,,23.85,24.41,,,,24.40,,24.22, , , , , , ,-0.37,0.19, , , ,0.18, ,"S phase of mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;G1/S transition of mitotic cell cycle;M/G1 transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;regulation of apoptotic process;gene expression;protein polyubiquitination;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle",nucleoplasm;cytosol;proteasome accessory complex;plasma membrane,,,,,,,,,,,,,,
2808,P62750,RPL23A,60S ribosomal protein L23a,KKKIRTSPTFRRP,_IRTS(ph)PTFR_,S43,+,26.66,26.29,26.07,26.08,26.11,25.53,26.49,25.72,25.22,24.96,25.30,25.41,24.06,25.68,0.97,0.61,0.38,0.39,0.43,-0.16,0.81,0.03,-0.46,-0.72,-0.39,-0.27,-1.62,"translational termination;translational elongation;cell proliferation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit;nucleus,,,,,,,,,,,,,,
2810,P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),AKRRRLSSLRAST,_RRLS(ph)S(ph)LR_,S235,+,32.03,26.01,26.65,30.77,27.42,23.66,26.03,26.01,25.78,25.48,23.74,23.93,,26.46,5.57,-0.45,0.19,4.31,0.96,-2.79,-0.43,-0.45,-0.68,-0.98,-2.72,-2.53, ,"translational termination;translational elongation;viral transcription;ribosomal small subunit biogenesis;glucose homeostasis;TOR signaling cascade;translational initiation;insulin receptor signaling pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2813,P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),RASTSKSESSQK_,_LSSLRAS(ph)TSKS(ph)ES(ph)SQK_,S244,,23.65,,,26.14,,,,,,,,,,24.90,-1.24, , ,1.24, , , , , , , , , ,"translational termination;translational elongation;viral transcription;ribosomal small subunit biogenesis;glucose homeostasis;TOR signaling cascade;translational initiation;insulin receptor signaling pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2815,P62753,RPS6,40S ribosomal protein S6 (Phosphoprotein NP33),TSKSESSQK____,_LSSLRAS(ph)TSKS(ph)ESS(ph)QK_,S247,,22.51,,,24.90,,,,,,,,,,23.70,-1.19, , ,1.19, , , , , , , , , ,"translational termination;translational elongation;viral transcription;ribosomal small subunit biogenesis;glucose homeostasis;TOR signaling cascade;translational initiation;insulin receptor signaling pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;positive regulation of apoptotic process;rRNA processing;SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2816,P62805,HIST1H4A,Histone H4,GGVKRISGLIYEE,_RIS(ph)GLIYEETR_,S48,,,,,,27.17,22.24,,,,,,,,24.71, , , , ,2.46,-2.46, , , , , , , ,negative regulation of megakaryocyte differentiation;CENP-A containing nucleosome assembly at centromere;telomere maintenance;phosphatidylinositol-mediated signaling,nucleoplasm;extracellular region;nucleolus;actin cytoskeleton;nucleosome,,,,,,,,,,,,,,
2817,P62807,HIST1H2BC,Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l),HPDTGISSKAMGI,_(gl)QVHPDTGIS(ph)SK_,S56,+,23.13,23.27,23.38,23.31,22.73,23.00,,22.37,23.50,21.87,23.65,,,23.02,0.11,0.25,0.36,0.29,-0.29,-0.02, ,-0.65,0.48,-1.15,0.63, , ,defense response to bacterium;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
2820,P62829,RPL23,60S ribosomal protein L23 (60S ribosomal protein L17),KNLYIISVKGIKG,_NLYIIS(ph)VK_,S35,,20.49,,,22.08,,,,,,,,23.19,,21.92,-1.43, , ,0.16, , , , , , , ,1.27, ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;ribosomal protein import into nucleus",cytosolic large ribosomal subunit;nucleolus,,,,,,,,,,,,,,
2821,P62888,RPL30,60S ribosomal protein L30,AKKTKKSLESINS,_S(ph)LESINSR_,S10,+,23.84,24.03,23.90,26.17,,23.94,24.60,,,22.29,22.93,23.10,22.97,23.78,0.06,0.25,0.13,2.39, ,0.16,0.83, , ,-1.49,-0.85,-0.68,-0.81,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2823,P62979,RPS27A,Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin;40S ribosomal protein S27a],EDGRTLSDYNIQK,_TLS(ph)DYNIQK_,S57,,24.33,24.64,,23.71,24.33,23.53,23.68,23.66,23.84,24.37,,24.36,24.16,24.06,0.28,0.59, ,-0.35,0.28,-0.53,-0.38,-0.39,-0.22,0.32, ,0.30,0.11,"S phase of mitotic cell cycle;G1 phase of mitotic cell cycle;fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;DNA repair;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;toll-like receptor 2 signaling pathway;nucleotide-binding oligomerization domain containing signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;viral transcription;activation of MAPK activity;endosomal transport;TRIF-dependent toll-like receptor signaling pathway;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;I-kappaB kinase/NF-kappaB cascade;Notch receptor processing;negative regulation of epidermal growth factor receptor signaling pathway;cellular membrane organization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;regulation of apoptotic process;toll-like receptor 1 signaling pathway;translational termination;egress of virus within host cell;JNK cascade;G1/S transition of mitotic cell cycle;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of transcription from RNA polymerase II promoter in response to hypoxia;apoptotic process;cytokine-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;translational elongation;transcription initiation from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;negative regulation of type I interferon production;innate immune response;M/G1 transition of mitotic cell cycle;T cell receptor signaling pathway;Notch signaling pathway;translational initiation;negative regulation of transcription from RNA polymerase II promoter;SRP-dependent cotranslational protein targeting to membrane;protein polyubiquitination",nucleoplasm;endosome membrane;cytosolic small ribosomal subunit;plasma membrane;endocytic vesicle membrane,,,,,,,,,,,,,,
2826,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",SPSPYYSRGGYRS,_RRS(ph)PSPYYS(ph)R_,S234,,28.57,,,30.14,,,,,26.96,,,,,28.56,0.01, , ,1.58, , , , ,-1.59, , , , ,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2827,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",_____MSDSGEQN,_(ac)S(ph)DSGEQNYGERESR_,S2,+,26.46,24.26,24.44,24.68,,,,,21.71,,24.86,25.95,24.29,24.58,1.88,-0.32,-0.14,0.10, , , , ,-2.87, ,0.28,1.37,-0.29,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2829,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",NYGERESRSASRS,_(ac)S(ph)DSGEQNYGERES(ph)R_,S14,+,28.86,29.25,28.47,28.17,28.25,27.57,27.78,27.42,27.51,26.66,,,,27.99,0.87,1.25,0.48,0.18,0.25,-0.43,-0.21,-0.58,-0.49,-1.33, , , ,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2830,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",SHRRSRSRSYSRD,_S(ph)RS(ph)YSRDYR_,S47,+,26.31,27.47,27.47,24.91,24.99,21.00,21.65,22.23,22.30,21.17,,19.82,,23.57,2.74,3.90,3.90,1.34,1.42,-2.57,-1.93,-1.34,-1.28,-2.40, ,-3.76, ,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2832,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",SRSRSYSRDYRRR,_S(ph)RS(ph)YS(ph)RDYR_,S51,,25.66,,,26.13,,,,,,,,,,25.89,-0.23, , ,0.23, , , , , , , , , ,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2833,P62995,TRA2B,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",SRSRSYSPRRRPS,_SYS(ph)PRR_,S310,,,20.40,20.02,20.76,,,,,,,,,,20.39, ,0.01,-0.37,0.37, , , , , , , , , ,"mRNA splicing, via spliceosome;regulation of alternative mRNA splicing, via spliceosome;positive regulation of mRNA splicing, via spliceosome",nucleus,,,,,,,,,,,,,,
2834,P63027,VAMP2,Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2),ASQFETSAAKLKR,_LSELDDRADALQAGASQFETS(ph)AAK_,S63,+,,23.15,23.15,,24.60,24.81,22.55,23.30,24.80,24.26,23.62,23.01,25.45,23.88, ,-0.73,-0.73, ,0.72,0.93,-1.33,-0.59,0.92,0.38,-0.26,-0.87,1.56,post-Golgi vesicle-mediated transport;regulation of insulin secretion;cellular membrane organization;small molecule metabolic process;energy reserve metabolic process;neurotransmitter secretion;glutamate secretion,clathrin-sculpted monoamine transport vesicle membrane;SNARE complex;neuron projection;secretory granule membrane;synaptic vesicle membrane;cell junction;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;clathrin-sculpted glutamate transport vesicle membrane;endocytic vesicle membrane;integral to plasma membrane,,,,,,,,,,,,,,
2835,P63104,YWHAZ,14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1),AELDTLSEESYKD,_TAFDEAIAELDTLS(ph)EESYK_,S207,,28.04,,,,,,,,,,,,,28.04,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;signal transduction;mRNA metabolic process;platelet activation;protein targeting to mitochondrion;histamine secretion by mast cell;gene expression,nucleoplasm;mitochondrion;cell leading edge;postsynaptic density;protein complex;perinuclear region of cytoplasm;cytosol;melanosome,,,,,,,,,,,,,,
2836,P63165,SUMO1,Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1),_____MSDQEAKP,_(ac)S(ph)DQEAKPSTEDLGDKK_,S2,+,32.51,31.93,32.32,31.18,28.84,29.59,31.33,29.37,31.79,31.68,29.83,29.83,28.80,30.69,1.82,1.24,1.63,0.48,-1.85,-1.10,0.64,-1.32,1.10,0.99,-0.86,-0.86,-1.89,"regulation of protein localization;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;regulation of interferon-gamma-mediated signaling pathway;DNA repair;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein complex assembly;protein sumoylation;interferon-gamma-mediated signaling pathway;negative regulation of sequence-specific DNA binding transcription factor activity;palate development",nucleoplasm;nuclear membrane;synapse;nuclear speck;nuclear pore;dendrite;cytoplasm,,,,,,,,,,,,,,
2838,P63313,TMSB10,Thymosin beta-10,DMGEIASFDKAKL,_(ac)ADKPDM(ox)GEIAS(ph)FDK_,S12,+,25.23,24.31,24.28,24.99,23.93,,24.32,24.72,,,,25.52,23.17,24.50,0.74,-0.19,-0.21,0.49,-0.56, ,-0.17,0.22, , , ,1.02,-1.33,sequestering of actin monomers;actin cytoskeleton organization,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2839,P67809,YBX1,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),PPAENSSAPEAEQ,_AADPPAENSS(ph)APEAEQGGAE_,S314,+,24.95,25.43,25.46,26.75,26.76,26.80,26.41,27.32,26.26,25.47,25.71,25.59,26.17,26.08,-1.13,-0.66,-0.63,0.67,0.68,0.72,0.33,1.24,0.18,-0.61,-0.37,-0.49,0.09,"positive regulation of cell division;negative regulation of striated muscle cell differentiation;negative regulation of transcription, DNA-dependent;in utero embryonic development;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;extracellular region;histone pre-mRNA 3'end processing complex;CRD-mediated mRNA stability complex;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
2840,P67809,YBX1,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),QQNYQNSESGEKN,_GPPRNYQQNYQNS(ph)ESGEK_,S165,+,26.43,27.34,26.73,29.58,27.96,27.27,27.39,27.80,27.55,27.07,25.53,27.25,24.64,27.12,-0.69,0.22,-0.39,2.46,0.84,0.15,0.27,0.68,0.44,-0.05,-1.58,0.13,-2.48,"positive regulation of cell division;negative regulation of striated muscle cell differentiation;negative regulation of transcription, DNA-dependent;in utero embryonic development;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;extracellular region;histone pre-mRNA 3'end processing complex;CRD-mediated mRNA stability complex;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
2842,P67809,YBX1,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),GEKNEGSESAPEG,_NEGS(ph)ESAPEGQAQQR_,S174,,,26.11,25.46,,22.48,25.60,,26.95,,,,,23.35,24.99, ,1.11,0.47, ,-2.51,0.61, ,1.96, , , , ,-1.64,"positive regulation of cell division;negative regulation of striated muscle cell differentiation;negative regulation of transcription, DNA-dependent;in utero embryonic development;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;extracellular region;histone pre-mRNA 3'end processing complex;CRD-mediated mRNA stability complex;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
2843,P67809,YBX1,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),KNEGSESAPEGQA,_NEGSES(ph)APEGQAQQR_,S176,+,25.59,25.99,26.69,29.17,21.78,24.70,27.29,25.51,27.42,26.58,25.13,26.83,24.40,25.93,-0.34,0.06,0.76,3.24,-4.15,-1.23,1.36,-0.42,1.49,0.65,-0.80,0.90,-1.53,"positive regulation of cell division;negative regulation of striated muscle cell differentiation;negative regulation of transcription, DNA-dependent;in utero embryonic development;transcription from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;extracellular region;histone pre-mRNA 3'end processing complex;CRD-mediated mRNA stability complex;cytoplasmic stress granule,Other TF domain,,,,,,,,,,,,,
2846,P67936,TPM4,Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4),_MAGLNSLEAVKR,_(ac)AGLNS(ph)LEAVK_,S6,+,21.73,,,22.72,22.20,,22.21,22.34,22.39,,22.00,,,22.23,-0.50, , ,0.49,-0.02, ,-0.02,0.11,0.16, ,-0.23, , ,response to oxidative stress;muscle filament sliding,cytosol;cortical cytoskeleton;stress fiber;podosome;muscle thin filament tropomyosin;filamentous actin,,,,,,,,,,,,,,
2847,P68363,TUBA1B,Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain),LLMERLSVDYGKK,_LS(ph)VDYGK_,S158,,24.80,25.66,23.02,24.75,,,,,,,,,,24.56,0.24,1.10,-1.54,0.19, , , , , , , , , ,protein polymerization;microtubule-based process;microtubule-based movement;'de novo' posttranslational protein folding;microtubule cytoskeleton organization;cytoskeleton-dependent intracellular transport;cell division,cytoplasmic microtubule;microtubule,,,,,,,,,,,,,,
2848,P68363,TUBA1B,Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain),IGGGDDSFNTFFS,_TIGGGDDS(ph)FNTFFSETGAGK_,S48,+,24.01,,,22.07,23.03,,22.34,22.88,,22.42,,23.56,,22.90,1.10, , ,-0.84,0.13, ,-0.56,-0.02, ,-0.48, ,0.66, ,protein polymerization;microtubule-based process;microtubule-based movement;'de novo' posttranslational protein folding;microtubule cytoskeleton organization;cytoskeleton-dependent intracellular transport;cell division,cytoplasmic microtubule;microtubule,,,,,,,,,,,,,,
2849,P68402,PAFAH1B2,Platelet-activating factor acetylhydrolase IB subunit beta (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta),_____MSQGDSNP,_(ac)S(ph)QGDSNPAAIPHAAEDIQGDDR_,S2,,22.99,,,,,,,21.67,,,,,,22.33,0.66, , , , , , ,-0.66, , , , , ,spermatogenesis;brain development;lipid catabolic process;positive regulation of macroautophagy;lipid metabolic process,cytosol;nucleolus;plasma membrane;cytoplasm,,,,,,,,,,,,,,
2850,P68431,HIST1H3A,Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l),IRRYQKSTELLIR,_S(ph)TELLIR_,S58,,,21.01,,21.17,,22.11,,,22.73,20.97,,20.61,,21.43, ,-0.43, ,-0.26, ,0.68, , ,1.30,-0.47, ,-0.82, ,blood coagulation;S phase;regulation of gene silencing;nucleosome assembly,nucleoplasm;extracellular region;nucleosome,,,,,,,,,,,,,,
2851,P78310,CXADR,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),FERTPQSPTLPPA,_TPQS(ph)PTLPPAK_,S291,+,23.50,23.99,24.14,24.66,,,21.95,,25.13,26.20,25.12,,,24.34,-0.84,-0.34,-0.19,0.32, , ,-2.39, ,0.80,1.86,0.78, , ,homotypic cell-cell adhesion;defense response to virus;regulation of immune response;cell-cell junction organization;blood coagulation;germ cell migration;virus-host interaction;cardiac muscle fiber development;mitochondrion organization;neutrophil chemotaxis;negative regulation of cardiac muscle cell proliferation;AV node cell to bundle of His cell communication;heterophilic cell-cell adhesion;actin cytoskeleton reorganization;epithelial structure maintenance;transepithelial transport,membrane raft;basolateral plasma membrane;cell body;tight junction;adherens junction;extracellular space;nucleus;integral to plasma membrane;acrosomal vesicle;intercalated disc;protein complex;filopodium;growth cone;neuromuscular junction;extracellular region;apicolateral plasma membrane,,,,,,,,,,,,,,
2853,P78310,CXADR,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),VAAPNLSRMGAIP,_VAAPNLS(ph)R_,S305,,23.07,,,,,,,,,,,21.00,,22.03,1.04, , , , , , , , , , ,-1.04, ,homotypic cell-cell adhesion;defense response to virus;regulation of immune response;cell-cell junction organization;blood coagulation;germ cell migration;virus-host interaction;cardiac muscle fiber development;mitochondrion organization;neutrophil chemotaxis;negative regulation of cardiac muscle cell proliferation;AV node cell to bundle of His cell communication;heterophilic cell-cell adhesion;actin cytoskeleton reorganization;epithelial structure maintenance;transepithelial transport,membrane raft;basolateral plasma membrane;cell body;tight junction;adherens junction;extracellular space;nucleus;integral to plasma membrane;acrosomal vesicle;intercalated disc;protein complex;filopodium;growth cone;neuromuscular junction;extracellular region;apicolateral plasma membrane,,,,,,,,,,,,,,
2854,P78312,FAM193A,Protein FAM193A (Protein IT14),KLVLAESPQPKGK,_LVLAES(ph)PQPK_,S998,+,24.86,24.55,24.95,24.41,25.51,24.72,25.51,25.39,24.30,24.09,23.30,24.19,24.21,24.61,0.25,-0.07,0.33,-0.20,0.90,0.11,0.90,0.78,-0.32,-0.53,-1.32,-0.42,-0.41,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
2855,P78314,SH3BP2,SH3 domain-binding protein 2 (3BP-2),DTGGDDSDEDYEK,_PRQPSQADTGGDDS(ph)DEDYEK_,S148,+,22.68,24.77,25.01,23.69,,,24.52,21.73,24.23,22.90,23.32,22.72,,23.56,-0.88,1.21,1.45,0.13, , ,0.97,-1.82,0.67,-0.66,-0.23,-0.84, ,signal transduction,,,,,+,,,,,,,,,,
2856,P78314,SH3BP2,SH3 domain-binding protein 2 (3BP-2),QSFRSFSFEKPRQ,_SFS(ph)FEK_,S131,,22.68,,,20.18,,,,,,,,,,21.43,1.25, , ,-1.25, , , , , , , , , ,signal transduction,,,,,+,,,,,,,,,,
2857,P78314,SH3BP2,SH3 domain-binding protein 2 (3BP-2),LPHLQRSPPDGQS,_S(ph)PPDGQSFR_,S120,+,25.06,24.75,25.09,24.56,23.12,23.89,23.89,23.35,23.74,23.09,,23.53,22.93,23.92,1.14,0.84,1.17,0.64,-0.79,-0.03,-0.03,-0.56,-0.18,-0.82, ,-0.39,-0.99,signal transduction,,,,,+,,,,,,,,,,
2858,P78316,NOP14,Nucleolar protein 14 (Nucleolar complex protein 14),EYNSNMSPEEKMM,_FGEYNSNM(ox)S(ph)PEEK_,S96,+,22.20,24.41,24.41,,26.10,23.99,25.75,25.76,24.42,25.22,,22.32,,24.46,-2.25,-0.05,-0.05, ,1.64,-0.46,1.29,1.31,-0.04,0.76, ,-2.14, ,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",small-subunit processome;mitochondrion;nucleolus;Noc4p-Nop14p complex,,,,,,,,,,,,,,
2859,P78316,NOP14,Nucleolar protein 14 (Nucleolar complex protein 14),DVQEEQSKEASDP,_M(ox)NVEEDVQEEQS(ph)K_,S349,+,23.52,22.83,22.83,23.39,,22.65,23.92,23.38,24.24,23.93,,,,23.41,0.11,-0.58,-0.58,-0.02, ,-0.76,0.51,-0.03,0.83,0.52, , , ,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",small-subunit processome;mitochondrion;nucleolus;Noc4p-Nop14p complex,,,,,,,,,,,,,,
2861,P78332,RBM6,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),TVKKEESPPPPKV,_KEES(ph)PPPPK_,S759,+,18.88,20.90,21.61,20.31,,17.22,,17.79,18.35,17.14,,19.20,,19.04,-0.16,1.85,2.57,1.26, ,-1.82, ,-1.25,-0.69,-1.91, ,0.16, ,RNA processing,nucleus,,,,,,,,,,,,,,
2862,P78332,RBM6,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),KLQSFDSPERKRI,_LQSFDS(ph)PERK_,S893,+,25.12,25.38,25.85,24.93,24.96,25.21,24.58,22.65,25.46,25.12,23.75,22.85,23.53,24.57,0.55,0.81,1.29,0.37,0.39,0.64,0.01,-1.92,0.89,0.55,-0.82,-1.72,-1.04,RNA processing,nucleus,,,,,,,,,,,,,,
2865,P78345,RPP38,Ribonuclease P protein subunit p38 (RNaseP protein p38) (EC 3.1.26.5),ADGRQASVTLQPL,_(gl)QAS(ph)VTLQPLK_,S253,,21.82,,,19.22,,,,,,,,,,20.52,1.30, , ,-1.30, , , , , , , , , ,tRNA processing,nucleolar ribonuclease P complex,,,,,,,,,,,,,,
2866,P78347,GTF2I,General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein),MAQVAMSTLPVED,_AQVAM(ox)S(ph)TLPVEDEESSESR_,S7,,22.71,23.55,23.55,24.54,24.33,24.77,23.78,24.34,23.52,,23.63,23.62,25.18,23.96,-1.25,-0.41,-0.41,0.58,0.37,0.81,-0.18,0.38,-0.44, ,-0.33,-0.34,1.22,transcription initiation from RNA polymerase II promoter;signal transduction;negative regulation of angiogenesis;embryo development,neuronal cell body;nucleus;cell projection;cytoplasm,Other TF domain,,,,,,,,,,,,,
2867,P78347,GTF2I,General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein),PVEDEESSESRMV,_(ac)AQVAM(ox)STLPVEDEES(ph)SESR_,S16,,23.97,,,,,,,,,,,,,23.97,0.00, , , , , , , , , , , , ,transcription initiation from RNA polymerase II promoter;signal transduction;negative regulation of angiogenesis;embryo development,neuronal cell body;nucleus;cell projection;cytoplasm,Other TF domain,,,,,,,,,,,,,
2871,P78362,SRPK2,SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal;SRSF protein kinase 2 C-terminal],DRSRTVSASSTGD,_TVS(ph)ASS(ph)TGDLPK_,S494,,26.35,22.98,22.98,23.89,,,23.17,23.03,,20.06,,,,23.21,3.14,-0.22,-0.22,0.68, , ,-0.04,-0.18, ,-3.15, , , ,"intracellular protein kinase cascade;cell differentiation;negative regulation of viral genome replication;angiogenesis;positive regulation of viral genome replication;positive regulation of gene expression;positive regulation of cell cycle;nuclear speck organization;innate immune response;spliceosomal complex assembly;positive regulation of neuron apoptotic process;positive regulation of cell proliferation;regulation of mRNA splicing, via spliceosome",nucleolus;cytoplasm,,+,,,,,,,,,,,,
2872,P78362,SRPK2,SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal;SRSF protein kinase 2 C-terminal],RTVSASSTGDLPK,_TVSASS(ph)TGDLPK_,S497,+,26.41,25.10,25.13,25.38,24.13,24.32,25.21,25.04,23.86,24.71,24.30,23.61,,24.77,1.64,0.33,0.36,0.62,-0.64,-0.45,0.45,0.28,-0.91,-0.06,-0.47,-1.16, ,"intracellular protein kinase cascade;cell differentiation;negative regulation of viral genome replication;angiogenesis;positive regulation of viral genome replication;positive regulation of gene expression;positive regulation of cell cycle;nuclear speck organization;innate immune response;spliceosomal complex assembly;positive regulation of neuron apoptotic process;positive regulation of cell proliferation;regulation of mRNA splicing, via spliceosome",nucleolus;cytoplasm,,+,,,,,,,,,,,,
2873,P78369,CLDN10,Claudin-10 (OSP-like protein),GATSVMSSRTKYH,_YTYNGATSVM(ox)S(ph)SR_,S200,,,,,,,,25.01,23.53,,,,,,24.27, , , , , , ,0.74,-0.74, , , , , ,calcium-independent cell-cell adhesion,tight junction;integral to membrane;plasma membrane,,,,,,,,,,,,,,
2874,P78371,CCT2,T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta),____MASLSLAPV,_(ac)AS(ph)LSLAPVNIFK_,S3,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,chaperone-mediated protein complex assembly;'de novo' posttranslational protein folding,cytosol;nucleus;microtubule;chaperonin-containing T-complex,,,,,,,,,,,,,,
2875,P78380,OLR1,"Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form]",QQAEEASQESENE,_QQAEEAS(ph)QESENELK_,S42,,,,,25.96,,,,,,,,,,25.96, , , ,0.00, , , , , , , , , ,blood circulation;inflammatory response;lipoprotein metabolic process;blood coagulation;proteolysis;response to hydrogen peroxide;cell death;leukocyte cell-cell adhesion;leukocyte migration,extracellular region;integral to plasma membrane,,,,,,,,,,,,,,
2876,P78524,ST5,Suppression of tumorigenicity 5 protein (DENN domain-containing protein 2B) (HeLa tumor suppression 1),LVQRINSIYNAKR,_INS(ph)IYNAK_,S94,,23.84,,,22.37,,,,,,,,,,23.11,0.74, , ,-0.74, , , , , , , , , ,positive regulation of ERK1 and ERK2 cascade,,,,,,,,,,,,,,,
2877,P78527,PRKDC,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460),PLPEDNSMNVDQD,_LTPLPEDNS(ph)M(ox)NVDQDGDPSDR_,S3205,,25.11,24.76,24.13,22.32,,,,,,,,,,24.08,1.03,0.68,0.05,-1.76, , , , , , , , , ,germ cell programmed cell death;T cell receptor V(D)J recombination;peptidyl-serine phosphorylation;T cell differentiation in thymus;cellular response to insulin stimulus;response to gamma radiation;apoptotic process;telomere maintenance;immunoglobulin V(D)J recombination;B cell lineage commitment;positive regulation of transcription from RNA polymerase II promoter;somitogenesis;brain development;pro-B cell differentiation;double-strand break repair via nonhomologous end joining;protein destabilization;T cell lineage commitment;heart development;positive regulation of apoptotic process,transcription factor complex;nucleolus;DNA-dependent protein kinase-DNA ligase 4 complex,,+,,,,,,,,,,,,
2880,P78536,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),SSTAAKSFEDLTD,_S(ph)FEDLTDHPVTR_,S791,+,26.90,26.30,26.75,26.42,26.19,25.85,27.51,26.00,27.01,27.01,26.45,27.90,25.90,26.63,0.27,-0.33,0.12,-0.21,-0.44,-0.78,0.88,-0.63,0.38,0.38,-0.18,1.27,-0.73,"positive regulation of transforming growth factor beta receptor signaling pathway;response to high density lipoprotein particle stimulus;response to drug;positive regulation of chemokine production;T cell differentiation in thymus;positive regulation of T cell chemotaxis;regulation of mast cell apoptotic process;B cell differentiation;positive regulation of cell growth;membrane protein intracellular domain proteolysis;positive regulation of cell proliferation;spleen development;cell adhesion mediated by integrin;response to lipopolysaccharide;PMA-inducible membrane protein ectodomain proteolysis;wound healing, spreading of epidermal cells;germinal center formation;JAK-STAT cascade involved in growth hormone signaling pathway;response to hypoxia;negative regulation of interleukin-8 production;neutrophil mediated immunity;epidermal growth factor receptor signaling pathway;Notch signaling pathway;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;nerve growth factor receptor signaling pathway;epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway",membrane raft;apical plasma membrane;integral to plasma membrane;cell surface;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
2881,P78545,ELF3,ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1),SSHSSDSGGSDVD,_SSHSSDS(ph)GGS(ph)DVDLDPTDGK_,S189,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,"mammary gland involution;inflammatory response;negative regulation of transcription, DNA-dependent;extracellular matrix organization;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;blastocyst development;epidermis development;epithelial cell differentiation;positive regulation of transcription from RNA polymerase II promoter",Golgi apparatus;nucleus,Other TF domain,,,,,,,,,,,,,
2882,P78545,ELF3,ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1),SSDSGGSDVDLDP,_SSHSSDS(ph)GGS(ph)DVDLDPTDGK_,S192,,24.28,,,,,,,,,,,,,24.28,0.00, , , , , , , , , , , , ,"mammary gland involution;inflammatory response;negative regulation of transcription, DNA-dependent;extracellular matrix organization;transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;blastocyst development;epidermis development;epithelial cell differentiation;positive regulation of transcription from RNA polymerase II promoter",Golgi apparatus;nucleus,Other TF domain,,,,,,,,,,,,,
2883,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],MEEVHPSDEEEED,_AELEEM(ox)EEVHPS(ph)DEEEEDATK_,S667,+,,23.61,22.92,25.00,,,23.68,,,,26.70,25.87,24.93,24.67, ,-1.06,-1.75,0.32, , ,-0.99, , , ,2.03,1.20,0.26,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2884,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],KDRGLDSGAETEE,_DRGLDS(ph)GAET(ph)EEEK_,S612,+,21.36,26.97,25.26,27.81,21.87,21.56,22.65,,,21.88,24.58,25.49,,23.94,-2.58,3.03,1.32,3.86,-2.08,-2.38,-1.29, , ,-2.07,0.64,1.54, ,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2887,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],ELSSPISPKSLQS,_ELSSPIS(ph)PK_,S2022,+,20.00,25.21,23.61,27.11,23.94,25.23,23.90,23.97,,,25.80,26.17,25.11,24.55,-4.55,0.66,-0.94,2.56,-0.61,0.68,-0.65,-0.58, , ,1.25,1.62,0.56,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2890,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],KMLEEKSPEKVKA,_M(ox)LEEKS(ph)PEK_,S1600,,,,,23.43,,,,,,,,,,23.43, , , ,0.00, , , , , , , , , ,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2891,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],HWDDSTSDSELEK,_SHWDDSTS(ph)DSELEK_,S2106,+,,24.96,,25.42,23.27,24.55,23.04,23.81,,,,25.04,23.61,24.21, ,0.75, ,1.21,-0.94,0.33,-1.18,-0.40, , , ,0.83,-0.60,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2892,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],DSSFSKSPESLPG,_S(ph)PESLPGPALEDIAIK_,S1326,,,,,24.63,,,,,,,23.80,23.84,,24.09, , , ,0.54, , , , , , ,-0.29,-0.25, ,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2894,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],SAPGQESPIPDPK,_VPSAPGQES(ph)PIPDPK_,S1818,,,22.52,,24.26,,22.06,,,,,,,,22.95, ,-0.43, ,1.32, ,-0.89, , , , , , , ,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
2896,P78563,ADARB1,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),RNLDNVSPKDGST,_NLDNVS(ph)PK_,S26,,22.05,27.42,,26.85,,,,,,,,,,25.44,-3.39,1.98, ,1.41, , , , , , , , , ,defense response to virus;regulation of cell cycle;negative regulation of cell proliferation;positive regulation of viral genome replication;adenosine to inosine editing;negative regulation of protein kinase activity by regulation of protein phosphorylation;innate immune response;base conversion or substitution editing;mRNA modification;negative regulation of cell migration;mRNA processing;gene expression;RNA processing,nucleoplasm;nucleolus;nucleus,,,,,,,,,,,,,,
2899,P82094,TMF1,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),DSFSVQSLDSRSV,_IDSFSVQS(ph)LDSR_,S333,,,,,22.27,,,,,,,22.25,,,22.26, , , ,0.01, , , , , , ,-0.01, , ,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",Golgi apparatus;nucleus;Golgi membrane,Other TF domain,,,,,,,,,,,,,
2900,P82094,TMF1,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),SNTEPQSPPIASP,_SNTEPQS(ph)PPIASPK_,S72,,23.26,,,22.79,23.89,,23.89,,23.73,,24.13,,,23.61,-0.35, , ,-0.83,0.27, ,0.27, ,0.12, ,0.51, , ,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",Golgi apparatus;nucleus;Golgi membrane,Other TF domain,,,,,,,,,,,,,
2901,P82094,TMF1,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),QSPPIASPKAITK,_SNTEPQSPPIAS(ph)PK_,S77,,21.68,23.64,23.64,23.36,,,,,23.34,23.19,23.11,,,23.14,-1.46,0.50,0.50,0.23, , , , ,0.20,0.05,-0.02, , ,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",Golgi apparatus;nucleus;Golgi membrane,Other TF domain,,,,,,,,,,,,,
2902,P82094,TMF1,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),SVSEINSDDELSG,_SVSEINS(ph)DDELSGK_,S344,+,,26.91,27.14,27.68,27.57,28.41,27.84,28.24,28.43,27.83,26.86,27.45,27.14,27.63, ,-0.72,-0.48,0.05,-0.06,0.79,0.22,0.62,0.80,0.21,-0.76,-0.18,-0.48,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",Golgi apparatus;nucleus;Golgi membrane,Other TF domain,,,,,,,,,,,,,
2906,P83731,RPL24,60S ribosomal protein L24 (60S ribosomal protein L30),RAITGASLADIMA,_AITGAS(ph)LADIM(ox)AK_,S86,,,,,23.00,,,25.31,24.36,,,22.82,,,23.87, , , ,-0.87, , ,1.44,0.49, , ,-1.06, , ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
2907,P83916,CBX1,Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta),GKRKADSDSEDKG,_ADS(ph)DSEDKGEESKPK_,S89,,18.82,23.14,,21.63,,,,19.40,20.18,,,19.33,,20.42,-1.60,2.72, ,1.22, , , ,-1.01,-0.24, , ,-1.09, ,"negative regulation of transcription, DNA-dependent","nucleoplasm;nuclear heterochromatin;male pronucleus;female pronucleus;chromocenter;centromeric heterochromatin;chromosome, centromeric region;spindle",,,,,,,,,,,,,,
2912,P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),DGEKGPSSEGPEE,_GPS(ph)SEGPEEEDGEGFSFK_,S127,,,,,21.03,,,24.56,25.09,,25.68,25.22,,22.59,24.03, , , ,-3.00, , ,0.53,1.06, ,1.65,1.19, ,-1.44,,integral to membrane,,,,,,,,,,,,,,
2914,P84157,MXRA7,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),EDGEGFSFKYSPG,_GPSSEGPEEEDGEGFS(ph)FK_,S140,,20.60,,,22.45,,,,,,,,22.56,,21.87,-1.27, , ,0.58, , , , , , , ,0.69, ,,integral to membrane,,,,,,,,,,,,,,
2916,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),KEEAPASPLRPLY,_EEAPAS(ph)PLRPLYPQIS(ph)PLK_,S213,+,27.32,25.38,25.69,24.35,,23.99,26.30,23.83,26.91,26.51,25.51,26.21,25.85,25.65,1.67,-0.28,0.03,-1.31, ,-1.66,0.65,-1.82,1.26,0.86,-0.14,0.55,0.19,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2917,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),PLYPQISPLKIHI,_EEAPAS(ph)PLRPLYPQIS(ph)PLK_,S223,,26.99,24.78,24.78,,22.75,,23.07,,23.50,23.58,,,,24.21,2.78,0.57,0.57, ,-1.46, ,-1.14, ,-0.70,-0.63, , , ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2918,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),CLSREGSPIPHDP,_EGS(ph)PIPHDPEFGSK_,S445,+,27.52,27.87,27.83,27.63,29.43,29.37,28.21,28.79,27.92,26.63,27.76,27.60,28.75,28.10,-0.58,-0.23,-0.27,-0.47,1.33,1.27,0.11,0.69,-0.18,-1.47,-0.34,-0.50,0.65,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2919,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),AASVRQSPGPALA,_(gl)QS(ph)PGPALAR_,S101,+,23.21,23.14,20.10,23.56,22.82,22.56,22.20,22.34,22.06,20.93,,21.46,,22.22,0.99,0.93,-2.12,1.35,0.61,0.34,-0.02,0.12,-0.15,-1.29, ,-0.76, ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2920,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),GPLSSRSAPASPT,_S(ph)APAS(ph)PTHPGLM(ox)SPR_,S416,+,27.68,25.51,25.37,26.13,24.70,,22.97,,23.42,,,,,25.11,2.57,0.40,0.26,1.02,-0.41, ,-2.14, ,-1.69, , , , ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2922,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),THPGLMSPRSGGL,_SAPAS(ph)PTHPGLM(ox)S(ph)PR_,S428,+,25.78,26.63,26.26,26.73,25.43,23.58,24.46,24.64,26.33,23.71,,,,25.35,0.42,1.28,0.90,1.38,0.08,-1.78,-0.89,-0.71,0.98,-1.65, , , ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2923,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),QTPECLSREGSPI,_SGGLQTPECLS(ph)R_,S441,,22.31,23.07,,23.69,,,,,,,,,,23.02,-0.71,0.05, ,0.66, , , , , , , , , ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
2924,P86452,ZBED6,Zinc finger BED domain-containing protein 6,VENRSESPIPVAE,_SES(ph)PIPVAEQGTLM(ox)R_,S381,,23.50,22.73,22.80,23.91,24.08,24.90,24.13,,23.12,22.81,,22.64,23.32,23.45,0.05,-0.72,-0.65,0.46,0.63,1.45,0.68, ,-0.33,-0.64, ,-0.81,-0.13,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleolus,Other TF domain,,,,,,,,,,,,,
2925,P98082,DAB2,Disabled homolog 2 (DOC-2) (Differentially-expressed protein 2),PAPRQVSLPVTKS,_QVS(ph)LPVTK_,S723,,,22.36,21.81,23.42,,,,,,,,23.32,,22.73, ,-0.37,-0.92,0.69, , , , , , , ,0.60, ,"positive regulation of Wnt receptor signaling pathway, planar cell polarity pathway;negative regulation of apoptotic process;positive regulation of transforming growth factor beta receptor signaling pathway;pinocytosis;negative regulation of canonical Wnt receptor signaling pathway;positive regulation of epithelial to mesenchymal transition;negative regulation of transcription, DNA-dependent;negative regulation of androgen receptor signaling pathway;positive regulation of SMAD protein import into nucleus;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of early endosome to late endosome transport;negative regulation of cell growth;cell morphogenesis involved in differentiation;protein transport;apoptotic process;excretion;Wnt receptor signaling pathway;positive regulation of pathway-restricted SMAD protein phosphorylation;positive regulation of clathrin-mediated endocytosis;in utero embryonic development;cell proliferation;negative regulation of protein binding;positive regulation of transcription, DNA-dependent",coated pit;apical plasma membrane;nucleus;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
2932,P98082,DAB2,Disabled homolog 2 (DOC-2) (Differentially-expressed protein 2),PNPFVGSPPKGLS,_SSPNPFVGS(ph)PPK_,S401,+,,26.14,26.35,29.05,25.21,25.48,26.38,23.97,25.49,23.66,27.18,30.03,26.52,26.29, ,-0.15,0.06,2.76,-1.08,-0.81,0.09,-2.32,-0.80,-2.62,0.89,3.75,0.23,"positive regulation of Wnt receptor signaling pathway, planar cell polarity pathway;negative regulation of apoptotic process;positive regulation of transforming growth factor beta receptor signaling pathway;pinocytosis;negative regulation of canonical Wnt receptor signaling pathway;positive regulation of epithelial to mesenchymal transition;negative regulation of transcription, DNA-dependent;negative regulation of androgen receptor signaling pathway;positive regulation of SMAD protein import into nucleus;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of early endosome to late endosome transport;negative regulation of cell growth;cell morphogenesis involved in differentiation;protein transport;apoptotic process;excretion;Wnt receptor signaling pathway;positive regulation of pathway-restricted SMAD protein phosphorylation;positive regulation of clathrin-mediated endocytosis;in utero embryonic development;cell proliferation;negative regulation of protein binding;positive regulation of transcription, DNA-dependent",coated pit;apical plasma membrane;nucleus;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
2933,P98172,EFNB1,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),QRAAALSLSTLAS,_AAALS(ph)LSTLASPK_,S281,,21.88,22.21,21.42,23.31,23.59,,22.83,22.94,24.89,22.46,22.39,23.69,22.98,22.88,-1.00,-0.67,-1.46,0.43,0.70, ,-0.05,0.06,2.01,-0.43,-0.49,0.80,0.10,positive regulation of T cell proliferation;cell adhesion;neural crest cell migration;embryonic pattern specification;axon guidance;cell-cell signaling,synapse;membrane raft;nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2934,P98172,EFNB1,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),AAALSLSTLASPK,_AAALSLS(ph)TLASPK_,S283,,23.12,,,23.21,,,23.06,22.41,,,,25.15,,23.39,-0.27, , ,-0.18, , ,-0.33,-0.98, , , ,1.76, ,positive regulation of T cell proliferation;cell adhesion;neural crest cell migration;embryonic pattern specification;axon guidance;cell-cell signaling,synapse;membrane raft;nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2935,P98172,EFNB1,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),SLSTLASPKGGSG,_AAALSLSTLAS(ph)PK_,S287,,,,,,,,,,23.06,22.50,,,22.71,22.75, , , , , , , , ,0.30,-0.26, , ,-0.05,positive regulation of T cell proliferation;cell adhesion;neural crest cell migration;embryonic pattern specification;axon guidance;cell-cell signaling,synapse;membrane raft;nucleus;integral to plasma membrane;cytoplasm,,,,,,,,,,,,,,
2936,P98174,FGD1,"FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3)",ILVKSLSLDPGQS,_SLS(ph)LDPGQSLEPHPEGPQR_,S116,+,,,,22.48,24.03,,23.78,23.59,,25.38,22.77,24.25,,23.75, , , ,-1.28,0.28, ,0.03,-0.17, ,1.63,-0.98,0.49, ,regulation of cell shape;small GTPase mediated signal transduction;regulation of Cdc42 GTPase activity;actin cytoskeleton organization;filopodium assembly;apoptotic process;nerve growth factor receptor signaling pathway;organ morphogenesis,cytosol;Golgi apparatus;plasma membrane;nucleus;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
2938,P98175,RBM10,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),AAYSGESDSEEEQ,_GLVAAYSGES(ph)DS(ph)EEEQER_,S735,,25.79,22.70,,,,,,,,,,,,24.24,1.55,-1.55, , , , , , , , , , , ,mRNA processing;RNA splicing,chromatin remodeling complex,C2H2-type,,,,,,,,,,+,,,
2939,P98175,RBM10,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),YSGESDSEEEQER,_GLVAAYSGES(ph)DS(ph)EEEQER_,S737,,25.55,,,,,,,,,,,,,25.55,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing,chromatin remodeling complex,C2H2-type,,,,,,,,,,+,,,
2940,P98175,RBM10,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),DLPKLASDDRPSP,_LAS(ph)DDRPSPPR_,S783,,26.65,25.98,23.30,26.14,26.38,26.16,25.41,26.31,25.41,,24.44,,,25.62,1.03,0.36,-2.32,0.52,0.76,0.54,-0.20,0.70,-0.21, ,-1.18, , ,mRNA processing;RNA splicing,chromatin remodeling complex,C2H2-type,,,,,,,,,,+,,,
2941,P98175,RBM10,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),ASDDRPSPPRGLV,_LASDDRPS(ph)PPR_,S788,+,26.27,26.84,23.11,27.16,27.64,27.32,26.57,26.66,26.00,24.78,26.44,24.14,25.64,26.04,0.23,0.80,-2.94,1.11,1.60,1.27,0.53,0.62,-0.04,-1.26,0.40,-1.90,-0.40,mRNA processing;RNA splicing,chromatin remodeling complex,C2H2-type,,,,,,,,,,+,,,
2945,Q00536,CDK16,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),EKLTLNSPIFDKP,_LTLNS(ph)PIFDK_,S138,,24.81,22.06,21.58,22.73,,,,,,21.81,,,21.33,22.39,2.43,-0.33,-0.81,0.34, , , , , ,-0.58, , ,-1.05,regulation of insulin secretion involved in cellular response to glucose stimulus;spermatogenesis;neuron projection development;exocytosis;cell cycle;growth hormone secretion,neuron projection;synapse;transport vesicle;extrinsic to internal side of plasma membrane;cell junction;cytoplasm,,+,,,,,,,,,,,,
2946,Q00536,CDK16,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),DINKRLSLPADIR,_RLS(ph)LPADIRLPEGYLEK_,S119,,20.46,,,,,,,,21.94,20.72,,23.54,,21.67,-1.21, , , , , , , ,0.28,-0.94, ,1.87, ,regulation of insulin secretion involved in cellular response to glucose stimulus;spermatogenesis;neuron projection development;exocytosis;cell cycle;growth hormone secretion,neuron projection;synapse;transport vesicle;extrinsic to internal side of plasma membrane;cell junction;cytoplasm,,+,,,,,,,,,,,,
2947,Q00536,CDK16,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),RRLRRVSLSEIGF,_RVS(ph)LSEIGFGK_,S153,+,24.14,22.51,22.10,23.50,22.00,,22.68,,23.89,22.10,22.79,25.21,,23.09,1.05,-0.58,-0.99,0.41,-1.10, ,-0.42, ,0.79,-1.00,-0.30,2.12, ,regulation of insulin secretion involved in cellular response to glucose stimulus;spermatogenesis;neuron projection development;exocytosis;cell cycle;growth hormone secretion,neuron projection;synapse;transport vesicle;extrinsic to internal side of plasma membrane;cell junction;cytoplasm,,+,,,,,,,,,,,,
2948,Q00537,CDK17,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),EKLQINSPPFDQP,_LQINS(ph)PPFDQPM(ox)SR_,S112,+,22.78,22.78,22.66,23.15,24.66,23.91,24.16,24.48,25.25,,24.80,,,23.87,-1.08,-1.08,-1.20,-0.71,0.79,0.05,0.30,0.61,1.39, ,0.93, , ,cell cycle,,,+,,,,,,,,,,,,
2949,Q00537,CDK17,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),RRSRRASLSEIGF,_RAS(ph)LSEIGFGK_,S127,+,,22.49,22.49,24.16,24.27,25.01,,23.78,25.27,21.98,23.89,26.04,,23.94, ,-1.45,-1.45,0.23,0.33,1.08, ,-0.16,1.33,-1.95,-0.05,2.10, ,cell cycle,,,+,,,,,,,,,,,,
2950,Q00537,CDK17,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),SRRASLSEIGFGK,_RASLS(ph)EIGFGK_,S129,,,22.53,,,,,25.27,,,,,,,23.90, ,-1.37, , , , ,1.37, , , , , , ,cell cycle,,,+,,,,,,,,,,,,
2951,Q00537,CDK17,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),RIHRRISMEDLNK,_RIS(ph)MEDLNK_,S84,,22.89,,,23.67,,,23.65,,24.53,,,,,23.69,-0.80, , ,-0.01, , ,-0.03, ,0.84, , , , ,cell cycle,,,+,,,,,,,,,,,,
2952,Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),LPQARASWESLDE,_AS(ph)WESLDEEWRAPQAGSR_,S343,+,,,,23.35,25.14,23.68,23.01,24.85,24.50,,24.80,23.36,24.71,24.16, , , ,-0.80,0.98,-0.48,-1.15,0.70,0.35, ,0.65,-0.79,0.56,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,endomembrane system;Golgi apparatus;plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2953,Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),ARASWESLDEEWR,_ASWES(ph)LDEEWRAPQAGSR_,S346,,21.71,,,,,,,,,,,25.10,,23.41,-1.69, , , , , , , , , , ,1.69, ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,endomembrane system;Golgi apparatus;plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2954,Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),PPRRMASPPAPSP,_M(ox)AS(ph)PPAPSPAPPAISPIIK_,S101,,,,,22.90,23.32,22.92,,,,23.54,,,24.04,23.35, , , ,-0.45,-0.02,-0.42, , , ,0.19, , ,0.70,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,endomembrane system;Golgi apparatus;plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2955,Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),IIKNAISLPQLNQ,_NAIS(ph)LPQLNQAAYDSLVVGK_,S121,,,,,25.64,25.57,,25.11,,,,25.47,26.07,26.62,25.75, , , ,-0.11,-0.18, ,-0.64, , , ,-0.27,0.32,0.87,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,endomembrane system;Golgi apparatus;plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2956,Q00587,CDC42EP1,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),GLRRSDSLLSFRL,_SDS(ph)LLSFR_,S192,+,24.39,,,24.93,24.52,25.44,23.65,23.09,23.39,,22.13,26.07,24.85,24.25,0.15, , ,0.69,0.28,1.19,-0.59,-1.16,-0.86, ,-2.12,1.82,0.60,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,endomembrane system;Golgi apparatus;plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
2957,Q00610,CLTC,Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17),DNFDNISLAQRLE,_TSIDAYDNFDNIS(ph)LAQR_,S1494,,24.69,,,,,,,,,,,,,24.69,0.00, , , , , , , , , , , , ,post-Golgi vesicle-mediated transport;receptor internalization;axon guidance;intracellular protein transport;cellular membrane organization;epidermal growth factor receptor signaling pathway;mitosis;negative regulation of epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;transferrin transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,clathrin coat;mitochondrion;clathrin-coated endocytic vesicle membrane;cytosol;extracellular vesicular exosome;plasma membrane;clathrin coat of trans-Golgi network vesicle;melanosome;clathrin coat of coated pit;trans-Golgi network membrane;spindle,,,,,,,,,,,,,,
2958,Q00613,HSF1,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),TEGRPPSPPPTST,_GHTDTEGRPPS(ph)PPPTSTPEK_,S298,+,21.86,24.08,,22.05,23.81,24.60,23.39,24.03,23.68,22.82,23.54,23.68,24.09,23.47,-1.61,0.61, ,-1.42,0.34,1.14,-0.08,0.56,0.21,-0.65,0.07,0.21,0.62,"negative regulation of cell proliferation;protein phosphorylation;negative regulation of tumor necrosis factor production;embryonic process involved in female pregnancy;spermatogenesis;embryonic placenta development;response to heat;transcription, DNA-dependent;response to lipopolysaccharide;positive regulation of multicellular organism growth",nucleus;protein complex;pronucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
2959,Q00613,HSF1,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),VKEEPPSPPQSPR,_VKEEPPS(ph)PPQS(ph)PR_,S238,,25.40,23.85,21.27,24.85,,,,,,,,,,23.84,1.55,0.01,-2.57,1.01, , , , , , , , , ,"negative regulation of cell proliferation;protein phosphorylation;negative regulation of tumor necrosis factor production;embryonic process involved in female pregnancy;spermatogenesis;embryonic placenta development;response to heat;transcription, DNA-dependent;response to lipopolysaccharide;positive regulation of multicellular organism growth",nucleus;protein complex;pronucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
2960,Q00613,HSF1,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),PPSPPQSPRVEEA,_VKEEPPS(ph)PPQS(ph)PR_,S242,,25.40,23.85,21.27,24.85,,,,,,,,,,23.84,1.55,0.01,-2.57,1.01, , , , , , , , , ,"negative regulation of cell proliferation;protein phosphorylation;negative regulation of tumor necrosis factor production;embryonic process involved in female pregnancy;spermatogenesis;embryonic placenta development;response to heat;transcription, DNA-dependent;response to lipopolysaccharide;positive regulation of multicellular organism growth",nucleus;protein complex;pronucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
2961,Q00653,NFKB2,Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit],TRDKLPSTAEVKE,_DKLPS(ph)TAEVK_,S858,,24.34,24.05,24.05,22.10,,,,,,,22.68,,,23.44,0.89,0.61,0.61,-1.35, , , , , , ,-0.76, , ,"germinal center formation;toll-like receptor 3 signaling pathway;toll-like receptor 4 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;extracellular matrix organization;positive regulation of type I interferon production;innate immune response;Toll signaling pathway;toll-like receptor 2 signaling pathway;transcription, DNA-dependent;MyD88-dependent toll-like receptor signaling pathway;spleen development;toll-like receptor 1 signaling pathway;follicular dendritic cell differentiation",nucleoplasm;cytosol;Bcl3/NF-kappaB2 complex,Other TF domain,,,,,,,,,,,,,
2962,Q00653,NFKB2,Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit],TRDKLPSTEVKED,_DKLPS(ph)TEVK_,S858,,24.22,23.99,23.99,,,,20.95,,,,21.09,,,22.85,1.37,1.14,1.14, , , ,-1.90, , , ,-1.76, , ,"germinal center formation;toll-like receptor 3 signaling pathway;toll-like receptor 4 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;extracellular matrix organization;positive regulation of type I interferon production;innate immune response;Toll signaling pathway;toll-like receptor 2 signaling pathway;transcription, DNA-dependent;MyD88-dependent toll-like receptor signaling pathway;spleen development;toll-like receptor 1 signaling pathway;follicular dendritic cell differentiation",nucleoplasm;cytosol;Bcl3/NF-kappaB2 complex,Other TF domain,,,,,,,,,,,,,
2973,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",LPAEQGSPRMAET,_GEQVSQNGLPAEQGS(ph)PR_,S2138,+,26.36,26.96,27.42,27.81,23.85,25.64,28.68,26.99,28.06,27.86,28.55,27.43,27.10,27.13,-0.77,-0.17,0.28,0.68,-3.28,-1.49,1.55,-0.14,0.93,0.73,1.42,0.30,-0.03,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
2974,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",DVRGRLSGIEERY,_GRLS(ph)GIEER_,S825,+,19.16,25.41,,22.91,24.42,23.89,21.83,22.71,23.44,,,22.67,,22.94,-3.77,2.47, ,-0.03,1.48,0.95,-1.10,-0.23,0.51, , ,-0.27, ,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
2976,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",LDPEDISVDHPDE,_LLDPEDIS(ph)VDHPDEK_,S257,,,,,,,22.68,22.91,,,,,,,22.79, , , , , ,-0.12,0.12, , , , , , ,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
2986,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",SISGPLSPAYTGQ,_TSS(ph)ISGPLS(ph)PAYTGQVPYNYNQLEGR_,S14,,27.41,25.12,25.12,,25.65,,,24.63,24.73,26.04,25.36,,24.17,25.36,2.05,-0.24,-0.24, ,0.29, , ,-0.73,-0.63,0.68,0.01, ,-1.19,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
2990,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",SKSRLRSKSPPKS,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_,S206,,28.57,27.59,24.94,26.72,23.50,,,22.55,,,,,,25.65,2.93,1.95,-0.71,1.07,-2.14, , ,-3.10, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
2992,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",SKSPPKSPEEEGA,_S(ph)KS(ph)PPKS(ph)PEEEGAVSS_,S212,+,27.33,26.28,26.50,23.85,24.18,,27.69,,,22.41,,,,25.46,1.87,0.82,1.04,-1.61,-1.28, ,2.22, , ,-3.05, , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
2994,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",SRSRSRSRSPPPV,_S(ph)RS(ph)PPPVSK_,S189,,27.35,26.40,25.19,26.75,,,20.51,,20.65,,,,,24.47,2.87,1.93,0.72,2.27, , ,-3.97, ,-3.82, , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
2995,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",SRSRSRSPPPVSK,_S(ph)RS(ph)PPPVSK_,S191,,27.35,26.40,25.19,26.75,,,20.51,,20.65,,,,,24.47,2.87,1.93,0.72,2.27, , ,-3.97, ,-3.82, , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
2996,Q01130,SRSF2,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",NLTYRTSPDTLRR,_VDNLTYRTS(ph)PDTLR_,S26,+,28.12,26.46,25.64,27.38,26.79,29.14,29.69,27.69,28.95,27.24,26.66,28.55,28.07,27.72,0.40,-1.26,-2.08,-0.34,-0.93,1.42,1.97,-0.04,1.22,-0.49,-1.06,0.83,0.35,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
2997,Q01167,FOXK2,Forkhead box protein K2 (Cellular transcription factor ILF-1) (FOXK1) (Interleukin enhancer-binding factor 1),GAGGGGSPPGGWA,_(ac)AAAAAALSGAGTPPAGGGAGGGGAGGGGS(ph)PPGGWAVAR_,S30,,25.82,25.63,,,27.12,27.22,,,27.51,,,,,26.66,-0.84,-1.03, , ,0.46,0.56, , ,0.85, , , , ,tissue development;embryo development;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process,transcription factor complex,Forkhead,,,,,,,,,,,,,
2999,Q01167,FOXK2,Forkhead box protein K2 (Cellular transcription factor ILF-1) (FOXK1) (Interleukin enhancer-binding factor 1),AQSAPGSPLSSQP,_FAQSAPGS(ph)PLSSQPVLITVQR_,S428,+,24.27,,,,23.39,22.33,21.87,,24.47,24.19,,21.23,22.42,23.02,1.25, , , ,0.37,-0.70,-1.15, ,1.45,1.17, ,-1.79,-0.60,tissue development;embryo development;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process,transcription factor complex,Forkhead,,,,,,,,,,,,,
3000,Q01201,RELB,Transcription factor RelB (I-Rel),FGGGLLSPGPEAT,_EAAFGGGLLS(ph)PGPEAT_,S570,,25.25,,,,,,,,,,,,,25.25,0.00, , , , , , , , , , , , ,"antigen processing and presentation;positive regulation of gene expression;transcription, DNA-dependent;myeloid dendritic cell differentiation;T-helper 1 cell differentiation",cytosol;nucleus;microtubule organizing center,Other TF domain,,,,,,,,,,,,,
3001,Q01432,AMPD3,AMP deaminase 3 (EC 3.5.4.6) (AMP deaminase isoform E) (Erythrocyte AMP deaminase),KMIRSQSLSLQMP,_SQS(ph)LSLQM(ox)PPQQDWK_,S85,,22.51,,,,,,,,,,,,,22.51,0.00, , , , , , , , , , , , ,purine nucleobase metabolic process;purine-containing compound salvage;AMP catabolic process;IMP salvage,cytosol,,,,,,,,,,,,,,
3002,Q01433,AMPD2,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),PLDLRTSMDGKCK,_HFPLDLRTS(ph)M(ox)DGK_,S118,+,21.25,22.88,22.88,,22.36,,23.47,23.27,22.62,20.71,23.31,25.90,,22.86,-1.62,0.01,0.01, ,-0.51, ,0.60,0.40,-0.24,-2.16,0.45,3.04, ,purine nucleobase metabolic process;purine nucleotide metabolic process;purine-containing compound salvage;IMP salvage,cytosol,,,,,,,,,,,,,,
3003,Q01433,AMPD2,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),RLERQISQDVKLE,_(gl)QIS(ph)QDVKLEPDILLR_,S168,+,27.90,28.12,28.44,28.67,28.13,25.89,28.14,28.99,27.76,26.67,28.46,29.08,27.38,27.97,-0.07,0.15,0.47,0.70,0.16,-2.08,0.17,1.02,-0.21,-1.30,0.49,1.11,-0.59,purine nucleobase metabolic process;purine nucleotide metabolic process;purine-containing compound salvage;IMP salvage,cytosol,,,,,,,,,,,,,,
3005,Q01433,AMPD2,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),DFLKTDSDSDLQL,_TDS(ph)DSDLQLYK_,S190,,24.83,22.14,,21.92,,,,,23.03,,22.99,25.75,,23.44,1.39,-1.30, ,-1.52, , , , ,-0.42, ,-0.45,2.31, ,purine nucleobase metabolic process;purine nucleotide metabolic process;purine-containing compound salvage;IMP salvage,cytosol,,,,,,,,,,,,,,
3007,Q01484,ANK2,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),RPKKSDSNASFLR,_SDS(ph)NASFLR_,S31,,,,,23.23,21.14,21.73,,,21.96,,23.90,,,22.39, , , ,0.84,-1.25,-0.66, , ,-0.43, ,1.51, , ,cellular calcium ion homeostasis;T-tubule organization;regulation of atrial cardiac muscle cell action potential;cardiac muscle contraction;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;positive regulation of potassium ion transmembrane transporter activity;positive regulation of calcium ion transmembrane transporter activity;positive regulation of calcium ion transport;regulation of ventricular cardiac muscle cell membrane repolarization;atrial septum development;positive regulation of cation channel activity;membrane depolarization involved in regulation of SA node cell action potential;regulation of heart rate by cardiac conduction;protein localization to endoplasmic reticulum;protein stabilization;positive regulation of gene expression;axon guidance;regulation of ventricular cardiac muscle cell action potential;protein localization to plasma membrane;positive regulation of potassium ion transport;protein localization to cell surface;sarcoplasmic reticulum calcium ion transport,Z disc;M band;intercalated disc;basolateral plasma membrane;apical plasma membrane;T-tubule;cytosol;cytoskeleton;costamere;integral to plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
3009,Q01518,CAP1,Adenylyl cyclase-associated protein 1 (CAP 1),APKPQTSPSPKRA,_PFSAPKPQTS(ph)PS(ph)PK_,S308,+,29.67,30.15,30.44,30.17,28.69,28.68,31.90,30.15,30.10,29.35,30.29,29.95,28.49,29.85,-0.18,0.30,0.59,0.32,-1.16,-1.17,2.06,0.30,0.25,-0.50,0.44,0.10,-1.36,platelet degranulation;platelet activation;activation of adenylate cyclase activity;axon guidance;actin cytoskeleton organization;signal transduction;establishment or maintenance of cell polarity;receptor-mediated endocytosis;ameboidal cell migration,cortical actin cytoskeleton;plasma membrane,,,,,,,,,,,,,,
3010,Q01518,CAP1,Adenylyl cyclase-associated protein 1 (CAP 1),KPQTSPSPKRATK,_PFSAPKPQTS(ph)PS(ph)PK_,S310,+,28.09,27.61,27.96,29.02,28.61,23.03,27.42,26.57,25.99,24.82,,24.04,,26.65,1.44,0.96,1.31,2.37,1.96,-3.62,0.76,-0.08,-0.66,-1.83, ,-2.62, ,platelet degranulation;platelet activation;activation of adenylate cyclase activity;axon guidance;actin cytoskeleton organization;signal transduction;establishment or maintenance of cell polarity;receptor-mediated endocytosis;ameboidal cell migration,cortical actin cytoskeleton;plasma membrane,,,,,,,,,,,,,,
3013,Q01581,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)",ATEHIPSPAKKVP,_RPTPNDDTLDEGVGLVHSNIATEHIPS(ph)PAK_,S484,+,,,,23.01,24.26,23.72,25.25,25.68,23.65,23.48,,,,24.15, , , ,-1.14,0.11,-0.43,1.10,1.53,-0.50,-0.67, , , ,male gonad development;cholesterol biosynthetic process;response to drug;response to purine-containing compound;liver development;cellular lipid metabolic process;brain development;cellular response to follicle-stimulating hormone stimulus;isoprenoid biosynthetic process;response to lipoprotein particle stimulus;response to tellurium ion;response to low light intensity stimulus;response to acid;response to vitamin E;cellular response to cholesterol,cytosol;plasma membrane;nucleus,,,,,,,,,,,,,,
3014,Q01628,IFITM3,Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U),TVQTFFSPVNSGQ,_(ac)M(ox)NHTVQTFFS(ph)PVNSGQPPNYEM(ox)LK_,S10,,23.73,23.12,23.12,,,,,,,25.08,,,,23.76,-0.03,-0.64,-0.64, , , , , , ,1.32, , , ,defense response to virus;response to interferon-alpha;negative regulation of viral genome replication;response to virus;negative regulation of viral transcription;type I interferon-mediated signaling pathway;negative regulation of viral entry into host cell;response to interferon-gamma;response to interferon-beta,integral to membrane;plasma membrane;late endosome membrane;lysosomal membrane,,,,,,,,,,,,,,
3015,Q01650,SLC7A5,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),KMLAAKSADGSAP,_S(ph)ADGSAPAGEGEGVTLQR_,S31,,22.07,,,22.81,,,,,23.19,22.16,,,,22.56,-0.48, , ,0.25, , , , ,0.63,-0.40, , , ,cell differentiation;blood coagulation;nervous system development;leukocyte migration;cellular amino acid metabolic process,cytosol;integral to membrane;apical plasma membrane;plasma membrane,,,,,,,,,,,,,,
3019,Q01664,TFAP4,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),QELSGSSPKRRRA,_RFIQELSGSS(ph)PK_,S64,+,23.03,,,22.38,,23.19,22.97,23.86,23.54,24.64,,,,23.37,-0.34, , ,-1.00, ,-0.18,-0.40,0.49,0.17,1.27, , , ,"negative regulation of cell cycle arrest;negative regulation of apoptotic process;negative regulation of cell proliferation;protein complex assembly;negative regulation of transcription, DNA-dependent;regulation of S phase of mitotic cell cycle;negative regulation of DNA binding;positive regulation by host of viral transcription;negative regulation by host of viral transcription;negative regulation of cyclin-dependent protein kinase activity;positive regulation of transcription, DNA-dependent;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of apoptotic process;cellular response to dexamethasone stimulus",transcriptional repressor complex,bHLH,,,,,,,,,,,,,
3020,Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),QRPKEESSEDENE,_VQRPKEES(ph)S(ph)EDENEVSNILR_,S957,,25.34,,,,22.18,24.14,24.64,,24.24,,,23.69,,24.04,1.30, , , ,-1.86,0.10,0.60, ,0.20, , ,-0.35, ,,,,,,,,,,,,,,,,
3021,Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),RPKEESSEDENEV,_VQRPKEES(ph)S(ph)EDENEVSNILR_,S958,,25.29,,,,25.06,24.14,,25.01,,25.63,,,23.76,24.82,0.48, , , ,0.25,-0.67, ,0.19, ,0.81, , ,-1.06,,,,,,,,,,,,,,,,
3023,Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),KGELDLSLENLDL,_GELDLS(ph)LENLDLSK_,S827,,24.60,,,,,,,,,,,,,24.60,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
3024,Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),TAADVVSPGANSV,_TAADVVS(ph)PGANSVDSR_,S940,+,24.95,23.29,22.87,23.75,25.04,23.38,24.78,24.77,24.40,24.85,24.19,22.80,23.24,24.02,0.92,-0.74,-1.15,-0.27,1.02,-0.65,0.76,0.75,0.37,0.83,0.17,-1.22,-0.79,,,,,,,,,,,,,,,,
3025,Q01804,OTUD4,OTU domain-containing protein 4 (HIV-1-induced protein HIN-1),NLSRTPSQIIRKP,_TPS(ph)QIIR_,S350,,25.75,,,25.08,,,,,,,,21.89,,24.24,1.51, , ,0.84, , , , , , , ,-2.35, ,,,,,,,,,,,,,,,,
3026,Q01813,PFKP,"6-phosphofructokinase type C (EC 2.7.1.11) (6-phosphofructokinase, platelet type) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphofructokinase 1) (Phosphohexokinase)",EHVQPWSV_____,_ASYDVSDSGQLEHVQPWS(ph)V_,S783,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,"fructose 6-phosphate metabolic process;protein homotetramerization;small molecule metabolic process;glycolysis;fructose 1,6-bisphosphate metabolic process",6-phosphofructokinase complex,,,,,,,,,,,,,,
3027,Q01813,PFKP,"6-phosphofructokinase type C (EC 2.7.1.11) (6-phosphofructokinase, platelet type) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphofructokinase 1) (Phosphohexokinase)",VRLRGRSFAGNLN,_S(ph)FAGNLNTYKR_,S386,+,26.90,26.06,25.97,26.52,26.67,25.87,27.07,27.63,25.49,26.23,26.29,27.14,24.78,26.36,0.55,-0.30,-0.38,0.16,0.32,-0.48,0.71,1.28,-0.87,-0.12,-0.07,0.78,-1.58,"fructose 6-phosphate metabolic process;protein homotetramerization;small molecule metabolic process;glycolysis;fructose 1,6-bisphosphate metabolic process",6-phosphofructokinase complex,,,,,,,,,,,,,,
3028,Q01831,XPC,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),IKDEALSDGDDLR,_DEALS(ph)DGDDLRDFPSDLK_,S94,+,25.08,,,,26.40,22.19,23.50,24.13,25.14,27.32,25.65,24.17,25.05,24.86,0.22, , , ,1.54,-2.67,-1.36,-0.74,0.27,2.45,0.79,-0.69,0.19,"response to UV-B;nucleotide-excision repair, DNA damage recognition;intra-S DNA damage checkpoint;nucleotide-excision repair, DNA damage removal;response to drug;cell cycle checkpoint",nucleoplasm;XPC complex;cytoplasm,DNA binding region,,,,,,,,,,,,,
3029,Q01831,XPC,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),DAGGGLSSDEEEG,_SEAAAPHTDAGGGLS(ph)S(ph)DEEEGTSSQAEAAR_,S883,,26.63,,,,24.85,,,,,24.53,,,,25.34,1.29, , , ,-0.49, , , , ,-0.81, , , ,"response to UV-B;nucleotide-excision repair, DNA damage recognition;intra-S DNA damage checkpoint;nucleotide-excision repair, DNA damage removal;response to drug;cell cycle checkpoint",nucleoplasm;XPC complex;cytoplasm,DNA binding region,,,,,,,,,,,,,
3030,Q01831,XPC,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),AGGGLSSDEEEGT,_SEAAAPHTDAGGGLS(ph)S(ph)DEEEGTSSQAEAAR_,S884,,26.63,,,,24.85,,,,,24.53,,,,25.34,1.29, , , ,-0.49, , , , ,-0.81, , , ,"response to UV-B;nucleotide-excision repair, DNA damage recognition;intra-S DNA damage checkpoint;nucleotide-excision repair, DNA damage removal;response to drug;cell cycle checkpoint",nucleoplasm;XPC complex;cytoplasm,DNA binding region,,,,,,,,,,,,,
3031,Q01954,BNC1,Zinc finger protein basonuclin-1,FERTQLSPEAKVK,_FERTQLS(ph)PEAK_,S331,,,24.58,24.58,,22.16,23.09,26.54,23.97,26.85,23.93,23.08,25.68,,24.44, ,0.13,0.13, ,-2.29,-1.36,2.09,-0.48,2.41,-0.51,-1.36,1.24, ,"regulation of transcription from RNA polymerase I promoter;wound healing;positive regulation of epithelial cell proliferation;regulation of transcription from RNA polymerase II promoter;chromosome organization;positive regulation of cell proliferation;transcription, DNA-dependent;epidermis development",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
3032,Q01954,BNC1,Zinc finger protein basonuclin-1,HKSLASSPSHLQ_,_SLASS(ph)PSHLQ_,S982,,,22.81,22.81,25.91,23.16,,23.65,22.14,24.50,,,22.85,22.51,23.37, ,-0.56,-0.56,2.54,-0.21, ,0.28,-1.23,1.13, , ,-0.52,-0.86,"regulation of transcription from RNA polymerase I promoter;wound healing;positive regulation of epithelial cell proliferation;regulation of transcription from RNA polymerase II promoter;chromosome organization;positive regulation of cell proliferation;transcription, DNA-dependent;epidermis development",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
3033,Q01970,PLCB3,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3)",SLEPQKSLGDEGL,_S(ph)LGDEGLNR_,S470,,26.74,25.17,,23.61,,,,24.38,,,24.93,,,24.97,1.77,0.21, ,-1.36, , , ,-0.58, , ,-0.04, , ,post-Golgi vesicle-mediated transport;regulation of systemic arterial blood pressure;lipid catabolic process;synaptic transmission;G-protein coupled receptor signaling pathway;intracellular signal transduction,cytosol;sarcolemma;protein complex,,,,,,,,,,,,,,
3034,Q01995,TAGLN,Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha) (SM22-alpha),KREFTESQLQEGK,_EFTES(ph)QLQEGK_,S166,,20.39,,,22.46,,,,,,,,,21.56,21.47,-1.08, , ,0.99, , , , , , , , ,0.09,muscle organ development,cytoplasm,,,,,,,,,,,,,,
3035,Q02040,AKAP17A,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",VVPEDGSPEKRCP,_VVPEDGS(ph)PEKR_,S537,+,24.05,25.55,25.33,26.98,24.27,25.51,24.60,23.35,25.09,26.00,24.71,24.25,23.70,24.88,-0.83,0.67,0.46,2.10,-0.60,0.63,-0.28,-1.52,0.21,1.13,-0.16,-0.63,-1.18,"signal transduction;B cell activation;mRNA processing;RNA splicing;regulation of transcription, DNA-dependent;regulation of RNA splicing",nuclear speck;spliceosomal complex,,,,,,,,,,,,,,
3037,Q02086,SP2,Transcription factor Sp2,PAPLPLSPGKNSF,_PAPLPLS(ph)PGK_,S71,,21.52,22.39,22.39,,,,23.34,,21.11,24.09,,,,22.47,-0.96,-0.08,-0.08, , , ,0.87, ,-1.36,1.61, , , ,"immune response;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
3038,Q02108,GUCY1A3,Guanylate cyclase soluble subunit alpha-3 (GCS-alpha-3) (EC 4.6.1.2) (GCS-alpha-1) (Soluble guanylate cyclase large subunit),EKNIQESLPQRKT,_NIQES(ph)LPQR_,S58,,28.16,28.78,25.36,30.61,26.57,25.70,26.30,27.31,,23.79,27.04,26.96,23.50,26.67,1.48,2.11,-1.32,3.93,-0.10,-0.97,-0.38,0.63, ,-2.88,0.37,0.29,-3.17,blood circulation;response to herbicide;positive regulation of cGMP biosynthetic process;response to defense-related host nitric oxide production;blood coagulation;nitric oxide mediated signal transduction;response to organic cyclic compound;regulation of blood pressure;relaxation of vascular smooth muscle,"guanylate cyclase complex, soluble",,,,,,,,,,,,,,
3039,Q02156,PRKCE,Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon),EEFKGFSYFGEDL,_GFS(ph)YFGEDLM(ox)P_,S729,,23.49,,,,,,,,,,,,,23.49,0.00, , , , , , , , , , , , ,"fibroblast growth factor receptor signaling pathway;positive regulation of epithelial cell migration;induction of apoptosis;cell division;intracellular signal transduction;platelet activation;TRAM-dependent toll-like receptor 4 signaling pathway;response to morphine;activation of phospholipase C activity;positive regulation of mucus secretion;epidermal growth factor receptor signaling pathway;cellular response to hypoxia;macrophage activation involved in immune response;nerve growth factor receptor signaling pathway;cell cycle;positive regulation of wound healing;positive regulation of cellular glucuronidation;positive regulation of fibroblast migration;positive regulation of MAPK cascade;positive regulation of cell cycle cytokinesis;positive regulation of actin filament polymerization;positive regulation of cell-substrate adhesion;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peptidyl-tyrosine phosphorylation;release of sequestered calcium ion into cytosol;positive regulation of lipid catabolic process;positive regulation of insulin secretion;positive regulation of synaptic transmission, GABAergic;regulation of insulin secretion involved in cellular response to glucose stimulus;lipopolysaccharide-mediated signaling pathway;cell adhesion;cellular response to ethanol;locomotory exploration behavior",mitochondrion;endoplasmic reticulum;Golgi membrane;perinuclear region of cytoplasm;cytosol;cytoskeleton;nucleus;plasma membrane,,+,,,,,,,,,,,,
3040,Q02241,KIF23,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),KLQRQFSDKRRLE,_LQRQFS(ph)DK_,S422,,22.95,25.56,25.46,24.54,,,21.32,,,,,,,23.97,-1.01,1.60,1.49,0.58, , ,-2.65, , , , , , ,blood coagulation;microtubule-based movement;cell cycle cytokinesis;spindle midzone assembly involved in mitosis;mitotic spindle elongation;positive regulation of cell cycle cytokinesis;antigen processing and presentation of exogenous peptide antigen via MHC class II,nucleoplasm;kinesin complex;centrosome;centralspindlin complex;cytosol;intercellular bridge;midbody;microtubule,,,,,,,,,,,,,,
3042,Q02241,KIF23,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),VTQRSVSPSPVPL,_SVS(ph)PSPVPLLFQPDQNAPPIRLR_,S501,+,25.98,24.55,25.44,26.38,28.05,,27.62,27.82,25.73,25.27,,24.69,28.93,26.40,-0.43,-1.85,-0.96,-0.02,1.64, ,1.21,1.42,-0.68,-1.14, ,-1.72,2.52,blood coagulation;microtubule-based movement;cell cycle cytokinesis;spindle midzone assembly involved in mitosis;mitotic spindle elongation;positive regulation of cell cycle cytokinesis;antigen processing and presentation of exogenous peptide antigen via MHC class II,nucleoplasm;kinesin complex;centrosome;centralspindlin complex;cytosol;intercellular bridge;midbody;microtubule,,,,,,,,,,,,,,
3045,Q02447,SP3,Transcription factor Sp3 (SPR-2),__IGPPSPGDDEE,_IGPPS(ph)PGDDEEEAAAAAGAPAAAGATGDLASAQLGGAPNRWEVLSATPTTIK_,S5,,25.87,,,,,,,,,,,,,25.87,0.00, , , , , , , , , , , , ,"embryonic skeletal system development;granulocyte differentiation;negative regulation of transcription, DNA-dependent;liver development;lung development;B cell differentiation;embryonic placenta development;enucleate erythrocyte differentiation;embryonic camera-type eye morphogenesis;ossification;trophectodermal cell differentiation;natural killer cell differentiation;embryonic process involved in female pregnancy;T cell differentiation;definitive hemopoiesis;megakaryocyte differentiation;positive regulation of transcription, DNA-dependent;monocyte differentiation",PML body;nucleus;transcriptional repressor complex,C2H2-type,,,,,,,,,,,,,
3048,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",KRKASGSENEGDY,_ASGS(ph)ENEGDYNPGRK_,S1524,,22.62,24.18,24.52,23.65,,,,,22.60,22.43,,,,23.33,-0.72,0.85,1.19,0.32, , , , ,-0.74,-0.90, , , ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3049,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",ELKVKASPITNDG,_VKAS(ph)PITNDGEDEFVPSDGLDK_,S1372,+,28.03,27.57,27.53,26.91,28.37,28.42,29.16,27.60,30.60,30.32,28.33,27.83,28.10,28.37,-0.34,-0.80,-0.84,-1.46,0.00,0.05,0.79,-0.76,2.23,1.95,-0.04,-0.54,-0.27,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3050,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",EDEFVPSDGLDKD,_VKAS(ph)PITNDGEDEFVPS(ph)DGLDK_,S1385,+,27.49,,,21.64,27.11,,25.75,,27.20,27.75,,26.17,24.03,25.89,1.60, , ,-4.25,1.22, ,-0.14, ,1.31,1.85, ,0.27,-1.86,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3051,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",KDEYTFSPGKSKA,_DEYTFS(ph)PGK_,S1396,+,26.54,26.33,20.92,28.09,23.11,23.84,28.18,23.98,27.99,28.43,25.49,26.53,24.04,25.65,0.89,0.68,-4.73,2.44,-2.54,-1.81,2.53,-1.67,2.34,2.78,-0.16,0.87,-1.62,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3052,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",DSAKFDSNEEDSA,_FDS(ph)NEEDSASVFSPSFGLK_,S1438,+,26.18,24.30,24.30,,27.90,,24.60,25.21,27.15,27.74,,26.31,25.74,25.94,0.24,-1.65,-1.65, ,1.96, ,-1.34,-0.74,1.21,1.80, ,0.37,-0.20,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3054,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",PWSDDESKSESDL,_RNPWS(ph)DDES(ph)K_,S1312,,26.21,27.32,27.66,25.49,,,,,,,,,,26.67,-0.46,0.65,0.99,-1.18, , , , , , , , , ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3056,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",VVEAVNSDSDSEF,_KVVEAVNS(ph)DS(ph)DSEFGIPK_,S1494,+,27.94,21.47,21.47,,26.30,24.53,24.95,25.13,22.83,28.50,,24.83,,24.80,3.15,-3.33,-3.33, ,1.51,-0.26,0.15,0.34,-1.97,3.70, ,0.04, ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3057,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",EAVNSDSDSEFGI,_KVVEAVNS(ph)DS(ph)DSEFGIPK_,S1496,+,27.78,,,,26.84,25.22,,23.43,26.46,26.62,22.37,24.83,25.14,25.41,2.37, , , ,1.43,-0.19, ,-1.98,1.05,1.21,-3.04,-0.58,-0.27,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3058,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",SDDESKSESDLEE,_S(ph)ES(ph)DLEETEPVVIPR_,S1314,,25.76,,,,,,,,,,,,,25.76,0.00, , , , , , , , , , , , ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3059,Q02880,TOP2B,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",DESKSESDLEETE,_S(ph)ES(ph)DLEETEPVVIPR_,S1316,,25.86,21.63,,,,,24.89,,27.57,28.09,,25.62,,25.61,0.25,-3.98, , , , ,-0.72, ,1.96,2.48, ,0.01, ,sister chromatid segregation;neuron migration;mitotic cell cycle G2/M transition decatenation checkpoint;axonogenesis;DNA topological change;mitotic recombination;forebrain development;resolution of meiotic recombination intermediates;DNA-dependent DNA replication,nucleoplasm;cytosol;synaptonemal complex;WINAC complex,,,,,,,,,,,,,,
3061,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),GDHKDPSLGAGEA,_DEGEGAAGAGDHKDPS(ph)LGAGEAASK_,S219,,,23.04,23.04,,,,26.19,23.24,,24.93,25.16,,,24.27, ,-1.23,-1.23, , , ,1.93,-1.03, ,0.66,0.90, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3062,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),KEESWVSIKKFIP,_EESWVS(ph)IK_,S806,,21.12,,,19.84,,,,,,,,,,20.48,0.64, , ,-0.64, , , , , , , , , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3063,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),GVTPWASFKKMVT,_EGVTPWAS(ph)FKK_,S612,+,24.58,22.02,22.02,19.15,26.46,22.73,24.80,24.89,23.88,25.24,25.04,23.24,,23.67,0.91,-1.66,-1.66,-4.52,2.79,-0.94,1.13,1.22,0.21,1.57,1.37,-0.43, ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3064,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),RPPAPSSFVFQEE,_ERPPAPSS(ph)FVFQEETK_,S1226,,,,,,,,,,23.20,,24.22,,22.92,23.45, , , , , , , , ,-0.25, ,0.78, ,-0.53,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3070,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),HTDKEVSVETVSI,_EVS(ph)VETVSILSK_,S1251,,19.79,,,,,,21.55,,,24.38,22.56,,,22.07,-2.28, , , , , ,-0.52, , ,2.31,0.49, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3071,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),ETVSILSKTEGTQ,_EVSVETVSILS(ph)K_,S1259,,,,,,,,,,,22.70,22.36,,,22.53, , , , , , , , , ,0.17,-0.17, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3074,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),AEEGATSDGEKKR,_GLAEVQQDGEAEEGATS(ph)DGEKKR_,S598,+,27.86,25.81,26.59,23.77,28.94,27.75,28.35,28.96,27.78,29.37,28.98,22.21,27.07,27.19,0.67,-1.38,-0.60,-3.41,1.75,0.56,1.16,1.77,0.59,2.19,1.80,-4.98,-0.12,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3075,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),AHEPRLSAEYEKV,_LTASEQAHPQEPAESAHEPRLS(ph)AEYEK_,S371,+,24.46,25.70,25.70,,,26.22,27.93,26.79,27.06,28.36,29.17,24.85,25.69,26.54,-2.08,-0.84,-0.84, , ,-0.32,1.39,0.25,0.52,1.82,2.63,-1.69,-0.84,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3078,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),PADSPDSQEEQKG,_RGGGDEESGEHTQVPADSPDS(ph)QEEQK_,S557,,,23.44,23.44,,,,25.16,,24.75,26.10,24.18,,,24.51, ,-1.07,-1.07, , , ,0.65, ,0.24,1.59,-0.33, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3079,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),KRVRRPSESDKED,_RPS(ph)ES(ph)DKEDELDK_,S627,+,27.86,25.29,23.96,24.85,26.75,26.19,26.62,27.48,26.59,25.07,28.07,23.15,25.02,25.91,1.94,-0.62,-1.96,-1.07,0.84,0.27,0.70,1.56,0.68,-0.84,2.16,-2.77,-0.90,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3080,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),VRRPSESDKEDEL,_RPS(ph)ES(ph)DKEDELDK_,S629,,27.37,22.82,,23.35,,,,,21.29,,,,,23.71,3.67,-0.89, ,-0.36, , , , ,-2.42, , , , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3081,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),PSKSAESPTSPVT,_SAES(ph)PTSPVTSETGSTFKK_,S283,+,27.40,25.08,25.08,,27.09,26.23,27.23,26.73,26.43,27.83,27.64,,25.69,26.58,0.81,-1.50,-1.50, ,0.51,-0.35,0.64,0.14,-0.15,1.24,1.05, ,-0.89,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3082,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),SAESPTSPVTSET,_SAES(ph)PTS(ph)PVTSETGSTFK_,S286,+,28.87,26.57,27.49,22.43,27.23,25.29,27.90,27.90,24.62,29.41,29.40,24.25,27.20,26.81,2.06,-0.24,0.68,-4.38,0.41,-1.53,1.09,1.09,-2.20,2.59,2.59,-2.56,0.39,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3084,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),VKSATLSSTESTA,_SATLS(ph)S(ph)TESTASEM(ox)QEEM(ox)K_,S644,,23.65,,,,22.15,,24.18,,,24.77,25.60,,22.88,23.87,-0.22, , , ,-1.72, ,0.31, , ,0.90,1.73, ,-0.99,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3086,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),STESTASEMQEEM,_SATLSSTESTAS(ph)EM(ox)QEEM(ox)K_,S651,,21.52,22.33,22.33,,,,22.95,,23.30,23.91,24.11,,,22.92,-1.40,-0.59,-0.59, , , ,0.03, ,0.38,0.99,1.19, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3087,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),SKLEEKSEDSIAG,_S(ph)EDSIAGSGVEHSTPDTEPGK_,S780,,,22.79,22.79,,,,25.39,,25.82,26.60,24.34,,,24.62, ,-1.84,-1.84, , , ,0.77, ,1.20,1.98,-0.28, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3091,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),LQSHAKSPPSPVE,_S(ph)PPSPVER_,S1328,,26.95,26.42,,26.07,,26.04,,,25.05,,,,24.32,25.81,1.14,0.61, ,0.26, ,0.23, , ,-0.76, , , ,-1.49,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3092,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),HAKSPPSPVEREM,_SPPS(ph)PVEREMVVQVEREK_,S1331,+,,26.91,27.89,26.67,29.94,28.95,29.17,29.81,28.86,29.63,29.45,25.42,28.63,28.44, ,-1.53,-0.55,-1.77,1.50,0.51,0.72,1.37,0.41,1.19,1.01,-3.03,0.18,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3095,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),GKAEVASEKLTAS,_VDTEEDGKAEVAS(ph)EK_,S347,,21.85,23.46,23.46,,,,26.05,21.06,25.61,26.70,26.75,,21.29,24.02,-2.18,-0.57,-0.57, , , ,2.02,-2.97,1.59,2.68,2.73, ,-2.74,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3096,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),EVEMLSSQERMKV,_VLSKPPEGVVSEVEM(ox)LSS(ph)QER_,S505,+,,22.13,22.13,,24.09,,23.02,25.96,22.17,23.97,26.14,,,23.70, ,-1.57,-1.57, ,0.39, ,-0.68,2.26,-1.53,0.27,2.44, , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3097,Q02978,SLC25A11,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11),_MAATASAGAGGI,_(ac)AATAS(ph)AGAGGIDGKPR_,S6,+,23.27,25.56,,22.95,24.39,25.51,,23.66,24.88,24.93,23.84,23.83,24.83,24.33,-1.06,1.22, ,-1.39,0.06,1.18, ,-0.67,0.55,0.60,-0.49,-0.50,0.50,small molecule metabolic process;gluconeogenesis,mitochondrial inner membrane;integral to plasma membrane,,,,,,,,,,,,,,
3098,Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),DPGIDPSVVKQQQ,_DLEDPGIDPS(ph)VVK_,S6083,,,,,,,25.99,26.83,26.31,23.78,,,,,25.73, , , , , ,0.26,1.10,0.58,-1.95, , , , ,hemidesmosome assembly;response to wounding;maintenance of cell polarity;cell adhesion;cell cycle arrest;cell motility;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;microtubule cytoskeleton organization,Z disc;axon part;microtubule plus end;hemidesmosome;cell cortex;integral to membrane;basement membrane;nucleus;endoplasmic reticulum membrane;axon;nuclear envelope;cell leading edge;H zone;intermediate filament cytoskeleton;actin cytoskeleton;microtubule cytoskeleton;intermediate filament;cytoplasmic membrane-bounded vesicle;basal plasma membrane,,,,,,,,,,,,,,
3100,Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),EDVDVSSPDEKSV,_LLDPEDVDVSS(ph)PDEK_,S237,,22.15,,,,24.40,,,,24.68,25.82,,,,24.26,-2.11, , , ,0.14, , , ,0.42,1.56, , , ,hemidesmosome assembly;response to wounding;maintenance of cell polarity;cell adhesion;cell cycle arrest;cell motility;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;microtubule cytoskeleton organization,Z disc;axon part;microtubule plus end;hemidesmosome;cell cortex;integral to membrane;basement membrane;nucleus;endoplasmic reticulum membrane;axon;nuclear envelope;cell leading edge;H zone;intermediate filament cytoskeleton;actin cytoskeleton;microtubule cytoskeleton;intermediate filament;cytoplasmic membrane-bounded vesicle;basal plasma membrane,,,,,,,,,,,,,,
3101,Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),KLKRQKSFSEDVI,_(gl)QKS(ph)FSEDVISHKGDLR_,S3968,+,,,,21.33,24.67,25.43,25.58,23.71,,25.42,23.53,,25.27,24.37, , , ,-3.04,0.30,1.06,1.22,-0.66, ,1.05,-0.84, ,0.90,hemidesmosome assembly;response to wounding;maintenance of cell polarity;cell adhesion;cell cycle arrest;cell motility;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;microtubule cytoskeleton organization,Z disc;axon part;microtubule plus end;hemidesmosome;cell cortex;integral to membrane;basement membrane;nucleus;endoplasmic reticulum membrane;axon;nuclear envelope;cell leading edge;H zone;intermediate filament cytoskeleton;actin cytoskeleton;microtubule cytoskeleton;intermediate filament;cytoplasmic membrane-bounded vesicle;basal plasma membrane,,,,,,,,,,,,,,
3102,Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),KRQKSFSEDVISH,_SFS(ph)EDVISHK_,S3970,,,,,,23.66,,,24.30,26.03,,,,25.00,24.75, , , , ,-1.08, , ,-0.45,1.28, , , ,0.25,hemidesmosome assembly;response to wounding;maintenance of cell polarity;cell adhesion;cell cycle arrest;cell motility;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;microtubule cytoskeleton organization,Z disc;axon part;microtubule plus end;hemidesmosome;cell cortex;integral to membrane;basement membrane;nucleus;endoplasmic reticulum membrane;axon;nuclear envelope;cell leading edge;H zone;intermediate filament cytoskeleton;actin cytoskeleton;microtubule cytoskeleton;intermediate filament;cytoplasmic membrane-bounded vesicle;basal plasma membrane,,,,,,,,,,,,,,
3103,Q03001,DST,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),SFRKAASLSSIPS,_AAS(ph)LSSIPSGIER_,S184,,,20.44,,23.85,,,,23.27,,22.15,,,,22.43, ,-1.99, ,1.42, , , ,0.84, ,-0.28, , , ,hemidesmosome assembly;response to wounding;maintenance of cell polarity;cell adhesion;cell cycle arrest;cell motility;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;microtubule cytoskeleton organization,Z disc;axon part;microtubule plus end;hemidesmosome;cell cortex;integral to membrane;basement membrane;nucleus;endoplasmic reticulum membrane;axon;nuclear envelope;cell leading edge;H zone;intermediate filament cytoskeleton;actin cytoskeleton;microtubule cytoskeleton;intermediate filament;cytoplasmic membrane-bounded vesicle;basal plasma membrane,,,,,,,,,,,,,,
3104,Q03060,CREM,cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER),GVVMAASPGSLHS,_APTAALPQGVVM(ox)AAS(ph)PGSLHSPQQLAEEATR_,S163,,,,,,22.91,23.16,23.27,23.54,23.44,,,23.31,,23.27, , , , ,-0.36,-0.11,0.00,0.27,0.17, , ,0.04, ,"retinoic acid receptor signaling pathway;multicellular organismal development;cell differentiation;regulation of circadian rhythm;regulation of transcription, DNA-dependent;spermatogenesis;signal transduction;fatty acid metabolic process;transcription, DNA-dependent;glucose metabolic process;glycosphingolipid metabolic process",transcription factor complex;nucleus,bZIP,,,,,,,,,,,,,
3106,Q03060,CREM,cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER),KILNELSSDVPGV,_ILNELS(ph)SDVPGVPK_,S96,,23.85,23.08,23.08,21.79,,,22.71,,,,,,,22.91,0.95,0.18,0.18,-1.11, , ,-0.19, , , , , , ,"retinoic acid receptor signaling pathway;multicellular organismal development;cell differentiation;regulation of circadian rhythm;regulation of transcription, DNA-dependent;spermatogenesis;signal transduction;fatty acid metabolic process;transcription, DNA-dependent;glucose metabolic process;glycosphingolipid metabolic process",transcription factor complex;nucleus,bZIP,,,,,,,,,,,,,
3108,Q03111,MLLT1,Protein ENL (YEATS domain-containing protein 1),ALEVEESNSEDEA,_ALEVEES(ph)NSEDEASFK_,S359,,21.72,,,,,23.19,23.04,22.56,,23.58,21.88,,,22.66,-0.94, , , , ,0.53,0.38,-0.10, ,0.91,-0.78, , ,"negative regulation of protein kinase activity;regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",nucleolus;cytoplasm,,,,,,,,,,,,,,
3112,Q03111,MLLT1,Protein ENL (YEATS domain-containing protein 1),RPATADSPKPSAK,_RPATADS(ph)PKPSAK_,S292,+,21.28,21.63,22.53,19.06,,,,18.32,,,18.23,17.59,,19.80,1.48,1.83,2.72,-0.75, , , ,-1.49, , ,-1.58,-2.22, ,"negative regulation of protein kinase activity;regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",nucleolus;cytoplasm,,,,,,,,,,,,,,
3115,Q03112,MECOM,MDS1 and EVI1 complex locus protein EVI1 (Ecotropic virus integration site 1 protein homolog) (EVI-1),SNHGSQSPRNVEE,_NFIGNSNHGSQS(ph)PR_,S851,+,24.33,24.76,,,23.78,23.16,,23.09,22.23,,23.03,,,23.48,0.85,1.28, , ,0.30,-0.32, ,-0.40,-1.25, ,-0.46, , ,"cell differentiation;inflammatory response;response to external stimulus;negative regulation of transcription, DNA-dependent;pericardium development;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;hematopoietic stem cell proliferation;renal system development;forebrain development;apoptotic process;positive regulation of transcription from RNA polymerase II promoter;regulation of cell cycle;post-embryonic development;in utero embryonic development;regulation of cell proliferation;negative regulation of programmed cell death;negative regulation of JNK cascade;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;response to bacterium;neutrophil homeostasis",nuclear speck,C2H2-type,,,,,,,,,,,,,
3116,Q03112,MECOM,MDS1 and EVI1 complex locus protein EVI1 (Ecotropic virus integration site 1 protein homolog) (EVI-1),QTNKSQSPLMTHP,_SQS(ph)PLM(ox)THPQILPATQDILK_,S338,,22.48,21.92,21.92,,,,,,,23.54,,,,22.47,0.01,-0.54,-0.54, , , , , , ,1.07, , , ,"cell differentiation;inflammatory response;response to external stimulus;negative regulation of transcription, DNA-dependent;pericardium development;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;hematopoietic stem cell proliferation;renal system development;forebrain development;apoptotic process;positive regulation of transcription from RNA polymerase II promoter;regulation of cell cycle;post-embryonic development;in utero embryonic development;regulation of cell proliferation;negative regulation of programmed cell death;negative regulation of JNK cascade;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;response to bacterium;neutrophil homeostasis",nuclear speck,C2H2-type,,,,,,,,,,,,,
3117,Q03135,CAV1,Caveolin-1,AMADELSEKQVYD,_AM(ox)ADELS(ph)EKQVYDAHTK_,S37,+,21.07,27.87,25.16,30.30,27.78,27.60,26.09,27.46,28.66,26.91,25.56,24.10,25.86,26.49,-5.43,1.37,-1.34,3.80,1.29,1.11,-0.41,0.97,2.17,0.41,-0.93,-2.39,-0.63,vesicle organization;apoptotic signaling pathway;response to estrogen stimulus;negative regulation of endothelial cell proliferation;caveolin-mediated endocytosis;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;positive regulation of metalloenzyme activity;nitric oxide homeostasis;positive regulation of endocytosis;vasoconstriction;negative regulation of protein binding;positive regulation of canonical Wnt receptor signaling pathway;negative regulation of JAK-STAT cascade;membrane depolarization;mammary gland involution;response to drug;cytosolic calcium ion homeostasis;lipid storage;negative regulation of tyrosine phosphorylation of Stat5 protein;skeletal muscle tissue development;negative regulation of anoikis;negative regulation of epithelial cell differentiation;small molecule metabolic process;caveola assembly;negative regulation of transcription from RNA polymerase II promoter;protein homooligomerization;maintenance of protein location in cell;leukocyte migration;MAPK cascade;negative regulation of cytokine-mediated signaling pathway;negative regulation of peptidyl-serine phosphorylation;nitric oxide metabolic process;negative regulation of protein ubiquitination;response to mechanical stimulus;positive regulation of vasoconstriction;cellular response to hyperoxia;negative regulation of nitric oxide biosynthetic process;cholesterol efflux;response to calcium ion;vasculogenesis;positive regulation of microtubule polymerization;inactivation of MAPK activity;positive regulation of intrinsic apoptotic signaling pathway;triglyceride metabolic process;positive regulation of calcium ion transport into cytosol;negative regulation of BMP signaling pathway;positive regulation of peptidyl-serine phosphorylation;regulation of nitric-oxide synthase activity;negative regulation of canonical Wnt receptor signaling pathway;calcium ion transport;T cell costimulation;cholesterol homeostasis;blood coagulation;regulation of blood coagulation;cholesterol transport;response to nutrient;virus-host interaction;cellular response to starvation;response to progesterone stimulus;microtubule polymerization;response to hypoxia;regulation of fatty acid metabolic process;response to glucocorticoid stimulus;receptor internalization involved in canonical Wnt receptor signaling pathway;regulation of smooth muscle contraction;lactation,mitochondrion;basolateral plasma membrane;flagellum;Golgi membrane;caveola;cell cortex;focal adhesion;endocytic vesicle membrane;integral to plasma membrane;acrosomal membrane;endosome;apical plasma membrane;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;lipid particle;cell surface;basal plasma membrane,,,,,,,,,,,,,,
3118,Q03135,CAV1,Caveolin-1,_____MSGGKYVD,_(ac)S(ph)GGKYVDSEGHLYTVPIR_,S2,,,,,,25.26,23.15,,24.38,,,,,,24.26, , , , ,1.00,-1.12, ,0.12, , , , , ,vesicle organization;apoptotic signaling pathway;response to estrogen stimulus;negative regulation of endothelial cell proliferation;caveolin-mediated endocytosis;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;positive regulation of metalloenzyme activity;nitric oxide homeostasis;positive regulation of endocytosis;vasoconstriction;negative regulation of protein binding;positive regulation of canonical Wnt receptor signaling pathway;negative regulation of JAK-STAT cascade;membrane depolarization;mammary gland involution;response to drug;cytosolic calcium ion homeostasis;lipid storage;negative regulation of tyrosine phosphorylation of Stat5 protein;skeletal muscle tissue development;negative regulation of anoikis;negative regulation of epithelial cell differentiation;small molecule metabolic process;caveola assembly;negative regulation of transcription from RNA polymerase II promoter;protein homooligomerization;maintenance of protein location in cell;leukocyte migration;MAPK cascade;negative regulation of cytokine-mediated signaling pathway;negative regulation of peptidyl-serine phosphorylation;nitric oxide metabolic process;negative regulation of protein ubiquitination;response to mechanical stimulus;positive regulation of vasoconstriction;cellular response to hyperoxia;negative regulation of nitric oxide biosynthetic process;cholesterol efflux;response to calcium ion;vasculogenesis;positive regulation of microtubule polymerization;inactivation of MAPK activity;positive regulation of intrinsic apoptotic signaling pathway;triglyceride metabolic process;positive regulation of calcium ion transport into cytosol;negative regulation of BMP signaling pathway;positive regulation of peptidyl-serine phosphorylation;regulation of nitric-oxide synthase activity;negative regulation of canonical Wnt receptor signaling pathway;calcium ion transport;T cell costimulation;cholesterol homeostasis;blood coagulation;regulation of blood coagulation;cholesterol transport;response to nutrient;virus-host interaction;cellular response to starvation;response to progesterone stimulus;microtubule polymerization;response to hypoxia;regulation of fatty acid metabolic process;response to glucocorticoid stimulus;receptor internalization involved in canonical Wnt receptor signaling pathway;regulation of smooth muscle contraction;lactation,mitochondrion;basolateral plasma membrane;flagellum;Golgi membrane;caveola;cell cortex;focal adhesion;endocytic vesicle membrane;integral to plasma membrane;acrosomal membrane;endosome;apical plasma membrane;endoplasmic reticulum;protein complex;perinuclear region of cytoplasm;cytosol;lipid particle;cell surface;basal plasma membrane,,,,,,,,,,,,,,
3120,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],VQASPTSPGGSPS,_ALSSAVQASPTS(ph)PGGSPSS(ph)PSSGQR_,S3473,,24.70,,,22.49,,,,,,,,,,23.60,1.11, , ,-1.11, , , , , , , , , ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3122,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],GPGEPDSPTPLHP,_GPGEPDS(ph)PTPLHPPT(ph)PPILSTDR_,S1799,+,24.96,22.79,22.79,22.48,24.20,23.95,23.97,,24.24,23.73,23.36,,24.38,23.71,1.25,-0.92,-0.92,-1.24,0.49,0.23,0.25, ,0.52,0.01,-0.35, ,0.67,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3123,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],GLQVPVSPTVPIQ,_NSSTPGLQVPVS(ph)PTVPIQNQK_,S2998,+,24.30,21.62,20.55,22.56,25.34,,23.04,24.47,24.78,24.57,,22.30,23.71,23.38,0.92,-1.77,-2.84,-0.82,1.95, ,-0.35,1.08,1.40,1.18, ,-1.09,0.32,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3124,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],TVEEEESNFSSPL,_TVEEEES(ph)NFS(ph)S(ph)PLMLWLQQEQK_,S3602,,,,,,22.33,,,23.25,,,,,,22.79, , , , ,-0.46, , ,0.46, , , , , ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3125,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],EEESNFSSPLMLW,_TVEEEES(ph)NFS(ph)S(ph)PLMLWLQQEQK_,S3605,,,,,,22.33,,,23.25,,,,,,22.79, , , , ,-0.46, , ,0.46, , , , , ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3126,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],EESNFSSPLMLWL,_TVEEEES(ph)NFS(ph)S(ph)PLMLWLQQEQK_,S3606,,,,,,22.33,,,23.25,,,,,,22.79, , , , ,-0.46, , ,0.46, , , , , ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
3128,Q03169,TNFAIP2,Tumor necrosis factor alpha-induced protein 2 (TNF alpha-induced protein 2) (Primary response gene B94 protein),__MSEASSEDLVP,_(ac)SEAS(ph)SEDLVPPLEAGAAPYREEEEAAK_,S5,,23.44,,,,,,,,22.10,25.35,,,24.34,23.81,-0.37, , , , , , , ,-1.71,1.54, , ,0.53,cell differentiation;angiogenesis,extracellular space,,,,,,,,,,,,,,
3129,Q03169,TNFAIP2,Tumor necrosis factor alpha-induced protein 2 (TNF alpha-induced protein 2) (Primary response gene B94 protein),EVKRIRSILDVSM,_S(ph)ILDVSM(ox)GAQEPSRPLFSLIK_,S632,,22.28,,,,,,,,,,,,,22.28,0.00, , , , , , , , , , , , ,cell differentiation;angiogenesis,extracellular space,,,,,,,,,,,,,,
3130,Q03188,CENPC,Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7),EIDNKVSDEEDKT,_KIEIDNKVS(ph)DEEDK_,S132,+,,23.70,23.72,24.12,21.29,23.30,25.22,22.62,25.71,,,23.65,22.77,23.61, ,0.09,0.11,0.51,-2.32,-0.31,1.61,-0.99,2.10, , ,0.04,-0.84,mitotic prometaphase;kinetochore assembly;chromosome segregation;cell division,"cytosol;condensed nuclear chromosome, centromeric region;condensed chromosome kinetochore;kinetochore;centromeric heterochromatin",,,,,,,,,,,,,,
3131,Q03188,CENPC,Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7),VVKSEESPVYSNS,_SEES(ph)PVYSNSSVR_,S445,,21.62,,,,23.63,23.40,,24.30,,,,22.32,,23.05,-1.44, , , ,0.58,0.35, ,1.24, , , ,-0.73, ,mitotic prometaphase;kinetochore assembly;chromosome segregation;cell division,"cytosol;condensed nuclear chromosome, centromeric region;condensed chromosome kinetochore;kinetochore;centromeric heterochromatin",,,,,,,,,,,,,,
3132,Q03252,LMNB2,Lamin-B2,GPATPLSPTRLSR,_AGGPATPLS(ph)PTR_,S17,+,26.42,25.49,24.63,25.02,26.63,25.45,25.58,25.66,24.85,23.36,24.65,23.31,25.84,25.15,1.28,0.34,-0.51,-0.13,1.49,0.30,0.44,0.52,-0.30,-1.78,-0.50,-1.84,0.69,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
3133,Q03252,LMNB2,Lamin-B2,VSRATSSSSGSLS,_ATSS(ph)SSGSLSATGR_,S400,+,,,,26.36,26.40,25.49,25.09,25.14,26.57,25.79,23.21,,24.26,25.37, , , ,0.99,1.03,0.12,-0.27,-0.23,1.20,0.43,-2.16, ,-1.11,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
3135,Q03252,LMNB2,Lamin-B2,TSSSSGSLSATGR,_ATSSSSGS(ph)LSATGR_,S404,+,24.17,,,23.80,24.22,,23.58,,25.27,24.09,23.19,22.88,22.64,23.76,0.41, , ,0.04,0.46, ,-0.19, ,1.51,0.33,-0.57,-0.88,-1.12,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
3136,Q03393,PTS,6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12),QVSRRISFSASHR,_RIS(ph)FSASHR_,S19,+,,,,,21.80,20.54,21.63,23.20,19.27,19.48,22.16,22.19,20.02,21.14, , , , ,0.65,-0.61,0.49,2.06,-1.87,-1.67,1.02,1.05,-1.13,regulation of nitric-oxide synthase activity;central nervous system development;tetrahydrobiopterin biosynthetic process;nitric oxide metabolic process;cellular amino acid metabolic process,cytosol;mitochondrion,,,,,,,,,,,,,,
3137,Q03701,CEBPZ,CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor),LDDHPESDDEENF,_SQLDDHPES(ph)DDEENFIDANDDEDM(ox)EK_,S629,+,27.46,,,21.91,26.23,25.96,27.10,24.78,28.75,28.82,25.89,27.00,26.34,26.39,1.08, , ,-4.48,-0.15,-0.43,0.72,-1.61,2.36,2.44,-0.50,0.61,-0.05,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter",nucleus,,,,,,,,,,,,,,
3138,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),PLKAALSEEELEK,_AALS(ph)EEELEKK_,S1198,+,26.14,25.18,24.46,24.83,23.23,24.74,24.28,25.03,23.27,24.47,24.04,24.58,,24.52,1.62,0.66,-0.06,0.31,-1.29,0.22,-0.24,0.51,-1.25,-0.05,-0.48,0.05, ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3140,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),AALPPVSPLKAAL,_REAALPPVS(ph)PLK_,S1191,+,28.10,26.81,27.07,27.23,29.11,27.32,28.34,29.21,27.12,27.66,28.35,26.01,28.64,27.77,0.33,-0.96,-0.70,-0.54,1.34,-0.44,0.57,1.45,-0.65,-0.11,0.58,-1.75,0.87,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3141,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),APGGRLSWGKGSS,_ITKPGSIDSNNQLFAPGGRLS(ph)WGK_,S1052,,23.98,,,,24.09,,23.07,,,23.65,,,,23.70,0.28, , , ,0.39, ,-0.63, , ,-0.05, , , ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3142,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),TPATKRSFSKEVE,_S(ph)FSKEVEER_,S1145,,,25.19,25.19,,29.16,22.57,,,,,,,,25.53, ,-0.34,-0.34, ,3.63,-2.96, , , , , , , ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3143,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),ATKRSFSKEVEER,_SFS(ph)KEVEER_,S1147,,,25.50,25.50,,28.25,,22.02,26.70,,,,,,25.60, ,-0.09,-0.09, ,2.66, ,-3.58,1.10, , , , , ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3147,Q04637,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),QLMAKGSDKRRGG,_VQQLM(ox)AKGS(ph)DK_,S988,+,24.35,23.47,23.47,25.63,,,20.16,,,20.12,,24.16,,23.05,1.30,0.42,0.42,2.58, , ,-2.89, , ,-2.93, ,1.11, ,"insulin receptor signaling pathway;cell death;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;nuclear-transcribed mRNA poly(A) tail shortening;cytokine-mediated signaling pathway;virus-host interaction",cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
3149,Q04695,KRT17,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",GGLGAGSCRLGSA,_LSGGLGAGS(ph)CR_,S39,,26.16,23.75,23.75,,,,,,,,,,,24.55,1.61,-0.80,-0.80, , , , , , , , , , ,positive regulation of hair follicle development;positive regulation of translation;positive regulation of cell growth;intermediate filament organization;keratinization;morphogenesis of an epithelium;epidermis development,cell periphery;intermediate filament;cytoplasm,,,,,,,,,,,,,,
3152,Q04695,KRT17,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",QFTSSSSIKGSSG,_(ac)TTSIRQFTSSSS(ph)IK_,S13,,31.07,30.87,31.87,21.99,,,,,,23.54,,,,27.87,3.20,3.01,4.00,-5.88, , , , , ,-4.33, , , ,positive regulation of hair follicle development;positive regulation of translation;positive regulation of cell growth;intermediate filament organization;keratinization;morphogenesis of an epithelium;epidermis development,cell periphery;intermediate filament;cytoplasm,,,,,,,,,,,,,,
3154,Q04724,TLE1,Transducin-like enhancer protein 1 (E(Sp1) homolog) (Enhancer of split groucho-like protein 1) (ESG1),KKDASSSPASTAS,_DASSS(ph)PASTASSASSTSLK_,S212,+,24.27,,,23.39,24.43,24.16,24.49,24.46,25.32,25.84,22.30,,,24.30,-0.03, , ,-0.90,0.13,-0.13,0.20,0.16,1.03,1.54,-1.99, , ,Notch signaling pathway;positive regulation of gene expression;Wnt receptor signaling pathway;organ morphogenesis;negative regulation of Wnt receptor signaling pathway;negative regulation of anoikis;negative regulation of I-kappaB kinase/NF-kappaB cascade,nucleoplasm;cytosol;transcription factor complex,,,,,,,,,,,,,,
3155,Q04726,TLE3,Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3),KKDAPTSPASVAS,_DAPTS(ph)PASVASSSSTPSSK_,S230,+,26.65,26.61,27.10,26.43,25.99,26.29,26.23,26.23,25.55,25.05,25.63,26.08,25.45,26.10,0.55,0.51,1.00,0.33,-0.11,0.19,0.13,0.13,-0.55,-1.05,-0.47,-0.02,-0.65,"Notch signaling pathway;Wnt receptor signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;organ morphogenesis",nucleoplasm,,,,,,,,,,,,,,
3156,Q04726,TLE3,Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3),SLSRYDSDGDKSD,_DSLSRYDS(ph)DGDK_,S184,,24.33,27.62,28.56,25.62,,,,,,21.37,,,,25.50,-1.17,2.12,3.06,0.12, , , , , ,-4.13, , , ,"Notch signaling pathway;Wnt receptor signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;organ morphogenesis",nucleoplasm,,,,,,,,,,,,,,
3158,Q04726,TLE3,Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3),SANNSVSPSESLR,_ESSANNSVS(ph)PSESLRASEK_,S147,+,26.48,25.93,25.26,26.55,26.89,26.87,25.84,26.89,26.43,25.36,24.44,25.67,25.43,26.00,0.48,-0.07,-0.75,0.55,0.88,0.87,-0.16,0.88,0.42,-0.64,-1.57,-0.33,-0.58,"Notch signaling pathway;Wnt receptor signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;organ morphogenesis",nucleoplasm,,,,,,,,,,,,,,
3159,Q04727,TLE4,Transducin-like enhancer protein 4,KKDAPISPASIAS,_DAPIS(ph)PASIASSSSTPSSK_,S267,+,,23.33,24.21,23.25,23.07,,23.35,23.72,24.14,23.64,22.73,,,23.49, ,-0.17,0.72,-0.24,-0.42, ,-0.14,0.22,0.65,0.15,-0.76, , ,Notch signaling pathway;negative regulation of transcription from RNA polymerase II promoter;Wnt receptor signaling pathway,nucleoplasm,,,,,,,,,,,,,,
3162,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),VDVSEDSPPPLPE,_DVDVSEDS(ph)PPPLPER_,S673,+,25.97,24.21,20.44,24.96,24.01,,25.68,24.64,24.76,,26.83,26.11,24.83,24.77,1.20,-0.56,-4.33,0.20,-0.76, ,0.92,-0.13,-0.01, ,2.06,1.34,0.06,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3163,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),TVSLTPSPTTQVE,_TVSLTPS(ph)PTTQVETPDLVDHDNTSPLFR_,S571,,25.62,,,,,,,,,,,,,25.62,0.00, , , , , , , , , , , , ,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3165,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),KLERNLSFEIKKV,_NLS(ph)FEIKKVPLQEGPK_,S435,+,26.60,26.11,25.81,26.43,25.67,25.11,26.81,26.41,25.51,25.24,25.43,27.55,25.04,25.98,0.62,0.13,-0.16,0.45,-0.31,-0.87,0.84,0.43,-0.47,-0.74,-0.55,1.57,-0.94,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3166,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),EPEKQDSPPPKPP,_(gl)QDS(ph)PPPKPPR_,S332,+,24.01,25.60,24.59,26.27,21.20,,25.45,,,23.72,23.53,24.30,,24.30,-0.29,1.31,0.29,1.98,-3.10, ,1.15, , ,-0.58,-0.77,0.00, ,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3167,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),LQEGPKSFDGNTL,_S(ph)FDGNTLLNR_,S449,,23.96,21.32,,22.91,,,,,,,,,,22.73,1.23,-1.41, ,0.18, , , , , , , , , ,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3168,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),FTNPLHSDDSDSD,_TPLSFTNPLHS(ph)DDS(ph)DSDERNSDGAVTQNK_,S603,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3169,Q05209,PTPN12,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),PLHSDDSDSDERN,_TPLSFTNPLHS(ph)DDS(ph)DSDERNSDGAVTQNK_,S606,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,,cytosol;podosome;cell junction;plasma membrane;cell projection;cytoplasm,,,+,,,,,,,+,,,,
3172,Q05397,PTK2,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),LGDFGLSRYIEDE,_LGDFGLS(ph)R_,S568,,21.15,,,,,,,,,,,,,21.15,0.00, , , , , , , , , , , , ,neuron migration;signal complex assembly;regulation of endothelial cell migration;negative regulation of synapse assembly;placenta development;regulation of focal adhesion assembly;peptidyl-tyrosine phosphorylation;integrin-mediated signaling pathway;regulation of Rho GTPase activity;netrin-activated signaling pathway;negative regulation of axonogenesis;regulation of cell shape;vasculogenesis;platelet activation;regulation of osteoblast differentiation;regulation of cytoskeleton organization;establishment of nucleus localization;ephrin receptor signaling pathway;central nervous system neuron axonogenesis;heart morphogenesis;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;negative regulation of cell-cell adhesion;protein autophosphorylation;cellular component disassembly involved in execution phase of apoptosis;embryo development;endothelial cell migration;growth hormone receptor signaling pathway;positive regulation of cell migration;cell motility;establishment of cell polarity;positive regulation of cell proliferation;positive regulation of phosphatidylinositol 3-kinase activity;microtubule cytoskeleton organization;negative regulation of anoikis;negative regulation of organ growth;angiogenesis;positive regulation of protein kinase B signaling cascade;regulation of cell adhesion mediated by integrin;extracellular matrix organization;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of protein kinase activity,apical plasma membrane;microtubule organizing center;cell cortex;cytosol;cytoskeleton;focal adhesion;nucleus;lamellipodium,,+,,,,,,,,+,,,,
3173,Q05397,PTK2,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),LQPQEISPPPTAN,_LQPQEIS(ph)PPPTANLDR_,S864,+,26.36,24.75,25.34,24.63,25.24,24.73,26.73,27.01,25.36,26.14,26.87,25.27,25.88,25.72,0.65,-0.96,-0.37,-1.09,-0.48,-0.99,1.01,1.29,-0.36,0.42,1.16,-0.44,0.16,neuron migration;signal complex assembly;regulation of endothelial cell migration;negative regulation of synapse assembly;placenta development;regulation of focal adhesion assembly;peptidyl-tyrosine phosphorylation;integrin-mediated signaling pathway;regulation of Rho GTPase activity;netrin-activated signaling pathway;negative regulation of axonogenesis;regulation of cell shape;vasculogenesis;platelet activation;regulation of osteoblast differentiation;regulation of cytoskeleton organization;establishment of nucleus localization;ephrin receptor signaling pathway;central nervous system neuron axonogenesis;heart morphogenesis;positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process;negative regulation of cell-cell adhesion;protein autophosphorylation;cellular component disassembly involved in execution phase of apoptosis;embryo development;endothelial cell migration;growth hormone receptor signaling pathway;positive regulation of cell migration;cell motility;establishment of cell polarity;positive regulation of cell proliferation;positive regulation of phosphatidylinositol 3-kinase activity;microtubule cytoskeleton organization;negative regulation of anoikis;negative regulation of organ growth;angiogenesis;positive regulation of protein kinase B signaling cascade;regulation of cell adhesion mediated by integrin;extracellular matrix organization;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of protein kinase activity,apical plasma membrane;microtubule organizing center;cell cortex;cytosol;cytoskeleton;focal adhesion;nucleus;lamellipodium,,+,,,,,,,,+,,,,
3174,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",EEQGYDSEKEKKE,_(gl)QVTRDYDEEEQGYDS(ph)EK_,S434,+,29.17,28.56,28.51,28.62,26.81,29.17,28.69,28.69,29.54,29.64,27.40,28.28,27.98,28.54,0.62,0.02,-0.03,0.07,-1.73,0.62,0.15,0.15,1.00,1.10,-1.15,-0.26,-0.56,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
3175,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",EKGTGDSLRESKV,_GTGDS(ph)LRESK_,S463,,21.83,22.59,,22.83,,,19.19,,19.99,,,,,21.29,0.54,1.31, ,1.54, , ,-2.09, ,-1.30, , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
3177,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",VAAGLVSPSLKSD,_LNHVAAGLVS(ph)PSLK_,S207,+,26.27,25.36,26.09,24.07,23.17,25.97,26.02,24.88,26.37,26.70,26.09,25.49,26.09,25.58,0.69,-0.22,0.51,-1.51,-2.42,0.39,0.44,-0.70,0.79,1.12,0.51,-0.09,0.51,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
3179,Q05519,SRSF11,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",EEQGYDSEKEKKE,_VTRDYDEEEQGYDS(ph)EK_,S433,+,29.36,29.00,29.21,28.94,26.85,29.61,29.38,28.92,30.16,29.87,28.37,28.75,28.61,29.00,0.35,0.00,0.20,-0.07,-2.15,0.61,0.37,-0.08,1.16,0.87,-0.63,-0.26,-0.39,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
3182,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],ENIFGESRASTFC,_ENIFGES(ph)R_,S503,,22.91,,,,,,,22.57,,,,21.32,21.45,22.06,0.84, , , , , , ,0.51, , , ,-0.74,-0.61,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
3183,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],QVTQRASRRSDSA,_LLAEALNQVTQRAS(ph)R_,S299,+,25.13,,,22.13,25.90,22.94,24.12,24.32,23.24,,23.05,25.46,23.85,24.01,1.11, , ,-1.89,1.89,-1.07,0.10,0.30,-0.77, ,-0.96,1.45,-0.17,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
3184,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],SAFAGFSFVNPKF,_NLIDSM(ox)DQSAFAGFS(ph)FVNPK_,S664,+,27.59,26.54,27.24,22.87,23.39,24.56,26.80,27.15,27.83,26.39,26.90,25.63,27.83,26.21,1.38,0.33,1.04,-3.34,-2.82,-1.65,0.59,0.94,1.62,0.18,0.69,-0.58,1.62,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
3186,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],ASRRSDSASSEPV,_SDS(ph)ASSEPVGIYQGFEK_,S304,+,26.26,24.02,24.88,23.44,26.53,22.53,25.25,24.74,25.11,24.97,26.07,25.30,24.36,24.88,1.38,-0.86,-0.01,-1.44,1.65,-2.35,0.37,-0.14,0.23,0.09,1.19,0.41,-0.52,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
3188,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],RSDSASSEPVGIY,_RSDS(ph)ASS(ph)EPVGIYQGFEK_,S307,,22.46,,,23.04,,,,,,,,,,22.75,-0.29, , ,0.29, , , , , , , , , ,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
3189,Q05682,CALD1,Caldesmon (CDM),SVDKVTSPTKV__,_VTS(ph)PTKV_,S534,+,23.56,24.96,25.88,26.83,29.23,27.85,,29.14,24.46,23.49,23.16,23.91,27.86,25.86,-2.30,-0.90,0.02,0.97,3.37,1.99, ,3.28,-1.41,-2.37,-2.70,-1.95,2.00,actin filament bundle assembly;muscle contraction;positive regulation of protein binding;cellular component movement,neuronal cell body;postsynaptic density;actin cytoskeleton;cytosol;actin filament;myofibril;actin cap;plasma membrane,,,,,,,,,,,,,,
3191,Q05682,CALD1,Caldesmon (CDM),EKPKRGSIGENQI,_RGS(ph)IGENQIKDEK_,S202,,29.08,31.15,30.57,31.86,28.65,28.90,29.51,28.77,30.40,28.90,29.70,31.23,28.17,29.76,-0.68,1.39,0.81,2.10,-1.11,-0.86,-0.25,-0.99,0.64,-0.86,-0.06,1.47,-1.59,actin filament bundle assembly;muscle contraction;positive regulation of protein binding;cellular component movement,neuronal cell body;postsynaptic density;actin cytoskeleton;cytosol;actin filament;myofibril;actin cap;plasma membrane,,,,,,,,,,,,,,
3192,Q06187,BTK,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),RGSKKGSIDVEKI,_KGS(ph)IDVEK_,S55,,,23.70,24.42,25.73,,,,,,,,,,24.62, ,-0.92,-0.20,1.12, , , , , , , , , ,"B cell activation;toll-like receptor 4 signaling pathway;apoptotic signaling pathway;regulation of B cell cytokine production;cell maturation;positive regulation of NF-kappaB transcription factor activity;positive regulation of B cell differentiation;Toll signaling pathway;peptidyl-tyrosine phosphorylation;regulation of B cell apoptotic process;toll-like receptor 2 signaling pathway;adaptive immune response;MyD88-dependent toll-like receptor signaling pathway;mesoderm development;calcium-mediated signaling;I-kappaB kinase/NF-kappaB cascade;innate immune response;B cell receptor signaling pathway;transcription, DNA-dependent;toll-like receptor 1 signaling pathway",cytosol;cytoplasmic vesicle;membrane raft;plasma membrane;nucleus,,+,,,,,,,,,,,,
3194,Q06210,GFPT1,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),NLSRVDSTTCLFP,_VDS(ph)TTCLFPVEEK_,S243,+,29.23,27.13,25.25,27.76,25.26,25.41,26.13,26.46,25.77,,26.19,26.63,,26.47,2.75,0.65,-1.22,1.28,-1.22,-1.07,-0.35,-0.01,-0.70, ,-0.29,0.16, ,protein homotetramerization;glutamine metabolic process;energy reserve metabolic process;response to sucrose stimulus;post-translational protein modification;dolichol-linked oligosaccharide biosynthetic process;fructose 6-phosphate metabolic process;negative regulation of glycogen biosynthetic process;carbohydrate biosynthetic process;glucosamine biosynthetic process;UDP-N-acetylglucosamine biosynthetic process;activation of signaling protein activity involved in unfolded protein response;cellular response to insulin stimulus;protein N-linked glycosylation via asparagine,cytosol,,,,,,,,,,,,,,
3195,Q06265,EXOSC9,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),KAPIDTSDVEEKA,_APIDTS(ph)DVEEK_,S222,+,27.93,27.70,28.34,28.73,26.17,27.73,29.20,27.02,29.14,28.73,27.41,28.68,27.23,28.00,-0.07,-0.30,0.34,0.73,-1.83,-0.27,1.20,-0.98,1.14,0.73,-0.59,0.68,-0.77,nuclear mRNA surveillance;immune response;positive regulation of cell growth;nuclear polyadenylation-dependent rRNA catabolic process;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;rRNA processing,cytosol;nucleolus;nucleus;nuclear exosome (RNase complex),,,,,,,,,,,,,,
3196,Q06330,RBPJ,Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30),PPAHAPSPGKFGE,_(ac)M(ox)DHTEGSPAEEPPAHAPS(ph)PGK_,S18,,22.52,23.47,23.48,,,,,,,,,,,23.16,-0.63,0.31,0.32, , , , , , , , , , ,positive regulation of BMP signaling pathway;positive regulation of cardiac muscle cell proliferation;negative regulation of ossification;epithelial to mesenchymal transition involved in endocardial cushion formation;blood vessel lumenization;positive regulation of cell proliferation involved in heart morphogenesis;outflow tract morphogenesis;dorsal aorta morphogenesis;regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation;cardiac left ventricle morphogenesis;ventricular trabecula myocardium morphogenesis;positive regulation of ERBB signaling pathway;positive regulation of transcription of Notch receptor target;transcription initiation from RNA polymerase II promoter;atrioventricular canal development;labyrinthine layer blood vessel development;angiogenesis;endocardium morphogenesis;positive regulation of ephrin receptor signaling pathway;blood vessel endothelial cell fate specification;negative regulation of transcription from RNA polymerase II promoter;Notch signaling involved in heart development,nucleoplasm;nucleolus;MAML1-RBP-Jkappa- ICN1 complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
3197,Q06418,TYRO3,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF),FGQAFDSVMARGE,_FGQAFDS(ph)VM(ox)AR_,S94,,19.07,,,20.59,21.08,,23.38,22.44,,,22.67,24.79,,22.00,-2.93, , ,-1.41,-0.92, ,1.37,0.43, , ,0.67,2.79, ,negative regulation of innate immune response;protein autophosphorylation;platelet aggregation;negative regulation of toll-like receptor signaling pathway;apoptotic cell clearance;spermatogenesis;forebrain cell migration;vagina development;substrate adhesion-dependent cell spreading;negative regulation of lymphocyte activation;phosphatidylinositol 3-kinase cascade;ovulation cycle;natural killer cell differentiation;negative regulation of inflammatory response;secretion by cell;protein kinase B signaling cascade;neuron homeostasis;negative regulation of neuron apoptotic process,nuclear envelope;integral to plasma membrane;endoplasmic reticulum membrane,,+,,,,,,,,,,,,
3198,Q06455,RUNX1T1,Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2),SHSRQQSPVNPDP,_(gl)QQS(ph)PVNPDPVALDAHR_,S380,,22.65,,,22.81,,,,,,,,,,22.73,-0.08, , ,0.08, , , , , , , , , ,"generation of precursor metabolites and energy;transcription, DNA-dependent",nuclear matrix,Other TF domain,,,,,,,,,,,,,
3199,Q06546,GABPA,GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60),QRAPRISGEDRSS,_APRIS(ph)GEDR_,S303,,24.29,21.93,,22.30,,,,,,19.59,,19.95,,21.61,2.68,0.32, ,0.69, , , , , ,-2.02, ,-1.67, ,negative regulation of transcription from RNA polymerase II promoter;in utero embryonic development,nuclear chromatin,Other TF domain,,,,,,,,,,,,,
3201,Q06710,PAX8,Paired box protein Pax-8,VVADPHSPFAIKQ,_NLST(ph)HQTYPVVADPHS(ph)PFAIK_,S303,,23.29,,,,,,,,,,,,,23.29,0.00, , , , , , , , , , , , ,"metanephric nephron tubule formation;mesonephric tubule development;otic vesicle development;pronephric field specification;regulation of thyroid-stimulating hormone secretion;positive regulation of thyroid hormone generation;mesenchymal to epithelial transition involved in metanephros morphogenesis;thyroid gland development;positive regulation of branching involved in ureteric bud morphogenesis;inner ear morphogenesis;positive regulation of transcription from RNA polymerase II promoter;negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;metanephric distal convoluted tubule development;negative regulation of apoptotic process involved in metanephric nephron tubule development;metanephric comma-shaped body morphogenesis;metanephric S-shaped body morphogenesis;branching involved in ureteric bud morphogenesis;regulation of metanephric nephron tubule epithelial cell differentiation;positive regulation of transcription, DNA-dependent;positive regulation of metanephric DCT cell differentiation;central nervous system development;cellular response to gonadotropin stimulus;negative regulation of apoptotic process involved in metanephric collecting duct development;transcription, DNA-dependent;positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;mesonephros development",nucleoplasm,Other TF domain,,,,,,,,,,,,,
3202,Q07002,CDK18,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),QKLQMESPDLPKP,_LQM(ox)ES(ph)PDLPKPLSR_,S79,+,21.29,23.07,22.37,,,,22.77,23.77,,,22.69,24.24,23.38,22.95,-1.65,0.12,-0.58, , , ,-0.17,0.82, , ,-0.26,1.29,0.43,cell cycle,,,+,,,,,,,,,,,,
3203,Q07002,CDK18,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),RMSRRASLSDIGF,_RAS(ph)LSDIGFGK_,S94,+,25.11,26.06,25.33,24.93,24.93,26.50,27.74,25.40,24.38,23.38,28.05,29.30,25.74,25.91,-0.80,0.15,-0.58,-0.98,-0.98,0.59,1.83,-0.51,-1.53,-2.53,2.13,3.39,-0.17,cell cycle,,,+,,,,,,,,,,,,
3204,Q07002,CDK18,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),QNQRRFSMEDVSK,_RFS(ph)M(ox)EDVSK_,S51,+,26.13,28.40,27.15,27.19,24.99,24.98,25.85,26.17,22.69,23.12,26.48,27.78,22.93,25.68,0.45,2.72,1.47,1.51,-0.69,-0.71,0.16,0.49,-3.00,-2.56,0.80,2.10,-2.76,cell cycle,,,+,,,,,,,,,,,,
3205,Q07002,CDK18,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),DVSKRLSLPMDIR,_RLS(ph)LPM(ox)DIR_,S60,+,23.30,24.51,19.42,22.64,,,22.65,24.06,,,25.89,25.82,,23.54,-0.24,0.98,-4.12,-0.89, , ,-0.89,0.52, , ,2.35,2.28, ,cell cycle,,,+,,,,,,,,,,,,
3206,Q07065,CKAP4,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),RERDFTSLENTVE,_DFTS(ph)LENTVEER_,S232,,27.35,23.66,23.17,,24.21,26.47,21.66,23.28,25.02,,24.25,21.73,25.36,24.20,3.15,-0.53,-1.02, ,0.01,2.27,-2.54,-0.91,0.83, ,0.05,-2.47,1.17,,integral to membrane;lipid particle;plasma membrane;cytoskeleton;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3207,Q07065,CKAP4,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),EKGAHPSGGADDV,_GAHPS(ph)GGADDVAK_,S26,,23.79,25.54,24.27,25.66,,,,,,,,20.41,,23.93,-0.14,1.61,0.34,1.73, , , , , , , ,-3.53, ,,integral to membrane;lipid particle;plasma membrane;cytoskeleton;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3208,Q07065,CKAP4,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),RLEGLGSSEADQD,_LEGLGS(ph)SEADQDGLASTVR_,S460,+,29.13,25.51,26.11,23.69,24.30,25.92,,25.33,24.71,24.80,,,,25.50,3.63,0.01,0.61,-1.81,-1.20,0.42, ,-0.17,-0.79,-0.70, , , ,,integral to membrane;lipid particle;plasma membrane;cytoskeleton;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3211,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),QKAEASSPVPYLS,_AEASS(ph)PVPYLSPETNPASSTSAVNHNVNLTNVR_,S927,,,24.25,,23.59,25.35,,26.12,,,,25.33,,,24.93, ,-0.68, ,-1.34,0.42, ,1.19, , , ,0.40, , ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3213,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),IFVKEISQDSLAA,_EIS(ph)QDSLAAR_,S212,,,,,24.21,,,,,,,,,,24.21, , , ,0.00, , , , , , , , , ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3214,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),PIHRIDSPGFKPA,_IDS(ph)PGFKPASQQK_,S912,+,20.95,24.96,,23.08,22.75,23.11,22.96,23.19,,,,,,23.00,-2.05,1.96, ,0.08,-0.26,0.11,-0.04,0.19, , , , , ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3215,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),APSTSYSPQADSL,_LEEPTPAPSTSYS(ph)PQADSLR_,S968,,,23.42,,23.98,22.40,,,,,23.46,,,23.15,23.28, ,0.14, ,0.70,-0.88, , , , ,0.18, , ,-0.13,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3216,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),YVEKQASRDLEQP,_(gl)QAS(ph)RDLEQPTYR_,S1051,+,,22.58,,24.60,22.55,22.42,22.62,22.81,21.68,,,23.63,,22.86, ,-0.28, ,1.73,-0.31,-0.44,-0.24,-0.05,-1.19, , ,0.77, ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3217,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),PFDNQHSQDLDSR,_(gl)QPYPSRPPFDNQHS(ph)QDLDSR_,S1111,,22.14,,,23.40,,,24.35,,22.89,,23.70,24.06,,23.42,-1.29, , ,-0.02, , ,0.93, ,-0.53, ,0.27,0.64, ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3218,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),KRNLRKSREDLSA,_S(ph)REDLSAQPVQTK_,S617,+,24.83,26.35,25.01,27.80,24.50,23.86,27.81,24.47,25.90,24.50,24.49,27.18,22.91,25.35,-0.53,0.99,-0.34,2.44,-0.86,-1.50,2.45,-0.88,0.55,-0.86,-0.86,1.83,-2.44,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3219,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),PDPEPVSDNEEDS,_VQIPVSRPDPEPVS(ph)DNEEDS(ph)YDEEIHDPR_,S125,+,26.14,,,,27.73,,25.22,25.61,25.73,27.60,26.32,26.70,,26.38,-0.24, , , ,1.35, ,-1.17,-0.77,-0.65,1.22,-0.06,0.32, ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3220,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),SDNEEDSYDEEIH,_VQIPVSRPDPEPVS(ph)DNEEDS(ph)YDEEIHDPR_,S131,+,26.14,,,,27.05,24.56,23.64,23.68,25.44,26.40,,24.31,,25.15,0.99, , , ,1.90,-0.59,-1.51,-1.48,0.28,1.25, ,-0.84, ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3221,Q07157,TJP1,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),PIHRIDSPGFKPA,_IDS(ph)PGFKPASQQVYR_,S912,,22.01,23.11,,21.61,,22.49,,,,,,,,22.30,-0.29,0.80, ,-0.70, ,0.19, , , , , , , ,cell-cell signaling involved in cell-cell junction organization;cell-cell junction assembly;blastocyst formation;cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,basolateral plasma membrane;apical part of cell;cell-cell adherens junction;tight junction;cytosol;intercellular canaliculus;nucleus;gap junction;apicolateral plasma membrane,,,,,,,,,,,,,,
3222,Q07352,ZFP36L1,"Zinc finger protein 36, C3H1 type-like 1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (Protein TIS11B)",AGARDLSADRPRL,_DLS(ph)ADRPR_,S175,,24.76,24.45,,24.25,,19.18,,,,,,21.10,,22.74,2.01,1.70, ,1.50, ,-3.57, , , , , ,-1.65, ,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;mRNA metabolic process;vasculogenesis;gene expression;T cell differentiation in thymus;regulation of translation;regulation of mRNA stability",cytosol;nucleus,,,,,,,,,,,,,,
3224,Q07352,ZFP36L1,"Zinc finger protein 36, C3H1 type-like 1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (Protein TIS11B)",FRDRSFSEGGERL,_SFS(ph)EGGERLLPTQK_,S92,+,26.41,25.19,24.36,25.78,,22.52,22.45,,24.33,22.91,23.03,26.58,22.78,24.21,2.20,0.97,0.15,1.57, ,-1.70,-1.76, ,0.12,-1.30,-1.18,2.36,-1.43,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;mRNA metabolic process;vasculogenesis;gene expression;T cell differentiation in thymus;regulation of translation;regulation of mRNA stability",cytosol;nucleus,,,,,,,,,,,,,,
3225,Q07666,KHDRBS1,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)",SSGRSGSMDPSGA,_SGS(ph)M(ox)DPSGAHPSVR_,S20,,25.46,22.10,,,,,,,,,,,,23.78,1.68,-1.68, , , , , , , , , , , ,"regulation of RNA export from nucleus;negative regulation of transcription, DNA-dependent;cell proliferation;G2/M transition of mitotic cell cycle;cell cycle arrest;mRNA processing;transcription, DNA-dependent;cell surface receptor signaling pathway",nucleus;membrane,,,,+,,,,,,,,,,
3228,Q07866,KLC1,Kinesin light chain 1 (KLC 1),SRALSASHTDLAH,_ALSAS(ph)HTDLAH_,S622,,26.86,26.48,23.47,29.71,26.98,25.13,28.22,27.87,25.53,24.13,27.04,29.12,,26.71,0.15,-0.23,-3.24,3.00,0.27,-1.58,1.51,1.16,-1.18,-2.58,0.33,2.41, ,stress granule disassembly;blood coagulation;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule,,,,,,,,,,,,,,
3230,Q07866,KLC1,Kinesin light chain 1 (KLC 1),GMKRASSLNVLNV,_ASS(ph)LNVLNVGGK_,S591,,24.02,23.90,,25.47,26.71,24.95,26.89,27.11,23.08,,26.63,27.76,24.86,25.58,-1.56,-1.68, ,-0.11,1.13,-0.63,1.31,1.53,-2.50, ,1.05,2.18,-0.72,stress granule disassembly;blood coagulation;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule,,,,,,,,,,,,,,
3231,Q07866,KLC1,Kinesin light chain 1 (KLC 1),KYDDDISPSEDKD,_KYDDDIS(ph)PSEDK_,S162,,24.59,25.20,25.55,24.51,,,,,,,,24.56,,24.88,-0.29,0.31,0.66,-0.37, , , , , , , ,-0.32, ,stress granule disassembly;blood coagulation;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule,,,,,,,,,,,,,,
3232,Q07866,KLC1,Kinesin light chain 1 (KLC 1),NMEKRRSRESLNV,_S(ph)RESLNVDVVK_,S521,+,,22.89,22.54,,24.00,24.19,,23.91,22.90,,,24.60,,23.58, ,-0.69,-1.04, ,0.42,0.62, ,0.34,-0.67, , ,1.02, ,stress granule disassembly;blood coagulation;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule,,,,,,,,,,,,,,
3233,Q07866,KLC1,Kinesin light chain 1 (KLC 1),KACKVDSPTVTTT,_VDS(ph)PTVTTTLK_,S460,+,25.24,23.96,24.40,24.73,21.27,,25.30,22.61,23.11,23.69,23.82,23.73,22.52,23.70,1.54,0.26,0.71,1.04,-2.43, ,1.60,-1.08,-0.59,-0.01,0.12,0.03,-1.18,stress granule disassembly;blood coagulation;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;kinesin complex;microtubule,,,,,,,,,,,,,,
3234,Q07889,SOS 1,Son of sevenless homolog 1 (SOS-1),TASAPNSPRTPLT,_IPESETESTASAPNS(ph)PR_,S752,+,,23.05,,23.62,22.65,23.35,,24.85,,,,21.81,24.25,23.37, ,-0.32, ,0.25,-0.72,-0.02, ,1.48, , , ,-1.56,0.88,platelet activation;fibroblast growth factor receptor signaling pathway;Ras protein signal transduction;axon guidance;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;leukocyte migration,cytosol;plasma membrane,,,,,,,,,,,,,,
3235,Q07889,SOS 1,Son of sevenless homolog 1 (SOS-1),FHSRSASVSSISL,_SAS(ph)VSSISLTK_,S789,,24.80,23.56,23.82,22.84,22.34,,22.02,22.40,,22.25,24.40,24.29,,23.27,1.53,0.29,0.55,-0.43,-0.94, ,-1.26,-0.87, ,-1.02,1.13,1.02, ,platelet activation;fibroblast growth factor receptor signaling pathway;Ras protein signal transduction;axon guidance;epidermal growth factor receptor signaling pathway;insulin receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;leukocyte migration,cytosol;plasma membrane,,,,,,,,,,,,,,
3236,Q07954,LRP1,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85);Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515);Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],GHGSRHSLASTDE,_HS(ph)LASTDEK_,S4520,,20.43,23.21,,22.84,,,,,17.75,,,,,21.06,-0.63,2.16, ,1.78, , , , ,-3.31, , , , ,aging;apoptotic cell clearance;aorta morphogenesis;negative regulation of smooth muscle cell migration;lipoprotein metabolic process;positive regulation of protein transport;negative regulation of platelet-derived growth factor receptor-beta signaling pathway;receptor-mediated endocytosis;cholesterol metabolic process;regulation of phospholipase A2 activity;regulation of actin cytoskeleton organization;protein kinase C-activating G-protein coupled receptor signaling pathway;cell proliferation;beta-amyloid clearance;negative regulation of Wnt receptor signaling pathway;positive regulation of cholesterol efflux,neuronal cell body;endosome;clathrin-coated vesicle;perinuclear region of cytoplasm;coated pit;nucleus;integral to plasma membrane;dendrite,,,,,,,,,,,,,,
3237,Q07954,LRP1,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85);Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515);Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],SRHSLASTDEKRE,_HSLAS(ph)TDEK_,S4523,+,21.39,25.78,25.30,26.05,,,,,22.00,,20.92,20.89,19.22,22.69,-1.31,3.09,2.60,3.36, , , , ,-0.70, ,-1.77,-1.81,-3.48,aging;apoptotic cell clearance;aorta morphogenesis;negative regulation of smooth muscle cell migration;lipoprotein metabolic process;positive regulation of protein transport;negative regulation of platelet-derived growth factor receptor-beta signaling pathway;receptor-mediated endocytosis;cholesterol metabolic process;regulation of phospholipase A2 activity;regulation of actin cytoskeleton organization;protein kinase C-activating G-protein coupled receptor signaling pathway;cell proliferation;beta-amyloid clearance;negative regulation of Wnt receptor signaling pathway;positive regulation of cholesterol efflux,neuronal cell body;endosome;clathrin-coated vesicle;perinuclear region of cytoplasm;coated pit;nucleus;integral to plasma membrane;dendrite,,,,,,,,,,,,,,
3238,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",_____MSGGGVIR,_(ac)S(ph)GGGVIRGPAGNNDCR_,S2,+,25.18,25.92,,26.43,24.60,23.59,,26.46,26.81,,24.38,23.76,24.59,25.17,0.01,0.74, ,1.26,-0.57,-1.58, ,1.29,1.64, ,-0.79,-1.41,-0.58,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
3239,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",PRRSRGSPRYSPR,_SRGS(ph)PRYS(ph)PR_,S234,+,27.40,28.12,27.19,28.01,22.66,,,18.63,20.36,,,,,24.63,2.77,3.49,2.56,3.39,-1.96, , ,-5.99,-4.26, , , , ,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
3240,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",RGSPRYSPRHSRS,_SRGS(ph)PRYS(ph)PR_,S238,+,27.40,28.12,27.19,28.01,22.66,,,18.63,20.36,,,,,24.63,2.77,3.49,2.56,3.39,-1.96, , ,-5.99,-4.26, , , , ,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
3243,Q07955,SRSF1,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",SPSYGRSRSRSRS,_VDGPRS(ph)PSYGRS(ph)R_,S205,+,28.24,30.86,30.86,27.27,,,23.23,,26.74,23.70,,,,27.27,0.96,3.59,3.59,0.00, , ,-4.04, ,-0.53,-3.57, , , ,mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA 5'-splice site recognition;cardiac muscle contraction;in utero embryonic development,nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
3246,Q07960,ARHGAP1,Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoOGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP),DDSKSSSPELVTH,_SSS(ph)PELVTHLK_,S51,+,26.99,26.04,26.60,26.89,23.55,25.40,26.60,25.95,26.00,26.00,26.79,26.23,24.22,25.94,1.05,0.10,0.66,0.95,-2.39,-0.55,0.66,0.00,0.05,0.06,0.85,0.29,-1.73,Rho protein signal transduction,cytosol;intracellular membrane-bounded organelle;plasma membrane;ruffle,,,,+,,,,,,,,,,
3247,Q08050,FOXM1,Forkhead box protein M1 (Forkhead-related protein FKHL16) (Hepatocyte nuclear factor 3 forkhead homolog 11) (HFH-11) (HNF-3/fork-head homolog 11) (M-phase phosphoprotein 2) (MPM-2 reactive phosphoprotein 2) (Transcription factor Trident) (Winged-helix factor from INS-1 cells),RPIKVESPPLEEW,_VES(ph)PPLEEWPSPAPSFK_,S465,,21.66,,,,,,,,,,,,,21.66,0.00, , , , , , , , , , , , ,"negative regulation of cell aging;regulation of cell growth;liver development;embryo development;regulation of sequence-specific DNA binding transcription factor activity;regulation of reactive oxygen species metabolic process;DNA repair;regulation of Ras protein signal transduction;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of double-strand break repair;vasculogenesis;tissue development;regulation of cell cycle arrest;regulation of cell proliferation;transcription from RNA polymerase II promoter;G2/M transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of transcription from RNA polymerase II promoter;cell cycle;negative regulation of stress-activated MAPK cascade;pattern specification process",transcription factor complex;cytoplasm,Forkhead,,,,,,,,,,,,,
3248,Q08170,SRSF4,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",REGRGESENAGTN,_EGRGES(ph)ENAGTNQETR_,S431,+,23.60,25.25,21.97,24.83,20.77,21.02,19.83,20.81,23.15,,20.55,,,22.18,1.42,3.07,-0.21,2.65,-1.41,-1.16,-2.35,-1.37,0.97, ,-1.63, , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,,,,,,,,,,
3249,Q08170,SRSF4,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",LIVENLSSRVSWQ,_LIVENLS(ph)SR_,S112,,25.70,23.39,23.39,25.91,25.32,26.49,25.10,24.77,24.93,,,24.26,,24.93,0.77,-1.54,-1.54,0.98,0.39,1.56,0.17,-0.15,0.00, , ,-0.67, ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,,,,,,,,,,
3250,Q08170,SRSF4,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",IVENLSSRCSWQD,_LIVENLSS(ph)R_,S113,,19.76,26.13,,,21.44,,,21.41,21.55,,,,,22.06,-2.30,4.07, , ,-0.62, , ,-0.65,-0.50, , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,,,,,,,,,,
3251,Q08170,SRSF4,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",SKPNLPSESRSRS,_SKPNLPS(ph)ESRS(ph)R_,S456,,22.60,24.50,22.94,22.09,,,,,,,,,,23.03,-0.43,1.47,-0.10,-0.94, , , , , , , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;nuclear speck,,,,,,,,,,,,,,
3254,Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),SDAPGDSPRIHLP,_FNLM(ox)SDAPGDS(ph)PR_,S715,,24.23,21.72,,,21.92,,,,,,,,,22.62,1.61,-0.90, , ,-0.70, , , , , , , , ,homophilic cell adhesion;nervous system development;cell-cell signaling,cell-cell junction;integral to plasma membrane,,,,,,,,,,,,,,
3255,Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),LNYPPGSPDLGRH,_IHLPLNYPPGS(ph)PDLGR_,S728,+,24.33,,,,25.39,25.42,25.66,24.81,25.31,25.24,24.71,,25.06,25.10,-0.78, , , ,0.29,0.32,0.55,-0.29,0.21,0.14,-0.40, ,-0.04,homophilic cell adhesion;nervous system development;cell-cell signaling,cell-cell junction;integral to plasma membrane,,,,,,,,,,,,,,
3256,Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),LGRHYRSNSPLPS,_S(ph)NSPLPSIQLQPQS(ph)PSASK_,S737,,23.49,,,,,22.85,,,,22.98,,,,23.11,0.38, , , , ,-0.25, , , ,-0.13, , , ,homophilic cell adhesion;nervous system development;cell-cell signaling,cell-cell junction;integral to plasma membrane,,,,,,,,,,,,,,
3257,Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),RHYRSNSPLPSIQ,_SNS(ph)PLPSIQLQPQS(ph)PSASKK_,S739,,25.09,21.86,21.86,,,22.85,,,,22.98,,,,22.93,2.16,-1.07,-1.07, , ,-0.08, , , ,0.05, , , ,homophilic cell adhesion;nervous system development;cell-cell signaling,cell-cell junction;integral to plasma membrane,,,,,,,,,,,,,,
3258,Q08174,PCDH1,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),IQLQPQSPSASKK,_S(ph)NSPLPSIQLQPQS(ph)PSASK_,S750,+,25.44,25.02,25.02,,25.10,22.13,25.83,25.34,26.26,24.52,24.40,,25.04,24.92,0.52,0.10,0.10, ,0.18,-2.79,0.92,0.43,1.34,-0.40,-0.51, ,0.12,homophilic cell adhesion;nervous system development;cell-cell signaling,cell-cell junction;integral to plasma membrane,,,,,,,,,,,,,,
3261,Q08211,DHX9,ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II),PAFGVASPPPLTD,_SEEVPAFGVAS(ph)PPPLTDTPDTTANAEGDLPTTM(ox)GGPLPPHLALK_,S87,+,27.19,27.10,27.55,27.18,27.89,27.84,28.88,28.31,28.94,28.78,28.52,27.46,29.77,28.11,-0.92,-1.01,-0.55,-0.93,-0.22,-0.27,0.77,0.20,0.83,0.67,0.41,-0.65,1.67,"CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome;cellular response to heat",nucleoplasm;ribonucleoprotein complex;nucleolus;CRD-mediated mRNA stability complex;centrosome,,,,,,,,,,,,,,
3262,Q08211,DHX9,ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II),TQPRRISAVSVAE,_RIS(ph)AVSVAER_,S449,+,23.16,23.69,23.69,22.97,25.65,,23.80,25.69,,23.97,23.34,24.65,24.56,24.11,-0.94,-0.42,-0.42,-1.14,1.54, ,-0.31,1.59, ,-0.14,-0.77,0.54,0.46,"CRD-mediated mRNA stabilization;mRNA splicing, via spliceosome;cellular response to heat",nucleoplasm;ribonucleoprotein complex;nucleolus;CRD-mediated mRNA stability complex;centrosome,,,,,,,,,,,,,,
3263,Q08357,SLC20A2,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),GALSRVSDESLSK,_EGALSRVS(ph)DES(ph)LSK_,S256,+,26.37,26.39,27.22,25.33,,,22.46,22.75,24.80,26.31,23.10,21.06,,24.58,1.79,1.81,2.64,0.75, , ,-2.12,-1.83,0.23,1.73,-1.48,-3.52, ,virus-host interaction,integral to plasma membrane,,,,,,,,,,,,,,
3264,Q08357,SLC20A2,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),SRVSDESLSKVQE,_EGALSRVS(ph)DES(ph)LSK_,S259,,26.26,25.94,26.70,25.25,,,,,24.80,23.32,,,,25.38,0.88,0.56,1.32,-0.13, , , , ,-0.57,-2.05, , , ,virus-host interaction,integral to plasma membrane,,,,,,,,,,,,,,
3267,Q08357,SLC20A2,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),KVQEAESPVFKEL,_VQEAES(ph)PVFK_,S268,,24.62,,,,,,23.86,,22.38,27.57,,,,24.60,0.01, , , , , ,-0.75, ,-2.23,2.96, , , ,virus-host interaction,integral to plasma membrane,,,,,,,,,,,,,,
3268,Q08378,GOLGA3,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),KGEASSSNPATPI,_GEASSS(ph)NPATPIK_,S1392,,23.79,,,,,,,,,,,,,23.79,0.00, , , , , , , , , , , , ,intra-Golgi vesicle-mediated transport,Golgi cisterna membrane;endoplasmic reticulum-Golgi intermediate compartment;nucleus;Golgi transport complex;Golgi membrane,,,,,,,,,,,,,,
3269,Q08378,GOLGA3,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),SQQRQDSLSSEVD,_QDS(ph)LSSEVDTLK_,S465,,22.15,22.06,,21.35,,,,,,,,,,21.85,0.29,0.21, ,-0.50, , , , , , , , , ,intra-Golgi vesicle-mediated transport,Golgi cisterna membrane;endoplasmic reticulum-Golgi intermediate compartment;nucleus;Golgi transport complex;Golgi membrane,,,,,,,,,,,,,,
3270,Q08495,DMTN,Dematin (Dematin actin-binding protein) (Erythrocyte membrane protein band 4.9),EEEDDDSGEEMKA,_RGAEEEEEEEDDDS(ph)GEEM(ox)K_,S201,+,22.38,23.70,24.09,23.04,22.18,20.97,24.01,23.63,24.60,24.48,23.39,,20.10,23.05,-0.67,0.65,1.05,0.00,-0.87,-2.07,0.96,0.58,1.56,1.43,0.34, ,-2.95,actin filament capping;actin filament bundle assembly,cortical cytoskeleton;nucleus;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3271,Q08495,DMTN,Dematin (Dematin actin-binding protein) (Erythrocyte membrane protein band 4.9),GTSKSSSLPAYGR,_SSS(ph)LPAYGR_,S264,,23.77,21.86,22.25,22.07,,,,,,,,,,22.49,1.28,-0.63,-0.24,-0.42, , , , , , , , , ,actin filament capping;actin filament bundle assembly,cortical cytoskeleton;nucleus;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3272,Q08499,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.17) (DPDE3) (PDE43)",KLSPVISPRNSPR,_LSPVIS(ph)PR_,S59,,20.41,21.47,21.89,22.76,22.77,21.21,22.57,22.09,21.80,,,22.47,,21.94,-1.53,-0.47,-0.06,0.82,0.83,-0.74,0.62,0.14,-0.14, , ,0.53, ,signal transduction;smooth muscle contraction;establishment of endothelial barrier;cAMP catabolic process,cytosol;membrane;microtubule organizing center,,,,,,,,,,,,,,
3273,Q08499,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.17) (DPDE3) (PDE43)",DSDYDLSPKSMSR,_SDSDYDLS(ph)PK_,S138,,22.45,,,,,,22.01,,,,,,,22.23,0.22, , , , , ,-0.22, , , , , , ,signal transduction;smooth muscle contraction;establishment of endothelial barrier;cAMP catabolic process,cytosol;membrane;microtubule organizing center,,,,,,,,,,,,,,
3274,Q08722,CD47,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),LNAFKESKGMMND,_AVEEPLNAFKES(ph)K_,S316,,24.05,23.65,23.30,,,,,,,24.40,,,,23.85,0.20,-0.20,-0.55, , , , , , ,0.55, , , ,positive regulation of inflammatory response;positive regulation of T cell activation;positive regulation of cell-cell adhesion;blood coagulation;cell adhesion;integrin-mediated signaling pathway;opsonization;positive regulation of cell proliferation;response to bacterium;positive regulation of phagocytosis;leukocyte migration,extracellular vesicular exosome;integral to plasma membrane,,,,,,,,,,,,,,
3276,Q08945,SSRP1,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),KEGMNPSYDEYAD,_EGM(ox)NPS(ph)YDEYADS(ph)DEDQHDAYLER_,S437,,23.07,,,,,,,,,,,,,23.07,0.00, , , , , , , , , , , , ,"DNA repair;viral reproduction;regulation of transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;DNA replication;positive regulation of viral transcription",nucleoplasm;nucleolus;chromosome;cytoplasm,HMG-box,,,,,,,,,,,,,
3278,Q08945,SSRP1,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),SRQLSESFKSKEF,_QLSES(ph)FK_,S659,,23.47,,,24.07,,,,20.76,21.30,,,,,22.40,1.07, , ,1.67, , , ,-1.64,-1.10, , , , ,"DNA repair;viral reproduction;regulation of transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;DNA replication;positive regulation of viral transcription",nucleoplasm;nucleolus;chromosome;cytoplasm,HMG-box,,,,,,,,,,,,,
3279,Q08999,RBL2,Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2),LEDGSESPAKRIC,_GILLEDGSES(ph)PAK_,S822,+,,23.39,,23.26,,25.35,23.80,,23.69,23.27,,,23.55,23.76, ,-0.37, ,-0.50, ,1.59,0.04, ,-0.07,-0.49, , ,-0.21,"regulation of lipid kinase activity;regulation of cell cycle;G1 phase of mitotic cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleoplasm;chromatin;transcription factor complex;nucleolus;cytoplasm,Other TF domain,,,,,,,,,,,,,
3282,Q08999,RBL2,Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2),KNETMLSPREKIF,_NETM(ox)LS(ph)PR_,S778,+,22.55,22.69,22.33,24.62,,,21.36,,22.56,21.45,21.11,,,22.33,0.22,0.35,0.00,2.28, , ,-0.97, ,0.23,-0.88,-1.23, , ,"regulation of lipid kinase activity;regulation of cell cycle;G1 phase of mitotic cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleoplasm;chromatin;transcription factor complex;nucleolus;cytoplasm,Other TF domain,,,,,,,,,,,,,
3283,Q08999,RBL2,Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2),SRSHQNSPTELNK,_SHQNS(ph)PTELNK_,S662,,21.43,24.86,,23.52,,,,,,,,,,23.27,-1.84,1.59, ,0.25, , , , , , , , , ,"regulation of lipid kinase activity;regulation of cell cycle;G1 phase of mitotic cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleoplasm;chromatin;transcription factor complex;nucleolus;cytoplasm,Other TF domain,,,,,,,,,,,,,
3284,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),EKYDGESDKEQFD,_YDGES(ph)DKEQFDDDQK_,S1121,,24.80,25.08,,25.14,23.49,26.54,27.23,26.74,26.09,25.16,26.79,27.02,26.12,25.85,-1.05,-0.77, ,-0.71,-2.36,0.69,1.38,0.89,0.24,-0.69,0.94,1.17,0.27,,microtubule;cytoplasm,,,,,,,,,,,,,,
3285,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),IKLNQSSPDNVTD,_LNQSS(ph)PDNVTDTK_,S572,,23.73,24.74,24.74,25.66,24.81,,,,22.66,23.46,,,,24.26,-0.52,0.48,0.48,1.41,0.55, , , ,-1.59,-0.80, , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
3286,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),SNRKSASFSVKSQ,_SAS(ph)FSVK_,S953,,23.00,,,,,,,,,,,,,23.00,0.00, , , , , , , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
3287,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),SVEGFLSPSRCGS,_SESVEGFLS(ph)PSR_,S1292,,22.74,22.00,,22.06,22.67,22.68,,23.59,23.15,21.98,24.24,21.38,24.44,22.81,-0.07,-0.81, ,-0.75,-0.14,-0.13, ,0.78,0.34,-0.83,1.43,-1.43,1.63,,microtubule;cytoplasm,,,,,,,,,,,,,,
3288,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),GITRSISNEGLTL,_SIS(ph)NEGLTLNNSHVSK_,S437,,24.69,24.83,24.86,25.12,25.59,24.59,25.72,24.91,24.81,23.36,24.96,26.41,24.26,24.93,-0.25,-0.10,-0.07,0.19,0.66,-0.34,0.79,-0.02,-0.12,-1.57,0.03,1.48,-0.67,,microtubule;cytoplasm,,,,,,,,,,,,,,
3289,Q08AD1,CAMSAP2,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),QAKWLKSPTTPID,_S(ph)PTTPIDPEK_,S835,,25.25,,,25.02,,,,,,24.99,,,23.13,24.60,0.65, , ,0.42, , , , , ,0.39, , ,-1.47,,microtubule;cytoplasm,,,,,,,,,,,,,,
3290,Q08AE8,SPIRE1,Protein spire homolog 1 (Spir-1),KFLPISSTPQPER,_FLPISS(ph)TPQPER_,S335,,,,,23.53,,,24.30,,,,,23.35,23.39,23.64, , , ,-0.11, , ,0.66, , , , ,-0.29,-0.25,Golgi vesicle transport,Golgi apparatus;cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3291,Q08AE8,SPIRE1,Protein spire homolog 1 (Spir-1),RKLRPVSPEEIRR,_LRPVS(ph)PEEIRR_,S228,+,,,,21.77,23.20,23.73,23.90,23.90,22.32,23.32,24.42,24.19,24.41,23.52, , , ,-1.75,-0.32,0.21,0.39,0.38,-1.19,-0.19,0.91,0.68,0.89,Golgi vesicle transport,Golgi apparatus;cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3292,Q08J23,NSUN2,tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4),RAGEPNSPDAEEA,_AGEPNS(ph)PDAEEANS(ph)PDVTAGCDPAGVHPPR_,S743,,23.75,,,,,,,,,,,,,23.75,0.00, , , , , , , , , , , , ,mitosis;cell division,nucleolus;spindle;cytoplasm,,,,,,,,,,,,,,
3293,Q08J23,NSUN2,tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4),DAEEANSPDVTAG,_AGEPNS(ph)PDAEEANS(ph)PDVTAGCDPAGVHPPR_,S751,,23.75,,,,,,,,,,,,,23.75,0.00, , , , , , , , , , , , ,mitosis;cell division,nucleolus;spindle;cytoplasm,,,,,,,,,,,,,,
3294,Q08J23,NSUN2,tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4),RESTQLSPADLTE,_ESTQLS(ph)PADLTEGKPTDPSK_,S456,+,25.25,25.39,25.74,24.68,22.44,23.23,26.87,,26.84,25.92,26.17,26.43,23.94,25.24,0.01,0.15,0.50,-0.56,-2.80,-2.01,1.63, ,1.60,0.68,0.93,1.18,-1.30,mitosis;cell division,nucleolus;spindle;cytoplasm,,,,,,,,,,,,,,
3299,Q09472,EP300,Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300),TSATQSSPAPGQS,_TEIKEEEDQPSTSATQSS(ph)PAPGQSK_,S1038,,,,,,,,24.84,,,24.34,23.71,,23.82,24.18, , , , , , ,0.67, , ,0.16,-0.47, ,-0.36,"N-terminal peptidyl-lysine acetylation;cellular response to hydrogen peroxide;histone H4 acetylation;liver development;positive regulation of glycoprotein biosynthetic process;positive regulation of protein import into nucleus, translocation;response to estrogen stimulus;positive regulation of cell size;somitogenesis;response to calcium ion;response to retinoic acid;positive regulation of sequence-specific DNA binding transcription factor activity;response to glucose stimulus;response to fatty acid;protein kinase B signaling cascade;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;transcription, DNA-dependent;protein-DNA complex assembly;heart development;cell cycle;regulation of angiotensin metabolic process;response to cobalt ion;nervous system development;positive regulation of axon extension;digestive tract development;response to drug;positive regulation of DNA binding;lung development;positive regulation of sarcomere organization;regulation of transcription from RNA polymerase II promoter in response to hypoxia;skeletal muscle tissue development;organ morphogenesis;response to ethanol;virus-host interaction;positive regulation of collagen biosynthetic process;positive regulation of transcription from RNA polymerase II promoter;positive regulation of proteolysis;positive regulation by host of viral transcription;innate immune response;positive regulation of protein binding;response to glucocorticoid stimulus;Notch signaling pathway;positive regulation of protein phosphorylation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of protein secretion;regulation of androgen receptor signaling pathway",nucleoplasm;chromatin;protein-DNA complex;transcription factor complex;histone acetyltransferase complex;cytoplasm,,,,,,,,,,,,,,
3300,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKADIKSPSLDVT,_ADIKS(ph)PSLDVTVPEAELNLETPEISVGGK_,S4993,,25.86,,,,,,,,,,,,,25.86,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3301,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AEAPLPSPKLEGE,_FKAEAPLPS(ph)PK_,S5110,+,30.76,29.90,30.31,28.86,27.73,26.46,28.95,27.79,28.91,28.99,28.99,28.31,28.13,28.78,1.99,1.13,1.53,0.08,-1.05,-2.32,0.17,-0.99,0.13,0.22,0.22,-0.47,-0.65,nervous system development,nucleus,,,,,,,,,,,,,,
3302,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KAGLRVSAPEVSV,_AGLRVS(ph)APEVSVGHK_,S332,,22.44,22.50,22.50,,23.03,22.46,23.30,23.00,22.35,24.50,24.53,24.05,,23.15,-0.71,-0.65,-0.65, ,-0.12,-0.70,0.15,-0.15,-0.81,1.35,1.38,0.90, ,nervous system development,nucleus,,,,,,,,,,,,,,
3303,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VSAPEVSVGHKGG,_VSAPEVS(ph)VGHK_,S337,,25.52,,,20.91,,,,,,23.30,,24.39,,23.53,1.99, , ,-2.62, , , , , ,-0.23, ,0.86, ,nervous system development,nucleus,,,,,,,,,,,,,,
3304,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GQGLDWSLKIPKM,_APDVEGQGLDWS(ph)LK_,S1123,,24.81,,,,,,,,,,,,,24.81,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3305,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IKAPKISIPDVDL,_IS(ph)IPDVDLDLK_,S4850,,23.40,,,,,,20.80,,23.49,23.04,21.18,23.98,,22.65,0.75, , , , , ,-1.85, ,0.84,0.39,-1.47,1.33, ,nervous system development,nucleus,,,,,,,,,,,,,,
3306,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),FRAPKMSLPDVDL,_MS(ph)LPDVDLDLK_,S1068,+,26.97,,,,,21.63,23.50,23.19,25.68,25.48,,25.07,25.90,24.68,2.29, , , , ,-3.05,-1.17,-1.49,1.00,0.81, ,0.40,1.22,nervous system development,nucleus,,,,,,,,,,,,,,
3307,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LKSSKASLGSLEG,_AS(ph)LGSLEGEAEAEASSPK_,S5749,+,26.65,24.86,25.49,24.63,27.04,25.24,26.95,24.16,28.23,25.37,27.24,27.42,27.55,26.22,0.43,-1.36,-0.73,-1.58,0.82,-0.98,0.74,-2.06,2.01,-0.84,1.03,1.20,1.33,nervous system development,nucleus,,,,,,,,,,,,,,
3308,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),SKASLGSLEGEAE,_ASLGS(ph)LEGEAEAEASS(ph)PK_,S5752,+,28.94,28.18,27.33,29.84,29.60,30.29,29.60,30.09,30.17,29.81,29.90,29.23,25.42,29.11,-0.17,-0.93,-1.77,0.73,0.50,1.18,0.49,0.98,1.06,0.71,0.79,0.12,-3.68,nervous system development,nucleus,,,,,,,,,,,,,,
3309,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),EAEAEASSPKGKF,_ASLGSLEGEAEAEAS(ph)SPK_,S5762,+,28.09,26.77,27.46,27.14,28.08,,25.90,29.16,23.02,28.75,23.65,28.14,29.44,27.13,0.96,-0.37,0.33,0.00,0.94, ,-1.23,2.02,-4.11,1.62,-3.48,1.01,2.31,nervous system development,nucleus,,,,,,,,,,,,,,
3311,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),QEVTQNSPAARTG,_DDGVFVQEVTQNS(ph)PAAR_,S41,,22.97,,,22.87,,22.98,,,,,,,24.12,23.24,-0.27, , ,-0.36, ,-0.25, , , , , , ,0.88,nervous system development,nucleus,,,,,,,,,,,,,,
3314,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),SDEREFSGPSTPT,_EFS(ph)GPSTPTGTLEFEGGEVSLEGGK_,S5790,,25.58,,,,,,,,,,,,,25.58,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3315,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TFGGLGSKSKGHY,_FGT(ph)FGGLGS(ph)K_,S5830,+,29.53,23.95,24.67,26.58,24.16,22.54,25.73,24.38,21.80,23.17,23.35,28.24,24.99,24.85,4.68,-0.90,-0.18,1.73,-0.70,-2.31,0.87,-0.47,-3.05,-1.69,-1.50,3.38,0.14,nervous system development,nucleus,,,,,,,,,,,,,,
3317,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),MPFLSISSPKVSM,_MPFLSIS(ph)SPK_,S3411,,26.91,23.89,24.75,23.19,23.09,22.13,,23.62,22.80,,25.58,25.09,,24.11,2.81,-0.22,0.65,-0.91,-1.02,-1.97, ,-0.48,-1.30, ,1.47,0.98, ,nervous system development,nucleus,,,,,,,,,,,,,,
3318,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PFLSISSPKVSMP,_M(ox)PFLSISS(ph)PK_,S3412,+,25.76,,,22.76,,22.65,25.07,,23.76,22.45,,24.83,,23.90,1.86, , ,-1.14, ,-1.25,1.18, ,-0.14,-1.45, ,0.93, ,nervous system development,nucleus,,,,,,,,,,,,,,
3319,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LPKFNFSGSKVQT,_FNFS(ph)GSK_,S3360,+,26.67,22.92,23.40,24.87,,,22.36,21.46,,,,24.51,,23.74,2.93,-0.82,-0.34,1.13, , ,-1.38,-2.28, , , ,0.77, ,nervous system development,nucleus,,,,,,,,,,,,,,
3320,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKFSMPSLKGEGP,_FSM(ox)PS(ph)LKGEGPEFDVNLSK_,S1010,,27.21,23.77,23.63,24.95,,,,23.70,,,21.95,27.80,21.64,24.33,2.88,-0.56,-0.70,0.62, , , ,-0.63, , ,-2.38,3.47,-2.69,nervous system development,nucleus,,,,,,,,,,,,,,
3321,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IPKFTFSGRELVG,_FTFS(ph)GR_,S5669,,21.65,,,19.08,,,,,,,,,,20.36,1.28, , ,-1.28, , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3322,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LDASVPSMKVHAP,_GDLDASVPS(ph)M(ox)K_,S5321,,26.47,,,23.48,,,21.91,,,,,25.44,,24.32,2.14, , ,-0.84, , ,-2.41, , , , ,1.11, ,nervous system development,nucleus,,,,,,,,,,,,,,
3323,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),HRKGDRSPEPGQT,_S(ph)PEPGQTWTR_,S93,+,28.27,29.60,28.99,28.96,30.65,29.46,30.52,30.56,30.36,29.53,29.71,29.32,28.57,29.58,-1.31,0.03,-0.59,-0.62,1.07,-0.12,0.94,0.98,0.79,-0.05,0.13,-0.25,-1.00,nervous system development,nucleus,,,,,,,,,,,,,,
3324,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LGEGHLSVKGSGG,_GGADVSGGVSAPDISLGEGHLS(ph)VK_,S5589,,24.56,,,,,,,,,,,26.00,24.99,25.18,-0.62, , , , , , , , , , ,0.82,-0.19,nervous system development,nucleus,,,,,,,,,,,,,,
3325,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KGGLKGSEVGFHG,_GGLKGS(ph)EVGFHGAAPDIS(ph)VK_,S5530,,24.33,,,,,,,,,,,,,24.33,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3326,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GAAPDISVKGPAF,_GGLKGS(ph)EVGFHGAAPDIS(ph)VK_,S5542,,23.03,,,,,,,,,,,,,23.03,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3327,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LQAPGLSVSGPQG,_GGQIGLQAPGLS(ph)VSGPQGHLESGSGK_,S5641,,24.65,,,,,,,,,,,25.38,,25.01,-0.37, , , , , , , , , , ,0.37, ,nervous system development,nucleus,,,,,,,,,,,,,,
3328,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KGGVTGSPEASIS,_GGVTGS(ph)PEASISGSK_,S5731,+,30.24,29.72,28.96,30.28,28.83,29.28,29.93,29.05,30.06,28.91,27.92,28.33,28.72,29.25,0.99,0.48,-0.28,1.03,-0.42,0.03,0.68,-0.20,0.81,-0.34,-1.33,-0.92,-0.53,nervous system development,nucleus,,,,,,,,,,,,,,
3329,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TGSPEASISGSKG,_GGVTGS(ph)PEAS(ph)ISGSK_,S5735,+,27.73,22.54,22.54,25.17,,,23.98,,,22.28,,27.08,22.96,24.28,3.45,-1.74,-1.74,0.88, , ,-0.31, , ,-2.01, ,2.80,-1.32,nervous system development,nucleus,,,,,,,,,,,,,,
3331,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),EASISGSKGDLKS,_GGVTGSPEASISGS(ph)KGDLK_,S5739,+,26.08,26.98,26.43,22.52,22.72,25.16,26.20,23.28,27.86,26.38,,,24.24,25.26,0.82,1.72,1.17,-2.74,-2.54,-0.10,0.94,-1.98,2.60,1.12, , ,-1.02,nervous system development,nucleus,,,,,,,,,,,,,,
3332,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),HYEVTGSDDETGK,_GHYEVTGS(ph)DDETGK_,S5841,+,30.65,31.08,31.28,31.48,26.69,28.12,31.24,28.80,31.14,30.56,29.75,30.01,26.99,29.83,0.82,1.25,1.45,1.65,-3.14,-1.71,1.41,-1.03,1.31,0.73,-0.08,0.18,-2.84,nervous system development,nucleus,,,,,,,,,,,,,,
3333,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TGKLQGSGVSLAS,_LQGS(ph)GVS(ph)LAS(ph)KK_,S5851,,25.20,26.10,24.20,25.24,,,21.30,,,,,,,24.41,0.79,1.70,-0.21,0.83, , ,-3.11, , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3334,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LQGSGVSLASKKS,_LQGS(ph)GVS(ph)LAS(ph)KK_,S5854,,28.00,25.02,24.89,25.95,,,,,,,,,,25.96,2.04,-0.94,-1.08,-0.02, , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3335,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),SGVSLASKKSRLS,_LQGS(ph)GVS(ph)LAS(ph)KK_,S5857,+,29.62,26.89,26.78,28.12,,,25.77,22.19,25.55,24.79,22.23,28.72,24.45,25.92,3.70,0.97,0.86,2.20, , ,-0.15,-3.73,-0.37,-1.12,-3.69,2.80,-1.47,nervous system development,nucleus,,,,,,,,,,,,,,
3337,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PAFNMASPESDFG,_GPAFNM(ox)AS(ph)PESDFGINLK_,S5552,+,26.53,22.40,22.40,21.03,24.46,23.10,24.75,24.06,25.37,26.78,25.55,,25.22,24.30,2.23,-1.90,-1.90,-3.27,0.15,-1.20,0.45,-0.24,1.06,2.47,1.25, ,0.91,nervous system development,nucleus,,,,,,,,,,,,,,
3338,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LPSVNLSMPKVSG,_GPGVDLPSVNLS(ph)M(ox)PK_,S5293,,23.21,21.72,21.72,,,,,,,,,,,22.22,1.00,-0.50,-0.50, , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3341,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),QVALKGSRVDIET,_GS(ph)RVDIETPNLEGTLTGPR_,S539,,23.12,,,,,,,,,,,22.63,,22.88,0.25, , , , , , , , , , ,-0.25, ,nervous system development,nucleus,,,,,,,,,,,,,,
3342,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TGPRLGSPSGKTG,_GSRVDIETPNLEGTLTGPRLGS(ph)PSGK_,S559,,,24.76,24.76,,,,24.93,23.28,24.63,27.49,,,,24.98, ,-0.21,-0.21, , , ,-0.05,-1.70,-0.35,2.52, , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3343,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KKPRHRSNSFSDE,_HRS(ph)NS(ph)FSDER_,S5780,,28.33,25.84,25.24,24.68,,,,,,,,,,26.02,2.31,-0.19,-0.78,-1.34, , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3344,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PRHRSNSFSDERE,_HRS(ph)NS(ph)FSDER_,S5782,+,28.50,27.19,26.96,28.04,26.91,25.27,24.96,26.52,27.17,23.60,26.80,27.36,26.95,26.63,1.87,0.56,0.33,1.41,0.28,-1.37,-1.68,-0.11,0.54,-3.04,0.17,0.72,0.32,nervous system development,nucleus,,,,,,,,,,,,,,
3346,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VTAPDVSIEEPEG,_IDVTAPDVS(ph)IEEPEGK_,S793,,23.77,,,,,,,,,,,,22.78,23.28,0.50, , , , , , , , , , , ,-0.50,nervous system development,nucleus,,,,,,,,,,,,,,
3347,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LDLHLKSPKAKGE,_ISM(ox)PDLDLHLKS(ph)PK_,S2397,,,,,,26.87,25.22,,26.80,,,,,26.34,26.31, , , , ,0.57,-1.09, ,0.49, , , , ,0.03,nervous system development,nucleus,,,,,,,,,,,,,,
3348,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VDLSLGSPKLKGD,_ISM(ox)QDVDLSLGS(ph)PK_,S511,+,28.66,25.65,26.12,25.06,27.49,25.83,28.15,27.39,28.69,29.01,27.31,26.66,27.73,27.21,1.45,-1.57,-1.09,-2.15,0.28,-1.38,0.94,0.18,1.47,1.80,0.09,-0.55,0.52,nervous system development,nucleus,,,,,,,,,,,,,,
3349,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TGTCRISMSEVDL,_IS(ph)MSEVDLNVAAPK_,S570,+,26.43,23.24,23.24,25.22,22.82,,25.41,25.36,23.92,22.48,25.15,,25.68,24.45,1.98,-1.21,-1.21,0.77,-1.63, ,0.96,0.91,-0.53,-1.97,0.70, ,1.23,nervous system development,nucleus,,,,,,,,,,,,,,
3350,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TCRISMSEVDLNV,_ISM(ox)S(ph)EVDLNVAAPK_,S572,+,25.75,20.74,20.74,,22.82,23.77,24.23,23.15,24.21,,24.65,26.30,,23.64,2.11,-2.90,-2.90, ,-0.81,0.13,0.60,-0.48,0.57, ,1.01,2.66, ,nervous system development,nucleus,,,,,,,,,,,,,,
3351,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LEGPDVSLKGPGV,_LEGPDVS(ph)LK_,S5279,,23.89,21.68,21.35,21.46,,,21.31,,,22.04,,22.55,,22.04,1.85,-0.36,-0.69,-0.58, , ,-0.73, , ,0.00, ,0.51, ,nervous system development,nucleus,,,,,,,,,,,,,,
3352,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IKPRLKSEDGVEG,_S(ph)EDGVEGDLGETQSR_,S135,+,30.41,30.08,29.89,30.21,30.47,29.74,31.13,31.86,32.26,31.31,31.53,31.28,31.44,30.89,-0.48,-0.81,-1.00,-0.68,-0.42,-1.16,0.24,0.97,1.36,0.42,0.64,0.39,0.54,nervous system development,nucleus,,,,,,,,,,,,,,
3354,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VKLPDMSVKTPKI,_LPDM(ox)S(ph)VK_,S691,,23.87,,,21.62,,,,,,,,22.10,,22.53,1.34, , ,-0.91, , , , , , , ,-0.43, ,nervous system development,nucleus,,,,,,,,,,,,,,
3355,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TVIRLPSGSGAAS,_LPS(ph)GSGAAS(ph)PTGSAVDIR_,S210,+,30.98,27.38,24.62,27.06,28.70,25.59,29.59,30.10,26.54,27.72,29.38,27.14,26.71,27.81,3.18,-0.43,-3.19,-0.75,0.89,-2.22,1.78,2.29,-1.27,-0.09,1.57,-0.67,-1.09,nervous system development,nucleus,,,,,,,,,,,,,,
3356,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IRLPSGSGAASPT,_LPS(ph)GS(ph)GAASPTGSAVDIR_,S212,+,28.35,25.85,25.85,25.18,27.56,,,23.27,27.96,29.25,30.31,27.39,27.56,27.14,1.21,-1.29,-1.29,-1.96,0.42, , ,-3.87,0.82,2.11,3.17,0.25,0.42,nervous system development,nucleus,,,,,,,,,,,,,,
3357,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),SGSGAASPTGSAV,_LPS(ph)GSGAAS(ph)PTGSAVDIR_,S216,+,30.86,28.80,26.91,29.42,30.35,29.95,30.03,30.02,30.34,29.84,29.56,29.49,29.98,29.66,1.20,-0.86,-2.75,-0.24,0.69,0.29,0.38,0.36,0.68,0.18,-0.10,-0.17,0.32,nervous system development,nucleus,,,,,,,,,,,,,,
3358,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AASPTGSAVDIRA,_TVIRLPSGSGAAS(ph)PTGS(ph)AVDIR_,S220,,25.96,,,,,,,,,,,21.94,,23.95,2.01, , , , , , , , , , ,-2.01, ,nervous system development,nucleus,,,,,,,,,,,,,,
3359,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),AKLSGPSLKMPSL,_LSGPS(ph)LK_,S4903,,26.80,24.22,24.22,25.49,,,,,,,,,,25.18,1.62,-0.96,-0.96,0.31, , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3360,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PSLKMPSLEISAP,_M(ox)PS(ph)LEISAPK_,S4908,+,25.06,23.56,23.70,22.36,,21.85,23.40,22.91,23.13,23.81,24.40,23.13,24.04,23.44,1.62,0.11,0.25,-1.09, ,-1.60,-0.04,-0.54,-0.32,0.37,0.95,-0.31,0.59,nervous system development,nucleus,,,,,,,,,,,,,,
3361,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VEFDIKSPKFKAE,_M(ox)YFPDVEFDIKS(ph)PK_,S5099,+,25.53,,,,25.20,,,24.44,22.93,21.54,24.80,,23.44,23.98,1.55, , , ,1.22, , ,0.46,-1.06,-2.44,0.82, ,-0.54,nervous system development,nucleus,,,,,,,,,,,,,,
3363,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),FKSPQISMSDIDL,_SPQIS(ph)M(ox)SDIDLNLK_,S4520,,23.17,,,,,,,,,,,24.22,,23.70,-0.52, , , , , , , , , , ,0.52, ,nervous system development,nucleus,,,,,,,,,,,,,,
3367,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),IDAPDVSIEGPDA,_VDIDAPDVS(ph)IEGPDAK_,S4360,,22.79,,,,,,,,,,,,,22.79,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3368,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TNAPDLSLEGPEG,_VDTNAPDLS(ph)LEGPEGK_,S1042,,24.32,22.93,22.39,22.54,,,,,,,23.06,23.25,,23.08,1.24,-0.15,-0.69,-0.54, , , , , , ,-0.02,0.17, ,nervous system development,nucleus,,,,,,,,,,,,,,
3369,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),VEVPDVSLEGPEG,_VDVEVPDVS(ph)LEGPEGK_,S1298,,24.72,,,,,,,,,24.09,,,,24.41,0.31, , , , , , , , ,-0.31, , , ,nervous system development,nucleus,,,,,,,,,,,,,,
3375,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),LEASEGSIKLPKM,_VSVGAPDLSLEASEGS(ph)IK_,S5400,+,29.17,23.30,24.17,24.24,26.71,23.81,25.30,25.94,24.87,26.93,25.32,28.79,25.85,25.72,3.45,-2.42,-1.55,-1.49,0.99,-1.91,-0.42,0.22,-0.85,1.21,-0.40,3.07,0.13,nervous system development,nucleus,,,,,,,,,,,,,,
3376,Q0JRZ9,FCHO2,FCH domain only protein 2,EIPRPFSPPVTSN,_LSGINEIPRPFS(ph)PPVTSNTSPPPAAPLAR_,S488,,24.76,23.39,,,,,,,,,,,,24.08,0.68,-0.68, , , , , , , , , , , ,protein localization to plasma membrane;membrane invagination;clathrin-mediated endocytosis;clathrin coat assembly,coated pit;plasma membrane;clathrin-coated vesicle,,,,,,,,,,,,,,
3377,Q0JRZ9,FCHO2,FCH domain only protein 2,PVTSNTSPPPAAP,_LSGINEIPRPFSPPVTSNTS(ph)PPPAAPLAR_,S496,,24.66,,,,,,24.32,24.25,,,,,,24.41,0.25, , , , , ,-0.09,-0.16, , , , , ,protein localization to plasma membrane;membrane invagination;clathrin-mediated endocytosis;clathrin coat assembly,coated pit;plasma membrane;clathrin-coated vesicle,,,,,,,,,,,,,,
3378,Q0JRZ9,FCHO2,FCH domain only protein 2,QMNRNLSNEELTK,_NLS(ph)NEELTK_,S403,,26.99,28.56,,22.64,26.53,,,27.44,26.71,,,,,26.48,0.51,2.08, ,-3.84,0.06, , ,0.96,0.23, , , , ,protein localization to plasma membrane;membrane invagination;clathrin-mediated endocytosis;clathrin coat assembly,coated pit;plasma membrane;clathrin-coated vesicle,,,,,,,,,,,,,,
3383,Q0ZGT2,NEXN,Nexilin (F-actin-binding protein) (Nelin),IKEMLASDDEEDV,_EM(ox)LAS(ph)DDEEDVSSKVEK_,S16,+,26.09,28.75,26.79,30.82,27.04,29.33,27.03,27.58,29.25,28.42,27.30,27.63,28.23,28.02,-1.92,0.73,-1.23,2.80,-0.98,1.31,-0.99,-0.44,1.23,0.40,-0.72,-0.39,0.21,regulation of cell migration;regulation of cytoskeleton organization,Z disc;cell-substrate adherens junction;cytoskeleton,,,,,,,,,,,,,,
3384,Q0ZGT2,NEXN,Nexilin (F-actin-binding protein) (Nelin),AKKESLSPGKLKL,_ESLS(ph)PGK_,S179,,,,,23.58,,,,,20.46,,,20.46,,21.50, , , ,2.08, , , , ,-1.04, , ,-1.04, ,regulation of cell migration;regulation of cytoskeleton organization,Z disc;cell-substrate adherens junction;cytoskeleton,,,,,,,,,,,,,,
3385,Q0ZGT2,NEXN,Nexilin (F-actin-binding protein) (Nelin),EMYKTISQEFLTP,_TIS(ph)QEFLTPGK_,S301,+,22.22,24.84,23.40,27.14,23.13,23.93,24.41,21.96,26.35,26.66,25.57,26.05,22.87,24.50,-2.29,0.33,-1.10,2.64,-1.38,-0.57,-0.09,-2.54,1.85,2.16,1.06,1.55,-1.63,regulation of cell migration;regulation of cytoskeleton organization,Z disc;cell-substrate adherens junction;cytoskeleton,,,,,,,,,,,,,,
3387,Q10570,CPSF1,Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit),DSGSLFSPSKEEA,_SGPEAEGLGSETSPTVDDEEEM(ox)LYGDSGSLFS(ph)PSK_,S678,,23.72,,,,,,,,,25.09,,,,24.40,-0.69, , , , , , , , ,0.69, , , ,"mRNA export from nucleus;termination of RNA polymerase II transcription;mRNA cleavage;mRNA splicing, via spliceosome;mRNA polyadenylation",mRNA cleavage and polyadenylation specificity factor complex,,,,,,,,,,,,,,
3388,Q12756,KIF1A,Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104),WRPRSDSLILDHQ,_SDS(ph)LILDHQWELEK_,S1370,,23.40,21.90,21.90,,,,,,,,,,,22.40,1.01,-0.50,-0.50, , , , , , , , , , ,cell death;anterograde axon cargo transport,nucleus;microtubule associated complex;microtubule;cytoplasm,,,,,,,,,,,,,,
3392,Q12770,SCAP,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),PEEPGDSPPLRHR,_AGPEEPGDS(ph)PPLR_,S458,+,,,,25.76,,25.68,,,25.58,21.90,24.42,23.09,,24.41, , , ,1.35, ,1.27, , ,1.18,-2.50,0.02,-1.32, ,regulation of fatty acid biosynthetic process;aging;response to hypoxia;positive regulation of low-density lipoprotein particle receptor biosynthetic process;response to insulin stimulus;cholesterol metabolic process;SREBP signaling pathway;negative regulation of cholesterol biosynthetic process,integral to membrane;Golgi apparatus;ER to Golgi transport vesicle membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein complex;Golgi membrane,,,,,,,,,,,,,,
3393,Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),SRAEELSPAALSP,_AEELS(ph)PAALS(ph)PSLEPIR_,S445,,25.96,,,,,,,,,,,,,25.96,0.00, , , , , , , , , , , , ,regulation of Rho GTPase activity;intracellular signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
3394,Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),LSPAALSPSLEPI,_AEELS(ph)PAALS(ph)PSLEPIR_,S450,+,27.15,,,,25.40,22.28,23.91,25.29,21.97,21.69,25.87,22.93,24.26,24.08,3.07, , , ,1.32,-1.79,-0.16,1.21,-2.11,-2.38,1.80,-1.15,0.18,regulation of Rho GTPase activity;intracellular signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
3395,Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),ALVSSESYLQRLS,_ALVSSES(ph)YLQR_,S1139,,22.78,,,,,,,,,,,,,22.78,0.00, , , , , , , , , , , , ,regulation of Rho GTPase activity;intracellular signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
3396,Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),YSTVSASPTALST,_DYSTVSAS(ph)PTALSTLK_,S662,,23.23,,,,,,,,,,,,,23.23,0.00, , , , , , , , , , , , ,regulation of Rho GTPase activity;intracellular signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
3397,Q12774,ARHGEF5,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),EAQRGASPPISAI,_GAS(ph)PPISAIEEFSIIPEAPM(ox)R_,S11,+,26.71,,,24.49,25.96,,24.28,23.98,,26.10,26.98,,,25.50,1.21, , ,-1.01,0.46, ,-1.22,-1.52, ,0.60,1.48, , ,regulation of Rho GTPase activity;intracellular signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
3402,Q12789,GTF3C1,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),SLGKDGSLEDDED,_DGS(ph)LEDDEDEEDDLDEGVGGK_,S1611,+,23.50,,,,24.06,23.83,22.96,24.29,23.69,24.99,,,,23.90,-0.40, , , ,0.16,-0.07,-0.94,0.39,-0.22,1.09, , , ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
3404,Q12789,GTF3C1,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),PRVRKNSSTDQGS,_VRKNS(ph)STDQGS(ph)DEEGSLQK_,S1062,,24.58,25.81,25.81,23.30,,,,,,,,,,24.88,-0.30,0.93,0.93,-1.57, , , , , , , , , ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
3406,Q12789,GTF3C1,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),SSTDQGSDEEGSL,_VRKNS(ph)STDQGS(ph)DEEGSLQK_,S1068,+,25.53,25.46,26.00,25.59,,25.58,23.62,24.04,,24.16,,,,25.00,0.53,0.46,1.01,0.59, ,0.58,-1.38,-0.96, ,-0.83, , , ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
3408,Q12789,GTF3C1,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),GEAEEDSQGKEGP,_TSQPPVPQGEAEEDS(ph)QGK_,S739,+,24.74,24.12,24.50,23.62,,,23.84,,24.53,24.24,,22.52,,24.01,0.73,0.11,0.49,-0.40, , ,-0.17, ,0.52,0.23, ,-1.49, ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex;ribonucleoprotein complex;nucleolus,,,,,,,,,,,,,,
3410,Q12792,TWF1,Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9),YLLSQSSPAPLTA,_YLLSQSS(ph)PAPLTAAEEELR_,S143,,25.93,,,,,,,,,,,,,25.93,0.00, , , , , , , , , , , , ,regulation of actin phosphorylation;barbed-end actin filament capping;sequestering of actin monomers,ruffle membrane;filopodium;cell-cell junction;myofibril;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3411,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),ALQLSNSPGASSA,_ALQLSNS(ph)PGASSAFLK_,S983,+,22.93,23.04,23.04,23.47,23.76,24.84,25.58,25.96,23.48,24.67,25.60,,25.04,24.28,-1.35,-1.24,-1.24,-0.82,-0.52,0.56,1.30,1.68,-0.80,0.39,1.31, ,0.75,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3412,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),EDEGIPSENEEEK,_DEDEGIPS(ph)ENEEEK_,S2325,,,23.35,22.22,23.75,,,,,,,,,,23.11, ,0.24,-0.88,0.64, , , , , , , , , ,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3413,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),TFSLANSPGSESV,_ELVPDQAVISDSTFSLANS(ph)PGSESVTK_,S790,,23.33,,,,,,,,,,,,,23.33,0.00, , , , , , , , , , , , ,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3414,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),WKFLSHSTDSLNK,_FLSHS(ph)TDSLNK_,S1911,+,26.06,26.08,26.17,26.14,26.09,27.23,26.14,26.66,26.56,24.87,,28.26,26.65,26.41,-0.35,-0.33,-0.24,-0.27,-0.32,0.82,-0.27,0.25,0.15,-1.54, ,1.85,0.24,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3415,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),LSHSTDSLNKISK,_FLSHS(ph)TDS(ph)LNK_,S1914,,24.32,21.71,21.71,23.29,,,,,,,,,,22.76,1.57,-1.05,-1.05,0.53, , , , , , , , , ,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3416,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),SPEEPPSPSAPSI,_IPSFFPSPEEPPS(ph)PSAPSIAK_,S2689,+,26.61,,,24.86,25.76,26.11,,26.14,,,27.19,23.98,,25.81,0.81, , ,-0.95,-0.04,0.30, ,0.33, , ,1.38,-1.82, ,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3417,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),MNHRSFSLEGLTG,_SFS(ph)LEGLTGGAGVGNK_,S1584,,,,,,,,22.13,,,,22.63,23.68,,22.81, , , , , , ,-0.68, , , ,-0.18,0.86, ,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3420,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),DSELSVSPKRNSI,_SGSLDSELSVS(ph)PK_,S2708,+,24.36,23.99,24.19,24.73,25.42,24.41,25.87,25.77,24.68,25.68,25.75,25.35,25.06,25.02,-0.66,-1.03,-0.83,-0.29,0.40,-0.61,0.85,0.75,-0.34,0.66,0.73,0.33,0.04,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3421,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),SSMRSLSPFRRHS,_SLS(ph)PFRR_,S1559,+,21.59,23.18,23.18,22.25,23.83,23.19,23.35,24.26,21.30,22.37,24.02,23.39,22.25,22.94,-1.35,0.25,0.25,-0.69,0.89,0.25,0.42,1.33,-1.63,-0.57,1.08,0.46,-0.68,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3422,Q12802,AKAP13,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),ALTRSLSRPSSLI,_SLS(ph)RPSSLIEQEK_,S2543,+,25.20,22.74,22.72,24.15,25.03,23.96,25.71,24.36,,24.00,22.73,26.75,22.28,24.14,1.06,-1.39,-1.41,0.01,0.89,-0.18,1.57,0.23, ,-0.14,-1.40,2.61,-1.86,regulation of glucocorticoid mediated signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction,cytosol;nucleus;membrane,,,,,,,,,,,,,,
3426,Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),DIDNVKSPEETEK,_KGDIDNVKS(ph)PEETEK_,S572,+,22.52,24.42,24.69,23.32,24.55,23.05,23.43,22.35,23.68,23.03,21.82,,21.39,23.19,-0.67,1.23,1.50,0.13,1.36,-0.14,0.24,-0.83,0.49,-0.16,-1.36, ,-1.80,"brain development;positive regulation of transcription, DNA-dependent;anterior/posterior pattern specification;embryonic placenta development;negative regulation of transcription from RNA polymerase II promoter;endoderm development;transcription, DNA-dependent;chromatin remodeling",NURF complex;cytoplasm,,,,,,,,,,,,,,
3429,Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),SKNLSESPVITKA,_NLSES(ph)PVITK_,S1168,+,21.07,22.26,22.26,21.69,22.93,22.47,22.45,22.94,22.61,22.84,,,,22.35,-1.29,-0.09,-0.09,-0.66,0.58,0.12,0.10,0.59,0.26,0.49, , , ,"brain development;positive regulation of transcription, DNA-dependent;anterior/posterior pattern specification;embryonic placenta development;negative regulation of transcription from RNA polymerase II promoter;endoderm development;transcription, DNA-dependent;chromatin remodeling",NURF complex;cytoplasm,,,,,,,,,,,,,,
3430,Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),KCPKQNSIENDIE,_(gl)QNS(ph)IENDIEEK_,S1247,,23.22,,,,,,,,,24.04,,,,23.63,-0.41, , , , , , , , ,0.41, , , ,"brain development;positive regulation of transcription, DNA-dependent;anterior/posterior pattern specification;embryonic placenta development;negative regulation of transcription from RNA polymerase II promoter;endoderm development;transcription, DNA-dependent;chromatin remodeling",NURF complex;cytoplasm,,,,,,,,,,,,,,
3431,Q12830,BPTF,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),RVHRPRSPILEEK,_S(ph)PILEEKDIPPLEFPK_,S216,,,,,,25.09,,,23.16,,,,,,24.13, , , , ,0.97, , ,-0.97, , , , , ,"brain development;positive regulation of transcription, DNA-dependent;anterior/posterior pattern specification;embryonic placenta development;negative regulation of transcription from RNA polymerase II promoter;endoderm development;transcription, DNA-dependent;chromatin remodeling",NURF complex;cytoplasm,,,,,,,,,,,,,,
3433,Q12846,STX4,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),ADENYNSVNTRMR,_AIEPQKEEADENYNS(ph)VNTR_,S117,+,24.92,26.26,25.95,24.51,26.29,26.59,25.73,26.48,25.57,26.11,26.01,25.09,26.89,25.88,-0.96,0.38,0.07,-1.37,0.42,0.71,-0.14,0.60,-0.30,0.23,0.13,-0.79,1.01,post-Golgi vesicle-mediated transport;intracellular protein transport;synaptic vesicle docking involved in exocytosis;cellular membrane organization;platelet activation;cellular membrane fusion;protein complex assembly,basolateral plasma membrane;apical plasma membrane;sarcolemma;vacuole;myelin sheath adaxonal region;specific granule;perinuclear region of cytoplasm;trans-Golgi network;SNARE complex;cytosol;lateral loop;integral to membrane;cell surface,,,,,,,,,,,,,,
3434,Q12846,STX4,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),GTARLGSPDEEFF,_LGS(ph)PDEEFFHK_,S36,,22.13,,,,,,,,,,,,,22.13,0.00, , , , , , , , , , , , ,post-Golgi vesicle-mediated transport;intracellular protein transport;synaptic vesicle docking involved in exocytosis;cellular membrane organization;platelet activation;cellular membrane fusion;protein complex assembly,basolateral plasma membrane;apical plasma membrane;sarcolemma;vacuole;myelin sheath adaxonal region;specific granule;perinuclear region of cytoplasm;trans-Golgi network;SNARE complex;cytosol;lateral loop;integral to membrane;cell surface,,,,,,,,,,,,,,
3436,Q12846,STX4,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),LRQGDDSSDEEDK,_THELRQGDDS(ph)S(ph)DEEDK_,S14,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,post-Golgi vesicle-mediated transport;intracellular protein transport;synaptic vesicle docking involved in exocytosis;cellular membrane organization;platelet activation;cellular membrane fusion;protein complex assembly,basolateral plasma membrane;apical plasma membrane;sarcolemma;vacuole;myelin sheath adaxonal region;specific granule;perinuclear region of cytoplasm;trans-Golgi network;SNARE complex;cytosol;lateral loop;integral to membrane;cell surface,,,,,,,,,,,,,,
3437,Q12846,STX4,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),RQGDDSSDEEDKE,_THELRQGDDS(ph)S(ph)DEEDK_,S15,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,post-Golgi vesicle-mediated transport;intracellular protein transport;synaptic vesicle docking involved in exocytosis;cellular membrane organization;platelet activation;cellular membrane fusion;protein complex assembly,basolateral plasma membrane;apical plasma membrane;sarcolemma;vacuole;myelin sheath adaxonal region;specific granule;perinuclear region of cytoplasm;trans-Golgi network;SNARE complex;cytosol;lateral loop;integral to membrane;cell surface,,,,,,,,,,,,,,
3438,Q12851,MAP4K2,Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein),EFQELDSPDDTMG,_SASEFQELDS(ph)PDDTM(ox)GTIK_,S394,,23.42,,,,,,,,,,,,,23.42,0.00, , , , , , , , , , , , ,positive regulation of JNK cascade;immune response;activation of JUN kinase activity;vesicle targeting;innate immune response,basolateral plasma membrane;Golgi membrane,,+,,,,,,,,,,,,
3439,Q12857,NFIA,Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein),YTGQGRSPGSGSQ,_S(ph)PGSGSQSSGWHEVEPGM(ox)PS(ph)PTTLK_,S278,,25.98,22.99,,22.41,,,,,,,,,,23.79,2.19,-0.80, ,-1.39, , , , , , , , , ,"transcription, DNA-dependent;DNA replication;viral genome replication",cell junction;nucleus,CTF/NF-I family,,,,,,,,,,,,,
3440,Q12857,NFIA,Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein),VEPGMPSPTTLKK,_S(ph)PGSGSQSSGWHEVEPGM(ox)PS(ph)PTTLK_,S297,,25.15,,,,,,,,,,,,,25.15,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;DNA replication;viral genome replication",cell junction;nucleus,CTF/NF-I family,,,,,,,,,,,,,
3441,Q12857,NFIA,Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein),STKRLKSVEDEMD,_S(ph)VEDEM(ox)DS(ph)PGEEPFYTGQGR_,S258,,25.24,,,,,,,,,,,,,25.24,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;DNA replication;viral genome replication",cell junction;nucleus,CTF/NF-I family,,,,,,,,,,,,,
3442,Q12857,NFIA,Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein),VEDEMDSPGEEPF,_S(ph)VEDEM(ox)DS(ph)PGEEPFYTGQGR_,S265,+,26.18,23.21,,,25.05,24.53,24.70,24.04,24.32,,24.17,24.37,,24.51,1.67,-1.30, , ,0.54,0.02,0.19,-0.46,-0.19, ,-0.34,-0.14, ,"transcription, DNA-dependent;DNA replication;viral genome replication",cell junction;nucleus,CTF/NF-I family,,,,,,,,,,,,,
3445,Q12872,SFSWAP,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",KKSGVSSDNEDDD,_SGVSS(ph)DNEDDDDEEDGNYLHPSLFASK_,S76,,25.82,,,,25.61,,,,23.98,25.56,,24.86,,25.17,0.65, , , ,0.44, , , ,-1.18,0.40, ,-0.31, ,"negative regulation of mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA splice site selection",nucleus,,,,,,,,,,,,,,
3447,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),GDGPPSSPTNDPT,_ELQGDGPPSS(ph)PTNDPTVK_,S713,,27.69,26.24,26.45,25.66,25.72,27.05,,25.14,26.87,25.32,,23.87,24.90,25.90,1.79,0.34,0.55,-0.24,-0.18,1.15, ,-0.76,0.97,-0.58, ,-2.03,-1.00,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
3448,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),TEADAPSPAPSLG,_M(ox)ETEADAPS(ph)PAPS(ph)LGERLEPR_,S1601,,27.88,26.33,26.47,26.95,27.42,28.29,26.90,26.71,28.11,27.09,25.35,25.76,27.88,27.01,0.87,-0.68,-0.54,-0.06,0.40,1.28,-0.11,-0.30,1.10,0.08,-1.66,-1.25,0.87,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
3449,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),APSPAPSLGERLE,_M(ox)ETEADAPS(ph)PAPS(ph)LGERLEPR_,S1605,,26.64,23.17,23.90,23.58,25.06,,,22.60,25.24,23.58,,,,24.22,2.42,-1.05,-0.32,-0.64,0.84, , ,-1.62,1.02,-0.64, , , ,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
3450,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),PPLDYGSGEDDGK,_NDM(ox)DEPPPLDYGS(ph)GEDDGK_,S597,,23.19,22.89,22.89,,,,23.96,,24.44,23.69,,22.89,,23.42,-0.23,-0.53,-0.53, , , ,0.54, ,1.01,0.26, ,-0.53, ,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
3452,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),SEDMPFSPKASVA,_SEDMPFS(ph)PK_,S265,+,27.82,28.16,27.04,28.57,27.34,28.50,27.18,27.52,27.91,27.63,27.22,27.28,27.55,27.67,0.15,0.49,-0.63,0.90,-0.33,0.83,-0.49,-0.15,0.24,-0.04,-0.45,-0.39,-0.12,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3453,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),LGIEDISPNLSPD,_ETAVPGPLGIEDIS(ph)PNLSPDDK_,S1426,,24.18,,,,,,,,,,,,,24.18,0.00, , , , , , , , , , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3454,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),DISPNLSPDDKSF,_ETAVPGPLGIEDISPNLS(ph)PDDK_,S1430,,25.56,,,,26.56,,,,,24.44,,,,25.52,0.04, , , ,1.04, , , , ,-1.08, , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3455,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),DGEVQLSQNDDKT,_FVPAENDSILMNPAQDGEVQLS(ph)QNDDK_,S580,,27.52,,,,,,23.66,,25.68,26.66,,,,25.88,1.64, , , , , ,-2.22, ,-0.20,0.78, , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3457,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),LLHFPSSQGEEEK,_GNLLHFPSS(ph)QGEEEK_,S1068,+,24.20,25.25,,22.93,23.34,25.07,24.50,24.73,24.86,,25.18,,26.34,24.64,-0.44,0.61, ,-1.71,-1.30,0.43,-0.14,0.09,0.22, ,0.53, ,1.70,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3458,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),EDTEPMSPVLNSK,_M(ox)ESLSSHRIDEDGENTQIEDTEPM(ox)S(ph)PVLNSK_,S552,+,27.09,26.64,25.62,27.05,28.49,29.08,28.02,28.76,28.27,25.75,28.40,28.19,29.17,27.73,-0.65,-1.10,-2.11,-0.69,0.76,1.34,0.29,1.02,0.54,-1.98,0.67,0.46,1.44,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3459,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),VAESVASPQKTMS,_NGSTAVAESVAS(ph)PQK_,S1028,+,25.59,26.67,27.32,26.84,25.74,26.06,26.54,26.13,26.46,26.83,25.10,25.22,25.98,26.19,-0.60,0.48,1.13,0.65,-0.45,-0.13,0.35,-0.06,0.27,0.64,-1.09,-0.97,-0.21,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3460,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),KRKLITSEEERSP,_LITS(ph)EEERS(ph)PAK_,S1673,,24.72,,,23.40,,,,,,,,,,24.06,0.66, , ,-0.66, , , , , , , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3461,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),TSEEERSPAKRGR,_LITSEEERS(ph)PAK_,S1678,+,27.23,28.70,28.70,25.88,24.72,22.69,26.01,24.47,24.27,25.63,23.46,24.83,22.83,25.34,1.89,3.36,3.36,0.54,-0.62,-2.65,0.67,-0.87,-1.07,0.29,-1.89,-0.51,-2.51,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3462,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),LSTSEYSQSPKME,_LM(ox)LSTSEYS(ph)QS(ph)PK_,S523,,24.08,23.43,,,,,,,,,,,,23.75,0.32,-0.32, , , , , , , , , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3463,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),TSEYSQSPKMESL,_LM(ox)LSTSEYS(ph)QS(ph)PK_,S525,+,24.69,24.43,24.43,24.60,24.95,25.21,24.27,,24.97,24.48,23.83,24.53,24.60,24.58,0.11,-0.15,-0.15,0.02,0.37,0.62,-0.31, ,0.39,-0.10,-0.75,-0.05,0.02,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3466,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),VIQGPSSPQGEAM,_M(ox)VIQGPSS(ph)PQGEAM(ox)VTDVLEDQK_,S1114,+,28.02,26.68,27.45,26.85,29.36,29.65,28.26,29.26,29.50,28.74,26.17,28.07,29.43,28.26,-0.24,-1.58,-0.82,-1.42,1.10,1.39,-0.01,1.00,1.23,0.48,-2.09,-0.19,1.17,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3467,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),EIEPKNSPEDLGL,_NS(ph)PEDLGLSLTGDSCK_,S500,,24.06,,,,24.17,,,23.58,24.84,24.45,,,,24.22,-0.16, , , ,-0.05, , ,-0.64,0.62,0.23, , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3471,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),ALRRSDSPEIPFQ,_RSDS(ph)PEIPFQAAAGPSDGLDASSPGNSFVGLR_,S1462,+,27.89,,,,27.74,26.14,25.83,26.47,27.82,26.75,,27.75,,27.05,0.84, , , ,0.69,-0.91,-1.22,-0.58,0.77,-0.30, ,0.70, ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3473,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),TRSEALSSVLDQE,_SEALS(ph)S(ph)VLDQEEAM(ox)EIK_,S639,,21.68,,,,22.41,22.68,,22.92,23.35,,,,,22.61,-0.93, , , ,-0.19,0.08, ,0.31,0.74, , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3474,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),RSEALSSVLDQEE,_SEALS(ph)S(ph)VLDQEEAM(ox)EIK_,S640,,22.48,,,,,,,,,,,,,22.48,0.00, , , , , , , , , , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3475,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),EPVEQDSSQPSLP,_SGTAETEPVEQDS(ph)SQPSLPLVR_,S830,,26.31,,,23.82,26.46,26.14,,26.00,25.83,,,24.36,,25.56,0.74, , ,-1.74,0.90,0.58, ,0.44,0.27, , ,-1.20, ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3476,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),PVEQDSSQPSLPL,_SGTAETEPVEQDSS(ph)QPSLPLVR_,S831,+,25.63,25.75,23.72,,,25.58,24.98,25.49,25.63,25.28,25.27,24.22,,25.16,0.47,0.59,-1.44, , ,0.43,-0.18,0.33,0.48,0.12,0.12,-0.93, ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3477,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),SDLVAPSPDAFRS,_SLVQDSLSTNSSDLVAPS(ph)PDAFR_,S366,,26.03,,,,25.47,,,,26.04,24.67,,26.03,25.04,25.55,0.48, , , ,-0.07, , , ,0.49,-0.88, ,0.48,-0.51,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3478,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),GLQIQKSPEPEVL,_S(ph)PEPEVLSTQEDLFDQSNK_,S294,+,26.90,25.91,25.93,25.44,23.10,23.35,27.26,25.35,28.86,28.66,26.98,27.91,25.43,26.24,0.66,-0.33,-0.31,-0.80,-3.14,-2.89,1.03,-0.88,2.63,2.42,0.74,1.67,-0.80,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3480,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),PFIVPSSPTEQEG,_STPFIVPSS(ph)PTEQEGR_,S380,+,27.77,26.92,25.04,27.50,28.37,27.82,28.05,26.50,28.61,27.40,27.46,28.22,27.83,27.50,0.27,-0.58,-2.46,0.00,0.87,0.32,0.55,-1.00,1.11,-0.10,-0.04,0.72,0.33,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3481,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),DTKEEKSVEYEGD,_S(ph)VEYEGDLK_,S809,+,23.83,25.28,25.48,25.13,21.83,24.46,25.24,24.05,24.80,24.11,22.80,23.61,23.63,24.17,-0.34,1.11,1.30,0.95,-2.35,0.29,1.06,-0.12,0.63,-0.06,-1.37,-0.56,-0.54,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3482,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),QPNRTSSVLGMSV,_TSS(ph)VLGM(ox)SVESAPAVEEEK_,S119,,24.19,23.02,,,,,,,21.99,,,,,23.07,1.12,-0.05, , , , , , ,-1.07, , , , ,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
3483,Q12893,TMEM115,Transmembrane protein 115 (Placental protein 6) (PP6) (Protein PL6),SGAKVDSPLPSDK,_VDS(ph)PLPSDK_,S320,,25.08,,,24.77,,,,,23.28,,,,,24.38,0.70, , ,0.39, , , , ,-1.09, , , , ,negative regulation of cell proliferation;replicative cell aging,integral to membrane;Golgi apparatus;nucleus,,,,,,,,,,,,,,
3484,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),GAEGRDSSKGEDS,_VLQDM(ox)GLPTGAEGRDS(ph)S(ph)K_,S476,+,28.04,25.85,21.39,24.13,23.36,,27.29,,22.86,28.07,24.14,27.19,,25.23,2.81,0.62,-3.84,-1.11,-1.87, ,2.06, ,-2.37,2.83,-1.09,1.96, ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
3485,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),AEGRDSSKGEDSA,_VLQDM(ox)GLPTGAEGRDS(ph)S(ph)K_,S477,,26.70,26.54,27.25,,,,,,25.09,23.27,,,,25.77,0.93,0.77,1.48, , , , , ,-0.68,-2.50, , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
3486,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),SSKGEDSAEETEA,_DSSKGEDS(ph)AEETEAK_,S482,+,29.71,25.69,26.32,26.43,29.37,28.06,28.10,28.68,29.18,30.35,29.12,28.30,30.52,28.45,1.26,-2.76,-2.13,-2.02,0.93,-0.39,-0.35,0.23,0.73,1.90,0.67,-0.15,2.07,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
3490,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),SSEQAESDNMDVP,_GSSEQAES(ph)DNM(ox)DVPPEDDSK_,S62,+,24.11,24.19,23.99,24.78,,24.92,24.49,,24.57,23.99,24.45,23.59,23.50,24.24,-0.12,-0.04,-0.24,0.55, ,0.69,0.26, ,0.33,-0.24,0.21,-0.65,-0.73,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
3492,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),LAGETLSVNDPPD,_VLAGETLS(ph)VNDPPDVLDR_,S190,,22.46,,,,,,,,,,,,,22.46,0.00, , , , , , , , , , , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
3493,Q12913,PTPRJ,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),AKNNEVSFSQIKP,_NNEVS(ph)FSQIKPK_,S1009,+,24.02,21.33,21.33,20.80,24.24,24.65,22.01,24.00,25.34,25.29,21.53,24.95,24.54,23.39,0.64,-2.05,-2.05,-2.59,0.85,1.26,-1.38,0.62,1.96,1.90,-1.86,1.56,1.15,negative regulation of cell proliferation;positive regulation of focal adhesion assembly;negative regulation of protein kinase B signaling cascade;negative regulation of MAP kinase activity;negative regulation of cell growth;negative regulation of cell migration;contact inhibition;platelet-derived growth factor receptor signaling pathway;positive regulation of protein kinase B signaling cascade;vasculogenesis;negative regulation of T cell receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;positive chemotaxis;negative regulation of platelet-derived growth factor receptor signaling pathway;heart development;negative regulation of vascular permeability,ruffle membrane;cell-cell junction;integral to plasma membrane;cell surface;immunological synapse,,,+,,,,,,,,,,,
3494,Q12913,PTPRJ,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),NNEVSFSQIKPKK,_NNEVSFS(ph)QIKPK_,S1011,,23.33,,,,,,,,,23.23,,23.47,,23.34,-0.01, , , , , , , , ,-0.11, ,0.12, ,negative regulation of cell proliferation;positive regulation of focal adhesion assembly;negative regulation of protein kinase B signaling cascade;negative regulation of MAP kinase activity;negative regulation of cell growth;negative regulation of cell migration;contact inhibition;platelet-derived growth factor receptor signaling pathway;positive regulation of protein kinase B signaling cascade;vasculogenesis;negative regulation of T cell receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;positive chemotaxis;negative regulation of platelet-derived growth factor receptor signaling pathway;heart development;negative regulation of vascular permeability,ruffle membrane;cell-cell junction;integral to plasma membrane;cell surface;immunological synapse,,,+,,,,,,,,,,,
3495,Q12923,PTPN13,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),NMGRAISTGSLAS,_AIS(ph)TGSLASSTLNK_,S876,,20.81,,,22.38,,22.89,22.56,,,,,,,22.16,-1.35, , ,0.22, ,0.73,0.40, , , , , , ,,neuron projection;plasma membrane;nucleus;cytoskeleton;lamellipodium;cell body;cytoplasm,,,+,,,,,,,,,,,
3496,Q12923,PTPN13,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),TYQIKGSPNLTLP,_GS(ph)PNLTLPK_,S1981,,,22.56,22.56,22.17,,,22.84,21.18,,21.90,,22.43,,22.24, ,0.33,0.33,-0.07, , ,0.61,-1.05, ,-0.34, ,0.20, ,,neuron projection;plasma membrane;nucleus;cytoskeleton;lamellipodium;cell body;cytoplasm,,,+,,,,,,,,,,,
3497,Q12923,PTPN13,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),VASLNRSPERRKH,_SVASLNRS(ph)PER_,S1001,,,,,,,,23.43,22.68,,,,,,23.05, , , , , , ,0.38,-0.38, , , , , ,,neuron projection;plasma membrane;nucleus;cytoskeleton;lamellipodium;cell body;cytoplasm,,,+,,,,,,,,,,,
3499,Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,EAFSELSKRKKNK,_AAEAFSELS(ph)K_,S298,,22.72,21.70,21.70,25.31,,,23.53,24.32,,,,,,23.21,-0.49,-1.51,-1.51,2.10, , ,0.32,1.11, , , , , ,cell proliferation;behavioral response to ethanol;epidermal growth factor receptor signaling pathway;actin cytoskeleton reorganization;actin filament bundle assembly;adult locomotory behavior,N-methyl-D-aspartate selective glutamate receptor complex;postsynaptic density,,,,+,,,,,,,,,,
3500,Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,NITRQNSSSSDSG,_(gl)QNS(ph)SSSDSGGSIVR_,S659,+,21.56,23.49,23.49,26.75,25.16,23.80,25.29,25.47,24.92,25.66,23.63,25.06,24.42,24.52,-2.96,-1.02,-1.02,2.23,0.64,-0.72,0.78,0.95,0.41,1.15,-0.88,0.54,-0.09,cell proliferation;behavioral response to ethanol;epidermal growth factor receptor signaling pathway;actin cytoskeleton reorganization;actin filament bundle assembly;adult locomotory behavior,N-methyl-D-aspartate selective glutamate receptor complex;postsynaptic density,,,,+,,,,,,,,,,
3501,Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,PVDRRKSQMEEVQ,_S(ph)QM(ox)EEVQDELIHR_,S685,+,22.82,22.11,22.16,23.56,,,25.21,22.15,24.77,23.89,24.88,26.09,22.66,23.66,-0.84,-1.56,-1.50,-0.10, , ,1.55,-1.52,1.11,0.22,1.22,2.42,-1.00,cell proliferation;behavioral response to ethanol;epidermal growth factor receptor signaling pathway;actin cytoskeleton reorganization;actin filament bundle assembly;adult locomotory behavior,N-methyl-D-aspartate selective glutamate receptor complex;postsynaptic density,,,,+,,,,,,,,,,
3502,Q12933,TRAF2,TNF receptor-associated factor 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3),SVTPPGSLELLQP,_(ac)AAASVT(ph)PPGS(ph)LELLQPGFSK_,S11,,25.80,,,,,,,,,,,,,25.80,0.00, , , , , , , , , , , , ,protein K63-linked ubiquitination;protein autoubiquitination;positive regulation of NF-kappaB transcription factor activity;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular protein complex assembly;positive regulation of interleukin-2 production;protein homotrimerization;positive regulation of extrinsic apoptotic signaling pathway;negative regulation of glial cell apoptotic process;positive regulation of T cell activation;positive regulation of JUN kinase activity;protein catabolic process;innate immune response;positive regulation of protein homodimerization activity;tumor necrosis factor-mediated signaling pathway;activation of NF-kappaB-inducing kinase activity;regulation of immunoglobulin secretion;positive regulation of T cell cytokine production,cytosol;cell cortex;CD40 receptor complex;membrane raft;internal side of plasma membrane,,,,,,,,,,,,,,
3504,Q12955,ANK3,Ankyrin-3 (ANK-3) (Ankyrin-G),LGARSASLRSFSS,_SAS(ph)LRS(ph)FSSDR_,S913,,24.77,,,,,,,,,,,,,24.77,0.00, , , , , , , , , , , , ,maintenance of protein location in plasma membrane;positive regulation of sodium ion transmembrane transporter activity;regulation of potassium ion transport;synapse organization;axonogenesis;Golgi to plasma membrane protein transport;cytokinesis after mitosis;positive regulation of sodium ion transport;protein targeting to plasma membrane;positive regulation of gene expression;positive regulation of membrane potential;regulation of action potential in neuron;axon guidance;membrane assembly;signal transduction;positive regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential,intercalated disc;basolateral plasma membrane;lateral plasma membrane;node of Ranvier;T-tubule;spectrin-associated cytoskeleton;costamere;postsynaptic membrane;cell surface;axon initial segment;lysosome,,,,,,,,,,,,,,
3505,Q12955,ANK3,Ankyrin-3 (ANK-3) (Ankyrin-G),RSASLRSFSSDRS,_SAS(ph)LRS(ph)FSSDR_,S916,,24.77,,,,,,,,,,,,,24.77,0.00, , , , , , , , , , , , ,maintenance of protein location in plasma membrane;positive regulation of sodium ion transmembrane transporter activity;regulation of potassium ion transport;synapse organization;axonogenesis;Golgi to plasma membrane protein transport;cytokinesis after mitosis;positive regulation of sodium ion transport;protein targeting to plasma membrane;positive regulation of gene expression;positive regulation of membrane potential;regulation of action potential in neuron;axon guidance;membrane assembly;signal transduction;positive regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential,intercalated disc;basolateral plasma membrane;lateral plasma membrane;node of Ranvier;T-tubule;spectrin-associated cytoskeleton;costamere;postsynaptic membrane;cell surface;axon initial segment;lysosome,,,,,,,,,,,,,,
3506,Q12959,DLG1,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),SSISSGSGSLRTS,_EQM(ox)M(ox)NSSISSGS(ph)GSLR_,S540,,26.60,,,25.32,,,,,,,,,,25.96,0.64, , ,-0.64, , , , , , , , , ,cell-cell adhesion;mitotic cell cycle G1/S transition checkpoint;embryonic skeletal system morphogenesis;immunological synapse formation;actin filament organization;reproductive structure development;negative regulation of epithelial cell proliferation;positive regulation of establishment of protein localization to plasma membrane;branching involved in ureteric bud morphogenesis;regulation of membrane potential;peristalsis;synaptic transmission;activation of protein kinase activity;negative regulation of T cell proliferation;tight junction assembly;negative regulation of mitotic cell cycle;hard palate development;amyloid precursor protein metabolic process;T cell activation;T cell cytokine production;positive regulation of actin filament polymerization;smooth muscle tissue development;establishment or maintenance of cell polarity;positive regulation of cell proliferation;lens development in camera-type eye;membrane raft organization;virus-host interaction;endothelial cell proliferation;cortical actin cytoskeleton organization;axon guidance;protein localization to plasma membrane;positive regulation of potassium ion transport,membrane raft;basolateral plasma membrane;lateral plasma membrane;node of Ranvier;tight junction;myelin sheath abaxonal region;nucleus;endoplasmic reticulum membrane;endoplasmic reticulum;Golgi apparatus;sarcolemma;internal side of plasma membrane;postsynaptic density;perinuclear region of cytoplasm;cell projection membrane;immunological synapse;cytosol;lateral loop;neuromuscular junction;microtubule;MPP7-DLG1-LIN7 complex;postsynaptic membrane,,,+,,,,,,,,,,,
3507,Q12959,DLG1,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),ISSGSGSLRTSQK,_EQM(ox)M(ox)NSSISSGSGS(ph)LR_,S542,,26.34,25.46,,24.61,22.15,,,,,,,,,24.64,1.70,0.82, ,-0.03,-2.49, , , , , , , , ,cell-cell adhesion;mitotic cell cycle G1/S transition checkpoint;embryonic skeletal system morphogenesis;immunological synapse formation;actin filament organization;reproductive structure development;negative regulation of epithelial cell proliferation;positive regulation of establishment of protein localization to plasma membrane;branching involved in ureteric bud morphogenesis;regulation of membrane potential;peristalsis;synaptic transmission;activation of protein kinase activity;negative regulation of T cell proliferation;tight junction assembly;negative regulation of mitotic cell cycle;hard palate development;amyloid precursor protein metabolic process;T cell activation;T cell cytokine production;positive regulation of actin filament polymerization;smooth muscle tissue development;establishment or maintenance of cell polarity;positive regulation of cell proliferation;lens development in camera-type eye;membrane raft organization;virus-host interaction;endothelial cell proliferation;cortical actin cytoskeleton organization;axon guidance;protein localization to plasma membrane;positive regulation of potassium ion transport,membrane raft;basolateral plasma membrane;lateral plasma membrane;node of Ranvier;tight junction;myelin sheath abaxonal region;nucleus;endoplasmic reticulum membrane;endoplasmic reticulum;Golgi apparatus;sarcolemma;internal side of plasma membrane;postsynaptic density;perinuclear region of cytoplasm;cell projection membrane;immunological synapse;cytosol;lateral loop;neuromuscular junction;microtubule;MPP7-DLG1-LIN7 complex;postsynaptic membrane,,,+,,,,,,,,,,,
3509,Q12965,MYO1E,Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E),PLPRQQSTSSDRV,_(gl)QQS(ph)TSSDRVSQTPESLDFLK_,S1002,,24.62,,,23.99,22.96,,24.62,,,22.08,,26.36,,24.11,0.51, , ,-0.11,-1.15, ,0.51, , ,-2.02, ,2.26, ,glomerular visceral epithelial cell development;glomerular basement membrane development;platelet-derived growth factor receptor signaling pathway;vasculogenesis;endocytosis;in utero embryonic development;actin filament-based movement;post-embryonic hemopoiesis;glomerular filtration,cell-cell junction;adherens junction;myosin complex;clathrin-coated vesicle;cytoplasm,,,,,,,,,,,,,,
3511,Q12982,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,EVIRKGSITEYTA,_KGS(ph)ITEYTAAEEK_,S114,+,26.22,26.82,25.97,27.67,24.92,27.24,27.05,26.16,26.84,25.30,27.63,26.75,26.67,26.56,-0.34,0.26,-0.59,1.11,-1.63,0.69,0.49,-0.40,0.28,-1.25,1.07,0.19,0.12,negative regulation of apoptotic process;positive regulation of small GTPase mediated signal transduction;positive regulation of muscle cell differentiation;positive regulation of MAPK cascade;positive regulation of neuron differentiation;striated muscle cell differentiation;apoptotic process;muscle cell differentiation,cytosol;nuclear envelope;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3512,Q12983,BNIP3,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,SETDTHSIGEKNS,_ASETDTHS(ph)IGEK_,S86,+,23.69,24.07,20.95,25.71,,20.53,,20.02,,,21.17,,,22.31,1.39,1.76,-1.35,3.41, ,-1.78, ,-2.29, , ,-1.14, , ,negative regulation of apoptotic process;defense response to virus;cellular response to hydrogen peroxide;positive regulation of release of cytochrome c from mitochondria;mitochondrial protein catabolic process;reactive oxygen species metabolic process;cellular response to cobalt ion;induction of apoptosis;cellular response to mechanical stimulus;neuron apoptotic process;brown fat cell differentiation;apoptotic DNA fragmentation;regulation of mitochondrial membrane permeability;chromatin remodeling;virus-host interaction;positive regulation of mitochondrial fission;negative regulation of membrane potential;response to hyperoxia;mitochondrial fragmentation involved in apoptotic process;negative regulation of mitochondrial fusion;cellular response to hypoxia;positive regulation of protein complex disassembly;autophagic cell death,nucleoplasm;nuclear envelope;integral to mitochondrial outer membrane;dendrite,,,,,,,,,,,,,,
3513,Q12983,BNIP3,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,EKNSSQSEEDDIE,_NSSQS(ph)EEDDIER_,S95,,24.06,23.95,,24.51,,,,,,,,,,24.17,-0.11,-0.22, ,0.34, , , , , , , , , ,negative regulation of apoptotic process;defense response to virus;cellular response to hydrogen peroxide;positive regulation of release of cytochrome c from mitochondria;mitochondrial protein catabolic process;reactive oxygen species metabolic process;cellular response to cobalt ion;induction of apoptosis;cellular response to mechanical stimulus;neuron apoptotic process;brown fat cell differentiation;apoptotic DNA fragmentation;regulation of mitochondrial membrane permeability;chromatin remodeling;virus-host interaction;positive regulation of mitochondrial fission;negative regulation of membrane potential;response to hyperoxia;mitochondrial fragmentation involved in apoptotic process;negative regulation of mitochondrial fusion;cellular response to hypoxia;positive regulation of protein complex disassembly;autophagic cell death,nucleoplasm;nuclear envelope;integral to mitochondrial outer membrane;dendrite,,,,,,,,,,,,,,
3514,Q12986,NFX1,"Transcriptional repressor NF-X1 (EC 6.3.2.-) (Nuclear transcription factor, X box-binding protein 1)",TDLREHSPSESEK,_SESGTDLREHS(ph)PSESEK_,S34,,,,,,,20.57,22.16,22.76,22.11,,23.05,21.32,,21.99, , , , , ,-1.42,0.16,0.77,0.12, ,1.05,-0.68, ,inflammatory response;negative regulation of transcription from RNA polymerase II promoter;negative regulation of MHC class II biosynthetic process;virus-host interaction;transcription from RNA polymerase II promoter,nucleus,Other TF domain,,,,,,,,,,,,,
3516,Q13009,TIAM1,T-lymphoma invasion and metastasis-inducing protein 1 (TIAM-1),TCQRANSLGDLYA,_ANS(ph)LGDLYAQK_,S231,+,24.04,,,,22.96,,22.54,22.85,22.49,23.73,,23.60,,23.17,0.87, , , ,-0.21, ,-0.63,-0.32,-0.69,0.56, ,0.42, ,ephrin receptor signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;positive regulation of axonogenesis,cytosol;cell-cell junction;plasma membrane,,,,,,,,,,,,,,
3517,Q13009,TIAM1,T-lymphoma invasion and metastasis-inducing protein 1 (TIAM-1),QLLKTESLPSSQQ,_TES(ph)LPSSQQYVPFGGK_,S1407,,22.93,,,,,,,,,,,,,22.93,0.00, , , , , , , , , , , , ,ephrin receptor signaling pathway;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;positive regulation of axonogenesis,cytosol;cell-cell junction;plasma membrane,,,,,,,,,,,,,,
3518,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),EDVFLPSPRDCFP,_ESTHQSEDVFLPS(ph)PR_,S968,,21.85,,,,23.12,,22.38,23.06,,,22.78,,,22.64,-0.78, , , ,0.48, ,-0.26,0.42, , ,0.14, , ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3519,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),DNPAITSDQELDD,_GGIDNPAITS(ph)DQELDDKK_,S1218,+,26.03,24.57,24.50,26.40,24.84,23.30,27.46,26.09,26.17,26.42,26.37,26.00,,25.68,0.35,-1.11,-1.18,0.72,-0.84,-2.38,1.78,0.41,0.49,0.74,0.70,0.32, ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3520,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),EEDPLLSPVETWK,_GSEEDPLLS(ph)PVETWK_,S1202,,23.19,,,,,,,,,,,,,23.19,0.00, , , , , , , , , , , , ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3521,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),HNLDVVSPIPANK,_HNLDVVS(ph)PIPANK_,S765,,23.17,,,,,,22.58,,21.22,22.53,,,,22.37,0.80, , , , , ,0.20, ,-1.15,0.15, , , ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3522,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),YYRRTHSDASDDE,_THS(ph)DAS(ph)DDEAFTTSK_,S1173,,25.08,23.65,23.65,24.60,23.53,,,24.36,,,,,,24.15,0.94,-0.49,-0.49,0.45,-0.62, , ,0.22, , , , , ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3523,Q13017,ARHGAP5,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),RTHSDASDDEAFT,_THS(ph)DAS(ph)DDEAFTTSK_,S1176,,25.08,23.65,23.65,24.43,,,,,,,,,,24.21,0.88,-0.55,-0.55,0.23, , , , , , , , , ,positive regulation of cell migration;cell adhesion;positive regulation of mesenchymal cell proliferation;Rho protein signal transduction;regulation of cell size,cytosol;membrane,,,,,,,,,,,,,,
3524,Q13029,PRDM2,PR domain zinc finger protein 2 (EC 2.1.1.43) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ),EEELNDSSEELYT,_EEEELNDS(ph)SEELYTTIK_,S922,,23.38,,,,,,,,,24.34,,,,23.86,-0.48, , , , , , , , ,0.48, , , ,"histone lysine methylation;transcription, DNA-dependent;response to estradiol stimulus",Golgi apparatus;nucleus,C2H2-type,,,,,,,,,,,,,
3525,Q13029,PRDM2,PR domain zinc finger protein 2 (EC 2.1.1.43) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ),KKRRTASPPALPK,_TAS(ph)PPALPK_,S361,+,23.96,22.62,22.14,22.90,24.04,23.65,22.54,23.14,22.66,21.94,,,22.64,22.93,1.03,-0.31,-0.79,-0.03,1.11,0.72,-0.39,0.21,-0.27,-0.99, , ,-0.29,"histone lysine methylation;transcription, DNA-dependent;response to estradiol stimulus",Golgi apparatus;nucleus,C2H2-type,,,,,,,,,,,,,
3526,Q13033,STRN3,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),WDKDDLSPTAEVW,_DDLS(ph)PTAEVWDVDQGLISK_,S335,,24.31,,,,,,,,,,,,,24.31,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;response to estradiol stimulus;positive regulation of transcription from RNA polymerase II promoter;negative regulation of intracellular estrogen receptor signaling pathway",nucleoplasm;neuronal cell body;Golgi apparatus;protein complex;cytoplasm;nucleus;plasma membrane;dendrite,,,,,,,,,,,,,,
3527,Q13033,STRN3,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),ILNGGESPKQKGQ,_NLEQILNGGES(ph)PKQK_,S229,+,25.95,23.27,23.66,23.95,25.50,25.05,25.43,26.05,25.65,26.83,25.53,,25.58,25.20,0.75,-1.93,-1.54,-1.25,0.29,-0.16,0.23,0.85,0.44,1.62,0.33, ,0.38,"negative regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;response to estradiol stimulus;positive regulation of transcription from RNA polymerase II promoter;negative regulation of intracellular estrogen receptor signaling pathway",nucleoplasm;neuronal cell body;Golgi apparatus;protein complex;cytoplasm;nucleus;plasma membrane;dendrite,,,,,,,,,,,,,,
3528,Q13043,STK4,Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N);Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)],QDDEENSEEDEMD,_EVDQDDEENS(ph)EEDEM(ox)DSGTM(ox)VR_,S320,,22.81,23.90,23.90,,23.90,,23.56,,,,,23.50,,23.59,-0.79,0.30,0.30, ,0.30, ,-0.03, , , , ,-0.09, ,intracellular protein kinase cascade;negative regulation of cell proliferation;protein autophosphorylation;peptidyl-serine phosphorylation;negative regulation of canonical Wnt receptor signaling pathway;patterning of blood vessels;hippo signaling cascade;induction of apoptosis;neural tube formation;apoptotic process;endocardium development;primitive hemopoiesis;keratinocyte differentiation;negative regulation of organ growth;cell differentiation involved in embryonic placenta development;cell morphogenesis;central nervous system development,cytosol;nucleus,,+,,,,,,,,,,,,
3529,Q13045,FLII,Protein flightless-1 homolog,AEAVLQSPGLSGK,_NAEAVLQS(ph)PGLSGK_,S856,+,24.94,24.55,24.33,25.79,27.31,26.30,27.39,27.63,25.35,24.64,25.96,25.95,25.67,25.83,-0.89,-1.28,-1.50,-0.04,1.47,0.47,1.56,1.79,-0.48,-1.19,0.13,0.12,-0.16,"multicellular organismal development;transcription, DNA-dependent;regulation of transcription, DNA-dependent;muscle contraction",nucleus;focal adhesion;centrosome,,,,,,,,,,,,,,
3530,Q13085,ACACA,Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)],SVSEDNSEDEISN,_FIIGSVSEDNS(ph)EDEISNLVK_,S29,+,22.94,,,,,25.07,23.19,24.10,24.32,25.30,25.13,25.90,,24.49,-1.56, , , , ,0.58,-1.30,-0.39,-0.17,0.80,0.63,1.41, ,triglyceride biosynthetic process;protein homotetramerization;response to drug;energy reserve metabolic process;multicellular organismal protein metabolic process;positive regulation of cellular metabolic process;malonyl-CoA biosynthetic process;tissue homeostasis;long-chain fatty-acyl-CoA biosynthetic process;acetyl-CoA metabolic process;response to organic cyclic compound;lipid homeostasis;fatty acid biosynthetic process,cytosol;mitochondrion,,,,,,,,,,,,,,
3531,Q13085,ACACA,Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)],__MDEPSPLAQPL,_(ac)M(ox)DEPS(ph)PLAQPLELNQHSR_,S5,+,24.27,21.59,21.59,22.09,24.77,22.27,24.19,24.03,,,23.88,23.28,23.66,23.24,1.03,-1.65,-1.65,-1.15,1.53,-0.97,0.96,0.79, , ,0.64,0.04,0.43,triglyceride biosynthetic process;protein homotetramerization;response to drug;energy reserve metabolic process;multicellular organismal protein metabolic process;positive regulation of cellular metabolic process;malonyl-CoA biosynthetic process;tissue homeostasis;long-chain fatty-acyl-CoA biosynthetic process;acetyl-CoA metabolic process;response to organic cyclic compound;lipid homeostasis;fatty acid biosynthetic process,cytosol;mitochondrion,,,,,,,,,,,,,,
3532,Q13085,ACACA,Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)],HIRSSMSGLHLVK,_SSM(ox)S(ph)GLHLVK_,S80,+,23.38,23.73,24.22,24.98,24.24,,24.98,25.51,22.68,23.52,25.70,26.70,,24.51,-1.13,-0.79,-0.29,0.47,-0.27, ,0.47,1.00,-1.83,-1.00,1.19,2.19, ,triglyceride biosynthetic process;protein homotetramerization;response to drug;energy reserve metabolic process;multicellular organismal protein metabolic process;positive regulation of cellular metabolic process;malonyl-CoA biosynthetic process;tissue homeostasis;long-chain fatty-acyl-CoA biosynthetic process;acetyl-CoA metabolic process;response to organic cyclic compound;lipid homeostasis;fatty acid biosynthetic process,cytosol;mitochondrion,,,,,,,,,,,,,,
3533,Q13098,GPS1,COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH),SPPREGSQGELTP,_SPPREGS(ph)QGELTPANSQSR_,S454,+,23.33,,,23.40,25.28,25.07,25.37,25.72,25.14,23.98,26.24,24.88,24.69,24.83,-1.50, , ,-1.43,0.45,0.24,0.54,0.89,0.31,-0.85,1.41,0.05,-0.14,inactivation of MAPK activity;cullin deneddylation;JNK cascade;cell cycle,signalosome;cytoplasm,,,,,,,,,,,,,,
3534,Q13103,SPP2,Secreted phosphoprotein 24 (Spp-24) (Secreted phosphoprotein 2),EQFYDRSLGIMRR,_S(ph)LGIM(ox)R_,S182,,,23.84,,,,,,,,,,,,23.84, ,0.00, , , , , , , , , , , ,skeletal system development;bone remodeling,extracellular region;protein complex,,,,,,,,,,,,,,
3535,Q13105,ZBTB17,Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60),LAEPATSPGGNAE,_SLAEPATS(ph)PGGNAEALATEGGDK_,S120,,23.14,23.25,23.25,23.11,,24.65,24.25,23.93,26.10,,,,,23.96,-0.82,-0.71,-0.71,-0.85, ,0.69,0.29,-0.03,2.14, , , , ,"positive regulation of transcription, DNA-dependent;activation of signaling protein activity involved in unfolded protein response;transcription, DNA-dependent;negative regulation of cell cycle;gastrulation with mouth forming second;ectoderm development",nucleoplasm,C2H2-type,,,,,,,,,,,,,
3536,Q13112,CHAF1B,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),QTHRGSSPGPRPV,_GSS(ph)PGPRPVEGTPASR_,S410,+,24.80,22.93,21.43,24.94,26.48,24.87,25.74,25.55,21.95,,22.27,,23.00,24.00,0.80,-1.07,-2.56,0.95,2.48,0.87,1.74,1.56,-2.04, ,-1.73, ,-0.99,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;protein complex assembly;cell cycle;DNA replication;DNA replication-dependent nucleosome assembly",cytoplasm;CAF-1 complex,,,,,,,,,,,,,,
3537,Q13112,CHAF1B,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),PGDAQGSPPELKR,_TDTPPSSVPTSVISTPSTEEIQSETPGDAQGS(ph)PPELK_,S538,,23.22,,,22.90,,,,,,23.98,,,,23.37,-0.14, , ,-0.47, , , , , ,0.61, , , ,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;protein complex assembly;cell cycle;DNA replication;DNA replication-dependent nucleosome assembly",cytoplasm;CAF-1 complex,,,,,,,,,,,,,,
3539,Q13127,REST,RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor),EDLSPPSPPLPKE,_ESVSTEDLSPPS(ph)PPLPK_,S841,+,24.86,24.10,24.04,24.24,24.22,25.93,25.17,25.13,25.71,25.25,,24.19,25.38,24.85,0.01,-0.75,-0.81,-0.61,-0.63,1.08,0.32,0.28,0.85,0.40, ,-0.66,0.53,"negative regulation of cortisol biosynthetic process;negative regulation of cell proliferation;cellular response to glucocorticoid stimulus;cellular response to electrical stimulus;negative regulation by host of viral transcription;negative regulation of neuron differentiation;cellular response to drug;histone H4 deacetylation;negative regulation of dense core granule biogenesis;negative regulation of calcium ion-dependent exocytosis;negative regulation of neurogenesis;negative regulation of aldosterone biosynthetic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of transcription, DNA-dependent;negative regulation of insulin secretion;cardiac muscle cell myoblast differentiation;negative regulation of amniotic stem cell differentiation;positive regulation of apoptotic process",cytosol;chromatin;transcriptional repressor complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
3540,Q13129,RLF,Zinc finger protein Rlf (Rearranged L-myc fusion gene protein) (Zn-15-related protein),KGICPKSPSAIPE,_S(ph)PSAIPEQNHSLNDQAK_,S326,,22.23,24.04,24.04,22.94,,,,,,24.23,,,22.70,23.36,-1.14,0.68,0.68,-0.42, , , , , ,0.87, , ,-0.67,"DNA mediated transformation;chromosome organization;DNA integration;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
3541,Q13131,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26),TPQRSGSVSNYRS,_SGS(ph)VSNYR_,S496,,23.85,22.15,,23.98,19.30,,,21.09,,,,22.55,,22.15,1.70,0.00, ,1.82,-2.86, , ,-1.06, , , ,0.40, ,"negative regulation of apoptotic process;cellular response to hydrogen peroxide;response to caffeine;fatty acid oxidation;fatty acid homeostasis;insulin receptor signaling pathway;negative regulation of lipid catabolic process;Wnt receptor signaling pathway;glucose metabolic process;fatty acid biosynthetic process;positive regulation of cholesterol biosynthetic process;cellular response to glucose starvation;negative regulation of TOR signaling cascade;activation of MAPK activity;cellular response to hypoxia;positive regulation of glycolysis;lipid biosynthetic process;transcription, DNA-dependent;regulation of vesicle-mediated transport;autophagy;cholesterol biosynthetic process;glucose homeostasis;positive regulation of autophagy;protein heterooligomerization;cell cycle arrest;response to activity;positive regulation of cell proliferation;regulation of circadian rhythm;regulation of energy homeostasis;negative regulation of glucosylceramide biosynthetic process;regulation of transcription, DNA-dependent;response to hypoxia;rhythmic process;cellular response to ethanol;regulation of fatty acid oxidation",cytosol;AMP-activated protein kinase complex;apical plasma membrane;nucleus,,+,,,,,,,,,,,,
3542,Q13131,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26),EITEAKSGTATPQ,_SIDDEITEAKS(ph)GTATPQR_,S486,,,,,,25.22,24.47,,25.59,,,22.39,,,24.42, , , , ,0.80,0.05, ,1.17, , ,-2.02, , ,"negative regulation of apoptotic process;cellular response to hydrogen peroxide;response to caffeine;fatty acid oxidation;fatty acid homeostasis;insulin receptor signaling pathway;negative regulation of lipid catabolic process;Wnt receptor signaling pathway;glucose metabolic process;fatty acid biosynthetic process;positive regulation of cholesterol biosynthetic process;cellular response to glucose starvation;negative regulation of TOR signaling cascade;activation of MAPK activity;cellular response to hypoxia;positive regulation of glycolysis;lipid biosynthetic process;transcription, DNA-dependent;regulation of vesicle-mediated transport;autophagy;cholesterol biosynthetic process;glucose homeostasis;positive regulation of autophagy;protein heterooligomerization;cell cycle arrest;response to activity;positive regulation of cell proliferation;regulation of circadian rhythm;regulation of energy homeostasis;negative regulation of glucosylceramide biosynthetic process;regulation of transcription, DNA-dependent;response to hypoxia;rhythmic process;cellular response to ethanol;regulation of fatty acid oxidation",cytosol;AMP-activated protein kinase complex;apical plasma membrane;nucleus,,+,,,,,,,,,,,,
3544,Q13136,PPFIA1,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),TSGKRSSDGSLSH,_RSS(ph)DGSLSHEEDLAK_,S239,+,23.42,25.43,25.94,24.44,25.30,25.52,26.21,26.71,25.48,25.42,25.81,25.60,24.76,25.39,-1.97,0.04,0.55,-0.95,-0.09,0.14,0.82,1.33,0.09,0.03,0.43,0.21,-0.62,cell-matrix adhesion,cytoplasm,,,,,,,,,,,,,,
3545,Q13136,PPFIA1,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),KRSSDGSLSHEED,_RS(ph)SDGS(ph)LSHEEDLAK_,S242,+,23.10,25.11,25.11,24.90,,,21.80,22.61,23.46,,,,,23.73,-0.63,1.38,1.38,1.18, , ,-1.93,-1.12,-0.27, , , , ,cell-matrix adhesion,cytoplasm,,,,,,,,,,,,,,
3549,Q13136,PPFIA1,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),IESRVGSGSLDNL,_VGS(ph)GSLDNLGR_,S666,+,,,,,22.96,24.16,22.69,23.02,23.04,,23.73,22.23,,23.12, , , , ,-0.16,1.04,-0.43,-0.10,-0.08, ,0.61,-0.89, ,cell-matrix adhesion,cytoplasm,,,,,,,,,,,,,,
3550,Q13136,PPFIA1,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),SRVGSGSLDNLGR,_VGSGS(ph)LDNLGR_,S668,,,,,22.85,,,21.63,,23.81,,,,,22.76, , , ,0.09, , ,-1.13, ,1.05, , , , ,cell-matrix adhesion,cytoplasm,,,,,,,,,,,,,,
3551,Q13144,EIF2B5,Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon),PDSRGGSPQMDDI,_GGS(ph)PQM(ox)DDIK_,S544,,22.41,25.56,,24.27,,,20.34,21.05,,,,,,22.73,-0.31,2.83, ,1.54, , ,-2.38,-1.68, , , , , ,positive regulation of translational initiation;astrocyte development;negative regulation of translational initiation in response to stress;RNA metabolic process;ovarian follicle development;response to glucose stimulus;myelination;response to peptide hormone stimulus;oligodendrocyte development;response to heat,cytosol;nucleus;eukaryotic translation initiation factor 2B complex,,,,,,,,,,,,,,
3553,Q13151,HNRNPA0,Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0),GGGGGGSRSSRGG,_EDIYSGGGGGGS(ph)R_,S188,,24.63,,,20.32,20.69,,,,,,,,,21.88,2.75, , ,-1.56,-1.19, , , , , , , , ,"inflammatory response;3'-UTR-mediated mRNA stabilization;mRNA splicing, via spliceosome;response to lipopolysaccharide",nucleoplasm;ribonucleoprotein complex,,,,,,,,,,,,,,
3554,Q13153,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),TRDVATSPISPTE,_DVATS(ph)PISPTENNTTPPDALTR_,S220,,22.24,,,,,,,,,,,,,22.24,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;neuromuscular junction development;cellular response to stress;protein autophosphorylation;T cell costimulation;wound healing;negative regulation of cell proliferation involved in contact inhibition;cellular response to insulin stimulus;apoptotic process;branching morphogenesis of a tube;exocytosis;positive regulation of JUN kinase activity;response to hypoxia;positive regulation of stress fiber assembly;axon guidance;T cell receptor signaling pathway;dendrite development;actin cytoskeleton reorganization;positive regulation of intracellular estrogen receptor signaling pathway;receptor clustering,Z disc;axon;intercalated disc;Golgi apparatus;protein complex;cytosol;growth cone;nuclear membrane;plasma membrane;focal adhesion;dendrite;ruffle,,+,,,,,,,,+,,,,
3555,Q13153,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),VATSPISPTENNT,_DVATSPIS(ph)PTENNTTPPDALTR_,S223,,26.35,,,,22.89,,,23.14,,,,,,24.13,2.23, , , ,-1.24, , ,-0.99, , , , , ,positive regulation of peptidyl-serine phosphorylation;neuromuscular junction development;cellular response to stress;protein autophosphorylation;T cell costimulation;wound healing;negative regulation of cell proliferation involved in contact inhibition;cellular response to insulin stimulus;apoptotic process;branching morphogenesis of a tube;exocytosis;positive regulation of JUN kinase activity;response to hypoxia;positive regulation of stress fiber assembly;axon guidance;T cell receptor signaling pathway;dendrite development;actin cytoskeleton reorganization;positive regulation of intracellular estrogen receptor signaling pathway;receptor clustering,Z disc;axon;intercalated disc;Golgi apparatus;protein complex;cytosol;growth cone;nuclear membrane;plasma membrane;focal adhesion;dendrite;ruffle,,+,,,,,,,,+,,,,
3557,Q13158,FADD,Protein FADD (FAS-associated death domain protein) (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity),NRSGAMSPMSWNS,_SGAM(ox)S(ph)PM(ox)SWNSDASTSEAS_,S194,,22.21,,,22.92,,,22.53,,,,,,,22.55,-0.34, , ,0.37, , ,-0.02, , , , , , ,defense response to virus;positive regulation of tumor necrosis factor production;necrotic cell death;innate immune response;extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of type I interferon-mediated signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of interleukin-8 production;cellular response to mechanical stimulus;positive regulation of extrinsic apoptotic signaling pathway;positive regulation of apoptotic process;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter,neuron projection;cytosol;CD95 death-inducing signaling complex;membrane raft;cell body,,,,,,,,,,,,,,
3558,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],EKDGFPSGTPALN,_DGFPS(ph)GTPALNAK_,S152,+,21.38,23.38,23.38,25.17,22.16,23.42,25.08,24.84,24.86,24.52,25.88,25.40,24.46,24.15,-2.77,-0.77,-0.77,1.02,-1.98,-0.73,0.93,0.69,0.71,0.37,1.73,1.26,0.31,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
3559,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],VLKFYDSNTVKQK,_FYDS(ph)NTVK_,S132,+,,24.12,24.37,25.37,22.99,21.76,23.98,24.14,,22.24,23.07,23.34,,23.54, ,0.58,0.83,1.83,-0.55,-1.78,0.45,0.60, ,-1.29,-0.47,-0.20, ,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
3560,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],KIISIFSGTEKGS,_IISIFS(ph)GTEK_,S58,,24.56,22.55,22.55,22.29,21.51,,,,,,,22.73,,22.70,1.86,-0.15,-0.15,-0.41,-1.19, , , , , , ,0.03, ,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
3561,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],VKQKYLSFTPPEK,_YLS(ph)FTPPEK_,S141,+,28.18,29.20,29.51,30.35,28.45,28.43,30.22,30.49,28.82,28.72,30.79,30.90,29.13,29.48,-1.30,-0.28,0.03,0.88,-1.02,-1.04,0.74,1.02,-0.66,-0.76,1.32,1.42,-0.35,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
3562,Q13177,PAK2,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27);PAK-2p34 (p34) (C-t-PAK2)],_____MSDNGELE,_(ac)S(ph)DNGELEDKPPAPPVR_,S2,+,26.95,25.21,24.80,26.84,27.51,27.00,27.86,28.24,26.48,25.95,26.83,27.38,25.96,26.69,0.26,-1.49,-1.89,0.14,0.82,0.30,1.17,1.54,-0.21,-0.74,0.13,0.69,-0.73,regulation of defense response to virus by virus;negative regulation of apoptotic process;protein autophosphorylation;T cell costimulation;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;axon guidance;T cell receptor signaling pathway;negative regulation of protein kinase activity;viral reproduction;positive regulation of extrinsic apoptotic signaling pathway;regulation of growth;virus-host interaction;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cytosol;plasma membrane;nucleus;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
3563,Q13185,CBX3,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),ERLTWHSCPEDEA,_LTWHS(ph)CPEDEAQ_,S176,,23.74,23.15,,23.85,,,22.92,22.23,,,,,,23.18,0.56,-0.03, ,0.67, , ,-0.26,-0.95, , , , , ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;chromatin remodeling","nuclear euchromatin;condensed chromosome, centromeric region;nuclear inner membrane;nuclear centromeric heterochromatin;spindle",,,,,,,,,,,,,,
3564,Q13185,CBX3,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),DGTKRKSLSDSES,_RKS(ph)LS(ph)DSESDDSK_,S93,+,26.81,24.29,24.92,21.41,22.42,21.78,19.13,23.14,19.18,,,,19.87,22.30,4.51,1.99,2.63,-0.89,0.13,-0.51,-3.17,0.85,-3.11, , , ,-2.42,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;chromatin remodeling","nuclear euchromatin;condensed chromosome, centromeric region;nuclear inner membrane;nuclear centromeric heterochromatin;spindle",,,,,,,,,,,,,,
3566,Q13188,STK3,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N);Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],EEEEENSDEDELD,_ELEEEEENS(ph)DEDELDSHTM(ox)VK_,S316,+,24.74,24.16,24.16,,25.34,25.03,24.60,24.99,23.87,24.38,24.75,,24.27,24.57,0.17,-0.42,-0.42, ,0.77,0.45,0.03,0.42,-0.71,-0.19,0.18, ,-0.30,intracellular protein kinase cascade;cell differentiation involved in embryonic placenta development;positive regulation of protein kinase B signaling cascade;negative regulation of cell proliferation;negative regulation of canonical Wnt receptor signaling pathway;hippo signaling cascade;positive regulation of JNK cascade;central nervous system development;neural tube formation;apoptotic process;endocardium development;primitive hemopoiesis;positive regulation of apoptotic process;negative regulation of organ growth,cytosol;nucleus,,+,,,,,,,,,,,,
3567,Q13188,STK3,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N);Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],MKRNATSPQVQRP,_NATS(ph)PQVQRPSFM(ox)DYFDK_,S385,,22.67,,,,,,,,,,,,23.32,23.00,-0.33, , , , , , , , , , , ,0.33,intracellular protein kinase cascade;cell differentiation involved in embryonic placenta development;positive regulation of protein kinase B signaling cascade;negative regulation of cell proliferation;negative regulation of canonical Wnt receptor signaling pathway;hippo signaling cascade;positive regulation of JNK cascade;central nervous system development;neural tube formation;apoptotic process;endocardium development;primitive hemopoiesis;positive regulation of apoptotic process;negative regulation of organ growth,cytosol;nucleus,,+,,,,,,,,,,,,
3568,Q13191,CBLB,E3 ubiquitin-protein ligase CBL-B (EC 6.3.2.-) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),AFPPPVSPRLNL_,_EFAFPPPVS(ph)PR_,S955,,22.67,20.56,,,,,,,,,,,,21.62,1.05,-1.05, , , , , , , , , , , ,negative regulation of alpha-beta T cell proliferation;T cell activation;immune response;response to gravity;negative regulation of T cell receptor signaling pathway;signal transduction;NLS-bearing substrate import into nucleus;response to hormone stimulus;positive regulation of protein catabolic process;positive regulation of T cell anergy;cell surface receptor signaling pathway;intracellular signal transduction,cytosol;membrane raft;plasma membrane;nucleus,,,,,,,,,,,,,,
3569,Q13191,CBLB,E3 ubiquitin-protein ligase CBL-B (EC 6.3.2.-) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),QNSPVTSPGSSPL,_QNSPVTS(ph)PGSS(ph)PLAQR_,S502,,,23.52,,23.81,,23.27,,,,,,,,23.53, ,-0.02, ,0.28, ,-0.27, , , , , , , ,negative regulation of alpha-beta T cell proliferation;T cell activation;immune response;response to gravity;negative regulation of T cell receptor signaling pathway;signal transduction;NLS-bearing substrate import into nucleus;response to hormone stimulus;positive regulation of protein catabolic process;positive regulation of T cell anergy;cell surface receptor signaling pathway;intracellular signal transduction,cytosol;membrane raft;plasma membrane;nucleus,,,,,,,,,,,,,,
3570,Q13191,CBLB,E3 ubiquitin-protein ligase CBL-B (EC 6.3.2.-) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),VTSPGSSPLAQRR,_QNSPVTS(ph)PGSS(ph)PLAQR_,S506,,,,,22.96,,,,,,,,,,22.96, , , ,0.00, , , , , , , , , ,negative regulation of alpha-beta T cell proliferation;T cell activation;immune response;response to gravity;negative regulation of T cell receptor signaling pathway;signal transduction;NLS-bearing substrate import into nucleus;response to hormone stimulus;positive regulation of protein catabolic process;positive regulation of T cell anergy;cell surface receptor signaling pathway;intracellular signal transduction,cytosol;membrane raft;plasma membrane;nucleus,,,,,,,,,,,,,,
3571,Q13200,PSMD2,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),PVQPQQSPAAAPG,_APVQPQQS(ph)PAAAPGGTDEKPSGK_,S16,+,26.91,27.96,28.11,27.53,,27.51,28.82,26.81,28.52,28.27,28.05,27.89,28.03,27.87,-0.96,0.09,0.24,-0.34, ,-0.36,0.95,-1.05,0.65,0.40,0.18,0.02,0.17,"regulation of protein catabolic process;S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome regulatory particle,,,,,,,,,,,,,,
3572,Q13200,PSMD2,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),NNRFGGSGSQVDS,_FGGS(ph)GSQVDSAR_,S361,,23.68,24.46,,25.32,,,,,,,,,,24.49,-0.81,-0.03, ,0.84, , , , , , , , , ,"regulation of protein catabolic process;S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome regulatory particle,,,,,,,,,,,,,,
3573,Q13206,DDX10,Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10),IEPRAPSLTNDEV,_APS(ph)LTNDEVEEFR_,S539,,25.39,,,23.75,22.85,,,,,,,,,24.00,1.39, , ,-0.25,-1.15, , , , , , , , ,,,,,,,,,,,,,,,,
3574,Q13216,ERCC8,DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA),_MLGFLSARQTGL,_(ac)M(ox)LGFLS(ph)AR_,S6,,25.11,21.44,21.44,,21.72,,,,,,,,,22.43,2.68,-0.99,-0.99, ,-0.71, , , , , , , , ,response to UV;response to oxidative stress;proteasomal ubiquitin-dependent protein catabolic process;protein autoubiquitination;transcription-coupled nucleotide-excision repair;response to X-ray;protein polyubiquitination;positive regulation of DNA repair,nucleoplasm;Cul4A-RING ubiquitin ligase complex;nucleotide-excision repair complex;nuclear matrix,,,,,,,,,,,,,,
3575,Q13233,MAP3K1,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),ATKLSASSEDISE,_LSAS(ph)SEDISER_,S923,+,23.52,23.22,22.19,24.42,22.61,,22.93,23.19,,22.30,,,,23.05,0.47,0.17,-0.86,1.38,-0.44, ,-0.12,0.14, ,-0.74, , , ,protein oligomerization;protein autophosphorylation;toll-like receptor 4 signaling pathway;peptidyl-serine phosphorylation;wound healing;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;Toll signaling pathway;positive regulation of actin filament polymerization;cellular response to mechanical stimulus;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;response to osmotic stress;apoptotic mitochondrial changes;regulation of cell migration;negative regulation of actin filament bundle assembly;innate immune response;positive regulation of apoptotic process;protein polyubiquitination;toll-like receptor 1 signaling pathway;camera-type eye development;positive regulation of viral transcription,cytosol;cytoskeleton,,+,,,,,,,,+,,,,
3577,Q13242,SRSF9,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",PYQSRGSPHYFSP,_GS(ph)PHYFS(ph)PFRPY_,S211,+,27.10,25.70,23.59,25.50,27.67,27.14,25.57,26.15,26.63,24.58,26.21,25.68,26.10,25.97,1.13,-0.27,-2.38,-0.47,1.70,1.17,-0.40,0.18,0.66,-1.39,0.24,-0.29,0.13,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm;nucleolus,,,,,,,,,,,,,,
3578,Q13242,SRSF9,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GSPHYFSPFRPY_,_GS(ph)PHYFS(ph)PFRPY_,S216,,26.45,20.75,,23.47,,,,,,,,,,23.56,2.90,-2.81, ,-0.09, , , , , , , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm;nucleolus,,,,,,,,,,,,,,
3581,Q13243,SRSF5,"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)",RSKSPASVDRQRS,_S(ph)PAS(ph)VDRQR_,S253,,24.88,23.82,24.04,25.02,,,,,,,,,,24.44,0.44,-0.62,-0.40,0.58, , , , , , , , , ,regulation of cell cycle;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;response to wounding;mRNA splice site selection,nucleolus;nuclear speck;cytoplasm,,,,,,,,,,,,,,
3584,Q13247,SRSF6,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",SQSRSNSPLPVPP,_SNS(ph)PLPVPPSK_,S303,+,26.01,,,26.65,26.33,26.30,,26.08,24.02,24.08,24.59,,,25.51,0.51, , ,1.14,0.82,0.80, ,0.57,-1.49,-1.43,-0.91, , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splice site selection",nucleoplasm,,,,,,,,,,,,,,
3585,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),ASAAAASAAAASA,_AASAAAAS(ph)AAAASAASGS(ph)PGPGEGSAGGEK_,S9,+,25.11,26.10,27.01,27.38,24.93,25.28,24.64,24.68,24.91,25.49,,27.47,25.30,25.69,-0.58,0.41,1.32,1.69,-0.76,-0.41,-1.05,-1.02,-0.78,-0.20, ,1.78,-0.40,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,,,,,,,,,,
3586,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),ASAAAASAASGSP,_AASAAAASAAAAS(ph)AASGSPGPGEGSAGGEK_,S14,+,24.05,23.90,23.90,23.07,23.80,24.22,,,,24.42,,,,23.91,0.14,-0.01,-0.01,-0.84,-0.11,0.31, , , ,0.51, , , ,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,,,,,,,,,,
3588,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),ASAASGSPGPGEG,_(ac)AASAAAASAAAASAASGS(ph)PGPGEGSAGGEK_,S19,+,32.11,30.52,30.59,31.10,31.95,31.63,31.20,31.56,31.65,31.49,30.67,30.58,31.38,31.26,0.85,-0.74,-0.67,-0.17,0.69,0.37,-0.06,0.29,0.38,0.22,-0.59,-0.69,0.11,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,,,,,,,,,,
3596,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),RLQEKLSPPYSSP,_LS(ph)PPYSSPQEFAQDVGR_,S752,,23.90,,,,22.45,,,,,23.52,,,,23.29,0.61, , , ,-0.84, , , , ,0.23, , , ,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,,,,,,,,,,
3605,Q13283,G3BP1,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1),DAQKSSSPAPADI,_SSS(ph)PAPADIAQTVQEDLR_,S232,+,31.55,27.18,26.76,30.36,32.50,30.46,30.10,31.36,30.26,29.35,30.76,30.41,30.09,30.09,1.46,-2.90,-3.32,0.27,2.41,0.38,0.01,1.27,0.18,-0.74,0.67,0.33,0.00,nucleic acid phosphodiester bond hydrolysis;transport;Ras protein signal transduction,cytosol;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
3606,Q13283,G3BP1,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1),TEPQEESEEEVEE,_YQDEVFGGFVTEPQEES(ph)EEEVEEPEER_,S149,+,29.31,,,,27.58,,22.97,,25.66,26.91,25.49,26.73,,26.38,2.93, , , ,1.21, ,-3.41, ,-0.72,0.53,-0.89,0.35, ,nucleic acid phosphodiester bond hydrolysis;transport;Ras protein signal transduction,cytosol;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
3608,Q13286,CLN3,Battenin (Batten disease protein) (Protein CLN3),RRRFSDSEGEETV,_RFS(ph)DS(ph)EGEETVPEPR_,S14,,25.41,,,23.84,25.29,,,,,22.06,,,,24.15,1.26, , ,-0.31,1.14, , , , ,-2.09, , , ,vacuolar transport;protein processing;neuromuscular process controlling balance;galactosylceramide metabolic process;protein folding;lysosomal lumen pH elevation;ionotropic glutamate receptor signaling pathway;cytosolic calcium ion homeostasis;cell death;receptor-mediated endocytosis;lysosomal lumen acidification;negative regulation of catalytic activity;negative regulation of macroautophagy;arginine transport;neurotransmitter metabolic process;negative regulation of proteolysis;sphingomyelin metabolic process;associative learning;vesicle transport along microtubule;protein catabolic process;amyloid precursor protein catabolic process;autophagic vacuole fusion;regulation of action potential;glucosylceramide metabolic process;negative regulation of neuron apoptotic process;cellular amino acid metabolic process;globoside metabolic process,mitochondrion;late endosome;synaptic vesicle;lysosomal membrane;Golgi membrane;early endosome;autophagic vacuole;trans-Golgi network;neuron projection;caveola;integral to endoplasmic reticulum membrane;Golgi stack;nucleus,,,,,,,,,,,,,,
3609,Q13287,NMI,N-myc-interactor (Nmi) (N-myc and STAT interactor),QILKEHSPDEFIK,_EHS(ph)PDEFIK_,S16,+,22.56,23.68,23.88,,,,23.28,,21.48,23.44,,22.80,,23.02,-0.45,0.66,0.86, , , ,0.27, ,-1.54,0.43, ,-0.22, ,inflammatory response;transcription from RNA polymerase II promoter;JAK-STAT cascade,nucleus;cytoplasm,,,,,,,,,,,,,,
3611,Q13322,GRB10,Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR),SIQPQVSPRQRVQ,_SIQPQVS(ph)PR_,S98,+,23.58,22.80,23.19,,23.71,22.75,23.81,23.73,21.98,,,,,23.19,0.39,-0.40,0.00, ,0.51,-0.44,0.62,0.53,-1.21, , , , ,negative regulation of insulin receptor signaling pathway;negative regulation of phosphorylation;positive regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of glycogen biosynthetic process;insulin receptor signaling pathway;insulin-like growth factor receptor signaling pathway;positive regulation of phosphorylation;negative regulation of Wnt receptor signaling pathway;negative regulation of glucose import,cytosol;plasma membrane,,,,+,,,,,,+,,,,
3613,Q13330,MTA1,Metastasis-associated protein MTA1,LPEASQSPLVLKQ,_LPEASQS(ph)PLVLK_,S505,+,23.23,21.10,,23.11,24.47,24.57,24.35,24.19,23.23,,22.68,,23.93,23.49,-0.26,-2.38, ,-0.37,0.98,1.08,0.87,0.70,-0.25, ,-0.81, ,0.45,signal transduction,NuRD complex;nucleus;cytoplasm,,,,,,,,,,,,,,
3614,Q13330,MTA1,Metastasis-associated protein MTA1,PVINNGSPTILGK,_VAPVINNGS(ph)PTILGKR_,S559,+,23.52,23.60,24.49,23.65,25.72,24.89,25.63,24.88,24.90,25.50,,24.10,25.58,24.71,-1.18,-1.10,-0.21,-1.06,1.01,0.18,0.92,0.18,0.20,0.80, ,-0.60,0.88,signal transduction,NuRD complex;nucleus;cytoplasm,,,,,,,,,,,,,,
3615,Q13371,PDCL,Phosducin-like protein (PHLP),TCHSEDSDLEID_,_NSATCHSEDS(ph)DLEID_,S296,,22.40,21.68,,22.65,,,22.67,,23.19,,,,,22.52,-0.12,-0.84, ,0.13, , ,0.15, ,0.67, , , , ,signal transduction;visual perception,,,,,,,,,,,,,,,
3617,Q13393,PLD1,Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),NTGSIRSLQTGVG,_S(ph)LQTGVGELHGETR_,S591,,22.42,23.16,,23.34,23.52,23.44,,23.23,22.93,22.30,22.70,,21.82,22.89,-0.46,0.27, ,0.45,0.63,0.56, ,0.34,0.05,-0.59,-0.18, ,-1.07,small molecule metabolic process;Ras protein signal transduction;phosphatidylglycerol biosynthetic process;chemotaxis;defense response to Gram-positive bacterium;phosphatidic acid biosynthetic process;positive regulation of cell migration;response to peptide hormone stimulus;phospholipid catabolic process,endosome;Golgi apparatus;late endosome membrane;Golgi cisterna;Golgi membrane;perinuclear region of cytoplasm;vesicle;endoplasmic reticulum membrane;lamellipodium,,,,,,,,,,,,,,
3618,Q13409,DYNC1I2,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",IVPPPMSPSSKSV,_RREAEALLQSM(ox)GLTPESPIVPPPM(ox)S(ph)PSSK_,S81,,27.70,24.92,24.86,23.85,26.41,26.38,26.69,29.11,26.03,26.57,26.89,26.41,28.85,26.51,1.18,-1.59,-1.65,-2.67,-0.10,-0.13,0.17,2.60,-0.48,0.06,0.37,-0.11,2.33,G2/M transition of mitotic cell cycle;transport;microtubule-based movement;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;cytoplasmic dynein complex;vesicle;microtubule;centrosome,,,,,,,,,,,,,,
3621,Q13409,DYNC1I2,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",APVQEESDLEKKR,_EAVAPVQEES(ph)DLEK_,S51,+,23.53,,,23.25,,,23.61,24.14,,22.96,24.50,23.08,,23.58,-0.05, , ,-0.33, , ,0.03,0.56, ,-0.62,0.92,-0.51, ,G2/M transition of mitotic cell cycle;transport;microtubule-based movement;virus-host interaction;antigen processing and presentation of exogenous peptide antigen via MHC class II,cytosol;cytoplasmic dynein complex;vesicle;microtubule;centrosome,,,,,,,,,,,,,,
3622,Q13415,ORC1,Origin recognition complex subunit 1 (Replication control protein 1),DKLQTLSPALKAP,_LQTLS(ph)PALK_,S287,,21.68,21.70,21.70,,,,21.71,,,21.64,,,,21.68,0.00,0.01,0.01, , , ,0.02, , ,-0.04, , , ,S phase of mitotic cell cycle;regulation of transcription involved in G1/S phase of mitotic cell cycle;cell cycle checkpoint;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;cytosol;nucleolus;plasma membrane;nuclear origin of replication recognition complex,,,,,,,,,,,,,,
3623,Q13421,MSLN,"Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF);Mesothelin, cleaved form]",GRFVAESAEVLLP,_FVAES(ph)AEVLLPR_,S200,+,26.41,23.07,20.07,20.51,22.45,,,22.74,,22.47,24.04,22.42,22.99,22.72,3.70,0.35,-2.65,-2.21,-0.27, , ,0.03, ,-0.25,1.32,-0.29,0.27,pancreas development;cell adhesion,extracellular space;Golgi apparatus;plasma membrane;membrane;cell surface;anchored to membrane,,,,,,,,,,,,,,
3626,Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),EGAAPQSPSFSGS,_KPSLVSDLPWEGAAPQS(ph)PSFSGSEDSGSPK_,S222,+,25.52,23.55,23.55,,,24.28,24.05,25.79,25.76,25.39,,,,24.74,0.78,-1.19,-1.19, , ,-0.46,-0.68,1.05,1.02,0.65, , , ,,dystrophin-associated glycoprotein complex;synapse;transport vesicle membrane;cell junction;microtubule;cytoplasm,,,,,,,,,,,,,,
3631,Q13425,SNTB2,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),SGCRSPSLGSDLT,_SPS(ph)LGSDLTFATR_,S395,+,23.52,,,22.21,23.61,23.76,22.81,24.02,22.94,22.66,23.27,,,23.20,0.32, , ,-0.99,0.41,0.56,-0.39,0.82,-0.26,-0.54,0.07, , ,,dystrophin-associated glycoprotein complex;synapse;transport vesicle membrane;cell junction;microtubule;cytoplasm,,,,,,,,,,,,,,
3634,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),SKIKQSSQDNELK,_IKQSS(ph)QDNELK_,S696,,25.58,27.13,27.91,23.46,,20.11,,,,20.48,,,,24.11,1.47,3.02,3.80,-0.66, ,-4.00, , , ,-3.63, , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
3637,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),TDHRNVSESPNRK,_ITDHRNVS(ph)ES(ph)PNRK_,S413,+,26.80,28.34,29.32,24.73,,,21.60,20.10,23.34,22.67,,,,24.61,2.19,3.73,4.71,0.12, , ,-3.01,-4.52,-1.27,-1.94, , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
3638,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),HRNVSESPNRKNE,_ITDHRNVS(ph)ES(ph)PNRK_,S415,+,26.81,28.43,29.41,24.73,,,21.60,20.10,23.40,22.67,,19.45,,24.07,2.75,4.36,5.34,0.66, , ,-2.47,-3.97,-0.66,-1.40, ,-4.62, ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
3640,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),KFDHESSPGTDED,_KFDHES(ph)S(ph)PGT(ph)DEDK_,S745,+,27.19,25.84,25.96,23.42,,,21.55,,22.83,24.16,,,,24.42,2.77,1.42,1.54,-1.00, , ,-2.87, ,-1.59,-0.27, , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
3641,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),RDRFRRSETPPHW,_S(ph)ET(ph)PPHWR_,S356,,27.49,26.03,25.28,25.90,22.55,,,,,,,,,25.45,2.04,0.58,-0.17,0.45,-2.90, , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
3643,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),LAPAKESPRKGAA,_AALAPAKES(ph)PRK_,S906,+,24.03,27.35,27.35,21.88,,,20.06,20.22,,19.95,18.54,20.13,,22.17,1.87,5.18,5.18,-0.29, , ,-2.11,-1.95, ,-2.22,-3.63,-2.03, ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3644,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SAPAKESPRKGAA,_AASAPAKES(ph)PRK_,S446,,17.91,22.74,22.74,,,,,,,,,,,21.13,-3.22,1.61,1.61, , , , , , , , , , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3645,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SEESSDSEEETPA,_AGKPEEDSESSSEESSDS(ph)EEETPAAK_,S349,,,24.18,,22.66,26.99,25.34,25.29,25.64,25.63,24.75,,,21.84,24.70, ,-0.52, ,-2.04,2.29,0.64,0.58,0.94,0.92,0.05, , ,-2.86,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3647,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SEEGSESEEEAPA,_AKKPEEESESSEEGSES(ph)EEEAPAGTR_,S279,,,,,,25.00,22.71,,24.32,,,,,,24.01, , , , ,0.99,-1.30, ,0.31, , , , , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3648,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SVSTKESPARKAA,_ASSVSTKES(ph)PARK_,S233,,18.59,23.63,23.63,19.70,,,,,,,,16.80,,20.47,-1.88,3.16,3.16,-0.77, , , , , , , ,-3.67, ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3652,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),GGEASVSPEKTST,_KLGAGEGGEASVS(ph)PEK_,S1378,+,27.46,27.41,28.24,26.75,28.09,27.26,28.28,27.64,27.24,28.77,25.54,26.38,26.46,27.35,0.11,0.06,0.90,-0.60,0.74,-0.09,0.93,0.29,-0.10,1.42,-1.80,-0.97,-0.89,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3654,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),ANTTLVSETEEEG,_SAEPSANTTLVS(ph)ETEEEGSVPAFGAAAK_,S171,,26.43,,,,23.98,,,,,23.36,,,,24.59,1.84, , , ,-0.61, , , , ,-1.23, , , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3655,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),TPKLDSSPSVSST,_LDSS(ph)PSVSSTLAAK_,S1228,+,26.70,27.50,27.55,26.30,24.01,24.08,28.03,,28.20,28.20,26.70,27.46,24.44,26.60,0.10,0.90,0.95,-0.30,-2.59,-2.52,1.43, ,1.60,1.60,0.10,0.87,-2.16,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3656,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),QAAGMLSPKTGGK,_QEAKPQQAAGM(ox)LS(ph)PK_,S1257,+,24.62,27.22,27.67,26.20,,,25.30,,25.69,25.96,23.32,24.80,,25.64,-1.02,1.57,2.02,0.56, , ,-0.35, ,0.05,0.32,-2.32,-0.84, ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3657,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),SSEESDSEEEAPA,_REEDSQSSSEESDS(ph)EEEAPAQAKPSGK_,S419,,,,,,,21.40,22.10,,22.52,24.73,,,,22.69, , , , , ,-1.29,-0.59, ,-0.17,2.04, , , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3660,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),GTLPATSPQSTSV,_TQPSSGVDSAVGTLPATS(ph)PQSTSVQAK_,S1111,+,21.89,,,24.82,,,23.75,25.69,23.22,26.05,22.58,,,24.00,-2.11, , ,0.82, , ,-0.25,1.69,-0.78,2.05,-1.42, , ,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3662,Q13428,TCOF1,Treacle protein (Treacher Collins syndrome protein),GTLPATSPQSTSV,_KQEGPATQVDSAVGTLPATS(ph)PQSTSVQAK_,S1073,,,,,22.81,,24.12,25.05,,,24.65,,23.01,24.29,23.99, , , ,-1.18, ,0.13,1.06, , ,0.66, ,-0.97,0.30,transcription of nuclear large rRNA transcript from RNA polymerase I promoter;skeletal system development,nucleolus;cytoplasm,,,,,,,,,,,,,,
3663,Q13433,SLC39A6,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),KYESQLSTNEEKV,_YESQLS(ph)TNEEK_,S45,+,25.86,25.82,26.05,26.62,,21.35,23.71,,24.94,25.44,23.46,24.36,22.06,24.51,1.34,1.31,1.53,2.11, ,-3.16,-0.81, ,0.42,0.93,-1.06,-0.16,-2.46,cellular zinc ion homeostasis;zinc ion transmembrane import,lamellipodium membrane;endoplasmic reticulum;integral to plasma membrane,,,,,,,,,,,,,,
3664,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),RQEEMNSQQEEEE,_ESRQEEM(ox)NS(ph)QQEEEEM(ox)ETDAR_,S289,,,,,,22.42,22.74,21.89,,23.42,23.75,,,22.38,22.77, , , , ,-0.34,-0.03,-0.88, ,0.65,0.98, , ,-0.39,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3665,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),EEEHKDSDDDSSD,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,S431,,27.15,,,,,,,,,,,,,27.15,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3666,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),KDSDDDSSDDEQE,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,S435,,27.30,,,,,,,,,,,,,27.30,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3667,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),DSDDDSSDDEQEK,_GFEEEHKDS(ph)DDDS(ph)S(ph)DDEQEK_,S436,,27.30,,,,,,,,,,,,,27.30,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3668,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),RSSLGQSASETEE,_SSLGQS(ph)AS(ph)ETEEDTVSVSKK_,S307,,23.64,23.24,23.24,23.83,22.23,,,22.43,,,,21.90,,22.93,0.71,0.31,0.31,0.90,-0.70, , ,-0.50, , , ,-1.03, ,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3669,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),SLGQSASETEEDT,_SSLGQSAS(ph)ETEEDTVSVSK_,S309,+,24.43,23.68,24.28,24.80,26.20,26.26,24.93,25.96,25.19,25.41,24.16,24.42,25.83,25.04,-0.62,-1.36,-0.76,-0.24,1.16,1.22,-0.11,0.92,0.15,0.37,-0.89,-0.62,0.78,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
3670,Q13439,GOLGA4,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),KEENPESDGEPVV,_EENPES(ph)DGEPVVEDGTSVK_,S266,+,27.15,26.67,26.69,26.62,24.82,25.62,28.07,24.64,28.43,28.92,27.05,26.85,25.91,26.73,0.42,-0.06,-0.04,-0.10,-1.90,-1.11,1.34,-2.08,1.70,2.19,0.32,0.12,-0.81,Golgi to plasma membrane protein transport;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
3671,Q13439,GOLGA4,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),MRSRTSSFTEQLD,_TSS(ph)FTEQLDEGTPNR_,S41,,23.66,24.71,,23.21,22.70,,,,,,,,,23.57,0.09,1.14, ,-0.36,-0.87, , , , , , , , ,Golgi to plasma membrane protein transport;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
3672,Q13439,GOLGA4,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),LQLRVPSVESLFR,_VPS(ph)VESLFR_,S71,+,25.78,23.39,19.99,24.35,24.09,23.71,22.90,23.16,23.81,20.61,24.22,23.68,23.63,23.33,2.45,0.06,-3.34,1.02,0.75,0.38,-0.43,-0.17,0.48,-2.72,0.89,0.34,0.30,Golgi to plasma membrane protein transport;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
3673,Q13439,GOLGA4,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),MRSRTSSFTEQLD,_TSS(ph)FTEQLDEGTPNRENASTHASK_,S41,+,23.66,24.71,,23.21,22.70,23.28,22.35,,24.49,,,,,23.49,0.17,1.22, ,-0.28,-0.78,-0.20,-1.13, ,1.01, , , , ,Golgi to plasma membrane protein transport;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
3674,Q13442,PDAP1,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),EKKSLDSDESEDE,_SLDS(ph)DES(ph)EDEEDDYQQK_,S60,+,28.98,27.58,27.65,26.05,29.46,28.61,27.36,28.55,27.46,28.11,27.26,25.76,26.32,27.63,1.35,-0.04,0.03,-1.58,1.83,0.98,-0.27,0.92,-0.17,0.48,-0.36,-1.86,-1.31,cell proliferation;signal transduction,,,,,,,,,,,,,,,
3675,Q13442,PDAP1,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),SLDSDESEDEEDD,_SLDS(ph)DES(ph)EDEEDDYQQKRK_,S63,+,28.85,25.56,25.32,24.90,27.18,25.78,25.69,25.79,25.11,25.43,24.82,24.01,,25.70,3.15,-0.15,-0.38,-0.80,1.48,0.08,-0.01,0.08,-0.60,-0.28,-0.88,-1.69, ,cell proliferation;signal transduction,,,,,,,,,,,,,,,
3677,Q13443,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),PSRQPGSVPRHVS,_NQANPSRQPGS(ph)VPR_,S752,,22.17,,,24.32,,,22.92,,,,,23.98,,23.35,-1.18, , ,0.97, , ,-0.43, , , , ,0.63, ,transforming growth factor beta receptor signaling pathway;positive regulation of macrophage fusion;monocyte activation;positive regulation of cell adhesion mediated by integrin;activation of MAPKK activity;integrin-mediated signaling pathway;positive regulation of membrane protein ectodomain proteolysis;positive regulation of keratinocyte migration;cell-cell adhesion mediated by integrin;keratinocyte differentiation;PMA-inducible membrane protein ectodomain proteolysis;response to calcium ion;cell-matrix adhesion;cellular response to lipopolysaccharide;response to glucocorticoid stimulus;response to hydrogen peroxide;response to tumor necrosis factor;positive regulation of protein secretion;response to manganese ion,intrinsic to external side of plasma membrane;extracellular space;integral to membrane;cytoplasm,,,,,,,,,,,,,,
3678,Q13451,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5) (FKBP-5) (FKBP54) (p54) (HSP90-binding immunophilin) (Rotamase),NEKGTDSQAMEEE,_GTDS(ph)QAM(ox)EEEKPEGHV_,S445,+,23.95,24.53,22.82,22.72,22.95,22.29,22.26,,25.39,21.01,,,23.76,23.17,0.78,1.36,-0.35,-0.44,-0.22,-0.88,-0.91, ,2.22,-2.16, , ,0.59,protein folding,nucleus;membrane;cytoplasm,,,,,,,,,,,,,,
3681,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),TEERRTSFSTSDV,_RTS(ph)FSTSDVSK_,S1354,+,24.73,27.29,27.24,26.91,,23.52,24.22,24.38,23.77,20.70,24.13,25.65,,24.78,-0.04,2.52,2.46,2.13, ,-1.26,-0.55,-0.39,-1.01,-4.08,-0.65,0.87, ,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3683,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),VQEKPDSPGGSTQ,_VQEKPDS(ph)PGGSTQIQR_,S1290,+,25.97,26.67,26.08,27.35,27.13,26.39,27.56,27.67,26.32,25.04,26.65,27.21,25.40,26.57,-0.60,0.10,-0.49,0.77,0.56,-0.18,0.99,1.10,-0.25,-1.53,0.07,0.64,-1.17,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3684,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),SPPAPGSAPETPE,_VSPPAPGS(ph)APET(ph)PEDK_,S1267,+,26.80,24.62,24.34,26.50,25.48,24.63,25.60,25.68,24.23,,25.35,,24.32,25.23,1.56,-0.61,-0.89,1.27,0.25,-0.60,0.37,0.44,-1.00, ,0.12, ,-0.92,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3689,Q13470,TNK1,Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1),MKGISRSLESVLS,_S(ph)LESVLSLGPRPTGGGSS(ph)PPEIR_,S497,,25.20,,,,21.18,,,,,,,,,23.19,2.01, , , ,-2.01, , , , , , , , ,protein autophosphorylation,membrane;cytoplasm,,+,,,,,,,,,,,,
3691,Q13492,PICALM,Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein),ITAAQHSVTGSAV,_(ac)SGQSLTDRITAAQHS(ph)VTGSAVSK_,S16,,25.18,,,22.96,,,,,,,,27.03,23.54,24.68,0.50, , ,-1.72, , , , , , , ,2.35,-1.13,"regulation of protein localization;endosomal transport;dendrite morphogenesis;clathrin coat assembly;receptor internalization;negative regulation of receptor-mediated endocytosis;axonogenesis;positive regulation of transcription, DNA-dependent;hemopoiesis",clathrin coat;Golgi apparatus;clathrin-coated vesicle;perinuclear region of cytoplasm;coated pit;nucleus;postsynaptic membrane;presynaptic membrane,,,,,,,,,,,,,,
3692,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),STGELQSLQMPES,_EVDPSTGELQS(ph)LQM(ox)PESEGPSS(ph)LDPSQEGPTGLK_,S355,,25.00,,,,,,,,,,,,,25.00,0.00, , , , , , , , , , , , ,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
3693,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),SLQMPESEGPSSL,_EVDPSTGELQSLQM(ox)PES(ph)EGPS(ph)SLDPSQEGPTGLK_,S361,,24.84,,,,,,,,,,,,,24.84,0.00, , , , , , , , , , , , ,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
3695,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),ESEGPSSLDPSQE,_EVDPSTGELQSLQM(ox)PES(ph)EGPSS(ph)LDPSQEGPTGLK_,S366,+,27.52,24.57,24.57,,,24.71,25.46,26.14,26.31,26.12,,26.35,,25.75,1.77,-1.18,-1.18, , ,-1.04,-0.29,0.39,0.56,0.37, ,0.60, ,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
3696,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),SRLTPVSPESSST,_SRLT(ph)PVS(ph)PESSSTEEK_,S272,+,28.81,27.67,24.32,28.80,29.09,28.79,29.02,30.63,28.55,27.14,30.07,29.46,29.74,28.62,0.19,-0.96,-4.30,0.17,0.46,0.17,0.40,2.01,-0.07,-1.48,1.45,0.84,1.12,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
3697,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),PVSPESSSTEEKS,_LTPVS(ph)PESS(ph)STEEK_,S276,,24.14,,,,,,,,,,,,,24.14,0.00, , , , , , , , , , , , ,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
3702,Q13506,NAB1,NGFI-A-binding protein 1 (EGR-1-binding protein 1) (Transcriptional regulatory protein p54),QSSEEHSPNGLTS,_(gl)QSS(ph)EEHS(ph)PNGLTSDNSDGQGERPLNLR_,S378,,23.21,,,,,,,,,,,,,23.21,0.00, , , , , , , , , , , , ,"myelination;endochondral ossification;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;Schwann cell differentiation;regulation of epidermis development",nucleus,,,,,,,,,,,,,,
3704,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),EMEDANSEKSINE,_EQPEMEDANS(ph)EK_,S20,+,27.17,29.21,30.17,27.11,25.46,27.60,29.82,25.75,29.98,30.80,26.47,28.74,26.52,28.06,-0.89,1.15,2.11,-0.96,-2.60,-0.46,1.76,-2.31,1.92,2.74,-1.59,0.67,-1.54,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3707,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),KEIIDASDKEGMS,_EIIDAS(ph)DKEGM(ox)S(ph)PAKR_,S87,,,28.17,,,,,25.02,24.78,24.98,,,,,25.74, ,2.43, , , , ,-0.72,-0.95,-0.76, , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3708,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),SDKEGMSPAKRTK,_EIIDAS(ph)DKEGM(ox)S(ph)PAKR_,S93,,,26.52,,,23.42,,26.70,26.85,26.13,,,,,25.92, ,0.59, , ,-2.51, ,0.78,0.93,0.21, , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3711,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),DANSEKSINEENG,_S(ph)INEENGEVS(ph)EDQSQNK_,S23,+,27.61,26.86,27.27,26.27,,22.72,26.84,22.77,27.32,27.15,24.93,25.33,,25.91,1.69,0.95,1.36,0.35, ,-3.20,0.92,-3.14,1.40,1.24,-0.99,-0.58, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3712,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),EENGEVSEDQSQN,_S(ph)INEENGEVS(ph)EDQSQNK_,S32,+,26.16,25.15,25.57,24.60,23.01,24.28,23.89,24.30,24.17,24.98,22.85,22.07,22.39,24.11,2.05,1.04,1.46,0.49,-1.10,0.17,-0.22,0.19,0.06,0.87,-1.26,-2.04,-1.72,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3713,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),RSPKRRSLSPKPR,_S(ph)LS(ph)PKPR_,S354,,25.51,23.32,22.61,25.62,22.55,,,20.16,,,,,,23.30,2.21,0.03,-0.69,2.33,-0.74, , ,-3.14, , , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3714,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),PKRRSLSPKPRDK,_S(ph)LS(ph)PKPR_,S356,,25.51,23.32,22.61,25.62,22.55,,,20.16,,,,,,23.30,2.21,0.03,-0.69,2.33,-0.74, , ,-3.14, , , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3716,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),RSKQSKSPSRTLS,_S(ph)PSRTLS(ph)PGRR_,S381,+,26.52,28.70,29.69,26.06,,,,20.51,23.53,21.50,,,,25.21,1.30,3.48,4.47,0.85, , , ,-4.71,-1.69,-3.71, , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3717,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),SPSRTLSPGRRAK,_S(ph)PSRTLS(ph)PGRR_,S387,+,26.52,27.77,28.75,26.06,,,,20.51,23.53,21.50,,,,24.95,1.57,2.82,3.80,1.12, , , ,-4.44,-1.42,-3.45, , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3721,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),SSTRTRSPSPDDI,_TRS(ph)PS(ph)PDDILER_,S578,,21.86,,,,,,,,,,,,,21.86,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3722,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),TRTRSPSPDDILE,_TRS(ph)PS(ph)PDDILER_,S580,,21.86,,,,,,,,,,,,,21.86,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3723,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),ILQGYESGSEEEG,_VQSGM(ox)GLILQGYES(ph)GS(ph)EEEGEIHEK_,S142,,24.27,,,,,,,,,,,,,24.27,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3724,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),QGYESGSEEEGEI,_VQSGM(ox)GLILQGYES(ph)GS(ph)EEEGEIHEK_,S144,,24.27,,,,,,,,24.64,24.64,,,,24.52,-0.25, , , , , , , ,0.12,0.12, , , ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
3725,Q13541,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I),LMECRNSPVTKTP,_FLM(ox)ECRNS(ph)PVTK_,S65,+,24.75,24.62,24.58,27.01,22.11,,24.81,21.42,24.05,23.55,23.13,26.52,,24.23,0.52,0.39,0.35,2.77,-2.12, ,0.58,-2.81,-0.18,-0.68,-1.10,2.29, ,TOR signaling cascade;translational initiation;insulin receptor signaling pathway;positive regulation of mitotic cell cycle;negative regulation of translational initiation;negative regulation of protein complex assembly;G1/S transition of mitotic cell cycle,cytosol;nucleus;protein complex,,,,,,,,,,,,,,
3727,Q13547,HDAC1,Histone deacetylase 1 (HD1) (EC 3.5.1.98),DAIPEESGDEDED,_M(ox)LPHAPGVQM(ox)QAIPEDAIPEES(ph)GDEDEDDPDKR_,S393,,28.75,,,,29.10,,,,27.65,29.42,,27.56,26.54,28.17,0.58, , , ,0.93, , , ,-0.52,1.24, ,-0.61,-1.63,negative regulation of apoptotic process;embryonic digit morphogenesis;mitotic cell cycle;eyelid development in camera-type eye;fungiform papilla formation;negative regulation of androgen receptor signaling pathway;negative regulation by host of viral transcription;transforming growth factor beta receptor signaling pathway;blood coagulation;epidermal cell differentiation;positive regulation of cell proliferation;chromatin remodeling;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;histone H4 deacetylation;transcription initiation from RNA polymerase II promoter;positive regulation of receptor biosynthetic process;hair follicle placode formation;negative regulation of cell cycle;Notch signaling pathway;histone H3 deacetylation;odontogenesis of dentin-containing tooth;nerve growth factor receptor signaling pathway,NuRD complex;cytosol;Sin3 complex,,,,,,,,,,,,,,
3728,Q13563,PKD2,Polycystin-2 (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321),PRSLDDSEEDDDE,_SLDDS(ph)EEDDDEDSGHSSR_,S756,+,23.71,27.07,26.66,27.76,25.63,25.64,24.69,25.28,26.36,24.97,24.42,24.48,23.38,25.39,-1.68,1.68,1.27,2.37,0.24,0.25,-0.70,-0.11,0.98,-0.42,-0.97,-0.91,-2.01,"negative regulation of cell proliferation;placenta blood vessel development;metanephric smooth muscle tissue development;liver development;JAK-STAT cascade;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;aorta development;centrosome duplication;negative regulation of ryanodine-sensitive calcium-release channel activity;renal tubule morphogenesis;cellular response to reactive oxygen species;regulation of calcium ion import;positive regulation of cell cycle arrest;metanephric ascending thin limb development;spinal cord development;metanephric S-shaped body morphogenesis;cellular response to osmotic stress;branching involved in ureteric bud morphogenesis;detection of mechanical stimulus;metanephric cortex development;detection of nodal flow;heart development;metanephric distal tubule development;renal artery morphogenesis;negative regulation of G1/S transition of mitotic cell cycle;cellular response to fluid shear stress;metanephric cortical collecting duct development;release of sequestered calcium ion into cytosol;embryonic placenta development;cell cycle arrest;positive regulation of transcription from RNA polymerase II promoter;metanephric mesenchyme development;mesonephric duct development;determination of heart left/right asymmetry;cytoplasmic sequestering of transcription factor;metanephric part of ureteric bud development;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;regulation of cAMP metabolic process;cellular response to hydrostatic pressure;neural tube development;positive regulation of nitric oxide biosynthetic process",nonmotile primary cilium;integral to lumenal side of endoplasmic reticulum membrane;integral to cytosolic side of endoplasmic reticulum membrane;microtubule basal body;cilium part;mitotic spindle;basal cortex;cell-cell junction;polycystin complex;integral to plasma membrane;lamellipodium;basal plasma membrane;motile primary cilium,,,,,,,,,,,,,,
3729,Q13573,SNW1,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),IPRGPPSPPAPVM,_GPPS(ph)PPAPVM(ox)HS(ph)PSRK_,S224,+,26.98,27.01,24.82,27.14,26.70,24.04,24.00,25.58,26.11,24.40,,,23.89,25.51,1.46,1.49,-0.69,1.63,1.19,-1.48,-1.51,0.06,0.59,-1.11, , ,-1.63,"transcription initiation from RNA polymerase II promoter;retinoic acid receptor signaling pathway;cellular response to retinoic acid;positive regulation of transforming growth factor beta receptor signaling pathway;regulation of retinoic acid receptor signaling pathway;positive regulation of vitamin D receptor signaling pathway;positive regulation of mRNA splicing, via spliceosome;positive regulation by host of viral transcription;positive regulation of neurogenesis;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;Notch signaling pathway;negative regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;positive regulation of histone H3-K4 methylation;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;chromatin;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
3730,Q13573,SNW1,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),PAPVMHSPSRKMT,_GPPS(ph)PPAPVM(ox)HS(ph)PSR_,S232,+,26.94,26.94,24.82,27.14,26.39,24.04,24.00,24.27,26.11,24.40,,,,25.51,1.43,1.44,-0.68,1.64,0.89,-1.47,-1.50,-1.23,0.60,-1.10, , , ,"transcription initiation from RNA polymerase II promoter;retinoic acid receptor signaling pathway;cellular response to retinoic acid;positive regulation of transforming growth factor beta receptor signaling pathway;regulation of retinoic acid receptor signaling pathway;positive regulation of vitamin D receptor signaling pathway;positive regulation of mRNA splicing, via spliceosome;positive regulation by host of viral transcription;positive regulation of neurogenesis;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;Notch signaling pathway;negative regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;positive regulation of histone H3-K4 methylation;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;chromatin;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
3732,Q13576,IQGAP2,Ras GTPase-activating-like protein IQGAP2,QRPRYGSIVDDER,_YGS(ph)IVDDER_,S16,,23.04,25.54,24.90,,,,,,,,,,,24.49,-1.45,1.04,0.41, , , , , , , , , , ,signal transduction;small GTPase mediated signal transduction;positive regulation of Ras GTPase activity,microtubule;microvillus;actin cytoskeleton,,,,,,,,,,,,,,
3733,Q13586,STIM1,Stromal interaction molecule 1,LHRAEQSLHDLQE,_DLEGLHRAEQS(ph)LHDLQER_,S257,+,24.26,26.35,,23.53,22.76,25.09,23.81,24.96,26.34,23.43,24.64,23.85,23.83,24.40,-0.14,1.95, ,-0.88,-1.64,0.68,-0.60,0.56,1.94,-0.97,0.24,-0.56,-0.58,blood coagulation;detection of calcium ion;calcium ion transport;activation of store-operated calcium channel activity,integral to endoplasmic reticulum membrane;microtubule;integral to plasma membrane;cortical endoplasmic reticulum,,,,,,,,,,,,,,
3736,Q13586,STIM1,Stromal interaction molecule 1,QRDLTHSDSESSL,_DLTHS(ph)DSESSLHM(ox)SDR_,S519,+,21.83,,,24.01,25.40,25.70,24.99,25.07,26.04,24.32,25.16,24.46,25.78,24.80,-2.97, , ,-0.79,0.60,0.90,0.20,0.27,1.25,-0.47,0.37,-0.34,0.98,blood coagulation;detection of calcium ion;calcium ion transport;activation of store-operated calcium channel activity,integral to endoplasmic reticulum membrane;microtubule;integral to plasma membrane;cortical endoplasmic reticulum,,,,,,,,,,,,,,
3737,Q13586,STIM1,Stromal interaction molecule 1,DLTHSDSESSLHM,_DLTHSDS(ph)ESSLHM(ox)SDR_,S521,+,24.85,22.58,,,23.49,23.17,22.46,22.72,,20.99,23.34,26.51,22.37,23.25,1.60,-0.67, , ,0.24,-0.08,-0.79,-0.53, ,-2.26,0.09,3.26,-0.88,blood coagulation;detection of calcium ion;calcium ion transport;activation of store-operated calcium channel activity,integral to endoplasmic reticulum membrane;microtubule;integral to plasma membrane;cortical endoplasmic reticulum,,,,,,,,,,,,,,
3738,Q13586,STIM1,Stromal interaction molecule 1,VEKLPDSPALAKK,_LPDS(ph)PALAKK_,S575,+,25.53,25.15,23.76,24.46,22.80,23.32,25.13,21.73,27.33,26.48,24.77,23.69,23.79,24.46,1.07,0.70,-0.70,0.00,-1.66,-1.13,0.67,-2.73,2.88,2.03,0.31,-0.77,-0.67,blood coagulation;detection of calcium ion;calcium ion transport;activation of store-operated calcium channel activity,integral to endoplasmic reticulum membrane;microtubule;integral to plasma membrane;cortical endoplasmic reticulum,,,,,,,,,,,,,,
3739,Q13586,STIM1,Stromal interaction molecule 1,DSSRSHSPSSPDP,_SHS(ph)PSSPDPDTPSPVGDSR_,S618,+,24.75,25.16,24.57,25.03,26.08,26.60,25.98,26.29,26.49,26.80,26.30,25.19,25.81,25.77,-1.03,-0.61,-1.20,-0.75,0.31,0.83,0.21,0.52,0.72,1.03,0.53,-0.58,0.04,blood coagulation;detection of calcium ion;calcium ion transport;activation of store-operated calcium channel activity,integral to endoplasmic reticulum membrane;microtubule;integral to plasma membrane;cortical endoplasmic reticulum,,,,,,,,,,,,,,
3742,Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),GGRRRDSYYDRGY,_RRDS(ph)YYDR_,S236,+,24.03,25.13,25.24,23.42,20.52,,18.62,,19.10,,,,,22.29,1.73,2.83,2.95,1.12,-1.78, ,-3.67, ,-3.19, , , , ,"mRNA splicing, via spliceosome",nucleus,,,,,,,,,,+,,,,
3743,Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),_____MSDVEENN,_(ac)S(ph)DVEENNFEGRES(ph)R_,S2,+,27.15,24.97,25.12,,26.46,26.67,25.15,25.16,25.70,25.52,,,22.46,25.43,1.72,-0.47,-0.32, ,1.02,1.24,-0.28,-0.28,0.26,0.08, , ,-2.98,"mRNA splicing, via spliceosome",nucleus,,,,,,,,,,+,,,,
3744,Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),NFEGRESRSQSKS,_(ac)S(ph)DVEENNFEGRES(ph)R_,S14,+,27.02,25.33,22.15,24.22,,23.93,23.11,23.61,23.47,24.89,,22.16,22.86,23.89,3.13,1.44,-1.74,0.33, ,0.05,-0.78,-0.28,-0.42,1.00, ,-1.72,-1.02,"mRNA splicing, via spliceosome",nucleus,,,,,,,,,,+,,,,
3745,Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),SRSQSKSPTGTPA,_S(ph)PTGT(ph)PARVK_,S20,,21.48,27.87,27.87,23.92,,,,,21.02,21.27,,,,23.90,-2.42,3.96,3.96,0.02, , , , ,-2.89,-2.63, , , ,"mRNA splicing, via spliceosome",nucleus,,,,,,,,,,+,,,,
3746,Q13596,SNX1,Sorting nexin-1,LPINNGSKENGIH,_ITTSLLPINNGS(ph)K_,S72,+,21.39,,,23.84,,,24.97,23.31,22.53,,23.36,23.47,22.73,23.20,-1.81, , ,0.64, , ,1.77,0.11,-0.67, ,0.17,0.27,-0.47,intracellular protein transport;early endosome to Golgi transport;endocytosis;positive regulation of protein catabolic process;cell communication,cytosol;Golgi apparatus;early endosome membrane,,,,,,,,,,,,,,
3747,Q13596,SNX1,Sorting nexin-1,EPEAGDSDTEGED,_LPPPFPGLEPESEGAAGGSEPEAGDS(ph)DTEGEDIFTGAAVVSK_,S39,,24.56,,,,,,,,,,,,,24.56,0.00, , , , , , , , , , , , ,intracellular protein transport;early endosome to Golgi transport;endocytosis;positive regulation of protein catabolic process;cell communication,cytosol;Golgi apparatus;early endosome membrane,,,,,,,,,,,,,,
3749,Q13601,KRR1,KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1),____MASPSLERP,_(ac)AS(ph)PSLERPEK_,S3,+,28.44,28.85,29.17,29.10,29.05,29.05,28.72,28.60,28.56,28.80,26.74,27.34,27.84,28.48,-0.05,0.37,0.69,0.62,0.57,0.57,0.24,0.12,0.08,0.32,-1.74,-1.14,-0.64,rRNA processing,ribonucleoprotein complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
3750,Q13610,PWP1,Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502),QEEGGGSDEEETG,_LQEEGGGS(ph)DEEETGSPSEDGM(ox)QSAR_,S50,+,25.79,26.60,26.12,28.00,27.70,28.32,27.40,28.17,27.42,27.26,26.25,25.42,26.44,26.99,-1.20,-0.39,-0.88,1.01,0.71,1.32,0.41,1.18,0.42,0.27,-0.74,-1.57,-0.55,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
3751,Q13610,PWP1,Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502),GSARNSSISGPFG,_NSS(ph)ISGPFGSR_,S485,+,24.16,22.42,22.11,23.91,24.07,23.84,24.19,24.54,23.16,22.97,24.34,,24.53,23.69,0.48,-1.27,-1.58,0.22,0.38,0.15,0.50,0.85,-0.53,-0.72,0.66, ,0.84,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
3752,Q13615,MTMR3,Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Zinc finger FYVE domain-containing protein 10),WQEHRRSLELSSL,_S(ph)LELSSLAGPGEDPLSADSLGKPTR_,S511,,22.23,,,,,,,,,,,,,22.23,0.00, , , , , , , , , , , , ,phosphatidylinositol biosynthetic process;small molecule metabolic process;phosphatidylinositol dephosphorylation,cytosol;nucleus;membrane,,,+,,,,,,,,,,,
3753,Q13619,CUL4A,Cullin-4A (CUL-4A),EAPRKGSFSALVG,_KGS(ph)FSALVGR_,S10,,24.63,,,19.87,,,21.69,,24.07,22.22,,23.59,,22.68,1.95, , ,-2.81, , ,-0.99, ,1.39,-0.46, ,0.91, ,negative regulation of cell proliferation;intrinsic apoptotic signaling pathway;G1/S transition of mitotic cell cycle;ubiquitin-dependent protein catabolic process;DNA repair;regulation of protein metabolic process;positive regulation of S phase of mitotic cell cycle;cell cycle arrest;virus-host interaction;protein ubiquitination,Cul4A-RING ubiquitin ligase complex,,,,,,,,,,,,,,
3756,Q13620,CUL4B,Cullin-4B (CUL-4B),TGFSSPSPSAAAA,_(ac)M(ox)FPTGFSSPS(ph)PSAAAAAQEVR_,S10,,,,,24.29,23.39,24.75,23.42,,23.87,,,,,23.94, , , ,0.35,-0.55,0.81,-0.53, ,-0.08, , , , ,DNA repair;positive regulation of S phase of mitotic cell cycle;positive regulation of protein catabolic process;cell cycle;ubiquitin-dependent protein catabolic process;protein ubiquitination,plasma membrane;nucleus;Cul4B-RING ubiquitin ligase complex,,,,,,,,,,,,,,
3757,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),RIPRPLSPTKLLP,_IPRPLS(ph)PTK_,S325,+,24.83,25.53,26.33,24.34,25.09,25.78,26.02,25.75,,,25.27,24.90,24.22,25.28,-0.45,0.25,1.05,-0.94,-0.19,0.50,0.74,0.47, , ,0.00,-0.38,-1.06,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3758,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),TLRKNQSSEDILR,_NQS(ph)SEDILR_,S107,+,25.66,24.21,24.08,23.38,,22.07,23.36,21.33,25.29,23.35,24.23,27.73,24.20,24.07,1.59,0.13,0.00,-0.70, ,-2.01,-0.71,-2.74,1.21,-0.72,0.16,3.66,0.13,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3759,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),PGSKQESPPAAAV,_(gl)QES(ph)PPAAAVRPFTPQPSK_,S203,,21.53,22.86,22.86,21.71,,,23.68,,23.14,24.01,,,,22.83,-1.29,0.03,0.03,-1.12, , ,0.85, ,0.32,1.19, , , ,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3760,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),VTASSESPVEIQN,_SASVTASSES(ph)PVEIQNPYLHVEPEK_,S410,,22.99,,,,,,,,,24.85,,22.34,,23.39,-0.41, , , , , , , , ,1.46, ,-1.05, ,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3761,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),QPRVLLSPSIPSV,_VLLS(ph)PSIPSVGQDQTLSPGSK_,S183,+,25.16,23.46,23.46,22.03,,,23.81,26.00,23.32,25.89,23.73,23.02,,23.99,1.18,-0.53,-0.53,-1.96, , ,-0.18,2.01,-0.66,1.90,-0.26,-0.97, ,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3763,Q13625,TP53BP2,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),GQDQTLSPGSKQE,_VLLSPSIPSVGQDQTLS(ph)PGSK_,S196,,24.14,21.57,21.57,,,,,26.00,,23.11,,,,23.28,0.86,-1.71,-1.71, , , , ,2.72, ,-0.17, , , ,negative regulation of cell cycle;response to ionizing radiation;induction of apoptosis;signal transduction;embryo development ending in birth or egg hatching;central nervous system development;apoptotic process;cell cycle;heart development,nucleus;perinuclear region of cytoplasm;cytoplasm,,,,+,,,,,,,,,,
3764,Q13641,TPBG,Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1),TNLSSNSDV____,_LTNLSSNS(ph)DV_,S418,+,24.01,23.76,23.00,24.34,24.75,,24.57,,,22.56,24.00,24.90,24.14,24.00,0.01,-0.24,-1.00,0.34,0.74, ,0.57, , ,-1.44,0.00,0.90,0.14,cell adhesion,endoplasmic reticulum;integral to plasma membrane,,,,,,,,,,,,,,
3765,Q13671,RIN1,Ras and Rab interactor 1 (Ras inhibitor JC99) (Ras interaction/interference protein 1),PLLRSMSAAFCSL,_SM(ox)S(ph)AAFCSLLAPER_,S44,,21.52,,,22.86,,,,23.58,,,,,,22.65,-1.13, , ,0.21, , , ,0.93, , , , , ,signal transduction;endocytosis;positive regulation of GTPase activity,plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3766,Q13753,LAMC2,Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit) (CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma),AERALGSAAADAQ,_ALGS(ph)AAADAQR_,S999,,,,,,,20.58,,,23.21,,,,,21.90, , , , , ,-1.31, , ,1.31, , , , ,hemidesmosome assembly;cell adhesion;epidermis development,laminin-2 complex;cell cortex;extracellular space;extracellular region;perinuclear region of cytoplasm;laminin-5 complex,,,,,,,,,,,,,,
3767,Q13765,NACA,Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (allergen Hom s 2),PTVQEESEEEEVD,_VQGEAVSNIQENTQTPTVQEES(ph)EEEEVDETGVEVK_,S87,,26.79,,,26.17,,,26.13,,25.65,27.66,26.69,27.30,24.53,26.37,0.43, , ,-0.20, , ,-0.24, ,-0.71,1.29,0.32,0.93,-1.83,"skeletal muscle tissue regeneration;positive regulation of transcription from RNA polymerase II promoter involved in heart development;negative regulation of striated muscle cell apoptotic process;positive regulation of cell proliferation involved in heart morphogenesis;positive regulation of skeletal muscle tissue growth;cardiac ventricle development;regulation of skeletal muscle fiber development;negative regulation of transcription from RNA polymerase II promoter involved in heart development;protein transport;translation;transcription, DNA-dependent;heart trabecula morphogenesis;virus-host interaction",nascent polypeptide-associated complex;nucleus,DNA binding region,,,,,,,,,,,,,
3769,Q13769,THOC5,THO complex subunit 5 homolog (Functional spliceosome-associated protein 79) (fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2) (PP39.2) (hTREX90),DSQDDESDSDAEE,_ALFKPPEDSQDDES(ph)DS(ph)DAEEEQTTK_,S312,,25.68,,,,,,,,,,,,,25.68,0.00, , , , , , , , , , , , ,monocyte differentiation;mRNA processing;RNA splicing;negative regulation of macrophage differentiation;primitive hemopoiesis;intronless viral mRNA export from host nucleus,THO complex part of transcription export complex;intermediate filament cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3770,Q13769,THOC5,THO complex subunit 5 homolog (Functional spliceosome-associated protein 79) (fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2) (PP39.2) (hTREX90),QDDESDSDAEEEQ,_ALFKPPEDSQDDES(ph)DS(ph)DAEEEQTTK_,S314,,25.68,,,,,,,,,,,,,25.68,0.00, , , , , , , , , , , , ,monocyte differentiation;mRNA processing;RNA splicing;negative regulation of macrophage differentiation;primitive hemopoiesis;intronless viral mRNA export from host nucleus,THO complex part of transcription export complex;intermediate filament cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3773,Q13796,SHROOM2,Protein Shroom2 (Apical-like protein) (Protein APXL),LGPRAQSPGSPLH,_AQS(ph)PGS(ph)PLHAR_,S1036,,23.92,23.02,,25.42,22.02,,,,,,,,,23.60,0.33,-0.57, ,1.83,-1.58, , , , , , , , ,establishment of melanosome localization;cell migration;negative regulation of actin filament depolymerization;lens morphogenesis in camera-type eye;cell-cell junction maintenance;brain development;cellular pigment accumulation;apical protein localization;melanosome organization;eye pigment granule organization;ear development,neuronal cell body;filamentous actin;apical plasma membrane;cell-cell adherens junction;cell cortex;tight junction;cytoskeleton;microtubule,,,,,,,,,,,,,,
3774,Q13796,SHROOM2,Protein Shroom2 (Apical-like protein) (Protein APXL),RAQSPGSPLHARG,_AQS(ph)PGS(ph)PLHAR_,S1039,,23.92,23.02,,25.77,23.43,,,,,,,,,24.04,-0.11,-1.01, ,1.74,-0.61, , , , , , , , ,establishment of melanosome localization;cell migration;negative regulation of actin filament depolymerization;lens morphogenesis in camera-type eye;cell-cell junction maintenance;brain development;cellular pigment accumulation;apical protein localization;melanosome organization;eye pigment granule organization;ear development,neuronal cell body;filamentous actin;apical plasma membrane;cell-cell adherens junction;cell cortex;tight junction;cytoskeleton;microtubule,,,,,,,,,,,,,,
3775,Q13796,SHROOM2,Protein Shroom2 (Apical-like protein) (Protein APXL),LLPKIPSPRSTEE,_LLPKIPS(ph)PR_,S1373,,,22.13,22.13,19.73,25.41,25.20,,24.80,21.88,21.28,,,23.36,22.88, ,-0.75,-0.75,-3.15,2.53,2.32, ,1.92,-1.00,-1.60, , ,0.48,establishment of melanosome localization;cell migration;negative regulation of actin filament depolymerization;lens morphogenesis in camera-type eye;cell-cell junction maintenance;brain development;cellular pigment accumulation;apical protein localization;melanosome organization;eye pigment granule organization;ear development,neuronal cell body;filamentous actin;apical plasma membrane;cell-cell adherens junction;cell cortex;tight junction;cytoskeleton;microtubule,,,,,,,,,,,,,,
3778,Q13813,SPTAN1,"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)",TDSKTASPWKSAR,_TAS(ph)PWK_,S1190,,22.89,24.03,24.03,24.57,26.84,,,24.62,,,,,,24.49,-1.60,-0.47,-0.47,0.07,2.34, , ,0.12, , , , , ,cellular component disassembly involved in execution phase of apoptosis;actin filament capping;axon guidance,Z disc;intracellular membrane-bounded organelle;lateral plasma membrane;cuticular plate;cytosol;microtubule cytoskeleton;fascia adherens;spectrin;membrane,,,,,,,,,,+,,,,
3780,Q13813,SPTAN1,"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)",RSKLGESQTLQQF,_LGES(ph)QTLQQFSR_,S1550,,21.82,21.80,21.80,,24.49,23.23,22.03,23.05,,,,,22.75,22.62,-0.80,-0.82,-0.82, ,1.87,0.60,-0.60,0.43, , , , ,0.13,cellular component disassembly involved in execution phase of apoptosis;actin filament capping;axon guidance,Z disc;intracellular membrane-bounded organelle;lateral plasma membrane;cuticular plate;cytosol;microtubule cytoskeleton;fascia adherens;spectrin;membrane,,,,,,,,,,+,,,,
3781,Q13813,SPTAN1,"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)",LNERWRSLQQLAE,_WRS(ph)LQQLAEER_,S1217,+,26.42,26.89,24.49,26.76,28.20,27.92,27.27,27.87,27.18,25.35,27.50,27.04,26.19,26.85,-0.43,0.04,-2.37,-0.09,1.35,1.07,0.42,1.02,0.33,-1.51,0.65,0.19,-0.66,cellular component disassembly involved in execution phase of apoptosis;actin filament capping;axon guidance,Z disc;intracellular membrane-bounded organelle;lateral plasma membrane;cuticular plate;cytosol;microtubule cytoskeleton;fascia adherens;spectrin;membrane,,,,,,,,,,+,,,,
3783,Q13884,SNTB1,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),ETPPPESPRLGGS,_KGSPVSEIGWET(ph)PPPES(ph)PR_,S219,,25.63,23.57,23.30,,,,,,,23.34,,,,23.96,1.67,-0.39,-0.66, , , , , , ,-0.62, , , ,muscle contraction,dystrophin-associated glycoprotein complex;synapse;cell junction;sarcolemma;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3784,Q13884,SNTB1,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),SPRLGGSTSDPPS,_LGGS(ph)TSDPPSSQSFSFHR_,S225,,24.74,,,21.54,,,23.72,,23.53,,,23.70,,23.44,1.30, , ,-1.91, , ,0.27, ,0.08, , ,0.25, ,muscle contraction,dystrophin-associated glycoprotein complex;synapse;cell junction;sarcolemma;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3786,Q13884,SNTB1,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),DPPSSQSFSFHRD,_LGGS(ph)TSDPPSSQS(ph)FSFHR_,S234,,24.41,,,21.54,,,23.72,,22.79,,,23.70,,23.23,1.18, , ,-1.69, , ,0.49, ,-0.44, , ,0.47, ,muscle contraction,dystrophin-associated glycoprotein complex;synapse;cell junction;sarcolemma;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
3787,Q13895,BYSL,Bystin,RMPQDGSDDEDEE,_M(ox)PQDGS(ph)DDEDEEWPTLEK_,S98,,26.17,,,22.87,28.32,24.62,25.08,,26.79,28.14,,25.20,23.90,25.68,0.50, , ,-2.81,2.65,-1.06,-0.59, ,1.11,2.46, ,-0.48,-1.78,female pregnancy;cell adhesion;ribosome biogenesis,nucleolus;cytoplasm,,,,,,,,,,,,,,
3790,Q13951,CBFB,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),RRQQDPSPGSNLG,_RQQDPS(ph)PGSNLGGGDDLK_,S173,,22.89,25.33,25.06,24.61,25.74,26.45,25.16,26.80,27.92,,25.91,25.83,24.70,25.53,-2.64,-0.21,-0.47,-0.92,0.21,0.92,-0.38,1.27,2.39, ,0.37,0.30,-0.83,myeloid cell differentiation;osteoblast differentiation;cell maturation;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;lymphocyte differentiation;definitive hemopoiesis,nucleus,,,,,,,,,,,+,,,
3791,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),ERGGDVSPSPYSS,_GGDVS(ph)PSPYSSSSWR_,S383,+,24.27,23.96,24.11,25.32,24.14,26.11,,23.53,22.59,24.69,,,24.38,24.31,-0.04,-0.35,-0.20,1.01,-0.17,1.80, ,-0.78,-1.72,0.38, , ,0.07,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
3792,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),SRSRHSSISPSTL,_HSS(ph)IS(ph)PSTLTLK_,S437,,23.63,,,,22.06,,,,,,,,,22.85,0.78, , , ,-0.78, , , , , , , , ,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
3793,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),SRHSSISPSTLTL,_HSS(ph)IS(ph)PSTLTLK_,S439,,23.63,,,,22.06,,,,,,,,,22.85,0.78, , , ,-0.78, , , , , , , , ,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
3794,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),KIEHAPSPSSGGT,_IEHAPS(ph)PSSGGTLK_,S525,+,,,,22.35,,22.48,23.14,,23.01,23.25,22.51,22.73,22.41,22.74, , , ,-0.38, ,-0.26,0.41, ,0.28,0.51,-0.22,0.00,-0.33,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
3803,Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),DEGHSNSSPRHSE,_IDASKNEEDEGHSNS(ph)SPR_,S82,+,21.86,26.15,25.19,25.49,,,,23.27,25.67,,,22.78,26.42,24.60,-2.74,1.55,0.58,0.89, , , ,-1.34,1.07, , ,-1.82,1.81,"positive regulation of transcription, DNA-dependent;RNA catabolic process;mRNA splicing, via spliceosome;transcription, DNA-dependent;mRNA stabilization",nucleoplasm;cytosol;ribonucleoprotein complex,Other TF domain,,,,,,,,,,,,,
3804,Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),EGHSNSSPRHSEA,_IDASKNEEDEGHSNSS(ph)PR_,S83,+,23.05,27.39,27.39,24.85,28.44,28.13,20.42,27.37,26.80,19.67,23.97,24.58,23.69,25.06,-2.01,2.33,2.33,-0.21,3.38,3.07,-4.64,2.32,1.74,-5.39,-1.09,-0.48,-1.37,"positive regulation of transcription, DNA-dependent;RNA catabolic process;mRNA splicing, via spliceosome;transcription, DNA-dependent;mRNA stabilization",nucleoplasm;cytosol;ribonucleoprotein complex,Other TF domain,,,,,,,,,,,,,
3805,Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),IFVGGLSPDTPEE,_IFVGGLS(ph)PDTPEEK_,S190,+,25.09,24.84,25.10,,22.91,25.29,24.49,22.80,25.57,25.35,24.07,,24.95,24.59,0.50,0.25,0.51, ,-1.68,0.70,-0.10,-1.79,0.98,0.77,-0.52, ,0.37,"positive regulation of transcription, DNA-dependent;RNA catabolic process;mRNA splicing, via spliceosome;transcription, DNA-dependent;mRNA stabilization",nucleoplasm;cytosol;ribonucleoprotein complex,Other TF domain,,,,,,,,,,,,,
3806,Q14103,HNRNPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),NSSPRHSEAATAQ,_NEEDEGHSNS(ph)SPRHS(ph)EAATAQR_,S87,,22.38,24.29,24.81,22.84,,,,,,,,,,23.58,-1.20,0.71,1.23,-0.74, , , , , , , , , ,"positive regulation of transcription, DNA-dependent;RNA catabolic process;mRNA splicing, via spliceosome;transcription, DNA-dependent;mRNA stabilization",nucleoplasm;cytosol;ribonucleoprotein complex,Other TF domain,,,,,,,,,,,,,
3808,Q14123,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) (hCam-3)",____MESPTKEIE,_(ac)M(ox)ES(ph)PTKEIEEFESNSLK_,S3,,,,,,25.88,,,26.56,,,,,,26.22, , , , ,-0.34, , ,0.34, , , , , ,epidermal growth factor receptor signaling pathway;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;nerve growth factor receptor signaling pathway,cytosol,,,,,,,,,,,,,,
3809,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),FTDKAASYTEEDE,_AAS(ph)YTEEDENHTAK_,S782,+,25.40,,,25.57,24.59,22.05,22.63,22.98,23.20,20.40,,24.37,21.79,23.30,2.10, , ,2.27,1.29,-1.25,-0.67,-0.31,-0.10,-2.90, ,1.07,-1.51,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
3810,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),EATMKGSSSASIV,_EATM(ox)KGS(ph)SSAS(ph)IVK_,S699,,24.13,22.25,22.25,,,,,,,,,,,22.88,1.25,-0.62,-0.62, , , , , , , , , , ,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
3811,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),KGSSSASIVKGQH,_GSSSAS(ph)IVK_,S703,,25.15,22.69,22.69,24.09,,,,,,,,21.80,,23.29,1.87,-0.59,-0.59,0.81, , , , , , , ,-1.49, ,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
3812,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),GRWEEHRSLLSGR,_S(ph)LLSGR_,S723,,23.60,,,21.54,,,,,,,,,,22.57,1.03, , ,-1.03, , , , , , , , , ,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
3813,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),PVDQGGSLVGRNG,_VVPSFLPVDQGGS(ph)LVGR_,S680,+,30.44,25.76,25.53,26.55,27.60,26.86,26.84,27.57,27.45,27.00,27.52,27.86,28.42,27.34,3.10,-1.58,-1.81,-0.78,0.27,-0.48,-0.50,0.23,0.11,-0.34,0.18,0.52,1.08,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
3814,Q14134,TRIM29,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),EARDARSPSGPSG,_S(ph)PSGPSGSLENGTK_,S21,,26.30,25.95,25.95,,,,,,,21.97,,,,25.04,1.26,0.91,0.91, , , , , , ,-3.07, , , ,transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
3815,Q14134,TRIM29,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),PSGPSGSLENGTK,_SPSGPSGS(ph)LENGTK_,S28,,22.90,,,,,,,,,,,,,22.90,0.00, , , , , , , , , , , , ,transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
3816,Q14134,TRIM29,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),SLKGYPSLMRSQS,_GYPS(ph)LM(ox)R_,S546,,23.33,,,,,,,,,,,,,23.33,0.00, , , , , , , , , , , , ,transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
3817,Q14134,TRIM29,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),GETRRNSYPRADT,_RNS(ph)YPRADTGLFSR_,S152,,23.52,26.14,26.14,,,,,,,,,,,25.27,-1.75,0.88,0.88, , , , , , , , , , ,transcription from RNA polymerase II promoter,cytoplasm,,,,,,,,,,,,,,
3819,Q14135,VGLL4,Transcription cofactor vestigial-like protein 4 (Vgl-4),TGPPPISPSKRKF,_TGPPPIS(ph)PSK_,S52,,25.24,22.94,22.58,23.13,21.32,21.61,,,,,,,,22.80,2.44,0.13,-0.23,0.33,-1.48,-1.19, , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
3820,Q14137,BOP 1.00,Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein),DEYAEDSSDEEDI,_IGDEYAEDS(ph)S(ph)DEEDIR_,S126,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,"cell proliferation;regulation of cell cycle;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",nucleoplasm;PeBoW complex,,,,,,,,,,,,,,
3821,Q14137,BOP 1.00,Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein),EYAEDSSDEEDIR,_IGDEYAEDS(ph)S(ph)DEEDIR_,S127,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,"cell proliferation;regulation of cell cycle;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",nucleoplasm;PeBoW complex,,,,,,,,,,,,,,
3822,Q14147,DHX34,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34),EEQDGGSSDEDRA,_LQEEQDGGS(ph)S(ph)DEDRAGPAPPGASDGVDIQDVK_,S749,,24.26,,,,,,,,,,,,,24.26,0.00, , , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
3823,Q14147,DHX34,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34),EQDGGSSDEDRAG,_LQEEQDGGS(ph)S(ph)DEDRAGPAPPGASDGVDIQDVK_,S750,,24.26,,,,,,,,,,,,,24.26,0.00, , , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
3824,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),QSSKADSLLAVVK,_ADS(ph)LLAVVK_,S288,+,22.36,20.60,21.03,19.80,,,21.86,,22.05,21.78,,,20.41,21.24,1.12,-0.63,-0.21,-1.43, , ,0.62, ,0.81,0.55, , ,-0.83,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3825,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),GSDKRLSEGRGLP,_DGWGGYGSDKRLS(ph)EGR_,S832,,,,,,23.81,23.75,,22.68,22.02,,25.96,,26.73,24.16, , , , ,-0.35,-0.41, ,-1.48,-2.14, ,1.80, ,2.57,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3826,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),EKRDILSFDKIKE,_DILS(ph)FDK_,S613,,20.81,,,,,,,,,,,,,20.81,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3828,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),PVKEESSELEQPF,_EESS(ph)ELEQPFAQDTSSVGPDRK_,S235,,22.22,23.87,24.45,,,,24.48,,,25.47,,,,24.10,-1.88,-0.23,0.35, , , ,0.38, , ,1.37, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3830,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),FAQDTSSVGPDRK,_EESSELEQPFAQDTSS(ph)VGPDRK_,S247,+,24.34,,,21.79,26.50,26.17,25.77,25.08,25.86,25.48,,24.46,26.63,25.21,-0.86, , ,-3.42,1.29,0.97,0.56,-0.13,0.66,0.27, ,-0.75,1.42,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3831,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),NGLEDDSRDGQED,_M(ox)EEEGTEDNGLEDDS(ph)R_,S109,,24.44,26.57,27.32,,,,22.28,,,,,,,25.15,-0.72,1.42,2.16, , , ,-2.87, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3833,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),APTEAPSPEARDS,_REPAEQPGDGERTDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPS(ph)PEAR_,S344,,25.03,,,,,,23.80,,26.26,27.74,,,,25.71,-0.67, , , , , ,-1.91, ,0.55,2.03, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3834,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),TPDIEESLLEPEN,_VTPDIEES(ph)LLEPENEK_,S207,,23.61,,,,21.10,,,,,22.01,,,,22.24,1.37, , , ,-1.14, , , , ,-0.23, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3835,Q14151,SAFB2,Scaffold attachment factor B2 (SAF-B2),VVTNARSPGARCY,_VVTNARS(ph)PGAR_,S443,+,22.31,26.74,26.74,22.55,21.39,22.25,21.79,20.56,22.62,21.75,,22.04,22.32,22.75,-0.44,3.99,3.99,-0.20,-1.37,-0.50,-0.97,-2.19,-0.14,-1.01, ,-0.72,-0.44,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
3836,Q14152,EIF3A,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185),AEKDRESLRRTKN,_DRES(ph)LRR_,S1364,+,24.48,18.97,19.48,22.45,19.33,,17.76,18.76,,,,19.01,,20.03,4.45,-1.06,-0.55,2.42,-0.70, ,-2.27,-1.27, , , ,-1.02, ,formation of translation initiation complex,cytosol;eukaryotic translation initiation factor 3 complex;nucleolus,,,,,,,,,,,,,,
3839,Q14153,FAM53B,Protein FAM53B,TMQRSSSFSLPSR,_SSS(ph)FSLPSR_,S167,+,25.20,23.21,,23.91,22.60,22.19,22.52,22.58,,20.55,21.83,22.90,,22.75,2.45,0.46, ,1.16,-0.15,-0.56,-0.22,-0.17, ,-2.20,-0.91,0.15, ,,,,,,,,,,,,,,,,
3840,Q14155,ARHGEF7,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),ASEKPVSPKSGTL,_ASEKPVS(ph)PK_,S71,,,22.25,22.25,20.34,,,18.29,19.03,,,,18.28,19.33,19.97, ,2.28,2.28,0.37, , ,-1.68,-0.93, , , ,-1.69,-0.64,lamellipodium assembly;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process;nervous system development,neuronal cell body;protein complex;cell cortex;cytosol;neuron projection;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
3841,Q14155,ARHGEF7,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),SSSRKESAPQVLL,_KES(ph)APQVLLPEEEK_,S560,,23.23,24.56,24.15,22.31,,,24.56,24.26,,22.26,26.60,26.46,26.05,24.45,-1.21,0.12,-0.30,-2.14, , ,0.12,-0.18, ,-2.18,2.16,2.02,1.60,lamellipodium assembly;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process;nervous system development,neuronal cell body;protein complex;cell cortex;cytosol;neuron projection;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
3842,Q14155,ARHGEF7,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),KPERKPSDEEFAS,_KPS(ph)DEEFASR_,S516,,22.23,23.90,,,20.80,22.43,,,20.76,,19.38,,,21.58,0.65,2.31, , ,-0.79,0.85, , ,-0.83, ,-2.20, , ,lamellipodium assembly;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process;nervous system development,neuronal cell body;protein complex;cell cortex;cytosol;neuron projection;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
3843,Q14155,ARHGEF7,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),SASPRMSGFIYQG,_M(ox)S(ph)GFIYQGK_,S340,+,27.27,28.83,,28.51,26.60,27.56,28.12,27.60,27.35,28.39,28.24,27.40,26.76,27.72,-0.45,1.11, ,0.79,-1.12,-0.16,0.40,-0.12,-0.37,0.67,0.52,-0.32,-0.96,lamellipodium assembly;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;positive regulation of apoptotic process;nervous system development,neuronal cell body;protein complex;cell cortex;cytosol;neuron projection;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
3848,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),LASNPYSGDLTKF,_DGSLASNPYS(ph)GDLTK_,S859,,22.69,,,,,,,,,,,,,22.69,0.00, , , , , , , , , , , , ,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3849,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),SDSAVHSPFTKRQ,_NPSDSAVHS(ph)PFTK_,S416,,23.65,21.60,21.60,,,,21.72,,,,,,,22.14,1.51,-0.55,-0.55, , , ,-0.42, , , , , , ,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3851,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),TRRYPSSISSSPQ,_RYPSS(ph)ISSS(ph)PQK_,S605,,25.06,24.64,25.34,25.25,21.18,,,22.33,,,,,,23.97,1.09,0.68,1.37,1.28,-2.78, , ,-1.64, , , , , ,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3853,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),PSSISSSPQKDLT,_RYPSSISSS(ph)PQK_,S609,+,27.34,27.54,28.20,27.46,28.10,26.40,27.67,28.10,26.87,26.49,26.46,26.50,25.24,27.11,0.24,0.43,1.09,0.36,1.00,-0.71,0.57,1.00,-0.23,-0.62,-0.64,-0.61,-1.87,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3855,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),APPPPSSPLPSKS,_SPAVATSTAAPPPPSS(ph)PLPSK_,S454,+,28.46,28.11,28.11,,28.23,26.93,,27.93,27.37,,,,,27.88,0.58,0.23,0.23, ,0.35,-0.95, ,0.05,-0.50, , , , ,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3856,Q14157,UBAP2L,Ubiquitin-associated protein 2-like (Protein NICE-4),TSAPQMSPGSSDN,_STSAPQM(ox)S(ph)PGSSDNQSSSPQPAQQK_,S467,+,25.72,26.05,26.65,23.33,25.92,22.61,24.27,24.81,26.46,25.99,22.02,24.99,24.67,24.88,0.84,1.17,1.76,-1.55,1.03,-2.28,-0.62,-0.07,1.57,1.11,-2.86,0.11,-0.21,binding of sperm to zona pellucida,,,,,,,,,,,,,,,
3858,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),APERALSPAELRA,_ALS(ph)PAELR_,S1486,+,25.89,23.43,21.49,24.82,24.00,23.71,22.80,23.22,21.91,,23.30,,22.56,23.38,2.51,0.06,-1.89,1.45,0.63,0.33,-0.58,-0.15,-1.47, ,-0.08, ,-0.81,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3859,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),AVVSAPSVKGVSF,_EGAVVSAPS(ph)VK_,S703,,22.75,,,22.03,,,,,,,,23.70,,22.83,-0.07, , ,-0.79, , , , , , , ,0.87, ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3862,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),TSPGRLSPDFAEE,_LAEAPSPAPTPSPTPVEDLGPQTSTSPGRLS(ph)PDFAEELR_,S1566,+,26.79,24.90,24.90,25.24,,26.90,27.98,28.65,27.39,,27.04,27.41,29.79,27.00,-0.21,-2.10,-2.10,-1.75, ,-0.10,0.98,1.65,0.39, ,0.04,0.41,2.79,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3863,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),EQPPWASPSPTSR,_LALDGETLGEEEQEDEQPPWAS(ph)PSPTSR_,S1437,,22.14,,,,,,,,,,,,,22.14,0.00, , , , , , , , , , , , ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3865,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),PLLPPESPGPLRQ,_LPLLPPES(ph)PGPLR_,S853,+,25.58,22.48,,23.30,,22.24,21.91,21.51,22.70,22.47,,21.37,22.48,22.60,2.97,-0.13, ,0.69, ,-0.36,-0.70,-1.09,0.10,-0.13, ,-1.23,-0.13,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3866,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),ERLRVQSPEPPAP,_VQS(ph)PEPPAPER_,S1475,+,,25.57,24.18,26.59,27.55,26.84,27.46,27.01,27.44,28.03,27.23,22.73,27.26,26.49, ,-0.93,-2.31,0.10,1.06,0.35,0.97,0.52,0.95,1.54,0.74,-3.76,0.77,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3868,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),GIGHRNSLESISS,_NS(ph)LESISSIDR_,S1220,,22.68,23.51,22.39,22.20,,,,,,21.57,,,,22.47,0.21,1.03,-0.08,-0.27, , , , , ,-0.90, , , ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3869,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),HRNSLESISSIDR,_NSLES(ph)ISS(ph)IDRELSPEGPGK_,S1223,,21.07,,,,,,,,,,,,,21.07,0.00, , , , , , , , , , , , ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3871,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),SLESISSIDRELS,_NSLES(ph)ISS(ph)IDRELSPEGPGK_,S1226,,21.07,,,,,,,23.27,,,,,,22.17,-1.10, , , , , , ,1.10, , , , , ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3872,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),SIDRELSPEGPGK,_NSLESISSIDRELS(ph)PEGPGK_,S1232,+,,,,,21.54,22.81,23.73,22.82,,26.37,22.93,,24.12,23.47, , , , ,-1.93,-0.67,0.26,-0.65, ,2.89,-0.54, ,0.64,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3873,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),SRQSPASPPPLGG,_(gl)QSPAS(ph)PPPLGGGAPVRTAK_,S1448,+,27.49,25.59,25.42,26.86,28.03,27.88,28.07,27.90,27.95,28.44,27.43,27.01,28.26,27.41,0.08,-1.82,-1.99,-0.55,0.62,0.47,0.66,0.49,0.54,1.03,0.02,-0.40,0.85,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3874,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),GPPKRVSLVGADD,_RVS(ph)LVGADDLRK_,S1378,+,21.02,22.33,22.08,,20.25,23.46,23.25,21.93,24.44,24.34,23.23,23.95,24.30,22.88,-1.86,-0.55,-0.80, ,-2.63,0.57,0.37,-0.95,1.56,1.46,0.35,1.07,1.42,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3875,Q14160,SCRIB,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),RAARMKSLEQDAL,_S(ph)LEQDALR_,S1508,+,26.21,24.96,25.13,25.26,,22.04,24.56,,25.10,,23.79,22.48,,24.39,1.81,0.57,0.74,0.87, ,-2.35,0.17, ,0.71, ,-0.60,-1.91, ,cell-cell adhesion;mammary gland duct morphogenesis;wound healing;synaptic vesicle endocytosis;establishment of apical/basal cell polarity;protein localization to adherens junction;apoptotic process involved in morphogenesis;activation of Rac GTPase activity;virus-host interaction;cell migration;positive regulation of receptor recycling;neural tube closure;cell proliferation;positive chemotaxis;asymmetric protein localization;positive regulation of apoptotic process;negative regulation of mitotic cell cycle;synaptic vesicle targeting,Scrib-APC-beta-catenin complex;basolateral plasma membrane;myelin sheath abaxonal region;plasma membrane;cell-cell adherens junction,,,,,,,,,,,,,,
3876,Q14161,GIT2,ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2),RQKSLDSDLSDGP,_SLDS(ph)DLSDGPVTVQEFM(ox)EVK_,S418,,21.20,,,21.98,,,,,,,,,,21.59,-0.39, , ,0.39, , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,nucleoplasm,,,,,,,,,,,,,,
3877,Q14161,GIT2,ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2),DYDSVASDEDTDL,_TINNQHSVESQDNDQPDYDSVAS(ph)DEDTDLETTASK_,S397,,,,,,24.68,,,,23.04,24.53,,,,24.09, , , , ,0.60, , , ,-1.04,0.45, , , ,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,nucleoplasm,,,,,,,,,,,,,,
3879,Q14166,TTLL12,Tubulin--tyrosine ligase-like protein 12,RPAERSSPGQTPE,_SS(ph)PGQTPEEGAQALAEFAALHGPALR_,S16,+,27.15,26.92,26.38,25.95,27.03,,26.91,28.72,,,27.74,25.64,,26.94,0.21,-0.02,-0.56,-0.99,0.09, ,-0.03,1.78, , ,0.80,-1.29, ,cellular protein modification process,,,,,,,,,,,,,,,
3880,Q14186,TFDP1,Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1),FIDQNLSPGKGVV,_VFIDQNLS(ph)PGK_,S23,+,24.75,24.87,25.71,24.50,21.93,23.98,25.78,24.65,24.75,25.60,23.50,23.83,25.30,24.55,0.20,0.32,1.16,-0.05,-2.62,-0.57,1.23,0.10,0.20,1.04,-1.05,-0.72,0.75,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;cell proliferation;G1 phase of mitotic cell cycle;G1/S transition of mitotic cell cycle;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;transcription factor complex,Other TF domain,,,,,,,,,,,,,
3881,Q14188,TFDP2,Transcription factor Dp-2 (E2F dimerization partner 2),FIDQNLSPTKGNI,_GFIDQNLS(ph)PTK_,S24,,21.91,,,,,22.67,,22.25,,,,,,22.28,-0.36, , , , ,0.39, ,-0.03, , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;G1 phase of mitotic cell cycle;heart development;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;transcription factor complex,Other TF domain,,,,,,,,,,,,,
3883,Q14195,DPYSL3,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),REPAPASPAPAGV,_EESREPAPAS(ph)PAPAGVEIR_,S102,,23.59,25.15,25.56,23.96,28.27,26.86,27.41,27.19,25.61,21.41,27.66,24.24,26.36,25.64,-2.04,-0.48,-0.08,-1.68,2.64,1.23,1.77,1.55,-0.03,-4.23,2.02,-1.40,0.72,actin crosslink formation;pyrimidine nucleobase catabolic process;response to axon injury;positive regulation of filopodium assembly;cellular response to cytokine stimulus;axon guidance;negative regulation of cell migration;positive regulation of neuron projection development;protein homooligomerization;actin filament bundle assembly;negative regulation of neuron projection development,growth cone;cytosol;extracellular space;filamentous actin;lamellipodium;cell body,,,,,,,,,,,,,,
3884,Q14195,DPYSL3,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),GGTPAGSARGSPT,_GGTPAGS(ph)ARGS(ph)PTRPNPPVR_,S632,,25.28,,,23.53,,,,,,,,,,24.41,0.87, , ,-0.87, , , , , , , , , ,actin crosslink formation;pyrimidine nucleobase catabolic process;response to axon injury;positive regulation of filopodium assembly;cellular response to cytokine stimulus;axon guidance;negative regulation of cell migration;positive regulation of neuron projection development;protein homooligomerization;actin filament bundle assembly;negative regulation of neuron projection development,growth cone;cytosol;extracellular space;filamentous actin;lamellipodium;cell body,,,,,,,,,,,,,,
3885,Q14195,DPYSL3,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),AGSARGSPTRPNP,_GS(ph)PTRPNPPVR_,S636,+,26.37,26.04,,26.01,27.01,24.75,27.60,26.69,24.79,,25.05,24.43,21.24,25.45,0.91,0.59, ,0.56,1.56,-0.70,2.14,1.23,-0.66, ,-0.40,-1.02,-4.21,actin crosslink formation;pyrimidine nucleobase catabolic process;response to axon injury;positive regulation of filopodium assembly;cellular response to cytokine stimulus;axon guidance;negative regulation of cell migration;positive regulation of neuron projection development;protein homooligomerization;actin filament bundle assembly;negative regulation of neuron projection development,growth cone;cytosol;extracellular space;filamentous actin;lamellipodium;cell body,,,,,,,,,,,,,,
3886,Q14204,DYNC1H1,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",KKTRTDSTSDGRP,_TDS(ph)TSDGRPAWM(ox)R_,S4368,+,26.08,25.17,25.98,25.26,26.62,25.60,26.12,26.22,23.61,24.94,25.94,24.69,23.44,25.36,0.73,-0.19,0.62,-0.10,1.26,0.24,0.76,0.86,-1.75,-0.42,0.58,-0.67,-1.92,transport;G2/M transition of mitotic cell cycle;mitotic spindle organization;cell death;microtubule-based movement;stress granule assembly;antigen processing and presentation of exogenous peptide antigen via MHC class II;cytoplasmic mRNA processing body assembly,cytosol;cytoplasmic dynein complex;extracellular vesicular exosome;Golgi apparatus;microtubule;centrosome,,,,,,,,,,,,,,
3888,Q14241,TCEB3,Transcription elongation factor B polypeptide 3 (Elongin 110 kDa subunit) (Elongin-A) (EloA) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110),KRKAFSSPQEEEE,_AFSS(ph)PQEEEEAGFTGRR_,S542,,,,,22.35,,22.51,,,22.23,22.86,,,23.07,22.60, , , ,-0.26, ,-0.09, , ,-0.37,0.25, , ,0.47,viral reproduction;regulation of transcription from RNA polymerase II promoter;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,nucleoplasm;transcription elongation factor complex;integral to membrane,,,,,,,,,,,,,,
3889,Q14241,TCEB3,Transcription elongation factor B polypeptide 3 (Elongin 110 kDa subunit) (Elongin-A) (EloA) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110),TGSRSYSPDHRQK,_SYS(ph)PDHR_,S151,+,19.15,21.80,19.13,24.16,18.38,,,19.51,19.47,,,,,20.23,-1.08,1.57,-1.10,3.93,-1.85, , ,-0.72,-0.76, , , , ,viral reproduction;regulation of transcription from RNA polymerase II promoter;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,nucleoplasm;transcription elongation factor complex;integral to membrane,,,,,,,,,,,,,,
3894,Q14244,MAP7,Ensconsin (Epithelial microtubule-associated protein of 115 kDa) (E-MAP-115) (Microtubule-associated protein 7) (MAP-7),SKRLSSSSATLLN,_LSSS(ph)SATLLNSPDR_,S56,,24.47,,,,,,,,,,,,,24.47,0.00, , , , , , , , , , , , ,protein localization to plasma membrane;establishment or maintenance of cell polarity;microtubule cytoskeleton organization;response to osmotic stress,basolateral plasma membrane;microtubule associated complex;microtubule;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
3897,Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),TQTPPVSPAPQPT,_TQT(ph)PPVS(ph)PAPQPTEERLPSS(ph)PVYEDAASFK_,S405,+,31.16,26.68,26.84,27.17,29.38,23.07,26.47,28.23,28.31,28.72,27.00,26.13,25.48,27.28,3.88,-0.60,-0.44,-0.11,2.11,-4.21,-0.81,0.95,1.03,1.44,-0.28,-1.15,-1.80,,cell cortex;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
3899,Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),EERLPSSPVYEDA,_LPSS(ph)PVYEDAASFK_,S418,+,29.77,27.12,27.14,26.88,26.37,26.13,26.14,26.59,25.52,24.98,28.31,26.09,26.70,26.75,3.02,0.37,0.39,0.13,-0.38,-0.62,-0.61,-0.16,-1.23,-1.76,1.56,-0.66,-0.05,,cell cortex;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
3900,Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),KLQLHESQKDYKT,_LQLHES(ph)QK_,S261,,27.83,24.00,,25.42,,,,,,,,26.74,,26.00,1.83,-1.99, ,-0.58, , , , , , , ,0.74, ,,cell cortex;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
3901,Q14254,FLOT2,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),KVDYLSSLGKTQT,_VDYLSS(ph)LGK_,S166,,,,,,,,,,,24.87,22.99,21.21,,23.03, , , , , , , , , ,1.85,-0.03,-1.81, ,cell adhesion;epidermis development,endosome;endocytic vesicle;plasma membrane;flotillin complex;cell surface;acrosomal membrane,,,,,,,,,,,,,,
3903,Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),GRERLGSFGSITR,_LGS(ph)FGSITR_,S2233,+,25.85,27.43,25.27,29.40,28.89,29.38,28.70,28.66,29.11,24.50,28.90,30.74,30.88,28.28,-2.44,-0.86,-3.02,1.12,0.60,1.10,0.42,0.38,0.82,-3.79,0.61,2.45,2.59,cell junction assembly,Z disc;cytosol;sarcolemma;cytoskeleton;costamere,,,,,,,,,,,,,,
3904,Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),RLGSFGSITRQQE,_LGSFGS(ph)ITR_,S2236,,,19.90,,24.70,,,21.68,,,,,24.88,,22.79, ,-2.89, ,1.91, , ,-1.11, , , , ,2.09, ,cell junction assembly,Z disc;cytosol;sarcolemma;cytoskeleton;costamere,,,,,,,,,,,,,,
3905,Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),SSSRGSSYSSIPK,_GSS(ph)YSSIPK_,S2624,+,22.27,24.22,22.67,25.76,22.89,,23.27,22.93,,,,23.48,,23.43,-1.17,0.79,-0.77,2.32,-0.55, ,-0.17,-0.51, , , ,0.05, ,cell junction assembly,Z disc;cytosol;sarcolemma;cytoskeleton;costamere,,,,,,,,,,,,,,
3908,Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),GDPVPKSPFVVNV,_S(ph)PFVVNVAPPLDLSK_,S954,,,23.22,23.19,25.71,,,,23.69,24.25,,25.74,25.86,23.98,24.45, ,-1.23,-1.26,1.26, , , ,-0.77,-0.20, ,1.28,1.41,-0.48,cell junction assembly,Z disc;cytosol;sarcolemma;cytoskeleton;costamere,,,,,,,,,,,,,,
3909,Q14315,FLNC,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),DQEVPRSPFKIKV,_YADQEVPRS(ph)PFK_,S1527,,,22.03,,24.84,24.40,24.87,25.72,25.50,23.49,,25.24,27.07,26.08,24.92, ,-2.90, ,-0.09,-0.52,-0.06,0.80,0.57,-1.43, ,0.32,2.15,1.16,cell junction assembly,Z disc;cytosol;sarcolemma;cytoskeleton;costamere,,,,,,,,,,,,,,
3910,Q14432,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)",GALAKISPLSSPC,_IS(ph)PLSSPCSSPLQGTPASSLVSK_,S520,,22.78,,,,,,,,,,,,,22.78,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;positive regulation of vascular permeability;cellular response to cGMP;response to drug;response to cAMP;positive regulation of oocyte development;lipid metabolic process;cellular response to transforming growth factor beta stimulus;blood coagulation;cAMP-mediated signaling;oocyte maturation;cAMP catabolic process;regulation of meiosis;negative regulation of vascular permeability;cGMP-mediated signaling,cytosol;integral to membrane,,,,,,,,,,,,,,
3911,Q14435,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3),FKTTNLSVEEQKE,_TTNLS(ph)VEEQK_,S134,,27.87,26.66,27.59,21.01,,,,,,,,,25.23,25.67,2.20,0.99,1.92,-4.66, , , , , , , , ,-0.44,O-glycan processing;protein O-linked glycosylation via serine;post-translational protein modification;protein O-linked glycosylation via threonine,Golgi cisterna membrane;integral to membrane;nucleus;Golgi membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3912,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),PFRKDKSPVREPI,_S(ph)PVREPIDNLTPEER_,S136,+,29.52,29.50,29.27,28.53,30.05,30.99,30.24,30.45,29.58,28.13,29.65,29.04,30.05,29.62,-0.09,-0.11,-0.34,-1.09,0.43,1.38,0.63,0.84,-0.04,-1.49,0.03,-0.58,0.43,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3913,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),KIGLPHSIKLSRR,_IGLPHS(ph)IK_,S117,,24.55,20.64,20.64,23.55,,,,,,,,25.88,21.43,22.78,1.77,-2.14,-2.14,0.77, , , , , , , ,3.10,-1.35,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3914,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),SRRRSRSKSPFRK,_S(ph)KS(ph)PFRK_,S127,,23.41,23.47,24.10,23.74,,,,,,,,,,23.68,-0.27,-0.21,0.42,0.06, , , , , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3915,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),RRSRSKSPFRKDK,_S(ph)KS(ph)PFRK_,S129,,23.41,23.47,24.10,23.74,,,,,,,,,,23.68,-0.27,-0.21,0.42,0.06, , , , , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3916,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),ERTDASSASSFLD,_TDASS(ph)ASSFLDSDELER_,S334,,24.24,,,,,,,,,,,,,24.24,0.00, , , , , , , , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3917,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),DASSASSFLDSDE,_TDASSASS(ph)FLDSDELER_,S337,,23.70,,,,,,,,,,,,,23.70,0.00, , , , , , , , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3919,Q14498,RBM39,RNA-binding protein 39 (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),FRGRYRSPYRRRS,_YRS(ph)PYR_,S97,,,24.32,25.03,22.24,20.10,,19.07,,,,,,,22.15, ,2.17,2.88,0.09,-2.06, ,-3.08, , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleoplasm;nuclear speck;centrosome,,,,,,,,,,,,,,
3920,Q14517,FAT1,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",EAFDPDSSSNDKL,_DVSVVQIEAFDPDS(ph)S(ph)SNDK_,S1168,,23.62,,,,,,24.59,,,22.13,,,24.86,23.80,-0.18, , , , , ,0.79, , ,-1.67, , ,1.06,anatomical structure morphogenesis;cell-cell adhesion;actin filament organization;homophilic cell adhesion;establishment or maintenance of cell polarity;cell migration;cell-cell signaling,filopodium;cell-cell junction;nucleus;lamellipodium;integral to plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3921,Q14517,FAT1,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",AFDPDSSSNDKLM,_DVSVVQIEAFDPDS(ph)S(ph)SNDK_,S1169,,23.62,,,,,,24.59,,,22.13,,,24.86,23.80,-0.18, , , , , ,0.79, , ,-1.67, , ,1.06,anatomical structure morphogenesis;cell-cell adhesion;actin filament organization;homophilic cell adhesion;establishment or maintenance of cell polarity;cell migration;cell-cell signaling,filopodium;cell-cell junction;nucleus;lamellipodium;integral to plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3922,Q14526,HIC1,Hypermethylated in cancer 1 protein (Hic-1) (Zinc finger and BTB domain-containing protein 29),RTIDRFSPT____,_TIDRFS(ph)PT_,S731,,,21.78,22.48,24.23,23.74,23.06,20.49,,23.16,,,22.58,23.05,22.73, ,-0.95,-0.25,1.50,1.01,0.33,-2.24, ,0.43, , ,-0.15,0.32,"multicellular organismal development;negative regulation of transcription from RNA polymerase II promoter;intrinsic apoptotic signaling pathway in response to DNA damage;positive regulation of DNA damage response, signal transduction by p53 class mediator;Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway",chromatin;nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
3923,Q14542,SLC29A2,"Equilibrative nucleoside transporter 2 (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2)",ENGIPSSPQKVAL,_AELLQSDENGIPSS(ph)PQK_,S252,,24.68,,,,,,,,,25.71,,,,25.20,-0.51, , , , , , , , ,0.51, , , ,nucleoside transport;uridine transport;nucleobase-containing compound metabolic process;guanine transport;adenine transport;cell proliferation;hypoxanthine transport;cellular response to insulin stimulus;thymine transport;lactation,nuclear membrane;basolateral plasma membrane;nucleolus;integral to plasma membrane,,,,,,,,,,,,,,
3924,Q14566,MCM6,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),IESEIDSEEELIN,_EIESEIDS(ph)EEELINK_,S762,,22.84,,,,,,23.42,,,24.59,,,,23.61,-0.78, , , , , ,-0.20, , ,0.97, , , ,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;MCM complex,,,,,,,,,,,,,,
3925,Q14566,MCM6,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),AEPGAGSQHLEVR,_(ac)M(ox)DLAAAAEPGAGS(ph)QHLEVR_,S13,,23.23,24.12,24.97,21.09,,,,,,,,,,23.35,-0.12,0.76,1.62,-2.26, , , , , , , , , ,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;DNA unwinding involved in replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;MCM complex,,,,,,,,,,,,,,
3926,Q14568,HSP90AA2,Putative heat shock protein HSP 90-alpha A2 (Heat shock 90 kDa protein 1 alpha-like 3),EIEDVGSDEEEEK,_PEIEDVGS(ph)DEEEEKK_,S263,+,26.44,29.18,30.10,25.68,23.04,22.90,26.70,25.62,25.54,25.77,,27.02,,26.18,0.26,3.00,3.92,-0.50,-3.14,-3.28,0.52,-0.56,-0.64,-0.41, ,0.84, ,protein folding;response to stress,cytoplasm,,,,,,,,,,,,,,
3927,Q14571,ITPR2,"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",PRMRAMSLVSNEG,_AM(ox)S(ph)LVSNEGDSEQNEIR_,S2633,+,,,,23.56,23.85,23.52,23.47,22.72,,,,22.96,24.12,23.46, , , ,0.10,0.39,0.06,0.01,-0.73, , , ,-0.49,0.66,small molecule metabolic process;platelet activation;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;cellular response to cAMP;response to hypoxia;energy reserve metabolic process;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway,cell cortex;integral to membrane;plasma membrane;platelet dense tubular network membrane;sarcoplasmic reticulum membrane,,,,,,,,,,,,,,
3928,Q14571,ITPR2,"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",EESNILSPVQDGT,_GGEEPIEESNILS(ph)PVQDGTK_,S1160,,23.17,,,,,,,,24.09,24.07,,,,23.77,-0.61, , , , , , , ,0.31,0.29, , , ,small molecule metabolic process;platelet activation;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;cellular response to cAMP;response to hypoxia;energy reserve metabolic process;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway,cell cortex;integral to membrane;plasma membrane;platelet dense tubular network membrane;sarcoplasmic reticulum membrane,,,,,,,,,,,,,,
3930,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",TKGRVASFSIPGS,_VAS(ph)FSIPGSSSR_,S1832,+,28.29,26.83,26.92,26.34,29.16,28.83,28.63,28.74,28.70,28.82,29.78,27.42,29.33,28.29,0.00,-1.46,-1.37,-1.95,0.87,0.54,0.34,0.45,0.41,0.53,1.49,-0.87,1.04,fibroblast growth factor receptor signaling pathway;sensory perception of umami taste;energy reserve metabolic process;sensory perception of sweet taste;protein heterooligomerization;sensory perception of bitter taste;platelet activation;response to calcium ion;small molecule metabolic process;activation of phospholipase C activity;G-protein coupled receptor signaling pathway;calcium ion transport into cytosol;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway;protein homooligomerization,nucleoplasm;neuronal cell body;myelin sheath;apical part of cell;brush border;nucleolus;endoplasmic reticulum membrane;integral to plasma membrane;platelet dense tubular network membrane;nuclear outer membrane,,,,,,,,,,+,,,,
3936,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",DVQNCISR_____,_LGFVDVQNCIS(ph)R_,S2670,,25.73,22.95,22.95,24.21,,,23.55,,25.17,25.48,,,,24.29,1.43,-1.34,-1.34,-0.08, , ,-0.74, ,0.88,1.19, , , ,fibroblast growth factor receptor signaling pathway;sensory perception of umami taste;energy reserve metabolic process;sensory perception of sweet taste;protein heterooligomerization;sensory perception of bitter taste;platelet activation;response to calcium ion;small molecule metabolic process;activation of phospholipase C activity;G-protein coupled receptor signaling pathway;calcium ion transport into cytosol;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway;protein homooligomerization,nucleoplasm;neuronal cell body;myelin sheath;apical part of cell;brush border;nucleolus;endoplasmic reticulum membrane;integral to plasma membrane;platelet dense tubular network membrane;nuclear outer membrane,,,,,,,,,,+,,,,
3938,Q14573,ITPR3,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",GSSSRYSLGPSLR,_YS(ph)LGPSLR_,S1843,+,23.06,21.93,20.57,21.76,22.81,23.77,23.93,24.03,23.43,24.11,24.36,22.85,23.58,23.09,-0.03,-1.16,-2.52,-1.34,-0.28,0.68,0.84,0.94,0.34,1.02,1.27,-0.24,0.48,fibroblast growth factor receptor signaling pathway;sensory perception of umami taste;energy reserve metabolic process;sensory perception of sweet taste;protein heterooligomerization;sensory perception of bitter taste;platelet activation;response to calcium ion;small molecule metabolic process;activation of phospholipase C activity;G-protein coupled receptor signaling pathway;calcium ion transport into cytosol;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;nerve growth factor receptor signaling pathway;protein homooligomerization,nucleoplasm;neuronal cell body;myelin sheath;apical part of cell;brush border;nucleolus;endoplasmic reticulum membrane;integral to plasma membrane;platelet dense tubular network membrane;nuclear outer membrane,,,,,,,,,,+,,,,
3939,Q14596,NBR1,Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B),PPCRQKSLQMTFA,_S(ph)LQM(ox)TFALPEGPLGNEK_,S652,,22.75,,,,,,,,,,,,,22.75,0.00, , , , , , , , , , , , ,regulation of bone mineralization;regulation of stress-activated MAPK cascade;protein oligomerization;macroautophagy;negative regulation of osteoblast differentiation,cytosol;cytoplasmic vesicle;M band;late endosome;pre-autophagosomal structure;lysosome;autophagic vacuole,,,,,,,,,,,,,,
3940,Q14643,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)",NAARRDSVLAASR,_RDS(ph)VLAASR_,S1574,+,24.00,26.39,26.01,26.10,23.61,22.66,,,,,,,22.34,24.44,-0.44,1.95,1.57,1.65,-0.83,-1.79, , , , , , ,-2.11,small molecule metabolic process;platelet activation;fibroblast growth factor receptor signaling pathway;activation of phospholipase C activity;response to hypoxia;energy reserve metabolic process;epidermal growth factor receptor signaling pathway;regulation of insulin secretion;release of sequestered calcium ion into cytosol;nerve growth factor receptor signaling pathway;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,integral to membrane;platelet dense granule membrane;endoplasmic reticulum membrane;platelet dense tubular network membrane,,,,,,,,,,+,,,,
3941,Q14667,KIAA0100,UPF0378 protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein),GKLETKSDLNMQQ,_LET(ph)KS(ph)DLNM(ox)QQQEEEEK_,S2169,,21.97,28.45,29.11,28.46,26.28,,30.44,26.89,29.62,29.77,28.56,30.14,,28.15,-6.19,0.30,0.96,0.31,-1.87, ,2.29,-1.27,1.47,1.61,0.41,1.98, ,,extracellular region,,,,,,,,,,,,,,
3942,Q14667,KIAA0100,UPF0378 protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein),RRSFRKSPEHPVD,_S(ph)PEHPVDDIDK_,S2064,,24.04,23.75,24.19,22.76,,,23.94,,24.08,23.80,,,,23.79,0.24,-0.04,0.39,-1.03, , ,0.15, ,0.28,0.01, , , ,,extracellular region,,,,,,,,,,,,,,
3943,Q14669,TRIP12,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),TAPTKTSPRNAKK,_AQTAPTKTS(ph)PR_,S1427,+,20.54,23.40,23.79,23.12,,20.87,20.60,,20.28,,20.10,,21.15,21.54,-1.00,1.87,2.25,1.58, ,-0.66,-0.94, ,-1.26, ,-1.44, ,-0.39,DNA repair;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;embryo development;response to DNA damage stimulus;negative regulation of double-strand break repair,nucleoplasm;cytoplasm,,,,,,,,,,+,,,,
3946,Q14669,TRIP12,E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (E3 ubiquitin-protein ligase for Arf) (ULF) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),TKKRSESPPAELP,_SES(ph)PPAELPSLRR_,S312,+,25.43,24.72,23.84,25.09,27.78,27.46,26.02,27.04,25.64,25.95,25.03,25.08,26.09,25.78,-0.36,-1.07,-1.94,-0.69,2.00,1.68,0.24,1.26,-0.14,0.17,-0.75,-0.70,0.31,DNA repair;negative regulation of histone H2A K63-linked ubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;embryo development;response to DNA damage stimulus;negative regulation of double-strand break repair,nucleoplasm;cytoplasm,,,,,,,,,,+,,,,
3949,Q14671,PUM1,Pumilio homolog 1 (HsPUM) (Pumilio-1),SGSRRDSLTGSSD,_RDS(ph)LTGSSDLYK_,S709,+,,,,26.24,25.07,,25.35,26.38,26.08,24.09,,,25.78,25.57, , , ,0.67,-0.50, ,-0.22,0.81,0.51,-1.48, , ,0.21,post-Golgi vesicle-mediated transport;cellular membrane organization;regulation of translation,cytosol,,,,,,,,,,,,,,
3950,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),PFGFIDSDTDAEE,_AQPFGFIDS(ph)DTDAEEERIPATPVVIPM(ox)K_,S201,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
3951,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),QPPFGDSDDSVEA,_DQPPFGDS(ph)DDS(ph)VEADK_,S367,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
3952,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),FGDSDDSVEADKS,_DQPPFGDS(ph)DDS(ph)VEADK_,S370,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
3953,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),QESQAGSDTDVEE,_GPGAPGLAHLQESQAGS(ph)DTDVEEGK_,S248,,24.64,,,24.70,24.20,,25.49,,25.62,25.26,,,,24.99,-0.35, , ,-0.28,-0.78, ,0.51, ,0.64,0.27, , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
3955,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),VEADKSSPGIHLE,_SS(ph)PGIHLER_,S377,+,23.96,25.59,26.13,23.89,,,23.12,,24.16,24.31,,22.36,,24.19,-0.23,1.40,1.94,-0.30, , ,-1.07, ,-0.03,0.12, ,-1.83, ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
3958,Q14677,CLINT1,Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR),YTGDKASPDQNAS,_AS(ph)PDQNASTHTPQSSVK_,S299,+,24.08,24.82,25.40,24.91,,,22.56,,,24.19,,23.35,,24.19,-0.11,0.64,1.21,0.72, , ,-1.62, , ,0.00, ,-0.84, ,post-Golgi vesicle-mediated transport;cellular membrane organization;endocytosis,cytosol;Golgi apparatus;membrane;clathrin-coated vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3959,Q14677,CLINT1,Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR),RKDREDSPERCSD,_DREDS(ph)PERCSDSDEEK_,S227,,21.72,23.87,24.37,22.08,,,,19.82,20.07,,,,,21.99,-0.27,1.88,2.38,0.09, , , ,-2.17,-1.92, , , , ,post-Golgi vesicle-mediated transport;cellular membrane organization;endocytosis,cytosol;Golgi apparatus;membrane;clathrin-coated vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3960,Q14677,CLINT1,Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR),VGVSSDSVGGFRY,_YVGVSSDS(ph)VGGFR_,S166,,23.25,,,,,,,,,,,,,23.25,0.00, , , , , , , , , , , , ,post-Golgi vesicle-mediated transport;cellular membrane organization;endocytosis,cytosol;Golgi apparatus;membrane;clathrin-coated vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
3962,Q14678,KANK1,KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein),VRRRSYSAGNASQ,_SYS(ph)AGNASQLEQLSR_,S167,,23.23,,,23.27,,,,26.18,,,,,,24.23,-1.00, , ,-0.96, , , ,1.95, , , , , ,"negative regulation of lamellipodium morphogenesis;negative regulation of insulin receptor signaling pathway;positive regulation of catenin import into nucleus;regulation of establishment of cell polarity;positive regulation of Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;negative regulation of ruffle assembly;negative regulation of Rho protein signal transduction;negative regulation of cell migration;negative regulation of substrate adhesion-dependent cell spreading;transcription, DNA-dependent;positive regulation of wound healing;negative regulation of neuron projection development;negative regulation of actin filament polymerization",ruffle membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
3963,Q14678,KANK1,KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein),SVMKSASTEELRN,_SAS(ph)TEELRNPDFQK_,S723,+,21.77,22.08,22.08,,,23.76,24.66,23.22,,23.82,22.65,,,23.00,-1.23,-0.93,-0.93, , ,0.76,1.66,0.21, ,0.82,-0.36, , ,"negative regulation of lamellipodium morphogenesis;negative regulation of insulin receptor signaling pathway;positive regulation of catenin import into nucleus;regulation of establishment of cell polarity;positive regulation of Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;negative regulation of ruffle assembly;negative regulation of Rho protein signal transduction;negative regulation of cell migration;negative regulation of substrate adhesion-dependent cell spreading;transcription, DNA-dependent;positive regulation of wound healing;negative regulation of neuron projection development;negative regulation of actin filament polymerization",ruffle membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
3964,Q14680,MELK,Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2),GAKVFGSLERGLD,_VFGS(ph)LERGLDK_,S90,+,22.21,23.65,23.65,23.82,23.60,22.81,22.90,23.32,21.39,21.21,22.00,22.06,22.76,22.72,-0.52,0.93,0.93,1.10,0.88,0.09,0.17,0.60,-1.34,-1.51,-0.72,-0.66,0.03,G2/M transition of mitotic cell cycle;protein autophosphorylation;apoptotic process;neural precursor cell proliferation;hemopoiesis;positive regulation of apoptotic process,cell cortex;plasma membrane,,+,,,,,,,,,,,,
3965,Q14683,SMC1A,Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8),MEEESQSQGRDLT,_M(ox)EEESQS(ph)QGRDLTLEENQVK_,S360,,23.55,23.93,23.93,,,,,23.88,,22.33,,,,23.53,0.03,0.41,0.41, , , , ,0.35, ,-1.19, , , ,"chromosome condensation;response to radiation;negative regulation of DNA endoreduplication;mitotic spindle organization;DNA repair;meiosis;mitotic metaphase/anaphase transition;mitotic prometaphase;mRNA splicing, via spliceosome;cell cycle checkpoint;cell division;DNA recombination;signal transduction in response to DNA damage;mitotic sister chromatid cohesion",nucleoplasm;condensed nuclear chromosome;cohesin core heterodimer;condensed chromosome kinetochore;meiotic cohesin complex;kinetochore;cytoplasm,,,,,,,,,,,,,,
3966,Q14684,RRP1B,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),DKSILVSPTGPSR,_SILVS(ph)PTGPSR_,S688,+,23.62,22.65,,23.00,24.85,24.28,24.25,23.80,24.51,24.96,23.52,23.24,24.74,23.95,-0.34,-1.30, ,-0.95,0.90,0.33,0.30,-0.15,0.56,1.01,-0.44,-0.71,0.79,rRNA processing;negative regulation of phosphatase activity,"cytosol;preribosome, small subunit precursor;nucleolus",,,,,,,,,,,,,,
3969,Q14684,RRP1B,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),LKTPTSSPASSPL,_TPTSS(ph)PASS(ph)PLVAK_,S714,+,25.05,24.38,25.23,23.73,24.37,23.64,,,24.11,,,22.54,,24.13,0.92,0.24,1.10,-0.40,0.24,-0.49, , ,-0.02, , ,-1.59, ,rRNA processing;negative regulation of phosphatase activity,"cytosol;preribosome, small subunit precursor;nucleolus",,,,,,,,,,,,,,
3974,Q14687,GSE1,Genetic suppressor element 1,QELDRDSEEEEEE,_GPPTQELDRDS(ph)EEEEEEDDEDGEDEEEVPK_,S303,,,,,,,,,,22.55,25.73,,23.42,,23.90, , , , , , , , ,-1.35,1.83, ,-0.48, ,,,,,,,,,,,,,,,,
3975,Q14687,GSE1,Genetic suppressor element 1,QELAPASGEKARL,_VQELAPAS(ph)GEK_,S172,,,23.45,23.83,24.88,25.60,24.96,,23.30,,23.04,,25.09,23.38,24.17, ,-0.72,-0.34,0.71,1.43,0.79, ,-0.87, ,-1.12, ,0.92,-0.79,,,,,,,,,,,,,,,,
3976,Q14692,BMS1,Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog),NFIDETSDIENLL,_LGPQNFIDETS(ph)DIENLLK_,S639,,26.38,,,,,,,,,,,,,26.38,0.00, , , , , , , , , , , , ,ribosome assembly;GTP catabolic process,nucleolus,,,,,,,,,,,,,,
3977,Q14693,LPIN1,Phosphatidate phosphatase LPIN1 (EC 3.1.3.4) (Lipin-1),QDIHSASA_____,_EPLPPFENQDIHSAS(ph)A_,S889,,20.93,,,24.16,22.40,,,23.21,,,23.28,,,22.80,-1.87, , ,1.37,-0.39, , ,0.41, , ,0.48, , ,"triglyceride biosynthetic process;triglyceride mobilization;mitochondrial fission;phosphatidylcholine biosynthetic process;positive regulation of histone deacetylation;ruffle organization;actin cytoskeleton reorganization;phosphatidylethanolamine biosynthetic process;fatty acid catabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of fat cell differentiation;cellular response to insulin stimulus;organ regeneration;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nuclear membrane;cytosol;transcription factor complex;endoplasmic reticulum membrane,,,,,,,,,,,,,,
3980,Q14693,LPIN1,Phosphatidate phosphatase LPIN1 (EC 3.1.3.4) (Lipin-1),RKRRRKSQLDSLK,_S(ph)QLDSLK_,S162,,22.66,24.07,24.62,26.11,,,,21.35,,,,,,23.76,-1.10,0.31,0.86,2.35, , , ,-2.41, , , , , ,"triglyceride biosynthetic process;triglyceride mobilization;mitochondrial fission;phosphatidylcholine biosynthetic process;positive regulation of histone deacetylation;ruffle organization;actin cytoskeleton reorganization;phosphatidylethanolamine biosynthetic process;fatty acid catabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of fat cell differentiation;cellular response to insulin stimulus;organ regeneration;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nuclear membrane;cytosol;transcription factor complex;endoplasmic reticulum membrane,,,,,,,,,,,,,,
3982,Q14694,USP10,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),YSPPAISPLVSEK,_YSPPAIS(ph)PLVSEK_,S370,+,21.31,22.48,22.48,,23.70,22.76,23.84,24.70,23.43,23.94,,22.62,24.18,23.22,-1.91,-0.74,-0.74, ,0.48,-0.46,0.62,1.48,0.21,0.72, ,-0.60,0.96,"regulation of autophagy;protein deubiquitination;DNA repair;autophagy;DNA damage response, signal transduction by p53 class mediator;ubiquitin-dependent protein catabolic process",intermediate filament cytoskeleton;nucleus;early endosome,,,,,,,,,,,,,,
3984,Q14738,PPP2R5D,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),KERRQSSSRFNLS,_(gl)QSS(ph)SRFNLSK_,S89,,24.34,,,27.93,26.79,,,,,25.13,,27.58,,26.35,-2.01, , ,1.57,0.44, , , , ,-1.22, ,1.22, ,signal transduction;nervous system development,nucleus;protein phosphatase type 2A complex;cytoplasm,,,+,,,,,,,,,,,
3985,Q14738,PPP2R5D,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),VLLRRKSELPQDV,_S(ph)ELPQDVYTIK_,S573,,,24.02,24.95,22.78,,,22.77,,,21.76,,22.97,,23.21, ,0.81,1.74,-0.43, , ,-0.44, , ,-1.45, ,-0.23, ,signal transduction;nervous system development,nucleus;protein phosphatase type 2A complex;cytoplasm,,,+,,,,,,,,,,,
3990,Q14764,MVP,Major vault protein (MVP) (Lung resistance-related protein),EKDTAKSLQPLAP,_S(ph)LQPLAPR_,S445,+,25.65,23.59,23.15,23.57,,23.32,22.54,23.16,22.58,23.55,23.09,22.63,22.66,23.29,2.35,0.30,-0.15,0.28, ,0.03,-0.76,-0.13,-0.71,0.26,-0.20,-0.66,-0.63,protein transport;response to drug;mRNA transport,ribonucleoprotein complex;extracellular vesicular exosome;nucleus;nuclear pore;cytoplasm,,,,,,,,,,,,,,
3992,Q14766,LTBP1,Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1),VPAGESSSEAGGE,_GFVPAGESS(ph)SEAGGENYK_,S1033,,,24.49,23.73,26.19,21.82,,,,25.16,,,,,24.28, ,0.21,-0.55,1.92,-2.46, , , ,0.89, , , , ,sequestering of TGFbeta in extracellular matrix,proteinaceous extracellular matrix,,,,,,,,,,,,,,
3993,Q14814,MEF2D,Myocyte-specific enhancer factor 2D,YVSARASPGLLPV,_AS(ph)PGLLPVANGNSLNK_,S164,,22.44,21.71,,,,,,,22.82,,,,,22.32,0.12,-0.62, , , , , , ,0.49, , , , ,endochondral ossification;osteoblast differentiation;adult heart development;apoptotic process;chondrocyte differentiation;muscle organ development;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleus,MADS-box domain,,,,,,,,,,,,,
3994,Q14814,MEF2D,Myocyte-specific enhancer factor 2D,TDPRLLSPQQPAL,_LLS(ph)PQQPALQR_,S180,+,24.42,22.72,22.28,23.31,25.11,,23.34,23.91,24.84,,24.12,23.25,24.19,23.77,0.65,-1.05,-1.49,-0.46,1.33, ,-0.43,0.14,1.07, ,0.35,-0.52,0.42,endochondral ossification;osteoblast differentiation;adult heart development;apoptotic process;chondrocyte differentiation;muscle organ development;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleus,MADS-box domain,,,,,,,,,,,,,
3995,Q14814,MEF2D,Myocyte-specific enhancer factor 2D,DKYRRASEELDGL,_RAS(ph)EELDGLFR_,S121,,21.74,,,,,,,,,,,,,21.74,0.00, , , , , , , , , , , , ,endochondral ossification;osteoblast differentiation;adult heart development;apoptotic process;chondrocyte differentiation;muscle organ development;nervous system development;positive regulation of transcription from RNA polymerase II promoter,nucleus,MADS-box domain,,,,,,,,,,,,,
3997,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),KMSQPGSPSPKTP,_M(ox)SQPGS(ph)PSPK_,S1528,+,22.79,23.21,23.69,23.76,20.70,21.47,21.87,21.25,22.00,,21.63,22.20,21.95,22.21,0.58,1.00,1.48,1.55,-1.51,-0.74,-0.34,-0.96,-0.21, ,-0.58,-0.01,-0.26,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
3998,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),IIKQEESVDPDYW,_QEES(ph)VDPDYWEK_,S1301,,22.93,22.78,22.78,,,,,,22.26,22.94,,,,22.74,0.19,0.04,0.04, , , , , ,-0.48,0.20, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
4000,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),KWGQPPSPTPVPR,_WGQPPS(ph)PTPVPRPPDADPNTPSPK_,S508,+,23.51,,,23.01,23.32,,24.63,,25.10,25.34,23.94,24.75,,24.20,-0.69, , ,-1.19,-0.88, ,0.43, ,0.90,1.14,-0.26,0.55, ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
4001,Q14847,LASP1,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),EPERRDSQDGSSY,_RDS(ph)QDGSSYR_,S146,+,24.37,27.47,23.82,26.78,25.31,25.61,24.42,25.71,23.83,,26.91,24.25,25.00,25.29,-0.92,2.18,-1.47,1.49,0.02,0.32,-0.87,0.42,-1.46, ,1.62,-1.04,-0.29,,cortical actin cytoskeleton;focal adhesion,,,,+,,,,,,,,,,
4003,Q14938,NFIX,Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein),TTKRPKSIDDSEM,_S(ph)IDDSEM(ox)ES(ph)PVDDVFYPGTGR_,S279,,26.14,,,,,,,,,,,,,26.14,0.00, , , , , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
4004,Q14938,NFIX,Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein),DDSEMESPVDDVF,_S(ph)IDDSEM(ox)ES(ph)PVDDVFYPGTGR_,S287,,24.68,,,,,,,,,,,,,24.68,0.00, , , , , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
4007,Q14938,NFIX,Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein),YPGTGRSPAAGSS,_S(ph)PAAGSSQSSGWPNDVDAGPASLKK_,S293,,22.84,,,22.46,22.42,,,,,,,,,22.57,0.27, , ,-0.12,-0.15, , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
4010,Q14966,ZNF638,Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein),TQVTEQSPKVQSR,_(gl)QSSVTQVTEQS(ph)PK_,S128,,22.08,,,,,,,,,,,,,22.08,0.00, , , , , , , , , , , , ,"RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear speck;cytoplasm,Other TF domain,,,,,,,,,,,,,
4011,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),KKAAESSSDSSDS,_AAESS(ph)SDSSDSDSSEDDEAPSKPAGTTK_,S362,+,22.37,,,,24.61,,22.44,23.21,22.91,23.90,,,20.75,22.88,-0.51, , , ,1.72, ,-0.45,0.32,0.03,1.02, , ,-2.14,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
4014,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),GEKRASSPFRRVR,_ASS(ph)PFRR_,S623,+,22.07,25.33,26.31,22.17,24.02,23.70,21.88,22.36,22.02,20.85,,22.71,22.87,23.02,-0.95,2.30,3.29,-0.85,1.00,0.67,-1.14,-0.66,-1.01,-2.17, ,-0.31,-0.16,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
4018,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),NSIKFDSE_____,_GGSISVQVNSIKFDS(ph)E_,S698,,25.13,,,,,,,,,23.06,,22.80,,23.66,1.47, , , , , , , , ,-0.60, ,-0.86, ,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
4019,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),KLKGKGSPRPQAP,_GKGS(ph)PRPQAPK_,S538,,20.72,22.17,23.01,,,,,,,,,,,21.97,-1.24,0.20,1.04, , , , , , , , , , ,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
4020,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),TFPEELSPPSHQA,_APVPSTCSSTFPEELS(ph)PPSHQAK_,S169,,23.72,25.16,25.16,23.23,,24.94,,,25.42,,,,,24.61,-0.88,0.56,0.56,-1.38, ,0.33, , ,0.81, , , , ,G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;nucleus organization;mitotic anaphase;cell division;lung epithelial cell differentiation,spindle microtubule;nucleoplasm;cytosol;chromosome;apical part of cell;spindle pole;nuclear matrix,,,,,,,,,,,,,,
4022,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),QLEEHLSQLQDNP,_LSQLEEHLS(ph)QLQDNPPQEK_,S395,,,23.65,23.90,,22.29,,21.76,,23.74,24.25,,,,23.26, ,0.38,0.63, ,-0.97, ,-1.50, ,0.48,0.98, , , ,G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;nucleus organization;mitotic anaphase;cell division;lung epithelial cell differentiation,spindle microtubule;nucleoplasm;cytosol;chromosome;apical part of cell;spindle pole;nuclear matrix,,,,,,,,,,,,,,
4024,Q14980,NUMA1,Nuclear mitotic apparatus protein 1 (NuMA protein) (SP-H antigen),VPGEPASPISQRL,_TQPDGTSVPGEPAS(ph)PISQRLPPK_,S1757,+,28.00,26.05,23.73,26.44,26.29,26.87,25.52,24.94,26.13,25.11,23.88,24.80,23.62,25.49,2.51,0.56,-1.76,0.95,0.80,1.38,0.03,-0.56,0.63,-0.38,-1.61,-0.69,-1.87,G2/M transition of mitotic cell cycle;establishment of mitotic spindle orientation;nucleus organization;mitotic anaphase;cell division;lung epithelial cell differentiation,spindle microtubule;nucleoplasm;cytosol;chromosome;apical part of cell;spindle pole;nuclear matrix,,,,,,,,,,,,,,
4026,Q14BN4,SLMAP,Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein),DFSDTLSPSKEKS,_ESDFSDTLS(ph)PSK_,S414,+,23.69,23.80,24.63,22.83,,23.22,24.33,23.25,23.22,25.40,23.04,22.53,23.79,23.64,0.05,0.15,0.98,-0.82, ,-0.43,0.69,-0.39,-0.43,1.75,-0.60,-1.11,0.15,protein folding;muscle contraction,prefoldin complex;sarcolemma;integral to plasma membrane;smooth endoplasmic reticulum;microtubule organizing center,,,,,,,,,,,,,,
4031,Q14C86,GAPVD1,GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6),RLVRSRSSDIVSS,_SRS(ph)SDIVSSVR_,S881,+,25.65,24.79,21.85,25.54,23.18,,23.27,22.42,,,24.04,26.26,,24.11,1.54,0.68,-2.26,1.43,-0.93, ,-0.84,-1.69, , ,-0.07,2.15, ,regulation of protein transport;signal transduction;endocytosis;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,endosome;cytosol;membrane,,,,,,,,,,,,,,
4033,Q14CS0,UBXN2B,UBX domain-containing protein 2B (NSFL1 cofactor p37) (p97 cofactor p37),IVSTPSSPEEEDK,_LGSLTPEIVSTPSS(ph)PEEEDK_,S235,+,24.43,,,,23.12,24.27,25.76,25.14,24.94,25.02,25.77,25.25,,24.86,-0.42, , , ,-1.74,-0.58,0.91,0.28,0.08,0.16,0.91,0.40, ,,cytosol;Golgi apparatus;endoplasmic reticulum;nucleus,,,,,,,,,,,,,,
4034,Q14D04,VEPH1,Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted),SGRRKISTEIEFP,_KIS(ph)TEIEFPEK_,S380,+,,,,,,25.13,25.27,23.92,25.86,,26.27,24.65,25.81,25.27, , , , , ,-0.15,0.00,-1.35,0.59, ,1.00,-0.62,0.53,,plasma membrane,,,,,,,,,,,,,,
4035,Q15007,WTAP,Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein),EDDFPSSPGNGNK,_EGNTTEDDFPSS(ph)PGNGNK_,S306,+,26.64,25.44,22.82,26.42,25.62,26.19,,25.41,25.72,24.59,24.71,,24.32,25.26,1.38,0.18,-2.44,1.16,0.36,0.93, ,0.15,0.46,-0.67,-0.55, ,-0.95,mRNA processing;RNA splicing;cell cycle,nucleoplasm;nuclear membrane,,,,,,,,,,,,,,
4038,Q15020,SART3,Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (hSART-3) (Tat-interacting protein of 110 kDa) (Tip110),ATAAETSASEPEA,_(ac)ATAAETS(ph)ASEPEAESK_,S8,+,26.53,26.86,,24.27,,24.15,26.60,23.94,,27.42,23.56,,23.98,25.26,1.27,1.60, ,-0.99, ,-1.11,1.35,-1.32, ,2.17,-1.69, ,-1.28,RNA processing,intracellular membrane-bounded organelle;nuclear speck;cytoplasm,,,,,,,,,,,,,,
4039,Q15020,SART3,Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (hSART-3) (Tat-interacting protein of 110 kDa) (Tip110),AAETSASEPEAES,_(ac)ATAAETSAS(ph)EPEAESK_,S10,+,27.05,26.23,27.09,26.71,27.20,28.12,,27.18,27.39,23.63,25.79,26.11,26.51,26.58,0.47,-0.35,0.51,0.12,0.61,1.53, ,0.60,0.81,-2.95,-0.79,-0.47,-0.07,RNA processing,intracellular membrane-bounded organelle;nuclear speck;cytoplasm,,,,,,,,,,,,,,
4040,Q15021,NCAPD2,Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog),PLASTASDNDFVT,_YQPLASTAS(ph)DNDFVTPEPR_,S1294,,,,,,26.04,,24.58,23.84,,23.54,,22.88,,24.17, , , , ,1.87, ,0.40,-0.34, ,-0.63, ,-1.30, ,mitotic chromosome condensation;cell division,nucleus;pronucleus;cytoplasm;condensin core heterodimer,,,,,,,,,,,,,,
4041,Q15022,SUZ12,Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog),MSEFLESEDGEVE,_ASM(ox)SEFLES(ph)EDGEVEQQR_,S523,,23.39,22.19,22.19,,24.88,23.63,23.75,23.72,23.61,24.42,,,23.93,23.57,-0.18,-1.38,-1.38, ,1.30,0.06,0.18,0.15,0.04,0.85, , ,0.36,"negative regulation of transcription from RNA polymerase II promoter;negative regulation of cell differentiation;positive regulation of cell proliferation;transcription, DNA-dependent;histone ubiquitination",ESC/E(Z) complex;sex chromatin,C2H2-type,,,,,,,,,,,,,
4042,Q15025,TNIP1,TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1) (ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1) (Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein) (VAN) (hVAN),ELLPPPSPSLGSF,_DNELLPPPS(ph)PSLGSFDPLAELTGK_,S77,,25.31,,,,,,,,,,,,,25.31,0.00, , , , , , , , , , , , ,negative regulation of viral genome replication;inflammatory response;positive regulation of inflammatory response;glycoprotein biosynthetic process;negative regulation of I-kappaB kinase/NF-kappaB cascade;leukocyte cell-cell adhesion;modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade;translation;MyD88-dependent toll-like receptor signaling pathway;negative regulation of ERK1 and ERK2 cascade;defense response;positive regulation of transcription from RNA polymerase II promoter,nucleus;cytoplasm,,,,,,,,,,,,,,
4043,Q15029,EFTUD2,"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog) (hSNU114) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)",IGPELDSDEDDDE,_(ac)M(ox)DTDLYDEFGNYIGPELDS(ph)DEDDDELGR_,S19,,25.99,,,,,,,,,,,,,25.99,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
4044,Q15032,R3HDM1,R3H domain-containing protein 1,AVTKASSFSGISV,_ASS(ph)FSGISVLTR_,S187,,23.40,21.69,,21.19,22.61,,22.77,22.59,,,,,,22.37,1.02,-0.69, ,-1.19,0.23, ,0.40,0.22, , , , , ,,,,,,,,,,,,,,,,
4045,Q15032,R3HDM1,R3H domain-containing protein 1,DDRRSKSIEEREE,_S(ph)IEEREEEYQR_,S88,,,,,,22.14,23.71,26.26,25.05,23.35,23.25,24.98,25.93,,24.33, , , , ,-2.20,-0.63,1.93,0.72,-0.98,-1.08,0.65,1.59, ,,,,,,,,,,,,,,,,
4048,Q15036,SNX17,Sorting nexin-17,SPPLLESPDATRE,_SPPLLES(ph)PDATR_,S396,,,,,22.98,,,,,,,,,,22.98, , , ,0.00, , , , , , , , , ,regulation of endocytosis;intracellular protein transport;signal transduction;receptor-mediated endocytosis;endosomal transport;cholesterol catabolic process,cytosol;cytoplasmic vesicle membrane;Golgi apparatus;cytoplasmic membrane-bounded vesicle;membrane;early endosome,,,,,,,,,,,,,,
4054,Q15051,IQCB1,IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein) (PIQ),KKLGEESGDEIDV,_KLGEES(ph)GDEIDVPK_,S439,,22.71,23.71,23.71,,,,,,,22.11,,22.69,,22.98,-0.28,0.72,0.72, , , , , , ,-0.88, ,-0.30, ,photoreceptor cell maintenance;maintenance of organ identity;cilium assembly,centrosome;photoreceptor outer segment;photoreceptor connecting cilium,,,,,,,,,,,,,,
4055,Q15052,ARHGEF6,Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6),SSTRKDSIPQVLL,_KDS(ph)IPQVLLPEEEK_,S530,,,22.77,,,,,,,,,21.54,,,22.16, ,0.62, , , , , , , , ,-0.62, , ,lamellipodium assembly;JNK cascade;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;cell junction assembly,cytosol;lamellipodium,,,,,,,,,,,,,,
4056,Q15052,ARHGEF6,Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6),SASPRMSGFIYQG,_M(ox)S(ph)GFIYQGK_,S334,+,27.27,28.83,,28.51,26.36,27.38,28.12,27.34,27.35,28.39,28.24,27.40,26.45,27.64,-0.37,1.20, ,0.87,-1.28,-0.25,0.48,-0.30,-0.29,0.75,0.60,-0.24,-1.18,lamellipodium assembly;JNK cascade;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;cell junction assembly,cytosol;lamellipodium,,,,,,,,,,,,,,
4057,Q15052,ARHGEF6,Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6),SSERPLSPKAVKG,_SSERPLS(ph)PK_,S71,,,25.47,26.14,,,,,,,,,,,25.80, ,-0.33,0.33, , , , , , , , , , ,lamellipodium assembly;JNK cascade;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction;cell junction assembly,cytosol;lamellipodium,,,,,,,,,,,,,,
4058,Q15054,POLD3,DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66),KANRQVSITGFFQ,_QVS(ph)ITGFFQR_,S352,,21.24,,,,,,,,,,,,,21.24,0.00, , , , , , , , , , , , ,"telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;base-excision repair;telomere maintenance via recombination;DNA synthesis involved in DNA repair;mismatch repair;transcription-coupled nucleotide-excision repair;DNA strand elongation involved in DNA replication;nucleotide-excision repair, DNA gap filling",nucleoplasm;delta DNA polymerase complex;mitochondrion,,,,,,,,,,,,,,
4059,Q15054,POLD3,DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66),GKRVALSDDETKE,_VALS(ph)DDETKETENM(ox)R_,S201,+,28.12,28.63,29.25,27.60,27.65,24.21,26.18,26.52,26.03,25.94,23.98,26.75,,26.74,1.38,1.89,2.51,0.86,0.91,-2.53,-0.56,-0.21,-0.71,-0.80,-2.75,0.01, ,"telomere maintenance via semi-conservative replication;S phase of mitotic cell cycle;base-excision repair;telomere maintenance via recombination;DNA synthesis involved in DNA repair;mismatch repair;transcription-coupled nucleotide-excision repair;DNA strand elongation involved in DNA replication;nucleotide-excision repair, DNA gap filling",nucleoplasm;delta DNA polymerase complex;mitochondrion,,,,,,,,,,,,,,
4060,Q15056,EIF4H,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),FGGGRGSRGSAGG,_AYSSFGGGRGS(ph)R_,S21,,25.83,,,25.07,,,,,,,,26.38,,25.76,0.07, , ,-0.69, , , , , , , ,0.62, ,regulation of translational initiation;virus-host interaction,cytosol;eukaryotic translation initiation factor 4F complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4061,Q15057,ACAP2,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",NRFQQDSQKF___,_FQQDS(ph)QKF_,S775,,22.51,,,,,,,,,,,,,22.51,0.00, , , , , , , , , , , , ,positive regulation of GTPase activity;regulation of ARF GTPase activity,,,,,,,,,,,,,,,
4062,Q15057,ACAP2,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",KYSISLSPPEQQK,_YSISLS(ph)PPEQQK_,S521,+,25.46,24.71,24.87,24.29,23.22,24.13,25.32,24.58,24.48,23.85,24.97,24.77,23.83,24.50,0.96,0.21,0.37,-0.21,-1.28,-0.37,0.82,0.08,-0.02,-0.65,0.47,0.28,-0.67,positive regulation of GTPase activity;regulation of ARF GTPase activity,,,,,,,,,,,,,,,
4066,Q15059,BRD3,Bromodomain-containing protein 3 (RING3-like protein),ASASYDSEEEEEG,_QASASYDS(ph)EEEEEGLPM(ox)SYDEKR_,S563,,23.34,,,,25.41,23.27,,,23.83,24.55,,,,24.08,-0.74, , , ,1.33,-0.81, , ,-0.25,0.47, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",nucleus,,+,,,,,,,,,,,,
4069,Q15121,PEA15,Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED),DIIRQPSEEEIIK,_YKDIIRQPS(ph)EEEIIK_,S116,+,30.91,30.56,30.69,30.23,29.08,30.01,32.38,31.32,29.73,30.22,32.78,33.08,30.57,30.89,0.02,-0.33,-0.20,-0.66,-1.81,-0.88,1.49,0.43,-1.16,-0.67,1.89,2.19,-0.32,negative regulation of apoptotic process;transport;carbohydrate transport;response to morphine;apoptotic process;negative regulation of glucose import,microtubule associated complex;cytoplasm,,,,,,,,,,,,,,
4070,Q15121,PEA15,Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED),KLTRIPSAKKYKD,_LTRIPS(ph)AK_,S104,+,28.43,29.53,30.02,28.84,26.69,25.42,27.01,28.55,25.60,25.30,27.37,28.83,24.38,27.38,1.05,2.15,2.64,1.46,-0.70,-1.96,-0.37,1.17,-1.78,-2.08,-0.02,1.45,-3.00,negative regulation of apoptotic process;transport;carbohydrate transport;response to morphine;apoptotic process;negative regulation of glucose import,microtubule associated complex;cytoplasm,,,,,,,,,,,,,,
4071,Q15124,PGM5,Phosphoglucomutase-like protein 5 (Aciculin) (Phosphoglucomutase-related protein) (PGM-RP),___MEGSPIPVLT,_(ac)M(ox)EGS(ph)PIPVLTVPTAPYEDQRPAGGGGLR_,S4,,22.86,,,,,,,,,,,,,22.86,0.00, , , , , , , , , , , , ,cell adhesion;glucose metabolic process,Z disc;intercalated disc;sarcolemma;internal side of plasma membrane;dystrophin-associated glycoprotein complex;stress fiber;focal adhesion;costamere;spot adherens junction,,,,,,,,,,,,,,
4072,Q15139,PRKD1,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),ALGERVSIL____,_ALGERVS(ph)IL_,S910,,21.60,,,,21.48,,,,,21.47,,,21.62,21.54,0.05, , , ,-0.06, , , , ,-0.07, , ,0.08,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;phospholipid metabolic process;inflammatory response;Golgi vesicle transport;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of blood vessel endothelial cell migration;integrin-mediated signaling pathway;apoptotic process;regulation of keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of cell death;angiogenesis;small molecule metabolic process;positive regulation of CREB transcription factor activity;innate immune response;cell proliferation;positive regulation of angiogenesis;cellular response to oxidative stress;positive regulation of osteoblast differentiation;positive regulation of neuron projection development;regulation of integrin-mediated signaling pathway;Golgi organization;positive regulation of endothelial cell proliferation;negative regulation of endocytosis;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;sphingolipid biosynthetic process,trans-Golgi network;cytosol;cell-cell junction;cell cortex;Golgi apparatus;nucleus;integral to plasma membrane,,+,,,,,,,,,,,,
4073,Q15139,PRKD1,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),VRRRRLSNVSLTG,_RLS(ph)NVS(ph)LTGVSTIR_,S205,,22.23,,,,,,,,,,,,,22.23,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;phospholipid metabolic process;inflammatory response;Golgi vesicle transport;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of blood vessel endothelial cell migration;integrin-mediated signaling pathway;apoptotic process;regulation of keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of cell death;angiogenesis;small molecule metabolic process;positive regulation of CREB transcription factor activity;innate immune response;cell proliferation;positive regulation of angiogenesis;cellular response to oxidative stress;positive regulation of osteoblast differentiation;positive regulation of neuron projection development;regulation of integrin-mediated signaling pathway;Golgi organization;positive regulation of endothelial cell proliferation;negative regulation of endocytosis;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;sphingolipid biosynthetic process,trans-Golgi network;cytosol;cell-cell junction;cell cortex;Golgi apparatus;nucleus;integral to plasma membrane,,+,,,,,,,,,,,,
4074,Q15139,PRKD1,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),RRLSNVSLTGVST,_RLS(ph)NVS(ph)LTGVSTIR_,S208,,22.23,,,,,,,,,,,,,22.23,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;phospholipid metabolic process;inflammatory response;Golgi vesicle transport;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of blood vessel endothelial cell migration;integrin-mediated signaling pathway;apoptotic process;regulation of keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of cell death;angiogenesis;small molecule metabolic process;positive regulation of CREB transcription factor activity;innate immune response;cell proliferation;positive regulation of angiogenesis;cellular response to oxidative stress;positive regulation of osteoblast differentiation;positive regulation of neuron projection development;regulation of integrin-mediated signaling pathway;Golgi organization;positive regulation of endothelial cell proliferation;negative regulation of endocytosis;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;sphingolipid biosynthetic process,trans-Golgi network;cytosol;cell-cell junction;cell cortex;Golgi apparatus;nucleus;integral to plasma membrane,,+,,,,,,,,,,,,
4076,Q15139,PRKD1,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),LLQKSPSESFIGR,_SPS(ph)ESFIGR_,S237,,24.64,,,23.88,,,,,,,22.10,,,23.54,1.10, , ,0.34, , , , , , ,-1.43, , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;phospholipid metabolic process;inflammatory response;Golgi vesicle transport;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of blood vessel endothelial cell migration;integrin-mediated signaling pathway;apoptotic process;regulation of keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of cell death;angiogenesis;small molecule metabolic process;positive regulation of CREB transcription factor activity;innate immune response;cell proliferation;positive regulation of angiogenesis;cellular response to oxidative stress;positive regulation of osteoblast differentiation;positive regulation of neuron projection development;regulation of integrin-mediated signaling pathway;Golgi organization;positive regulation of endothelial cell proliferation;negative regulation of endocytosis;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;sphingolipid biosynthetic process,trans-Golgi network;cytosol;cell-cell junction;cell cortex;Golgi apparatus;nucleus;integral to plasma membrane,,+,,,,,,,,,,,,
4077,Q15139,PRKD1,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),STIRTSSAELSTS,_TSS(ph)AELSTSAPDEPLLQK_,S219,,24.56,,,,22.97,,,23.13,,,,,,23.56,1.01, , , ,-0.59, , ,-0.42, , , , , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;phospholipid metabolic process;inflammatory response;Golgi vesicle transport;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of blood vessel endothelial cell migration;integrin-mediated signaling pathway;apoptotic process;regulation of keratinocyte proliferation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of cell death;angiogenesis;small molecule metabolic process;positive regulation of CREB transcription factor activity;innate immune response;cell proliferation;positive regulation of angiogenesis;cellular response to oxidative stress;positive regulation of osteoblast differentiation;positive regulation of neuron projection development;regulation of integrin-mediated signaling pathway;Golgi organization;positive regulation of endothelial cell proliferation;negative regulation of endocytosis;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway;sphingolipid biosynthetic process,trans-Golgi network;cytosol;cell-cell junction;cell cortex;Golgi apparatus;nucleus;integral to plasma membrane,,+,,,,,,,,,,,,
4078,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),EFADMLSGNAGGF,_AGTLSITEFADM(ox)LS(ph)GNAGGFRSR_,S4237,+,,,,20.24,24.24,24.16,23.86,23.32,27.17,22.68,,26.83,26.11,24.29, , , ,-4.05,-0.05,-0.13,-0.43,-0.97,2.88,-1.61, ,2.54,1.82,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4080,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),QLEPVASPAKKPK,_AQLEPVAS(ph)PAKKPK_,S1298,+,28.26,28.51,29.22,28.51,26.48,27.90,28.99,28.28,28.68,28.56,27.69,28.39,30.15,28.43,-0.18,0.08,0.78,0.08,-1.95,-0.53,0.56,-0.16,0.25,0.13,-0.75,-0.05,1.72,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4081,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SDEGQLSPATRGA,_ARSDEGQLS(ph)PATR_,S583,+,27.49,28.26,27.23,28.86,28.05,27.38,26.85,27.36,27.49,27.09,27.31,26.36,26.04,27.37,0.13,0.89,-0.14,1.49,0.68,0.02,-0.52,-0.01,0.13,-0.28,-0.06,-1.01,-1.33,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4082,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),KELEEVSPETPVV,_ELEEVS(ph)PETPVVPATTQR_,S149,+,22.55,,,23.46,24.88,26.34,24.87,23.12,23.98,,,,25.54,24.34,-1.79, , ,-0.89,0.54,1.99,0.53,-1.23,-0.36, , , ,1.20,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4083,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),STKGYYSPYSVSG,_GYYS(ph)PYSVSGSGSTAGSR_,S4476,,26.42,25.83,25.43,,,,,,,,,,,25.90,0.52,-0.06,-0.46, , , , , , , , , , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4084,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),GYYSPYSVSGSGS,_GYYSPYS(ph)VSGSGSTAGSR_,S4479,+,22.30,22.94,,23.90,,24.85,24.07,24.33,24.59,27.65,23.89,22.50,,24.10,-1.80,-1.16, ,-0.21, ,0.75,-0.03,0.23,0.49,3.54,-0.22,-1.60, ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4085,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),YSPYSVSGSGSTA,_GYYSPYSVS(ph)GSGSTAGSR_,S4481,+,20.22,,,21.78,28.79,25.25,,23.21,27.86,,,,,24.52,-4.30, , ,-2.73,4.27,0.73, ,-1.31,3.34, , , , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4087,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SVSGSGSTAGSRT,_GYYSPYSVSGSGS(ph)T(ph)AGSR_,S4485,,26.71,,,27.68,,28.81,,,,,,,28.68,27.97,-1.26, , ,-0.29, ,0.84, , , , , , ,0.71,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4088,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SGSTAGSRTGSRT,_GYYSPYSVSGS(ph)GSTAGS(ph)RT(ph)GSR_,S4489,,26.39,,,,,,,,,,,,,26.39,0.00, , , , , , , , , , , , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4092,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),GLRRKVSAQRLQE,_KVS(ph)AQRLQEAGILSAEELQR_,S2654,,,,,,21.81,,,23.40,23.32,,,25.01,,23.39, , , , ,-1.58, , ,0.02,-0.06, , ,1.62, ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4093,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),EAARQRSQVEEEL,_(gl)QRS(ph)QVEEELFSVR_,S2224,,,,,,23.68,,,22.03,,,23.28,,23.73,23.18, , , , ,0.50, , ,-1.15, , ,0.10, ,0.55,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4095,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),AGSRRGSFDATGS,_RGS(ph)FDATGSGFSM(ox)TFSSSSYSSSGYGR_,S4505,+,,,,,24.46,24.29,23.91,25.34,25.60,23.86,26.20,24.71,26.59,25.00, , , , ,-0.53,-0.71,-1.08,0.34,0.61,-1.14,1.20,-0.29,1.59,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4099,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),TAQLERSLQEEHV,_S(ph)LQEEHVAVAQLR_,S1595,,22.23,,,22.16,,,,,,,,,,22.20,0.03, , ,-0.03, , , , , , , , , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4103,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),RSSSVGSSSSYPI,_SSS(ph)VGS(ph)SSSYPISPAVSR_,S4252,+,28.16,22.92,22.00,25.02,27.11,23.25,23.35,26.48,25.71,24.62,25.91,24.41,,24.91,3.24,-1.99,-2.91,0.11,2.20,-1.66,-1.56,1.57,0.80,-0.29,1.00,-0.50, ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4104,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SSSYPISPAVSRT,_SSS(ph)VGS(ph)SSSYPIS(ph)PAVSR_,S4259,+,27.40,24.82,24.70,26.09,26.87,26.62,27.04,26.49,24.81,25.94,25.85,,24.87,25.96,1.44,-1.14,-1.26,0.13,0.92,0.66,1.08,0.53,-1.14,-0.02,-0.11, ,-1.09,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4105,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),QLIRSWSLATFRT,_SWS(ph)LATFR_,S910,+,23.24,20.98,19.79,,,24.54,,24.11,24.42,,23.70,22.82,24.16,23.08,0.16,-2.10,-3.30, , ,1.46, ,1.03,1.33, ,0.61,-0.26,1.07,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4106,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),SRTQLASWSDPTE,_TQLAS(ph)WSDPTEETGPVAGILDTETLEK_,S4269,,27.72,,,,,,,,25.12,26.86,25.81,,,26.38,1.34, , , , , , , ,-1.26,0.48,-0.57, , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4107,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),TQRSRRSGGGAGS,_S(ph)GGGAGSNGSVLDPAER_,S42,,23.30,,,23.08,23.17,22.36,23.06,23.43,23.75,,22.69,22.93,23.12,23.09,0.21, , ,-0.01,0.08,-0.73,-0.03,0.34,0.66, ,-0.40,-0.15,0.03,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
4110,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),ILEDHGSPAGEID,_RILEDHGS(ph)PAGEIDDEDK_,S1675,+,24.27,25.28,25.52,22.49,22.97,,25.90,,25.34,25.69,24.95,25.09,,24.75,-0.48,0.53,0.77,-2.26,-1.78, ,1.14, ,0.59,0.94,0.20,0.34, ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4114,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),RVTNDISPESSPG,_RVTNDIS(ph)PESSPGVGR_,S65,+,26.95,27.53,27.80,27.16,26.74,28.01,28.54,28.73,27.32,27.34,27.97,27.67,28.19,27.69,-0.74,-0.16,0.11,-0.53,-0.95,0.32,0.85,1.04,-0.37,-0.35,0.28,-0.02,0.50,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4115,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),NDISPESSPGVGR,_RVTNDIS(ph)PES(ph)SPGVGR_,S68,,25.30,22.84,,23.63,27.95,26.59,,,22.81,,,,,24.86,0.45,-2.01, ,-1.22,3.10,1.73, , ,-2.04, , , , ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4116,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),DISPESSPGVGRR,_VTNDIS(ph)PESS(ph)PGVGR_,S69,+,22.97,22.06,22.06,23.02,23.11,,,,22.36,,23.04,,,22.66,0.31,-0.60,-0.60,0.36,0.45, , , ,-0.30, ,0.38, , ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4117,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),GNISQKSDEEDFV,_S(ph)DEEDFVK_,S1903,+,25.93,27.39,28.02,25.27,,,25.05,,24.12,25.45,,23.75,,25.62,0.31,1.77,2.40,-0.35, , ,-0.57, ,-1.51,-0.17, ,-1.87, ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4118,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),SLSSHRSSLVDEH,_S(ph)SLVDEHPEDAEFEQK_,S643,,,,,,23.59,,,,22.08,,,,,22.83, , , , ,0.75, , , ,-0.75, , , , ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4120,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),RYMSQMSVPEQAE,_YM(ox)SQM(ox)S(ph)VPEQAELEK_,S93,,25.17,24.05,24.60,24.94,,,25.32,22.70,,,,,,24.46,0.71,-0.42,0.14,0.47, , ,0.86,-1.76, , , , , ,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
4121,Q15185,PTGES3,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),KDWEDDSDEDMSN,_DWEDDS(ph)DEDMSNFDR_,S113,+,32.61,25.82,25.92,26.28,29.91,27.47,29.74,26.74,28.31,28.95,27.86,30.39,25.37,28.11,4.50,-2.29,-2.19,-1.83,1.81,-0.63,1.63,-1.37,0.20,0.85,-0.24,2.29,-2.73,signal transduction;telomere maintenance;prostaglandin biosynthetic process;chaperone cofactor-dependent protein refolding,"cytosol;chromosome, telomeric region;telomerase holoenzyme complex",,,,,,,,,,,,,,
4122,Q15185,PTGES3,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),DGADDDSQDSDDE,_FSEMM(ox)NNM(ox)GGDEDVDLPEVDGADDDS(ph)QDS(ph)DDEK_,S148,,28.46,,,,,,,,,,,,,28.46,0.00, , , , , , , , , , , , ,signal transduction;telomere maintenance;prostaglandin biosynthetic process;chaperone cofactor-dependent protein refolding,"cytosol;chromosome, telomeric region;telomerase holoenzyme complex",,,,,,,,,,,,,,
4123,Q15185,PTGES3,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),DDDSQDSDDEKMP,_FSEMM(ox)NNM(ox)GGDEDVDLPEVDGADDDS(ph)QDS(ph)DDEK_,S151,,29.00,,,,,,,,,23.94,,,,26.47,2.53, , , , , , , , ,-2.53, , , ,signal transduction;telomere maintenance;prostaglandin biosynthetic process;chaperone cofactor-dependent protein refolding,"cytosol;chromosome, telomeric region;telomerase holoenzyme complex",,,,,,,,,,,,,,
4124,Q15276,RABEP1,Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17),GLRRAQSTDSLGT,_AQS(ph)TDSLGTSGSLQSK_,S364,+,23.42,22.82,23.07,25.26,22.32,22.26,24.42,23.18,22.68,22.97,,24.36,22.48,23.27,0.15,-0.45,-0.20,1.99,-0.95,-1.00,1.15,-0.09,-0.59,-0.30, ,1.09,-0.79,endocytosis;protein transport;cellular membrane fusion;positive regulation of GTPase activity;apoptotic process,endocytic vesicle;recycling endosome;early endosome,,,,,,,,,,,,,,
4125,Q15287,RNPS1,RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2),PPPRRFSPPRRML,_RFS(ph)PPRR_,S251,+,24.04,25.71,25.78,24.61,24.85,23.44,23.36,23.74,23.66,23.76,23.44,23.30,22.23,23.99,0.04,1.71,1.79,0.61,0.86,-0.55,-0.63,-0.26,-0.33,-0.23,-0.55,-0.70,-1.77,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck,,,,,,,,,,,,,,
4126,Q15287,RNPS1,RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2),SSTRAPSPTKRKD,_SSTRAPS(ph)PTK_,S27,+,22.33,23.10,24.04,23.03,19.86,20.95,,20.30,20.33,18.69,19.95,20.63,20.66,21.16,1.18,1.95,2.88,1.87,-1.30,-0.21, ,-0.86,-0.82,-2.46,-1.21,-0.53,-0.49,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck,,,,,,,,,,,,,,
4127,Q15291,RBBP5,Retinoblastoma-binding protein 5 (RBBP-5) (Retinoblastoma-binding protein RBQ-3),EYEERESEFDIED,_ES(ph)EFDIEDEDK_,S350,,23.04,25.44,25.44,,,,,,20.98,22.27,,,,23.43,-0.39,2.00,2.00, , , , , ,-2.45,-1.16, , , ,"histone H3-K4 methylation;response to estrogen stimulus;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to DNA damage stimulus",MLL1 complex;Set1C/COMPASS complex,,,,,,,,,,,,,,
4128,Q15293,RCN1,Reticulocalbin-1,QLTPDESKERLGK,_TFDQLTPDES(ph)K_,S80,,26.60,24.33,24.13,,,,,,22.47,,22.45,,,23.99,2.60,0.34,0.13, , , , , ,-1.53, ,-1.55, , ,in utero embryonic development;camera-type eye development,endoplasmic reticulum lumen,,,,,,,,,,,,,,
4130,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),QEIASLSKEDVSK,_IAQEIASLS(ph)K_,S463,+,25.10,26.58,26.81,27.33,23.43,25.16,27.21,25.95,,26.13,26.01,25.57,,25.93,-0.83,0.64,0.88,1.39,-2.50,-0.78,1.27,0.01, ,0.19,0.08,-0.37, ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
4131,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),YRTGEPSPPHDIL,_TGEPS(ph)PPHDILHEPPDVVS(ph)DDEK_,S48,,24.00,,,,,,,,23.36,,,,,23.68,0.32, , , , , , , ,-0.32, , , , ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
4132,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),EPPDVVSDDEKDH,_TGEPSPPHDILHEPPDVVS(ph)DDEK_,S62,+,24.00,,,,,23.73,24.89,24.35,25.38,24.28,26.43,25.26,,24.79,-0.79, , , , ,-1.06,0.10,-0.44,0.59,-0.51,1.64,0.47, ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
4133,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),GLTRTPSSEEISP,_TPS(ph)SEEISPTK_,S29,+,26.62,,,26.66,25.85,24.96,25.62,26.40,25.45,22.56,25.84,22.09,24.58,25.15,1.47, , ,1.52,0.70,-0.19,0.47,1.26,0.30,-2.59,0.69,-3.06,-0.57,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
4135,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),PSSEEISPTKFPG,_TPS(ph)SEEIS(ph)PTKFPGLYR_,S34,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
4136,Q15326,ZMYND11,Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Protein BS69),TEAVSSSQEIPTM,_KEEPEPETEAVSSS(ph)QEIPTM(ox)PQPIEK_,S216,,22.30,,,,,,,23.05,23.30,23.55,,,,23.05,-0.75, , , , , , ,0.00,0.25,0.50, , , ,"negative regulation of I-kappaB kinase/NF-kappaB cascade;cell proliferation;negative regulation of JNK cascade;negative regulation of transcription from RNA polymerase II promoter;negative regulation of extrinsic apoptotic signaling pathway;cell cycle;chromatin modification;transcription, DNA-dependent;virus-host interaction",chromosome;nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
4139,Q15334,LLGL1,Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein),VKSLKKSLRQSFR,_S(ph)LRQS(ph)FRR_,S638,,25.27,23.58,23.98,25.07,,,,,,,,,,24.47,0.80,-0.90,-0.49,0.59, , , , , , , , , ,axonogenesis;maintenance of apical/basal cell polarity;cortical actin cytoskeleton organization;Golgi to plasma membrane transport;exocytosis;protein complex assembly,axon;myelin sheath abaxonal region;cortical actin cytoskeleton;Golgi membrane;Golgi cis cisterna;trans-Golgi network membrane;early endosome membrane,,,,,,,,,,,,,,
4140,Q15334,LLGL1,Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein),KKSLRQSFRRIRK,_S(ph)LRQS(ph)FRR_,S642,,25.27,23.58,23.98,25.07,,,,,,,,,,24.47,0.80,-0.90,-0.49,0.59, , , , , , , , , ,axonogenesis;maintenance of apical/basal cell polarity;cortical actin cytoskeleton organization;Golgi to plasma membrane transport;exocytosis;protein complex assembly,axon;myelin sheath abaxonal region;cortical actin cytoskeleton;Golgi membrane;Golgi cis cisterna;trans-Golgi network membrane;early endosome membrane,,,,,,,,,,,,,,
4142,Q15361,TTF1,Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I),SGDADDSDADLGS,_YLSADSGDADDS(ph)DADLGSAVK_,S487,,24.03,,,,24.17,,,,,22.85,,,,23.68,0.34, , , ,0.49, , , , ,-0.83, , , ,"transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;negative regulation of DNA replication;regulation of transcription, DNA-dependent;chromatin remodeling",nucleoplasm;nucleolus,Other TF domain,,,,,,,,,,,,,
4144,Q15365,PCBP1,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),LETLSQSPQGRVM,_(gl)QICLVM(ox)LETLSQS(ph)PQGR_,S173,+,26.93,21.06,21.08,22.36,25.36,,22.73,21.62,25.34,24.39,23.32,24.60,,23.53,3.41,-2.46,-2.45,-1.17,1.84, ,-0.80,-1.91,1.81,0.87,-0.20,1.07, ,"mRNA splicing, via spliceosome",nucleoplasm;ribonucleoprotein complex;cytoplasm,,,,,,,,,,,,,,
4147,Q15365,PCBP1,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),QPMPASSPVICAG,_VM(ox)TIPYQPM(ox)PASS(ph)PVICAGGQDR_,S190,+,26.87,25.55,25.29,25.24,24.31,26.40,24.11,26.11,27.71,26.39,25.05,24.07,25.76,25.60,1.27,-0.06,-0.31,-0.36,-1.29,0.80,-1.50,0.50,2.10,0.78,-0.56,-1.54,0.16,"mRNA splicing, via spliceosome",nucleoplasm;ribonucleoprotein complex;cytoplasm,,,,,,,,,,,,,,
4150,Q15366,PCBP2,Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2),RPKPSSSPVIFAG,_PSSS(ph)PVIFAGGQDR_,S185,+,27.13,25.54,22.35,20.95,,,26.49,,26.05,24.72,,,24.88,24.76,2.37,0.78,-2.42,-3.81, , ,1.73, ,1.28,-0.04, , ,0.12,"defense response to virus;proteasomal ubiquitin-dependent protein catabolic process;negative regulation of type I interferon production;mRNA splicing, via spliceosome;negative regulation of defense response to virus;innate immune response",nucleoplasm;cytosol;ribonucleoprotein complex,,,,,,,,,,,,,,
4152,Q15388,TOMM20,Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20),ISQRIVSAQSLAE,_IVS(ph)AQSLAEDDVE_,S135,,23.69,,,22.16,,,,,,24.17,,,25.61,23.91,-0.22, , ,-1.75, , , , , ,0.26, , ,1.70,cellular protein metabolic process;protein targeting to mitochondrion,integral to membrane;mitochondrial outer membrane translocase complex,,,,,,,,,,,,,,
4153,Q15388,TOMM20,Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20),RIVSAQSLAEDDV,_IVSAQS(ph)LAEDDVE_,S138,+,25.19,21.73,21.73,22.57,25.57,24.91,24.68,24.53,25.11,26.20,24.81,24.63,,24.30,0.88,-2.58,-2.58,-1.73,1.27,0.61,0.38,0.22,0.80,1.90,0.50,0.32, ,cellular protein metabolic process;protein targeting to mitochondrion,integral to membrane;mitochondrial outer membrane translocase complex,,,,,,,,,,,,,,
4154,Q15390,MTFR1,Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region),APSRQISLPDLSQ,_QIS(ph)LPDLSQEEPQLK_,S76,,23.95,22.69,22.69,20.84,,,,,24.12,24.58,,,,23.14,0.81,-0.46,-0.46,-2.30, , , , ,0.97,1.43, , , ,mitochondrial fission;aerobic respiration,mitochondrion;plasma membrane,,,,,,,,,,,,,,
4156,Q15417,CNN3,"Calponin-3 (Calponin, acidic isoform)",PRDYQYSDQGIDY,_DYQYS(ph)DQGIDY_,S323,,23.73,,,,22.63,,,,,,,,,23.18,0.55, , , ,-0.55, , , , , , , , ,negative regulation of ATPase activity;actomyosin structure organization;smooth muscle contraction,neuronal cell body;postsynaptic density,,,,,,,,,,,,,,
4157,Q15418,RPS6KA1,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),SRTPKDSPGIPPS,_DS(ph)PGIPPSAGAHQLFR_,S271,,22.72,22.41,22.41,,24.10,22.38,,22.98,22.59,,,,,22.80,-0.08,-0.39,-0.39, ,1.30,-0.41, ,0.18,-0.21, , , , ,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of hepatic stellate cell activation;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway,nucleoplasm;cytosol;spindle,,+,,,,,,,,+,,,,
4158,Q15418,RPS6KA1,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),QLFRGFSFVATGL,_GFS(ph)FVATGLM(ox)EDDGKPR_,S288,,22.65,,,,,,,,,,,,,22.65,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of hepatic stellate cell activation;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway,nucleoplasm;cytosol;spindle,,+,,,,,,,,+,,,,
4159,Q15418,RPS6KA1,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),RVRKLPSTTL___,_KLPS(ph)TTL_,S640,+,23.87,22.19,22.55,22.48,22.08,,,,21.65,21.98,22.70,23.43,22.33,22.53,1.35,-0.33,0.02,-0.05,-0.45, , , ,-0.87,-0.55,0.18,0.90,-0.19,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of hepatic stellate cell activation;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway,nucleoplasm;cytosol;spindle,,+,,,,,,,,+,,,,
4161,Q15435,PPP1R7,Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22),VDRRVESEESGDE,_RVES(ph)EESGDEEGK_,S24,,18.91,21.58,18.66,21.02,,,,,,,,,,20.04,-1.13,1.53,-1.39,0.98, , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
4162,Q15435,PPP1R7,Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22),RVESEESGDEEGK,_RVESEES(ph)GDEEGKK_,S27,,20.26,22.32,19.20,22.14,,,,,,,,18.83,,20.55,-0.28,1.77,-1.35,1.59, , , , , , , ,-1.72, ,,nucleus;cytoplasm,,,,,,,,,,,,,,
4165,Q15459,SF3A1,Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114),QDMDEGSDDEEEG,_AEEPPSQLDQDTQVQDMDEGS(ph)DDEEEGQK_,S359,+,27.15,24.86,25.35,25.06,,,26.22,,27.60,27.28,,25.49,,26.13,1.02,-1.26,-0.78,-1.07, , ,0.09, ,1.48,1.15, ,-0.63, ,mRNA 3'-splice site recognition,nucleoplasm;U2-type spliceosomal complex;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
4168,Q15527,SURF2,Surfeit locus protein 2 (Surf-2),GKKQLGSLKKKFK,_(gl)QLGS(ph)LKK_,S234,,,,,24.14,,,,,,,,,,24.14, , , ,0.00, , , , , , , , , ,,,,,,,,,,,,,,,,
4170,Q15554,TERF2,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),TQALPASPALKNK,_DLVLPTQALPAS(ph)PALK_,S323,+,25.82,25.38,26.18,25.65,26.58,27.08,27.35,27.33,26.74,27.21,,,27.71,26.64,-0.82,-1.26,-0.46,-0.99,-0.06,0.44,0.71,0.69,0.10,0.57, , ,1.07,"age-dependent telomere shortening;telomere maintenance via telomerase;protein localization to chromosome, telomeric region;negative regulation of telomere maintenance via semi-conservative replication;in utero embryonic development;cellular senescence;protection from non-homologous end joining at telomere;positive regulation of telomere maintenance;telomeric loop formation;cell cycle",nucleoplasm;male germ cell nucleus;Golgi apparatus;nuclear telomere cap complex,,,,,,,,,,,,,,
4171,Q15596,NCOA2,Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2),LLQDSSSPVDLAK,_LLQDSSS(ph)PVDLAK_,S699,+,24.03,,,23.89,23.13,23.98,24.22,24.26,23.93,24.22,,22.71,24.36,23.87,0.15, , ,0.01,-0.74,0.10,0.35,0.39,0.06,0.35, ,-1.16,0.48,"cerebellum development;histone acetylation;small molecule metabolic process;regulation of transcription, DNA-dependent;cellular lipid metabolic process;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;neuronal cell body;rough endoplasmic reticulum;Golgi apparatus;microtubule;postsynaptic density;presynaptic active zone,bHLH,,,,,,,,,,,,,
4172,Q15629,TRAM1,Translocating chain-associated membrane protein 1,TSNVADSPRNKKE,_GTENGVNGTLTSNVADS(ph)PR_,S279,+,25.60,,,22.21,24.03,21.95,24.25,23.38,24.04,22.92,24.38,23.61,,23.64,1.96, , ,-1.43,0.39,-1.69,0.62,-0.26,0.41,-0.72,0.74,-0.03, ,translation;SRP-dependent cotranslational protein targeting to membrane;virus-host interaction,integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
4174,Q15637,SF1,Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162),PNPEDRSPSPEPI,_LRTGDLGIPPNPEDRS(ph)PS(ph)PEPIYNSEGK_,S80,,27.61,21.81,21.81,,26.13,,23.98,23.89,27.42,27.47,,,,25.01,2.59,-3.20,-3.20, ,1.11, ,-1.04,-1.13,2.41,2.46, , , ,"regulation of transcription, DNA-dependent;male sex determination;Leydig cell differentiation;negative regulation of smooth muscle cell proliferation;mRNA 3'-splice site recognition;cell cycle process;regulation of steroid biosynthetic process;transcription, DNA-dependent",ribosome;spliceosomal complex,,,,,,,,,,,,,,
4175,Q15637,SF1,Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162),PEDRSPSPEPIYN,_LRTGDLGIPPNPEDRS(ph)PS(ph)PEPIYNSEGK_,S82,,27.61,21.81,21.81,,26.13,,23.98,23.89,27.42,27.47,,,,25.01,2.59,-3.20,-3.20, ,1.11, ,-1.04,-1.13,2.41,2.46, , , ,"regulation of transcription, DNA-dependent;male sex determination;Leydig cell differentiation;negative regulation of smooth muscle cell proliferation;mRNA 3'-splice site recognition;cell cycle process;regulation of steroid biosynthetic process;transcription, DNA-dependent",ribosome;spliceosomal complex,,,,,,,,,,,,,,
4176,Q15642,TRIP10,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),PMNRAPSDSSLGT,_APS(ph)DSS(ph)LGTPSDGRPELRGPGR_,S296,+,27.15,25.82,22.45,26.53,24.66,24.74,24.16,25.18,23.44,,25.91,22.94,,24.82,2.33,1.01,-2.37,1.71,-0.15,-0.07,-0.66,0.37,-1.37, ,1.10,-1.88, ,endocytosis;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,Golgi apparatus;perinuclear region of cytoplasm;cell cortex;cytosol;cytoskeleton;cell projection;phagocytic cup;lysosome,,,,,,,,,,,,,,
4177,Q15642,TRIP10,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),RAPSDSSLGTPSD,_APS(ph)DSS(ph)LGTPSDGRPELR_,S299,,26.50,22.72,,25.01,,,,,,,,,,24.75,1.76,-2.02, ,0.27, , , , , , , , , ,endocytosis;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,Golgi apparatus;perinuclear region of cytoplasm;cell cortex;cytosol;cytoskeleton;cell projection;phagocytic cup;lysosome,,,,,,,,,,,,,,
4178,Q15642,TRIP10,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),LSNRGDSLSRHAR,_VLSNRGDS(ph)LSR_,S426,+,28.75,26.09,26.12,26.44,21.38,,,,,21.00,,21.02,,24.40,4.35,1.69,1.72,2.04,-3.02, , , , ,-3.40, ,-3.37, ,endocytosis;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,Golgi apparatus;perinuclear region of cytoplasm;cell cortex;cytosol;cytoskeleton;cell projection;phagocytic cup;lysosome,,,,,,,,,,,,,,
4179,Q15643,TRIP11,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),DMKPLDSPGRRKR,_PLDS(ph)PGRR_,S1891,+,20.08,23.71,23.87,24.01,,,,,24.90,23.87,,23.17,24.13,23.47,-3.39,0.24,0.40,0.54, , , , ,1.44,0.40, ,-0.30,0.67,protein targeting to Golgi;transcription from RNA polymerase II promoter,Golgi apparatus;nucleus;cytoskeleton;membrane,,,,,,,,,,,,,,
4180,Q15643,TRIP11,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),LGGGSKSVPNTPL,_S(ph)VPNTPLRPNQQSVVNSSFSELFVK_,S1842,,,23.90,23.76,24.04,,,,,26.67,,,,,24.59, ,-0.69,-0.83,-0.56, , , , ,2.08, , , , ,protein targeting to Golgi;transcription from RNA polymerase II promoter,Golgi apparatus;nucleus;cytoskeleton;membrane,,,,,,,,,,,,,,
4183,Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),TPQNLDSESESGS,_SPAYTPQNLDS(ph)ESESGSSIAEK_,S1463,,22.62,,,,22.81,,,,,24.18,,,,23.20,-0.59, , , ,-0.39, , , , ,0.98, , , ,"negative regulation of apoptotic process;mRNA transcription from RNA polymerase II promoter;fat cell differentiation;regulation of transcription from RNA polymerase I promoter;liver development;positive regulation of hepatocyte proliferation;erythrocyte development;embryonic hindlimb morphogenesis;positive regulation of protein import into nucleus, translocation;thyroid hormone generation;retinal pigment epithelium development;keratinocyte differentiation;cell morphogenesis;epithelial cell proliferation involved in mammary gland duct elongation;cellular response to epidermal growth factor stimulus;positive regulation of intracellular estrogen receptor signaling pathway;monocyte differentiation;organ regeneration;cellular response to thyroid hormone stimulus;DNA replication;mammary gland branching involved in pregnancy;thyroid hormone mediated signaling pathway;negative regulation of keratinocyte proliferation;embryonic heart tube development;positive regulation of keratinocyte differentiation;enucleate erythrocyte development;cellular response to hepatocyte growth factor stimulus;embryonic hemopoiesis;cellular response to steroid hormone stimulus;embryonic placenta development;negative regulation of neuron differentiation;ventricular trabecula myocardium morphogenesis;androgen receptor signaling pathway;lens development in camera-type eye;positive regulation of interferon-gamma-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;megakaryocyte development;transcription initiation from RNA polymerase II promoter;mammary gland branching involved in thelarche;regulation of cell cycle;positive regulation of mammary gland epithelial cell proliferation;angiogenesis;small molecule metabolic process;peroxisome proliferator activated receptor signaling pathway;cellular lipid metabolic process;regulation of vitamin D receptor signaling pathway;positive regulation of G0 to G1 transition;ERK1 and ERK2 cascade;brain development;negative regulation of transcription from RNA polymerase II promoter;androgen biosynthetic process;lactation",nucleolus;mediator complex,Other TF domain,,,,,,,,,,,,,
4184,Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),EKSYQNSPSSDDG,_SYQNS(ph)PSS(ph)DDGIRPLPEYSTEK_,S1479,,25.01,,,,,,,,,,,,,25.01,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;mRNA transcription from RNA polymerase II promoter;fat cell differentiation;regulation of transcription from RNA polymerase I promoter;liver development;positive regulation of hepatocyte proliferation;erythrocyte development;embryonic hindlimb morphogenesis;positive regulation of protein import into nucleus, translocation;thyroid hormone generation;retinal pigment epithelium development;keratinocyte differentiation;cell morphogenesis;epithelial cell proliferation involved in mammary gland duct elongation;cellular response to epidermal growth factor stimulus;positive regulation of intracellular estrogen receptor signaling pathway;monocyte differentiation;organ regeneration;cellular response to thyroid hormone stimulus;DNA replication;mammary gland branching involved in pregnancy;thyroid hormone mediated signaling pathway;negative regulation of keratinocyte proliferation;embryonic heart tube development;positive regulation of keratinocyte differentiation;enucleate erythrocyte development;cellular response to hepatocyte growth factor stimulus;embryonic hemopoiesis;cellular response to steroid hormone stimulus;embryonic placenta development;negative regulation of neuron differentiation;ventricular trabecula myocardium morphogenesis;androgen receptor signaling pathway;lens development in camera-type eye;positive regulation of interferon-gamma-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;megakaryocyte development;transcription initiation from RNA polymerase II promoter;mammary gland branching involved in thelarche;regulation of cell cycle;positive regulation of mammary gland epithelial cell proliferation;angiogenesis;small molecule metabolic process;peroxisome proliferator activated receptor signaling pathway;cellular lipid metabolic process;regulation of vitamin D receptor signaling pathway;positive regulation of G0 to G1 transition;ERK1 and ERK2 cascade;brain development;negative regulation of transcription from RNA polymerase II promoter;androgen biosynthetic process;lactation",nucleolus;mediator complex,Other TF domain,,,,,,,,,,,,,
4186,Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),YQNSPSSDDGIRP,_SYQNSPSS(ph)DDGIRPLPEYSTEK_,S1482,+,25.01,,,,24.69,,23.40,23.90,24.54,25.39,23.34,,23.54,24.23,0.78, , , ,0.46, ,-0.82,-0.32,0.31,1.16,-0.89, ,-0.69,"negative regulation of apoptotic process;mRNA transcription from RNA polymerase II promoter;fat cell differentiation;regulation of transcription from RNA polymerase I promoter;liver development;positive regulation of hepatocyte proliferation;erythrocyte development;embryonic hindlimb morphogenesis;positive regulation of protein import into nucleus, translocation;thyroid hormone generation;retinal pigment epithelium development;keratinocyte differentiation;cell morphogenesis;epithelial cell proliferation involved in mammary gland duct elongation;cellular response to epidermal growth factor stimulus;positive regulation of intracellular estrogen receptor signaling pathway;monocyte differentiation;organ regeneration;cellular response to thyroid hormone stimulus;DNA replication;mammary gland branching involved in pregnancy;thyroid hormone mediated signaling pathway;negative regulation of keratinocyte proliferation;embryonic heart tube development;positive regulation of keratinocyte differentiation;enucleate erythrocyte development;cellular response to hepatocyte growth factor stimulus;embryonic hemopoiesis;cellular response to steroid hormone stimulus;embryonic placenta development;negative regulation of neuron differentiation;ventricular trabecula myocardium morphogenesis;androgen receptor signaling pathway;lens development in camera-type eye;positive regulation of interferon-gamma-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;megakaryocyte development;transcription initiation from RNA polymerase II promoter;mammary gland branching involved in thelarche;regulation of cell cycle;positive regulation of mammary gland epithelial cell proliferation;angiogenesis;small molecule metabolic process;peroxisome proliferator activated receptor signaling pathway;cellular lipid metabolic process;regulation of vitamin D receptor signaling pathway;positive regulation of G0 to G1 transition;ERK1 and ERK2 cascade;brain development;negative regulation of transcription from RNA polymerase II promoter;androgen biosynthetic process;lactation",nucleolus;mediator complex,Other TF domain,,,,,,,,,,,,,
4187,Q15651,HMGN3,High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7) (TR-interacting protein 7) (TRIP-7),EAQKTESVDNEGE,_AEEAQKTES(ph)VDNEGE_,S93,,24.51,,,24.30,,,,20.60,22.55,,,,,22.99,1.52, , ,1.31, , , ,-2.39,-0.44, , , , ,regulation of insulin secretion involved in cellular response to glucose stimulus;chromatin modification;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter,chromatin;nucleus;cytoplasm,,,,,,,,,,,,,,
4188,Q15652,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8),PNKRKGSDSSIPD,_RKGS(ph)DSS(ph)IPDEEK_,S317,,24.51,23.99,24.38,23.55,,21.73,,21.12,,,,,,23.21,1.30,0.78,1.17,0.34, ,-1.49, ,-2.09, , , , , ,"blood coagulation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleoplasm,,,,,,,,,,,,,,
4190,Q15652,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8),RKGSDSSIPDEEK,_RKGS(ph)DSS(ph)IPDEEK_,S320,,23.80,23.99,24.38,23.55,,21.73,,21.12,,,,,,23.10,0.71,0.90,1.29,0.46, ,-1.37, ,-1.98, , , , , ,"blood coagulation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleoplasm,,,,,,,,,,,,,,
4191,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),SLGPSISEPDLTS,_AISM(ox)SRTDPPAVNGASLGPSIS(ph)EPDLTSVK_,S809,+,,,,,26.08,22.83,22.70,24.71,23.65,24.68,23.71,24.73,,24.14, , , , ,1.94,-1.31,-1.43,0.57,-0.48,0.54,-0.43,0.60, ,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
4192,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),CTEQSNSPPPIRR,_ICTEQSNS(ph)PPPIR_,S314,,,,,24.36,22.77,,23.85,23.78,24.20,,22.98,,,23.66, , , ,0.70,-0.88, ,0.19,0.12,0.55, ,-0.68, , ,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
4193,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),RPRPATSTPDLAS,_PATS(ph)TPDLASHR_,S578,+,,23.39,22.63,25.43,26.32,24.80,26.45,26.47,24.94,23.42,24.68,25.00,22.99,24.71, ,-1.32,-2.08,0.72,1.61,0.10,1.74,1.76,0.23,-1.29,-0.03,0.29,-1.72,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
4194,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),GPRKSVSNGALRQ,_SVS(ph)NGALR_,S760,,19.76,,,25.20,,,,,,,,,,22.48,-2.72, , ,2.72, , , , , , , , , ,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
4197,Q15678,PTPN14,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),HKYVSGSSPDLVT,_YVSGS(ph)S(ph)PDLVTRK_,S593,,,,,24.12,23.79,,,,23.61,22.93,,24.06,,23.70, , , ,0.42,0.09, , , ,-0.09,-0.77, ,0.36, ,negative regulation of cell proliferation;lymphangiogenesis;regulation of protein export from nucleus,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
4199,Q15696,ZRSR2,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",NRDIYLSPDRTGS,_NPNNEFWEANRDIYLS(ph)PDR_,S349,+,22.96,23.90,24.36,22.42,25.40,,,22.84,23.47,21.92,,,,23.41,-0.45,0.50,0.96,-0.99,1.99, , ,-0.57,0.06,-1.49, , , ,spliceosomal complex assembly,U12-type spliceosomal complex,,,,,,,,,,,,,,
4200,Q15742,NAB2,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),_MHRAPSPTAEQP,_APS(ph)PTAEQPPGGGDSAR_,S6,,23.12,22.33,,23.07,,,,,,,,,,22.84,0.28,-0.51, ,0.23, , , , , , , , , ,"negative regulation of transcription from RNA polymerase III promoter;endochondral ossification;Schwann cell differentiation;regulation of epidermis development;cell proliferation;myelination;transcription, DNA-dependent;nervous system development",nucleus,,,,,,,,,,,,,,
4201,Q15742,NAB2,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),ELGEKLSPLPGGP,_S(ph)PLELGEKLS(ph)PLPGGPGAGDPR_,S171,+,27.18,22.69,22.99,23.56,23.52,24.84,23.48,23.81,25.65,23.22,24.34,24.91,,24.18,3.00,-1.49,-1.19,-0.62,-0.66,0.66,-0.70,-0.37,1.47,-0.96,0.16,0.73, ,"negative regulation of transcription from RNA polymerase III promoter;endochondral ossification;Schwann cell differentiation;regulation of epidermis development;cell proliferation;myelination;transcription, DNA-dependent;nervous system development",nucleus,,,,,,,,,,,,,,
4202,Q15742,NAB2,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),GSARSFSPKSPLE,_SFS(ph)PKS(ph)PLELGEK_,S159,,25.67,,,,25.77,26.29,,25.94,,,,,23.80,25.49,0.18, , , ,0.28,0.79, ,0.44, , , , ,-1.69,"negative regulation of transcription from RNA polymerase III promoter;endochondral ossification;Schwann cell differentiation;regulation of epidermis development;cell proliferation;myelination;transcription, DNA-dependent;nervous system development",nucleus,,,,,,,,,,,,,,
4203,Q15742,NAB2,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),RSFSPKSPLELGE,_S(ph)PLELGEKLS(ph)PLPGGPGAGDPR_,S162,,27.22,24.85,24.96,24.64,,,22.20,,23.15,,,,,24.50,2.72,0.35,0.46,0.14, , ,-2.30, ,-1.36, , , , ,"negative regulation of transcription from RNA polymerase III promoter;endochondral ossification;Schwann cell differentiation;regulation of epidermis development;cell proliferation;myelination;transcription, DNA-dependent;nervous system development",nucleus,,,,,,,,,,,,,,
4205,Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",KDEVEVSDDDEKE,_DEVEVS(ph)DDDEKEPEVDYR_,S1438,,24.36,,,,,,24.24,,25.55,25.54,,26.37,,25.21,-0.85, , , , , ,-0.97, ,0.34,0.33, ,1.15, ,positive regulation of calcium ion transport;tonic smooth muscle contraction;positive regulation of cell migration;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;positive regulation of wound healing;bleb assembly,cytosol;stress fiber;plasma membrane;lamellipodium;cleavage furrow,,+,,,,,,,,,,,,
4206,Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",LSGRKSSTGSPTS,_KSS(ph)TGSPTS(ph)PLNAEK_,S1700,,24.17,,,,,,,,,,,,,24.17,0.00, , , , , , , , , , , , ,positive regulation of calcium ion transport;tonic smooth muscle contraction;positive regulation of cell migration;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;positive regulation of wound healing;bleb assembly,cytosol;stress fiber;plasma membrane;lamellipodium;cleavage furrow,,+,,,,,,,,,,,,
4207,Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",RKSSTGSPTSPLN,_SSTGS(ph)PTSPLNAEK_,S1703,+,,24.20,23.28,24.29,,,,21.96,25.16,,23.82,23.96,23.00,23.71, ,0.49,-0.43,0.58, , , ,-1.75,1.45, ,0.11,0.25,-0.71,positive regulation of calcium ion transport;tonic smooth muscle contraction;positive regulation of cell migration;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;positive regulation of wound healing;bleb assembly,cytosol;stress fiber;plasma membrane;lamellipodium;cleavage furrow,,+,,,,,,,,,,,,
4208,Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",STGSPTSPLNAEK,_SSTGSPTS(ph)PLNAEK_,S1706,+,25.57,25.23,25.06,26.57,,23.09,24.74,22.94,26.31,,25.12,25.02,,24.97,0.60,0.26,0.10,1.60, ,-1.88,-0.22,-2.02,1.34, ,0.16,0.05, ,positive regulation of calcium ion transport;tonic smooth muscle contraction;positive regulation of cell migration;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;positive regulation of wound healing;bleb assembly,cytosol;stress fiber;plasma membrane;lamellipodium;cleavage furrow,,+,,,,,,,,,,,,
4209,Q15746,MYLK,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",VSTKTLSEDDLKE,_TLS(ph)EDDLK_,S911,,,22.18,20.78,23.30,,,,,22.25,,,21.16,,21.93, ,0.25,-1.15,1.36, , , , ,0.32, , ,-0.78, ,positive regulation of calcium ion transport;tonic smooth muscle contraction;positive regulation of cell migration;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;positive regulation of wound healing;bleb assembly,cytosol;stress fiber;plasma membrane;lamellipodium;cleavage furrow,,+,,,,,,,,,,,,
4210,Q15758,SLC1A5,Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5),ADPPRDSKGLAAA,_(ac)M(ox)VADPPRDS(ph)K_,S9,,20.18,24.65,,24.89,,,,,,,,,,23.24,-3.06,1.41, ,1.65, , , , , , , , , ,,Golgi apparatus;melanosome;integral to plasma membrane,,,,,,,,,,,,,,
4212,Q15772,SPEG,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),FQQKAASLDERTR,_AAS(ph)LDERTR_,S476,,,,,,,,,,,,22.25,24.91,21.83,23.00, , , , , , , , , , ,-0.75,1.91,-1.16,negative regulation of cell proliferation;muscle cell differentiation;muscle organ development,nucleus,,+,,,,,,,,,,,,
4214,Q15772,SPEG,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),PLRKARSLEQPKS,_ARS(ph)LEQPK_,S435,,21.98,24.02,24.49,24.12,,,21.38,20.91,,19.14,22.19,23.55,21.21,22.30,-0.31,1.72,2.19,1.82, , ,-0.92,-1.39, ,-3.16,-0.11,1.25,-1.09,negative regulation of cell proliferation;muscle cell differentiation;muscle organ development,nucleus,,+,,,,,,,,,,,,
4215,Q15772,SPEG,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),WGTPGASQEELRA,_GAPWGTPGAS(ph)QEELRAPGSVAER_,S453,,,,,,22.52,,,23.09,,,24.09,,,23.23, , , , ,-0.72, , ,-0.14, , ,0.86, , ,negative regulation of cell proliferation;muscle cell differentiation;muscle organ development,nucleus,,+,,,,,,,,,,,,
4216,Q15772,SPEG,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),ERTRQRSPASDLE,_(gl)QRS(ph)PASDLELR_,S485,,,,,,22.78,22.54,24.32,24.30,,,23.90,24.99,24.91,23.96, , , , ,-1.18,-1.42,0.35,0.34, , ,-0.07,1.03,0.95,negative regulation of cell proliferation;muscle cell differentiation;muscle organ development,nucleus,,+,,,,,,,,,,,,
4217,Q15772,SPEG,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),GLQKSSSFSQGEA,_SSS(ph)FSQGEAEPR_,S2130,,22.51,,,22.89,,,,,,,,23.07,,22.82,-0.32, , ,0.07, , , , , , , ,0.25, ,negative regulation of cell proliferation;muscle cell differentiation;muscle organ development,nucleus,,+,,,,,,,,,,,,
4218,Q15773,MLF 2.00,Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2),IQGPEDSPSRQSR,_LAIQGPEDS(ph)PSRQSR_,S238,+,29.49,27.11,,26.57,27.47,26.36,25.42,27.22,27.05,26.10,22.62,24.11,26.93,26.37,3.12,0.74, ,0.20,1.10,-0.01,-0.95,0.85,0.68,-0.27,-3.75,-2.26,0.56,defense response,nucleus;cytoplasm,,,,,,,,,,,,,,
4219,Q15773,MLF 2.00,Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2),DSPSRQSRRYDW_,_LAIQGPEDS(ph)PSRQS(ph)R_,S243,,24.29,,,,,,,,,,,,,24.29,0.00, , , , , , , , , , , , ,defense response,nucleus;cytoplasm,,,,,,,,,,,,,,
4220,Q15785,TOMM34,Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit),TKNRVPSAGDVEK,_NRVPS(ph)AGDVEK_,S186,+,22.58,24.91,25.59,25.19,25.26,24.09,25.80,25.85,24.11,24.13,25.06,25.84,22.57,24.69,-2.11,0.22,0.90,0.50,0.57,-0.61,1.11,1.16,-0.58,-0.56,0.37,1.15,-2.12,protein targeting to mitochondrion,mitochondrial outer membrane;integral to membrane,,,,,,,,,,,,,,
4222,Q15811,ITSN1,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),ATATGSSPSPVLG,_SAFTPATATGSS(ph)PS(ph)PVLGQGEK_,S897,,23.58,,,26.47,,,28.68,,,,,,,26.24,-2.66, , ,0.23, , ,2.44, , , , , , ,positive regulation of protein kinase B signaling cascade;synaptic vesicle endocytosis;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;negative regulation of neuron apoptotic process;regulation of small GTPase mediated signal transduction,endocytic vesicle;coated pit;cytosol;neuron projection;synapse;cell junction;plasma membrane;lamellipodium,,,,,,,,,,,,,,
4223,Q15811,ITSN1,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),ATGSSPSPVLGQG,_SAFTPATATGSS(ph)PS(ph)PVLGQGEK_,S899,+,27.25,26.53,25.99,27.65,25.71,27.52,26.93,27.96,27.62,26.78,28.66,28.50,28.29,27.34,-0.09,-0.81,-1.35,0.31,-1.63,0.18,-0.41,0.63,0.28,-0.56,1.32,1.16,0.96,positive regulation of protein kinase B signaling cascade;synaptic vesicle endocytosis;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;negative regulation of neuron apoptotic process;regulation of small GTPase mediated signal transduction,endocytic vesicle;coated pit;cytosol;neuron projection;synapse;cell junction;plasma membrane;lamellipodium,,,,,,,,,,,,,,
4226,Q15811,ITSN1,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),PIRKSTSMDSGSS,_STS(ph)M(ox)DSGSSESPASLK_,S973,+,24.09,23.18,23.18,23.65,23.92,24.33,22.63,23.40,23.19,,22.86,,23.39,23.44,0.65,-0.26,-0.26,0.21,0.48,0.89,-0.81,-0.04,-0.25, ,-0.58, ,-0.05,positive regulation of protein kinase B signaling cascade;synaptic vesicle endocytosis;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;apoptotic process;nerve growth factor receptor signaling pathway;negative regulation of neuron apoptotic process;regulation of small GTPase mediated signal transduction,endocytic vesicle;coated pit;cytosol;neuron projection;synapse;cell junction;plasma membrane;lamellipodium,,,,,,,,,,,,,,
4228,Q15836,VAMP3,Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3),PTAATGSNRRLQQ,_(ac)STGPTAATGS(ph)NRR_,S11,+,24.76,22.98,22.46,27.65,24.46,,22.94,21.36,21.86,,,25.69,21.08,23.53,1.24,-0.54,-1.07,4.13,0.94, ,-0.58,-2.16,-1.66, , ,2.16,-2.44,"calcium ion-dependent exocytosis;positive regulation of receptor recycling;protein complex assembly;vesicle docking involved in exocytosis;cellular membrane fusion;protein transport;substrate adhesion-dependent cell spreading;retrograde transport, endosome to Golgi",apical plasma membrane;recycling endosome;clathrin-coated vesicle;SNARE complex;neuron projection;synapse;integral to membrane;cell junction;plasma membrane;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
4232,Q15911,ZFHX3,Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3),NTPREVSPLLPKL,_EVS(ph)PLLPKLPEEPEAESK_,S3432,,21.93,,,,23.83,23.23,,,,,,,22.67,22.91,-0.99, , , ,0.92,0.32, , , , , , ,-0.25,"negative regulation of transcription from RNA polymerase II promoter;negative regulation of myoblast differentiation;positive regulation of myoblast differentiation;negative regulation of transcription, DNA-dependent;muscle organ development",mitochondrion;transcription factor complex,C2H2-type,,,,,,,,,,,,,
4236,Q15942,ZYX,Zyxin (Zyxin-2),PREKVSSIDLEID,_VSS(ph)IDLEIDSLSSLLDDM(ox)TK_,S143,+,27.55,,,25.15,,,25.86,26.54,27.96,21.03,27.94,24.02,28.17,26.03,1.52, , ,-0.88, , ,-0.16,0.52,1.94,-5.00,1.91,-2.01,2.14,signal transduction;cell adhesion;virus-host interaction;cell-cell signaling,stress fiber;nucleus;focal adhesion;integral to plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,+,,,,
4237,Q15942,ZYX,Zyxin (Zyxin-2),PVASKFSPGAPGG,_FS(ph)PGAPGGSGSQPNQK_,S281,+,,,,23.73,24.72,22.00,27.47,27.51,25.36,22.90,22.49,22.37,25.35,24.39, , , ,-0.66,0.33,-2.39,3.08,3.12,0.97,-1.49,-1.90,-2.02,0.96,signal transduction;cell adhesion;virus-host interaction;cell-cell signaling,stress fiber;nucleus;focal adhesion;integral to plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,+,,,,
4238,Q15942,ZYX,Zyxin (Zyxin-2),APAPKFSPVTPKF,_GPPASSPAPAPKFS(ph)PVTPK_,S267,+,24.56,25.96,25.41,27.09,26.90,26.42,27.16,27.25,25.68,24.74,27.03,26.18,25.49,26.14,-1.59,-0.18,-0.73,0.94,0.75,0.27,1.02,1.11,-0.46,-1.40,0.89,0.03,-0.65,signal transduction;cell adhesion;virus-host interaction;cell-cell signaling,stress fiber;nucleus;focal adhesion;integral to plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,+,,,,
4240,Q15942,ZYX,Zyxin (Zyxin-2),LSAGTGSPQPPSF,_LGHPEALSAGTGS(ph)PQPPSFTYAQQR_,S308,+,,,,23.03,26.05,24.95,26.15,26.12,24.82,,,25.25,25.70,25.26, , , ,-2.23,0.79,-0.31,0.89,0.86,-0.44, , ,-0.01,0.44,signal transduction;cell adhesion;virus-host interaction;cell-cell signaling,stress fiber;nucleus;focal adhesion;integral to plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,+,,,,
4241,Q15942,ZYX,Zyxin (Zyxin-2),NQNQVRSPGAPGP,_S(ph)PGAPGPLTLK_,S344,+,27.93,26.75,26.15,28.49,25.97,27.20,29.58,28.90,27.83,28.03,29.49,28.66,28.09,27.93,0.00,-1.17,-1.78,0.57,-1.96,-0.73,1.65,0.97,-0.10,0.10,1.56,0.73,0.16,signal transduction;cell adhesion;virus-host interaction;cell-cell signaling,stress fiber;nucleus;focal adhesion;integral to plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,+,,,,
4243,Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),ISMEIDSPENMMR,_DISM(ox)EIDS(ph)PENM(ox)M(ox)R_,S254,,23.34,,,,23.48,,23.15,,,,21.68,,,22.91,0.43, , , ,0.57, ,0.24, , , ,-1.23, , ,,cytoskeleton;cytoplasm,,,,,,,,,,,+,,,
4244,Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),KLDQPVSAPPSPR,_LDQPVS(ph)APPS(ph)PR_,S240,+,29.58,26.89,27.12,27.31,24.36,22.95,24.18,24.87,,,,,,25.91,3.67,0.98,1.21,1.40,-1.55,-2.95,-1.73,-1.04, , , , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,+,,,
4246,Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),ALCRQLSESESSL,_QLS(ph)ESESSLEM(ox)DDER_,S323,,25.86,23.90,,,,,,,,,,,,24.88,0.98,-0.98, , , , , , , , , , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,+,,,
4247,Q16204,CCDC6,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),SGGIVISPFRLEE,_SGGIVIS(ph)PFRLEELTNR_,S52,,23.13,,,,,,,,,,,,,23.13,0.00, , , , , , , , , , , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,+,,,
4251,Q16236,NFE2L2,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2)",ETTMVPSPEAKLT,_LVETTM(ox)VPS(ph)PEAK_,S199,,23.81,22.54,22.67,22.15,,,,,,,,,22.84,22.80,1.01,-0.26,-0.13,-0.65, , , , , , , , ,0.04,negative regulation of apoptotic process;positive regulation of reactive oxygen species metabolic process;positive regulation of blood coagulation;cellular response to hydrogen peroxide;regulation of removal of superoxide radicals;regulation of embryonic development;transcription from RNA polymerase II promoter;endoplasmic reticulum unfolded protein response;cellular response to laminar fluid shear stress;positive regulation of transcription from RNA polymerase II promoter in response to stress,cytosol;chromatin;plasma membrane;nucleus;centrosome,bZIP,,,,,,,,,,,,,
4253,Q16512,PKN1,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),GTDSDSSPQKSSR,_LNLGTDSDSS(ph)PQK_,S562,+,,24.63,25.32,,,24.70,25.56,26.01,24.67,22.89,,23.36,,24.64, ,-0.01,0.67, , ,0.06,0.92,1.37,0.03,-1.76, ,-1.28, ,"activation of JUN kinase activity;regulation of cell motility;hyperosmotic response;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;epithelial cell migration",endosome;midbody;plasma membrane;nucleus;cytoplasmic membrane-bounded vesicle;cleavage furrow,,+,,,,,,,,,,,,
4254,Q16512,PKN1,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),GEAPTLSPPRDAR,_TDVSNFDEEFTGEAPTLS(ph)PPR_,S916,,22.32,,,,,,,,,,,,,22.32,0.00, , , , , , , , , , , , ,"activation of JUN kinase activity;regulation of cell motility;hyperosmotic response;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;epithelial cell migration",endosome;midbody;plasma membrane;nucleus;cytoplasmic membrane-bounded vesicle;cleavage furrow,,+,,,,,,,,,,,,
4255,Q16513,PKN2,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),APPRASSLGEIDE,_ASS(ph)LGEIDESSELR_,S567,+,27.93,25.87,,26.81,27.24,26.96,26.86,27.86,27.75,24.29,27.50,25.95,27.35,26.86,1.07,-1.00, ,-0.05,0.38,0.10,0.00,0.99,0.89,-2.58,0.64,-0.92,0.48,"regulation of transcription, DNA-dependent;positive regulation of cell cycle cytokinesis;epithelial cell migration;signal transduction;apical junction assembly;regulation of cell motility;cell adhesion;apoptotic process;positive regulation of mitotic cell cycle;transcription, DNA-dependent;cell cycle;cell division",cleavage furrow;cytoplasm;apical junction complex;midbody;cytoskeleton;nucleus;lamellipodium;membrane,,+,,,,,,,,+,,,,
4257,Q16514,TAF12,Transcription initiation factor TFIID subunit 12 (Transcription initiation factor TFIID 20/15 kDa subunits) (TAFII-20/TAFII-15) (TAFII20/TAFII15),GAGGRLSPENNQV,_LS(ph)PENNQVLTK_,S21,+,26.28,26.41,26.65,24.83,26.25,27.30,26.96,26.04,27.31,27.02,25.69,26.60,26.47,26.45,-0.17,-0.03,0.20,-1.61,-0.20,0.85,0.52,-0.41,0.86,0.57,-0.76,0.16,0.02,transcription initiation from RNA polymerase II promoter;viral reproduction;histone H3 acetylation;transcription elongation from RNA polymerase II promoter;positive regulation of sequence-specific DNA binding transcription factor activity,transcription factor TFTC complex;PCAF complex;STAGA complex;transcription factor TFIID complex,,,,,,,,,,,,,,
4258,Q16539,MAPK14,Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a),_____MSQERPTF,_(ac)S(ph)QERPTFYR_,S2,+,23.74,25.11,24.93,21.89,22.33,23.62,,22.38,22.98,23.36,23.35,,22.96,23.33,0.41,1.78,1.60,-1.44,-1.01,0.29, ,-0.96,-0.35,0.03,0.02, ,-0.37,"toll-like receptor 4 signaling pathway;positive regulation of erythrocyte differentiation;peptidyl-serine phosphorylation;response to muramyl dipeptide;Ras protein signal transduction;regulation of sequence-specific DNA binding transcription factor activity;osteoclast differentiation;fatty acid oxidation;striated muscle cell differentiation;mRNA metabolic process;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;glucose metabolic process;gene expression;positive regulation of reactive oxygen species metabolic process;platelet activation;cell morphogenesis;vascular endothelial growth factor receptor signaling pathway;TRIF-dependent toll-like receptor signaling pathway;response to glucose stimulus;3'-UTR-mediated mRNA stabilization;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;muscle cell differentiation;toll-like receptor 1 signaling pathway;signal transduction in response to DNA damage;chondrocyte differentiation;cellular response to vascular endothelial growth factor stimulus;protein autophosphorylation;cellular response to ionizing radiation;Toll signaling pathway;chemotaxis;stress-activated MAPK cascade;apoptotic process;skeletal muscle tissue development;cellular component movement;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;angiogenesis;positive regulation of muscle cell differentiation;DNA damage checkpoint;innate immune response;stress-induced premature senescence;lipopolysaccharide-mediated signaling pathway",nucleoplasm;cytosol;mitochondrion;cytosolic part;spindle pole,,+,,,,,,,,,,,,
4260,Q16576,RBBP7,Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46),KIGEEQSAEDAED,_IGEEQS(ph)AEDAEDGPPELLFIHGGHTAK_,S354,,,,,,23.06,,,23.93,23.94,24.59,,,,23.88, , , , ,-0.82, , ,0.05,0.06,0.71, , , ,"multicellular organismal development;cell proliferation;negative regulation of cell growth;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;DNA replication;cellular heat acclimation",NuRD complex;ESC/E(Z) complex,,,,,,,,,,,,,,
4262,Q16623,STX1A,Syntaxin-1A (Neuron-specific antigen HPC-1),LRTAKDSDDDDDV,_TAKDS(ph)DDDDDVAVTVDRDR_,S14,,,,,,25.02,,24.20,,,,23.77,,,24.33, , , , ,0.69, ,-0.13, , , ,-0.56, , ,synaptic vesicle docking involved in exocytosis;small molecule metabolic process;calcium ion-dependent exocytosis;response to gravity;positive regulation of neurotransmitter secretion;energy reserve metabolic process;glutamate secretion;intracellular protein transport;regulation of insulin secretion;neurotransmitter secretion;positive regulation of exocytosis,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex;neuron projection;secretory granule;SNARE complex;synaptic vesicle membrane;extracellular region;integral to membrane;cell junction;plasma membrane;synaptobrevin 2-SNAP-25-syntaxin-1a complex;actomyosin,,,,,,,,,,,,,,
4264,Q16625,OCLN,Occludin,QELPLTSPVDDFR,_STPVPEVVQELPLTS(ph)PVDDFRQPR_,S358,,,,,,,,,,,28.04,24.71,,,26.38, , , , , , , , , ,1.66,-1.66, , ,S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;protein complex assembly;response to testosterone stimulus;S-adenosylhomocysteine metabolic process,tight junction;cytosol;integral to membrane;plasma membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
4265,Q16625,OCLN,Occludin,FRQPRYSSGGNFE,_YS(ph)SGGNFETPSK_,S369,,22.79,23.73,23.18,20.73,,,,,,23.73,,,,22.83,-0.05,0.90,0.35,-2.10, , , , , ,0.89, , , ,S-adenosylmethionine metabolic process;cell-cell junction organization;cellular component disassembly involved in execution phase of apoptosis;protein complex assembly;response to testosterone stimulus;S-adenosylhomocysteine metabolic process,tight junction;cytosol;integral to membrane;plasma membrane;apicolateral plasma membrane,,,,,,,,,,,,,,
4266,Q16629,SRSF7,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",SISLRRSRSASLR,_S(ph)RS(ph)ASLRR_,S171,,24.41,18.78,17.87,18.35,18.91,,,,,,,,,19.66,4.75,-0.89,-1.79,-1.31,-0.76, , , , , , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
4267,Q16629,SRSF7,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",SLRRSRSASLRRS,_S(ph)RS(ph)ASLRR_,S173,,24.41,18.78,17.87,18.35,18.91,,,,,,,,,19.66,4.75,-0.89,-1.79,-1.31,-0.76, , , , , , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
4268,Q16629,SRSF7,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",GSRYFQSPSRSRS,_YFQS(ph)PS(ph)R_,S192,+,26.89,26.96,24.19,27.17,23.54,23.27,,22.51,22.17,,,,,24.59,2.30,2.37,-0.39,2.58,-1.05,-1.32, ,-2.08,-2.41, , , , ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
4269,Q16629,SRSF7,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",RYFQSPSRSRSRS,_YFQS(ph)PS(ph)R_,S194,+,26.85,26.63,23.64,26.02,,,,,,21.89,21.30,22.04,,24.05,2.79,2.58,-0.41,1.97, , , , , ,-2.17,-2.75,-2.01, ,"negative regulation of mRNA splicing, via spliceosome;mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
4270,Q16630,CPSF6,Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit) (CFIm68) (CPSF 68 kDa subunit) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7),RRHKSRSRDRHDD,_S(ph)RDRHDDYYR_,S440,,20.90,19.70,19.70,19.96,21.48,,17.50,,,,,,,19.87,1.02,-0.17,-0.17,0.09,1.61, ,-2.37, , , , , , ,protein tetramerization;mRNA polyadenylation,mRNA cleavage factor complex;ribonucleoprotein complex;paraspeckles,,,,,,,,,,,,,,
4272,Q16637,SMN1,Survival motor neuron protein (Component of gems 1) (Gemin-1),RRGTGQSDDSDIW,_GTGQS(ph)DDSDIWDDTALIK_,S28,,24.13,,,,27.98,,,24.36,22.13,24.81,,,,24.68,-0.55, , , ,3.30, , ,-0.32,-2.55,0.13, , , ,ncRNA metabolic process;spliceosomal complex assembly;cell death;spliceosomal snRNP assembly,cytosol;Cajal body;spliceosomal complex,,,,,,,,,,,,,,
4273,Q16637,SMN1,Survival motor neuron protein (Component of gems 1) (Gemin-1),TGQSDDSDIWDDT,_RGTGQSDDS(ph)DIWDDTALIK_,S31,,21.43,,,,25.85,,,,,,,,,23.64,-2.21, , , ,2.21, , , , , , , , ,ncRNA metabolic process;spliceosomal complex assembly;cell death;spliceosomal snRNP assembly,cytosol;Cajal body;spliceosomal complex,,,,,,,,,,,,,,
4274,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),MAGVSFSGHRLEL,_(ac)AGVSFS(ph)GHR_,S7,+,23.64,22.64,22.40,22.74,,22.95,22.41,,,22.56,,,23.65,22.87,0.76,-0.23,-0.47,-0.14, ,0.08,-0.47, , ,-0.32, , ,0.78,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4275,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),QETQEPSPILDSE,_ALDEVTSSQPPPLPPPPPPAQETQEPS(ph)PILDSEETR_,S381,+,26.10,,,,25.59,,23.58,24.17,26.17,26.05,25.95,23.44,26.56,25.29,0.81, , , ,0.30, ,-1.71,-1.12,0.88,0.76,0.66,-1.85,1.27,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4277,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),GLARLSSPVLHRL,_LSS(ph)PVLHR_,S142,+,29.58,29.22,28.92,29.32,29.30,28.21,28.79,28.19,28.81,28.31,28.02,28.29,27.31,28.64,0.94,0.58,0.28,0.69,0.66,-0.42,0.16,-0.45,0.18,-0.33,-0.62,-0.34,-1.33,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4278,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),TPIPTRSPSDSST,_S(ph)PSDSSTASTPVAEQIER_,S337,+,25.95,,,,25.47,23.78,24.46,24.55,23.81,24.99,,,25.32,24.79,1.16, , , ,0.68,-1.01,-0.34,-0.24,-0.98,0.20, , ,0.53,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4279,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),IPTRSPSDSSTAS,_SPS(ph)DSSTASTPVAEQIER_,S339,+,25.69,25.72,25.94,24.58,24.25,26.93,,27.45,30.22,27.64,25.80,27.57,,26.53,-0.83,-0.80,-0.59,-1.95,-2.27,0.41, ,0.92,3.69,1.11,-0.73,1.04, ,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4281,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),RSPSDSSTASTPV,_SPSDSS(ph)TAST(ph)PVAEQIER_,S342,,24.99,,,,,,,,,,,,,24.99,0.00, , , , , , , , , , , , ,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
4285,Q16649,NFIL3,Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A),PKGPIHSPVELKH,_GPIHS(ph)PVELK_,S301,+,23.62,24.87,24.87,,,22.53,22.39,23.19,24.31,,,22.45,,23.53,0.09,1.34,1.34, , ,-1.00,-1.14,-0.34,0.78, , ,-1.08, ,immune response;positive regulation of gene expression;circadian rhythm,nucleus,bZIP,,,,,,,,,,,,,
4287,Q16649,NFIL3,Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A),ATQKLSSPIDMTS,_LSS(ph)PIDM(ox)TSK_,S353,+,25.04,24.44,,24.45,,,,20.44,22.76,22.26,,21.53,,22.99,2.05,1.46, ,1.46, , , ,-2.55,-0.23,-0.73, ,-1.46, ,immune response;positive regulation of gene expression;circadian rhythm,nucleus,bZIP,,,,,,,,,,,,,
4290,Q16666,IFI16,Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator),KEVDATSPAPSTS,_EVDATS(ph)PAPSTSSTVK_,S110,+,28.35,29.18,29.66,28.52,26.81,28.22,28.19,27.12,27.91,27.56,26.95,26.90,27.38,27.90,0.44,1.27,1.76,0.62,-1.09,0.32,0.28,-0.78,0.00,-0.34,-0.95,-1.01,-0.52,"regulation of autophagy;negative regulation of innate immune response;defense response to virus;autophagy;inflammatory response;cellular response to ionizing radiation;negative regulation of DNA binding;negative regulation of cysteine-type endopeptidase activity;activation of cysteine-type endopeptidase activity;positive regulation of transcription from RNA polymerase II promoter;cellular response to glucose starvation;negative regulation of viral genome replication;innate immune response;intrinsic apoptotic signaling pathway by p53 class mediator;cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;monocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of interleukin-1 beta production;activation of innate immune response",nucleolus;nuclear speck;cytoplasm,Other TF domain,,,,,,,,,,,,,
4292,Q16666,IFI16,Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator),AMGRSPSPKTSLS,_VSEEQTQPPS(ph)PAGAGM(ox)STAM(ox)GRSPS(ph)PK_,S172,+,,29.43,29.43,25.88,24.96,,24.85,25.02,26.84,24.11,,,,26.32, ,3.12,3.12,-0.43,-1.36, ,-1.47,-1.30,0.52,-2.21, , , ,"regulation of autophagy;negative regulation of innate immune response;defense response to virus;autophagy;inflammatory response;cellular response to ionizing radiation;negative regulation of DNA binding;negative regulation of cysteine-type endopeptidase activity;activation of cysteine-type endopeptidase activity;positive regulation of transcription from RNA polymerase II promoter;cellular response to glucose starvation;negative regulation of viral genome replication;innate immune response;intrinsic apoptotic signaling pathway by p53 class mediator;cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;monocyte differentiation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of interleukin-1 beta production;activation of innate immune response",nucleolus;nuclear speck;cytoplasm,Other TF domain,,,,,,,,,,,,,
4293,Q16790,CA9,Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1),GTKGGVSYRPAEV,_GGVS(ph)YRPAEVAETGA_,S448,+,26.58,26.96,24.25,25.54,23.12,,22.47,22.53,,,,27.99,23.21,24.74,1.84,2.22,-0.49,0.80,-1.62, ,-2.27,-2.21, , , ,3.25,-1.53,regulation of transcription from RNA polymerase II promoter in response to hypoxia;small molecule metabolic process;secretion;one-carbon metabolic process;bicarbonate transport;morphogenesis of an epithelium,microvillus membrane;integral to membrane;nucleolus;plasma membrane,,,,,,,,,,,,,,
4296,Q16851,UGP2,UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase),DLSKAMSQDGASQ,_AM(ox)S(ph)QDGASQFQEVIR_,S13,,,21.04,,21.19,,,,,,,,,,21.12, ,-0.08, ,0.08, , , , , , , , , ,xenobiotic metabolic process;UDP-glucuronate biosynthetic process;glucose 1-phosphate metabolic process;UDP-glucose metabolic process;glucose metabolic process;phosphorylation;glycogen biosynthetic process,cytosol,,,,,,,,,,,,,,
4297,Q16851,UGP2,UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase),_____MSQDGASQ,_(ac)S(ph)QDGASQFQEVIR_,S2,,22.70,,,,,,,,,,,,,22.70,0.00, , , , , , , , , , , , ,xenobiotic metabolic process;UDP-glucuronate biosynthetic process;glucose 1-phosphate metabolic process;UDP-glucose metabolic process;glucose metabolic process;phosphorylation;glycogen biosynthetic process,cytosol,,,,,,,,,,,,,,
4298,Q16875,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105);Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",PLMRRNSVTPLAS,_RNS(ph)VTPLAS(ph)PEPTK_,S461,+,27.59,25.20,26.07,22.67,,,,21.76,,24.36,22.49,24.23,,24.30,3.29,0.91,1.77,-1.62, , , ,-2.53, ,0.06,-1.80,-0.07, ,"small molecule metabolic process;glycolysis;fructose 2,6-bisphosphate metabolic process;fructose metabolic process",cytosol,,,,,,,,,,,,,,
4299,Q16875,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105);Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",SVTPLASPEPTKK,_RNS(ph)VTPLAS(ph)PEPTK_,S467,,26.66,24.72,24.72,,,,,,,21.64,22.45,,,24.04,2.62,0.68,0.68, , , , , , ,-2.40,-1.59, , ,"small molecule metabolic process;glycolysis;fructose 2,6-bisphosphate metabolic process;fructose metabolic process",cytosol,,,,,,,,,,,,,,
4301,Q16890,TPD52L1,Tumor protein D53 (hD53) (Tumor protein D52-like 1),NSPTFKSFEERVE,_S(ph)FEERVETTVTSLK_,S120,,24.38,22.14,22.14,,,,22.71,,,24.08,,27.52,,23.83,0.55,-1.69,-1.69, , , ,-1.12, , ,0.25, ,3.70, ,positive regulation of MAP kinase activity;G2/M transition of mitotic cell cycle;positive regulation of JNK cascade;apoptotic DNA fragmentation;induction of apoptosis,perinuclear region of cytoplasm,,,,,,,,,,,,,,
4302,Q16891,IMMT,Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89),PGWKGMSVSDLAD,_GM(ox)S(ph)VSDLADK_,S377,+,20.80,23.20,22.08,22.83,,21.65,,,22.75,22.38,,,,22.24,-1.44,0.95,-0.16,0.59, ,-0.59, , ,0.51,0.14, , , ,mitochondrial calcium ion homeostasis,mitochondrial inner membrane;integral to mitochondrial inner membrane,,,,,,,,,,,,,,
4303,Q16891,IMMT,Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89),GPLKISSVSEVMK,_ISS(ph)VSEVM(ox)K_,S113,,22.76,23.81,23.81,24.24,,23.58,21.98,22.13,22.68,23.01,,,,23.11,-0.35,0.70,0.70,1.13, ,0.46,-1.13,-0.98,-0.43,-0.10, , , ,mitochondrial calcium ion homeostasis,mitochondrial inner membrane;integral to mitochondrial inner membrane,,,,,,,,,,,,,,
4304,Q16891,IMMT,Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89),LKISSVSEVMKES,_ISSVS(ph)EVM(ox)K_,S115,,20.57,22.69,22.69,23.11,,23.97,22.68,22.85,22.81,22.67,,,,22.67,-2.10,0.02,0.02,0.44, ,1.30,0.01,0.18,0.13,0.00, , , ,mitochondrial calcium ion homeostasis,mitochondrial inner membrane;integral to mitochondrial inner membrane,,,,,,,,,,,,,,
4305,Q16891,IMMT,Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89),VPLPKKSIQSGPL,_S(ph)IQSGPLK_,S103,,,24.49,,23.10,,,,,,,,,,23.80, ,0.69, ,-0.69, , , , , , , , , ,mitochondrial calcium ion homeostasis,mitochondrial inner membrane;integral to mitochondrial inner membrane,,,,,,,,,,,,,,
4306,Q17R89,ARHGAP44,Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2),__DKRDSEEESES,_RDS(ph)EEESESTAL_,S5,,,23.35,23.35,,23.10,23.39,,23.86,22.65,21.98,24.40,23.34,23.69,23.31, ,0.04,0.04, ,-0.21,0.08, ,0.55,-0.66,-1.33,1.09,0.03,0.38,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
4307,Q17R98,ZNF827,Zinc finger protein 827,TIRTTTSPFFSED,_TTTS(ph)PFFSEDTFR_,S30,,20.87,,,21.58,23.01,23.83,,,22.40,,,,,22.34,-1.46, , ,-0.76,0.67,1.49, , ,0.06, , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
4308,Q17RY0,CPEB4,Cytoplasmic polyadenylation element-binding protein 4 (CPE-BP4) (CPE-binding protein 4) (hCPEB-4),LEKQQLSPSPGQE,_QQLS(ph)PSPGQEAGILPETEK_,S97,+,25.68,24.71,25.27,25.79,25.00,26.04,26.69,27.11,25.95,25.36,27.59,26.55,27.05,26.06,-0.38,-1.36,-0.79,-0.27,-1.06,-0.02,0.63,1.05,-0.11,-0.70,1.53,0.49,0.99,,synapse,,,,,,,,,,,,,,
4309,Q17RY0,CPEB4,Cytoplasmic polyadenylation element-binding protein 4 (CPE-BP4) (CPE-binding protein 4) (hCPEB-4),KQQLSPSPGQEAG,_QQLSPS(ph)PGQEAGILPETEK_,S99,+,23.44,23.59,,24.96,24.27,26.00,25.09,25.97,25.32,23.47,25.73,25.93,25.21,24.91,-1.47,-1.33, ,0.04,-0.65,1.09,0.17,1.06,0.40,-1.45,0.82,1.02,0.30,,synapse,,,,,,,,,,,,,,
4312,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),DEPEERSGDETPG,_EEDEPEERS(ph)GDET(ph)PGS(ph)EVPGDK_,S161,+,31.57,31.90,31.93,30.54,30.49,31.27,30.77,31.03,31.47,31.89,30.70,29.65,30.24,31.04,0.54,0.87,0.89,-0.49,-0.54,0.23,-0.27,-0.01,0.44,0.86,-0.34,-1.38,-0.79,,nucleus,SAP-domain,,,,,,,,,,,,,
4313,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),GDETPGSEVPGDK,_SGDET(ph)PGS(ph)EVPGDK_,S168,,26.49,,,24.05,,,,,,,,,23.69,24.74,1.74, , ,-0.69, , , , , , , , ,-1.06,,nucleus,SAP-domain,,,,,,,,,,,,,
4314,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),EAYHSRSKSPLPP,_S(ph)KSPLPPEEEAKDEEEDQTLVNLDTYTSDLHFQVSK_,S226,,,23.58,23.58,23.89,,,23.81,24.67,26.08,26.45,,,,24.58, ,-1.00,-1.00,-0.69, , ,-0.77,0.09,1.50,1.87, , , ,,nucleus,SAP-domain,,,,,,,,,,,,,
4315,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),YHSRSKSPLPPEE,_S(ph)PLPPEEEAK_,S228,+,28.00,29.55,29.91,28.16,27.76,28.24,27.73,28.07,29.08,28.25,28.61,27.71,20.32,27.80,0.20,1.75,2.11,0.36,-0.03,0.44,-0.07,0.27,1.28,0.45,0.81,-0.09,-7.48,,nucleus,SAP-domain,,,,,,,,,,,,,
4317,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),MWASLSSPDAEAV,_EHNSM(ox)WASLSS(ph)PDAEAVEPDFSSIER_,S589,+,23.56,,,,26.19,,,25.59,26.10,26.59,25.72,25.44,25.68,25.61,-2.05, , , ,0.59, , ,-0.02,0.49,0.98,0.11,-0.17,0.07,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4318,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),EDTAPESALDTSL,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,S1183,,26.66,,,,,,,,,23.38,,,,25.02,1.64, , , , , , , , ,-1.64, , , ,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4319,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),ESALDTSLDKSFS,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,S1188,+,27.93,,,23.45,25.81,27.08,28.71,27.86,28.37,28.85,28.06,26.80,26.96,27.26,0.66, , ,-3.81,-1.45,-0.18,1.45,0.60,1.11,1.59,0.79,-0.46,-0.30,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4322,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),EDAVTDSSGSGTL,_SFSEDAVTDS(ph)SGSGTLPR_,S1201,,,,,22.27,,23.47,,,,23.09,,23.98,23.21,23.20, , , ,-0.93, ,0.26, , , ,-0.11, ,0.77,0.01,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4324,Q29RF7,PDS5A,Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),AAVGQESPGGLEA,_RAAVGQES(ph)PGGLEAGNAK_,S1305,+,24.52,24.75,24.71,24.96,25.39,26.07,26.25,25.41,26.51,25.32,22.87,24.07,25.77,25.12,-0.60,-0.38,-0.41,-0.17,0.27,0.95,1.13,0.29,1.39,0.20,-2.25,-1.05,0.65,mitosis;negative regulation of DNA replication;cell division,chromatin;plasma membrane;nucleus,,,,,,,,,,,,,,
4328,Q2KHT3,CLEC16A,Protein CLEC16A,DQGRRGSSDPTVQ,_RGS(ph)SDPTVQR_,S845,,23.09,21.33,19.95,22.85,,,,,,,,19.23,,21.29,1.80,0.04,-1.34,1.56, , , , , , , ,-2.05, ,,,,,,,,,,,,,,,,
4330,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),LAGEKESPSSVAD,_ES(ph)PSSVADDHLVQK_,S1252,,,,,,,,,,,22.55,,22.65,,22.60, , , , , , , , , ,-0.05, ,0.05, ,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
4331,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),DENVLDSPKQRRS,_SDENVLDS(ph)PK_,S1355,,23.07,23.90,20.44,23.93,,,,,,,,,,22.84,0.24,1.06,-2.40,1.10, , , , , , , , , ,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
4334,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),IRVDAASPGPRVT,_VGETEELPEIRVDAAS(ph)PGPR_,S3653,,,,,,,,,,,24.25,24.61,,25.38,24.75, , , , , , , , , ,-0.49,-0.14, ,0.63,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
4335,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),NEQDNSSLTKTQR,_VVFENEQDNSS(ph)LTK_,S2755,+,23.17,24.62,,24.69,25.63,,25.26,25.09,25.71,25.62,24.29,25.17,25.33,24.96,-1.79,-0.35, ,-0.27,0.67, ,0.30,0.13,0.75,0.65,-0.67,0.21,0.36,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
4336,Q2LD37,KIAA1109,Uncharacterized protein KIAA1109 (Fragile site-associated protein),YTAGSASPTPTFK,_YTAGSAS(ph)PTPTFK_,S2603,,21.62,22.43,,22.57,23.83,24.64,23.62,23.11,23.84,23.62,,,23.90,23.32,-1.70,-0.89, ,-0.75,0.51,1.32,0.30,-0.21,0.52,0.30, , ,0.59,regulation of epithelial cell differentiation;regulation of cell growth,integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
4337,Q2M2I3,FAM83E,Protein FAM83E,___MAASQLAALE,_(ac)AAS(ph)QLAALEGVDSGPR_,S4,,24.54,,,,,,,,,,,,,24.54,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4338,Q2M2I3,FAM83E,Protein FAM83E,RVSRRRSVAPASP,_S(ph)VAPAS(ph)PPPPDGPLAHR_,S319,,24.24,,,,,,,,,,,,,24.24,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4339,Q2M2I3,FAM83E,Protein FAM83E,RSVAPASPPPPDG,_S(ph)VAPAS(ph)PPPPDGPLAHR_,S324,,24.24,,,,,,,,,,,,,24.24,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4340,Q2M2I3,FAM83E,Protein FAM83E,TPGPALSDILRSV,_VSPATPGPALS(ph)DILR_,S351,,25.78,,,,,,,,,,,,,25.78,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4342,Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),GHRRILSDVTHSA,_ILS(ph)DVTHSAVFGVPASK_,S636,,26.49,21.32,21.32,,22.76,,,,,,,23.76,,23.13,3.37,-1.81,-1.81, ,-0.37, , , , , , ,0.63, ,protein stabilization;protein autophosphorylation;endocytosis;regulation of protein localization;positive regulation of Notch signaling pathway;regulation of clathrin-mediated endocytosis,coated pit;cell leading edge;extrinsic to plasma membrane;clathrin complex;terminal button;clathrin-coated vesicle,,+,,,,,,,,,,,,
4344,Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),SLTPPSSPKTQRA,_VGSLT(ph)PPSS(ph)PKTQR_,S623,+,21.80,23.32,23.59,26.30,25.69,,25.22,23.90,25.28,22.10,23.93,,,24.11,-2.31,-0.79,-0.53,2.18,1.58, ,1.11,-0.22,1.17,-2.01,-0.18, , ,protein stabilization;protein autophosphorylation;endocytosis;regulation of protein localization;positive regulation of Notch signaling pathway;regulation of clathrin-mediated endocytosis,coated pit;cell leading edge;extrinsic to plasma membrane;clathrin complex;terminal button;clathrin-coated vesicle,,+,,,,,,,,,,,,
4347,Q2NKX8,ERCC6L,DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15),KARRIVSDGEDED,_RIVS(ph)DGEDEDDSFK_,S905,+,,22.19,22.19,24.59,,,26.21,,22.63,22.95,22.86,24.21,,23.48, ,-1.29,-1.29,1.11, , ,2.73, ,-0.85,-0.53,-0.62,0.73, ,mitotic prometaphase;cell division,cytosol;condensed chromosome kinetochore,,,,,,,,,,,,,,
4348,Q2NKX8,ERCC6L,DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15),TPKNDISPPGRFF,_NDIS(ph)PPGR_,S946,,20.90,,,25.17,,,25.12,24.81,,,,23.80,,23.96,-3.06, , ,1.21, , ,1.16,0.85, , , ,-0.16, ,mitotic prometaphase;cell division,cytosol;condensed chromosome kinetochore,,,,,,,,,,,,,,
4350,Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),ILVRRSSSPAELD,_RSS(ph)S(ph)PAELDLK_,S820,+,27.92,25.52,26.27,23.00,,,22.34,,22.79,25.03,23.70,,,24.57,3.35,0.95,1.70,-1.57, , ,-2.23, ,-1.78,0.46,-0.87, , ,activation of Ral GTPase activity,cytosol;nucleus,,,,,,,,,,,,,,
4351,Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),LVRRSSSPAELDL,_RSS(ph)S(ph)PAELDLK_,S821,,27.71,25.65,25.65,23.00,,,,,,23.16,,,,25.04,2.68,0.62,0.62,-2.04, , , , , ,-1.87, , , ,activation of Ral GTPase activity,cytosol;nucleus,,,,,,,,,,,,,,
4352,Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),TVGRSFSLSWRSH,_SFS(ph)LSWR_,S696,+,25.13,22.16,22.16,19.53,22.56,21.43,20.93,,20.56,22.47,21.53,21.40,,21.81,3.32,0.35,0.35,-2.27,0.75,-0.37,-0.87, ,-1.24,0.66,-0.28,-0.40, ,activation of Ral GTPase activity,cytosol;nucleus,,,,,,,,,,,,,,
4353,Q2PPJ7,RALGAPA2,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),SWGRTYSFTSAMS,_TYS(ph)FTSAM(ox)SR_,S486,,26.51,25.20,25.20,,24.06,22.45,,,,,,,,24.69,1.82,0.52,0.52, ,-0.62,-2.23, , , , , , , ,activation of Ral GTPase activity,cytosol;nucleus,,,,,,,,,,,,,,
4354,Q2TAC2,CCDC57,Coiled-coil domain-containing protein 57,ELERVHSDKNGEI,_LELERVHS(ph)DK_,S136,,,,,,,,23.54,24.98,21.83,21.42,23.91,,,23.14, , , , , , ,0.40,1.84,-1.31,-1.72,0.78, , ,,,,,,,,,,,,,,,,
4356,Q2TBE0,CWF19L2,CWF19-like protein 2,KSTFAGSPERESI,_STFAGS(ph)PERESIHILSVDEK_,S360,+,,,,,25.17,25.38,24.16,24.60,24.88,,24.27,24.15,25.20,24.73, , , , ,0.44,0.65,-0.56,-0.13,0.15, ,-0.45,-0.58,0.47,metabolic process,,,,,,,,,,,,,,,
4358,Q2V2M9,FHOD3,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),LGRGSISPDAEPN,_GSIS(ph)PDAEPNDKVPETAPVQPK_,S541,,,,,,24.80,24.72,23.85,24.97,23.96,22.45,24.81,,24.78,24.29, , , , ,0.51,0.43,-0.44,0.67,-0.33,-1.84,0.52, ,0.49,sarcomere organization;negative regulation of actin filament polymerization,Z disc;nucleolus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4359,Q2VPK5,CTU2,Cytoplasmic tRNA 2-thiolation protein 2,RLSQMQSPIPLTE,_LSQM(ox)QS(ph)PIPLTETR_,S332,,21.11,,,,,,23.11,22.94,22.90,,,,,22.51,-1.40, , , , , ,0.60,0.42,0.38, , , , ,tRNA thio-modification;tRNA wobble uridine modification,mitochondrion;protein complex,,,,,,,,,,,,,,
4360,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),VRKALDSNSLEND,_ALDS(ph)NSLENDDLSAPGREPGHFNPESR_,S742,+,,23.97,23.97,,25.30,23.03,25.57,26.55,23.50,25.18,26.73,23.46,24.63,24.72, ,-0.75,-0.75, ,0.58,-1.68,0.85,1.83,-1.21,0.46,2.01,-1.26,-0.09,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4361,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),KALDSNSLENDDL,_ALDSNS(ph)LENDDLSAPGREPGHFNPESR_,S744,+,,24.71,24.71,,26.51,26.20,26.54,27.35,25.04,24.84,27.22,25.69,25.28,25.83, ,-1.12,-1.12, ,0.68,0.37,0.72,1.52,-0.79,-0.98,1.39,-0.13,-0.55,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4363,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),DGATQSSPAEPKS,_IDGATQSS(ph)PAEPKSEDADR_,S690,+,24.55,25.47,26.07,26.10,26.75,23.98,26.17,26.76,23.08,24.47,,25.06,22.89,25.11,-0.56,0.36,0.96,0.98,1.64,-1.13,1.06,1.65,-2.04,-0.64, ,-0.06,-2.22,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4366,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),RRNTSASDEDERM,_NTSAS(ph)DEDERM(ox)SVGSR_,S68,,22.99,21.83,22.19,23.89,23.46,20.70,22.10,24.11,20.50,22.85,23.48,22.91,22.08,22.54,0.45,-0.72,-0.35,1.34,0.91,-1.85,-0.44,1.56,-2.05,0.31,0.94,0.37,-0.47,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4367,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),TSSRRGSGDTSIS,_RGS(ph)GDTSISIDTEASIR_,S120,+,18.35,20.13,20.13,19.39,22.68,20.03,21.66,25.08,22.37,21.32,23.56,18.96,23.17,21.30,-2.94,-1.16,-1.16,-1.91,1.39,-1.27,0.37,3.78,1.08,0.03,2.27,-2.34,1.88,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4369,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),KSTDRKSAVEAQN,_S(ph)AVEAQNEVTENPK_,S594,,,23.74,23.74,23.25,,,24.15,,,,,,,23.72, ,0.02,0.02,-0.47, , ,0.43, , , , , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4370,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),EPDEEKSDQQGEA,_S(ph)DQQGEALDSSQKK_,S531,,,25.16,26.04,,,,,,,,,,,25.60, ,-0.44,0.44, , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4371,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),GTLGRASEVEVKN,_STGDGTLGRAS(ph)EVEVK_,S276,,22.20,,,,22.30,23.01,,,,22.28,23.80,,23.21,22.80,-0.60, , , ,-0.50,0.21, , , ,-0.52,1.00, ,0.41,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4372,Q32MZ4,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),KTEVPGSPAGTEG,_TEVPGS(ph)PAGTEGNCQEATGPSTVDTQNEPLDM(ox)KEPDEEK_,S497,,,22.50,22.50,,,,24.63,,,24.33,23.76,24.21,,23.66, ,-1.15,-1.15, , , ,0.97, , ,0.68,0.10,0.55, ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent",nucleus;cytoskeleton;cytoplasm,DNA binding region,,,,,,,,,,,,,
4373,Q32P44,EML3,Echinoderm microtubule-associated protein-like 3 (EMAP-3),LSRKAISSANLLV,_AIS(ph)SANLLVR_,S176,+,25.42,26.50,26.44,26.87,24.59,,27.42,26.20,,,,,,26.21,-0.79,0.30,0.23,0.67,-1.62, ,1.22,0.00, , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
4374,Q32P44,EML3,Echinoderm microtubule-associated protein-like 3 (EMAP-3),DTPRRNSSSSSSP,_RNS(ph)SSSSSPSERPR_,S156,,19.01,22.45,20.65,21.67,,,,,,,,,,20.94,-1.94,1.51,-0.29,0.72, , , , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
4375,Q3B726,TWISTNB,DNA-directed RNA polymerase I subunit RPA43 (Twist neighbor protein),KKKRKHSEEAEFT,_KHS(ph)EEAEFTPPLK_,S316,,,,,,23.94,23.32,22.23,,22.30,,22.24,,23.18,22.87, , , , ,1.07,0.46,-0.64, ,-0.57, ,-0.63, ,0.31,"transcription, DNA-dependent",microtubule cytoskeleton;nucleolus,,,,,,,,,,,,,,
4376,Q3KP66,C1orf106,Uncharacterized protein C1orf106,VCVLRRSPDGAPV,_S(ph)PDGAPVQVFVPEK_,S200,,22.32,,,,,,,,,23.40,,,,22.86,-0.54, , , , , , , , ,0.54, , , ,,,,,,,,,,,,,,,,
4379,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),ESAAPASPAPSPA,_ESAAPAS(ph)PAPSPAPSPTPAPPQK_,S512,+,27.16,26.18,26.51,25.98,21.90,25.56,26.54,26.13,26.13,25.71,26.58,25.82,26.78,25.92,1.24,0.26,0.59,0.06,-4.03,-0.36,0.62,0.21,0.21,-0.21,0.66,-0.10,0.86,,spindle;cytoplasm,,,,,,,,,,,,,,
4380,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),PASPAPSPAPSPT,_ESAAPAS(ph)PAPS(ph)PAPS(ph)PTPAPPQK_,S516,,26.23,,,,,,,,,,,,,26.23,0.00, , , , , , , , , , , , ,,spindle;cytoplasm,,,,,,,,,,,,,,
4382,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),STASELSPKSKAR,_LSASTASELS(ph)PK_,S428,+,25.70,26.15,26.15,26.10,25.87,24.16,26.51,26.49,25.07,24.44,25.40,25.17,24.94,25.55,0.15,0.60,0.60,0.55,0.32,-1.39,0.96,0.94,-0.48,-1.11,-0.15,-0.38,-0.61,,spindle;cytoplasm,,,,,,,,,,,,,,
4383,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),APPQEESPSSEAK,_QLPLEPESPSGQVGPRPAPPQEES(ph)PSSEAK_,S86,+,20.21,,,24.91,27.52,24.89,27.14,27.60,,,,26.03,,25.47,-5.26, , ,-0.56,2.05,-0.58,1.67,2.13, , , ,0.56, ,,spindle;cytoplasm,,,,,,,,,,,,,,
4384,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),LPLEPESPSGQVG,_QLPLEPES(ph)PSGQVGPRPAPPQEESPSSEAK_,S70,+,25.99,25.25,25.25,23.17,26.05,,25.83,26.07,25.65,24.76,27.57,23.09,25.78,25.37,0.62,-0.12,-0.12,-2.20,0.68, ,0.45,0.70,0.28,-0.61,2.20,-2.28,0.41,,spindle;cytoplasm,,,,,,,,,,,,,,
4387,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),RPPRRSSQPSPTA,_RSS(ph)QPS(ph)PTAVPASDSPPTK_,S113,+,26.71,26.51,25.50,27.02,23.90,25.96,25.64,25.32,23.13,24.82,28.61,24.95,27.01,25.77,0.94,0.74,-0.27,1.24,-1.88,0.18,-0.13,-0.45,-2.65,-0.96,2.84,-0.83,1.23,,spindle;cytoplasm,,,,,,,,,,,,,,
4388,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),RRSSQPSPTAVPA,_RSS(ph)QPS(ph)PTAVPASDSPPTK_,S116,,25.94,26.16,,25.63,,,,,,,,,,25.91,0.03,0.25, ,-0.28, , , , , , , , , ,,spindle;cytoplasm,,,,,,,,,,,,,,
4389,Q3KQU3,MAP7D1,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),VCPRSASASPLTP,_SAS(ph)ASPLTPCSVTR_,S334,,21.93,,,22.08,,,,,,,,,,22.01,-0.07, , ,0.07, , , , , , , , , ,,spindle;cytoplasm,,,,,,,,,,,,,,
4393,Q3L8U1,CHD9,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),DELAELSEAESEG,_DELAELS(ph)EAES(ph)EGDEKPK_,S1468,,22.67,,,,,,,,,23.69,,,,23.18,-0.51, , , , , , , , ,0.51, , , ,"small molecule metabolic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification;cellular lipid metabolic process",nucleoplasm;cytoplasm,Other TF domain,,,,,,,,,,,,,
4394,Q3L8U1,CHD9,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),ELSEAESEGDEKP,_DELAELS(ph)EAES(ph)EGDEKPK_,S1472,,22.67,,,,,,23.52,,24.72,24.30,,,,23.80,-1.13, , , , , ,-0.28, ,0.92,0.50, , , ,"small molecule metabolic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification;cellular lipid metabolic process",nucleoplasm;cytoplasm,Other TF domain,,,,,,,,,,,,,
4395,Q3L8U1,CHD9,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),IKSEPVSPKNGVL,_TLIKSEPVS(ph)PK_,S2079,,,,,,22.85,,,21.75,,,,,,22.30, , , , ,0.55, , ,-0.55, , , , , ,"small molecule metabolic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification;cellular lipid metabolic process",nucleoplasm;cytoplasm,Other TF domain,,,,,,,,,,,,,
4396,Q3L8U1,CHD9,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),NIPRVMSPENFPT,_VM(ox)S(ph)PENFPTASVEGK_,S550,+,23.09,23.05,22.74,24.71,25.09,24.46,25.90,24.21,25.92,24.32,,,24.22,24.34,-1.25,-1.28,-1.60,0.38,0.75,0.12,1.56,-0.13,1.59,-0.01, , ,-0.12,"small molecule metabolic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification;cellular lipid metabolic process",nucleoplasm;cytoplasm,Other TF domain,,,,,,,,,,,,,
4397,Q3MII6,TBC1D25,TBC1 domain family member 25,RLLRQASLDGLQQ,_(gl)QAS(ph)LDGLQQLR_,S173,+,24.00,22.07,,22.97,22.17,,22.78,22.69,21.16,,21.43,23.01,,22.48,1.53,-0.41, ,0.49,-0.31, ,0.31,0.21,-1.32, ,-1.04,0.54, ,regulation of autophagic vacuole maturation;autophagy,cytoplasmic vesicle;autophagic vacuole,,,,,,,,,,,,,,
4398,Q3SY84,KRT71,"Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34)",DRVRLDSELRNVR,_LDS(ph)ELR_,SNaN,,22.21,25.21,25.21,,,,,,,,,,,24.21,-2.00,1.00,1.00, , , , , , , , , , ,hair follicle morphogenesis,keratin filament,,,,,,,,,,,,,,
4400,Q9H869,YY1AP1,YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein) (Hepatocellular carcinoma-associated protein 2),LEPQELSPLSATV,_LEPQELS(ph)PLSATVFPK_,S382,,24.09,,,,,,,,,,,,,24.09,0.00, , , , , , , , , , , , ,"regulation of cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4405,Q3V6T2,CCDC88A,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),VQIKSSSQENLLD,_SSS(ph)QENLLDEVM(ox)K_,S1619,+,,,,24.72,23.83,24.36,23.53,24.31,25.09,22.87,23.47,,24.30,24.05, , , ,0.66,-0.22,0.31,-0.52,0.26,1.03,-1.19,-0.58, ,0.25,lamellipodium assembly;regulation of actin cytoskeleton organization;regulation of neuron projection development;cell migration;regulation of DNA replication;regulation of cell proliferation;activation of protein kinase B activity;TOR signaling cascade;cellular membrane organization;microtubule cytoskeleton organization;DNA replication,cytosol;cytoplasmic vesicle;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lamellipodium,,,,,,,,,,,,,,
4407,Q3YBR2,TBRG1,Transforming growth factor beta regulator 1 (Nuclear interactor of ARF and Mdm2),LDGLASSPRAPLQ,_(ac)SLLDGLASS(ph)PR_,S10,,20.83,,,,,,,,,,,,22.61,21.72,-0.89, , , , , , , , , , , ,0.89,negative regulation of cell proliferation;protein stabilization;nucleolus to nucleoplasm transport;cell cycle arrest;DNA replication,nucleus,,,,,,,,,,,,,,
4408,Q3YEC7,RABL6,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),PVRDDPSDVTDED,_RADDFPVRDDPS(ph)DVT(ph)DEDEGPAEPPPPPK_,S596,,24.03,,,,,,,,,24.82,,,,24.43,-0.40, , , , , , , , ,0.40, , , ,small GTPase mediated signal transduction,nucleus;centrosome,,,,,,,,,,,,,,
4411,Q3ZCW2,LGALSL,Galectin-related protein (Lectin galactoside-binding-like protein),LNNSLSSPVQADV,_LDDGHLNNSLSS(ph)PVQADVYFPR_,S25,,23.93,,,,,,,,,,,,,23.93,0.00, , , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
4412,Q460N5,PARP14,Poly [ADP-ribose] polymerase 14 (PARP-14) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2),VMSKLASFLGFSK,_LAS(ph)FLGFSK_,S1322,,22.71,,,,,,,,,,,,,22.71,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
4413,Q494U1,PLEKHN1,Pleckstrin homology domain-containing family N member 1 (PH domain-containing family N member 1),SSAREGSPEPWLP,_EGS(ph)PEPWLPLTDGR_,S124,,23.98,,,,23.63,,,22.84,,,,,,23.49,0.50, , , ,0.15, , ,-0.65, , , , , ,,,,,,,,,,,,,,,,
4414,Q49A26,GLYR1,Putative oxidoreductase GLYR1 (EC 1.-.-.-) (3-hydroxyisobutyrate dehydrogenase-like protein) (Cytokine-like nuclear factor N-PAC) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Nuclear protein of 60 kDa),DEKRKLSLSEGKV,_KLS(ph)LSEGK_,S130,,23.73,22.92,,21.87,21.59,,,,,,,,,22.53,1.20,0.39, ,-0.66,-0.94, , , , , , , , ,pentose-phosphate shunt,nucleus,,,,,,,,,,,,,,
4415,Q49MG5,MAP9,Microtubule-associated protein 9 (Aster-associated protein),MNDFHISDDEEKN,_M(ox)NDFHIS(ph)DDEEK_,S7,+,23.15,23.66,23.69,,,,23.98,,23.89,23.32,23.02,,,23.53,-0.38,0.13,0.16, , , ,0.45, ,0.36,-0.21,-0.51, , ,mitosis;cell division,Golgi apparatus;nucleus;microtubule;spindle,,,,,,,,,,,,,,
4418,Q4ADV7,KIAA1432,Protein RIC1 homolog (Connexin-43-interacting protein of 150 kDa),FRNRSISLSQSAE,_SIS(ph)LSQSAENVPASK_,S1017,,21.37,23.87,23.87,24.11,,,,,23.25,,,23.15,,23.27,-1.90,0.60,0.60,0.84, , , , ,-0.02, , ,-0.12, ,,integral to membrane,,,,,,,,,,,,,,
4419,Q4G0A6,FAM188B,Protein FAM188B,KIDKLHSEPSLDV,_IDKLHS(ph)EPSLDVK_,S187,,,,,,,,,,22.36,,22.91,,24.58,23.28, , , , , , , , ,-0.92, ,-0.37, ,1.29,,,,,,,,,,,,,,,,
4420,Q4G0F5,VPS26B,Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B),RFEGTTSLGEVRT,_FEGTTS(ph)LGEVR_,S318,,22.90,,,22.70,,,,,,,,,,22.80,0.10, , ,-0.10, , , , , , , , , ,vacuolar transport;protein transport,cytosol;retromer complex,,,,,,,,,,,,,,
4421,Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),NRDIEISTEEEKD,_ENRDIEIS(ph)T(ph)EEEK_,S337,+,27.24,26.08,26.76,25.24,24.43,23.90,26.46,,26.65,26.70,24.72,,23.30,25.59,1.65,0.49,1.18,-0.35,-1.16,-1.68,0.87, ,1.06,1.11,-0.87, ,-2.29,RNA processing,nucleoplasm;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
4424,Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),KRKRSSSEDAESL,_S(ph)SS(ph)EDAESLAPR_,S300,+,27.24,,,,23.13,24.17,24.64,23.15,25.15,25.88,,,,24.77,2.47, , , ,-1.64,-0.59,-0.13,-1.62,0.39,1.11, , , ,RNA processing,nucleoplasm;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
4425,Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),KRSRPTSEGSDIE,_SRPTS(ph)EGS(ph)DIESTEPQK_,S258,+,27.49,24.30,23.90,25.44,,23.91,,23.46,24.97,24.39,,,22.30,24.46,3.02,-0.16,-0.57,0.98, ,-0.55, ,-1.01,0.51,-0.07, , ,-2.16,RNA processing,nucleoplasm;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
4426,Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),RPTSEGSDIESTE,_SRPTS(ph)EGS(ph)DIESTEPQK_,S261,+,27.97,27.89,28.62,26.46,26.44,26.71,27.32,27.53,27.76,27.46,26.04,26.51,26.08,27.14,0.83,0.75,1.48,-0.68,-0.70,-0.42,0.19,0.39,0.62,0.33,-1.10,-0.63,-1.06,RNA processing,nucleoplasm;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
4428,Q4KMP7,TBC1D10B,TBC1 domain family member 10B (Rab27A-GAP-beta),AAGGAPSPPPPVR,_AAGGAPS(ph)PPPPVR_,S678,+,23.86,24.93,22.90,26.02,24.98,24.87,24.57,25.07,24.50,23.14,25.09,24.32,25.13,24.57,-0.71,0.37,-1.67,1.45,0.41,0.30,0.00,0.50,-0.06,-1.43,0.52,-0.24,0.56,,cytoplasm,,,,,,,,,,,,,,
4429,Q4KMP7,TBC1D10B,TBC1 domain family member 10B (Rab27A-GAP-beta),LHPSLPSPTGNST,_ASAGPAPGPVVTAEGLHPSLPS(ph)PTGNSTPLGSSK_,S707,,22.07,,,,,,23.69,23.52,,24.30,,,23.94,23.50,-1.44, , , , , ,0.19,0.02, ,0.80, , ,0.44,,cytoplasm,,,,,,,,,,,,,,
4430,Q4KMQ1,TPRN,Taperin,GDLGPASPSQELG,_GDLGPAS(ph)PSQELGSQPVPGGDGAPALGK_,S160,,24.45,25.05,25.05,,,,,,,25.48,24.26,,,24.86,-0.41,0.19,0.19, , , , , , ,0.62,-0.60, , ,sensory perception of sound,stereocilium,,,,,,,,,,,,,,
4432,Q4KMQ1,TPRN,Taperin,SLHPPPSPGTPSA,_VESGDPSLHPPPS(ph)PGTPSATPAS(ph)PPASATPSQR_,S62,,23.25,,,,,,,,,,,,,23.25,0.00, , , , , , , , , , , , ,sensory perception of sound,stereocilium,,,,,,,,,,,,,,
4433,Q4KMQ1,TPRN,Taperin,PSATPASPPASAT,_VESGDPSLHPPPSPGTPSATPAS(ph)PPASATPSQR_,S72,,23.84,,,,,,,,,24.46,23.32,,,23.88,-0.04, , , , , , , , ,0.59,-0.55, , ,sensory perception of sound,stereocilium,,,,,,,,,,,,,,
4435,Q4KMQ2,ANO6,Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F),NNLRPKSE_____,_M(ox)IEAVDNNLRPKS(ph)E_,S930,,,,,,,24.03,,,,,22.57,,25.16,23.92, , , , , ,0.11, , , , ,-1.35, ,1.24,phosphatidylserine exposure on blood platelet;blood coagulation;activation of blood coagulation via clotting cascade,plasma membrane;intracellular;chloride channel complex,,,,,,,,,,,,,,
4436,Q4L180,FILIP1L,Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1),LNGRRISDPQVFS,_RIS(ph)DPQVFSK_,S551,,,,,27.05,25.69,26.54,,25.13,26.89,24.06,24.60,28.49,26.17,26.07, , , ,0.98,-0.38,0.47, ,-0.94,0.82,-2.01,-1.47,2.43,0.10,,nucleus;myosin complex;membrane;cytoplasm,,,,,,,,,,,,,,
4437,Q4L180,FILIP1L,Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1),QFQRSNSNSSSVI,_SNS(ph)NSSSVITTEDNK_,S809,,,22.95,22.95,26.64,,,,,,,,23.86,,24.10, ,-1.15,-1.15,2.54, , , , , , , ,-0.24, ,,nucleus;myosin complex;membrane;cytoplasm,,,,,,,,,,,,,,
4438,Q4LE39,ARID4B,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1),KDIEVLSEDTDYE,_DIEVLS(ph)EDT(ph)DYEEDEVTK_,S790,,24.62,,,,,,,,,,,,,24.62,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
4439,Q4LE39,ARID4B,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1),KEKEDNSSEEEEE,_EKEDNS(ph)S(ph)EEEEEIEPFPEER_,S295,,23.23,,,,,,,,,,,,,23.23,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
4440,Q4LE39,ARID4B,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1),EKEDNSSEEEEEI,_EKEDNS(ph)S(ph)EEEEEIEPFPEER_,S296,,23.23,,,,,,,,,,,,,23.23,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
4441,Q4V328,GRIPAP1,GRIP1-associated protein 1 (GRASP-1),ARSLSSSPQAQPP,_SLSSS(ph)PQAQPPRPAELSDEEVAELFQR_,S661,+,,25.72,,,25.96,25.02,26.53,26.63,,25.01,,,26.70,25.94, ,-0.22, , ,0.02,-0.91,0.59,0.69, ,-0.93, , ,0.76,,early endosome,,,,,,,,,,,,,,
4445,Q4VCS5,AMOT,Angiomotin,TTVISHSPNTSYD,_DTTVISHS(ph)PNTSYDTALEAR_,S714,,22.73,,,,23.63,24.21,,,,,,,,23.52,-0.79, , , ,0.11,0.68, , , , , , , ,negative regulation of angiogenesis;hippo signaling cascade;blood vessel endothelial cell migration;negative regulation of GTPase activity;cell migration involved in gastrulation;actin cytoskeleton organization;chemotaxis;positive regulation of cell size;positive regulation of blood vessel endothelial cell migration;regulation of small GTPase mediated signal transduction;regulation of cell migration;vasculogenesis;cell-cell junction assembly;positive regulation of stress fiber assembly;cellular protein localization;gastrulation with mouth forming second;in utero embryonic development;positive regulation of embryonic development;establishment of cell polarity involved in ameboidal cell migration;negative regulation of vascular permeability,endocytic vesicle;external side of plasma membrane;cytoplasm;tight junction;cytosol;actin filament;stress fiber;integral to membrane;lamellipodium;cell surface;ruffle,,,,,,,,,,,,,,
4447,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),IFERATSFEESER,_ATS(ph)FEESERK_,S949,+,26.84,26.53,26.24,26.22,26.73,24.21,27.38,27.33,26.09,25.34,25.67,25.89,24.33,26.06,0.78,0.47,0.18,0.16,0.66,-1.85,1.32,1.27,0.03,-0.72,-0.39,-0.17,-1.73,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4449,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),TKIRPVSLPVDRL,_IRPVS(ph)LPVDR_,S1019,+,21.88,,,,22.54,,22.83,22.32,23.90,22.29,22.22,,22.79,22.60,-0.72, , , ,-0.05, ,0.24,-0.28,1.31,-0.31,-0.38, ,0.19,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4450,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),DRLLLASPPNERN,_LLLAS(ph)PPNER_,S1029,+,24.74,,,,25.46,23.63,26.34,26.19,25.03,24.64,25.86,23.48,25.05,25.04,-0.30, , , ,0.41,-1.41,1.30,1.14,-0.01,-0.40,0.82,-1.56,0.01,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4451,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),FPKPLLSPEERDI,_PLLS(ph)PEERDIER_,S913,+,26.94,25.06,25.72,25.18,,,28.70,,27.34,28.98,28.93,26.28,25.74,26.89,0.06,-1.83,-1.16,-1.71, , ,1.81, ,0.45,2.09,2.04,-0.61,-1.15,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4454,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),LDSESISPGDFHR,_SLDSESIS(ph)PGDFHR_,S559,+,23.82,,,,24.11,22.73,25.78,24.02,23.68,23.35,22.59,,24.03,23.79,0.03, , , ,0.32,-1.06,1.99,0.23,-0.11,-0.44,-1.20, ,0.24,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4456,Q52LW3,ARHGAP29,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),KSLFFSSKEDIHT,_SLFFSS(ph)K_,S930,,22.54,,,21.22,,,24.92,23.65,24.56,,,,22.36,23.21,-0.67, , ,-1.98, , ,1.71,0.45,1.35, , , ,-0.85,Rho protein signal transduction,cytosol,,,,,,,,,,,,,,
4457,Q53EL6,PDCD4,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),DSGRGDSVSDSGS,_DSGRGDS(ph)VSDSGSDALR_,S62,,25.92,23.42,,24.61,,22.06,,21.30,,,,,,23.46,2.46,-0.05, ,1.15, ,-1.40, ,-2.16, , , , , ,"apoptotic process;negative regulation of transcription, DNA-dependent;negative regulation of JUN kinase activity;negative regulation of cell cycle;cell aging",cytosol;nucleus,,,,,,,,,,,,,,
4459,Q53EL6,PDCD4,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),GLTVPTSPKGRLL,_SGLTVPTS(ph)PK_,S80,+,27.69,26.30,24.19,27.97,25.32,27.74,25.91,25.75,26.45,23.10,26.71,25.35,25.04,25.96,1.73,0.33,-1.77,2.01,-0.64,1.77,-0.06,-0.21,0.49,-2.87,0.75,-0.61,-0.92,"apoptotic process;negative regulation of transcription, DNA-dependent;negative regulation of JUN kinase activity;negative regulation of cell cycle;cell aging",cytosol;nucleus,,,,,,,,,,,,,,
4463,Q53EP0,FNDC3B,Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37),RQNRLNSPPSSIY,_LNS(ph)PPSSIYK_,S208,+,26.39,25.96,24.50,28.19,27.43,28.09,26.98,26.75,27.30,26.60,26.53,26.59,27.36,26.82,-0.43,-0.86,-2.32,1.37,0.61,1.27,0.15,-0.07,0.48,-0.22,-0.29,-0.23,0.54,positive regulation of fat cell differentiation,integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
4465,Q53ET0,CRTC2,CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2) (TORC-2) (Transducer of CREB protein 2),QLPKQFSPTMSPT,_(gl)QFS(ph)PT(ph)M(ox)SPTLSSITQGVPLDTSK_,S136,,23.35,,,22.56,,,,,,,,,,22.96,0.40, , ,-0.40, , , , , , , , , ,"protein homotetramerization;glucose homeostasis;gluconeogenesis;transcription, DNA-dependent;positive regulation of CREB transcription factor activity;virus-host interaction",nucleus;cytoplasm,,,,,,,,,,,,,,
4467,Q53GA4,PHLDA2,Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C) (p17-BWR1C),LSLFPASPRARPK,_LSLFPAS(ph)PR_,S42,,22.18,,,,21.94,,,22.40,,21.15,,,,21.92,0.26, , , ,0.03, , ,0.48, ,-0.77, , , ,apoptotic process;organ morphogenesis,membrane;cytoplasm,,,,,,,,,,,,,,
4468,Q53GA4,PHLDA2,Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C) (p17-BWR1C),SEPSRPSPQPKPR,_TAPAAPAEDAVAAAAAAPSEPSEPSRPS(ph)PQPK_,S144,,,,,,,,24.67,,24.69,24.13,,,,24.49, , , , , , ,0.18, ,0.19,-0.37, , , ,apoptotic process;organ morphogenesis,membrane;cytoplasm,,,,,,,,,,,,,,
4469,Q53GS7,GLE1,Nucleoporin GLE1 (hGLE1) (GLE1-like protein),PSFVPKSPDASSA,_S(ph)PDASSAFSPASPATPNGTK_,S88,+,22.48,22.67,22.45,22.82,,,23.95,21.88,,23.98,,,,22.89,-0.41,-0.22,-0.44,-0.07, , ,1.06,-1.01, ,1.09, , , ,poly(A)+ mRNA export from nucleus;mRNA export from nucleus;protein transport,nuclear pore;cytoplasm,,,,,,,,,,,,,,
4472,Q53H47,SETMAR,Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion gene-containing protein) (HsMar1) (Metnase) [Includes: Histone-lysine N-methyltransferase (EC 2.1.1.43);Mariner transposase Hsmar1 (EC 3.1.-.-)],YDNRRRSAQWLDQ,_S(ph)AQWLDQEEAPK_,S252,,21.61,,,,,,,,,,,,,21.61,0.00, , , , , , , , , , , , ,"negative regulation of cell cycle arrest;positive regulation of double-strand break repair via nonhomologous end joining;DNA double-strand break processing;DNA catabolic process, endonucleolytic;DNA integration;transposition, DNA-mediated;negative regulation of chromosome organization",chromosome;nucleus,,,,,,,,,,,,,,
4473,Q53H80,AKIRIN2,Akirin-2,PLLSPASPKRRRC,_TLDFDPLLSPAS(ph)PK_,S21,,21.38,,,,,,,,,,,,,21.38,0.00, , , , , , , , , , , , ,"positive regulation of interleukin-6 production;negative regulation of transcription, DNA-dependent;embryo development;innate immune response;positive regulation of cell proliferation;transcription, DNA-dependent;response to lipopolysaccharide;positive regulation of transcription from RNA polymerase II promoter",transcriptional repressor complex,,,,,,,,,,,,,,
4474,Q53HL2,CDCA8,Borealin (Cell division cycle-associated protein 8) (Dasra-B) (hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein),NISGNGSPLADSK,_IYNISGNGS(ph)PLADSK_,S219,+,23.10,24.11,24.11,23.91,22.75,24.94,25.25,24.19,24.42,25.16,21.94,23.94,24.64,24.03,-0.94,0.07,0.07,-0.13,-1.28,0.90,1.22,0.15,0.38,1.12,-2.10,-0.09,0.61,mitotic prometaphase;chromosome organization;mitotic metaphase;cell division,"cytosol;chromosome, centromeric region;chromosome passenger complex;nucleolus;half bridge of spindle pole body",,,,,,,,,,,,,,
4476,Q53LP3,SOWAHC,Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C),DLVMGSSPQLKRS,_DLVM(ox)GSS(ph)PQLK_,S213,+,26.60,23.85,24.57,23.67,23.95,24.19,24.30,25.91,24.98,24.54,23.58,,22.97,24.43,2.17,-0.57,0.14,-0.76,-0.48,-0.23,-0.12,1.49,0.55,0.11,-0.85, ,-1.46,,,,,,,,,,,,,,,,
4477,Q53QV2,LBH,Protein LBH (hLBH),LKDRLPSIVVEPT,_DRLPS(ph)IVVEPTEGEVESGELR_,S46,,24.38,,,,,,,,,,,22.75,,23.57,0.82, , , , , , , , , , ,-0.82, ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent",nucleolus;cytoplasm,,,,,,,,,,,,,,
4478,Q53SF7,COBLL1,Cordon-bleu protein-like 1,KRDQTASAPATPL,_DQTAS(ph)APAT(ph)PLVNK_,S256,,26.35,23.75,,22.94,24.33,,24.28,25.49,23.05,22.01,23.56,22.40,23.35,23.77,2.58,-0.02, ,-0.83,0.56, ,0.51,1.72,-0.73,-1.77,-0.21,-1.38,-0.42,,,,,,,,,,,,,,,,
4479,Q53SF7,COBLL1,Cordon-bleu protein-like 1,ERDMLPSPEQTLS,_EAERDM(ox)LPS(ph)PEQTLSPLSK_,S911,,,,,,,,24.39,24.28,23.94,26.07,,24.85,24.55,24.68, , , , , , ,-0.29,-0.40,-0.74,1.39, ,0.17,-0.13,,,,,,,,,,,,,,,,
4480,Q53SF7,COBLL1,Cordon-bleu protein-like 1,SPEQTLSPLSKMP,_EAERDM(ox)LPSPEQTLS(ph)PLSK_,S917,,22.52,22.87,22.87,21.76,,,24.16,23.43,24.72,25.56,25.52,22.89,25.06,23.76,-1.24,-0.89,-0.89,-2.01, , ,0.40,-0.33,0.96,1.80,1.76,-0.87,1.30,,,,,,,,,,,,,,,,
4481,Q53SF7,COBLL1,Cordon-bleu protein-like 1,DSAISESPEEPLP,_ETAIQTEDSAISES(ph)PEEPLPNLKPK_,S788,,,,,,,,,,,25.99,24.23,24.04,,24.75, , , , , , , , , ,1.24,-0.52,-0.72, ,,,,,,,,,,,,,,,,
4483,Q53SF7,COBLL1,Cordon-bleu protein-like 1,TVMRQSSLTFQSS,_QSS(ph)LTFQSSDPEQM(ox)R_,S1070,,25.53,23.73,,25.01,,,,23.59,,22.81,24.55,23.84,,24.15,1.38,-0.42, ,0.86, , , ,-0.56, ,-1.34,0.40,-0.31, ,,,,,,,,,,,,,,,,
4484,Q53SF7,COBLL1,Cordon-bleu protein-like 1,QAPAEASPPPIAP,_TDDDVIGQAPAEAS(ph)PPPIAPK_,S947,,24.34,22.90,22.90,,,,24.70,,23.46,25.26,25.13,,,24.10,0.24,-1.20,-1.20, , , ,0.61, ,-0.64,1.16,1.04, , ,,,,,,,,,,,,,,,,
4485,Q53SF7,COBLL1,Cordon-bleu protein-like 1,VEAENISPKSQDI,_VEAENIS(ph)PK_,S438,,25.65,25.25,25.77,25.56,,,,,,23.93,,,,25.23,0.42,0.02,0.54,0.33, , , , , ,-1.30, , , ,,,,,,,,,,,,,,,,
4486,Q53T59,HS1BP3,HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3),GPGRKLSPQDPSE,_KLS(ph)PQDPSEDVSSVDPLK_,S249,+,24.83,25.06,24.49,24.97,,25.72,27.13,26.74,,,,,26.60,25.69,-0.87,-0.63,-1.21,-0.72, ,0.02,1.44,1.05, , , , ,0.91,cell communication,,,,,,,,,,,,,,,
4487,Q53TN4,CYBRD1,Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3),GNNMDKSDSELNS,_S(ph)DSELNSEVAAR_,S202,,,28.07,28.07,27.21,,25.97,,25.01,,,,21.66,24.44,25.77, ,2.29,2.29,1.43, ,0.20, ,-0.76, , , ,-4.11,-1.34,cellular iron ion homeostasis;electron transport chain;response to iron ion;transmembrane transport,integral to membrane;plasma membrane;brush border membrane,,,,,,,,,,,,,,
4488,Q53TN4,CYBRD1,Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3),NMDKSDSELNSEV,_SDS(ph)ELNSEVAAR_,S204,,26.33,,,26.23,,,,,,,,,,26.28,0.05, , ,-0.05, , , , , , , , , ,cellular iron ion homeostasis;electron transport chain;response to iron ion;transmembrane transport,integral to membrane;plasma membrane;brush border membrane,,,,,,,,,,,,,,
4489,Q53TN4,CYBRD1,Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3),DEAGQRSTM____,_NLALDEAGQRS(ph)TM(ox)_,S226,,23.27,25.41,26.32,25.89,29.14,29.84,27.52,29.36,27.32,24.30,27.78,21.43,28.81,26.64,-3.37,-1.23,-0.33,-0.75,2.49,3.19,0.88,2.71,0.67,-2.34,1.14,-5.21,2.16,cellular iron ion homeostasis;electron transport chain;response to iron ion;transmembrane transport,integral to membrane;plasma membrane;brush border membrane,,,,,,,,,,,,,,
4494,Q567U6,CCDC93,Coiled-coil domain-containing protein 93,ELSAEESPEKLGT,_(gl)QSELSAEES(ph)PEK_,S304,+,23.06,24.69,24.69,24.43,24.58,22.77,24.38,25.39,,,21.55,23.72,,23.93,-0.87,0.77,0.77,0.50,0.65,-1.15,0.45,1.47, , ,-2.37,-0.21, ,,,,,,,,,,,,,,,,
4495,Q58F21,BRDT,Bromodomain testis-specific protein (Cancer/testis antigen 9) (CT9) (RING3-like protein),EQLRHCSEILKEM,_VTEQLRHCS(ph)EILK_,S277,+,25.32,24.83,24.30,25.08,25.20,25.86,26.39,25.69,24.65,24.72,,28.24,25.75,25.50,-0.18,-0.67,-1.21,-0.42,-0.30,0.35,0.88,0.18,-0.85,-0.78, ,2.74,0.25,"cell differentiation;histone displacement;regulation of RNA splicing;spermatogenesis;male meiosis I;mRNA processing;RNA splicing;transcription, DNA-dependent;chromatin remodeling;positive regulation of transcription during meiosis",nucleus,,+,,,,,,,,,,,,
4496,Q58WW2,DCAF6,DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),GDRSEGSGQENEN,_ADRLEGDRSEGS(ph)GQENENEDEE_,S870,,,,,,,23.55,,,24.00,,,,,23.78, , , , , ,-0.22, , ,0.22, , , , ,protein ubiquitination;positive regulation of transcription from RNA polymerase II promoter,nucleus;Cul4-RING ubiquitin ligase complex,,,,,,,,,,,,,,
4497,Q58WW2,DCAF6,DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),ERDGEQSPNVSLM,_DGEQS(ph)PNVSLM(ox)QR_,S336,,24.34,23.24,,23.50,,22.39,,,22.12,,,,,23.12,1.22,0.12, ,0.38, ,-0.73, , ,-1.00, , , , ,protein ubiquitination;positive regulation of transcription from RNA polymerase II promoter,nucleus;Cul4-RING ubiquitin ligase complex,,,,,,,,,,,,,,
4499,Q5BKZ1,ZNF326,DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1),KISLSKSPTKTDP,_ISLSKS(ph)PTK_,S270,,21.95,23.56,23.56,23.35,,24.04,,,,,,,,23.29,-1.34,0.27,0.27,0.06, ,0.74, , , , , , , ,"regulation of DNA-dependent transcription, elongation;positive regulation of transcription, DNA-dependent;mRNA processing;RNA splicing;transcription, DNA-dependent",DBIRD complex;nuclear matrix,Other TF domain,,,,,,,,,,,,,
4500,Q5F1R6,DNAJC21,DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3),KEFGDGSDENEME,_EFGDGS(ph)DENEM(ox)EEHELK_,S283,+,24.85,26.16,26.81,24.95,,,26.48,,24.65,26.04,,26.02,,25.74,-0.90,0.41,1.07,-0.80, , ,0.73, ,-1.09,0.30, ,0.27, ,protein folding,ribosome,C2H2-type,,,,,,,,,,,,,
4501,Q5F1R6,DNAJC21,DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3),NPLDDNSEEEMED,_QQLEEEEENFSRPQIDENPLDDNS(ph)EEEM(ox)EDAPK_,S370,,23.83,,,,25.24,,,23.65,,23.96,,,,24.17,-0.34, , , ,1.07, , ,-0.52, ,-0.21, , , ,protein folding,ribosome,C2H2-type,,,,,,,,,,,,,
4502,Q5FBB7,SGOL1,Shugoshin-like 1 (hSgo1) (Serologically defined breast cancer antigen NY-BR-85),KDQVNLSPKLIQP,_DQVNLS(ph)PK_,S256,,23.16,24.79,24.79,24.22,22.50,,22.25,,22.16,,,,,23.41,-0.25,1.38,1.38,0.81,-0.91, ,-1.16, ,-1.25, , , , ,meiotic chromosome segregation;attachment of spindle microtubules to kinetochore;mitotic prometaphase;cell division;centriole-centriole cohesion,"centrosome;condensed nuclear chromosome, centromeric region;condensed chromosome kinetochore;cytosol;condensed chromosome, centromeric region;kinetochore;mitotic cohesin complex;spindle pole",,,,,,,,,,,,,,
4504,Q5H9L2,TCEAL5,Transcription elongation factor A protein-like 5 (TCEA-like protein 5) (Transcription elongation factor S-II protein-like 5),DRGTDDSPKDSQE,_GTDDS(ph)PKDSQEDLQER_,S121,+,25.22,26.64,23.30,26.41,25.83,26.09,24.27,25.88,24.57,23.53,24.33,,22.68,24.90,0.32,1.74,-1.60,1.51,0.94,1.19,-0.62,0.99,-0.33,-1.37,-0.57, ,-2.21,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
4506,Q5H9R7,PPP6R3,Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL),QFDDGGSDEEDIW,_ERIQQFDDGGS(ph)DEEDIWEEK_,S571,,21.90,,,,26.01,,,24.85,24.44,26.22,,,,24.68,-2.79, , , ,1.32, , ,0.17,-0.25,1.54, , , ,regulation of phosphoprotein phosphatase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
4510,Q5HYJ3,FAM76B,Protein FAM76B,HKISNLSPEEEQG,_ISNLS(ph)PEEEQGLWK_,S193,+,26.43,24.64,25.14,24.90,26.56,26.39,25.53,25.60,26.35,25.63,,,25.45,25.69,0.74,-1.05,-0.56,-0.79,0.87,0.70,-0.16,-0.10,0.65,-0.06, , ,-0.24,,nuclear speck,,,,,,,,,,,,,,
4511,Q5IJ48,CRB2,Protein crumbs homolog 2 (Crumbs-like protein 2),ARLEMDSVLKVPP,_LEM(ox)DS(ph)VLKVPPEER_,S1274,,,21.87,21.87,,,,25.57,22.73,,,24.37,24.93,25.56,23.84, ,-1.98,-1.98, , , ,1.73,-1.11, , ,0.53,1.09,1.71,,integral to membrane;extracellular region;plasma membrane,,,,,,,,,,,,,,
4513,Q5J8M3,EMC4,ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85),GRSDRGSGQGDSL,_SDRGS(ph)GQGDSLYPVGYLDK_,S36,+,,,,23.43,24.65,25.19,,24.54,25.23,25.29,24.32,23.91,,24.57, , , ,-1.14,0.08,0.62, ,-0.03,0.66,0.72,-0.25,-0.66, ,apoptotic process,ER membrane protein complex,,,,,,,,,,,,,,
4514,Q5JPE7,NOMO2,Nodal modulator 2 (pM5 protein 2),QAASDNSGPEDAK,_LQGVGALGQAASDNS(ph)GPEDAK_,S1205,,,,,21.85,,,,,23.35,24.74,,22.49,,23.11, , , ,-1.26, , , , ,0.24,1.64, ,-0.62, ,,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
4515,Q5JRA6,MIA3,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),SQALKQSP_____,_DLLPSGSRDEPPPASQSTSQDCSQALKQS(ph)P_,S1906,+,,,,,23.25,23.48,23.70,24.58,24.58,24.20,,,23.55,23.91, , , , ,-0.65,-0.43,-0.21,0.68,0.67,0.30, , ,-0.35,negative regulation of cell adhesion;negative regulation of cell migration;protein transport;exocytosis;wound healing;positive regulation of leukocyte migration,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
4517,Q5JRA6,MIA3,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),EPEGELSKEDHEN,_TSGLAGEPEGELS(ph)K_,S876,,28.30,27.80,27.80,24.50,,,,,,25.56,24.70,,,26.44,1.86,1.36,1.36,-1.94, , , , , ,-0.89,-1.75, , ,negative regulation of cell adhesion;negative regulation of cell migration;protein transport;exocytosis;wound healing;positive regulation of leukocyte migration,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
4518,Q5JRA6,MIA3,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),EEDDYPSEELLED,_VEEDDYPS(ph)EELLEDENAINAK_,S727,+,27.85,,,,24.60,25.00,,25.53,25.95,27.20,25.79,22.94,23.63,25.39,2.46, , , ,-0.79,-0.39, ,0.15,0.56,1.81,0.40,-2.45,-1.75,negative regulation of cell adhesion;negative regulation of cell migration;protein transport;exocytosis;wound healing;positive regulation of leukocyte migration,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
4521,Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),SDQATASPIVART,_ELSDQATAS(ph)PIVAR_,S96,+,25.40,23.86,23.15,24.46,23.89,24.14,24.85,24.66,23.39,,23.80,24.37,23.35,24.11,1.29,-0.25,-0.96,0.35,-0.22,0.03,0.74,0.55,-0.72, ,-0.31,0.26,-0.76,regulation of cell migration,cytosol;endosome membrane;Golgi apparatus;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4522,Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),SNDAAQSDDEEKL,_EYVSNDAAQS(ph)DDEEK_,S403,+,25.84,27.26,27.26,27.82,26.66,25.88,26.39,27.37,25.13,25.29,25.30,26.00,22.68,26.07,-0.23,1.20,1.20,1.75,0.59,-0.19,0.32,1.31,-0.94,-0.78,-0.76,-0.06,-3.39,regulation of cell migration,cytosol;endosome membrane;Golgi apparatus;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4526,Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),PPRKRKSELEFET,_RKS(ph)ELEFETLK_,S262,+,,23.55,23.50,22.21,,,24.83,21.74,23.74,22.37,24.18,25.24,,23.49, ,0.06,0.02,-1.27, , ,1.35,-1.75,0.25,-1.11,0.69,1.76, ,regulation of cell migration,cytosol;endosome membrane;Golgi apparatus;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4529,Q5JSH3,WDR44,WD repeat-containing protein 44 (Rabphilin-11),NTEGRVSPSPSQE,_VS(ph)PSPSQESLSSSK_,S561,+,22.37,25.30,25.37,24.99,,23.28,25.10,23.23,22.74,25.20,25.85,26.57,23.35,24.45,-2.08,0.86,0.93,0.55, ,-1.16,0.65,-1.22,-1.71,0.75,1.40,2.12,-1.09,regulation of cell migration,cytosol;endosome membrane;Golgi apparatus;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
4534,Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),RREGPGSEPDSQV,_EGPGS(ph)EPDSQVDGGLSGASLGEK_,S1395,,,,,22.46,24.20,23.30,24.53,23.82,24.29,24.30,22.81,22.92,,23.62, , , ,-1.16,0.58,-0.33,0.90,0.19,0.66,0.67,-0.82,-0.71, ,,,,,,,,,,,,,,,,
4535,Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),EKEVPWSPSAEKA,_EVPWS(ph)PSAEK_,S556,,24.33,24.57,25.10,24.95,25.66,25.11,25.48,25.10,24.99,25.92,25.35,24.91,24.86,25.10,-0.77,-0.53,0.00,-0.16,0.56,0.01,0.38,0.00,-0.11,0.82,0.25,-0.19,-0.24,,,,,,,,,,,,,,,,
4537,Q5JSZ5,PRRC2B,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),VASETHSEGSEYE,_VASETHS(ph)EGSEYEELPK_,S1136,,,,,24.02,25.15,25.78,25.66,25.71,,,25.45,,24.74,25.22, , , ,-1.20,-0.06,0.56,0.44,0.49, , ,0.23, ,-0.47,,,,,,,,,,,,,,,,
4538,Q5JTD0,TJAP1,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),ELNLPISPEEERQ,_EEEELNLPIS(ph)PEEER_,S357,,23.31,,,,,,,,,,,,,23.31,0.00, , , , , , , , , , , , ,,tight junction;Golgi apparatus;nucleus,,,,,,,,,,,,,,
4539,Q5JTD0,TJAP1,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),LGTARGSPEEELP,_GS(ph)PEEELPLPAFEK_,S166,+,24.90,23.06,21.92,23.23,25.33,,23.16,24.19,23.82,,,,,23.70,1.20,-0.64,-1.78,-0.47,1.63, ,-0.54,0.49,0.12, , , , ,,tight junction;Golgi apparatus;nucleus,,,,,,,,,,,,,,
4540,Q5JTD0,TJAP1,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),HLHRKDSLTQAQE,_KDS(ph)LTQAQEQGNLLN_,S411,+,24.85,,,25.41,24.36,25.68,24.99,23.84,25.04,23.75,23.76,24.50,24.67,24.62,0.23, , ,0.79,-0.26,1.06,0.37,-0.78,0.41,-0.87,-0.86,-0.12,0.05,,tight junction;Golgi apparatus;nucleus,,,,,,,,,,,,,,
4541,Q5JTH9,RRP12,RRP12-like protein,EEILADSEDEEDN,_GDSIEEILADS(ph)EDEEDNEEEER_,S980,,25.95,,,,,,,,22.77,27.49,,24.71,,25.23,0.72, , , , , , , ,-2.46,2.25, ,-0.52, ,,nuclear membrane;integral to membrane;nucleolus,,,,,,,,,,,,,,
4543,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),GLRDSHSSEEDEA,_DSHS(ph)S(ph)EEDEASSQTDLSQTISK_,S156,,24.59,,,,25.02,,,,,23.25,,,,24.29,0.30, , , ,0.74, , , , ,-1.03, , , ,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4544,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),LRDSHSSEEDEAS,_DSHS(ph)S(ph)EEDEASSQTDLSQTISK_,S157,,24.59,,,,25.02,,,,23.36,,,,,24.33,0.26, , , ,0.70, , , ,-0.96, , , , ,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4545,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),QPPLQPSPVMTRR,_LQQQHSEQPPLQPS(ph)PVM(ox)TR_,S143,,22.75,24.71,,,26.43,24.31,,,,,25.69,,24.37,24.71,-1.96,0.00, , ,1.72,-0.40, , , , ,0.98, ,-0.34,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4546,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),TRMQNDSILKSEL,_M(ox)QNDS(ph)ILK_,S305,,23.53,22.27,,25.53,,,,,,,,,,23.78,-0.24,-1.51, ,1.75, , , , , , , , , ,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4547,Q5JTV8,TOR1AIP1,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),SELGNQSPSTSSR,_SELGNQS(ph)PSTSSR_,S315,+,22.69,23.40,23.64,24.17,,,21.94,22.15,,21.63,,,21.11,22.59,0.10,0.81,1.05,1.58, , ,-0.65,-0.44, ,-0.96, , ,-1.48,nuclear membrane organization;protein localization to nucleus,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4549,Q5JU85,IQSEC2,IQ motif and SEC7 domain-containing protein 2,NMRMQFSFEEYEK,_M(ox)QFS(ph)FEEYEK_,S188,+,23.07,21.64,21.64,23.86,21.65,,23.18,22.95,,,23.03,24.34,,22.82,0.25,-1.18,-1.18,1.04,-1.16, ,0.36,0.13, , ,0.21,1.52, ,regulation of ARF protein signal transduction;actin cytoskeleton organization,cell junction;nucleus;cytoplasm,,,,,,,,,,,,,,
4551,Q5JXC2,MIIP,Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45) (IIp45),HIHRRKSFDASDT,_S(ph)FDASDTLALPR_,S303,,23.91,,,,21.84,,21.49,,21.73,23.21,,,,22.44,1.48, , , ,-0.60, ,-0.95, ,-0.70,0.77, , , ,,,,,,,,,,,,,,,,
4553,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),PAPREFSVTVSRE,_EFS(ph)VTVSR_,S31,,23.32,,,,,,,,,,,21.64,,22.48,0.84, , , , , , , , , , ,-0.84, ,,nucleus,,,,,,,,,,,,,,
4554,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),NFQKELSDLEEEN,_ELS(ph)DLEEENRVLK_,S160,,,,,,23.70,,,23.44,22.63,24.31,,23.98,,23.61, , , , ,0.08, , ,-0.17,-0.98,0.70, ,0.37, ,,nucleus,,,,,,,,,,,,,,
4556,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),VHKTPRSPLSGIP,_S(ph)PLSGIPVR_,S766,+,24.01,,,21.83,23.24,22.81,,23.48,22.87,,21.79,,22.51,22.82,1.19, , ,-0.99,0.42,-0.01, ,0.66,0.06, ,-1.03, ,-0.31,,nucleus,,,,,,,,,,,,,,
4557,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),HLRKSPSLESLSR,_SPS(ph)LESLSRPPSLGFGDTR_,S833,,23.55,21.04,21.04,22.08,,22.54,,,24.99,,,24.75,,22.86,0.70,-1.81,-1.81,-0.77, ,-0.32, , ,2.14, , ,1.89, ,,nucleus,,,,,,,,,,,,,,
4558,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),PSNPRKSVSSPTS,_S(ph)VSSPTSSNTPTPTK_,S50,,24.87,,,24.47,,,,,,,,23.85,,24.40,0.48, , ,0.08, , , , , , , ,-0.55, ,,nucleus,,,,,,,,,,,,,,
4559,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),PRKSVSSPTSSNT,_SVSS(ph)PTSSNTPTPTK_,S53,+,24.10,,,24.09,22.43,,22.72,22.32,22.53,23.44,,,,23.09,1.01, , ,1.00,-0.66, ,-0.37,-0.77,-0.56,0.35, , , ,,nucleus,,,,,,,,,,,,,,
4560,Q5M775,SPECC1,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),VCVSRTSPTPPES,_TS(ph)PTPPESATTVK_,S729,+,26.43,24.12,23.17,26.91,25.56,25.64,,25.05,25.06,23.34,24.84,,23.49,24.87,1.56,-0.76,-1.71,2.04,0.69,0.77, ,0.17,0.19,-1.54,-0.03, ,-1.38,,nucleus,,,,,,,,,,,,,,
4563,Q5PRF9,SAMD4B,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),PDHAPLSPQSSVA,_AAFTTPDHAPLS(ph)PQSSVASSGSEQTEEQGSSR_,S271,,21.73,,,,24.20,,,24.69,,,26.04,,25.03,24.34,-2.61, , , ,-0.14, , ,0.35, , ,1.71, ,0.69,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4564,Q5PRF9,SAMD4B,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),GRMGLLSPSGIGG,_M(ox)GLLS(ph)PSGIGGVSPR_,S592,,23.77,,,,,,,,,,,,,23.77,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4566,Q5QJE6,DNTTIP2,Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2),EEEDKASEVAIEE,_AS(ph)EVAIEEEK_,S512,,23.81,26.72,27.57,25.90,,,,,,,,,,26.00,-2.19,0.72,1.57,-0.10, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,,,,,,,,,,,,,,
4567,Q5QJE6,DNTTIP2,Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2),YTEEIVSEAESHV,_ESYTEEIVS(ph)EAESHVSGISR_,S141,,24.42,,,,,,,,25.58,25.24,,,,25.08,-0.66, , , , , , , ,0.50,0.16, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,,,,,,,,,,,,,,
4568,Q5R3F8,ELFN2,Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62),PLQRQLSADAAVT,_(gl)QLS(ph)ADAAVTRK_,S619,,,,,,,,23.31,22.78,24.27,24.70,23.01,22.95,,23.50, , , , , , ,-0.19,-0.73,0.77,1.20,-0.49,-0.56, ,negative regulation of phosphatase activity,integral to membrane,,,,,,,,,,,,,,
4569,Q5SNT2,TMEM201,Transmembrane protein 201 (Spindle-associated membrane protein 1),SLTRADSGYLFSG,_ADS(ph)GYLFSGSRPPSQVSR_,S466,,23.30,,,,,,,,,,,,,23.30,0.00, , , , , , , , , , , , ,,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4570,Q5SNT2,TMEM201,Transmembrane protein 201 (Spindle-associated membrane protein 1),RLSRALSLGTIPS,_ALS(ph)LGTIPSLTR_,S454,,25.78,,,,22.58,,21.47,,,,,,,23.28,2.50, , , ,-0.70, ,-1.81, , , , , , ,,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4571,Q5SNT2,TMEM201,Transmembrane protein 201 (Spindle-associated membrane protein 1),RSPRRTSPSSLPG,_RTS(ph)PSSLPGR_,S441,,24.13,24.87,24.87,24.60,,,,,,,,,,24.62,-0.48,0.25,0.25,-0.02, , , , , , , , , ,,integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
4574,Q5SNT6,FAM21B,WASH complex subunit FAM21B,KEKAVASPEATVS,_AVAS(ph)PEATVSQTDENK_,S410,+,23.05,24.14,24.79,23.84,24.93,24.38,26.27,25.69,23.92,23.90,24.36,25.65,25.07,24.62,-1.57,-0.48,0.18,-0.78,0.32,-0.23,1.65,1.07,-0.69,-0.71,-0.26,1.03,0.46,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4575,Q5SNT6,FAM21B,WASH complex subunit FAM21B,VVKKDHSVDSFKN,_DHS(ph)VDSFK_,S821,,23.58,22.35,,,,,,,,20.95,,,21.10,21.99,1.59,0.36, , , , , , , ,-1.05, , ,-0.90,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4576,Q5SNT6,FAM21B,WASH complex subunit FAM21B,EKEEEESDEDFAH,_EEEES(ph)DEDFAHHS(ph)DNEQNR_,S142,,24.16,24.73,,24.70,,,21.48,,,,,,,23.77,0.39,0.96, ,0.93, , ,-2.28, , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4577,Q5SNT6,FAM21B,WASH complex subunit FAM21B,EDFAHHSDNEQNR,_EEEES(ph)DEDFAHHS(ph)DNEQNR_,S150,,24.16,24.73,,24.70,,,21.48,,,,,,,23.77,0.39,0.96, ,0.93, , ,-2.28, , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4578,Q5SNT6,FAM21B,WASH complex subunit FAM21B,KERRTPSDDEEDN,_TPS(ph)DDEEDNLFTPPK_,S245,,24.09,,,,,,22.24,,,,23.69,,,23.34,0.75, , , , , ,-1.10, , , ,0.35, , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4580,Q5SNT6,FAM21B,WASH complex subunit FAM21B,TQKGLFSDEEDSE,_GLFS(ph)DEEDSEDLFSSQSASK_,S451,,23.96,,,,,,,,,,,,,23.96,0.00, , , , , , , , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4581,Q5SNT6,FAM21B,WASH complex subunit FAM21B,LTDEDFSPFGSGG,_LTDEDFS(ph)PFGSGGGLFSGGK_,S264,,24.03,,,,,,,,,,,,,24.03,0.00, , , , , , , , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4583,Q5SNT6,FAM21B,WASH complex subunit FAM21B,ALGEASSDDDLFQ,_SPM(ox)FPALGEASS(ph)DDDLFQSAKPK_,S1092,,22.80,,,,,,,,,24.51,,24.95,,24.08,-1.29, , , , , , , , ,0.43, ,0.86, ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4584,Q5SNT6,FAM21B,WASH complex subunit FAM21B,NTRPKRSRPTSFA,_S(ph)RPTS(ph)FADELAAR_,S196,,27.14,,,,22.31,,,,,,,,,24.73,2.42, , , ,-2.42, , , , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4585,Q5SNT6,FAM21B,WASH complex subunit FAM21B,KRSRPTSFADELA,_S(ph)RPTS(ph)FADELAAR_,S200,+,27.17,22.08,,,24.79,,22.37,24.68,22.29,22.11,23.87,,22.74,23.57,3.61,-1.49, , ,1.22, ,-1.19,1.11,-1.28,-1.46,0.30, ,-0.82,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4586,Q5SNT6,FAM21B,WASH complex subunit FAM21B,RTKTVLSLFDEEE,_TVLS(ph)LFDEEEDK_,S714,,24.25,,,,,,,,,,,,,24.25,0.00, , , , , , , , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4587,Q5SNT6,FAM21B,WASH complex subunit FAM21B,KTGKVQSTADIFG,_VQS(ph)TADIFGDEEGDLFK_,S390,,22.92,,,,,,,,,,,,,22.92,0.00, , , , , , , , , , , , ,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4588,Q5SRE5,NUP188,Nucleoporin NUP188 homolog (hNup188),RRGAPSSPATGVL,_GAPSS(ph)PATGVLPS(ph)PQGK_,S1598,+,26.90,25.24,25.24,25.54,,26.28,26.40,25.81,25.52,25.40,24.41,,25.46,25.66,1.25,-0.42,-0.42,-0.12, ,0.63,0.75,0.16,-0.13,-0.26,-1.24, ,-0.19,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear envelope;nuclear pore,,,,,,,,,,,,,,
4589,Q5SRE5,NUP188,Nucleoporin NUP188 homolog (hNup188),ATGVLPSPQGKST,_GAPSS(ph)PATGVLPS(ph)PQGK_,S1606,,26.34,23.91,23.91,22.82,,,,24.44,,,,,24.62,24.34,2.00,-0.43,-0.43,-1.53, , , ,0.10, , , , ,0.27,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear envelope;nuclear pore,,,,,,,,,,,,,,
4591,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),DEDEDESSEEDSE,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,S441,,26.29,,,,,,,,,,,,,26.29,0.00, , , , , , , , , , , , ,nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
4592,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),EDEDESSEEDSED,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,S442,,26.29,,,,,,,,,,,,,26.29,0.00, , , , , , , , , , , , ,nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
4593,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),ESSEEDSEDEEPP,_KEPDDSRDEDEDEDES(ph)S(ph)EEDS(ph)EDEEPPPK_,S446,,26.29,,,,,,,,,,,,,26.29,0.00, , , , , , , , , , , , ,nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
4598,Q5SSJ5,HP1BP3,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),WATLSASQLARAQ,_TIPSWATLSAS(ph)QLAR_,S142,,23.08,23.83,23.83,,22.98,25.06,,,22.03,,25.44,,,23.75,-0.67,0.08,0.08, ,-0.77,1.31, , ,-1.72, ,1.69, , ,nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
4599,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),ARLGEASDSELAD,_LGEAS(ph)DSELADADK_,S1075,+,23.51,25.64,23.78,26.87,24.88,27.02,26.79,25.06,27.58,26.09,23.31,25.32,27.65,25.65,-2.14,-0.01,-1.87,1.22,-0.77,1.37,1.14,-0.60,1.92,0.43,-2.34,-0.34,2.00,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4601,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),IRERSESLDPDSS,_SES(ph)LDPDSSM(ox)DTTLILK_,S844,,21.95,,,21.11,,,,,22.27,,25.09,23.81,24.65,23.15,-1.20, , ,-2.03, , , , ,-0.87, ,1.94,0.66,1.50,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4602,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),HDDGTQSDSENAG,_HDDGTQS(ph)DSENAGAHRR_,S280,,20.63,25.16,,24.16,,,,,20.04,,,,,22.50,-1.87,2.66, ,1.67, , , , ,-2.46, , , , ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4604,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),RRTRLGSLSARSD,_LGS(ph)LSAR_,S1123,,24.57,,,23.45,,,,,,,,,,24.01,0.56, , ,-0.56, , , , , , , , , ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4607,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),SLVRQGSFTIEKP,_(gl)QGS(ph)FTIEK_,S801,+,26.52,27.12,26.02,28.86,23.27,22.89,28.04,28.67,26.69,25.96,26.43,27.17,23.90,26.27,0.25,0.85,-0.25,2.59,-3.00,-3.38,1.77,2.40,0.41,-0.31,0.16,0.90,-2.38,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4608,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),KLLKQKSEEPSVS,_(gl)QKS(ph)EEPSVSIPFLQTALLR_,S409,,25.38,,,,,,,,,,,,,25.38,0.00, , , , , , , , , , , , ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4609,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),DSKSIKSDVPVYL,_S(ph)IKS(ph)DVPVYLK_,S260,+,24.56,24.90,24.97,22.94,24.21,23.77,24.59,23.64,24.44,23.31,22.68,23.42,,23.95,0.60,0.94,1.02,-1.02,0.26,-0.18,0.64,-0.31,0.49,-0.64,-1.27,-0.53, ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4610,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),TEEDSKSIKSDVP,_S(ph)IKS(ph)DVPVYLK_,S257,,24.30,,,,,,,,,,,,,24.30,0.00, , , , , , , , , , , , ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4612,Q5SW79,CEP170,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),KVVTQRSEIGEKQ,_VVTQRS(ph)EIGEK_,S630,,22.86,24.69,24.69,24.24,,,21.10,,,,,23.62,,23.53,-0.67,1.16,1.16,0.71, , ,-2.44, , , , ,0.09, ,,centriole;microtubule;centrosome;spindle,,,,,,,,,,,,,,
4613,Q5SWA1,PPP1R15B,Protein phosphatase 1 regulatory subunit 15B,IVPEEPSDSEKDL,_IVPEEPS(ph)DSEK_,S418,,23.39,24.06,24.19,24.78,,23.38,23.50,22.76,23.78,23.76,,23.19,,23.68,-0.29,0.38,0.51,1.11, ,-0.30,-0.17,-0.92,0.10,0.08, ,-0.49, ,ER overload response;response to hydrogen peroxide;regulation of translation,protein phosphatase type 1 complex,,,,,,,,,,,,,,
4614,Q5SY16,NOL9,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9),ADEEKESPVEFTG,_ES(ph)PVEFTGHK_,S487,,23.30,25.18,25.83,,,,,,,23.18,,,,24.37,-1.08,0.81,1.46, , , , , , ,-1.19, , , ,maturation of 5.8S rRNA,nucleolus,,,,,,,,,,,,,,
4616,Q5SYE7,NHSL1,NHS-like protein 1,RPVRKNSGAEAAQ,_KNS(ph)GAEAAQLSER_,S1085,+,23.32,,,23.69,25.28,,22.77,23.56,22.33,,21.63,21.07,,22.96,0.37, , ,0.74,2.32, ,-0.19,0.61,-0.63, ,-1.33,-1.89, ,,,,,,,,,,,,,,,,
4617,Q5SYE7,NHSL1,NHS-like protein 1,LMPRSLSFSGPRY,_SLS(ph)FSGPR_,S1491,,22.33,,,,21.21,,21.21,,,,,,,21.58,0.75, , , ,-0.38, ,-0.37, , , , , , ,,,,,,,,,,,,,,,,
4618,Q5T0N5,FNBP1L,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),VTQGRESPEGSYT,_ES(ph)PEGSYTDDANQEVR_,S321,,23.66,24.27,,23.08,,,,,,,,,,23.67,-0.01,0.60, ,-0.59, , , , , , , , , ,autophagy;vesicle transport along actin filament;membrane invagination;clathrin-mediated endocytosis;membrane budding;positive regulation of filopodium assembly;membrane tubulation,cell cortex;plasma membrane;cytoskeleton;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
4619,Q5T0N5,FNBP1L,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),HIYRTISDGTISA,_TIS(ph)DGTISASK_,S115,+,27.69,25.99,26.22,26.78,23.88,24.50,26.22,24.76,25.37,25.33,25.19,26.28,23.90,25.55,2.14,0.45,0.67,1.23,-1.67,-1.04,0.67,-0.79,-0.18,-0.22,-0.35,0.73,-1.65,autophagy;vesicle transport along actin filament;membrane invagination;clathrin-mediated endocytosis;membrane budding;positive regulation of filopodium assembly;membrane tubulation,cell cortex;plasma membrane;cytoskeleton;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
4620,Q5T0W9,FAM83B,Protein FAM83B,KKEVKGSPSFLKK,_GS(ph)PSFLK_,S764,,22.55,21.18,21.18,,,,,,,20.18,,,,21.27,1.28,-0.09,-0.09, , , , , , ,-1.09, , , ,,,,,,,,,,,,,,,,
4621,Q5T0W9,FAM83B,Protein FAM83B,ENKRTPSPGPVES,_RTPS(ph)PGPVESK_,S869,,25.21,24.60,25.49,,,,20.56,,,22.68,21.21,,,23.29,1.92,1.31,2.19, , , ,-2.73, , ,-0.61,-2.08, , ,,,,,,,,,,,,,,,,
4622,Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,QARGEGSPSEATR,_GEGS(ph)PSEATRLPTQGAR_,S736,+,24.33,23.83,21.82,,24.92,22.08,25.46,24.73,,22.40,21.92,,24.01,23.55,0.78,0.28,-1.73, ,1.37,-1.47,1.91,1.18, ,-1.15,-1.63, ,0.46,,,,,,,,,,,,,,,,
4623,Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,QYLGRQSSPPRNN,_(gl)QS(ph)SPPRNNYSDLR_,S1010,,26.22,25.79,25.69,25.26,25.72,,,26.10,24.65,26.93,,25.11,,25.72,0.50,0.07,-0.03,-0.46,0.00, , ,0.38,-1.06,1.21, ,-0.61, ,,,,,,,,,,,,,,,,
4624,Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,YLGRQSSPPRNNY,_QSS(ph)PPRNNYSDLR_,S1011,+,26.02,25.03,25.09,22.71,25.04,24.81,26.62,25.73,23.58,26.54,26.79,23.71,25.69,25.18,0.84,-0.15,-0.09,-2.47,-0.14,-0.37,1.44,0.55,-1.61,1.35,1.61,-1.47,0.51,,,,,,,,,,,,,,,,
4626,Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,SFSSPPSPSNKRE,_SFSSPPS(ph)PSNK_,S969,+,26.20,28.38,28.38,26.04,,,25.60,,23.61,28.68,,22.34,,26.15,0.05,2.23,2.23,-0.11, , ,-0.56, ,-2.54,2.53, ,-3.81, ,,,,,,,,,,,,,,,,
4628,Q5T0Z8,C6orf132,Uncharacterized protein C6orf132,GTGRSLSSPNCFG,_SLS(ph)SPNCFGPQPGGPEM(ox)R_,S1087,,24.29,,,,,,,,,,,,,24.29,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4629,Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),RDSAAPSPIPGAD,_DSAAPS(ph)PIPGADNLSADPVVSPPTSIPFK_,S311,+,25.11,27.11,,27.31,26.55,26.27,26.58,27.58,26.12,,26.16,25.96,26.37,26.47,-1.35,0.65, ,0.84,0.09,-0.20,0.11,1.12,-0.35, ,-0.31,-0.51,-0.09,protein folding;endocytosis;negative regulation of phosphatase activity,growth cone;axon;actin filament;early endosome,,,,,,,,,,,,,,
4631,Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),ERPRRPSQEQSAS,_RPS(ph)QEQSASASSGQPQAPLNR_,S956,,,24.38,,23.36,23.48,22.62,,,,,,,22.84,23.34, ,1.05, ,0.02,0.14,-0.71, , , , , , ,-0.50,protein folding;endocytosis;negative regulation of phosphatase activity,growth cone;axon;actin filament;early endosome,,,,,,,,,,,,,,
4633,Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),LRTKSNSLSEQLA,_SNS(ph)LSEQLAINTSPDAVK_,S346,,,23.14,23.50,22.35,23.69,,,22.15,23.72,,,,,23.09, ,0.05,0.41,-0.74,0.59, , ,-0.94,0.63, , , , ,protein folding;endocytosis;negative regulation of phosphatase activity,growth cone;axon;actin filament;early endosome,,,,,,,,,,,,,,
4635,Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),HHSQRSSLSGDEE,_SS(ph)LS(ph)GDEEDELFK_,S1162,,24.62,23.47,,,,23.94,,,,,,22.50,23.03,23.51,1.11,-0.04, , , ,0.43, , , , , ,-1.01,-0.48,protein folding;endocytosis;negative regulation of phosphatase activity,growth cone;axon;actin filament;early endosome,,,,,,,,,,,,,,
4636,Q5T1M5,FKBP15,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),SQRSSLSGDEEDE,_SSLS(ph)GDEEDELFK_,S1164,+,24.48,23.27,23.27,23.96,25.51,24.80,24.46,24.55,24.29,24.41,24.58,24.29,24.36,24.32,0.15,-1.06,-1.06,-0.36,1.19,0.48,0.13,0.22,-0.03,0.09,0.25,-0.03,0.03,protein folding;endocytosis;negative regulation of phosphatase activity,growth cone;axon;actin filament;early endosome,,,,,,,,,,,,,,
4638,Q5T1V6,DDX59,Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5),ADSEPESPLNASY,_ADSEPES(ph)PLNASYVYK_,S160,,23.05,22.35,22.35,22.32,,,23.31,,23.70,,,,,22.85,0.20,-0.49,-0.49,-0.53, , ,0.46, ,0.85, , , , ,,intracellular,,,,,,,,,,,,,,
4643,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,GNIETTSEDGQVF,_GNIETTS(ph)EDGQVFSPK_,S986,+,24.27,23.99,,24.07,24.42,24.75,23.39,24.63,24.20,,23.09,,24.11,24.09,0.18,-0.10, ,-0.02,0.32,0.66,-0.70,0.53,0.11, ,-1.01, ,0.02,,,,,,,,,,,,,,,,
4644,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,EDGQVFSPKKGQK,_GNIETTSEDGQVFS(ph)PKK_,S993,+,23.53,24.33,,23.91,25.31,25.92,24.89,25.47,25.24,,24.66,23.21,24.82,24.66,-1.14,-0.33, ,-0.75,0.64,1.26,0.23,0.81,0.58, ,0.00,-1.45,0.16,,,,,,,,,,,,,,,,
4645,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,KGPRTPSPPPPIP,_T(ph)PS(ph)PPPPIPEDIALGKK_,S265,,25.55,,,21.49,,,,,,,,,,23.52,2.03, , ,-2.03, , , , , , , , , ,,,,,,,,,,,,,,,,
4646,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,KTSAVSSPLLDQQ,_TSAVSS(ph)PLLDQQR_,S242,+,25.91,25.26,24.87,26.21,27.06,,27.30,26.43,,23.59,,25.51,,25.79,0.11,-0.54,-0.92,0.42,1.27, ,1.51,0.64, ,-2.21, ,-0.28, ,,,,,,,,,,,,,,,,
4647,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,ERERLISDSVERD,_LIS(ph)DSVER_,S1364,,23.88,,,22.46,,21.41,,,,,21.40,,,22.29,1.59, , ,0.17, ,-0.88, , , , ,-0.88, , ,,,,,,,,,,,,,,,,
4649,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,GRLRSPSNDSAHR,_LRS(ph)PS(ph)NDSAHR_,S1210,,22.37,,,16.80,,,,18.94,,,,,,19.37,3.00, , ,-2.57, , , ,-0.43, , , , , ,,,,,,,,,,,,,,,,
4655,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,TPPLRRSASPYPS,_S(ph)AS(ph)PYPSHSLSS(ph)PQR_,S370,,25.46,,,23.72,,,,,,,,,,24.59,0.87, , ,-0.87, , , , , , , , , ,,,,,,,,,,,,,,,,
4656,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,PLRRSASPYPSHS,_S(ph)AS(ph)PYPSHSLSS(ph)PQR_,S372,,25.46,,,23.72,,,,,,,,,,24.59,0.87, , ,-0.87, , , , , , , , , ,,,,,,,,,,,,,,,,
4657,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,PSHSLSSPQRKQS,_S(ph)AS(ph)PYPSHSLSS(ph)PQR_,S381,,25.27,,,22.66,,,,,,,,,,23.97,1.30, , ,-1.30, , , , , , , , , ,,,,,,,,,,,,,,,,
4658,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,KSERTESLEGDDE,_SERTES(ph)LEGDDESK_,S1438,+,23.68,25.06,25.79,23.56,,,21.45,,23.00,23.18,20.51,21.85,,23.12,0.56,1.94,2.67,0.44, , ,-1.67, ,-0.12,0.06,-2.61,-1.27, ,,,,,,,,,,,,,,,,
4659,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,VHSRSGSFDSRDR,_SGS(ph)FDSRDR_,S1292,+,24.16,22.41,21.63,24.28,,24.13,23.49,23.58,24.96,24.27,,22.37,19.67,23.18,0.99,-0.77,-1.55,1.10, ,0.96,0.31,0.40,1.78,1.10, ,-0.81,-3.51,,,,,,,,,,,,,,,,
4660,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,EKKRKKSKGDSDI,_S(ph)KGDS(ph)DIS(ph)DEEAAQQSK_,S1010,,23.26,,,,,,,,,,,,,23.26,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4661,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,KKSKGDSDISDEE,_S(ph)KGDS(ph)DIS(ph)DEEAAQQSK_,S1014,,23.26,,,,,,,,,,,,,23.26,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4662,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,KGDSDISDEEAAQ,_S(ph)KGDS(ph)DIS(ph)DEEAAQQSK_,S1017,,23.26,,,,,,,,,,,,,23.26,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4663,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,VVRSKLSPSPSLR,_SKLS(ph)PS(ph)PSLR_,S207,+,27.51,26.67,25.91,26.29,28.33,,21.24,,23.74,,,,,25.67,1.84,1.00,0.24,0.62,2.66, ,-4.43, ,-1.93, , , , ,,,,,,,,,,,,,,,,
4664,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,RSKLSPSPSLRKS,_SKLS(ph)PS(ph)PSLRK_,S209,+,27.51,26.67,25.91,26.29,22.63,,21.24,,23.74,,,,,24.85,2.66,1.81,1.05,1.43,-2.23, ,-3.61, ,-1.12, , , , ,,,,,,,,,,,,,,,,
4665,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,QESRSLSPSHLTE,_SLS(ph)PSHLTEDR_,S877,+,27.44,27.89,27.97,27.63,28.71,28.70,27.59,28.20,28.19,27.55,26.99,26.83,27.59,27.79,-0.35,0.10,0.18,-0.16,0.92,0.91,-0.20,0.41,0.40,-0.24,-0.80,-0.96,-0.20,,,,,,,,,,,,,,,,
4667,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,DKPRSTSPAGQHH,_ST(ph)S(ph)PAGQHHS(ph)PISSR_,S318,+,25.12,24.90,24.71,24.09,21.61,,,19.34,20.72,,,,,22.93,2.19,1.97,1.78,1.16,-1.32, , ,-3.59,-2.20, , , , ,,,,,,,,,,,,,,,,
4668,Q5T200,ZC3H13,Zinc finger CCCH domain-containing protein 13,PAGQHHSPISSRH,_ST(ph)S(ph)PAGQHHS(ph)PISSR_,S325,+,25.12,24.90,24.71,24.09,21.61,,,19.34,20.72,,,,,22.93,2.19,1.97,1.78,1.16,-1.32, , ,-3.59,-2.20, , , , ,,,,,,,,,,,,,,,,
4670,Q5T3J3,LRIF1,Ligand-dependent nuclear receptor-interacting factor 1 (Receptor-interacting factor 1),LQTVSSSPVTEIS,_DTLQTVSSS(ph)PVTEISR_,S402,,22.68,,,,,,,,,,,,,22.68,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;nuclear matrix,,,,,,,,,,,,,,
4674,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),DQKELASPVSPEL,_ELAS(ph)PVSPELRQK_,S178,+,25.05,23.18,22.97,24.47,24.77,24.03,24.90,24.76,24.66,24.32,25.58,23.30,24.22,24.32,0.73,-1.14,-1.35,0.15,0.45,-0.30,0.57,0.44,0.34,-0.01,1.25,-1.03,-0.11,virus-host interaction,integral to membrane;nucleus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4675,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),ELASPVSPELRQK,_ELASPVS(ph)PELRQK_,S181,,24.04,23.28,,23.70,,,22.04,,,,24.79,,24.07,23.65,0.39,-0.37, ,0.04, , ,-1.61, , , ,1.14, ,0.42,virus-host interaction,integral to membrane;nucleus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4676,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),RHVTLPSSPRSNT,_HVTLPS(ph)SPR_,S2729,,,,,,,,25.53,26.65,23.54,,,,23.63,24.84, , , , , , ,0.69,1.81,-1.30, , , ,-1.21,virus-host interaction,integral to membrane;nucleus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4677,Q5T4S7,UBR4,E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),HVTLPSSPRSNTP,_HVTLPSS(ph)PR_,S2730,+,24.75,27.47,,25.02,27.36,25.04,25.53,26.65,,,26.35,25.71,23.84,25.77,-1.02,1.70, ,-0.75,1.58,-0.73,-0.24,0.87, , ,0.58,-0.06,-1.93,virus-host interaction,integral to membrane;nucleus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4681,Q5T5C0,STXBP5,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),RSSSVTSIDKESR,_SSSVTS(ph)IDK_,S420,,,23.21,22.28,26.71,,,,,,,22.25,21.30,,23.15, ,0.06,-0.87,3.56, , , , , , ,-0.90,-1.85, ,protein transport;exocytosis;positive regulation of exocytosis,cytoplasmic vesicle membrane;acetylcholine-gated channel complex;synaptic vesicle;cell junction,,,,,,,,,,,,,,
4684,Q5T5P2,KIAA1217,Sickle tail protein homolog,TDDQFESPKKKFK,_GEDATDDQFES(ph)PKK_,S1568,,28.20,27.71,27.71,23.44,,,23.62,,25.46,26.17,24.09,,25.37,25.75,2.45,1.96,1.96,-2.31, , ,-2.13, ,-0.29,0.41,-1.66, ,-0.39,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4685,Q5T5P2,KIAA1217,Sickle tail protein homolog,SKIPALSPSSGKS,_IPALS(ph)PSSGK_,S1806,,25.78,23.96,23.96,,,23.91,,,23.00,,21.55,,,23.69,2.09,0.27,0.27, , ,0.22, , ,-0.69, ,-2.14, , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4686,Q5T5P2,KIAA1217,Sickle tail protein homolog,PRDRISSLPVSRP,_ISS(ph)LPVSRPIS(ph)PSPSAILER_,S353,,25.91,,,,,,,,,,21.26,,,23.59,2.33, , , , , , , , , ,-2.33, , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4688,Q5T5P2,KIAA1217,Sickle tail protein homolog,PVSRPISPSPSAI,_ISSLPVSRPIS(ph)PSPSAILER_,S361,+,26.98,,,22.06,25.44,25.90,,25.11,23.76,23.74,24.62,23.12,24.86,24.56,2.42, , ,-2.50,0.88,1.34, ,0.56,-0.80,-0.82,0.06,-1.44,0.30,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4689,Q5T5P2,KIAA1217,Sickle tail protein homolog,SRPISPSPSAILE,_ISSLPVSRPIS(ph)PS(ph)PSAILER_,S363,,22.06,,,,,,,,,,,,,22.06,0.00, , , , , , , , , , , , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4690,Q5T5P2,KIAA1217,Sickle tail protein homolog,PSIESTSPISRTD,_RQEQPSIESTS(ph)PISR_,S1650,,25.37,,,,24.28,,22.97,24.37,,,23.05,,,24.01,1.36, , , ,0.27, ,-1.04,0.36, , ,-0.96, , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4691,Q5T5P2,KIAA1217,Sickle tail protein homolog,NTISEMSPKALVD,_(gl)QLENTISEM(ox)S(ph)PK_,S1684,,24.14,,,,,,,,,,,22.58,,23.36,0.78, , , , , , , , , , ,-0.78, ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4692,Q5T5P2,KIAA1217,Sickle tail protein homolog,GDFKPTSPSLPAS,_SGGDFKPTS(ph)PSLPASK_,S1794,,24.28,,,,22.04,,22.95,,22.85,21.73,,,,22.77,1.51, , , ,-0.74, ,0.18, ,0.08,-1.04, , , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4693,Q5T5P2,KIAA1217,Sickle tail protein homolog,VELSEDSPNSEQD,_VELSEDS(ph)PNSEQDLEK_,S1030,,25.87,24.23,24.23,,,,,,23.14,25.08,24.16,,,24.45,1.42,-0.22,-0.22, , , , , ,-1.31,0.63,-0.29, , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4694,Q5T5P2,KIAA1217,Sickle tail protein homolog,SEDSPNSEQDLEK,_VELSEDS(ph)PNS(ph)EQDLEK_,S1033,,22.14,,,,,,,,,,,,,22.14,0.00, , , , , , , , , , , , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4695,Q5T5P2,KIAA1217,Sickle tail protein homolog,ASAWTPSPPPVTT,_YPAEEPASAWTPS(ph)PPPVTTSSSK_,S1111,,22.33,,,,,,,,,23.31,,,,22.82,-0.49, , , , , , , , ,0.49, , , ,embryonic skeletal system development,cytoplasm,,,,,,,,,,,,,,
4696,Q5T5U3,ARHGAP21,Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21),EIQVPPSPTDVAK,_M(ox)EIQVPPS(ph)PTDVAK_,S252,,,,,21.88,24.26,23.36,,22.74,23.40,,24.05,,,23.28, , , ,-1.40,0.98,0.08, ,-0.54,0.12, ,0.77, , ,signal transduction;organelle transport along microtubule;establishment of Golgi localization;positive regulation of GTPase activity;Golgi organization;maintenance of Golgi location,cytoplasmic vesicle membrane;Golgi apparatus;cell junction;cytoskeleton;Golgi membrane,,,,,,,,,,,,,,
4697,Q5T5U3,ARHGAP21,Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21),LIRRQLSHDHESV,_(gl)QLS(ph)HDHESVGPPSLDAQPNSK_,S856,+,21.74,21.44,,23.01,23.25,,23.13,,24.93,21.39,23.02,23.01,,22.77,-1.03,-1.33, ,0.24,0.48, ,0.36, ,2.16,-1.38,0.25,0.24, ,signal transduction;organelle transport along microtubule;establishment of Golgi localization;positive regulation of GTPase activity;Golgi organization;maintenance of Golgi location,cytoplasmic vesicle membrane;Golgi apparatus;cell junction;cytoskeleton;Golgi membrane,,,,,,,,,,,,,,
4699,Q5T5U3,ARHGAP21,Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21),KTERSKSYDEGLD,_S(ph)YDEGLDDYREDAK_,S880,+,22.94,24.13,24.21,23.55,,,24.85,,26.12,24.59,23.00,24.84,,24.25,-1.31,-0.12,-0.04,-0.70, , ,0.61, ,1.87,0.34,-1.24,0.59, ,signal transduction;organelle transport along microtubule;establishment of Golgi localization;positive regulation of GTPase activity;Golgi organization;maintenance of Golgi location,cytoplasmic vesicle membrane;Golgi apparatus;cell junction;cytoskeleton;Golgi membrane,,,,,,,,,,,,,,
4700,Q5T5Y3,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,PEFPRASPRALGL,_ADVVPQQADPEFPRAS(ph)PR_,S285,+,23.90,24.27,,21.99,26.16,25.65,26.00,26.38,24.87,22.68,26.17,26.30,23.71,24.84,-0.94,-0.56, ,-2.85,1.32,0.81,1.16,1.54,0.03,-2.16,1.33,1.46,-1.13,regulation of cell morphogenesis;cytoskeleton organization,microtubule;cytoplasm,,,,,,,,,,,,,,
4703,Q5T7W0,ZNF618,Zinc finger protein 618,ASNQSRSPPAVVE,_S(ph)PPAVVEEK_,S336,,23.53,25.38,,25.17,,21.15,,,,,,,,23.81,-0.27,1.57, ,1.36, ,-2.66, , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
4704,Q5T8D3,ACBD5,Acyl-CoA-binding domain-containing protein 5,KAESSDSGAESEE,_AESSDS(ph)GAESEEEEAQEEVK_,S152,,25.37,21.02,,,,,,,,25.36,,,21.71,23.37,2.01,-2.34, , , , , , , ,1.99, , ,-1.66,transport,intracellular membrane-bounded organelle;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
4705,Q5T8D3,ACBD5,Acyl-CoA-binding domain-containing protein 5,SDSGAESEEEEAQ,_AESSDS(ph)GAES(ph)EEEEAQEEVK_,S156,,25.43,,,,,,,,22.49,23.90,,,,23.94,1.49, , , , , , , ,-1.45,-0.04, , , ,transport,intracellular membrane-bounded organelle;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
4706,Q5T8D3,ACBD5,Acyl-CoA-binding domain-containing protein 5,HRMQHLSEGTKGR,_M(ox)QHLS(ph)EGTK_,S374,,,23.79,23.79,21.10,,,,,,,,,,22.89, ,0.90,0.90,-1.80, , , , , , , , , ,transport,intracellular membrane-bounded organelle;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
4707,Q5T8P6,RBM26,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),SRRLNHSPPQSSS,_RLNHS(ph)PPQSSSR_,S127,+,21.69,22.49,23.23,21.73,21.64,,19.72,20.36,17.91,,19.65,,,20.94,0.76,1.55,2.29,0.79,0.70, ,-1.22,-0.57,-3.02, ,-1.28, , ,mRNA processing;negative regulation of phosphatase activity,,,,,,,,,,,,,,,
4709,Q5TCQ9,MAGI3,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",ISTQNGSPRLNRA,_IFYGEKQPEDDSSQAFISTQNGS(ph)PR_,S832,,,,,,23.60,23.19,,,,,,,,23.40, , , , ,0.20,-0.20, , , , , , , ,positive regulation of JUN kinase activity;apoptotic process;virus-host interaction;intracellular signal transduction,tight junction;plasma membrane;nucleus;membrane,,,,,,,,,,+,,,,
4711,Q5TCX8,MLK4,Mitogen-activated protein kinase kinase kinase MLK4 (EC 2.7.11.25) (Mixed lineage kinase 4),KITVQASPNLDKR,_ITVQAS(ph)PNLDK_,S528,+,24.20,22.72,23.12,22.82,21.42,22.70,23.31,23.49,22.98,24.18,,22.82,,23.07,1.13,-0.35,0.05,-0.25,-1.65,-0.37,0.24,0.42,-0.09,1.11, ,-0.25, ,protein autophosphorylation;activation of JUN kinase activity;activation of MAPKK activity,,,+,,,,,,,,,,,,
4712,Q5TCZ1,SH3PXD2A,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),LAERAASQGSDSP,_AAS(ph)QGSDSPLLPAQR_,S965,,24.18,21.96,,22.65,,,,,,,,22.35,,22.78,1.39,-0.83, ,-0.13, , , , , , , ,-0.43, ,superoxide metabolic process;cell communication,podosome;cell junction;cell projection;cytoplasm,,,,,,,,,,,,,,
4713,Q5TCZ1,SH3PXD2A,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),QRAQISSPNLRTR,_AQISS(ph)PNLR_,S348,+,25.98,21.42,21.42,24.11,23.46,,22.50,22.58,24.60,,,22.47,22.62,23.12,2.86,-1.70,-1.70,0.99,0.34, ,-0.61,-0.53,1.49, , ,-0.65,-0.49,superoxide metabolic process;cell communication,podosome;cell junction;cell projection;cytoplasm,,,,,,,,,,,,,,
4715,Q5TCZ1,SH3PXD2A,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),ALRRNESLTATDG,_NES(ph)LTATDGLR_,S929,,24.82,,,23.94,21.16,,,,,,,22.63,,23.14,1.68, , ,0.80,-1.97, , , , , , ,-0.51, ,superoxide metabolic process;cell communication,podosome;cell junction;cell projection;cytoplasm,,,,,,,,,,,,,,
4718,Q5TGY3,AHDC1,AT-hook DNA-binding motif-containing protein 1,RKQKLASPQPSYA,_LAS(ph)PQPSYAADANDSK_,S596,+,23.59,23.09,23.09,24.79,,,23.83,,23.28,23.74,23.15,23.35,,23.54,0.04,-0.46,-0.46,1.24, , ,0.28, ,-0.26,0.19,-0.40,-0.19, ,,,,,,,,,,,,,,,,
4719,Q5TH69,ARFGEF3,Brefeldin A-inhibited guanine nucleotide-exchange protein 3,DLLLPPSPKVEKK,_AGGGDLLLPPS(ph)PK_,S1920,,22.63,23.70,23.70,,,,,,,21.76,,,,22.94,-0.32,0.75,0.75, , , , , , ,-1.19, , , ,vesicle-mediated transport;regulation of ARF protein signal transduction;negative regulation of phosphatase activity,trans-Golgi network;integral to membrane,,,,,,,,,,,,,,
4720,Q5THJ4,VPS13D,Vacuolar protein sorting-associated protein 13D,RDSRAQSPVSGPN,_AQS(ph)PVSGPNVAHLTDGATLNDR_,S1042,,,,,,24.59,,,24.68,,,,,,24.63, , , , ,-0.05, , ,0.05, , , , , ,protein localization,,,,,,,,,,,,,,,
4721,Q5THJ4,VPS13D,Vacuolar protein sorting-associated protein 13D,KEKDDLSPQPLMT,_EKDDLS(ph)PQPLM(ox)TDFER_,S1138,,23.92,21.91,21.91,21.65,,,24.00,,23.63,22.96,25.31,,25.44,23.41,0.51,-1.51,-1.51,-1.77, , ,0.59, ,0.22,-0.45,1.89, ,2.02,protein localization,,,,,,,,,,,,,,,
4722,Q5THJ4,VPS13D,Vacuolar protein sorting-associated protein 13D,PLTPPPSPTVDEP,_DYPLT(ph)PPPS(ph)PTVDEPK_,S1765,,24.53,,,22.62,,,,,24.10,24.04,,,,23.82,0.71, , ,-1.20, , , , ,0.28,0.21, , , ,protein localization,,,,,,,,,,,,,,,
4723,Q5THJ4,VPS13D,Vacuolar protein sorting-associated protein 13D,SRHRNSSSESAIV,_NSS(ph)SESAIVPK_,S2435,+,24.21,23.91,24.15,23.52,21.57,,22.17,21.82,,,,,,23.05,1.16,0.86,1.10,0.47,-1.48, ,-0.88,-1.23, , , , , ,protein localization,,,,,,,,,,,,,,,
4727,Q5UIP0,RIF1,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),LVSANDSPSGMQT,_LRELDPSLVSANDS(ph)PSGM(ox)QTR_,S2161,+,21.59,,,,24.98,23.89,24.63,24.45,,24.33,,,24.71,24.08,-2.49, , , ,0.90,-0.20,0.55,0.37, ,0.25, , ,0.63,stem cell maintenance;cell cycle;response to DNA damage stimulus,"male pronucleus;chromosome, telomeric region;female pronucleus;spindle;cytoplasm",,,,,,,,,,,,,,
4728,Q5UIP0,RIF1,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),YQTRRASQGLLSS,_RAS(ph)QGLLSSIENSESDSSEAK_,S1542,,24.27,,,,,,23.35,,,,,25.58,,24.40,-0.13, , , , , ,-1.05, , , , ,1.18, ,stem cell maintenance;cell cycle;response to DNA damage stimulus,"male pronucleus;chromosome, telomeric region;female pronucleus;spindle;cytoplasm",,,,,,,,,,,,,,
4729,Q5UIP0,RIF1,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),RLHKRDSFDNCSL,_RDS(ph)FDNCSLGESSK_,S1688,,24.15,,,,,,,,,,,24.28,,24.22,-0.07, , , , , , , , , , ,0.07, ,stem cell maintenance;cell cycle;response to DNA damage stimulus,"male pronucleus;chromosome, telomeric region;female pronucleus;spindle;cytoplasm",,,,,,,,,,,,,,
4731,Q5UIP0,RIF1,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),KNKSNESVDIQDQ,_SNES(ph)VDIQDQEEK_,S1579,+,27.40,25.10,25.45,26.80,,21.64,25.98,23.76,24.25,23.94,,25.71,,25.00,2.40,0.10,0.44,1.79, ,-3.37,0.98,-1.24,-0.76,-1.06, ,0.71, ,stem cell maintenance;cell cycle;response to DNA damage stimulus,"male pronucleus;chromosome, telomeric region;female pronucleus;spindle;cytoplasm",,,,,,,,,,,,,,
4733,Q5VSL9,STRIP1,Striatin-interacting protein 1 (Protein FAM40A),RNMRAASPPASAS,_AAS(ph)PPASASDLIEQQQK_,S335,+,26.95,26.72,26.81,27.08,27.31,27.17,27.52,28.11,27.46,28.05,27.71,26.66,27.57,27.32,-0.36,-0.60,-0.50,-0.23,-0.01,-0.15,0.20,0.80,0.14,0.73,0.39,-0.66,0.25,regulation of cell morphogenesis;cortical actin cytoskeleton organization,nucleus;cytoplasm,,,,,,,,,,,,,,
4735,Q5VSL9,STRIP1,Striatin-interacting protein 1 (Protein FAM40A),RNQRKDSEGYSES,_KDS(ph)EGYSESPDLEFEYADTDK_,S59,,24.95,,,,,,24.36,,25.93,26.44,,,24.08,25.15,-0.20, , , , , ,-0.79, ,0.78,1.29, , ,-1.07,regulation of cell morphogenesis;cortical actin cytoskeleton organization,nucleus;cytoplasm,,,,,,,,,,,,,,
4736,Q5VT06,CEP350,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),RLLELKSPTELMK,_LLELKS(ph)PTELM(ox)K_,S631,,20.51,,,,22.95,22.21,,22.04,,,,,,21.93,-1.42, , , ,1.03,0.28, ,0.11, , , , , ,,nucleus;centrosome;spindle,,,,,,,,,,,,,,
4737,Q5VT25,CDC42BPA,Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha),SPRKTKSLSLEST,_S(ph)LSLESTDR_,S1678,,20.05,21.47,,22.99,,,,,,,,,,21.50,-1.45,-0.03, ,1.49, , , , , , , , , ,nuclear migration;actomyosin structure organization;actin cytoskeleton reorganization;cell migration;regulation of small GTPase mediated signal transduction;microtubule cytoskeleton organization;intracellular signal transduction,cell-cell junction;cell leading edge;cytoplasm;actomyosin,,+,,,,,,,,,,,,
4738,Q5VT25,CDC42BPA,Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha),RKTKSLSLESTDR,_SLS(ph)LESTDR_,S1680,,,24.68,,,21.71,,21.11,21.85,,,,,,22.34, ,2.34, , ,-0.63, ,-1.23,-0.49, , , , , ,nuclear migration;actomyosin structure organization;actin cytoskeleton reorganization;cell migration;regulation of small GTPase mediated signal transduction;microtubule cytoskeleton organization;intracellular signal transduction,cell-cell junction;cell leading edge;cytoplasm;actomyosin,,+,,,,,,,,,,,,
4739,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,KASIGQSPGLPST,_ASIGQS(ph)PGLPSTTFK_,S577,+,24.19,22.88,22.23,23.18,22.86,23.54,,,24.63,24.65,23.08,,,23.47,0.72,-0.59,-1.24,-0.29,-0.61,0.07, , ,1.16,1.18,-0.39, , ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4740,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,VEDMELSDVEDDG,_DVEDM(ox)ELS(ph)DVEDDGSK_,S337,+,27.66,23.65,23.65,,26.51,26.07,24.78,23.72,24.52,25.91,24.42,25.59,25.41,25.16,2.50,-1.50,-1.50, ,1.35,0.91,-0.38,-1.44,-0.64,0.75,-0.74,0.43,0.26,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4741,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,LESESTSPSLEMK,_LESESTS(ph)PSLEM(ox)K_,S628,+,25.82,25.78,26.05,25.84,23.90,25.69,25.69,,25.83,25.94,24.10,25.10,,25.43,0.39,0.35,0.62,0.41,-1.53,0.26,0.26, ,0.40,0.50,-1.33,-0.33, ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4743,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,SPGTPTSPSNLTS,_NTGVSPASRPSPGTPTS(ph)PSNLTSGLK_,S448,+,23.39,24.13,24.13,,24.49,,24.73,24.99,,25.03,,24.30,25.31,24.50,-1.11,-0.37,-0.37, ,-0.01, ,0.23,0.49, ,0.53, ,-0.21,0.81,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4744,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,ASNRRMSGEPIQT,_RM(ox)S(ph)GEPIQTVESIR_,S1062,,20.94,,,,22.06,,,21.28,,,,,,21.42,-0.48, , , ,0.63, , ,-0.15, , , , , ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4745,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,TMESEKSATPEPV,_S(ph)AT(ph)PEPVTDNRDVEDM(ox)ELS(ph)DVEDDGSK_,S319,,24.63,,,,,,,,,,,,,24.63,0.00, , , , , , , , , , , , ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4746,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,PKSFNYSPNSSTS,_SFNYS(ph)PNSSTSEVSSTSASK_,S556,+,25.26,24.33,24.65,24.41,26.45,26.34,25.65,25.06,25.88,25.94,24.32,24.64,24.49,25.19,0.07,-0.85,-0.54,-0.78,1.27,1.15,0.46,-0.13,0.69,0.76,-0.86,-0.54,-0.69,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
4750,Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),DRRRSQSIEQESQ,_RRS(ph)QS(ph)IEQESQEK_,S529,+,27.83,27.15,25.87,27.13,22.83,,22.87,21.54,21.94,,,,,24.64,3.19,2.51,1.22,2.49,-1.81, ,-1.78,-3.11,-2.71, , , , ,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,+,,,,
4751,Q5VTL8,PRPF38B,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),QSIEQESQEKQHK,_RRS(ph)QSIEQES(ph)QEK_,S534,,26.53,26.83,,,,,,,,,,,,26.68,-0.15,0.15, , , , , , , , , , , ,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,+,,,,
4754,Q5VTR2,RNF20,E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 6.3.2.-) (RING finger protein 20),PEPEPDSDSNQER,_ALVVPEPEPDS(ph)DSNQER_,S136,+,25.29,23.35,23.02,,23.64,26.71,27.34,22.25,26.95,22.58,,27.44,24.19,24.80,0.49,-1.45,-1.77, ,-1.15,1.92,2.54,-2.55,2.16,-2.22, ,2.64,-0.61,"positive regulation of transcription, DNA-dependent;negative regulation of cell migration;histone H2B ubiquitination;histone monoubiquitination;protein polyubiquitination;ubiquitin-dependent protein catabolic process",nucleolus;HULC complex,,,,,,,,,,,,,,
4755,Q5VTR2,RNF20,E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 6.3.2.-) (RING finger protein 20),PEPDSDSNQERKD,_ALVVPEPEPDSDS(ph)NQERK_,S138,+,26.06,27.11,27.11,24.60,26.40,,25.94,25.50,26.04,27.81,26.23,26.41,25.34,26.21,-0.15,0.90,0.90,-1.61,0.18, ,-0.27,-0.71,-0.17,1.60,0.01,0.20,-0.87,"positive regulation of transcription, DNA-dependent;negative regulation of cell migration;histone H2B ubiquitination;histone monoubiquitination;protein polyubiquitination;ubiquitin-dependent protein catabolic process",nucleolus;HULC complex,,,,,,,,,,,,,,
4758,Q5VUA4,ZNF318,Zinc finger protein 318 (Endocrine regulatory protein),RSVRIPSPNILKT,_IPS(ph)PNILK_,S2101,+,22.46,23.40,21.61,23.32,24.62,24.91,23.69,22.84,23.00,22.68,23.65,22.21,23.86,23.25,-0.79,0.15,-1.64,0.07,1.37,1.66,0.44,-0.41,-0.25,-0.57,0.40,-1.04,0.61,"meiosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4759,Q5VUA4,ZNF318,Zinc finger protein 318 (Endocrine regulatory protein),LSEGRNSPEKAEN,_LEDQLSEGRNS(ph)PEK_,S1243,+,25.25,26.37,27.03,25.40,,23.39,27.23,23.54,27.23,26.32,25.20,25.31,23.71,25.50,-0.25,0.87,1.53,-0.09, ,-2.11,1.73,-1.96,1.73,0.83,-0.30,-0.19,-1.79,"meiosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4761,Q5VUA4,ZNF318,Zinc finger protein 318 (Endocrine regulatory protein),YLLTKNSPPFLKS,_NS(ph)PPFLK_,S709,+,22.87,23.84,23.68,23.83,22.14,23.80,24.65,22.81,24.67,23.90,22.97,22.74,23.09,23.46,-0.59,0.38,0.21,0.37,-1.32,0.34,1.19,-0.65,1.21,0.44,-0.49,-0.72,-0.37,"meiosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4762,Q5VUA4,ZNF318,Zinc finger protein 318 (Endocrine regulatory protein),QEKRRRSFPDIED,_S(ph)FPDIEDEEK_,S527,+,23.68,23.02,21.93,24.27,22.68,24.18,23.81,23.82,23.99,21.06,23.08,22.37,,23.16,0.52,-0.14,-1.23,1.11,-0.48,1.02,0.65,0.66,0.84,-2.10,-0.07,-0.79, ,"meiosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
4763,Q5VUB5,FAM171A1,Protein FAM171A1 (Astroprincin),KRDQSTSMSHINL,_DQSTS(ph)M(ox)SHINLLFSR_,S358,+,23.49,,,21.22,23.20,23.36,22.76,22.48,23.61,22.39,22.75,,24.12,22.94,0.55, , ,-1.72,0.26,0.42,-0.18,-0.46,0.67,-0.55,-0.19, ,1.18,,integral to membrane,,,,,,,,,,,,,,
4766,Q5VUB5,FAM171A1,Protein FAM171A1 (Astroprincin),PAGLESSKRDQST,_LQLPAGLESS(ph)K_,S351,,22.45,,,,,,,,,,,,,22.45,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
4768,Q5VUB5,FAM171A1,Protein FAM171A1 (Astroprincin),LYPAPSSPEKEQL,_LTIQEHLYPAPSS(ph)PEK_,S525,+,22.74,22.98,22.98,,,,24.04,,25.85,26.84,25.27,22.03,24.29,24.11,-1.37,-1.14,-1.14, , , ,-0.08, ,1.74,2.73,1.16,-2.09,0.18,,integral to membrane,,,,,,,,,,,,,,
4770,Q5VV41,ARHGEF16,Rho guanine nucleotide exchange factor 16 (Ephexin-4),_MAQRHSDSSLEE,_(ac)AQRHS(ph)DSSLEEK_,S6,,24.65,24.10,25.01,22.54,,,,,,22.05,,,,23.67,0.98,0.43,1.34,-1.13, , , , , ,-1.62, , , ,positive regulation of establishment of protein localization to plasma membrane;activation of Rac GTPase activity;small GTPase mediated signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;activation of Cdc42 GTPase activity;cell chemotaxis,cytosol,,,,,,,,,,,,,,
4773,Q5VV41,ARHGEF16,Rho guanine nucleotide exchange factor 16 (Ephexin-4),TPARHQSFGAAVL,_HQS(ph)FGAAVLSR_,S107,,22.81,,,,,,,,,,,,,22.81,0.00, , , , , , , , , , , , ,positive regulation of establishment of protein localization to plasma membrane;activation of Rac GTPase activity;small GTPase mediated signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;activation of Cdc42 GTPase activity;cell chemotaxis,cytosol,,,,,,,,,,,,,,
4774,Q5VW32,BROX,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),ELFTDLSCNPEMM,_LLELFT(ph)DLS(ph)CNPEMMK_,S51,,,24.21,,26.17,,26.70,,26.56,25.65,25.55,,,,25.81, ,-1.60, ,0.37, ,0.89, ,0.75,-0.16,-0.26, , , ,,membrane,,,,,,,,,,,,,,
4775,Q5VWG9,TAF3,Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140),GKRPLDSPEAEEL,_RPLDS(ph)PEAEELPAM(ox)K_,S183,+,24.32,24.57,25.33,22.96,25.91,24.96,25.48,25.78,25.50,25.78,23.72,25.03,26.14,25.04,-0.71,-0.47,0.29,-2.08,0.87,-0.08,0.44,0.74,0.47,0.74,-1.32,0.00,1.10,"maintenance of protein location in nucleus;negative regulation of transcription from RNA polymerase II promoter;negative regulation of sequence-specific DNA binding transcription factor activity;transcription, DNA-dependent",transcription factor TFIID complex,,,,,,,,,,,,,,
4777,Q5VWQ8,DAB2IP,Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein),SSSKGDSPELKPR,_GDS(ph)PELKPR_,S369,,23.15,26.21,,,,,,,,20.86,,,,23.41,-0.25,2.80, , , , , , , ,-2.55, , , ,negative regulation of canonical Wnt receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to tumor necrosis factor;negative regulation of MAP kinase activity;negative regulation of fibroblast proliferation;negative regulation of epithelial cell migration;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial to mesenchymal transition;negative regulation of Ras GTPase activity;activation of JUN kinase activity;negative regulation of catenin import into nucleus;cellular response to epidermal growth factor stimulus;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;negative regulation of Ras protein signal transduction;positive regulation of apoptotic process,intrinsic to internal side of plasma membrane;cytoplasm,,,,+,,,,,,,,,,
4778,Q5VWQ8,DAB2IP,Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein),QGPSPVSPNALDR,_QGPSPVS(ph)PNALDR_,S386,,25.09,,,22.89,22.43,,,,,,23.98,,23.47,23.57,1.52, , ,-0.68,-1.14, , , , , ,0.41, ,-0.10,negative regulation of canonical Wnt receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to tumor necrosis factor;negative regulation of MAP kinase activity;negative regulation of fibroblast proliferation;negative regulation of epithelial cell migration;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial to mesenchymal transition;negative regulation of Ras GTPase activity;activation of JUN kinase activity;negative regulation of catenin import into nucleus;cellular response to epidermal growth factor stimulus;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;negative regulation of Ras protein signal transduction;positive regulation of apoptotic process,intrinsic to internal side of plasma membrane;cytoplasm,,,,+,,,,,,,,,,
4779,Q5VWQ8,DAB2IP,Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein),LARRQMSLTEKGG,_RQM(ox)S(ph)LTEK_,S286,,21.95,20.05,20.24,20.83,,,,,,,,,,20.77,1.18,-0.72,-0.52,0.06, , , , , , , , , ,negative regulation of canonical Wnt receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to tumor necrosis factor;negative regulation of MAP kinase activity;negative regulation of fibroblast proliferation;negative regulation of epithelial cell migration;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial to mesenchymal transition;negative regulation of Ras GTPase activity;activation of JUN kinase activity;negative regulation of catenin import into nucleus;cellular response to epidermal growth factor stimulus;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;negative regulation of Ras protein signal transduction;positive regulation of apoptotic process,intrinsic to internal side of plasma membrane;cytoplasm,,,,+,,,,,,,,,,
4780,Q5VWQ8,DAB2IP,Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein),NGGKSLSMVDLQD,_SLS(ph)M(ox)VDLQDAR_,S138,+,24.12,22.86,,23.16,22.79,24.33,24.06,24.53,22.98,23.24,23.18,22.54,22.57,23.36,0.75,-0.50, ,-0.20,-0.57,0.97,0.70,1.17,-0.39,-0.12,-0.18,-0.82,-0.79,negative regulation of canonical Wnt receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to tumor necrosis factor;negative regulation of MAP kinase activity;negative regulation of fibroblast proliferation;negative regulation of epithelial cell migration;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;positive regulation of transcription from RNA polymerase II promoter;negative regulation of epithelial to mesenchymal transition;negative regulation of Ras GTPase activity;activation of JUN kinase activity;negative regulation of catenin import into nucleus;cellular response to epidermal growth factor stimulus;negative regulation of epidermal growth factor receptor signaling pathway;negative regulation of transcription from RNA polymerase II promoter;negative regulation of Ras protein signal transduction;positive regulation of apoptotic process,intrinsic to internal side of plasma membrane;cytoplasm,,,,+,,,,,,,,,,
4781,Q5VYS8,ZCCHC6,Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6),SEMEAGSPENKKQ,_DLTSLETTSEM(ox)EAGS(ph)PENKK_,S172,,,23.04,23.04,,,,23.42,23.08,,22.23,,,,22.96, ,0.08,0.08, , , ,0.45,0.12, ,-0.73, , , ,RNA 3'-end processing,,,,,,,,,,,,,,,
4782,Q5VZ89,DENND4C,DENN domain-containing protein 4C,HKERSTSLSALVR,_STS(ph)LSALVR_,S562,,24.31,22.98,23.74,,,,22.37,,,,,24.04,,23.49,0.82,-0.51,0.25, , , ,-1.12, , , , ,0.55, ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4783,Q5VZ89,DENND4C,DENN domain-containing protein 4C,AKHSQPSPEPHSP,_HSQPS(ph)PEPHS(ph)PTEPPAWGSSIVK_,S208,,23.56,23.93,23.93,,,,,,,,,,,23.81,-0.25,0.12,0.12, , , , , , , , , , ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4784,Q5VZ89,DENND4C,DENN domain-containing protein 4C,PSPEPHSPTEPPA,_HSQPS(ph)PEPHS(ph)PTEPPAWGSSIVK_,S213,,23.56,23.93,23.93,,,,,,,,,,,23.81,-0.25,0.12,0.12, , , , , , , , , , ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4785,Q5VZ89,DENND4C,DENN domain-containing protein 4C,QTMKISSVPNSLS,_ISS(ph)VPNSLSK_,S860,+,22.71,23.92,24.21,22.91,21.40,,,22.69,21.38,22.32,22.57,21.87,,22.60,0.12,1.33,1.61,0.31,-1.20, , ,0.09,-1.22,-0.28,-0.03,-0.72, ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4786,Q5VZ89,DENND4C,DENN domain-containing protein 4C,SEDKLFSPVIARN,_LFS(ph)PVIAR_,S462,,24.77,22.52,23.39,20.55,,,,,,23.98,23.44,,,23.11,1.66,-0.59,0.28,-2.56, , , , , ,0.87,0.33, , ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4789,Q5VZ89,DENND4C,DENN domain-containing protein 4C,LGSKSSSMELHRE,_SSS(ph)M(ox)ELHREENR_,S489,,20.56,23.54,23.54,20.30,,,,,,,,,,21.99,-1.42,1.55,1.55,-1.69, , , , , , , , , ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4790,Q5VZ89,DENND4C,DENN domain-containing protein 4C,SIVKVPSGIFDVN,_VPS(ph)GIFDVNSR_,S229,+,23.86,22.29,21.62,22.42,,,21.73,,22.13,,23.79,24.44,,22.79,1.07,-0.49,-1.16,-0.36, , ,-1.06, ,-0.65, ,1.00,1.65, ,protein localization to plasma membrane;protein transport;cellular response to insulin stimulus,cytosol;cytoplasmic vesicle membrane;plasma membrane;insulin-responsive compartment,,,,,,,,,,,,,,
4794,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),QSSPQPSPRTFSQ,_ERDGQSS(ph)PQPS(ph)PR_,S1274,,23.08,,,,20.54,,,,,,,,,21.81,1.27, , , ,-1.27, , , , , , , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4795,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),KIFPGLSPVRIMK,_IFPGLS(ph)PVR_,S122,+,22.19,19.48,,20.59,,,21.69,22.26,,21.59,,21.67,,21.35,0.84,-1.87, ,-0.76, , ,0.34,0.90, ,0.24, ,0.32, ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4799,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),MTEEPSSPKGAVR,_SERPPTILM(ox)TEEPSS(ph)PK_,S1094,+,27.10,25.80,25.80,23.14,,,24.27,22.80,,26.22,24.85,,,25.00,2.10,0.80,0.80,-1.85, , ,-0.72,-2.20, ,1.22,-0.15, , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4800,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),KRDSRKSSGFLNL,_S(ph)SGFLNLIK_,S1067,,21.06,,,,,,,,,,,,,21.06,0.00, , , , , , , , , , , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4801,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),RDSRKSSGFLNLI,_SS(ph)GFLNLIK_,S1068,,21.75,,,,,,,,,,,,,21.75,0.00, , , , , , , , , , , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4802,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),QEVSRRSWGQQAQ,_S(ph)WGQQAQEYQEQK_,S1286,+,24.72,22.80,23.08,24.12,,,22.64,23.58,,,22.94,23.09,,23.37,1.35,-0.57,-0.30,0.75, , ,-0.73,0.20, , ,-0.43,-0.28, ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4803,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),QKPRTASRPDDIP,_TAS(ph)RPDDIPDS(ph)PSS(ph)PK_,S1235,,25.82,,,,,,,,,,,,,25.82,0.00, , , , , , , , , , , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4804,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),PDDIPDSPSSPKV,_TASRPDDIPDS(ph)PSS(ph)PK_,S1243,,28.62,22.48,22.48,,,,,,,22.78,,,,24.09,4.53,-1.61,-1.61, , , , , , ,-1.31, , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4806,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),IPDSPSSPKVALL,_TASRPDDIPDS(ph)PSS(ph)PK_,S1246,+,28.47,24.11,24.11,22.90,22.70,22.48,22.32,22.86,,26.46,,23.44,,23.99,4.49,0.12,0.12,-1.09,-1.29,-1.50,-1.66,-1.12, ,2.47, ,-0.54, ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4807,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),TLPQQESLEIELA,_TLPQQES(ph)LEIELAEEKPVK_,S880,,24.60,,,,,,,,,24.56,23.44,23.81,,24.10,0.49, , , , , , , , ,0.46,-0.66,-0.29, ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
4810,Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),SLVRENSKETFSG,_DFSLVRENS(ph)K_,S162,,22.83,,,22.31,,,,,,,,24.70,,23.28,-0.45, , ,-0.97, , , , , , , ,1.42, ,regulation of cell morphogenesis;multicellular organismal development;cytoskeleton organization,,,,,,,,,,,,,,,
4812,Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),RRGRKKSIVAVEP,_S(ph)IVAVEPR_,S1092,,25.89,19.93,19.93,24.04,,,,,,,,24.30,,22.82,3.07,-2.89,-2.89,1.22, , , , , , , ,1.48, ,regulation of cell morphogenesis;multicellular organismal development;cytoskeleton organization,,,,,,,,,,,,,,,
4813,Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),EDKVTESIEDIKE,_VTES(ph)IEDIK_,S941,+,24.31,24.33,24.86,23.64,,20.38,23.25,,24.19,23.43,21.45,22.63,,23.25,1.06,1.09,1.61,0.39, ,-2.87,0.01, ,0.95,0.18,-1.80,-0.61, ,regulation of cell morphogenesis;multicellular organismal development;cytoskeleton organization,,,,,,,,,,,,,,,
4814,Q5W0B1,RNF219,RING finger protein 219,AEVDNRSPQKFGR,_AEVDNRS(ph)PQK_,S210,,18.42,20.41,20.41,,,,19.46,,,,,,,19.67,-1.26,0.73,0.73, , , ,-0.21, , , , , , ,,,,,,,,,,,,,,,,
4816,Q5W0Z9,ZDHHC20,Probable palmitoyltransferase ZDHHC20 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20) (DHHC-20),MDPEQASVTNQNE,_LVGM(ox)DPEQAS(ph)VTNQNEYAR_,S242,+,23.00,22.69,,23.70,24.80,24.64,24.70,24.40,24.22,23.40,23.81,23.27,23.02,23.81,-0.80,-1.12, ,-0.10,0.99,0.84,0.90,0.60,0.42,-0.40,0.00,-0.54,-0.79,,integral to membrane,,,,,,,,,,,,,,
4818,Q5XUX1,FBXW9,F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9),RTWDDDSDPESET,_TWDDDS(ph)DPESETDPDAQAK_,S18,,23.30,,,22.55,,,,,,,,,,22.93,0.37, , ,-0.37, , , , , , , , , ,,,,,,,,,,,,,,,,
4819,Q5XUX1,FBXW9,F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9),YVARVLSPPKSGL,_VLS(ph)PPK_,S39,,24.43,24.79,24.38,24.05,,,,,,,,,,24.41,0.01,0.37,-0.03,-0.36, , , , , , , , , ,,,,,,,,,,,,,,,,
4821,Q63HK5,TSHZ3,Teashirt homolog 3 (Zinc finger protein 537),DGCKDGSPLAEPV,_DGS(ph)PLAEPVENGK_,S499,,,23.13,23.13,23.56,,,,,24.63,,,22.12,22.35,23.15, ,-0.02,-0.02,0.41, , , , ,1.47, , ,-1.04,-0.81,"kidney smooth muscle cell differentiation;regulation of respiratory gaseous exchange by neurological system process;ureteric bud development;positive regulation of smooth muscle cell differentiation;negative regulation of transcription, DNA-dependent;metanephros development;in utero embryonic development;ureter smooth muscle cell differentiation;sensory perception of touch;lung development;musculoskeletal movement;ureteric peristalsis;transcription, DNA-dependent;kidney morphogenesis",growth cone;mitochondrion;nucleus,C2H2-type,,,,,,,,,,,,,
4823,Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213 (EC 6.3.2.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213),SWTVQESKKKKRK,_ASWTVQES(ph)K_,S88,,22.98,22.53,22.53,23.55,,,,,,,,,,22.90,0.08,-0.37,-0.37,0.65, , , , , , , , , ,protein autoubiquitination,cytoplasm,,,,,,,,,,,,,,
4824,Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213 (EC 6.3.2.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213),LHTSDQSPGKHMV,_DFATPSLHTSDQS(ph)PGK_,S2273,,22.00,23.88,23.88,21.50,22.52,23.54,24.01,23.80,22.57,23.46,22.39,23.34,22.24,23.01,-1.01,0.87,0.87,-1.51,-0.48,0.53,1.00,0.79,-0.44,0.45,-0.62,0.33,-0.77,protein autoubiquitination,cytoplasm,,,,,,,,,,,,,,
4825,Q63HN8,RNF213,E3 ubiquitin-protein ligase RNF213 (EC 6.3.2.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213),EAAELLSEPEEES,_EDQEAAELLS(ph)EPEEESER_,S1258,,24.73,,,,,,,,,,,,,24.73,0.00, , , , , , , , , , , , ,protein autoubiquitination,cytoplasm,,,,,,,,,,,,,,
4826,Q63HR2,TENC1,Tensin-like C1 domain-containing phosphatase (EC 3.1.3.-) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-2),PRAGSISPGSPPY,_AGSIS(ph)PGSPPYPQSR_,S822,,,,,25.09,24.68,25.11,,24.30,,,,,,24.80, , , ,0.29,-0.12,0.32, ,-0.49, , , , , ,negative regulation of cell proliferation;kidney development;multicellular organism growth;cellular homeostasis;multicellular organismal homeostasis;response to muscle activity;collagen metabolic process;intracellular signal transduction,plasma membrane;intracellular;focal adhesion,,,,,,,,,,,,,,
4827,Q63HR2,TENC1,Tensin-like C1 domain-containing phosphatase (EC 3.1.3.-) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-2),TLPRSFSLDPLME,_SFS(ph)LDPLM(ox)ER_,S120,,19.29,,,22.46,22.01,,,,,,,,,21.25,-1.96, , ,1.21,0.76, , , , , , , , ,negative regulation of cell proliferation;kidney development;multicellular organism growth;cellular homeostasis;multicellular organismal homeostasis;response to muscle activity;collagen metabolic process;intracellular signal transduction,plasma membrane;intracellular;focal adhesion,,,,,,,,,,,,,,
4828,Q63HR2,TENC1,Tensin-like C1 domain-containing phosphatase (EC 3.1.3.-) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-2),RLCRSLSEGLYPY,_SLS(ph)EGLYPYPPEM(ox)GK_,S648,,,,,22.35,,,,,,,,,,22.35, , , ,0.00, , , , , , , , , ,negative regulation of cell proliferation;kidney development;multicellular organism growth;cellular homeostasis;multicellular organismal homeostasis;response to muscle activity;collagen metabolic process;intracellular signal transduction,plasma membrane;intracellular;focal adhesion,,,,,,,,,,,,,,
4829,Q63HR2,TENC1,Tensin-like C1 domain-containing phosphatase (EC 3.1.3.-) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-2),DGASPRSPVPTTL,_S(ph)PVPTTLPGLR_,S993,,19.81,,,23.04,,20.61,21.43,,,,,,,21.22,-1.41, , ,1.82, ,-0.61,0.21, , , , , , ,negative regulation of cell proliferation;kidney development;multicellular organism growth;cellular homeostasis;multicellular organismal homeostasis;response to muscle activity;collagen metabolic process;intracellular signal transduction,plasma membrane;intracellular;focal adhesion,,,,,,,,,,,,,,
4830,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),MPGRPESPPVFRS,_ALAM(ox)PGRPES(ph)PPVFR_,S375,+,26.35,23.95,23.69,25.39,27.10,27.17,26.37,26.19,26.50,22.82,25.70,26.52,26.14,25.68,0.66,-1.74,-2.00,-0.29,1.42,1.49,0.69,0.50,0.82,-2.86,0.02,0.84,0.46,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
4831,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),GTPGPASPPAFPA,_(ac)AQVLHVPAPFPGTPGPAS(ph)PPAFPAK_,S19,,26.34,27.02,27.55,27.27,,,27.18,,27.63,24.65,27.02,,,26.83,-0.49,0.19,0.72,0.44, , ,0.35, ,0.79,-2.18,0.19, , ,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
4832,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),PRERVPSVAEAPQ,_ERVPS(ph)VAEAPQLRPAGTAAAK_,S540,+,21.16,22.81,22.81,21.14,,23.90,23.53,,23.65,,22.89,22.72,23.09,22.77,-1.61,0.04,0.04,-1.63, ,1.13,0.76, ,0.88, ,0.12,-0.05,0.32,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
4833,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),RRPRLSSLPRGPG,_LSS(ph)LPR_,S72,,24.19,23.48,,,,,,,,,,,,23.84,0.36,-0.36, , , , , , , , , , , ,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
4834,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),AWPPPDSPVRVDT,_QADPQPQAWPPPDS(ph)PVRVDTVR_,S323,,25.00,,,23.02,25.80,23.42,,,25.20,,24.07,,23.06,24.22,0.78, , ,-1.21,1.58,-0.81, , ,0.98, ,-0.15, ,-1.17,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
4836,Q641Q2,FAM21A,WASH complex subunit FAM21A,KERRTPSDDEEDN,_TPS(ph)DDEEDNLFAPPK_,S245,,24.32,24.28,23.58,25.29,24.66,23.62,26.75,24.93,25.69,25.01,26.56,27.32,25.16,25.17,-0.84,-0.89,-1.59,0.12,-0.51,-1.55,1.58,-0.24,0.52,-0.15,1.39,2.16,-0.01,"retrograde transport, endosome to Golgi",WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
4840,Q659C4,LARP1B,La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2),NSPRIGSPLSPKK,_IGS(ph)PLS(ph)PKK_,S293,,24.96,24.32,,25.79,,,,,,,,,,25.02,-0.06,-0.71, ,0.77, , , , , , , , , ,,,,,,,,,,,,,,,,
4841,Q659C4,LARP1B,La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2),RIGSPLSPKKNSE,_IGS(ph)PLS(ph)PKK_,S296,,24.96,24.32,,25.79,,,,,,,,,,25.02,-0.06,-0.71, ,0.77, , , , , , , , , ,,,,,,,,,,,,,,,,
4842,Q659C4,LARP1B,La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2),GPGENVSEDEAQS,_LNGPGENVS(ph)EDEAQSSNQRK_,S60,+,22.68,23.62,23.62,23.41,,23.72,24.98,24.11,24.00,24.27,23.89,24.08,23.73,23.84,-1.16,-0.22,-0.22,-0.43, ,-0.12,1.14,0.27,0.16,0.43,0.04,0.23,-0.11,,,,,,,,,,,,,,,,
4843,Q66GS9,CEP135,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),IKRRDRSPSRLDT,_DRS(ph)PSRLDTFLK_,S439,,19.29,,,,24.32,,,24.05,,,,,22.39,22.51,-3.22, , , ,1.81, , ,1.54, , , , ,-0.12,G2/M transition of mitotic cell cycle;centriole replication;centriole-centriole cohesion,cytosol;centriole,,,,,,,,,,,,,,
4844,Q66K14,TBC1D9B,TBC1 domain family member 9B,IGSRKASVVDPST,_KAS(ph)VVDPSTESSPAPQEGSEQPASPAS(ph)PLSSR_,S411,,25.66,23.59,,,,,,24.65,,,,26.98,,25.22,0.44,-1.63, , , , , ,-0.57, , , ,1.76, ,positive regulation of Rab GTPase activity,integral to membrane;intracellular,,,,,,,,,,,,,,
4845,Q66K14,TBC1D9B,TBC1 domain family member 9B,GSEQPASPASPLS,_ASVVDPSTESSPAPQEGSEQPAS(ph)PAS(ph)PLSSR_,S432,,24.70,,,21.97,,,,24.41,,,,,,23.69,1.01, , ,-1.73, , , ,0.72, , , , , ,positive regulation of Rab GTPase activity,integral to membrane;intracellular,,,,,,,,,,,,,,
4846,Q66K14,TBC1D9B,TBC1 domain family member 9B,QPASPASPLSSRQ,_ASVVDPSTESSPAPQEGSEQPAS(ph)PAS(ph)PLSSR_,S435,+,26.36,23.94,23.55,24.12,25.86,25.11,26.73,26.93,25.14,24.37,26.14,24.91,25.22,25.26,1.10,-1.32,-1.71,-1.14,0.60,-0.15,1.47,1.67,-0.12,-0.89,0.88,-0.35,-0.04,positive regulation of Rab GTPase activity,integral to membrane;intracellular,,,,,,,,,,,,,,
4847,Q66K14,TBC1D9B,TBC1 domain family member 9B,RPHRNISALKRDL,_NIS(ph)ALKR_,S275,,23.43,,,,,,,,,,,,,23.43,0.00, , , , , , , , , , , , ,positive regulation of Rab GTPase activity,integral to membrane;intracellular,,,,,,,,,,,,,,
4849,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],APGAADSDEDTEG,_AGGLGAEETPPTSVSESLPTLSDSDPVPLAPGAADS(ph)DEDTEGFGVPR_,S809,,27.09,,,,,,,,,,,,,27.09,0.00, , , , , , , , , , , , ,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,,,,,,,,,,
4850,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],MAPAPASPGSSND,_AVPM(ox)APAPAS(ph)PGSSNDSSAR_,S759,+,28.38,28.38,27.98,27.55,27.95,27.48,28.37,28.60,26.98,27.02,28.77,27.24,28.33,27.93,0.46,0.46,0.06,-0.37,0.02,-0.45,0.44,0.67,-0.95,-0.91,0.85,-0.68,0.40,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,,,,,,,,,,
4852,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],SERLSLSPLRGGE,_LSLS(ph)PLR_,S657,+,25.63,26.27,,24.61,24.07,23.53,23.47,24.07,22.02,22.05,25.60,22.91,24.13,24.03,1.60,2.24, ,0.58,0.04,-0.50,-0.56,0.04,-2.01,-1.98,1.57,-1.12,0.10,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,,,,,,,,,,
4854,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],PRPRTPSPESHRS,_T(ph)PS(ph)PESHRSPAEGSER_,S640,,25.35,27.18,,24.75,20.23,,,,,,,,,24.38,0.97,2.80, ,0.38,-4.15, , , , , , , , ,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,,,,,,,,,,
4855,Q66PJ3,ARL6IP4,ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4) (HSP-975) (HSVI-binding protein) (SR-15) (SRp25) (SR-25),LDQWHRSAGEEED,_S(ph)AGEEEDGPVLTDEQK_,S130,+,28.49,26.44,25.90,27.91,26.35,26.84,26.59,27.43,26.09,23.71,26.12,25.27,25.45,26.35,2.14,0.09,-0.45,1.56,-0.01,0.49,0.24,1.08,-0.26,-2.64,-0.24,-1.08,-0.91,RNA splicing,nucleus,,,,,,,,,,,,,,
4856,Q674X7,KAZN,Kazrin,RAADSGSWERVRQ,_AADSGS(ph)WER_,S8,,22.30,,,,20.97,,,,,,,20.77,,21.35,0.95, , , ,-0.38, , , , , , ,-0.58, ,keratinization,nuclear membrane;cornified envelope;desmosome;cytoplasm,,,,,,,,,,,,,,
4857,Q674X7,KAZN,Kazrin,EKMGFGSISRVFA,_M(ox)GFGS(ph)ISR_,S381,,25.16,,,,,,,,,,,,,25.16,0.00, , , , , , , , , , , , ,keratinization,nuclear membrane;cornified envelope;desmosome;cytoplasm,,,,,,,,,,,,,,
4858,Q676U5,ATG16L1,Autophagy-related protein 16-1 (APG16-like 1),RAATRRSVSSFPV,_S(ph)VSSFPVPQDNVDTHPGSGK_,S124,,23.54,,,,,,,,,21.28,23.36,22.94,,22.78,0.76, , , , , , , , ,-1.50,0.58,0.16, ,protein transport;protein homooligomerization;autophagic vacuole assembly,pre-autophagosomal structure membrane;autophagic vacuole membrane;autophagic vacuole,,,,,,,,,,,,,,
4860,Q68CZ2,TNS3,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),KASEAASPLPDSP,_ASEAAS(ph)PLPDSPGDK_,S909,+,24.05,24.60,24.14,26.96,23.87,24.32,,22.43,,,24.92,,24.47,24.42,-0.37,0.19,-0.28,2.55,-0.55,-0.10, ,-1.99, , ,0.50, ,0.05,lung alveolus development;cell migration;positive regulation of cell proliferation,focal adhesion,,,,,,,,,,,,,,
4861,Q68CZ2,TNS3,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),ASPLPDSPGDKLV,_ASEAASPLPDS(ph)PGDK_,S914,+,26.03,23.53,23.82,24.29,24.18,,24.12,23.47,24.44,,24.62,,,24.28,1.76,-0.75,-0.46,0.01,-0.10, ,-0.16,-0.81,0.16, ,0.34, , ,lung alveolus development;cell migration;positive regulation of cell proliferation,focal adhesion,,,,,,,,,,,,,,
4863,Q68CZ2,TNS3,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),GRLRKLSLGQYDN,_KLS(ph)LGQYDNDAGGQLPFSK_,S536,,25.02,,,24.97,24.66,,23.53,,,,,25.96,24.06,24.70,0.32, , ,0.27,-0.04, ,-1.17, , , , ,1.26,-0.64,lung alveolus development;cell migration;positive regulation of cell proliferation,focal adhesion,,,,,,,,,,,,,,
4864,Q68CZ2,TNS3,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),SKVMIGSPKKV__,_VM(ox)IGS(ph)PK_,S1201,,19.80,,,24.36,,,,,,,,,,22.08,-2.28, , ,2.28, , , , , , , , , ,lung alveolus development;cell migration;positive regulation of cell proliferation,focal adhesion,,,,,,,,,,,,,,
4865,Q68D06,SLFN13,Schlafen family member 13,NLINEGSPPSKIM,_YNLINEGS(ph)PPSK_,S170,,22.64,24.03,24.03,20.92,,22.99,,24.39,,,,,,23.17,-0.52,0.86,0.86,-2.24, ,-0.17, ,1.22, , , , , ,,intracellular,,,,,,,,,,,,,,
4866,Q68DA7,FMN1,Formin-1 (Limb deformity protein homolog),GEVKPKSPETALE,_S(ph)PETALEAFK_,S397,,22.35,,,,,,,,,,,,,22.35,0.00, , , , , , , , , , , , ,positive regulation of actin nucleation;positive regulation of actin filament polymerization;forelimb morphogenesis;skeletal system morphogenesis;hindlimb morphogenesis;gene expression;actin cytoskeleton organization,adherens junction;plasma membrane;nucleus;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4867,Q68E01,INTS3,Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A),EFCSSPSPPVEVK,_FPEFCSSPS(ph)PPVEVK_,S501,,22.95,,,,,,,,,23.14,,,,23.04,-0.10, , , , , , , , ,0.10, , , ,DNA repair;G2/M transition checkpoint;snRNA processing;response to ionizing radiation,integrator complex;SOSS complex,,,,,,,,,,,,,,
4868,Q68EM7,ARHGAP17,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),PSPGDGSPPKPKD,_AESSSGGGTVPSSAGILEQGPSPGDGS(ph)PPKPK_,S575,,,,,,23.71,,26.62,25.83,,,,25.96,25.01,25.43, , , , ,-1.72, ,1.19,0.40, , , ,0.54,-0.41,calcium ion-dependent exocytosis;actin filament organization;small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,tight junction;cytosol;membrane,,,,,,,,,,,,,,
4870,Q68EM7,ARHGAP17,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),PPTRSPSPPTQHT,_SPS(ph)PPTQHTGQPPGQPSAPSQLSAPR_,S676,+,23.72,,,24.22,25.30,24.88,25.74,25.57,23.83,,25.94,26.22,23.93,24.94,-1.22, , ,-0.71,0.36,-0.05,0.80,0.63,-1.11, ,1.01,1.29,-1.00,calcium ion-dependent exocytosis;actin filament organization;small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,tight junction;cytosol;membrane,,,,,,,,,,,,,,
4873,Q69YN4,KIAA1429,Protein virilizer homolog,EDQFNGSPPRPQP,_EDQFNGS(ph)PPRPQPR_,S173,+,24.06,25.66,26.14,25.52,,24.79,25.43,,27.69,25.63,25.36,26.54,26.10,25.72,-1.66,-0.06,0.42,-0.20, ,-0.93,-0.29, ,1.97,-0.09,-0.36,0.82,0.37,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
4874,Q69YN4,KIAA1429,Protein virilizer homolog,DYFEPISPDRNSV,_EEDAPHREDYFEPIS(ph)PDR_,S222,+,22.55,22.97,23.58,,,,24.16,,23.58,23.21,23.04,24.76,,23.48,-0.93,-0.51,0.10, , , ,0.68, ,0.10,-0.27,-0.44,1.28, ,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
4875,Q69YN4,KIAA1429,Protein virilizer homolog,SFLSEPSSPGRTK,_SFLSEPS(ph)SPGR_,S1578,,,27.83,,27.07,26.30,,,,25.16,,24.55,,24.56,25.91, ,1.92, ,1.16,0.39, , , ,-0.76, ,-1.36, ,-1.35,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
4876,Q69YN4,KIAA1429,Protein virilizer homolog,FLSEPSSPGRTKT,_SFLSEPSS(ph)PGRTK_,S1579,+,27.61,25.68,26.56,23.78,27.38,28.15,26.30,27.53,27.11,25.72,26.22,24.64,26.32,26.38,1.22,-0.70,0.18,-2.61,1.00,1.77,-0.09,1.15,0.73,-0.67,-0.16,-1.74,-0.07,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
4878,Q69YQ0,SPECC1L,Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like) (SPECC1-like protein),GINEDHSEGDEKS,_AQLGINEDHS(ph)EGDEK_,S220,+,23.07,24.29,23.23,26.53,23.85,26.51,27.19,26.73,26.92,26.02,26.30,26.63,25.88,25.63,-2.56,-1.34,-2.39,0.90,-1.78,0.88,1.56,1.10,1.29,0.39,0.67,1.01,0.26,cell cycle;cell division,gap junction;spindle;cytoplasm,,,,,,,,,,,,,,
4879,Q69YQ0,SPECC1L,Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like) (SPECC1-like protein),GLSRRSSTSSEPT,_RSS(ph)TSSEPTPTVK_,S832,+,22.56,24.41,24.97,25.99,,21.15,,,,22.04,22.31,23.49,21.58,23.17,-0.60,1.25,1.80,2.82, ,-2.02, , , ,-1.13,-0.86,0.33,-1.59,cell cycle;cell division,gap junction;spindle;cytoplasm,,,,,,,,,,,,,,
4880,Q69YQ0,SPECC1L,Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like) (SPECC1-like protein),IPRTPLSPSPMKT,_TPLS(ph)PSPM(ox)K_,S868,,24.67,,,,,,,,21.54,,,,,23.10,1.56, , , , , , , ,-1.56, , , , ,cell cycle;cell division,gap junction;spindle;cytoplasm,,,,,,,,,,,,,,
4882,Q6AI08,HEATR6,HEAT repeat-containing protein 6 (Amplified in breast cancer protein 1),LEETSVSSPKGSS,_APAGPSLEETSVS(ph)SPK_,S489,+,23.13,24.10,23.49,,23.71,,25.13,,24.56,27.67,,,,24.54,-1.41,-0.44,-1.05, ,-0.83, ,0.59, ,0.02,3.13, , , ,,,,,,,,,,,,,,,,
4883,Q6AI08,HEATR6,HEAT repeat-containing protein 6 (Amplified in breast cancer protein 1),EETSVSSPKGSSE,_APAGPSLEETSVSS(ph)PK_,S490,,,,,24.41,,,,24.20,,,,25.35,,24.66, , , ,-0.25, , , ,-0.45, , , ,0.70, ,,,,,,,,,,,,,,,,
4884,Q6AWC2,WWC2,Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2),RLNRSDSDSSTLA,_LNRSDS(ph)DSSTLAK_,S150,+,21.48,21.69,,26.11,,19.50,22.43,,,,22.97,20.42,,22.08,-0.61,-0.39, ,4.02, ,-2.59,0.35, , , ,0.88,-1.67, ,,,,,,,,,,,,,,,,
4886,Q6BAA4,FCRLB,Fc receptor-like B (Fc receptor homolog expressed in B-cells protein 2) (FREB-2) (Fc receptor-like and mucin-like protein 2) (Fc receptor-like protein 2) (Fc receptor-related protein Y) (FcRY),PGNRPLSFRKPPV,_PLS(ph)FRK_,S315,,21.27,24.02,24.32,24.24,,,21.75,,21.77,20.97,21.68,22.47,20.73,22.32,-1.05,1.70,2.00,1.92, , ,-0.57, ,-0.56,-1.35,-0.64,0.15,-1.59,,endoplasmic reticulum;cytoplasm,,,,,,,,,,,,,,
4889,Q6DN12,MCTP2,Multiple C2 and transmembrane domain-containing protein 2,KPSVWGSLKQRTR,_(ac)M(ox)DLDKPSVWGS(ph)LK_,S11,,23.01,,,22.26,,,,,,,,22.77,,22.68,0.33, , ,-0.42, , , , , , , ,0.09, ,calcium-mediated signaling,integral to membrane,,,,,,,,,,,,,,
4890,Q6DN90,IQSEC1,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein),NMRMQFSFEGPEK,_M(ox)QFS(ph)FEGPEK_,S58,,23.68,22.66,,24.85,,22.15,23.28,22.49,22.29,21.95,,25.84,22.61,23.18,0.50,-0.52, ,1.67, ,-1.03,0.10,-0.69,-0.89,-1.23, ,2.66,-0.57,regulation of ARF protein signal transduction;actin cytoskeleton organization,nucleolus;cell junction;cytoplasm,,,,,,,,,,,,,,
4893,Q6GQQ9,OTUD7B,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),TPESGDSDKESVG,_STPESGDS(ph)DKESVGSSSTSNEGGR_,S467,,,,,,23.02,21.83,,23.61,,,21.45,,,22.48, , , , ,0.55,-0.64, ,1.13, , ,-1.03, , ,protein deubiquitination;proteolysis;negative regulation of I-kappaB kinase/NF-kappaB cascade,microtubule cytoskeleton;nucleus;cytoplasm,,,,,,,,,,,,,,
4894,Q6GQQ9,OTUD7B,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),PLAQPESPTASAG,_WIPLSSDAQAPLAQPES(ph)PTASAGDEPR_,S449,,24.21,,,,24.11,,,,,,23.93,,,24.08,0.12, , , ,0.03, , , , , ,-0.15, , ,protein deubiquitination;proteolysis;negative regulation of I-kappaB kinase/NF-kappaB cascade,microtubule cytoskeleton;nucleus;cytoplasm,,,,,,,,,,,,,,
4895,Q6GYQ0,RALGAPA1,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),TMTRRGSSPGSLE,_RGS(ph)SPGSLEIPK_,S860,+,24.08,24.01,24.01,20.32,,,24.85,,,23.58,24.64,23.61,24.24,23.70,0.37,0.31,0.31,-3.38, , ,1.15, , ,-0.13,0.93,-0.09,0.54,"activation of Ral GTPase activity;regulation of transcription, DNA-dependent",cytosol;mitochondrion;nucleus,,,,,,,,,,,,,,
4898,Q6GYQ0,RALGAPA1,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),PLPRSSSTSDILE,_SSS(ph)TSDILEPFTVER_,S797,,24.99,,,,25.35,23.47,,,,24.73,25.23,,22.92,24.45,0.54, , , ,0.90,-0.98, , , ,0.28,0.78, ,-1.53,"activation of Ral GTPase activity;regulation of transcription, DNA-dependent",cytosol;mitochondrion;nucleus,,,,,,,,,,,,,,
4901,Q6H8Q1,ABLIM2,Actin-binding LIM protein 2 (abLIM-2) (Actin-binding LIM protein family member 2),KQCRTSSPSSTGS,_TSS(ph)PSSTGSVSLGR_,S132,,24.40,,,,,,,,,,23.84,,,24.12,0.28, , , , , , , , , ,-0.28, , ,cytoskeleton organization;axon guidance,intermediate filament cytoskeleton;nucleus;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4904,Q6IAA8,LAMTOR1,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),LLLDPSSPPTKAL,_LLLDPSS(ph)PPTK_,S27,+,24.24,25.32,25.88,24.74,25.66,25.36,26.29,25.96,25.09,26.21,25.53,25.38,26.39,25.54,-1.31,-0.22,0.34,-0.80,0.12,-0.18,0.75,0.42,-0.45,0.67,-0.01,-0.16,0.85,regulation of cholesterol efflux;regulation of cholesterol esterification;lysosome organization;endosome organization;positive regulation of MAPK cascade;cellular response to amino acid stimulus;cellular protein localization;cell growth;positive regulation of TOR signaling cascade;regulation of receptor recycling;regulation of cholesterol import;cholesterol homeostasis;lysosome localization;endosome localization,Ragulator complex;Golgi apparatus;plasma membrane;lysosomal membrane;lysosome,,,,,,,,,,,,,,
4906,Q6IAA8,LAMTOR1,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),EQALLSSILAKTA,_TDEQALLSS(ph)ILAK_,S56,+,22.38,,,24.87,25.08,26.31,23.97,24.90,,,,25.47,25.26,24.78,-2.40, , ,0.09,0.30,1.53,-0.81,0.12, , , ,0.69,0.48,regulation of cholesterol efflux;regulation of cholesterol esterification;lysosome organization;endosome organization;positive regulation of MAPK cascade;cellular response to amino acid stimulus;cellular protein localization;cell growth;positive regulation of TOR signaling cascade;regulation of receptor recycling;regulation of cholesterol import;cholesterol homeostasis;lysosome localization;endosome localization,Ragulator complex;Golgi apparatus;plasma membrane;lysosomal membrane;lysosome,,,,,,,,,,,,,,
4907,Q6IBW4,NCAPH2,Condensin-2 complex subunit H2 (Chromosome-associated protein H2) (hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2),EPKESRSPQQSAA,_ESRS(ph)PQQSAALPR_,S262,+,19.95,23.24,23.24,22.54,23.84,22.68,22.79,22.66,20.80,22.03,,,21.25,22.28,-2.32,0.97,0.97,0.27,1.56,0.41,0.51,0.38,-1.48,-0.24, , ,-1.02,chromosome condensation,chromosome;nucleus,,,,,,,,,,,,,,
4908,Q6IN85,SMEK1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),NLSGRQSPSFKLS,_TNLSGRQS(ph)PSFK_,S741,+,23.73,23.12,23.87,22.31,23.53,,,,,22.59,21.42,,,22.94,0.79,0.18,0.93,-0.63,0.59, , , , ,-0.35,-1.52, , ,,nucleus;microtubule organizing center,,,,,,,,,,,,,,
4910,Q6IN85,SMEK1,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),SPGSPGSPGSPGS,_TNLTSQSSTTNLPGSPGSPGS(ph)PGS(ph)PGSPGSVPK_,S774,,23.68,23.18,23.18,,22.96,,23.83,23.73,,,,,,23.43,0.26,-0.25,-0.25, ,-0.47, ,0.40,0.30, , , , , ,,nucleus;microtubule organizing center,,,,,,,,,,,,,,
4912,Q6IPX3,TCEAL6,Transcription elongation factor A protein-like 6 (TCEA-like protein 6) (Transcription elongation factor S-II protein-like 6),PDDEGKSDEEEKP,_S(ph)DEEEKPDAEGK_,S30,,22.53,23.11,23.11,,,,,,,,,,,22.92,-0.39,0.20,0.20, , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
4913,Q6IQ22,RAB12,Ras-related protein Rab-12,GGLGAGSPALSGG,_AGGGGGLGAGS(ph)PALSGGQGR_,S21,+,24.35,24.49,,22.42,24.19,25.05,23.56,23.77,25.36,24.87,23.43,23.19,24.33,24.09,0.27,0.41, ,-1.67,0.11,0.97,-0.52,-0.32,1.27,0.78,-0.66,-0.89,0.25,endosome to lysosome transport;cellular protein catabolic process;protein transport;small GTPase mediated signal transduction,Golgi membrane;recycling endosome membrane;lysosome,,,,,,,,,,,,,,
4914,Q6IQ22,RAB12,Ras-related protein Rab-12,GQERFNSITSAYY,_FNS(ph)ITSAYYR_,S106,,22.93,23.25,,21.11,23.06,21.99,,,21.38,,,,,22.29,0.64,0.97, ,-1.17,0.78,-0.30, , ,-0.91, , , , ,endosome to lysosome transport;cellular protein catabolic process;protein transport;small GTPase mediated signal transduction,Golgi membrane;recycling endosome membrane;lysosome,,,,,,,,,,,,,,
4915,Q6IQ23,PLEKHA7,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),DRSKARSPYSPAE,_ARS(ph)PYSPAEEDALFM(ox)DLPTGPR_,S363,,21.68,,,,23.48,,,24.42,,,,,24.71,23.57,-1.89, , , ,-0.09, , ,0.84, , , , ,1.14,zonula adherens maintenance;epithelial cell-cell adhesion,zonula adherens;nucleus;centrosome,,,,,,,,,,,,,,
4916,Q6IQ23,PLEKHA7,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),QLRKVTSPLQSPT,_VTS(ph)PLQSPTK_,S903,,25.63,24.30,24.30,,,,,,,23.52,,,,24.44,1.19,-0.13,-0.13, , , , , , ,-0.92, , , ,zonula adherens maintenance;epithelial cell-cell adhesion,zonula adherens;nucleus;centrosome,,,,,,,,,,,,,,
4917,Q6IQ23,PLEKHA7,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),VTSPLQSPTKAKP,_KVTS(ph)PLQS(ph)PTK_,S907,,25.40,,,,,,,,,,,,,25.40,0.00, , , , , , , , , , , , ,zonula adherens maintenance;epithelial cell-cell adhesion,zonula adherens;nucleus;centrosome,,,,,,,,,,,,,,
4918,Q6IQ23,PLEKHA7,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),DISLGDSPRRARG,_SVDISLGDS(ph)PRR_,S612,+,20.61,22.54,,,23.25,23.83,22.96,24.53,,23.44,22.59,,26.06,23.31,-2.71,-0.77, , ,-0.07,0.52,-0.35,1.22, ,0.13,-0.72, ,2.75,zonula adherens maintenance;epithelial cell-cell adhesion,zonula adherens;nucleus;centrosome,,,,,,,,,,,,,,
4919,Q6IQ23,PLEKHA7,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),KPPPQPSPPTSPV,_TVPLFPHPPVPSLSTSESKPPPQPS(ph)PPT(ph)SPVRTPLEVR_,S867,,22.48,23.52,23.52,,,,,25.83,,26.58,24.81,,,24.46,-1.97,-0.94,-0.94, , , , ,1.38, ,2.12,0.36, , ,zonula adherens maintenance;epithelial cell-cell adhesion,zonula adherens;nucleus;centrosome,,,,,,,,,,,,,,
4921,Q6IQ26,DENND5A,DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1),KLQRFNSYDISRD,_FNS(ph)YDISR_,S169,,20.35,24.14,,23.83,,,,,,,,,,22.78,-2.42,1.37, ,1.06, , , , , , , , , ,,Golgi apparatus,,,,,,,,,,,,,,
4923,Q6JBY9,RCSD1,CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1),MVSPFHSPPSTPS,_AM(ox)VSPFHS(ph)PPSTPSSPGVR_,S90,+,,24.00,24.77,,24.67,22.81,25.66,25.98,24.18,21.63,25.63,22.27,23.08,24.06, ,-0.06,0.71, ,0.61,-1.25,1.59,1.92,0.12,-2.43,1.57,-1.79,-0.98,skeletal muscle contraction;cellular hyperosmotic response,actin filament,,,,,,,,,,,,,,
4925,Q6JBY9,RCSD1,CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1),KSKAPGSPLSSEG,_APGS(ph)PLSSEGAAGEGVR_,S186,+,,25.69,26.10,23.86,27.39,25.34,29.30,29.82,27.75,21.88,30.16,23.74,25.94,26.42, ,-0.72,-0.31,-2.55,0.98,-1.07,2.89,3.41,1.33,-4.54,3.75,-2.68,-0.47,skeletal muscle contraction;cellular hyperosmotic response,actin filament,,,,,,,,,,,,,,
4932,Q6KB66,KRT80,"Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)",MSEKYFSQESEVS,_YFS(ph)QESEVSE_,S445,,,,,,,21.53,21.58,,,23.17,,,23.48,22.44, , , , , ,-0.91,-0.86, , ,0.73, , ,1.04,,keratin filament,,,,,,,,,,,,,,
4933,Q6KB66,KRT80,"Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)",SQESEVSE_____,_YFSQESEVS(ph)E_,S451,,24.27,22.39,22.67,,24.40,,25.14,26.04,22.86,25.22,26.11,24.79,25.35,24.48,-0.21,-2.08,-1.81, ,-0.08, ,0.66,1.56,-1.62,0.75,1.64,0.31,0.88,,keratin filament,,,,,,,,,,,,,,
4934,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),MYDIISSPSKDST,_AAM(ox)YDIISS(ph)PSK_,S350,,,25.92,25.92,25.09,23.32,26.41,,,26.27,25.27,,,,25.46, ,0.46,0.46,-0.37,-2.14,0.95, , ,0.81,-0.18, , , ,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
4935,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),SLLGGGSPKNNTA,_AITSLLGGGS(ph)PK_,S2658,+,28.02,27.56,28.16,27.56,28.06,28.32,28.09,27.73,28.41,28.35,26.55,27.16,27.81,27.83,0.19,-0.27,0.33,-0.27,0.23,0.49,0.26,-0.10,0.58,0.52,-1.28,-0.67,-0.01,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
4938,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),PKYAEISSDEDND,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSRK_,S1089,,23.36,,,,,,,,,,,,,23.36,0.00, , , , , , , , , , , , ,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
4939,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),KYAEISSDEDNDS,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSRK_,S1090,,23.36,,,,,,,,,,,,,23.36,0.00, , , , , , , , , , , , ,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
4940,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),SDEDNDSDEAFES,_YAEIS(ph)S(ph)DEDNDS(ph)DEAFESSRK_,S1096,,23.36,,,,,,,,,,,,,23.36,0.00, , , , , , , , , , , , ,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
4944,Q6MZP7,LIN54,Protein lin-54 homolog (CXC domain-containing protein 1),PNKIAISPLKSPN,_IAIS(ph)PLKS(ph)PNK_,S89,+,23.29,24.54,24.54,22.13,21.74,,22.07,,21.42,21.96,,,,22.71,0.58,1.83,1.83,-0.58,-0.97, ,-0.64, ,-1.29,-0.75, , , ,"mitotic cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm,Other TF domain,,,,,,,,,,,,,
4945,Q6MZP7,LIN54,Protein lin-54 homolog (CXC domain-containing protein 1),AISPLKSPNKAVK,_IAIS(ph)PLKS(ph)PNK_,S93,+,22.87,24.32,24.32,21.47,23.58,,22.14,23.31,,20.91,,,,22.86,0.01,1.45,1.45,-1.40,0.71, ,-0.73,0.45, ,-1.95, , , ,"mitotic cell cycle;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm,Other TF domain,,,,,,,,,,,,,
4946,Q6MZQ0,PRR5L,Proline-rich protein 5-like (Protein observed with Rictor-2) (Protor-2),PRPRFMSSPVLSD,_FM(ox)S(ph)SPVLSDLPR_,S28,,22.25,,,21.16,22.05,,,,,,,24.40,,22.47,-0.21, , ,-1.31,-0.42, , , , , , ,1.94, ,,mitochondrion,,,,,,,,,,,,,,
4950,Q6NSJ2,PHLDB3,Pleckstrin homology-like domain family B member 3,EEEDRDSPGPQVP,_(gl)QEEEDRDS(ph)PGPQVPDPK_,S254,,23.29,,,,,,,,,,,,,23.29,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4952,Q6NUK4,REEP3,Receptor expression-enhancing protein 3,EAEGPYSDNEMLT,_TDEEAEGPYS(ph)DNEM(ox)LTHK_,S210,+,23.80,25.43,25.91,24.92,,23.39,24.37,23.48,27.40,26.74,24.92,24.34,23.99,24.89,-1.09,0.54,1.02,0.03, ,-1.50,-0.52,-1.41,2.51,1.85,0.03,-0.55,-0.90,,integral to membrane,,,,,,,,,,,,,,
4954,Q6NUM9,RETSAT,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",LKGKRGSDYETFK,_RGS(ph)DYETFK_,S484,,,,,,,22.03,21.82,21.80,23.64,24.04,23.86,23.65,,22.98, , , , , ,-0.95,-1.16,-1.17,0.67,1.06,0.88,0.68, ,retinol metabolic process,endoplasmic reticulum membrane;nuclear outer membrane,,,,,,,,,,,,,,
4955,Q6NV74,KIAA1211L,Uncharacterized protein KIAA1211-like,STAPAPSPPAPKS,_IGTEPSTAPAPS(ph)PPAPK_,S490,,23.50,22.88,,,,,,22.50,,,,,,22.96,0.54,-0.08, , , , , ,-0.46, , , , , ,,,,,,,,,,,,,,,,
4956,Q6NWY9,PRPF40B,Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C),AELPNRSPGFGIK,_DRELQQAELPNRS(ph)PGFGIK_,S819,,,,,,,,23.59,,24.62,23.60,,22.36,,23.54, , , , , , ,0.04, ,1.08,0.06, ,-1.18, ,mRNA processing;RNA splicing,nuclear speck,,,,,,,,,,,,,,
4960,Q6NXT4,SLC30A6,Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6),TPAKPSSPPPEFS,_GTDDLNPVTSTPAKPSS(ph)PPPEFSFNTPGK_,S185,,23.49,23.10,23.10,,,,,,24.77,24.33,,,,23.76,-0.27,-0.66,-0.66, , , , , ,1.02,0.57, , , ,zinc ion transport;transmembrane transport,integral to membrane;Golgi membrane,,,,,,,,,,,,,,
4963,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),EVESRLSPGESAY,_LS(ph)PGESAYQK_,S224,+,24.01,25.55,25.52,26.61,25.15,25.53,25.91,25.09,26.14,,25.77,,24.78,25.46,-1.45,0.09,0.06,1.15,-0.31,0.07,0.45,-0.37,0.68, ,0.31, ,-0.68,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4964,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),AESREQSPRRKEV,_LAESREQS(ph)PR_,S213,,,24.44,24.44,,22.22,22.31,22.31,22.46,22.87,,22.08,23.10,23.06,22.93, ,1.51,1.51, ,-0.71,-0.62,-0.62,-0.47,-0.06, ,-0.85,0.17,0.13,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4965,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),AEKLLESPGVEAG,_LLES(ph)PGVEAGEGEAEKEEAGAQGRPLR_,S368,+,26.27,26.51,26.92,26.81,24.92,26.24,28.15,26.09,28.29,27.78,27.91,26.22,26.78,26.84,-0.57,-0.32,0.08,-0.03,-1.92,-0.59,1.31,-0.75,1.46,0.95,1.07,-0.62,-0.06,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4966,Q6NYC8,PPP1R18,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),PPPAPLSPPPPAP,_(gl)QQEEEAVELQPPPPAPLS(ph)PPPPAPTAPQPPGDPLM(ox)SR_,S432,,24.89,,,24.15,,,,,,,24.93,,,24.66,0.24, , ,-0.51, , , , , , ,0.27, , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
4968,Q6P582,MZT2A,Mitotic-spindle organizing protein 2A (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A),RMPRQPSATRLPK,_(gl)QPS(ph)ATRLPK_,S103,+,25.21,25.08,25.18,26.39,25.48,24.79,25.42,25.49,24.51,23.31,24.72,25.89,24.79,25.10,0.12,-0.02,0.08,1.29,0.38,-0.31,0.32,0.39,-0.59,-1.79,-0.38,0.80,-0.30,,gamma-tubulin ring complex;centrosome;spindle,,,,,,,,,,,,,,
4969,Q6NZI2,PTRF,Polymerase I and transcript release factor (Cavin-1),KLPAKLSISKSLK,_LPAKLS(ph)ISK_,S149,+,24.24,28.68,27.65,27.81,29.21,29.91,29.46,29.53,29.74,25.63,29.91,28.48,30.35,28.51,-4.27,0.17,-0.86,-0.69,0.70,1.40,0.95,1.02,1.24,-2.88,1.40,-0.03,1.84,"transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;regulation of transcription, DNA-dependent",nucleoplasm;cytosol;caveola;mitochondrion;endoplasmic reticulum,,,,,,,,,,,,,,
4974,Q6NZI2,PTRF,Polymerase I and transcript release factor (Cavin-1),KLSISKSLKESEA,_S(ph)LKESEALPEK_,S153,+,,,,,22.62,26.96,22.39,26.17,,21.27,,,27.55,24.49, , , , ,-1.87,2.47,-2.11,1.67, ,-3.22, , ,3.05,"transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;regulation of transcription, DNA-dependent",nucleoplasm;cytosol;caveola;mitochondrion;endoplasmic reticulum,,,,,,,,,,,,,,
4975,Q6NZI2,PTRF,Polymerase I and transcript release factor (Cavin-1),VKTVRGSLERQAG,_TVRGS(ph)LER_,S109,,,26.98,27.56,24.81,,22.41,,,21.67,20.08,21.47,,,23.57, ,3.41,3.99,1.24, ,-1.15, , ,-1.90,-3.49,-2.10, , ,"transcription initiation from RNA polymerase I promoter;termination of RNA polymerase I transcription;regulation of transcription, DNA-dependent",nucleoplasm;cytosol;caveola;mitochondrion;endoplasmic reticulum,,,,,,,,,,,,,,
4976,Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8,PLTPSDSPQTRTA,_GTPPLTPSDS(ph)PQTR_,S500,+,21.76,,,22.68,22.90,23.32,22.71,,22.40,22.81,,,22.58,22.65,-0.88, , ,0.04,0.26,0.68,0.06, ,-0.24,0.16, , ,-0.07,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
4977,Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8,TATKIHSPIPDMS,_IHS(ph)PIPDM(ox)SK_,S658,,19.81,24.77,25.36,,22.79,,,,22.37,22.15,,,,22.88,-3.06,1.89,2.48, ,-0.09, , , ,-0.51,-0.72, , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
4978,Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8,LFPADTSPSTATK,_LFPADTS(ph)PSTATK_,S649,,,24.37,24.50,,,25.04,,,24.70,24.30,,,25.50,24.74, ,-0.37,-0.24, , ,0.30, , ,-0.04,-0.43, , ,0.77,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
4980,Q6P0Q8,MAST2,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),LLFRKLSNPDIFS,_KLS(ph)NPDIFSSTGK_,S74,+,,,,23.12,23.52,23.39,,24.49,,,24.51,24.77,23.82,23.95, , , ,-0.82,-0.43,-0.56, ,0.55, , ,0.56,0.83,-0.13,regulation of interleukin-12 biosynthetic process;protein phosphorylation;spermatid differentiation,microtubule cytoskeleton;plasma membrane;cytoplasm,,+,,,,,,,,,,,,
4981,Q6P0Q8,MAST2,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),PTKLHLSPPLGRQ,_LHLS(ph)PPLGR_,S1381,,,21.11,21.11,20.65,22.40,21.84,23.00,23.14,21.53,21.68,23.10,23.93,22.47,22.16, ,-1.06,-1.06,-1.52,0.24,-0.32,0.84,0.98,-0.64,-0.48,0.94,1.77,0.31,regulation of interleukin-12 biosynthetic process;protein phosphorylation;spermatid differentiation,microtubule cytoskeleton;plasma membrane;cytoplasm,,+,,,,,,,,,,,,
4982,Q6P0Q8,MAST2,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),NQSLGQSAPSLTA,_NQSLGQS(ph)APSLTAGLK_,S148,,,,,25.02,,,,,,,,,,25.02, , , ,0.00, , , , , , , , , ,regulation of interleukin-12 biosynthetic process;protein phosphorylation;spermatid differentiation,microtubule cytoskeleton;plasma membrane;cytoplasm,,+,,,,,,,,,,,,
4983,Q6P158,DHX57,Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57),QDADAGSERGLSG,_DLQEQDADAGS(ph)ER_,S127,+,23.34,24.14,,25.70,23.60,22.53,22.96,23.01,,,,,,23.61,-0.27,0.53, ,2.09,-0.01,-1.08,-0.65,-0.60, , , , , ,,,,,,,,,,,,,,,,
4984,Q6P1L5,FAM117B,Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein),APGARGSPPRPPP,_GS(ph)PPRPPPPPPLLGTVS(ph)SPS(ph)SSPTHLWTGEVSAAPPPAR_,S136,,23.98,,,,,,,,,,,,,23.98,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
4988,Q6P1L5,FAM117B,Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein),SHKRSASWGSTDQ,_SAS(ph)WGSTDQLK_,S273,,23.68,,,,,,,21.40,,,,,,22.54,1.14, , , , , , ,-1.14, , , , , ,,,,,,,,,,,,,,,,
4992,Q6P1M3,LLGL2,Lethal(2) giant larvae protein homolog 2 (HGL),DPNENFSAQGEDE,_VFLTDTDPNENFS(ph)AQGEDEWPPLRK_,S469,,23.76,,,,,,,,,24.72,,,,24.24,-0.48, , , , , , , , ,0.48, , , ,regulation of establishment or maintenance of cell polarity;exocytosis;cell cycle;cell division,intracellular membrane-bounded organelle;cytoplasm,,,,,,,,,,,,,,
4993,Q6P1N0,CC2D1A,Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1) (Putative NF-kappa-B-activating protein 023N),ATAPASSPGLAKP,_VTLEGPSATAPASS(ph)PGLAK_,S239,,24.94,,,,,,,,,,23.87,,,24.40,0.54, , , , , , , , , ,-0.54, , ,positive regulation of I-kappaB kinase/NF-kappaB cascade,nucleus;microtubule organizing center,Other TF domain,,,,,,,,,,,,,
4995,Q6P1X5,TAF2,Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150),KEPFTFSSPASGR,_DKEPFTFS(ph)S(ph)PASGR_,S1184,+,22.46,24.48,24.85,24.26,,,21.54,,24.06,23.49,,,23.65,23.60,-1.14,0.88,1.25,0.66, , ,-2.06, ,0.46,-0.11, , ,0.05,transcription initiation from RNA polymerase II promoter;G2/M transition of mitotic cell cycle;response to organic cyclic compound;positive regulation of transcription from RNA polymerase II promoter,transcription factor TFTC complex;transcription factor TFIID complex,,,,,,,,,,,,,,
4996,Q6P1X5,TAF2,Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150),EPFTFSSPASGRS,_DKEPFTFSS(ph)PASGR_,S1185,+,24.27,24.52,24.59,24.51,23.36,24.04,25.48,23.58,,24.56,,24.09,23.84,24.26,0.02,0.26,0.33,0.25,-0.89,-0.21,1.22,-0.68, ,0.30, ,-0.17,-0.42,transcription initiation from RNA polymerase II promoter;G2/M transition of mitotic cell cycle;response to organic cyclic compound;positive regulation of transcription from RNA polymerase II promoter,transcription factor TFTC complex;transcription factor TFIID complex,,,,,,,,,,,,,,
4997,Q6P1X5,TAF2,Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150),TFSSPASGRSIRS,_DKEPFTFS(ph)SPAS(ph)GR_,S1188,,22.46,24.21,24.40,24.26,,,21.54,,,,,,,23.37,-0.91,0.83,1.02,0.89, , ,-1.83, , , , , , ,transcription initiation from RNA polymerase II promoter;G2/M transition of mitotic cell cycle;response to organic cyclic compound;positive regulation of transcription from RNA polymerase II promoter,transcription factor TFTC complex;transcription factor TFIID complex,,,,,,,,,,,,,,
4998,Q6P2E9,EDC4,Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls),DASAEQSDHDDEV,_DSQDASAEQS(ph)DHDDEVASLASASGGFGTK_,S879,,22.89,,,,23.46,,,,24.57,24.43,,24.03,,23.87,-0.99, , , ,-0.42, , , ,0.70,0.56, ,0.15, ,gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,cytosol;nucleus;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5000,Q6P3S6,FBXO42,F-box only protein 42 (Just one F-box and Kelch domain-containing protein),LAPRRGSLPDQKD,_RGS(ph)LPDQK_,S488,,24.12,23.32,23.20,24.72,20.98,,,,19.97,20.00,,,,22.33,1.79,0.99,0.86,2.39,-1.35, , , ,-2.36,-2.33, , , ,,,,,,,,,,,,,,,,
5001,Q6P3W7,SCYL2,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),NKHKRASLTLEEK,_RAS(ph)LTLEEK_,S677,+,24.10,25.73,25.76,24.62,,23.05,24.40,23.53,24.09,24.02,25.18,25.25,23.11,24.40,-0.30,1.33,1.36,0.22, ,-1.35,0.00,-0.87,-0.32,-0.38,0.77,0.85,-1.29,endosome to lysosome transport;receptor internalization involved in canonical Wnt receptor signaling pathway;negative regulation of canonical Wnt receptor signaling pathway;positive regulation of receptor internalization;positive regulation of clathrin-mediated endocytosis,endosome membrane;Golgi apparatus;clathrin-coated vesicle;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
5003,Q6P4E1,CASC4,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),VDPQHGSKLADYN,_FFDENESPVDPQHGS(ph)K_,S353,,,,,22.01,23.47,25.71,23.60,24.62,23.83,24.28,23.55,25.00,25.02,24.11, , , ,-2.09,-0.64,1.60,-0.51,0.51,-0.28,0.17,-0.56,0.89,0.91,,integral to membrane,,,,,,,,,,,,,,
5004,Q6P4E1,CASC4,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),QRLIPGSNLDSEP,_LIPGS(ph)NLDS(ph)EPR_,S307,,24.61,23.50,23.03,24.36,24.64,26.41,23.47,25.29,25.04,24.65,24.91,24.12,25.75,24.60,0.01,-1.10,-1.57,-0.23,0.05,1.81,-1.13,0.69,0.44,0.05,0.32,-0.48,1.15,,integral to membrane,,,,,,,,,,,,,,
5005,Q6P4E1,CASC4,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),PGSNLDSEPRIQT,_LIPGS(ph)NLDS(ph)EPR_,S311,,24.95,25.88,24.52,23.26,23.40,24.31,,22.22,23.68,23.66,28.20,23.95,24.00,24.34,0.61,1.54,0.18,-1.08,-0.93,-0.03, ,-2.11,-0.66,-0.67,3.86,-0.39,-0.33,,integral to membrane,,,,,,,,,,,,,,
5006,Q6P4Q7,CNNM4,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),PLSRSASLSYPDR,_SAS(ph)LSYPDR_,S664,,24.89,23.36,22.44,,,,,,,,,,,23.56,1.33,-0.20,-1.12, , , , , , , , , , ,response to stimulus;visual perception;ion transport;biomineral tissue development,integral to membrane;plasma membrane,,,,,,,,,,,,,,
5007,Q6P4Q7,CNNM4,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),AHPTPLSRSASLS,_SPAHPTPLS(ph)R_,S660,,24.46,,,21.30,,,,,,,,,,22.88,1.58, , ,-1.58, , , , , , , , , ,response to stimulus;visual perception;ion transport;biomineral tissue development,integral to membrane;plasma membrane,,,,,,,,,,,,,,
5008,Q6P4R8,NFRKB,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),VVTTAPSPKQAPE,_AVSTVVVTTAPS(ph)PK_,S1290,+,24.40,24.22,24.64,23.95,25.33,25.64,25.14,24.17,25.25,25.06,23.54,25.27,25.25,24.76,-0.36,-0.54,-0.12,-0.81,0.57,0.88,0.38,-0.59,0.49,0.31,-1.22,0.52,0.49,"DNA repair;inflammatory response;regulation of transcription, DNA-dependent;DNA recombination;transcription from RNA polymerase II promoter",Ino80 complex,Other TF domain,,,,,,,,,,,,,
5009,Q6P4R8,NFRKB,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),SPARSPSPAVPLR,_SPS(ph)PAVPLR_,S228,,24.05,23.39,,21.14,19.59,23.43,21.63,,,,,,,22.21,1.85,1.19, ,-1.07,-2.61,1.22,-0.57, , , , , , ,"DNA repair;inflammatory response;regulation of transcription, DNA-dependent;DNA recombination;transcription from RNA polymerase II promoter",Ino80 complex,Other TF domain,,,,,,,,,,,,,
5010,Q6P597,KLC3,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),GMKRAMSLNTLNV,_AM(ox)S(ph)LNTLNVDAPR_,S465,,26.09,,,,,,21.33,,,,,25.13,,24.18,1.91, , , , , ,-2.86, , , , ,0.95, ,,neuron projection;kinesin complex;microtubule-based flagellum;ciliary rootlet;microtubule;cytoplasm,,,,,,,,,,,,,,
5011,Q6P597,KLC3,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),KAPRTLSASTQDL,_TLS(ph)ASTQDLS(ph)PH_,S494,,25.22,,,,,,,,,,,,,25.22,0.00, , , , , , , , , , , , ,,neuron projection;kinesin complex;microtubule-based flagellum;ciliary rootlet;microtubule;cytoplasm,,,,,,,,,,,,,,
5012,Q6P597,KLC3,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),PRTLSASTQDLSP,_TLSAS(ph)TQDLSPH_,S496,+,27.44,22.42,,22.23,21.88,,23.79,23.72,,,,25.69,,23.88,3.56,-1.46, ,-1.65,-2.00, ,-0.09,-0.16, , , ,1.81, ,,neuron projection;kinesin complex;microtubule-based flagellum;ciliary rootlet;microtubule;cytoplasm,,,,,,,,,,,,,,
5013,Q6P597,KLC3,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),ASTQDLSPH____,_TLSASTQDLS(ph)PH_,S501,+,26.34,24.36,24.36,,22.10,,22.48,23.16,,23.65,23.95,22.13,,23.61,2.73,0.74,0.74, ,-1.51, ,-1.13,-0.45, ,0.04,0.34,-1.49, ,,neuron projection;kinesin complex;microtubule-based flagellum;ciliary rootlet;microtubule;cytoplasm,,,,,,,,,,,,,,
5016,Q6P6C2,ALKBH5,RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),RKYQEDSDPERSD,_YQEDS(ph)DPERS(ph)DYEEQQLQK_,S64,+,24.09,23.76,22.86,23.24,,,24.61,,25.01,24.09,23.21,24.44,,23.92,0.17,-0.16,-1.07,-0.68, , ,0.69, ,1.09,0.17,-0.71,0.51, ,,,,,,,,,,,,,,,,
5017,Q6P6C2,ALKBH5,RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),DSDPERSDYEEQQ,_YQEDS(ph)DPERS(ph)DYEEQQLQK_,S69,,23.77,,,,,,,,,,,,,23.77,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5018,Q6P996,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-),RGSDALSETSSVS,_GSDALS(ph)ETSSVSHIEDLEK_,S690,+,23.20,24.97,,25.06,24.63,26.70,26.51,25.59,26.66,23.39,26.87,25.31,26.29,25.43,-2.23,-0.46, ,-0.37,-0.80,1.27,1.08,0.16,1.23,-2.04,1.44,-0.12,0.86,carboxylic acid metabolic process,,,,,,,,,,,,,,,
5020,Q6P996,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-),ALSETSSVSHIED,_GSDALSETSS(ph)VSHIEDLEK_,S694,+,22.11,22.21,,,21.09,24.77,21.98,23.04,25.68,,,,25.14,23.25,-1.14,-1.04, , ,-2.16,1.52,-1.27,-0.22,2.43, , , ,1.89,carboxylic acid metabolic process,,,,,,,,,,,,,,,
5021,Q6P996,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-),HPEDDHSQVEGPE,_GVPHPEDDHS(ph)QVEGPESLR_,S751,+,,23.02,23.02,,23.14,23.76,23.31,23.80,23.71,,,23.46,22.91,23.35, ,-0.32,-0.32, ,-0.21,0.41,-0.04,0.45,0.36, , ,0.11,-0.44,carboxylic acid metabolic process,,,,,,,,,,,,,,,
5024,Q6P9G4,TMEM154,Transmembrane protein 154,EPSSQGSQSALQT,_QEPSSQGS(ph)QSALQTYELGSENVK_,S115,,,,,,22.48,,,,23.47,22.47,23.42,,,22.96, , , , ,-0.47, , , ,0.51,-0.49,0.46, , ,,integral to membrane,,,,,,,,,,,,,,
5026,Q6P9H4,CNKSR3,Connector enhancer of kinase suppressor of ras 3 (Connector enhancer of KSR 3) (CNK homolog protein 3) (CNK3) (CNKSR family member 3) (Maguin-like protein),GPKGSESPNSFLD,_GSES(ph)PNSFLDQESR_,S145,,23.20,22.36,22.36,,21.30,21.76,,,22.76,24.25,,,,22.57,0.63,-0.21,-0.21, ,-1.27,-0.81, , ,0.19,1.68, , , ,positive regulation of sodium ion transport;negative regulation of ERK1 and ERK2 cascade;negative regulation of peptidyl-serine phosphorylation,membrane;cytoplasm,,,,,,,,,,,,,,
5027,Q6PCB5,RSBN1L,Round spermatid basic protein 1-like protein,_MAEPPSPVHCVA,_(ac)AEPPS(ph)PVHCVAAAAPTATVSEK_,S6,,25.20,24.43,25.35,24.00,,,23.43,,25.18,23.04,,,,24.38,0.82,0.06,0.98,-0.38, , ,-0.95, ,0.81,-1.34, , , ,,nucleus,,,,,,,,,,,,,,
5028,Q6PCE3,PGM2L1,"Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1)",GVMITASHNRKED,_AVAGVM(ox)ITAS(ph)HNRK_,S175,+,19.63,21.96,21.96,,,,21.88,,22.07,24.19,24.04,21.80,,22.19,-2.56,-0.23,-0.23, , , ,-0.31, ,-0.12,1.99,1.85,-0.39, ,glucose metabolic process;carbohydrate catabolic process,cytosol,,,,,,,,,,,,,,
5030,Q6PD62,CTR9,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),SSSDDSSDEDKLK,_AIISSSDDSS(ph)DEDKLK_,S1021,+,22.68,,,,23.34,24.95,22.57,24.21,21.58,23.35,,,23.01,23.21,-0.53, , , ,0.13,1.74,-0.64,1.00,-1.63,0.14, , ,-0.20,"stem cell maintenance;histone H2B ubiquitination;JAK-STAT cascade;positive regulation of histone H3-K79 methylation;Wnt receptor signaling pathway;interleukin-6-mediated signaling pathway;positive regulation of histone H3-K4 methylation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of myeloid cell differentiation;cellular response to lipopolysaccharide;histone monoubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone H3-K4 trimethylation;endodermal cell fate commitment;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nuclear speck;transcriptionally active chromatin;Cdc73/Paf1 complex,,,,,,,,,,,,,,
5032,Q6PHR2,ULK3,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),KEGLSESVRSSCT,_EGLSES(ph)VR_,S345,,,20.81,20.81,24.37,,,,,,,,,,22.00, ,-1.19,-1.19,2.37, , , , , , , , , ,autophagy;positive regulation of smoothened signaling pathway;negative regulation of smoothened signaling pathway;protein autophosphorylation;cellular senescence,pre-autophagosomal structure,,+,,,,,,,,,,,,
5036,Q6PIJ6,FBXO38,F-box only protein 38 (Modulator of KLF7 activity homolog) (MoKA),GGSSEPSPTEVDV,_TVNS(ph)GGSSEPS(ph)PTEVDVSR_,S11,,23.06,,,,,,,,,,,,,23.06,0.00, , , , , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
5037,Q6PJF5,RHBDF2,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),GIPHSASPVSPDG,_GIPHSAS(ph)PVS(ph)PDGVQIPLK_,S296,,23.77,20.50,20.19,,,,,,23.83,22.56,,,,22.17,1.60,-1.67,-1.98, , , , , ,1.66,0.39, , , ,proteolysis;negative regulation of protein secretion;protein transport,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5038,Q6PJF5,RHBDF2,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),HSASPVSPDGVQI,_GIPHSAS(ph)PVS(ph)PDGVQIPLK_,S299,,23.77,20.19,20.19,,,,,,,,,,,21.39,2.38,-1.19,-1.19, , , , , , , , , , ,proteolysis;negative regulation of protein secretion;protein transport,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5039,Q6PJF5,RHBDF2,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),GFRRQASLSQSIR,_(gl)QAS(ph)LSQSIRK_,S84,+,24.11,24.72,25.18,25.64,22.80,21.79,,23.54,,,23.54,,21.74,23.67,0.43,1.04,1.51,1.97,-0.87,-1.88, ,-0.13, , ,-0.13, ,-1.93,proteolysis;negative regulation of protein secretion;protein transport,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5040,Q6PJF5,RHBDF2,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),SYRRSISSTVQRQ,_SIS(ph)STVQR_,S358,,23.58,23.49,,25.59,,,,,23.35,22.65,22.27,,,23.49,0.09,0.00, ,2.10, , , , ,-0.14,-0.84,-1.22, , ,proteolysis;negative regulation of protein secretion;protein transport,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5041,Q6PJF5,RHBDF2,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),AYLKSVSLQEPRS,_SVS(ph)LQEPR_,S61,+,26.16,26.28,26.47,26.35,,22.45,,20.75,23.99,,,,,24.64,1.53,1.65,1.83,1.71, ,-2.19, ,-3.89,-0.64, , , , ,proteolysis;negative regulation of protein secretion;protein transport,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5042,Q6PJG2,ELMSAN1,ELM2 and SANT domain-containing protein 1,RRRRRASQEANLL,_RAS(ph)QEANLLTLAQK_,S461,+,23.69,22.19,23.14,21.77,24.27,23.95,24.20,23.97,24.43,24.24,23.59,24.62,23.85,23.68,0.01,-1.50,-0.55,-1.91,0.58,0.27,0.52,0.28,0.75,0.55,-0.10,0.93,0.16,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5044,Q6PJG9,LRFN4,Leucine-rich repeat and fibronectin type-III domain-containing protein 4,CRGVGGSAERLEE,_GVGGS(ph)AERLEESVV_,S320,,21.55,,,21.63,,,,,23.43,24.13,22.96,,,22.74,-1.19, , ,-1.11, , , , ,0.69,1.39,0.22, , ,,integral to membrane,,,,,,,,,,,,,,
5045,Q6PJT7,ZC3H14,Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37),QPDKPASPKFIVT,_DLVQPDKPAS(ph)PK_,S490,+,28.08,28.38,28.53,28.09,28.99,29.35,28.59,28.63,28.52,28.06,26.84,27.92,27.44,28.26,-0.18,0.12,0.27,-0.17,0.72,1.08,0.33,0.36,0.26,-0.21,-1.42,-0.34,-0.82,,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
5046,Q6PK04,CCDC137,Coiled-coil domain-containing protein 137,VQAGPGSPRRARG,_VQAGPGS(ph)PR_,S18,+,,22.66,22.66,24.64,,,22.26,22.67,22.36,20.87,21.21,22.67,21.61,22.36, ,0.29,0.29,2.28, , ,-0.10,0.31,0.00,-1.49,-1.15,0.31,-0.75,,,,,,,,,,,,,,,,
5047,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),AEGPAISDGEEGG,_ESPRPLQLPGAEGPAIS(ph)DGEEGGGEPGAGGGAAGAAGAGRR_,S90,+,24.04,,,,25.12,23.79,26.59,24.42,,24.95,27.37,26.73,27.33,25.59,-1.56, , , ,-0.47,-1.80,1.00,-1.17, ,-0.65,1.77,1.13,1.74,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5048,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),YQKETESAPGSPR,_ETES(ph)APGSPRAVTPVPTK_,S517,+,26.50,27.72,28.66,26.42,24.58,24.07,26.71,26.08,26.31,27.43,23.49,,23.87,25.99,0.52,1.73,2.67,0.43,-1.41,-1.92,0.73,0.09,0.33,1.45,-2.49, ,-2.12,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5049,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),TESAPGSPRAVTP,_ETES(ph)APGS(ph)PRAVT(ph)PVPTK_,S521,+,26.37,27.31,28.29,24.53,26.59,23.46,26.48,24.95,26.96,26.19,22.77,23.32,,25.60,0.77,1.71,2.69,-1.07,0.99,-2.15,0.88,-0.66,1.36,0.59,-2.84,-2.28, ,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5050,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),PKGLSASLPDLDS,_GLSAS(ph)LPDLDSENWIEVK_,S548,,27.59,,,,,,,,,,,,,27.59,0.00, , , , , , , , , , , , ,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5051,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),NTFTAWSDEESDY,_NTFTAWS(ph)DEES(ph)DYEIDDRDVNK_,S627,+,26.88,,,,26.99,,23.34,24.30,24.43,27.19,,24.10,,25.32,1.56, , , ,1.67, ,-1.98,-1.02,-0.89,1.87, ,-1.22, ,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5052,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),AWSDEESDYEIDD,_NTFTAWS(ph)DEES(ph)DYEIDDRDVNK_,S631,,26.88,,,,,,,,22.22,,,,,24.55,2.33, , , , , , , ,-2.33, , , , ,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5054,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),PSTIARSLPTTVP,_S(ph)LPTTVPES(ph)PNYRNTRTPR_,S766,+,28.06,26.53,26.66,25.88,26.05,24.96,25.10,25.96,26.48,24.85,25.90,24.81,25.83,25.93,2.13,0.60,0.73,-0.05,0.12,-0.97,-0.83,0.03,0.55,-1.08,-0.03,-1.12,-0.10,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5055,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),PTTVPESPNYRNT,_SLPTTVPES(ph)PNYRNTR_,S774,+,29.16,26.57,27.49,28.99,28.90,28.24,28.83,29.18,26.96,27.93,26.36,28.67,27.46,28.06,1.10,-1.48,-0.57,0.93,0.84,0.19,0.78,1.12,-1.09,-0.13,-1.70,0.61,-0.60,positive regulation of macroautophagy,,,,,,,,,,,,,,,
5057,Q6PL18,ATAD2,ATPase family AAA domain-containing protein 2 (EC 3.6.1.3) (AAA nuclear coregulator cancer-associated protein) (ANCCA),MTRARRSQVEQQQ,_S(ph)QVEQQQLITVEK_,S1302,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;ATP catabolic process",nucleus,,,,,,,,,,,,,,
5059,Q6QNY0,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3 (BLOC-1 subunit 3),EAAETDSEPEPEP,_VAGEAAET(ph)DS(ph)EPEPEPEPTAAPR_,S65,+,27.35,22.39,,,23.79,,24.95,23.84,,,23.08,22.97,,24.05,3.30,-1.67, , ,-0.26, ,0.90,-0.21, , ,-0.97,-1.08, ,post-Golgi vesicle-mediated transport;positive regulation of natural killer cell activation;neuron projection development;secretion of lysosomal enzymes;platelet activation;anterograde synaptic vesicle transport;melanosome transport;response to drug;eye development;anterograde axon cargo transport;cellular membrane organization;platelet dense granule organization;endosome to melanosome transport;developmental pigmentation;melanosome organization,transport vesicle;BLOC-1 complex,,,,,,,,,,,,,,
5060,Q6R327,RICTOR,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3),RFMKALSYASLDK,_ALS(ph)YASLDK_,S1385,,23.62,,,21.24,,,,,,,,22.87,,22.57,1.04, , ,-1.34, , , , , , , ,0.30, ,regulation of actin cytoskeleton organization;positive regulation of peptidyl-tyrosine phosphorylation;fibroblast growth factor receptor signaling pathway;T cell costimulation;embryo development;positive regulation of TOR signaling cascade;regulation of Rac GTPase activity;positive regulation of actin filament polymerization;actin cytoskeleton reorganization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;regulation of protein kinase B signaling cascade;phosphatidylinositol-mediated signaling,cytosol;TORC2 complex,,,,,,,,,,,,,,
5061,Q6R327,RICTOR,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3),SASSTKSTELLLG,_S(ph)TELLLGVK_,S1591,,21.82,21.08,21.08,,,,21.60,,22.79,23.13,,22.59,,22.01,-0.19,-0.94,-0.94, , , ,-0.42, ,0.78,1.12, ,0.58, ,regulation of actin cytoskeleton organization;positive regulation of peptidyl-tyrosine phosphorylation;fibroblast growth factor receptor signaling pathway;T cell costimulation;embryo development;positive regulation of TOR signaling cascade;regulation of Rac GTPase activity;positive regulation of actin filament polymerization;actin cytoskeleton reorganization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;regulation of protein kinase B signaling cascade;phosphatidylinositol-mediated signaling,cytosol;TORC2 complex,,,,,,,,,,,,,,
5062,Q6SPF0,SAMD1,Atherin (Sterile alpha motif domain-containing protein 1) (SAM domain-containing protein 1),AATAPPSPGPAQP,_AAAAAATAPPS(ph)PGPAQPGPR_,S161,+,25.90,23.60,24.00,24.11,25.11,25.03,24.35,23.89,24.25,23.77,,22.15,,24.20,1.70,-0.59,-0.19,-0.09,0.92,0.84,0.16,-0.31,0.05,-0.43, ,-2.05, ,,extracellular region;cytoplasm,,,,,,,,,,,,,,
5067,Q6UB99,ANKRD11,Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1),NLYRSVSVDIRRT,_SVS(ph)VDIR_,S1792,+,22.96,22.38,21.90,23.80,22.19,22.92,22.46,22.52,23.10,21.68,,,,22.59,0.37,-0.21,-0.69,1.21,-0.40,0.33,-0.13,-0.07,0.51,-0.91, , , ,tissue homeostasis;skeletal system morphogenesis;multicellular organism growth;odontogenesis of dentin-containing tooth;bone development;in utero embryonic development;face morphogenesis,nucleus,,,,,,,,,,,,,,
5070,Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),TKAEFTSPPSLFK,_AEFTS(ph)PPSLFK_,S259,+,22.01,22.47,23.35,22.28,23.13,23.25,24.33,23.28,23.71,24.48,23.20,22.60,24.06,23.24,-1.23,-0.77,0.11,-0.96,-0.11,0.00,1.09,0.04,0.47,1.24,-0.04,-0.64,0.82,mRNA processing,mRNA cleavage and polyadenylation specificity factor complex;nucleus,,,,,,,,,,,,,,
5071,Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),RYGRAESPDLRRL,_YGRAES(ph)PDLR_,S304,+,26.55,26.84,25.39,28.05,26.83,25.41,24.42,25.62,25.79,25.99,24.30,24.92,24.04,25.70,0.85,1.13,-0.31,2.34,1.12,-0.29,-1.29,-0.08,0.09,0.29,-1.40,-0.79,-1.66,mRNA processing,mRNA cleavage and polyadenylation specificity factor complex;nucleus,,,,,,,,,,,,,,
5072,Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),ERERDHSPTPSVF,_DHS(ph)PTPSVFNSDEER_,S492,+,27.23,27.17,27.43,26.47,28.30,28.38,27.46,27.76,27.44,26.27,26.50,25.38,27.20,27.15,0.07,0.01,0.28,-0.68,1.14,1.23,0.31,0.61,0.29,-0.88,-0.65,-1.77,0.05,mRNA processing,mRNA cleavage and polyadenylation specificity factor complex;nucleus,,,,,,,,,,,,,,
5073,Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),DHSPTPSVFNSDE,_DHS(ph)PTPS(ph)VFNSDEERYR_,S496,,23.07,22.04,22.04,22.73,23.64,,,,,,,,,22.71,0.36,-0.66,-0.66,0.03,0.94, , , , , , , , ,mRNA processing,mRNA cleavage and polyadenylation specificity factor complex;nucleus,,,,,,,,,,,,,,
5074,Q6UN15,FIP1L1,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),TPSVFNSDEERYR,_DHS(ph)PTPSVFNS(ph)DEER_,S500,,24.81,,,,,23.92,,22.73,22.76,,21.54,,,23.15,1.66, , , , ,0.77, ,-0.43,-0.39, ,-1.62, , ,mRNA processing,mRNA cleavage and polyadenylation specificity factor complex;nucleus,,,,,,,,,,,,,,
5077,Q6UWJ1,TMCO3,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),EKDVGLSDEEKLF,_DVGLS(ph)DEEK_,S85,,,24.13,24.82,23.56,,24.04,,23.58,,,,22.39,,23.76, ,0.37,1.07,-0.19, ,0.29, ,-0.18, , , ,-1.36, ,,integral to membrane,,,,,,,,,,,,,,
5079,Q6UWZ7,FAM175A,BRCA1-A complex subunit Abraxas (Coiled-coil domain-containing protein 98) (Protein FAM175A),FGEYSRSPTF___,_GFGEYSRS(ph)PTF_,S357,+,23.66,23.84,24.41,24.30,25.05,25.94,25.78,24.72,26.41,26.25,24.58,24.16,25.10,24.94,-1.28,-1.10,-0.53,-0.64,0.11,1.00,0.84,-0.22,1.47,1.31,-0.36,-0.78,0.16,double-strand break repair;G2/M transition DNA damage checkpoint;chromatin modification;response to ionizing radiation;positive regulation of DNA repair,BRCA1-A complex,,,,,,,,,,,,,,
5080,Q6UX65,DRAM2,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),ERTRLLSRDI___,_TRLLS(ph)RDI_,S263,+,20.78,24.02,24.02,20.52,23.48,23.86,22.81,,22.72,24.45,25.06,24.86,23.94,23.38,-2.60,0.64,0.64,-2.86,0.10,0.48,-0.56, ,-0.65,1.07,1.68,1.48,0.56,apoptotic process;induction of apoptosis,integral to membrane;Golgi apparatus;lysosomal membrane;lysosome,,,,,,,,,,,,,,
5081,Q6UX71,PLXDC2,Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein),MKFRRGSGHPAYA,_GS(ph)GHPAYAEVEPVGEK_,S369,,,25.71,,24.96,,24.35,22.88,23.47,,,,24.85,,24.37, ,1.34, ,0.59, ,-0.02,-1.49,-0.90, , , ,0.48, ,,integral to membrane,,,,,,,,,,,,,,
5082,Q6UXH1,CRELD2,Cysteine-rich with EGF-like domain protein 2,TLSKYESSEIRLL,_YES(ph)SEIR_,S70,+,25.19,,,24.06,25.00,26.96,20.71,24.92,22.59,,21.59,19.79,20.29,23.11,2.08, , ,0.95,1.89,3.86,-2.40,1.81,-0.52, ,-1.52,-3.32,-2.82,,extracellular space;Golgi apparatus;endoplasmic reticulum,,,,,,,,,,,,,,
5083,Q6UXV4,APOOL,Apolipoprotein O-like (Protein FAM121A),EKTKLGSSSEIEV,_LGS(ph)SSEIEVPAK_,S203,,,22.16,,,,,,,21.46,21.53,,,,21.71, ,0.45, , , , , , ,-0.26,-0.19, , , ,,extracellular region;mitochondrial inner membrane,,,,,,,,,,,,,,
5085,Q6UXY1,BAIAP2L2,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2 (BAI1-associated protein 2-like protein 2) (Planar intestinal- and kidney-specific BAR domain protein) (Pinkbar),VPSRAPSPAPPPL,_APS(ph)PAPPPLPSSR_,S156,,,,,24.34,,,,,,26.40,,,,25.37, , , ,-1.03, , , , , ,1.03, , , ,filopodium assembly;signal transduction;cellular membrane organization,cytoplasmic vesicle membrane;plasma membrane;vesicle membrane;cell-cell contact zone,,,,,,,,,,,,,,
5086,Q6V0I7,FAT4,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),LSQVNESDADDED,_LSQVNES(ph)DADDEDNYGAR_,S413,,,,,,22.72,22.82,22.81,22.16,22.99,,,,22.69,22.70, , , , ,0.02,0.12,0.11,-0.53,0.29, , , ,-0.01,homophilic cell adhesion,integral to membrane;plasma membrane,,,,,,,,,,,,,,
5087,Q6VMQ6,ATF7IP,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),EAFLVLSDEEDIS,_EAFLVLS(ph)DEEDISGEK_,S496,,24.63,,,,,,,,23.43,24.83,,,,24.30,0.33, , , , , , , ,-0.87,0.53, , , ,"regulation of RNA polymerase II transcriptional preinitiation complex assembly;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;DNA methylation;virus-host interaction",transcription factor complex;nucleus,,,,,,,,,,,,,,
5089,Q6VMQ6,ATF7IP,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),MESSFGSPSKQES,_M(ox)ESSFGS(ph)PSK_,S477,+,23.28,25.26,25.26,25.46,24.93,26.15,,25.76,23.70,25.71,21.41,22.39,24.94,24.52,-1.24,0.74,0.74,0.94,0.41,1.63, ,1.24,-0.82,1.18,-3.11,-2.13,0.42,"regulation of RNA polymerase II transcriptional preinitiation complex assembly;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;DNA methylation;virus-host interaction",transcription factor complex;nucleus,,,,,,,,,,,,,,
5094,Q6VY07,PACS1,Phosphofurin acidic cluster sorting protein 1 (PACS-1),LGKDTTSPMELAA,_DTTS(ph)PM(ox)ELAALEK_,S430,+,24.29,23.89,23.89,22.61,,22.36,24.68,21.76,22.75,22.48,23.95,24.04,,23.34,0.95,0.55,0.55,-0.72, ,-0.97,1.34,-1.58,-0.58,-0.85,0.61,0.70, ,regulation of defense response to virus by virus;protein targeting to plasma membrane;viral reproduction;protein targeting to Golgi;virus-host interaction;positive regulation of protein binding,cytosol;COPI-coated vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5098,Q6W2J9,BCOR,BCL-6 corepressor (BCoR),DRKDGSSPPLLEK,_DGSS(ph)PPLLEK_,S423,,24.63,,,24.59,,,24.37,,,,,,,24.53,0.10, , ,0.06, , ,-0.16, , , , , , ,"negative regulation of histone H3-K36 methylation;odontogenesis;specification of axis polarity;negative regulation of bone mineralization;negative regulation of histone H3-K4 methylation;histone H2A monoubiquitination;negative regulation of transcription from RNA polymerase II promoter;palate development;transcription, DNA-dependent;heart development;negative regulation of tooth mineralization",nucleus,,,,,,,,,,,,,,
5099,Q6WKZ4,RAB11FIP1,Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein),TTPSVDSDDESVV,_DSGSDTASAIIPSTTPSVDS(ph)DDESVVK_,S202,,25.85,,,,25.52,,,23.58,,26.90,,,,25.46,0.39, , , ,0.06, , ,-1.89, ,1.44, , , ,protein transport,phagocytic vesicle membrane;intracellular membrane-bounded organelle;recycling endosome;cytoplasm,,,,,,,,,,,,,,
5102,Q6WKZ4,RAB11FIP1,Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein),RNNMTASMFDLSM,_NNM(ox)TAS(ph)M(ox)FDLSM(ox)K_,S156,+,25.06,23.33,23.90,24.27,21.91,23.11,24.61,23.82,23.06,24.46,22.93,26.21,23.56,23.86,1.19,-0.53,0.04,0.41,-1.95,-0.76,0.75,-0.05,-0.80,0.59,-0.93,2.34,-0.30,protein transport,phagocytic vesicle membrane;intracellular membrane-bounded organelle;recycling endosome;cytoplasm,,,,,,,,,,,,,,
5104,Q6XQN6,NAPRT1,Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1),SLCAGQSP_____,_LQALVNSLCAGQS(ph)P_,S537,,25.04,,,,,,,,,,,21.05,,23.05,2.00, , , , , , , , , , ,-2.00, ,response to oxidative stress;water-soluble vitamin metabolic process;NAD metabolic process;nicotinamide metabolic process;nicotinate nucleotide salvage;NAD biosynthetic process,cytosol;Golgi apparatus;nucleus,,,,,,,,,,,,,,
5107,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),SGGSITSPPLSPA,_ALSSGGSITS(ph)PPLS(ph)PALPK_,S26,,27.26,24.65,25.47,25.15,27.02,25.72,27.41,26.93,26.33,26.84,27.10,26.55,26.79,26.40,0.86,-1.75,-0.93,-1.25,0.62,-0.68,1.01,0.53,-0.07,0.44,0.70,0.14,0.39,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
5108,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),ITSPPLSPALPKY,_ALSSGGSITS(ph)PPLS(ph)PALPK_,S30,,26.37,,,,,,,,,,,,,26.37,0.00, , , , , , , , , , , , ,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
5109,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),EFIRSESENWRIF,_SES(ph)ENWR_,S201,,24.44,23.35,,25.76,,,,,,,,21.42,,23.74,0.70,-0.39, ,2.02, , , , , , , ,-2.33, ,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
5110,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),CGFYQRSFDEVEG,_S(ph)FDEVEGVFGR_,S139,,22.30,,,,,,,,,,,,,22.30,0.00, , , , , , , , , , , , ,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
5114,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),ERWRPHSPDGPRS,_WRPHS(ph)PDGPR_,S236,+,21.65,25.57,25.72,25.43,26.84,25.61,26.19,26.40,25.54,24.95,24.98,25.85,23.18,25.22,-3.57,0.34,0.50,0.20,1.62,0.39,0.96,1.17,0.32,-0.27,-0.25,0.63,-2.04,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
5116,Q6ZN18,AEBP2,Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2),EELSRLSPLPPGS,_(ac)AAAITDMADLEELSRLS(ph)PLPPGS(ph)PGSAAR_,S18,,25.34,,,,,,,,,,,,,25.34,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",ESC/E(Z) complex,C2H2-type,,,,,,,,,,,,,
5117,Q6ZN18,AEBP2,Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2),SPLPPGSPGSAAR,_(ac)AAAITDM(ox)ADLEELSRLS(ph)PLPPGS(ph)PGSAAR_,S24,,25.34,,,,,,,,,,,,,25.34,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",ESC/E(Z) complex,C2H2-type,,,,,,,,,,,,,
5118,Q6ZN18,AEBP2,Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2),SGGRRGSLEMSSD,_RGS(ph)LEM(ox)SSDGEPLSR_,S140,+,22.52,22.44,,23.22,25.00,25.03,24.79,24.87,23.75,,23.92,24.74,23.64,23.99,-1.47,-1.55, ,-0.77,1.01,1.03,0.80,0.87,-0.24, ,-0.07,0.75,-0.35,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",ESC/E(Z) complex,C2H2-type,,,,,,,,,,,,,
5120,Q6ZN55,ZNF574,Zinc finger protein 574,APVVLGSPVVLGP,_APAPVVLGS(ph)PVVLGPPVGQAR_,S164,,22.09,21.36,21.36,,,,,,,,,,,21.61,0.48,-0.24,-0.24, , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5121,Q6ZNC8,MBOAT1,Lysophospholipid acyltransferase 1 (LPLAT 1) (EC 2.3.1.-) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1) (O-acyltransferase domain-containing protein 1),RPQTLNSINKRKT,_RPQTLNS(ph)INK_,S488,,25.55,,,,20.07,,21.16,,,,,,,22.26,3.29, , , ,-2.19, ,-1.10, , , , , , ,phosphatidylserine acyl-chain remodeling;glycerophospholipid biosynthetic process;phosphatidylethanolamine acyl-chain remodeling,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5122,Q6ZNJ1,NBEAL2,Neurobeachin-like protein 2,RSSRRISQVSSGE,_RIS(ph)QVSSGETEYNPTEAR_,S2027,,24.36,22.46,22.46,,22.24,,25.00,24.60,,,,22.88,,23.43,0.93,-0.97,-0.97, ,-1.19, ,1.57,1.18, , , ,-0.55, ,platelet formation,endoplasmic reticulum,,,,,,,,,,,,,,
5123,Q6ZNJ1,NBEAL2,Neurobeachin-like protein 2,ATDEAGSPLAAAA,_VLNTSSLESATDEAGS(ph)PLAAAAAAAAAER_,S935,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,platelet formation,endoplasmic reticulum,,,,,,,,,,,,,,
5124,Q6ZRP7,QSOX2,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),SADQGDSSEGGTL,_(gl)QHYGRDNLLDTYSADQGDS(ph)SEGGTLARGEEEEK_,S578,,26.97,,,,,,23.63,,25.38,26.28,,,,25.57,1.40, , , , , ,-1.94, ,-0.18,0.71, , , ,cell redox homeostasis,nuclear membrane;integral to membrane;extracellular region;plasma membrane,,,,,,,,,,,,,,
5126,Q6ZRS2,SRCAP,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),SEADAGSGPPTPG,_DEEQSEADAGS(ph)GPPT(ph)PGPTTLGPKK_,S568,,23.35,,,,,,,,,24.05,,,,23.70,-0.35, , , , , , , , ,0.35, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;virus-host interaction",Golgi apparatus;nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
5129,Q6ZRS2,SRCAP,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),PPKNPPSPRPSQL,_NPPS(ph)PRPSQLPVLDR_,S2858,+,21.76,,,20.95,22.74,22.32,23.07,22.10,23.68,23.93,22.58,22.42,23.82,22.67,-0.91, , ,-1.72,0.07,-0.35,0.40,-0.57,1.01,1.26,-0.09,-0.25,1.15,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;virus-host interaction",Golgi apparatus;nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
5130,Q6ZRS2,SRCAP,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),PPKKNRSPADAGR,_NRS(ph)PADAGRGVDEAPSSTLK_,S2711,,,,,,,23.93,24.39,22.77,23.91,,,,,23.75, , , , , ,0.18,0.64,-0.98,0.16, , , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;virus-host interaction",Golgi apparatus;nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
5131,Q6ZRS2,SRCAP,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),LRSGPPSPPSTAT,_SGPPS(ph)PPSTATSFGGPRPR_,S1701,,22.69,23.21,23.21,23.25,24.14,,23.42,23.90,23.44,23.20,,,,23.39,-0.70,-0.18,-0.18,-0.13,0.76, ,0.03,0.52,0.06,-0.19, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;virus-host interaction",Golgi apparatus;nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
5133,Q6ZRV2,FAM83H,Protein FAM83H,REVRHGSDPAFAP,_HGS(ph)DPAFAPGPR_,S523,+,26.54,24.72,23.59,20.79,26.54,22.82,25.98,24.80,22.79,25.91,24.82,23.11,24.75,24.40,2.14,0.32,-0.81,-3.60,2.14,-1.58,1.58,0.40,-1.61,1.51,0.43,-1.29,0.35,biomineral tissue development,,,,,,,,,,,,,,,
5134,Q6ZRV2,FAM83H,Protein FAM83H,YPERKGSPTPGFS,_KGS(ph)PTPGFSTR_,S881,+,26.73,26.12,26.50,26.01,25.12,,25.51,24.58,24.03,26.08,24.18,25.04,21.88,25.15,1.58,0.98,1.35,0.86,-0.03, ,0.36,-0.57,-1.12,0.93,-0.97,-0.11,-3.26,biomineral tissue development,,,,,,,,,,,,,,,
5136,Q6ZRV2,FAM83H,Protein FAM83H,FIEQKGSPTSAYP,_GS(ph)PTSAYPERR_,S903,+,24.38,24.42,25.02,23.11,24.60,,,23.05,,22.87,,20.59,,23.51,0.87,0.91,1.52,-0.40,1.09, , ,-0.45, ,-0.63, ,-2.91, ,biomineral tissue development,,,,,,,,,,,,,,,
5137,Q6ZRV2,FAM83H,Protein FAM83H,YPERRGSPVPPVP,_RGS(ph)PVPPVPERR_,S914,+,25.25,23.90,22.62,25.24,26.33,25.44,26.05,25.94,23.71,22.22,25.32,24.02,25.05,24.70,0.55,-0.80,-2.08,0.54,1.63,0.74,1.35,1.24,-0.99,-2.48,0.63,-0.68,0.35,biomineral tissue development,,,,,,,,,,,,,,,
5140,Q6ZRV2,FAM83H,Protein FAM83H,PRARLSSATANAL,_LSS(ph)ATANALYSSNLRDDTK_,S1025,+,24.96,23.44,23.44,22.43,22.61,,,22.71,,25.39,24.91,24.41,,23.81,1.15,-0.37,-0.37,-1.38,-1.20, , ,-1.10, ,1.58,1.10,0.60, ,biomineral tissue development,,,,,,,,,,,,,,,
5141,Q6ZRV2,FAM83H,Protein FAM83H,ENGQPESPRRLSL,_RM(ox)EDEGGFPVPQENGQPES(ph)PR_,S998,,25.38,21.72,21.72,,,,,,,,,,,22.94,2.44,-1.22,-1.22, , , , , , , , , , ,biomineral tissue development,,,,,,,,,,,,,,,
5142,Q6ZRV2,FAM83H,Protein FAM83H,RLRQLLSPKGERR,_(gl)QLLS(ph)PKGER_,S974,+,22.61,,,23.25,25.06,23.65,24.13,24.91,22.68,23.80,23.86,22.63,25.24,23.80,-1.19, , ,-0.55,1.26,-0.15,0.32,1.11,-1.12,0.00,0.06,-1.18,1.44,biomineral tissue development,,,,,,,,,,,,,,,
5143,Q6ZRV2,FAM83H,Protein FAM83H,FSTRRGSPTTGFI,_RGS(ph)PTTGFIEQK_,S892,+,26.68,26.49,26.95,25.97,26.83,26.78,28.01,27.14,26.59,28.49,27.12,27.12,28.47,27.13,-0.45,-0.64,-0.17,-1.15,-0.30,-0.35,0.88,0.01,-0.54,1.37,-0.01,-0.01,1.34,biomineral tissue development,,,,,,,,,,,,,,,
5144,Q6ZRV2,FAM83H,Protein FAM83H,ESPRRLSLGQGDS,_RLS(ph)LGQGDSTEAATEER_,S1003,+,25.38,24.98,24.18,24.29,26.55,26.62,26.33,27.14,25.16,25.47,27.25,,,25.76,-0.37,-0.78,-1.58,-1.47,0.79,0.86,0.57,1.38,-0.60,-0.29,1.49, , ,biomineral tissue development,,,,,,,,,,,,,,,
5146,Q6ZRV2,FAM83H,Protein FAM83H,VPERRSSPVPPVP,_RSS(ph)PVPPVPER_,S925,+,24.88,24.25,23.73,23.99,25.99,22.62,25.42,25.39,,23.85,22.77,24.27,24.90,24.34,0.55,-0.09,-0.61,-0.35,1.65,-1.71,1.09,1.05, ,-0.49,-1.57,-0.07,0.56,biomineral tissue development,,,,,,,,,,,,,,,
5147,Q6ZRV2,FAM83H,Protein FAM83H,VGGERRSLESCLL,_S(ph)LESCLLDLR_,S785,,22.10,,,,,,,,,,,,,22.10,0.00, , , , , , , , , , , , ,biomineral tissue development,,,,,,,,,,,,,,,
5151,Q6ZRV2,FAM83H,Protein FAM83H,PVPGPGSGGNGPE,_VPVPGPGS(ph)GGNGPEREGPEEPGLAK_,S647,+,26.27,25.42,25.53,25.85,,24.34,27.16,23.55,24.98,27.30,26.15,26.27,26.04,25.74,0.53,-0.32,-0.21,0.11, ,-1.40,1.42,-2.19,-0.76,1.56,0.41,0.53,0.30,biomineral tissue development,,,,,,,,,,,,,,,
5152,Q6ZS17,FAM65A,Protein FAM65A,FSTYSQSPPDTPS,_FSTYSQS(ph)PPDTPSLR_,S342,+,,22.59,22.18,25.10,24.68,24.42,25.51,26.14,23.90,22.30,26.54,24.57,24.95,24.41, ,-1.81,-2.22,0.69,0.27,0.02,1.11,1.73,-0.51,-2.10,2.13,0.16,0.54,,cytoplasm,,,,,,,,,,,,,,
5153,Q6ZS17,FAM65A,Protein FAM65A,RVNRSQSFAGVLG,_SQS(ph)FAGVLGSHERGPR_,S17,+,23.64,22.83,,22.00,24.74,,23.85,24.84,20.41,,24.77,23.00,,23.34,0.30,-0.51, ,-1.35,1.40, ,0.51,1.50,-2.93, ,1.43,-0.34, ,,cytoplasm,,,,,,,,,,,,,,
5158,Q6ZSZ5,ARHGEF18,Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF),LPATPLSAKEDAS,_AGGTALLPGPPAPSPLPATPLS(ph)AK_,S1002,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,regulation of cell shape;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;actin cytoskeleton organization;transforming growth factor beta receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;cell junction;plasma membrane;apical part of cell,,,,,,,,,,,,,,
5160,Q6ZSZ5,ARHGEF18,Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF),WRGPPNSPDLKLS,_DWRGPPNS(ph)PDLK_,S602,,,,,,,,24.93,22.31,,21.36,,20.33,22.15,22.22, , , , , , ,2.72,0.09, ,-0.85, ,-1.88,-0.07,regulation of cell shape;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;actin cytoskeleton organization;transforming growth factor beta receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;cell junction;plasma membrane;apical part of cell,,,,,,,,,,,,,,
5161,Q6ZSZ5,ARHGEF18,Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF),RNRRSLSPILPGR,_SLS(ph)PILPGR_,S945,+,24.70,23.96,21.26,25.21,25.18,24.68,25.44,25.44,23.74,,24.89,24.50,24.63,24.47,0.23,-0.51,-3.21,0.74,0.71,0.21,0.97,0.97,-0.73, ,0.42,0.03,0.16,regulation of cell shape;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;actin cytoskeleton organization;transforming growth factor beta receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;cell junction;plasma membrane;apical part of cell,,,,,,,,,,,,,,
5162,Q6ZT52,FAM43B,Protein FAM43B,RELRTCSLRGAPA,_ELRT(ph)CS(ph)LR_,S301,,24.18,22.90,20.46,23.93,,,21.30,,,,22.66,23.27,,22.67,1.51,0.23,-2.21,1.26, , ,-1.37, , , ,-0.01,0.60, ,,,,,,,,,,,,,,,,
5164,Q6ZUT6,C15orf52,Uncharacterized protein C15orf52,ASPALASPEGPKG,_LGSAPAASPALAS(ph)PEGPK_,S324,,,22.59,22.59,22.81,,,24.88,,24.17,25.95,24.96,24.97,,24.12, ,-1.52,-1.52,-1.31, , ,0.77, ,0.06,1.83,0.84,0.86, ,,,,,,,,,,,,,,,,
5165,Q6ZUT6,C15orf52,Uncharacterized protein C15orf52,GGRVTRSPPTQVA,_S(ph)PPTQVAISSDSAR_,S133,+,,,,22.70,24.49,22.53,,24.92,,22.73,23.40,,22.43,23.31, , , ,-0.61,1.18,-0.78, ,1.61, ,-0.59,0.09, ,-0.89,,,,,,,,,,,,,,,,
5166,Q6ZUT9,DENND5B,DENN domain-containing protein 5B (Rab6IP1-like protein),TTARRLSITSLTG,_RLS(ph)ITSLTGK_,S543,,,,,20.97,20.95,,22.39,,,,,23.99,,22.08, , , ,-1.10,-1.13, ,0.32, , , , ,1.91, ,,integral to membrane,,,,,,,,,,,,,,
5168,Q6ZV73,FGD6,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",VLKKAASEELLEK,_AAS(ph)EELLEK_,S515,+,24.26,22.95,22.82,24.11,22.49,,23.72,,,22.45,22.12,23.14,,23.12,1.14,-0.17,-0.29,0.99,-0.63, ,0.60, , ,-0.66,-1.00,0.02, ,filopodium assembly;regulation of cell shape;regulation of Cdc42 GTPase activity;actin cytoskeleton organization,Golgi apparatus;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
5169,Q6ZV73,FGD6,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",NGLRAESLDDQML,_AES(ph)LDDQM(ox)LSR_,S721,,25.37,,,23.38,,,,,,,,,,24.38,1.00, , ,-1.00, , , , , , , , , ,filopodium assembly;regulation of cell shape;regulation of Cdc42 GTPase activity;actin cytoskeleton organization,Golgi apparatus;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
5170,Q6ZV73,FGD6,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",KPIKAYSTENYSL,_AYS(ph)TENYSLESQK_,S692,,22.93,,,,,,23.11,,21.38,22.55,,22.77,,22.55,0.39, , , , , ,0.56, ,-1.17,0.00, ,0.22, ,filopodium assembly;regulation of cell shape;regulation of Cdc42 GTPase activity;actin cytoskeleton organization,Golgi apparatus;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
5172,Q6ZV73,FGD6,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",TKPRAKSLSAMDV,_S(ph)LSAM(ox)DVEK_,S605,,24.11,22.53,22.80,23.96,,,22.05,,,21.54,,,,22.83,1.28,-0.30,-0.03,1.13, , ,-0.78, , ,-1.29, , , ,filopodium assembly;regulation of cell shape;regulation of Cdc42 GTPase activity;actin cytoskeleton organization,Golgi apparatus;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
5173,Q6ZW76,ANKS3,Ankyrin repeat and SAM domain-containing protein 3,CCRDVTSPINERD,_DVTS(ph)PINER_,S114,,22.75,23.74,23.27,24.64,,,,,,,,,,23.60,-0.85,0.14,-0.33,1.04, , , , , , , , , ,,,,,,,,,,,,,,,,
5175,Q709C8,VPS13C,Vacuolar protein sorting-associated protein 13C,VTLMKKSEKKGRP,_EVVVT(ph)LM(ox)KKS(ph)EK_,S1399,+,24.52,25.71,25.35,25.51,23.58,27.34,26.90,25.22,26.98,26.49,28.11,28.52,23.98,26.02,-1.49,-0.31,-0.67,-0.50,-2.44,1.32,0.88,-0.80,0.96,0.48,2.09,2.51,-2.03,protein localization,,,,,,,,,,,,,,,
5176,Q709C8,VPS13C,Vacuolar protein sorting-associated protein 13C,QKTTNSSLEEIMD,_TTNSS(ph)LEEIM(ox)DK_,S694,+,24.80,24.61,23.46,25.14,22.21,23.08,25.55,22.95,24.70,24.80,24.62,25.40,23.05,24.18,0.62,0.42,-0.73,0.96,-1.97,-1.10,1.37,-1.23,0.52,0.62,0.44,1.21,-1.13,protein localization,,,,,,,,,,,,,,,
5181,Q70E73,RAPH1,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),PPAESGSPSKETL,_FTPPAESGS(ph)PSK_,S1012,,24.52,,,25.81,,,,,,,,,23.46,24.60,-0.07, , ,1.22, , , , , , , , ,-1.14,signal transduction;cell-matrix adhesion,filopodium;plasma membrane;cytoskeleton;lamellipodium;cytoplasm,,,,,,,,,,,,,,
5182,Q70E73,RAPH1,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),VPQVPTSPKSSLS,_LTQAEISEQPTM(ox)ATVVPQVPTS(ph)PK_,S1154,+,24.65,23.54,22.21,25.66,,24.37,24.02,26.49,25.30,,24.87,25.93,22.90,24.54,0.11,-1.00,-2.33,1.12, ,-0.17,-0.52,1.95,0.76, ,0.33,1.39,-1.64,signal transduction;cell-matrix adhesion,filopodium;plasma membrane;cytoskeleton;lamellipodium;cytoplasm,,,,,,,,,,,,,,
5183,Q70E73,RAPH1,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),__MEQLSDEEIDH,_(ac)MEQLS(ph)DEEIDHGAEEDS(ph)DKEDQDLDK_,S5,,26.26,,,,24.18,,24.60,24.22,,23.19,,24.62,,24.51,1.75, , , ,-0.33, ,0.09,-0.29, ,-1.32, ,0.10, ,signal transduction;cell-matrix adhesion,filopodium;plasma membrane;cytoskeleton;lamellipodium;cytoplasm,,,,,,,,,,,,,,
5184,Q70E73,RAPH1,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),HGAEEDSDKEDQD,_(ac)MEQLS(ph)DEEIDHGAEEDS(ph)DKEDQDLDK_,S17,,26.26,,,,,,,,,,,,,26.26,0.00, , , , , , , , , , , , ,signal transduction;cell-matrix adhesion,filopodium;plasma membrane;cytoskeleton;lamellipodium;cytoplasm,,,,,,,,,,,,,,
5185,Q70EL1,USP54,Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54),HTSKKGSLIERKR,_KGS(ph)LIER_,S254,,23.48,21.97,,,,,,19.43,,,,,,21.63,1.86,0.34, , , , , ,-2.20, , , , , ,ubiquitin-dependent protein catabolic process,,,,,,,,,,,,,,,
5187,Q719H9,KCTD1,BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1),RPLITRSPASPLN,_S(ph)PAS(ph)PLNNQGIPTPAQLTK_,S9,,23.29,,,,,,,,,,,,,23.29,0.00, , , , , , , , , , , , ,"protein homooligomerization;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5188,Q719H9,KCTD1,BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1),ITRSPASPLNNQG,_S(ph)PAS(ph)PLNNQGIPTPAQLTK_,S12,,25.08,,,,23.36,,,24.32,,21.01,,,,23.44,1.64, , , ,-0.08, , ,0.88, ,-2.44, , , ,"protein homooligomerization;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5189,Q71F56,MED13L,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),QGERLLSREAPEE,_LLS(ph)REAPEELK_,S2083,+,23.40,23.32,23.32,,21.76,24.64,23.80,23.12,24.57,23.30,,,24.05,23.53,-0.13,-0.20,-0.20, ,-1.77,1.11,0.27,-0.40,1.04,-0.23, , ,0.52,,mediator complex,,,,,,,,,,,,,,
5190,Q71F56,MED13L,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),VEDGLGSPKPEEI,_M(ox)EVEDGLGS(ph)PKPEEIK_,S923,+,25.32,25.01,25.25,23.95,,24.47,25.19,22.46,24.20,25.34,24.28,25.50,23.55,24.55,0.78,0.47,0.71,-0.60, ,-0.07,0.65,-2.08,-0.34,0.80,-0.26,0.95,-0.99,,mediator complex,,,,,,,,,,,,,,
5192,Q71RC2,LARP4,La-related protein 4 (La ribonucleoprotein domain family member 4),SRASTASPCNNNI,_ASTAS(ph)PCNNNINAATAVALQEPRK_,S526,+,,,,21.76,23.44,24.38,25.74,25.28,25.00,23.90,24.09,24.10,24.98,24.27, , , ,-2.51,-0.83,0.11,1.48,1.01,0.73,-0.36,-0.17,-0.17,0.71,regulation of cell morphogenesis;cytoskeleton organization,,,,,,,,,,,,,,,
5194,Q71RC2,LARP4,La-related protein 4 (La ribonucleoprotein domain family member 4),QYVPPRSPK____,_EQYVPPRS(ph)PK_,S651,+,22.48,23.50,24.12,23.32,22.22,23.30,23.07,24.15,23.13,22.74,23.11,23.97,22.31,23.19,-0.70,0.31,0.93,0.14,-0.97,0.11,-0.12,0.96,-0.05,-0.45,-0.08,0.78,-0.87,regulation of cell morphogenesis;cytoskeleton organization,,,,,,,,,,,,,,,
5195,Q71RC2,LARP4,La-related protein 4 (La ribonucleoprotein domain family member 4),LRSNVVSPTKNED,_SNVVS(ph)PTK_,S576,+,21.15,,,24.40,,,22.53,20.55,21.57,20.83,,22.49,,21.93,-0.78, , ,2.47, , ,0.60,-1.39,-0.36,-1.11, ,0.56, ,regulation of cell morphogenesis;cytoskeleton organization,,,,,,,,,,,,,,,
5197,Q765P7,MTSS1L,MTSS1-like protein (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1),TPTVPDSPGYMGP,_TPTVPDS(ph)PGYM(ox)GPTR_,S601,+,24.33,22.29,,22.85,22.81,23.11,23.42,24.33,22.61,,,23.12,,23.21,1.13,-0.92, ,-0.36,-0.40,-0.09,0.21,1.12,-0.60, , ,-0.09, ,filopodium assembly;signal transduction,,,,,,,,,,,,,,,
5198,Q76FK4,NOL8,Nucleolar protein 8 (Nucleolar protein Nop132),RFLETDSEEEQEE,_FLET(ph)DS(ph)EEEQEEVNEKK_,S764,+,23.80,,,,23.36,24.22,23.48,,23.94,23.97,,,23.23,23.72,0.09, , , ,-0.35,0.51,-0.24, ,0.23,0.25, , ,-0.49,positive regulation of cell growth;rRNA processing;DNA replication,nucleolus;cytoplasm,,,,,,,,,,,,,,
5199,Q76FK4,NOL8,Nucleolar protein 8 (Nucleolar protein Nop132),DDDESDSEDDSNR,_LFDSSDDDESDS(ph)EDDSNRFK_,S719,,,,,,23.03,22.34,,,,23.86,,,,23.08, , , , ,-0.04,-0.74, , , ,0.78, , , ,positive regulation of cell growth;rRNA processing;DNA replication,nucleolus;cytoplasm,,,,,,,,,,,,,,
5200,Q76FK4,NOL8,Nucleolar protein 8 (Nucleolar protein Nop132),TDHRNSSPGEASL,_NSS(ph)PGEASLLEK_,S973,,22.46,24.69,,23.90,,,,,,,,,21.38,23.11,-0.65,1.58, ,0.79, , , , , , , , ,-1.73,positive regulation of cell growth;rRNA processing;DNA replication,nucleolus;cytoplasm,,,,,,,,,,,,,,
5201,Q76I76,SSH2,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L),KKDITTSADQIAE,_DITTS(ph)ADQIAEVK_,S487,+,,22.42,22.27,23.37,24.37,25.31,,24.36,23.90,,,,25.35,23.92, ,-1.50,-1.65,-0.55,0.45,1.39, ,0.44,-0.01, , , ,1.43,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation;actin cytoskeleton organization,cytoskeleton;cytoplasm,,,+,,,,,,,+,,,,
5202,Q76I76,SSH2,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L),HTPKKNSIHELLL,_KNS(ph)IHELLLER_,S784,+,,,,,22.56,22.02,23.24,22.61,22.47,21.48,22.22,23.43,22.48,22.50, , , , ,0.06,-0.48,0.73,0.11,-0.03,-1.02,-0.28,0.93,-0.02,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation;actin cytoskeleton organization,cytoskeleton;cytoplasm,,,+,,,,,,,+,,,,
5204,Q76N32,CEP68,Centrosomal protein of 68 kDa (Cep68),SEEEVESDDEYLA,_SEEEVES(ph)DDEYLALPAR_,S90,,22.85,,,,,,,,,,,,,22.85,0.00, , , , , , , , , , , , ,centrosome organization,centrosome,,,,,,,,,,,,,,
5210,Q7KZ85,SUPT6H,Transcription elongation factor SPT6 (hSPT6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),MSDFVESEAEESE,_(ac)SDFVES(ph)EAEES(ph)EEEYNDEGEVVPR_,S7,,24.79,,,,,,,,,,,,,24.79,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling;virus-host interaction",nucleus,,,,,,,,,,,,,,
5211,Q7KZ85,SUPT6H,Transcription elongation factor SPT6 (hSPT6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),ESEAEESEEEYND,_(ac)SDFVES(ph)EAEES(ph)EEEYNDEGEVVPR_,S12,,25.14,,,,,,,,,,,,,25.14,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling;virus-host interaction",nucleus,,,,,,,,,,,,,,
5212,Q7KZ85,SUPT6H,Transcription elongation factor SPT6 (hSPT6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),RTRTPASINATPA,_TRT(ph)PAS(ph)INATPANINLADLTR_,S1535,,22.64,,,,22.02,,,,,,,,,22.33,0.31, , , ,-0.31, , , , , , , , ,"regulation of DNA-dependent transcription, elongation;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling;virus-host interaction",nucleus,,,,,,,,,,,,,,
5213,Q7KZF4,SND1,Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator),ADEFGYSR_____,_ADDADEFGYS(ph)R_,S909,,22.62,22.73,,,,,,,,,,,,22.67,-0.06,0.06, , , , , , , , , , , ,"nucleic acid phosphodiester bond hydrolysis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;gene silencing by RNA",RNA-induced silencing complex;mitochondrion;nucleus;melanosome;cytoplasm,,,,,,,,,,,,,,
5215,Q7KZF4,SND1,Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator),TRLGTLSPAFSTR,_LGTLS(ph)PAFSTR_,S781,+,22.56,22.55,22.36,22.07,23.11,22.40,22.43,22.99,23.01,22.72,23.46,22.82,22.90,22.72,-0.16,-0.17,-0.36,-0.65,0.39,-0.32,-0.29,0.27,0.29,0.00,0.73,0.09,0.18,"nucleic acid phosphodiester bond hydrolysis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;gene silencing by RNA",RNA-induced silencing complex;mitochondrion;nucleus;melanosome;cytoplasm,,,,,,,,,,,,,,
5216,Q7KZI7,MARK2,Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b),ASLGQASIQNGKD,_ASLGQAS(ph)IQNGK_,S464,,23.88,,,,,,,,,,,23.17,22.02,23.02,0.86, , , , , , , , , , ,0.15,-1.01,response to oxidative stress;intracellular protein kinase cascade;protein autophosphorylation;regulation of axonogenesis;neuron migration;regulation of cytoskeleton organization;establishment or maintenance of epithelial cell apical/basal polarity;establishment of cell polarity;positive regulation of neuron projection development;Wnt receptor signaling pathway,plasma membrane;nucleus;membrane;basal cortex,,+,,,,,,,,,,,,
5217,Q7KZI7,MARK2,Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b),TAKVPASPLPGLE,_VPAS(ph)PLPGLER_,S422,+,26.40,23.81,23.81,22.96,22.69,,26.09,23.52,,,25.13,,25.13,24.39,2.01,-0.58,-0.58,-1.44,-1.70, ,1.70,-0.87, , ,0.74, ,0.73,response to oxidative stress;intracellular protein kinase cascade;protein autophosphorylation;regulation of axonogenesis;neuron migration;regulation of cytoskeleton organization;establishment or maintenance of epithelial cell apical/basal polarity;establishment of cell polarity;positive regulation of neuron projection development;Wnt receptor signaling pathway,plasma membrane;nucleus;membrane;basal cortex,,+,,,,,,,,,,,,
5218,Q7KZI7,MARK2,Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b),PKQRRFSDQAGPA,_FS(ph)DQAGPAIPTSNSYSK_,S376,,22.60,,,,,,,,,,,,,22.60,0.00, , , , , , , , , , , , ,response to oxidative stress;intracellular protein kinase cascade;protein autophosphorylation;regulation of axonogenesis;neuron migration;regulation of cytoskeleton organization;establishment or maintenance of epithelial cell apical/basal polarity;establishment of cell polarity;positive regulation of neuron projection development;Wnt receptor signaling pathway,plasma membrane;nucleus;membrane;basal cortex,,+,,,,,,,,,,,,
5221,Q7KZI7,MARK2,Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b),TNRSRNSPLLERA,_SRNS(ph)PLLER_,S452,+,26.35,26.37,26.42,25.86,26.03,23.96,24.65,25.15,24.59,25.44,24.71,25.18,22.34,25.16,1.19,1.22,1.26,0.70,0.88,-1.20,-0.51,-0.01,-0.57,0.28,-0.45,0.02,-2.82,response to oxidative stress;intracellular protein kinase cascade;protein autophosphorylation;regulation of axonogenesis;neuron migration;regulation of cytoskeleton organization;establishment or maintenance of epithelial cell apical/basal polarity;establishment of cell polarity;positive regulation of neuron projection development;Wnt receptor signaling pathway,plasma membrane;nucleus;membrane;basal cortex,,+,,,,,,,,,,,,
5222,Q7L014,DDX46,Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog),ALGLQDSDDEDAA,_AALGLQDS(ph)DDEDAAVDIDEQIESM(ox)FNSK_,S804,,25.53,,,,,,,,,,,,,25.53,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing,nucleolus;nuclear speck;Cajal body,,,,,,,,,,,,,,
5224,Q7L1Q6,BZW1,Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf),KNAEEESESEAEE,_NAEEES(ph)ESEAEEGD_,S345,+,22.73,22.57,22.50,23.12,19.90,22.70,23.87,25.34,23.59,20.92,23.42,24.26,23.08,22.92,-0.19,-0.36,-0.42,0.20,-3.03,-0.22,0.94,2.42,0.66,-2.00,0.49,1.34,0.16,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",cytoplasm,,,,,,,,,,,,,,
5225,Q7L1Q6,BZW1,Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf),AEEESESEAEEGD,_NAEEESES(ph)EAEEGD_,S347,+,,,,,23.18,,23.50,23.46,22.95,22.58,21.90,23.12,,22.96, , , , ,0.22, ,0.55,0.50,0.00,-0.37,-1.06,0.17, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",cytoplasm,,,,,,,,,,,,,,
5226,Q7L1V2,MON1B,Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein),DKDQPPSPSPPPQ,_DKDQPPS(ph)PSPPPQSEALSSTSR_,S59,+,21.96,,,,,,24.25,22.95,23.17,23.71,22.31,24.35,,23.24,-1.28, , , , , ,1.00,-0.29,-0.08,0.47,-0.93,1.11, ,,,,,,,,,,,,,,,,
5228,Q7L266,ASRGL1,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain;Isoaspartyl peptidase/L-asparaginase beta chain],GGAGPISKDRKER,_(ac)M(ox)NPIVVVHGGGAGPIS(ph)K_,S16,,24.03,22.97,22.97,,,,,,,,,,,23.32,0.70,-0.35,-0.35, , , , , , , , , , ,proteolysis;asparagine catabolic process via L-aspartate,microtubule cytoskeleton;nucleus;cytoplasm,,,,,,,,,,,,,,
5231,Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),GHVVLASPLKTGR,_DITDPLSLNTCTDEGHVVLAS(ph)PLK_,S254,,23.21,,,,,,,,,,,,,23.21,0.00, , , , , , , , , , , , ,snRNA modification,,,,,,,,,,,,,,,
5232,Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),NAETPKSSPLPAK,_TLNAET(ph)PKS(ph)SPLPAK_,S216,+,26.99,24.63,24.28,25.27,23.90,,24.04,21.71,24.78,,,,,24.45,2.54,0.18,-0.17,0.82,-0.55, ,-0.41,-2.74,0.33, , , , ,snRNA modification,,,,,,,,,,,,,,,
5233,Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),AETPKSSPLPAKG,_TLNAET(ph)PKSS(ph)PLPAK_,S217,,,23.36,22.28,24.44,24.38,,,,,,,,,23.62, ,-0.25,-1.33,0.83,0.76, , , , , , , , ,snRNA modification,,,,,,,,,,,,,,,
5235,Q7L4E1,FAM73B,Protein FAM73B,TASEPLSEPESQR,_DGLRNPETASEPLS(ph)EPESQRK_,S224,+,,,,,22.56,24.68,23.42,23.98,,22.43,24.01,,23.98,23.58, , , , ,-1.02,1.10,-0.16,0.40, ,-1.15,0.43, ,0.40,,integral to membrane,,,,,,,,,,,,,,
5237,Q7L4I2,RSRC2,Arginine/serine-rich coiled-coil protein 2,___MAASDTERDG,_AAS(ph)DTERDGLAPEK_,S4,+,29.30,28.59,28.44,28.70,26.01,27.69,28.32,26.71,28.30,28.46,26.75,27.87,26.69,27.83,1.47,0.75,0.60,0.87,-1.82,-0.15,0.48,-1.12,0.47,0.63,-1.08,0.04,-1.15,,,,,,,,,,,,,,,,
5239,Q7L4I2,RSRC2,Arginine/serine-rich coiled-coil protein 2,KEQSEVSVSPRAS,_KKEQSEVS(ph)VS(ph)PR_,S30,+,25.70,22.22,22.52,21.83,,22.22,21.39,21.73,,,21.67,,21.19,22.27,3.43,-0.05,0.25,-0.45, ,-0.05,-0.89,-0.55, , ,-0.61, ,-1.09,,,,,,,,,,,,,,,,
5241,Q7L591,DOK3,Docking protein 3 (Downstream of tyrosine kinase 3),PLPRATSLPSLDT,_ATS(ph)LPSLDTPGELR_,S274,,,26.49,26.51,,,,,,,,,,,26.50, ,-0.01,0.01, , , , , , , , , , ,Ras protein signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
5242,Q7L7X3,TAOK1,Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1),RASDPQSPPQVSR,_ASDPQS(ph)PPQVSR_,S421,+,,23.84,24.10,24.80,25.13,,24.91,24.32,23.73,23.21,22.96,23.10,,24.01, ,-0.17,0.09,0.79,1.11, ,0.90,0.31,-0.28,-0.80,-1.05,-0.91, ,DNA repair;positive regulation of JNK cascade;mitotic prometaphase;G2/M transition DNA damage checkpoint;apoptotic process;regulation of cytoskeleton organization;positive regulation of protein kinase activity,cytosol,,+,,,,,,,,,,,,
5243,Q7L7X3,TAOK1,Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1),ATIRTASLVTRQM,_TAS(ph)LVTR_,S445,,23.36,,,,,,,,,,,,,23.36,0.00, , , , , , , , , , , , ,DNA repair;positive regulation of JNK cascade;mitotic prometaphase;G2/M transition DNA damage checkpoint;apoptotic process;regulation of cytoskeleton organization;positive regulation of protein kinase activity,cytosol,,+,,,,,,,,,,,,
5245,Q7L804,RAB11FIP2,Rab11 family-interacting protein 2 (Rab11-FIP2) (NRip11),PHRRTLSFDTSKM,_TLS(ph)FDTSK_,S277,+,23.26,22.89,23.01,24.03,22.06,22.30,22.79,22.51,,23.02,21.90,23.89,21.42,22.76,0.50,0.13,0.26,1.27,-0.70,-0.46,0.03,-0.24, ,0.27,-0.86,1.13,-1.33,protein transport;establishment of cell polarity;water transport;transmembrane transport,endosome;cytoplasmic vesicle membrane;plasma membrane;nucleus;recycling endosome membrane,,,,,,,,,,,,,,
5246,Q7L8J4,SH3BP5L,SH3 domain-binding protein 5-like (SH3BP-5-like),EDEVPRSPVAEEP,_ETPQGELRPEVVEDEVPRS(ph)PVAEEPGGGGSSSSEAK_,S30,,,,,,,,,24.88,,,26.33,24.98,24.53,25.18, , , , , , , ,-0.31, , ,1.15,-0.20,-0.65,,,,,,,,,,,,,,,,
5247,Q7L8J4,SH3BP5L,SH3 domain-binding protein 5-like (SH3BP-5-like),GLSDHVSLDGQEL,_GLSDHVS(ph)LDGQELGTR_,S362,+,22.87,23.56,22.34,24.56,24.52,25.35,25.09,26.47,22.87,,27.65,26.40,24.44,24.67,-1.81,-1.12,-2.33,-0.11,-0.16,0.67,0.41,1.79,-1.81, ,2.97,1.72,-0.24,,,,,,,,,,,,,,,,
5250,Q7LBC6,KDM3B,Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA),EAVKRFSLDERSL,_RFS(ph)LDER_,S798,,24.97,23.58,23.58,,,,,,22.35,,,22.60,,23.41,1.55,0.16,0.16, , , , , ,-1.07, , ,-0.81, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
5254,Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),TKDRLGSPLAVDE,_DRLGS(ph)PLAVDEALRR_,S1310,+,21.35,22.49,22.49,,22.40,23.05,24.17,24.06,22.39,23.66,24.50,24.03,24.22,23.23,-1.89,-0.75,-0.75, ,-0.84,-0.18,0.94,0.83,-0.84,0.43,1.26,0.79,0.99,actin filament depolymerization;exocytosis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5255,Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),ALLKGKSEEELEA,_GKS(ph)EEELEASK_,S977,,,,,,,,,,,20.67,21.58,,,21.13, , , , , , , , , ,-0.46,0.46, , ,actin filament depolymerization;exocytosis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5256,Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),KLTRNESVARSSK,_LTRNES(ph)VAR_,S517,,21.70,23.96,23.96,22.30,,,20.69,21.04,19.76,19.85,19.02,22.17,,21.44,0.26,2.51,2.51,0.86, , ,-0.75,-0.41,-1.68,-1.60,-2.43,0.73, ,actin filament depolymerization;exocytosis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5258,Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),SYSVEKSPQDEGL,_S(ph)PQDEGLHLLK_,S1371,,20.19,,,22.35,,,22.68,,,23.71,22.00,,,22.19,-1.99, , ,0.16, , ,0.49, , ,1.52,-0.18, , ,actin filament depolymerization;exocytosis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5259,Q7RTP6,MICAL3,Protein-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.-) (Molecule interacting with CasL protein 3) (MICAL-3),KRSSLFSPRRNKK,_SSLFS(ph)PR_,S1704,,,,,19.33,21.78,,,22.20,,,,21.62,,21.23, , , ,-1.90,0.54, , ,0.97, , , ,0.39, ,actin filament depolymerization;exocytosis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5260,Q7Z2K8,GPRIN1,G protein-regulated inducer of neurite outgrowth 1 (GRIN1),LPLEKGSPVTTTK,_VGSLPLEKGS(ph)PVTTTK_,S615,,,,,,26.27,24.22,,24.10,,,,,,24.86, , , , ,1.40,-0.64, ,-0.76, , , , , ,neuron projection development,growth cone;plasma membrane,,,,,,,,,,,,,,
5262,Q7Z2W4,ZC3HAV1,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),QISHRASLEDAPV,_AS(ph)LEDAPVDDLTR_,S284,,22.31,22.92,,,,23.52,,,,,24.50,22.13,,23.08,-0.76,-0.15, , , ,0.44, , , , ,1.42,-0.94, ,defense response to virus;negative regulation of viral genome replication;response to virus;positive regulation of interferon-alpha production;positive regulation of type I interferon production;innate immune response;positive regulation of RIG-I signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to exogenous dsRNA;positive regulation of mRNA catabolic process;regulation of defense response to virus by host;positive regulation of interferon-beta production,Golgi apparatus;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
5265,Q7Z2W4,ZC3HAV1,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),RRKTVFSPTLPAA,_TVFS(ph)PTLPAAR_,S378,+,25.75,25.59,26.34,25.19,25.71,25.36,25.58,25.56,25.77,26.36,26.16,25.79,25.24,25.72,0.03,-0.14,0.61,-0.53,-0.01,-0.36,-0.14,-0.16,0.05,0.63,0.44,0.07,-0.49,defense response to virus;negative regulation of viral genome replication;response to virus;positive regulation of interferon-alpha production;positive regulation of type I interferon production;innate immune response;positive regulation of RIG-I signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;cellular response to exogenous dsRNA;positive regulation of mRNA catabolic process;regulation of defense response to virus by host;positive regulation of interferon-beta production,Golgi apparatus;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
5266,Q7Z2Z1,TICRR,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",KLHPDGSPDVAGE,_LHPDGS(ph)PDVAGEK_,S598,,23.14,24.08,24.08,,22.95,,,,,,,,22.14,23.28,-0.14,0.80,0.80, ,-0.33, , , , , , , ,-1.13,DNA repair;regulation of DNA-dependent DNA replication initiation;G2/M transition checkpoint;formation of translation preinitiation complex;response to ionizing radiation;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleus,,,,,,,,,,,,,,
5267,Q7Z2Z1,TICRR,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",NRLLYNSPEYEAS,_LLYNS(ph)PEYEASFPR_,S292,,,,,,23.49,,,22.47,,,,,,22.98, , , , ,0.51, , ,-0.51, , , , , ,DNA repair;regulation of DNA-dependent DNA replication initiation;G2/M transition checkpoint;formation of translation preinitiation complex;response to ionizing radiation;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleus,,,,,,,,,,,,,,
5270,Q7Z2Z1,TICRR,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",ALIRHKSIAEVSQ,_S(ph)IAEVSQNLR_,S864,,21.42,,,,,,,,,,,,,21.42,0.00, , , , , , , , , , , , ,DNA repair;regulation of DNA-dependent DNA replication initiation;G2/M transition checkpoint;formation of translation preinitiation complex;response to ionizing radiation;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleus,,,,,,,,,,,,,,
5271,Q7Z2Z1,TICRR,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",RRSVSGSPESDEL,_SVSGS(ph)PESDELQELR_,S837,+,22.01,21.41,21.41,,22.38,22.91,,22.90,21.93,,22.80,,,22.22,-0.21,-0.81,-0.81, ,0.16,0.69, ,0.68,-0.29, ,0.58, , ,DNA repair;regulation of DNA-dependent DNA replication initiation;G2/M transition checkpoint;formation of translation preinitiation complex;response to ionizing radiation;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleus,,,,,,,,,,,,,,
5272,Q7Z2Z1,TICRR,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",SVQRVHSFQQDKS,_VHS(ph)FQQDK_,S1044,,21.80,20.36,20.36,20.07,,,,,,,,,,20.65,1.15,-0.29,-0.29,-0.58, , , , , , , , , ,DNA repair;regulation of DNA-dependent DNA replication initiation;G2/M transition checkpoint;formation of translation preinitiation complex;response to ionizing radiation;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleus,,,,,,,,,,,,,,
5273,Q7Z309,FAM122B,Protein FAM122B,IDFTPVSPAPSPT,_RIDFTPVS(ph)PAPS(ph)PTR_,S62,,24.44,,,,,,,,,,,,21.78,23.11,1.33, , , , , , , , , , , ,-1.33,,,,,,,,,,,,,,,,
5274,Q7Z309,FAM122B,Protein FAM122B,PVSPAPSPTRGFG,_RIDFTPVS(ph)PAPS(ph)PTR_,S66,,24.44,,,,,,,,,,,,21.78,23.11,1.33, , , , , , , , , , , ,-1.33,,,,,,,,,,,,,,,,
5278,Q7Z3B3,KANSL1,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),QGSSRLSPGTDSS,_LS(ph)PGTDSSSNLGGVK_,S249,,22.92,,,23.95,,,,,,,,,,23.43,-0.52, , ,0.52, , , , , , , , , ,histone H4-K8 acetylation;histone H4-K5 acetylation;histone H4-K16 acetylation,histone acetyltransferase complex;MLL1 complex,,,,,,,,,,,,,,
5279,Q7Z3B3,KANSL1,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),KLEGKKSPLSSIL,_S(ph)PLSSILFSALDSDTR_,S268,,23.18,,,,,,,,,,,,,23.18,0.00, , , , , , , , , , , , ,histone H4-K8 acetylation;histone H4-K5 acetylation;histone H4-K16 acetylation,histone acetyltransferase complex;MLL1 complex,,,,,,,,,,,,,,
5280,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),RLEASYSDSPPGE,_LEASYS(ph)DSPPGEEDLLVHVAEGSK_,S16,,23.76,,,,,,,,,,,,23.86,23.81,-0.05, , , , , , , , , , , ,0.05,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5281,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),EASYSDSPPGEED,_LEASYSDS(ph)PPGEEDLLVHVAEGSK_,S18,,20.88,,,,24.01,,,23.00,,,,,,22.63,-1.75, , , ,1.38, , ,0.37, , , , , ,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5282,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),VWHRRESDESGES,_RES(ph)DES(ph)GES(ph)APDEGGEGARAPQSIPR_,S735,,25.11,27.48,,23.98,,,,,,,19.86,,,24.11,1.00,3.37, ,-0.13, , , , , , ,-4.25, , ,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5283,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),RRESDESGESAPD,_RES(ph)DES(ph)GES(ph)APDEGGEGARAPQSIPR_,S738,,24.07,,,,,,,,,,,,,24.07,0.00, , , , , , , , , , , , ,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5284,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),SDESGESAPDEGG,_RES(ph)DES(ph)GES(ph)APDEGGEGARAPQSIPR_,S741,,24.07,,,,,,,,,,,,,24.07,0.00, , , , , , , , , , , , ,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5285,Q7Z3C6,ATG9A,Autophagy-related protein 9A (APG9-like 1) (mATG9),SALRSFSPLQPGQ,_SFS(ph)PLQPGQAPTGR_,S656,+,24.23,23.86,23.85,24.16,24.98,24.86,24.56,25.69,24.14,24.31,24.65,23.70,24.89,24.45,-0.22,-0.59,-0.60,-0.29,0.52,0.41,0.11,1.24,-0.31,-0.14,0.20,-0.75,0.43,protein transport;autophagic vacuole assembly,cytoplasmic vesicle;autophagic vacuole membrane;integral to membrane;Golgi apparatus;late endosome membrane,,,,,,,,,,,,,,
5288,Q7Z3E2,C10orf118,Uncharacterized protein C10orf118 (CTCL tumor antigen HD-CL-01/L14-2),SSAEDRSPENTGS,_SSAEDRS(ph)PENTGSSVAVDNFPQVDK_,S740,,21.34,,,,,23.31,23.38,24.58,24.02,,,,,23.33,-1.99, , , , ,-0.02,0.05,1.26,0.69, , , , ,,,,,,,,,,,,,,,,
5291,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),GEHSESSTPRPRS,_LSGEHS(ph)ESS(ph)TPRPR_,S1272,,23.29,24.42,,24.09,20.80,,,,22.67,20.26,,,,22.59,0.70,1.83, ,1.50,-1.79, , , ,0.08,-2.33, , , ,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,,,,,,,,,,
5292,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),PDGNINSPTRNAD,_SFLVASVLPGPDGNINS(ph)PTR_,S1243,,25.24,,,,,,,,,,,,,25.24,0.00, , , , , , , , , , , , ,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,,,,,,,,,,
5294,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),SAAKPPSPEKTAP,_SLDSEPSVPSAAKPPS(ph)PEK_,S330,+,25.65,26.61,27.08,25.42,26.30,28.05,27.01,27.02,26.83,27.24,25.59,26.45,26.66,26.61,-0.96,0.00,0.47,-1.19,-0.31,1.44,0.40,0.41,0.22,0.64,-1.02,-0.16,0.05,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,,,,,,,,,,
5295,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),TPIPALSPPTKVP,_TAPVASTPSSTPIPALS(ph)PPTK_,S350,+,23.34,21.53,21.96,23.31,,,23.98,,24.36,25.02,,23.96,,23.43,-0.10,-1.90,-1.48,-0.12, , ,0.55, ,0.93,1.59, ,0.53, ,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,,,,,,,,,,
5296,Q7Z3T8,ZFYVE16,Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein),RNEIIQSPISQVP,_NEIIQS(ph)PISQVPSVEK_,S939,,23.72,,,21.92,,,,,,,23.02,,,22.89,0.83, , ,-0.97, , , , , , ,0.13, , ,regulation of endocytosis;vesicle organization;BMP signaling pathway;protein targeting to lysosome;endosomal transport,early endosome membrane,,,,,,,,,,,,,,
5297,Q7Z3T8,ZFYVE16,Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein),PISQVPSVEKLSM,_NEIIQSPISQVPS(ph)VEK_,S946,,22.43,,,21.38,,,,,,,,,,21.90,0.53, , ,-0.53, , , , , , , , , ,regulation of endocytosis;vesicle organization;BMP signaling pathway;protein targeting to lysosome;endosomal transport,early endosome membrane,,,,,,,,,,,,,,
5298,Q7Z401,DENND4A,C-myc promoter-binding protein (DENN domain-containing protein 4A),SLEKESSDDDTPF,_ESS(ph)DDDTPFDGSNYLADK_,S1099,,22.34,,,,,,,,,,,22.25,,22.30,0.05, , , , , , , , , , ,-0.05, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5299,Q7Z401,DENND4A,C-myc promoter-binding protein (DENN domain-containing protein 4A),IFPMARSISTSGP,_S(ph)ISTSGPLDK_,S1587,,,,,,,,,,,23.03,,22.89,,22.96, , , , , , , , , ,0.07, ,-0.07, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5300,Q7Z401,DENND4A,C-myc promoter-binding protein (DENN domain-containing protein 4A),PMARSISTSGPLD,_SIS(ph)TSGPLDK_,S1589,+,24.21,25.42,25.04,24.90,,24.56,25.42,22.05,25.18,22.76,24.62,21.96,23.56,24.14,0.07,1.28,0.90,0.76, ,0.42,1.28,-2.09,1.04,-1.38,0.48,-2.18,-0.58,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5301,Q7Z403,TMC6,Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4),TLRILASMPSRTI,_ILAS(ph)MPSR_,S84,,19.97,,,,23.21,23.18,,22.55,22.24,21.73,24.63,,,22.50,-2.53, , , ,0.71,0.68, ,0.05,-0.26,-0.77,2.12, , ,,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5302,Q7Z404,TMC4,Transmembrane channel-like protein 4,HRQRNASRDQVVY,_NAS(ph)RDQVVYGSGTK_,S103,,25.39,22.78,23.34,19.82,22.90,,,,,22.72,,,,22.82,2.57,-0.04,0.51,-3.01,0.08, , , , ,-0.11, , , ,,integral to membrane,,,,,,,,,,,,,,
5303,Q7Z406,MYH14,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",LEEGVASDEEAEE,_LEEGVAS(ph)DEEAEEAQPGSGPS(ph)PEPEGS(ph)PPAHPQ_,S1977,,29.57,25.21,25.74,,,,,,,,,,,26.84,2.73,-1.63,-1.10, , , , , , , , , , ,regulation of cell shape;axon guidance;actin filament-based movement,growth cone;axon;stress fiber;myosin complex;cytoplasm,,,,,,,,,,,,,,
5305,Q7Z406,MYH14,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",QPGSGPSPEPEGS,_LEEGVAS(ph)DEEAEEAQPGSGPS(ph)PEPEGS(ph)PPAHPQ_,S1991,,27.12,,,,,,,,,,,,,27.12,0.00, , , , , , , , , , , , ,regulation of cell shape;axon guidance;actin filament-based movement,growth cone;axon;stress fiber;myosin complex;cytoplasm,,,,,,,,,,,,,,
5306,Q7Z406,MYH14,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",SPEPEGSPPAHPQ,_LEEGVAS(ph)DEEAEEAQPGSGPS(ph)PEPEGS(ph)PPAHPQ_,S1997,,27.82,,,,,,,,,,,,,27.82,0.00, , , , , , , , , , , , ,regulation of cell shape;axon guidance;actin filament-based movement,growth cone;axon;stress fiber;myosin complex;cytoplasm,,,,,,,,,,,,,,
5308,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),SQNPLASPTNTLL,_DYEIESQNPLAS(ph)PTNTLLGSAK_,S629,+,29.24,25.97,26.83,27.09,26.71,,27.02,27.00,27.78,27.38,27.93,25.60,26.74,27.11,2.13,-1.14,-0.28,-0.02,-0.39, ,-0.09,-0.11,0.67,0.28,0.82,-1.51,-0.37,,polysomal ribosome;nucleus,,,,,,,,,,,,,,
5310,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),GLERNDSWGSFDL,_NDS(ph)WGS(ph)FDLR_,S652,+,28.45,,,23.13,26.27,,,23.96,24.70,24.76,23.38,,,24.95,3.50, , ,-1.82,1.32, , ,-0.99,-0.25,-0.18,-1.57, , ,,polysomal ribosome;nucleus,,,,,,,,,,,,,,
5312,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),ISLKNLSSDEATN,_NLS(ph)SDEATNPISR_,S112,+,26.93,24.78,24.32,26.39,25.71,25.74,,25.85,25.40,25.41,24.91,25.65,25.16,25.52,1.41,-0.74,-1.20,0.87,0.19,0.22, ,0.33,-0.12,-0.11,-0.61,0.13,-0.36,,polysomal ribosome;nucleus,,,,,,,,,,,,,,
5313,Q7Z417,NUFIP2,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),YNEAMDSPDQ___,_RIITYNEAM(ox)DS(ph)PDQ_,S692,,23.85,,,,,,,,,24.68,,,,24.27,-0.41, , , , , , , , ,0.41, , , ,,polysomal ribosome;nucleus,,,,,,,,,,,,,,
5314,Q7Z422,SZRD1,SUZ domain-containing protein 1 (Putative MAPK-activating protein PM18/PM20/PM22),RILGSASPEEEQE,_ILGSAS(ph)PEEEQEKPILDRPTR_,S87,+,,,,,26.85,24.88,24.64,26.15,24.01,24.47,23.69,24.58,23.54,24.76, , , , ,2.09,0.12,-0.12,1.39,-0.75,-0.28,-1.07,-0.18,-1.22,,,,,,,,,,,,,,,,
5315,Q7Z422,SZRD1,SUZ domain-containing protein 1 (Putative MAPK-activating protein PM18/PM20/PM22),TAGKSKSPPKVPI,_SKS(ph)PPKVPIVIQDDSLPAGPPPQIR_,S19,,21.44,22.57,22.57,,23.47,,26.00,25.97,,,,24.18,23.71,23.74,-2.30,-1.17,-1.17, ,-0.27, ,2.26,2.23, , , ,0.44,-0.03,,,,,,,,,,,,,,,,
5316,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),ETQAPESPGENSE,_EPSYPM(ox)PVQETQAPES(ph)PGENSEQALQTLS(ph)PR_,S152,,25.02,,,,,,,,,26.31,,,,25.67,-0.65, , , , , , , , ,0.65, , , ,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
5317,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),QALQTLSPRAIPR,_EPSYPM(ox)PVQETQAPESPGENSEQALQTLS(ph)PR_,S165,+,25.49,24.73,24.73,,24.59,23.52,24.34,24.58,25.26,27.05,25.63,,25.83,25.07,0.42,-0.34,-0.34, ,-0.48,-1.55,-0.73,-0.49,0.19,1.98,0.56, ,0.76,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
5318,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),GLGSELSKPGVLA,_GLGSELS(ph)K_,S419,,22.97,,,26.01,,,22.65,,22.09,,,22.45,,23.23,-0.26, , ,2.78, , ,-0.58, ,-1.14, , ,-0.79, ,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
5319,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),PSRGPVSPSVSFQ,_GPVS(ph)PSVSFQPLAR_,S222,,26.19,,,,,23.47,,23.27,,,24.69,,24.11,24.34,1.84, , , , ,-0.88, ,-1.08, , ,0.35, ,-0.24,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
5320,Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),EKFSFRSQEDLNE,_S(ph)QEDLNEPIK_,S1129,+,23.83,24.66,24.36,24.92,24.78,25.26,25.78,25.31,25.30,26.05,25.68,25.75,23.43,25.01,-1.18,-0.35,-0.64,-0.09,-0.22,0.26,0.77,0.30,0.29,1.04,0.67,0.75,-1.58,establishment of spindle orientation;microtubule anchoring;microtubule organizing center organization;axon guidance;G2/M transition of mitotic cell cycle;microtubule nucleation;mitotic prometaphase;microtubule bundle formation;negative regulation of microtubule depolymerization;exit from mitosis;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;centrosomal corona;cortical microtubule cytoskeleton;cytosol;cytoplasmic microtubule;kinetochore,,,,,,,,,,,,,,
5321,Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),KNSSNTSVGSPSN,_NSSNTS(ph)VGSPSNTIGR_,S1060,,24.60,24.69,24.69,23.96,,,23.61,24.07,,,,,23.66,24.18,0.42,0.51,0.51,-0.23, , ,-0.57,-0.11, , , , ,-0.52,establishment of spindle orientation;microtubule anchoring;microtubule organizing center organization;axon guidance;G2/M transition of mitotic cell cycle;microtubule nucleation;mitotic prometaphase;microtubule bundle formation;negative regulation of microtubule depolymerization;exit from mitosis;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;centrosomal corona;cortical microtubule cytoskeleton;cytosol;cytoplasmic microtubule;kinetochore,,,,,,,,,,,,,,
5325,Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),SLQRSRSDIDVNA,_SRS(ph)DIDVNAAASAK_,S600,+,25.65,25.12,,26.35,26.23,,26.36,25.80,25.36,23.94,25.46,25.72,,25.60,0.05,-0.48, ,0.75,0.63, ,0.76,0.20,-0.24,-1.66,-0.14,0.12, ,establishment of spindle orientation;microtubule anchoring;microtubule organizing center organization;axon guidance;G2/M transition of mitotic cell cycle;microtubule nucleation;mitotic prometaphase;microtubule bundle formation;negative regulation of microtubule depolymerization;exit from mitosis;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;centrosomal corona;cortical microtubule cytoskeleton;cytosol;cytoplasmic microtubule;kinetochore,,,,,,,,,,,,,,
5328,Q7Z460,CLASP1,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),GCSRETSPNRIGL,_ETS(ph)PNRIGLDR_,S731,+,25.98,25.92,26.48,26.16,27.42,27.15,27.37,27.56,26.19,25.82,27.70,26.09,26.29,26.62,-0.64,-0.71,-0.14,-0.46,0.79,0.53,0.74,0.94,-0.44,-0.80,1.07,-0.53,-0.34,establishment of spindle orientation;microtubule anchoring;microtubule organizing center organization;axon guidance;G2/M transition of mitotic cell cycle;microtubule nucleation;mitotic prometaphase;microtubule bundle formation;negative regulation of microtubule depolymerization;exit from mitosis;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;centrosomal corona;cortical microtubule cytoskeleton;cytosol;cytoplasmic microtubule;kinetochore,,,,,,,,,,,,,,
5330,Q7Z478,DHX29,ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) (Nucleic acid helicase DDXx),KIYSFNSTNDSSG,_IYSFNS(ph)TNDSSGPANLDK_,S71,,22.51,,,,,,,,,,,,,22.51,0.00, , , , , , , , , , , , ,,mitochondrion,,,,,,,,,,,,,,
5331,Q7Z4H7,HAUS6,HAUS augmin-like complex subunit 6,RAVLSDSPQLSEG,_AVLSDS(ph)PQLSEGK_,S416,+,23.13,22.85,22.86,23.19,24.06,23.74,24.34,24.47,23.82,,,,,23.61,-0.48,-0.76,-0.74,-0.42,0.45,0.13,0.74,0.87,0.21, , , , ,centrosome organization;mitosis;spindle assembly;cell division,nucleus;microtubule;centrosome;HAUS complex;spindle,,,,,,,,,,,,,,
5332,Q7Z4S6,KIF21A,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),SGSSTFSPTILSS,_APYFSGSSTFS(ph)PTILSSDK_,S524,,22.93,,,,,,22.11,,,,,,,22.52,0.41, , , , , ,-0.41, , , , , , ,microtubule-based movement,microtubule associated complex;microtubule;cytoplasm,,,,,,,,,,,,,,
5333,Q7Z4S6,KIF21A,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),AREKELSPPPGLP,_ELS(ph)PPPGLPSK_,S1176,+,24.58,23.52,24.29,23.91,24.01,23.65,24.99,25.32,23.10,24.86,25.02,24.10,24.41,24.29,0.29,-0.77,0.00,-0.38,-0.28,-0.64,0.70,1.03,-1.19,0.57,0.73,-0.19,0.12,microtubule-based movement,microtubule associated complex;microtubule;cytoplasm,,,,,,,,,,,,,,
5337,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),SDSKADSDGAKPE,_ADS(ph)DGAKPEPVAMAR_,S240,+,28.05,28.49,25.98,29.99,,22.84,26.66,23.04,27.20,27.31,25.57,26.93,21.43,26.12,1.93,2.36,-0.14,3.87, ,-3.28,0.54,-3.08,1.07,1.18,-0.56,0.81,-4.69,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5341,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),FALKVDSPDVKRC,_FALKVDS(ph)PDVK_,S490,,,,,,,24.00,,23.24,,,,,,23.62, , , , , ,0.38, ,-0.38, , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5342,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),GEAERGSGGSSGD,_GEAERGS(ph)GGS(ph)S(ph)GDELREDDEPVK_,S366,,25.27,,,,,,,,,,,,,25.27,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5343,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),ERGSGGSSGDELR,_GEAERGS(ph)GGS(ph)S(ph)GDELREDDEPVK_,S369,,27.06,,,,22.34,,,,,,,,,24.70,2.36, , , ,-2.36, , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5344,Q7Z4V5,HDGFRP2,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),RGSGGSSGDELRE,_GEAERGS(ph)GGS(ph)S(ph)GDELREDDEPVK_,S370,,27.06,,,,22.34,,,,,,,,,24.70,2.36, , , ,-2.36, , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5346,Q7Z569,BRAP,BRCA1-associated protein (EC 6.3.2.-) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (Renal carcinoma antigen NY-REN-63),INAAPDSPSKQLP,_ECINAAPDS(ph)PSK_,S87,,24.20,24.68,24.75,25.78,21.77,,,,,,22.08,,,23.88,0.32,0.80,0.87,1.90,-2.11, , , , , ,-1.80, , ,negative regulation of signal transduction;MAPK cascade;Ras protein signal transduction,ubiquitin ligase complex;cytoplasm,,,,,,,,,,,,,,
5347,Q7Z589,EMSY,Protein EMSY,SIATVKSPRPASP,_S(ph)PRPAS(ph)PASNVVVLPSGSTVYVK_,S168,,24.29,,,,,,,,,,,,,24.29,0.00, , , , , , , , , , , , ,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
5348,Q7Z589,EMSY,Protein EMSY,KSPRPASPASNVV,_S(ph)PRPAS(ph)PASNVVVLPSGSTVYVK_,S173,,24.29,,,,,,,,,,,,,24.29,0.00, , , , , , , , , , , , ,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
5349,Q7Z589,EMSY,Protein EMSY,TITVPVSGSPKMS,_TITVPVS(ph)GSPK_,S236,,22.97,22.31,23.10,21.10,22.68,22.35,23.25,21.72,23.11,,,,,22.51,0.46,-0.20,0.59,-1.41,0.17,-0.16,0.74,-0.79,0.60, , , , ,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
5351,Q7Z589,EMSY,Protein EMSY,KRRRTNSSSSSPV,_TNS(ph)SSSSPVVLK_,S209,+,24.67,23.64,23.92,24.06,23.40,23.66,23.60,23.10,24.13,23.02,23.35,22.75,22.45,23.52,1.15,0.12,0.40,0.54,-0.12,0.14,0.08,-0.42,0.61,-0.50,-0.17,-0.77,-1.07,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
5354,Q7Z5J4,RAI1,Retinoic acid-induced protein 1,SPGNPLSPSLSDK,_APGASPGNPLS(ph)PSLSDK_,S1358,+,25.07,23.60,23.60,23.05,,24.05,24.44,23.15,24.36,23.73,,23.48,,23.85,1.22,-0.26,-0.26,-0.80, ,0.20,0.59,-0.70,0.51,-0.13, ,-0.37, ,negative regulation of multicellular organism growth;regulation of transcription from RNA polymerase II promoter;skeletal system development,nucleus;cytoplasm,,,,,,,,,,,,,,
5355,Q7Z5J4,RAI1,Retinoic acid-induced protein 1,EERPEGSPTLFKR,_EERPEGS(ph)PTLFK_,S1266,+,23.93,24.22,24.22,22.99,,,23.17,,24.16,24.36,,22.62,,23.71,0.22,0.52,0.52,-0.72, , ,-0.54, ,0.45,0.65, ,-1.09, ,negative regulation of multicellular organism growth;regulation of transcription from RNA polymerase II promoter;skeletal system development,nucleus;cytoplasm,,,,,,,,,,,,,,
5356,Q7Z5J4,RAI1,Retinoic acid-induced protein 1,LKGAGGSPVGVEE,_GAGGS(ph)PVGVEEGLVNVGTGQK_,S1374,+,24.01,22.74,21.61,21.57,22.80,23.88,24.65,22.78,25.33,24.38,,,,23.38,0.64,-0.64,-1.76,-1.80,-0.58,0.50,1.27,-0.59,1.95,1.01, , , ,negative regulation of multicellular organism growth;regulation of transcription from RNA polymerase II promoter;skeletal system development,nucleus;cytoplasm,,,,,,,,,,,,,,
5357,Q7Z5K2,WAPAL,Wings apart-like protein homolog (Friend of EBNA2 protein),FGKRPESPSEISP,_RPES(ph)PSEISPIK_,S221,+,27.42,26.65,27.25,26.35,25.39,27.03,27.24,25.21,27.48,25.69,26.43,27.09,26.55,26.60,0.82,0.06,0.66,-0.25,-1.21,0.43,0.64,-1.39,0.88,-0.91,-0.17,0.49,-0.05,negative regulation of DNA replication;response to toxin;protein localization to chromatin;regulation of cohesin localization to chromatin;negative regulation of chromatin binding;mitosis;negative regulation of sister chromatid cohesion;cell division;virus-host interaction,microtubule cytoskeleton;chromatin;synaptonemal complex;cohesin complex;nucleus;cytoplasm,,,,,,,,,,,,,,
5358,Q7Z5K2,WAPAL,Wings apart-like protein homolog (Friend of EBNA2 protein),ESPSEISPIKGSV,_RPES(ph)PSEIS(ph)PIK_,S226,+,27.26,25.95,26.71,25.64,24.52,,,22.35,24.32,23.96,,,,25.09,2.17,0.86,1.63,0.55,-0.57, , ,-2.74,-0.77,-1.13, , , ,negative regulation of DNA replication;response to toxin;protein localization to chromatin;regulation of cohesin localization to chromatin;negative regulation of chromatin binding;mitosis;negative regulation of sister chromatid cohesion;cell division;virus-host interaction,microtubule cytoskeleton;chromatin;synaptonemal complex;cohesin complex;nucleus;cytoplasm,,,,,,,,,,,,,,
5359,Q7Z5K2,WAPAL,Wings apart-like protein homolog (Friend of EBNA2 protein),DPFGFDSDDESLP,_VEEESTGDPFGFDS(ph)DDESLPVSSK_,S77,,26.42,,,,,,,,,,,,,26.42,0.00, , , , , , , , , , , , ,negative regulation of DNA replication;response to toxin;protein localization to chromatin;regulation of cohesin localization to chromatin;negative regulation of chromatin binding;mitosis;negative regulation of sister chromatid cohesion;cell division;virus-host interaction,microtubule cytoskeleton;chromatin;synaptonemal complex;cohesin complex;nucleus;cytoplasm,,,,,,,,,,,,,,
5361,Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),PELNRQSPNPRRG,_LEEPPELNRQS(ph)PNPRR_,S175,+,28.07,27.79,27.71,27.36,27.49,29.14,28.56,27.79,29.39,29.68,27.53,27.86,27.75,28.16,-0.09,-0.37,-0.46,-0.80,-0.67,0.97,0.39,-0.37,1.23,1.52,-0.63,-0.31,-0.42,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
5362,Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),NSNSPPSPSSMNQ,_NSNSPPS(ph)PSSM(ox)NQR_,S444,+,20.16,21.48,21.48,22.94,21.85,20.80,20.94,21.50,21.87,22.32,,,20.04,21.40,-1.24,0.08,0.08,1.54,0.45,-0.60,-0.46,0.10,0.47,0.92, , ,-1.36,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
5363,Q7Z5L9,IRF2BP2,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),ARKRKPSPEPEGE,_RKPS(ph)PEPEGEVGPPK_,S344,+,23.61,26.72,27.43,24.63,24.59,26.81,26.67,25.97,26.76,27.47,25.04,23.97,24.77,25.73,-2.11,0.99,1.70,-1.09,-1.14,1.09,0.95,0.24,1.04,1.74,-0.69,-1.76,-0.96,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
5367,Q7Z5R6,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1) (PREL-1) (Proline-rich protein 73) (Rap1-GTP-interacting adapter molecule) (RIAM) (Retinoic acid-responsive proline-rich protein 1) (RARP-1),PPVRRSSDTSGSP,_RSS(ph)DTSGSPATPLK_,S526,,,25.64,25.72,23.60,,23.23,,,,,,,,24.55, ,1.09,1.18,-0.95, ,-1.32, , , , , , , ,signal transduction;platelet activation,cytosol;plasma membrane;focal adhesion;cytoskeleton;lamellipodium,,,,,,,,,,,,,,
5368,Q7Z6B0,CCDC91,Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein),IKQDVESLMEKHN,_QDVES(ph)LM(ox)EK_,S161,,,,,,22.65,,24.72,24.21,22.24,22.19,27.09,,24.90,24.00, , , , ,-1.35, ,0.72,0.21,-1.76,-1.81,3.09, ,0.90,protein transport,Golgi apparatus;nucleus;membrane,,,,,,,,,,,,,,
5369,Q7Z6B7,SRGAP1,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),SSKDMNSPTDRHP,_DM(ox)NS(ph)PTDRHPDGYLAR_,S772,,22.98,,,,,,24.36,,23.21,23.72,23.94,,23.32,23.59,-0.61, , , , , ,0.78, ,-0.38,0.13,0.35, ,-0.26,cell migration;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;Rho protein signal transduction;axon guidance,cytosol,,,,,,,,,,,,,,
5370,Q7Z6B7,SRGAP1,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),RGLNNDSPERRRR,_GLNNDS(ph)PERR_,S843,,23.62,,,22.67,,,19.99,,19.55,,,19.91,,21.15,2.47, , ,1.53, , ,-1.16, ,-1.60, , ,-1.24, ,cell migration;small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;Rho protein signal transduction;axon guidance,cytosol,,,,,,,,,,,,,,
5372,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),DKDDFESEEEDVK,_WDKDDFES(ph)EEEDVK_,S1294,+,28.26,27.53,27.80,27.10,26.95,27.53,28.10,26.34,28.40,28.22,26.15,27.49,26.31,27.40,0.87,0.13,0.40,-0.30,-0.45,0.13,0.70,-1.06,1.00,0.82,-1.25,0.09,-1.09,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5373,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),ANRENFSPERFLP,_PSANRENFS(ph)PER_,S827,+,24.77,25.91,24.38,25.60,26.43,24.90,24.59,24.42,25.41,25.56,23.53,21.04,24.71,24.71,0.06,1.20,-0.33,0.89,1.71,0.18,-0.12,-0.29,0.70,0.85,-1.18,-3.67,0.00,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5374,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),PLNIRNSPFTRGR,_FLPLNIRNS(ph)PFTR_,S839,+,22.47,,,,23.62,,21.65,,,23.68,,23.21,23.25,22.98,-0.51, , , ,0.64, ,-1.33, , ,0.70, ,0.23,0.27,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5375,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),TEIVKPSPKRKME,_LEVTEIVKPS(ph)PK_,S1145,+,25.85,26.32,26.35,25.15,26.14,27.04,27.04,25.01,27.68,27.81,25.69,27.09,26.83,26.46,-0.61,-0.14,-0.11,-1.31,-0.32,0.58,0.58,-1.46,1.22,1.35,-0.78,0.63,0.36,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5376,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),KLGYLVSPPQQIR,_LGYLVS(ph)PPQQIR_,S516,+,21.57,20.75,20.75,21.09,22.58,22.14,22.53,22.57,22.45,23.05,,,,21.95,-0.38,-1.20,-1.20,-0.86,0.64,0.19,0.58,0.62,0.50,1.10, , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5377,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),SHSSRLSSDLTRE,_LS(ph)SDLTR_,S1591,,24.18,23.39,,22.74,,,,,,,,,,23.44,0.74,-0.05, ,-0.69, , , , , , , , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5378,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),HSSRLSSDLTRET,_LSS(ph)DLTR_,S1592,,23.92,21.87,21.72,23.73,,,,,,,,,,22.81,1.11,-0.94,-1.09,0.92, , , , , , , , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5380,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),LQPLMRSPISRQQ,_NLQPLM(ox)RS(ph)PISR_,S360,+,23.23,22.23,22.77,23.68,23.04,23.78,23.25,23.34,23.24,21.10,,,22.74,22.95,0.29,-0.71,-0.17,0.73,0.09,0.83,0.30,0.39,0.30,-1.85, , ,-0.20,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5381,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),LETSRKSREPTGV,_S(ph)REPTGVEENK_,S926,,21.93,23.94,23.80,23.42,,,19.43,,,20.77,,,,22.22,-0.29,1.72,1.58,1.21, , ,-2.78, , ,-1.45, , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5382,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),DGERERSPRSEPP,_VDGERERS(ph)PR_,S1018,+,21.85,23.18,23.18,19.10,,20.74,18.88,20.83,20.34,,19.18,19.13,,20.64,1.21,2.54,2.54,-1.54, ,0.10,-1.76,0.19,-0.30, ,-1.47,-1.51, ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5384,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),TSSTGGSPVRKSE,_VTGTEGSSSTLVDYTSTSSTGGS(ph)PVRK_,S1243,,,22.95,22.95,,,,23.99,,24.56,,,24.08,23.80,23.72, ,-0.77,-0.77, , , ,0.27, ,0.84, , ,0.35,0.08,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
5385,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",MDQRAESPEEVAC,_AES(ph)PEEVACR_,S1395,,22.51,24.48,,22.87,,,,,,,22.99,,,23.21,-0.70,1.27, ,-0.34, , , , , , ,-0.22, , ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5386,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",EQPRAGSSTPGDA,_AGS(ph)STPGDAPPAVAEVQGR_,S2887,+,24.60,25.05,,25.01,,,,26.69,24.91,25.00,25.09,26.90,,25.41,-0.80,-0.35, ,-0.40, , , ,1.28,-0.50,-0.40,-0.32,1.49, ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5388,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",DEPPPLSPAPLTP,_DEPPPLS(ph)PAPLTPATPSSLDPFFSR_,S3903,,25.59,,,,,,,,,,,,,25.59,0.00, , , , , , , , , , , , ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5389,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",LERDGGSGNSTII,_DGGS(ph)GNSTIIVSR_,S2362,+,,25.68,,23.27,25.46,25.42,25.58,26.99,24.15,22.52,,24.28,,24.81, ,0.86, ,-1.55,0.64,0.60,0.76,2.17,-0.67,-2.30, ,-0.53, ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5390,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",GVVRDLSMSEEDQ,_DLS(ph)M(ox)SEEDQM(ox)M(ox)R_,S1368,+,23.76,22.90,22.70,,22.62,21.83,22.50,23.17,21.92,,22.95,22.24,,22.66,1.10,0.24,0.04, ,-0.04,-0.83,-0.16,0.50,-0.74, ,0.29,-0.42, ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5393,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",RGSGTASDDEFEN,_GSGTAS(ph)DDEFENLRIK_,S1907,+,28.70,26.90,25.11,28.06,28.47,28.81,29.33,29.28,28.10,28.32,29.16,29.38,28.11,28.29,0.41,-1.39,-3.17,-0.23,0.19,0.53,1.04,0.99,-0.19,0.03,0.87,1.10,-0.18,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5394,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",GSSGLGSASSIQA,_LGSSGLGS(ph)ASSIQAAVR_,S3741,+,22.33,22.25,,23.61,23.77,,24.08,24.27,,22.11,24.05,24.56,22.76,23.38,-1.04,-1.13, ,0.23,0.39, ,0.70,0.89, ,-1.27,0.67,1.18,-0.62,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
5400,Q86SQ0,PHLDB2,Pleckstrin homology-like domain family B member 2 (Protein LL5-beta),TFPKASSESSYLS,_ASS(ph)ESSYLSILPK_,S563,,22.51,,,21.87,,,,,,,23.27,,,22.55,-0.04, , ,-0.68, , , , , , ,0.72, , ,,intermediate filament cytoskeleton;plasma membrane;cytoplasm,,,,,,,,,,,,,,
5403,Q86SQ0,PHLDB2,Pleckstrin homology-like domain family B member 2 (Protein LL5-beta),TLSVPASPRVARK,_TSASEGNPYVSSTLSVPAS(ph)PR_,S334,+,24.50,,,23.11,23.86,24.02,,24.04,25.01,,25.21,25.04,,24.35,0.16, , ,-1.24,-0.49,-0.33, ,-0.31,0.66, ,0.86,0.69, ,,intermediate filament cytoskeleton;plasma membrane;cytoplasm,,,,,,,,,,,,,,
5404,Q86SQ7,SDCCAG8,Serologically defined colon cancer antigen 8 (Antigen NY-CO-8) (Centrosomal colon cancer autoantigen protein) (hCCCAP),___MAKSPENSTL,_S(ph)PENSTLEEILGQYQR_,S4,,21.12,,,,,,,,,,,,,21.12,0.00, , , , , , , , , , , , ,G2/M transition of mitotic cell cycle;establishment of cell polarity;tube formation,cytosol;centriole;cell-cell junction,,,,,,,,,,,,,,
5405,Q86T03,TMEM55B,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)",VHPGPLSPEPQPM,_IINLGPVHPGPLS(ph)PEPQPM(ox)GVR_,S162,,21.76,,,,22.10,,,22.79,,22.38,24.09,,,22.62,-0.87, , , ,-0.52, , ,0.17, ,-0.25,1.47, , ,,integral to membrane;late endosome membrane;lysosomal membrane,,,,,,,,,,,,,,
5406,Q86T65,DAAM2,Disheveled-associated activator of morphogenesis 2,HQKELGSTEDIYL,_ELGS(ph)TEDIYLASRK_,S656,+,23.92,22.19,,,23.22,24.62,24.40,24.27,,,20.81,,,23.35,0.57,-1.16, , ,-0.13,1.27,1.06,0.93, , ,-2.54, , ,actin cytoskeleton organization,,,,,,,,,,,,,,,
5408,Q86TB9,PATL1,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) (hPat1b),LPRRSTSPIIGSP,_STS(ph)PIIGSPPVR_,S179,+,25.41,25.06,24.69,24.87,25.94,25.30,25.43,25.92,24.46,25.06,24.36,25.87,24.25,25.12,0.29,-0.07,-0.44,-0.26,0.82,0.18,0.30,0.80,-0.66,-0.06,-0.77,0.74,-0.88,deadenylation-dependent decapping of nuclear-transcribed mRNA;gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;cytoplasmic mRNA processing body assembly,cytosol;intracellular membrane-bounded organelle;PML body;nuclear speck;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5409,Q86TB9,PATL1,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) (hPat1b),TSPIIGSPPVRAV,_STS(ph)PIIGS(ph)PPVR_,S184,,22.57,,,,,,,,,,,,,22.57,0.00, , , , , , , , , , , , ,deadenylation-dependent decapping of nuclear-transcribed mRNA;gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;cytoplasmic mRNA processing body assembly,cytosol;intracellular membrane-bounded organelle;PML body;nuclear speck;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5410,Q86TI0,TBC1D1,TBC1 domain family member 1,PMRKSFSQPGLRS,_SFS(ph)QPGLR_,S237,+,23.19,25.05,25.20,25.32,24.81,23.86,25.96,26.44,23.94,21.48,23.62,24.59,22.07,24.27,-1.08,0.78,0.93,1.05,0.54,-0.41,1.69,2.17,-0.33,-2.79,-0.65,0.32,-2.21,positive regulation of Rab GTPase activity;regulation of protein localization,nucleus,,,,,,,,,,,,,,
5413,Q86TV6,TTC7B,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1),LSEVASSLQSSAP,_VEQALSEVASS(ph)LQSSAPK_,S106,,,21.87,,22.92,23.28,,,,22.05,,,,22.83,22.59, ,-0.72, ,0.33,0.69, , , ,-0.54, , , ,0.24,,,,,,,,,,,,,,,,
5414,Q86U06,RBM23,Probable RNA-binding protein 23 (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2),PHFREKSPVREPV,_S(ph)PVREPVDNLSPEER_,S149,+,24.33,24.07,24.18,22.83,,22.70,26.07,22.26,25.23,24.85,23.44,24.34,22.76,23.92,0.41,0.15,0.26,-1.09, ,-1.22,2.15,-1.66,1.31,0.93,-0.48,0.42,-1.16,mRNA processing,nucleus,,,,,,,,,,,,,,
5415,Q86U42,PABPN1,Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1),GSGAPGSQEEEEE,_APPGAPGPGPGSGAPGS(ph)QEEEEEPGLVEGDPGDGAIEDPELEAIK_,S95,,27.05,,,23.76,25.04,,,,26.67,27.03,,,,25.91,1.14, , ,-2.15,-0.87, , , ,0.76,1.12, , , ,"poly(A)+ mRNA export from nucleus;mRNA 3'-end processing;modification by virus of host mRNA processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome;viral infectious cycle;muscle contraction",nucleoplasm;ribonucleoprotein complex;cytoplasm,,,,,,,,,,,,,,
5416,Q86U42,PABPN1,Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1),EKQMNMSPPPGNA,_QM(ox)NM(ox)S(ph)PPPGNAGPVIMSIEEK_,S150,+,26.65,26.45,26.18,26.21,25.63,27.73,27.32,27.10,28.15,28.51,27.36,26.63,28.06,27.07,-0.42,-0.63,-0.90,-0.86,-1.44,0.65,0.25,0.03,1.07,1.43,0.28,-0.44,0.98,"poly(A)+ mRNA export from nucleus;mRNA 3'-end processing;modification by virus of host mRNA processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome;viral infectious cycle;muscle contraction",nucleoplasm;ribonucleoprotein complex;cytoplasm,,,,,,,,,,,,,,
5418,Q86U44,METTL3,N6-adenosine-methyltransferase 70 kDa subunit (MT-A70) (EC 2.1.1.62) (Methyltransferase-like protein 3),HKKQLDSLRERLQ,_(gl)QLDS(ph)LRER_,S17,,23.69,,,21.10,,,,,,,,,,22.40,1.30, , ,-1.30, , , , , , , , , ,gene expression,nucleoplasm;nuclear speck,,,,,,,,,,,,,,
5420,Q86U86,PBRM1,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),DDDDMASPKLKLS,_ELGPLPDDDDM(ox)AS(ph)PKLK_,S636,,,,,,23.46,22.43,,,,,,,22.68,22.85, , , , ,0.60,-0.43, , , , , , ,-0.18,"negative regulation of cell proliferation;mitosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;heart development;chromatin remodeling;placenta development",nuclear chromosome;kinetochore,HMG-box,,,,,,,,,,,,,
5421,Q86U86,PBRM1,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),ERLWEDSAGEKWL,_LWEDS(ph)AGEK_,S986,,24.31,23.01,22.70,,,,21.35,21.95,22.15,,,,21.52,22.43,1.89,0.58,0.27, , , ,-1.07,-0.48,-0.28, , , ,-0.91,"negative regulation of cell proliferation;mitosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;heart development;chromatin remodeling;placenta development",nuclear chromosome;kinetochore,HMG-box,,,,,,,,,,,,,
5422,Q86U86,PBRM1,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),GLHRTYSQDCSFK,_TYS(ph)QDCSFK_,S947,,23.19,,,,,,,,,,,,,23.19,0.00, , , , , , , , , , , , ,"negative regulation of cell proliferation;mitosis;transcription, DNA-dependent;regulation of transcription, DNA-dependent;heart development;chromatin remodeling;placenta development",nuclear chromosome;kinetochore,HMG-box,,,,,,,,,,,,,
5423,Q86U90,YRDC,"YrdC domain-containing protein, mitochondrial (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP)",RLFRPPSPAPAAP,_LFRPPS(ph)PAPAAPGAR_,S37,+,23.55,23.79,23.97,23.72,24.90,24.09,25.39,24.94,23.62,24.40,,,24.57,24.27,-0.72,-0.47,-0.30,-0.55,0.63,-0.18,1.13,0.67,-0.65,0.13, , ,0.30,negative regulation of transport,mitochondrion;membrane,,,,,,,,,,,,,,
5424,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),KLSSQISAGEEKW,_LSSQIS(ph)AGEEK_,S298,+,30.93,28.53,28.64,29.23,23.53,26.81,26.59,,28.12,26.74,28.19,26.08,,27.58,3.35,0.95,1.06,1.65,-4.05,-0.77,-0.99, ,0.54,-0.84,0.61,-1.50, ,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5425,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),EKWNSVSPASAGK,_WNSVS(ph)PASAGK_,S308,+,26.19,25.11,25.74,25.13,23.66,24.34,24.62,23.89,24.30,24.20,,24.68,24.00,24.65,1.54,0.45,1.08,0.47,-0.99,-0.32,-0.04,-0.77,-0.35,-0.45, ,0.02,-0.65,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5426,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),KQGEDNSTAQDTE,_(gl)QGEDNS(ph)TAQDTEELEK_,S457,,20.74,,,21.45,,22.42,21.81,,22.91,,,,,21.87,-1.13, , ,-0.41, ,0.56,-0.06, ,1.04, , , , ,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5428,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),PDDQKVSDDDKEK,_SQEPIPDDQKVS(ph)DDDKEK_,S426,+,31.10,31.32,31.65,30.78,27.14,29.29,31.78,28.87,32.06,32.36,31.17,31.10,29.41,30.62,0.48,0.70,1.03,0.17,-3.48,-1.33,1.16,-1.75,1.45,1.74,0.55,0.48,-1.20,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5429,Q86UE4,MTDH,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),FSLKTISTSDPAE,_TIS(ph)TSDPAEVLVK_,S494,+,25.03,23.13,23.13,23.01,,22.34,23.20,22.82,23.40,24.38,23.68,24.09,23.62,23.49,1.55,-0.36,-0.36,-0.47, ,-1.15,-0.28,-0.66,-0.08,0.90,0.19,0.61,0.13,negative regulation of apoptotic process;positive regulation of protein kinase B signaling cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of angiogenesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;lipopolysaccharide-mediated signaling pathway;negative regulation of transcription from RNA polymerase II promoter;positive regulation of autophagy;tight junction assembly,nuclear body;apical plasma membrane;perinuclear region of cytoplasm;tight junction;nuclear membrane;integral to membrane;intercellular canaliculus;nucleolus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5430,Q86UP2,KTN1,Kinectin (CG-1 antigen) (Kinesin receptor),IENSDVSPETESS,_AAGDTTVIENSDVS(ph)PETESSEK_,S1313,,25.74,25.14,25.08,24.42,,26.59,25.83,25.00,26.75,27.31,26.46,25.79,26.76,25.91,-0.17,-0.76,-0.83,-1.49, ,0.68,-0.07,-0.90,0.85,1.40,0.56,-0.11,0.86,microtubule-based movement,integral to plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5432,Q86UP3,ZFHX4,Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4),SPKNLLSPSSFKA,_NLLS(ph)PSSFK_,S460,+,,20.62,21.09,22.23,23.48,23.44,23.15,23.23,23.43,23.24,21.00,,22.98,22.54, ,-1.91,-1.45,-0.30,0.94,0.91,0.61,0.70,0.89,0.71,-1.54, ,0.44,"transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5433,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),AKANQISPSNSSL,_ANQIS(ph)PSNSSLK_,S88,+,26.69,28.40,28.40,25.95,26.63,28.56,,28.14,,,27.43,,23.88,27.12,-0.43,1.28,1.28,-1.17,-0.49,1.44, ,1.02, , ,0.31, ,-3.24,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5434,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),KVKRDRSVSVDSG,_DRS(ph)VS(ph)VDSGEQR_,S116,+,24.81,22.39,22.39,24.62,19.91,,,20.79,,,20.83,21.25,,22.12,2.69,0.26,0.26,2.50,-2.21, , ,-1.34, , ,-1.29,-0.87, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5435,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),KRDRSVSVDSGEQ,_SVS(ph)VDSGEQREAGTPSLDSEAK_,S118,+,24.86,,,,23.95,25.77,25.09,24.21,25.41,23.38,23.86,25.18,24.68,24.64,0.22, , , ,-0.69,1.13,0.45,-0.43,0.78,-1.26,-0.78,0.54,0.04,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5436,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),RREAPGSPPLSPR,_EAPGS(ph)PPLS(ph)PR_,S21,+,26.83,25.61,24.88,26.19,26.43,26.75,26.32,26.57,26.25,25.54,25.45,25.38,25.97,26.01,0.82,-0.40,-1.14,0.17,0.41,0.74,0.30,0.55,0.24,-0.47,-0.56,-0.63,-0.04,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5437,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),PGSPPLSPRGHCP,_EAPGS(ph)PPLS(ph)PR_,S25,+,25.28,22.60,22.15,23.80,22.94,23.22,,22.45,23.10,,,,,23.19,2.09,-0.59,-1.04,0.61,-0.26,0.03, ,-0.75,-0.10, , , , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5438,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),GGRGLLSPPMGQS,_GLLS(ph)PPM(ox)GQSGLR_,S750,+,23.08,,,24.22,23.69,24.43,22.54,23.65,22.87,,24.13,,,23.58,-0.50, , ,0.64,0.11,0.85,-1.03,0.08,-0.70, ,0.55, , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5439,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),MGPQGLSPEEMAR,_M(ox)RGPGDLM(ox)GPQGLS(ph)PEEM(ox)AR_,S813,,,,,,24.74,23.42,24.36,24.66,23.17,23.01,,,,23.89, , , , ,0.85,-0.48,0.47,0.77,-0.73,-0.88, , , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5441,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),PSANLKSPQTPSQ,_S(ph)PQT(ph)PSQM(ox)VPLPSANPPGPLK_,S954,+,26.60,22.21,22.54,22.36,,,,,24.59,25.27,24.26,24.40,,24.03,2.57,-1.82,-1.48,-1.67, , , , ,0.56,1.25,0.23,0.37, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5442,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),PPGPLKSPQVLGS,_S(ph)PQVLGSSLSVRS(ph)PTGS(ph)PSR_,S975,+,25.79,23.13,21.79,23.59,,,24.18,,23.19,22.63,23.39,,,23.46,2.33,-0.33,-1.67,0.13, , ,0.72, ,-0.27,-0.83,-0.07, , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5444,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),SSLSVRSPTGSPS,_S(ph)PQVLGSSLSVRS(ph)PTGS(ph)PSR_,S987,+,23.93,24.16,24.16,,22.91,,23.36,23.74,25.07,23.50,,,,23.86,0.07,0.31,0.31, ,-0.95, ,-0.49,-0.12,1.22,-0.35, , , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5446,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),SRLKSPSMAVPSP,_SPS(ph)M(ox)AVPSPGWVASPK_,S999,,24.10,22.66,22.79,22.30,,,23.38,,24.16,22.96,23.69,23.30,23.14,23.25,0.85,-0.59,-0.45,-0.95, , ,0.13, ,0.92,-0.29,0.44,0.05,-0.11,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5447,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),PSMAVPSPGWVAS,_SPSM(ox)AVPS(ph)PGWVAS(ph)PK_,S1004,+,23.17,22.20,22.79,22.25,23.42,,,23.98,23.38,23.07,,,,23.03,0.14,-0.83,-0.25,-0.78,0.39, , ,0.94,0.35,0.04, , , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5449,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),GMGHLKSPTLSQV,_S(ph)PTLSQVHSPLVTS(ph)PSANLK_,S934,+,26.67,21.75,21.75,22.53,22.84,23.49,24.38,,,23.56,,23.52,23.88,23.44,3.23,-1.69,-1.69,-0.90,-0.60,0.05,0.95, , ,0.13, ,0.08,0.44,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5450,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),TLSQVHSPLVTSP,_SPT(ph)LSQVHS(ph)PLVTS(ph)PSANLK_,S942,,25.37,,,,,,,,,,,21.47,,23.42,1.95, , , , , , , , , , ,-1.95, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5451,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),HSPLVTSPSANLK,_S(ph)PTLSQVHSPLVTS(ph)PSANLK_,S947,+,27.05,23.96,24.65,24.79,,,,,23.98,22.78,,21.47,,24.10,2.96,-0.13,0.56,0.69, , , , ,-0.12,-1.32, ,-2.63, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5453,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),LRQRSVSLDSQMG,_SVS(ph)LDSQM(ox)GYLPAPGGM(ox)ANLPF_,S1434,,25.25,,,,,,,,,,,,,25.25,0.00, , , , , , , , , , , , ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
5454,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),CVQRKLSSGDLRV,_KLS(ph)SGDLR_,S307,+,23.56,21.51,21.51,21.80,23.30,23.15,23.98,22.96,22.01,21.80,22.98,25.41,23.17,22.86,0.71,-1.35,-1.35,-1.06,0.44,0.30,1.13,0.10,-0.84,-1.06,0.13,2.55,0.31,,,,,,,,,,,,,,,,
5455,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),TQRLWESMERSDE,_LWES(ph)M(ox)ERSDEENLK_,S422,,,,,21.60,,,23.18,,,,22.88,24.38,,23.01, , , ,-1.41, , ,0.17, , , ,-0.13,1.37, ,,,,,,,,,,,,,,,,
5457,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),NSITEISDNEDDL,_NSITEIS(ph)DNEDDLLEYHRR_,S327,,,,,,23.73,,24.47,,24.78,,23.85,25.29,24.10,24.37, , , , ,-0.64, ,0.10, ,0.41, ,-0.52,0.92,-0.27,,,,,,,,,,,,,,,,
5458,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),LVGRTFSDGLATR,_TFS(ph)DGLATR_,S174,,23.49,,,22.24,,,22.10,21.11,,,21.15,,,22.02,1.47, , ,0.23, , ,0.08,-0.91, , ,-0.87, , ,,,,,,,,,,,,,,,,
5459,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),TLQPPESPRLGRR,_TLQPPES(ph)PR_,S187,,,22.17,,24.17,,,,,,,,,,23.17, ,-1.00, ,1.00, , , , , , , , , ,,,,,,,,,,,,,,,,
5460,Q86UU1,PHLDB1,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),ERVLTTSPSRQLV,_VLTTS(ph)PSR_,S163,,22.36,,,25.27,,,,21.24,,,19.56,20.90,,21.86,0.50, , ,3.40, , , ,-0.63, , ,-2.31,-0.97, ,,,,,,,,,,,,,,,,
5462,Q86UV5,USP48,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific-processing protease 48),ELNVSSSETEEDK,_DSAPELNVS(ph)SS(ph)ETEEDK_,S888,,22.82,,,,,,,,,,,,,22.82,0.00, , , , , , , , , , , , ,ubiquitin-dependent protein catabolic process,mitochondrion;nucleus,,,,,,,,,,,,,,
5463,Q86UZ6,ZBTB46,Zinc finger and BTB domain-containing protein 46 (BTB-ZF protein expressed in effector lymphocytes) (BZEL) (BTB/POZ domain-containing protein 4) (Zinc finger protein 340),MAGRSISPWLARR,_SIS(ph)PWLAR_,S168,,21.14,,,,,,,,,,,,,21.14,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5465,Q86V15,CASZ1,Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693),APTAASSP_____,_TPALAALAALGAPGPAPTAASS(ph)P_,S1758,,28.23,,,,,,,,,,,,,28.23,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
5466,Q86V48,LUZP1,Leucine zipper protein 1,GREKPDSDDDLDI,_EKPDS(ph)DDDLDIASLVTAK_,S659,,24.27,,,,25.95,,,,,25.56,,23.91,,24.92,-0.65, , , ,1.03, , , , ,0.64, ,-1.01, ,neural fold bending;artery development;ventricular septum development,nucleus,,,,,,,,,,,,,,
5467,Q86V48,LUZP1,Leucine zipper protein 1,IRWKSHSAPSEVG,_SHS(ph)APSEVGFSDAR_,S905,,,22.34,,22.75,23.74,22.67,22.68,,24.11,,,,,23.05, ,-0.71, ,-0.30,0.69,-0.38,-0.37, ,1.06, , , , ,neural fold bending;artery development;ventricular septum development,nucleus,,,,,,,,,,,,,,
5468,Q86V48,LUZP1,Leucine zipper protein 1,SRRDLKSLEDPPT,_S(ph)LEDPPTR_,S932,,23.22,23.11,,25.18,,,,,24.89,,,,,24.10,-0.88,-0.99, ,1.08, , , , ,0.79, , , , ,neural fold bending;artery development;ventricular septum development,nucleus,,,,,,,,,,,,,,
5471,Q86VB7,CD163,Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],CLKLAVSSRLRPF,_LAVS(ph)SR_,S1084,,,24.14,24.94,23.12,,,,,,,,,,24.06, ,0.08,0.87,-0.95, , , , , , , , , ,acute-phase response,extracellular region;integral to plasma membrane,,,,,,,,,,,,,,
5472,Q86VE0,MYPOP,"Myb-related transcription factor, partner of profilin (Myb-related protein p42POP) (Partner of profilin)",RPKERESPPPSAL,_ERES(ph)PPPSALQPVQLPR_,S202,,,,,,,23.18,,23.20,22.96,,,21.65,23.50,22.90, , , , , ,0.28, ,0.30,0.06, , ,-1.25,0.61,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5473,Q86VI3,IQGAP3,Ras GTPase-activating-like protein IQGAP3,PLRRHRSLTAHSL,_S(ph)LTAHSLLPLAEK_,S1381,,,22.20,22.20,23.52,24.07,,24.04,23.85,,,,,,23.31, ,-1.11,-1.11,0.20,0.76, ,0.73,0.54, , , , , ,positive regulation of mammary gland epithelial cell proliferation;negative regulation of gene expression;positive regulation of gene expression;cellular response to organic substance;activation of MAPK activity;Ras protein signal transduction;G1/S transition of mitotic cell cycle;ERK1 and ERK2 cascade;regulation of cell size;positive regulation of Ras GTPase activity,cell-cell junction;lateral plasma membrane;cytoplasm,,,,,,,,,,,,,,
5474,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),GAGVRASDLEDEE,_AS(ph)DLEDEESAAR_,S46,+,25.56,26.85,24.98,26.01,26.62,26.81,24.92,,25.41,21.83,25.60,23.44,25.51,25.30,0.26,1.55,-0.32,0.72,1.32,1.52,-0.37, ,0.11,-3.46,0.30,-1.85,0.22,,nucleus,,,,,,,,,,,,,,
5477,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),ILRDSGSDQDLDG,_DSGS(ph)DQDLDGAGVR_,S34,,21.18,24.47,,,,,,,,,,,,22.83,-1.64,1.64, , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5479,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),DEEDRASEPKSQD,_GPSQEEEDNHS(ph)DEEDRAS(ph)EPK_,S74,,24.38,26.69,26.78,25.56,,,21.03,,22.16,,,,,24.43,-0.05,2.26,2.35,1.13, , ,-3.40, ,-2.27, , , , ,,nucleus,,,,,,,,,,,,,,
5480,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),KKKLGVSVSPSRA,_KLGVS(ph)VS(ph)PSR_,S532,,26.82,24.07,23.94,24.82,22.22,,,,22.31,,,,,24.03,2.79,0.04,-0.09,0.79,-1.81, , , ,-1.72, , , , ,,nucleus,,,,,,,,,,,,,,
5481,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),KLGVSVSPSRARR,_LGVSVS(ph)PSRAR_,S534,+,28.26,27.39,27.69,28.76,28.95,28.19,28.55,28.35,28.14,28.18,27.16,27.94,26.79,28.03,0.23,-0.64,-0.33,0.73,0.93,0.17,0.52,0.33,0.11,0.16,-0.87,-0.09,-1.24,,nucleus,,,,,,,,,,,,,,
5483,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),_MDVAESPERDPH,_(ac)M(ox)DVAES(ph)PERDPHSPEDEEQPQGLSDDDILR_,S6,+,,,,,25.74,25.00,24.47,24.82,24.34,23.74,,,25.34,24.78, , , , ,0.96,0.22,-0.31,0.05,-0.44,-1.04, , ,0.56,,nucleus,,,,,,,,,,,,,,
5484,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),DRKRQLSPQSKSS,_RQLS(ph)PQSK_,S893,+,20.28,22.10,22.89,23.39,,18.69,19.48,18.24,19.80,,18.69,19.74,19.58,20.26,0.02,1.84,2.63,3.12, ,-1.57,-0.78,-2.02,-0.46, ,-1.57,-0.52,-0.69,,nucleus,,,,,,,,,,,,,,
5485,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),GKPKPRSPQPPSR,_S(ph)PQPPSR_,S487,+,21.06,22.89,22.40,24.29,,,,,23.10,21.09,,22.25,22.00,22.38,-1.33,0.50,0.01,1.91, , , , ,0.72,-1.29, ,-0.14,-0.38,,nucleus,,,,,,,,,,,,,,
5486,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),RASEPKSQDQDSE,_S(ph)QDQDS(ph)EVNELSR_,S78,+,25.77,25.94,25.09,25.57,,22.59,25.35,22.70,26.07,25.90,23.54,25.03,,24.87,0.90,1.07,0.22,0.70, ,-2.28,0.48,-2.17,1.20,1.03,-1.33,0.16, ,,nucleus,,,,,,,,,,,,,,
5487,Q86VM9,ZC3H18,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),KSQDQDSEVNELS,_S(ph)QDQDS(ph)EVNELSR_,S83,,24.52,,,,,,,,,,,,,24.52,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5488,Q86VP3,PACS2,Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein),RITKTESLVIPST,_TES(ph)LVIPSTR_,S341,,23.26,22.24,,20.30,,,,,,,,21.71,,21.88,1.38,0.36, ,-1.58, , , , , , , ,-0.16, ,protein targeting to plasma membrane;apoptotic process;virus-host interaction,mitochondrion;endoplasmic reticulum;endoplasmic reticulum lumen,,,,,,,,,,,,,,
5490,Q86VR2,FAM134C,Protein FAM134C,RAMDNHSDSEEEL,_AM(ox)DNHS(ph)DS(ph)EEELAAFCPQLDDSTVAR_,S258,,24.01,,,,,,,,,,,,,24.01,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
5491,Q86VR2,FAM134C,Protein FAM134C,MDNHSDSEEELAA,_AM(ox)DNHS(ph)DS(ph)EEELAAFCPQLDDSTVAR_,S260,,24.01,,,,,,,,,,,,,24.01,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
5492,Q86VR2,FAM134C,Protein FAM134C,RGRRDVSGSWERD,_DVS(ph)GSWER_,S26,+,24.49,24.58,24.44,24.77,21.21,,,,21.94,,22.57,,,23.43,1.06,1.15,1.01,1.35,-2.22, , , ,-1.49, ,-0.85, , ,,integral to membrane,,,,,,,,,,,,,,
5493,Q86VR2,FAM134C,Protein FAM134C,TPLTEGSEDLDGH,_GQTPLT(ph)EGS(ph)EDLDGHS(ph)DPEESFAR_,S313,,26.29,,,,24.68,,,24.55,,,,,,25.17,1.12, , , ,-0.49, , ,-0.62, , , , , ,,integral to membrane,,,,,,,,,,,,,,
5495,Q86W56,PARG,Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143),QLSLDKSPTEKST,_LENVSQLSLDKS(ph)PTEK_,S29,,19.89,,,,22.53,22.95,,24.47,,,,,,22.46,-2.57, , , ,0.07,0.49, ,2.01, , , , , ,detection of bacterium;carbohydrate metabolic process;response to DNA damage stimulus;positive regulation of DNA repair,cytosol;chromatin;nucleus;mitochondrial matrix;cytoplasm,,,,,,,,,,,,,,
5496,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),KDFAARSPSASIT,_DFAARS(ph)PSASITDEDSNV_,S993,+,26.88,25.31,26.17,25.47,25.98,28.33,27.83,27.92,28.09,29.40,24.43,27.54,28.08,27.03,-0.15,-1.73,-0.86,-1.56,-1.06,1.30,0.79,0.89,1.06,2.36,-2.60,0.51,1.04,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5498,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),ARSPSASITDEDS,_DFAARS(ph)PSAS(ph)ITDEDSNV_,S997,+,24.69,22.76,22.76,,,,,24.66,23.63,25.31,24.27,,24.24,24.04,0.65,-1.28,-1.28, , , , ,0.62,-0.41,1.27,0.23, ,0.20,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5500,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),FQIPPPSPDSKKK,_NSPFQIPPPS(ph)PDSK_,S573,+,24.21,21.30,21.30,24.10,25.53,25.24,24.94,24.75,25.68,23.76,25.57,23.14,25.32,24.22,-0.01,-2.91,-2.91,-0.12,1.32,1.02,0.72,0.53,1.46,-0.46,1.35,-1.08,1.10,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5503,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),KLRRSQSTTFNPD,_SQS(ph)TTFNPDDM(ox)SEPEFK_,S595,+,27.30,23.10,23.10,26.86,24.40,24.09,26.66,26.10,25.47,23.64,25.29,26.93,24.67,25.20,2.10,-2.10,-2.10,1.66,-0.80,-1.11,1.46,0.89,0.27,-1.56,0.08,1.73,-0.53,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5507,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),NLDRKRSASAPTL,_S(ph)ASAPTLAETEK_,S532,,21.69,24.40,25.04,24.88,21.17,24.30,25.05,,24.92,24.19,24.91,25.31,,24.17,-2.48,0.23,0.87,0.71,-3.00,0.13,0.88, ,0.75,0.02,0.74,1.14, ,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5508,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),DRKRSASAPTLAE,_SAS(ph)APTLAETEK_,S534,,23.93,23.70,23.08,25.17,22.29,,25.99,24.78,23.75,,24.42,22.95,23.76,23.98,-0.06,-0.28,-0.90,1.19,-1.70, ,2.01,0.80,-0.23, ,0.44,-1.04,-0.22,cell adhesion,plasma membrane,,,,,,,,,,,,,,
5510,Q86WA9,SLC26A11,Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11),___MPSSVTALGQ,_PSS(ph)VTALGQAR_,S4,,22.55,23.91,,22.75,23.46,23.20,,,,,,22.66,,23.09,-0.54,0.82, ,-0.34,0.37,0.11, , , , , ,-0.42, ,sulfate transport,integral to membrane;Golgi apparatus;endoplasmic reticulum;plasma membrane;lysosomal membrane,,,,,,,,,,,,,,
5513,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),SQSVNGSPQAEQP,_DTSATSQSVNGS(ph)PQAEQPSLESTSK_,S62,+,23.97,25.02,24.62,25.10,24.39,23.97,25.73,24.85,24.32,25.64,,,23.25,24.62,-0.66,0.40,0.00,0.47,-0.23,-0.66,1.11,0.23,-0.30,1.02, , ,-1.37,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5514,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),LPLVPESPRRMMT,_LPLVPES(ph)PRR_,S278,+,25.43,22.85,21.69,22.17,25.05,24.36,23.12,22.95,19.66,,22.21,22.12,24.20,22.98,2.44,-0.14,-1.30,-0.82,2.07,1.37,0.14,-0.03,-3.32, ,-0.78,-0.86,1.22,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5515,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),WGAVVRSPEGTPQ,_NWGAVVRS(ph)PEGTPQK_,S24,+,,23.92,24.84,,25.29,24.77,24.09,24.71,24.00,24.94,,22.44,,24.33, ,-0.41,0.51, ,0.95,0.44,-0.25,0.38,-0.33,0.60, ,-1.89, ,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5517,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),GLEVPSSPLRKAK,_SM(ox)GTGDTPGLEVPSS(ph)PLRK_,S352,+,26.76,25.86,26.59,25.05,28.01,26.92,26.23,27.24,27.44,27.96,26.37,26.79,27.46,26.82,-0.06,-0.96,-0.23,-1.77,1.19,0.10,-0.59,0.41,0.62,1.14,-0.45,-0.03,0.64,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5518,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),SEQAEKSPGPIVS,_S(ph)PGPIVSR_,S301,+,26.32,26.58,26.67,26.91,28.36,27.47,24.06,27.31,24.64,24.32,22.68,23.28,25.87,25.73,0.59,0.85,0.94,1.18,2.63,1.74,-1.67,1.58,-1.09,-1.41,-3.05,-2.45,0.14,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5519,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),SQDATFSPGSEQA,_SQDATFS(ph)PGSEQAEK_,S292,+,25.34,25.55,26.23,25.27,24.94,24.50,25.79,24.34,25.47,26.37,24.03,25.01,,25.24,0.11,0.31,0.99,0.03,-0.30,-0.74,0.55,-0.89,0.23,1.14,-1.21,-0.23, ,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5520,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),IVSRTRSWDSSSP,_TRS(ph)WDSSSPVDRPEPEAASPTTR_,S311,,,22.60,22.60,22.47,24.15,,,23.73,24.63,,23.54,,,23.39, ,-0.79,-0.79,-0.92,0.76, , ,0.34,1.24, ,0.15, , ,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5521,Q86WB0,ZC3HC1,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),RSWDSSSPVDRPE,_SWDSSS(ph)PVDRPEPEAASPTTR_,S316,+,,22.65,,,25.51,25.22,23.79,25.47,,,24.49,23.44,,24.37, ,-1.72, , ,1.14,0.86,-0.58,1.11, , ,0.12,-0.93, ,mitosis;cell division;protein ubiquitination,nuclear membrane,,,,,,,,,,,,,,
5529,Q86WR0,CCDC25,Coiled-coil domain-containing protein 25,NQDGNDSDEFM__,_VENM(ox)SSNQDGNDS(ph)DEFM(ox)_,S136,+,23.21,22.94,22.94,22.81,23.44,23.18,,23.70,23.91,23.47,,23.76,,23.34,-0.12,-0.39,-0.39,-0.52,0.10,-0.16, ,0.36,0.58,0.13, ,0.42, ,,,,,,,,,,,,,,,,
5530,Q86WR7,PROSER2,Proline and serine-rich protein 2,RELRAPSPPVEHP,_APS(ph)PPVEHPR_,S179,,23.24,,,,,,20.72,,,,,,,21.98,1.26, , , , , ,-1.26, , , , , , ,,,,,,,,,,,,,,,,
5531,Q86WR7,PROSER2,Proline and serine-rich protein 2,CRLRAFSRGGSLE,_LRAFS(ph)R_,S27,,23.79,,,,,,,,,,,21.47,,22.63,1.16, , , , , , , , , , ,-1.16, ,,,,,,,,,,,,,,,,
5532,Q86WR7,PROSER2,Proline and serine-rich protein 2,AGNEALSPTSPFR,_M(ox)AGNEALS(ph)PTS(ph)PFR_,S212,,27.23,24.39,24.39,,,,,,,,,,,25.34,1.89,-0.95,-0.95, , , , , , , , , , ,,,,,,,,,,,,,,,,
5533,Q86WR7,PROSER2,Proline and serine-rich protein 2,EALSPTSPFREGR,_M(ox)AGNEALS(ph)PTS(ph)PFR_,S215,,24.92,,,,,,,,,,,,,24.92,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5534,Q86WR7,PROSER2,Proline and serine-rich protein 2,SSSRSRSFTLDDE,_S(ph)RS(ph)FTLDDESLK_,S43,+,26.35,24.44,25.26,22.72,25.74,25.46,26.84,25.72,26.54,25.84,25.71,27.07,25.82,25.66,0.70,-1.22,-0.39,-2.93,0.08,-0.20,1.18,0.07,0.89,0.19,0.05,1.42,0.17,,,,,,,,,,,,,,,,
5535,Q86WR7,PROSER2,Proline and serine-rich protein 2,FTLDDESLKYLTH,_SFTLDDES(ph)LK_,S50,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5536,Q86WR7,PROSER2,Proline and serine-rich protein 2,RSSSSRSRSFTLD,_S(ph)RS(ph)FTLDDESLK_,S41,,23.30,,,22.99,,,,,,23.81,,,,23.37,-0.06, , ,-0.38, , , , , ,0.44, , , ,,,,,,,,,,,,,,,,
5537,Q86WV6,TMEM173,Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173),PLRTDFS______,_PLPLRTDFS(ph)_,S379,,23.01,,,,,,,,,,,,,23.01,0.00, , , , , , , , , , , , ,"defense response to virus;cellular response to interferon-beta;positive regulation of transcription factor import into nucleus;positive regulation of protein binding;innate immune response;positive regulation of protein import into nucleus, translocation;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;apoptotic process;interferon-beta production;positive regulation of transcription from RNA polymerase II promoter;activation of innate immune response",mitochondrial outer membrane;integral to membrane;plasma membrane;endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5542,Q86X10,RALGAPB,Ral GTPase-activating protein subunit beta (p170),SRPRSDSAPPTPV,_SDS(ph)APPTPVNR_,S359,+,25.59,24.53,24.47,23.38,22.92,22.63,22.88,22.75,22.45,,23.48,,,23.51,2.08,1.02,0.96,-0.13,-0.59,-0.88,-0.62,-0.76,-1.06, ,-0.03, , ,activation of Ral GTPase activity,intracellular,,,,,,,,,,,,,,
5543,Q86X27,RALGPS2,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),LPQTPPSPRNLIP,_SVAAEGALLPQT(ph)PPS(ph)PR_,S112,,22.32,23.31,23.31,,24.34,,24.98,,,,,,,23.65,-1.33,-0.34,-0.34, ,0.69, ,1.33, , , , , , ,small GTPase mediated signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
5544,Q86X53,ERICH1,Glutamate-rich protein 1,EEGADASEEDPTP,_QEEGADAS(ph)EEDPTPAGEEDVK_,S160,+,24.63,23.22,23.22,23.65,,22.66,,,24.70,,22.92,22.88,,23.49,1.14,-0.26,-0.26,0.16, ,-0.82, , ,1.21, ,-0.56,-0.60, ,,,,,,,,,,,,,,,,
5545,Q86X53,ERICH1,Glutamate-rich protein 1,EDGADASEEDLTR,_EEDGADAS(ph)EEDLTRAR_,S144,+,26.37,25.41,25.72,25.88,26.49,26.30,24.80,25.57,25.94,25.78,26.00,24.25,25.63,25.70,0.66,-0.29,0.02,0.17,0.79,0.60,-0.90,-0.13,0.24,0.07,0.30,-1.45,-0.08,,,,,,,,,,,,,,,,
5546,Q86X95,CIR1,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin),SQEYVASEGEEDP,_NLTANDPSQEYVAS(ph)EGEEDPEVEFLK_,S202,,26.56,,,,23.65,,,,,23.59,,,,24.60,1.96, , , ,-0.95, , , , ,-1.01, , , ,"mRNA processing;RNA splicing;negative regulation of transcription, DNA-dependent",nuclear speck;nucleus;microtubule organizing center,,,,,,,,,,,,,,
5548,Q86XL3,ANKLE2,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),AFAGPLSPAKAED,_AFAGPLS(ph)PAK_,S466,+,21.96,21.56,21.56,21.52,,,,,21.58,21.79,20.90,,21.82,21.58,0.38,-0.03,-0.03,-0.07, , , , ,-0.01,0.21,-0.69, ,0.23,mitotic nuclear envelope reassembly;mitosis;positive regulation of protein dephosphorylation;negative regulation of phosphorylation;cell division,nuclear envelope;integral to endoplasmic reticulum membrane,,,,,,,,,,,,,,
5549,Q86XL3,ANKLE2,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),NAARNNSPPTVGA,_NNS(ph)PPTVGAFGHTR_,S600,+,21.91,23.12,23.74,23.90,25.56,24.38,24.76,26.09,23.86,22.85,23.25,26.14,25.72,24.25,-2.34,-1.14,-0.51,-0.36,1.31,0.13,0.51,1.84,-0.39,-1.40,-1.01,1.89,1.47,mitotic nuclear envelope reassembly;mitosis;positive regulation of protein dephosphorylation;negative regulation of phosphorylation;cell division,nuclear envelope;integral to endoplasmic reticulum membrane,,,,,,,,,,,,,,
5550,Q86XL3,ANKLE2,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),KTSLPLSPVKTAP,_TSLPLS(ph)PVK_,S206,+,23.77,21.74,22.56,22.64,22.61,22.22,23.03,22.62,22.95,23.83,,21.63,,22.69,1.08,-0.95,-0.13,-0.05,-0.08,-0.47,0.33,-0.07,0.26,1.14, ,-1.06, ,mitotic nuclear envelope reassembly;mitosis;positive regulation of protein dephosphorylation;negative regulation of phosphorylation;cell division,nuclear envelope;integral to endoplasmic reticulum membrane,,,,,,,,,,,,,,
5551,Q86XN7,PROSER1,Proline and serine-rich protein 1,IKTEPTSPTPSAF,_TEPTS(ph)PTPSAFK_,S552,,23.84,23.43,23.43,23.10,,,23.68,,,23.69,23.35,22.43,,23.37,0.47,0.06,0.06,-0.27, , ,0.31, , ,0.32,-0.02,-0.94, ,,,,,,,,,,,,,,,,
5554,Q86Y82,STX12,Syntaxin-12,ARARAGSRLSAEE,_ARAGS(ph)RLS(ph)AEER_,S139,,,26.65,27.05,25.91,,,,20.28,,,,,,24.97, ,1.68,2.08,0.94, , , ,-4.70, , , , , ,intracellular protein transport;vesicle-mediated transport;protein stabilization;cholesterol efflux,SNARE complex;endosome membrane;membrane raft;integral to membrane;Golgi membrane;phagocytic vesicle,,,,,,,,,,,,,,
5555,Q86Y82,STX12,Syntaxin-12,RAGSRLSAEERQR,_ARAGS(ph)RLS(ph)AEER_,S142,+,25.64,29.83,29.52,29.60,26.95,26.08,26.17,27.09,25.67,24.49,27.98,27.98,26.13,27.16,-1.53,2.67,2.35,2.44,-0.21,-1.09,-0.99,-0.07,-1.50,-2.67,0.82,0.82,-1.03,intracellular protein transport;vesicle-mediated transport;protein stabilization;cholesterol efflux,SNARE complex;endosome membrane;membrane raft;integral to membrane;Golgi membrane;phagocytic vesicle,,,,,,,,,,,,,,
5559,Q86YD1,PTOV1,Prostate tumor-overexpressed gene 1 protein (PTOV-1) (Activator interaction domain-containing protein 2),RAVRSRSWPASPR,_SRS(ph)WPASPR_,S36,+,22.19,22.06,,23.38,23.39,22.55,22.26,23.25,21.42,22.15,22.41,,,22.51,-0.31,-0.45, ,0.87,0.89,0.05,-0.24,0.75,-1.09,-0.36,-0.10, , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",plasma membrane;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5560,Q86YP4,GATAD2A,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),SERRPPSPDVIVL,_RPPS(ph)PDVIVLS(ph)DNEQPS(ph)SPR_,S100,+,26.75,,,,24.71,23.70,22.70,23.72,23.12,,23.91,,24.36,24.12,2.63, , , ,0.59,-0.43,-1.42,-0.40,-1.01, ,-0.21, ,0.24,"embryonic body morphogenesis;neural fold formation;anterior neuropore closure;negative regulation of transcription, DNA-dependent;in utero embryonic development;programmed cell death;transcription, DNA-dependent;DNA methylation;blood vessel development",NuRD complex;nuclear speck,,,,,,,,,,,,,,
5561,Q86YP4,GATAD2A,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),PDVIVLSDNEQPS,_RPPS(ph)PDVIVLS(ph)DNEQPSS(ph)PR_,S107,,26.28,,,,23.12,,,,,,,,,24.70,1.58, , , ,-1.58, , , , , , , , ,"embryonic body morphogenesis;neural fold formation;anterior neuropore closure;negative regulation of transcription, DNA-dependent;in utero embryonic development;programmed cell death;transcription, DNA-dependent;DNA methylation;blood vessel development",NuRD complex;nuclear speck,,,,,,,,,,,,,,
5563,Q86YP4,GATAD2A,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),DNEQPSSPRVNGL,_RPPS(ph)PDVIVLSDNEQPSS(ph)PR_,S114,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,"embryonic body morphogenesis;neural fold formation;anterior neuropore closure;negative regulation of transcription, DNA-dependent;in utero embryonic development;programmed cell death;transcription, DNA-dependent;DNA methylation;blood vessel development",NuRD complex;nuclear speck,,,,,,,,,,,,,,
5564,Q86YV5,SGK223,Tyrosine-protein kinase SgK223 (EC 2.7.10.2) (Sugen kinase 223),GMSKSASFAFEFP,_SAS(ph)FAFEFPK_,S694,,23.47,,,21.00,,,,,,,,23.30,,22.59,0.88, , ,-1.59, , , , , , , ,0.71, ,,,,+,,,,,,,,,,,,
5565,Q86YV5,SGK223,Tyrosine-protein kinase SgK223 (EC 2.7.10.2) (Sugen kinase 223),GSAESLSPSFRGV,_VSQGSAESLS(ph)PSFR_,S743,+,24.26,,,23.21,24.91,,23.34,23.84,23.43,,24.52,,23.88,23.92,0.34, , ,-0.71,0.99, ,-0.58,-0.08,-0.49, ,0.59, ,-0.05,,,,+,,,,,,,,,,,,
5566,Q8IU81,IRF2BP1,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 6.3.2.-),ETPGVPSPIAALK,_HWVAPGGPYSAETPGVPS(ph)PIAALK_,S421,+,21.08,,,,25.54,26.05,,25.23,25.38,,,26.19,,24.91,-3.83, , , ,0.63,1.14, ,0.32,0.46, , ,1.28, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5568,Q8IU81,IRF2BP1,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 6.3.2.-),AEALGHSPKDPGG,_NVAEALGHS(ph)PKDPGGGGGPVR_,S436,,24.45,23.67,23.63,,23.20,,,,,23.65,,,,23.72,0.73,-0.05,-0.09, ,-0.52, , , , ,-0.07, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5570,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),KISKKLSFLSWGT,_KLS(ph)FLS(ph)WGTNK_,S639,,24.27,21.82,21.82,,,,,23.01,,22.57,,,,22.70,1.57,-0.88,-0.88, , , , ,0.31, ,-0.13, , , ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
5571,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),KKLSFLSWGTNKN,_KLS(ph)FLS(ph)WGTNK_,S642,,23.96,,,,,,,,,,22.23,,,23.09,0.87, , , , , , , , , ,-0.87, , ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
5572,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),NRQKSASTLCLPS,_SAS(ph)TLCLPSVGAARPQVK_,S654,,24.00,21.26,21.26,,,21.14,,22.19,,22.48,22.38,,,22.10,1.90,-0.84,-0.84, , ,-0.96, ,0.09, ,0.38,0.28, , ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
5573,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),GMQKTYSMICLAI,_TYS(ph)M(ox)ICLAIDDDDK_,S616,,23.23,,,23.40,,,,,,,23.25,,,23.29,-0.06, , ,0.11, , , , , , ,-0.05, , ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
5574,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),LLDSTSSMHNKSA,_VVSLLDSTSS(ph)M(ox)HNK_,S599,,26.18,22.41,22.55,,,,,21.78,,23.05,,20.83,,22.80,3.38,-0.40,-0.25, , , , ,-1.02, ,0.25, ,-1.97, ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
5575,Q8IUD2,ERC1,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),RSPRLPRSPRLGH,_LPRS(ph)PR_,S27,,24.59,23.64,24.44,,,20.76,,21.77,,,22.18,,,22.90,1.69,0.74,1.54, , ,-2.13, ,-1.12, , ,-0.72, , ,"multicellular organismal development;I-kappaB phosphorylation;protein transport;retrograde transport, endosome to Golgi;positive regulation of NF-kappaB transcription factor activity",IkappaB kinase complex;presynaptic membrane;Golgi membrane,,,,,,,,,,,,,,
5576,Q8IUW5,RELL1,RELT-like protein 1,TPSTPGSPPVSPG,_AM(ox)VADNSLYDPESPVTPSTPGS(ph)PPVSPGPLSPGGTPGK_,S178,,,,,,,,23.72,,24.92,25.01,,,,24.55, , , , , , ,-0.83, ,0.37,0.46, , , ,,microtubule cytoskeleton;integral to membrane;plasma membrane;cytoplasm,,,,,,,,,,,,,,
5579,Q8IV36,HID1,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),QSLEDGSPAKGEP,_SLEPEPQQSLEDGS(ph)PAK_,S652,+,25.18,22.56,22.59,,23.30,24.47,22.14,,,,,22.79,23.68,23.34,1.84,-0.78,-0.74, ,-0.04,1.13,-1.20, , , , ,-0.55,0.34,intracellular protein transport;response to brefeldin A,extrinsic to Golgi membrane;plasma membrane;Golgi trans cisterna;Golgi medial cisterna,,,,,,,,,,,,,,
5580,Q8IV36,HID1,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),PLSRTGSQEGTSM,_TGS(ph)QEGTSM(ox)EGSRPAAPAEPGTLK_,S592,,25.31,23.28,,,,,22.55,,,22.69,22.85,21.22,,22.98,2.32,0.30, , , , ,-0.44, , ,-0.30,-0.14,-1.76, ,intracellular protein transport;response to brefeldin A,extrinsic to Golgi membrane;plasma membrane;Golgi trans cisterna;Golgi medial cisterna,,,,,,,,,,,,,,
5581,Q8IV56,PRR15,Proline-rich protein 15,TPPAPPSPDWTSS,_EAAVGVPPPAQPAPGEPTPPAPPS(ph)PDWTSSSR_,S49,,24.60,23.13,23.13,25.26,,,,,24.30,,,,,24.08,0.52,-0.95,-0.95,1.18, , , , ,0.21, , , , ,multicellular organismal development,,,,,,,,,,,,,,,
5582,Q8IV63,VRK3,Inactive serine/threonine-protein kinase VRK3 (Serine/threonine-protein pseudokinase VRK3) (Vaccinia-related kinase 3),FSDGDSSESEDTL,_LSLFSDGDSS(ph)ESEDTLSSSER_,S83,,22.97,,,,,,,,,,,,,22.97,0.00, , , , , , , , , , , , ,negative regulation of ERK1 and ERK2 cascade;positive regulation of phosphoprotein phosphatase activity,nucleus,,+,,,,,,,,,,,,
5583,Q8IV63,VRK3,Inactive serine/threonine-protein kinase VRK3 (Serine/threonine-protein pseudokinase VRK3) (Vaccinia-related kinase 3),PQVTRGSPQKTSC,_SPQVTRGS(ph)PQK_,S122,,20.43,24.06,24.06,,21.03,20.30,,,,,19.54,,18.93,21.19,-0.77,2.87,2.87, ,-0.16,-0.89, , , , ,-1.66, ,-2.26,negative regulation of ERK1 and ERK2 cascade;positive regulation of phosphoprotein phosphatase activity,nucleus,,+,,,,,,,,,,,,
5584,Q8IVF2,AHNAK2,Protein AHNAK2,RDAHDVSPTSTDT,_DAHDVS(ph)PTSTDTEAQLTVER_,S194,+,27.48,24.16,23.35,23.88,27.86,26.78,26.95,27.84,26.56,22.02,28.66,26.92,28.44,26.22,1.26,-2.06,-2.87,-2.34,1.64,0.55,0.73,1.62,0.34,-4.20,2.43,0.70,2.22,,nucleus,,,,,,,,,,,,,,
5585,Q8IVF2,AHNAK2,Protein AHNAK2,SQRERLSWPKFQS,_ERLS(ph)WPK_,S160,+,22.87,22.06,21.71,21.77,23.10,22.52,23.92,24.59,23.35,22.47,24.79,22.96,24.34,23.11,-0.24,-1.05,-1.41,-1.35,-0.01,-0.59,0.81,1.48,0.24,-0.64,1.68,-0.15,1.23,,nucleus,,,,,,,,,,,,,,
5586,Q8IVF2,AHNAK2,Protein AHNAK2,DARESFSPEEKEE,_ESFS(ph)PEEK_,S5641,,23.20,,,,,,,,,,,,,23.20,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5587,Q8IVF2,AHNAK2,Protein AHNAK2,IPSLGWSPSKHTK,_IPSLGWS(ph)PSK_,S493,,23.25,,,,23.59,,24.71,22.65,,,,,23.86,23.61,-0.36, , , ,-0.03, ,1.10,-0.96, , , , ,0.25,,nucleus,,,,,,,,,,,,,,
5588,Q8IVF2,AHNAK2,Protein AHNAK2,PVMSPLSPGERVQ,_FVFSVPQM(ox)AVPEGDLHAAVGAPVM(ox)SPLS(ph)PGER_,S4797,,25.99,,,,,,,,,,26.86,,,26.43,-0.44, , , , , , , , , ,0.44, , ,,nucleus,,,,,,,,,,,,,,
5589,Q8IVF2,AHNAK2,Protein AHNAK2,PKIKLPSFRWSPK,_IKLPS(ph)FR_,S4862,,22.17,,,19.96,21.18,,23.07,21.57,,,,24.43,,22.06,0.11, , ,-2.10,-0.88, ,1.01,-0.50, , , ,2.37, ,,nucleus,,,,,,,,,,,,,,
5590,Q8IVF2,AHNAK2,Protein AHNAK2,EVLTVESPEEEAM,_KPDAEVLTVES(ph)PEEEAM(ox)TK_,S5075,,23.27,,,,,22.44,,,,,24.01,,24.09,23.45,-0.18, , , , ,-1.01, , , , ,0.56, ,0.63,,nucleus,,,,,,,,,,,,,,
5591,Q8IVF2,AHNAK2,Protein AHNAK2,PKLDLKSPKAEVT,_LDLKS(ph)PK_,S1012,,24.83,23.36,23.36,,,,,,,21.76,22.23,,,23.11,1.72,0.25,0.25, , , , , , ,-1.35,-0.88, , ,,nucleus,,,,,,,,,,,,,,
5594,Q8IVF2,AHNAK2,Protein AHNAK2,PKLQMPSFKVPKV,_LQM(ox)PS(ph)FK_,S1318,,25.57,,,22.29,,,23.27,21.61,,,,23.99,,23.35,2.22, , ,-1.05, , ,-0.08,-1.74, , , ,0.65, ,,nucleus,,,,,,,,,,,,,,
5595,Q8IVF2,AHNAK2,Protein AHNAK2,PSFGMLSPGKSIE,_M(ox)PSFGM(ox)LS(ph)PGK_,S4377,,23.50,,,,,,,,,,23.10,,22.63,23.08,0.43, , , , , , , , , ,0.02, ,-0.45,,nucleus,,,,,,,,,,,,,,
5596,Q8IVF2,AHNAK2,Protein AHNAK2,PKFKMPSFGVSAP,_M(ox)PS(ph)FGVSAPGK_,S742,,22.05,,,,,,21.83,,,,22.26,23.17,21.48,22.16,-0.11, , , , , ,-0.33, , , ,0.10,1.01,-0.68,,nucleus,,,,,,,,,,,,,,
5598,Q8IVF2,AHNAK2,Protein AHNAK2,PTKKSKSTEDGAE,_SKS(ph)TEDGAELEEQK_,S5614,,24.59,,,,,,,,,,23.84,,,24.22,0.38, , , , , , , , , ,-0.38, , ,,nucleus,,,,,,,,,,,,,,
5599,Q8IVF2,AHNAK2,Protein AHNAK2,VSAPGKSMEDSVD,_S(ph)M(ox)EDSVDVSAPK_,S751,,23.79,,,,,,,23.02,23.79,,23.66,,,23.57,0.22, , , , , , ,-0.54,0.22, ,0.10, , ,,nucleus,,,,,,,,,,,,,,
5600,Q8IVF2,AHNAK2,Protein AHNAK2,PKVDLKSPQVDIK,_VDLKS(ph)PQVDIK_,S3308,,24.62,,,20.11,,,,,23.56,,24.09,22.33,22.49,22.87,1.75, , ,-2.76, , , , ,0.70, ,1.23,-0.54,-0.38,,nucleus,,,,,,,,,,,,,,
5603,Q8IVF2,AHNAK2,Protein AHNAK2,KVEADVSLPSMQG,_VEADVS(ph)LPSM(ox)QGDLK_,S1098,,23.88,,,,,,,,,,,,,23.88,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5604,Q8IVF2,AHNAK2,Protein AHNAK2,PKVEMPSFKMPKV,_VEMPS(ph)FK_,S823,+,25.82,19.96,19.91,23.04,,,24.29,20.94,,,,25.17,,22.73,3.08,-2.77,-2.83,0.31, , ,1.56,-1.79, , , ,2.44, ,,nucleus,,,,,,,,,,,,,,
5606,Q8IVF2,AHNAK2,Protein AHNAK2,PKVQMPSFKMPKV,_VQMPS(ph)FK_,S1483,,26.35,,,23.67,,,23.63,23.13,,,,23.97,,24.15,2.20, , ,-0.48, , ,-0.52,-1.02, , , ,-0.18, ,,nucleus,,,,,,,,,,,,,,
5607,Q8IVF2,AHNAK2,Protein AHNAK2,PKVQMPSLKMPKV,_VQM(ox)PS(ph)LK_,S1153,,23.17,,,,,,,,,,,,,23.17,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5609,Q8IVH2,FOXP4,Forkhead box protein P4 (Fork head-related protein-like A),PPKMTGSPTLVKN,_M(ox)TGS(ph)PTLVK_,S93,,23.64,,,22.82,,,,,,,,,,23.23,0.41, , ,-0.41, , , , , , , , , ,tissue development;heart development;embryonic foregut morphogenesis;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process,transcription factor complex;cytoplasm,C2H2-type,,,,,,,,,,,,,
5610,Q8IVL0,NAV3,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3) (unc53H3),LNRRSQSFNSIDK,_SQS(ph)FNSIDK_,S275,,,21.41,21.41,25.48,21.67,,23.70,22.61,,,,,,22.71, ,-1.30,-1.30,2.77,-1.05, ,0.98,-0.11, , , , , ,,nuclear outer membrane,,,,,,,,,,,,,,
5612,Q8IVL1,NAV2,Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2),QVSISASPRQSMG,_APSQVSISAS(ph)PR_,S1854,+,22.56,,,,23.65,23.25,22.83,24.22,22.32,,23.87,,,23.24,-0.68, , , ,0.41,0.01,-0.42,0.98,-0.93, ,0.63, , ,optic nerve development;locomotory behavior;sensory perception of smell;sensory perception of sound;vagus nerve development;regulation of systemic arterial blood pressure by baroreceptor feedback;glossopharyngeal nerve development,interstitial matrix;nucleus,,,,,,,,,,,,,,
5616,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),GLRRALSSDSILS,_ALS(ph)SDSILSPAPDAR_,S394,+,27.50,25.35,22.92,,27.37,24.20,28.38,27.46,22.84,28.99,26.74,28.96,25.50,26.35,1.15,-1.00,-3.43, ,1.02,-2.15,2.03,1.11,-3.51,2.64,0.39,2.61,-0.85,,,,,,,,,,,,,,,,
5617,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),LRRALSSDSILSP,_ALSS(ph)DSILSPAPDAR_,S395,,25.27,,,,,,24.73,,,26.52,,,,25.51,-0.24, , , , , ,-0.77, , ,1.01, , , ,,,,,,,,,,,,,,,,
5618,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),RALSSDSILSPAP,_ALS(ph)SDS(ph)ILSPAPDAR_,S397,,24.95,,,,,,,,,23.32,,22.95,,23.74,1.20, , , , , , , , ,-0.42, ,-0.79, ,,,,,,,,,,,,,,,,
5619,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),SSDSILSPAPDAR,_ALSSDSILS(ph)PAPDAR_,S400,,24.01,,,,,,,,,24.75,,22.95,,23.91,0.11, , , , , , , , ,0.85, ,-0.96, ,,,,,,,,,,,,,,,,
5620,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),PLLTKLSLITAPR,_LS(ph)LITAPR_,S335,,21.55,,,,,,,,,,,22.22,,21.88,-0.33, , , , , , , , , , ,0.33, ,,,,,,,,,,,,,,,,
5621,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),LFPEVFSPTPDEN,_NALFPEVFS(ph)PTPDENSDQNSR_,S575,,24.54,,,,,,,,,,,,,24.54,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5622,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),RLQKSQSSDLLER,_SQS(ph)SDLLERER_,S543,,26.29,25.22,,21.82,,,,24.34,,,25.16,26.31,,24.86,1.44,0.37, ,-3.04, , , ,-0.52, , ,0.31,1.45, ,,,,,,,,,,,,,,,,
5623,Q8IVT5,KSR1,Kinase suppressor of Ras 1,EPEAGKSEAEDDE,_S(ph)EAEDDEDEVDDLPSSR_,S282,,22.90,,,21.71,23.75,,,,23.15,,24.12,24.31,,23.32,-0.42, , ,-1.61,0.42, , , ,-0.17, ,0.79,0.99, ,Ras protein signal transduction,intracellular;endoplasmic reticulum membrane,,+,,,,,,,,,,,,
5624,Q8IVT5,KSR1,Kinase suppressor of Ras 1,TLTRSKSHESQLG,_S(ph)HESQLGNR_,S46,,21.60,21.51,,22.15,,,,,,,,,,21.75,-0.15,-0.24, ,0.39, , , , , , , , , ,Ras protein signal transduction,intracellular;endoplasmic reticulum membrane,,+,,,,,,,,,,,,
5625,Q8IVT5,KSR1,Kinase suppressor of Ras 1,RLRRTESVPSDIN,_TES(ph)VPSDINNPVDR_,S141,,25.59,23.25,,24.27,,,,,,,,,,24.37,1.22,-1.12, ,-0.10, , , , , , , , , ,Ras protein signal transduction,intracellular;endoplasmic reticulum membrane,,+,,,,,,,,,,,,
5626,Q8IW50,FAM219A,Protein FAM219A,VALDTDSDDDFDM,_PLVALDTDS(ph)DDDFDM(ox)SR_,S87,,22.70,,,,,,,,,,,,,22.70,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5627,Q8IWA0,WDR75,WD repeat-containing protein 75,MEEEKESEDSDEE,_EIPEDVDM(ox)EEEKES(ph)EDS(ph)DEENDFTEK_,S779,,25.15,,,,,,,,,,,,,25.15,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5628,Q8IWA0,WDR75,WD repeat-containing protein 75,EKESEDSDEENDF,_ESEDS(ph)DEENDFTEK_,S782,,25.30,23.09,23.09,,,,,,,24.62,,,,24.03,1.28,-0.94,-0.94, , , , , , ,0.60, , , ,,nucleus,,,,,,,,,,,,,,
5629,Q8IWA0,WDR75,WD repeat-containing protein 75,EKVQDTSNTGLGE,_VQDTS(ph)NTGLGEDIIHQLSK_,S796,,,,,,24.70,24.12,25.07,25.55,,25.09,,,24.55,24.85, , , , ,-0.15,-0.73,0.22,0.70, ,0.24, , ,-0.30,,nucleus,,,,,,,,,,,,,,
5630,Q8IWA4,MFN1,Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1),_MAEPVSPLKHFV,_(ac)AEPVS(ph)PLK_,S6,,23.80,22.42,22.42,21.20,,,,,,,,,22.29,22.43,1.37,0.00,0.00,-1.23, , , , , , , , ,-0.14,mitochondrial fusion,mitochondrial outer membrane;integral to membrane,,,,,,,,,,,,,,
5631,Q8IWB9,TEX2,Testis-expressed sequence 2 protein (Transmembrane protein 96),SLVKSLSTEVEPK,_SLS(ph)TEVEPK_,S196,+,25.30,25.92,25.54,26.35,23.82,23.96,24.98,24.38,24.83,24.19,24.52,25.30,25.40,24.96,0.34,0.96,0.58,1.38,-1.14,-1.00,0.02,-0.58,-0.13,-0.77,-0.44,0.34,0.44,signal transduction;sphingolipid metabolic process,integral to membrane,,,,,,,,,,,,,,
5632,Q8IWB9,TEX2,Testis-expressed sequence 2 protein (Transmembrane protein 96),SKTAPSSPLTSPS,_TAPSS(ph)PLTS(ph)PSDTR_,S266,+,24.09,,,22.82,,23.40,,24.09,,,23.93,21.62,,23.33,0.76, , ,-0.50, ,0.08, ,0.77, , ,0.60,-1.70, ,signal transduction;sphingolipid metabolic process,integral to membrane,,,,,,,,,,,,,,
5633,Q8IWB9,TEX2,Testis-expressed sequence 2 protein (Transmembrane protein 96),PSSPLTSPSDTRS,_TAPSS(ph)PLTS(ph)PSDTR_,S270,+,24.08,,,23.53,,,,23.65,22.24,,24.78,,23.09,23.56,0.52, , ,-0.03, , , ,0.09,-1.32, ,1.22, ,-0.47,signal transduction;sphingolipid metabolic process,integral to membrane,,,,,,,,,,,,,,
5634,Q8IWC1,MAP7D3,MAP7 domain-containing protein 3,ANKRSASTEKLEQ,_SAS(ph)TEKLEQGTSALIR_,S185,,,,,,25.16,,,25.30,,,,,,25.23, , , , ,-0.07, , ,0.07, , , , , ,,nucleus;centrosome;spindle,,,,,,,,,,,,,,
5635,Q8IWE2,FAM114A1,Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1),LMERTVSLSQMLR,_TVS(ph)LSQM(ox)LR_,S261,,21.13,,,24.62,,,,,22.10,,,25.00,,23.21,-2.08, , ,1.40, , , , ,-1.11, , ,1.79, ,,cytoplasm,,,,,,,,,,,,,,
5637,Q8IWI9,MGA,MAX gene-associated protein (MAX dimerization protein 5),GKMEDISPVQTDA,_M(ox)EDIS(ph)PVQTDALDSVR_,S1430,,22.71,,,,,,,,,,,,,22.71,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",MLL1 complex,bHLH,,,,,,,,,,,,,
5639,Q8IWI9,MGA,MAX gene-associated protein (MAX dimerization protein 5),PQPEVLSPTVKGK,_PLLLPQPEVLS(ph)PTVK_,S1195,,21.59,,,,,,,,,,,,,21.59,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",MLL1 complex,bHLH,,,,,,,,,,,,,
5641,Q8IWI9,MGA,MAX gene-associated protein (MAX dimerization protein 5),TPDGPLSPGKMED,_SGSETPDGPLS(ph)PGK_,S1422,,23.72,,,,,,,,,23.05,,,,23.39,0.33, , , , , , , , ,-0.33, , , ,"transcription, DNA-dependent",MLL1 complex,bHLH,,,,,,,,,,,,,
5642,Q8IWI9,MGA,MAX gene-associated protein (MAX dimerization protein 5),ILPYPVSPKQKYS,_SILPYPVS(ph)PK_,S924,,24.28,22.22,22.22,22.16,21.75,,22.45,22.22,21.80,21.70,,22.20,22.54,22.32,1.96,-0.10,-0.10,-0.16,-0.57, ,0.12,-0.11,-0.53,-0.62, ,-0.12,0.22,"transcription, DNA-dependent",MLL1 complex,bHLH,,,,,,,,,,,,,
5643,Q8IWI9,MGA,MAX gene-associated protein (MAX dimerization protein 5),SKWLPSSPSGVAK,_WLPSS(ph)PSGVAK_,S449,,24.08,22.60,22.60,23.26,,,23.27,,23.18,24.22,22.53,22.49,,23.14,0.94,-0.53,-0.53,0.12, , ,0.13, ,0.04,1.09,-0.61,-0.65, ,"transcription, DNA-dependent",MLL1 complex,bHLH,,,,,,,,,,,,,
5644,Q8IWJ2,GCC2,GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53),LNETFLSDSEKEK,_EISELNETFLS(ph)DSEK_,S446,,22.19,,,,,,,,,23.48,,,,22.83,-0.65, , , , , , , , ,0.65, , , ,regulation of protein exit from endoplasmic reticulum;microtubule anchoring;microtubule organizing center organization;late endosome to Golgi transport;protein localization to Golgi apparatus;Golgi ribbon formation;protein targeting to lysosome;protein targeting to Golgi;recycling endosome to Golgi transport,trans-Golgi network;Golgi apparatus;nucleus;membrane,,,,,,,,,,,,,,
5649,Q8IWT3,CUL9,Cullin-9 (CUL-9) (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein),FRVGLQSPSVEAW,_VGLQS(ph)PSVEAWEAK_,S2326,,21.65,21.62,,,22.26,,,23.12,,22.62,22.67,22.48,,22.35,-0.70,-0.73, , ,-0.08, , ,0.77, ,0.28,0.32,0.14, ,ubiquitin-dependent protein catabolic process,cullin-RING ubiquitin ligase complex;cytoplasm,,,,,,,,,,,,,,
5652,Q8IWT6,LRRC8A,Leucine-rich repeat-containing protein 8A,MLQRTKSRIEQGI,_S(ph)RIEQGIVDR_,S217,+,24.12,25.71,24.18,26.94,24.86,25.77,27.91,25.55,26.71,26.29,27.30,26.81,25.99,26.01,-1.89,-0.30,-1.83,0.93,-1.15,-0.24,1.90,-0.46,0.70,0.28,1.29,0.80,-0.02,pre-B cell differentiation,integral to membrane,,,,,,,,,,,,,,
5653,Q8IWU2,LMTK2,Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2),DNRSQDSPGESEE,_SQDS(ph)PGESEETLR_,S886,,23.46,23.01,,,,,,,24.38,,,,,23.61,-0.16,-0.60, , , , , , ,0.76, , , , ,early endosome to late endosome transport;protein autophosphorylation;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;endocytic recycling;transferrin transport;receptor recycling,integral to membrane;Golgi apparatus;recycling endosome;perinuclear region of cytoplasm;early endosome,,+,,,,,,,,,,,,
5654,Q8IWU5,SULF2,Extracellular sulfatase Sulf-2 (hSulf-2) (EC 3.1.6.-),GLKDGGSYEQYRQ,_DGGS(ph)YEQYR_,S838,,,24.70,,25.46,23.76,23.64,,,25.72,24.59,22.96,,,24.40, ,0.30, ,1.05,-0.65,-0.76, , ,1.32,0.18,-1.45, , ,glomerular basement membrane development;embryonic skeletal system development;positive regulation vascular endothelial growth factor production;positive regulation of Wnt receptor signaling pathway;bone development;heparan sulfate proteoglycan metabolic process;chondrocyte development;glial cell-derived neurotrophic factor receptor signaling pathway;negative regulation of fibroblast growth factor receptor signaling pathway;innervation;glomerular filtration;esophagus smooth muscle contraction,extracellular space;Golgi stack;endoplasmic reticulum;plasma membrane;cell surface,,,,,,,,,,,,,,
5655,Q8IWW6,ARHGAP12,Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12),NQGRPDSPVYANL,_ATT(ph)PPNQGRPDS(ph)PVYANLQELK_,S240,,27.05,,,,25.43,,24.53,25.06,,,25.10,,,25.44,1.61, , , ,0.00, ,-0.90,-0.37, , ,-0.34, , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
5658,Q8IWW6,ARHGAP12,Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12),SLHLQRSTENVNK,_S(ph)TENVNKLPELSSFGK_,S103,,23.19,20.76,20.76,20.90,,,24.51,,,21.84,23.56,26.14,,22.71,0.48,-1.95,-1.95,-1.81, , ,1.80, , ,-0.87,0.86,3.43, ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
5659,Q8IWX8,CHERP,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),RRNKSYSFIARMK,_SYS(ph)FIAR_,S904,,25.22,,,23.78,,,,,,,,24.94,,24.65,0.57, , ,-0.86, , , , , , , ,0.29, ,negative regulation of cell proliferation;release of sequestered calcium ion into cytosol;positive regulation of NFAT protein import into nucleus;RNA processing;nervous system development,sarcoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5660,Q8IWZ3,ANKHD1,Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK),IKLNLTSPKRGQK,_LNLTS(ph)PK_,S1679,+,25.03,25.51,26.28,25.42,24.78,22.99,25.38,25.51,23.77,23.81,22.63,24.06,23.30,24.50,0.53,1.01,1.78,0.92,0.29,-1.51,0.88,1.01,-0.73,-0.69,-1.87,-0.44,-1.20,,nucleus;cytoplasm,,,,,,,,,,,,,,
5661,Q8IWZ8,SUGP1,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),QRDVDASPSPLSV,_DVDAS(ph)PSPLSVQDLK_,S409,,23.44,22.33,22.33,,,,,,,,,,,22.70,0.74,-0.37,-0.37, , , , , , , , , , ,"mRNA splicing, via spliceosome",nucleoplasm;spliceosomal complex,,,,,,,,,,,,,,
5663,Q8IX01,SUGP2,"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)",IQAKAPSSLSDAV,_APS(ph)SLSDAVPQR_,S572,,22.45,,,22.34,22.77,23.74,,,22.74,,,,22.22,22.71,-0.26, , ,-0.37,0.06,1.03, , ,0.03, , , ,-0.49,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5665,Q8IX01,SUGP2,"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)",LPRRKMSFDIIDK,_RKM(ox)S(ph)FDIIDK_,S315,+,,,,,,20.16,22.49,,21.72,22.63,21.49,25.63,21.53,22.24, , , , , ,-2.08,0.26, ,-0.51,0.39,-0.74,3.40,-0.71,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5667,Q8IX03,WWC1,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),RLNRSDSDSSTLS,_LNRSDS(ph)DSSTLSK_,S724,+,24.84,23.47,23.39,22.66,,,21.15,21.83,,22.25,21.15,22.67,,22.60,2.24,0.87,0.79,0.06, , ,-1.45,-0.77, ,-0.35,-1.45,0.07, ,"regulation of hippo signaling cascade;cell migration;transcription, DNA-dependent;regulation of transcription, DNA-dependent;positive regulation of MAPK cascade;hippo signaling cascade",ruffle membrane;cytosol;Golgi apparatus;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5668,Q8IX03,WWC1,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),KSMTSLSPRSSLS,_SM(ox)TSLS(ph)PR_,S312,,23.00,23.58,23.07,21.79,24.36,,,24.40,24.52,23.68,23.77,,,23.57,-0.57,0.01,-0.50,-1.79,0.78, , ,0.82,0.95,0.10,0.20, , ,"regulation of hippo signaling cascade;cell migration;transcription, DNA-dependent;regulation of transcription, DNA-dependent;positive regulation of MAPK cascade;hippo signaling cascade",ruffle membrane;cytosol;Golgi apparatus;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5674,Q8IXM2,BAP18,Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa),KADVTLSALNDSD,_ADVTLS(ph)ALNDSDANSDVVDIEGLGETPPAK_,S141,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,chromatin modification,NURF complex;MLL1 complex,,,,,,,,,,,,,,
5675,Q8IXM2,BAP18,Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa),IPLPAESPKKGPK,_VYEDSGIPLPAES(ph)PKK_,S96,+,27.73,26.14,26.62,25.37,25.57,26.48,27.78,26.38,26.89,28.24,26.51,25.63,27.99,26.72,1.02,-0.57,-0.10,-1.35,-1.15,-0.23,1.06,-0.34,0.17,1.53,-0.21,-1.09,1.27,chromatin modification,NURF complex;MLL1 complex,,,,,,,,,,,,,,
5678,Q8IXQ3,C9orf40,Uncharacterized protein C9orf40,PSKRRDSGDNSAP,_RRDS(ph)GDNSAPSGQER_,S76,,19.44,23.21,,21.56,,,,,,,,,,21.40,-1.97,1.81, ,0.16, , , , , , , , , ,,,,,,,,,,,,,,,,
5679,Q8IXQ4,KIAA1704,Uncharacterized protein KIAA1704 (Lipopolysaccharide-specific response protein 7),GQQETDSSEDEDI,_GRDDPGQQETDS(ph)S(ph)EDEDIIGPM(ox)PAK_,S140,,21.80,,,,,,23.13,,,23.15,22.79,,,22.72,-0.92, , , , , ,0.41, , ,0.43,0.07, , ,,,,,,,,,,,,,,,,
5680,Q8IXQ4,KIAA1704,Uncharacterized protein KIAA1704 (Lipopolysaccharide-specific response protein 7),QQETDSSEDEDII,_GRDDPGQQETDS(ph)S(ph)EDEDIIGPM(ox)PAK_,S141,,21.80,,,,,,23.13,,,23.15,22.79,,,22.72,-0.92, , , , , ,0.41, , ,0.43,0.07, , ,,,,,,,,,,,,,,,,
5682,Q8IXS8,FAM126B,Protein FAM126B,EGKELLSPGAPLT,_ELLS(ph)PGAPLTK_,S508,,23.77,,,,,,,,,,,,,23.77,0.00, , , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
5684,Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),EDFRHSSEDFRFP,_HSS(ph)EDFR_,S562,,19.98,22.53,,17.88,,,,,,,,17.19,,19.39,0.58,3.13, ,-1.52, , , , , , , ,-2.20, ,,,,,,,,,,,,,,,,
5685,Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),GDVLRRSEEHSPP,_S(ph)EEHS(ph)PPRGINDR_,S250,,24.98,24.96,24.77,24.69,,,,,21.15,,,,,24.11,0.87,0.85,0.66,0.58, , , , ,-2.96, , , , ,,,,,,,,,,,,,,,,
5686,Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),RRSEEHSPPRGIN,_S(ph)EEHS(ph)PPRGINDR_,S254,,24.98,24.96,24.77,24.69,,,,,21.15,,,,,24.11,0.87,0.85,0.66,0.58, , , , ,-2.96, , , , ,,,,,,,,,,,,,,,,
5687,Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),EEDFRRSPTEDFR,_S(ph)PTEDFRQLPEEDFR_,S638,,21.80,21.54,21.54,,,,,,,,,,,21.63,0.17,-0.09,-0.09, , , , , , , , , , ,,,,,,,,,,,,,,,,
5688,Q8IXU6,SLC35F2,Solute carrier family 35 member F2,NLQETHSAVL___,_LEENLQETHS(ph)AVL_,S371,+,,,,,,,23.96,23.49,22.99,22.59,24.58,25.92,24.80,24.05, , , , , , ,-0.09,-0.56,-1.06,-1.46,0.53,1.88,0.76,transport,integral to membrane,,,,,,,,,,,,,,
5689,Q8IY17,PNPLA6,Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6),SRDEGGSPEGASP,_DEGGS(ph)PEGASPSTASEM(ox)EEEK_,S1291,+,22.78,23.69,23.28,,22.35,23.06,,22.80,,,22.64,,22.40,22.88,-0.10,0.81,0.41, ,-0.52,0.18, ,-0.07, , ,-0.24, ,-0.47,phosphatidylcholine metabolic process;angiogenesis;cell death;lipid catabolic process;organ morphogenesis,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5690,Q8IY17,PNPLA6,Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6),PLRLFPSPGLPTR,_LFPS(ph)PGLPTR_,S306,+,22.37,20.73,19.88,20.91,,,22.81,,23.62,24.04,,22.22,25.38,22.44,-0.07,-1.71,-2.56,-1.53, , ,0.36, ,1.18,1.60, ,-0.22,2.94,phosphatidylcholine metabolic process;angiogenesis;cell death;lipid catabolic process;organ morphogenesis,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5691,Q8IY17,PNPLA6,Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6),GLPTRTSPVRGSK,_LFPSPGLPTRTS(ph)PVR_,S314,+,23.27,24.42,,23.10,24.79,26.73,24.54,24.65,24.72,25.44,24.56,24.30,,24.59,-1.32,-0.18, ,-1.49,0.20,2.13,-0.05,0.06,0.13,0.85,-0.03,-0.29, ,phosphatidylcholine metabolic process;angiogenesis;cell death;lipid catabolic process;organ morphogenesis,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5692,Q8IY22,CMIP,C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip),LRLLHPSPDLVSQ,_LLHPS(ph)PDLVSQEATLSEAR_,S190,,20.30,,,,,,21.65,23.12,,,,,,21.69,-1.39, , , , , ,-0.04,1.43, , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
5697,Q8IY63,AMOTL1,Angiomotin-like protein 1,THSRQTSLTSSQL,_(gl)QTS(ph)LTSSQLAEEK_,S759,,22.73,,,,,,,,23.48,23.99,,,,23.40,-0.67, , , , , , , ,0.08,0.59, , , ,positive regulation of blood vessel endothelial cell migration;Wnt receptor signaling pathway;hippo signaling cascade;establishment of cell polarity involved in ameboidal cell migration,tight junction;cytosol;cytoplasmic vesicle;apical plasma membrane;lamellipodium,,,,,,,,,,,,,,
5698,Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),THRPPLSPKSGAE,_(ac)AADVSVTHRPPLS(ph)PK_,S14,,28.83,28.89,28.77,27.84,30.43,30.41,29.68,29.77,29.71,29.36,28.29,29.29,29.46,29.29,-0.46,-0.40,-0.51,-1.44,1.15,1.13,0.39,0.48,0.42,0.08,-0.99,0.00,0.17,,nucleus;cytoplasm,,,,,,,,,,,,,,
5699,Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),PPLSPKSGAEVEA,_S(ph)GAEVEAGDAAER_,S17,,23.87,22.52,,23.71,,,,,,,,,,23.37,0.50,-0.84, ,0.34, , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
5700,Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),PSRHKMSPPPSGF,_M(ox)S(ph)PPPSGFGER_,S617,,23.10,24.58,24.21,24.30,24.28,24.95,24.72,24.78,25.35,24.83,,23.77,21.76,24.22,-1.12,0.36,-0.01,0.08,0.06,0.73,0.50,0.56,1.13,0.61, ,-0.45,-2.46,,nucleus;cytoplasm,,,,,,,,,,,,,,
5701,Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),LKSRLLSPLSSAR,_LLS(ph)PLSSAR_,S567,,24.32,23.74,,22.88,25.41,26.07,23.59,24.04,24.39,,23.58,21.94,25.59,24.14,0.18,-0.40, ,-1.26,1.27,1.93,-0.55,-0.10,0.25, ,-0.56,-2.20,1.45,,nucleus;cytoplasm,,,,,,,,,,,,,,
5702,Q8IY81,FTSJ3,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),ALDISLSSGEEDE,_ALDISLS(ph)S(ph)GEEDEGDEEDSTAGTTK_,S335,,25.96,,,,,,,,,,,,,25.96,0.00, , , , , , , , , , , , ,RNA methylation;rRNA processing,nucleolus,,,,,,,,,,,,,,
5703,Q8IY81,FTSJ3,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),LDISLSSGEEDEG,_ALDISLS(ph)S(ph)GEEDEGDEEDSTAGTTK_,S336,,25.96,,,,,,,,,,,,,25.96,0.00, , , , , , , , , , , , ,RNA methylation;rRNA processing,nucleolus,,,,,,,,,,,,,,
5704,Q8IY81,FTSJ3,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),KGTEASSGTEAAT,_GTEASS(ph)GTEAATGLEGEEK_,S599,,22.41,22.95,22.89,24.32,,,,,24.49,23.15,22.31,23.77,23.95,23.36,-0.95,-0.41,-0.47,0.96, , , , ,1.13,-0.21,-1.05,0.41,0.59,RNA methylation;rRNA processing,nucleolus,,,,,,,,,,,,,,
5705,Q8IY81,FTSJ3,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),LKTEIMSPLYQDE,_TEIM(ox)S(ph)PLYQDEAPK_,S584,+,24.80,24.20,24.86,25.59,24.50,25.88,26.22,22.95,26.17,26.69,26.33,26.20,25.53,25.38,-0.58,-1.18,-0.51,0.21,-0.88,0.50,0.84,-2.43,0.79,1.31,0.96,0.82,0.15,RNA methylation;rRNA processing,nucleolus,,,,,,,,,,,,,,
5706,Q8IY92,SLX4,Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12),KKALEISPRSCEL,_ALEIS(ph)PR_,S873,+,22.78,23.03,23.54,23.93,23.38,23.06,23.90,23.31,23.20,23.04,,21.82,22.88,23.16,-0.38,-0.12,0.39,0.78,0.22,-0.10,0.74,0.15,0.04,-0.12, ,-1.34,-0.27,DNA double-strand break processing involved in repair via single-strand annealing;nucleotide-excision repair;double-strand break repair via homologous recombination,Slx1-Slx4 complex,,,,,,,,,,,,,,
5707,Q8IY95,TMEM192,Transmembrane protein 192,GFRTISSLEEIVE,_TISS(ph)LEEIVEK_,S226,,23.09,,,,21.54,21.62,,,21.51,22.72,24.07,23.36,,22.56,0.53, , , ,-1.02,-0.94, , ,-1.05,0.16,1.51,0.81, ,,late endosome;integral to membrane;lysosomal membrane,,,,,,,,,,,,,,
5708,Q8IYB1,MB21D2,Protein MB21D2 (Mab-21 domain-containing protein 2),ELQRRGSTTSIPS,_RGS(ph)TTSIPSPQSDGGDPNQPDDRLAK_,S318,,,,,,,,22.78,,,,22.64,24.64,,23.35, , , , , , ,-0.57, , , ,-0.71,1.29, ,,,,,,,,,,,,,,,,
5709,Q8IYB7,DIS3L2,DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-),EKEEEESDGEPED,_RPGTQGHLGPEKEEEES(ph)DGEPEDSSTS_,S875,,,,,,24.72,24.83,,27.08,,,23.24,,,24.97, , , , ,-0.25,-0.13, ,2.11, , ,-1.73, , ,negative regulation of cell proliferation;mitotic sister chromatid separation;cell division,cytoplasm,,,,,,,,,,,,,,
5710,Q8IYB8,SUPV3L1,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",KATEPPSPDAGEL,_ATEPPS(ph)PDAGELSLASR_,S725,+,22.38,22.51,22.12,22.59,,23.59,23.54,23.68,24.24,25.12,23.80,,23.91,23.41,-1.03,-0.90,-1.29,-0.81, ,0.18,0.13,0.27,0.83,1.71,0.39, ,0.51,negative regulation of apoptotic process;mitochondrion morphogenesis;mitochondrial mRNA catabolic process;mitochondrial mRNA surveillance;mitochondrial RNA 3'-end processing;positive regulation of mitochondrial RNA catabolic process;positive regulation of cell growth;chromatin maintenance;mitochondrial ncRNA surveillance;DNA recombination,mitochondrial nucleoid;nucleus;mitochondrial degradosome,,,,,,,,,,,,,,
5711,Q8IYH5,ZZZ3,ZZ-type zinc finger-containing protein 3,RQTEPVSPVLKRI,_QTEPVS(ph)PVLK_,S113,+,23.35,23.34,23.34,21.54,22.83,22.48,23.25,22.82,22.22,22.82,,,22.58,22.78,0.57,0.56,0.56,-1.24,0.05,-0.29,0.47,0.04,-0.56,0.04, , ,-0.20,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
5713,Q8IYJ3,SYTL1,Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1),QPRVPPSPDDLPS,_VPPS(ph)PDDLPSR_,S145,+,23.68,23.56,,23.49,23.80,23.96,23.47,24.42,24.09,26.78,24.64,,24.95,24.26,-0.58,-0.69, ,-0.77,-0.46,-0.30,-0.79,0.17,-0.17,2.52,0.38, ,0.69,intracellular protein transport;exocytosis,extrinsic to plasma membrane;melanosome,,,,,,,,,,,,,,
5714,Q8IYM0,FAM186B,Protein FAM186B,ERPVAESLGHKDK,_WERPVAES(ph)LGHK_,S346,,,,,,24.86,25.32,26.13,21.99,25.39,,27.01,,26.13,25.26, , , , ,-0.40,0.06,0.87,-3.27,0.13, ,1.75, ,0.87,,protein complex,,,,,,,,,,,,,,
5715,Q8IYS0,GRAMD1C,GRAM domain-containing protein 1C,KLSKSISFTSESI,_SIS(ph)FTSESISR_,S36,,22.52,,,,,,,,,,,,,22.52,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
5716,Q8IZ21,PHACTR4,Phosphatase and actin regulator 4,TLGRTRSLPITIE,_S(ph)LPITIEM(ox)LK_,S448,+,23.65,21.60,22.10,20.82,,,21.91,20.69,,23.93,23.19,,,22.24,1.42,-0.64,-0.14,-1.41, , ,-0.32,-1.55, ,1.70,0.95, , ,negative regulation of integrin-mediated signaling pathway;regulation of cell cycle;closure of optic fissure;neural crest cell migration;Rho protein signal transduction;neural tube closure;actin cytoskeleton organization;enteric nervous system development,lamellipodium;cytoplasm,,,,,,,,,,,,,,
5717,Q8IZ21,PHACTR4,Phosphatase and actin regulator 4,ISPRSPSPPLPTH,_SPS(ph)PPLPTHIPPEPPRT(ph)PPFPAK_,S328,,,,,,23.86,,,,23.22,,,,,23.54, , , , ,0.32, , , ,-0.32, , , , ,negative regulation of integrin-mediated signaling pathway;regulation of cell cycle;closure of optic fissure;neural crest cell migration;Rho protein signal transduction;neural tube closure;actin cytoskeleton organization;enteric nervous system development,lamellipodium;cytoplasm,,,,,,,,,,,,,,
5720,Q8IZ21,PHACTR4,Phosphatase and actin regulator 4,GNARSSSPVQVEE,_SSS(ph)PVQVEEEPVRLAS(ph)LRK_,S102,+,26.80,26.19,25.78,27.24,26.58,26.99,25.74,27.59,26.01,25.59,26.93,26.10,25.98,26.42,0.37,-0.23,-0.64,0.82,0.15,0.56,-0.68,1.17,-0.42,-0.84,0.51,-0.33,-0.45,negative regulation of integrin-mediated signaling pathway;regulation of cell cycle;closure of optic fissure;neural crest cell migration;Rho protein signal transduction;neural tube closure;actin cytoskeleton organization;enteric nervous system development,lamellipodium;cytoplasm,,,,,,,,,,,,,,
5721,Q8IZ21,PHACTR4,Phosphatase and actin regulator 4,EPVRLASLRKAIP,_SSS(ph)PVQVEEEPVRLAS(ph)LRK_,S115,,24.76,24.95,24.95,21.25,,,,,,,,,,23.98,0.78,0.97,0.97,-2.72, , , , , , , , , ,negative regulation of integrin-mediated signaling pathway;regulation of cell cycle;closure of optic fissure;neural crest cell migration;Rho protein signal transduction;neural tube closure;actin cytoskeleton organization;enteric nervous system development,lamellipodium;cytoplasm,,,,,,,,,,,,,,
5723,Q8IZA0,KIAA0319L,Dyslexia-associated protein KIAA0319-like protein,TPLKARSPREEIL,_ARS(ph)PREEIL_,S1043,,,22.79,22.79,,24.83,24.84,24.55,24.34,24.16,25.09,23.81,22.96,25.72,24.17, ,-1.38,-1.38, ,0.66,0.67,0.38,0.17,-0.01,0.91,-0.36,-1.21,1.55,,integral to membrane;cytoplasmic vesicle part,,,,,,,,,,,,,,
5724,Q8IZD4,DCP1B,mRNA-decapping enzyme 1B (EC 3.-.-.-),GVVRSLSYEEPRR,_SLS(ph)YEEPR_,S149,+,25.56,25.35,22.32,26.56,22.30,22.36,22.43,22.54,,,22.03,,,23.50,2.06,1.86,-1.17,3.07,-1.19,-1.14,-1.06,-0.96, , ,-1.46, , ,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay",cytosol;intracellular membrane-bounded organelle;nucleus,,,,,,,,,,,,,,
5727,Q8IZL8,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",VEREGESPAAGPP,_EGES(ph)PAAGPPPQELVEEEPSAPPTLLEEETEDGSDK_,S1043,,25.76,,,,,,,,26.44,25.93,,25.06,,25.80,-0.04, , , , , , , ,0.64,0.14, ,-0.74, ,"transcription, DNA-dependent",MLL1 complex;cytoplasm,,,,,,,,,,,,,,
5729,Q8IZL8,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",APEALPSQGEVER,_GADTAPTLAPEALPS(ph)QGEVER_,S1033,,22.26,22.00,22.44,,,,,,,,,,,22.23,0.03,-0.23,0.21, , , , , , , , , , ,"transcription, DNA-dependent",MLL1 complex;cytoplasm,,,,,,,,,,,,,,
5730,Q8IZP0,ABI1,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),SPARLGSQHSPGR,_LGS(ph)QHSPGR_,S217,,24.74,24.61,,23.73,,,,,,,,,,24.36,0.38,0.25, ,-0.63, , , , , , , , , ,peptidyl-tyrosine phosphorylation;negative regulation of cell proliferation;actin polymerization or depolymerization;transmembrane receptor protein tyrosine kinase signaling pathway;somitogenesis;cellular component movement,endoplasmic reticulum;cytosol;filopodium;growth cone;synapse;cell junction;cytoskeleton;nucleus;lamellipodium,,,,,,,,,,,,,,
5731,Q8IZP0,ABI1,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),RLGSQHSPGRTAS,_LGSQHS(ph)PGR_,S220,+,,21.26,21.83,22.90,19.85,18.43,20.66,20.92,19.24,,,20.90,,20.67, ,0.59,1.17,2.24,-0.82,-2.24,0.00,0.25,-1.42, , ,0.24, ,peptidyl-tyrosine phosphorylation;negative regulation of cell proliferation;actin polymerization or depolymerization;transmembrane receptor protein tyrosine kinase signaling pathway;somitogenesis;cellular component movement,endoplasmic reticulum;cytosol;filopodium;growth cone;synapse;cell junction;cytoskeleton;nucleus;lamellipodium,,,,,,,,,,,,,,
5732,Q8IZP0,ABI1,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),SPGRTASLNQRPR,_TAS(ph)LNQRPR_,S226,+,24.94,22.37,22.37,23.84,,,,,,21.02,21.80,19.72,,22.29,2.64,0.07,0.07,1.55, , , , , ,-1.27,-0.49,-2.58, ,peptidyl-tyrosine phosphorylation;negative regulation of cell proliferation;actin polymerization or depolymerization;transmembrane receptor protein tyrosine kinase signaling pathway;somitogenesis;cellular component movement,endoplasmic reticulum;cytosol;filopodium;growth cone;synapse;cell junction;cytoskeleton;nucleus;lamellipodium,,,,,,,,,,,,,,
5733,Q8IZP0,ABI1,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),PTQKPPSPPMSGR,_TNPPTQKPPS(ph)PPM(ox)SGR_,S178,+,25.25,23.70,22.53,24.62,25.27,24.63,24.06,25.61,25.01,25.41,24.57,23.78,22.10,24.35,0.90,-0.64,-1.82,0.27,0.92,0.28,-0.29,1.26,0.66,1.06,0.22,-0.57,-2.24,peptidyl-tyrosine phosphorylation;negative regulation of cell proliferation;actin polymerization or depolymerization;transmembrane receptor protein tyrosine kinase signaling pathway;somitogenesis;cellular component movement,endoplasmic reticulum;cytosol;filopodium;growth cone;synapse;cell junction;cytoskeleton;nucleus;lamellipodium,,,,,,,,,,,,,,
5734,Q8IZR5,CMTM4,CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4),VSVRQQSTNDYIR,_(gl)QQS(ph)TNDYIR_,S154,,22.86,,,20.67,,,,,,,,22.44,,21.99,0.87, , ,-1.32, , , , , , , ,0.45, ,chemotaxis,extracellular space;integral to membrane,,,,,,,,,,,,,,
5735,Q8IZW8,TNS4,Tensin-4 (C-terminal tensin-like protein),QPRTPHSPPLAKE,_TPHS(ph)PPLAK_,S350,,25.27,,,,,,,,,,,,,25.27,0.00, , , , , , , , , , , , ,protein localization;apoptotic process,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5736,Q8N0Z3,SPICE1,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein),LVGLNLSPPMSPV,_LVGLNLS(ph)PPM(ox)S(ph)PVQLPLR_,S656,,23.76,,,,,,,,,,,,,23.76,0.00, , , , , , , , , , , , ,spindle assembly involved in mitosis;regulation of centriole replication;metaphase plate congression;cell division,centriole;spindle,,,,,,,,,,,,,,
5737,Q8N0Z3,SPICE1,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein),NLSPPMSPVQLPL,_LVGLNLS(ph)PPM(ox)S(ph)PVQLPLR_,S660,,23.76,,,,,,,,,,,,,23.76,0.00, , , , , , , , , , , , ,spindle assembly involved in mitosis;regulation of centriole replication;metaphase plate congression;cell division,centriole;spindle,,,,,,,,,,,,,,
5738,Q8N0Z3,SPICE1,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein),NTQQSRSPTFSEE,_S(ph)PTFSEELPVLGDGQQLR_,S536,,24.02,,,,,,,,,,,,,24.02,0.00, , , , , , , , , , , , ,spindle assembly involved in mitosis;regulation of centriole replication;metaphase plate congression;cell division,centriole;spindle,,,,,,,,,,,,,,
5740,Q8N103,TAGAP,T-cell activation Rho GTPase-activating protein (T-cell activation GTPase-activating protein),NQTLTKSEGDFPV,_S(ph)EGDFPVPR_,S191,,18.15,21.83,21.83,,,,,,,,,,,20.61,-2.46,1.23,1.23, , , , , , , , , , ,small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
5744,Q8N108,MIER1,Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (hMi-er1),ASSRAPSPPPTAS,_LLDESESAASSRAPS(ph)PPPTASNSSNSQSEK_,S350,,22.13,,,,,,23.44,,23.56,,23.54,,,23.17,-1.04, , , , , ,0.27, ,0.39, ,0.37, , ,"positive regulation of I-kappaB kinase/NF-kappaB cascade;transcription, DNA-dependent;positive regulation of chromatin silencing",transcriptional repressor complex;cytoplasm,,,,,,,,,,,,,,
5747,Q8N122,RPTOR,Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein),RLRSVSSYGNIRA,_SVSS(ph)YGNIR_,S564,,25.40,22.92,,24.88,,,,,,,,,,24.40,1.00,-1.48, ,0.48, , , , , , , , , ,cellular response to amino acid stimulus;cell growth;positive regulation of transcription from RNA polymerase III promoter;positive regulation of TOR signaling cascade;TOR signaling cascade;insulin receptor signaling pathway;positive regulation of protein serine/threonine kinase activity;cell cycle arrest;positive regulation of endothelial cell proliferation;regulation of cell size;cellular response to nutrient levels,TORC1 complex;neuronal cell body;cytosol;dendrite;lysosome,,,,,,,,,,,,,,
5748,Q8N122,RPTOR,Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein),TSSLTQSAPASPT,_VLDTSSLTQS(ph)APAS(ph)PTNK_,S701,,25.63,,,24.18,,,,,,,,,,24.90,0.72, , ,-0.72, , , , , , , , , ,cellular response to amino acid stimulus;cell growth;positive regulation of transcription from RNA polymerase III promoter;positive regulation of TOR signaling cascade;TOR signaling cascade;insulin receptor signaling pathway;positive regulation of protein serine/threonine kinase activity;cell cycle arrest;positive regulation of endothelial cell proliferation;regulation of cell size;cellular response to nutrient levels,TORC1 complex;neuronal cell body;cytosol;dendrite;lysosome,,,,,,,,,,,,,,
5749,Q8N122,RPTOR,Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein),TQSAPASPTNKGV,_VLDTSSLTQS(ph)APAS(ph)PTNK_,S705,+,27.11,25.42,24.76,27.28,25.96,26.92,28.32,28.05,26.43,26.38,27.77,27.08,27.14,26.82,0.29,-1.40,-2.06,0.47,-0.86,0.10,1.51,1.23,-0.39,-0.44,0.95,0.26,0.32,cellular response to amino acid stimulus;cell growth;positive regulation of transcription from RNA polymerase III promoter;positive regulation of TOR signaling cascade;TOR signaling cascade;insulin receptor signaling pathway;positive regulation of protein serine/threonine kinase activity;cell cycle arrest;positive regulation of endothelial cell proliferation;regulation of cell size;cellular response to nutrient levels,TORC1 complex;neuronal cell body;cytosol;dendrite;lysosome,,,,,,,,,,,,,,
5750,Q8N163,KIAA1967,DBIRD complex subunit KIAA1967 (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (p30 DBC),EDSEVRSVASNQS,_S(ph)VAS(ph)NQSEM(ox)EFSSLQDM(ox)PK_,S675,+,26.60,22.74,,,26.80,25.50,,23.52,26.55,26.74,,,,25.49,1.11,-2.75, , ,1.31,0.00, ,-1.97,1.05,1.25, , , ,"regulation of DNA-dependent transcription, elongation;mRNA processing;RNA splicing;apoptotic process;positive regulation of apoptotic process",DBIRD complex;nucleus;mitochondrial matrix,,,,,,,,,,,,,,
5751,Q8N163,KIAA1967,DBIRD complex subunit KIAA1967 (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (p30 DBC),EVRSVASNQSEME,_LEDSEVRS(ph)VAS(ph)NQS(ph)EM(ox)EFSSLQDM(ox)PK_,S678,+,28.19,26.59,26.66,26.39,28.67,28.44,27.52,27.74,28.37,28.38,26.52,26.86,27.56,27.53,0.66,-0.94,-0.87,-1.14,1.14,0.91,-0.01,0.21,0.84,0.85,-1.01,-0.67,0.03,"regulation of DNA-dependent transcription, elongation;mRNA processing;RNA splicing;apoptotic process;positive regulation of apoptotic process",DBIRD complex;nucleus;mitochondrial matrix,,,,,,,,,,,,,,
5752,Q8N163,KIAA1967,DBIRD complex subunit KIAA1967 (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (p30 DBC),SVASNQSEMEFSS,_SVAS(ph)NQS(ph)EM(ox)EFSSLQDM(ox)PK_,S681,,26.31,,,,,,,,,,,,,26.31,0.00, , , , , , , , , , , , ,"regulation of DNA-dependent transcription, elongation;mRNA processing;RNA splicing;apoptotic process;positive regulation of apoptotic process",DBIRD complex;nucleus;mitochondrial matrix,,,,,,,,,,,,,,
5753,Q8N163,KIAA1967,DBIRD complex subunit KIAA1967 (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (p30 DBC),LPEKVVSPPEPEK,_VVS(ph)PPEPEKEEAAK_,S569,,26.25,27.21,,25.32,21.69,21.72,,,25.89,24.79,22.94,23.50,22.12,24.14,2.11,3.06, ,1.18,-2.45,-2.42, , ,1.74,0.65,-1.20,-0.64,-2.02,"regulation of DNA-dependent transcription, elongation;mRNA processing;RNA splicing;apoptotic process;positive regulation of apoptotic process",DBIRD complex;nucleus;mitochondrial matrix,,,,,,,,,,,,,,
5754,Q8N1F7,NUP93,Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),ISQRLESLSAATT,_LES(ph)LSAATTFEPLEPVK_,S80,,23.52,,,,,,,,,,,,,23.52,0.00, , , , , , , , , , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear membrane;nuclear envelope;nuclear pore,,,,,,,,,,,,,,
5756,Q8N1F8,STK11IP,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),STRDHGSWSLSPP,_DHGS(ph)WSLSPPPER_,S773,,,,,21.92,23.98,23.35,22.89,22.98,,22.31,,,,22.91, , , ,-0.99,1.08,0.44,-0.02,0.07, ,-0.59, , , ,protein localization,cytoplasm,,,,,,,,,,,,,,
5757,Q8N1F8,STK11IP,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),HGSWSLSPPPERC,_DHGSWSLS(ph)PPPER_,S777,,,,,,23.74,22.97,22.40,,,22.00,,23.23,22.47,22.80, , , , ,0.94,0.17,-0.40, , ,-0.80, ,0.43,-0.33,protein localization,cytoplasm,,,,,,,,,,,,,,
5758,Q8N1F8,STK11IP,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),VRVRRASISEPSD,_RAS(ph)ISEPSDTDPEPR_,S387,+,24.86,26.18,26.28,24.33,26.40,27.26,26.51,26.70,25.79,26.03,27.16,28.04,27.24,26.37,-1.51,-0.19,-0.09,-2.04,0.03,0.89,0.14,0.33,-0.58,-0.34,0.79,1.67,0.88,protein localization,cytoplasm,,,,,,,,,,,,,,
5759,Q8N1G0,ZNF687,Zinc finger protein 687,DIPASASPPPVAG,_ATDIPASAS(ph)PPPVAGVPFFK_,S253,,25.95,25.51,24.90,24.52,23.54,,25.40,,,,,,,24.97,0.98,0.54,-0.07,-0.45,-1.43, ,0.43, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,C2H2-type,,,,,,,,,,,,,
5760,Q8N1G0,ZNF687,Zinc finger protein 687,PGGTATSPKMIAK,_AVVLPGGTATS(ph)PK_,S433,+,,26.48,26.48,,25.86,,25.88,,,25.57,24.07,25.50,,25.69, ,0.79,0.79, ,0.17, ,0.19, , ,-0.12,-1.62,-0.19, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,C2H2-type,,,,,,,,,,,,,
5761,Q8N1G0,ZNF687,Zinc finger protein 687,LQLGAQSPGRGTT,_HGLQLGAQS(ph)PGR_,S1057,+,24.36,23.90,23.08,24.14,24.18,23.81,25.22,25.40,24.50,23.27,,,21.83,23.97,0.39,-0.07,-0.89,0.17,0.21,-0.16,1.25,1.43,0.53,-0.70, , ,-2.14,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,C2H2-type,,,,,,,,,,,,,
5762,Q8N1G0,ZNF687,Zinc finger protein 687,ASLLKLSPATPTS,_LS(ph)PATPTSEGPK_,S374,+,24.56,25.50,24.66,25.62,,23.42,25.12,,25.86,24.90,23.98,24.43,,24.81,-0.24,0.69,-0.15,0.81, ,-1.39,0.31, ,1.05,0.10,-0.82,-0.38, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,C2H2-type,,,,,,,,,,,,,
5764,Q8N1G2,FTSJD2,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein) (ISG95),TTSLSGSDSETEG,_ASTTSLSGS(ph)DSETEGK_,S53,+,23.27,24.35,,23.63,,,22.37,,23.02,22.64,,22.17,,23.06,0.20,1.29, ,0.57, , ,-0.69, ,-0.05,-0.43, ,-0.89, ,7-methylguanosine mRNA capping,nucleus;cytoplasm,,,,,,,,,,,,,,
5765,Q8N1G4,LRRC47,Leucine-rich repeat-containing protein 47,ENKEEGSLSDTEA,_EEGS(ph)LSDTEADAVSGQLPDPTTNPSAGK_,S518,+,27.29,23.71,23.71,,23.59,,25.95,,25.97,28.32,24.16,25.54,,25.36,1.93,-1.65,-1.65, ,-1.77, ,0.59, ,0.61,2.96,-1.20,0.18, ,,,,,,,,,,,,,,,,
5767,Q8N1I0,DOCK4,Dedicator of cytokinesis protein 4,PSSARASPLLSDK,_AS(ph)PLLSDK_,S607,,,23.26,19.65,23.56,,,,22.92,,,,,,22.35, ,0.91,-2.70,1.21, , , ,0.58, , , , , ,small GTPase mediated signal transduction;cell chemotaxis,cytosol;endomembrane system;stereocilium;membrane,,,,,,,,,,,,,,
5771,Q8N1W1,ARHGEF28,Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor),NISRAESLPLSSN,_AES(ph)LPLSSNLQSK_,S535,,,21.56,,,22.57,,,23.54,23.36,,,,,22.76, ,-1.20, , ,-0.19, , ,0.78,0.61, , , , ,cell differentiation;regulation of Rho protein signal transduction;intracellular signal transduction,microtubule cytoskeleton;plasma membrane;cytoplasm,,,,,,,,,,,,,,
5772,Q8N201,INTS1,Integrator complex subunit 1 (Int1),IAEEKLSPEQEGQ,_LS(ph)PEQEGQLM(ox)PR_,S307,+,24.95,26.01,26.44,24.86,,22.47,24.66,22.73,24.98,25.78,,24.50,,24.74,0.21,1.27,1.70,0.12, ,-2.27,-0.07,-2.01,0.25,1.04, ,-0.24, ,negative regulation of apoptotic process;inner cell mass cell proliferation;snRNA processing;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;U2 snRNA 3'-end processing,nuclear membrane;integrator complex;integral to membrane,,,,,,,,,,,,,,
5776,Q8N201,INTS1,Integrator complex subunit 1 (Int1),ARVVQGSPEVPGI,_VVQGS(ph)PEVPGITVR_,S1395,,21.63,,,,22.57,22.96,22.33,22.82,,,,,,22.46,-0.83, , , ,0.11,0.50,-0.13,0.35, , , , , ,negative regulation of apoptotic process;inner cell mass cell proliferation;snRNA processing;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;U2 snRNA 3'-end processing,nuclear membrane;integrator complex;integral to membrane,,,,,,,,,,,,,,
5779,Q8N271,PROM2,Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2),IRKRLSSTSSEET,_LSS(ph)TSS(ph)EETQLFHIPR_,S341,,24.93,,,,,,,,,,,,,24.93,0.00, , , , , , , , , , , , ,,microvillus membrane;prominosome;integral to membrane;basolateral plasma membrane;apical plasma membrane;cilium membrane,,,,,,,,,,,,,,
5781,Q8N271,PROM2,Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2),RLSSTSSEETQLF,_LSS(ph)TSS(ph)EETQLFHIPR_,S344,,24.93,,,,,,,,,,,,,24.93,0.00, , , , , , , , , , , , ,,microvillus membrane;prominosome;integral to membrane;basolateral plasma membrane;apical plasma membrane;cilium membrane,,,,,,,,,,,,,,
5783,Q8N2F6,ARMC10,Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein),GIRSSKSAEDLTD,_S(ph)AEDLTDGSYDDVLNAEQLQK_,S45,,27.61,,,,25.44,24.09,,24.02,25.80,26.92,23.03,23.69,,25.07,2.53, , , ,0.36,-0.98, ,-1.05,0.73,1.85,-2.05,-1.39, ,regulation of growth,mitochondrion;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5786,Q8N2G8,GHDC,GH3 domain-containing protein,HCSLRRSTDISTF,_S(ph)TDISTFR_,S31,,23.31,,,21.65,22.70,21.16,21.92,23.47,22.39,22.62,22.72,,23.30,22.52,0.79, , ,-0.87,0.18,-1.37,-0.61,0.94,-0.13,0.10,0.20, ,0.77,,nuclear envelope;endoplasmic reticulum,,,,,,,,,,,,,,
5787,Q8N2M8,CLASRP,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",RDGHRYSRSPARR,_DGHRYS(ph)RS(ph)PAR_,S454,,24.39,24.09,24.40,,18.53,,,,,,,,,22.85,1.54,1.24,1.55, ,-4.32, , , , , , , , ,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5788,Q8N2M8,CLASRP,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",GHRYSRSPARRGG,_DGHRYS(ph)RS(ph)PAR_,S456,,24.39,24.09,24.40,,18.53,,,,,,,,,22.85,1.54,1.24,1.55, ,-4.32, , , , , , , , ,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5789,Q8N2M8,CLASRP,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",LRGRKISPPSYAR,_KIS(ph)PPSYAR_,S285,,22.33,,,,25.23,,25.62,,,,,,23.20,24.10,-1.76, , , ,1.13, ,1.53, , , , , ,-0.90,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5790,Q8N2M8,CLASRP,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",LTRPAASPAVGEK,_LTRPAAS(ph)PAVGEK_,S547,+,25.19,25.97,26.22,24.60,25.95,25.28,25.15,25.39,25.85,24.63,24.24,24.39,24.07,25.15,0.04,0.82,1.07,-0.55,0.80,0.13,0.00,0.25,0.70,-0.52,-0.91,-0.76,-1.08,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5791,Q8N2M8,CLASRP,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",SYARRDSPTYDPY,_RDS(ph)PTYDPYK_,S294,+,23.27,23.69,,,21.45,22.51,23.76,21.80,23.74,,,,22.77,22.87,0.39,0.81, , ,-1.42,-0.36,0.89,-1.07,0.87, , , ,-0.10,mRNA processing;RNA splicing,nucleus,,,,,,,,,,,,,,
5792,Q8N2U9,PQLC1,PQ-loop repeat-containing protein 1,LNARRRSFTAADS,_S(ph)FTAADSKDEEVK_,S110,+,25.33,26.37,,25.69,,26.04,25.82,25.82,26.19,25.66,25.97,24.60,25.35,25.71,-0.39,0.66, ,-0.03, ,0.32,0.11,0.11,0.48,-0.05,0.26,-1.12,-0.37,,integral to membrane,,,,,,,,,,,,,,
5793,Q8N344,MIER2,Mesoderm induction early response protein 2 (Mi-er2),SSLGRQSPRVVSC,_(ac)AEASSLGRQS(ph)PR_,S11,+,25.34,25.60,25.73,27.11,26.47,,26.01,,,,25.21,25.72,26.01,25.91,-0.57,-0.31,-0.18,1.20,0.56, ,0.09, , , ,-0.70,-0.20,0.10,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
5794,Q8N3C0,ASCC3,"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)",NTKVSDSLTDLAL,_VSDS(ph)LTDLALK_,S2195,,23.07,,,20.38,,,22.88,,,23.86,,24.04,,22.84,0.22, , ,-2.47, , ,0.03, , ,1.01, ,1.20, ,"cell proliferation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA dealkylation involved in DNA repair",nucleus;cytoplasm,,,,,,,,,,,,,,
5799,Q8N3E9,PLCD3,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",EDGRALSDREEEE,_ALS(ph)DREEEEEDDEEEEEEVEAAAQRR_,S496,,23.46,,,,25.66,25.98,24.51,23.34,24.38,,26.19,,26.80,25.04,-1.58, , , ,0.62,0.94,-0.53,-1.70,-0.66, ,1.15, ,1.76,labyrinthine layer blood vessel development;angiogenesis;lipid catabolic process;regulation of cell proliferation;intracellular signal transduction,membrane;cleavage furrow;cytoplasm,,,,,,,,,,,,,,
5800,Q8N3E9,PLCD3,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",IREAGNSFVRHNA,_EAGNS(ph)FVR_,S573,,24.14,,,21.40,,,,,,,,,,22.77,1.37, , ,-1.37, , , , , , , , , ,labyrinthine layer blood vessel development;angiogenesis;lipid catabolic process;regulation of cell proliferation;intracellular signal transduction,membrane;cleavage furrow;cytoplasm,,,,,,,,,,,,,,
5801,Q8N3F8,MICALL1,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),PRAPSASPLALHA,_APSAS(ph)PLALHASR_,S486,,,,,,21.69,,22.97,22.99,,,,22.74,,22.60, , , , ,-0.91, ,0.37,0.39, , , ,0.15, ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5802,Q8N3F8,MICALL1,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),APSLATSPALGHP,_EEEAPAAPSLATS(ph)PALGHPESTPK_,S447,,,23.77,23.77,,,,,,,24.38,,23.54,,23.87, ,-0.10,-0.10, , , , , , ,0.52, ,-0.33, ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5806,Q8N3F8,MICALL1,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),EQMPQASPGLAPR,_VEQM(ox)PQAS(ph)PGLAPR_,S578,+,24.34,25.44,25.60,25.46,26.06,25.97,25.13,25.67,25.05,23.88,26.03,26.15,24.92,25.36,-1.02,0.08,0.24,0.10,0.70,0.61,-0.24,0.31,-0.31,-1.49,0.67,0.79,-0.44,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5808,Q8N3R9,MPP5,MAGUK p55 subfamily member 5,ELDLNSSMRLKKL,_KQELDLNSS(ph)M(ox)R_,S84,,24.22,22.36,,,,,23.22,,21.33,23.43,,23.75,,23.05,1.16,-0.69, , , , ,0.17, ,-1.72,0.38, ,0.70, ,peripheral nervous system myelin maintenance;protein localization to myelin sheath abaxonal region;tight junction assembly,tight junction;lateral loop;endomembrane system;plasma membrane;Schmidt-Lanterman incisure;myelin sheath adaxonal region;cytoplasm,,,,,,,,,,,,,,
5810,Q8N3R9,MPP5,MAGUK p55 subfamily member 5,GHVTEESDSEVKN,_(ac)TTSHM(ox)NGHVTEES(ph)DSEVK_,S14,,21.83,,,,,,23.19,,,23.98,21.76,22.04,,22.56,-0.73, , , , , ,0.63, , ,1.42,-0.80,-0.52, ,peripheral nervous system myelin maintenance;protein localization to myelin sheath abaxonal region;tight junction assembly,tight junction;lateral loop;endomembrane system;plasma membrane;Schmidt-Lanterman incisure;myelin sheath adaxonal region;cytoplasm,,,,,,,,,,,,,,
5811,Q8N3U4,STAG2,Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2),DTMSVISGISSRG,_NSLLAGGDDDTM(ox)SVIS(ph)GIS(ph)SR_,S992,,23.59,,,,,,,,,,,,,23.59,0.00, , , , , , , , , , , , ,negative regulation of DNA endoreduplication;meiosis;sister chromatid cohesion;mitotic metaphase/anaphase transition;mitotic prometaphase;cell division,"nucleoplasm;chromatin;chromosome, centromeric region",,,,,,,,,,,,,,
5815,Q8N3V7,SYNPO,Synaptopodin,PPPRMRSPQPARP,_M(ox)RS(ph)PQPARPGSAAVPGAAFAPIPR_,S804,,,,,,23.63,23.15,23.94,23.59,24.52,,22.89,,,23.62, , , , ,0.01,-0.47,0.32,-0.03,0.90, ,-0.73, , ,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
5816,Q8N3V7,SYNPO,Synaptopodin,PFLYRRSPTDSDV,_S(ph)PTDSDVSLDSEDSGAK_,S854,,24.42,24.46,24.03,,,25.33,26.16,25.01,22.82,24.21,26.16,,25.27,24.79,-0.37,-0.32,-0.76, , ,0.55,1.37,0.23,-1.96,-0.58,1.37, ,0.49,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
5818,Q8N3V7,SYNPO,Synaptopodin,EDSGAKSPGILGY,_S(ph)PGILGYNICPR_,S871,,23.78,,,22.15,,,23.69,,25.43,,24.43,22.08,,23.59,0.19, , ,-1.44, , ,0.09, ,1.84, ,0.84,-1.52, ,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
5820,Q8N3V7,SYNPO,Synaptopodin,LASWVRSPPSYSV,_S(ph)PPSYSVLYPSSDPK_,S336,,23.60,,,,,,23.90,,,,,,,23.75,-0.15, , , , , ,0.15, , , , , , ,positive regulation of actin filament bundle assembly;regulation of stress fiber assembly,postsynaptic density;actin cytoskeleton;cytoplasm;tight junction;dendritic spine;stress fiber;perikaryon;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
5822,Q8N3X1,FNBP4,Formin-binding protein 4 (Formin-binding protein 30),GSVSGSSPRSDIS,_ALEEGDGSVSGSS(ph)PR_,S432,+,26.93,22.94,22.68,26.61,,,20.74,24.85,24.29,21.71,24.01,22.68,23.10,23.69,3.25,-0.74,-1.01,2.92, , ,-2.95,1.16,0.60,-1.97,0.32,-1.01,-0.58,,nucleus,,,,,,,,,,,,,,
5823,Q8N3X1,FNBP4,Formin-binding protein 4 (Formin-binding protein 30),EMEVEESPEKIKV,_IDENS(ph)DKEM(ox)EVEES(ph)PEK_,S508,,24.01,23.98,23.98,24.50,,,,,,22.12,,,,23.72,0.30,0.26,0.26,0.78, , , , , ,-1.60, , , ,,nucleus,,,,,,,,,,,,,,
5824,Q8N3X1,FNBP4,Formin-binding protein 4 (Formin-binding protein 30),EKIDENSDKEMEV,_IDENS(ph)DKEM(ox)EVEES(ph)PEK_,S499,+,23.65,,,24.92,,24.76,24.79,22.79,26.44,24.48,25.43,24.78,24.70,24.67,-1.02, , ,0.25, ,0.08,0.12,-1.89,1.76,-0.19,0.75,0.11,0.03,,nucleus,,,,,,,,,,,,,,
5825,Q8N3X1,FNBP4,Formin-binding protein 4 (Formin-binding protein 30),RPILQLSPPGPRG,_RPILQLS(ph)PPGPR_,S18,+,22.18,,,21.40,24.23,23.03,23.72,24.32,23.39,21.55,23.65,23.89,23.53,23.17,-0.99, , ,-1.77,1.06,-0.14,0.55,1.15,0.22,-1.62,0.48,0.71,0.36,,nucleus,,,,,,,,,,,,,,
5826,Q8N3Z3,GTPBP8,GTP-binding protein 8,LRIFDPSPEDIAR,_IFDPS(ph)PEDIAR_,S59,,22.28,,,,,,,,,,,,,22.28,0.00, , , , , , , , , , , , ,barrier septum assembly,mitochondrion,,,,,,,,,,,,,,
5829,Q8N4C6,NIN,Ninein (hNinein) (Glycogen synthase kinase 3 beta-interacting protein) (GSK3B-interacting protein),NQQKRLSWDKLDH,_RLS(ph)WDK_,S1124,,,23.75,23.98,22.84,,,20.73,,21.85,20.92,,21.48,,22.22, ,1.53,1.76,0.62, , ,-1.49, ,-0.37,-1.30, ,-0.74, ,centrosome-templated microtubule nucleation;microtubule anchoring at centrosome;centrosome localization,centriole;microtubule;centrosome,,,,,,,,,,,,,,
5831,Q8N4C8,MINK1,Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6),AVIRQNSDPTSEG,_(gl)QNS(ph)DPTSEGPGPSPNPPAWVRPDNEAPPK_,S621,,22.92,,,,,,,,,,,,,22.92,0.00, , , , , , , , , , , , ,regulation of cell migration;protein autophosphorylation;JNK cascade;regulation of cell-matrix adhesion;regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity;dendrite morphogenesis;regulation of cell-cell adhesion;actin cytoskeleton reorganization;negative thymic T cell selection;positive regulation of JNK cascade;synaptic transmission,axon;Golgi apparatus;cell junction;plasma membrane;postsynaptic density;postsynaptic membrane,,+,,,,,,,,,,,,
5833,Q8N4C8,MINK1,Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6),ARPRSNSAWQIYL,_SNS(ph)AWQIYLQR_,S681,,23.95,,,,,,,,,,,,,23.95,0.00, , , , , , , , , , , , ,regulation of cell migration;protein autophosphorylation;JNK cascade;regulation of cell-matrix adhesion;regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity;dendrite morphogenesis;regulation of cell-cell adhesion;actin cytoskeleton reorganization;negative thymic T cell selection;positive regulation of JNK cascade;synaptic transmission,axon;Golgi apparatus;cell junction;plasma membrane;postsynaptic density;postsynaptic membrane,,+,,,,,,,,,,,,
5835,Q8N4S0,CCDC82,Coiled-coil domain-containing protein 82,DQEKHLSQEDNDL,_HLS(ph)QEDNDLNK_,S131,+,26.50,26.63,27.24,24.05,,,23.92,,23.30,23.18,,,,24.97,1.52,1.66,2.26,-0.92, , ,-1.05, ,-1.68,-1.79, , , ,,,,,,,,,,,,,,,,
5836,Q8N4S0,CCDC82,Coiled-coil domain-containing protein 82,VVEDEGSSVEMEQ,_RVVEDEGS(ph)S(ph)VEM(ox)EQK_,S219,,22.87,,,,,,,,,,,,,22.87,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5837,Q8N4S0,CCDC82,Coiled-coil domain-containing protein 82,VEDEGSSVEMEQK,_RVVEDEGS(ph)S(ph)VEM(ox)EQK_,S220,,22.87,,,,,,,,,,,,,22.87,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5838,Q8N4S9,MARVELD2,MARVEL domain-containing protein 2 (Tricellulin),PRDPYGSLDRHTQ,_EADAVFPRDPYGS(ph)LDR_,S161,,22.53,23.64,,21.52,,,,21.71,23.38,25.29,,,,23.01,-0.48,0.63, ,-1.49, , , ,-1.30,0.37,2.28, , , ,cell-cell junction organization;sensory perception of sound,tight junction;integral to membrane;plasma membrane,,,,,,,,,,,,,,
5839,Q8N4T4,ARHGEF39,Rho guanine nucleotide exchange factor 39,___MELSCPGSRC,_(ac)M(ox)ELS(ph)CPGSR_,S4,,27.11,24.28,,25.27,27.45,25.16,27.13,26.39,21.63,22.17,21.75,29.77,22.13,25.02,2.09,-0.74, ,0.26,2.43,0.14,2.11,1.37,-3.39,-2.85,-3.27,4.75,-2.89,positive regulation of cell migration;regulation of Rho protein signal transduction,plasma membrane;intracellular,,,,,,,,,,,,,,
5840,Q8N4X5,AFAP1L2,Actin filament-associated protein 1-like 2 (AFAP1-like protein 2),_MQRKFSEPNTYI,_KFS(ph)EPNTYIDGLPSQDR_,S6,,22.27,,,,,,,21.80,,22.48,,,,22.18,0.09, , , , , , ,-0.39, ,0.30, , , ,"regulation of mitotic cell cycle;regulation of interleukin-6 production;positive regulation of transcription, DNA-dependent;positive regulation of interleukin-8 production;inflammatory response;positive regulation of epidermal growth factor receptor signaling pathway",aggresome;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
5845,Q8N556,AFAP1,Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110),VVKRTGSNAAQYK,_RTGS(ph)NAAQYK_,S548,,,22.86,23.21,23.97,,,,,20.44,,,,,22.62, ,0.24,0.59,1.35, , , , ,-2.18, , , , ,,focal adhesion;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5847,Q8N556,AFAP1,Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110),GTSSPQSPVFRHR,_SGTSSPQS(ph)PVFR_,S668,+,27.57,28.49,27.16,29.89,29.48,29.94,29.84,29.70,30.02,27.76,29.04,29.42,29.36,29.05,-1.48,-0.56,-1.89,0.84,0.43,0.89,0.78,0.65,0.97,-1.29,-0.01,0.37,0.31,,focal adhesion;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5848,Q8N565,MREG,Melanoregulin (Dilute suppressor protein homolog),HYLPFPSP_____,_ELHYLPFPS(ph)P_,S213,,24.23,,,,,,,,,,,,,24.23,0.00, , , , , , , , , , , , ,anagen;melanocyte differentiation,apical plasma membrane,,,,,,,,,,,,,,
5850,Q8N573,OXR1,Oxidation resistance protein 1,RPARVVSSTSEEE,_VVS(ph)ST(ph)SEEEEAFTEK_,S193,,26.48,,,22.79,,,,,21.57,,,23.56,,23.60,2.88, , ,-0.81, , , , ,-2.03, , ,-0.03, ,response to oxidative stress;cell wall macromolecule catabolic process,mitochondrion;nucleolus,,,,,,,,,,,,,,
5851,Q8N573,OXR1,Oxidation resistance protein 1,PARVVSSTSEEEE,_VVSS(ph)TSEEEEAFTEK_,S194,+,25.45,23.73,22.63,23.87,,23.49,24.13,24.25,23.60,,23.84,24.42,23.70,23.92,1.53,-0.19,-1.29,-0.05, ,-0.43,0.21,0.34,-0.32, ,-0.08,0.51,-0.22,response to oxidative stress;cell wall macromolecule catabolic process,mitochondrion;nucleolus,,,,,,,,,,,,,,
5852,Q8N573,OXR1,Oxidation resistance protein 1,RVVSSTSEEEEAF,_VVSSTS(ph)EEEEAFTEK_,S196,,23.52,,,,24.13,,,,,,,,,23.82,-0.30, , , ,0.30, , , , , , , , ,response to oxidative stress;cell wall macromolecule catabolic process,mitochondrion;nucleolus,,,,,,,,,,,,,,
5853,Q8N594,MPND,MPN domain-containing protein (EC 3.4.-.-),AAPEPLSPAGGAG,_(ac)AAPEPLS(ph)PAGGAGEEAPEEDEDEAEAEDPERPNAGAGGGR_,S8,,23.94,,,,24.97,,,24.56,25.64,25.15,,,,24.85,-0.92, , , ,0.12, , ,-0.29,0.79,0.30, , , ,proteolysis,,,,,,,,,,,,,,,
5854,Q8N5F7,NKAP,NF-kappa-B-activating protein,PEVWGLSPKNPEP,_IGELGAPEVWGLS(ph)PK_,S149,+,26.62,25.37,24.43,26.15,26.86,24.86,25.35,26.27,26.33,26.52,26.75,26.14,25.44,25.93,0.69,-0.56,-1.50,0.22,0.93,-1.07,-0.58,0.35,0.40,0.59,0.82,0.21,-0.49,"positive regulation of alpha-beta T cell differentiation;stem cell maintenance;granulocyte differentiation;negative regulation of transcription, DNA-dependent;T cell differentiation in thymus;Notch signaling pathway;hematopoietic stem cell proliferation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
5856,Q8N5G2,TMEM57,Macoilin (Transmembrane protein 57),SGVVNSSPRSHSA,_NASGVVNSS(ph)PR_,S332,+,24.48,22.91,22.91,24.61,,,,,19.89,20.30,21.25,21.26,,22.20,2.28,0.71,0.71,2.41, , , , ,-2.31,-1.90,-0.95,-0.94, ,brain development,synapse part;nuclear membrane;axon;neuron projection terminus;integral to membrane,,,,,,,,,,,,,,
5857,Q8N5G2,TMEM57,Macoilin (Transmembrane protein 57),NNDLVGSTENLLK,_RLNNDLVGS(ph)TENLLK_,S305,,,,,,,22.77,22.57,21.57,,24.11,,23.61,23.24,22.98, , , , , ,-0.21,-0.40,-1.40, ,1.13, ,0.63,0.26,brain development,synapse part;nuclear membrane;axon;neuron projection terminus;integral to membrane,,,,,,,,,,,,,,
5858,Q8N5I9,C12orf45,Uncharacterized protein C12orf45,KIEVLDSPASKKK,_IEVLDS(ph)PASK_,S178,+,23.90,22.10,21.52,22.32,,27.13,,,,22.14,,,21.51,22.95,0.96,-0.85,-1.43,-0.62, ,4.19, , , ,-0.81, , ,-1.44,,,,,,,,,,,,,,,,
5860,Q8N5V2,NGEF,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),RRTKFVSFTSRLL,_FVS(ph)FTSR_,S329,,,,,,22.48,,24.25,22.10,,,,24.05,,23.22, , , , ,-0.74, ,1.03,-1.12, , , ,0.83, ,regulation of GTPase activity;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;negative regulation of dendritic spine morphogenesis;ephrin receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,growth cone;cytosol;plasma membrane,,,,,,,,,,,,,,
5861,Q8N5Y2,MSL3,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),NKDEEISEESDIE,_DEEIS(ph)EES(ph)DIEEK_,S85,,23.02,,,,,,,,,,,,,23.02,0.00, , , , , , , , , , , , ,multicellular organismal development;histone H4-K16 acetylation;transcription from RNA polymerase II promoter,MSL complex,Other TF domain,,,,,,,,,,,,,
5862,Q8N5Y2,MSL3,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),EEISEESDIEEKT,_DEEIS(ph)EES(ph)DIEEK_,S88,,23.02,,,,,,,,,,,,,23.02,0.00, , , , , , , , , , , , ,multicellular organismal development;histone H4-K16 acetylation;transcription from RNA polymerase II promoter,MSL complex,Other TF domain,,,,,,,,,,,,,
5863,Q8N5Y2,MSL3,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),QEELSPSPPLLNP,_SQEELSPS(ph)PPLLNPSTPQSTESQPTTGEPATPK_,S252,,23.86,,,,23.89,,,,,,,,,23.87,-0.01, , , ,0.01, , , , , , , , ,multicellular organismal development;histone H4-K16 acetylation;transcription from RNA polymerase II promoter,MSL complex,Other TF domain,,,,,,,,,,,,,
5864,Q8N5Y2,MSL3,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),VHSRSSSPIPLTP,_SSS(ph)PIPLT(ph)PSK_,S341,+,25.89,24.58,24.50,24.29,24.08,25.09,24.58,24.46,24.99,24.34,22.55,23.28,23.52,24.32,1.57,0.26,0.19,-0.03,-0.24,0.77,0.26,0.14,0.67,0.03,-1.77,-1.04,-0.80,multicellular organismal development;histone H4-K16 acetylation;transcription from RNA polymerase II promoter,MSL complex,Other TF domain,,,,,,,,,,,,,
5865,Q8N655,C10orf12,Uncharacterized protein C10orf12,FTDENPSETEESE,_ESSTFTDENPS(ph)ETEESEAAGGIGK_,S283,,21.40,,,,,,,,,24.24,,,,22.82,-1.42, , , , , , , , ,1.42, , , ,,,,,,,,,,,,,,,,
5868,Q8N697,SLC15A4,Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1),___MEGSGGGAGE,_(ac)M(ox)EGS(ph)GGGAGERAPLLGAR_,S4,,23.92,24.48,25.29,26.33,26.91,24.90,23.43,24.22,23.95,23.81,24.01,24.51,24.49,24.64,-0.71,-0.15,0.65,1.69,2.27,0.27,-1.21,-0.41,-0.69,-0.83,-0.62,-0.12,-0.15,oligopeptide transport;protein transport;ion transport;transmembrane transport,integral to membrane;lysosomal membrane,,,,,,,,,,,,,,
5871,Q8N699,MYCT1,Myc target protein 1 (Myc target in myeloid cells protein 1),TFQRQASLEQANS,_(gl)QAS(ph)LEQANSFPRK_,S101,+,,,,,27.32,25.11,27.73,23.84,27.42,21.78,25.33,,25.12,25.46, , , , ,1.87,-0.35,2.28,-1.62,1.96,-3.68,-0.13, ,-0.34,,nucleus,,,,,,,,,,,,,,
5872,Q8N699,MYCT1,Myc target protein 1 (Myc target in myeloid cells protein 1),SGCERRSNLSLAS,_S(ph)NLSLASLTFQR_,S87,,,,,,22.45,,21.62,,21.80,,,,,21.95, , , , ,0.49, ,-0.33, ,-0.16, , , , ,,nucleus,,,,,,,,,,,,,,
5873,Q8N699,MYCT1,Myc target protein 1 (Myc target in myeloid cells protein 1),SNLSLASLTFQRQ,_SNLSLAS(ph)LTFQR_,S93,,,,,,22.39,,22.95,,,,,21.66,,22.34, , , , ,0.06, ,0.62, , , , ,-0.68, ,,nucleus,,,,,,,,,,,,,,
5875,Q8N6H7,ARFGAP2,ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289),AGAKAISSDMFFG,_AIS(ph)SDMFFGR_,S296,+,24.06,20.83,20.30,23.27,,,22.12,21.90,,,,23.88,,22.34,1.73,-1.51,-2.04,0.93, , ,-0.22,-0.43, , , ,1.54, ,vesicle-mediated transport;protein transport;positive regulation of GTPase activity;regulation of ARF GTPase activity,nucleolus;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
5876,Q8N6H7,ARFGAP2,ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289),QKVSSQSFSEIER,_VSSQS(ph)FSEIER_,S104,,23.03,,,,,,,,,,,,,23.03,0.00, , , , , , , , , , , , ,vesicle-mediated transport;protein transport;positive regulation of GTPase activity;regulation of ARF GTPase activity,nucleolus;Golgi apparatus;Golgi membrane,,,,,,,,,,,,,,
5877,Q8N6N3,C1orf52,UPF0690 protein C1orf52 (BCL10-associated gene protein),GEETLESDDEKDE,_ARLLPEGEETLES(ph)DDEK_,S158,+,28.34,25.69,26.27,25.53,26.07,26.13,28.54,25.98,28.70,28.35,27.29,27.96,26.24,27.01,1.33,-1.32,-0.74,-1.48,-0.93,-0.88,1.53,-1.03,1.70,1.35,0.28,0.96,-0.76,,,,,,,,,,,,,,,,
5881,Q8N7R7,CCNYL1,Cyclin-Y-like protein 1,AMRRSFSADNFIG,_SFS(ph)ADNFIGIQR_,S274,+,26.14,24.53,24.53,22.96,27.84,24.71,25.21,26.52,26.60,26.99,25.95,27.57,26.85,25.88,0.27,-1.34,-1.34,-2.92,1.97,-1.17,-0.67,0.64,0.73,1.11,0.07,1.69,0.97,regulation of cyclin-dependent protein kinase activity,,,,,,,,,,,,,,,
5882,Q8N8A6,DDX51,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),EDAGAESNEEAPG,_ADGEDAGAES(ph)NEEAPGEPSAGSSEEAPGEPSAGSSEEAPGER_,S103,+,23.46,,,23.54,,24.38,24.73,23.17,24.64,24.89,,23.40,,24.03,-0.57, , ,-0.49, ,0.36,0.70,-0.85,0.61,0.86, ,-0.62, ,rRNA processing,nucleolus,,,,,,,,,,,,,,
5885,Q8N954,GPATCH11,G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75),GIGHEASLKRKAE,_SGIGHEAS(ph)LK_,S12,,24.42,,,21.59,,,,,,,,21.38,,22.46,1.96, , ,-0.87, , , , , , , ,-1.08, ,,,,,,,,,,,,,,,,
5886,Q8N9B5,JMY,Junction-mediating and -regulatory protein,SPRSTRSLLGDPR,_S(ph)LLGDPR_,S121,,22.22,,,,,,,,,,,,,22.22,0.00, , , , , , , , , , , , ,regulation of transcription from RNA polymerase II promoter;positive regulation of sequence-specific DNA binding transcription factor activity;induction of apoptosis;Arp2/3 complex-mediated actin nucleation;DNA repair;'de novo' actin filament nucleation;cell cycle arrest;actin polymerization-dependent cell motility,cell leading edge;nucleus;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
5887,Q8N9T8,KRI1,Protein KRI1 homolog,RAFVEDSEDEDGA,_AFVEDS(ph)EDEDGAGEGGSSLLQKR_,S173,+,29.43,,,24.46,28.22,25.66,25.36,25.90,26.74,25.38,25.43,25.98,25.92,26.23,3.21, , ,-1.77,2.00,-0.57,-0.86,-0.33,0.51,-0.85,-0.79,-0.25,-0.31,,,,,,,,,,,,,,,,
5890,Q8N9T8,KRI1,Protein KRI1 homolog,TASSSDSEEDPEA,_TASSSDS(ph)EEDPEALEK_,S99,,21.83,24.45,,,,,,23.18,25.49,25.32,,,23.75,24.00,-2.18,0.45, , , , , ,-0.82,1.49,1.31, , ,-0.25,,,,,,,,,,,,,,,,
5891,Q8N9T8,KRI1,Protein KRI1 homolog,SLMGPESPPAQEE,_(gl)QLPALDGSLM(ox)GPES(ph)PPAQEEEAPVS(ph)PHK_,S630,+,28.66,23.54,,23.88,,,26.39,23.55,28.06,26.38,25.58,26.79,25.57,25.84,2.82,-2.30, ,-1.96, , ,0.55,-2.29,2.22,0.54,-0.26,0.95,-0.27,,,,,,,,,,,,,,,,
5892,Q8N9T8,KRI1,Protein KRI1 homolog,EEEAPVSPHKKPA,_(gl)QLPALDGSLM(ox)GPES(ph)PPAQEEEAPVS(ph)PHK_,S641,,28.28,,,,,,23.30,,,,,,,25.79,2.49, , , , , ,-2.49, , , , , , ,,,,,,,,,,,,,,,,
5893,Q8N9U0,TC2N,Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus) (Tac2-N),VKRLYGSVCDLRT,_LYGS(ph)VCDLR_,S156,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5895,Q8N9U0,TC2N,Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus) (Tac2-N),SPGLSKSMFDLTN,_S(ph)M(ox)FDLTNSSQR_,S174,,22.99,,,,,,,,,,,,,22.99,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
5897,Q8NAF0,ZNF579,Zinc finger protein 579,QAQAPTSPPPPPP,_AAALQALQAQAPTS(ph)PPPPPPPLK_,S483,+,25.35,24.70,25.08,26.41,,25.84,27.51,25.88,27.16,26.66,27.26,27.50,27.42,26.40,-1.05,-1.69,-1.32,0.02, ,-0.56,1.11,-0.52,0.76,0.26,0.87,1.10,1.02,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5898,Q8NAF0,ZNF579,Zinc finger protein 579,RFSRAYSLLRHQR,_AYS(ph)LLR_,S455,,21.42,,,20.59,,,,,,,,21.69,,21.23,0.18, , ,-0.64, , , , , , , ,0.46, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5899,Q8NAP3,ZBTB38,Zinc finger and BTB domain-containing protein 38,VLTRSKSPNNEGD,_S(ph)PNNEGDVHFSR_,S309,,22.83,24.07,,21.87,,,,,,,,,,22.92,-0.09,1.15, ,-1.06, , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
5900,Q8NAP3,ZBTB38,Zinc finger and BTB domain-containing protein 38,REHDGSSPGNTGK,_SQPVREHDGSS(ph)PGNTGK_,S244,,22.13,21.57,21.98,18.73,,,,,19.84,,,,,20.85,1.28,0.72,1.13,-2.12, , , , ,-1.01, , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
5901,Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A,KLERVPSPDHRRR,_VPS(ph)PDHR_,S209,+,25.34,26.76,26.71,26.11,22.88,23.81,25.76,23.84,26.15,25.24,24.60,25.05,22.45,24.98,0.37,1.79,1.74,1.13,-2.09,-1.17,0.78,-1.14,1.18,0.26,-0.38,0.07,-2.53,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,,,,,
5902,Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A,PDHRRRSYRDLDK,_S(ph)YRDLDK_,S216,,22.49,24.66,24.81,25.33,,,20.28,,,,,21.27,,23.14,-0.65,1.52,1.67,2.19, , ,-2.86, , , , ,-1.87, ,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,,,,,
5903,Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A,DMDDVESSEEEEE,_VSALEEDMDDVES(ph)S(ph)EEEEEEDEK_,S193,,28.40,,,,,,,,,,,,,28.40,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,,,,,
5904,Q8NAV1,PRPF38A,Pre-mRNA-splicing factor 38A,MDDVESSEEEEEE,_VSALEEDMDDVES(ph)S(ph)EEEEEEDEK_,S194,,28.40,,,,,,,,,,,,,28.40,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing,spliceosomal complex,,,,,,,,,,,,,,
5905,Q8NB49,ATP11C,Probable phospholipid-transporting ATPase IG (EC 3.6.3.1) (ATPase IQ) (ATPase class VI type 11C),LLLRTFSDESNVL,_TFS(ph)DESNVL_,S1126,,20.19,,,,22.46,,,,21.48,22.85,21.95,,,21.79,-1.59, , , ,0.67, , , ,-0.31,1.07,0.17, , ,phospholipid translocation;cation transport;ion transmembrane transport,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
5907,Q8NBJ4,GOLM1,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),DENEAESETDKQA,_LRGEDDYNM(ox)DENEAES(ph)ETDK_,S350,,,25.93,,,23.85,26.69,,25.05,23.35,26.89,27.53,28.06,27.44,26.09, ,-0.15, , ,-2.24,0.60, ,-1.03,-2.74,0.80,1.44,1.97,1.35,,Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
5908,Q8NBJ5,COLGALT1,Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1),LQSPLDSAARDEL,_NSDVLQSPLDS(ph)AARDEL_,S616,,24.83,22.64,21.95,20.53,22.44,,,,,21.48,,,,22.31,2.52,0.33,-0.36,-1.78,0.13, , , , ,-0.83, , , ,lipopolysaccharide biosynthetic process;extracellular matrix organization,endoplasmic reticulum lumen,,,,,,,,,,,,,,
5909,Q8NBN3,TMEM87A,Transmembrane protein 87A,FAFSPLSEEEEED,_FAFSPLS(ph)EEEEEDEQK_,S451,,24.27,,,,23.64,,,,,,,,,23.96,0.31, , , ,-0.31, , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
5910,Q8NBN3,TMEM87A,Transmembrane protein 87A,LPALLDSDEERMI,_WVEENVPSSVTDVALPALLDS(ph)DEER_,S516,,26.65,,,,,,,,,,,,,26.65,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
5911,Q8NBP7,PCSK9,Proprotein convertase subtilisin/kexin type 9 (EC 3.4.21.-) (Neural apoptosis-regulated convertase 1) (NARC-1) (Proprotein convertase 9) (PC9) (Subtilisin/kexin-like protease PC9),RHLAQASQELQ__,_SRHLAQAS(ph)QELQ_,S688,,,,,,22.16,,,23.59,,24.13,21.62,,,22.88, , , , ,-0.71, , ,0.71, ,1.26,-1.25, , ,phospholipid metabolic process;low-density lipoprotein particle receptor catabolic process;kidney development;liver development;lipoprotein metabolic process;induction of apoptosis;cholesterol homeostasis;proteolysis;neuron differentiation;positive regulation of neuron apoptotic process;cellular response to insulin stimulus;apoptotic process;cholesterol metabolic process;regulation of low-density lipoprotein particle receptor catabolic process;positive regulation of receptor internalization;negative regulation of catalytic activity;cellular response to starvation;negative regulation of receptor recycling;regulation of receptor activity;protein autoprocessing;lysosomal transport;triglyceride metabolic process;negative regulation of low-density lipoprotein particle clearance,late endosome;Golgi apparatus;endoplasmic reticulum;perinuclear region of cytoplasm;early endosome;extrinsic to external side of plasma membrane;rough endoplasmic reticulum;extracellular space;lysosome,,,,,,,,,,,,,,
5912,Q8NBU5,ATAD1,ATPase family AAA domain-containing protein 1 (EC 3.6.1.3) (Thorase),NSTSEESHDEDEI,_EYVNSTSEES(ph)HDEDEIRPVQQQDLHR_,S322,+,,21.98,,,25.10,25.35,24.32,,23.36,24.16,24.60,24.59,25.00,24.28, ,-2.29, , ,0.83,1.08,0.04, ,-0.91,-0.11,0.33,0.31,0.73,"memory;positive regulation of receptor internalization;learning;negative regulation of synaptic transmission, glutamatergic",mitochondrion;peroxisomal membrane;cell junction;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
5913,Q8NC44,FAM134A,Protein FAM134A,EDLDQQSLPSEPE,_ATTPQLTDVSEDLDQQS(ph)LPSEPEETLSR_,S344,,24.37,,,,,,,,,,,,,24.37,0.00, , , , , , , , , , , , ,,integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
5914,Q8NC44,FAM134A,Protein FAM134A,SPEEPHSDSEGAG,_FLPDVSASSPEEPHS(ph)DSEGAGSGAR_,S138,,,,,,22.99,,,23.59,,,25.46,24.53,25.18,24.35, , , , ,-1.36, , ,-0.76, , ,1.11,0.18,0.83,,integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
5915,Q8NC44,FAM134A,Protein FAM134A,SRQALDSEEEEED,_(gl)QALDS(ph)EEEEEDVAAKETLLR_,S385,+,28.06,26.53,26.90,26.30,27.24,26.80,25.19,25.68,27.72,28.85,27.60,27.59,27.17,27.05,1.01,-0.52,-0.15,-0.75,0.19,-0.25,-1.86,-1.37,0.67,1.80,0.56,0.54,0.12,,integral to membrane;endoplasmic reticulum,,,,,,,,,,,,,,
5918,Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),YIQKQISYNYSDL,_(gl)QIS(ph)YNYSDLDQSNVTEETPEGEEHHPVADTENK_,S243,,23.88,,,,,,,,,,,,,23.88,0.00, , , , , , , , , , , , ,regulation of mRNA stability,plasma membrane;nucleus;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
5921,Q8NC51,SERBP1,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),LTDLDQSNVTEET,_DELTDLDQS(ph)NVTEETPEGEEHHPVADTENK_,S237,,,,,,,,25.71,,24.51,,,25.90,,25.37, , , , , , ,0.33, ,-0.86, , ,0.53, ,regulation of mRNA stability,plasma membrane;nucleus;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
5922,Q8NC56,LEMD2,LEM domain-containing protein 2 (hLEM2),__MAGLSDLELRR,_(ac)AGLS(ph)DLELRR_,S5,,25.30,19.96,19.96,21.42,25.35,23.92,23.01,23.47,23.30,22.82,24.38,24.05,24.29,23.17,2.13,-3.21,-3.21,-1.75,2.18,0.75,-0.16,0.30,0.12,-0.36,1.21,0.88,1.12,skeletal muscle cell differentiation;negative regulation of MAPK cascade,integral to nuclear inner membrane,,,,,,,,,,,,,,
5923,Q8NC56,LEMD2,LEM domain-containing protein 2 (hLEM2),RASVRGSSEEDED,_ASVRGS(ph)S(ph)EEDEDARTPDR_,S138,+,26.43,27.68,,24.00,25.83,25.75,23.75,24.58,24.28,23.44,25.55,21.58,25.00,24.82,1.61,2.86, ,-0.82,1.00,0.93,-1.07,-0.25,-0.54,-1.38,0.72,-3.24,0.18,skeletal muscle cell differentiation;negative regulation of MAPK cascade,integral to nuclear inner membrane,,,,,,,,,,,,,,
5924,Q8NC56,LEMD2,LEM domain-containing protein 2 (hLEM2),ASVRGSSEEDEDA,_ASVRGS(ph)S(ph)EEDEDARTPDR_,S139,,26.77,27.31,,24.88,24.62,,,22.63,,,20.36,,,24.43,2.34,2.88, ,0.45,0.19, , ,-1.80, , ,-4.06, , ,skeletal muscle cell differentiation;negative regulation of MAPK cascade,integral to nuclear inner membrane,,,,,,,,,,,,,,
5926,Q8NC56,LEMD2,LEM domain-containing protein 2 (hLEM2),TKPSSFSDSER__,_PSSFS(ph)DSER_,S499,+,27.65,27.72,27.75,27.77,28.72,29.87,28.55,29.19,28.58,29.14,28.70,28.32,28.39,28.49,-0.84,-0.77,-0.74,-0.71,0.23,1.38,0.06,0.71,0.09,0.65,0.21,-0.17,-0.10,skeletal muscle cell differentiation;negative regulation of MAPK cascade,integral to nuclear inner membrane,,,,,,,,,,,,,,
5927,Q8NC74,RBBP8NL,RBBP8 N-terminal-like protein,SPVAKISPGATLP,_IS(ph)PGATLPESR_,S196,,25.57,,,,,,,,,,,,,25.57,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5928,Q8NC74,RBBP8NL,RBBP8 N-terminal-like protein,ATEGPGSPRDAED,_LTATEGPGS(ph)PR_,S645,,26.09,,,,,,,,,,,,,26.09,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
5931,Q8NCD3,HJURP,Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9),YRGGPASPGGLQG,_GGPAS(ph)PGGLQGLETR_,S388,,,,,21.75,23.38,,22.19,22.53,22.07,21.76,,,,22.28, , , ,-0.53,1.10, ,-0.08,0.25,-0.21,-0.52, , , ,chromosome segregation;CENP-A containing nucleosome assembly at centromere;regulation of DNA binding;cell cycle;regulation of protein complex assembly,nucleoplasm;nucleolus;condensed chromosome kinetochore;cytoplasm,,,,,,,,,,,,,,
5932,Q8NCF5,NFATC2IP,"NFATC2-interacting protein (45 kDa NF-AT-interacting protein) (45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)",SPLSPPSPRTKSR,_KKTEFLDLDNSPLSPPS(ph)PR_,S204,+,22.65,,,22.04,24.98,,,24.31,24.25,23.49,,23.22,,23.56,-0.92, , ,-1.53,1.42, , ,0.75,0.69,-0.07, ,-0.34, ,"cytokine production;regulation of transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
5933,Q8NCN4,RNF169,E3 ubiquitin-protein ligase RNF169 (EC 6.3.2.-) (RING finger protein 169),PDGRVLSPLIIKS,_VLS(ph)PLIIK_,S403,+,22.94,22.32,20.91,21.66,22.90,23.47,21.98,22.06,23.21,22.88,,21.85,22.19,22.36,0.58,-0.04,-1.45,-0.70,0.53,1.11,-0.38,-0.30,0.85,0.52, ,-0.52,-0.17,response to DNA damage stimulus;negative regulation of double-strand break repair;protein ubiquitination,nucleoplasm;site of double-strand break,,,,,,,,,,,,,,
5934,Q8NCP5,ZBTB44,Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851),IVMSPESPVKCGT,_SYIVM(ox)SPES(ph)PVK_,S107,+,23.59,23.22,23.22,21.83,22.40,24.60,,,22.94,22.57,21.76,,,22.90,0.68,0.32,0.32,-1.07,-0.50,1.70, , ,0.03,-0.33,-1.14, , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5937,Q8ND30,PPFIBP2,Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2) (PTPRF-interacting protein-binding protein 2),PSERTLSINEEEP,_TLS(ph)INEEEPEGGFSK_,S171,,26.50,,,25.27,,,,26.35,,,,,,26.04,0.46, , ,-0.77, , , ,0.31, , , , , ,cell communication,intracellular,,,,,,,,,,,,,,
5938,Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),LDPLRKSPTMEQA,_S(ph)PTM(ox)EQAVQTASAHLPAPAAVGRR_,S192,+,,25.66,24.78,24.33,21.90,,25.47,,24.56,25.60,26.53,,,24.85, ,0.80,-0.07,-0.52,-2.96, ,0.62, ,-0.29,0.74,1.67, , ,multicellular organismal development;regulation of translation;cytoplasmic mRNA processing body assembly,intracellular membrane-bounded organelle;cytoplasmic stress granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5939,Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),AAVGRRSPVSTRP,_S(ph)PVSTRPLPSASQK_,S216,+,28.39,28.52,28.71,28.07,29.12,28.65,29.06,29.42,28.02,28.30,27.83,28.22,27.51,28.45,-0.06,0.07,0.26,-0.38,0.68,0.20,0.61,0.97,-0.42,-0.15,-0.62,-0.23,-0.94,multicellular organismal development;regulation of translation;cytoplasmic mRNA processing body assembly,intracellular membrane-bounded organelle;cytoplasmic stress granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5942,Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),SLKTQLSQGRSSP,_TQLS(ph)QGRSS(ph)PQLDPLRK_,S178,,27.22,25.84,26.32,25.65,,,,,22.81,,,,,25.57,1.65,0.28,0.75,0.08, , , , ,-2.76, , , , ,multicellular organismal development;regulation of translation;cytoplasmic mRNA processing body assembly,intracellular membrane-bounded organelle;cytoplasmic stress granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5944,Q8ND76,CCNY,Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X),RSARKRSASADNL,_S(ph)ASADNLTLPR_,S299,,21.91,,,23.00,,,,23.42,26.22,21.99,,,,23.31,-1.40, , ,-0.31, , , ,0.11,2.92,-1.32, , , ,G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein kinase activity;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,,,,,,,,,,,,,
5945,Q8ND76,CCNY,Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X),ARKRSASADNLTL,_SAS(ph)ADNLTLPR_,S301,+,26.87,27.17,26.80,26.56,28.46,29.15,27.61,28.01,28.18,27.22,27.47,26.86,28.06,27.57,-0.70,-0.41,-0.77,-1.01,0.89,1.58,0.04,0.44,0.61,-0.35,-0.10,-0.71,0.49,G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein kinase activity;Wnt receptor signaling pathway;regulation of canonical Wnt receptor signaling pathway;cell division,plasma membrane;nucleus;cytoplasmic cyclin-dependent protein kinase holoenzyme complex,,,,,,,,,,,,,,
5949,Q8ND82,ZNF280C,Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633),IKSEPHSPGIPEI,_SEPHS(ph)PGIPEIFR_,S80,+,20.07,18.31,18.31,,21.50,21.98,21.70,,23.73,23.63,,20.66,23.72,21.36,-1.29,-3.05,-3.05, ,0.14,0.62,0.34, ,2.37,2.27, ,-0.70,2.36,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5952,Q8NDC0,MAPK1IP1L,MAPK-interacting and spindle-stabilizing protein-like (Mitogen-activated protein kinase 1-interacting protein 1-like),DALPEHSPAKTSA,_(ac)SDEFSLADALPEHS(ph)PAK_,S15,+,28.12,24.61,25.30,25.40,28.01,25.55,27.53,27.84,26.35,26.87,27.51,27.69,26.58,26.72,1.40,-2.11,-1.42,-1.32,1.29,-1.17,0.81,1.12,-0.37,0.15,0.79,0.97,-0.14,,,,,,,,,,,,,,,,
5953,Q8NDI1,EHBP1,EH domain-binding protein 1,ETQRKPSEDEVLN,_AAITETQRKPS(ph)EDEVLNK_,S987,+,23.02,24.93,24.93,,23.23,,24.50,24.73,23.32,24.86,23.53,24.37,23.94,24.12,-1.10,0.80,0.80, ,-0.89, ,0.38,0.61,-0.80,0.73,-0.59,0.25,-0.18,,membrane;cytoplasm,,,,,,,,,,,,,,
5954,Q8NDI1,EHBP1,EH domain-binding protein 1,GKDLSTSPKPSPI,_DLSTS(ph)PKPSPIPS(ph)PVLGR_,S393,,25.44,,,,,,,,,,,,,25.44,0.00, , , , , , , , , , , , ,,membrane;cytoplasm,,,,,,,,,,,,,,
5955,Q8NDI1,EHBP1,EH domain-binding protein 1,STSPKPSPIPSPV,_DLSTS(ph)PKPS(ph)PIPS(ph)PVLGR_,S397,,25.42,,,,,,,,,,,,,25.42,0.00, , , , , , , , , , , , ,,membrane;cytoplasm,,,,,,,,,,,,,,
5956,Q8NDI1,EHBP1,EH domain-binding protein 1,KPSPIPSPVLGRK,_DLSTS(ph)PKPS(ph)PIPS(ph)PVLGR_,S401,,26.39,,,23.18,21.63,,,,,,,,,23.73,2.66, , ,-0.56,-2.10, , , , , , , , ,,membrane;cytoplasm,,,,,,,,,,,,,,
5957,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),PGASGMSPRASPL,_ASGDPGASGM(ox)S(ph)PR_,S109,+,20.15,,,23.48,19.96,21.09,20.29,21.02,21.41,,20.30,21.18,21.18,21.00,-0.86, , ,2.48,-1.04,0.08,-0.72,0.01,0.41, ,-0.71,0.17,0.17,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5958,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),YQYKQRSLSPVAA,_(gl)QRS(ph)LS(ph)PVAAPPLREPR_,S265,,25.99,21.21,21.21,22.69,,,21.33,,23.75,24.62,,,,22.97,3.02,-1.76,-1.76,-0.28, , ,-1.65, ,0.78,1.65, , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5959,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),YKQRSLSPVAAPP,_(gl)QRS(ph)LS(ph)PVAAPPLREPR_,S267,+,26.25,24.36,23.98,24.59,27.01,26.83,25.85,26.08,26.16,26.08,25.37,25.16,26.44,25.70,0.54,-1.34,-1.73,-1.12,1.30,1.12,0.15,0.37,0.46,0.38,-0.33,-0.55,0.74,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5960,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),SSDRRNSLEGYSR,_SSDRRNS(ph)LEGYSR_,S562,+,21.22,24.03,24.77,22.95,24.47,23.36,22.95,23.05,23.71,23.19,,22.99,20.69,23.12,-1.90,0.91,1.66,-0.17,1.36,0.25,-0.16,-0.07,0.59,0.07, ,-0.12,-2.43,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5961,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),LEGDWTSPSKSSD,_TFLEGDWTS(ph)PSK_,S552,+,24.48,21.59,,23.81,25.01,24.50,,24.32,23.65,,23.39,,,23.85,0.63,-2.26, ,-0.03,1.17,0.65, ,0.48,-0.19, ,-0.45, , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5962,Q8NDT2,RBM15B,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),RGRTTHSPYEERS,_TTHS(ph)PYEER_,S609,,24.01,25.32,,25.04,20.55,21.50,,,,,,,,23.29,0.73,2.03, ,1.76,-2.73,-1.79, , , , , , , ,"mRNA processing;RNA splicing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction;regulation of alternative mRNA splicing, via spliceosome",nucleoplasm,,,,,,,,,,,,,,
5963,Q8NDV7,TNRC6A,Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa),TGWEEPSPESIRR,_EEEPTGWEEPS(ph)PESIR_,S43,+,22.23,22.53,,24.25,,,24.55,,23.91,22.71,,24.46,,23.52,-1.29,-0.99, ,0.73, , ,1.03, ,0.39,-0.81, ,0.94, ,negative regulation of translation involved in gene silencing by miRNA;Notch signaling pathway;gene expression;cellular response to starvation,cytosol;micro-ribonucleoprotein complex;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
5966,Q8NDX5,PHC3,Polyhomeotic-like protein 3 (Early development regulatory protein 3) (Homolog of polyhomeotic 3) (hPH3),PPPPTLSPAAITV,_M(ox)DRT(ph)PPPPTLS(ph)PAAITVGR_,S575,,25.32,21.34,21.91,22.04,,,,22.83,,,,,,22.69,2.63,-1.35,-0.78,-0.64, , , ,0.14, , , , , ,multicellular organismal development,actin cytoskeleton;PRC1 complex,,,,,,,,,,,,,,
5967,Q8NDX6,ZNF740,Zinc finger protein 740 (OriLyt TD-element-binding protein 7),NGERAGSPDVLRC,_(gl)QAENGERAGS(ph)PDVLR_,S44,+,27.17,25.91,25.91,,25.14,25.05,24.31,23.87,25.30,24.44,,,22.66,24.98,2.19,0.94,0.94, ,0.16,0.08,-0.67,-1.11,0.32,-0.54, , ,-2.32,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
5968,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),KKAEQGSEEEGEG,_KAEQGS(ph)EEEGEGEEEEEEGGESKADDPYAHLSK_,S228,+,28.08,29.42,29.34,29.23,27.18,27.52,29.37,28.38,29.17,28.75,28.17,27.95,26.34,28.38,-0.29,1.04,0.96,0.86,-1.20,-0.86,0.99,0.01,0.79,0.38,-0.21,-0.43,-2.04,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5969,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),RINKAVSEEQQPA,_AVS(ph)EEQQPALK_,S166,,26.58,24.29,24.20,,,,,,,,,,,25.02,1.55,-0.73,-0.82, , , , , , , , , , ,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5970,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),ALIQDQSEEEEEE,_GGNVFAALIQDQS(ph)EEEEEEEK_,S140,,26.67,,,,,,,,,,,,,26.67,0.00, , , , , , , , , , , , ,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5971,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),ERLKKLSVPTSDE,_KLS(ph)VPT(ph)S(ph)DEEDEVPAPKPR_,S105,,28.31,,,,,,21.99,,,,,,,25.15,3.16, , , , , ,-3.16, , , , , , ,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5972,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),KLSVPTSDEEDEV,_KLS(ph)VPT(ph)S(ph)DEEDEVPAPKPR_,S109,+,29.51,27.62,27.52,26.86,29.95,29.21,29.75,29.75,28.65,29.00,29.51,28.78,28.18,28.79,0.72,-1.17,-1.28,-1.93,1.16,0.42,0.96,0.96,-0.14,0.21,0.72,-0.01,-0.61,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5974,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),GDGESTSPSDKVV,_QQPPEPEWIGDGESTS(ph)PSDK_,S22,,25.73,23.64,23.64,23.02,24.42,22.54,,,,,,23.72,,23.82,1.91,-0.17,-0.17,-0.79,0.61,-1.28, , , , , ,-0.10, ,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
5977,Q8NEF9,SRFBP1,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP),AVTIANSPSKPSE,_AVTIANS(ph)PSKPSEK_,S203,+,24.99,25.16,25.86,23.85,24.60,22.70,24.19,22.85,22.35,23.78,21.35,23.02,22.02,23.59,1.40,1.57,2.27,0.26,1.00,-0.90,0.59,-0.74,-1.25,0.19,-2.25,-0.58,-1.57,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5978,Q8NEF9,SRFBP1,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP),KEYFDDSTEERFY,_EYFDDS(ph)TEERFYK_,S264,+,26.98,26.99,26.52,27.83,24.52,26.62,26.55,25.96,27.73,27.69,25.36,26.39,26.78,26.61,0.37,0.38,-0.09,1.22,-2.09,0.01,-0.06,-0.65,1.12,1.08,-1.25,-0.22,0.17,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
5980,Q8NEG4,FAM83F,Protein FAM83F,___MAESQLNCLD,_(ac)AES(ph)QLNCLDEAHVNEK_,S4,,21.30,22.77,22.77,,,,,,,24.27,,,,22.77,-1.48,-0.01,-0.01, , , , , , ,1.49, , , ,,,,,,,,,,,,,,,,
5981,Q8NEJ9,NGDN,Neuroguidin (EIF4E-binding protein),NMMSKLSSEDEEE,_LS(ph)S(ph)EDEEEDEAEDDQSEASGKK_,S142,+,24.49,24.46,,22.77,22.51,,22.60,,25.13,,,,23.69,23.66,0.82,0.79, ,-0.89,-1.15, ,-1.06, ,1.46, , , ,0.02,regulation of translation,filopodium;axon;nucleus;dendrite;cytoplasm,,,,,,,,,,,,,,
5982,Q8NEJ9,NGDN,Neuroguidin (EIF4E-binding protein),MMSKLSSEDEEED,_LS(ph)S(ph)EDEEEDEAEDDQSEASGKK_,S143,+,25.13,,,,25.88,25.13,24.36,24.76,25.08,24.77,,,,25.02,0.11, , , ,0.86,0.12,-0.66,-0.25,0.06,-0.24, , , ,regulation of translation,filopodium;axon;nucleus;dendrite;cytoplasm,,,,,,,,,,,,,,
5984,Q8NEN9,PDZD8,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),AQSLSHSPKRVPT,_DEAQSLSHS(ph)PK_,S521,+,23.56,23.25,23.94,22.86,,,19.95,,20.60,21.32,,22.45,,22.24,1.32,1.01,1.70,0.62, , ,-2.29, ,-1.64,-0.92, ,0.21, ,regulation of cell morphogenesis;cytoskeleton organization;virus-host interaction;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
5985,Q8NEN9,PDZD8,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),KPLGAISPVLNRK,_PLGAIS(ph)PVLNR_,S538,+,24.19,21.41,19.83,23.32,23.94,23.46,25.46,23.13,26.48,26.60,25.34,25.58,24.04,24.06,0.13,-2.65,-4.23,-0.74,-0.12,-0.60,1.40,-0.93,2.42,2.55,1.28,1.52,-0.02,regulation of cell morphogenesis;cytoskeleton organization;virus-host interaction;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
5987,Q8NEV8,EXPH5,Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b) (SlaC2-b) (Slp homolog lacking C2 domains b),RESGAPSPITFTS,_ESGAPS(ph)PITFTSLR_,S1657,,23.01,,,,,22.86,,,,,,,,22.94,0.07, , , , ,-0.07, , , , , , , ,intracellular protein transport;multivesicular body sorting pathway;positive regulation of protein secretion;positive regulation of exocytosis,endosome,,,,,,,,,,,,,,
5988,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),LDSDNISLKSIGS,_AVALDSDNIS(ph)LK_,S754,+,,22.11,22.38,24.80,,23.27,24.89,24.42,24.36,,23.90,24.16,23.76,23.80, ,-1.69,-1.43,1.00, ,-0.54,1.08,0.62,0.56, ,0.09,0.35,-0.05,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
5992,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),TASRRNSTIVLRT,_RNS(ph)TIVLRTDSEK_,S452,,,,,,,,,,,,21.90,24.30,,23.10, , , , , , , , , , ,-1.20,1.20, ,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
5994,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),DSSAPSSPKLQHG,_SASSYSDIEEIATPDSSAPSS(ph)PK_,S1250,,,22.47,,24.00,23.76,25.16,26.10,26.11,,,26.33,25.24,,24.90, ,-2.43, ,-0.90,-1.14,0.27,1.21,1.21, , ,1.43,0.34, ,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
5995,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),SLKSIGSPESTPK,_SIGS(ph)PESTPK_,S760,+,22.41,25.98,26.45,27.72,25.31,24.35,25.26,25.86,24.06,20.74,24.59,24.84,23.27,24.68,-2.27,1.30,1.77,3.04,0.63,-0.33,0.58,1.18,-0.62,-3.94,-0.09,0.16,-1.41,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
5996,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),SNIQYRSLPRPAK,_S(ph)LPRPAK_,S672,+,,24.64,24.41,26.15,21.52,,21.58,22.01,,,,22.99,,23.33, ,1.31,1.08,2.82,-1.81, ,-1.75,-1.32, , , ,-0.34, ,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
5997,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),NLRKQKSLTNLSF,_S(ph)LTNLSFLTDSEK_,S90,,21.92,,,21.79,,,,,,,,22.46,,22.06,-0.13, , ,-0.27, , , , , , , ,0.40, ,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
6000,Q8NEY1,NAV1,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),DKVNSNSLDLPSS,_VNSNS(ph)LDLPSSSDTTHASK_,S808,,,,,25.59,,,,,24.37,,23.58,27.05,23.58,24.83, , , ,0.75, , , , ,-0.46, ,-1.26,2.22,-1.26,microtubule bundle formation;neuron migration,microtubule;cytoplasm,,,,,,,,,,,,,,
6001,Q8NEY8,PPHLN1,Periphilin-1 (Gastric cancer antigen Ga50),NTFFRESPVGRKD,_DNTFFRES(ph)PVGRK_,S133,+,28.21,25.72,24.78,27.06,29.26,29.56,27.47,28.47,27.68,25.51,27.21,27.14,28.84,27.46,0.75,-1.73,-2.68,-0.40,1.81,2.11,0.02,1.02,0.22,-1.95,-0.25,-0.31,1.38,keratinization,nucleus;cytoplasm,,,,,,,,,,,,,,
6002,Q8NEY8,PPHLN1,Periphilin-1 (Gastric cancer antigen Ga50),VSSRSYSPERSKS,_SYS(ph)PER_,S155,+,20.28,24.08,24.82,24.96,20.91,21.05,21.10,20.98,21.65,,19.69,20.70,20.19,21.70,-1.42,2.38,3.12,3.26,-0.79,-0.65,-0.60,-0.72,-0.06, ,-2.02,-1.00,-1.51,keratinization,nucleus;cytoplasm,,,,,,,,,,,,,,
6003,Q8NEZ4,KMT2C,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),QLPEKASPPASPP,_AS(ph)PPAS(ph)PPIAFPPAFEAAQVEAKPDELK_,S4300,,25.57,,,,,,,,,,,,,25.57,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;intracellular signal transduction",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
6004,Q8NEZ4,KMT2C,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),KASPPASPPIAFP,_AS(ph)PPAS(ph)PPIAFPPAFEAAQVEAKPDELK_,S4304,,25.57,,,,,,,,,,,,,25.57,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;intracellular signal transduction",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
6005,Q8NEZ4,KMT2C,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),PPEPVPSPIIPIL,_EEPPEPVPS(ph)PIIPILPSTAGK_,S4034,,25.65,,,,,,,,,,,,,25.65,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;intracellular signal transduction",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
6006,Q8NEZ4,KMT2C,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),TEIKEQSAEEDAE,_EQS(ph)AEEDAEAEVDNSK_,S89,,24.05,24.08,24.08,23.56,,,,,,,,,,23.94,0.11,0.13,0.13,-0.38, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;intracellular signal transduction",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
6007,Q8NEZ4,KMT2C,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),IPSLPQSPMRETP,_ESIPSLPQS(ph)PM(ox)R_,S4267,,22.25,,,,,,,,,,,,,22.25,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;intracellular signal transduction",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
6008,Q8NF91,SYNE1,Nesprin-1 (Enaptin) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),MSRALPSEDEEGQ,_ALPS(ph)EDEEGQDDKDFYLR_,S7915,+,,24.59,24.90,26.60,25.03,26.53,,23.39,,,,,25.65,25.24, ,-0.65,-0.35,1.36,-0.21,1.29, ,-1.85, , , , ,0.41,nuclear matrix anchoring at nuclear membrane;cell death;Golgi organization;muscle cell differentiation;cytoskeletal anchoring at nuclear membrane,Golgi apparatus;nuclear membrane;integral to membrane;SUN-KASH complex;cytoskeleton;sarcomere;postsynaptic membrane;nuclear outer membrane,,,,,,,,,,,,,,
6011,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),APPEAESPLASTS,_ATGPVLISTADFEGPM(ox)PSAPPEAES(ph)PLASTSK_,S2203,,24.12,,,,,,,,,,,,,24.12,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6012,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),DKDVTLSPVKAGP,_DVTLS(ph)PVK_,S1531,+,26.74,26.62,27.13,26.12,22.45,25.08,26.00,24.71,26.35,26.35,23.91,25.29,25.48,25.56,1.18,1.06,1.57,0.57,-3.10,-0.48,0.45,-0.84,0.80,0.79,-1.64,-0.27,-0.07,,,,,,,,,,,,,,,,
6013,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),DKKEQESDEEEEE,_KEQES(ph)DEEEEEEEEDEPSGATTR_,S2986,+,23.85,24.85,,26.14,25.34,25.19,25.69,24.53,27.49,27.05,23.66,24.56,23.49,25.15,-1.31,-0.30, ,0.99,0.19,0.03,0.53,-0.62,2.33,1.90,-1.49,-0.59,-1.66,,,,,,,,,,,,,,,,
6016,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),CENRRGSLSQEMA,_RGS(ph)LSQEM(ox)AK_,S1077,,22.08,,,,,,,,,,,,,22.08,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6017,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),SDDAESSEPERKR,_RSLTVSDDAESS(ph)EPERK_,S2964,,,,,,,22.16,23.04,,23.86,24.77,,22.36,21.89,23.01, , , , , ,-0.85,0.03, ,0.84,1.76, ,-0.65,-1.13,,,,,,,,,,,,,,,,
6019,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),EKSTADSGGEGLE,_STADS(ph)GGEGLETAPK_,S266,,24.61,24.00,,,,,,,23.96,,,,21.94,23.63,0.98,0.37, , , , , , ,0.33, , , ,-1.69,,,,,,,,,,,,,,,,
6020,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),ERKRQKSVSDPVE,_S(ph)VSDPVEDK_,S2973,+,24.32,24.21,24.48,24.65,,,,,22.29,22.75,,21.28,,23.43,0.90,0.79,1.05,1.22, , , , ,-1.14,-0.67, ,-2.15, ,,,,,,,,,,,,,,,,
6021,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),RSKTQLSPSIKRK,_TQLS(ph)PSIK_,S3019,+,24.81,24.93,25.43,24.28,22.01,22.93,23.54,22.30,23.59,23.89,21.77,,,23.59,1.23,1.35,1.84,0.69,-1.58,-0.66,-0.05,-1.29,0.00,0.30,-1.82, , ,,,,,,,,,,,,,,,,
6022,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),LYSKYYSDSDDEL,_YYS(ph)DS(ph)DDELTVEQR_,S482,,24.35,,,,24.81,,,22.69,24.50,,,,,24.09,0.26, , , ,0.73, , ,-1.39,0.41, , , , ,,,,,,,,,,,,,,,,
6023,Q8NFC6,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Protein FAM44A),SKYYSDSDDELTV,_YYS(ph)DS(ph)DDELTVEQR_,S484,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6024,Q8NFD5,ARID1B,AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R),SLENRMSPSKSPF,_SLENRM(ox)S(ph)PSK_,S805,+,21.03,25.06,25.06,21.44,18.79,19.47,20.77,20.21,20.68,19.33,19.62,20.52,,21.00,0.03,4.06,4.06,0.44,-2.21,-1.53,-0.23,-0.79,-0.32,-1.67,-1.38,-0.48, ,"chromatin-mediated maintenance of transcription;transcription, DNA-dependent;nervous system development",SWI/SNF complex,ARID domain,,,,,,,,,,,,,
6028,Q8NFH5,NUP35,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),PLLAGGSPPQPVV,_SPLLAGGS(ph)PPQPVVPAHK_,S56,+,,22.71,22.71,,23.04,22.77,23.80,23.35,22.19,,,,23.44,23.00, ,-0.29,-0.29, ,0.04,-0.24,0.80,0.35,-0.81, , , ,0.44,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear membrane;intermediate filament cytoskeleton;plasma membrane;nuclear pore,,,,,,,,,,,,,,
6029,Q8NFH8,REPS2,RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2),THSRASSLDLNKV,_ASS(ph)LDLNK_,S353,+,23.09,24.42,,25.47,22.35,22.58,22.05,23.44,,,24.34,,22.28,23.33,-0.25,1.08, ,2.14,-0.99,-0.76,-1.28,0.11, , ,1.00, ,-1.05,epidermal growth factor receptor signaling pathway;receptor-mediated endocytosis;protein complex assembly,cytoplasm,,,,,,,,,,,,,,
6030,Q8NFH8,REPS2,RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2),SLIRSFSVERELQ,_SFS(ph)VER_,S120,,25.71,25.39,25.03,26.50,21.76,,23.02,22.74,21.56,,,,,23.96,1.74,1.42,1.07,2.54,-2.20, ,-0.95,-1.23,-2.40, , , , ,epidermal growth factor receptor signaling pathway;receptor-mediated endocytosis;protein complex assembly,cytoplasm,,,,,,,,,,,,,,
6031,Q8NFH8,REPS2,RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2),PRSRSYSSTSIEE,_SYS(ph)STSIEEAM(ox)K_,S323,,,,,,,,22.88,,22.61,,23.79,,,23.09, , , , , , ,-0.21, ,-0.48, ,0.70, , ,epidermal growth factor receptor signaling pathway;receptor-mediated endocytosis;protein complex assembly,cytoplasm,,,,,,,,,,,,,,
6033,Q8NFJ5,GPRC5A,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Orphan G-protein-coupling receptor PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),RAHAWPSPYKDYE,_AHAWPS(ph)PYK_,S345,,22.13,,,,,21.94,24.52,,,,,24.56,,23.29,-1.15, , , , ,-1.35,1.23, , , , ,1.27, ,,cytoplasmic vesicle membrane;Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
6034,Q8NFJ5,GPRC5A,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Orphan G-protein-coupling receptor PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),VENRAYSQEEITQ,_AYS(ph)QEEITQGFEETGDTLYAPYSTHFQLQNQPPQK_,S301,,25.69,,,26.87,,,26.84,,,,28.20,28.55,28.28,27.40,-1.71, , ,-0.53, , ,-0.57, , , ,0.80,1.14,0.87,,cytoplasmic vesicle membrane;Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
6035,Q8NFJ5,GPRC5A,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Orphan G-protein-coupling receptor PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),PPQKEFSIPRAHA,_EFS(ph)IPR_,S336,+,29.13,25.20,24.48,25.51,,24.27,26.31,26.90,22.88,22.28,27.72,28.13,28.96,25.98,3.14,-0.78,-1.50,-0.47, ,-1.71,0.33,0.92,-3.10,-3.70,1.74,2.15,2.98,,cytoplasmic vesicle membrane;Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
6036,Q8NFQ8,TOR1AIP2,Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1),REPQEDSQKDLEN,_(ac)ADSGLREPQEDS(ph)QK_,S13,,23.23,24.16,,,,,,,,,,,,23.69,-0.46,0.46, , , , , , , , , , , ,,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6037,Q8NFQ8,TOR1AIP2,Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1),DPDPSHSPSDKVG,_EPLDPDPSHS(ph)PSDK_,S120,+,22.91,23.90,24.53,24.15,,,25.03,,24.43,24.96,,23.55,,24.18,-1.27,-0.29,0.35,-0.03, , ,0.85, ,0.25,0.78, ,-0.63, ,,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6039,Q8NHG8,ZNRF2,E3 ubiquitin-protein ligase ZNRF2 (EC 6.3.2.-) (Protein Ells2) (RING finger protein 202) (Zinc/RING finger protein 2),RLLVSRSLGGAVG,_S(ph)LGGAVGSVASGAR_,S20,,24.90,24.37,24.70,,,,22.89,22.64,,22.61,,23.87,,23.71,1.19,0.66,0.99, , , ,-0.82,-1.07, ,-1.10, ,0.16, ,protein ubiquitination,endosome membrane;cell junction;plasma membrane;lysosomal membrane;presynaptic membrane,,,,,,,,,,,,,,
6040,Q8NHJ6,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4 (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3) (ILT-3) (Leukocyte immunoglobulin-like receptor 5) (LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k),EMASPPSPLSGEF,_REM(ox)ASPPS(ph)PLSGEFLDTK_,S378,,,24.63,25.15,,21.53,,,,,,22.70,,,23.50, ,1.13,1.65, ,-1.97, , , , , ,-0.80, , ,signal transduction;negative regulation of osteoclast differentiation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
6044,Q8NHM5,KDM2B,Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B),NQQPIKSEPESEG,_TENSLANENQQPIKS(ph)EPES(ph)EGEEPK_,S906,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,"fourth ventricle development;lateral ventricle development;third ventricle development;initiation of neural tube closure;midbrain-hindbrain boundary morphogenesis;spermatogenesis;histone H3-K36 demethylation;negative regulation of transcription from RNA polymerase II promoter;histone H2A monoubiquitination;negative regulation of neural precursor cell proliferation;embryonic camera-type eye morphogenesis;transcription, DNA-dependent;negative regulation of neuron apoptotic process;midbrain development",nucleolus;nucleus,,,,,,,,,,,,,,
6045,Q8NHM5,KDM2B,Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B),IKSEPESEGEEPK,_TENSLANENQQPIKS(ph)EPES(ph)EGEEPK_,S910,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,"fourth ventricle development;lateral ventricle development;third ventricle development;initiation of neural tube closure;midbrain-hindbrain boundary morphogenesis;spermatogenesis;histone H3-K36 demethylation;negative regulation of transcription from RNA polymerase II promoter;histone H2A monoubiquitination;negative regulation of neural precursor cell proliferation;embryonic camera-type eye morphogenesis;transcription, DNA-dependent;negative regulation of neuron apoptotic process;midbrain development",nucleolus;nucleus,,,,,,,,,,,,,,
6046,Q8NHM5,KDM2B,Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B),PKTPTGSPATEVS,_TPTGS(ph)PATEVSAK_,S466,,22.07,24.05,24.05,21.87,,,,,,,,,,23.01,-0.94,1.04,1.04,-1.14, , , , , , , , , ,"fourth ventricle development;lateral ventricle development;third ventricle development;initiation of neural tube closure;midbrain-hindbrain boundary morphogenesis;spermatogenesis;histone H3-K36 demethylation;negative regulation of transcription from RNA polymerase II promoter;histone H2A monoubiquitination;negative regulation of neural precursor cell proliferation;embryonic camera-type eye morphogenesis;transcription, DNA-dependent;negative regulation of neuron apoptotic process;midbrain development",nucleolus;nucleus,,,,,,,,,,,,,,
6047,Q8NHP6,MOSPD2,Motile sperm domain-containing protein 2,ETLETISNEEQTP,_ETLETIS(ph)NEEQTPLLK_,S283,,20.31,22.14,22.14,,,,23.02,,23.31,24.02,,23.49,,22.63,-2.32,-0.49,-0.49, , , ,0.39, ,0.68,1.39, ,0.86, ,,integral to membrane,,,,,,,,,,,,,,
6049,Q8NHQ8,RASSF8,Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1),APFQSGSLKRPGS,_EAPFQSGS(ph)LK_,S387,,,,,24.36,,,,,,,,23.48,,23.92, , , ,0.44, , , , , , , ,-0.44, ,signal transduction,,,,,,,,,,,,,,,
6051,Q8NHQ9,DDX55,ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55),RKREEGSDIEDED,_KREEGS(ph)DIEDEDM(ox)EELLNDTR_,S513,,26.45,,,,25.18,,,,,,,,,25.81,0.64, , , ,-0.64, , , , , , , , ,,,,,,,,,,,,,,,,
6052,Q8NI08,NCOA7,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),IKDALPSPGEWED,_DALPS(ph)PGEWEDLASEK_,S295,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;cell wall macromolecule catabolic process",nucleus;intracellular,,,,,,,,,,,,,,
6053,Q8NI08,NCOA7,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),TLKECLSLDPEER,_ECLS(ph)LDPEER_,S430,,21.86,,,,,,,,,,,,,21.86,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;cell wall macromolecule catabolic process",nucleus;intracellular,,,,,,,,,,,,,,
6056,Q8NI08,NCOA7,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),PIERVLSSTSEED,_VLS(ph)STSEEDEPGVVK_,S208,,26.38,,,,,,,,,,,23.06,,24.72,1.66, , , , , , , , , , ,-1.66, ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;cell wall macromolecule catabolic process",nucleus;intracellular,,,,,,,,,,,,,,
6057,Q8NI08,NCOA7,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),RVLSSTSEEDEPG,_VLS(ph)STS(ph)EEDEPGVVK_,S211,,26.71,24.50,24.19,25.65,25.35,26.15,26.13,25.51,25.28,,24.08,25.36,23.97,25.24,1.47,-0.74,-1.05,0.41,0.11,0.91,0.89,0.27,0.04, ,-1.16,0.12,-1.27,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;cell wall macromolecule catabolic process",nucleus;intracellular,,,,,,,,,,,,,,
6058,Q8NI27,THOC2,THO complex subunit 2 (Tho2) (hTREX120),KIDTHPSPSHSST,_IDTHPS(ph)PSHSSTVK_,S1417,+,22.45,24.36,,23.47,,,21.67,21.69,21.97,21.88,,,,22.50,-0.05,1.86, ,0.97, , ,-0.83,-0.81,-0.53,-0.61, , , ,mRNA processing;RNA splicing;intronless viral mRNA export from host nucleus,THO complex part of transcription export complex,,,,,,,,,,,,,,
6059,Q8NI27,THOC2,THO complex subunit 2 (Tho2) (hTREX120),VSGSLKSPVPRSD,_S(ph)PVPRSDIPEPEREQK_,S1393,,,,,,,,,,,25.14,,22.72,,23.93, , , , , , , , , ,1.21, ,-1.21, ,mRNA processing;RNA splicing;intronless viral mRNA export from host nucleus,THO complex part of transcription export complex,,,,,,,,,,,,,,
6060,Q8NI35,INADL,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),KALTDDSDENEEE,_ALTDDS(ph)DENEEEDAFTDQK_,S1212,+,26.88,,,,25.86,24.11,24.10,23.05,22.53,28.59,23.50,24.78,24.75,24.82,2.06, , , ,1.05,-0.71,-0.71,-1.77,-2.29,3.78,-1.31,-0.03,-0.07,tight junction assembly;intracellular signal transduction,tight junction;apical plasma membrane;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6061,Q8NI35,INADL,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),LEKVPDSPENELK,_VPDS(ph)PENELK_,S522,+,26.39,24.90,25.71,22.79,24.73,23.61,23.35,25.90,23.30,27.65,25.54,25.08,25.24,24.94,1.46,-0.04,0.77,-2.15,-0.20,-1.33,-1.59,0.96,-1.64,2.71,0.60,0.14,0.30,tight junction assembly;intracellular signal transduction,tight junction;apical plasma membrane;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6062,Q8NI35,INADL,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),LFDDEASVDEPRR,_RLFDDEAS(ph)VDEPR_,S645,+,26.53,23.07,22.75,,25.44,25.46,25.14,25.93,22.14,25.99,25.44,25.73,25.66,24.94,1.59,-1.87,-2.19, ,0.50,0.52,0.20,0.99,-2.80,1.05,0.50,0.79,0.72,tight junction assembly;intracellular signal transduction,tight junction;apical plasma membrane;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6063,Q8NI35,INADL,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),QLPESESFKLAVS,_(gl)QLPESES(ph)FK_,S1372,,23.70,,,,,,,,,23.61,,,,23.65,0.04, , , , , , , , ,-0.04, , , ,tight junction assembly;intracellular signal transduction,tight junction;apical plasma membrane;plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6065,Q8TAD7,OCC1,Overexpressed in colon carcinoma 1 protein (OCC-1) (AGD3),KDVTEESVTEDDK,_DVTEES(ph)VTEDDK_,S28,,22.62,23.88,23.61,24.13,,24.25,23.98,21.65,25.59,26.42,,,23.91,24.00,-1.39,-0.12,-0.40,0.13, ,0.25,-0.03,-2.35,1.58,2.42, , ,-0.09,,,,,,,,,,,,,,,,
6066,Q8TAD8,SNIP1,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),VKQERLSPEVAPP,_QERLS(ph)PEVAPPAHR_,S35,+,25.11,26.00,21.98,25.76,26.32,27.80,25.87,26.52,25.80,23.03,26.09,25.43,26.67,25.57,-0.46,0.43,-3.59,0.19,0.75,2.23,0.30,0.95,0.23,-2.53,0.53,-0.14,1.11,"production of miRNAs involved in gene silencing by miRNA;regulation of transcription, DNA-dependent;I-kappaB kinase/NF-kappaB cascade",nucleus;cytoplasm,,,,,,,,,,,,,,
6068,Q8TAD8,SNIP1,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),HSGGSPSPPTSEP,_RPDHSGGS(ph)PS(ph)PPTSEPAR_,S54,,23.48,24.60,,23.56,23.12,,,,21.02,,,,,23.16,0.32,1.44, ,0.41,-0.03, , , ,-2.14, , , , ,"production of miRNAs involved in gene silencing by miRNA;regulation of transcription, DNA-dependent;I-kappaB kinase/NF-kappaB cascade",nucleus;cytoplasm,,,,,,,,,,,,,,
6071,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),KDMDEPSPVPNVE,_DM(ox)DEPS(ph)PVPNVEEVTLPK_,S347,+,29.63,26.53,26.87,26.54,27.55,28.72,28.50,28.20,29.94,29.16,27.76,28.25,29.25,28.22,1.41,-1.70,-1.35,-1.68,-0.68,0.50,0.27,-0.02,1.72,0.93,-0.46,0.03,1.02,"positive regulation of transcription, DNA-dependent;nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;chromatin remodeling;nervous system development",SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6073,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),YKKRKRSPSPSPT,_KRS(ph)PS(ph)PSPTPEAK_,S302,,24.34,24.76,23.32,24.46,23.00,,,,,,,,,23.98,0.37,0.79,-0.65,0.48,-0.98, , , , , , , , ,"positive regulation of transcription, DNA-dependent;nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;chromatin remodeling;nervous system development",SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6074,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),KRKRSPSPSPTPE,_KRS(ph)PS(ph)PSPTPEAK_,S304,,23.90,23.99,22.42,23.78,21.95,,,,,,,,,23.21,0.69,0.78,-0.79,0.58,-1.26, , , , , , , , ,"positive regulation of transcription, DNA-dependent;nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;chromatin remodeling;nervous system development",SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6076,Q8TAQ2,SMARCC2,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),EKESEKSDGDPIV,_S(ph)DGDPIVDPEK_,S813,+,27.72,27.44,27.95,25.27,21.95,,24.95,20.83,25.76,26.34,23.42,24.77,,25.13,2.60,2.31,2.82,0.14,-3.18, ,-0.18,-4.29,0.63,1.22,-1.71,-0.36, ,"positive regulation of transcription, DNA-dependent;nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;chromatin remodeling;nervous system development",SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6079,Q8TB45,DEPTOR,DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6),DNRKSTSFMSVSP,_STS(ph)FM(ox)SVSPSK_,S260,,25.52,,,,,,,21.19,,,,,,23.35,2.17, , , , , , ,-2.17, , , , , ,negative regulation of cell size;negative regulation of TOR signaling cascade;negative regulation of protein kinase activity;regulation of apoptotic process;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
6080,Q8TB45,DEPTOR,DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6),TSFMSVSPSKEIK,_STSFM(ox)SVS(ph)PSK_,S265,+,25.43,24.32,24.32,23.65,,22.98,,23.36,,,,22.46,,23.79,1.64,0.53,0.53,-0.14, ,-0.81, ,-0.43, , , ,-1.34, ,negative regulation of cell size;negative regulation of TOR signaling cascade;negative regulation of protein kinase activity;regulation of apoptotic process;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
6081,Q8TB61,SLC35B2,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2),KAVPVESPVQKV_,_KAVPVES(ph)PVQKV_,S378,+,24.73,26.30,27.07,26.44,27.81,27.16,27.01,26.96,26.62,29.48,26.47,26.98,27.22,26.94,-2.22,-0.64,0.13,-0.50,0.87,0.22,0.07,0.02,-0.32,2.54,-0.47,0.03,0.27,positive regulation of I-kappaB kinase/NF-kappaB cascade;3'-phosphoadenosine 5'-phosphosulfate transport,integral to membrane;Golgi membrane,,,,,,,,,,,,,,
6082,Q8TB72,PUM2,Pumilio homolog 2 (Pumilio-2),DQKGKASPFEEDQ,_GKAS(ph)PFEEDQNRDLK_,S80,+,24.74,25.93,25.95,23.77,23.48,24.07,26.13,24.29,26.40,26.49,24.90,24.49,23.62,24.94,-0.20,0.99,1.00,-1.17,-1.46,-0.87,1.19,-0.65,1.45,1.54,-0.04,-0.45,-1.32,stress granule assembly;regulation of translation,cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6083,Q8TB72,PUM2,Pumilio homolog 2 (Pumilio-2),PGSRQASPTEVVE,_QAS(ph)PTEVVER_,S126,+,27.74,26.73,26.44,25.56,26.38,26.85,26.75,27.24,26.70,25.80,26.05,24.78,26.00,26.39,1.35,0.34,0.06,-0.82,-0.01,0.46,0.37,0.85,0.31,-0.59,-0.33,-1.61,-0.39,stress granule assembly;regulation of translation,cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6084,Q8TB72,PUM2,Pumilio homolog 2 (Pumilio-2),SATRRESLSTSSD,_RES(ph)LSTSSDLYK_,S531,,24.83,21.83,21.83,23.29,,,22.15,,22.58,,,23.71,,22.89,1.94,-1.06,-1.06,0.40, , ,-0.73, ,-0.31, , ,0.82, ,stress granule assembly;regulation of translation,cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6085,Q8TB72,PUM2,Pumilio homolog 2 (Pumilio-2),FNRTPGSRQASPT,_TPGS(ph)RQAS(ph)PTEVVER_,S122,,22.42,22.83,22.83,21.95,,,,,,,,,,22.51,-0.09,0.32,0.32,-0.56, , , , , , , , , ,stress granule assembly;regulation of translation,cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6086,Q8TBA6,GOLGA5,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),FVRRKKSEPDDEL,_S(ph)EPDDELLFDFLNSSQK_,S116,,23.98,,,,,,,,,,,,,23.98,0.00, , , , , , , , , , , , ,"Golgi vesicle transport;retrograde transport, vesicle recycling within Golgi;Golgi organization",integral to membrane;COPI-coated vesicle membrane;Golgi cisterna;Golgi trans cisterna;Golgi cis cisterna;cis-Golgi network;Golgi medial cisterna,,,,,,,,,,,,,,
6090,Q8TBZ3,WDR20,WD repeat-containing protein 20 (Protein DMR),PLPRSNSLPHSAV,_SNS(ph)LPHSAVSNAGSK_,S177,+,24.64,25.16,25.71,24.91,23.35,22.03,24.69,24.10,24.04,23.91,23.61,24.40,,24.21,0.43,0.94,1.50,0.69,-0.86,-2.18,0.48,-0.11,-0.17,-0.30,-0.60,0.19, ,,,,,,,,,,,,,,,,
6092,Q8TC07,TBC1D15,TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP),LYARKDSSSVVEW,_KDS(ph)SSVVEWTQAPK_,S70,,24.01,21.76,21.88,,,,,,21.69,,,22.57,,22.38,1.63,-0.62,-0.50, , , , , ,-0.69, , ,0.19, ,,mitochondrion;extracellular region;cytoplasm,,,,,,,,,,,,,,
6093,Q8TCJ2,STT3B,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),NPPVEDSSDEDDK,_ENPPVEDS(ph)S(ph)DEDDKRNQGNLYDK_,S498,+,26.52,27.35,27.42,27.55,27.80,28.57,26.40,28.47,27.66,26.75,25.73,25.26,27.58,27.16,-0.63,0.19,0.26,0.39,0.64,1.41,-0.76,1.31,0.50,-0.41,-1.43,-1.90,0.42,ER-associated protein catabolic process;glycoprotein catabolic process;response to unfolded protein;protein N-linked glycosylation via asparagine;post-translational protein modification;co-translational protein modification,oligosaccharyltransferase complex;integral to membrane,,,,,,,,,,,,,,
6094,Q8TCJ2,STT3B,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),PPVEDSSDEDDKR,_ENPPVEDS(ph)S(ph)DEDDKRNQGNLYDK_,S499,+,27.11,27.31,27.70,28.09,25.76,22.17,25.31,,27.30,27.43,24.98,26.26,22.22,25.97,1.14,1.34,1.73,2.12,-0.21,-3.80,-0.66, ,1.33,1.46,-0.99,0.29,-3.75,ER-associated protein catabolic process;glycoprotein catabolic process;response to unfolded protein;protein N-linked glycosylation via asparagine;post-translational protein modification;co-translational protein modification,oligosaccharyltransferase complex;integral to membrane,,,,,,,,,,,,,,
6095,Q8TCJ2,STT3B,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),LMALGNSRHGHHG,_SSLNSSPWSGLM(ox)ALGNS(ph)R_,S29,,26.68,,,23.04,,,,,,,,,,24.86,1.82, , ,-1.82, , , , , , , , , ,ER-associated protein catabolic process;glycoprotein catabolic process;response to unfolded protein;protein N-linked glycosylation via asparagine;post-translational protein modification;co-translational protein modification,oligosaccharyltransferase complex;integral to membrane,,,,,,,,,,,,,,
6096,Q8TCN5,ZNF507,Zinc finger protein 507,NENEKLSPTSNTS,_LS(ph)PTSNTSYSLEK_,S884,,22.39,20.54,20.54,21.72,,22.09,22.46,22.10,21.88,22.32,23.66,24.32,,22.18,0.21,-1.65,-1.65,-0.46, ,-0.09,0.28,-0.09,-0.30,0.14,1.48,2.13, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6097,Q8TCT9,HM13,Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase),FPTVSGSPASLAD,_LTHFPTVSGS(ph)PASLADSM(ox)QQK_,S368,,21.58,23.62,23.62,21.06,,22.93,,22.63,,24.27,,,23.48,22.90,-1.32,0.72,0.72,-1.84, ,0.03, ,-0.27, ,1.37, , ,0.58,membrane protein proteolysis,rough endoplasmic reticulum;integral to lumenal side of endoplasmic reticulum membrane;plasma membrane;integral to cytosolic side of endoplasmic reticulum membrane;cell surface,,,,,,,,,,,,,,
6098,Q8TCY9,URGCP,Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein),____MASPGHSDL,_(ac)AS(ph)PGHSDLGEVAPEIK_,S3,,21.47,23.71,23.71,23.22,23.65,,24.11,24.38,22.38,,,25.06,22.86,23.46,-1.99,0.25,0.25,-0.23,0.20, ,0.65,0.93,-1.07, , ,1.61,-0.59,cell cycle,nucleus;cytoplasm,,,,,,,,,,,,,,
6100,Q8TD16,BICD2,Protein bicaudal D homolog 2 (Bic-D 2),SPGGRTSPEARGR,_EGQGGAGRT(ph)SPGGRTS(ph)PEAR_,S574,+,23.93,26.39,26.93,26.88,23.22,,21.18,22.45,21.43,,,,,24.05,-0.12,2.33,2.88,2.83,-0.83, ,-2.87,-1.60,-2.62, , , , ,microtubule anchoring at microtubule organizing center;minus-end-directed organelle transport along microtubule,cytoplasmic vesicle;Golgi apparatus;plasma membrane;cytoskeleton,,,,,,,,,,,,,,
6105,Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L (EC 6.3.2.-) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (Rhysin-2) (Rhysin2),SHLRPPSPLLVRV,_(ac)ASHLRPPS(ph)PLLVR_,S9,+,25.28,26.20,26.74,26.20,26.00,25.48,26.26,26.93,24.71,26.21,26.49,26.12,25.97,26.05,-0.76,0.15,0.69,0.16,-0.04,-0.56,0.22,0.89,-1.33,0.16,0.44,0.07,-0.08,histone monoubiquitination;response to DNA damage stimulus,nucleus;cytoplasm,,,,,,,,,,,,,,
6106,Q8TDB6,DTX3L,E3 ubiquitin-protein ligase DTX3L (EC 6.3.2.-) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (Rhysin-2) (Rhysin2),ERDSCISPSEPET,_DSCIS(ph)PSEPETK_,S221,,,23.91,23.91,23.52,,,,,,,,,,23.78, ,0.13,0.13,-0.26, , , , , , , , , ,histone monoubiquitination;response to DNA damage stimulus,nucleus;cytoplasm,,,,,,,,,,,,,,
6109,Q8TDD1,DDX54,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54),KIDDRDSDEEGAS,_(gl)QKIDDRDS(ph)DEEGASDR_,S782,+,27.38,27.76,26.06,28.76,27.94,28.16,27.03,26.36,27.10,25.58,25.86,26.26,24.90,26.86,0.53,0.90,-0.80,1.91,1.08,1.30,0.17,-0.50,0.24,-1.28,-1.00,-0.59,-1.95,"intracellular estrogen receptor signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nucleolus,,,,,,,,,,,,,,
6110,Q8TDI0,CHD5,Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.12) (ATP-dependent helicase CHD5),TEKAPPSPEQLPR,_APPS(ph)PEQLPREEVLPEK_,S1631,,,,,,,,23.76,,,,,24.69,22.94,23.80, , , , , , ,-0.04, , , , ,0.89,-0.85,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,Other TF domain,,,,,,,,,,,,,
6113,Q8TDM6,DLG5,Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG),SSARLGSSSNLQF,_LGS(ph)SSNLQFK_,S923,+,23.38,,,23.80,22.87,24.16,23.46,23.56,25.05,,22.47,22.14,23.90,23.48,-0.10, , ,0.33,-0.61,0.68,-0.02,0.08,1.57, ,-1.01,-1.34,0.42,negative regulation of cell proliferation;cell-cell adhesion;regulation of apoptotic process;intracellular signal transduction,plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,,,,,
6114,Q8TDM6,DLG5,Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG),RNLLQQSWEDMKR,_NLLQQS(ph)WEDMKR_,S264,+,23.27,21.39,,,22.99,25.73,,24.52,24.51,23.12,22.91,23.40,,23.54,-0.26,-2.15, , ,-0.55,2.19, ,0.98,0.97,-0.42,-0.63,-0.13, ,negative regulation of cell proliferation;cell-cell adhesion;regulation of apoptotic process;intracellular signal transduction,plasma membrane;cell-cell adherens junction;cytoplasm,,,,,,,,,,,,,,
6116,Q8TDN4,CABLES1,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),LISQRSSLETLED,_SS(ph)LETLEDIEENAPLRR_,S26,,22.85,,,,,,,,,,,,,22.85,0.00, , , , , , , , , , , , ,regulation of cell cycle;blood coagulation;regulation of cell division;cell cycle;cell division;nervous system development,cytosol;nucleus,,,,,,,,,,,,,,
6117,Q8TDR0,TRAF3IP1,TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Microtubule-interacting protein associated with TRAF3) (MIP-T3),VEGDSTSDAEGDA,_NSVEGDSTS(ph)DAEGDAGPAGQDK_,S359,,22.69,23.16,23.01,23.42,,,23.13,,23.36,,22.88,22.62,22.04,22.92,-0.24,0.24,0.09,0.50, , ,0.21, ,0.44, ,-0.05,-0.30,-0.88,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6118,Q8TDY2,RB1CC1,RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200),CLGRLDSLPEHED,_LDS(ph)LPEHEDSEK_,S222,,24.49,25.51,,24.19,,,23.12,,,,,23.83,,24.23,0.26,1.28, ,-0.04, , ,-1.11, , , , ,-0.40, ,"regulation of autophagy;negative regulation of apoptotic process;JNK cascade;regulation of transcription, DNA-dependent;liver development;autophagic vacuole assembly;positive regulation of protein phosphorylation;positive regulation of cell size;transcription, DNA-dependent;cell cycle;heart development",pre-autophagosomal structure membrane;cytosol;ULK1-ATG13-FIP200 complex;nucleus,,,,,,,,,,,,,,
6120,Q8TDY2,RB1CC1,RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200),RQKLVSSQEQDRE,_LVSS(ph)QEQDREQLIQK_,S1222,,,,,,,23.48,21.76,,,,,,22.15,22.46, , , , , ,1.02,-0.71, , , , , ,-0.31,"regulation of autophagy;negative regulation of apoptotic process;JNK cascade;regulation of transcription, DNA-dependent;liver development;autophagic vacuole assembly;positive regulation of protein phosphorylation;positive regulation of cell size;transcription, DNA-dependent;cell cycle;heart development",pre-autophagosomal structure membrane;cytosol;ULK1-ATG13-FIP200 complex;nucleus,,,,,,,,,,,,,,
6122,Q8TDY2,RB1CC1,RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200),NESLLTSFPKSVE,_TTNESLLTS(ph)FPK_,S257,,21.46,,,21.82,,,,,,,,,,21.64,-0.18, , ,0.18, , , , , , , , , ,"regulation of autophagy;negative regulation of apoptotic process;JNK cascade;regulation of transcription, DNA-dependent;liver development;autophagic vacuole assembly;positive regulation of protein phosphorylation;positive regulation of cell size;transcription, DNA-dependent;cell cycle;heart development",pre-autophagosomal structure membrane;cytosol;ULK1-ATG13-FIP200 complex;nucleus,,,,,,,,,,,,,,
6123,Q8TDZ2,MICAL1,Protein-methionine sulfoxide oxidase MICAL1 (EC 1.14.13.-) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains),RQIRLSSPERQRL,_LSS(ph)PERQR_,S810,+,19.86,24.17,24.75,25.96,20.64,20.69,,21.86,21.08,17.93,22.54,,,21.95,-2.09,2.22,2.81,4.01,-1.31,-1.26, ,-0.09,-0.87,-4.02,0.59, , ,negative regulation of apoptotic process;actin filament depolymerization;signal transduction;negative regulation of protein phosphorylation;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,intermediate filament;cytoplasm,,,,,,,,,,,,,,
6127,Q8TE68,EPS8L1,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),SVRAVISTVERGA,_AVIS(ph)TVER_,S137,,22.95,,,,,,,,,,,21.71,,22.33,0.62, , , , , , , , , , ,-0.62, ,,cytoplasm,,,,,,,,,,,,,,
6128,Q8TE68,EPS8L1,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),ELQRDRSPAAETP,_DRS(ph)PAAET(ph)PPLQR_,S118,+,27.08,24.68,,21.35,,,,22.96,24.36,23.92,,,22.76,23.87,3.20,0.81, ,-2.52, , , ,-0.91,0.49,0.05, , ,-1.11,,cytoplasm,,,,,,,,,,,,,,
6131,Q8TE77,SSH3,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),LVTVSRSPPGSGA,_S(ph)PPGSGASTPVGPWDQAVQR_,S9,+,26.49,26.78,,26.70,,25.74,25.65,27.30,24.98,22.52,23.35,26.31,,25.58,0.91,1.20, ,1.12, ,0.16,0.07,1.72,-0.60,-3.06,-2.23,0.73, ,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
6132,Q8TE77,SSH3,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),FGQGSQSPQKQEE,_APSEEELHGDQTDFGQGSQS(ph)PQK_,S87,,23.65,24.25,24.25,,,,25.03,,23.72,,22.63,,,23.92,-0.27,0.33,0.33, , , ,1.11, ,-0.20, ,-1.29, , ,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
6133,Q8TE77,SSH3,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),KVVRQASVHDSGE,_VVRQAS(ph)VHDS(ph)GEEGEA_,S649,+,22.85,27.57,28.54,24.15,24.32,24.62,26.69,26.37,25.45,22.98,25.17,27.13,23.19,25.31,-2.46,2.26,3.23,-1.16,-0.99,-0.69,1.38,1.06,0.14,-2.33,-0.14,1.82,-2.12,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
6135,Q8TE77,SSH3,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),RLQRRQSFAVLRG,_RQS(ph)FAVLR_,S37,,23.27,,,22.31,,,22.22,,,,,25.44,,23.31,-0.04, , ,-1.00, , ,-1.09, , , , ,2.13, ,regulation of actin polymerization or depolymerization;regulation of axonogenesis;regulation of lamellipodium assembly;peptidyl-tyrosine dephosphorylation,nucleus;cytoskeleton;cytoplasm,,,+,,,,,,,,,,,
6136,Q8TEA8,DTD1,D-tyrosyl-tRNA(Tyr) deacylase 1 (EC 3.1.-.-) (Histidyl-tRNA synthase-related),KEDRSASSGAEGD,_SAS(ph)S(ph)GAEGDVSSEREP_,S196,+,28.33,27.73,,23.46,26.89,27.08,28.03,28.56,26.53,,,,,27.08,1.25,0.66, ,-3.62,-0.19,0.01,0.96,1.48,-0.55, , , , ,D-amino acid catabolic process,nucleolus;cytoplasm,,,,,,,,,,,,,,
6137,Q8TEA8,DTD1,D-tyrosyl-tRNA(Tyr) deacylase 1 (EC 3.1.-.-) (Histidyl-tRNA synthase-related),EDRSASSGAEGDV,_SASS(ph)GAEGDVSSEREP_,S197,+,24.38,25.05,25.92,28.88,,,25.97,,23.28,25.76,27.67,27.59,26.27,26.08,-1.69,-1.03,-0.16,2.80, , ,-0.11, ,-2.79,-0.31,1.60,1.51,0.19,D-amino acid catabolic process,nucleolus;cytoplasm,,,,,,,,,,,,,,
6140,Q8TEH3,DENND1A,DENN domain-containing protein 1A (Connecdenn 1) (Connecdenn) (Protein FAM31A),PLGQAKSLEDLRA,_S(ph)LEDLRAPK_,S455,+,24.97,27.05,27.00,26.46,25.06,25.79,26.03,25.99,24.71,25.54,25.47,25.83,25.13,25.77,-0.80,1.28,1.23,0.68,-0.71,0.02,0.26,0.22,-1.06,-0.23,-0.30,0.06,-0.64,endocytosis;protein transport;synaptic vesicle endocytosis,neuronal cell body;cell junction;plasma membrane;presynaptic membrane;dendrite;clathrin-coated vesicle;clathrin-coated vesicle membrane,,,,,,,,,,,,,,
6141,Q8TEK3,DOT1L,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",KWKSTFSPISDIG,_STFS(ph)PISDIGLAK_,S1246,,20.09,,,,,,,,21.36,22.63,,,,21.36,-1.27, , , , , , , ,0.00,1.27, , , ,regulation of transcription regulatory region DNA binding;regulation of JAK-STAT cascade,nucleus,,,,,,,,,,,,,,
6142,Q8TEK3,DOT1L,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",ADAPMDSGAEEEK,_VAGPADAPM(ox)DS(ph)GAEEEK_,S374,,24.86,25.60,25.60,,22.12,,24.43,,,25.62,,,,24.70,0.15,0.89,0.89, ,-2.58, ,-0.27, , ,0.92, , , ,regulation of transcription regulatory region DNA binding;regulation of JAK-STAT cascade,nucleus,,,,,,,,,,,,,,
6144,Q8TEQ0,SNX29,Sorting nexin-29 (RUN domain-containing protein 2A),QKLDVKSIDDEDV,_S(ph)IDDEDVDENEDDVYGNSSGRK_,S344,,,22.65,22.65,,,,22.94,,23.13,,,,,22.84, ,-0.19,-0.19, , , ,0.10, ,0.29, , , , ,cell communication,,,,,,,,,,,,,,,
6145,Q8TEQ6,GEMIN5,Gem-associated protein 5 (Gemin5),TPVKLESIDGNEE,_LES(ph)IDGNEEESM(ox)K_,S756,+,24.90,24.18,24.25,22.85,,,23.77,,,25.26,22.44,23.21,,23.86,1.04,0.32,0.40,-1.01, , ,-0.09, , ,1.40,-1.41,-0.65, ,ncRNA metabolic process;protein complex assembly;spliceosomal snRNP assembly,cytosol;nuclear body;Cajal body;spliceosomal complex,,,,,,,,,,,,,,
6146,Q8TER5,ARHGEF40,Rho guanine nucleotide exchange factor 40 (Protein SOLO),GDSAPLSPGDKED,_GGDSAPLS(ph)PGDK_,S401,,22.66,,,,,,,,,,,,,22.66,0.00, , , , , , , , , , , , ,regulation of Rho protein signal transduction,cytoplasm,,,,,,,,,,,,,,
6147,Q8TER5,ARHGEF40,Rho guanine nucleotide exchange factor 40 (Protein SOLO),DSSGDVSPGPRNS,_QISLAPETLDSSGDVS(ph)PGPR_,S1474,,22.27,,,,,,,,,,,,,22.27,0.00, , , , , , , , , , , , ,regulation of Rho protein signal transduction,cytoplasm,,,,,,,,,,,,,,
6150,Q8TEV9,SMCR8,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,VLSKSDSQASLTV,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_,S489,,22.10,,,,,,,,,,,,,22.10,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
6151,Q8TEV9,SMCR8,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,KSDSQASLTVPLS,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_,S492,,22.10,,,,,,,,,,,,,22.10,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
6152,Q8TEV9,SMCR8,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,SLTVPLSPQVVRS,_SDS(ph)QAS(ph)LTVPLS(ph)PQVVR_,S498,,22.10,,,,,,,,,,,,,22.10,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
6153,Q8TEV9,SMCR8,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,VLISVGSYKSSVE,_VLISVGS(ph)YK_,S417,+,22.66,23.59,24.03,23.19,23.53,23.98,24.21,23.93,24.06,23.20,24.32,23.77,24.52,23.77,-1.11,-0.18,0.26,-0.57,-0.24,0.21,0.44,0.16,0.29,-0.57,0.56,0.00,0.75,,nucleus,,,,,,,,,,,,,,
6154,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),DDQKAGSPSRDVG,_AGS(ph)PSRDVGPSLGLK_,S870,+,21.62,22.99,22.99,23.25,,22.61,26.10,22.57,23.99,26.76,23.13,25.28,23.60,23.74,-2.12,-0.75,-0.75,-0.49, ,-1.13,2.35,-1.17,0.25,3.02,-0.62,1.54,-0.14,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6156,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),SDQPSHSLERQMN,_ESVSTASDQPSHS(ph)LER_,S970,,21.85,22.73,,23.97,25.53,24.43,25.40,25.36,24.47,25.00,23.24,24.13,24.41,24.21,-2.36,-1.48, ,-0.24,1.32,0.22,1.19,1.15,0.26,0.79,-0.97,-0.08,0.20,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6157,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),YYSSRFSPDSQYI,_FS(ph)PDSQYIDNR_,S383,+,23.47,,,22.73,24.73,24.55,24.54,22.05,25.84,24.54,23.90,,,24.04,-0.57, , ,-1.31,0.70,0.51,0.50,-1.99,1.80,0.50,-0.14, , ,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6161,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),KNNYYSSRFSPDS,_NNYYSS(ph)RFSPDSQYIDNR_,S380,+,21.96,23.44,23.44,,25.07,,25.53,25.44,,25.45,24.84,,,24.40,-2.44,-0.95,-0.95, ,0.67, ,1.13,1.05, ,1.05,0.44, , ,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6164,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),KTRKSKSMDLGIA,_S(ph)M(ox)DLGIADETK_,S849,+,25.29,24.74,24.81,25.45,21.98,25.03,26.67,24.91,25.42,25.98,,25.10,23.40,24.90,0.39,-0.15,-0.08,0.55,-2.92,0.13,1.77,0.01,0.52,1.08, ,0.20,-1.49,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6166,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),ELKSPGSPPGPEL,_SPGS(ph)PPGPELPIETALDDRER_,S695,+,25.80,23.87,23.87,,25.25,24.55,26.62,26.14,25.27,27.71,26.17,25.44,25.26,25.49,0.30,-1.63,-1.63, ,-0.25,-0.95,1.12,0.65,-0.22,2.21,0.68,-0.06,-0.23,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
6169,Q8TEW8,PARD3B,Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein),GLKKSSSLESLQT,_SSS(ph)LESLQTAVAEVR_,S746,+,23.03,20.98,,21.20,,,22.90,,23.36,24.74,,22.65,,22.70,0.33,-1.71, ,-1.49, , ,0.20, ,0.67,2.05, ,-0.04, ,cell cycle;cell division,tight junction;endomembrane system;membrane,,,,,,,,,,,,,,
6170,Q8TEW8,PARD3B,Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein),NLKASKSMDLVPD,_S(ph)M(ox)DLVPDESK_,S710,,21.23,23.79,23.79,23.13,,,,,22.22,20.46,,,,22.44,-1.21,1.35,1.35,0.69, , , , ,-0.21,-1.98, , , ,cell cycle;cell division,tight junction;endomembrane system;membrane,,,,,,,,,,,,,,
6172,Q8TF01,PNISR,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",QRSKFDSDEEEED,_FDS(ph)DEEEEDTENVEAASSGK_,S290,+,24.92,23.91,24.04,22.93,26.66,25.79,25.25,24.98,26.03,26.45,24.29,,24.84,25.01,-0.08,-1.10,-0.97,-2.08,1.65,0.78,0.24,-0.03,1.03,1.44,-0.72, ,-0.16,,nuclear speck,,,,,,,,,,,,,,
6173,Q8TF01,PNISR,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",FRDRQRSPIALPV,_S(ph)PIALPVK_,S211,+,27.64,27.42,27.37,27.37,27.82,27.86,27.58,27.42,28.19,27.82,26.95,26.94,27.43,27.52,0.11,-0.10,-0.15,-0.15,0.30,0.33,0.05,-0.11,0.67,0.30,-0.57,-0.58,-0.09,,nuclear speck,,,,,,,,,,,,,,
6174,Q8TF01,PNISR,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",SGKVTRSPSPVPQ,_VTRS(ph)PS(ph)PVPQEEHS(ph)DPEM(ox)TEEEK_,S311,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,,nuclear speck,,,,,,,,,,,,,,
6175,Q8TF01,PNISR,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",KVTRSPSPVPQEE,_VTRS(ph)PS(ph)PVPQEEHS(ph)DPEM(ox)TEEEK_,S313,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,,nuclear speck,,,,,,,,,,,,,,
6176,Q8TF01,PNISR,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",VPQEEHSDPEMTE,_VTRS(ph)PS(ph)PVPQEEHS(ph)DPEM(ox)TEEEK_,S321,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,,nuclear speck,,,,,,,,,,,,,,
6178,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),WRDRPGSPESPLL,_DRPGS(ph)PES(ph)PLLDAPFSR_,S688,+,26.79,23.66,23.64,20.40,25.73,23.64,24.49,25.57,25.38,24.87,25.95,24.70,25.20,24.62,2.17,-0.95,-0.97,-4.22,1.11,-0.97,-0.13,0.96,0.76,0.25,1.34,0.08,0.58,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6179,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RPGSPESPLLDAP,_DRPGS(ph)PES(ph)PLLDAPFSR_,S691,,26.06,,,,,,,,,,,,,26.06,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6180,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),HAAREDSLPEESS,_EDS(ph)LPEESSAPDFANLK_,S1219,,26.31,,,,,,,,,,,,,26.31,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6181,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),TKSAFSSLQNIPE,_SAFSS(ph)LQNIPESLRR_,S442,,23.81,,,,,,,,,,,,,23.81,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6182,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RAGKSMSAEDLLE,_SM(ox)S(ph)AEDLLER_,S999,,23.50,,,,,,,,,,,,,23.50,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6183,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),HTVLEKSPENSPP,_S(ph)PENSPPVKPK_,S217,,24.49,24.85,25.26,,,,,,,22.58,,,,24.30,0.19,0.56,0.96, , , , , , ,-1.71, , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6184,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RLLRSQSTFQLSS,_SQS(ph)TFQLSSEPEREPEWR_,S668,,23.63,,,,,,,,,,,,,23.63,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6185,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RPHRTVSTSSTSG,_TVS(ph)TSSTSGNDFEETK_,S594,,25.15,,,,,,,,,,,,,25.15,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6186,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RTVSTSSTSGNDF,_TVS(ph)TSS(ph)TSGNDFEETK_,S597,,22.89,,,,,,,,,,,,,22.89,0.00, , , , , , , , , , , , ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6187,Q8TF72,SHROOM3,Protein Shroom3 (Shroom-related protein) (hShrmL),RVLGATSFRRRDL,_VLGATS(ph)FR_,S718,,23.31,,,20.18,,,,,,,,21.63,,21.71,1.60, , ,-1.53, , , , , , , ,-0.08, ,regulation of cell shape;cell morphogenesis;neural tube closure;columnar/cuboidal epithelial cell development;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization;pattern specification process,adherens junction;apical plasma membrane;microtubule;cytoskeleton;cytoplasm;apical junction complex,,,,,,,,,,,,,,
6188,Q8TF74,WIPF2,WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein),PVKPPPSPVNIRT,_EGPPAPPPVKPPPS(ph)PVNIR_,S85,,24.24,,,,22.05,,,,,,23.06,,,23.12,1.13, , , ,-1.07, , , , , ,-0.06, , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6192,Q8WTW3,COG1,Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1),ESSTSNSPSNKHI,_ELLVSALQELESSTSNS(ph)PSNK_,S459,+,24.00,23.84,24.68,23.75,,,,,25.40,25.14,25.00,23.59,25.52,24.55,-0.55,-0.71,0.13,-0.80, , , , ,0.86,0.60,0.45,-0.96,0.97,protein transport;intra-Golgi vesicle-mediated transport;Golgi organization,Golgi transport complex;Golgi membrane,,,,,,,,,,,,,,
6194,Q8WU20,FRS2,Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1) (SNT-1),WEARKLSRDEDDN,_KLS(ph)RDEDDNLGPK_,S365,,,,,,23.74,23.50,23.82,,25.11,23.53,23.15,22.80,,23.66, , , , ,0.07,-0.16,0.15, ,1.45,-0.14,-0.51,-0.87, ,"transmembrane receptor protein tyrosine phosphatase signaling pathway;fibroblast growth factor receptor signaling pathway;regulation of epithelial cell proliferation;optic placode formation involved in camera-type eye formation;organ induction;insulin receptor signaling pathway;forebrain development;prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis;activation of MAPKK activity;ventricular septum development;activation of MAPK activity;G-protein coupled receptor signaling pathway;gastrulation with mouth forming second;anterior/posterior axis specification, embryo;nerve growth factor receptor signaling pathway;neuroblast proliferation",endosome;endomembrane system;integral to plasma membrane,,,,+,,,,,,+,,,,
6195,Q8WU79,SMAP2,Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like),LLASVPSPSSSGS,_DLDLLASVPS(ph)PSSSGSRK_,S139,+,21.69,22.93,23.31,21.02,,20.80,23.32,23.23,22.17,22.67,,,22.61,22.38,-0.68,0.55,0.93,-1.35, ,-1.57,0.95,0.85,-0.21,0.30, , ,0.24,positive regulation of GTPase activity;regulation of ARF GTPase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
6197,Q8WUA4,GTF3C2,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),LIPYQDSPEGPDH,_ADLIPYQDS(ph)PEGPDHSSASSGVPNPPK_,S765,,,,,,23.84,,,,23.90,23.28,,,,23.67, , , , ,0.17, , , ,0.22,-0.39, , , ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex,,,,,,,,,,,,,,
6200,Q8WUA4,GTF3C2,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),DRPESQSPKRPPE,_DLDRPESQS(ph)PK_,S167,+,25.05,26.08,24.98,26.47,,,,,22.04,22.91,,21.88,,24.20,0.85,1.88,0.78,2.27, , , , ,-2.16,-1.29, ,-2.33, ,tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex,,,,,,,,,,,,,,
6207,Q8WUF5,PPP1R13L,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),GPEPELSPITEGS,_HGGPGPGGPEPELS(ph)PITEGSEAR_,S567,+,21.98,,,,22.80,22.80,23.90,24.42,23.28,22.14,23.74,22.68,22.91,23.06,-1.08, , , ,-0.26,-0.26,0.83,1.35,0.22,-0.93,0.67,-0.38,-0.15,"post-embryonic development;hair cycle;cardiac right ventricle morphogenesis;cardiac muscle contraction;embryonic camera-type eye development;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;ventricular cardiac muscle tissue development;transcription, DNA-dependent;multicellular organismal homeostasis",nucleus;cytoplasm,,,,,,,,,,,,,,
6208,Q8WUF5,PPP1R13L,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),PFGRSESAPTLHP,_SES(ph)APTLHPYSPLS(ph)PK_,S102,,23.08,,,,,,,,,,,,,23.08,0.00, , , , , , , , , , , , ,"post-embryonic development;hair cycle;cardiac right ventricle morphogenesis;cardiac muscle contraction;embryonic camera-type eye development;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;ventricular cardiac muscle tissue development;transcription, DNA-dependent;multicellular organismal homeostasis",nucleus;cytoplasm,,,,,,,,,,,,,,
6210,Q8WUF5,PPP1R13L,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),HPYSPLSPKGRPS,_SESAPTLHPYSPLS(ph)PK_,S113,,23.98,,,,,,,,,,23.28,,,23.63,0.35, , , , , , , , , ,-0.35, , ,"post-embryonic development;hair cycle;cardiac right ventricle morphogenesis;cardiac muscle contraction;embryonic camera-type eye development;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;ventricular cardiac muscle tissue development;transcription, DNA-dependent;multicellular organismal homeostasis",nucleus;cytoplasm,,,,,,,,,,,,,,
6211,Q8WUI4,HDAC7,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),PLSRAQSSPAAPA,_AQS(ph)SPAAPASLSAPEPASQAR_,S449,+,26.91,25.42,25.55,26.61,26.39,25.35,27.34,26.51,22.98,24.06,26.37,26.80,,25.86,1.06,-0.44,-0.31,0.76,0.53,-0.51,1.48,0.66,-2.88,-1.80,0.51,0.94, ,"vasculogenesis;cell-cell junction assembly;negative regulation of interleukin-2 production;Notch signaling pathway;histone H3 deacetylation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell migration involved in sprouting angiogenesis;transcription, DNA-dependent;histone H4 deacetylation;negative regulation of osteoblast differentiation",histone deacetylase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6213,Q8WUI4,HDAC7,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),RLRQIPSAEDLET,_QIPS(ph)AEDLETDGGGPGQVVDDGLEHR_,S368,,23.14,,,,,,,,,,,,,23.14,0.00, , , , , , , , , , , , ,"vasculogenesis;cell-cell junction assembly;negative regulation of interleukin-2 production;Notch signaling pathway;histone H3 deacetylation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell migration involved in sprouting angiogenesis;transcription, DNA-dependent;histone H4 deacetylation;negative regulation of osteoblast differentiation",histone deacetylase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6215,Q8WUM0,NUP133,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),MFPAAPSPRTPGT,_(ac)M(ox)FPAAPS(ph)PR_,S7,+,24.52,20.52,21.03,20.22,22.72,22.40,,22.24,22.28,22.00,,21.95,,21.99,2.53,-1.47,-0.96,-1.77,0.74,0.41, ,0.25,0.29,0.01, ,-0.04, ,paraxial mesoderm development;glucose transport;small molecule metabolic process;nuclear pore organization;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;mRNA export from nucleus;mitotic prometaphase;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;condensed chromosome kinetochore;nuclear pore outer ring,,,,,,,,,,,,,,
6216,Q8WUM9,SLC20A1,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),EREIKCSPSESPL,_EIKCS(ph)PSES(ph)PLM(ox)EK_,S265,,,,,23.41,,,,,,,,,,23.41, , , ,0.00, , , , , , , , , ,positive regulation of I-kappaB kinase/NF-kappaB cascade;phosphate-containing compound metabolic process,integral to plasma membrane,,,,,,,,,,,,,,
6217,Q8WUM9,SLC20A1,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),KCSPSESPLMEKK,_EIKCS(ph)PSES(ph)PLM(ox)EK_,S269,,,,,23.41,,,,,,,,,,23.41, , , ,0.00, , , , , , , , , ,positive regulation of I-kappaB kinase/NF-kappaB cascade;phosphate-containing compound metabolic process,integral to plasma membrane,,,,,,,,,,,,,,
6219,Q8WUM9,SLC20A1,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),TWPNADSKKRIRM,_LTWPNADS(ph)K_,S455,,17.67,,,22.23,,,23.95,22.41,20.49,,,23.05,,21.63,-3.96, , ,0.59, , ,2.32,0.78,-1.15, , ,1.41, ,positive regulation of I-kappaB kinase/NF-kappaB cascade;phosphate-containing compound metabolic process,integral to plasma membrane,,,,,,,,,,,,,,
6220,Q8WUX9,CHMP7,Charged multivesicular body protein 7 (Chromatin-modifying protein 7),VPNPRISDAELEA,_IS(ph)DAELEAELEK_,S417,+,23.53,24.40,,24.46,23.77,,24.58,24.16,22.93,23.60,25.40,25.55,,24.24,-0.71,0.17, ,0.22,-0.47, ,0.34,-0.07,-1.31,-0.64,1.17,1.31, ,cellular membrane organization;late endosome to vacuole transport,cytosol;ESCRT III complex;nucleus,,,,,,,,,,,,,,
6221,Q8WUZ0,BCL7C,B-cell CLL/lymphoma 7 protein family member C,QKGTEPSPGGTPQ,_GTEPS(ph)PGGTPQPSRPVS(ph)PAGPPEGVPEEAQPPR_,S114,,26.52,25.15,,24.22,,24.18,,,24.18,,,,,24.85,1.67,0.30, ,-0.63, ,-0.67, , ,-0.67, , , , ,apoptotic process,,,,,,,,,,,,,,,
6223,Q8WUZ0,BCL7C,B-cell CLL/lymphoma 7 protein family member C,QPSRPVSPAGPPE,_GTEPS(ph)PGGTPQPSRPVS(ph)PAGPPEGVPEEAQPPR_,S126,,26.52,25.15,,24.22,,24.18,,,24.18,,,,,24.85,1.67,0.30, ,-0.63, ,-0.67, , ,-0.67, , , , ,apoptotic process,,,,,,,,,,,,,,,
6224,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),MEDLFGSDADSEA,_(ac)ADM(ox)EDLFGS(ph)DADSEAERK_,S10,,22.71,,,,23.89,,,,,24.44,,,,23.68,-0.97, , , ,0.21, , , , ,0.76, , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6225,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),FGSDADSEAERKD,_(ac)ADM(ox)EDLFGSDADS(ph)EAERK_,S14,,25.01,,,,24.44,22.60,,,24.40,27.00,,23.84,,24.55,0.46, , , ,-0.11,-1.95, , ,-0.14,2.45, ,-0.71, ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6226,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),EEEKANSDDERPV,_ANS(ph)DDERPVAS(ph)DNDDEK_,S212,+,24.89,25.92,25.42,24.29,,,22.48,,24.44,24.43,21.57,23.07,,24.06,0.83,1.86,1.37,0.23, , ,-1.58, ,0.39,0.37,-2.48,-0.99, ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6227,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),DERPVASDNDDEK,_ANS(ph)DDERPVAS(ph)DNDDEK_,S220,,22.51,,,23.35,,,,,,,,,,22.93,-0.42, , ,0.42, , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6229,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),SDSDEGSEEDKAQ,_ARIYSSDSDEGS(ph)EEDK_,S554,+,21.38,,,23.09,26.70,25.40,23.85,24.90,24.77,25.14,21.77,,21.19,23.82,-2.44, , ,-0.73,2.88,1.58,0.03,1.08,0.95,1.32,-2.05, ,-2.62,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6230,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),SESARGSDSEDEV,_SESARGS(ph)DS(ph)EDEVLR_,S277,,24.20,,,,,,,,,,,,,24.20,0.00, , , , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6231,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),SARGSDSEDEVLR,_GSDS(ph)EDEVLR_,S279,+,25.94,25.17,22.15,24.27,24.40,23.87,22.66,23.50,,,,,,24.00,1.94,1.18,-1.85,0.28,0.41,-0.13,-1.34,-0.49, , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6233,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),HKKYVISDEEEED,_YVIS(ph)DEEEEDDD_,S598,+,26.76,25.17,25.68,25.76,26.99,27.77,27.33,26.70,27.25,26.66,25.33,26.26,26.58,26.48,0.28,-1.31,-0.80,-0.72,0.51,1.29,0.85,0.22,0.77,0.18,-1.15,-0.22,0.10,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6234,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),EERPQLSDDERQQ,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,S197,,25.71,24.01,24.01,,,,,,,,,,,24.58,1.13,-0.57,-0.57, , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6235,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),DERQQLSEEEKAN,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,S205,,24.80,,,,,,,,,,,,,24.80,0.00, , , , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6236,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),RKNAIASDSEADS,_NAIAS(ph)DS(ph)EADS(ph)DTEVPK_,S294,+,26.99,23.29,23.06,22.75,,,23.15,,23.50,24.58,,23.39,23.40,23.79,3.20,-0.50,-0.73,-1.04, , ,-0.64, ,-0.29,0.78, ,-0.40,-0.39,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6237,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),NAIASDSEADSDT,_NAIAS(ph)DS(ph)EADS(ph)DTEVPK_,S296,,25.83,,,,,,,,,,,,,25.83,0.00, , , , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6238,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),SDSEADSDTEVPK,_NAIAS(ph)DS(ph)EADS(ph)DTEVPK_,S300,+,27.52,24.30,24.72,24.05,,,24.81,,25.37,25.62,,24.63,23.63,24.96,2.56,-0.66,-0.24,-0.91, , ,-0.15, ,0.41,0.66, ,-0.34,-1.33,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6239,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),DDEKQNSDDEEQP,_(gl)QNS(ph)DDEEQPQLS(ph)DEEK_,S229,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6240,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),EEQPQLSDEEKMQ,_(gl)QNS(ph)DDEEQPQLS(ph)DEEK_,S238,,25.85,23.46,23.46,21.99,,,22.60,,23.81,24.18,,,,23.62,2.23,-0.16,-0.16,-1.63, , ,-1.02, ,0.19,0.56, , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
6244,Q8WVM8,SCFD1,Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2),KRKNKKSYDLTPV,_S(ph)YDLTPVDK_,S316,,23.07,22.82,23.06,23.57,23.07,24.16,,,24.03,23.59,,24.01,24.09,23.55,-0.47,-0.72,-0.49,0.03,-0.48,0.61, , ,0.48,0.04, ,0.46,0.54,"retrograde vesicle-mediated transport, Golgi to ER;post-Golgi vesicle-mediated transport;response to toxin;protein transport;regulation of ER to Golgi vesicle-mediated transport;response to hypoxia;vesicle docking involved in exocytosis",Golgi cisterna membrane;plasma membrane;endoplasmic reticulum membrane;Golgi transport complex;cis-Golgi network;Golgi-associated vesicle,,,,,,,,,,,,,,
6245,Q8WVM8,SCFD1,Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2),SSGVENSPAGARP,_VNLEESSGVENS(ph)PAGARPK_,S303,+,25.69,25.35,22.31,23.83,26.04,25.95,25.54,25.84,25.91,25.32,26.53,25.54,26.43,25.40,0.28,-0.06,-3.09,-1.58,0.63,0.54,0.13,0.43,0.50,-0.08,1.13,0.14,1.02,"retrograde vesicle-mediated transport, Golgi to ER;post-Golgi vesicle-mediated transport;response to toxin;protein transport;regulation of ER to Golgi vesicle-mediated transport;response to hypoxia;vesicle docking involved in exocytosis",Golgi cisterna membrane;plasma membrane;endoplasmic reticulum membrane;Golgi transport complex;cis-Golgi network;Golgi-associated vesicle,,,,,,,,,,,,,,
6246,Q8WVT3,TRAPPC12,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15),___MVKSPSFGGA,_S(ph)PSFGGASEASAR_,S4,,24.18,24.05,24.05,23.58,,,,,23.82,23.50,,,,23.86,0.32,0.19,0.19,-0.29, , , , ,-0.05,-0.36, , , ,vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment,,,,,,,,,,,,,,
6247,Q8WVT3,TRAPPC12,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15),_MVKSPSFGGASE,_SPS(ph)FGGASEASAR_,S6,,22.96,23.74,,23.78,,22.42,,,,,23.85,23.80,23.20,23.39,-0.44,0.35, ,0.39, ,-0.97, , , , ,0.46,0.41,-0.19,vesicle-mediated transport,endoplasmic reticulum-Golgi intermediate compartment,,,,,,,,,,,,,,
6248,Q8WVV4,POF1B,Protein POF1B (Premature ovarian failure protein 1B),NSREVLSPLKTTS,_EVLS(ph)PLK_,S76,,25.13,,,,,,,,,,,,,25.13,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6254,Q8WVV9,HNRNPLL,Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor),MSSSSSSPRETYE,_(ac)SSSSSS(ph)PRETYEEDREYESQAK_,S7,,,,,,,26.58,25.84,,,,,,,26.21, , , , , ,0.37,-0.37, , , , , , ,mRNA processing;positive regulation of RNA splicing,ribonucleoprotein complex;nucleus,,,,,,,,,,,,,,
6255,Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),TSAGPNSFNKGKH,_NIGRDTPTSAGPNS(ph)FNK_,S147,,28.42,21.76,21.76,25.31,,,,,,,24.90,25.81,,24.66,3.76,-2.90,-2.90,0.65, , , , , , ,0.24,1.15, ,proteasomal ubiquitin-dependent protein catabolic process;cell cycle;protein ubiquitination,nucleus,,,,,,,,,,,,,,
6256,Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),FGFAIGSQTTKKA,_FGFAIGS(ph)QTTK_,S77,,23.52,,,,,,,,,,,21.15,,22.33,1.19, , , , , , , , , , ,-1.19, ,proteasomal ubiquitin-dependent protein catabolic process;cell cycle;protein ubiquitination,nucleus,,,,,,,,,,,,,,
6257,Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),LAPKTLSVAAAFN,_TLS(ph)VAAAFNEDEDSEPEEM(ox)PPEAK_,S108,,23.85,,,,,,,,,,,,,23.85,0.00, , , , , , , , , , , , ,proteasomal ubiquitin-dependent protein catabolic process;cell cycle;protein ubiquitination,nucleus,,,,,,,,,,,,,,
6258,Q8WW12,PCNP,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),FNEDEDSEPEEMP,_TLSVAAAFNEDEDS(ph)EPEEM(ox)PPEAK_,S119,,25.37,,,,,,,,,,,,,25.37,0.00, , , , , , , , , , , , ,proteasomal ubiquitin-dependent protein catabolic process;cell cycle;protein ubiquitination,nucleus,,,,,,,,,,,,,,
6260,Q8WW38,ZFPM2,Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2),WQQMAKSPEFPSV,_S(ph)PEFPSVSEK_,S312,,,21.97,21.97,23.54,,,23.78,,,,,23.46,,22.94, ,-0.97,-0.97,0.59, , ,0.84, , , , ,0.51, ,"vasculogenesis;outflow tract septum morphogenesis;negative regulation of transcription, DNA-dependent;in utero embryonic development;negative regulation of fat cell differentiation;lung development;blood coagulation;embryonic organ development;ventricular septum morphogenesis;negative regulation of transcription from RNA polymerase II promoter;positive regulation of male gonad development;right ventricular cardiac muscle tissue morphogenesis;negative regulation of female gonad development;negative regulation of cell death",nucleoplasm;cytoplasm,C2H2-type,,,,,,,,,,,,,
6261,Q8WW38,ZFPM2,Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2),VFPNPESERNSPD,_VFPNPES(ph)ERNSPDVSYER_,S631,,,23.11,23.11,,24.52,26.01,25.01,24.50,,,,,24.92,24.45, ,-1.35,-1.35, ,0.07,1.55,0.55,0.05, , , , ,0.47,"vasculogenesis;outflow tract septum morphogenesis;negative regulation of transcription, DNA-dependent;in utero embryonic development;negative regulation of fat cell differentiation;lung development;blood coagulation;embryonic organ development;ventricular septum morphogenesis;negative regulation of transcription from RNA polymerase II promoter;positive regulation of male gonad development;right ventricular cardiac muscle tissue morphogenesis;negative regulation of female gonad development;negative regulation of cell death",nucleoplasm;cytoplasm,C2H2-type,,,,,,,,,,,,,
6268,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),GREGFESDTDSEF,_EGFES(ph)DTDSEFTFK_,S185,,21.74,,,,,,,,23.18,,,,,22.46,-0.72, , , , , , , ,0.72, , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6269,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),DVTRLPSPTSPFS,_EVAATEEDVTRLPS(ph)PTS(ph)PFSSLSQDQAATSK_,S553,+,26.41,25.17,25.17,23.17,,26.23,25.45,25.45,26.31,27.55,25.82,24.35,26.52,25.63,0.78,-0.47,-0.47,-2.46, ,0.59,-0.18,-0.19,0.68,1.91,0.19,-1.28,0.89,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6270,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),RLPSPTSPFSSLS,_EVAATEEDVTRLPS(ph)PTS(ph)PFSSLSQDQAATSK_,S556,,25.95,,,,,,24.27,24.40,24.63,,24.90,,24.55,24.78,1.17, , , , , ,-0.51,-0.38,-0.15, ,0.11, ,-0.24,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6274,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),SRRRMYSFDDVLE,_M(ox)YS(ph)FDDVLEEGK_,S370,,24.94,,,,,,,,,25.31,,23.42,,24.56,0.39, , , , , , , , ,0.75, ,-1.14, ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6275,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),IQLPSQSPVEEQS,_VTTEIQLPSQS(ph)PVEEQSPASLSSLR_,S432,,27.08,,,,23.91,,,,24.82,27.12,,,,25.73,1.34, , , ,-1.82, , , ,-0.91,1.39, , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6276,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),HHKREDSFESLDS,_REDS(ph)FESLDSLGSR_,S155,+,21.49,21.80,21.80,23.32,22.26,24.63,25.20,,26.18,24.99,,25.04,24.49,23.75,-2.25,-1.95,-1.95,-0.42,-1.48,0.89,1.45, ,2.43,1.24, ,1.29,0.75,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6277,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),VSTPAPSPDASQL,_RTPNNVVSTPAPS(ph)PDASQLASSLSSQK_,S525,+,24.82,24.23,24.82,,,25.01,25.95,23.56,26.40,27.08,24.90,,25.26,25.20,-0.39,-0.98,-0.38, , ,-0.20,0.75,-1.64,1.20,1.88,-0.30, ,0.05,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6278,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),IRQRSASVNKEPV,_SAS(ph)VNKEPVSLPGIM(ox)R_,S1085,+,25.83,24.03,23.43,23.75,24.03,22.59,22.99,22.82,24.74,25.03,,,23.76,23.91,1.92,0.12,-0.48,-0.16,0.12,-1.32,-0.92,-1.09,0.83,1.12, , ,-0.15,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6280,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),TFSRSKSMSDVSA,_S(ph)M(ox)SDVSAEDVQNLR_,S269,,26.54,24.32,24.40,23.54,,,,,,,,,,24.70,1.84,-0.38,-0.30,-1.16, , , , , , , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6282,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),DRNKSRSTTELDD,_SRS(ph)TTELDDYSTNK_,S1015,+,25.12,25.38,25.34,25.48,,25.18,26.18,24.96,,26.92,23.99,,,25.39,-0.28,-0.01,-0.06,0.08, ,-0.22,0.79,-0.43, ,1.53,-1.40, , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6284,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),GVATTQSPTPRSH,_TSTTGVATTQS(ph)PTPR_,S1178,,24.46,23.47,24.16,21.77,,,,,,22.44,,,,23.26,1.20,0.21,0.90,-1.49, , , , , ,-0.82, , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6285,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),STRVSASLPRSYR,_VSAS(ph)LPR_,S460,,23.38,22.94,22.43,23.40,,,,,,,,,,23.04,0.35,-0.10,-0.61,0.37, , , , , , , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
6287,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),CPSQTGSPPVGLI,_EDKPPLAPSGGTEGPEQPPPPCPSQTGS(ph)PPVGLIK_,S634,+,23.03,23.69,23.80,22.91,,,,,24.98,25.11,,24.42,,23.99,-0.96,-0.30,-0.19,-1.08, , , , ,0.99,1.12, ,0.43, ,,membrane,,,,,,,,,,,,,,
6288,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),AREIESSPQYRLR,_EIESS(ph)PQYR_,S306,,,,,,24.40,,,,21.27,,,,,22.84, , , , ,1.57, , , ,-1.57, , , , ,,membrane,,,,,,,,,,,,,,
6290,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),TSEPMGSPVSSKT,_EKEVDGLLTSEPM(ox)GS(ph)PVSSK_,S594,+,28.72,27.08,27.44,27.42,26.66,26.47,28.66,27.01,28.53,29.02,28.00,27.54,27.03,27.66,1.06,-0.58,-0.22,-0.24,-1.00,-1.19,1.00,-0.65,0.87,1.36,0.34,-0.12,-0.63,,membrane,,,,,,,,,,,,,,
6291,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),GKGPPQSPVFEGV,_GQSTGKGPPQS(ph)PVFEGVYNNSR_,S111,+,28.19,27.16,27.40,27.71,27.46,27.28,28.18,27.65,28.47,28.62,28.13,27.04,27.66,27.77,0.43,-0.61,-0.37,-0.06,-0.30,-0.49,0.41,-0.11,0.71,0.85,0.37,-0.73,-0.11,,membrane,,,,,,,,,,,,,,
6294,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),KLQPSSSPENSLD,_LQPSSS(ph)PENSLDPFPPR_,S559,+,25.30,23.46,21.13,25.72,26.01,25.76,25.93,25.89,25.46,25.60,25.58,,25.73,25.13,0.17,-1.67,-4.00,0.59,0.88,0.63,0.80,0.76,0.33,0.47,0.45, ,0.60,,membrane,,,,,,,,,,,,,,
6296,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),AVQRQGSGRESPS,_(gl)QGS(ph)GRESPS(ph)LASR_,S335,,25.49,,,,,,,,,,,,,25.49,0.00, , , , , , , , , , , , ,,membrane,,,,,,,,,,,,,,
6298,Q8WWM7,ATXN2L,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),SGRESPSLASREG,_(gl)QGS(ph)GRESPS(ph)LASR_,S341,,25.12,,,,,,,,,,,,,25.12,0.00, , , , , , , , , , , , ,,membrane,,,,,,,,,,,,,,
6301,Q8WWN8,ARAP3,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3) (Cnt-d3)",PLTSQKSLDQPFL,_S(ph)LDQPFLSK_,S1444,+,23.13,,,23.02,22.16,21.97,24.90,24.01,23.66,,23.07,22.40,22.38,23.07,0.06, , ,-0.05,-0.91,-1.10,1.83,0.94,0.60, ,0.00,-0.67,-0.69,regulation of cell shape;small GTPase mediated signal transduction;negative regulation of Rho protein signal transduction;negative regulation of cell migration;vesicle-mediated transport;negative regulation of Rac protein signal transduction;cytoskeleton organization;regulation of ARF GTPase activity,cytosol;plasma membrane;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
6302,Q8WWN8,ARAP3,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3) (Cnt-d3)",GPGVSRSPEPSPR,_S(ph)PEPSPR_,S128,,,21.58,,22.08,20.41,21.31,20.40,20.90,21.00,,18.10,20.73,20.76,20.73, ,0.85, ,1.36,-0.32,0.58,-0.33,0.17,0.28, ,-2.63,0.00,0.03,regulation of cell shape;small GTPase mediated signal transduction;negative regulation of Rho protein signal transduction;negative regulation of cell migration;vesicle-mediated transport;negative regulation of Rac protein signal transduction;cytoskeleton organization;regulation of ARF GTPase activity,cytosol;plasma membrane;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
6303,Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),LRNRAQSYDIQAW,_AQS(ph)YDIQAWK_,S1315,+,25.69,20.12,,22.28,23.74,24.00,21.97,20.89,23.04,23.42,,,,22.79,2.90,-2.67, ,-0.52,0.94,1.21,-0.83,-1.91,0.25,0.62, , , ,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of mitosis;positive regulation of insulin-like growth factor receptor signaling pathway;positive regulation of peptidyl-threonine phosphorylation;regulation of cell morphogenesis;positive regulation of transcription, DNA-dependent;regulation of protein phosphorylation;insulin receptor signaling pathway;positive regulation of cell proliferation;protein import into nucleus;cytoskeleton organization;regulation of growth;positive regulation of transcription from RNA polymerase II promoter",nucleus,,,,,,,,,,,,,,
6305,Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),MKKKVLSDSEDEE,_KVLS(ph)DS(ph)EDEEKDADVPGTSTR_,S1281,,26.78,,,,24.10,,,,,,,,,25.44,1.34, , , ,-1.34, , , , , , , , ,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of mitosis;positive regulation of insulin-like growth factor receptor signaling pathway;positive regulation of peptidyl-threonine phosphorylation;regulation of cell morphogenesis;positive regulation of transcription, DNA-dependent;regulation of protein phosphorylation;insulin receptor signaling pathway;positive regulation of cell proliferation;protein import into nucleus;cytoskeleton organization;regulation of growth;positive regulation of transcription from RNA polymerase II promoter",nucleus,,,,,,,,,,,,,,
6306,Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),KKVLSDSEDEEKD,_KVLS(ph)DS(ph)EDEEKDADVPGTSTR_,S1283,,26.78,,,,24.10,,,,,,,,,25.44,1.34, , , ,-1.34, , , , , , , , ,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of mitosis;positive regulation of insulin-like growth factor receptor signaling pathway;positive regulation of peptidyl-threonine phosphorylation;regulation of cell morphogenesis;positive regulation of transcription, DNA-dependent;regulation of protein phosphorylation;insulin receptor signaling pathway;positive regulation of cell proliferation;protein import into nucleus;cytoskeleton organization;regulation of growth;positive regulation of transcription from RNA polymerase II promoter",nucleus,,,,,,,,,,,,,,
6307,Q8WWQ0,PHIP,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),FYNEDDSEEEQRQ,_TAFYNEDDS(ph)EEEQR_,S1783,,26.79,23.89,23.31,23.78,23.63,22.89,,,,,,,,24.05,2.74,-0.16,-0.74,-0.27,-0.42,-1.16, , , , , , , ,"positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process;positive regulation of mitosis;positive regulation of insulin-like growth factor receptor signaling pathway;positive regulation of peptidyl-threonine phosphorylation;regulation of cell morphogenesis;positive regulation of transcription, DNA-dependent;regulation of protein phosphorylation;insulin receptor signaling pathway;positive regulation of cell proliferation;protein import into nucleus;cytoskeleton organization;regulation of growth;positive regulation of transcription from RNA polymerase II promoter",nucleus,,,,,,,,,,,,,,
6308,Q8WX92,NELFB,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),LDHRKPSPAQAAE,_KPS(ph)PAQAAETPALELPLPSVPAPAPL_,S557,,26.84,27.75,,25.90,24.13,,,,,,23.59,,25.19,25.56,1.28,2.18, ,0.33,-1.43, , , , , ,-1.98, ,-0.38,"viral reproduction;negative regulation of transcription, DNA-dependent;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription",NELF complex;cytoplasm,,,,,,,,,,,,,,
6309,Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),RTARIASDEEIQG,_IAS(ph)DEEIQGTKDAVIQDLER_,S287,+,26.95,27.45,27.54,29.45,29.63,27.99,29.67,30.65,29.88,29.12,28.94,28.46,29.06,28.83,-1.88,-1.38,-1.29,0.62,0.80,-0.84,0.84,1.82,1.05,0.29,0.11,-0.37,0.23,cytoskeleton organization,Z disc;actin filament;nucleus;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
6311,Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),RRPRSRSRDSGDE,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,S512,,22.59,,,,,,,,,,,,,22.59,0.00, , , , , , , , , , , , ,cytoskeleton organization,Z disc;actin filament;nucleus;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
6312,Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),RSRSRDSGDENEP,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,S515,+,24.73,25.43,25.66,26.75,27.08,25.33,26.15,26.87,26.52,25.69,25.04,25.51,23.16,25.69,-0.96,-0.26,-0.03,1.07,1.39,-0.35,0.47,1.19,0.83,0.00,-0.65,-0.17,-2.53,cytoskeleton organization,Z disc;actin filament;nucleus;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
6313,Q8WX93,PALLD,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),HVRRPRSRSRDSG,_S(ph)RS(ph)RDS(ph)GDENEPIQER_,S510,,22.59,,,,,,,,,,,,,22.59,0.00, , , , , , , , , , , , ,cytoskeleton organization,Z disc;actin filament;nucleus;focal adhesion;lamellipodium;ruffle,,,,,,,,,,,,,,
6314,Q8WXE0,CASKIN2,Caskin-2 (CASK-interacting protein 2),GTPRSQSFALRAR,_SQS(ph)FALR_,S776,,23.77,,,23.34,,,,,,,,23.20,,23.44,0.33, , ,-0.09, , , , , , , ,-0.24, ,,cytoplasm,,,,,,,,,,,,,,
6315,Q8WXE0,CASKIN2,Caskin-2 (CASK-interacting protein 2),PAGDRNSVGSEGS,_VGLSPDSPAGDRNS(ph)VGSEGSVGSIR_,S321,+,22.50,,,,24.41,,24.25,24.62,23.91,,23.78,24.88,23.71,24.01,-1.51, , , ,0.40, ,0.24,0.61,-0.10, ,-0.23,0.87,-0.30,,cytoplasm,,,,,,,,,,,,,,
6316,Q8WXE1,ATRIP,ATR-interacting protein (ATM and Rad3-related-interacting protein),PSVSHVSPRKNPS,_LAAPSVSHVS(ph)PR_,S131,,,,,,23.73,21.96,,23.13,,22.02,,,,22.71, , , , ,1.02,-0.75, ,0.42, ,-0.69, , , ,DNA repair;DNA replication;DNA damage checkpoint,nucleoplasm,,,,,,,,,,,,,,
6317,Q8WXF7,ATL1,Atlastin-1 (EC 3.6.5.-) (Brain-specific GTP-binding protein) (GTP-binding protein 3) (GBP-3) (hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A),NRRDRNSWGGFSE,_DRNS(ph)WGGFSEK_,S10,+,24.07,25.32,25.08,25.74,26.44,26.20,26.19,26.28,25.59,25.28,26.80,27.07,26.81,25.91,-1.84,-0.60,-0.83,-0.17,0.53,0.29,0.28,0.37,-0.32,-0.63,0.89,1.16,0.90,axonogenesis;endoplasmic reticulum organization;cell death;protein homooligomerization,axon;integral to membrane;endoplasmic reticulum membrane;Golgi membrane;Golgi cis cisterna,,,,,,,,,,,,,,
6319,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),DEKAEPSPQSWSS,_AEPS(ph)PQSWSSLWK_,S4136,,23.31,,,,,,,,,,,,,23.31,0.00, , , , , , , , , , , , ,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6320,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),EDEKEASENETDM,_EAS(ph)ENETDM(ox)EDPREIQTDSWRK_,S6361,+,25.54,23.88,23.88,,,,24.23,,25.15,28.90,23.16,25.24,,25.00,0.54,-1.12,-1.12, , , ,-0.77, ,0.15,3.91,-1.84,0.25, ,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6322,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),KNLTDVSPDLDIR,_NLTDVS(ph)PDLDIR_,S841,,23.88,,,,20.88,,,,,,,,,22.38,1.50, , , ,-1.50, , , , , , , , ,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6323,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),ILARQQSVESLAE,_QQS(ph)VESLAEEVK_,S2781,+,27.76,24.42,24.95,21.84,21.73,,24.98,22.44,26.41,23.83,,,24.32,24.27,3.49,0.16,0.68,-2.43,-2.53, ,0.71,-1.83,2.14,-0.44, , ,0.05,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6327,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),VKHRKKSLIRLDK,_S(ph)LIRLDK_,S1469,,24.69,24.74,24.74,21.05,24.53,,25.17,24.50,25.62,25.28,,22.95,24.60,24.35,0.34,0.39,0.39,-3.30,0.18, ,0.82,0.15,1.26,0.93, ,-1.40,0.25,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6328,Q8WXH0,SYNE2,Nesprin-2 (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),NMVLELSPKELDE,_VLQNM(ox)VLELS(ph)PK_,S3145,,23.56,,,,,,,,,,,,,23.56,0.00, , , , , , , , , , , , ,protein localization to nucleus;centrosome localization;fibroblast migration;cytoskeletal anchoring at nuclear membrane;positive regulation of cell migration;establishment or maintenance of cell polarity;nuclear envelope organization;nuclear migration along microfilament,Z disc;nucleoplasm;nuclear lumen;lamellipodium membrane;sarcoplasmic reticulum membrane;nuclear membrane;sarcoplasmic reticulum;integral to membrane;SUN-KASH complex;cytoskeleton;focal adhesion;mitochondrial part;nuclear outer membrane;filopodium membrane,,,,,,,,,,,,,,
6332,Q8WXI7,MUC16,Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125),DTWPTRSAQFSSS,_S(ph)AQFS(ph)S(ph)SHLVSELR_,S908,,,22.78,,22.13,,,,,,,,,,22.45, ,0.32, ,-0.32, , , , , , , , , ,O-glycan processing;cell adhesion;post-translational protein modification,extracellular space;integral to membrane;plasma membrane;Golgi lumen;extrinsic to membrane,,,,,,,,,,,,,,
6338,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),RGRLTPSPDIIVL,_GRLT(ph)PS(ph)PDIIVLS(ph)DNEASSPR_,S122,,24.88,,,,21.15,23.13,,,,,,,,23.06,1.83, , , ,-1.90,0.08, , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6339,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),PDIIVLSDNEASS,_GRLT(ph)PS(ph)PDIIVLS(ph)DNEASSPR_,S129,,25.27,,,,24.47,23.13,,,,,,,,24.29,0.98, , , ,0.18,-1.16, , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6341,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),SDNEASSPRSSSR,_LTPSPDIIVLSDNEASS(ph)PR_,S135,,26.15,22.05,,,22.82,23.72,,,20.50,,,,,23.05,3.11,-1.00, , ,-0.23,0.67, , ,-2.55, , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6342,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),QQQAALSPTTAPA,_LQQQAALS(ph)PTTAPAVSSVSK_,S486,+,25.07,21.65,,23.47,23.25,23.69,24.09,22.91,24.35,,22.38,21.92,24.81,23.42,1.65,-1.77, ,0.05,-0.16,0.27,0.68,-0.51,0.93, ,-1.04,-1.49,1.40,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6343,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),AVNRVSSPLPSPS,_VSS(ph)PLPS(ph)PSAM(ox)TDAANSQAAAK_,S334,,24.65,,,,,,,,,,,,21.66,23.15,1.50, , , , , , , , , , , ,-1.50,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6344,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),VSSPLPSPSAMTD,_VSS(ph)PLPS(ph)PSAM(ox)TDAANSQAAAK_,S338,,24.65,,,,,,,,,,,,21.66,23.15,1.50, , , , , , , , , , , ,-1.50,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6345,Q8WY22,BRI3BP,BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1),LESLDRSKDK___,_VLESLDRS(ph)K_,S248,+,26.25,24.98,,23.29,23.08,,22.49,,21.42,23.04,,,,23.51,2.75,1.47, ,-0.22,-0.42, ,-1.02, ,-2.09,-0.47, , , ,,mitochondrial outer membrane;integral to membrane,,,,,,,,,,,,,,
6347,Q8WY36,BBX,HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2),TNKPVKSPTPTVN,_S(ph)PTPTVNPR_,S159,,23.42,22.35,,22.86,21.22,,,,,,22.35,,19.73,21.99,1.43,0.36, ,0.87,-0.77, , , , , ,0.36, ,-2.26,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
6348,Q8WY36,BBX,HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2),TADGRVSPAGGTL,_TADGRVS(ph)PAGGTLDDKPK_,S794,+,23.68,24.19,24.59,23.84,,24.90,24.77,23.92,26.16,23.75,23.63,24.66,22.72,24.24,-0.55,-0.05,0.35,-0.39, ,0.67,0.54,-0.31,1.92,-0.49,-0.60,0.43,-1.51,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
6350,Q8WYA6,CTNNBL1,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19),NIGDGRSPEFREN,_EYAENIGDGRS(ph)PEFRENEQK_,S545,+,23.73,24.84,24.91,,23.96,25.80,24.41,25.13,25.72,25.31,24.56,24.42,25.01,24.82,-1.09,0.03,0.09, ,-0.86,0.99,-0.40,0.31,0.90,0.49,-0.25,-0.40,0.19,mRNA processing;somatic diversification of immunoglobulins;RNA splicing;apoptotic process;positive regulation of apoptotic process,Prp19 complex;spliceosomal complex,,,,,,,,,,,,,,
6352,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),LVAGLLSPRFVDV,_CLVAGLLS(ph)PR_,S528,,22.46,,,,,,,,,,,,,22.46,0.00, , , , , , , , , , , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6353,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),TSFFLNSPEKEHQ,_DRTTSFFLNS(ph)PEK_,S1283,+,25.74,25.95,26.90,23.16,,24.58,26.19,24.73,26.00,27.61,25.00,22.06,26.19,25.34,0.40,0.61,1.56,-2.18, ,-0.77,0.85,-0.61,0.66,2.27,-0.34,-3.28,0.85,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6354,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),MDEGSQSLEKLDV,_EHQEM(ox)DEGSQS(ph)LEK_,S1297,+,21.35,25.02,25.62,21.91,,,21.32,,21.98,21.25,,,,22.64,-1.28,2.39,2.99,-0.73, , ,-1.32, ,-0.65,-1.39, , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6356,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),VRGREVSPSDVRE,_EVS(ph)PSDVR_,S1944,,24.35,24.87,24.92,25.19,,,,,,,,,,24.83,-0.48,0.04,0.09,0.36, , , , , , , , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6357,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),KLPISDSPPDTQE,_LPISDS(ph)PPDTQEIHVIEQEK_,S1513,,23.12,,,,,,,22.03,24.19,25.29,,,,23.66,-0.54, , , , , , ,-1.63,0.53,1.63, , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6358,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),EEARNLSFNELYP,_NLS(ph)FNELYPSGTLK_,S1541,,22.76,,,,24.39,,,,,,,,,23.58,-0.81, , , ,0.81, , , , , , , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6359,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),SSQLKGSPQAISR,_SLPSSSQLKGS(ph)PQAISR_,S1160,,,,,,26.08,22.36,,24.36,,,,,,24.27, , , , ,1.81,-1.90, ,0.09, , , , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6360,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),QQSSMKSPLYLVS,_S(ph)PLYLVSR_,S1142,+,22.85,22.43,22.43,23.42,,,24.33,,23.63,23.38,,23.39,,23.23,-0.38,-0.80,-0.80,0.19, , ,1.10, ,0.40,0.15, ,0.16, ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6361,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),RSTPLASPSPSPG,_STPLAS(ph)PSPS(ph)PGRSPQR_,S1214,,24.22,,,22.70,,22.22,,,,,,,,23.05,1.18, , ,-0.35, ,-0.83, , , , , , , ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6362,Q8WYP5,AHCTF1,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),SPSPGRSPQRLKE,_STPLASPSPSPGRS(ph)PQR_,S1222,+,23.70,,,,25.34,23.56,24.23,24.96,24.01,23.88,22.98,22.87,,23.95,-0.25, , , ,1.39,-0.38,0.28,1.01,0.06,-0.07,-0.97,-1.08, ,mitotic prometaphase;protein transport;nuclear pore complex assembly;mRNA transport;cytokinesis,nucleoplasm;nuclear membrane;cytosol;condensed chromosome kinetochore;nuclear pore;nuclear matrix,,,,,,,,,,,,,,
6363,Q8WYQ5,DGCR8,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8),TPSGDVSPVKPLS,_DNEEREQSSDLTPSGDVS(ph)PVK_,S377,+,24.22,23.79,24.04,24.54,24.71,24.76,25.57,23.88,25.41,26.08,24.37,23.31,23.81,24.50,-0.28,-0.70,-0.46,0.04,0.21,0.26,1.07,-0.62,0.91,1.58,-0.13,-1.19,-0.69,primary miRNA processing,nucleoplasm;microtubule cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6364,Q8WYQ5,DGCR8,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8),EKYGGDSDHPSDG,_YGGDS(ph)DHPS(ph)DGETSVQPM(ox)M(ox)TK_,S271,,24.05,,,23.12,,,,,,,,,,23.59,0.47, , ,-0.47, , , , , , , , , ,primary miRNA processing,nucleoplasm;microtubule cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6365,Q8WYQ5,DGCR8,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8),GDSDHPSDGETSV,_YGGDS(ph)DHPS(ph)DGETSVQPM(ox)M(ox)TK_,S275,,24.05,,,23.12,,,,,,,,,,23.59,0.47, , ,-0.47, , , , , , , , , ,primary miRNA processing,nucleoplasm;microtubule cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6366,Q8WZ73,RFFL,E3 ubiquitin-protein ligase rififylin (EC 6.3.2.-) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like),VPGRRASLSDLTD,_RAS(ph)LSDLTDLEDIEGLTVR_,S103,+,,,,,27.72,,26.37,27.35,27.73,27.12,27.93,28.09,28.33,27.58, , , , ,0.14, ,-1.21,-0.23,0.15,-0.46,0.35,0.51,0.75,intracellular protein transport;apoptotic process;protein ubiquitination,cytoplasmic membrane-bounded vesicle;membrane,SAP-domain,,,,,,,,,,,,,
6367,Q8WZ73,RFFL,E3 ubiquitin-protein ligase rififylin (EC 6.3.2.-) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like),AEDETQSIDSEDS,_VPAEDETQS(ph)IDSEDSFVPGR_,S89,,22.41,,,,24.38,23.43,,24.49,,,24.32,,24.11,23.86,-1.45, , , ,0.53,-0.43, ,0.63, , ,0.47, ,0.25,intracellular protein transport;apoptotic process;protein ubiquitination,cytoplasmic membrane-bounded vesicle;membrane,SAP-domain,,,,,,,,,,,,,
6368,Q8WZ73,RFFL,E3 ubiquitin-protein ligase rififylin (EC 6.3.2.-) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like),ETQSIDSEDSFVP,_VPAEDETQSIDS(ph)EDSFVPGR_,S92,+,22.41,,,,26.23,25.21,24.38,24.57,24.89,24.31,24.83,24.30,25.65,24.68,-2.27, , , ,1.55,0.53,-0.30,-0.11,0.21,-0.37,0.15,-0.38,0.98,intracellular protein transport;apoptotic process;protein ubiquitination,cytoplasmic membrane-bounded vesicle;membrane,SAP-domain,,,,,,,,,,,,,
6370,Q8WZA1,POMGNT1,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)",DTRRAISEANEDP,_AIS(ph)EANEDPEPEQDYDEALGR_,S44,,,,,,,24.40,,,,,24.22,,25.27,24.63, , , , , ,-0.23, , , , ,-0.41, ,0.64,protein O-linked glycosylation,integral to membrane;Golgi membrane,,,,,,,,,,,,,,
6374,Q92499,DDX1,ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB),TRPGANSPEMWSE,_DNTRPGANS(ph)PEM(ox)WSEAIK_,S481,+,,22.46,22.46,,23.94,25.10,23.89,24.69,23.81,23.47,,22.93,,23.64, ,-1.18,-1.18, ,0.30,1.46,0.25,1.05,0.17,-0.17, ,-0.71, ,"multicellular organismal development;double-strand break repair;response to virus;regulation of translational initiation;regulation of transcription, DNA-dependent;DNA duplex unwinding;spliceosomal complex assembly;transcription, DNA-dependent;response to exogenous dsRNA",tRNA-splicing ligase complex;cytoplasmic stress granule;cleavage body,Other TF domain,,,,,,,,,,,,,
6375,Q92504,SLC39A7,Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7),STKEKQSSEEEEK,_EKQS(ph)SEEEEKETR_,S256,,,21.66,21.66,,,20.96,,21.68,,,,,,21.49, ,0.17,0.17, , ,-0.53, ,0.19, , , , , ,zinc ion transport;transmembrane transport,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6376,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),LEPGPDSPGGSSP,_DPGLEPGPDS(ph)PGGSSPPR_,S1391,+,21.78,24.53,22.86,26.11,23.24,25.86,26.35,24.16,23.02,26.96,28.42,25.39,25.70,24.95,-3.17,-0.42,-2.09,1.15,-1.72,0.91,1.40,-0.80,-1.93,2.01,3.47,0.44,0.74,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6379,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),ERDVDASPTAGLQ,_ELDDDERDVDAS(ph)PTAGLQEAATLAPTRR_,S165,,,,,,26.00,,24.38,25.34,24.18,27.18,26.28,24.22,26.52,25.51, , , , ,0.48, ,-1.13,-0.17,-1.33,1.67,0.77,-1.29,1.01,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6380,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),TGYHTRSGSEEAV,_S(ph)GSEEAVTDPGEREAGASLYQGLM(ox)R_,S1619,,,,,,26.03,26.74,,,26.47,26.69,,,26.81,26.55, , , , ,-0.52,0.19, , ,-0.08,0.14, , ,0.27,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6381,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),YHTRSGSEEAVTD,_SGS(ph)EEAVTDPGER_,S1621,,,26.40,,26.29,27.23,26.34,27.13,26.33,28.04,26.43,27.99,26.58,27.21,26.91, ,-0.51, ,-0.61,0.32,-0.56,0.23,-0.58,1.13,-0.48,1.08,-0.33,0.30,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6385,Q92522,H1FX,Histone H1x,_____MSVELEEA,_(ac)S(ph)VELEEALPVTTAEGM(ox)AK_,S2,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
6389,Q92538,GBF1,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1),LDRGYTSDSEVYT,_GYTS(ph)DSEVYTDHGRPGK_,S1318,+,23.13,25.31,23.52,25.79,25.09,,25.22,25.86,25.13,,27.21,,24.82,25.11,-1.98,0.20,-1.59,0.68,-0.01, ,0.11,0.75,0.02, ,2.10, ,-0.29,"retrograde vesicle-mediated transport, Golgi to ER;post-Golgi vesicle-mediated transport;COPI coating of Golgi vesicle;regulation of ARF protein signal transduction",trans-Golgi network;Golgi membrane,,,,,,,,,,,,,,
6390,Q92539,LPIN2,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),QTACPKSDSELEV,_S(ph)DSELEVKPAESLLR_,S243,+,24.41,23.43,24.17,22.69,22.88,,24.48,,24.37,25.09,25.56,25.50,,24.26,0.15,-0.83,-0.09,-1.57,-1.38, ,0.22, ,0.11,0.83,1.30,1.24, ,"triglyceride biosynthetic process;phosphatidylethanolamine biosynthetic process;fatty acid metabolic process;transcription, DNA-dependent;phosphatidylcholine biosynthetic process;positive regulation of transcription from RNA polymerase II promoter",cytosol;nucleus;endoplasmic reticulum membrane,,,+,,,,,,,,,,,
6398,Q92567,FAM168A,Protein FAM168A (Tongue cancer chemotherapy resistance-associated protein 1),_MNPVYSPVQPGA,_(ac)M(ox)NPVYS(ph)PVQPGAPYGNPK_,S6,,22.44,,,,,,,,,,,,,22.44,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6399,Q92576,PHF3,PHD finger protein 3,PPVDDLSPKKVKV,_M(ox)APPVDDLS(ph)PKK_,S1045,+,24.98,25.65,26.35,24.97,26.26,26.51,25.48,24.69,26.20,25.57,21.15,22.38,24.73,24.99,-0.01,0.65,1.35,-0.03,1.26,1.51,0.48,-0.30,1.21,0.58,-3.85,-2.61,-0.26,"multicellular organismal development;transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6400,Q92576,PHF3,PHD finger protein 3,VANTARSPQFINL,_S(ph)PQFINLK_,S1554,,21.83,22.61,,21.53,21.35,,,,,,,,,21.83,0.00,0.78, ,-0.30,-0.48, , , , , , , , ,"multicellular organismal development;transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6404,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),_____MSREMQDV,_(ac)S(ph)REMQDVDLAEVKPLVEK_,S2,+,28.26,25.63,26.29,23.44,24.76,25.35,25.04,25.84,25.46,26.89,25.94,24.86,,25.65,2.62,-0.02,0.64,-2.20,-0.88,-0.30,-0.61,0.19,-0.18,1.24,0.30,-0.79, ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6405,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),MTRLMRSRTASGS,_S(ph)RT(ph)AS(ph)GSSVTSLDGTR_,S288,,27.61,,,22.05,,,,,,,,,,24.83,2.78, , ,-2.78, , , , , , , , , ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6406,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),MRSRTASGSSVTS,_TAS(ph)GSSVTS(ph)LDGTR_,S292,+,33.49,29.92,27.86,27.65,29.00,28.92,28.22,30.32,,27.73,29.61,29.48,25.30,28.96,4.53,0.96,-1.10,-1.31,0.04,-0.04,-0.74,1.36, ,-1.23,0.65,0.52,-3.66,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6408,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),RTASGSSVTSLDG,_SRTAS(ph)GSS(ph)VTS(ph)LDGTR_,S295,+,30.24,25.66,23.50,23.53,24.12,,,23.58,,,,22.90,,24.79,5.45,0.87,-1.28,-1.26,-0.67, , ,-1.21, , , ,-1.89, ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6409,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),SGSSVTSLDGTRS,_SRTASGSS(ph)VTS(ph)LDGTR_,S298,+,29.97,26.54,24.00,25.65,23.47,,,25.49,22.09,,24.95,,,25.27,4.70,1.27,-1.27,0.38,-1.80, , ,0.22,-3.18, ,-0.31, , ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6410,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),SLDGTRSRSHTSE,_S(ph)RTAS(ph)GSSVTSLDGTRS(ph)R_,S304,,24.34,,,22.05,,,,,,,,,,23.20,1.14, , ,-1.14, , , , , , , , , ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6411,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),GYMPSASMTRLMR,_YFVQGM(ox)GYM(ox)PSAS(ph)M(ox)TR_,S281,,22.99,,,,,,,,,,,,,22.99,0.00, , , , , , , , , , , , ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
6412,Q92598,HSPH1,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein),PKPKIESPKLERT,_PKIES(ph)PKLER_,S809,+,28.17,26.31,27.12,29.17,30.39,25.62,27.98,27.09,27.25,26.85,28.75,28.65,26.98,27.72,0.45,-1.41,-0.60,1.45,2.68,-2.10,0.26,-0.63,-0.46,-0.87,1.03,0.94,-0.74,positive regulation of NK T cell activation;response to unfolded protein;chaperone mediated protein folding requiring cofactor;positive regulation of MHC class I biosynthetic process,extracellular region;nucleus;microtubule;cytoplasm,,,,,,,,,,,,,,
6413,Q92598,HSPH1,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein),TSQSPPSPELTSE,_NVQQDNSEAGTQPQVQTDAQQTSQSPPS(ph)PELTSEENKIPDADK_,S557,+,25.42,25.18,25.89,24.20,,23.73,28.42,26.63,27.46,26.69,27.88,27.23,26.73,26.29,-0.87,-1.11,-0.39,-2.09, ,-2.56,2.14,0.34,1.17,0.40,1.59,0.94,0.44,positive regulation of NK T cell activation;response to unfolded protein;chaperone mediated protein folding requiring cofactor;positive regulation of MHC class I biosynthetic process,extracellular region;nucleus;microtubule;cytoplasm,,,,,,,,,,,,,,
6416,Q92608,DOCK2,Dedicator of cytokinesis protein 2,KRTKRSSVVFADE,_RSS(ph)VVFADEK_,S1706,+,24.91,25.81,26.43,21.53,23.17,,24.78,23.89,,,,,,24.36,0.55,1.45,2.07,-2.83,-1.19, ,0.42,-0.47, , , , , ,regulation of defense response to virus by virus;alpha-beta T cell proliferation;small GTPase mediated signal transduction;establishment of T cell polarity;actin cytoskeleton organization;chemotaxis;negative thymic T cell selection;myeloid dendritic cell activation involved in immune response;positive thymic T cell selection;immunological synapse formation;macropinocytosis;viral reproduction;positive regulation of phagocytosis;membrane raft polarization,cytosol;endomembrane system;cytoskeleton;membrane,,,,,,,,,,+,,,,
6417,Q92608,DOCK2,Dedicator of cytokinesis protein 2,EQEEPISPGSTLP,_VEQEEPIS(ph)PGSTLPEVK_,S1685,,,23.55,23.30,,21.40,,,,,,,,,22.75, ,0.80,0.55, ,-1.35, , , , , , , , ,regulation of defense response to virus by virus;alpha-beta T cell proliferation;small GTPase mediated signal transduction;establishment of T cell polarity;actin cytoskeleton organization;chemotaxis;negative thymic T cell selection;myeloid dendritic cell activation involved in immune response;positive thymic T cell selection;immunological synapse formation;macropinocytosis;viral reproduction;positive regulation of phagocytosis;membrane raft polarization,cytosol;endomembrane system;cytoskeleton;membrane,,,,,,,,,,+,,,,
6419,Q92609,TBC1D5,TBC1 domain family member 5,NISSSPSVESLPG,_NISSSPS(ph)VESLPGGR_,S541,+,22.87,24.65,,22.65,,23.53,,21.58,23.66,21.92,24.05,23.48,,23.16,-0.29,1.50, ,-0.51, ,0.37, ,-1.57,0.51,-1.23,0.90,0.32, ,positive regulation of Rab GTPase activity,intracellular;retromer complex,,,,,,,,,,,,,,
6423,Q92609,TBC1D5,TBC1 domain family member 5,RLMKSESMPVQLN,_SES(ph)M(ox)PVQLNK_,S522,,24.00,22.30,22.20,,,,,,,,,,,22.83,1.17,-0.54,-0.63, , , , , , , , , , ,positive regulation of Rab GTPase activity,intracellular;retromer complex,,,,,,,,,,,,,,
6427,Q92610,ZNF592,Zinc finger protein 592,NTSRQESFEAEKD,_NTSRQES(ph)FEAEK_,S78,+,20.30,25.50,25.50,21.63,,,,,23.53,22.94,21.04,21.86,,22.79,-2.49,2.71,2.71,-1.16, , , , ,0.74,0.16,-1.75,-0.93, ,"cell death;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6433,Q92610,ZNF592,Zinc finger protein 592,LYAPNLSPPADSR,_VLHSSNPVPLYAPNLS(ph)PPADSR_,S573,+,,,,21.67,24.02,24.08,23.74,23.91,,24.53,24.15,23.53,24.91,23.84, , , ,-2.17,0.18,0.24,-0.10,0.08, ,0.69,0.31,-0.31,1.08,"cell death;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6434,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),RAAKFGSLAKQNS,_FGS(ph)LAK_,S126,,23.24,23.52,22.75,,,,,,,,,,,23.17,0.07,0.35,-0.42, , , , , , , , , , ,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6435,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),NKLEGDSDVDSEL,_NKLEGDS(ph)DVDS(ph)ELEDRVDGVK_,S1970,+,25.98,,,,25.85,24.25,25.38,25.13,25.99,26.33,26.52,26.55,25.34,25.73,0.25, , , ,0.12,-1.48,-0.35,-0.60,0.26,0.60,0.79,0.82,-0.39,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6436,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),GDSDVDSELEDRV,_NKLEGDS(ph)DVDS(ph)ELEDRVDGVK_,S1974,,25.49,,,,,,,,,,,,,25.49,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6437,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),MIVKRFSFSQRSR,_RFS(ph)FSQR_,S140,,25.19,,,,,,,,,,23.68,24.71,23.86,24.36,0.83, , , , , , , , , ,-0.68,0.35,-0.50,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6438,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),SLAPDRSDDEHDP,_SLAPDRS(ph)DDEHDPLDNTSRPR_,S2020,+,23.14,24.63,25.21,23.55,25.00,24.52,25.73,25.67,,24.91,25.52,25.84,24.52,24.85,-1.71,-0.22,0.35,-1.30,0.15,-0.34,0.88,0.82, ,0.06,0.66,0.99,-0.34,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6439,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),GSLKSSSPTSYWK,_SSS(ph)PTSYWK_,S2007,+,25.20,23.59,,,,22.09,23.68,23.00,22.69,23.40,,22.87,21.33,23.09,2.11,0.49, , , ,-1.01,0.58,-0.09,-0.40,0.31, ,-0.23,-1.77,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6440,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),TLQRSTSFRQGPE,_STS(ph)FRQGPEESGLGDGTGPK_,S728,+,25.44,22.96,22.96,24.12,21.97,22.76,23.32,21.63,22.43,21.90,,26.84,,23.30,2.14,-0.34,-0.34,0.81,-1.33,-0.55,0.02,-1.67,-0.87,-1.40, ,3.54, ,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6441,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),YSHSYLSDSDTEA,_YSHSYLS(ph)DS(ph)DTEAK_,S2041,+,26.65,24.19,24.55,,,23.50,,,23.46,,23.98,24.88,,24.46,2.19,-0.26,0.09, , ,-0.95, , ,-1.00, ,-0.48,0.42, ,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6442,Q92614,MYO18A,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain),HSYLSDSDTEAKL,_YSHSYLS(ph)DS(ph)DTEAK_,S2043,,26.65,,,,,,,,,25.26,,,,25.96,0.69, , , , , , , , ,-0.69, , , ,negative regulation of apoptotic process;actomyosin structure organization;cell migration;DNA metabolic process,endoplasmic reticulum-Golgi intermediate compartment;myosin complex;actomyosin,,,,,,,,,,,,,,
6443,Q92615,LARP4B,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),TPPKPPSPSFELG,_FTSSQTQSPT(ph)PPKPPS(ph)PSFELGLSSFPPLPGAAGNLK_,S524,,25.19,,,,,,,,,,,,,25.19,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6444,Q92615,LARP4B,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),TYERSPSPAHLPD,_SPS(ph)PAHLPDDPK_,S601,+,27.60,26.35,25.47,27.46,24.72,26.42,25.92,25.74,25.60,,27.24,25.69,25.94,26.18,1.42,0.17,-0.71,1.28,-1.46,0.24,-0.26,-0.44,-0.58, ,1.07,-0.49,-0.24,,,,,,,,,,,,,,,,
6446,Q92622,KIAA0226,Run domain Beclin-1 interacting and cysteine-rich containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron),SHIRSHSDTSIAS,_SHS(ph)DTSIASR_,S42,,,24.90,,23.97,20.16,,,,,,,,,23.01, ,1.89, ,0.96,-2.85, , , , , , , , ,autophagy;endocytosis;negative regulation of endocytosis;negative regulation of autophagy,late endosome;lysosome;early endosome,,,,,,,,,,,,,,
6447,Q92625,ANKS1A,Ankyrin repeat and SAM domain-containing protein 1A (Odin),KAELKLSRSLSKS,_AELKLS(ph)R_,S620,+,26.06,24.73,25.05,22.01,20.61,,21.25,,,,21.81,,,23.07,2.98,1.65,1.98,-1.07,-2.46, ,-1.82, , , ,-1.26, , ,neuron remodeling;ephrin receptor signaling pathway;substrate-dependent cell migration,neuron projection;nucleus;cytoplasm,,,,,,,,,,,,,,
6448,Q92625,ANKS1A,Ankyrin repeat and SAM domain-containing protein 1A (Odin),MGSRSESLSNCSI,_SES(ph)LSNCSIGK_,S647,+,23.49,24.54,23.97,24.61,,,22.68,22.51,,21.02,,,,23.26,0.23,1.28,0.71,1.35, , ,-0.58,-0.75, ,-2.24, , , ,neuron remodeling;ephrin receptor signaling pathway;substrate-dependent cell migration,neuron projection;nucleus;cytoplasm,,,,,,,,,,,,,,
6449,Q92625,ANKS1A,Ankyrin repeat and SAM domain-containing protein 1A (Odin),RLEKSPSFASEWD,_SPS(ph)FASEWDEIEK_,S663,+,26.91,22.85,23.25,24.01,23.93,22.73,23.36,23.94,23.56,23.79,23.24,24.77,,23.86,3.05,-1.01,-0.61,0.14,0.07,-1.13,-0.50,0.08,-0.30,-0.07,-0.62,0.91, ,neuron remodeling;ephrin receptor signaling pathway;substrate-dependent cell migration,neuron projection;nucleus;cytoplasm,,,,,,,,,,,,,,
6450,Q92667,AKAP1,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",PCRRSESSGILPN,_SES(ph)SGILPNTTDM(ox)R_,S107,,23.92,,,,,,,,,,,,,23.92,0.00, , , , , , , , , , , , ,blood coagulation;negative regulation of cardiac muscle hypertrophy;cellular response to insulin stimulus;negative regulation of NFAT protein import into nucleus;negative regulation of protein dephosphorylation,mitochondrion;mitochondrial crista;cytosol;mitochondrial outer membrane;neuromuscular junction;integral to membrane;lipid particle;postsynaptic membrane;mitochondrial matrix,,,,,,,,,,,,,,
6453,Q92667,AKAP1,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",LKSLLSSPTKDSK,_SLLSS(ph)PTK_,S445,+,25.57,25.39,25.39,23.73,23.04,,,23.73,22.69,23.62,21.67,,22.31,23.71,1.85,1.68,1.68,0.01,-0.67, , ,0.01,-1.03,-0.09,-2.04, ,-1.40,blood coagulation;negative regulation of cardiac muscle hypertrophy;cellular response to insulin stimulus;negative regulation of NFAT protein import into nucleus;negative regulation of protein dephosphorylation,mitochondrion;mitochondrial crista;cytosol;mitochondrial outer membrane;neuromuscular junction;integral to membrane;lipid particle;postsynaptic membrane;mitochondrial matrix,,,,,,,,,,,,,,
6454,Q92667,AKAP1,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",GLPAEGSPPPKTY,_TVLGPDTAEPATAEAAVAPPDAGLPLPGLPAEGS(ph)PPPK_,S429,,25.90,,,,,,,,,,,,,25.90,0.00, , , , , , , , , , , , ,blood coagulation;negative regulation of cardiac muscle hypertrophy;cellular response to insulin stimulus;negative regulation of NFAT protein import into nucleus;negative regulation of protein dephosphorylation,mitochondrion;mitochondrial crista;cytosol;mitochondrial outer membrane;neuromuscular junction;integral to membrane;lipid particle;postsynaptic membrane;mitochondrial matrix,,,,,,,,,,,,,,
6455,Q92673,SORL1,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),PLRRKRSAALQPE,_S(ph)AALQPEPIK_,S82,,22.91,,,,,,,,,,,,,22.91,0.00, , , , , , , , , , , , ,receptor-mediated endocytosis;cholesterol metabolic process;lipid transport,low-density lipoprotein particle;integral to plasma membrane,,,,,,,,,,,,,,
6456,Q92674,CENPI,Centromere protein I (CENP-I) (FSH primary response protein 1) (Follicle-stimulating hormone primary response protein) (Interphase centromere complex protein 19) (Leucine-rich primary response protein 1),QRNRGPSPEPLKL,_GPS(ph)PEPLK_,S284,,,,,23.04,,,,,,,,,,23.04, , , ,0.00, , , , , , , , , ,follicle-stimulating hormone signaling pathway;mitotic prometaphase;CENP-A containing nucleosome assembly at centromere;sex differentiation,nucleoplasm;cytosol;kinetochore,,,,,,,,,,,,,,
6457,Q92685,ALG3,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",KRGRSGSAAQAEG,_SGS(ph)AAQAEGLCK_,S13,+,25.82,25.65,24.97,26.62,22.67,,,,24.17,,22.44,24.04,,24.55,1.27,1.10,0.42,2.07,-1.88, , , ,-0.37, ,-2.11,-0.50, ,dolichol-linked oligosaccharide biosynthetic process;protein N-linked glycosylation via asparagine;post-translational protein modification,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6460,Q92729,PTPRU,Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi),SSLLGGSPRRPCG,_SGGVTEASSLLGGS(ph)PR_,S843,,24.34,22.21,22.29,,,,,,,,,,,22.95,1.39,-0.74,-0.66, , , , , , , , , , ,homotypic cell-cell adhesion;cell differentiation;transmembrane receptor protein tyrosine phosphatase signaling pathway;negative regulation of cell proliferation;cell-cell adhesion;canonical Wnt receptor signaling pathway;negative regulation of cell migration;protein localization to cell surface,cell-cell junction;integral to plasma membrane,,,+,,,,,,,,,,,
6461,Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),ELHKGDSDSEEDE,_IAAPELHKGDS(ph)DS(ph)EEDEPTK_,S157,+,28.73,26.18,26.18,21.52,25.78,26.03,25.37,25.16,25.70,25.88,24.06,23.78,25.21,25.35,3.37,0.83,0.83,-3.83,0.43,0.68,0.02,-0.19,0.35,0.53,-1.29,-1.57,-0.14,mitotic cell cycle checkpoint,nucleus,,,,,,,,,,,,,,
6462,Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),HKGDSDSEEDEPT,_IAAPELHKGDS(ph)DS(ph)EEDEPTK_,S159,+,28.62,25.08,25.78,21.52,25.78,25.56,24.65,24.56,25.73,26.20,,,,25.35,3.27,-0.27,0.44,-3.83,0.43,0.21,-0.69,-0.79,0.38,0.85, , , ,mitotic cell cycle checkpoint,nucleus,,,,,,,,,,,,,,
6463,Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),RKPSDGSPDTKPS,_KPSDGS(ph)PDTKPSR_,S212,,19.25,17.54,17.54,,,,,,,,,,,18.11,1.14,-0.57,-0.57, , , , , , , , , , ,mitotic cell cycle checkpoint,nucleus,,,,,,,,,,,,,,
6464,Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),LGLGLPSPRGPGL,_LQPPPPLPFGLGGFPPPPGVSPAEAAGVGEGLGLGLPS(ph)PR_,S114,,24.83,,,,,,,,,,,,,24.83,0.00, , , , , , , , , , , , ,mitotic cell cycle checkpoint,nucleus,,,,,,,,,,,,,,
6465,Q92733,PRCC,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),TQEEDDSDEEVAP,_QITQEEDDS(ph)DEEVAPENFFSLPEK_,S267,,27.52,,,,,,,,,,,,,27.52,0.00, , , , , , , , , , , , ,mitotic cell cycle checkpoint,nucleus,,,,,,,,,,,,,,
6466,Q92734,TFG,Protein TFG (TRK-fused gene protein),LTDDQVSGPPSAP,_NVM(ox)SAFGLTDDQVS(ph)GPPSAPAEDR_,S193,,24.05,,,,,,,,,,,,,24.05,0.00, , , , , , , , , , , , ,positive regulation of I-kappaB kinase/NF-kappaB cascade;cell death,cytoplasm,,,,,,,,,,,,,,
6470,Q92738,USP6NL,USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre),YSGNSGSPKNGKL,_IEVLPVDTGAGGYSGNSGS(ph)PK_,S716,,23.46,22.52,22.52,21.68,23.19,,,,23.44,23.54,,,,22.91,0.55,-0.39,-0.39,-1.22,0.29, , , ,0.54,0.63, , , ,positive regulation of Rab GTPase activity,intracellular,,,,,,,,,,,,,,
6472,Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),SRPRANSGGVDLD,_ANS(ph)GGVDLDSSGEFASIEK_,S1167,,24.34,,,23.36,24.82,,,,23.48,24.92,23.78,,,24.12,0.23, , ,-0.75,0.70, , , ,-0.64,0.80,-0.34, , ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;Ras protein signal transduction;transcription from RNA polymerase II promoter",nuclear body;nuclear speck;cytoplasm,C2H2-type,,,,,,,,,,,,,
6473,Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),TATAPPSPLKRRR,_DPNSATATAPPS(ph)PLK_,S161,+,27.10,25.74,26.44,24.29,,24.27,24.77,23.73,25.10,26.76,24.47,24.00,24.62,25.11,1.99,0.63,1.33,-0.82, ,-0.83,-0.33,-1.38,-0.01,1.66,-0.64,-1.11,-0.49,"multicellular organismal development;positive regulation of transcription, DNA-dependent;Ras protein signal transduction;transcription from RNA polymerase II promoter",nuclear body;nuclear speck;cytoplasm,C2H2-type,,,,,,,,,,,,,
6476,Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),EETEGPSDGESAA,_LAEETEGPS(ph)DGESAAEK_,S1475,+,26.75,,,,,26.52,,22.64,22.68,24.34,23.61,22.68,22.30,23.94,2.81, , , , ,2.58, ,-1.30,-1.26,0.40,-0.33,-1.26,-1.64,"multicellular organismal development;positive regulation of transcription, DNA-dependent;Ras protein signal transduction;transcription from RNA polymerase II promoter",nuclear body;nuclear speck;cytoplasm,C2H2-type,,,,,,,,,,,,,
6477,Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),ATAETASPVHREE,_QVAGDAPVEQATAETAS(ph)PVHR_,S1320,+,25.91,23.99,,,24.60,24.48,21.33,22.97,22.56,,,,,23.69,2.22,0.30, , ,0.91,0.79,-2.36,-0.73,-1.13, , , , ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;Ras protein signal transduction;transcription from RNA polymerase II promoter",nuclear body;nuclear speck;cytoplasm,C2H2-type,,,,,,,,,,,,,
6478,Q92766,RREB1,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),GDLNPESPAALGQ,_VTAGWPSEPGQGDLNPES(ph)PAALGQDLLEPR_,S1653,,26.28,25.42,25.60,23.98,,,,,,25.64,,,,25.38,0.90,0.03,0.21,-1.40, , , , , ,0.26, , , ,"multicellular organismal development;positive regulation of transcription, DNA-dependent;Ras protein signal transduction;transcription from RNA polymerase II promoter",nuclear body;nuclear speck;cytoplasm,C2H2-type,,,,,,,,,,,,,
6479,Q92769,HDAC2,Histone deacetylase 2 (HD2) (EC 3.5.1.98),ACDEEFSDSEDEG,_RIACDEEFS(ph)DS(ph)EDEGEGGRR_,S392,,26.91,,,,22.64,,,,,,,,,24.77,2.13, , , ,-2.13, , , , , , , , ,"negative regulation of apoptotic process;embryonic digit morphogenesis;positive regulation of oligodendrocyte differentiation;eyelid development in camera-type eye;negative regulation of canonical Wnt receptor signaling pathway;fungiform papilla formation;negative regulation of MHC class II biosynthetic process;blood coagulation;negative regulation of sequence-specific DNA binding transcription factor activity;epidermal cell differentiation;positive regulation of cell proliferation;negative regulation of neuron projection development;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;positive regulation of collagen biosynthetic process;histone H4 deacetylation;positive regulation of proteolysis;positive regulation of receptor biosynthetic process;hair follicle placode formation;negative regulation of cell cycle;dendrite development;negative regulation of transcription from RNA polymerase II promoter;hippocampus development;histone H3 deacetylation;odontogenesis of dentin-containing tooth;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;maintenance of chromatin silencing",NuRD complex;ESC/E(Z) complex;transcription factor complex;Sin3 complex;replication fork;heterochromatin;cytoplasm,,,,,,,,,,,,,,
6480,Q92769,HDAC2,Histone deacetylase 2 (HD2) (EC 3.5.1.98),DEEFSDSEDEGEG,_RIACDEEFS(ph)DS(ph)EDEGEGGRR_,S394,,26.91,,,,22.64,,,,,,,,,24.77,2.13, , , ,-2.13, , , , , , , , ,"negative regulation of apoptotic process;embryonic digit morphogenesis;positive regulation of oligodendrocyte differentiation;eyelid development in camera-type eye;negative regulation of canonical Wnt receptor signaling pathway;fungiform papilla formation;negative regulation of MHC class II biosynthetic process;blood coagulation;negative regulation of sequence-specific DNA binding transcription factor activity;epidermal cell differentiation;positive regulation of cell proliferation;negative regulation of neuron projection development;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;positive regulation of collagen biosynthetic process;histone H4 deacetylation;positive regulation of proteolysis;positive regulation of receptor biosynthetic process;hair follicle placode formation;negative regulation of cell cycle;dendrite development;negative regulation of transcription from RNA polymerase II promoter;hippocampus development;histone H3 deacetylation;odontogenesis of dentin-containing tooth;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;maintenance of chromatin silencing",NuRD complex;ESC/E(Z) complex;transcription factor complex;Sin3 complex;replication fork;heterochromatin;cytoplasm,,,,,,,,,,,,,,
6481,Q92769,HDAC2,Histone deacetylase 2 (HD2) (EC 3.5.1.98),DAVHEDSGDEDGE,_M(ox)LPHAPGVQMQAIPEDAVHEDS(ph)GDEDGEDPDKR_,S364,+,28.55,25.64,25.64,,29.66,29.48,30.20,28.95,30.58,30.96,28.83,29.43,29.28,28.93,-0.39,-3.29,-3.29, ,0.73,0.54,1.26,0.02,1.65,2.03,-0.10,0.50,0.34,"negative regulation of apoptotic process;embryonic digit morphogenesis;positive regulation of oligodendrocyte differentiation;eyelid development in camera-type eye;negative regulation of canonical Wnt receptor signaling pathway;fungiform papilla formation;negative regulation of MHC class II biosynthetic process;blood coagulation;negative regulation of sequence-specific DNA binding transcription factor activity;epidermal cell differentiation;positive regulation of cell proliferation;negative regulation of neuron projection development;chromatin remodeling;positive regulation of transcription from RNA polymerase II promoter;positive regulation of collagen biosynthetic process;histone H4 deacetylation;positive regulation of proteolysis;positive regulation of receptor biosynthetic process;hair follicle placode formation;negative regulation of cell cycle;dendrite development;negative regulation of transcription from RNA polymerase II promoter;hippocampus development;histone H3 deacetylation;odontogenesis of dentin-containing tooth;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;maintenance of chromatin silencing",NuRD complex;ESC/E(Z) complex;transcription factor complex;Sin3 complex;replication fork;heterochromatin;cytoplasm,,,,,,,,,,,,,,
6482,Q92785,DPF2,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",GEDKEDSQPPTPV,_EDS(ph)QPPTPVSQR_,S244,,24.15,25.37,26.06,23.98,,,,,,,,,21.73,24.26,-0.11,1.11,1.80,-0.27, , , , , , , , ,-2.53,"apoptotic signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;induction of apoptosis",nucleus;centrosome,C2H2-type,,,,,,,,,,,,,
6483,Q92785,DPF2,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",PRVDDDSLGEFPV,_RGAPDPRVDDDS(ph)LGEFPVTNSR_,S142,+,22.86,,,,26.16,24.47,25.49,25.61,25.71,27.35,25.14,26.29,25.57,25.46,-2.61, , , ,0.70,-1.00,0.02,0.14,0.24,1.89,-0.32,0.83,0.10,"apoptotic signaling pathway;transcription, DNA-dependent;regulation of transcription, DNA-dependent;induction of apoptosis",nucleus;centrosome,C2H2-type,,,,,,,,,,,,,
6484,Q92793,CREBBP,CREB-binding protein (EC 2.3.1.48),QPPRSISPSALQD,_SIS(ph)PSALQDLLR_,S2063,,24.38,,,,,,,,,,,,,24.38,0.00, , , , , , , , , , , , ,transcription initiation from RNA polymerase II promoter;N-terminal peptidyl-lysine acetylation;embryonic digit morphogenesis;small molecule metabolic process;regulation of S phase;protein complex assembly;cellular lipid metabolic process;regulation of smoothened signaling pathway;innate immune response;cell proliferation;regulation of transcription from RNA polymerase II promoter in response to hypoxia;Notch signaling pathway;homeostatic process;virus-host interaction;germ-line stem cell maintenance,nuclear chromatin;transcription factor complex;nuclear body;histone acetyltransferase complex;cytoplasm;condensed chromosome outer kinetochore,,,,,,,,,,,,,,
6485,Q92793,CREBBP,CREB-binding protein (EC 2.3.1.48),LSAMGKSPLSQGD,_S(ph)PLSQGDSSAPSLPK_,S121,,22.13,22.21,,23.55,,,24.21,,24.21,23.71,,,,23.34,-1.20,-1.13, ,0.21, , ,0.87, ,0.87,0.37, , , ,transcription initiation from RNA polymerase II promoter;N-terminal peptidyl-lysine acetylation;embryonic digit morphogenesis;small molecule metabolic process;regulation of S phase;protein complex assembly;cellular lipid metabolic process;regulation of smoothened signaling pathway;innate immune response;cell proliferation;regulation of transcription from RNA polymerase II promoter in response to hypoxia;Notch signaling pathway;homeostatic process;virus-host interaction;germ-line stem cell maintenance,nuclear chromatin;transcription factor complex;nuclear body;histone acetyltransferase complex;cytoplasm;condensed chromosome outer kinetochore,,,,,,,,,,,,,,
6486,Q92797,SYMPK,Symplekin,TLKEERSPQTLAP,_EERS(ph)PQTLAPVGEDAM(ox)K_,S1243,+,25.48,26.12,26.73,25.11,22.75,24.18,26.53,23.30,25.30,27.58,25.47,25.98,25.49,25.39,0.10,0.73,1.34,-0.27,-2.64,-1.21,1.15,-2.09,-0.09,2.20,0.09,0.60,0.11,mRNA processing;cell adhesion,tight junction;nucleoplasm;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6490,Q92817,EVPL,Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210),AKQGSESPAQAGR,_(gl)QGSES(ph)PAQAGRESEALK_,S906,,21.24,25.01,25.01,,,,22.18,22.10,,,,,,23.11,-1.87,1.90,1.90, , , ,-0.93,-1.01, , , , , ,peptide cross-linking;keratinocyte differentiation;keratinization,cornified envelope;desmosome;cytoplasm,,,,,,,,,,,,,,
6491,Q92817,EVPL,Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210),RCYRSASPTVPRS,_SAS(ph)PTVPR_,S2025,,23.94,24.27,22.55,23.58,,,,20.45,,,,,,22.96,0.98,1.31,-0.40,0.62, , , ,-2.51, , , , , ,peptide cross-linking;keratinocyte differentiation;keratinization,cornified envelope;desmosome;cytoplasm,,,,,,,,,,,,,,
6492,Q92823,NRCAM,Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),GTFGEYSDAEDHK,_EDDGTFGEYS(ph)DAEDHKPLK_,S1133,,,23.68,23.68,21.92,,22.32,24.78,,25.76,26.83,23.47,,22.53,23.89, ,-0.21,-0.21,-1.96, ,-1.57,0.90, ,1.88,2.94,-0.42, ,-1.35,cell-cell adhesion;angiogenesis;neuron migration;axon guidance;synapse assembly;positive regulation of neuron differentiation;central nervous system development;protein localization;axonal fasciculation;clustering of voltage-gated sodium channels;neuronal action potential propagation;retinal ganglion cell axon guidance;regulation of axon extension,synapse;integral to plasma membrane;external side of plasma membrane;axon initial segment,,,,,,,,,,,,,,
6494,Q92844,TANK,TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) (I-TRAF),RDEEDTSFESLSK,_DEEDTS(ph)FESLSK_,S116,,23.50,22.79,22.72,,,,,,,,,,23.47,23.12,0.39,-0.33,-0.40, , , , , , , , , ,0.35,signal transduction;I-kappaB kinase/NF-kappaB cascade;innate immune response,cytosol,C2H2-type,,,,,,,,,,,,,
6497,Q92870,APBB2,Amyloid beta A4 precursor protein-binding family B member 2 (Protein Fe65-like 1),DPNKNLSPTAVIN,_NLS(ph)PTAVINITSEK_,S106,+,22.86,22.46,23.01,24.39,,22.84,23.74,23.23,25.92,25.06,24.69,25.59,24.58,24.03,-1.17,-1.57,-1.02,0.36, ,-1.19,-0.29,-0.80,1.89,1.03,0.66,1.56,0.55,"negative regulation of cell growth;cell cycle arrest;regulation of transcription, DNA-dependent;negative regulation of S phase of mitotic cell cycle;intracellular signal transduction",growth cone;synapse;nucleus;lamellipodium;membrane,,,,,,,,,,,,,,
6498,Q92882,OSTF1,Osteoclast-stimulating factor 1,DAVRTLSNAEDYL,_TLS(ph)NAEDYLDDEDS(ph)D_,S202,,24.94,,,,,,,,,,,,,24.94,0.00, , , , , , , , , , , , ,signal transduction;ossification,intracellular;cytoplasm,,,,,,,,,,,,,,
6499,Q92882,OSTF1,Osteoclast-stimulating factor 1,YLDDEDSD_____,_TLS(ph)NAEDYLDDEDS(ph)D_,S213,,24.98,,,,,,,,,,,,,24.98,0.00, , , , , , , , , , , , ,signal transduction;ossification,intracellular;cytoplasm,,,,,,,,,,,,,,
6500,Q92890,UFD1L,Ubiquitin fusion degradation protein 1 homolog (UB fusion protein 1),FSGEGQSLRKKGR,_FVAFSGEGQS(ph)LR_,S299,,27.18,,,24.93,,,,,,,,25.16,,25.76,1.42, , ,-0.82, , , , , , , ,-0.60, ,proteasomal ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;skeletal system development,cytosol;nucleus,,,,,,,,,,,,,,
6501,Q92890,UFD1L,Ubiquitin fusion degradation protein 1 homolog (UB fusion protein 1),GVEPSPSPIKPGD,_GVEPSPS(ph)PIKPGDIK_,S247,+,23.60,24.65,24.65,22.67,22.30,23.21,25.33,23.40,,23.60,23.69,23.82,23.65,23.72,-0.11,0.94,0.94,-1.04,-1.42,-0.51,1.62,-0.31, ,-0.12,-0.03,0.10,-0.06,proteasomal ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;skeletal system development,cytosol;nucleus,,,,,,,,,,,,,,
6503,Q92917,GPKOW,G patch domain and KOW motifs-containing protein (G patch domain-containing protein 5) (Protein MOS2 homolog) (Protein T54),GDGAGPSPEEKDF,_LADSGDGAGPS(ph)PEEKDFLK_,S42,,23.04,22.56,22.56,24.09,,,,22.85,,,,,,23.02,0.02,-0.46,-0.46,1.06, , , ,-0.17, , , , , ,,nucleus,,,,,,,,,,,,,,
6504,Q92922,SMARCC1,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),ARKRKHSPSPPPP,_KHS(ph)PS(ph)PPPPTPTESR_,S328,+,24.26,25.29,25.82,24.97,25.10,20.78,21.00,20.73,22.28,21.23,,,,23.15,1.11,2.14,2.68,1.83,1.96,-2.37,-2.14,-2.42,-0.87,-1.92, , , ,"nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;insulin receptor signaling pathway;transcription, DNA-dependent;organ morphogenesis;chromatin remodeling;nervous system development;positive regulation of transcription from RNA polymerase II promoter",XY body;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6505,Q92922,SMARCC1,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),KRKHSPSPPPPTP,_KHS(ph)PS(ph)PPPPTPTESR_,S330,+,24.26,25.29,25.82,24.97,25.10,20.78,21.00,20.73,22.28,21.23,,,,23.15,1.11,2.14,2.68,1.83,1.96,-2.37,-2.14,-2.42,-0.87,-1.92, , , ,"nucleosome disassembly;regulation of transcription from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;insulin receptor signaling pathway;transcription, DNA-dependent;organ morphogenesis;chromatin remodeling;nervous system development;positive regulation of transcription from RNA polymerase II promoter",XY body;WINAC complex;SWI/SNF complex;npBAF complex;nBAF complex,,,,,,,,,,,,,,
6508,Q92925,SMARCD2,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B),YISNTFSPSKAEG,_IYISNTFS(ph)PSK_,S128,,24.29,22.88,,23.52,,,23.73,22.93,24.38,23.22,,,,23.56,0.73,-0.68, ,-0.05, , ,0.16,-0.63,0.81,-0.34, , , ,"nucleosome disassembly;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin remodeling",SWI/SNF complex,,,,,,,,,,,,,,
6510,Q92934,BAD,Bcl2 antagonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-XL/Bcl-2-associated death promoter),RELRRMSDEFVDS,_RM(ox)S(ph)DEFVDSFK_,S118,+,24.31,22.62,21.65,23.01,23.97,,24.55,22.57,22.74,23.22,26.30,25.77,23.34,23.67,0.64,-1.05,-2.02,-0.66,0.30, ,0.88,-1.10,-0.93,-0.45,2.63,2.10,-0.33,cellular response to nicotine;intrinsic apoptotic signaling pathway;positive regulation of release of cytochrome c from mitochondria;pore complex assembly;fibroblast growth factor receptor signaling pathway;positive regulation of B cell differentiation;induction of apoptosis;positive regulation of mitochondrial membrane potential;glucose homeostasis;cellular response to mechanical stimulus;positive regulation of autophagy;glucose catabolic process;ADP metabolic process;regulation of mitochondrial membrane permeability;cellular response to lipid;cytokine-mediated signaling pathway;phosphatidylinositol-mediated signaling;type B pancreatic cell proliferation;positive regulation of glucokinase activity;extrinsic apoptotic signaling pathway;positive regulation of T cell differentiation;positive regulation of epithelial cell proliferation;positive regulation of insulin secretion;cellular response to hypoxia;epidermal growth factor receptor signaling pathway;cellular process regulating host cell cycle in response to virus;positive regulation of insulin secretion involved in cellular response to glucose stimulus;nerve growth factor receptor signaling pathway;positive regulation of type B pancreatic cell development;ATP metabolic process,mitochondrial outer membrane;cytosol,,,,,,,,,,,,,,
6511,Q92934,BAD,Bcl2 antagonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-XL/Bcl-2-associated death promoter),FRGRSRSAPPNLW,_S(ph)APPNLWAAQR_,S99,+,24.38,,,23.41,22.38,22.05,,23.90,22.55,,23.58,,,23.18,1.20, , ,0.23,-0.79,-1.13, ,0.73,-0.63, ,0.40, , ,cellular response to nicotine;intrinsic apoptotic signaling pathway;positive regulation of release of cytochrome c from mitochondria;pore complex assembly;fibroblast growth factor receptor signaling pathway;positive regulation of B cell differentiation;induction of apoptosis;positive regulation of mitochondrial membrane potential;glucose homeostasis;cellular response to mechanical stimulus;positive regulation of autophagy;glucose catabolic process;ADP metabolic process;regulation of mitochondrial membrane permeability;cellular response to lipid;cytokine-mediated signaling pathway;phosphatidylinositol-mediated signaling;type B pancreatic cell proliferation;positive regulation of glucokinase activity;extrinsic apoptotic signaling pathway;positive regulation of T cell differentiation;positive regulation of epithelial cell proliferation;positive regulation of insulin secretion;cellular response to hypoxia;epidermal growth factor receptor signaling pathway;cellular process regulating host cell cycle in response to virus;positive regulation of insulin secretion involved in cellular response to glucose stimulus;nerve growth factor receptor signaling pathway;positive regulation of type B pancreatic cell development;ATP metabolic process,mitochondrial outer membrane;cytosol,,,,,,,,,,,,,,
6513,Q92945,KHSRP,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),LPERSVSLTGAPE,_SVS(ph)LTGAPESVQK_,S193,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"RNA splicing, via transesterification reactions;mRNA processing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA transport",nucleoplasm;cytosol,Other TF domain,,,,,,,,,,,,,
6514,Q92945,KHSRP,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),GCKVQISPDSGGL,_VQIS(ph)PDS(ph)GGLPER_,S181,+,28.55,25.90,25.11,26.78,27.74,28.62,27.97,27.86,28.27,27.52,26.46,26.16,27.37,27.26,1.29,-1.36,-2.14,-0.47,0.48,1.36,0.72,0.61,1.01,0.26,-0.79,-1.09,0.12,"RNA splicing, via transesterification reactions;mRNA processing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA transport",nucleoplasm;cytosol,Other TF domain,,,,,,,,,,,,,
6515,Q92945,KHSRP,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),VQISPDSGGLPER,_VQIS(ph)PDS(ph)GGLPER_,S184,,23.39,,,,,,,,,,,,,23.39,0.00, , , , , , , , , , , , ,"RNA splicing, via transesterification reactions;mRNA processing;transcription, DNA-dependent;regulation of transcription, DNA-dependent;mRNA transport",nucleoplasm;cytosol,Other TF domain,,,,,,,,,,,,,
6519,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),GLRRILSQSTDSL,_ILS(ph)QSTDSLNM(ox)R_,S145,,21.86,,,,,,,,,,,,,21.86,0.00, , , , , , , , , , , , ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
6520,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),RRILSQSTDSLNM,_ILSQS(ph)TDSLNM(ox)R_,S147,+,25.87,23.56,22.96,25.79,24.26,,,22.67,,,,24.46,,24.22,1.64,-0.67,-1.26,1.56,0.04, , ,-1.55, , , ,0.24, ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
6526,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),TALQSVSLRSKTT,_NNTALQSVS(ph)LR_,S82,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
6529,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),VDPRRRSLPAGDA,_S(ph)LPAGDALYLSFNPPQPSR_,S858,,26.04,,,,,,,,,,,,,26.04,0.00, , , , , , , , , , , , ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
6530,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),SLAKSVSTTNIAG,_SVS(ph)TTNIAGHFNDESPLGLR_,S124,,23.90,,,21.78,22.31,,,,,,,22.81,,22.70,1.20, , ,-0.92,-0.39, , , , , , ,0.11, ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
6532,Q92997,DVL3,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),YKFFFKSMDDDFG,_S(ph)M(ox)DDDFGVVK_,S48,,25.44,22.44,,24.73,,,24.72,,,,,26.54,,24.77,0.66,-2.33, ,-0.04, , ,-0.05, , , , ,1.77, ,"response to drug;positive regulation of JUN kinase activity;outflow tract septum morphogenesis;non-canonical Wnt receptor signaling pathway via JNK cascade;convergent extension;canonical Wnt receptor signaling pathway;planar cell polarity pathway involved in neural tube closure;positive regulation of transcription, DNA-dependent;cochlea morphogenesis;intracellular signal transduction",cell cortex,,,,,,,,,,,,,,
6533,Q93008,USP9X,"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",DVDDDMSGDEKQD,_NGILAIEGTGSDVDDDM(ox)S(ph)GDEK_,S1600,,,,,,,,,,23.60,24.53,24.03,25.18,,24.33, , , , , , , , ,-0.74,0.19,-0.31,0.85, ,transcription initiation from RNA polymerase II promoter;protein deubiquitination;chromosome segregation;ubiquitin-dependent protein catabolic process;female gamete generation;transforming growth factor beta receptor signaling pathway;mitosis;BMP signaling pathway;negative regulation of transcription from RNA polymerase II promoter;cell division,cytosol;apical part of cell,,,,,,,,,,,,,,
6534,Q93009,USP7,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),AGEQQLSEPEDME,_AGEQQLS(ph)EPEDM(ox)EMEAGDTDDPPR_,S18,+,28.16,26.42,24.42,27.07,27.64,27.76,26.33,26.87,26.10,24.10,26.00,23.42,26.75,26.23,1.92,0.18,-1.82,0.84,1.40,1.53,0.10,0.64,-0.13,-2.13,-0.23,-2.82,0.52,protein deubiquitination;multicellular organismal development;maintenance of DNA methylation;regulation of protein stability;negative regulation of NF-kappaB transcription factor activity;ubiquitin-dependent protein catabolic process;induction of apoptosis;transcription-coupled nucleotide-excision repair;virus-host interaction,cytosol;PML body;nucleus,,,,,,,,,,,,,,
6536,Q93074,MED12,Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component) (ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein),PGPRPPSPFDDPA,_GDLAFGAPGPRPPS(ph)PFDDPADDPEHK_,S635,,,,,,,,24.87,24.31,25.62,25.40,,25.25,,25.09, , , , , , ,-0.22,-0.78,0.53,0.31, ,0.16, ,transcription initiation from RNA polymerase II promoter;negative regulation of Wnt receptor signaling pathway;androgen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter,mediator complex,,,,,,,,,,,,,,
6539,Q93100,PHKB,Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta),AFLRSGSVYEPLK,_SGS(ph)VYEPLK_,S20,,21.95,,,,,,,,,,,,,21.95,0.00, , , , , , , , , , , , ,small molecule metabolic process;glucose metabolic process;glycogen catabolic process,cytosol;plasma membrane;phosphorylase kinase complex,,,,,,,,,,,,,,
6540,Q969E4,TCEAL3,Transcription elongation factor A protein-like 3 (TCEA-like protein 3) (Transcription elongation factor S-II protein-like 3),QLEDEGSQEKQGR,_REDEGEPGDEGQLEDEGS(ph)QEK_,S65,+,26.51,27.59,26.25,25.00,22.49,,25.75,25.73,26.67,22.91,24.30,25.40,24.22,25.24,1.27,2.36,1.02,-0.24,-2.75, ,0.52,0.50,1.44,-2.33,-0.93,0.17,-1.02,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6542,Q969G5,PRKCDBP,Protein kinase C delta-binding protein (Cavin-3) (Serum deprivation response factor-related gene product that binds to C-kinase) (hSRBC),SVRRIQSGLGALS,_IQS(ph)GLGALSR_,S62,+,,22.61,21.32,22.85,24.68,24.69,24.02,23.98,24.25,22.73,23.65,,24.55,23.58, ,-0.96,-2.26,-0.73,1.10,1.11,0.44,0.41,0.67,-0.85,0.08, ,0.98,,,,,,,,,,,,,,,,
6543,Q969H4,CNKSR1,Connector enhancer of kinase suppressor of ras 1 (Connector enhancer of KSR 1) (CNK homolog protein 1) (CNK1) (hCNK1) (Connector enhancer of KSR-like),DSPHQRSPSLSLA,_S(ph)PSLSLAPLS(ph)PR_,S40,,23.00,,,,,,,,,,,,,23.00,0.00, , , , , , , , , , , , ,transmembrane receptor protein tyrosine kinase signaling pathway;Rho protein signal transduction,cell-cell junction;cell cortex;plasma membrane,,,,,,,,,,,,,,
6544,Q969H4,CNKSR1,Connector enhancer of kinase suppressor of ras 1 (Connector enhancer of KSR 1) (CNK homolog protein 1) (CNK1) (hCNK1) (Connector enhancer of KSR-like),LSLAPLSPRAPSE,_S(ph)PSLSLAPLS(ph)PR_,S49,,23.58,,,,,,,,,,,,,23.58,0.00, , , , , , , , , , , , ,transmembrane receptor protein tyrosine kinase signaling pathway;Rho protein signal transduction,cell-cell junction;cell cortex;plasma membrane,,,,,,,,,,,,,,
6545,Q969L2,MAL2,Protein MAL2,_____MSAGGASV,_(ac)S(ph)AGGASVPPPPNPAVSFPPPR_,S2,,25.81,24.08,,22.20,25.21,,24.06,25.35,25.27,26.45,25.36,,24.95,24.87,0.94,-0.80, ,-2.67,0.33, ,-0.81,0.48,0.39,1.58,0.49, ,0.07,,endomembrane system;integral to membrane;apical plasma membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6546,Q969R5,L3MBTL2,Lethal(3)malignant brain tumor-like protein 2 (H-l(3)mbt-like protein 2) (L(3)mbt-like protein 2),SPDKASSPELPVS,_ASS(ph)PELPVSVENIK_,S689,,26.09,24.21,24.21,24.06,,,24.65,,,,,,,24.64,1.45,-0.44,-0.43,-0.58, , ,0.00, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
6547,Q969R5,L3MBTL2,Lethal(3)malignant brain tumor-like protein 2 (H-l(3)mbt-like protein 2) (L(3)mbt-like protein 2),AGELPTSPLHLLS,_EAGELPTS(ph)PLHLLSPGTPR_,S67,,22.29,21.42,21.42,,,,,,,,,,,21.71,0.58,-0.29,-0.29, , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
6551,Q969V6,MKL1,MKL/myocardin-like protein 1 (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein) (Myocardin-related transcription factor A) (MRTF-A),GLARQNSTSLTGK,_(gl)QNS(ph)TSLTGKPGALPANLDDM(ox)K_,S333,,22.98,,,23.71,,,,,,,,24.46,,23.72,-0.73, , ,-0.01, , , , , , , ,0.74, ,"smooth muscle cell differentiation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
6554,Q969X1,TMBIM1,Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1),GEERAVSDSFGPG,_AVS(ph)DSFGPGEWDDR_,S81,+,,,,,24.34,23.92,23.59,23.69,,24.49,24.64,23.90,,24.08, , , , ,0.26,-0.16,-0.50,-0.40, ,0.40,0.56,-0.18, ,,endosome membrane;integral to membrane;lysosomal membrane,,,,,,,,,,,,,,
6556,Q96A00,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A (17 kDa PKC-potentiated inhibitory protein of PP1) (Protein kinase C-potentiated inhibitor protein of 17 kDa) (CPI-17),PGLRQPSPSHDGS,_(gl)QPGLRQPS(ph)PSHDGSLSPLQDR_,S101,+,26.33,24.22,,23.23,23.47,,22.27,25.24,22.56,,,,,23.90,2.43,0.32, ,-0.67,-0.44, ,-1.63,1.33,-1.34, , , , ,regulation of phosphorylation,cytoplasm,,,,,,,,,,,,,,
6558,Q96A00,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A (17 kDa PKC-potentiated inhibitory protein of PP1) (Protein kinase C-potentiated inhibitor protein of 17 kDa) (CPI-17),SHDGSLSPLQDRA,_(gl)QPS(ph)PSHDGS(ph)LS(ph)PLQDR_,S109,,25.10,,,,,,,,,,,,,25.10,0.00, , , , , , , , , , , , ,regulation of phosphorylation,cytoplasm,,,,,,,,,,,,,,
6559,Q96A57,TMEM230,Transmembrane protein 230,KYSRLSSTDDGYI,_LSS(ph)TDDGYIDLQFK_,S24,+,25.23,22.80,20.82,22.77,21.02,24.42,22.85,23.36,25.61,,25.21,25.01,24.66,23.65,1.58,-0.84,-2.83,-0.88,-2.63,0.78,-0.80,-0.28,1.97, ,1.56,1.37,1.01,,integral to membrane,,,,,,,,,,,,,,
6564,Q96AD5,PNPLA2,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2) (Desnutrin) (IPLA2-zeta) (Pigment epithelium-derived factor) (TTS2.2) (Transport-secretion protein 2) (TTS2),WMRNNLSLGDALA,_NNLS(ph)LGDALAK_,S428,,22.73,,,,,,,,,,,,,22.73,0.00, , , , , , , , , , , , ,triglyceride catabolic process;small molecule metabolic process;glycerophospholipid biosynthetic process;positive regulation of triglyceride catabolic process;negative regulation of sequestering of triglyceride;acylglycerol acyl-chain remodeling,cytosol;integral to membrane;lipid particle;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6565,Q96AD5,PNPLA2,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2) (Desnutrin) (IPLA2-zeta) (Pigment epithelium-derived factor) (TTS2.2) (Transport-secretion protein 2) (TTS2),ELRRVQSLPSVPL,_VQS(ph)LPSVPLSCAAYR_,S404,,21.92,22.23,21.89,21.84,,,,,22.82,,22.49,,,22.20,-0.28,0.03,-0.31,-0.36, , , , ,0.62, ,0.29, , ,triglyceride catabolic process;small molecule metabolic process;glycerophospholipid biosynthetic process;positive regulation of triglyceride catabolic process;negative regulation of sequestering of triglyceride;acylglycerol acyl-chain remodeling,cytosol;integral to membrane;lipid particle;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6566,Q96AH8,RAB7B,Ras-related protein Rab-7b,ENHLTESIKLSPD,_YQSILENHLTES(ph)IK_,S186,,,,,,,,,,,,22.81,24.68,24.31,23.93, , , , , , , , , , ,-1.12,0.75,0.38,positive regulation of interleukin-6 production;small GTPase mediated signal transduction;late endosome to Golgi transport;positive regulation of NF-kappaB transcription factor activity;positive regulation of megakaryocyte differentiation;protein transport;negative regulation of toll-like receptor 9 signaling pathway;negative regulation of toll-like receptor 4 signaling pathway,trans-Golgi network;late endosome;Golgi apparatus;lysosome,,,,,,,,,,,,,,
6570,Q96AT1,KIAA1143,Uncharacterized protein KIAA1143,KNSSLLSFDNEDE,_NSSLLS(ph)FDNEDENE_,S146,,24.96,,,,21.19,,,,,,,23.53,,23.23,1.73, , , ,-2.03, , , , , , ,0.30, ,,,,,,,,,,,,,,,,
6571,Q96AT1,KIAA1143,Uncharacterized protein KIAA1143,DEDGDHSDKEDEQ,_RIQPQPPDEDGDHS(ph)DK_,S50,,20.85,25.92,25.92,,,,,,,,22.00,,,23.67,-2.82,2.25,2.25, , , , , , , ,-1.68, , ,,,,,,,,,,,,,,,,
6572,Q96AX9,MIB2,E3 ubiquitin-protein ligase MIB2 (EC 6.3.2.-) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1),ELQRRVSADSQPF,_RVS(ph)ADSQPFQHGDK_,S309,+,20.67,23.95,23.73,,23.15,,24.09,24.45,23.64,22.52,,,,23.28,-2.60,0.68,0.45, ,-0.12, ,0.81,1.17,0.37,-0.76, , , ,positive regulation of I-kappaB kinase/NF-kappaB cascade;Notch signaling pathway,endosome,,,,,,,,,,,,,,
6574,Q96B23,C18orf25,Uncharacterized protein C18orf25,AKEEDGSVELESQ,_EEDGS(ph)VELESQVQK_,S34,,,,,,,,,,,24.00,22.78,,23.07,23.28, , , , , , , , , ,0.72,-0.51, ,-0.21,,,,,,,,,,,,,,,,
6577,Q96B23,C18orf25,Uncharacterized protein C18orf25,MELRRDSSESQLA,_RDS(ph)SESQLASTESDKPTTGR_,S66,+,24.49,25.34,25.10,24.64,26.92,26.93,25.89,26.91,25.19,26.04,25.46,24.58,25.36,25.60,-1.11,-0.26,-0.50,-0.96,1.32,1.33,0.29,1.30,-0.42,0.44,-0.14,-1.02,-0.25,,,,,,,,,,,,,,,,
6578,Q96B23,C18orf25,Uncharacterized protein C18orf25,KSRRSRSESETST,_SRS(ph)ESETSTM(ox)AAKK_,S145,,,24.13,25.04,21.61,,,,,,18.74,,,18.76,21.66, ,2.47,3.39,-0.05, , , , , ,-2.91, , ,-2.90,,,,,,,,,,,,,,,,
6579,Q96B36,AKT1S1,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),PAPQPPSPTPSPP,_AATAARPPAPPPAPQPPS(ph)PTPS(ph)PPRPTLAR_,S108,+,25.76,25.05,25.78,24.62,27.26,,26.11,27.04,25.53,23.89,26.45,26.01,,25.77,-0.01,-0.72,0.01,-1.16,1.49, ,0.33,1.27,-0.25,-1.89,0.68,0.24, ,negative regulation of TOR signaling cascade;fibroblast growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of cell size;negative regulation of protein kinase activity;nerve growth factor receptor signaling pathway;regulation of neuron apoptotic process;phosphatidylinositol-mediated signaling,nucleus;cytosolic part;protein complex,,,,,,,,,,,,,,
6580,Q96B36,AKT1S1,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),PPSPTPSPPRPTL,_AATAARPPAPPPAPQPPS(ph)PTPS(ph)PPRPTLAR_,S112,+,25.76,23.88,24.16,24.62,27.26,,26.11,27.04,25.53,23.89,26.45,26.01,,25.52,0.24,-1.64,-1.35,-0.90,1.74, ,0.59,1.52,0.01,-1.63,0.93,0.49, ,negative regulation of TOR signaling cascade;fibroblast growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of cell size;negative regulation of protein kinase activity;nerve growth factor receptor signaling pathway;regulation of neuron apoptotic process;phosphatidylinositol-mediated signaling,nucleus;cytosolic part;protein complex,,,,,,,,,,,,,,
6581,Q96B36,AKT1S1,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),TQQYAKSLPVSVP,_S(ph)LPVSVPVWGFK_,S203,+,,23.46,23.59,25.78,23.27,,22.82,23.38,24.01,22.90,,24.61,,23.76, ,-0.30,-0.17,2.02,-0.49, ,-0.93,-0.38,0.25,-0.86, ,0.85, ,negative regulation of TOR signaling cascade;fibroblast growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of cell size;negative regulation of protein kinase activity;nerve growth factor receptor signaling pathway;regulation of neuron apoptotic process;phosphatidylinositol-mediated signaling,nucleus;cytosolic part;protein complex,,,,,,,,,,,,,,
6583,Q96B36,AKT1S1,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),ENGPPSSPDLDRI,_SS(ph)DEENGPPSS(ph)PDLDR_,S232,+,25.73,25.21,,25.24,,,25.07,23.25,22.19,23.72,24.46,,,24.36,1.37,0.85, ,0.89, , ,0.71,-1.11,-2.17,-0.64,0.10, , ,negative regulation of TOR signaling cascade;fibroblast growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of cell size;negative regulation of protein kinase activity;nerve growth factor receptor signaling pathway;regulation of neuron apoptotic process;phosphatidylinositol-mediated signaling,nucleus;cytosolic part;protein complex,,,,,,,,,,,,,,
6584,Q96B97,SH3KBP1,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),AGHRANSPSLFGT,_ANS(ph)PSLFGTEGKPK_,S550,+,,,,22.53,24.26,22.96,24.42,23.93,,,23.06,24.70,,23.69, , , ,-1.16,0.57,-0.73,0.72,0.24, , ,-0.64,1.01, ,regulation of cell shape;endocytosis;cell migration;cell-cell signaling;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;cytoskeleton organization,neuron projection;cytosol;cytoplasmic vesicle membrane;synapse;plasma membrane;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
6585,Q96B97,SH3KBP1,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),DIFDSPSPEEDKE,_ATGRRPPSQSLTSSSLSSPDIFDSPS(ph)PEEDK_,S474,,,,,,,,26.74,,25.86,,26.91,28.20,24.15,26.37, , , , , , ,0.37, ,-0.52, ,0.54,1.83,-2.22,regulation of cell shape;endocytosis;cell migration;cell-cell signaling;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;cytoskeleton organization,neuron projection;cytosol;cytoplasmic vesicle membrane;synapse;plasma membrane;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
6586,Q96B97,SH3KBP1,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),IKLRPRSIEVEND,_S(ph)IEVENDFLPVEK_,S193,+,24.33,22.61,23.34,22.42,25.73,21.79,25.56,25.43,25.03,24.13,25.98,25.39,25.46,24.40,-0.07,-1.79,-1.06,-1.98,1.33,-2.61,1.16,1.03,0.63,-0.27,1.58,0.99,1.06,regulation of cell shape;endocytosis;cell migration;cell-cell signaling;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;cytoskeleton organization,neuron projection;cytosol;cytoplasmic vesicle membrane;synapse;plasma membrane;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
6587,Q96B97,SH3KBP1,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),ETTGSESDGGDSS,_SSLRETTGSES(ph)DGGDSSSTK_,S146,+,20.71,26.59,26.59,23.44,,,22.73,21.90,21.63,21.24,22.82,22.97,,23.06,-2.36,3.53,3.53,0.38, , ,-0.33,-1.16,-1.43,-1.83,-0.24,-0.09, ,regulation of cell shape;endocytosis;cell migration;cell-cell signaling;epidermal growth factor receptor signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;apoptotic process;cytoskeleton organization,neuron projection;cytosol;cytoplasmic vesicle membrane;synapse;plasma membrane;focal adhesion;cytoskeleton,,,,,,,,,,,,,,
6588,Q96BD0,SLCO4A1,Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),SPGTPLSPGSLRS,_ASPGTPLS(ph)PGSLR_,S40,,26.58,22.14,21.53,,21.77,,,,,26.59,,,,23.72,2.85,-1.58,-2.19, ,-1.95, , , , ,2.87, , , ,thyroid hormone metabolic process;sodium-independent organic anion transport;transmembrane transport,integral to membrane;plasma membrane,,,,,,,,,,,,,,
6590,Q96BD0,SLCO4A1,Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),LRSAAHSPLDTSK,_SAAHS(ph)PLDTSK_,S50,,22.88,,,,,,,,,20.79,,,,21.83,1.05, , , , , , , , ,-1.05, , , ,thyroid hormone metabolic process;sodium-independent organic anion transport;transmembrane transport,integral to membrane;plasma membrane,,,,,,,,,,,,,,
6592,Q96BD5,PHF21A,PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80),QSSHPDSPENEKT,_YNAVLGFGALTPTS(ph)PQSSHPDS(ph)PENEK_,S455,,23.27,,,,,,,,,,,,,23.27,0.00, , , , , , , , , , , , ,"suckling behavior;blood coagulation;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",histone deacetylase complex,Other TF domain,,,,,,,,,,,,,
6593,Q96BH1,RNF25,E3 ubiquitin-protein ligase RNF25 (EC 6.3.2.-) (RING finger protein 25),PGTRRESLGLESK,_RES(ph)LGLESK_,S450,,23.39,,,23.87,,,,,,,,,,23.63,-0.24, , ,0.24, , , , , , , , , ,positive regulation of NF-kappaB transcription factor activity,cytosol;nucleus,,,,,,,,,,,,,,
6594,Q96BT3,CENPT,Centromere protein T (CENP-T) (Interphase centromere complex protein 22),ASGRAASPESASS,_AAS(ph)PESASSTPESLQAR_,S397,,22.33,22.79,,23.39,24.14,23.11,,,,,,,,23.15,-0.82,-0.36, ,0.24,0.99,-0.04, , , , , , , ,mitotic prometaphase;kinetochore assembly;chromosome segregation;cell division,cytosol;nucleus;condensed chromosome kinetochore;kinetochore,,,,,,,,,,,,,,
6595,Q96BY7,ATG2B,Autophagy-related protein 2 homolog B,LPSRSVSVDESRP,_SVS(ph)VDESRPELIFR_,S497,+,22.82,20.26,,22.88,23.58,,23.82,23.48,23.28,23.19,24.96,26.08,22.92,23.39,-0.57,-3.12, ,-0.51,0.19, ,0.43,0.09,-0.11,-0.20,1.57,2.69,-0.47,autophagy,,,,,,,,,,,,,,,
6596,Q96BZ8,LENG1,Leukocyte receptor cluster member 1,KARHQNSLPELEA,_HQNS(ph)LPELEAAEAGAPGSGPVDLFR_,S59,,21.68,,,,,,,,,,,,,21.68,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6597,Q96C19,EFHD2,EF-hand domain-containing protein D2 (Swiprosin-1),GIGEPQSPSRRVF,_RADLNQGIGEPQS(ph)PSRR_,S74,+,24.54,23.58,,,23.88,22.01,22.69,22.52,23.70,24.97,23.48,23.42,23.30,23.46,1.08,0.11, , ,0.42,-1.46,-0.77,-0.94,0.24,1.51,0.02,-0.04,-0.16,,membrane raft,,,,,,,,,,,,,,
6598,Q96C19,EFHD2,EF-hand domain-containing protein D2 (Swiprosin-1),ELATKLSRRLQME,_(ac)ATDELATKLS(ph)R_,S11,,24.41,,,,,,,,,,,,,24.41,0.00, , , , , , , , , , , , ,,membrane raft,,,,,,,,,,,,,,
6602,Q96C90,PPP1R14B,Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein),PRVYFQSPPGAAG,_VYFQS(ph)PPGAAGEGPGGADDEGPVRR_,S32,,,,,,25.07,,24.04,24.55,,,,,,24.55, , , , ,0.52, ,-0.52,0.00, , , , , ,regulation of phosphorylation,cytoplasm,,,,,,,,,,,,,,
6603,Q96CB9,NSUN4,5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4),LAANDLSPSRIAR,_NLAANDLS(ph)PSR_,S73,+,24.03,23.98,,23.73,23.66,23.92,23.47,23.87,23.17,,,,,23.73,0.31,0.25, ,0.00,-0.06,0.19,-0.26,0.14,-0.56, , , , ,,mitochondrial large ribosomal subunit,,,,,,,,,,,,,,
6604,Q96CC6,RHBDF1,Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho),VLQRQTSITQTIR,_(gl)QTS(ph)ITQTIR_,S76,+,24.79,22.83,21.19,25.69,24.09,22.12,25.56,24.80,23.54,22.39,24.94,25.83,23.36,23.93,0.86,-1.11,-2.74,1.75,0.15,-1.81,1.63,0.87,-0.39,-1.55,1.01,1.90,-0.57,cell proliferation;proteolysis;regulation of epidermal growth factor receptor signaling pathway;negative regulation of protein secretion;protein transport;cell migration;regulation of proteasomal protein catabolic process,integral to membrane;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
6605,Q96CC6,RHBDF1,Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho),YRKRIDSFVKRQI,_RIDS(ph)FVK_,S390,+,22.70,24.34,24.27,25.21,21.62,23.43,25.17,22.20,25.56,,26.10,25.22,24.38,24.18,-1.48,0.16,0.08,1.03,-2.56,-0.75,0.99,-1.99,1.38, ,1.91,1.04,0.19,cell proliferation;proteolysis;regulation of epidermal growth factor receptor signaling pathway;negative regulation of protein secretion;protein transport;cell migration;regulation of proteasomal protein catabolic process,integral to membrane;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
6606,Q96CJ1,EAF2,ELL-associated factor 2 (Testosterone-regulated apoptosis inducer and tumor suppressor protein),DKMSPASPIDDIE,_M(ox)SPAS(ph)PIDDIER_,S24,,21.89,21.43,21.43,20.10,,,,,,,,,,21.21,0.68,0.22,0.22,-1.11, , , , , , , , , ,"positive regulation of transcription, DNA-dependent;negative regulation of cell growth;negative regulation of epithelial cell proliferation involved in prostate gland development;apoptotic process;transcription, DNA-dependent;induction of apoptosis",nuclear speck;nucleus,,,,,,,,,,,,,,
6609,Q96CP6,GRAMD1A,GRAM domain-containing protein 1A,DRSQEPSPVGSRR,_SQEPS(ph)PVGSR_,S260,,22.23,25.33,,24.71,,,,24.90,,,,,25.89,24.61,-2.38,0.72, ,0.10, , , ,0.29, , , , ,1.28,,integral to membrane,,,,,,,,,,,,,,
6612,Q96CT7,CCDC124,Coiled-coil domain-containing protein 124,RVLEEGSVEARTI,_VLEEGS(ph)VEAR_,S141,,24.11,,,,,,,,,,,,,24.11,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6613,Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),VKEIKHSPGPTRT,_EIKHS(ph)PGPTR_,S141,,20.25,22.86,22.86,19.46,,,,18.99,,,19.06,17.84,,20.19,0.06,2.67,2.67,-0.73, , , ,-1.20, , ,-1.13,-2.35, ,signal transduction;Golgi to plasma membrane protein transport;cell death;Golgi ribbon formation;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;cytoplasmic membrane-bounded vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6614,Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),RHGARTSDSDQQA,_TS(ph)DSDQQAYLVQR_,S469,+,25.68,,,26.14,,23.63,,,23.81,22.27,26.07,,22.21,24.26,1.42, , ,1.88, ,-0.63, , ,-0.45,-1.99,1.81, ,-2.05,signal transduction;Golgi to plasma membrane protein transport;cell death;Golgi ribbon formation;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;cytoplasmic membrane-bounded vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6616,Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),ALERKNSAIPSEL,_KNS(ph)AIPSELNEK_,S285,+,24.48,23.96,24.86,24.96,,22.93,24.66,23.64,,,25.81,26.56,25.01,24.69,-0.21,-0.73,0.17,0.28, ,-1.76,-0.03,-1.04, , ,1.12,1.87,0.32,signal transduction;Golgi to plasma membrane protein transport;cell death;Golgi ribbon formation;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;cytoplasmic membrane-bounded vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6617,Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),SGSSEDSFVEIRM,_LNSSGSSEDS(ph)FVEIR_,S120,,25.28,,,,23.79,,,,,,,,,24.54,0.75, , , ,-0.75, , , , , , , , ,signal transduction;Golgi to plasma membrane protein transport;cell death;Golgi ribbon formation;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;cytoplasmic membrane-bounded vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6618,Q96CV9,OPTN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),GPTRTVSTGTALS,_TVS(ph)TGTALSK_,S149,,23.28,,,,,,,,,,,,,23.28,0.00, , , , , , , , , , , , ,signal transduction;Golgi to plasma membrane protein transport;cell death;Golgi ribbon formation;protein targeting to Golgi,trans-Golgi network;Golgi apparatus;cytoplasmic membrane-bounded vesicle;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6620,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),GVHKEGSLGDELL,_EGS(ph)LGDELLPLGYSEPEQQEGASAGAPS(ph)PTLELASR_,S151,,24.83,,,,,,,,,,,,,24.83,0.00, , , , , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
6622,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),ASAGAPSPTLELA,_EGSLGDELLPLGYSEPEQQEGASAGAPS(ph)PTLELASR_,S176,,30.18,,,,,,,,,,,,,30.18,0.00, , , , , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
6623,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),LELASRSPSGGAA,_S(ph)PSGGAAGPLLTPSQSLDGSRR_,S185,+,27.87,24.44,24.63,24.20,24.97,23.71,23.03,25.57,25.26,,23.20,21.42,22.84,24.26,3.61,0.18,0.37,-0.06,0.71,-0.55,-1.23,1.31,1.00, ,-1.07,-2.84,-1.42,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
6624,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),LASRSPSGGAAGP,_SPS(ph)GGAAGPLLTPSQSLDGSR_,S187,,26.80,23.85,,24.01,,,,,23.73,,,,,24.60,2.21,-0.75, ,-0.59, , , , ,-0.87, , , , ,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
6626,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),LLTPSQSLDGSRR,_SPSGGAAGPLLT(ph)PSQS(ph)LDGSRR_,S200,,25.94,,,,,,,,,,,,,25.94,0.00, , , , , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
6627,Q96D09,GPRASP2,G-protein coupled receptor-associated sorting protein 2 (GASP-2),VGFRSTSPFGIPE,_STS(ph)PFGIPEEASEM(ox)LEAKPK_,S512,,,,,,23.50,22.06,23.73,24.92,,,24.44,23.47,,23.69, , , , ,-0.18,-1.63,0.04,1.23, , ,0.75,-0.22, ,,cytoplasm,,,,,,,,,,,,,,
6628,Q96D46,NMD3,60S ribosomal export protein NMD3 (hNMD3),SAIPVESDTDDEG,_DSAIPVES(ph)DT(ph)DDEGAPR_,S468,+,26.84,21.33,21.33,23.35,25.78,23.92,23.42,22.52,24.69,,,24.49,,23.77,3.07,-2.44,-2.44,-0.42,2.02,0.16,-0.35,-1.25,0.92, , ,0.73, ,protein transport,nucleoplasm;nucleolus;cytoplasm,,,,,,,,,,,,,,
6629,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),VKKGSVSHDTVQP,_KGSVS(ph)HDTVQPR_,S145,,23.71,24.26,24.73,,,,,,,,,,,24.24,-0.52,0.03,0.49, , , , , , , , , , ,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6630,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),EVGYSGSPAEAPP,_LIDLEDSADVGDQPGEVGYSGS(ph)PAEAPPSK_,S392,,25.37,,,,,,,,,25.12,,,,25.25,0.12, , , , , , , , ,-0.12, , , ,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6631,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),IEIRRQSSSYDDP,_RQS(ph)S(ph)SYDDPWK_,S272,+,24.38,24.36,24.60,24.17,24.99,24.57,25.36,25.33,24.58,22.56,24.37,26.19,23.53,24.54,-0.15,-0.18,0.07,-0.37,0.45,0.03,0.83,0.79,0.04,-1.98,-0.17,1.65,-1.01,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6632,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),EIRRQSSSYDDPW,_RQS(ph)S(ph)SYDDPWK_,S273,,23.71,,,,,,,,,,,,,23.71,0.00, , , , , , , , , , , , ,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6633,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),DHTNPTSPLLVKP,_RTGSDHTNPTS(ph)PLLVKPSDLLEENK_,S455,+,,22.01,22.01,,,22.49,24.38,23.56,23.38,23.64,,,23.49,23.12, ,-1.11,-1.11, , ,-0.63,1.26,0.44,0.26,0.52, , ,0.37,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6634,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),VRRRLKSEDELRP,_S(ph)EDELRPEVDEHTQK_,S650,+,22.85,25.89,25.89,,,,24.82,22.09,24.95,24.35,,25.09,,24.49,-1.64,1.40,1.40, , , ,0.33,-2.40,0.45,-0.14, ,0.60, ,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6635,Q96D71,REPS1,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),SHSRSSSLDMNRT,_SSS(ph)LDM(ox)NR_,S535,,18.99,,,22.18,16.80,,18.78,,,,,19.56,,19.26,-0.27, , ,2.92,-2.46, ,-0.48, , , , ,0.30, ,receptor-mediated endocytosis,coated pit;plasma membrane,,,,,,,,,,,,,,
6637,Q96DF8,DGCR14,Protein DGCR14 (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2),ELIPQESPRVGGF,_VGPDGKELIPQES(ph)PR_,S292,+,25.19,24.86,24.87,25.60,25.36,,,23.08,25.00,,24.49,23.71,,24.68,0.51,0.18,0.18,0.91,0.67, , ,-1.60,0.32, ,-0.20,-0.98, ,"mRNA splicing, via spliceosome;nervous system development",catalytic step 2 spliceosome,,,,,,,,,,,,,,
6638,Q96DR7,ARHGEF26,Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor),KALDIDSDEESEP,_ALDIDS(ph)DEESEPK_,S392,+,23.51,,,23.89,24.73,24.24,26.48,25.23,24.12,23.05,25.32,27.09,25.31,24.81,-1.31, , ,-0.93,-0.09,-0.58,1.67,0.41,-0.70,-1.77,0.50,2.28,0.49,regulation of Rho protein signal transduction,intracellular;ruffle,,,,,,,,,,,,,,
6642,Q96DT7,ZBTB10,Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF),KSEAPESVVVDYN,_SEAPES(ph)VVVDYNNRK_,S182,,,24.99,24.99,22.60,,,,,,,,,,24.19, ,0.80,0.80,-1.59, , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6643,Q96DY7,MTBP,Mdm2-binding protein (hMTBP),VLTPELSPGKLQV,_TFVLTPELS(ph)PGK_,S639,,24.06,,,,,,22.62,,21.98,22.96,,,,22.91,1.16, , , , , ,-0.28, ,-0.93,0.05, , , ,negative regulation of cell proliferation;cell cycle arrest;traversing start control point of mitotic cell cycle,,,,,,,,,,,,,,,
6645,Q96E09,FAM122A,Protein FAM122A,IDFIPVSPAPSPT,_RIDFIPVS(ph)PAPS(ph)PTR_,S143,,25.98,,,,24.15,,,,,,,22.46,,24.20,1.79, , , ,-0.05, , , , , , ,-1.74, ,,,,,,,,,,,,,,,,
6646,Q96E09,FAM122A,Protein FAM122A,PVSPAPSPTRGIG,_RIDFIPVS(ph)PAPS(ph)PTRGIGK_,S147,+,26.04,21.36,,,24.71,23.74,22.41,22.89,22.73,,22.44,22.46,22.98,23.18,2.86,-1.82, , ,1.53,0.56,-0.76,-0.29,-0.45, ,-0.74,-0.72,-0.19,,,,,,,,,,,,,,,,
6649,Q96E09,FAM122A,Protein FAM122A,TTDSPVSPAQAAS,_VSTTTDSPVS(ph)PAQAASPFIPLDELSSK_,S270,+,,24.80,,25.70,25.56,,26.66,,26.83,,25.17,24.36,,25.58, ,-0.78, ,0.12,-0.03, ,1.08, ,1.24, ,-0.41,-1.22, ,,,,,,,,,,,,,,,,
6650,Q96E39,RBMXL1,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)",YGGSRDSYSSSRS,_DGYGGSRDS(ph)YSSSR_,S326,+,24.67,24.97,23.22,25.38,23.96,22.78,21.00,22.66,23.42,,22.49,,,23.45,1.22,1.52,-0.24,1.93,0.50,-0.67,-2.46,-0.79,-0.04, ,-0.97, , ,mRNA processing;RNA splicing,ribonucleoprotein complex;nucleus,,,,,,,,,,,,,,
6651,Q96E39,RBMXL1,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)",ERGLPPSVERGYP,_GLPPS(ph)VER_,S351,+,24.37,24.21,22.31,24.25,23.64,23.62,22.15,23.65,24.69,23.63,,21.70,21.64,23.32,1.05,0.89,-1.01,0.93,0.32,0.30,-1.17,0.33,1.37,0.31, ,-1.62,-1.68,mRNA processing;RNA splicing,ribonucleoprotein complex;nucleus,,,,,,,,,,,,,,
6655,Q96EN8,MOCOS,Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (hMCS) (EC 2.8.1.9),MGRRSLSPQEDAL,_SLS(ph)PQEDALTGSR_,S530,,22.71,20.90,20.90,,23.58,,,24.16,,23.30,,23.54,,22.73,-0.02,-1.83,-1.83, ,0.85, , ,1.44, ,0.57, ,0.81, ,Mo-molybdopterin cofactor biosynthetic process;water-soluble vitamin metabolic process;molybdopterin cofactor biosynthetic process,cytosol,,,,,,,,,,,,,,
6656,Q96EP0,RNF31,E3 ubiquitin-protein ligase RNF31 (EC 6.3.2.-) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (Zinc in-between-RING-finger ubiquitin-associated domain protein),RLAQPPSLVVDSR,_LAQPPS(ph)LVVDSR_,S198,,23.38,,,,,,,,,,,,,23.38,0.00, , , , , , , , , , , , ,positive regulation of I-kappaB kinase/NF-kappaB cascade;T cell receptor signaling pathway;CD40 signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein linear polyubiquitination,CD40 receptor complex;LUBAC complex;internal side of plasma membrane;cytoplasm,,,,,,,,,,,,,,
6657,Q96EP0,RNF31,E3 ubiquitin-protein ligase RNF31 (EC 6.3.2.-) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (Zinc in-between-RING-finger ubiquitin-associated domain protein),GPPRRLSAPLPSS,_RLS(ph)APLPSSCGDPEK_,S281,,21.27,,,22.60,,,,,22.90,,,23.81,,22.64,-1.37, , ,-0.04, , , , ,0.25, , ,1.16, ,positive regulation of I-kappaB kinase/NF-kappaB cascade;T cell receptor signaling pathway;CD40 signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein linear polyubiquitination,CD40 receptor complex;LUBAC complex;internal side of plasma membrane;cytoplasm,,,,,,,,,,,,,,
6658,Q96EQ0,SGTB,Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2),NHIRSRSFSSSAE,_SRS(ph)FSSSAEEHS_,S295,+,18.04,24.30,23.82,24.62,22.08,20.73,21.52,22.41,21.18,,22.33,23.73,,22.25,-4.21,2.05,1.57,2.37,-0.17,-1.52,-0.73,0.16,-1.07, ,0.08,1.48, ,,,,,,,,,,,,,,,,
6659,Q96EQ0,SGTB,Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2),IRSRSFSSSAEEH,_SFS(ph)SSAEEHS_,S297,+,21.48,25.29,24.22,25.69,22.00,,21.68,22.05,21.72,,23.66,22.59,,23.04,-1.55,2.25,1.18,2.65,-1.04, ,-1.36,-0.99,-1.32, ,0.63,-0.44, ,,,,,,,,,,,,,,,,
6660,Q96EV2,RBM33,RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33),KDIKEESDEEEED,_EES(ph)DEEEEDDEESGRLR_,S205,+,26.40,26.89,26.81,25.13,27.77,27.86,27.49,27.45,27.64,27.52,26.35,22.47,26.75,26.66,-0.26,0.23,0.16,-1.52,1.11,1.21,0.83,0.79,0.98,0.87,-0.31,-4.19,0.10,,,,,,,,,,,,,,,,
6661,Q96EV2,RBM33,RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33),VTHRTNSGGGDGP,_TNS(ph)GGGDGPHISSK_,S973,,24.26,21.55,,,,,20.65,,,,,,,22.15,2.11,-0.60, , , , ,-1.51, , , , , , ,,,,,,,,,,,,,,,,
6663,Q96EY5,MVB12A,Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A),RDMQGLSLDAASQ,_DM(ox)QGLS(ph)LDAASQPSK_,S78,,25.24,,,24.54,,,,,,,,25.46,,25.08,0.16, , ,-0.54, , , , , , , ,0.38, ,protein transport,aggresome;nucleus;late endosome membrane;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
6664,Q96EZ8,MCRS1,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),DQVLNFSDAEDLI,_GDQVLNFS(ph)DAEDLIDDSK_,S295,,24.73,,,,,,,,,,,,,24.73,0.00, , , , , , , , , , , , ,"DNA repair;histone H4-K8 acetylation;histone H4-K5 acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent;histone H4-K16 acetylation;DNA recombination",histone acetyltransferase complex;MLL1 complex;Ino80 complex;cytoplasm,,,,,,,,,,,,,,
6665,Q96F63,CCDC97,Coiled-coil domain-containing protein 97,EPEDAPSPELDGD,_DEEERYFDEEEPEDAPS(ph)PELDGD_,S337,,24.94,,,,,,,,,,,,,24.94,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6666,Q96F86,EDC3,Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1),FRRRHNSWSSSSR,_HNS(ph)WSSSSR_,S161,,19.75,22.50,,22.51,,,,,,,,,,21.59,-1.84,0.92, ,0.92, , , , , , , , , ,gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,cytosol;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
6671,Q96FQ6,S100A16,Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16),_____MSDCYTEL,_(ac)S(ph)DCYTELEK_,S2,,24.11,,,,,,,,,22.91,,,,23.51,0.60, , , , , , , , ,-0.60, , , ,response to calcium ion,cytosol;nucleolus;plasma membrane,,,,,,,,,,,,,,
6672,Q96FS4,SIPA1,Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1),TQDRPGSPSGSED,_PSVPSADSETPLTQDRPGS(ph)PSGSEDK_,S782,+,,25.25,24.98,24.15,,,26.05,,26.73,25.29,26.09,26.67,23.83,25.45, ,-0.20,-0.47,-1.30, , ,0.60, ,1.28,-0.16,0.64,1.22,-1.62,negative regulation of cell adhesion;cell proliferation;negative regulation of cell growth;negative regulation of cell cycle;cytoskeleton organization;intracellular signal transduction,cytosol;endomembrane system;nucleus;membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6673,Q96FS4,SIPA1,Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1),PLLRSGSDAGEAR,_SGS(ph)DAGEARPPTPASPR_,S55,+,,25.15,25.85,24.71,24.16,23.16,24.62,23.60,25.39,22.58,23.17,25.42,23.21,24.25, ,0.90,1.60,0.46,-0.09,-1.09,0.36,-0.65,1.14,-1.67,-1.08,1.17,-1.04,negative regulation of cell adhesion;cell proliferation;negative regulation of cell growth;negative regulation of cell cycle;cytoskeleton organization;intracellular signal transduction,cytosol;endomembrane system;nucleus;membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6675,Q96FT9,IFT43,Intraflagellar transport protein 43 homolog,KFRRKASEEIEDF,_KAS(ph)EEIEDFR_,S78,+,22.89,23.61,,,24.68,,,25.08,23.32,,25.06,,23.49,24.02,-1.13,-0.41, , ,0.66, , ,1.06,-0.70, ,1.04, ,-0.53,intraflagellar retrograde transport;cilium morphogenesis,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
6677,Q96FV9,THOC1,THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) (p84N5) (hTREX84),_____MSPTPPLF,_(ac)M(ox)S(ph)PTPPLFSLPEAR_,S2,+,,24.36,,24.11,27.46,,25.13,25.32,26.27,25.31,24.92,23.87,26.22,25.29, ,-0.94, ,-1.19,2.16, ,-0.16,0.02,0.97,0.01,-0.38,-1.43,0.92,"intronless viral mRNA export from host nucleus;regulation of DNA-dependent transcription, elongation;signal transduction;mRNA processing;apoptotic process;RNA splicing;transcription, DNA-dependent;RNA processing",THO complex part of transcription export complex;nuclear speck;nuclear matrix;cytoplasm,Other TF domain,,,,,,,,,+,,,,
6678,Q96FZ5,CMTM7,CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7),_____MSHGAGLV,_(ac)S(ph)HGAGLVR_,S2,,23.34,22.73,,,,,,,,,,,,23.04,0.30,-0.30, , , , , , , , , , , ,chemotaxis,extracellular space;integral to membrane,,,,,,,,,,,,,,
6681,Q96G23,CERS2,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),DREETESSEGEEA,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,S348,,25.61,,,,,,,,,,,,,25.61,0.00, , , , , , , , , , , , ,phospholipid metabolic process;small molecule metabolic process;ceramide biosynthetic process;sphingolipid biosynthetic process,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,Homeobox,,,,,,,,,,,,,
6682,Q96G23,CERS2,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),REETESSEGEEAA,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,S349,,25.61,,,,,,,,,,,,,25.61,0.00, , , , , , , , , , , , ,phospholipid metabolic process;small molecule metabolic process;ceramide biosynthetic process;sphingolipid biosynthetic process,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,Homeobox,,,,,,,,,,,,,
6684,Q96GM8,TOE1,Target of EGR1 protein 1,__MAADSDDGAVS,_AADS(ph)DDGAVSAPAASDGGVSK_,S5,+,25.49,25.17,25.71,25.95,26.95,26.44,26.17,27.09,26.81,26.37,,25.07,24.85,26.01,-0.52,-0.84,-0.30,-0.06,0.95,0.44,0.17,1.08,0.81,0.37, ,-0.94,-1.16,,nucleolus;nuclear speck,,,,,,,,,,,,,,
6685,Q96GN5,CDCA7L,Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2),GKASLVSEEEEDE,_ASLVS(ph)EEEEDEEEDK_,S83,,,22.73,22.73,23.75,,,23.49,,23.16,23.22,,23.73,,23.26, ,-0.53,-0.53,0.49, , ,0.23, ,-0.10,-0.04, ,0.47, ,"positive regulation of cell proliferation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus;cytoplasm,,,,,,,,,,,,,,
6686,Q96GP6,SCARF2,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),AAGRAPSPPPPGS,_APS(ph)PPPPGSEAAPSPSK_,S682,,,24.38,,24.25,,23.56,,,23.23,,23.86,,23.74,23.84, ,0.54, ,0.41, ,-0.27, , ,-0.61, ,0.02, ,-0.10,heterophilic cell-cell adhesion,integral to membrane,,,,,,,,,,,,,,
6688,Q96GP6,SCARF2,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),GLSLSPSPERRKP,_ARGEIGGLSLSPS(ph)PER_,S648,+,,20.74,,23.66,24.50,24.84,24.30,24.38,24.73,,24.68,23.73,25.47,24.10, ,-3.36, ,-0.44,0.40,0.74,0.19,0.28,0.63, ,0.57,-0.37,1.37,heterophilic cell-cell adhesion,integral to membrane,,,,,,,,,,,,,,
6689,Q96GP6,SCARF2,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),KPPRKKSREAAGE,_S(ph)REAAGELGR_,S850,+,21.30,25.76,24.50,26.07,21.60,21.47,,,23.76,20.40,22.60,22.92,16.80,22.47,-1.17,3.29,2.03,3.60,-0.87,-1.00, , ,1.29,-2.07,0.13,0.45,-5.67,heterophilic cell-cell adhesion,integral to membrane,,,,,,,,,,,,,,
6691,Q96GV9,C5orf30,UNC119-binding protein C5orf30,PGAEANSPGKAEA,_STLTTLPFPGAEANS(ph)PGK_,S25,,23.06,22.88,22.88,,,,,,21.75,,,,,22.64,0.42,0.24,0.24, , , , , ,-0.90, , , , ,protein transport;cilium morphogenesis,ciliary transition zone;cytoplasm,,,,,,,,,,,,,,
6692,Q96GX5,MASTL,Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L),DLELALSPIHNSS,_DLELALS(ph)PIHNSSALPTTGR_,S370,,22.13,,,,,,,,,,,,,22.13,0.00, , , , , , , , , , , , ,G2/M transition of mitotic cell cycle;regulation of cell cycle;mitosis;negative regulation of protein phosphatase type 2A activity;response to DNA damage stimulus;cell division,nucleus;centrosome;cleavage furrow,,+,,,,,,,,,,,,
6693,Q96GX9,APIP,Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (hAPIP),KDISGPSPSKKLK,_DISGPS(ph)PSK_,S87,+,23.14,22.99,22.99,25.63,,21.19,,22.68,21.92,20.87,,21.90,,22.59,0.55,0.40,0.40,3.04, ,-1.40, ,0.09,-0.67,-1.72, ,-0.69, ,negative regulation of apoptotic process;L-methionine salvage from methylthioadenosine;polyamine metabolic process;apoptotic process,cytosol,,,,,,,,,,,,,,
6694,Q96GY3,LIN37,Protein lin-37 homolog (Antolefinin),CRSRIPSPLQPEM,_SRIPS(ph)PLQPEM(ox)QGTPDDEPSEPEPSPSTLIYR_,S83,+,21.85,,,,25.40,25.01,24.55,24.36,24.88,24.45,,,,24.36,-2.51, , , ,1.04,0.66,0.19,0.00,0.53,0.09, , , ,mitotic cell cycle,nucleoplasm,,,,,,,,,,,,,,
6697,Q96HB5,CCDC120,Coiled-coil domain-containing protein 120,RTRRSNSSEALLV,_SNS(ph)SEALLVDR_,S348,+,23.62,21.20,,22.21,22.91,,24.02,23.30,,,,22.33,,22.80,0.82,-1.60, ,-0.59,0.11, ,1.22,0.50, , , ,-0.46, ,,,,,,,,,,,,,,,,
6698,Q96HC4,PDLIM5,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),KPVPITSPAVSKV,_EVVKPVPITS(ph)PAVSK_,S111,+,23.90,23.50,24.34,23.41,25.11,23.11,25.19,25.12,23.84,23.02,24.47,25.51,24.58,24.24,-0.33,-0.74,0.10,-0.83,0.87,-1.13,0.95,0.88,-0.40,-1.22,0.23,1.27,0.34,regulation of synapse assembly;regulation of dendritic spine morphogenesis,Z disc;postsynaptic density;actin cytoskeleton;cytosol;cell junction;plasma membrane;membrane;postsynaptic membrane,,,,,,,,,,,,,,
6699,Q96HC4,PDLIM5,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),STGVIKSPSWQRP,_S(ph)PSWQRPNQGVPSTGR_,S360,+,22.92,23.69,23.69,24.02,23.01,,25.03,,24.36,,24.04,25.03,,23.98,-1.06,-0.29,-0.29,0.05,-0.97, ,1.05, ,0.38, ,0.07,1.05, ,regulation of synapse assembly;regulation of dendritic spine morphogenesis,Z disc;postsynaptic density;actin cytoskeleton;cytosol;cell junction;plasma membrane;membrane;postsynaptic membrane,,,,,,,,,,,,,,
6700,Q96HE7,ERO1L,ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha),AVKPCQSDEVPDG,_DCAVKPCQS(ph)DEVPDGIK_,S106,,25.35,23.89,24.74,,,,,,,,,21.53,,23.88,1.47,0.01,0.86, , , , , , , , ,-2.35, ,electron transport chain;endoplasmic reticulum unfolded protein response;cellular protein modification process;release of sequestered calcium ion into cytosol;brown fat cell differentiation;response to temperature stimulus;chaperone mediated protein folding requiring cofactor;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,endoplasmic reticulum membrane;membrane;endoplasmic reticulum lumen,,,,,,,,,,,,,,
6701,Q96HE7,ERO1L,ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha),LGAVDESLSEETQ,_LGAVDES(ph)LS(ph)EETQK_,S143,,24.00,,,,,,,,,,,,,24.00,0.00, , , , , , , , , , , , ,electron transport chain;endoplasmic reticulum unfolded protein response;cellular protein modification process;release of sequestered calcium ion into cytosol;brown fat cell differentiation;response to temperature stimulus;chaperone mediated protein folding requiring cofactor;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,endoplasmic reticulum membrane;membrane;endoplasmic reticulum lumen,,,,,,,,,,,,,,
6702,Q96HE7,ERO1L,ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Oxidoreductin-1-L-alpha),AVDESLSEETQKA,_LGAVDESLS(ph)EETQK_,S145,,26.94,23.71,24.60,22.43,,,23.64,,,,,,,24.26,2.68,-0.56,0.34,-1.84, , ,-0.62, , , , , , ,electron transport chain;endoplasmic reticulum unfolded protein response;cellular protein modification process;release of sequestered calcium ion into cytosol;brown fat cell differentiation;response to temperature stimulus;chaperone mediated protein folding requiring cofactor;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,endoplasmic reticulum membrane;membrane;endoplasmic reticulum lumen,,,,,,,,,,,,,,
6703,Q96HH4,TMEM169,Transmembrane protein 169,SIIIYRSDNEKTD,_ESRPESIIIYRS(ph)DNEK_,S57,,,,,,,,20.38,,21.32,22.94,,,,21.54, , , , , , ,-1.17, ,-0.22,1.39, , , ,,integral to membrane,,,,,,,,,,,,,,
6705,Q96HH9,GRAMD3,GRAM domain-containing protein 3 (HCV NS3-transactivated protein 2),DFNDEFSDLDGVV,_ADRPSSLPLDFNDEFS(ph)DLDGVVQQR_,S252,,25.96,,,,,,,,,,,,,25.96,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6707,Q96HH9,GRAMD3,GRAM domain-containing protein 3 (HCV NS3-transactivated protein 2),SLWSKSSFDGASL,_SS(ph)FDGASLASDK_,S72,,28.08,,,26.13,,21.59,,,,28.61,25.48,,,25.98,2.11, , ,0.15, ,-4.39, , , ,2.63,-0.50, , ,,,,,,,,,,,,,,,,
6709,Q96HH9,GRAMD3,GRAM domain-containing protein 3 (HCV NS3-transactivated protein 2),NTSVGNSPNPSSA,_SVCGHLENTS(ph)VGNS(ph)PNPSSAENSFR_,S225,,22.97,,,,,,,,,,,,,22.97,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6710,Q96HP0,DOCK6,Dedicator of cytokinesis protein 6,PPGLRNSLNRASF,_LPQLM(ox)APTPPGLRNS(ph)LNR_,S2036,,23.25,,,,22.51,22.63,,,23.18,,,,23.82,23.08,0.17, , , ,-0.57,-0.45, , ,0.10, , , ,0.74,blood coagulation;small GTPase mediated signal transduction,cytosol;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6711,Q96HP0,DOCK6,Dedicator of cytokinesis protein 6,VFEQDASGDERSG,_QVFEQDAS(ph)GDER_,S159,,23.91,22.51,,,,,,,20.62,,,,,22.35,1.57,0.16, , , , , , ,-1.73, , , , ,blood coagulation;small GTPase mediated signal transduction,cytosol;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6712,Q96HP0,DOCK6,Dedicator of cytokinesis protein 6,NDSRRGSGSPEDT,_RGS(ph)GSPEDTPR_,S176,,22.56,21.21,,19.92,,,,,18.94,,,,,20.66,1.90,0.55, ,-0.73, , , , ,-1.72, , , , ,blood coagulation;small GTPase mediated signal transduction,cytosol;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6717,Q96HR3,MED30,Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (TRAP/Mediator complex component TRAP25) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25),_____MSTPPLAA,_(ac)S(ph)TPPLAASGM(ox)APGPFAGPQAQQAAR_,S2,,22.78,22.08,22.08,,24.29,24.44,,24.28,,,,,,23.32,-0.55,-1.24,-1.24, ,0.96,1.11, ,0.96, , , , , ,"transcription initiation from RNA polymerase II promoter;positive regulation of transcription, DNA-dependent;androgen receptor signaling pathway",mediator complex,,,,,,,,,,,,,,
6718,Q96HR8,NAF1,H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1),PEALDFSDDEKEK,_NDQEPPPEALDFS(ph)DDEK_,S315,,24.58,,,,,,24.95,,24.52,25.75,23.96,24.45,,24.70,-0.12, , , , , ,0.24, ,-0.18,1.05,-0.74,-0.25, ,snRNA pseudouridine synthesis;rRNA processing;ribosome biogenesis,cell junction;small nucleolar ribonucleoprotein complex;nucleus;centrosome,,,,,,,,,,,,,,
6719,Q96HS1,PGAM5,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)",RKRNVESGEEELA,_RNVES(ph)GEEELASK_,S80,+,21.61,23.72,22.68,24.09,21.55,24.26,24.25,22.66,,25.67,24.79,23.70,23.86,23.57,-1.96,0.15,-0.89,0.52,-2.02,0.69,0.68,-0.91, ,2.10,1.22,0.13,0.29,,mitochondrial outer membrane;integral to membrane,,,+,,,,,,,,,,,
6720,Q96HS1,PGAM5,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)",GEEELASKLDHYK,_RNVESGEEELAS(ph)K_,S87,,21.29,22.60,,,22.83,21.92,23.31,,23.77,23.84,,,,22.79,-1.51,-0.19, , ,0.03,-0.87,0.52, ,0.98,1.05, , , ,,mitochondrial outer membrane;integral to membrane,,,+,,,,,,,,,,,
6723,Q96I25,RBM17,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),RERRKRSMGGAAI,_S(ph)M(ox)GGAAIAPPTSLVEK_,S169,,25.66,,,22.58,,,22.47,22.46,,,,23.88,,23.41,2.25, , ,-0.83, , ,-0.94,-0.95, , , ,0.47, ,mRNA processing;RNA splicing,nucleus;spliceosomal complex,,,,,,,,,,+,,,,
6724,Q96IF1,AJUBA,LIM domain-containing protein ajuba,PTAPALSPRSSFA,_LEPTAPALS(ph)PR_,S119,,,23.61,22.06,24.59,,,,,,22.15,,,,23.10, ,0.51,-1.05,1.49, , , , , ,-0.95, , , ,"regulation of GTPase activity;positive regulation of MAP kinase activity;lamellipodium assembly;glycerophospholipid biosynthetic process;focal adhesion assembly;positive regulation of gene silencing by miRNA;positive regulation of protein complex assembly;positive regulation of I-kappaB kinase/NF-kappaB cascade;negative regulation of hippo signaling cascade;regulation of cellular response to hypoxia;wound healing, spreading of epidermal cells;negative regulation of kinase activity;regulation of cell migration;positive regulation of cellular biosynthetic process;response to hypoxia;cellular protein localization;gene silencing by miRNA;calcium-dependent cell-cell adhesion;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;cell cycle",microtubule organizing center;cell-cell junction;cytosol;transcription factor complex;focal adhesion;nucleus;plasma membrane;lamellipodium;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
6726,Q96IY1,NSL1,Kinetochore-associated protein NSL1 homolog,___MAGSPELVVL,_(ac)AGS(ph)PELVVLDPPWDK_,S4,,23.74,,,,,,,,,,,,,23.74,0.00, , , , , , , , , , , , ,mitotic prometaphase;chromosome segregation;cell division,cytosol;plasma membrane;nucleus;MIS12/MIND type complex,,,,,,,,,,,,,,
6727,Q96IZ0,PAWR,PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4),RYKSTTSVSEEDV,_STTS(ph)VSEEDVSSR_,S231,,25.27,,,25.04,,,21.92,,,,,23.82,,24.01,1.25, , ,1.03, , ,-2.09, , , , ,-0.19, ,"negative regulation of cell proliferation;positive regulation of amyloid precursor protein biosynthetic process;interleukin-2 biosynthetic process;negative regulation of T cell receptor signaling pathway;induction of apoptosis;negative regulation of transcription from RNA polymerase II promoter;negative regulation of B cell proliferation;actin filament bundle assembly;apoptotic process;transcription, DNA-dependent;negative regulation of T cell proliferation",actin filament;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
6728,Q96J01,THOC3,THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45),RRLASGSFDKTAS,_RLASGS(ph)FDK_,S74,,23.42,22.87,20.40,24.19,22.32,,,,24.88,25.19,23.05,,23.52,23.31,0.10,-0.45,-2.92,0.88,-0.99, , , ,1.56,1.88,-0.26, ,0.20,mRNA processing;RNA splicing;intronless viral mRNA export from host nucleus,transcription export complex,,,,,,,,,,,,,,
6730,Q96JB2,COG3,Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94),RFFRLNSNNALIE,_LNS(ph)NNALIEFLLEGTPEIR_,S663,,23.59,,,,,,,,,,,,,23.59,0.00, , , , , , , , , , , , ,"retrograde vesicle-mediated transport, Golgi to ER;intracellular protein transport;protein stabilization;protein glycosylation;ER to Golgi vesicle-mediated transport;protein localization to organelle;intra-Golgi vesicle-mediated transport",Golgi cisterna membrane;plasma membrane;nucleus;Golgi transport complex;cis-Golgi network,,,,,,,,,,,,,,
6731,Q96JC9,EAF1,ELL-associated factor 1,PLKDNPSPEPQLD,_DNPS(ph)PEPQLDDIKR_,S64,+,26.68,28.12,27.29,26.72,24.10,24.79,27.58,25.12,27.81,26.58,26.46,26.92,26.38,26.50,0.18,1.61,0.79,0.22,-2.40,-1.71,1.08,-1.39,1.31,0.07,-0.05,0.42,-0.13,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nuclear speck;Cajal body,,,,,,,,,,,,,,
6733,Q96JG6,CCDC132,Coiled-coil domain-containing protein 132,FMEQSRSPSVSPS,_FM(ox)EQSRS(ph)PSVS(ph)PSK_,S464,,23.80,24.99,24.99,23.78,,,,,,,,,,24.39,-0.59,0.60,0.60,-0.61, , , , , , , , , ,,,,,,,,,,,,,,,,
6734,Q96JG6,CCDC132,Coiled-coil domain-containing protein 132,SRSPSVSPSKQPV,_FM(ox)EQSRS(ph)PSVS(ph)PSK_,S468,,23.80,24.99,24.99,23.78,,,,,,,,,,24.39,-0.59,0.60,0.60,-0.61, , , , , , , , , ,,,,,,,,,,,,,,,,
6735,Q96JG6,CCDC132,Coiled-coil domain-containing protein 132,AYQEYDSDSDVPE,_SAYQEYDS(ph)DSDVPEELKR_,S529,+,25.21,,,,25.56,,24.83,24.95,23.19,25.58,25.57,25.80,,25.09,0.12, , , ,0.47, ,-0.26,-0.13,-1.89,0.49,0.49,0.72, ,,,,,,,,,,,,,,,,
6736,Q96JG6,CCDC132,Coiled-coil domain-containing protein 132,QEYDSDSDVPEEL,_SAYQEYDS(ph)DS(ph)DVPEELK_,S531,,22.92,,,,,,,,,,,,,22.92,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6737,Q96JI7,SPG11,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),PLRRVHSTSSLDS,_VHS(ph)TSSLDSQK_,S1955,,,23.44,23.78,23.39,,,,20.40,19.86,18.64,,,,21.58, ,1.85,2.19,1.81, , , ,-1.19,-1.72,-2.95, , , ,cell death,cytosol;cytoplasmic vesicle;integral to membrane;nucleolus;plasma membrane,,,,,,,,,,,,,,
6738,Q96JJ7,TMX3,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),KEQQEPSSGGSVV,_EQQEPS(ph)SGGSVVPTVQEPK_,S433,,22.40,,,,,,,,22.11,,,,,22.26,0.15, , , , , , , ,-0.15, , , , ,protein folding;glycerol ether metabolic process;cell redox homeostasis,integral to membrane;endoplasmic reticulum membrane;cell surface,,,,,,,,,,,,,,
6739,Q96JK2,DCAF5,DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22),RAEEPPSPPVPKA,_AEEPPS(ph)PPVPK_,S712,+,24.22,24.79,24.98,25.26,26.33,26.57,25.74,25.85,26.08,25.83,25.21,24.40,25.63,25.45,-1.23,-0.66,-0.47,-0.19,0.88,1.12,0.29,0.39,0.62,0.38,-0.24,-1.05,0.18,protein ubiquitination,mitochondrion;Cul4-RING ubiquitin ligase complex,,,,,,,,,,,,,,
6742,Q96JM2,ZNF462,Zinc finger protein 462,DFPLDLSPVKKRT,_LANDFPLDLS(ph)PVK_,S585,,,,,22.27,23.49,,,22.83,,24.58,,,,23.29, , , ,-1.02,0.20, , ,-0.46, ,1.29, , , ,"transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
6743,Q96JM2,ZNF462,Zinc finger protein 462,RNNSRVSPVPLSG,_NNSRVS(ph)PVPLSGAAAGTEQK_,S2069,+,,22.86,22.68,22.66,23.28,23.65,24.92,23.61,25.81,25.52,,,,23.89, ,-1.03,-1.21,-1.23,-0.61,-0.24,1.03,-0.28,1.92,1.63, , , ,"transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of transcription from RNA polymerase II promoter",nucleus,C2H2-type,,,,,,,,,,,,,
6744,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KAVPPVSPELRKP,_AVPPVS(ph)PELR_,S416,+,23.33,24.55,,23.91,24.07,25.39,22.76,22.88,22.22,21.63,,22.76,22.78,23.30,0.04,1.25, ,0.61,0.77,2.09,-0.53,-0.42,-1.08,-1.67, ,-0.54,-0.52,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6745,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KDNQESSDAELSS,_DNQESS(ph)DAELSSSEYIK_,S627,,,,,22.72,,,24.14,23.78,24.56,24.34,,23.17,,23.79, , , ,-1.07, , ,0.35,-0.01,0.78,0.56, ,-0.61, ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6747,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KPGPPLSPEIRSP,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,S427,+,23.78,22.55,,20.35,23.40,24.29,23.04,22.63,23.19,,23.17,21.56,22.45,22.76,1.01,-0.22, ,-2.41,0.64,1.52,0.27,-0.14,0.43, ,0.40,-1.20,-0.31,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6748,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),LSPEIRSPAGSPE,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,S432,,23.98,21.53,,,,,21.84,,22.78,,22.15,,,22.45,1.52,-0.93, , , , ,-0.61, ,0.32, ,-0.31, , ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6749,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),IRSPAGSPELRKP,_KPGPPLS(ph)PEIRS(ph)PAGS(ph)PELR_,S436,,23.98,21.53,,,,,21.84,,22.78,,22.15,,,22.45,1.52,-0.93, , , , ,-0.61, ,0.32, ,-0.31, , ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6750,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),PSGPSESPKAASD,_KPGPSGPSES(ph)PK_,S507,,23.02,,,22.70,,,,,,,,,,22.86,0.16, , ,-0.16, , , , , , , , , ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6752,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),PDQRKTSPASLDF,_KTS(ph)PASLDFPESQK_,S459,+,23.05,25.04,25.40,24.93,27.14,26.25,26.25,25.31,26.37,26.21,23.42,25.56,25.26,25.40,-2.35,-0.36,0.00,-0.47,1.74,0.85,0.85,-0.09,0.97,0.81,-1.98,0.16,-0.14,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6753,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KLAPVPSPEPQKP,_LAPVPS(ph)PEPQKPAPVS(ph)PESVK_,S204,+,27.96,24.58,24.98,27.42,28.44,27.93,27.31,27.94,28.64,27.45,24.57,25.98,26.92,26.93,1.03,-2.35,-1.95,0.49,1.50,1.00,0.37,1.01,1.71,0.52,-2.36,-0.95,-0.01,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6754,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),QKPAPVSPESVKA,_LAPVPS(ph)PEPQKPAPVS(ph)PESVK_,S214,+,27.91,26.33,26.57,27.36,28.11,27.31,27.05,27.59,28.39,28.09,26.13,24.87,25.93,27.05,0.86,-0.72,-0.48,0.31,1.06,0.26,0.00,0.54,1.34,1.04,-0.92,-2.18,-1.11,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6755,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KPAPSVSPGPWKP,_PAPSVS(ph)PGPWK_,S344,,,21.68,,,,,21.76,,22.80,22.60,,22.29,,22.23, ,-0.55, , , , ,-0.46, ,0.57,0.37, ,0.07, ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6758,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),WKSPPASPESWKS,_SPPAS(ph)PESWK_,S386,+,22.87,23.37,24.09,22.71,22.94,23.20,22.08,22.49,23.01,23.07,,,,22.98,-0.11,0.39,1.10,-0.27,-0.04,0.21,-0.90,-0.49,0.02,0.09, , , ,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6760,Q96JM3,CHAMP1,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),KTAPTLSPEHWKA,_TAPTLS(ph)PEHWK_,S405,+,23.12,24.60,25.57,23.48,26.33,26.27,24.16,24.59,23.66,25.33,23.30,24.09,23.02,24.42,-1.30,0.18,1.14,-0.94,1.90,1.84,-0.27,0.16,-0.76,0.91,-1.13,-0.33,-1.40,protein localization to microtubule;protein localization to kinetochore;sister chromatid biorientation,nucleus;condensed chromosome kinetochore;spindle;cytoplasm,C2H2-type,,,,,,,,,,,,,
6761,Q96JM7,L3MBTL3,Lethal(3)malignant brain tumor-like protein 3 (H-l(3)mbt-like protein 3) (L(3)mbt-like protein 3) (MBT-1),GEMPPASPSFPRN,_LSGEM(ox)PPAS(ph)PSFPR_,S583,,24.44,23.46,,23.27,,23.71,,22.24,,,,,,23.42,1.02,0.03, ,-0.15, ,0.29, ,-1.18, , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",nucleus,,,,,,,,,,,,,,
6763,Q96JN0,LCOR,Ligand-dependent corepressor (LCoR) (Mblk1-related protein 2),ASPVTTSPTAATT,_ASPVTTS(ph)PTAATTQNPVLSK_,S24,+,22.31,22.07,22.07,,24.20,23.32,23.40,23.49,23.32,24.41,,,23.66,23.23,-0.92,-1.16,-1.16, ,0.98,0.10,0.18,0.27,0.10,1.18, , ,0.44,negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter,nucleus,Other TF domain,,,,,,,,,,,,,
6764,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),VLVLPPSPGPRSS,_AGDSAVLVLPPS(ph)PGPR_,S197,+,25.52,24.20,18.41,23.58,25.91,24.77,27.08,27.40,25.07,25.70,27.44,26.63,26.46,25.24,0.27,-1.05,-6.83,-1.67,0.67,-0.47,1.84,2.16,-0.17,0.45,2.20,1.39,1.22,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6765,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),LSPRAGSPFSPPP,_AGS(ph)PFS(ph)PPPSSSSLTGEAAISR_,S134,+,23.98,,,,24.98,,25.29,25.15,,22.97,,24.95,,24.55,-0.57, , , ,0.42, ,0.74,0.60, ,-1.58, ,0.40, ,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6766,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),RAGSPFSPPPSSS,_AGS(ph)PFS(ph)PPPSSSSLTGEAAISR_,S137,+,24.42,,,,20.49,,24.47,24.98,22.03,22.43,25.83,24.14,,23.60,0.82, , , ,-3.11, ,0.87,1.38,-1.57,-1.17,2.23,0.54, ,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6767,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),FLPSSLSPQSSLP,_GGTPAFLPSSLS(ph)PQSSLPASR_,S266,,23.71,,,22.00,23.09,,23.50,21.02,,,22.91,,,22.71,1.00, , ,-0.70,0.39, ,0.80,-1.68, , ,0.20, , ,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6768,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),DRSQATSPGQTNG,_SQATS(ph)PGQTNGDSSLEVLATR_,S87,,,,,,23.24,,,24.90,,,,,,24.07, , , , ,-0.83, , ,0.83, , , , , ,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6769,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),LRSSYSSPTSLSP,_SSYSS(ph)PTSLS(ph)PR_,S124,+,26.15,25.06,24.40,24.34,24.87,24.30,24.78,25.87,,23.88,25.48,25.63,23.17,24.83,1.32,0.23,-0.43,-0.49,0.04,-0.53,-0.04,1.04, ,-0.95,0.65,0.80,-1.65,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6770,Q96JY6,PDLIM2,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),SSPTSLSPRAGSP,_SSYSSPTSLS(ph)PR_,S129,+,26.15,23.04,23.52,24.22,22.55,22.57,,26.63,,,26.20,24.99,,24.43,1.72,-1.39,-0.91,-0.21,-1.88,-1.86, ,2.20, , ,1.77,0.56, ,,stress fiber;cortical actin cytoskeleton;nucleus;focal adhesion;cell surface;actin cytoskeleton,,,,,,,,,,,,,,
6772,Q96K21,ZFYVE19,Zinc finger FYVE domain-containing protein 19 (MLL partner containing FYVE domain),DYRLPDSDDDEDE,_LPDS(ph)DDDEDEETAIQR_,S286,+,25.39,,,24.59,24.97,,23.42,,,,23.15,23.06,22.39,23.85,1.54, , ,0.74,1.12, ,-0.43, , , ,-0.70,-0.79,-1.46,,,,,,,,,,,,,,,,
6773,Q96K49,TMEM87B,Transmembrane protein 87B,LPVLVDSDEEIMT,_WVEENIPSSFTDVALPVLVDS(ph)DEEIM(ox)TR_,S533,,25.02,,,,,,,,,,,,,25.02,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
6774,Q96K58,ZNF668,Zinc finger protein 668,EAAEARSPAPGYK,_(ac)M(ox)EVEAAEARS(ph)PAPGYK_,S10,,20.80,23.14,23.14,22.38,,,23.17,,23.36,23.04,,22.37,23.04,22.72,-1.92,0.42,0.42,-0.34, , ,0.46, ,0.65,0.33, ,-0.35,0.32,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6775,Q96K76,USP47,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),VLLPEQSPVSYSK,_LFVLLPEQS(ph)PVSYSK_,S744,,22.63,,,,,,,,,,,,,22.63,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;cellular response to UV;monoubiquitinated protein deubiquitination;base-excision repair;response to drug;negative regulation of transcription, DNA-dependent;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ubiquitin-dependent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;positive regulation of cell growth",SCF ubiquitin ligase complex;cytoplasm,,,,,,,,,,,,,,
6776,Q96K76,USP47,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),DFENIESPLNERD,_STETSDFENIES(ph)PLNERDSSASVDNR_,S822,,,,,,23.79,,23.85,24.36,,,24.24,23.98,,24.04, , , , ,-0.25, ,-0.20,0.32, , ,0.20,-0.07, ,"negative regulation of apoptotic process;cellular response to UV;monoubiquitinated protein deubiquitination;base-excision repair;response to drug;negative regulation of transcription, DNA-dependent;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;ubiquitin-dependent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;positive regulation of cell growth",SCF ubiquitin ligase complex;cytoplasm,,,,,,,,,,,,,,
6777,Q96KC8,DNAJC1,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),IAEQNESSDEESL,_DFDIAEQNES(ph)S(ph)DEESLRK_,S479,,26.96,,,21.06,,,23.95,,25.26,23.71,,,,24.19,2.77, , ,-3.13, , ,-0.24, ,1.08,-0.48, , , ,regulation of protein secretion;protein folding;negative regulation of proteolysis;regulation of translation,nuclear membrane;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6778,Q96KC8,DNAJC1,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),AEQNESSDEESLR,_DFDIAEQNES(ph)S(ph)DEESLRK_,S480,+,26.99,23.35,,22.56,23.90,24.32,23.90,24.74,24.43,24.92,21.34,25.67,24.46,24.22,2.78,-0.86, ,-1.65,-0.32,0.10,-0.31,0.52,0.21,0.70,-2.87,1.46,0.25,regulation of protein secretion;protein folding;negative regulation of proteolysis;regulation of translation,nuclear membrane;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6779,Q96KC8,DNAJC1,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),EEQEGDSGEQETG,_EDAEGVAAEEEQEGDS(ph)GEQETGATDARPR_,S430,+,23.59,24.80,23.10,25.00,25.56,25.75,23.86,25.14,24.05,24.32,25.07,25.85,26.08,24.78,-1.19,0.02,-1.68,0.21,0.77,0.97,-0.92,0.36,-0.73,-0.46,0.29,1.06,1.30,regulation of protein secretion;protein folding;negative regulation of proteolysis;regulation of translation,nuclear membrane;integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
6780,Q96KG9,SCYL1,N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase),TQPRPDSWGEDNW,_PSTQPRPDS(ph)WGEDNWEGLETDSR_,S653,,22.61,,,,24.19,,,22.51,,,23.82,,,23.28,-0.67, , , ,0.91, , ,-0.77, , ,0.54, , ,"retrograde vesicle-mediated transport, Golgi to ER;transcription, DNA-dependent;regulation of transcription, DNA-dependent",endoplasmic reticulum-Golgi intermediate compartment;nucleus;COPI vesicle coat;cis-Golgi network;microtubule organizing center,Other TF domain,+,,,,,,,,,,,,
6781,Q96KM6,ZNF512B,Zinc finger protein 512B,KAAGPASPPEEDP,_AAGPAS(ph)PPEEDPERTK_,S409,+,23.83,24.69,24.69,,24.58,25.39,25.43,24.78,,24.70,23.56,23.59,24.34,24.51,-0.68,0.18,0.18, ,0.07,0.89,0.92,0.28, ,0.19,-0.94,-0.92,-0.16,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
6782,Q96KQ4,PPP1R13B,Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B),SLPRPLSPTKLTP,_EPEQDGPAAPADGSTVESLPRPLS(ph)PTK_,S90,,24.05,23.69,23.69,23.07,,,25.62,,,24.06,,25.28,,24.21,-0.16,-0.52,-0.52,-1.14, , ,1.41, , ,-0.15, ,1.07, ,apoptotic process;negative regulation of cell cycle;induction of apoptosis,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
6783,Q96KR1,ZFR,Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog),RKRRRDSDGVDGF,_RRDS(ph)DGVDGFEAEGK_,S1054,+,26.50,25.75,23.91,25.91,25.42,25.82,26.81,25.63,27.07,25.99,26.36,26.48,25.11,25.90,0.59,-0.16,-1.99,0.01,-0.48,-0.09,0.91,-0.28,1.17,0.08,0.46,0.57,-0.80,multicellular organismal development,chromosome;nucleus;cytoplasm,,,,,,,,,,,,,,
6784,Q96L73,NSD1,"Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (EC 2.1.1.43) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (H4-K20-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)",AFDSEHSADEKEK,_SLAFDSEHS(ph)ADEK_,S217,,21.22,,,,,,23.65,23.55,,,,,,22.81,-1.59, , , , , ,0.85,0.74, , , , , ,"positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;gastrulation with mouth forming second",chromosome;nucleus,,,,,,,,,,,,,,
6785,Q96L91,EP400,E1A-binding protein p400 (EC 3.6.4.-) (CAG repeat protein 32) (Domino homolog) (hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein),ATNKALSPVTSRT,_ALS(ph)PVTSR_,S700,+,25.27,23.48,22.40,25.50,23.28,22.25,22.36,,21.89,,,,,23.30,1.97,0.17,-0.90,2.19,-0.02,-1.05,-0.94, ,-1.42, , , , ,histone H2A acetylation;histone H4 acetylation,nuclear speck;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
6787,Q96LD4,TRIM47,Tripartite motif-containing protein 47 (Gene overexpressed in astrocytoma protein) (RING finger protein 100),RGGIPASPIDPFQ,_RGGIPAS(ph)PIDPFQSR_,S350,,24.42,23.80,23.80,,,,21.99,22.48,,23.60,,,,23.35,1.07,0.45,0.45, , , ,-1.36,-0.86, ,0.25, , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
6788,Q96M96,FGD4,"FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)",VDEMPRSADLPHS,_S(ph)ADLPHSFK_,S609,,24.16,23.05,23.48,,,,,,,,,,,23.56,0.60,-0.52,-0.08, , , , , , , , , , ,lamellipodium assembly;regulation of cell shape;activation of JUN kinase activity;small GTPase mediated signal transduction;regulation of Cdc42 GTPase activity;actin cytoskeleton organization;filopodium assembly;microspike assembly;apoptotic process;nerve growth factor receptor signaling pathway,filopodium;cytosol;Golgi apparatus;lamellipodium;actin cytoskeleton;ruffle,,,,,,,,,,,,,,
6789,Q96MU7,YTHDC1,YTH domain-containing protein 1 (Putative splicing factor YT521),KRARGISPIVFDR,_GIS(ph)PIVFDR_,S308,+,27.83,27.78,27.52,26.95,27.71,28.02,26.95,26.86,27.31,27.13,26.33,26.08,26.99,27.19,0.64,0.59,0.33,-0.23,0.52,0.84,-0.23,-0.33,0.12,-0.06,-0.86,-1.11,-0.20,"mRNA splicing, via spliceosome",nuclear body,,,,,,,,,,,,,,
6792,Q96MY1,C20orf112,Uncharacterized protein C20orf112,LEIYQSSQDEPIA,_LEIYQSS(ph)QDEPIALDK_,S295,,24.68,,,,,,,,,,,,,24.68,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6794,Q96MY1,C20orf112,Uncharacterized protein C20orf112,HLASSLSPSQDER,_(ac)SDSTWM(ox)SADPHLASSLS(ph)PSQDER_,S18,,24.31,22.06,22.06,24.16,26.12,25.43,24.14,25.35,25.72,23.90,,,,24.33,-0.01,-2.27,-2.27,-0.17,1.80,1.10,-0.18,1.03,1.40,-0.43, , , ,,,,,,,,,,,,,,,,
6795,Q96MY1,C20orf112,Uncharacterized protein C20orf112,VKTTPESPPYSSG,_TTPES(ph)PPYSSGSYDSIK_,S130,+,25.40,24.71,25.11,25.10,24.98,25.21,25.88,24.49,,25.16,24.69,24.71,24.18,24.97,0.43,-0.26,0.14,0.13,0.01,0.24,0.91,-0.48, ,0.19,-0.28,-0.26,-0.79,,,,,,,,,,,,,,,,
6796,Q96N64,PWWP2A,PWWP domain-containing protein 2A,PGELARSPEAVGP,_S(ph)PEAVGPELEAEEK_,S81,+,24.84,24.33,,26.09,26.34,26.95,26.20,26.29,26.39,24.56,24.74,25.80,25.69,25.68,-0.84,-1.35, ,0.40,0.66,1.27,0.52,0.60,0.70,-1.13,-0.94,0.11,0.00,,,,,,,,,,,,,,,,
6799,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,TYPNSSSPGPGGL,_LPNTYPNSSS(ph)PGPGGLGGSVHYATM(ox)AR_,S864,,,,,,,,,25.06,,24.29,,25.37,,24.91, , , , , , , ,0.15, ,-0.62, ,0.46, ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6800,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,VFERMNSLTFKKS,_M(ox)NS(ph)LTFK_,S1383,,25.06,25.17,25.73,23.69,22.88,,,,,,,,,24.51,0.55,0.67,1.23,-0.82,-1.63, , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6801,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,SERRNSSIVGRRS,_NSS(ph)IVGRR_,S440,,23.98,,,25.42,,,19.95,,,,,23.32,,23.17,0.82, , ,2.25, , ,-3.22, , , , ,0.16, ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6802,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,SAVRPASLNLNRS,_SAVRPAS(ph)LNLNR_,S888,+,24.41,23.83,24.30,22.97,24.52,24.22,24.38,23.63,25.02,25.36,24.20,25.87,25.09,24.45,-0.03,-0.62,-0.14,-1.48,0.07,-0.22,-0.06,-0.81,0.57,0.91,-0.24,1.43,0.64,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6805,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,SRSLSNSNPDISG,_S(ph)RSLSNS(ph)NPDISGTPTS(ph)PDDEVR_,S900,+,25.17,26.60,,,26.52,27.42,23.63,,23.24,,,24.83,26.14,25.45,-0.28,1.16, , ,1.08,1.98,-1.81, ,-2.20, , ,-0.62,0.70,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6806,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,NSNPDISGTPTSP,_SLSNSNPDIS(ph)GTPTSPDDEVR_,S905,,25.12,25.07,25.07,,,,26.43,26.42,,,,,,25.62,-0.50,-0.55,-0.55, , , ,0.81,0.80, , , , , ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6807,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,ISGTPTSPDDEVR,_S(ph)RSLSNS(ph)NPDISGTPTS(ph)PDDEVR_,S910,,24.42,,,25.49,26.92,,,,,23.50,26.19,,,25.31,-0.89, , ,0.18,1.62, , , , ,-1.80,0.89, , ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6808,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,DDLKRRSMSIDDT,_S(ph)M(ox)SIDDTPR_,S180,+,23.61,23.34,,24.80,22.85,22.31,,22.03,19.50,,,,21.47,22.49,1.12,0.85, ,2.32,0.36,-0.18, ,-0.46,-2.99, , , ,-1.02,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6809,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,LKRRSMSIDDTPR,_SMS(ph)IDDTPR_,S182,,24.33,21.92,,25.17,,,,,,,,,,23.81,0.53,-1.89, ,1.36, , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6811,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,QLERSPSGSAFGS,_SPS(ph)GSAFGSQENLR_,S1423,,26.39,23.44,22.63,25.98,,,22.02,,,22.53,,26.34,,24.19,2.20,-0.75,-1.56,1.79, , ,-2.17, , ,-1.66, ,2.15, ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6812,Q96N67,DOCK7,Dedicator of cytokinesis protein 7,SGSAFGSQENLRW,_SPS(ph)GSAFGS(ph)QENLR_,S1429,,25.05,,,,,,,,,,,24.32,,24.69,0.37, , , , , , , , , , ,-0.37, ,positive regulation of peptidyl-serine phosphorylation;pigmentation;axonogenesis;activation of Rac GTPase activity;small GTPase mediated signal transduction;microtubule cytoskeleton organization;establishment of neuroblast polarity,growth cone;axon;basal part of cell,,,,,,,,,,,,,,
6814,Q96NE9,FRMD6,FERM domain-containing protein 6 (Willin),TSTDRHSLSLDDI,_TSTDRHS(ph)LSLDDIR_,S534,,,,,,,,,,,,22.45,,23.36,22.91, , , , , , , , , , ,-0.46, ,0.46,regulation of actin filament-based process;cellular protein localization;apical constriction,mitochondrion;plasma membrane;cytoskeleton;apical junction complex,,,,,,,,,,,,,,
6815,Q96NT5,SLC46A1,Proton-coupled folate transporter (G21) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1),FQQFPQSP_____,_ADPHLEFQQFPQS(ph)P_,S429,,22.97,,,,,,,,,,,,,22.97,0.00, , , , , , , , , , , , ,cellular iron ion homeostasis;folic acid metabolic process;transmembrane transport,integral to membrane;apical plasma membrane;cytoplasm,,,,,,,,,,,,,,
6818,Q96P11,NSUN5,Putative methyltransferase NSUN5 (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein),APERTPSPAPKRK,_ASAPERTPS(ph)PAPK_,S444,,22.07,24.79,25.68,23.21,22.18,20.97,,20.88,21.51,22.31,20.89,,20.85,22.30,-0.23,2.49,3.37,0.91,-0.12,-1.34, ,-1.42,-0.80,0.00,-1.42, ,-1.45,,,,,,,,,,,,,,,,
6819,Q96P11,NSUN5,Putative methyltransferase NSUN5 (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein),PGAGTPSPVRLHA,_(gl)QLEEPGAGTPS(ph)PVR_,S327,,22.89,,,,,,,,,21.28,,21.78,,21.98,0.90, , , , , , , , ,-0.70, ,-0.20, ,,,,,,,,,,,,,,,,
6820,Q96P48,ARAP1,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2)",FPEFDDSDYDEVP,_LFPEFDDS(ph)DYDEVPEEGPGAPAR_,S229,,23.37,,,,,,,,,,,,,23.37,0.00, , , , , , , , , , , , ,negative regulation of stress fiber assembly;regulation of cell shape;positive regulation of Cdc42 GTPase activity;actin filament reorganization involved in cell cycle;small GTPase mediated signal transduction;regulation of cellular component movement;positive regulation of filopodium assembly;regulation of ARF GTPase activity,Golgi cisterna membrane;cytosol;Golgi apparatus;plasma membrane,,,,,,,,,,,,,,
6823,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),NLLGSLSPKTGLP,_AATSEEPTGFSVDSNLLGSLS(ph)PK_,S764,,23.74,,,,,,,,,,,,,23.74,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6824,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),SDAPPGSPDWAGD,_M(ox)GAQQDDGSDAPPGS(ph)PDWAGDVTR_,S619,,23.97,,,23.34,23.17,22.77,,24.71,23.64,,,,,23.60,0.37, , ,-0.26,-0.43,-0.83, ,1.11,0.04, , , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6826,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),EAYRSLSDPIPQR,_SLS(ph)DPIPQR_,S735,+,23.66,25.34,,25.96,24.95,25.63,24.30,25.23,24.70,,25.50,24.88,25.00,25.01,-1.35,0.33, ,0.95,-0.06,0.62,-0.71,0.22,-0.31, ,0.48,-0.14,-0.02,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6827,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),RPLRSLSPSVRQL,_SLS(ph)PSVR_,S79,,23.72,22.15,22.64,24.07,,,,,20.81,20.50,,,,22.31,1.40,-0.16,0.33,1.75, , , , ,-1.50,-1.82, , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6828,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),GVYRSPSFGAGEG,_SPS(ph)FGAGEGLLR_,S420,+,24.75,,,23.63,21.27,,21.59,21.82,,,22.89,24.04,,22.86,1.90, , ,0.77,-1.59, ,-1.27,-1.04, , ,0.04,1.19, ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6831,Q96PE2,ARHGEF17,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),GSSRYSSTETLKD,_YSS(ph)TETLK_,S395,,,24.04,24.04,24.27,,,,,,,,,,24.12, ,-0.08,-0.08,0.16, , , , , , , , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;nerve growth factor receptor signaling pathway;apoptotic process;regulation of small GTPase mediated signal transduction;actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
6833,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),SDYRRLSESQLSF,_RLS(ph)ESQLSFR_,S618,,24.38,21.40,,22.55,,,,,,,,24.53,,23.21,1.16,-1.82, ,-0.66, , , , , , , ,1.32, ,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,,,,,,,,,,
6835,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),LSESQLSFRRSPT,_LSESQLS(ph)FR_,S623,+,22.14,,,22.33,,25.57,26.32,25.58,,27.02,,25.33,,24.90,-2.76, , ,-2.57, ,0.67,1.42,0.68, ,2.12, ,0.43, ,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,,,,,,,,,,
6836,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),QLSFRRSPTKSSL,_S(ph)PTKSSLDYR_,S627,+,,25.06,25.06,,25.09,22.19,24.30,,23.59,24.88,,23.75,23.22,24.13, ,0.94,0.94, ,0.96,-1.93,0.17, ,-0.54,0.76, ,-0.38,-0.91,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,,,,,,,,,,
6837,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),RSPLRRSPPRASY,_S(ph)PLRRS(ph)PPR_,S220,+,24.38,24.81,24.56,25.24,25.83,,24.56,24.81,23.10,24.77,24.43,24.91,,24.67,-0.29,0.13,-0.11,0.56,1.16, ,-0.12,0.14,-1.57,0.10,-0.24,0.24, ,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,,,,,,,,,,
6840,Q96PM5,RCHY1,RING finger and CHY zinc finger domain-containing protein 1 (EC 6.3.2.-) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2),AGGRRISLDQQ__,_RIS(ph)LDQQ_,S113,+,25.54,25.73,25.54,27.56,,,,,,,23.50,24.74,21.93,24.93,0.60,0.79,0.61,2.62, , , , , , ,-1.43,-0.19,-3.01,positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein ubiquitination;protein autoubiquitination;protein ubiquitination involved in ubiquitin-dependent protein catabolic process,ubiquitin ligase complex;nuclear speck;nucleus;cytoplasm,,,,,,,,,,+,,,,
6843,Q96PU5,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like (EC 6.3.2.-) (NEDD4.2) (Nedd4-2),RRPRSLSSPTVTL,_SLS(ph)SPTVTLSAPLEGAK_,S384,+,27.80,25.33,25.44,25.62,26.76,25.33,27.76,27.91,26.52,26.71,27.78,28.02,25.82,26.68,1.12,-1.35,-1.24,-1.06,0.09,-1.35,1.08,1.24,-0.16,0.03,1.11,1.35,-0.86,regulation of protein catabolic process;negative regulation of transforming growth factor beta receptor signaling pathway;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;cellular sodium ion homeostasis;excretion;water homeostasis;virus-host interaction;transcription initiation from RNA polymerase II promoter;positive regulation of endocytosis;regulation of potassium ion transmembrane transporter activity;regulation of membrane potential;negative regulation of sodium ion transport;negative regulation of transcription from RNA polymerase II promoter;sodium ion transport;response to metal ion,nucleoplasm;cytosol,,,,,,,,,,,,,,
6844,Q96PU5,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like (EC 6.3.2.-) (NEDD4.2) (Nedd4-2),RPRSLSSPTVTLS,_SLS(ph)S(ph)PTVTLSAPLEGAK_,S385,,23.61,,,,,,,,,,,,,23.61,0.00, , , , , , , , , , , , ,regulation of protein catabolic process;negative regulation of transforming growth factor beta receptor signaling pathway;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;cellular sodium ion homeostasis;excretion;water homeostasis;virus-host interaction;transcription initiation from RNA polymerase II promoter;positive regulation of endocytosis;regulation of potassium ion transmembrane transporter activity;regulation of membrane potential;negative regulation of sodium ion transport;negative regulation of transcription from RNA polymerase II promoter;sodium ion transport;response to metal ion,nucleoplasm;cytosol,,,,,,,,,,,,,,
6849,Q96PY5,FMNL2,Formin-like protein 2 (Formin homology 2 domain-containing protein 2),EQQDPKSPSHKSK,_LLEQEALM(ox)EQQDPKS(ph)PSHK_,S1016,+,22.05,,,,24.09,23.24,23.93,24.51,23.88,25.03,,,23.52,23.78,-1.73, , , ,0.31,-0.55,0.15,0.73,0.10,1.25, , ,-0.26,regulation of cell morphogenesis;cortical actin cytoskeleton organization,cytoplasm,,,,,,,,,,,,,,
6852,Q96PY6,NEK1,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),KMLRTCSLPDLSK,_TCS(ph)LPDLSK_,S983,+,20.98,23.47,,24.56,22.46,23.38,23.23,23.76,22.66,22.63,23.60,23.15,22.34,23.02,-2.04,0.45, ,1.54,-0.56,0.36,0.21,0.74,-0.36,-0.39,0.58,0.14,-0.68,mitosis;cilium assembly;response to ionizing radiation;response to DNA damage stimulus;cell division,nuclear membrane;nucleolus;pericentriolar material,,+,,,,,,,,,,,,
6853,Q96Q05,TRAPPC9,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) (Tularik gene 1 protein),FESFPESPGEKGQ,_FNFESFPES(ph)PGEK_,S797,+,24.51,,,,,,24.65,,23.66,24.82,24.39,23.69,24.27,24.28,0.23, , , , , ,0.37, ,-0.62,0.53,0.11,-0.60,-0.02,cell differentiation,Golgi apparatus;endoplasmic reticulum,,,,,,,,,,,,,,
6855,Q96Q15,SMG1,Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein),QKNLATSADTPPS,_NLATS(ph)ADT(ph)PPSTVPGTGK_,S2940,,24.06,22.05,22.05,22.18,22.28,,,,,,23.49,,,22.69,1.38,-0.64,-0.64,-0.50,-0.40, , , , , ,0.80, , ,"protein autophosphorylation;phosphatidylinositol phosphorylation;peptidyl-serine phosphorylation;response to stress;DNA repair;mRNA export from nucleus;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;gene expression",cytosol;nucleus,,,,,,,,,,,,,,
6856,Q96Q42,ALS2,Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein),GGSRRLSLPGLLS,_RLS(ph)LPGLLS(ph)QVSPR_,S483,,25.25,,,,,,,,,,,,,25.25,0.00, , , , , , , , , , , , ,"response to oxidative stress;neuromuscular junction development;vesicle organization;locomotory behavior;endosome organization;axonogenesis;cell death;positive regulation of Rac GTPase activity;behavioral fear response;endosomal transport;in utero embryonic development;regulation of Rab GTPase activity;protein localization;regulation of endosome size;neuron projection morphogenesis;positive regulation of Rac protein signal transduction;synaptic transmission, glutamatergic;receptor recycling;Rac protein signal transduction",neuronal cell body;axon;centrosome;postsynaptic density;protein complex;early endosome;cytosol;growth cone;vesicle;lamellipodium;dendrite;membrane;ruffle,,,,,,,,,,,,,,
6858,Q96Q42,ALS2,Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein),GLLSQVSPRLLRK,_RLS(ph)LPGLLSQVS(ph)PR_,S492,,23.88,,,,,,,,,,,,,23.88,0.00, , , , , , , , , , , , ,"response to oxidative stress;neuromuscular junction development;vesicle organization;locomotory behavior;endosome organization;axonogenesis;cell death;positive regulation of Rac GTPase activity;behavioral fear response;endosomal transport;in utero embryonic development;regulation of Rab GTPase activity;protein localization;regulation of endosome size;neuron projection morphogenesis;positive regulation of Rac protein signal transduction;synaptic transmission, glutamatergic;receptor recycling;Rac protein signal transduction",neuronal cell body;axon;centrosome;postsynaptic density;protein complex;early endosome;cytosol;growth cone;vesicle;lamellipodium;dendrite;membrane;ruffle,,,,,,,,,,,,,,
6859,Q96Q42,ALS2,Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein),SDSRSESPEPGYV,_SES(ph)PEPGYVVTSSGLLLPVLLPR_,S1464,,24.40,,,,,,,,,,,,,24.40,0.00, , , , , , , , , , , , ,"response to oxidative stress;neuromuscular junction development;vesicle organization;locomotory behavior;endosome organization;axonogenesis;cell death;positive regulation of Rac GTPase activity;behavioral fear response;endosomal transport;in utero embryonic development;regulation of Rab GTPase activity;protein localization;regulation of endosome size;neuron projection morphogenesis;positive regulation of Rac protein signal transduction;synaptic transmission, glutamatergic;receptor recycling;Rac protein signal transduction",neuronal cell body;axon;centrosome;postsynaptic density;protein complex;early endosome;cytosol;growth cone;vesicle;lamellipodium;dendrite;membrane;ruffle,,,,,,,,,,,,,,
6860,Q96Q45,TMEM237,Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein),NTPASASLEGLAQ,_NTPASAS(ph)LEGLAQTAGR_,S49,,,,,21.54,,22.46,,,21.37,,,,,21.79, , , ,-0.25, ,0.67, , ,-0.42, , , , ,regulation of Wnt receptor signaling pathway;cilium assembly,integral to membrane;ciliary transition zone,,,,,,,,,,,,,,
6862,Q96Q91,SLC4A9,Anion exchange protein 4 (AE 4) (Anion exchanger 4) (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9),THPRKASDNEEAP,_KAS(ph)DNEEAPLR_,S177,,19.55,25.64,25.64,24.32,,22.60,21.57,22.50,23.31,22.17,23.62,21.67,23.03,22.97,-3.42,2.67,2.67,1.35, ,-0.37,-1.40,-0.47,0.34,-0.80,0.65,-1.30,0.06,bicarbonate transport;transmembrane transport,integral to membrane;basolateral plasma membrane;plasma membrane;apical part of cell,,,,,,,,,,,,,,
6863,Q96QC0,PPP1R10,Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99),KKKKVLSPTAAKP,_VLS(ph)PTAAKPSPFEGK_,S313,+,26.31,26.16,26.31,26.14,27.84,28.25,27.09,26.98,27.01,27.44,26.32,26.60,27.53,26.92,-0.61,-0.76,-0.61,-0.78,0.92,1.33,0.17,0.05,0.09,0.52,-0.61,-0.32,0.61,"transcription, DNA-dependent;protein import into nucleus",PTW/PP1 phosphatase complex;nuclear chromatin;chromatin;nucleus,,,,,,,,,,,,,,
6865,Q96QD9,FYTTD1,UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3),PPPKARSNENLDK,_ARS(ph)NENLDKIDM(ox)SLDDIIK_,S23,,,,,,22.39,,,23.35,,,,,24.49,23.41, , , , ,-1.02, , ,-0.06, , , , ,1.08,mRNA export from nucleus,nuclear speck,,,,,,,,,,,,,,
6868,Q96QF0,RAB3IP,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),LSSSPTSPTQEPL,_TLVLSSSPTS(ph)PTQEPLPGGK_,S140,,25.04,,,,,,22.63,,,23.78,22.88,,,23.58,1.45, , , , , ,-0.95, , ,0.20,-0.70, , ,protein transport;Golgi to plasma membrane transport;protein localization to organelle;cilium assembly,cytosol;nucleus;centrosome;microtubule basal body;lamellipodium;actin cortical patch,,,,,,,,,,,,,,
6869,Q96QH2,PRAM1,PML-RARA-regulated adapter molecule 1 (PRAM) (PRAM-1),GLPRTSSEPEFNS,_TSS(ph)EPEFNSLPR_,S334,,,24.35,23.74,,,,,,,,,,,24.05, ,0.31,-0.31, , , , , , , , , , ,regulation of neutrophil degranulation;integrin-mediated signaling pathway,,,,,,,,,,,,,,,
6870,Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),_MADGDSGSERGG,_(ac)ADGDS(ph)GS(ph)ERGGGGGPCGFQPASR_,S6,+,26.70,24.25,23.32,25.23,23.43,23.98,25.53,23.80,25.51,24.11,24.13,24.01,23.27,24.41,2.29,-0.15,-1.08,0.82,-0.98,-0.42,1.12,-0.61,1.11,-0.30,-0.28,-0.39,-1.14,"regulation of myeloid cell differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",DNA replication factor A complex,Other TF domain,,,,,,,,,,,,,
6871,Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),ADGDSGSERGGGG,_(ac)ADGDS(ph)GS(ph)ERGGGGGPCGFQPASR_,S8,,26.14,,,,,,,,,,,,,26.14,0.00, , , , , , , , , , , , ,"regulation of myeloid cell differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",DNA replication factor A complex,Other TF domain,,,,,,,,,,,,,
6872,Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),AQLGPSSPEQLAA,_DSLGDFIEHYAQLGPSS(ph)PEQLAAGAEEGGGPRR_,S101,,25.03,,,,,,,,,,,,,25.03,0.00, , , , , , , , , , , , ,"regulation of myeloid cell differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",DNA replication factor A complex,Other TF domain,,,,,,,,,,,,,
6873,Q96QR8,PURB,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),ERRGGGSGGGEES,_RGGGS(ph)GGGEES(ph)EGEEVDED_,S298,,24.67,,,,,,,,,23.47,,,,24.07,0.60, , , , , , , , ,-0.60, , , ,"regulation of myeloid cell differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",DNA replication factor A complex,Other TF domain,,,,,,,,,,,,,
6875,Q96QT4,TRPM7,Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7),KISRRPSTEDTHE,_RPS(ph)TEDTHEVDSK_,S1503,,,23.00,,20.20,,,19.22,,,,,,,20.81, ,2.19, ,-0.61, , ,-1.58, , , , , , ,actomyosin structure organization;protein autophosphorylation;cell death;calcium-dependent cell-matrix adhesion,integral to membrane;plasma membrane;ruffle,,+,,,,,,,,,,,,
6876,Q96QT6,PHF12,PHD finger protein 12 (PHD factor 1) (Pf1),SGKRTTSPSSDTD,_TTS(ph)PSSDTDLLDR_,S113,,25.44,,,20.96,23.72,,21.75,,,,23.28,,23.11,23.04,2.40, , ,-2.08,0.67, ,-1.30, , , ,0.24, ,0.07,,Sin3 complex;transcriptional repressor complex,,,,,,,,,,,,,,
6879,Q96QU8,XPO6,Exportin-6 (Exp6) (Ran-binding protein 20),AATPPPSPTSGES,_HSVTAAT(ph)PPPS(ph)PTSGESGDLLSNLLQSPSSAK_,S194,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,protein export from nucleus,nucleolus;plasma membrane;nuclear pore;cytoplasm,,,,,,,,,,,,,,
6880,Q96RL1,UIMC1,BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1),RRDLNESPVKSFV,_DLNES(ph)PVK_,S511,,25.33,24.81,,26.45,,,,,24.57,22.56,,21.55,,24.21,1.12,0.60, ,2.24, , , , ,0.36,-1.65, ,-2.67, ,"double-strand break repair;G2/M transition DNA damage checkpoint;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of DNA repair;histone H2A K63-linked deubiquitination",BRCA1-A complex,,,,,,,,,,,,,,
6881,Q96RL1,UIMC1,BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1),EAREVNSQEEEEE,_EVNS(ph)QEEEEEELLRK_,S101,+,23.44,23.98,24.02,21.30,23.35,23.42,22.62,23.02,23.81,,23.01,,23.16,23.19,0.25,0.79,0.83,-1.89,0.16,0.22,-0.57,-0.17,0.62, ,-0.19, ,-0.03,"double-strand break repair;G2/M transition DNA damage checkpoint;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of DNA repair;histone H2A K63-linked deubiquitination",BRCA1-A complex,,,,,,,,,,,,,,
6882,Q96RL1,UIMC1,BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1),DLEREVSPGSRDI,_EVS(ph)PGSRDILDGVR_,S297,+,22.97,22.81,22.52,21.54,23.82,23.88,23.09,23.53,22.94,22.37,22.85,20.56,22.26,22.70,0.27,0.11,-0.18,-1.16,1.12,1.17,0.39,0.83,0.24,-0.33,0.15,-2.14,-0.45,"double-strand break repair;G2/M transition DNA damage checkpoint;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of DNA repair;histone H2A K63-linked deubiquitination",BRCA1-A complex,,,,,,,,,,,,,,
6884,Q96RR4,CAMKK2,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),LLTKQGSEDNLQG,_(gl)QGS(ph)EDNLQGTDPPPVGEEEVLL_,S479,,21.37,,,,,,,,,,,,,21.37,0.00, , , , , , , , , , , , ,"positive regulation of transcription, DNA-dependent;MAPK cascade;protein autophosphorylation;calcium-mediated signaling;regulation of protein kinase activity",cytoplasm,,+,,,,,,,,,,,,
6885,Q96RR4,CAMKK2,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),TMIRKRSFGNPFE,_S(ph)FGNPFEGSR_,S452,+,23.42,23.05,23.38,23.04,23.56,22.57,23.08,24.10,22.50,22.74,23.52,24.04,22.80,23.22,0.21,-0.16,0.16,-0.17,0.35,-0.64,-0.13,0.88,-0.72,-0.48,0.30,0.83,-0.42,"positive regulation of transcription, DNA-dependent;MAPK cascade;protein autophosphorylation;calcium-mediated signaling;regulation of protein kinase activity",cytoplasm,,+,,,,,,,,,,,,
6886,Q96RS0,TGS1,Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N2 methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT),DESELDSEAELMR,_GIGLDESELDS(ph)EAELM(ox)R_,S89,,23.49,,,,,,,,,,,,,23.49,0.00, , , , , , , , , , , , ,"ncRNA metabolic process;small molecule metabolic process;ribonucleoprotein complex import into nucleus;regulation of transcription, DNA-dependent;cellular lipid metabolic process;7-methylguanosine RNA capping;transcription, DNA-dependent;spliceosomal snRNP assembly",nucleoplasm;cytosol;small nuclear ribonucleoprotein complex;Cajal body,,,,,,,,,,,,,,
6888,Q96RT1,ERBB2IP,Protein LAP2 (Densin-180-like protein) (Erbb2-interacting protein) (Erbin),DLGISKSTEDLSP,_S(ph)TEDLSPQK_,S852,,,23.83,,25.88,,,,,23.56,21.86,,,,23.78, ,0.05, ,2.10, , , , ,-0.22,-1.92, , , ,basal protein localization;cell growth;epidermal growth factor receptor signaling pathway;establishment or maintenance of epithelial cell apical/basal polarity;protein targeting;cell adhesion;intermediate filament cytoskeleton organization;integrin-mediated signaling pathway;cell cycle,nuclear membrane;hemidesmosome;basement membrane;nucleus;basal plasma membrane;cytoplasm,,,,,,,,,,,,,,
6889,Q96RU3,FNBP1,Formin-binding protein 1 (Formin-binding protein 17) (hFBP17),PMKRTVSDNSLSN,_TVS(ph)DNSLSNSRGEGKPDLK_,S296,+,24.95,25.32,23.42,24.83,25.30,24.07,,25.78,,,21.11,,23.43,24.25,0.70,1.08,-0.83,0.59,1.05,-0.18, ,1.54, , ,-3.13, ,-0.82,endocytosis;nervous system development,coated pit;cell cortex;plasma membrane;cytoskeleton;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
6890,Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),ERAKGPSPPGAKR,_AKGPS(ph)PPGAK_,S65,,21.88,22.74,22.59,21.77,,,,19.58,,,,,,21.71,0.17,1.02,0.88,0.06, , , ,-2.13, , , , , ,regulation of DNA-dependent DNA replication initiation;DNA synthesis involved in DNA repair;DNA replication,mitochondrion;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6891,Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),AKRRRLSESSALK,_RLS(ph)ESSALK_,S75,+,28.11,26.55,23.85,24.71,,,22.69,21.08,23.59,23.01,22.68,,,24.03,4.08,2.52,-0.18,0.68, , ,-1.34,-2.95,-0.44,-1.02,-1.35, , ,regulation of DNA-dependent DNA replication initiation;DNA synthesis involved in DNA repair;DNA replication,mitochondrion;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6892,Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),RRLSESSALKQPA,_RLS(ph)ESS(ph)ALK_,S78,,24.06,,,26.06,,,,21.08,,,,,,23.73,0.33, , ,2.33, , , ,-2.66, , , , , ,regulation of DNA-dependent DNA replication initiation;DNA synthesis involved in DNA repair;DNA replication,mitochondrion;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6894,Q96S66,CLCC1,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),FQTGNKSPEVLRA,_FQTGNKS(ph)PEVLR_,S253,+,24.01,,,,23.55,22.02,22.35,23.71,,,23.58,,23.90,23.30,0.71, , , ,0.25,-1.28,-0.95,0.40, , ,0.27, ,0.60,,integral to membrane;Golgi apparatus;endoplasmic reticulum;nucleus,,,,,,,,,,,,,,
6895,Q96S82,UBL7,Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132),FLFEGLSDDEDDF,_DM(ox)PGGFLFEGLS(ph)DDEDDFHPNTR_,S174,,23.23,,,,,,,,,,,,,23.23,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
6896,Q96S90,LYSMD1,LysM and putative peptidoglycan-binding domain-containing protein 1,LFNGLDSEEEKDG,_DLFNGLDS(ph)EEEKDGEEK_,S51,+,23.18,21.95,21.17,23.60,22.76,23.40,22.04,23.80,,22.25,22.54,23.32,22.81,22.74,0.45,-0.79,-1.57,0.86,0.02,0.67,-0.69,1.06, ,-0.48,-0.20,0.59,0.08,cell wall macromolecule catabolic process,,,,,,,,,,,,,,,
6897,Q96S94,CCNL2,Cyclin-L2 (Paneth cell-enhanced expression protein),KKAKADSPVNGLP,_AKADS(ph)PVNGLPK_,S147,+,24.53,26.09,26.63,25.31,24.19,25.55,25.62,25.19,25.77,26.09,24.22,25.13,24.66,25.31,-0.77,0.79,1.33,0.00,-1.12,0.25,0.31,-0.12,0.46,0.78,-1.08,-0.18,-0.65,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck;nucleus,,,,,,,,,,,,,,
6898,Q96S94,CCNL2,Cyclin-L2 (Paneth cell-enhanced expression protein),DGTSGFSPAPKLV,_GLLPGGTQVLDGTSGFS(ph)PAPK_,S108,+,23.30,23.59,23.59,25.00,24.40,25.17,24.81,24.24,25.96,24.71,,,25.49,24.57,-1.27,-0.98,-0.98,0.43,-0.17,0.60,0.25,-0.33,1.39,0.14, , ,0.92,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck;nucleus,,,,,,,,,,,,,,
6900,Q96S94,CCNL2,Cyclin-L2 (Paneth cell-enhanced expression protein),APKLVESPKEGKG,_LVES(ph)PKEGK_,S116,+,21.49,,,,,22.94,,22.42,,19.99,19.50,,21.90,21.37,0.12, , , , ,1.57, ,1.05, ,-1.39,-1.87, ,0.53,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck;nucleus,,,,,,,,,,,,,,
6903,Q96S97,MYADM,Myeloid-associated differentiation marker (Protein SB135),SSSGLGSPMIVGS,_TTITTTTTSSSGLGS(ph)PM(ox)IVGSPR_,S22,,,,,,,,,,,24.15,24.16,,23.42,23.91, , , , , , , , , ,0.24,0.25, ,-0.49,,integral to membrane,,,,,,,,,,,,,,
6904,Q96S99,PLEKHF1,Pleckstrin homology domain-containing family F member 1 (PH domain-containing family F member 1) (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains) (Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15),EEQGAGSPGQPAH,_(gl)QEEAEEQGAGS(ph)PGQPAHLAR_,S227,,21.87,,,,,,,,,,,,,21.87,0.00, , , , , , , , , , , , ,vesicle organization;protein localization to plasma membrane;positive regulation of autophagy;endosome organization;apoptotic process;induction of apoptosis,endosome membrane;nucleus;lysosomal membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
6905,Q96SB3,PPP1R9B,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),SLPRASSLNENVD,_ASS(ph)LNENVDHSALLK_,S100,,21.46,22.60,22.60,,23.44,,,,22.37,23.13,,,,22.60,-1.14,0.00,0.00, ,0.84, , , ,-0.23,0.53, , , ,cell differentiation;cell migration;regulation of cell proliferation;regulation of opioid receptor signaling pathway;regulation of exit from mitosis;filopodium assembly;regulation of cell growth by extracellular stimulus;negative regulation of cell growth;cell cycle arrest;cellular response to morphine;RNA splicing;nervous system development,protein phosphatase type 1 complex;nucleoplasm;filopodium;ruffle membrane;adherens junction;dendritic spine;synapse;cytoskeleton;lamellipodium,,,,,,,,,,,,,,
6906,Q96SB3,PPP1R9B,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),VVRFNGSTEALDK,_FNGS(ph)TEALDK_,S190,+,,25.59,23.54,27.54,,,25.42,,26.89,23.62,23.69,24.22,,25.06, ,0.53,-1.52,2.47, , ,0.36, ,1.82,-1.44,-1.38,-0.84, ,cell differentiation;cell migration;regulation of cell proliferation;regulation of opioid receptor signaling pathway;regulation of exit from mitosis;filopodium assembly;regulation of cell growth by extracellular stimulus;negative regulation of cell growth;cell cycle arrest;cellular response to morphine;RNA splicing;nervous system development,protein phosphatase type 1 complex;nucleoplasm;filopodium;ruffle membrane;adherens junction;dendritic spine;synapse;cytoskeleton;lamellipodium,,,,,,,,,,,,,,
6907,Q96SB3,PPP1R9B,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),LDADAVSPTVSQL,_LDADAVS(ph)PTVSQLSAVFEK_,S203,,25.20,,,,19.58,,,,,,,,,22.39,2.81, , , ,-2.81, , , , , , , , ,cell differentiation;cell migration;regulation of cell proliferation;regulation of opioid receptor signaling pathway;regulation of exit from mitosis;filopodium assembly;regulation of cell growth by extracellular stimulus;negative regulation of cell growth;cell cycle arrest;cellular response to morphine;RNA splicing;nervous system development,protein phosphatase type 1 complex;nucleoplasm;filopodium;ruffle membrane;adherens junction;dendritic spine;synapse;cytoskeleton;lamellipodium,,,,,,,,,,,,,,
6909,Q96SB4,SRPK1,SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),PNKQEESESPVER,_QEES(ph)ES(ph)PVERPLK_,S293,,26.28,24.28,24.28,23.04,,,,,24.30,,,24.57,,24.46,1.82,-0.18,-0.18,-1.42, , , , ,-0.16, , ,0.11, ,"intracellular protein kinase cascade;negative regulation of viral genome replication;positive regulation of viral genome replication;chromosome segregation;innate immune response;mRNA processing;sperm chromatin condensation;RNA splicing;virus-host interaction;regulation of mRNA splicing, via spliceosome",endoplasmic reticulum;nucleus;nuclear matrix;cytoplasm,,+,,,,,,,,,,,,
6910,Q96SB4,SRPK1,SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),KQEESESPVERPL,_QEES(ph)ES(ph)PVERPLK_,S295,+,27.25,26.78,27.20,26.47,21.83,,27.25,22.19,25.87,27.23,25.70,26.07,23.15,25.58,1.67,1.19,1.62,0.89,-3.75, ,1.67,-3.40,0.29,1.64,0.11,0.49,-2.43,"intracellular protein kinase cascade;negative regulation of viral genome replication;positive regulation of viral genome replication;chromosome segregation;innate immune response;mRNA processing;sperm chromatin condensation;RNA splicing;virus-host interaction;regulation of mRNA splicing, via spliceosome",endoplasmic reticulum;nucleus;nuclear matrix;cytoplasm,,+,,,,,,,,,,,,
6911,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),RKAAVLSDSEDEE,_AAVLS(ph)DS(ph)EDEEKASAKK_,S398,+,27.91,26.03,26.04,24.24,27.32,25.63,24.29,25.01,25.60,25.65,22.94,22.92,24.24,25.22,2.69,0.81,0.82,-0.98,2.10,0.42,-0.93,-0.21,0.39,0.43,-2.27,-2.29,-0.98,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6912,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),AAVLSDSEDEEKA,_AAVLS(ph)DS(ph)EDEEK_,S400,+,28.88,27.38,27.56,25.03,27.63,25.60,25.27,25.66,25.89,26.24,23.38,,23.80,26.03,2.86,1.35,1.54,-1.00,1.60,-0.43,-0.76,-0.37,-0.13,0.21,-2.65, ,-2.23,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6914,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),RKKFHSSDSEEEE,_FHSS(ph)DS(ph)EEEEHK_,S363,,25.71,23.07,21.44,22.24,,,,,,,,,,23.12,2.60,-0.04,-1.67,-0.88, , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6915,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KFHSSDSEEEEHK,_FHSS(ph)DS(ph)EEEEHKK_,S365,,25.85,23.91,22.99,22.70,,,,,18.21,,,,,22.73,3.12,1.18,0.26,-0.04, , , , ,-4.52, , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6916,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),PQKGPASDSETED,_GPAS(ph)DSETEDASR_,S313,+,22.90,24.85,25.05,23.17,,,21.77,,23.62,21.16,21.17,21.21,,22.77,0.13,2.08,2.28,0.40, , ,-1.00, ,0.85,-1.60,-1.60,-1.56, ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6917,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KGPASDSETEDAS,_GPASDS(ph)ETEDASR_,S315,+,22.95,25.20,26.12,22.18,,,21.13,,19.71,21.73,19.73,21.83,,22.29,0.66,2.92,3.84,-0.11, , ,-1.15, ,-2.58,-0.56,-2.55,-0.46, ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6918,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),VGKHPASDSEIEE,_HPAS(ph)DS(ph)EIEELQK_,S157,,23.47,24.72,24.67,,,,22.31,,22.72,24.15,,,,23.67,-0.20,1.05,1.00, , , ,-1.36, ,-0.95,0.48, , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6919,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KHPASDSEIEELQ,_HPAS(ph)DS(ph)EIEELQK_,S159,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6921,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),LPKPRISDSESED,_IS(ph)DSESEDPPR_,S248,,23.71,24.69,,23.69,,,,,,,,,,24.03,-0.32,0.66, ,-0.34, , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6923,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KKSRVVSDADDSD,_SRVVS(ph)DADDS(ph)DS(ph)DAVSDK_,S415,,23.62,,,,,,,,,,,,,23.62,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6924,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),VSDADDSDSDAVS,_SRVVS(ph)DADDS(ph)DS(ph)DAVSDK_,S420,,23.62,,,,,,,,,,,,,23.62,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6925,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),DADDSDSDAVSDK,_SRVVS(ph)DADDS(ph)DS(ph)DAVSDK_,S422,,23.62,,,,,,,,,,,,,23.62,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6926,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),REKTIASDSEEEA,_TIAS(ph)DS(ph)EEEAGK_,S438,+,25.67,25.13,24.86,23.84,,23.77,23.23,23.27,,24.05,,21.76,,23.95,1.72,1.18,0.91,-0.11, ,-0.18,-0.73,-0.68, ,0.10, ,-2.20, ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6927,Q96ST2,IWS1,Protein IWS1 homolog (IWS1-like protein),KTIASDSEEEAGK,_TIAS(ph)DS(ph)EEEAGK_,S440,,24.63,,,,,,,,,,,,,24.63,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
6928,Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),KRDKSDSPAIQLR,_DKSDS(ph)PAIQLR_,S940,+,21.10,23.15,23.75,23.34,24.74,24.26,22.54,25.08,24.16,23.89,,,,23.60,-2.50,-0.45,0.15,-0.26,1.14,0.66,-1.07,1.48,0.56,0.28, , , ,negative regulation of apoptotic process;aging;response to organic nitrogen;blood coagulation;interphase of mitotic cell cycle;cellular response to glucose stimulus;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;negative regulation of transcription regulatory region DNA binding;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;cellular protein localization;in utero embryonic development;response to methylglyoxal;negative regulation of transcription from RNA polymerase II promoter;positive regulation of defense response to virus by host;DNA replication;activation of innate immune response;positive regulation of chromatin silencing,transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex;kinetochore,,,,,,,,,,,,,,
6929,Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),AQRGDLSDVEEEE,_GDLS(ph)DVEEEEEEEM(ox)DVDEATGAVKK_,S832,,27.54,,,,28.22,,,,,25.26,,,23.72,26.18,1.35, , , ,2.03, , , , ,-0.92, , ,-2.47,negative regulation of apoptotic process;aging;response to organic nitrogen;blood coagulation;interphase of mitotic cell cycle;cellular response to glucose stimulus;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;negative regulation of transcription regulatory region DNA binding;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;cellular protein localization;in utero embryonic development;response to methylglyoxal;negative regulation of transcription from RNA polymerase II promoter;positive regulation of defense response to virus by host;DNA replication;activation of innate immune response;positive regulation of chromatin silencing,transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex;kinetochore,,,,,,,,,,,,,,
6930,Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),PYASPRSPPVQPH,_S(ph)PPVQPHT(ph)PVTISLGTAPSLQNNQPVEFNHAINYVNK_,S277,,23.58,,,22.85,,,,24.63,23.80,23.75,,,,23.72,-0.15, , ,-0.87, , , ,0.91,0.08,0.03, , , ,negative regulation of apoptotic process;aging;response to organic nitrogen;blood coagulation;interphase of mitotic cell cycle;cellular response to glucose stimulus;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;negative regulation of transcription regulatory region DNA binding;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;cellular protein localization;in utero embryonic development;response to methylglyoxal;negative regulation of transcription from RNA polymerase II promoter;positive regulation of defense response to virus by host;DNA replication;activation of innate immune response;positive regulation of chromatin silencing,transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex;kinetochore,,,,,,,,,,,,,,
6932,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),KDAQRLSPIPEEV,_TFLDKDAQRLS(ph)PIPEEVPK_,S573,+,28.22,28.19,28.30,27.77,27.55,29.98,29.39,28.39,29.76,29.33,28.50,28.61,29.59,28.74,-0.52,-0.55,-0.44,-0.96,-1.18,1.24,0.65,-0.35,1.02,0.60,-0.24,-0.13,0.85,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6934,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),TKEESYSPSKDRN,_FYETKEESYS(ph)PSK_,S442,,,,,,24.02,24.53,,24.11,,,,,24.44,24.28, , , , ,-0.26,0.26, ,-0.17, , , , ,0.17,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6935,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),KPYRIESDEEEDF,_PYRIES(ph)DEEEDFENVGK_,S1314,+,28.84,25.31,25.07,26.39,26.62,26.98,27.96,25.85,28.15,27.95,26.73,27.98,26.41,26.94,1.90,-1.63,-1.87,-0.55,-0.32,0.04,1.02,-1.09,1.21,1.01,-0.21,1.04,-0.53,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6936,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),LSDDFDSPVKGPL,_LSDDFDS(ph)PVK_,S366,+,25.56,24.02,24.02,21.22,22.49,22.31,23.44,22.01,22.55,25.40,,23.99,22.81,23.32,2.24,0.70,0.70,-2.10,-0.82,-1.01,0.12,-1.31,-0.77,2.08, ,0.67,-0.51,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6940,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),DNSSRESPSLEDE,_NSSQQDNSSRES(ph)PSLEDEETK_,S196,+,24.78,25.51,26.03,23.27,,,22.48,,27.14,25.66,23.30,24.72,,24.76,0.02,0.74,1.26,-1.50, , ,-2.28, ,2.38,0.89,-1.47,-0.05, ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6941,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),INYKEDSESDGSQ,_RQINYKEDS(ph)ES(ph)DGS(ph)QK_,S1190,,23.44,,,,,,,,,,,,,23.44,0.00, , , , , , , , , , , , ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6942,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),YKEDSESDGSQKS,_RQINYKEDS(ph)ES(ph)DGS(ph)QK_,S1192,,23.44,,,,,,,,,,,,,23.44,0.00, , , , , , , , , , , , ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6943,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),DSESDGSQKSLRR,_RQINYKEDS(ph)ES(ph)DGS(ph)QK_,S1195,,23.44,,,,,,,,,,,,,23.44,0.00, , , , , , , , , , , , ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6944,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),NVGKVGSPLDYSL,_VGS(ph)PLDYSLVDLPSTNGQSPGK_,S1328,,24.68,,,23.32,21.88,,,21.01,,,,,,22.73,1.96, , ,0.60,-0.84, , ,-1.72, , , , , ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6946,Q96T23,RSF1,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),PSTNGQSPGKAIE,_VGSPLDYSLVDLPSTNGQS(ph)PGK_,S1344,,23.76,,,22.95,,24.40,,,,,,,,23.71,0.05, , ,-0.75, ,0.70, , , , , , , ,"nucleosome positioning;DNA-dependent transcription, initiation;positive regulation of transcription, DNA-dependent;CENP-A containing nucleosome assembly at centromere;negative regulation of transcription, DNA-dependent;negative regulation of DNA binding;positive regulation of viral transcription",nucleoplasm;RSF complex,,,,,,,,,,,,,,
6947,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),KRHCAPSPDRSPE,_HCAPS(ph)PDRS(ph)PELSSSR_,S670,,24.14,24.90,,23.54,22.84,,,,,,,,,23.85,0.29,1.04, ,-0.31,-1.02, , , , , , , , ,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
6948,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),APSPDRSPELSSS,_HCAPS(ph)PDRS(ph)PELSSSR_,S674,,24.14,24.90,,23.54,22.84,,,,,,,,,23.85,0.29,1.04, ,-0.31,-1.02, , , , , , , , ,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
6949,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),GRHLDRSPESDRP,_HLDRS(ph)PESDRPR_,S656,+,22.65,24.18,22.45,24.02,25.22,22.96,21.61,22.75,21.78,20.66,21.51,20.36,21.65,22.45,0.21,1.73,0.00,1.57,2.77,0.51,-0.83,0.30,-0.66,-1.78,-0.94,-2.08,-0.79,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
6953,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),GGQRSLSPGGAAL,_SLS(ph)PGGAALGYRDYR_,S294,+,28.41,27.58,27.72,28.09,29.02,29.11,28.44,28.30,28.58,28.68,27.20,28.03,27.80,28.23,0.18,-0.65,-0.51,-0.14,0.79,0.88,0.21,0.07,0.35,0.46,-1.03,-0.19,-0.42,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
6954,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),APTEGKSPLKKED,_TTAPTEGKS(ph)PLK_,S741,,23.85,24.41,,23.56,,,,,,21.08,,,,23.23,0.63,1.18, ,0.34, , , , , ,-2.15, , , ,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
6955,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),EPGEVPSDSDEDG,_DLEPGEVPS(ph)DS(ph)DEDGEHK_,S1380,,26.28,,,,,22.99,22.48,22.39,23.50,,,,,23.53,2.76, , , , ,-0.54,-1.05,-1.14,-0.02, , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6956,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),GEVPSDSDEDGEH,_DLEPGEVPS(ph)DS(ph)DEDGEHK_,S1382,,25.65,,,,,,,,,,,,,25.65,0.00, , , , , , , , , , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6957,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),VSASGPSPEATQL,_EDVSASGPS(ph)PEATQLAK_,S2159,+,25.07,25.57,25.51,25.33,24.75,26.28,24.13,,24.06,24.04,25.56,22.78,,24.83,0.25,0.75,0.68,0.51,-0.07,1.45,-0.69, ,-0.77,-0.79,0.73,-2.04, ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6958,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),SGVVAVSPEKSES,_ESGVVAVS(ph)PEK_,S2120,,26.58,26.34,26.74,26.09,,,,,23.44,,,,,25.84,0.74,0.50,0.90,0.25, , , , ,-2.39, , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6959,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),LLSVKGSPKVDEK,_LLSVKGS(ph)PK_,S1287,+,22.55,24.05,24.05,22.75,24.88,25.08,,24.55,,,,,23.80,23.96,-1.41,0.09,0.09,-1.22,0.91,1.12, ,0.59, , , , ,-0.16,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6960,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),RLNTVASPKDCQE,_LNTVAS(ph)PK_,S1062,,21.85,,,24.24,,,,,21.24,,,,,22.44,-0.59, , ,1.80, , , , ,-1.20, , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6963,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),SERTGGSPSVRHG,_(gl)QISEDSERTGGS(ph)PSVR_,S1261,+,,22.15,22.15,,25.08,24.83,24.40,24.22,24.85,24.23,23.49,23.22,24.98,23.96, ,-1.82,-1.82, ,1.11,0.87,0.43,0.25,0.88,0.27,-0.47,-0.74,1.02,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6964,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),REERRASYDYNQD,_RAS(ph)YDYNQDR_,S623,,23.87,22.54,22.11,,,20.36,,,,,,,,22.22,1.65,0.32,-0.11, , ,-1.85, , , , , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6965,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),PIERSQSPVHLRR,_SQS(ph)PVHLR_,S727,,23.97,23.49,,23.92,21.92,20.93,,,,,,,,22.85,1.12,0.64, ,1.07,-0.93,-1.92, , , , , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6966,Q96T58,SPEN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),DDSPARSVQSAAV,_S(ph)VQSAAVPAPTSQLLSSLEK_,S309,,20.50,,,,,,,,,,,,,20.50,0.00, , , , , , , , , , , , ,"positive regulation of neurogenesis;positive regulation of transcription, DNA-dependent;Notch signaling pathway;virus-host interaction",transcriptional repressor complex,Other TF domain,,,,,,,,,,+,,,
6967,Q96T60,PNKP,Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase);Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)],ETRTPESQPDTPP,_WEETRTPES(ph)QPDT(ph)PPGTPLVSQDEK_,S75,,25.02,,,,,,,,,,,,,25.02,0.00, , , , , , , , , , , , ,"response to oxidative stress;nucleotide-excision repair, DNA damage removal;DNA damage response, detection of DNA damage;response to radiation;DNA-dependent DNA replication",nucleolus,,,+,,,,,,,,,,,
6969,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),AAPEASSPPASPL,_AAPEASS(ph)PPAS(ph)PLQHLLPGK_,S679,+,30.49,27.72,28.27,27.54,30.10,28.80,29.78,30.23,27.52,30.03,28.72,28.99,29.55,29.06,1.44,-1.34,-0.79,-1.51,1.04,-0.26,0.72,1.17,-1.53,0.98,-0.34,-0.07,0.49,negative regulation of apoptotic process,cytosol;adherens junction,,,,,,,,,,,,,,
6970,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),ASSPPASPLQHLL,_AAPEASS(ph)PPAS(ph)PLQHLLPGK_,S683,+,30.45,26.01,26.86,26.30,28.66,,25.46,27.20,26.94,27.86,24.25,,24.16,26.74,3.71,-0.74,0.12,-0.45,1.92, ,-1.28,0.46,0.20,1.12,-2.49, ,-2.58,negative regulation of apoptotic process,cytosol;adherens junction,,,,,,,,,,,,,,
6974,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),GAPAGESPQPKAA,_GLLAQGLRPES(ph)PPPAGPLLNGAPAGES(ph)PQPK_,S668,,26.27,,,,25.88,,,,,,,,,26.07,0.20, , , ,-0.20, , , , , , , , ,negative regulation of apoptotic process,cytosol;adherens junction,,,,,,,,,,,,,,
6975,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),FEASPESPPPASP,_QVVSVVQDEEVGLPFEASPES(ph)PPPAS(ph)PDGVTEIR_,S628,+,29.41,23.65,23.65,26.76,26.79,,25.95,26.11,27.52,25.93,28.74,27.94,29.29,26.81,2.60,-3.16,-3.16,-0.05,-0.02, ,-0.87,-0.70,0.71,-0.88,1.93,1.13,2.48,negative regulation of apoptotic process,cytosol;adherens junction,,,,,,,,,,,,,,
6976,Q96TA1,FAM129B,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),ESPPPASPDGVTE,_QVVSVVQDEEVGLPFEASPES(ph)PPPAS(ph)PDGVTEIR_,S633,,28.99,,,,,,,,24.83,,,,,26.91,2.08, , , , , , , ,-2.08, , , , ,negative regulation of apoptotic process,cytosol;adherens junction,,,,,,,,,,,,,,
6977,Q96TC7,RMDN3,Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51),RHGRSQSLPNSLD,_SQS(ph)LPNSLDYTQTSDPGR_,S46,+,27.56,26.94,26.37,28.24,28.39,28.39,28.05,28.67,28.13,27.98,29.15,28.19,28.40,28.03,-0.48,-1.09,-1.66,0.21,0.36,0.35,0.02,0.63,0.09,-0.06,1.11,0.15,0.36,cell differentiation;cellular calcium ion homeostasis;apoptotic process,mitochondrial outer membrane;integral to membrane;nucleus;microtubule;spindle pole,,,,,,,,,,,,,,
6978,Q96TC7,RMDN3,Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51),SQSLPNSLDYTQT,_SQSLPNS(ph)LDYTQTSDPGR_,S50,,,,,24.82,,,24.36,,,,25.54,23.65,,24.59, , , ,0.23, , ,-0.24, , , ,0.95,-0.94, ,cell differentiation;cellular calcium ion homeostasis;apoptotic process,mitochondrial outer membrane;integral to membrane;nucleus;microtubule;spindle pole,,,,,,,,,,,,,,
6980,Q99081,TCF12,Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4),SRGRTSSTNEDED,_TSS(ph)TNEDEDLNPEQK_,S193,,,,,,,,24.71,23.90,26.54,,,24.90,,25.01, , , , , , ,-0.30,-1.12,1.53, , ,-0.11, ,"positive regulation of transcription, DNA-dependent;positive regulation of neuron differentiation;immune response;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;muscle organ development",transcription factor complex;nucleus,bHLH,,,,,,,,,,,,,
6983,Q99460,PSMD1,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),GKTPEASPEPKDQ,_TSSAFVGKT(ph)PEAS(ph)PEPK_,S315,+,25.37,25.75,25.35,25.36,23.15,,24.46,22.97,25.23,24.91,,23.38,,24.59,0.78,1.16,0.76,0.77,-1.44, ,-0.13,-1.62,0.63,0.32, ,-1.22, ,"regulation of protein catabolic process;S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome regulatory particle,,,,,,,,,,,,,,
6984,Q99466,NOTCH4,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation;Notch 4 intracellular domain],EDPCPPSFCSKRG,_LEDPCPPS(ph)FCS(ph)K_,S125,,27.45,28.81,28.39,28.95,26.76,27.67,29.14,27.55,28.22,28.24,29.34,29.60,25.92,28.16,-0.71,0.65,0.23,0.80,-1.39,-0.48,0.98,-0.61,0.06,0.08,1.18,1.44,-2.23,transcription initiation from RNA polymerase II promoter;cell fate determination;patterning of blood vessels;embryo development;negative regulation of endothelial cell differentiation;Notch receptor processing;endothelial cell morphogenesis;mammary gland development;hemopoiesis;positive regulation of transcription of Notch receptor target,nucleoplasm;cytosol;extracellular region;integral to plasma membrane;endoplasmic reticulum membrane;Golgi membrane;cell surface,,,,,,,,,,,,,,
6985,Q99466,NOTCH4,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation;Notch 4 intracellular domain],CPPSFCSKRGRCH,_LEDPCPPS(ph)FCS(ph)K_,S128,,27.45,28.81,28.39,28.95,26.76,27.67,29.14,27.55,28.22,28.24,29.34,29.60,25.92,28.16,-0.71,0.65,0.23,0.80,-1.39,-0.48,0.98,-0.61,0.06,0.08,1.18,1.44,-2.23,transcription initiation from RNA polymerase II promoter;cell fate determination;patterning of blood vessels;embryo development;negative regulation of endothelial cell differentiation;Notch receptor processing;endothelial cell morphogenesis;mammary gland development;hemopoiesis;positive regulation of transcription of Notch receptor target,nucleoplasm;cytosol;extracellular region;integral to plasma membrane;endoplasmic reticulum membrane;Golgi membrane;cell surface,,,,,,,,,,,,,,
6986,Q99500,S1PR3,Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3),GRGARASPIQPAL,_AS(ph)PIQPALDPSR_,S326,+,21.28,20.92,,23.78,24.32,24.19,23.14,,,,22.29,,23.99,22.99,-1.71,-2.07, ,0.79,1.33,1.20,0.15, , , ,-0.70, ,1.00,anatomical structure morphogenesis;inflammatory response;cytokine production;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;sphingosine-1-phosphate signaling pathway;regulation of interleukin-1 beta production;elevation of cytosolic calcium ion concentration;positive regulation of cell proliferation,integral to plasma membrane,,,,,,,,,,,,,,
6987,Q99501,GAS2L1,GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1),RLSRVSSPSPELG,_VSS(ph)PSPELGTTPASIFR_,S490,+,,,,22.06,24.16,22.70,22.90,23.88,23.28,,24.25,,,23.32, , , ,-1.26,0.85,-0.62,-0.42,0.56,-0.04, ,0.93, , ,regulation of cell cycle;negative regulation of gene expression;negative regulation of erythrocyte differentiation;negative regulation of cell growth;microtubule bundle formation;cell cycle arrest;negative regulation of microtubule depolymerization;cellular response to thyroid hormone stimulus;cellular response to starvation,stress fiber;microtubule;cytoplasm,,,,,,,,,,,,,,
6988,Q99523,SORT1,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),SGYHDDSDEDLLE,_SGYHDDS(ph)DEDLLE_,S825,+,26.60,,,21.84,26.92,26.22,26.04,25.17,26.15,29.16,24.49,23.92,24.36,25.54,1.06, , ,-3.70,1.38,0.69,0.51,-0.36,0.62,3.63,-1.04,-1.61,-1.17,regulation of gene expression;negative regulation of apoptotic process;vesicle organization;neuropeptide signaling pathway;endosome to lysosome transport;myotube differentiation;endocytosis;apoptotic signaling pathway;response to insulin stimulus;glucose import;negative regulation of lipoprotein lipase activity;plasma membrane to endosome transport;ossification;endosome transport via multivesicular body sorting pathway;Golgi to endosome transport,neuronal cell body;trans-Golgi network transport vesicle;clathrin-coated vesicle;Golgi cisterna membrane;integral to membrane;plasma membrane;endoplasmic reticulum membrane;dendrite;Golgi apparatus;lysosomal membrane;early endosome;perinuclear region of cytoplasm;coated pit;nuclear membrane;endosome membrane;cell surface,,,,,,,,,,,,,,
6991,Q99543,DNAJC2,DnaJ homolog subfamily C member 2 (M-phase phosphoprotein 11) (Zuotin-related factor 1),RRNRNASASFQEL,_NAS(ph)AS(ph)FQELEDKK_,S47,+,28.10,26.99,27.02,26.88,,25.50,27.46,24.81,26.48,26.41,26.13,26.22,24.66,26.39,1.71,0.60,0.63,0.49, ,-0.89,1.07,-1.58,0.10,0.02,-0.26,-0.17,-1.73,"positive regulation of transcription, DNA-dependent;negative regulation of cell growth;transcription, DNA-dependent;chromatin modification;G2 phase of mitotic cell cycle;DNA replication;'de novo' cotranslational protein folding",nuclear membrane;cytosol,,,,,,,,,,,,,,
6992,Q99543,DNAJC2,DnaJ homolog subfamily C member 2 (M-phase phosphoprotein 11) (Zuotin-related factor 1),NRNASASFQELED,_NAS(ph)AS(ph)FQELEDKK_,S49,,27.05,24.47,25.22,25.51,,,,,21.76,22.66,,,,24.44,2.60,0.03,0.78,1.06, , , , ,-2.68,-1.79, , , ,"positive regulation of transcription, DNA-dependent;negative regulation of cell growth;transcription, DNA-dependent;chromatin modification;G2 phase of mitotic cell cycle;DNA replication;'de novo' cotranslational protein folding",nuclear membrane;cytosol,,,,,,,,,,,,,,
6993,Q99549,MPHOSPH8,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),AEAFGDSEEDGED,_GAEAFGDS(ph)EEDGEDVFEVEK_,S51,+,27.17,,,,27.92,24.00,23.77,23.78,26.15,27.34,22.65,24.47,24.59,25.18,1.99, , , ,2.74,-1.18,-1.42,-1.41,0.97,2.16,-2.54,-0.71,-0.59,"regulation of DNA methylation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;cell cycle",nuclear heterochromatin;nucleolus;plasma membrane;nuclear nucleosome;cytoplasm,,,,,,,,,,,,,,
6994,Q99549,MPHOSPH8,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),GLWSTDSAEEDKE,_GLWSTDS(ph)AEEDKETK_,S403,+,24.60,23.48,23.48,24.63,,25.95,25.14,24.94,25.35,24.04,22.76,24.19,23.75,24.36,0.24,-0.88,-0.88,0.27, ,1.59,0.78,0.58,1.00,-0.31,-1.60,-0.17,-0.61,"regulation of DNA methylation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;cell cycle",nuclear heterochromatin;nucleolus;plasma membrane;nuclear nucleosome;cytoplasm,,,,,,,,,,,,,,
6995,Q99549,MPHOSPH8,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),PLDSAMSAEEDTD,_PLDSAM(ox)S(ph)AEEDTDVR_,S319,+,22.41,24.25,24.48,25.95,,22.59,26.55,23.54,26.24,25.13,25.53,25.73,23.97,24.70,-2.29,-0.45,-0.22,1.25, ,-2.11,1.85,-1.16,1.54,0.44,0.83,1.03,-0.73,"regulation of DNA methylation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;cell cycle",nuclear heterochromatin;nucleolus;plasma membrane;nuclear nucleosome;cytoplasm,,,,,,,,,,,,,,
6996,Q99567,NUP88,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),DVEVAESPLRVLA,_EDVEVAES(ph)PLR_,S517,,23.88,,,24.37,,24.85,,,23.80,22.95,,,23.55,23.90,-0.02, , ,0.47, ,0.95, , ,-0.10,-0.95, , ,-0.35,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
6999,Q99567,NUP88,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),SSSLPSSPPPQLL,_PASSSLPSS(ph)PPPQLLTR_,S50,+,24.16,23.38,23.03,22.81,24.94,25.30,25.34,24.83,25.53,25.73,25.34,22.43,25.06,24.45,-0.29,-1.07,-1.42,-1.64,0.48,0.85,0.88,0.38,1.08,1.28,0.89,-2.03,0.60,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
7000,Q99569,PKP4,Plakophilin-4 (p0071),PAARAASPYSQRP,_AAS(ph)PYSQRPAS(ph)PTAIR_,S229,,23.29,,,,,,,,,,,,,23.29,0.00, , , , , , , , , , , , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7001,Q99569,PKP4,Plakophilin-4 (p0071),YSQRPASPTAIRR,_AAS(ph)PYSQRPAS(ph)PTAIR_,S237,,23.29,,,,,,,,,,,,,23.29,0.00, , , , , , , , , , , , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7002,Q99569,PKP4,Plakophilin-4 (p0071),VPSRAQSPSYVIS,_AQS(ph)PSYVIS(ph)TGVSPSRGSLR_,S177,,23.43,,,,,,,,,,,,,23.43,0.00, , , , , , , , , , , , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7006,Q99569,PKP4,Plakophilin-4 (p0071),CRLGAESPSIAST,_LGAES(ph)PSIASTSSTEK_,S31,,23.13,22.84,,,,,,22.56,22.35,22.58,,,,22.69,0.44,0.15, , , , , ,-0.13,-0.34,-0.12, , , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7007,Q99569,PKP4,Plakophilin-4 (p0071),DLLGKESPSKDSE,_LLGLNELDDLLGKES(ph)PSK_,S731,,25.30,22.49,,,,,23.17,,25.67,26.10,23.28,,,24.33,0.97,-1.85, , , , ,-1.16, ,1.33,1.76,-1.05, , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7008,Q99569,PKP4,Plakophilin-4 (p0071),DLRSAVSPDLHIT,_SAVS(ph)PDLHITPIYEGR_,S362,+,23.11,,,,22.68,,23.13,22.98,,25.90,22.89,,23.15,23.40,-0.30, , , ,-0.72, ,-0.27,-0.42, ,2.49,-0.51, ,-0.26,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7009,Q99569,PKP4,Plakophilin-4 (p0071),ALYRTGSVGIGNL,_TGS(ph)VGIGNLQR_,S447,,25.00,21.41,,,21.50,,22.00,21.69,,,,22.51,,22.35,2.65,-0.94, , ,-0.85, ,-0.35,-0.66, , , ,0.16, ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7012,Q99569,PKP4,Plakophilin-4 (p0071),TTARVGSPLTLTD,_VGS(ph)PLTLTDAQTR_,S270,+,26.65,25.17,25.05,24.45,27.69,26.36,26.06,26.17,25.98,26.52,25.89,24.88,25.85,25.90,0.75,-0.74,-0.85,-1.46,1.78,0.46,0.16,0.27,0.08,0.62,-0.02,-1.02,-0.05,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
7013,Q99575,POP1,Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5),EEPSVASSPNGKE,_VQAYEEPSVAS(ph)SPNGK_,S729,+,25.15,21.94,21.94,26.89,27.20,27.25,26.96,24.99,,25.19,26.22,25.78,26.65,25.51,-0.36,-3.57,-3.57,1.37,1.69,1.74,1.45,-0.52, ,-0.32,0.70,0.26,1.13,tRNA catabolic process;tRNA 5'-leader removal,nucleolar ribonuclease P complex;ribonuclease MRP complex,,,,,,,,,,,,,,
7014,Q99575,POP1,Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5),EPSVASSPNGKES,_VQAYEEPSVASS(ph)PNGK_,S730,+,25.27,24.29,24.16,27.24,24.80,,,25.92,26.75,,,,,25.49,-0.22,-1.20,-1.33,1.75,-0.69, , ,0.43,1.26, , , , ,tRNA catabolic process;tRNA 5'-leader removal,nucleolar ribonuclease P complex;ribonuclease MRP complex,,,,,,,,,,,,,,
7015,Q99576,TSC22D3,TSC22 domain family protein 3 (DSIP-immunoreactive peptide) (Protein DIP) (hDIP) (Delta sleep-inducing peptide immunoreactor) (Glucocorticoid-induced leucine zipper protein) (GILZ) (TSC-22-like protein) (TSC-22-related protein) (TSC-22R),ENNNPGSPTVSNF,_GSSGENNNPGS(ph)PTVSNFR_,S42,,,,,23.34,23.84,,23.43,23.77,21.95,,23.74,,,23.34, , , ,-0.01,0.50, ,0.09,0.43,-1.40, ,0.40, , ,negative regulation of skeletal muscle tissue development;body fluid secretion;negative regulation of transcription from RNA polymerase II promoter;response to osmotic stress,nucleus;cytoplasm,,,,,,,,,,,,,,
7016,Q99584,S100A13,Protein S100-A13 (S100 calcium-binding protein A13),QEGRKDSLSVNEF,_(gl)QEGRKDS(ph)LSVNEFK_,S32,+,24.39,23.90,23.44,22.03,24.69,25.90,25.32,26.20,24.89,23.44,26.36,24.79,24.49,24.60,-0.21,-0.70,-1.16,-2.58,0.09,1.30,0.71,1.59,0.28,-1.16,1.75,0.19,-0.12,positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of cell shape;mast cell degranulation;positive regulation of cell proliferation;response to electrical stimulus;response to copper ion;interleukin-1 alpha secretion,cytosol;extracellular space;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
7018,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",SPSTTWSPNKDTP,_FHS(ph)PSTTWS(ph)PNK_,S487,,25.25,24.95,24.95,25.08,,,,,22.20,,,,,24.49,0.77,0.46,0.46,0.59, , , , ,-2.28, , , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7019,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",KFVEQQSYKRKSE,_FVEQQS(ph)YK_,S807,,23.08,,,23.74,,,,,,,,,,23.41,-0.33, , ,0.33, , , , , , , , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7020,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",IDRDSYSPRWKGR,_IDRDSYS(ph)PR_,S648,+,23.85,24.83,23.54,24.72,23.69,22.71,,22.23,23.44,,,,21.32,23.37,0.48,1.46,0.17,1.35,0.32,-0.66, ,-1.14,0.07, , , ,-2.05,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7021,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",SPKLESSEGEIIQ,_LESS(ph)EGEIIQTVDR_,S299,,22.63,,,,,,,,,,,,,22.63,0.00, , , , , , , , , , , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7022,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",DQISGLSQSEVKT,_QDQISGLS(ph)QSEVK_,S218,+,23.70,23.30,23.68,21.26,22.08,23.04,,,,22.99,,,,22.87,0.84,0.43,0.81,-1.60,-0.78,0.18, , , ,0.13, , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7026,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",KSSSNDSVDEETA,_SSSNDS(ph)VDEETAESDTSPVLEK_,S90,+,25.12,23.89,23.93,23.70,25.69,26.08,24.95,,26.28,24.92,23.76,,24.35,24.79,0.33,-0.90,-0.86,-1.09,0.90,1.29,0.16, ,1.49,0.13,-1.03, ,-0.44,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7027,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",DEETAESDTSPVL,_SSSNDSVDEETAES(ph)DTSPVLEK_,S98,,24.24,,,,,,,,,23.35,,,,23.80,0.45, , , , , , , , ,-0.45, , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7028,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",TEELIESPKLESS,_TEELIES(ph)PK_,S293,+,26.06,26.48,27.11,24.29,24.41,,24.29,,24.96,24.60,24.54,,25.31,25.21,0.85,1.28,1.91,-0.91,-0.80, ,-0.92, ,-0.25,-0.61,-0.67, ,0.11,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7029,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",EKVETVSQPSESP,_VETVS(ph)QPSES(ph)PKDTIDK_,S456,,26.63,24.59,25.10,25.72,,,,,23.77,,,,,25.16,1.47,-0.57,-0.06,0.56, , , , ,-1.39, , , , ,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7030,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",ETVSQPSESPKDT,_VETVSQPS(ph)ESPKDTIDK_,S459,+,,26.58,26.58,24.19,,23.46,25.65,,,,24.15,24.73,24.73,25.01, ,1.57,1.57,-0.81, ,-1.55,0.65, , , ,-0.86,-0.28,-0.27,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7031,Q99590,SCAF11,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",VSQPSESPKDTID,_VETVS(ph)QPSES(ph)PKDTIDK_,S461,+,27.59,26.04,25.68,26.37,,,25.42,24.07,27.02,26.90,24.37,25.77,23.83,25.73,1.86,0.31,-0.05,0.64, , ,-0.32,-1.66,1.29,1.16,-1.36,0.04,-1.90,spliceosomal complex assembly,nucleus,,,,,,,,,,,,,,
7033,Q99594,TEAD3,Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3) (TEAD-3),SWNASSSPGEARE,_(ac)ASNSWNASSS(ph)PGEAREDGPEGLDK_,S11,,27.07,24.77,24.72,25.15,24.14,25.83,,24.59,26.39,24.03,,,,25.19,1.88,-0.41,-0.47,-0.03,-1.05,0.64, ,-0.60,1.20,-1.16, , , ,transcription initiation from RNA polymerase II promoter;female pregnancy;regulation of transcription from RNA polymerase II promoter;hippo signaling cascade;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;transcription factor complex,Other TF domain,,,,,,,,,,,,,
7034,Q99594,TEAD3,Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3) (TEAD-3),NKFSPPSPLPQAV,_FSPPS(ph)PLPQAVFSTSSR_,S148,,26.12,20.53,20.53,,,,20.64,,,,23.09,22.09,,22.16,3.96,-1.64,-1.64, , , ,-1.53, , , ,0.93,-0.08, ,transcription initiation from RNA polymerase II promoter;female pregnancy;regulation of transcription from RNA polymerase II promoter;hippo signaling cascade;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;transcription factor complex,Other TF domain,,,,,,,,,,,,,
7035,Q99598,TSNAX,Translin-associated protein X (Translin-associated factor X),KDVNSSSPVMLAF,_DVNSSS(ph)PVM(ox)LAFK_,S33,+,23.13,22.96,22.91,22.94,,21.74,22.88,22.66,22.74,22.50,22.45,22.32,22.14,22.61,0.52,0.34,0.29,0.32, ,-0.87,0.27,0.05,0.13,-0.11,-0.16,-0.30,-0.48,multicellular organismal development;cell differentiation;spermatogenesis,Golgi apparatus;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
7036,Q99607,ELF4,ETS-related transcription factor Elf-4 (E74-like factor 4) (Myeloid Elf-1-like factor),KGNRSTSPVTDPS,_STS(ph)PVTDPSIPIR_,S188,+,24.36,24.78,,25.20,26.38,26.37,25.79,26.09,25.63,,,,26.05,25.63,-1.26,-0.84, ,-0.43,0.75,0.74,0.16,0.46,0.00, , , ,0.43,"NK T cell proliferation;natural killer cell proliferation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",PML body,Other TF domain,,,,,,,,,+,,,,
7038,Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),ESESSLSGEELVT,_(ac)SRFFTTGSDSESESSLS(ph)GEELVTKPVGGNYGK_,S18,,,,,,24.86,23.81,23.66,,24.71,26.78,,,25.39,24.87, , , , ,-0.01,-1.06,-1.20, ,-0.16,1.91, , ,0.52,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
7040,Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),EEDSEGSSDEDED,_NEEDSEGS(ph)SDEDEDEDGVSAATFLK_,S166,,24.01,,,,,,,,,26.44,,,,25.23,-1.21, , , , , , , , ,1.21, , , ,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
7042,Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),KQNPEQSADEDAE,_QNPEQS(ph)ADEDAEK_,S151,+,28.28,28.67,28.61,30.14,25.42,22.15,29.79,24.73,28.87,28.54,27.24,28.57,25.64,27.43,0.85,1.24,1.17,2.71,-2.02,-5.28,2.36,-2.71,1.44,1.10,-0.20,1.13,-1.79,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
7043,Q99613,EIF3C,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),KQPLLLSEDEEDT,_(gl)QPLLLS(ph)EDEEDTK_,S39,+,30.55,27.69,28.37,29.23,29.97,28.28,30.58,30.06,29.16,29.52,30.17,30.17,28.91,29.44,1.11,-1.75,-1.07,-0.20,0.53,-1.15,1.14,0.63,-0.28,0.09,0.74,0.74,-0.52,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
7045,Q99618,CDCA3,Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1) (TOME-1),SSGDPPSPLVKQL,_TSSGDPPS(ph)PLVK_,S87,,25.62,24.31,24.31,,23.05,21.51,21.71,23.39,,,,,,23.41,2.20,0.90,0.90, ,-0.36,-1.90,-1.70,-0.02, , , , , ,mitosis;cell division;protein ubiquitination,cytosol,,,,,,,,,,,,,,
7046,Q99638,RAD9A,Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A),PVLAEDSEGEG__,_SPQGPSPVLAEDS(ph)EGEG_,S387,,24.50,,,,,,,,,,,,,24.50,0.00, , , , , , , , , , , , ,DNA repair;DNA replication checkpoint;cellular response to ionizing radiation;positive regulation of apoptotic process;DNA replication;DNA damage checkpoint,nucleoplasm;cytoplasm;checkpoint clamp complex,,,,,,,,,,,,,,
7047,Q99638,RAD9A,Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A),LPSISLSPGPQPP,_VLPSISLS(ph)PGPQPPK_,S328,+,23.42,23.07,23.56,22.06,,,23.86,,24.02,24.42,22.93,24.09,,23.49,-0.07,-0.42,0.07,-1.43, , ,0.37, ,0.53,0.93,-0.56,0.59, ,DNA repair;DNA replication checkpoint;cellular response to ionizing radiation;positive regulation of apoptotic process;DNA replication;DNA damage checkpoint,nucleoplasm;cytoplasm;checkpoint clamp complex,,,,,,,,,,,,,,
7048,Q99650,OSMR,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),FLGTRKSLTETEL,_S(ph)LTETELTKPNYLYLLPTEK_,S826,+,23.59,24.27,24.90,25.19,,25.78,,,26.62,24.72,24.58,24.49,27.45,25.16,-1.57,-0.88,-0.26,0.03, ,0.62, , ,1.46,-0.44,-0.58,-0.67,2.29,cell proliferation;positive regulation of cell proliferation;positive regulation of acute inflammatory response,oncostatin-M receptor complex,,,,,,,,,,,,,,
7051,Q99683,MAP3K5,Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5),ENFEDHSAPPSPE,_TLFLGIPDENFEDHS(ph)APPS(ph)PEEK_,S276,,22.49,,,,,,,,,,,,,22.49,0.00, , , , , , , , , , , , ,cellular response to hydrogen peroxide;activation of JUN kinase activity;hydrogen peroxide-mediated programmed cell death;positive regulation of apoptotic process;intrinsic apoptotic signaling pathway in response to oxidative stress;virus-host interaction;innate immune response,endoplasmic reticulum,,+,,,,,,,,,,,,
7052,Q99683,MAP3K5,Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5),DHSAPPSPEEKDS,_TLFLGIPDENFEDHS(ph)APPS(ph)PEEK_,S280,,23.76,,,,,,,,23.48,23.11,,,,23.45,0.31, , , , , , , ,0.03,-0.34, , , ,cellular response to hydrogen peroxide;activation of JUN kinase activity;hydrogen peroxide-mediated programmed cell death;positive regulation of apoptotic process;intrinsic apoptotic signaling pathway in response to oxidative stress;virus-host interaction;innate immune response,endoplasmic reticulum,,+,,,,,,,,,,,,
7053,Q99700,ATXN2,Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein),LENDDRSEEEKYT,_ARVALENDDRS(ph)EEEK_,S387,+,,24.12,24.12,,,23.32,24.28,,23.62,23.52,23.75,24.49,,23.90, ,0.22,0.22, , ,-0.58,0.38, ,-0.28,-0.39,-0.15,0.58, ,neuromuscular process;cerebellar Purkinje cell differentiation;RNA metabolic process;homeostasis of number of cells;negative regulation of multicellular organism growth;cell death;negative regulation of receptor internalization;RNA transport;neuron projection morphogenesis;stress granule assembly;regulation of translation;cytoplasmic mRNA processing body assembly,trans-Golgi network;Golgi apparatus;nucleus;polysome;cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
7059,Q99708,RBBP8,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),PLRPRESLETENV,_IPLRPRES(ph)LETENVLDDIK_,S593,,21.28,,,,,,,,,,,,,21.28,0.00, , , , , , , , , , , , ,blastocyst hatching;G2/M transition DNA damage checkpoint;G1/S transition of mitotic cell cycle;meiosis;mitosis;DNA double-strand break processing involved in repair via single-strand annealing;cell division;double-strand break repair via homologous recombination,transcriptional repressor complex,,,,,,,,,,,,,,
7061,Q99708,RBBP8,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),LPTRVSSPVFGAT,_VSS(ph)PVFGATSSIK_,S327,,24.47,23.11,,21.01,,21.80,,,,22.59,22.04,,,22.50,1.97,0.61, ,-1.50, ,-0.70, , , ,0.08,-0.46, , ,blastocyst hatching;G2/M transition DNA damage checkpoint;G1/S transition of mitotic cell cycle;meiosis;mitosis;DNA double-strand break processing involved in repair via single-strand annealing;cell division;double-strand break repair via homologous recombination,transcriptional repressor complex,,,,,,,,,,,,,,
7062,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),__MADHSFSDGVP,_(ac)ADHS(ph)FSDGVPSDSVEAAK_,S5,+,24.50,23.45,24.02,24.26,26.55,25.62,26.92,26.23,24.26,24.34,24.58,25.64,25.19,25.04,-0.55,-1.59,-1.02,-0.78,1.50,0.58,1.88,1.18,-0.78,-0.71,-0.46,0.59,0.15,nucleosome assembly,chromatin assembly complex;cytoplasm,,,,,,,,,,,,,,
7063,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),MADHSFSDGVPSD,_(ac)ADHSFS(ph)DGVPSDSVEAAK_,S7,+,24.44,23.53,23.53,24.52,25.67,,25.98,25.74,,25.23,25.24,25.54,24.20,24.87,-0.43,-1.35,-1.35,-0.35,0.79, ,1.10,0.86, ,0.35,0.37,0.66,-0.67,nucleosome assembly,chromatin assembly complex;cytoplasm,,,,,,,,,,,,,,
7064,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),FSDGVPSDSVEAA,_(ac)ADHSFSDGVPS(ph)DSVEAAK_,S12,+,23.94,23.21,23.21,23.78,24.56,,,24.49,23.05,24.04,,23.93,23.17,23.74,0.20,-0.53,-0.53,0.04,0.82, , ,0.75,-0.69,0.30, ,0.19,-0.57,nucleosome assembly,chromatin assembly complex;cytoplasm,,,,,,,,,,,,,,
7066,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),AESEWHSENEEEE,_EFITGDVEPTDAESEWHS(ph)ENEEEEK_,S125,+,25.66,,,,28.90,23.81,25.25,26.76,25.64,27.33,25.32,28.27,24.90,26.19,-0.53, , , ,2.72,-2.38,-0.93,0.58,-0.55,1.15,-0.86,2.09,-1.28,nucleosome assembly,chromatin assembly complex;cytoplasm,,,,,,,,,,,,,,
7068,Q99741,CDC6,Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6),VKALPLSPRKRLG,_ALPLS(ph)PR_,S54,,22.46,,,19.58,22.22,,,21.56,,,,,,21.45,1.00, , ,-1.87,0.76, , ,0.11, , , , , ,S phase of mitotic cell cycle;negative regulation of cell proliferation;regulation of transcription involved in G1/S phase of mitotic cell cycle;positive regulation of chromosome segregation;negative regulation of DNA replication;regulation of mitotic anaphase;positive regulation of cell cycle cytokinesis;M/G1 transition of mitotic cell cycle;DNA replication checkpoint;mitosis;regulation of cyclin-dependent protein kinase activity;traversing start control point of mitotic cell cycle;cell division;DNA replication,nucleoplasm;cytosol;spindle midzone;spindle pole,,,,,,,,,,,,,,
7071,Q99856,ARID3A,AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),GLGHPASPGGSED,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_,S77,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",membrane raft;nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
7072,Q99856,ARID3A,AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),PASPGGSEDGPPG,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_,S81,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",membrane raft;nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
7073,Q99856,ARID3A,AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),EDGPPGSEEEDAA,_AAAAGLGHPAS(ph)PGGS(ph)EDGPPGS(ph)EEEDAAR_,S88,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",membrane raft;nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
7074,Q99856,ARID3A,AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),REGTPGSPGRGRE,_EGTPGS(ph)PGRGR_,S101,,,19.57,,21.20,,,,,,,,,,20.39, ,-0.81, ,0.81, , , , , , , , , ,"transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",membrane raft;nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
7075,Q99958,FOXC2,Forkhead box protein C2 (Forkhead-related protein FKHL14) (Mesenchyme fork head protein 1) (MFH-1 protein) (Transcription factor FKH-14),IKSEAASPALPVI,_SEAAS(ph)PALPVITK_,S48,,,,,,,21.49,,,25.83,,,,,23.66, , , , , ,-2.17, , ,2.17, , , , ,ventricular cardiac muscle tissue morphogenesis;ureteric bud development;embryonic heart tube development;regulation of organ growth;patterning of blood vessels;metanephros development;positive regulation of vascular wound healing;collagen fibril organization;regulation of sequence-specific DNA binding transcription factor activity;neural crest cell development;lymphangiogenesis;insulin receptor signaling pathway;positive regulation of cell adhesion mediated by integrin;glomerular visceral epithelial cell differentiation;ossification;cardiac muscle cell proliferation;artery morphogenesis;vasculogenesis;somitogenesis;vascular endothelial growth factor receptor signaling pathway;glomerular endothelium development;glomerular mesangial cell development;blood vessel remodeling;Notch signaling pathway;embryonic viscerocranium morphogenesis;paraxial mesodermal cell fate commitment;negative regulation of transcription from RNA polymerase II promoter;regulation of blood vessel size;positive regulation of cell migration involved in sprouting angiogenesis;neural crest cell fate commitment;camera-type eye development,transcription factor complex,Forkhead,,,,,,,,,,,,,
7076,Q99959,PKP2,Plakophilin-2,QAAAGGSGNLLTE,_AHLTVGQAAAGGS(ph)GNLLTER_,S329,+,24.29,22.64,22.64,21.13,23.32,23.53,24.03,25.20,24.84,23.95,24.09,,,23.60,0.68,-0.97,-0.97,-2.48,-0.28,-0.08,0.42,1.59,1.24,0.34,0.48, , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7081,Q99959,PKP2,Plakophilin-2,LRRLEISPDSSPE,_RLEIS(ph)PDS(ph)S(ph)PER_,S151,+,30.83,27.14,27.73,27.82,28.29,27.82,28.20,28.75,27.61,27.72,28.48,27.84,27.96,28.17,2.67,-1.03,-0.44,-0.35,0.12,-0.35,0.03,0.58,-0.56,-0.45,0.31,-0.33,-0.21,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7083,Q99959,PKP2,Plakophilin-2,EISPDSSPERAHY,_RLEIS(ph)PDS(ph)S(ph)PER_,S155,+,30.36,22.01,22.77,26.48,26.74,25.99,25.47,,23.69,23.27,25.68,,,25.24,5.11,-3.24,-2.47,1.23,1.49,0.75,0.22, ,-1.56,-1.98,0.43, , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7084,Q99959,PKP2,Plakophilin-2,NLSRNLSLQNEIA,_NLS(ph)LQNEIAK_,S717,,22.45,,,20.63,,,21.10,,22.30,21.76,,,,21.65,0.80, , ,-1.02, , ,-0.55, ,0.65,0.11, , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7085,Q99959,PKP2,Plakophilin-2,RQYQHGSVSDTVF,_(gl)QYQHGS(ph)VSDTVFDSIPANPALLTYPRPGTSR_,S225,,25.27,,,,,,,,,,,,,25.27,0.00, , , , , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7086,Q99959,PKP2,Plakophilin-2,PPRYARSEIVGVS,_S(ph)EIVGVSR_,S197,,26.66,23.99,23.99,21.74,,,,21.84,,,,21.97,,23.37,3.30,0.63,0.63,-1.62, , , ,-1.53, , , ,-1.40, ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7087,Q99959,PKP2,Plakophilin-2,SEIVGVSRAGTTS,_SEIVGVS(ph)R_,S203,,25.59,,,,,,,,,,,,,25.59,0.00, , , , , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7089,Q99959,PKP2,Plakophilin-2,YQYSQRSQAGHTL,_S(ph)QAGHTLHHQES(ph)R_,S172,,22.35,22.07,22.07,19.40,,,,,,,,,,21.47,0.88,0.60,0.60,-2.07, , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7090,Q99959,PKP2,Plakophilin-2,TLHHQESRRAALL,_S(ph)QAGHTLHHQES(ph)R_,S183,,22.50,22.07,22.07,19.40,,,,,,,,,,21.51,0.99,0.56,0.56,-2.11, , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7092,Q99959,PKP2,Plakophilin-2,SSWHQSSFHSTRT,_SS(ph)WHQSS(ph)FHS(ph)TR_,S294,,25.92,,,21.98,,,,,,,,,,23.95,1.97, , ,-1.97, , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7094,Q99959,PKP2,Plakophilin-2,RSTFTDSQLGNAD,_STFTDS(ph)QLGNADM(ox)EM(ox)TLER_,S342,,24.65,,,,,,,,,,,,,24.65,0.00, , , , , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7095,Q99959,PKP2,Plakophilin-2,NLHRTSSVPEYVY,_TSS(ph)VPEYVYNLHLVENDFVGGR_,S82,,25.89,,,,,,,,,,,,,25.89,0.00, , , , , , , , , , , , ,negative regulation of cell proliferation;cell-cell adhesion;ventricular cardiac muscle tissue morphogenesis;intermediate filament bundle assembly;regulation of tight junction assembly;negative regulation of cell migration;lipid homeostasis;bundle of His cell to Purkinje myocyte communication;positive regulation of sodium ion transport;regulation of heart rate by cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;cell-cell signaling involved in cardiac conduction;gap junction assembly;regulation of ventricular cardiac muscle cell action potential;desmosome assembly;adherens junction maintenance;maintenance of organ identity,intercalated disc;adherens junction;intermediate filament;integral to membrane;plasma membrane;nucleus;desmosome,,,,,,,,,,,,,,
7097,Q99961,SH3GL1,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),KIAASSSFRSSDK,_IAASSS(ph)FR_,S273,+,28.82,25.64,25.54,28.06,25.49,24.16,24.72,24.75,22.84,,23.25,26.63,22.31,25.18,3.64,0.46,0.36,2.87,0.31,-1.03,-0.47,-0.44,-2.34, ,-1.93,1.45,-2.88,signal transduction;endocytosis;central nervous system development,early endosome membrane;cytoplasm,,,,,,,,,,,,,,
7098,Q9BPX3,NCAPG,Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog),EGTEINSDDEQES,_TLHCEGTEINS(ph)DDEQESK_,S674,+,22.01,23.47,23.80,23.94,24.30,,26.39,23.93,25.00,24.79,,23.40,,24.10,-2.09,-0.63,-0.30,-0.16,0.19, ,2.29,-0.17,0.89,0.69, ,-0.70, ,mitotic chromosome condensation;cell division,nucleus;centrosome;condensin complex;actin cytoskeleton,,,,,,,,,,,,,,
7099,Q9BPZ7,MAPKAP1,Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) (mSIN1),KLNRRTSFSFQKE,_TS(ph)FSFQK_,S81,+,22.64,20.65,,23.18,,,22.47,,21.76,,20.46,22.68,,21.98,0.67,-1.33, ,1.20, , ,0.49, ,-0.22, ,-1.52,0.71, ,epidermal growth factor receptor signaling pathway;fibroblast growth factor receptor signaling pathway;T cell costimulation;nerve growth factor receptor signaling pathway;response to stress;phosphatidylinositol-mediated signaling,cytosol;plasma membrane;nucleus;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
7100,Q9BQ39,DDX50,ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2),YDSDEKSETRENG,_S(ph)ETRENGVTDDLDAPK_,S45,,20.71,23.54,23.93,23.72,,,,,24.58,25.37,23.40,24.86,21.73,23.54,-2.83,0.00,0.39,0.18, , , , ,1.04,1.83,-0.13,1.32,-1.80,,nucleolus;plasma membrane,,,,,,,,,,,,,,
7102,Q9BQ61,C19orf43,Uncharacterized protein C19orf43,GPGSTLSFVGKRR,_GGPGSTLS(ph)FVGK_,S114,,23.92,,,22.42,,,23.01,22.83,,,,23.20,,23.08,0.84, , ,-0.66, , ,-0.07,-0.24, , , ,0.13, ,,,,,,,,,,,,,,,,
7105,Q9BQE3,TUBA1C,Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain),EEVGADSADGEDE,_DYEEVGADS(ph)ADGEDEGEEY_,S439,,24.46,,,,23.39,,,,,23.30,,,,23.72,0.75, , , ,-0.33, , , , ,-0.42, , , ,protein polymerization;microtubule-based process;microtubule-based movement;'de novo' posttranslational protein folding;cytoskeleton-dependent intracellular transport;cell division,cytoplasmic microtubule;microtubule,,,,,,,,,,,,,,
7106,Q9BQE9,BCL7B,B-cell CLL/lymphoma 7 protein family member B (allergen Hom s 3),STNSSPSPQQSES,_VDSSTNSSPS(ph)PQQSES(ph)LSPAHTSDFR_,S114,,22.73,,,,,,,,,,,,,22.73,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7108,Q9BQE9,BCL7B,B-cell CLL/lymphoma 7 protein family member B (allergen Hom s 3),QQSESLSPAHTSD,_VDSSTNSSPSPQQSESLS(ph)PAHTSDFR_,S122,,,,,,24.34,23.99,,24.10,,,,,24.11,24.14, , , , ,0.21,-0.14, ,-0.04, , , , ,-0.03,,,,,,,,,,,,,,,,
7111,Q9BQG0,MYBBP1A,Myb-binding protein 1A,ALGGEDSENEEEL,_ALGGEDS(ph)ENEEELGDEAM(ox)M(ox)ALDQSLASLFAEQK_,S775,,26.18,,,,,,,,,,,,,26.18,0.00, , , , , , , , , , , , ,"cellular response to glucose starvation;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;respiratory electron transport chain;intrinsic apoptotic signaling pathway by p53 class mediator;nucleocytoplasmic transport;transcription, DNA-dependent;positive regulation of cell cycle arrest",NLS-dependent protein nuclear import complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
7112,Q9BQG0,MYBBP1A,Myb-binding protein 1A,IPSATQSPISKKR,_EIPSATQS(ph)PISK_,S1163,+,26.04,26.77,27.54,26.42,28.14,26.10,26.86,26.87,25.79,26.14,24.04,25.13,26.37,26.32,-0.28,0.45,1.21,0.10,1.82,-0.23,0.54,0.55,-0.53,-0.19,-2.29,-1.20,0.05,"cellular response to glucose starvation;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;respiratory electron transport chain;intrinsic apoptotic signaling pathway by p53 class mediator;nucleocytoplasmic transport;transcription, DNA-dependent;positive regulation of cell cycle arrest",NLS-dependent protein nuclear import complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
7113,Q9BQG0,MYBBP1A,Myb-binding protein 1A,DPAQPMSPGEATQ,_DPAQPM(ox)S(ph)PGEATQSGARPADR_,S11,+,,25.91,24.27,,27.75,26.81,26.57,26.03,26.40,25.61,26.51,26.16,27.41,26.31, ,-0.40,-2.04, ,1.43,0.50,0.26,-0.28,0.09,-0.71,0.20,-0.16,1.09,"cellular response to glucose starvation;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;respiratory electron transport chain;intrinsic apoptotic signaling pathway by p53 class mediator;nucleocytoplasmic transport;transcription, DNA-dependent;positive regulation of cell cycle arrest",NLS-dependent protein nuclear import complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
7114,Q9BQG0,MYBBP1A,Myb-binding protein 1A,VNGAPGSPTEPAG,_PSQVNGAPGS(ph)PTEPAGQK_,S1267,+,25.14,25.66,25.98,26.23,26.83,26.27,27.11,26.86,27.24,27.48,25.28,25.57,24.40,26.16,-1.02,-0.49,-0.17,0.07,0.67,0.12,0.95,0.70,1.08,1.32,-0.88,-0.59,-1.76,"cellular response to glucose starvation;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;respiratory electron transport chain;intrinsic apoptotic signaling pathway by p53 class mediator;nucleocytoplasmic transport;transcription, DNA-dependent;positive regulation of cell cycle arrest",NLS-dependent protein nuclear import complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
7115,Q9BQG0,MYBBP1A,Myb-binding protein 1A,LVIRSPSLLQSGA,_SPS(ph)LLQSGAK_,S1310,,21.22,,,23.09,,,,,,,,,,22.15,-0.93, , ,0.93, , , , , , , , , ,"cellular response to glucose starvation;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;respiratory electron transport chain;intrinsic apoptotic signaling pathway by p53 class mediator;nucleocytoplasmic transport;transcription, DNA-dependent;positive regulation of cell cycle arrest",NLS-dependent protein nuclear import complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
7116,Q9BQK8,LPIN3,Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like),ELTSPKSDSELEV,_S(ph)DSELEVRTPEPSPLR_,S224,,,,,,,,,,,22.55,,23.53,,23.04, , , , , , , , , ,-0.49, ,0.49, ,phosphatidylethanolamine biosynthetic process;fatty acid metabolic process;phosphatidylcholine biosynthetic process,nucleus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7117,Q9BQK8,LPIN3,Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like),TSPKSDSELEVRT,_SDS(ph)ELEVR_,S226,,25.43,,,26.63,,,23.52,,,,,,,25.19,0.24, , ,1.44, , ,-1.67, , , , , , ,phosphatidylethanolamine biosynthetic process;fatty acid metabolic process;phosphatidylcholine biosynthetic process,nucleus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7119,Q9BRD0,BUD13,BUD13 homolog,RRARHDSPDLAPN,_HDS(ph)PDLAPNVTYSLPR_,S271,+,23.55,,,,25.06,24.49,22.64,24.25,24.23,22.45,,24.99,23.75,23.93,-0.39, , , ,1.13,0.56,-1.29,0.32,0.30,-1.49, ,1.06,-0.19,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
7120,Q9BRD0,BUD13,BUD13 homolog,ATDSDLSSPRHKQ,_ATDSDLS(ph)SPR_,S357,,23.95,23.62,,24.38,,21.90,,,,,,,,23.46,0.49,0.16, ,0.92, ,-1.56, , , , , , , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
7128,Q9BRD0,BUD13,BUD13 homolog,GSSDISSPRRVHN,_HGSSDISS(ph)PR_,S240,,22.01,,,,18.22,,,19.56,20.35,17.52,,,,19.53,2.48, , , ,-1.31, , ,0.02,0.82,-2.01, , , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
7130,Q9BRD0,BUD13,BUD13 homolog,EYDPDISPPRKKQ,_YEYDPDIS(ph)PPRK_,S325,+,24.38,24.09,24.18,24.10,23.43,24.30,25.85,22.07,25.98,24.25,24.46,24.92,23.68,24.28,0.10,-0.20,-0.10,-0.18,-0.85,0.02,1.57,-2.21,1.69,-0.04,0.18,0.64,-0.61,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
7131,Q9BRG2,SH2D3A,SH2 domain-containing protein 3A (Novel SH2-containing protein 1),LGTVADSLRASDG,_APAPLGTVADS(ph)LRASDGQLQAK_,S197,,25.15,,,,,,21.98,,,23.93,,,,23.69,1.46, , , , , ,-1.71, , ,0.24, , , ,JNK cascade;small GTPase mediated signal transduction,intracellular,,,,+,,,,,,,,,,
7133,Q9BRG2,SH2D3A,SH2 domain-containing protein 3A (Novel SH2-containing protein 1),PLRRSFSEDTLMD,_SFS(ph)EDTLM(ox)DGPAR_,S125,+,26.71,23.30,23.15,22.66,22.85,,23.55,23.40,,23.60,22.45,,,23.52,3.19,-0.22,-0.36,-0.86,-0.67, ,0.03,-0.11, ,0.08,-1.07, , ,JNK cascade;small GTPase mediated signal transduction,intracellular,,,,+,,,,,,,,,,
7134,Q9BRG2,SH2D3A,SH2 domain-containing protein 3A (Novel SH2-containing protein 1),ALPRTSSDPVLLK,_TSS(ph)DPVLLK_,S180,+,26.76,23.65,23.13,22.96,20.18,,23.54,22.82,19.74,22.73,22.59,,,22.81,3.95,0.84,0.32,0.15,-2.63, ,0.73,0.01,-3.07,-0.08,-0.22, , ,JNK cascade;small GTPase mediated signal transduction,intracellular,,,,+,,,,,,,,,,
7137,Q9BRK4,LZTS2,Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1),AAGVGGSLRAQVE,_AAAGVGGS(ph)LR_,S208,+,26.10,24.51,23.16,26.37,24.59,24.00,23.78,23.77,24.09,23.62,23.77,25.15,22.08,24.23,1.87,0.28,-1.07,2.14,0.36,-0.23,-0.45,-0.46,-0.14,-0.61,-0.46,0.92,-2.15,mitosis;Wnt receptor signaling pathway;cell division;positive regulation of cell death,midbody;microtubule;membrane;microtubule organizing center,,,,,,,,,,,,,,
7138,Q9BRK5,SDF4,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),LVDYARSVHEEF_,_S(ph)VHEEF_,S357,,24.18,25.69,25.31,24.87,24.80,26.52,24.36,25.04,26.43,24.33,22.74,24.18,25.66,24.93,-0.76,0.76,0.38,-0.06,-0.13,1.59,-0.57,0.10,1.50,-0.60,-2.19,-0.75,0.73,cerebellum development;UV protection;fat cell differentiation;zymogen granule exocytosis;response to ethanol,late endosome;plasma membrane;Golgi lumen;bleb,,,,,,,,,,,,,,
7139,Q9BRS2,RIOK1,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (RIO kinase 1),QFDDADSSDSENR,_VVPGQFDDADS(ph)S(ph)DSENRDLK_,S14,+,23.24,22.63,,24.55,25.60,,25.95,25.86,24.47,,24.27,25.29,,24.65,-1.42,-2.03, ,-0.11,0.95, ,1.30,1.21,-0.18, ,-0.38,0.64, ,,,,+,,,,,,,,,,,,
7140,Q9BRS2,RIOK1,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (RIO kinase 1),FDDADSSDSENRD,_VVPGQFDDADSS(ph)DSENRDLK_,S15,+,26.76,25.14,25.14,,24.34,24.41,24.08,24.32,23.17,25.67,23.58,,23.90,24.59,2.17,0.55,0.55, ,-0.25,-0.18,-0.51,-0.27,-1.42,1.08,-1.02, ,-0.70,,,,+,,,,,,,,,,,,
7141,Q9BRS8,LARP6,La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6),LSPGWGSASEEEP,_YLSPGWGS(ph)ASEEEPSR_,S56,,,22.82,,23.47,,22.66,,24.40,,,23.36,,,23.34, ,-0.53, ,0.12, ,-0.68, ,1.06, , ,0.02, , ,RNA processing;regulation of translation,ribonucleoprotein complex;Golgi apparatus;nucleus,,,,,,,,,,,,,,
7143,Q9BS91,SLC35A5,Probable UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5),KPKSDESDEDTF_,_LTKPKS(ph)DES(ph)DEDTF_,S189,,24.04,,,,26.21,25.50,,24.88,,,,,24.27,24.98,-0.94, , , ,1.23,0.52, ,-0.10, , , , ,-0.71,nucleotide-sugar transport,integral to membrane;Golgi membrane,,,,,,,,,,,,,,
7145,Q9BSJ8,ESYT1,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),QKKRTLSPEFNER,_TLS(ph)PEFNER_,S1044,+,25.77,24.73,23.81,24.29,24.39,24.04,21.85,23.71,22.43,22.69,,,,23.77,2.00,0.96,0.04,0.52,0.62,0.27,-1.92,-0.07,-1.34,-1.08, , , ,,integral to membrane,,,,,,,,,,,,,,
7146,Q9BSJ8,ESYT1,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),RLTHVDSPLEAPA,_LTHVDS(ph)PLEAPAGPLGQVK_,S973,,22.85,,,,20.93,,,,,23.27,,,,22.35,0.50, , , ,-1.42, , , , ,0.92, , , ,,integral to membrane,,,,,,,,,,,,,,
7151,Q9BST9,RTKN,Rhotekin,ATKLSSSLGRSSG,_LSSS(ph)LGR_,S170,+,26.40,24.10,,25.73,22.46,,22.99,23.09,,,21.06,,,23.69,2.71,0.41, ,2.04,-1.23, ,-0.70,-0.60, , ,-2.63, , ,apoptotic process;Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
7152,Q9BST9,RTKN,Rhotekin,ALAKQGSLYHEMA,_(gl)QGS(ph)LYHEM(ox)AIEPLDDIAAVTDILTQR_,S398,,23.86,,,,,,,,,,,,,23.86,0.00, , , , , , , , , , , , ,apoptotic process;Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
7154,Q9BST9,RTKN,Rhotekin,GRPRTFSLDAVPP,_TFS(ph)LDAVPPDHSPR_,S470,,21.82,20.95,,,,,,22.92,,,,,,21.90,-0.08,-0.94, , , , , ,1.02, , , , , ,apoptotic process;Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
7155,Q9BT43,POLR3GL,DNA-directed RNA polymerase III subunit RPC7-like (RNA polymerase III subunit C7-like) (DNA-directed RNA polymerase III subunit G-like),KEEEVTSEEDEEK,_KEEEVTS(ph)EEDEEK_,S140,,24.26,26.11,25.53,24.74,,,,,,20.65,,,,24.26,0.01,1.85,1.27,0.48, , , , , ,-3.61, , , ,transcription elongation from RNA polymerase III promoter;termination of RNA polymerase III transcription,nucleoplasm,,,,,,,,,,,,,,
7158,Q9BTC0,DIDO1,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),IPDLEDSPPVSDS,_QEAIPDLEDS(ph)PPVS(ph)DSEEQQESAR_,S805,,25.49,,,,22.48,,23.62,,,,,,,23.86,1.63, , , ,-1.39, ,-0.24, , , , , , ,"apoptotic process;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
7159,Q9BTC0,DIDO1,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),EDSPPVSDSEEQQ,_QEAIPDLEDS(ph)PPVS(ph)DSEEQQESAR_,S809,,25.21,,,,22.48,,,,24.37,25.85,,,,24.48,0.74, , , ,-2.00, , , ,-0.11,1.37, , , ,"apoptotic process;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
7161,Q9BTC0,DIDO1,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),ADVRRNSVERPAE,_RNS(ph)VERPAEPVAGAATPSLVEQQK_,S1456,+,,,,,25.55,25.87,24.90,24.62,24.49,,24.16,24.35,24.63,24.82, , , , ,0.72,1.05,0.08,-0.20,-0.34, ,-0.66,-0.47,-0.19,"apoptotic process;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
7165,Q9BTC0,DIDO1,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),STSESRSPPEGDT,_S(ph)PPEGDTTLFLSR_,S1040,,23.28,22.58,21.15,22.16,22.15,21.75,,,,,,,,22.18,1.10,0.40,-1.03,-0.01,-0.03,-0.43, , , , , , , ,"apoptotic process;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
7168,Q9BTC8,MTA3,Metastasis-associated protein MTA3,EEKLSPSPTTEDP,_LSPS(ph)PTTEDPR_,S429,+,26.94,24.32,23.54,,,23.79,22.69,,23.10,24.69,22.61,,,23.96,2.98,0.36,-0.42, , ,-0.17,-1.27, ,-0.86,0.73,-1.35, , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
7169,Q9BTE3,MCMBP,Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein),PSRHKRSYEDDDD,_S(ph)YEDDDDM(ox)DLQPNK_,S167,,22.36,,,,,,,,,,,,,22.36,0.00, , , , , , , , , , , , ,sister chromatid cohesion;S phase of mitotic cell cycle;mitosis;cell division;DNA-dependent DNA replication,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7172,Q9BTK6,PAGR1,PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1),EDPSPASPPLRSS,_DLFSLDSEDPSPAS(ph)PPLR_,S237,,26.53,,,,23.12,22.29,22.99,,,,,,,23.73,2.80, , , ,-0.61,-1.44,-0.75, , , , , , ,,histone methyltransferase complex,,,,,,,,,,,,,,
7173,Q9BTK6,PAGR1,PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1),PTPEAQSEEERSD,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_,S143,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,,histone methyltransferase complex,,,,,,,,,,,,,,
7174,Q9BTK6,PAGR1,PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1),QSEEERSDEEPEA,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_,S148,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,,histone methyltransferase complex,,,,,,,,,,,,,,
7175,Q9BTL3,FAM103A1,RNMT-activating mini protein (RAM) (Protein FAM103A1),LKRPPESPPIVEE,_RPPES(ph)PPIVEEWNSR_,S36,+,25.05,21.49,,21.05,24.56,24.73,23.58,25.48,25.03,25.43,24.02,22.82,23.85,23.92,1.12,-2.44, ,-2.87,0.64,0.81,-0.35,1.56,1.10,1.50,0.10,-1.10,-0.08,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex;methylation,nucleus;mRNA cap binding complex,,,,,,,,,,,,,,
7176,Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),__MDETSPLVSPE,_(ac)M(ox)DETS(ph)PLVSPER_,S5,+,23.18,22.27,,,24.95,24.55,24.49,24.72,24.29,,26.70,23.43,25.44,24.40,-1.22,-2.13, , ,0.54,0.15,0.09,0.32,-0.11, ,2.30,-0.97,1.04,phosphatidylinositol biosynthetic process;small molecule metabolic process;basophil degranulation,neuronal cell body;mitochondrion;membrane raft;host cell presynaptic membrane;synaptic vesicle membrane;cell junction;integral to plasma membrane;presynaptic membrane;dendrite;early endosome membrane;endosome;exocytic vesicle;protein complex;cytosol;cytoplasmic vesicle;growing cell tip;perikaryon,,,,,,,,,,,,,,
7177,Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),SHQRSSSESYTQS,_SSS(ph)ESYTQSFQSR_,S462,+,24.56,26.10,26.10,25.91,26.26,26.36,26.27,26.62,26.52,26.50,26.99,25.63,25.70,26.12,-1.55,-0.01,-0.02,-0.20,0.14,0.24,0.15,0.50,0.40,0.38,0.87,-0.49,-0.41,phosphatidylinositol biosynthetic process;small molecule metabolic process;basophil degranulation,neuronal cell body;mitochondrion;membrane raft;host cell presynaptic membrane;synaptic vesicle membrane;cell junction;integral to plasma membrane;presynaptic membrane;dendrite;early endosome membrane;endosome;exocytic vesicle;protein complex;cytosol;cytoplasmic vesicle;growing cell tip;perikaryon,,,,,,,,,,,,,,
7178,Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),VAAAAGSGPSPPG,_VAAAAGS(ph)GPSPPGS(ph)PGHDRER_,S44,,,,,25.58,,,,,,,,,22.77,24.18, , , ,1.41, , , , , , , , ,-1.41,phosphatidylinositol biosynthetic process;small molecule metabolic process;basophil degranulation,neuronal cell body;mitochondrion;membrane raft;host cell presynaptic membrane;synaptic vesicle membrane;cell junction;integral to plasma membrane;presynaptic membrane;dendrite;early endosome membrane;endosome;exocytic vesicle;protein complex;cytosol;cytoplasmic vesicle;growing cell tip;perikaryon,,,,,,,,,,,,,,
7179,Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),AAGSGPSPPGSPG,_VAAAAGSGPS(ph)PPGS(ph)PGHDR_,S47,+,25.20,26.72,25.90,26.06,27.60,27.10,26.58,27.03,26.60,25.04,25.19,26.40,23.98,26.11,-0.90,0.61,-0.21,-0.04,1.49,0.99,0.47,0.92,0.50,-1.06,-0.92,0.29,-2.12,phosphatidylinositol biosynthetic process;small molecule metabolic process;basophil degranulation,neuronal cell body;mitochondrion;membrane raft;host cell presynaptic membrane;synaptic vesicle membrane;cell junction;integral to plasma membrane;presynaptic membrane;dendrite;early endosome membrane;endosome;exocytic vesicle;protein complex;cytosol;cytoplasmic vesicle;growing cell tip;perikaryon,,,,,,,,,,,,,,
7180,Q9BTU6,PI4K2A,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),GPSPPGSPGHDRE,_VAAAAGSGPS(ph)PPGS(ph)PGHDR_,S51,+,25.12,26.18,25.20,26.30,27.15,23.40,24.93,26.44,26.06,24.69,23.80,23.34,22.77,25.03,0.09,1.15,0.17,1.27,2.12,-1.63,-0.10,1.41,1.03,-0.34,-1.23,-1.69,-2.26,phosphatidylinositol biosynthetic process;small molecule metabolic process;basophil degranulation,neuronal cell body;mitochondrion;membrane raft;host cell presynaptic membrane;synaptic vesicle membrane;cell junction;integral to plasma membrane;presynaptic membrane;dendrite;early endosome membrane;endosome;exocytic vesicle;protein complex;cytosol;cytoplasmic vesicle;growing cell tip;perikaryon,,,,,,,,,,,,,,
7181,Q9BTV4,TMEM43,Transmembrane protein 43 (Protein LUMA),ANYSSTSTRREHV,_(ac)AANYSSTS(ph)TRR_,S9,,23.76,23.22,,27.13,,,,,,,,22.77,,24.22,-0.46,-1.00, ,2.91, , , , , , , ,-1.45, ,,integral to membrane;nuclear inner membrane;Golgi apparatus;endoplasmic reticulum,,,,,,,,,,,,,,
7185,Q9BU76,MMTAG2,Multiple myeloma tumor-associated protein 2 (hMMTAG2),PAEATSSPTSPER,_RPAEATSS(ph)PTS(ph)PERPR_,S217,+,25.42,24.45,23.36,26.06,26.02,21.33,21.80,21.06,22.90,,,,,23.60,1.81,0.85,-0.24,2.46,2.42,-2.27,-1.80,-2.54,-0.70, , , , ,,,,,,,,,,,,,,,,
7187,Q9BUA3,C11orf84,Uncharacterized protein C11orf84,GLPRAESPSPAPP,_AES(ph)PSPAPPPGLR_,S308,+,26.70,24.74,22.46,26.32,25.66,26.47,24.62,25.56,24.38,23.58,25.95,24.37,25.27,25.08,1.62,-0.34,-2.62,1.24,0.58,1.38,-0.46,0.47,-0.70,-1.51,0.87,-0.71,0.19,,,,,,,,,,,,,,,,
7188,Q9BUA3,C11orf84,Uncharacterized protein C11orf84,PDPEPPSPDSPTE,_NLDPDPEPPS(ph)PDS(ph)PTETFAAPAEVR_,S248,,23.52,,,,,28.08,26.80,26.71,,,,24.80,,25.98,-2.47, , , , ,2.10,0.82,0.73, , , ,-1.18, ,,,,,,,,,,,,,,,,
7189,Q9BUA3,C11orf84,Uncharacterized protein C11orf84,EPPSPDSPTETFA,_NLDPDPEPPSPDS(ph)PTETFAAPAEVR_,S251,,24.93,,,,24.30,28.08,26.80,26.71,,,,24.80,,25.94,-1.01, , , ,-1.63,2.14,0.86,0.77, , , ,-1.14, ,,,,,,,,,,,,,,,,
7190,Q9BUH6,C9orf142,Uncharacterized protein C9orf142,AEETAVSPRKSPR,_LAAAEETAVS(ph)PRK_,S148,+,26.56,26.53,26.65,23.42,25.12,23.07,26.57,25.55,24.32,24.07,24.47,24.23,22.53,24.85,1.71,1.68,1.79,-1.43,0.26,-1.78,1.71,0.69,-0.53,-0.78,-0.38,-0.62,-2.33,,,,,,,,,,,,,,,,
7191,Q9BUH6,C9orf142,Uncharacterized protein C9orf142,AVSPRKSPRPAGP,_S(ph)PRPAGPQLFLPDPDPQR_,S152,,25.22,,,,,,,,,,,,,25.22,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7192,Q9BUH8,BEGAIN,Brain-enriched guanylate kinase-associated protein,RRDRRPSVDAPVT,_DRRPS(ph)VDAPVTDVGFLR_,S246,,,,,,24.29,22.83,23.94,24.06,,,23.52,23.74,,23.73, , , , ,0.56,-0.90,0.21,0.33, , ,-0.21,0.01, ,,membrane;cytoplasm,,,,,,,,,,,,,,
7193,Q9BUJ2,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5),QTNVYGSAQRRKM,_NYILDQTNVYGS(ph)AQR_,S512,,21.08,,,,22.87,,21.72,22.90,,,,21.41,,22.00,-0.92, , , ,0.88, ,-0.27,0.91, , , ,-0.59, ,"response to virus;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;ribonucleoprotein complex,SAP-domain,,,,,,,,,,,,,
7194,Q9BUL5,PHF23,PHD finger protein 23 (PDH-containing protein JUNE-1),RLQAPDSATLLEK,_LQAPDS(ph)ATLLEK_,S124,,22.03,,,,,,22.47,,22.03,22.60,,,,22.28,-0.25, , , , , ,0.19, ,-0.25,0.32, , , ,,,,,,,,,,,,,,,,
7195,Q9BUQ8,DDX23,Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD),KKDRDASPSKEER,_DRDAS(ph)PSKEER_,S14,,,,,,,22.92,,22.27,,,,,,22.60, , , , , ,0.32, ,-0.32, , , , , ,cis assembly of pre-catalytic spliceosome,nucleoplasm;mitochondrion;plasma membrane;catalytic step 2 spliceosome;U5 snRNP,,,,,,,,,,,,,,
7196,Q9BUQ8,DDX23,Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD),KDRKRSSLSPGRG,_RSS(ph)LS(ph)PGRGK_,S107,,23.83,25.19,26.13,23.90,,,,,19.91,,,,,23.79,0.04,1.40,2.34,0.10, , , , ,-3.88, , , , ,cis assembly of pre-catalytic spliceosome,nucleoplasm;mitochondrion;plasma membrane;catalytic step 2 spliceosome;U5 snRNP,,,,,,,,,,,,,,
7197,Q9BUQ8,DDX23,Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD),RKRSSLSPGRGKD,_RSS(ph)LS(ph)PGRGK_,S109,,23.83,25.19,26.13,23.90,,,,,19.91,,,,,23.79,0.04,1.40,2.34,0.10, , , , ,-3.88, , , , ,cis assembly of pre-catalytic spliceosome,nucleoplasm;mitochondrion;plasma membrane;catalytic step 2 spliceosome;U5 snRNP,,,,,,,,,,,,,,
7198,Q9BUR4,WRAP53,Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD40 repeat-containing protein encoding RNA antisense to p53),FPEPTESGDEGEE,_VFPEPTES(ph)GDEGEELGLPLLSTR_,S458,,25.45,,,,,,,,,,,,,25.45,0.00, , , , , , , , , , , , ,telomere formation via telomerase;positive regulation of telomerase activity,nucleolus;Cajal body;telomerase holoenzyme complex;cytoplasm,,,,,,,,,,,,,,
7199,Q9BUU2,METTL22,Methyltransferase-like protein 22 (EC 2.1.1.-),RRPRAASDSNPAG,_AAS(ph)DSNPAGPLRDK_,S132,+,23.12,24.12,23.40,24.90,22.23,23.49,22.47,23.01,23.65,,,22.74,,23.31,-0.19,0.80,0.09,1.58,-1.08,0.18,-0.84,-0.31,0.34, , ,-0.58, ,,,,,,,,,,,,,,,,
7200,Q9BUZ4,TRAF4,TNF receptor-associated factor 4 (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),PGTWRGSLDESSL,_GS(ph)LDESSLGFGYPK_,S426,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,respiratory gaseous exchange;positive regulation of protein kinase activity;positive regulation of protein homodimerization activity;positive regulation of JNK cascade;signal transduction;respiratory tube development;apoptotic process;regulation of apoptotic process,tight junction;plasma membrane;nucleus;cytoskeleton;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
7201,Q9BV36,MLPH,Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a) (SlaC2-a) (Synaptotagmin-like protein 2a),RRGRASSESQIFE,_ASS(ph)ESQIFELNK_,S337,+,,,,23.26,22.46,23.48,23.56,23.23,24.03,,,24.19,24.65,23.61, , , ,-0.35,-1.15,-0.13,-0.05,-0.38,0.42, , ,0.58,1.04,protein targeting;melanosome localization;melanocyte differentiation,stress fiber;microtubule plus end;cortical actin cytoskeleton;microtubule organizing center,,,,,,,,,,,,,,
7202,Q9BV36,MLPH,Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a) (SlaC2-a) (Synaptotagmin-like protein 2a),RRGRASSESQGLG,_ASS(ph)ESQGLGAGVR_,S337,,23.90,,,23.34,,,,,,,,,,23.62,0.28, , ,-0.28, , , , , , , , , ,protein targeting;melanosome localization;melanocyte differentiation,stress fiber;microtubule plus end;cortical actin cytoskeleton;microtubule organizing center,,,,,,,,,,,,,,
7203,Q9BVC5,C2orf49,Ashwin,PSGPVKSPPLSPV,_S(ph)PPLS(ph)PVGTTPVK_,S147,+,27.21,27.40,26.95,26.60,24.18,24.99,26.79,,27.42,27.63,26.71,26.16,25.24,26.44,0.77,0.96,0.51,0.16,-2.26,-1.45,0.35, ,0.98,1.19,0.27,-0.28,-1.20,,tRNA-splicing ligase complex,,,,,,,,,,,,,,
7204,Q9BVC5,C2orf49,Ashwin,VKSPPLSPVGTTP,_S(ph)PPLS(ph)PVGTTPVK_,S151,,26.50,25.06,25.73,23.11,,,,,24.72,24.54,,,,24.94,1.56,0.12,0.78,-1.83, , , , ,-0.23,-0.40, , , ,,tRNA-splicing ligase complex,,,,,,,,,,,,,,
7205,Q9BVC6,TMEM109,Transmembrane protein 109 (Mitsugumin-23) (Mg23),AAKGARSVEEE__,_GARS(ph)VEEE_,S239,+,20.96,22.48,22.48,22.77,20.06,,20.55,20.13,21.55,19.58,,,20.34,21.09,-0.13,1.39,1.39,1.68,-1.03, ,-0.54,-0.96,0.46,-1.51, , ,-0.75,,nuclear membrane;integral to membrane;sarcoplasmic reticulum membrane;nuclear outer membrane;cytoplasm,,,,,,,,,,,,,,
7206,Q9BVG4,PBDC1,Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1),GEKGADSGEEKEE,_GADS(ph)GEEKEEGINREDK_,S197,,,22.32,22.32,,21.99,21.17,,24.12,,,,,21.24,22.19, ,0.13,0.13, ,-0.20,-1.02, ,1.93, , , , ,-0.96,,,,,,,,,,,,,,,,
7207,Q9BVG9,PTDSS2,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),GGPRPESPVPAGR,_DAGGPRPES(ph)PVPAGR_,S16,+,26.54,27.52,27.04,28.02,29.00,29.30,28.76,29.03,28.83,29.14,28.52,27.74,29.08,28.35,-1.81,-0.83,-1.31,-0.32,0.65,0.95,0.42,0.68,0.48,0.79,0.18,-0.61,0.73,phosphatidylserine biosynthetic process,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7208,Q9BVG9,PTDSS2,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),VPAGRASLEEPPD,_DAGGPRPESPVPAGRAS(ph)LEEPPDGPSAGQATGPGEGR_,S24,,,,,,,,,23.78,,23.01,24.68,,24.82,24.07, , , , , , , ,-0.29, ,-1.06,0.61, ,0.75,phosphatidylserine biosynthetic process,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7209,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),ETKDSGSQEVLSE,_DSGS(ph)QEVLSELR_,S453,+,23.35,22.70,,22.62,,,23.22,21.67,23.47,22.27,23.27,,22.91,22.83,0.52,-0.13, ,-0.21, , ,0.39,-1.16,0.64,-0.56,0.44, ,0.08,rRNA processing,small-subunit processome;nucleolus,,,,,,,,,,,,,,
7210,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),PKDYLLSESEDEG,_DYLLS(ph)ES(ph)EDEGDNDGERK_,S29,+,25.73,22.47,22.38,22.07,,25.47,25.71,22.58,26.57,25.58,24.41,24.94,24.84,24.40,1.34,-1.92,-2.01,-2.33, ,1.07,1.32,-1.82,2.18,1.18,0.01,0.54,0.44,rRNA processing,small-subunit processome;nucleolus,,,,,,,,,,,,,,
7211,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),DYLLSESEDEGDN,_DYLLS(ph)ES(ph)EDEGDNDGERK_,S31,+,25.63,,,21.52,,23.36,24.09,21.54,24.25,25.70,,22.46,22.50,23.45,2.18, , ,-1.93, ,-0.09,0.64,-1.91,0.80,2.25, ,-0.99,-0.95,rRNA processing,small-subunit processome;nucleolus,,,,,,,,,,,,,,
7213,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),RKRSELSQDAEPA,_RSELS(ph)QDAEPAGSQETK_,S437,,,,,,,23.10,23.54,,23.82,23.13,,22.14,,23.15, , , , , ,-0.04,0.39, ,0.67,-0.02, ,-1.01, ,rRNA processing,small-subunit processome;nucleolus,,,,,,,,,,,,,,
7214,Q9BVJ6,UTP14A,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),DAEPAGSQETKDS,_RSELSQDAEPAGS(ph)QETK_,S445,+,21.00,22.78,22.78,22.47,,22.30,24.78,,24.76,25.14,21.41,21.11,,22.85,-1.85,-0.07,-0.07,-0.38, ,-0.55,1.93, ,1.91,2.29,-1.45,-1.74, ,rRNA processing,small-subunit processome;nucleolus,,,,,,,,,,,,,,
7215,Q9BVS4,RIOK2,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),GSEFSFSDGEVAE,_EGSEFSFS(ph)DGEVAEK_,S337,+,,,,21.95,,23.80,22.13,,24.34,,24.55,24.85,24.28,23.70, , , ,-1.75, ,0.10,-1.57, ,0.64, ,0.85,1.15,0.58,,,,+,,,,,,,,,,,,
7216,Q9BVS4,RIOK2,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),EQIKEDSLSEESA,_SSGDPEQIKEDS(ph)LSEESADAR_,S380,,,,,,24.02,22.96,23.52,24.27,22.81,,,,,23.51, , , , ,0.50,-0.56,0.00,0.75,-0.70, , , , ,,,,+,,,,,,,,,,,,
7217,Q9BW04,SARG,Specifically androgen-regulated gene protein,SFLDKISPSVLRN,_IS(ph)PSVLR_,S519,,24.30,23.67,24.34,,,,23.55,,,23.70,21.61,,,23.53,0.77,0.14,0.81, , , ,0.02, , ,0.17,-1.92, , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7222,Q9BW04,SARG,Specifically androgen-regulated gene protein,LGLRSGSYSLPRN,_SGS(ph)YSLPR_,S131,,24.22,21.42,22.12,,,,,,,21.30,,,,22.27,1.95,-0.84,-0.14, , , , , , ,-0.96, , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7223,Q9BW04,SARG,Specifically androgen-regulated gene protein,LRSGSYSLPRNIH,_SGSYS(ph)LPR_,S133,,24.27,23.79,23.79,,,,23.08,,,,,,,23.73,0.54,0.06,0.06, , , ,-0.65, , , , , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7226,Q9BW61,DDA1,DET1- and DDB1-associated protein 1 (Placenta cross-immune reaction antigen 1) (PCIA-1),KVARTDSPDMHED,_VARTDS(ph)PDM(ox)HEDT_,S95,+,23.81,25.70,25.70,23.16,21.60,23.65,23.21,22.64,24.71,22.81,22.36,21.65,22.82,23.37,0.44,2.33,2.33,-0.21,-1.78,0.28,-0.16,-0.73,1.34,-0.56,-1.01,-1.73,-0.55,,,,,,,,,,,,,,,,
7227,Q9BW71,HIRIP3,HIRA-interacting protein 3,AQRGEESSEEEEK,_DLPAQRGEES(ph)S(ph)EEEEK_,S159,,25.74,,,,21.49,23.75,,,,,22.75,,24.69,23.68,2.06, , , ,-2.20,0.07, , , , ,-0.94, ,1.01,chromatin assembly or disassembly,nucleus,,,,,,,,,,,,,,
7228,Q9BW71,HIRIP3,HIRA-interacting protein 3,QRGEESSEEEEKG,_DLPAQRGEES(ph)S(ph)EEEEK_,S160,,25.74,,,,21.49,23.75,,,,,22.75,,24.69,23.68,2.06, , , ,-2.20,0.07, , , , ,-0.94, ,1.01,chromatin assembly or disassembly,nucleus,,,,,,,,,,,,,,
7229,Q9BW71,HIRIP3,HIRA-interacting protein 3,KQAREESEESEAE,_QAREES(ph)EES(ph)EAEPVQR_,S196,,24.06,,,,,,,,,,,,,24.06,0.00, , , , , , , , , , , , ,chromatin assembly or disassembly,nucleus,,,,,,,,,,,,,,
7233,Q9BW71,HIRIP3,HIRA-interacting protein 3,KRLLGDSDSEEEQ,_RLLGDS(ph)DS(ph)EEEQK_,S289,,26.34,,,,,,,,,,,,,26.34,0.00, , , , , , , , , , , , ,chromatin assembly or disassembly,nucleus,,,,,,,,,,,,,,
7234,Q9BW71,HIRIP3,HIRA-interacting protein 3,LLGDSDSEEEQKE,_RLLGDS(ph)DS(ph)EEEQK_,S291,,26.34,,,,,,,,,,,,,26.34,0.00, , , , , , , , , , , , ,chromatin assembly or disassembly,nucleus,,,,,,,,,,,,,,
7239,Q9BWH2,FUNDC2,FUN14 domain-containing protein 2 (Cervical cancer proto-oncogene 3 protein) (HCC-3) (Hepatitis C virus core-binding protein 6),QLKIRKSNQIPTE,_S(ph)NQIPTEVR_,S151,+,27.24,26.22,25.27,,23.47,25.23,25.06,24.63,,,25.96,24.72,,25.31,1.93,0.91,-0.04, ,-1.84,-0.08,-0.25,-0.68, , ,0.65,-0.59, ,,mitochondrion,,,,,,,,,,,,,,
7240,Q9BWN1,PRR14,Proline-rich protein 14,PQPPPPSPPMKLE,_TPQPPPPS(ph)PPM(ox)K_,S250,,23.73,23.97,23.97,,,,22.38,22.26,,,,,,23.26,0.47,0.70,0.70, , , ,-0.88,-1.00, , , , , ,,,,,,,,,,,,,,,,
7241,Q9BWU0,SLC4A1AP,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),KMLGEDSDEEEEM,_M(ox)LGEDS(ph)DEEEEM(ox)DTSERK_,S312,+,25.12,25.40,26.30,24.17,27.09,26.48,26.63,26.66,25.77,26.07,24.86,26.52,25.19,25.87,-0.75,-0.46,0.44,-1.70,1.22,0.61,0.76,0.79,-0.10,0.20,-1.00,0.65,-0.68,,nucleus;cytoplasm,,,,,,,,,,,,,,
7242,Q9BWU0,SLC4A1AP,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),KPALPVSPAARSK,_PALPVS(ph)PAAR_,S82,+,23.81,23.69,24.30,22.98,,,25.54,,23.78,22.99,23.98,24.74,23.54,23.93,-0.12,-0.24,0.36,-0.96, , ,1.60, ,-0.15,-0.95,0.04,0.81,-0.39,,nucleus;cytoplasm,,,,,,,,,,,,,,
7245,Q9BWW4,SSBP3,Single-stranded DNA-binding protein 3 (Sequence-specific single-stranded-DNA-binding protein),DGLPKNSPNNISG,_NS(ph)PNNISGISNPPGTPR_,S320,,24.10,23.84,,22.97,,,,,,,,,,23.64,0.46,0.20, ,-0.66, , , , , , , , , ,"negative regulation of apoptotic process;prechordal plate formation;protein complex assembly;midbrain-hindbrain boundary initiation;head morphogenesis;positive regulation of cell proliferation;transcription, DNA-dependent;positive regulation of anterior head development;positive regulation of transcription from RNA polymerase II promoter",nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
7250,Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),ASHQKGSLPSGTT,_GS(ph)LPSGTTIEWLEPK_,S286,,21.06,,,,,,,,,,,,,21.06,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7251,Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),PPLKSRSFSLASS,_S(ph)FSLASSSNSPISQR_,S172,,22.90,,,,,,,,,,,,,22.90,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7252,Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),LKSRSFSLASSSN,_SFS(ph)LASSSNSPISQR_,S174,,24.00,,,21.86,,,,,,,,,,22.93,1.07, , ,-1.07, , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7253,Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),LASSSNSPISQRR,_SFSLASSSNS(ph)PISQR_,S181,,23.12,21.65,,22.32,,,,,,22.36,,,,22.36,0.76,-0.72, ,-0.04, , , , , ,0.00, , , ,lipid transport,,,,,,,,,,,,,,,
7254,Q9BXF6,RAB11FIP5,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),AAPVEGSPDRKQS,_PLSAAPVEGS(ph)PDRK_,S538,+,24.65,25.06,25.50,24.53,,,26.45,,25.97,25.46,26.14,26.18,23.69,25.36,-0.72,-0.30,0.14,-0.83, , ,1.09, ,0.61,0.09,0.78,0.82,-1.68,protein transport,mitochondrial outer membrane;centrosome;recycling endosome membrane,,,,,,,,,,,,,,
7261,Q9BXI6,TBC1D10A,TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha),APAAGESLSGTRE,_APAAGES(ph)LSGTR_,S18,,23.21,,,21.25,,,,,,,,,,22.23,0.98, , ,-0.98, , , , , , , , , ,positive regulation of Rab GTPase activity,intracellular;microvillus,,,,,,,,,,,,,,
7265,Q9BXK5,BCL2L13,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),INAREESLVEELS,_EINAREES(ph)LVEELSPASEK_,S420,+,,,,,,21.96,23.39,22.69,22.99,23.99,23.14,24.72,25.26,23.52, , , , , ,-1.56,-0.13,-0.83,-0.53,0.47,-0.38,1.20,1.74,induction of apoptosis,mitochondrion;integral to membrane;nucleus;mitochondrial membrane,,,,,,,,,,,,,,
7269,Q9BXK5,BCL2L13,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),EGKSRLSPAGEMK,_SRLS(ph)PAGEM(ox)K_,S444,,19.56,22.98,,,,,20.68,,,21.65,22.86,,,21.55,-1.99,1.43, , , , ,-0.87, , ,0.10,1.32, , ,induction of apoptosis,mitochondrion;integral to membrane;nucleus;mitochondrial membrane,,,,,,,,,,,,,,
7272,Q9BXL7,CARD11,Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1) (Carma 1),TSDPRVSPRLSRA,_NTLQPEEALSTSDPRVS(ph)PR_,S886,,,,,,,,23.36,23.28,,,,,,23.32, , , , , , ,0.04,-0.04, , , , , ,regulation of T cell differentiation;T cell costimulation;positive regulation of NF-kappaB transcription factor activity;positive regulation of interleukin-2 biosynthetic process;positive regulation of I-kappaB kinase/NF-kappaB cascade;thymic T cell selection;T cell receptor signaling pathway;positive regulation of B cell proliferation;positive regulation of T cell proliferation;regulation of B cell differentiation;positive regulation of cytokine production;regulation of apoptotic process,cytosol;membrane raft;plasma membrane,,,,,,,,,,,,,,
7277,Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),IQARLGSIAEIDL,_LGS(ph)IAEIDLGVPPPVM(ox)K_,S136,,25.64,,,,,,,,,,,,,25.64,0.00, , , , , , , , , , , , ,"cell proliferation;neuronal stem cell maintenance;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to arsenic-containing substance;primary miRNA processing",nucleoplasm;cytoplasm,,,,,,,,,,,,,,
7278,Q9BXS9,SLC26A6,Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1),PRPVPDSPVSVTR,_PVPDS(ph)PVSVTRL_,S47,+,21.75,,,23.77,24.68,25.16,22.23,24.57,22.35,,,22.79,22.22,23.28,-1.53, , ,0.49,1.40,1.88,-1.05,1.29,-0.93, , ,-0.49,-1.06,sulfate transport;ion transport;transmembrane transport,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7279,Q9BXW9,FANCD2,Fanconi anemia group D2 protein (Protein FACD2),GEEDEVSAGEKEQ,_ATEDGEEDEVS(ph)AGEK_,S1435,,24.85,26.31,27.15,26.02,,,25.67,21.90,25.01,24.98,,24.02,,25.10,-0.25,1.21,2.05,0.92, , ,0.57,-3.20,-0.09,-0.13, ,-1.08, ,DNA repair;synapsis;response to gamma radiation;gamete generation,nucleoplasm;condensed chromosome,,,,,,,,,,,,,,
7281,Q9BXY0,MAK16,Protein MAK16 homolog (NNP78) (Protein RBM13),DGEVDESDISDFE,_EFVEDGEVDES(ph)DIS(ph)DFEDM(ox)DK_,S229,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,,nucleolus,,,,,,,,,,,,,,
7282,Q9BXY0,MAK16,Protein MAK16 homolog (NNP78) (Protein RBM13),VDESDISDFEDMD,_EFVEDGEVDES(ph)DIS(ph)DFEDM(ox)DK_,S232,,23.47,,,,,,,,,,,,,23.47,0.00, , , , , , , , , , , , ,,nucleolus,,,,,,,,,,,,,,
7283,Q9BY44,EIF2A,Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A),RNTVSQSISGDPE,_NTVSQS(ph)ISGDPEIDK_,S526,,22.97,,,,,,,,,,,,,22.97,0.00, , , , , , , , , , , , ,ribosome assembly;protein phosphorylation;SREBP signaling pathway;positive regulation of signal transduction;regulation of translation,eukaryotic translation initiation factor 2 complex,,,,,,,,,,,,,,
7285,Q9BY44,EIF2A,Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A),EARSDKSPDLAPT,_S(ph)PDLAPTPAPQSTPR_,S506,+,27.59,25.94,25.70,27.07,26.91,26.28,27.99,28.50,27.00,27.16,27.11,27.90,26.93,27.08,0.51,-1.14,-1.38,-0.02,-0.17,-0.81,0.90,1.42,-0.08,0.08,0.03,0.82,-0.15,ribosome assembly;protein phosphorylation;SREBP signaling pathway;positive regulation of signal transduction;regulation of translation,eukaryotic translation initiation factor 2 complex,,,,,,,,,,,,,,
7290,Q9BY89,KIAA1671,Uncharacterized protein KIAA1671,SPRKEESDEEETA,_KEES(ph)DEEETASKAER_,S1701,+,,22.41,22.41,,24.66,,19.03,22.86,18.73,18.89,,18.57,,20.95, ,1.47,1.47, ,3.72, ,-1.91,1.91,-2.22,-2.06, ,-2.37, ,,,,,,,,,,,,,,,,
7292,Q9BY89,KIAA1671,Uncharacterized protein KIAA1671,WAPQPKSPKSPFQ,_S(ph)PKS(ph)PFQPGVLGSR_,S1757,,23.35,,,,,23.68,,,23.35,23.70,,,,23.52,-0.17, , , , ,0.16, , ,-0.17,0.18, , , ,,,,,,,,,,,,,,,,
7293,Q9BY89,KIAA1671,Uncharacterized protein KIAA1671,QPKSPKSPFQPGV,_S(ph)PKS(ph)PFQPGVLGSR_,S1760,,23.35,,,,,23.68,,,23.35,23.70,,,,23.52,-0.17, , , , ,0.16, , ,-0.17,0.18, , , ,,,,,,,,,,,,,,,,
7294,Q9BY89,KIAA1671,Uncharacterized protein KIAA1671,EGPRTSSPLFNKA,_TSS(ph)PLFNK_,S128,,24.40,22.86,,21.75,,,,,,,,,,23.00,1.40,-0.15, ,-1.26, , , , , , , , , ,,,,,,,,,,,,,,,,
7295,Q9BYD6,MRPL1,"39S ribosomal protein L1, mitochondrial (L1mt) (MRP-L1)",EVKNEESEKEDA_,_EVKNEES(ph)EKEDA_,S320,,18.84,20.16,,22.70,20.71,22.75,21.68,23.90,22.04,,21.19,21.40,23.38,21.70,-2.87,-1.54, ,1.00,-1.00,1.05,-0.02,2.19,0.34, ,-0.51,-0.31,1.68,translation,mitochondrion;large ribosomal subunit,,,,,,,,,,,,,,
7296,Q9BYG3,MKI67IP,MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67) (hNIFK),FLERRKSQVAELN,_S(ph)QVAELNDDDKDDEIVFK_,S247,+,25.65,24.65,25.36,25.88,20.90,,,,22.26,,,27.49,,24.60,1.05,0.05,0.77,1.28,-3.70, , , ,-2.33, , ,2.89, ,rRNA metabolic process;rRNA transcription;protein complex assembly;negative regulation of phosphatase activity,nucleoplasm;condensed nuclear chromosome;nucleolus;cytoplasm,,,,,,,,,,,,,,
7297,Q9BYK8,HELZ2,"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)",PGDEALSPASRDI,_AEPGDEALS(ph)PASR_,S1006,,23.33,,,23.60,23.08,,23.73,,,,,,24.62,23.67,-0.34, , ,-0.07,-0.59, ,0.06, , , , , ,0.95,"small molecule metabolic process;transcription, DNA-dependent;cellular lipid metabolic process;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm,C2H2-type,,,,,,,,,,,,,
7298,Q9BYK8,HELZ2,"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)",VASGPISPTNYRQ,_SSVASGPIS(ph)PTNYR_,S338,+,,24.84,25.25,25.44,23.71,22.28,23.72,23.50,,24.28,24.59,,22.85,24.05, ,0.79,1.20,1.40,-0.34,-1.77,-0.33,-0.54, ,0.24,0.54, ,-1.19,"small molecule metabolic process;transcription, DNA-dependent;cellular lipid metabolic process;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm,C2H2-type,,,,,,,,,,,,,
7299,Q9BYW2,SETD2,Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (SET domain-containing protein 2) (hSET2) (p231HBP),EREKAGSPAPSNR,_AGS(ph)PAPSNRLNDS(ph)PTLK_,S614,,23.74,24.61,24.61,23.01,23.35,,,,23.18,,,,,23.75,-0.01,0.86,0.86,-0.74,-0.40, , , ,-0.57, , , , ,"angiogenesis;stem cell development;histone H3-K36 methylation;regulation of transcription, DNA-dependent;pericardium development;neural tube closure;embryonic cranial skeleton morphogenesis;peptidyl-lysine trimethylation;mesoderm morphogenesis;cell migration involved in vasculogenesis;forebrain development;coronary vasculature morphogenesis;transcription, DNA-dependent;morphogenesis of a branching structure;embryonic placenta morphogenesis",chromosome;nucleus,Other TF domain,,,,,,,,,,+,,,
7302,Q9BYX4,IFIH1,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),NVAARASPEPELQ,_AS(ph)PEPELQLRPYQM(ox)EVAQPALEGK_,S301,,23.14,24.67,24.67,22.74,,,,23.98,,,,,,23.84,-0.70,0.83,0.83,-1.10, , , ,0.14, , , , , ,regulation of type III interferon production;positive regulation of interferon-alpha production;negative regulation of type I interferon production;innate immune response;protein sumoylation;cytoplasmic pattern recognition receptor signaling pathway in response to virus;regulation of apoptotic process;virus-host interaction;detection of virus;positive regulation of interferon-beta production,cytosol;nucleus,,,,,,,,,,,,,,
7303,Q9BZ23,PANK2,"Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2)",RRDRLGSYSGPTS,_LGS(ph)YSGPTSVSR_,S66,+,26.14,26.96,27.43,26.69,,24.42,25.16,25.43,24.70,24.03,22.09,26.65,,25.43,0.71,1.53,2.01,1.27, ,-1.00,-0.27,0.01,-0.72,-1.40,-3.34,1.22, ,pantothenate metabolic process;cell death;coenzyme A biosynthetic process;coenzyme biosynthetic process,mitochondrial intermembrane space,,,,,,,,,,,,,,
7304,Q9BZ29,DOCK9,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1),AEPYVASEYKTVH,_YAYKAEPYVAS(ph)EYK_,S926,+,26.34,25.46,25.63,25.08,22.80,25.32,27.11,25.27,27.10,26.84,25.30,24.19,27.58,25.69,0.64,-0.23,-0.07,-0.62,-2.89,-0.37,1.42,-0.42,1.41,1.14,-0.39,-1.51,1.89,blood coagulation;small GTPase mediated signal transduction,cytosol;endomembrane system;membrane,,,,,,,,,,,,,,
7305,Q9BZ29,DOCK9,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1),GEVEAESPGPVPA,_DAAQGEVEAES(ph)PGPVPAKPK_,S37,,,,,,24.00,,25.03,,25.74,25.74,22.74,,,24.65, , , , ,-0.65, ,0.38, ,1.09,1.09,-1.91, , ,blood coagulation;small GTPase mediated signal transduction,cytosol;endomembrane system;membrane,,,,,,,,,,,,,,
7309,Q9BZ67,FRMD8,FERM domain-containing protein 8,KPKRTTSFFSRQL,_RTTS(ph)FFSR_,S383,+,,23.56,23.84,23.11,24.31,,24.67,24.33,22.12,,24.17,,23.28,23.71, ,-0.15,0.13,-0.60,0.60, ,0.96,0.62,-1.59, ,0.46, ,-0.43,,cytoskeleton,,,,,,,,,,,,,,
7311,Q9BZ67,FRMD8,FERM domain-containing protein 8,ERSHRSSVSSVGA,_SHRSS(ph)VS(ph)SVGAR_,S21,,24.30,24.93,24.10,25.21,19.54,,,,,,,,,23.62,0.68,1.31,0.49,1.59,-4.08, , , , , , , , ,,cytoskeleton,,,,,,,,,,,,,,
7312,Q9BZ67,FRMD8,FERM domain-containing protein 8,SHRSSVSSVGARE,_SHRSS(ph)VS(ph)SVGAR_,S23,,22.80,24.52,24.61,24.18,19.54,,,,,,,,,23.13,-0.33,1.39,1.48,1.05,-3.59, , , , , , , , ,,cytoskeleton,,,,,,,,,,,,,,
7313,Q9BZ67,FRMD8,FERM domain-containing protein 8,HRSSVSSVGAREV,_SHRSS(ph)VSS(ph)VGAR_,S24,,23.59,25.00,25.39,24.76,,,,,,,,,,24.68,-1.10,0.32,0.70,0.08, , , , , , , , , ,,cytoskeleton,,,,,,,,,,,,,,
7314,Q9BZ71,PITPNM3,"Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1)",LLDAPASPPQASR,_DSPPLLDAPAS(ph)PPQASR_,S468,,19.85,,,,,,23.64,,,,24.33,,23.59,22.85,-3.00, , , , , ,0.79, , , ,1.48, ,0.73,phosphatidylinositol metabolic process,endomembrane system;integral to membrane;intracellular,,,,,,,,,,,,,,
7316,Q9BZC7,ABCA2,ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2),VSEEDQSLENSEA,_VSEEDQS(ph)LENS(ph)EADVK_,S1327,,23.54,,,,,,,,,,,,,23.54,0.00, , , , , , , , , , , , ,cholesterol homeostasis;response to steroid hormone stimulus;response to drug;regulation of transcription from RNA polymerase II promoter;regulation of intracellular cholesterol transport;lipid metabolic process,endosome;ATP-binding cassette (ABC) transporter complex;lysosomal membrane;microtubule organizing center;endosome membrane;integral to membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
7317,Q9BZC7,ABCA2,ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2),DQSLENSEADVKE,_VSEEDQS(ph)LENS(ph)EADVK_,S1331,,23.54,,,,,,,,,,,,,23.54,0.00, , , , , , , , , , , , ,cholesterol homeostasis;response to steroid hormone stimulus;response to drug;regulation of transcription from RNA polymerase II promoter;regulation of intracellular cholesterol transport;lipid metabolic process,endosome;ATP-binding cassette (ABC) transporter complex;lysosomal membrane;microtubule organizing center;endosome membrane;integral to membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
7318,Q9BZD4,NUF2,Kinetochore protein Nuf2 (hNuf2) (hNuf2R) (hsNuf2) (Cell division cycle-associated protein 1),KTKIVDSPEKLKN,_IVDS(ph)PEKLK_,S247,,,,,,26.00,22.26,,22.52,,,,,,23.59, , , , ,2.41,-1.34, ,-1.08, , , , , ,mitotic prometaphase;chromosome segregation;cell division,Ndc80 complex;cytosol;nucleus;condensed chromosome kinetochore,,,,,,,,,,,,,,
7319,Q9BZE4,GTPBP4,Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB),RTPRDVSGLRDVK,_DVS(ph)GLRDVK_,S578,,25.69,,,24.96,24.36,,26.56,24.72,22.98,,,,,24.88,0.81, , ,0.08,-0.52, ,1.68,-0.15,-1.90, , , , ,negative regulation of collagen binding;negative regulation of cell proliferation;protein stabilization;negative regulation of DNA replication;ribosome biogenesis;negative regulation of protein ubiquitination;negative regulation of cell migration;regulation of cyclin-dependent protein kinase activity;negative regulation of cell-cell adhesion,nuclear membrane;nucleolus;Golgi apparatus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
7322,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),DQEHDESDNEVMG,_ENDQEHDES(ph)DNEVM(ox)GK_,S342,,24.67,27.10,27.51,25.67,,,,24.59,,,,,,25.91,-1.24,1.19,1.60,-0.24, , , ,-1.31, , , , , ,lipid transport,,,,,,,,,,,,,,,
7323,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),EPDIQDSSGSEAQ,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,S807,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7324,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),PDIQDSSGSEAQS,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,S808,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7325,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),IQDSSGSEAQSVK,_GYSSPEPDIQDS(ph)S(ph)GS(ph)EAQSVKPSTR_,S810,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
7326,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),GEPDRTSLLGDSK,_(ac)M(ox)EGGLADGEPDRTS(ph)LLGDSK_,S14,,25.78,24.26,24.83,24.51,,25.15,25.69,24.19,,27.33,23.61,24.67,25.93,25.09,0.70,-0.82,-0.26,-0.58, ,0.06,0.61,-0.89, ,2.24,-1.48,-0.42,0.84,lipid transport,,,,,,,,,,,,,,,
7327,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),KDQDMYSDKSDKE,_(gl)QHFKDQDM(ox)YS(ph)DK_,S328,+,23.52,24.52,24.92,24.06,,,,,24.77,,,20.65,21.63,23.44,0.08,1.08,1.48,0.62, , , , ,1.33, , ,-2.79,-1.81,lipid transport,,,,,,,,,,,,,,,
7328,Q9BZG1,RAB34,Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah),DVVRINSDDSNLY,_INS(ph)DDSNLYLTASK_,S219,,23.72,,,,,,,,,,,,,23.72,0.00, , , , , , , , , , , , ,endocytosis;protein transport;small GTPase mediated signal transduction,Golgi apparatus;ruffle;early endosome,,,,,,,,,,,,,,
7330,Q9BZL4,PPP1R12C,Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85),GLQRSASSSWLEG,_SAS(ph)SSWLEGTSTQAK_,S408,,23.71,,,25.25,,,23.40,,24.15,,,26.04,,24.51,-0.80, , ,0.74, , ,-1.11, ,-0.36, , ,1.53, ,,cytoplasm,,,,,,,,,,,,,,
7331,Q9BZL4,PPP1R12C,Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85),PHPSPKSPVLEEA,_S(ph)PVLEEAPFSR_,S364,,23.36,22.96,,23.55,,,23.79,,23.72,24.23,23.27,,,23.55,-0.19,-0.59, ,-0.01, , ,0.24, ,0.16,0.68,-0.29, , ,,cytoplasm,,,,,,,,,,,,,,
7332,Q9BZL6,PRKD2,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),EGGKAQSSLGYIP,_AQS(ph)SLGYIPLM(ox)R_,S374,,23.53,,,,,,,,,,,,,23.53,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of ERK1 and ERK2 cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of vascular endothelial growth factor receptor signaling pathway;cell death;positive regulation of interleukin-2 production;positive regulation of blood vessel endothelial cell migration;endothelial tube morphogenesis;positive regulation of transcription from RNA polymerase II promoter;angiogenesis;positive regulation of DNA biosynthetic process;positive regulation of CREB transcription factor activity;positive regulation of T cell receptor signaling pathway;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of fibroblast growth factor receptor signaling pathway;T cell receptor signaling pathway;positive regulation of interleukin-8 production;cell adhesion;positive regulation of endothelial cell proliferation;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,Golgi apparatus;plasma membrane;nucleus;cytoplasm,,+,,,,,,,,,,,,
7334,Q9BZL6,PRKD2,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),RLGTSESLPCTAE,_LGTSES(ph)LPCTAEELSR_,S214,,25.34,,,22.70,,,,,,,24.26,,,24.10,1.24, , ,-1.40, , , , , , ,0.16, , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of ERK1 and ERK2 cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of vascular endothelial growth factor receptor signaling pathway;cell death;positive regulation of interleukin-2 production;positive regulation of blood vessel endothelial cell migration;endothelial tube morphogenesis;positive regulation of transcription from RNA polymerase II promoter;angiogenesis;positive regulation of DNA biosynthetic process;positive regulation of CREB transcription factor activity;positive regulation of T cell receptor signaling pathway;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of fibroblast growth factor receptor signaling pathway;T cell receptor signaling pathway;positive regulation of interleukin-8 production;cell adhesion;positive regulation of endothelial cell proliferation;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,Golgi apparatus;plasma membrane;nucleus;cytoplasm,,+,,,,,,,,,,,,
7335,Q9BZL6,PRKD2,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),EKSFRRSVVGTPA,_S(ph)VVGTPAYLAPEVLLNQGYNR_,S710,,25.54,,,22.94,25.38,,,,,25.03,23.63,,,24.51,1.04, , ,-1.57,0.88, , , , ,0.52,-0.87, , ,positive regulation of peptidyl-serine phosphorylation;intracellular protein kinase cascade;protein autophosphorylation;peptidyl-serine phosphorylation;positive regulation of ERK1 and ERK2 cascade;positive regulation of NF-kappaB transcription factor activity;positive regulation of vascular endothelial growth factor receptor signaling pathway;cell death;positive regulation of interleukin-2 production;positive regulation of blood vessel endothelial cell migration;endothelial tube morphogenesis;positive regulation of transcription from RNA polymerase II promoter;angiogenesis;positive regulation of DNA biosynthetic process;positive regulation of CREB transcription factor activity;positive regulation of T cell receptor signaling pathway;positive regulation of cell adhesion;positive regulation of angiogenesis;positive regulation of fibroblast growth factor receptor signaling pathway;T cell receptor signaling pathway;positive regulation of interleukin-8 production;cell adhesion;positive regulation of endothelial cell proliferation;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,Golgi apparatus;plasma membrane;nucleus;cytoplasm,,+,,,,,,,,,,,,
7337,Q9BZQ8,FAM129A,Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A),SLAKGESLSLPGP,_GES(ph)LSLPGPSPPPDGTEQVIISR_,S639,,24.64,,,,21.70,,,,,,,,,23.17,1.47, , , ,-1.47, , , , , , , , ,positive regulation of protein phosphorylation;positive regulation of translation;response to endoplasmic reticulum stress;negative regulation of protein phosphorylation,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7338,Q9BZQ8,FAM129A,Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A),LSLPGPSPPPDGT,_GESLSLPGPS(ph)PPPDGTEQVIISR_,S646,,24.27,,,,,,23.28,,,,,,,23.77,0.49, , , , , ,-0.49, , , , , , ,positive regulation of protein phosphorylation;positive regulation of translation;response to endoplasmic reticulum stress;negative regulation of protein phosphorylation,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7339,Q9BZQ8,FAM129A,Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A),SPARRASAILPGV,_RAS(ph)AILPGVLGSETLSNEVFQESEEEKQPEVPSSLAK_,S602,,27.85,25.10,24.22,,,,,,,26.08,26.39,,,25.93,1.92,-0.83,-1.71, , , , , , ,0.15,0.46, , ,positive regulation of protein phosphorylation;positive regulation of translation;response to endoplasmic reticulum stress;negative regulation of protein phosphorylation,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7341,Q9C040,TRIM2,Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86),EGTNIPSPVVRQI,_(ac)ASEGTNIPS(ph)PVVR_,S10,,22.75,23.61,23.61,22.57,,,,,,,,,22.44,23.00,-0.25,0.61,0.61,-0.42, , , , , , , , ,-0.56,regulation of neuron apoptotic process,cytoplasm,,,,,,,,,,,,,,
7342,Q9C040,TRIM2,Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86),IRSADVSPTTEGV,_SADVS(ph)PTTEGVK_,S428,,25.09,26.76,26.76,,22.17,,22.41,22.74,,25.89,,,,24.55,0.54,2.22,2.22, ,-2.37, ,-2.14,-1.81, ,1.34, , , ,regulation of neuron apoptotic process,cytoplasm,,,,,,,,,,,,,,
7343,Q9C086,INO80B,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),GPEGPGSPLLAT_,_LGGPEGPGS(ph)PLLAT_,S336,,23.40,22.00,22.00,23.24,22.76,,23.42,,,22.89,,,,22.82,0.58,-0.81,-0.81,0.42,-0.05, ,0.60, , ,0.07, , , ,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination",nucleolus;plasma membrane;Ino80 complex;cytoplasm,,,,,,,,,,,,,,
7344,Q9C0A6,SETD5,SET domain-containing protein 5,DLNGLPSPVEERC,_SDLNGLPS(ph)PVEER_,S72,+,22.47,22.12,22.12,22.97,,24.89,,,22.73,,,22.96,22.62,22.86,-0.39,-0.74,-0.74,0.11, ,2.03, , ,-0.12, , ,0.10,-0.24,,,,,,,,,,,,,,,,
7345,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),KLSRGDSLKEPTS,_GDS(ph)LKEPTSIAESSR_,S327,+,24.46,25.06,,24.57,25.15,25.46,24.43,25.26,24.78,22.79,24.78,23.36,26.13,24.69,-0.23,0.37, ,-0.12,0.46,0.77,-0.26,0.58,0.09,-1.89,0.10,-1.32,1.44,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7346,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),RGRGVGSPEPGPT,_GVGS(ph)PEPGPTAPYLGR_,S568,+,25.92,23.60,24.16,24.22,24.72,23.97,25.72,25.03,25.04,25.88,24.75,24.57,25.52,24.85,1.06,-1.25,-0.69,-0.64,-0.13,-0.89,0.86,0.17,0.19,1.02,-0.10,-0.28,0.67,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7348,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),EKLLRQSPPLPGR,_(gl)QS(ph)PPLPGREEEPGLGDSGIQSTPGSGHAPR_,S501,,,,,,24.13,25.90,,,24.40,23.89,,,25.07,24.68, , , , ,-0.55,1.22, , ,-0.27,-0.79, , ,0.39,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7349,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),RSSSLKSAQGTGF,_S(ph)AQGTGFELGQLQSIR_,S379,+,24.85,,,21.18,,,22.55,,22.60,23.05,23.10,22.68,24.31,23.04,1.81, , ,-1.86, , ,-0.49, ,-0.44,0.01,0.06,-0.36,1.27,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7350,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),RHPSYRSEPSLEP,_S(ph)EPSLEPESFR_,S345,,21.87,23.36,,22.10,,,,,,,,,,22.45,-0.57,0.92, ,-0.34, , , , , , , , , ,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7351,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),PSLEPESFRSPTF,_SEPSLEPES(ph)FRSPTFGK_,S353,,,,,,,23.44,24.13,,,24.85,26.31,24.16,24.71,24.60, , , , , ,-1.16,-0.47, , ,0.25,1.71,-0.44,0.11,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7352,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),EPESFRSPTFGKS,_SEPSLEPESFRS(ph)PTFGK_,S356,,,,,,23.65,,24.69,24.02,26.14,24.90,,24.01,,24.57, , , , ,-0.91, ,0.12,-0.55,1.57,0.33, ,-0.56, ,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7353,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),SPTFGKSFHFDPL,_S(ph)FHFDPLSSGSR_,S362,,22.67,,,,,,,,,,,23.75,,23.21,-0.54, , , , , , , , , , ,0.54, ,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7358,Q9C0B5,ZDHHC5,Palmitoyltransferase ZDHHC5 (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),SDDSKRSPLGKTP,_TSSSSDDSKRS(ph)PLGK_,S540,,17.00,21.98,21.92,21.90,19.00,18.88,,18.72,19.40,,,18.49,,19.70,-2.70,2.29,2.22,2.20,-0.70,-0.82, ,-0.98,-0.30, , ,-1.21, ,protein palmitoylation,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7361,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,DLAKAASSELPAD,_AAS(ph)SELPADISK_,S260,,20.98,21.43,20.97,22.42,,,23.49,,23.92,22.98,22.74,,,22.37,-1.39,-0.94,-1.40,0.05, , ,1.12, ,1.55,0.62,0.38, , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7362,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,QDLCRASPEPPGP,_AS(ph)PEPPGPESSSR_,S672,+,28.99,28.19,25.87,28.47,27.24,27.80,27.42,28.03,27.26,25.71,27.42,26.62,26.07,27.31,1.68,0.87,-1.44,1.16,-0.08,0.49,0.10,0.72,-0.05,-1.61,0.11,-0.70,-1.24,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7364,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,RASRVPSSDEEVV,_VPS(ph)S(ph)DEEVVEEPQSR_,S1620,+,29.46,24.73,24.98,23.72,29.81,27.65,27.32,26.78,27.07,26.34,26.29,23.01,24.51,26.28,3.17,-1.55,-1.31,-2.56,3.53,1.36,1.03,0.50,0.79,0.06,0.01,-3.27,-1.77,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7365,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,ASRVPSSDEEVVE,_VPS(ph)S(ph)DEEVVEEPQSR_,S1621,+,29.50,25.22,25.38,24.03,29.87,23.58,25.98,26.98,25.93,26.20,25.84,24.75,25.85,26.08,3.41,-0.87,-0.71,-2.05,3.79,-2.51,-0.11,0.89,-0.16,0.12,-0.24,-1.33,-0.23,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7366,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,EFGKRDSLGTYSS,_RDS(ph)LGTYSSR_,S872,+,26.43,27.27,26.20,27.32,29.86,26.73,28.44,30.47,27.83,23.87,29.66,27.17,29.61,27.76,-1.33,-0.49,-1.56,-0.44,2.10,-1.03,0.68,2.72,0.07,-3.89,1.91,-0.59,1.85,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7369,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,GSGGLFSPSTAHV,_GSGGLFS(ph)PSTAHVPDGALGQR_,S1029,+,25.99,,,,24.44,24.56,24.01,25.04,22.66,22.41,25.99,,24.74,24.43,1.56, , , ,0.02,0.14,-0.42,0.61,-1.77,-2.01,1.56, ,0.31,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7370,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,TLFRGWSQEGPVK,_GWS(ph)QEGPVK_,S221,,27.38,24.82,22.92,25.20,,,,,,22.88,,,,24.64,2.74,0.18,-1.72,0.56, , , , , ,-1.76, , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7371,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,ELKDTQSPSTCSE,_DTQS(ph)PSTCSEGLLGWSQK_,S712,,25.06,,,,,,,,,22.71,,,,23.89,1.18, , , , , , , , ,-1.18, , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7372,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,FQKRDVSLGTYGS,_DVS(ph)LGTYGSR_,S936,,22.76,,,,,22.64,,22.38,,,,,,22.59,0.16, , , , ,0.05, ,-0.21, , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7373,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,QREAAFSPGQQDW,_EAAFS(ph)PGQQDWSR_,S1103,,24.53,,,21.98,22.77,,,,,22.25,,,,22.88,1.65, , ,-0.91,-0.11, , , , ,-0.63, , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7374,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,RKEVLASPDRLWG,_EVLAS(ph)PDRLWGSR_,S178,+,26.07,22.77,22.77,19.50,,21.18,24.78,23.71,23.49,23.56,21.87,24.65,,23.12,2.95,-0.35,-0.35,-3.62, ,-1.95,1.66,0.58,0.37,0.44,-1.25,1.53, ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7375,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,LVQRRFSEGVLQS,_RFS(ph)EGVLQSPSQDQEK_,S429,+,27.85,24.77,24.35,26.00,26.76,26.29,27.16,27.23,26.07,25.30,26.42,28.61,25.95,26.37,1.48,-1.59,-2.02,-0.36,0.40,-0.08,0.79,0.86,-0.30,-1.07,0.05,2.24,-0.42,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7376,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,SEGVLQSPSQDQE,_FSEGVLQS(ph)PSQDQEK_,S435,+,25.24,22.68,23.25,22.75,24.77,24.60,23.73,24.32,24.64,24.13,23.73,23.38,24.51,23.98,1.26,-1.30,-0.73,-1.23,0.79,0.62,-0.25,0.34,0.66,0.15,-0.25,-0.60,0.53,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7377,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,GLRHNGSLSPGLE,_HNGS(ph)LS(ph)PGLEARDPLEAR_,S1383,,23.40,,,,,,,,,,,,,23.40,0.00, , , , , , , , , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7379,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,GVWRLDSPPPSPI,_LDS(ph)PPPS(ph)PITEASEAAEAAEAGNLAVSSR_,S494,+,27.66,,,26.02,23.14,24.40,25.71,,,,27.48,,27.39,25.97,1.69, , ,0.05,-2.83,-1.57,-0.26, , , ,1.51, ,1.42,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7380,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,LDSPPPSPITEAS,_LDS(ph)PPPS(ph)PITEASEAAEAAEAGNLAVSSR_,S498,,27.00,,,,,,,,,,,,,27.00,0.00, , , , , , , , , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7381,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,APGAVCSPGESKE,_NM(ox)APGAVCS(ph)PGESK_,S1297,,23.93,,,22.35,,,20.99,,21.26,22.11,,,,22.13,1.80, , ,0.22, , ,-1.14, ,-0.86,-0.01, , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7383,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,QLGTQRSQEADVQ,_S(ph)QEADVQDWEFRK_,S836,+,28.78,24.32,23.99,25.65,26.52,25.71,25.51,25.95,26.69,25.58,27.81,26.37,26.01,26.07,2.71,-1.75,-2.08,-0.42,0.45,-0.36,-0.56,-0.12,0.62,-0.49,1.75,0.31,-0.06,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7384,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,ENGGPASPGLPAE,_PWIPSSPAPSSENGGPAS(ph)PGLPAEASGSGPGSPHLHPPDK_,S287,,24.01,,,,,,,,,,25.81,25.68,,25.17,-1.16, , , , , , , , , ,0.64,0.51, ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7385,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,SGSGPGSPHLHPP,_PWIPSSPAPSSENGGPAS(ph)PGLPAEASGSGPGS(ph)PHLHPPDK_,S301,,24.01,,,,,,,,,,,,,24.01,0.00, , , , , , , , , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7386,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,EFGKRDSLGAYAS,_RDS(ph)LGAYASQDANEQGQDLGK_,S893,+,25.69,25.87,26.20,25.93,,24.01,28.43,25.04,28.55,27.77,28.22,27.69,25.83,26.60,-0.91,-0.73,-0.40,-0.68, ,-2.59,1.83,-1.56,1.94,1.17,1.62,1.09,-0.77,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7387,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,EFRKRDSQGTYSS,_RDS(ph)QGTYSSRDAELQDQEFGK_,S851,,,23.96,23.96,,,,25.30,,24.99,26.30,,25.75,,25.04, ,-1.09,-1.09, , , ,0.26, ,-0.05,1.26, ,0.71, ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7391,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,PLSSGFSPEEAQQ,_SFGTRPLSSGFS(ph)PEEAQQQDEEFEK_,S987,+,23.17,,,,25.36,24.25,25.09,25.94,24.06,24.61,25.44,24.17,24.91,24.70,-1.53, , , ,0.66,-0.45,0.39,1.24,-0.64,-0.09,0.74,-0.53,0.21,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7392,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,PEKSSGSEGSSPN,_SSGS(ph)EGSSPNWLQALK_,S1711,,22.42,,,,,,,,,,,,,22.42,0.00, , , , , , , , , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7395,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,NLFPGLSPSALKA,_VNLFPGLS(ph)PSALK_,S1652,,24.35,,,,,,,,,,,,,24.35,0.00, , , , , , , , , , , , ,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7396,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,VSGAGFSPSSKME,_VSGAGFS(ph)PSSK_,S1138,+,27.60,23.79,23.79,26.69,24.44,23.69,24.54,24.60,23.76,21.73,24.63,,23.42,24.39,3.21,-0.60,-0.60,2.30,0.05,-0.70,0.15,0.21,-0.63,-2.66,0.24, ,-0.97,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7397,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,LDDLLASPPPSGG,_WLDDLLAS(ph)PPPSGGGAR_,S691,+,27.49,21.47,21.47,25.10,27.91,25.54,26.42,24.98,26.59,26.13,27.15,26.24,26.80,25.64,1.85,-4.17,-4.17,-0.54,2.27,-0.10,0.78,-0.65,0.95,0.49,1.51,0.61,1.16,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7398,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,SSAARWSDQGPAQ,_WS(ph)DQGPAQTSR_,S1533,+,24.79,,,26.20,25.04,24.35,,25.55,,,25.92,,24.09,25.13,-0.35, , ,1.07,-0.09,-0.78, ,0.41, , ,0.78, ,-1.04,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7399,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,PLAGQESPLPLAT,_YESQEPLAGQES(ph)PLPLATR_,S601,+,29.95,27.83,27.68,27.51,29.55,28.91,28.81,30.12,28.54,27.50,29.30,26.89,28.75,28.57,1.39,-0.73,-0.89,-1.06,0.99,0.34,0.25,1.56,-0.02,-1.06,0.73,-1.68,0.19,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7400,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,HHGRYSSQDADEQ,_YSS(ph)QDADEQDWEFQKR_,S920,,21.41,,,,25.97,24.58,,25.65,,,,,22.32,23.98,-2.57, , , ,1.98,0.60, ,1.66, , , , ,-1.67,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
7401,Q9C0C9,UBE2O,Ubiquitin-conjugating enzyme E2 O (EC 6.3.2.19) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),DKPEGQSPVKAEW,_EDKPEGQS(ph)PVK_,S896,+,22.11,23.69,24.28,24.63,,,21.08,,19.95,,,21.67,,22.49,-0.38,1.20,1.80,2.15, , ,-1.41, ,-2.54, , ,-0.82, ,,,,,,,,,,,,,,,,
7402,Q9C0C9,UBE2O,Ubiquitin-conjugating enzyme E2 O (EC 6.3.2.19) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),LTGSPTSPTVEPE,_NM(ox)TVEQLLTGSPTS(ph)PTVEPEKPTR_,S839,+,24.35,22.80,,23.38,24.94,23.86,24.11,25.22,24.20,,25.38,24.66,24.27,24.29,0.07,-1.49, ,-0.91,0.65,-0.43,-0.18,0.93,-0.09, ,1.09,0.37,-0.02,,,,,,,,,,,,,,,,
7406,Q9C0E2,XPO4,Exportin-4 (Exp4),QQQLLASPGSSTV,_HQQQLLAS(ph)PGSSTVDNK_,S521,+,23.16,23.31,23.94,23.47,24.56,23.54,24.81,24.88,24.08,22.60,22.11,23.87,,23.69,-0.54,-0.38,0.25,-0.22,0.87,-0.15,1.12,1.19,0.38,-1.09,-1.59,0.17, ,protein transport;positive regulation of protein export from nucleus,nucleus;cytoplasm,,,,,,,,,,,,,,
7408,Q9C0H2,TTYH3,Protein tweety homolog 3 (hTTY3),PRQAHDSLYRVHM,_(gl)QAHDS(ph)LYR_,S266,+,21.80,23.06,22.61,24.99,24.04,23.38,22.70,23.06,22.69,,,,,23.15,-1.34,-0.09,-0.54,1.84,0.89,0.23,-0.45,-0.09,-0.45, , , , ,,plasma membrane;chloride channel complex,,,,,,,,,,,,,,
7411,Q9C0H2,TTYH3,Protein tweety homolog 3 (hTTY3),RPDSSGSH_____,_YLATSQPRPDSSGS(ph)H_,S351,+,,,,23.10,23.95,,23.43,,23.50,23.81,23.01,22.38,23.89,23.38, , , ,-0.29,0.57, ,0.05, ,0.12,0.43,-0.38,-1.00,0.50,,plasma membrane;chloride channel complex,,,,,,,,,,,,,,
7412,Q9C0H5,ARHGAP39,Rho GTPase-activating protein 39,PVVRAFSEDEALA,_AFS(ph)EDEALAQQENR_,S604,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;axon guidance,cytosol;nucleus;cytoskeleton,,,,,,,,,,,,,,
7413,Q9C0H5,ARHGAP39,Rho GTPase-activating protein 39,EDSGSSSPPGVFL,_EDSGSSS(ph)PPGVFLEK_,S173,,22.40,22.91,22.91,,,,,,,24.19,,,,23.10,-0.70,-0.19,-0.19, , , , , , ,1.08, , , ,small GTPase mediated signal transduction;regulation of small GTPase mediated signal transduction;axon guidance,cytosol;nucleus;cytoskeleton,,,,,,,,,,,,,,
7414,Q9C0I1,MTMR12,Myotubularin-related protein 12 (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein),EHQRQLSLPLTQS,_QLS(ph)LPLTQSK_,S454,,26.01,21.15,,21.58,,,,,,,,23.48,,23.06,2.96,-1.91, ,-1.47, , , , , , , ,0.42, ,,cytoplasm,,,,,,,,,,,,,,
7415,Q9C0J8,WDR33,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein WDC146),MATEIGSPPRFFH,_(ac)ATEIGS(ph)PPR_,S7,+,20.75,25.20,25.32,25.55,26.57,26.14,25.77,25.95,25.37,25.60,23.96,25.93,25.27,25.18,-4.44,0.01,0.14,0.36,1.38,0.96,0.59,0.77,0.19,0.42,-1.22,0.75,0.09,spermatogenesis;postreplication repair;mRNA processing,collagen;nucleus,,,,,,,,,,,,,,
7416,Q9GZM8,NDEL1,Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),AVQASLSLPATPV,_M(ox)DSAVQASLS(ph)LPATPVGK_,S215,,21.53,,,,,,,,,,,,,21.53,0.00, , , , , , , , , , , , ,positive regulation of axon regeneration;positive regulation of axon extension;retrograde axon cargo transport;chromosome segregation;nuclear envelope disassembly;neuron migration;neurofilament cytoskeleton organization;vesicle transport along microtubule;centrosome localization;central nervous system neuron axonogenesis;mitotic prometaphase;cerebral cortex radially oriented cell migration;inner cell mass cell proliferation;microtubule cytoskeleton organization;activation of Cdc42 GTPase activity,axon;nuclear envelope;kinesin complex;cell leading edge;centrosome;condensed chromosome kinetochore;cell body;cytosol;microtubule;kinetochore;spindle;neurofilament cytoskeleton,,,,,,,,,,,,,,
7417,Q9GZP8,IMUP,Immortalization up-regulated protein (Hepatocyte growth factor activator inhibitor type 2-related small protein) (H2RSP) (HAI-2-related small protein),GGDPKLSPHKVQG,_(ac)M(ox)EFDLGAALEPTSQKPGVGAGHGGDPKLS(ph)PHK_,S29,+,25.91,,,,23.49,24.48,26.59,26.62,25.02,,26.02,24.69,,25.35,0.55, , , ,-1.86,-0.87,1.24,1.27,-0.33, ,0.67,-0.67, ,,nucleus,,,,,,,,,,,,,,
7418,Q9GZP8,IMUP,Immortalization up-regulated protein (Hepatocyte growth factor activator inhibitor type 2-related small protein) (H2RSP) (HAI-2-related small protein),GSKQHESIPGKAK,_(gl)QHES(ph)IPGK_,S147,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
7420,Q9GZR7,DDX24,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),RKAQAVSEEEEEE,_RKAQAVS(ph)EEEEEEEGK_,S39,+,27.71,28.43,28.76,29.32,27.21,27.86,28.34,27.75,28.05,28.60,26.94,27.58,25.39,27.84,-0.13,0.59,0.92,1.48,-0.63,0.02,0.50,-0.09,0.21,0.76,-0.90,-0.27,-2.45,RNA metabolic process,nucleolus;cytoplasm,,,,,,,,,,,,,,
7421,Q9GZR7,DDX24,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),AGAETRSPGKAEA,_TEAGAETRS(ph)PGK_,S244,,18.21,19.23,19.23,20.75,,,,,,,,18.88,,19.26,-1.05,-0.03,-0.03,1.49, , , , , , , ,-0.38, ,RNA metabolic process,nucleolus;cytoplasm,,,,,,,,,,,,,,
7422,Q9GZT3,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",PKLPQTSDDEKKD,_LPQTS(ph)DDEKK_,S100,+,23.72,24.15,24.66,24.74,27.25,26.80,23.10,26.81,22.76,20.73,23.20,23.25,24.97,24.32,-0.60,-0.17,0.34,0.42,2.93,2.48,-1.22,2.49,-1.56,-3.59,-1.12,-1.07,0.65,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",mitochondrion;nucleus,,,,,,,,,,,,,,
7423,Q9GZU1,MCOLN1,Mucolipin-1 (MG-2) (Mucolipidin),PAGPRGSETERLL,_(ac)TAPAGPRGS(ph)ETER_,S10,+,24.77,25.57,25.26,26.20,25.22,25.06,23.75,24.52,22.94,23.13,24.76,23.77,,24.58,0.20,0.99,0.69,1.62,0.64,0.48,-0.83,-0.06,-1.63,-1.45,0.18,-0.81, ,cellular iron ion homeostasis;calcium ion transport;transferrin transport,endosome membrane;late endosome membrane;lysosomal membrane;integral to plasma membrane,,,,,,,,,,,,,,
7424,Q9GZY8,MFF,Mitochondrial fission factor,QLVRNDSLVTPSP,_NDS(ph)LVTPSPQQAR_,S146,,25.03,24.58,,26.16,22.62,,,,,,,23.90,22.23,24.09,0.94,0.49, ,2.08,-1.47, , , , , , ,-0.18,-1.86,positive regulation of release of cytochrome c from mitochondria;peroxisome fission;mitochondrion morphogenesis;release of cytochrome c from mitochondria;mitochondrial fragmentation involved in apoptotic process;regulation of peroxisome organization;protein homooligomerization;protein targeting to mitochondrion,mitochondrial outer membrane;integral to mitochondrial membrane;peroxisome,,,,,,,,,,,,,,
7425,Q9GZY8,MFF,Mitochondrial fission factor,KRERSMSENAVRQ,_SMS(ph)ENAVR_,S131,+,20.44,22.95,,24.92,,21.36,17.93,,16.80,,21.18,19.83,,20.68,-0.24,2.27, ,4.24, ,0.69,-2.75, ,-3.88, ,0.51,-0.84, ,positive regulation of release of cytochrome c from mitochondria;peroxisome fission;mitochondrion morphogenesis;release of cytochrome c from mitochondria;mitochondrial fragmentation involved in apoptotic process;regulation of peroxisome organization;protein homooligomerization;protein targeting to mitochondrion,mitochondrial outer membrane;integral to mitochondrial membrane;peroxisome,,,,,,,,,,,,,,
7427,Q9H019,MTFR1L,Mitochondrial fission regulator 1-like,SLSKASSFADMMG,_ASS(ph)FADM(ox)M(ox)GILK_,S226,+,25.92,26.16,25.90,26.47,26.23,26.90,26.67,26.54,27.89,27.14,26.52,26.74,26.83,26.61,-0.69,-0.45,-0.70,-0.13,-0.38,0.29,0.06,-0.07,1.28,0.53,-0.09,0.13,0.22,,,,,,,,,,,,,,,,
7428,Q9H019,MTFR1L,Mitochondrial fission regulator 1-like,VMQRNASVPNLRG,_NAS(ph)VPNLRGSEER_,S103,+,27.43,28.02,26.92,28.98,27.89,27.87,28.87,28.85,29.35,26.60,27.05,28.35,26.17,27.87,-0.45,0.14,-0.95,1.11,0.01,0.00,1.00,0.98,1.48,-1.27,-0.82,0.47,-1.70,,,,,,,,,,,,,,,,
7429,Q9H063,MAF 1.00,Repressor of RNA polymerase III transcription MAF1 homolog,PSRLSKSQGGEEE,_S(ph)QGGEEEGPLSDK_,S75,+,22.72,24.57,25.06,25.88,21.76,22.08,23.09,22.30,23.59,,,,,23.45,-0.73,1.12,1.61,2.43,-1.70,-1.37,-0.36,-1.15,0.14, , , , ,"negative regulation of transcription from RNA polymerase III promoter;transcription, DNA-dependent",nucleus;cytoplasm,,,,,,,,,,,,,,
7430,Q9H0A0,NAT10,N-acetyltransferase 10 (EC 2.3.1.-),PTMKTLSDDLDEA,_TLS(ph)DDLDEAAK_,S934,+,21.89,21.78,21.80,,22.74,24.03,23.60,22.65,23.20,23.42,,22.70,22.75,22.78,-0.89,-1.00,-0.98, ,-0.04,1.25,0.82,-0.13,0.42,0.64, ,-0.08,-0.03,,nucleolus;nucleus,,,,,,,,,,,,,,
7432,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),RMKRASSLNFLNK,_ASS(ph)LNFLNK_,S582,+,24.69,25.52,24.70,25.05,26.67,25.79,24.16,25.58,25.29,24.84,26.41,26.94,25.22,25.45,-0.76,0.06,-0.75,-0.40,1.22,0.34,-1.29,0.12,-0.17,-0.61,0.96,1.49,-0.23,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7433,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),KLDEDASPNEEKG,_KLDEDAS(ph)PNEEK_,S151,+,23.28,24.13,23.32,23.79,,,21.52,,21.45,23.59,22.36,,,22.93,0.35,1.20,0.39,0.86, , ,-1.41, ,-1.48,0.66,-0.57, , ,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7434,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),LNFLNKSVEEPTQ,_S(ph)VEEPTQPGGTGLSDSR_,S589,,,22.13,,21.95,,,23.64,22.87,,,24.23,22.05,,22.81, ,-0.68, ,-0.86, , ,0.83,0.05, , ,1.42,-0.76, ,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7435,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),DSRTLSSSSMDLS,_TLSS(ph)SSM(ox)DLSR_,S609,,25.98,22.27,22.27,27.15,,,,,,,,,,24.42,1.56,-2.15,-2.15,2.73, , , , , , , , , ,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7436,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),SRTLSSSSMDLSR,_TLSSS(ph)SMDLSR_,S610,+,25.17,26.45,,26.59,24.69,22.99,25.57,25.65,22.63,,24.14,24.53,,24.84,0.33,1.61, ,1.75,-0.15,-1.85,0.73,0.81,-2.21, ,-0.70,-0.31, ,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7437,Q9H0B6,KLC2,Kinesin light chain 2 (KLC 2),KACKVDSPTVNTT,_VDS(ph)PTVNTTLR_,S445,,23.19,,,,,,,,,,,,,23.19,0.00, , , , , , , , , , , , ,blood coagulation;microtubule-based movement;axon cargo transport;antigen processing and presentation of exogenous peptide antigen via MHC class II,neuron projection;cytosol;ciliary rootlet;microtubule;kinesin I complex,,,,,,,,,,,,,,
7442,Q9H0D6,XRN2,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),KAEDSDSEPEPED,_RKAEDS(ph)DS(ph)EPEPEDNVR_,S501,+,29.45,25.21,25.23,26.17,27.07,,22.86,,23.49,21.74,,,,25.15,4.30,0.06,0.08,1.02,1.92, ,-2.29, ,-1.66,-3.41, , , ,"regulation of transcription, DNA-dependent;cell growth;DNA-dependent transcription, termination;spermatogenesis;DNA catabolic process, exonucleolytic;mRNA processing;RNA catabolic process;RNA processing",nucleolus;aggresome,,,,,,,,,,,,,,
7446,Q9H0D6,XRN2,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),RMQNNSSPSISPN,_M(ox)QNNSS(ph)PSIS(ph)PNTSFTSDGSPSPLGGIK_,S471,+,24.62,,,,24.87,23.62,,,25.91,25.23,23.99,,24.77,24.72,-0.09, , , ,0.15,-1.10, , ,1.19,0.51,-0.72, ,0.06,"regulation of transcription, DNA-dependent;cell growth;DNA-dependent transcription, termination;spermatogenesis;DNA catabolic process, exonucleolytic;mRNA processing;RNA catabolic process;RNA processing",nucleolus;aggresome,,,,,,,,,,,,,,
7448,Q9H0D6,XRN2,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),NSSPSISPNTSFT,_M(ox)QNNSS(ph)PSIS(ph)PNTSFTSDGSPSPLGGIK_,S475,,25.14,,,23.97,25.91,,25.12,24.92,,,23.99,,,24.84,0.30, , ,-0.87,1.07, ,0.28,0.08, , ,-0.85, , ,"regulation of transcription, DNA-dependent;cell growth;DNA-dependent transcription, termination;spermatogenesis;DNA catabolic process, exonucleolytic;mRNA processing;RNA catabolic process;RNA processing",nucleolus;aggresome,,,,,,,,,,,,,,
7451,Q9H0E3,SAP130,Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130),DMMETNSTDDEKS,_QQHVISTEEGDM(ox)M(ox)ETNS(ph)T(ph)DDEK_,S420,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation;transcription, DNA-dependent",STAGA complex,,,,,,,,,,,,,,
7452,Q9H0E9,BRD8,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),KATPPPSPLLSEL,_AT(ph)PPPS(ph)PLLSELLK_,S23,,26.64,,,,,,,,,,,,,26.64,0.00, , , , , , , , , , , , ,histone H2A acetylation;histone H4 acetylation;regulation of growth;cell surface receptor signaling pathway,mitochondrion;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
7453,Q9H0E9,BRD8,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),EEEDGVSEAASLE,_DAPGEDEEEDGVS(ph)EAAS(ph)LEEPK_,S465,,24.22,,,,,,,,,,,,,24.22,0.00, , , , , , , , , , , , ,histone H2A acetylation;histone H4 acetylation;regulation of growth;cell surface receptor signaling pathway,mitochondrion;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
7454,Q9H0E9,BRD8,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),GVSEAASLEEPKE,_DAPGEDEEEDGVS(ph)EAAS(ph)LEEPK_,S469,,24.76,,,,,,,,,23.83,,,,24.30,0.47, , , , , , , , ,-0.47, , , ,histone H2A acetylation;histone H4 acetylation;regulation of growth;cell surface receptor signaling pathway,mitochondrion;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
7456,Q9H0E9,BRD8,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),GSLLPTSPRLVNE,_GSLLPTS(ph)PR_,S39,,23.46,22.32,21.69,22.34,24.35,23.40,22.73,22.16,24.72,22.19,21.96,,22.29,22.80,0.66,-0.48,-1.11,-0.46,1.55,0.60,-0.07,-0.64,1.92,-0.61,-0.84, ,-0.51,histone H2A acetylation;histone H4 acetylation;regulation of growth;cell surface receptor signaling pathway,mitochondrion;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
7457,Q9H0G5,NSRP1,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),SVFGNDSDDDDET,_PSVFGNDS(ph)DDDDETSVSESLQR_,S33,,25.20,,,,25.01,,,,,24.59,,,,24.93,0.26, , , ,0.08, , , , ,-0.34, , , ,"nucleocytoplasmic transport;mRNA processing;RNA splicing;developmental process;regulation of alternative mRNA splicing, via spliceosome",ribonucleoprotein complex;nuclear speck,,,,,,,,,,,,,,
7458,Q9H0G5,NSRP1,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),SDFDAKSSADDEI,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,S254,,24.63,,,,,,,,,,,,,24.63,0.00, , , , , , , , , , , , ,"nucleocytoplasmic transport;mRNA processing;RNA splicing;developmental process;regulation of alternative mRNA splicing, via spliceosome",ribonucleoprotein complex;nuclear speck,,,,,,,,,,,,,,
7459,Q9H0G5,NSRP1,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),DFDAKSSADDEIE,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,S255,,24.42,24.84,,23.55,,,,,,,,,,24.27,0.15,0.57, ,-0.72, , , , , , , , , ,"nucleocytoplasmic transport;mRNA processing;RNA splicing;developmental process;regulation of alternative mRNA splicing, via spliceosome",ribonucleoprotein complex;nuclear speck,,,,,,,,,,,,,,
7460,Q9H0G5,NSRP1,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),ENPDADSDFDAKS,_VEENPDADS(ph)DFDAKS(ph)S(ph)ADDEIEETR_,S248,+,25.36,24.87,25.16,23.56,22.30,22.45,25.01,,26.33,27.27,24.30,24.87,,24.68,0.68,0.19,0.48,-1.12,-2.38,-2.23,0.33, ,1.65,2.59,-0.38,0.19, ,"nucleocytoplasmic transport;mRNA processing;RNA splicing;developmental process;regulation of alternative mRNA splicing, via spliceosome",ribonucleoprotein complex;nuclear speck,,,,,,,,,,,,,,
7461,Q9H0H5,RACGAP1,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),PVKKTRSIGSAVD,_S(ph)IGSAVDQGNESIVAK_,S203,,22.92,,,21.34,,,21.55,,,,,,,21.93,0.98, , ,-0.60, , ,-0.38, , , , , , ,"cytokinesis, actomyosin contractile ring assembly;small GTPase mediated signal transduction;embryo development;positive regulation of cell cycle cytokinesis;sulfate transport;spermatogenesis;regulation of attachment of spindle microtubules to kinetochore;blood coagulation;cytokinesis, initiation of separation;microtubule-based movement;regulation of small GTPase mediated signal transduction;spindle midzone assembly involved in mitosis;neuroblast proliferation;antigen processing and presentation of exogenous peptide antigen via MHC class II",acrosomal vesicle;spindle midzone;centralspindlin complex;cleavage furrow;cytosol;midbody;microtubule;nucleus,,,,,,,,,,,,,,
7463,Q9H0K1,SIK2,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),REGRRASDTSLTQ,_RAS(ph)DTSLTQGIVAFR_,S587,,21.91,,,19.75,22.41,,22.16,,,20.54,,25.46,,22.04,-0.13, , ,-2.29,0.37, ,0.13, , ,-1.50, ,3.43, ,intracellular protein kinase cascade;protein autophosphorylation;insulin receptor signaling pathway;regulation of insulin receptor signaling pathway,Golgi apparatus;nucleus,,+,,,,,,,,,,,,
7467,Q9H0L4,CSTF2T,Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant) (CSTF 64 kDa subunit tau variant) (TauCstF-64),SQPSSFSPGQSQV,_QGGSQPSSFS(ph)PGQSQVTPQDQEK_,S563,,22.71,22.77,,22.78,,,,,24.90,24.44,,,,23.52,-0.81,-0.75, ,-0.74, , , , ,1.38,0.92, , , ,mRNA processing,nucleus;intracellular,,,,,,,,,,,,,,
7468,Q9H0S4,DDX47,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),APEEHDSPTEASQ,_(ac)AAPEEHDS(ph)PTEASQPIVEEEETK_,S9,+,27.61,25.90,26.00,24.77,28.07,27.42,27.30,25.25,26.21,28.05,,26.51,25.14,26.52,1.09,-0.61,-0.52,-1.75,1.55,0.90,0.78,-1.27,-0.31,1.53, ,-0.01,-1.38,mRNA processing;RNA splicing;apoptotic process;rRNA processing,nucleolus,,,,,,,,,,,,,,
7470,Q9H0X4,ITFG3,Protein ITFG3,KNEERKSQENLGN,_S(ph)QENLGNPSK_,S21,,,,,23.56,,,21.27,,22.92,21.41,,,,22.29, , , ,1.27, , ,-1.02, ,0.63,-0.88, , , ,,integral to membrane,,,,,,,,,,,,,,
7471,Q9H0X9,OSBPL5,Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1),QTTFLGSPGPRHE,_(gl)QTTFLGS(ph)PGPRHER_,S747,+,,21.00,21.04,23.80,24.46,24.50,23.69,23.72,23.85,23.76,22.72,24.27,24.30,23.43, ,-2.43,-2.39,0.38,1.04,1.08,0.26,0.29,0.42,0.33,-0.71,0.85,0.88,Golgi to plasma membrane transport;cholesterol metabolic process;cholesterol transport,cytosol;integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7473,Q9H165,BCL11A,B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856),KKLLLGSPSSLSP,_LLLGS(ph)PSSLSPFSK_,S294,,23.31,,,,,,,,,,,,,23.31,0.00, , , , , , , , , , , , ,"negative regulation of gene expression;regulation of dendrite development;regulation of transcription, DNA-dependent;T cell differentiation;negative regulation of axon extension;protein sumoylation;negative regulation of collateral sprouting;negative regulation of protein homooligomerization;B cell differentiation;positive regulation of neuron projection development;transcription, DNA-dependent;hemopoiesis;negative regulation of dendrite development;positive regulation of transcription from RNA polymerase II promoter;positive regulation of collateral sprouting",nuclear body;nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
7480,Q9H1A4,ANAPC1,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),DFEGSLSPVIAPK,_NFDFEGSLS(ph)PVIAPK_,S688,+,25.02,24.97,25.31,25.33,26.98,25.67,26.26,26.39,26.36,26.39,26.00,25.33,26.86,25.91,-0.89,-0.95,-0.60,-0.58,1.06,-0.24,0.35,0.48,0.44,0.48,0.09,-0.58,0.95,protein K11-linked ubiquitination;mitosis;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cell division;mitotic cell cycle spindle assembly checkpoint,nucleoplasm;cytosol;anaphase-promoting complex,,,,,,,,,,,,,,
7481,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),SLSRAPSAPPGTG,_APS(ph)APPGTGALPPAAPSGR_,S519,,21.80,,,,,,,,,,,,,21.80,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
7482,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),LRKRKASPEPPDS,_AS(ph)PEPPDSAEGALK_,S547,+,25.82,26.55,26.63,25.17,25.01,27.45,26.14,25.38,27.43,26.67,25.90,26.73,26.27,26.24,-0.42,0.31,0.39,-1.07,-1.23,1.20,-0.10,-0.87,1.19,0.43,-0.35,0.48,0.03,,nucleus,,,,,,,,,,,,,,
7483,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),ASARRNSSSPVSP,_RNS(ph)SS(ph)PVSPASVPGQR_,S657,+,27.54,24.75,24.09,25.07,22.56,,,,22.46,,,22.61,,24.15,3.39,0.59,-0.06,0.92,-1.60, , , ,-1.70, , ,-1.54, ,,nucleus,,,,,,,,,,,,,,
7485,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),ARRNSSSPVSPAS,_RNS(ph)SS(ph)PVSPASVPGQR_,S659,+,27.81,26.06,25.17,26.14,24.78,25.85,24.27,24.79,25.32,24.41,24.37,25.34,24.71,25.31,2.50,0.75,-0.14,0.83,-0.53,0.54,-1.04,-0.52,0.01,-0.90,-0.94,0.03,-0.60,,nucleus,,,,,,,,,,,,,,
7486,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),NSSSPVSPASVPG,_RNS(ph)SS(ph)PVS(ph)PASVPGQR_,S662,+,26.09,22.96,,,22.51,23.60,21.81,22.35,22.87,,,,,23.17,2.92,-0.21, , ,-0.66,0.43,-1.36,-0.82,-0.30, , , , ,,nucleus,,,,,,,,,,,,,,
7487,Q9H1B7,IRF2BPL,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),GGKRPGSVSSTDQ,_RPGS(ph)VSSTDQER_,S334,,25.25,25.05,24.83,25.13,,,,,20.16,,,,,24.08,1.16,0.97,0.75,1.04, , , , ,-3.93, , , , ,,nucleus,,,,,,,,,,,,,,
7488,Q9H1C4,UNC93B1,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),YLEEDNSDESDAE,_YLEEDNS(ph)DES(ph)DAEGEHGDGAEEEAPPAGPRPGPEPAGLGR_,S547,,26.55,,,,24.27,,,,,24.70,,,,25.17,1.37, , , ,-0.90, , , , ,-0.48, , , ,toll-like receptor 7 signaling pathway;intracellular protein transport;defense response to virus;toll-like receptor 3 signaling pathway;toll-like receptor 9 signaling pathway;innate immune response,endosome;integral to membrane;early phagosome;endoplasmic reticulum membrane;Golgi membrane;lysosome,,,,,,,,,,,,,,
7489,Q9H1C4,UNC93B1,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),EDNSDESDAEGEH,_YLEEDNS(ph)DES(ph)DAEGEHGDGAEEEAPPAGPRPGPEPAGLGR_,S550,,26.55,,,,24.27,,,,,24.70,,,,25.17,1.37, , , ,-0.90, , , , ,-0.48, , , ,toll-like receptor 7 signaling pathway;intracellular protein transport;defense response to virus;toll-like receptor 3 signaling pathway;toll-like receptor 9 signaling pathway;innate immune response,endosome;integral to membrane;early phagosome;endoplasmic reticulum membrane;Golgi membrane;lysosome,,,,,,,,,,,,,,
7491,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),KKDDSHSAEDSED,_DDSHS(ph)AEDS(ph)EDEKEDHKNVR_,S75,,20.41,19.89,,17.92,21.10,,19.41,,,,,19.27,,19.67,0.74,0.23, ,-1.75,1.43, ,-0.26, , , , ,-0.40, ,,nucleus,,,,,,,,,,,,,,
7492,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),SHSAEDSEDEKED,_DDSHSAEDS(ph)EDEKEDHKNVR_,S79,+,22.03,24.40,23.59,22.44,24.80,23.19,20.12,23.03,,,,,20.11,22.64,-0.60,1.76,0.95,-0.19,2.17,0.56,-2.52,0.40, , , , ,-2.53,,nucleus,,,,,,,,,,,,,,
7493,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),PFQEKDSGSDEDF,_DS(ph)GS(ph)DEDFLM(ox)EDDDDS(ph)DYGSSK_,S130,,26.04,,,,,,,,,25.85,,,,25.95,0.10, , , , , , , , ,-0.10, , , ,,nucleus,,,,,,,,,,,,,,
7494,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),QEKDSGSDEDFLM,_DS(ph)GS(ph)DEDFLM(ox)EDDDDS(ph)DYGSSK_,S132,,26.29,,,,25.75,,,,23.31,23.70,,,,24.76,1.53, , , ,0.99, , , ,-1.45,-1.07, , , ,,nucleus,,,,,,,,,,,,,,
7495,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),MEDDDDSDYGSSK,_DSGS(ph)DEDFLM(ox)EDDDDS(ph)DYGSSK_,S144,,25.65,,,,26.75,24.06,,,23.63,24.12,,,,24.84,0.81, , , ,1.91,-0.78, , ,-1.21,-0.72, , , ,,nucleus,,,,,,,,,,,,,,
7496,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),EDEEPESPPEKKT,_TPSPKEEDEEPES(ph)PPEKK_,S214,+,30.23,30.80,30.66,30.20,29.52,31.13,30.98,30.88,30.81,28.88,29.14,29.54,29.31,30.16,0.06,0.64,0.50,0.04,-0.64,0.97,0.82,0.72,0.65,-1.28,-1.02,-0.62,-0.85,,nucleus,,,,,,,,,,,,,,
7497,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),SKEKTPSPKEEDE,_EKT(ph)PS(ph)PKEEDEEPES(ph)PPEK_,S204,+,29.20,28.21,23.35,27.29,23.23,24.70,24.07,24.35,25.85,24.25,22.12,,,25.15,4.06,3.06,-1.80,2.14,-1.92,-0.45,-1.08,-0.80,0.71,-0.90,-3.03, , ,,nucleus,,,,,,,,,,,,,,
7498,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),LMEDVGSEEEQEE,_QREMLM(ox)EDVGS(ph)EEEQEEEDEAPFQEK_,S113,+,31.05,28.03,28.60,26.89,28.96,27.58,30.05,28.65,30.78,29.98,28.43,30.10,28.19,29.02,2.03,-0.99,-0.42,-2.14,-0.06,-1.44,1.02,-0.38,1.75,0.96,-0.59,1.08,-0.83,,nucleus,,,,,,,,,,,,,,
7500,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),EKKTSTSPPPEKS,_TSTS(ph)PPPEK_,S223,+,22.94,25.69,,23.66,,20.65,22.51,21.68,22.39,21.08,20.35,23.65,20.72,22.30,0.63,3.39, ,1.36, ,-1.65,0.21,-0.62,0.08,-1.22,-1.95,1.35,-1.58,,nucleus,,,,,,,,,,,,,,
7501,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),SPPPEKSGDEGSE,_KTSTSPPPEKS(ph)GDEGSEDEAPSGED_,S229,,,,,,23.79,25.13,,24.64,,,,,22.28,23.96, , , , ,-0.17,1.17, ,0.68, , , , ,-1.68,,nucleus,,,,,,,,,,,,,,
7503,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),KNSQEDSEDSEDK,_NSQEDS(ph)EDSEDKDVK_,S58,+,,22.46,22.32,,20.76,24.89,20.93,24.66,21.32,,,,20.24,22.20, ,0.26,0.12, ,-1.43,2.69,-1.27,2.47,-0.88, , , ,-1.96,,nucleus,,,,,,,,,,,,,,
7505,Q9H1E5,TMX4,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),EEEKDDSNEEENK,_SEEAHRAEQLQDAEEEKDDS(ph)NEEENK_,S251,+,26.92,26.54,26.54,25.05,,22.90,23.74,,25.89,24.74,23.84,24.62,22.64,24.86,2.06,1.68,1.68,0.20, ,-1.95,-1.12, ,1.03,-0.11,-1.02,-0.24,-2.22,electron transport chain;cell redox homeostasis,integral to membrane,,,,,,,,,,,,,,
7506,Q9H1E5,TMX4,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),EEENKDSLVDDEE,_DS(ph)LVDDEEEK_,S259,+,26.98,28.18,28.82,27.25,,,26.27,,27.37,28.58,,27.18,,27.58,-0.60,0.60,1.24,-0.33, , ,-1.31, ,-0.21,1.00, ,-0.40, ,electron transport chain;cell redox homeostasis,integral to membrane,,,,,,,,,,,,,,
7507,Q9H1E5,TMX4,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),GVDEERSEANDQG,_S(ph)EANDQGPPGEDGVTR_,S294,,23.16,24.55,24.88,24.02,,,,,,,,,,24.15,-0.99,0.40,0.73,-0.13, , , , , , , , , ,electron transport chain;cell redox homeostasis,integral to membrane,,,,,,,,,,,,,,
7509,Q9H1K1,ISCU,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)",RLRRAASALLLRS,_AAS(ph)ALLLR_,S14,,,22.48,,,21.39,,21.48,22.85,,,,22.69,,22.18, ,0.30, , ,-0.79, ,-0.70,0.67, , , ,0.51, ,iron-sulfur cluster assembly;nitrogen fixation,cytosol;mitochondrion;nucleus,,,,,,,,,,,,,,
7510,Q9H1K1,ISCU,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)",LPARELSAPARLY,_ELS(ph)APAR_,S29,,23.10,23.65,21.22,24.51,19.93,,,,,,,,,22.48,0.61,1.17,-1.26,2.03,-2.55, , , , , , , , ,iron-sulfur cluster assembly;nitrogen fixation,cytosol;mitochondrion;nucleus,,,,,,,,,,,,,,
7511,Q9H1Z4,WDR13,WD repeat-containing protein 13,QRYGPLSEPGSAR,_YGPLS(ph)EPGSAR_,S70,+,24.99,25.04,25.20,23.98,24.38,,25.02,26.08,,24.15,26.04,26.13,24.21,25.02,-0.03,0.02,0.18,-1.04,-0.64, ,0.00,1.06, ,-0.87,1.02,1.11,-0.81,,nucleus;cytoplasm,,,,,,,,,,,,,,
7517,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),KTKDSGSISLQET,_DSGS(ph)ISLQETRR_,S779,,22.60,,,,,,23.31,,,25.38,23.25,24.74,,23.86,-1.26, , , , , ,-0.55, , ,1.53,-0.60,0.89, ,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7518,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),NKEEIGSLSKTET,_EEIGS(ph)LSK_,S728,,23.99,,,23.35,,,,,,,,,,23.67,0.32, , ,-0.32, , , , , , , , , ,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7519,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),KIFKLGSEKKKKQ,_IFKLGS(ph)EK_,S14,,23.00,22.93,22.93,,,,,22.70,,,,,,22.89,0.11,0.04,0.04, , , , ,-0.19, , , , , ,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7520,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),PASKRASSDLSIA,_RAS(ph)SDLSIASSEEDK_,S340,+,,24.95,25.07,23.52,,24.19,24.22,23.55,,22.89,25.37,25.71,24.18,24.36, ,0.58,0.71,-0.84, ,-0.18,-0.15,-0.81, ,-1.48,1.01,1.35,-0.19,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7521,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),SDLSIASSEEDKL,_RASSDLSIAS(ph)S(ph)EEDK_,S347,+,24.25,24.93,25.40,24.97,,,26.37,23.73,24.00,25.12,25.85,,24.06,24.87,-0.62,0.06,0.53,0.10, , ,1.51,-1.14,-0.87,0.25,0.98, ,-0.81,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7522,Q9H2G2,SLK,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),DLSIASSEEDKLS,_RASSDLSIAS(ph)S(ph)EEDK_,S348,,24.25,,,,,,26.37,,,22.25,,,,24.29,-0.04, , , , , ,2.09, , ,-2.04, , , ,protein autophosphorylation;apoptotic process,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
7525,Q9H2H9,SLC38A1,Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),RRSLTNSHLEKKK,_S(ph)LTNS(ph)HLEK_,S56,,28.14,25.97,26.11,28.32,,,,,,,,,,27.13,1.01,-1.17,-1.03,1.19, , , , , , , , , ,neurotransmitter uptake,axon;integral to membrane;plasma membrane,,,,,,,,,,,,,,
7529,Q9H2I8,C10orf11,Leucine-rich repeat-containing protein C10orf11,SEDVASSPERHYT,_ASSEDVASS(ph)PERHYTPLPSASR_,S153,+,,24.23,,,23.68,24.31,,23.38,,22.61,,23.48,24.39,23.73, ,0.51, , ,-0.05,0.58, ,-0.35, ,-1.12, ,-0.25,0.67,,,,,,,,,,,,,,,,
7530,Q9H2J4,PDCL3,Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1),VLMKRDSDSEGD_,_SVLM(ox)KRDS(ph)DSEGD_,S234,,,,,,,20.66,19.96,22.60,,,,,,21.07, , , , , ,-0.41,-1.11,1.53, , , , , ,apoptotic process;virus-host interaction,cytoplasm,,,,,,,,,,,,,,
7532,Q9H2J7,SLC6A15,Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Sodium-coupled branched-chain amino-acid transporter 1) (Solute carrier family 6 member 15) (Transporter v7-3),IPSEMPSPNFGKN,_IPSEM(ox)PS(ph)PNFGK_,S678,+,,,,,23.40,24.56,25.29,,24.90,,22.50,25.50,23.76,24.27, , , , ,-0.87,0.29,1.02, ,0.63, ,-1.77,1.22,-0.51,proline transport;leucine transport;transmembrane transport,integral to membrane;plasma membrane;integral to plasma membrane,,,,,,,,,,,,,,
7533,Q9H2K8,TAOK3,Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3),NGPLNESQEDEED,_NGPLNES(ph)QEDEEDSEHGTSLNR_,S324,+,24.79,24.41,24.80,24.54,,,24.47,24.81,23.39,,23.79,25.11,,24.46,0.34,-0.05,0.35,0.09, , ,0.02,0.35,-1.07, ,-0.67,0.65, ,negative regulation of JNK cascade;DNA repair;positive regulation of JNK cascade;MAPK cascade;protein autophosphorylation;G2/M transition DNA damage checkpoint;positive regulation of JUN kinase activity,mitochondrion;plasma membrane,,+,,,,,,,,,,,,
7534,Q9H2M9,RAB3GAP2,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),PEKADFSPFGNSQ,_ADFS(ph)PFGNSQGPSR_,S450,,,,,,,,,,,24.00,23.42,,22.84,23.42, , , , , , , , , ,0.58,0.00, ,-0.58,intracellular protein transport,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7535,Q9H2P0,ADNP,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),KLMHNASDSEVDQ,_LM(ox)HNAS(ph)DS(ph)EVDQDDVVEWK_,S953,+,26.59,21.65,21.65,,25.57,23.10,22.63,,24.10,25.98,22.68,24.47,,23.84,2.74,-2.19,-2.19, ,1.73,-0.74,-1.21, ,0.26,2.14,-1.16,0.63, ,"positive regulation of axon extension;negative regulation of gene expression;short-term memory;positive regulation of synapse assembly;response to inorganic substance;regulation of protein ADP-ribosylation;nitric oxide homeostasis;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of cGMP biosynthetic process;negative regulation of synaptic transmission;negative regulation of protein binding;estrous cycle phase;cellular response to extracellular stimulus;response to carbohydrate stimulus;positive regulation of neuron projection development;transcription, DNA-dependent;negative regulation of neuron apoptotic process;activation of protein kinase activity",neuronal cell body;axon;extracellular space;nucleus;dendrite;cytoplasm,C2H2-type,,,,,,,,,,+,,,
7536,Q9H2P0,ADNP,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),MHNASDSEVDQDD,_LM(ox)HNAS(ph)DS(ph)EVDQDDVVEWK_,S955,,26.04,,,,,,,,,,,,,26.04,0.00, , , , , , , , , , , , ,"positive regulation of axon extension;negative regulation of gene expression;short-term memory;positive regulation of synapse assembly;response to inorganic substance;regulation of protein ADP-ribosylation;nitric oxide homeostasis;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of cGMP biosynthetic process;negative regulation of synaptic transmission;negative regulation of protein binding;estrous cycle phase;cellular response to extracellular stimulus;response to carbohydrate stimulus;positive regulation of neuron projection development;transcription, DNA-dependent;negative regulation of neuron apoptotic process;activation of protein kinase activity",neuronal cell body;axon;extracellular space;nucleus;dendrite;cytoplasm,C2H2-type,,,,,,,,,,+,,,
7537,Q9H2P0,ADNP,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),PSRLNQSPSLAPV,_LNQS(ph)PSLAPVK_,S709,,23.40,20.81,,21.81,,,,,20.97,,,,,21.75,1.65,-0.93, ,0.06, , , , ,-0.78, , , , ,"positive regulation of axon extension;negative regulation of gene expression;short-term memory;positive regulation of synapse assembly;response to inorganic substance;regulation of protein ADP-ribosylation;nitric oxide homeostasis;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of cGMP biosynthetic process;negative regulation of synaptic transmission;negative regulation of protein binding;estrous cycle phase;cellular response to extracellular stimulus;response to carbohydrate stimulus;positive regulation of neuron projection development;transcription, DNA-dependent;negative regulation of neuron apoptotic process;activation of protein kinase activity",neuronal cell body;axon;extracellular space;nucleus;dendrite;cytoplasm,C2H2-type,,,,,,,,,,+,,,
7538,Q9H2P0,ADNP,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),VIPEDASESEEKL,_VIPEDAS(ph)ESEEK_,S921,+,28.07,26.70,27.13,26.90,,,25.14,,25.19,25.17,,23.62,,25.99,2.08,0.71,1.14,0.91, , ,-0.85, ,-0.80,-0.82, ,-2.37, ,"positive regulation of axon extension;negative regulation of gene expression;short-term memory;positive regulation of synapse assembly;response to inorganic substance;regulation of protein ADP-ribosylation;nitric oxide homeostasis;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of cGMP biosynthetic process;negative regulation of synaptic transmission;negative regulation of protein binding;estrous cycle phase;cellular response to extracellular stimulus;response to carbohydrate stimulus;positive regulation of neuron projection development;transcription, DNA-dependent;negative regulation of neuron apoptotic process;activation of protein kinase activity",neuronal cell body;axon;extracellular space;nucleus;dendrite;cytoplasm,C2H2-type,,,,,,,,,,+,,,
7541,Q9H2Y7,ZNF106,Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474),LEKEPHSPADQPE,_EPHS(ph)PADQPEQQAESTLTSAETR_,S556,,23.30,,,,,,25.45,,24.72,,,24.44,24.19,24.42,-1.12, , , , , ,1.03, ,0.30, , ,0.02,-0.23,insulin receptor signaling pathway,cytosol;nucleolus,C2H2-type,,,,,,,,,,,,,
7542,Q9H2Y7,ZNF106,Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474),ARKRSLSESSVIM,_SLS(ph)ESSVIM(ox)DR_,S89,,22.23,21.51,,22.74,23.76,23.98,,23.71,,,,,,22.99,-0.76,-1.48, ,-0.25,0.77,1.00, ,0.72, , , , , ,insulin receptor signaling pathway,cytosol;nucleolus,C2H2-type,,,,,,,,,,,,,
7544,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),SEKQQDSQPEEVM,_QQDS(ph)QPEEVM(ox)DVLEMVENVK_,S381,,27.81,,,,24.56,,18.92,,,,17.87,,,22.29,5.52, , , ,2.27, ,-3.37, , , ,-4.42, , ,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
7549,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),DRKRSISESSRSG,_RSIS(ph)ESSR_,S692,+,19.15,21.97,22.12,23.07,,,19.85,,,19.35,18.31,20.30,,20.51,-1.37,1.46,1.60,2.56, , ,-0.67, , ,-1.17,-2.20,-0.22, ,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
7550,Q9H307,PNN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),KECKSLSPGKENV,_SLS(ph)PGKENVSALDM(ox)EK_,S443,,,,,,28.13,29.82,23.93,28.83,,,,,27.49,27.64, , , , ,0.49,2.18,-3.71,1.19, , , , ,-0.15,"cell adhesion;mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent",cell-cell junction;intermediate filament;nuclear speck;plasma membrane;catalytic step 2 spliceosome;desmosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
7552,Q9H330,TMEM245,Transmembrane protein 245 (Protein CG-2),DAPSLRSSPGPAP,_(ac)ADGGGPKDAPSLRS(ph)SPGPAPR_,S15,+,,24.53,,23.83,26.44,26.26,26.52,,26.32,,24.33,24.73,,25.37, ,-0.84, ,-1.54,1.07,0.89,1.14, ,0.95, ,-1.04,-0.64, ,,integral to membrane,,,,,,,,,,,,,,
7553,Q9H330,TMEM245,Transmembrane protein 245 (Protein CG-2),APSLRSSPGPAPR,_DAPSLRSS(ph)PGPAPR_,S16,,,22.44,22.44,24.58,24.00,,26.43,21.97,,25.36,,26.10,27.76,24.56, ,-2.13,-2.13,0.01,-0.56, ,1.86,-2.59, ,0.80, ,1.54,3.20,,integral to membrane,,,,,,,,,,,,,,
7556,Q9H330,TMEM245,Transmembrane protein 245 (Protein CG-2),PSPTSPSPTLGRR,_GESAPTLSTSPSPSSPSPTSPS(ph)PTLGR_,S332,+,24.53,26.03,24.77,25.94,26.21,26.79,25.69,26.74,27.13,25.17,26.49,24.94,27.21,25.97,-1.44,0.05,-1.20,-0.03,0.24,0.82,-0.29,0.77,1.16,-0.80,0.52,-1.03,1.23,,integral to membrane,,,,,,,,,,,,,,
7557,Q9H3N1,TMX1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),ADEEDVSEEEAES,_KVEEEQEADEEDVS(ph)EEEAESKEGTNK_,S247,+,30.22,30.87,30.61,30.73,29.75,31.48,31.55,31.07,31.91,31.76,30.24,30.86,31.21,30.94,-0.72,-0.07,-0.33,-0.22,-1.20,0.54,0.61,0.12,0.97,0.82,-0.70,-0.08,0.26,"negative regulation of apoptotic process;leukocyte activation;electron transport chain;cell redox homeostasis;response to stress;cell proliferation;signal transduction;positive regulation of transcription, DNA-dependent;ER to Golgi vesicle-mediated transport;DNA replication;positive regulation of growth",integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7558,Q9H3N1,TMX1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),PSKKLLSESAQPL,_LLS(ph)ESAQPLK_,S226,,23.63,21.12,21.12,19.57,,,,,,22.14,,,,21.52,2.11,-0.40,-0.40,-1.94, , , , , ,0.63, , , ,"negative regulation of apoptotic process;leukocyte activation;electron transport chain;cell redox homeostasis;response to stress;cell proliferation;signal transduction;positive regulation of transcription, DNA-dependent;ER to Golgi vesicle-mediated transport;DNA replication;positive regulation of growth",integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7559,Q9H3N1,TMX1,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),NAIRQRSLGPSLA,_S(ph)LGPSLATDKS_,S270,+,27.72,26.35,25.99,26.83,26.50,26.02,25.50,25.93,25.17,25.68,25.19,25.85,26.13,26.07,1.66,0.28,-0.08,0.77,0.43,-0.04,-0.56,-0.13,-0.90,-0.39,-0.88,-0.21,0.06,"negative regulation of apoptotic process;leukocyte activation;electron transport chain;cell redox homeostasis;response to stress;cell proliferation;signal transduction;positive regulation of transcription, DNA-dependent;ER to Golgi vesicle-mediated transport;DNA replication;positive regulation of growth",integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7560,Q9H3P2,NELFA,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),EEPSAPSPTLPAQ,_EASRPPEEPSAPS(ph)PTLPAQFK_,S363,+,24.91,23.49,,23.13,25.21,25.36,25.04,25.12,25.66,25.23,,,,24.80,0.12,-1.30, ,-1.66,0.42,0.57,0.25,0.32,0.86,0.44, , , ,multicellular organismal development;negative regulation of transcription elongation from RNA polymerase II promoter;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,NELF complex,,,,,,,,,,,,,,
7561,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),GEPDGESLDEQPS,_AGEPDGES(ph)LDEQPSSSSSK_,S64,+,25.30,23.56,23.43,24.13,24.88,25.44,24.25,25.25,24.59,,23.85,24.53,24.70,24.49,0.81,-0.93,-1.06,-0.36,0.39,0.95,-0.24,0.76,0.10, ,-0.64,0.04,0.21,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7562,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),WAAAAPSPGSARS,_AGPDLPSLPSHALEDEGWAAAAPS(ph)PGS(ph)AR_,S292,+,26.88,22.83,22.83,,27.89,25.74,26.65,26.79,26.66,22.93,26.84,28.33,23.47,25.65,1.23,-2.83,-2.83, ,2.23,0.09,0.99,1.14,1.01,-2.72,1.19,2.68,-2.18,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7563,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),AAPSPGSARSMGS,_AGPDLPSLPSHALEDEGWAAAAPS(ph)PGS(ph)AR_,S295,,25.59,,,,23.07,,,,,26.18,,,27.49,25.58,0.01, , , ,-2.51, , , , ,0.60, , ,1.91,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7564,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),QRDMLGSLRDSAL,_DM(ox)LGS(ph)LR_,S105,,25.83,,,20.88,,,,,,,,22.92,,23.21,2.62, , ,-2.33, , , , , , , ,-0.29, ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7565,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),FVKNAMSLPQLNE,_NAM(ox)S(ph)LPQLNEK_,S118,,24.17,,,21.26,,,,22.48,,20.68,,,,22.15,2.02, , ,-0.88, , , ,0.33, ,-1.47, , , ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7566,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),GAAGPHSPDPLLD,_NGAAGPHS(ph)PDPLLDEQAFGDLTDLPVVPK_,S174,,26.95,,,,24.32,,25.36,27.08,,26.76,,,,26.09,0.86, , , ,-1.78, ,-0.74,0.99, ,0.67, , , ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7567,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),KQLVSSSVHSKRR,_(gl)QLVSSS(ph)VHSK_,S11,,26.44,,,22.64,,,,,,,,25.02,,24.70,1.74, , ,-2.06, , , , , , , ,0.32, ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7569,Q9H3Q1,CDC42EP4,Cdc42 effector protein 4 (Binder of Rho GTPases 4),GILEERSPAFRGP,_S(ph)PAFRGPDR_,S322,,25.40,25.17,,24.53,23.01,21.65,22.68,21.98,,,,,,23.49,1.91,1.68, ,1.04,-0.48,-1.84,-0.80,-1.51, , , , , ,regulation of cell shape;positive regulation of pseudopodium assembly;Rho protein signal transduction,microtubule cytoskeleton;endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7573,Q9H3S7,PTPN23,Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14),ADLLSSSPESQHG,_GAAAADLLSSS(ph)PESQHGGTQSPGGGQPLLQPTK_,S1123,+,,,,22.42,,,25.37,23.90,23.60,24.24,,25.42,23.69,24.09, , , ,-1.67, , ,1.28,-0.19,-0.49,0.15, ,1.33,-0.41,cilium morphogenesis;peptidyl-tyrosine dephosphorylation,endosome;nucleus;cytoplasmic membrane-bounded vesicle;microtubule basal body;cilium,,,,,,,,,,,,,,
7575,Q9H3Z4,DNAJC5,DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP),QRQRSLSTSGESL,_SLS(ph)TSGESLYHVLGLDK_,S10,+,29.08,30.45,30.40,29.66,31.44,31.37,31.02,31.18,31.86,29.80,31.71,31.02,32.06,30.85,-1.77,-0.40,-0.45,-1.19,0.59,0.52,0.16,0.33,1.01,-1.05,0.86,0.16,1.21,protein folding;cell death;negative regulation of neuron apoptotic process;neurotransmitter secretion,synaptic vesicle;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;plasma membrane;melanosome,,,,,,,,,,,,,,
7576,Q9H3Z4,DNAJC5,DnaJ homolog subfamily C member 5 (Cysteine string protein) (CSP),LSTSGESLYHVLG,_SLSTSGES(ph)LYHVLGLDK_,S15,,22.10,21.65,,,,,20.26,,22.79,,,,,21.70,0.40,-0.05, , , , ,-1.44, ,1.09, , , , ,protein folding;cell death;negative regulation of neuron apoptotic process;neurotransmitter secretion,synaptic vesicle;clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane;plasma membrane;melanosome,,,,,,,,,,,,,,
7577,Q9H410,DSN1,Kinetochore-associated protein DSN1 homolog,SKSLHLSPQEQSA,_SLHLS(ph)PQEQSASYQDRR_,S81,,,,,,24.15,22.69,23.53,23.69,,,,,,23.51, , , , ,0.64,-0.82,0.01,0.17, , , , , ,mitotic prometaphase;chromosome segregation;cell division,cytosol;nucleus;MIS12/MIND type complex,,,,,,,,,,,,,,
7578,Q9H444,CHMP4B,Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2),LENWAGSM_____,_ELENWAGS(ph)M(ox)_,S223,+,23.27,22.04,22.04,22.12,,,22.26,,21.10,22.09,22.33,22.38,,22.18,1.09,-0.14,-0.14,-0.06, , ,0.08, ,-1.08,-0.10,0.15,0.19, ,cellular membrane organization;protein transport;endosomal transport,cytosol;late endosome membrane,,,,,,,,,,,,,,
7579,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),SKDRPVSQPSLVG,_DRPVS(ph)QPSLVGSK_,S167,,24.78,23.03,,,,,,,21.81,,23.36,22.91,,23.18,1.60,-0.15, , , , , , ,-1.37, ,0.19,-0.27, ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7583,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),VDDGSGSPHSPHQ,_DVDDGSGS(ph)PHS(ph)PHQLSSK_,S1754,,26.57,24.98,24.92,23.79,23.12,,,,21.30,,,,,24.11,2.45,0.86,0.81,-0.32,-0.99, , , ,-2.81, , , , ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7584,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),GSGSPHSPHQLSS,_DVDDGSGS(ph)PHS(ph)PHQLSSK_,S1757,+,26.67,25.81,25.74,23.79,25.12,,,25.06,23.87,,,,,25.15,1.52,0.66,0.59,-1.36,-0.03, , ,-0.09,-1.28, , , , ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7585,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),KEGPVASPPFMDL,_EGPVAS(ph)PPFM(ox)DLEQAVLPAVIPK_,S1703,,26.13,,,,,,,,,,,,,26.13,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7586,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),SHLNGPSSDPEAA,_EKPELSEPSHLNGPS(ph)SDPEAAFLSR_,S1736,,,,,,24.76,24.50,,,24.25,,,25.41,,24.73, , , , ,0.03,-0.22, , ,-0.48, , ,0.68, ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7589,Q9H4A3,WNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),NLQKSISNPPGSN,_SIS(ph)NPPGSNLR_,S2097,+,26.80,22.45,22.45,24.59,23.00,22.81,24.04,24.64,22.91,21.44,24.06,,,23.56,3.24,-1.11,-1.11,1.03,-0.57,-0.76,0.48,1.07,-0.65,-2.13,0.50, , ,intracellular protein kinase cascade;neuron development;negative regulation of protein kinase activity;ion transport;positive regulation of systemic arterial blood pressure;negative regulation of phosphatase activity;negative regulation of pancreatic juice secretion,cytoplasm,,+,,,,,,,,,,,,
7590,Q9H4A4,RNPEP,Aminopeptidase B (AP-B) (EC 3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase),MASGEHSPGSGAA,_(ac)ASGEHS(ph)PGSGAAR_,S7,+,22.90,24.21,24.59,24.08,24.07,20.71,,20.58,,,20.73,,20.80,22.52,0.38,1.69,2.08,1.56,1.55,-1.81, ,-1.93, , ,-1.79, ,-1.72,proteolysis;aging;retina development in camera-type eye;negative regulation of blood pressure;leukotriene biosynthetic process,secretory granule;extracellular space;extracellular region;Golgi apparatus;plasma membrane;external side of plasma membrane,,,,,,,,,,,,,,
7591,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),AGLREGSEEKVKP,_AGLREGS(ph)EEK_,S455,,23.76,,,21.68,,,18.84,19.71,20.12,,,,,20.82,2.94, , ,0.86, , ,-1.98,-1.11,-0.70, , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7592,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),RPRAPESDTGDED,_APES(ph)DT(ph)GDEDQDQERDTVFLK_,S469,,26.47,,,,22.69,,,22.74,25.27,,,,23.46,24.13,2.34, , , ,-1.43, , ,-1.39,1.15, , , ,-0.67,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7593,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),YRETDPSPEERDK,_AVVYRETDPS(ph)PEERDK_,S761,,20.41,24.34,24.34,,,21.91,,,24.45,25.26,23.09,22.27,,23.26,-2.85,1.08,1.08, , ,-1.35, , ,1.19,2.00,-0.17,-0.99, ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7594,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),RDEDGESGGQRSE,_DEDGES(ph)GGQRS(ph)EAEEGEVRT(ph)PTK_,S364,,25.12,,,,,,,,,,,,,25.12,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7595,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),ESGGQRSEAEEGE,_S(ph)EAEEGEVRT(ph)PTK_,S369,,26.12,,,,,,,,,,,,,26.12,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7596,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),SEADGLSERTTPS,_DYSEADGLS(ph)ER_,S13,,25.91,24.44,24.83,23.61,,21.90,,,,,,,,24.14,1.77,0.30,0.70,-0.53, ,-2.24, , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7597,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),RERRLPSSPASPS,_RLPS(ph)S(ph)PAS(ph)PSPK_,S431,,25.93,,,,,,,,,,,,,25.93,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7598,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),ERRLPSSPASPSP,_RLPS(ph)S(ph)PAS(ph)PSPK_,S432,,26.38,24.44,24.44,,,,,,,,,,24.50,24.94,1.43,-0.50,-0.50, , , , , , , , , ,-0.44,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7599,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),LPSSPASPSPKGT,_RLPSS(ph)PAS(ph)PSPK_,S435,,28.11,23.95,24.72,,,,,,23.32,,,,24.50,24.92,3.18,-0.97,-0.20, , , , , ,-1.60, , , ,-0.42,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7600,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),SSPASPSPKGTPE,_RLPSSPAS(ph)PS(ph)PK_,S437,,23.93,,,,,,,,,,,,,23.93,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7601,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),TFFRLVSPEPPPK,_LVS(ph)PEPPPK_,S281,+,26.95,24.61,25.45,21.31,,,,,22.57,23.00,21.70,,,23.66,3.29,0.96,1.79,-2.35, , , , ,-1.08,-0.66,-1.95, , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7602,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),AQTRQASALIDRP,_(gl)QAS(ph)ALIDRPAPFFER_,S310,,24.95,,,,,,,,,,,,,24.95,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7604,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),DRDKSDSDTEGLL,_SDS(ph)DTEGLLFSR_,S541,,27.04,,,,,22.02,,,22.19,,,,,23.75,3.29, , , , ,-1.73, , ,-1.56, , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7605,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),RYTMSRSLDGAEF,_S(ph)LDGAEFSRPAS(ph)VSENHDAGPDGDK_,S333,,24.30,24.13,24.13,,,,,,,,,,,24.18,0.12,-0.06,-0.06, , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7606,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),LDGAEFSRPASVS,_SLDGAEFS(ph)RPAS(ph)VSENHDAGPDGDK_,S340,,24.04,24.01,24.01,,,,,,,,,,,24.02,0.02,-0.01,-0.01, , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7607,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),EFSRPASVSENHD,_SLDGAEFS(ph)RPAS(ph)VSENHDAGPDGDK_,S344,,25.41,26.15,26.15,,,,,,23.55,22.95,,23.74,,24.66,0.75,1.49,1.49, , , , , ,-1.11,-1.71, ,-0.92, ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7608,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),FEDFSRSLPELDR,_S(ph)LPELDRDK_,S530,,23.66,22.88,,,,,20.46,,25.10,,,,,23.02,0.63,-0.14, , , , ,-2.57, ,2.08, , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7609,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),TEIRSLSPIIGKD,_SLS(ph)PIIGK_,S675,+,28.39,24.48,,24.56,21.39,24.10,23.69,23.22,26.05,23.79,24.29,25.35,24.59,24.49,3.90,-0.01, ,0.06,-3.10,-0.39,-0.80,-1.27,1.56,-0.70,-0.20,0.86,0.10,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
7610,Q9H4I2,ZHX3,Zinc fingers and homeoboxes protein 3 (Triple homeobox protein 1) (Zinc finger and homeodomain protein 3),KAEENASQEEEEA,_KAEENAS(ph)QEEEEAAEDEGGEEDLASELR_,S680,,,,,,,24.64,,24.11,25.09,,24.20,,,24.51, , , , , ,0.13, ,-0.40,0.58, ,-0.31, , ,"cell differentiation;positive regulation of osteoblast differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleolus;cytoplasm,C2H2-type,,,,,,,,,,,,,
7612,Q9H4I2,ZHX3,Zinc fingers and homeoboxes protein 3 (Triple homeobox protein 1) (Zinc finger and homeodomain protein 3),EPFDTSSPQAGRQ,_VPEASSEPFDTSS(ph)PQAGR_,S946,,,25.14,,,,26.13,22.32,,24.80,23.12,,,,24.30, ,0.84, , , ,1.83,-1.98, ,0.50,-1.19, , , ,"cell differentiation;positive regulation of osteoblast differentiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleolus;cytoplasm,C2H2-type,,,,,,,,,,,,,
7613,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),ALVHQLSNESRLS,_ALVHQLS(ph)NESR_,S437,+,24.64,,,,24.03,24.94,24.60,25.09,24.97,24.10,25.60,25.41,23.39,24.68,-0.04, , , ,-0.65,0.26,-0.08,0.42,0.29,-0.58,0.93,0.74,-1.29,lipid transport,,,,,,,,,,,,,,,
7614,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),ESLLLDSPAVAKS,_IHAESLLLDS(ph)PAVAK_,S410,+,,,,,24.82,22.21,24.90,24.48,23.61,23.95,23.40,23.40,23.73,23.83, , , , ,0.99,-1.62,1.06,0.65,-0.22,0.12,-0.43,-0.43,-0.11,lipid transport,,,,,,,,,,,,,,,
7618,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),EQDASSSPSAQVI,_(gl)QLM(ox)EQDASSS(ph)PSAQVIGLK_,S372,+,23.28,,,21.35,24.00,23.88,25.10,25.92,25.94,25.53,25.87,22.92,,24.38,-1.10, , ,-3.03,-0.38,-0.50,0.72,1.54,1.56,1.15,1.49,-1.46, ,lipid transport,,,,,,,,,,,,,,,
7619,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),VLHRTYSAPAINA,_TYS(ph)APAINAIQGGSFESPKK_,S251,,,,,,,22.27,23.05,,24.30,,23.48,21.69,22.42,22.87, , , , , ,-0.60,0.18, ,1.43, ,0.61,-1.18,-0.45,lipid transport,,,,,,,,,,,,,,,
7621,Q9H4L5,OSBPL3,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),VLHRTYSAPAINA,_TYS(ph)APAINAIQVPK_,S251,,23.63,21.96,,20.55,,,,,,,24.04,,,22.54,1.09,-0.58, ,-2.00, , , , , , ,1.49, , ,lipid transport,,,,,,,,,,,,,,,
7622,Q9H4L7,SMARCAD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),DTVIIVSEPSEDE,_DTVIIVS(ph)EPS(ph)EDEESQGLPTM(ox)AR_,S124,,23.43,,,,,,,,,,,,,23.43,0.00, , , , , , , , , , , , ,"ATP-dependent chromatin remodeling;DNA double-strand break processing;chromosome separation;nucleotide metabolic process;positive regulation of transcription, DNA-dependent;histone H3 deacetylation;protein homooligomerization;regulation of DNA recombination;histone H4 deacetylation",site of double-strand break;nuclear replication fork;heterochromatin;nuclear matrix,,,,,,,,,,,,,,
7623,Q9H4L7,SMARCAD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),IIVSEPSEDEESQ,_DTVIIVS(ph)EPS(ph)EDEESQGLPTM(ox)AR_,S127,,23.43,,,,,,,,,,,,,23.43,0.00, , , , , , , , , , , , ,"ATP-dependent chromatin remodeling;DNA double-strand break processing;chromosome separation;nucleotide metabolic process;positive regulation of transcription, DNA-dependent;histone H3 deacetylation;protein homooligomerization;regulation of DNA recombination;histone H4 deacetylation",site of double-strand break;nuclear replication fork;heterochromatin;nuclear matrix,,,,,,,,,,,,,,
7626,Q9H4L7,SMARCAD1,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),SELEDLSELEDLK,_RNDDISELEDLS(ph)ELEDLK_,S152,,20.83,,,,23.71,,,,,,,,,22.27,-1.44, , , ,1.44, , , , , , , , ,"ATP-dependent chromatin remodeling;DNA double-strand break processing;chromosome separation;nucleotide metabolic process;positive regulation of transcription, DNA-dependent;histone H3 deacetylation;protein homooligomerization;regulation of DNA recombination;histone H4 deacetylation",site of double-strand break;nuclear replication fork;heterochromatin;nuclear matrix,,,,,,,,,,,,,,
7627,Q9H4M7,PLEKHA4,Pleckstrin homology domain-containing family A member 4 (PH domain-containing family A member 4) (Phosphoinositol 3-phosphate-binding protein 1) (PEPP-1),GDKDLASPHLGLG,_DLAS(ph)PHLGLGS(ph)PR_,S527,,22.38,,,,,,,,,,20.95,,,21.66,0.72, , , , , , , , , ,-0.72, , ,,membrane;cytoplasm,,,,,,,,,,,,,,
7628,Q9H4M7,PLEKHA4,Pleckstrin homology domain-containing family A member 4 (PH domain-containing family A member 4) (Phosphoinositol 3-phosphate-binding protein 1) (PEPP-1),PHLGLGSPRVSRA,_DLAS(ph)PHLGLGS(ph)PR_,S534,,24.50,23.06,23.06,19.25,22.20,25.26,,,23.92,21.61,20.95,,22.43,22.62,1.87,0.44,0.44,-3.37,-0.42,2.63, , ,1.30,-1.02,-1.68, ,-0.19,,membrane;cytoplasm,,,,,,,,,,,,,,
7629,Q9H4M7,PLEKHA4,Pleckstrin homology domain-containing family A member 4 (PH domain-containing family A member 4) (Phosphoinositol 3-phosphate-binding protein 1) (PEPP-1),EGRISESPEVTRL,_ISES(ph)PEVTR_,S194,,25.17,23.38,23.11,25.08,,,,22.43,,,,,,23.83,1.34,-0.46,-0.72,1.25, , , ,-1.40, , , , , ,,membrane;cytoplasm,,,,,,,,,,,,,,
7630,Q9H4M9,EHD1,EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin),EIFYTLSPVNGKI,_DKPTYDEIFYTLS(ph)PVNGK_,S456,+,19.13,,,,24.89,,24.08,25.27,22.33,23.28,,25.14,,23.44,-4.32, , , ,1.44, ,0.63,1.82,-1.11,-0.16, ,1.69, ,endocytosis;endocytic recycling;GTP catabolic process;cholesterol homeostasis;intracellular protein transport;blood coagulation;positive regulation of cholesterol storage;protein homooligomerization;low-density lipoprotein particle clearance,endocytic vesicle;lipid particle;plasma membrane;platelet dense tubular network membrane;recycling endosome membrane;early endosome membrane,,,,,,,,,,,,,,
7631,Q9H4X1,RGCC,Regulator of cell cycle RGCC (Response gene to complement 32 protein) (RGC-32),SDEKLNSPTDSTP,_LNS(ph)PTDSTPALLSATVTPQK_,S77,,23.32,,,,,,,,24.37,,,,,23.85,-0.52, , , , , , , ,0.52, , , , ,positive regulation of extracellular matrix constituent secretion;negative regulation of angiogenesis;positive regulation of mitosis;positive regulation of epithelial to mesenchymal transition;regulation of M/G1 transition of mitotic cell cycle;fibroblast activation;negative regulation of cytokine secretion;negative regulation of exit from mitosis;positive regulation of S phase of mitotic cell cycle;negative regulation of endothelial cell proliferation;mitotic cell cycle arrest;negative regulation of cell-cell adhesion mediated by cadherin;positive regulation of cell cycle arrest;positive regulation of collagen biosynthetic process;complement activation;positive regulation of DNA biosynthetic process;negative regulation of blood vessel endothelial cell migration;positive regulation of stress fiber assembly;positive regulation of cytokine secretion;positive regulation of sequence-specific DNA binding transcription factor activity;cellular response to hypoxia;positive regulation of cyclin-dependent protein kinase activity involved in G1/S;positive regulation of gene expression involved in extracellular matrix organization;positive regulation of endothelial cell apoptotic process;negative regulation of fibroblast growth factor production,nucleolus;centrosome,,,,,,,,,,,,,,
7635,Q9H4Z3,PCIF1,Phosphorylated CTD-interacting factor 1,LKMWGTSPEDKQQ,_M(ox)WGTS(ph)PEDK_,S159,,23.84,23.91,23.35,23.84,,,,,22.55,,,,,23.50,0.34,0.41,-0.15,0.34, , , , ,-0.95, , , , ,negative regulation of phosphatase activity,nucleus;half bridge of spindle pole body;actin cytoskeleton,,,,,,,,,,,,,,
7636,Q9H4Z3,PCIF1,Phosphorylated CTD-interacting factor 1,PRKRQLSEEQPSG,_(gl)QLS(ph)EEQPSGNGVK_,S116,,22.84,,,,,,,,,,,,,22.84,0.00, , , , , , , , , , , , ,negative regulation of phosphatase activity,nucleus;half bridge of spindle pole body;actin cytoskeleton,,,,,,,,,,,,,,
7637,Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),ALAEEASEEELPS,_ALAEEAS(ph)EEELPS(ph)DVDLNDPYFAEEVK_,S657,,25.71,,,,,,,,,,,,,25.71,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
7638,Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),SEEELPSDVDLND,_ALAEEAS(ph)EEELPS(ph)DVDLNDPYFAEEVK_,S663,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
7639,Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),SAKDGTSPEEEIE,_DGTS(ph)PEEEIEIERQK_,S694,+,24.96,22.07,21.76,23.12,24.49,,22.40,,23.86,24.98,,22.73,,23.37,1.59,-1.31,-1.62,-0.25,1.12, ,-0.97, ,0.48,1.60, ,-0.64, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
7640,Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),KIDSNISPKKDSK,_IDSNIS(ph)PKK_,S153,+,23.21,24.92,25.60,23.63,24.47,20.98,22.59,20.78,21.82,22.85,20.29,21.26,20.74,22.55,0.66,2.37,3.05,1.08,1.92,-1.57,0.04,-1.77,-0.73,0.30,-2.26,-1.29,-1.81,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
7642,Q9H501,ESF1,ESF1 homolog (ABT1-associated protein),DSDSNLSGEDSKA,_RFYDLSDSDSNLS(ph)GEDSK_,S82,,,,,,23.30,23.44,,,22.37,24.78,,,,23.47, , , , ,-0.18,-0.03, , ,-1.10,1.31, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
7645,Q9H5H4,ZNF768,Zinc finger protein 768,TELKTQSPEFEAQ,_TQS(ph)PEFEAQSSK_,S129,,23.42,23.87,24.06,23.83,,,,,22.03,,,,,23.44,-0.02,0.43,0.62,0.39, , , , ,-1.41, , , , ,"regulation of transcription, DNA-dependent;transcription from RNA polymerase II promoter","DNA-directed RNA polymerase II, core complex",C2H2-type,,,,,,,,,,,,,
7649,Q9H5V8,CDCP1,CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318),EEPPPRSPPESES,_LATEEPPPRS(ph)PPESESEPYTFSHPNNGDVSSK_,S797,,,,,,,,23.60,,24.33,25.57,24.19,23.55,,24.25, , , , , , ,-0.65, ,0.08,1.32,-0.06,-0.70, ,,integral to membrane;extracellular region;plasma membrane,,,,,,,,,,,,,,
7650,Q9H694,BICC1,Protein bicaudal C homolog 1 (Bic-C),EVGMPRSPSHSGN,_S(ph)PSHSGNAGDLK_,S633,,,22.96,,22.62,,,,,,,,,,22.79, ,0.17, ,-0.17, , , , , , , , , ,multicellular organismal development;negative regulation of canonical Wnt receptor signaling pathway,,,,,,,,,,,,,,,
7651,Q9H694,BICC1,Protein bicaudal C homolog 1 (Bic-C),SGSEQTSPKSSPT,_VLSANHGDPSIQTSGSEQTS(ph)PK_,S612,,,,,,,,,,23.58,25.30,,,22.69,23.86, , , , , , , , ,-0.28,1.44, , ,-1.16,multicellular organismal development;negative regulation of canonical Wnt receptor signaling pathway,,,,,,,,,,,,,,,
7652,Q9H6A9,PCNXL3,Pecanex-like protein 3,LLKGSLSQELSKS,_GSLS(ph)QELSK_,S246,,,,,22.50,21.67,,,22.19,23.12,23.78,,,,22.65, , , ,-0.15,-0.98, , ,-0.46,0.47,1.13, , , ,,integral to membrane,,,,,,,,,,,,,,
7653,Q9H6A9,PCNXL3,Pecanex-like protein 3,PELEERSLETARA,_LFPELEERS(ph)LETAR_,S1025,,,,,,22.93,23.70,23.65,22.22,25.08,24.35,23.35,,24.75,23.75, , , , ,-0.82,-0.06,-0.10,-1.54,1.32,0.60,-0.40, ,1.00,,integral to membrane,,,,,,,,,,,,,,
7654,Q9H6E5,TUT1,Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52),_MAAVDSDVESLP,_(ac)AAVDS(ph)DVESLPR_,S6,,23.32,,,,23.10,,,,,22.67,,,,23.03,0.29, , , ,0.07, , , , ,-0.36, , , ,mRNA cleavage;mRNA polyadenylation;snRNA processing,nucleolus;nuclear speck,C2H2-type,,,,,,,,,,,,,
7655,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),QRAGLGSPERPPK,_AGLGS(ph)PERPPK_,S58,+,23.95,26.07,26.21,26.82,24.32,24.30,25.46,23.73,24.68,25.55,25.04,25.76,23.72,25.05,-1.10,1.03,1.16,1.77,-0.72,-0.75,0.41,-1.32,-0.37,0.51,-0.01,0.72,-1.33,virus-host interaction,nucleolus,,,,,,,,,,,,,,
7656,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),PKTSPGSPRLQQG,_AGLGSPERPPKTSPGS(ph)PR_,S69,,,,,,24.23,24.63,,24.86,,,,,,24.57, , , , ,-0.34,0.06, ,0.28, , , , , ,virus-host interaction,nucleolus,,,,,,,,,,,,,,
7661,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),PEPGAASPQRQQD,_LQQGAGLES(ph)PQGQPEPGAAS(ph)PQR_,S91,+,26.71,26.33,,27.10,26.45,26.57,24.31,23.63,,,25.22,23.35,24.64,25.43,1.28,0.90, ,1.67,1.01,1.14,-1.12,-1.80, , ,-0.21,-2.08,-0.79,virus-host interaction,nucleolus,,,,,,,,,,,,,,
7662,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),PEYSPESPRCQPK,_(gl)QPEYSPES(ph)PR_,S113,,25.68,25.53,,25.80,23.38,23.58,,,,,21.79,,,24.29,1.39,1.24, ,1.50,-0.92,-0.72, , , , ,-2.50, , ,virus-host interaction,nucleolus,,,,,,,,,,,,,,
7663,Q9H6F5,CCDC86,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),QDLHLESPQRQPE,_(gl)QQDLHLES(ph)PQRQPEYSPES(ph)PR_,S102,,21.98,,,23.01,,,,,,,,,,22.50,-0.52, , ,0.52, , , , , , , , , ,virus-host interaction,nucleolus,,,,,,,,,,,,,,
7664,Q9H6H4,REEP4,Receptor expression-enhancing protein 4,GRLRSFSMQDLRS,_SFS(ph)M(ox)QDLR_,S152,+,27.37,26.79,27.04,27.98,25.93,24.96,27.17,27.64,25.96,26.59,26.31,28.14,24.28,26.63,0.74,0.17,0.41,1.35,-0.70,-1.67,0.54,1.01,-0.67,-0.04,-0.32,1.51,-2.35,,integral to membrane,,,,,,,,,,,,,,
7665,Q9H6H4,REEP4,Receptor expression-enhancing protein 4,PLIRSQSLRVVKR,_SQS(ph)LRVVK_,S224,,22.80,24.20,24.20,23.43,,,22.08,22.17,,,,23.13,,23.14,-0.35,1.06,1.06,0.29, , ,-1.06,-0.97, , , ,-0.02, ,,integral to membrane,,,,,,,,,,,,,,
7669,Q9H6S3,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),QHRGGDSPEAKNR,_QSILPPPQGPAPIPFQHRGGDS(ph)PEAK_,S217,,,,,,,,23.63,24.13,22.31,24.98,,,,23.76, , , , , , ,-0.13,0.37,-1.46,1.22, , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7670,Q9H6S3,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),GFRRRESQEEPRA,_RES(ph)QEEPRAVLAQK_,S240,,,24.62,24.62,,,,23.63,22.08,,25.21,,22.56,21.21,23.42, ,1.20,1.20, , , ,0.21,-1.34, ,1.79, ,-0.85,-2.21,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7672,Q9H6T3,RPAP3,RNA polymerase II-associated protein 3,STHESLSQESESE,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,S116,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7673,Q9H6T3,RPAP3,RNA polymerase II-associated protein 3,ESLSQESESEEDG,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,S119,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7674,Q9H6T3,RPAP3,RNA polymerase II-associated protein 3,LSQESESEEDGIH,_DDSTHESLS(ph)QES(ph)ES(ph)EEDGIHVDSQK_,S121,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7675,Q9H6X2,ANTXR1,Anthrax toxin receptor 1 (Tumor endothelial marker 8),RPPPRPSV_____,_APPPSRPPPRPS(ph)V_,S563,,,23.90,,23.92,24.59,25.90,24.97,25.20,24.71,,25.18,25.46,25.06,24.89, ,-0.98, ,-0.97,-0.30,1.01,0.08,0.31,-0.18, ,0.29,0.57,0.17,reproductive process;actin cytoskeleton reorganization;substrate adhesion-dependent cell spreading,lamellipodium membrane;integral to membrane;filopodium membrane,,,,,,,,,,,,,,
7676,Q9H6X2,ANTXR1,Anthrax toxin receptor 1 (Tumor endothelial marker 8),PPPAEESEEEDDD,_EVPPPPAEES(ph)EEEDDDGLPKK_,S362,+,,24.43,24.42,24.75,22.98,26.32,26.26,,26.02,22.79,26.06,26.76,26.25,25.19, ,-0.76,-0.76,-0.43,-2.20,1.13,1.07, ,0.84,-2.39,0.87,1.58,1.06,reproductive process;actin cytoskeleton reorganization;substrate adhesion-dependent cell spreading,lamellipodium membrane;integral to membrane;filopodium membrane,,,,,,,,,,,,,,
7678,Q9H6Z4,RANBP3,Ran-binding protein 3 (RanBP3),MSERVLSPPKLNE,_VLS(ph)PPK_,S260,+,25.37,25.58,25.04,24.30,25.63,25.74,23.17,25.70,22.73,24.32,24.56,,25.58,24.81,0.56,0.77,0.24,-0.51,0.82,0.93,-1.64,0.89,-2.08,-0.49,-0.25, ,0.77,protein transport;intracellular transport,nucleus;cytoplasm,,,,,,,,,,,,,,
7679,Q9H6Z4,RANBP3,Ran-binding protein 3 (RanBP3),SNEEDDSDDDDVL,_M(ox)PAPEPGAAPSNEEDDS(ph)DDDDVLAPSGATAAGAGDEGDGQTTGST_,S466,,24.78,,,,,,,,,,,,,24.78,0.00, , , , , , , , , , , , ,protein transport;intracellular transport,nucleus;cytoplasm,,,,,,,,,,,,,,
7680,Q9H6Z4,RANBP3,Ran-binding protein 3 (RanBP3),KRERTSSLTQFPP,_TSS(ph)LTQFPPSQSEER_,S58,+,25.56,23.79,23.65,24.56,25.94,23.34,24.74,25.30,25.82,23.88,24.19,25.63,23.50,24.61,0.95,-0.81,-0.95,-0.05,1.33,-1.27,0.13,0.69,1.21,-0.73,-0.42,1.03,-1.10,protein transport;intracellular transport,nucleus;cytoplasm,,,,,,,,,,,,,,
7681,Q9H706,GAREM,GRB2-associated and regulator of MAPK protein (GRB2-associated and regulator of MAPK1),EDPKSGSPDLSED,_SGS(ph)PDLSEDQYFVK_,S636,,,22.47,22.47,23.09,,,,,,23.80,,24.16,,23.20, ,-0.73,-0.73,-0.11, , , , , ,0.60, ,0.96, ,cellular response to epidermal growth factor stimulus;epidermal growth factor receptor signaling pathway;positive regulation of ERK1 and ERK2 cascade;positive regulation of cell proliferation,plasma membrane,,,,,,,,,,,,,,
7682,Q9H788,SH2D4A,SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38),SEEFTNSLKTKSQ,_THSEEFTNS(ph)LK_,S124,,22.27,23.22,23.22,23.23,23.02,23.70,21.53,23.13,,,24.19,,21.42,22.89,-0.62,0.33,0.33,0.34,0.13,0.81,-1.36,0.24, , ,1.30, ,-1.47,negative regulation of phosphatase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
7683,Q9H788,SH2D4A,SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38),GVVRTLSSSAQED,_TLS(ph)SSAQEDIIR_,S315,+,27.75,26.15,25.00,28.05,25.86,25.46,27.05,27.15,24.62,24.77,28.75,29.07,25.60,26.56,1.19,-0.41,-1.56,1.49,-0.70,-1.10,0.49,0.59,-1.94,-1.79,2.20,2.51,-0.96,negative regulation of phosphatase activity,nucleus;cytoplasm,,,,,,,,,,,,,,
7685,Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),FRANTLSPVRFFV,_ANTLS(ph)PVR_,S281,+,20.65,25.67,22.48,27.42,25.26,27.32,26.35,25.85,27.52,25.32,26.73,26.91,28.38,25.84,-5.19,-0.16,-3.36,1.59,-0.58,1.49,0.52,0.01,1.69,-0.52,0.89,1.07,2.55,protein autophosphorylation;substrate adhesion-dependent cell spreading;cell migration,focal adhesion;actin cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
7686,Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),IKPVTPSPSKLVT,_DPSIKPVTPS(ph)PSK_,S854,+,,21.15,21.15,23.25,,,23.18,,24.26,22.02,,22.49,24.15,22.71, ,-1.56,-1.56,0.54, , ,0.47, ,1.55,-0.68, ,-0.21,1.44,protein autophosphorylation;substrate adhesion-dependent cell spreading;cell migration,focal adhesion;actin cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
7687,Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),DIESYDSLERPLR,_GLDIESYDS(ph)LERPLRK_,S1217,+,,,,,22.46,23.44,,,24.45,22.57,23.00,22.48,24.64,23.29, , , , ,-0.84,0.15, , ,1.16,-0.72,-0.29,-0.81,1.35,protein autophosphorylation;substrate adhesion-dependent cell spreading;cell migration,focal adhesion;actin cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
7688,Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),PSKLVTSPQSEPP,_LVTS(ph)PQSEPPAPFPPPR_,S861,,,22.81,,25.35,23.28,23.75,,23.58,25.04,24.77,24.51,24.49,,24.17, ,-1.36, ,1.17,-0.89,-0.42, ,-0.60,0.86,0.60,0.34,0.31, ,protein autophosphorylation;substrate adhesion-dependent cell spreading;cell migration,focal adhesion;actin cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
7691,Q9H792,PEAK1,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),HKSAPTSPTATNI,_SAPTS(ph)PTATNISSK_,S572,+,,24.75,25.01,25.38,23.98,26.19,20.83,26.63,25.75,24.26,,,24.57,24.74, ,0.01,0.28,0.65,-0.76,1.45,-3.90,1.90,1.01,-0.47, , ,-0.17,protein autophosphorylation;substrate adhesion-dependent cell spreading;cell migration,focal adhesion;actin cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
7692,Q9H7D0,DOCK5,Dedicator of cytokinesis protein 5,PQSTPLSPPPLTP,_LSPFHGSSPPQSTPLS(ph)PPPLTPK_,S1789,+,,,,22.34,23.00,,24.10,23.98,22.21,,25.54,24.39,24.52,23.76, , , ,-1.42,-0.76, ,0.34,0.22,-1.55, ,1.78,0.63,0.76,small GTPase mediated signal transduction,cytoplasm,,,,,,,,,,,,,,
7693,Q9H7D0,DOCK5,Dedicator of cytokinesis protein 5,KAQRPKSLQLMDN,_S(ph)LQLM(ox)DNR_,S1766,+,23.29,25.10,20.83,27.11,22.06,22.23,24.45,25.06,23.97,,24.50,24.18,22.18,23.75,-0.46,1.36,-2.92,3.36,-1.69,-1.52,0.70,1.31,0.22, ,0.75,0.43,-1.57,small GTPase mediated signal transduction,cytoplasm,,,,,,,,,,,,,,
7696,Q9H7D7,WDR26,WD repeat-containing protein 26 (CUL4- and DDB1-associated WDR protein 2) (Myocardial ischemic preconditioning up-regulated protein 2),KKKKRLSQSDEDV,_KRLS(ph)QSDEDVIR_,S121,+,25.37,26.38,24.55,27.08,27.33,27.83,27.57,27.81,27.09,25.60,28.18,27.85,27.32,26.92,-1.55,-0.54,-2.37,0.16,0.41,0.91,0.65,0.89,0.17,-1.32,1.26,0.93,0.40,,nucleus;cytoplasm,,,,,,,,,,,,,,
7698,Q9H7F0,ATP13A3,Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1),LETYPVSSPKSMS,_VLSLETYPVS(ph)SPK_,S97,+,22.16,,,,22.69,22.05,22.30,22.22,22.05,,23.81,,,22.47,-0.31, , , ,0.22,-0.42,-0.17,-0.25,-0.42, ,1.34, , ,cation transport;ATP catabolic process,integral to membrane,,,,,,,,,,,,,,
7700,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),SCRGRESDEDTED,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,S45,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
7701,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),EDTEDASETDLAK,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,S53,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
7702,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),SPKRPASPSSPEH,_RPAS(ph)PSS(ph)PEHLPATPAESPAQR_,S234,,25.92,24.55,22.89,24.83,25.22,,,,23.93,,,,,24.56,1.36,-0.01,-1.67,0.28,0.66, , , ,-0.62, , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
7704,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),RPASPSSPEHLPA,_RPAS(ph)PSS(ph)PEHLPATPAESPAQR_,S237,,25.92,24.55,22.89,24.83,25.22,,,,23.93,,,,,24.56,1.36,-0.01,-1.67,0.28,0.66, , , ,-0.62, , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
7705,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),EDEELESAEDDER,_(ac)SAAGLLAPAPAQAGAPPAPEYYPEEDEELES(ph)AEDDER_,S32,,26.99,,,,,,,,,,,,,26.99,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
7706,Q9H7M9,C10orf54,Platelet receptor Gi24,ELVRMDSNIQGIE,_M(ox)DS(ph)NIQGIENPGFEASPPAQGIPEAK_,S41,,24.00,22.53,22.53,,,,,,23.88,,,,24.69,23.52,0.48,-1.00,-1.00, , , , , ,0.35, , , ,1.16,,integral to membrane,,,,,,,,,,,,,,
7707,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",APPAPASPWDSKK,_EAASSSSGTQPAPPAPAS(ph)PWDSK_,S548,+,23.39,24.56,24.56,23.01,24.51,25.26,22.99,23.00,25.06,23.98,,23.03,,23.94,-0.55,0.62,0.62,-0.94,0.57,1.32,-0.95,-0.94,1.12,0.04, ,-0.91, ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7708,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",REVLYDSEGLSGE,_REVLYDS(ph)EGLS(ph)GEER_,S734,,25.44,23.85,23.85,,,,,,,21.85,,,,23.75,1.69,0.10,0.10, , , , , , ,-1.90, , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7709,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",YDSEGLSGEERGG,_REVLYDS(ph)EGLS(ph)GEER_,S738,,25.44,23.85,23.85,,,,,,,21.85,,,,23.75,1.69,0.10,0.10, , , , , , ,-1.90, , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7710,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",PTDEAYSPPPAPE,_FDIYDPFHPTDEAYS(ph)PPPAPEQK_,S239,+,25.91,,,24.73,28.43,26.52,26.63,26.58,27.88,27.42,,26.67,,26.75,-0.84, , ,-2.02,1.68,-0.23,-0.12,-0.18,1.13,0.66, ,-0.08, ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7711,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",AEETSWSGEERAA,_GAEETSWS(ph)GEER_,S965,+,25.58,26.13,26.24,26.74,25.96,26.45,25.18,25.35,26.35,25.69,24.49,24.44,24.59,25.63,-0.05,0.50,0.61,1.11,0.33,0.82,-0.45,-0.28,0.72,0.06,-1.14,-1.19,-1.04,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7712,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",ERYRQRSPSPAPA,_S(ph)PS(ph)PAPAPAPAAAAGPPTR_,S498,+,28.20,25.43,25.17,26.23,26.84,,23.02,24.68,26.15,24.46,22.75,,,25.29,2.91,0.14,-0.12,0.93,1.55, ,-2.27,-0.62,0.86,-0.84,-2.54, , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7713,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",YRQRSPSPAPAPA,_S(ph)PS(ph)PAPAPAPAAAAGPPTR_,S500,+,28.20,25.36,25.17,26.17,26.74,,,23.82,26.01,24.03,,,,25.69,2.51,-0.33,-0.52,0.48,1.05, , ,-1.87,0.32,-1.66, , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7714,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",SDPRGPSPAPASS,_SDPRGPS(ph)PAPASS(ph)PK_,S719,,23.25,24.85,25.53,,,,,,,,,,,24.54,-1.29,0.31,0.98, , , , , , , , , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7716,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",RDRESRSPFLKPD,_S(ph)PFLKPDER_,S874,,23.85,27.03,,,,,,,,,,,,25.44,-1.59,1.59, , , , , , , , , , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
7718,Q9H845,ACAD9,"Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-)",GRRLRDSLGRTVD,_LRDS(ph)LGR_,S474,,25.44,25.60,25.97,24.42,21.60,,,,,,,,,24.61,0.83,1.00,1.36,-0.18,-3.01, , , , , , , , ,,mitochondrion;nucleus;dendrite,,,,,,,,,,,,,,
7719,Q9H8G2,CAAP1,Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP),GDNGMDSDMEEEA,_ILEGDNGM(ox)DS(ph)DM(ox)EEEADDGSK_,S203,+,24.00,23.56,23.66,23.46,24.75,25.11,24.83,23.52,25.35,25.72,,23.24,23.25,24.20,-0.20,-0.65,-0.54,-0.75,0.55,0.91,0.63,-0.69,1.14,1.51, ,-0.97,-0.95,apoptotic process,,,,,,,,,,,,,,,
7720,Q9H8G2,CAAP1,Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP),ERRKRRSTDSSSV,_RRS(ph)TDSSSVSGSLQQETK_,S89,,,,,,21.70,,22.55,,24.75,23.46,22.47,,22.01,22.82, , , , ,-1.12, ,-0.27, ,1.93,0.63,-0.35, ,-0.81,apoptotic process,,,,,,,,,,,,,,,
7722,Q9H8G2,CAAP1,Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP),LGLAESSPNEPKA,_SVNEILGLAESS(ph)PNEPK_,S312,+,24.84,22.03,22.03,23.25,26.62,24.91,24.55,23.21,26.30,26.96,25.00,25.42,25.61,24.67,0.17,-2.65,-2.65,-1.42,1.95,0.24,-0.12,-1.46,1.63,2.29,0.33,0.75,0.94,apoptotic process,,,,,,,,,,,,,,,
7723,Q9H8M2,BRD9,Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8),DQHHLGSPSRLSV,_DQHHLGS(ph)PSR_,S175,,21.44,22.02,18.71,21.62,,,,,,,,,,20.95,0.49,1.07,-2.24,0.67, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",,,,,,,,,,,,,,,
7724,Q9H8M2,BRD9,Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8),PYEFLQSPEPAAS,_LSVGEQPDVTHDPYEFLQS(ph)PEPAASAKT_,S197,,22.81,,,,25.16,,22.90,23.54,24.10,,,,,23.70,-0.90, , , ,1.46, ,-0.80,-0.16,0.40, , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification",,,,,,,,,,,,,,,
7725,Q9H8M9,EVA1A,Protein eva-1 homolog A (Protein FAM176A) (Transmembrane protein 166),NKNVFTSAEELER,_NVFTS(ph)AEELER_,S102,+,22.83,23.18,,25.12,24.27,25.57,23.88,24.77,26.38,24.36,24.00,25.74,26.02,24.68,-1.85,-1.50, ,0.44,-0.41,0.89,-0.80,0.10,1.70,-0.31,-0.67,1.06,1.34,autophagy;apoptotic process,intracellular membrane-bounded organelle;integral to membrane;plasma membrane;lysosomal membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7726,Q9H8N7,ZNF395,Zinc finger protein 395 (HD-regulating factor 2) (HDRF-2) (Huntington disease gene regulatory region-binding protein 2) (HD gene regulatory region-binding protein 2) (HDBP-2) (Papillomavirus regulatory factor 1) (PRF-1) (Papillomavirus-binding factor),VRSRSLSFSEPQQ,_SLS(ph)FSEPQQPAPAM(ox)K_,S449,+,24.75,23.34,23.12,24.84,22.67,22.18,,23.31,,21.88,22.48,25.59,,23.42,1.33,-0.07,-0.30,1.42,-0.74,-1.24, ,-0.11, ,-1.53,-0.94,2.17, ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
7728,Q9H8W4,PLEKHF2,Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2) (PH and FYVE domain-containing protein 2) (Phafin-2) (Zinc finger FYVE domain-containing protein 18),QPARSDSYSQSLK,_SDS(ph)YSQSLK_,S226,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,,transport vesicle,,,,,,,,,,,,,,
7729,Q9H8Y5,ANKZF1,Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744),QLGAPTSPIPDSA,_LAAQLGAPTS(ph)PIPDSAIVNTRR_,S465,,24.29,21.16,21.16,,,,,,,,,,,22.21,2.08,-1.04,-1.04, , , , , , , , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
7730,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),KADAASSLTVDVT,_ADAASS(ph)LTVDVTPPTAK_,S362,,23.02,22.85,22.93,,,,,,,,,,23.25,23.01,0.01,-0.16,-0.08, , , , , , , , , ,0.24,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,,,,,,,,,,
7734,Q9H910,HN1L,Hematological and neurological expressed 1-like protein (HN1-like protein),TSDIFGSPVTATS,_TSDIFGS(ph)PVTATSR_,S97,+,23.27,22.68,23.03,22.97,24.19,23.75,23.87,23.70,,23.52,,23.28,,23.43,-0.16,-0.75,-0.40,-0.45,0.77,0.32,0.44,0.27, ,0.09, ,-0.14, ,,plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7735,Q9H930,SP140L,Nuclear body protein SP140-like protein,QGEVPESPEARKE,_(gl)QGEVPES(ph)PEARK_,S180,+,23.92,26.74,27.63,25.32,21.26,,23.91,22.45,24.49,,21.92,21.49,22.96,23.83,0.09,2.92,3.80,1.49,-2.57, ,0.09,-1.37,0.66, ,-1.91,-2.34,-0.87,,nucleus,,,,,,,,,,,,,,
7736,Q9H9C1,VIPAS39,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),SRTRPGSFQSLSD,_TRPGS(ph)FQSLSDALSDTPAK_,S72,,24.95,20.03,20.03,22.27,,,,,21.79,,,26.30,,22.56,2.39,-2.53,-2.53,-0.29, , , , ,-0.77, , ,3.74, ,"intracellular protein transport;cell differentiation;spermatogenesis;endosome to lysosome transport;transcription, DNA-dependent;regulation of transcription, DNA-dependent",late endosome;cytoplasmic membrane-bounded vesicle;recycling endosome;early endosome,,,,,,,,,,,,,,
7738,Q9HAC8,UBTD1,Ubiquitin domain-containing protein 1,GKDVRLSASLPDT,_DVRLS(ph)ASLPDTVGQLK_,S164,,,,,,,,,,23.27,21.96,22.90,,,22.71, , , , , , , , ,0.56,-0.75,0.19, , ,,,,,,,,,,,,,,,,
7739,Q9HAR2,LPHN3,Latrophilin-3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Lectomedin-3),PAHLVTSL_____,_GPAHLVTS(ph)L_,S1446,,,,,20.11,,,,21.57,23.15,22.40,,,22.37,21.92, , , ,-1.81, , , ,-0.35,1.23,0.48, , ,0.45,neuropeptide signaling pathway,integral to membrane;plasma membrane,,,,,,,,,,,,,,
7740,Q9HAS0,C17orf75,Protein Njmu-R1,DEKELESSEEGGS,_ELES(ph)SEEGGSAEER_,S18,,25.99,25.97,25.63,26.83,23.56,23.47,26.04,24.69,26.12,24.91,24.85,24.60,23.25,25.07,0.92,0.90,0.56,1.76,-1.51,-1.60,0.97,-0.38,1.05,-0.16,-0.22,-0.47,-1.82,spermatogenesis,,,,,,,,,,,,,,,
7742,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),IGASDQSPLQSPS,_GLNVIGASDQS(ph)PLQS(ph)PSNLR_,S933,,26.14,,,,,,,,,,,,,26.14,0.00, , , , , , , , , , , , ,,cytoplasm,,,,,,,,,,,,,,
7743,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),DQSPLQSPSNLRD,_GLNVIGASDQS(ph)PLQS(ph)PSNLR_,S937,,25.70,,,,,,,,,,,,,25.70,0.00, , , , , , , , , , , , ,,cytoplasm,,,,,,,,,,,,,,
7744,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),DYRLYKSEPELTT,_LYKS(ph)EPELTTVAEVDESNGEEK_,S809,,20.97,,,,,,,24.04,23.65,,,,24.16,23.21,-2.23, , , , , , ,0.83,0.45, , , ,0.96,,cytoplasm,,,,,,,,,,,,,,
7747,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),LTLQSVSPQSLQG,_SVPAGLTLQSVS(ph)PQSLQGK_,S607,,21.87,,,,24.28,,,,,,,,,23.08,-1.20, , , ,1.20, , , , , , , , ,,cytoplasm,,,,,,,,,,,,,,
7748,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),VIQRTNSMQQLEQ,_TNS(ph)M(ox)QQLEQWIK_,S410,,22.69,,,,21.25,,,,,,,24.95,,22.97,-0.27, , , ,-1.71, , , , , , ,1.98, ,,cytoplasm,,,,,,,,,,,,,,
7750,Q9HAW4,CLSPN,Claspin (hClaspin),GGFRSPSPGLFRA,_SPS(ph)PGLFR_,S746,,21.80,,,,,,,,,,,,,21.80,0.00, , , , , , , , , , , , ,DNA repair;G2/M transition DNA damage checkpoint;peptidyl-serine phosphorylation;cellular component disassembly involved in execution phase of apoptosis;activation of protein kinase activity;DNA replication;mitotic cell cycle DNA replication checkpoint,nucleoplasm,,,,,,,,,,,,,,
7751,Q9HB09,BCL2L12,Bcl-2-like protein 12 (Bcl2-L-12) (Bcl-2-related proline-rich protein),PGPPPPSPEPLAR,_ACPGPPPPS(ph)PEPLAR_,S272,+,21.55,,,22.85,23.96,23.42,23.49,22.32,23.52,,22.44,,,22.94,-1.39, , ,-0.10,1.02,0.47,0.55,-0.62,0.57, ,-0.51, , ,apoptotic process,,,,,,,,,,,,,,,
7753,Q9HB19,PLEKHA2,Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (Tandem PH domain-containing protein 2) (TAPP-2),ALCKAPSVASSWQ,_APS(ph)VASSWQPWTPVPQAGEK_,S299,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,positive regulation of cell-matrix adhesion,plasma membrane;nucleus;protein complex;membrane;cytoplasm,,,,,,,,,,,,,,
7754,Q9HB19,PLEKHA2,Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (Tandem PH domain-containing protein 2) (TAPP-2),SFSRSISLTRPGS,_SIS(ph)LTRPGSSSLSSGPNSILCR_,S264,,21.32,21.11,21.11,,,,,,,,,23.52,,21.77,-0.45,-0.65,-0.65, , , , , , , , ,1.75, ,positive regulation of cell-matrix adhesion,plasma membrane;nucleus;protein complex;membrane;cytoplasm,,,,,,,,,,,,,,
7755,Q9HB19,PLEKHA2,Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (Tandem PH domain-containing protein 2) (TAPP-2),ILRRSQSYIPTSG,_SQS(ph)YIPTSGCR_,S134,,24.39,,,24.02,,,23.05,23.55,,,,23.70,,23.74,0.65, , ,0.28, , ,-0.69,-0.19, , , ,-0.05, ,positive regulation of cell-matrix adhesion,plasma membrane;nucleus;protein complex;membrane;cytoplasm,,,,,,,,,,,,,,
7756,Q9HB21,PLEKHA1,Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1),TASRSNSLVSTFT,_SNS(ph)LVSTFTM(ox)EK_,S332,,27.14,,,,,,,,,,,,,27.14,0.00, , , , , , , , , , , , ,establishment of protein localization;cellular response to hydrogen peroxide;negative regulation of protein kinase B signaling cascade;Leydig cell differentiation;spermatogenesis;palate development;phosphatidylinositol 3-kinase cascade;estrogen metabolic process;platelet-derived growth factor receptor signaling pathway;post-embryonic development;skeletal system morphogenesis;face morphogenesis;androgen metabolic process;ruffle organization;multicellular organism growth;B cell receptor signaling pathway;luteinization,ruffle membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
7757,Q9HB58,SP110,Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110),PQEMPHSPLGSMP,_DKEDPQEM(ox)PHS(ph)PLGSM(ox)PEIR_,S41,+,22.70,27.33,27.33,23.30,23.44,24.75,,24.52,,,22.85,22.06,23.12,24.14,-1.44,3.19,3.19,-0.84,-0.70,0.61, ,0.38, , ,-1.29,-2.08,-1.02,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleolus,Other TF domain,,,,,,,,,,,,,
7758,Q9HB58,SP110,Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110),PEIRDNSPEPNDP,_DNS(ph)PEPNDPEEPQEVSSTPSDKK_,S53,,24.87,26.78,27.58,26.00,,23.35,,23.40,,,,,,25.33,-0.46,1.45,2.25,0.67, ,-1.98, ,-1.93, , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleolus,Other TF domain,,,,,,,,,,,,,
7759,Q9HB58,SP110,Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110),VTQGAASPGHGIQ,_RVTQGAAS(ph)PGHGIQEK_,S177,,,25.71,25.71,22.36,,,,,,,,,,24.59, ,1.11,1.11,-2.23, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleolus,Other TF domain,,,,,,,,,,,,,
7760,Q9HB90,RRAGC,Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929),ETLFLESTNKIYK,_M(ox)SPNETLFLES(ph)TNK_,S95,+,26.41,26.64,26.87,26.80,26.43,28.46,24.51,23.42,26.85,27.23,27.80,23.90,27.98,26.41,0.00,0.23,0.47,0.39,0.02,2.06,-1.90,-2.99,0.44,0.82,1.39,-2.50,1.57,"small GTPase mediated signal transduction;cellular response to amino acid stimulus;cellular protein localization;cell growth;positive regulation of TOR signaling cascade;apoptotic process;RNA splicing;transcription, DNA-dependent",nucleus;lysosome,,,,,,,,,,,,,,
7761,Q9HB90,RRAGC,Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929),ETPLAGSYGAADS,_(ac)SLQYGAEETPLAGS(ph)YGAADSFPK_,S15,+,26.19,,,25.40,25.86,,,24.31,24.71,27.33,27.32,24.57,27.17,25.87,0.31, , ,-0.47,-0.01, , ,-1.56,-1.17,1.46,1.45,-1.30,1.30,"small GTPase mediated signal transduction;cellular response to amino acid stimulus;cellular protein localization;cell growth;positive regulation of TOR signaling cascade;apoptotic process;RNA splicing;transcription, DNA-dependent",nucleus;lysosome,,,,,,,,,,,,,,
7763,Q9HB96,FANCE,Fanconi anemia group E protein (Protein FACE),ADGGSASPIKDQP,_SLESLADGGSAS(ph)PIK_,S249,,23.94,23.32,23.32,21.67,,,,,23.04,23.21,,,,23.08,0.86,0.24,0.24,-1.42, , , , ,-0.05,0.13, , , ,DNA repair,Fanconi anaemia nuclear complex,,,,,,,,,,,,,,
7764,Q9HBH9,MKNK2,MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2),QRRQRASLSSAPV,_(gl)QRAS(ph)LSSAPVVLVGDHA_,S136,,22.59,,,,,,,,,,,,,22.59,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;cellular response to arsenic-containing substance;apoptotic process;hemopoiesis;regulation of translation;cell surface receptor signaling pathway,PML body;cytoplasm,,+,,,,,,,,,,,,
7765,Q9HBL0,TNS1,Tensin-1,LRRRAASDGQYEN,_AAS(ph)DGQYENQSPEATSPR_,S898,,23.26,24.40,,24.54,,22.60,,,,,,,,23.70,-0.44,0.70, ,0.84, ,-1.10, , , , , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7766,Q9HBL0,TNS1,Tensin-1,GQYENQSPEATSP,_AASDGQYENQS(ph)PEATSPR_,S906,,,,,24.76,23.17,24.65,,22.81,23.49,,,,,23.78, , , ,0.98,-0.61,0.88, ,-0.96,-0.29, , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7767,Q9HBL0,TNS1,Tensin-1,VHTVPGSPQARHR,_AQFSVAGVHTVPGS(ph)PQAR_,S1155,+,23.93,22.18,22.18,22.80,24.12,25.74,23.03,22.89,25.44,,,23.82,24.54,23.70,0.23,-1.52,-1.52,-0.90,0.42,2.04,-0.67,-0.81,1.75, , ,0.12,0.84,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7769,Q9HBL0,TNS1,Tensin-1,EGTSPSSPPPSGV,_EAFEEM(ox)EGTSPSS(ph)PPPSGVR_,S962,+,25.91,23.79,24.20,22.79,,24.01,,,25.01,,23.12,,24.24,24.13,1.77,-0.34,0.07,-1.35, ,-0.12, , ,0.88, ,-1.01, ,0.10,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7771,Q9HBL0,TNS1,Tensin-1,EATSDPSRTPEEE,_EATSDPS(ph)RTPEEEPLNLEGLVAHR_,S857,,22.29,,,,24.19,24.85,,,24.82,,,,,24.04,-1.74, , , ,0.15,0.81, , ,0.79, , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7772,Q9HBL0,TNS1,Tensin-1,AAFRQGSPTPALP,_QGS(ph)PTPALPEK_,S1359,+,27.96,26.87,24.74,28.30,26.05,27.91,25.93,25.66,26.92,24.49,24.71,24.68,26.46,26.21,1.76,0.66,-1.46,2.09,-0.16,1.71,-0.28,-0.55,0.71,-1.72,-1.50,-1.53,0.26,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7775,Q9HBL0,TNS1,Tensin-1,GMFRSQSFSEAEP,_SQS(ph)FSEAEPQLPPAPVR_,S621,,24.25,,,23.28,,22.71,,,,,,,,23.41,0.83, , ,-0.13, ,-0.71, , , , , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7778,Q9HBL0,TNS1,Tensin-1,SATAALSPQEKRE,_TDEPVPGASSATAALS(ph)PQEK_,S433,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7781,Q9HBL0,TNS1,Tensin-1,INGKVSSPVASGM,_VSS(ph)PVASGM(ox)SS(ph)PSGGSTVSFSHTLPDFSK_,S1391,,25.59,,,,,,,,,,,24.32,,24.96,0.63, , , , , , , , , , ,-0.63, ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7782,Q9HBL0,TNS1,Tensin-1,VASGMSSPSGGST,_VSS(ph)PVASGM(ox)SS(ph)PSGGSTVSFSHTLPDFSK_,S1399,,25.17,,,,,,,,,,,,,25.17,0.00, , , , , , , , , , , , ,cell-substrate junction assembly;fibroblast migration,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
7783,Q9HBM6,TAF9B,Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L),SVGAVSSKPTTPT,_LSVGAVSS(ph)KPTT(ph)PTIATPQTVSVPNK_,S153,,22.82,,,,,,,,24.27,22.69,,,,23.26,-0.44, , , , , , , ,1.01,-0.57, , , ,"negative regulation of apoptotic process;DNA-dependent transcription, initiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell growth;response to organic cyclic compound;programmed cell death",transcription factor TFTC complex;transcription factor TFIID complex,,,,,,,,,,,,,,
7784,Q9HBR0,SLC38A10,Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10),GGNQAASQLEEAG,_AGGNQAAS(ph)QLEEAGR_,S685,,,26.14,,23.76,,,,,,,,,,24.95, ,1.19, ,-1.19, , , , , , , , , ,amino acid transport;sodium ion transport,integral to membrane,,,,,,,,,,,,,,
7785,Q9HBR0,SLC38A10,Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10),QDLNQRSLEHSEG,_S(ph)LEHSEGPVGR_,S802,+,,25.62,,22.59,24.22,24.47,22.92,23.98,23.38,,23.53,23.03,23.21,23.69, ,1.93, ,-1.11,0.52,0.78,-0.78,0.28,-0.32, ,-0.17,-0.66,-0.49,amino acid transport;sodium ion transport,integral to membrane,,,,,,,,,,,,,,
7786,Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),SPQIRASPSPQPS,_AS(ph)PS(ph)PQPSSQPLQIHR_,S144,,24.64,20.87,,,,,,,,,,,,22.76,1.88,-1.88, , , , , , , , , , , ,mitosis;microtubule-based process,microtubule;cytoplasm,,,,,,,,,,,,,,
7787,Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),QIRASPSPQPSSQ,_AS(ph)PS(ph)PQPSSQPLQIHR_,S146,+,25.71,20.87,,,23.38,22.67,23.16,23.74,,,,23.39,,23.27,2.43,-2.40, , ,0.10,-0.60,-0.11,0.46, , , ,0.12, ,mitosis;microtubule-based process,microtubule;cytoplasm,,,,,,,,,,,,,,
7788,Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),EDQQDPSPSS___,_ATLLEDQQDPS(ph)PSS_,S978,,22.82,21.37,21.37,,,,,,,21.53,,,,21.77,1.04,-0.40,-0.40, , , , , , ,-0.24, , , ,mitosis;microtubule-based process,microtubule;cytoplasm,,,,,,,,,,,,,,
7790,Q9HC52,CBX8,Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (hPc3) (Rectachrome 1),VDDKPSSPGDSSK,_VDDKPSS(ph)PGDSSK_,S166,,21.17,22.43,20.45,23.74,,,,20.53,,,,,,21.66,-0.49,0.77,-1.21,2.08, , , ,-1.14, , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;histone ubiquitination",nuclear chromatin;ubiquitin ligase complex;heterochromatin;PRC1 complex,,,,,,,,,,,,,,
7793,Q9HCD5,NCOA5,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),DSRRDRSPIRGSP,_DRS(ph)PIRGS(ph)PR_,S29,,28.60,28.72,28.50,28.17,21.56,,,,,19.92,,,,25.91,2.69,2.81,2.59,2.26,-4.35, , , , ,-5.99, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
7794,Q9HCD5,NCOA5,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),RSPIRGSPRREPR,_DRS(ph)PIRGS(ph)PR_,S34,,28.60,28.72,28.50,28.17,21.56,,,,,19.92,,,,25.91,2.69,2.81,2.59,2.26,-4.35, , , , ,-5.99, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
7796,Q9HCD5,NCOA5,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),TAPSRPSPTRRDP,_(ac)M(ox)NTAPSRPS(ph)PTR_,S9,+,26.96,26.78,24.80,27.06,25.84,25.52,25.07,25.04,24.51,23.98,24.32,,,25.44,1.52,1.34,-0.64,1.62,0.39,0.07,-0.37,-0.40,-0.93,-1.47,-1.13, , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
7801,Q9HCD6,TANC2,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",SSRKNRSSDGGSE,_NRS(ph)SDGGSEEPPDRR_,S21,,23.02,,,22.10,,,16.80,16.80,,,19.11,,,19.57,3.45, , ,2.54, , ,-2.77,-2.77, , ,-0.46, , ,in utero embryonic development,,,,,,,,,,,,,,,
7802,Q9HCD6,TANC2,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",GLPVIQSPPSSPP,_PSQGLPVIQS(ph)PPS(ph)SPPHR_,S1442,,21.70,22.80,,20.36,,,,,,,,,,21.62,0.08,1.18, ,-1.26, , , , , , , , , ,in utero embryonic development,,,,,,,,,,,,,,,
7804,Q9HCD6,TANC2,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",RQIASDSPHASPK,_(gl)QIASDS(ph)PHASPK_,S400,+,23.20,24.76,,25.17,21.97,21.94,23.06,21.48,22.49,,,,,23.01,0.19,1.75, ,2.16,-1.04,-1.07,0.05,-1.53,-0.52, , , , ,in utero embryonic development,,,,,,,,,,,,,,,
7806,Q9HCE3,ZNF532,Zinc finger protein 532,SKGSPSSPAGSTP,_GSPSS(ph)PAGSTPAIPK_,S350,,,23.32,23.32,23.44,,23.30,23.11,,23.10,,,,,23.27, ,0.06,0.06,0.18, ,0.03,-0.16, ,-0.16, , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
7807,Q9HCE3,ZNF532,Zinc finger protein 532,PRAADKSPESQNL,_S(ph)PESQNLIDGTK_,S314,,,23.86,23.86,22.71,,22.15,,,,23.92,,,,23.30, ,0.56,0.56,-0.59, ,-1.15, , , ,0.62, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
7808,Q9HCE6,ARHGEF10L,Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF),KEEEIHSANKCRL,_EEEIHS(ph)ANKCR_,S466,,,,,,,22.98,25.82,23.06,26.01,25.04,26.42,26.50,23.78,24.95, , , , , ,-1.97,0.87,-1.89,1.06,0.09,1.47,1.55,-1.17,regulation of Rho protein signal transduction,cytoplasm,,,,,,,,,,,,,,
7811,Q9HCG8,CWC22,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb),YEEQERSPRDRDY,_YEEQERS(ph)PR_,S39,,18.86,22.53,22.55,19.83,,,,,,,,,,20.94,-2.08,1.58,1.61,-1.11, , , , , , , , , ,"mRNA splicing, via spliceosome;regulation of mRNA splicing, via spliceosome",catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
7812,Q9HCH0,NCKAP5L,Nck-associated protein 5-like (NCKAP5-like),LQIGPPSPGEAQG,_LQIGPPS(ph)PGEAQGPLLPSPAR_,S155,,23.94,,,,,,,,,,,,,23.94,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
7813,Q9HCH0,NCKAP5L,Nck-associated protein 5-like (NCKAP5-like),PCRNSGSDGSPSP,_NSGS(ph)DGSPSPLLAR_,S208,,22.53,,,21.72,,,,,,,,21.78,22.56,22.15,0.38, , ,-0.43, , , , , , , ,-0.37,0.41,,,,,,,,,,,,,,,,
7815,Q9HCH0,NCKAP5L,Nck-associated protein 5-like (NCKAP5-like),VDLEPVSPRSCLT,_VDLEPVS(ph)PR_,S482,,24.79,21.00,21.76,,21.34,,,,,,21.52,,,22.08,2.71,-1.09,-0.32, ,-0.74, , , , , ,-0.57, , ,,,,,,,,,,,,,,,,
7816,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),APGYPSSPVTTAS,_APGYPSS(ph)PVTTASGTTLR_,S2519,,24.92,,,,23.50,24.40,,23.82,23.24,,,,23.52,23.90,1.02, , , ,-0.39,0.50, ,-0.08,-0.66, , , ,-0.38,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7817,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),DDLVEFSDLESED,_DDDLVEFS(ph)DLES(ph)EDDERPR_,S1420,,23.64,,,,,,,,,23.39,,,,23.52,0.13, , , , , , , , ,-0.13, , , ,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7818,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),EFSDLESEDDERP,_DDDLVEFS(ph)DLES(ph)EDDERPR_,S1424,,24.68,,,,,,,,,,,,,24.68,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7819,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),DAPVEKSPEETAT,_S(ph)PEETATQVPSLESLTLK_,S2008,+,25.07,23.54,23.87,23.12,,,,,24.16,24.04,25.36,,,24.17,0.90,-0.62,-0.30,-1.05, , , , ,0.00,-0.12,1.19, , ,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7820,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),YTSRTASPLPLRP,_TAS(ph)PLPLRPDAPVEK_,S1995,+,25.40,24.47,24.04,22.67,21.94,25.62,23.36,23.53,24.25,,24.30,,24.37,24.00,1.40,0.48,0.05,-1.33,-2.06,1.63,-0.63,-0.47,0.25, ,0.31, ,0.37,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7821,Q9HCK8,CHD8,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),DYEMRVSPSDTTP,_VS(ph)PSDTTPLVSR_,S2046,,24.39,22.99,,23.13,21.98,,,21.83,,,,,,22.87,1.52,0.13, ,0.27,-0.88, , ,-1.03, , , , , ,"negative regulation of apoptotic process;ATP-dependent chromatin remodeling;negative regulation of transcription, DNA-dependent;in utero embryonic development;positive regulation of transcription from RNA polymerase III promoter;canonical Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",MLL1 complex,Other TF domain,,,,,,,,,,,,,
7824,Q9HCM4,EPB41L5,Band 4.1-like protein 5,IENLPQSPGTDQH,_SALPVSPSISSAPVPVEIENLPQS(ph)PGTDQHDRK_,S436,+,23.00,,,,24.13,,23.52,23.74,24.13,25.28,24.13,,,23.99,-0.99, , , ,0.14, ,-0.47,-0.25,0.14,1.29,0.14, , ,"paraxial mesoderm development;neural plate morphogenesis;mesoderm migration involved in gastrulation;left/right axis specification;actomyosin structure organization;somite rostral/caudal axis specification;positive regulation of focal adhesion assembly;positive regulation of epithelial to mesenchymal transition;apical constriction;unidimensional cell growth;positive regulation of epithelial cell migration;substrate-dependent cell migration, cell attachment to substrate;posttranscriptional regulation of gene expression;cellular response to transforming growth factor beta stimulus;epithelial to mesenchymal transition;axial mesoderm morphogenesis;regulation of establishment of protein localization;embryonic foregut morphogenesis;in utero embryonic development;positive regulation of protein binding;negative regulation of protein binding;endoderm development;ectoderm development;negative regulation of cell-cell adhesion",ruffle membrane;focal adhesion;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
7825,Q9HCN4,GPN1,GPN-loop GTPase 1 (MBD2-interacting protein) (MBDin) (XPA-binding protein 1),TAKDSLSPVLHPS,_DSLS(ph)PVLHPSDLILTR_,S219,+,25.94,24.70,24.82,23.62,22.93,24.23,27.19,25.62,25.92,26.65,26.58,25.70,25.67,25.35,0.59,-0.65,-0.53,-1.73,-2.42,-1.12,1.84,0.27,0.57,1.30,1.23,0.35,0.32,,intracellular membrane-bounded organelle;cytoplasm,,,,,,,,,,,,,,
7826,Q9HCN4,GPN1,GPN-loop GTPase 1 (MBD2-interacting protein) (MBDin) (XPA-binding protein 1),EDEEADSDTDDID,_GTLDEEDEEADS(ph)DTDDIDHR_,S243,+,24.45,23.91,,,24.35,23.25,23.28,23.58,,,,22.05,,23.55,0.89,0.36, , ,0.80,-0.30,-0.27,0.02, , , ,-1.50, ,,intracellular membrane-bounded organelle;cytoplasm,,,,,,,,,,,,,,
7827,Q9HCS5,EPB41L4A,Band 4.1-like protein 4A (Protein NBL4),IKIIAPSPVKSFK,_IIAPS(ph)PVK_,S16,,24.27,24.63,25.24,23.03,,22.98,23.16,24.16,25.51,25.58,23.61,22.85,23.73,24.06,0.21,0.57,1.17,-1.04, ,-1.08,-0.90,0.09,1.45,1.52,-0.45,-1.22,-0.33,,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
7828,Q9HD20,ATP13A1,Probable cation-transporting ATPase 13A1 (EC 3.6.3.-),SQRDRLSQVLRDL,_DRLS(ph)QVLR_,S817,,,23.73,,22.66,,,,,,,,,,23.20, ,0.53, ,-0.53, , , , , , , , , ,cation transport;ATP catabolic process,integral to membrane,,,,,,,,,,,,,,
7829,Q9HD20,ATP13A1,Probable cation-transporting ATPase 13A1 (EC 3.6.3.-),RRRPRDSPTLSNS,_DS(ph)PTLSNSGIR_,S781,+,24.22,24.23,24.04,,23.98,,24.77,,24.00,23.65,,24.09,,24.12,0.10,0.11,-0.08, ,-0.15, ,0.65, ,-0.12,-0.47, ,-0.04, ,cation transport;ATP catabolic process,integral to membrane,,,,,,,,,,,,,,
7830,Q9HDC5,JPH1,Junctophilin-1 (JP-1) (Junctophilin type 1),GTTPPRSPEASPK,_GTT(ph)PPRS(ph)PEASPK_,S360,,,23.40,,24.13,,,,,,,,,,23.77, ,-0.36, ,0.36, , , , , , , , , ,regulation of ryanodine-sensitive calcium-release channel activity;calcium ion transport into cytosol;muscle organ development,Z disc;junctional membrane complex;integral to membrane;plasma membrane;junctional sarcoplasmic reticulum membrane,,,,,,,,,,,,,,
7831,Q9HDC9,APMAP,Adipocyte plasma membrane-associated protein (Protein BSCv),_____MSEADGLR,_(ac)S(ph)EADGLRQR_,S2,,23.54,,,24.52,,,,22.60,22.09,,20.50,21.65,,22.48,1.06, , ,2.04, , , ,0.11,-0.39, ,-1.99,-0.83, ,biosynthetic process,integral to membrane;membrane;cell surface,,,,,,,,,,,,,,
7832,Q9NP64,ZCCHC17,Nucleolar protein of 40 kDa (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) (Zinc finger CCHC domain-containing protein 17),EERRRRSFQDYTG,_S(ph)FQDYTGQK_,S90,+,24.69,22.92,23.27,22.78,21.47,,,21.63,21.12,,,22.58,,22.56,2.13,0.36,0.71,0.23,-1.09, , ,-0.93,-1.44, , ,0.02, ,,cytosolic large ribosomal subunit;nucleolus,,,,,,,,,,,,,,
7833,Q9NP66,HMG20A,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1),DSNAPKSPLTGYV,_S(ph)PLTGYVR_,S105,+,24.73,25.11,25.39,25.34,27.09,26.98,25.88,25.95,26.02,25.84,24.04,24.62,25.59,25.58,-0.86,-0.47,-0.19,-0.24,1.51,1.39,0.30,0.37,0.44,0.26,-1.54,-0.97,0.00,"chromatin organization;transcription, DNA-dependent;chromatin modification",nucleus,HMG-box,,,,,,,,,,,,,
7834,Q9NPA5,ZFP64,"Zinc finger protein 64 homolog, isoforms 1 and 2 (Zfp-64) (Zinc finger protein 338)",QILRQVSLIAPPQ,_(gl)QVS(ph)LIAPPQSSR_,S389,,22.89,19.56,,,,,,,,,,,,21.23,1.67,-1.67, , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
7835,Q9NPG3,UBN1,Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein),LQFRQASESEDDF,_QAS(ph)ESEDDFIK_,S173,,,23.05,,23.20,20.79,23.54,22.34,,23.50,22.90,,,22.21,22.69, ,0.36, ,0.51,-1.90,0.85,-0.35, ,0.81,0.21, , ,-0.48,regulation of transcription from RNA polymerase II promoter;chromatin modification;negative regulation of phosphatase activity;virus-host interaction,tight junction;PML body;nucleus,,,,,,,,,,,,,,
7838,Q9NPH3,IL1RAP,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),SPRRSSSDEQGLS,_RSS(ph)S(ph)DEQGLSYSSLK_,S557,,23.71,,,23.89,25.65,,,,23.81,,,,,24.27,-0.55, , ,-0.38,1.39, , , ,-0.46, , , , ,inflammatory response;immune response;protein complex assembly;interleukin-2 biosynthetic process;innate immune response,extracellular region;intracellular;integral to plasma membrane,,,,,,,,,,,,,,
7839,Q9NPI1,BRD7,Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1),MGISIPSPVMENN,_AM(ox)GISIPS(ph)PVM(ox)ENNFVDLTEDTEEPK_,S621,,23.71,,,,,,,,,,,,,23.71,0.00, , , , , , , , , , , , ,"negative regulation of cell proliferation;regulation of transcription from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent;negative regulation of G1/S transition of mitotic cell cycle;positive regulation of transcription, DNA-dependent;Wnt receptor signaling pathway;cell cycle;transcription, DNA-dependent;positive regulation of histone acetylation",nucleus;cytoplasm,,,,,,,,,,,,,,
7841,Q9NPI6,DCP1A,mRNA-decapping enzyme 1A (EC 3.-.-.-) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF),RKASSPSPLTIGT,_ASSPS(ph)PLTIGTPESQR_,S487,+,22.97,23.77,,24.40,22.66,24.27,23.28,24.83,22.75,21.92,22.72,,,23.36,-0.39,0.41, ,1.05,-0.70,0.91,-0.07,1.47,-0.61,-1.43,-0.64, , ,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;gene expression;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay",cytosol;nucleus;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
7842,Q9NPL8,TIMMDC1,Translocase of inner mitochondrial membrane domain-containing protein 1 (Protein M5-14),PEKIESSLQEDEP,_IESS(ph)LQEDEPENDAK_,S119,,,23.17,,22.19,,,,,22.91,,,,,22.76, ,0.42, ,-0.56, , , , ,0.15, , , , ,,mitochondrion;integral to membrane,,,,,,,,,,,,,,
7843,Q9NPQ8,RIC8A,Synembryn-A (Protein Ric-8A),RPEGQYSEDEDTD,_GLM(ox)AGGRPEGQYS(ph)EDEDT(ph)DTDEYK_,S435,+,26.04,23.04,23.04,23.71,25.17,24.22,25.34,26.30,23.85,24.04,25.37,24.90,,24.59,1.45,-1.54,-1.54,-0.88,0.58,-0.36,0.76,1.72,-0.74,-0.54,0.79,0.31, ,vasculature development;cell-cell adhesion involved in gastrulation;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;in utero embryonic development;visual learning;cell migration involved in gastrulation;basement membrane organization,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7844,Q9NPQ8,RIC8A,Synembryn-A (Protein Ric-8A),IQPMGMSPRGHLT,_VIQPM(ox)GM(ox)S(ph)PR_,S501,+,23.69,23.00,,25.24,22.00,20.95,,22.14,21.18,,,,,22.60,1.09,0.40, ,2.64,-0.60,-1.64, ,-0.46,-1.42, , , , ,vasculature development;cell-cell adhesion involved in gastrulation;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;in utero embryonic development;visual learning;cell migration involved in gastrulation;basement membrane organization,plasma membrane;cytoplasm,,,,,,,,,,,,,,
7845,Q9NPR2,SEMA4B,Semaphorin-4B,YQSLSDSPPGSRV,_GYQSLSDS(ph)PPGSR_,S788,,23.35,,,22.57,23.36,,,23.52,25.06,,,,,23.57,-0.22, , ,-1.00,-0.21, , ,-0.06,1.48, , , , ,cell differentiation;nervous system development,integral to membrane,,,,,,,,,,,,,,
7846,Q9NPR2,SEMA4B,Semaphorin-4B,SRVFTESEKRPLS,_VFTES(ph)EK_,S798,,24.11,23.03,22.43,20.54,,,,,,,,,,22.53,1.58,0.51,-0.09,-1.99, , , , , , , , , ,cell differentiation;nervous system development,integral to membrane,,,,,,,,,,,,,,
7847,Q9NPR2,SEMA4B,Semaphorin-4B,PRVRLGSEIRDSV,_LGS(ph)EIRDSVV_,S825,,26.73,18.58,18.58,,25.14,26.20,26.16,25.35,26.62,23.74,24.03,22.70,24.73,24.05,2.68,-5.46,-5.46, ,1.10,2.15,2.11,1.30,2.57,-0.31,-0.02,-1.35,0.68,cell differentiation;nervous system development,integral to membrane,,,,,,,,,,,,,,
7848,Q9NQ55,PPAN,Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog),KARVGGSDEEASG,_VGGS(ph)DEEASGIPSR_,S359,+,28.53,28.82,28.32,30.15,30.73,30.65,30.75,30.53,30.01,30.25,29.21,29.64,30.20,29.83,-1.30,-1.01,-1.51,0.32,0.90,0.82,0.92,0.70,0.18,0.42,-0.62,-0.19,0.37,RNA splicing,nucleus;cytoplasm,,,,,,,,,,,,,,
7849,Q9NQ84,GPRC5C,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),VENKAFSMDEPVA,_AFS(ph)M(ox)DEPVAAK_,S344,,23.40,,,,,22.60,22.81,,22.99,25.25,23.91,,23.19,23.45,-0.05, , , , ,-0.85,-0.64, ,-0.46,1.80,0.46, ,-0.26,,cytoplasmic vesicle membrane;mitochondrion;integral to plasma membrane,,,,,,,,,,,,,,
7850,Q9NQ84,GPRC5C,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),KEQKGQSMFVENK,_GQS(ph)M(ox)FVENK_,S335,,25.45,,,21.80,,,,,,,,22.76,,23.33,2.11, , ,-1.54, , , , , , , ,-0.57, ,,cytoplasmic vesicle membrane;mitochondrion;integral to plasma membrane,,,,,,,,,,,,,,
7851,Q9NQ84,GPRC5C,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),LMHKVPSEGAYDI,_VPS(ph)EGAYDIILPR_,S383,+,24.97,21.56,19.50,,22.43,,23.08,,24.50,24.12,24.81,25.27,,23.36,1.61,-1.80,-3.86, ,-0.93, ,-0.28, ,1.14,0.76,1.45,1.91, ,,cytoplasmic vesicle membrane;mitochondrion;integral to plasma membrane,,,,,,,,,,,,,,
7855,Q9NQC3,RTN4,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),SPLVSSSDSPPRP,_(ac)M(ox)EDLDQSPLVSSS(ph)DSPPRPQPAFK_,S13,,22.29,25.89,25.89,26.38,23.80,,,28.27,,24.86,,,,25.34,-3.05,0.55,0.55,1.04,-1.54, , ,2.93, ,-0.48, , , ,regulation of branching morphogenesis of a nerve;aging;cerebral cortex radial glia guided migration;regulation of axon regeneration;olfactory nerve development;positive regulation of glial cell differentiation;negative regulation of neuron differentiation;response to activity;apoptotic process;regulation of cell migration;angiogenesis;endoplasmic reticulum tubular network organization;regulation of sensory perception of pain;negative regulation of neuron projection regeneration;positive regulation of dopamine secretion;negative regulation of axon extension;cardiac epithelial to mesenchymal transition;axonal fasciculation;nerve growth factor receptor signaling pathway;oligodendrocyte differentiation;regulation of apoptotic process,neuronal cell body;neuron projection;nuclear envelope;integral to endoplasmic reticulum membrane;plasma membrane;myelin sheath;protein complex,,,,,,,,,,,,,,
7856,Q9NQC3,RTN4,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),LVSSSDSPPRPQP,_(ac)MEDLDQSPLVSSSDS(ph)PPRPQPAFK_,S15,+,31.82,31.59,32.09,32.69,33.59,33.41,33.20,33.55,32.64,33.19,33.03,32.66,33.87,32.87,-1.05,-1.28,-0.79,-0.18,0.72,0.54,0.33,0.68,-0.23,0.32,0.16,-0.21,1.00,regulation of branching morphogenesis of a nerve;aging;cerebral cortex radial glia guided migration;regulation of axon regeneration;olfactory nerve development;positive regulation of glial cell differentiation;negative regulation of neuron differentiation;response to activity;apoptotic process;regulation of cell migration;angiogenesis;endoplasmic reticulum tubular network organization;regulation of sensory perception of pain;negative regulation of neuron projection regeneration;positive regulation of dopamine secretion;negative regulation of axon extension;cardiac epithelial to mesenchymal transition;axonal fasciculation;nerve growth factor receptor signaling pathway;oligodendrocyte differentiation;regulation of apoptotic process,neuronal cell body;neuron projection;nuclear envelope;integral to endoplasmic reticulum membrane;plasma membrane;myelin sheath;protein complex,,,,,,,,,,,,,,
7857,Q9NQC3,RTN4,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),APKRRGSSGSVDE,_RRGS(ph)S(ph)GSVDETLFALPAASEPVIR_,S181,+,24.30,,,,21.83,,24.83,,26.21,26.69,25.05,27.69,,25.23,-0.93, , , ,-3.40, ,-0.40, ,0.98,1.46,-0.18,2.46, ,regulation of branching morphogenesis of a nerve;aging;cerebral cortex radial glia guided migration;regulation of axon regeneration;olfactory nerve development;positive regulation of glial cell differentiation;negative regulation of neuron differentiation;response to activity;apoptotic process;regulation of cell migration;angiogenesis;endoplasmic reticulum tubular network organization;regulation of sensory perception of pain;negative regulation of neuron projection regeneration;positive regulation of dopamine secretion;negative regulation of axon extension;cardiac epithelial to mesenchymal transition;axonal fasciculation;nerve growth factor receptor signaling pathway;oligodendrocyte differentiation;regulation of apoptotic process,neuronal cell body;neuron projection;nuclear envelope;integral to endoplasmic reticulum membrane;plasma membrane;myelin sheath;protein complex,,,,,,,,,,,,,,
7864,Q9NQG1,MANBAL,Protein MANBAL,PKAAVPSVNKRPK,_AAVPS(ph)VNK_,S72,,20.51,,,24.40,,,,,,,,21.32,,22.08,-1.57, , ,2.33, , , , , , , ,-0.76, ,,integral to membrane,,,,,,,,,,,,,,
7867,Q9NQG5,RPRD1B,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),DYPGSYSPQDPSA,_TFQQIQEEEDDDYPGSYS(ph)PQDPSAGPLLTEELIK_,S166,,27.52,,,,,,,,,25.68,,25.56,,26.25,1.26, , , , , , , , ,-0.57, ,-0.69, ,"dephosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;transcription, DNA-dependent;regulation of cell cycle process;positive regulation of transcription from RNA polymerase II promoter","DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
7870,Q9NQP4,PFDN4,Prefoldin subunit 4 (Protein C-1),LYAKFGSNINLEA,_FGS(ph)NINLEADES_,S125,+,22.42,,,,22.74,21.76,22.77,22.55,,22.06,,,21.87,22.31,0.11, , , ,0.43,-0.55,0.46,0.24, ,-0.25, , ,-0.44,'de novo' posttranslational protein folding,cytosol;mitochondrion;prefoldin complex;nucleus,,,,,,,,,,,,,,
7871,Q9NQQ7,SLC35C2,Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein),ALKGLGSSPDLEL,_GLGS(ph)SPDLELLLR_,S200,+,25.90,23.94,24.08,25.77,25.24,23.90,,24.99,26.20,24.63,24.93,24.82,25.25,24.97,0.93,-1.03,-0.89,0.80,0.27,-1.07, ,0.02,1.23,-0.34,-0.04,-0.15,0.28,transport,integral to membrane,,,,,,,,,,,,,,
7873,Q9NQS3,PVRL3,Poliovirus receptor-related protein 3 (CDw113) (Nectin-3) (CD antigen CD113),QQDELDSYPDSVK,_ESQIDVLQQDELDS(ph)YPDSVKK_,S465,,,,,,24.22,,,,24.94,24.40,,,,24.52, , , , ,-0.30, , , ,0.42,-0.12, , , ,fertilization;adherens junction organization;homophilic cell adhesion;lens morphogenesis in camera-type eye;retina morphogenesis in camera-type eye;cell junction assembly,integral to membrane;plasma membrane;cell-cell adherens junction;apical junction complex,,,,,,,,,,,,,,
7874,Q9NQS7,INCENP,Inner centromere protein,LRIAQVSPGPRDS,_IAQVS(ph)PGPR_,S263,+,24.17,20.61,20.61,24.36,24.46,22.86,23.75,22.85,,,,23.46,23.07,23.02,1.15,-2.41,-2.41,1.34,1.44,-0.16,0.73,-0.17, , , ,0.44,0.05,mitotic prometaphase;chromosome segregation;cytokinesis,condensed chromosome kinetochore;centromeric heterochromatin;central element;cytosol;midbody;microtubule;kinetochore;spindle,,,,,,,,,,,,,,
7875,Q9NQT8,KIF13B,Kinesin-like protein KIF13B (Kinesin-like protein GAKIN),LSRRSISSPNVNR,_SIS(ph)SPNVNR_,S1381,+,25.79,23.84,23.71,26.81,,,22.92,23.24,,22.00,22.63,23.48,,23.82,1.97,0.01,-0.12,2.98, , ,-0.91,-0.58, ,-1.83,-1.19,-0.34, ,T cell activation;signal transduction;microtubule-based movement;protein targeting;regulation of axonogenesis,axon;microtubule associated complex;microtubule;cytoplasm,,,,,,,,,,,,,,
7876,Q9NQU5,PAK6,Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6),DVPKRKSLVGTPY,_S(ph)LVGTPYWM(ox)APEVISR_,S560,,22.28,,,,,,,,,,,,,22.28,0.00, , , , , , , , , , , , ,"apoptotic process;regulation of transcription, DNA-dependent;cytoskeleton organization",nucleus;cytoplasm,,+,,,,,,,,,,,,
7877,Q9NQV6,PRDM10,PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10) (Tristanin),SENGEKSDDGTQD,_S(ph)DDGTQDLLHFPTK_,S141,,23.83,19.87,19.87,,,,,,22.98,24.69,,,,22.25,1.58,-2.38,-2.38, , , , , ,0.73,2.45, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
7879,Q9NQW6,ANLN,Actin-binding protein anillin,SEEKAASPPRPLL,_AAS(ph)PPRPLLSNASATPVGR_,S182,,,23.72,23.72,21.88,,,25.37,24.65,,,,,,23.87, ,-0.15,-0.15,-1.99, , ,1.50,0.79, , , , , ,regulation of exit from mitosis;mitosis;septin ring assembly;cytokinesis,actomyosin contractile ring;nucleus,,,,,,,,,,,,,,
7880,Q9NQW6,ANLN,Actin-binding protein anillin,TSRSDESPKPGKF,_DTSRSDES(ph)PKPGK_,S604,,17.01,22.42,22.42,18.92,,,,,,,,,,20.19,-3.18,2.23,2.23,-1.27, , , , , , , , , ,regulation of exit from mitosis;mitosis;septin ring assembly;cytokinesis,actomyosin contractile ring;nucleus,,,,,,,,,,,,,,
7881,Q9NQW6,ANLN,Actin-binding protein anillin,IVKSTLSQTVPSK,_STLS(ph)QTVPSK_,S339,,24.60,22.36,22.54,22.64,,,,,21.83,,,,,22.80,1.81,-0.43,-0.25,-0.15, , , , ,-0.96, , , , ,regulation of exit from mitosis;mitosis;septin ring assembly;cytokinesis,actomyosin contractile ring;nucleus,,,,,,,,,,,,,,
7882,Q9NQW6,ANLN,Actin-binding protein anillin,LPKTPISPLKTGV,_TPIS(ph)PLK_,S323,+,26.80,26.82,27.78,24.63,25.23,25.47,26.42,25.71,24.75,24.38,22.77,24.50,25.09,25.41,1.39,1.41,2.37,-0.78,-0.18,0.06,1.01,0.30,-0.66,-1.03,-2.64,-0.91,-0.33,regulation of exit from mitosis;mitosis;septin ring assembly;cytokinesis,actomyosin contractile ring;nucleus,,,,,,,,,,,,,,
7883,Q9NQW6,ANLN,Actin-binding protein anillin,GVSKTQSLPVTEK,_TQS(ph)LPVTEK_,S485,+,27.76,25.81,25.81,24.19,24.09,,24.24,23.34,,22.07,,21.80,,24.35,3.42,1.46,1.46,-0.16,-0.25, ,-0.11,-1.01, ,-2.27, ,-2.55, ,regulation of exit from mitosis;mitosis;septin ring assembly;cytokinesis,actomyosin contractile ring;nucleus,,,,,,,,,,,,,,
7884,Q9NQZ2,UTP3,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (CRL1) (Disrupter of silencing SAS10) (UTP3 homolog),DLGLPPSPGDTSY,_AGPTLTDENGDDLGLPPS(ph)PGDTSYYQDQVDDFHEAR_,S37,,,,,,23.83,,,,,23.86,,24.78,,24.16, , , , ,-0.33, , , , ,-0.30, ,0.62, ,brain development;chromatin modification,nucleolus,,,,,,,,,,,,,,
7885,Q9NR09,BIRC6,Baculoviral IAP repeat-containing protein 6 (EC 6.3.2.-) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),DDLLEDSDSEEHS,_LEGDSDDLLEDS(ph)DSEEHSR_,S480,,24.60,,,,23.00,,22.85,,,,22.02,21.84,,22.86,1.74, , , ,0.14, ,-0.01, , , ,-0.84,-1.02, ,negative regulation of apoptotic process;protein phosphorylation;regulation of cytokinesis;regulation of cell proliferation;mitosis;labyrinthine layer development;spongiotrophoblast layer development;apoptotic process;positive regulation of cell proliferation;cell division,trans-Golgi network;endosome;midbody;Golgi apparatus;spindle pole;membrane;microtubule organizing center,,,,,,,,,,,,,,
7886,Q9NR09,BIRC6,Baculoviral IAP repeat-containing protein 6 (EC 6.3.2.-) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),SSNSHRSLDGLSR,_S(ph)LDGLSR_,S590,,22.30,,,22.41,,,,,,,,,,22.36,-0.05, , ,0.05, , , , , , , , , ,negative regulation of apoptotic process;protein phosphorylation;regulation of cytokinesis;regulation of cell proliferation;mitosis;labyrinthine layer development;spongiotrophoblast layer development;apoptotic process;positive regulation of cell proliferation;cell division,trans-Golgi network;endosome;midbody;Golgi apparatus;spindle pole;membrane;microtubule organizing center,,,,,,,,,,,,,,
7888,Q9NR19,ACSS2,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme)",GDSTSQSPPIKRS,_AELGM(ox)GDSTSQS(ph)PPIK_,S267,+,24.47,22.61,22.18,24.98,25.28,25.39,25.96,25.46,24.53,23.92,24.94,24.51,25.04,24.56,-0.09,-1.95,-2.38,0.42,0.72,0.83,1.40,0.90,-0.03,-0.64,0.38,-0.05,0.48,xenobiotic metabolic process;acetyl-CoA biosynthetic process from acetate;lipid biosynthetic process;ethanol oxidation,cytosol;nucleus,,,,,,,,,,,,,,
7890,Q9NR19,ACSS2,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme)",GRARSWSPPPEVS,_SWS(ph)PPPEVSR_,S30,+,27.37,27.13,26.89,28.25,27.50,27.65,28.22,28.54,26.51,26.95,27.45,27.67,25.79,27.38,-0.01,-0.25,-0.49,0.87,0.12,0.27,0.84,1.16,-0.87,-0.42,0.07,0.30,-1.59,xenobiotic metabolic process;acetyl-CoA biosynthetic process from acetate;lipid biosynthetic process;ethanol oxidation,cytosol;nucleus,,,,,,,,,,,,,,
7892,Q9NR28,DIABLO,"Diablo homolog, mitochondrial (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)",GEERAESEQEAYL,_AES(ph)EQEAYLRED_,S177,,,23.71,,,,,,,,,,,,23.71, ,0.00, , , , , , , , , , , ,intrinsic apoptotic signaling pathway;intrinsic apoptotic signaling pathway in response to oxidative stress;induction of apoptosis;extrinsic apoptotic signaling pathway via death domain receptors;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,cytosol;CD40 receptor complex;internal side of plasma membrane;mitochondrial intermembrane space,,,,,,,,,,,,,,
7893,Q9NR30,DDX21,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),PSQNDISPKTKSL,_KKEEPSQNDIS(ph)PK_,S89,+,23.86,27.27,28.12,27.97,27.98,24.13,25.38,25.39,24.25,25.56,21.29,24.32,22.22,25.21,-1.35,2.06,2.91,2.76,2.77,-1.09,0.17,0.18,-0.96,0.35,-3.92,-0.89,-2.99,response to virus;response to exogenous dsRNA,nucleolus,,,,,,,,,,,,,,
7894,Q9NR30,DDX21,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),SEVDMNSPKSKKA,_KKAEPSEVDM(ox)NS(ph)PK_,S71,+,24.27,27.30,28.21,25.86,25.25,22.35,24.44,24.23,22.86,24.70,21.70,23.43,22.72,24.41,-0.14,2.89,3.80,1.45,0.84,-2.06,0.03,-0.18,-1.55,0.29,-2.71,-0.98,-1.69,response to virus;response to exogenous dsRNA,nucleolus,,,,,,,,,,,,,,
7895,Q9NR30,DDX21,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),SDAGLESDTAMKK,_LRSDAGLES(ph)DTAM(ox)K_,S13,+,22.89,23.37,23.97,25.07,,21.39,24.35,22.86,22.20,23.48,,23.79,,23.34,-0.44,0.04,0.63,1.73, ,-1.95,1.01,-0.48,-1.14,0.14, ,0.45, ,response to virus;response to exogenous dsRNA,nucleolus,,,,,,,,,,,,,,
7896,Q9NR30,DDX21,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),TKNEEPSEEEIDA,_VTKNEEPS(ph)EEEIDAPKPK_,S121,+,28.06,28.60,28.99,29.52,28.72,28.86,29.81,29.07,29.17,30.20,27.84,28.68,28.55,28.93,-0.87,-0.33,0.07,0.60,-0.21,-0.07,0.88,0.14,0.24,1.27,-1.09,-0.25,-0.37,response to virus;response to exogenous dsRNA,nucleolus,,,,,,,,,,,,,,
7900,Q9NRA2,SLC17A5,Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter),RNDGEESTDRTPL,_NDGEES(ph)TDRTPLLPGAPR_,S16,,21.54,21.68,21.68,,,,,23.50,,23.73,,,24.60,22.79,-1.25,-1.11,-1.11, , , , ,0.72, ,0.94, , ,1.81,sialic acid transport;anion transport,cytoplasmic membrane-bounded vesicle;lysosomal membrane;integral to plasma membrane,,,,,,,,,,,,,,
7901,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),LGQRAPSPPLSQV,_APS(ph)PPLSQVFQTR_,S389,+,24.72,23.94,,24.31,23.95,23.07,24.79,24.34,,,23.90,23.94,,24.11,0.61,-0.17, ,0.20,-0.16,-1.03,0.68,0.23, , ,-0.20,-0.17, ,,cytosol;PML body;nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
7905,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),SGSRSSSLGSTPH,_SSS(ph)LGSTPHEELER_,S190,+,21.76,22.32,22.32,22.84,23.87,23.53,23.98,,22.28,,24.39,23.22,,23.05,-1.29,-0.73,-0.73,-0.21,0.82,0.48,0.93, ,-0.77, ,1.34,0.17, ,,cytosol;PML body;nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
7907,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),RFSRWFSNPSRSG,_WFS(ph)NPSR_,S179,,21.63,20.02,20.42,,,,,,,,,,,20.69,0.95,-0.67,-0.27, , , , , , , , , , ,,cytosol;PML body;nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
7908,Q9NRA8,EIF4ENIF1,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),RWFSNPSRSGSRS,_WFSNPS(ph)R_,S182,,22.99,,,23.44,,,20.77,,,,,,,22.40,0.59, , ,1.04, , ,-1.63, , , , , , ,,cytosol;PML body;nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
7909,Q9NRF8,CTPS2,CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2),SSSDRYSDASDDS,_LSSSDRYS(ph)DAS(ph)DDSFSEPR_,S568,,24.50,,,,,,,,,,,21.90,,23.20,1.30, , , , , , , , , , ,-1.30, ,glutamine metabolic process;pyrimidine nucleotide metabolic process;nucleobase-containing small molecule interconversion;'de novo' CTP biosynthetic process,cytosol;mitochondrion,,,,,,,,,,,,,,
7910,Q9NRF8,CTPS2,CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2),DRYSDASDDSFSE,_LSSSDRYS(ph)DAS(ph)DDSFSEPR_,S571,,24.50,,,,,,,,,,,21.90,,23.20,1.30, , , , , , , , , , ,-1.30, ,glutamine metabolic process;pyrimidine nucleotide metabolic process;nucleobase-containing small molecule interconversion;'de novo' CTP biosynthetic process,cytosol;mitochondrion,,,,,,,,,,,,,,
7913,Q9NRG9,AAAS,Aladin (Adracalin),AQFPRFSPVLGRA,_FS(ph)PVLGR_,S495,+,26.84,26.51,25.16,26.95,27.96,27.81,27.70,27.46,27.61,27.16,25.66,26.79,26.20,26.91,-0.07,-0.40,-1.75,0.04,1.06,0.90,0.79,0.55,0.70,0.25,-1.24,-0.12,-0.71,glucose transport;fertilization;small molecule metabolic process;regulation of nucleocytoplasmic transport;carbohydrate metabolic process;transmembrane transport;regulation of glucose transport;nucleocytoplasmic transport;viral reproduction;cytokine-mediated signaling pathway;learning,nuclear membrane;centrosome;nuclear pore,,,,,,,,,,,,,,
7914,Q9NRH2,SNRK,SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase),HATVPQSPARAAD,_IDVPQDLEDDLTATPLSHATVPQS(ph)PAR_,S184,,21.67,,,,,,,,,,,,,21.67,0.00, , , , , , , , , , , , ,myeloid cell differentiation,nucleus,,+,,,,,,,,,,,,
7915,Q9NRL2,BAZ1A,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),RCRKRQSPEPSPV,_RQS(ph)PEPSPVTLGR_,S1412,+,,,,23.21,24.15,22.79,23.93,23.61,23.32,24.52,,,22.52,23.51, , , ,-0.30,0.64,-0.71,0.43,0.10,-0.18,1.01, , ,-0.99,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin remodeling;DNA-dependent DNA replication",ACF complex;nuclear chromosome;chromatin accessibility complex,,,,,,,,,,,,,,
7916,Q9NRS6,SNX15,Sorting nexin-15,EEGAAPSPTHVAE,_EEGAAPS(ph)PTHVAELATM(ox)EVESAR_,S227,+,22.31,22.57,23.07,,,,22.92,21.70,21.91,,23.95,23.40,,22.73,-0.42,-0.16,0.34, , , ,0.19,-1.03,-0.82, ,1.22,0.67, ,intracellular protein transport;cell communication,cytosol;cytoplasmic vesicle membrane;nucleolus;membrane,,,,,,,,,,,,,,
7917,Q9NRW1,RAB6B,Ras-related protein Rab-6B,_____MSAGGDFG,_(ac)S(ph)AGGDFGNPLRK_,S2,,22.44,,,,20.97,,,22.36,,22.15,22.01,,23.14,22.18,0.27, , , ,-1.21, , ,0.18, ,-0.03,-0.17, ,0.96,"retrograde vesicle-mediated transport, Golgi to ER;protein transport;small GTPase mediated signal transduction",Golgi apparatus;cytoplasmic membrane-bounded vesicle;Golgi membrane,,,,,,,,,,,,,,
7918,Q9NRX5,SERINC1,Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2),TLTSDESTLIEDG,_LTLTSDES(ph)TLIEDGGAR_,S351,,22.80,,,,23.96,,,,,,,24.97,,23.91,-1.11, , , ,0.05, , , , , , ,1.06, ,phosphatidylserine metabolic process;positive regulation of transferase activity;sphingolipid metabolic process;phospholipid biosynthetic process,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7919,Q9NRX5,SERINC1,Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2),GARSDGSLEDGDD,_SDGS(ph)LEDGDDVHR_,S364,+,26.11,27.06,26.42,26.66,26.17,26.16,25.67,25.30,26.57,25.66,24.54,25.72,24.10,25.86,0.25,1.20,0.56,0.80,0.32,0.31,-0.18,-0.56,0.71,-0.20,-1.32,-0.14,-1.76,phosphatidylserine metabolic process;positive regulation of transferase activity;sphingolipid metabolic process;phospholipid biosynthetic process,integral to membrane;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
7920,Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),NSPRAGSPLCNSN,_AGS(ph)PLCNSNLQDSEEDIEPSYSLFR_,S975,,21.82,,,,,,,,,,,,,21.82,0.00, , , , , , , , , , , , ,"regulation of cell shape;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent;neural tube closure;axon guidance;forebrain development;transcription, DNA-dependent;camera-type eye development;negative regulation of vascular permeability",cytosol;nucleus;actin cytoskeleton,Other TF domain,,,,,,,,,,,,,
7921,Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),NLNLVSSTASIKD,_RNLNLVSS(ph)TAS(ph)IK_,S770,,22.69,,,,,,,,,,,,,22.69,0.00, , , , , , , , , , , , ,"regulation of cell shape;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent;neural tube closure;axon guidance;forebrain development;transcription, DNA-dependent;camera-type eye development;negative regulation of vascular permeability",cytosol;nucleus;actin cytoskeleton,Other TF domain,,,,,,,,,,,,,
7922,Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),LVSSTASIKDLAD,_RNLNLVSS(ph)TAS(ph)IK_,S773,,22.69,,,,,,,,,,,,,22.69,0.00, , , , , , , , , , , , ,"regulation of cell shape;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent;neural tube closure;axon guidance;forebrain development;transcription, DNA-dependent;camera-type eye development;negative regulation of vascular permeability",cytosol;nucleus;actin cytoskeleton,Other TF domain,,,,,,,,,,,,,
7923,Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),DRNQKNSLSDPNI,_NS(ph)LSDPNIDR_,S589,,25.86,,,24.16,,,21.09,,,,,,,23.70,2.16, , ,0.45, , ,-2.61, , , , , , ,"regulation of cell shape;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent;neural tube closure;axon guidance;forebrain development;transcription, DNA-dependent;camera-type eye development;negative regulation of vascular permeability",cytosol;nucleus;actin cytoskeleton,Other TF domain,,,,,,,,,,,,,
7924,Q9NRY4,ARHGAP35,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),TSFSVGSDDELGP,_TSFSVGS(ph)DDELGPIR_,S1179,+,25.39,,,,24.09,,24.31,22.56,25.00,24.53,24.96,25.80,,24.58,0.81, , , ,-0.49, ,-0.27,-2.02,0.42,-0.05,0.38,1.22, ,"regulation of cell shape;small GTPase mediated signal transduction;negative regulation of transcription, DNA-dependent;neural tube closure;axon guidance;forebrain development;transcription, DNA-dependent;camera-type eye development;negative regulation of vascular permeability",cytosol;nucleus;actin cytoskeleton,Other TF domain,,,,,,,,,,,,,
7925,Q9NRY5,FAM114A2,Protein FAM114A2,NRNATLSQVLREA,_NATLS(ph)QVLREAK_,S209,,22.74,,,24.60,,,22.85,,,,,25.33,,23.88,-1.14, , ,0.72, , ,-1.03, , , , ,1.45, ,,,,,,,,,,,,,,,,
7926,Q9NS56,TOPORS,E3 ubiquitin-protein ligase Topors (EC 6.3.2.-) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),TVPADASPDSKCP,_LQQTVPADAS(ph)PDSK_,S33,+,26.31,26.12,26.32,25.89,23.04,26.79,26.48,26.26,26.43,25.95,24.66,25.54,26.73,25.88,0.42,0.23,0.43,0.01,-2.84,0.90,0.59,0.38,0.54,0.06,-1.23,-0.34,0.84,"negative regulation of apoptotic process;proteasomal ubiquitin-dependent protein catabolic process;photoreceptor cell outer segment organization;positive regulation of ubiquitin-protein ligase activity;retina layer formation;regulation of cell proliferation;protein monoubiquitination;maintenance of protein location in nucleus;protein K48-linked ubiquitination;protein sumoylation;positive regulation of transcription, DNA-dependent;intrinsic apoptotic signaling pathway in response to DNA damage;retinal rod cell development;retinal cone cell development;transcription, DNA-dependent",centriole;cilium basal body;nuclear speck;midbody;gamma-tubulin complex;PML body;spindle pole;photoreceptor connecting cilium,DNA binding region,,,,,,,,,,,,,
7927,Q9NS69,TOMM22,Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog),GAGEPQSPDELLP,_(ac)AAAVAAAGAGEPQS(ph)PDELLPKGDAEKPEEELEEDDDEELDETLSER_,S15,+,30.90,25.69,25.34,24.10,27.86,,25.63,,28.30,31.35,29.54,28.54,28.25,27.77,3.13,-2.09,-2.43,-3.67,0.08, ,-2.14, ,0.53,3.58,1.76,0.76,0.48,cellular protein metabolic process;protein import into mitochondrial outer membrane,integral to membrane;mitochondrial inner membrane;mitochondrial outer membrane translocase complex,,,,,,,,,,,,,,
7929,Q9NS91,RAD18,E3 ubiquitin-protein ligase RAD18 (EC 6.3.2.-) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73),LQDTEISPRQNRR,_NDLQDTEIS(ph)PR_,S471,+,24.79,25.19,25.87,24.86,24.05,23.85,26.49,24.24,25.32,24.49,24.97,24.65,25.07,24.91,-0.12,0.28,0.96,-0.05,-0.86,-1.06,1.57,-0.67,0.41,-0.42,0.06,-0.26,0.16,response to UV;negative regulation of DNA recombination;DNA repair;spermatogenesis;protein ubiquitination,chromatin;XY body;replication fork;nucleus,SAP-domain,,,,,,,,,,,,,
7930,Q9NS91,RAD18,E3 ubiquitin-protein ligase RAD18 (EC 6.3.2.-) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73),LQFALESPAKSPA,_NHLLQFALES(ph)PAK_,S99,+,,21.52,22.11,21.10,,,,22.88,,23.20,23.14,23.31,,22.46, ,-0.95,-0.36,-1.36, , , ,0.41, ,0.73,0.67,0.85, ,response to UV;negative regulation of DNA recombination;DNA repair;spermatogenesis;protein ubiquitination,chromatin;XY body;replication fork;nucleus,SAP-domain,,,,,,,,,,,,,
7931,Q9NSI6,BRWD1,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),IPELVGSPTQSTS,_IIPELVGS(ph)PTQSTSSR_,S1475,,22.60,,,22.63,23.93,24.11,23.64,23.98,24.40,23.92,24.02,,24.16,23.74,-1.14, , ,-1.11,0.19,0.37,-0.10,0.24,0.67,0.18,0.28, ,0.42,"regulation of cell shape;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;cytoskeleton organization",nucleolus;cytoplasm,,,,,,,,,,,,,,
7933,Q9NSI6,BRWD1,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),KKLLHNSEDEQSL,_LLHNS(ph)EDEQSLK_,S1678,,23.48,24.08,23.86,,,20.25,23.39,,24.19,24.44,23.03,,,23.34,0.14,0.74,0.52, , ,-3.09,0.05, ,0.85,1.10,-0.31, , ,"regulation of cell shape;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;cytoskeleton organization",nucleolus;cytoplasm,,,,,,,,,,,,,,
7934,Q9NSI6,BRWD1,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),DEQSLKSEIEEEE,_S(ph)EIEEEELK_,S1686,,23.49,23.90,24.50,23.18,,,,,21.88,,,,,23.39,0.10,0.51,1.11,-0.21, , , , ,-1.51, , , , ,"regulation of cell shape;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;cytoskeleton organization",nucleolus;cytoplasm,,,,,,,,,,,,,,
7935,Q9NSK0,KLC4,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),NMKRAASLNYLNQ,_AAS(ph)LNYLNQPSAAPLQVSR_,S590,+,22.90,22.28,22.71,23.38,23.95,,24.44,25.52,,,24.03,,22.50,23.52,-0.63,-1.24,-0.82,-0.15,0.43, ,0.91,2.00, , ,0.51, ,-1.02,,kinesin complex;microtubule;cytoplasm,,,,,,,,,,,,,,
7937,Q9NSK0,KLC4,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),SDGRRTSQEGPGD,_RTS(ph)QEGPGDSVK_,S519,+,,22.34,20.70,,19.35,,,,18.97,24.30,25.10,25.19,,22.28, ,0.06,-1.58, ,-2.93, , , ,-3.31,2.02,2.82,2.92, ,,kinesin complex;microtubule;cytoplasm,,,,,,,,,,,,,,
7938,Q9NSK0,KLC4,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),RDVLRRSSELLVR,_S(ph)SELLVRK_,S565,,18.73,22.84,23.58,21.92,,,20.62,,,,,,,21.54,-2.80,1.31,2.04,0.38, , ,-0.92, , , , , , ,,kinesin complex;microtubule;cytoplasm,,,,,,,,,,,,,,
7939,Q9NSK0,KLC4,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),KACKVSSPTVNTT,_VSS(ph)PTVNTTLR_,S460,,22.85,,,,,,,,,,,,,22.85,0.00, , , , , , , , , , , , ,,kinesin complex;microtubule;cytoplasm,,,,,,,,,,,,,,
7940,Q9NSV4,DIAPH3,Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (MDia2),DVRQSLSPMSQRP,_(gl)QSLS(ph)PM(ox)SQRPVLK_,S1093,,,,,21.90,23.42,,23.73,22.99,,,,24.47,,23.30, , , ,-1.40,0.12, ,0.43,-0.31, , , ,1.17, ,actin cytoskeleton organization,cytosol,,,,,,,,,,,,,,
7944,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),NEDEQNSPPKKGK,_LKEDILENEDEQNS(ph)PPKK_,S1283,,25.71,27.32,28.03,26.08,24.20,26.18,27.76,24.42,27.28,25.71,22.52,26.56,,25.98,-0.28,1.34,2.05,0.10,-1.78,0.20,1.78,-1.56,1.30,-0.27,-3.46,0.58, ,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,,,,,,,,,,
7945,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),KRGHTASESDEQQ,_GHTAS(ph)ESDEQQWPEEK_,S1257,,23.68,25.43,26.09,24.88,25.51,25.40,23.22,25.67,26.51,25.81,23.62,25.29,23.73,24.99,-1.31,0.44,1.10,-0.11,0.52,0.42,-1.77,0.68,1.52,0.82,-1.37,0.31,-1.26,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,,,,,,,,,,
7948,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),SSEMDHSENEDYT,_GRLDSS(ph)EM(ox)DHS(ph)ENEDYTM(ox)SSPLPGK_,S1182,,25.57,24.66,25.44,22.55,25.14,25.97,25.04,24.55,25.59,24.90,23.96,23.71,23.71,24.68,0.90,-0.02,0.76,-2.13,0.46,1.30,0.37,-0.12,0.92,0.23,-0.72,-0.97,-0.97,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,,,,,,,,,,
7949,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),SSSNPSSPGRIKG,_M(ox)ETVSNASSSSNPSS(ph)PGRIK_,S1166,,24.55,25.27,25.87,26.16,26.62,26.59,26.36,26.32,25.62,26.51,24.74,24.96,25.61,25.78,-1.23,-0.51,0.09,0.38,0.83,0.81,0.58,0.53,-0.16,0.73,-1.04,-0.82,-0.17,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,,,,,,,,,,
7951,Q9NTJ3,SMC4,Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog),SPDGASSDAEPEP,_RREEGPPPPSPDGASS(ph)DAEPEPPSGR_,S28,+,,,,23.62,25.10,22.74,25.96,26.36,22.41,,,24.71,,24.41, , , ,-0.79,0.68,-1.67,1.55,1.94,-2.00, , ,0.29, ,DNA repair;sister chromatid cohesion;mitotic chromosome condensation;DNA recombination;cell division,nucleus;condensin complex;cytoplasm,,,,,,,,,,,,,,
7952,Q9NTJ3,SMC4,Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog),PSGRTESPATAAE,_TES(ph)PATAAETASEELDNR_,S41,+,24.73,24.41,24.63,27.21,27.43,26.59,25.86,26.95,24.91,,,24.52,24.05,25.57,-0.84,-1.16,-0.95,1.64,1.86,1.02,0.29,1.38,-0.66, , ,-1.05,-1.52,DNA repair;sister chromatid cohesion;mitotic chromosome condensation;DNA recombination;cell division,nucleus;condensin complex;cytoplasm,,,,,,,,,,,,,,
7954,Q9NU22,MDN1,Midasin (MIDAS-containing protein),ENTDQASPQEDYA,_AEENTDQAS(ph)PQEDYAGFER_,S4538,+,24.89,23.27,23.75,24.50,23.49,25.53,25.45,25.36,24.95,25.80,22.87,23.78,25.35,24.54,0.35,-1.27,-0.79,-0.04,-1.05,0.99,0.91,0.83,0.42,1.26,-1.67,-0.76,0.82,protein complex assembly,nucleolus;nucleus,,,,,,,,,,,,,,
7956,Q9NU22,MDN1,Midasin (MIDAS-containing protein),EEDDEKSDSEGGD,_M(ox)HDGELEEQEEDDEKS(ph)DS(ph)EGGDLDK_,S4752,,23.45,,,,,,,,,,,,,23.45,0.00, , , , , , , , , , , , ,protein complex assembly,nucleolus;nucleus,,,,,,,,,,,,,,
7957,Q9NU22,MDN1,Midasin (MIDAS-containing protein),DDEKSDSEGGDLD,_M(ox)HDGELEEQEEDDEKS(ph)DS(ph)EGGDLDK_,S4754,,23.45,,,,,,,,,,,,,23.45,0.00, , , , , , , , , , , , ,protein complex assembly,nucleolus;nucleus,,,,,,,,,,,,,,
7958,Q9NUL3,STAU2,Double-stranded RNA-binding protein Staufen homolog 2,SSFFSISPTSNSS,_DM(ox)NQPSSSFFSIS(ph)PTSNSSATIAR_,S417,,23.31,,,,,,,,,,,,,23.31,0.00, , , , , , , , , , , , ,transport,nucleolus;endoplasmic reticulum;microtubule,,,,,,,,,,,,,,
7959,Q9NUL3,STAU2,Double-stranded RNA-binding protein Staufen homolog 2,TTLGYLSPKDMNQ,_VISGTTLGYLS(ph)PK_,S402,+,24.94,24.05,24.05,21.55,20.65,,23.72,21.94,22.53,23.77,,,23.06,23.03,1.91,1.03,1.03,-1.48,-2.37, ,0.69,-1.09,-0.49,0.74, , ,0.03,transport,nucleolus;endoplasmic reticulum;microtubule,,,,,,,,,,,,,,
7960,Q9NUQ6,SPATS2L,SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein) (SGNP),PAKSQGSGNEAEP,_SQGS(ph)GNEAEPLGK_,S455,,22.26,,,25.00,,,,,,,,,,23.63,-1.37, , ,1.37, , , , , , , , , ,,nucleolus;cytoplasm,,,,,,,,,,,,,,
7961,Q9NUY8,TBC1D23,TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1),VREKVISFIENTS,_VIS(ph)FIENTSTPVDR_,S507,,21.67,,,,,,,,,,,,,21.67,0.00, , , , , , , , , , , , ,positive regulation of Rab GTPase activity,intracellular,,,,,,,,,,,,,,
7962,Q9NV56,MRGBP,MRG/MORF4L-binding protein (MRG-binding protein),ANSNPSSPSAAKR,_VLTANSNPSS(ph)PSAAK_,S195,+,25.03,24.39,25.12,,23.06,21.54,22.79,22.84,23.32,,,22.26,21.50,23.19,1.84,1.20,1.93, ,-0.12,-1.64,-0.40,-0.34,0.14, , ,-0.92,-1.69,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin modification;regulation of growth",nucleus;H4/H2A histone acetyltransferase complex,,,,,,,,,,,,,,
7963,Q9NV70,EXOC1,Exocyst complex component 1 (Exocyst complex component Sec3),SGKLTGSTSSLNK,_LTGS(ph)TSSLNK_,S455,,22.20,,,24.91,,,,,,20.90,,22.25,,22.57,-0.37, , ,2.35, , , , , ,-1.66, ,-0.31, ,protein transport;exocytosis,plasma membrane;exocyst,,,,,,,,,,,,,,
7964,Q9NV70,EXOC1,Exocyst complex component 1 (Exocyst complex component Sec3),LTGSTSSLNKLSV,_LTGSTSS(ph)LNK_,S458,,23.82,,,25.94,,,,,,,,22.51,,24.09,-0.27, , ,1.85, , , , , , , ,-1.58, ,protein transport;exocytosis,plasma membrane;exocyst,,,,,,,,,,,,,,
7965,Q9NVA2,SEP11,Septin-11,VAVGRPSNEELRN,_(ac)AVAVGRPS(ph)NEELR_,S9,,23.55,,,24.39,,,,,22.57,22.51,,,,23.25,0.30, , ,1.13, , , , ,-0.69,-0.74, , , ,protein heterooligomerization;cell cycle;cell division,axon;dendritic spine;synapse;stress fiber;septin complex;cell junction;cytoplasm,,,,,,,,,,,,,,
7966,Q9NVD7,PARVA,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),ATSPQKSPSVPKS,_(ac)ATSPQKS(ph)PSVPK_,S8,+,24.22,25.10,25.81,25.93,27.65,27.62,26.34,29.35,25.67,22.76,25.63,,25.86,25.99,-1.78,-0.89,-0.18,-0.07,1.65,1.62,0.34,3.36,-0.32,-3.24,-0.36, ,-0.13,regulation of cell shape;outflow tract septum morphogenesis;heterotypic cell-cell adhesion;actin cytoskeleton organization;actin-mediated cell contraction;protein heterooligomerization;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity;smooth muscle cell chemotaxis;cilium morphogenesis;cell junction assembly;sprouting angiogenesis,Z disc;protein complex;actin cytoskeleton;cytosol;focal adhesion;nucleus;plasma membrane;lamellipodium,,,,,,,,,,+,,,,
7967,Q9NVD7,PARVA,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),SRKKDDSFLGKLG,_DDS(ph)FLGK_,S28,,21.58,,,,,,,,,,,,,21.58,0.00, , , , , , , , , , , , ,regulation of cell shape;outflow tract septum morphogenesis;heterotypic cell-cell adhesion;actin cytoskeleton organization;actin-mediated cell contraction;protein heterooligomerization;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity;smooth muscle cell chemotaxis;cilium morphogenesis;cell junction assembly;sprouting angiogenesis,Z disc;protein complex;actin cytoskeleton;cytosol;focal adhesion;nucleus;plasma membrane;lamellipodium,,,,,,,,,,+,,,,
7968,Q9NVD7,PARVA,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),SPSVPKSPTPKSP,_S(ph)PTPKS(ph)PPSR_,S14,,22.18,20.73,20.73,24.38,24.51,23.54,,25.84,,,,,,23.13,-0.95,-2.40,-2.40,1.25,1.38,0.41, ,2.71, , , , , ,regulation of cell shape;outflow tract septum morphogenesis;heterotypic cell-cell adhesion;actin cytoskeleton organization;actin-mediated cell contraction;protein heterooligomerization;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity;smooth muscle cell chemotaxis;cilium morphogenesis;cell junction assembly;sprouting angiogenesis,Z disc;protein complex;actin cytoskeleton;cytosol;focal adhesion;nucleus;plasma membrane;lamellipodium,,,,,,,,,,+,,,,
7969,Q9NVD7,PARVA,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),KSPTPKSPPSRKK,_S(ph)PTPKS(ph)PPSR_,S19,+,22.67,24.22,24.22,25.14,25.37,24.79,22.39,26.22,21.77,,22.99,19.88,21.85,23.46,-0.79,0.77,0.77,1.68,1.91,1.33,-1.07,2.76,-1.69, ,-0.47,-3.58,-1.61,regulation of cell shape;outflow tract septum morphogenesis;heterotypic cell-cell adhesion;actin cytoskeleton organization;actin-mediated cell contraction;protein heterooligomerization;substrate adhesion-dependent cell spreading;establishment or maintenance of cell polarity;smooth muscle cell chemotaxis;cilium morphogenesis;cell junction assembly;sprouting angiogenesis,Z disc;protein complex;actin cytoskeleton;cytosol;focal adhesion;nucleus;plasma membrane;lamellipodium,,,,,,,,,,+,,,,
7970,Q9NVI1,FANCI,Fanconi anemia group I protein (Protein FACI),GKTIETSPSLSRM,_TIETS(ph)PSLSR_,S234,,,,,21.17,24.27,22.09,,23.97,21.59,,,,,22.62, , , ,-1.45,1.66,-0.53, ,1.35,-1.03, , , , ,DNA repair;positive regulation of protein ubiquitination;cell cycle,nucleoplasm;plasma membrane,,,,,,,,,,,,,,
7974,Q9NVM9,ASUN,Protein asunder homolog (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Sarcoma antigen NY-SAR-95),IKDSPDSPEPPNK,_EELAEAEIIKDSPDS(ph)PEPPNK_,S626,+,24.04,24.40,24.87,23.86,,,26.08,,26.16,26.81,25.01,26.19,,25.27,-1.23,-0.87,-0.40,-1.41, , ,0.81, ,0.89,1.55,-0.25,0.92, ,sperm motility;regulation of mitotic cell cycle;mitosis;regulation of fertilization;cell division,nucleus;cytoplasm,,,,,,,,,,,,,,
7976,Q9NVR2,INTS10,Integrator complex subunit 10 (Int10),DTSDLMSPSKRSS,_STQIENQHQGAQDTSDLM(ox)S(ph)PSK_,S231,+,22.25,24.02,24.73,,,,24.95,24.78,25.28,25.38,23.84,23.53,24.69,24.35,-2.09,-0.32,0.38, , , ,0.61,0.44,0.93,1.03,-0.51,-0.82,0.34,snRNA processing,integrator complex;cytoplasm,,,,,,,,,,,,,,
7979,Q9NVU0,POLR3E,DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit C5) (DNA-directed RNA polymerase III 80 kDa polypeptide),IKEEPVSEEGEED,_EEPVS(ph)EEGEEDEEQEAEEEPM(ox)DTSPSGLHSK_,S503,,,,,,25.11,24.21,24.77,24.86,,24.62,24.86,,,24.74, , , , ,0.37,-0.53,0.03,0.12, ,-0.12,0.12, , ,defense response to virus;transcription elongation from RNA polymerase III promoter;termination of RNA polymerase III transcription;innate immune response,nucleoplasm,,,,,,,,,,,,,,
7980,Q9NVU7,SDAD1,Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA),KYIEIDSDEEPRG,_YIEIDS(ph)DEEPR_,S585,+,26.24,,,22.09,25.52,,21.02,,23.03,22.39,,24.95,,23.61,2.64, , ,-1.52,1.92, ,-2.58, ,-0.58,-1.22, ,1.35, ,ribosomal large subunit biogenesis;protein transport,nucleolus,,,,,,,,,,,,,,
7982,Q9NW68,BSDC1,BSD domain-containing protein 1,NNGKKGSSTDISE,_KGS(ph)STDISEDWEK_,S292,+,23.84,24.90,25.30,24.38,,23.22,24.72,24.16,25.77,25.86,24.77,24.93,23.70,24.63,-0.79,0.27,0.68,-0.25, ,-1.41,0.09,-0.47,1.14,1.23,0.15,0.30,-0.93,,,,,,,,,,,,,,,,
7983,Q9NW81,ATP5SL,ATP synthase subunit s-like protein,QPRDTASPVPA__,_SGPEEQPRDTAS(ph)PVPA_,S226,+,22.94,23.40,23.40,,23.96,23.81,22.96,23.83,24.42,24.38,23.39,24.98,23.89,23.78,-0.84,-0.38,-0.38, ,0.18,0.03,-0.82,0.05,0.64,0.60,-0.39,1.20,0.11,,,,,,,,,,,,,,,,
7984,Q9NW82,WDR70,WD repeat-containing protein 70,MFAQVESDDEEAK,_TM(ox)FAQVES(ph)DDEEAK_,S638,+,25.54,25.00,25.22,25.96,,22.98,24.67,22.73,25.53,24.95,24.23,24.90,,24.70,0.84,0.30,0.52,1.25, ,-1.72,-0.03,-1.97,0.83,0.24,-0.47,0.20, ,,,,,,,,,,,,,,,,
7985,Q9NW97,TMEM51,Transmembrane protein 51,HAQEEDSQEEEEE,_(gl)QGEDLAHVQHPTGAGPHAQEEDS(ph)QEEEEEDEEAASR_,S115,,,23.20,23.20,,,24.32,,23.53,24.40,26.25,,,,24.15, ,-0.95,-0.95, , ,0.17, ,-0.62,0.25,2.10, , , ,,integral to membrane,,,,,,,,,,,,,,
7988,Q9NWB6,ARGLU1,Arginine and glutamate-rich protein 1,RESRSRSRSTNTA,_S(ph)RS(ph)TNTAVSRR_,S58,,22.31,22.88,23.84,20.66,,,18.18,,,,,,,21.57,0.74,1.31,2.27,-0.91, , ,-3.40, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
7989,Q9NWB6,ARGLU1,Arginine and glutamate-rich protein 1,SRSRSRSTNTAVS,_S(ph)RS(ph)TNTAVSRR_,S60,,22.31,22.88,23.84,20.66,,,18.18,,,,,,,21.57,0.74,1.31,2.27,-0.91, , ,-3.40, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
7990,Q9NWC5,TMEM45A,Transmembrane protein 45A (DNA polymerase-transactivated protein 4) (Dermal papilla-derived protein 7),AEREQESEEEM__,_NAEREQES(ph)EEEM(ox)_,S271,+,,,,24.13,,19.53,19.55,20.42,21.85,,,21.69,20.58,21.11, , , ,3.03, ,-1.57,-1.55,-0.69,0.74, , ,0.58,-0.53,,integral to membrane,,,,,,,,,,,,,,
7991,Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),QHSSNASPINRIV,_AGAGM(ox)ITQHSSNAS(ph)PINR_,S1002,+,24.67,24.55,22.85,25.65,25.56,26.12,25.18,25.80,26.25,25.01,24.03,24.77,23.72,24.93,-0.26,-0.39,-2.09,0.72,0.62,1.18,0.24,0.86,1.32,0.07,-0.91,-0.16,-1.22,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,SAP-domain,,,,,,,,,,,,,
7992,Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),QDAIAQSPEKESK,_ITDSEASKPKDGQDAIAQS(ph)PEK_,S289,+,27.34,27.90,27.86,29.21,24.80,26.60,,26.86,,28.55,25.39,,26.27,27.08,0.26,0.82,0.78,2.13,-2.28,-0.48, ,-0.22, ,1.47,-1.69, ,-0.81,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,SAP-domain,,,,,,,,,,,,,
7993,Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),HSKELLSAEENKR,_ELLS(ph)AEENK_,S144,,22.65,23.46,23.46,23.57,,,23.06,,23.84,24.03,,,,23.44,-0.79,0.02,0.02,0.13, , ,-0.37, ,0.40,0.59, , , ,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,SAP-domain,,,,,,,,,,,,,
7994,Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),KRISSKSPGHMVI,_S(ph)PGHM(ox)VILDQTK_,S553,+,26.82,28.38,28.38,27.98,27.42,28.67,29.33,27.73,29.00,29.09,27.52,27.71,27.26,28.10,-1.28,0.28,0.28,-0.12,-0.68,0.57,1.23,-0.37,0.90,0.99,-0.58,-0.39,-0.84,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,SAP-domain,,,,,,,,,,,,,
7995,Q9NWH9,SLTM,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),VVTNARSPGAKCY,_VVTNARS(ph)PGAK_,S421,+,,24.23,24.23,20.72,21.13,20.29,19.87,19.69,20.84,,19.57,20.28,20.63,21.04, ,3.19,3.19,-0.32,0.08,-0.76,-1.17,-1.36,-0.20, ,-1.47,-0.77,-0.42,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,SAP-domain,,,,,,,,,,,,,
7996,Q9NWQ4,GPATCH2L,G patch domain-containing protein 2-like,APVTNFSDSDDTM,_EVAPVTNFS(ph)DSDDTM(ox)VAK_,S86,,22.78,,,,,22.86,,22.86,23.24,,,,23.22,22.99,-0.21, , , , ,-0.13, ,-0.13,0.25, , , ,0.23,,,,,,,,,,,,,,,,
7997,Q9NWQ8,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),SATDTTSETNKRF,_EGGEAEESATDTTS(ph)ETNK_,S288,,20.38,23.98,23.72,25.14,,22.79,,22.76,25.24,,23.71,24.99,21.91,23.46,-3.08,0.52,0.26,1.68, ,-0.67, ,-0.70,1.78, ,0.25,1.53,-1.55,T cell receptor signaling pathway;regulation of T cell activation;epidermal growth factor receptor signaling pathway;negative regulation of T cell activation;intracellular signal transduction,membrane raft;integral to membrane;plasma membrane;intracellular,,,,+,,,,,,,,,,
7998,Q9NWQ8,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),KKPRQHSGDHENL,_(gl)QHS(ph)GDHENLM(ox)NVPSDK_,S50,,,,,,,,22.60,22.81,23.56,,22.82,23.00,22.49,22.88, , , , , , ,-0.28,-0.07,0.68, ,-0.06,0.12,-0.39,T cell receptor signaling pathway;regulation of T cell activation;epidermal growth factor receptor signaling pathway;negative regulation of T cell activation;intracellular signal transduction,membrane raft;integral to membrane;plasma membrane;intracellular,,,,+,,,,,,,,,,
7999,Q9NWQ8,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),KRFSSLSYKSREE,_RFSSLS(ph)YK_,S298,,,22.26,22.26,,,,,,20.83,,,22.61,22.62,22.12, ,0.15,0.15, , , , , ,-1.29, , ,0.50,0.50,T cell receptor signaling pathway;regulation of T cell activation;epidermal growth factor receptor signaling pathway;negative regulation of T cell activation;intracellular signal transduction,membrane raft;integral to membrane;plasma membrane;intracellular,,,,+,,,,,,,,,,
8000,Q9NWS9,ZNF446,Zinc finger protein 446 (Zinc finger protein with KRAB and SCAN domains 20),TEEPLGSPHPSGT,_TEEPLGS(ph)PHPSGTVESPGEGPQDTR_,S137,+,22.43,,,21.73,22.95,24.67,23.30,22.87,,,23.49,,,23.06,-0.63, , ,-1.33,-0.11,1.61,0.23,-0.20, , ,0.43, , ,"viral reproduction;transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8001,Q9NWS9,ZNF446,Zinc finger protein 446 (Zinc finger protein with KRAB and SCAN domains 20),PSGTVESPGEGPQ,_TEEPLGS(ph)PHPSGTVES(ph)PGEGPQDTR_,S146,,22.65,,,21.73,,,,,,,,,,22.19,0.46, , ,-0.46, , , , , , , , , ,"viral reproduction;transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8003,Q9NWU2,GID8,Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1),_____MSYAEKPD,_(ac)S(ph)YAEKPDEITK_,S2,,21.62,24.45,24.61,24.68,,,,,,23.23,,23.14,,23.62,-2.00,0.83,0.99,1.06, , , , , ,-0.39, ,-0.49, ,,nucleus,,,,,,,,,,,,,,
8006,Q9NWV8,BABAM1,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),ASVGSRSEGEGEA,_S(ph)EGEGEAASADDGSLNTSGAGPK_,S49,,23.16,,,23.71,,22.17,,,,,,,,23.01,0.14, , ,0.70, ,-0.84, , , , , , , ,protein K63-linked deubiquitination;double-strand break repair;G2/M transition DNA damage checkpoint;chromatin modification;response to ionizing radiation;positive regulation of DNA repair,BRISC complex;BRCA1-A complex;cytoplasm,,,,,,,,,,,,,,
8007,Q9NWV8,BABAM1,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),PRPRTRSNPEGAE,_S(ph)NPEGAEDRAVGAQASVGSR_,S29,+,24.03,25.18,24.44,25.52,25.47,25.41,25.60,26.02,24.95,,25.72,25.55,23.74,25.13,-1.11,0.04,-0.70,0.39,0.33,0.28,0.46,0.88,-0.18, ,0.58,0.42,-1.40,protein K63-linked deubiquitination;double-strand break repair;G2/M transition DNA damage checkpoint;chromatin modification;response to ionizing radiation;positive regulation of DNA repair,BRISC complex;BRCA1-A complex;cytoplasm,,,,,,,,,,,,,,
8009,Q9NX02,NLRP2,"NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)",NVTASESDAEVER,_ENLPENVTASES(ph)DAEVER_,S649,,22.77,,,,,,,,,,,,,22.77,0.00, , , , , , , , , , , , ,positive regulation of interleukin-1 beta secretion;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,cytoplasm,,,,,,,,,,,,,,
8013,Q9NX63,CHCHD3,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial",SKSQRYSGAYGAS,_YS(ph)GAYGASVSDEELK_,S50,+,,24.27,23.06,25.77,25.78,26.69,25.82,25.90,25.84,25.83,26.98,26.12,25.62,25.64, ,-1.37,-2.58,0.13,0.14,1.05,0.18,0.26,0.20,0.19,1.34,0.48,-0.02,mitochondrial fusion;inner mitochondrial membrane organization,mitochondrial inner membrane;nucleus,,,,,,,,,,,,,,
8015,Q9NXC5,MIOS,WD repeat-containing protein mio,QYGVSGSPTKSKV,_GFSQYGVSGS(ph)PTK_,S766,+,22.85,24.08,24.08,24.35,,24.03,24.63,24.94,23.20,23.58,23.23,23.84,,23.89,-1.04,0.19,0.19,0.46, ,0.14,0.74,1.05,-0.69,-0.32,-0.66,-0.05, ,,,,,,,,,,,,,,,,
8017,Q9NXE8,CWC25,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),KKMANSSPVLSKV,_M(ox)ANSS(ph)PVLSK_,S155,,22.23,,,23.58,,,,,,,,,,22.91,-0.67, , ,0.67, , , , , , , , , ,,,,,,,,,,,,,,,,
8018,Q9NXG2,THUMPD1,THUMP domain-containing protein 1,DKDQQPSGSEGED,_FTDKDQQPS(ph)GS(ph)EGEDDDAEAALK_,S86,+,29.15,26.26,26.26,24.68,24.16,,25.26,24.87,26.20,26.11,23.49,,25.23,25.61,3.54,0.66,0.66,-0.93,-1.44, ,-0.35,-0.73,0.59,0.50,-2.11, ,-0.38,,,,,,,,,,,,,,,,
8019,Q9NXG2,THUMPD1,THUMP domain-containing protein 1,DQQPSGSEGEDDD,_FTDKDQQPS(ph)GS(ph)EGEDDDAEAALK_,S88,+,28.86,26.01,26.67,24.68,24.16,,22.48,,23.75,22.46,,,,24.88,3.97,1.12,1.79,-0.20,-0.72, ,-2.40, ,-1.14,-2.42, , , ,,,,,,,,,,,,,,,,
8021,Q9NXH8,TOR4A,Torsin-4A (Torsin family 4 member A),APRPGCSPRAPRA,_LLQPGGGPDVGTGAPRPGCS(ph)PR_,S63,+,22.25,23.01,,23.34,,,23.65,24.07,,24.36,24.48,25.10,,23.78,-1.53,-0.78, ,-0.44, , ,-0.13,0.29, ,0.57,0.70,1.32, ,chaperone mediated protein folding requiring cofactor,integral to membrane,,,,,,,,,,,,,,
8022,Q9NXH8,TOR4A,Torsin-4A (Torsin family 4 member A),RKKRRRSRLVLYP,_S(ph)RLVLYPETSR_,S97,,,23.52,23.79,23.17,24.87,24.66,22.93,24.23,23.05,24.79,24.44,24.12,24.69,24.02, ,-0.50,-0.23,-0.85,0.85,0.64,-1.09,0.21,-0.97,0.77,0.42,0.09,0.67,chaperone mediated protein folding requiring cofactor,integral to membrane,,,,,,,,,,,,,,
8025,Q9NY27,PPP4R2,Serine/threonine-protein phosphatase 4 regulatory subunit 2,SEVSSVSPLKNKH,_NHSDSSTSESEVSSVS(ph)PLK_,S226,+,24.54,26.21,27.14,23.45,24.50,25.37,26.06,26.53,,26.33,22.48,25.11,25.27,25.25,-0.71,0.96,1.89,-1.80,-0.75,0.12,0.81,1.28, ,1.08,-2.77,-0.14,0.02,cellular protein modification process;regulation of double-strand break repair via homologous recombination;mRNA processing;RNA splicing,protein phosphatase 4 complex;nucleus;centrosome,,,,,,,,,,,,,,
8027,Q9NY61,AATF,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),TKPNAGSEEISSE,_YLVDGTKPNAGS(ph)EEIS(ph)S(ph)EDDELVEEK_,S316,,24.47,,,,,,,,,,,,,24.47,0.00, , , , , , , , , , , , ,"regulation of mitotic cell cycle;negative regulation of apoptotic process;embryonic cleavage;response to DNA damage stimulus;ribosome biogenesis;cell adhesion;negative regulation of superoxide anion generation;apoptotic process;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;negative regulation of amyloid precursor protein biosynthetic process;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Golgi apparatus;focal adhesion;centrosome,,,,,,,,,,,,,,
8028,Q9NY61,AATF,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),AGSEEISSEDDEL,_YLVDGTKPNAGSEEIS(ph)S(ph)EDDELVEEK_,S320,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,"regulation of mitotic cell cycle;negative regulation of apoptotic process;embryonic cleavage;response to DNA damage stimulus;ribosome biogenesis;cell adhesion;negative regulation of superoxide anion generation;apoptotic process;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;negative regulation of amyloid precursor protein biosynthetic process;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Golgi apparatus;focal adhesion;centrosome,,,,,,,,,,,,,,
8029,Q9NY61,AATF,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),GSEEISSEDDELV,_YLVDGTKPNAGSEEIS(ph)S(ph)EDDELVEEK_,S321,,25.79,,,,,,,,,,,,,25.79,0.00, , , , , , , , , , , , ,"regulation of mitotic cell cycle;negative regulation of apoptotic process;embryonic cleavage;response to DNA damage stimulus;ribosome biogenesis;cell adhesion;negative regulation of superoxide anion generation;apoptotic process;nerve growth factor receptor signaling pathway;transcription, DNA-dependent;negative regulation of amyloid precursor protein biosynthetic process;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Golgi apparatus;focal adhesion;centrosome,,,,,,,,,,,,,,
8030,Q9NYB0,TERF2IP,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1),LGDAPVSPSSQKL,_YLLGDAPVS(ph)PSSQK_,S203,+,26.85,26.08,26.75,26.21,27.48,27.64,27.69,27.93,27.28,27.25,26.90,26.69,27.16,27.07,-0.22,-0.99,-0.32,-0.86,0.41,0.57,0.62,0.86,0.21,0.18,-0.17,-0.38,0.09,"telomere maintenance via telomerase;protein localization to chromosome, telomeric region;negative regulation of DNA recombination at telomere;positive regulation of NF-kappaB transcription factor activity;negative regulation of telomere maintenance;positive regulation of I-kappaB kinase/NF-kappaB cascade;protection from non-homologous end joining at telomere;regulation of double-strand break repair via homologous recombination;transcription, DNA-dependent",nucleoplasm;nuclear telomere cap complex;cytoplasm,,,,,,,,,,,,,,
8031,Q9NYB9,ABI2,Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1),MAPSQQSPVRTAS,_NM(ox)APSQQS(ph)PVRTASVNQR_,S221,+,,22.49,22.49,,23.92,22.84,24.19,24.39,23.31,23.10,,23.18,22.55,23.25, ,-0.76,-0.76, ,0.68,-0.40,0.95,1.14,0.06,-0.15, ,-0.07,-0.69,peptidyl-tyrosine phosphorylation;dendrite development;actin polymerization or depolymerization;cell migration;learning or memory;camera-type eye development,filopodium;cytosol;cytoskeleton;lamellipodium;cell-cell adherens junction;dendrite,,,,,,,,,,+,,,,
8032,Q9NYF3,FAM53C,Protein FAM53C,PRRLRPSLDFDKM,_LRPS(ph)LDFDK_,S299,+,22.42,23.30,23.36,23.30,22.15,23.48,24.13,23.94,23.25,22.52,23.31,25.21,,23.36,-0.94,-0.07,0.00,-0.07,-1.22,0.12,0.76,0.58,-0.11,-0.84,-0.05,1.85, ,,,,,,,,,,,,,,,,
8033,Q9NYF3,FAM53C,Protein FAM53C,RHCRSLSVPVDLS,_SLS(ph)VPVDLSR_,S122,+,24.29,22.61,22.10,23.54,,23.52,,23.92,,22.39,23.36,24.29,,23.34,0.95,-0.72,-1.23,0.20, ,0.18, ,0.59, ,-0.95,0.03,0.95, ,,,,,,,,,,,,,,,,
8035,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),EALDYFSDKESGK,_AEGEWEDQEALDYFS(ph)DK_,S383,,23.59,,,,24.01,,,,,,,,,23.80,-0.21, , , ,0.21, , , , , , , , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8036,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),KDLFDYSPPLHKN,_LKDLFDYS(ph)PPLHK_,S510,+,29.92,29.03,29.42,28.66,30.20,30.58,30.29,30.03,31.21,31.61,29.28,29.62,30.26,30.01,-0.09,-0.98,-0.59,-1.35,0.19,0.57,0.28,0.02,1.20,1.60,-0.73,-0.39,0.25,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8037,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),TFEHDPSESIDEF,_DTFEHDPS(ph)ESIDEFNK_,S194,+,24.52,23.12,23.68,21.88,,,24.90,,26.46,25.25,,23.94,,24.22,0.30,-1.10,-0.54,-2.34, , ,0.69, ,2.24,1.03, ,-0.28, ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8038,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),EHDPSESIDEFNK,_DTFEHDPSES(ph)IDEFNK_,S196,+,25.44,25.30,25.30,22.53,,,25.81,,26.57,26.53,23.74,26.15,,25.26,0.18,0.03,0.03,-2.73, , ,0.55, ,1.31,1.27,-1.53,0.88, ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8039,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),STFREESPLRIKM,_STFREES(ph)PLRIK_,S529,+,29.45,29.35,28.54,29.39,30.03,30.49,29.41,29.27,28.95,28.83,28.47,28.62,29.01,29.22,0.23,0.13,-0.67,0.17,0.82,1.28,0.19,0.06,-0.26,-0.38,-0.75,-0.59,-0.21,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8042,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),HRRIDISPSTLRK,_IDIS(ph)PSTLR_,S656,+,29.27,29.53,28.96,29.28,32.11,31.32,30.39,30.35,30.29,30.84,29.68,29.98,30.45,30.19,-0.92,-0.66,-1.23,-0.91,1.92,1.14,0.20,0.16,0.10,0.65,-0.51,-0.21,0.26,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8044,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),PSQHSHSIQHSPE,_NTPSQHSHS(ph)IQHS(ph)PER_,S262,,23.52,,,24.06,,,,,,,,,,23.79,-0.27, , ,0.27, , , , , , , , , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8047,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),FKKSGSSPKWTHD,_SGSS(ph)PKWTHDK_,S882,,,25.04,25.04,,20.72,21.88,,22.36,,,,,,23.01, ,2.03,2.03, ,-2.29,-1.13, ,-0.64, , , , , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8048,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),SPLKSKSQEEPKD,_S(ph)QEEPKDTFEHDPSESIDEFNK_,S181,,,,,,24.13,24.27,,23.53,,,,,,23.98, , , , ,0.15,0.30, ,-0.45, , , , , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8050,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),LSAYDNSPRSPHS,_SSATSGDIWPGLSAYDNS(ph)PR_,S220,+,26.70,22.09,,23.16,25.95,23.83,,23.28,24.16,23.55,24.22,21.00,23.22,23.74,2.95,-1.66, ,-0.58,2.21,0.09, ,-0.46,0.42,-0.19,0.47,-2.74,-0.52,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8053,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),NGSSRYSPSQNSP,_YS(ph)PSQNS(ph)PIHHIPSR_,S283,,23.48,26.20,,24.15,,,,,,,,,22.82,24.16,-0.68,2.04, ,-0.01, , , , , , , , ,-1.34,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8054,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),YSPSQNSPIHHIP,_YS(ph)PSQNS(ph)PIHHIPSR_,S288,,23.48,26.20,,24.15,,,,,,,,,22.82,24.16,-0.68,2.04, ,-0.01, , , , , , , , ,-1.34,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
8055,Q9NYI0,PSD3,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),GLKKSHSSPSLNP,_SHS(ph)SPSLNPDTSPITAK_,S339,,,,,25.40,22.19,,,,22.23,,23.15,23.63,,23.32, , , ,2.08,-1.13, , , ,-1.09, ,-0.17,0.31, ,neuron differentiation;regulation of ARF protein signal transduction,cell junction;plasma membrane;postsynaptic density;postsynaptic membrane,,,,,,,,,,,,,,
8057,Q9NYJ8,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2),GNNSATSPRVVVT,_AIGNNSATS(ph)PR_,S450,,,,,24.44,21.71,,21.73,,,,,,21.31,22.30, , , ,2.14,-0.59, ,-0.56, , , , , ,-0.99,toll-like receptor 4 signaling pathway;JNK cascade;positive regulation of NF-kappaB transcription factor activity;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;nucleotide-binding oligomerization domain containing signaling pathway;toll-like receptor 3 signaling pathway;activation of MAPK activity;TRIF-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB cascade;innate immune response;T cell receptor signaling pathway;heart development;toll-like receptor 1 signaling pathway,cytosol;endosome membrane;plasma membrane,,,,,,,,,,,,,,
8058,Q9NYJ8,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2),TVYIAASPPNTDE,_NQPTVYIAAS(ph)PPNTDELM(ox)SR_,S372,+,22.08,,,22.23,23.76,22.87,23.05,23.86,,,23.76,,,23.09,-1.01, , ,-0.86,0.67,-0.21,-0.04,0.77, , ,0.67, , ,toll-like receptor 4 signaling pathway;JNK cascade;positive regulation of NF-kappaB transcription factor activity;Toll signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;nucleotide-binding oligomerization domain containing signaling pathway;toll-like receptor 3 signaling pathway;activation of MAPK activity;TRIF-dependent toll-like receptor signaling pathway;I-kappaB kinase/NF-kappaB cascade;innate immune response;T cell receptor signaling pathway;heart development;toll-like receptor 1 signaling pathway,cytosol;endosome membrane;plasma membrane,,,,,,,,,,,,,,
8059,Q9NYL2,MLTK,Mitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),GLTKNFSSLHLNS,_NFS(ph)SLHLNSR_,S648,,22.99,,,,,,,,,,,22.99,,22.99,0.00, , , , , , , , , , ,0.00, ,cell differentiation;activation of JUN kinase activity;response to radiation;DNA damage checkpoint;cell proliferation;cell death;cell cycle arrest;cytoskeleton organization;positive regulation of apoptotic process,nucleus;cytoplasm,,+,,,,,,,,,,,,
8060,Q9NYL2,MLTK,Mitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),NQSRSSSPTQYGL,_SSS(ph)PTQYGLTK_,S637,+,24.84,25.08,25.69,25.77,24.44,23.07,26.07,25.02,25.14,25.31,22.41,23.55,,24.70,0.14,0.38,0.99,1.07,-0.26,-1.63,1.37,0.32,0.44,0.61,-2.29,-1.15, ,cell differentiation;activation of JUN kinase activity;response to radiation;DNA damage checkpoint;cell proliferation;cell death;cell cycle arrest;cytoskeleton organization;positive regulation of apoptotic process,nucleus;cytoplasm,,+,,,,,,,,,,,,
8061,Q9NYL9,TMOD3,Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod),ELLGNLSETELKQ,_YKDLDEDELLGNLS(ph)ETELK_,S25,,24.98,,,,24.64,,,22.32,23.35,24.01,,,,23.86,1.12, , , ,0.78, , ,-1.54,-0.51,0.15, , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8063,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",KMDGKESKGSPVF,_ES(ph)KGSPVFLPR_,S420,,21.16,,,20.90,,25.18,22.11,,,,,,23.32,22.53,-1.37, , ,-1.64, ,2.65,-0.43, , , , , ,0.79,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8064,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",GKESKGSPVFLPR,_GS(ph)PVFLPR_,S423,+,24.68,24.21,19.40,25.69,24.51,25.00,25.24,24.95,25.39,24.50,,24.55,24.52,24.39,0.30,-0.18,-4.99,1.30,0.12,0.61,0.85,0.56,1.00,0.11, ,0.17,0.14,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8065,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",LPGGDLSPPDSPE,_HLLTDLPLPPELPGGDLS(ph)PPDS(ph)PEPK_,S681,,25.09,,,,,,,,,,,,,25.09,0.00, , , , , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8066,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",DLSPPDSPEPKAI,_HLLTDLPLPPELPGGDLS(ph)PPDS(ph)PEPK_,S685,,25.09,,,,,,,,,,,,,25.09,0.00, , , , , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8067,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",SRSRHSSISPVRL,_HSS(ph)IS(ph)PVRLPLNSSLGAELSR_,S383,,22.66,,,,,,,,,,,,,22.66,0.00, , , , , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8068,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",SRHSSISPVRLPL,_HSS(ph)IS(ph)PVRLPLNSSLGAELSR_,S385,,22.66,,,,,,,,,,,,,22.66,0.00, , , , , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8069,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",EPVKNSSPAPPQP,_NSS(ph)PAPPQPAPGK_,S1083,,26.71,,,27.45,,,,,,,,,,27.08,-0.37, , ,0.37, , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8071,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",GRRRSSSPFLSKR,_SS(ph)S(ph)PFLSK_,S334,,26.85,,,25.01,23.91,,,,21.69,,,,,24.36,2.49, , ,0.64,-0.45, , , ,-2.68, , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
8072,Q9NYV6,RRN3,RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA),ENDFFNSPPRKTV,_ALENDFFNS(ph)PPRK_,S11,+,19.85,23.31,23.31,21.21,22.29,,22.59,,,22.76,22.95,,23.36,22.40,-2.56,0.91,0.91,-1.19,-0.11, ,0.19, , ,0.35,0.55, ,0.96,"transcription initiation from RNA polymerase I promoter;negative regulation of apoptotic process;regulation of DNA-dependent transcription, initiation;nucleolus organization;cytoplasm organization;in utero embryonic development;homeostasis of number of cells;ribosome biogenesis;cell proliferation;positive regulation of transcription, DNA-dependent",nucleoplasm;nucleolus,,,,,,,,,,,,,,
8074,Q9NYZ1,TVP23B,Golgi apparatus membrane protein TVP23 homolog B,_MLQQDSNDDTED,_(ac)M(ox)LQQDS(ph)NDDTEDVSLFDAEEETTNRPR_,S6,,25.19,,,,24.96,,,,24.36,26.14,,,,25.17,0.03, , , ,-0.20, , , ,-0.80,0.98, , , ,,integral to membrane,,,,,,,,,,,,,,
8077,Q9NZ63,C9orf78,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),RRRRGDSESEEDE,_RGDS(ph)ES(ph)EEDEQDSEEVR_,S15,,23.01,,,,,,,,,,,,,23.01,0.00, , , , , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
8078,Q9NZ63,C9orf78,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),RRGDSESEEDEQD,_RGDS(ph)ES(ph)EEDEQDSEEVR_,S17,,23.01,,,,,,,,,,,,,23.01,0.00, , , , , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
8079,Q9NZ63,C9orf78,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),KPEPERSPPNRKR,_VGDTEKPEPERS(ph)PPNR_,S261,+,23.81,24.82,21.55,24.68,25.26,,,,23.07,,23.22,,22.06,23.56,0.25,1.26,-2.02,1.12,1.70, , , ,-0.49, ,-0.34, ,-1.50,,nucleus;cytoplasm,,,,,,,,,,,,,,
8080,Q9NZB2,FAM120A,Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A),VAPQVPSPGGAPG,_PVAPQVPS(ph)PGGAPGQGPYPYSLSEPAPLTLDTSGK_,S383,+,26.31,24.92,24.58,28.06,,,27.49,,27.38,27.59,,26.49,,26.60,-0.29,-1.68,-2.03,1.45, , ,0.89, ,0.78,0.99, ,-0.12, ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
8081,Q9NZD8,SPG21,Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein),KGSLGISQEEQ__,_GSLGIS(ph)QEEQ_,S277,+,23.84,23.88,23.88,24.89,,24.60,23.08,23.10,22.18,21.26,23.34,24.54,23.77,23.53,0.31,0.35,0.35,1.36, ,1.07,-0.45,-0.43,-1.35,-2.26,-0.19,1.01,0.24,antigen receptor-mediated signaling pathway;cell death,cytosol;trans-Golgi network transport vesicle;endosome membrane;nucleus,,,,,,,,,,,,,,
8082,Q9NZI6,TFCP2L1,Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1) (CRTR-1) (Transcription factor LBP-9),QEEPQLSPENEAR,_(gl)QEEPQLS(ph)PENEAR_,S37,,24.42,,,,,,,,,,,,,24.42,0.00, , , , , , , , , , , , ,"cytoplasm organization;cell morphogenesis;steroid biosynthetic process;regulation of transcription from RNA polymerase II promoter;female pregnancy;negative regulation of transcription from RNA polymerase II promoter;determination of adult lifespan;epithelial cell maturation;transcription, DNA-dependent;salivary gland development;positive regulation of growth",mitochondrion;nucleolus;membrane,Other TF domain,,,,,,,,,,,,,
8083,Q9NZJ4,SACS,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),APSTPTSPTEFLT,_DSAPSTPTS(ph)PTEFLTPGLR_,S4264,,20.73,,,,24.75,23.97,23.90,,,,,,,23.34,-2.60, , , ,1.41,0.63,0.56, , , , , , ,protein folding;cell death;negative regulation of inclusion body assembly,axon;mitochondrion;nucleus;cell body fiber;dendrite,,,,,,,,,,,,,,
8087,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),GPVGTVSEAQLAR,_GPVGT(ph)VS(ph)EAQLAR_,S174,+,27.46,26.42,26.51,24.35,26.55,,27.15,26.59,27.24,26.28,26.76,26.40,27.09,26.57,0.89,-0.14,-0.06,-2.22,-0.01, ,0.58,0.02,0.67,-0.28,0.20,-0.17,0.52,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
8088,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),IEGRQLSGNNIRP,_(gl)QLS(ph)GNNIRPVVK_,S212,,21.21,22.33,,19.45,,,,,24.21,25.16,,,,22.47,-1.26,-0.14, ,-3.02, , , , ,1.74,2.69, , , ,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
8089,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),RKLRSRSLSQIHE,_S(ph)LSQIHEAAVR_,S716,+,20.95,23.34,23.47,,23.44,23.73,23.96,23.96,24.04,25.77,24.54,24.40,24.41,23.83,-2.89,-0.49,-0.37, ,-0.39,-0.10,0.13,0.13,0.20,1.93,0.71,0.56,0.58,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
8090,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),LRSRSLSQIHEAA,_SLS(ph)QIHEAAVR_,S718,+,21.43,23.11,,,24.34,24.54,24.19,24.43,23.94,,24.27,23.58,,23.76,-2.33,-0.65, , ,0.58,0.78,0.43,0.67,0.18, ,0.51,-0.18, ,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
8091,Q9NZM3,ITSN2,Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein),VSPGSVSPIHGQG,_TVSPGSVS(ph)PIHGQGQVVENLK_,S889,+,23.55,23.46,24.15,21.41,,23.16,24.09,23.87,24.27,24.25,,24.06,23.42,23.61,-0.06,-0.15,0.54,-2.20, ,-0.45,0.48,0.26,0.67,0.64, ,0.45,-0.19,endocytosis;regulation of Rho protein signal transduction,cytoplasm,,,,+,,,,,,,,,,
8092,Q9NZN4,EHD2,EH domain-containing protein 2 (PAST homolog 2),EDGEEGSDDEAEW,_GPDEAM(ox)EDGEEGS(ph)DDEAEWVVTKDK_,S438,,25.38,,,22.19,25.64,,,,,,,,,24.40,0.98, , ,-2.21,1.23, , , , , , , , ,blood coagulation;endocytosis;cortical actin cytoskeleton organization;endocytic recycling;GTP catabolic process,plasma membrane;nucleus;recycling endosome membrane,,,,,,,,,,,,,,
8094,Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),KPIRHGSILNRES,_HGS(ph)ILNR_,S22,,24.36,,,22.80,,,,,,,,,,23.58,0.78, , ,-0.78, , , , , , , , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;axon guidance;termination of G-protein coupled receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
8095,Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),STPSSVSPEPQDS,_HLSTPSSVS(ph)PEPQDSAK_,S618,+,23.21,23.65,23.65,,25.28,23.63,24.57,25.56,,24.08,24.40,,,24.23,-1.01,-0.57,-0.57, ,1.05,-0.60,0.34,1.34, ,-0.15,0.18, , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;axon guidance;termination of G-protein coupled receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
8096,Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),TQSLVGSPSTRIA,_SETIQDTDTQSLVGS(ph)PSTR_,S322,+,24.71,23.53,23.53,,24.76,24.27,25.16,24.73,24.62,25.20,25.76,23.52,,24.53,0.19,-1.00,-1.00, ,0.23,-0.25,0.63,0.20,0.09,0.68,1.24,-1.01, ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;axon guidance;termination of G-protein coupled receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
8097,Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),PRYRTASQGPQTD,_TAS(ph)QGPQTDSVIQNSENIK_,S1269,+,24.36,,,,23.19,23.60,22.38,22.59,23.13,,23.19,,,23.21,1.16, , , ,-0.02,0.39,-0.83,-0.61,-0.08, ,-0.02, , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;axon guidance;termination of G-protein coupled receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
8103,Q9NZT2,OGFR,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),DRPEPLSPKESKK,_SQGDEAGGHGEDRPEPLS(ph)PK_,S378,+,25.03,26.46,26.89,25.00,25.89,25.64,26.59,26.84,26.47,25.69,25.73,26.27,24.79,25.95,-0.92,0.52,0.94,-0.95,-0.06,-0.30,0.64,0.89,0.53,-0.26,-0.21,0.32,-1.16,regulation of cell growth,nucleus;membrane;cytoplasm,,,,,,,,,,,,,,
8104,Q9NZT2,OGFR,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),EGPQPRSVEPQDA,_S(ph)VEPQDAGPLER_,S349,+,24.65,23.95,24.42,24.46,25.14,24.34,24.13,24.25,23.90,22.68,23.31,,,24.11,0.54,-0.17,0.30,0.35,1.03,0.23,0.02,0.13,-0.21,-1.43,-0.80, , ,regulation of cell growth,nucleus;membrane;cytoplasm,,,,,,,,,,,,,,
8105,Q9NZU0,FLRT3,Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3),GTKKDNSILEIRE,_DNS(ph)ILEIR_,S585,+,22.06,,,23.23,21.25,22.26,22.53,21.51,,22.09,21.61,23.68,22.25,22.25,-0.18, , ,0.98,-1.00,0.01,0.29,-0.74, ,-0.16,-0.64,1.43,0.01,cell adhesion,proteinaceous extracellular matrix;integral to plasma membrane,,,,,,,,,,,,,,
8106,Q9P035,PTPLAD1,Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein tyrosine phosphatase-like protein PTPLAD1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),NKLRLESEGSPET,_LES(ph)EGSPETLTNLR_,S135,,19.96,,,,22.50,,,,,,22.50,,23.17,22.03,-2.07, , , ,0.47, , , , , ,0.47, ,1.14,activation of JUN kinase activity;Rho protein signal transduction;I-kappaB kinase/NF-kappaB cascade;fatty acid biosynthetic process;Rac protein signal transduction,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8107,Q9P035,PTPLAD1,Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein tyrosine phosphatase-like protein PTPLAD1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),DRWLDESDAEMEL,_WLDES(ph)DAEM(ox)ELRAK_,S114,+,29.42,23.17,22.68,,26.98,22.30,24.01,21.55,24.19,25.96,25.51,25.01,23.27,24.50,4.92,-1.34,-1.82, ,2.47,-2.21,-0.49,-2.96,-0.31,1.46,1.01,0.51,-1.24,activation of JUN kinase activity;Rho protein signal transduction;I-kappaB kinase/NF-kappaB cascade;fatty acid biosynthetic process;Rac protein signal transduction,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8109,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),FKAEISSIRENKD,_AEISS(ph)IRENK_,S289,+,26.03,26.71,27.58,25.20,,,23.96,,24.42,24.57,24.88,24.42,22.06,24.98,1.04,1.73,2.60,0.22, , ,-1.03, ,-0.57,-0.41,-0.11,-0.56,-2.92,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8111,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),ISPTQLSDVSSPR,_KAPPPPISPTQLS(ph)DVSSPR_,S278,,,,,,24.05,,,23.25,,,,,,23.65, , , , ,0.40, , ,-0.40, , , , , ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8112,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),DVSSPRSITSTPL,_S(ph)ITSTPLSGK_,S285,,,19.20,,,24.57,,,,,,,,,21.88, ,-2.69, , ,2.69, , , , , , , , ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8113,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),ITSTPLSGKESVF,_SITSTPLS(ph)GK_,S292,+,23.41,24.11,,24.65,23.28,23.24,25.63,24.89,23.85,,25.07,,24.30,24.24,-0.83,-0.13, ,0.41,-0.96,-1.00,1.38,0.65,-0.40, ,0.83, ,0.06,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8114,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),DYRKRKSLEDVTA,_S(ph)LEDVTAEYIHK_,S638,+,,20.96,20.96,,22.89,,23.39,,24.38,24.81,24.55,24.34,23.12,23.27, ,-2.31,-2.31, ,-0.37, ,0.12, ,1.12,1.54,1.28,1.07,-0.15,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8116,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),PPDSKSSPSVLIH,_SS(ph)PSVLIHSLGK_,S383,+,22.96,22.08,,20.11,,,24.91,22.43,25.91,25.07,24.95,24.84,,23.70,-0.73,-1.62, ,-3.59, , ,1.22,-1.26,2.22,1.38,1.25,1.15, ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
8119,Q9P0M6,H2AFY2,Core histone macro-H2A.2 (Histone macroH2A2) (mH2A2),KSETILSPPPEKR,_SETILS(ph)PPPEK_,S129,,22.01,,,20.11,,,21.76,,,23.15,,,,21.76,0.26, , ,-1.65, , ,0.00, , ,1.39, , , ,dosage compensation;nucleosome assembly;chromatin modification,Barr body;nucleosome,,,,,,,,,,,,,,
8120,Q9P0P8,C6orf203,Uncharacterized protein C6orf203,KVDEEDSDEESHH,_VDEEDS(ph)DEESHHDEM(ox)S(ph)EQEEELEDDPTVVK_,S106,,22.82,,,,,,,,,,,,,22.82,0.00, , , , , , , , , , , , ,,mitochondrion,,,,,,,,,,,,,,
8122,Q9P0P8,C6orf203,Uncharacterized protein C6orf203,SHHDEMSEQEEEL,_VDEEDS(ph)DEESHHDEM(ox)S(ph)EQEEELEDDPTVVK_,S116,,22.82,,,,,,,,,,,,,22.82,0.00, , , , , , , , , , , , ,,mitochondrion,,,,,,,,,,,,,,
8123,Q9P0T7,TMEM9,Transmembrane protein 9 (Dermal papilla-derived protein 4),ENEDARSMAAAAA,_S(ph)M(ox)AAAAASLGGPR_,S137,+,,23.68,22.58,24.20,,23.59,23.09,23.95,22.71,25.07,,23.90,,23.64, ,0.03,-1.06,0.56, ,-0.05,-0.56,0.31,-0.93,1.43, ,0.26, ,transport,late endosome;integral to membrane;late endosome membrane;lysosomal membrane;lysosome,,,,,,,,,,,,,,
8124,Q9P0U4,CXXC1,CpG-binding protein (CXXC-type zinc finger protein 1) (PHD finger and CXXC domain-containing protein 1),_MEGDGSDPEPPD,_(ac)M(ox)EGDGS(ph)DPEPPDAGEDSK_,S6,,24.11,,,23.29,,,23.60,,,24.35,,,,23.84,0.28, , ,-0.55, , ,-0.24, , ,0.51, , , ,"positive regulation of transcription, DNA-dependent;histone H3-K4 methylation;activation of signaling protein activity involved in unfolded protein response;transcription, DNA-dependent",nuclear speck;Set1C/COMPASS complex;nuclear matrix,Other TF domain,,,,,,,,,,,,,
8125,Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),DNPFFRSKRSYSL,_DNPFFRS(ph)K_,S241,,,,,,21.88,,22.62,22.50,22.12,,,25.55,22.50,22.86, , , , ,-0.98, ,-0.24,-0.36,-0.75, , ,2.69,-0.36,endocytosis,coated pit;nucleus;clathrin-coated vesicle,,,,,,,,,,,,,,
8126,Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),IDNLPDSPDEVAK,_NSTLSDSGM(ox)IDNLPDS(ph)PDEVAK_,S131,+,23.92,,,21.51,24.27,25.27,24.94,23.69,26.78,26.98,25.16,25.19,25.75,24.86,-0.94, , ,-3.35,-0.58,0.41,0.08,-1.17,1.92,2.12,0.30,0.34,0.89,endocytosis,coated pit;nucleus;clathrin-coated vesicle,,,,,,,,,,,,,,
8127,Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),FFRSKRSYSLSEL,_RS(ph)YSLSELSVLQAK_,S244,,,,,,23.16,23.59,,23.50,24.13,22.54,23.13,26.14,23.56,23.72, , , , ,-0.56,-0.13, ,-0.22,0.41,-1.18,-0.59,2.42,-0.16,endocytosis,coated pit;nucleus;clathrin-coated vesicle,,,,,,,,,,,,,,
8128,Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),RSKRSYSLSELSV,_SYS(ph)LSELSVLQAK_,S246,,22.63,,,23.02,23.49,,,,,,,,,23.05,-0.42, , ,-0.02,0.44, , , , , , , , ,endocytosis,coated pit;nucleus;clathrin-coated vesicle,,,,,,,,,,,,,,
8129,Q9P0V3,SH3BP4,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),APEQFQSREDFRT,_SPAPEQFQS(ph)REDFR_,S279,,,,,23.35,22.72,23.82,23.59,23.92,22.91,,,22.94,,23.32, , , ,0.03,-0.60,0.50,0.27,0.60,-0.42, , ,-0.38, ,endocytosis,coated pit;nucleus;clathrin-coated vesicle,,,,,,,,,,,,,,
8130,Q9P0W5,SCHIP1,Schwannomin-interacting protein 1 (SCHIP-1),SLDTPLSPMSKQS,_TETSLDTPLS(ph)PM(ox)SK_,S87,,23.12,22.78,22.78,22.39,,,,,22.00,,,,,22.61,0.51,0.17,0.17,-0.23, , , , ,-0.62, , , , ,,cytoplasm,,,,,,,,,,,,,,
8131,Q9P107,GMIP,GEM-interacting protein (GMIP),ESRSLDSPTSSPG,_SLDS(ph)PTSSPGAGTR_,S181,+,26.17,24.94,,24.44,23.25,22.14,24.88,24.34,23.09,23.23,24.24,,,24.07,2.10,0.87, ,0.37,-0.82,-1.93,0.80,0.27,-0.98,-0.84,0.17, , ,small GTPase mediated signal transduction;negative regulation of Rho GTPase activity,cytosol,,,,,,,,,,,,,,
8135,Q9P1Q0,VPS54,Vacuolar protein sorting-associated protein 54 (Hepatocellular carcinoma protein 8) (Tumor antigen HOM-HCC-8) (Tumor antigen SLP-8p),KIEVDPSKHIRPV,_IEVDPS(ph)KHIR_,S27,,25.20,,,,,,,,,,,,,25.20,0.00, , , , , , , , , , , , ,"musculoskeletal movement;growth;protein transport;retrograde transport, endosome to Golgi;neurofilament cytoskeleton organization;homeostasis of number of cells within a tissue",GARP complex,,,,,,,,,,,,,,
8139,Q9P1Y5,CAMSAP3,Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha),PDGHAASPRGTEA,_DLPDGHAAS(ph)PR_,S334,+,28.09,25.37,24.64,24.27,23.39,,21.93,,,,23.00,,,24.39,3.70,0.98,0.26,-0.11,-0.99, ,-2.45, , , ,-1.38, , ,microtubule anchoring;zonula adherens maintenance;epithelial cell-cell adhesion;regulation of microtubule cytoskeleton organization;negative regulation of phosphatase activity,zonula adherens;microtubule;cytoplasm,,,,,,,,,,,,,,
8140,Q9P1Y5,CAMSAP3,Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha),NNSGSSSPVFTFR,_GTEASPPQNNSGSSS(ph)PVFTFR_,S351,,22.19,22.13,,,,,,,,,,,,22.16,0.03,-0.03, , , , , , , , , , , ,microtubule anchoring;zonula adherens maintenance;epithelial cell-cell adhesion;regulation of microtubule cytoskeleton organization;negative regulation of phosphatase activity,zonula adherens;microtubule;cytoplasm,,,,,,,,,,,,,,
8141,Q9P1Y5,CAMSAP3,Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha),VLLRSVSSDSLGP,_SVS(ph)SDSLGPPRPAPAR_,S431,,25.60,23.89,24.56,,,,20.18,,,,,,,23.56,2.04,0.33,1.00, , , ,-3.38, , , , , , ,microtubule anchoring;zonula adherens maintenance;epithelial cell-cell adhesion;regulation of microtubule cytoskeleton organization;negative regulation of phosphatase activity,zonula adherens;microtubule;cytoplasm,,,,,,,,,,,,,,
8143,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,KAEAPSSPDVAPA,_AEAPSS(ph)PDVAPAGKEDS(ph)PSASGR_,S1360,+,27.59,27.96,28.06,27.74,25.77,27.89,27.06,27.28,27.69,27.18,25.03,26.49,27.58,27.18,0.41,0.78,0.88,0.56,-1.41,0.71,-0.12,0.10,0.52,0.00,-2.15,-0.69,0.40,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8144,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,PAGKEDSPSASGR,_AEAPSS(ph)PDVAPAGKEDS(ph)PSASGR_,S1371,,24.23,24.23,,25.04,,23.21,,25.21,23.95,,,,,24.31,-0.08,-0.08, ,0.73, ,-1.10, ,0.90,-0.36, , , , ,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8145,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,GAVREASPAPLAQ,_EAS(ph)PAPLAQGEPGREDLPTR_,S1202,+,22.29,,,24.16,26.66,27.18,24.06,26.03,24.50,23.62,26.27,,26.71,25.15,-2.86, , ,-0.99,1.51,2.03,-1.09,0.89,-0.64,-1.53,1.12, ,1.56,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8146,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,PRGRECSPTSSLE,_ECS(ph)PTSSLER_,S1124,+,22.84,24.45,25.00,24.15,21.23,,22.13,,22.80,22.55,,21.55,,22.97,-0.13,1.48,2.03,1.18,-1.74, ,-0.83, ,-0.17,-0.41, ,-1.42, ,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8147,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,QRKENPSPLFSIK,_ENPS(ph)PLFSIKK_,S814,+,21.48,21.00,21.45,,21.44,,22.38,,,22.47,21.74,,22.34,21.79,-0.31,-0.79,-0.34, ,-0.35, ,0.59, , ,0.68,-0.04, ,0.55,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8149,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,__MDDDSLDELVA,_(ac)M(ox)DDDS(ph)LDELVAR_,S5,,23.41,,,,23.62,,,,,22.32,,,,23.12,0.30, , , ,0.50, , , , ,-0.80, , , ,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8150,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,SSAPGSSPERSGP,_SEVYDPSDPTGSDSSAPGSS(ph)PER_,S846,,22.52,22.41,,,,,,,,,,,,22.46,0.05,-0.05, , , , , , , , , , , ,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8153,Q9P1Y6,PHRF1,PHD and RING finger domain-containing protein 1,VELRPPSRSRSTS,_VVELRPPS(ph)R_,S991,+,23.46,24.58,,24.29,24.22,23.84,23.19,23.50,23.42,,,,,23.81,-0.36,0.76, ,0.48,0.41,0.03,-0.62,-0.31,-0.40, , , , ,mRNA processing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
8154,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,GLRRAFSWLRGKR,_AFS(ph)WLR_,S39,,21.99,,,,20.89,,,,,,,21.12,,21.33,0.66, , , ,-0.45, , , , , , ,-0.21, ,,,,,,,,,,,,,,,,
8155,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,PLRRALSGRASPV,_ALS(ph)GRAS(ph)PVPAPSSGLHAAVR_,S917,,24.25,22.10,22.10,21.08,,,,,,,,,,22.38,1.87,-0.29,-0.29,-1.30, , , , , , , , , ,,,,,,,,,,,,,,,,
8156,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,ALSGRASPVPAPS,_ALS(ph)GRAS(ph)PVPAPSSGLHAAVR_,S921,,24.25,22.10,22.10,21.08,,,,,,,,,,22.38,1.87,-0.29,-0.29,-1.30, , , , , , , , , ,,,,,,,,,,,,,,,,
8157,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,VISKDQSPPPSPP,_DQS(ph)PPPS(ph)PPPSYHPPPPPTK_,S728,+,26.25,26.14,26.67,24.97,,,24.20,,26.03,25.18,23.97,,,25.43,0.83,0.72,1.25,-0.46, , ,-1.23, ,0.60,-0.24,-1.46, , ,,,,,,,,,,,,,,,,
8158,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,DQSPPPSPPPSYH,_DQS(ph)PPPS(ph)PPPSYHPPPPPTK_,S732,+,26.25,26.14,26.67,24.97,,,24.20,,26.03,25.18,23.97,,,25.43,0.83,0.72,1.25,-0.46, , ,-1.23, ,0.60,-0.24,-1.46, , ,,,,,,,,,,,,,,,,
8159,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,SLGRFSSVSSPQP,_FSS(ph)VSSPQPR_,S398,,23.66,21.19,,,,,,,,,,22.87,,22.57,1.09,-1.39, , , , , , , , , ,0.29, ,,,,,,,,,,,,,,,,
8161,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,RFSSVSSPQPRSR,_FSSVSS(ph)PQPR_,S401,+,25.16,25.30,25.86,24.27,23.27,23.00,23.23,23.35,24.67,23.38,22.45,22.98,,23.91,1.25,1.39,1.95,0.36,-0.64,-0.91,-0.68,-0.56,0.76,-0.53,-1.46,-0.93, ,,,,,,,,,,,,,,,,
8164,Q9P206,KIAA1522,Uncharacterized protein KIAA1522,KVPAPFSPPPSKP,_VPAPFS(ph)PPPSK_,S671,,21.42,22.90,22.90,,,,22.76,,22.28,,22.91,23.14,,22.62,-1.19,0.28,0.28, , , ,0.14, ,-0.33, ,0.29,0.52, ,,,,,,,,,,,,,,,,
8165,Q9P219,CCDC88C,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),LHGRSESFSSEDL,_SES(ph)FSSEDLIPSR_,S51,,22.22,,,,,,,,,,,,,22.22,0.00, , , , , , , , , , , , ,regulation of protein phosphorylation;protein homooligomerization;protein destabilization;Wnt receptor signaling pathway;microtubule cytoskeleton organization,cytoplasm,,,,,,,,,,,,,,
8167,Q9P246,STIM2,Stromal interaction molecule 2,RSIVPSSPQPQRA,_SIVPSS(ph)PQPQR_,S523,,21.39,22.32,22.32,,23.34,24.10,,22.66,,,,,23.09,22.74,-1.35,-0.42,-0.42, ,0.59,1.36, ,-0.09, , , , ,0.34,positive regulation of calcium ion transport;cellular calcium ion homeostasis;activation of store-operated calcium channel activity,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8168,Q9P260,KIAA1468,LisH domain and HEAT repeat-containing protein KIAA1468,NPFLSDSDEDDDE,_(ac)AAM(ox)APGGSGSGGGVNPFLSDS(ph)DEDDDEVAATEERR_,S22,,22.50,,,,,,,,,,,,,22.50,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
8169,Q9P260,KIAA1468,LisH domain and HEAT repeat-containing protein KIAA1468,QLNRAGSISTLDS,_AGS(ph)ISTLDSLDFAR_,S180,+,24.50,21.91,,21.68,22.73,21.82,21.97,22.71,21.87,,22.98,23.13,,22.53,1.97,-0.62, ,-0.85,0.20,-0.71,-0.56,0.18,-0.66, ,0.45,0.60, ,,,,,,,,,,,,,,,,
8171,Q9P260,KIAA1468,LisH domain and HEAT repeat-containing protein KIAA1468,TIPKENSPNSFPR,_ENS(ph)PNSFPR_,S453,,24.23,24.62,,24.65,,,22.58,22.66,,,22.22,,,23.49,0.73,1.13, ,1.16, , ,-0.91,-0.84, , ,-1.28, , ,,,,,,,,,,,,,,,,
8172,Q9P265,DIP2B,Disco-interacting protein 2 homolog B (DIP2 homolog B),VKGTSGSLADVFA,_GTSGS(ph)LADVFANTR_,S203,,22.59,,,20.15,21.77,,20.90,,,,,,,21.35,1.24, , ,-1.20,0.42, ,-0.45, , , , , , ,,nucleus,,,,,,,,,,,,,,
8173,Q9P266,KIAA1462,Junctional protein associated with coronary artery disease (JCAD),NKNRGLSAPDLRS,_NRGLS(ph)APDLR_,S1044,,,24.45,21.73,27.08,26.44,26.91,27.80,26.83,26.00,,25.51,25.48,25.65,25.81, ,-1.36,-4.08,1.28,0.63,1.10,1.99,1.02,0.20, ,-0.30,-0.33,-0.16,cell adhesion,cell-cell junction;adherens junction,,,,,,,,,,,,,,
8174,Q9P266,KIAA1462,Junctional protein associated with coronary artery disease (JCAD),SFRNADSQEDAEE,_NADS(ph)QEDAEELKATTR_,S1281,,,,,25.34,25.15,22.47,,21.69,,,,22.25,,23.38, , , ,1.96,1.77,-0.91, ,-1.69, , , ,-1.13, ,cell adhesion,cell-cell junction;adherens junction,,,,,,,,,,,,,,
8175,Q9P266,KIAA1462,Junctional protein associated with coronary artery disease (JCAD),PREPQESPKITSA,_PLPASYPAEPREPQES(ph)PK_,S1002,,,,,,,,24.79,,23.28,,,,,24.04, , , , , , ,0.75, ,-0.75, , , , ,cell adhesion,cell-cell junction;adherens junction,,,,,,,,,,,,,,
8176,Q9P266,KIAA1462,Junctional protein associated with coronary artery disease (JCAD),VGFRGNSPEMRVE,_QEDVGFRGNS(ph)PEM(ox)R_,S885,,22.42,24.46,23.04,26.76,26.81,27.53,26.56,26.51,25.40,24.38,25.75,,25.74,25.45,-3.03,-0.99,-2.41,1.32,1.37,2.09,1.11,1.06,-0.05,-1.07,0.30, ,0.29,cell adhesion,cell-cell junction;adherens junction,,,,,,,,,,,,,,
8177,Q9P266,KIAA1462,Junctional protein associated with coronary artery disease (JCAD),KGHRSLSPSSNSA,_SLS(ph)PSSNSAFSR_,S757,,22.67,24.84,22.96,27.75,26.56,27.60,27.38,27.51,26.78,23.12,25.89,23.08,26.85,25.61,-2.95,-0.78,-2.66,2.14,0.94,1.98,1.77,1.90,1.16,-2.49,0.28,-2.53,1.24,cell adhesion,cell-cell junction;adherens junction,,,,,,,,,,,,,,
8180,Q9P270,SLAIN2,SLAIN motif-containing protein 2,PSSGAASPRGFPL,_AGASIPSSGAAS(ph)PR_,S63,+,24.86,23.55,23.23,22.33,23.30,23.25,23.40,23.74,22.77,22.75,23.35,22.03,,23.21,1.65,0.34,0.02,-0.89,0.08,0.04,0.19,0.53,-0.45,-0.46,0.14,-1.18, ,microtubule nucleation;positive regulation of microtubule polymerization;cytoplasmic microtubule organization,centrosome,,,,,,,,,,,,,,
8181,Q9P270,SLAIN2,SLAIN motif-containing protein 2,TRRGTFSDQELDA,_GTFS(ph)DQELDAQSLDDEDDNM(ox)HHAVYPAVNR_,S315,,,,,,25.50,,,24.95,25.15,,,23.44,24.40,24.69, , , , ,0.81, , ,0.26,0.46, , ,-1.25,-0.29,microtubule nucleation;positive regulation of microtubule polymerization;cytoplasmic microtubule organization,centrosome,,,,,,,,,,,,,,
8183,Q9P275,USP36,Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),HRARAVSPAPQSS,_AVS(ph)PAPQSSSR_,S442,+,19.84,20.94,,22.85,20.71,21.06,20.73,20.87,21.72,,,21.09,20.65,21.05,-1.21,-0.11, ,1.80,-0.33,0.01,-0.32,-0.17,0.67, , ,0.04,-0.39,ubiquitin-dependent protein catabolic process,nucleolus,,,,,,,,,,,,,,
8184,Q9P287,BCCIP,BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1),DEDDDDSDKEKDE,_EVENEDEDDDDS(ph)DKEK_,S42,,,,,21.30,,,21.78,,21.58,,,21.22,,21.47, , , ,-0.17, , ,0.31, ,0.11, , ,-0.25, ,DNA repair;regulation of cyclin-dependent protein kinase activity;neuroendocrine cell differentiation;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex,,,,,,,,,,,,,,
8185,Q9P289,MST4,Serine/threonine-protein kinase MST4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 4) (MST-4) (Mst3 and SOK1-related kinase) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK),___MAHSPVAVQV,_(ac)AHS(ph)PVAVQVPGM(ox)QNNIADPEELFTK_,S4,,24.93,,,,,,,,,,,27.37,,26.15,-1.22, , , , , , , , , , ,1.22, ,cellular component disassembly involved in execution phase of apoptosis;regulation of apoptotic process,cytosol;Golgi membrane,,+,,,,,,,,,,,,
8186,Q9P289,MST4,Serine/threonine-protein kinase MST4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 4) (MST-4) (Mst3 and SOK1-related kinase) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK),WKAEGHSDDESDS,_WKAEGHS(ph)DDESDSEGSDSESTSR_,S300,,,,,,22.24,,,23.62,,,,,,22.93, , , , ,-0.69, , ,0.69, , , , , ,cellular component disassembly involved in execution phase of apoptosis;regulation of apoptotic process,cytosol;Golgi membrane,,+,,,,,,,,,,,,
8189,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,PPSRDLSPTLIDN,_DLS(ph)PTLIDNSAAK_,S488,,24.37,24.12,,24.41,,,23.70,,,,,,,24.15,0.22,-0.03, ,0.26, , ,-0.45, , , , , , ,,actin cytoskeleton,,,,,,,,,,,,,,
8190,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,QASGLQSPPSRDL,_FQSQADQDQQASGLQS(ph)PPSRDLSPTLIDNSAAK_,S481,,,,,,,,23.66,,,23.91,24.77,23.81,,24.04, , , , , , ,-0.38, , ,-0.13,0.73,-0.23, ,,actin cytoskeleton,,,,,,,,,,,,,,
8191,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,TPGKVSSPLSPLS,_VSS(ph)PLSPLS(ph)PGIKS(ph)PTIPR_,S557,+,25.03,22.27,22.27,22.66,20.96,,22.94,21.27,23.28,24.22,,22.18,22.74,22.71,2.32,-0.44,-0.44,-0.05,-1.75, ,0.23,-1.44,0.57,1.51, ,-0.53,0.03,,actin cytoskeleton,,,,,,,,,,,,,,
8192,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,KVSSPLSPLSPGI,_VSSPLS(ph)PLS(ph)PGIK_,S560,+,25.65,22.50,22.83,22.76,21.62,22.02,23.12,22.62,23.24,24.27,23.32,,23.30,23.11,2.55,-0.60,-0.27,-0.34,-1.49,-1.09,0.02,-0.48,0.14,1.17,0.22, ,0.19,,actin cytoskeleton,,,,,,,,,,,,,,
8193,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,SPLSPLSPGIKSP,_VSSPLS(ph)PLS(ph)PGIK_,S563,+,26.84,24.82,24.56,24.50,,,24.02,22.81,24.61,25.26,24.73,,24.04,24.62,2.22,0.20,-0.06,-0.12, , ,-0.60,-1.81,-0.01,0.64,0.11, ,-0.58,,actin cytoskeleton,,,,,,,,,,,,,,
8194,Q9P2B4,CTTNBP2NL,CTTNBP2 N-terminal-like protein,LSPGIKSPTIPRA,_VSSPLSPLSPGIKS(ph)PTIPR_,S568,+,26.48,23.36,23.88,23.59,,24.85,25.36,25.24,25.04,23.63,24.88,23.47,25.44,24.60,1.88,-1.24,-0.73,-1.01, ,0.25,0.76,0.64,0.44,-0.97,0.28,-1.14,0.84,,actin cytoskeleton,,,,,,,,,,,,,,
8195,Q9P2D0,IBTK,Inhibitor of Bruton tyrosine kinase (IBtk),SPRDLQSPDFTTG,_DLQS(ph)PDFTTGFHSDK_,S844,+,24.34,24.51,23.43,25.26,25.85,25.75,26.15,26.30,26.42,26.79,25.71,26.06,24.95,25.50,-1.17,-0.99,-2.07,-0.24,0.35,0.25,0.65,0.80,0.92,1.29,0.21,0.56,-0.55,release of sequestered calcium ion into cytosol,nucleus;membrane;cytoplasm,,,,,,,,,,,,,,
8196,Q9P2D1,CHD7,Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7),IDEFANSPSEDKE,_DEIDEFANS(ph)PSEDK_,S1874,,23.84,24.41,24.41,20.69,,,,,21.12,23.74,,,,23.03,0.80,1.38,1.38,-2.35, , , , ,-1.91,0.70, , , ,"face development;blood circulation;regulation of growth hormone secretion;retina development in camera-type eye;adult walking behavior;nose development;embryonic hindlimb morphogenesis;cranial nerve development;limb development;palate development;inner ear morphogenesis;genitalia development;positive regulation of multicellular organism growth;semicircular canal morphogenesis;artery morphogenesis;sensory perception of sound;regulation of transcription, DNA-dependent;in utero embryonic development;T cell differentiation;adult heart development;female genitalia development;central nervous system development;heart morphogenesis;transcription, DNA-dependent;chromatin modification;cognition;skeletal system development",nucleus,Other TF domain,,,,,,,,,,,,,
8197,Q9P2D1,CHD7,Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7),GETLEGSDAEESL,_DGETLEGS(ph)DAEESLDK_,S2956,,24.51,,,21.47,,,,,23.75,24.22,,,,23.49,1.02, , ,-2.02, , , , ,0.26,0.73, , , ,"face development;blood circulation;regulation of growth hormone secretion;retina development in camera-type eye;adult walking behavior;nose development;embryonic hindlimb morphogenesis;cranial nerve development;limb development;palate development;inner ear morphogenesis;genitalia development;positive regulation of multicellular organism growth;semicircular canal morphogenesis;artery morphogenesis;sensory perception of sound;regulation of transcription, DNA-dependent;in utero embryonic development;T cell differentiation;adult heart development;female genitalia development;central nervous system development;heart morphogenesis;transcription, DNA-dependent;chromatin modification;cognition;skeletal system development",nucleus,Other TF domain,,,,,,,,,,,,,
8199,Q9P2D3,HEATR5B,HEAT repeat-containing protein 5B,STKVSDSPSHIAT,_VSDS(ph)PSHIATK_,S1737,,23.76,24.55,24.72,,,,,,,22.18,,,,23.80,-0.04,0.75,0.92, , , , , , ,-1.62, , , ,,,,,,,,,,,,,,,,
8200,Q9P2E5,CHPF2,Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase),RARLDQSDEDFKP,_ARLDQS(ph)DEDFKPR_,S64,,23.44,24.42,24.27,24.69,24.17,26.45,22.90,25.61,23.65,24.49,24.14,24.75,24.25,24.40,-0.96,0.02,-0.13,0.29,-0.23,2.04,-1.51,1.21,-0.75,0.09,-0.26,0.35,-0.15,chondroitin sulfate biosynthetic process;carbohydrate metabolic process,Golgi cisterna membrane;integral to membrane;Golgi membrane,,,,,,,,,,,,,,
8201,Q9P2F8,SIPA1L2,Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2),TGERSPSPLTGKV,_EFM(ox)DTTGERSPS(ph)PLTGK_,S1652,+,,22.81,23.40,21.90,,,22.86,23.04,22.93,25.35,22.39,,22.90,23.06, ,-0.25,0.34,-1.17, , ,-0.20,-0.03,-0.14,2.29,-0.67, ,-0.17,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
8202,Q9P2F8,SIPA1L2,Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2),LHREYGSTSSIDR,_EYGS(ph)TSSIDR_,S194,,23.38,25.57,,25.97,,,,,,,22.04,,,24.24,-0.86,1.33, ,1.73, , , , , , ,-2.20, , ,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
8203,Q9P2F8,SIPA1L2,Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2),KLMLPDSPLVEEG,_LM(ox)LPDS(ph)PLVEEGRRK_,S1461,+,23.18,23.89,23.89,,,,,,21.99,24.19,24.84,23.49,23.01,23.56,-0.37,0.33,0.33, , , , , ,-1.57,0.63,1.28,-0.07,-0.55,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
8205,Q9P2F8,SIPA1L2,Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2),SLYRTLSDESICS,_TLS(ph)DESICSNR_,S1488,,,23.53,22.80,23.97,,,,,,24.18,23.32,,,23.56, ,-0.03,-0.76,0.41, , , , , ,0.62,-0.24, , ,positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,intracellular,,,,,,,,,,,,,,
8206,Q9P2G1,ANKIB1,Ankyrin repeat and IBR domain-containing protein 1,GVAPADSPEAPRR,_GVAPADS(ph)PEAPRR_,S89,+,25.14,27.25,27.46,27.22,26.06,25.53,24.22,25.64,25.06,25.18,25.65,25.23,24.18,25.68,-0.54,1.57,1.78,1.54,0.38,-0.14,-1.46,-0.04,-0.62,-0.49,-0.03,-0.45,-1.50,,,,,,,,,,,,,,,,
8207,Q9P2I0,CPSF2,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),KEADIDSSDESDI,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,S419,,25.10,,,,,,,,,,,,,25.10,0.00, , , , , , , , , , , , ,"mRNA export from nucleus;termination of RNA polymerase II transcription;histone mRNA 3'-end processing;mRNA splicing, via spliceosome",mRNA cleavage and polyadenylation specificity factor complex,,,,,,,,,,,,,,
8208,Q9P2I0,CPSF2,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),EADIDSSDESDIE,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,S420,,25.10,,,,,,,,,,,,,25.10,0.00, , , , , , , , , , , , ,"mRNA export from nucleus;termination of RNA polymerase II transcription;histone mRNA 3'-end processing;mRNA splicing, via spliceosome",mRNA cleavage and polyadenylation specificity factor complex,,,,,,,,,,,,,,
8209,Q9P2I0,CPSF2,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),IDSSDESDIEEDI,_EADIDS(ph)S(ph)DES(ph)DIEEDIDQPSAHK_,S423,,25.10,,,,,,,,,,,,,25.10,0.00, , , , , , , , , , , , ,"mRNA export from nucleus;termination of RNA polymerase II transcription;histone mRNA 3'-end processing;mRNA splicing, via spliceosome",mRNA cleavage and polyadenylation specificity factor complex,,,,,,,,,,,,,,
8211,Q9P2K5,MYEF2,Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156),GATGGDSPHLQPA,_(ac)ADANKAEVPGATGGDS(ph)PHLQPAEPPGEPR_,S17,+,29.05,28.15,25.76,25.48,29.32,29.67,28.93,29.58,28.96,27.41,29.32,27.11,29.02,28.29,0.76,-0.14,-2.53,-2.81,1.03,1.38,0.64,1.29,0.67,-0.88,1.03,-1.18,0.73,"neuron differentiation;myotube differentiation;transcription, DNA-dependent",Golgi apparatus;nucleus,,,,,,,,,,,,,,
8212,Q9P2M7,CGN,Cingulin,SVRRKVSLVLEKM,_RKVS(ph)LVLEK_,S332,+,24.88,23.51,24.13,,23.42,22.23,23.81,24.39,,25.82,24.00,25.29,21.82,23.94,0.95,-0.43,0.19, ,-0.52,-1.70,-0.13,0.46, ,1.88,0.07,1.35,-2.12,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8213,Q9P2M7,CGN,Cingulin,AQSQNLSPLSGFS,_(gl)QPAQSQNLS(ph)PLSGFSR_,S252,,24.27,22.38,22.38,,,,,,,,,,,23.01,1.26,-0.63,-0.63, , , , , , , , , , ,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8214,Q9P2M7,CGN,Cingulin,KLLRSHSQASLAG,_SHS(ph)QAS(ph)LAGPGPVDPSNR_,S131,+,26.18,23.04,,,21.99,24.05,,24.29,,,22.54,25.24,,23.90,2.27,-0.86, , ,-1.91,0.15, ,0.39, , ,-1.36,1.33, ,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8215,Q9P2M7,CGN,Cingulin,RSHSQASLAGPGP,_SHS(ph)QAS(ph)LAGPGPVDPSNR_,S134,,24.43,,,,,,,,,,,,,24.43,0.00, , , , , , , , , , , , ,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8216,Q9P2M7,CGN,Cingulin,QRKRSKSLDSRLP,_S(ph)LDSRLPR_,S208,+,23.06,25.83,25.83,,,,24.70,23.62,,,23.61,25.34,21.63,24.20,-1.14,1.63,1.63, , , ,0.49,-0.58, , ,-0.59,1.14,-2.57,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8217,Q9P2M7,CGN,Cingulin,PSNRSNSMLELAP,_SNS(ph)M(ox)LELAPK_,S149,,24.69,23.03,,,,,,,,,,,,23.86,0.83,-0.83, , , , , , , , , , , ,transforming growth factor beta receptor signaling pathway,tight junction;myosin complex,,,,,,,,,,,,,,
8220,Q9P2N5,RBM27,RNA-binding protein 27 (RNA-binding motif protein 27),HKPKVPSISTETE,_VPS(ph)ISTETEEEEVK_,S1020,,24.85,24.58,24.58,23.62,,,,,,23.99,,,,24.33,0.53,0.26,0.26,-0.71, , , , , ,-0.33, , , ,mRNA processing,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
8222,Q9P2P5,HECW2,"E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2)",TLQRANSDTDLVT,_ANS(ph)DTDLVTSESR_,S48,,23.32,,,,,,,,,,,,,23.32,0.00, , , , , , , , , , , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
8226,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),DAEEPESPPPPPR,_EEALDDAEEPES(ph)PPPPPRS(ph)PS(ph)PEPTVVDTPSHASQSAR_,S552,,24.16,,,,,,,,,,,,,24.16,0.00, , , , , , , , , , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8227,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),PPPPPRSPSPEPT,_EEALDDAEEPES(ph)PPPPPRS(ph)PS(ph)PEPTVVDTPSHASQSAR_,S559,,24.16,,,,,,,,,,,,,24.16,0.00, , , , , , , , , , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8228,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),PPPRSPSPEPTVV,_EEALDDAEEPES(ph)PPPPPRS(ph)PS(ph)PEPTVVDTPSHASQSAR_,S561,,24.16,,,,,,,,,,,,,24.16,0.00, , , , , , , , , , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8229,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),RKKQPASPDGRTS,_KQPAS(ph)PDGRT(ph)SPINEDIR_,S40,,24.90,25.22,25.03,24.84,23.43,,,,23.79,,,,,24.53,0.37,0.69,0.50,0.30,-1.11, , , ,-0.75, , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8230,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),SPDGRTSPINEDI,_KQPAS(ph)PDGRTS(ph)PINEDIR_,S46,,24.90,25.39,,24.84,23.43,,,,23.79,,,,,24.47,0.43,0.92, ,0.37,-1.04, , , ,-0.68, , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8231,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),ARPHVMSPTNRNH,_PHVM(ox)S(ph)PTNR_,S712,,20.55,22.51,,20.75,,,,,,,,,,21.27,-0.72,1.24, ,-0.52, , , , , , , , , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8232,Q9P2R6,RERE,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),EISRPNSPSEGEG,_TQEISRPNS(ph)PSEGEGESSDSR_,S125,+,20.96,,,,23.31,23.79,22.52,23.59,22.33,,22.95,,,22.78,-1.82, , , ,0.53,1.01,-0.26,0.81,-0.45, ,0.18, , ,"multicellular organismal development;NLS-bearing substrate import into nucleus;transcription, DNA-dependent;chromatin remodeling",histone deacetylase complex;mitochondrion;nucleus,,,,,,,,,,,,,,
8236,Q9P2Y4,ZNF219,Zinc finger protein 219,SGHLAPSPPAFDG,_APSGHLAPS(ph)PPAFDGELDLQR_,S16,,22.19,,,,,,,,,,,,,22.19,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",integral to membrane;nucleus,C2H2-type,,,,,,,,,,,,,
8237,Q9UBB5,MBD2,Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2),MDIEMDSGDEA__,_AADTEEMDIEM(ox)DS(ph)GDEA_,S407,+,28.41,25.93,26.27,26.08,28.03,26.94,26.48,25.98,27.55,27.34,25.24,25.74,26.38,26.65,1.77,-0.72,-0.37,-0.56,1.39,0.30,-0.16,-0.67,0.90,0.70,-1.40,-0.91,-0.26,"negative regulation of transcription from RNA polymerase II promoter;cellular protein complex assembly;positive regulation of Wnt receptor signaling pathway;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;maternal behavior;regulation of cell proliferation",histone deacetylase complex;nucleus;heterochromatin;cytoplasm,Other TF domain,,,,,,,,,,,,,
8239,Q9UBB9,TFIP11,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),EAELEDSDDEEKP,_KGAAEEAELEDS(ph)DDEEKPVK_,S98,+,24.24,25.79,25.79,23.22,24.96,,25.92,24.83,26.43,26.33,24.47,23.53,,25.05,-0.81,0.75,0.75,-1.83,-0.08, ,0.87,-0.22,1.38,1.28,-0.58,-1.52, ,"mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;biomineral tissue development",proteinaceous extracellular matrix;nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
8240,Q9UBB9,TFIP11,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),DFPVVDSEEEAEE,_TTQSM(ox)QDFPVVDS(ph)EEEAEEEFQK_,S210,+,26.44,,,,26.28,23.64,,,25.61,26.76,24.16,24.16,,25.29,1.15, , , ,0.99,-1.65, , ,0.32,1.47,-1.14,-1.14, ,"mRNA splicing, via spliceosome;regulation of transcription, DNA-dependent;biomineral tissue development",proteinaceous extracellular matrix;nuclear speck;catalytic step 2 spliceosome;cytoplasm,,,,,,,,,,,,,,
8241,Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),SLRSTPSHGSVSS,_STPS(ph)HGSVSSLNSTGSLS(ph)PK_,S241,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis,coated pit;plasma membrane;nucleus,,,,,,,,,,,,,,
8244,Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),SSGSLGSGEFTGV,_GTPGPDSSGSLGS(ph)GEFTGVK_,S377,,23.34,,,,,,,,,,,,,23.34,0.00, , , , , , , , , , , , ,negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis,coated pit;plasma membrane;nucleus,,,,,,,,,,,,,,
8245,Q9UBC2,EPS15L1,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),VPVLPASPPPKDS,_TVFPGAVPVLPAS(ph)PPPK_,S229,+,25.44,25.69,26.23,25.91,25.47,25.44,26.55,26.19,26.56,27.44,27.33,26.59,26.46,26.25,-0.81,-0.57,-0.02,-0.35,-0.78,-0.81,0.30,-0.06,0.30,1.19,1.08,0.34,0.20,negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;endocytosis,coated pit;plasma membrane;nucleus,,,,,,,,,,,,,,
8246,Q9UBC3,DNMT3B,DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB),___MEPSPEPPSL,_(ac)MEPS(ph)PEPPS(ph)LES(ph)MK_,S4,,23.83,24.16,,,,25.91,22.84,,,,,,23.61,24.07,-0.24,0.09, , , ,1.84,-1.23, , , , , ,-0.46,positive regulation of gene expression;response to drug;DNA methylation involved in embryo development;DNA methylation on cytosine within a CG sequence;cellular response to amino acid stimulus;response to ionizing radiation;S-adenosylmethioninamine metabolic process;methylation-dependent chromatin silencing;positive regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;regulation of gene expression by genetic imprinting;protein complex localization;positive regulation of histone H3-K4 methylation;S-adenosylhomocysteine metabolic process,"nuclear heterochromatin;chromosome, centromeric region;nucleus;cytoplasm",,,,,,,,,,,,,,
8247,Q9UBC3,DNMT3B,DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB),PSPEPPSLESMKG,_(ac)MEPS(ph)PEPPS(ph)LES(ph)MK_,S9,,23.83,24.16,,,,25.91,22.84,,,,,,23.61,24.07,-0.24,0.09, , , ,1.84,-1.23, , , , , ,-0.46,positive regulation of gene expression;response to drug;DNA methylation involved in embryo development;DNA methylation on cytosine within a CG sequence;cellular response to amino acid stimulus;response to ionizing radiation;S-adenosylmethioninamine metabolic process;methylation-dependent chromatin silencing;positive regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;regulation of gene expression by genetic imprinting;protein complex localization;positive regulation of histone H3-K4 methylation;S-adenosylhomocysteine metabolic process,"nuclear heterochromatin;chromosome, centromeric region;nucleus;cytoplasm",,,,,,,,,,,,,,
8248,Q9UBC3,DNMT3B,DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB),EPPSLESMKGDTR,_(ac)MEPS(ph)PEPPS(ph)LES(ph)MK_,S12,,25.10,24.16,,,,25.91,22.84,24.85,25.59,26.28,,,26.53,25.16,-0.06,-0.99, , , ,0.75,-2.32,-0.31,0.44,1.12, , ,1.37,positive regulation of gene expression;response to drug;DNA methylation involved in embryo development;DNA methylation on cytosine within a CG sequence;cellular response to amino acid stimulus;response to ionizing radiation;S-adenosylmethioninamine metabolic process;methylation-dependent chromatin silencing;positive regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;regulation of gene expression by genetic imprinting;protein complex localization;positive regulation of histone H3-K4 methylation;S-adenosylhomocysteine metabolic process,"nuclear heterochromatin;chromosome, centromeric region;nucleus;cytoplasm",,,,,,,,,,,,,,
8250,Q9UBF8,PI4KB,Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92),RIRSTRSVENLPE,_S(ph)VENLPECGITHEQR_,S413,+,23.69,23.33,22.91,24.21,23.70,22.31,24.40,24.63,22.70,,24.85,23.76,,23.68,0.01,-0.35,-0.77,0.53,0.02,-1.37,0.72,0.95,-0.98, ,1.17,0.08, ,phosphatidylinositol biosynthetic process;signal transduction;small molecule metabolic process;receptor-mediated endocytosis;phosphatidylinositol-mediated signaling,mitochondrial outer membrane;endosome;cytosol;Golgi membrane;rough endoplasmic reticulum membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8252,Q9UBH6,XPR1,Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor),SWKYNQSISLRRP,_YNQS(ph)ISLR_,S601,,23.06,,,24.11,22.37,,,21.16,,,,,,22.67,0.39, , ,1.43,-0.30, , ,-1.52, , , , , ,response to virus,integral to plasma membrane,,,,,,,,,,,,,,
8253,Q9UBH6,XPR1,Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor),KYNQSISLRRPRL,_YNQSIS(ph)LR_,S603,,24.38,,,,,,24.16,23.53,,,,,,24.02,0.36, , , , , ,0.14,-0.49, , , , , ,response to virus,integral to plasma membrane,,,,,,,,,,,,,,
8254,Q9UBI6,GNG12,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,QLRLEASIERIKV,_LEAS(ph)IERIK_,S26,+,26.54,26.52,26.41,27.69,27.05,27.02,26.85,26.90,26.10,26.31,26.12,26.87,27.12,26.73,-0.19,-0.21,-0.33,0.96,0.32,0.29,0.12,0.17,-0.64,-0.42,-0.61,0.14,0.39,small molecule metabolic process;G-protein coupled receptor signaling pathway;energy reserve metabolic process;cerebral cortex development;signal transduction;synaptic transmission;response to lipopolysaccharide;cellular response to glucagon stimulus,actin filament;plasma membrane;heterotrimeric G-protein complex,,,,,,,,,,,,,,
8257,Q9UBL3,ASH2L,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),EVDGRRSPPWEP_,_S(ph)PPWEP_,S484,,23.75,20.80,20.80,,,22.83,,,,,,,,22.04,1.71,-1.25,-1.25, , ,0.79, , , , , , , ,"regulation of transcription, DNA-dependent;response to DNA damage stimulus;transcription from RNA polymerase II promoter;histone H3-K4 methylation;response to estrogen stimulus;positive regulation of cell proliferation;hemopoiesis;positive regulation of transcription from RNA polymerase II promoter",Set1C/COMPASS complex,DNA binding region,,,,,,,,,,,,,
8258,Q9UBM7,DHCR7,7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Putative sterol reductase SR-2) (Sterol Delta(7)-reductase),NIPKAKSLDGVTN,_S(ph)LDGVTNDR_,S14,+,26.41,26.13,26.13,27.87,26.19,25.37,25.59,25.63,26.37,26.81,20.64,25.34,23.77,25.56,0.85,0.57,0.57,2.31,0.64,-0.19,0.03,0.08,0.81,1.26,-4.92,-0.21,-1.79,cell differentiation;post-embryonic development;cholesterol biosynthetic process;regulation of cell proliferation;lung development;multicellular organism growth;regulation of cholesterol biosynthetic process;blood vessel development,integral to membrane;endoplasmic reticulum membrane;nuclear outer membrane,,,,,,,,,,,,,,
8259,Q9UBS0,RPS6KB2,Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta),SPRAPVSPLKFSP,_APVS(ph)PLK_,S423,,23.17,,,21.90,,,,,,,,,,22.53,0.64, , ,-0.64, , , , , , , , , ,positive regulation of translational initiation;protein kinase B signaling cascade;epidermal growth factor receptor signaling pathway;fibroblast growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;translation;phosphatidylinositol-mediated signaling,nucleoplasm;cytoplasm,,+,,,,,,,,,,,,
8261,Q9UBS9,SUCO,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),VEPLKFSPEKKKK,_EVDPNDLYIVEPLKFS(ph)PEK_,S732,,22.68,,,,,,,,,,,,,22.68,0.00, , , , , , , , , , , , ,regulation of bone remodeling;multicellular organismal development;positive regulation of osteoblast differentiation;positive regulation of collagen biosynthetic process;ossification,rough endoplasmic reticulum;integral to membrane;membrane;rough endoplasmic reticulum membrane,,,,,,,,,,,,,,
8262,Q9UBS9,SUCO,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),IQTKSGSLPSLHD,_SGS(ph)LPSLHDIIK_,S855,,21.54,20.66,20.51,,,22.48,,21.52,23.25,22.51,,22.07,,21.82,-0.28,-1.15,-1.31, , ,0.67, ,-0.30,1.44,0.69, ,0.25, ,regulation of bone remodeling;multicellular organismal development;positive regulation of osteoblast differentiation;positive regulation of collagen biosynthetic process;ossification,rough endoplasmic reticulum;integral to membrane;membrane;rough endoplasmic reticulum membrane,,,,,,,,,,,,,,
8263,Q9UBS9,SUCO,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),PLMRSKSLQLTGK,_S(ph)LQLTGK_,S710,,24.36,23.52,23.16,24.78,,,,,,,,,,23.95,0.40,-0.43,-0.79,0.83, , , , , , , , , ,regulation of bone remodeling;multicellular organismal development;positive regulation of osteoblast differentiation;positive regulation of collagen biosynthetic process;ossification,rough endoplasmic reticulum;integral to membrane;membrane;rough endoplasmic reticulum membrane,,,,,,,,,,,,,,
8264,Q9UBU7,DBF4,Protein DBF4 homolog A (Activator of S phase kinase) (Chiffon homolog A) (DBF4-type zinc finger-containing protein 1),SQPKQKSDTVLFP,_(gl)QKS(ph)DTVLFPAK_,S79,,22.11,22.86,23.22,20.12,,,,,22.23,21.73,,,,22.05,0.07,0.82,1.18,-1.92, , , , ,0.18,-0.32, , , ,cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication;M/G1 transition of mitotic cell cycle,nucleoplasm,,,,,,,,,,,,,,
8268,Q9UBV2,SEL1L,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),GQIFLDSEESELE,_VVAGQIFLDS(ph)EESELESSIQEEEDSLK_,S63,,27.24,,,,,,,,,,,,,27.24,0.00, , , , , , , , , , , , ,Notch signaling pathway;response to endoplasmic reticulum stress,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8269,Q9UBW5,BIN2,Bridging integrator 2 (Breast cancer-associated protein 1),LGTGTASPRTSLE,_ASLGTGTAS(ph)PR_,S426,,19.83,25.21,24.92,23.15,,,,,,,,,,23.28,-3.45,1.93,1.64,-0.12, , , , , , , , , ,,cytoplasm,,,,,,,,,,,,,,
8271,Q9UBW7,ZMYM2,Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198),PGVDSLSPVASLP,_(gl)QPGVDSLS(ph)PVASLPK_,S305,+,25.23,22.87,22.87,21.69,23.90,24.09,23.23,23.01,23.27,23.54,,,,23.37,1.86,-0.50,-0.50,-1.68,0.53,0.72,-0.14,-0.36,-0.10,0.17, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",cytosol;PML body,,,,,,,,,,,,,,
8272,Q9UD71,PPP1R1B,Protein phosphatase 1 regulatory subunit 1B (DARPP-32) (Dopamine- and cAMP-regulated neuronal phosphoprotein),LNENQASEEEDEL,_IAESHLQSISNLNENQAS(ph)EEEDELGELRELGYPR_,S66,,25.00,,,,,,,,,,,,,25.00,0.00, , , , , , , , , , , , ,signal transduction,cytosol,,,,,,,,,,,,,,
8274,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),DQLRDNSPPPAFK,_DNS(ph)PPPAFKPEPPK_,S963,+,25.44,25.44,26.01,23.21,25.37,26.43,27.22,26.81,24.40,26.41,25.80,24.98,26.43,25.69,-0.25,-0.25,0.32,-2.48,-0.32,0.74,1.53,1.13,-1.28,0.72,0.11,-0.70,0.74,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8275,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),DYERAYSPEYRRG,_AYS(ph)PEYR_,S243,+,27.52,28.69,29.09,27.76,29.15,28.45,29.31,29.06,27.94,27.75,27.60,28.82,27.65,28.37,-0.85,0.32,0.73,-0.61,0.78,0.08,0.94,0.69,-0.43,-0.62,-0.77,0.45,-0.72,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8276,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),SREHPHSRSPSPE,_EHPHS(ph)RS(ph)PS(ph)PEPR_,S269,,24.47,21.06,21.06,19.07,19.73,,,,,,,,,21.08,3.39,-0.02,-0.02,-2.01,-1.34, , , , , , , , ,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8277,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),EHPHSRSPSPEPR,_EHPHS(ph)RS(ph)PS(ph)PEPR_,S271,,24.47,21.06,21.06,19.07,19.73,,,,,,,,,21.08,3.39,-0.02,-0.02,-2.01,-1.34, , , , , , , , ,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8278,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),PHSRSPSPEPRGR,_EHPHS(ph)RS(ph)PS(ph)PEPR_,S273,,24.47,21.06,21.06,19.07,19.73,,,,,,,,,21.08,3.39,-0.02,-0.02,-2.01,-1.34, , , , , , , , ,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8281,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),LKERPSSREDTPS,_ERPSS(ph)REDTPSR_,S418,+,25.77,24.49,24.49,20.49,,19.70,21.09,21.27,20.79,20.10,20.55,20.53,20.92,21.68,4.09,2.80,2.80,-1.19, ,-1.98,-0.59,-0.41,-0.89,-1.59,-1.13,-1.16,-0.76,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8283,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),TRGSYGSDAEEEE,_GSYGS(ph)DAEEEEYRQQLSEHSK_,S1136,+,25.48,25.05,24.35,23.22,27.17,26.74,24.44,27.52,26.26,25.06,26.65,26.40,26.16,25.73,-0.25,-0.68,-1.38,-2.51,1.44,1.01,-1.29,1.79,0.53,-0.67,0.92,0.67,0.43,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8284,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),VAALQASPPLDQD,_VQVAALQAS(ph)PPLDQDDRAFEVM(ox)DEFDGR_,S107,+,25.01,,,,26.42,,24.22,24.82,,25.40,26.62,26.11,23.46,25.26,-0.25, , , ,1.16, ,-1.04,-0.44, ,0.15,1.36,0.85,-1.80,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8286,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),GEEVGESSEEQDN,_SILKPSTPIPPQEGEEVGES(ph)SEEQDNAPK_,S1044,+,23.28,,,,24.79,24.32,25.52,25.32,25.03,24.93,24.79,24.68,25.55,24.82,-1.54, , , ,-0.03,-0.50,0.70,0.50,0.21,0.11,-0.03,-0.14,0.73,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8287,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),DRSRGRSLERGLD,_S(ph)LERGLDHDFGPSR_,S197,,,,,,22.97,,23.24,23.24,,21.51,22.18,,,22.63, , , , ,0.34, ,0.62,0.61, ,-1.12,-0.45, , ,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8288,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),DRSRGRSLERGLD,_S(ph)LERGLDQDHAR_,S177,+,,25.62,25.62,,25.48,23.63,26.75,25.73,24.64,24.36,22.82,23.35,21.90,24.54, ,1.08,1.08, ,0.95,-0.90,2.22,1.19,0.10,-0.18,-1.71,-1.19,-2.64,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8289,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),HGGRSRSWEDSPE,_SRS(ph)WEDSPER_,S147,+,26.69,25.49,25.57,25.52,28.33,25.23,26.69,27.68,25.32,24.11,26.08,25.60,23.32,25.82,0.88,-0.33,-0.25,-0.29,2.51,-0.59,0.87,1.86,-0.50,-1.71,0.26,-0.21,-2.49,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8291,Q9UDY2,TJP2,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),ESIRKPSPEPRAQ,_SSEPVQHEESIRKPS(ph)PEPR_,S943,+,,23.37,23.62,,,23.68,24.41,24.82,23.18,23.82,23.05,23.86,23.58,23.74, ,-0.37,-0.12, , ,-0.06,0.67,1.08,-0.56,0.08,-0.69,0.12,-0.16,cellular component disassembly involved in execution phase of apoptosis;hippo signaling cascade,tight junction;nucleoplasm;cytosol;adherens junction;plasma membrane,,,,,,,,,,+,,,,
8293,Q9UEE9,CFDP1,Craniofacial development protein 1 (Bucentaur),SKLDWESFKEEEG,_SKLDWES(ph)FK_,S250,,22.95,,,20.49,,,,,,,,,,21.72,1.23, , ,-1.23, , , , , , , , , ,multicellular organismal development;regulation of cell shape;cell adhesion;regulation of cell proliferation,,,,,,,,,,,,,,,
8294,Q9UER7,DAXX,Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein),GKDGDKSPMSSLQ,_DGDKS(ph)PM(ox)SSLQISNEK_,S420,+,25.86,27.21,27.41,25.56,24.78,26.22,26.05,25.66,26.59,26.53,25.67,25.45,23.99,25.92,-0.06,1.29,1.49,-0.36,-1.14,0.29,0.13,-0.26,0.67,0.61,-0.25,-0.47,-1.93,"cytokinesis after mitosis;activation of JUN kinase activity;negative regulation of transcription, DNA-dependent;induction of apoptosis;extrinsic apoptotic signaling pathway via death domain receptors;regulation of protein ubiquitination;androgen receptor signaling pathway;transcription, DNA-dependent;virus-host interaction","cell body;cell cortex;cytosol;neuron projection;chromosome, centromeric region;nucleolus;PML body;heterochromatin",,,,,,,,,,,,,,
8295,Q9UEW8,STK39,STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39),DGDWEWSDDEMDE,_TEDGDWEWS(ph)DDEMDEK_,S385,,25.97,,,,,,23.55,,,25.02,23.28,24.32,,24.43,1.54, , , , , ,-0.88, , ,0.59,-1.15,-0.11, ,positive regulation of potassium ion transport;response to stress,basolateral plasma membrane;apical plasma membrane;nucleus;cytoskeleton;cytoplasm,,+,,,,,,,,,,,,
8296,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),KIEEVLSPEGSPS,_IEEVLS(ph)PEGS(ph)PSKS(ph)PSK_,S673,+,27.37,23.50,24.17,23.24,,,25.26,,22.15,24.84,23.71,23.00,,24.14,3.24,-0.64,0.03,-0.90, , ,1.13, ,-1.99,0.70,-0.43,-1.14, ,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,,,,,,,,,,
8297,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),VLSPEGSPSKSPS,_IEEVLS(ph)PEGS(ph)PSKS(ph)PSK_,S677,+,27.54,26.98,26.93,26.68,23.01,25.81,27.11,23.03,27.02,26.62,25.33,25.80,25.12,25.92,1.62,1.05,1.01,0.75,-2.91,-0.11,1.19,-2.89,1.10,0.70,-0.59,-0.12,-0.80,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,,,,,,,,,,
8299,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),EGSPSKSPSKKKK,_IEEVLSPEGSPSKS(ph)PSK_,S681,+,27.24,27.74,27.28,27.85,22.26,29.55,28.35,27.71,29.30,27.73,27.90,28.21,28.46,27.66,-0.42,0.08,-0.38,0.19,-5.40,1.89,0.69,0.05,1.64,0.07,0.24,0.55,0.80,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,,,,,,,,,,
8303,Q9UFC0,LRWD1,Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein),DVPLSLSPSKRAC,_RPDDVPLSLS(ph)PSK_,S243,+,23.36,26.35,26.35,22.55,23.22,24.07,26.22,24.27,24.40,25.11,23.88,24.90,24.25,24.53,-1.17,1.82,1.82,-1.98,-1.31,-0.46,1.69,-0.26,-0.14,0.58,-0.66,0.36,-0.28,G1 phase of mitotic cell cycle;establishment of protein localization to chromatin;chromatin organization;chromatin modification;DNA replication initiation,nuclear origin of replication recognition complex;telomeric heterochromatin;centromeric heterochromatin,,,,,,,,,,,,,,
8305,Q9UGH3,SLC23A2,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2),LAETLDSTGSLDP,_SSLAETLDS(ph)TGS(ph)LDPQR_,S78,,24.06,,,,,22.29,,,23.65,,,,,23.34,0.73, , , , ,-1.05, , ,0.32, , , , ,response to oxidative stress;transepithelial L-ascorbic acid transport;nucleobase-containing compound metabolic process;molecular hydrogen transport;L-ascorbic acid metabolic process,basolateral plasma membrane;apical plasma membrane;integral to plasma membrane;basal plasma membrane;cytoplasm,,,,,,,,,,,,,,
8306,Q9UGH3,SLC23A2,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2),TLDSTGSLDPQRS,_SSLAETLDS(ph)TGS(ph)LDPQR_,S81,,24.06,,,,23.27,24.36,,,,,23.60,,24.07,23.87,0.19, , , ,-0.61,0.49, , , , ,-0.27, ,0.20,response to oxidative stress;transepithelial L-ascorbic acid transport;nucleobase-containing compound metabolic process;molecular hydrogen transport;L-ascorbic acid metabolic process,basolateral plasma membrane;apical plasma membrane;integral to plasma membrane;basal plasma membrane;cytoplasm,,,,,,,,,,,,,,
8307,Q9UGJ0,PRKAG2,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p),PFSYQESPPRSPR,_TVFPFSYQES(ph)PPRS(ph)PR_,S69,,21.39,,,,,,,,,,,,,21.39,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;regulation of fatty acid biosynthetic process;glycogen metabolic process;sterol biosynthetic process;positive regulation of peptidyl-threonine phosphorylation;cellular lipid metabolic process;carnitine shuttle;regulation of glucose import;regulation of glycolysis;insulin receptor signaling pathway;cell cycle arrest;regulation of fatty acid oxidation;fatty acid biosynthetic process;ATP biosynthetic process,nucleoplasm;cytosol;AMP-activated protein kinase complex,,,,,,,,,,,,,,
8308,Q9UGJ0,PRKAG2,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p),QESPPRSPRRMSF,_TVFPFSYQES(ph)PPRS(ph)PR_,S73,,21.39,,,,,,,,,,,,,21.39,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;regulation of fatty acid biosynthetic process;glycogen metabolic process;sterol biosynthetic process;positive regulation of peptidyl-threonine phosphorylation;cellular lipid metabolic process;carnitine shuttle;regulation of glucose import;regulation of glycolysis;insulin receptor signaling pathway;cell cycle arrest;regulation of fatty acid oxidation;fatty acid biosynthetic process;ATP biosynthetic process,nucleoplasm;cytosol;AMP-activated protein kinase complex,,,,,,,,,,,,,,
8310,Q9UGP4,LIMD1,LIM domain-containing protein 1,LNHRQLSLSSSRS,_(gl)QLS(ph)LSSSR_,S233,,22.03,,,18.65,,,,,,,,,,20.34,1.69, , ,-1.69, , , , , , , , , ,"negative regulation of canonical Wnt receptor signaling pathway;negative regulation of transcription, DNA-dependent;positive regulation of gene silencing by miRNA;phosphorylation;negative regulation of hippo signaling cascade;cytoskeleton organization;negative regulation of osteoblast differentiation;multicellular organismal development;regulation of cell shape;cell migration;response to hypoxia;gene silencing by miRNA;osteoblast development;signal transduction;transcription, DNA-dependent;cytoplasmic mRNA processing body assembly",RNA-induced silencing complex;nucleus;focal adhesion;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
8311,Q9UGU0,TCF20,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),SSKDLPSPDSRNC,_DLPS(ph)PDSR_,S1322,+,23.28,24.42,23.68,26.04,23.63,23.49,24.69,23.87,25.05,25.29,22.20,23.95,21.51,23.93,-0.65,0.49,-0.26,2.11,-0.30,-0.44,0.76,-0.06,1.12,1.36,-1.73,0.02,-2.42,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
8313,Q9UGU0,TCF20,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),PPRLNASPAAREE,_LNAS(ph)PAAREEATS(ph)PGAK_,S574,,23.86,23.10,,23.95,,,,,,,,,,23.64,0.22,-0.54, ,0.32, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
8314,Q9UGU0,TCF20,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),AREEATSPGAKDM,_LNAS(ph)PAAREEATS(ph)PGAK_,S583,,23.86,23.10,,23.95,,,,,,,,,,23.64,0.22,-0.54, ,0.32, , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
8315,Q9UGU5,HMGXB4,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),SSVGVLSPQKKSP,_ASSVGVLS(ph)PQK_,S497,+,23.18,23.77,23.77,22.15,,,21.76,20.97,,21.45,,,20.98,22.25,0.93,1.52,1.52,-0.11, , ,-0.49,-1.28, ,-0.81, , ,-1.27,endosome to lysosome transport;Wnt receptor signaling pathway;negative regulation of Wnt receptor signaling pathway,NURF complex,HMG-box,,,,,,,,,,,,,
8316,Q9UGU5,HMGXB4,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),LSPQKKSPPTTML,_S(ph)PPTTM(ox)LLPASPAK_,S502,+,25.22,23.68,,24.27,,22.63,22.75,,24.34,23.06,23.47,22.93,,23.59,1.62,0.08, ,0.67, ,-0.97,-0.84, ,0.75,-0.53,-0.13,-0.66, ,endosome to lysosome transport;Wnt receptor signaling pathway;negative regulation of Wnt receptor signaling pathway,NURF complex,HMG-box,,,,,,,,,,,,,
8317,Q9UGU5,HMGXB4,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),TMLLPASPAKAPE,_SPPTTM(ox)LLPAS(ph)PAK_,S512,+,25.47,24.46,24.46,23.54,,,23.97,,23.78,25.05,,,22.90,24.20,1.27,0.25,0.25,-0.66, , ,-0.23, ,-0.42,0.85, , ,-1.31,endosome to lysosome transport;Wnt receptor signaling pathway;negative regulation of Wnt receptor signaling pathway,NURF complex,HMG-box,,,,,,,,,,,,,
8320,Q9UGV2,NDRG3,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),ARSRTHSTSSSLG,_THS(ph)TSSSLGSGESPFSR_,S319,,25.52,,,,,,,,,,,25.33,,25.43,0.09, , , , , , , , , , ,-0.09, ,cell differentiation;spermatogenesis;negative regulation of cell growth,cytoplasm,,,,,,,,,,,,,,
8321,Q9UGV2,NDRG3,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),RTHSTSSSLGSGE,_THS(ph)TSS(ph)SLGSGESPFSR_,S322,,22.69,,,,,,,,,,,,,22.69,0.00, , , , , , , , , , , , ,cell differentiation;spermatogenesis;negative regulation of cell growth,cytoplasm,,,,,,,,,,,,,,
8322,Q9UH62,ARMCX3,Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3) (Protein ALEX3),ARYNDWSDDDDDS,_YNDWS(ph)DDDDDSNESK_,S61,+,25.12,24.13,24.13,25.07,25.74,26.38,25.66,25.48,25.85,25.42,25.38,24.54,25.22,25.24,-0.12,-1.11,-1.11,-0.17,0.50,1.14,0.42,0.24,0.61,0.18,0.14,-0.70,-0.02,cellular protein localization;positive regulation of transcription from RNA polymerase II promoter,integral to mitochondrial outer membrane,,,,,,,,,,,,,,
8324,Q9UH99,SUN2,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),STLFKDSPLRTLK,_DS(ph)PLRTLK_,S38,,,,,23.01,,23.83,24.91,,25.88,,,,,24.41, , , ,-1.40, ,-0.58,0.50, ,1.47, , , , ,nuclear matrix anchoring at nuclear membrane;mitotic spindle organization;positive regulation of cell migration;nuclear migration along microfilament;nuclear envelope organization;centrosome localization;cytoskeletal anchoring at nuclear membrane,nuclear membrane;endosome membrane;integral to membrane;SUN-KASH complex;nuclear inner membrane,,,,,,,,,,,,,,
8325,Q9UH99,SUN2,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),QRLTRYSQGDDDG,_LTRYS(ph)QGDDDGSSSSGGSSVAGSQSTLFK_,S12,+,,,,,24.93,25.30,25.73,,26.44,25.43,25.59,25.02,25.19,25.45, , , , ,-0.52,-0.16,0.27, ,0.98,-0.02,0.14,-0.43,-0.26,nuclear matrix anchoring at nuclear membrane;mitotic spindle organization;positive regulation of cell migration;nuclear migration along microfilament;nuclear envelope organization;centrosome localization;cytoskeletal anchoring at nuclear membrane,nuclear membrane;endosome membrane;integral to membrane;SUN-KASH complex;nuclear inner membrane,,,,,,,,,,,,,,
8326,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),SPDSRASSLSESS,_PLSPDS(ph)RAS(ph)SLSES(ph)SPPK_,S368,,24.71,24.71,24.71,25.21,,,22.27,,,23.87,,,,24.25,0.46,0.47,0.47,0.96, , ,-1.97, , ,-0.38, , , ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8329,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),ASSLSESSPPKAM,_PLSPDS(ph)RAS(ph)SLSES(ph)SPPK_,S373,,23.23,23.87,23.87,28.29,,,,,,,,,,24.82,-1.58,-0.95,-0.95,3.48, , , , , , , , , ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8330,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),SSLSESSPPKAMK,_ASSLSESS(ph)PPK_,S374,+,24.41,27.13,27.60,28.20,25.02,24.71,25.25,25.20,24.30,23.75,24.38,26.79,24.46,25.48,-1.07,1.65,2.12,2.73,-0.46,-0.77,-0.23,-0.27,-1.17,-1.73,-1.09,1.31,-1.02,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8331,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),VENGADSDEDDNS,_EGHSLEM(ox)ENENLVENGADS(ph)DEDDNSFLK_,S686,+,26.42,,,,26.91,22.55,26.18,23.48,26.62,29.28,25.83,28.14,26.03,26.14,0.27, , , ,0.77,-3.59,0.04,-2.66,0.47,3.14,-0.31,1.99,-0.11,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8332,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),ARETPHSPGVEDA,_ETPHS(ph)PGVEDAPIAK_,S490,+,29.86,30.98,30.77,31.24,32.22,31.71,32.05,32.08,31.34,32.04,31.80,31.33,32.36,31.52,-1.67,-0.54,-0.75,-0.29,0.70,0.19,0.53,0.56,-0.18,0.52,0.28,-0.19,0.84,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8333,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),PIRKGWSMSEQSE,_GWS(ph)M(ox)SEQSEESVGGR_,S617,,23.19,,,25.15,21.72,,,,,,,23.98,,23.51,-0.32, , ,1.64,-1.79, , , , , , ,0.47, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8334,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),ASGRKISENSYSL,_KIS(ph)ENSYSLDDLEIGPGQLSSSTFDSEK_,S225,+,,,,26.92,24.14,25.56,27.42,27.83,28.03,28.67,29.22,28.11,30.69,27.66, , , ,-0.74,-3.52,-2.10,-0.24,0.17,0.37,1.01,1.56,0.45,3.03,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8336,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),PRSRLRSPPEALV,_S(ph)PPEALVQGR_,S132,+,25.74,23.01,22.64,23.15,24.55,23.13,25.54,26.22,24.62,27.84,26.91,25.14,25.68,24.94,0.80,-1.92,-2.30,-1.79,-0.38,-1.81,0.61,1.29,-0.32,2.90,1.97,0.21,0.75,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8337,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),LELPRLSETSIKD,_NLELPRLS(ph)ETSIK_,S263,,,,,,,,22.52,,,22.83,22.72,23.44,24.17,23.14, , , , , , ,-0.62, , ,-0.30,-0.42,0.31,1.04,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8338,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),VHPKPLSPDSRAS,_PLS(ph)PDSR_,S362,+,24.92,26.44,26.96,27.30,27.28,27.43,27.89,28.94,26.66,28.33,28.26,27.73,28.51,27.43,-2.51,-1.00,-0.47,-0.14,-0.15,0.00,0.45,1.50,-0.77,0.89,0.82,0.29,1.08,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8339,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),KPLSPDSRASSLS,_PLSPDS(ph)RASS(ph)LSESSPPK_,S365,+,26.23,24.91,24.91,25.70,22.49,,23.22,,,23.87,,23.02,,24.29,1.93,0.62,0.62,1.40,-1.80, ,-1.07, , ,-0.43, ,-1.27, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8340,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),SFLKQQSPQEPKS,_(gl)QQS(ph)PQEPK_,S698,+,23.17,21.97,22.42,25.92,,23.32,24.02,23.94,24.47,23.11,23.90,25.72,24.81,23.90,-0.73,-1.93,-1.48,2.02, ,-0.57,0.12,0.04,0.58,-0.79,0.00,1.82,0.92,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8341,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),RQWTSLSLRVTAK,_QWTSLS(ph)LR_,S15,+,26.44,21.71,20.67,21.87,20.86,,21.83,,,22.94,,23.72,,22.50,3.94,-0.80,-1.83,-0.64,-1.65, ,-0.68, , ,0.44, ,1.21, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8342,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),TTQNQKSQDVELW,_S(ph)QDVELWEGEVVK_,S726,,20.97,,,23.02,,,,,22.56,,,23.56,,22.53,-1.56, , ,0.49, , , , ,0.03, , ,1.04, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8344,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),KSPKTVSPPIRKG,_TVS(ph)PPIRK_,S609,+,22.78,25.46,26.07,25.03,23.44,22.56,23.10,23.60,21.86,,,23.13,,23.70,-0.92,1.75,2.37,1.33,-0.26,-1.14,-0.61,-0.10,-1.84, , ,-0.58, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8345,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),VHPKPLSPDSRAS,_PLS(ph)PDSR_,S363,+,24.92,26.44,26.96,27.30,27.48,27.43,27.89,28.94,26.66,28.33,28.26,27.73,28.51,27.45,-2.52,-1.01,-0.48,-0.15,0.03,-0.02,0.44,1.49,-0.79,0.88,0.81,0.28,1.06,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8346,Q9UHB6,LIMA1,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),KPLSPDSRASSLS,_PLSPDS(ph)RASS(ph)LSESSPPK_,S366,+,26.23,24.91,24.91,25.70,22.49,,23.22,,,23.87,,23.02,,24.29,1.93,0.62,0.62,1.40,-1.80, ,-1.07, , ,-0.43, ,-1.27, ,ruffle organization;negative regulation of actin filament depolymerization;actin filament bundle assembly,stress fiber;plasma membrane;focal adhesion;cytoplasm,,,,,,,,,,,,,,
8347,Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),GMPSPVSPKLSPG,_AVGM(ox)PSPVS(ph)PK_,S1058,,24.98,25.34,25.82,24.79,,,,,,24.43,,,23.84,24.87,0.11,0.47,0.95,-0.07, , , , , ,-0.44, , ,-1.03,spermatid development;transcription from RNA polymerase II promoter,mitochondrion;nucleolus,,,,,,,,,,,,,,
8348,Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),EKDLLPSPAGPVP,_DLLPS(ph)PAGPVPSK_,S814,+,25.83,25.40,25.59,25.04,24.30,25.19,25.66,24.44,26.92,26.96,26.48,25.50,25.71,25.62,0.21,-0.22,-0.03,-0.58,-1.31,-0.42,0.05,-1.18,1.30,1.35,0.87,-0.12,0.09,spermatid development;transcription from RNA polymerase II promoter,mitochondrion;nucleolus,,,,,,,,,,,,,,
8349,Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),ELLSPLSEPDDRY,_ELLSPLS(ph)EPDDRYPLIVK_,S706,+,,,,,25.81,23.91,,24.72,25.90,25.85,,25.44,25.80,25.35, , , , ,0.46,-1.43, ,-0.63,0.55,0.50, ,0.10,0.45,spermatid development;transcription from RNA polymerase II promoter,mitochondrion;nucleolus,,,,,,,,,,,,,,
8351,Q9UHB7,AFF4,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),NNSQAPSPGLGSK,_NSYNNSQAPS(ph)PGLGSK_,S1043,+,25.40,23.92,24.14,23.90,23.72,24.06,23.76,23.64,25.22,23.79,,23.22,23.78,24.05,1.35,-0.13,0.10,-0.15,-0.33,0.01,-0.29,-0.40,1.18,-0.26, ,-0.82,-0.27,spermatid development;transcription from RNA polymerase II promoter,mitochondrion;nucleolus,,,,,,,,,,,,,,
8353,Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),DSLSQRSPKASLR,_HVDSLSQRS(ph)PK_,S85,+,25.88,26.42,27.01,26.82,26.73,25.37,25.34,26.26,25.35,25.13,25.85,27.23,24.83,26.02,-0.14,0.41,0.99,0.81,0.71,-0.65,-0.68,0.24,-0.66,-0.89,-0.17,1.21,-1.18,protein heterooligomerization;cell cycle;cell division,stress fiber;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8355,Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),GPALKRSFEVEEV,_S(ph)FEVEEVETPNSTPPRRVQTPLLR_,S30,+,27.16,25.60,23.50,27.17,28.46,26.69,29.17,28.98,26.90,26.32,30.06,30.18,28.21,27.57,-0.41,-1.97,-4.06,-0.40,0.89,-0.88,1.61,1.41,-0.67,-1.25,2.49,2.62,0.64,protein heterooligomerization;cell cycle;cell division,stress fiber;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8358,Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),FEALKRSFEVEEV,_S(ph)FEVEEVETPNSTPPRRVQTPLLR_,S23,,27.16,25.60,23.50,27.17,28.40,26.69,28.90,28.89,26.79,26.17,29.88,30.02,28.02,27.48,-0.32,-1.88,-3.97,-0.31,0.92,-0.79,1.42,1.41,-0.69,-1.30,2.41,2.55,0.55,protein heterooligomerization;cell cycle;cell division,stress fiber;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8359,Q9UHD8,SEP9,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),_____MSDPAVNA,_(ac)S(ph)DPAVNAQLDGIISDFEALK_,S2,,22.74,,,,,,,,,,,,,22.74,0.00, , , , , , , , , , , , ,protein heterooligomerization;cell cycle;cell division,stress fiber;microtubule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8361,Q9UHF7,TRPS1,Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79),GSSERGSPIEKYM,_GSSERGS(ph)PIEK_,S1066,,21.47,23.52,23.80,23.84,18.74,18.54,,,,,,19.48,,21.34,0.13,2.18,2.46,2.50,-2.60,-2.80, , , , , ,-1.86, ,NLS-bearing substrate import into nucleus;negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;skeletal system development;regulation of chondrocyte differentiation,nucleus,C2H2-type,,,,,,,,,,,,,
8362,Q9UHF7,TRPS1,Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79),AKHPNYSPPGSPI,_HPNYS(ph)PPGS(ph)PIEK_,S1081,,23.70,22.96,23.34,23.76,,,,,,,,,,23.44,0.26,-0.48,-0.10,0.32, , , , , , , , , ,NLS-bearing substrate import into nucleus;negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;skeletal system development;regulation of chondrocyte differentiation,nucleus,C2H2-type,,,,,,,,,,,,,
8363,Q9UHF7,TRPS1,Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79),NYSPPGSPIEKYQ,_HPNYS(ph)PPGS(ph)PIEK_,S1085,,23.70,22.96,23.34,23.76,,,,,,,,,,23.44,0.26,-0.48,-0.10,0.32, , , , , , , , , ,NLS-bearing substrate import into nucleus;negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;skeletal system development;regulation of chondrocyte differentiation,nucleus,C2H2-type,,,,,,,,,,,,,
8364,Q9UHF7,TRPS1,Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79),PDPAPLSPELQDF,_TDLLVNDNPDPAPLS(ph)PELQDFK_,S216,,23.40,,,,23.98,23.10,22.24,,23.14,23.03,,,,23.15,0.25, , , ,0.83,-0.05,-0.91, ,-0.01,-0.12, , , ,NLS-bearing substrate import into nucleus;negative regulation of transcription from RNA polymerase II promoter;transcription from RNA polymerase II promoter;skeletal system development;regulation of chondrocyte differentiation,nucleus,C2H2-type,,,,,,,,,,,,,
8365,Q9UHG0,DCDC2,Doublecortin domain-containing protein 2 (Protein RU2S),NVKLKNSQETIPN,_LKNS(ph)QETIPNSDEGIFK_,S300,,,,,,,,,,26.24,26.21,25.29,,,25.91, , , , , , , , ,0.33,0.30,-0.63, , ,cellular defense response;neuron migration;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
8366,Q9UHG0,DCDC2,Doublecortin domain-containing protein 2 (Protein RU2S),GSSDNSSPQPLKR,_STVGSSDNSS(ph)PQPLK_,S270,,24.54,23.56,23.98,,23.70,,23.46,23.44,25.54,,,22.90,,23.89,0.65,-0.33,0.09, ,-0.19, ,-0.44,-0.45,1.65, , ,-0.99, ,cellular defense response;neuron migration;intracellular signal transduction,intracellular,,,,,,,,,,,,,,
8367,Q9UHI6,DDX20,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3),ASSRNNSVSGLSV,_NNS(ph)VSGLSVK_,S500,,24.69,,,23.18,,,,,,,,,,23.93,0.75, , ,-0.75, , , , , , , , , ,assembly of spliceosomal tri-snRNP;ncRNA metabolic process;negative regulation of transcription from RNA polymerase II promoter;positive regulation of apoptotic process;induction of apoptosis,nucleoplasm;cytosol;cytoskeleton;Cajal body;transcriptional repressor complex;spliceosomal complex,,,,,,,,,,,,,,
8369,Q9UHI6,DDX20,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3),SYLEGSSDNQLKD,_SYLEGSS(ph)DNQLK_,S678,+,24.06,23.89,24.19,23.99,22.09,23.60,24.23,23.54,23.44,24.34,,23.63,,23.73,0.33,0.16,0.46,0.26,-1.64,-0.13,0.50,-0.19,-0.29,0.62, ,-0.10, ,assembly of spliceosomal tri-snRNP;ncRNA metabolic process;negative regulation of transcription from RNA polymerase II promoter;positive regulation of apoptotic process;induction of apoptosis,nucleoplasm;cytosol;cytoskeleton;Cajal body;transcriptional repressor complex;spliceosomal complex,,,,,,,,,,,,,,
8370,Q9UHK0,NUFIP1,Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1),DSSAPKSPSQDVK,_TEADVLAENQVLDSSAPKS(ph)PSQDVK_,S403,,,23.62,23.62,,,,25.04,,25.51,,,,,24.45, ,-0.83,-0.83, , , ,0.59, ,1.06, , , , ,box C/D snoRNP assembly;RNA processing;positive regulation of transcription from RNA polymerase II promoter,pre-snoRNP complex;cytosolic ribosome;transcription elongation factor complex;nucleolus;perichromatin fibrils;presynaptic active zone;nuclear matrix,C2H2-type,,,,,,,,,,,,,
8371,Q9UHL9,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1 (GTF2I repeat domain-containing protein 1) (General transcription factor III) (MusTRD1/BEN) (Muscle TFII-I repeat domain-containing protein 1) (Slow-muscle-fiber enhancer-binding protein) (USE B1-binding protein) (Williams-Beuren syndrome chromosomal region 11 protein) (Williams-Beuren syndrome chromosomal region 12 protein),TKLEPASPPEDTS,_LEPAS(ph)PPEDTSAEVSR_,S448,+,24.21,22.93,22.70,23.47,,,23.18,,23.80,23.24,,23.54,22.91,23.33,0.88,-0.40,-0.63,0.14, , ,-0.15, ,0.47,-0.09, ,0.21,-0.42,embryo development,nucleus;cytoplasm,Other TF domain,,,,,,,,,,,,,
8373,Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),SGTPQASPMIERS,_TPASTPVSGT(ph)PQAS(ph)PM(ox)IER_,S261,+,26.86,25.91,26.45,24.80,25.66,25.98,25.30,26.07,27.39,25.62,26.57,25.76,25.56,25.99,0.87,-0.08,0.45,-1.20,-0.33,-0.02,-0.69,0.08,1.40,-0.38,0.58,-0.24,-0.43,positive regulation of actin filament polymerization;filopodium assembly;signal transduction;positive regulation of actin cytoskeleton reorganization;response to bacterium,cytosol;cell junction;plasma membrane;nucleus;cytoskeleton,,,,,,,,,,,,,,
8375,Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),SLQRSVSVATGLN,_SVS(ph)VATGLNM(ox)M(ox)K_,S331,,21.90,,,,,,,,,,25.83,27.22,,24.98,-3.08, , , , , , , , , ,0.85,2.24, ,positive regulation of actin filament polymerization;filopodium assembly;signal transduction;positive regulation of actin cytoskeleton reorganization;response to bacterium,cytosol;cell junction;plasma membrane;nucleus;cytoskeleton,,,,,,,,,,,,,,
8376,Q9UHR5,SAP30BP,SAP30-binding protein (Transcriptional regulator protein HCNGP),EKGGLVSDAYGED,_GGLVS(ph)DAYGEDDFSR_,S43,,23.30,,,,,,22.20,,,,,,,22.75,0.55, , , , , ,-0.55, , , , , , ,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;induction of apoptosis",intermediate filament cytoskeleton;nucleus,,,,,,,,,,,,,,
8377,Q9UHR5,SAP30BP,SAP30-binding protein (Transcriptional regulator protein HCNGP),QSEDDDSETEKPE,_(gl)QSEDDDS(ph)ETEKPEADDPK_,S77,,23.43,24.72,24.42,,,,,,21.65,,,,,23.55,-0.13,1.17,0.86, , , , , ,-1.90, , , , ,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;induction of apoptosis",intermediate filament cytoskeleton;nucleus,,,,,,,,,,,,,,
8378,Q9UHR5,SAP30BP,SAP30-binding protein (Transcriptional regulator protein HCNGP),ERVRNMSPDEIKI,_VRNM(ox)S(ph)PDEIK_,S113,+,24.20,25.55,25.96,24.13,,,22.36,,23.12,22.79,21.75,,,23.73,0.47,1.82,2.23,0.40, , ,-1.37, ,-0.61,-0.94,-1.99, , ,"apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;induction of apoptosis",intermediate filament cytoskeleton;nucleus,,,,,,,,,,,,,,
8380,Q9UHY1,NRBP1,Nuclear receptor-binding protein,_____MSEGESQT,_(ac)S(ph)EGESQTVLSSGSDPK_,S2,+,27.45,26.10,26.30,26.12,26.11,25.39,27.00,26.83,25.52,25.49,26.30,26.30,25.11,26.15,1.29,-0.05,0.15,-0.04,-0.05,-0.77,0.84,0.67,-0.64,-0.67,0.14,0.15,-1.04,transcription initiation from RNA polymerase II promoter;ER to Golgi vesicle-mediated transport,nucleoplasm;cell cortex;endomembrane system;lamellipodium;membrane;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
8381,Q9UHY1,NRBP1,Nuclear receptor-binding protein,ESQTVLSSGSDPK,_(ac)S(ph)EGESQTVLS(ph)SGSDPK_,S11,,24.30,23.22,23.38,22.62,,,,,,,,,,23.38,0.92,-0.16,0.00,-0.76, , , , , , , , , ,transcription initiation from RNA polymerase II promoter;ER to Golgi vesicle-mediated transport,nucleoplasm;cell cortex;endomembrane system;lamellipodium;membrane;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
8383,Q9UHY1,NRBP1,Nuclear receptor-binding protein,TVLSSGSDPKVES,_(ac)S(ph)EGESQTVLSSGS(ph)DPK_,S14,,24.22,23.49,,,,,,,,,22.66,,,23.46,0.76,0.03, , , , , , , , ,-0.79, , ,transcription initiation from RNA polymerase II promoter;ER to Golgi vesicle-mediated transport,nucleoplasm;cell cortex;endomembrane system;lamellipodium;membrane;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
8384,Q9UI08,EVL,Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like),PWERSNSVEKPVS,_SNS(ph)VEKPVSSILSRTPSVAK_,S296,+,,23.30,23.99,21.80,22.20,,,23.04,21.74,,,23.24,,22.76, ,0.54,1.23,-0.96,-0.56, , ,0.28,-1.02, , ,0.48, ,protein homotetramerization;actin polymerization or depolymerization;organ morphogenesis;axon guidance;cell surface receptor signaling pathway,cytosol;focal adhesion;cytoskeleton;lamellipodium,,,,,,,,,,,,,,
8385,Q9UI10,EIF2B4,Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta),QYSRQNSLTQFMS,_(gl)QNS(ph)LTQFM(ox)SIPSSVIHPAM(ox)VR_,S188,,22.77,,,,,,,,,,,,,22.77,0.00, , , , , , , , , , , , ,negative regulation of translational initiation in response to stress;ovarian follicle development;response to glucose stimulus;myelination;response to peptide hormone stimulus;translational initiation;oligodendrocyte development;response to heat,cytosol;eukaryotic translation initiation factor 2B complex,,,,,,,,,,,,,,
8388,Q9UID6,ZNF639,Zinc finger protein 639 (Zinc finger protein ANC_2H01) (Zinc finger protein ZASC1),DNKDDDSDTETSN,_DDDS(ph)DTETSNDLPK_,S60,,23.87,23.34,23.34,,,,,,,21.78,,,,23.08,0.79,0.26,0.26, , , , , , ,-1.30, , , ,"positive regulation of cell growth;viral entry into host cell;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;positive regulation by host of viral transcription;negative regulation by host of viral transcription",nucleus,C2H2-type,,,,,,,,,,,,,
8389,Q9UID6,ZNF639,Zinc finger protein 639 (Zinc finger protein ANC_2H01) (Zinc finger protein ZASC1),QNYLVPSPVLRIL,_NQNYLVPS(ph)PVLR_,S88,+,23.71,22.00,22.22,21.16,23.69,23.39,22.99,22.87,24.08,,,,,22.90,0.81,-0.90,-0.68,-1.74,0.79,0.49,0.09,-0.03,1.18, , , , ,"positive regulation of cell growth;viral entry into host cell;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;positive regulation by host of viral transcription;negative regulation by host of viral transcription",nucleus,C2H2-type,,,,,,,,,,,,,
8390,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),PGEMPQSPTGLGQ,_AGDPGEM(ox)PQS(ph)PTGLGQPK_,S1365,+,25.73,23.89,24.02,24.27,25.55,25.14,24.27,25.16,25.32,24.29,23.76,22.35,,24.48,1.25,-0.59,-0.46,-0.20,1.07,0.67,-0.21,0.68,0.84,-0.19,-0.72,-2.13, ,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8391,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),VTSPKASPVTSPA,_AS(ph)PVTSPAAAFPTASPANK_,S464,,22.39,,,,,,,,,,,,,22.39,0.00, , , , , , , , , , , , ,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8392,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),AAFPTASPANKDV,_ASPVTSPAAAFPTAS(ph)PANK_,S477,+,24.94,23.70,24.30,24.88,22.87,24.65,25.38,24.72,25.70,25.72,24.25,24.44,,24.63,0.31,-0.93,-0.33,0.25,-1.76,0.02,0.76,0.09,1.07,1.09,-0.38,-0.19, ,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8393,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),LLRGRESPAAGPR,_GRES(ph)PAAGPR_,S1738,+,22.90,20.83,19.53,23.44,,,,18.15,18.91,,,18.72,19.70,20.27,2.63,0.56,-0.74,3.17, , , ,-2.12,-1.36, , ,-1.56,-0.57,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8394,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),RIMEETSGMEEEE,_IM(ox)EETS(ph)GM(ox)EEEEEEESIAAVPGRR_,S1019,,,,,,23.52,,,23.70,23.85,23.42,23.49,,25.39,23.89, , , , ,-0.38, , ,-0.20,-0.05,-0.48,-0.40, ,1.50,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8395,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),GSRQPSSPSHNTN,_(gl)QPSS(ph)PSHNTNLR_,S133,+,26.85,23.76,23.86,24.81,25.34,23.90,24.69,,24.39,,,22.90,,24.50,2.35,-0.74,-0.64,0.31,0.84,-0.60,0.19, ,-0.11, , ,-1.60, ,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8396,Q9UIF9,BAZ2A,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),YSEEGLSPSKRRR,_YSEEGLS(ph)PSK_,S1751,+,26.31,24.73,25.29,24.90,25.84,23.50,,24.64,25.11,23.98,23.65,,24.52,24.77,1.54,-0.04,0.51,0.13,1.07,-1.27, ,-0.13,0.34,-0.79,-1.12, ,-0.25,"histone H4-K20 methylation;histone H3-K9 methylation;histone deacetylation;chromatin silencing at rDNA;transcription, DNA-dependent;DNA methylation;chromatin remodeling;heterochromatin assembly involved in chromatin silencing;histone H4 deacetylation",rDNA heterochromatin;nucleolus;chromatin silencing complex,Other TF domain,,,,,,,,,,,,,
8397,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),CKDHTVSGDEDYC,_DHTVS(ph)GDEDYCPR_,S943,,,,,23.46,,,,,,,,,,23.46, , , ,0.00, , , , , , , , , ,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,,,,,,,,,,
8398,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),DEGRRESINDRAR,_ES(ph)INDR_,S189,,24.02,,,22.77,,,,,,,,,,23.40,0.63, , ,-0.63, , , , , , , , , ,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,,,,,,,,,,
8399,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),AEDEGDSEPEAVG,_LAEDEGDS(ph)EPEAVGQSR_,S1464,+,28.67,26.62,25.96,27.97,28.06,28.93,28.65,27.29,28.85,28.48,26.52,27.78,27.76,27.81,0.86,-1.19,-1.85,0.16,0.25,1.12,0.84,-0.52,1.04,0.67,-1.29,-0.03,-0.05,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,,,,,,,,,,
8401,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),HLKKSLSGSPLKV,_SLS(ph)GSPLK_,S347,,25.89,21.88,21.88,23.64,,,20.79,,,,,,,22.82,3.08,-0.94,-0.94,0.83, , ,-2.03, , , , , , ,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,,,,,,,,,,
8402,Q9UIG0,BAZ1B,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),KKSLSGSPLKVKN,_SLSGS(ph)PLK_,S349,,23.98,25.20,25.20,23.65,,,,,,,,,,24.51,-0.53,0.69,0.69,-0.85, , , , , , , , , ,"double-strand break repair;ATP-dependent chromatin remodeling;chromatin-mediated maintenance of transcription;DNA replication-dependent nucleosome disassembly;heart morphogenesis;transcription, DNA-dependent",condensed chromosome;WINAC complex;centromeric heterochromatin,,,,,,,,,,,,,,
8403,Q9UIL8,PHF11,PHD finger protein 11 (BRCA1 C-terminus-associated protein) (Renal carcinoma antigen NY-REN-34),__MAQASPPRPER,_(ac)AQAS(ph)PPRPER_,S5,,23.44,23.08,23.10,24.58,23.44,22.04,,,22.05,22.87,,22.86,22.26,22.97,0.47,0.10,0.13,1.60,0.47,-0.93, , ,-0.92,-0.10, ,-0.11,-0.71,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
8408,Q9UJ14,GGT7,Gamma-glutamyltransferase 7 (GGT 7) (EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) (Glutathione hydrolase 7) (EC 3.4.19.13) [Cleaved into: Gamma-glutamyltransferase 7 heavy chain;Gamma-glutamyltransferase 7 light chain],RLQRLPSSSSEMG,_LPS(ph)SSSEM(ox)GSQDGSPLR_,S72,,23.87,23.69,,23.50,,,,,,,,,,23.69,0.18,0.00, ,-0.18, , , , , , , , , ,leukotriene biosynthetic process;glutathione metabolic process;glutathione biosynthetic process,integral to membrane;anchored to external side of plasma membrane,,,,,,,,,,,,,,
8409,Q9UJ41,RABGEF1,Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5),SINRQTSIETDRV,_QTS(ph)IETDRVSK_,S132,+,27.83,27.65,26.62,28.81,26.06,27.00,26.98,27.58,27.12,23.86,27.20,27.72,26.23,26.97,0.85,0.67,-0.35,1.84,-0.91,0.03,0.00,0.61,0.15,-3.12,0.23,0.75,-0.75,endocytosis;protein transport,recycling endosome;early endosome,,,,,,,,,,,,,,
8410,Q9UJ70,NAGK,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase),SLGLSLSGGDQED,_SLGLSLS(ph)GGDQEDAGR_,S76,+,25.38,25.26,,,23.91,23.38,23.40,24.71,23.48,,25.39,24.14,25.05,24.41,0.97,0.85, , ,-0.50,-1.03,-1.01,0.30,-0.93, ,0.98,-0.27,0.64,N-acetylneuraminate catabolic process;N-acetylmannosamine metabolic process;N-acetylglucosamine metabolic process,,,,,,,,,,,,,,,
8411,Q9UJM3,ERRFI1,ERBB receptor feedback inhibitor 1 (Mitogen-inducible gene 6 protein) (MIG-6),HLSYVVSP_____,_HLSYVVS(ph)P_,S461,+,22.60,20.16,20.16,23.11,21.11,,21.22,,,,,22.39,,21.53,1.07,-1.38,-1.38,1.58,-0.43, ,-0.32, , , , ,0.85, ,regulation of keratinocyte differentiation;lung alveolus development;lung epithelium development;response to stress;negative regulation of protein autophosphorylation;lung vasculature development;negative regulation of epidermal growth factor-activated receptor activity;skin morphogenesis,extrinsic to internal side of plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
8412,Q9UJM3,ERRFI1,ERBB receptor feedback inhibitor 1 (Mitogen-inducible gene 6 protein) (MIG-6),RLRRSHSGPAGSF,_SHS(ph)GPAGSFNK_,S251,+,22.90,23.99,22.98,25.91,,,,20.63,20.78,,,24.19,,23.05,-0.15,0.93,-0.07,2.86, , , ,-2.42,-2.27, , ,1.13, ,regulation of keratinocyte differentiation;lung alveolus development;lung epithelium development;response to stress;negative regulation of protein autophosphorylation;lung vasculature development;negative regulation of epidermal growth factor-activated receptor activity;skin morphogenesis,extrinsic to internal side of plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
8413,Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),QKERAMSTTSISS,_AM(ox)S(ph)TTSISSPQPGK_,S269,,26.07,23.27,,23.88,,,,,,,,24.52,,24.43,1.64,-1.17, ,-0.56, , , , , , , ,0.09, ,endocytosis;activation of JUN kinase activity;cellular component disassembly involved in execution phase of apoptosis;Rac protein signal transduction,cytosol;cell cortex;postsynaptic density;lamellipodium;ruffle,,,,,,,,,,,,,,
8415,Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),STTSISSPQPGKL,_ERAM(ox)S(ph)TTSISS(ph)PQPGK_,S275,,25.03,,,,22.57,,,,,,,,,23.80,1.23, , , ,-1.23, , , , , , , , ,endocytosis;activation of JUN kinase activity;cellular component disassembly involved in execution phase of apoptosis;Rac protein signal transduction,cytosol;cell cortex;postsynaptic density;lamellipodium;ruffle,,,,,,,,,,,,,,
8416,Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),QPGKLRSPFLQKQ,_LRS(ph)PFLQK_,S283,+,22.53,23.34,23.34,,21.88,,22.58,22.49,,21.00,,21.93,,22.39,0.15,0.95,0.95, ,-0.51, ,0.19,0.10, ,-1.38, ,-0.46, ,endocytosis;activation of JUN kinase activity;cellular component disassembly involved in execution phase of apoptosis;Rac protein signal transduction,cytosol;cell cortex;postsynaptic density;lamellipodium;ruffle,,,,,,,,,,,,,,
8417,Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),EQGGEASPQRTWE,_YQEQGGEAS(ph)PQRTWEQQQEVVSR_,S232,,,,,,24.13,,,23.87,,,,,,24.00, , , , ,0.13, , ,-0.13, , , , , ,endocytosis;activation of JUN kinase activity;cellular component disassembly involved in execution phase of apoptosis;Rac protein signal transduction,cytosol;cell cortex;postsynaptic density;lamellipodium;ruffle,,,,,,,,,,,,,,
8419,Q9UJV9,DDX41,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog),PAGGSRSEAEDED,_S(ph)EAEDEDDEDYVPYVPLR_,S23,,25.94,,,,25.39,,,,,,,,,25.67,0.27, , , ,-0.27, , , , , , , , ,"multicellular organismal development;defense response to virus;mRNA splicing, via spliceosome;apoptotic process;cellular response to interferon-beta;positive regulation of transcription from RNA polymerase II promoter",endoplasmic reticulum;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8420,Q9UJX2,CDC23,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),TPTRRVSPLNLSS,_RVS(ph)PLNLSSVTP_,S470,+,23.98,22.81,22.26,24.84,25.42,26.03,25.24,25.59,24.71,22.92,24.76,23.42,25.60,24.43,-0.45,-1.62,-2.17,0.41,0.99,1.60,0.81,1.16,0.28,-1.51,0.33,-1.01,1.17,G1 phase of mitotic cell cycle;mitotic metaphase plate congression;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;regulation of exit from mitosis;protein K11-linked ubiquitination;mitotic metaphase/anaphase transition;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,nucleoplasm;cytosol;anaphase-promoting complex,,,,,,,,,,,,,,
8424,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),VKAEEKSPISINV,_S(ph)PIS(ph)INVK_,S352,+,28.05,27.76,27.96,27.46,25.82,26.16,27.49,25.24,27.94,27.49,24.61,26.96,25.54,26.81,1.24,0.96,1.15,0.65,-0.99,-0.65,0.69,-1.57,1.13,0.68,-2.20,0.16,-1.26,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8425,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),EEKSPISINVKTV,_S(ph)PIS(ph)INVK_,S355,,23.14,,,,,,,,,,26.18,,,24.66,-1.52, , , , , , , , , ,1.52, , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8426,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),RDRRERSRSFERS,_ERS(ph)RS(ph)FER_,S502,,26.95,24.64,24.74,21.97,,,,,,,,,,24.58,2.38,0.07,0.16,-2.60, , , , , , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8427,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),RRERSRSFERSHK,_ERS(ph)RS(ph)FER_,S504,,26.95,24.64,24.74,21.97,,,,,,,,,,24.58,2.38,0.07,0.16,-2.60, , , , , , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8428,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),STLGGFSPASKPS,_GLNPDGTPALSTLGGFS(ph)PAS(ph)KPS(ph)SPR_,S335,,25.73,,,,,,,,,24.50,,,,25.12,0.61, , , , , , , , ,-0.61, , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8429,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),GGFSPASKPSSPR,_GLNPDGTPALSTLGGFS(ph)PAS(ph)KPS(ph)SPR_,S338,,25.97,,,,,,,,,,,,,25.97,0.00, , , , , , , , , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8432,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),IPEERLSPTPSMQ,_LS(ph)PTPSM(ox)QDGLDLPSETDLR_,S65,,24.09,22.68,,,,,,,,,,,,23.38,0.70,-0.70, , , , , , , , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8433,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),RQQASKSPYNGVR,_(gl)QQASKS(ph)PYNGVR_,S374,,,,,,23.70,23.17,,22.81,,,,,,23.22, , , , ,0.47,-0.06, ,-0.42, , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
8434,Q9UK61,FAM208A,Protein FAM208A (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140),GNLPPVSPNDSGA,_GGNLPPVS(ph)PNDSGAK_,S1103,,,24.20,24.20,24.62,,,,,,24.58,,23.04,,24.13, ,0.07,0.07,0.49, , , , , ,0.45, ,-1.08, ,,,,,,,,,,,,,,,,
8439,Q9UK61,FAM208A,Protein FAM208A (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140),DYQFPSSPFTDTL,_SSDYQFPSS(ph)PFTDTLK_,S979,+,22.48,,,22.07,,,23.56,,24.65,24.47,23.53,23.65,,23.49,-1.01, , ,-1.42, , ,0.08, ,1.17,0.98,0.04,0.17, ,,,,,,,,,,,,,,,,
8440,Q9UK61,FAM208A,Protein FAM208A (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140),KQRSSHSLDYDKD,_SSHS(ph)LDYDK_,S673,,23.36,,,,,,,,,,,,,23.36,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
8441,Q9UK76,HN1,Hematological and neurological expressed 1 protein (Androgen-regulated protein 2),PAAPVPSPVAPAP,_PVPAAPVPS(ph)PVAPAPVPSR_,S131,,23.56,,,21.64,,,25.89,,,22.23,25.32,25.98,,24.10,-0.54, , ,-2.46, , ,1.79, , ,-1.88,1.22,1.87, ,,nucleus,,,,,,,,,,,,,,
8442,Q9UK76,HN1,Hematological and neurological expressed 1 protein (Androgen-regulated protein 2),GLQRRNSSEASSG,_RNS(ph)SEASSGDFLDLK_,S87,+,28.25,27.81,26.80,29.03,27.44,27.98,32.24,29.51,29.64,29.20,31.48,31.42,29.35,29.24,-0.99,-1.44,-2.44,-0.22,-1.80,-1.27,3.00,0.27,0.40,-0.04,2.24,2.18,0.11,,nucleus,,,,,,,,,,,,,,
8443,Q9UKA4,AKAP11,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),EDSGLFSPIRSSA,_EDSGLFS(ph)PIR_,S448,,,20.88,,,22.64,,,21.42,,,,,,21.65, ,-0.77, , ,0.99, , ,-0.22, , , , , ,intracellular protein kinase cascade;regulation of protein kinase A signaling cascade,nucleolus;plasma membrane;protein complex;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
8446,Q9UKA4,AKAP11,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),QSQRSVSPTFLNP,_SVS(ph)PTFLNPSDENLK_,S1242,+,25.21,25.96,26.13,27.14,27.19,27.11,27.10,27.46,26.39,25.79,26.83,27.26,26.63,26.63,-1.42,-0.67,-0.50,0.51,0.56,0.48,0.47,0.83,-0.24,-0.84,0.20,0.63,0.00,intracellular protein kinase cascade;regulation of protein kinase A signaling cascade,nucleolus;plasma membrane;protein complex;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
8447,Q9UKE5,TNIK,TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),EMPRQNSDPTSEN,_QNS(ph)DPTSENPPLPTR_,S556,+,24.37,24.06,,25.25,,,25.29,25.02,,,25.96,25.60,22.75,24.79,-0.41,-0.73, ,0.46, , ,0.50,0.23, , ,1.17,0.82,-2.04,activation of JNKK activity;actin cytoskeleton reorganization;protein autophosphorylation;Wnt receptor signaling pathway;regulation of dendrite morphogenesis,nucleus;cytoskeleton;recycling endosome;cytoplasm,,+,,,,,,,,,,,,
8448,Q9UKE5,TNIK,TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),NSKSEGSPVLPHE,_SEGS(ph)PVLPHEPAK_,S685,+,24.17,25.87,25.69,26.60,26.48,26.39,28.66,28.10,26.36,28.22,29.05,28.05,26.74,26.95,-2.78,-1.08,-1.26,-0.35,-0.47,-0.56,1.71,1.15,-0.59,1.27,2.10,1.09,-0.21,activation of JNKK activity;actin cytoskeleton reorganization;protein autophosphorylation;Wnt receptor signaling pathway;regulation of dendrite morphogenesis,nucleus;cytoskeleton;recycling endosome;cytoplasm,,+,,,,,,,,,,,,
8450,Q9UKE5,TNIK,TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),QRTTSISPALARK,_TTSIS(ph)PALAR_,S596,+,23.47,24.54,22.66,26.73,,24.63,26.21,26.67,23.89,24.32,26.35,,24.36,24.89,-1.43,-0.35,-2.23,1.84, ,-0.27,1.31,1.78,-1.01,-0.58,1.46, ,-0.53,activation of JNKK activity;actin cytoskeleton reorganization;protein autophosphorylation;Wnt receptor signaling pathway;regulation of dendrite morphogenesis,nucleus;cytoskeleton;recycling endosome;cytoplasm,,+,,,,,,,,,,,,
8451,Q9UKF7,PITPNC1,Cytoplasmic phosphatidylinositol transfer protein 1 (Mammalian rdgB homolog beta) (M-rdgB beta) (MrdgBbeta) (Retinal degeneration B homolog beta) (RdgBbeta),DRPRKKSAPETLT,_S(ph)APETLTLPDPEK_,S299,,,,,,,,24.08,,,23.65,23.48,,,23.74, , , , , , ,0.34, , ,-0.08,-0.26, , ,signal transduction,cytoplasm,,,,,,,,,,,,,,
8452,Q9UKG1,APPL1,"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",LEAVTPSPSFQQR,_VNQSALEAVTPS(ph)PSFQQR_,S384,+,24.32,22.40,,,25.77,24.49,25.86,25.78,25.42,,,24.08,23.75,24.65,-0.33,-2.26, , ,1.12,-0.16,1.21,1.13,0.77, , ,-0.57,-0.90,cell proliferation;regulation of glucose import;regulation of establishment of protein localization to plasma membrane;insulin receptor signaling pathway;apoptotic process;regulation of apoptotic process;cell cycle,cytosol;endosome membrane;nucleus;vesicle membrane;early endosome membrane,,,,,,,,,,,,,,
8453,Q9UKI2,CDC42EP3,Cdc42 effector protein 3 (Binder of Rho GTPases 2) (MSE55-related Cdc42-binding protein),EFFRANSTSDSVF,_ANS(ph)TSDSVFTETPS(ph)PVLK_,S89,,23.08,,,24.51,22.97,,,23.34,23.21,,,,,23.42,-0.34, , ,1.09,-0.46, , ,-0.08,-0.21, , , , ,signal transduction;regulation of cell shape,endomembrane system;membrane;actin cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8455,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,KPEPPGSGSPAPP,_GPKPEPPGS(ph)GSPAPPR_,S660,,,23.78,,,25.21,24.29,22.64,23.42,22.42,21.25,,,,23.29, ,0.49, , ,1.92,1.00,-0.65,0.13,-0.87,-2.03, , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8456,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,EPPGSGSPAPPRR,_GPKPEPPGSGS(ph)PAPPR_,S662,,22.25,24.04,,22.53,24.34,24.15,22.68,23.50,22.78,22.26,,21.13,22.28,22.90,-0.66,1.14, ,-0.38,1.43,1.24,-0.22,0.60,-0.12,-0.64, ,-1.78,-0.62,,intracellular,C2H2-type,,,,,,,,,,,,,
8457,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,RSKIYRSQSPHYF,_IYRS(ph)QS(ph)PHYFR_,S955,,22.79,23.01,23.81,,23.53,,21.91,22.59,23.59,,,,,23.03,-0.24,-0.02,0.78, ,0.50, ,-1.12,-0.44,0.55, , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8458,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,KIYRSQSPHYFRS,_SQS(ph)PHYFR_,S957,,23.87,23.01,23.81,24.13,24.38,,21.91,23.70,23.59,,21.64,,,23.34,0.53,-0.33,0.47,0.80,1.05, ,-1.43,0.36,0.25, ,-1.70, , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8459,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,KVERKPSVSEEVQ,_KPS(ph)VSEEVQATPNK_,S1029,,23.47,22.68,,22.95,22.26,22.69,22.53,22.99,22.95,,23.27,21.65,22.36,22.71,0.76,-0.03, ,0.24,-0.45,-0.01,-0.18,0.29,0.24, ,0.56,-1.06,-0.35,,intracellular,C2H2-type,,,,,,,,,,,,,
8460,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,PGGSHGSETEDTG,_(gl)QEPGGSHGS(ph)ETEDTGR_,S575,,,24.78,24.53,25.70,,,23.80,,24.38,23.32,,21.50,,24.00, ,0.78,0.53,1.70, , ,-0.20, ,0.38,-0.68, ,-2.50, ,,intracellular,C2H2-type,,,,,,,,,,,,,
8461,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,DDSQRRSLPAEEG,_S(ph)LPAEEGSSGKK_,S680,,22.77,24.80,24.65,24.00,,,,,20.95,,,,,23.44,-0.66,1.36,1.21,0.57, , , , ,-2.48, , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8462,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,SGSRKRSWGHESP,_S(ph)WGHES(ph)PEER_,S931,,23.91,,,,,,,,,,,,,23.91,0.00, , , , , , , , , , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8463,Q9UKJ3,GPATCH8,G patch domain-containing protein 8,RSWGHESPEERHS,_S(ph)WGHES(ph)PEER_,S936,,23.91,,,,,,,,,,,,,23.91,0.00, , , , , , , , , , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8464,Q9UKK3,PARP4,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),WPELRLSKRKHRK,_NQSLLASSEWPELRLS(ph)K_,S1236,,22.98,23.32,23.32,,21.69,,22.81,23.35,,,,,,22.91,0.06,0.41,0.41, ,-1.22, ,-0.10,0.44, , , , , ,DNA repair;transport;protein ADP-ribosylation;inflammatory response;cell death;response to drug,spindle microtubule;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
8466,Q9UKL0,RCOR1,REST corepressor 1 (Protein CoREST),KREREESEDELEE,_REREES(ph)EDELEEANGNNPIDIEVDQNK_,S257,+,26.18,,,,26.37,24.05,25.76,,26.20,28.00,,25.77,25.25,25.95,0.23, , , ,0.43,-1.90,-0.18, ,0.25,2.06, ,-0.18,-0.70,blood coagulation;virus-host interaction;histone H4 deacetylation,transcriptional repressor complex,,,,,,,,,,,,,,
8467,Q9UKL0,RCOR1,REST corepressor 1 (Protein CoREST),NQKPVKSPDNSIK,_S(ph)PDNSIKM(ox)PEEEDEAPVLDVR_,S457,+,23.74,23.18,,,,,23.08,,24.91,25.54,21.83,21.73,,23.43,0.31,-0.25, , , , ,-0.35, ,1.48,2.11,-1.60,-1.70, ,blood coagulation;virus-host interaction;histone H4 deacetylation,transcriptional repressor complex,,,,,,,,,,,,,,
8468,Q9UKL3,CASP8AP2,CASP8-associated protein 2 (FLICE-associated huge protein),FDVFSASPLKNND,_(ac)AADDDNGDGTSLFDVFSAS(ph)PLK_,S20,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,"cellular response to mechanical stimulus;transcription, DNA-dependent;regulation of transcription, DNA-dependent;cell cycle;extrinsic apoptotic signaling pathway via death domain receptors",nucleus;cytoplasm,,,,,,,,,,,,,,
8469,Q9UKN8,GTF3C4,General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta),KILLVDSPGMGNA,_ILLVDS(ph)PGM(ox)GNADDEQQEEGTSSK_,S611,+,26.28,24.75,24.75,23.85,26.80,27.01,26.46,26.29,27.22,27.21,24.73,25.15,25.01,25.81,0.47,-1.06,-1.06,-1.96,0.99,1.20,0.66,0.48,1.41,1.40,-1.07,-0.66,-0.79,transcription initiation from RNA polymerase III promoter;tRNA transcription from RNA polymerase III promoter;5S class rRNA transcription from RNA polymerase III type 1 promoter,transcription factor TFIIIC complex,,,,,,,,,,,,,,
8470,Q9UKS6,PACSIN3,Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511),TAPPPQSPGSPGT,_DGTAPPPQS(ph)PGSPGTGQDEEWS(ph)DEESPRK_,S341,,22.86,,,,,,,,,,,,,22.86,0.00, , , , , , , , , , , , ,endocytosis;positive regulation of membrane protein ectodomain proteolysis;negative regulation of endocytosis,plasma membrane;cytoplasm,,,,,,,,,,,,,,
8471,Q9UKS6,PACSIN3,Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511),GQDEEWSDEESPR,_DGTAPPPQSPGSPGTGQDEEWS(ph)DEESPRK_,S354,+,24.94,,,23.01,25.85,25.81,24.68,24.82,,24.32,23.81,,23.50,24.53,0.41, , ,-1.52,1.32,1.28,0.15,0.30, ,-0.20,-0.72, ,-1.02,endocytosis;positive regulation of membrane protein ectodomain proteolysis;negative regulation of endocytosis,plasma membrane;cytoplasm,,,,,,,,,,,,,,
8472,Q9UKS6,PACSIN3,Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511),KEKGGRSPDEVTL,_GGRS(ph)PDEVTLTSIVPTR_,S319,,23.50,,,,,,21.90,,22.94,23.52,,,,22.97,0.54, , , , , ,-1.06, ,-0.03,0.55, , , ,endocytosis;positive regulation of membrane protein ectodomain proteolysis;negative regulation of endocytosis,plasma membrane;cytoplasm,,,,,,,,,,,,,,
8473,Q9UKV5,AMFR,E3 ubiquitin-protein ligase AMFR (EC 6.3.2.-) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78),RVPLDLSPRLEET,_VPLDLS(ph)PR_,S101,,22.33,,,,,,,,,,,,,22.33,0.00, , , , , , , , , , , , ,endoplasmic reticulum unfolded protein response;protein oligomerization;ER-associated protein catabolic process;aging;protein polyubiquitination;learning or memory;cellular component movement,neuronal cell body;growth cone;integral to endoplasmic reticulum membrane;nucleus;dendrite,,,,,,,,,,,,,,
8474,Q9UKV8,AGO2,Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer),KLMRSASFNTDPY,_SAS(ph)FNTDPYVR_,S387,,,,,22.37,,,,,,,,,,22.37, , , ,0.00, , , , , , , , , ,"pre-miRNA processing;negative regulation of translation involved in gene silencing by miRNA;post-embryonic development;mRNA cleavage involved in gene silencing by miRNA;regulation of transcription, DNA-dependent;negative regulation of translational initiation;Notch signaling pathway;transcription, DNA-dependent",RNA-induced silencing complex;cytosol;nucleus;mRNA cap binding complex;polysome;micro-ribonucleoprotein complex;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
8475,Q9UKX7,NUP50,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),VAAETQSPSLFGS,_VAAETQS(ph)PSLFGSTK_,S193,+,25.44,24.56,24.56,23.51,,23.82,24.29,23.17,25.12,24.66,24.02,23.54,24.09,24.23,1.20,0.33,0.33,-0.72, ,-0.41,0.06,-1.06,0.89,0.43,-0.21,-0.69,-0.14,glucose transport;small molecule metabolic process;intracellular transport;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nucleoplasm;nuclear membrane;nuclear pore,,,,,,,,,,,,,,
8476,Q9UKY4,POMT2,Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2),AEAVARSPKRPAW,_DVAAEAVARS(ph)PK_,S48,,,22.63,,22.42,22.44,23.11,22.58,22.76,22.82,,22.96,,22.10,22.65, ,-0.02, ,-0.23,-0.20,0.46,-0.06,0.12,0.17, ,0.31, ,-0.55,protein O-linked glycosylation,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8477,Q9UKY7,CDV3,Protein CDV3 homolog,AETEERSLDNFFA,_(ac)AETEERS(ph)LDNFFAK_,S8,,23.53,,,21.61,,,22.12,22.28,22.84,,,,,22.47,1.05, , ,-0.87, , ,-0.36,-0.19,0.36, , , , ,cell proliferation,nucleolus;cytoplasm,,,,,,,,,,,,,,
8478,Q9UKY7,CDV3,Protein CDV3 homolog,QAMQISSEKEEDD,_VQAM(ox)QISS(ph)EKEEDDNEK_,S107,+,25.68,25.03,,25.25,,,24.64,24.08,23.15,22.22,24.13,25.07,21.36,24.06,1.62,0.97, ,1.19, , ,0.58,0.02,-0.91,-1.85,0.07,1.01,-2.70,cell proliferation,nucleolus;cytoplasm,,,,,,,,,,,,,,
8479,Q9UL01,DSE,Dermatan-sulfate epimerase (DS epimerase) (EC 5.1.3.19) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2),DRIFAISQQQQQQ,_IFAIS(ph)QQQQQQSK_,S464,,,,,21.82,,,,,,,,,,21.82, , , ,0.00, , , , , , , , , ,chondroitin sulfate metabolic process;heparan sulfate proteoglycan biosynthetic process;dermatan sulfate biosynthetic process;chondroitin sulfate biosynthetic process;carbohydrate metabolic process,integral to membrane;endoplasmic reticulum;Golgi membrane,,,,,,,,,,,,,,
8483,Q9ULD2,MTUS1,Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1),AISRQLSTEQAVL,_QLS(ph)TEQAVLQESLEK_,S1149,,23.19,,,,22.91,,,,,,,,,23.05,0.14, , , ,-0.14, , , , , , , , ,,mitochondrion;Golgi apparatus;plasma membrane;nucleus;microtubule;spindle;microtubule organizing center,,,,,,,,,,,,,,
8484,Q9ULD2,MTUS1,Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1),KVNKRLSMENEEL,_RLS(ph)M(ox)ENEELLWK_,S1170,,,20.35,20.35,,22.98,23.09,23.58,22.77,,,,24.14,,22.47, ,-2.11,-2.11, ,0.51,0.62,1.11,0.31, , , ,1.68, ,,mitochondrion;Golgi apparatus;plasma membrane;nucleus;microtubule;spindle;microtubule organizing center,,,,,,,,,,,,,,
8485,Q9ULD9,ZNF608,Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36),QLKAPASPGAGNP,_APAS(ph)PGAGNPPGTPK_,S200,+,22.83,23.31,23.31,23.30,,24.49,23.85,23.56,23.28,,,,,23.49,-0.66,-0.18,-0.18,-0.19, ,1.00,0.36,0.07,-0.21, , , , ,,intracellular,C2H2-type,,,,,,,,,,,,,
8486,Q9ULD9,ZNF608,Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36),MRSKASSPSDIIS,_ASS(ph)PSDIISSK_,S537,+,24.15,23.80,23.80,23.71,22.97,,23.86,23.46,24.80,24.86,22.60,,22.67,23.70,0.45,0.10,0.10,0.01,-0.73, ,0.16,-0.24,1.11,1.16,-1.10, ,-1.02,,intracellular,C2H2-type,,,,,,,,,,,,,
8489,Q9ULG6,CCPG1,Cell cycle progression protein 1 (Cell cycle progression restoration protein 8),ARKKTVSASESED,_TVS(ph)ASESEDRLVAEQETEPSK_,S42,,,,,,,,24.37,,24.19,23.73,,,25.03,24.33, , , , , , ,0.04, ,-0.14,-0.60, , ,0.70,cell cycle,integral to membrane,,,,,,,,,,,,,,
8490,Q9ULH0,KIDINS220,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),RYQKLPSDEDESG,_YQKLPS(ph)DEDES(ph)GTEESDNTPLLK_,S1422,,23.58,,,,23.08,25.18,24.87,24.09,24.01,,,,,24.13,-0.56, , , ,-1.05,1.04,0.74,-0.05,-0.12, , , , ,nerve growth factor receptor signaling pathway;dendrite morphogenesis;activation of MAPKK activity;in utero embryonic development,cytosol;integral to membrane,,,,,,,,,,,,,,
8492,Q9ULH0,KIDINS220,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),TITRQMSFDLTKL,_QM(ox)S(ph)FDLTK_,S876,+,25.87,25.19,25.56,26.49,26.84,27.03,26.78,26.62,27.53,26.55,25.98,25.92,26.54,26.38,-0.51,-1.19,-0.82,0.11,0.46,0.65,0.40,0.24,1.16,0.18,-0.40,-0.45,0.16,nerve growth factor receptor signaling pathway;dendrite morphogenesis;activation of MAPKK activity;in utero embryonic development,cytosol;integral to membrane,,,,,,,,,,,,,,
8493,Q9ULH0,KIDINS220,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),VERVPKSPEHSAE,_S(ph)PEHSAEPIR_,S1456,,24.00,25.34,,,,,,,,21.91,,,,23.75,0.25,1.59, , , , , , , ,-1.84, , , ,nerve growth factor receptor signaling pathway;dendrite morphogenesis;activation of MAPKK activity;in utero embryonic development,cytosol;integral to membrane,,,,,,,,,,,,,,
8494,Q9ULH1,ASAP1,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",AIQKQASEDSNDL,_(gl)QAS(ph)EDSNDLTPTLPETPVPLPRK_,S1041,,25.57,,,,,,23.59,,,,22.65,25.62,,24.36,1.21, , , , , ,-0.77, , , ,-1.70,1.26, ,filopodium assembly;signal transduction;positive regulation of GTPase activity;cilium morphogenesis;regulation of ARF GTPase activity,membrane;cytoplasm,,,,,,,,,,,,,,
8497,Q9ULH1,ASAP1,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",GHKRTLSDPPSPL,_TLS(ph)DPPSPLPHGPPNK_,S839,+,23.51,,,23.90,24.97,24.52,,25.36,22.97,,23.93,24.30,,24.18,-0.67, , ,-0.28,0.78,0.34, ,1.18,-1.21, ,-0.25,0.11, ,filopodium assembly;signal transduction;positive regulation of GTPase activity;cilium morphogenesis;regulation of ARF GTPase activity,membrane;cytoplasm,,,,,,,,,,,,,,
8498,Q9ULH1,ASAP1,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",TLSDPPSPLPHGP,_RTLS(ph)DPPS(ph)PLPHGPPNK_,S843,,23.51,23.92,23.92,23.90,,,,,22.97,,,,,23.65,-0.14,0.28,0.28,0.25, , , , ,-0.67, , , , ,filopodium assembly;signal transduction;positive regulation of GTPase activity;cilium morphogenesis;regulation of ARF GTPase activity,membrane;cytoplasm,,,,,,,,,,,,,,
8501,Q9ULH7,MKL2,MKL/myocardin-like protein 2 (Megakaryoblastic leukemia 2) (Myocardin-related transcription factor B) (MRTF-B),IMPPLKSPAAFHE,_S(ph)PAAFHEQIK_,S77,,25.21,23.77,,,22.68,,,,,,,,,23.89,1.32,-0.12, , ,-1.20, , , , , , , , ,"cell differentiation;positive regulation of striated muscle tissue development;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;muscle organ development",nucleus,SAP-domain,,,,,,,,,,,,,
8502,Q9ULI0,ATAD2B,ATPase family AAA domain-containing protein 2B,EKLEPGSDVEVKD,_LEPGS(ph)DVEVK_,S515,,25.08,25.16,25.16,,,,22.94,,25.06,24.88,,,21.80,24.30,0.78,0.86,0.86, , , ,-1.35, ,0.76,0.58, , ,-2.50,,,,,,,,,,,,,,,,
8503,Q9ULI3,HEG1,Protein HEG homolog 1,EMHENGSTKNLLQ,_EAIEM(ox)HENGS(ph)TK_,S1319,,20.24,,,24.89,,19.65,20.16,,20.10,,21.54,21.91,19.80,21.04,-0.79, , ,3.85, ,-1.38,-0.88, ,-0.94, ,0.50,0.87,-1.23,cardiac atrium morphogenesis;ventricular septum development;post-embryonic development;vasculogenesis;cell-cell junction organization;in utero embryonic development;pericardium development;lung development;lymph circulation;multicellular organism growth;endothelial cell morphogenesis;lymph vessel development;venous blood vessel morphogenesis;regulation of body fluid levels,cell-cell junction;integral to membrane;extracellular region;external side of plasma membrane,,,,,,,,,,,,,,
8504,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),EHAPLASPVENKE,_EHAPLAS(ph)PVENK_,S714,+,23.42,23.28,23.28,22.63,,22.46,22.52,22.36,23.52,23.21,,,,22.96,0.45,0.32,0.32,-0.34, ,-0.51,-0.44,-0.60,0.55,0.25, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8505,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),IKTEPSSPLSDPS,_IKTEPSS(ph)PLSDPSDIIR_,S435,+,24.48,,,21.06,26.02,26.15,,25.73,23.25,,,,25.87,24.65,-0.17, , ,-3.59,1.37,1.50, ,1.08,-1.40, , , ,1.22,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8506,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),QPLEPDSPTGLSE,_IQPLEPDS(ph)PTGLSENPTPATEK_,S1003,+,25.62,24.13,24.13,23.15,26.26,25.66,25.29,25.45,25.32,25.49,22.99,20.76,24.28,24.50,1.12,-0.37,-0.37,-1.35,1.76,1.16,0.78,0.95,0.82,0.99,-1.52,-3.74,-0.22,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8507,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),HRLRSFSASQSTD,_SFS(ph)ASQSTDREGASPVTEVR_,S411,+,22.91,22.07,22.68,21.86,,24.23,23.35,23.99,24.22,22.75,22.82,,23.32,23.11,-0.20,-1.04,-0.43,-1.25, ,1.12,0.24,0.88,1.11,-0.36,-0.29, ,0.21,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8508,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),LLRRSLSMDSQVP,_SLS(ph)M(ox)DSQVPVYSPSIDLK_,S345,,24.19,,,21.89,23.62,,,,,,,,,23.23,0.96, , ,-1.35,0.39, , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8509,Q9ULJ8,PPP1R9A,Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A),NRGSTDSLDSLSS,_GSTDS(ph)LDS(ph)LSSR_,S187,,23.95,21.43,,,21.50,,,,,,,,,22.29,1.66,-0.86, , ,-0.80, , , , , , , , ,cell differentiation;nervous system development,neuron projection;synapse;cell junction;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8510,Q9ULJ8,PPP1R9A,Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A),STDSLDSLSSRTE,_GSTDS(ph)LDS(ph)LSSR_,S190,,22.45,,,,,,,,,,,,,22.45,0.00, , , , , , , , , , , , ,cell differentiation;nervous system development,neuron projection;synapse;cell junction;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8511,Q9ULJ8,PPP1R9A,Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A),LYDSVSSTDGEDS,_LYDSVSS(ph)TDGEDSLER_,S909,,21.61,,,,,,,,,,,,,21.61,0.00, , , , , , , , , , , , ,cell differentiation;nervous system development,neuron projection;synapse;cell junction;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8513,Q9ULJ8,PPP1R9A,Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A),IFERRTSLGEVSK,_RTS(ph)LGEVSK_,S840,,25.29,27.73,27.73,23.56,,,,,,23.39,,,,25.54,-0.26,2.19,2.19,-1.98, , , , , ,-2.15, , , ,cell differentiation;nervous system development,neuron projection;synapse;cell junction;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
8514,Q9ULL1,PLEKHG1,Pleckstrin homology domain-containing family G member 1,QKDGWASPQESSL,_DGWAS(ph)PQESSLLR_,S868,,23.02,,,,,21.39,,,,,,,,22.20,0.82, , , , ,-0.82, , , , , , , ,regulation of Rho protein signal transduction,intracellular,,,,,,,,,,,,,,
8516,Q9ULL5,PRR12,Proline-rich protein 12,ETLPSFSSDEEDS,_RNLETLPSFS(ph)S(ph)DEEDSVAK_,S560,,25.16,,,,,22.57,,,,,23.28,,,23.67,1.49, , , , ,-1.10, , , , ,-0.39, , ,,,,,,,,,,,,,,,,
8517,Q9ULL5,PRR12,Proline-rich protein 12,TLPSFSSDEEDSV,_RNLETLPSFS(ph)S(ph)DEEDSVAK_,S561,,25.16,,,,,22.57,,,,,23.28,,,23.67,1.49, , , , ,-1.10, , , , ,-0.39, , ,,,,,,,,,,,,,,,,
8518,Q9ULL5,PRR12,Proline-rich protein 12,LEPAAPSPRLRPE,_SHGLEPAAPS(ph)PR_,S44,,21.11,,,,22.94,23.23,,23.01,,22.48,,,,22.55,-1.44, , , ,0.38,0.68, ,0.45, ,-0.07, , , ,,,,,,,,,,,,,,,,
8519,Q9ULM3,YEATS2,YEATS domain-containing protein 2,IKKFLESPSRSSS,_FLES(ph)PSR_,S118,+,23.39,22.34,21.16,23.71,22.94,,,21.96,21.22,,,,21.60,22.29,1.10,0.05,-1.13,1.42,0.65, , ,-0.33,-1.07, , , ,-0.69,negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation,Ada2/Gcn5/Ada3 transcription activator complex,,,,,,,,,,,,,,
8520,Q9ULM3,YEATS2,YEATS domain-containing protein 2,QVPNPESPGKSFQ,_IVPQSQVPNPES(ph)PGK_,S447,+,24.24,23.58,24.35,23.06,24.29,24.50,23.89,24.03,23.98,23.72,21.98,,23.61,23.77,0.47,-0.19,0.58,-0.71,0.52,0.73,0.12,0.26,0.21,-0.05,-1.79, ,-0.16,negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation,Ada2/Gcn5/Ada3 transcription activator complex,,,,,,,,,,,,,,
8521,Q9ULM3,YEATS2,YEATS domain-containing protein 2,CKIVSGSPISTPS,_IVSGS(ph)PISTPSPSPLPR_,S465,+,23.91,22.16,21.48,22.11,24.42,24.62,23.48,23.18,24.68,22.98,,22.29,24.13,23.29,0.62,-1.13,-1.81,-1.17,1.14,1.33,0.19,-0.11,1.39,-0.30, ,-0.99,0.85,negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation,Ada2/Gcn5/Ada3 transcription activator complex,,,,,,,,,,,,,,
8522,Q9ULM3,YEATS2,YEATS domain-containing protein 2,ISTPSPSPLPRTP,_IVSGS(ph)PISTPSPS(ph)PLPR_,S473,,22.06,,,,,,,,,,,,,22.06,0.00, , , , , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation,Ada2/Gcn5/Ada3 transcription activator complex,,,,,,,,,,,,,,
8524,Q9ULQ0,STRIP2,Striatin-interacting protein 2 (Protein FAM40B),KSMRAASPPSYTL,_AAS(ph)PPSYTLDLGESQLAPPPSK_,S318,,,,,23.19,24.13,23.02,24.19,24.41,22.27,22.31,24.85,25.99,24.13,23.85, , , ,-0.65,0.28,-0.83,0.35,0.56,-1.58,-1.54,1.00,2.14,0.28,regulation of cell shape;cell migration;cytoskeleton organization,cytoplasm,,,,,,,,,,,,,,
8526,Q9ULS5,TMCC3,Transmembrane and coiled-coil domains protein 3,IRNKFGSADNIAH,_FGS(ph)ADNIAHLK_,S216,+,26.48,25.58,25.58,,,,24.27,,24.29,26.33,24.21,26.94,24.50,25.35,1.12,0.23,0.23, , , ,-1.09, ,-1.06,0.98,-1.14,1.59,-0.86,,integral to membrane,,,,,,,,,,,,,,
8527,Q9ULS5,TMCC3,Transmembrane and coiled-coil domains protein 3,IAHLKNSLEEFRP,_NS(ph)LEEFRPEASAR_,S226,,23.90,22.87,22.87,,,,22.80,,23.25,25.39,,23.94,,23.57,0.32,-0.71,-0.71, , , ,-0.77, ,-0.33,1.82, ,0.37, ,,integral to membrane,,,,,,,,,,,,,,
8528,Q9ULS5,TMCC3,Transmembrane and coiled-coil domains protein 3,___MPGSDTALTV,_PGS(ph)DTALTVDR_,S4,,26.83,25.25,,22.64,,23.15,,23.30,24.03,23.99,,,,24.17,2.66,1.08, ,-1.53, ,-1.02, ,-0.87,-0.14,-0.18, , , ,,integral to membrane,,,,,,,,,,,,,,
8529,Q9ULT0,TTC7A,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),GLEKDGSFGEGLT,_DGS(ph)FGEGLTM(ox)KK_,S647,+,24.44,25.61,25.84,24.99,23.77,26.00,25.29,24.87,25.72,25.37,23.17,25.58,24.56,25.02,-0.58,0.60,0.82,-0.03,-1.25,0.98,0.27,-0.14,0.70,0.35,-1.84,0.57,-0.46,cellular iron ion homeostasis;hemopoiesis,,,,,,,,,,,,,,,
8530,Q9ULT0,TTC7A,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),LERLPNSIASRFR,_LPNS(ph)IASR_,S182,+,23.83,23.70,23.52,24.60,23.74,24.24,22.74,22.11,24.41,23.28,,23.74,23.95,23.66,0.17,0.05,-0.14,0.95,0.08,0.58,-0.91,-1.54,0.76,-0.37, ,0.08,0.29,cellular iron ion homeostasis;hemopoiesis,,,,,,,,,,,,,,,
8533,Q9ULT8,HECTD1,E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),GLRRLDSSGERSH,_RLDS(ph)SGER_,S357,,16.80,21.16,20.23,24.15,,,18.94,,,,,,,20.26,-3.46,0.90,-0.03,3.89, , ,-1.31, , , , , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process;neural tube closure,nucleus;cytoplasm,,,,,,,,,,,,,,
8535,Q9ULT8,HECTD1,E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),TLAGPSSDDENEE,_VSTLAGPSS(ph)DDENEEESKPEK_,S632,+,25.45,26.16,26.49,25.58,,23.86,25.32,24.79,23.05,25.25,23.81,23.94,,24.88,0.57,1.28,1.61,0.69, ,-1.02,0.44,-0.09,-1.83,0.37,-1.07,-0.94, ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process;neural tube closure,nucleus;cytoplasm,,,,,,,,,,,,,,
8536,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),AVKDKASPEPEKD,_DKAS(ph)PEPEKDFSEK_,S662,,,,,,25.04,23.87,,24.80,,,,,,24.57, , , , ,0.47,-0.70, ,0.23, , , , , ,,nucleus,,,,,,,,,,,,,,
8537,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),TPVPLISPKRQIR,_ELSESVQQQSTPVPLIS(ph)PK_,S541,+,26.03,24.21,24.95,23.37,25.62,25.28,25.24,24.52,26.23,26.86,25.26,25.01,23.96,25.12,0.91,-0.90,-0.17,-1.75,0.50,0.16,0.12,-0.60,1.11,1.74,0.14,-0.10,-1.16,,nucleus,,,,,,,,,,,,,,
8538,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),NFDMTASPKILMS,_LNFDM(ox)TAS(ph)PK_,S261,+,27.40,25.80,25.80,22.17,,25.71,22.31,,26.99,26.15,,24.82,21.72,24.89,2.51,0.91,0.91,-2.72, ,0.82,-2.58, ,2.10,1.27, ,-0.06,-3.17,,nucleus,,,,,,,,,,,,,,
8539,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),GTGRRISLSDMPR,_RIS(ph)LSDM(ox)PR_,S419,+,26.61,25.60,24.16,24.69,25.56,25.26,24.68,24.86,24.85,,23.98,,24.28,24.96,1.65,0.64,-0.79,-0.26,0.61,0.30,-0.28,-0.10,-0.10, ,-0.98, ,-0.68,,nucleus,,,,,,,,,,,,,,
8540,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),LSDMPRSPMSTNS,_S(ph)PM(ox)STNSSVHTGS(ph)DVEQDAEK_,S426,,24.27,24.47,,,,,,,,,,,,24.37,-0.10,0.10, , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
8541,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),SSVHTGSDVEQDA,_S(ph)PM(ox)STNSSVHTGS(ph)DVEQDAEK_,S438,+,24.90,24.88,,22.03,24.58,,24.17,24.51,23.01,,,,,24.01,0.89,0.86, ,-1.99,0.57, ,0.16,0.50,-1.00, , , , ,,nucleus,,,,,,,,,,,,,,
8542,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),KTGQAGSLSGSPK,_TGQAGS(ph)LSGS(ph)PKPFSPQLSAPITTK_,S480,,26.55,,,23.88,,,,,24.75,,,,,25.06,1.49, , ,-1.18, , , , ,-0.31, , , , ,,nucleus,,,,,,,,,,,,,,
8543,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),AGSLSGSPKPFSP,_TGQAGS(ph)LSGS(ph)PKPFSPQLSAPITTK_,S484,+,26.93,23.43,23.58,24.30,24.72,25.73,24.48,23.94,25.94,24.82,24.46,22.89,24.51,24.59,2.34,-1.16,-1.02,-0.29,0.12,1.13,-0.11,-0.65,1.35,0.23,-0.13,-1.71,-0.08,,nucleus,,,,,,,,,,,,,,
8544,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),GSPKPFSPQLSAP,_TGQAGSLSGS(ph)PKPFS(ph)PQLSAPITTK_,S489,,22.62,,,23.12,,,,,,,,,,22.87,-0.25, , ,0.25, , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
8545,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),PSTTVGSHSPPET,_TPPSTTVGS(ph)HSPPETPVLTR_,S748,,,24.17,24.17,23.78,,,,,,,,24.32,,24.11, ,0.06,0.06,-0.33, , , , , , , ,0.21, ,,nucleus,,,,,,,,,,,,,,
8546,Q9ULU4,ZMYND8,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),TTVGSHSPPETPV,_TPPSTTVGSHS(ph)PPETPVLTR_,S750,+,25.20,,,23.58,24.30,24.42,25.17,,24.95,24.22,24.48,,,24.54,0.66, , ,-0.96,-0.24,-0.12,0.63, ,0.41,-0.32,-0.06, , ,,nucleus,,,,,,,,,,,,,,
8548,Q9ULW0,TPX2,Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100),PLTVPVSPKFSTR,_SSDQPLTVPVS(ph)PK_,S596,+,26.12,25.08,25.95,24.67,25.56,24.60,25.65,24.40,25.03,24.50,,23.74,24.26,24.96,1.15,0.11,0.99,-0.29,0.60,-0.36,0.68,-0.56,0.07,-0.46, ,-1.22,-0.70,cell proliferation;mitosis;apoptotic process;activation of protein kinase activity;regulation of mitotic spindle organization;cell division,nucleus;microtubule;spindle pole;spindle;cytoplasm,,,,,,,,,,,,,,
8549,Q9ULX3,NOB1,RNA-binding protein NOB1 (Phosphorylation regulatory protein HP-10) (Protein ART-4),EDRKDDSDDDGGG,_DDS(ph)DDDGGGWITPSNIK_,S201,,23.36,,,,,,,,,23.30,,,,23.33,0.03, , , , , , , , ,-0.03, , , ,,nucleus,,,,,,,,,,,,,,
8550,Q9ULX6,AKAP8L,A-kinase anchor protein 8-like (AKAP8-like protein) (Helicase A-binding protein 95) (HAP95) (Homologous to AKAP95 protein) (HA95) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95),ENPFTDSPEEEKE,_GENPFTDS(ph)PEEEK_,S491,+,24.40,23.75,24.25,22.86,,,,,23.59,24.82,21.80,22.79,,23.53,0.87,0.21,0.71,-0.67, , , , ,0.06,1.29,-1.74,-0.74, ,,nuclear matrix;cytoplasm,,,,,,,,,,,,,,
8551,Q9ULX9,MAFF,Transcription factor MafF (U-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog F),KIKRELSENTPHL,_ELS(ph)ENTPHLSDEALM(ox)GLSVR_,S18,,22.98,,,,,,,,,,,,,22.98,0.00, , , , , , , , , , , , ,regulation of epidermal cell differentiation;blood coagulation;parturition;in utero embryonic development;transcription from RNA polymerase II promoter,nucleoplasm,bZIP,,,,,,,,,,,,,
8552,Q9UM21,MGAT4A,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form]",SEGLEISKETKDK,_SEGLEIS(ph)K_,S346,,24.84,24.94,25.45,,,,,,,,,,,25.08,-0.24,-0.13,0.37, , , , , , , , , , ,N-glycan processing;protein N-linked glycosylation via asparagine;post-translational protein modification,integral to membrane;extracellular region;Golgi membrane,,,,,,,,,,,,,,
8553,Q9UM82,SPATA2,Spermatogenesis-associated protein 2 (Spermatogenesis-associated protein PD1),LQVKMVSFELFLA,_M(ox)VS(ph)FELFLAK_,S26,,18.93,24.80,24.80,20.62,,,,,21.82,,20.83,,18.61,21.49,-2.56,3.31,3.31,-0.86, , , , ,0.34, ,-0.66, ,-2.87,multicellular organismal development;cell differentiation;spermatogenesis,nucleus;cytoplasm,,,,,,,,,,,,,,
8554,Q9UMN6,KMT2B,Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7),RPSGPESPVQGPR,_ERPSGPES(ph)PVQGPR_,S861,,,,,,24.84,23.85,21.05,23.14,21.21,,,,,22.82, , , , ,2.02,1.03,-1.77,0.32,-1.61, , , , ,"ovulation;oocyte differentiation;chromatin-mediated maintenance of transcription;gene silencing;regulation of histone H3-K4 methylation;ovarian follicle development;histone H3-K4 trimethylation;transcription, DNA-dependent",histone methyltransferase complex,Other TF domain,,,,,,,,,,,,,
8556,Q9UMS6,SYNPO2,Synaptopodin-2 (Genethonin-2) (Myopodin),HAARAQSPTPSLP,_AQS(ph)PTPSLPASWK_,S854,,19.54,,,25.05,23.18,,,,,,,,,22.59,-3.05, , ,2.46,0.59, , , , , , , , ,,Z disc;nucleus;actin cytoskeleton,,,,,,,,,,,,,,
8558,Q9UMX0,UBQLN1,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),___MAESGESGGP,_AES(ph)GESGGPPGSQDSAAGAEGAGAPAAAASAEPK_,S4,,23.22,,,24.75,,,,25.87,,,,,,24.61,-1.39, , ,0.14, , , ,1.26, , , , , ,regulation of protein ubiquitination;apoptotic process;response to hypoxia,proteasome complex;endoplasmic reticulum;nucleus;protein complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8563,Q9UMY4,SNX12,Sorting nexin-12,CVRRRYSDFEWLK,_RRYS(ph)DFEWLK_,S73,,,,,,,,,22.29,21.68,,,24.38,,22.78, , , , , , , ,-0.50,-1.10, , ,1.59, ,protein transport;cell communication,membrane,,,,,,,,,,,,,,
8564,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),ALKEEASPVPLTS,_EEAS(ph)PVPLTSNVGSTVK_,S559,+,23.99,23.53,23.53,21.49,,,24.64,,23.59,24.51,23.75,22.77,,23.53,0.46,0.00,0.00,-2.04, , ,1.11, ,0.05,0.98,0.22,-0.76, ,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8565,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),KETSFGSSENITM,_ETSFGS(ph)SENITM(ox)TSLSK_,S729,+,24.07,24.03,24.53,24.20,25.42,25.71,25.39,26.05,24.34,25.02,25.65,25.26,24.75,24.96,-0.89,-0.93,-0.42,-0.75,0.47,0.75,0.44,1.09,-0.61,0.06,0.69,0.30,-0.20,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8567,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),DVFRQLSLEGSGL,_QLS(ph)LEGSGLGVEDLK_,S591,+,25.71,20.55,,23.88,,,22.69,,23.19,22.19,23.84,,,23.15,2.56,-2.59, ,0.73, , ,-0.46, ,0.04,-0.96,0.69, , ,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8571,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),SGSLDDSFSDFQE,_SGSLDDS(ph)FSDFQELPASSK_,S312,,23.47,,,,23.27,,,,,,,,,23.37,0.10, , , ,-0.10, , , , , , , , ,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8572,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),DSASVKSLDLPSI,_S(ph)LDLPSIGGSSVGK_,S651,,,,,,,,,,,24.95,,23.04,,24.00, , , , , , , , , ,0.95, ,-0.95, ,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8573,Q9UMZ2,SYNRG,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),KTADSVSPLEPPT,_TADSVS(ph)PLEPPTK_,S419,+,23.58,23.62,23.62,22.66,,22.49,23.95,23.08,22.85,24.46,23.35,24.13,22.52,23.36,0.22,0.26,0.26,-0.70, ,-0.87,0.59,-0.28,-0.51,1.10,-0.01,0.77,-0.84,intracellular protein transport;endocytosis,AP-1 adaptor complex,,,,,,,,,,,,,,
8574,Q9UN36,NDRG2,Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613),SRSRTASLTSAAS,_SRT(ph)AS(ph)LTSAASVDGNR_,S289,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,regulation of vascular endothelial growth factor production;cell differentiation;negative regulation of cytokine production;negative regulation of smooth muscle cell proliferation;negative regulation of ERK1 and ERK2 cascade;regulation of platelet-derived growth factor production;Wnt receptor signaling pathway;nervous system development,growth cone;cytosol;Golgi apparatus;nucleus;centrosome;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8575,Q9UN70,PCDHGC3,Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43),YRAPVSSLYRTPG,_APVSS(ph)LYR_,S733,+,,,,21.12,23.09,19.91,23.25,22.99,,,,22.89,21.60,22.12, , , ,-1.00,0.97,-2.21,1.13,0.87, , , ,0.76,-0.52,calcium-dependent cell-cell adhesion;homophilic cell adhesion,integral to membrane;plasma membrane;membrane,,,,,,,,,,,,,,
8576,Q9UN76,SLC6A14,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14),KEKVSASSENFHV,_VSAS(ph)SENFHVGENDENQDR_,S21,,22.64,,,,24.21,,,23.75,,25.18,,,,23.94,-1.30, , , ,0.27, , ,-0.20, ,1.23, , , ,response to toxin;cellular amino acid metabolic process,integral to membrane;plasma membrane;brush border membrane,,,,,,,,,,,,,,
8577,Q9UN79,SOX13,Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12),LPNTSSSPSLKMS,_APELPNTSSS(ph)PSLK_,S177,,,24.06,24.06,22.85,25.00,24.79,24.62,24.10,24.35,,,,,24.23, ,-0.17,-0.17,-1.38,0.77,0.56,0.39,-0.13,0.12, , , , ,"anatomical structure morphogenesis;transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
8579,Q9UN79,SOX13,Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12),LISLDSSPAKERL,_DLISLDSS(ph)PAK_,S253,,24.32,,,22.47,25.11,,24.49,,,25.00,,,24.13,24.25,0.06, , ,-1.78,0.86, ,0.24, , ,0.75, , ,-0.13,"anatomical structure morphogenesis;transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
8583,Q9UNE0,EDAR,Tumor necrosis factor receptor superfamily member EDAR (Anhidrotic ectodysplasin receptor 1) (Downless homolog) (EDA-A1 receptor) (Ectodermal dysplasia receptor) (Ectodysplasin-A receptor),SENDASSENEQLL,_SENDASS(ph)ENEQLLSR_,S274,,22.45,23.42,23.42,,,,,,,23.72,,,,23.25,-0.80,0.17,0.17, , , , , , ,0.47, , , ,cell differentiation;positive regulation of NF-kappaB import into nucleus;salivary gland cavitation;pigmentation;hair follicle development;odontogenesis of dentin-containing tooth;apoptotic process;epidermis development,integral to membrane;plasma membrane;apical part of cell,,,,,,,,,,,,,,
8585,Q9UNE7,STUB1,E3 ubiquitin-protein ligase CHIP (EC 6.3.2.-) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (STIP1 homology and U box-containing protein 1),LGAGGGSPEKSPS,_LGAGGGS(ph)PEKSPSAQELK_,S19,+,26.75,27.92,28.67,27.04,28.88,29.02,24.41,29.97,25.27,23.87,,20.24,28.53,26.71,0.04,1.20,1.96,0.33,2.17,2.30,-2.30,3.25,-1.44,-2.85, ,-6.47,1.82,protein K63-linked ubiquitination;proteasomal ubiquitin-dependent protein catabolic process;negative regulation of transforming growth factor beta receptor signaling pathway;protein autoubiquitination;misfolded or incompletely synthesized protein catabolic process;regulation of glucocorticoid metabolic process;positive regulation of chaperone-mediated protein complex assembly;transforming growth factor beta receptor signaling pathway;DNA repair;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein ubiquitination;cellular response to misfolded protein;ubiquitin-dependent SMAD protein catabolic process;protein maturation,cytosol;ubiquitin ligase complex;ubiquitin conjugating enzyme complex;nuclear inclusion body,,,,,,,,,,+,,,,
8586,Q9UNE7,STUB1,E3 ubiquitin-protein ligase CHIP (EC 6.3.2.-) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (STIP1 homology and U box-containing protein 1),GGSPEKSPSAQEL,_LGAGGGS(ph)PEKS(ph)PSAQELK_,S23,+,26.57,23.63,23.56,25.64,24.90,,22.77,23.55,23.87,,,,,24.31,2.26,-0.68,-0.75,1.33,0.59, ,-1.54,-0.76,-0.44, , , , ,protein K63-linked ubiquitination;proteasomal ubiquitin-dependent protein catabolic process;negative regulation of transforming growth factor beta receptor signaling pathway;protein autoubiquitination;misfolded or incompletely synthesized protein catabolic process;regulation of glucocorticoid metabolic process;positive regulation of chaperone-mediated protein complex assembly;transforming growth factor beta receptor signaling pathway;DNA repair;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein ubiquitination;cellular response to misfolded protein;ubiquitin-dependent SMAD protein catabolic process;protein maturation,cytosol;ubiquitin ligase complex;ubiquitin conjugating enzyme complex;nuclear inclusion body,,,,,,,,,,+,,,,
8592,Q9UNL2,SSR3,Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma),GSSKQQSEEDLLL,_(gl)QQS(ph)EEDLLLQDFSR_,S11,,23.73,,,,,,,,,,,,,23.73,0.00, , , , , , , , , , , , ,translation;SRP-dependent cotranslational protein targeting to membrane,integral to endoplasmic reticulum membrane;Sec61 translocon complex,,,,,,,,,,,,,,
8593,Q9UNN5,FAF1,FAS-associated factor 1 (hFAF1) (UBX domain-containing protein 12) (UBX domain-containing protein 3A),LRIRTPSGEFLER,_TPS(ph)GEFLER_,S582,,23.61,,,21.68,,,,,,,21.76,,,22.35,1.26, , ,-0.67, , , , , , ,-0.59, , ,regulation of protein catabolic process;proteasomal ubiquitin-dependent protein catabolic process;regulation of cell adhesion;positive regulation of protein complex assembly;cell death;apoptotic process;positive regulation of apoptotic process;cytoplasmic sequestering of NF-kappaB,cytosol;CD95 death-inducing signaling complex;nuclear envelope;nucleus;Cdc48p-Npl4p-Ufd1p AAA ATPase complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8596,Q9UNZ2,NSFL1C,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),RFYAGGSERSGQQ,_FYAGGS(ph)ER_,S99,,22.46,,,21.10,,,,,,,,,,21.78,0.68, , ,-0.68, , , , , , , , , ,,Golgi stack;chromosome;nucleus,,,,,,,,,,,,,,
8597,Q9UNZ2,NSFL1C,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),GPPRKKSPNELVD,_S(ph)PNELVDDLFK_,S114,+,26.14,24.08,24.31,22.31,26.29,24.74,25.47,26.69,25.84,26.86,25.60,25.90,25.37,25.35,0.79,-1.28,-1.04,-3.04,0.94,-0.62,0.12,1.33,0.49,1.51,0.24,0.54,0.02,,Golgi stack;chromosome;nucleus,,,,,,,,,,,,,,
8598,Q9UNZ2,NSFL1C,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),QVLSTSSPAQQAE,_LGSTAPQVLSTSS(ph)PAQQAENEAK_,S272,,,,,21.65,22.85,,23.35,23.38,,,,22.90,,22.82, , , ,-1.17,0.02, ,0.53,0.55, , , ,0.07, ,,Golgi stack;chromosome;nucleus,,,,,,,,,,,,,,
8600,Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",AELEQNSPKIQKV,_AFLAELEQNS(ph)PKIQK_,S4516,,,,,,26.21,24.45,,25.48,,,,,23.00,24.78, , , , ,1.43,-0.33, ,0.69, , , , ,-1.79,regulation of microtubule-based process;wound healing;positive regulation of Wnt receptor signaling pathway;regulation of epithelial cell migration;regulation of focal adhesion assembly;Golgi to plasma membrane protein transport;cell cycle arrest;Wnt receptor signaling pathway,ruffle membrane;Golgi apparatus;microtubule,,,,,,,,,,,,,,
8601,Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",LIAQLPSPAIDHE,_ALIAQLPS(ph)PAIDHEQLR_,S5912,,22.80,22.52,,20.08,24.45,23.73,22.72,23.62,23.46,23.39,24.38,,24.22,23.22,-0.41,-0.70, ,-3.13,1.23,0.51,-0.49,0.41,0.24,0.18,1.16, ,1.01,regulation of microtubule-based process;wound healing;positive regulation of Wnt receptor signaling pathway;regulation of epithelial cell migration;regulation of focal adhesion assembly;Golgi to plasma membrane protein transport;cell cycle arrest;Wnt receptor signaling pathway,ruffle membrane;Golgi apparatus;microtubule,,,,,,,,,,,,,,
8605,Q9UPN3,MACF1,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",KRRRMLSSSDAIT,_M(ox)LS(ph)SSDAITQEFM(ox)DLR_,S1371,+,26.26,21.23,21.23,,26.22,,24.96,25.01,25.58,26.30,26.18,,26.15,24.91,1.35,-3.68,-3.68, ,1.31, ,0.05,0.10,0.66,1.39,1.26, ,1.24,regulation of microtubule-based process;wound healing;positive regulation of Wnt receptor signaling pathway;regulation of epithelial cell migration;regulation of focal adhesion assembly;Golgi to plasma membrane protein transport;cell cycle arrest;Wnt receptor signaling pathway,ruffle membrane;Golgi apparatus;microtubule,,,,,,,,,,,,,,
8608,Q9UPN4,AZI1,5-azacytidine-induced protein 1 (Centrosomal protein of 131 kDa) (Cep131) (Pre-acrosome localization protein 1),QPAQELSPTPGGT,_(gl)QPAQELS(ph)PTPGGTAHQALK_,S381,+,23.83,21.78,,22.88,25.05,24.67,24.25,25.01,22.52,,,,23.70,23.74,0.09,-1.97, ,-0.87,1.31,0.93,0.51,1.27,-1.23, , , ,-0.05,multicellular organismal development;G2/M transition of mitotic cell cycle;cell differentiation;spermatogenesis,cytosol;intracellular membrane-bounded organelle;centrosome,,,,,,,,,,,,,,
8611,Q9UPN6,SCAF8,Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8),TVQTTQSPTPVEK,_ETVQTTQS(ph)PTPVEK_,S617,+,27.80,27.84,28.05,27.70,24.88,24.48,27.44,26.91,27.56,26.90,25.62,25.97,26.48,26.74,1.06,1.10,1.31,0.96,-1.86,-2.26,0.70,0.17,0.82,0.16,-1.12,-0.77,-0.26,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,spliceosomal complex;nuclear matrix,,,,,,,,,,,,,,
8612,Q9UPN9,TRIM33,E3 ubiquitin-protein ligase TRIM33 (EC 6.3.2.-) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),SLVNGKSPIRSLM,_(gl)QSGLSSLVNGKS(ph)PIR_,S862,,20.18,19.68,19.68,,22.60,,,,,,,,,20.53,-0.35,-0.86,-0.86, ,2.06, , , , , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway,nucleoplasm,Other TF domain,+,,,,,,,,,,,,
8613,Q9UPP1,PHF8,Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8),IYPSLESDDDDPA,_DAEYIYPSLES(ph)DDDDPALK_,S343,,25.42,,,,,,,,,22.61,,,,24.01,1.41, , , , , , , , ,-1.41, , , ,"brain development;positive regulation of transcription from RNA polymerase I promoter;negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;G1/S transition of mitotic cell cycle",nucleolus,,,,,,,,,,,,,,
8614,Q9UPP1,PHF8,Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8),SDDAPWSPKARVT,_NSDDAPWS(ph)PK_,S366,+,23.02,23.95,24.35,23.21,23.03,23.53,23.21,23.19,22.96,23.64,,22.00,,23.28,-0.26,0.66,1.07,-0.07,-0.25,0.25,-0.07,-0.09,-0.32,0.36, ,-1.28, ,"brain development;positive regulation of transcription from RNA polymerase I promoter;negative regulation of chromatin silencing at rDNA;transcription, DNA-dependent;G1/S transition of mitotic cell cycle",nucleolus,,,,,,,,,,,,,,
8616,Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,KVVKPKSPEPEAT,_S(ph)PEPEATLTFPFLDK_,S552,,26.76,23.21,24.07,24.88,,,21.50,,26.14,28.96,26.09,,25.16,25.20,1.57,-1.98,-1.13,-0.32, , ,-3.70, ,0.94,3.77,0.89, ,-0.04,actomyosin structure organization,,,,,,,,,,,,,,,
8617,Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,RSRQTPSPDVVLR,_(gl)QTPS(ph)PDVVLR_,S63,,24.85,24.27,,22.80,,,,,,22.21,21.86,,,23.20,1.65,1.07, ,-0.40, , , , , ,-0.99,-1.34, , ,actomyosin structure organization,,,,,,,,,,,,,,,
8618,Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,DRRWKKSFQGDDS,_S(ph)FQGDDSDLLLK_,S708,,23.80,,,,,,,,,23.24,,,,23.52,0.28, , , , , , , , ,-0.28, , , ,actomyosin structure organization,,,,,,,,,,,,,,,
8620,Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,SQFFSQSVDSPSS,_SQFFSQS(ph)VDSPSSEK_,S601,,23.81,,,,,,,,,,,,,23.81,0.00, , , , , , , , , , , , ,actomyosin structure organization,,,,,,,,,,,,,,,
8621,Q9UPQ0,LIMCH1,LIM and calponin homology domains-containing protein 1,WKSRRRSVSQDLI,_S(ph)VSQDLIK_,S211,,26.00,23.06,23.06,23.83,,,,,,22.88,,22.01,,23.47,2.53,-0.41,-0.41,0.35, , , , , ,-0.59, ,-1.47, ,actomyosin structure organization,,,,,,,,,,,,,,,
8623,Q9UPQ9,TNRC6B,Trinucleotide repeat-containing gene 6B protein,SGWEEPSPQSISR,_DEEPSGWEEPS(ph)PQSISR_,S879,+,24.67,23.61,23.69,24.23,22.42,22.20,24.82,24.49,25.56,25.51,,,,24.12,0.55,-0.51,-0.43,0.11,-1.70,-1.92,0.70,0.37,1.44,1.39, , , ,Notch signaling pathway;gene expression;regulation of translation;gene silencing by RNA,cytosol;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
8627,Q9UPS8,ANKRD26,Ankyrin repeat domain-containing protein 26,SKESVNSPVFGKA,_ESVNS(ph)PVFGK_,S188,+,,23.02,23.50,24.69,22.77,24.32,24.73,24.29,24.22,,23.16,,23.72,23.84, ,-0.82,-0.34,0.85,-1.07,0.48,0.89,0.45,0.38, ,-0.68, ,-0.12,regulation of feeding behavior;regulation of fatty acid metabolic process;negative regulation of multicellular organism growth;negative regulation of organ growth,actin filament;centrosome,,,,,,,,,,,,,,
8628,Q9UPT5,EXOC7,Exocyst complex component 7 (Exocyst complex component Exo70),SSGVPYSPAIPNK,_SSSSSGVPYS(ph)PAIPNK_,S250,+,23.22,23.96,24.02,22.66,23.47,,,,25.20,24.12,24.73,,,23.92,-0.70,0.04,0.10,-1.26,-0.46, , , ,1.28,0.19,0.81, , ,protein transport;exocytosis,cytosol;plasma membrane;growth cone membrane;exocyst;centriolar satellite,,,,,,,,,,,,,,
8630,Q9UPT6,MAPK8IP3,C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3),LFSSSSSPPPAKR,_LFSSSSS(ph)PPPAK_,S579,,25.69,23.42,,21.71,,,,,,,,21.77,,23.15,2.54,0.27, ,-1.43, , , , , , , ,-1.38, ,respiratory gaseous exchange;regulation of gene expression;post-embryonic development;activation of JUN kinase activity;lung alveolus development;lung morphogenesis;in utero embryonic development;axon guidance;regulation of JNK cascade;vesicle-mediated transport;forebrain development;protein localization,smooth endoplasmic reticulum;Golgi membrane;dendrite;axolemma,,,,+,,,,,,,,,,
8632,Q9UPT6,MAPK8IP3,C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3),LDRTGSSPTQGIV,_TGSS(ph)PTQGIVNK_,S365,+,26.89,24.17,23.92,23.40,24.76,22.97,22.22,22.25,22.19,,,,22.59,23.54,3.35,0.64,0.39,-0.13,1.22,-0.57,-1.32,-1.28,-1.34, , , ,-0.95,respiratory gaseous exchange;regulation of gene expression;post-embryonic development;activation of JUN kinase activity;lung alveolus development;lung morphogenesis;in utero embryonic development;axon guidance;regulation of JNK cascade;vesicle-mediated transport;forebrain development;protein localization,smooth endoplasmic reticulum;Golgi membrane;dendrite;axolemma,,,,+,,,,,,,,,,
8635,Q9UPT8,ZC3H4,Zinc finger CCCH domain-containing protein 4,SPSGDASPPATAP,_PGPAEAPSPTASPSGDAS(ph)PPATAPYDPR_,S1114,+,24.84,23.35,,24.65,25.33,28.06,24.87,26.85,27.13,26.36,25.62,24.69,,25.61,-0.77,-2.26, ,-0.97,-0.29,2.45,-0.74,1.24,1.52,0.74,0.01,-0.92, ,,,,,,,,,,,,,,,,
8637,Q9UPT8,ZC3H4,Zinc finger CCCH domain-containing protein 4,PKTGSGSPFAGNS,_TGSGS(ph)PFAGNS(ph)PAREGEQDAASLK_,S1269,+,25.91,25.06,25.14,25.43,23.61,24.47,,25.57,25.78,24.58,,,,25.06,0.85,0.00,0.08,0.37,-1.45,-0.59, ,0.51,0.72,-0.49, , , ,,,,,,,,,,,,,,,,
8638,Q9UPT8,ZC3H4,Zinc finger CCCH domain-containing protein 4,SPFAGNSPAREGE,_TGSGS(ph)PFAGNS(ph)PAREGEQDAASLK_,S1275,+,26.31,25.90,26.69,26.08,25.81,27.46,26.41,25.24,26.45,25.46,24.76,26.36,25.66,26.04,0.26,-0.15,0.64,0.03,-0.23,1.41,0.36,-0.80,0.41,-0.58,-1.28,0.31,-0.39,,,,,,,,,,,,,,,,
8639,Q9UPU5,USP24,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),SSYRQLSVSDRSS,_QLS(ph)VSDR_,S1139,,25.08,,,23.30,,,,,,,,,,24.19,0.89, , ,-0.89, , , , , , , , , ,ubiquitin-dependent protein catabolic process,,,,,,,,,,,,,,,
8640,Q9UPU5,USP24,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),TFQRTISAQDTLA,_TIS(ph)AQDTLAYATALLNEK_,S2401,,24.97,,,,,,,,,,,,,24.97,0.00, , , , , , , , , , , , ,ubiquitin-dependent protein catabolic process,,,,,,,,,,,,,,,
8643,Q9UPU9,SAMD4A,Protein Smaug homolog 1 (Smaug 1) (hSmaug1) (Sterile alpha motif domain-containing protein 4A) (SAM domain-containing protein 4A),PIKAYSSPSTTPE,_AYSS(ph)PSTTPEAR_,S11,+,24.01,24.99,24.47,25.71,,,23.14,,22.77,23.40,22.35,22.84,,23.74,0.27,1.25,0.73,1.97, , ,-0.60, ,-0.97,-0.34,-1.40,-0.90, ,positive regulation of translation,synapse;cell junction;dendrite;cytoplasm,,,,,,,,,,,,,,
8645,Q9UPW0,FOXJ3,Forkhead box protein J3,DQDGSDSPRSSLN,_VTLYNTDQDGSDS(ph)PR_,S34,,23.96,,,,21.71,22.89,,,,,,,,22.86,1.11, , , ,-1.14,0.03, , , , , , , ,"positive regulation of transcription, DNA-dependent;tissue development;embryo development;regulation of sequence-specific DNA binding transcription factor activity;pattern specification process;organ development",transcription factor complex,Forkhead,,,,,,,,,,,,,
8646,Q9UPX0,IGSF9B,Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B),LSSRTGSPELAAR,_TGS(ph)PELAAR_,S1057,,23.73,24.79,24.88,23.61,,,,21.19,,,,20.85,,23.18,0.56,1.62,1.71,0.43, , , ,-1.99, , , ,-2.33, ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
8647,Q9UPX8,SHANK2,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),TPTVPGSPKAPFL,_QGIAVM(ox)TPTVPGS(ph)PK_,S110,,,,,,,,22.22,,22.43,23.28,,,,22.65, , , , , , ,-0.42, ,-0.22,0.64, , , ,intracellular signal transduction,dendritic spine;cell junction;postsynaptic density;postsynaptic membrane;cytoplasm;cilium membrane,,,,,,,,,,,,,,
8648,Q9UPX8,SHANK2,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),GTRRAPSPVVSPT,_RAPS(ph)PVVSPTEM(ox)NK_,S988,,,,,,,,21.90,22.64,,23.23,22.85,,,22.65, , , , , , ,-0.76,-0.02, ,0.58,0.20, , ,intracellular signal transduction,dendritic spine;cell junction;postsynaptic density;postsynaptic membrane;cytoplasm;cilium membrane,,,,,,,,,,,,,,
8649,Q9UPY3,DICER1,Endoribonuclease Dicer (EC 3.1.26.-) (Helicase with RNase motif) (Helicase MOI),RTLLSESPGKLHV,_TLLSES(ph)PGK_,S1160,,22.27,22.60,23.48,22.50,19.82,,,,21.34,,,,,22.00,0.27,0.60,1.48,0.50,-2.18, , , ,-0.66, , , , ,pre-miRNA processing;negative regulation of apoptotic process;defense response to virus;stem cell maintenance;spindle assembly;production of siRNA involved in RNA interference;embryonic hindlimb morphogenesis;intestinal epithelial cell development;spleen development;hair follicle morphogenesis;regulation of viral genome replication;post-embryonic development;positive regulation of myelination;negative regulation of Schwann cell proliferation;multicellular organism growth;regulation of enamel mineralization;cardiac muscle cell development;cerebral cortex development;lung development;targeting of mRNA for destruction involved in RNA interference;nerve development;regulation of oligodendrocyte differentiation;apoptotic process;branching morphogenesis of a tube;positive regulation of transcription from RNA polymerase II promoter;hair follicle cell proliferation;angiogenesis;regulation of cell cycle;regulation of neuron differentiation;negative regulation of transcription from RNA polymerase II promoter;peripheral nervous system myelin formation;olfactory bulb interneuron differentiation;positive regulation of Schwann cell differentiation;neuron projection morphogenesis;spinal cord motor neuron differentiation;zygote asymmetric cell division,RNA-induced silencing complex;cytosol,,,,,,,,,,,,,,
8650,Q9UPY5,SLC7A11,Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT),VNGRLPSLGNKEP,_LPS(ph)LGNK_,S26,,23.74,,,24.11,21.11,,,,,,,22.30,,22.82,0.92, , ,1.29,-1.70, , , , , , ,-0.51, ,response to oxidative stress;brain development;blood coagulation;lens fiber cell differentiation;response to toxin;response to nicotine;leukocyte migration,rough endoplasmic reticulum;integral to membrane;plasma membrane;cytoskeleton,,,,,,,,,,,,,,
8651,Q9UPZ3,HPS5,Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog) (Ru2),IGTLHTSPDLKVR,_IGTLHTS(ph)PDLK_,S449,+,,23.01,23.01,21.44,24.30,,23.91,24.16,,21.95,22.09,22.63,22.76,22.93, ,0.08,0.08,-1.49,1.37, ,0.99,1.24, ,-0.98,-0.83,-0.30,-0.16,pigmentation;blood coagulation;organelle organization,cytosol,,,,,,,,,,,,,,
8652,Q9UPZ3,HPS5,Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog) (Ru2),EKEKRDSLGNEES,_RDS(ph)LGNEESVDK_,S581,,,23.96,24.47,,,,,,,21.39,,21.20,,22.75, ,1.20,1.72, , , , , , ,-1.37, ,-1.55, ,pigmentation;blood coagulation;organelle organization,cytosol,,,,,,,,,,,,,,
8654,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),VEKAGMSSNQSIS,_AGM(ox)S(ph)S(ph)NQSISSPVLDAVPR_,S1397,,21.67,,,,21.58,,,23.96,,23.08,,22.84,,22.63,-0.96, , , ,-1.04, , ,1.33, ,0.46, ,0.21, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8655,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),EKAGMSSNQSISS,_AGM(ox)S(ph)S(ph)NQSISSPVLDAVPR_,S1398,,23.23,,,,21.58,,,23.96,,23.08,,22.84,,22.94,0.29, , , ,-1.35, , ,1.02, ,0.14, ,-0.10, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8656,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GMSSNQSISSPVL,_AGM(ox)SSNQS(ph)ISSPVLDAVPR_,S1401,,24.09,,,,,22.87,,,,,,,,23.48,0.61, , , , ,-0.61, , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8657,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SSNQSISSPVLDA,_AGM(ox)SSNQSIS(ph)SPVLDAVPRT(ph)PSRER_,S1403,+,24.76,24.99,24.99,23.94,,25.96,,25.34,26.50,,,23.16,,24.95,-0.19,0.03,0.03,-1.01, ,1.01, ,0.38,1.54, , ,-1.80, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8658,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SNQSISSPVLDAV,_AGM(ox)SSNQSISS(ph)PVLDAVPR_,S1404,+,28.32,26.71,26.10,27.43,28.98,28.52,27.87,28.32,27.33,27.37,27.52,27.35,28.34,27.70,0.61,-1.00,-1.60,-0.28,1.27,0.82,0.17,0.62,-0.37,-0.34,-0.19,-0.35,0.64,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8659,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),AVPRTPSRERSSS,_AGM(ox)SSNQSISSPVLDAVPRT(ph)PS(ph)RER_,S1415,+,24.92,25.04,,25.23,25.52,,,23.68,24.44,23.75,,,,24.65,0.26,0.38, ,0.57,0.86, , ,-0.98,-0.21,-0.90, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8660,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),AQSGSDSSPEPKA,_AQSGSDS(ph)S(ph)PEPKAPAPR_,S1620,,22.07,,,,26.18,25.32,,,,,,,21.71,23.82,-1.75, , , ,2.36,1.50, , , , , , ,-2.12,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8661,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QSGSDSSPEPKAP,_AQSGSDS(ph)S(ph)PEPKAPAPR_,S1621,,22.07,,,,25.42,,,,,,,,,23.75,-1.68, , , ,1.68, , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8662,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SLSGSKSPCPQEK,_AQT(ph)PPGPSLSGSKS(ph)PCPQEK_,S1014,,25.71,25.60,25.87,25.59,,,,22.41,24.22,,,,,24.90,0.81,0.70,0.97,0.69, , , ,-2.49,-0.68, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8664,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GTPSRHSLSGSSP,_DGSGT(ph)PSRHS(ph)LSGS(ph)SPGM(ox)K_,S1458,,24.20,23.97,,,,,,,,,,,,24.08,0.12,-0.12, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8665,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RHSLSGSSPGMKD,_DGSGT(ph)PSRHS(ph)LSGS(ph)SPGM(ox)K_,S1462,,24.20,23.97,,,,,,,,,,,,24.08,0.12,-0.12, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8667,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RQKDKFSPFPVQD,_DKFS(ph)PFPVQDRPESSLVFK_,S1188,+,24.40,24.16,24.00,,23.66,25.55,26.14,24.92,27.08,26.50,26.04,26.19,26.59,25.44,-1.04,-1.27,-1.43, ,-1.77,0.11,0.70,-0.51,1.65,1.06,0.60,0.75,1.15,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8668,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PEHKELSNSPLRE,_ELS(ph)NS(ph)PLRENSFGSPLEFR_,S1318,,25.55,,,,,,,,,,,,,25.55,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8669,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),HKELSNSPLRENS,_ELS(ph)NS(ph)PLRENSFGSPLEFR_,S1320,+,29.95,27.43,25.37,27.45,29.34,28.68,29.24,29.47,29.82,28.87,29.36,29.51,29.85,28.80,1.15,-1.36,-3.43,-1.35,0.54,-0.12,0.45,0.68,1.03,0.07,0.57,0.72,1.05,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8670,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SPLRENSFGSPLE,_ELSNS(ph)PLRENS(ph)FGSPLEFR_,S1326,,28.07,,,,,,,,,20.81,,,,24.44,3.63, , , , , , , , ,-3.63, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8671,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RENSFGSPLEFRN,_ELSNS(ph)PLRENSFGS(ph)PLEFR_,S1329,,27.87,21.25,,,25.82,22.46,,22.18,,22.56,,,,23.69,4.18,-2.44, , ,2.13,-1.23, ,-1.51, ,-1.13, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8673,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SALPTSSQDEELM,_EQNSALPTSS(ph)QDEELM(ox)EVVEK_,S1233,+,25.86,24.13,24.26,23.77,,24.58,24.34,23.63,24.41,25.95,,,25.54,24.65,1.21,-0.52,-0.39,-0.87, ,-0.07,-0.31,-1.02,-0.24,1.31, , ,0.89,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8675,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KEQSTRSSGHSSS,_S(ph)SGHSS(ph)SELSPDAVEK_,S1378,,24.39,22.43,,,21.73,,,,,,,,,22.85,1.54,-0.42, , ,-1.12, , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8677,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TRSSGHSSSELSP,_SSGHS(ph)SSELSPDAVEK_,S1382,+,26.62,25.51,24.38,25.46,24.54,26.49,24.09,24.25,26.37,25.51,24.47,22.00,25.36,25.01,1.62,0.51,-0.63,0.46,-0.46,1.49,-0.91,-0.76,1.36,0.51,-0.53,-3.01,0.36,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8678,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSSGHSSSELSPD,_SSGHSS(ph)SELSPDAVEK_,S1383,+,24.53,24.68,,,23.35,24.19,,,24.53,24.09,23.50,,23.58,24.06,0.47,0.62, , ,-0.71,0.14, , ,0.47,0.04,-0.55, ,-0.48,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8680,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),HSSSELSPDAVEK,_SSGHS(ph)SSELS(ph)PDAVEK_,S1387,+,27.51,27.02,26.25,26.91,27.87,27.49,27.15,27.36,26.99,27.45,26.46,27.15,26.05,27.05,0.46,-0.03,-0.80,-0.14,0.82,0.44,0.10,0.31,-0.06,0.40,-0.59,0.10,-1.00,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8681,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PTVDSNSLLGQSR,_FQSDSSSYPTVDSNS(ph)LLGQSR_,S1152,,24.31,,,,,,,,,,,,,24.31,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8682,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QDRGEFSASPMLK,_GEFS(ph)AS(ph)PM(ox)LK_,S1122,,24.68,,,20.55,,21.83,,,,,20.47,,,21.88,2.80, , ,-1.33, ,-0.06, , , , ,-1.42, , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8683,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RGEFSASPMLKSG,_GEFS(ph)AS(ph)PM(ox)LK_,S1124,+,30.10,28.96,27.21,29.40,29.03,29.43,27.85,28.13,25.04,26.71,24.98,27.19,28.22,27.87,2.23,1.10,-0.66,1.54,1.17,1.57,-0.02,0.26,-2.83,-1.15,-2.89,-0.68,0.36,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8687,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),STQRPSSPETATK,_RGEGDAPFSEPGTTSTQRPSS(ph)PETATK_,S323,+,26.99,29.04,,27.47,24.28,27.71,26.90,23.81,27.10,24.37,,26.30,27.52,26.50,0.49,2.54, ,0.97,-2.22,1.21,0.40,-2.69,0.60,-2.13, ,-0.20,1.02,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8688,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ATKQPSSPYEDKD,_QPSS(ph)PYEDK_,S333,+,26.18,25.56,25.92,25.54,,23.69,25.77,22.57,26.73,24.16,24.45,25.62,23.60,24.98,1.20,0.57,0.94,0.56, ,-1.29,0.79,-2.41,1.75,-0.82,-0.53,0.64,-1.38,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8689,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GGSGYHSRSPARQ,_GGS(ph)GYHS(ph)RS(ph)PARQESSR_,S1822,,24.80,22.88,20.26,23.73,,,,,,19.80,,,,22.30,2.51,0.59,-2.03,1.43, , , , , ,-2.49, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8690,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SGYHSRSPARQES,_GGSGYHS(ph)RS(ph)PAR_,S1824,,24.80,22.88,20.26,23.73,,,,,,19.80,,,,22.30,2.51,0.59,-2.03,1.43, , , , , ,-2.49, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8693,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),DHRSDTSSPEVRQ,_GQSQTS(ph)PDHRSDTS(ph)S(ph)PEVR_,S1072,,25.56,24.19,,23.54,,,21.19,,20.58,,,,,23.01,2.54,1.17, ,0.53, , ,-1.82, ,-2.43, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8694,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),HRSDTSSPEVRQS,_GQSQTS(ph)PDHRSDTS(ph)S(ph)PEVR_,S1073,,26.02,24.19,,,,,,,,,,,,25.10,0.92,-0.92, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8696,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GSSSTESSPEHPP,_GRGPSPEGSS(ph)STES(ph)S(ph)PEHPPK_,S1657,,25.64,25.72,,,,,,,24.39,,,,,25.25,0.39,0.47, , , , , , ,-0.86, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8697,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SSSTESSPEHPPK,_GRGPSPEGSS(ph)STES(ph)S(ph)PEHPPK_,S1658,,25.64,25.72,,,,,,,24.39,,,,,25.25,0.39,0.47, , , , , , ,-0.86, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8698,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KVSRHASSSPESP,_HAS(ph)S(ph)SPES(ph)PKPAPAPGSHR_,S435,,24.73,23.88,,23.05,,,,,,,,,,23.89,0.84,-0.01, ,-0.83, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8699,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),VSRHASSSPESPK,_HAS(ph)S(ph)SPES(ph)PKPAPAPGSHR_,S436,,24.25,,,,,,,,,,,,,24.25,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8701,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ASSSPESPKPAPA,_HASS(ph)S(ph)PES(ph)PKPAPAPGSHR_,S440,,24.97,23.88,,23.05,,,,,,,,,,23.97,1.00,-0.09, ,-0.91, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8702,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),AERHGGSPQPLAT,_HGGS(ph)PQPLATTPLSQEPVNPPSEAS(ph)PTR_,S377,+,26.13,24.64,,24.63,,,22.43,,23.04,23.14,23.75,,,23.96,2.16,0.67, ,0.66, , ,-1.54, ,-0.93,-0.82,-0.22, , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8703,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),EPVNPPSEASPTR,_HGGS(ph)PQPLATTPLSQEPVNPPS(ph)EAS(ph)PTR_,S395,,23.17,,,,,,,,,,,,,23.17,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8704,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),NPPSEASPTRDRS,_HGGS(ph)PQPLATTPLSQEPVNPPS(ph)EAS(ph)PTR_,S398,+,26.13,24.64,,24.63,,,22.43,,23.04,23.14,23.75,,,23.96,2.16,0.67, ,0.66, , ,-1.54, ,-0.93,-0.82,-0.22, , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8705,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RLLPRYSHSGSSS,_LLPRYS(ph)HSGSS(ph)S(ph)PDTK_,S968,,23.94,,,,,,,,,,,,,23.94,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8706,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),YSHSGSSSPDTKV,_LLPRYS(ph)HSGSS(ph)S(ph)PDTK_,S973,,23.94,,,,,,,,,,,,,23.94,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8707,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SHSGSSSPDTKVK,_LLPRYS(ph)HSGSS(ph)S(ph)PDTK_,S974,,23.94,,,,,,,,,,,,,23.94,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8708,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SESSPPSPQPTKV,_LPQSSSSESSPPS(ph)PQPTK_,S424,+,24.56,24.70,24.59,25.76,,22.19,25.00,,25.22,26.79,23.77,23.71,,24.63,-0.07,0.07,-0.04,1.13, ,-2.44,0.37, ,0.59,2.16,-0.86,-0.92, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8709,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QEDATASPPRQKD,_M(ox)ALPPQEDATAS(ph)PPR_,S1179,+,27.07,27.40,27.48,26.52,27.78,26.33,27.40,27.47,27.55,27.12,27.56,27.16,28.37,27.32,-0.26,0.08,0.15,-0.80,0.46,-1.00,0.07,0.15,0.22,-0.20,0.24,-0.16,1.05,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8710,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SGANLTSPRVPLS,_M(ox)APALSGANLTS(ph)PR_,S2382,+,25.54,24.29,24.00,24.57,22.44,,,22.54,25.69,24.65,,,,24.22,1.32,0.08,-0.21,0.35,-1.78, , ,-1.68,1.47,0.44, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8711,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),AQDQPRSPVPSAF,_S(ph)PVPSAFSDQSR_,S2449,+,27.46,26.73,25.69,26.75,28.51,28.88,28.19,27.87,28.64,27.06,27.73,27.63,28.71,27.68,-0.22,-0.95,-1.99,-0.94,0.83,1.20,0.51,0.19,0.95,-0.62,0.04,-0.05,1.03,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8712,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SCFSRPSMSPTPL,_M(ox)SCFSRPS(ph)M(ox)S(ph)PTPLDR_,S2121,+,28.14,24.96,24.96,24.99,25.13,,22.00,,22.97,22.07,,,,24.40,3.74,0.56,0.56,0.59,0.73, ,-2.40, ,-1.44,-2.33, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8713,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),FSRPSMSPTPLDR,_PSM(ox)S(ph)PTPLDR_,S2123,+,28.50,25.01,24.96,26.49,25.13,21.62,22.90,,23.98,22.42,,,,24.56,3.94,0.45,0.41,1.93,0.57,-2.94,-1.65, ,-0.58,-2.13, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8715,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PATRNHSGSRTPP,_NHS(ph)GS(ph)RT(ph)PPVALNSSR_,S2100,,27.95,22.26,,22.98,23.58,,,,,,,23.54,,24.06,3.89,-1.80, ,-1.09,-0.49, , , , , , ,-0.52, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8716,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TRNHSGSRTPPVA,_NHS(ph)GS(ph)RT(ph)PPVALNSSR_,S2102,,27.95,22.26,,22.98,24.70,,,,,20.80,,23.54,,23.70,4.25,-1.44, ,-0.73,1.00, , , , ,-2.91, ,-0.16, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8717,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),YVQRNLSLVRGRR,_NLS(ph)LVR_,S24,,26.07,21.88,,,,,22.03,,,,,26.22,21.91,23.62,2.45,-1.74, , , , ,-1.59, , , , ,2.60,-1.71,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8719,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ALPKPASPKKPPP,_PGPQALPKPAS(ph)PK_,S2664,+,25.34,25.54,24.52,25.59,,,26.50,,26.63,27.16,26.15,26.57,24.32,25.83,-0.50,-0.29,-1.32,-0.24, , ,0.67, ,0.80,1.33,0.32,0.74,-1.51,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8720,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),IDSLRDSRSLSYS,_PIDSLRDS(ph)R_,S2688,,22.54,24.72,,,,,,,,,,,,23.63,-1.09,1.09, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8723,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),EVRQSHSESPSLQ,_QSHS(ph)ESPSLQSK_,S1081,,,,,,23.90,,,,23.54,,,,,23.72, , , , ,0.18, , , ,-0.18, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8727,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RQSHSGSISPYPK,_QSHSGS(ph)IS(ph)PYPK_,S992,,24.70,24.68,,22.37,,,,,,,,,,23.92,0.78,0.76, ,-1.55, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8728,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SHSGSISPYPKVK,_QSHSGS(ph)IS(ph)PYPK_,S994,+,26.82,26.74,24.89,26.42,24.68,26.21,25.12,25.07,24.25,26.27,23.55,,24.54,25.38,1.44,1.36,-0.49,1.03,-0.70,0.83,-0.26,-0.31,-1.13,0.89,-1.83, ,-0.84,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8730,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RPSPQPSPRDQQS,_RRPS(ph)PQPS(ph)PR_,S2706,+,28.45,28.52,28.05,28.04,22.84,17.87,18.99,20.19,21.22,,,,,23.80,4.65,4.73,4.25,4.24,-0.95,-5.92,-4.81,-3.60,-2.57, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8731,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PPRHRRSPSVSSP,_S(ph)PSVSSPEPAEK_,S1727,,23.77,24.09,,23.44,21.44,22.47,,,,,,,22.40,22.93,0.84,1.15, ,0.51,-1.50,-0.47, , , , , , ,-0.54,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8732,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RHRRSPSVSSPEP,_RSPS(ph)VS(ph)SPEPAEK_,S1729,,24.16,23.78,,,,,,,22.41,,21.91,,22.40,22.93,1.23,0.85, , , , , , ,-0.52, ,-1.02, ,-0.53,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8733,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSPSVSSPEPAE,_SPSVS(ph)SPEPAEK_,S1731,+,25.49,25.09,,20.72,,23.01,,,24.91,,21.91,,23.70,23.55,1.94,1.55, ,-2.83, ,-0.54, , ,1.37, ,-1.64, ,0.15,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8734,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSPSVSSPEPAEK,_RSPSVS(ph)S(ph)PEPAEK_,S1732,,23.40,23.86,,,,,,,,,,,,23.63,-0.23,0.23, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8736,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PPRRRSSRSSPEL,_RSS(ph)RSS(ph)PELTR_,S1691,,27.54,27.42,28.02,27.03,22.65,,,,,,,,,26.53,1.01,0.89,1.49,0.50,-3.89, , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8739,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QWRRSRSAQRWGR,_S(ph)AQRWGR_,S518,,23.16,28.74,28.74,,,20.13,21.28,21.22,,,,,,23.88,-0.72,4.86,4.86, , ,-3.74,-2.60,-2.65, , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8740,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KSATRPSPSPERS,_SATRPS(ph)PS(ph)PER_,S351,+,29.27,27.00,26.06,28.51,30.67,25.29,27.48,28.22,29.38,29.11,,26.67,,27.97,1.30,-0.97,-1.91,0.54,2.70,-2.68,-0.49,0.25,1.41,1.14, ,-1.30, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8741,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ATRPSPSPERSST,_SATRPS(ph)PS(ph)PER_,S353,+,29.48,27.54,26.22,28.71,30.75,26.23,27.55,28.32,29.54,29.18,24.04,26.89,25.36,27.68,1.80,-0.14,-1.46,1.03,3.08,-1.45,-0.12,0.64,1.86,1.50,-3.63,-0.79,-2.31,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8744,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),VTPQRRSCFESSP,_S(ph)CFESSPDPELK_,S871,+,25.26,23.23,23.11,23.29,,23.46,22.16,,25.35,23.53,21.81,,22.48,23.37,1.89,-0.14,-0.26,-0.07, ,0.09,-1.21, ,1.98,0.16,-1.56, ,-0.88,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8745,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSCFESSPDPEL,_SCFES(ph)SPDPELK_,S875,,,22.96,23.32,22.83,,,,,24.06,23.35,,,,23.31, ,-0.35,0.02,-0.47, , , , ,0.76,0.05, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8746,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSCFESSPDPELK,_SCFESS(ph)PDPELK_,S876,+,28.63,28.37,28.20,28.88,28.24,28.85,28.24,27.78,28.17,28.27,26.63,27.93,27.01,28.09,0.53,0.28,0.11,0.78,0.14,0.76,0.15,-0.31,0.07,0.18,-1.46,-0.16,-1.08,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8752,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),MLKSGMSPEQSRF,_SGMS(ph)PEQSR_,S1132,+,20.92,22.15,,24.32,19.67,27.19,,,25.70,26.34,,,,23.75,-2.84,-1.61, ,0.57,-4.08,3.44, , ,1.94,2.58, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8753,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSRSGSSPEVKDK,_SGS(ph)S(ph)PEVKDKPR_,S1601,,,22.74,22.74,,22.23,,,19.14,,20.57,,,,21.48, ,1.26,1.26, ,0.74, , ,-2.35, ,-0.91, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8755,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QRSRSGSSQELDV,_SGS(ph)S(ph)QELDVKPSASPQER_,S1541,+,27.03,25.80,25.38,25.50,25.29,26.74,24.24,24.47,26.76,25.37,25.84,24.33,25.04,25.52,1.51,0.28,-0.14,-0.02,-0.23,1.22,-1.28,-1.06,1.24,-0.15,0.31,-1.19,-0.48,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8756,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSRSGSSQELDVK,_SGS(ph)S(ph)QELDVKPSAS(ph)PQER_,S1542,,26.36,,,22.58,23.58,,,,,,,,,24.17,2.19, , ,-1.59,-0.60, , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8757,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ELDVKPSASPQER,_SGS(ph)S(ph)QELDVKPS(ph)ASPQER_,S1550,,24.68,24.19,23.12,23.98,,,,,,,,,,23.99,0.69,0.20,-0.87,-0.01, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8758,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),DVKPSASPQERSE,_SGS(ph)SQELDVKPSAS(ph)PQER_,S1552,,25.43,23.98,23.98,23.59,,,,,,,,,,24.24,1.18,-0.27,-0.27,-0.65, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8759,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SLRDSRSLSYSPV,_S(ph)LSYS(ph)PVER_,S2690,+,24.63,23.66,23.23,25.10,24.16,,23.74,,22.80,22.54,23.01,23.17,,23.60,1.03,0.06,-0.37,1.49,0.56, ,0.14, ,-0.80,-1.07,-0.60,-0.43, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8760,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RDSRSLSYSPVER,_SLS(ph)YS(ph)PVER_,S2692,+,28.80,24.81,24.83,26.11,26.35,25.00,24.49,25.29,24.96,25.12,22.74,26.18,23.12,25.21,3.58,-0.41,-0.38,0.89,1.14,-0.21,-0.73,0.07,-0.26,-0.10,-2.48,0.97,-2.09,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8761,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),SRSLSYSPVERRR,_SLS(ph)YS(ph)PVER_,S2694,+,29.51,27.15,26.83,27.14,28.05,28.59,26.73,26.33,27.80,28.28,25.82,26.20,26.91,27.33,2.18,-0.19,-0.51,-0.20,0.71,1.26,-0.61,-1.00,0.46,0.95,-1.52,-1.13,-0.42,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8764,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PLDRCRSPGMLEP,_S(ph)PGM(ox)LEPLGSSR_,S2132,+,27.71,25.10,24.32,26.44,25.98,26.19,25.34,25.33,24.90,,23.42,24.76,24.93,25.37,2.34,-0.27,-1.04,1.07,0.61,0.83,-0.03,-0.04,-0.47, ,-1.95,-0.60,-0.44,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8766,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRGRSRSPQRPGW,_S(ph)PQRPGWSR_,S536,+,25.73,24.96,25.89,23.35,26.69,20.48,24.53,24.53,26.13,22.91,,,,24.52,1.21,0.44,1.37,-1.17,2.17,-4.04,0.02,0.01,1.61,-1.61, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8769,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRGRSRSRSLVRR,_S(ph)RS(ph)LVRR_,S704,,24.94,24.56,24.85,24.30,20.76,,,17.36,,,,,,22.79,2.14,1.76,2.06,1.51,-2.04, , ,-5.44, , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8770,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GRSRSRSLVRRGR,_S(ph)RS(ph)LVRR_,S706,,24.94,24.56,24.85,24.30,20.76,,,17.36,,,,,,22.79,2.14,1.76,2.06,1.51,-2.04, , ,-5.44, , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8772,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PQRRGRSRSPQRP,_S(ph)RS(ph)PQRPGWSR_,S534,+,26.28,,,23.35,26.46,,23.99,23.79,24.44,,,,,24.72,1.56, , ,-1.37,1.74, ,-0.72,-0.93,-0.28, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8775,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),QTPRPRSRSPSSP,_S(ph)RS(ph)PSSPELNNK_,S1497,+,26.22,25.51,24.27,26.44,21.98,,,,22.18,,,20.12,,23.82,2.40,1.69,0.45,2.63,-1.84, , , ,-1.64, , ,-3.70, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8776,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PRPRSRSPSSPEL,_S(ph)RS(ph)PSSPELNNK_,S1499,,25.83,25.33,,26.23,21.98,,,,22.18,,,20.12,,23.61,2.22,1.72, ,2.62,-1.63, , , ,-1.43, , ,-3.49, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8777,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RSRSPSSPELNNK,_S(ph)RSPSS(ph)PELNNK_,S1502,,23.99,24.69,24.27,24.65,,,,,,,,,,24.40,-0.41,0.29,-0.13,0.25, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8778,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PATHRRSRSRTPL,_S(ph)RS(ph)RTPLISR_,S1876,+,24.55,24.09,24.09,23.66,23.88,,22.12,22.30,23.28,,,,,23.50,1.05,0.60,0.60,0.17,0.38, ,-1.38,-1.20,-0.22, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8780,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PAIRRRSRSRTPL,_S(ph)RS(ph)RTPLLPR_,S2030,+,23.98,23.70,23.70,22.97,24.31,21.27,22.98,22.49,23.43,23.24,,,,23.21,0.78,0.49,0.49,-0.24,1.10,-1.94,-0.23,-0.72,0.22,0.04, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8785,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TRRRSRSRTSPVT,_S(ph)RTS(ph)PVTR_,S1984,+,24.62,24.76,24.44,25.91,19.13,,19.79,19.83,19.96,,,,,22.31,2.31,2.46,2.14,3.61,-3.18, ,-2.52,-2.47,-2.35, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8792,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KGGRSRSSSPVTE,_S(ph)SS(ph)PVTELAS(ph)RSPIRQDR_,S1101,,28.29,,,20.77,,,,,,,,,,24.53,3.76, , ,-3.76, , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8794,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GRSRSSSPVTELA,_SSS(ph)PVTELASR_,S1103,+,28.99,26.41,25.47,26.78,26.60,25.46,,,,,31.26,,24.11,26.89,2.10,-0.48,-1.41,-0.10,-0.28,-1.42, , , , ,4.38, ,-2.78,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8796,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TELASRSPIRQDR,_SSS(ph)PVTELASRS(ph)PIRQDR_,S1112,,26.62,25.47,25.47,,,,,,,,,,,25.86,0.76,-0.38,-0.38, , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8799,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),TPRRSRSVSPCSN,_S(ph)VS(ph)PCSNVESR_,S952,,26.35,23.75,23.71,24.46,,,,,22.31,,,,,24.12,2.23,-0.36,-0.41,0.34, , , , ,-1.80, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8803,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),AAMNLASPRTAVA,_TPAAAAAMNLAS(ph)PR_,S2272,+,28.45,25.72,24.88,26.55,25.90,25.34,24.92,24.77,25.81,25.94,24.26,24.41,25.28,25.56,2.89,0.17,-0.68,1.00,0.34,-0.22,-0.63,-0.78,0.25,0.39,-1.30,-1.15,-0.28,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8804,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RVSGRTSPPLLDR,_VSGRTS(ph)PPLLDR_,S2398,+,30.78,29.30,24.64,30.25,29.71,30.67,30.82,30.26,30.70,30.05,28.39,30.68,30.62,29.76,1.02,-0.46,-5.12,0.49,-0.05,0.91,1.06,0.50,0.94,0.29,-1.37,0.92,0.86,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8805,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KVKAIISPRQRSH,_VKAIIS(ph)PR_,S924,,,23.08,23.08,,27.08,,,22.93,,,,,,24.04, ,-0.96,-0.96, ,3.04, , ,-1.11, , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
8807,Q9UQ80,PA2G4,Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1),_____MSGEDEQQ,_S(ph)GEDEQQEQT(ph)IAEDLVVTK_,S2,+,28.69,24.42,24.40,24.90,27.60,25.25,26.56,25.54,26.16,27.42,27.06,26.25,26.03,26.18,2.51,-1.75,-1.77,-1.27,1.42,-0.92,0.39,-0.64,-0.02,1.24,0.88,0.07,-0.14,"cell proliferation;cell cycle arrest;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;rRNA processing;regulation of translation",ribonucleoprotein complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
8808,Q9UQ84,EXO1,Exonuclease 1 (hExo1) (EC 3.1.-.-) (Exonuclease I) (hExoI),FRRKSDSPTSLPE,_SDS(ph)PTSLPENNM(ox)SDVSQLK_,S38,,22.24,22.47,22.47,,,,,,,,,,,22.39,-0.15,0.07,0.07, , , , , , , , , , ,mismatch repair;meiosis;humoral immune response mediated by circulating immunoglobulin;isotype switching;somatic hypermutation of immunoglobulin genes;DNA recombination,nucleus,,,,,,,,,,,,,,
8810,Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),AQPKSLSPPQSQS,_SLS(ph)PPQSQSK_,S325,+,23.20,23.93,24.22,,23.50,22.35,,23.23,20.87,23.50,,,,23.10,0.10,0.83,1.12, ,0.40,-0.76, ,0.12,-2.23,0.40, , , ,regulation of actin cytoskeleton organization;filopodium assembly;axonogenesis;dendrite development;insulin receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;response to bacterium,filopodium;cytosol;cell junction;plasma membrane;nucleus;cytoskeleton;ruffle,,,,,,,,,,+,,,,
8811,Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),TLPRSSSMAAGLE,_SSS(ph)M(ox)AAGLER_,S366,+,24.76,24.10,,25.43,,,23.31,23.12,,,22.37,,21.98,23.58,1.18,0.52, ,1.84, , ,-0.27,-0.46, , ,-1.21, ,-1.60,regulation of actin cytoskeleton organization;filopodium assembly;axonogenesis;dendrite development;insulin receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;response to bacterium,filopodium;cytosol;cell junction;plasma membrane;nucleus;cytoskeleton;ruffle,,,,,,,,,,+,,,,
8812,Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),QQGKSSSTGNLLD,_SSS(ph)TGNLLDK_,S454,+,24.90,25.26,24.07,27.37,,,23.59,,25.37,22.99,,25.30,,24.85,0.04,0.40,-0.79,2.52, , ,-1.27, ,0.52,-1.87, ,0.44, ,regulation of actin cytoskeleton organization;filopodium assembly;axonogenesis;dendrite development;insulin receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;response to bacterium,filopodium;cytosol;cell junction;plasma membrane;nucleus;cytoskeleton;ruffle,,,,,,,,,,+,,,,
8815,Q9UQC2,GAB2,GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100),KGSLTGSETDNED,_GSLTGS(ph)ETDNEDVYTFK_,S247,,21.46,,,,,,,,,,,,,21.46,0.00, , , , , , , , , , , , ,positive regulation of mast cell degranulation;positive regulation of cell proliferation;phosphatidylinositol-mediated signaling;osteoclast differentiation,cytosol;plasma membrane,,,,+,,,,,,,,,,
8816,Q9UQC2,GAB2,GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100),DELPFKSPITKSW,_NNTVIDELPFKS(ph)PITK_,S505,,23.84,,,,,,,,,,21.94,,,22.89,0.95, , , , , , , , , ,-0.95, , ,positive regulation of mast cell degranulation;positive regulation of cell proliferation;phosphatidylinositol-mediated signaling;osteoclast differentiation,cytosol;plasma membrane,,,,+,,,,,,,,,,
8819,Q9UQN3,CHMP2B,Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b) (CHMP2b) (Vacuolar protein sorting-associated protein 2-2) (Vps2-2) (hVps2-2),TSKATISDEEIER,_ATIS(ph)DEEIER_,S158,+,27.51,27.21,26.99,28.49,27.73,28.31,28.78,28.45,26.22,26.73,27.86,29.67,27.04,27.77,-0.26,-0.56,-0.78,0.73,-0.04,0.54,1.02,0.68,-1.55,-1.04,0.09,1.90,-0.73,cellular membrane organization;cell death;protein transport;endosomal transport,cytosol;mitochondrion;nucleus;late endosome membrane,,,,,,,,,,,,,,
8820,Q9UQR0,SCML2,Sex comb on midleg-like protein 2,PLVGDISPKSSPH,_SVPGTTSSPLVGDIS(ph)PK_,S105,+,23.12,23.00,23.16,21.94,24.65,23.52,23.49,23.47,22.67,24.27,21.89,,24.19,23.28,-0.16,-0.28,-0.12,-1.34,1.37,0.24,0.21,0.19,-0.61,1.00,-1.39, ,0.91,"anatomical structure morphogenesis;transcription, DNA-dependent",PcG protein complex,,,,,,,,,,,,,,
8822,Q9UQR1,ZNF148,Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89),EEDSGFSTSPKDN,_GGLLTSEEDSGFS(ph)TSPK_,S304,,25.41,24.27,24.27,24.58,21.47,,25.24,23.15,26.34,,24.53,,,24.36,1.05,-0.09,-0.09,0.22,-2.89, ,0.88,-1.21,1.98, ,0.17, , ,negative regulation of transcription from RNA polymerase II promoter;cellular defense response;protein complex assembly;gamete generation;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,Golgi apparatus;nucleus,C2H2-type,,,,,,,,,,,,,
8824,Q9UQR1,ZNF148,Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89),EQNQTISPLSTYE,_(gl)QPLEQNQTIS(ph)PLSTYEESK_,S412,+,25.92,23.25,23.25,22.72,,,23.69,,25.42,25.06,,,22.51,23.98,1.94,-0.73,-0.73,-1.26, , ,-0.29, ,1.45,1.08, , ,-1.47,negative regulation of transcription from RNA polymerase II promoter;cellular defense response;protein complex assembly;gamete generation;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter,Golgi apparatus;nucleus,C2H2-type,,,,,,,,,,,,,
8825,Q9Y232,CDYL,Chromodomain Y-like protein (CDY-like) (EC 2.3.1.48),KILVPKSPVKSRT,_ILVPKS(ph)PVK_,S147,+,22.97,25.27,25.27,22.17,26.04,25.25,22.33,25.14,22.72,22.78,,,24.81,24.07,-1.10,1.20,1.20,-1.90,1.97,1.18,-1.73,1.08,-1.35,-1.29, , ,0.74,"spermatogenesis;histone acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
8826,Q9Y232,CDYL,Chromodomain Y-like protein (CDY-like) (EC 2.3.1.48),DGFQSESPEKLDP,_SRTAVDGFQSES(ph)PEK_,S162,+,27.32,26.98,27.82,25.23,,,26.11,,25.56,27.10,23.78,25.77,24.30,26.00,1.33,0.99,1.82,-0.77, , ,0.11, ,-0.43,1.10,-2.22,-0.22,-1.70,"spermatogenesis;histone acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
8828,Q9Y241,HIGD1A,"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)",STDTGVSLPSYEE,_(ac)STDTGVS(ph)LPSYEEDQGSK_,S8,,22.78,,,,,24.14,,,24.28,25.90,,,23.79,24.18,-1.40, , , , ,-0.04, , ,0.10,1.72, , ,-0.39,negative regulation of apoptotic process;electron transport chain;response to stress,respiratory chain;integral to membrane;mitochondrial inner membrane;protein complex,,,,,,,,,,,,,,
8829,Q9Y241,HIGD1A,"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)",TGVSLPSYEEDQG,_(ac)STDTGVSLPS(ph)YEEDQGSK_,S11,,23.12,,,,,,,,,24.69,,,,23.91,-0.79, , , , , , , , ,0.79, , , ,negative regulation of apoptotic process;electron transport chain;response to stress,respiratory chain;integral to membrane;mitochondrial inner membrane;protein complex,,,,,,,,,,,,,,
8830,Q9Y248,GINS2,DNA replication complex GINS protein PSF2 (GINS complex subunit 2),PLESTQSQDF___,_LRTNLQPLESTQS(ph)QDF_,S182,,23.50,,,,24.39,24.49,,24.53,,,23.87,,24.68,24.25,-0.74, , , ,0.15,0.25, ,0.29, , ,-0.38, ,0.44,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication,nucleoplasm,,,,,,,,,,,,,,
8831,Q9Y253,POLH,DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein),QGDKRLSSLRRCC,_RLS(ph)S(ph)LR_,S295,+,30.90,22.37,22.37,31.25,26.19,23.66,24.50,24.98,24.88,23.84,22.46,22.42,,24.99,5.92,-2.61,-2.61,6.27,1.20,-1.32,-0.48,-0.01,-0.10,-1.15,-2.53,-2.57, ,response to UV-C;regulation of DNA repair;postreplication repair;DNA synthesis involved in DNA repair;DNA replication;pyrimidine dimer repair,nucleoplasm;cytoplasm,,,,,,,,,,,,,,
8832,Q9Y253,POLH,DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein),GDKRLSSLRRCCA,_RLS(ph)S(ph)LR_,S296,+,30.90,22.37,22.37,31.21,26.19,23.66,24.50,24.98,24.88,23.84,22.46,22.42,,24.98,5.92,-2.61,-2.61,6.23,1.21,-1.32,-0.48,-0.01,-0.10,-1.14,-2.52,-2.56, ,response to UV-C;regulation of DNA repair;postreplication repair;DNA synthesis involved in DNA repair;DNA replication;pyrimidine dimer repair,nucleoplasm;cytoplasm,,,,,,,,,,,,,,
8833,Q9Y266,NUDC,Nuclear migration protein nudC (Nuclear distribution protein C homolog),KNGSLDSPGKQDT,_NGSLDS(ph)PGKQDTEEDEEEDEK_,S139,+,24.83,24.69,23.84,25.42,23.24,26.38,27.43,27.13,27.47,26.63,25.62,27.10,25.65,25.80,-0.97,-1.11,-1.96,-0.38,-2.56,0.58,1.63,1.33,1.67,0.83,-0.18,1.30,-0.15,nuclear migration;multicellular organismal development;cell proliferation;response to peptide hormone stimulus;mitotic prometaphase;cytokinesis,nucleoplasm;cytosol;Golgi apparatus;microtubule,,,,,,,,,,,,,,
8834,Q9Y272,RASD1,Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1),KLLRAGSGGGGGD,_AGS(ph)GGGGGDPGDAFGIVAPFAR_,S145,,25.22,,,,,,,,,,,,,25.22,0.00, , , , , , , , , , , , ,"small GTPase mediated signal transduction;nitric oxide mediated signal transduction;negative regulation of transcription, DNA-dependent;G-protein coupled receptor signaling pathway",plasma membrane;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
8835,Q9Y281,CFL2,"Cofilin-2 (Cofilin, muscle isoform)",____MASGVTVND,_(ac)AS(ph)GVTVNDEVIK_,S3,+,,22.71,,24.00,,25.25,24.07,24.04,24.27,22.74,,25.13,23.28,23.95, ,-1.24, ,0.06, ,1.31,0.12,0.10,0.33,-1.20, ,1.18,-0.66,,cytoskeleton;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
8836,Q9Y282,ERGIC3,Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84),KDGIPVSSEAERH,_DGIPVS(ph)SEAERHELGK_,S117,,21.60,24.01,24.01,,,,24.50,,27.32,25.17,24.32,,24.40,24.42,-2.82,-0.41,-0.41, , , ,0.09, ,2.90,0.75,-0.09, ,-0.01,vesicle-mediated transport,integral to membrane;Golgi apparatus;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8838,Q9Y286,SIGLEC7,Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328),TIRGSASQGNLTE,_GSAS(ph)QGNLTESWADDNPR_,S313,,,23.64,,,,,,,,,,,,23.64, ,0.00, , , , , , , , , , , ,cell adhesion,integral to plasma membrane,,,,,,,,,,,,,,
8841,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),SLQVPVSPSSTTS,_DALGDSLQVPVS(ph)PSSTTSSR_,S152,,25.83,27.17,26.85,29.32,29.53,27.40,27.00,28.23,29.91,26.19,28.89,26.85,30.91,28.01,-2.18,-0.83,-1.16,1.31,1.53,-0.61,-1.01,0.22,1.91,-1.81,0.88,-1.16,2.91,,,,,,,,,,,,,,,,
8845,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),FEPPQVSSPVQEK,_PQSM(ox)FEPPQVS(ph)SPVQEK_,S630,,,26.34,,26.07,,22.96,25.39,,21.59,27.20,,26.25,,25.11, ,1.23, ,0.96, ,-2.16,0.28, ,-3.53,2.09, ,1.13, ,,,,,,,,,,,,,,,,
8846,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),EPPQVSSPVQEKR,_DGAEQQGPEATVEEAEAAAFGSEKPQSM(ox)FEPPQVSS(ph)PVQEK_,S631,,,24.98,25.58,26.10,,,23.79,,26.75,,27.64,,,25.81, ,-0.83,-0.22,0.29, , ,-2.02, ,0.94, ,1.83, , ,,,,,,,,,,,,,,,,
8847,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),AAKGQKSPGALET,_S(ph)PGALETPSAAGSQGNTASQGK_,S393,,24.18,27.35,27.47,27.35,24.63,25.12,26.33,25.95,26.91,27.20,27.08,26.43,27.18,26.40,-2.21,0.95,1.07,0.96,-1.77,-1.28,-0.07,-0.45,0.51,0.80,0.68,0.03,0.78,,,,,,,,,,,,,,,,
8848,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),TNPRPPSVGGPPE,_PLTNPRPPS(ph)VGGPPEDSGASAAK_,S375,,20.06,22.79,22.73,22.39,,,22.80,,24.10,24.55,25.06,25.18,,23.29,-3.24,-0.51,-0.56,-0.91, , ,-0.49, ,0.81,1.26,1.76,1.88, ,,,,,,,,,,,,,,,,
8849,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),RKQRTLSMIEEEI,_TLS(ph)M(ox)IEEEIR_,S720,,23.63,20.53,,24.62,24.63,,,,22.03,21.55,24.42,,23.27,23.08,0.55,-2.56, ,1.54,1.54, , , ,-1.05,-1.54,1.33, ,0.18,,,,,,,,,,,,,,,,
8850,Q9Y2D5,AKAP2,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),VLQSTQSPRTKNA,_QVLQSTQS(ph)PR_,S748,,25.92,25.96,26.29,27.15,24.95,24.86,25.44,25.79,27.04,26.65,26.22,24.59,26.74,25.97,-0.04,-0.01,0.32,1.18,-1.02,-1.11,-0.53,-0.18,1.07,0.68,0.25,-1.38,0.77,,,,,,,,,,,,,,,,
8852,Q9Y2D8,SSX2IP,Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein),STGTVISDVEEDA,_ERVDDSTGTVIS(ph)DVEEDAGELSR_,S115,,24.18,,,,23.74,,,,,,,,,23.96,0.22, , , ,-0.22, , , , , , , , ,cell adhesion,nucleus;cell-cell adherens junction;protein complex,,,,,,,,,,,,,,
8853,Q9Y2F5,KIAA0947,Uncharacterized protein KIAA0947,LRLDTGSPEPETR,_LDTGS(ph)PEPETR_,S1854,,24.76,24.52,,25.69,,23.21,,,20.95,,,,,23.83,0.94,0.69, ,1.87, ,-0.62, , ,-2.87, , , , ,,,,,,,,,,,,,,,,
8854,Q9Y2F5,KIAA0947,Uncharacterized protein KIAA0947,AAVKSISPEVSAS,_SIS(ph)PEVSASR_,S925,+,24.09,23.54,23.73,24.02,24.34,,22.76,,,22.22,,21.19,,23.23,0.85,0.31,0.49,0.79,1.10, ,-0.48, , ,-1.02, ,-2.05, ,,,,,,,,,,,,,,,,
8855,Q9Y2G1,MYRF,Myelin regulatory factor (Myelin gene regulatory factor),HPTRAPSPPWPPQ,_APS(ph)PPWPPQGPLSPGPGSLPLSIAR_,S294,,,,,24.69,,,,,,,23.18,,,23.94, , , ,0.75, , , , , , ,-0.75, , ,"positive regulation of transcription, DNA-dependent;positive regulation of myelination;transcription, DNA-dependent;central nervous system myelin maintenance",integral to membrane;nucleus,Other TF domain,,,,,,,,,,,,,
8857,Q9Y2G3,ATP11B,Probable phospholipid-transporting ATPase IF (EC 3.6.3.1) (ATPase IR) (ATPase class VI type 11B),HISRSWSASDPFY,_SWS(ph)ASDPFYTNDR_,S869,,23.72,,,22.30,22.09,,,,22.84,,22.97,,,22.78,0.94, , ,-0.49,-0.70, , , ,0.05, ,0.19, , ,phospholipid translocation;cation transport;aminophospholipid transport,integral to membrane;nuclear inner membrane;endoplasmic reticulum;plasma membrane;recycling endosome;recycling endosome membrane;early endosome,,,,,,,,,,,,,,
8858,Q9Y2H0,DLGAP4,Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4),ASVRQNSATESAD,_QNS(ph)ATESADSIEIYVPEAQTR_,S434,,25.83,,,20.22,,,,,,,,,,23.03,2.81, , ,-2.81, , , , , , , , , ,cell-cell signaling,neuronal cell body;synapse;plasma membrane;dendrite,,,,,,,,,,,,,,
8860,Q9Y2H5,PLEKHA6,Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3),VPPRTKSPTDDEV,_TKS(ph)PTDDEVTPSAVVRR_,S777,+,22.52,26.62,27.52,24.81,26.04,26.13,28.06,26.60,26.47,28.69,26.47,24.59,23.90,26.03,-3.51,0.59,1.49,-1.23,0.01,0.10,2.03,0.57,0.44,2.66,0.43,-1.45,-2.14,,,,,,,,,,,,,,,,
8861,Q9Y2H5,PLEKHA6,Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3),EPDTPLSPEELKE,_YIDLEPDTPLS(ph)PEELKEK_,S940,,,,,,23.56,,,22.97,,,,,,23.27, , , , ,0.29, , ,-0.29, , , , , ,,,,,,,,,,,,,,,,
8862,Q9Y2H6,FNDC3A,Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts),QKDKMSSPPSSPQ,_M(ox)SS(ph)PPSSPQK_,S147,+,,22.32,22.24,22.69,,20.64,22.02,19.54,,21.69,,21.73,21.06,21.55, ,0.77,0.69,1.14, ,-0.91,0.47,-2.01, ,0.14, ,0.18,-0.48,spermatid development;fertilization;Sertoli cell development;cell-cell adhesion,cytosol;acrosomal vesicle;integral to membrane;Golgi apparatus;vesicle membrane;Golgi membrane,,,,,,,,,,,,,,
8864,Q9Y2I7,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase),ARNRSASITNLSL,_SAS(ph)ITNLSLDR_,S307,+,25.33,21.58,21.58,24.55,23.00,23.69,23.19,,,,22.13,25.60,22.86,23.35,1.98,-1.77,-1.77,1.20,-0.35,0.34,-0.16, , , ,-1.22,2.25,-0.49,"protein localization to nucleus;small molecule metabolic process;cellular protein metabolic process;retrograde transport, endosome to Golgi;intracellular signal transduction",membrane raft;late endosome membrane;vesicle membrane;Golgi membrane;perinuclear region of cytoplasm;cytoplasmic vesicle;cytosol;early endosome membrane,,,+,,,,,,,,,,,
8866,Q9Y2J2,EPB41L3,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",LEDDKLSQKSSSS,_(gl)QLEYQQLEDDKLS(ph)QK_,S88,+,22.38,26.83,26.84,25.72,22.98,,22.46,22.56,23.95,25.73,24.75,,23.87,24.37,-1.99,2.46,2.47,1.36,-1.39, ,-1.91,-1.81,-0.42,1.36,0.38, ,-0.50,cortical actin cytoskeleton organization,cell-cell junction;juxtaparanode region of axon;plasma membrane;paranode region of axon;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
8867,Q9Y2J2,EPB41L3,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",RSLDGASVNENHE,_SLDGAS(ph)VNENHEIYM(ox)K_,S448,,,23.41,23.78,22.78,,22.06,22.19,,,,22.56,,22.71,22.78, ,0.63,1.00,-0.01, ,-0.72,-0.60, , , ,-0.22, ,-0.07,cortical actin cytoskeleton organization,cell-cell junction;juxtaparanode region of axon;plasma membrane;paranode region of axon;cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
8869,Q9Y2J4,AMOTL2,Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP),SSQRAASLDSVAT,_AAS(ph)LDSVATSR_,S759,+,22.90,25.12,,25.70,25.36,25.30,24.40,25.20,24.90,22.95,24.56,24.79,25.21,24.70,-1.80,0.42, ,1.00,0.66,0.60,-0.30,0.50,0.21,-1.75,-0.14,0.09,0.51,Wnt receptor signaling pathway;hippo signaling cascade,tight junction;cytosol;cytoplasmic vesicle;apical plasma membrane;recycling endosome,,,,,,,,,,,,,,
8871,Q9Y2J4,AMOTL2,Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP),SSGSGGSPELSAL,_QAGAPGGSSGSGGS(ph)PELSALR_,S540,+,23.16,,,23.57,25.52,23.48,25.07,,23.97,23.52,23.64,,24.03,23.99,-0.83, , ,-0.43,1.52,-0.51,1.07, ,-0.03,-0.48,-0.35, ,0.03,Wnt receptor signaling pathway;hippo signaling cascade,tight junction;cytosol;cytoplasmic vesicle;apical plasma membrane;recycling endosome,,,,,,,,,,,,,,
8873,Q9Y2K6,USP20,Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2),DEGESESEDDDLK,_AVPIAVADEGES(ph)ES(ph)EDDDLKPR_,S134,,24.35,,,,,,,,,,,,,24.35,0.00, , , , , , , , , , , , ,protein K63-linked deubiquitination;regulation of G-protein coupled receptor protein signaling pathway;protein K48-linked deubiquitination;endocytosis;ubiquitin-dependent protein catabolic process,perinuclear region of cytoplasm,,,,,,,,,,,,,,
8874,Q9Y2K7,KDM2A,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),KRKMEESDEEAVQ,_RKM(ox)EES(ph)DEEAVQAK_,S675,+,23.37,24.68,25.48,22.96,23.69,21.76,22.18,22.83,21.96,22.57,21.52,,21.26,22.85,0.51,1.82,2.63,0.11,0.83,-1.10,-0.67,-0.02,-0.89,-0.29,-1.33, ,-1.60,"histone H3-K36 demethylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear chromatin,Other TF domain,,,,,,,,,,,,,
8875,Q9Y2K7,KDM2A,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),VRPAAASPIVSGA,_LTPVRPAAAS(ph)PIVSGAR_,S541,+,22.87,22.04,20.58,21.38,23.30,23.16,23.27,22.40,22.37,23.08,,,22.69,22.47,0.40,-0.43,-1.88,-1.09,0.83,0.69,0.80,-0.07,-0.10,0.62, , ,0.23,"histone H3-K36 demethylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear chromatin,Other TF domain,,,,,,,,,,,,,
8876,Q9Y2K7,KDM2A,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),YEDDGISDDEIEG,_YEDDGIS(ph)DDEIEGK_,S11,+,25.13,23.53,23.53,,24.06,,23.84,,24.42,24.73,,22.99,,24.03,1.10,-0.50,-0.50, ,0.03, ,-0.19, ,0.39,0.70, ,-1.04, ,"histone H3-K36 demethylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear chromatin,Other TF domain,,,,,,,,,,,,,
8877,Q9Y2K7,KDM2A,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),EEEEDDSAEEGGA,_TPQRGDEEGLGGEEEEEEEEEEEDDS(ph)AEEGGAAR_,S852,,23.49,,,,24.35,,,,,,,,,23.92,-0.43, , , ,0.43, , , , , , , , ,"histone H3-K36 demethylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleoplasm;nuclear chromatin,Other TF domain,,,,,,,,,,,,,
8878,Q9Y2L6,FRMD4B,FERM domain-containing protein 4B (GRP1-binding protein GRSP1),IHFRKSSINEQFV,_KSS(ph)INEQFVDTR_,S574,,,,,,,,,23.92,,,23.64,23.30,,23.62, , , , , , , ,0.30, , ,0.02,-0.32, ,establishment of epithelial cell polarity,cytoskeleton;ruffle;cytoplasm,,,,,,,,,,,,,,
8879,Q9Y2R4,DDX52,Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52),FDTRRFSADAARF,_RFS(ph)ADAAR_,S22,,25.12,,,24.85,,,,19.86,,,,22.64,,23.12,2.00, , ,1.73, , , ,-3.26, , , ,-0.47, ,,nucleolus,,,,,,,,,,,,,,
8880,Q9Y2U5,MAP3K2,Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2),RMPRAQSYPDNHQ,_AQS(ph)YPDNHQEFSDYDNPIFEK_,S239,+,,,,,24.22,23.28,25.27,24.80,23.73,23.84,24.16,23.89,,24.15, , , , ,0.08,-0.87,1.12,0.65,-0.42,-0.31,0.01,-0.26, ,"positive regulation of transcription, DNA-dependent;cellular response to mechanical stimulus;activation of JUN kinase activity;activation of MAPKK activity",cytosol;nucleus,,+,,,,,,,,+,,,,
8883,Q9Y2U5,MAP3K2,Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2),ERKKRLSIIGPTS,_RLS(ph)IIGPTSR_,S153,,22.46,21.87,22.17,21.40,,,,,,,22.52,,,22.08,0.37,-0.22,0.09,-0.68, , , , , , ,0.44, , ,"positive regulation of transcription, DNA-dependent;cellular response to mechanical stimulus;activation of JUN kinase activity;activation of MAPKK activity",cytosol;nucleus,,+,,,,,,,,+,,,,
8885,Q9Y2U8,LEMD3,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),SCRENYSDSEEED,_ENYS(ph)DS(ph)EEEDDDDVASSR_,S259,+,25.59,24.56,,,25.27,25.50,24.22,24.35,24.86,25.02,,,23.90,24.81,0.78,-0.25, , ,0.47,0.69,-0.58,-0.46,0.05,0.21, , ,-0.90,negative regulation of activin receptor signaling pathway;regulation of cell cycle;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;negative regulation of BMP signaling pathway,integral to nuclear inner membrane,,,,,,,,,,,,,,
8886,Q9Y2U8,LEMD3,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),RENYSDSEEEDDD,_ENYS(ph)DS(ph)EEEDDDDVASSR_,S261,,27.48,,,24.17,,,,,,,23.82,,,25.16,2.32, , ,-0.99, , , , , , ,-1.34, , ,negative regulation of activin receptor signaling pathway;regulation of cell cycle;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;negative regulation of BMP signaling pathway,integral to nuclear inner membrane,,,,,,,,,,,,,,
8888,Q9Y2U8,LEMD3,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),GFSSDESDVEASP,_VLLGFSSDES(ph)DVEASPR_,S144,,25.43,,,,,,,,,21.16,,,,23.30,2.14, , , , , , , , ,-2.14, , , ,negative regulation of activin receptor signaling pathway;regulation of cell cycle;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;negative regulation of BMP signaling pathway,integral to nuclear inner membrane,,,,,,,,,,,,,,
8890,Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),SRERSPSPLRGNV,_ERS(ph)PS(ph)PLRGNVVPSPLPTR_,S32,,26.91,,,25.45,23.81,23.35,,,,,,,26.87,25.28,1.63, , ,0.17,-1.47,-1.93, , , , , , ,1.60,"regulation of transcription, DNA-dependent;regulation of mRNA stability;intracellular signal transduction",cytosol;P granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
8892,Q9Y2V2,CARHSP1,Calcium-regulated heat stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),PPTHQASVGLLDT,_(ac)SSEPPPPPQPPTHQAS(ph)VGLLDTPR_,S17,,24.14,,,,,,,,,,,,,24.14,0.00, , , , , , , , , , , , ,"regulation of transcription, DNA-dependent;regulation of mRNA stability;intracellular signal transduction",cytosol;P granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
8895,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),SRASAVSELSPRE,_ASAVS(ph)ELS(ph)PR_,S240,,23.52,,,,,,,,,,,,,23.52,0.00, , , , , , , , , , , , ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8897,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),LSPRERSPALKSP,_ERS(ph)PALKSPLQSVVVR_,S248,+,26.24,28.03,28.83,28.05,29.27,28.89,28.97,29.31,30.73,29.56,25.73,26.98,27.07,28.28,-2.04,-0.25,0.54,-0.23,0.99,0.61,0.69,1.03,2.45,1.28,-2.55,-1.31,-1.21,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8898,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),KIKEKGSFSDTGL,_EKGS(ph)FSDTGLGDGK_,S377,,24.97,,,23.21,,,,,21.98,,,,,23.39,1.58, , ,-0.18, , , , ,-1.41, , , , ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8899,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),KEKGSFSDTGLGD,_GSFS(ph)DTGLGDGK_,S379,+,27.46,26.40,26.30,27.94,26.24,27.70,27.26,26.85,27.40,26.38,25.39,26.35,25.63,26.72,0.74,-0.31,-0.42,1.23,-0.47,0.98,0.54,0.13,0.68,-0.33,-1.32,-0.36,-1.08,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8900,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),RSPALKSPLQSVV,_S(ph)PLQSVVVR_,S253,+,28.54,28.51,28.23,28.26,26.94,25.66,28.92,25.80,29.33,28.96,27.41,28.38,25.90,27.76,0.79,0.75,0.47,0.50,-0.81,-2.09,1.16,-1.96,1.57,1.20,-0.35,0.62,-1.85,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8901,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),WAHDKFSGEEGEI,_WAHDKFS(ph)GEEGEIEDDES(ph)GTENREEK_,S928,+,26.65,27.24,27.35,25.86,25.93,26.73,26.96,26.24,27.87,27.96,25.78,26.06,24.87,26.58,0.07,0.66,0.77,-0.72,-0.65,0.15,0.39,-0.33,1.29,1.39,-0.80,-0.52,-1.71,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8902,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),EIEDDESGTENRE,_FSGEEGEIEDDES(ph)GTENREEK_,S939,+,28.23,28.57,28.80,28.11,27.12,30.25,30.01,28.08,30.54,30.17,27.77,27.80,28.87,28.79,-0.56,-0.22,0.00,-0.68,-1.67,1.46,1.21,-0.71,1.74,1.38,-1.02,-1.00,0.07,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8906,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),VNVRMDSFDEDLA,_M(ox)DS(ph)FDEDLARPSGLLAQERK_,S575,+,27.59,23.24,,23.56,26.43,,25.18,23.36,25.33,26.12,25.28,27.55,23.91,25.23,2.35,-1.99, ,-1.67,1.20, ,-0.06,-1.87,0.10,0.89,0.05,2.31,-1.32,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8908,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),EKPFRGSQSPKRY,_TDSEKPFRGS(ph)QS(ph)PK_,S406,+,26.09,26.70,27.39,25.66,21.34,25.59,,,20.99,,,,,24.82,1.26,1.88,2.57,0.84,-3.48,0.77, , ,-3.84, , , , ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8910,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),NYRQAYSPRRGRS,_QAYS(ph)PR_,S119,+,21.68,23.57,24.18,24.75,20.81,21.35,21.44,21.71,22.80,20.32,19.80,22.54,,22.08,-0.40,1.49,2.10,2.67,-1.27,-0.73,-0.64,-0.37,0.72,-1.76,-2.28,0.46, ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8911,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),KSPVGKSPPSTGS,_S(ph)PVGKS(ph)PPSTGSTYGSSQK_,S320,+,26.05,26.83,26.79,27.45,,,,,25.39,25.00,23.18,23.98,,25.58,0.47,1.25,1.21,1.86, , , , ,-0.19,-0.58,-2.41,-1.61, ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8913,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),VVVRRRSPRPSPV,_S(ph)PRPSPVPK_,S264,+,21.06,24.18,23.56,24.05,22.74,22.58,22.67,21.46,23.35,23.19,22.06,22.79,20.31,22.62,-1.55,1.56,0.95,1.44,0.12,-0.03,0.05,-1.15,0.73,0.58,-0.55,0.18,-2.31,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8914,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),LSPSKKSPVGKSP,_S(ph)PVGKS(ph)PPSTGSTYGSSQK_,S315,,25.66,26.03,26.31,26.10,,,,,23.75,21.17,,,,24.84,0.83,1.19,1.48,1.27, , , , ,-1.09,-3.67, , , ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8915,Q9Y2W1,THRAP3,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),SRSRSRSYSPAHN,_S(ph)YS(ph)PAHNRER_,S53,+,24.31,27.01,28.01,23.11,20.44,,19.11,,20.00,18.38,,,,22.55,1.76,4.47,5.46,0.56,-2.11, ,-3.44, ,-2.54,-4.16, , , ,"transcription initiation from RNA polymerase II promoter;nuclear-transcribed mRNA catabolic process;mRNA stabilization;androgen receptor signaling pathway;regulation of alternative mRNA splicing, via spliceosome;positive regulation of transcription from RNA polymerase II promoter;positive regulation of mRNA splicing, via spliceosome",mediator complex,,,,,,,,,,,,,,
8918,Q9Y2W2,WBP11,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),DDDEDDSDDSEAE,_EVEEFSEDDDEDDS(ph)DDS(ph)EAEK_,S361,,24.53,,,,,,,,,,,,,24.53,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing;rRNA processing,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
8919,Q9Y2W2,WBP11,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),EDDSDDSEAEKQS,_EVEEFSEDDDEDDS(ph)DDS(ph)EAEK_,S364,,24.53,,,,,,,,,,,,,24.53,0.00, , , , , , , , , , , , ,mRNA processing;RNA splicing;rRNA processing,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
8920,Q9Y2W2,WBP11,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),DKSDGESDGDEFV,_SDGES(ph)DGDEFVHR_,S283,,22.13,24.77,22.68,,,,,,,21.77,,,,22.84,-0.71,1.93,-0.16, , , , , , ,-1.07, , , ,mRNA processing;RNA splicing;rRNA processing,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
8924,Q9Y2X3,NOP58,Nucleolar protein 58 (Nucleolar protein 5),IKEEPLSEEEPCT,_HIKEEPLS(ph)EEEPCTSTAIASPEK_,S502,+,28.08,26.47,26.75,26.81,24.56,25.94,26.98,24.98,28.57,28.23,25.77,26.76,24.88,26.52,1.56,-0.05,0.23,0.29,-1.96,-0.58,0.46,-1.54,2.05,1.71,-0.75,0.24,-1.64,snRNP protein import into nucleus;cell growth;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;Cajal body;cytoplasm,,,,,,,,,,,,,,
8925,Q9Y2X3,NOP58,Nucleolar protein 58 (Nucleolar protein 5),TSTAIASPEKKKK,_EEPLSEEEPCTSTAIAS(ph)PEK_,S514,,27.16,26.13,26.13,22.44,,,22.66,,,24.80,,,,24.89,2.27,1.24,1.24,-2.45, , ,-2.22, , ,-0.09, , , ,snRNP protein import into nucleus;cell growth;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;Cajal body;cytoplasm,,,,,,,,,,,,,,
8926,Q9Y2X3,NOP58,Nucleolar protein 58 (Nucleolar protein 5),LIAHAGSLLNLAK,_LIAHAGS(ph)LLNLAK_,S304,,,21.80,21.80,21.90,,,,,,,,,,21.83, ,-0.03,-0.03,0.07, , , , , , , , , ,snRNP protein import into nucleus;cell growth;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;Cajal body;cytoplasm,,,,,,,,,,,,,,
8927,Q9Y2X3,NOP58,Nucleolar protein 58 (Nucleolar protein 5),AEEEETSVKKKKK,_VAEEEETS(ph)VKK_,S483,+,,21.00,,22.79,,,23.12,,21.96,24.62,,22.02,21.07,22.37, ,-1.37, ,0.43, , ,0.75, ,-0.41,2.25, ,-0.35,-1.30,snRNP protein import into nucleus;cell growth;rRNA processing,box C/D snoRNP complex;pre-snoRNP complex;Cajal body;cytoplasm,,,,,,,,,,,,,,
8928,Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),KLSRHGSGADSDY,_HGS(ph)GADSDYENTQSGDPLLGLEGK_,S592,+,22.85,,,,,,25.04,24.88,23.13,24.09,25.46,24.02,,24.21,-1.36, , , , , ,0.84,0.67,-1.08,-0.12,1.25,-0.19, ,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,focal adhesion;cytoplasm,,,,,,,,,,,,,,
8929,Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),QGKSLSSPTDNLE,_SLSS(ph)PTDNLELSLR_,S362,+,25.88,,,,25.59,,23.58,,,26.01,24.98,24.38,25.42,25.12,0.76, , , ,0.47, ,-1.54, , ,0.89,-0.14,-0.74,0.30,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,focal adhesion;cytoplasm,,,,,,,,,,,,,,
8930,Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),DQHDYDSVASDED,_SQSDLDDQHDYDS(ph)VAS(ph)DEDTDQEPLR_,S385,,24.46,,,,,,,,,,,,,24.46,0.00, , , , , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,focal adhesion;cytoplasm,,,,,,,,,,,,,,
8931,Q9Y2X7,GIT1,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),DYDSVASDEDTDQ,_SQSDLDDQHDYDS(ph)VAS(ph)DEDTDQEPLR_,S388,+,25.07,,,,25.96,23.36,25.25,25.37,24.26,23.79,24.04,23.58,,24.52,0.55, , , ,1.44,-1.16,0.73,0.85,-0.26,-0.73,-0.48,-0.95, ,regulation of G-protein coupled receptor protein signaling pathway;positive regulation of GTPase activity;regulation of ARF GTPase activity,focal adhesion;cytoplasm,,,,,,,,,,,,,,
8932,Q9Y2Y9,KLF13,Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1),GGSRTGSLSDYSR,_TGS(ph)LSDYSR_,S268,,24.19,,,,,,,,,,23.24,,,23.72,0.48, , , , , , , , , ,-0.48, , ,negative regulation of cell proliferation;transcription from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;negative regulation of erythrocyte differentiation,nucleus,C2H2-type,,,,,,,,,,,,,
8934,Q9Y314,NOSIP,Nitric oxide synthase-interacting protein (eNOS-interacting protein),KALSGTSPDDVQP,_ALSGTS(ph)PDDVQPGPSVGPPSK_,S138,,23.62,22.51,22.51,,,,23.07,22.30,22.55,22.29,,,,22.69,0.93,-0.18,-0.18, , , ,0.38,-0.40,-0.14,-0.40, , , ,negative regulation of nitric-oxide synthase activity;small molecule metabolic process;nitric oxide metabolic process,cytosol;nucleus;Golgi membrane,,,,,,,,,,,,,,
8936,Q9Y342,PLLP,Plasmolipin (Plasma membrane proteolipid),EFPSKVSTRTSSP,_(ac)AEFPSKVS(ph)TR_,S9,,26.90,24.21,23.76,23.10,24.43,23.39,26.37,25.80,23.10,25.75,24.65,29.78,25.21,25.11,1.79,-0.90,-1.35,-2.01,-0.68,-1.72,1.26,0.69,-2.01,0.64,-0.46,4.67,0.10,myelination;response to wounding,compact myelin;membrane raft;integral to membrane,,,,,,,,,,,,,,
8937,Q9Y365,STARD10,PCTP-like protein (PCTP-L) (Antigen NY-CO-28) (START domain-containing protein 10) (StARD10) (Serologically defined colon cancer antigen 28) (StAR-related lipid transfer protein 10),GAGGEGSDDDTSL,_M(ox)GGAGGEGS(ph)DDDTSLT_,S238,,23.42,,,,,22.48,,22.53,22.48,,,,,22.73,0.69, , , , ,-0.25, ,-0.20,-0.25, , , , ,lipid transport,flagellum;membrane;cytoplasm,,,,,,,,,,,,,,
8939,Q9Y383,LUC7L2,Putative RNA-binding protein Luc7-like 2,RSEDRRSSEEREA,_S(ph)SEEREAGEI_,S383,,26.43,,,24.49,,,,,21.15,,,,,24.02,2.41, , ,0.47, , , , ,-2.87, , , , ,,nuclear speck,,,,,,,,,,,,,,
8940,Q9Y385,UBE2J1,Ubiquitin-conjugating enzyme E2 J1 (EC 6.3.2.19) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),ELARQISFKAEVN,_ELARQIS(ph)FK_,S184,,19.20,25.13,25.13,,,,,,,22.77,,,,23.06,-3.85,2.07,2.07, , , , , , ,-0.29, , , ,ER-associated protein catabolic process;protein N-linked glycosylation via asparagine,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,+,,,,
8942,Q9Y388,RBMX2,"RNA-binding motif protein, X-linked 2",QAEQPSSSSPRRK,_EKADREVQAEQPSS(ph)SSPR_,S186,+,21.34,22.87,22.87,25.49,,23.63,22.82,23.90,22.96,21.52,21.01,,,22.84,-1.50,0.02,0.02,2.65, ,0.79,-0.02,1.06,0.12,-1.32,-1.83, , ,,,,,,,,,,,,,,,,
8944,Q9Y388,RBMX2,"RNA-binding motif protein, X-linked 2",EQPSSSSPRRKTV,_ADREVQAEQPSSSS(ph)PR_,S188,+,22.53,24.12,23.48,24.48,23.89,22.26,22.58,22.67,25.38,22.64,22.79,22.77,21.30,23.14,-0.61,0.97,0.34,1.34,0.74,-0.88,-0.57,-0.47,2.23,-0.50,-0.36,-0.37,-1.85,,,,,,,,,,,,,,,,
8945,Q9Y3B3,TMED7,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),LLKSFFSDKRTTT,_SFFS(ph)DKR_,S213,,22.36,,,,20.48,21.30,21.23,,20.85,21.93,21.06,21.49,22.27,21.44,0.92, , , ,-0.96,-0.14,-0.21, ,-0.59,0.49,-0.38,0.05,0.83,protein transport,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;endoplasmic reticulum;endoplasmic reticulum-Golgi intermediate compartment membrane;COPII vesicle coat;COPI vesicle coat;endoplasmic reticulum membrane,,,,,,,,,,,,,,
8947,Q9Y3B9,RRP15,RRP15-like protein (Ribosomal RNA-processing protein 15),APDSRVSEEENLK,_(ac)AAAAPDSRVS(ph)EEENLK_,S11,+,22.64,23.95,24.49,25.00,25.09,24.27,25.62,25.41,24.44,24.76,23.16,25.51,23.65,24.46,-1.82,-0.51,0.02,0.54,0.62,-0.19,1.16,0.95,-0.02,0.30,-1.30,1.05,-0.81,,mitochondrion;nucleolus,,,,,,,,,,,,,,
8948,Q9Y3B9,RRP15,RRP15-like protein (Ribosomal RNA-processing protein 15),EKDHFYSDDDAIE,_DHFYS(ph)DDDAIEADS(ph)EGDAEPCDK_,S58,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,,mitochondrion;nucleolus,,,,,,,,,,,,,,
8949,Q9Y3B9,RRP15,RRP15-like protein (Ribosomal RNA-processing protein 15),DAIEADSEGDAEP,_DHFYS(ph)DDDAIEADS(ph)EGDAEPCDK_,S67,,23.66,,,,,,,,,,,,,23.66,0.00, , , , , , , , , , , , ,,mitochondrion;nucleolus,,,,,,,,,,,,,,
8950,Q9Y3B9,RRP15,RRP15-like protein (Ribosomal RNA-processing protein 15),PESASDSDT____,_DWDKESDGPDDSRPESASDS(ph)DT_,S280,+,21.48,22.87,,22.62,24.53,,23.21,23.08,24.10,24.46,,21.51,,23.10,-1.62,-0.23, ,-0.47,1.44, ,0.11,-0.02,1.01,1.37, ,-1.58, ,,mitochondrion;nucleolus,,,,,,,,,,,,,,
8952,Q9Y3E1,HDGFRP3,Hepatoma-derived growth factor-related protein 3 (HRP-3) (Hepatoma-derived growth factor 2) (HDGF-2),KEEENKSSSEGGD,_S(ph)SSEGGDAGNDTRNTTSDLQK_,S178,,,24.14,24.14,,,,23.66,,24.84,23.75,,22.86,,23.90, ,0.24,0.24, , , ,-0.23, ,0.94,-0.15, ,-1.04, ,cell proliferation,nucleus;cytoplasm,,,,,,,,,,,,,,
8955,Q9Y3E7,CHMP3,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24),PGAMAASEDEEEE,_VTDALPEPEPPGAM(ox)AAS(ph)EDEEEEEEALEAM(ox)QSR_,S160,,25.74,,,,,,,,,,,,,25.74,0.00, , , , , , , , , , , , ,endosome to lysosome transport;endosomal transport;cellular membrane organization;protein transport;regulation of endosome size;apoptotic process;cell cycle;cytokinesis,cytosol;midbody;late endosome membrane;early endosome,,,,,,,,,,,,,,
8956,Q9Y3M2,CBY1,"Protein chibby homolog 1 (ARPP-binding protein) (Cytosolic leucine-rich protein) (PIGEA-14) (PKD2 interactor, Golgi and endoplasmic reticulum-associated 1)",PPRKSASLSNLHS,_SAS(ph)LSNLHSLDR_,S20,+,,22.96,,23.95,21.83,25.73,24.75,25.26,22.05,21.61,23.17,24.63,24.70,23.69, ,-0.73, ,0.25,-1.87,2.03,1.05,1.57,-1.64,-2.08,-0.52,0.94,1.00,"fat cell differentiation;protein localization;negative regulation of canonical Wnt receptor signaling pathway;negative regulation of Wnt receptor signaling pathway;negative regulation of transcription, DNA-dependent;cilium assembly;cardiac muscle cell differentiation",trans-Golgi network;nuclear speck;Golgi apparatus;nucleus;microtubule basal body,,,,,,,,,,,,,,
8957,Q9Y3M8,STARD13,StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13),TFPKALSIESLSP,_ALS(ph)IESLSPTDSSNGVNWR_,S293,,,,,22.22,23.50,,,22.77,,,,,,22.83, , , ,-0.61,0.67, , ,-0.06, , , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol;lipid particle;mitochondrial membrane,,,,,,,,,,,,,,
8958,Q9Y3M9,ZNF337,Zinc finger protein 337,CKDCERSFSQKST,_DCERS(ph)FSQK_,S283,,24.37,26.55,27.50,27.25,26.18,,,,,,,,,26.37,-2.00,0.18,1.13,0.88,-0.20, , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
8959,Q9Y3Q8,TSC22D4,TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1),ASLVHKSPDPFGA,_S(ph)PDPFGAVAAQK_,S279,,25.28,23.88,23.88,24.12,,,24.53,,,,,24.77,,24.41,0.87,-0.53,-0.53,-0.29, , ,0.12, , , , ,0.36, ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;response to osmotic stress",nucleus;cytoplasm,,,,,,,,,,,,,,
8962,Q9Y3R0,GRIP1,Glutamate receptor-interacting protein 1 (GRIP-1),LAVRRQSIPEEFK,_RQS(ph)IPEEFK_,S69,+,23.78,24.49,,22.91,,23.59,,,25.90,25.79,25.56,25.56,,24.69,-0.92,-0.21, ,-1.78, ,-1.11, , ,1.20,1.09,0.86,0.86, ,"positive regulation of transcription, DNA-dependent;protein localization;synaptic transmission;androgen receptor signaling pathway;intracellular signal transduction",membrane raft;endoplasmic reticulum;cytosol;neuron projection;cell junction;cytoplasmic membrane-bounded vesicle;plasma membrane;postsynaptic membrane,,,,,,,,,,,,,,
8963,Q9Y3R5,DOPEY2,Protein dopey-2,SLVRVDSDKTQAS,_LSLVRVDS(ph)DK_,S1183,,21.56,21.63,21.63,,,,,,,23.69,,21.83,,22.07,-0.51,-0.44,-0.44, , , , , , ,1.62, ,-0.24, ,multicellular organismal development;endoplasmic reticulum organization;protein transport;Golgi to endosome transport,Golgi membrane,,,,,,,,,,,,,,
8964,Q9Y3S1,WNK2,Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43),RPSRAGSLGPETP,_AGS(ph)LGPETPSR_,S1852,,23.44,,,,,,,,,,,,,23.44,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;negative regulation of cell proliferation;protein autophosphorylation;positive regulation of sodium ion transmembrane transporter activity;negative regulation of ERK1 and ERK2 cascade;regulation of ion homeostasis,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
8965,Q9Y3T6,R3HCC1,R3H and coiled-coil domain-containing protein 1,MATRFGSTLQLDL,_FGS(ph)TLQLDLEK_,S49,,20.29,,,22.79,,,22.19,,,,,23.34,,22.15,-1.86, , ,0.64, , ,0.04, , , , ,1.19, ,,,,,,,,,,,,,,,,
8966,Q9Y3T9,NOC2L,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),DLFDLNSSEEDDT,_DLFDLNS(ph)SEEDDTEGFSER_,S672,,24.00,,,,,,,,,,,,,24.00,0.00, , , , , , , , , , , , ,"cellular response to UV;nucleolus to nucleoplasm transport;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone acetylation;apoptotic process;transcription, DNA-dependent;negative regulation of B cell apoptotic process",nucleoplasm;chromatin assembly complex;nucleolus,,,,,,,,,,,,,,
8967,Q9Y3T9,NOC2L,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),LFDLNSSEEDDTE,_DLFDLNSS(ph)EEDDTEGFSER_,S673,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"cellular response to UV;nucleolus to nucleoplasm transport;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone acetylation;apoptotic process;transcription, DNA-dependent;negative regulation of B cell apoptotic process",nucleoplasm;chromatin assembly complex;nucleolus,,,,,,,,,,,,,,
8969,Q9Y3T9,NOC2L,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),PDKPGGSPSASRR,_SPDKPGGS(ph)PSASR_,S56,+,19.64,22.00,,23.33,20.51,20.19,21.13,,19.79,,19.59,,20.06,20.69,-1.05,1.30, ,2.63,-0.18,-0.50,0.44, ,-0.91, ,-1.10, ,-0.64,"cellular response to UV;nucleolus to nucleoplasm transport;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone acetylation;apoptotic process;transcription, DNA-dependent;negative regulation of B cell apoptotic process",nucleoplasm;chromatin assembly complex;nucleolus,,,,,,,,,,,,,,
8970,Q9Y3X0,CCDC9,Coiled-coil domain-containing protein 9,ETPQPTSPETSPK,_EGAASPAPETPQPTS(ph)PETSPK_,S368,+,27.29,25.44,26.23,25.03,25.34,24.10,24.86,25.02,25.74,25.77,25.71,24.31,25.08,25.38,1.91,0.06,0.85,-0.35,-0.04,-1.28,-0.52,-0.36,0.36,0.39,0.33,-1.07,-0.30,,,,,,,,,,,,,,,,
8971,Q9Y3X0,CCDC9,Coiled-coil domain-containing protein 9,PTSPETSPKETPM,_EGAASPAPETPQPTS(ph)PETS(ph)PK_,S372,,24.70,23.75,23.75,,,,,,,,,,,24.07,0.63,-0.32,-0.32, , , , , , , , , , ,,,,,,,,,,,,,,,,
8972,Q9Y3Z3,SAMHD1,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1),SAEADWSPGLELH,_TPSNTPSAEADWS(ph)PGLELHPDYK_,S33,,25.47,,,24.46,26.03,24.40,,26.03,24.25,,,,,25.11,0.37, , ,-0.64,0.93,-0.71, ,0.92,-0.86, , , , ,defense response to virus;regulation of innate immune response;immune response;metabolic process;innate immune response,nucleus,,,,,,,,,,,,,,
8974,Q9Y426,C2CD2,C2 domain-containing protein 2,IIISGISKVPSWW,_STIIISGIS(ph)K_,S364,,22.04,,,,,,,,23.20,,,,,22.62,-0.58, , , , , , , ,0.58, , , , ,,cytosol;extracellular region;nucleus,,,,,,,,,,,,,,
8975,Q9Y446,PKP3,Plakophilin-3,ADYDTLSLRSLRL,_ADYDTLS(ph)LR_,S180,,27.27,20.60,,,,,,,,,,,,23.93,3.33,-3.33, , , , , , , , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8976,Q9Y446,PKP3,Plakophilin-3,DTLSLRSLRLGPG,_ADYDTLS(ph)LRS(ph)LR_,S183,,24.14,,,,,,,,,,,,,24.14,0.00, , , , , , , , , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8977,Q9Y446,PKP3,Plakophilin-3,PEATEVSPSRTIR,_AGGLDWPEATEVS(ph)PSR_,S238,,27.68,22.60,22.85,,24.44,,,,,,,,,24.39,3.29,-1.79,-1.54, ,0.04, , , , , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8978,Q9Y446,PKP3,Plakophilin-3,PVARAPSVRSLSL,_GVGGAVPGAVLEPVARAPS(ph)VR_,S280,,23.06,,,,,,,,,,,,,23.06,0.00, , , , , , , , , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8979,Q9Y446,PKP3,Plakophilin-3,RTLQRLSSGFDDI,_TLQRLS(ph)S(ph)GFDDIDLPSAVK_,S313,,25.16,,,,25.37,,,23.34,,,,,,24.62,0.53, , , ,0.75, , ,-1.29, , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8980,Q9Y446,PKP3,Plakophilin-3,TLQRLSSGFDDID,_LSS(ph)GFDDIDLPSAVK_,S314,,30.70,,,,25.45,,,21.90,,,,,,26.02,4.68, , , ,-0.56, , ,-4.12, , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8982,Q9Y446,PKP3,Plakophilin-3,ASWSSRSAVDLSC,_S(ph)AVDLSCSR_,S123,,25.06,,,,,,,,,,,,,25.06,0.00, , , , , , , , , , , , ,cell adhesion,cell-cell junction;nucleus;desmosome,,,,,,,,,,,,,,
8984,Q9Y450,HBS1L,HBS1-like protein (ERFS),PSVRLSSTDSLES,_LSS(ph)TDSLESLLSK_,S246,,23.23,,,,,,,,,,,,,23.23,0.00, , , , , , , , , , , , ,signal transduction;translation;GTP catabolic process,,,,,,,,,,,,,,,
8985,Q9Y478,PRKAB1,5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb),PKILMDSPEDADL,_ILM(ox)DS(ph)PEDADLFHSEEIK_,S40,,22.83,,,,,,,,,,,,,22.83,0.00, , , , , , , , , , , , ,protein heterooligomerization;insulin receptor signaling pathway;cell cycle arrest;regulation of fatty acid oxidation;regulation of catalytic activity;fatty acid biosynthetic process,cytosol;AMP-activated protein kinase complex;nucleus,,,,,,,,,,,,,,
8986,Q9Y485,DMXL1,DmX-like protein 1 (X-like 1 protein),PFYRASSFLDTSK,_ASS(ph)FLDTSK_,S1723,,24.37,23.99,24.07,23.82,,,,,,22.12,,,,23.67,0.70,0.32,0.39,0.14, , , , , ,-1.55, , , ,,,,,,,,,,,,,,,,
8987,Q9Y485,DMXL1,DmX-like protein 1 (X-like 1 protein),SPEKILSPFSQKY,_ILS(ph)PFSQK_,S751,,20.90,21.01,21.01,,,,,,20.42,23.01,21.60,,20.71,21.24,-0.34,-0.23,-0.23, , , , , ,-0.82,1.78,0.36, ,-0.52,,,,,,,,,,,,,,,,
8993,Q9Y490,TLN1,Talin-1,MLEDSVSPKKSTV,_DHFGLEGDEESTM(ox)LEDSVS(ph)PKK_,S425,+,,24.67,24.67,23.16,25.35,22.97,27.53,27.06,25.79,24.69,26.02,27.09,25.68,25.39, ,-0.72,-0.72,-2.23,-0.04,-2.42,2.14,1.67,0.40,-0.70,0.63,1.70,0.29,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,,,,,,+,,,,
8995,Q9Y490,TLN1,Talin-1,ASKRLLSDSLPPS,_RLLS(ph)DSLPPSTGTFQEAQSR_,S1225,,21.87,,,,25.37,23.14,25.01,25.45,25.17,,,24.15,,24.31,-2.44, , , ,1.06,-1.17,0.70,1.14,0.86, , ,-0.16, ,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,,,,,,+,,,,
8997,Q9Y490,TLN1,Talin-1,VQNAAGSQEKLAQ,_VLVQNAAGS(ph)QEK_,S2040,+,22.86,26.52,25.08,27.84,23.99,23.24,24.15,25.71,23.97,22.26,,23.39,21.99,24.25,-1.39,2.27,0.83,3.59,-0.26,-1.01,-0.10,1.46,-0.28,-1.99, ,-0.86,-2.26,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,,,,,,+,,,,
8998,Q9Y490,TLN1,Talin-1,MVTNVTSLLKTVK,_VM(ox)VTNVTS(ph)LLK_,S2127,,,21.25,20.77,22.40,,21.34,21.70,22.38,21.80,19.96,21.42,,,21.45, ,-0.20,-0.68,0.96, ,-0.11,0.25,0.93,0.35,-1.49,-0.02, , ,platelet degranulation;platelet activation;cortical actin cytoskeleton organization;cell-cell junction assembly;axon guidance;activation of signaling protein activity involved in unfolded protein response;cell adhesion;cell-substrate junction assembly;cytoskeletal anchoring at plasma membrane;muscle contraction;cellular component movement,intracellular membrane-bounded organelle;centrosome;actin cytoskeleton;ruffle membrane;cell-cell junction;cytosol;extracellular vesicular exosome;focal adhesion;plasma membrane;ruffle,,,,,,,,,,+,,,,
8999,Q9Y496,KIF3A,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),EKLLEESNMELEE,_LLEES(ph)NM(ox)ELEERR_,S500,,22.72,,,,,,,,,,,,,22.72,0.00, , , , , , , , , , , , ,smoothened signaling pathway;kidney development;in utero embryonic development;organelle organization;dorsal/ventral neural tube patterning;blood coagulation;anterior/posterior pattern specification;plus-end-directed vesicle transport along microtubule;cilium assembly;heart development;determination of left/right symmetry;antigen processing and presentation of exogenous peptide antigen via MHC class II,spindle microtubule;cytosol;kinesin II complex;centrosome;primary cilium;photoreceptor connecting cilium,,,,,,,,,,,,,,
9000,Q9Y496,KIF3A,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),TGRRKRSAKPETV,_S(ph)AKPETVIDSLLQ_,S687,,22.37,,,,,,,,,,,,,22.37,0.00, , , , , , , , , , , , ,smoothened signaling pathway;kidney development;in utero embryonic development;organelle organization;dorsal/ventral neural tube patterning;blood coagulation;anterior/posterior pattern specification;plus-end-directed vesicle transport along microtubule;cilium assembly;heart development;determination of left/right symmetry;antigen processing and presentation of exogenous peptide antigen via MHC class II,spindle microtubule;cytosol;kinesin II complex;centrosome;primary cilium;photoreceptor connecting cilium,,,,,,,,,,,,,,
9001,Q9Y4A5,TRRAP,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),VFGRSQSLPGADS,_SQS(ph)LPGADSLLAKPIDK_,S1798,+,25.12,23.55,23.55,20.97,,21.57,21.61,,22.95,23.20,,,,22.82,2.30,0.74,0.74,-1.85, ,-1.25,-1.21, ,0.14,0.39, , , ,"mitotic cell cycle checkpoint;histone H2A acetylation;histone deubiquitination;histone H4 acetylation;transcription, DNA-dependent;regulation of transcription, DNA-dependent",transcription factor TFTC complex;PCAF complex;STAGA complex;NuA4 histone acetyltransferase complex,,+,,,,,,,,,,,,
9002,Q9Y4B5,SOGA2,Protein SOGA2 (Coiled-coil domain-containing protein 165),GPVGGESDSEEMF,_REGPVGGES(ph)DSEEM(ox)FEK_,S416,,,,,21.28,,,26.09,25.16,24.40,26.16,23.64,,,24.46, , , ,-3.17, , ,1.63,0.71,-0.05,1.70,-0.81, , ,,,,,,,,,,,,,,,,
9004,Q9Y4B6,VPRBP,Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein),KLGFSSSDPDRMF,_LGFSSS(ph)DPDR_,S289,,22.30,,,,,,,,,,,,,22.30,0.00, , , , , , , , , , , , ,virus-host interaction;protein ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
9009,Q9Y4E1,FAM21C,WASH complex subunit FAM21C (Vaccinia virus penetration factor) (VPEF),TQKGLFSDEEDSE,_GLFS(ph)DEEDSEDLFSSQSASNLK_,S539,,22.66,,,,,,,,,,,,,22.66,0.00, , , , , , , , , , , , ,"retrograde transport, endosome to Golgi",plasma membrane;WASH complex;early endosome membrane;early endosome,,,,,,,,,,,,,,
9010,Q9Y4E8,USP15,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4),STLPKISPSSLSN,_IS(ph)PSSLSNNYNNM(ox)NNR_,S242,,,,,22.82,,,22.80,,,,,,,22.81, , , ,0.01, , ,-0.01, , , , , , ,transforming growth factor beta receptor signaling pathway;monoubiquitinated protein deubiquitination;BMP signaling pathway;pathway-restricted SMAD protein phosphorylation;negative regulation of transforming growth factor beta receptor signaling pathway;ubiquitin-dependent protein catabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
9011,Q9Y4E8,USP15,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4),GPSTPKSPGASNF,_S(ph)PGASNFSTLPK_,S229,+,26.78,25.79,25.79,26.20,,24.13,26.29,,24.90,25.00,25.48,,24.19,25.46,1.33,0.34,0.34,0.75, ,-1.33,0.83, ,-0.55,-0.45,0.02, ,-1.27,transforming growth factor beta receptor signaling pathway;monoubiquitinated protein deubiquitination;BMP signaling pathway;pathway-restricted SMAD protein phosphorylation;negative regulation of transforming growth factor beta receptor signaling pathway;ubiquitin-dependent protein catabolic process,nucleus;cytoplasm,,,,,,,,,,,,,,
9012,Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",QRPTPGSRLGAPE,_(ac)GEIEQRPTPGS(ph)R_,S12,,24.67,24.75,,23.76,,,,,,,,,,24.39,0.28,0.36, ,-0.63, , , , , , , , , ,regulation of Rho protein signal transduction;negative regulation of phosphatase activity,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
9014,Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",TAADQESEDDLSA,_SPDEATAADQES(ph)EDDLSASR_,S889,+,24.09,25.41,24.39,25.04,,21.68,24.38,,26.05,27.84,25.45,25.04,,24.94,-0.85,0.47,-0.55,0.10, ,-3.26,-0.55, ,1.11,2.91,0.51,0.11, ,regulation of Rho protein signal transduction;negative regulation of phosphatase activity,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
9019,Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",PEFLASSPPDNKS,_SSSPAPEFLASS(ph)PPDNK_,S872,+,23.22,23.32,23.56,22.47,,,,,24.30,27.65,24.64,24.04,,24.15,-0.93,-0.83,-0.59,-1.68, , , , ,0.14,3.50,0.49,-0.11, ,regulation of Rho protein signal transduction;negative regulation of phosphatase activity,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
9021,Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",EPGSHPSPAPRRS,_VSAGEPGSHPS(ph)PAPR_,S427,+,25.15,25.13,25.13,24.40,26.14,25.70,23.50,24.44,26.15,26.79,23.38,23.43,22.00,24.72,0.43,0.41,0.41,-0.31,1.42,0.98,-1.21,-0.28,1.43,2.07,-1.34,-1.29,-2.72,regulation of Rho protein signal transduction;negative regulation of phosphatase activity,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
9022,Q9Y4F3,KIAA0430,Meiosis arrest female protein 1 (Limkain-b1),WLLRSKSPVGNPQ,_S(ph)PVGNPQLIQFSR_,S695,+,22.69,22.41,22.99,23.97,24.13,24.19,23.28,24.39,23.25,24.40,24.09,22.41,23.40,23.51,-0.82,-1.09,-0.52,0.46,0.62,0.68,-0.23,0.88,-0.26,0.90,0.58,-1.10,-0.10,regulation of gene expression;cell differentiation;female meiosis;negative regulation of phosphatase activity;oogenesis,peroxisome,,,,,,,,,,,,,,
9023,Q9Y4F4,FAM179B,Protein FAM179B,LHKAGESNTFIRE,_AGES(ph)NT(ph)FIREDVDK_,S376,,,,,27.49,,22.78,25.93,,25.47,,,25.35,22.85,24.98, , , ,2.51, ,-2.20,0.95, ,0.49, , ,0.37,-2.13,,,,,,,,,,,,,,,,
9025,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),HEDGTQSDSEDPL,_HEDGTQS(ph)DSEDPLAK_,S290,+,23.42,23.45,23.95,23.52,,23.31,24.30,,23.73,24.16,22.42,23.31,,23.56,-0.14,-0.10,0.39,-0.04, ,-0.25,0.74, ,0.17,0.61,-1.14,-0.25, ,,microtubule;cytoplasm,,,,,,,,,,,,,,
9026,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),ARLGDASDTEAAD,_LGDAS(ph)DTEAADGER_,S1065,+,25.25,23.48,22.21,24.82,24.11,23.68,23.06,23.07,,,22.29,,22.69,23.47,1.79,0.02,-1.26,1.35,0.64,0.21,-0.41,-0.39, , ,-1.17, ,-0.77,,microtubule;cytoplasm,,,,,,,,,,,,,,
9027,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),VFGVLESPELSRA,_M(ox)IDQVFGVLES(ph)PELSR_,S527,,24.51,,,,,,,,,,,,,24.51,0.00, , , , , , , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
9028,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),SGKSGPSPTTPQP,_SGPS(ph)PTTPQPLR_,S902,,23.64,22.45,,22.21,21.80,22.30,,,,,,,,22.48,1.16,-0.03, ,-0.27,-0.68,-0.18, , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
9029,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),QLRPGRSPEPDGP,_S(ph)PEPDGPAPAFLR_,S783,,22.58,,,,,,,,,,,,,22.58,0.00, , , , , , , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
9030,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),QDSRRRSPQEGPT,_S(ph)PQEGPTWSR_,S702,,22.50,,,,,,,,,,,,,22.50,0.00, , , , , , , , , , , , ,,microtubule;cytoplasm,,,,,,,,,,,,,,
9031,Q9Y4F9,FAM65B,Protein FAM65B,GIIRSQSFAGFSG,_SQS(ph)FAGFSGLQER_,S21,+,25.73,24.25,,24.74,23.02,,25.19,24.39,,,23.27,24.48,,24.38,1.35,-0.14, ,0.36,-1.36, ,0.80,0.01, , ,-1.12,0.10, ,cell differentiation;muscle organ development,filopodium;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
9032,Q9Y4G2,PLEKHM1,Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162),VVSSPTSPKNKSW,_LVVSSPTS(ph)PK_,S346,+,21.96,24.60,24.60,24.46,22.02,,23.19,24.40,22.92,23.63,24.32,23.18,,23.57,-1.61,1.03,1.03,0.88,-1.55, ,-0.39,0.83,-0.65,0.06,0.75,-0.39, ,intracellular signal transduction,cytoplasm,,,,,,,,,,,,,,
9033,Q9Y4G8,RAPGEF2,Rap guanine nucleotide exchange factor 2 (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF),PVKSETSPVAPRA,_SETS(ph)PVAPR_,S128,+,22.11,24.55,22.96,26.87,,21.91,,21.38,22.88,21.64,22.79,,,23.01,-0.90,1.54,-0.05,3.86, ,-1.10, ,-1.63,-0.13,-1.37,-0.22, , ,MAPK cascade;regulation of synaptic plasticity;small GTPase mediated signal transduction;cAMP-mediated signaling,intracellular;integral to plasma membrane,,,,,,,,,,,,,,
9034,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),ASSPAESSPEDSG,_ASSPAES(ph)SPEDSGYM(ox)R_,S736,,23.35,24.22,23.16,26.15,23.81,,,,,,24.40,,,24.18,-0.83,0.04,-1.02,1.97,-0.37, , , , , ,0.22, , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9035,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),SSPAESSPEDSGY,_ASSPAESS(ph)PEDSGYM(ox)R_,S737,+,,23.63,23.63,26.25,,25.01,24.43,25.31,23.76,,,23.58,23.39,24.33, ,-0.70,-0.70,1.92, ,0.67,0.10,0.98,-0.57, , ,-0.76,-0.94,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9036,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),RATFSGSAGRLCP,_ATFSGS(ph)AGR_,S609,+,20.18,,,26.82,,20.49,,20.86,,,20.87,21.59,,21.80,-1.62, , ,5.02, ,-1.31, ,-0.94, , ,-0.94,-0.21, ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9037,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),PSCPASSPKVAYH,_LCPSCPASS(ph)PK_,S621,,19.35,,,26.20,22.57,,,,,,,,,22.70,-3.36, , ,3.50,-0.14, , , , , , , , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9038,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),PVSVAGSPLSPGP,_PVSVAGS(ph)PLS(ph)PGPVRAPLSR_,S389,,21.70,,,,,,,,,,,,,21.70,0.00, , , , , , , , , , , , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9039,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),VAGSPLSPGPVRA,_PVSVAGS(ph)PLS(ph)PGPVRAPLSR_,S392,,21.70,,,,,,,,,,,,,21.70,0.00, , , , , , , , , , , , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9042,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),PQPSSASLDEYTL,_QRPVPQPSSAS(ph)LDEYTLM(ox)R_,S595,+,24.72,25.43,25.22,27.06,27.24,27.40,26.70,27.67,26.22,26.02,28.25,27.37,27.24,26.66,-1.94,-1.23,-1.43,0.40,0.59,0.74,0.04,1.01,-0.43,-0.64,1.59,0.72,0.58,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9043,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),SDSRQRSPLSDYM,_(gl)QRS(ph)PLSDYM(ox)NLDFSSPK_,S974,+,23.36,,,24.08,22.86,24.04,,24.22,23.36,,24.72,,24.50,23.89,-0.53, , ,0.18,-1.03,0.15, ,0.33,-0.53, ,0.83, ,0.60,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9044,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),RSYRRVSGDAAQD,_RVS(ph)GDAAQDLDRGLR_,S561,+,25.85,27.59,,29.67,27.24,27.27,26.24,28.37,25.33,,27.33,26.98,23.47,26.85,-1.00,0.74, ,2.82,0.40,0.42,-0.61,1.53,-1.52, ,0.48,0.13,-3.38,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9045,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),DDYMPMSPASVSA,_SDDYM(ox)PM(ox)S(ph)PASVSAPK_,S680,,24.14,,,25.12,,,,23.43,,,23.52,,,24.05,0.09, , ,1.07, , , ,-0.62, , ,-0.53, , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9046,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),MPMSPASVSAPKQ,_SDDYM(ox)PM(ox)SPAS(ph)VSAPK_,S683,,23.98,21.96,,24.78,22.19,23.25,,,,,,22.43,23.66,23.18,0.80,-1.22, ,1.60,-0.99,0.07, , , , , ,-0.75,0.49,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9048,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),LPPEPKSPGEYIN,_S(ph)PGEYINIDFGEPGAR_,S916,,22.61,,,20.98,,21.59,,,,,,,,21.73,0.88, , ,-0.75, ,-0.14, , , , , , , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9049,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),FRPRSKSQSSGSS,_S(ph)QSSGSSATHPISVPGAR_,S307,,21.92,,,24.25,,,22.14,,,,,23.52,,22.96,-1.04, , ,1.30, , ,-0.82, , , , ,0.56, ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9052,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),CRVRTASEGDGGA,_TAS(ph)EGDGGAAAGAAAAGAR_,S366,+,23.64,24.76,,26.23,22.35,,,21.93,,22.84,23.92,,21.98,23.46,0.19,1.30, ,2.78,-1.11, , ,-1.53, ,-0.62,0.46, ,-1.48,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9053,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),LRKRTYSLTTPAR,_TYS(ph)LTTPAR_,S578,+,21.28,,,24.67,24.63,23.52,21.49,25.46,,,,,25.64,23.81,-2.53, , ,0.86,0.82,-0.30,-2.33,1.65, , , , ,1.83,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9054,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),EAARVASPTSGVK,_VAS(ph)PTSGVK_,S1101,+,22.35,23.72,,27.23,22.36,22.82,22.73,23.73,,,19.14,23.80,22.46,23.03,-0.68,0.68, ,4.19,-0.67,-0.21,-0.31,0.69, , ,-3.90,0.77,-0.58,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9055,Q9Y4I1,MYO5A,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)",DDEKAISPTSATS,_AIS(ph)PTSATSSGR_,S600,+,20.70,22.96,,23.90,,21.70,,21.87,21.76,,22.76,,,22.24,-1.54,0.72, ,1.67, ,-0.53, ,-0.37,-0.48, ,0.53, , ,"insulin secretion;odontogenesis;synapse organization;myelination;locomotion involved in locomotory behavior;cellular response to insulin stimulus;secretory granule localization;melanocyte differentiation;exocytosis;melanosome transport;long-chain fatty acid biosynthetic process;actin filament-based movement;protein localization to plasma membrane;regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;vesicle-mediated transport;visual perception;endoplasmic reticulum localization;anagen;synaptic transmission;melanin biosynthetic process",neuronal cell body;microtubule plus end;Golgi apparatus;myosin complex;growth cone;intermediate filament;melanosome;insulin-responsive compartment;ruffle;photoreceptor outer segment;actomyosin,,,,,,,,,,,,,,
9056,Q9Y4J8,DTNA,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin) (Dystrophin-related protein 3),LNSEVGSETESNV,_ELNSEVGS(ph)ETESNVDSEFAR_,S289,+,,,,23.15,24.70,25.14,24.51,24.43,24.05,23.32,24.23,24.01,24.43,24.20, , , ,-1.04,0.50,0.94,0.31,0.23,-0.15,-0.87,0.03,-0.19,0.23,signal transduction;striated muscle contraction;neuromuscular synaptic transmission,synapse;cell junction;plasma membrane;protein complex;cytoplasm,,,,,,,,,,,,,,
9058,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),GVASAASPESKPS,_AALDGGVASAAS(ph)PESKPSPGTK_,S75,,23.33,,,,,,,,,24.34,,,,23.83,-0.51, , , , , , , , ,0.51, , , ,,,,,,,,,,,,,,,,
9059,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),SPESKPSPGTKGQ,_AALDGGVASAASPESKPS(ph)PGTK_,S81,,23.13,,,,,,,,,,,,,23.13,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
9060,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),KDTCVQSPISSFP,_DTCVQS(ph)PISSFPCTDLK_,S484,,24.06,,,,,,,,,24.27,,,,24.17,-0.10, , , , , , , , ,0.10, , , ,,,,,,,,,,,,,,,,
9064,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),EAADSKSLVLENV,_S(ph)LVLENVTDTAQDIPTTVDTK_,S417,,26.37,,,,,,,,,,,,,26.37,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
9066,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),SQKSTDSPGADAE,_ST(ph)DS(ph)PGADAELPESAAR_,S22,,27.46,22.92,23.36,,,,,,,21.84,,,,23.90,3.57,-0.98,-0.53, , , , , , ,-2.06, , , ,,,,,,,,,,,,,,,,
9067,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),ETKVTVSEEEILP,_VTVS(ph)EEEILPATR_,S348,,23.44,,,,,,,,,23.50,23.46,,,23.47,-0.03, , , , , , , , ,0.04,-0.01, , ,,,,,,,,,,,,,,,,
9068,Q9Y4K4,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5),RAERTASEINFDK,_TAS(ph)EINFDK_,S335,+,,25.66,25.66,26.48,22.79,25.28,27.07,26.59,25.75,26.39,27.02,27.37,22.69,25.73, ,-0.07,-0.07,0.75,-2.94,-0.45,1.34,0.86,0.02,0.66,1.29,1.64,-3.04,activation of JUN kinase activity,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
9069,Q9Y4K4,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5),PKPRISSYPEDNF,_ISS(ph)YPEDNFPDEEK_,S400,+,,22.30,22.30,22.60,22.56,,23.77,23.79,22.88,23.50,23.98,,22.65,23.03, ,-0.73,-0.73,-0.43,-0.47, ,0.74,0.76,-0.16,0.47,0.94, ,-0.38,activation of JUN kinase activity,plasma membrane;cytoplasm,,+,,,,,,,,,,,,
9070,Q9Y4L1,HYOU1,Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170),ETLVEDSAEEEST,_VESVFETLVEDS(ph)AEEESTLTK_,S567,,27.45,,,,,,,,,,,,,27.45,0.00, , , , , , , , , , , , ,activation of signaling protein activity involved in unfolded protein response;response to hypoxia,endoplasmic reticulum lumen,,,,,,,,,,,,,,
9072,Q9Y4P1,ATG4B,Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B),ILGRKYSIFTEKD,_KYS(ph)IFTEK_,S34,,18.93,21.40,21.40,,,,22.03,,,21.13,,23.83,,21.45,-2.52,-0.06,-0.06, , , ,0.58, , ,-0.32, ,2.38, ,proteolysis;protein transport;positive regulation of protein catabolic process;autophagic vacuole assembly,cytoplasm,,,,,,,,,,,,,,
9073,Q9Y4P8,WIPI2,WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2),GTYVPSSPTRLAY,_GTYVPSS(ph)PTR_,S395,+,25.92,25.27,24.27,26.48,24.62,22.92,24.39,25.32,22.16,,26.40,23.75,23.48,24.58,1.34,0.69,-0.31,1.90,0.03,-1.66,-0.19,0.74,-2.42, ,1.82,-0.83,-1.10,autophagic vacuole assembly,pre-autophagosomal structure membrane;cytosol;autophagic vacuole membrane;nucleus;protein complex,,,,,,,,,,,,,,
9074,Q9Y4R8,TELO2,Telomere length regulation protein TEL2 homolog (Protein clk-2 homolog) (hCLK2),RLLPPASP_____,_NRLLPPAS(ph)P_,S359,+,22.37,23.07,23.07,21.49,,,24.19,22.73,22.47,22.90,24.08,23.63,22.73,22.98,-0.61,0.10,0.10,-1.48, , ,1.21,-0.25,-0.51,-0.07,1.10,0.66,-0.25,,"chromosome, telomeric region;nucleus;membrane;cytoplasm",,,,,,,,,,,,,,
9075,Q9Y4W2,LAS1L,Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog),QQEEQGSVNDVKE,_AQQQEEQGS(ph)VNDVKEEEKEEK_,S543,+,25.75,26.70,25.42,26.91,24.08,25.15,26.63,25.57,27.22,26.93,25.15,24.40,23.11,25.62,0.13,1.08,-0.20,1.29,-1.54,-0.47,1.02,-0.05,1.60,1.32,-0.47,-1.22,-2.51,rRNA processing,MLL1 complex;cytoplasm,,,,,,,,,,,,,,
9076,Q9Y4W2,LAS1L,Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog),FSTGQESPTAENA,_M(ox)EVGPFSTGQES(ph)PTAENAR_,S600,+,26.63,27.38,27.18,25.99,27.26,27.01,26.51,27.25,26.24,26.50,26.26,25.47,26.23,26.61,0.02,0.77,0.57,-0.62,0.65,0.40,-0.10,0.64,-0.37,-0.11,-0.35,-1.14,-0.38,rRNA processing,MLL1 complex;cytoplasm,,,,,,,,,,,,,,
9078,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),QKLPDLSPVENKE,_LPDLS(ph)PVENK_,S2105,+,26.78,25.45,26.09,25.66,25.76,26.37,27.80,26.95,27.19,27.78,26.56,26.36,26.51,26.56,0.22,-1.11,-0.47,-0.89,-0.80,-0.19,1.24,0.40,0.63,1.22,0.00,-0.20,-0.05,,,,,,,,,,,,,,,,
9079,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),VFTRQDSNRSEKE,_EEEPVFTRQDS(ph)NRS(ph)EK_,S633,,25.71,25.14,25.14,23.28,,,,,,22.08,,,,24.27,1.44,0.87,0.87,-0.99, , , , , ,-2.19, , , ,,,,,,,,,,,,,,,,
9080,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),RQDSNRSEKEATP,_EEEPVFTRQDS(ph)NRS(ph)EK_,S636,+,25.27,26.62,26.62,24.16,,,25.08,23.06,25.29,24.81,24.05,25.05,,25.00,0.27,1.62,1.62,-0.84, , ,0.08,-1.94,0.29,-0.19,-0.95,0.05, ,,,,,,,,,,,,,,,,
9081,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),LRQREESETRSES,_(gl)QREES(ph)ETRS(ph)ESSDFEVVPK_,S1242,,22.90,,,,24.30,24.80,23.79,,,,,,,23.95,-1.05, , , ,0.35,0.85,-0.16, , , , , , ,,,,,,,,,,,,,,,,
9082,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),EESETRSESSDFE,_EESETRS(ph)ESSDFEVVPK_,S1246,+,24.68,23.75,23.75,22.60,23.97,23.53,21.92,22.08,,,,,,23.28,1.40,0.47,0.47,-0.69,0.68,0.24,-1.36,-1.21, , , , , ,,,,,,,,,,,,,,,,
9083,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),SETRSESSDFEVV,_SES(ph)SDFEVVPK_,S1248,+,25.40,23.87,22.13,22.78,,,23.30,,21.89,22.51,,,,23.12,2.27,0.75,-0.99,-0.35, , ,0.17, ,-1.23,-0.62, , , ,,,,,,,,,,,,,,,,
9084,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),ETRSESSDFEVVP,_S(ph)ESS(ph)DFEVVPK_,S1249,,23.18,,,,22.96,,,,,,,,,23.07,0.11, , , ,-0.11, , , , , , , , ,,,,,,,,,,,,,,,,
9085,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),RRRQRGSETDTDS,_QRGS(ph)ETDTDSEIHESASDK_,S1263,+,23.33,25.50,25.01,23.82,,22.04,25.42,23.66,25.39,26.18,24.71,23.71,23.04,24.32,-0.98,1.18,0.69,-0.49, ,-2.28,1.10,-0.65,1.07,1.86,0.39,-0.61,-1.28,,,,,,,,,,,,,,,,
9087,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),QPSRKRSVSHGSN,_S(ph)VSHGSNHTQKPDEQR_,S924,,22.94,22.14,22.69,19.88,,,,,,,,,,21.91,1.03,0.22,0.78,-2.03, , , , , , , , , ,,,,,,,,,,,,,,,,
9088,Q9Y572,RIPK3,Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3),FRNQMPSPTSTGT,_NQM(ox)PS(ph)PTSTGTPSPGPR_,S91,,25.59,,,,,,,,,,,,,25.59,0.00, , , , , , , , , , , , ,apoptotic signaling pathway;positive regulation of NF-kappaB transcription factor activity;positive regulation of type I interferon production;I-kappaB kinase/NF-kappaB cascade;positive regulation of necroptosis;innate immune response;induction of apoptosis;protein heterooligomerization;protein homooligomerization;activation of protein kinase activity,cytosol;mitochondrion;plasma membrane,,+,,,,,,,,,,,,
9089,Q9Y580,RBM7,RNA-binding protein 7 (RNA-binding motif protein 7),RKVRMNSYPYLAD,_M(ox)NS(ph)YPYLADR_,S204,,22.17,,,,,,,,,,,,,22.17,0.00, , , , , , , , , , , , ,meiosis,,,,,,,,,,,,,,,
9090,Q9Y580,RBM7,RNA-binding protein 7 (RNA-binding motif protein 7),IIQRSFSSPENFQ,_SFS(ph)SPENFQR_,S136,+,26.50,23.35,23.73,23.22,,,22.97,,22.08,22.08,,21.76,,23.21,3.29,0.14,0.52,0.01, , ,-0.24, ,-1.13,-1.13, ,-1.45, ,meiosis,,,,,,,,,,,,,,,
9091,Q9Y580,RBM7,RNA-binding protein 7 (RNA-binding motif protein 7),IQRSFSSPENFQR,_SFSS(ph)PENFQR_,S137,+,20.22,,,,23.25,22.94,22.94,22.63,22.73,22.78,,21.55,,22.38,-2.16, , , ,0.87,0.56,0.55,0.25,0.35,0.40, ,-0.83, ,meiosis,,,,,,,,,,,,,,,
9093,Q9Y597,KCTD3,BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45),NISERKSPGVEIK,_S(ph)PGVEIK_,S463,,21.00,21.60,21.96,23.98,,,,,,,,,,22.14,-1.14,-0.53,-0.17,1.84, , , , , , , , , ,protein homooligomerization,,,,,,,,,,,,,,,
9095,Q9Y5A9,YTHDF2,YTH domain family protein 2 (CLL-associated antigen KW-14) (High-glucose-regulated protein 8) (Renal carcinoma antigen NY-REN-2),_____MSASSLLE,_(ac)S(ph)ASSLLEQRPK_,S2,,22.92,22.29,22.76,22.63,23.48,,23.24,,,,,,,22.89,0.04,-0.60,-0.12,-0.26,0.59, ,0.35, , , , , , ,humoral immune response,,,,,,,,,,,,,,,
9096,Q9Y5B0,CTDP1,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),DILGEGSDDSDSE,_EVDDILGEGS(ph)DDS(ph)DSEK_,S869,,26.04,,,,,,,,21.49,,,,,23.77,2.27, , , , , , , ,-2.27, , , , ,mitosis;viral reproduction;exit from mitosis;transcription elongation from RNA polymerase II promoter;protein dephosphorylation;cell division;positive regulation of viral transcription,nucleoplasm;spindle midzone;midbody;centrosome;spindle pole;actin cytoskeleton,,,+,,,,,,,,,,,
9097,Q9Y5B0,CTDP1,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),GEGSDDSDSEKRR,_EVDDILGEGSDDS(ph)DSEK_,S872,,26.39,,,,,,,,23.44,25.75,,23.10,,24.67,1.72, , , , , , , ,-1.23,1.08, ,-1.58, ,mitosis;viral reproduction;exit from mitosis;transcription elongation from RNA polymerase II promoter;protein dephosphorylation;cell division;positive regulation of viral transcription,nucleoplasm;spindle midzone;midbody;centrosome;spindle pole;actin cytoskeleton,,,+,,,,,,,,,,,
9098,Q9Y5B6,PAXBP1,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),EDENDASDDEDDD,_LVREDENDAS(ph)DDEDDDEK_,S262,+,24.44,26.06,26.06,24.14,23.85,26.01,27.33,25.26,27.86,27.31,24.17,24.71,23.10,25.41,-0.97,0.65,0.65,-1.26,-1.56,0.61,1.92,-0.15,2.45,1.90,-1.24,-0.70,-2.31,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",cytosol;nucleus,Other TF domain,,,,,,,,,,,,,
9101,Q9Y5B6,PAXBP1,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),VRKRNDSEEEERE,_RNDS(ph)EEEERER_,S16,+,22.86,25.15,25.19,21.55,20.19,19.80,,18.82,,,,,,21.94,0.92,3.21,3.25,-0.39,-1.74,-2.14, ,-3.11, , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",cytosol;nucleus,Other TF domain,,,,,,,,,,,,,
9102,Q9Y5B9,SUPT16H,FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16),GIVKQDSLVINLN,_(gl)QDS(ph)LVINLNR_,S650,,20.58,,,,,,,,,,,,,20.58,0.00, , , , , , , , , , , , ,"DNA repair;viral reproduction;positive regulation of DNA-dependent transcription, elongation;nucleosome disassembly;transcription elongation from RNA polymerase II promoter;DNA replication;positive regulation of viral transcription",nucleoplasm;chromosome,,,,,,,,,,,,,,
9104,Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),TKRKTSSDDESEE,_TSS(ph)DDES(ph)EEDEDDLLQR_,S182,,25.24,,,,,,,,,,,,,25.24,0.00, , , , , , , , , , , , ,rRNA processing,nucleolus;nucleus,,,,,,,,,,,,,,
9105,Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),TSSDDESEEDEDD,_TSS(ph)DDES(ph)EEDEDDLLQR_,S186,,25.34,,,,24.71,,,,,,,,,25.02,0.31, , , ,-0.31, , , , , , , , ,rRNA processing,nucleolus;nucleus,,,,,,,,,,,,,,
9107,Q9Y5J1,UTP18,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),HEDSGDSEVENEA,_VQEHEDS(ph)GDS(ph)EVENEAK_,S100,+,28.32,25.78,26.08,26.20,26.79,25.18,23.44,24.42,26.22,24.06,,,22.30,25.35,2.98,0.44,0.73,0.86,1.44,-0.17,-1.90,-0.93,0.87,-1.28, , ,-3.04,rRNA processing,nucleolus;nucleus,,,,,,,,,,,,,,
9109,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),RFNGGHSPTHSPE,_FNGGHS(ph)PTHSPEK_,S510,+,24.50,21.58,,23.15,20.18,,,19.93,,20.43,20.54,,,21.47,3.03,0.11, ,1.68,-1.29, , ,-1.54, ,-1.04,-0.94, , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9110,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),GHSPTHSPEKILK,_FNGGHS(ph)PTHS(ph)PEK_,S514,,23.29,,,23.38,,,,,,,,,,23.33,-0.04, , ,0.04, , , , , , , , , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9111,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),DIFKEGSVKLRTR,_GIGFGDIFKEGS(ph)VK_,S224,,23.22,,,,,,,,,,,,,23.22,0.00, , , , , , , , , , , , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9112,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),DDVKKNSLDELRA,_KNS(ph)LDELR_,S582,,23.07,23.89,,,,,,,,,,,,23.48,-0.41,0.41, , , , , , , , , , , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9114,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),LRTRTSSSETEEK,_LRTRTSS(ph)SETEEK_,S233,,,27.17,27.17,19.02,,,20.45,19.30,20.19,16.80,,,,21.44, ,5.73,5.73,-2.43, , ,-0.99,-2.14,-1.25,-4.64, , , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9117,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),LPLRPKSVDFDSL,_S(ph)VDFDSLTVR_,S458,+,23.59,,,22.26,22.69,22.18,21.94,22.74,24.63,23.06,24.04,23.21,23.47,23.07,0.52, , ,-0.81,-0.38,-0.89,-1.13,-0.33,1.55,-0.01,0.96,0.14,0.39,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9118,Q9Y5K6,CD2AP,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),KSVDFDSLTVRTS,_SVDFDS(ph)LTVR_,S463,,22.54,,,,,,,,,,,,,22.54,0.00, , , , , , , , , , , , ,"signal transduction;mitosis;substrate-dependent cell migration, cell extension;protein complex assembly;cell division",filamentous actin;nucleolus;plasma membrane;ruffle;cytoplasm,,,,,,,,,,,,,,
9119,Q9Y5M8,SRPRB,Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1),NNNRGNSLTLIDL,_VNNNRGNS(ph)LTLIDLPGHESLR_,S112,+,,,,,23.11,24.30,,23.13,23.09,,24.06,23.59,24.25,23.65, , , , ,-0.54,0.66, ,-0.52,-0.56, ,0.41,-0.06,0.60,activation of signaling protein activity involved in unfolded protein response;small GTPase mediated signal transduction;translation;SRP-dependent cotranslational protein targeting to membrane,integral to membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
9120,Q9Y5P4,COL4A3BP,Collagen type IV alpha-3-binding protein (Ceramide transfer protein) (hCERT) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11),FVQKPYSRSSSMS,_FVQKPYS(ph)R_,S373,,22.82,21.34,,22.74,,,,,,,,,,22.30,0.52,-0.96, ,0.44, , , , , , , , , ,phospholipid metabolic process;immune response;endoplasmic reticulum organization;response to endoplasmic reticulum stress;lipid homeostasis;cell morphogenesis;small molecule metabolic process;mitochondrion morphogenesis;ER to Golgi ceramide transport;in utero embryonic development;cell proliferation;signal transduction;ceramide metabolic process;heart morphogenesis;muscle contraction;sphingolipid biosynthetic process,cytosol;mitochondrion;Golgi apparatus;nucleus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
9122,Q9Y5S2,CDC42BPB,Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta),NPSGPPSPNSPHR,_HSTPSNSSNPSGPPS(ph)PNSPHR_,S1690,,,,,,,,21.86,,21.23,,23.05,,,22.05, , , , , , ,-0.19, ,-0.82, ,1.00, , ,signal transduction;actomyosin structure organization;actin cytoskeleton reorganization;establishment or maintenance of cell polarity;cell migration;intracellular signal transduction,cell-cell junction;cell leading edge;plasma membrane;cytoplasm;actomyosin,,+,,,,,,,,,,,,
9124,Q9Y5S9,RBM8A,RNA-binding protein 8A (Binder of OVCA1-1) (BOV-1) (RNA-binding motif protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein RBM8A),MREDYDSVEQDGD,_M(ox)REDYDS(ph)VEQDGDEPGPQR_,S56,,25.11,,,,26.90,25.92,25.64,24.47,,,,,,25.61,-0.50, , , ,1.29,0.31,0.04,-1.13, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;regulation of translation",nucleoplasm;cytosol;exon-exon junction complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,+,,,,
9125,Q9Y5T5,USP16,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-processing protease UBP-M) (Ubiquitin-specific-processing protease 16),EDEDQDSEEEKDN,_KTVEDEDQDS(ph)EEEKDNDSYIK_,S400,+,21.41,,,23.12,26.04,25.76,21.83,26.24,23.23,,20.25,21.95,,23.31,-1.91, , ,-0.20,2.72,2.45,-1.48,2.92,-0.08, ,-3.06,-1.37, ,"protein homotetramerization;response to DNA damage stimulus;ubiquitin-dependent protein catabolic process;histone H2A K63-linked deubiquitination;mitosis;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;cell division;positive regulation of translational elongation",nucleus;cytoplasm,,,,,,,,,,,,,,
9127,Q9Y5T5,USP16,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-processing protease UBP-M) (Ubiquitin-specific-processing protease 16),LEVLTSSPTRNLN,_NINM(ox)DNDLEVLTSS(ph)PTR_,S537,+,24.14,,,22.10,24.13,23.30,24.30,24.48,23.71,,24.09,,24.09,23.81,0.32, , ,-1.71,0.31,-0.52,0.48,0.67,-0.11, ,0.27, ,0.28,"protein homotetramerization;response to DNA damage stimulus;ubiquitin-dependent protein catabolic process;histone H2A K63-linked deubiquitination;mitosis;positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;cell division;positive regulation of translational elongation",nucleus;cytoplasm,,,,,,,,,,,,,,
9131,Q9Y5Y0,FLVCR1,Feline leukemia virus subgroup C receptor-related protein 1 (Feline leukemia virus subgroup C receptor) (hFLVCR),KAIPADSPTDQEP,_AIPADS(ph)PTDQEPK_,S335,+,,23.96,24.56,23.74,24.77,24.46,24.70,24.80,24.32,25.78,24.20,,23.66,24.45, ,-0.49,0.11,-0.71,0.32,0.00,0.25,0.35,-0.13,1.33,-0.25, ,-0.79,multicellular organismal development;embryonic digit morphogenesis;heme export;cellular iron ion homeostasis;regulation of organ growth;in utero embryonic development;head morphogenesis;transmembrane transport;multicellular organism growth;cell death;erythrocyte differentiation;spleen development,integral to plasma membrane,,,,,,,,,,,,,,
9135,Q9Y606,PUS1,"tRNA pseudouridine synthase A, mitochondrial (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)",PSPLEGSEGDGDT,_VPSPLEGS(ph)EGDGDT(ph)D_,S367,,22.85,,,,,,,,,,,,,22.85,0.00, , , , , , , , , , , , ,tRNA processing;tRNA pseudouridine synthesis;positive regulation of transcription from RNA polymerase II promoter,mitochondrion;transcription factor complex;nucleolus;nucleus,,,,,,,,,,,,,,
9138,Q9Y608,LRRFIP2,Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2),PLSGNSSRRGSGD,_NSASATTPLSGNSS(ph)R_,S324,,24.38,,,26.91,,,,,,,,,,25.65,-1.26, , ,1.26, , , , , , , , , ,Wnt receptor signaling pathway,,,,,,,,,,,,,,,
9139,Q9Y608,LRRFIP2,Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2),NSSRRGSGDTSSL,_RGS(ph)GDTSSLIDPDTSLSELR_,S328,+,25.82,24.29,,23.73,26.13,,24.43,27.00,,25.56,27.58,27.62,23.60,25.58,0.24,-1.29, ,-1.85,0.56, ,-1.15,1.42, ,-0.01,2.01,2.04,-1.98,Wnt receptor signaling pathway,,,,,,,,,,,,,,,
9141,Q9Y608,LRRFIP2,Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2),NSSRRGSGDTSSL,_RGS(ph)GDTSSLIDPDTSLSELR_,S96,+,25.82,24.29,,22.55,25.19,,24.43,25.81,,25.35,25.87,,23.60,24.77,1.05,-0.48, ,-2.22,0.42, ,-0.34,1.04, ,0.58,1.10, ,-1.17,Wnt receptor signaling pathway,,,,,,,,,,,,,,,
9143,Q9Y613,FHOD1,FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1),EPLIPASPKAEPI,_SLAPEPKEPLIPAS(ph)PK_,S102,+,22.17,24.13,24.60,24.27,,,25.55,21.95,24.09,,25.68,24.47,,24.10,-1.93,0.02,0.50,0.17, , ,1.45,-2.15,-0.02, ,1.58,0.37, ,positive regulation of stress fiber assembly;positive regulation of transcription from RNA polymerase II promoter;actin cytoskeleton organization,nucleus;cytoskeleton;bleb;cytoplasm,,,,,,,,,,,,,,
9144,Q9Y617,PSAT1,Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT),LELNMLSLKGHRS,_ALELNM(ox)LS(ph)LK_,S331,,22.93,,,,,,,,,,,,,22.93,0.00, , , , , , , , , , , , ,L-serine biosynthetic process;pyridoxine biosynthetic process,cytosol,,,,,,,,,,,,,,
9145,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",DPRANASPQKPLD,_ANAS(ph)PQKPLDLK_,S938,+,23.59,23.05,23.95,23.85,25.94,24.15,25.21,25.42,24.35,23.38,23.09,23.61,24.97,24.20,-0.61,-1.15,-0.25,-0.34,1.74,-0.05,1.02,1.22,0.16,-0.82,-1.10,-0.59,0.77,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9146,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",RIIGEDSPSRLDR,_IIGEDS(ph)PSRLDR_,S1241,+,22.60,23.69,,24.55,26.14,26.26,23.63,24.59,25.11,23.84,,,25.56,24.60,-2.00,-0.91, ,-0.05,1.55,1.66,-0.96,-0.01,0.51,-0.76, , ,0.96,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9147,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",VKQEQLSPRGQAG,_LAPFSGVKQEQLS(ph)PR_,S1163,,,,,,22.78,23.14,,21.61,,,,,,22.51, , , , ,0.27,0.63, ,-0.90, , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9148,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",GKLEPVSPPSPPH,_LEPVS(ph)PPS(ph)PPHTDPELELVPPR_,S149,,26.63,,,23.81,23.18,,,,,,,,,24.54,2.09, , ,-0.73,-1.36, , , , , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9149,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",EPVSPPSPPHTDP,_LEPVS(ph)PPS(ph)PPHTDPELELVPPR_,S152,,26.63,,,23.81,23.18,,,,,,,,,24.54,2.09, , ,-0.73,-1.36, , , , , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9151,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",SRMGSKSPGNTSQ,_S(ph)PGNTSQPPAFFSK_,S2248,+,26.94,25.49,25.97,26.98,26.57,26.32,27.43,26.24,,27.52,26.60,27.60,26.22,26.66,0.28,-1.17,-0.69,0.33,-0.09,-0.34,0.78,-0.42, ,0.86,-0.05,0.94,-0.44,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9156,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",GLEPASSPSKGSE,_SGLEPASS(ph)PSK_,S1961,+,24.27,,,26.15,23.54,,,23.28,20.16,,22.23,,,23.27,1.00, , ,2.88,0.27, , ,0.01,-3.11, ,-1.04, , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9157,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",YHGSSYSPEGVEP,_SLGYHGSSYS(ph)PEGVEPVS(ph)PVSSPSLTHDK_,S2036,,24.19,,,,24.60,,,,,,,,,24.40,-0.21, , , ,0.21, , , , , , , , ,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9158,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",EGVEPVSPVSSPS,_SLGYHGSSYSPEGVEPVS(ph)PVSSPSLTHDK_,S2044,+,24.67,,,,24.60,24.09,26.41,24.23,23.80,,24.59,25.81,25.29,24.83,-0.16, , , ,-0.23,-0.74,1.58,-0.60,-1.03, ,-0.24,0.98,0.46,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9160,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",VRSLIGSPGRTFP,_SLIGS(ph)PGR_,S1469,+,24.23,23.71,20.99,26.04,24.46,24.43,23.11,23.10,23.79,21.82,21.28,22.23,23.05,23.25,0.98,0.46,-2.26,2.79,1.21,1.18,-0.14,-0.15,0.54,-1.42,-1.97,-1.02,-0.20,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
9163,Q9Y624,F11R,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),VIYSQPSARSEGE,_KVIYSQPS(ph)AR_,S281,+,29.32,27.61,27.32,27.61,25.78,22.58,27.02,26.75,22.88,25.34,25.27,27.24,,26.23,3.10,1.39,1.10,1.38,-0.44,-3.64,0.79,0.52,-3.34,-0.89,-0.96,1.02, ,inflammatory response;transforming growth factor beta receptor signaling pathway;blood coagulation;cell adhesion;epithelial cell differentiation;leukocyte migration;tight junction assembly;virus-host interaction,tight junction;cell-cell junction;integral to membrane;plasma membrane,,,,,,,,,,,,,,
9164,Q9Y624,F11R,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),SQPSARSEGEFKQ,_VIYSQPS(ph)ARS(ph)EGEFK_,S284,,24.66,,,,,,23.81,,,,,,,24.23,0.43, , , , , ,-0.43, , , , , , ,inflammatory response;transforming growth factor beta receptor signaling pathway;blood coagulation;cell adhesion;epithelial cell differentiation;leukocyte migration;tight junction assembly;virus-host interaction,tight junction;cell-cell junction;integral to membrane;plasma membrane,,,,,,,,,,,,,,
9168,Q9Y657,SPIN1,Spindlin-1 (Ovarian cancer-related protein),MPDSNDSPPAERE,_IM(ox)PDSNDS(ph)PPAEREPGEVVDSLVGK_,S199,+,23.05,22.66,,23.66,25.32,24.74,,24.87,25.30,24.38,,,,24.25,-1.20,-1.58, ,-0.59,1.08,0.49, ,0.62,1.05,0.13, , , ,multicellular organismal development;cell cycle;gamete generation,nucleus;spindle,,,,,,,,,,,,,,
9169,Q9Y666,SLC12A7,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),YRSRDTSLSGFKD,_DTS(ph)LSGFK_,S997,,25.93,23.70,,23.60,,,,21.50,,24.83,,21.39,,23.49,2.43,0.20, ,0.11, , , ,-1.99, ,1.34, ,-2.10, ,cell volume homeostasis;potassium ion transport,integral to plasma membrane,,,,,,,,,,,,,,
9171,Q9Y666,SLC12A7,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),PEPERPSPGDGNP,_TEAPGT(ph)PEGPEPERPS(ph)PGDGNPR_,S40,,22.54,,,,,,,,,,,,,22.54,0.00, , , , , , , , , , , , ,cell volume homeostasis;potassium ion transport,integral to plasma membrane,,,,,,,,,,,,,,
9173,Q9Y6A5,TACC3,Transforming acidic coiled-coil-containing protein 3 (ERIC-1),QTHRILSPSMASK,_ILS(ph)PSM(ox)ASK_,S19,,22.66,,,,,,,,,,,,,22.66,0.00, , , , , , , , , , , , ,regulation of microtubule-based process;regulation of cell cycle;interkinetic nuclear migration;astral microtubule organization;cytoplasmic sequestering of transcription factor;response to stress;cerebral cortex development;neurogenesis;hemopoiesis,centrosome,,,,,,,,,,,,,,
9174,Q9Y6A5,TACC3,Transforming acidic coiled-coil-containing protein 3 (ERIC-1),PGKVSGSPEQAVE,_VSGS(ph)PEQAVEENLSSYSLDRR_,S125,,22.19,22.23,22.23,,,,23.99,,24.65,25.21,,23.27,,23.40,-1.20,-1.17,-1.17, , , ,0.60, ,1.25,1.81, ,-0.13, ,regulation of microtubule-based process;regulation of cell cycle;interkinetic nuclear migration;astral microtubule organization;cytoplasmic sequestering of transcription factor;response to stress;cerebral cortex development;neurogenesis;hemopoiesis,centrosome,,,,,,,,,,,,,,
9178,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),IQSKPQSPVIQAA,_PIQSKPQS(ph)PVIQAAAVS(ph)PK_,S218,+,27.39,25.14,25.57,24.57,,,23.65,24.19,,23.68,,,,24.88,2.51,0.26,0.69,-0.32, , ,-1.23,-0.70, ,-1.21, , , ,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9179,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),IQAAAVSPKFVRL,_PQSPVIQAAAVS(ph)PK_,S227,+,27.83,26.70,26.89,26.69,24.92,24.78,27.64,26.32,25.78,27.01,27.29,28.10,24.33,26.48,1.35,0.21,0.40,0.21,-1.56,-1.70,1.16,-0.17,-0.70,0.53,0.81,1.61,-2.15,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9181,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),PRERGSSLSGTDD,_GSS(ph)LSGTDDGAQEVVK_,S277,+,27.95,27.03,26.55,27.80,22.67,25.18,27.67,24.56,26.80,26.73,27.42,27.01,26.24,26.43,1.52,0.60,0.12,1.37,-3.76,-1.25,1.24,-1.87,0.37,0.29,0.98,0.58,-0.19,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9182,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),RGQSQLSNPTDDS,_GQSQLS(ph)NPTDDSWK_,S1528,,,,,24.93,23.86,,23.63,23.88,,,23.38,22.73,,23.74, , , ,1.20,0.12, ,-0.10,0.14, , ,-0.36,-1.00, ,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9183,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),VDLDRQSLSSIDK,_HLDVDLDRQS(ph)LSSIDK_,S1511,,,,,,,,24.07,,23.02,24.42,24.83,,,24.08, , , , , , ,-0.02, ,-1.06,0.33,0.74, , ,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9185,Q9Y6D5,ARFGEF2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),DRQSLSSADNLES,_(gl)QSLSS(ph)ADNLESDAQGHQVAAR_,S349,,20.00,23.11,21.02,22.15,,,,,21.50,,,,,21.56,-1.55,1.56,-0.54,0.59, , , , ,-0.05, , , , ,positive regulation of tumor necrosis factor production;Golgi to plasma membrane transport;exocytosis;endosome organization;endomembrane system organization;protein transport;regulation of ARF protein signal transduction;receptor recycling;intracellular signal transduction,axonemal microtubule;asymmetric synapse;symmetric synapse;recycling endosome;Golgi membrane;perinuclear region of cytoplasm;microtubule organizing center;trans-Golgi network;cytoplasmic vesicle;cytosol;dendritic spine;cell junction;cytoplasmic membrane-bounded vesicle,,,,,,,,,,,,,,
9186,Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),AETEKQSPPHGEA,_AETEKQS(ph)PPHGEAK_,S52,,19.48,20.81,21.57,19.56,,,,,,,,,,20.35,-0.88,0.46,1.22,-0.80, , , , , , , , , ,positive regulation of protein glycosylation in Golgi;regulation of establishment of cell polarity;exocytosis;negative regulation of Rho GTPase activity;endomembrane system organization;protein transport;Golgi organization;regulation of ARF protein signal transduction;positive regulation of wound healing;negative regulation of actin filament polymerization,trans-Golgi network;cytosol;small nuclear ribonucleoprotein complex;nucleolus;nuclear matrix;Golgi membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9188,Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),KPLDTISQKSVDI,_PLDTIS(ph)QK_,S1566,+,25.26,24.14,24.25,24.15,21.29,,21.24,,,,21.78,,,23.16,2.10,0.98,1.09,0.99,-1.86, ,-1.92, , , ,-1.38, , ,positive regulation of protein glycosylation in Golgi;regulation of establishment of cell polarity;exocytosis;negative regulation of Rho GTPase activity;endomembrane system organization;protein transport;Golgi organization;regulation of ARF protein signal transduction;positive regulation of wound healing;negative regulation of actin filament polymerization,trans-Golgi network;cytosol;small nuclear ribonucleoprotein complex;nucleolus;nuclear matrix;Golgi membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9192,Q9Y6D6,ARFGEF1,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),DTISQKSVDIHDS,_S(ph)VDIHDSIQPR_,S1569,+,26.92,26.25,27.03,24.65,25.04,24.85,27.68,25.45,25.80,27.73,27.07,26.44,25.47,26.18,0.74,0.07,0.85,-1.53,-1.15,-1.33,1.50,-0.73,-0.38,1.54,0.89,0.26,-0.71,positive regulation of protein glycosylation in Golgi;regulation of establishment of cell polarity;exocytosis;negative regulation of Rho GTPase activity;endomembrane system organization;protein transport;Golgi organization;regulation of ARF protein signal transduction;positive regulation of wound healing;negative regulation of actin filament polymerization,trans-Golgi network;cytosol;small nuclear ribonucleoprotein complex;nucleolus;nuclear matrix;Golgi membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9194,Q9Y6E0,STK24,Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N);Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)],___MAHSPVQSGL,_(ac)AHS(ph)PVQSGLPGM(ox)QNLK_,S4,,29.00,27.21,27.81,26.89,25.89,26.83,27.70,26.94,26.81,27.87,26.44,26.91,26.66,27.15,1.85,0.06,0.66,-0.27,-1.26,-0.32,0.55,-0.21,-0.34,0.72,-0.71,-0.24,-0.49,negative regulation of cell migration;protein autophosphorylation;cellular component disassembly involved in execution phase of apoptosis;intrinsic apoptotic signaling pathway in response to oxidative stress;regulation of axon regeneration;induction of apoptosis,nucleoplasm;cytosol;membrane,,+,,,,,,,,,,,,
9196,Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",RKPVTVSPTTPTS,_KPVTVS(ph)PTTPTS(ph)PTEGEAS_,S510,+,25.30,24.42,23.56,25.42,26.52,24.70,25.67,27.10,25.38,25.44,26.81,25.27,26.24,25.53,-0.23,-1.10,-1.96,-0.10,0.99,-0.83,0.14,1.57,-0.14,-0.09,1.29,-0.26,0.72,transport;mitosis;regulation of centrosome cycle;cell division;virus-host interaction;positive regulation of mitotic cell cycle spindle assembly checkpoint,cytoplasmic dynein complex;plasma membrane;microtubule;centrosome;condensed chromosome kinetochore;spindle pole;kinetochore,,,,,,,,,,,,,,
9197,Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",SPTTPTSPTEGEA,_KPVTVSPTTPTS(ph)PTEGEAS_,S516,+,28.37,26.10,26.08,27.46,27.33,27.52,27.74,28.43,27.98,27.02,27.39,26.84,27.92,27.40,0.97,-1.30,-1.32,0.06,-0.07,0.12,0.34,1.03,0.58,-0.38,-0.01,-0.56,0.52,transport;mitosis;regulation of centrosome cycle;cell division;virus-host interaction;positive regulation of mitotic cell cycle spindle assembly checkpoint,cytoplasmic dynein complex;plasma membrane;microtubule;centrosome;condensed chromosome kinetochore;spindle pole;kinetochore,,,,,,,,,,,,,,
9198,Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",SNVASVSPIPAGS,_SVSSNVASVS(ph)PIPAGSK_,S421,,22.92,,,,23.77,22.82,23.35,23.07,,,,,,23.19,-0.27, , , ,0.58,-0.36,0.17,-0.11, , , , , ,transport;mitosis;regulation of centrosome cycle;cell division;virus-host interaction;positive regulation of mitotic cell cycle spindle assembly checkpoint,cytoplasmic dynein complex;plasma membrane;microtubule;centrosome;condensed chromosome kinetochore;spindle pole;kinetochore,,,,,,,,,,,,,,
9199,Q9Y6I3,EPN1,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),LAEAVGSPPPAAT,_GSLAEAVGS(ph)PPPAATPTPTPPTR_,S428,+,23.24,,,,,23.56,22.84,20.90,,22.75,24.27,21.84,,22.77,0.46, , , , ,0.79,0.07,-1.87, ,-0.02,1.50,-0.93, ,Notch signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;embryonic organ development;female pregnancy;endocytosis;in utero embryonic development,coated pit;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
9200,Q9Y6I3,EPN1,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),GEVPARSPGAFDM,_S(ph)PGAFDM(ox)SGVR_,S409,,25.07,23.66,,,,,21.41,,,,,23.63,,23.44,1.62,0.22, , , , ,-2.04, , , , ,0.19, ,Notch signaling pathway;negative regulation of epidermal growth factor receptor signaling pathway;epidermal growth factor receptor signaling pathway;embryonic organ development;female pregnancy;endocytosis;in utero embryonic development,coated pit;plasma membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
9204,Q9Y6K1,DNMT3A,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA),QPTDPASPTVATT,_VEEASPPAVQQPTDPAS(ph)PTVATTPEPVGSDAGDK_,S255,,23.34,24.03,24.03,23.19,,,24.57,,24.45,24.66,,,,24.04,-0.70,-0.01,-0.01,-0.85, , ,0.53, ,0.41,0.63, , , ,DNA methylation involved in embryo development;DNA methylation on cytosine within a CG sequence;cellular response to amino acid stimulus;S-adenosylmethioninamine metabolic process;methylation-dependent chromatin silencing;spermatogenesis;negative regulation of transcription from RNA polymerase II promoter;hypermethylation of CpG island;DNA methylation involved in gamete generation;regulation of gene expression by genetic imprinting;S-adenosylhomocysteine metabolic process,"nuclear heterochromatin;chromosome, centromeric region;euchromatin;nuclear matrix;cytoplasm",,,,,,,,,,,+,,,
9206,Q9Y6M1,IGF2BP2,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),PDEEVSSPSPPQR,_ISYIPDEEVSS(ph)PSPPQR_,S162,+,29.06,25.74,25.25,25.99,28.31,27.73,28.31,28.58,28.75,26.87,27.70,26.70,27.69,27.44,1.62,-1.69,-2.19,-1.45,0.87,0.30,0.87,1.14,1.32,-0.56,0.26,-0.74,0.25,anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process,cytosol;cytoskeletal part;nucleus,,,,,,,,,,,,,,
9207,Q9Y6M1,IGF2BP2,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),EEVSSPSPPQRAQ,_ISYIPDEEVSSPS(ph)PPQR_,S164,+,28.68,25.39,24.46,26.64,28.09,27.77,27.09,28.09,28.01,25.77,27.14,26.32,27.63,27.01,1.67,-1.62,-2.54,-0.37,1.08,0.76,0.09,1.09,1.00,-1.23,0.13,-0.69,0.63,anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process,cytosol;cytoskeletal part;nucleus,,,,,,,,,,,,,,
9208,Q9Y6M1,IGF2BP2,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),LYIGNLSPAVTAD,_LYIGNLS(ph)PAVTADDLR_,S11,,23.17,,,,,,,,,,,,,23.17,0.00, , , , , , , , , , , , ,anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process,cytosol;cytoskeletal part;nucleus,,,,,,,,,,,,,,
9212,Q9Y6M5,SLC30A1,Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1),NKQPESSL_____,_NM(ox)PNKQPESS(ph)L_,S506,,,25.06,,26.17,,23.98,,,22.47,25.18,,,,24.57, ,0.49, ,1.60, ,-0.59, , ,-2.10,0.61, , , ,cellular calcium ion homeostasis;cadmium ion transmembrane transport;zinc ion transport;negative regulation of neurotransmitter secretion;negative regulation of calcium ion import;detoxification of cadmium ion;in utero embryonic development;calcium ion import;negative regulation of zinc ion transmembrane import;cellular zinc ion homeostasis,T-tubule;integral to membrane,,,,,,,,,,,,,,
9214,Q9Y6N7,ROBO1,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),KRNGLTSTYAGIR,_NGLTS(ph)TYAGIR_,S894,,,,,22.14,,,,,,,,23.69,,22.91, , , ,-0.78, , , , , , , ,0.78, ,axon midline choice point recognition;negative regulation of mammary gland epithelial cell proliferation;cell migration involved in sprouting angiogenesis;spinal cord development;Roundabout signaling pathway;regulation of dendrite morphogenesis;mammary duct terminal end bud growth;negative regulation of negative chemotaxis;activation of cysteine-type endopeptidase activity involved in apoptotic process;homophilic cell adhesion;negative regulation of chemokine-mediated signaling pathway;chemorepulsion involved in postnatal olfactory bulb interneuron migration;positive regulation of axonogenesis,neuronal cell body;integral to plasma membrane;cell surface;axolemma;cytoplasm,,,,,,,,,,,,,,
9215,Q9Y6Q9,NCOA3,Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1),PYNRAVSLDSPVS,_AVS(ph)LDSPVSVGSSPPVK_,S652,+,25.35,21.97,,24.34,24.31,,24.96,23.85,24.03,22.75,,24.79,,24.04,1.31,-2.07, ,0.30,0.27, ,0.92,-0.19,-0.01,-1.29, ,0.76, ,"mammary gland branching involved in thelarche;small molecule metabolic process;cellular lipid metabolic process;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of keratinocyte differentiation;receptor transactivation;developmental growth;multicellular organism growth;positive regulation of intracellular estrogen receptor signaling pathway;vagina development;transcription, DNA-dependent;androgen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;Golgi apparatus;cytoplasm,bHLH,,,,,,,,,,,,,
9216,Q9Y6Q9,NCOA3,Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1),LEDINASPEMRQR,_TPHDILEDINAS(ph)PEM(ox)R_,S16,+,22.79,21.34,,,23.61,24.24,23.69,23.89,24.27,,23.34,23.06,23.54,23.38,-0.59,-2.04, , ,0.23,0.86,0.31,0.51,0.89, ,-0.04,-0.32,0.17,"mammary gland branching involved in thelarche;small molecule metabolic process;cellular lipid metabolic process;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of keratinocyte differentiation;receptor transactivation;developmental growth;multicellular organism growth;positive regulation of intracellular estrogen receptor signaling pathway;vagina development;transcription, DNA-dependent;androgen receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter",nucleoplasm;Golgi apparatus;cytoplasm,bHLH,,,,,,,,,,,,,
9217,Q9Y6R0,NUMBL,Numb-like protein (Numb-related protein) (Numb-R),GHKRTPSEAERWL,_RTPS(ph)EAER_,S370,+,,19.57,18.76,22.50,22.33,,,22.77,22.92,,,24.10,,21.85, ,-2.28,-3.09,0.65,0.48, , ,0.92,1.07, , ,2.25, ,protein metabolic process;lateral ventricle development;positive regulation of neurogenesis;axonogenesis;adherens junction organization;neuroblast division in subventricular zone;cytokine-mediated signaling pathway;positive regulation of dendrite morphogenesis,cytoplasm,,,,,,,,,,,,,,
9218,Q9Y6R9,CCDC61,Coiled-coil domain-containing protein 61,QRNRLGSGGSGDG,_LGS(ph)GGS(ph)GDGPSVSWSR_,S193,,24.38,,,20.13,,,,,,,,,,22.26,2.12, , ,-2.12, , , , , , , , , ,,centrosome,,,,,,,,,,,,,,
9219,Q9Y6R9,CCDC61,Coiled-coil domain-containing protein 61,RLGSGGSGDGPSV,_LGS(ph)GGS(ph)GDGPSVSWSR_,S196,,24.83,21.73,,23.14,24.78,24.63,,23.65,22.76,,,,,23.65,1.19,-1.92, ,-0.50,1.14,0.98, ,0.01,-0.88, , , , ,,centrosome,,,,,,,,,,,,,,
9222,Q9Y6X4,FAM169A,Soluble lamin-associated protein of 75 kDa (SLAP75) (Protein FAM169A),AEKAVDSSSEEIE,_AVDS(ph)SSEEIEVEVPVVDRR_,S575,,,,,,22.63,,,23.22,,25.04,,22.53,22.54,23.19, , , , ,-0.56, , ,0.03, ,1.85, ,-0.66,-0.65,,nuclear inner membrane,,,,,,,,,,,,,,
9224,Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),KDSNELSDSAGEE,_KDSNELS(ph)DS(ph)AGEEDSADLK_,S715,,25.90,,,,,,,,23.06,23.17,,,,24.04,1.86, , , , , , , ,-0.99,-0.87, , , ,,cytosol;nucleus,,,,,,,,,,,,,,
9225,Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),SNELSDSAGEEDS,_KDSNELS(ph)DS(ph)AGEEDSADLK_,S717,,25.90,,,,,,,,,,,,,25.90,0.00, , , , , , , , , , , , ,,cytosol;nucleus,,,,,,,,,,,,,,
9227,Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),TPSRKRSVAVSDE,_S(ph)VAVS(ph)DEEEVEEEAER_,S677,,21.66,,,,,,,,,,,,,21.66,0.00, , , , , , , , , , , , ,,cytosol;nucleus,,,,,,,,,,,,,,
9228,Q9Y6X9,MORC2,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),KRSVAVSDEEEVE,_S(ph)VAVS(ph)DEEEVEEEAER_,S681,+,24.30,,,22.96,24.84,26.08,23.76,25.65,23.08,,,,24.10,24.35,-0.05, , ,-1.39,0.50,1.73,-0.59,1.30,-1.26, , , ,-0.24,,cytosol;nucleus,,,,,,,,,,,,,,
9229,Q9Y6Y0,IVNS1ABP,Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3),KLSKSLSFEMQQD,_SLS(ph)FEM(ox)QQDELIEK_,S39,+,26.08,24.26,24.26,23.80,24.98,,24.99,25.30,24.07,27.19,,,,24.99,1.09,-0.73,-0.73,-1.19,-0.02, ,0.00,0.30,-0.92,2.20, , , ,response to virus;RNA splicing;transcription from RNA polymerase III promoter;virus-host interaction,transcription factor complex;cytoskeleton;spliceosomal complex;cytoplasm,,,,,,,,,,,,,,
9230,Q9Y6Y8,SEC23IP,SEC23-interacting protein (p125),RTKDMASLPSESN,_DM(ox)AS(ph)LPSESNEPK_,S737,,23.37,23.55,23.55,,,,,,,,,,,23.49,-0.12,0.06,0.06, , , , , , , , , , ,intracellular protein transport;Golgi organization,endoplasmic reticulum-Golgi intermediate compartment;ER to Golgi transport vesicle membrane;endoplasmic reticulum,,,,,,,,,,,,,,
9233,Q9P2E9,RRBP1,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),NTDVAQSPEAPKQ,_NTDVAQS(ph)PEAPKQEAPAK_,S745,,26.69,24.56,22.48,23.28,26.66,25.82,25.71,26.53,25.05,24.46,,22.10,25.46,24.90,1.78,-0.34,-2.42,-1.62,1.76,0.92,0.81,1.63,0.15,-0.44, ,-2.81,0.56,signal transduction;protein transport;translation,integral to endoplasmic reticulum membrane;ribosome,,,,,,,,,,,,,,
9236,Q53GL7,PARP10,Poly [ADP-ribose] polymerase 10 (PARP-10) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 10) (ARTD10),SGLPGRSPDT___,_ASPDDPSGLPGRS(ph)PDT_,S728,,,,,23.77,,,,22.98,,,,,,23.38, , , ,0.40, , , ,-0.40, , , , , ,protein poly-ADP-ribosylation;regulation of chromatin assembly;negative regulation of fibroblast proliferation,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9237,O94901,SUN1,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),LDPVFDSPRMSRR,_LDPVFDS(ph)PR_,S48,,20.74,,,18.75,,,,,,,,,,19.75,0.99, , ,-0.99, , , , , , , , , ,nuclear matrix anchoring at nuclear membrane;nuclear envelope organization;cytoskeletal anchoring at nuclear membrane,nuclear membrane;integral to membrane;SUN-KASH complex;nuclear inner membrane,,,,,,,,,,,,,,
9238,P06756,ITGAV,Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain;Integrin alpha-V light chain],ENGEGNSET____,_EQLQPHENGEGNS(ph)ET_,S1010,+,24.43,26.03,25.39,26.74,25.76,25.17,25.11,25.26,26.28,,,23.12,,25.33,-0.90,0.70,0.06,1.41,0.43,-0.16,-0.22,-0.07,0.95, , ,-2.21, ,"negative regulation of apoptotic process;viral entry into host cell;apoptotic cell clearance;positive regulation of cell migration;blood coagulation;negative regulation of entry of bacterium into host cell;negative regulation of low-density lipoprotein particle receptor biosynthetic process;positive regulation of cell proliferation;integrin-mediated signaling pathway;regulation of apoptotic cell clearance;entry of symbiont into host cell by promotion of host phagocytosis;negative regulation of macrophage derived foam cell differentiation;angiogenesis;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of lipid transport;negative regulation of lipoprotein metabolic process;positive regulation of osteoblast proliferation;cell-matrix adhesion;negative regulation of lipid storage;axon guidance;ERK1 and ERK2 cascade;positive regulation of cell adhesion;leukocyte migration",alphav-beta3 integrin-IGF-1-IGF1R complex;integrin complex;external side of plasma membrane;cell surface;phagocytic vesicle,,,,,,,,,,,,,,
9239,Q9BT76,UPK3B,Uroplakin-3b (UP3b) (Uroplakin IIIb) (UPIIIb) (p35),EQLRIGSFMGKRY,_IGS(ph)FM(ox)GKR_,S241,,25.01,27.47,25.56,23.72,23.80,23.38,27.75,27.26,20.48,,24.34,27.83,24.81,25.12,-0.10,2.35,0.44,-1.39,-1.32,-1.74,2.63,2.14,-4.64, ,-0.77,2.71,-0.31,negative regulation of gene expression,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9240,Q9UDT6,CLIP2,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),IRIGFPSTSPAKA,_IGFPS(ph)TSPAK_,S292,+,,21.39,20.93,,,23.81,24.72,,23.66,,23.32,24.17,,23.14, ,-1.76,-2.21, , ,0.67,1.57, ,0.52, ,0.18,1.03, ,,cytoplasmic microtubule;microtubule associated complex,,,,,,,,,,,,,,
9241,Q9UDT6,CLIP2,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),IGFPSTSPAKAKK,_IGFPSTS(ph)PAK_,S294,,,,,24.09,25.61,,,25.38,,,,,,25.03, , , ,-0.94,0.58, , ,0.35, , , , , ,,cytoplasmic microtubule;microtubule associated complex,,,,,,,,,,,,,,
9242,Q9Y3Y4,PYGO1,Pygopus homolog 1,PGVQLGSPDKKKR,_GGDSGLDGLGGPGVQLGS(ph)PDK_,S34,,,,,,,23.71,23.83,23.25,24.63,,,,,23.86, , , , , ,-0.15,-0.03,-0.60,0.78, , , , ,protein localization to nucleus;post-embryonic development;kidney development;Wnt receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
9246,Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),ALSSASSETGTRR,_(ac)AETLSGLGDSGAAGAAALSSASS(ph)ETGTR_,S24,,25.24,,,,24.87,,,,,,,,,25.05,0.18, , , ,-0.18, , , , , , , , ,"hormone metabolic process;intracellular estrogen receptor signaling pathway;growth;chromatin organization;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,SAP-domain,,,,,,,,,,,,,
9247,Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),GADQKMSSPEDDS,_ESSTSEGADQKM(ox)S(ph)S(ph)PEDDSDTK_,S383,,23.59,,,,,,,,20.61,20.52,,,,21.57,2.02, , , , , , , ,-0.96,-1.05, , , ,"hormone metabolic process;intracellular estrogen receptor signaling pathway;growth;chromatin organization;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,SAP-domain,,,,,,,,,,,,,
9253,Q15424,SAFB,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),EKRSVVSFDKVKE,_S(ph)VVS(ph)FDK_,S604,+,29.08,30.31,30.25,28.95,28.39,30.05,30.32,27.24,30.38,30.58,29.10,22.88,24.77,28.64,0.44,1.67,1.61,0.31,-0.25,1.41,1.68,-1.40,1.74,1.94,0.46,-5.76,-3.87,"hormone metabolic process;intracellular estrogen receptor signaling pathway;growth;chromatin organization;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus,SAP-domain,,,,,,,,,,,,,
9255,O95232,LUC7L3,Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1),TSEDIKSEGDTQS,_NEVNGTSEDIKS(ph)EGDTQSN_,S425,+,23.47,,,23.87,,22.87,23.85,,24.50,22.30,22.86,,22.41,23.26,0.20, , ,0.60, ,-0.40,0.58, ,1.23,-0.97,-0.40, ,-0.86,mRNA processing;RNA splicing;apoptotic process;response to stress,nuclear speck;plasma membrane;nucleus;focal adhesion,,,,,,,,,,,,,,
9256,O95232,LUC7L3,Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1),SEGDTQSN_____,_ESDTKNEVNGTSEDIKSEGDTQS(ph)N_,S431,,,,,,,24.26,,24.60,,,,,,24.43, , , , , ,-0.17, ,0.17, , , , , ,mRNA processing;RNA splicing;apoptotic process;response to stress,nuclear speck;plasma membrane;nucleus;focal adhesion,,,,,,,,,,,,,,
9259,Q8N328,PGBD3,PiggyBac transposable element-derived protein 3,YAPKDDSPDEVPS,_DDS(ph)PDEVPSTFTVQQPPPSRR_,S554,,23.41,23.14,,,,,25.97,,23.21,22.70,25.00,23.36,,23.83,-0.42,-0.69, , , , ,2.14, ,-0.62,-1.12,1.17,-0.46, ,,,,,,,,,,,,,,,,
9260,Q03468,ERCC6,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),KIIEQLSPQAATS,_IIEQLS(ph)PQAATSR_,S158,+,20.86,,,22.27,25.03,24.44,24.97,24.83,22.27,,22.56,,24.04,23.47,-2.61, , ,-1.20,1.55,0.96,1.49,1.35,-1.20, ,-0.91, ,0.57,"response to oxidative stress;photoreceptor cell maintenance;response to toxin;pyrimidine dimer repair;intrinsic apoptotic signaling pathway in response to DNA damage;positive regulation of DNA-dependent transcription, elongation;response to gamma radiation;activation of JNKK activity;response to UV;response to UV-B;activation of JUN kinase activity;base-excision repair;response to superoxide;transcription from RNA polymerase II promoter;transcription-coupled nucleotide-excision repair;response to X-ray",transcription elongation factor complex;nucleolus,Other TF domain,,,,,,,,,,,,,
9261,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),GLKRAASAIYRLF,_AAS(ph)AIYR_,S106,,24.26,23.72,23.72,,,,,,,,,,,23.90,0.36,-0.18,-0.18, , , , , , , , , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
9262,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),EGLLTHSEEELEH,_TRDDGDEEGLLT(ph)HS(ph)EEELEHSQDTDADDGALQ_,S289,+,28.48,,,,29.90,28.23,28.48,28.36,29.67,29.26,27.84,28.11,28.05,28.64,-0.16, , , ,1.26,-0.41,-0.16,-0.28,1.03,0.63,-0.79,-0.53,-0.59,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
9263,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),EEELEHSQDTDAD,_TRDDGDEEGLLTHS(ph)EEELEHS(ph)QDT(ph)DADDGALQ_,S296,,27.14,,,,,,,,,,,,,27.14,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
9264,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),DYRGRLSPVPVPR,_LS(ph)PVPVPR_,S135,+,27.67,26.64,26.94,26.96,28.30,29.09,30.31,27.65,28.45,28.01,27.38,27.38,28.05,27.91,-0.24,-1.27,-0.97,-0.95,0.39,1.18,2.40,-0.26,0.54,0.10,-0.53,-0.53,0.13,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
9267,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),ETQAPESPGENSE,_PVQETQAPES(ph)PGENSEQALQTLSPR_,S11,,,,,,,,,,,24.59,,,22.97,23.78, , , , , , , , , ,0.81, , ,-0.81,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
9268,Q7Z434,MAVS,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),QALQTLSPRAIPR,_PVQETQAPESPGENSEQALQTLS(ph)PR_,S24,+,,23.91,23.91,,24.09,23.43,23.69,24.38,24.59,25.83,23.99,,,24.20, ,-0.29,-0.29, ,-0.12,-0.77,-0.51,0.18,0.39,1.62,-0.21, , ,"defense response to virus;positive regulation of tumor necrosis factor production;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of peroxisome organization;positive regulation of protein import into nucleus, translocation;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;positive regulation of interferon-beta production;negative regulation of viral genome replication;negative regulation of type I interferon production;positive regulation of interferon-alpha production;positive regulation of sequence-specific DNA binding transcription factor activity;positive regulation of transcription factor import into nucleus;innate immune response;positive regulation of type I interferon-mediated signaling pathway;positive regulation of interleukin-8 production;positive regulation of protein phosphorylation;defense response to bacterium;cellular response to exogenous dsRNA;positive regulation of defense response to virus by host;positive regulation of chemokine (C-C motif) ligand 5 production;positive regulation of IP-10 production;activation of innate immune response",mitochondrial outer membrane;integral to membrane;peroxisomal membrane,,,,,,,,,,,,,,
9272,Q9Y2L9,LRCH1,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),NEIRENSPAVSPT,_ENS(ph)PAVS(ph)PTTNSTAPFGLKPR_,S532,,24.25,21.84,21.84,,,,,,,,,,,22.64,1.60,-0.80,-0.80, , , , , , , , , , ,,,,,,,,,,,,,,,,
9273,Q9Y2L9,LRCH1,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),ENSPAVSPTTNST,_ENS(ph)PAVS(ph)PTTNSTAPFGLKPR_,S536,,24.25,21.84,21.84,,,,,,,,,,,22.64,1.60,-0.80,-0.80, , , , , , , , , , ,,,,,,,,,,,,,,,,
9275,P00519,ABL1,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),ESSPGSSPPNLTP,_DIM(ox)ESSPGSS(ph)PPNLTPK_,S1312,,,21.91,,,,,23.28,,,22.91,23.59,,,22.92, ,-1.01, , , , ,0.36, , ,-0.01,0.66, , ,regulation of autophagy;autophagy;positive regulation of oxidoreductase activity;negative regulation of protein serine/threonine kinase activity;actin cytoskeleton organization;regulation of endocytosis;mismatch repair;peptidyl-tyrosine phosphorylation;blood coagulation;regulation of cell motility;intrinsic apoptotic signaling pathway in response to DNA damage;DNA damage induced protein phosphorylation;regulation of transcription involved in S phase of mitotic cell cycle;regulation of cell cycle;endocytosis;positive regulation of muscle cell differentiation;regulation of cell adhesion;axon guidance;regulation of response to DNA damage stimulus;regulation of actin cytoskeleton reorganization;cell adhesion;muscle cell differentiation;positive regulation of apoptotic process;signal transduction in response to DNA damage,nuclear membrane;cytosol;mitochondrion;nucleolus;actin cytoskeleton;perinuclear region of cytoplasm,DNA binding region,+,,,,,,,,,,,,
9276,P00519,ABL1,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),DHEPAVSPLLPRK,_GQGESDPLDHEPAVS(ph)PLLPR_,S1072,,,21.24,,,23.07,,,,,,,,,22.16, ,-0.92, , ,0.92, , , , , , , , ,regulation of autophagy;autophagy;positive regulation of oxidoreductase activity;negative regulation of protein serine/threonine kinase activity;actin cytoskeleton organization;regulation of endocytosis;mismatch repair;peptidyl-tyrosine phosphorylation;blood coagulation;regulation of cell motility;intrinsic apoptotic signaling pathway in response to DNA damage;DNA damage induced protein phosphorylation;regulation of transcription involved in S phase of mitotic cell cycle;regulation of cell cycle;endocytosis;positive regulation of muscle cell differentiation;regulation of cell adhesion;axon guidance;regulation of response to DNA damage stimulus;regulation of actin cytoskeleton reorganization;cell adhesion;muscle cell differentiation;positive regulation of apoptotic process;signal transduction in response to DNA damage,nuclear membrane;cytosol;mitochondrion;nucleolus;actin cytoskeleton;perinuclear region of cytoplasm,DNA binding region,+,,,,,,,,,,,,
9278,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KKAASPSPQSVRR,_AAS(ph)PS(ph)PQSVR_,S752,+,26.22,26.16,,27.13,23.25,20.23,,22.54,,,,,20.97,23.79,2.43,2.37, ,3.34,-0.54,-3.56, ,-1.24, , , , ,-2.81,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9279,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PRAPQTSSSPPPV,_APQTS(ph)S(ph)SPPPVRR_,S706,+,25.38,24.40,24.40,24.22,23.73,,,,22.36,22.38,,24.24,,23.89,1.49,0.51,0.51,0.34,-0.16, , , ,-1.53,-1.51, ,0.35, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9285,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),GFFRGTSAEQDNR,_GTS(ph)AEQDNRFSNK_,S10,+,24.35,24.47,25.06,23.60,,24.70,,22.87,26.09,,23.13,,,24.28,0.07,0.19,0.78,-0.69, ,0.41, ,-1.41,1.80, ,-1.15, , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9287,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KPPAPPSPVQSQS,_KPPAPPS(ph)PVQSQS(ph)PSTNWSPAVPVK_,S781,+,27.71,26.58,27.01,26.45,25.69,,,25.10,25.56,25.00,,,,26.14,1.58,0.44,0.87,0.31,-0.45, , ,-1.04,-0.58,-1.14, , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9289,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),SPVQSQSPSTNWS,_KPPAPPS(ph)PVQSQS(ph)PSTNWSPAVPVK_,S787,+,27.57,26.58,27.01,26.45,24.44,,,23.21,24.89,24.34,,,,25.56,2.01,1.02,1.45,0.89,-1.12, , ,-2.36,-0.67,-1.22, , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9290,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),SPSTNWSPAVPVK,_KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPVK_,S793,,26.79,23.64,23.64,23.73,,,,,,,,,,24.45,2.34,-0.81,-0.81,-0.72, , , , , , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9292,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),KVELSESEEDKGG,_KVELS(ph)ES(ph)EEDKGGK_,S463,+,30.44,30.36,30.29,30.08,28.54,26.69,29.18,28.88,30.25,29.44,22.71,28.35,26.32,28.58,1.86,1.78,1.71,1.50,-0.04,-1.89,0.60,0.30,1.67,0.86,-5.87,-0.23,-2.26,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9293,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RKTRRLSPSASPP,_RLS(ph)PS(ph)AS(ph)PPR_,S389,,26.87,24.54,,27.73,25.90,,,,,,23.50,,,25.71,1.16,-1.17, ,2.02,0.19, , , , , ,-2.21, , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9294,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TRRLSPSASPPRR,_RLS(ph)PS(ph)AS(ph)PPR_,S391,,26.90,24.46,,27.70,,,,,23.11,,,,,25.54,1.36,-1.08, ,2.15, , , , ,-2.43, , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9295,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RLSPSASPPRRRH,_RLS(ph)PS(ph)AS(ph)PPR_,S393,+,27.18,25.27,21.62,25.56,26.01,23.48,22.38,21.87,24.10,23.74,23.81,,21.22,23.85,3.33,1.41,-2.23,1.71,2.16,-0.37,-1.48,-1.99,0.25,-0.12,-0.04, ,-2.63,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9296,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PEPKEPSPEKNSK,_VPKPEPIPEPKEPS(ph)PEK_,S260,+,27.04,28.78,28.89,27.47,25.90,29.77,29.72,27.52,30.11,29.97,29.28,29.41,29.81,28.74,-1.70,0.03,0.14,-1.27,-2.85,1.03,0.98,-1.22,1.37,1.22,0.53,0.66,1.07,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9298,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PPKQRSSPVTKRR,_(gl)QRSS(ph)PVTK_,S658,+,,,,23.80,,21.29,20.90,20.96,21.87,19.45,19.71,22.08,,21.26, , , ,2.54, ,0.04,-0.36,-0.30,0.61,-1.81,-1.55,0.82, ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9300,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),QRRQSPSPSTRPI,_(gl)QS(ph)PS(ph)PSTRPIR_,S727,,28.75,26.39,23.09,28.86,25.17,,,,,,,,,26.45,2.30,-0.06,-3.36,2.41,-1.28, , , , , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9303,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PVTKRRSPSLSSK,_RRS(ph)PS(ph)LSSK_,S665,+,26.49,26.50,25.82,24.65,20.50,,18.55,18.91,,,,,,23.06,3.43,3.44,2.76,1.59,-2.56, ,-4.51,-4.15, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9304,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),TKRRSPSLSSKHR,_RRS(ph)PS(ph)LSSK_,S667,,25.24,25.41,25.61,24.38,19.77,,,,,,,,,24.08,1.16,1.32,1.52,0.30,-4.31, , , , , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9305,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RRSPSLSSKHRKG,_RRS(ph)PSLS(ph)SK_,S669,,24.81,25.40,20.12,20.15,,,,,,,,,,22.62,2.19,2.78,-2.50,-2.47, , , , , , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9310,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),RPIRRVSRTPEPK,_RVS(ph)RT(ph)PEPK_,S737,+,26.09,26.24,24.29,27.26,22.39,19.95,18.43,19.62,,,,,,23.03,3.06,3.21,1.26,4.23,-0.64,-3.09,-4.61,-3.41, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9311,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),MGKRWQSPVTKSG,_WQS(ph)PVTK_,S550,,26.26,27.15,24.81,27.30,26.70,25.46,25.04,25.27,25.87,25.87,24.46,25.22,23.54,25.61,0.65,1.54,-0.80,1.69,1.09,-0.15,-0.57,-0.34,0.26,0.26,-1.16,-0.39,-2.07,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9312,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PSPRRYSPPIQRR,_RYS(ph)PPIQR_,S609,+,26.53,27.95,27.98,27.19,28.57,28.14,27.87,28.64,28.26,27.32,26.35,26.91,26.18,27.53,-1.00,0.42,0.45,-0.34,1.04,0.61,0.34,1.11,0.73,-0.21,-1.18,-0.62,-1.35,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
9318,P19484,TFEB,Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35),ASSRRSSFSMEEG,_RSS(ph)FSM(ox)EEGDVL_,S553,+,22.85,23.13,,23.04,24.04,24.65,24.03,25.14,22.34,,25.48,,,23.86,-1.00,-0.72, ,-0.82,0.18,0.80,0.17,1.29,-1.52, ,1.63, , ,"humoral immune response;embryonic placenta development;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;nucleus;cytoplasm,bHLH,,,,,,,,,,,,,
9319,Q96KQ7,EHMT2,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a),KRRKLNSGGGLSE,_LNS(ph)GGGLSEELGSAR_,S232,,23.69,,,21.81,,,,,,,,,,22.75,0.94, , ,-0.94, , , , , , , , , ,spermatid development;fertilization;pachytene;regulation of DNA replication;peptidyl-lysine dimethylation;organ growth;DNA methylation on cytosine within a CG sequence;synaptonemal complex assembly;negative regulation of transcription from RNA polymerase II promoter;DNA methylation,chromosome;nucleus,,,,,,,,,,,,,,
9320,Q96KQ7,EHMT2,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a),MTGAGKSPPSVQS,_S(ph)PPSVQSLAM(ox)R_,S140,,23.66,,,23.46,,,22.68,,,,22.11,22.66,,22.91,0.75, , ,0.54, , ,-0.24, , , ,-0.80,-0.26, ,spermatid development;fertilization;pachytene;regulation of DNA replication;peptidyl-lysine dimethylation;organ growth;DNA methylation on cytosine within a CG sequence;synaptonemal complex assembly;negative regulation of transcription from RNA polymerase II promoter;DNA methylation,chromosome;nucleus,,,,,,,,,,,,,,
9321,P85299,PRR5,Proline-rich protein 5 (Protein observed with Rictor-1) (Protor-1),RRLKFMSSPSLSD,_FM(ox)S(ph)SPSLSDLGK_,S11,,23.75,21.19,21.19,21.21,,,,,,21.82,,,,21.83,1.92,-0.64,-0.64,-0.62, , , , , ,-0.01, , , ,cell cycle,,,,,,,,,,,,,,,
9324,Q00341,HDLBP,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),QITRDFSVQIKFP,_DFS(ph)VQIK_,S904,,21.94,,,,,,,,,,,,,21.94,0.00, , , , , , , , , , , , ,cholesterol metabolic process;lipid transport,plasma membrane;nucleus;high-density lipoprotein particle;cytoplasm,,,,,,,,,,,,,,
9325,Q00341,HDLBP,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),KVATLNSEEESDP,_VATLNS(ph)EEESDPPTYK_,S31,+,26.41,26.98,27.05,28.20,27.63,28.54,28.67,28.49,27.98,27.46,28.03,28.26,27.66,27.80,-1.39,-0.82,-0.75,0.41,-0.16,0.74,0.87,0.69,0.19,-0.34,0.23,0.47,-0.14,cholesterol metabolic process;lipid transport,plasma membrane;nucleus;high-density lipoprotein particle;cytoplasm,,,,,,,,,,,,,,
9331,Q14789,GOLGB1,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),KWERKFSDAIQSK,_KFS(ph)DAIQSK_,S2141,,24.32,24.53,24.66,23.12,,,,,22.96,22.57,22.02,,,23.46,0.87,1.08,1.21,-0.34, , , , ,-0.50,-0.88,-1.44, , ,Golgi organization,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;Golgi stack;Golgi membrane,,,,,,,,,,,,,,
9332,Q14789,GOLGB1,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),QYQRQASPETSAS,_QAS(ph)PETSASPDGSQNLVYETELLR_,S2935,,24.72,,,,,,,,22.95,,,,,23.84,0.88, , , , , , , ,-0.88, , , , ,Golgi organization,endoplasmic reticulum-Golgi intermediate compartment;integral to membrane;Golgi stack;Golgi membrane,,,,,,,,,,,,,,
9340,B3KN83,C14orf46,"Chromosome 14 open reading frame 46 (cDNA FLJ13917 fis, clone Y79AA1000355, highly similar to 12.5 kDa retinal tissue protein)",____MASPTDGTD,_(ac)AS(ph)PTDGTDLEASLLSFEK_,S3,,23.73,,,,,,,,,,,,,23.73,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
9341,Q9HD15,SRA1,Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP),SSKAPRSPPVGSG,_S(ph)PPVGSGPASGVEPTSFPVESEAR_,S87,+,,23.60,,25.50,26.80,27.10,27.55,28.30,26.69,24.95,27.18,,26.62,26.43, ,-2.83, ,-0.93,0.37,0.67,1.12,1.87,0.26,-1.48,0.75, ,0.19,"cell proliferation;cell differentiation;apoptotic process;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;ribonucleoprotein complex;cell leading edge;nucleus;cytoplasm,,,,,,,,,,,,,,
9342,Q5PSV4,BRMS1L,Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40),KRKDPFSPDKKKP,_DPFS(ph)PDK_,S139,,23.68,22.84,22.84,22.21,,,,,20.47,,,,,22.41,1.27,0.44,0.44,-0.20, , , , ,-1.94, , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;regulation of growth",nucleus,,,,,,,,,,,,,,
9349,Q9NZJ5,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK),IEIIAPSPQRSRS,_EHIEIIAPS(ph)PQR_,S564,,22.60,,,,22.05,,,,21.45,22.67,22.42,,,22.24,0.36, , , ,-0.19, , , ,-0.79,0.43,0.19, , ,negative regulation of myelination;insulin secretion;fat cell differentiation;protein autophosphorylation;endoplasmic reticulum organization;activation of cysteine-type endopeptidase activity involved in apoptotic process;bone mineralization;translation;calcium-mediated signaling;endocrine pancreas development;negative regulation of translational initiation in response to stress;chondrocyte development;positive regulation of signal transduction;positive regulation of protein binding;ER overload response;regulation of fatty acid metabolic process;insulin-like growth factor receptor signaling pathway;activation of signaling protein activity involved in unfolded protein response;protein homooligomerization;SREBP signaling pathway;lactation;virus-infected cell apoptotic process,integral to membrane;endoplasmic reticulum membrane,,+,,,,,,,,,,,,
9357,B4DGG4,SERHL2,"Serine hydrolase-like protein (cDNA FLJ60497, highly similar to Serine hydrolase-like protein (EC 3.1.-.-))",HSFALLSPRWRRG,_FSILGHSFALLS(ph)PR_,S113,,24.76,,,20.26,,20.94,,20.97,,,,,,21.74,3.03, , ,-1.47, ,-0.80, ,-0.76, , , , , ,,,,,,,,,,,,,,,,
9358,Q96S06,LMF1,Lipase maturation factor 1 (Transmembrane protein 112),MAAPAESLRRRKT,_(ac)AAPAES(ph)LRR_,S7,,23.86,22.83,22.83,26.28,,,23.79,,,,,24.81,,24.07,-0.21,-1.24,-1.24,2.22, , ,-0.28, , , , ,0.74, ,regulation of cholesterol metabolic process;protein secretion;protein glycosylation in Golgi;regulation of triglyceride metabolic process;chylomicron remnant clearance;ER to Golgi vesicle-mediated transport;positive regulation of lipoprotein lipase activity;protein maturation,integral to membrane;Golgi apparatus;endoplasmic reticulum membrane,,,,,,,,,,,,,,
9360,P04259,KRT6B,"Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)",SSRRGFSASSARL,_GFS(ph)ASSAR_,S19,,26.99,,,23.22,23.34,,23.08,,,22.54,20.41,21.30,,22.98,4.01, , ,0.24,0.36, ,0.10, , ,-0.45,-2.57,-1.68, ,ectoderm development,keratin filament,,,,,,,,,,,,,,
9362,P04259,KRT6B,"Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)",RGFSASSARLPGV,_RGFSASS(ph)AR_,S22,,27.99,21.60,,,22.38,,22.45,,,21.75,,,,23.23,4.76,-1.64, , ,-0.86, ,-0.78, , ,-1.48, , , ,ectoderm development,keratin filament,,,,,,,,,,,,,,
9363,P04259,KRT6B,"Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)",SGFSSISVSRSRG,_SGFSSIS(ph)VSR_,S37,,25.07,,,,21.92,,,21.95,,,,,,22.98,2.09, , , ,-1.06, , ,-1.03, , , , , ,ectoderm development,keratin filament,,,,,,,,,,,,,,
9364,B4DKY2,PTPN12,Tyrosine-protein phosphatase non-receptortype 12,EPEKQDSPPPKPP,_(gl)QDS(ph)PPPKPPR_,S202,,24.01,25.60,24.59,26.27,24.03,,25.45,,,23.72,24.73,24.30,24.70,24.74,-0.73,0.86,-0.15,1.54,-0.71, ,0.71, , ,-1.02,-0.01,-0.44,-0.04,peptidyl-tyrosine dephosphorylation,,,,,,,,,,,+,,,,
9368,Q68DQ2,CRYBG3,Beta/gamma crystallin domain-containing protein 3,ESTNLPSPNKSIR,_SDGSDTTEQESTNLPS(ph)PNK_,S457,,23.92,25.17,25.17,,,,23.58,,,,,,,24.46,-0.54,0.71,0.71, , , ,-0.88, , , , , , ,,,,,,,,,,,,,,,,
9369,Q68DQ2,CRYBG3,Beta/gamma crystallin domain-containing protein 3,EVDALGSPPALLK,_YEDKPEPEVDALGS(ph)PPALLK_,S931,,,,,,,,,,,,24.65,23.95,,24.30, , , , , , , , , , ,0.35,-0.35, ,,,,,,,,,,,,,,,,
9371,Q96GM8,TOE1,Target of EGR1 protein 1,__MAADSDDGAVS,_AADS(ph)DDGAVSAPAASDGER_,S5,,21.92,,,,24.13,,,22.70,,,,,,22.92,-0.99, , , ,1.21, , ,-0.22, , , , , ,,nucleolus;nuclear speck,,,,,,,,,,,,,,
9372,Q05682,CALD1,Caldesmon (CDM),SVDKVTSPTKEPV,_VTS(ph)PTKEPVSK_,S483,,18.95,25.67,25.67,23.38,,20.07,,,,20.49,,,21.97,22.31,-3.37,3.36,3.36,1.07, ,-2.25, , , ,-1.83, , ,-0.35,actin filament bundle assembly;muscle contraction;positive regulation of protein binding;cellular component movement,neuronal cell body;postsynaptic density;actin cytoskeleton;cytosol;actin filament;myofibril;actin cap;plasma membrane,,,,,,,,,,,,,,
9374,P30305,CDC25B,M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B),QNKRRRSVTPPEE,_S(ph)VTPPEEQQEAEEPK_,S262,+,,,,23.83,24.36,24.51,24.98,25.59,23.11,,23.65,23.94,23.48,24.16, , , ,-0.33,0.20,0.35,0.82,1.43,-1.05, ,-0.51,-0.22,-0.68,protein phosphorylation;female meiosis I;positive regulation of protein kinase activity;positive regulation of cell cycle cytokinesis;G2/M transition of mitotic cell cycle;mitosis;positive regulation of cell proliferation;positive regulation of mitotic cell cycle;cell division;oocyte maturation,nucleoplasm;cytosol;centrosome;spindle pole,,,+,,,,,,,,,,,
9375,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),ARAAKLSEGSQPA,_AAKLS(ph)EGS(ph)QPAEEEEDQETPSRNLR_,S142,+,26.48,25.20,25.63,25.99,25.57,25.37,24.88,25.76,24.36,25.63,25.06,23.23,25.97,25.32,1.16,-0.12,0.31,0.67,0.25,0.05,-0.44,0.44,-0.96,0.31,-0.25,-2.09,0.65,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9377,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),SDTKAESPAEKVP,_AES(ph)PAEKVPEESVLPLVQK_,S392,+,27.73,26.98,27.62,24.72,24.99,25.87,28.36,25.57,29.07,29.19,27.86,27.10,26.41,27.04,0.70,-0.05,0.58,-2.32,-2.05,-1.17,1.33,-1.47,2.04,2.15,0.82,0.07,-0.63,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9378,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),LPEQTASEEETPP,_ASLVALPEQTAS(ph)EEETPPPLLTK_,S312,+,26.22,25.32,25.32,25.57,26.93,,,25.58,25.43,25.74,25.58,24.99,26.12,25.71,0.51,-0.39,-0.39,-0.14,1.22, , ,-0.13,-0.28,0.03,-0.13,-0.72,0.41,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9386,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),RTAQVPSPPRGKI,_TAQVPS(ph)PPRGK_,S908,+,27.39,27.86,26.89,26.83,28.17,28.01,27.37,27.60,28.32,28.10,26.56,27.20,27.60,27.53,-0.14,0.33,-0.64,-0.70,0.64,0.48,-0.16,0.07,0.79,0.57,-0.97,-0.33,0.07,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9387,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),QGLKEKSKSPSPP,_S(ph)KSPS(ph)PPRLTEDR_,S286,+,24.19,24.50,23.66,24.48,23.90,,,21.88,22.49,,21.88,,,23.37,0.82,1.12,0.29,1.11,0.53, , ,-1.50,-0.88, ,-1.50, , ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9388,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),LKEKSKSPSPPRL,_SKS(ph)PS(ph)PPRLTEDR_,S288,,25.74,26.17,24.60,25.69,,,,,24.27,,,,,25.30,0.45,0.88,-0.69,0.40, , , , ,-1.03, , , , ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9390,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),SSNSRKSLSPGVS,_S(ph)LS(ph)PGVSRDSSTSYTETK_,S559,+,26.33,25.77,25.77,24.26,,,22.19,,25.17,26.26,,,,25.11,1.22,0.67,0.67,-0.85, , ,-2.92, ,0.06,1.15, , , ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9391,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),NSRKSLSPGVSRD,_S(ph)LS(ph)PGVSRDSSTSYTETK_,S561,+,26.66,25.98,26.02,27.37,24.18,24.39,23.94,24.15,25.48,27.09,22.49,22.66,22.18,24.81,1.85,1.16,1.21,2.55,-0.64,-0.42,-0.87,-0.67,0.66,2.28,-2.32,-2.16,-2.64,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9393,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),KEMKTTSPLEEEE,_TTS(ph)PLEEEER_,S267,+,27.40,27.83,27.69,26.00,26.49,27.69,25.20,25.65,27.22,27.60,25.72,23.11,24.64,26.33,1.07,1.50,1.37,-0.32,0.17,1.36,-1.12,-0.67,0.89,1.27,-0.60,-3.22,-1.69,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9394,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),MTVEKASPVGDGN,_AS(ph)PVGDGNFR_,S903,,24.54,24.81,,25.83,,23.20,23.54,,,,,,,24.38,0.15,0.43, ,1.45, ,-1.18,-0.84, , , , , , ,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9395,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),AAQRATSVDYSSF,_ATS(ph)VDYSSFADR_,S864,,,23.19,,23.93,23.52,24.55,22.87,22.77,24.91,,22.89,24.34,,23.66, ,-0.47, ,0.26,-0.15,0.89,-0.80,-0.89,1.25, ,-0.77,0.68, ,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9398,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),FLPACNSPSKEMK,_LSSPAAFLPACNS(ph)PSK_,S260,+,25.02,23.43,23.43,24.20,,23.50,23.32,24.00,24.40,24.16,,,,23.94,1.08,-0.51,-0.51,0.26, ,-0.44,-0.62,0.06,0.46,0.22, , , ,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9401,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),NQTYSFSPSKSYS,_NQTYSFS(ph)PSK_,S295,+,25.68,25.94,26.16,25.89,23.84,24.99,25.23,25.68,25.27,25.11,24.92,,24.87,25.30,0.38,0.64,0.87,0.59,-1.46,-0.31,-0.07,0.38,-0.02,-0.19,-0.38, ,-0.43,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9404,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),RLLRSQSESSDEV,_SQS(ph)ESS(ph)DEVTELDLSHGK_,S659,,24.78,,,21.48,,,,,,,,,,23.13,1.65, , ,-1.65, , , , , , , , , ,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9405,Q86YS7,C2CD5,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),RSQSESSDEVTEL,_SQS(ph)ESS(ph)DEVTELDLSHGK_,S662,,24.78,,,21.48,,,,,,,,,,23.13,1.65, , ,-1.65, , , , , , , , , ,protein localization to plasma membrane;positive regulation of glucose import in response to insulin stimulus;vesicle fusion,plasma membrane,,,,,,,,,,,,,,
9411,Q9BT70,SORBS3,SORBS3 protein (Fragment),RSARHPSSPSALR,_HPS(ph)SPSALRS(ph)PADPTDLGGQTS(ph)PR_,S141,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
9414,Q9BT70,SORBS3,SORBS3 protein (Fragment),DLGGQTSPRRTGF,_SPADPTDLGGQTS(ph)PRR_,S160,,26.60,25.88,,26.59,25.77,26.55,27.65,27.67,27.13,22.55,27.03,26.87,25.51,26.32,0.29,-0.44, ,0.27,-0.55,0.23,1.34,1.36,0.81,-3.77,0.71,0.56,-0.81,,,,,,,,,,,,,,,,
9415,B4DY08,HNRNPC,"Heterogeneous nuclear ribonucleoproteins C1/C2 (cDNA FLJ53542, highly similar to Heterogeneous nuclear ribonucleoproteins C)",TNVKMESEGGADD,_M(ox)ES(ph)EGGADDS(ph)AEEGDLLDDDDNEDRGDDQVK_,S240,,23.64,,,,,,,,,,,,,23.64,0.00, , , , , , , , , , , , ,,ribonucleoprotein complex,,,,,,,,,,+,,,,
9417,O43172,PRPF4,U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4),KEVIDASDKEGMS,_RKEVIDAS(ph)DK_,S73,,29.80,26.86,27.86,28.50,27.52,23.14,,,23.65,23.59,21.59,24.29,21.05,25.26,4.54,1.60,2.60,3.24,2.26,-2.12, , ,-1.61,-1.67,-3.67,-0.97,-4.21,"mRNA splicing, via spliceosome",U4/U6 snRNP;nuclear speck;Cajal body;spliceosomal complex,,,,,,,,,,,,,,
9422,Q14699,RFTN1,Raftlin (Cell migration-inducing gene 2 protein) (Raft-linking protein),PAGRNQSPEPSSG,_NQS(ph)PEPSSGPRGEVPLAK_,S434,+,22.15,,,25.24,25.19,26.44,25.56,25.41,24.34,24.71,26.38,25.69,26.60,25.25,-3.10, , ,-0.01,-0.05,1.19,0.31,0.17,-0.91,-0.53,1.13,0.45,1.36,,membrane raft;plasma membrane,,,,,,,,,,,,,,
9424,Q9Y2K5,R3HDM2,R3H domain-containing protein 2,PVTKASSFSGISI,_ASS(ph)FSGISILTR_,S114,+,23.48,,,22.24,22.32,,21.36,22.53,,,21.80,20.97,,22.10,1.38, , ,0.14,0.22, ,-0.74,0.43, , ,-0.30,-1.13, ,,nucleus,,,,,,,,,,,,,,
9426,Q9Y2K5,R3HDM2,R3H domain-containing protein 2,QALKSASTDLGTA,_SAS(ph)TDLGTADVVLGR_,S620,+,23.93,22.05,22.05,20.64,23.71,,23.48,23.25,22.47,23.09,22.66,24.20,,22.87,1.07,-0.82,-0.82,-2.23,0.84, ,0.61,0.39,-0.39,0.22,-0.21,1.34, ,,nucleus,,,,,,,,,,,,,,
9427,H7C0E9,R3HDM2,R3H domain-containing protein 2 (Fragment),DGRRSKSIEEREE,_S(ph)IEEREEEYQR_,S34,,,,,,22.14,23.71,26.26,25.05,23.35,,24.98,25.57,,24.44, , , , ,-2.30,-0.73,1.82,0.61,-1.09, ,0.55,1.13, ,,,,,,,,,,,,,,,,
9429,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),RAKDRESPRSYSS,_DRES(ph)PRSYSSTLTDM(ox)GR_,S469,,,,,,24.70,,24.79,25.10,25.44,27.65,24.22,,24.04,25.13, , , , ,-0.44, ,-0.35,-0.03,0.30,2.51,-0.91, ,-1.09,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9430,C9JKV9,SORBS2,Sorbin and SH3 domain-containing protein 2,TGRDSQSPDSAWR,_DSQS(ph)PDSAWR_,S9,,22.99,,,,24.85,23.30,21.74,21.39,24.55,24.68,22.62,,23.08,23.24,-0.26, , , ,1.61,0.05,-1.50,-1.86,1.31,1.44,-0.63, ,-0.17,,,,,,,,,,,,,,,,
9431,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),FRKRRKSEPAVGP,_S(ph)EPAVGPPR_,S417,+,26.84,23.64,23.48,23.80,,,23.35,,24.58,27.05,22.87,,,24.45,2.39,-0.81,-0.97,-0.65, , ,-1.10, ,0.13,2.60,-1.59, , ,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9432,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),TSSSPSSPSRAKD,_SFTSSSPSS(ph)PSR_,S460,,26.69,,,23.09,23.32,,,22.48,22.49,25.04,,,,23.85,2.84, , ,-0.77,-0.53, , ,-1.37,-1.36,1.19, , , ,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9433,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),PLSKSHSDNSPNA,_SHS(ph)DNSPNAFK_,S240,,23.12,,,,,,,,,,,,,23.12,0.00, , , , , , , , , , , , ,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9439,Q14562,DHX8,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),KQSMDMSPIKIVK,_(gl)QSM(ox)DM(ox)S(ph)PIKIVK_,S460,,,,,,25.00,,22.14,,,,,,,23.57, , , , ,1.43, ,-1.43, , , , , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
9440,Q2M389,KIAA1033,WASH complex subunit 7,MAVETLSPDWEFD,_(ac)AVETLS(ph)PDWEFDRVDDGSQK_,S7,,21.45,,,,,,,,,,,,,21.45,0.00, , , , , , , , , , , , ,endosomal transport,endosome;WASH complex,,,,,,,,,,,,,,
9451,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),PDGSSLSPAQSPS,_DQPDGSSLS(ph)PAQSPSQSQPPAASSLREPGLESK_,S219,+,25.86,24.29,24.29,24.64,,,26.04,,26.39,27.06,25.37,24.95,24.34,25.32,0.53,-1.03,-1.03,-0.68, , ,0.72, ,1.07,1.74,0.04,-0.37,-0.99,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9452,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),SLSPAQSPSQSQP,_DQPDGSSLS(ph)PAQS(ph)PSQSQPPAASSLREPGLESK_,S223,,26.17,24.60,24.60,24.10,,,,,,26.70,,,,25.24,0.93,-0.63,-0.63,-1.13, , , , , ,1.46, , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9453,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),RMEVDRSPGLPMS,_M(ox)EVDRS(ph)PGLPM(ox)SDLK_,S618,+,24.07,25.24,25.38,25.06,25.97,26.09,26.16,26.19,26.44,25.05,26.69,24.87,26.85,25.70,-1.62,-0.46,-0.32,-0.64,0.28,0.39,0.47,0.49,0.74,-0.64,0.99,-0.83,1.15,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9454,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),RNIRSKSLKEGLT,_SKS(ph)LKEGLTVQER_,S1015,,,,,,24.17,,,23.36,,,,,,23.77, , , , ,0.40, , ,-0.40, , , , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9455,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),DIMKSKSNPDFLK,_S(ph)NPDFLKK_,S992,+,23.47,24.59,24.68,26.70,23.59,,25.71,22.71,25.82,25.65,24.21,25.62,,24.80,-1.32,-0.20,-0.11,1.90,-1.21, ,0.91,-2.08,1.02,0.85,-0.59,0.83, ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9456,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),GGEATGSPLAQGK,_TLLTGDGGGEATGS(ph)PLAQGK_,S890,,23.10,,,,,,22.24,,23.55,24.01,,,,23.22,-0.13, , , , , ,-0.99, ,0.33,0.79, , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9457,Q6WCQ1,MPRIP,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),VESGYFSLEKTKQ,_VRVESGYFS(ph)LEK_,S268,+,,,,,23.72,24.02,24.86,24.15,24.78,24.72,24.11,24.47,25.08,24.43, , , , ,-0.72,-0.42,0.42,-0.29,0.35,0.28,-0.33,0.04,0.65,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9458,Q15042,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP),DEGKKTSASDVTN,_KTS(ph)ASDVTNIYPGDAGK_,S537,+,22.18,24.09,24.73,22.15,,,24.74,,23.96,24.07,25.89,24.99,25.00,24.18,-2.00,-0.09,0.55,-2.03, , ,0.56, ,-0.22,-0.11,1.71,0.81,0.82,hypothalamus development;face morphogenesis;camera-type eye development,nucleus;centrosome,,,,,,,,,,,,,,
9459,Q14938,NFIX,Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein),NDVDAGSPRATAS,_SPAAGSSQSSGWPNDVDAGS(ph)PR_,S319,,23.44,,,,,,,,,,,,,23.44,0.00, , , , , , , , , , , , ,negative regulation of transcription from RNA polymerase II promoter;DNA replication;positive regulation of transcription from RNA polymerase II promoter,nucleus,CTF/NF-I family,,,,,,,,,,,,,
9460,Q9BXT5,TEX15,Testis-expressed sequence 15 protein (Cancer/testis antigen 42) (CT42),HNSFGKSCDKILI,_ESESHNSFGKS(ph)CDK_,S575,,29.32,29.82,26.09,29.11,24.80,,,22.63,,28.94,25.06,27.81,22.53,26.61,2.71,3.21,-0.53,2.50,-1.81, , ,-3.98, ,2.33,-1.55,1.20,-4.08,fertilization;protein localization to chromosome;regulation of protein localization;male genitalia development;male meiosis;synaptonemal complex assembly;spermatogenesis;regulation of double-strand break repair via homologous recombination;homeostasis of number of cells within a tissue,,,,,,,,,,,,,,,
9461,P48681,NES,Nestin,FADEEESGEEGEE,_DGESDGFADEEES(ph)GEEGEEDQEEGREPGAGR_,S1418,,,,,,25.01,23.58,,23.48,24.96,23.66,,23.63,,24.05, , , , ,0.95,-0.48, ,-0.57,0.91,-0.39, ,-0.42, ,negative regulation of apoptotic process;response to nutrient levels;response to drug;response to ionizing radiation;cell projection morphogenesis;embryonic camera-type eye development;G2/M transition of mitotic cell cycle;negative regulation of protein binding;brain development;stem cell proliferation;positive regulation of neural precursor cell proliferation;negative regulation of catalytic activity;positive regulation of intermediate filament depolymerization,intermediate filament;cytoplasm,,,,,,,,,,,,,,
9464,P48681,NES,Nestin,SLAPPLSPDHSSL,_(gl)QEASTGQSPEDHASLAPPLS(ph)PDHSSLEAK_,S471,,,24.15,,,23.86,,,,,,,,,24.00, ,0.15, , ,-0.15, , , , , , , , ,negative regulation of apoptotic process;response to nutrient levels;response to drug;response to ionizing radiation;cell projection morphogenesis;embryonic camera-type eye development;G2/M transition of mitotic cell cycle;negative regulation of protein binding;brain development;stem cell proliferation;positive regulation of neural precursor cell proliferation;negative regulation of catalytic activity;positive regulation of intermediate filament depolymerization,intermediate filament;cytoplasm,,,,,,,,,,,,,,
9466,P48681,NES,Nestin,TQQRRRSLGEQDQ,_S(ph)LGEQDQM(ox)TLRPPEK_,S768,+,20.95,25.10,25.01,24.28,20.99,23.21,23.27,,24.41,25.44,,25.20,,23.79,-2.83,1.32,1.22,0.50,-2.80,-0.58,-0.52, ,0.62,1.65, ,1.42, ,negative regulation of apoptotic process;response to nutrient levels;response to drug;response to ionizing radiation;cell projection morphogenesis;embryonic camera-type eye development;G2/M transition of mitotic cell cycle;negative regulation of protein binding;brain development;stem cell proliferation;positive regulation of neural precursor cell proliferation;negative regulation of catalytic activity;positive regulation of intermediate filament depolymerization,intermediate filament;cytoplasm,,,,,,,,,,,,,,
9467,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),KEDGRESPSYDTP,_EDGRES(ph)PSYDTPSQR_,S93,+,25.30,27.46,26.84,26.93,25.61,24.81,27.06,24.34,27.74,27.61,24.09,24.30,22.05,25.70,-0.40,1.76,1.13,1.23,-0.10,-0.89,1.36,-1.37,2.03,1.91,-1.61,-1.40,-3.65,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9468,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),GGSRENSTVDFSK,_ENS(ph)TVDFSK_,S292,,23.97,25.19,,24.26,,,,,,,,,,24.47,-0.50,0.72, ,-0.21, , , , , , , , , ,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9470,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),GNGSGGSRENSTV,_GNGSGGS(ph)RENSTVDFSK_,S288,+,23.04,24.81,24.66,24.60,,21.78,24.97,,26.07,25.53,,,,24.43,-1.40,0.37,0.23,0.17, ,-2.65,0.53, ,1.63,1.10, , , ,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9471,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),DIGKKHSDPHLLE,_KHS(ph)DPHLLER_,S251,,,22.03,,20.87,,,20.07,20.19,22.51,20.25,,,,20.99, ,1.04, ,-0.12, , ,-0.92,-0.79,1.52,-0.74, , , ,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9474,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),ILASPQSAPGNLD,_NGILASPQS(ph)APGNLDNSK_,S267,,25.01,25.52,23.35,26.03,25.16,24.72,24.58,25.14,26.91,25.04,24.87,25.22,24.10,25.05,-0.04,0.47,-1.70,0.98,0.11,-0.33,-0.47,0.09,1.86,0.00,-0.18,0.17,-0.95,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9475,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),RIPLVRSFADIGK,_S(ph)FADIGK_,S242,+,26.06,25.69,23.77,26.26,22.57,,23.05,,25.72,,,,,24.73,1.33,0.95,-0.96,1.52,-2.16, ,-1.68, ,0.99, , , , ,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9476,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),LLTRVTSRGPDEE,_VTS(ph)RGPDEEAVVDLGK_,S19,,23.99,24.12,24.06,23.03,27.09,23.43,25.33,24.60,25.31,25.09,24.99,25.11,23.42,24.58,-0.59,-0.46,-0.52,-1.55,2.51,-1.15,0.75,0.02,0.73,0.50,0.41,0.52,-1.16,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9477,Q9Y6M7,SLC4A7,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),KYSVDPSIVNISD,_YSVDPS(ph)IVNISDEM(ox)AK_,S1077,,23.78,,,,,,,,,,,23.80,,23.79,-0.01, , , , , , , , , , ,0.01, ,retina vasculature morphogenesis in camera-type eye;auditory receptor cell development;retinal cell programmed cell death;cochlear nucleus development,integral to membrane;basolateral plasma membrane;apical plasma membrane;plasma membrane;stereocilium,,,,,,,,,,,,,,
9481,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),SIDRRASDSVFQP,_AS(ph)DSVFQPK_,S699,,24.66,22.59,20.71,25.21,22.40,,,21.92,,,24.69,21.89,,23.01,1.66,-0.42,-2.30,2.20,-0.61, , ,-1.09, , ,1.68,-1.12, ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9482,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),SGQESESIPEYTA,_DSGQESES(ph)IPEYTAEEER_,S2866,,22.21,,,,,,,,21.67,,,,,21.94,0.27, , , , , , , ,-0.27, , , , ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9484,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),NVKDTHSPDAPAA,_DTHS(ph)PDAPAASGTSESEALISHLDK_,S1268,,,,,,,,,23.98,,25.72,24.87,,,24.86, , , , , , , ,-0.88, ,0.87,0.01, , ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9486,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),EGRLIESPFEREL,_LIES(ph)PFER_,S1846,+,24.64,21.28,20.50,,21.91,,20.76,22.17,,,,21.85,,21.87,2.77,-0.60,-1.38, ,0.04, ,-1.11,0.29, , , ,-0.03, ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9487,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),QDKNEESLPFQNL,_NEES(ph)LPFQNLPM(ox)EK_,S737,,22.27,,,21.91,,,,,,,,,,22.09,0.18, , ,-0.18, , , , , , , , , ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9488,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),NSERNLSLTDFVG,_NLS(ph)LTDFVGDESPSPER_,S586,,24.65,,,,,,,,,,,,,24.65,0.00, , , , , , , , , , , , ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
9490,D6W625,CHAF1A,"Chromatin assembly factor 1, subunit A (P150), isoform CRA_a",KATLTASPLGAS_,_ATLTAS(ph)PLGAS_,S951,,23.69,22.45,22.45,22.26,22.67,23.84,24.53,,23.62,23.90,,,23.72,23.31,0.38,-0.86,-0.86,-1.06,-0.64,0.53,1.22, ,0.31,0.58, , ,0.41,,,,,,,,,,,,,,,,
9491,Q13111,CHAF1A,Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150) (hp150),GSPRSPSTTYLHT,_SPS(ph)TTYLHTPTPSEDAAIPSK_,S777,+,22.71,22.33,23.00,22.82,24.44,23.77,24.60,24.80,,23.58,,22.51,23.10,23.42,-0.71,-1.10,-0.42,-0.60,1.02,0.34,1.18,1.38, ,0.15, ,-0.91,-0.32,"DNA repair;transcription, DNA-dependent;regulation of transcription, DNA-dependent;protein complex assembly;cell cycle;DNA replication;DNA replication-dependent nucleosome assembly",WINAC complex;CAF-1 complex,,,,,,,,,,,,,,
9492,Q6NXG1,ESRP1,Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A),LNRNGLSPPPCKL,_NGLS(ph)PPPCK_,S543,,24.40,23.25,,,,,,,,,,,,23.83,0.58,-0.58, , , , , , , , , , , ,mRNA processing;RNA splicing;regulation of RNA splicing,plasma membrane;nucleus,,,,,,,,,,,,,,
9493,E1CKY7,sm-M20,Smooth muscle type of myosin light chain phosphatase small subunit,RKSQSDSPPASPS,_SQSDS(ph)PPASPSPTAK_,S21,,19.71,23.93,23.93,,,,,,,,,,,22.53,-2.81,1.41,1.41, , , , , , , , , , ,,,,,,,,,,,,,,,,
9495,O95208,EPN2,Epsin-2 (EPS-15-interacting protein 2),YGKAGGSPASYHG,_AGGS(ph)PAS(ph)YHGSTSPR_,S192,,24.09,25.94,25.09,26.05,21.92,,,,,,,,,24.62,-0.53,1.32,0.47,1.43,-2.70, , , , , , , , ,regulation of endocytosis;Notch signaling pathway;embryonic organ development;endocytosis;in utero embryonic development,clathrin coat of endocytic vesicle,,,,,,,,,,,,,,
9496,O95208,EPN2,Epsin-2 (EPS-15-interacting protein 2),AGGSPASYHGSTS,_AGGS(ph)PAS(ph)YHGSTSPR_,S195,,24.09,25.94,25.09,26.05,21.92,,,,,,,,,24.62,-0.53,1.32,0.47,1.43,-2.70, , , , , , , , ,regulation of endocytosis;Notch signaling pathway;embryonic organ development;endocytosis;in utero embryonic development,clathrin coat of endocytic vesicle,,,,,,,,,,,,,,
9497,O95208,EPN2,Epsin-2 (EPS-15-interacting protein 2),__MTTSSIRRQMK,_(ac)TTSS(ph)IRR_,S5,,23.12,,,25.18,,,21.29,,,18.85,,23.43,,22.37,0.75, , ,2.81, , ,-1.08, , ,-3.53, ,1.06, ,regulation of endocytosis;Notch signaling pathway;embryonic organ development;endocytosis;in utero embryonic development,clathrin coat of endocytic vesicle,,,,,,,,,,,,,,
9498,O95819,MAP4K4,Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase),ASSLNLSNGETES,_AASSLNLS(ph)NGETESVK_,S774,+,,,,23.01,24.55,23.94,23.87,25.24,,21.24,22.43,22.68,,23.37, , , ,-0.36,1.18,0.57,0.50,1.87, ,-2.13,-0.94,-0.69, ,regulation of JNK cascade;intracellular protein kinase cascade;response to stress,cytoplasm,,+,,,,,,,,,,,,
9502,O95819,MAP4K4,Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase),VRTTSRSPVLSRR,_TTS(ph)RS(ph)PVLSR_,S600,+,24.20,24.88,23.98,26.41,24.41,22.97,23.55,24.12,22.93,21.81,25.03,23.71,20.99,23.77,0.43,1.11,0.21,2.64,0.64,-0.80,-0.22,0.35,-0.84,-1.96,1.26,-0.06,-2.78,regulation of JNK cascade;intracellular protein kinase cascade;response to stress,cytoplasm,,+,,,,,,,,,,,,
9503,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),QLVGGLSPLSSPS,_ELLVSQHTVQLVGGLS(ph)PLSSPSDTK_,S438,,24.79,23.61,,,,,,,,,25.17,23.19,,24.19,0.60,-0.58, , , , , , , , ,0.98,-1.00, ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
9506,P46527,CDKN1B,Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1),VRVSNGSPSLERM,_VSNGS(ph)PSLER_,S10,,25.21,24.51,,23.97,22.01,21.85,,,,,,,,23.51,1.70,1.00, ,0.46,-1.50,-1.66, , , , , , , ,"negative regulation of apoptotic process;S phase of mitotic cell cycle;negative regulation of cell proliferation;G1 phase of mitotic cell cycle;inner ear development;fibroblast growth factor receptor signaling pathway;cellular response to antibiotic;negative regulation of transcription, DNA-dependent;G1/S transition of mitotic cell cycle;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to organic cyclic compound;negative regulation of cell growth;cellular response to lithium ion;positive regulation of protein catabolic process;positive regulation of cell proliferation;mitotic cell cycle arrest;phosphatidylinositol-mediated signaling;potassium ion transport;negative regulation of epithelial cell proliferation involved in prostate gland development;sensory perception of sound;positive regulation of microtubule polymerization;negative regulation of cyclin-dependent protein kinase activity;epidermal growth factor receptor signaling pathway;regulation of cyclin-dependent protein kinase activity;nerve growth factor receptor signaling pathway;negative regulation of cellular component movement;autophagic cell death;negative regulation of mitotic cell cycle",nucleoplasm;endosome;cytosol,,,,,,,,,,,,,,
9512,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),GLLKDMSPLSETE,_DM(ox)S(ph)PLSETEM(ox)ALGK_,S524,+,26.90,26.74,26.98,27.40,23.85,26.41,27.84,27.00,27.71,29.08,28.79,27.81,28.07,27.27,-0.37,-0.53,-0.30,0.13,-3.43,-0.87,0.56,-0.28,0.44,1.80,1.51,0.54,0.79,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9513,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),KDMSPLSETEMAL,_DM(ox)S(ph)PLS(ph)ETEM(ox)ALGK_,S527,,24.08,,,,,,,,,,,,,24.08,0.00, , , , , , , , , , , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9514,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),SQIQETSI_____,_EAQTLDSQIQETS(ph)I_,S2296,,21.35,,,,,22.25,,,,,,,,21.80,-0.45, , , , ,0.45, , , , , , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9516,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),APTFMISPETVTG,_GISEDSHLESLQDVGQSAAPTFM(ox)IS(ph)PETVTGTGK_,S641,,,,,,,24.95,,26.69,23.65,,,,,25.10, , , , , ,-0.14, ,1.59,-1.44, , , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9517,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),GTGKKCSLPAEED,_KCS(ph)LPAEEDSVLEK_,S653,+,24.96,26.54,26.96,26.54,26.47,27.33,27.54,27.91,26.18,25.73,26.80,28.45,27.08,26.81,-1.85,-0.27,0.16,-0.26,-0.34,0.53,0.73,1.11,-0.63,-1.08,-0.01,1.64,0.27,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9518,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),VDLTLLSPKSEND,_KVDLTLLS(ph)PK_,S1679,,18.76,22.93,22.93,20.78,21.01,,23.59,21.44,21.73,23.80,23.72,23.27,,22.18,-3.42,0.75,0.75,-1.40,-1.17, ,1.41,-0.73,-0.45,1.62,1.54,1.09, ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9519,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),EKVALSSETEVAL,_VALSS(ph)ETEVALAR_,S457,,22.24,,,21.32,,,,23.17,22.09,,,,22.98,22.36,-0.12, , ,-1.04, , , ,0.81,-0.28, , , ,0.62,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9520,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),PELLGGSPPWKTL,_VPPELLGGS(ph)PPWK_,S723,,19.88,,,21.60,22.99,,20.87,,,,,,,21.33,-1.46, , ,0.27,1.66, ,-0.47, , , , , , ,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
9521,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),AVAAPQSPLSPEG,_AGNPAVAAPQS(ph)PLS(ph)PEGAHFR_,S20,,24.18,,,,,,,,,,,,,24.18,0.00, , , , , , , , , , , , ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
9522,Q15311,RALBP1,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),APQSPLSPEGAHF,_AGNPAVAAPQS(ph)PLS(ph)PEGAHFR_,S23,,23.01,,,,,,,,,,,,,23.01,0.00, , , , , , , , , , , , ,chemotaxis;transport;positive regulation of Cdc42 GTPase activity;small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
9523,E9PAS5,SORBS2,Sorbin and SH3 domain-containing protein 2,AGRDSQSPDSAWR,_DSQS(ph)PDSAWR_,S26,,22.99,,,,21.99,,,21.39,,22.35,,,,22.18,0.81, , , ,-0.19, , ,-0.79, ,0.17, , , ,,,,,,,,,,,,,,,,
9529,E9PDY7,PHLDB2,Pleckstrin homology-like domain family B member 2,VIDLTVSLTSIYR,_LVIFISTVIDLT(ph)VS(ph)LT(ph)SIYR_,S458,,,22.01,,23.74,26.87,,25.26,25.90,,,,26.66,,25.07, ,-3.06, ,-1.33,1.80, ,0.19,0.82, , , ,1.59, ,,intermediate filament cytoskeleton;plasma membrane;cytoplasm,,,,,,,,,,,,,,
9530,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),KQLSDVSSPRSIT,_(gl)QLSDVS(ph)SPR_,S260,,,24.22,,24.03,23.62,23.40,23.21,21.30,24.32,22.20,25.72,22.17,,23.42, ,0.80, ,0.61,0.20,-0.02,-0.21,-2.12,0.90,-1.22,2.30,-1.25, ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
9531,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),QLSDVSSPRSITS,_(gl)QLSDVSS(ph)PR_,S261,,23.21,,,22.03,,,,23.61,,23.83,24.30,,23.64,23.44,-0.23, , ,-1.40, , , ,0.17, ,0.39,0.86, ,0.21,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
9532,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),DVSSPRSITSTPL,_S(ph)ITSTPLSGK_,S264,,,19.20,,,24.57,,,,,,,,,21.88, ,-2.69, , ,2.69, , , , , , , , ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
9533,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),ITSTPLSGKESVF,_SITSTPLS(ph)GK_,S271,+,23.41,24.11,,24.65,23.28,23.24,25.63,24.89,23.85,,25.07,,24.30,24.24,-0.83,-0.13, ,0.41,-0.96,-1.00,1.38,0.65,-0.40, ,0.83, ,0.06,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
9535,Q5VU43,PDE4DIP,Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein),NTELVGSPGKHQH,_INTELVGS(ph)PGK_,S1293,,,,,22.00,,,,,,,,,21.57,21.78, , , ,0.22, , , , , , , , ,-0.22,cellular protein complex assembly,myofibril;Golgi apparatus;nucleus;centrosome,,,,,,,,,,,,,,
9541,P54687,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)",____MASPLRSAA,_(ac)AS(ph)PLRSAAALAR_,S3,,,23.20,23.20,,24.56,,,23.98,22.63,,22.50,23.00,,23.30, ,-0.10,-0.10, ,1.27, , ,0.68,-0.66, ,-0.80,-0.29, ,cell proliferation;branched-chain amino acid catabolic process;G1/S transition of mitotic cell cycle;cellular nitrogen compound metabolic process;branched-chain amino acid biosynthetic process,cytosol,,,,,,,,,,,,,,
9542,O75122,CLASP2,CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2),GSSKASSLPGSLQ,_ASS(ph)LPGSLQR_,S593,,,,,23.52,22.80,,23.42,23.22,,,,23.04,20.86,22.81, , , ,0.71,-0.01, ,0.61,0.41, , , ,0.23,-1.95,microtubule anchoring;microtubule organizing center organization;axon guidance;microtubule nucleation;mitotic prometaphase;establishment or maintenance of cell polarity;negative regulation of microtubule depolymerization;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;microtubule organizing center;trans-Golgi network;cell cortex;cytosol;ruffle membrane;cytoplasmic microtubule,,,,,,,,,,,,,,
9543,O75122,CLASP2,CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2),GCSREASPSRLSV,_EAS(ph)PSRLSVAR_,S740,+,22.53,26.46,26.46,22.77,24.91,22.88,25.11,25.37,23.35,24.25,,,,24.41,-1.88,2.05,2.05,-1.64,0.50,-1.53,0.70,0.96,-1.06,-0.15, , , ,microtubule anchoring;microtubule organizing center organization;axon guidance;microtubule nucleation;mitotic prometaphase;establishment or maintenance of cell polarity;negative regulation of microtubule depolymerization;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;microtubule organizing center;trans-Golgi network;cell cortex;cytosol;ruffle membrane;cytoplasmic microtubule,,,,,,,,,,,,,,
9544,O75122,CLASP2,CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2),PGSLQRSRSDIDV,_S(ph)RSDIDVNAAAGAK_,S601,,,,,,24.77,24.01,,,24.38,24.13,,,,24.32, , , , ,0.45,-0.31, , ,0.05,-0.19, , , ,microtubule anchoring;microtubule organizing center organization;axon guidance;microtubule nucleation;mitotic prometaphase;establishment or maintenance of cell polarity;negative regulation of microtubule depolymerization;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;microtubule organizing center;trans-Golgi network;cell cortex;cytosol;ruffle membrane;cytoplasmic microtubule,,,,,,,,,,,,,,
9545,O75122,CLASP2,CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2),SLQRSRSDIDVNA,_SRS(ph)DIDVNAAAGAK_,S603,+,23.51,23.64,24.07,24.79,,,25.50,24.84,22.88,,23.46,25.81,21.97,24.05,-0.54,-0.40,0.02,0.74, , ,1.46,0.79,-1.17, ,-0.59,1.76,-2.08,microtubule anchoring;microtubule organizing center organization;axon guidance;microtubule nucleation;mitotic prometaphase;establishment or maintenance of cell polarity;negative regulation of microtubule depolymerization;cell division,kinetochore microtubule;Golgi apparatus;condensed chromosome kinetochore;microtubule organizing center;trans-Golgi network;cell cortex;cytosol;ruffle membrane;cytoplasmic microtubule,,,,,,,,,,,,,,
9546,Q9Y2B0,CNPY2,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4),VGRNGESSELDLQ,_NGES(ph)SELDLQGIR_,S115,,27.38,22.16,22.16,,,,,22.59,,,,,,23.58,3.81,-1.41,-1.41, , , , ,-0.99, , , , , ,positive regulation of low-density lipoprotein particle receptor biosynthetic process;negative regulation of gene expression;regulation of low-density lipoprotein particle clearance,endoplasmic reticulum;integral to plasma membrane,,,,,,,,,,,,,,
9547,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),GAEGRDSSKGEDS,_VLQDM(ox)GLPTGAEGRDS(ph)S(ph)K_,S476,+,28.04,25.85,21.39,24.13,23.36,,27.29,,22.86,28.07,24.14,27.19,,25.23,2.81,0.62,-3.84,-1.11,-1.87, ,2.06, ,-2.37,2.83,-1.09,1.96, ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
9548,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),AEGRDSSKGEDSA,_VLQDM(ox)GLPTGAEGRDS(ph)S(ph)K_,S477,,26.70,26.54,27.25,,,,,,25.09,23.27,,,,25.77,0.93,0.77,1.48, , , , , ,-0.68,-2.50, , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
9549,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),SSKGEDSAEETEA,_DSSKGEDS(ph)AEETEAK_,S482,+,28.96,25.86,25.95,26.91,26.95,,28.47,,29.58,30.49,28.27,29.01,27.22,27.97,0.99,-2.12,-2.02,-1.06,-1.02, ,0.50, ,1.61,2.52,0.30,1.04,-0.75,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
9553,Q9Y2K2,SIK3,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),PLSKQLSADSAEA,_(gl)QLS(ph)ADSAEAHSLNVNR_,S908,,24.69,,,24.42,22.93,,24.58,24.25,,,,,,24.17,0.52, , ,0.25,-1.25, ,0.41,0.08, , , , , ,,cytoplasm,,+,,,,,,,,,,,,
9554,H0Y9Y2,BOD1L1,Biorientation of chromosomes in cell division protein 1-like 1 (Fragment),ATSKLGSPDTVSP,_LGS(ph)PDTVSPR_,S138,,21.61,,,22.53,,,22.51,,,23.64,,,22.16,22.49,-0.88, , ,0.04, , ,0.02, , ,1.15, , ,-0.33,,,,,,,,,,,,,,,,
9556,Q8NBP0,TTC13,Tetratricopeptide repeat protein 13 (TPR repeat protein 13),MKVTLASEWQSMF,_VT(ph)LAS(ph)EWQSMFLEEK_,S100,,,,,,,,23.27,,21.94,,,,22.15,22.45, , , , , , ,0.82, ,-0.51, , , ,-0.30,,,,,,,,,,,,,,,,
9561,Q02790,FKBP4,"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]",GGSLEPSR_____,_VGGSLEPS(ph)R_,S83,,,,,,,24.78,20.76,21.65,21.85,,,,,22.26, , , , , ,2.52,-1.51,-0.61,-0.41, , , , ,male sex differentiation;embryo implantation;prostate gland development;negative regulation of microtubule polymerization or depolymerization;protein folding;copper ion transport;steroid hormone receptor complex assembly;androgen receptor signaling pathway;negative regulation of neuron projection development;protein complex localization,cytosol;nucleus;microtubule;membrane;axonal growth cone,,,,,,,,,,,,,,
9562,H0YGG4,EIF2B1,Translation initiation factor eIF-2B subunit alpha (Fragment),URGRLGSPGAPQQ,_LGS(ph)PGAPQQEDAM(ox)DDKELIEYFK_,S7,,20.25,24.44,24.88,23.26,25.04,25.34,26.26,25.99,23.13,25.29,25.08,24.82,24.96,24.52,-4.27,-0.08,0.36,-1.25,0.52,0.83,1.74,1.47,-1.39,0.77,0.56,0.30,0.44,cellular metabolic process,,,,,,,,,,,,,,,
9563,Q04759,PRKCQ,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),DRALINSMDQNMF,_ALINS(ph)M(ox)DQNM(ox)FR_,S458,,25.66,,,,,,,,,,,,,25.66,0.00, , , , , , , , , , , , ,inflammatory response;positive regulation of NF-kappaB transcription factor activity;tissue regeneration;regulation of G2/M transition of mitotic cell cycle;intracellular signal transduction;platelet activation;positive regulation of NF-kappaB import into nucleus;respiratory burst;positive regulation of filopodium assembly;response to glucose stimulus;response to insulin stimulus;positive regulation of interleukin-17 production;response to organic cyclic compound;negative regulation of T cell apoptotic process;aging;regulation of cell growth;cellular component disassembly involved in execution phase of apoptosis;regulation of platelet aggregation;regulation of vasoconstriction;negative regulation of insulin receptor signaling pathway;membrane protein ectodomain proteolysis;positive regulation of T-helper 17 type immune response;positive regulation of stress fiber assembly;response to hypoxia;axon guidance;positive regulation of interleukin-4 production;positive regulation of interleukin-2 biosynthetic process;T cell receptor signaling pathway;positive regulation of T cell proliferation;response to heat;positive regulation of protein secretion;positive regulation of T-helper 2 cell activation,neuromuscular junction;cytosol;sarcolemma;plasma membrane;nucleus;immunological synapse,,+,,,,,,,,,,,,
9564,Q04759,PRKCQ,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),NEKPRLSFADRAL,_PRLS(ph)FADR_,S449,,26.54,26.53,26.53,,,,23.35,,,,,23.36,22.70,24.84,1.70,1.69,1.69, , , ,-1.49, , , , ,-1.47,-2.14,inflammatory response;positive regulation of NF-kappaB transcription factor activity;tissue regeneration;regulation of G2/M transition of mitotic cell cycle;intracellular signal transduction;platelet activation;positive regulation of NF-kappaB import into nucleus;respiratory burst;positive regulation of filopodium assembly;response to glucose stimulus;response to insulin stimulus;positive regulation of interleukin-17 production;response to organic cyclic compound;negative regulation of T cell apoptotic process;aging;regulation of cell growth;cellular component disassembly involved in execution phase of apoptosis;regulation of platelet aggregation;regulation of vasoconstriction;negative regulation of insulin receptor signaling pathway;membrane protein ectodomain proteolysis;positive regulation of T-helper 17 type immune response;positive regulation of stress fiber assembly;response to hypoxia;axon guidance;positive regulation of interleukin-4 production;positive regulation of interleukin-2 biosynthetic process;T cell receptor signaling pathway;positive regulation of T cell proliferation;response to heat;positive regulation of protein secretion;positive regulation of T-helper 2 cell activation,neuromuscular junction;cytosol;sarcolemma;plasma membrane;nucleus;immunological synapse,,+,,,,,,,,,,,,
9565,Q04759,PRKCQ,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),EIGLPCSIKNEAR,_EGPVEIGLPCS(ph)IK_,S96,,23.68,,,,,,,,,,,,,23.68,0.00, , , , , , , , , , , , ,inflammatory response;positive regulation of NF-kappaB transcription factor activity;tissue regeneration;regulation of G2/M transition of mitotic cell cycle;intracellular signal transduction;platelet activation;positive regulation of NF-kappaB import into nucleus;respiratory burst;positive regulation of filopodium assembly;response to glucose stimulus;response to insulin stimulus;positive regulation of interleukin-17 production;response to organic cyclic compound;negative regulation of T cell apoptotic process;aging;regulation of cell growth;cellular component disassembly involved in execution phase of apoptosis;regulation of platelet aggregation;regulation of vasoconstriction;negative regulation of insulin receptor signaling pathway;membrane protein ectodomain proteolysis;positive regulation of T-helper 17 type immune response;positive regulation of stress fiber assembly;response to hypoxia;axon guidance;positive regulation of interleukin-4 production;positive regulation of interleukin-2 biosynthetic process;T cell receptor signaling pathway;positive regulation of T cell proliferation;response to heat;positive regulation of protein secretion;positive regulation of T-helper 2 cell activation,neuromuscular junction;cytosol;sarcolemma;plasma membrane;nucleus;immunological synapse,,+,,,,,,,,,,,,
9566,Q04759,PRKCQ,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),NMFRNFSFMNPGM,_NFS(ph)FMNPGM(ox)ER_,S468,,26.93,,,,22.21,21.83,22.28,23.64,,,,,,23.38,3.55, , , ,-1.17,-1.55,-1.10,0.27, , , , , ,inflammatory response;positive regulation of NF-kappaB transcription factor activity;tissue regeneration;regulation of G2/M transition of mitotic cell cycle;intracellular signal transduction;platelet activation;positive regulation of NF-kappaB import into nucleus;respiratory burst;positive regulation of filopodium assembly;response to glucose stimulus;response to insulin stimulus;positive regulation of interleukin-17 production;response to organic cyclic compound;negative regulation of T cell apoptotic process;aging;regulation of cell growth;cellular component disassembly involved in execution phase of apoptosis;regulation of platelet aggregation;regulation of vasoconstriction;negative regulation of insulin receptor signaling pathway;membrane protein ectodomain proteolysis;positive regulation of T-helper 17 type immune response;positive regulation of stress fiber assembly;response to hypoxia;axon guidance;positive regulation of interleukin-4 production;positive regulation of interleukin-2 biosynthetic process;T cell receptor signaling pathway;positive regulation of T cell proliferation;response to heat;positive regulation of protein secretion;positive regulation of T-helper 2 cell activation,neuromuscular junction;cytosol;sarcolemma;plasma membrane;nucleus;immunological synapse,,+,,,,,,,,,,,,
9569,Q9HAH7,FBRS,Probable fibrosin-1,QLQLRVSPFGLRT,_VS(ph)PFGLR_,S177,,21.33,21.92,,20.55,,,,,,,,,,21.27,0.07,0.65, ,-0.72, , , , , , , , , ,,,,,,,,,,,,,,,,
9570,A6NCI4,VWA3A,von Willebrand factor A domain-containing protein 3A,RDLTHHSLKPTQQ,_DLTHHS(ph)LK_,S495,,22.30,23.64,23.30,23.68,23.82,24.30,22.25,23.48,22.89,22.34,,23.68,24.00,23.31,-1.01,0.33,-0.01,0.37,0.51,1.00,-1.06,0.17,-0.41,-0.97, ,0.37,0.70,,extracellular region,,,,,,,,,,,,,,
9571,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),VKEPTPSIASDIS,_EPTPS(ph)IASDIS(ph)LPIATQELR_,S718,,26.40,,,,,,,,,,,,,26.40,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9572,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),PTPSIASDISLPI,_EPTPSIAS(ph)DISLPIATQELR_,S721,,27.87,,,,,,,,,,,,,27.87,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9573,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),SIASDISLPIATQ,_EPTPSIAS(ph)DIS(ph)LPIATQELR_,S724,,28.21,,,,,,,,,,,,,28.21,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9574,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),DLGRSSSSLLASP,_SSS(ph)S(ph)LLASPGHISVK_,S701,,24.56,,,22.44,,,,,,,,,,23.50,1.06, , ,-1.06, , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9575,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),LGRSSSSLLASPG,_SSS(ph)S(ph)LLASPGHISVK_,S702,,23.85,,,22.44,,,,,,,,,,23.15,0.70, , ,-0.70, , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9576,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),LGEVTGSPSPPPR,_LGEVTGS(ph)PS(ph)PPPRSGAPTPSSR_,S344,,22.98,,,,,,,,,,,,,22.98,0.00, , , , , , , , , , , , ,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9577,O94875,SORBS2,Sorbin and SH3 domain-containing protein 2 (Arg/Abl-interacting protein 2) (ArgBP2) (Sorbin),EVTGSPSPPPRSG,_LGEVTGSPS(ph)PPPR_,S346,,25.48,,,,23.86,,,21.34,22.31,23.16,,,21.53,22.95,2.54, , , ,0.91, , ,-1.61,-0.64,0.21, , ,-1.41,,Z disc;nucleus;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9578,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),ALGPAASPPPSPP,_GRPPAQALGPAAS(ph)PPPS(ph)PPLGPSLG_,S265,,24.81,,,,,,,,,,,,,24.81,0.00, , , , , , , , , , , , ,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
9579,Q12873,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),AASPPPSPPLGPS,_GRPPAQALGPAAS(ph)PPPS(ph)PPLGPSLG_,S269,,24.81,,,,,,,,,,,,,24.81,0.00, , , , , , , , , , , , ,"centrosome organization;spindle organization;transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;intermediate filament cytoskeleton;nucleolus;centrosome,Other TF domain,,,,,,,,,,,,,
9580,Q13950,RUNX2,Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit),STSRRFSPPSSSL,_RFS(ph)PPSSSLQPGK_,S28,,,,,,22.92,23.17,,21.22,23.32,,,,,22.66, , , , ,0.26,0.51, ,-1.44,0.67, , , , ,"osteoblast fate commitment;cell maturation;negative regulation of transcription, DNA-dependent;cellular response to BMP stimulus;stem cell differentiation;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;positive regulation of cell proliferation;transcription initiation from RNA polymerase II promoter;negative regulation of smoothened signaling pathway;endochondral ossification;osteoblast differentiation;chondrocyte development;T cell differentiation;embryonic cranial skeleton morphogenesis;osteoblast development;BMP signaling pathway;regulation of odontogenesis of dentin-containing tooth;odontogenesis of dentin-containing tooth;positive regulation of osteoblast differentiation;regulation of fibroblast growth factor receptor signaling pathway;positive regulation of chondrocyte differentiation",nuclear chromatin;transcription factor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
9581,Q13950,RUNX2,Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit),YSVVASSPEAAPR,_YSVVASS(ph)PEAAPR_,S420,,,,,22.34,23.31,22.94,,22.79,23.93,,,,,23.06, , , ,-0.72,0.25,-0.13, ,-0.27,0.87, , , , ,"osteoblast fate commitment;cell maturation;negative regulation of transcription, DNA-dependent;cellular response to BMP stimulus;stem cell differentiation;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus;positive regulation of cell proliferation;transcription initiation from RNA polymerase II promoter;negative regulation of smoothened signaling pathway;endochondral ossification;osteoblast differentiation;chondrocyte development;T cell differentiation;embryonic cranial skeleton morphogenesis;osteoblast development;BMP signaling pathway;regulation of odontogenesis of dentin-containing tooth;odontogenesis of dentin-containing tooth;positive regulation of osteoblast differentiation;regulation of fibroblast growth factor receptor signaling pathway;positive regulation of chondrocyte differentiation",nuclear chromatin;transcription factor complex;cytoplasm,Other TF domain,,,,,,,,,,,,,
9583,Q96RK0,CIC,Protein capicua homolog,PKAQSVSPVQAPP,_AQSVS(ph)PVQAPPPGGSAQLLPGK_,S1813,,22.91,21.97,21.91,22.42,,24.32,,,,24.05,,,23.50,23.01,-0.11,-1.04,-1.10,-0.59, ,1.30, , , ,1.04, , ,0.49,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9584,Q96RK0,CIC,Protein capicua homolog,AGFRAVSPAVPFS,_AVS(ph)PAVPFSR_,S768,,25.23,25.36,,24.78,25.07,25.33,23.73,24.48,25.16,,24.55,,25.18,24.89,0.35,0.47, ,-0.11,0.19,0.44,-1.16,-0.41,0.28, ,-0.34, ,0.29,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9585,Q96RK0,CIC,Protein capicua homolog,PEEVLPSPTLQSL,_FAELPEFRPEEVLPS(ph)PTLQSLATS(ph)PR_,S2279,,27.04,,,,,,,,,,,,,27.04,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9586,Q96RK0,CIC,Protein capicua homolog,LQSLATSPRAILG,_FAELPEFRPEEVLPS(ph)PTLQSLATS(ph)PR_,S2288,,27.04,,,,,,,,,,,,,27.04,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9587,Q96RK0,CIC,Protein capicua homolog,APEDPTSPKRKMR,_NSTDLDSAPEDPTS(ph)PK_,S2315,+,,25.06,24.32,24.44,23.94,25.65,25.56,24.96,25.72,25.53,24.35,23.00,24.49,24.75, ,0.31,-0.43,-0.31,-0.81,0.90,0.80,0.21,0.97,0.77,-0.40,-1.75,-0.27,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9590,Q96RK0,CIC,Protein capicua homolog,VRQVRRSQDLGVQ,_S(ph)QDLGVQFPGDR_,S227,,24.34,,,,,,,,,,,,,24.34,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9593,Q96RK0,CIC,Protein capicua homolog,GKRRTQSLSALPK,_TQS(ph)LSALPK_,S1082,+,24.99,23.65,22.21,24.39,23.90,,23.53,23.83,23.77,22.97,23.50,23.66,22.05,23.54,1.46,0.11,-1.33,0.85,0.36, ,-0.01,0.29,0.23,-0.57,-0.03,0.13,-1.49,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9594,Q96RK0,CIC,Protein capicua homolog,FGRKVFSPVIRSS,_VFS(ph)PVIR_,S1405,+,24.45,23.81,23.92,23.64,22.85,24.87,23.98,23.40,24.27,24.74,23.96,23.38,24.38,23.97,0.48,-0.16,-0.05,-0.34,-1.12,0.90,0.00,-0.57,0.29,0.77,-0.01,-0.60,0.40,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,HMG-box,,,,,,,,,,,,,
9595,A4UGR9,XIRP2,Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin),SRDIMQSKSACEI,_EVLQSSRDIMQS(ph)K_,S2669,,25.01,25.15,25.80,26.75,26.09,27.58,26.94,26.35,26.63,26.17,24.35,27.81,27.34,26.31,-1.29,-1.16,-0.50,0.44,-0.22,1.28,0.64,0.05,0.33,-0.13,-1.96,1.50,1.03,actin cytoskeleton organization,cell junction,,,,,,,,,,,,,,
9596,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),QPPLSLSPAPETK,_ADSGPTQPPLSLS(ph)PAPETK_,S2083,+,25.76,24.91,21.28,25.29,23.44,,25.06,23.32,24.22,24.17,26.28,24.62,,24.40,1.36,0.52,-3.12,0.89,-0.95, ,0.67,-1.07,-0.18,-0.22,1.88,0.23, ,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
9600,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),PDGPLASPARVPM,_LLPSAPQTLPDGPLAS(ph)PAR_,S1964,,23.98,20.62,,,,,,,,,,,,22.30,1.68,-1.68, , , , , , , , , , , ,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
9602,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),FKQIDSSPVGGET,_QIDSS(ph)PVGGETDETTVSQNYR_,S569,,23.76,23.28,,23.74,24.87,24.53,24.95,25.27,24.47,22.65,24.81,23.32,,24.15,-0.40,-0.87, ,-0.41,0.72,0.38,0.80,1.12,0.32,-1.50,0.66,-0.83, ,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
9606,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),VLSSAASLPGSEL,_VLSSAAS(ph)LPGSELPSSRPEGSQGGELSR_,S2271,,21.62,,,,,,,23.66,,23.00,,,24.16,23.11,-1.49, , , , , , ,0.55, ,-0.11, , ,1.05,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
9608,Q9HCD6,TANC2,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",MEGMSRSLPSSPL,_S(ph)LPSS(ph)PLLTHQSISVR_,S57,,24.36,,,,,,,,,,,,,24.36,0.00, , , , , , , , , , , , ,in utero embryonic development,,,,,,,,,,,,,,,
9609,Q9HCD6,TANC2,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",SRSLPSSPLLTHQ,_S(ph)LPSS(ph)PLLTHQSISVR_,S61,,24.36,,,,,,,,,,,,,24.36,0.00, , , , , , , , , , , , ,in utero embryonic development,,,,,,,,,,,,,,,
9610,Q03252,LMNB2,Lamin-B2,GPATPLSPTRLSR,_AGGPATPLS(ph)PTR_,S37,+,26.42,25.12,22.29,25.02,26.63,25.45,25.58,25.66,24.85,23.36,24.65,23.31,25.84,24.94,1.48,0.19,-2.65,0.08,1.69,0.51,0.65,0.73,-0.09,-1.57,-0.29,-1.63,0.90,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
9611,P32245,MC4R,Melanocortin receptor 4 (MC4-R),HHGMHTSLHLWNR,_(ac)VNSTHHGMHT(ph)S(ph)LHLWNR_,S12,,25.36,26.20,24.37,25.41,,,28.85,28.51,26.90,,,24.08,29.15,26.54,-1.17,-0.33,-2.17,-1.13, , ,2.32,1.98,0.36, , ,-2.46,2.61,insulin secretion;energy reserve metabolic process;positive regulation of bone resorption;response to insulin stimulus;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;positive regulation of cAMP biosynthetic process;diet induced thermogenesis;feeding behavior,integral to membrane;plasma membrane,,,,,,,,,,,,,,
9612,Q15552,tb,CACCC box-binding protein,DSGFSTSPKDNSL,_SEEDSGFSTS(ph)PK_,S306,,,24.52,22.57,23.55,24.60,25.21,,,23.95,23.02,,,21.65,23.63, ,0.88,-1.06,-0.08,0.97,1.57, , ,0.32,-0.62, , ,-1.99,"positive regulation of transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
9614,Q2NL81,SEMA4B,"Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (Semaphorin) 4B",YQSLSDSPPGARV,_GYQSLSDS(ph)PPGAR_,S793,,26.03,25.15,,,20.98,,,,,23.80,,,22.54,23.70,2.33,1.45, , ,-2.72, , , , ,0.10, , ,-1.16,multicellular organismal development,integral to membrane,,,,,,,,,,,,,,
9615,Q2NL81,SEMA4B,"Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (Semaphorin) 4B",ARVFTESEKRPLS,_VFTES(ph)EK_,S803,,24.11,23.03,22.43,20.54,,,,,,,,,,22.53,1.58,0.51,-0.09,-1.99, , , , , , , , , ,multicellular organismal development,integral to membrane,,,,,,,,,,,,,,
9617,P24821,TNC,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),VDLESASGEKDLA,_LPVGSQCSVDLESAS(ph)GEK_,S104,,,23.85,,,,26.99,,26.37,26.85,24.77,,,,25.76, ,-1.92, , , ,1.22, ,0.60,1.09,-1.00, , , ,neuromuscular junction development;prostate gland epithelium morphogenesis;positive regulation of gene expression;response to wounding;signal transduction;peripheral nervous system axon regeneration;cell adhesion;positive regulation of cell proliferation;mesenchymal-epithelial cell signaling involved in prostate gland development,extracellular space;interstitial matrix;basement membrane,,,,,,,,,,,,,,
9618,Q99569,PKP4,Plakophilin-4 (p0071),ALYRTGSGIGNLQ,_TGS(ph)GIGNLQR_,S403,,24.75,,,,,,,21.56,,,,,,23.16,1.59, , , , , , ,-1.59, , , , , ,positive regulation of Rho GTPase activity;cell adhesion;positive regulation of cell cycle cytokinesis,spindle midzone;internal side of plasma membrane;mitotic spindle;cytoplasm;cell-cell junction;midbody;spindle pole;desmosome,,,,,,,,,,,,,,
9619,Q16555,DPYSL2,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),ASSAKTSPAKQQA,_TVTPASSAKTS(ph)PAK_,S578,+,20.77,26.86,26.86,25.18,22.81,,22.87,24.18,20.97,20.31,21.44,22.24,20.90,22.95,-2.18,3.91,3.91,2.23,-0.14, ,-0.08,1.23,-1.98,-2.64,-1.51,-0.71,-2.05,synaptic vesicle transport;regulation of neuron differentiation;spinal cord development;response to drug;pyrimidine nucleobase catabolic process;response to amphetamine;nucleobase-containing compound metabolic process;axon guidance;positive regulation of glutamate secretion;signal transduction;olfactory bulb development;response to cocaine;cytoskeleton organization,neuronal cell body;growth cone;cytosol;mitochondrion;terminal button;protein complex;dendrite,,,,,,,,,,,,,,
9623,Q5CZB5,DKFZp686M0430,Putative uncharacterized protein DKFZp686M0430,DVSERDSDKEMAT,_DSEDVSERDS(ph)DKEM(ox)ATK_,S15,,19.97,24.19,25.11,22.88,29.14,27.12,21.03,26.80,22.78,20.55,21.87,20.23,25.15,23.60,-3.63,0.58,1.50,-0.72,5.54,3.52,-2.57,3.20,-0.82,-3.05,-1.74,-3.37,1.55,signal transduction;protein targeting,,,,,,,,,,,,,,,
9624,Q12955,ANK3,Ankyrin-3 (ANK-3) (Ankyrin-G),NEVLDMSDDEGED,_M(ox)NVPETM(ox)NEVLDM(ox)S(ph)DDEGEDAM(ox)TGDTDK_,S457,,22.58,,,,,,,,,,,,,22.58,0.00, , , , , , , , , , , , ,maintenance of protein location in plasma membrane;positive regulation of sodium ion transmembrane transporter activity;regulation of potassium ion transport;synapse organization;axonogenesis;Golgi to plasma membrane protein transport;cytokinesis after mitosis;positive regulation of sodium ion transport;protein targeting to plasma membrane;positive regulation of gene expression;positive regulation of membrane potential;regulation of action potential in neuron;axon guidance;membrane assembly;signal transduction;positive regulation of membrane depolarization involved in regulation of cardiac muscle cell action potential,intercalated disc;basolateral plasma membrane;lateral plasma membrane;node of Ranvier;T-tubule;spectrin-associated cytoskeleton;costamere;postsynaptic membrane;cell surface;axon initial segment;lysosome,,,,,,,,,,,,,,
9627,Q5T5P0,KIAA1217,Sickle tail protein homolog (Fragment),DAPTPFSRGSRTR,_(ac)SEGDAPTPFS(ph)RGSR_,S11,,23.31,21.39,21.39,,,,,,,22.24,,,,22.08,1.23,-0.70,-0.70, , , , , , ,0.16, , , ,embryonic skeletal system development,,,,,,,,,,,,,,,
9634,Q96A65,EXOC4,Exocyst complex component 4 (Exocyst complex component Sec8),SVIRTLSTSDDVE,_TLS(ph)TSDDVEDRENEK_,S32,+,24.97,,,23.10,23.01,22.93,24.22,23.63,25.33,22.96,24.52,22.98,22.90,23.69,1.29, , ,-0.59,-0.68,-0.76,0.53,-0.06,1.65,-0.72,0.84,-0.70,-0.79,regulation of protein transport;protein targeting to membrane;Golgi to transport vesicle transport;positive regulation of calcium-mediated signaling;vesicle docking involved in exocytosis;establishment of cell polarity;oligodendrocyte differentiation;synaptic transmission;membrane biogenesis,neuronal cell body;endosome;Golgi apparatus;postsynaptic density;cytoplasm;myelin sheath abaxonal region;plasma membrane;dendritic shaft;exocyst;growth cone membrane,,,,,,,,,,,,,,
9635,Q9H9E3,COG4,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),__ADLDSPPKLSG,_(ac)ADLDS(ph)PPK_,S5,,24.50,,,,25.65,,23.71,,,24.07,21.40,22.15,22.87,23.48,1.02, , , ,2.17, ,0.23, , ,0.59,-2.08,-1.32,-0.61,"retrograde vesicle-mediated transport, Golgi to ER;protein transport;Golgi vesicle prefusion complex stabilization;Golgi organization",Golgi transport complex;Golgi membrane,,,,,,,,,,,,,,
9638,Q9BZ29,DOCK9,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1),_MGCTTSVILFKG,_(ac)MGCTT(ph)S(ph)VILFK_,S6,,22.25,23.64,23.32,23.55,23.13,24.66,24.71,24.09,23.46,23.69,24.70,25.89,25.13,24.02,-1.77,-0.38,-0.69,-0.47,-0.88,0.64,0.70,0.08,-0.56,-0.33,0.69,1.87,1.12,blood coagulation;small GTPase mediated signal transduction,cytosol;endomembrane system;membrane,,,,,,,,,,,,,,
9639,Q08334,IL10RB,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b),IAEDSESGKQNPG,_LSVIAEDSES(ph)GK_,S306,,25.01,24.30,24.51,22.63,,,,,,22.86,22.31,21.21,,23.26,1.75,1.04,1.25,-0.64, , , , , ,-0.40,-0.95,-2.05, ,signal transduction;inflammatory response;immune response,interleukin-28 receptor complex,,,,,,,,,,,,,,
9640,Q7Z3D7,DKFZp686E2459,Putative uncharacterized protein DKFZp686E2459,AAYSGESDSEEEQ,_GLVAAYSGES(ph)DS(ph)EEEQER_,S801,,25.18,22.70,,,,,,,,,,,,23.94,1.24,-1.24, , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
9641,Q7Z3D7,DKFZp686E2459,Putative uncharacterized protein DKFZp686E2459,YSGESDSEEEQER,_GLVAAYSGES(ph)DS(ph)EEEQER_,S803,,24.79,,,,,,,,,,,,,24.79,0.00, , , , , , , , , , , , ,,intracellular,,,,,,,,,,,,,,
9642,Q7Z3D7,DKFZp686E2459,Putative uncharacterized protein DKFZp686E2459,___MSGSPSLTAR,_(ac)SGS(ph)PSLTARAEK_,S4,+,20.38,24.98,25.40,26.56,23.90,24.39,24.26,22.39,24.19,25.62,,23.16,22.68,23.99,-3.61,0.99,1.41,2.56,-0.10,0.40,0.27,-1.61,0.20,1.63, ,-0.83,-1.31,,intracellular,,,,,,,,,,,,,,
9645,Q9NUM4,TMEM106B,Transmembrane protein 106B,RNGLVNSEVHNED,_NGLVNS(ph)EVHNEDGR_,S73,+,,23.44,23.91,23.55,23.73,24.60,22.47,23.03,,22.45,22.94,23.60,23.14,23.35, ,0.08,0.56,0.20,0.38,1.25,-0.89,-0.32, ,-0.91,-0.41,0.25,-0.21,,integral to membrane;late endosome membrane;lysosomal membrane,,,,,,,,,,,,,,
9652,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,PSIYAPSTYAHLS,_AATSGVPS(ph)IYAPS(ph)TYAHLSPAK_,S264,,22.81,,,,,,,,,,,,,22.81,0.00, , , , , , , , , , , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9653,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,RVERAMSEVTSLH,_AM(ox)S(ph)EVTS(ph)LHEDDWR_,S370,,25.16,22.95,,,,,,,,,,,,24.06,1.11,-1.11, , , , , , , , , , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9654,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,AMSEVTSLHEDDW,_AM(ox)SEVTS(ph)LHEDDWR_,S374,+,25.91,24.74,25.49,20.57,22.90,,23.63,21.48,,25.38,,22.77,,23.65,2.25,1.09,1.84,-3.08,-0.75, ,-0.02,-2.17, ,1.73, ,-0.88, ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9655,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,RRPRARSVDALDD,_S(ph)VDALDDLTPPSTAESGSR_,S431,,27.75,22.00,,,23.73,,23.31,23.64,,24.90,,,,24.22,3.53,-2.22, , ,-0.49, ,-0.91,-0.58, ,0.68, , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9661,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,KKNLALSRESLVV,_NLALS(ph)RES(ph)LVV_,S582,,24.64,23.19,23.19,,,,,,,24.94,,,,23.99,0.65,-0.80,-0.80, , , , , , ,0.95, , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9662,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,LALSRESLVV___,_NLALS(ph)RES(ph)LVV_,S585,+,25.44,22.41,23.35,20.49,22.04,,21.58,,,24.37,,,,22.81,2.62,-0.40,0.54,-2.32,-0.77, ,-1.23, , ,1.56, , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9663,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,MPPRSRSRDDLYD,_S(ph)RDDLYDQDDSRDFPR_,S469,+,26.10,23.78,23.78,,24.86,,24.86,24.65,,25.91,,24.73,,24.83,1.26,-1.05,-1.05, ,0.02, ,0.03,-0.18, ,1.08, ,-0.10, ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
9670,P02663,CSN1S2,Alpha-S2-casein [Cleaved into: Casocidin-1 (Casocidin-I)],KTVDMESTEVFTK,_TVDM(ox)ES(ph)TEVFTK_,S143,,,,,20.67,,,23.76,,,,22.73,21.82,22.70,22.34, , , ,-1.66, , ,1.42, , , ,0.39,-0.52,0.37,,,,,,,,,,,,,,,,
9671,P02666,CSN2,Beta-casein [Cleaved into: Casoparan;Antioxidant peptide;Casohypotensin],KIEKFQSEEQQQT,_FQS(ph)EEQQQTEDELQDK_,S35,+,22.96,23.06,,23.12,,25.49,26.42,23.43,,24.55,23.32,,25.51,24.21,-1.25,-1.15, ,-1.08, ,1.28,2.21,-0.78, ,0.35,-0.88, ,1.30,,,,,,,,,,,,,,,,
9672,P05784,Krt18,"Keratin, type I cytoskeletal 18 (Cytokeratin endo B) (Keratin D) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",YLDKVKSLETENR,_S(ph)LETENRR_,S92,,21.52,22.71,21.34,23.00,,,17.14,20.76,,,,,,21.08,0.44,1.63,0.26,1.93, , ,-3.94,-0.31, , , , , ,negative regulation of apoptotic process;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;apoptotic process,nucleolus;keratin filament;nuclear matrix;centriolar satellite,,,,,,,,,,,,,,
9676,P12763,AHSG,Alpha-2-HS-glycoprotein (Asialofetuin) (Fetuin-A),GVASVESSSGEAF,_HTFSGVASVES(ph)SSGEAFHVGK_,S323,+,,,,,23.56,26.62,24.72,24.14,25.56,,26.55,,27.61,25.54, , , , ,-1.97,1.08,-0.82,-1.40,0.03, ,1.01, ,2.07,,,,,,,,,,,,,,,,
9677,P19001,Krt19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",GVFRAPSIHGGSG,_APS(ph)IHGGSGGR_,S35,+,31.11,27.96,27.67,27.98,26.22,24.24,25.39,26.10,23.42,21.26,21.94,29.31,25.40,26.00,5.11,1.97,1.67,1.98,0.22,-1.76,-0.61,0.10,-2.58,-4.74,-4.06,3.31,-0.60,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization,Z disc;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
9678,P19001,Krt19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",PSIHGGSGGRGVS,_APSIHGGS(ph)GGR_,S40,,25.17,22.32,,19.85,21.02,,20.91,21.48,18.65,23.82,25.02,19.40,21.02,21.70,3.47,0.63, ,-1.85,-0.67, ,-0.79,-0.21,-3.05,2.12,3.33,-2.29,-0.67,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization,Z disc;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
9679,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",QKQTPASPECDYS,_(gl)QTPAS(ph)PECDYSQYFK_,S148,,23.46,,,,,,,,,,,,,23.46,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
9680,P28800,SERPINF2,Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2),LKLGPPSEEDYAQ,_LGPPS(ph)EEDYAQPSSPK_,S481,,,21.29,,21.80,,23.10,,,22.72,,22.38,,,22.26, ,-0.97, ,-0.46, ,0.84, , ,0.47, ,0.12, , ,,,,,,,,,,,,,,,,
9681,P31096,SPP1,Osteopontin (Bone sialoprotein 1) (Secreted phosphoprotein 1) (SPP-1),ISHELDSASSEVN,_ISHELDS(ph)AS(ph)SEVN_,S256,,23.07,28.69,,,,,,,,23.09,,,25.57,25.11,-2.03,3.58, , , , , , , ,-2.02, , ,0.47,,,,,,,,,,,,,,,,
9682,P31096,SPP1,Osteopontin (Bone sialoprotein 1) (Secreted phosphoprotein 1) (SPP-1),HELDSASSEVN__,_ISHELDS(ph)AS(ph)SEVN_,S258,,22.59,28.18,,,22.47,,,,25.74,23.92,25.50,,,24.73,-2.14,3.45, , ,-2.27, , , ,1.00,-0.81,0.77, , ,,,,,,,,,,,,,,,,
9683,P31096,SPP1,Osteopontin (Bone sialoprotein 1) (Secreted phosphoprotein 1) (SPP-1),LDLDHKSEEDKHL,_LDLDHKS(ph)EEDK_,S240,,,25.54,,,,,,,,,,,,25.54, ,0.00, , , , , , , , , , , ,,,,,,,,,,,,,,,,
9684,Q5XQN5,KRT5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",RSGGGRSFSTASA,_S(ph)FSTASAITPSVSR_,S16,,29.31,26.22,26.83,,,,,,23.39,,,22.28,,25.61,3.70,0.62,1.22, , , , , ,-2.21, , ,-3.33, ,,,,,,,,,,,,,,,,
9685,Q5XQN5,KRT5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGGRSFSTASAIT,_SFS(ph)TASAITPSVSR_,S18,,27.80,25.49,26.43,,,,,,,21.87,,,23.23,24.96,2.84,0.53,1.47, , , , , , ,-3.10, , ,-1.73,,,,,,,,,,,,,,,,
9686,Q5XQN5,KRT5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",RSFSTASAITPSV,_S(ph)FSTAS(ph)AITPSVSR_,S21,,25.16,24.45,24.45,,,,,,22.07,22.06,,,,23.64,1.53,0.81,0.81, , , , , ,-1.57,-1.58, , , ,,,,,,,,,,,,,,,,
9689,Q922U2,Krt5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGYGSRSLYNVGG,_S(ph)LYNVGGSKR_,S61,+,25.66,24.67,25.59,21.98,24.21,22.20,24.54,24.21,,,,,,24.13,1.52,0.54,1.46,-2.15,0.08,-1.93,0.41,0.08, , , , , ,,mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
9788,A0MZ66,KIAA1598,Shootin-1,NSPSPPTPEPGEG,_TLEAEFNSPSPPT(ph)PEPGEGPR_,T477,,23.41,,,,,,,,,,,,,23.41,0.00, , , , , , , , , , , , ,axon guidance,cytosol;axon,,,,,,,,,,,,,,
9790,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,EKDSLITPHVSRS,_DSLIT(ph)PHVS(ph)R_,T2450,,26.94,25.96,24.52,25.29,,,,,,,,,,25.68,1.26,0.28,-1.16,-0.39, , , , , , , , , ,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
9791,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,SGTSVGTDEESDV,_LNQSGTSVGT(ph)DEESDVTQEEER_,T2293,+,24.86,23.88,24.33,23.43,24.42,,23.49,23.40,22.15,22.53,,,22.65,23.51,1.35,0.37,0.82,-0.09,0.90, ,-0.02,-0.11,-1.36,-0.99, , ,-0.87,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
9792,A6NKT7,RGPD3,RanBP2-like and GRIP domain-containing protein 3,YKYSPKTPPRWAE,_T(ph)PPRWAEDQNSLLK_,T799,+,23.11,24.03,24.41,24.13,24.51,,25.56,23.38,25.86,27.08,22.43,25.87,21.92,24.36,-1.25,-0.33,0.05,-0.22,0.15, ,1.20,-0.98,1.50,2.72,-1.93,1.51,-2.44,protein targeting to Golgi,intracellular,,,,,,,,,,,,,,
9798,O00267,SUPT5H,Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein),EHLEPITPTKNNK,_VVSISSEHLEPIT(ph)PTK_,T1030,+,22.30,23.93,23.93,20.42,22.77,22.34,22.21,23.42,,22.38,,,22.40,22.61,-0.31,1.32,1.32,-2.19,0.16,-0.27,-0.40,0.81, ,-0.23, , ,-0.21,"7-methylguanosine mRNA capping;negative regulation of DNA-dependent transcription, elongation;retroviral genome replication;positive regulation of transcription elongation from RNA polymerase II promoter;negative regulation of transcription from RNA polymerase II promoter;positive regulation of DNA-dependent transcription, elongation;cell cycle;positive regulation of macroautophagy;transcription elongation from RNA polymerase II promoter;chromatin remodeling;response to organic substance;positive regulation of viral transcription;positive regulation of transcription from RNA polymerase II promoter",DSIF complex,,,,,,,,,,,,,,
9800,O00461,GOLIM4,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",EHNAEETYGENDE,_ELEHNAEET(ph)YGENDENTDDK_,T640,,,24.01,24.55,25.65,26.13,25.22,27.00,22.28,26.81,25.10,26.94,27.10,23.94,25.39, ,-1.38,-0.84,0.25,0.73,-0.18,1.60,-3.11,1.42,-0.30,1.55,1.71,-1.45,transport,Golgi cisterna membrane;endosome membrane;endocytic vesicle;integral to membrane;nucleus;Golgi lumen;cis-Golgi network,,,,,,,,,,,,,,
9803,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),SLARQRTLEDEEE,_(gl)QRT(ph)LEDEEEQERER_,T19,,24.92,24.59,24.59,,,,,,,,,,,24.70,0.23,-0.11,-0.11, , , , , , , , , , ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
9804,O00515,LAD1,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),SLVSDKTSISEKV,_SLVSDKT(ph)SISEK_,T200,,23.15,,,,,22.44,22.02,,,,,21.77,,22.34,0.81, , , , ,0.10,-0.33, , , , ,-0.58, ,,basement membrane;actin cytoskeleton,,,,,,,,,,,,,,
9807,O00767,SCD,Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase),VKEKGSTLDLSDL,_GST(ph)LDLSDLEAEK_,T199,+,21.29,,,25.30,20.85,22.55,23.18,23.36,23.42,22.61,,25.32,22.10,23.00,-1.71, , ,2.30,-2.15,-0.45,0.18,0.37,0.42,-0.39, ,2.33,-0.90,fatty acid biosynthetic process,integral to membrane;endoplasmic reticulum;endoplasmic reticulum membrane,,,,,,,,,,,,,,
9809,O14672,ADAM10,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),PKPLPGTLKRRRP,_LPPPKPLPGT(ph)LK_,T719,+,20.88,21.17,21.36,22.90,,,23.11,,,,21.99,24.00,,22.20,-1.32,-1.03,-0.84,0.69, , ,0.91, , , ,-0.21,1.80, ,constitutive protein ectodomain proteolysis;protein phosphorylation;in utero embryonic development;cell-cell signaling;negative regulation of cell adhesion;positive regulation of T cell chemotaxis;Notch signaling pathway;epidermal growth factor receptor signaling pathway;Notch receptor processing;positive regulation of cell growth;monocyte activation;response to tumor necrosis factor;positive regulation of cell proliferation;integrin-mediated signaling pathway;PMA-inducible membrane protein ectodomain proteolysis,endomembrane system;integral to membrane;plasma membrane;nucleus;postsynaptic density;cell surface;Golgi-associated vesicle,,,,,,,,,,,,,,
9814,O14974,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),RQSRRSTQGVTLT,_RST(ph)QGVTLTDLQEAEK_,T640,+,26.84,22.24,22.24,26.42,25.71,24.82,28.02,25.75,24.24,22.54,,29.34,25.29,25.29,1.56,-3.04,-3.04,1.13,0.42,-0.47,2.73,0.46,-1.05,-2.75, ,4.05,0.00,centrosome organization;mitosis;regulation of nucleocytoplasmic transport;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;protein dephosphorylation;positive regulation of transcription from RNA polymerase II promoter,PTW/PP1 phosphatase complex;contractile fiber;centrosome;kinetochore,,,,,,,,,,+,,,,
9815,O15014,ZNF609,Zinc finger protein 609,ELESPLTPGKVCR,_ELESPLT(ph)PGK_,T746,+,23.85,23.90,24.12,24.72,,25.65,24.67,24.13,25.25,24.79,23.02,24.48,24.44,24.42,-0.57,-0.51,-0.30,0.30, ,1.23,0.25,-0.29,0.83,0.38,-1.39,0.06,0.02,,nucleus,C2H2-type,,,,,,,,,,,,,
9817,O15047,SETD1A,Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1),KRPRPSTPAEEDE,_RPRPST(ph)PAEEDEDDPEQEK_,T916,+,23.09,25.21,25.65,23.88,22.62,26.54,25.95,25.52,26.56,26.00,24.47,25.02,24.40,24.99,-1.91,0.22,0.65,-1.11,-2.37,1.55,0.95,0.53,1.57,1.01,-0.52,0.03,-0.59,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nuclear speck;chromosome;Set1C/COMPASS complex,,,,,,,,,,,,,,
9819,O15085,ARHGEF11,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),RSLENPTPPFTPK,_SLENPT(ph)PPFT(ph)PK_,T668,,23.84,,,,22.20,,22.44,22.96,22.54,,,,,22.80,1.04, , , ,-0.59, ,-0.36,0.16,-0.25, , , , ,"regulation of cell growth;positive regulation of GTPase activity;striated muscle contraction;actin cytoskeleton organization;establishment of cell polarity;apoptotic process;regulation of small GTPase mediated signal transduction;cellular component movement;cytokinesis;regulation of Rho protein signal transduction;G-protein coupled receptor signaling pathway;axon guidance;Rho protein signal transduction;termination of G-protein coupled receptor signaling pathway;positive regulation of transcription, DNA-dependent;nerve growth factor receptor signaling pathway",cytosol;membrane,,,,,,,,,,,,,,
9821,O15173,PGRMC2,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),EEPSEYTDEEDTK,_PGEEPSEYT(ph)DEEDTK_,T211,+,31.92,31.74,31.24,32.07,29.68,31.95,32.76,30.58,33.61,32.75,32.62,32.01,32.17,31.93,-0.01,-0.19,-0.69,0.14,-2.25,0.02,0.83,-1.35,1.68,0.82,0.69,0.08,0.24,,integral to membrane,,,,,,,,,,,,,,
9822,O15173,PGRMC2,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),YTDEEDTKDHNKQ,_LLKPGEEPSEYT(ph)DEEDT(ph)K_,T216,,23.34,,,,,,,,,,,,,23.34,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
9823,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),QPADPSTPERQSS,_GGQGDPAVPAQQPADPST(ph)PERQS(ph)SPSGSEQLVR_,T448,,27.67,27.04,23.87,24.73,28.11,27.25,28.25,28.46,27.98,26.39,25.71,,26.36,26.82,0.85,0.22,-2.95,-2.08,1.29,0.44,1.44,1.64,1.16,-0.43,-1.11, ,-0.46,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9826,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),SSTSGDTEEEEEE,_RSS(ph)TSGDT(ph)EEEEEEEVVPFSSDEQK_,T158,,27.09,,,,25.58,24.04,,,24.77,26.54,24.35,,,25.39,1.70, , , ,0.19,-1.36, , ,-0.63,1.15,-1.04, , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9830,O15231,ZNF185,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),SSTSGDTEEEEEE,_RSS(ph)TSGDT(ph)EEEEEEEVVPFSSDEQK_,T23,,27.09,,,,25.58,24.04,,,24.77,26.54,24.35,,,25.39,1.70, , , ,0.19,-1.36, , ,-0.63,1.15,-1.04, , ,,focal adhesion;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
9832,O15427,SLC16A3,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),NGEVVHTPETSV_,_NGEVVHT(ph)PETSV_,T460,,,,,23.69,,,23.52,,24.60,,23.15,,,23.74, , , ,-0.05, , ,-0.22, ,0.86, ,-0.59, , ,blood coagulation;pyruvate metabolic process;leukocyte migration,nuclear membrane;integral to plasma membrane;actin cytoskeleton,,,,,,,,,,,,,,
9840,O43294,TGFB1I1,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),RPAEPLTPPPSYG,_ERPAEPLT(ph)PPPSYGHQPQTGSGESSGASGDK_,T33,,,,,,,,23.90,,24.35,,23.91,,,24.05, , , , , , ,-0.16, ,0.30, ,-0.14, , ,"negative regulation of cell proliferation;positive regulation of transforming growth factor beta receptor signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;positive regulation of epithelial to mesenchymal transition;transcription from RNA polymerase II promoter;negative regulation of fat cell differentiation;positive regulation of transcription, DNA-dependent;cell adhesion;Wnt receptor signaling pathway;ubiquitin-dependent SMAD protein catabolic process;androgen receptor signaling pathway;cell fate commitment;morphogenesis of embryonic epithelium;epithelial cell differentiation",intracellular;focal adhesion;cytoskeleton;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
9845,O43399,TPD52L2,Tumor protein D54 (hD54) (Tumor protein D52-like 2),FEDRVGTIKSKVV,_S(ph)FEDRVGT(ph)IK_,T173,,23.89,,,,,,,,,,,,,23.89,0.00, , , , , , , , , , , , ,regulation of cell proliferation,perinuclear region of cytoplasm,,,,,,,,,,,,,,
9846,O43426,SYNJ1,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",ASAGRLTPESQSK,_ASAGRLT(ph)PESQSK_,T73,,,24.27,24.27,22.82,21.32,,,20.97,20.07,,20.67,,,22.06, ,2.22,2.22,0.76,-0.74, , ,-1.09,-1.99, ,-1.38, , ,small molecule metabolic process;phosphatidylinositol phosphorylation;phosphatidylinositol dephosphorylation;synaptic vesicle uncoating;synaptic vesicle endocytosis;response to retinoic acid;positive regulation of receptor-mediated endocytosis;inositol phosphate dephosphorylation;phosphatidylinositol biosynthetic process;brain development;positive regulation of gliogenesis;synaptic vesicle priming;response to cytokine stimulus;learning,cytosol;membrane coat,,,+,,,,,,,,,,,
9847,O43491,EPB41L2,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),KKQKSYTLVVAKD,_SYT(ph)LVVAK_,T89,+,26.27,24.32,24.24,26.34,,,25.50,,,,20.97,26.73,22.88,24.66,1.62,-0.34,-0.42,1.68, , ,0.85, , , ,-3.68,2.07,-1.78,cortical actin cytoskeleton organization,cell junction;plasma membrane;nucleus;spectrin;extrinsic to membrane,,,,,,,,,,,,,,
9852,O43896,KIF1C,Kinesin-like protein KIF1C,RYPPYTTPPRMRR,_YPPYTT(ph)PPR_,T1083,+,,22.61,22.77,22.77,23.81,,24.55,24.21,22.74,23.23,24.76,,,23.49, ,-0.89,-0.72,-0.72,0.32, ,1.05,0.72,-0.75,-0.27,1.27, , ,"retrograde vesicle-mediated transport, Golgi to ER;microtubule-based movement",Golgi apparatus;endoplasmic reticulum;microtubule associated complex;microtubule,,,,,,,,,,,,,,
9855,O60271,SPAG9,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),GYKGSSTPTKGIE,_DLSGYKGSST(ph)PTK_,T365,,,22.58,22.58,,,22.61,,25.63,,,,,,23.35, ,-0.77,-0.77, , ,-0.74, ,2.28, , , , , ,"positive regulation of muscle cell differentiation;activation of JUN kinase activity;negative regulation of protein homodimerization activity;striated muscle cell differentiation;spermatogenesis;positive regulation of cell migration;positive regulation of neuron differentiation;protein homooligomerization;retrograde transport, endosome to Golgi;muscle cell differentiation",cytosol;acrosomal vesicle;integral to membrane;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9859,O60293,ZFC3H1,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),ENDPLRTPEALPE,_ENDPLRT(ph)PEALPEEK_,T766,+,23.57,23.25,23.25,,23.24,25.10,24.33,23.80,24.76,23.71,23.66,22.91,23.77,23.78,-0.21,-0.53,-0.53, ,-0.54,1.32,0.55,0.02,0.98,-0.07,-0.12,-0.87,-0.01,RNA processing,intracellular,,,,,,,,,,,,,,
9860,O60487,MPZL2,Myelin protein zero-like protein 2 (Epithelial V-like antigen 1),SVYLEDTD_____,_VSVYLEDT(ph)D_,T214,,25.68,,,,,,,,,,,,22.44,24.06,1.62, , , , , , , , , , , ,-1.62,anatomical structure morphogenesis;homophilic cell adhesion;T cell differentiation in thymus,integral to membrane;plasma membrane;cytoskeleton,,,,,,,,,,,,,,
9863,O60583,CCNT2,Cyclin-T2 (CycT2),ASSSSVTSPIKMK,_(gl)QGQSQAASSSSVT(ph)SPIK_,T304,,,23.73,23.73,23.34,,,23.92,,,,,,,23.68, ,0.05,0.05,-0.34, , ,0.24, , , , , , ,transcription initiation from RNA polymerase II promoter;transforming growth factor beta receptor signaling pathway;regulation of cyclin-dependent protein kinase activity;viral reproduction;cell cycle;cell division;transcription elongation from RNA polymerase II promoter;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm,,,,,,,,,,,,,,
9865,O60716,CTNND1,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),EDPANDTVDFPKR,_KPIEDPANDT(ph)VDFPK_,T637,,,,,,,23.07,24.21,,23.87,24.55,,,23.20,23.78, , , , , ,-0.71,0.43, ,0.09,0.77, , ,-0.58,"cell-cell adhesion;negative regulation of canonical Wnt receptor signaling pathway;regulation of transcription, DNA-dependent;morphogenesis of a polarized epithelium;adherens junction organization;salivary gland morphogenesis;cell adhesion;epithelial cell differentiation involved in salivary gland development;Wnt receptor signaling pathway;transcription, DNA-dependent;cell junction assembly;keratinocyte differentiation",cytosol;cell-cell junction;midbody;plasma membrane;nucleus;lamellipodium;cell-cell adherens junction,,,,,,,,,,,,,,
9866,O60749,SNX2,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),PAVTPVTPTTLIA,_EPILSSEPSPAVTPVT(ph)PTTLIAPR_,T104,,25.10,,,,,,,,,,,,,25.10,0.00, , , , , , , , , , , , ,intracellular protein transport;endocytosis;cell communication,endosome membrane;early endosome membrane,,,,,,,,,,,,,,
9867,O60784,TOM1,Target of Myb protein 1,MLSPIHTPQRTVF,_GLEFPM(ox)TDLDM(ox)LS(ph)PIHT(ph)PQR_,T164,,22.53,,,,,,,,,,,,,22.53,0.00, , , , , , , , , , , , ,intracellular protein transport;endocytosis;protein transport;endosomal transport,cytosol;membrane;early endosome,,,,,,,,,,,,,,
9872,O60936,NOL3,Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein) (Myp) (Nucleolar protein of 30 kDa) (Nop30),EAVQSGTPEEPEP,_ASDPDEAGGPEGSEAVQSGT(ph)PEEPEPELEAEASK_,T149,,24.55,,,,,,23.53,,,,23.93,,,24.00,0.55, , , , , ,-0.47, , , ,-0.07, , ,negative regulation of apoptotic process;mRNA processing;RNA splicing;apoptotic process;response to hypoxia,cytosol;mitochondrion;sarcoplasm;nucleolus,,,,,,,,,,,,,,
9873,O75113,N4BP1,NEDD4-binding protein 1 (N4BP1),ARNKAGTPVSELT,_AGT(ph)PVSELTK_,T242,+,22.04,24.16,24.30,24.32,,22.85,22.74,,22.66,21.89,21.72,22.71,,22.94,-0.90,1.22,1.36,1.38, ,-0.09,-0.20, ,-0.28,-1.05,-1.22,-0.23, ,negative regulation of protein ubiquitination;negative regulation of proteasomal ubiquitin-dependent protein catabolic process,PML body;nucleolus,,,,,,,,,,,,,,
9874,O75167,PHACTR2,Phosphatase and actin regulator 2,PTAGSQTPPFKRK,_ASIANSDGPTAGSQT(ph)PPFK_,T25,,23.07,,,,24.18,25.47,,24.72,,,,23.64,24.63,24.29,-1.21, , , ,-0.11,1.18, ,0.44, , , ,-0.64,0.34,,,,,,,,,,,,,,,,
9877,O75367,H2AFY,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),DSTTEGTPADGFT,_AASADSTTEGT(ph)PADGFTVLSTK_,T177,+,25.38,,,,24.33,23.46,22.92,,24.64,26.57,,,23.78,24.44,0.94, , , ,-0.11,-0.99,-1.52, ,0.20,2.13, , ,-0.66,dosage compensation;nucleosome assembly;chromatin modification,condensed chromosome;Barr body;nucleosome,,,,,,,,,,,,,,
9879,O75369,FLNB,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),PYRIRATQTGDAS,_IRAT(ph)QTGDASK_,T1640,+,,22.53,,19.25,19.04,18.92,,19.77,,,20.16,20.94,18.17,19.85, ,2.68, ,-0.60,-0.81,-0.93, ,-0.08, , ,0.31,1.09,-1.68,cell differentiation;cytoskeletal anchoring at plasma membrane;skeletal muscle tissue development;cytokine-mediated signaling pathway;actin cytoskeleton organization,Z disc;actin cytoskeleton;cell cortex;cytosol;integral to membrane;stress fiber;focal adhesion;plasma membrane,,,,,,,,,,+,,,,
9881,O75400,PRPF40A,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),ETVADFTPKKEEE,_(gl)QETVADFT(ph)PK_,T355,+,26.94,27.39,27.61,25.55,23.06,,25.62,,26.79,26.80,,25.60,,26.15,0.79,1.24,1.46,-0.60,-3.09, ,-0.53, ,0.64,0.65, ,-0.55, ,regulation of cell shape;cell migration;regulation of cytokinesis;mRNA processing;RNA splicing;cell cycle;cytoskeleton organization;cell division,nuclear speck;nuclear matrix,,,,,,,,,,+,,,,
9882,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),KAVDITTPKAARR,_AVDITT(ph)PK_,T141,,23.11,23.86,24.56,24.38,22.99,22.49,23.20,22.56,,,21.28,22.15,,23.06,0.05,0.80,1.50,1.33,-0.07,-0.56,0.14,-0.50, , ,-1.78,-0.91, ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
9883,O75475,PSIP1,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),SVSKEDTDHEEKA,_ETSVSKEDT(ph)DHEEK_,T122,,22.39,20.49,,23.14,,,19.36,,21.11,,,,,21.30,1.09,-0.81, ,1.84, , ,-1.94, ,-0.18, , , , ,"response to oxidative stress;response to heat;viral reproduction;mRNA 5'-splice site recognition;transcription, DNA-dependent;regulation of transcription, DNA-dependent;virus-host interaction",nucleoplasm;nuclear heterochromatin;cytosol;nuclear periphery;transcriptionally active chromatin,Other TF domain,,,,,,,,,,,,,
9884,O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),GDSIGETPTPGAS,_GGDSIGET(ph)PTPGASK_,T326,+,24.34,24.56,,24.02,22.26,,22.61,23.10,20.99,,,,21.74,22.95,1.39,1.61, ,1.07,-0.70, ,-0.34,0.15,-1.96, , , ,-1.21,"anterior/posterior pattern specification;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,,+,,,
9885,O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),SWDQAETPGHTPS,_LSSWDQAET(ph)PGHT(ph)PSLR_,T223,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,"anterior/posterior pattern specification;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,,+,,,
9886,O75533,SF3B1,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),AETPGHTPSLRWD,_LSSWDQAET(ph)PGHT(ph)PSLR_,T227,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,"anterior/posterior pattern specification;mRNA splicing, via spliceosome",nucleoplasm;U12-type spliceosomal complex;nuclear speck;catalytic step 2 spliceosome,,,,,,,,,,,+,,,
9889,O75676,RPS6KA4,Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB),SSPPLRTPDVLES,_SS(ph)PPLRT(ph)PDVLESSGPAVR_,T439,,22.02,,,,,,,,,,,,,22.02,0.00, , , , , , , , , , , , ,intracellular protein kinase cascade;inflammatory response;histone H3-S28 phosphorylation;negative regulation of cytokine production;positive regulation of NF-kappaB transcription factor activity;positive regulation of histone phosphorylation;positive regulation of CREB transcription factor activity;axon guidance;interleukin-1-mediated signaling pathway;histone H3-S10 phosphorylation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of histone acetylation,nucleus;cytoplasm,,+,,,,,,,,,,,,
9890,O75691,UTP20,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),DNGQPGTPDPADS,_SLSDNGQPGT(ph)PDPADSGGTSAK_,T1741,+,24.92,25.46,25.46,26.17,25.80,26.47,26.24,25.66,26.85,26.11,25.31,,26.60,25.92,-1.01,-0.46,-0.46,0.25,-0.12,0.55,0.32,-0.26,0.93,0.19,-0.61, ,0.68,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);negative regulation of cell proliferation;endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)","small-subunit processome;nucleoplasm;preribosome, small subunit precursor;nucleolus;cytoplasm;90S preribosome",,,,,,,,,,,,,,
9894,O75822,EIF3J,Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35),EEPKVLTPEEQLA,_VLT(ph)PEEQLADK_,T109,+,25.90,23.34,23.39,25.49,,23.15,25.40,23.91,24.28,25.85,24.98,25.12,24.04,24.57,1.33,-1.23,-1.18,0.92, ,-1.42,0.83,-0.66,-0.29,1.27,0.41,0.55,-0.54,translational initiation,cytosol;eukaryotic translation initiation factor 3 complex,,,,,,,,,,,,,,
9897,O75976,CPD,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),HEFQDETDTEEET,_SLLSHEFQDET(ph)DT(ph)EEETLYSSKH_,T1368,,25.16,,,,23.69,,,,22.78,23.24,,,,23.72,1.44, , , ,-0.03, , , ,-0.93,-0.48, , , ,proteolysis;cellular response to interleukin-2,trans-Golgi network;integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
9898,O75976,CPD,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),FQDETDTEEETLY,_SLLSHEFQDET(ph)DT(ph)EEETLYSSK_,T1370,,25.16,,,,,,,,23.42,27.15,,23.64,,24.84,0.32, , , , , , , ,-1.43,2.31, ,-1.20, ,proteolysis;cellular response to interleukin-2,trans-Golgi network;integral to membrane;nucleus;membrane,,,,,,,,,,,,,,
9904,O94842,TOX4,TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1),EDRLSTTPSPTSS,_LSTT(ph)PS(ph)PTSS(ph)LHEDGVEDFRR_,T104,,24.80,,,,,,,,,,,,,24.80,0.00, , , , , , , , , , , , ,,PTW/PP1 phosphatase complex;chromatin;nucleus,HMG-box,,,,,,,,,,,,,
9907,O94906,PRPF6,Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),DSVSGQTVVDPKG,_LSQVSDSVSGQT(ph)VVDPK_,T266,+,,22.72,22.72,,23.76,23.62,24.25,23.44,23.76,,22.80,22.53,,23.29, ,-0.57,-0.57, ,0.47,0.33,0.96,0.15,0.47, ,-0.49,-0.76, ,assembly of spliceosomal tri-snRNP;RNA localization;spliceosomal complex assembly;positive regulation of transcription from RNA polymerase II promoter,U4/U6 snRNP;nucleoplasm;nuclear speck;U4/U6 x U5 tri-snRNP complex;catalytic step 2 spliceosome;U5 snRNP,,,,,,,,,,+,,,,
9913,O95295,SNAPIN,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),AVSGAGTPVAGPT,_(ac)AGAGSAAVSGAGT(ph)PVAGPTGR_,T14,,23.31,,,,,,,,,,,,22.16,22.73,0.58, , , , , , , , , , , ,-0.58,neuron projection development;synaptic vesicle exocytosis;anterograde synaptic vesicle transport;anterograde axon cargo transport;intracellular protein transport;terminal button organization;synaptic vesicle maturation;melanosome organization;virus-host interaction;synaptic vesicle fusion to presynaptic membrane,synaptic vesicle;Golgi apparatus;Golgi membrane;perinuclear region of cytoplasm;neuron projection;synaptic vesicle membrane;cell junction;nucleolus;BLOC-1 complex,,,,,,,,,,,,,,
9914,O95425,SVIL,Supervillin (Archvillin) (p205/p250),MNARYQTQPVTLG,_YQT(ph)QPVTLGEVEQVQSGK_,T426,+,22.95,22.00,22.00,,24.04,24.32,24.65,24.61,22.85,25.44,23.38,22.17,,23.49,-0.54,-1.50,-1.50, ,0.55,0.83,1.16,1.12,-0.64,1.95,-0.11,-1.32, ,skeletal muscle tissue development;cytoskeleton organization,podosome;cell junction;plasma membrane;nucleus;costamere;actin cytoskeleton;invadopodium,,,,,,,,,,,,,,
9915,O95436,SLC34A2,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),ETFDNITISREAQ,_APETFDNIT(ph)ISR_,T668,+,26.17,25.52,25.86,21.70,22.73,,,23.64,,26.27,22.14,,22.56,24.07,2.10,1.46,1.80,-2.37,-1.34, , ,-0.42, ,2.20,-1.93, ,-1.51,response to fructose stimulus;response to estrogen stimulus;aging;cellular phosphate ion homeostasis;in utero embryonic development;response to estradiol stimulus,apical plasma membrane;brush border membrane;integral to plasma membrane,,,,,,,,,,,,,,
9916,O95602,POLR1A,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),LPEEVATPTTDEE,_LPEEVAT(ph)PTTDEEK_,T357,,22.95,,,,22.35,22.79,,,,,,,,22.70,0.26, , , ,-0.35,0.09, , , , , , , ,transcription initiation from RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter;termination of RNA polymerase I transcription;rRNA transcription,nucleoplasm;DNA-directed RNA polymerase I complex,,,,,,,,,,,,,,
9919,O95817,BAG3,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),TAPAEATPPKPGE,_AAPSTAPAEAT(ph)PPKPGEAEAPPK_,T406,,,,,23.44,,,25.50,22.58,,,24.63,24.87,22.89,23.99, , , ,-0.55, , ,1.51,-1.40, , ,0.65,0.89,-1.09,protein folding;negative regulation of apoptotic process;brain development;spinal cord development;apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
9921,O95835,LATS1,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),EKKQITTSPITVR,_(gl)QITT(ph)SPITVRK_,T612,,,,,,24.06,,,24.70,23.28,,,,,24.02, , , , ,0.05, , ,0.69,-0.73, , , , ,positive regulation of peptidyl-serine phosphorylation;sister chromatid segregation;negative regulation of canonical Wnt receptor signaling pathway;hippo signaling cascade;cytoplasmic sequestering of protein;negative regulation of cyclin-dependent protein kinase activity;G2/M transition of mitotic cell cycle;regulation of actin filament polymerization;mitosis;cell division;hormone-mediated signaling pathway;keratinocyte differentiation,cytosol;spindle pole;microtubule organizing center,,+,,,,,,,,,,,,
9923,P00367,GLUD1,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)",GANGPTTPEADKI,_IIAEGANGPTT(ph)PEADK_,T361,+,23.64,22.80,,23.59,,,22.81,22.53,24.36,24.27,23.93,,24.74,23.63,0.01,-0.83, ,-0.04, , ,-0.82,-1.11,0.73,0.64,0.30, ,1.11,glutamate catabolic process;glutamate biosynthetic process;positive regulation of insulin secretion;cellular nitrogen compound metabolic process,mitochondrial matrix,,,,,,,,,,,,,,
9926,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],RLSPSPTSQRSRG,_LSPSPT(ph)SQR_,T394,,,,,27.54,,,,,,,,,,27.54, , , ,0.00, , , , , , , , , ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
9928,P02545,LMNA,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],GAQASSTPLSPTR,_SGAQASST(ph)PLSPTR_,T19,+,26.00,24.10,23.19,24.50,24.33,23.64,23.46,23.09,,23.96,23.22,22.03,,23.77,2.23,0.33,-0.58,0.73,0.56,-0.13,-0.32,-0.69, ,0.18,-0.56,-1.74, ,sterol regulatory element binding protein import into nucleus;regulation of cell migration;protein localization to nucleus;cellular component disassembly involved in execution phase of apoptosis;establishment or maintenance of microtubule cytoskeleton polarity;spermatogenesis;cellular response to hypoxia;ventricular cardiac muscle cell development;activation of signaling protein activity involved in unfolded protein response;nuclear envelope organization;regulation of apoptotic process;positive regulation of cell aging;muscle organ development,nucleoplasm;lamin filament;nuclear envelope;nuclear matrix;perinuclear region of cytoplasm;cytoplasm,,,,,,,,,,,,,,
9936,P04626,ERBB2,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),ELVEPLTPSGAMP,_RLLQETELVEPLT(ph)PSGAM(ox)PNQAQM(ox)R_,T686,,28.21,,,,,,,,,26.34,,,,27.28,0.93, , , , , , , , ,-0.93, , , ,"positive regulation of MAP kinase activity;neuromuscular junction development;negative regulation of apoptotic process;regulation of microtubule-based process;regulation of ERK1 and ERK2 cascade;liver development;positive regulation of Rho GTPase activity;positive regulation of translation;positive regulation of transcription from RNA polymerase I promoter;positive regulation of cell growth;phosphatidylinositol 3-kinase cascade;regulation of angiogenesis;positive regulation of epithelial cell proliferation;peripheral nervous system development;transcription, DNA-dependent;heart development;mammary gland involution;protein autophosphorylation;wound healing;response to drug;response to axon injury;estrus;positive regulation of transcription from RNA polymerase III promoter;myelination;mammary gland development;sympathetic nervous system development;negative regulation of immature T cell proliferation in thymus;response to progesterone stimulus;positive regulation of Ras protein signal transduction;axon guidance;positive regulation of phosphatidylinositol 3-kinase cascade;positive regulation of cell adhesion;cell proliferation;tongue development;glial cell differentiation;motor neuron axon guidance",membrane raft;basolateral plasma membrane;apical plasma membrane;receptor complex;perinuclear region of cytoplasm;lateral loop;endosome membrane;integral to membrane;nucleus;postsynaptic membrane;basal plasma membrane;microvillus,,+,,,,,,,,,,,,
9939,P05187,ALPP,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",GARPDVTESESGS,_DGARPDVT(ph)ESESGSPEYR_,T432,,24.24,,,,,,,,,,,,,24.24,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane;cell surface;anchored to membrane,,,+,,,,,,,,,,,
9940,P05556,ITGB1,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),MNAKWDTGENPIY,_WDT(ph)GENPIYK_,T777,+,21.61,23.14,22.75,25.14,24.41,23.12,23.82,23.15,23.90,22.99,22.92,24.00,,23.41,-1.80,-0.27,-0.66,1.73,1.00,-0.30,0.41,-0.26,0.48,-0.42,-0.49,0.59, ,regulation of immune response;negative regulation of cell proliferation;cell fate specification;response to transforming growth factor beta stimulus;cellular response to mechanical stimulus;leukocyte cell-cell adhesion;B cell differentiation;homophilic cell adhesion;integrin-mediated signaling pathway;cell-cell adhesion mediated by integrin;cardiac muscle cell differentiation;positive regulation of endocytosis;in utero embryonic development;cellular response to vitamin D;cell junction assembly;tight junction assembly;cellular calcium ion homeostasis;maternal process involved in female pregnancy;cell migration involved in sprouting angiogenesis;response to drug;cellular response to ionizing radiation;positive regulation of MAPK cascade;G1/S transition of mitotic cell cycle;calcium-independent cell-matrix adhesion;positive regulation of cell-substrate adhesion;tissue homeostasis;blood coagulation;germ cell migration;positive regulation of cell migration;negative regulation of neuron differentiation;response to activity;response to gonadotropin stimulus;positive regulation of cell proliferation;negative regulation of anoikis;virus-host interaction;regulation of cell cycle;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of cell projection organization;axon guidance;regulation of G-protein coupled receptor protein signaling pathway;positive regulation of neuron differentiation;cellular defense response;positive regulation of neuron projection development;sarcomere organization;protein transport within lipid bilayer;positive regulation of apoptotic process;leukocyte migration,membrane raft;alpha3-beta1 integrin complex;cleavage furrow;hemidesmosome;myelin sheath abaxonal region;alpha8-beta1 integrin complex;basement membrane;focal adhesion;melanosome;acrosomal vesicle;intercalated disc;alpha9-beta1 integrin complex;sarcolemma;external side of plasma membrane;neuromuscular junction;cell surface;ruffle,,,,,,,,,,,,,,
9941,P05771,PRKCB,Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13),RHPPVLTPPDQEV,_HPPVLT(ph)PPDQEVIR_,T641,,,24.49,21.48,,,,,,,,,,,22.99, ,1.50,-1.50, , , , , , , , , , ,"cellular calcium ion homeostasis;B cell activation;lipoprotein transport;calcium ion transport;positive regulation of B cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;positive regulation of I-kappaB kinase/NF-kappaB cascade;positive regulation of vascular endothelial growth factor receptor signaling pathway;apoptotic process;negative regulation of glucose transport;intracellular signal transduction;negative regulation of insulin receptor signaling pathway;platelet activation;regulation of transcription from RNA polymerase II promoter;positive regulation of angiogenesis;B cell receptor signaling pathway;transcription, DNA-dependent;synaptic transmission;cellular response to carbohydrate stimulus",cytosol;plasma membrane;nucleus,,+,,,,,,,,,,,,
9944,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",FSSRSYTSGPGSR,_SYT(ph)SGPGSR_,T26,+,28.84,25.78,,28.29,25.20,,25.86,,,23.35,24.95,,25.46,25.97,2.87,-0.18, ,2.33,-0.77, ,-0.11, , ,-2.61,-1.02, ,-0.51,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
9945,P05787,KRT8,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",SAYGGLTSPGLSY,_TTSGYAGGLSSAYGGLT(ph)SPGLSYSLGSSFGSGAGSSSFSR_,T431,,26.16,,,,,,,,,,,,,26.16,0.00, , , , , , , , , , , , ,cytoskeleton organization;virus-host interaction,nucleoplasm;intermediate filament;keratin filament;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
9946,P06400,RB1,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),ISEGLPTPTKMTP,_ISEGLPT(ph)PTK_,T821,,23.38,23.17,23.17,,,,,22.22,,23.43,,,,23.08,0.30,0.10,0.10, , , , ,-0.85, ,0.35, , , ,"S phase of mitotic cell cycle;regulation of centromere complex assembly;neuron projection development;G1 phase of mitotic cell cycle;mitotic cell cycle G1/S transition checkpoint;Ras protein signal transduction;positive regulation of mitotic metaphase/anaphase transition;negative regulation of transcription, DNA-dependent;striated muscle cell differentiation;neuron apoptotic process;enucleate erythrocyte differentiation;negative regulation of epithelial cell proliferation;cell division;negative regulation of transcription involved in G1/S phase of mitotic cell cycle;negative regulation of smoothened signaling pathway;regulation of cohesin localization to chromatin;positive regulation of transcription, DNA-dependent;cell morphogenesis involved in neuron differentiation;protein localization to chromosome, centromeric region;transcription, DNA-dependent;regulation of transcription involved in G1/S phase of mitotic cell cycle;digestive tract development;negative regulation of cell growth;myoblast differentiation;negative regulation of protein kinase activity;cell cycle arrest;negative regulation of sequence-specific DNA binding transcription factor activity;androgen receptor signaling pathway;chromatin remodeling;virus-host interaction;negative regulation of S phase of mitotic cell cycle;neuron maturation;positive regulation of transcription from RNA polymerase II promoter;positive regulation of macrophage differentiation;sister chromatid biorientation;regulation of lipid kinase activity;maintenance of mitotic sister chromatid cohesion",chromatin;SWI/SNF complex;PML body;spindle;Rb-E2F complex,Other TF domain,,,,,,,,,,,,,
9950,P06493,CDK1,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),EKIGEGTYGVVYK,_IGEGT(ph)YGVVYKGR_,T14,+,25.39,24.95,25.73,,26.71,25.63,26.81,27.16,24.60,24.90,24.10,25.74,24.79,25.54,-0.15,-0.59,0.19, ,1.17,0.09,1.27,1.62,-0.94,-0.64,-1.44,0.19,-0.75,"response to cadmium ion;negative regulation of apoptotic process;cellular response to hydrogen peroxide;fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;response to toxin;Ras protein signal transduction;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA repair;positive regulation of protein import into nucleus, translocation;insulin receptor signaling pathway;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cell division;response to amine stimulus;protein localization to kinetochore;activation of MAPK activity;cell migration;regulation of embryonic development;TRIF-dependent toll-like receptor signaling pathway;cell aging;pronuclear fusion;epidermal growth factor receptor signaling pathway;regulation of Schwann cell differentiation;positive regulation of mitotic cell cycle;organ regeneration;nerve growth factor receptor signaling pathway;response to organic cyclic compound;DNA replication;toll-like receptor 1 signaling pathway;positive regulation of DNA replication;positive regulation of cardiac muscle cell proliferation;regulation of transcription involved in G1/S phase of mitotic cell cycle;response to drug;chromosome condensation;response to axon injury;Toll signaling pathway;ventricular cardiac muscle cell development;stress-activated MAPK cascade;response to activity;apoptotic process;activation of MAPKK activity;response to ethanol;mitotic cell cycle G2/M transition DNA damage checkpoint;toll-like receptor 3 signaling pathway;positive regulation of gene expression;protein complex assembly;axon guidance;innate immune response;centrosome cycle;G2/M transition of mitotic cell cycle;mitosis;response to copper ion",spindle microtubule;nucleoplasm;cytosol;mitochondrion;midbody;microtubule organizing center,,+,,,,,,,,,,,,
9951,P06744,GPI,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36),LRNRSNTPILVDG,_SNT(ph)PILVDGK_,T109,,24.36,23.50,23.50,23.79,21.57,21.81,,,,,,,,23.09,1.27,0.41,0.41,0.70,-1.52,-1.28, , , , , , , ,angiogenesis;small molecule metabolic process;aldehyde catabolic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;learning or memory;hemostasis;glucose 6-phosphate metabolic process;methylglyoxal biosynthetic process;gluconeogenesis;humoral immune response;glycolysis;negative regulation of neuron apoptotic process,cytosol;extracellular space;plasma membrane;nucleus,,,,,,,,,,,,,,
9953,P07355,ANXA2,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),LEGDHSTPPSAYG,_LSLEGDHST(ph)PPSAYGSVK_,T19,+,24.94,25.38,25.74,24.58,26.56,25.87,27.10,26.27,25.33,26.55,26.56,26.05,26.44,25.95,-1.01,-0.57,-0.21,-1.38,0.61,-0.08,1.15,0.32,-0.62,0.60,0.60,0.10,0.49,body fluid secretion;angiogenesis;positive regulation of binding;collagen fibril organization;positive regulation of vesicle fusion;cellular response to acid;fibrinolysis;skeletal system development,extrinsic to plasma membrane;sarcolemma;Schmidt-Lanterman incisure;myelin sheath adaxonal region;protein complex;perinuclear region of cytoplasm;early endosome;midbody;extracellular vesicular exosome;basement membrane;lipid particle;plasma membrane;melanosome,,,,,,,,,,,,,,
9956,P08670,VIM,Vimentin,GQVINETSQHHDD,_DGQVINET(ph)SQHHDDLE_,T458,+,21.26,22.89,,22.88,23.99,28.64,,,25.66,24.50,27.09,,24.20,24.57,-3.30,-1.68, ,-1.69,-0.58,4.07, , ,1.09,-0.06,2.52, ,-0.37,muscle filament sliding;astrocyte development;intermediate filament organization;cellular component disassembly involved in execution phase of apoptosis;lens fiber cell development;Bergmann glial cell differentiation;negative regulation of neuron projection development;virus-host interaction,cytosol;axon;intermediate filament;extracellular vesicular exosome;cell leading edge;peroxisome,,,,,,,,,,,,,,
9960,P08727,KRT19,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",KAALEDTLAETEA,_AALEDT(ph)LAETEAR_,T323,,,22.63,,,26.49,25.96,26.33,26.54,23.92,22.71,24.49,25.42,24.87,24.94, ,-2.31, , ,1.55,1.02,1.40,1.61,-1.01,-2.23,-0.44,0.48,-0.06,cell differentiation involved in embryonic placenta development;response to estrogen stimulus;sarcomere organization;virus-host interaction,Z disc;cell periphery;dystrophin-associated glycoprotein complex;intermediate filament;sarcolemma;costamere,,,,,,,,,,,,,,
9962,P08729,KRT7,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",YQTKFETLQAQAG,_FET(ph)LQAQAGK_,T289,,23.43,23.64,23.31,19.75,,,24.42,21.98,23.15,22.83,24.45,23.35,,23.03,0.40,0.61,0.28,-3.28, , ,1.39,-1.05,0.12,-0.20,1.42,0.32, ,interphase;cytoskeleton organization;DNA replication;virus-host interaction;regulation of translation,intermediate filament;Golgi apparatus;nucleus;keratin filament,,,,,,,,,,,,,,
9964,P0C1Z6,TFPT,TCF3 fusion partner (INO80 complex subunit F) (Protein FB1),RAGNALTPELAPV,_AGNALT(ph)PELAPVQIK_,T198,+,21.28,21.13,,22.31,,,22.40,,24.14,23.44,,22.52,,22.46,-1.18,-1.33, ,-0.15, , ,-0.06, ,1.68,0.98, ,0.06, ,"DNA repair;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;DNA recombination;induction of apoptosis",Ino80 complex;cytoplasm,,,,,,,,,,,,,,
9965,P0C7T5,ATXN1L,Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1),APAHRGTPDTDLE,_VEVAAPAHRGT(ph)PDTDLEVQR_,T330,+,,,,,24.00,24.62,22.75,22.96,23.07,,23.31,22.45,24.68,23.48, , , , ,0.52,1.14,-0.73,-0.52,-0.41, ,-0.17,-1.03,1.20,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;dendrite,Other TF domain,,,,,,,,,,,,,
9967,P10412,HIST1H1E,Histone H1.4 (Histone H1b) (Histone H1s-4),___MSETAPAAPA,_(ac)SET(ph)APAAPAAPAPAEKT(ph)PVK_,T4,,,23.24,23.14,21.87,,,,,,,,,,22.75, ,0.49,0.39,-0.88, , , , , , , , , ,nucleosome positioning;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
9968,P10412,HIST1H1E,Histone H1.4 (Histone H1b) (Histone H1s-4),PAPAEKTPVKKKA,_(ac)SETAPAAPAAPAPAEKT(ph)PVKK_,T18,+,29.49,29.77,30.72,28.46,29.45,30.34,29.86,30.21,28.98,29.04,26.71,28.77,30.22,29.39,0.11,0.39,1.33,-0.93,0.06,0.95,0.48,0.82,-0.41,-0.34,-2.67,-0.62,0.83,nucleosome positioning;nucleosome assembly,nucleus;nucleosome,,,,,,,,,,,,,,
9970,P10451,SPP1,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),NLLAPQTLPSKSN,_QNLLAPQT(ph)LPSK_,T59,,,25.83,,,,,,,,27.35,,,,26.59, ,-0.76, , , , , , , ,0.76, , , ,inflammatory response;decidualization;osteoblast differentiation;neutrophil chemotaxis;negative regulation of collateral sprouting of intact axon in response to injury;embryo implantation;biomineral tissue development;positive regulation of cell-substrate adhesion;positive regulation of bone resorption;response to vitamin D;cell adhesion;response to steroid hormone stimulus,extracellular space;apical part of cell;cell projection;perinuclear region of cytoplasm;membrane-bounded vesicle,,,,,,,,,,,,,,
9971,P11021,HSPA5,78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP),PTGEEDTAEKDEL,_LYGSAGPPPTGEEDT(ph)AEKDEL_,T648,,29.03,27.08,27.77,,23.15,25.38,,23.71,,,,,25.30,25.92,3.11,1.16,1.85, ,-2.76,-0.54, ,-2.21, , , , ,-0.62,platelet degranulation;negative regulation of apoptotic process;cellular response to glucose starvation;platelet activation;ER-associated protein catabolic process;negative regulation of transforming growth factor beta receptor signaling pathway;cerebellar Purkinje cell layer development;cerebellum structural organization;regulation of protein folding in endoplasmic reticulum;ER overload response;positive regulation of protein ubiquitination;activation of signaling protein activity involved in unfolded protein response,endoplasmic reticulum-Golgi intermediate compartment;endoplasmic reticulum lumen;integral to endoplasmic reticulum membrane;midbody;endoplasmic reticulum chaperone complex;nucleus;melanosome;cell surface,,,,,,,,,,,,,,
9975,P11137,MAP2,Microtubule-associated protein 2 (MAP-2),TAITPGTPPSYSS,_SGTSTPTTPGSTAITPGT(ph)PPSYSSR_,T1601,+,21.69,24.78,24.78,26.83,24.63,23.98,25.84,26.00,22.48,,26.87,25.28,26.57,24.98,-3.29,-0.20,-0.20,1.85,-0.35,-1.00,0.87,1.02,-2.50, ,1.90,0.30,1.59,axonogenesis;microtubule bundle formation;cellular response to organic substance;dendrite morphogenesis;peptidyl-threonine phosphorylation;central nervous system neuron development,neuronal cell body;nuclear periphery;microtubule associated complex;microtubule;dendritic shaft;cytoplasm,,,,,,,,,,,,,,
9977,P12956,XRCC6,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),TEKIMATPEQVGK,_IM(ox)AT(ph)PEQVGK_,T455,,,,,24.65,24.14,22.39,,,,22.82,,,,23.50, , , ,1.15,0.64,-1.11, , , ,-0.68, , , ,"negative regulation of transcription, DNA-dependent;response to ionizing radiation;positive regulation of neurogenesis;double-strand break repair via nonhomologous end joining;viral reproduction;V(D)J recombination;DNA ligation;telomere maintenance;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",transcription factor complex;nonhomologous end joining complex;Ku70:Ku80 complex;nuclear telomere cap complex;DNA-dependent protein kinase-DNA ligase 4 complex;membrane;cytoplasm,SAP-domain,,,,,,,,,,,,,
9980,P13639,EEF2,Elongation factor 2 (EF-2),ETRFTDTRKDEQE,_FTDT(ph)RKDEQER_,T59,,23.15,,,,,,20.85,21.00,,,,20.00,,21.25,1.90, , , , , ,-0.40,-0.25, , , ,-1.25, ,translational elongation,cytosol;ribonucleoprotein complex;polysome,,,,,,,,,,,,,,
9981,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GSRSFSTASAITP,_SFST(ph)ASAITPSVSR_,T19,,21.39,27.63,28.32,20.83,21.63,,,,,23.78,,,,23.93,-2.54,3.70,4.39,-3.09,-2.30, , , , ,-0.15, , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
9982,P13647,KRT5,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",STASAITPSVSRT,_SFSTASAIT(ph)PSVSR_,T24,,21.75,,,,,,,,,,,,,21.75,0.00, , , , , , , , , , , , ,hemidesmosome assembly;epidermis development,cytosol;mitochondrion;plasma membrane;keratin filament,,,,,,,,,,,,,,
9984,P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),ETAKESTAEKDEL,_EST(ph)AEKDEL_,T797,,27.59,,,,,,,,,,,,,27.59,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;ER-associated protein catabolic process;response to hypoxia;actin rod assembly;innate immune response;protein folding;sequestering of calcium ion;activation of signaling protein activity involved in unfolded protein response;protein transport;regulation of phosphoprotein phosphatase activity;cellular response to ATP,cytosol;midbody;plasma membrane part;melanosome;endoplasmic reticulum membrane;endoplasmic reticulum lumen;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9989,P14625,HSP90B1,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),EEMDVGTDEEEET,_VEEEPEEEPEETAEDTTEDTEQDEDEEM(ox)DVGT(ph)DEEEETAK_,T786,,30.26,,,,24.78,,,,,28.40,,,,27.81,2.45, , , ,-3.03, , , , ,0.58, , , ,negative regulation of apoptotic process;ER-associated protein catabolic process;response to hypoxia;actin rod assembly;innate immune response;protein folding;sequestering of calcium ion;activation of signaling protein activity involved in unfolded protein response;protein transport;regulation of phosphoprotein phosphatase activity;cellular response to ATP,cytosol;midbody;plasma membrane part;melanosome;endoplasmic reticulum membrane;endoplasmic reticulum lumen;perinuclear region of cytoplasm,,,,,,,,,,,,,,
9991,P14923,JUP,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),ACGRQYTLKKTTT,_(gl)QYT(ph)LKK_,T54,,24.83,,,20.45,,,,,,,,,,22.64,2.19, , ,-2.19, , , , , , , , , ,cellular response to indole-3-methanol;negative regulation of Wnt receptor signaling pathway involved in heart development;endothelial cell-cell adhesion;negative regulation of heart induction by canonical Wnt receptor signaling pathway;adherens junction organization;oocyte development;cytoskeletal anchoring at plasma membrane;bundle of His cell to Purkinje myocyte communication;skin development;regulation of heart rate by cardiac conduction;cell morphogenesis;cell migration;gastrulation;positive regulation of protein import into nucleus;regulation of cell proliferation;positive regulation of sequence-specific DNA binding transcription factor activity;regulation of ventricular cardiac muscle cell action potential;detection of mechanical stimulus;desmosome assembly;regulation of apoptotic process;positive regulation of canonical Wnt receptor signaling pathway;morphogenesis of embryonic epithelium;atrioventricular valve morphogenesis;ectoderm development;nervous system development,Z disc;protein-DNA complex;basolateral plasma membrane;lateral plasma membrane;internal side of plasma membrane;gamma-catenin-TCF7L2 complex;actin cytoskeleton;cytosol;zonula adherens;fascia adherens;catenin complex;apicolateral plasma membrane;desmosome,,,,,,,,,,,,,,
9992,P15336,ATF2,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1),VIVADQTPTPTRF,_NDSVIVADQT(ph)PT(ph)PTR_,T69,,23.86,,,,,,,,,,,,,23.86,0.00, , , , , , , , , , , , ,toll-like receptor 3 signaling pathway;fat cell differentiation;toll-like receptor 4 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;innate immune response;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;adipose tissue development;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transforming growth factor beta2 production;response to osmotic stress;toll-like receptor 1 signaling pathway,nucleoplasm,bZIP,,,,,,,,,,,,,
9993,P15336,ATF2,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1),VADQTPTPTRFLK,_NDSVIVADQT(ph)PT(ph)PTR_,T71,,24.68,,,,,,,,,,,,,24.68,0.00, , , , , , , , , , , , ,toll-like receptor 3 signaling pathway;fat cell differentiation;toll-like receptor 4 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;regulation of sequence-specific DNA binding transcription factor activity;outflow tract morphogenesis;innate immune response;Toll signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;adipose tissue development;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transforming growth factor beta2 production;response to osmotic stress;toll-like receptor 1 signaling pathway,nucleoplasm,bZIP,,,,,,,,,,,,,
9994,P15531,NME1,Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (Tumor metastatic process-associated protein) (nm23-H1),RVMLGETNPADSK,_VM(ox)LGET(ph)NPADSKPGTIR_,T94,+,23.15,24.25,,23.46,23.52,23.47,23.04,24.03,22.24,,24.39,23.24,23.31,23.46,-0.31,0.78, ,0.00,0.05,0.00,-0.42,0.56,-1.22, ,0.93,-0.22,-0.15,cell differentiation;negative regulation of cell proliferation;endocytosis;positive regulation of epithelial cell proliferation;positive regulation of DNA binding;UTP biosynthetic process;regulation of apoptotic process;GTP biosynthetic process;CTP biosynthetic process;nucleobase-containing small molecule interconversion;nervous system development,cytosol;nucleus,,,,,,,,,,,,,,
9998,P15941,MUC1,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha);Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],YVPPSSTDRSPYE,_YVPPSST(ph)DRSPYEK_,T1233,+,,24.09,,22.39,22.84,23.09,,22.62,21.83,26.78,21.88,,,23.19, ,0.90, ,-0.80,-0.35,-0.10, ,-0.57,-1.36,3.59,-1.31, , ,"negative regulation of apoptotic process;negative regulation of transcription by competitive promoter binding;post-translational protein modification;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;O-glycan processing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4 acetylation;positive regulation of transcription from RNA polymerase II promoter in response to stress",nuclear chromatin;extracellular region;apical plasma membrane;Golgi lumen;integral to plasma membrane;cell surface,,,,,,,,,,,,,,
10000,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),TAGVPDTPTRLVF,_LTAGVPDT(ph)PTR_,T1460,,23.96,24.31,,22.00,20.73,,,,,,,,,22.75,1.21,1.56, ,-0.75,-2.02, , , , , , , , ,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
10001,P16144,ITGB4,Integrin beta-4 (GP150) (CD antigen CD104),FAFPGSTNSLHRM,_M(ox)DFAFPGST(ph)NSLHR_,T1385,,,,,,,,,,,,,24.04,22.98,23.51, , , , , , , , , , , ,0.53,-0.53,multicellular organismal development;hemidesmosome assembly;cell-matrix adhesion;response to wounding;filopodium assembly;cell adhesion;cell motility;integrin-mediated signaling pathway,hemidesmosome;integrin complex;cell leading edge;basement membrane;cell surface;basal plasma membrane,,,,,,,,,,,,,,
10002,P16383,GCFC2,GC-rich sequence DNA-binding factor 2 (GC-rich sequence DNA-binding factor) (Transcription factor 9) (TCF-9),RTLDVSTDEEDKI,_TLDVS(ph)T(ph)DEEDK_,T97,+,25.33,24.19,24.21,22.67,20.62,,23.03,,,21.49,,21.95,,22.94,2.39,1.26,1.27,-0.27,-2.32, ,0.09, , ,-1.44, ,-0.98, ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
10004,P16401,HIST1H1B,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),APAETATPAPVEK,_(ac)SETAPAETAT(ph)PAPVEKSPAK_,T11,+,27.12,27.05,27.05,26.28,24.93,,26.52,,27.48,26.71,22.50,25.20,,26.08,1.04,0.97,0.97,0.20,-1.16, ,0.43, ,1.39,0.63,-3.58,-0.88, ,nucleosome assembly,nuclear chromatin;nucleosome,,,,,,,,,,,,,,
10006,P16402,HIST1H1D,Histone H1.3 (Histone H1c) (Histone H1s-2),PAPAEKTPVKKKA,_(ac)SETAPLAPTIPAPAEKT(ph)PVK_,T18,+,26.75,26.20,27.09,25.34,27.58,28.00,28.37,26.52,26.38,27.50,23.63,26.01,26.23,26.59,0.17,-0.39,0.51,-1.25,1.00,1.42,1.78,-0.07,-0.20,0.92,-2.95,-0.57,-0.35,nucleosome positioning;nucleosome assembly,nuclear chromatin;nucleosome,,,,,,,,,,,,,,
10007,P17096,HMGA1,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),EPSEVPTPKRPRG,_EPSEVPT(ph)PK_,T53,,22.28,26.80,26.80,,23.54,,23.43,23.30,,,,,,24.36,-2.07,2.44,2.44, ,-0.82, ,-0.93,-1.06, , , , , ,"negative regulation of cell proliferation;response to virus;negative regulation of chromatin silencing;base-excision repair;positive regulation of cellular senescence;nucleosome disassembly;protein complex assembly;negative regulation of transcription, DNA-dependent;viral reproduction;DNA unwinding involved in replication;transcription, DNA-dependent;oncogene-induced senescence;virus-host interaction;senescence-associated heterochromatin focus assembly",cytosol;senescence-associated heterochromatin focus;transcription factor complex,Other TF domain,,,,,,,,,,,,,
10011,P17275,JUNB,Transcription factor jun-B,ARSRDATPPVSPI,_S(ph)RDAT(ph)PPVS(ph)PINMEDQER_,T255,,28.07,25.77,25.77,24.88,24.75,,,22.45,,,,,,25.28,2.79,0.49,0.49,-0.41,-0.53, , ,-2.83, , , , , ,response to light stimulus;response to drug;osteoclast differentiation;transforming growth factor beta receptor signaling pathway;response to peptide hormone stimulus;positive regulation of cell differentiation;response to mechanical stimulus;positive regulation of transcription from RNA polymerase II promoter;trophectodermal cell differentiation;transcription initiation from RNA polymerase II promoter;response to progesterone stimulus;labyrinthine layer blood vessel development;decidualization;regulation of cell cycle;vasculogenesis;osteoblast differentiation;response to cAMP;cellular response to calcium ion;embryonic process involved in female pregnancy;positive regulation of transcription from RNA polymerase II promoter during mitosis;response to corticosterone stimulus;cellular response to hormone stimulus;osteoblast proliferation;response to cytokine stimulus,nucleoplasm;chromatin,bZIP,,,,,,,,,,,,,
10017,P18206,VCL,Vinculin (Metavinculin) (MV),GEISALTSKLADL,_SLGEISALT(ph)SK_,T442,,,,,20.29,23.43,22.62,24.48,24.70,,21.61,,23.73,,22.98, , , ,-2.69,0.45,-0.36,1.50,1.72, ,-1.37, ,0.75, ,platelet degranulation;lamellipodium assembly;platelet activation;epithelial cell-cell adhesion;cell-matrix adhesion;negative regulation of cell migration;apical junction assembly;protein localization to cell surface;adherens junction assembly;muscle contraction;cellular component movement;morphogenesis of an epithelium,cell-cell adherens junction;protein complex;cytosol;actin filament;stress fiber;extracellular region;fascia adherens;plasma membrane;cytoskeleton;focal adhesion;costamere,,,,,,,,,,+,,,,
10020,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),KTSKAETPTESVS,_AET(ph)PTESVSEPEVATK_,T164,+,25.95,24.75,25.68,23.87,23.69,22.86,,24.08,24.09,24.75,22.71,24.03,,24.22,1.72,0.53,1.46,-0.35,-0.54,-1.36, ,-0.14,-0.14,0.53,-1.52,-0.19, ,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
10022,P18858,LIG1,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),DGDQPTTPPKPLK,_EGEDGDQPTT(ph)PPKPLK_,T152,+,24.10,24.76,24.76,22.54,,23.08,24.87,,23.40,24.52,,23.46,22.65,23.81,0.28,0.95,0.95,-1.27, ,-0.73,1.05, ,-0.41,0.70, ,-0.36,-1.17,"telomere maintenance via semi-conservative replication;anatomical structure morphogenesis;S phase of mitotic cell cycle;lagging strand elongation;base-excision repair;telomere maintenance via recombination;transcription-coupled nucleotide-excision repair;cell division;DNA ligation involved in DNA repair;double-strand break repair via homologous recombination;nucleotide-excision repair, DNA gap filling",nucleoplasm;mitochondrion;chromosome,,,,,,,,,,,,,,
10023,P18887,XRCC1,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),SPQKPPTPEETKA,_TKPTQAAGPSS(ph)PQKPPT(ph)PEETK_,T422,+,25.45,25.48,25.83,24.90,23.31,,,24.09,24.67,22.99,,,,24.59,0.86,0.89,1.24,0.31,-1.28, , ,-0.50,0.08,-1.60, , , ,single strand break repair;base-excision repair;response to drug;response to hypoxia;response to organic substance,nucleoplasm,,,,,,,,,,,,,,
10024,P19012,KRT15,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",DWYQKQTPTSPEC,_(gl)QT(ph)PTSPECDYSQYFK_,T145,,24.21,,,,,,,,,,,,,24.21,0.00, , , , , , , , , , , , ,epidermis development,intermediate filament,,,,,,,,,,,,,,
10025,P19013,KRT4,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",KIISTTTLNKRR_,_IISTTT(ph)LNK_,T529,,24.59,,,,,,,,,,,,,24.59,0.00, , , , , , , , , , , , ,cytoskeleton organization;negative regulation of epithelial cell proliferation;epithelial cell differentiation,intermediate filament;keratin filament,,,,,,,,,,,,,,
10027,P20020,ATP2B1,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),IPLIDDTDAEDDA,_IEDS(ph)EPHIPLIDDT(ph)DAEDDAPTK_,T1129,,24.43,,,,,,,,,,,,,24.43,0.00, , , , , , , , , , , , ,blood coagulation;ATP biosynthetic process,integral to plasma membrane,,,,,,,,,,,,,,
10028,P20042,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta),SDVQEPTEPEDDL,_IESDVQEPT(ph)EPEDDLDIM(ox)LGNKK_,T111,+,25.04,,,23.08,24.79,,24.82,23.94,25.62,25.38,25.76,26.60,24.31,24.94,0.10, , ,-1.85,-0.14, ,-0.12,-0.99,0.68,0.45,0.83,1.67,-0.63,,cytosol;eukaryotic translation initiation factor 2 complex,,,,,,,,,,,+,,,
10031,P20700,LMNB1,Lamin-B1,RAGGPTTPLSPTR,_AGGPTT(ph)PLSPTR_,T20,+,26.22,24.26,24.23,24.11,25.95,24.36,24.06,23.68,25.48,24.19,,22.84,22.26,24.30,1.92,-0.04,-0.07,-0.19,1.65,0.05,-0.24,-0.63,1.18,-0.11, ,-1.46,-2.04,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
10032,P20700,LMNB1,Lamin-B1,__MATATPVPPRM,_(ac)ATAT(ph)PVPPR_,T5,,23.93,,,,22.61,,,,,20.41,,,,22.32,1.61, , , ,0.30, , , , ,-1.91, , , ,cellular component disassembly involved in execution phase of apoptosis,nucleoplasm;lamin filament;nuclear envelope;nuclear inner membrane;nuclear matrix,,,,,,,,,,,,,,
10034,P21127,CDK11B,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),QRVKRGTSPRPPE,_RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK_,T726,+,25.11,24.63,25.15,22.79,22.07,25.88,25.72,25.29,27.14,27.36,22.88,26.12,26.99,25.16,-0.05,-0.54,-0.01,-2.37,-3.09,0.72,0.56,0.13,1.98,2.19,-2.29,0.96,1.82,"cell proliferation;mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,,,,,,,,,,,,,
10036,P21333,FLNA,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),GDARRLTVSSLQE,_LT(ph)VS(ph)S(ph)LQESGLK_,T2328,+,28.31,22.12,21.49,22.34,,,,,24.54,24.78,,25.73,24.75,24.26,4.05,-2.14,-2.77,-1.92, , , , ,0.28,0.53, ,1.47,0.50,platelet degranulation;establishment of protein localization;positive regulation of I-kappaB kinase/NF-kappaB cascade;epithelial to mesenchymal transition;negative regulation of sequence-specific DNA binding transcription factor activity;cilium assembly;adenylate cyclase-inhibiting dopamine receptor signaling pathway;early endosome to late endosome transport;protein stabilization;actin crosslink formation;platelet activation;cytoplasmic sequestering of protein;negative regulation of protein catabolic process;positive regulation of transcription factor import into nucleus;spindle assembly involved in mitosis;actin cytoskeleton reorganization;protein localization to cell surface;receptor clustering;cell junction assembly,actin cytoskeleton;cell cortex;cytosol;trans-Golgi network;extracellular vesicular exosome;Myb complex;nucleus;plasma membrane,,,,,,,,,,+,,,,
10040,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),NAAGDGTIREGML,_GSGVNAAGDGT(ph)IR_,T104,,25.22,,,,,,,,,,,,,25.22,0.00, , , , , , , , , , , , ,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
10042,P22735,TGM1,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),PLQPPTTPSPEPE,_WGGNPLQPPTT(ph)PS(ph)PEPEPEPDGR_,T22,,26.12,,,,,,,27.98,,,,,,27.05,-0.93, , , , , , ,0.93, , , , , ,cellular protein modification process;cell envelope organization;peptide cross-linking;organ morphogenesis;keratinocyte differentiation;keratinization,intrinsic to membrane;cornified envelope;cell-cell adherens junction,,,,,,,,,,,,,,
10044,P23396,RPS3,40S ribosomal protein S3,DEILPTTPISEQK,_DEILPTT(ph)PISEQK_,T221,+,30.32,30.20,30.33,30.30,28.52,28.84,30.07,29.66,29.95,31.15,29.41,29.26,28.58,29.74,0.59,0.46,0.59,0.56,-1.22,-0.90,0.34,-0.08,0.22,1.41,-0.33,-0.48,-1.16,"translational termination;translational elongation;viral transcription;negative regulation of DNA repair;negative regulation of NF-kappaB transcription factor activity;response to DNA damage stimulus;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",ruffle membrane;cytosolic small ribosomal subunit;nucleus,,,,,,,,,,,,,,
10045,P23443,RPS6KB1,Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),FIGSPRTPVSPVK,_FIGS(ph)PRT(ph)PVS(ph)PVK_,T391,,22.32,,,,,,,,,,,,,22.32,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;long-term memory;germ cell development;response to toxin;TOR signaling cascade;response to electrical stimulus involved in regulation of muscle adaptation;insulin receptor signaling pathway;response to mechanical stimulus;response to lipopolysaccharide;positive regulation of translational initiation;response to leucine;cell migration;response to glucagon stimulus;response to glucose stimulus;regulation of glucose import;protein kinase B signaling cascade;positive regulation of smooth muscle cell migration;response to tumor necrosis factor;positive regulation of mitotic cell cycle;aging;response to drug;response to wounding;G1/S transition of mitotic cell cycle;response to testosterone stimulus;positive regulation of skeletal muscle tissue growth;apoptotic process;cellular response to growth factor stimulus;response to ethanol;response to nutrient;phosphatidylinositol-mediated signaling;negative regulation of insulin receptor signaling pathway;skeletal muscle contraction;skeletal muscle atrophy;response to glucocorticoid stimulus;response to heat;positive regulation of smooth muscle cell proliferation,mitochondrion;perinuclear region of cytoplasm;cytoplasm;cytosol;mitochondrial outer membrane;neuron projection;synapse;cell junction;nucleus;cell surface,,+,,,,,,,,,,,,
10047,P23634,ATP2B4,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 3.6.3.8) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),EEELPRTPLLDEE,_T(ph)PLLDEEEEENPDK_,T1133,+,23.74,23.42,23.43,21.37,,,,,,23.90,24.38,25.61,25.09,23.87,-0.13,-0.44,-0.44,-2.50, , , , , ,0.03,0.52,1.74,1.22,neural retina development;blood coagulation;ATP biosynthetic process,integral to plasma membrane,,,,,,,,,,,,,,
10049,P24928,POLR2A,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),SPTYSPTSPKYSP,_YSPTSPTYSPT(ph)SPK_,T1919,,,,,,24.64,25.06,,,,,,,,24.85, , , , ,-0.21,0.21, , , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;protein phosphorylation;regulation of transcription, DNA-dependent;transcription-coupled nucleotide-excision repair;viral reproduction;mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription","DNA-directed RNA polymerase II, core complex",,,,,,,,,,,,,,
10052,P24941,CDK2,Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase),EKIGEGTYGVVYK,_IGEGT(ph)Y(ph)GVVYK_,TNaN,+,25.39,25.73,25.73,,26.14,25.38,26.81,27.07,24.42,24.43,24.10,25.74,24.38,25.44,-0.05,0.29,0.29, ,0.70,-0.07,1.37,1.63,-1.02,-1.01,-1.34,0.29,-1.06,"S phase of mitotic cell cycle;positive regulation of DNA-dependent DNA replication initiation;regulation of gene silencing;Ras protein signal transduction;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA repair;blood coagulation;centrosome duplication;positive regulation of cell proliferation;cell division;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;potassium ion transport;M/G1 transition of mitotic cell cycle;G2/M transition of mitotic cell cycle;meiosis;positive regulation of transcription, DNA-dependent;mitosis;cellular response to nitric oxide;histone phosphorylation;DNA replication;G2 phase of mitotic cell cycle","endosome;cyclin-dependent protein kinase holoenzyme complex;X chromosome;centrosome;Cajal body;Y chromosome;condensed chromosome;cytosol;chromosome, telomeric region;transcription factor complex",,+,,,,,,,,,,,,
10055,P25205,MCM3,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),EMPQVHTPKTADS,_DGDSYDPYDFS(ph)DTEEEM(ox)PQVHT(ph)PK_,T722,,25.74,,,,,,,,,25.22,,,,25.48,0.26, , , , , , , , ,-0.26, , , ,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;alpha DNA polymerase:primase complex;centrosome;perinuclear region of cytoplasm;MCM complex,,,,,,,,,,,,,,
10056,P25205,MCM3,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),SEDESETEDEEEK,_KRSEDES(ph)ET(ph)EDEEEK_,T674,+,24.98,24.80,24.80,22.76,19.20,,,,22.62,,20.12,,21.96,22.66,2.32,2.15,2.15,0.10,-3.45, , , ,-0.04, ,-2.54, ,-0.69,S phase of mitotic cell cycle;DNA strand elongation involved in DNA replication;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication initiation;M/G1 transition of mitotic cell cycle,nucleoplasm;alpha DNA polymerase:primase complex;centrosome;perinuclear region of cytoplasm;MCM complex,,,,,,,,,,,,,,
10060,P26232,CTNNA2,Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein),SRTSVQTEDDQLI,_SRTS(ph)VQT(ph)EDDQLIAGQSAR_,T658,,26.34,22.47,22.77,23.05,,,,,,,,,,23.66,2.69,-1.19,-0.89,-0.61, , , , , , , , , ,cell-cell adhesion;positive regulation of muscle cell differentiation;dendrite morphogenesis;prepulse inhibition;axonogenesis;regulation of synapse structural plasticity;brain morphogenesis;radial glia guided migration of Purkinje cell;muscle cell differentiation,cytosol;axon;adherens junction;basolateral plasma membrane;lamellipodium;cell-cell adherens junction;actin cytoskeleton,,,,,,,,,,,,,,
10061,P26358,DNMT1,DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT),KSTRQTTITSHFA,_(gl)QTT(ph)ITSHFAK_,T166,,24.00,,,20.46,,,,,,,,22.09,,22.18,1.82, , ,-1.72, , , , , , , ,-0.10, ,"maintenance of DNA methylation;positive regulation of gene expression;gene silencing;cellular response to amino acid stimulus;regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;negative regulation of histone H3-K9 methylation;transcription, DNA-dependent;chromatin modification;positive regulation of histone H3-K4 methylation",replication fork;nucleus;centromeric heterochromatin,Other TF domain,,,,,,,,,,,,,
10062,P26373,RPL13,60S ribosomal protein L13 (Breast basic conserved protein 1),RRRNKSTESLQAN,_NKST(ph)ESLQANVQR_,T107,,23.32,,,,,,,21.32,,,,,,22.32,1.00, , , , , , ,-1.00, , , , , ,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane",cytosolic large ribosomal subunit,,,,,,,,,,,,,,
10063,P27361,MAPK3,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),DHTGFLTEYVATR,_IADPEHDHTGFLT(ph)EY(ph)VATR_,T202,,24.62,,,,,,,,,,,,,24.62,0.00, , , , , , , , , , , , ,fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;sensory perception of pain;positive regulation of ERK1 and ERK2 cascade;Ras protein signal transduction;positive regulation of histone phosphorylation;negative regulation of apolipoprotein binding;regulation of sequence-specific DNA binding transcription factor activity;cellular response to mechanical stimulus;insulin receptor signaling pathway;caveolin-mediated endocytosis;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;regulation of stress-activated MAPK cascade;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;activation of MAPK activity;TRIF-dependent toll-like receptor signaling pathway;regulation of cytoskeleton organization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;cell cycle;toll-like receptor 1 signaling pathway;response to exogenous dsRNA;positive regulation of histone acetylation;Toll signaling pathway;stress-activated MAPK cascade;apoptotic process;activation of MAPKK activity;regulation of Golgi inheritance;organ morphogenesis;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase I promoter;toll-like receptor 3 signaling pathway;regulation of early endosome to late endosome transport;response to DNA damage stimulus;axon guidance;interleukin-1-mediated signaling pathway;innate immune response;lipopolysaccharide-mediated signaling pathway;BMP signaling pathway;cartilage development;peptidyl-tyrosine autophosphorylation,nucleoplasm;mitochondrion;late endosome;Golgi apparatus;pseudopodium;early endosome;caveola;cytosol;microtubule cytoskeleton;focal adhesion,,+,,,,,,,,,,,,
10064,P27448,MARK3,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),VGGKLDTFCGSPP,_LDT(ph)FCGSPPYAAPELFQGK_,T175,,23.96,23.30,23.30,,,,,,,,,,,23.52,0.44,-0.22,-0.22, , , , , , , , , , ,,plasma membrane,,+,,,,,,,,,,,,
10069,P28290,SSFA2,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),RASVALTPTAPSR,_ASVALT(ph)PTAPSR_,T1134,,22.38,,,,21.91,,,,,,21.71,,,22.00,0.38, , , ,-0.09, , , , , ,-0.29, , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10074,P29317,EPHA2,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),EDDPEATYTTSGG,_VLEDDPEAT(ph)YTTSGGKIPIR_,T771,,,,,,22.92,,,23.91,,,,,22.23,23.02, , , , ,-0.10, , ,0.89, , , , ,-0.79,regulation of ERK1 and ERK2 cascade;negative regulation of protein kinase B signaling cascade;osteoclast differentiation;cell chemotaxis;bone remodeling;response to growth factor stimulus;neuron differentiation;activation of Rac GTPase activity;apoptotic process;regulation of lamellipodium assembly;keratinocyte differentiation;regulation of angiogenesis;angiogenesis;vasculogenesis;positive regulation of establishment of protein localization to plasma membrane;lens fiber cell morphogenesis;regulation of cell adhesion mediated by integrin;osteoblast differentiation;branching involved in mammary gland duct morphogenesis;notochord cell development;axial mesoderm formation;protein kinase B signaling cascade;ephrin receptor signaling pathway;cell adhesion;neural tube development;notochord formation;skeletal system development;regulation of blood vessel endothelial cell migration;mammary gland epithelial cell proliferation,ruffle membrane;lamellipodium membrane;leading edge membrane;focal adhesion;integral to plasma membrane,,+,,,,,,,,,,,,
10077,P29590,PML,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),SPEAASTPRDPID,_ASPEAAST(ph)PRDPIDVDLPEEAER_,T409,+,24.24,,,,24.19,,24.72,,26.79,26.06,25.90,,25.29,25.31,-1.07, , , ,-1.13, ,-0.59, ,1.48,0.75,0.59, ,-0.02,"retinoic acid receptor signaling pathway;defense response to virus;negative regulation of cell proliferation;negative regulation of transcription, DNA-dependent;SMAD protein import into nucleus;induction of apoptosis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;transforming growth factor beta receptor signaling pathway;regulation of MHC class I biosynthetic process;PML body organization;maintenance of protein location in nucleus;activation of cysteine-type endopeptidase activity involved in apoptotic process;myeloid cell differentiation;protein targeting;response to gamma radiation;positive regulation of extrinsic apoptotic signaling pathway;response to UV;regulation of calcium ion transport into cytosol;protein stabilization;endoplasmic reticulum calcium ion homeostasis;cell aging;positive regulation of histone deacetylation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of defense response to virus by host;negative regulation of telomerase activity;transcription, DNA-dependent;negative regulation of mitotic cell cycle;common-partner SMAD protein phosphorylation;negative regulation of angiogenesis;negative regulation of telomere maintenance via telomerase;interferon-gamma-mediated signaling pathway;negative regulation of cell growth;regulation of protein phosphorylation;cell cycle arrest;intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of translation in response to oxidative stress;cell fate commitment;virus-host interaction;response to hypoxia;branching involved in mammary gland duct morphogenesis;protein complex assembly;negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process",nuclear matrix;cytoplasm;cytosol;nuclear membrane;PML body;extrinsic to endoplasmic reticulum membrane;nucleolus;nucleus;early endosome membrane,Other TF domain,,,,,,,,,+,,,,
10078,P29692,EEF1D,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),PAKKPATPAEDDE,_KPAT(ph)PAEDDEDDDIDLFGS(ph)DNEEEDK_,T147,,28.68,,,,,,,,,,,,,28.68,0.00, , , , , , , , , , , , ,translational elongation;positive regulation of I-kappaB kinase/NF-kappaB cascade,cytosol;eukaryotic translation elongation factor 1 complex,Other TF domain,,,,,,,,,,,,,
10079,P29966,MARCKS,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",PSPSNETPKKKKK,_AEDGATPSPSNET(ph)PKK_,T150,+,27.38,28.62,28.68,29.49,26.45,27.67,28.08,23.65,28.81,26.85,23.72,27.89,25.63,27.15,0.23,1.47,1.54,2.34,-0.70,0.52,0.93,-3.49,1.66,-0.30,-3.43,0.74,-1.52,regulation of insulin secretion;small molecule metabolic process;energy reserve metabolic process,cell cortex;plasma membrane;centrosome;germinal vesicle;actin cytoskeleton,,,,,,,,,,,,,,
10082,P30041,PRDX6,Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.-) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (EC 1.11.1.9) (Red blood cells page spot 12),SHPRDFTPVCTTE,_DFT(ph)PVCTTELGR_,T44,,23.14,,,22.25,,,,,,,,21.74,,22.38,0.77, , ,-0.13, , , , , , , ,-0.64, ,response to oxidative stress;phospholipid catabolic process;hydrogen peroxide catabolic process,cytosol;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
10084,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],GNARLDTPDINIV,_LDT(ph)PDINIVLK_,T855,,21.65,,,,,,,,,,,,,21.65,0.00, , , , , , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,,,,,,,,,,
10086,P30414,NKTR,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],GTIRYHTPPRSRS,_YHT(ph)PPRS(ph)R_,T43,,21.73,23.24,,23.23,17.86,,,,,,,,,21.52,0.22,1.72, ,1.72,-3.66, , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization,membrane,,,,,,,,,,,,,,
10089,P32418,SLC8A1,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),DDKQPLTSKEEEE,_QPLT(ph)S(ph)KEEEER_,T51,,22.91,25.27,,24.58,28.00,28.20,23.48,27.49,,25.35,23.06,,25.89,25.42,-2.52,-0.15, ,-0.84,2.58,2.78,-1.94,2.06, ,-0.07,-2.36, ,0.47,response to drug;cardiac muscle cell development;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;telencephalon development;regulation of heart rate;relaxation of smooth muscle;blood coagulation;sodium ion export;regulation of the force of heart contraction;cellular response to reactive oxygen species;response to nutrient;vascular smooth muscle contraction;response to ATP;cell communication by electrical coupling involved in cardiac conduction;cellular response to cAMP;response to hypoxia;calcium ion transport into cytosol;response to glucose stimulus;calcium ion import;cellular response to caffeine;response to hydrogen peroxide;regulation of sodium ion transport;reduction of cytosolic calcium ion concentration;relaxation of cardiac muscle,Z disc;T-tubule;mitochondrion;intercalated disc;dendritic spine;microtubule;integral to plasma membrane,,,,,,,,,,,,,,
10091,P35221,CTNNA1,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),DDSDFETEDFDVR,_TPEELDDS(ph)DFET(ph)EDFDVR_,T645,,23.08,,,,,,,,,,,,,23.08,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;male gonad development;negative regulation of neuroblast proliferation;cellular response to indole-3-methanol;aging;ovarian follicle development;axon regeneration;apical junction assembly;response to estrogen stimulus;adherens junction organization;establishment or maintenance of cell polarity;positive regulation of muscle cell differentiation;gap junction assembly;positive regulation of smoothened signaling pathway;cell adhesion;odontogenesis of dentin-containing tooth;muscle cell differentiation,cytosol;cell-cell junction;acrosomal vesicle;zonula adherens;lamellipodium;catenin complex;actin cytoskeleton,,,,,,,,,,,,,,
10093,P35269,GTF2F1,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),GNSRPGTPSAEGG,_GNS(ph)RPGT(ph)PSAEGGSTSSTLR_,T389,,24.88,23.54,,23.83,,,,,,,,,,24.08,0.79,-0.54, ,-0.25, , , , , , , , , ,"transcription initiation from RNA polymerase II promoter;7-methylguanosine mRNA capping;response to virus;mRNA splicing, via spliceosome;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of transcription from RNA polymerase II promoter;positive regulation of viral transcription",transcription factor TFIIF complex;cell junction,Other TF domain,,,,,,,,,,,,,
10099,P35659,DEK,Protein DEK,AAEGEGTPTQPAS,_(ac)SASAPAAEGEGT(ph)PTQPASEK_,T13,+,27.68,27.46,27.24,26.83,26.98,27.49,27.37,26.94,27.38,27.43,24.64,25.40,26.22,26.85,0.83,0.61,0.38,-0.02,0.12,0.64,0.52,0.09,0.53,0.58,-2.21,-1.45,-0.63,signal transduction;regulation of double-strand break repair;regulation of transcription from RNA polymerase II promoter;chromatin modification;viral genome replication;transcription from RNA polymerase II promoter,nucleus,SAP-domain,,,,,,,,,,,,,
10101,P36507,MAP2K2,Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2),RLNQPGTPTRTAV,_LNQPGT(ph)PTR_,T394,,25.41,,,26.22,,21.67,,,,,21.92,,,23.81,1.61, , ,2.41, ,-2.13, , , , ,-1.89, , ,fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;Ras protein signal transduction;peptidyl-serine autophosphorylation;Toll signaling pathway;insulin receptor signaling pathway;stress-activated MAPK cascade;toll-like receptor 2 signaling pathway;regulation of Golgi inheritance;activation of MAPKK activity;MyD88-dependent toll-like receptor signaling pathway;positive regulation of cell motility;toll-like receptor 3 signaling pathway;regulation of stress-activated MAPK cascade;regulation of early endosome to late endosome transport;TRIF-dependent toll-like receptor signaling pathway;axon guidance;ERK1 and ERK2 cascade;innate immune response;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;toll-like receptor 1 signaling pathway,mitochondrion;late endosome;Golgi apparatus;endoplasmic reticulum;internal side of plasma membrane;perinuclear region of cytoplasm;early endosome;cell cortex;cell-cell junction;cytosol;extracellular region;peroxisomal membrane;nucleus;microtubule;focal adhesion,,+,,,,,,,,,,,,
10102,P36915,GNL1,Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1),ERREEQTDTSDGE,_EEQT(ph)DTS(ph)DGESVTHHIR_,T46,,23.72,23.42,23.42,,,22.34,,,,22.77,,,,23.13,0.59,0.28,0.28, , ,-0.79, , , ,-0.37, , , ,signal transduction;T cell mediated immunity;response to DNA damage stimulus;ribosome biogenesis,cytosol;extracellular space,,,,,,,,,,,,,,
10104,P39880,CUX1,Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (Homeobox protein cux-1),ESVKSLTELVQQP,_SLT(ph)ELVQQPCPPIEASK_,T1082,,23.74,,,,,,,,22.32,24.38,,,,23.48,0.26, , , , , , , ,-1.16,0.90, , , ,"multicellular organismal development;negative regulation of transcription from RNA polymerase II promoter;retrograde transport, vesicle recycling within Golgi;auditory receptor cell differentiation;transcription, DNA-dependent;lung development",cytosol;nucleus;Golgi membrane,Homeobox,,,,,,,,,,,,,
10106,P41212,ETV6,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),QERISYTPPESPV,_ISYT(ph)PPES(ph)PVPSYASSTPLHVPVPR_,T18,,26.80,,,,26.41,,,,,27.04,,,,26.75,0.05, , , ,-0.34, , , , ,0.29, , , ,"cell differentiation;transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
10107,P41743,PRKCI,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),PGDTTSTFCGTPN,_EGLRPGDTTST(ph)FCGTPNYIAPEILR_,T412,,23.24,,,,,,23.20,23.02,,,23.98,,,23.36,-0.12, , , , , ,-0.16,-0.34, , ,0.62, , ,positive regulation of NF-kappaB transcription factor activity;establishment of apical/basal cell polarity;actin filament organization;cellular response to insulin stimulus;cytoskeleton organization;positive regulation of glucose import;intracellular signal transduction;protein targeting to membrane;negative regulation of glial cell apoptotic process;positive regulation of establishment of protein localization to plasma membrane;positive regulation of glial cell proliferation;establishment or maintenance of epithelial cell apical/basal polarity;cellular membrane organization;vesicle-mediated transport;secretion;eye photoreceptor cell development;positive regulation of neuron projection development;nerve growth factor receptor signaling pathway;positive regulation of endothelial cell apoptotic process;negative regulation of neuron apoptotic process;tight junction assembly,endosome;cytosol;polarisome;apical plasma membrane;plasma membrane;nucleus;Schmidt-Lanterman incisure,,+,,,,,,,,,,,,
10109,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",TESRSSTPLPTIS,_SST(ph)PLPTISSSAENTR_,T160,,29.98,27.09,21.93,28.24,28.18,29.69,27.65,27.80,28.80,22.49,26.96,27.48,27.67,27.23,2.75,-0.14,-5.30,1.01,0.96,2.46,0.42,0.57,1.57,-4.74,-0.26,0.25,0.44,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
10110,P42166,TMPO,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",DEEREPTPVLGSG,_GPPDFSSDEEREPT(ph)PVLGSGAAAAGR_,T74,,29.28,27.79,27.58,26.27,28.48,30.02,28.60,28.18,30.68,29.51,27.11,28.40,28.99,28.53,0.74,-0.74,-0.95,-2.27,-0.05,1.49,0.07,-0.35,2.15,0.98,-1.42,-0.13,0.46,"regulation of transcription, DNA-dependent",chromatin;nuclear envelope,,,,,,,,,,,,,,
10111,P42167,TMPO,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin);Thymopentin (TP5)]",TESRSSTPLPTIS,_SST(ph)PLPTISSSAENTR_,T160,+,29.98,27.09,21.93,28.24,28.18,29.69,27.65,27.80,28.80,22.49,26.96,27.48,27.67,27.23,2.75,-0.14,-5.30,1.01,0.96,2.46,0.42,0.57,1.57,-4.74,-0.26,0.25,0.44,,nuclear envelope;integral to membrane;nuclear inner membrane,,,,,,,,,,,,,,
10118,P46087,NOP2,Putative ribosomal RNA methyltransferase NOP2 (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),EEEKEVTPESGPP,_EVT(ph)PESGPPK_,T191,+,25.88,26.02,26.02,27.05,,,24.27,,24.29,24.90,22.59,,,25.13,0.75,0.89,0.89,1.92, , ,-0.85, ,-0.84,-0.22,-2.54, , ,positive regulation of cell proliferation;rRNA processing,nucleolus,,,,,,,,,,,,,,
10119,P46782,RPS5,"40S ribosomal protein S5 [Cleaved into: 40S ribosomal protein S5, N-terminally processed]",APAVAETPDIKLF,_(ac)TEWETAAPAVAET(ph)PDIK_,T14,,22.95,21.99,21.99,,,,,,,,,,23.25,22.55,0.40,-0.55,-0.55, , , , , , , , , ,0.71,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;SRP-dependent cotranslational protein targeting to membrane;regulation of translational fidelity",cytosolic small ribosomal subunit,,,,,,,,,,,,,,
10128,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SDISPLTPRESSP,_SDIS(ph)PLT(ph)PR_,T1788,+,24.14,22.39,21.77,24.60,25.08,24.18,25.26,24.83,23.21,22.26,26.10,24.65,25.15,24.13,0.01,-1.74,-2.35,0.47,0.95,0.05,1.14,0.71,-0.91,-1.86,1.98,0.53,1.03,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
10129,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],SVNFSLTPNEIKV,_SVNFSLT(ph)PNEIK_,T1282,+,,,,21.90,23.40,24.77,25.00,24.61,23.36,22.86,24.44,,25.45,23.98, , , ,-2.08,-0.57,0.80,1.02,0.63,-0.61,-1.12,0.46, ,1.47,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
10130,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],IGKTTKTPEDGDY,_TTKT(ph)PEDGDYSYEIIEK_,T1932,+,,,,,25.34,23.66,24.90,24.84,23.69,23.52,24.83,,23.03,24.23, , , , ,1.11,-0.56,0.68,0.61,-0.54,-0.71,0.61, ,-1.20,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
10133,P46821,MAP1B,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain;MAP1 light chain LC1],IEKTTRTPEEGGY,_TTRT(ph)PEEGGYSYDISEK_,T1949,+,20.91,,,,24.10,23.60,24.11,24.07,,22.48,25.06,23.75,23.38,23.50,-2.59, , , ,0.61,0.10,0.61,0.57, ,-1.01,1.57,0.25,-0.12,positive regulation of axon extension;negative regulation of intracellular transport;response to drug;establishment of monopolar cell polarity;embryo development;developmental maturation;cellular process;response to vitamin A;response to peptide hormone stimulus;response to mechanical stimulus;response to insecticide;response to inorganic substance;induction of synaptic plasticity by chemical substance;positive regulation of microtubule polymerization;response to estradiol stimulus;synapse assembly;dendrite development;axon extension involved in development;peripheral nervous system axon regeneration;positive regulation of neuron differentiation;response to carbohydrate stimulus;central nervous system development;microtubule bundle formation;mitochondrion transport along microtubule;negative regulation of microtubule depolymerization,axon;microtubule associated complex;postsynaptic density;perinuclear region of cytoplasm;cytosol;growth cone;cell junction;plasma membrane;microtubule;perikaryon,,,,,,,,,,,,,,
10136,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),PPPVLLTPKAVGT,_EAPPPVLLT(ph)PK_,T1347,,23.52,22.38,22.38,21.73,,21.41,21.84,22.35,21.82,21.83,22.35,22.24,23.01,22.24,1.28,0.14,0.14,-0.51, ,-0.83,-0.40,0.12,-0.42,-0.41,0.12,0.00,0.78,,nucleus;cytoplasm,,,,,,,,,,,,,,
10138,P48634,PRRC2A,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),EVPPPTTPPVPKV,_EGPEPPEEVPPPTT(ph)PPVPK_,T610,,26.31,26.50,26.85,26.29,24.19,24.79,27.63,25.62,27.27,27.25,27.57,26.83,27.70,26.52,-0.21,-0.02,0.33,-0.24,-2.33,-1.73,1.10,-0.90,0.75,0.73,1.04,0.30,1.18,,nucleus;cytoplasm,,,,,,,,,,,,,,
10140,P49006,MARCKSL1,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),EGKAAATPESQEP,_AAAT(ph)PESQEPQAK_,T148,+,21.90,24.02,24.50,24.38,23.84,23.21,22.41,22.60,23.69,24.33,22.24,21.45,21.88,23.11,-1.21,0.91,1.39,1.27,0.73,0.10,-0.70,-0.51,0.57,1.22,-0.87,-1.66,-1.24,vesicle-mediated transport;positive regulation of cell proliferation,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10146,P49321,NASP,Nuclear autoantigenic sperm protein (NASP),NDNIDETEGSEED,_TEDESLVENNDNIDET(ph)EGS(ph)EEDDK_,T138,,24.16,,,,,,,,,,,,,24.16,0.00, , , , , , , , , , , , ,cell proliferation;blastocyst development;protein transport;cell cycle;DNA replication;histone exchange,nucleus;cytoplasm,,,,,,,,,,,,,,
10147,P49327,FASN,Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38);[Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39);3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41);3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100);3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59);Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39);Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],SELACPTPKEDGL,_ADEASELACPT(ph)PK_,T2204,+,22.91,24.42,24.42,25.66,22.79,,25.24,,24.49,24.61,23.72,24.16,,24.24,-1.33,0.18,0.18,1.42,-1.45, ,1.00, ,0.25,0.37,-0.52,-0.08, ,triglyceride biosynthetic process;pantothenate metabolic process;long-chain fatty-acyl-CoA biosynthetic process;fatty acid metabolic process;energy reserve metabolic process;fatty acid biosynthetic process;positive regulation of cellular metabolic process,cytosol;mitochondrion;glycogen granule;Golgi apparatus;plasma membrane;melanosome,,,,,,,,,,,,,,
10151,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),RTNPSPTNPFSSD,_(gl)QRTNPSPT(ph)NPFSSDLQK_,T577,,,,,,,,,,,24.40,23.13,,,23.77, , , , , , , , , ,0.63,-0.63, , ,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,,,,,,,,,,
10152,P49757,NUMB,Protein numb homolog (h-Numb) (Protein S171),QAGHRRTPSEADR,_T(ph)PSEADRWLEEVSK_,T377,+,22.45,,,21.21,,21.43,21.40,22.95,,,23.16,23.05,,22.23,0.21, , ,-1.02, ,-0.81,-0.84,0.71, , ,0.93,0.82, ,lateral ventricle development;negative regulation of Notch signaling pathway;axon guidance;lung epithelial cell differentiation;positive regulation of neurogenesis;Notch signaling pathway;positive regulation of polarized epithelial cell differentiation;adherens junction organization;neuroblast division in subventricular zone;positive regulation of dendrite morphogenesis,basolateral plasma membrane;extrinsic to plasma membrane;nucleus;apical part of cell;integral to plasma membrane;early endosome,,,,,,,,,,,,,,
10154,P49792,RANBP2,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],LAETVFTPKTSPE,_ELVGPPLAETVFT(ph)PK_,T1396,,24.79,,,,,,,,,,,,,24.79,0.00, , , , , , , , , , , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;mRNA transport;protein folding;regulation of glucose transport;protein sumoylation;mitotic prometaphase;protein peptidyl-prolyl isomerization;viral reproduction;protein import into nucleus;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
10157,P50238,CRIP1,Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP),CEKCGKTLTSGGH,_T(ph)LTSGGHAEHEGK_,T37,,23.40,18.99,19.76,,,,,,,,,,,20.72,2.69,-1.73,-0.96, , , , , , , , , , ,regulation of gene expression;response to zinc ion;immune response;cellular response to UV-B;cellular response to antibiotic;cell proliferation;apoptotic process;heart development;prostate gland stromal morphogenesis;response to organic substance,cytoplasm,,,,,,,,,,,,,,
10158,P50548,ERF,ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2),EAGGPLTPRRVSS,_GEGPGEAGGPLT(ph)PR_,T516,,23.29,,,,22.73,,,,,,,,,23.01,0.28, , , ,-0.28, , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;cell cycle",nucleus,Other TF domain,,,,,,,,,,,,,
10167,P52948,NUP98,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98);Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],AKPIPQTPESAGN,_PIPQT(ph)PESAGNK_,T670,,23.46,,,,,,,,,,,,,23.46,0.00, , , , , , , , , , , , ,"glucose transport;small molecule metabolic process;protein import into nucleus, docking;nuclear pore organization;carbohydrate metabolic process;mRNA transport;regulation of glucose transport;mitotic prometaphase;viral reproduction;cytokine-mediated signaling pathway;DNA replication;virus-host interaction",nucleoplasm;nuclear membrane;cytosol;nuclear pore outer ring,,,,,,,,,,,,,,
10168,P53367,ARFIP1,Arfaptin-1 (ADP-ribosylation factor-interacting protein 1),FHIKLKTPGVDAP,_LKT(ph)PGVDAPSWLEEQ_,T361,,23.12,,,,,,,,,,,,,23.12,0.00, , , , , , , , , , , , ,regulation of protein secretion;intracellular protein transport,cytosol;Golgi membrane,,,,,,,,,,,,,,
10169,P53611,RABGGTB,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),____MGTPQKDVI,_(ac)GT(ph)PQKDVIIKSDAPDTLLLEK_,T3,,,,,,26.11,23.48,,26.13,,,,,22.25,24.49, , , , ,1.62,-1.01, ,1.63, , , , ,-2.24,protein geranylgeranylation;cellular protein modification process;visual perception,,,,,,,,,,,,,,,
10175,P55081,MFAP1,Microfibrillar-associated protein 1,ALDALNTDDENDE,_SLAALDALNT(ph)DDENDEEEYEAWKVR_,T267,,26.06,,,,25.46,,,,23.89,24.91,,24.64,,24.99,1.07, , , ,0.46, , , ,-1.11,-0.08, ,-0.35, ,,microfibril,,,,,,,,,,,,,,
10176,P55209,NAP1L1,Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNRP),LDGLVETPTGYIE,_LDGLVET(ph)PTGYIESLPR_,T62,,25.36,,,,,,,,,,,,,25.36,0.00, , , , , , , , , , , , ,positive regulation of cell proliferation;nucleosome assembly;DNA replication,chromatin assembly complex;melanosome,,,,,,,,,,,,,,
10177,P55265,ADAR,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),KTAESQTPTPSAT,_TAESQT(ph)PTPSATSFFSGK_,T619,+,26.96,25.09,25.84,23.87,23.55,23.36,24.46,24.33,25.62,25.34,24.40,24.27,23.62,24.67,2.29,0.41,1.16,-0.80,-1.12,-1.31,-0.21,-0.34,0.95,0.67,-0.27,-0.40,-1.05,negative regulation of apoptotic process;defense response to virus;response to interferon-alpha;response to virus;protein export from nucleus;positive regulation of viral genome replication;type I interferon-mediated signaling pathway;adenosine to inosine editing;negative regulation of protein kinase activity by regulation of protein phosphorylation;mRNA modification;mRNA processing;protein import into nucleus;gene expression;gene silencing by RNA,nucleoplasm;nucleolus;nucleus;supraspliceosomal complex;cytoplasm,,,,,,,,,,,,,,
10178,P55265,ADAR,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),AESQTPTPSATSF,_TAES(ph)QTPT(ph)PSATSFFSGK_,T621,,21.66,,,,,,,,,,,,,21.66,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;defense response to virus;response to interferon-alpha;response to virus;protein export from nucleus;positive regulation of viral genome replication;type I interferon-mediated signaling pathway;adenosine to inosine editing;negative regulation of protein kinase activity by regulation of protein phosphorylation;mRNA modification;mRNA processing;protein import into nucleus;gene expression;gene silencing by RNA,nucleoplasm;nucleolus;nucleus;supraspliceosomal complex;cytoplasm,,,,,,,,,,,,,,
10179,P58107,EPPK1,Epiplakin (450 kDa epidermal antigen),QLISRKTLDELSQ,_T(ph)LDELSQGTTTVK_,T1543,,23.88,,,,,,,,,,,,,23.88,0.00, , , , , , , , , , , , ,,cytoskeleton;cytoplasm,,,,,,,,,,,,,,
10180,P61160,ACTR2,Actin-related protein 2 (Actin-like protein 2),EPPMNPTKNREKI,_ILLTEPPM(ox)NPT(ph)K_,T117,,23.86,24.08,24.52,,,,22.44,,,,23.38,,,23.66,0.21,0.42,0.87, , , ,-1.21, , , ,-0.28, , ,cellular component movement,Arp2/3 protein complex;cell projection;cytoplasm,,,,,,,,,,,,,,
10182,P61978,HNRNPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),____METEQPEET,_M(ox)ET(ph)EQPEETFPNTETNGEFGK_,T3,+,24.02,24.91,24.93,25.37,25.16,26.12,24.18,,24.49,26.98,24.36,25.27,26.89,25.22,-1.20,-0.32,-0.29,0.15,-0.07,0.90,-1.04, ,-0.73,1.75,-0.86,0.05,1.66,"positive regulation of low-density lipoprotein particle receptor biosynthetic process;signal transduction;regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter;mRNA splicing, via spliceosome;regulation of low-density lipoprotein particle clearance;positive regulation of receptor-mediated endocytosis;virus-host interaction",nucleoplasm;nuclear chromatin;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
10183,P62158,CALM1,Calmodulin (CaM),_MADQLTEEQIAE,_ADQLT(ph)EEQIAEFK_,T6,,21.99,,,,,24.16,,23.46,,23.76,24.84,24.38,,23.76,-1.77, , , , ,0.39, ,-0.31, ,-0.01,1.08,0.62, ,regulation of nitric-oxide synthase activity;platelet degranulation;fibroblast growth factor receptor signaling pathway;nitric oxide metabolic process;negative regulation of ryanodine-sensitive calcium-release channel activity;glucose metabolic process;glycogen catabolic process;small molecule metabolic process;response to calcium ion;platelet activation;activation of phospholipase C activity;positive regulation of ryanodine-sensitive calcium-release channel activity;G-protein coupled receptor signaling pathway;regulation of cytokinesis;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;synaptic transmission;muscle contraction;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,spindle microtubule;nucleoplasm;cytosol;extracellular region;plasma membrane;centrosome;spindle pole,,,,,,,,,,,,,,
10184,P62241,RPS8,40S ribosomal protein S8,KKGAKLTPEEEEI,_LT(ph)PEEEEILNK_,T130,+,25.54,23.65,23.98,23.20,23.56,25.08,25.01,25.18,25.42,28.26,25.43,24.40,23.13,24.76,0.78,-1.11,-0.77,-1.55,-1.19,0.32,0.26,0.42,0.67,3.50,0.67,-0.36,-1.63,"translational termination;translational elongation;viral transcription;translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);SRP-dependent cotranslational protein targeting to membrane",cytosolic small ribosomal subunit,,,,,,,,,,,,,,
10185,P62310,LSM 3.00,U6 snRNA-associated Sm-like protein LSm3,DVDQQQTTNTVEE,_ADDVDQQQT(ph)TNTVEEPLDLIR_,T10,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,"mRNA splicing, via spliceosome;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay",cytosol;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10186,P62316,SNRPD2,Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2),KPKSEMTPEELQK,_SEM(ox)T(ph)PEELQK_,T12,+,23.52,24.16,24.44,24.22,20.48,,22.28,,,22.58,,,,23.10,0.42,1.06,1.34,1.13,-2.62, ,-0.82, , ,-0.52, , , ,ncRNA metabolic process;spliceosomal complex assembly;spliceosomal snRNP assembly,nucleoplasm;cytosol;U12-type spliceosomal complex;small nuclear ribonucleoprotein complex;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10187,P62324,BTG1,Protein BTG1 (B-cell translocation gene 1 protein),ELLLGRTSPSKNY,_EELLLGRT(ph)SPSK_,T158,,23.52,23.36,23.36,,,,,,,,,,,23.42,0.10,-0.05,-0.05, , , , , , , , , , ,"response to oxidative stress;negative regulation of cell proliferation;cell migration;regulation of transcription, DNA-dependent;positive regulation of myoblast differentiation;positive regulation of angiogenesis;spermatogenesis;negative regulation of cell growth;protein methylation;response to peptide hormone stimulus;positive regulation of endothelial cell differentiation;regulation of apoptotic process",nucleus;cytoplasm,,,,,,,,,,,,,,
10192,P63208,SKP1,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B) (p19A) (p19skp1),NMIKGKTPEEIRK,_GKT(ph)PEEIRK_,T131,+,25.18,24.34,24.34,20.71,19.70,,,18.42,17.13,,,,,21.40,3.77,2.94,2.94,-0.70,-1.71, , ,-2.98,-4.28, , , , ,S phase of mitotic cell cycle;G1 phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;Notch signaling pathway;histone H2A monoubiquitination;viral reproduction;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,nucleoplasm;cytosol;SCF ubiquitin ligase complex,,,,,,,,,,+,,,,
10193,P63241,EIF5A,Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D),DDLDFETGDAGAS,_ADDLDFET(ph)GDAGASATFPM(ox)QCSALRK_,T9,+,,22.50,22.50,22.77,23.23,,23.73,,,22.85,24.30,25.30,,23.40, ,-0.90,-0.90,-0.63,-0.17, ,0.33, , ,-0.55,0.91,1.90, ,negative regulation of apoptotic process;protein export from nucleus;positive regulation of muscle cell differentiation;aging;positive regulation of translational termination;post-translational protein modification;induction of apoptosis;mRNA export from nucleus;apoptotic process;positive regulation of cell proliferation;translational frameshifting;peptidyl-lysine modification to hypusine;positive regulation of translational elongation,neuronal cell body;cytosol;annulate lamellae;endoplasmic reticulum membrane;nuclear pore;dendrite,,,,,,,,,,,,,,
10196,P68431,HIST1H3A,Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l),IAQDFKTDLRFQS,_EIAQDFKT(ph)DLR_,T81,+,24.75,22.72,23.27,22.17,23.87,,,,21.62,21.74,23.28,22.92,,22.93,1.82,-0.21,0.34,-0.75,0.94, , , ,-1.31,-1.18,0.35,0.00, ,blood coagulation;S phase;regulation of gene silencing;nucleosome assembly,nucleoplasm;extracellular region;nucleosome,,,,,,,,,,,,,,
10200,P78344,EIF4G2,Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97),QPPRTQTPPLGQT,_TQT(ph)PPLGQTPQLGLK_,T508,,23.75,22.80,,23.27,22.72,,22.96,,,,22.16,,,22.95,0.81,-0.14, ,0.32,-0.22, ,0.02, , , ,-0.78, , ,cell death;cell cycle arrest;RNA metabolic process;regulation of translational initiation;cytokine-mediated signaling pathway,cytosol;eukaryotic translation initiation factor 4F complex,,,,,,,,,,,,,,
10202,P78559,MAP1A,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain;MAP1 light chain LC2],LDSGAETEEEKDT,_DRGLDS(ph)GAET(ph)EEEK_,T616,,,24.13,,26.02,21.87,21.56,,,,,,,,23.39, ,0.73, ,2.63,-1.53,-1.83, , , , , , , ,sensory perception of sound,cytosol;microtubule associated complex;microtubule,,,,,,,,,,,,,,
10207,P84022,SMAD3,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3),SSILPFTPPIVKR,_(ac)SSILPFT(ph)PPIVK_,T8,+,24.27,21.97,,21.34,25.01,23.27,24.57,24.70,23.89,24.61,24.92,24.20,24.21,23.91,0.35,-1.94, ,-2.57,1.10,-0.65,0.66,0.78,-0.03,0.70,1.01,0.29,0.30,regulation of striated muscle tissue development;regulation of immune response;negative regulation of transforming growth factor beta receptor signaling pathway;regulation of epithelial cell proliferation;negative regulation of osteoblast proliferation;transforming growth factor beta receptor signaling pathway;primary miRNA processing;immune system development;somitogenesis;protein stabilization;negative regulation of protein phosphorylation;evasion or tolerance of host defenses by virus;in utero embryonic development;positive regulation of alkaline phosphatase activity;positive regulation of interleukin-1 beta production;positive regulation of canonical Wnt receptor signaling pathway;endoderm development;positive regulation of chondrocyte differentiation;negative regulation of mitotic cell cycle;transport;pericardium development;thyroid gland development;negative regulation of cell growth;cell cycle arrest;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;SMAD protein complex assembly;negative regulation of inflammatory response;negative regulation of transcription from RNA polymerase II promoter;positive regulation of gene expression involved in extracellular matrix organization;negative regulation of apoptotic process;immune response;cell-cell junction organization;positive regulation of focal adhesion assembly;embryonic pattern specification;liver development;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of transforming growth factor beta3 production;negative regulation of wound healing;negative regulation of protein catabolic process;transdifferentiation;embryonic cranial skeleton morphogenesis;nodal signaling pathway;lens fiber cell differentiation;positive regulation of positive chemotaxis;paraxial mesoderm morphogenesis;mesoderm formation;positive regulation of bone mineralization;positive regulation of catenin import into nucleus;T cell activation;ureteric bud development;wound healing;positive regulation of epithelial to mesenchymal transition;release of cytochrome c from mitochondria;positive regulation of cell migration;regulation of transforming growth factor beta2 production;regulation of binding;transcription initiation from RNA polymerase II promoter;embryonic foregut morphogenesis;positive regulation of stress fiber assembly;response to hypoxia;developmental growth;positive regulation of transcription factor import into nucleus;osteoblast development;heart looping,cytosol;transcription factor complex;nuclear inner membrane;receptor complex;plasma membrane;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
10208,P84022,SMAD3,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3),HYQRVETPVLPPV,_VET(ph)PVLPPVLVPR_,T132,,21.11,,,,,,,,,,,,,21.11,0.00, , , , , , , , , , , , ,regulation of striated muscle tissue development;regulation of immune response;negative regulation of transforming growth factor beta receptor signaling pathway;regulation of epithelial cell proliferation;negative regulation of osteoblast proliferation;transforming growth factor beta receptor signaling pathway;primary miRNA processing;immune system development;somitogenesis;protein stabilization;negative regulation of protein phosphorylation;evasion or tolerance of host defenses by virus;in utero embryonic development;positive regulation of alkaline phosphatase activity;positive regulation of interleukin-1 beta production;positive regulation of canonical Wnt receptor signaling pathway;endoderm development;positive regulation of chondrocyte differentiation;negative regulation of mitotic cell cycle;transport;pericardium development;thyroid gland development;negative regulation of cell growth;cell cycle arrest;positive regulation of transcription from RNA polymerase II promoter;negative regulation of osteoblast differentiation;SMAD protein complex assembly;negative regulation of inflammatory response;negative regulation of transcription from RNA polymerase II promoter;positive regulation of gene expression involved in extracellular matrix organization;negative regulation of apoptotic process;immune response;cell-cell junction organization;positive regulation of focal adhesion assembly;embryonic pattern specification;liver development;induction of apoptosis;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of transforming growth factor beta3 production;negative regulation of wound healing;negative regulation of protein catabolic process;transdifferentiation;embryonic cranial skeleton morphogenesis;nodal signaling pathway;lens fiber cell differentiation;positive regulation of positive chemotaxis;paraxial mesoderm morphogenesis;mesoderm formation;positive regulation of bone mineralization;positive regulation of catenin import into nucleus;T cell activation;ureteric bud development;wound healing;positive regulation of epithelial to mesenchymal transition;release of cytochrome c from mitochondria;positive regulation of cell migration;regulation of transforming growth factor beta2 production;regulation of binding;transcription initiation from RNA polymerase II promoter;embryonic foregut morphogenesis;positive regulation of stress fiber assembly;response to hypoxia;developmental growth;positive regulation of transcription factor import into nucleus;osteoblast development;heart looping,cytosol;transcription factor complex;nuclear inner membrane;receptor complex;plasma membrane;SMAD protein complex,Other TF domain,,,,,,,,,,,,,
10210,P85037,FOXK1,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),RSGGLQTPECLSR,_SGGLQT(ph)PECLSR_,T436,,22.07,25.91,,,,,,,,,,,,23.99,-1.92,1.92, , , , , , , , , , , ,"cell differentiation;tissue development;negative regulation of transcription, DNA-dependent;embryo development;regulation of sequence-specific DNA binding transcription factor activity;negative regulation of cell growth;positive regulation of transcription, DNA-dependent;muscle organ development;pattern specification process",transcription factor complex;nucleolus,Forkhead,,,,,,,,,,,,,
10212,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",ASSRAQTLPTSVV,_AQT(ph)LPTSVVTITSESSPGKR_,T2328,+,,,,,23.56,22.43,23.59,24.63,22.62,,24.88,23.03,23.01,23.47, , , , ,0.09,-1.03,0.12,1.16,-0.85, ,1.41,-0.43,-0.46,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
10214,Q01082,SPTBN1,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",SASTQSTPASSRA,_HEVSASTQST(ph)PASSR_,T2320,+,20.06,24.62,,23.02,,,21.79,,23.59,20.22,20.00,21.58,,21.86,-1.80,2.76, ,1.16, , ,-0.07, ,1.73,-1.64,-1.86,-0.28, ,cytokinesis after mitosis;protein targeting to plasma membrane;common-partner SMAD protein phosphorylation;membrane assembly;axon guidance;SMAD protein import into nucleus;Golgi to plasma membrane protein transport;actin filament capping,cytosol;M band;spectrin-associated cytoskeleton;nucleolus;plasma membrane;spectrin;cuticular plate,,,,,,,,,,,,,,
10222,Q01518,CAP1,Adenylyl cyclase-associated protein 1 (CAP 1),SAPKPQTSPSPKR,_PFSAPKPQT(ph)SPSPK_,T307,+,28.39,28.17,28.57,29.40,28.81,23.03,26.42,28.11,26.12,25.11,30.26,28.84,,27.60,0.79,0.57,0.96,1.80,1.20,-4.57,-1.19,0.51,-1.48,-2.49,2.66,1.24, ,platelet degranulation;platelet activation;activation of adenylate cyclase activity;axon guidance;actin cytoskeleton organization;signal transduction;establishment or maintenance of cell polarity;receptor-mediated endocytosis;ameboidal cell migration,cortical actin cytoskeleton;plasma membrane,,,,,,,,,,,,,,
10226,Q02818,NUCB1,Nucleobindin-1 (CALNUC),DPQNQHTFEARDL,_(gl)QFEHLDPQNQHT(ph)FEAR_,T148,,23.30,23.95,23.94,,22.53,23.94,,22.92,22.31,,22.24,,,23.14,0.16,0.81,0.80, ,-0.61,0.80, ,-0.22,-0.83, ,-0.90, , ,,microtubule cytoskeleton;extracellular space;endoplasmic reticulum-Golgi intermediate compartment;Golgi apparatus;membrane,,,,,,,,,,,,,,
10227,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),ESDKAITPQAQEE,_AIT(ph)PQAQEELQK_,T1760,,,,,,,,,,,26.44,,,24.19,25.31, , , , , , , , , ,1.13, , ,-1.13,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
10230,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),SPTSPVTSETGST,_SAESPTS(ph)PVT(ph)SETGSTFK_,T289,,23.59,,,,,,,,,,,,,23.59,0.00, , , , , , , , , , , , ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
10233,Q02952,AKAP12,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),KVVGQTTPESFEK,_VVGQTT(ph)PESFEK_,T1116,+,26.37,25.51,25.51,24.95,26.10,26.52,27.90,,27.88,28.22,27.47,23.66,,26.37,0.00,-0.86,-0.86,-1.42,-0.27,0.14,1.53, ,1.51,1.85,1.10,-2.71, ,protein targeting;positive regulation of protein kinase A signaling cascade;positive regulation of cAMP biosynthetic process;G-protein coupled receptor signaling pathway,cell cortex;plasma membrane;cytoskeleton;cytoplasm,,,,,,,,,,,,,,
10236,Q03164,KMT2A,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320);MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],TPLHPPTPPILST,_GPGEPDS(ph)PTPLHPPT(ph)PPILSTDR_,T1807,,24.31,,,,,,,,,,,,,24.31,0.00, , , , , , , , , , , , ,positive regulation of cellular response to drug;protein complex assembly;histone H4-K16 acetylation;histone H3-K4 trimethylation;transcription from RNA polymerase II promoter;embryonic hemopoiesis;apoptotic process;positive regulation of transporter activity;positive regulation of transcription from RNA polymerase II promoter,MLL1 complex,Other TF domain,,,,,,,,,,,,,
10237,Q03252,LMNB2,Lamin-B2,RAGGPATPLSPTR,_AGGPAT(ph)PLSPTR_,T14,+,24.71,25.44,,24.00,25.55,25.15,24.59,,24.88,24.27,,,24.98,24.84,-0.13,0.60, ,-0.84,0.71,0.31,-0.25, ,0.04,-0.57, , ,0.14,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
10243,Q05655,PRKCD,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit;Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],EALNQVTQRASRR,_LLAEALNQVT(ph)QR_,T295,,25.27,23.17,23.17,,,,,,,,,,,23.87,1.40,-0.70,-0.70, , , , , , , , , , ,fibroblast growth factor receptor signaling pathway;immunoglobulin mediated immune response;mRNA metabolic process;positive regulation of superoxide anion generation;gene expression;negative regulation of actin filament polymerization;intracellular signal transduction;protein stabilization;platelet activation;B cell proliferation;activation of phospholipase C activity;regulation of receptor activity;cellular senescence;interleukin-10 production;positive regulation of sphingomyelin catabolic process;negative regulation of protein binding;epidermal growth factor receptor signaling pathway;defense response to bacterium;nerve growth factor receptor signaling pathway;cell cycle;negative regulation of platelet aggregation;cellular component disassembly involved in execution phase of apoptosis;negative regulation of MAP kinase activity;interferon-gamma-mediated signaling pathway;positive regulation of ceramide biosynthetic process;neutrophil activation;negative regulation of insulin receptor signaling pathway;termination of signal transduction;negative regulation of glial cell apoptotic process;positive regulation of protein dephosphorylation;negative regulation of inflammatory response;positive regulation of glucosylceramide catabolic process;interleukin-12 production;negative regulation of filopodium assembly;positive regulation of phospholipid scramblase activity;positive regulation of response to DNA damage stimulus;negative regulation of peptidyl-tyrosine phosphorylation;peptidyl-threonine phosphorylation,nucleoplasm;mitochondrion;endoplasmic reticulum;nuclear matrix;perinuclear region of cytoplasm;cell-cell junction;cytosol;plasma membrane,,+,,,,,,,,+,,,,
10254,Q08AE8,SPIRE1,Protein spire homolog 1 (Spir-1),FLPISSTPQPERR,_FLPISST(ph)PQPER_,T336,,,22.59,,23.76,,,,,23.36,,24.10,,,23.45, ,-0.87, ,0.31, , , , ,-0.09, ,0.65, , ,Golgi vesicle transport,Golgi apparatus;cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10257,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),EFSGPSTPTGTLE,_EFSGPST(ph)PTGTLEFEGGEVSLEGGK_,T5794,,25.84,,,,,,,,,,,,,25.84,0.00, , , , , , , , , , , , ,nervous system development,nucleus,,,,,,,,,,,,,,
10258,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),GKLKFGTFGGLGS,_FGT(ph)FGGLGS(ph)K_,T5824,+,24.46,20.14,20.65,,,,23.11,,21.05,,22.66,25.22,21.89,22.40,2.06,-2.25,-1.75, , , ,0.71, ,-1.35, ,0.26,2.83,-0.51,nervous system development,nucleus,,,,,,,,,,,,,,
10259,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PSLDIDTPDVNIE,_GPSLDIDT(ph)PDVNIEGPEGK_,T4430,,24.47,,,,,,,,,24.93,,,,24.70,-0.23, , , , , , , , ,0.23, , , ,nervous system development,nucleus,,,,,,,,,,,,,,
10260,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),TPNLEGTLTGPRL,_VDIETPNLEGT(ph)LTGPR_,T551,,24.36,,,,,,,,22.12,,23.52,,,23.33,1.03, , , , , , , ,-1.21, ,0.18, , ,nervous system development,nucleus,,,,,,,,,,,,,,
10263,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKVDIDTPDIDIH,_VDIDT(ph)PDIDIHGPEGK_,T4100,,26.12,,,,,,,,25.53,27.19,,24.52,,25.84,0.28, , , , , , , ,-0.31,1.35, ,-1.32, ,nervous system development,nucleus,,,,,,,,,,,,,,
10264,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKVDIDTPDINIE,_VDIDT(ph)PDINIEGSEGK_,T3716,,24.58,,,,,,,,23.14,27.45,,,,25.06,-0.47, , , , , , , ,-1.92,2.39, , , ,nervous system development,nucleus,,,,,,,,,,,,,,
10265,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKVDINTPDVDVH,_VDINT(ph)PDVDVHGPDWHLK_,T4766,,22.09,,,,,,,,23.72,23.27,,21.45,23.31,22.77,-0.68, , , , , , , ,0.95,0.50, ,-1.32,0.54,nervous system development,nucleus,,,,,,,,,,,,,,
10266,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),PKVGIDTPDIDIH,_VGIDT(ph)PDIDIHGPEGK_,T4564,,25.25,,,,21.73,,,,,23.73,,22.16,23.14,23.20,2.05, , , ,-1.47, , , , ,0.53, ,-1.04,-0.06,nervous system development,nucleus,,,,,,,,,,,,,,
10267,Q09666,AHNAK,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),KGTKVKTPEMIIQ,_VKT(ph)PEM(ox)IIQKPK_,T490,+,23.75,23.88,24.24,22.82,23.73,22.13,26.38,23.44,26.67,26.44,25.34,25.81,22.33,24.38,-0.63,-0.50,-0.14,-1.56,-0.65,-2.25,2.00,-0.94,2.29,2.06,0.96,1.43,-2.05,nervous system development,nucleus,,,,,,,,,,,,,,
10271,Q12792,TWF1,Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9),AETEATTD_____,_LIRGPAETEATT(ph)D_,T349,+,26.07,24.91,24.91,25.03,24.47,24.68,25.27,25.47,24.62,24.66,24.59,25.21,23.46,24.87,1.19,0.04,0.04,0.16,-0.40,-0.20,0.40,0.60,-0.26,-0.21,-0.28,0.34,-1.42,regulation of actin phosphorylation;barbed-end actin filament capping;sequestering of actin monomers,ruffle membrane;filopodium;cell-cell junction;myofibril;actin cytoskeleton;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10274,Q12888,TP53BP1,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),SEDPPTTPIRGNL,_SEDPPTT(ph)PIR_,T1056,+,26.94,26.41,24.06,26.94,23.31,26.21,25.35,25.25,,,,25.11,23.28,25.29,1.66,1.12,-1.23,1.66,-1.98,0.92,0.07,-0.04, , , ,-0.18,-2.01,positive regulation of sequence-specific DNA binding transcription factor activity;double-strand break repair via homologous recombination;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;replication fork;condensed chromosome kinetochore;cytoplasm,Other TF domain,,,,,,,,,,+,,,
10276,Q12893,TMEM115,Transmembrane protein 115 (Placental protein 6) (PP6) (Protein PL6),PSDKAPTPPGKGA,_VDSPLPSDKAPT(ph)PPGK_,T329,+,22.38,24.78,25.43,24.55,22.10,23.84,26.07,23.02,25.96,26.13,25.56,25.10,24.90,24.60,-2.22,0.18,0.83,-0.05,-2.50,-0.76,1.47,-1.58,1.36,1.52,0.96,0.50,0.30,negative regulation of cell proliferation;replicative cell aging,integral to membrane;Golgi apparatus;nucleus,,,,,,,,,,,,,,
10278,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),VVEAVSTPSAAFP,_PAVVAPAPVVEAVST(ph)PSAAFPSDATAEQGPILTK_,T504,,26.31,,,,,,,,,,,,,26.31,0.00, , , , , , , , , , , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
10279,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),EKLFPDTPLALDA,_LFPDT(ph)PLALDANK_,T592,,24.51,,,,23.98,,22.93,,23.25,23.85,,,,23.71,0.81, , , ,0.28, ,-0.77, ,-0.45,0.14, , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
10280,Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,PGEGVLTLRAKPP,_GPGEGVLT(ph)LR_,T317,+,19.27,,,,21.86,20.87,23.88,23.63,,21.82,24.01,25.28,22.91,22.61,-3.34, , , ,-0.76,-1.74,1.26,1.02, ,-0.80,1.40,2.67,0.30,cell proliferation;behavioral response to ethanol;epidermal growth factor receptor signaling pathway;actin cytoskeleton reorganization;actin filament bundle assembly;adult locomotory behavior,N-methyl-D-aspartate selective glutamate receptor complex;postsynaptic density,,,,+,,,,,,,,,,
10281,Q12929,EPS8,Epidermal growth factor receptor kinase substrate 8,APAPPGTVTQVDV,_M(ox)ISNADPSIPPPPRAPAPAPPGT(ph)VTQVDVR_,T223,,,,,,23.14,,23.93,24.24,,,,24.82,,24.03, , , , ,-0.89, ,-0.10,0.21, , , ,0.79, ,cell proliferation;behavioral response to ethanol;epidermal growth factor receptor signaling pathway;actin cytoskeleton reorganization;actin filament bundle assembly;adult locomotory behavior,N-methyl-D-aspartate selective glutamate receptor complex;postsynaptic density,,,,+,,,,,,,,,,
10282,Q12933,TRAF2,TNF receptor-associated factor 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3),MAAASVTPPGSLE,_(ac)AAASVT(ph)PPGS(ph)LELLQPGFSK_,T7,,26.84,,,,,,,,,,,,,26.84,0.00, , , , , , , , , , , , ,protein K63-linked ubiquitination;protein autoubiquitination;positive regulation of NF-kappaB transcription factor activity;activation of cysteine-type endopeptidase activity involved in apoptotic process;cellular protein complex assembly;positive regulation of interleukin-2 production;protein homotrimerization;positive regulation of extrinsic apoptotic signaling pathway;negative regulation of glial cell apoptotic process;positive regulation of T cell activation;positive regulation of JUN kinase activity;protein catabolic process;innate immune response;positive regulation of protein homodimerization activity;tumor necrosis factor-mediated signaling pathway;activation of NF-kappaB-inducing kinase activity;regulation of immunoglobulin secretion;positive regulation of T cell cytokine production,cytosol;cell cortex;CD40 receptor complex;membrane raft;internal side of plasma membrane,,,,,,,,,,,,,,
10283,Q12965,MYO1E,Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E),LPRQQSTSSDRVS,_(gl)QQST(ph)SSDRVSQTPESLDFLK_,T1003,,23.78,,,22.47,,,23.05,,,21.53,,24.28,,23.02,0.76, , ,-0.55, , ,0.03, , ,-1.49, ,1.26, ,glomerular visceral epithelial cell development;glomerular basement membrane development;platelet-derived growth factor receptor signaling pathway;vasculogenesis;endocytosis;in utero embryonic development;actin filament-based movement;post-embryonic hemopoiesis;glomerular filtration,cell-cell junction;adherens junction;myosin complex;clathrin-coated vesicle;cytoplasm,,,,,,,,,,,,,,
10284,Q12982,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,IRKGSITEYTAAE,_KGSIT(ph)EYTAAEEK_,T116,+,22.80,23.79,,24.16,,23.62,,23.07,23.53,,23.98,,,23.56,-0.76,0.22, ,0.59, ,0.06, ,-0.49,-0.04, ,0.42, , ,negative regulation of apoptotic process;positive regulation of small GTPase mediated signal transduction;positive regulation of muscle cell differentiation;positive regulation of MAPK cascade;positive regulation of neuron differentiation;striated muscle cell differentiation;apoptotic process;muscle cell differentiation,cytosol;nuclear envelope;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10289,Q13153,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),IEPLPVTPTRDVA,_SVIEPLPVT(ph)PTR_,T212,,24.63,,,,,,,,,,,,,24.63,0.00, , , , , , , , , , , , ,positive regulation of peptidyl-serine phosphorylation;neuromuscular junction development;cellular response to stress;protein autophosphorylation;T cell costimulation;wound healing;negative regulation of cell proliferation involved in contact inhibition;cellular response to insulin stimulus;apoptotic process;branching morphogenesis of a tube;exocytosis;positive regulation of JUN kinase activity;response to hypoxia;positive regulation of stress fiber assembly;axon guidance;T cell receptor signaling pathway;dendrite development;actin cytoskeleton reorganization;positive regulation of intracellular estrogen receptor signaling pathway;receptor clustering,Z disc;axon;intercalated disc;Golgi apparatus;protein complex;cytosol;growth cone;nuclear membrane;plasma membrane;focal adhesion;dendrite;ruffle,,+,,,,,,,,+,,,,
10291,Q13263,TRIM28,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 6.3.2.-) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (Tripartite motif-containing protein 28),GTAPAGTPGAPPL,_GAAAAATGQPGTAPAGT(ph)PGAPPLAGM(ox)AIVK_,T541,,25.11,21.77,21.77,21.11,,,22.52,,23.82,25.25,,,,23.05,2.06,-1.28,-1.28,-1.94, , ,-0.53, ,0.77,2.20, , , ,"transcription initiation from RNA polymerase II promoter;protein oligomerization;protein autophosphorylation;convergent extension involved in axis elongation;negative regulation of transcription, DNA-dependent;DNA repair;epithelial to mesenchymal transition;protein sumoylation;positive regulation of transcription, DNA-dependent;negative regulation of transcription from RNA polymerase II promoter;embryonic placenta morphogenesis;positive regulation of DNA repair",nucleoplasm;nuclear heterochromatin;nuclear euchromatin,,+,,,,,,,,,,,,
10295,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),RSRERRTPPGRSR,_ERRT(ph)PPGR_,T611,,20.89,19.88,17.16,19.75,,,,19.27,,,,,,19.39,1.50,0.50,-2.23,0.36, , , ,-0.12, , , , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
10296,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),HESSPGTDEDKSG,_KFDHES(ph)S(ph)PGT(ph)DEDK_,T748,,27.53,25.10,25.83,23.83,,,,,,,,,,25.57,1.96,-0.47,0.26,-1.74, , , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
10297,Q13427,PPIG,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),RFRRSETPPHWRQ,_S(ph)ET(ph)PPHWR_,T358,,27.49,26.03,25.28,25.90,22.55,,,,,,,,,25.45,2.04,0.58,-0.17,0.45,-2.90, , , , , , , , ,protein folding;protein peptidyl-prolyl isomerization;RNA splicing,nucleoplasm;nuclear speck;nuclear matrix;cytoplasm,,,,,,,,,,,,,,
10303,Q13435,SF3B2,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),AMDGSETPQLFTV,_KIEEAM(ox)DGSET(ph)PQLFTVLPEK_,T780,,23.51,,,,,,24.00,23.84,24.17,24.26,,24.98,,24.13,-0.62, , , , , ,-0.13,-0.29,0.04,0.13, ,0.86, ,"mRNA splicing, via spliceosome;virus-host interaction",nucleoplasm;U12-type spliceosomal complex;catalytic step 2 spliceosome,SAP-domain,,,,,,,,,+,,,,
10304,Q13443,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),RHVSPVTPPREVP,_HVS(ph)PVT(ph)PPREVPIYANR_,T761,+,21.80,23.69,23.69,,25.26,22.86,25.21,25.13,25.15,24.92,23.73,22.88,24.14,24.04,-2.23,-0.35,-0.35, ,1.22,-1.18,1.17,1.09,1.11,0.88,-0.31,-1.15,0.10,transforming growth factor beta receptor signaling pathway;positive regulation of macrophage fusion;monocyte activation;positive regulation of cell adhesion mediated by integrin;activation of MAPKK activity;integrin-mediated signaling pathway;positive regulation of membrane protein ectodomain proteolysis;positive regulation of keratinocyte migration;cell-cell adhesion mediated by integrin;keratinocyte differentiation;PMA-inducible membrane protein ectodomain proteolysis;response to calcium ion;cell-matrix adhesion;cellular response to lipopolysaccharide;response to glucocorticoid stimulus;response to hydrogen peroxide;response to tumor necrosis factor;positive regulation of protein secretion;response to manganese ion,intrinsic to external side of plasma membrane;extracellular space;integral to membrane;cytoplasm,,,,,,,,,,,,,,
10305,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),ATGAALTPTEERR,_ATGAALT(ph)PTEER_,T1346,,26.20,25.34,22.51,25.93,,,,,,,,,,24.99,1.21,0.34,-2.48,0.94, , , , , , , , , ,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10306,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),EPSRRVTQEQGVS,_RVT(ph)QEQGVSLLEDK_,T1183,,,,,,26.80,21.60,,23.15,,,,,,23.85, , , , ,2.95,-2.25, ,-0.70, , , , , ,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10307,Q13459,MYO9B,Unconventional myosin-IXb (Unconventional myosin-9b),PGSAPETPEDKSK,_VSPPAPGS(ph)APET(ph)PEDK_,T1271,+,26.80,25.71,25.41,26.50,23.98,24.29,24.52,25.93,23.90,23.44,25.11,24.91,25.14,25.05,1.75,0.66,0.36,1.45,-1.07,-0.76,-0.53,0.88,-1.15,-1.61,0.06,-0.14,0.10,Rho protein signal transduction;actin filament-based movement,cytosol;cell cortex;filamentous actin;myosin complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10310,Q13501,SQSTM1,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),GKRSRLTPVSPES,_SRLT(ph)PVS(ph)PESSSTEEK_,T269,+,26.39,26.24,,24.61,26.70,25.67,25.92,27.18,25.63,,27.73,28.03,26.79,26.44,-0.06,-0.20, ,-1.83,0.26,-0.78,-0.52,0.74,-0.82, ,1.29,1.59,0.35,cell differentiation;regulation of I-kappaB kinase/NF-kappaB cascade;macroautophagy;endosomal transport;ubiquitin-dependent protein catabolic process;regulation of Ras protein signal transduction;protein localization;apoptotic process;nerve growth factor receptor signaling pathway;intracellular signal transduction;positive regulation of transcription from RNA polymerase II promoter,nucleoplasm;cytosol;late endosome;endoplasmic reticulum;pre-autophagosomal structure;autophagic vacuole,,,,,,,,,,,,,,
10311,Q13541,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I),PGDYSTTPGGTLF,_VVLGDGVQLPPGDYSTT(ph)PGGTLFSTT(ph)PGGTRIIYDRK_,T37,,25.99,24.19,,26.25,,,24.94,26.76,,,,26.29,,25.74,0.25,-1.54, ,0.51, , ,-0.80,1.03, , , ,0.55, ,TOR signaling cascade;translational initiation;insulin receptor signaling pathway;positive regulation of mitotic cell cycle;negative regulation of translational initiation;negative regulation of protein complex assembly;G1/S transition of mitotic cell cycle,cytosol;nucleus;protein complex,,,,,,,,,,,,,,
10314,Q13555,CAMK2G,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),MMHRQETVECLRK,_QET(ph)VECLRK_,T222,,26.25,,,23.60,,,,,,,,,,24.92,1.32, , ,-1.32, , , , , , , , , ,response to oxidative stress;regulation of skeletal muscle adaptation;regulation of calcium ion transport;cell differentiation;insulin secretion;protein autophosphorylation;calcium ion transport;protein phosphorylation;response to hypoxia;G1/S transition of mitotic cell cycle;interferon-gamma-mediated signaling pathway;synaptic transmission;nervous system development,nucleoplasm;cytosol;calcium- and calmodulin-dependent protein kinase complex;plasma membrane;endocytic vesicle membrane;sarcoplasmic reticulum membrane,,+,+,,,,,,,,,,,
10315,Q13557,CAMK2D,Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17),TESSNTTIEDEDV,_ESTESSNTT(ph)IEDEDVK_,T337,+,24.95,26.13,25.97,24.32,,25.38,,24.91,,,,,24.25,25.13,-0.18,1.00,0.84,-0.81, ,0.25, ,-0.22, , , , ,-0.88,protein autophosphorylation;regulation of cell growth;calcium ion transport;protein phosphorylation;cardiac muscle contraction;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;positive regulation of cardiac muscle hypertrophy;G1/S transition of mitotic cell cycle;regulation of ryanodine-sensitive calcium-release channel activity;interferon-gamma-mediated signaling pathway;synaptic transmission,nucleoplasm;sarcoplasmic reticulum membrane;cytosol;neuromuscular junction;T-tubule;calcium- and calmodulin-dependent protein kinase complex;endocytic vesicle membrane;plasma membrane,,+,,,,,,,,,,,,
10316,Q13557,CAMK2D,Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17),MMHRQETVDCLKK,_(gl)QET(ph)VDCLKK_,T287,,24.26,21.49,,24.18,,,23.25,,,,,,,23.29,0.97,-1.81, ,0.88, , ,-0.04, , , , , , ,protein autophosphorylation;regulation of cell growth;calcium ion transport;protein phosphorylation;cardiac muscle contraction;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;positive regulation of cardiac muscle hypertrophy;G1/S transition of mitotic cell cycle;regulation of ryanodine-sensitive calcium-release channel activity;interferon-gamma-mediated signaling pathway;synaptic transmission,nucleoplasm;sarcoplasmic reticulum membrane;cytosol;neuromuscular junction;T-tubule;calcium- and calmodulin-dependent protein kinase complex;endocytic vesicle membrane;plasma membrane,,+,,,,,,,,,,,,
10317,Q13561,DCTN2,Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin),GGKTTGTPPDSSL,_TTGT(ph)PPDSSLVTYELHSRPEQDK_,T198,+,,22.30,22.30,,,23.93,23.66,24.19,22.97,23.60,24.89,23.88,,23.52, ,-1.22,-1.22, , ,0.41,0.14,0.66,-0.56,0.07,1.36,0.35, ,mitotic spindle organization;G2/M transition of mitotic cell cycle;cell proliferation;mitosis;antigen processing and presentation of exogenous peptide antigen via MHC class II,centrosome;cytosol;dynactin complex;growth cone;vesicle;dynein complex;microtubule;kinetochore;membrane,,,,,,,,,,,,,,
10318,Q13595,TRA2A,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),SKSPTGTPARVKS,_S(ph)PTGT(ph)PARVK_,T24,,21.48,27.33,27.33,23.78,,,,,21.02,20.58,,,,23.59,-2.10,3.75,3.75,0.19, , , , ,-2.57,-3.00, , , ,"mRNA splicing, via spliceosome",nucleus,,,,,,,,,,+,,,,
10323,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),EESRPYTNKVITL,_LYSSEESRPYT(ph)NK_,T871,+,24.69,26.36,27.00,24.78,25.99,28.05,27.86,27.32,27.65,26.92,26.66,26.50,26.67,26.65,-1.96,-0.29,0.35,-1.87,-0.66,1.40,1.21,0.67,1.00,0.27,0.01,-0.15,0.02,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
10324,Q14004,CDK13,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),KQTDPSTPQQESS,_QTDPST(ph)PQQESSKPLGGIQPSSQTIQPK_,T1087,,,,,,,25.58,,23.81,23.70,22.83,,,24.64,24.11, , , , , ,1.46, ,-0.30,-0.41,-1.28, , ,0.53,"phosphorylation of RNA polymerase II C-terminal domain;positive regulation of cell proliferation;alternative mRNA splicing, via spliceosome;hemopoiesis;cell cycle;regulation of mitosis;virus-host interaction",nuclear cyclin-dependent protein kinase holoenzyme complex;nuclear speck,,+,,,,,,,,,,,,
10327,Q14118,DAG1,Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG);Beta-dystroglycan (Beta-DG)],TLEDQATFIKKGV,_LTLEDQAT(ph)FIKK_,T790,+,22.41,21.81,,24.27,24.16,22.53,25.92,24.90,23.06,,23.49,26.96,24.36,23.99,-1.57,-2.18, ,0.28,0.18,-1.46,1.93,0.92,-0.93, ,-0.50,2.98,0.37,microtubule anchoring;negative regulation of MAPK cascade;membrane protein ectodomain proteolysis;calcium-dependent cell-matrix adhesion;negative regulation of protein kinase B signaling cascade;branching involved in salivary gland morphogenesis;NLS-bearing substrate import into nucleus;nerve maturation;negative regulation of cell migration;morphogenesis of an epithelial sheet;response to peptide hormone stimulus;myelination in peripheral nervous system;cytoskeletal anchoring at plasma membrane;epithelial tube branching involved in lung morphogenesis;virus-host interaction,nucleoplasm;membrane raft;node of Ranvier;extracellular space;contractile ring;dystroglycan complex;integral to membrane;basement membrane;focal adhesion;sarcolemma;cell-cell adherens junction;cytoplasm;filopodium;cell outer membrane;dystrophin-associated glycoprotein complex;cytoskeleton;costamere;lamellipodium;postsynaptic membrane,,,,,,,,,,,,,,
10328,Q14126,DSG2,Desmoglein-2 (Cadherin family member 5) (HDGC),FTPIPGTIEMLHP,_GFTPIPGT(ph)IEM(ox)LHPWNNEGAPPEDK_,T650,,24.98,,,,,,,,,,,26.20,,25.59,-0.61, , , , , , , , , , ,0.61, ,regulation of ventricular cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;homophilic cell adhesion;cell adhesion;cellular component disassembly involved in execution phase of apoptosis;bundle of His cell to Purkinje myocyte communication,cell-cell junction;integral to membrane;plasma membrane;desmosome,,,,,,,,,,,,,,
10335,Q14195,DPYSL3,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),VFDLTTTPKGGTP,_GM(ox)YDGPVFDLTTT(ph)PK_,T623,+,26.48,26.35,26.83,25.40,,26.12,28.51,26.76,26.90,,27.96,26.34,25.98,26.69,-0.21,-0.35,0.13,-1.30, ,-0.57,1.82,0.07,0.20, ,1.27,-0.36,-0.72,actin crosslink formation;pyrimidine nucleobase catabolic process;response to axon injury;positive regulation of filopodium assembly;cellular response to cytokine stimulus;axon guidance;negative regulation of cell migration;positive regulation of neuron projection development;protein homooligomerization;actin filament bundle assembly;negative regulation of neuron projection development,growth cone;cytosol;extracellular space;filamentous actin;lamellipodium;cell body,,,,,,,,,,,,,,
10337,Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),ARAKTQTPPVSPA,_TQT(ph)PPVS(ph)PAPQPTEER_,T401,+,31.48,28.19,27.98,28.05,29.80,27.94,28.61,29.41,29.35,29.06,29.02,26.74,27.87,28.73,2.75,-0.54,-0.75,-0.68,1.07,-0.79,-0.12,0.68,0.62,0.33,0.29,-1.99,-0.86,,cell cortex;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
10338,Q14247,CTTN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),SPAPQPTEERLPS,_TQT(ph)PPVSPAPQPT(ph)EERLPSSPVYEDAASFK_,T411,,,25.42,25.42,,26.20,,,,27.25,,,,,26.08, ,-0.65,-0.65, ,0.13, , , ,1.18, , , , ,,cell cortex;cytoskeleton;lamellipodium;ruffle,,,,,,,,,,,,,,
10339,Q14667,KIAA0100,UPF0378 protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein),VRGKLETKSDLNM,_LET(ph)KS(ph)DLNM(ox)QQQEEEEK_,T2167,,21.97,28.45,29.11,28.46,26.28,,30.44,26.89,29.62,29.77,28.56,30.14,,28.15,-6.19,0.30,0.96,0.31,-1.87, ,2.29,-1.27,1.47,1.61,0.41,1.98, ,,extracellular region,,,,,,,,,,,,,,
10343,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),MVINSDTDDEEEV,_SQASM(ox)VINSDT(ph)DDEEEVSAALTLAHLK_,T276,,22.97,,,,,,,,,,,,,22.97,0.00, , , , , , , , , , , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
10345,Q14676,MDC 1.00,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),TERDSDTDVEEEE,_SQTTTERDS(ph)DT(ph)DVEEEELPVENR_,T327,,25.15,,,,24.17,,,24.34,,,,,,24.55,0.59, , , ,-0.38, , ,-0.21, , , , , ,intra-S DNA damage checkpoint;cell cycle;double-strand break repair via homologous recombination,nucleoplasm;chromosome;focal adhesion,,,,,,,,,,,,,,
10348,Q14802,FXYD3,FXYD domain-containing ion transport regulator 3 (Chloride conductance inducer protein Mat-8) (Mammary tumor 8 kDa protein) (Phospholemman-like),GHHPGETPPLITP,_SGHHPGET(ph)PPLITPGSAQS_,T76,,22.68,22.92,22.92,,,,,,,,,,,22.84,-0.16,0.08,0.08, , , , , , , , , , ,regulation of catalytic activity,chloride channel complex;integral to plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
10349,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),KSAIDLTPIVVED,_SAIDLT(ph)PIVVEDK_,T1646,,24.22,,,,,,,,,25.12,,,,24.67,-0.45, , , , , , , , ,0.45, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
10352,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),KTPTPSTPGDTQP,_TPTPST(ph)PGDTQPNTPAPVPPAEDGIK_,T1538,,22.75,,,,,,,,,,,,,22.75,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
10353,Q14839,CHD4,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),GDTQPNTPAPVPP,_TPTPSTPGDTQPNT(ph)PAPVPPAEDGIK_,T1546,,24.30,,,,,,,,,24.68,,,,24.49,-0.19, , , , , , , , ,0.19, , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;chromatin modification",NuRD complex;centrosome,Other TF domain,,,,,,,,,,+,,,
10354,Q14865,ARID5B,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2),AGEKGPTPPLPSA,_GPT(ph)PPLPSAPLAPEK_,T296,,23.86,24.31,22.93,24.07,,26.74,23.98,24.86,26.41,22.87,24.75,24.67,26.42,24.66,-0.80,-0.35,-1.72,-0.59, ,2.08,-0.67,0.21,1.76,-1.78,0.09,0.01,1.76,"male gonad development;fat pad development;muscle organ morphogenesis;fat cell differentiation;adrenal gland development;kidney development;negative regulation of transcription, DNA-dependent;liver development;palate development;adipose tissue development;skeletal system morphogenesis;post-embryonic development;platelet-derived growth factor receptor signaling pathway;positive regulation of sequence-specific DNA binding transcription factor activity;face morphogenesis;fibroblast migration;female gonad development;multicellular organism growth;cell development;transcription, DNA-dependent",nucleus,ARID domain,,,,,,,,,,,,,
10355,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),KKIKLQTPNTFPK,_LQT(ph)PNT(ph)FPK_,T607,,,,,22.79,,,,,,,,,,22.79, , , ,0.00, , , , , , , , , ,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
10356,Q14978,NOLC1,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),KLQTPNTFPKRKK,_LQT(ph)PNT(ph)FPK_,T610,,,,,22.79,,,,,,,,,,22.79, , , ,0.00, , , , , , , , , ,"nucleolus organization;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;mitosis;positive regulation of transcription, DNA-dependent;positive regulation of cell proliferation;transcription, DNA-dependent;response to osmotic stress;rRNA processing",nucleolus;Cajal body;cytoplasm,,,,,,,,,,,,,,
10362,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),VSGSGSTAGSRTG,_GYYSPYSVSGSGS(ph)T(ph)AGSR_,T4486,,26.53,,,22.51,,,,,,,,,,24.52,2.01, , ,-2.01, , , , , , , , , ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
10364,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),GLRKQITMEELVR,_QIT(ph)MEELVR_,T3893,+,28.45,25.66,26.20,27.70,26.76,25.83,26.18,24.04,25.95,26.47,25.76,29.37,26.47,26.53,1.92,-0.87,-0.33,1.17,0.24,-0.70,-0.35,-2.49,-0.58,-0.05,-0.77,2.85,-0.06,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
10365,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),VRNRRLTVNEAVK,_RLT(ph)VNEAVK_,T2749,,,,,,,23.90,,23.74,,,,23.39,,23.67, , , , , ,0.22, ,0.06, , , ,-0.28, ,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
10366,Q15149,PLEC,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),YVRRRLTAEDLFE,_RRLT(ph)AEDLFEAR_,T3648,+,,,,,23.34,24.13,23.06,23.21,22.60,,,23.42,25.13,23.56, , , , ,-0.22,0.58,-0.50,-0.34,-0.96, , ,-0.14,1.57,hemidesmosome assembly;cellular component disassembly involved in execution phase of apoptosis,hemidesmosome;cytosol;intermediate filament cytoskeleton;sarcoplasm;sarcolemma;focal adhesion;costamere,,,,,,,,,,,,,,
10369,Q15303,ERBB4,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)],ELVEPLTPSGTAP,_FLETELVEPLT(ph)PSGTAPNQAQLR_,T689,,23.50,,,,,,,,,,,,,23.50,0.00, , , , , , , , , , , , ,"negative regulation of apoptotic process;surfactant homeostasis;negative regulation of cell proliferation;positive regulation of ERK1 and ERK2 cascade;embryonic pattern specification;peptidyl-tyrosine phosphorylation;positive regulation of glucose import;positive regulation of epithelial cell proliferation;neural crest cell migration;positive regulation of transcription, DNA-dependent;response to hydrogen peroxide;transcription, DNA-dependent;heart development;mammary gland epithelial cell differentiation;mammary gland alveolus development;positive regulation of cardiac muscle cell proliferation;protein autophosphorylation;response to drug;cardiac muscle tissue regeneration;positive regulation of cell migration;apoptotic process;positive regulation of phosphatidylinositol 3-kinase activity;cell fate commitment;response to progesterone stimulus;regulation of cell migration;synapse maturation;cell proliferation;positive regulation of synaptic transmission, GABAergic;transmembrane receptor protein tyrosine kinase signaling pathway;central nervous system morphogenesis;olfactory bulb interneuron differentiation;signal transduction by phosphorylation;positive regulation of tyrosine phosphorylation of Stat5 protein;lactation;positive regulation of STAT protein import into nucleus",nucleoplasm;basolateral plasma membrane;postsynaptic density;caveola;cytosol;extracellular region;integral to membrane;mitochondrial matrix,,+,,,,,,,,,,,,
10370,Q15418,RPS6KA1,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),TEFTSRTPKDSPG,_T(ph)PKDS(ph)PGIPPSAGAHQLFR_,T267,,22.72,22.41,22.41,,24.10,22.38,,22.98,22.59,,,,,22.80,-0.08,-0.39,-0.39, ,1.30,-0.41, ,0.18,-0.21, , , , ,negative regulation of apoptotic process;toll-like receptor 4 signaling pathway;Toll signaling pathway;positive regulation of cell differentiation;stress-activated MAPK cascade;positive regulation of hepatic stellate cell activation;positive regulation of cell growth;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;positive regulation of transcription from RNA polymerase II promoter;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;axon guidance;innate immune response;regulation of DNA-dependent transcription in response to stress;regulation of translation in response to stress;nerve growth factor receptor signaling pathway;cell cycle;synaptic transmission;toll-like receptor 1 signaling pathway,nucleoplasm;cytosol;spindle,,+,,,,,,,,+,,,,
10371,Q15527,SURF2,Surfeit locus protein 2 (Surf-2),TEDGDGTDDFLTD,_DLGSTEDGDGT(ph)DDFLTDK_,T190,,23.44,,,,,,,,,25.13,,,,24.28,-0.84, , , , , , , , ,0.84, , , ,,,,,,,,,,,,,,,,
10372,Q15527,SURF2,Surfeit locus protein 2 (Surf-2),GTDDFLTDKEDEK,_DLGSTEDGDGTDDFLT(ph)DKEDEK_,T195,,24.34,,,,24.23,23.16,22.93,,,23.72,,,,23.68,0.66, , , ,0.56,-0.51,-0.75, , ,0.04, , , ,,,,,,,,,,,,,,,,
10373,Q15648,MED1,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),SAGRSQTPPGVAT,_SQT(ph)PPGVATPPIPK_,T1051,+,26.71,25.32,24.73,25.46,26.65,26.86,25.85,26.27,27.20,25.95,25.59,25.25,26.26,26.01,0.70,-0.69,-1.28,-0.55,0.64,0.86,-0.16,0.26,1.19,-0.06,-0.41,-0.76,0.25,"negative regulation of apoptotic process;mRNA transcription from RNA polymerase II promoter;fat cell differentiation;regulation of transcription from RNA polymerase I promoter;liver development;positive regulation of hepatocyte proliferation;erythrocyte development;embryonic hindlimb morphogenesis;positive regulation of protein import into nucleus, translocation;thyroid hormone generation;retinal pigment epithelium development;keratinocyte differentiation;cell morphogenesis;epithelial cell proliferation involved in mammary gland duct elongation;cellular response to epidermal growth factor stimulus;positive regulation of intracellular estrogen receptor signaling pathway;monocyte differentiation;organ regeneration;cellular response to thyroid hormone stimulus;DNA replication;mammary gland branching involved in pregnancy;thyroid hormone mediated signaling pathway;negative regulation of keratinocyte proliferation;embryonic heart tube development;positive regulation of keratinocyte differentiation;enucleate erythrocyte development;cellular response to hepatocyte growth factor stimulus;embryonic hemopoiesis;cellular response to steroid hormone stimulus;embryonic placenta development;negative regulation of neuron differentiation;ventricular trabecula myocardium morphogenesis;androgen receptor signaling pathway;lens development in camera-type eye;positive regulation of interferon-gamma-mediated signaling pathway;positive regulation of transcription from RNA polymerase II promoter;megakaryocyte development;transcription initiation from RNA polymerase II promoter;mammary gland branching involved in thelarche;regulation of cell cycle;positive regulation of mammary gland epithelial cell proliferation;angiogenesis;small molecule metabolic process;peroxisome proliferator activated receptor signaling pathway;cellular lipid metabolic process;regulation of vitamin D receptor signaling pathway;positive regulation of G0 to G1 transition;ERK1 and ERK2 cascade;brain development;negative regulation of transcription from RNA polymerase II promoter;androgen biosynthetic process;lactation",nucleolus;mediator complex,Other TF domain,,,,,,,,,,,,,
10375,Q15796,SMAD2,Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2),SSILPFTPPVVKR,_(ac)SSILPFT(ph)PPVVK_,T8,+,,25.31,25.44,24.50,26.93,25.94,27.25,,26.66,26.01,26.51,,,26.06, ,-0.75,-0.62,-1.56,0.87,-0.12,1.19, ,0.60,-0.05,0.45, , ,pancreas development;negative regulation of cell proliferation;negative regulation of transforming growth factor beta receptor signaling pathway;transforming growth factor beta receptor signaling pathway;palate development;primary miRNA processing;intracellular signal transduction;post-embryonic development;organ growth;in utero embryonic development;response to glucose stimulus;embryonic cranial skeleton morphogenesis;nodal signaling pathway;paraxial mesoderm morphogenesis;endoderm development;mesoderm formation;positive regulation of BMP signaling pathway;insulin secretion;ureteric bud development;common-partner SMAD protein phosphorylation;positive regulation of epithelial to mesenchymal transition;positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry;pericardium development;lung development;anterior/posterior pattern specification;cell fate commitment;positive regulation of transcription from RNA polymerase II promoter;regulation of binding;transcription initiation from RNA polymerase II promoter;SMAD protein complex assembly;embryonic foregut morphogenesis;response to cholesterol;developmental growth;negative regulation of transcription from RNA polymerase II promoter;zygotic specification of dorsal/ventral axis,cytosol;activin responsive factor complex;SMAD protein complex,Other TF domain,,,,,,,,,,+,,,
10376,Q15907,RAB11B,Ras-related protein Rab-11B (GTP-binding protein YPT3),____MGTRDDEYD,_(ac)GT(ph)RDDEYDYLFK_,T3,,23.73,,,,,,,,,,,,,23.73,0.00, , , , , , , , , , , , ,protein transport;melanosome transport;small GTPase mediated signal transduction;cell cycle,mitochondrion;plasma membrane;cytoplasmic membrane-bounded vesicle;recycling endosome,,,,,,,,,,,,,,
10378,Q15910,EZH2,Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.43) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6),PAEDVDTPPRKKK,_ESSIIAPAPAEDVDT(ph)PPRK_,T405,+,21.51,23.59,23.59,23.03,22.99,25.48,25.45,24.70,24.13,24.50,,23.58,24.04,23.88,-2.37,-0.29,-0.29,-0.85,-0.89,1.60,1.57,0.82,0.25,0.62, ,-0.31,0.15,"S phase of mitotic cell cycle;negative regulation of striated muscle cell differentiation;histone H3-K27 methylation;negative regulation of transcription, DNA-dependent;regulation of cell proliferation;regulation of protein phosphorylation;G1 to G0 transition;negative regulation of transcription elongation from RNA polymerase II promoter;regulation of gliogenesis;cerebellar cortex development;transcription, DNA-dependent;negative regulation of epidermal cell differentiation;negative regulation of retinoic acid receptor signaling pathway",ESC/E(Z) complex;pronucleus,,,,,,,,,,,,,,
10379,Q16181,SEP7,Septin-7 (CDC10 protein homolog),QQNSSRTLEKNKK,_ILEQQNSSRT(ph)LEK_,T399,,,24.11,24.11,23.98,,,23.83,,,,,22.38,23.31,23.62, ,0.49,0.49,0.36, , ,0.21, , , , ,-1.24,-0.31,mitosis;regulation of embryonic cell shape;protein heterooligomerization;cilium morphogenesis;cytokinesis,septin complex;condensed chromosome kinetochore;cleavage furrow;cytoplasm;microtubule cytoskeleton;midbody;stress fiber;nucleolus;plasma membrane;spindle;cilium axoneme,,,,,,,,,,,,,,
10380,Q16181,SEP7,Septin-7 (CDC10 protein homolog),IYEFPETDDEEEN,_IYEFPET(ph)DDEEENK_,T201,+,22.74,,,,24.25,22.59,24.85,,23.55,24.10,23.27,23.90,,23.65,-0.92, , , ,0.59,-1.07,1.19, ,-0.10,0.45,-0.39,0.24, ,mitosis;regulation of embryonic cell shape;protein heterooligomerization;cilium morphogenesis;cytokinesis,septin complex;condensed chromosome kinetochore;cleavage furrow;cytoplasm;microtubule cytoskeleton;midbody;stress fiber;nucleolus;plasma membrane;spindle;cilium axoneme,,,,,,,,,,,,,,
10381,Q16513,PKN2,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),SEAPILTPPREPR,_GREDVSNFDDEFTSEAPILT(ph)PPREPR_,T942,+,,,,,23.99,24.14,25.46,25.88,25.16,25.82,26.25,24.61,26.49,25.31, , , , ,-1.32,-1.17,0.15,0.57,-0.16,0.51,0.94,-0.70,1.18,"regulation of transcription, DNA-dependent;positive regulation of cell cycle cytokinesis;epithelial cell migration;signal transduction;apical junction assembly;regulation of cell motility;cell adhesion;apoptotic process;positive regulation of mitotic cell cycle;transcription, DNA-dependent;cell cycle;cell division",cleavage furrow;cytoplasm;apical junction complex;midbody;cytoskeleton;nucleus;lamellipodium;membrane,,+,,,,,,,,+,,,,
10388,Q16643,DBN1,Drebrin (Developmentally-regulated brain protein),DSSTASTPVAEQI,_SPSDSSTAST(ph)PVAEQIER_,T346,+,27.00,,,,24.03,,22.85,,23.99,24.43,24.71,,26.03,24.72,2.28, , , ,-0.69, ,-1.87, ,-0.73,-0.29,-0.01, ,1.31,regulation of dendrite development;actin filament organization;neural precursor cell proliferation;regulation of neuronal synaptic plasticity,dendrite;cytoplasm;actomyosin,,,,,,,,,,,,,,
10391,Q1KMD3,HNRNPUL2,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),ERSGDETPGSEVP,_EEDEPEERS(ph)GDET(ph)PGS(ph)EVPGDK_,T165,+,28.71,28.21,27.16,26.70,25.05,27.54,25.95,26.04,27.65,26.79,23.46,25.32,26.36,26.53,2.18,1.67,0.63,0.16,-1.48,1.01,-0.58,-0.49,1.11,0.26,-3.08,-1.22,-0.17,,nucleus,SAP-domain,,,,,,,,,,,,,
10392,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),DEDEEDTAPESAL,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,T1179,+,27.87,,,,25.45,24.98,25.97,25.60,26.07,27.41,26.50,26.35,25.71,26.19,1.68, , , ,-0.74,-1.21,-0.22,-0.60,-0.12,1.22,0.31,0.16,-0.48,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10393,Q27J81,INF2,Inverted formin-2 (HBEBP2-binding protein C),PESALDTSLDKSF,_GARPPAAGPGGDEDEDEEDT(ph)APES(ph)ALDT(ph)S(ph)LDK_,T1187,,24.49,23.15,23.15,,,,,,,,,,,23.59,0.89,-0.45,-0.45, , , , , , , , , , ,actin cytoskeleton organization,endoplasmic reticulum;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10394,Q29RF7,PDS5A,Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),VRIISVTPVKNID,_IISVT(ph)PVK_,T1208,+,22.18,22.25,,22.29,21.89,22.33,21.79,22.16,20.87,,,,,21.97,0.21,0.28, ,0.32,-0.08,0.37,-0.18,0.19,-1.10, , , , ,mitosis;negative regulation of DNA replication;cell division,chromatin;plasma membrane;nucleus,,,,,,,,,,,,,,
10397,Q2M2I8,AAK1,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),QKVGSLTPPSSPK,_VGSLT(ph)PPS(ph)SPK_,T619,+,27.85,26.69,26.73,27.09,25.88,24.31,25.73,25.66,25.16,26.20,24.73,,,26.00,1.85,0.69,0.72,1.09,-0.12,-1.69,-0.27,-0.34,-0.84,0.20,-1.27, , ,protein stabilization;protein autophosphorylation;endocytosis;regulation of protein localization;positive regulation of Notch signaling pathway;regulation of clathrin-mediated endocytosis,coated pit;cell leading edge;extrinsic to plasma membrane;clathrin complex;terminal button;clathrin-coated vesicle,,+,,,,,,,,,,,,
10403,Q3V6T2,CCDC88A,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),ERQKSLTLTPTRS,_SLT(ph)LTPTR_,T1364,,,23.58,,23.97,,21.58,,,,,,21.94,,22.77, ,0.81, ,1.20, ,-1.18, , , , , ,-0.83, ,lamellipodium assembly;regulation of actin cytoskeleton organization;regulation of neuron projection development;cell migration;regulation of DNA replication;regulation of cell proliferation;activation of protein kinase B activity;TOR signaling cascade;cellular membrane organization;microtubule cytoskeleton organization;DNA replication,cytosol;cytoplasmic vesicle;Golgi apparatus;endoplasmic reticulum;plasma membrane;cytoplasmic membrane-bounded vesicle;lamellipodium,,,,,,,,,,,,,,
10404,Q3YEC7,RABL6,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),DDPSDVTDEDEGP,_RADDFPVRDDPS(ph)DVT(ph)DEDEGPAEPPPPPK_,T599,,24.03,,,,,,22.59,,23.56,25.21,23.81,,,23.84,0.19, , , , , ,-1.25, ,-0.28,1.37,-0.03, , ,small GTPase mediated signal transduction,nucleus;centrosome,,,,,,,,,,,,,,
10405,Q4G0J3,LARP7,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),RDIEISTEEEKDT,_ENRDIEIS(ph)T(ph)EEEK_,T338,+,27.09,26.25,26.56,25.12,22.28,22.61,25.44,,26.30,26.26,,22.66,22.08,24.79,2.31,1.46,1.77,0.33,-2.51,-2.18,0.66, ,1.51,1.48, ,-2.12,-2.71,RNA processing,nucleoplasm;ribonucleoprotein complex;nucleus;cytoplasm,,,,,,,,,,,,,,
10407,Q4LE39,ARID4B,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1),EVLSEDTDYEEDE,_DIEVLS(ph)EDT(ph)DYEEDEVTK_,T793,,24.62,,,,,,,,,,,,,24.62,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus;cytoplasm,ARID domain,,,,,,,,,,,,,
10409,Q53SF7,COBLL1,Cordon-bleu protein-like 1,TASAPATPLVNKH,_DQTAS(ph)APAT(ph)PLVNK_,T260,,23.91,,,,,,,,,,,,22.49,23.20,0.71, , , , , , , , , , , ,-0.71,,,,,,,,,,,,,,,,
10410,Q53SF7,COBLL1,Cordon-bleu protein-like 1,KPYISNTLPSDAP,_PYISNT(ph)LPSDAPK_,T284,,22.98,22.65,22.68,22.35,,,22.78,,,24.22,23.70,22.74,,23.01,-0.03,-0.36,-0.34,-0.66, , ,-0.24, , ,1.21,0.69,-0.27, ,,,,,,,,,,,,,,,,
10412,Q53TN4,CYBRD1,Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3),EAGQRSTM_____,_RNLALDEAGQRST(ph)M(ox)_,T227,+,24.50,28.21,28.58,26.52,25.33,28.39,29.88,25.11,29.23,26.12,29.09,29.89,28.15,27.61,-3.12,0.60,0.96,-1.09,-2.29,0.78,2.26,-2.51,1.62,-1.49,1.47,2.28,0.53,cellular iron ion homeostasis;electron transport chain;response to iron ion;transmembrane transport,integral to membrane;plasma membrane;brush border membrane,,,,,,,,,,,,,,
10413,Q58FF8,HSP90AB2P,Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b) (Heat shock protein 90Bb),CKFMKETLDKKVE,_FENLCKFMKET(ph)LDK_,T343,,,,,,25.29,23.91,23.58,25.17,23.75,22.84,24.21,,22.17,23.87, , , , ,1.42,0.05,-0.29,1.31,-0.12,-1.02,0.34, ,-1.70,protein folding;response to stress,cytoplasm,,,,,,,,,,,,,,
10415,Q5C9Z4,NOM1,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),EDDDEDTEEEQGE,_KAQEAEAQSEDDDEDT(ph)EEEQGEEK_,T287,,,,,,,22.69,,22.11,24.16,23.80,,,,23.19, , , , , ,-0.50, ,-1.08,0.97,0.61, , , ,RNA metabolic process,nucleolus,,,,,,,,,,,,,,
10426,Q5R3F8,ELFN2,Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62),LEAGLDTPKVATK,_GLEAGLDT(ph)PK_,T493,,18.54,20.11,20.11,,21.66,22.56,,,21.91,24.16,,,,21.29,-2.75,-1.18,-1.18, ,0.37,1.27, , ,0.61,2.87, , , ,negative regulation of phosphatase activity,integral to membrane,,,,,,,,,,,,,,
10438,Q5THJ4,VPS13D,Vacuolar protein sorting-associated protein 13D,DKDYPLTPPPSPT,_DYPLT(ph)PPPS(ph)PTVDEPK_,T1761,,24.53,,,22.62,,,,,24.10,24.04,,,,23.82,0.71, , ,-1.20, , , , ,0.28,0.21, , , ,protein localization,,,,,,,,,,,,,,,
10442,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,ESEKSATPEPVTD,_S(ph)AT(ph)PEPVTDNRDVEDM(ox)ELS(ph)DVEDDGSK_,T321,,25.40,,,,,,,,,,,,,25.40,0.00, , , , , , , , , , , , ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
10443,Q5VT52,RPRD2,Regulation of nuclear pre-mRNA domain-containing protein 2,RDERSGTPTQDEM,_SGT(ph)PTQDEM(ox)M(ox)DKPTSSSVDTM(ox)SLLSK_,T695,,24.43,24.43,24.43,23.43,26.24,,,,,23.80,,,,24.46,-0.03,-0.03,-0.03,-1.03,1.78, , , , ,-0.66, , , ,,"DNA-directed RNA polymerase II, holoenzyme",,,,,,,,,,,,,,
10446,Q5VW32,BROX,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),RLLELFTDLSCNP,_LLELFT(ph)DLS(ph)CNPEMMK_,T48,,,24.21,,26.17,,26.70,,26.56,25.65,25.55,,,,25.81, ,-1.60, ,0.37, ,0.89, ,0.75,-0.16,-0.26, , , ,,membrane,,,,,,,,,,,,,,
10447,Q5VZK9,LRRC16A,Leucine-rich repeat-containing protein 16A (CARMIL homolog),LDTCMMTPKSKRK,_LEDLDTCM(ox)M(ox)T(ph)PK_,T916,,25.45,24.11,23.77,23.63,,,,,,,,,,24.24,1.21,-0.13,-0.47,-0.61, , , , , , , , , ,ruffle organization;lamellipodium assembly;blood coagulation;actin filament organization;urate metabolic process;cell migration,cytosol;nucleus;lamellipodium,,,,,,,,,,,,,,
10448,Q5VZL5,ZMYM4,Zinc finger MYM-type protein 4 (Zinc finger protein 262),EVERRVTQHESDN,_VT(ph)QHESDNENEIQIQNK_,T118,,,25.10,,,,,,,,,,,,25.10, ,0.00, , , , , , , , , , , ,regulation of cell morphogenesis;multicellular organismal development;cytoskeleton organization,,,,,,,,,,,,,,,
10449,Q63ZY3,KANK2,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),RSSGLSTPVPPSA,_SS(ph)GLST(ph)PVPPSAGHLAHVR_,T176,,23.94,,,,,,,,,,,,,23.94,0.00, , , , , , , , , , , , ,"negative regulation of G1/S transition of mitotic cell cycle;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;transcription, DNA-dependent;negative regulation of programmed cell death;negative regulation of intracellular estrogen receptor signaling pathway",mitochondrion,,,,,,,,,,,,,,
10451,Q66K14,TBC1D9B,TBC1 domain family member 9B,VERQFSTASDHEQ,_QFST(ph)ASDHEQPGVSG_,T1221,+,25.15,23.63,22.62,23.34,22.82,,24.13,23.61,,,23.50,22.55,,23.48,1.67,0.15,-0.86,-0.14,-0.66, ,0.64,0.13, , ,0.02,-0.94, ,positive regulation of Rab GTPase activity,integral to membrane;intracellular,,,,,,,,,,,,,,
10452,Q66K74,MAP1S,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain;MAP1S light chain],SIPRPRTPSPESH,_T(ph)PS(ph)PESHRSPAEGSER_,T638,,25.35,27.18,,24.75,20.23,,,,,,,,,24.38,0.97,2.80, ,0.38,-4.15, , , , , , , , ,brain development;microtubule bundle formation;mitochondrion transport along microtubule;neuron projection morphogenesis;apoptotic process,neuronal cell body;microtubule associated complex;perinuclear region of cytoplasm;cytosol;synapse;microtubule;nucleus;dendrite;spindle,,,,,,,,,,,,,,
10456,Q6GYQ0,RALGAPA1,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),SIVRQKTVDIDDA,_T(ph)VDIDDAQILPR_,T754,,26.14,19.29,19.29,22.39,,,23.87,,,,23.39,25.65,,22.86,3.28,-3.57,-3.57,-0.47, , ,1.01, , , ,0.53,2.79, ,"activation of Ral GTPase activity;regulation of transcription, DNA-dependent",cytosol;mitochondrion;nucleus,,,,,,,,,,,,,,
10461,Q6KC79,NIPBL,Nipped-B-like protein (Delangin) (SCC2 homolog),NNTAAETEDDESD,_NNTAAET(ph)EDDES(ph)DGEDRGGGTSGSLRR_,T2667,,23.81,24.64,24.64,,,,,,21.95,,,,,23.76,0.05,0.88,0.88, , , , , ,-1.81, , , , ,uterus morphogenesis;fat cell differentiation;gall bladder development;regulation of hair cycle;eye morphogenesis;metanephros development;embryonic forelimb morphogenesis;outflow tract morphogenesis;regulation of developmental growth;positive regulation of multicellular organism growth;ear morphogenesis;cellular response to X-ray;regulation of embryonic development;sensory perception of sound;positive regulation of ossification;cellular protein localization;response to DNA damage stimulus;external genitalia morphogenesis;face morphogenesis;positive regulation of histone deacetylation;developmental growth;brain development;embryonic viscerocranium morphogenesis;negative regulation of transcription from RNA polymerase II promoter;embryonic digestive tract morphogenesis;maintenance of mitotic sister chromatid cohesion;cognition,SMC loading complex,,,,,,,,,,,,,,
10464,Q6NUK4,REEP3,Receptor expression-enhancing protein 3,KDGDEKTDEEAEG,_T(ph)DEEAEGPYSDNEM(ox)LTHK_,T201,,,25.48,25.48,,,,25.01,,25.87,22.90,,,,24.95, ,0.53,0.53, , , ,0.06, ,0.92,-2.05, , , ,,integral to membrane,,,,,,,,,,,,,,
10465,Q6NZY4,ZCCHC8,Zinc finger CCHC domain-containing protein 8,PPLPRGTPPPVFT,_GT(ph)PPPVFTPPLPK_,T479,,21.92,22.73,,21.41,22.25,,21.15,,,,,,,21.89,0.03,0.84, ,-0.48,0.36, ,-0.75, , , , , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
10472,Q6PD62,CTR9,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),EFVNDDTDDDLPI,_SKKGGEFDEFVNDDT(ph)DDDLPISK_,T925,,25.87,,,,27.66,,,,23.56,25.68,,23.68,,25.29,0.58, , , ,2.37, , , ,-1.73,0.39, ,-1.61, ,"stem cell maintenance;histone H2B ubiquitination;JAK-STAT cascade;positive regulation of histone H3-K79 methylation;Wnt receptor signaling pathway;interleukin-6-mediated signaling pathway;positive regulation of histone H3-K4 methylation;positive regulation of transcription from RNA polymerase II promoter;negative regulation of myeloid cell differentiation;cellular response to lipopolysaccharide;histone monoubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone H3-K4 trimethylation;endodermal cell fate commitment;negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent",nuclear speck;transcriptionally active chromatin;Cdc73/Paf1 complex,,,,,,,,,,,,,,
10475,Q6PJG2,ELMSAN1,ELM2 and SANT domain-containing protein 1,TNSAEVTPPVLSV,_TNS(ph)AEVT(ph)PPVLSVM(ox)GEATPVSIEPR_,T704,,24.50,,,,,,22.87,,,,,,,23.69,0.81, , , , , ,-0.81, , , , , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleus,Other TF domain,,,,,,,,,,,,,
10478,Q6PKG0,LARP1,La-related protein 1 (La ribonucleoprotein domain family member 1),ARSLPTTVPESPN,_SLPTT(ph)VPESPNYR_,T770,,,27.22,,,27.94,,,,26.53,,27.60,,,27.32, ,-0.11, , ,0.62, , , ,-0.79, ,0.27, , ,positive regulation of macroautophagy,,,,,,,,,,,,,,,
10481,Q6QNY0,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3 (BLOC-1 subunit 3),AGEAAETDSEPEP,_VAGEAAET(ph)DS(ph)EPEPEPEPTAAPR_,T63,,26.79,,,,24.78,,23.81,24.99,,,,,,25.10,1.70, , , ,-0.31, ,-1.29,-0.10, , , , , ,post-Golgi vesicle-mediated transport;positive regulation of natural killer cell activation;neuron projection development;secretion of lysosomal enzymes;platelet activation;anterograde synaptic vesicle transport;melanosome transport;response to drug;eye development;anterograde axon cargo transport;cellular membrane organization;platelet dense granule organization;endosome to melanosome transport;developmental pigmentation;melanosome organization,transport vesicle;BLOC-1 complex,,,,,,,,,,,,,,
10485,Q6Y7W6,GIGYF2,PERQ amino acid-rich with GYF domain-containing protein 2 (GRB10-interacting GYF protein 2) (Trinucleotide repeat-containing gene 15 protein),SSARPGTPSDHQS,_VGVEASEETPQTSSSSARPGT(ph)PSDHQSQEASQFER_,T382,,,,,,24.09,25.18,,26.43,,,23.43,,,24.78, , , , ,-0.70,0.40, ,1.65, , ,-1.35, , ,S phase of mitotic cell cycle;post-embryonic development;neuromuscular process controlling balance;musculoskeletal movement;multicellular organism growth;cell death;cellular protein metabolic process;insulin-like growth factor receptor signaling pathway;homeostasis of number of cells within a tissue;spinal cord motor neuron differentiation;adult locomotory behavior;feeding behavior,,,,,,,,,,,,,,,
10487,Q6ZRS2,SRCAP,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),AGSGPPTPGPTTL,_DEEQSEADAGS(ph)GPPT(ph)PGPTTLGPKK_,T572,,23.35,,,,,,,,,,,,,23.35,0.00, , , , , , , , , , , , ,"transcription, DNA-dependent;regulation of transcription from RNA polymerase II promoter;virus-host interaction",Golgi apparatus;nucleus;protein complex,Other TF domain,,,,,,,,,,,,,
10488,Q6ZSS7,MFSD6,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),DKVAILTDDEEEQ,_VAILT(ph)DDEEEQK_,T10,+,26.62,26.47,26.47,23.93,,25.43,26.50,23.91,26.73,27.89,26.07,,25.71,25.98,0.64,0.49,0.49,-2.04, ,-0.54,0.53,-2.06,0.75,1.92,0.10, ,-0.27,transmembrane transport,integral to membrane,,,,,,,,,,,,,,
10491,Q709C8,VPS13C,Vacuolar protein sorting-associated protein 13C,IKEVVVTLMKKSE,_EVVVT(ph)LM(ox)KKS(ph)EK_,T1394,+,24.52,25.71,25.35,25.51,23.58,27.34,26.90,25.22,26.98,26.49,28.11,28.52,23.98,26.02,-1.49,-0.31,-0.67,-0.50,-2.44,1.32,0.88,-0.80,0.96,0.48,2.09,2.51,-2.03,protein localization,,,,,,,,,,,,,,,
10498,Q76FK4,NOL8,Nucleolar protein 8 (Nucleolar protein Nop132),DSRFLETDSEEEQ,_FLET(ph)DS(ph)EEEQEEVNEKK_,T762,,23.80,,,,,,,,,,,,,23.80,0.00, , , , , , , , , , , , ,positive regulation of cell growth;rRNA processing;DNA replication,nucleolus;cytoplasm,,,,,,,,,,,,,,
10501,Q7L2J0,MEPCE,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),RTLNAETPKSSPL,_TLNAET(ph)PKS(ph)SPLPAK_,T213,+,26.99,24.75,24.58,25.62,25.19,,24.04,21.71,24.78,,,,,24.71,2.28,0.04,-0.13,0.91,0.48, ,-0.67,-3.00,0.07, , , , ,snRNA modification,,,,,,,,,,,,,,,
10503,Q7L9L4,MOB1B,MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A),LKHAEATLGSGNL,_HAEAT(ph)LGSGNLR_,T35,,,,,,23.36,,24.69,,,,21.51,25.36,21.77,23.34, , , , ,0.03, ,1.35, , , ,-1.83,2.02,-1.57,protein autophosphorylation;hippo signaling cascade,cytosol;nucleus,,,,,,,,,,,,,,
10505,Q7Z3K3,POGZ,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),EHSESSTPRPRSS,_LSGEHS(ph)ESST(ph)PRPR_,T1273,+,25.51,26.64,26.87,25.52,21.67,,,,22.18,20.60,,,,24.14,1.37,2.49,2.73,1.37,-2.47, , , ,-1.96,-3.54, , , ,kinetochore assembly;cell division;mitotic sister chromatid cohesion,nuclear chromatin;cytoplasm,C2H2-type,,,,,,,,,,,,,
10507,Q7Z406,MYH14,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",QRQLVSTLEKKQR,_QLVST(ph)LEK_,T1470,,23.73,,,,,,,,,,,,,23.73,0.00, , , , , , , , , , , , ,regulation of cell shape;axon guidance;actin filament-based movement,growth cone;axon;stress fiber;myosin complex;cytoplasm,,,,,,,,,,,,,,
10511,Q7Z6E9,RBBP6,E3 ubiquitin-protein ligase RBBP6 (EC 6.3.2.-) (Proliferation potential-related protein) (Protein P2P-R) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),SSNKDFTPNRDKK,_DFT(ph)PNRDK_,T1434,,,26.33,26.15,25.86,,,,,24.07,,,,,25.60, ,0.73,0.55,0.26, , , , ,-1.53, , , , ,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,nucleolus;chromosome;microtubule organizing center,,,,,,,,,,,,,,
10513,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",PRAGSSTPGDAPP,_AGSST(ph)PGDAPPAVAEVQGR_,T2889,+,26.20,25.47,25.55,25.24,25.79,26.06,26.35,26.37,24.98,24.47,25.85,25.97,,25.69,0.51,-0.22,-0.14,-0.45,0.10,0.37,0.66,0.67,-0.71,-1.22,0.15,0.28, ,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
10514,Q7Z6Z7,HUWE1,"E3 ubiquitin-protein ligase HUWE1 (EC 6.3.2.-) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",ENKGNDTPLALES,_GNDT(ph)PLALESTNTEK_,T1722,,22.82,,,,,,,,22.90,22.14,22.82,22.21,23.04,22.66,0.17, , , , , , , ,0.24,-0.52,0.16,-0.44,0.39,cell differentiation;base-excision repair;protein ubiquitination involved in ubiquitin-dependent protein catabolic process;protein polyubiquitination;protein monoubiquitination;histone ubiquitination,nucleus;cytoplasm,,,,,,,,,,,,,,
10520,Q86UP2,KTN1,Kinectin (CG-1 antigen) (Kinesin receptor),PVTKQPTPPSEAA,_QPT(ph)PPSEAAASK_,T153,+,25.46,23.64,,23.15,,22.01,23.44,22.08,23.91,23.63,23.39,23.38,,23.41,2.05,0.23, ,-0.26, ,-1.40,0.03,-1.33,0.50,0.22,-0.02,-0.03, ,microtubule-based movement,integral to plasma membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
10521,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),NLKSPQTPSQMVP,_S(ph)PQT(ph)PSQM(ox)VPLPSANPPGPLK_,T957,+,26.95,,,24.90,,,26.90,23.32,26.94,26.65,26.16,25.78,,25.95,1.00, , ,-1.05, , ,0.95,-2.63,0.99,0.70,0.21,-0.17, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
10523,Q86UU0,BCL9L,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),GHLKSPTLSQVHS,_SPT(ph)LSQVHSPLVTSPSANLK_,T936,,26.45,22.81,23.00,24.56,,,,,24.92,22.78,,24.33,,24.12,2.33,-1.31,-1.13,0.43, , , , ,0.80,-1.34, ,0.21, ,"somatic stem cell maintenance;negative regulation of transforming growth factor beta receptor signaling pathway;skeletal muscle cell differentiation;positive regulation of epithelial to mesenchymal transition;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter;canonical Wnt receptor signaling pathway",nucleus,,,,,,,,,,,,,,
10527,Q86VR2,FAM134C,Protein FAM134C,AEGVPTTPGPASG,_(ac)AEAEGVPTT(ph)PGPASGSTFR_,T10,+,26.31,24.91,24.91,23.33,24.51,22.26,24.04,21.47,25.36,26.60,26.18,,26.89,24.73,1.58,0.18,0.18,-1.41,-0.22,-2.47,-0.69,-3.26,0.63,1.87,1.45, ,2.15,,integral to membrane,,,,,,,,,,,,,,
10528,Q86VR2,FAM134C,Protein FAM134C,NLSRGQTPLTEGS,_GQT(ph)PLTEGSEDLDGHS(ph)DPEESFAR_,T307,,23.36,,,,21.97,,,,,,,,,22.66,0.70, , , ,-0.70, , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
10529,Q86VR2,FAM134C,Protein FAM134C,RGQTPLTEGSEDL,_GQTPLT(ph)EGS(ph)EDLDGHS(ph)DPEESFAR_,T310,,24.58,,,,,,,,,,,,,24.58,0.00, , , , , , , , , , , , ,,integral to membrane,,,,,,,,,,,,,,
10530,Q86W92,PPFIBP1,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),SPSASITDEDSNV,_DFAARSPSASIT(ph)DEDSNV_,T999,+,22.58,22.16,21.86,23.01,23.90,25.19,,,,25.02,,22.18,,23.24,-0.66,-1.08,-1.38,-0.23,0.66,1.96, , , ,1.78, ,-1.06, ,cell adhesion,plasma membrane,,,,,,,,,,,,,,
10537,Q86X27,RALGPS2,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),AEFKSATFPNAGP,_SAT(ph)FPNAGPR_,T144,+,25.46,24.43,23.60,24.92,25.06,24.72,25.38,26.33,24.60,23.47,25.24,25.94,23.90,24.85,0.61,-0.42,-1.25,0.07,0.21,-0.13,0.53,1.48,-0.25,-1.38,0.39,1.09,-0.95,small GTPase mediated signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10538,Q86X27,RALGPS2,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),GALLPQTPPSPRN,_SVAAEGALLPQT(ph)PPS(ph)PR_,T109,+,25.25,22.84,,23.33,,24.06,,25.71,24.67,23.95,25.25,24.89,,24.44,0.81,-1.60, ,-1.11, ,-0.38, ,1.27,0.23,-0.49,0.81,0.45, ,small GTPase mediated signal transduction,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10540,Q86YP4,GATAD2A,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),DGDMRVTPEPGAG,_GLLASDLNTDGDM(ox)RVT(ph)PEPGAGPTQGLLR_,T49,+,23.48,,,22.14,24.56,24.25,23.98,24.13,24.74,23.83,23.61,,24.52,23.92,-0.45, , ,-1.78,0.63,0.32,0.06,0.21,0.82,-0.09,-0.31, ,0.59,"embryonic body morphogenesis;neural fold formation;anterior neuropore closure;negative regulation of transcription, DNA-dependent;in utero embryonic development;programmed cell death;transcription, DNA-dependent;DNA methylation;blood vessel development",NuRD complex;nuclear speck,,,,,,,,,,,,,,
10541,Q8IUC4,RHPN2,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),MHNKSATYSVGMQ,_SAT(ph)YSVGM(ox)QK_,T606,,24.59,23.44,23.44,,,,21.88,,,21.95,,,,23.06,1.53,0.38,0.38, , , ,-1.19, , ,-1.11, , , ,signal transduction,perinuclear region of cytoplasm,,,,,,,,,,,,,,
10544,Q8IVF2,AHNAK2,Protein AHNAK2,DVSPTSTDTEAQL,_DAHDVS(ph)PTST(ph)DTEAQLTVER_,T198,,23.07,,,,,,,,,,,,,23.07,0.00, , , , , , , , , , , , ,,nucleus,,,,,,,,,,,,,,
10546,Q8IVT2,MISP,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),HVGRASTPDWVSE,_AST(ph)PDWVSEGPQPGLR_,T377,,23.53,22.33,,,24.65,,23.64,,,26.80,,22.40,,23.89,-0.36,-1.56, , ,0.76, ,-0.25, , ,2.91, ,-1.49, ,,,,,,,,,,,,,,,,
10552,Q8IWV7,UBR1,E3 ubiquitin-protein ligase UBR1 (EC 6.3.2.-) (N-recognin-1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I),SAELPQTPQRLAS,_M(ox)EISAELPQT(ph)PQR_,T21,+,23.95,23.66,,22.74,23.92,23.97,24.10,24.15,24.19,21.99,24.19,25.06,23.98,23.82,0.12,-0.16, ,-1.08,0.10,0.14,0.28,0.32,0.36,-1.83,0.36,1.24,0.15,negative regulation of TOR signaling cascade;ubiquitin-dependent protein catabolic process;cellular response to leucine,cytosol;proteasome complex;ubiquitin ligase complex,,,,,,,,,,,,,,
10553,Q8IWW6,ARHGAP12,Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12),EQIRATTPPNQGR,_ATT(ph)PPNQGRPDS(ph)PVYANLQELK_,T231,,27.05,,,,24.51,,,,,,,,,25.78,1.27, , , ,-1.27, , , , , , , , ,small GTPase mediated signal transduction;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction,cytosol,,,,,,,,,,,,,,
10557,Q8IX12,CCAR1,Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain),EAKEISTPTHWSK,_EIST(ph)PTHWSK_,T612,,23.10,24.49,24.47,23.63,,,,,25.22,24.74,,,,24.28,-1.18,0.22,0.20,-0.64, , , , ,0.95,0.46, , , ,"mRNA splicing, via spliceosome;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;cell cycle",nucleoplasm;perinuclear region of cytoplasm,SAP-domain,,,,,,,,,,,,,
10558,Q8IXS8,FAM126B,Protein FAM126B,VLKVEVTPTVPRI,_VEVT(ph)PTVPR_,T306,,24.59,22.89,22.39,22.13,20.12,,22.73,,22.84,26.26,,23.40,21.73,22.91,1.68,-0.02,-0.52,-0.78,-2.79, ,-0.18, ,-0.07,3.35, ,0.50,-1.18,,intracellular,,,,,,,,,,,,,,
10559,Q8IXT5,RBM12B,RNA-binding protein 12B (RNA-binding motif protein 12B),DFRRSPTEDFRQL,_SPT(ph)EDFR_,T640,+,25.14,26.11,22.88,25.60,20.53,,,,,,20.80,,21.58,23.23,1.91,2.88,-0.35,2.37,-2.71, , , , , ,-2.44, ,-1.66,,,,,,,,,,,,,,,,
10562,Q8IY67,RAVER1,Ribonucleoprotein PTB-binding 1 (Protein raver-1),PPAAQLTPPPAPV,_EALGLGPPAAQLT(ph)PPPAPVGLR_,T463,,25.05,23.18,23.18,24.49,25.12,24.93,25.17,24.94,25.28,23.43,24.25,23.11,,24.34,0.70,-1.16,-1.16,0.14,0.78,0.59,0.82,0.59,0.93,-0.91,-0.10,-1.23, ,,nucleus;cytoplasm,,,,,,,,,,,,,,
10564,Q8IZL8,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",ILAPSGTPPPTIP,_AGSNEDPILAPSGT(ph)PPPTIPPDETFGGRVPR_,T745,+,24.59,25.78,,25.05,27.66,27.42,24.40,26.73,,,,22.81,26.93,25.71,-1.12,0.08, ,-0.66,1.95,1.71,-1.31,1.02, , , ,-2.90,1.23,"transcription, DNA-dependent",MLL1 complex;cytoplasm,,,,,,,,,,,,,,
10565,Q8IZL8,PELP1,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",AEEEMETETEAEA,_VQPPPETPAEEEM(ox)ET(ph)ETEAEALQEK_,T1090,,22.67,,,22.56,,,,,,,,,,22.62,0.05, , ,-0.05, , , , , , , , , ,"transcription, DNA-dependent",MLL1 complex;cytoplasm,,,,,,,,,,,,,,
10566,Q8IZP2,ST13P4,Putative protein FAM10A4 (Suppression of tumorigenicity 13 pseudogene 4),DENAEITEEVMDQ,_EGVIEPDTDAPQEM(ox)GDENAEIT(ph)EEVMDQANDK_,T103,,,,,,,,,,,23.56,,25.01,,24.29, , , , , , , , , ,-0.72, ,0.72, ,,cytoplasm,,,,,,,,,,,,,,
10572,Q8N1G0,ZNF687,Zinc finger protein 687,LKLSPATPTSEGP,_LSPAT(ph)PTSEGPK_,T377,+,26.55,24.47,24.78,24.25,23.08,,,22.81,23.77,24.21,,,,24.24,2.31,0.23,0.54,0.01,-1.16, , ,-1.43,-0.47,-0.03, , , ,"transcription, DNA-dependent;regulation of transcription, DNA-dependent",nucleolus,C2H2-type,,,,,,,,,,,,,
10574,Q8N1I0,DOCK4,Dedicator of cytokinesis protein 4,VRKESKTPPPYSV,_ESKT(ph)PPPYSVYER_,T768,,,,,,23.15,,23.78,23.55,,,,,,23.49, , , , ,-0.34, ,0.29,0.06, , , , , ,small GTPase mediated signal transduction;cell chemotaxis,cytosol;endomembrane system;stereocilium;membrane,,,,,,,,,,,,,,
10579,Q8N357,SLC35F6,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),LLGGTRTPINDAS,_LLGGTRT(ph)PINDAS_,T218,+,25.66,25.87,26.33,26.06,26.60,27.32,,25.87,24.81,26.18,26.50,,26.36,26.14,-0.48,-0.28,0.18,-0.08,0.46,1.17, ,-0.27,-1.33,0.04,0.36, ,0.22,,integral to membrane;Golgi apparatus;nucleus;lysosomal membrane,,,,,,,,,,,,,,
10582,Q8N3X1,FNBP4,Formin-binding protein 4 (Formin-binding protein 30),SKTGRDTPENGET,_TGRDT(ph)PENGETAIGAENSEK_,T479,+,24.55,26.05,26.14,25.71,,,26.52,,25.83,26.46,,25.78,,25.88,-1.33,0.17,0.26,-0.17, , ,0.64, ,-0.05,0.58, ,-0.10, ,,nucleus,,,,,,,,,,,,,,
10585,Q8N5Y2,MSL3,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),SSPIPLTPSKEGS,_SSS(ph)PIPLT(ph)PSK_,T346,,24.24,,,20.97,,,,,,,,,,22.61,1.63, , ,-1.63, , , , , , , , , ,multicellular organismal development;histone H4-K16 acetylation;transcription from RNA polymerase II promoter,MSL complex,Other TF domain,,,,,,,,,,,,,
10587,Q8N699,MYCT1,Myc target protein 1 (Myc target in myeloid cells protein 1),LRVGLSTPPPPAY,_VGLST(ph)PPPPAYESIIK_,T171,,,,,,,23.15,,,25.45,,24.00,,,24.20, , , , , ,-1.05, , ,1.25, ,-0.20, , ,,nucleus,,,,,,,,,,,,,,
10591,Q8NBJ4,GOLM1,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),QVEKEETNEIQVV,_(gl)QVEKEET(ph)NEIQVVNEEPQRDR_,T245,+,23.16,25.46,25.36,25.23,,25.36,22.55,25.38,24.22,24.52,26.03,23.03,,24.57,-1.41,0.88,0.79,0.66, ,0.79,-2.02,0.81,-0.35,-0.05,1.46,-1.55, ,,Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
10597,Q8ND56,LSM14A,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),PLRKSPTMEQAVQ,_SPT(ph)M(ox)EQAVQTASAHLPAPAAVGR_,T194,,25.30,24.24,24.24,24.74,,,25.14,,,,,25.08,,24.79,0.51,-0.55,-0.55,-0.05, , ,0.35, , , , ,0.29, ,multicellular organismal development;regulation of translation;cytoplasmic mRNA processing body assembly,intracellular membrane-bounded organelle;cytoplasmic stress granule;cytoplasmic mRNA processing body,,,,,,,,,,,,,,
10598,Q8NDX5,PHC3,Polyhomeotic-like protein 3 (Early development regulatory protein 3) (Homolog of polyhomeotic 3) (hPH3),CVRMDRTPPPPTL,_M(ox)DRT(ph)PPPPTLSPAAITVGR_,T568,+,25.57,21.34,21.91,22.04,23.82,24.65,,24.41,,,23.19,,24.08,23.45,2.12,-2.11,-1.54,-1.40,0.37,1.20, ,0.97, , ,-0.25, ,0.63,multicellular organismal development,actin cytoskeleton;PRC1 complex,,,,,,,,,,,,,,
10599,Q8NE71,ABCF1,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),KKLSVPTSDEEDE,_KLS(ph)VPT(ph)S(ph)DEEDEVPAPKPR_,T108,+,28.68,22.82,,,26.31,,23.80,28.84,22.17,24.09,,,,25.24,3.44,-2.42, , ,1.06, ,-1.44,3.59,-3.07,-1.16, , , ,inflammatory response;translational initiation;ATP catabolic process,nucleoplasm;nuclear envelope;ribosome;polysomal ribosome,,,,,,,,,,,,,,
10602,Q8NF91,SYNE1,Nesprin-1 (Enaptin) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),NIIRSKTPTGPEL,_SKT(ph)PTGPELDTSYK_,T7970,+,,23.26,22.20,24.69,23.32,25.31,25.49,,25.63,,25.72,26.20,24.87,24.67, ,-1.41,-2.47,0.03,-1.35,0.64,0.82, ,0.96, ,1.05,1.53,0.20,nuclear matrix anchoring at nuclear membrane;cell death;Golgi organization;muscle cell differentiation;cytoskeletal anchoring at nuclear membrane,Golgi apparatus;nuclear membrane;integral to membrane;SUN-KASH complex;cytoskeleton;sarcomere;postsynaptic membrane;nuclear outer membrane,,,,,,,,,,,,,,
10604,Q8NFH5,NUP35,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),PIKTLGTPTQPGS,_TLGT(ph)PTQPGSTPR_,T256,,22.56,24.81,24.81,22.84,,,,,24.58,25.21,,,,24.14,-1.58,0.67,0.67,-1.29, , , , ,0.45,1.07, , , ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear membrane;intermediate filament cytoskeleton;plasma membrane;nuclear pore,,,,,,,,,,,,,,
10605,Q8NG27,PJA1,E3 ubiquitin-protein ligase Praja-1 (Praja1) (EC 6.3.2.-) (RING finger protein 70),PKIFFDTDDDDDM,_IFFDT(ph)DDDDDM(ox)PHSTSR_,T73,,,,,,24.55,,,,22.67,,,22.18,,23.13, , , , ,1.42, , , ,-0.46, , ,-0.95, ,protein catabolic process,cytoplasm,,,,,,,,,,,,,,
10610,Q8TBE7,SLC35G2,Solute carrier family 35 member G2 (Transmembrane protein 22),____MDTSPSRKY,_(ac)M(ox)DT(ph)SPSRKYPVK_,T3,,,25.67,25.67,,,24.52,24.62,24.79,24.30,23.03,23.48,24.60,23.62,24.43, ,1.24,1.24, , ,0.09,0.19,0.36,-0.13,-1.40,-0.95,0.17,-0.81,,integral to membrane;Golgi apparatus,,,,,,,,,,,,,,
10612,Q8TD19,NEK9,Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8),KRPRSSTVTEAPI,_SST(ph)VTEAPIAVVTSR_,T333,,,22.04,,23.00,23.53,23.00,,,,,22.97,,,22.91, ,-0.87, ,0.10,0.62,0.09, , , , ,0.06, , ,mitosis;cell division,mitochondrion;nucleus,,+,,,,,,,,,,,,
10615,Q8TE68,EPS8L1,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),RSPAAETPPLQRR,_SPAAET(ph)PPLQR_,T123,+,27.58,23.52,,21.35,,,,22.32,24.36,24.30,,,22.94,23.77,3.81,-0.25, ,-2.42, , , ,-1.44,0.59,0.54, , ,-0.82,,cytoplasm,,,,,,,,,,,,,,
10616,Q8TE68,EPS8L1,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),ARSLNSTPPPPPA,_SLNST(ph)PPPPPAPAPAPPPALARPR_,T489,,23.68,,,,,,,23.06,,,,,,23.37,0.31, , , , , , ,-0.31, , , , , ,,cytoplasm,,,,,,,,,,,,,,
10617,Q8TEM1,NUP210,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),AVPAALTPRASPG,_DLAVPAALT(ph)PR_,T1844,+,25.13,23.12,23.27,22.10,25.18,25.38,24.52,25.08,23.28,25.25,22.90,22.98,23.96,24.01,1.12,-0.90,-0.74,-1.91,1.17,1.37,0.51,1.07,-0.73,1.24,-1.11,-1.04,-0.05,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,nuclear membrane;nuclear envelope;endoplasmic reticulum membrane;nuclear pore,,,,,,,,,,,,,,
10618,Q8TEW0,PARD3,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),DEDIVLTPDGTRE,_AEDEDIVLT(ph)PDGTR_,T579,,22.62,,,,,,,,,,,,,22.62,0.00, , , , , , , , , , , , ,"protein targeting to membrane;wound healing, spreading of cells;protein kinase C-activating G-protein coupled receptor signaling pathway;protein complex assembly;apical constriction;centrosome localization;transforming growth factor beta receptor signaling pathway;regulation of actin filament-based process;establishment of epithelial cell polarity;axonogenesis;asymmetric cell division;cell cycle;microtubule cytoskeleton organization;tight junction assembly",endomembrane system;apical part of cell;cell-cell adherens junction;protein complex;tight junction;cell cortex;cytosol;plasma membrane;spindle,,,,,,,,,,+,,,,
10619,Q8WUF5,PPP1R13L,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),DNLTSATLPRNYK,_DNLTSAT(ph)LPR_,T308,,21.81,,,,,21.48,21.71,,22.14,,,22.21,22.07,21.90,-0.09, , , , ,-0.42,-0.19, ,0.24, , ,0.30,0.17,"post-embryonic development;hair cycle;cardiac right ventricle morphogenesis;cardiac muscle contraction;embryonic camera-type eye development;multicellular organism growth;negative regulation of transcription from RNA polymerase II promoter;apoptotic process;ventricular cardiac muscle tissue development;transcription, DNA-dependent;multicellular organismal homeostasis",nucleus;cytoplasm,,,,,,,,,,,,,,
10621,Q8WVC0,LEO1,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),DEKMQNTDDEERP,_M(ox)QNT(ph)DDEERPQLS(ph)DDERQQLS(ph)EEEK_,T188,,25.71,24.01,24.01,,,,,,,,,,,24.58,1.13,-0.57,-0.57, , , , , , , , , , ,"negative regulation of myeloid cell differentiation;stem cell maintenance;histone H2B ubiquitination;positive regulation of transcription elongation from RNA polymerase II promoter;histone monoubiquitination;endodermal cell fate commitment;mRNA polyadenylation;Wnt receptor signaling pathway;transcription, DNA-dependent;positive regulation of mRNA 3'-end processing;positive regulation of transcription from RNA polymerase II promoter",nucleolus;Cdc73/Paf1 complex,,,,,,,,,,,,,,
10623,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),RISINQTPGKSLD,_ISINQT(ph)PGK_,T613,+,23.82,24.12,24.59,24.97,22.96,,23.40,23.34,,,,,,23.89,-0.06,0.23,0.71,1.09,-0.93, ,-0.48,-0.55, , , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
10624,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),PNNVVSTPAPSPD,_RTPNNVVST(ph)PAPS(ph)PDASQLASSLSSQK_,T521,,24.30,,,,,,,,,,,,,24.30,0.00, , , , , , , , , , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
10627,Q8WWI1,LMO7,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),DRRKSYTSDLQKK,_SYT(ph)SDLQK_,T318,,26.66,24.49,24.79,25.16,,,,,,,,,,25.27,1.38,-0.79,-0.49,-0.11, , , , , , , , , ,,ubiquitin ligase complex;nucleus;cytoplasm,,,,,,,,,,,,,,
10631,Q8WXI9,GATAD2B,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),PERGRLTPSPDII,_GRLT(ph)PS(ph)PDIIVLS(ph)DNEASSPR_,T120,,25.56,,,,21.15,23.13,,,,,,,,23.28,2.28, , , ,-2.13,-0.15, , , , , , , ,"transcription, DNA-dependent",nucleus,,,,,,,,,,,,,,
10632,Q92503,SEC14L1,SEC14-like protein 1,PEPVVGTPDDKLD,_EGLSGDALSSPSAPEPVVGT(ph)PDDKLDADYIK_,T234,,,,,,,,22.56,,,25.16,,25.01,,24.24, , , , , , ,-1.69, , ,0.92, ,0.77, ,transport,integral to membrane;Golgi apparatus;membrane,,,,,,,,,,,,,,
10633,Q92508,PIEZO1,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),QDAVSGTPLLREE,_QDAVSGT(ph)PLLR_,T734,,20.93,,,20.90,21.75,22.23,22.26,22.26,22.46,,23.65,,,22.06,-1.12, , ,-1.15,-0.30,0.17,0.20,0.21,0.40, ,1.60, , ,regulation of membrane potential;detection of mechanical stimulus;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin,integral to membrane;endoplasmic reticulum;plasma membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;endoplasmic reticulum membrane,,,,,,,,,,,,,,
10637,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),RLMRSRTASGSSV,_S(ph)RT(ph)AS(ph)GSSVTSLDGTR_,T290,+,31.16,27.39,26.56,26.79,,,,,,23.35,22.05,21.93,,25.60,5.55,1.79,0.95,1.18, , , , , ,-2.25,-3.55,-3.67, ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
10639,Q92597,NDRG1,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),VTSLDGTRSRSHT,_TASGSSVTSLDGT(ph)R_,T302,,24.32,22.47,21.49,21.23,,,,,,,,,,22.38,1.94,0.09,-0.89,-1.15, , , , , , , , , ,"cellular response to hypoxia;mast cell activation;positive regulation of spindle checkpoint;peripheral nervous system myelin maintenance;response to metal ion;DNA damage response, signal transduction by p53 class mediator",centrosome;cell-cell adherens junction;perinuclear region of cytoplasm;cytosol;microtubule;nucleus;plasma membrane;recycling endosome membrane,,,,,,,,,,,,,,
10643,Q92615,LARP4B,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),SQTQSPTPPKPPS,_FTSSQTQSPT(ph)PPKPPS(ph)PSFELGLSSFPPLPGAAGNLK_,T518,,25.19,,,,,,,,,,,,,25.19,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
10644,Q92667,AKAP1,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",PRDKAITPPLPES,_AIT(ph)PPLPESTVPFSNGVLK_,T533,,23.13,,,,,,,,,,,,,23.13,0.00, , , , , , , , , , , , ,blood coagulation;negative regulation of cardiac muscle hypertrophy;cellular response to insulin stimulus;negative regulation of NFAT protein import into nucleus;negative regulation of protein dephosphorylation,mitochondrion;mitochondrial crista;cytosol;mitochondrial outer membrane;neuromuscular junction;integral to membrane;lipid particle;postsynaptic membrane;mitochondrial matrix,,,,,,,,,,,,,,
10645,Q92692,PVRL2,Poliovirus receptor-related protein 2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin-2) (CD antigen CD112),PSYKPPTPKAKLE,_EQTLQGAEEDEDLEGPPSYKPPT(ph)PK_,T410,,21.10,,,,,25.77,26.40,,,24.88,,25.12,,24.65,-3.56, , , , ,1.12,1.74, , ,0.23, ,0.46, ,"spermatid development;acrosome assembly;cell part morphogenesis;viral entry into host cell via membrane fusion with the plasma membrane;spermatid nucleus differentiation;establishment of mitochondrion localization;susceptibility to natural killer cell mediated cytotoxicity;adherens junction organization;homophilic cell adhesion;flagellum organization;cytoskeleton organization;positive regulation of mast cell activation;virion attachment, binding of host cell surface coreceptor;susceptibility to T cell mediated cytotoxicity;fertilization;sperm mitochondrion organization;positive regulation of immunoglobulin mediated immune response;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;adhesion to symbiont;cell junction assembly",zonula adherens;integral to membrane;plasma membrane;cell surface,,,,,,,,,,,,,,
10646,Q92692,PVRL2,Poliovirus receptor-related protein 2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin-2) (CD antigen CD112),RYHELPTLEERSG,_YHELPT(ph)LEER_,T459,+,,,,,23.55,23.25,22.17,22.37,22.61,22.35,22.62,,,22.70, , , , ,0.85,0.55,-0.53,-0.33,-0.10,-0.35,-0.08, , ,"spermatid development;acrosome assembly;cell part morphogenesis;viral entry into host cell via membrane fusion with the plasma membrane;spermatid nucleus differentiation;establishment of mitochondrion localization;susceptibility to natural killer cell mediated cytotoxicity;adherens junction organization;homophilic cell adhesion;flagellum organization;cytoskeleton organization;positive regulation of mast cell activation;virion attachment, binding of host cell surface coreceptor;susceptibility to T cell mediated cytotoxicity;fertilization;sperm mitochondrion organization;positive regulation of immunoglobulin mediated immune response;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;adhesion to symbiont;cell junction assembly",zonula adherens;integral to membrane;plasma membrane;cell surface,,,,,,,,,,,,,,
10649,Q92878,RAD50,DNA repair protein RAD50 (hRAD50) (EC 3.6.-.-),CQRVFQTEAELQE,_VFQT(ph)EAELQEVISDLQSK_,T690,,25.15,16.80,,16.80,24.45,,,,,24.74,,,,21.59,3.57,-4.79, ,-4.79,2.86, , , , ,3.15, , , ,positive regulation of protein autophosphorylation;telomere maintenance via telomerase;positive regulation of kinase activity;DNA duplex unwinding;nucleic acid phosphodiester bond hydrolysis;regulation of mitotic recombination;reciprocal meiotic recombination;double-strand break repair via homologous recombination,"nucleoplasm;nuclear chromosome, telomeric region;pronucleus;Mre11 complex",,,,,,,,,,,,,,
10651,Q92974,ARHGEF2,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),GVELLLTPREPAL,_DLLVGPGVELLLT(ph)PR_,T651,,25.27,,,,,,,,,,,,,25.27,0.00, , , , , , , , , , , , ,negative regulation of neurogenesis;cell morphogenesis;establishment of mitotic spindle orientation;small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of NF-kappaB transcription factor activity;regulation of cell proliferation;intracellular protein transport;mitosis;actin filament organization;nerve growth factor receptor signaling pathway;apoptotic process;negative regulation of microtubule depolymerization;cell division,neuronal cell body;Golgi apparatus;cytosol;ruffle membrane;tight junction;microtubule;dendritic shaft;spindle,,,,,,,,,,,,,,
10658,Q969E2,SCAMP4,Secretory carrier-associated membrane protein 4 (Secretory carrier membrane protein 4),TEWNTGTWRNPPS,_AQTEWNTGT(ph)WR_,T160,,,,,22.41,,,,,,,,24.88,,23.64, , , ,-1.24, , , , , , , ,1.24, ,protein transport,integral to membrane;transport vesicle,,,,,,,,,,,,,,
10659,Q969V6,MKL1,MKL/myocardin-like protein 1 (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein) (Myocardin-related transcription factor A) (MRTF-A),FGSTGSTPPVSPT,_FGSTGST(ph)PPVS(ph)PTPSER_,T450,,24.18,,,23.47,,22.72,,22.63,,,23.75,23.81,,23.43,0.75, , ,0.05, ,-0.70, ,-0.80, , ,0.32,0.38, ,"smooth muscle cell differentiation;transcription, DNA-dependent;positive regulation of transcription from RNA polymerase II promoter",nucleus;cytoplasm,SAP-domain,,,,,,,,,,,,,
10667,Q96CX2,KCTD12,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),AAGPLLTPSQSLD,_SPSGGAAGPLLT(ph)PS(ph)QSLDGSRR_,T196,,26.90,,,,,,,,,,,,,26.90,0.00, , , , , , , , , , , , ,regulation of G-protein coupled receptor protein signaling pathway;protein homooligomerization,cell junction;receptor complex;plasma membrane;presynaptic membrane;postsynaptic membrane,,,,,,,,,,,,,,
10668,Q96D46,NMD3,60S ribosomal export protein NMD3 (hNMD3),IPVESDTDDEGAP,_DSAIPVES(ph)DT(ph)DDEGAPR_,T470,+,27.29,,,22.64,24.54,,23.13,,22.40,,23.18,23.56,,23.82,3.47, , ,-1.18,0.72, ,-0.69, ,-1.42, ,-0.64,-0.26, ,protein transport,nucleoplasm;nucleolus;cytoplasm,,,,,,,,,,,,,,
10669,Q96DU7,ITPKC,"Inositol-trisphosphate 3-kinase C (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase C) (IP3 3-kinase C) (IP3K C) (InsP 3-kinase C)",LIITPETPEPEAQ,_LIITPET(ph)PEPEAQPVGPPSR_,T336,,24.42,,,,,,,,,,,,,24.42,0.00, , , , , , , , , , , , ,,nucleus;cytoplasm,,,,,,,,,,,,,,
10670,Q96G23,CERS2,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),RSDREETESSEGE,_LVEDERS(ph)DREET(ph)ES(ph)S(ph)EGEEAAAGGGAK_,T346,,25.61,,,,,,,,,,,,,25.61,0.00, , , , , , , , , , , , ,phospholipid metabolic process;small molecule metabolic process;ceramide biosynthetic process;sphingolipid biosynthetic process,nuclear membrane;integral to membrane;endoplasmic reticulum membrane,Homeobox,,,,,,,,,,,,,
10675,Q96I25,RBM17,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),DRQIVDTPPHVAA,_(gl)QIVDT(ph)PPHVAAGLK_,T71,+,23.66,22.75,,23.29,,,22.82,,23.30,22.35,,23.11,22.03,22.91,0.75,-0.16, ,0.38, , ,-0.10, ,0.38,-0.56, ,0.20,-0.88,mRNA processing;RNA splicing,nucleus;spliceosomal complex,,,,,,,,,,+,,,,
10676,Q96IG2,FBXL20,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),AYFAPVTPPPSVG,_VHAYFAPVT(ph)PPPSVGGS(ph)R_,T385,,22.85,,,,,24.54,,,24.26,,23.89,,23.52,23.81,-0.96, , , , ,0.73, , ,0.45, ,0.07, ,-0.29,,cytoplasm,,,,,,,,,,,,,,
10681,Q96MW1,CCDC43,Coiled-coil domain-containing protein 43,AQYADVTDEEDEA,_AALLAQYADVT(ph)DEEDEADEK_,T139,,26.80,,,,24.94,23.76,,,,25.31,,27.05,,25.57,1.23, , , ,-0.64,-1.81, , , ,-0.26, ,1.48, ,,,,,,,,,,,,,,,,
10685,Q96PK6,RBM14,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),GQARQPTPPFFGR,_QPT(ph)PPFFGRDR_,T206,+,30.12,27.58,26.74,28.09,29.33,29.02,28.17,28.42,28.44,27.17,29.03,27.52,28.90,28.35,1.77,-0.77,-1.61,-0.26,0.99,0.68,-0.18,0.07,0.09,-1.18,0.68,-0.83,0.55,intracellular estrogen receptor signaling pathway;histone deacetylation;DNA repair;glucocorticoid receptor signaling pathway;response to hormone stimulus;DNA recombination;DNA replication;positive regulation of transcription from RNA polymerase II promoter,transcription factor complex;ribonucleoprotein complex;mediator complex,,,,,,,,,,,,,,
10686,Q96PZ0,PUS7,Pseudouridylate synthase 7 homolog (EC 5.4.99.-),DNLEGKTPPVFAS,_IPLFNTDVDNLEGKT(ph)PPVFASEGK_,T610,,21.89,,,,,,,,,,,,,21.89,0.00, , , , , , , , , , , , ,tRNA processing;pseudouridine synthesis,,,,,,,,,,,,,,,
10688,Q96Q15,SMG1,Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein),LATSADTPPSTVP,_NLATS(ph)ADT(ph)PPSTVPGTGK_,T2943,,23.48,,,,,,,,,,,,,23.48,0.00, , , , , , , , , , , , ,"protein autophosphorylation;phosphatidylinositol phosphorylation;peptidyl-serine phosphorylation;response to stress;DNA repair;mRNA export from nucleus;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;gene expression",cytosol;nucleus,,,,,,,,,,,,,,
10691,Q96QT6,PHF12,PHD finger protein 12 (PHD factor 1) (Pf1),NATRVLTPPQAAG,_VLT(ph)PPQAAGDGILATTANQR_,T653,,22.26,,,,,,,,,,,,,22.26,0.00, , , , , , , , , , , , ,,Sin3 complex;transcriptional repressor complex,,,,,,,,,,,,,,
10692,Q96QU8,XPO6,Exportin-6 (Exp6) (Ran-binding protein 20),HSVTAATPPPSPT,_HSVTAAT(ph)PPPS(ph)PTSGESGDLLSNLLQSPSSAK_,T190,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,protein export from nucleus,nucleolus;plasma membrane;nuclear pore;cytoplasm,,,,,,,,,,,,,,
10694,Q96RN5,MED15,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein),NDMAVPTPPPPPV,_NDM(ox)AVPT(ph)PPPPPVPPTK_,T492,+,,23.42,23.00,22.11,,,24.09,,24.20,24.58,23.36,22.56,,23.41, ,0.01,-0.42,-1.31, , ,0.67, ,0.79,1.17,-0.05,-0.85, ,transcription initiation from RNA polymerase II promoter,nucleoplasm;mediator complex;Golgi apparatus,,,,,,,,,,,,,,
10696,Q96S44,TP53RK,TP53-regulating kinase (EC 2.7.11.1) (Nori-2) (p53-related protein kinase),AAARATTPADGEE,_ATT(ph)PADGEEPAPEAEALAAAR_,T8,+,26.23,24.20,23.84,22.83,24.19,24.82,23.75,22.06,,,,,22.95,23.87,2.36,0.33,-0.04,-1.05,0.32,0.95,-0.13,-1.82, , , , ,-0.93,lipopolysaccharide biosynthetic process,nucleus;membrane,,+,,,,,,,,,,,,
10697,Q96S55,WRNIP1,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),SYDAPPTPSGARL,_ESYDAPPT(ph)PSGAR_,T116,,25.59,,,,,,,,,,,,,25.59,0.00, , , , , , , , , , , , ,regulation of DNA-dependent DNA replication initiation;DNA synthesis involved in DNA repair;DNA replication,mitochondrion;nucleus;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10704,Q96ST3,SIN3A,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),PPVQPHTPVTISL,_S(ph)PPVQPHT(ph)PVTISLGTAPSLQNNQPVEFNHAINYVNK_,T284,,23.58,,,,,,,,,,,,,23.58,0.00, , , , , , , , , , , , ,negative regulation of apoptotic process;aging;response to organic nitrogen;blood coagulation;interphase of mitotic cell cycle;cellular response to glucose stimulus;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;negative regulation of protein localization to nucleus;negative regulation of histone H3-K27 acetylation;negative regulation of transcription regulatory region DNA binding;positive regulation of transcription from RNA polymerase II promoter;small molecule metabolic process;cellular lipid metabolic process;cellular protein localization;in utero embryonic development;response to methylglyoxal;negative regulation of transcription from RNA polymerase II promoter;positive regulation of defense response to virus by host;DNA replication;activation of innate immune response;positive regulation of chromatin silencing,transcription factor complex;nucleolus;Sin3 complex;transcriptional repressor complex;kinetochore,,,,,,,,,,,,,,
10706,Q96T37,RBM15,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),RGARDRTPPLLYR,_DRT(ph)PPLLYRDR_,T568,+,26.66,26.30,26.21,26.24,27.61,27.36,26.71,26.84,26.52,25.35,26.60,26.52,26.50,26.57,0.09,-0.27,-0.36,-0.33,1.04,0.79,0.14,0.27,-0.05,-1.22,0.03,-0.06,-0.08,negative regulation of myeloid cell differentiation;ventricular septum morphogenesis;spleen development;placenta blood vessel development;patterning of blood vessels;positive regulation of transcription of Notch receptor target;virus-host interaction,nucleus,,,,,,,,,,,,,,
10707,Q96T60,PNKP,Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase);Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)],PESQPDTPPGTPL,_TPESQPDT(ph)PPGTPLVSQDEK_,T79,+,25.60,21.89,21.21,21.49,25.19,23.64,,24.12,22.21,,,,,23.17,2.43,-1.28,-1.96,-1.68,2.02,0.47, ,0.95,-0.96, , , , ,"response to oxidative stress;nucleotide-excision repair, DNA damage removal;DNA damage response, detection of DNA damage;response to radiation;DNA-dependent DNA replication",nucleolus,,,+,,,,,,,,,,,
10708,Q99442,SEC62,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),EELEQQTDGDCEE,_EELEQQT(ph)DGDCEEDEEEENDGETPK_,T375,,25.46,23.68,,24.60,,,24.12,,25.29,25.72,,,,24.81,0.65,-1.14, ,-0.21, , ,-0.69, ,0.48,0.90, , , ,cotranslational protein targeting to membrane,rough endoplasmic reticulum;intermediate filament cytoskeleton;integral to membrane;aggresome;endoplasmic reticulum membrane,,,,,,,,,,,,,,
10710,Q99459,CDC5L,Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein),LKGGLNTPLHESD,_GGLNT(ph)PLHESDFSGVTPQR_,T385,,22.42,,,23.23,,22.63,22.88,,24.66,,,,,23.16,-0.74, , ,0.06, ,-0.53,-0.28, ,1.50, , , , ,"mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent;cell cycle",nucleolus;nuclear speck;Prp19 complex;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
10711,Q99459,CDC5L,Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein),SDFSGVTPQRQVV,_GGLNT(ph)PLHESDFSGVT(ph)PQR_,T396,,,,,23.23,,,,,,,,,,23.23, , , ,0.00, , , , , , , , , ,"mRNA splicing, via spliceosome;transcription, DNA-dependent;regulation of transcription, DNA-dependent;cell cycle",nucleolus;nuclear speck;Prp19 complex;catalytic step 2 spliceosome;cytoplasm,Other TF domain,,,,,,,,,,,,,
10712,Q99460,PSMD1,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),SAFVGKTPEASPE,_TSSAFVGKT(ph)PEAS(ph)PEPK_,T311,+,25.37,25.75,25.35,25.36,23.15,,24.46,22.97,25.23,24.91,,23.38,,24.59,0.78,1.16,0.76,0.77,-1.44, ,-0.13,-1.62,0.63,0.32, ,-1.22, ,"regulation of protein catabolic process;S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome regulatory particle,,,,,,,,,,,,,,
10713,Q99460,PSMD1,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),NLRTVGTPIASVP,_TVGT(ph)PIASVPGSTNTGTVPGSEK_,T273,+,26.01,25.75,25.66,25.83,26.86,27.10,27.37,27.34,26.65,27.17,27.37,26.13,26.44,26.59,-0.58,-0.84,-0.93,-0.76,0.27,0.51,0.78,0.75,0.05,0.58,0.78,-0.46,-0.16,"regulation of protein catabolic process;S phase of mitotic cell cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;mRNA metabolic process;regulation of cellular amino acid metabolic process;viral reproduction;apoptotic process;gene expression;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;small molecule metabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;M/G1 transition of mitotic cell cycle;regulation of apoptotic process;protein polyubiquitination",nucleoplasm;cytosol;proteasome regulatory particle,,,,,,,,,,,,,,
10714,Q99567,NUP88,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),LRVLAETPDSFEK,_VLAET(ph)PDSFEK_,T525,+,22.80,23.53,,23.89,24.73,24.47,25.09,23.66,23.54,,,23.31,,23.89,-1.09,-0.36, ,-0.01,0.84,0.58,1.20,-0.23,-0.35, , ,-0.58, ,glucose transport;small molecule metabolic process;carbohydrate metabolic process;transmembrane transport;mRNA transport;regulation of glucose transport;protein transport;viral reproduction;cytokine-mediated signaling pathway,cytosol;nuclear pore,,,,,,,,,,,,,,
10718,Q99650,OSMR,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),GTRKSLTETELTK,_SLT(ph)ETELTK_,T828,,24.01,22.70,20.49,24.98,,,22.99,,,21.58,,24.34,,23.01,1.00,-0.31,-2.53,1.97, , ,-0.02, , ,-1.44, ,1.32, ,cell proliferation;positive regulation of cell proliferation;positive regulation of acute inflammatory response,oncostatin-M receptor complex,,,,,,,,,,,,,,
10719,Q99653,CHP1,Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22),MGSRASTLLRDEE,_AST(ph)LLRDEELEEIKK_,T7,,,,,,,24.76,24.40,23.20,24.56,24.44,26.54,26.26,26.53,25.09, , , , , ,-0.32,-0.68,-1.89,-0.52,-0.65,1.46,1.17,1.45,calcium ion-dependent exocytosis;negative regulation of NF-kappaB transcription factor activity;positive regulation of protein glycosylation;transcytosis;negative regulation of protein ubiquitination;membrane fusion;negative regulation of protein autophosphorylation;negative regulation of protein kinase activity;regulation of intracellular pH;negative regulation of protein import into nucleus;negative regulation of calcineurin-NFAT signaling cascade;positive regulation of protein targeting to membrane;protein stabilization;protein export from nucleus;potassium ion transport;cellular response to acidity;small GTPase mediated signal transduction;microtubule bundle formation;positive regulation of sodium:hydrogen antiporter activity;membrane docking;cytoplasmic microtubule organization;negative regulation of phosphatase activity,endoplasmic reticulum-Golgi intermediate compartment;transport vesicle;endoplasmic reticulum;Golgi membrane;cytosol;microtubule cytoskeleton;nucleus;plasma membrane,,,,,,,,,,,,,,
10720,Q99700,ATXN2,Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein),ASNRAVTPSSEAK,_AVT(ph)PSSEAK_,T662,+,23.03,,,,23.77,,,20.26,,19.09,21.26,22.30,21.57,21.61,1.42, , , ,2.16, , ,-1.35, ,-2.52,-0.35,0.68,-0.04,neuromuscular process;cerebellar Purkinje cell differentiation;RNA metabolic process;homeostasis of number of cells;negative regulation of multicellular organism growth;cell death;negative regulation of receptor internalization;RNA transport;neuron projection morphogenesis;stress granule assembly;regulation of translation;cytoplasmic mRNA processing body assembly,trans-Golgi network;Golgi apparatus;nucleus;polysome;cytoplasmic stress granule;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10723,Q99708,RBBP8,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),SDSTSKTPPQEEL,_T(ph)PPQEELPT(ph)RVSSPVFGATSSIK_,T315,,22.46,,,,,,,,,,,,,22.46,0.00, , , , , , , , , , , , ,blastocyst hatching;G2/M transition DNA damage checkpoint;G1/S transition of mitotic cell cycle;meiosis;mitosis;DNA double-strand break processing involved in repair via single-strand annealing;cell division;double-strand break repair via homologous recombination,transcriptional repressor complex,,,,,,,,,,,,,,
10724,Q99708,RBBP8,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),PQEELPTRVSSPV,_T(ph)PPQEELPT(ph)RVSSPVFGATSSIK_,T323,,22.46,,,,,,,,,,,,,22.46,0.00, , , , , , , , , , , , ,blastocyst hatching;G2/M transition DNA damage checkpoint;G1/S transition of mitotic cell cycle;meiosis;mitosis;DNA double-strand break processing involved in repair via single-strand annealing;cell division;double-strand break repair via homologous recombination,transcriptional repressor complex,,,,,,,,,,,,,,
10725,Q99733,NAP1L4,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),LDNVPHTPSSYIE,_LDNVPHT(ph)PSSYIETLPK_,T51,,21.87,,,,22.54,,22.85,23.55,21.61,,,,23.12,22.59,-0.72, , , ,-0.05, ,0.26,0.96,-0.98, , , ,0.53,nucleosome assembly,chromatin assembly complex;cytoplasm,,,,,,,,,,,,,,
10726,Q99816,TSG101,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),GPSRDGTISEDTI,_DGT(ph)ISEDTIR_,T220,+,23.60,24.16,23.35,24.44,23.04,23.49,21.73,23.09,23.31,21.81,,,,23.20,0.40,0.95,0.15,1.24,-0.16,0.29,-1.48,-0.11,0.11,-1.39, , , ,"negative regulation of cell proliferation;endosome to lysosome transport;egress of virus within host cell;regulation of cell growth;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;endosomal transport;negative regulation of transcription, DNA-dependent;protein monoubiquitination;cellular membrane organization;protein transport;cell cycle arrest;non-lytic virus budding;cell division;keratinocyte differentiation",endosome membrane;nucleolus;plasma membrane;late endosome membrane;multivesicular body;early endosome,,,,,,,,,,,,,,
10728,Q9BQA1,WDR77,Methylosome protein 50 (MEP-50) (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50),__MRKETPPPLVP,_KET(ph)PPPLVPPAAR_,T5,+,23.04,23.20,21.91,23.01,25.58,23.94,25.28,24.36,22.21,,23.32,,22.56,23.49,-0.45,-0.29,-1.59,-0.48,2.08,0.45,1.79,0.87,-1.28, ,-0.17, ,-0.93,ncRNA metabolic process;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;positive regulation of cell proliferation;negative regulation of epithelial cell proliferation involved in prostate gland development;regulation of transcription from RNA polymerase II promoter;spliceosomal snRNP assembly,cytosol;Golgi apparatus;nucleus,,,,,,,,,,,,,,
10730,Q9BRD0,BUD13,BUD13 homolog,RKDRHDTPDPSPR,_DRHDT(ph)PDPS(ph)PRR_,T147,,25.33,25.03,24.53,24.92,,,,23.53,18.87,,,,,23.70,1.63,1.32,0.83,1.22, , , ,-0.17,-4.83, , , , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
10731,Q9BRD0,BUD13,BUD13 homolog,RRARHDTPDPSPL,_HDT(ph)PDPS(ph)PLRGAR_,T159,,26.04,25.53,,25.08,,,,,,,,,,25.55,0.49,-0.02, ,-0.47, , , , , , , , , ,"mRNA export from nucleus;mRNA splicing, via spliceosome",RES complex,,,,,,,,,,,,,,
10732,Q9BRK5,SDF4,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),LKVDEETQEVLEN,_VDEET(ph)QEVLENLK_,T193,+,26.13,25.60,25.21,23.29,23.42,,,,23.30,25.37,23.90,25.67,,24.65,1.47,0.94,0.56,-1.36,-1.24, , , ,-1.36,0.72,-0.75,1.02, ,cerebellum development;UV protection;fat cell differentiation;zymogen granule exocytosis;response to ethanol,late endosome;plasma membrane;Golgi lumen;bleb,,,,,,,,,,,,,,
10733,Q9BRQ0,PYGO2,Pygopus homolog 2,SGRGGGTPDANSL,_GGGT(ph)PDANSLAPPGK_,T265,+,27.41,26.81,24.94,26.14,26.18,27.21,25.68,26.38,25.94,23.84,25.07,24.86,,25.87,1.54,0.94,-0.93,0.27,0.30,1.34,-0.19,0.51,0.06,-2.03,-0.80,-1.01, ,post-embryonic development;kidney development;in utero embryonic development;regulation of histone H3-K4 methylation;developmental growth;canonical Wnt receptor signaling pathway;brain development;mammary gland development;palate development;lens development in camera-type eye;regulation of mammary gland epithelial cell proliferation,nucleus,,,,,,,,,,,,,,
10734,Q9BTK6,PAGR1,PAXIP1-associated glutamate-rich protein 1 (PAXIP1-associated protein 1) (PTIP-associated protein 1),LPRRPPTPEAQSE,_RPPT(ph)PEAQS(ph)EEERS(ph)DEEPEAK_,T138,,24.57,,,,,,,,,,,,,24.57,0.00, , , , , , , , , , , , ,,histone methyltransferase complex,,,,,,,,,,,,,,
10735,Q9BU76,MMTAG2,Multiple myeloma tumor-associated protein 2 (hMMTAG2),EATSSPTSPERPR,_RPAEATSS(ph)PT(ph)SPERPR_,T219,+,23.62,23.10,,23.55,26.02,,19.57,21.06,20.40,,,,,22.48,1.15,0.63, ,1.08,3.54, ,-2.91,-1.41,-2.08, , , , ,,,,,,,,,,,,,,,,
10736,Q9BV40,VAMP8,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB),TEDLEATSEHFKT,_TEDLEAT(ph)SEHFK_,T54,+,23.69,24.49,25.20,21.76,,21.21,22.51,,,23.35,22.71,26.62,21.65,23.32,0.37,1.17,1.88,-1.56, ,-2.11,-0.80, , ,0.03,-0.61,3.30,-1.67,post-Golgi vesicle-mediated transport;cellular membrane organization;protein complex assembly;vesicle fusion,mitochondrion;late endosome membrane;lysosomal membrane;recycling endosome;early endosome;SNARE complex;secretory granule membrane;integral to membrane;plasma membrane,,,,,,,,,,,,,,
10739,Q9BVT8,TMUB1,Transmembrane and ubiquitin-like domain-containing protein 1 (Dendritic cell-derived ubiquitin-like protein) (DULP) (Hepatocyte odd protein shuttling protein) (Ubiquitin-like protein SB144),EAPGAETPSLRHR,_GEAPGAET(ph)PSLR_,T71,,24.04,,,,,,,,,,,,22.02,23.03,1.01, , , , , , , , , , , ,-1.01,,integral to membrane;nucleus;cytoplasm,,,,,,,,,,,,,,
10740,Q9BW04,SARG,Specifically androgen-regulated gene protein,RANSALTPPKPES,_ANSALT(ph)PPKPESGLTLQESNTPGLR_,T456,,22.82,,,,24.06,,25.26,25.53,,25.53,25.11,,,24.72,-1.90, , , ,-0.66, ,0.55,0.81, ,0.82,0.39, , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10742,Q9BXB4,OSBPL11,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),GQATAVTPNKNSS,_LEGQATAVT(ph)PNK_,T27,,22.65,24.08,24.08,23.65,,,,,,,,,,23.61,-0.96,0.46,0.46,0.04, , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
10743,Q9BXP5,SRRT,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),WASEPGTPPLPTS,_TQLWASEPGT(ph)PPLPTSLPSQNPILK_,T543,,28.40,,,26.65,26.11,,,,,,,,,27.05,1.35, , ,-0.41,-0.94, , , , , , , , ,"cell proliferation;neuronal stem cell maintenance;transcription, DNA-dependent;regulation of transcription, DNA-dependent;response to arsenic-containing substance;primary miRNA processing",nucleoplasm;cytoplasm,,,,,,,,,,,,,,
10745,Q9BYG3,MKI67IP,MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67) (hNIFK),VSGTLDTPEKTVD,_KVSGTLDT(ph)PEK_,T223,+,25.27,27.07,27.07,25.62,21.52,21.24,23.40,23.32,22.19,24.41,21.10,22.02,21.90,23.55,1.73,3.52,3.52,2.07,-2.03,-2.31,-0.15,-0.23,-1.35,0.86,-2.45,-1.53,-1.65,rRNA metabolic process;rRNA transcription;protein complex assembly;negative regulation of phosphatase activity,nucleoplasm;condensed nuclear chromosome;nucleolus;cytoplasm,,,,,,,,,,,,,,
10746,Q9BZC7,ABCA2,ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2),EPEDLDTEDEGLI,_ALVADEPEDLDT(ph)EDEGLISFEEER_,T2412,,23.00,,,,,,,,,,,,,23.00,0.00, , , , , , , , , , , , ,cholesterol homeostasis;response to steroid hormone stimulus;response to drug;regulation of transcription from RNA polymerase II promoter;regulation of intracellular cholesterol transport;lipid metabolic process,endosome;ATP-binding cassette (ABC) transporter complex;lysosomal membrane;microtubule organizing center;endosome membrane;integral to membrane;cytoplasmic membrane-bounded vesicle;lysosome,,,,,,,,,,,,,,
10747,Q9BZF1,OSBPL8,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),DESQLLTPGKMSQ,_DVLGPSTVVANSDESQLLT(ph)PGK_,T39,,22.18,,,,,,,,,,,,,22.18,0.00, , , , , , , , , , , , ,lipid transport,,,,,,,,,,,,,,,
10749,Q9BZI7,UPF3B,Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X),FLESYATDNEKMT,_FLESYAT(ph)DNEK_,T169,,20.00,,,22.35,21.73,22.55,23.17,22.68,,,,,,22.08,-2.08, , ,0.27,-0.35,0.47,1.10,0.60, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;positive regulation of translation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome",nucleoplasm;cytosol;exon-exon junction complex,,,,,,,,,,,,,,
10750,Q9BZL4,PPP1R12C,Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85),RQSRRSTQGVTLT,_RST(ph)QGVTLTDLK_,T516,,20.79,,,22.49,,,,,,,,25.46,,22.91,-2.12, , ,-0.42, , , , , , , ,2.54, ,,cytoplasm,,,,,,,,,,,,,,
10753,Q9C0C2,TNKS1BP1,182 kDa tankyrase-1-binding protein,EEPPPLTPPARCA,_EEPPPLT(ph)PPAR_,T131,+,26.95,25.14,25.13,24.66,,,26.01,21.80,25.76,25.90,26.10,25.39,23.49,25.12,1.83,0.02,0.01,-0.46, , ,0.89,-3.33,0.64,0.78,0.98,0.27,-1.63,telomere maintenance via telomerase;nuclear-transcribed mRNA poly(A) tail shortening,nuclear telomeric heterochromatin;cytosol;cytoskeleton,,,,,,,,,,,,,,
10757,Q9H0E3,SAP130,Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130),MMETNSTDDEKST,_QQHVISTEEGDM(ox)M(ox)ETNS(ph)T(ph)DDEK_,T421,,23.67,,,,,,,,,,,,,23.67,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;histone H3 acetylation;transcription, DNA-dependent",STAGA complex,,,,,,,,,,,,,,
10758,Q9H0E9,BRD8,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),MLGQKATPPPSPL,_AT(ph)PPPS(ph)PLLSELLK_,T19,,27.10,,,,,,,,,,,,,27.10,0.00, , , , , , , , , , , , ,histone H2A acetylation;histone H4 acetylation;regulation of growth;cell surface receptor signaling pathway,mitochondrion;NuA4 histone acetyltransferase complex,,,,,,,,,,,,,,
10759,Q9H0G5,NSRP1,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),REKVIETPENDFK,_VIET(ph)PENDFK_,T275,+,24.72,24.95,25.01,24.71,23.19,25.31,25.22,24.30,25.96,25.15,22.95,23.46,24.50,24.57,0.15,0.38,0.44,0.13,-1.38,0.74,0.65,-0.28,1.39,0.58,-1.62,-1.12,-0.07,"nucleocytoplasmic transport;mRNA processing;RNA splicing;developmental process;regulation of alternative mRNA splicing, via spliceosome",ribonucleoprotein complex;nuclear speck,,,,,,,,,,,,,,
10761,Q9H165,BCL11A,B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856),EHGSPLTPRSNLV,_IYLESEHGS(ph)PLT(ph)PR_,T56,,22.07,,,21.15,,,,,,,,,,21.61,0.46, , ,-0.46, , , , , , , , , ,"negative regulation of gene expression;regulation of dendrite development;regulation of transcription, DNA-dependent;T cell differentiation;negative regulation of axon extension;protein sumoylation;negative regulation of collateral sprouting;negative regulation of protein homooligomerization;B cell differentiation;positive regulation of neuron projection development;transcription, DNA-dependent;hemopoiesis;negative regulation of dendrite development;positive regulation of transcription from RNA polymerase II promoter;positive regulation of collateral sprouting",nuclear body;nucleus;cytoplasm,C2H2-type,,,,,,,,,,,,,
10762,Q9H1E3,NUCKS1,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),KASKEKTPSPKEE,_EKT(ph)PS(ph)PKEEDEEPES(ph)PPEK_,T202,+,29.17,28.14,23.35,27.27,23.23,24.70,24.07,24.35,25.85,24.25,22.12,,,25.14,4.04,3.00,-1.78,2.13,-1.91,-0.43,-1.07,-0.78,0.72,-0.89,-3.02, , ,,nucleus,,,,,,,,,,,,,,
10765,Q9H2H9,SLC38A1,Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),ESRRSLTNSHLEK,_S(ph)LT(ph)NSHLEK_,T54,,24.00,,,,,,,,,,,,,24.00,0.00, , , , , , , , , , , , ,neurotransmitter uptake,axon;integral to membrane;plasma membrane,,,,,,,,,,,,,,
10767,Q9H3P2,NELFA,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),AKRRRKTLDAEVV,_T(ph)LDAEVVEK_,T277,+,24.90,22.41,22.52,22.25,,21.52,,21.47,23.21,22.62,,,21.11,22.45,2.46,-0.04,0.07,-0.20, ,-0.93, ,-0.97,0.77,0.17, , ,-1.33,multicellular organismal development;negative regulation of transcription elongation from RNA polymerase II promoter;viral reproduction;transcription elongation from RNA polymerase II promoter;positive regulation of viral transcription,NELF complex,,,,,,,,,,,,,,
10771,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),RAPESDTGDEDQD,_APES(ph)DT(ph)GDEDQDQERDTVFLK_,T471,,25.31,,,,,,,,,,,,,25.31,0.00, , , , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
10772,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),EEGEVRTPTKIKE,_SEAEEGEVRT(ph)PTK_,T378,+,28.46,25.45,25.86,23.09,,,,20.49,21.76,,21.71,,,23.83,4.63,1.62,2.03,-0.74, , , ,-3.34,-2.07, ,-2.12, , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
10774,Q9H4G0,EPB41L1,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),GLSERTTPSKAQK,_DYSEADGLSERTT(ph)PSK_,T17,,24.01,25.84,25.84,,,,,,,,,,,25.23,-1.22,0.61,0.61, , , , , , , , , , ,cortical actin cytoskeleton organization;synaptic transmission,cytosol;plasma membrane;cytoskeleton;extrinsic to membrane,,,,,,,,,,+,,,,
10775,Q9H4Z3,PCIF1,Phosphorylated CTD-interacting factor 1,SPSIPGTPTLKMW,_IEIPVTPTGQSVPSS(ph)PSIPGT(ph)PTLK_,T150,,24.33,,,,,,,,,,,,,24.33,0.00, , , , , , , , , , , , ,negative regulation of phosphatase activity,nucleus;half bridge of spindle pole body;actin cytoskeleton,,,,,,,,,,,,,,
10777,Q9H6S3,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),PAEGVLTLRARPP,_APAEGVLT(ph)LR_,T303,,22.13,,,,,,,21.41,,,,,,21.77,0.36, , , , , , ,-0.36, , , , , ,,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10779,Q9H7L9,SUDS3,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),RESDEDTEDASET,_GRES(ph)DEDT(ph)EDAS(ph)ETDLAK_,T49,,25.69,,,,,,,,,,,,,25.69,0.00, , , , , , , , , , , , ,"negative regulation of transcription from RNA polymerase II promoter;transcription, DNA-dependent;positive regulation of apoptotic process;histone deacetylation",Sin3 complex,,,,,,,,,,,,,,
10781,Q9H7N4,SCAF1,"Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",VDSSCKTPEVSFL,_T(ph)PEVSFLPEEATEEAGVR_,T1001,,23.99,,,,,,,,,22.79,,,,23.39,0.60, , , , , , , , ,-0.60, , , ,mRNA processing;RNA splicing;transcription from RNA polymerase II promoter,nucleus,,,,,,,,,,,,,,
10783,Q9H8V3,ECT2,Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene),LYEKANTPELKKS,_ANT(ph)PELKK_,T31,,22.91,25.08,25.08,,20.51,,20.08,,,18.92,,,,22.10,0.81,2.98,2.98, ,-1.59, ,-2.01, , ,-3.17, , , ,positive regulation of Cdc42 GTPase activity;cellular response to hydrogen peroxide;cellular response to ionizing radiation;positive regulation of cell cycle cytokinesis;positive regulation of I-kappaB kinase/NF-kappaB cascade;regulation of attachment of spindle microtubules to kinetochore;protein transport;activation of Rac GTPase activity;apoptotic process;cell morphogenesis;small GTPase mediated signal transduction;cell cycle cytokinesis;cellular response to calcium ion;positive regulation of protein import into nucleus;positive regulation of neuron differentiation;nerve growth factor receptor signaling pathway;protein homooligomerization;activation of protein kinase activity;positive regulation of apoptotic process;tight junction assembly,tight junction;cytosol;midbody;nucleus;centralspindlin complex;cleavage furrow,,,,,,,,,,,,,,
10785,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),SLTVDVTPPTAKA,_ADAASSLTVDVT(ph)PPTAK_,T368,+,23.66,23.75,23.75,23.75,,23.82,24.58,24.50,,25.98,24.32,24.15,25.75,24.36,-0.70,-0.61,-0.61,-0.61, ,-0.55,0.21,0.13, ,1.61,-0.04,-0.22,1.39,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,,,,,,,,,,
10787,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),DRVGDSTPVSEKP,_APTTVEDRVGDST(ph)PVSEK_,T386,+,25.52,23.17,23.28,25.28,27.63,,26.74,,24.73,26.87,28.15,26.05,22.11,25.41,0.11,-2.24,-2.13,-0.13,2.21, ,1.33, ,-0.68,1.46,2.74,0.64,-3.30,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,,,,,,,,,,
10788,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),PGQMAGTPITPLK,_ISLPGQM(ox)AGT(ph)PIT(ph)PLK_,T175,,25.63,23.17,23.17,23.60,,,,,25.54,27.92,,,25.48,24.93,0.70,-1.76,-1.76,-1.33, , , , ,0.61,2.99, , ,0.55,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,,,,,,,,,,
10789,Q9H8Y8,GORASP2,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),MAGTPITPLKDGF,_ISLPGQM(ox)AGT(ph)PIT(ph)PLK_,T178,+,26.76,24.99,25.46,24.97,22.47,24.87,25.81,,26.29,26.35,25.49,24.55,24.61,25.22,1.54,-0.23,0.24,-0.24,-2.75,-0.35,0.59, ,1.07,1.13,0.27,-0.67,-0.61,Golgi organization;organelle organization,Golgi apparatus;membrane;Golgi membrane;Golgi medial cisterna,,,,,,,,,,,,,,
10790,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),PRAKSPTPESSTI,_SPT(ph)PESSTIASYVTLR_,T857,,,,,,,,23.10,24.60,,,,,25.87,24.53, , , , , , ,-1.42,0.08, , , , ,1.35,,cytoplasm,,,,,,,,,,,,,,
10791,Q9HAU0,PLEKHA5,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),GVISYQTLPRNMP,_GVISYQT(ph)LPR_,T438,+,21.71,,,22.36,24.16,23.55,24.37,24.25,22.43,,23.25,24.36,22.40,23.29,-1.57, , ,-0.92,0.87,0.27,1.09,0.96,-0.85, ,-0.03,1.08,-0.89,,cytoplasm,,,,,,,,,,,,,,
10793,Q9HAU5,UPF2,Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2),SNKENETDEENTE,_ENET(ph)DEENTEVM(ox)IK_,T1088,,24.33,24.97,24.97,23.78,,,23.90,,23.48,23.65,,,,24.15,0.18,0.82,0.82,-0.37, , ,-0.26, ,-0.67,-0.50, , , ,"mRNA export from nucleus;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;organ regeneration;liver development;gene expression",cytosol;exon-exon junction complex;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10797,Q9HBM6,TAF9B,Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L),VSSKPTTPTIATP,_LSVGAVSS(ph)KPTT(ph)PTIATPQTVSVPNK_,T157,,22.82,,,,,,,,24.27,22.69,,,,23.26,-0.44, , , , , , , ,1.01,-0.57, , , ,"negative regulation of apoptotic process;DNA-dependent transcription, initiation;negative regulation of transcription from RNA polymerase II promoter;positive regulation of cell growth;response to organic cyclic compound;programmed cell death",transcription factor TFTC complex;transcription factor TFIID complex,,,,,,,,,,,,,,
10798,Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),SVIQSNTPTPPPS,_APVSSTESVIQSNT(ph)PT(ph)PPPSQPLNETAEEESR_,T897,,26.24,,,,,,,,,,,,,26.24,0.00, , , , , , , , , , , , ,mitosis;microtubule-based process,microtubule;cytoplasm,,,,,,,,,,,,,,
10799,Q9HC35,EML4,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),IQSNTPTPPPSQP,_APVSSTESVIQSNTPT(ph)PPPSQPLNETAEEESR_,T899,,26.69,,,,23.53,,24.46,,,,,,,24.89,1.80, , , ,-1.36, ,-0.44, , , , , , ,mitosis;microtubule-based process,microtubule;cytoplasm,,,,,,,,,,,,,,
10801,Q9NPF5,DMAP1,DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1),VVGAPLTPNSRKR,_DTIIDVVGAPLT(ph)PNSRK_,T435,+,24.81,23.94,24.53,22.63,22.35,,25.55,,25.97,26.37,23.76,24.47,23.28,24.33,0.48,-0.39,0.20,-1.70,-1.99, ,1.22, ,1.64,2.04,-0.57,0.13,-1.05,"histone H2A acetylation;negative regulation of transcription from RNA polymerase II promoter;histone H4 acetylation;transcription, DNA-dependent;DNA methylation;regulation of growth;positive regulation of transcription factor import into nucleus",replication fork;NuA4 histone acetyltransferase complex;cytoplasm,,,,,,,,,,,,,,
10802,Q9NPJ8,NXT2,NTF2-related export protein 2 (Protein p15-2),TREEVVTPTLPEH,_EEVVT(ph)PTLPEHTATR_,T43,,22.47,,,,,,,,,,,,,22.47,0.00, , , , , , , , , , , , ,protein transport;mRNA transport,nucleus;cytoplasm,,,,,,,,,,,,,,
10803,Q9NPQ8,RIC8A,Synembryn-A (Protein Ric-8A),YSEDEDTDTDEYK,_GLM(ox)AGGRPEGQYS(ph)EDEDT(ph)DTDEYK_,T440,,25.86,23.04,23.04,23.71,25.17,,,,,22.82,,,,23.94,1.92,-0.90,-0.90,-0.23,1.23, , , , ,-1.12, , , ,vasculature development;cell-cell adhesion involved in gastrulation;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;in utero embryonic development;visual learning;cell migration involved in gastrulation;basement membrane organization,plasma membrane;cytoplasm,,,,,,,,,,,,,,
10804,Q9NQ84,GPRC5C,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),RGVGYETILKEQK,_GVGYET(ph)ILK_,T326,+,24.46,23.21,,20.71,,,23.32,23.63,20.92,21.67,23.65,24.64,23.02,22.92,1.53,0.29, ,-2.21, , ,0.40,0.71,-2.01,-1.25,0.73,1.72,0.09,,cytoplasmic vesicle membrane;mitochondrion;integral to plasma membrane,,,,,,,,,,,,,,
10805,Q9NR31,SAR1A,GTP-binding protein SAR1a (COPII-associated small GTPase),GNKIDRTDAISEE,_IDRT(ph)DAISEEK_,T139,,21.73,24.31,24.64,,21.82,21.90,,,,,,,20.91,22.55,-0.82,1.76,2.09, ,-0.74,-0.66, , , , , , ,-1.64,intracellular protein transport;ER to Golgi vesicle-mediated transport,sarcoplasmic reticulum;Golgi apparatus;endoplasmic reticulum,,,,,,,,,,,,,,
10806,Q9NRL2,BAZ1A,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),LDQDMVTEDEDDP,_ELDQDM(ox)VT(ph)EDEDDPGSHK_,T730,+,25.33,26.76,27.68,25.47,,25.14,26.47,23.74,26.84,26.63,23.55,24.27,25.02,25.57,-0.25,1.18,2.11,-0.11, ,-0.43,0.89,-1.84,1.26,1.06,-2.02,-1.31,-0.55,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;chromatin remodeling;DNA-dependent DNA replication",ACF complex;nuclear chromosome;chromatin accessibility complex,,,,,,,,,,,,,,
10810,Q9NTI5,PDS5B,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),IESTQSTPQKGRG,_AES(ph)PESSAIESTQST(ph)PQK_,T1370,,24.87,,,23.15,,,,,,,,,,24.01,0.86, , ,-0.86, , , , , , , , , ,cell proliferation;negative regulation of cell proliferation;cell division;mitotic sister chromatid cohesion,chromatin;nucleus,,,,,,,,,,,,,,
10812,Q9NU22,MDN1,Midasin (MIDAS-containing protein),KNGGEDTDNEEGE,_NGGEDT(ph)DNEEGEEENPLEIK_,T4898,,25.83,,,,22.51,,25.21,,25.40,26.69,,24.09,,24.96,0.87, , , ,-2.45, ,0.26, ,0.45,1.73, ,-0.86, ,protein complex assembly,nucleolus;nucleus,,,,,,,,,,,,,,
10814,Q9NVM1,EVA1B,Protein eva-1 homolog B (Protein FAM176B),DEDEEDTVTRLGP,_SSTLEPEDDDEDEEDT(ph)VTR_,T85,,21.98,,,21.97,22.01,23.27,,,,,22.24,,,22.29,-0.31, , ,-0.33,-0.29,0.97, , , , ,-0.05, , ,,integral to membrane,,,,,,,,,,,,,,
10815,Q9NW97,TMEM51,Transmembrane protein 51,PSIEPLTPPPQYD,_NVPPPSIEPLT(ph)PPPQYDEVQEK_,T234,,24.61,24.31,24.56,23.88,,,,,25.13,27.07,,,,24.93,-0.32,-0.62,-0.36,-1.05, , , , ,0.20,2.14, , , ,,integral to membrane,,,,,,,,,,,,,,
10822,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),DSEGDDTEETEDY,_FNDS(ph)EGDDT(ph)EETEDYR_,T400,,26.49,,,,25.46,26.06,24.38,,26.30,,23.90,,,25.43,1.05, , , ,0.03,0.63,-1.05, ,0.87, ,-1.53, , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
10823,Q9NYF8,BCLAF1,Bcl-2-associated transcription factor 1 (Btf),VHSAKNTPSQHSH,_NT(ph)PSQHSHSIQHS(ph)PER_,T255,,24.12,26.06,26.00,25.09,19.87,,,,,,,,,24.23,-0.11,1.83,1.77,0.86,-4.36, , , , , , , , ,"positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway;positive regulation of DNA-dependent transcription, initiation;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;regulation of DNA-dependent transcription in response to stress;induction of apoptosis",nucleolus;cytoplasm,Other TF domain,,,,,,,,,,+,,,
10826,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",PEPKAITPPQQPY,_AIT(ph)PPQQPYK_,T692,+,23.74,24.39,,,23.71,24.56,24.10,,24.22,24.52,23.47,,24.31,24.11,-0.37,0.28, , ,-0.40,0.45,-0.01, ,0.10,0.40,-0.64, ,0.20,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
10827,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",KDMGLVTPEAASL,_DM(ox)GLVT(ph)PEAASLGTVIK_,T57,,20.58,,,,,,,,,22.89,,,,21.73,-1.15, , , , , , , , ,1.15, , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
10828,Q9NYV4,CDK12,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",LKEEIVTPKETET,_EEIVT(ph)PK_,T514,,24.18,24.14,23.76,24.56,,,,,,,,,,24.16,0.02,-0.02,-0.40,0.40, , , , , , , , , ,phosphorylation of RNA polymerase II C-terminal domain;regulation of MAP kinase activity;protein autophosphorylation;mRNA processing;RNA splicing;cell cycle,nuclear cyclin-dependent protein kinase holoenzyme complex;nucleolus;nuclear speck,,+,,,,,,,,,+,,,
10830,Q9NYZ1,TVP23B,Golgi apparatus membrane protein TVP23 homolog B,QFLRQNTGDDQTS,_QFLRQNT(ph)GDDQTS_,T199,,23.53,25.39,25.39,,,,,,24.13,25.33,,,,24.75,-1.23,0.64,0.64, , , , , ,-0.63,0.58, , , ,,integral to membrane,,,,,,,,,,,,,,
10831,Q9NZI5,GRHL1,Grainyhead-like protein 1 homolog (Mammalian grainyhead) (NH32) (Transcription factor CP2-like 2) (Transcription factor LBP-32),PNAQRRTPDSTFS,_T(ph)PDSTFSETFK_,T211,,23.72,,,,,,,,,,,,,23.72,0.00, , , , , , , , , , , , ,"multicellular organismal development;small molecule metabolic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent;cellular lipid metabolic process",nucleoplasm;Golgi apparatus,Other TF domain,,,,,,,,,,,,,
10832,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),PKGPVGTVSEAQL,_GPVGT(ph)VS(ph)EAQLAR_,T172,,23.56,,,,,,,,,20.94,,22.24,,22.25,1.31, , , , , , , , ,-1.31, ,0.00, ,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
10833,Q9NZM1,MYOF,Myoferlin (Fer-1-like protein 3),GPPFNITPRKAKK,_SLGPPGPPFNIT(ph)PR_,T1768,,,,,,22.83,,22.48,20.61,,21.38,,,,21.83, , , , ,1.01, ,0.66,-1.22, ,-0.45, , , ,blood circulation;plasma membrane repair;regulation of vascular endothelial growth factor receptor signaling pathway;muscle contraction;cellular response to heat,nuclear membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;caveola;nuclear envelope;integral to membrane;extracellular vesicular exosome,,,,,,,,,,,,,,
10834,Q9NZN5,ARHGEF12,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),GDTLDGTPRTLNT,_QVGETSAPGDTLDGT(ph)PR_,T684,,24.81,,,,,,,,,,,,,24.81,0.00, , , , , , , , , , , , ,small GTPase mediated signal transduction;regulation of Rho protein signal transduction;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;axon guidance;termination of G-protein coupled receptor signaling pathway;apoptotic process;nerve growth factor receptor signaling pathway;regulation of small GTPase mediated signal transduction,cytosol;membrane,,,,,,,,,,,,,,
10837,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),QDADLKTPTKPKQ,_ISQDADLKT(ph)PTKPK_,T249,,,,,,24.52,,22.82,,,,,,23.15,23.50, , , , ,1.02, ,-0.68, , , , , ,-0.34,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
10838,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),SSPRSITSTPLSG,_SIT(ph)STPLSGK_,T287,+,24.22,23.55,23.55,25.48,,24.49,24.63,25.11,25.50,23.61,24.79,24.23,,24.47,-0.25,-0.92,-0.92,1.01, ,0.02,0.16,0.64,1.03,-0.86,0.33,-0.24, ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
10841,Q9P289,MST4,Serine/threonine-protein kinase MST4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 4) (MST-4) (Mst3 and SOK1-related kinase) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK),AGQLTDTQIKRNT,_LADFGVAGQLTDT(ph)QIK_,T153,,,,,,,,,,,23.28,,24.01,24.02,23.77, , , , , , , , , ,-0.49, ,0.24,0.25,cellular component disassembly involved in execution phase of apoptosis;regulation of apoptotic process,cytosol;Golgi membrane,,+,,,,,,,,,,,,
10845,Q9P2N5,RBM27,RNA-binding protein 27 (RNA-binding motif protein 27),ERLQLGTPPPLLA,_LQLGT(ph)PPPLLAAR_,T447,,22.25,19.72,19.72,,,,,,21.61,21.35,,,,20.93,1.32,-1.21,-1.21, , , , , ,0.68,0.42, , , ,mRNA processing,nuclear speck;nucleus;cytoplasm,,,,,,,,,,,,,,
10849,Q9UBD5,ORC3,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),FQSLDETKEEEDA,_IEEFLAQFQSLDET(ph)K_,T507,,23.49,23.47,23.35,23.14,23.35,24.74,23.39,23.27,25.13,,,23.56,,23.69,-0.20,-0.22,-0.34,-0.55,-0.34,1.05,-0.30,-0.42,1.44, , ,-0.13, ,S phase of mitotic cell cycle;cell cycle checkpoint;G1/S transition of mitotic cell cycle;DNA replication;M/G1 transition of mitotic cell cycle,nucleoplasm;nuclear origin of replication recognition complex,,,,,,,,,,,,,,
10850,Q9UBH6,XPR1,Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor),KVLIEDTDDEANT,_VLIEDT(ph)DDEANT_,T625,+,26.24,,,,25.46,24.41,24.41,22.91,25.57,25.49,22.88,23.74,24.20,24.53,1.70, , , ,0.93,-0.12,-0.12,-1.62,1.04,0.96,-1.65,-0.79,-0.33,response to virus,integral to plasma membrane,,,,,,,,,,,,,,
10852,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),ASQGVITTPPPPS,_(ac)SSDASQGVIT(ph)TPPPPSM(ox)PHK_,T11,,25.24,24.70,24.70,,,24.97,25.29,,,,,24.22,24.92,24.86,0.38,-0.16,-0.16, , ,0.11,0.42, , , , ,-0.64,0.06,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,,,,,,,,,,
10853,Q9UEY8,ADD3,Gamma-adducin (Adducin-like protein 70),SQGVITTPPPPSM,_(ac)SSDASQGVITT(ph)PPPPSM(ox)PHK_,T12,+,25.58,23.90,23.90,,25.54,,25.32,24.74,25.21,26.05,25.73,23.99,25.35,25.03,0.55,-1.13,-1.13, ,0.51, ,0.29,-0.29,0.18,1.02,0.70,-1.04,0.32,response to drug,condensed nuclear chromosome;cell-cell junction;cell cortex;plasma membrane;cytoskeleton;membrane,,,,,,,,,,,,,,
10857,Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),IKTPASTPVSGTP,_TPAST(ph)PVSGT(ph)PQAS(ph)PM(ox)IER_,T252,,22.68,,,,,,,,,,,,,22.68,0.00, , , , , , , , , , , , ,positive regulation of actin filament polymerization;filopodium assembly;signal transduction;positive regulation of actin cytoskeleton reorganization;response to bacterium,cytosol;cell junction;plasma membrane;nucleus;cytoskeleton,,,,,,,,,,,,,,
10858,Q9UHR4,BAIAP2L1,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),STPVSGTPQASPM,_TPASTPVSGT(ph)PQAS(ph)PM(ox)IER_,T257,+,27.17,22.92,23.42,22.98,,,25.60,22.61,25.77,26.29,,,,24.59,2.57,-1.67,-1.18,-1.61, , ,1.01,-1.99,1.18,1.69, , , ,positive regulation of actin filament polymerization;filopodium assembly;signal transduction;positive regulation of actin cytoskeleton reorganization;response to bacterium,cytosol;cell junction;plasma membrane;nucleus;cytoskeleton,,,,,,,,,,,,,,
10860,Q9UHX1,PUF60,Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1),PLLTPATPGGLPP,_AVTPPM(ox)PLLTPAT(ph)PGGLPPAAAVAAAAATAK_,T254,,24.76,,,,,,,,,,,,,24.76,0.00, , , , , , , , , , , , ,"mRNA processing;RNA splicing;apoptotic process;transcription, DNA-dependent;regulation of transcription, DNA-dependent",ribonucleoprotein complex;nucleus,Other TF domain,,,,,,,,,,,,,
10861,Q9UHY1,NRBP1,Nuclear receptor-binding protein,PSVKTPTPEPAEV,_TPT(ph)PEPAEVETRK_,T433,+,26.58,26.51,26.70,25.86,24.26,23.06,26.94,24.67,24.95,24.04,26.08,26.23,23.18,25.31,1.27,1.19,1.39,0.55,-1.05,-2.25,1.63,-0.64,-0.37,-1.27,0.76,0.91,-2.13,transcription initiation from RNA polymerase II promoter;ER to Golgi vesicle-mediated transport,nucleoplasm;cell cortex;endomembrane system;lamellipodium;membrane;perinuclear region of cytoplasm,,+,,,,,,,,,,,,
10863,Q9UJU6,DBNL,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),FLQKQLTQPETHF,_(gl)QLT(ph)QPETHFGR_,T291,,23.68,21.91,,23.75,,,22.86,,,,,26.74,23.01,23.66,0.02,-1.75, ,0.10, , ,-0.80, , , , ,3.08,-0.65,endocytosis;activation of JUN kinase activity;cellular component disassembly involved in execution phase of apoptosis;Rac protein signal transduction,cytosol;cell cortex;postsynaptic density;lamellipodium;ruffle,,,,,,,,,,,,,,
10864,Q9UJX2,CDC23,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),LNLSSVTP_____,_VSPLNLSSVT(ph)P_,T478,+,22.80,,,,23.20,21.29,22.06,22.54,22.05,22.69,,,22.19,22.35,0.45, , , ,0.85,-1.06,-0.30,0.19,-0.30,0.34, , ,-0.16,G1 phase of mitotic cell cycle;mitotic metaphase plate congression;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;mitotic cell cycle spindle assembly checkpoint;regulation of exit from mitosis;protein K11-linked ubiquitination;mitotic metaphase/anaphase transition;cell division;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,nucleoplasm;cytosol;anaphase-promoting complex,,,,,,,,,,,,,,
10865,Q9UJZ1,STOML2,"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)",KAPVPGTPDSLSS,_APVPGT(ph)PDSLSSGSSR_,T327,+,25.17,25.78,24.94,25.70,,27.00,25.35,26.66,26.27,25.78,25.97,24.56,26.25,25.79,-0.61,0.00,-0.85,-0.09, ,1.21,-0.43,0.87,0.48,0.00,0.18,-1.23,0.47,,mitochondrial inner membrane;cytoskeleton,,,,,,,,,,,,,,
10866,Q9UK58,CCNL1,Cyclin-L1 (Cyclin-L),EERLSPTPSMQDG,_LSPT(ph)PSM(ox)QDGLDLPSETDLR_,T67,,22.98,22.69,,,,,,,,,,,,22.84,0.15,-0.15, , , , , , , , , , , ,"regulation of cyclin-dependent protein kinase activity;transcription, DNA-dependent;regulation of transcription, DNA-dependent;RNA processing",nuclear speck,,,,,,,,,,,,,,
10868,Q9UKA4,AKAP11,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),GEESQLTPEKSPK,_ESLPVSGEESQLT(ph)PEK_,T981,,20.36,23.56,23.56,22.78,,,23.71,,,22.83,,,,22.80,-2.44,0.76,0.76,-0.02, , ,0.91, , ,0.03, , , ,intracellular protein kinase cascade;regulation of protein kinase A signaling cascade,nucleolus;plasma membrane;protein complex;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
10869,Q9UKA4,AKAP11,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),RNVIPDTPPSTPL,_NVIPDT(ph)PPSTPLVPSR_,T1100,+,23.44,22.37,,23.82,24.30,23.86,23.87,24.13,23.78,22.33,24.19,25.06,24.62,23.81,-0.38,-1.44, ,0.01,0.48,0.05,0.05,0.31,-0.03,-1.48,0.37,1.24,0.81,intracellular protein kinase cascade;regulation of protein kinase A signaling cascade,nucleolus;plasma membrane;protein complex;microtubule organizing center;cytoplasm,,,,,,,,,,,,,,
10872,Q9UL01,DSE,Dermatan-sulfate epimerase (DS epimerase) (EC 5.1.3.19) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2),FSDKRQTEEAIDR,_RQT(ph)EEAIDR_,T453,,,25.76,,25.06,,20.60,,21.81,,21.70,20.02,,20.55,22.22, ,3.55, ,2.85, ,-1.61, ,-0.40, ,-0.51,-2.20, ,-1.66,chondroitin sulfate metabolic process;heparan sulfate proteoglycan biosynthetic process;dermatan sulfate biosynthetic process;chondroitin sulfate biosynthetic process;carbohydrate metabolic process,integral to membrane;endoplasmic reticulum;Golgi membrane,,,,,,,,,,,,,,
10873,Q9ULA0,DNPEP,Aspartyl aminopeptidase (EC 3.4.11.21),EELEKGTPEPGPL,_GT(ph)PEPGPLNAVDER_,T203,,23.07,22.52,20.98,22.96,,22.87,,,,,,,,22.48,0.59,0.04,-1.50,0.48, ,0.39, , , , , , , ,proteolysis;peptide metabolic process,cytoplasm,,,,,,,,,,,,,,
10877,Q9ULJ3,ZBTB21,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),TEVRIKTEPSSPL,_IKT(ph)EPSS(ph)PLSDPSDIIR_,T431,,24.38,,,,,,,,,,,,24.01,24.19,0.18, , , , , , , , , , , ,-0.18,"transcription, DNA-dependent;regulation of transcription, DNA-dependent;negative regulation of transcription, DNA-dependent",nucleus,C2H2-type,,,,,,,,,,,,,
10881,Q9UN36,NDRG2,Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613),RLSRSRTASLTSA,_SRT(ph)AS(ph)LTSAASVDGNR_,T287,,23.55,,,,,,,,,,,,,23.55,0.00, , , , , , , , , , , , ,regulation of vascular endothelial growth factor production;cell differentiation;negative regulation of cytokine production;negative regulation of smooth muscle cell proliferation;negative regulation of ERK1 and ERK2 cascade;regulation of platelet-derived growth factor production;Wnt receptor signaling pathway;nervous system development,growth cone;cytosol;Golgi apparatus;nucleus;centrosome;perinuclear region of cytoplasm,,,,,,,,,,,,,,
10885,Q9UP95,SLC12A4,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),ADKIQMTWTRDKY,_IQM(ox)T(ph)WTRDK_,T983,+,,23.15,21.87,21.56,,21.49,23.03,,24.47,23.98,21.33,23.08,21.47,22.54, ,0.61,-0.67,-0.99, ,-1.06,0.48, ,1.92,1.44,-1.22,0.54,-1.07,cell volume homeostasis;potassium ion transport,integral to plasma membrane,,,,,,,,,,,,,,
10888,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),LDAVPRTPSRERS,_AGM(ox)SSNQSISSPVLDAVPRT(ph)PS(ph)RER_,T1413,+,27.16,25.32,25.56,24.98,27.31,25.96,24.76,25.72,26.92,25.86,23.40,23.16,23.95,25.39,1.77,-0.07,0.17,-0.41,1.92,0.57,-0.63,0.33,1.53,0.47,-1.98,-2.23,-1.44,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10890,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PKVKAQTPPGPSL,_AQT(ph)PPGPSLSGSK_,T1003,+,29.69,29.52,29.03,29.51,25.92,27.45,29.04,26.40,29.13,29.24,27.97,28.58,27.48,28.38,1.31,1.14,0.65,1.13,-2.46,-0.93,0.66,-1.98,0.75,0.86,-0.41,0.19,-0.90,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10893,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),LRDGSGTPSRHSL,_DGSGT(ph)PSRHS(ph)LSGS(ph)SPGM(ox)K_,T1453,,24.20,23.97,,,,,,,,,,,,24.08,0.12,-0.12, , , , , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10895,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),FKDTLRTPPRERS,_DTLRT(ph)PPRER_,T1208,+,27.66,29.05,29.55,27.30,25.31,27.01,27.07,25.58,27.75,27.29,26.78,27.52,25.85,27.21,0.45,1.84,2.34,0.09,-1.90,-0.20,-0.14,-1.62,0.54,0.08,-0.43,0.32,-1.36,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10901,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),NHSGSRTPPVALN,_T(ph)PPVALNSSR_,T2104,+,28.14,22.26,,25.35,24.70,21.45,,,,20.80,,23.54,,23.75,4.39,-1.49, ,1.60,0.95,-2.30, , , ,-2.95, ,-0.21, ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10907,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),PKVKSGTPPRQGS,_SGT(ph)PPRQGSITSPQANEQSVT(ph)PQRR_,T848,+,26.81,27.09,27.39,27.09,24.16,23.80,23.77,,26.23,24.55,,,,25.65,1.15,1.44,1.74,1.43,-1.49,-1.86,-1.89, ,0.58,-1.10, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10908,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RGKRSLTRSPPAI,_S(ph)LT(ph)RS(ph)PPAIR_,T2069,,29.13,,,,,,,,,22.51,,,,25.82,3.31, , , , , , , , ,-3.31, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10911,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTSPITRR,_S(ph)RT(ph)SPITR_,T1974,,,26.45,,26.79,,,21.56,23.68,,,,,,24.62, ,1.83, ,2.17, , ,-3.06,-0.94, , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10912,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),RRSRSRTSPVTRR,_SRT(ph)SPVTR_,T1986,,,23.92,24.47,,,,,,21.25,18.95,,,,22.15, ,1.77,2.32, , , , , ,-0.90,-3.19, , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10916,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),KRSRSRTSPAPWK,_S(ph)RT(ph)SPAPWKR_,T1856,+,27.12,26.11,26.40,26.06,24.84,21.38,,,23.00,,,,,24.99,2.13,1.12,1.41,1.07,-0.14,-3.61, , ,-1.98, , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10918,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),NLADPRTPTAPAV,_TAVAPSAVNLADPRT(ph)PTAPAVNLAGAR_,T2289,,24.41,,,,22.45,,,,,,,,,23.43,0.98, , , ,-0.98, , , , , , , , ,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10919,Q9UQ35,SRRM2,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),ERVSGRTSPPLLD,_VSGRT(ph)SPPLLDR_,T2397,+,,29.49,29.49,29.00,23.92,23.61,24.04,29.74,29.29,,28.39,,24.79,27.18, ,2.31,2.31,1.82,-3.25,-3.57,-3.14,2.56,2.12, ,1.22, ,-2.38,"mRNA splicing, via spliceosome",nuclear speck;Cajal body;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10922,Q9UQ80,PA2G4,Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1),DEQQEQTIAEDLV,_S(ph)GEDEQQEQT(ph)IAEDLVVTK_,T11,,24.66,,,,,,,,,,,,,24.66,0.00, , , , , , , , , , , , ,"cell proliferation;cell cycle arrest;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;rRNA processing;regulation of translation",ribonucleoprotein complex;nucleolus;cytoplasm,,,,,,,,,,,,,,
10923,Q9UQ88,CDK11A,Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2),SPLKAYTPVVVTQ,_AYT(ph)PVVVTQWYR_,T570,,22.90,,,21.30,22.80,,,,,,,,,22.33,0.57, , ,-1.03,0.47, , , , , , , , ,"mitosis;regulation of cell growth;apoptotic process;regulation of transcription, DNA-dependent;regulation of mRNA processing",nucleus;cytoplasm,,+,,,,,,,,,,,,
10924,Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),SDSYSNTLPVRKS,_LSDSYSNT(ph)LPVRK_,T340,+,,21.62,22.05,20.70,23.32,22.32,24.41,24.97,21.99,22.10,22.69,25.90,23.38,22.95, ,-1.33,-0.90,-2.26,0.37,-0.64,1.46,2.01,-0.96,-0.85,-0.27,2.94,0.42,regulation of actin cytoskeleton organization;filopodium assembly;axonogenesis;dendrite development;insulin receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;response to bacterium,filopodium;cytosol;cell junction;plasma membrane;nucleus;cytoskeleton;ruffle,,,,,,,,,,+,,,,
10925,Q9UQB8,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),SGTLVSTV_____,_SM(ox)SSGSGTLVST(ph)V_,T520,,22.77,,,22.00,,22.52,22.95,,,,23.36,,22.73,22.72,0.04, , ,-0.73, ,-0.20,0.23, , , ,0.64, ,0.01,regulation of actin cytoskeleton organization;filopodium assembly;axonogenesis;dendrite development;insulin receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;response to bacterium,filopodium;cytosol;cell junction;plasma membrane;nucleus;cytoskeleton;ruffle,,,,,,,,,,+,,,,
10926,Q9UQC2,GAB2,GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100),TIPRRNTLPAMDN,_RNT(ph)LPAM(ox)DNSR_,T353,,24.58,23.14,23.14,,,,20.48,,,,20.91,22.33,,22.43,2.15,0.71,0.71, , , ,-1.95, , , ,-1.52,-0.10, ,positive regulation of mast cell degranulation;positive regulation of cell proliferation;phosphatidylinositol-mediated signaling;osteoclast differentiation,cytosol;plasma membrane,,,,+,,,,,,,,,,
10931,Q9Y266,NUDC,Nuclear migration protein nudC (Nuclear distribution protein C homolog),SPGKQDTEEDEEE,_NGSLDSPGKQDT(ph)EEDEEEDEK_,T145,+,23.86,23.46,22.72,25.52,23.97,24.80,27.34,26.89,25.19,25.57,25.68,26.54,,25.13,-1.26,-1.67,-2.41,0.39,-1.16,-0.33,2.21,1.76,0.06,0.44,0.56,1.41, ,nuclear migration;multicellular organismal development;cell proliferation;response to peptide hormone stimulus;mitotic prometaphase;cytokinesis,nucleoplasm;cytosol;Golgi apparatus;microtubule,,,,,,,,,,,,,,
10934,Q9Y2E4,DIP2C,Disco-interacting protein 2 homolog C (DIP2 homolog C),IQQLVNTLKRPKR,_IQQLVNT(ph)LK_,T264,,,,,20.04,,,22.08,,21.33,22.35,,23.74,,21.91, , , ,-1.86, , ,0.17, ,-0.58,0.44, ,1.83, ,,nucleus,,,,,,,,,,,,,,
10935,Q9Y2H0,DLGAP4,Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4),SWQLVETPEKRKE,_ANSWQLVET(ph)PEK_,T376,+,24.95,24.22,24.22,23.27,23.08,23.56,24.73,24.56,23.96,23.36,23.21,23.96,23.53,23.89,1.05,0.32,0.32,-0.62,-0.81,-0.33,0.84,0.67,0.07,-0.53,-0.68,0.07,-0.36,cell-cell signaling,neuronal cell body;synapse;plasma membrane;dendrite,,,,,,,,,,,,,,
10939,Q9Y2S7,POLDIP2,Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38),IFSLSGTLETVRG,_IFSLSGT(ph)LETVR_,T292,+,21.48,,,,23.60,21.86,,21.99,22.65,22.55,23.90,22.70,23.80,22.73,-1.24, , , ,0.87,-0.87, ,-0.74,-0.08,-0.17,1.17,-0.02,1.07,,mitochondrial nucleoid;nucleus,,,,,,,,,,,,,,
10942,Q9Y2Z0,SUGT1,Suppressor of G2 allele of SKP1 homolog (Protein 40-6-3) (Sgt1),GQGDVPTPKQFVA,_LEGQGDVPT(ph)PK_,T265,+,24.43,23.57,24.16,23.12,,,22.83,23.13,22.61,22.14,,,,23.25,1.18,0.32,0.91,-0.13, , ,-0.42,-0.13,-0.64,-1.11, , , ,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;mitosis;innate immune response",cytosol;ubiquitin ligase complex;nucleus;kinetochore,,,,,,,,,,,,,,
10946,Q9Y3P9,RABGAP1,Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA),EVLDEDTDEEKET,_EVLDEDT(ph)DEEK_,T996,+,25.37,22.24,22.33,25.82,,25.21,25.23,24.62,23.64,23.82,,24.21,25.06,24.32,1.05,-2.09,-1.99,1.49, ,0.89,0.91,0.29,-0.68,-0.50, ,-0.11,0.74,positive regulation of Rab GTPase activity;cell cycle,cytosol;microtubule associated complex;centrosome,,,,,,,,,,,,,,
10947,Q9Y3Q8,TSC22D4,TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1),GGSGARTPPLSRR,_VEAEAGGSGART(ph)PPLSR_,T229,,24.44,24.56,24.26,,,,,,,,,,,24.42,0.02,0.14,-0.16, , , , , , , , , , ,"transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;response to osmotic stress",nucleus;cytoplasm,,,,,,,,,,,,,,
10949,Q9Y3Z3,SAMHD1,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1),VIAPLITPQKKEW,_NFTKPQDGDVIAPLIT(ph)PQK_,T592,,23.36,19.74,,,23.21,,23.36,24.04,,,,,,22.74,0.62,-3.00, , ,0.47, ,0.62,1.30, , , , , ,defense response to virus;regulation of innate immune response;immune response;metabolic process;innate immune response,nucleus,,,,,,,,,,,,,,
10952,Q9Y4F1,FARP1,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",ENSGISTLERGQK,_LGAPENSGIST(ph)LER_,T24,+,27.42,27.32,24.83,27.83,28.28,28.46,26.66,27.42,26.98,27.11,28.32,26.28,27.52,27.26,0.16,0.06,-2.44,0.57,1.01,1.19,-0.61,0.16,-0.29,-0.15,1.06,-0.98,0.26,regulation of Rho protein signal transduction;negative regulation of phosphatase activity,cytoskeleton;extrinsic to membrane;cytoplasm,,,,,,,,,,,,,,
10954,Q9Y4F4,FAM179B,Protein FAM179B,KAGESNTFIREDV,_AGES(ph)NT(ph)FIREDVDK_,T378,,,,,27.49,,22.78,25.93,,25.47,,,25.35,22.85,24.98, , , ,2.51, ,-2.20,0.95, ,0.49, , ,0.37,-2.13,,,,,,,,,,,,,,,,
10956,Q9Y4F5,CEP170B,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),SPVGPPTPPPAPT,_VPPVLPAPLTPHGTSPVGPPT(ph)PPPAPTDPQLTK_,T472,,24.25,23.53,23.53,22.82,,21.93,24.13,,23.43,24.30,25.41,23.76,,23.71,0.54,-0.18,-0.18,-0.89, ,-1.78,0.42, ,-0.28,0.59,1.70,0.05, ,,microtubule;cytoplasm,,,,,,,,,,,,,,
10958,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),CSHRSNTPESIAE,_SNT(ph)PESIAETPPAR_,T521,+,24.02,23.77,21.55,27.13,23.98,25.15,23.61,25.00,,,26.13,25.62,24.03,24.54,-0.52,-0.78,-2.99,2.58,-0.57,0.61,-0.93,0.46, , ,1.58,1.08,-0.52,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
10959,Q9Y4H2,IRS2,Insulin receptor substrate 2 (IRS-2),PESIAETPPARDG,_SNTPESIAET(ph)PPAR_,T528,,,23.35,,25.26,21.94,,,,,,,,,23.52, ,-0.17, ,1.75,-1.58, , , , , , , , ,negative regulation of plasma membrane long-chain fatty acid transport;positive regulation of glycogen biosynthetic process;positive regulation of cell migration;insulin receptor signaling pathway;positive regulation of mesenchymal cell proliferation;mammary gland development;glucose metabolic process;lipid homeostasis;positive regulation of glucose import;phosphatidylinositol-mediated signaling;JAK-STAT cascade involved in growth hormone signaling pathway;negative regulation of kinase activity;positive regulation of fatty acid beta-oxidation;positive regulation of insulin secretion;response to glucose stimulus;cell proliferation;brain development;positive regulation of B cell proliferation;nerve growth factor receptor signaling pathway;negative regulation of B cell apoptotic process,cytosol;plasma membrane,,,,,,,,,,,,,,
10962,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),ELGGETTPPLSTE,_M(ox)PLLELGGETT(ph)PPLSTER_,T525,,25.37,,,,,,,,,,,,,25.37,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
10963,Q9Y4K1,AIM1,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),RGSQKSTDSPGAD,_ST(ph)DS(ph)PGADAELPESAAR_,T20,,26.81,,,,,,,,,,,,,26.81,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
10965,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),IDIKPGTPPIAGR,_AFGSGIDIKPGT(ph)PPIAGR_,T2673,+,23.00,20.69,20.69,,24.61,23.22,23.70,23.52,23.27,23.86,23.10,24.66,24.75,23.25,-0.26,-2.57,-2.57, ,1.36,-0.03,0.44,0.26,0.01,0.60,-0.16,1.41,1.49,,,,,,,,,,,,,,,,
10968,Q9Y520,PRRC2C,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),IAGRSTTPTSSPF,_STT(ph)PTSSPFR_,T2682,+,25.18,,,25.19,25.45,25.83,,25.75,25.34,,,,24.56,25.33,-0.15, , ,-0.14,0.12,0.50, ,0.42,0.01, , , ,-0.77,,,,,,,,,,,,,,,,
10972,Q9Y5Z4,HEBP2,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),AAQAVETPGWKAP,_(ac)AEPLQPDPGAAEDAAAQAVET(ph)PGWK_,T22,,25.60,,,,,,,,,,,,,25.60,0.00, , , , , , , , , , , , ,,mitochondrion;cytoplasm,,,,,,,,,,,,,,
10973,Q9Y606,PUS1,"tRNA pseudouridine synthase A, mitochondrial (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)",SEGDGDTD_____,_VPSPLEGS(ph)EGDGDT(ph)D_,T373,,26.01,,,,24.50,,23.39,,24.12,24.72,,,,24.55,1.47, , , ,-0.05, ,-1.16, ,-0.43,0.17, , , ,tRNA processing;tRNA pseudouridine synthesis;positive regulation of transcription from RNA polymerase II promoter,mitochondrion;transcription factor complex;nucleolus;nucleus,,,,,,,,,,,,,,
10976,Q9Y618,NCOR2,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",LLKREGTPPPPPP,_EGT(ph)PPPPPPSRDLTEAYK_,T1373,+,,,,,24.83,25.39,24.04,24.47,23.96,23.68,23.02,24.50,23.68,24.17, , , , ,0.66,1.22,-0.13,0.30,-0.22,-0.50,-1.16,0.33,-0.50,transforming growth factor beta receptor signaling pathway;transcription initiation from RNA polymerase II promoter;Notch signaling pathway;small molecule metabolic process;negative regulation of transcription from RNA polymerase II promoter;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;cellular lipid metabolic process,nuclear body;nucleus;transcriptional repressor complex,Other TF domain,,,,,,,,,,,,,
10978,Q9Y666,SLC12A7,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),RTEAPGTPEGPEP,_TEAPGT(ph)PEGPEPERPSPGDGNPR_,T30,,25.62,24.38,23.74,23.51,23.04,,,,,,23.12,,,23.90,1.72,0.48,-0.16,-0.39,-0.86, , , , , ,-0.78, , ,cell volume homeostasis;potassium ion transport,integral to plasma membrane,,,,,,,,,,,,,,
10980,Q9Y6G9,DYNC1LI1,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",VTVSPTTPTSPTE,_KPVTVSPTT(ph)PTS(ph)PTEGEAS_,T513,,26.29,,,,,,,,22.45,,,,,24.37,1.92, , , , , , , ,-1.92, , , , ,transport;mitosis;regulation of centrosome cycle;cell division;virus-host interaction;positive regulation of mitotic cell cycle spindle assembly checkpoint,cytoplasmic dynein complex;plasma membrane;microtubule;centrosome;condensed chromosome kinetochore;spindle pole;kinetochore,,,,,,,,,,,,,,
10983,Q9Y6M1,IGF2BP2,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),IVPRDQTPDENEE,_DQT(ph)PDENEEVIVR_,T507,,23.63,,,,,,,,,,,,,23.63,0.00, , , , , , , , , , , , ,anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process,cytosol;cytoskeletal part;nucleus,,,,,,,,,,,,,,
10984,Q9Y6N7,ROBO1,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),EDERGPTPPVRGA,_M(ox)YLQQDELEEEEDERGPT(ph)PPVR_,T1140,+,,,,22.01,24.05,24.91,23.25,24.08,,,24.75,,25.63,24.10, , , ,-2.09,-0.04,0.82,-0.85,-0.02, , ,0.66, ,1.53,axon midline choice point recognition;negative regulation of mammary gland epithelial cell proliferation;cell migration involved in sprouting angiogenesis;spinal cord development;Roundabout signaling pathway;regulation of dendrite morphogenesis;mammary duct terminal end bud growth;negative regulation of negative chemotaxis;activation of cysteine-type endopeptidase activity involved in apoptotic process;homophilic cell adhesion;negative regulation of chemokine-mediated signaling pathway;chemorepulsion involved in postnatal olfactory bulb interneuron migration;positive regulation of axonogenesis,neuronal cell body;integral to plasma membrane;cell surface;axolemma;cytoplasm,,,,,,,,,,,,,,
10985,Q9Y6R4,MAP3K4,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),EYEGDDTEGELKE,_GNEPEYEGDDT(ph)EGELK_,T447,,23.52,22.85,22.85,23.21,,,23.90,,,,,,,23.27,0.25,-0.42,-0.42,-0.06, , ,0.64, , , , , , ,male germ-line sex determination;JNK cascade;positive regulation of JUN kinase activity,perinuclear region of cytoplasm;cytoplasm,,+,,,,,,,,,,,,
10987,P06756,ITGAV,Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain;Integrin alpha-V light chain],GEGNSET______,_EQLQPHENGEGNSET(ph)_,T1012,,,,,,,,,,,24.51,24.56,,,24.53, , , , , , , , , ,-0.02,0.02, , ,"negative regulation of apoptotic process;viral entry into host cell;apoptotic cell clearance;positive regulation of cell migration;blood coagulation;negative regulation of entry of bacterium into host cell;negative regulation of low-density lipoprotein particle receptor biosynthetic process;positive regulation of cell proliferation;integrin-mediated signaling pathway;regulation of apoptotic cell clearance;entry of symbiont into host cell by promotion of host phagocytosis;negative regulation of macrophage derived foam cell differentiation;angiogenesis;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;negative regulation of lipid transport;negative regulation of lipoprotein metabolic process;positive regulation of osteoblast proliferation;cell-matrix adhesion;negative regulation of lipid storage;axon guidance;ERK1 and ERK2 cascade;positive regulation of cell adhesion;leukocyte migration",alphav-beta3 integrin-IGF-1-IGF1R complex;integrin complex;external side of plasma membrane;cell surface;phagocytic vesicle,,,,,,,,,,,,,,
10990,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),DEEGLLTHSEEEL,_TRDDGDEEGLLT(ph)HS(ph)EEELEHSQDTDADDGALQ_,T287,,25.98,23.85,23.85,,26.41,,,,,,,,,25.02,0.96,-1.17,-1.17, ,1.38, , , , , , , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
10991,Q9UKM9,RALY,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),LEHSQDTDADDGA,_TRDDGDEEGLLTHS(ph)EEELEHS(ph)QDT(ph)DADDGALQ_,T299,,27.81,,,,23.98,,,,,23.90,,,,25.23,2.58, , , ,-1.24, , , , ,-1.33, , , ,"mRNA splicing, via spliceosome",catalytic step 2 spliceosome,,,,,,,,,,,,,,
10993,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PEKKEKTPELPEP,_T(ph)PELPEPSVK_,T220,+,29.34,29.92,29.77,29.47,29.68,29.81,30.12,29.20,30.48,30.99,29.52,29.86,29.95,29.86,-0.52,0.06,-0.08,-0.38,-0.18,-0.05,0.27,-0.65,0.63,1.14,-0.33,0.00,0.10,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
10995,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),PEPKKETESEAED,_KET(ph)ES(ph)EAEDNLDDLEK_,T884,+,28.87,26.05,26.62,24.96,28.36,27.69,26.85,27.01,27.01,28.18,25.90,27.25,26.17,26.99,1.87,-0.94,-0.38,-2.03,1.37,0.70,-0.14,0.01,0.01,1.19,-1.10,0.26,-0.83,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
11000,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),IRRVSRTPEPKKI,_RVS(ph)RT(ph)PEPK_,T739,+,26.09,26.24,24.29,27.26,22.39,19.95,18.43,19.62,,,,,,23.03,3.06,3.21,1.26,4.23,-0.64,-3.09,-4.61,-3.41, , , , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
11003,P51114,FXR1,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),KEKGYATDESTVS,_GYAT(ph)DESTVSSVQGSR_,T313,,,21.90,,23.88,,,,,,,,,,22.89, ,-0.99, ,0.99, , , , , , , , , ,cell differentiation;negative regulation of translation;apoptotic process;muscle organ development,nucleolus;polysome;costamere;cytoplasm,,,,,,,,,,,,,,
11005,Q9UKV3,ACIN1,Apoptotic chromatin condensation inducer in the nucleus (Acinus),TASEEETPPPLLT,_ASLVALPEQTASEEET(ph)PPPLLTK_,T316,,25.29,23.61,,,25.16,,25.96,,27.25,26.67,,,,25.66,-0.37,-2.05, , ,-0.50, ,0.31, ,1.60,1.01, , , ,positive regulation of monocyte differentiation;apoptotic chromosome condensation;erythrocyte differentiation,cytosol;nuclear speck;nucleus,SAP-domain,,,,,,,,,+,,,,
11006,Q6ZMJ2,SCARA5,Scavenger receptor class A member 5 (Scavenger receptor hlg),_MLNAVTEDLRLK,_(ac)M(ox)LNAVT(ph)EDLR_,T6,,,24.49,,24.15,,,,,,,,,,24.32, ,0.17, ,-0.17, , , , , , , , , ,cellular iron ion homeostasis;protein homotrimerization;iron ion transmembrane transport;cellular response to heat,integral to plasma membrane;cell surface,,,,,,,,,,,,,,
11007,Q9BT70,SORBS3,SORBS3 protein (Fragment),TDLGGQTSPRRTG,_SPADPTDLGGQT(ph)SPR_,T159,,26.62,,,27.31,26.96,,,26.25,24.88,24.32,25.08,26.10,,25.94,0.68, , ,1.37,1.03, , ,0.31,-1.06,-1.62,-0.86,0.16, ,,,,,,,,,,,,,,,,
11012,Q9BZ29,DOCK9,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1),HDRKSQTLPVSRN,_SQT(ph)LPVSR_,T17,,24.70,20.40,,,23.80,21.73,24.18,,,23.46,22.55,28.70,24.46,23.77,0.92,-3.38, , ,0.03,-2.04,0.41, , ,-0.32,-1.22,4.93,0.68,blood coagulation;small GTPase mediated signal transduction,cytosol;endomembrane system;membrane,,,,,,,,,,,,,,
11013,Q8IYB3,SRRM1,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),SVSPGRTSVTKHK,_VSVS(ph)PGRT(ph)SVTK_,T435,,25.19,23.86,22.97,22.70,,,,,,24.66,,,,23.88,1.32,-0.02,-0.91,-1.17, , , , , ,0.78, , , ,"mRNA export from nucleus;mRNA 3'-end processing;termination of RNA polymerase II transcription;mRNA splicing, via spliceosome",nucleoplasm;cytosol;nuclear speck;nuclear matrix;catalytic step 2 spliceosome,,,,,,,,,,,,,,
11014,Q15154,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),DGAGAETPVIENR,_IIEDGDGAGAET(ph)PVIENR_,T1557,,23.06,,,,23.38,23.08,22.09,22.40,23.05,22.70,22.64,,23.59,22.89,0.18, , , ,0.49,0.19,-0.80,-0.49,0.16,-0.19,-0.24, ,0.70,centrosome organization;microtubule anchoring;negative regulation of neurogenesis;interkinetic nuclear migration;neuronal stem cell maintenance;microtubule anchoring at centrosome;protein localization to centrosome;G2/M transition of mitotic cell cycle;cilium assembly,nuclear membrane;cytosol;pericentriolar material;centriolar satellite,,,,,,,,,,,,,,
11017,Q8WUY3,PRUNE2,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),SEGHPETPVDGDL,_LTLSEGHPET(ph)PVDGDLGK_,T2335,,23.14,,,,21.05,,,,,24.85,24.68,23.28,,23.40,-0.26, , , ,-2.35, , , , ,1.45,1.28,-0.12, ,apoptotic process,Golgi apparatus;nucleus,,,,,,,,,,,,,,
11019,P27816,MAP4,Microtubule-associated protein 4 (MAP-4),TLANNVTPAKDVP,_DGVLTLANNVT(ph)PAK_,T588,+,,26.73,26.73,25.55,,23.46,27.22,24.23,25.90,25.61,25.26,26.84,25.47,25.73, ,1.00,1.00,-0.18, ,-2.27,1.49,-1.49,0.18,-0.11,-0.47,1.11,-0.25,mitotic spindle organization;establishment of spindle orientation;microtubule sliding;cell division,plasma membrane;microtubule associated complex;microtubule;mitotic spindle;cytoplasm,,,,,,,,,,,,,,
11022,Q9P0K7,RAI14,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),SSPRSITSTPLSG,_SIT(ph)STPLSGK_,T266,+,24.22,23.55,23.55,25.48,,24.49,24.63,25.11,25.50,23.61,24.79,24.23,,24.47,-0.25,-0.92,-0.92,1.01, ,0.02,0.16,0.64,1.03,-0.86,0.33,-0.24, ,,cell cortex;mitochondrion;cytoskeleton,,,,,,,,,,,,,,
11024,Q12906,ILF3,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),VVEAVSTPSAAFP,_PAVVAPAPVVEAVST(ph)PSAAFPSDATAENVK_,T504,,26.13,,,,,,,,,26.50,,,,26.32,-0.19, , , , , , , , ,0.19, , , ,"positive regulation of transcription, DNA-dependent;transcription, DNA-dependent;negative regulation of transcription, DNA-dependent;M phase",mitochondrion;ribonucleoprotein complex;nucleolus;nucleus,Other TF domain,,,,,,,,,,,,,
11025,Q8NBP0,TTC13,Tetratricopeptide repeat protein 13 (TPR repeat protein 13),LPIMKVTLASEWQ,_VT(ph)LAS(ph)EWQSMFLEEK_,T97,,,,,,,,23.27,,21.94,,,,22.15,22.45, , , , , , ,0.82, ,-0.51, , , ,-0.30,,,,,,,,,,,,,,,,
11027,A0FGR8,ESYT2,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),ISVKEPTPSIASD,_EPT(ph)PSIASDISLPIATQELR_,T716,,23.98,,,,,,,,,,,,,23.98,0.00, , , , , , , , , , , , ,,integral to membrane;plasma membrane,,,,,,,,,,,,,,
11031,O15027,SEC16A,Protein transport protein Sec16A (SEC16 homolog A),GKFANLTPSRTVP,_FANLT(ph)PSR_,T2054,,23.59,,,22.03,20.46,23.49,22.25,22.68,,,,,,22.42,1.17, , ,-0.39,-1.96,1.07,-0.17,0.27, , , , , ,COPII vesicle coating;endoplasmic reticulum organization;protein transport,cytosol;endoplasmic reticulum membrane;Golgi membrane,,,,,,,,,,,,,,
11032,Q03252,LMNB2,Lamin-B2,RAGGPATPLSPTR,_AGGPAT(ph)PLSPTR_,T34,+,24.71,25.44,,24.00,25.55,25.15,24.59,,24.88,24.27,,,24.98,24.84,-0.13,0.60, ,-0.84,0.71,0.31,-0.25, ,0.04,-0.57, , ,0.14,,intermediate filament;nuclear inner membrane;nuclear lamina,,,,,,,,,,,,,,
11033,P32245,MC4R,Melanocortin receptor 4 (MC4-R),THHGMHTSLHLWN,_(ac)VNSTHHGMHT(ph)S(ph)LHLWNR_,T11,,25.36,26.20,24.37,25.41,,,28.85,28.51,26.90,,,24.08,29.15,26.54,-1.17,-0.33,-2.17,-1.13, , ,2.32,1.98,0.36, , ,-2.46,2.61,insulin secretion;energy reserve metabolic process;positive regulation of bone resorption;response to insulin stimulus;adenylate cyclase-modulating G-protein coupled receptor signaling pathway;positive regulation of cAMP biosynthetic process;diet induced thermogenesis;feeding behavior,integral to membrane;plasma membrane,,,,,,,,,,,,,,
11034,Q16555,DPYSL2,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),VCEVSVTPKTVTP,_GLYDGPVCEVSVT(ph)PK_,T565,+,,22.43,22.77,23.87,23.75,23.60,24.74,24.83,23.34,,,,23.32,23.63, ,-1.20,-0.86,0.24,0.12,-0.03,1.12,1.21,-0.29, , , ,-0.30,synaptic vesicle transport;regulation of neuron differentiation;spinal cord development;response to drug;pyrimidine nucleobase catabolic process;response to amphetamine;nucleobase-containing compound metabolic process;axon guidance;positive regulation of glutamate secretion;signal transduction;olfactory bulb development;response to cocaine;cytoskeleton organization,neuronal cell body;growth cone;cytosol;mitochondrion;terminal button;protein complex;dendrite,,,,,,,,,,,,,,
11035,Q16555,DPYSL2,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),VTPKTVTPASSAK,_TVT(ph)PASSAKT(ph)SPAKQQAPPVR_,T570,+,20.77,24.58,24.58,25.00,24.50,,21.57,22.98,20.97,,,20.74,,22.86,-2.08,1.73,1.73,2.15,1.65, ,-1.29,0.12,-1.88, , ,-2.12, ,synaptic vesicle transport;regulation of neuron differentiation;spinal cord development;response to drug;pyrimidine nucleobase catabolic process;response to amphetamine;nucleobase-containing compound metabolic process;axon guidance;positive regulation of glutamate secretion;signal transduction;olfactory bulb development;response to cocaine;cytoskeleton organization,neuronal cell body;growth cone;cytosol;mitochondrion;terminal button;protein complex;dendrite,,,,,,,,,,,,,,
11036,Q16555,DPYSL2,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),PASSAKTSPAKQQ,_TVT(ph)PASSAKT(ph)SPAKQQAPPVR_,T577,+,,,,23.94,24.67,20.18,21.27,22.44,,19.26,20.04,,,21.69, , , ,2.25,2.98,-1.51,-0.42,0.75, ,-2.42,-1.64, , ,synaptic vesicle transport;regulation of neuron differentiation;spinal cord development;response to drug;pyrimidine nucleobase catabolic process;response to amphetamine;nucleobase-containing compound metabolic process;axon guidance;positive regulation of glutamate secretion;signal transduction;olfactory bulb development;response to cocaine;cytoskeleton organization,neuronal cell body;growth cone;cytosol;mitochondrion;terminal button;protein complex;dendrite,,,,,,,,,,,,,,
11038,Q9BZ29,DOCK9,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1),__MGCTTSVILFK,_(ac)MGCTT(ph)S(ph)VILFK_,T5,,22.25,23.64,23.32,23.55,23.13,24.66,24.71,24.09,23.46,23.69,24.70,25.89,25.13,24.02,-1.77,-0.38,-0.69,-0.47,-0.88,0.64,0.70,0.08,-0.56,-0.33,0.69,1.87,1.12,blood coagulation;small GTPase mediated signal transduction,cytosol;endomembrane system;membrane,,,,,,,,,,,,,,
11039,Q86X29,LSR,Lipolysis-stimulated lipoprotein receptor,DALDDLTPPSTAE,_SVDALDDLT(ph)PPSTAESGSR_,T439,,25.45,23.08,22.80,,,,,,,24.18,,,,23.88,1.57,-0.80,-1.08, , , , , , ,0.30, , , ,liver development;embryo development;regulation of lipid metabolic process,low-density lipoprotein particle;integral to membrane;plasma membrane;very-low-density lipoprotein particle;chylomicron,,,,,,,,,,,,,,
11041,Q5XQN5,KRT5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",GGRSFSTASAITP,_SFST(ph)ASAITPSVSR_,T19,,21.39,27.63,28.32,20.83,21.63,,,,,23.78,,,,23.93,-2.54,3.70,4.39,-3.09,-2.30, , , , ,-0.15, , , ,,,,,,,,,,,,,,,,
11042,Q5XQN5,KRT5,"Keratin, type II cytoskeletal 5 (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",STASAITPSVSRT,_SFSTASAIT(ph)PSVSR_,T24,,21.75,,,,,,,,,,,,,21.75,0.00, , , , , , , , , , , , ,,,,,,,,,,,,,,,,
11043,Q6IFX2,Krt42,"Keratin, type I cytoskeletal 42 (Cytokeratin-42) (CK-42) (Keratin-17n) (Keratin-42) (K42) (Type I keratin Ka22)",GGSEKETMQNLND,_ET(ph)MQNLNDR_,T97,,20.40,24.31,22.91,23.41,22.31,24.42,23.25,25.36,,,26.59,23.60,,23.66,-3.26,0.66,-0.74,-0.24,-1.34,0.76,-0.41,1.71, , ,2.93,-0.06, ,,intermediate filament;cytoplasm,,,,,,,,,,,,,,
11056,O00148,DDX39A,ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49),ENDLLDYDEEEEP,_AEQDVENDLLDY(ph)DEEEEPQAPQESTPAPPKK_,Y13,,,,,,25.63,26.56,25.96,26.11,,,,25.81,26.86,26.15, , , , ,-0.53,0.41,-0.20,-0.05, , , ,-0.34,0.71,"mRNA export from nucleus;mRNA splicing, via spliceosome",nucleus;cytoplasm,,,,,,,,,,,,,,
11058,O00461,GOLIM4,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",KGREEHYEEEEEE,_GREEHY(ph)EEEEEEEEDGAAVAEK_,Y673,+,,,,,24.40,26.66,24.89,24.95,25.57,24.06,25.27,25.32,27.18,25.37, , , , ,-0.96,1.29,-0.48,-0.42,0.20,-1.31,-0.09,-0.05,1.81,transport,Golgi cisterna membrane;endosome membrane;endocytic vesicle;integral to membrane;nucleus;Golgi lumen;cis-Golgi network,,,,,,,,,,,,,,
11060,O15230,LAMA5,Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha),IKALGKYVDLKRL,_Y(ph)VDLKR_,Y3100,,22.64,25.94,25.94,24.86,24.29,22.94,,24.05,24.07,22.72,23.93,23.13,22.99,23.96,-1.32,1.98,1.98,0.90,0.33,-1.02, ,0.09,0.11,-1.24,-0.03,-0.82,-0.97,embryo development;focal adhesion assembly;morphogenesis of a polarized epithelium;lung development;branching involved in salivary gland morphogenesis;hair follicle development;substrate adhesion-dependent cell spreading;integrin-mediated signaling pathway;cilium assembly;cytoskeleton organization;muscle organ development;regulation of cell migration;angiogenesis;cell migration;regulation of embryonic development;regulation of cell adhesion;neural crest cell migration;regulation of cell proliferation;branching involved in ureteric bud morphogenesis;cell proliferation;odontogenesis of dentin-containing tooth;morphogenesis of embryonic epithelium;endothelial cell differentiation;establishment of protein localization to plasma membrane;cell recognition,laminin-1 complex;extracellular space;laminin-10 complex;laminin-11 complex,,,,,,,,,,,,,,
11061,O43852,CALU,Calumenin (Crocalbin) (IEF SSP 9302),DAQSFDYDHDAFL,_VHNDAQS(ph)FDY(ph)DHDAFLGAEEAK_,Y47,+,25.91,,,24.40,24.19,25.04,26.09,23.88,25.73,24.31,24.11,26.76,29.26,25.43,0.48, , ,-1.03,-1.24,-0.38,0.66,-1.55,0.30,-1.12,-1.32,1.34,3.84,platelet degranulation;platelet activation,extracellular region;Golgi apparatus;endoplasmic reticulum;sarcoplasmic reticulum lumen;melanosome,,,,,,,,,,,,,,
11063,P06241,FYN,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn),LIEDNEYTARQGA,_LIEDNEY(ph)TAR_,Y426,+,24.71,22.60,22.74,23.42,,,22.58,22.04,,,,24.13,,23.18,1.54,-0.58,-0.44,0.24, , ,-0.59,-1.13, , , ,0.96, ,intracellular protein kinase cascade;negative regulation of gene expression;protein autophosphorylation;T cell costimulation;calcium ion transport;response to drug;neuron migration;dendrite morphogenesis;activated T cell proliferation;detection of mechanical stimulus involved in sensory perception of pain;peptidyl-tyrosine phosphorylation;forebrain development;viral reproduction;cellular response to growth factor stimulus;response to ethanol;virus-host interaction;regulation of defense response to virus by virus;regulation of cell shape;platelet activation;axon guidance;negative regulation of protein catabolic process;T cell receptor signaling pathway;cellular response to peptide hormone stimulus;feeding behavior;learning;leukocyte migration,endosome;cytosol;mitochondrion;plasma membrane;nucleus,,+,,,,,,,,,,,,
11064,P06493,CDK1,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),KIGEGTYGVVYKG,_IGEGT(ph)Y(ph)GVVYK_,Y15,+,26.35,26.49,27.37,25.96,26.48,22.97,27.50,26.19,24.13,25.09,,23.80,24.60,25.58,0.77,0.92,1.79,0.38,0.90,-2.60,1.92,0.62,-1.45,-0.49, ,-1.78,-0.98,"response to cadmium ion;negative regulation of apoptotic process;cellular response to hydrogen peroxide;fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;response to toxin;Ras protein signal transduction;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;DNA repair;positive regulation of protein import into nucleus, translocation;insulin receptor signaling pathway;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;cell cycle checkpoint;positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;cell division;response to amine stimulus;protein localization to kinetochore;activation of MAPK activity;cell migration;regulation of embryonic development;TRIF-dependent toll-like receptor signaling pathway;cell aging;pronuclear fusion;epidermal growth factor receptor signaling pathway;regulation of Schwann cell differentiation;positive regulation of mitotic cell cycle;organ regeneration;nerve growth factor receptor signaling pathway;response to organic cyclic compound;DNA replication;toll-like receptor 1 signaling pathway;positive regulation of DNA replication;positive regulation of cardiac muscle cell proliferation;regulation of transcription involved in G1/S phase of mitotic cell cycle;response to drug;chromosome condensation;response to axon injury;Toll signaling pathway;ventricular cardiac muscle cell development;stress-activated MAPK cascade;response to activity;apoptotic process;activation of MAPKK activity;response to ethanol;mitotic cell cycle G2/M transition DNA damage checkpoint;toll-like receptor 3 signaling pathway;positive regulation of gene expression;protein complex assembly;axon guidance;innate immune response;centrosome cycle;G2/M transition of mitotic cell cycle;mitosis;response to copper ion",spindle microtubule;nucleoplasm;cytosol;mitochondrion;midbody;microtubule organizing center,,+,,,,,,,,,,,,
11066,P24941,CDK2,Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase),KIGEGTYGVVYKA,_IGEGT(ph)Y(ph)GVVYK_,YNaN,+,26.35,26.42,27.37,25.96,26.05,,27.50,26.01,23.89,24.68,,23.80,24.13,25.65,0.70,0.77,1.72,0.31,0.40, ,1.85,0.36,-1.77,-0.97, ,-1.85,-1.53,"S phase of mitotic cell cycle;positive regulation of DNA-dependent DNA replication initiation;regulation of gene silencing;Ras protein signal transduction;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process;G1/S transition of mitotic cell cycle;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA repair;blood coagulation;centrosome duplication;positive regulation of cell proliferation;cell division;regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle;potassium ion transport;M/G1 transition of mitotic cell cycle;G2/M transition of mitotic cell cycle;meiosis;positive regulation of transcription, DNA-dependent;mitosis;cellular response to nitric oxide;histone phosphorylation;DNA replication;G2 phase of mitotic cell cycle","endosome;cyclin-dependent protein kinase holoenzyme complex;X chromosome;centrosome;Cajal body;Y chromosome;condensed chromosome;cytosol;chromosome, telomeric region;transcription factor complex",,+,,,,,,,,,,,,
11068,P27361,MAPK3,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),TGFLTEYVATRWY,_IADPEHDHTGFLT(ph)EY(ph)VATR_,Y204,,24.62,,,,,,,,,,,,,24.62,0.00, , , , , , , , , , , , ,fibroblast growth factor receptor signaling pathway;toll-like receptor 4 signaling pathway;sensory perception of pain;positive regulation of ERK1 and ERK2 cascade;Ras protein signal transduction;positive regulation of histone phosphorylation;negative regulation of apolipoprotein binding;regulation of sequence-specific DNA binding transcription factor activity;cellular response to mechanical stimulus;insulin receptor signaling pathway;caveolin-mediated endocytosis;toll-like receptor 2 signaling pathway;MyD88-dependent toll-like receptor signaling pathway;regulation of stress-activated MAPK cascade;JAK-STAT cascade involved in growth hormone signaling pathway;platelet activation;activation of MAPK activity;TRIF-dependent toll-like receptor signaling pathway;regulation of cytoskeleton organization;epidermal growth factor receptor signaling pathway;nerve growth factor receptor signaling pathway;cell cycle;toll-like receptor 1 signaling pathway;response to exogenous dsRNA;positive regulation of histone acetylation;Toll signaling pathway;stress-activated MAPK cascade;apoptotic process;activation of MAPKK activity;regulation of Golgi inheritance;organ morphogenesis;virus-host interaction;positive regulation of transcription from RNA polymerase II promoter;transcription initiation from RNA polymerase I promoter;toll-like receptor 3 signaling pathway;regulation of early endosome to late endosome transport;response to DNA damage stimulus;axon guidance;interleukin-1-mediated signaling pathway;innate immune response;lipopolysaccharide-mediated signaling pathway;BMP signaling pathway;cartilage development;peptidyl-tyrosine autophosphorylation,nucleoplasm;mitochondrion;late endosome;Golgi apparatus;pseudopodium;early endosome;caveola;cytosol;microtubule cytoskeleton;focal adhesion,,+,,,,,,,,,,,,
11071,P49840,GSK3A,Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1),GEPNVSYICSRYY,_QLVRGEPNVSY(ph)ICSR_,Y216,+,23.19,25.67,25.75,22.11,24.92,25.75,26.44,26.06,25.92,25.46,25.52,26.54,25.06,25.26,-2.07,0.41,0.49,-3.15,-0.34,0.49,1.18,0.80,0.66,0.19,0.26,1.28,-0.20,fibroblast growth factor receptor signaling pathway;regulation of systemic arterial blood pressure;positive regulation of peptidyl-threonine phosphorylation;cellular response to organic cyclic compound;cellular response to lithium ion;insulin receptor signaling pathway;Wnt receptor signaling pathway;negative regulation of glucose import;positive regulation of glycogen (starch) synthase activity;negative regulation of TOR signaling cascade;negative regulation of type B pancreatic cell development;cell migration;negative regulation of glycogen (starch) synthase activity;negative regulation of UDP-glucose catabolic process;epidermal growth factor receptor signaling pathway;activation of signaling protein activity involved in unfolded protein response;nerve growth factor receptor signaling pathway;nervous system development;positive regulation of peptidyl-serine phosphorylation;glycogen metabolic process;negative regulation of canonical Wnt receptor signaling pathway;positive regulation of heart contraction;negative regulation of glycogen biosynthetic process;cardiac left ventricle morphogenesis;hypermethylation of CpG island;positive regulation of protein catabolic process;positive regulation of cAMP biosynthetic process;phosphatidylinositol-mediated signaling;positive regulation of transcription from RNA polymerase II promoter;negative regulation of insulin receptor signaling pathway;negative regulation of cell growth involved in cardiac muscle cell development;positive regulation of adrenergic receptor signaling pathway;regulation of gene expression by genetic imprinting,cytosol;beta-catenin destruction complex,,+,,,,,,,,,,,,
11073,Q06124,PTPN11,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),IQNTGDYYDLYGG,_IQNTGDY(ph)YDLYGGEK_,Y62,,22.41,,,,,,24.09,24.59,,23.49,,24.49,,23.81,-1.40, , , , , ,0.28,0.77, ,-0.32, ,0.67, ,negative regulation of growth hormone secretion;fibroblast growth factor receptor signaling pathway;T cell costimulation;hormone metabolic process;interferon-gamma-mediated signaling pathway;blood coagulation;glucose homeostasis;positive regulation of glucose import in response to insulin stimulus;insulin receptor signaling pathway;regulation of protein export from nucleus;multicellular organismal reproductive process;positive regulation of hormone secretion;regulation of cell adhesion mediated by integrin;activation of MAPK activity;negative regulation of cortisol secretion;type I interferon-mediated signaling pathway;organ growth;axon guidance;DNA damage checkpoint;regulation of type I interferon-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;epidermal growth factor receptor signaling pathway;negative regulation of insulin secretion;ephrin receptor signaling pathway;triglyceride metabolic process;nerve growth factor receptor signaling pathway;regulation of multicellular organism growth;hormone-mediated signaling pathway;leukocyte migration,cytosol;mitochondrion;protein complex,,,+,+,,,,,,,,,,
11074,Q13523,PRPF4B,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),DNDITPYLVSRFY,_LCDFGSASHVADNDITPY(ph)LVSR_,Y849,+,26.83,23.45,23.85,22.88,26.92,24.49,25.84,,27.62,27.42,25.46,26.27,,25.55,1.28,-2.10,-1.70,-2.66,1.37,-1.06,0.29, ,2.07,1.87,-0.09,0.72, ,"mRNA splicing, via spliceosome",chromosome;catalytic step 2 spliceosome,,+,,,,,,,,,,,,
11075,Q13627,DYRK1A,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),GQRIYQYIQSRFY,_IYQY(ph)IQSR_,Y321,+,27.25,27.38,27.25,28.03,26.36,27.37,27.11,27.48,27.09,26.62,25.94,25.94,25.95,26.90,0.35,0.47,0.35,1.12,-0.55,0.46,0.21,0.57,0.19,-0.29,-0.97,-0.97,-0.96,"peptidyl-tyrosine phosphorylation;protein autophosphorylation;mitotic cell cycle;peptidyl-threonine phosphorylation;positive regulation of protein deacetylation;nervous system development;negative regulation of DNA damage response, signal transduction by p53 class mediator",ribonucleoprotein complex;nuclear speck,,+,,,,,,,,,,,,
11077,Q7Z3U7,MON2,Protein MON2 homolog (Protein SF21),QDVLHRYIEDERL,_Y(ph)IEDER_,Y1622,,25.32,27.13,26.01,26.48,,,,,20.75,,21.80,,,24.58,0.74,2.55,1.42,1.90, , , , ,-3.83, ,-2.78, , ,protein transport;Golgi to endosome transport;actin cytoskeleton organization,trans-Golgi network,,,,,,,,,,,,,,
11080,Q8NBJ4,GOLM1,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),LRGEDDYNMDENE,_LRGEDDY(ph)NM(ox)DENEAESETDK_,Y341,,,26.14,26.14,25.62,25.92,27.11,26.70,26.04,26.12,,26.34,,27.86,26.40, ,-0.26,-0.26,-0.78,-0.48,0.71,0.30,-0.35,-0.28, ,-0.06, ,1.46,,Golgi apparatus;integral to plasma membrane,,,,,,,,,,,,,,
11086,Q96QL0,RPL3,Ribosomal protein L3,NNASTDYDLPDKS,_NNASTDY(ph)DLPDK_,Y307,,25.13,23.05,23.05,22.66,25.53,25.04,25.49,25.40,25.01,24.58,24.65,25.62,24.59,24.60,0.53,-1.55,-1.55,-1.94,0.93,0.44,0.89,0.80,0.41,-0.02,0.05,1.02,-0.01,translation,ribosome,,,,,,,,,,,,,,